eHDSI Terminologies
0.1.0 - ci-build
eHDSI Terminologies, published by HL7 Europe. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/EHDSI-Terminology-package/ and changes regularly. See the Directory of published versions
| Official URL: http://hl7europe.org/fhir/terminology/ehdsi/ValueSet/eHDSILabCode | Version: 0.1.0 | |||
| Draft as of 2024-11-03 | Computable Name: eHDSILabCode | |||
| Other Identifiers: UUID:eHDSILabCode | ||||
This Value Set is used for the standard laboratory codes
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Generated Narrative: ValueSet eHDSILabCode
http://loinc.org/| Code | Display |
| 1945-5 | Beta glucuronidase [Enzymatic activity/volume] in Urine |
| 20400-8 | Smooth nuclear envelope nuclear Ab pattern [Titer] in Serum |
| 20586-4 | CD1 cells/100 cells in Specimen |
| 20623-5 | Coproporphyrin [Mass/volume] in 24 hour Urine |
| 2098-2 | Cholinesterase [Enzymatic activity/volume] in Serum or Plasma |
| 21006-2 | Hepatitis B virus surface Ab [Units/volume] in Serum from Donor by Immunoassay |
| 101213-7 | Hantavirus dobrava [Presence] in Serum or Plasma by Line blot |
| 13320-7 | Ova and parasites identified in Stool by Light microscopy--3rd specimen |
| 1414-2 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst |
| 14313-1 | Tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method |
| 102943-8 | Gerbil hair IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14498-0 | Virus identified in Urethra by Immunofluorescence |
| 14739-7 | Gastrin [Moles/volume] in Serum or Plasma --2 minutes post 0.2 U/kg secretin |
| 104384-3 | Dengue virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 10587-4 | Sexual abstinence duration |
| 15407-0 | Methanol [Presence] in Meconium |
| 16582-9 | Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 16855-9 | Fat [Mass/time] in 48 hour Stool |
| 1695-6 | 5-Hydroxyindoleacetate [Mass/time] in 24 hour Urine |
| 17195-9 | CD77 cells/100 cells in Blood |
| 61190-5 | Prothrombin time (PT) in Platelet poor plasma from Fetus by Coagulation assay |
| 93464-6 | p-Fluorofentanyl [Mass/volume] in Urine by Confirmatory method |
| 61223-4 | Crawfish IgE Ab/IgE total in Serum |
| 62357-9 | Chromosome analysis overall interpretation Qualitative |
| 94286-2 | Contactin-associated protein 2 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 63108-5 | Pecan or Hickory Nut IgG Ab [Mass/volume] in Serum |
| 78827-3 | fentaNYL cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 94474-4 | VEGFA gene c.-634C>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 63408-9 | DNA double strand Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 6499-8 | Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid by Immunoassay |
| 78876-0 | Pheniramine [Presence] in Urine |
| 6898-1 | dilTIAZem [Mass/volume] in Serum or Plasma |
| 8095-2 | Smooth muscle Ab [Titer] in Serum |
| 81099-4 | Leptospira interrogans sv Bulgarica Ab [Titer] in Serum by Agglutination |
| 96974-1 | PALB2 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 69841-5 | 2-Hydroxyadipate [Moles/volume] in Serum or Plasma |
| 81628-0 | Methotrexate monoglutamate [Moles/volume] in Red Blood Cells |
| 70164-9 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Vaginal fluid by NAA with probe detection |
| 8252-9 | Service comment 10 |
| 7205-8 | Cheese cheddar type triggered histamine release [Units/volume] in Blood |
| 7208-2 | Cream Cheese triggered histamine release [Units/volume] in Blood |
| 72410-4 | Testosterone [Moles/volume] in Serum or Plasma --pre dose HCG |
| 99444-2 | Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgG4 Ab [Mass/volume] in Serum |
| 99896-3 | Calcium oxalate monohydrate crystals [#/volume] in Urine sediment by Computer assisted method |
| 85970-2 | Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum --2nd specimen |
| 86049-4 | Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum --2nd specimen |
| 86207-8 | Porcine epidemic diarrhea virus IgG Ab [Presence] in Serum by Immunofluorescence |
| 86222-7 | Lipoprotein.alpha 3 [Moles/volume] in Serum |
| 73293-3 | Losartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7337-9 | Gladiolus IgE Ab [Units/volume] in Serum |
| 87493-3 | AB-FUBINACA oxobutanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 73524-1 | Amoxicillin+Clavulanate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88514-5 | Natural killer cell cytotoxicity.1.88:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
| 74331-0 | MICA*024 IgG Ab [Presence] in Serum |
| 5936-0 | Benzoylecgonine [Mass/mass] in Hair |
| 5967-5 | Plasmin inhibitor Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 50800-2 | Acetone [Moles/volume] in Body fluid |
| 50999-2 | Leishmania donovani IgG and IgM [Interpretation] in Serum |
| 30421-2 | Lymphocytes/100 leukocytes in Bronchial specimen |
| 30530-0 | Intrinsic factor Ab [Presence] in Serum |
| 31052-4 | Coxsackievirus A16 Ab [Titer] in Body fluid by Complement fixation |
| 31138-1 | Cefotaxime [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC) |
| 4176-4 | Chlormerodrin [Mass] of Dose |
| 42241-0 | Cocaine+Benzoylecgonine [Presence] in Urine by Screen method |
| 42535-5 | Tipranavir [Susceptibility] |
| 59937-3 | Nicotine [Moles/volume] in Gastric fluid |
| 60004-9 | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 21286-0 | Gastrin [Mass/volume] in Serum or Plasma --1.5 hours post 0.2 U/kg secretin |
| 21305-8 | Glucose [Mass/volume] in 24 hour Urine |
| 31587-9 | Rhodococcus equi Ab [Presence] in Serum |
| 21717-4 | NF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21763-8 | HTT gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 31825-3 | Escherichia coli K1 Ag [Presence] in Specimen |
| 226-1 | Doxycycline [Susceptibility] by Disk diffusion (KB) |
| 22698-5 | Alanine/Creatinine [Molar ratio] in Urine |
| 52879-4 | Cytoplasmic CD22 cells/100 cells in Bone marrow |
| 43949-7 | CD2 cells [#/volume] in Cerebral spinal fluid |
| 22905-4 | Bovine herpesvirus 1 Ab [Presence] in Milk |
| 32700-7 | Microscopic observation [Identifier] in Blood by Malaria smear |
| 32843-5 | Epstein Barr virus capsid IgG Ab [Units/volume] in Serum --1st specimen |
| 44649-2 | Grading system in Breast tumor |
| 23397-3 | Rift valley fever virus Ab [Presence] in Serum |
| 33422-7 | Amphiphysin Ab [Presence] in Serum |
| 3345-6 | Diethylpropion [Presence] in Urine |
| 33530-7 | Platelet aggregation EPINEPHrine induced in Control Platelet rich plasma |
| 3361-3 | Atenolol [Mass/volume] in Urine |
| 53574-0 | Lambda light chains.free [Mass/volume] in 24 hour Urine |
| 53712-6 | Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid |
| 44931-4 | Prolactin [Units/volume] in Serum or Plasma --pre dose TRH IV |
| 45021-3 | Metanephrine and Normetanephrine [Interpretation] in Serum or Plasma |
| 23762-8 | Nitrate+Nitrite [Mass/volume] in Specimen |
| 23966-5 | Borrelia burgdorferi IgG Ab [Titer] in Cerebral spinal fluid |
| 54081-5 | Hemoglobinopathies newborn screening panel |
| 45383-7 | Leukocytes [#/area] in Urine sediment by Microscopy low power field |
| 4621-9 | Hemoglobin S [Presence] in Blood |
| 46276-2 | Rh [Type] in Blood--after transfusion reaction |
| 24471-5 | Platelet function (closure time) collagen+EPINEPHrine induced [Time] in Blood |
| 2450-5 | Hydroxyproline Free [Mass/time] in 24 hour Urine |
| 343-4 | Moxalactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 34348-3 | Normetanephrine/Creatinine [Molar ratio] in Urine |
| 55363-6 | Argatroban [Mass/volume] in Platelet poor plasma |
| 55561-5 | Oxprenolol [Moles/volume] in Serum or Plasma |
| 47086-4 | 11-Hydroxyandrostenedione [Moles/volume] in Serum or Plasma |
| 34912-6 | Immature eosinophils [#/volume] in Blood |
| 35405-0 | Leishmania brasilensis IgM Ab [Presence] in Serum |
| 35407-6 | Leishmania mexicana IgM Ab [Presence] in Serum |
| 3570-9 | diphenhydrAMINE [Mass/volume] in Serum or Plasma |
| 48162-2 | Thymidine [Moles/volume] in Serum or Plasma |
| 56665-3 | Taenia solium IgG Ab [Titer] in Serum by Immunofluorescence |
| 27234-4 | Phentermine [Mass/volume] in Vitreous fluid |
| 57461-6 | Activated T cells lymphocytes/100 lymphocytes.small in Bronchial specimen |
| 57532-4 | 17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --2 days post dose dexamethasone |
| 49186-0 | Coxiella burnetii phase 1 IgG Ab [Titer] in Body fluid |
| 49619-0 | Indinavir+Ritonavir [Susceptibility] by Genotype method |
| 29502-2 | 2-Hydroxyglutarate/Creatinine [Molar ratio] in Urine |
| 3974-3 | Pipradrol [Mass/volume] in Urine |
| 58507-5 | C peptide [Moles/volume] in Serum or Plasma --2 minutes post 1 mg glucagon IV |
| 58621-4 | Corticotropin [Moles/volume] in Plasma --pre dose dexamethasone |
| 58626-3 | Corticotropin [Moles/volume] in Plasma --pre dose insulin IV |
| 58712-1 | Quinupristin+Dalfopristin [Susceptibility] by Method for Slow-growing mycobacteria |
| 58768-3 | Gamma glutamyl transferase [Enzymatic activity/time] in 24 hour Urine |
| 49983-0 | Borrelia burgdorferi 37kD IgM Ab [Presence] in Serum by Immunoblot |
| 29627-7 | 3-Hydroxyvalerate [Presence] in Urine |
| 4040-2 | Sulfonamide [Mass/volume] in Serum or Plasma |
| 40472-3 | Tetradecadienoate (C14:2)/Creatinine [Mass Ratio] in Urine |
| 4066-7 | Triamterene [Mass/volume] in Urine |
| 58838-4 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma --baseline |
| 58883-0 | Somatotropin [Mass/volume] in Serum or Plasma --22nd specimen |
| 58969-7 | Ganglioside GD1a IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 50419-1 | Corticotropin [Mass/volume] in Plasma --pre 500 ug dexamethasone PO 2.5 day low dose q6h |
| 30069-9 | Tyrosine [Moles/volume] in Amniotic fluid |
| 41040-7 | Palmitoylcarnitine (C16) [Moles/volume] in Blood |
| 1921-6 | Atrial natriuretic factor [Mass/volume] in Arterial blood |
| 20967-6 | Staphylococcus sp identified in Milk by Organism specific culture |
| 100087-6 | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot |
| 101194-9 | Mesocolic excision plane [Anatomy] in Colorectal cancer specimen |
| 101379-6 | DDIT3 gene rearrangement in Blood or Tissue by FISH |
| 101519-7 | Hemorrhagic enteritis virus Ab [Titer] in Serum by Immunoassay |
| 13228-2 | Eastern equine encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 13268-8 | Mycoplasma pneumoniae Ab [Units/volume] in Serum --1st specimen |
| 1340-9 | Xg sup(a) Ag [Presence] on Red Blood Cells from Donor |
| 101765-6 | Trichophyton benhamiae (yellow) DNA [Presence] in Specimen by NAA with probe detection |
| 13458-5 | Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation |
| 13774-5 | Methylhippurate/Creatinine [Mass Ratio] in Urine |
| 102618-6 | Swine epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103024-6 | Cantaloupe IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10583-3 | Prostaglandin F1 alpha [Moles/volume] in Semen |
| 10605-4 | Spermatozoa Agglutinated/100 spermatozoa in Semen |
| 10987-6 | Fluconazole [Mass/volume] in Serum or Plasma |
| 12212-7 | Epstein Barr virus nuclear IgG Ab [Titer] in Serum by Immunofluorescence |
| 17662-8 | Succinylpurines [Presence] in Urine |
| 1818-4 | Alpha mannosidase [Enzymatic activity/volume] in Serum or Plasma |
| 18228-7 | Glucose-6-Phosphate dehydrogenase [Presence] in Tissue |
| 90332-8 | PRRSV IgA Ab/Positive control in Specimen by Immunoassay |
| 90832-7 | Ma+Ta Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 91805-2 | Mycobacterium leprae DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 76657-6 | Iodine [Mass/mass] in Hair |
| 92821-8 | Allelic frequency in Population |
| 92963-8 | Parainfluenza virus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 93330-9 | Glycoursodeoxycholate [Moles/volume] in Serum or Plasma |
| 61367-9 | Clostridioides difficile DNA [Presence] in Specimen by NAA with probe detection |
| 6141-6 | Hop IgE Ab [Units/volume] in Serum |
| 6164-8 | Virginia Live Oak IgE Ab [Units/volume] in Serum |
| 77101-4 | MRPL18A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77384-6 | Influenza virus B Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
| 77744-1 | HTLV I and II Ab band pattern [Interpretation] in Serum or Plasma |
| 94054-4 | Bacterial katG gene drug resistance mutation [Identifier] by Molecular method |
| 94208-6 | MLYCD gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 78224-3 | RARA gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 78352-2 | Vaccenate (C18:1w7) [Entitic substance] in Red Blood Cells |
| 78436-3 | Primidone and PHENobarbital trough panel - Serum or Plasma |
| 63424-6 | Bacterial enterohemolysin ehlyA gene [Presence] in Specimen by NAA with probe detection |
| 7920-2 | Influenza virus A Ab [Units/volume] in Serum |
| 79300-0 | D- and L-2-hydroxyglutarate pattern [Interpretation] in Serum or Plasma Narrative |
| 95211-9 | Bluetongue virus Ag/Negative control in Serum by Immunoassay |
| 95678-9 | Western equine encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay |
| 66714-7 | Common wasp recombinant (rVes v) 1 IgE Ab [Units/volume] in Serum |
| 66744-4 | Heparin/Body weight [Mass/mass] in Blood |
| 66745-1 | Clot Lysis [Length fraction] in Blood by Thromboelastography --30 minutes post maximum clot amplitude |
| 66746-9 | Specimen type |
| 79564-1 | Mucopolysaccharidosis type I newborn screen interpretation |
| 79629-2 | R-beta aminoisobutyrate [Moles/volume] in Cerebral spinal fluid |
| 95703-5 | West Nile virus IgA Ab [Presence] in Specimen by Immunoassay |
| 96432-0 | Borrelia burgdorferi 49736 IgG bands [#] in Specimen by Immunoblot |
| 68380-5 | Chromatin Ab [Presence] in Serum or Plasma |
| 80676-0 | Escherichia coli O157 rfbE gene [Presence] in Stool by NAA with probe detection |
| 8092-9 | SCL-70 extractable nuclear Ab [Presence] in Serum |
| 81428-5 | Influenza virus A H7 Eurasia RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 96818-0 | English yew IgE Ab [Units/volume] in Serum |
| 69425-7 | Calcium [Mass/volume] in Semen |
| 69797-9 | 1-Hydroxymidazolam [Mass/volume] in Serum or Plasma |
| 70019-5 | Klebsiella oxytoca DNA [Presence] in Blood by NAA with probe detection |
| 81859-1 | GRN gene full mutation analysis in Blood or Tissue by Sequencing |
| 97913-8 | Thrombin peak [Molar amount] in Platelet poor plasma by Chromogenic method --after addition of factor VIII Ab |
| 82486-2 | TRBV19 gene segments/TRBV gene segments.total in Blood |
| 99006-9 | Leptospira interrogans sv Wolffi Ab [Titer] in Serum by Agglutination |
| 72483-1 | BK virus subtype in Serum or Plasma by NAA with probe detection |
| 84889-5 | Extramural vein invasion [Presence] in Colorectal cancer specimen by Light microscopy |
| 87572-4 | Fumonisin B2 [Mass/mass] in Specimen |
| 73558-9 | Staphylococcus aureus and Staphylococcus sp.coagulase negative rRNA [Identifier] by FISH in Positive blood culture |
| 88896-6 | Reboxetine [Mass/volume] in Serum or Plasma |
| 88991-5 | Zotepine [Mass/volume] in Serum or Plasma |
| 59578-5 | Glucagon [Mass/volume] in Serum or Plasma --6th specimen fasting |
| 59740-1 | Silver [Mass/volume] in Red Blood Cells |
| 50688-1 | Plasmodium sp lactate dehydrogenase [Identifier] in Blood |
| 41856-6 | Variola virus DNA [Presence] in Specimen by NAA with probe detection |
| 42358-2 | HLA-B*57:01 [Presence] in Specimen |
| 42488-7 | Aspergillus sp Ab [Titer] in Pleural fluid by Complement fixation |
| 60314-2 | Mefenamate [Moles/volume] in Specimen |
| 2136-0 | Coproporphyrin [Presence] in Urine |
| 31203-3 | 5-Hydroxyindoleacetate [Mass/volume] in 24 hour Urine |
| 31534-1 | Neuronal IgG Ab [Presence] in Body fluid |
| 31548-1 | Parainfluenza virus 1 Ab [Units/volume] in Body fluid |
| 51132-9 | CD23 blasts/100 blasts in Specimen |
| 4301-8 | LORazepam [Mass] of Dose |
| 43190-8 | Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Serum by Immunoassay |
| 21729-9 | PSAP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21753-9 | TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 22200-0 | Chlamydia trachomatis G+F+K IgA Ab [Titer] in Serum |
| 31839-4 | Haemophilus influenzae E Ag [Presence] in Cerebral spinal fluid |
| 43292-2 | Neutrophil oxidative burst/unstimulated in Blood |
| 22371-9 | Junin virus Ab [Presence] in Serum |
| 2261-6 | Estrone (E1).unconjugated [Mass/volume] in Serum or Plasma |
| 5211-8 | Herpes virus 6 IgG Ab [Units/volume] in Serum |
| 22880-9 | Border disease virus Ag [Presence] in Specimen by Immune stain |
| 22939-3 | Brucella ovis Ab [Units/volume] in Serum |
| 22980-7 | Caprine herpesvirus 1 neutralizing antibody [Presence] in Serum by Neutralization test |
| 32762-7 | Epithelial cells [Presence] in Specimen by Wet preparation |
| 32802-1 | Color of Bronchial specimen |
| 53193-9 | Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 53444-6 | Citrate synthase [Enzymatic activity/mass] in Control Leukocytes |
| 23379-1 | Abnormal Prion Protein [Presence] in Brain by Immunoblot |
| 23391-6 | Rabies virus Ag [Presence] in Specimen by Immune stain |
| 23486-4 | Toxoplasma gondii Ab [Presence] in Serum by Latex agglutination |
| 23493-0 | Transmissible gastroenteritis virus Ag [Presence] in Specimen by Neutralization test |
| 33704-8 | Clostridium botulinum toxin A+B+E [Presence] in Specimen by Mouse bioassay neutralization |
| 53840-5 | TGFB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 24020-0 | Streptococcus agalactiae Ag [Presence] in Urine |
| 34189-1 | aPTT.factor substitution in Platelet poor plasma --30M post incubation with normal plasma |
| 4562-5 | Hemoglobin C/Hemoglobin.total in Blood by Electrophoresis alkaline (pH 8.9) |
| 243-6 | Ethambutol [Susceptibility] by Serum bactericidal titer |
| 54943-6 | N-methyldiethanolamine [Mass/volume] in Urine |
| 55559-9 | Norpropoxyphene [Moles/volume] in Serum or Plasma |
| 47095-5 | Acetaminophen [Moles/volume] in Gastric fluid |
| 47476-7 | Reagin Ab [Titer] in Specimen |
| 25221-3 | Imipenem 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25387-2 | Cyanide [Moles/volume] in Serum or Plasma |
| 55632-4 | Cephalothin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
| 55869-2 | Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma |
| 56021-9 | Platelet aggregation thrombin induced ATP secretion [Presence] in Blood --1 U/mL |
| 56264-5 | Glycyphagus domesticus IgG4 Ab [Mass/volume] in Serum |
| 56974-9 | Oligoclonal bands [Interpretation] in Serum or Plasma by Isoelectric focusing |
| 48352-9 | Reboxetine [Moles/volume] in Serum or Plasma |
| 48554-0 | Myocardium Ab [Titer] in Pleural fluid by Immunofluorescence |
| 27067-8 | Propoxyphene [Mass/mass] in Meconium |
| 27165-0 | Hexobarbital [Mass/volume] in Urine |
| 3879-4 | Opiates [Presence] in Urine |
| 39299-3 | Influenza virus A H12 Ab [Titer] in Serum by Hemagglutination inhibition |
| 58072-0 | Rg sup(a) Ab [Presence] in Serum or Plasma |
| 49608-3 | Hepatitis C virus RNA [log units/volume] (viral load) in Tissue by NAA with probe detection |
| 49715-6 | Housefly IgE Ab [Units/volume] in Serum |
| 2933-0 | Secretin [Mass/volume] in Plasma |
| 39780-2 | Urea [Moles/volume] in Peritoneal dialysis fluid |
| 40055-6 | Albumin [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
| 58389-8 | Normeperidine [Mass/volume] in Urine by Confirmatory method |
| 4997-3 | Cytomegalovirus DNA [Presence] in Tissue by Probe |
| 50183-3 | Calcitonin [Mass/volume] in Serum or Plasma --1 minute post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV |
| 30183-8 | Mold Allergen Mix 2 (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Units/volume] in Serum by Multidisk |
| 41016-7 | Bilirubin.total [Moles/volume] in Urine by Test strip |
| 19674-1 | Phentermine [Presence] in Urine by Screen method |
| 12442-0 | Acetaminophen [Mass/volume] in Specimen |
| 12702-7 | Antimony [Presence] in Serum or Plasma |
| 13069-0 | Phosphatidylserine IgA Ab [Units/volume] in Serum |
| 13210-0 | Brucella sp IgG Ab [Units/volume] in Serum |
| 101748-2 | Maraviroc anticipated activity in Blood Qualitative by RT-PCR |
| 102092-4 | HLA-ABDR typing panel - Blood or Tissue |
| 13691-1 | 3-Methylcrotonylglycine/Creatinine [Mass Ratio] in Urine |
| 10246-7 | Oxygen content in Right pulmonary artery |
| 102519-6 | Rough Pigweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14128-3 | Rabies virus Ab [Titer] in Serum |
| 14193-7 | Tripelennamine [Presence] in Urine |
| 102896-8 | Oriental Cockroach IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14749-6 | Glucose [Moles/volume] in Serum or Plasma |
| 103156-6 | CD3 cells recipient derived/Cells.CD3 in Blood by Molecular genetics method --post bone marrow transplant |
| 10366-3 | Cotinine [Mass/volume] in Urine |
| 104266-2 | Immunoglobulins and heavy-light chain panel - Serum or Plasma |
| 15267-8 | Tree Allergen Mix 6 (Boxelder+Silver birch+American beech+White oak+California walnut) IgE Ab [Presence] in Serum by Multidisk |
| 16231-3 | Flurazepam [Mass/volume] in Urine by Confirmatory method |
| 16596-9 | Chlamydia trachomatis IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 12306-7 | Cyclohexane [Mass/volume] in Blood |
| 758-3 | Neutrophils [#/volume] in Peritoneal fluid by Automated count |
| 92952-1 | Staphylococcus aureus DNA [NCncRange] in Sputum by NAA with non-probe detection |
| 62315-7 | Niemann Pick disease A/B newborn screening panel |
| 77391-1 | Parainfluenza virus 2 Ag [Presence] in Nasopharynx by Immunofluorescence |
| 9390-6 | Pyridostigmine [Mass/volume] in Serum or Plasma |
| 624-7 | Bacteria identified in Sputum by Respiratory culture |
| 63104-4 | Cranberry IgG Ab [Mass/volume] in Serum |
| 7852-7 | Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma |
| 94575-8 | Heavy metals panel - 24 hour Urine |
| 7886-5 | Epstein Barr virus capsid IgM Ab [Units/volume] in Serum |
| 9495-3 | Brucella canis IgG Ab [Units/volume] in Serum by Immunoassay |
| 7952-5 | Legionella pneumophila 5 Ab [Titer] in Serum by Immunofluorescence |
| 79603-7 | Beta alanine and Beta aminoisobutyrate and Gamma aminobutyrate panel - Cerebral spinal fluid |
| 80661-2 | Color of Peritoneal dialysis fluid |
| 6926-0 | Ganglioside GM1 IgM Ab [Titer] in Serum |
| 699-9 | Organism count [#/volume] in Specimen by Microscopic count |
| 81729-6 | Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 9735-2 | Uroporphyrin/Porphyrins.total in 24 hour Stool |
| 97610-0 | Bacteroides fragilis DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 97613-4 | Citrobacter sp DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 7160-5 | Brussel Sprouts IgE Ab [Units/volume] in Serum |
| 71880-9 | Methemoglobin/Hemoglobin.total [Pure mass fraction] in Mixed venous blood |
| 85299-6 | BRAF V600E mutant protein [Presence] in Cancer specimen by Immune stain |
| 99445-9 | Bumble Bee IgG4 Ab [Mass/volume] in Serum |
| 72561-4 | Creatine Kinase aberrant band/Creatine kinase.total [Pure catalytic fraction] in Serum or Plasma by Electrophoresis |
| 73460-8 | Celecoxib induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73474-9 | Cefadroxil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73810-4 | CD3-CD16+CD56+HLA-DR+ (activated Natural Killer) cells/100 cells.CD3-CD16+CD56+ (Natural killer) cells in Blood by Flow cytometry (FC) |
| 51035-4 | CD11a blasts [Units/volume] in Blood |
| 42363-2 | Streptococcus pneumoniae 7 serotypes IgG panel A [Mass/volume] - Serum |
| 42639-5 | Immune complex.IgG [Units/volume] in Serum or Plasma by C1q binding assay |
| 31330-4 | Coxsackievirus B4 Ab [Units/volume] in Body fluid |
| 22534-2 | Sarcocystis neurona Ab [Presence] in Serum |
| 22563-1 | Streptococcus pneumoniae IgG Ab [Ratio] in Serum --1st specimen/2nd specimen |
| 22627-4 | Xylose [Mass/time] in 5 hour Urine --post 5 g xylose PO |
| 32068-9 | diphenhydrAMINE+dimenhyDRINATE [Presence] in Specimen |
| 32538-1 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
| 52131-0 | t(9;22)(q34.1;q11)(ABL1,BCR) b3a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
| 5257-1 | Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay |
| 5265-4 | Pancreatic islet cell Ab [Presence] in Serum by Immunofluorescence |
| 52898-4 | Bismuth [Moles/volume] in Urine |
| 52937-0 | Barium/Creatinine [Molar ratio] in 24 hour Urine |
| 44581-7 | HTLV I+II p38 tax Ab [Presence] in Serum by Immunoblot |
| 23535-8 | Trypanosoma sp Ag [Presence] in Blood by Immunoassay |
| 45165-8 | Borrelia burgdorferi IgA Ab [Units/volume] in Serum by Immunofluorescence |
| 45299-5 | Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose lactose PO |
| 24088-7 | Iduronate-2-Sulfatase [Enzymatic activity/mass] in Fibroblast |
| 55477-4 | Estradiol (E2) [Moles/volume] in Serum or Plasma --4 hours post XXX challenge |
| 47387-6 | Neisseria gonorrhoeae DNA [Presence] in Genital specimen by NAA with probe detection |
| 47403-1 | CYP2D6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 25518-2 | Sarcosine [Moles/time] in 24 hour Urine |
| 55797-5 | Platelet aggregation ADP induced [Presence] in Platelet rich plasma --2.5 umol/L |
| 47665-5 | Insulin [Units/volume] in Serum or Plasma --5 minutes post dose glucose |
| 47690-3 | Lysine/Amino acids.total in Hair |
| 35387-0 | Cholesterol. in Lipoprotein (a) [Presence] in Serum or Plasma |
| 48065-7 | Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma |
| 48259-6 | Kentucky blue grass triggered leukotriene release [Mass/volume] by Leukocytes |
| 2646-8 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Serum |
| 26-5 | Amphotericin B [Susceptibility] by Serum bactericidal titer |
| 3716-8 | Lidocaine [Presence] in Urine |
| 56743-8 | Mi-2 Ab [Presence] in Serum by Immunoblot |
| 57020-0 | Urinalysis dipstick W Reflex Microscopic panel - Urine |
| 26821-9 | Lipoprotein.beta [Presence] in Body fluid |
| 26888-8 | Sulfate [Moles/volume] in 24 hour Urine |
| 38474-3 | Acylcarnitine [Moles/volume] in DBS |
| 38583-1 | 1,2-Dibromo-3-Chloropropane [Mass/volume] in Air |
| 57430-1 | CD235a cells/100 cells in Body fluid |
| 5746-3 | Thallium [Mass/time] in 24 hour Urine |
| 57541-5 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --4th specimen post dose gonadotropin releasing hormone |
| 27876-2 | CD14+CD11b+ cells/100 cells in Blood |
| 49344-5 | BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 28648-4 | Oxygen [Partial pressure] in Arterial cord blood |
| 39955-0 | Creatinine [Mass/volume] in Serum or Plasma --pre XXX challenge |
| 29530-3 | Amphetamines [Presence] in Specimen |
| 50409-2 | Cholesterol in HDL 2+3 [Mass/volume] in Serum or Plasma |
| 30294-3 | Nelfinavir [Susceptibility] by Genotype method |
| 40783-3 | Polio virus IgG Ab [Titer] in Cerebral spinal fluid --2nd specimen |
| 40936-7 | Yersinia pseudotuberculosis Ab [Presence] in Serum |
| 20864-5 | Iodine [Mass/volume] in Milk |
| 100795-4 | S100 calcium binding protein B [Mass/volume] in Body fluid |
| 100808-5 | Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge |
| 101067-7 | Cs^b Ab [Presence] in Serum or Plasma |
| 12443-8 | Trimipramine [Mass/volume] in Urine |
| 12707-6 | Thorium [Mass/volume] in Serum or Plasma |
| 12861-1 | Borrelia burgdorferi 88kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 12934-6 | Thyrotropin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 102180-7 | Lactalbumin beta IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13524-4 | Leukocytes other/100 leukocytes in Body fluid by Manual count |
| 14189-5 | Phenyltoloxamine [Mass/volume] in Urine |
| 1465-4 | EPINEPHrine [Mass/volume] in Plasma --supine |
| 10618-7 | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Immunobead |
| 15257-9 | Regional Allergen Mix 2 (Alternaria alternata+Cat dander+American house dust mite+Dog dander+Horse dander) IgE Ab [Presence] in Serum by Multidisk |
| 1570-1 | Insulin [Mass/volume] in Serum or Plasma --baseline |
| 11046-0 | EPINEPHrine [Mass/volume] in Urine |
| 16253-7 | Meperidine [Mass/volume] in Urine by Confirmatory method |
| 16419-4 | azaTHIOprine [Mass/volume] in Serum or Plasma |
| 11206-0 | 18-Hydroxydeoxycorticosterone [Mass/volume] in Serum or Plasma |
| 123-0 | Cefprozil [Susceptibility] by Minimum lethal concentration (MLC) |
| 1712-9 | Prostatic acid phosphatase [Enzymatic activity/volume] in Vaginal fluid |
| 91067-9 | Enterovirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 74812-9 | Mirtazapine [Presence] in Urine |
| 6037-6 | Barley IgE Ab [Units/volume] in Serum |
| 93463-8 | Ocfentanil [Mass/volume] in Urine by Confirmatory method |
| 77638-5 | HLA-DP and DQ and DR (class II) IgG panel [Identifier] - Serum or Plasma by Immunoassay |
| 77680-7 | Renin [Mass/volume] in Plasma --4 hours post XXX challenge |
| 94291-2 | Hydroxybupropion [Presence] in Serum or Plasma by Screen method |
| 63086-3 | Chub Mackerel IgG Ab [Mass/volume] in Serum |
| 94645-9 | SARS-CoV-2 (COVID-19) RdRp gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 6440-2 | Influenza virus A+B+C Ag [Presence] in Throat by Immunofluorescence |
| 95054-3 | EPINEPHrine [Mass/volume] in Plasma --standing |
| 6552-4 | Streptococcus pneumoniae Ab [Presence] in Serum by Immunoassay |
| 9611-5 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum by Immunoassay |
| 6747-0 | Glucose [Presence] in Urine by Test strip --1 hour post 50 g lactose PO |
| 80960-8 | cefTAZidime free [Mass/volume] in Serum or Plasma |
| 69774-8 | Propionylcarnitine (C3) [Moles/volume] in Urine |
| 69942-1 | Glucose [Moles/volume] in Serum or Plasma --40 minutes post dose lactose PO |
| 70010-4 | Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 70056-7 | Hantavirus saaremaa IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 97942-7 | Texture.yeast colony [Type] in Isolate by Culture |
| 70245-6 | PAH gene.p.Arg408Trp [Presence] in Blood or Tissue by Molecular genetics method |
| 70910-5 | Cryptococcus sp Ag [Presence] in Serum by Rapid immunoassay |
| 82381-5 | Hepatitis C virus genotype 1 NS5b gene mutations detected [Identifier] |
| 98119-1 | Angiopoietin receptor 2 [Mass/volume] in Serum or Plasma |
| 7190-2 | Cauliflower IgG Ab [Units/volume] in Serum |
| 85359-8 | Phosphatidylserine-prothrombin complex IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 85365-5 | Neutrophil membrane Ab [Presence] in Serum by Immunofluorescence |
| 72936-8 | Valproate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73287-5 | metFORMIN induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86951-1 | Lipoprotein associated phospholipase A2 [Enzymatic activity/volume] in Serum or Plasma |
| 74003-5 | CYP3A4 gene c.-392A>G (*1B) [Presence] in Blood or Tissue by Molecular genetics method |
| 74385-6 | Normirtazapine [Mass/mass] in Hair |
| 88597-0 | Respiratory syncytial virus B RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 89318-0 | CD25-CD127+ cells/100 CD4 cells in Blood |
| 41435-9 | Cyclospora carcopitheci DNA [Presence] in Specimen by NAA with probe detection |
| 30407-1 | Leukocytes other/100 leukocytes in Pericardial fluid |
| 31160-5 | Polymorphonuclear cells/100 leukocytes in Blood by Manual count |
| 21527-7 | Sodium [Mass/time] in 24 hour Urine |
| 42953-0 | Snowshoe hare virus IgM Ab [Titer] in Serum |
| 42986-0 | Neisseria meningitidis serogroup A IgG Ab [Mass/volume] in Serum |
| 21743-0 | WT1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 22090-5 | Avian encephalomyelitis virus Ab [Presence] in Serum |
| 51678-1 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 51728-4 | Platelet aggregation ADP induced [Presence] in Platelet rich plasma --10 umol/L |
| 43318-5 | Avian metapneumovirus A Ab [Presence] in Serum by Immunofluorescence |
| 22454-3 | Pseudorabies virus Clinease gene deletion Ab [Presence] in Serum |
| 2270-7 | Fat [Presence] in Stool |
| 32071-3 | Ethchlorvynol [Moles/volume] in Serum or Plasma |
| 32520-9 | CD7-CD13+CD33+ cells/100 cells in Specimen |
| 53390-1 | Trichothecene IgG Ab [Units/volume] in Serum |
| 44740-9 | Ganglioside GD1a Ab [Presence] in Serum |
| 23258-7 | Mycoplasma capricolum ss capricolum Ab [Presence] in Serum by Complement fixation |
| 33702-2 | Clostridium botulinum toxin E [Presence] in Specimen by Mouse bioassay neutralization |
| 44883-7 | Malignant cells [#/volume] in Cerebral spinal fluid by Manual count |
| 23814-7 | Amantadine [Mass/volume] in Urine |
| 54013-8 | Vinculin Ab [Presence] in Serum by Immunofluorescence |
| 54069-0 | Hemoglobin Barts/Hemoglobin.total in DBS |
| 24121-6 | Barmah forest virus IgG Ab [Presence] in Serum by Immunoassay |
| 24204-0 | Legionella pneumophila Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
| 34373-1 | Serotonin [Moles/volume] in Urine |
| 3447-0 | cefoTEtan [Mass/volume] in Serum or Plasma |
| 55356-0 | Osmolality of Urine--5 hours post fluid fast |
| 25164-5 | CD21 cells [#/volume] in Blood |
| 25427-6 | Gamma aminobutyrate [Moles/time] in 24 hour Urine |
| 35330-0 | pH of Body fluid--1st specimen post Sincalide |
| 55610-0 | Follitropin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 55629-0 | Cephaloglycin [Susceptibility] by Gradient strip |
| 55881-7 | Hydroxocobalamin [Moles/volume] in Serum or Plasma |
| 55945-0 | Neopterin [Moles/volume] in 24 hour Urine |
| 47718-2 | Parathyrin [Mass/volume] in Serum or Plasma --4 hours post dose calcium |
| 25730-3 | Parvovirus B19 IgM Ab [Titer] in Serum by Immunofluorescence |
| 35755-8 | Avilamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 564-5 | Colony count [#] in Specimen by Visual count |
| 47978-2 | 17-Ketosteroids [Mass/volume] in Serum |
| 48160-6 | HTLV I rgp21 Ab [Presence] in Serum by Immunoblot |
| 35848-1 | Tiamulin [Susceptibility] |
| 3707-7 | Labetalol [Mass/time] in 24 hour Urine |
| 5676-2 | Lead [Mass/volume] in Urine |
| 56781-8 | Epidermal Allergen Mix C (Canary feather+Parakeet feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk |
| 48893-2 | Coxiella burnetii phase 2 IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 27109-8 | PARoxetine [Presence] in Urine |
| 27240-1 | PHENobarbital [Mass/mass] in Stool |
| 38304-2 | Ethylene dibromide [Mass/volume] in Water |
| 38540-1 | Spermatozoa Motile/100 spermatozoa in Semen --pre washing |
| 38572-4 | Benzidine [Mass/volume] in Air |
| 57313-9 | Pyrazole IgE Ab [Units/volume] in Serum |
| 49020-1 | Respiratory allergen panel, US - Coastal California - Serum |
| 28076-8 | SUMAtriptan [Mass/volume] in Serum or Plasma |
| 39456-9 | Acetaminophen [Moles/volume] in Urine |
| 39484-1 | OLANZapine [Moles/volume] in Serum or Plasma |
| 49438-5 | Pneumocystis jiroveci DNA [#/volume] in Bronchoalveolar lavage by NAA with probe detection |
| 2912-4 | Pyruvate kinase [Enzymatic activity/volume] in Red Blood Cells |
| 58766-7 | Epithelial cells [#/area] in Semen by Microscopy high power field |
| 49934-3 | Adipolactone/Creatinine [Molar ratio] in Urine |
| 29941-2 | Antimony/Creatinine [Mass Ratio] in 24 hour Urine |
| 40351-9 | MT-ND4 gene m.11778G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 40511-8 | Snowshoe hare virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 50286-4 | 3-Dechloroethylifosfamide [Mass/volume] in Blood --2 days post dose ifosfamide |
| 30197-8 | Fatty acids.very long chain C26:0 (Hexacosanoate) [Moles/volume] in Serum or Plasma |
| 30314-9 | A Ab [Titer] in Serum or Plasma |
| 30402-2 | Leukocytes [#/volume] in Gastric fluid |
| 41056-3 | SLC22A18 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19158-5 | Urea nitrogen comment - 24 hour Urine Narrative |
| 100427-4 | Stigmasterol [Mass/volume] in Serum or Plasma |
| 12915-5 | Beta galactosidase [Enzymatic activity/volume] in Leukocytes |
| 101412-5 | Dolutegravir [Mass/volume] in Serum or Plasma by LC/MS/MS --trough |
| 101443-0 | Soluble urokinase plasminogen activator receptor [Mass/volume] in Plasma |
| 101662-5 | Abnormal Prion Protein [Presence] in Cerebral spinal fluid by RT-QuIC |
| 13185-4 | Nettle IgG Ab [Units/volume] in Serum |
| 13331-4 | CD2+CD26+ cells/100 cells in Blood |
| 101989-2 | Candida dubliniensis DNA [Presence] in Body fluid by Probe.amp.tar |
| 13505-3 | Herpes simplex virus 1+2 Ab pattern [Interpretation] in Serum |
| 13877-6 | Bilirubin.total [Presence] in Amniotic fluid |
| 103099-8 | Lipolase IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103661-5 | Campylobacter and Salmonella and Shigella sp identified in Stool by Organism specific culture |
| 103717-5 | Crimean-Congo hemorrhagic fever virus RNA [Presence] in Blood by NAA with non-probe detection |
| 104190-4 | Mucopolysaccharidosis type II comment [Text] in DBS Narrative |
| 104402-3 | Francisella tularensis Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 11056-9 | Melatonin [Flow] in 24 hour Urine |
| 16710-6 | Cystine crystals [Presence] in Stone by Infrared spectroscopy |
| 11596-4 | Shigella dysenteriae Ab [Units/volume] in Serum |
| 12186-3 | Colloid oncotic pressure [Partial pressure] in Plasma |
| 1736-8 | Alanine [Presence] in Serum or Plasma |
| 17782-4 | Lipoprotein.beta.subparticle [Entitic length] in Serum or Plasma |
| 90225-4 | Coagulation factor VII activity and inhibitor panel - Platelet poor plasma by Coagulation assay |
| 90842-6 | PCA-1 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
| 90887-1 | Porcine circovirus type 3 ORF2 gene [Nucleotide sequence] in Isolate by Sequencing |
| 74486-2 | Cytokeratin 5 and p63 and Cytokeratin AE1 Ag [Identifier] in Tissue by Immune stain |
| 91823-5 | Rubella virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 60578-2 | TCRG gene rearrangements [Presence] in Body fluid by Molecular genetics method |
| 61074-1 | diazePAM [Presence] in Specimen |
| 93323-4 | Tauroursodeoxycholate [Moles/volume] in Serum or Plasma |
| 77186-5 | Uranium [Mass/mass] in Hair |
| 93866-2 | C4 nephritic factor [Presence] in Serum or Plasma |
| 93988-4 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post dose carbohydrate |
| 94232-6 | FLCN gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 77950-4 | Toscana virus IgM Ab [Presence] in Serum by Immunoassay |
| 78442-1 | Bilirubin.indirect [Moles/volume] in Peritoneal fluid |
| 78759-8 | 6-Monoacetylmorphine (6-MAM) [Presence] in Blood by Screen method |
| 79246-5 | Methedrone [Mass/volume] in Urine by Confirmatory method |
| 79256-4 | Carisoprodol+Meprobamate cutoff [Mass/volume] in Urine for Screen method |
| 9525-7 | Hepatitis D virus IgM Ab [Units/volume] in Serum |
| 6562-3 | Treponema pallidum IgM Ab [Presence] in Serum |
| 79719-1 | DPYD gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
| 80119-1 | Acebutolol [Mass/mass] in Hair by Confirmatory method |
| 68547-9 | Ureaplasma sp DNA [Presence] in Specimen by NAA with probe detection |
| 68927-3 | Cytokeratin 19 [Mass/volume] in Peritoneal fluid |
| 69049-5 | Coagulation specialist review of results |
| 96763-8 | SARS-CoV-2 (COVID-19) E gene [Presence] in Respiratory system specimen by NAA with probe detection |
| 97013-7 | Reduction in kaolin induced clot strength [Length fraction] in Blood by Resonance TEG --30 minutes post maximum clot amplitude |
| 69753-2 | Bordetella pertussis+Bordetella parapertussis filamentous hemagglutinin IgA Ab [Presence] in Serum by Line blot |
| 81782-5 | Timothy IgG Ab [Mass/volume] in Serum |
| 97289-3 | Normeperidine [Presence] in Cord tissue by Confirmatory method |
| 70267-0 | Protein in peritoneal fluid/Protein in serum |
| 98229-8 | Ofloxacin IgE Ab [Units/volume] in Serum |
| 71892-4 | Cortisone [Moles/volume] in Saliva (oral fluid) --AM peak specimen |
| 72396-5 | PHENobarbital [Mass/volume] in Blood by Confirmatory method |
| 85093-3 | Crystal casts [Presence] in Urine sediment by Light microscopy |
| 85291-3 | Surgical margin tumor involvement.deep [Presence] in Colorectal cancer specimen by Light microscopy |
| 72593-7 | Alpha 1 globulin/Protein.total [Pure mass fraction] in Urine by Electrophoresis |
| 72896-4 | Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose lactose PO |
| 85979-3 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum --1st specimen |
| 86610-3 | SUFentanil/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 87436-2 | Chromosome X and Y aneuploidy in Blood or Tissue by FISH |
| 4151-7 | Canrenone [Mass] of Dose |
| 59832-6 | Gastrin [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 5060-9 | Borrelia burgdorferi Ab [Units/volume] in Serum by Immunoassay |
| 30413-9 | Abnormal lymphocytes/100 leukocytes in Blood |
| 31082-1 | Ethylene glycol [Mass/volume] in Gastric fluid |
| 4214-3 | Dextromethorphan [Mass] of Dose |
| 60185-6 | Thallium [Mass/volume] in Red Blood Cells |
| 60301-9 | Disopyramide [Moles/volume] in Specimen |
| 21308-2 | Glucose [Mass/volume] in Serum or Plasma --105 minutes post XXX challenge |
| 2132-9 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma |
| 21628-3 | ATP7B gene c.2337delC [Presence] in Blood or Tissue by Molecular genetics method |
| 21657-2 | COL2A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 31742-0 | Bovine diarrhea virus Ag [Presence] in Stool |
| 43346-6 | Avian paramyxovirus 7 Ab [Titer] in Serum |
| 22604-3 | Varicella zoster virus IgG Ab [Units/volume] in Serum --2nd specimen |
| 22829-6 | Avian paramyxovirus 1 Ab [Presence] in Serum by Hemagglutination inhibition |
| 32571-2 | HIV 1 Ab [Presence] in Urine by Immunoblot |
| 53192-1 | Tetradecanoylcarnitine (C14) [Moles/volume] in DBS |
| 44412-5 | Tetrahydrodeoxycortisol/Creatinine [Mass Ratio] in Urine |
| 23236-3 | Mycobacterium avium ss avium rRNA [Presence] in Tissue by Probe |
| 53532-8 | Microalbumin [Mass/time] in 24 hour Urine by Detection limit <= 1.0 mg/L |
| 53896-7 | SMC1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 23838-6 | Chlamydia trachomatis rRNA [Presence] in Genital fluid by Probe |
| 54175-5 | Caspofungin [Susceptibility] by Disk diffusion (KB) |
| 54466-8 | Alpha 2 globulin/Protein.total in Dialysis fluid by Electrophoresis |
| 24234-7 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum --1st specimen |
| 2464-6 | IgG [Mass/volume] in Cerebral spinal fluid |
| 47067-4 | Rickettsia typhi IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 47083-1 | IgG [Mass/volume] in 24 hour Urine |
| 47416-3 | RB1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 25150-4 | Calcium sulfate crystals [#/area] in Urine sediment by Microscopy high power field |
| 25223-9 | Doxycycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25400-3 | Entamoeba histolytica Ab [Titer] in Serum by Immunofluorescence |
| 3500-6 | Clorprenaline [Mass/volume] in Urine |
| 35077-7 | Abnormal lymphocytes/100 leukocytes in Body fluid |
| 55778-5 | Eosinophils [#] in Cerebral spinal fluid by Manual count |
| 47758-8 | Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose glucagon |
| 47818-0 | 3-Hydroxyhexanoate (3-OH-C6:0)/Creatinine [Molar ratio] in Urine |
| 47850-3 | Cortisol [Mass/volume] in Serum or Plasma --post dose corticotropin |
| 25705-5 | Ketones [Presence] in Urine --1 hour post 50 g glucose PO |
| 25845-9 | Aldosterone [Moles/volume] in 24 hour Urine |
| 35656-8 | 3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Serum or Plasma |
| 5654-9 | Gallium [Mass/volume] in Urine |
| 26528-0 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin |
| 35854-9 | Trospectinomycin [Susceptibility] |
| 38161-6 | Pentacarboxylporphyrins/Creatinine [Mass Ratio] in Urine |
| 48637-3 | Cholesterol in LDL pattern BI [Presence] in Serum or Plasma by Electrophoresis |
| 57383-2 | Tipranavir [Mass/volume] in Serum |
| 49313-0 | Chronic leukemia markers [Interpretation] in Specimen |
| 39086-4 | Microscopic observation [Identifier] in Vaginal fluid by Cyto stain.thin prep |
| 3956-0 | Phentermine [Mass/volume] in Blood |
| 28594-0 | 3-Methylhistidine/Creatinine [Ratio] in Urine |
| 58648-7 | Cortisol [Mass/volume] in Saliva (oral fluid) --15 minutes post 1 ug/kg CRH IV |
| 49810-5 | 2-Hydroxy-3-Methylvalerate/Creatinine [Molar ratio] in 24 hour Urine |
| 29598-0 | Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 29792-9 | Powassan virus IgM Ab [Presence] in Specimen by Immunofluorescence |
| 29910-7 | Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection |
| 50429-0 | Cortisol [Mass/volume] in Serum or Plasma --9 AM specimen |
| 1916-6 | Aspartate aminotransferase/Alanine aminotransferase [Enzymatic activity ratio] in Serum or Plasma |
| 19410-0 | Cocaethylene cutoff [Mass/volume] in Urine for Confirmatory method |
| 20509-6 | Hemoglobin [Mass/volume] in Blood by calculation |
| 13721-6 | Chloride/Creatinine [Mass Ratio] in 24 hour Urine |
| 102290-4 | Rough Marsh Elder IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14459-2 | Virus identified in Penis by Culture |
| 103142-6 | Cell-free DNA.donor/Cell-free DNA.total in Blood by Sequencing --post transplant |
| 10914-0 | Methylenediamine [Mass/volume] in Urine |
| 11215-1 | Delta aminolevulinate [Mass/volume] in Urine |
| 1155-1 | little c Ab [Presence] in Serum or Plasma from Donor |
| 17266-8 | Methotrexate [Mass/volume] in Urine |
| 17852-5 | Ureaplasma urealyticum [Presence] in Specimen by Organism specific culture |
| 18906-8 | Ciprofloxacin [Susceptibility] |
| 18973-8 | Pyrazinamide [Susceptibility] |
| 91089-3 | Fungal BT2 gene [Presence] in Lower respiratory specimen by NAA with probe detection |
| 75043-0 | Pyridoxine [Moles/volume] in Cerebral spinal fluid |
| 6049-1 | Botrytis cinerea IgE Ab [Units/volume] in Serum |
| 61111-1 | Mitochondria tRNA targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 76082-7 | Microscopic observation [Identifier] in Bronchoalveolar lavage by Methenamine silver nitrate stain |
| 76683-2 | Mean platelet component [Mass/volume] in Blood by calculation |
| 93350-7 | Monocytes.HLA-DR/100 Monocytes in Blood by Flow cytometry (FC) |
| 61430-5 | Aquaporin 4 water channel Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 6151-5 | Italian Cypress IgE Ab [Units/volume] in Serum |
| 77054-5 | MTR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77070-1 | PLOD2 gene full mutation analysis in Blood or Tissue by Sequencing |
| 77094-1 | MRPS2 gene full mutation analysis in Blood or Tissue by Sequencing |
| 77181-6 | Niobium [Moles/volume] in Blood |
| 9393-0 | risperiDONE [Mass/volume] in Serum or Plasma |
| 94676-4 | Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 9507-5 | Chloromethane [Mass/volume] in Blood |
| 95721-7 | Glycine receptor Ab [Titer] in Cerebral spinal fluid by Immunoassay |
| 96366-0 | Naltrexone [Presence] in Saliva (oral fluid) by Confirmatory method |
| 6779-3 | IgA [Mass/volume] in Urine by Immunoassay |
| 67815-1 | HTLV I Ab [Units/volume] in Serum by Immunoassay |
| 69039-6 | Enterocyte Ab panel - Serum |
| 96648-1 | HLA-DPB1 [Type] by Low resolution |
| 695-7 | Neisseria gonorrhoeae [Presence] in Synovial fluid by Organism specific culture |
| 69833-2 | 3-Hydroxy,3-Methylglutarate [Moles/volume] in Amniotic fluid |
| 69879-5 | Service comment 52 |
| 82863-2 | 3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone [Moles/volume] in Urine |
| 84873-9 | Myelin oligodendrocyte glycoprotein IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 85429-9 | Penicillin [Susceptibility] for pneumonia by Minimum inhibitory concentration (MIC) |
| 72668-7 | Mirtazapine [Mass/volume] in Serum or Plasma --trough |
| 73823-7 | Cocaine+Benzoylecgonine [Presence] in Serum, Plasma or Blood by Screen method |
| 88619-2 | Human coronavirus OC43 RNA [Presence] in Aspirate by NAA with probe detection |
| 88620-0 | Human coronavirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 41282-5 | Nucleated erythrocytes/100 leukocytes [Ratio] in Body fluid by Manual count |
| 59310-3 | Milnacipran [Mass/volume] in Blood |
| 59800-3 | Protein.monoclonal band 2/Protein.total in Urine by Electrophoresis |
| 50801-0 | Aluminum [Moles/mass] in Hair |
| 30511-0 | Cortisone/Creatinine [Mass Ratio] in Urine |
| 30996-3 | Timothy recombinant (rPhl p) 5 IgE Ab [Units/volume] in Serum |
| 21057-5 | Alanine+Histidine+Leucine+Phenylalanine+Tyrosine [Presence] in Serum or Plasma |
| 21080-7 | Asialoganglioside GM1 Ab [Titer] in Serum |
| 21334-8 | HIV 2 gp105 Ab [Presence] in Serum by Immunoblot |
| 51261-6 | CD16B cells/100 cells in Cerebral spinal fluid |
| 31907-9 | Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid |
| 51836-5 | Angiotensin II [Mass/volume] in Plasma --upright |
| 43594-1 | Nidus [Mass] in Stone |
| 32185-1 | Itraconazole [Mass/volume] in Serum or Plasma --trough |
| 52925-5 | Platinum/Creatinine [Molar ratio] in Urine |
| 44391-1 | Immune complex [Presence] in Serum or Plasma by C1q binding assay |
| 53158-2 | Homocitrulline [Moles/volume] in DBS |
| 5321-5 | Rickettsia typhus group IgM Ab [Units/volume] in Serum by Immunoassay |
| 53400-8 | Stearoylcarnitine (C18)/Propionylcarnitine (C3) [Molar ratio] in DBS |
| 44683-1 | Distance of invasive melanoma to closest lateral margin [Length] in Skin melanoma |
| 44687-2 | Melanoma in situ.location relative to closest uninvolved lateral margin |
| 23407-0 | Rinderpest virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 23454-2 | Taylorella equigenitalis Ab [Presence] in Serum |
| 33643-8 | Limulus amebocyte lysate test [Units/volume] in Nonbiological fluid |
| 2370-5 | Glutamine [Mass/volume] in Cerebral spinal fluid |
| 54002-1 | Centromere protein F Ab [Titer] in Serum by Immunofluorescence |
| 46758-9 | Congenital adrenal hyperplasia newborn screen interpretation |
| 34407-7 | Interleukin 1 [Mass/volume] in Serum or Plasma |
| 47782-8 | Taurine [Moles/volume] in DBS |
| 25692-5 | Insulin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 35402-7 | Leishmania donovani IgG Ab [Presence] in Serum |
| 35406-8 | Leishmania mexicana IgG Ab [Presence] in Serum |
| 35467-0 | M-chlorophenylpiperazine [Presence] in Serum or Plasma |
| 48233-1 | Lepidoglyphus destructor triggered leukotriene release [Mass/volume] by Leukocytes |
| 26514-0 | Neutrophils/100 leukocytes in Peritoneal fluid |
| 2667-4 | Norepinephrine [Mass/volume] in Urine |
| 35832-5 | Polymyxin B [Susceptibility] by Gradient strip |
| 35833-3 | Pristinamycin [Susceptibility] by Disk diffusion (KB) |
| 3606-1 | Ethacrynate [Mass/volume] in Urine |
| 3784-6 | Methaqualone [Presence] in Serum or Plasma |
| 56730-5 | Smith extractable nuclear Ab [Presence] in Serum by Immunoblot |
| 48787-6 | Glucose [Mass/volume] in Peritoneal fluid --24 hours post peritoneal dialysis |
| 57440-0 | Platelet Ab [Presence] in Serum by Immunofluorescence |
| 57795-7 | Fecal hydrolysis panel - Stool |
| 49656-2 | HIV protease gene mutations by Genotype method |
| 28610-4 | Sarcosine/Creatinine [Ratio] in Urine |
| 4030-3 | Sotalol [Presence] in Urine |
| 58413-6 | Nucleated erythrocytes/100 leukocytes [Ratio] in Blood by Automated count |
| 58554-7 | Corticotropin [Mass/volume] in Plasma --1 hour post dose glucagon |
| 58593-5 | Corticotropin [Moles/volume] in Plasma --30 minutes pre XXX challenge |
| 49783-4 | Onchocerca sp IgG4 Ab [Units/volume] in Serum by Immunoassay |
| 49817-0 | 2-Oxoisocaproate/Creatinine [Molar ratio] in 24 hour Urine |
| 40401-2 | Thyrotropin [Units/volume] in Serum or Plasma --pre dose triple bolus |
| 40865-8 | 11-Oxo-Androsterone [Mass/time] in 24 hour Urine |
| 41132-2 | Measles virus IgG Ab [Presence] in Cerebral spinal fluid |
| 19274-0 | Barbiturates positive [Identifier] in Urine by Confirmatory method |
| 20520-3 | Bromazepam [Mass/volume] in Urine by Confirmatory method |
| 20702-7 | Bluetongue virus [Presence] in Specimen by Organism specific culture |
| 12991-6 | Polychlorinated biphenyl.Aroclor 1254 [Mass/volume] in Serum or Plasma |
| 13734-9 | EPINEPHrine/Creatinine [Mass Ratio] in Urine |
| 102539-4 | Potato IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13950-1 | Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 14056-6 | Carbamazepine 10,11-epoxide free [Mass/volume] in Serum or Plasma |
| 14100-2 | Strontium [Presence] in Urine |
| 102786-1 | Peanut IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102908-1 | Staphylococcus aureus enterotoxin B IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14478-2 | Bacteria identified in Penis by Aerobe culture |
| 14715-7 | Estradiol (E2) [Moles/volume] in Serum or Plasma |
| 103686-2 | Pneumocystis jiroveci DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 103843-9 | Tripartite motif containing 46 [Presence] in Specimen by Immunofluorescence |
| 15090-4 | Porphyrins [Moles/time] in 24 hour Stool |
| 10662-5 | Filaria identified in Blood by Concentration |
| 12183-0 | Cholesterol [Mass/volume] in Body fluid |
| 17348-4 | Neutrophil IgA Ab [Units/volume] in Serum |
| 17647-9 | Streptococcus pneumoniae Ab [Units/volume] in Serum |
| 17790-7 | Leukocytes Left Shift [Presence] in Blood by Automated count |
| 18488-7 | Calcium [Mass/volume] in 24 hour Urine |
| 18883-9 | Cefonicid [Susceptibility] |
| 900-1 | Blood group antibody screen.cell III [Presence] in Serum or Plasma by Prewarmed |
| 74786-5 | Influenza virus B Yamagata lineage RNA [Presence] in Specimen by NAA with probe detection |
| 92002-5 | SMN1 gene [Cycle Threshold #] in DBS by NAA with probe detection |
| 75133-9 | Adenine [Moles/volume] in Cerebral spinal fluid |
| 75634-6 | Rheumatoid arthritis disease activity score level Qualitative by VectraDA |
| 61156-6 | Hepatitis B virus codon V173L [Presence] by Genotype method |
| 76578-4 | Pseudomonas aeruginosa regA gene [Presence] in Swab specimen by NAA with probe detection |
| 61205-1 | Coastal Maple IgE Ab/IgE total in Serum |
| 94209-4 | NAGLU gene full mutation analysis in Blood or Tissue by Sequencing |
| 94223-5 | PTEN gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 6306-5 | Adenovirus 40+41 Ag [Presence] in Stool by Immunoassay |
| 77951-2 | Toscana virus IgG Ab [Presence] in Serum by Immunoassay |
| 9439-1 | Casts [#/area] in Urine sediment by Microscopy high power field |
| 94511-3 | SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Specimen by NAA with probe detection |
| 63558-1 | HLA-DQB1*06:02 [Presence] |
| 80349-4 | Escherichia coli enteroaggregative pAA plasmid aggR+aatA genes [Presence] in Stool by NAA with non-probe detection |
| 80375-9 | Norovirus Ag [Presence] in Stool by Rapid immunoassay |
| 96620-0 | HLA-B unresolved alleles [Type] by High resolution |
| 98243-9 | Spermatozoa [#/volume] in Urine by Light microscopy --post ejaculation |
| 85082-6 | Nuclear membrane pores nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
| 72760-2 | fentaNYL [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 72927-7 | Urea [Moles/volume] in Arterial blood |
| 86190-6 | Zika virus RNA [Presence] in Plasma from Donor by NAA with probe detection |
| 86456-1 | Brucella sp Ab [Presence] in Serum by Card agglutination |
| 7317-1 | Flounder IgG Ab [Units/volume] in Serum |
| 87420-6 | Vinculin Ab [Units/volume] in Serum by Immunoassay |
| 87671-4 | Cholecalciferol (Vit D3) [Mass/mass] in Specimen |
| 73573-8 | Magnesium Ionized [Moles/volume] adjusted to pH 7.4 in Blood by Ion-selective membrane electrode (ISE) |
| 73589-4 | rifAXIMin [Susceptibility] |
| 73989-6 | 2,3',4,4',5-Pentachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
| 88718-2 | Chlamydophila pneumoniae DNA [Presence] in Nasopharynx by NAA with probe detection |
| 88971-7 | Mixed cellular casts [#/area] in Urine sediment |
| 89587-0 | Herpes simplex virus 2 DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 50911-7 | Sodium [Moles/volume] in Gastric fluid |
| 50952-1 | Phosphoserine IgG Ab [Presence] in Serum or Plasma |
| 41867-3 | von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma |
| 42612-2 | Salicylurate [Mass/volume] in Urine |
| 60098-1 | Loratadine [Mass/volume] in Urine |
| 6010-3 | Protein C inhibitor [Mass/volume] in Platelet poor plasma by Immunoassay |
| 31328-8 | Coxsackievirus B3 Ab [Units/volume] in Body fluid |
| 51068-5 | CD13 blasts [Units/volume] in Specimen |
| 51183-2 | CD117 Ag [Presence] in Bone marrow by Immune stain |
| 42920-9 | Isovalerylcarnitine (C5) [Moles/volume] in DBS |
| 43122-1 | Doxepin and Nordoxepin panel - Serum or Plasma |
| 43127-0 | clomiPRAMINE and Norclomipramine panel - Serum or Plasma |
| 22294-3 | Epstein Barr virus early Ab [Titer] in Serum |
| 31730-5 | Bladder tumor Ag [Units/volume] in Urine |
| 31913-7 | Neisseria meningitidis serogroup B Ag [Presence] in Specimen |
| 43688-1 | 16-Alpha hydroxypregnenolone/Creatinine [Mass Ratio] in Urine |
| 22596-1 | Trichinella spiralis Ab [Titer] in Serum |
| 22751-2 | Tobramycin [Moles/volume] in Serum or Plasma --peak |
| 32173-7 | Eosinophils [Presence] in Blood by Wright stain |
| 53050-1 | Glucose [Mass/volume] in Total parental nutrition |
| 22915-3 | Bovine leukemia virus Ab [Presence] in Milk |
| 23170-4 | Leptospira interrogans sv Bataviae Ab [Presence] in Serum |
| 44720-1 | Methylmalonate/Homocystine [Molar ratio] in Serum or Plasma |
| 23545-7 | Venezuelan equine encephalitis virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 33616-4 | Cytomegalovirus early Ag [Presence] in Urine |
| 23802-2 | Grass Allergen Mix D (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass) IgE Ab [Presence] in Serum by Multidisk |
| 54348-8 | Alpha-1-Fetoprotein [Mass/volume] in Cord blood |
| 34282-4 | Dehydroepiandrosterone sulfate (DHEA-S)/Creatinine [Molar ratio] in Urine |
| 34447-3 | Cache valley virus RNA [Presence] in Blood by NAA with probe detection |
| 47214-2 | Homeostasis model assessment |
| 34991-0 | Unidentified cells [#/volume] in Synovial fluid |
| 25749-3 | Rickettsia conorii IgG Ab [Titer] in Serum by Immunofluorescence |
| 56209-0 | Castor Bean IgG4 Ab [Mass/volume] in Serum |
| 48060-8 | Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool |
| 48133-3 | 3-Oxovalerate [Moles/volume] in Plasma |
| 26775-7 | Myelin associated glycoprotein Ab [Presence] in Serum by Immunoassay |
| 38333-1 | Trichloroethane [Mass/volume] in Water |
| 27345-8 | Hemoglobin A2 [Presence] in Blood by Electrophoresis |
| 38711-8 | 2-Nitropropane [Mass/volume] in Air |
| 3888-5 | Oxedrine [Mass/volume] in Urine |
| 39304-1 | Influenza virus A H3 Ab [Titer] in Serum by Hemagglutination inhibition |
| 57838-5 | dRVVT W excess phospholipid (LA confirm) |
| 49429-4 | Parvovirus B19 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
| 2915-7 | Renin [Enzymatic activity/volume] in Plasma |
| 29239-1 | Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis |
| 40057-2 | Albumin [Mass/volume] in Serum or Plasma --6.5 hours post XXX challenge |
| 40070-5 | Calcium [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 40241-2 | Calcium [Moles/volume] in Serum or Plasma --14 hours post XXX challenge |
| 49911-1 | Isovalerylglycine/Creatinine [Molar ratio] in 24 hour Urine |
| 50141-1 | 3-O-Methyldopa [Moles/volume] in Serum or Plasma |
| 29607-9 | Tropheryma whipplei DNA [Presence] in Tissue by NAA with probe detection |
| 40397-2 | Thyrotropin [Units/volume] in Serum or Plasma --15 minutes post dose triple bolus |
| 4044-4 | Tetracaine [Mass/volume] in Serum or Plasma |
| 58854-1 | Estradiol (E2) [Mass/volume] in Serum or Plasma --4 days post XXX challenge |
| 59198-2 | Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma |
| 50314-4 | Cytokeratin 19 Ag [Presence] in Tissue by Immune stain |
| 30106-9 | Acetylcholinesterase [Presence] in Amniotic fluid |
| 19380-5 | Butorphanol cutoff [Mass/volume] in Urine for Confirmatory method |
| 20375-2 | Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria |
| 20547-6 | MethylePHEDrine [Mass/volume] in Urine by Confirmatory method |
| 12351-3 | Tetrahydrocannabinol [Presence] in Stool |
| 100765-7 | Homocysteine and methylmalonate and methylcitrate panel - DBS |
| 12633-4 | Glucose [Mass/volume] in Peritoneal dialysis fluid --4th specimen |
| 101756-5 | Trichophyton interdigitale DNA [Presence] in Specimen by NAA with probe detection |
| 13921-2 | Mumps virus [Presence] in Specimen by Organism specific culture |
| 1411-8 | Cortisol [Mass/volume] in Serum or Plasma --26 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 14145-7 | Somatotropin [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 14519-3 | Pneumocystis jiroveci Ag [Presence] in Eye by Immunofluorescence |
| 14635-7 | 25-hydroxyvitamin D3 [Moles/volume] in Serum or Plasma |
| 15152-2 | Bilirubin.conjugated [Mass/volume] in Serum or Plasma |
| 15404-7 | Levomethamphetamine/Amphetamines.total in Urine |
| 15422-9 | Service comment 31 |
| 16267-7 | Calcium carbonate crystals [Presence] in Stone by Infrared spectroscopy |
| 16291-7 | Herpes simplex virus 1 [Presence] in Specimen by Organism specific culture |
| 11186-4 | Foxtail Millet IgE Ab [Units/volume] in Serum |
| 12317-4 | Phenolphthalein [Presence] in Urine |
| 17053-0 | Legionella longbeachae 1 IgG Ab [Presence] in Serum |
| 17070-4 | Legionella pneumophila 6 Ab [Titer] in Serum |
| 17071-2 | Legionella pneumophila 7 Ab [Presence] in Serum |
| 18278-2 | Hemoglobin F [Presence] in Meconium by Apt-Downey method |
| 18964-7 | Penicillin [Susceptibility] |
| 90433-4 | Mycobacterium preliminary growth [Presence] in Sputum by Organism specific culture |
| 91813-6 | Bordetella sp DNA [Identifier] in Upper respiratory specimen by NAA with probe detection |
| 92726-9 | 17-Hydroxyprogesterone [Mass/volume] in DBS by LC/MS/MS |
| 60426-4 | SARS coronavirus Ab [Titer] in Serum |
| 76589-1 | Haemophilus influenzae lex2 gene [#/mass] in XXX.tissue by NAA with probe detection |
| 93318-4 | Platelet CD61 actual/normal in Blood by Flow cytometry (FC) |
| 61293-7 | Passion fruit IgE Ab/IgE total in Serum |
| 62239-9 | Leukocytes [#/volume] in Blood from Fetus by Automated count |
| 77150-1 | Energy content [Energy/mass] in 24 hour Stool.dried |
| 7756-0 | Vanilla IgE Ab [Units/volume] in Serum |
| 93840-7 | Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection |
| 94289-6 | West Nile virus neutralizing antibody [Presence] in Specimen by Neutralization test |
| 63157-2 | House dust Greer IgG Ab [Mass/volume] in Serum |
| 7855-0 | Dengue virus 1+2+3+4 RNA [Presence] in Serum by NAA with probe detection |
| 78750-7 | Hepatitis E virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 78754-9 | 11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Urine by Screen method |
| 94438-9 | HLA-DRB3 and HLA-DRB4 and HLA DRB5 IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC) |
| 6376-8 | Cytomegalovirus Ag [Presence] in Serum or Plasma by Immunoassay |
| 6567-2 | Trichomonas vaginalis Ag [Presence] in Genital specimen by Immunofluorescence |
| 9625-5 | Amoxapine+8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma |
| 67866-4 | Babesia identification panel - Specimen |
| 96618-4 | HLA-B [Type] in Donor by High resolution |
| 69790-4 | 2-Methylbutyrylglycine [Moles/volume] in Serum or Plasma |
| 8210-7 | Opiates [Presence] in Gastric fluid |
| 7057-3 | Trimethoprim+Sulfamethoxazole [Susceptibility] by Gradient strip |
| 71609-2 | Macrophages/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
| 82490-4 | TRBV14 gene segments/TRBV gene segments.total in Blood |
| 98015-1 | Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 72382-5 | HER2 [Units/volume] in Tissue by Immunoassay |
| 72409-6 | Testosterone [Moles/volume] in Serum or Plasma --post dose HCG |
| 85052-9 | Ceftobiprole [Susceptibility] by Gradient strip |
| 85533-8 | Influenza virus A porcine origin nucleoprotein IgG Ab/Positive control in Specimen by Immunoassay |
| 99959-9 | Urothelial carcinoma gene expression score in Urine by Molecular genetics method |
| 73135-6 | Sulindac induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7375-9 | Sorghum grass IgE Ab [Units/volume] in Serum |
| 59398-8 | Ascorbate [Mass/volume] in Semen |
| 59829-2 | Leukocytes in 3 hour Urine sediment by Light microscopy |
| 30554-0 | HIV reverse transcriptase gene mutations detected [Identifier] |
| 42327-7 | Leukocytes [Presence] in Stool by Methylene blue stain |
| 4240-8 | Etamivan [Mass] of Dose |
| 60112-0 | Oxipurinol [Mass/volume] in Blood |
| 60193-0 | Topiramate [Mass/volume] in Urine |
| 21336-3 | HIV 2 gp15 Ab [Presence] in Serum by Immunoblot |
| 21339-7 | HIV 2 p55 Ab [Presence] in Serum by Immunoblot |
| 31409-6 | Hantavirus sin nombre IgM Ab [Units/volume] in Serum |
| 5106-0 | Coxsackievirus B2 Ab [Titer] in Serum by Complement fixation |
| 51264-0 | CD19 cells/100 cells in Tissue |
| 42968-8 | Rickettsia rickettsii IgG Ab [Presence] in Serum |
| 43161-9 | Microorganism [#/volume] in Specimen by Viability count |
| 4319-0 | Methamphetamine [Mass] of Dose |
| 21780-2 | t(11;22)(p13;q12.2)(WT1,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 21823-0 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript minor break points [Presence] in Blood or Tissue by Molecular genetics method |
| 32020-0 | Homocysteine [Moles/volume] in Urine |
| 32035-8 | Polymorphonuclear cells [Presence] in Body fluid by Wright stain |
| 43267-4 | Uranium depleted cutoff [Mass/volume] in Urine |
| 32078-8 | glyBURIDE [Moles/volume] in Serum or Plasma |
| 32244-6 | Glycine [Moles/volume] in Vitreous fluid |
| 4384-4 | Pentetrazol [Mass] of Dose |
| 23099-5 | Equine infectious anemia virus Ag [Presence] in Specimen by Immunoassay |
| 23106-8 | Foot and mouth disease virus Ab [Presence] in Serum |
| 32751-0 | HLA-DR+ cells/100 cells in Specimen |
| 32827-8 | HIV 1 p17+p18 Ab [Presence] in Serum by Immunoblot |
| 32829-4 | Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 53199-6 | Palmitoylcarnitine (C16) [Moles/volume] in DBS |
| 5335-5 | Rubella virus IgM Ab [Units/volume] in Serum by Immunoassay |
| 44570-0 | Influenza virus B Ab [Presence] in Serum |
| 23350-2 | Peste des petits ruminants virus Ab [Titer] in Serum |
| 23409-6 | Rinderpest virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 33301-3 | Norchlordiazepoxide [Presence] in Urine by Screen method |
| 45094-0 | Chlamydia trachomatis [Presence] in Conjunctival specimen by Organism specific culture |
| 45363-9 | Lymphocyte proliferation stimulated by 1.0 ug phytohemagglutinin in Blood |
| 33758-4 | Polyp stalk length by CAP cancer protocols |
| 54036-9 | Western equine encephalitis virus RNA [Presence] in Specimen by NAA with probe detection |
| 54088-0 | Toxoplasma gondii IgM Ab [Presence] in DBS |
| 46093-1 | Calcium.ionized [Moles/volume] in Dialysis fluid |
| 24276-8 | Saint Louis encephalitis virus Ab [Titer] in Serum --2nd specimen |
| 34299-8 | Estrone (E1)/Creatinine [Molar ratio] in Urine |
| 55143-2 | California serogroup RNA [Presence] in Specimen by NAA with probe detection |
| 55205-9 | Vasoactive intestinal peptide [Mass/volume] in Cerebral spinal fluid |
| 55389-1 | Insulin [Moles/volume] in Serum or Plasma --5 hours post XXX challenge |
| 47295-1 | Bacteria # 8 identified in Wound shallow by Aerobe culture |
| 47454-4 | Influenza virus A H5 Ab [Titer] in Serum |
| 25338-5 | Dengue virus IgM Ab [Presence] in Serum |
| 25899-6 | D-Lactate [Moles/volume] in Serum or Plasma --1st specimen post excercise |
| 35358-1 | LHON syndrome gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 56527-5 | Vasopressin [Mass/volume] in Plasma --1 hour post XXX challenge |
| 26604-9 | Beta alanine [Moles/volume] in Serum or Plasma |
| 56915-2 | Coxiella burnetii IgG Ab [Presence] in Serum by Immunofluorescence |
| 56948-3 | Insulin [Units/volume] in Serum or Plasma --44 hour post XXX challenge |
| 5728-1 | Silicon [Mass/volume] in Blood |
| 4912-2 | HLA-Dw6 [Presence] in Donor |
| 39482-5 | Trimeprazine [Moles/volume] in Serum or Plasma |
| 57999-5 | Manganese [Mass/volume] in Cerebral spinal fluid |
| 58041-5 | Norclostebol [Presence] in Urine |
| 58366-6 | LORazepam/Creatinine [Mass Ratio] in Urine |
| 49689-3 | Glucose tolerance [Interpretation] in Serum or Plasma Narrative--post 100 g glucose PO |
| 29678-0 | Rickettsia conorii Ab [Titer] in Serum |
| 4031-1 | Sotalol [Mass/volume] in Urine |
| 40584-5 | Arbovirus IgM Ab [Presence] in Serum |
| 58857-4 | Somatotropin [Mass/volume] in Serum or Plasma --9th specimen |
| 50605-5 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre XXX challenge |
| 30300-8 | Didanosine [Susceptibility] |
| 20383-6 | Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria |
| 20695-3 | Bacteria [#/volume] in Mother's milk |
| 12560-9 | Cortisol [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 101235-0 | Glial nuclear type 1 Ab [Presence] in Serum by Immunoblot |
| 101251-7 | Dense fine speckled 70 protein Ab [Presence] in Serum or Plasma |
| 102086-6 | Endometrial stromal tumor in Tissue Document by FISH |
| 1386-2 | Catecholamines Free fractionated [Mass/volume] in Plasma --2 hours post 300 ug cloNIDine PO |
| 13916-2 | Bordetella parapertussis Ag [Presence] in Specimen by Immunofluorescence |
| 1435-7 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 1032-2 | Fy sup(b) Ag [Presence] on Red Blood Cells from Donor |
| 15213-2 | Epidermal Allergen Mix 2 (Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) IgE Ab [Presence] in Serum by Multidisk |
| 10539-5 | glipiZIDE [Mass/volume] in Serum or Plasma |
| 10807-6 | Microscopic observation [Identifier] in Tissue by Sevier-Munger stain |
| 10837-3 | Organic acids [Presence] in Serum or Plasma |
| 16290-9 | Neutrophils [Presence] in Stool |
| 16449-1 | Benzthiazide [Mass/volume] in Serum or Plasma |
| 16794-0 | Echinococcus sp IgM Ab [Units/volume] in Serum |
| 16930-0 | Helminth IgE Ab [Units/volume] in Serum |
| 17958-0 | Bacteria # 3 identified in Body fluid by Anaerobe culture |
| 17959-8 | Bacteria # 2 identified in Peritoneal fluid by Culture |
| 18271-7 | Alpha 1 antitrypsin fecal clearance in 24 hour |
| 91112-3 | Cholesterol in LDL 1 [Moles/volume] in Serum or Plasma |
| 7449-2 | Lamb triggered histamine release [Units/volume] in Blood |
| 74817-8 | Desomorphine [Mass/volume] in Urine by Confirmatory method |
| 92139-5 | Parainfluenza virus 2 RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 75369-9 | Diuretics [Interpretation] in Urine Qualitative by Screen method |
| 75753-4 | Vancomycin resistance vanD gene [Presence] by Molecular method |
| 76475-3 | Cortisone free [Moles/volume] in Serum or Plasma |
| 6143-2 | Horse dander IgE Ab [Units/volume] in Serum |
| 9410-2 | Histamine [Mass/time] in 24 hour Urine |
| 64959-0 | Kiwi recombinant (rAct d) 8 IgE Ab [Units/volume] in Serum |
| 79336-4 | Hypoglycemics.oral [Presence] in Serum or Plasma by Screen method |
| 65321-2 | Ge Ab [Presence] in Serum or Plasma |
| 655-1 | Microscopic observation [Identifier] in Specimen by Acid fast stain.Kinyoun modified |
| 66762-6 | Choriogonadotropin.beta subunit [Units/volume] in Pleural fluid |
| 95714-2 | Varicella zoster virus IgG Ab [Units/volume] in Specimen by Immunoassay |
| 95716-7 | 17 alpha-Hydroxylase Ab [Titer] in Serum by Immunofluorescence |
| 96356-1 | Equine herpesvirus 3 [Presence] in Specimen by Organism specific culture |
| 96422-1 | Cortisone [Mass/volume] in DBS |
| 80592-9 | Parainfluenza virus 1 F gene [Presence] in Nasopharynx by NAA with probe detection |
| 80622-4 | Zika virus neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen |
| 96566-5 | Cabotegravir [Susceptibility] by Genotype method |
| 69548-6 | Genetic variant assessment |
| 69924-9 | European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 70203-5 | Cholesterol in VLDL 3 [Moles/volume] in Serum or Plasma |
| 99100-0 | Norepinephrine [Mass/volume] in Serum or Plasma |
| 83060-4 | NRAS gene [VCF] in Cancer specimen by Sequencing |
| 848-2 | A1 B Ag [Presence] on Red Blood Cells from Blood product unit |
| 72602-6 | Beta hydroxybutyrate + Acetoacetate [Moles/volume] in Blood --post meal |
| 85791-2 | CD3+CD4+CD45RO+ cells/100 CD3 cells in Blood |
| 73035-8 | Citalopram induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86703-6 | Porcine respiratory coronavirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 86859-6 | Dengue virus 3 neutralizing antibody [Titer] in Specimen by Neutralization test |
| 41290-8 | HIV 1+2 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 41401-1 | Yersinia sp IgG Ab [Presence] in Serum by Immunoblot |
| 50725-1 | Monoblasts/100 leukocytes in Bone marrow by Manual count |
| 50980-2 | pH of Mixed venous blood adjusted to patient's actual temperature |
| 30438-6 | Monocytes+Macrophages/100 leukocytes in Synovial fluid |
| 30546-6 | Polio virus 1 Ab [Presence] in Serum |
| 4207-7 | cycloSPORINE [Mass] of Dose |
| 60261-5 | Coxiella burnetii DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 2112-1 | Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Urine |
| 21296-9 | Gastrin [Mass/volume] in Serum or Plasma --7 minutes post 0.2 U/kg secretin |
| 216-2 | Demeclocycline [Susceptibility] by Minimum lethal concentration (MLC) |
| 31217-3 | Adenovirus Ab [Units/volume] in Body fluid |
| 51712-8 | Ma+Ta Ab [Titer] in Serum by Immunofluorescence |
| 51838-1 | Treponema pallidum IgG Ab [Units/volume] in Serum by Immunoassay |
| 51923-1 | Nelfinavir [Mass/volume] in Serum or Plasma --peak |
| 32383-2 | Pristinamycin [Susceptibility] |
| 22827-0 | Influenza virus A subtype [Identifier] in Specimen by NAA with probe detection |
| 22924-5 | Brucella abortus IgG1 Ab [Presence] in Serum |
| 229-5 | Enoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2314-3 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in Red Blood Cells |
| 5318-1 | Rickettsia typhus group Ab [Titer] in Serum by Immunofluorescence |
| 44508-0 | Herpes simplex virus Ag [Presence] in Cervix |
| 33366-6 | Chloride [Moles/volume] in Peritoneal fluid |
| 3354-8 | Amphotericin B [Mass/volume] in Serum or Plasma |
| 33593-5 | Hemoglobin G - Coushatta/Hemoglobin.total in Blood |
| 33638-8 | Lymphocyte proliferation stimulated by phytohemagglutinin [Mass/volume] in Blood |
| 53549-2 | Dodeicosanoylcarnitine (C22) [Moles/volume] in Urine |
| 53566-6 | Platelet aggregation collagen induced in Platelet rich plasma --8.0 ug/mL |
| 44946-2 | Borrelia burgdorferi 31kD IgG Ab [Presence] in Serum by Immunoblot |
| 45113-8 | Chlamydia sp Ag [Presence] in Urethra by Immunoassay |
| 45325-8 | Campylobacter jejuni IgG Ab [Titer] in Serum |
| 23698-4 | Canine herpesvirus Ag [Presence] in Tissue by Immunofluorescence |
| 23940-0 | Xylose [Mass/volume] in Blood --1 hour post dose xylose PO |
| 3403-3 | Bolasterone [Mass/volume] in Urine |
| 54014-6 | Vinculin Ab [Titer] in Serum by Immunofluorescence |
| 2497-6 | Iron [Mass/mass] in Hair |
| 34592-6 | HIV 1 Ab [Presence] in Body fluid by Immunoblot |
| 34690-8 | CV2 Ab [Presence] in Serum or Plasma |
| 47314-0 | Influenza virus B IgG Ab [Units/volume] in Serum by Immunoassay |
| 25240-3 | cefOXitin [Mass/volume] in Specimen |
| 3492-6 | clomiPRAMINE [Mass/volume] in Urine |
| 25878-0 | Citrulline/Creatinine [Molar ratio] in 24 hour Urine |
| 35414-2 | Specific gravity of Body fluid by Refractometry |
| 35613-9 | Glutethimide [Mass/volume] in Serum or Plasma by Screen method |
| 56244-7 | Dates IgG4 Ab [Mass/volume] in Serum |
| 56313-0 | Mango IgG4 Ab [Mass/volume] in Serum |
| 26583-5 | 3-Hydroxy,3-Methylglutarate/Creatinine [Molar ratio] in Urine |
| 26689-0 | Butabarbital [Mass/volume] in Vitreous fluid |
| 56572-1 | Somatotropin [Mass/volume] in Serum or Plasma --20 hours post XXX challenge |
| 2685-6 | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma |
| 38274-7 | Columbid circovirus DNA [Presence] in Specimen by NAA with probe detection |
| 49241-3 | Xylose absorption [Interpretation] in Urine and Serum or Plasma Narrative |
| 3878-6 | Opiates [Presence] in Serum or Plasma |
| 39774-5 | Porphyrins [Moles/mass] in Stool |
| 40203-2 | Glucose [Moles/volume] in Serum or Plasma --9 minutes post XXX challenge |
| 50142-9 | 3-O-Methyldopa [Moles/volume] in Urine |
| 50467-0 | C peptide [Moles/volume] in Serum or Plasma --7th specimen |
| 30209-1 | Coccidioides immitis Ab [Presence] in Cerebral spinal fluid by Complement fixation |
| 12349-7 | Trichlormethiazide [Presence] in Urine |
| 100799-6 | 21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge |
| 100803-6 | 21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge |
| 12580-7 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --5th specimen |
| 12833-0 | Prolactin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 101492-7 | cefOXitin [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 101517-1 | Canine parvovirus DNA VP2 gene [Presence] in Isolate by Sequencing |
| 13418-9 | Tryptophan [Mass/volume] in Amniotic fluid |
| 102156-7 | Groundsel Tree IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102670-7 | Tuna IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102783-8 | Parsley IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103009-7 | Amylase IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14425-3 | Globulin [Mass/volume] in Amniotic fluid |
| 14665-4 | Copper [Moles/volume] in Serum or Plasma |
| 14793-4 | Imipramine+Desipramine [Presence] in Urine |
| 10533-8 | Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma |
| 10569-2 | Color of Semen |
| 16200-8 | Propoxyphene [Presence] in Urine by Confirmatory method |
| 16271-9 | Calcium [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 16333-7 | Aldrin [Mass/volume] in Blood |
| 1122-1 | Le sup(x) Ab [Presence] in Serum or Plasma from Blood product unit |
| 17115-7 | CD126 cells/100 cells in Blood |
| 17175-1 | CD55 cells/100 cells in Blood |
| 17376-5 | Norpropoxyphene [Presence] in Urine by Confirmatory method |
| 74802-0 | Glucose challenge (hydrogen breath test) [Interpretation] in Exhaled gas |
| 75723-7 | CYP1A2 gene c.2385G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 60418-1 | Dengue virus 4 RNA [Presence] in Serum by NAA with probe detection |
| 76073-6 | Fungus identified in Nose by Culture |
| 92936-4 | 4q25 g.111710169C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 9327-8 | Phosphatidylserine IgM Ab [Presence] in Serum by Immunoassay |
| 77102-2 | NARS2 gene full mutation analysis in Blood or Tissue by Sequencing |
| 63068-1 | TOP2A gene copy number/Chromosome 17 copy number in Tissue by FISH |
| 78202-9 | 9q34 chromosome region deletion [Presence] in Blood or Tissue by FISH |
| 6601-9 | Influenza virus identified in Sputum by Organism specific culture |
| 9576-0 | Rubella virus Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 80536-6 | Methylenedioxyethylamphetamine [Mass/volume] in Blood |
| 96515-2 | Sandfly fever Sicilian virus IgG Ab [Presence] in Specimen by Immunoassay |
| 96807-3 | Vancomycin IgE Ab [Units/volume] in Serum |
| 69843-1 | Alpha hydroxybutyrate [Moles/volume] in Serum or Plasma |
| 97772-8 | Protein.monoclonal band 1 [Mass/volume] in Urine by Electrophoresis |
| 98183-7 | Wild boar dander IgE Ab [Units/volume] in Serum |
| 99069-7 | Jo-1 extractable nuclear Ab [Units/volume] in Serum by Line blot |
| 86172-4 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 87316-6 | Enterovirus G RNA [Presence] in Specimen by NAA with probe detection |
| 87396-8 | GenBank accession number |
| 87974-2 | Microscopic observation [Identifier] in Burn by Gram stain |
| 89598-7 | Mycoplasma hominis DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 59704-7 | LORazepam [Mass/mass] in Tissue |
| 5977-4 | Plasminogen activator inhibitor 2 Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
| 50819-2 | Barium [Moles/time] in 24 hour Urine |
| 50919-0 | Thorium [Moles/mass] in Tissue |
| 50995-0 | BRCA1+BRCA2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 30906-2 | Cobalamin (Vitamin B12) [Units/volume] in 24 hour Urine --post dose cyanocobalamin+intrinsic factor |
| 60011-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 60053-6 | aMILoride [Mass/volume] in Blood |
| 3135-1 | Xylose [Mass/volume] in Urine |
| 4281-2 | Ibuprofen [Mass] of Dose |
| 21670-5 | F7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 31714-9 | Adenovirus Ag [Presence] in Specimen |
| 51614-6 | Hemoglobin M/Hemoglobin.total in Blood |
| 51745-8 | Borrelia burgdorferi G39/40 IgG Ab [Presence] in Serum by Immunoblot |
| 4375-2 | Para hydroxyamphetamine [Mass] of Dose |
| 32108-3 | PHENobarbital [Presence] in Specimen |
| 32116-6 | Theophylline [Moles/volume] in Serum or Plasma --trough |
| 32669-4 | Borrelia burgdorferi DNA [Presence] in Synovial fluid by NAA with probe detection |
| 3280-5 | Kininogen LMW [Mass/volume] in Serum by Immunoassay |
| 53071-7 | Carnitine [Moles/volume] in Cerebral spinal fluid |
| 53259-8 | Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence |
| 53396-8 | Asparagine+Ornithine/Phenylalanine [Molar ratio] in DBS |
| 44818-3 | Brucella abortus IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 23211-6 | Listeria sp Ab [Presence] in Serum by Agglutination |
| 23552-3 | Venezuelan equine encephalitis virus subtype [Identifier] in Specimen by Neutralization test |
| 335-0 | Minocycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 33687-5 | Yersinia pestis Ag [Presence] in Specimen by Immunofluorescence |
| 53907-2 | Microscopic observation [Identifier] in Pleural fluid by Rhodamine-auramine fluorochrome stain |
| 23756-0 | Neospora caninum Ab [Units/volume] in Serum by Immunoassay |
| 23765-1 | Porcine adenovirus Ag [Presence] in Tissue by Immunofluorescence |
| 4559-1 | Hemoglobin Barts [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 46245-7 | Mycobacterium tuberculosis pncA gene pyrazinamide resistance mutation [Identifier] by Molecular method |
| 46246-5 | Mycobacterium tuberculosis katG gene isoniazid high level resistance mutation [Identifier] by Molecular method |
| 34604-9 | M Ab [Titer] in Serum or Plasma |
| 55170-5 | Cytoplasmic Ab [Titer] in Serum by Immunofluorescence |
| 55486-5 | Insulin [Moles/volume] in Serum or Plasma --1 minute post dose glucose IV |
| 55501-1 | Lutropin [Units/volume] in Serum or Plasma --4 hours post XXX challenge |
| 25200-7 | Rifabutin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 3478-5 | Chlorthalidone [Presence] in Urine |
| 26447-3 | Blasts/100 leukocytes in Cerebral spinal fluid |
| 35797-0 | Enrofloxacin [Susceptibility] by Disk diffusion (KB) |
| 56587-9 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 56931-9 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose lactulose |
| 56995-4 | Urea [Mass/volume] in Pleural fluid |
| 48384-2 | Collagen.bovine type 2 Ab [Units/volume] in Serum |
| 38578-1 | Carbon tetrachloride [Mass/volume] in Air |
| 57585-2 | Aldosterone [Mass/volume] in Serum or Plasma --3 hours post 25 mg captopril PO |
| 57662-9 | U1 small nuclear ribonucleoprotein Ab [Units/volume] in Serum by Immunoassay |
| 48899-9 | Orientia tsutsugamushi Karp IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 49109-2 | Toxoplasma gondii Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 2737-5 | Pepsinogen I [Mass/volume] in Urine |
| 28003-2 | Sodium/Potassium [Molar ratio] in Serum or Plasma |
| 394-7 | Penicillin G [Susceptibility] by Serum bactericidal titer |
| 39539-2 | Cockatiel droppings IgG Ab [Presence] in Serum |
| 57837-7 | Beta-1 transferrin [Presence] in Body fluid |
| 49682-8 | Lymphocyte proliferation stimulated by phytohemagglutinin [Ratio] in Blood --3 days post incubation |
| 4969-2 | HLA-DR52 [Presence] |
| 2943-9 | Sialate [Mass/volume] in Plasma |
| 40299-0 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose cloNIDine |
| 58684-2 | Uroporphyrin 1 isomer/Creatinine [Molar ratio] in Urine |
| 29898-4 | Borrelia burgdorferi IgG Ab [Presence] in Specimen by Immunoblot |
| 40537-3 | Monocytes/100 leukocytes in Peritoneal dialysis fluid by Manual count |
| 59136-2 | CD11c+CD103+ cells/100 cells in Bone marrow |
| 30135-8 | Echovirus Ab [Presence] in Serum --2nd specimen |
| 4113-7 | Amantadine [Mass] of Dose |
| 19184-1 | Tissue polypeptide specific Ag [Units/volume] in Serum or Plasma |
| 20952-8 | Salmonella sp identified in Egg by Organism specific culture |
| 100762-4 | HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method |
| 12914-8 | Beta-N-acetylhexosaminidase.A/Beta-n-acetylhexosaminidase.total in Serum or Plasma |
| 101309-3 | Glucose [Mass/volume] in Serum or Plasma --2 hours post dose arginine |
| 101512-2 | Salmonella typhimurium DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 12955-1 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 13828-9 | Cadmium/Creatinine [Mass Ratio] in 24 hour Urine |
| 14178-8 | Sucrase [Enzymatic activity/mass] in Tissue |
| 102922-2 | Cedar IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14613-4 | Nuclear Ab [Titer] in Body fluid |
| 103788-6 | Bacteria Identification and Susceptibilty in Positive blood culture Document |
| 104110-2 | Human bocavirus DNA [Presence] in Upper respiratory specimen by NAA with non-probe detection |
| 14883-3 | Porphyrins [Interpretation] in Serum or Plasma |
| 16830-2 | Erythromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 17056-3 | Legionella longbeachae 2 IgM Ab [Presence] in Serum |
| 17311-2 | Myelin associated glycoprotein IgA Ab [Units/volume] in Serum |
| 17670-1 | Sulfatide IgM Ab [Units/volume] in Serum by Immunofluorescence |
| 90338-5 | Cryptococcus sp rRNA gene [Presence] in Blood by NAA with probe detection |
| 90822-8 | CV2 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
| 74653-7 | Methylenedioxymethamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method |
| 91835-9 | Herpes simplex virus 1 Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
| 7648-9 | False ragweed triggered histamine release [Units/volume] in Blood |
| 61272-1 | Sunflower Seed IgE Ab/IgE total in Serum |
| 61406-5 | XXX blood group Ab [Titer] in Serum or Plasma |
| 62236-5 | Pyridoxal phosphate [Moles/volume] in Serum or Plasma |
| 62356-1 | Chromosome analysis result in ISCN expression |
| 94099-9 | Hantavirus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 64420-3 | KIR gene allele 2DS1 [Presence] in Blood or Tissue by Molecular genetics method |
| 79173-1 | Somatotropin [Units/volume] in Serum or Plasma --2 hours post XXX challenge |
| 95144-2 | Hepatitis D virus RNA panel - Serum or Plasma |
| 95665-6 | Snowshoe hare virus IgG Ab [Presence] in Specimen by Immunoassay |
| 66488-8 | Serotonin release.heparin.unfractionated in Serum Narrative |
| 66753-5 | Clot formation [Time] in Blood by Thromboelastography --after addition of heparinase |
| 80162-1 | Bile alcohols [Interpretation] in Urine Qualitative |
| 80546-5 | rifAMPin [Mass/volume] in DBS |
| 97558-1 | Acetylcholine receptor binding IgG+IgM Ab [Moles/volume] in Serum by Immunoassay |
| 70108-6 | Glutathione S-transferase T1 Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 98957-4 | Coccidioides immitis IgG Ab [Units/volume] in Specimen by Immunoassay |
| 71703-3 | Rotavirus IgG Ab [Titer] in Serum by Immunoassay |
| 72276-9 | Mycobacterium tuberculosis gyrA gene fluoroquinolone resistance mutation [Presence] by Molecular method |
| 72439-3 | 3-Methylglutarate [Moles/volume] in Serum or Plasma |
| 84880-4 | Position of rectal tumor in relation to anterior peritoneal reflection [Anatomy] in Tumor |
| 99861-7 | Erythrocytes.non-dysmorphic [#/volume] in Urine sediment by Computer assisted method |
| 7294-2 | Egg yolk IgG Ab [Units/volume] in Serum |
| 73188-5 | Propoxyphene+Acetaminophen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87242-4 | Geobacillus stearothermophilus [Presence] in Laboratory device by Culture |
| 87672-2 | Tocopherol+tocotrienol [Mass/mass] in Specimen |
| 73618-1 | Marbofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 88044-3 | P sup(k) Ab [Presence] in Serum or Plasma from Blood product unit |
| 73938-3 | fentaNYL [Mass/volume] in Blood by Confirmatory method |
| 73961-5 | Escherichia coli and Klebsiella pneumoniae and Pseudomonas aeruginosa rRNA [Identifier] by FISH in Positive blood culture |
| 89307-3 | Naloxone-3-glucuronide [Presence] in Urine by Screen method |
| 89333-9 | CD28+HLA DR+ cells/100 CD3+CD4+ cells in Blood |
| 41742-8 | Mold Allergen Mix 1 (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) IgE Ab [Units/volume] in Serum by Multidisk |
| 4175-6 | chlordiazePOXIDE [Mass] of Dose |
| 59333-5 | Norsibutramine [Mass/volume] in Serum or Plasma |
| 50733-5 | Serotonin release interpretation in Serum |
| 51016-4 | CD1 blasts [Units/volume] in Blood |
| 30922-9 | Magnesium [Mass/volume] in Urine collected for unspecified duration |
| 42622-1 | CD13+CD56+ cells/100 cells in Bone marrow |
| 60205-2 | Trimethadione [Mass/volume] in Urine |
| 21615-0 | CDKN2B gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
| 31608-3 | Orientia tsutsugamushi Karp Ab [Units/volume] in Serum |
| 51075-0 | CD14 blasts/100 blasts in Bone marrow |
| 5126-8 | Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 5255-5 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay |
| 43867-1 | Beta-2 transferrin [Presence] in Serum |
| 43897-8 | Baclofen [Presence] in Serum or Plasma |
| 44005-7 | Chlamydia trachomatis D and K IgA and IgG and IgM [Interpretation] in Serum |
| 44362-2 | Glutamine/Creatinine [Mass Ratio] in 24 hour Urine |
| 23070-6 | Equine arteritis virus Ab [Presence] in Serum by Immunoassay |
| 32809-6 | Fungus identified in Bronchial specimen by Fungus stain |
| 44524-7 | Histoplasma capsulatum Ag [Presence] in Urine by Immunoassay |
| 33358-3 | Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis |
| 33691-7 | Yersinia pestis DNA [Presence] in Specimen by NAA with probe detection |
| 33716-2 | Non-gynecological cytology study |
| 45229-2 | Toxocara cati Ab [Presence] in Serum |
| 23935-0 | Staphylococcus aureus toxic shock syndrome toxin 1 [Presence] in Specimen |
| 46980-9 | N-desalkylflurazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 2419-0 | Histidine [Mass/volume] in Blood |
| 24256-0 | Coxsackievirus B2 Ab [Titer] in Serum --2nd specimen |
| 55241-4 | HBB gene c.19G>A [Presence] in Blood by Molecular genetics method |
| 25160-3 | Granular casts [Presence] in Urine sediment by Light microscopy |
| 35316-9 | Lipase [Enzymatic activity/volume] in Body fluid --2nd specimen post Sincalide |
| 55694-4 | Ornidazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 47522-8 | Cytology report of Nipple discharge Cyto stain |
| 47527-7 | Cytology report of Cervical or vaginal smear or scraping Cyto stain.thin prep |
| 47576-4 | Aspartate/Amino acids.total in Amniotic fluid |
| 35353-2 | FSHD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 35653-5 | CD158 cells [#/volume] in Blood |
| 35764-0 | Cefetamet [Susceptibility] by Disk diffusion (KB) |
| 56174-6 | White Elm IgG4 Ab [Mass/volume] in Serum |
| 48315-6 | Leishmania mexicana IgM Ab [Titer] in Serum by Immunofluorescence |
| 26695-7 | Glucose [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 3812-5 | Methyprylon [Mass/volume] in Serum or Plasma |
| 56778-4 | Articaine IgE Ab [Units/volume] in Serum |
| 4869-4 | HLA-Dw10 [Presence] |
| 57498-8 | 11-Deoxycortisol [Moles/volume] in Serum or Plasma --2 days post dose dexamethasone |
| 48920-3 | Respiratory allergen panel, US - Southern Florida - Serum |
| 3874-5 | Nortriptyline [Presence] in Urine |
| 57718-9 | Sample quality of Dried blood spot |
| 58368-2 | Oxazepam/Creatinine [Mass Ratio] in Urine |
| 40147-1 | Creatinine [Moles/volume] in Urine --1 day post XXX challenge |
| 40202-4 | Glucose [Moles/volume] in Serum or Plasma --8 minutes post XXX challenge |
| 58714-7 | Oxidants [Presence] in Urine |
| 50066-0 | 1-Methylhistidine [Moles/volume] in Body fluid |
| 29794-5 | Anaplasma phagocytophilum IgM Ab [Presence] in Specimen by Immunoblot |
| 29815-8 | La Crosse virus IgG Ab [Presence] in Serum by Immunofluorescence |
| 29856-2 | Anaplasma phagocytophilum IgG Ab [Presence] in Serum |
| 2990-0 | Testosterone.free+weakly bound [Mass/volume] in Serum or Plasma |
| 58868-1 | Somatotropin [Mass/volume] in Serum or Plasma --40th specimen |
| 50502-4 | Insulin [Units/volume] in Serum or Plasma --2nd specimen |
| 30050-9 | Hydroxylysine/Creatinine [Ratio] in Urine |
| 19422-5 | Dextroamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
| 19593-3 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine by Confirmatory method |
| 21043-5 | 3-Methoxy-4-Hydroxyphenylglycol [Mass/volume] in 24 hour Urine |
| 100128-8 | Cryptococcus sp Ag panel - Serum |
| 100817-6 | Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 13401-5 | Hydroxyproline [Mass/volume] in Amniotic fluid |
| 13603-6 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin |
| 13633-3 | Insulin receptor Ab [Presence] in Serum |
| 13846-1 | CD7 blasts/100 blasts in Blood |
| 102559-2 | Giant Ragweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14707-4 | Doxepin+Nordoxepin [Moles/volume] in Serum or Plasma |
| 103170-7 | Clostridium botulinum DNA [Presence] in Wound by NAA with probe detection |
| 16132-3 | HIV 1 p15+p18 Ab [Presence] in Serum by Immunoblot |
| 10798-7 | Microscopic observation [Identifier] in Tissue by Oil red O stain |
| 10898-5 | Eastern equine encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 10-9 | Amdinocillin [Susceptibility] by Serum bactericidal titer |
| 11116-1 | Normoblasts Orthochromic/100 cells in Bone marrow by Manual count |
| 11165-8 | Chinchilla IgE Ab [Units/volume] in Serum |
| 1117-1 | Le sup(b) Ab [Presence] in Serum or Plasma from Donor |
| 1743-4 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P |
| 18208-9 | Cocaine [Mass/volume] in Specimen |
| 74939-0 | Vigabatrin [Mass/volume] in Serum or Plasma --trough |
| 91870-6 | Bordetella sp Ag [Presence] in Throat by Immunofluorescence |
| 6048-3 | Blue mussel IgE Ab [Units/volume] in Serum |
| 60538-6 | Influenza virus A H1+H3+B RNA [Presence] in Specimen by NAA with probe detection |
| 62367-8 | Chromosome analysis panel by FISH |
| 77056-0 | CYP11B1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 62425-4 | Creatinine [Moles/volume] in Serum or Plasma --post XXX challenge |
| 63456-8 | European house dust mite native (nDer p) 1 IgE Ab [Units/volume] in Serum |
| 79159-0 | Cold agglutinin [Titer] in Serum by 4 deg C incubation --24 hour post incubation |
| 96495-7 | ABL2 gene rearrangements in Blood or Tissue by FISH |
| 68320-1 | Polio virus Ab panel [Titer] - Serum |
| 96598-8 | Triglyceride [Mass/volume] in DBS |
| 96641-6 | HLA-DPA1 [Type] in Donor by High resolution |
| 9679-2 | Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma |
| 81833-6 | ALDH3A2 gene full mutation analysis in Blood or Tissue by Sequencing |
| 81959-9 | Public health laboratory ask at order entry panel |
| 82108-2 | Regional Allergen Mix 4 (Bermuda grass+Perennial rye grass+Brome+Common ragweed+Mugwort+English plantain) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 70106-0 | Methotrexate [Moles/volume] in Serum or Plasma --9th specimen |
| 8269-3 | Service comment 08 |
| 71704-1 | Rotavirus IgA Ab [Units/volume] in Serum by Immunoassay |
| 85686-4 | HIV 1 Ab [Presence] in Serum, Plasma or Blood by Immunofluorescence |
| 86591-5 | Toscana virus RNA [Presence] in Serum by NAA with probe detection |
| 73996-1 | oxyCODONE [Presence] in Meconium by Screen method |
| 74113-2 | Coumafuryl [Presence] in Specimen by Screen method |
| 74315-3 | PRRSV RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 41679-2 | Cefpodoxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 50968-7 | HLA Ab [Type] in Serum |
| 42329-3 | Bordetella pertussis IgM Ab [Units/volume] in Serum by Immunoassay |
| 42482-0 | Protein.monoclonal [Mass/time] in 24 hour Urine by Electrophoresis |
| 4260-6 | FLUoxetine [Mass] of Dose |
| 42675-9 | HLA Ag [Interpretation] |
| 60061-9 | buPROPion [Mass/volume] in Blood |
| 60308-4 | Ibuprofen [Moles/volume] in Specimen |
| 21361-1 | Laxatives present [Identifier] in Stool by Screen method |
| 21407-2 | Myelin IgA Ab [Titer] in Serum |
| 3131-0 | Xanthine [Mass/volume] in Serum |
| 51289-7 | CD30 cells/100 cells in Bone marrow |
| 42902-7 | Elastase.pancreatic [Presence] in Stool |
| 31779-2 | Chlamydophila psittaci Ag [Presence] in Genital specimen |
| 51704-5 | Herpes virus 6 Ab [Units/volume] in Serum by Immunoassay |
| 43714-5 | Adenovirus Ab [Presence] in Specimen |
| 22709-0 | Glycine/Creatinine [Molar ratio] in Urine |
| 22733-0 | Phosphate [Moles/volume] in Specimen |
| 32133-1 | Lactate [Moles/volume] in Plasma venous |
| 44045-3 | Aspergillus fumigatus O Ab [Presence] in Serum |
| 23034-2 | Duck hepatitis virus 1 Ab [Presence] in Serum |
| 44410-9 | Superoxide dismutase [Presence] in Plasma |
| 23216-5 | Lumpy skin disease virus Ab [Presence] in Serum |
| 23316-3 | Nairobi sheep disease virus Ab [Presence] in Serum |
| 33648-7 | Cryoglobulin Rheumatoid Factor [Units/volume] in Serum |
| 33713-9 | Clostridium botulinum toxin B [Presence] in Specimen |
| 53944-5 | Escherichia coli enteroinvasive [Presence] in Isolate |
| 45022-1 | Methadone+Metabolite [Presence] in Serum or Plasma by Confirmatory method |
| 45118-7 | Vesicular stomatitis Indiana virus Ag [Presence] in Specimen by Complement fixation |
| 23876-6 | HIV 1 RNA [Units/volume] (viral load) in Plasma by Probe with signal amplification |
| 54238-1 | LDL.oxidized [Units/volume] in Serum or Plasma |
| 547-0 | Streptococcus.beta-hemolytic [Presence] in Specimen by Organism specific culture |
| 55098-8 | Parainfluenza virus 2 [Presence] in Specimen by Organism specific culture |
| 47030-2 | Phosphatidate IgA Ab [Units/volume] in Serum by Immunoassay |
| 25443-3 | Hydroxylysine [Moles/time] in 24 hour Urine |
| 34947-2 | Herpes virus 7 IgG and IgM panel - Serum |
| 55799-1 | Platelet aggregation ristocetin induced [Presence] in Platelet rich plasma --1125 mg/L |
| 47661-4 | Insulin [Units/volume] in Serum or Plasma --20 minutes post dose glucose |
| 47702-6 | Methionine/Amino acids.total in Cerebral spinal fluid |
| 47741-4 | Purine nucleoside phosphorylase [Entitic Catalytic Activity] in Leukocytes |
| 25658-6 | Gastrin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 35557-8 | Cladosporium cladosporioides IgG Ab [Mass/volume] in Serum |
| 35576-8 | Hydrocarbon and Oxygenated Volatiles panel - Serum or Plasma |
| 35584-2 | Aniline [Mass/volume] in Blood |
| 56348-6 | Parsley IgG4 Ab [Mass/volume] in Serum |
| 56477-3 | Thyroperoxidase Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 56501-0 | Somatotropin [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
| 48130-9 | Somatotropin [Units/volume] in Serum or Plasma --30 minutes pre dose propranolol+glucagon |
| 48238-0 | Cockroach triggered leukotriene release [Mass/volume] by Leukocytes |
| 26627-0 | Legionella polyvalent A Ab [Presence] in Serum |
| 26749-2 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --2nd specimen |
| 3603-8 | Etamivan [Mass/volume] in Urine |
| 3672-3 | Heptaminol [Presence] in Urine |
| 5702-6 | Nickel [Mass/volume] in Serum or Plasma |
| 27095-9 | Parvovirus B19 IgG Ab [Titer] in Cerebral spinal fluid |
| 38636-7 | Di(2-Ethylhexyl) phthalate [Mass/volume] in Air |
| 48977-3 | SGCG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 49166-2 | Orientia tsutsugamushi Kato IgG Ab [Titer] in Body fluid |
| 49195-1 | California encephalitis virus IgG Ab [Units/volume] in Serum |
| 49253-8 | Beta-N-acetylhexosaminidase A and B [Interpretation] in Blood Narrative |
| 57753-6 | IKBKG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 49488-0 | Collection time of Body fluid |
| 29377-9 | Narcotics and opioids [Identifier] in Gastric fluid |
| 40196-8 | Glucose [Moles/volume] in Serum or Plasma --8 minutes pre XXX challenge |
| 49916-0 | Sweet gum IgE Ab/IgE total in Serum |
| 49977-2 | Borrelia burgdorferi 35kD IgG Ab [Presence] in Serum by Immunoblot |
| 50033-0 | Cephalosporin IgE Ab [Units/volume] in Serum |
| 29904-0 | Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection |
| 29936-2 | Nickel [Mass/volume] in 24 hour Urine |
| 30010-3 | Borrelia burgdorferi 93kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
| 20903-1 | Mycotoxin identified in Feed |
| 100999-2 | Somatotropin post dose insulin IV panel - Serum or Plasma |
| 12762-1 | Insulin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 101224-4 | PKD1 and PKD2 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
| 14401-4 | Creatinine [Mass/volume] in Synovial fluid |
| 103955-1 | KRAS Somatic mutation analysis in Tumor by Molecular genetics method |
| 14821-3 | Lymphocytes/100 leukocytes in Peritoneal fluid by Manual count |
| 1499-3 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.5 g/kg glucose IV |
| 15170-4 | Complement total hemolytic C50 [Units/volume] in Synovial fluid by Immunoassay |
| 104352-0 | Borrelia recurrentis DNA [Presence] in Blood by NAA with probe detection |
| 10567-6 | Citrate [Moles/volume] in Semen |
| 15355-1 | Estrone sulfate [Mass/volume] in Serum or Plasma |
| 15497-1 | Pseudorabies virus Ab [Presence] in Serum by Immunoassay |
| 16156-2 | Gastrin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 10823-3 | Mucopolysaccharides.microscopic observation [Identifier] in Tissue by Colloidal ferric oxide stain.Hale |
| 10955-3 | Long Leaf Pine IgE Ab [Units/volume] in Serum |
| 16507-6 | Calcitonin [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
| 1145-2 | Lu sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
| 16801-3 | Echovirus 3 Ab [Units/volume] in Serum by Complement fixation |
| 17100-9 | CD103 cells/100 cells in Blood |
| 17687-5 | Testosterone/Epitestosterone [Mass Ratio] in Serum or Plasma |
| 17866-5 | Carnitine/Creatinine [Ratio] in Urine |
| 1819-2 | Alpha mannosidase [Enzymatic activity/mass] in Tissue |
| 90850-9 | cefTAZidime 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 74530-7 | Dicarboxypalmitoleylcarnitine (C16:1-DC) [Moles/volume] in Serum or Plasma |
| 92254-2 | Microorganism identification and resistance pattern determination panel by Molecular genetics method |
| 75404-4 | West Nile virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 75601-5 | Fetal 1p36 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 60841-4 | Oxygen content in Venous blood by calculation |
| 7676-0 | Safflower IgE Ab [Units/volume] in Serum |
| 61227-5 | White Birch IgE Ab/IgE total in Serum |
| 77323-4 | diazePAM [Moles/volume] in Specimen |
| 62488-2 | Ova1 test [Presence] in Serum |
| 63175-4 | Epidermophyton floccosum IgG Ab [Mass/volume] in Serum |
| 94422-3 | Candida albicans, C. dubliniensis, C. parapsilosis, and C. tropicalis RNA [Presence] in Vaginal fluid by NAA with probe detection |
| 94615-2 | Bovine herpesvirus 1 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 95526-0 | Chromium [Mass/volume] in Synovial fluid |
| 79515-3 | Gentisate [Moles/volume] in Serum or Plasma |
| 677-5 | Microscopic observation [Identifier] in Specimen by Toluidine blue O stain |
| 96683-8 | Activated clotting time.glass bead induced of Blood by Microviscometry --post heparin neutralization |
| 69778-9 | Suberylcarnitine (C8-DC) [Moles/volume] in Amniotic fluid |
| 97510-2 | Glucose measurements in range out of Total glucose measurements during reporting period |
| 70142-5 | Benzodiazepines [Presence] in Urine by Screen method >300 ng/mL |
| 82895-4 | Pregnanediol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
| 85767-2 | Streptococcus agalactiae DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 87440-4 | Dengue virus 1+2+3+4 IgA+IgG+IgM Ab [Interpretation] in Specimen Qualitative by Immunoassay |
| 73929-2 | JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
| 41242-9 | Yeast [Presence] in Cerebral spinal fluid by Light microscopy |
| 59369-9 | Leptospira interrogans sv Hebdomadis Ab [Titer] in Serum by Agglutination |
| 59388-9 | Taenia solium larva DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 59700-5 | LORazepam [Mass/volume] in Blood by Confirmatory method |
| 59844-1 | Methylenedioxyethylamphetamine [Presence] in Urine by Screen method |
| 50864-8 | Hydrogen ion [Moles/volume] in Venous blood |
| 5100-3 | Coxiella burnetii Ab [Titer] in Serum by Complement fixation |
| 30992-2 | Aspergillus fumigatus recombinant (rAsp f) 4 IgE Ab [Units/volume] in Serum |
| 31037-5 | Moxifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 41762-6 | Megestrol acetate [Mass/volume] in Serum or Plasma |
| 42586-8 | Benzodiazepines [Mass/volume] in Blood by Confirmatory method |
| 21203-5 | Citrate [Mass/volume] in 24 hour Urine |
| 31475-7 | Leishmania donovani Ab [Units/volume] in Serum |
| 51146-9 | CD3 blasts [Units/volume] in Bone marrow |
| 51265-7 | CD19 cells/100 cells in Cerebral spinal fluid |
| 51326-7 | CD42b cells/100 cells in Cerebral spinal fluid |
| 31791-7 | Cryptococcus sp Ag [Units/volume] in Serum |
| 31996-2 | Basophils/100 leukocytes in Peritoneal fluid by Manual count |
| 51495-0 | Cortisol [Mass/volume] in Saliva (oral fluid) --baseline |
| 32184-4 | Itraconazole [Mass/volume] in Serum or Plasma --peak |
| 5266-2 | Paracoccidioides brasiliensis Ab [Titer] in Serum by Complement fixation |
| 43929-9 | Anthraquinone [Mass/volume] in Urine |
| 22955-9 | Brucella suis DNA [Presence] in Specimen by NAA with probe detection |
| 23112-6 | Foot and mouth disease virus Ag [Presence] in Tissue by Complement fixation |
| 32758-5 | CD11b cells/100 cells in Specimen |
| 32806-2 | Monocytes+Macrophages/100 leukocytes in Bronchial specimen by Manual count |
| 53326-5 | Specific gravity of Urine by Automated test strip |
| 23365-0 | Porcine parvovirus Ab [Presence] in Serum by Hemagglutination inhibition |
| 23403-9 | Rift valley fever virus Ag [Presence] in Specimen by Immunofluorescence |
| 4501-3 | Complement C4a [Mass/volume] in Plasma |
| 23722-2 | Feline herpesvirus neutralizing antibody [Titer] in Serum by Neutralization test |
| 2384-6 | Glyceraldehyde 3 phosphate dehydrogenase [Enzymatic activity/volume] in Serum |
| 23996-2 | Epstein Barr virus early IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 4596-3 | Hemoglobin J - Baltimore [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 34313-7 | Heptacarboxylporphyrin [Mass/mass] in Stool |
| 34453-1 | Jamestown canyon virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 47473-4 | Legionella pneumophila 9 IgG Ab [Titer] in Serum |
| 25316-1 | 17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma |
| 55619-1 | Avilamycin [Susceptibility] by Gradient strip |
| 25607-3 | Miconazole [Susceptibility] |
| 25632-1 | Plasmodium sp Ab [Titer] in Serum |
| 25798-0 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 25997-8 | Urate [Moles/volume] in 24 hour Urine |
| 26033-1 | Pronormoblasts/100 cells in Bone marrow |
| 56221-5 | Chinese Elm IgG4 Ab [Mass/volume] in Serum |
| 56441-9 | Latex IgG4 Ab [Mass/volume] in Serum |
| 26486-1 | Monocytes/100 leukocytes in Cerebral spinal fluid |
| 56746-1 | Leeks IgE Ab [Units/volume] in Serum |
| 56969-9 | Paper wasp IgG4 Ab [Units/volume] in Serum |
| 27062-9 | Ketones [Presence] in Urine --1 hour post XXX challenge |
| 48931-0 | Respiratory allergen panel, US - AZ, Southeastern CA, Western NM - Serum |
| 5803-2 | pH of Urine by Test strip |
| 58374-0 | Meprobamate [Mass/volume] in Urine by Confirmatory method |
| 49362-7 | Hepatitis B virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 28543-7 | Basophils/100 leukocytes in Body fluid |
| 40024-2 | Glucose [Mass/volume] in Serum or Plasma --1 day post XXX challenge |
| 5847-9 | Herpes simplex virus 2 Ag [Presence] in Genital specimen by Immunofluorescence |
| 50136-1 | 3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in Urine |
| 29639-2 | Alkaline phosphatase [Enzymatic activity/mass] in Tissue |
| 59214-7 | Succinyladenosine/Creatinine [Molar ratio] in Urine |
| 30178-8 | West Nile virus IgG Ab [Presence] in Specimen by Immunoassay |
| 40813-8 | 11-Hydroxyetiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine |
| 1991-9 | Calciferol binding proteins [Mass/volume] in Serum |
| 20464-4 | Toxoplasma gondii Ab [Interpretation] in Serum |
| 12714-2 | N-methylhistamine [Mass/volume] in Urine |
| 12751-4 | Insulin [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge |
| 13021-1 | Pesticides [Identifier] in Gastric fluid |
| 13133-4 | Streptococcus pneumoniae Danish serotype 6B Ab [Units/volume] in Serum |
| 13624-2 | DOXOrubicin [Mass/volume] in Serum or Plasma |
| 102447-0 | Chrysonilia sitophila IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102626-9 | Tetramin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14219-0 | HTLV I p26 Ab [Presence] in Serum |
| 102722-6 | Coffee IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102888-5 | Swine serum albumin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103672-2 | Amoxicillin+Clavulanate [Susceptibility] for UTI |
| 103950-2 | NOTCH3 gene full mutation analysis in Specimen by Molecular genetics method |
| 104359-5 | Brucella melitensis DNA [Presence] in Specimen by NAA with non-probe detection |
| 1060-3 | I Ab [Presence] in Serum or Plasma |
| 1074-4 | Jk sup(b) Ab [Presence] in Serum or Plasma from Donor |
| 10864-7 | Immune complex [Units/volume] in Serum or Plasma by Raji cell assay |
| 16315-4 | Acid phosphatase [Enzymatic activity/volume] in Blood by Tartrate inhibited |
| 16594-4 | Chlamydia trachomatis IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 12333-1 | Butorphanol [Presence] in Urine |
| 17740-2 | Trichlorophenoxyacetate [Presence] in Blood |
| 18244-4 | Niacin [Mass/volume] in Serum or Plasma |
| 18340-0 | Nortramadol [Mass/volume] in Serum or Plasma by Confirmatory method |
| 18406-9 | Arsenic trioxide [Mass/volume] in Urine |
| 90990-3 | Protein.monoclonal isotype [Identifier] in Serum or Plasma by MS.MALDI-TOF |
| 75118-0 | Octadecanoate (C18:0) [Entitic substance] in Red Blood Cells |
| 75603-1 | Comment on fetal 1p36 deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 76613-9 | Transferrin.carbohydrate deficient.pentasialo+hexasialo/Transferrin.total in Serum or Plasma |
| 61212-7 | Grey Alder IgE Ab/IgE total in Serum |
| 93796-1 | MYCN gene amplification in Blood or Tissue by FISH |
| 94548-5 | Porphyrin fractions panel [Mass/time] - 24 hour Stool |
| 63549-0 | Albumin in serum - albumin in peritoneal fluid [Mass concentration difference] |
| 6472-5 | Microscopic observation [Identifier] in Tissue by Calcofluor white |
| 95227-5 | Other cells/100 leukocytes in Stem cell product by Manual count |
| 9539-8 | La Crosse virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 95670-6 | Ross River virus IgG Ab [Presence] in Specimen by Immunoassay |
| 6542-5 | Rickettsia prowazekii Ab [Units/volume] in Serum by Complement fixation |
| 95914-8 | Blastomyces sp DNA [Presence] in Tissue by NAA with probe detection |
| 96309-0 | Methicillin resistance mecA+mecC genes+SCCmec+OrfX junction [Presence] by Molecular method |
| 68435-7 | Erythrocytes [#/volume] in Vitreous fluid by Automated count |
| 68935-6 | LDL.oxidized Ab [Units/volume] in Serum by Immunoassay |
| 69874-6 | Service comment 47 |
| 82722-0 | Potassium [Mass/volume] in Red Blood Cells |
| 98023-5 | Epithelial cells [#/area] in Cervical or vaginal smear or scraping by Light microscopy |
| 98204-1 | Borrelia burgdorferi IgG and IgM bands panel - Serum by Immunoblot |
| 98492-2 | Apolipoprotein E and beta amyloid Alzheimer's risk panel - Cerebral spinal fluid |
| 72565-5 | Creatine kinase.BB/Creatine kinase.total [Pure catalytic fraction] in Serum or Plasma by Electrophoresis |
| 86322-5 | Enterovirus [Presence] in Specimen by Organism specific culture |
| 73046-5 | Cefepime induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73315-4 | Leuprolide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73714-8 | Food Allergen Mix 71 (Caraway+Cardamon+Mace+Clove) IgE Ab [Units/volume] in Serum by Multidisk |
| 87782-9 | Diclofenac/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 88213-4 | Rhinovirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 88255-5 | Enterobacter sp gyrB+metB genes [Presence] by Probe in Positive blood culture |
| 74110-8 | traMADol [Presence] in Saliva (oral fluid) by Screen method |
| 59422-6 | Leptospira interrogans sv Javanica Ab [Titer] in Serum by Agglutination |
| 5983-2 | Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis |
| 30994-8 | Timothy recombinant (rPhl p) 1 IgE Ab [Units/volume] in Serum |
| 42356-6 | Tigecycline [Susceptibility] by Disk diffusion (KB) |
| 42629-6 | Glucose [Mass/volume] in Urine --4 hours post dose lactose PO |
| 60103-9 | O-desmethylvenlafaxine [Mass/volume] in Body fluid |
| 21413-0 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Urine |
| 31346-0 | Ganglioside GD1b IgG Ab [Units/volume] in Serum |
| 31418-7 | Heterophile Ab [Presence] in Serum |
| 31560-6 | Peste des petits ruminants virus Ab [Units/volume] in Serum |
| 4275-4 | hydroCHLOROthiazide [Mass] of Dose |
| 21800-8 | t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 31980-6 | Trypanosoma sp Ag [Presence] in Blood |
| 51531-2 | Beta lactoglobulin IgG Ab [Presence] in Serum |
| 51679-9 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 32274-3 | Thiosulfate/Creatinine [Ratio] in Urine |
| 43881-2 | Bordetella pertussis filamentous hemagglutinin IgG Ab [Presence] in Serum |
| 44000-8 | Choriogonadotropin [Units/volume] in Amniotic fluid |
| 32674-4 | Cryptococcus sp Ag [Titer] in Cerebral spinal fluid |
| 32723-9 | Trichinella sp IgG Ab [Units/volume] in Serum by Immunoassay |
| 44608-8 | KCNQ1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 44804-3 | Taenia solium IgG Ab [Units/volume] in Serum by Immunoblot |
| 44822-5 | La Crosse virus IgM Ab [Titer] in Serum by Immunoassay |
| 334-3 | Minocycline [Susceptibility] by Minimum lethal concentration (MLC) |
| 53511-2 | Dodecenoylcarnitine (C12:1)/Creatinine [Molar ratio] in Urine |
| 55145-7 | Saint Louis encephalitis virus RNA [Presence] in Specimen by NAA with probe detection |
| 55341-2 | Xg sup(a) Ab [Titer] in Serum or Plasma |
| 55543-3 | Hydroxychloroquine [Moles/volume] in Serum or Plasma |
| 47271-2 | Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --4th specimen post XXX challenge |
| 55701-7 | Paromomycin [Susceptibility] by Disk diffusion (KB) |
| 55737-1 | Cefotiam hexetil [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 56019-3 | Platelet aggregation thrombin induced ATP secretion in Blood --1 U/mL |
| 47586-3 | C peptide [Moles/volume] in Serum or Plasma --1 hour post dose glucose |
| 47694-5 | Lysine/Amino acids.total in DBS |
| 35378-9 | HNPCC genes mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 5640-8 | Ethanol [Mass/volume] in Blood |
| 4798-5 | HLA-B75(15) [Presence] in Donor |
| 48092-1 | Corticotropin [Mass/volume] in Plasma --12 PM specimen |
| 48212-5 | Pork triggered leukotriene release [Mass/volume] by Leukocytes |
| 26653-6 | Colorado tick fever virus Ab [Presence] in Serum |
| 56600-0 | European Hornet IgG Ab [Mass/volume] in Serum |
| 56784-2 | Fibrinogen fragments [Mass/volume] in Urine |
| 56980-6 | Sodium/Creatinine [Ratio] in 24 hour Urine |
| 57034-1 | Penicillium sp Ab [Presence] in Serum by Immune diffusion (ID) |
| 27083-5 | Norflunitrazepam [Mass/volume] in Urine |
| 38379-4 | Mycobacterium tuberculosis complex DNA [Presence] in Specimen by NAA with probe detection |
| 57287-5 | Chlamydia trachomatis rRNA [Presence] in Anal by NAA with probe detection |
| 57509-2 | 11-Hydroxyandrosterone [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
| 57561-3 | 21-Deoxycorticosterone [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin |
| 3936-2 | Phencyclidine [Presence] in Urine |
| 39589-7 | HTLV I p19 Ab [Units/volume] in Serum |
| 5772-9 | Calcium carbonate crystals [Presence] in Synovial fluid by Light microscopy |
| 5810-7 | Specific gravity of Urine by Refractometry |
| 3992-5 | Propranolol [Mass/volume] in Serum or Plasma |
| 39995-6 | Creatinine [Mass/volume] in Urine --8 hours post XXX challenge |
| 40067-1 | Calcium [Mass/volume] in Serum or Plasma --baseline |
| 40099-4 | aPTT in Platelet poor plasma by Coagulation assay --2 hours pre XXX challenge |
| 40125-7 | Creatinine [Moles/volume] in Serum or Plasma --18 hours post XXX challenge |
| 40130-7 | Creatinine [Moles/volume] in Urine --1.5 hours pre XXX challenge |
| 29907-3 | Haemophilus influenzae B DNA [Presence] in Specimen by NAA with probe detection |
| 40386-5 | Nicotine [Presence] in Hair |
| 40609-0 | Benzoylecgonine [Presence] in Specimen |
| 5032-8 | Parvovirus B19 RNA [Presence] in Specimen by NAA with probe detection |
| 50337-5 | carBAMazepine and metabolites panel - Serum or Plasma |
| 30163-0 | Sweat Bee IgE Ab [Units/volume] in Serum |
| 19384-7 | Carboxy tetrahydrocannabinol cutoff [Mass/volume] in Urine for Confirmatory method |
| 19756-6 | Sheep milk IgE Ab [Units/volume] in Serum |
| 1979-4 | Biopterin [Mass/volume] in 24 hour Urine |
| 20660-7 | Tyrosine [Moles/volume] in Serum or Plasma |
| 20760-5 | Clostridium chauvoei Ag [Presence] in Tissue by Immunofluorescence |
| 12803-3 | Phenylalanine [Presence] in Blood by Guthrie test |
| 12904-9 | Renin [Enzymatic activity/volume] in Plasma --6th specimen post XXX challenge |
| 101296-2 | Mycoplasma pneumoniae DNA [Presence] in Throat by NAA with non-probe detection |
| 101387-9 | HBA1 and HBA2 gene full mutation analysis in Blood or Tissue by Molecular genetics method |
| 101407-5 | Laceyella sacchari IgG Ab [Units/volume] in Serum |
| 101561-9 | Rotavirus C RNA [Presence] in Stool by NAA with probe detection |
| 101981-9 | Maximum amplitude kaolin induced [Length] in Blood by Resonance TEG |
| 13485-8 | Beta-2-Microglobulin/Creatinine [Mass Ratio] in Urine |
| 102246-6 | Coconut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102529-5 | Eastern White Pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14201-8 | Chlamydia trachomatis B IgM Ab [Titer] in Serum by Immunofluorescence |
| 102771-3 | Red mulberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14382-6 | Mononuclear cells/100 leukocytes in Synovial fluid by Manual count |
| 104373-6 | Corynebacterium ulcerans [Presence] in Specimen by Organism specific culture |
| 16685-0 | Coxsackievirus B IgG Ab [Units/volume] in Serum by Neutralization test |
| 11481-9 | Human papilloma virus identified in Specimen |
| 1-8 | Acyclovir [Susceptibility] |
| 74832-7 | OLANZapine [Mass] of Dose |
| 74877-2 | Argininosuccinate [Moles/volume] in DBS --post therapeutic diet |
| 7544-0 | Okra IgE Ab [Units/volume] in Serum |
| 92878-8 | Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 9312-0 | Aminocaproate [Mass/volume] in Serum or Plasma |
| 9355-9 | Bumetanide [Mass/volume] in Serum or Plasma |
| 61350-5 | Lymphocyte proliferation stimulated by 2.5 ug concanavalin A in Blood |
| 62346-2 | Chromosome analysis.interphase panel - Amniotic fluid by FISH |
| 77670-8 | Gastrin [Moles/volume] in Serum or Plasma --pre XXX challenge |
| 63042-6 | 17-Hydroxyprogesterone/Creatinine [Mass Ratio] in Urine |
| 78743-2 | Steroid fractions interpretation in Urine Narrative |
| 63431-1 | Bordetella sp DNA [Presence] in Specimen by NAA with probe detection |
| 6349-5 | Chlamydia trachomatis [Presence] in Specimen by Organism specific culture |
| 78862-0 | Naloxol [Mass/volume] in Urine by Confirmatory method |
| 78965-1 | Neurofilament medium chain Ab [Mass/volume] in Cerebral spinal fluid |
| 7897-2 | Hantavirus puumala IgG Ab [Units/volume] in Serum |
| 66759-2 | Heparin neutralization [Presence] in Blood by Thromboelastography |
| 66876-4 | FMR1 gene premutation/premutation+full mutation in Blood by Molecular genetics method |
| 6714-0 | Beef IgG Ab [Units/volume] in Serum |
| 671-8 | Microscopic observation [Identifier] in Specimen by Methylene blue stain.Loeffler |
| 79581-5 | Alanylproline [Moles/volume] in Serum or Plasma |
| 8011-9 | Rotavirus [Presence] in Stool by Electron microscopy |
| 9586-9 | Borrelia burgdorferi Ab [Interpretation] in Serum |
| 96462-7 | Sirolimus [Moles/volume] in Blood by Immunoassay |
| 97526-8 | Balamuthia mandrillaris Ag [Presence] in Specimen by Immunofluorescence |
| 97753-8 | Ammonia [Moles/mass] in Stool |
| 82475-5 | Borrelia miyamotoi glpQ gene [Presence] in Blood by NAA with non-probe detection |
| 8265-1 | Service comment 04 |
| 98103-5 | Interleukin 9 [Mass/volume] in Serum or Plasma |
| 72422-9 | Gamma aminobutyrate [Moles/volume] in Blood from Fetus |
| 86184-9 | Streptococcus pneumoniae Danish serotype 9N Ab [Mass/volume] in Serum --2nd specimen |
| 86609-5 | Noroxymorphone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 73177-8 | quiNINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88340-5 | Mite [Presence] in Ear by Light microscopy |
| 74417-7 | Measles virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 88894-1 | Brivaracetam [Mass/volume] in Serum or Plasma |
| 88925-3 | Microsporidia DNA [Presence] in Stool by NAA with probe detection |
| 89342-0 | Babesia sp 18S rRNA [Presence] in Blood by NAA with probe detection |
| 4172-3 | Chloral hydrate [Mass] of Dose |
| 59797-1 | Glucose [Molar concentration difference] in Serum or Plasma --5 hours post XXX challenge |
| 50909-1 | Silver [Moles/volume] in Urine |
| 31000-3 | Timothy recombinant (rPhl p) 11 IgE Ab [Units/volume] in Serum |
| 310-3 | Lymecycline [Susceptibility] by Minimum lethal concentration (MLC) |
| 21357-9 | Ketones [Presence] in Urine --1.5 hours post XXX challenge |
| 21592-1 | Varicella zoster virus Ab [Titer] in Cerebral spinal fluid |
| 51419-0 | Sodium [Moles/volume] corrected for glucose in Serum or Plasma |
| 51448-9 | Dihydrocodeine+Hydrocodol [Mass/volume] in Urine |
| 31935-0 | Pneumocystis jiroveci Ag [Presence] in Eye |
| 51684-9 | Pregnenolone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 51819-1 | Leptospira sp IgM Ab [Units/volume] in Serum by Immunoassay |
| 43242-7 | ACADM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 43728-5 | Lipoprotein.pre-beta.subparticle.large [Moles/volume] in Serum or Plasma |
| 43808-5 | Urease [Presence] in Tissue --30 minutes post incubation |
| 32310-5 | Cortisol [Moles/time] in 24 hour Urine |
| 3236-7 | Coagulation factor XIII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
| 52974-3 | Influenza virus B Ab [Units/volume] in Serum by Complement fixation |
| 53030-3 | Liver kidney microsomal Ab [Presence] in Serum by Immunofluorescence |
| 328-5 | metroNIDAZOLE [Susceptibility] by Disk diffusion (KB) |
| 53117-8 | Thermolabile hemoglobin [Presence] in Red Blood Cells |
| 23285-0 | Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum |
| 23559-8 | Vesicular stomatitis virus Ag [Presence] in Skin by Complement fixation |
| 23571-3 | Vesicular stomatitis virus serotype [Identifier] in Tissue by Immunoassay |
| 45057-7 | Cardiolipin IgA and IgG and IgM panel - Serum |
| 45062-7 | C reactive protein [Mass/volume] in Cerebral spinal fluid |
| 23683-6 | Brucella canis Ab [Titer] in Serum by Immunofluorescence |
| 23906-1 | Mycophenolate glucuronide [Mass/volume] in Serum or Plasma |
| 24027-5 | Streptococcus pneumoniae Ag [Presence] in Urine |
| 33967-1 | SARS coronavirus Urbani RNA [Presence] in Serum or Plasma by NAA with probe detection |
| 3419-9 | Butabarbital [Presence] in Urine |
| 46751-4 | Other organic acidemias newborn screen interpretation |
| 24130-7 | Bordetella pertussis secretory IgA Ab [Presence] in Specimen by Immunoassay |
| 34364-0 | Pregnanetriolone/Creatinine [Molar ratio] in Urine |
| 34431-7 | Salmonella enteritidis H Ab [Titer] in Serum by Agglutination |
| 55343-8 | Anidulafungin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 55546-6 | Ketoprofen [Moles/volume] in Serum or Plasma |
| 2548-6 | Lactate dehydrogenase 5/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis |
| 558-7 | Chlamydia sp identified in Throat by Organism specific culture |
| 47566-5 | Arginine/Amino acids.total in Amniotic fluid |
| 25885-5 | Cortisol Free [Moles/time] in 24 hour Urine by HPLC |
| 48057-4 | Human bocavirus IgG Ab [Presence] in Specimen by Immunoassay |
| 48196-0 | Cephalosporin C triggered leukotriene release [Mass/volume] by Leukocytes |
| 26474-7 | Lymphocytes [#/volume] in Blood |
| 26758-3 | Cocaine [Mass/mass] in Stool |
| 38188-9 | Bile acid.trihydroxy [Moles/volume] in Serum or Plasma |
| 56970-7 | Porphyrins [Mass/volume] in 24 hour Urine |
| 57008-5 | Legionella pneumophila IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 48650-6 | Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 500 copies/mL |
| 27125-4 | Zinc [Mass/mass] in Red Blood Cells |
| 57596-9 | Aldosterone [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM |
| 49268-6 | Glycosaminoglycans pattern [Interpretation] in Urine Narrative |
| 49277-7 | Immunofixation for 24 hour Urine Narrative |
| 27314-4 | HYDROmorphone Free [Mass/mass] in Stool |
| 27384-7 | Leptospira sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 3926-3 | PENTobarbital [Mass/volume] in Urine |
| 3939-6 | Phendimetrazine [Presence] in Urine |
| 58811-1 | Renin [Mass/volume] in Plasma --post XXX challenge |
| 49942-6 | Somatotropin [Units/volume] in Serum or Plasma --1 AM specimen |
| 29553-5 | Age calculated |
| 29620-2 | Zonisamide [Mass/volume] in Serum or Plasma |
| 29766-3 | Triglyceride [Moles/volume] in Body fluid |
| 29915-6 | Tellurium [Mass/time] in 24 hour Urine |
| 29967-7 | Neutrophil cytoplasmic IgG Ab [Titer] in Serum by Immunofluorescence |
| 59156-0 | Glucose [Moles/volume] in Urine by Automated test strip |
| 30005-3 | CYP21A2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 30307-3 | Indinavir [Susceptibility] |
| 19768-1 | Reviewing cytologist who read Cyto stain of Cervical or vaginal smear or scraping |
| 100146-0 | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot |
| 12864-5 | Borrelia burgdorferi 25kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 101156-8 | Alpha hydroxyetizolam [Presence] in Urine by Confirmatory method |
| 13003-9 | Halogenated organic molecules [Identifier] in Blood |
| 13170-6 | Immune complex [Units/volume] in Serum or Plasma by Conglutinin assay |
| 13237-3 | Epstein Barr virus early restricted Ab [Presence] in Serum by Immunofluorescence |
| 101747-4 | PCA-Tr Ab [Titer] in Serum by Cell binding immunofluorescent assay |
| 1356-5 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --8 hours post 30 mg/kg metyraPONE PO |
| 13618-4 | Tetrahydroaldosterone [Mass/time] in 24 hour Urine |
| 13805-7 | Pyruvate/Creatinine [Mass Ratio] in Urine |
| 13834-7 | Total IgE [Units/volume] in Serum by Radioallergosorbent test (RAST) |
| 102392-8 | Isocyanate MDI IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102433-0 | Whiff IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14348-7 | Specific gravity of Peritoneal fluid by Refractometry |
| 103093-1 | Latex recombinant (rHev b) 5 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10349-9 | Brucella sp Ab [Units/volume] in Serum |
| 1036-3 | G Ab [Presence] in Serum or Plasma from Blood product unit |
| 10391-1 | Cytomegalovirus immune globulin given [Volume] |
| 15181-1 | IgA [Mass/volume] in Body fluid |
| 15196-9 | CD3-CD19+ cells/100 cells in Blood |
| 104345-4 | Borna disease virus Ag [Presence] in Brain tissue by Immune stain |
| 104377-7 | Coxiella burnetii IgG Ab [Titer] in Serum by Immunoassay --1st specimen |
| 10459-6 | Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain |
| 10634-4 | Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma |
| 15350-2 | Amylase [Enzymatic activity/time] in 2 hour Urine |
| 10946-2 | Passion fruit IgE Ab [Units/volume] in Serum |
| 11101-3 | Bacteria [#/area] in Synovial fluid by Microscopy high power field |
| 11134-4 | Appearance of Spun Body fluid |
| 16519-1 | Calcium [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 17329-4 | Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 17559-6 | Salicylates [Presence] in Blood |
| 17581-0 | Ganglioside GQ1b IgM Ab [Presence] in Serum |
| 90817-8 | Aquaporin 4 water channel Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 91854-0 | Human papilloma virus 18 DNA [Presence] in Genital specimen by NAA with probe detection |
| 92236-9 | Lab observation result status |
| 75764-1 | Tripelennamine [Presence] in Serum or Plasma or Urine by Screen method |
| 6201-8 | Parrot droppings IgE Ab [Units/volume] in Serum |
| 78697-0 | Olive IgG Ab [Mass/volume] in Serum |
| 78859-6 | Mirtazapine [Presence] in Urine by Confirmatory method |
| 6444-4 | Lactoferrin [Presence] in Specimen by Latex agglutination |
| 6445-1 | Legionella pneumophila Ag [Presence] in Sputum by Immunofluorescence |
| 7924-4 | Influenza virus A Leningrad Ab [Units/volume] in Serum |
| 79295-2 | D- and L-2-hydroxyglutarate panel - Serum or Plasma |
| 65323-8 | He Ab [Presence] in Serum or Plasma |
| 6652-2 | Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 66724-6 | Adenovirus DNA [Log #/volume] (viral load) in Stool by NAA with probe detection |
| 79586-4 | R- and S-beta aminoisobutyrate and D- and L-serine panel - Cerebral spinal fluid |
| 95695-3 | Colorado tick fever virus IgA Ab [Presence] in Specimen by Immunoassay |
| 69963-7 | t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
| 81776-7 | Ureidopropionate/Creatinine [Molar ratio] in Urine |
| 70165-6 | Trichomonas vaginalis rRNA [Presence] in Vaginal fluid by NAA with probe detection |
| 71596-1 | Eosinophils/Leukocytes [Pure number fraction] in Bronchial specimen by Manual count |
| 82993-7 | Mj IgG Ab [Presence] in Serum by Line blot |
| 7200-9 | Chaetomium globosum IgE Ab [Units/volume] in Serum |
| 99457-4 | Tyrophagus putrescentiae IgG Ab [Mass/volume] in Serum |
| 72750-3 | oxyCODONE [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 86083-3 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum by Immunoassay |
| 73818-7 | Heparin induced platelet IgG Ab in Serum or Plasma by Immunoassay |
| 88527-7 | Respiratory syncytial virus [Presence] in Cornea or Conjunctiva by Organism specific culture |
| 41503-4 | Neisseria meningitidis serogroup B Ag [Presence] in Body fluid |
| 31056-5 | Coxsackievirus B4 Ab [Titer] in Body fluid by Complement fixation |
| 31190-2 | Microscopic observation [Identifier] in Salivary gland fine needle aspirate by Cyto stain |
| 31572-1 | PRRSV Ab [Units/volume] in Serum |
| 51359-8 | CD61 cells/100 cells in Tissue |
| 43058-7 | Chlamydia trachomatis D+K IgM Ab [Titer] in Serum |
| 22221-6 | Coxsackievirus A9 Ab [Titer] in Cerebral spinal fluid |
| 32000-2 | Catecholamines [Mass/volume] in 24 hour Urine |
| 51523-9 | Grass Allergen Mix 2 (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass+Bahia grass) IgE Ab [Presence] in Serum by Multidisk |
| 51526-2 | Regional Allergy Mix 5 (Aspergillus fumigatus+Cockroach+Cat dander+European house dust mite) IgE Ab [Presence] in Serum by Multidisk |
| 51987-6 | Coenzyme Q10 [Presence] in Serum or Plasma |
| 23171-2 | Leptospira interrogans sv Bratislava Ab [Presence] in Serum by Agglutination |
| 23185-2 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Presence] in Serum |
| 32587-8 | Androstenedione [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
| 33054-8 | BCL2 Ag [Presence] in Tissue by Immune stain |
| 44707-8 | Albumin/Creatinine [Mass Ratio] in Cerebral spinal fluid |
| 53868-6 | Glucose tetrasaccharide/Creatinine [Molar ratio] in Urine |
| 45126-0 | Vesicular stomatitis Alagoas virus Ag [Presence] in Specimen by Immunoassay |
| 23706-5 | Canine parvovirus Ag [Presence] in Stool by Immunofluorescence |
| 54412-2 | Cryoprecipitate poor plasma units given [#] |
| 47172-2 | Norepinephrine [Moles/volume] in Urine --6th specimen post XXX challenge |
| 47435-3 | Epstein Barr virus early IgA Ab [Titer] in Serum |
| 25110-8 | Hydroxyproline/Creatinine [Molar ratio] in Urine |
| 25325-2 | Ascaris sp IgE Ab [Units/volume] in Serum by Immunoassay |
| 35310-2 | Trypsin [Enzymatic activity/volume] in Body fluid --3rd specimen post Sincalide |
| 25752-7 | Rickettsia prowazekii IgM Ab [Titer] in Serum by Immunofluorescence |
| 25934-1 | Hydroxyproline [Moles/volume] in 24 hour Urine |
| 25953-1 | Lysine/Creatinine [Molar ratio] in 24 hour Urine |
| 48126-7 | Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose ornithine |
| 26578-5 | Beta alanine/Creatinine [Molar ratio] in Urine |
| 35865-5 | Lipoprotein.intermediate density [Presence] in Serum or Plasma |
| 368-1 | Norfloxacin [Susceptibility] by Disk diffusion (KB) |
| 48591-2 | Activated protein C resistance [Interpretation] in Platelet poor plasma |
| 48645-6 | Pseudomonas sp DNA [Identifier] in Specimen by NAA with probe detection |
| 48783-5 | Dipyrone IgE Ab [Units/volume] in Serum |
| 48883-3 | Bartonella henselae IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 26863-1 | HYDROcodone [Mass/mass] in Meconium |
| 26887-0 | Alpha hydroxyalprazolam [Mass/mass] in Hair |
| 38298-6 | Dinoseb [Mass/volume] in Water |
| 38313-3 | Toluene [Mass/volume] in Water |
| 38527-8 | Number of specimens received of Stool |
| 38609-4 | Methyl tert-butyl ether [Mass/volume] in Air |
| 38732-4 | Trifluralin [Mass/volume] in Air |
| 39549-1 | Escargot IgE Ab/IgE total in Serum |
| 57738-7 | Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay |
| 57761-9 | Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay |
| 5792-7 | Glucose [Mass/volume] in Urine by Test strip |
| 5830-5 | Adenovirus Ag [Presence] in Tissue by Immunofluorescence |
| 5837-0 | Cytomegalovirus [Presence] in Urine by Organism specific culture |
| 29408-2 | Imipramine [Mass/volume] in Gastric fluid |
| 40269-3 | Creatinine [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 58792-3 | Coxsackievirus A9 IgG Ab [Titer] in Serum by Immunofluorescence |
| 40327-9 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --pre dose triple bolus |
| 58953-1 | Meperidine and Normeperidine panel - Urine |
| 59234-5 | Reducing substances [Moles/volume] in Urine |
| 30022-8 | Botrytis cinerea IgG Ab [Units/volume] in Serum |
| 19245-0 | clonazePAM [Presence] in Urine |
| 19387-0 | chlordiazePOXIDE cutoff [Mass/volume] in Urine for Screen method |
| 19610-5 | Naltrexone [Mass/volume] in Urine by Confirmatory method |
| 2012-3 | Cancer Ag 27-29 [Presence] in Serum or Plasma |
| 2069-3 | Chloride [Moles/volume] in Blood |
| 101229-3 | Zinc finger protein of the cerebellum 4 Ab [Presence] in Serum by Immunoblot |
| 101250-9 | Aspergillus fumigatus [Presence] in Isolate |
| 101289-7 | SARS-CoV-2 (COVID-19) RNA [Presence] in Throat by NAA with non-probe detection |
| 101418-2 | Microorganism level similarity to reference sample [Score] in Isolate or Specimen by MS.MALDI-TOF |
| 13036-9 | C peptide [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 13175-5 | Liver cytosol Ab [Presence] in Serum |
| 102024-7 | Cortisol [Moles/volume] in Serum or Plasma --60M post dose glucagon |
| 102104-7 | Streptococcus agalactiae [Susceptibility] in Urine by Culture |
| 102373-8 | Honeysuckle IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102438-9 | Milk IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102662-4 | Black Willow IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14235-6 | Jo-1 extractable nuclear Ab [Titer] in Serum |
| 14294-3 | Lysosomal enzymes screen [Identifier] in Plasma and Urine |
| 102847-1 | Brewer's yeast IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1453-0 | Creatinine [Mass/volume] in 24 hour Urine --48 hours post 40 ug corticotropin IM BID 3 day |
| 14617-5 | Appearance of Pericardial fluid |
| 15069-8 | Fructosamine [Moles/volume] in Serum or Plasma |
| 15206-6 | Rheumatoid factor [Units/volume] in Synovial fluid by Nephelometry |
| 16168-7 | Glucose [Mass/volume] in Serum or Plasma --3 PM specimen |
| 10761-5 | Iron.microscopic observation [Identifier] in Tissue by Other stain |
| 11177-3 | Lactalbumin beta IgE Ab [Units/volume] in Serum |
| 16988-8 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose glucose |
| 17059-7 | Legionella pneumophila Ag [Presence] in Urine by Immunofluorescence |
| 17564-6 | Salmonella typhi O D Ab [Presence] in Serum by Latex agglutination |
| 17802-0 | Prolymphocytes/100 leukocytes in Body fluid |
| 90226-2 | Nicotine and Cotinine panel - Serum or Plasma |
| 7500-2 | Aedes mosquito triggered histamine release [Units/volume] in Blood |
| 75080-2 | N-acetyl-L-aspartate [Moles/volume] in Serum or Plasma |
| 60411-6 | Turkey IgG Ab [Mass/volume] in Serum |
| 61426-3 | Nortriptyline/Creatinine [Mass Ratio] in Urine |
| 7759-4 | Venison IgE Ab [Units/volume] in Serum |
| 63284-4 | Mitochondria M5 Ab [Presence] in Serum by Immunofluorescence |
| 9446-6 | Heptacarboxylporphyrin [Mass/volume] in Red Blood Cells |
| 94551-9 | Hexacarboxylporphyrin III [Mass/time] in 24 hour Stool |
| 94673-1 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2/24,25-dihydroxyvitamin D3+24,25-dihydroxyvitamin D2 [Mass Ratio] in Serum or Plasma |
| 63460-0 | HTLV I+II Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 6393-3 | Echovirus 30 neutralizing antibody [Units/volume] in Serum by Neutralization test |
| 6470-9 | Microscopic observation [Identifier] in Stool by Wet preparation |
| 79328-1 | Trimethyllysine [Moles/volume] in Serum or Plasma |
| 79385-1 | Yersinia enterocolitica recN gene [Presence] in Stool by NAA with probe detection |
| 6635-7 | Influenza virus A England Ab [Units/volume] in Serum by Hemagglutination inhibition |
| 79623-5 | Alpha aminoisobutyrate/Creatinine [Molar ratio] in Urine |
| 96123-5 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Upper respiratory specimen by NAA with probe detection |
| 96476-7 | IgLON5 IgG Ab [Presence] in Serum by Immunofluorescence |
| 68123-9 | Circulating tumor cells.prostate [#/volume] in Blood |
| 80961-6 | Cefotaxime free [Mass/volume] in Serum or Plasma |
| 81709-8 | Microsatellite markers exhibiting instability [#] in Cancer specimen |
| 97657-1 | Vancomycin [Mass/volume] in Serum or Plasma --2 hours post dose |
| 70665-5 | Cold agglutinin [Presence] in Serum by 18 degree C incubation |
| 99281-8 | Lefamulin [Susceptibility] |
| 72580-4 | Gamma globulin/Protein.total [Pure mass fraction] in 24 hour Urine by Electrophoresis |
| 72916-0 | HNA 1b/1b Ab [Presence] in Serum by Immunoassay |
| 86095-7 | Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 86330-8 | Adenovirus B(11) DNA [Presence] in Specimen by NAA with probe detection |
| 86453-8 | O-nortramadol [Presence] in Urine |
| 73110-9 | Topiramate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88558-2 | Cytomegalovirus DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 31073-0 | HIV 2 Ab band pattern [Interpretation] in Serum by Immunoblot |
| 60201-1 | Salicylates [Mass/volume] in Blood |
| 31344-5 | Ganglioside GD1a Ab [Units/volume] in Serum |
| 42810-2 | Hemoglobin [Entitic mass] in Reticulocytes |
| 3164-1 | Volume [Flow] of 24 hour Stool |
| 31767-7 | Chlamydia sp Ag [Presence] in Specimen |
| 51824-1 | Hepatitis C virus IgM Ab [Units/volume] in Serum by Immunoassay |
| 51869-6 | Washed packed erythrocytes given [Volume] |
| 22585-4 | Treponema pallidum Ab [Units/volume] in Blood |
| 44304-4 | Carnosine/Creatinine [Mass Ratio] in 24 hour Urine |
| 44336-6 | Magnesium/Creatinine [Mass Ratio] in 24 hour Urine |
| 32735-3 | Beta 2 globulin [Mass/time] in 24 hour Urine by Electrophoresis |
| 5312-4 | Rickettsia spotted fever group IgG Ab [Units/volume] in Serum by Immunoassay |
| 44617-9 | PWS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 44828-2 | Teriflunomide [Mass/volume] in Serum or Plasma |
| 23491-4 | Transmissible gastroenteritis virus Ab [Presence] in Serum by Immunoassay |
| 23524-2 | Trypanosoma evansi Ab [Units/volume] in Serum by Immunoassay |
| 53725-8 | SLC25A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 23929-3 | Ribonucleoprotein extractable nuclear IgG Ab [Presence] in Serum |
| 24080-4 | Cholesterol esterase [Enzymatic activity/mass] in Leukocytes |
| 24098-6 | N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Leukocytes |
| 3401-7 | Benzthiazide [Mass/time] in 24 hour Urine |
| 46202-8 | Psittacid herpesvirus 1 Ab [Presence] in Serum |
| 34332-7 | Lormetazepam [Mass/volume] in Serum or Plasma |
| 25394-8 | Nortrimipramine [Moles/volume] in Serum or Plasma |
| 25468-0 | Mephenytoin [Moles/volume] in Serum or Plasma |
| 47625-9 | Glutamate/Amino acids.total in Cerebral spinal fluid |
| 25682-6 | Kappa light chains [Mass/time] in 24 hour Urine |
| 2569-2 | Lipids [Mass/volume] in Serum |
| 25855-8 | 3-Alpha-Androstanediol glucuronide [Moles/time] in 24 hour Urine |
| 35401-9 | Cytomegalovirus DNA [Presence] in Bronchial specimen by NAA with probe detection |
| 35596-6 | Theophylline [Mass/volume] in Serum or Plasma by Screen method |
| 47971-7 | SGSH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 48137-4 | 4,5-Dihydroxyhexanoate/Creatinine [Molar ratio] in Urine |
| 2631-0 | Methylmalonyl CoA mutase [Enzymatic activity/volume] in Serum |
| 3834-9 | N-acetylprocainamide [Mass/volume] in Serum or Plasma |
| 38426-3 | C peptide [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
| 48898-1 | Orientia tsutsugamushi Karp IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 2732-6 | Parathyrin.mid molecule [Mass/volume] in Serum or Plasma |
| 27872-1 | Insulin [Units/volume] in Serum or Plasma --6 hours post 75 g glucose PO |
| 28078-4 | Bladder tumor Ag [Presence] in Urine by Immunoassay |
| 38901-5 | Leflunomide [Mass/volume] in Serum or Plasma |
| 57910-2 | Bartonella quintana DNA [Presence] in Specimen by NAA with probe detection |
| 4968-4 | HLA-DR52 [Presence] in Donor |
| 29321-7 | Rickettsia typhi IgG Ab [Presence] in Body fluid |
| 58488-8 | Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --5th specimen post XXX challenge |
| 586-8 | Streptococcus agalactiae [Presence] in Specimen by Organism specific culture |
| 58780-8 | Coxsackievirus B IgG Ab [Titer] in Serum |
| 29743-2 | Cryofibrinogen [Presence] in Plasma by 3 day RT incubation |
| 29885-1 | Actinobacillus sp identified in Specimen by Organism specific culture |
| 58976-2 | Ganglioside GQ1b IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 30144-0 | Legionella sp Ab [Presence] in Serum --2nd specimen |
| 30263-8 | Glucose [Moles/volume] in Serum or Plasma --20 minutes post dose glucose |
| 19467-0 | Flunitrazepam [Presence] in Urine by Confirmatory method |
| 20709-2 | Bovine diarrhea virus RNA [Presence] in Tissue by NAA with probe detection |
| 100357-3 | Naloxone [Presence] in Cord tissue by Screen method |
| 12490-9 | Allyl-sec-butyl-barbiturate [Mass/volume] in Serum or Plasma |
| 12826-4 | Prolactin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 1287-2 | P1 Ab [Presence] in Serum or Plasma from Donor |
| 101357-2 | Borrelia burgdorferi.VlsE+OspC IgG+IgM Ab [Presence] in Serum by Immunoassay |
| 101416-6 | Pediatric autoimmune central nervous system disorders evaluation panel - Cerebral spinal fluid |
| 101945-4 | Candida tropicalis DNA [Presence] in Specimen by NAA with probe detection |
| 1348-2 | Yt sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
| 14318-0 | Microscopic observation [Identifier] in Cervix by Wet preparation |
| 14513-6 | Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunofluorescence |
| 14627-4 | Bicarbonate [Moles/volume] in Venous blood |
| 14767-8 | Glucose [Moles/volume] in Serum or Plasma --5 hours post dose glucose |
| 10652-6 | Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification |
| 10836-5 | Niacin [Mass/volume] in Blood |
| 16483-0 | Borrelia hermsii [Presence] in Specimen by Organism specific culture |
| 11155-9 | Cortisol/Creatinine [Mass Ratio] in Urine |
| 74931-7 | ARIPiprazole [Mass/volume] in Serum or Plasma --trough |
| 92128-8 | Bordetella pertussis DNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 75155-2 | Allantoine/Creatinine [Molar ratio] in Urine |
| 75160-2 | Adenosine/Creatinine [Molar ratio] in Urine |
| 60543-6 | Mupirocin 200 ug [Susceptibility] by Disk diffusion (KB) |
| 61117-8 | Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma by Immune stain |
| 7605-9 | Pigweed IgG Ab [Units/volume] in Serum |
| 92874-7 | Herpes simplex virus 2 DNA [Presence] in Skin by NAA with probe detection |
| 7707-3 | Oat smut IgE Ab [Units/volume] in Serum |
| 77321-8 | Cyanide [Moles/volume] in Specimen |
| 93947-0 | Rh antigens and K Ag panel - Cord blood |
| 6584-7 | Virus identified in Specimen by Culture |
| 6593-8 | Yellow fever virus IgM Ab [Units/volume] in Serum by Immunoassay |
| 80366-8 | Neisseria gonorrhoeae rRNA [Presence] in Anorectal by NAA with probe detection |
| 804-5 | Leukocytes [#/volume] in Blood by Manual count |
| 95952-8 | Azorubine IgE Ab [Units/volume] in Serum |
| 68384-7 | Specific gravity of Pericardial fluid by Refractometry |
| 80701-6 | CD27- cells/100 CD3+CD8+ cells in Blood |
| 69487-7 | TNFRSF13B gene full mutation analysis in Blood or Tissue by Sequencing |
| 82189-2 | Cytomegalovirus DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
| 82976-2 | Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 98987-1 | C reactive protein [Units/volume] in Body fluid |
| 72653-9 | Subtelomere analysis.short arm [Interpretation] in Blood or Tissue by FISH Narrative |
| 86200-3 | Porcine epidemic diarrhea virus [Presence] in Specimen by Organism specific culture |
| 86539-4 | Herpes simplex virus 1 DNA [Presence] in Tissue by NAA with probe detection |
| 86541-0 | Herpes simplex virus 2 DNA [Presence] in Tissue by NAA with probe detection |
| 73148-9 | Simvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73375-8 | FLUoxetine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73481-4 | Carvedilol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73852-6 | 7-Dehydrocholesterol and 8-Dehydrocholesterol panel - Serum or Plasma |
| 88163-1 | Acanthamoeba sp DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 88459-3 | Serotonin release 1.0 IU/mL heparin.low molecular weight [Units/volume] in Serum |
| 744-3 | Monocytes/100 leukocytes in Blood by Manual count |
| 887-0 | Am Ab [Presence] in Serum or Plasma |
| 89541-7 | Ganglioside GM1 IgG Ab [Presence] in Cerebral spinal fluid by Line blot |
| 41415-1 | Babesia duncani Ab [Titer] in Serum by Immunofluorescence |
| 31146-4 | Reagin Ab [Titer] in Cerebral spinal fluid by VDRL |
| 31172-0 | Fonofos [Mass/volume] in Blood |
| 41995-2 | Hemoglobin A1c [Mass/volume] in Blood |
| 42224-6 | Thallium [Moles/time] in 24 hour Urine |
| 60027-0 | Specific gravity of Pericardial fluid |
| 31259-5 | Blastomyces dermatitidis Ab [Presence] in Body fluid |
| 51082-6 | CD15 blasts/100 blasts in Specimen |
| 43082-7 | Bluetongue virus 10 Ab [Titer] in Serum |
| 22198-6 | Chlamydia trachomatis C IgG Ab [Titer] in Serum |
| 22312-3 | Hepatitis A virus Ab [Units/volume] in Serum |
| 32046-5 | Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma |
| 51471-1 | Sporothrix schenckii Ab [Presence] in Cerebral spinal fluid |
| 5149-0 | Echovirus NOS Ab [Titer] in Serum by Complement fixation |
| 51583-3 | Anulocytes [Presence] in Blood by Light microscopy |
| 22741-3 | Serine [Moles/volume] in Specimen |
| 32519-1 | CD3-CD16+CD56+ (Natural killer) cells/100 cells in Specimen |
| 44021-4 | Coxiella burnetii Ab [Interpretation] in Serum |
| 44386-1 | Hydroxyproline/Creatinine [Mass Ratio] in 24 hour Urine |
| 22897-3 | Bovine diarrhea virus Ag [Presence] in Specimen by Immune stain |
| 33222-1 | Oval fat bodies (globules) [#/area] in Urine sediment by Automated count |
| 53069-1 | Cystathionine [Moles/volume] in Body fluid |
| 53783-7 | HTT gene mutation panel - Blood or Tissue by Molecular genetics method |
| 44932-2 | Protein.monoclonal band 2/Protein.total in Serum or Plasma by Electrophoresis |
| 45161-7 | Hepatitis B virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 2378-8 | Glutathione reductase [Enzymatic activity/volume] in Red Blood Cells |
| 23891-5 | Magnesium [Moles/volume] in 24 hour Stool |
| 34272-5 | Collagen crosslinked N-telopeptide/Creatinine [Ratio] in Urine |
| 54354-6 | Beta 2 globulin [Mass/volume] in Urine by Electrophoresis |
| 35127-0 | Hemoglobin A2.prime/Hemoglobin.total in Blood |
| 35273-2 | Hepatitis D virus IgG Ab [Presence] in Serum by Immunoassay |
| 35348-2 | Corynebacterium diphtheriae Ab [Titer] in Serum |
| 35351-6 | Myotonic dystrophy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 47516-0 | Cocal virus Ab [Titer] in Serum |
| 47582-2 | Biopterin/Creatinine [Molar ratio] in Urine |
| 25848-3 | Alpha aminobutyrate [Moles/volume] in 24 hour Urine |
| 563-7 | Clostridioides difficile [Presence] in Specimen by Organism specific culture |
| 48312-3 | Yersinia enterocolitica O:5 Ab [Titer] in Serum by Agglutination |
| 35805-1 | Bambermycins [Susceptibility] |
| 36924-9 | 14-3-3 Ag [Mass/volume] in Cerebral spinal fluid |
| 56745-3 | PL-12 Ab [Presence] in Serum by Immunoblot |
| 5699-4 | Molybdenum [Mass/volume] in Urine |
| 27084-3 | 7-Aminoflunitrazepam [Mass/volume] in Urine |
| 57617-3 | 5-Alpha tetrahydrocortisol [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
| 27322-7 | Threonine [Moles/volume] in Urine |
| 38693-8 | Ethyl acrylate [Mass/volume] in Air |
| 3970-1 | Pholedrine [Mass/volume] in Urine |
| 57965-6 | Fosamprenavir+Ritonavir [Susceptibility] by Phenotype method |
| 49658-8 | HIV nucleoside reverse transcriptase susceptibility panel by Genotype method |
| 2906-6 | Pyruvate [Mass/volume] in Arterial blood |
| 29389-4 | Acetaminophen [Presence] in Gastric fluid |
| 2951-2 | Sodium [Moles/volume] in Serum or Plasma |
| 3989-1 | Promethazine [Mass/volume] in Urine |
| 40209-9 | Glucose [Moles/volume] in Serum or Plasma --25 minutes post XXX challenge |
| 58538-0 | Corticotropin [Mass/volume] in Plasma --10th specimen post XXX challenge |
| 58669-3 | Cortisol [Moles/volume] in Saliva (oral fluid) --4 PM specimen |
| 49774-3 | Glomerular basement membrane Ab [Units/volume] in Serum |
| 29623-6 | 3-Hydroxydodecanoate (3-OH-C12:0) [Presence] in Urine |
| 40343-6 | MT-TK gene m.8296A>G [Presence] in Blood or Tissue by Molecular genetics method |
| 40426-9 | FGD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 40518-3 | Plasma cells/100 leukocytes in Peritoneal fluid by Manual count |
| 59200-6 | Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma |
| 30023-6 | Bacillus subtilis IgE Ab [Units/volume] in Serum |
| 30157-2 | Heterophils/100 leukocytes in Blood |
| 41098-5 | GPC3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19213-8 | pH of Mixed venous blood |
| 19505-7 | Methotrimeprazine cutoff [Mass/volume] in Urine for Confirmatory method |
| 2015-6 | Cancer Ag 72-4 [Presence] in Serum or Plasma |
| 20915-5 | Organochlorine pesticides [Presence] in Milk by Screen method |
| 12636-7 | Glucose [Mass/volume] in Peritoneal dialysis fluid --7th specimen |
| 101733-4 | JC virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection |
| 102197-1 | Burrobrush IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103600-3 | Baclofen [Mass/volume] in Urine by LC/MS/MS |
| 15203-3 | Rheumatoid factor [Units/volume] in Body fluid by Nephelometry |
| 104366-0 | Chlamydophila psittaci Ab [Titer] in Serum by Immunoassay --1st specimen |
| 10445-5 | CD11c Ag [Presence] in Tissue by Immune stain |
| 15253-8 | Food Allergen Mix 7 (Onion+Garlic+Celery+Tomato+Yeast) IgE Ab [Presence] in Serum by Multidisk |
| 11580-8 | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.005 mIU/L |
| 16774-2 | Diethylcarbamazepine [Mass/volume] in Serum or Plasma |
| 17088-6 | LORazepam [Mass/volume] in Urine by Confirmatory method |
| 17099-3 | CD102 cells/100 cells in Blood |
| 89992-2 | Hydroxybupropion [Presence] in Urine by Screen method |
| 90738-6 | Erythrocytes.CD59 complete loss/100 erythrocytes in Blood |
| 90814-5 | AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 74587-7 | Succinate cytochrome C reductase/Citrate synthase [Enzymatic activity ratio] in Tissue |
| 75540-5 | Hepatitis A virus RNA+Parvovirus B19 DNA [Interpretation] in Plasma from Donor Qualitative by NAA with probe detection |
| 60336-5 | Trimipramine [Moles/volume] in Specimen |
| 92805-1 | Blood Fungal Pathogens Panel by NAA with probe detection in Positive blood culture |
| 92987-7 | Adenovirus DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 93394-5 | Morganella morganii DNA [Presence] by NAA with probe detection in Positive blood culture |
| 77059-4 | GNMT gene full mutation analysis in Blood or Tissue by Sequencing |
| 77359-8 | Protein [Mass/volume] in Saliva (oral fluid) |
| 7812-1 | Babesia microti Ab [Units/volume] in Serum |
| 9431-8 | Isobutanol [Mass/volume] in Blood |
| 78886-9 | Venlafaxine cutoff [Mass/volume] in Urine for Confirmatory method |
| 79195-4 | Glucose [Mass/volume] in Serum or Plasma --45 minutes post dose arginine+insulin |
| 79254-9 | LORazepam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 79263-0 | Creatinine [Moles/volume] in Peritoneal dialysis fluid --overnight dwell |
| 65353-5 | Proinsulin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 6728-0 | Latex glove extract IgE Ab [Units/volume] in Serum |
| 7988-9 | Burkholderia pseudomallei IgG Ab [Units/volume] in Serum |
| 68376-3 | Nuclear Ab [Titer] in Body fluid by Immunofluorescence |
| 81309-7 | Influenza virus B RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection |
| 96755-4 | SARS-CoV-2 (COVID-19) variant interpretation in Specimen Narrative |
| 6964-1 | Yersinia enterocolitica IgA Ab [Units/volume] in Serum by Immunoassay |
| 81826-0 | HGD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 82212-2 | Rotavirus A RNA [Presence] in Stool by NAA with non-probe detection |
| 70151-6 | Opiates [Presence] in Urine by Screen method >300 ng/mL |
| 7130-8 | Red Kidney Bean IgG Ab [Units/volume] in Serum |
| 7151-4 | Blackberry IgE Ab [Units/volume] in Serum |
| 71632-4 | Eosinophils/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
| 82503-4 | Methylsuccinate [Moles/volume] in DBS |
| 8270-1 | Service comment 09 |
| 985-2 | Di sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
| 71839-5 | Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial blood |
| 7244-7 | Cola IgE Ab [Units/volume] in Serum |
| 83116-4 | Testosterone [Mass/volume] in Serum or Plasma by Immunoassay |
| 85373-9 | Neutrophil.fMLP stimulated.DHR/Neutrophil.fMLP stimulated.total in Blood by Flow cytometry (FC) |
| 99381-6 | Mercury [Moles/volume] in Dialysis fluid |
| 99769-2 | Interleukin 8 [Mass/volume] in Cerebral spinal fluid |
| 86543-6 | Herpes virus 6 DNA [Presence] in Bone marrow by NAA with probe detection |
| 73452-5 | chlorproPAMIDE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88212-6 | HIV 1 proviral DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 88576-4 | Bordetella holmesii hIS1001 DNA [Presence] in Nasopharynx by NAA with probe detection |
| 73900-3 | CD3- CD8- CD57+ Cells/100 leukocytes in Blood by Flow cytometry (FC) |
| 74138-9 | Immature monocytes [Presence] in Blood |
| 89529-2 | Jo-1 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
| 4171-5 | Cephalothin [Mass] of Dose |
| 59635-3 | cloBAZam [Mass/volume] in Urine by Confirmatory method |
| 60021-3 | Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Pyruvate to lactate reaction |
| 21064-1 | Acid alpha glucosidase [Enzymatic activity/volume] in Amniotic fluid |
| 21769-5 | SCA genes CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 31761-0 | Canine parvovirus Ag [Presence] in Stool |
| 43799-6 | Choriogonadotropin.beta subunit [Presence] in Specimen |
| 32312-1 | Cortisol [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
| 43894-5 | Bismuth [Presence] in Serum or Plasma |
| 44361-4 | Glutamate+Glutamine/Creatinine [Mass Ratio] in Urine |
| 23071-4 | Equine arteritis virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 53422-2 | Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --4th specimen post XXX challenge |
| 23230-6 | Mareks disease virus Ag [Presence] in Feather by Immune diffusion (ID) |
| 53528-6 | Triglyceride in HDL 3 [Moles/volume] in Serum or Plasma |
| 53537-7 | Measles virus IgM Ab [Presence] in Body fluid by Immunoassay |
| 53622-7 | von Willebrand factor (vWf) cleaving protease actual/normal in Platelet poor plasma by Chromogenic method |
| 53726-6 | KCNC3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 45117-9 | Mycobacterium kansasii rRNA [Presence] in Specimen by NAA with probe detection |
| 45139-3 | Listeria monocytogenes O4b IgM Ab [Titer] in Serum |
| 23982-2 | Borrelia burgdorferi IgM Ab [Presence] in Body fluid by Immunoblot |
| 34265-9 | Chloride/Creatinine [Molar ratio] in Urine |
| 54093-0 | Pesticides [Presence] in Gastric fluid by Screen method |
| 54173-0 | Arbekacin [Susceptibility] by Disk diffusion (KB) |
| 25119-9 | N-acetyltyrosine/Creatinine [Molar ratio] in Urine |
| 25127-2 | Phosphate/Creatinine [Molar ratio] in 24 hour Urine |
| 55721-5 | Tinidazole [Susceptibility] by Disk diffusion (KB) |
| 5604-4 | Boron [Mass/volume] in Blood |
| 47674-7 | Isoleucine/Amino acids.total in Amniotic fluid |
| 47823-0 | 4-Hydroxy-3-Methoxyphenyllactate/Creatinine [Molar ratio] in Urine |
| 25734-5 | Prolactin [Mass/volume] in Serum or Plasma --10 minutes post 200 ug TRH IV |
| 35699-8 | Anti-hyperglycemics [Identifier] in Serum or Plasma by Screen method |
| 26778-1 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose lactose PO |
| 48574-8 | Hepatitis C virus genotype [Identifier] in Blood by NAA with probe detection |
| 27008-2 | Xylose [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 27352-4 | Homocystine [Units/volume] in Serum or Plasma |
| 2765-6 | Phenylalanine [Mass/volume] in Serum or Plasma |
| 50007-4 | Cytology report of Bronchoalveolar lavage Cyto stain |
| 29622-8 | Beta hydroxybutyrate [Presence] in Urine |
| 29737-4 | Rickettsia rickettsii Ab [Titer] in Serum |
| 29798-6 | Eastern equine encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 29850-5 | Jamestown canyon virus IgM Ab [Presence] in Serum |
| 40429-3 | NOD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 59004-2 | Lactate [Moles/volume] in Serum or Plasma --baseline |
| 59179-2 | Insulin [Moles/volume] in Serum or Plasma --fasting |
| 50324-3 | MSH-6 Ag [Presence] in Tissue by Immune stain |
| 41147-0 | Herpes virus 6 IgM Ab [Presence] in Serum |
| 19688-1 | Psilocybin [Mass/volume] in Urine by Confirmatory method |
| 20654-0 | Phosphoserine [Moles/volume] in Serum or Plasma |
| 20685-4 | Anaplasma marginale Ab [Presence] in Serum by Card agglutination |
| 20715-9 | Bovine diarrhea virus Ag [Presence] in Serum by Immune stain |
| 20928-8 | Oxalate [Mass/mass] in Plant |
| 12425-5 | Chlorzoxazone [Mass/volume] in Serum or Plasma |
| 100029-8 | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method |
| 100120-5 | Chlamydia trachomatis Ab panel - Serum |
| 101361-4 | Bacillus anthracis plasmid pXO2 DNA [Presence] in Blood by NAA with non-probe detection |
| 102107-0 | Oxalate and Glycolate and Glyoxylate and Glycerate [Interpretation] in Serum or Plasma |
| 13862-8 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin |
| 1417-5 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IV rapid |
| 1436-5 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 30 mg/kg metyraPONE PO |
| 102918-0 | Pepsin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14666-2 | Copper [Moles/time] in 24 hour Urine |
| 15125-8 | Alpha 1 globulin/Protein.total in Synovial fluid by Electrophoresis |
| 10489-3 | IgA.heavy chain Ag [Presence] in Tissue by Immune stain |
| 1584-2 | Lactose [Mass/volume] in Serum or Plasma --30 minutes post 50 g lactose PO |
| 10969-4 | Cystine+Homocysteine [Presence] in Urine |
| 16550-6 | Carbohydrates [Identifier] in Urine |
| 16592-8 | Chlamydia sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 11278-9 | Bladder cells [#/area] in Urine sediment by Microscopy high power field |
| 17096-9 | Kappa lymphocytes/100 lymphocytes in Blood |
| 17664-4 | Sulfalazine IgE Ab [Units/volume] in Serum |
| 17727-9 | Treponema pallidum IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 17882-2 | Bacteria # 6 identified in Bronchial specimen by Aerobe culture |
| 17887-1 | Bacteria # 6 identified in Genital specimen by Aerobe culture |
| 90452-4 | Herpes simplex virus 1 DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 90459-9 | Yellow fever virus RNA [Presence] in Blood by NAA with probe detection |
| 74908-5 | 3-ketoacyl-CoA thiolase [Enzymatic activity/mass] in Fibroblast |
| 92792-1 | Candida dubliniensis DNA [Presence] by NAA with probe detection in Positive blood culture |
| 92902-6 | Fetal Chromosome region 8q24 deletion [Presence] based on Plasma cell-free DNA by Sequencing |
| 94217-7 | TP53 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 62424-7 | Human bocavirus DNA [Presence] in Specimen by NAA with probe detection |
| 63072-3 | Mycobacterium tuberculosis inhA gene isoniazid low level resistance mutation [Presence] by Molecular method |
| 78766-3 | fentaNYL [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine |
| 79230-9 | Amiodarone [Mass/mass] in Hair |
| 9538-0 | La Crosse virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 95516-1 | Angiotensin (1-7) [Mass/volume] in Plasma |
| 95772-0 | IDH1 and IDH2 genes targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 95825-6 | SARS-CoV-2 (COVID-19) Ab [Presence] in DBS by Immunoassay |
| 96793-5 | Softwood Mix (Beech+Pine+Red cedar+Silver fir) IgE Ab [Units/volume] in Serum by Multidisk |
| 82185-0 | Neisseria meningitidis DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
| 7128-2 | Green Bean triggered histamine release [Units/volume] in Blood |
| 7142-3 | Yellow Bean IgG Ab [Units/volume] in Serum |
| 8239-6 | Phencyclidine [Mass/volume] in Unknown substance |
| 8241-2 | Phencyclidine [Presence] in Unknown substance by Confirmatory method |
| 98064-9 | Beta-lactam resistance ESBL blaCTX-M-14 gene [Presence] by Molecular method |
| 9819-4 | Cryptococcus sp Ag [Titer] in Cerebral spinal fluid by Latex agglutination |
| 72268-6 | Streptococcus pyogenes exotoxin B speB gene [Presence] in Specimen by NAA with probe detection |
| 84925-7 | PCA-2 Ab [Presence] in Serum by Immunofluorescence |
| 86586-5 | Parechovirus A RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 73413-7 | Diphenoxylate and Atropine (Lomatil) induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73512-6 | Atorvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88561-6 | Parainfluenza virus 4 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 89593-8 | Bartonella sp DNA [Presence] in Tissue by NAA with probe detection |
| 41624-8 | Brucella sp Ag [Presence] in Specimen by Immunofluorescence |
| 59590-0 | 1-Hydroxymidazolam [Mass/volume] in Urine by Confirmatory method |
| 59881-3 | Chlorpheniramine [Moles/volume] in Serum or Plasma |
| 50915-8 | Strontium [Moles/time] in 24 hour Urine |
| 31163-9 | Ganglioside GD1b Ab [Titer] in Serum |
| 42337-6 | Herpes simplex virus 1 glycoprotein G IgG Ab [Units/volume] in Serum |
| 42590-0 | Borrelia sp Ab [Titer] in Serum |
| 60087-4 | Hyoscyamine [Mass/volume] in Blood |
| 21331-4 | HIV 1 p24 Ab [Titer] in Serum by Immunoblot |
| 31532-5 | Neuronal Ab [Units/volume] in Serum |
| 5137-5 | Echovirus 1 Ab [Titer] in Serum by Complement fixation |
| 51805-0 | Rickettsia conorii IgM Ab [Units/volume] in Serum by Immunoassay |
| 32146-3 | Platelets Large [Presence] in Blood by Light microscopy |
| 32207-3 | Platelet distribution width [Entitic volume] in Blood by Automated count |
| 5193-8 | Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 53130-1 | Ammonium urate crystals [#/area] in Urine sediment by Microscopy low power field |
| 23231-4 | Mareks disease virus DNA [Presence] in Specimen by NAA with probe detection |
| 23232-2 | Mite identified in Skin by Flotation |
| 33277-5 | Acetaminophen+Phenacetin [Presence] in Urine by Screen method |
| 33475-5 | Organic acids pattern [Interpretation] in Serum or Plasma |
| 53934-6 | Lactate dehydrogenase in peritoneal fluid/Lactate dehydrogenase in serum |
| 45146-8 | Triflupromazine [Presence] in Serum or Plasma |
| 45148-4 | OmpC IgA Ab [Presence] in Serum |
| 23825-3 | Beta-N-acetylhexosaminidase.A/Beta-n-acetylhexosaminidase.total in Leukocytes |
| 23846-9 | Coproporphyrin 3 [Mass/time] in 24 hour Stool |
| 23969-9 | Echovirus 7 Ab [Titer] in Cerebral spinal fluid |
| 33763-4 | Natriuretic peptide.B prohormone N-Terminal [Moles/volume] in Serum or Plasma |
| 46131-9 | Clostridioides difficile toxin B [Presence] in Stool by Cytotoxin tissue culture assay |
| 55545-8 | Indomethacin [Moles/volume] in Serum or Plasma |
| 4723-3 | HLA-A25(10) [Presence] |
| 25224-7 | Erythromycin 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25448-2 | Iodine [Moles/volume] in Serum or Plasma |
| 25459-9 | Lead [Moles/volume] in Serum or Plasma |
| 34743-5 | Stable Hemoglobin [Presence] in Blood by Isopropanol stability |
| 35034-8 | Mesothelial cells [#/volume] in Cerebral spinal fluid |
| 25833-5 | Cerebroside sulfatase activator [Interpretation] in Fibroblast |
| 25922-6 | Glycine/Creatinine [Molar ratio] in 24 hour Urine |
| 35746-7 | Hyperchromia [Presence] in Blood by Automated count |
| 48051-7 | Erythrocytes [Presence] in Vaginal fluid |
| 56895-6 | CD13+HLA-DR+ cells/100 cells in Bone marrow |
| 4838-9 | HLA-B51(5) [Presence] in Donor |
| 4861-1 | HLA-Cw6 [Presence] |
| 48866-8 | Ehrlichia sp DNA [Presence] in Specimen by NAA with probe detection |
| 26905-0 | PHENobarbital [Mass/mass] in Hair |
| 57356-8 | Lactate [Mass/volume] in Serum or Plasma --1 minute post XXX challenge |
| 49091-2 | Fetal Neural tube defect risk [Likelihood] Based on maternal age |
| 27379-7 | Insulin [Units/volume] in Serum or Plasma --1 hour post XXX challenge |
| 38725-8 | Styrene-7,8-Oxide [Mass/volume] in Air |
| 3901-6 | Para hydroxyamphetamine [Presence] in Urine |
| 58023-3 | Rabies virus IgG Ab [Units/volume] in Serum |
| 49597-8 | Trichothecene IgE Ab [Units/volume] in Serum by Immunoassay |
| 28557-7 | Chlamydia trachomatis D+K IgA Ab [Titer] in Serum by Immunofluorescence |
| 2929-8 | Saccharides [Presence] in Urine |
| 58802-0 | Mononuclear cells/100 leukocytes in Peritoneal dialysis fluid |
| 50059-5 | Oligoclonal bands/Protein.total in Urine by Electrophoresis |
| 29681-4 | Rickettsia akari Ab [Presence] in Serum |
| 29721-8 | Influenza virus C Ag [Presence] in Specimen by Immunofluorescence |
| 50279-9 | 3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Urine |
| 40931-8 | Yersinia sp Ab [Presence] in Serum |
| 41036-5 | Cocaine [Presence] in Blood by Confirmatory method |
| 19358-1 | Benzoylecgonine cutoff [Mass/volume] in Urine for Confirmatory method |
| 19651-9 | Para hydroxyamphetamine [Presence] in Urine by Screen method |
| 12454-5 | Urate crystals amorphous [Presence] in Urine sediment by Light microscopy |
| 12505-4 | Cadmium [Mass/volume] in Red Blood Cells |
| 12642-5 | Glucose [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge |
| 101290-5 | Human metapneumovirus RNA [Presence] in Throat by NAA with non-probe detection |
| 13281-1 | Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 101823-3 | Apolipoprotein C-III [Presence] in Serum or Plasma by Isoelectric focusing |
| 14344-6 | Eosinophils/100 leukocytes in Pleural fluid by Manual count |
| 14518-5 | Pneumocystis jiroveci Ag [Presence] in Throat by Immunofluorescence |
| 103616-9 | Creatinine [Moles/volume] in Serum or Plasma by LC/MS/MS |
| 103626-8 | Mycobacterium ulcerans DNA [Presence] in Specimen by NAA with probe detection |
| 16148-9 | Aldosterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 10941-3 | Milk powder IgE Ab [Units/volume] in Serum |
| 16458-2 | Bethanechol [Mass/volume] in Serum or Plasma |
| 16467-3 | Bismuth [Presence] in Blood |
| 1798-8 | Amylase [Enzymatic activity/volume] in Serum or Plasma |
| 18859-9 | Amdinocillin [Susceptibility] |
| 7473-2 | Black Locust IgE Ab [Units/volume] in Serum |
| 91834-2 | Herpes simplex virus 2 Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
| 75108-1 | Arachidate (C20:0) [Entitic substance] in Red Blood Cells |
| 7530-9 | Gamble Oak IgE Ab [Units/volume] in Serum |
| 60676-4 | Ethyl sulfate [Mass/volume] in Urine |
| 7661-2 | Red Snapper IgE Ab [Units/volume] in Serum |
| 61230-9 | Cockroach IgE Ab/IgE total in Serum |
| 94696-2 | Dementia autoimmune Ab panel - Serum or Plasma |
| 94762-2 | SARS-CoV-2 (COVID-19) Ab [Presence] in Serum or Plasma by Immunoassay |
| 63358-6 | Smooth muscle Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 6461-8 | Bacteria identified in Stool by Anaerobe culture |
| 79286-1 | Carnitine biosynthesis intermediates panel - Cerebral spinal fluid |
| 95567-4 | 5-Pregnenediol [Mass/time] in 24 hour Urine |
| 9604-0 | Taenia solium larva 21kD Ab [Presence] in Serum by Immunoblot |
| 8160-4 | Beryllium [Mass/volume] in Saliva (oral fluid) |
| 96966-7 | CD79A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 97207-5 | PCA-Tr Ab [Presence] in Serum |
| 69768-0 | 2-Oxoadipate [Moles/volume] in Serum or Plasma |
| 69829-0 | Methylsuccinate [Moles/volume] in Serum or Plasma |
| 70050-0 | Mononuclear cells [#/volume] in Synovial fluid by Automated count |
| 8179-4 | Cannabinoids [Presence] in Unknown substance by Screen method |
| 97944-3 | Color.yeast colony [Type] in Isolate by Culture--with canavanine glycine+bromothymol blue |
| 82726-1 | Natural killer cell cytotoxicity.12.5:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
| 99037-4 | Trimethoprim dfrA12 gene [Presence] by Molecular method |
| 71878-3 | Hemoglobin A/Hemoglobin.total [Pure mass fraction] in Blood by Electrophoresis |
| 72307-2 | Brucella sp IgG Ab [Titer] in Serum --2nd specimen |
| 99136-4 | Rabies virus IgM Ab [Titer] in Specimen by Immunofluorescence |
| 99870-8 | Erythrocytes.ghost cells [#/area] in Urine sediment by Computer assisted method |
| 7270-2 | Curry IgE Ab [Units/volume] in Serum |
| 72746-1 | Norbuprenorphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 72786-7 | Cotinine [Mass/volume] in Urine by Screen method |
| 73270-1 | metroNIDAZOLE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86702-8 | Rotavirus B RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 86929-7 | Lawsonia intracellularis Ab/Negative control in Serum by Immunoassay |
| 87763-9 | Ezogabine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 87932-0 | Bacteria identified in Sinus by Aerobe culture |
| 87993-2 | Toxoplasma gondii DNA [Presence] in Cord blood by NAA with probe detection |
| 89592-0 | Bartonella quintana DNA [Presence] in Tissue by NAA with probe detection |
| 41499-5 | Legionella pneumophila 1 Ag [Presence] in Urine by Immunoassay |
| 59726-0 | Oxazepam [Mass/volume] in Blood by Confirmatory method |
| 50830-9 | Boron [Moles/volume] in Urine |
| 50970-3 | XXX blood group Ab [Titer] in Serum or Plasma by Antihuman globulin |
| 42714-6 | t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 21411-4 | Myelin associated glycoprotein IgM Ab [Units/volume] in Serum |
| 316-0 | Meclocycline [Susceptibility] by Disk diffusion (KB) |
| 31601-8 | Rickettsia spotted fever group IgM Ab [Units/volume] in Cerebral spinal fluid |
| 51216-0 | CD10 cells/100 cells in Bone marrow |
| 43029-8 | Herpes simplex virus 2 Ab [Titer] in Cerebral spinal fluid |
| 31916-0 | Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid |
| 51488-5 | Cortisol [Mass/volume] in Saliva (oral fluid) --6th specimen post XXX challenge |
| 51721-9 | Purkinje cells Ab [Titer] in Serum by Immunofluorescence |
| 43593-3 | Plasmodium malariae IgG Ab [Titer] in Serum |
| 2246-7 | Estradiol (E2).unconjugated [Mass/time] in 24 hour Urine |
| 44354-9 | Ethylmalonate/Creatinine [Mass Ratio] in 24 hour Urine |
| 23079-7 | Equine arteritis virus RNA [Presence] in Specimen by NAA with probe detection |
| 53368-7 | Colorado tick fever virus Ab [Presence] in Specimen |
| 44551-0 | Human papilloma virus DNA [Presence] in Tissue by Probe |
| 44721-9 | Histiocytes [Presence] in Blood by Light microscopy |
| 33490-4 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose lactose PO |
| 33690-9 | Yersinia pestis Ab [Titer] in Serum by Immunoassay |
| 23783-4 | Taylorella equigenitalis Ab [Titer] in Serum by Complement fixation |
| 33840-0 | Monoblasts/100 leukocytes in Blood by Manual count |
| 34240-2 | Androstenedione/Creatinine [Molar ratio] in Urine |
| 54194-6 | Mezlocillin+Sulbactam [Susceptibility] |
| 46953-6 | Megestrol acetate [Mass/volume] in Urine |
| 24107-5 | Hairy cells [#/volume] in Blood by Manual count |
| 55336-2 | N Ab [Titer] in Serum or Plasma |
| 25301-3 | Alanine [Moles/time] in 24 hour Urine |
| 477-0 | Sulfonamide [Susceptibility] by Disk diffusion (KB) |
| 259-2 | Framycetin [Susceptibility] by Disk diffusion (KB) |
| 25977-0 | Pyridinoline [Moles/volume] in 24 hour Urine |
| 26432-5 | Wasp venom IgG4 Ab [Units/volume] in Serum or Plasma |
| 36899-3 | Arbovirus Ab [Identifier] in Specimen |
| 56757-8 | Renin [Enzymatic activity/volume] in Plasma --100 minutes post XXX challenge |
| 56998-8 | Valine/Creatinine [Ratio] in 24 hour Urine |
| 38551-8 | Cortisol [Mass/volume] in Serum or Plasma --pre or post dose dexamethasone |
| 57342-8 | Chloride [Moles/time] in 12 hour Urine |
| 57390-7 | Volume [Flow] of 12 hour Urine |
| 57573-8 | 3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum or Plasma --pre dose corticotropin |
| 2757-3 | Phenol [Mass/volume] in Blood |
| 39574-9 | Hexacarboxylporphyrin [Mass/time] in 24 hour Stool |
| 57701-5 | Infectious diseases newborn screening comment-discussion |
| 57976-3 | HIV 2 gp140 Ab [Presence] in Serum by Immunoblot |
| 57994-6 | Leucine/Alanine [Mass Ratio] in DBS |
| 58001-9 | Matrix metallopeptidase 9 [Mass/volume] in Blood |
| 40186-9 | Glucose [Moles/volume] in Serum or Plasma --19.5 hours post XXX challenge |
| 58466-4 | DNA double strand IgG Ab [Titer] in Serum by Immunofluorescence (IF) Crithidia luciliae |
| 58503-4 | C peptide [Mass/volume] in Serum or Plasma --1 hour post dose glucose |
| 29541-0 | HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 296-4 | Ketoconazole [Susceptibility] by Disk diffusion (KB) |
| 29839-8 | Jamestown canyon virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 29844-8 | Anaplasma phagocytophilum IgG Ab [Presence] in Cerebral spinal fluid |
| 40475-6 | WFS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 50207-0 | Glucose [Mass/volume] in Serum or Plasma --7th specimen |
| 50583-4 | Glucose screen gestational panel - Urine and Serum or Plasma |
| 30271-1 | Zalcitabine [Susceptibility] by Phenotype method |
| 40987-0 | Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection |
| 41165-2 | Uranium 235/Uranium 238 [Mass Ratio] in 24 hour Urine |
| 20495-8 | Gliadin IgA Ab [Units/volume] in Serum by Immunoassay |
| 20692-0 | Bacillus cereus [Presence] in Food by Culture FDA method |
| 21012-0 | CD15 cells [#/volume] in Blood |
| 12336-4 | hydrALAZINE [Presence] in Serum or Plasma |
| 12379-4 | Halazepam [Mass/volume] in Serum or Plasma |
| 100849-9 | Leukocytes [#/volume] in Amniotic fluid by Manual count |
| 12612-8 | Glucose [Mass/volume] in Dialysis fluid --2 hour specimen |
| 101553-6 | Aeromonas hydrophila DNA [Presence] in Stool by NAA with probe detection |
| 13551-7 | Clorazepate [Presence] in Serum or Plasma |
| 1389-6 | Cortisol Free [Mass/volume] in 24 hour Urine --24 hours post 40 ug corticotropin IM BID 3 day |
| 102511-3 | Pepper tree IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14206-7 | Coccidioides immitis exoantigen [Identifier] in Isolate |
| 102979-2 | White Birch IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103062-6 | Conalbumin native (nGal d) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103130-1 | Peanut recombinant (rAra h) 5 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104304-1 | Regorafenib [Mass/volume] in Serum or Plasma |
| 1586-7 | Lead [Mass/volume] in Urine --post EDTA therapy |
| 1071-0 | Jk sup(a) Ag [Presence] on Red Blood Cells from Donor |
| 16517-5 | Calcium.ionized [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 16630-6 | aPTT in Control Blood by Coagulation 1:1 saline |
| 16850-0 | Ethylene oxide [Mass/volume] in Blood |
| 182-6 | Cinoxacin [Susceptibility] by Disk diffusion (KB) |
| 89982-3 | 9-Hydroxyrisperidone [Presence] in Serum or Plasma by Screen method |
| 90048-0 | Somatotropin binding protein [Mass/volume] in Serum or Plasma by Immunoassay |
| 91054-7 | Drugs of abuse panel - Body fluid |
| 74625-5 | 1,1-Dimethoxyhexadecane (DMA 16:0)/palmitate (C16:0) [Molar ratio] in Red Blood Cells |
| 91852-4 | Human papilloma virus DNA [Presence] in Genital specimen by NAA with probe detection |
| 7502-8 | Moth IgE Ab [Units/volume] in Serum |
| 92900-0 | Fetal Chromosome region 4p16 deletion [Presence] based on Plasma cell-free DNA by Sequencing |
| 61379-4 | Human papilloma virus 44 DNA [Presence] in Specimen by NAA with probe detection |
| 93885-2 | Methane/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose carbohydrate |
| 94271-4 | PCA-1 IgG Ab [Presence] in Serum by Line blot |
| 6323-0 | Borrelia sp identified in Specimen by Organism specific culture |
| 94694-7 | Acetylcholine receptor ganglionic neuronal Ab [Moles/volume] in Serum by Immunoassay |
| 6419-6 | Helicobacter pylori Ab [Presence] in Serum by Immunofluorescence |
| 9548-9 | Legionella pneumophila 4 IgG Ab [Titer] in Serum by Immunofluorescence |
| 66742-8 | CYP2C19 gene c.806C>T(*17) [Presence] in Blood or Tissue by Molecular genetics method |
| 7954-1 | Legionella pneumophila 7 Ab [Titer] in Serum by Immunofluorescence |
| 9634-7 | Saint Louis encephalitis virus IgG Ab [Titer] in Specimen |
| 96454-4 | Coagulation factor II inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
| 68932-3 | IgA.secretory [Mass/volume] in Tear |
| 69025-5 | Methylenedioxymethamphetamine [Mass/mass] in Meconium by Confirmatory method |
| 80716-4 | T-cell activated (CD38+HLA-DR+) subsets panel - Blood |
| 81205-7 | Cryoglobulin IgA and IgG and IgM and C3 panel - Serum |
| 8155-4 | Amphetamines [Presence] in Unknown substance by Confirmatory method |
| 96973-3 | CDH1 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 97198-6 | Hemolysis interference index of Cerebral spinal fluid |
| 69557-7 | OJ Ab [Presence] in Serum by Immunoblot |
| 81866-6 | MYH7 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 72471-6 | UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Urine by Confirmatory method |
| 99361-8 | Horse hair+Horse dander IgG Ab [Mass/volume] in Serum |
| 99873-2 | Superficial transitional cells [#/area] in Urine sediment by Computer assisted method |
| 72783-4 | JWH-018 pentanoate (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
| 72903-8 | Urea [Moles/volume] in Blood |
| 73272-7 | Metoprolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87344-8 | Pseudorabies virus glycoprotein B Ab/Negative control in Serum by Immunoassay |
| 87426-3 | Inhibin A and B panel - Serum or Plasma |
| 73539-9 | Allopurinol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73844-3 | 16-Alpha hydroxydehydroepiandrosterone [Moles/volume] in Urine |
| 73885-6 | Steroid fractions panel - 24 hour Urine |
| 89658-9 | Microscopic observation [Identifier] in Lower respiratory specimen by Methenamine silver nitrate stain |
| 41418-5 | Gnathostoma sp Ab [Presence] in Serum by Immunoblot |
| 59320-2 | Ramelteon [Mass/mass] in Tissue |
| 59846-6 | Salmonella sp identified [Type] in Isolate |
| 50636-0 | Giant Japanese spider crab IgE Ab [Units/volume] in Serum |
| 3070-0 | Tryptophan [Mass/volume] in Serum or Plasma |
| 31033-4 | Indinavir [Mass/volume] in Serum or Plasma |
| 31148-0 | Heavy metals [Identifier] in Tissue |
| 4222-6 | Digoxin [Mass] of Dose |
| 59938-1 | Norclobazam [Moles/volume] in Urine |
| 60149-2 | Pentazocine [Mass/volume] in Blood |
| 42956-3 | SARS coronavirus IgM Ab [Presence] in Serum |
| 22192-9 | Chlamydia trachomatis IgM Ab [Units/volume] in Cerebral spinal fluid |
| 22289-3 | Entamoeba histolytica IgM Ab [Units/volume] in Serum |
| 51534-6 | American house dust mite IgG Ab [Presence] in Serum |
| 32361-8 | West Nile virus RNA [Presence] in Serum by NAA with probe detection |
| 32493-9 | CD25 cells/100 cells in Bone marrow |
| 44029-7 | Aspergillus nidulans B Ab [Presence] in Serum by Immune diffusion (ID) |
| 22932-8 | Brucella melitensis Ab [Presence] in Serum by Immunoassay |
| 326-9 | metroNIDAZOLE [Susceptibility] by Minimum lethal concentration (MLC) |
| 32832-8 | Variant lymphocytes/100 leukocytes in Bronchial specimen |
| 33020-9 | Triple phosphate crystals [#/area] in Urine sediment by Microscopy low power field |
| 446-5 | Roxithromycin [Susceptibility] by Serum bactericidal titer |
| 44725-0 | HLA-B1 [Presence] |
| 23254-6 | Mycoplasma arginini Ab [Presence] in Serum by Complement fixation |
| 33606-5 | Dengue virus Ab [Titer] in Serum |
| 53651-6 | pH of 2 hour Urine |
| 53767-0 | HLA-A+B+C SBT [Interpretation] by High resolution |
| 53848-8 | Mixed cellular casts [#/area] in Urine sediment by Microscopy high power field |
| 45290-4 | Coxsackievirus B3 Ab [Presence] in Body fluid |
| 2368-9 | Glutamate dehydrogenase.NAD [Enzymatic activity/volume] in Serum or Plasma |
| 23970-7 | Epstein Barr virus nuclear IgG Ab [Titer] in Cerebral spinal fluid |
| 3377-9 | Barbiturates [Presence] in Urine |
| 54001-3 | Centromere protein F Ab [Presence] in Serum by Immunofluorescence |
| 54015-3 | Azurocidin Ab [Presence] in Serum |
| 46967-6 | CD40 cells [#/volume] in Blood |
| 24469-9 | Hemoglobin XXX/Hemoglobin.total in Blood by Electrophoresis |
| 34504-1 | GJB6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 5579-8 | Antimony [Mass/mass] in Hair |
| 25587-7 | Chromogranin A [Moles/volume] in Serum or Plasma |
| 35655-0 | Butyrylcarnitine (C4) [Moles/volume] in Serum or Plasma |
| 56356-9 | Perch IgG4 Ab [Mass/volume] in Serum |
| 48011-1 | Genechip version [Identifier] in Blood or Tissue by Molecular genetics method |
| 56608-3 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 38372-9 | Human papilloma virus 6+11+16+18+31+33+35+39+42+43+44+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification |
| 38463-6 | Legionella sp Ag [Presence] in Urine by Immunofluorescence |
| 38515-3 | Cytoplasmic Ig mu cells [#/volume] in Blood |
| 38627-6 | Benzene [Mass/volume] in Air |
| 3918-0 | Pentazocine [Mass/volume] in Urine |
| 57897-1 | Influenza virus A+B.neuraminidase inhibitor resistance [Susceptibility] in Specimen by Genotype method |
| 57946-6 | Coccidioides immitis IgG Ab [Presence] in Cerebral spinal fluid by Complement fixation |
| 49327-0 | Androstenedione [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 2913-2 | Pyruvate kinase [Enzymatic activity/volume] in Serum or Plasma |
| 29523-8 | 2-Ethyl-3-Hydroxypropionate/Creatinine [Molar ratio] in Urine |
| 58556-2 | Corticotropin [Mass/volume] in Plasma --1 hour post dose glucose |
| 58580-2 | Corticotropin [Moles/volume] in Plasma --30 minutes post 1 ug/kg CRH IV |
| 50026-4 | Food Allergen Mix 30 (Peanut+White bean+Soybean+Lentil+ Peas) IgE Ab [Units/volume] in Serum by Multidisk |
| 29655-8 | Oxazepam [Moles/volume] in Serum or Plasma |
| 29901-6 | HTLV I+II Ab [Presence] in Serum by Immunoassay |
| 29934-7 | Cobalt/Creatinine [Mass Ratio] in 24 hour Urine |
| 29937-0 | Aluminum/Creatinine [Mass Ratio] in 24 hour Urine |
| 58938-2 | LCT gene mutations found [Type] in Blood or Tissue by Molecular genetics method |
| 30141-6 | IgG [Presence] in 24 hour Urine by Immunoelectrophoresis |
| 30379-2 | Eosinophils/100 leukocytes in Pleural fluid |
| 20468-5 | Thiamine [Moles/volume] in Serum or Plasma |
| 101091-7 | Hr^s Ab [Presence] in Serum or Plasma |
| 101237-6 | Titin Ab [Presence] in Serum by Immunoblot |
| 12945-2 | Thyrotropin [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 102165-8 | Bayleaf IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14007-9 | Prostaglandin F2 alpha [Mass/time] in 24 hour Urine |
| 10498-4 | Keratin Ag [Presence] in Tissue by Immune stain |
| 10701-1 | Ova and parasites identified in Stool by Concentration |
| 10782-1 | Microscopic observation [Identifier] in Tissue by Congo red stain |
| 1185-8 | little i Ab [Presence] in Serum or Plasma from Donor |
| 18305-3 | Amoeba identified in Aspirate by Iron hematoxylin stain |
| 19048-8 | Nucleated erythrocytes/100 leukocytes [Ratio] in Blood |
| 90980-4 | Meropenem+Vaborbactam [Susceptibility] by Gradient strip |
| 74891-3 | Medium-chain Acyl CoA dehydrogenase [Enzymatic activity/mass] in Leukocytes |
| 75081-0 | Fumarate [Moles/volume] in Serum or Plasma |
| 7542-4 | Wild Oats IgE Ab [Units/volume] in Serum |
| 60466-0 | Neisseria meningitidis serogroup Y IgG Ab [Mass/volume] in Serum by Immunoassay |
| 9310-4 | Androstenedione [Mass/time] in 24 hour Urine |
| 93782-1 | Large B-cell lymphoma [Type] in Tissue |
| 94013-0 | Osmolality of Serum or Plasma--2 hours post dose vasopressin |
| 77883-7 | QUEtiapine cutoff [Mass/volume] in Urine for Confirmatory method |
| 94345-6 | Glutamate decarboxylase 65 IgG+IgM Ab [Moles/volume] in Serum by Immunoassay |
| 94359-7 | Glutamate decarboxylase 65 IgG+IgM Ab [Moles/volume] in Cerebral spinal fluid by Immunoassay |
| 94815-8 | CV2 IgG Ab [Titer] in Serum by Immunofluorescence |
| 7929-3 | Influenza virus A Victoria Ab [Units/volume] in Serum |
| 95850-4 | Somatotropin [Mass/volume] in Serum by Immunoassay --30 minutes post dose macimorelin |
| 96423-9 | Progesterone [Mass/volume] in DBS |
| 80705-7 | CD27+CD45RA+ cells/100 CD3+CD8+ cells in Blood |
| 96810-7 | White willow IgE Ab [Units/volume] in Serum |
| 97180-4 | Yersinia outer protein Ab band pattern [Interpretation] in Serum by Line blot |
| 69427-3 | Supervisor review of results |
| 69814-2 | 2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --3 days post dose ifosfamide |
| 81794-0 | Tetrahydrocortisol/Creatinine [Molar ratio] in Urine |
| 97278-6 | Midazolam [Presence] in Cord tissue by Screen method |
| 70135-9 | Rickettsia spotted fever group IgM Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 82391-4 | Centromere protein B Ab [Units/volume] in Serum by Line blot |
| 98129-0 | Thymol turbidity test in Blood |
| 71715-7 | Brucella abortus IgG1 and IgG2 Ab [Presence] in Serum by Immunoassay |
| 71796-7 | Promyelocytic leukemia protein distribution pattern [Interpretation] in Blood or Tissue Qualitative by Immunofluorescence |
| 718-7 | Hemoglobin [Mass/volume] in Blood |
| 72444-3 | 3-Hydroxytetradecanedioate [Moles/volume] in Serum or Plasma |
| 72480-7 | Barbiturates panel - Blood by Confirmatory method |
| 84890-3 | Distant metastases confirmed by histology [Presence] in Cancer specimen |
| 99893-0 | Microorganism casts [#/volume] in Urine sediment by Computer assisted method |
| 85806-8 | Measles virus RNA and N gene panel - Specimen by NAA with probe detection |
| 73088-7 | Valsartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87757-1 | Platelet glycoprotein IV Ab [Presence] in Serum or Plasma by Immunoassay |
| 87983-3 | Toxoplasma gondii DNA [Presence] in Placenta by NAA with probe detection |
| 880-5 | A,B Ag [Presence] on Red Blood Cells |
| 74464-9 | Platelets [#/volume] in Capillary blood by Manual count |
| 89335-4 | CD27+CD45RO+CD62L+CCR7+ cells/100 CD3+CD8+ cells in Blood |
| 89348-7 | CD27+IgD-IgM+ cells/100 CD19 cells in Blood |
| 41244-5 | Western equine encephalitis virus IgG Ab [Presence] in Serum |
| 41254-4 | Xylose [Mass/volume] in Serum or Plasma --4 hours post 25 g xylose PO |
| 41285-8 | Uranium depleted/Creatinine [Mass Ratio] in 24 hour Urine |
| 51026-3 | CD117 blasts/100 blasts in Blood |
| 30431-1 | Mesothelial cells/100 leukocytes in Pleural fluid |
| 60146-8 | Pentane [Mass/volume] in Serum or Plasma |
| 21119-3 | Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid by Immunoassay |
| 21306-6 | Glucose [Mass/time] in 8 hour Urine |
| 31455-9 | Legionella pneumophila 1 IgG Ab [Units/volume] in Serum |
| 51241-8 | CD13+CD33+HLA-DR+ cells/100 cells in Tissue |
| 51295-4 | CD36 cells/100 cells in Cerebral spinal fluid |
| 42726-0 | Cerebroside sulfatase [Enzymatic activity/volume] in 24 hour Urine |
| 31726-3 | Bacillus anthracis Ag [Presence] in Specimen |
| 5171-4 | Neutrophil Ab [Units/volume] in Serum |
| 51718-5 | Normoblasts Polychromatophilic/100 cells in Blood by Microscopy |
| 43413-4 | Blood product units requested [#] |
| 322-8 | Methicillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 32812-0 | Microscopic observation [Identifier] in Bronchial specimen by Oil red O stain |
| 33044-9 | Pyknosis [Presence] in Blood by Light microscopy |
| 2340-8 | Glucose [Mass/volume] in Blood by Automated test strip |
| 33488-8 | Patient symptoms [Interpretation] --2.5 hours post dose lactose PO |
| 53589-8 | Beta globulin.abnormal band/Protein.total in Serum or Plasma by Electrophoresis |
| 53814-0 | Platelet aggregation arachidonate induced [Units/volume] in Blood |
| 53821-5 | Chloroamphetamine [Mass/volume] in Serum |
| 45377-9 | Time of transfusion reaction |
| 33787-3 | Calcitonin [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 3407-4 | Brompheniramine [Presence] in Serum or Plasma |
| 54020-3 | Actin.filamentous Ab [Presence] in Serum or Plasma |
| 24383-2 | Intrinsic factor Ab [Presence] in Serum by Immunoassay |
| 54930-3 | Fava bean IgE Ab [Units/volume] in Serum |
| 47207-6 | Secretin [Mass] of Dose |
| 25209-8 | cycloSERINE 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25275-9 | Erythromycin [Mass/volume] in Specimen |
| 25512-5 | Protoporphyrin [Moles/time] in 24 hour Stool |
| 3484-3 | Ciprofloxacin [Mass/volume] in Serum or Plasma |
| 35792-1 | Difloxacin [Susceptibility] |
| 3605-3 | Ethacrynate [Presence] in Urine |
| 48386-7 | Platelets Large/Platelets in Blood by Automated count |
| 49334-6 | Adenovirus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 49478-1 | CXCR5 Ag [Presence] in Tissue by Immune stain |
| 49506-9 | MYOC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 5853-7 | Herpes simplex virus Ag [Presence] in Skin by Immunofluorescence |
| 49775-0 | Hepatitis D virus IgG Ab [Units/volume] in Serum by Immunoassay |
| 49845-1 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --with normal plasma 1H post incubation separate tubes |
| 5001-3 | Enterococcus sp rRNA [Presence] in Specimen by Probe |
| 40417-8 | Chromium [Moles/time] in 24 hour Urine |
| 58909-3 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 59299-8 | Desloratadine [Mass/volume] in Blood |
| 30172-1 | Cortisol Free/Creatinine [Molar ratio] in Urine |
| 4110-3 | Alphaprodine [Mass] of Dose |
| 20433-9 | Follitropin [Units/volume] in Serum or Plasma by 2nd IRP |
| 20929-6 | Paraquat [Mass/volume] in Gastric fluid |
| 20935-3 | Pasteurella multocida serotype [Identifier] in Isolate by Immune diffusion (ID) |
| 20960-1 | Selenium [Mass/mass] in Gastric fluid |
| 1236-9 | Mi sup(a) Ab [Presence] in Serum or Plasma from Donor |
| 12597-1 | Estrogen [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 13001-3 | Mandelate/Creatinine [Mass Ratio] in Urine |
| 13289-4 | Hantavirus hantaan Ab [Units/volume] in Serum |
| 13316-5 | Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture |
| 13330-6 | Barr bodies [Presence] in Cervix by Light microscopy |
| 13663-0 | Asialoganglioside GM1 IgG Ab [Titer] in Serum |
| 13735-6 | Epinephrine+Norepinephrine/Creatinine [Mass Ratio] in Urine |
| 102271-4 | Daisy IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102489-2 | Budgerigar droppings IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1401-9 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM rapid |
| 103100-4 | Termamyl IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14544-1 | Measles virus Ag [Presence] in Urethra by Immunofluorescence |
| 1516-4 | Glucose [Mass/volume] in Urine --2 hours post 100 g glucose PO |
| 15439-3 | Infectious bronchitis virus Ark-99 Ab [Titer] in Serum by Hemagglutination inhibition |
| 16615-7 | Cholesterol.total/Cholesterol in LDL [Mass Ratio] in Serum or Plasma |
| 19092-6 | Cotinine cutoff [Mass/volume] in Urine |
| 74576-0 | Tripeptidyl peptidase I [Enzymatic activity/mass] in Fibroblast |
| 74855-8 | HIV 1 proviral DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
| 92701-2 | Staphylococcus aureus DNA [Presence] in Nose by NAA with probe detection |
| 92789-7 | Gram positive blood culture panel by NAA with probe detection in Positive blood culture |
| 75037-2 | 2-Hydroxyglutarate [Moles/volume] in DBS |
| 75400-2 | KCNJ11 gene full mutation analysis in Blood or Tissue by Sequencing |
| 7556-4 | Ovalbumin IgE Ab [Units/volume] in Serum |
| 75587-6 | Fetal Angelman syndrome prior risk [Likelihood] based on general population risk Narrative |
| 6059-0 | Candida albicans IgE Ab [Units/volume] in Serum |
| 7604-2 | Common Pigweed IgE Ab [Units/volume] in Serum |
| 76144-5 | Cefteram [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 61355-4 | Capreomycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 94114-6 | cloBAZam [Presence] in Urine by Screen method |
| 63114-3 | Paprika IgG Ab [Mass/volume] in Serum |
| 77880-3 | risperiDONE [Mass/volume] in Urine by Confirmatory method |
| 94344-9 | Neuronal nuclear type 3 IgG Ab [Titer] in Serum by Immunofluorescence |
| 63355-2 | Smooth muscle Ab [Presence] in Body fluid by Immunofluorescence |
| 6399-0 | Entamoeba histolytica Ag [Units/volume] in Specimen by Immunoassay |
| 78863-8 | Naloxol cutoff [Mass/volume] in Urine for Confirmatory method |
| 79160-8 | Cold agglutinin panel - Serum |
| 95070-9 | Chromosome 9 and 11 and 15 aneuploidy in Bone marrow by FISH |
| 95102-0 | Glucose post fasting and meal stimulation panel - Serum or Plasma |
| 95171-5 | Mycoplasma synoviae DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 66130-6 | fentaNYL+Norfentanyl [Presence] in Serum or Plasma by Confirmatory method |
| 66728-7 | Adenovirus DNA [Log #/volume] (viral load) in Skin by NAA with probe detection |
| 6837-9 | Cinnamon IgE Ab [Units/volume] in Serum |
| 80738-8 | TPMT gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
| 81145-5 | CYP3A4 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
| 70016-1 | Staphylococcus sp.coagulase negative DNA [Presence] in Blood by NAA with probe detection |
| 97639-9 | Streptococcus sp DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 82447-4 | Sulfatide IgM Ab [Presence] in Serum by Line blot |
| 82880-6 | Escitalopram+norescitalopram [Mass/volume] in Serum or Plasma |
| 99081-2 | Furanylfentanyl [Presence] in Urine by Confirmatory method |
| 72320-5 | Mitochondria M2-3E IgG Ab [Presence] in Serum by Immunoassay |
| 72430-2 | 4-Hydroxyphenyllactate [Moles/volume] in Serum or Plasma |
| 86326-6 | Bordetella holmesii hIS1001 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 86620-2 | Methicillin resistance mecA+mecC genes [Presence] in Nose by NAA with probe detection |
| 7298-3 | Elder IgG Ab [Units/volume] in Serum |
| 73215-6 | PARoxetine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73235-4 | OLANZapine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87486-7 | PB-22 3-carboxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 73748-6 | APOB gene p.Arg3500Gln and p.Arg3500Trp [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 88125-0 | Escherichia coli enterotoxigenic gene panel - Specimen by NAA with probe detection |
| 7414-6 | Hop IgG Ab [Units/volume] in Serum |
| 74328-6 | MICA*030 IgG Ab [Presence] in Serum |
| 74413-6 | Differential panel - Cord blood |
| 88883-4 | Connective tissue autoimmune Ab panel - Serum |
| 41697-4 | Gemifloxacin [Susceptibility] by Gradient strip |
| 50647-7 | Latex recombinant (rHev b) 11 IgE Ab [Units/volume] in Serum |
| 30439-4 | Monocytes+Macrophages/100 leukocytes in Specimen |
| 3101-3 | Uridyl transferase [Enzymatic activity/mass] in Tissue |
| 42246-9 | Hemoglobin F/Hemoglobin.total in Blood by HPLC |
| 60304-3 | FLUoxetine [Moles/volume] in Specimen |
| 51128-7 | CD22 blasts [Units/volume] in Blood |
| 42749-2 | Phosphatidylethanolamine IgM Ab B2GP1 dependent [Multiple of the median] in Serum |
| 42871-4 | CD138 cells/100 cells in Body fluid |
| 431-7 | Ristocetin [Susceptibility] by Minimum lethal concentration (MLC) |
| 22216-6 | Coxsackievirus A2 Ab [Titer] in Serum |
| 31631-5 | Spermatozoa Ab [Presence] in Serum |
| 22753-8 | Iron binding capacity.unsaturated [Moles/volume] in Serum or Plasma |
| 44056-0 | CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Bone marrow |
| 4418-0 | Pyrilamine [Mass] of Dose |
| 44323-4 | Iodine [Presence] in Serum or Plasma |
| 32582-9 | Phenylpropionylglycine [Presence] in Urine |
| 330-1 | Mezlocillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 33028-2 | Leukocytes [#/volume] in Blood from Blood product unit |
| 23389-0 | Rabies virus Ag [Presence] in Brain by Immunoassay |
| 2363-0 | Glutamate [Presence] in Serum or Plasma |
| 53787-8 | Zolpidem [Presence] in Urine by Confirmatory method |
| 538-9 | Mycobacterium sp identified in Synovial fluid by Organism specific culture |
| 45127-8 | Vesicular stomatitis New Jersey virus Ag [Presence] in Specimen by Immunoassay |
| 45162-5 | Escherichia coli O157 Ag [Presence] in Isolate by Latex agglutination |
| 24010-1 | Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid |
| 54197-9 | Piperacillin+Sulbactam [Susceptibility] |
| 24517-5 | Phoma sp IgG Ab [Units/volume] in Serum |
| 250-1 | Fluconazole [Susceptibility] by Disk diffusion (KB) |
| 47151-6 | EPINEPHrine [Moles/volume] in Plasma --7th specimen post XXX challenge |
| 47170-6 | Norepinephrine [Moles/volume] in Urine --5th specimen post XXX challenge |
| 25225-4 | Minocycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 35150-2 | Laurate (C12:0) [Moles/volume] in Serum or Plasma |
| 35327-6 | pH of Body fluid--4th specimen post Sincalide |
| 4760-5 | HLA-B53 [Presence] in Donor |
| 47739-8 | Protein [Mass/volume] in Stool |
| 35586-7 | 4-Tert-Butylphenol [Mass/volume] in Urine |
| 35692-3 | G0+G1 phase cells/100 cells in Specimen by Flow cytometry (FC) |
| 48069-9 | Spherocytes.micro [Presence] in Blood by Light microscopy |
| 4811-6 | HLA-B15 [Presence] |
| 48393-3 | Coccidioides immitis IgM Ab [Units/volume] in Body fluid |
| 2733-4 | Parathyrin.N-terminal [Mass/volume] in Serum or Plasma |
| 58017-5 | Olive Pollen IgE Ab/IgE total in Serum |
| 58401-1 | Tapentadol [Presence] in Urine by Confirmatory method |
| 49922-8 | Lymphocyte proliferation stimulated by phytohemagglutinin in Blood |
| 50003-3 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post XXX challenge |
| 29617-8 | CD23 Ag [Presence] in Tissue by Immune stain |
| 5892-5 | Protein S [Units/volume] in Platelet poor plasma by Coagulation assay |
| 50185-8 | Magnolia IgE Ab [Units/volume] in Serum |
| 299-8 | Lincomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 20496-6 | Gliadin IgG Ab [Units/volume] in Serum by Immunoassay |
| 20544-3 | Mesoridazine [Mass/volume] in Urine by Confirmatory method |
| 2056-0 | Catecholamines [Mass/volume] in Plasma |
| 20909-8 | Organochlorine pesticides [Identifier] in Gastric fluid |
| 100696-4 | CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal |
| 12798-5 | Oxalate [Mass/volume] in Urine --10th specimen post XXX challenge |
| 101503-1 | Cefuroxime [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 13287-8 | Toxoplasma gondii Ab [Units/volume] in Cerebral spinal fluid |
| 102160-9 | Barley Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13571-5 | Norclozapine [Presence] in Serum or Plasma |
| 13703-4 | Adipate/Creatinine [Mass Ratio] in Urine |
| 102316-7 | Meadow Foxtail IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102534-5 | English plantain IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102603-8 | Spinach IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103030-3 | Cottonwood IgG Ab [Presence] in Serum or Plasma by Radioallergosorbent test (RAST) |
| 104390-0 | Ebola virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 104450-2 | Salmonella typhi DNA [Presence] in Isolate by NAA with probe detection |
| 15388-2 | Mycoplasma hominis [Presence] in Specimen by Organism specific culture |
| 16204-0 | clonazePAM [Presence] in Urine by Confirmatory method |
| 1107-2 | Kp sup(b) Ag [Presence] on Red Blood Cells from Donor |
| 16651-2 | Corticosterone [Mass/volume] in Serum or Plasma --post XXX challenge |
| 16847-6 | Ethoheptazine [Presence] in Serum or Plasma |
| 16971-4 | Histoplasma capsulatum IgA Ab [Presence] in Serum by Immune diffusion (ID) |
| 16976-3 | HIV 1 Ag [Units/volume] in Serum |
| 17080-3 | Fatty acids.very long chain [Identifier] in Serum or Plasma |
| 17393-0 | Ovary Ab [Presence] in Serum |
| 180-0 | Cinoxacin [Susceptibility] by Minimum lethal concentration (MLC) |
| 18291-5 | Hemoglobin F/Hemoglobin.total in Blood from Newborn |
| 18501-7 | Microscopic observation [Identifier] in Buccal smear by Cyto stain |
| 18911-8 | Colistimethate |
| 90289-0 | Norovirus genogroup II RNA [Presence] in Vomitus by NAA with probe detection |
| 91606-4 | clomiPRAMINE+Norclomipramine [Mass/volume] in Urine |
| 92751-7 | Glucopsychosine [Moles/volume] in Blood |
| 60354-8 | Red Kidney Bean IgG Ab [Mass/volume] in Serum |
| 92869-7 | Herpes simplex virus 1 and 2 DNA panel - Bronchoalveolar lavage by NAA with probe detection |
| 93431-5 | Blastomyces sp Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay |
| 61270-5 | Gluten IgE Ab/IgE total in Serum |
| 6234-9 | Saltwort IgE Ab [Units/volume] in Serum |
| 77047-9 | ACSF3 gene full mutation analysis in Blood or Tissue by Sequencing |
| 77373-9 | Lathosterol [Moles/volume] in Serum or Plasma |
| 93945-4 | E Ag [Presence] in Cord red blood cells |
| 63336-2 | SCL-70 extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
| 78814-1 | Cannabicyclohexanol cutoff [Mass/volume] in Urine for Confirmatory method |
| 9462-3 | Aluminum [Mass/volume] in Water |
| 95233-3 | Microalbumin/Creatinine Qualitative in Urine by Test strip |
| 66493-8 | Epstein Barr virus nuclear 1 IgG Ab [Units/volume] in Serum |
| 79694-6 | Eicosadienoate (C20:2w6) [Moles/volume] in Serum or Plasma |
| 95773-8 | ACADM gene full mutation analysis in Blood or Tissue by Sequencing |
| 96271-2 | DNA mismatch repair protein Msh3 [Presence] in Cancer specimen by Immune stain |
| 96496-5 | Glycine receptor alpha-1 subunit IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 81893-0 | Patient satisfaction with healthcare delivery [Score] |
| 8246-1 | Amorphous sediment [Presence] in Urine sediment by Light microscopy |
| 72216-5 | t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
| 86050-2 | Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 86540-2 | Herpes simplex virus 2 Ag [Presence] in Tissue by Immunofluorescence |
| 73316-2 | Lepirudin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88190-4 | Crimean-Congo hemorrhagic fever virus IgM Ab [Presence] in Serum by Immunoassay |
| 88200-1 | Influenza virus identified in Cornea or Conjunctiva by Organism specific culture |
| 88235-7 | Microscopic observation [Identifier] in Synovial fluid by Giemsa stain |
| 31167-0 | Methyl propyl ketone [Mass/volume] in Urine |
| 31195-1 | Microscopic observation [Identifier] in Soft tissue fine needle aspirate by Cyto stain |
| 5115-1 | Corynebacterium diphtheriae Ab [Units/volume] in Serum |
| 43064-5 | Chikungunya virus Ab [Titer] in Serum |
| 31877-4 | Measles virus Ag [Presence] in Eye |
| 51765-6 | Dihydrocodeine+Hydrocodol [Mass/volume] in Serum or Plasma |
| 43293-0 | HTLV I+II p28 Ab [Presence] in Serum |
| 43697-2 | Herpes simplex virus identified in Specimen by Shell vial culture |
| 32247-9 | Histidine [Moles/volume] in Vitreous fluid |
| 51983-5 | Levodopa [Presence] in Serum or Plasma |
| 52111-2 | Blood product unit 3 expiration [Date and time] |
| 52122-9 | Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --post heparin neutralization |
| 52125-2 | Osmotic fragility of Red Blood Cells--0.90% sodium chloride 24 hour 37 degree C incubation |
| 23194-4 | Leptospira borgpetersenii sv Sejroe Ab [Presence] in Serum by Agglutination |
| 3317-5 | Amantadine [Mass/volume] in Serum or Plasma |
| 33231-2 | Fatty casts [#/area] in Urine by Computer assisted method |
| 44416-6 | Urea nitrogen/Creatinine [Mass Ratio] in Urine |
| 53768-8 | CD55+CD59 RBC actual/normal in Blood |
| 53861-1 | FKTN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 45085-8 | Chlamydia trachomatis rRNA [Presence] in Nasopharynx by Probe |
| 4525-2 | Complement membrane C3b-C4b cofactor protein [Entitic number] in Leukocytes |
| 45342-3 | Tick identified in Specimen |
| 23730-5 | Feline infectious peritonitis virus Ag [Presence] in Small intestine Tissue by Immunofluorescence |
| 2474-5 | Indicans [Presence] in Urine |
| 54923-8 | Propyphenazone IgE Ab [Units/volume] in Serum |
| 35160-1 | Docosenoate (C22:1) [Moles/volume] in Serum or Plasma |
| 55653-0 | Cefuroxime Oral [Susceptibility] by Gradient strip |
| 475-4 | Sulfonamide [Susceptibility] by Minimum lethal concentration (MLC) |
| 47597-0 | Calcium [Moles/volume] corrected for total protein in Blood |
| 47777-8 | Somatotropin [Units/volume] in Serum or Plasma --pre dose insulin IV |
| 47778-6 | Somatotropin [Units/volume] in Serum or Plasma --pre dose TRH |
| 2586-6 | Lysine [Mass/volume] in Urine |
| 56154-8 | Protein.abnormal band/Protein.total in Serum or Plasma by Electrophoresis |
| 480-4 | Talampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 48248-9 | Hazelnut Pollen triggered leukotriene release [Mass/volume] by Leukocytes |
| 26630-4 | Corynebacterium diphtheriae toxin Ab [Presence] in Serum |
| 56653-9 | Mercury/Creatinine [Ratio] in Urine |
| 56691-9 | Insulin [Mass/volume] in Serum or Plasma --20 hours post XXX challenge |
| 56882-4 | Pellitory (Parietaria judaica) recombinant (rPar j) 2 IgE Ab [Units/volume] in Serum |
| 48580-5 | KCNQ1OT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 48832-0 | Respiratory allergen panel, US - Great plains states a - Serum |
| 38250-7 | Calcium [Mass/volume] in Specimen |
| 38375-2 | Adenovirus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 57503-5 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --1 day post dose metyraPONE |
| 57537-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 49133-2 | Cholesterol in VLDL [Mass/volume] in Serum or Plasma by Electrophoresis |
| 39311-6 | Influenza virus A N1 neutralizing antibody [Presence] in Serum by Neutralization test |
| 57756-9 | Procollagen type III.N-terminal propeptide [Units/volume] in Serum |
| 57909-4 | ADNFLE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 49409-6 | Herpes virus 8 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
| 49678-6 | CPT2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 39998-0 | Glucose [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge |
| 2961-1 | Somatostatin [Mass/volume] in Plasma |
| 29644-2 | Proteinase 3 [Presence] in Serum by Immunoassay |
| 2997-5 | Tetrahydrofolate [Mass/volume] in Plasma |
| 4071-7 | Chloral hydrate [Mass/volume] in Blood |
| 59207-1 | Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Serum or Plasma |
| 50203-9 | Iron [Mass/volume] in Serum or Plasma --6th specimen |
| 30278-6 | Indinavir [Susceptibility] by Phenotype method |
| 40778-3 | Histoplasma capsulatum IgG Ab [Titer] in Serum --2nd specimen |
| 41012-6 | Respiratory syncytial virus IgG Ab [Presence] in Serum |
| 19171-8 | Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid |
| 19261-7 | Amphetamines [Presence] in Urine by Screen method |
| 20964-3 | Shigella sp identified in Feed by Organism specific culture |
| 100139-5 | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot |
| 100670-9 | RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus |
| 102146-8 | Arrowroot IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1367-2 | Corticotropin [Mass/volume] in Plasma --pre 1 ug/kg CRH IV |
| 14221-6 | HTLV I p32 Ab [Presence] in Serum |
| 102815-8 | Schistosoma sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10685-6 | Hydatid cyst identified in Lung tissue by Wet preparation |
| 10835-7 | Lipoprotein a [Mass/volume] in Serum or Plasma |
| 16452-5 | Beta alanine [Presence] in Urine |
| 16719-7 | Cytomegalovirus inclusion bodies [Presence] in Urine by Microscopic observation |
| 1140-3 | Lu sup(ab) Ab [Presence] in Serum or Plasma from Donor |
| 12245-7 | Porphobilinogen [Presence] in 24 hour Urine |
| 17033-2 | Ketamine [Presence] in Urine by Confirmatory method |
| 17066-2 | Legionella pneumophila 4 Ab [Titer] in Serum |
| 17339-3 | Neuronal Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 17606-5 | Volume of Stool |
| 17748-5 | Trimethylamine [Presence] in Urine |
| 17963-0 | Bacteria # 6 identified in Peritoneal fluid by Culture |
| 17976-2 | Virus # 3 identified in Specimen by Culture |
| 1898-6 | Argininosuccinate lyase [Enzymatic activity/volume] in Serum |
| 91827-6 | Mycoplasma hominis DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 92513-1 | C Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 92935-6 | 4q25 g.111720761T>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 933-2 | Blood product type |
| 6266-1 | Tomato IgE Ab [Units/volume] in Serum |
| 63286-9 | Myelin Ab [Presence] in Body fluid by Immunofluorescence |
| 7819-6 | Brugia malayi Ab [Presence] in Serum |
| 785-6 | MCH [Entitic mass] by Automated count |
| 78782-0 | Aluminum [Moles/volume] in Water |
| 94764-8 | SARS-CoV-2 (COVID-19) whole genome [Nucleotide sequence] in Isolate or Specimen by Sequencing |
| 79231-7 | Amoxapine [Mass/volume] in Body fluid |
| 79403-2 | Nitrogen [Moles/volume] in Urine |
| 79462-8 | Iduronate-2-Sulfatase [Enzymatic activity/volume] in DBS |
| 9519-0 | Echovirus 4 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 66441-7 | Beta hydroxybutyrate [Moles/volume] in Blood by Test strip |
| 6738-9 | Yellow Dock IgE Ab [Units/volume] in Serum |
| 96616-8 | HLA-A unresolved alleles [Type] in Donor by High resolution |
| 6932-8 | Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 70011-2 | Enterovirus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 97316-4 | Vibrio vulnificus DNA [Presence] in Stool by NAA with probe detection |
| 82395-5 | Ganglioside GD1a IgG Ab [Presence] in Serum by Line blot |
| 82430-0 | OJ Ab [Units/volume] in Serum by Line blot |
| 99084-6 | Aspergillus sp Ag [Units/volume] in Body fluid by Immunoassay |
| 7206-6 | Cottage Cheese IgE Ab [Units/volume] in Serum |
| 72330-4 | Nucleated cells/100 round cells in Semen by Manual count |
| 72392-4 | Cortisol/Cortisone [Mass Ratio] in Serum or Plasma |
| 85051-1 | Telavancin [Susceptibility] by Gradient strip |
| 85328-3 | Cells.HER2 uniform intense membrane staining/100 cells in Breast cancer specimen by Immune stain |
| 72846-9 | Hepatitis B virus codon 194 [Identifier] by Genotype method |
| 72891-5 | Staphylococcus protein A spa gene [Presence] in Isolate or Specimen by NAA with probe detection |
| 73142-2 | Sucralfate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73321-2 | Ketorolac induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87657-3 | Fenthion [Mass/mass] in Specimen |
| 73663-7 | Barbiturates panel - Saliva (oral fluid) by Confirmatory method |
| 87835-5 | Protein.monoclonal [Mass/volume] in Urine by Immunofixation |
| 88137-5 | Respiratory pathogens panel - Nasopharynx by Immunofluorescence |
| 88623-4 | Cytomegalovirus [Presence] in Cerebral spinal fluid by Organism specific culture |
| 413-5 | Piperacillin+Tazobactam [Susceptibility] by Disk diffusion (KB) |
| 50895-2 | pH of Pleural fluid by Test strip |
| 42610-6 | Salicylurate [Mass/volume] in Serum or Plasma |
| 600-7 | Bacteria identified in Blood by Culture |
| 21113-6 | Bismuth [Mass/volume] in 24 hour Urine |
| 21172-2 | XXX cells/100 cells in Specimen |
| 43106-4 | Amitriptyline and Nortriptyline panel - Serum or Plasma |
| 31853-5 | Herpes simplex virus Ag [Presence] in Serum |
| 43699-8 | Enterovirus identified in Cerebral spinal fluid by Shell vial culture |
| 43724-4 | 2,5-Dichlorophenol [Presence] in Urine |
| 22684-5 | Serine/Creatinine [Molar ratio] in Urine |
| 32134-9 | Adenovirus+Rotavirus [Identifier] in Stool |
| 3249-0 | Fibrin fragments [Identifier] in Platelet poor plasma by Immunoelectrophoresis |
| 51932-2 | Saquinavir [Mass/volume] in Serum or Plasma --trough |
| 51973-6 | Gas panel - Mixed venous blood |
| 43893-7 | Babesia microti IgG Ab [Presence] in Serum |
| 3265-6 | Fibrinopeptide B Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
| 32668-6 | Borrelia burgdorferi DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 44492-7 | Herpes simplex virus 2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 23956-6 | Aspergillus sp Ab [Titer] in Cerebral spinal fluid |
| 33849-1 | Plasma cell precursor/100 leukocytes in Blood by Manual count |
| 33962-2 | Melanoma inhibitory activity protein [Mass/volume] in Serum or Plasma |
| 54258-9 | Glucose [Moles/volume] in Serum or Plasma --2 hours post dose insulin IV |
| 54439-5 | Calcium bilirubinate/Total in Stone |
| 24215-6 | Influenza virus A Ab [Titer] in Serum by Complement fixation --1st specimen |
| 34383-0 | Trypanosoma brucei Ab [Titer] in Serum by Immunofluorescence |
| 55190-3 | cefTRIAXone [Susceptibility] for meningitis by Disk diffusion (KB) |
| 47037-7 | Streptococcus pneumoniae Danish serotype 9V IgG Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen |
| 47197-9 | Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 47303-3 | Anaplastic lymphoma kinase Ag [Presence] in Tissue by Immune stain |
| 4746-4 | HLA-B42 [Presence] in Donor |
| 25121-5 | Octenedioate (C8:1)/Creatinine [Molar ratio] in Urine |
| 55859-3 | Folate [Mass/volume] in Cerebral spinal fluid |
| 47503-8 | Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum --1st specimen |
| 47759-6 | Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose insulin IV |
| 47922-0 | Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose ornithine |
| 3574-1 | Dipipanone [Mass/volume] in Urine |
| 35761-6 | Cefditoren [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 56255-3 | Whole Egg IgG4 Ab [Mass/volume] in Serum |
| 4831-4 | HLA-B40 [Presence] |
| 35816-8 | Gemifloxacin [Susceptibility] |
| 56677-8 | Cystine/Creatinine [Ratio] in 24 hour Urine |
| 56981-4 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post resting |
| 57031-7 | Herpesviruses 6 DNA panel - Specimen by NAA with probe detection |
| 27027-2 | Cystine [Moles/volume] in Amniotic fluid |
| 38532-8 | SPG3A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 57612-4 | 6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
| 4930-4 | HLA-DPw6 [Presence] in Donor |
| 2736-7 | Pepsinogen I [Mass/volume] in Serum or Plasma |
| 27854-9 | Lutropin [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 29266-4 | Coproporphyrin [Moles/mass] in Stool |
| 2959-5 | Sodium/Potassium [Molar ratio] in Urine |
| 29836-4 | Eastern equine encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid |
| 5884-2 | Virus identified in Cerebral spinal fluid by Culture |
| 59032-3 | Lactate [Mass/volume] in Blood |
| 50190-8 | Iron and Iron binding capacity panel - Serum or Plasma |
| 5027-8 | Mycobacterium tuberculosis rRNA [Presence] in Specimen by Probe |
| 50295-5 | 4-Hydroxyifosfamide [Mass/volume] in Blood --3 days post dose ifosfamide |
| 50417-5 | Corticotropin [Mass/volume] in Plasma --pre 2 mg dexamethasone PO overnight |
| 50557-8 | Ketones [Mass/volume] in Urine by Automated test strip |
| 40933-4 | Yersinia enterocolitica O:5 Ab [Presence] in Serum |
| 19557-8 | Methamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
| 20669-8 | Cardiolipin IgA Ab [Titer] in Serum |
| 100969-5 | Pathology report additional specified observation in Specimen Narrative |
| 101367-1 | Marburg virus RNA [Presence] in Blood by NAA with non-probe detection |
| 101640-1 | NUTM1 gene rearrangements in Blood or Tissue by FISH |
| 13274-6 | Toxocara canis Ab [Units/volume] in Cerebral spinal fluid |
| 13335-5 | CD4+CD29+ cells/100 cells in Blood |
| 13407-2 | 3-Methylhistidine [Mass/volume] in Amniotic fluid |
| 102167-4 | Green Coffee Bean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102214-4 | Japanese Cedar IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102265-6 | Curry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10236-8 | Oxygen content in Low right atrium |
| 14533-4 | Rubella virus Ag [Presence] in Urethra by Immunofluorescence |
| 103841-3 | Zolpidem [Presence] in Meconium |
| 14907-0 | Rh [Type] in Blood from Blood product unit |
| 14952-6 | Xylose [Moles/volume] in Blood --1 hour post 25 g xylose PO |
| 1571-9 | Insulin [Mass/volume] in Serum or Plasma --pre dose TOLBUTamide IV |
| 10990-0 | Ketoconazole [Mass/volume] in Serum or Plasma |
| 16675-1 | Cortisol [Mass/volume] in Serum or Plasma --80 minutes post XXX challenge |
| 11213-6 | Corticotropin releasing hormone [Mass/volume] in Serum or Plasma |
| 17231-2 | Lysosomal enzymes [Identifier] in Plasma |
| 17944-0 | Bacteria # 4 identified in Line specimen by IV Line culture |
| 1801-0 | Amylase renal clearance in 24 hour Urine and Serum or Plasma |
| 74881-4 | Isoleucine [Moles/volume] in DBS --post therapeutic diet |
| 75068-7 | Malate [Moles/volume] in Serum or Plasma |
| 92937-2 | Eslicarbazepine [Mass/volume] in Serum or Plasma |
| 93699-7 | Beta-lactam resistance AmpC blaCMY-2 gene [Presence] by Molecular method |
| 6126-7 | Glycyphagus domesticus IgE Ab [Units/volume] in Serum |
| 6212-5 | Penicillium notatum IgE Ab [Units/volume] in Serum |
| 77731-8 | oxyCODONE+oxyMORphone [Interpretation] in Serum, Plasma or Blood Qualitative by Confirmatory method |
| 63149-9 | Okra IgG Ab [Mass/volume] in Serum |
| 63236-4 | DNA double strand IgM Ab [Presence] in Serum by Immunofluorescence |
| 78435-5 | Mirtazapine trough and Normirtazapine panel - Serum or Plasma |
| 79152-5 | Acenocoumarol [Mass/volume] in Body fluid |
| 79380-2 | HIV 1 RNA+proviral DNA [Presence] in Blood by NAA with probe detection |
| 79495-8 | Azelate [Moles/volume] in Serum or Plasma |
| 96291-0 | Pregnenolone sulfate [Mass/volume] in Serum or Plasma |
| 68382-1 | pH of Pericardial fluid by Test strip |
| 69029-7 | Lymphocyte proliferation.tetanus toxoid.maximum/CD3 in Blood by Flow cytometry (FC) |
| 81182-8 | Distance of tumor from closest proximal margin [Length] in Specimen by Light microscopy |
| 96604-4 | Acrylic fiber IgE Ab [Units/volume] in Serum |
| 70025-2 | Candida krusei DNA [Presence] in Blood by NAA with probe detection |
| 81711-4 | Microsatellite instability marker panel - Cancer specimen |
| 97871-8 | Hantavirus IgG and IgM panel - Serum or Plasma |
| 70205-0 | clonazePAM [Moles/volume] in Serum or Plasma by Screen method |
| 70278-7 | t(3;21)(q26;q22.3)(MECOM,RUNX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 7035-9 | Netilmicin [Susceptibility] by Gradient strip |
| 82570-3 | Mahi mahi IgE Ab [Units/volume] in Serum |
| 82892-1 | Para methylhippurate/Creatinine [Molar ratio] in Urine |
| 98102-7 | Chemokine (C-X-C motif) ligand 10 [Mass/volume] in Serum, Plasma or Blood |
| 9832-7 | Cholesterol in HDL 2 [Mass/volume] in Serum or Plasma |
| 98491-4 | Liver fibrosis score panel by Calculated by FIB4 |
| 99104-2 | Choriogonadotropin [Mass/volume] in Urine |
| 85770-6 | Acinetobacter baumannii DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 99408-7 | Matrix metallopeptidase 9 [Mass/volume] in Serum by Immunoassay |
| 72600-0 | Albumin/Protein.total [Pure mass fraction] in Body fluid by Electrophoresis |
| 85963-7 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum --2nd specimen |
| 86154-2 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 73133-1 | Tacrolimus induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87747-2 | Chlorpyrifos [Mass/mass] in Specimen |
| 73511-8 | Azithromycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7384-1 | Haddock IgE Ab [Units/volume] in Serum |
| 88630-9 | Chikungunya virus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 41468-0 | Barbiturates/Creatinine [Mass Ratio] in Urine |
| 41723-8 | Thiamphenicol [Susceptibility] by Disk diffusion (KB) |
| 50990-1 | Horowitz index adjusted to patients actual temperature in Mixed venous blood |
| 30447-7 | Myelocytes/100 leukocytes in Cerebral spinal fluid |
| 59977-9 | Venlafaxine [Moles/volume] in Urine |
| 60253-2 | DNA index 4 in Specimen by Flow cytometry (FC) |
| 21094-8 | Basophils/100 leukocytes in Sputum by Manual count |
| 31350-2 | Echovirus 11 Ab [Presence] in Serum |
| 43204-7 | Parainfluenza virus 2 Ab [Units/volume] in Cerebral spinal fluid |
| 31660-4 | Striated muscle IgG Ab [Units/volume] in Serum |
| 51590-8 | Chloride [Moles/volume] in Capillary blood |
| 43990-1 | Clarithromycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 22926-0 | Brucella abortus rRNA [Presence] in Specimen by Probe |
| 33236-1 | Bilirubin crystals [Presence] in Urine by Computer assisted method |
| 53090-7 | Carbon dioxide, total [Moles/volume] in Nonbiological fluid |
| 23575-4 | Rabbit hemorrhagic disease virus Ab [Titer] in Serum |
| 33601-6 | CD23+CD38+ cells [#/volume] in Blood |
| 53924-7 | Rheumatoid factor [Titer] in Synovial fluid by Latex agglutination |
| 44881-1 | Staphylococcus aureus toxic shock syndrome toxin gene [Presence] in Specimen by NAA with probe detection |
| 45014-8 | Adenosine monophosphate.cyclic [Moles/volume] in Urine --6 hours post XXX challenge |
| 23844-4 | C3 nephritic factor [Units/volume] in Serum or Plasma |
| 33944-0 | Lambda light chains.free [Mass/volume] in Serum or Plasma |
| 34273-3 | Copper [Moles/volume] in Urine |
| 54200-1 | Griseofulvin [Susceptibility] |
| 47144-1 | EPINEPHrine [Moles/volume] in Plasma --4 hours post XXX challenge |
| 47286-0 | Differential panel - Bone marrow |
| 2510-6 | Isoleucine [Mass/time] in 24 hour Urine |
| 5598-8 | Bismuth [Mass/volume] in Urine |
| 47642-4 | Hexadecenoate (C16:1w9)/Creatinine [Molar ratio] in Urine |
| 47830-5 | Argininosuccinate synthase [Enzymatic activity/mass] in Chorionic villus sample |
| 48134-1 | Alanine aminotransferase.macromolecular [Enzymatic activity/volume] in Serum or Plasma |
| 2644-3 | Alpha-N-acetylglucosaminidase [Enzymatic activity/volume] in Urine |
| 26508-2 | Band form neutrophils/100 leukocytes in Blood |
| 3806-7 | Methylphenidate [Presence] in Serum or Plasma |
| 56602-6 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 26879-7 | Triiodothyronine (T3) [Mass/volume] in Saliva (oral fluid) |
| 57388-1 | Urea [Mass/volume] in 24 hour Peritoneal dialysis fluid |
| 57525-8 | 17-Ketogenic steroids [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
| 27339-1 | Nicotinamide [Presence] in Blood |
| 39006-2 | Hepatitis B virus e Ab [Presence] in Body fluid |
| 57883-1 | Cantaloupe IgE Ab [Units/volume] in Serum |
| 49372-6 | Hepatitis C virus RNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
| 49555-6 | HLA-A+B+C (class I) Ag [Presence] in Tissue by Immune stain |
| 4957-7 | HLA-DR13(6) [Presence] |
| 2887-8 | Protein [Presence] in Urine |
| 58793-1 | Phytonadione [Moles/volume] in Serum or Plasma |
| 49855-0 | Tetracycline IgE Ab [Units/volume] in Serum |
| 50086-8 | 2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in DBS |
| 29675-6 | Parvovirus B19 IgG Ab [Presence] in Serum |
| 2988-4 | Testosterone [Mass/volume] in Urine |
| 29925-5 | Scandium/Creatinine [Mass Ratio] in 24 hour Urine |
| 40572-0 | Band form neutrophils [#/volume] in Body fluid by Manual count |
| 58876-4 | Somatotropin [Mass/volume] in Serum or Plasma --31st specimen |
| 30091-3 | Burkholderia pseudomallei IgM Ab [Titer] in Specimen by Immunofluorescence |
| 30273-7 | Abacavir [Susceptibility] by Phenotype method |
| 30370-1 | Fractional oxyhemoglobin in Arterial cord blood |
| 19309-4 | Thiazides cutoff [Mass/volume] in Urine for Confirmatory method |
| 19348-2 | Amphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
| 19681-6 | Prazepam cutoff [Mass/volume] in Urine for Confirmatory method |
| 12799-3 | Parathyrin Ab [Units/volume] in Serum |
| 13018-7 | Pesticides [Identifier] in Urine |
| 13451-0 | Creatinine dialysis fluid clearance |
| 13969-1 | Creatine kinase.MB [Mass/volume] in Serum or Plasma |
| 14087-1 | Herpes simplex virus 1 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 14363-6 | Microscopic observation [Identifier] in Synovial fluid by Gram stain |
| 14788-4 | Helminth+Arthropod identified in Specimen by Rearing/Culture |
| 16784-1 | DOPamine [Mass/volume] in Urine --2nd specimen post XXX challenge |
| 17106-6 | CD115 cells/100 cells in Blood |
| 17413-6 | Papova virus SV 40 Ab [Units/volume] in Serum |
| 18235-2 | Ketone solvents [Identifier] in Blood |
| 18885-4 | Ceforanide [Susceptibility] |
| 91064-6 | Dengue virus NS1 Ag [Presence] in Serum or Plasma by Immunoassay |
| 92006-6 | T-cell receptor excision circle [Cycle Threshold #] in DBS |
| 92138-7 | Parainfluenza virus 3 RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 75622-1 | HIV 1 and 2 tests - Meaningful Use set |
| 60471-0 | busPIRone [Mass/volume] in Urine |
| 61126-9 | Blasts/100 cells in Specimen by Flow cytometry (FC) |
| 75978-7 | Fetal Chromosome 18 trisomy [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative |
| 76680-8 | Color of Cerebral spinal fluid--2nd tube |
| 93347-3 | Available treatment related to genetic variant and not to patient diagnosis [Identifier] in Blood or Tissue Nominal |
| 62322-3 | Severe combined immunodeficiency newborn screening comment-discussion |
| 77380-4 | Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Interpretation] in Anorectal |
| 93948-8 | D Ag [Presence] in Cord red blood cells |
| 63326-3 | Ribosomal P Ab [Presence] in Body fluid by Immunoassay |
| 6391-7 | Echinococcus sp Ab [Units/volume] in Serum by Immunoassay |
| 7908-7 | Herpes simplex virus 1 Ab [Units/volume] in Serum |
| 7935-0 | Japanese encephalitis virus Ab [Units/volume] in Serum by Hemagglutination inhibition |
| 800-3 | Schistocytes [Presence] in Blood by Light microscopy |
| 81177-8 | Serosal classification [Appearance] in Stomach cancer |
| 96972-5 | PTEN gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 9710-5 | Coxiella burnetii phase 1 IgM Ab [Titer] in Serum |
| 97561-5 | Necrotizing myopathy autoimmune Ab panel - Serum |
| 7119-1 | Basil IgG Ab [Units/volume] in Serum |
| 713-8 | Eosinophils/100 leukocytes in Blood by Automated count |
| 98189-4 | Benzocaine IgE Ab [Units/volume] in Serum |
| 7250-4 | Cotton gin dust IgE Ab [Units/volume] in Serum |
| 72598-6 | Albumin/Protein.total [Pure mass fraction] in Serum or Plasma by Electrophoresis |
| 72724-8 | PM-SCL-75 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 85985-0 | Streptococcus pneumoniae Danish serotype 12F Ab [Mass/volume] in Serum --1st specimen |
| 73070-5 | Allopurinol induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87472-7 | Copper [Mass/mass] in Specimen |
| 87573-2 | Fumonisin B1 [Mass/mass] in Specimen |
| 73456-6 | chlordiazePOXIDE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7364-3 | Meadow Fescue IgG Ab [Units/volume] in Serum |
| 73728-8 | Norcocaine [Presence] in Meconium |
| 87792-8 | Cefovecin [Susceptibility] |
| 74108-2 | Meperidine [Presence] in Saliva (oral fluid) by Screen method |
| 89517-7 | Ganglioside GM2 IgG+IgM Ab [Presence] in Serum by Line blot |
| 898-7 | Blood group antibody screen.cell I [Presence] in Serum or Plasma by Prewarmed |
| 41755-0 | Flunisolide [Mass/volume] in Serum or Plasma |
| 50792-1 | Protein.monoclonal band 3/Protein.total in Serum or Plasma by Electrophoresis |
| 31055-7 | Coxsackievirus B3 Ab [Titer] in Body fluid by Complement fixation |
| 60009-8 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 60143-5 | Pendimethalin [Mass/volume] in Serum or Plasma |
| 21437-9 | Oxychlordane [Mass/volume] in Serum or Plasma |
| 31304-9 | Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum |
| 21698-6 | HRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 51692-2 | Phencyclidine [Presence] in Blood by Screen method |
| 51775-5 | Chromatin Ab [Units/volume] in Serum or Plasma |
| 43377-1 | Spermatozoa Progressive [Presence] in Semen --pre washing |
| 22749-6 | Amylase.pancreatic [Enzymatic activity/volume] in Urine |
| 32110-9 | Procyclidine [Moles/volume] in Serum or Plasma |
| 32384-0 | Thiacetazone [Susceptibility] |
| 32548-0 | Nitroprusside reacting substances [Presence] in Urine |
| 52900-8 | Vanadium/Creatinine [Molar ratio] in 24 hour Urine |
| 44316-8 | DOPamine/Creatinine [Mass Ratio] in 24 hour Urine |
| 44839-9 | Choriogonadotropin [Presence] in Control Serum |
| 23598-6 | Dermatophilus congolensis Ag [Presence] in Exudate by Immunofluorescence |
| 33257-7 | Cortisol [Mass/volume] in Cerebral spinal fluid |
| 53502-1 | Calcium [Moles/mass] in Specimen |
| 44928-0 | Prolactin [Units/volume] in Serum or Plasma --15 minutes pre dose TRH IV |
| 45098-1 | Chlamydia sp identified in Cervix by Organism specific culture |
| 45316-7 | Hexacarboxylate/Creatinine [Molar ratio] in Urine |
| 23673-7 | Bluetongue virus 13 neutralizing antibody [Titer] in Serum by Neutralization test |
| 3395-1 | Cocaine [Presence] in Serum or Plasma |
| 34256-8 | Cancer Ag 50 [Units/volume] in Serum or Plasma |
| 34450-7 | Eastern equine encephalitis virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 54924-6 | Purkinje cells Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 55331-3 | Lu sup(b) Ab [Titer] in Serum or Plasma |
| 35179-1 | Omega 6 fatty acids (w6) [Moles/volume] in Serum or Plasma |
| 35291-4 | UBE3A gene mutations found [Identifier] in Blood by Molecular genetics method Nominal |
| 35328-4 | pH of Body fluid--3rd specimen post Sincalide |
| 5593-9 | Beryllium [Presence] in Serum or Plasma |
| 35550-3 | Phthalic anhydride IgG Ab [Mass/volume] in Serum |
| 35770-7 | Cefotaxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 4817-3 | HLA-B18 [Presence] |
| 35859-8 | Virginiamycin [Susceptibility] by Disk diffusion (KB) |
| 56618-2 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 48830-4 | Respiratory allergen panel, US - Northern midwest states a - Serum |
| 27086-8 | Cannabinoids [Presence] in Vitreous fluid |
| 57103-4 | Lutropin [Units/volume] in Serum or Plasma --1.5 hours post dose gonadotropin releasing hormone |
| 57600-9 | 6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
| 27355-7 | Lipoprotein.pre-beta [Presence] in Pleural fluid |
| 27844-0 | Somatotropin [Mass/volume] in Serum or Plasma --21st specimen post XXX challenge |
| 27996-8 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --baseline |
| 38678-9 | Sperm Head IgG Ab/100 spermatozoa in Specimen by Immunobead |
| 3872-9 | Nortriptyline [Mass/volume] in Serum or Plasma |
| 57855-9 | Atenolol [Moles/volume] in Specimen |
| 5836-2 | Cytomegalovirus [Presence] in Tissue by Organism specific culture |
| 49391-6 | Herpes virus 6 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
| 49588-7 | First trimester maternal screen with nuchal translucency [Interpretation] Narrative |
| 40307-1 | Somatotropin [Mass/volume] in Serum or Plasma --3.5 hours post dose arginine |
| 49898-0 | Metabolic syndrome [Presence] in Serum or Plasma |
| 4999-9 | Cytomegalovirus DNA [Presence] in Urine by NAA with probe detection |
| 29728-3 | Leptospira interrogans sv Javanica Ab [Presence] in Serum by Agglutination |
| 29813-3 | Jamestown canyon virus IgM Ab [Presence] in Serum by Immunofluorescence |
| 29931-3 | Vanadium [Mass/volume] in 24 hour Urine |
| 40362-6 | Follitropin [Units/volume] in Serum or Plasma --20 minutes post dose triple bolus |
| 40636-3 | Kappa light chains [Presence] in Urine by Immunofixation |
| 58863-2 | Somatotropin [Mass/volume] in Serum or Plasma --45th specimen |
| 20537-7 | Ketamine [Mass/volume] in Urine by Confirmatory method |
| 2064-4 | Ceruloplasmin [Mass/volume] in Serum or Plasma |
| 102051-0 | 1-deoxysphinganine [Mass/volume] in Serum by LC/MS/MS |
| 13563-2 | Glutethimide [Presence] in Serum or Plasma |
| 13831-3 | Vanadium/Creatinine [Mass Ratio] in Urine |
| 102592-3 | Sheep Sorrel IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 143-8 | cefTRIAXone [Susceptibility] by Serum bactericidal titer |
| 103124-4 | Latex recombinant (rHev b) 10 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103636-7 | Atlantic wreckfish IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104289-4 | Chromosome 5 and 9 and 15 aneuploidy in Bone marrow by FISH |
| 1564-4 | Insulin [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
| 10789-6 | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Harris regressive stain |
| 17097-7 | CD10+CD20+ cells/100 cells in Blood |
| 17225-4 | SMIg lymphocytes/100 lymphocytes in Blood |
| 17370-8 | Norepinephrine [Mass/volume] in Urine --3rd specimen post XXX challenge |
| 17586-9 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 17933-3 | Bacteria # 6 identified in Blood by Aerobe culture |
| 74784-0 | Influenza virus B lineage RNA [Identifier] in Specimen by NAA with probe detection |
| 77376-2 | Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA - Anorectal |
| 7754-5 | Turnip IgE Ab [Units/volume] in Serum |
| 62459-3 | Coccidioides immitis IgG Ab [Presence] in Serum by Immune diffusion (ID) |
| 94476-9 | Borrelia burgdorferi G39/40 IgG bands [#] in Blood by Immunoblot |
| 94820-8 | Whole mRNA transcriptome sequence analysis in Blood or Tissue by Sequencing |
| 63420-4 | Gliadin peptide+tissue transglutaminase IgA+IgG Ab [Presence] in Serum by Immunoassay |
| 79296-0 | D- and L-2-hydroxyglutarate panel - Amniotic fluid |
| 9567-9 | Mumps virus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 66853-3 | Myeloperoxidase [Moles/volume] in Plasma |
| 7984-8 | Parvovirus B19 IgM Ab [Units/volume] in Serum |
| 8133-1 | CD56 cells/100 cells in Blood |
| 96628-3 | HLA-A and B and C (class I) typing panel - Blood or Tissue from Donor by Low resolution |
| 6951-8 | TOLAZamide [Mass/volume] in Specimen |
| 69824-1 | 2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --7 days post dose ifosfamide |
| 81787-4 | Myeloperoxidase IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 81811-2 | 3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in DBS |
| 82134-8 | Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection |
| 71862-7 | Hemoglobin H/Hemoglobin.total [Pure mass fraction] in Blood by Electrophoresis |
| 72736-2 | Methylenedioxyamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 72840-2 | Hepatitis B virus codon 250 [Identifier] by Genotype method |
| 72964-0 | quiNINE induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86085-8 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum --1st specimen |
| 86604-6 | Alfentanil/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 73888-0 | Tetrahydrocorticosterone [Moles/time] in 24 hour Urine |
| 74386-4 | Normirtazapine [Mass/mass] in Specimen |
| 88979-0 | Mucus [Presence] in Urine sediment |
| 89337-0 | CD27-CD45RO+CD62L-CCR7- cells/100 CD3+CD4+ cells in Blood |
| 30919-5 | Iron [Mass/volume] in Urine collected for unspecified duration |
| 31103-5 | Osmotic fragility of Red Blood Cells--0.0% sodium chloride 24 hour 37 degree C incubation |
| 31530-9 | Neuronal Ab [Units/volume] in Cerebral spinal fluid |
| 51165-9 | CD34 blasts [Units/volume] in Blood |
| 51742-5 | Borrelia burgdorferi 49736 IgM Ab [Units/volume] in Serum by Immunoassay |
| 51771-4 | Histoplasma capsulatum DNA [#/volume] in Specimen by NAA with probe detection |
| 22610-0 | Western equine encephalitis virus Ab [Presence] in Cerebral spinal fluid |
| 5241-5 | Lymphocytic choriomeningitis virus Ab [Titer] in Serum by Complement fixation |
| 52823-2 | La Crosse virus IgG Ab [Presence] in Serum by Immunoassay |
| 43856-4 | CD3+CD25+ cells/100 cells in Body fluid |
| 23174-6 | Leptospira interrogans sv Canicola Ab [Presence] in Serum by Agglutination |
| 23186-0 | Leptospira interrogans Ab [Presence] in Serum by Immunoassay |
| 53129-3 | Sodium urate crystals [#/area] in Urine sediment by Microscopy high power field |
| 53450-3 | Cytarabine [Mass/volume] in Serum or Plasma |
| 23253-8 | Mycoplasma arginini Ab [Presence] in Serum |
| 23601-8 | Mareks disease virus serotype [Identifier] in Tissue by Organism specific culture |
| 33655-2 | Beta-N-acetylhexosaminidase [Moles/volume] in Leukocytes |
| 44911-6 | Beta 2 globulin+Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
| 33862-4 | Waxy casts [Presence] in Urine sediment by Light microscopy |
| 341-8 | Miocamycin [Susceptibility] by Serum bactericidal titer |
| 54321-5 | Octanoylcarnitine (C8) [Moles/volume] in Cerebral spinal fluid |
| 47001-3 | Brucella sp Ag [Presence] in Specimen by Agglutination |
| 24524-1 | DOPamine/Creatinine [Molar ratio] in Urine |
| 34381-4 | Thioguanine [Mass/volume] in Serum or Plasma |
| 34523-1 | Succinate semialdehyde dehydrogenase [Enzymatic activity/mass] in Leukocytes |
| 3468-6 | Chlorphentermine [Mass/volume] in Blood |
| 55334-7 | little k Ab [Titer] in Serum or Plasma |
| 47250-6 | Adenosine monophosphate.cyclic [Moles/volume] in Urine --2nd specimen post XXX challenge |
| 25122-3 | Phosphoethanolamine/Creatinine [Molar ratio] in Urine |
| 34887-0 | Peste des petits ruminants virus Ag [Presence] in Tissue by Immunofluorescence |
| 35047-0 | Abnormal lymphocytes [#/volume] in Cerebral spinal fluid |
| 35109-8 | Phenprocoumon [Mass/volume] in Serum or Plasma |
| 55780-1 | Nucleated erythrocytes [#] in Cerebral spinal fluid by Manual count |
| 55954-2 | Octenoylcarnitine (C8:1) [Moles/volume] in Urine |
| 56017-7 | Platelet aggregation collagen induced ATP secretion [Presence] in Blood --5 ug/mL |
| 47510-3 | Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum --2nd specimen |
| 47675-4 | Isoleucine/Amino acids.total in Serum or Plasma |
| 47878-4 | Propionylglycine [Moles/volume] in Plasma |
| 25779-0 | Stachybotrys chartarum IgG Ab [Units/volume] in Serum |
| 25790-7 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 35-6 | Azithromycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 56370-0 | Giant Ragweed IgG4 Ab [Mass/volume] in Serum |
| 56554-9 | Porphyrins [Mass/time] in 72 hour Stool |
| 48239-8 | Alternaria alternata triggered leukotriene release [Mass/volume] by Leukocytes |
| 26706-2 | Vanillylmandelate [Mass/volume] in 24 hour Urine |
| 3633-5 | Fenproporex [Presence] in Urine |
| 3822-4 | Minocycline [Mass/volume] in Serum or Plasma |
| 38369-5 | U1 small nuclear ribonucleoprotein IgG Ab [Presence] in Serum |
| 57552-2 | 18-Hydroxydeoxycorticosterone [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin |
| 27373-0 | Calcium [Mass/volume] in Dialysis fluid |
| 2871-2 | Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
| 49978-0 | Borrelia burgdorferi 35kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 29920-6 | Beryllium/Creatinine [Mass Ratio] in 24 hour Urine |
| 40461-6 | GJB1 gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 58837-6 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 50393-8 | 3-Keto n-Valerate/Creatinine [Molar ratio] in Urine |
| 41101-7 | GJB2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 1944-8 | Beta glucuronidase [Enzymatic activity/mass] in Tissue |
| 19769-9 | Pathologist who read Cyto stain of Cervical or vaginal smear or scraping |
| 20461-0 | Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria |
| 2060-2 | Cerebroside sulfatase [Enzymatic activity/mass] in Tissue |
| 20632-6 | Activated T cells lymphocytes/100 lymphocytes.small in Specimen |
| 12387-7 | Primidone [Mass/volume] in Urine |
| 13417-1 | Tyrosine [Mass/volume] in Amniotic fluid |
| 13658-0 | Urobilinogen [Presence] in Urine |
| 14026-9 | HTLV I+II p53 Ab [Presence] in Serum by Immunoblot |
| 102938-8 | Lactoglobulin IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14579-7 | ABO group [Type] in Blood from Donor |
| 103623-5 | Enterococcus faecalis+Enterococcus faecium DNA [Presence] in Specimen by NAA with probe detection |
| 10378-8 | Polychromasia [Presence] in Blood by Light microscopy |
| 1491-0 | Glucose [Mass/volume] in Urine --30 minutes post 100 g glucose PO |
| 104313-2 | Niraparib [Mass/volume] in Serum or Plasma |
| 15284-3 | Grey Alder IgE Ab [Units/volume] in Serum |
| 10715-1 | Schistosoma sp identified in Urine sediment by Light microscopy |
| 16658-7 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --1 minute post XXX challenge |
| 16659-5 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --2.5 hours post XXX challenge |
| 17005-0 | IgA subclass 1 [Mass/volume] in Cerebral spinal fluid |
| 17102-5 | CD105 cells/100 cells in Blood |
| 17927-5 | Bacteria # 3 identified in Wound deep by Anaerobe culture |
| 1848-1 | Androstanolone [Mass/volume] in Serum or Plasma |
| 18900-1 | Cephalothin [Susceptibility] |
| 90285-8 | Trichomonas vaginalis [Presence] in Vaginal fluid by Organism specific culture |
| 91001-8 | Myelin associated glycoprotein IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay |
| 74904-4 | DOPamine [Moles/volume] in Cerebral spinal fluid |
| 91847-4 | Streptococcus agalactiae DNA [Presence] in Genital specimen by NAA with probe detection |
| 753-4 | Neutrophils [#/volume] in Blood by Manual count |
| 61042-8 | fentaNYL [Presence] in Specimen |
| 759-1 | Neutrophils [#/volume] in Peritoneal fluid by Manual count |
| 92970-3 | Klebsiella pneumoniae+Klebsiella variicola+Klebsiella quasipneumoniae DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
| 62361-1 | Cells counted [#] |
| 77065-1 | AHCY gene full mutation analysis in Blood or Tissue by Sequencing |
| 63147-3 | Horseradish IgG Ab [Mass/volume] in Serum |
| 77788-8 | cloZAPine cutoff [Mass/volume] in Urine for Confirmatory method |
| 94622-8 | Bovine diarrhea virus Ag/Positive control in Specimen by Immunoassay |
| 79396-8 | NADH:ubiquinone reductase [Enzymatic activity/mass] in Tissue |
| 6721-5 | Codfish IgG Ab [Units/volume] in Serum |
| 95708-4 | Yellow fever virus IgA Ab [Presence] in Specimen by Immunoassay |
| 96396-7 | Cytomegalovirus DNA [log units/volume] (viral load) in Specimen by NAA with probe detection |
| 80619-0 | Zika virus IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 97566-4 | Myasthenia gravis and Lambert-Eaton syndrome autoimmune Ab panel - Serum |
| 70131-8 | Rickettsia typhus group IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 70289-4 | Del(1)(p32p32)(STIL,TAL1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 71358-6 | GJB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 71646-4 | Eosinophils/Leukocytes [Pure number fraction] in Body fluid by Manual count |
| 72342-9 | Neutrophils/100 round cells in Semen by Manual count |
| 72560-6 | HIV integrase inhibitor susceptibility panel by Genotype method |
| 86155-9 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum --2nd specimen |
| 73095-2 | Valdecoxib induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73848-4 | 16-Ketoandrostenediol [Moles/time] in 24 hour Urine |
| 88447-8 | Liver fibrosis interpretation in Serum Qualitative |
| 7394-0 | Helminthosporium maydis IgE Ab [Units/volume] in Serum |
| 74453-2 | Histiocytes/100 cells in Bone marrow |
| 88891-7 | Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 89357-8 | CD19+CD38+IgM+ cells [#/volume] in Blood |
| 50816-8 | Arsenic organic [Moles/volume] in Urine |
| 50844-0 | cloZAPine [Moles/volume] in Urine |
| 50900-0 | Platinum [Moles/mass] in Hair |
| 30466-7 | Promonocytes/100 leukocytes in Blood |
| 30894-0 | Aldosterone/Renin [Ratio] in Plasma |
| 41760-0 | Interleukin 12 [Mass/volume] in Serum or Plasma |
| 42236-0 | Borrelia burgdorferi DNA [Presence] in Tick by NAA with probe detection |
| 60105-4 | OLANZapine [Mass/volume] in Blood |
| 21590-5 | Valproate.bound/Valproate.total in Serum or Plasma |
| 31445-0 | Intrinsic factor blocking IgG Ab [Units/volume] in Serum |
| 51161-8 | Cytoplasmic CD34 blasts/100 blasts in Specimen |
| 22096-2 | Influenza virus A Ab [Presence] in Serum |
| 51873-8 | Platelet concentrate units given [#] |
| 43340-9 | Psittacid herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence |
| 4353-9 | Nitrofurantoin [Mass] of Dose |
| 32337-8 | Protein [Mass/volume] in Specimen |
| 22855-1 | Babesia divergens Ab [Presence] in Serum |
| 33388-0 | Band form neutrophils/100 leukocytes in Pericardial fluid |
| 53857-9 | Hemoglobin F [Mass/volume] in Blood |
| 53864-5 | GAA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 23680-2 | Bromide [Mass/volume] in Specimen |
| 33909-3 | Prolactin [Moles/volume] in Serum or Plasma --2 hours post 200 ug TRH IV |
| 54148-2 | Autoantibodies [Interpretation] in Serum by Immunofluorescence (IF) Hep2 substrate Narrative |
| 3448-8 | cefOXitin [Mass/volume] in Serum or Plasma |
| 55530-0 | Cocaethylene [Moles/volume] in Serum or Plasma |
| 47393-4 | Gliadin peptide IgA Ab [Presence] in Serum by Immunoassay |
| 25117-3 | Methylsuccinate/Creatinine [Molar ratio] in Urine |
| 25343-5 | Fasciola sp IgG Ab [Units/volume] in Serum |
| 3479-3 | Chlorthalidone [Mass/volume] in Urine |
| 34883-9 | Mycoplasma sp Ag [Presence] in Tissue by Immune stain |
| 35057-9 | Histiocytes [#/volume] in Body fluid |
| 48046-7 | Phosphate cutoff [Mass/mass] in Stool |
| 265-9 | Ganciclovir [Susceptibility] |
| 26686-6 | Triazolam [Mass/volume] in Vitreous fluid |
| 3659-0 | Furosemide [Mass/volume] in Serum or Plasma |
| 48423-8 | Protein Fractions [Interpretation] in Body fluid by Electrophoresis |
| 27203-9 | Follitropin [Units/volume] in 24 hour Urine |
| 3828-1 | Morphine Free [Presence] in Urine |
| 38305-9 | Glyphosate [Mass/volume] in Water |
| 57101-8 | Follitropin [Units/volume] in Serum or Plasma --20 minutes post dose gonadotropin releasing hormone |
| 57668-6 | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 27-3 | Ampicillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 2745-8 | pH of Capillary blood |
| 28062-8 | Borrelia burgdorferi 23kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 39319-9 | Influenza virus A N9 neutralizing antibody [Presence] in Serum by Neutralization test |
| 49471-6 | IgG subclass 4 Ag [Presence] in Tissue by Immune stain |
| 49481-5 | TCL-1A Ag [Presence] in Tissue by Immune stain |
| 49605-9 | Hepatitis C virus RNA [log units/volume] (viral load) in Specimen by NAA with probe detection |
| 29379-5 | Insulin [Units/volume] in Serum or Plasma --6 hours post XXX challenge |
| 39993-1 | Creatinine [Mass/volume] in Urine --5.5 hours post XXX challenge |
| 40222-2 | Glucose [Moles/volume] in Serum or Plasma --2 days post XXX challenge |
| 40288-3 | Insulin [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 58459-9 | Ganglioside GT1b Ab [Presence] in Serum by Immunofluorescence |
| 29869-5 | 4-Hydroxycyclohexylacetate [Presence] in Urine |
| 59043-0 | Somatotropin [Mass/volume] in Serum or Plasma --34th specimen |
| 40836-9 | Sulfonamide crystals [#/area] in Urine sediment by Microscopy low power field |
| 12374-5 | cloBAZam [Mass/volume] in Urine |
| 12378-6 | diazePAM [Presence] in Stool |
| 101306-9 | Plasmodium falciparum DNA [Presence] in Blood by NAA with non-probe detection |
| 13932-9 | Testes IgG Ab [Titer] in Serum |
| 102283-9 | Dog epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102523-8 | Long Leaf Pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102531-1 | Pistachio IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13964-2 | Methylmalonate [Moles/volume] in Serum or Plasma |
| 14152-3 | Bilirubin.direct [Mass/volume] in Body fluid |
| 14423-8 | Bilirubin.total [Mass/volume] in Synovial fluid |
| 14554-0 | Mumps virus Ag [Presence] in Penis by Immunofluorescence |
| 14586-2 | Aldosterone [Moles/volume] in Serum or Plasma |
| 14757-9 | Glucose [Moles/volume] in Serum or Plasma --2 hours post 100 g glucose PO |
| 103678-9 | CTNNB1 gene targeted mutation analysis in Tumor by Molecular genetics method |
| 103745-6 | Time interval between troponin I.high-sensitivity assays |
| 1112-2 | Le sup(a) Ab [Presence] in Serum or Plasma |
| 17598-4 | Specific gravity of Synovial fluid |
| 18474-7 | HER2 Ag [Presence] in Tissue by Immune stain |
| 90837-6 | Neuronal nuclear type 3 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 74785-7 | Influenza virus B Victoria lineage RNA [Presence] in Specimen by NAA with probe detection |
| 74851-7 | Blasts/100 cells in Lymph node by Manual count |
| 92481-1 | Sc2 Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 75040-6 | D-Lactate [Moles/volume] in Cerebral spinal fluid |
| 75409-3 | Hepatitis B virus surface Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 6051-7 | Brewer's yeast IgE Ab [Units/volume] in Serum |
| 60564-2 | Amikacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 77128-7 | USH1C gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77346-5 | Enterobius vermicularis [Presence] in Anal by Pinworm exam --3rd specimen |
| 93928-0 | C Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant |
| 77932-2 | Cortisol [Moles/volume] in Serum or Plasma --8 hours post XXX challenge |
| 79-4 | Cefixime [Susceptibility] by Minimum lethal concentration (MLC) |
| 95136-8 | Cytomegalovirus DNA panel - Amniotic fluid by NAA with probe detection |
| 95267-1 | Connective tissue autoimmune IgG panel - Serum or Plasma |
| 6564-9 | Trichomonas vaginalis [Presence] in Genital specimen by Complement fixation |
| 80158-9 | Galactosylhydroxylysine/Creatinine [Molar ratio] in Urine |
| 6957-5 | Western equine encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 82170-2 | Influenza virus B RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 97542-5 | Oxygen content in Central venous blood |
| 706-2 | Basophils/100 leukocytes in Blood by Automated count |
| 99277-6 | Pyrazolam [Mass/volume] in Urine by Confirmatory method |
| 86146-8 | Streptococcus pneumoniae Danish serotype 8 Ab [Mass/volume] in Serum |
| 73036-6 | Citalopram induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86725-9 | Erysipelothrix rhusiopathiae Ag [Presence] in Tissue by Immune stain |
| 73727-0 | Methadone [Presence] in Hair |
| 3059-3 | Trypsin [Enzymatic activity/volume] in Duodenal fluid |
| 31004-5 | Mold Allergen Mix 3 (Staphylococcus aureus enterotoxin A+Staphylococcus aureus enterotoxin B) IgE Ab [Presence] in Serum by Multidisk |
| 41870-7 | Tryptase.mature [Enzymatic activity/volume] in Serum or Plasma |
| 51225-1 | CD105 cells/100 cells in Body fluid |
| 51428-1 | Lactate [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
| 51433-1 | Renin [Mass/volume] in Plasma --pre or post XXX challenge |
| 42866-4 | CD117 cells/100 cells in Bone marrow |
| 51504-9 | Penicillin G benzathine [Susceptibility] |
| 51672-4 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 43353-2 | Avian metapneumovirus C Ab [Presence] in Serum |
| 22408-9 | Lymphocytic choriomeningitis virus Ab [Titer] in Serum |
| 22552-4 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum |
| 53054-3 | Carnitine free (C0) [Moles/volume] in Amniotic fluid |
| 22819-7 | Avian infectious laryngotracheitis virus Ag [Presence] in Specimen by Immune diffusion (ID) |
| 53398-4 | Arginine/Phenylalanine [Molar ratio] in DBS |
| 23256-1 | Mycoplasma bovis Ab [Presence] in Serum by Complement fixation |
| 3334-0 | Amitriptyline [Presence] in Urine |
| 45160-9 | Acremonium sp Ab [Presence] in Serum by Immune diffusion (ID) |
| 45198-9 | Decenoylcarnitine (C10:1) [Moles/volume] in DBS |
| 33797-2 | Creatine [Moles/time] in 12 hour Urine |
| 24336-0 | Gas panel - Arterial blood |
| 34353-3 | Pentacarboxylporphyrins/Creatinine [Molar ratio] in Urine |
| 47025-2 | Cytokeratin 5/6 Ag [Presence] in Tissue by Immune stain |
| 25095-1 | Deoxypyridinoline/Creatinine [Molar ratio] in Urine |
| 34929-0 | CD3+CD4+CD45RO+CD45RA- cells/100 cells in Blood |
| 3517-0 | Cyclacillin [Mass/volume] in Serum or Plasma |
| 47832-1 | C peptide [Moles/volume] in Serum or Plasma --4 minutes post 1 mg glucagon |
| 2567-6 | Phospholipid phosphorus [Mass/volume] in Serum |
| 25702-2 | Josamycine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2588-2 | Lysolecithin acyltransferase [Enzymatic activity/volume] in Red Blood Cells |
| 35390-4 | Vaccinia virus DNA [Presence] in Specimen by NAA with probe detection |
| 35425-8 | Herpes simplex virus identified in Placenta by Organism specific culture |
| 35721-0 | Chlamydia sp rRNA [Presence] in Anal by Probe |
| 56408-8 | Tuna IgG4 Ab [Mass/volume] in Serum |
| 47976-6 | Selenium [Mass/volume] in 24 hour Urine |
| 26491-1 | Mononuclear cells [#/volume] in Synovial fluid |
| 3618-6 | Ethylmorphine [Presence] in Urine |
| 36911-6 | SCA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 56678-6 | Ethanolamine/Creatinine [Ratio] in 24 hour Urine |
| 48367-7 | cis-Vaccenate (C18:1w7) [Moles/volume] in Serum or Plasma |
| 48609-2 | Adenovirus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
| 48722-3 | Microscopic observation [Identifier] in Body fluid by Crystal violet stain |
| 38487-5 | IgA [Units/volume] in Serum |
| 57460-8 | Activated T cells lymphocytes/100 lymphocytes.small in Bronchoalveolar lavage |
| 57598-5 | 6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
| 57663-7 | Norepinephrine [Mass/volume] in Plasma --post XXX challenge |
| 4955-1 | HLA-DR12(5) [Presence] |
| 29394-4 | Gastrin [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 58531-5 | Corticotropin [Moles/volume] in Plasma --1.5 hours post dose insulin IV |
| 5865-1 | Influenza virus B Ag [Presence] in Throat by Immunofluorescence |
| 58651-1 | Cortisol [Moles/volume] in Saliva (oral fluid) --15 minutes pre 1 ug/kg CRH IV |
| 58734-5 | Collection date of Amniotic fluid |
| 29826-5 | Jamestown canyon virus IgM Ab [Presence] in Specimen |
| 40714-8 | Giardia lamblia IgM Ab [Presence] in Serum by Immunoassay |
| 59031-5 | CD25+C69+ cells/100 cells in Blood |
| 59251-9 | N-carbamoyl beta alanine/Creatinine [Molar ratio] in Urine |
| 30143-2 | Legionella sp Ab [Presence] in Serum --1st specimen |
| 19251-8 | Prolactin [Mass/volume] in Serum or Plasma --post XXX challenge |
| 19490-2 | Hydroxyalprazolam [Presence] in Urine by Confirmatory method |
| 20752-2 | Chlamydophila psittaci [Presence] in Specimen by Organism specific culture |
| 20874-4 | Manganese [Mass/mass] in Tissue |
| 100820-0 | Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge |
| 101421-6 | Human coronavirus NL63 RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 101567-6 | Parainfluenza virus RNA in Specimen Document |
| 13128-4 | Immunosuppressive acidic protein [Units/volume] in Serum or Plasma |
| 13201-9 | Blastomyces dermatitidis Ab [Units/volume] in Cerebral spinal fluid |
| 13988-1 | Beta globulin/Protein.total in 24 hour Urine by Electrophoresis |
| 14614-2 | Nuclear Ab [Titer] in Pleural fluid |
| 103151-7 | Kidney transplant acute cellular rejection risk [Score] in Plasma cell-free DNA by Calculated by AlloMap |
| 14873-4 | pH of Cord blood |
| 1495-1 | Glucose [Mass/volume] in Urine --1.5 hours post 100 g glucose PO |
| 1505-7 | Glucose [Mass/volume] in Urine --1 hour post 50 g glucose PO |
| 15211-6 | Biopsy [Interpretation] in Thyroid Narrative |
| 104369-4 | Clostridium baratii [Presence] in Specimen |
| 10482-8 | Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain |
| 16214-9 | Lysergate diethylamide [Presence] in Urine by Confirmatory method |
| 10812-6 | Microscopic observation [Identifier] in Tissue by Steiner stain |
| 16876-5 | Francisella tularensis IgA Ab [Presence] in Serum by Latex agglutination |
| 17201-5 | CD83 cells/100 cells in Blood |
| 17923-4 | Bacteria # 2 identified in Tissue by Anaerobe culture |
| 74751-9 | Collection time of Urine |
| 74837-6 | CD20 cells [#/volume] in Specimen |
| 74935-8 | Palmitoyl protein thioesterase [Enzymatic activity/mass] in Leukocytes |
| 7634-9 | Prune IgE Ab [Units/volume] in Serum |
| 93503-1 | NMDAR subunit 1 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 77175-8 | Coxiella burnetii phase 1 and 2 IgG and IgM panel - Serum |
| 93721-9 | O-nortramadol [Mass/mass] in Meconium by Confirmatory method |
| 93814-2 | SERPINC1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 627-0 | Bacteria identified in Tissue by Aerobe culture |
| 6456-8 | Listeria monocytogenes Ab [Titer] in Serum by Complement fixation |
| 95238-2 | Hepatitis D virus Ab [Interpretation] in Serum or Plasma |
| 6677-9 | Microscopic observation [Identifier] in Tissue by Rhodamine-auramine fluorochrome stain |
| 80199-3 | Nonsteroidal antiinflammatory drugs [Presence] in Body fluid by Screen method |
| 80893-1 | Projected heparin concentration to reach target ACT [Units/volume] in Blood by calculation |
| 96689-5 | Clot formation.glass bead induced panel - Blood by Microviscometry |
| 97181-2 | Muscle relaxants [Presence] in Saliva (oral fluid) by Confirmatory method |
| 6930-2 | Psilocybin [Mass/volume] in Urine |
| 81727-0 | Mitochondria M2-3E Ab [Presence] in Serum by Line blot |
| 81790-8 | English walnut recombinant (rJug r) 1 IgE Ab [Units/volume] in Serum |
| 70256-3 | Nuclear IgG Ab [Ratio] in Serum by Immunoassay |
| 71374-3 | Food Allergen Mix 51 (Carrot+Tomato+Mustard+Potato+Garlic) IgE Ab [Units/volume] in Serum by Multidisk |
| 71849-4 | Oxygen saturation [Pure mass fraction] in Cord blood |
| 72461-7 | JWH-018 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 99624-9 | Japanese encephalitis virus IgG Ab [Presence] in Serum by Immunoassay |
| 99885-6 | Hyaline-granular casts [Presence] in Urine sediment by Computer assisted method |
| 99888-0 | Crystal casts [Presence] in Urine sediment by Computer assisted method |
| 72742-0 | Noroxycodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 72866-7 | Mycobacterium tuberculosis ethA gene ethionamide resistance mutation [Presence] by Molecular method |
| 72961-6 | Ramipril induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87499-0 | 3-Methoxytyramine.free [Molar ratio] in Urine |
| 87956-9 | Legionella sp identified in Tissue by Organism specific culture |
| 88969-1 | Tyrosine crystals [#/area] in Urine sediment |
| 30418-8 | Lymphocytes clefted [#/volume] in Blood |
| 4182-2 | Chloroquine [Mass] of Dose |
| 42000-0 | Lopinavir+Ritonavir [Susceptibility] by Genotype method |
| 31385-8 | Feline coronavirus Ab [Units/volume] in Serum |
| 43036-3 | Feline herpesvirus Ab [Titer] in Serum |
| 2204-6 | Dermatan sulfate [Mass/volume] in Urine |
| 31818-8 | Equine herpesvirus 1+4 Ag [Presence] in Body fluid |
| 31974-9 | Taenia hydatigena Ag [Presence] in Stool |
| 51650-0 | HLA-B [Interpretation] by NAA with probe detection |
| 51921-5 | Lopinavir [Mass/volume] in Serum or Plasma --trough |
| 43611-3 | Adenovirus Ag [Presence] in Bronchial specimen by Immunofluorescence |
| 22360-2 | HTLV I IgG Ab [Presence] in Serum |
| 22388-3 | Legionella pneumophila 4 IgM Ab [Titer] in Serum |
| 4412-3 | Promethazine [Mass] of Dose |
| 2284-8 | Folate [Mass/volume] in Serum or Plasma |
| 53189-7 | 3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in DBS |
| 53287-9 | Epithelial casts [#/volume] in Urine by Computer assisted method |
| 53879-3 | Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by NAA with probe detection |
| 53905-6 | Microscopic observation [Identifier] in Urine by Rhodamine-auramine fluorochrome stain |
| 44927-2 | Prolactin [Units/volume] in Serum or Plasma --30 minutes post dose TRH IV |
| 23859-2 | Erythrocytes [#/volume] in Specimen by Light microscopy |
| 23897-2 | Mesothelial cells [Presence] in Specimen by Light microscopy |
| 33860-8 | Somatotropin/Creatinine [Ratio] in 24 hour Urine |
| 54186-2 | Posaconazole [Susceptibility] by Gradient strip |
| 46405-7 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes pre 1 g/kg glucose PO |
| 47121-9 | Mercury [Moles/mass] in Specimen |
| 47438-7 | Fowl adenovirus Ab [Presence] in Serum |
| 3515-4 | Crotethamide [Mass/volume] in Urine |
| 35265-8 | Pathology report addendum in Specimen Narrative |
| 55679-5 | Framycetin [Susceptibility] by Gradient strip |
| 35740-0 | Rickettsia sp IgG and IgM panel - Serum |
| 56175-3 | American Sycamore IgG4 Ab [Mass/volume] in Serum |
| 48885-8 | Bartonella quintana IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 27218-7 | quiNINE [Mass/volume] in Urine |
| 38461-0 | Legionella sp Ag [Presence] in Pleural fluid by Immunofluorescence |
| 38497-4 | Spermatozoa Amorphous Head [Presence] in Semen |
| 38506-2 | Thyroxine (T4) [Presence] in DBS |
| 57609-0 | 6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
| 57672-8 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --2 days post XXX challenge |
| 49227-2 | Stavudine [Mass/volume] in Serum or Plasma |
| 27288-0 | Midazolam [Mass/mass] in Stool |
| 38743-1 | Hydrogen chloride [Mass/volume] in Air |
| 393-9 | Penicillin G [Susceptibility] by Disk diffusion (KB) |
| 39581-4 | Rubella virus Ab [Presence] in Cerebral spinal fluid |
| 29315-9 | Isoniazid 0.4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 40065-5 | Calcium [Mass/volume] in Serum or Plasma --45 minutes pre XXX challenge |
| 29706-9 | Rickettsia rickettsii Ab [Presence] in Serum by Immunofluorescence |
| 29855-4 | Powassan virus IgM Ab [Presence] in Serum |
| 5904-8 | Russell viper venom time in Platelet poor plasma by Coagulation assay |
| 50253-4 | Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --1st specimen fasting |
| 50321-9 | Hepatocyte Ag [Presence] in Tissue by Immune stain |
| 19562-8 | Methylenediamine [Presence] in Urine by Confirmatory method |
| 100129-6 | Schistosoma sp Ab [Titer] in Serum by Hemagglutination |
| 12608-6 | Glucose [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen |
| 101399-4 | Monkeypox virus and Orthopoxvirus.non-variola DNA [Identifier] in Specimen by NAA with probe detection |
| 102004-9 | Clot angle.kaolin induced in Blood by Thromboelastography^after addition of heparinase |
| 102326-6 | Glycyphagus domesticus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1396-1 | Cortisol Free [Mass/volume] in 24 hour Urine --pre 2 mg dexamethasone PO 2.5 day high dose q6h |
| 1397-9 | Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting |
| 102876-0 | Horse meat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102961-0 | Mucor racemosus IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14708-2 | Endomysium Ab [Titer] in Serum |
| 103635-9 | Chromium IgE Ab [Units/volume] in Serum |
| 14896-5 | Protein Fractions [Interpretation] in Urine by Immunofixation |
| 14905-4 | Retinol [Moles/volume] in Serum or Plasma |
| 1044-7 | H Ab [Presence] in Serum |
| 16173-7 | Amyl ether [Mass/volume] in Blood |
| 1081-9 | Js sup(a) Ab [Presence] in Serum or Plasma |
| 11096-5 | Gamma chlordane [Mass/volume] in Serum or Plasma |
| 16704-9 | Cyproheptadine [Mass/volume] in Serum or Plasma |
| 16899-7 | Giardia lamblia Ag [Presence] in Specimen |
| 17038-1 | La Crosse virus IgG Ab [Titer] in Serum |
| 17776-6 | Yersinia sp IgG Ab [Units/volume] in Serum |
| 1796-2 | Amylase [Enzymatic activity/volume] in Pleural fluid |
| 1833-3 | Alpha-1-Fetoprotein [Mass/volume] in Cerebral spinal fluid |
| 18339-2 | Nortramadol [Presence] in Serum or Plasma by Confirmatory method |
| 18917-5 | Doxycycline [Susceptibility] |
| 74886-3 | Stigmasterol [Moles/volume] in Serum or Plasma |
| 91800-3 | Parainfluenza virus 3 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 92766-5 | Alpha-aminoadipic semialdehyde+Delta-1-piperideine-6-carboxylate [Moles/volume] in Serum or Plasma |
| 75227-9 | Baclofen [Mass/volume] in Urine |
| 610-6 | Bacteria identified in Body fluid by Aerobe culture |
| 9365-8 | Clostridioides difficile Ab [Titer] in Serum |
| 61414-9 | Doxepin/Creatinine [Mass Ratio] in Urine |
| 77747-4 | HTLV II gp46-II Ab [Presence] in Serum or Plasma by Immunoblot |
| 63219-0 | Desmoglein 3 Ab [Presence] in Serum by Immunoassay |
| 7851-9 | Cytomegalovirus Ab [Units/volume] in Serum or Plasma |
| 78535-2 | Glucose [Moles/volume] in Peritoneal dialysis fluid --4 hour dwell specimen |
| 665-0 | Microscopic observation [Identifier] in Specimen by Hematoxylin and eosin stain |
| 80125-8 | Aluminum [Mass/mass] in Tissue |
| 97099-6 | Influenza virus A and B and SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay |
| 9719-6 | Toxocara canis IgM Ab [Units/volume] in Serum by Immunoassay |
| 6953-4 | Zolpidem [Mass/volume] in Serum or Plasma |
| 69785-4 | 2-Hydroxysebacate [Moles/volume] in Serum or Plasma |
| 81646-2 | Clostridium botulinum toxin E botE gene [Presence] in Specimen by NAA with probe detection |
| 97308-1 | Triazolam [Presence] in Cord tissue by Screen method |
| 9734-5 | Alpha 1 globulin [Mass/volume] in Urine by Electrophoresis |
| 82469-8 | Etanercept Ab [Mass/volume] in Serum or Plasma by Immunoassay |
| 98405-4 | Malassezia sp identified in Isolate by MS.MALDI-TOF |
| 71677-9 | Monocytes/Leukocytes [Pure number fraction] in Blood by Automated count |
| 72211-6 | t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
| 99922-7 | Schistosoma haematobium [#/area] in Urine sediment by Computer assisted method |
| 72741-2 | Nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 72789-1 | Naltrexone/Creatinine [Mass Ratio] in Urine |
| 73039-0 | Celecoxib induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73260-2 | Mirtazapine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 59397-0 | Echovirus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 50848-1 | Cortisol [Moles/volume] in 24 hour Urine |
| 30487-3 | Catecholamines [Mass/volume] in Plasma --1 hour post XXX challenge |
| 31150-6 | ERBB2 gene duplication [Presence] in Tissue by FISH |
| 31281-9 | Cancer associated retinopathy Ab [Presence] in Serum |
| 51164-2 | CD34 blasts [Units/volume] in Bone marrow |
| 515-7 | Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum lethal concentration (MLC) |
| 32117-4 | Thiopental [Moles/volume] in Serum or Plasma |
| 23199-3 | Leptospira sp IgG Ab [Presence] in Serum by Immunoassay |
| 3263-1 | Fibrinopeptide B beta (43-47) Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
| 33064-7 | Chromate [Mass/volume] in Urine |
| 53111-1 | Butyrylcarnitine (C4)/Creatinine [Molar ratio] in Urine |
| 53472-7 | Sebacylcarnitine (C10-DC) [Moles/volume] in Serum or Plasma |
| 33700-6 | Spore [Identifier] in Specimen by Malachite green stain |
| 45312-6 | Uroporphyrin 3 isomer [Moles/mass] in Stool |
| 45370-4 | Platelet crossmatch [Interpretation] |
| 24074-7 | Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Fibroblast |
| 54202-7 | Griseofulvin [Susceptibility] by Disk diffusion (KB) |
| 4585-6 | Hemoglobin G - Philadelphia [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 4615-1 | Hemoglobin N - Seattle [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 46425-5 | Lipemic interference index of Serum or Plasma |
| 34584-3 | Candida sp IgM Ab [Presence] in Serum |
| 55517-7 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose glucagon |
| 55542-5 | Hydroxybupropion [Moles/volume] in Serum or Plasma |
| 55583-9 | Tranylcypromine [Moles/volume] in Serum or Plasma |
| 55597-9 | Js sup(b) Ab [Titer] in Serum or Plasma |
| 47136-7 | EPINEPHrine [Moles/volume] in Plasma --1 hour post 300 ug cloNIDine PO |
| 25269-2 | Polymyxin B [Mass/volume] in Specimen |
| 25406-0 | Fasciola sp Ab [Titer] in Serum by Immunofluorescence |
| 34-9 | Ampicillin+Sulbactam [Susceptibility] by Serum bactericidal titer |
| 35140-3 | Trans-3-Hydroxycotinine [Mass/volume] in Serum or Plasma |
| 3520-4 | cycloSPORINE [Mass/volume] in Blood |
| 47564-0 | Arginine/Amino acids.total in Hair |
| 4769-6 | HLA-B57(17) [Presence] |
| 25580-2 | C peptide [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 35419-1 | Herpes simplex virus identified in Cerebral spinal fluid by Organism specific culture |
| 56307-2 | Lettuce IgG4 Ab [Mass/volume] in Serum |
| 48053-3 | Turbidity [Presence] of Synovial fluid Qualitative |
| 35858-0 | Tylosin [Susceptibility] |
| 3711-9 | Levorphanol [Presence] in Urine |
| 57033-3 | Alternaria alternata Ab [Presence] in Serum by Immune diffusion (ID) |
| 48394-1 | Coccidioides sp Ab [Presence] in Body fluid by Immune diffusion (ID) |
| 48842-9 | Bartonella bacilliformis IgG Ab [Titer] in Serum by Immunofluorescence |
| 48858-5 | Rickettsia africae IgG Ab [Titer] in Serum by Immunofluorescence |
| 26995-1 | Carboxy tetrahydrocannabinol [Mass/volume] in Blood |
| 38311-7 | Thallium [Mass/volume] in Water |
| 27301-1 | Glutarate [Moles/volume] in Serum or Plasma |
| 27968-7 | Pyruvate [Mass/volume] in Blood --2 hours post XXX challenge |
| 58014-2 | Nordoxepin [Presence] in Urine |
| 2888-6 | Protein [Mass/volume] in Urine |
| 29219-3 | FLUoxetine [Mass/volume] in Body fluid |
| 58443-3 | Other cells [#/volume] in Blood by Automated count |
| 49847-7 | Enterovirus RNA [Presence] in Serum by NAA with probe detection |
| 5911-3 | Lipoprotein fractions [Interpretation] in Serum or Plasma |
| 50344-1 | Parvovirus B19 DNA [Presence] in Body fluid by NAA with probe detection |
| 50355-7 | Perch IgE Ab/IgE total in Serum |
| 50465-4 | C peptide [Moles/volume] in Serum or Plasma --5th specimen |
| 30076-4 | Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection |
| 40816-1 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 19388-8 | chlordiazePOXIDE cutoff [Mass/volume] in Urine for Confirmatory method |
| 19547-9 | Mesoridazine [Presence] in Urine by Confirmatory method |
| 102306-8 | Finch feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102413-2 | Linden IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13996-4 | Hydroxyproline/Creatinine [Molar ratio] in 24 hour Urine |
| 102892-7 | Bougainvillea IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14474-1 | Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunoassay |
| 104027-8 | Bile acid malabsorption panel |
| 14990-6 | little i-2 subtype [Presence] on Red Blood Cells from Donor |
| 104260-5 | Hepatitis A virus cellular receptor 1 [Ratio] in Urine by Calculation |
| 104443-7 | Rickettsia prowazekii IgG Ab [Titer] in Serum by Immunoassay --1st specimen |
| 10453-9 | Xylose [Mass/volume] in Serum or Plasma --1 hour post dose xylose PO |
| 11016-3 | Microscopic observation [Identifier] in Blood or Marrow by Esterase stain.non-specific |
| 16728-8 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 11273-0 | Erythrocytes [Morphology] in Blood by Automated count |
| 11595-6 | Echovirus 18 Ab [Units/volume] in Serum |
| 18476-2 | Uroporphyrinogen decarboxylase [Presence] in Red Blood Cells |
| 19059-5 | Amphetamines cutoff [Mass/volume] in Urine |
| 91872-2 | Bordetella sp identified in Throat by Organism specific culture |
| 92533-9 | Kp sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 75146-1 | Succinylaminoimidazole carboxamide riboside [Moles/volume] in Serum or Plasma |
| 75721-1 | CYP1A2 gene c.5166G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 75886-2 | HCV antibody screening - Meaningful Use set |
| 7689-3 | Savinase IgE Ab [Units/volume] in Serum |
| 7693-5 | Schistosoma sp IgE Ab [Units/volume] in Serum |
| 92798-8 | Candida lusitaniae DNA [Presence] by NAA with probe detection in Positive blood culture |
| 93946-2 | C Ag [Presence] in Cord red blood cells |
| 62438-7 | Nucleated erythrocytes [#/volume] in Synovial fluid by Automated count |
| 63204-2 | Privet IgG Ab [Mass/volume] in Serum |
| 94589-9 | Hematologic neoplasm chromosome analysis in Blood or Marrow by Mate pair sequencing |
| 94825-7 | Parvovirus B19 DNA [log units/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 95145-9 | Hepatitis B virus core Ab panel - Serum or Plasma |
| 95645-8 | Murray Valley encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 80185-2 | Xanthopterin/Creatinine [Molar ratio] in Urine |
| 80213-2 | Beta blockers [Presence] in Blood by Screen method |
| 95838-9 | Nucleated cells.recovered/Nucleated cells.total |
| 80647-1 | Monoethyl methylphosphonate [Mass/volume] in Blood |
| 6910-4 | Brucella abortus IgA Ab [Units/volume] in Serum |
| 69949-6 | Epstein Barr virus capsid IgG Ab avidity [Presence] in Serum by Immunoassay |
| 81693-4 | DNA mismatch repair protein Msh6 [Presence] in Cancer specimen by Immune stain |
| 81766-8 | Eicosatrienoate (C20:3w3) [Entitic substance] in Serum or Plasma |
| 82087-8 | Occupational Allergen Mix 2 (Acarus siro+Lepidoglyphus destructor+Horse bot fly+Grain weevel) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 9751-9 | Coxsackievirus A10 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 70295-1 | Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection |
| 85336-6 | DCIS intraductal extension in Breast cancer specimen Qualitative by Light microscopy |
| 72660-4 | Beta-trace protein [Mass/volume] in Ear fluid |
| 72980-6 | Pantoprazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86032-0 | Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 86151-8 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 87452-9 | Sodium [Mass/mass] in Specimen |
| 73476-4 | Caspofungin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88129-2 | Respiratory pathogens panel - Throat by Immunofluorescence |
| 88156-5 | Microscopic observation [Identifier] in Amniotic fluid by Acid fast stain |
| 73893-0 | Tetrahydrocortisone [Moles/volume] in 24 hour Urine |
| 88974-1 | Granular casts [#/area] in Urine sediment |
| 89873-4 | Unique identifier [Identifier] of Initial sample |
| 41446-6 | Parasite identified in Specimen by Culture |
| 41671-9 | Cefotaxime+Clavulanate [Susceptibility] by Gradient strip |
| 30917-9 | DNA ploidy [Interpretation] in Specimen by Flow cytometry (FC) Narrative |
| 31101-9 | Creatinine [Mass/time] in 24 hour Body fluid |
| 42667-6 | Fatty acids [Presence] in Urine |
| 31335-3 | Cryptococcus sp Ab [Units/volume] in Serum |
| 31495-5 | Lymphocytic choriomeningitis virus IgM Ab [Units/volume] in Serum |
| 42896-1 | Colorado tick fever virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 221-2 | Dicloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 51490-1 | Cortisol [Mass/volume] in Saliva (oral fluid) --5th specimen post XXX challenge |
| 5168-0 | Gall canaliculi Ab [Units/volume] in Serum |
| 2251-7 | Estriol (E3) [Mass/volume] in Serum or Plasma |
| 22776-9 | African horse sickness virus serotype [Identifier] in Specimen by Neutralization test |
| 32360-0 | Insulin [Units/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 52990-9 | Leptospira sp DNA [Presence] in Urine by NAA with probe detection |
| 22811-4 | Avian infectious laryngotracheitis virus [Presence] in Specimen by Electron microscopy |
| 22885-8 | Border disease virus RNA [Presence] in Blood by NAA with probe detection |
| 32705-6 | Neisseria gonorrhoeae DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 32845-0 | Epstein Barr virus capsid IgG Ab [Ratio] in Serum --1st specimen/2nd specimen |
| 33051-4 | Erythrocytes [Presence] in Urine |
| 23321-3 | Ovine herpesvirus 2 Ab [Presence] in Serum |
| 53568-2 | Platelet aggregation arachidonate induced in Platelet rich plasma --500 ug/mL |
| 452-3 | Spectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 23775-0 | Rhodococcus equi Ab [Titer] in Serum |
| 23911-1 | Osmotic fragility of Red Blood Cells--0.30% sodium chloride |
| 46963-5 | Tube number of Serum, Plasma or Blood |
| 24173-7 | Polio virus 3 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen |
| 244-4 | Floxacillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 24499-6 | Cryptostroma corticale Ab [Presence] in Serum by Immune diffusion (ID) |
| 55245-5 | HBB gene c.220G>A [Presence] in Blood by Molecular genetics method |
| 47456-9 | Influenza virus A H7 Ab [Titer] in Serum |
| 25418-5 | Mumps virus IgG Ab [Units/volume] in Serum by Immunoassay |
| 25526-5 | Silicon [Moles/volume] in Serum or Plasma |
| 347-5 | Nafcillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 55789-2 | Myelocytes [#] in Cerebral spinal fluid by Manual count |
| 5608-5 | Bufotenine [Mass/volume] in Urine |
| 47621-8 | Glucose.IV [Mass] of Dose |
| 258-4 | Framycetin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 35709-5 | La Crosse virus Ab [Titer] in Body fluid |
| 56364-3 | Povertyweed IgG4 Ab [Mass/volume] in Serum |
| 26457-2 | Erythrocytes [#/volume] in Peritoneal fluid |
| 56583-8 | C peptide [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 26894-6 | Glutamine [Moles/volume] in Amniotic fluid |
| 48940-1 | Benzodiazepines [Mass/volume] in Specimen by Confirmatory method |
| 48988-0 | Glucose [Mass/volume] in Serum or Plasma --12 PM specimen |
| 27304-5 | Lysine [Moles/volume] in Urine |
| 27317-7 | Asparagine [Moles/volume] in Urine |
| 58000-1 | Maple sugar IgE Ab/IgE total in Serum |
| 50072-8 | 11-Deoxycortisol [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin |
| 50082-7 | 18-Hydroxycorticosterone [Moles/volume] in Serum or Plasma |
| 58916-8 | Canary feather IgG Ab [Mass/volume] in Serum |
| 59052-1 | HIV 1+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 30028-5 | O-Ethyl O-(p-nitrophenyl) phenylphosphonothionate [Mass/volume] in Serum or Plasma |
| 30350-3 | Hemoglobin [Mass/volume] in Venous blood |
| 41139-7 | Influenza virus A N4 Ab [Presence] in Serum |
| 12399-2 | Emetine [Mass/volume] in Serum or Plasma |
| 100914-1 | Protein.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis |
| 101454-7 | Neurochondrin Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 101768-0 | Trichophyton eriotrephon DNA [Presence] in Specimen by NAA with probe detection |
| 101996-7 | Erythrocytes.Plasmodium falciparum infected/100 erythrocytes in Blood by Microscopy |
| 102826-5 | Strawberry IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10373-9 | Fragments [Presence] in Blood by Light microscopy |
| 148-7 | Cephalexin [Susceptibility] by Minimum lethal concentration (MLC) |
| 15164-7 | Complement C3 [Mass/volume] in Synovial fluid |
| 10986-8 | Doxycycline [Mass/volume] in Serum or Plasma |
| 11478-5 | Microscopic observation [Identifier] in Stool by Acid fast stain |
| 16758-5 | Dicamba [Mass/volume] in Serum or Plasma |
| 74510-9 | 3-Hydroxyeicosanoylcarnitine (C20-OH) [Moles/volume] in Serum or Plasma |
| 74778-2 | Human papilloma virus 11 DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
| 74845-9 | Sindbis virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 75020-8 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Bone marrow by Molecular genetics method |
| 61191-3 | aPTT in Platelet poor plasma from Fetus by Coagulation assay |
| 77188-1 | Zirconium [Moles/volume] in Urine |
| 63135-8 | Chick Pea IgG Ab [Mass/volume] in Serum |
| 94757-2 | SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory system specimen by Nucleic acid amplification using CDC primer-probe set N2 |
| 79271-3 | 3-Hydroxytrimethyl-L-lysine/Creatinine [Molar ratio] in Urine |
| 6612-6 | Haemophilus influenzae C Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 66482-1 | OmpC IgA Ab [Units/volume] in Serum by Immunoassay |
| 6662-1 | Microscopic observation [Identifier] in Tissue by Giemsa stain |
| 7977-2 | Paragonimus sp Ab [Units/volume] in Serum |
| 7986-3 | Polio virus 2 Ab [Units/volume] in Serum |
| 8049-9 | Varicella zoster virus DNA [Presence] in Serum by NAA with probe detection |
| 96448-6 | SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N1 |
| 80652-1 | Everolimus [Mass] of Dose |
| 97217-4 | Alpha pyrrolidinovalerophenone [Presence] in Cord tissue by Confirmatory method |
| 71674-6 | Eosinophils/Leukocytes [Pure number fraction] in Blood by Manual count |
| 71713-2 | Pyruvate kinase [Enzymatic activity/substance] in Red Blood Cells |
| 72278-5 | Volume of Prostatic fluid |
| 7291-8 | Whole Egg IgE Ab [Units/volume] in Serum |
| 85829-0 | Carbapenem resistance blaSPM gene [Presence] by Molecular method |
| 86042-9 | Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 73265-1 | Minocycline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73373-3 | Fluvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87639-1 | Dichlorodiphenyltrichloroethane [Mass/mass] in Specimen |
| 73914-4 | JWH-018 (synthetic cannabinoid) [Presence] in Urine by Confirmatory method |
| 74095-1 | Didesmethylcitalopram [Mass/volume] in Serum or Plasma |
| 74422-7 | Mumps virus IgG Ab [Presence] in Body fluid by Immunoassay |
| 88736-4 | PM-SCL-75 Ab [Units/volume] in Serum by Line blot |
| 88886-7 | Telavancin [Susceptibility] |
| 89538-3 | Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid by Line blot |
| 59392-1 | Hydroxyproline [Mass/volume] in 24 hour Urine |
| 30526-8 | Borrelia burgdorferi IgM Ab [Presence] in Serum by Immunofluorescence |
| 3109-6 | Urobilinogen [Mass/time] in 2 hour Urine |
| 41855-8 | Staphylococcus aureus enterotoxin B [Presence] in Specimen by Immunofluorescence |
| 4217-6 | diazePAM [Mass] of Dose |
| 42355-8 | Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2114-7 | Choriogonadotropin.beta subunit [Moles/volume] in Urine |
| 31334-6 | Coxsackievirus B6 Ab [Units/volume] in Body fluid |
| 217-0 | Demeclocycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 4359-6 | Norfloxacin [Mass] of Dose |
| 43614-7 | Adenovirus Ag [Presence] in Nose |
| 22632-4 | Xylose/Xylose dose in 5 hour Urine --post dose xylose PO |
| 5225-8 | HIV 2 Ab [Presence] in Serum by Immunoblot |
| 22987-2 | Capripox virus Ag [Presence] in Tissue by Immune stain |
| 23048-2 | Eastern equine encephalitis virus Ag [Presence] in Specimen by Immunofluorescence |
| 32636-3 | Islet cell 512 Ab [Titer] in Serum |
| 33195-9 | Viable cells/100 cells in Bone marrow |
| 53154-1 | Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Alanine [Molar ratio] in DBS |
| 53302-6 | Calcium carbonate crystals [#/volume] in Urine by Computer assisted method |
| 4476-8 | Complement C1 esterase inhibitor.functional [Mass/volume] in Serum or Plasma |
| 23381-7 | Abnormal Prion Protein [Presence] in Brain by Electron microscopy |
| 53894-2 | TRAPPC2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 23942-6 | Xylose [Mass/volume] in Blood --2 hours post 5 g xylose PO |
| 33955-6 | cycloSPORINE.monoclonal [Mass/volume] in Blood |
| 34209-7 | 11-Hydroxyandrosterone/Creatinine [Molar ratio] in Urine |
| 54341-3 | Myristoleate (C14:1)/Creatinine [Molar ratio] in Urine |
| 24304-8 | Coxsackievirus A7 Ab [Titer] in Serum --1st specimen |
| 34443-2 | ZOLMitriptan [Mass/volume] in Serum or Plasma |
| 55117-6 | Centers for Environmental Health trace metals screen panel [Mass/volume] - Urine |
| 25407-8 | Fasciola sp IgG Ab [Units/volume] in Serum by Immunoassay |
| 55706-6 | Piromidate [Susceptibility] |
| 25748-5 | Ribosomal Ab [Titer] in Serum by Immunofluorescence |
| 35376-3 | MJD gene allele 2 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 35409-2 | Leishmania tropica IgM Ab [Presence] in Serum |
| 3549-3 | diazePAM [Presence] in Serum or Plasma |
| 48727-2 | Bacteria # 2 identified in Blood by Culture |
| 27023-1 | CD8+CD11b+ cells [#/volume] in Blood |
| 27236-9 | Azatadine [Mass/volume] in Serum or Plasma |
| 57481-4 | 11-Ketoandrosterone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
| 48954-2 | Hydroxytriazolam [Mass/volume] in Specimen |
| 49036-7 | Parathyrin.intact [Mass/volume] in Serum or Plasma --post excision |
| 27291-4 | Hydroxylysine [Moles/volume] in Urine |
| 27834-1 | Insulin [Units/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO |
| 3914-9 | Penicillin V [Mass/volume] in Serum or Plasma |
| 57728-8 | Lactate [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 49520-0 | Influenza virus A H1 RNA [Presence] in Isolate by NAA with probe detection |
| 58400-3 | Specimen pH acceptable of Urine |
| 58718-8 | Lymphocyte proliferation stimulated by 10 ug concanavalin A actual/normal in Blood |
| 29806-7 | Anaplasma phagocytophilum IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 40381-6 | Methamphetamine [Presence] in Specimen |
| 40659-5 | Parvovirus B19 IgM Ab [Presence] in Serum by Immunofluorescence |
| 59222-0 | Squamous cell carcinoma Ag [Mass/volume] in Pleural fluid |
| 30049-1 | Ornithine/Creatinine [Ratio] in Urine |
| 30377-6 | Eosinophils/100 leukocytes in Bronchial specimen |
| 30403-0 | Leukocytes [#/volume] in Pericardial fluid |
| 1997-6 | Calcium [Moles/volume] in Cerebral spinal fluid |
| 2042-0 | Carnitine free (C0) [Presence] in Serum or Plasma |
| 20427-1 | Acetylcholine receptor Ab [Moles/volume] in Serum |
| 12630-0 | Glucose [Mass/volume] in Peritoneal dialysis fluid --1st specimen |
| 12854-6 | Neuronal nuclear type 1 Ab [Units/volume] in Serum |
| 101206-1 | Dengue virus NS1 Ag [Units/volume] in Serum or Plasma by Immunoassay |
| 101932-2 | Calcium hydrogen phosphate dihydrate crystals [Energy Difference] in Urine |
| 102132-8 | Allspice IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102261-5 | Cranberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102573-3 | Rhubarb IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14143-2 | Somatotropin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 1035-5 | Fresh frozen plasma given [Volume] |
| 103833-0 | N-nortramadol [Presence] in Meconium |
| 10484-4 | Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain |
| 12210-1 | Eosinophils/100 leukocytes in Urine sediment by Manual count |
| 12255-6 | Volume of 5 hour Urine |
| 16741-1 | American house dust mite IgG Ab [Presence] in Blood |
| 1748-3 | Albumin [Mass/volume] in Pleural fluid |
| 1775-6 | Alkaline phosphatase [Mass/volume] in Body fluid |
| 18495-2 | Ova and parasites identified in Stool by Trichrome stain--3rd specimen |
| 92492-8 | Lu sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 75137-0 | Acadesine [Moles/volume] in Serum or Plasma |
| 75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
| 75639-5 | Lactate dehydrogenase in body fluid/Lactate dehydrogenase in serum |
| 92855-6 | Bordetella parapertussis IS1001 DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 93314-3 | Platelet glycoprotein VI actual/normal in Blood by Flow cytometry (FC) |
| 62373-6 | Human reference assembly release, UCSC version [Identifier] |
| 62385-0 | Recommendation [Interpretation] Document |
| 94316-7 | SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by NAA with probe detection |
| 9536-4 | Influenza virus B IgM Ab [Titer] in Serum |
| 7960-8 | Leptospira interrogans Ab [Units/volume] in Serum by Hemagglutination |
| 79652-4 | 5-Aminoimidazole-4-carboxamide [Moles/volume] in Cerebral spinal fluid |
| 79680-5 | 2,8-dihydroxyadenine [Moles/volume] in Cerebral spinal fluid |
| 80206-6 | Japanese encephalitis+Tick-borne encephalitis+West Nile+Yellow fever virus IgM Ab [Presence] in Serum by Immunofluorescence |
| 80374-2 | Adenovirus and Norovirus and Rotavirus Ag panel - Stool by Rapid immunoassay |
| 96370-2 | Sertraline [Presence] in Saliva (oral fluid) by Confirmatory method |
| 81753-6 | Somatotropin [Mass/volume] in Serum or Plasma --1.75 hours post dose arginine+insulin |
| 97939-3 | Medium induced in vitro yeast conversion [Identifier] in Isolate by Culture |
| 98019-3 | Promegakaryocytes/100 cells in Bone marrow by Manual count |
| 98861-8 | Transforming growth factor beta [Mass/volume] in Serum or Plasma |
| 98999-6 | Nucleated cells [#/volume] in Synovial fluid by Automated count |
| 71857-7 | Hemoglobin S/Hemoglobin.total [Pure mass fraction] in Blood |
| 72926-9 | Urea [Moles/volume] in Venous blood |
| 87453-7 | Selenium [Mass/mass] in Specimen |
| 74168-6 | Barbiturates [Mass/volume] in Saliva (oral fluid) by Screen method |
| 89505-2 | Proteinase 3 Ab [Presence] in Serum by Line blot |
| 59582-7 | Coxsackievirus A24 IgG Ab [Titer] in Serum by Immunofluorescence |
| 60019-7 | Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid by Lactate to pyruvate reaction |
| 60293-8 | chlordiazePOXIDE [Moles/volume] in Specimen |
| 60302-7 | Doxepin [Moles/volume] in Specimen |
| 51315-0 | CD4+CD7-CD49D- cells/100 cells in Body fluid |
| 5147-4 | Echovirus 9 Ab [Titer] in Serum by Complement fixation |
| 51876-1 | Whole blood units given [#] |
| 2233-5 | Epitestosterone [Mass/volume] in Serum or Plasma |
| 3233-4 | Coagulation factor XII activity [Units/volume] in Platelet poor plasma by Chromogenic method |
| 32826-0 | Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 23354-4 | Peste des petits ruminants virus Ab [Presence] in Serum by Immunoassay |
| 33401-1 | Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Urine by Latex agglutination |
| 53862-9 | FIG4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 53917-1 | Streptococcus pneumoniae DNA [Presence] in Blood by NAA with probe detection |
| 23916-0 | Osmotic fragility of Red Blood Cells--0.55% sodium chloride |
| 54095-5 | Chemotherapy effectiveness panel [Identifier] - Blood or Tissue |
| 54161-5 | Cytoplasmic Ab pattern.PL-7+PL-12 [Presence] in Serum by Immunofluorescence |
| 54234-0 | Cell count and Diff panel with Gluc and Prot - Body fluid |
| 45380-3 | Basophilic stippling fine [Presence] in Blood by Light microscopy |
| 34549-6 | Follitropin and Lutropin panel [Units/volume] - Serum or Plasma |
| 47346-2 | Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 47388-4 | Salmonella typhi H D Ab [Titer] in Serum by Agglutination |
| 47404-9 | N-desalkylflurazepam [Mass/volume] in Blood by Confirmatory method |
| 25278-3 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 25357-5 | Butabarbital [Moles/volume] in Serum or Plasma |
| 55699-3 | Oxytetracycline [Susceptibility] by Gradient strip |
| 5582-2 | Arsenic [Presence] in Blood |
| 55970-8 | Phenylalanine [Moles/mass] in Hair |
| 47827-1 | Adenosyl homocysteine hydrolase [Enzymatic activity/mass] in Red Blood Cells |
| 47896-6 | Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose propranolol+glucagon |
| 5617-6 | Cesium [Mass/volume] in Red Blood Cells |
| 56393-2 | Strawberry IgG4 Ab [Mass/volume] in Serum |
| 56965-7 | Phosphate/Creatinine [Ratio] in 24 hour Urine |
| 48871-8 | Rickettsia typhus group DNA [Presence] in Specimen by NAA with probe detection |
| 26840-9 | Nordiazepam [Mass/mass] in Hair |
| 38396-8 | Parainfluenza virus 1 Ag [Presence] in Nose by Immunofluorescence |
| 5745-5 | Thallium [Mass/volume] in Urine |
| 27840-8 | Somatotropin [Mass/volume] in Serum or Plasma --16th specimen post XXX challenge |
| 57973-0 | Histoplasma capsulatum IgM Ab [Presence] in Cerebral spinal fluid |
| 57985-4 | Influenza virus A H2 RNA [Presence] in Specimen by NAA with probe detection |
| 49365-0 | Hepatitis B virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
| 49440-1 | Pneumocystis jiroveci DNA [#/volume] in Serum or Plasma by NAA with probe detection |
| 49562-2 | Holoprosencephaly gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 49717-2 | Interleukin 1 beta [Mass/volume] in Body fluid |
| 58426-8 | Carisoprodol [Presence] in Urine by Confirmatory method |
| 40463-2 | TNFRSF1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 59186-7 | Cyanide [Moles/volume] in Blood |
| 502-5 | Ticarcillin [Susceptibility] by Serum bactericidal titer |
| 50474-6 | Calcitonin [Mass/volume] in Serum or Plasma --6th specimen |
| 30252-1 | Glucose [Moles/volume] in Serum or Plasma --3.3 hours post dose glucose |
| 30312-3 | 3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Serum or Plasma |
| 40880-7 | CD3-CD56+ cells/100 cells in Tissue |
| 19736-8 | Coralbumin IgE Ab [Units/volume] in Serum |
| 20871-0 | Listeria sp [Presence] in Cheese by Organism specific culture |
| 2091-7 | Cholesterol in VLDL [Mass/volume] in Serum or Plasma |
| 12386-9 | Nordoxepin [Mass/volume] in Urine |
| 12424-8 | Triprolidine [Mass/volume] in Serum or Plasma |
| 100910-9 | Gram negative bacteria.colistin resistant identified in Stool by Organism specific culture |
| 12478-4 | Levomethamphetamine [Mass/volume] in Urine |
| 12743-1 | Insulin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 12749-8 | Insulin [Mass/volume] in Serum or Plasma --5.5 hours post XXX challenge |
| 1290-6 | P1 Ag [Presence] on Red Blood Cells from Donor |
| 13279-5 | Rubella virus IgG Ab [Units/volume] in Serum --1st specimen |
| 102060-1 | Perfluoroheptanoate [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 13546-7 | Amikacin [Mass/volume] in Body fluid |
| 13716-6 | C peptide/Creatinine [Mass Ratio] in Urine |
| 102375-3 | Horn beam IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14298-4 | Plasma units available [#] |
| 14369-3 | Yeast [Presence] in Cervix by Wet preparation |
| 15089-6 | Phospholipid [Moles/volume] in Serum or Plasma |
| 10467-9 | Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain |
| 10505-6 | Myoglobin Ag [Presence] in Tissue by Immune stain |
| 11267-2 | Streptococcus.beta-hemolytic [Presence] in Genital specimen by Organism specific culture |
| 11602-0 | Shigella boydii Ab [Units/volume] in Serum |
| 12272-1 | Virus identified in Specimen by Immunofluorescence |
| 16891-4 | Gastrin [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge |
| 17569-5 | SCL-70 extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 17683-4 | 2-Methyl-2-Propanol [Mass/volume] in Blood |
| 17721-2 | Trans nonachlor [Mass/volume] in Blood |
| 17870-7 | Orotidine/Creatinine [Molar ratio] in Urine |
| 1800-2 | Amylase [Enzymatic activity/time] in 24 hour Urine |
| 18247-7 | Nitrogen [Mass/volume] in Dialysis fluid |
| 18965-4 | Penicillin G [Susceptibility] |
| 18980-3 | Spectinomycin [Susceptibility] |
| 19102-3 | Genetic screen in Specimen by Molecular genetics method Narrative |
| 19125-4 | Meconium [Presence] in Amniotic fluid |
| 90458-1 | Actinomyces sp identified in Aspirate by Organism specific culture |
| 74993-7 | Chloride and sodium panel [Moles/volume] - Sweat |
| 61038-6 | ALPRAZolam [Presence] in Specimen |
| 7610-9 | Pondorosa Pine IgE Ab [Units/volume] in Serum |
| 77012-3 | Fetal Chromosome 18 trisomy [Presence] based on Plasma cell-free DNA by Sequencing |
| 61375-2 | Human papilloma virus 31 DNA [Presence] in Specimen by NAA with probe detection |
| 93930-6 | D Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant |
| 93952-0 | Metamyelocytes.neutrophilic/100 leukocytes in Bone marrow by Manual count |
| 78531-1 | Vesicular stomatitis Indiana virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 94555-0 | dRVVT/dRVVT.excess phospholipid [Ratio] in Platelet poor plasma by Coagulation assay --post DOAC neutralization |
| 63365-1 | Thyrotropin receptor Ab [Units/volume] in Body fluid |
| 6433-7 | HTLV I IgG Ab [Presence] in Serum by Immunoassay |
| 78890-1 | Barium [Moles/volume] in Blood |
| 95536-9 | Human papilloma virus 45 DNA [Presence] in Cervix by NAA with probe detection |
| 6621-7 | Leishmania sp Ab [Presence] in Serum by Immunofluorescence |
| 801-1 | Sickle cells [Presence] in Blood by Light microscopy |
| 9601-6 | Taenia solium larva 13kD Ab [Presence] in Serum by Immunoblot |
| 96325-6 | Moraxella catarrhalis DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection |
| 6840-3 | Gerbil IgE Ab [Units/volume] in Serum |
| 6892-4 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma by Dialysis |
| 96602-8 | Methadone and EDDP panel - Serum or Plasma |
| 69781-3 | 2-Hydroxyisovalerate [Moles/volume] in Serum or Plasma |
| 82248-6 | Chromosome region 7q11.23 deletion in Blood or Tissue by FISH |
| 97224-0 | Butalbital [Presence] in Cord tissue by Screen method |
| 97917-9 | Oropouche virus RNA [Presence] in Specimen by NAA with probe detection |
| 7102-7 | Aspen IgG Ab [Units/volume] in Serum |
| 71620-9 | Leukocytes other/Leukocytes [Pure number fraction] in Synovial fluid by Manual count |
| 82733-7 | AMPAR1+AMPAR2 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 82873-1 | Brallobarbital [Mass/volume] in Serum or Plasma |
| 82968-9 | Secobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 9823-6 | Mycobacterium sp identified in Bronchial specimen by Organism specific culture |
| 71842-9 | Oxygen saturation [Pure mass fraction] Calculated from oxygen partial pressure in Capillary blood |
| 72310-6 | NPM1 gene c.960insCATG transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
| 99459-0 | Budgerigar droppings IgG Ab [Mass/volume] in Serum |
| 85953-8 | Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum |
| 73098-6 | Ursodeoxycholate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73113-3 | Tolterodine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87429-7 | Cortisol AM and PM panel - Serum or Plasma |
| 87632-6 | Toxaphene [Mass/mass] in Specimen |
| 734-4 | Variant lymphocytes [#/volume] in Blood by Manual count |
| 73477-2 | Caspofungin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74004-3 | ABCB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 88634-1 | Microscopic observation [Identifier] in Saliva (oral fluid) by Gram stain |
| 41448-2 | Plasmodium malariae DNA [Presence] in Blood by NAA with probe detection |
| 3050-2 | Triiodothyronine resin uptake (T3RU) in Serum or Plasma |
| 30895-7 | Renin [Units/volume] in Plasma |
| 31128-2 | CD11c-CD20+ cells/100 cells in Blood |
| 4201-0 | Cropropamide [Mass] of Dose |
| 42357-4 | Tigecycline [Susceptibility] |
| 60244-1 | Androstanolone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 21187-0 | Chlamydia trachomatis DNA [Presence] in Conjunctival specimen by NAA with probe detection |
| 31196-9 | Microscopic observation [Identifier] in Abdomen fine needle aspirate by Cyto stain |
| 21795-0 | t(9;22)(q34.1;q11)(ABL1,BCR) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 31952-5 | Rinderpest virus Ag [Presence] in Exudate |
| 5156-5 | Epstein Barr virus nuclear IgG Ab [Presence] in Serum by Immunoassay |
| 43441-5 | Bacteria identified in Bronchoalveolar lavage by Aerobe culture |
| 22657-1 | Alanine [Moles/volume] in Cerebral spinal fluid |
| 32180-2 | Herpes simplex virus 1 Ab [Units/volume] in Synovial fluid |
| 32202-4 | Unidentified cells [#/volume] in Pericardial fluid by Manual count |
| 52967-7 | Bacteria identified in Gastric fluid by Culture |
| 44052-9 | Phosphofructokinase [Enzymatic activity/mass] in Blood |
| 22849-4 | Babesia bovis Ab [Presence] in Serum by Immunofluorescence |
| 32746-0 | CD62P cells/100 cells in Specimen |
| 53435-4 | Argininosuccinate lyase [Enzymatic activity/mass] in Chorionic villus sample |
| 44584-1 | IgA Ab [Presence] in Serum or Plasma |
| 33587-7 | Trichinella sp IgA Ab [Units/volume] in Serum |
| 53887-6 | PCCA gene+PCCB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 53904-9 | Microscopic observation [Identifier] in Sputum by Rhodamine-auramine fluorochrome stain |
| 45152-6 | OJ Ab [Presence] in Serum |
| 23685-1 | Canine adenovirus 1 neutralizing antibody [Presence] in Serum by Neutralization test |
| 34241-0 | Androsterone [Moles/volume] in 24 hour Urine |
| 54096-3 | Identity testing [Identifier] in Index case from Comparison case by Molecular genetics method Narrative |
| 54421-3 | Transfuse frozen erythrocytes pediatric units [#] |
| 45389-4 | Calcium carbonate crystals [#/area] in Urine sediment by Microscopy low power field |
| 46247-3 | Mycobacterium tuberculosis embB gene ethambutol resistance mutation [Identifier] by Molecular method |
| 4667-2 | Osmotic fragility of Red Blood Cells |
| 24260-2 | Coxsackievirus B3 Ab [Titer] in Serum --2nd specimen |
| 2448-9 | Hydroxyproline Free [Mass/volume] in Serum or Plasma |
| 55370-1 | Hemoglobin A2+C+E+O/Hemoglobin.total in Blood |
| 55541-7 | hydroCHLOROthiazide [Moles/volume] in Serum or Plasma |
| 34720-3 | Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection |
| 34730-2 | Chromosome breakage [Interpretation] in Specimen |
| 47683-8 | Leucine/Amino acids.total in Serum or Plasma |
| 47751-3 | Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose TRH |
| 47804-0 | Valine/Amino acids.total in DBS |
| 25877-2 | Citrulline [Moles/volume] in 24 hour Urine |
| 56271-0 | Goldenrod IgG4 Ab [Mass/volume] in Serum |
| 38510-4 | CD11b+CD11c+ cells/100 cells in Specimen |
| 5732-3 | Silver [Mass/volume] in Blood |
| 57348-5 | Phosphate [Mass/volume] in 12 hour Urine |
| 57454-1 | Chromosome 13 aneuploidy in Amniotic fluid or Chorionic villus sample by FISH Nominal |
| 57554-8 | 18-Hydroxycorticosterone [Moles/volume] in Serum or Plasma --pre dose corticotropin |
| 48965-8 | Temazepam [Mass/volume] in Specimen |
| 49235-5 | Patient symptoms [Interpretation] Narrative--1 hour post dose lactose PO |
| 27902-6 | Enterococcus sp IgG Ab [Units/volume] in Serum |
| 49701-6 | pH of Blood adjusted to patient's actual temperature |
| 49738-8 | Neuronal nuclear Ab [Presence] in Serum by Immunofluorescence |
| 29279-7 | Ethylene glycol [Presence] in Urine |
| 40016-8 | Glucose [Mass/volume] in Serum or Plasma --18 hours post XXX challenge |
| 40022-6 | Glucose [Mass/volume] in Serum or Plasma --22 hours post XXX challenge |
| 40251-1 | Creatinine [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 58665-1 | Cortisol [Moles/volume] in Saliva (oral fluid) --3rd specimen post XXX challenge |
| 58674-3 | Cortisol [Mass/volume] in Saliva (oral fluid) --8 AM specimen |
| 29957-8 | Herpes simplex virus Ag [Presence] in Serum by Immunoblot |
| 4065-9 | traZODone [Presence] in Urine |
| 30187-9 | Food Allergen Mix 5 (Peanut+Cow milk+Egg white+Cod+Soybean+Wheat) IgE Ab [Units/volume] in Serum by Multidisk |
| 30335-4 | Echovirus 4 Ab [Presence] in Serum by Complement fixation |
| 41120-7 | ALDOB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 101220-2 | SUMO-activating enzyme subunit 1 IgG Ab [Units/volume] in Serum by Immunoassay |
| 101623-7 | Semen [Volume] in Urine by Light microscopy --post ejaculation |
| 12932-0 | Thyrotropin [Units/volume] in Serum or Plasma --post XXX challenge |
| 12995-7 | Cyclohexanone [Mass/volume] in Blood |
| 14286-9 | Carnitine free (C0) [Moles/volume] in Serum or Plasma |
| 1524-8 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.1 U/kg insulin |
| 15265-2 | Tree Allergen Mix E (American sycamore+Cottonwood+White oak+Willow+White elm) IgE Ab [Presence] in Serum by Multidisk |
| 15383-3 | Leishmania donovani IgM Ab [Titer] in Serum |
| 16163-8 | Parathyrin.intact [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 1634-5 | Somatotropin [Mass/volume] in Serum or Plasma --52 hours post 250 ug L-dopa TID 2day PO |
| 12215-0 | Fatty acids.very long chain [Moles/volume] in Serum or Plasma |
| 16842-7 | Ethanol [Mass/volume] in Unknown substance |
| 17337-7 | Neuronal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 17638-8 | Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 17850-9 | Herpes simplex virus 1 IgG Ab [Presence] in Serum |
| 74650-3 | Methylenedioxyethylamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method |
| 7477-3 | Mango Pollen IgE Ab [Units/volume] in Serum |
| 607-2 | Bacteria identified in Drain by Aerobe culture |
| 61170-7 | Hepatitis B virus codon M250V [Presence] by Genotype method |
| 75741-9 | Beta sitosterol [Mass/volume] in Serum or Plasma |
| 93364-8 | Genetic variant diagnostic significance [Interpretation] in Blood or Tissue Narrative |
| 93469-5 | 4-Fluorobutyrylfentanyl [Mass/volume] in Urine by Confirmatory method |
| 7729-7 | Swordfish IgG Ab [Units/volume] in Serum |
| 93914-0 | Blood group antigens panel - Red Blood Cells |
| 94055-1 | Bacterial inhA gene drug resistance mutation [Identifier] by Molecular method |
| 6272-9 | Velvet grass IgE Ab [Units/volume] in Serum |
| 63137-4 | Crawfish IgG Ab [Mass/volume] in Serum |
| 6322-2 | Borrelia burgdorferi Ag [Units/volume] in Serum |
| 6426-1 | Histoplasma capsulatum Ab [Units/volume] in Serum by Immunoassay |
| 79414-9 | MSH6 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
| 80598-6 | Respiratory syncytial virus B F gene [Presence] in Nasopharynx by NAA with probe detection |
| 80724-8 | Estimated Non-liquefied volume [Volume Fraction] in Semen |
| 8111-7 | CD14 cells/100 cells in Blood |
| 971-2 | Weak D Ag [Presence] on Red Blood Cells from Donor |
| 69878-7 | Service comment 51 |
| 819-3 | A Ag [Presence] on Red Blood Cells from Donor |
| 97975-7 | Peanut recombinant (rAra h) 3 IgG4 Ab [Mass/volume] in Serum |
| 82417-7 | Human upstream binding factor Ab [Units/volume] in Serum by Line blot |
| 99094-5 | Streptococcus pneumoniae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 83097-6 | Estradiol (E2) [Moles/volume] in Serum or Plasma by Immunoassay |
| 7282-7 | Discase IgE Ab [Units/volume] in Serum |
| 73170-3 | Ramipril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87278-8 | Borrelia afzelii+burgdorferi+garinii IgM band pattern [Interpretation] in Serum by Line blot |
| 87314-1 | Encephalomyocarditis virus [Presence] in Tissue by Organism specific culture |
| 87954-4 | Bacteria identified in Cord blood by Aerobe culture |
| 73956-5 | JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
| 74037-3 | Transmissible spongiform encephalopathy [Identifier] in Brain by Light microscopy |
| 89347-9 | CD19+CD27+IgD-IgM+ cells [#/volume] in Blood |
| 41204-9 | Paper wasp IgE Ab/IgE total in Serum |
| 41476-3 | Rickettsia rickettsii IgG Ab [Presence] in Serum by Immunoassay |
| 5980-8 | Plasminogen activator inhibitor Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
| 50714-5 | Bitter dock IgE Ab [Units/volume] in Serum |
| 50753-3 | Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post dose insulin IV |
| 21659-8 | CTNNB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 31291-8 | Chicken serum Ab [Presence] in Serum |
| 42739-3 | Phosphatidylcholine IgA Ab B2GP1 dependent [Multiple of the median] in Serum |
| 22104-4 | Babesia caballi Ab [Presence] in Serum |
| 320-2 | Methacycline [Susceptibility] by Disk diffusion (KB) |
| 43633-7 | 5-Oxoproline [Presence] in 24 hour Urine |
| 22711-6 | Glutamate/Creatinine [Molar ratio] in Urine |
| 5198-7 | Hepatitis C virus Ab [Units/volume] in Serum by Immunoassay |
| 22953-4 | Brucella suis Ab [Units/volume] in Serum by Complement fixation |
| 33057-1 | Heinz bodies/100 erythrocytes in Blood by Light microscopy |
| 44865-4 | Ammonium urate [Presence] in Stone |
| 23390-8 | Rabies virus Ag [Presence] in Brain by Immune stain |
| 23437-7 | Swine influenza virus Ab [Presence] in Serum |
| 23647-1 | Actinobacillus pleuropneumoniae serotype 7 Ab [Presence] in Serum by Immunoassay |
| 53897-5 | SPAST gene + KIAA0196 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 23669-5 | Biochanin A [Mass/volume] in Serum or Plasma |
| 2377-0 | Glutathione peroxidase [Enzymatic activity/volume] in Red Blood Cells |
| 23871-7 | Hepatitis C virus NS5 Ab [Presence] in Serum by Immunoblot |
| 24012-7 | HIV 1 Ag [Presence] in Serum |
| 24050-7 | Acid alpha glucosidase [Enzymatic activity/mass] in Fibroblast |
| 34595-9 | Collection time of Gastric fluid |
| 3460-3 | Chlormerodrin [Presence] in Urine |
| 54494-0 | Chloride [Mass/volume] in Water |
| 55203-4 | aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --5 minutes post incubation after addition of normal plasma |
| 4724-1 | HLA-A26(10) [Presence] in Donor |
| 25445-8 | IgG [Presence] in Urine by Immunoelectrophoresis |
| 35080-1 | Mononuclear cells [#/volume] in Peritoneal fluid |
| 55609-2 | Urea [Moles/volume] in Urine collected for unspecified duration |
| 35540-4 | Mushroom IgG Ab [Mass/volume] in Serum |
| 48166-3 | Beta-2-Microglobulin [Mass/volume] in Body fluid |
| 27164-3 | Acetohexamide [Mass/volume] in Urine |
| 27248-4 | Benzoylecgonine [Mass/mass] in Stool |
| 57417-8 | CD18 cells/100 cells in Body fluid |
| 57482-2 | 11-Ketoandrosterone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
| 57553-0 | 18-Hydroxydeoxycorticosterone [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
| 49213-2 | Anaplasma phagocytophilum IgG Ab [Titer] in Body fluid |
| 27367-2 | Manganese/Creatinine [Mass Ratio] in Urine |
| 38722-5 | Propyleneimine [Mass/volume] in Air |
| 39588-9 | Histoplasma capsulatum IgG Ab [Presence] in Serum by Immunoassay |
| 57768-4 | Campylobacter jejuni+Campylobacter coli Ag [Presence] in Stool |
| 57889-8 | Pregnanediol [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
| 49333-8 | Galactitol [Moles/volume] in Amniotic fluid |
| 29229-2 | Valproate [Mass/volume] in Body fluid |
| 29342-3 | Methylmalonate [Mass/time] in 24 hour Urine |
| 4003-0 | Pseudoephedrine [Presence] in Urine |
| 49877-4 | Hepatitis B virus codon 173 [Identifier] by Genotype method |
| 50009-0 | Fetal lung maturity panel - Amniotic fluid |
| 29677-2 | Chlamydia sp IgA Ab [Presence] in Serum |
| 50230-2 | Granular casts [Presence] in Urine by Computer assisted method |
| 50434-0 | Cortisol [Mass/volume] in Serum or Plasma --6 AM specimen |
| 40748-6 | Dengue virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 1975-2 | Bilirubin.total [Mass/volume] in Serum or Plasma |
| 20783-7 | Cyanide [Units/mass] in Plant Qualitative |
| 100710-3 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection |
| 12627-6 | Glucose [Mass/volume] in Serum or Plasma --15th specimen post XXX challenge |
| 12703-5 | Gallium [Mass/volume] in Serum or Plasma |
| 13359-5 | Character of Semen |
| 101861-3 | 4F-MDMB-BUTICA/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 13465-0 | Mercury/Creatinine [Mass Ratio] in Urine |
| 13534-3 | Sucrose hemolysis [Presence] of Blood |
| 1377-1 | Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post 2.4 mg/kg calcium short IV |
| 102256-5 | Cottonwood IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102891-9 | Mealworm IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14381-8 | Mononuclear cells/100 leukocytes in Peritoneal fluid by Manual count |
| 14432-9 | Albumin/Globulin [Mass Ratio] in Amniotic fluid |
| 14514-4 | Pneumocystis jiroveci Ag [Presence] in Blood by Immunofluorescence |
| 14552-4 | Mumps virus Ag [Presence] in Vaginal fluid by Immunofluorescence |
| 14710-8 | ePHEDrine+Pseudoephedrine [Presence] in Gastric fluid |
| 104354-6 | Borrelia recurrentis DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 15367-6 | Ganciclovir [Mass/volume] in Serum or Plasma |
| 15415-3 | Service comment 24 |
| 15450-0 | Avian paramyxovirus 3 Ab [Titer] in Serum by Hemagglutination inhibition |
| 15490-6 | Mycoplasma synoviae Ab [Presence] in Serum by Agglutination |
| 11047-8 | Glucose phosphate isomerase [Enzymatic activity/volume] in Red Blood Cells |
| 164-4 | Cephapirin [Susceptibility] by Minimum lethal concentration (MLC) |
| 16700-7 | Cyclohexanol/Creatinine [Mass Ratio] in Urine |
| 17734-5 | Trichinella spiralis IgG Ab [Units/volume] in Serum |
| 1844-0 | Ammonium ion [Moles/volume] in Arterial blood |
| 90447-4 | Delafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 90880-6 | Peanut recombinant (rAra h) 6 IgE Ab [Units/volume] in Serum |
| 74511-7 | COMT gene c.1947G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 74762-6 | Megasphaera sp DNA [Log #/volume] in Vaginal fluid by NAA with probe detection |
| 74928-3 | Allopurinol [Mass/volume] in Serum or Plasma --trough |
| 91770-8 | Enterovirus identified in Upper respiratory specimen by Organism specific culture |
| 91782-3 | Respiratory syncytial virus [Presence] in Lower respiratory specimen by Organism specific culture |
| 75551-2 | Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 60358-9 | Cabbage IgG Ab [Mass/volume] in Serum |
| 61186-3 | Spermatozoa thin midpiece/100 spermatozoa in Semen |
| 77060-2 | GNMT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77328-3 | Methadone [Moles/volume] in Specimen |
| 77677-3 | Glucose [Moles/volume] in Serum, Plasma or Blood --2 hours post meal |
| 94599-8 | Equine herpesvirus 3 RNA [Presence] in Specimen by NAA with probe detection |
| 94623-6 | Ureaplasma diversum DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 94626-9 | Ovine herpesvirus 2 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 94838-0 | Enterovirus RNA [Presence] in Amniotic fluid by NAA with probe detection |
| 69822-5 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --7 days post dose ifosfamide |
| 8169-5 | Tetrahydrocannabinol [Presence] in Meconium by Screen method |
| 71633-2 | Monocytes/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
| 72661-2 | Intrinsic coagulation factor activity 4 panel - Platelet poor plasma by Coagulation assay |
| 72807-1 | JWH-073 carboxylated (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
| 86115-3 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum --2nd specimen |
| 88551-7 | Scedosporium apiospermum DNA [Presence] in Aspirate by NAA with probe detection |
| 7431-0 | Isocyanate TDI IgE Ab [Units/volume] in Serum |
| 7446-8 | Lactalbumin triggered histamine release [Units/volume] in Blood |
| 88595-4 | Respiratory syncytial virus A RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 41256-9 | Xylose [Mass/volume] in Serum or Plasma --3 hours post 25 g xylose PO |
| 50650-1 | Lupin seed IgE Ab [Units/volume] in Serum |
| 30535-9 | Liver kidney microsomal 1 Ab [Presence] in Serum |
| 31352-8 | Echovirus 30 Ab [Units/volume] in Body fluid |
| 51311-9 | CD4+CD7-CD26- cells/100 cells in Blood |
| 51688-0 | Pregnenolone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 22697-7 | Arginine/Creatinine [Molar ratio] in Urine |
| 53160-8 | Propionylcarnitine (C3) [Moles/volume] in DBS |
| 53305-9 | Urinalysis type of crystal panel [#/area] - Urine by Computer assisted method |
| 53455-2 | Calcium [Mass/mass] in Specimen |
| 44677-3 | Margin(s) involved by DCIS in Breast tumor |
| 3351-4 | Amphetaminil [Mass/volume] in Urine |
| 33518-2 | Platelet aggregation ADP induced in Platelet rich plasma --High dose |
| 4630-0 | Hemoglobin Zurich [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 46960-1 | TCR alpha beta Ag [Presence] in Tissue by Immune stain |
| 24437-6 | Butyrylglycine/Creatinine [Molar ratio] in Urine |
| 34388-9 | Zinc [Moles/volume] in 24 hour Urine |
| 34623-9 | Colorado tick fever virus Ab [Titer] in Serum |
| 55233-1 | Genetic analysis master panel |
| 55601-9 | Microscopic observation [Identifier] in Pericardial fluid by Cyto stain |
| 47079-9 | Legionella pneumophila 8 IgM Ab [Titer] in Serum by Immunofluorescence |
| 25352-6 | Bordetella pertussis IgG Ab [Titer] in Serum by Immunofluorescence |
| 25420-1 | Rubella virus IgM Ab [Presence] in Serum by Latex agglutination |
| 35287-2 | Toxoplasma gondii HS Ab [Units/volume] in Serum by Agglutination |
| 25589-3 | Citalopram [Moles/volume] in Serum or Plasma |
| 25863-2 | Asparagine/Creatinine [Molar ratio] in 24 hour Urine |
| 25966-3 | Ornithine/Creatinine [Molar ratio] in 24 hour Urine |
| 25975-4 | Proline [Moles/volume] in 24 hour Urine |
| 35566-9 | Parathyrin [Mass/volume] in Serum or Plasma --baseline |
| 35578-4 | 1,2-Glyceryl dinitrate [Mass/volume] in Blood |
| 38174-9 | Borrelia burgdorferi C6 Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 56760-2 | Liver kidney microsomal Ab [Presence] in Serum by Immunoblot |
| 48630-8 | Creatinine [Mass/volume] in Peritoneal fluid --pre dialysis |
| 27202-1 | Halothane [Mass/volume] in Blood |
| 49156-3 | Rickettsia akari IgM Ab [Titer] in Body fluid |
| 27961-2 | Lactate [Mass/volume] in Blood --3 hours post XXX challenge |
| 3906-5 | Pefloxacin [Mass/volume] in Serum or Plasma |
| 49499-7 | Blood.dried/Total of Stone |
| 28540-3 | MCHC [Mass/volume] |
| 29264-9 | Collection time of Blood |
| 39994-9 | Creatinine [Mass/volume] in Urine --6 hours post XXX challenge |
| 58602-4 | Corticotropin [Moles/volume] in Plasma --3rd specimen post XXX challenge |
| 29785-3 | Eastern equine encephalitis virus IgG Ab [Presence] in Specimen by Immunofluorescence |
| 40315-4 | Cortisol [Moles/volume] in Serum or Plasma --1.5 hours post dose triple bolus |
| 40728-8 | Herpes simplex virus IgG Ab [Presence] in Serum by Immunoassay |
| 59143-8 | CD19+CD38+ cells/100 cells in Blood |
| 59172-7 | Methotrimeprazine metabolite [Presence] in Urine |
| 50602-2 | HPA-5 [Type] in Blood |
| 30349-5 | Glutarylcarnitine (C5-DC) [Moles/volume] in Serum or Plasma |
| 19429-0 | Propoxyphene [Presence] in Urine by Screen method |
| 20394-3 | Sample lipemic [Presence] of Serum or Plasma Qualitative |
| 20832-2 | Gossypol [Mass/mass] in Feed |
| 100131-2 | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot |
| 100755-8 | Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing |
| 12905-6 | Renin [Enzymatic activity/volume] in Plasma --7th specimen post XXX challenge |
| 1013-2 | E sup(w) Ag [Presence] on Red Blood Cells from Blood product unit |
| 101876-1 | IgLON5 IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay |
| 102221-9 | Chamomile IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13757-0 | Histidine/Creatinine [Mass Ratio] in Urine |
| 14385-9 | Mononuclear cells/100 leukocytes in Gastric fluid by Manual count |
| 103139-2 | Systemic lupus Ab panel - Serum or Plasma |
| 103197-0 | Sarcoptes scabiei DNA [Presence] in Specimen by NAA with probe detection |
| 10379-6 | Erythrocytes.dual population [Presence] in Blood by Light microscopy |
| 104355-3 | Borrelia recurrentis DNA [Presence] in Cerebral spinal fluid by Sequencing |
| 15454-2 | Reticuloendotheliosis virus Ab [Presence] in Serum by Immunoassay |
| 16227-1 | diazePAM [Mass/volume] in Urine by Confirmatory method |
| 1654-3 | 1-Naphthalene [Mass/volume] in Urine |
| 16916-9 | Glutamate [Presence] in Urine |
| 17105-8 | CD107b cells/100 cells in Blood |
| 17714-7 | Toxaphene [Mass/volume] in Serum or Plasma |
| 17818-6 | Gamma globulin/Protein.total in Body fluid by Electrophoresis |
| 17821-0 | Oligoclonal bands [Interpretation] in Body fluid by Electrophoresis Narrative |
| 17956-4 | Bacteria identified in Body fluid by Anaerobe culture |
| 90361-7 | Chlamydia trachomatis L1 IgA Ab [Titer] in Serum by Immunoassay |
| 90848-3 | Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay |
| 74936-6 | QUEtiapine [Mass/volume] in Serum or Plasma --trough |
| 60433-0 | Leukocytes by Light microscopy in Urine sediment collected for unspecified duration |
| 7588-7 | Black Pepper IgG Ab [Units/volume] in Serum |
| 7595-2 | Red Pepper triggered histamine release [Units/volume] in Blood |
| 76036-3 | GLA gene full mutation analysis in Blood or Tissue by Sequencing |
| 76668-3 | Protein [Mass/volume] in Cerebral spinal fluid --4th tube |
| 61405-7 | Staphylococcus epidermidis DNA [Presence] in Specimen by NAA with probe detection |
| 62364-5 | Test performance information in Specimen Narrative |
| 6237-2 | Salmon IgE Ab [Units/volume] in Serum |
| 77117-0 | RPGRIP1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 77673-2 | Gastrin [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge |
| 63282-8 | Mitochondria M2 Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 78216-9 | TRA+TRD gene rearrangements [Presence] in Blood or Tissue by FISH |
| 78529-5 | Adenovirus Ag [Presence] in Stool by Rapid immunoassay |
| 94482-7 | Human coronavirus OC43 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 9566-1 | Measles virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 96456-9 | Coagulation factor VIII activity and inhibitor panel - Platelet poor plasma by Coagulation assay |
| 6743-9 | Leukocytes [#/volume] in Body fluid by Manual count |
| 68409-2 | Macrophages [#/volume] in Peritoneal fluid by Manual count |
| 68967-9 | Dantu Ab [Presence] in Serum or Plasma |
| 96696-0 | Rate of fibrin formation.glass bead induced [Units] in Blood by Microviscometry |
| 6920-3 | Chlamydia trachomatis IgM Ab [Titer] in Serum by Immunofluorescence |
| 81773-4 | Amyloid A [Mass/mass] in Tissue |
| 71357-8 | PDGFRA gene exon 18 targeted mutation analysis in Blood or Tissue by Sequencing |
| 82856-6 | Tetrahydrocortisol+allo-tetrahydrocortisol/Tetrahydrocortisone [Molar ratio] in Urine |
| 99080-4 | O-nortramadol [Presence] in Urine by Confirmatory method |
| 85363-0 | 21-Hydroxylase Ab [Presence] in Serum |
| 85378-8 | Erythrocytes.EMA mean fluorescence intensity actual/normal in Blood by Flow cytometry (FC) |
| 72499-7 | Oval fat bodies (globules) [#/area] in Stool by Microscopy low power field |
| 85952-0 | Streptococcus pneumoniae Danish serotype 1 Ab [Mass/volume] in Serum |
| 73301-4 | Lisinopril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87765-4 | levETIRAcetam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 7367-6 | Quack grass IgE Ab [Units/volume] in Serum |
| 88445-2 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --50M post dose lactose PO |
| 73958-1 | Cholesterol esterase [Enzymatic activity/volume] in DBS |
| 88987-3 | Maraviroc [Mass/volume] in Serum or Plasma |
| 59360-8 | Desethylvardenafil [Mass/volume] in Urine |
| 50613-9 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3.5 hours post XXX challenge |
| 31043-3 | Moxifloxacin [Susceptibility] by Gradient strip |
| 42662-7 | Benzodiazepines [Presence] in Blood |
| 21243-1 | Diethyl ether [Mass/volume] in Urine |
| 21535-0 | Spermatozoa Motile/100 spermatozoa in Semen --6 hours post ejaculation |
| 51067-7 | CD13 blasts [Units/volume] in Blood |
| 42745-0 | Phosphatidylethanolamine IgA Ab B2GP1 dependent [Multiple of the median] in Serum |
| 4290-3 | Isoniazid [Mass] of Dose |
| 22087-1 | Aspergillus sp Ab [Titer] in Serum |
| 22204-2 | Coccidioides immitis Ab [Presence] in Cerebral spinal fluid |
| 31671-1 | Sulfatide IgM Ab [Units/volume] in Serum |
| 51774-8 | Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 3237-5 | Coagulation factor XIII activated [Units/volume] in Platelet poor plasma by Coagulation assay |
| 52886-9 | Tellurium [Moles/time] in 24 hour Urine |
| 23060-7 | Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Complement fixation |
| 23181-1 | Leptospira interrogans sv Hardjo Ab [Presence] in Serum |
| 32765-0 | Yeast [Presence] in Specimen by Wet preparation |
| 33206-4 | CD235a cells/100 cells in Pleural fluid |
| 53336-4 | 17-Hydroxyprogesterone+Androstenedione/Cortisol [Mass Ratio] in DBS |
| 3353-0 | Amphotericin B [Mass/volume] in Cerebral spinal fluid |
| 53517-9 | Erythrocytes [#/volume] in Dialysis fluid by Manual count |
| 23946-7 | Xylose [Moles/volume] in Blood --1 hour post dose xylose PO |
| 33929-1 | Tacrolimus [Mass/volume] in Serum or Plasma --trough |
| 54287-8 | Guanidinoacetate [Moles/volume] in Cerebral spinal fluid |
| 46206-9 | Treponema pallidum Ab [Presence] in Serum from Donor |
| 34499-4 | GPC3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 47164-9 | Norepinephrine [Moles/volume] in Plasma --3rd specimen post XXX challenge |
| 47198-7 | Vasopressin [Mass/volume] in Plasma --1st specimen post XXX challenge |
| 25227-0 | Tobramycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25253-6 | Clarithromycin [Mass/volume] in Specimen |
| 25502-6 | Phosphoethanolamine [Moles/volume] in Urine |
| 47638-2 | Glycine/Amino acids.total in DBS |
| 56506-9 | Corticotropin [Mass/volume] in Plasma --2 hours post XXX challenge |
| 47926-1 | Somatotropin [Units/volume] in Serum or Plasma --5 minutes post dose ornithine |
| 26623-9 | Chikungunya virus Ab [Presence] in Serum |
| 26649-4 | Snowshoe hare virus Ab [Presence] in Serum |
| 56748-7 | Norovirus RNA [Presence] in Specimen by NAA with probe detection |
| 56959-0 | Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 48825-4 | Respiratory allergen panel, US - Mid Atlantic states - Serum |
| 57367-5 | Magnesium [Mass/volume] in 12 hour Urine |
| 57431-9 | Extractable nuclear Ab [Presence] in Serum by Immunoblot |
| 27305-2 | Phentermine [Mass/mass] in Stool |
| 38741-5 | 2,4-Dinitrophenol [Mass/volume] in Air |
| 2949-6 | Sodium [Moles/volume] in Dialysis fluid |
| 40039-0 | Glucose [Mass/volume] in Serum or Plasma --27 hours post XXX challenge |
| 29779-6 | West Nile virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 50238-5 | Tyrosine crystals [Presence] in Urine by Computer assisted method |
| 29977-6 | Silver [Mass/volume] in 24 hour Urine |
| 30177-0 | Powassan virus IgG Ab [Titer] in Specimen by Immunofluorescence |
| 40982-1 | Influenza virus B RNA [Presence] in Specimen by NAA with probe detection |
| 19452-2 | Dimetamphetamine [Presence] in Urine by Screen method |
| 19696-4 | Secobarbital cutoff [Mass/volume] in Urine for Screen method |
| 100873-9 | Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method |
| 12753-0 | Insulin [Mass/volume] in Serum or Plasma --9 hours post XXX challenge |
| 101228-5 | PCA-Tr Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 101368-9 | Bacillus anthracis DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 13965-9 | Homocysteine [Moles/volume] in Serum or Plasma |
| 14591-2 | ALPRAZolam [Moles/volume] in Serum or Plasma |
| 15190-2 | Leukocytes other [Identifier] in Blood by Automated count |
| 1520-6 | Glucose [Mass/volume] in Urine --2 hours post 75 g glucose PO |
| 10922-3 | Bovine serum albumin (BSA) IgE Ab [Units/volume] in Serum |
| 16464-0 | Bile acid [Units/volume] in Exhaled gas |
| 16766-8 | Dichloroethane [Presence] in Blood |
| 17733-7 | Trichinella spiralis IgA Ab [Presence] in Serum |
| 1831-7 | Alpha 1 antitrypsin ZZ [Mass/volume] in Serum or Plasma |
| 74522-4 | Complement lectin pathway actual/normal in Serum by Immunoassay |
| 74976-2 | Phenytoin [Mass/volume] in Serum or Plasma --trough |
| 92486-0 | LW sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 92759-0 | 7-Alpha,12-alpha dihydroxycholest-4-en-3-one [Moles/volume] in Blood |
| 76593-3 | Pseudomonas aeruginosa regA gene [#/mass] in XXX.tissue by NAA with probe detection |
| 92984-4 | Enterobacter cloacae complex DNA [NCncRange] in Sputum by NAA with non-probe detection |
| 93197-2 | CYP4F2 gene c.1297G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 93334-1 | Glycocholate [Moles/volume] in Serum or Plasma |
| 93420-8 | APOA1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 93921-5 | C Ag [Presence] on Red Blood Cells --after transfusion reaction |
| 7806-3 | Ascaris lumbricoides Ab [Units/volume] in Serum |
| 78770-5 | Methadone [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine |
| 63472-5 | Ganglioside GD3 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 95081-6 | C peptide [Mass/volume] in Serum or Plasma --1.5 hours post meal |
| 95654-0 | Eastern equine encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 65796-5 | Kiwi native (nAct d) 2 IgE Ab [Units/volume] in Serum |
| 6670-4 | Microscopic observation [Identifier] in Tissue by Malaria smear |
| 6730-6 | Orange IgG Ab [Units/volume] in Serum |
| 9583-6 | Afipia felis IgM Ab [Titer] in Serum by Immunofluorescence |
| 96279-5 | European silver fir wood dust IgE Ab [Units/volume] in Serum |
| 96481-7 | IgLON5 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 8109-1 | CD11c cells/100 cells in Blood |
| 81151-3 | Dengue virus 1+2+3+4 5' UTR RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 8205-7 | Mercury [Mass/mass] in Tissue |
| 82190-0 | Herpes simplex virus 1 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
| 70126-8 | Leukocytes [#/volume] corrected for nucleated erythrocytes in Pleural fluid |
| 70253-0 | Islet cell 512 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 7060-7 | Abalone IgE Ab [Units/volume] in Serum |
| 99397-2 | Siderocytes.Type 2/100 Erythroblasts in Blood or Marrow by Prussian blue stain |
| 72995-4 | metFORMIN induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87635-9 | Aldicarb sulfone [Mass/mass] in Specimen |
| 74123-1 | Phospho-S6 ribosomal protein Ag [Presence] in Tissue by Immune stain |
| 41751-9 | COL3A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 59363-2 | Leptospira interrogans sv Manhao Ab [Titer] in Serum by Agglutination |
| 41758-4 | GNAS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 5994-9 | Platelet aggregation calcium ionophore induced in Platelet rich plasma |
| 59988-6 | Testosterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 60135-1 | Pargyline [Mass/volume] in Serum or Plasma |
| 21560-8 | Thermoactinomyces candidus Ab [Presence] in Serum |
| 51275-6 | CD3+CD16+ cells/100 cells in Cerebral spinal fluid |
| 51366-3 | CD64 cells/100 cells in Body fluid |
| 31645-5 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum --1st specimen |
| 31920-2 | Neisseria meningitidis serogroup w135 Ag [Presence] in Specimen |
| 43239-3 | Norsildenafil [Mass/volume] in Serum or Plasma |
| 43284-9 | Spermatozoa IgA binding location [Identifier] in Semen |
| 4338-0 | Moxalactam [Mass] of Dose |
| 22611-8 | Western equine encephalitis virus Ab [Presence] in Serum |
| 32154-7 | Basophils+Eosinophils+Monocytes [#/volume] in Blood by Automated count |
| 5195-3 | Hepatitis B virus surface Ag [Presence] in Serum |
| 5196-1 | Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay |
| 5273-8 | Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay |
| 52789-5 | Clot initiation [Time] in Blood by Thromboelastography |
| 44015-6 | Helicobacter pylori [Presence] in Gastric fluid by Organism specific culture |
| 44087-5 | Escherichia coli O157 Ag [Presence] in Specimen |
| 22797-5 | Anaplasma marginale DNA [Presence] in Tissue by NAA with probe detection |
| 44488-5 | Herpes simplex virus 2 [Presence] in Throat by Organism specific culture |
| 45174-0 | Herpes gestationis Ab panel - Serum |
| 45282-1 | Echovirus 30 Ab [Presence] in Body fluid |
| 45304-3 | Urea [Moles/volume] in Dialysis fluid --4 hour specimen |
| 23707-3 | Canine parvovirus DNA [Presence] in Stool by Probe |
| 2371-3 | Glutamine [Presence] in Serum or Plasma |
| 23721-4 | Feline herpesvirus 1 DNA [Presence] in Specimen by NAA with probe detection |
| 33927-5 | Amphiphysin Ab [Titer] in Serum |
| 3427-2 | Cannabinoids [Presence] in Urine |
| 46966-8 | CD69 cells [#/volume] in Blood |
| 24357-6 | Urinalysis macro (dipstick) panel - Urine |
| 55161-4 | Bordetella pertussis IgA and IgG panel - Serum by Immunoassay |
| 34976-1 | DNA index 2 in Specimen by Flow cytometry (FC) |
| 3507-1 | Codeine [Presence] in Urine |
| 5610-1 | Cadmium [Mass/mass] in Hair |
| 25570-3 | C peptide [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge |
| 25598-4 | Cladosporium cladosporioides IgG Ab [Units/volume] in Serum |
| 35666-7 | Lymphocytic choriomeningitis virus IgG and IgM panel - Serum |
| 4796-9 | HLA-B73 [Presence] in Donor |
| 26598-3 | Sarcosine [Moles/volume] in Cerebral spinal fluid |
| 26617-1 | Trypanosoma brucei gambiense Ab [Presence] in Serum |
| 3624-4 | Fencamfamin [Presence] in Urine |
| 3706-9 | Labetalol [Mass/volume] in Urine |
| 56624-0 | Fructose [Moles/volume] in Serum |
| 26962-1 | Cystine [Moles/volume] in Urine |
| 27269-0 | Isocitrate [Presence] in Urine |
| 58380-7 | fentaNYL/Creatinine [Mass Ratio] in Urine |
| 58452-4 | Hepatitis B virus surface Ag [Units/volume] in Serum |
| 58513-3 | C peptide [Moles/volume] in Serum or Plasma --4.5 hours post dose glucose |
| 58521-6 | C peptide [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 58809-5 | Rickettsia conorii IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 40694-2 | Sulfamethoxazole IgE Ab [Presence] in Serum |
| 30342-0 | Extractable nuclear Ab [Units/volume] in Serum |
| 40960-7 | Parietal cell IgG Ab [Units/volume] in Serum |
| 19260-9 | Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Specimen by Latex agglutination |
| 19271-6 | Barbiturates tested for in Urine by Screen method Nominal |
| 201-4 | Colistimethate by Minimum inhibitory concentration (MIC) |
| 20710-0 | Bovine diarrhea virus RNA [Presence] in Serum by NAA with probe detection |
| 20924-7 | Ova and parasites identified in Stool by Parasite sedimentation |
| 1237-7 | Mi sup(a) Ab [Presence] in Serum or Plasma |
| 100094-2 | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot |
| 12598-9 | Fat.neutral [Presence] in Stool |
| 12987-4 | Acetonitrile [Mass/volume] in Urine |
| 1329-2 | V Ab [Presence] in Serum or Plasma from Blood product unit |
| 13611-9 | 6-Beta-Hydroxycortisol [Mass/time] in 24 hour Urine |
| 13999-8 | Transferrin.carbohydrate deficient [Units/volume] in Serum or Plasma |
| 14491-5 | Virus identified in Throat by Immunofluorescence |
| 14578-9 | ABO group [Type] in Blood from Blood product unit |
| 1460-5 | Cobalamin (Vitamin B12) [Mass/time] in 24 hour Urine --post dose cyanocobalamin |
| 103203-6 | Cells.CD65/100 cells in Blood or Marrow by Flow cytometry (FC) |
| 10328-3 | Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
| 103738-1 | RBC membrane multigene analysis in Specimen by Sequencing |
| 10637-7 | Microscopic observation [Identifier] in Tissue by Night blue stain |
| 15236-3 | Occupational Allergen Mix 2 (Acarus siro+Lepidoglyphus destructor+Horse bot fly+Grain weevel) IgE Ab [Presence] in Serum by Multidisk |
| 1542-0 | Glucose [Mass/volume] in Serum or Plasma --5 hours post 75 g glucose PO |
| 11099-9 | Methoxychlor [Mass/volume] in Serum or Plasma |
| 11281-3 | Auer rods [Presence] in Blood by Light microscopy |
| 11603-8 | Salmonella sp Ab [Units/volume] in Serum |
| 12187-1 | Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by Electrophoresis |
| 12231-7 | Prolactin [Mass/volume] in Serum or Plasma --baseline |
| 17369-0 | Norepinephrine [Mass/volume] in Urine --2nd specimen post XXX challenge |
| 17378-1 | Novobiocin [Mass/volume] in Serum or Plasma |
| 1779-8 | Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma |
| 92482-9 | Sc1 Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 92672-5 | Hydroxyglutarates and glutarate and ethylmalonate and methylsuccinate panel - DBS |
| 7578-8 | Pear IgG Ab [Units/volume] in Serum |
| 76583-4 | Klebsiella pneumoniae phoE gene [Presence] in Swab specimen by NAA with probe detection |
| 93048-7 | Reason for specimen rejection [Type] |
| 93419-0 | Alpha 1 antitrypsin fecal clearance panel - Serum or Plasma and Stool |
| 6121-8 | Fusarium moniliforme IgE Ab [Units/volume] in Serum |
| 62306-6 | Fabry disease newborn screening comment-discussion |
| 94012-2 | Urea nitrogen [Mass/volume] in Serum or Plasma --2 hours post dose vasopressin |
| 6244-8 | Sheep Sorrel IgE Ab [Units/volume] in Serum |
| 62460-1 | Candida sp DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 6312-3 | Bartonella henselae IgM Ab [Units/volume] in Serum by Immunoassay |
| 78220-1 | PDGFRB gene rearrangements [Presence] in Blood or Tissue by FISH |
| 63550-8 | Calcium magnesium phosphate/Total in Stone |
| 79268-9 | 3-Hydroxytrimethyl-L-lysine [Moles/volume] in Serum or Plasma |
| 94845-5 | SARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |
| 65757-7 | Kidney Pathology biopsy report |
| 66951-5 | Complement C1.functional [Units/volume] in Serum |
| 79600-3 | Glutathione.reduced [Moles/volume] in Serum or Plasma |
| 95842-1 | Lymphocytes/100 leukocytes in Sputum by Manual count |
| 95973-4 | SARS-CoV-2 stimulated gamma interferon release by T-cells [Units/volume] in Blood |
| 68428-2 | Leukocytes other [#/volume] in Pericardial fluid by Manual count |
| 6864-3 | Hemoglobin S [Presence] in Blood by Solubility test |
| 80721-4 | Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood |
| 8159-6 | Beryllium [Mass/volume] in Blood |
| 6975-7 | Amikacin [Susceptibility] by Gradient strip |
| 69941-3 | Glucose [Moles/volume] in Serum or Plasma --20 minutes post dose lactose PO |
| 81621-5 | Herpes simplex virus 1 and 2 IgG panel - Serum or Plasma |
| 97748-8 | Cytokeratin 19 [Mass/volume] in Aspirate |
| 71619-1 | Mononuclear cells/Leukocytes [Pure number fraction] in Synovial fluid by Manual count |
| 8237-0 | Phencyclidine [Presence] in Urine by SAMHSA confirm method |
| 82394-8 | Fibrillarin Ab [Presence] in Serum by Line blot |
| 82886-3 | Meta methylhippurate/Creatinine [Molar ratio] in Urine |
| 98122-5 | Neutrophil.fMLP and PMA stimulated DHR panel by Flow cytometry (FC) |
| 98398-1 | Fungus identified in Isolate by NAA with probe detection |
| 72261-1 | Bilirubin excess [Moles/volume] in Serum and CSF |
| 99514-2 | Weight of Lung - right |
| 86549-3 | HIV 2 RNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 73268-5 | Midazolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87369-5 | Lawsonia intracellularis VNTR pattern [Type] in Specimen by Molecular genetics method |
| 74167-8 | Opiates [Mass/volume] in Saliva (oral fluid) by Screen method |
| 743-5 | Monocytes [#/volume] in Blood by Manual count |
| 89578-9 | Troponin I.cardiac [Interpretation] in Serum or Plasma Qualitative by High sensitivity method |
| 59322-8 | Ramelteon [Mass/volume] in Urine |
| 59390-5 | Neuronal nuclear Ab [Titer] in Serum by Immunofluorescence |
| 59660-1 | diazePAM [Mass/mass] in Tissue |
| 59666-8 | Estazolam [Mass/volume] in Body fluid |
| 59692-4 | Hydroxytriazolam [Mass/volume] in Body fluid |
| 30457-6 | Nonhematic cells/100 leukocytes in Body fluid |
| 42237-8 | Borrelia burgdorferi 18kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
| 4225-9 | Phenytoin [Mass] of Dose |
| 6001-2 | Platelet factor 3 [Units/volume] in Platelet poor plasma |
| 51407-5 | Streptococcus pneumoniae capsular polysaccharide IgG Ab [Mass/volume] in Serum by Immunoassay |
| 319-4 | Methacycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 51543-7 | Cladosporium cladosporioides IgG Ab [Presence] in Serum |
| 43209-6 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68+70 DNA [Presence] in Anal by Probe with signal amplification |
| 43359-9 | 11-Ketoetiocholanolone [Mass/volume] in 24 hour Urine |
| 52939-6 | Arsenic.inorganic/Creatinine [Molar ratio] in Urine |
| 53046-9 | Beta globulin+Gamma globulin [Mass/volume] in Body fluid by Electrophoresis |
| 44037-0 | Glucosylceramidase [Presence] in Blood |
| 44325-9 | Iron [Presence] in Hair |
| 22925-2 | Brucella abortus IgG1 Ab [Presence] in Milk |
| 23051-6 | Eastern equine encephalitis virus RNA [Presence] in Tissue by NAA with probe detection |
| 4464-4 | Cervical Mucus Penetration Test [Interpretation] in Semen |
| 23417-9 | Rinderpest virus RNA [Presence] in Specimen by NAA with probe detection |
| 2348-1 | Glucose [Mass/volume] in Synovial fluid |
| 23508-5 | Trypanosoma congolense DNA [Presence] in Blood by NAA with probe detection |
| 53540-1 | Alpha globulin.abnormal band/Protein.total in Serum or Plasma by Electrophoresis |
| 5361-1 | Spermatozoa Ab [Units/volume] in Semen |
| 5365-2 | Saint Louis encephalitis virus Ab [Units/volume] in Serum |
| 53707-6 | CV2 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 53866-0 | GCH1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 33823-6 | Interleukin 18 [Mass/volume] in Serum or Plasma |
| 54207-6 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor V depleted plasma |
| 54382-7 | Cytochrome C oxidase [Enzymatic activity/mass] in Amniotic fluid cells |
| 34402-8 | Coproporphyrin/Hemoglobin [Mass Ratio] in Red Blood Cells |
| 34507-4 | PRX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55349-5 | Ethyl glucuronide [Presence] in Urine |
| 47169-8 | Norepinephrine [Moles/volume] in Plasma --5th specimen post XXX challenge |
| 47173-0 | Catecholamines [Moles/volume] in Plasma --7th specimen post XXX challenge |
| 25537-2 | Thallium [Moles/volume] in Serum or Plasma |
| 35306-0 | TTR gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 25657-8 | Gastrin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 5622-6 | Chromium [Mass/volume] in Serum or Plasma |
| 47965-9 | Mycoplasma penetrans DNA [Presence] in Specimen by NAA with probe detection |
| 3630-1 | Fenfluramine [Mass/volume] in Serum or Plasma |
| 38232-5 | CD13+CD16+ cells/100 cells in Blood |
| 56712-3 | Dexamethasone IgE Ab [Units/volume] in Serum |
| 26943-1 | 11-Ketoandrosterone [Mass/volume] in 24 hour Urine |
| 27063-7 | Benzodiazepines [Mass/mass] in Stool |
| 27264-1 | Aluminum [Mass/volume] in Cerebral spinal fluid |
| 27267-4 | Homovanillate [Presence] in Urine |
| 27412-6 | ePHEDrine+Pseudoephedrine [Mass/volume] in Vitreous fluid |
| 3907-3 | Pemoline [Mass/volume] in Serum or Plasma |
| 57706-4 | Congenital adrenal hyperplasia newborn screening comment-discussion |
| 57778-3 | Immunoglobulin light chains.free panel - Serum |
| 5833-9 | Adenovirus Ag [Presence] in Specimen by Immunoassay |
| 58360-9 | Buprenorphine/Creatinine [Mass Ratio] in Urine |
| 29410-8 | Doxepin [Mass/volume] in Gastric fluid |
| 40090-3 | Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --1 hour post XXX challenge |
| 40110-9 | aPTT in Platelet poor plasma by Coagulation assay --1 day post XXX challenge |
| 40216-4 | Glucose [Moles/volume] in Serum or Plasma --27 hours post XXX challenge |
| 58662-8 | Cortisol [Moles/volume] in Saliva (oral fluid) --30 minutes pre 1 ug/kg CRH IV |
| 29854-7 | Powassan virus IgG Ab [Presence] in Serum |
| 58886-3 | Pyruvate [Mass/volume] in Blood --30 minutes post XXX challenge |
| 50430-8 | Cortisol [Mass/volume] in Serum or Plasma --3 PM specimen |
| 50478-7 | Follitropin [Units/volume] in Serum or Plasma --2nd specimen |
| 30171-3 | Cortisol Free/Creatinine [Molar ratio] in 24 hour Urine |
| 30272-9 | Stavudine [Susceptibility] by Phenotype method |
| 40878-1 | CPT2 gene p.Gln413FSer+Gly549Asp [Presence] in Blood or Tissue by Molecular genetics method |
| 19495-1 | Hydroxyethylflurazepam cutoff [Mass/volume] in Urine for Screen method |
| 2014-9 | Cancer Ag 549 [Presence] in Serum or Plasma |
| 20405-7 | Urobilinogen [Mass/volume] in Urine by Test strip |
| 100106-4 | Filaria IgG Ab [Presence] in Serum by Immunoassay |
| 1257-5 | N Ab [Presence] in Serum or Plasma from Donor |
| 101162-6 | p-Fluorofentanyl [Presence] in Urine by Confirmatory method |
| 13310-8 | Kell group Ag [Type] on Red Blood Cells |
| 102417-3 | Black Locust IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102564-2 | Rat epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102602-0 | Sole IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103018-8 | Silver Birch recombinant (rBet v) 4 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103133-5 | Celery recombinant (rApi g) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103732-4 | Hereditary congenital myasthenic syndrome multigene analysis in Blood or Tissue by Molecular genetics method |
| 14893-2 | Propranolol [Moles/time] in 24 hour Urine |
| 1604-8 | Norepinephrine [Mass/volume] in Plasma --2 hours post 300 ug cloNIDine PO |
| 10708-6 | Toxic Plant identified in Vomitus by Light microscopy |
| 1075-1 | Jk sup(b) Ab [Presence] in Serum or Plasma |
| 1139-5 | Lu sup(ab) Ab [Presence] in Serum or Plasma from Blood product unit |
| 17966-3 | Bacteria # 4 identified in Stool by Culture |
| 1809-3 | Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma |
| 90284-1 | Mycobacterium sp identified in Bile fluid by Organism specific culture |
| 74669-3 | Lactobacillus sp DNA [Log #/volume] in Vaginal fluid by NAA with probe detection |
| 92241-9 | Vancomycin [Susceptibility] by Genotype method |
| 75140-4 | Allantoine [Moles/volume] in Cerebral spinal fluid |
| 604-9 | Bacteria identified in Bronchial specimen by Aerobe culture |
| 76029-8 | HEXB gene full mutation analysis in Blood or Tissue by Sequencing |
| 93045-3 | Carbon monoxide [Mass/volume] in Air |
| 77161-8 | Prothrombin activity [Units/volume] in Platelet poor plasma by Coagulation assay --immediately after addition of factor II depleted plasma |
| 93800-1 | 1p/1q chromosome deletion [# Ratio] in Tissue by FISH |
| 93938-9 | C Ag [Presence] on Red Blood Cells --during infancy |
| 62423-9 | Human coronavirus HKU1 RNA [Presence] in Specimen by NAA with probe detection |
| 63148-1 | Maple syrup IgG Ab [Mass/volume] in Serum |
| 7815-4 | Bartonella henselae IgG Ab [Units/volume] in Serum by Immunoassay |
| 94660-8 | SARS-CoV-2 (COVID-19) RNA [Presence] in Serum or Plasma by NAA with probe detection |
| 79241-6 | Methedrone cutoff [Mass/volume] in Urine for Confirmatory method |
| 95284-6 | PINK1 gene deletion in Blood or Tissue by Molecular genetics method |
| 68383-9 | Microscopic observation [Identifier] in Body fluid by KOH preparation |
| 80962-4 | ceFAZolin free [Mass/volume] in Serum or Plasma |
| 7006-0 | Demeclocycline [Susceptibility] by Gradient strip |
| 81732-0 | PM-SCL-100 Ab [Presence] in Serum by Line blot |
| 97245-5 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Cord tissue by Confirmatory method |
| 97284-4 | Norfentanyl [Presence] in Cord tissue by Screen method |
| 97632-4 | Salmonella sp DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 977-9 | D Ag [Presence] on Red Blood Cells from Donor |
| 82575-2 | Urobilinogen [Moles/mass] in Stool |
| 72174-6 | Rotavirus Ag [Presence] in Stool by Rapid immunoassay |
| 85744-1 | Streptococcus pneumoniae Danish serotype 2 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 72581-2 | Gamma globulin/Protein.total [Pure mass fraction] in Urine by Electrophoresis |
| 86040-3 | Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 73173-7 | Raloxifene induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87649-0 | Lindane [Mass/mass] in Specimen |
| 88849-5 | Microbiology CNAMTS panel - Vaginal fluid |
| 41626-3 | Brucella sp DNA [Presence] in Specimen by NAA with probe detection |
| 50910-9 | Silver [Moles/volume] in 24 hour Urine |
| 31062-3 | Echovirus 30 Ab [Titer] in Body fluid by Complement fixation |
| 42205-5 | Human antimouse IgG Ab [Mass/volume] in Serum |
| 60268-0 | Orientia tsutsugamushi DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 51302-8 | CD4+CD7- cells/100 cells in Tissue |
| 31860-0 | Influenza virus A+B Ag [Presence] in Throat |
| 22484-0 | Rickettsia sp Ab [Titer] in Serum |
| 32090-3 | Mepivacaine [Presence] in Urine |
| 3220-1 | Coagulation factor X Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 52969-3 | Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture |
| 4398-4 | Phenylephrine [Mass] of Dose |
| 23172-0 | Leptospira interrogans sv Bratislava Ab [Presence] in Serum |
| 32728-8 | Beta 1 globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
| 33029-0 | CD3+TCR cells/100 cells in Blood |
| 53317-4 | Leukocyte clumps [Presence] in Urine by Automated |
| 44708-6 | Asialoganglioside GM1 IgG Ab [Units/volume] in Serum by Immunoassay |
| 23318-9 | Nairobi sheep disease virus Ag [Presence] in Specimen by Complement fixation |
| 33403-7 | Fatty acids.very long chain C26:0 (Hexacosanoate) [Mass/volume] in Serum or Plasma |
| 33551-3 | Platelet aggregation ristocetin induced in Platelet rich plasma --1200 ug/mL |
| 23777-6 | Salmonella pullorum Ab [Titer] in Serum by Agglutination |
| 23939-2 | Xylose [Mass/volume] in Blood --1 hour post 5 g xylose PO |
| 23989-7 | Burkholderia pseudomallei IgM Ab [Titer] in Serum by Immunofluorescence |
| 3399-3 | Benzthiazide [Presence] in Urine |
| 54464-3 | Albumin/Protein.total in Dialysis fluid by Electrophoresis |
| 4575-7 | Hemoglobin E/Hemoglobin.total in Blood |
| 2411-7 | Hexokinase 1/Hexokinase.total in Red Blood Cells |
| 47292-8 | Fungus # 7 identified in Specimen by Culture |
| 47470-0 | Legionella pneumophila 7 IgM Ab [Titer] in Serum |
| 4747-2 | HLA-B42 [Presence] |
| 34997-7 | Promonocytes [#/volume] in Body fluid |
| 55645-6 | Cefotiam [Susceptibility] by Gradient strip |
| 5587-1 | Arsenic [Mass/time] in 24 hour Urine |
| 56266-0 | Cockroach IgG4 Ab [Mass/volume] in Serum |
| 48049-1 | Eosinophils [Presence] in Stool by Wright stain |
| 2641-9 | Myoglobin [Mass/volume] in Urine |
| 56584-6 | C peptide [Mass/volume] in Serum or Plasma --12 minutes post XXX challenge |
| 56676-0 | Citrulline/Creatinine [Ratio] in 24 hour Urine |
| 4857-9 | HLA-Cw4 [Presence] |
| 27130-4 | Mercury [Mass/mass] in Red Blood Cells |
| 27199-9 | 18-Hydroxycortisol/Creatinine [Mass Ratio] in 24 hour Urine |
| 2787-0 | Phosphatidylinositol [Mass/volume] in Serum |
| 39473-4 | Creatinine [Moles/volume] in 72 hour Urine |
| 57836-9 | Basophils/100 leukocytes in Synovial fluid by Manual count |
| 2840-7 | Proinsulin [Mass/volume] in Serum or Plasma |
| 29498-3 | Platelet associated IgM Ab [Presence] in Blood by Flow cytometry (FC) |
| 40223-0 | Calcium [Moles/volume] in Serum or Plasma --pre XXX challenge |
| 584-3 | Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture |
| 58555-4 | Corticotropin [Moles/volume] in Plasma --1 hour post dose glucagon |
| 40338-6 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose triple bolus |
| 50598-2 | HPA-15 [Type] in Blood |
| 40831-0 | Adenovirus+Rotavirus Ag [Presence] in Stool |
| 19474-6 | Flurazepam [Presence] in Urine by Screen method |
| 19541-2 | Mephobarbital cutoff [Mass/volume] in Urine for Confirmatory method |
| 19636-0 | Norpropoxyphene cutoff [Mass/volume] in Urine for Screen method |
| 19683-2 | Psilocin [Presence] in Urine by Confirmatory method |
| 2049-5 | Carnosine [Presence] in Serum or Plasma |
| 100796-2 | Thyroglobulin [Mass/volume] in Body fluid |
| 101096-6 | Jo sup(a) Ab [Presence] in Serum or Plasma |
| 12638-3 | Glucose [Mass/volume] in Serum or Plasma --pre dose lactose PO |
| 13071-6 | Phosphatidate IgM Ab [Units/volume] in Serum |
| 101724-3 | Certolizumab Ab [Mass/volume] in Serum or Plasma by SPR |
| 13829-7 | Copper/Creatinine [Mass Ratio] in Urine |
| 14023-6 | HTLV I+II p28 Ab [Presence] in Serum by Immunoblot |
| 103038-6 | Common wasp recombinant (rVes v) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14442-8 | Cholesterol [Mass/volume] in Semen |
| 103566-6 | Metagenomic DNA and RNA Sequencing |
| 104108-6 | Xylazine [Presence] in Serum or Plasma |
| 104419-7 | Legionella sp Ab [Titer] in Serum Qualitative by Immunoassay --1st specimen |
| 10529-6 | Amoxapine metabolite [Mass/volume] in Serum or Plasma |
| 15249-6 | Food Allergen Mix 19 (Cucumber+Carrot+Potato+Spinach) IgE Ab [Presence] in Serum by Multidisk |
| 16325-3 | Alanine aminotransferase/Aspartate aminotransferase [Enzymatic activity ratio] in Serum or Plasma |
| 17204-9 | CD87 cells/100 cells in Blood |
| 19079-3 | CD43 cells/100 cells in Specimen |
| 74945-7 | clomiPRAMINE+Norclomipramine [Mass/volume] in Serum or Plasma --trough |
| 92497-7 | Js sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 7624-0 | Pork triggered histamine release [Units/volume] in Blood |
| 6230-7 | Rice IgE Ab [Units/volume] in Serum |
| 7794-1 | Normocytic/Normochromic polychromasia [Presence] in Blood by Light microscopy |
| 78775-4 | Acenocoumarol [Mass/volume] in Urine |
| 94566-7 | Maple syrup urine disease therapy monitoring panel - Serum or Plasma |
| 79102-0 | Heart transplant acute cellular rejection risk [Score] in Mononuclear cells Calculated by AlloMap |
| 95515-3 | Angiotensin II (1-8) and angiotensin (1-7) panel - Plasma |
| 6566-4 | Trichomonas vaginalis Ag [Presence] in Genital specimen by Immunoassay |
| 66885-5 | Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing |
| 79596-3 | D-serine/Creatinine [Molar ratio] in Urine |
| 79705-0 | Eicosadienoate (C20:2w6) [Entitic substance] in Red Blood Cells |
| 96487-4 | Neuronal intermediate filament IgG Ab [Titer] in Serum by Immunofluorescence |
| 8201-6 | Gadolinium [Mass/time] in 24 hour Urine |
| 97262-0 | Methylenedioxyamphetamine [Presence] in Cord tissue by Screen method |
| 97528-4 | Naegleria fowleri Ag [Presence] in Specimen by Immunofluorescence |
| 70105-2 | Methotrexate [Moles/volume] in Serum or Plasma --8th specimen |
| 70269-6 | Triglyceride in pleural fluid/Triglyceride in serum |
| 8235-4 | Phencyclidine [Presence] in Serum or Plasma by Confirmatory method |
| 82432-6 | Platelet-derived growth factor receptor Ab [Presence] in Serum by Line blot |
| 82439-1 | SUMO-activating enzyme subunit 1 Ab [Units/volume] in Serum by Line blot |
| 98278-5 | Protocol used for examination of sentinel lymph nodes |
| 99053-1 | Cells Counted Total [#] in Bronchoalveolar lavage |
| 71719-9 | Mycobacterium avium complex DNA [Presence] in Specimen by NAA with probe detection |
| 72599-4 | Albumin/Protein.total [Pure mass fraction] in Cerebral spinal fluid by Electrophoresis |
| 72730-5 | Mitragynine/Creatinine [Mass Ratio] in Urine |
| 72895-6 | Glucose [Moles/volume] in Serum or Plasma --2.5 hours post dose lactose PO |
| 86697-0 | Rotavirus A RNA [Nucleotide sequence] in Isolate by Sequencing |
| 87579-9 | Ergocornine [Mass/mass] in Specimen |
| 73475-6 | Cefadroxil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73605-8 | Ceftaroline [Susceptibility] |
| 889-6 | Blood group antibodies identified in Blood product unit |
| 89540-9 | Ganglioside GM1 IgM Ab [Presence] in Cerebral spinal fluid by Line blot |
| 595-9 | Bacteria identified in Abscess by Aerobe culture |
| 59716-1 | Nordiazepam [Mass/volume] in Blood |
| 50833-3 | Cadmium [Moles/mass] in Hair |
| 31041-7 | Moxifloxacin [Susceptibility] by Disk diffusion (KB) |
| 21384-3 | Mesothelial cells [Presence] in Peritoneal fluid by Light microscopy |
| 31219-9 | Afipia felis IgM Ab [Units/volume] in Serum |
| 51180-8 | CD36+CD235a+ blasts/100 blasts in Blood |
| 5132-6 | DNA single strand Ab [Units/volume] in Serum |
| 22223-2 | Coxsackievirus B IgG Ab [Units/volume] in Serum |
| 31823-8 | Equine influenza virus Ag [Presence] in Nose |
| 31876-6 | Measles virus Ag [Presence] in Cervix |
| 31930-1 | Pasteurella multocida Ag [Units/volume] in Specimen |
| 51499-2 | Estradiol (E2) [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 5176-3 | Helicobacter pylori IgG Ab [Units/volume] in Serum by Immunoassay |
| 51904-1 | Orange IgG Ab [Mass/volume] in Serum |
| 5191-2 | Hepatitis B virus e Ag [Units/volume] in Serum by Immunoassay |
| 43273-2 | CD19+CD27+IgD+ cells/100 cells in Blood or Tissue |
| 4379-4 | Penicillin G benzathine [Mass] of Dose |
| 22322-2 | Hepatitis B virus surface Ab [Presence] in Serum |
| 52778-8 | Maximum clot firmness [Length] in Blood by Thromboelastography |
| 52964-4 | cloBAZam [Moles/volume] in Gastric fluid |
| 53052-7 | Collagen crosslinked C-telopeptide [Mass/time] in 24 hour Urine |
| 2317-6 | Gamma aminobutyrate [Presence] in Serum or Plasma |
| 53318-2 | Epithelial cells.squamous [Presence] in Urine by Automated |
| 44513-0 | Herpes simplex virus Ag [Presence] in Bronchial specimen by Immunofluorescence |
| 23303-1 | Myxoma virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 33317-9 | Schistosoma sp IgG Ab [Presence] in Serum |
| 5378-5 | Thermoactinomyces vulgaris Ab [Units/volume] in Serum |
| 44878-7 | Staphylococcus aureus enterotoxin A sea gene [Presence] in Specimen by NAA with probe detection |
| 45277-1 | Lymphocytic choriomeningitis virus IgM Ab [Presence] in Body fluid |
| 45285-4 | Date and time of Dose |
| 45323-3 | Mycobacterium tuberculosis tuberculin stimulated gamma interferon [Presence] in Blood |
| 23710-7 | Dirofilaria immitis Ag [Presence] in Serum by Immunoassay |
| 23959-0 | Blastomyces dermatitidis Ab [Titer] in Cerebral spinal fluid |
| 33843-4 | Norepinephrine [Moles/volume] in Plasma --standing |
| 34207-1 | 11-Hydroxyandrosterone [Moles/volume] in 24 hour Urine |
| 54364-5 | Calcium [Moles/volume] in Nonbiological fluid |
| 46158-2 | Bartonella sp IgG Ab [Units/volume] in Serum |
| 46204-4 | Salmonella typhi O D Ab [Titer] in Serum |
| 46698-7 | Cyanide [Presence] in Blood |
| 46964-3 | Cryptococcus sp Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 34509-0 | UGT1A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 34514-0 | SLC22A18 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 3464-5 | Chlorothiazide [Mass/volume] in Serum or Plasma |
| 34646-0 | Sulfatides [Presence] in Urine |
| 55587-0 | Methamphetamine [Moles/volume] in Urine |
| 47220-9 | Cholesterol in HDL 4+5 [Mass/volume] in Serum or Plasma |
| 25084-5 | 2-Oxoisocaproate/Creatinine [Molar ratio] in Urine |
| 25159-5 | Fatty casts [Presence] in Urine sediment by Light microscopy |
| 25181-9 | Ciprofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25257-7 | Imipenem [Mass/volume] in Specimen |
| 25546-3 | Tryptophan [Moles/time] in 24 hour Urine |
| 55625-8 | Cefacetrile [Susceptibility] |
| 47736-4 | Proline/Amino acids.total in DBS |
| 25622-2 | Cortisol [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 35507-3 | Amino acids panel [Moles/volume] - Cerebral spinal fluid |
| 3572-5 | diphenhydrAMINE [Mass/volume] in Urine |
| 56179-5 | Asparagus IgG4 Ab [Mass/volume] in Serum |
| 3655-8 | Flurazepam [Mass/volume] in Urine |
| 3722-6 | Lithium renal clearance in 24 hour Urine and Serum or Plasma |
| 56909-5 | Chlamydia sp IgG Ab [Presence] in Serum by Immunoassay |
| 4875-1 | HLA-Dw13 [Presence] |
| 57650-4 | C peptide [Moles/volume] in Serum or Plasma --70 minutes pre XXX challenge |
| 49068-0 | Saint Louis encephalitis virus IgG and IgM [Interpretation] in Cerebral spinal fluid |
| 27351-6 | Pantothenate [Presence] in Serum, Plasma or Blood |
| 38712-6 | N-nitrosodimethylamine [Mass/volume] in Air |
| 57773-4 | Colorado tick fever virus IgG and IgM [Interpretation] in Serum Narrative |
| 57966-4 | Furazabol metabolite [Presence] in Urine |
| 49696-8 | Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial cord blood |
| 40052-3 | Albumin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 29784-6 | Highlands J virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 29851-3 | Jamestown canyon virus IgG Ab [Units/volume] in Serum |
| 29900-8 | Hepatitis B virus DNA [Mass/volume] (viral load) in Serum by Probe with signal amplification |
| 404-4 | Pipemidate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 50214-6 | Glucose [Mass/volume] in Serum or Plasma --4th specimen |
| 30147-3 | Respiratory syncytial virus Ab [Presence] in Serum --1st specimen |
| 40779-1 | Mexiletine [Mass/volume] in Serum or Plasma --trough |
| 40899-7 | CD3+CD8+ (T8 suppressor) cells [#/volume] in Tissue |
| 100408-4 | Emmental cheese IgG Ab [Units/volume] in Serum |
| 100965-3 | Dengue virus IgG Ab [Interpretation] in Serum, Plasma or Blood |
| 12535-1 | Amyl nitrite [Presence] in Blood |
| 101587-4 | Histoplasma capsulatum+Blastomyces dermatitidis Ag panel - Serum or Plasma |
| 12941-1 | Thyrotropin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 13186-2 | Yellow Dock IgG Ab [Units/volume] in Serum |
| 13294-4 | Hepatitis E virus Ab [Presence] in Serum |
| 13425-4 | EPINEPHrine [Mass/volume] in Plasma --7th specimen post XXX challenge |
| 13655-6 | Leukocytes [Presence] in Stool by Light microscopy |
| 102568-3 | Canary grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14326-3 | Eosinophils/100 leukocytes in Stool by Manual count |
| 102853-9 | Maple IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102914-9 | Sheep whey IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14462-6 | Chlamydia trachomatis [Presence] in Cerebral spinal fluid by Organism specific culture |
| 1085-0 | Js sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
| 16559-7 | Catecholamines [Mass/volume] in Plasma --3 hours post XXX challenge |
| 12200-2 | Cryoglobulin [Presence] in Serum by 4 hour cold incubation |
| 16953-2 | Herpes simplex virus 1 DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 17541-4 | Rickettsia typhi IgG Ab [Presence] in Serum by Immunoassay |
| 18430-9 | Rickettsia rickettsii IgM Ab [Units/volume] in Cerebral spinal fluid |
| 92518-0 | U Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 92577-6 | Chlamydophila pneumoniae DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 92787-1 | Bacillus subtilis group DNA [Presence] by NAA with probe detection in Positive blood culture |
| 7506-9 | Mucor plumbeus IgE Ab [Units/volume] in Serum |
| 76652-7 | Thorium [Mass/mass] in Hair |
| 61231-7 | Botrytis cinerea IgE Ab/IgE total in Serum |
| 94216-9 | STK11 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 63075-6 | American house dust mite IgG Ab [Mass/volume] in Serum |
| 94580-8 | Herpes simplex virus 1 and 2 DNA panel - Specimen by NAA with non-probe detection |
| 78922-2 | Respiratory pathogens DNA and RNA panel - Nasopharynx by NAA with probe detection |
| 79154-1 | Alizapride [Mass/volume] in Body fluid |
| 79282-0 | Biopterin/Biopterin+Neopterin [Molar ratio] in Urine |
| 9545-5 | Legionella pneumophila 2 IgM Ab [Titer] in Serum by Immunofluorescence |
| 669-2 | Microscopic observation [Identifier] in Specimen by Macchiavello stain |
| 96320-7 | Streptococcus agalactiae DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection |
| 67562-9 | Achromobacter sp DNA [Presence] in Specimen by NAA with probe detection |
| 6850-2 | Papaya (Carica papaya) IgE Ab [Units/volume] in Serum |
| 8081-2 | Myelin IgM Ab [Units/volume] in Serum |
| 81119-0 | Epstein Barr virus capsid IgG Ab avidity [Ratio] in Serum by Immunoassay |
| 81426-9 | Microscopic observation [Identifier] in Venous blood by Acetate esterase stain |
| 9664-4 | HIV 1 p24 Ab [Presence] in Serum by Immunoblot |
| 96672-1 | HLA-DRB3 and HLA-DRB4 and HLA DRB5 [Type] by Low resolution |
| 97186-1 | Bordetella parapertussis IS1001 DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 72615-8 | Nordiazepam [Presence] in Saliva (oral fluid) |
| 72852-7 | Cytomegalovirus resistance panel by Genotype method |
| 72947-5 | Sulfamethoxazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86017-1 | Streptococcus pneumoniae Danish serotype 18F IgG Ab [Mass/volume] in Serum by Immunoassay |
| 86567-5 | Influenza virus A IgM Ab [Presence] in Serum by Immunoassay |
| 86579-0 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Urine by NAA with probe detection |
| 872-2 | A3 B Ag [Presence] on Red Blood Cells from Blood product unit |
| 87448-7 | Vanadium [Mass/mass] in Specimen |
| 89656-3 | Fungus identified in Lower respiratory specimen by Culture |
| 41694-1 | Everninomicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 59752-6 | Temazepam [Mass/mass] in Tissue |
| 50690-7 | Reagin Ab [Titer] in Serum by VDRL |
| 50826-7 | Bismuth [Moles/mass] in Hair |
| 51018-0 | CD10 blasts/100 blasts in Bone marrow |
| 30914-6 | Hyperdiploid cells/100 cells in Specimen by Flow cytometry (FC) |
| 60158-3 | Pergolide [Mass/volume] in Blood |
| 60275-5 | SARS coronavirus RNA [Presence] in Isolate by NAA with probe detection |
| 21431-2 | Opiates [Presence] in Urine by Screen method >2000 ng/mL |
| 21500-4 | Measles virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 31545-7 | Nuclear IgG Ab [Presence] in Serum |
| 43045-4 | Cytomegalovirus IgM Ab [Presence] in Cerebral spinal fluid |
| 21752-1 | TCRD gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 22099-6 | Avian paramyxovirus 2 Ab [Titer] in Serum |
| 31738-8 | Borrelia burgdorferi Ag [Presence] in Specimen |
| 32019-2 | Hepatitis B virus surface Ab [Titer] in Serum |
| 22328-9 | Hepatitis C virus superoxide dismutase Ab [Presence] in Serum |
| 22663-9 | Estrone (E1) [Moles/volume] in Serum or Plasma |
| 22707-4 | Homocystine/Creatinine [Molar ratio] in Urine |
| 53049-3 | Glucose [Mass/volume] in Serum or Plasma --pre-meal |
| 43848-1 | Chlamydia trachomatis IgG Ab [Presence] in Serum |
| 22842-9 | Avian pox virus DNA [Presence] in Tissue by NAA with probe detection |
| 32698-3 | Magnesium Ionized [Mass/volume] in Serum or Plasma |
| 53086-5 | Bicarbonate [Moles/volume] in Nonbiological fluid |
| 53360-4 | Erythrocyte clumps [#/volume] in Urine by Computer assisted method |
| 44836-5 | 5-Hydroxymethyl-2-Furoate [Presence] in Urine |
| 44838-1 | Catecholamines [Interpretation] in Plasma |
| 53703-5 | Mycobacterium bovis tuberculin stimulated gamma interferon panel - Blood |
| 53920-5 | Thyroglobulin [Mass/volume] in Lymph node fine needle aspirate |
| 45095-7 | Chlamydia trachomatis [Presence] in Genital specimen by Organism specific culture |
| 45135-1 | Chlamydia trachomatis IgG Ab [Presence] in Serum by Immunoassay |
| 45159-1 | Hepatitis B virus and Hepatitis D virus Ab [Interpretation] in Serum Narrative |
| 23735-4 | Feline leukemia virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 23760-2 | Neospora caninum Ag [Presence] in Fixed tissue by Immune stain |
| 24064-8 | Beta glucuronidase [Enzymatic activity/mass] in Fibroblast |
| 54146-6 | Mycobacterium tuberculosis IgG Ab [Units/volume] in Serum by Immunoassay |
| 24458-2 | Interleukin 2 receptor [Mass/volume] in Serum or Plasma |
| 2489-3 | Intrinsic factor blocking Ab [Titer] in Serum |
| 34612-2 | Iron [Mass/volume] in Stool |
| 47421-3 | Aspergillus flavus B Ab [Presence] in Serum |
| 3508-9 | Codeine [Mass/volume] in Urine |
| 47595-4 | C peptide [Moles/volume] in Serum or Plasma --pre dose glucose |
| 25729-5 | Parvovirus B19 IgG Ab [Titer] in Serum by Immunofluorescence |
| 35506-5 | Chronic lymphocytic leukemia gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 35583-4 | Hydrazine/Creatinine [Mass Ratio] in Urine |
| 35591-7 | Creatinine renal clearance predicted by Cockcroft-Gault formula |
| 56159-7 | LDLR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 56330-4 | Nettle IgG4 Ab [Mass/volume] in Serum |
| 48013-7 | Genomic reference sequence [ID] |
| 26711-2 | Phendimetrazine [Mass/mass] in Meconium |
| 26954-8 | Aspergillus fumigatus IgG Ab [Mass/volume] in Serum |
| 26967-0 | Phenylalanine [Moles/volume] in Urine |
| 27088-4 | Folate [Presence] in Blood |
| 38603-7 | Hydrogen sulfide [Mass/volume] in Air |
| 2742-5 | Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma |
| 38897-5 | Fibers [Presence] in Stool by Light microscopy |
| 49482-3 | Vascular endothelial growth factor Ag [Presence] in Tissue by Immune stain |
| 49494-8 | Leukemia markers [Interpretation] in Pleural fluid Narrative |
| 49680-2 | CD36 cells/100 cells in Tissue |
| 39800-8 | risperiDONE+9-Hydroxyrisperidone [Moles/volume] in Serum or Plasma |
| 50128-8 | 3-Hydroxypropionate (3-OH-C3) [Moles/volume] in Cerebral spinal fluid |
| 29797-8 | Highlands J virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test |
| 40500-1 | Lymphocytic choriomeningitis virus IgG Ab [Titer] in Serum by Immunoassay |
| 30394-1 | Granulocytes [#/volume] in Blood |
| 40988-8 | Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection |
| 19325-0 | Alpha hydroxyalprazolam [Presence] in Urine by Screen method |
| 19532-1 | Meperidine [Presence] in Urine by Screen method |
| 19645-1 | oxyCODONE cutoff [Mass/volume] in Urine for Confirmatory method |
| 20490-9 | Epstein Barr virus capsid IgG Ab [Titer] in Serum |
| 12384-4 | Triazolam [Presence] in Stool |
| 100149-4 | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma |
| 101089-1 | Ge3 Ag [Presence] on Red Blood Cells |
| 101244-2 | Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 13858-6 | Androstenedione [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
| 102563-4 | Raspberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102716-8 | Clam IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103054-3 | European house dust mite recombinant (rDer p) 2 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103090-7 | Honey bee phospholipase A2 native (nApi m) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15002-9 | Xylose [Moles/volume] in Serum or Plasma --2 hours post 25 g xylose PO |
| 1533-9 | Glucose [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO |
| 10720-1 | Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 11163-3 | Carageenan IgE Ab [Units/volume] in Serum |
| 12332-3 | Antihistamines [Identifier] in Urine |
| 16983-9 | hydrALAZINE [Presence] in Urine |
| 1721-0 | Adenosine triphosphate [Mass/volume] in Blood |
| 18915-9 | Demeclocycline [Susceptibility] |
| 18985-2 | Sulfamethoxazole [Susceptibility] |
| 89979-9 | Ziprasidone [Presence] in Serum or Plasma by Screen method |
| 74687-5 | Glucose [Moles/volume] in 12 hour Urine |
| 7470-8 | Llama fur IgE Ab [Units/volume] in Serum |
| 74876-4 | Arginine [Moles/volume] in DBS --post therapeutic diet |
| 74895-4 | Maltose/Creatinine [Molar ratio] in Urine |
| 74905-1 | Desmosterol [Moles/volume] in Serum or Plasma |
| 74995-2 | Osteocalcin [Z-score] in Serum or Plasma |
| 75149-5 | Deoxyguanosine [Moles/volume] in Cerebral spinal fluid |
| 60565-9 | Amikacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 76675-8 | Appearance of Cerebral spinal fluid--1st tube |
| 7701-6 | Shrimp triggered histamine release [Units/volume] in Blood |
| 77681-5 | Glucose [Moles/volume] in Serum or Plasma --11 hour post XXX challenge |
| 77755-7 | 6-Monoacetylmorphine (6-MAM) cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 94504-8 | SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay |
| 63400-6 | SCL-70 extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 95191-3 | CD107a+b expressing HLA-A1 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC) |
| 6546-6 | Rickettsia sp identified in Specimen by Organism specific culture |
| 66730-3 | Adenovirus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 79591-4 | N-alpha acetyllysine [Moles/volume] in Serum or Plasma |
| 6852-8 | Green Pepper IgE Ab [Units/volume] in Serum |
| 81279-2 | Meperidine and Normeperidine panel - Specimen |
| 96712-5 | Leukocytes [#/area] in Body fluid by Light microscopy |
| 70077-3 | Interleukin 2 [Mass/volume] in Cerebral spinal fluid |
| 81820-3 | ASS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 7022-7 | Kanamycin [Susceptibility] by Gradient strip |
| 71856-9 | Hemoglobin.other/Hemoglobin.total [Pure mass fraction] in Blood by HPLC |
| 85037-0 | HIV 1 and 2 Ab and HIV 1 p24 Ag panel - Serum or Plasma by Immunoassay |
| 72938-4 | Trimethoprim induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86568-3 | Influenza virus A RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 73849-2 | 16-Ketoandrostenediol [Moles/volume] in Urine |
| 88267-0 | Proteus sp atpD gene [Presence] by Probe in Positive blood culture |
| 5096-3 | Coccidioides immitis Ab [Titer] in Serum by Complement fixation |
| 30923-7 | Chromium [Mass/volume] in Urine collected for unspecified duration |
| 60220-1 | Sodium [Moles/volume] in Mother's milk |
| 31270-2 | Bovine diarrhea virus 1 Ab [Units/volume] in Serum |
| 21771-1 | Chromosome 21 trisomy [Presence] in Blood or Tissue by Cytogenetics |
| 22159-8 | Brucella sp Ab [Titer] in Serum |
| 31899-8 | Mumps virus Ag [Presence] in Urethra |
| 43352-4 | Avian metapneumovirus B Ab [Titer] in Serum |
| 4371-1 | Oxymesterone [Mass] of Dose |
| 51981-9 | HER2 [Presence] in Serum by Immunoassay |
| 52759-8 | Prekallikrein (Fletcher Factor) activity actual/normal in Platelet poor plasma by Coagulation assay |
| 44392-9 | Immune complex [Presence] in Serum or Plasma by Raji cell assay |
| 23180-3 | Leptospira interrogans sv Hardjo Ab [Presence] in Serum by Agglutination |
| 3300-1 | Acetazolamide [Mass/volume] in Serum or Plasma |
| 53478-4 | Anthranilate [Moles/time] in 24 hour Urine |
| 44486-9 | Herpes simplex virus 2 [Presence] in Skin by Organism specific culture |
| 44703-7 | MC4R gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 23366-8 | Porcine parvovirus Ab [Presence] in Serum |
| 23412-0 | Rinderpest virus Ag [Units/volume] in Tissue by Immunoassay |
| 2359-8 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Serum |
| 45320-9 | Ecgonine methyl ester [Presence] in Serum or Plasma by Confirmatory method |
| 46233-3 | ZAP70 cells/100 cells in Body fluid |
| 4633-4 | Hemoglobin F/Hemoglobin.total in Blood by Kleihauer-Betke method |
| 34306-1 | Follitropin [Units/volume] in 24 hour Urine by 2nd IRP |
| 55195-2 | DHCR7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 47062-5 | Legionella pneumophila 14 IgM Ab [Titer] in Serum by Immunofluorescence |
| 47294-4 | Bacteria # 7 identified in Wound shallow by Aerobe culture |
| 25458-1 | lamoTRIgine [Moles/volume] in Serum or Plasma |
| 25487-0 | Nickel [Moles/time] in 24 hour Urine |
| 35155-1 | Hexadecenoate (C16:1w9) [Moles/volume] in Serum or Plasma |
| 55811-4 | 18-Hydroxycortisol [Moles/time] in 24 hour Urine |
| 56004-5 | Platelet aggregation ADP induced ATP secretion [Presence] in Blood --5 umol/L |
| 56238-9 | Cucumber IgG4 Ab [Mass/volume] in Serum |
| 5655-6 | Germanium [Mass/volume] in Urine |
| 48292-7 | Sodium salicylate triggered leukotriene release [Mass/volume] by Leukocytes |
| 26473-9 | Leukocytes other/100 leukocytes in Body fluid |
| 26554-6 | Glucose [Mass/volume] in Serum or Plasma --2.5 hours post dose glucose |
| 36912-4 | CATCH22 syndrome gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 48351-1 | Methotrimeprazine [Moles/volume] in Serum or Plasma |
| 48638-1 | Cryoglobulin type [Identifier] in Serum by Immunofixation |
| 57432-7 | CD19+Kappa+ cells/100 cells in Body fluid |
| 4896-7 | HLA-Dw23 [Presence] in Donor |
| 27959-6 | Pyruvate [Mass/volume] in Blood --baseline |
| 49667-9 | Tipranavir [Susceptibility] by Phenotype method |
| 28609-6 | Alpha aminobutyrate/Creatinine [Ratio] in 24 hour Urine |
| 58510-9 | C peptide [Mass/volume] in Serum or Plasma --30 minutes post dose glucose |
| 49819-6 | 3-Hydroxy,3-Methylglutarate/Creatinine [Molar ratio] in 24 hour Urine |
| 29816-6 | La Crosse virus IgM Ab [Presence] in Serum by Immunofluorescence |
| 40464-0 | Drugs identified in Urine by Confirmatory method |
| 59180-0 | Monoethylglycinexylidide [Presence] in Urine |
| 50601-4 | HPA-4 [Type] in Blood |
| 30176-2 | La Crosse virus neutralizing antibody [Presence] in Specimen by Neutralization test |
| 40832-8 | Pistachio IgE Ab/IgE total in Serum |
| 20718-3 | Bromide [Mass/volume] in Ocular fluid |
| 100424-1 | 8(9)-Cholestenol [Mass/volume] in Serum or Plasma |
| 101282-2 | Mitragynine [Presence] in Cord tissue |
| 101338-2 | Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method |
| 102212-8 | Cauliflower IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13884-2 | Estradiol (E2).bioavailable [Mass/volume] in Serum or Plasma |
| 14254-7 | Ganglioside GQ1b IgG Ab [Titer] in Serum |
| 102690-5 | Soybean IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102759-8 | Beta galactosidase IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10331-7 | Rh [Type] in Blood |
| 15087-0 | Parathyrin related protein [Moles/volume] in Serum or Plasma |
| 104321-5 | CXCR4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 10622-9 | Spermatozoa Normal/100 spermatozoa in Semen |
| 15391-6 | Parainfluenza virus 1 IgM Ab [Titer] in Serum |
| 16453-3 | Beta aminoisobutyrate [Presence] in Urine |
| 12282-0 | Warfarin [Presence] in Urine |
| 17763-4 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 18379-8 | Urate [Mass/time] in 6 hour Urine |
| 91682-5 | Histoplasma capsulatum Ab [Identifier] in Cerebral spinal fluid by Immune diffusion (ID) |
| 91802-9 | Parainfluenza virus 1 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 91856-5 | Human papilloma virus 16 DNA [Presence] in Genital specimen by NAA with probe detection |
| 92768-1 | Candida albicans+glabrata+krusei+parapsilosis DNA [Presence] by NAA with probe detection in Positive blood culture |
| 92950-5 | Streptococcus agalactiae DNA [NCncRange] in Sputum by NAA with non-probe detection |
| 61261-4 | Gum-Tree IgE Ab/IgE total in Serum |
| 61399-2 | Klebsiella pneumoniae DNA [Presence] in Specimen by NAA with probe detection |
| 62347-0 | Chromosome analysis.prenatal panel by FISH |
| 77173-3 | Hepatocyte growth factor receptor Ag [Presence] in Tissue by Immune stain |
| 78825-7 | Ecgonine methyl ester [Mass/mass] in Hair |
| 951-4 | C little e Ab [Presence] in Serum or Plasma |
| 65753-6 | Cervix Pathology biopsy report |
| 80179-5 | S-adenosylmethionine and S-adenosylhomocystine panel - Cerebral spinal fluid |
| 95915-5 | Coccidioides sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 9610-7 | Hepatitis C virus c33c Ab [Presence] in Serum by Immunoblot |
| 96472-6 | Rho GTPase-activating protein 26 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 68992-7 | Specimen-related information panel |
| 96971-7 | STK11 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 97586-2 | Tetrahydrocannabinol [Presence] in Cord tissue by Screen method |
| 7137-3 | Soybean triggered histamine release [Units/volume] in Blood |
| 97985-6 | Honey bee phospholipase A2 recombinant (rApi m) 1 IgG4 Ab [Mass/volume] in Serum |
| 983-7 | Di sup(a) Ag [Presence] on Red Blood Cells from Donor |
| 85290-5 | Surgical margin tumor involvement [Presence] in Colorectal cancer specimen by Light microscopy |
| 85346-5 | Tissue blocks examined [#] in Specimen |
| 85529-6 | PRRSV North American strain IgG Ab [Presence] in Serum by Immunofluorescence |
| 85752-4 | Streptococcus pneumoniae Danish serotypes 9A+9V DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 72647-1 | Albumin in serum - albumin in pleural fluid [Mass concentration difference] |
| 72775-0 | Venlafaxine/Creatinine [Mass Ratio] in Urine |
| 72885-7 | Respiratory syncytial virus Ag [Presence] in Nasopharynx by Rapid immunoassay |
| 86006-4 | Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum --2nd specimen |
| 73141-4 | Sulfamethoxazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73465-7 | cefTRIAXone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73854-2 | Aldosterone-18-glucuronide [Moles/time] in 24 hour Urine |
| 74040-7 | Influenza virus A N2 RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 74339-3 | MICA*009 IgG Ab [Presence] in Serum |
| 89037-6 | CDKN2A gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 89659-7 | Microscopic observation [Identifier] in Implanted device by Gram stain |
| 41269-2 | Beta hydroxybutyrate + Gamma aminobutyrate [Moles/volume] in Serum or Plasma |
| 41598-4 | Bacteria [Presence] in Pericardial fluid by Light microscopy |
| 59321-0 | Ramelteon M-II [Mass/volume] in Urine |
| 59691-6 | Hydroxytriazolam [Mass/volume] in Blood by Confirmatory method |
| 59796-3 | Glucose [Molar concentration difference] in Serum or Plasma --4 hours post XXX challenge |
| 60108-8 | Oxychlordane [Mass/volume] in Body fluid |
| 21377-7 | Magnesium [Mass/volume] in Blood |
| 21406-4 | Mycoplasma pneumoniae IgM Ab [Presence] in Serum |
| 31584-6 | Reticulin IgG Ab [Units/volume] in Serum |
| 3159-1 | Volume of Plasma |
| 51453-9 | Coxsackievirus A9+B1+B2+B3+B4+B5+B6 Ab [Titer] in Serum |
| 42727-8 | Fibrin D-dimer DDU [Mass/volume] in Cerebral spinal fluid by Latex agglutination |
| 43097-5 | COL3A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2216-0 | DOPamine [Mass/volume] in Serum or Plasma |
| 31610-9 | Orientia tsutsugamushi Litchfield Ab [Units/volume] in Serum |
| 32008-5 | Coproporphyrin/Creatinine [Molar ratio] in 24 hour Urine |
| 51515-5 | Lactate dehydrogenase 3/Lactate dehydrogenase.total in Peritoneal fluid by Electrophoresis |
| 22510-2 | Saint Louis encephalitis virus Ab [Titer] in Serum |
| 324-4 | Methicillin [Susceptibility] by Disk diffusion (KB) |
| 43995-0 | Trisomy 21 risk [Likelihood] in Fetus |
| 44329-1 | Isoleucine/Creatinine [Mass Ratio] in 24 hour Urine |
| 44422-4 | Interleukin 2 receptor alpha chain soluble [Units/volume] in Serum or Plasma |
| 23251-2 | Mycoplasma agalactiae Ab [Presence] in Serum |
| 33256-9 | Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood by Automated count |
| 33310-4 | Phosphatidylserine Ab [Presence] in Serum |
| 33629-7 | Hepatitis B virus sequencing [Identifier] in Serum by NAA with probe detection |
| 45050-2 | Cortisol [Moles/volume] in Serum or Plasma --8 AM specimen |
| 24054-9 | Alpha-N-acetylgalactosaminidase [Enzymatic activity/mass] in Fibroblast |
| 34179-2 | Herpes virus 6 IgG Ab [Titer] in Serum by Immunoassay |
| 34237-8 | Androstenediol [Moles/volume] in 24 hour Urine |
| 54345-4 | Acetylcarnitine (C2) [Moles/volume] in Semen |
| 54396-7 | Glucose [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 462-2 | Streptomycin [Susceptibility] by Serum bactericidal titer |
| 46962-7 | Vasoactive intestinal peptide Ag [Presence] in Tissue by Immune stain |
| 35083-5 | Amino acids panel [Moles/volume] - Serum or Plasma |
| 47536-8 | 3-Hydroxypropionate (3-OH-C3) [Moles/volume] in Plasma |
| 47693-7 | Lysine/Amino acids.total in Serum or Plasma |
| 25662-8 | Gastrin [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 56540-8 | Glutamate decarboxylase 65 Ab [Units/volume] in Serum by Immunoassay |
| 48064-0 | Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool |
| 48102-8 | Cortisol [Mass/volume] in Serum or Plasma --4 AM specimen |
| 26654-4 | Hantavirus sin nombre IgG Ab [Presence] in Serum |
| 3798-6 | Methoxyphenamine [Presence] in Urine |
| 56684-4 | Hydroxylysine/Creatinine [Ratio] in 24 hour Urine |
| 56762-8 | Oligoclonal Bands IgG [Presence] in Serum or Plasma |
| 57029-1 | Fetal chromosome 13+18+21+X+Y aneuploidy in Tissue by Molecular genetics method Nominal |
| 48597-9 | cycloSPORINE [Mass/volume] in Blood by Immunoassay --trough |
| 4865-2 | HLA-Cw8 [Presence] |
| 38300-0 | Diquat [Mass/volume] in Water |
| 5725-7 | Selenium [Mass/mass] in Tissue |
| 49124-1 | Coxiella burnetii identified in Specimen by Sequencing |
| 27439-9 | Alpha hydroxyalprazolam [Mass/mass] in Stool |
| 27914-1 | Gamma aminoadipate [Moles/time] in 24 hour Urine |
| 388-9 | Oxytetracycline [Susceptibility] by Disk diffusion (KB) |
| 39080-7 | EPM2A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 57844-3 | Imatinib mesylate [Mass/volume] in Serum or Plasma |
| 40068-9 | Calcium [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 58394-8 | HYDROmorphone/Creatinine [Mass Ratio] in Urine |
| 58482-1 | Protein S Ag/Coagulation factor IX Ag [Mass Ratio] in Platelet poor plasma by Immunoassay |
| 5861-0 | Influenza virus A Ag [Presence] in Throat by Immunofluorescence |
| 49796-6 | t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [#/volume] in Blood or Tissue by Molecular genetics method |
| 29888-5 | Pseudorabies virus G1 gene deletion Ab [Presence] in Serum by Immunoassay |
| 29913-1 | Xylose [Mass/volume] in Serum or Plasma --2 hours post 5 g xylose PO |
| 29923-0 | Scandium [Mass/volume] in 24 hour Urine |
| 40637-1 | Kappa light chains.free [Presence] in Urine |
| 58977-0 | Ganglioside GD1b IgM Ab [Units/volume] in Serum by Immunoassay |
| 59063-8 | Lymphocyte proliferation panel - Blood |
| 30297-6 | Amprenavir [Susceptibility] by Genotype method |
| 30346-1 | Glucose [Mass/volume] in Serum or Plasma --3 hours post 1.2 g/kg lactose PO |
| 40953-2 | Yersinia enterocolitica O:3 Ab [Titer] in Serum by Complement fixation |
| 19252-6 | Megakaryocytes/100 leukocytes in Blood |
| 19360-7 | Cocaine [Presence] in Urine by Confirmatory method |
| 19418-3 | Tetrahydrocannabinol cutoff [Mass/volume] in Urine for Confirmatory method |
| 1963-8 | Bicarbonate [Moles/volume] in Serum or Plasma |
| 19698-0 | Temazepam [Presence] in Urine by Screen method |
| 2073-5 | Chloride [Moles/volume] in Red Blood Cells |
| 20736-5 | Cache valley virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 21013-8 | CD22 cells [#/volume] in Blood |
| 100403-5 | Guineafowl IgG Ab [Units/volume] in Serum |
| 101477-8 | Ampicillin [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 102666-5 | Baker's yeast IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1423-3 | Cortisol [Mass/volume] in Serum or Plasma --45 minutes post 1 ug/kg CRH IV |
| 14285-1 | Carnitine free (C0) [Moles/volume] in Urine |
| 102960-2 | Kiwifruit IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103039-4 | Chlorhexidine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10923-1 | Bromelin IgE Ab [Units/volume] in Serum |
| 16370-9 | Amphotericin B [Mass/volume] in Urine |
| 1639-4 | Testosterone [Mass/volume] in Serum or Plasma --pre 5000 U HCG IM |
| 16823-7 | Epstein Barr virus early Ab [Units/volume] in Serum by Immunoassay |
| 17695-8 | Tetrachlorodiphenylethane [Mass/volume] in Blood |
| 17770-9 | Western equine encephalitis virus Ab [Titer] in Serum |
| 17786-5 | Thyrotropin [Interpretation] in Specimen--post dose TRH |
| 17954-9 | Bacteria # 5 identified in Body fluid by Aerobe culture |
| 18389-7 | Methaqualone [Presence] in Urine by Confirmatory method |
| 74579-4 | Pyruvate dehydrogenase E1 [Enzymatic activity/mass] in Fibroblast |
| 74828-5 | Snowshoe hare virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 91586-8 | Coding system [Identifier] in Referral lab test |
| 75646-0 | Ethylene glycol [Presence] in Gastric fluid |
| 6066-5 | Acremonium sp IgE Ab [Units/volume] in Serum |
| 6085-5 | Common Ragweed IgE Ab [Units/volume] in Serum |
| 93404-2 | Enterobacter cloacae complex DNA [Presence] by NAA with probe detection in Positive blood culture |
| 61327-3 | Corn IgE Ab/IgE total in Serum |
| 6183-8 | Mugwort IgE Ab [Units/volume] in Serum |
| 79473-5 | Hexanoylglycine [Moles/volume] in Serum or Plasma |
| 9506-7 | Chloroethane [Mass/volume] in Blood |
| 95288-7 | YARS gene full mutation analysis in Blood or Tissue by Sequencing |
| 9532-3 | Influenza virus A IgG Ab [Titer] in Serum |
| 6510-2 | Human papilloma virus Ab [Presence] in Genital specimen by Immunoassay |
| 65331-1 | little cE Ab [Presence] in Serum or Plasma |
| 6618-3 | Acanthamoeba sp Ab [Presence] in Cornea by Immunofluorescence |
| 67827-6 | Lymphocytes [#/volume] in Pericardial fluid |
| 80635-6 | Aldicarb sulfoxide [Mass/volume] in Urine |
| 9659-4 | Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 6965-8 | Yersinia enterocolitica IgG Ab [Units/volume] in Serum by Immunoassay |
| 69885-2 | Service comment 58 |
| 81777-5 | Nonanoylcarnitine (C9)/Creatinine [Molar ratio] in Urine |
| 8188-5 | Benzoylecgonine [Presence] in Meconium by Confirmatory method |
| 82169-4 | Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 97920-3 | Tick-borne encephalitis virus RNA [Presence] in Specimen by NAA with probe detection |
| 7063-1 | Smooth Alder IgE Ab [Units/volume] in Serum |
| 82558-8 | Food Allergen Mix 75 (Cow milk+Egg white+Cod+Wheat) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 72443-5 | 3-Methyladipate [Moles/volume] in Serum or Plasma |
| 83123-0 | Toxoplasma gondii IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 73328-7 | Irbesartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87482-6 | Aluminum [Mass/volume] in Specimen |
| 88837-0 | Microbiology CNAMTS panel - Sputum |
| 59319-4 | Ramelteon M-II [Mass/mass] in Tissue |
| 50763-2 | B IgM Ab [Titer] in Serum or Plasma |
| 50924-0 | Titanium [Moles/volume] in Serum or Plasma |
| 51038-8 | CD11b blasts/100 blasts in Blood |
| 31018-5 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum --2nd specimen |
| 31144-9 | Thyroxine (T4) [Mass/volume] in DBS |
| 59966-2 | quiNINE [Moles/volume] in Urine |
| 5997-2 | Platelet aggregation norepinephrine induced in Platelet rich plasma |
| 31220-7 | African horse sickness virus Ab [Units/volume] in Serum |
| 31377-5 | Equine herpesvirus 1 Ab [Units/volume] in Serum |
| 31480-7 | Leptospira interrogans sv Hardjo Ab [Units/volume] in Serum |
| 42766-6 | Aspergillus sp Ab [Interpretation] in Serum by Immune diffusion (ID) Narrative |
| 42907-6 | Helminthosporium sp IgG Ab [Mass/volume] in Serum |
| 21817-2 | t(6;9)(p22;q34)(DEK,NUP214) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 31743-8 | Bovine diarrhea virus Ag [Presence] in Specimen |
| 51835-7 | Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid |
| 52972-7 | Food Allergen Mix 3 (Oat+Buckwheat+Sesame seed+Wheat+Corn) IgE Ab [Units/volume] in Serum by Multidisk |
| 52973-5 | Bacteria identified in Sputum tracheal aspirate by Culture |
| 43934-9 | Amphetamines [Mass/mass] in Meconium by Confirmatory method |
| 44004-0 | Estriol (E3).unconjugated [Multiple of the median] in Amniotic fluid |
| 23100-1 | Equine influenza virus A1 Ab [Presence] in Serum by Complement fixation |
| 53206-9 | Salicylylcarnitine (SalC) [Moles/volume] in DBS |
| 23455-9 | Taylorella equigenitalis Ag [Presence] in Specimen by Immunofluorescence |
| 3380-3 | Bendroflumethiazide [Mass/time] in 24 hour Urine |
| 53975-9 | Drug crystals [Presence] in Urine sediment by Light microscopy |
| 465-5 | sulfADIAZINE [Susceptibility] by Disk diffusion (KB) |
| 34441-6 | Spermatozoa [Velocity] in Semen |
| 55382-6 | Insulin [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge |
| 47200-1 | Methionine+Homocysteine [Mass] of Dose |
| 47422-1 | Aspergillus flavus H Ab [Presence] in Serum |
| 25401-1 | Estradiol (E2) [Moles/time] in 24 hour Urine |
| 35050-4 | Lymphoblasts [#/volume] in Blood |
| 47543-4 | 4-Hydroxymandelate/Creatinine [Molar ratio] in Urine |
| 25628-9 | Cortisol [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 35581-8 | Hydroxyethyl valine [Mass/volume] in Blood |
| 26690-8 | Western equine encephalitis virus RNA [Presence] in Cerebral spinal fluid by Probe |
| 26720-3 | Codeine [Mass/mass] in Hair |
| 3639-2 | 5-Fluorocytosine [Mass/volume] in Serum or Plasma |
| 38182-2 | Parainfluenza virus 1 IgG Ab [Units/volume] in Serum |
| 5677-0 | Lead [Mass/time] in 24 hour Urine |
| 26947-2 | Mycoplasma pneumoniae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 38284-6 | Lymphocyte proliferation stimulated by 19.3 ug/mL tetanus toxoid [Units/volume] in Blood |
| 38556-7 | Spermatozoa.head Motile w IgM/100 spermatozoa in Semen by Immunobead |
| 57131-5 | Newborn conditions with positive markers [Identifier] in DBS |
| 2756-5 | pH of Urine |
| 27966-1 | Legionella pneumophila atypical Ab [Titer] in Serum by Immunofluorescence |
| 3886-9 | Oxazepam [Mass/volume] in Serum or Plasma |
| 38929-6 | FAH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 39587-1 | Neutrophil Ab [Presence] in Serum by Immunoassay |
| 49459-1 | Alzheimer precursor protein Ag [Presence] in Tissue by Immune stain |
| 29156-7 | Lutropin [Units/volume] in 24 hour Urine |
| 58791-5 | Coxsackievirus A9 IgM Ab [Titer] in Serum by Immunofluorescence |
| 49892-3 | Somatotropin [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 29809-1 | Saint Louis encephalitis virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 40380-8 | Meprobamate [Presence] in Gastric fluid |
| 58983-8 | Honey bee phospholipase A2 native (nApi m) 1 IgE Ab [Units/volume] in Serum |
| 50248-4 | 17-Hydroxycorticosteroids [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
| 50353-2 | Parrot feather IgE Ab/IgE total in Serum |
| 30068-1 | Alanine/Creatinine [Ratio] in Urine |
| 30180-4 | Basophils/100 leukocytes in Blood |
| 41085-2 | MPZ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 192-5 | Clindamycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 19743-4 | Horse meat IgE Ab [Units/volume] in Serum |
| 2063-6 | Cerebroside sulfatase [Enzymatic activity/volume] in Leukocytes |
| 2066-9 | Chenodeoxycholylglycine [Mass/volume] in Serum |
| 12347-1 | metOLazone [Presence] in Urine |
| 12764-7 | Insulin [Mass/volume] in Serum or Plasma --22 minutes post XXX challenge |
| 13181-3 | Bahia grass IgG Ab [Units/volume] in Serum |
| 102341-5 | Koehlers grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102591-5 | Sheep epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14288-5 | Carnitine [Moles/volume] in Serum or Plasma |
| 1457-1 | Creatinine [Mass/volume] in 24 hour Urine --pre 40 ug corticotropin IM 3 day |
| 14857-7 | Leukocytes other/100 leukocytes in Pericardial fluid by Manual count |
| 15473-2 | Equine arteritis virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 16164-6 | Parathyrin.intact [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 10920-7 | Bamboo shoot IgE Ab [Units/volume] in Serum |
| 1167-6 | little f Ab [Presence] in Serum or Plasma from Donor |
| 17049-8 | Latex glove extract ammoniated IgE Ab [Units/volume] in Blood |
| 17111-6 | CD12 cells/100 cells in Blood |
| 1780-6 | Alkaline phosphatase.placental [Enzymatic activity/volume] in Serum or Plasma |
| 1887-9 | Appearance of Amniotic fluid |
| 18955-5 | Nitrofurantoin [Susceptibility] |
| 90278-3 | Bacteria identified in Synovial fluid by Aerobe culture |
| 74645-3 | HYDROmorphone [Presence] in Saliva (oral fluid) by Confirmatory method |
| 92493-6 | Lu sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 92788-9 | Bacillus cereus group DNA [Presence] by NAA with probe detection in Positive blood culture |
| 75595-9 | Fetal 5p deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 60357-1 | Brussel Sprouts IgG Ab [Mass/volume] in Serum |
| 92837-4 | Perineural invasion [Presence] in Cancer specimen |
| 93366-3 | Gene studied with no variant found [Identifier] in Blood or Tissue Nominal |
| 93470-3 | Furanylfentanyl [Mass/volume] in Urine by Confirmatory method |
| 94229-2 | MECP2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 94238-3 | F12 gene full mutation analysis in Blood or Tissue by Sequencing |
| 62465-0 | Toxoplasma gondii DNA [#/volume] in Cerebral spinal fluid by NAA with probe detection |
| 63234-9 | DNA double strand IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 94689-7 | CD20 cells/100 CD19 cells in Blood |
| 95153-3 | Ornithobacterium rhinotracheale RNA [#/volume] in Specimen by NAA with probe detection |
| 79707-6 | Fatty acids.very long chain C26:1 (Hexacosenoate)/C22:0 (Docosanoate) [Molar ratio] in Serum or Plasma |
| 80150-6 | Trimeprazine [Mass/mass] in Hair |
| 95778-7 | TERT gene promotor region targeted mutation analysis in Tissue by Molecular genetics method |
| 6816-3 | Histoplasma capsulatum mycelial phase Ab [Presence] in Serum |
| 68423-3 | Monocytes/100 leukocytes in Vitreous fluid by Manual count |
| 80677-8 | Escherichia coli enterotoxigenic eltA+estB genes [Presence] in Stool by NAA with probe detection |
| 97179-6 | Yersinia outer protein E Ab [Presence] in Serum by Line blot |
| 97628-2 | Peptoniphilus sp DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 98985-5 | 10-Hydroxycarbazepine [Mass/volume] in Urine by Confirmatory method |
| 71773-6 | Mycobacterium tuberculosis stimulated gamma interferon [Interpretation] in Blood Qualitative |
| 7233-0 | Clam triggered histamine release [Units/volume] in Blood |
| 854-0 | A2 Ag [Presence] on Red Blood Cells from Blood product unit |
| 99374-1 | Silver Birch IgG Ab [Mass/volume] in Serum |
| 72892-3 | MRSA SCCmec and mecA genes panel - Nose by NAA with probe detection |
| 73159-6 | Rosiglitazone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86860-4 | Dengue virus 1 neutralizing antibody [Titer] in Specimen by Neutralization test |
| 73449-1 | Cilastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 41421-9 | Paragonimus sp Ab [Presence] in Serum by Immunoblot |
| 41489-6 | Echovirus 11 neutralizing antibody [Titer] in Serum by Neutralization test |
| 50824-2 | Beta-2-Microglobulin [Moles/volume] in 24 hour Urine |
| 31084-7 | Methadone [Mass/volume] in Bile fluid |
| 59955-5 | Perphenazine [Moles/volume] in Gastric fluid |
| 60150-0 | Pentazocine [Mass/volume] in Body fluid |
| 21585-5 | Uranium [Mass/volume] in 24 hour Urine |
| 31491-4 | Lymphocytic choriomeningitis virus Ab [Units/volume] in Cerebral spinal fluid |
| 42887-0 | CD79b cells/100 cells in Tissue |
| 21806-5 | t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 51480-2 | Bacteria [#/volume] in Urine by Automated count |
| 43701-2 | Cytomegalovirus [Presence] in Specimen by Shell vial culture |
| 5259-7 | Myelin basic protein Ab [Titer] in Serum by Immunofluorescence |
| 44389-5 | IgA [Presence] in Serum |
| 22946-8 | Brucella sp Ag [Presence] in Tissue from Fetus by Immunofluorescence |
| 32841-9 | Neisseria meningitidis serogroups C+w135 Ag [Presence] in Specimen |
| 53433-9 | Creatine kinase [Enzymatic activity/volume] in Dialysis fluid |
| 44428-1 | Adenosine monophosphate.cyclic.nephrogenous/Creatinine [Molar ratio] in Urine |
| 23378-3 | Porcine respiratory coronavirus RNA [Presence] in Specimen by Probe |
| 33381-5 | Coccidioides sp Ab [Units/volume] in Serum |
| 53910-6 | Microscopic observation [Identifier] in Peritoneal fluid by Rhodamine-auramine fluorochrome stain |
| 44896-9 | Malignant cells/100 cells in Synovial fluid by Manual count |
| 54152-4 | Nuclear mitotic apparatus Ab [Presence] in Serum by Immunofluorescence |
| 54171-4 | Imipenem+EDTA [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2457-0 | IgA [Mass/volume] in Cerebral spinal fluid |
| 2480-2 | Inositol Free [Mass/volume] in Serum |
| 55340-4 | V Ab [Titer] in Serum or Plasma |
| 4745-6 | HLA-B41 [Presence] |
| 55607-6 | Triglyceride/Cholesterol in HDL [Molar ratio] in Serum or Plasma |
| 47849-5 | Cortisol [Moles/volume] in Serum or Plasma --post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 4787-8 | HLA-B67 [Presence] |
| 25738-6 | Prolactin [Mass/volume] in Serum or Plasma --2 hours post 200 ug TRH IV |
| 48163-0 | Cytokeratin 19 [Mass/volume] in Body fluid |
| 37991-7 | Neutrophil cytoplasmic Ab.perinuclear [Units/volume] in Serum by Immunoassay |
| 56992-1 | Trichinella sp IgG Ab [Presence] in Serum by Immunofluorescence |
| 48805-6 | Platelet aggregation panel - Platelet rich plasma |
| 26843-3 | Cystine [Presence] in 24 hour Urine |
| 48979-9 | TSC1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 27404-3 | Chlamydophila psittaci IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 38717-5 | Phosphate [Mass/volume] in Air |
| 39607-7 | Spermatozoa Motile [#/area] in Semen by Microscopy high power field |
| 49392-4 | Herpes virus 6 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 29372-0 | Codeine [Mass/volume] in Gastric fluid |
| 58425-0 | Ethyl sulfate [Mass/volume] in Urine by Confirmatory method |
| 58663-6 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes pre 1 ug/kg CRH IV |
| 49863-4 | Aspergillus sp DNA [Presence] in Specimen by NAA with probe detection |
| 29871-1 | 4-Hydroxyphenylpyruvate [Presence] in Urine |
| 40664-5 | Pyrophosphate crystals [Presence] in Body fluid |
| 50377-1 | von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay |
| 30339-6 | Epstein Barr virus capsid IgG Ab [Presence] in Serum |
| 40762-7 | Coxsackievirus A Ab [Titer] in Serum --1st specimen |
| 40794-0 | Alkaline phosphatase.intestinal [Presence] in Serum or Plasma |
| 19481-1 | Haloperidol cutoff [Mass/volume] in Urine for Confirmatory method |
| 20601-1 | CD33 cells/100 cells in Specimen |
| 21049-2 | Acetone [Mass/mass] in Tissue |
| 100908-3 | Pseudomonas aeruginosa [Presence] in Lower respiratory specimen by Organism specific culture |
| 101559-3 | Listeria monocytogenes DNA [Presence] in Stool by NAA with probe detection |
| 13329-8 | Escherichia coli labile toxin [Presence] in Specimen |
| 101944-7 | Candida parapsilosis DNA [Presence] in Urine by NAA with probe detection |
| 13501-2 | Herpes simplex virus 2 Ab pattern [Interpretation] in Serum |
| 13626-7 | Mitotane [Mass/volume] in Serum or Plasma |
| 13878-4 | Collagen type 1 IgG Ab [Units/volume] in Serum |
| 102581-6 | Common Sagebrush IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 140-4 | cefTRIAXone [Susceptibility] by Minimum lethal concentration (MLC) |
| 14495-6 | Virus identified in Urine sediment by Immunofluorescence |
| 14862-7 | Oxalate [Moles/time] in 24 hour Urine |
| 14898-1 | Protriptyline [Moles/volume] in Serum or Plasma |
| 14929-4 | Triiodothyronine (T3).reverse [Moles/volume] in Serum or Plasma |
| 1501-6 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 100 g glucose PO |
| 15040-9 | Coproporphyrin [Moles/time] in 24 hour Stool |
| 15101-9 | Chloramphenicol [Moles/volume] in Serum or Plasma |
| 16406-1 | Arylamidase [Enzymatic activity/volume] in Urine |
| 11253-2 | Tacrolimus [Mass/volume] in Blood |
| 12275-4 | Yeast [Presence] in Genital specimen by Wet preparation |
| 12294-5 | Nicotine [Presence] in Urine |
| 17342-7 | Neuronal nuclear type 2 Ab [Units/volume] in Serum |
| 17438-3 | Phenolphthalein [Mass/volume] in Blood |
| 1751-7 | Albumin [Mass/volume] in Serum or Plasma |
| 17577-8 | Ganglioside GQ1a IgM Ab [Presence] in Serum |
| 17815-2 | Beta globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
| 17830-1 | Centromere Ab [Units/volume] in Body fluid |
| 18477-0 | Lithium [Moles/time] in 24 hour Urine |
| 18996-9 | Tobramycin [Susceptibility] |
| 90434-2 | Microorganism preliminary growth [Presence] in Platelets from Blood product unit by Aerobe culture |
| 91139-6 | Thiopurine methyltransferase activity panel - Red Blood Cells |
| 75067-9 | Indole-3-Acetate [Moles/volume] in Serum or Plasma |
| 75598-3 | Fetal 1p36 deletion prior risk [Likelihood] based on general population risk |
| 60410-8 | Tuna IgG Ab [Mass/volume] in Serum |
| 61051-9 | Nordiazepam [Presence] in Specimen |
| 76623-8 | Mitochondrial respiratory chain enzyme analysis panel - Fibroblast |
| 93436-4 | Busulfan [Mass/volume] in Plasma --immediately post busulfan infusion completion |
| 6181-2 | Mouse urine proteins IgE Ab [Units/volume] in Serum |
| 6282-8 | Eastern White Pine IgE Ab [Units/volume] in Serum |
| 63283-6 | Mitochondria M2 Ab [Presence] in Serum by Immunoassay |
| 78-6 | ceFAZolin [Susceptibility] by Serum bactericidal titer |
| 79244-0 | Ethylone cutoff [Mass/volume] in Urine for Confirmatory method |
| 65318-8 | At sup(a) Ab [Presence] in Serum or Plasma |
| 8004-4 | Rickettsia rickettsii IgM Ab [Units/volume] in Serum |
| 81246-1 | HIV 2 RNA panel - Serum or Plasma by NAA with probe detection |
| 81284-2 | Malignant cells/100 cells in Bronchoalveolar lavage by Manual count |
| 96590-5 | Creatinine [Mass/volume] in DBS |
| 97195-2 | Phenytoin [Moles/volume] in Serum or Plasma --trough |
| 8218-0 | Opiates [Presence] in Serum or Plasma by Confirmatory method |
| 97546-6 | Base excess in Central venous blood by calculation |
| 97911-2 | Endogenous thrombin potential [Area under the curve] in Platelet poor plasma by Chromogenic method --after addition of factor VIII Ab |
| 97912-0 | Thrombin peak [Molar amount] in Platelet poor plasma by Chromogenic method |
| 82515-8 | NBN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 98108-4 | Chemokine (C-C motif) ligand 11 [Mass/volume] in Serum or Plasma |
| 7187-8 | Catfish IgE Ab [Units/volume] in Serum |
| 72412-0 | BK virus subtype in Urine by NAA with probe detection |
| 84883-8 | Deepest extent of tumor invasion [Type] in Colorectal cancer specimen |
| 85751-6 | Streptococcus pneumoniae Danish serotype 16F DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 72568-9 | Cholinesterase.fluoride inhibited/Cholinesterase [Pure catalytic fraction] in Serum or Plasma |
| 85783-9 | Candida krusei DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 86538-6 | Hantavirus RNA [Presence] in Urine by NAA with probe detection |
| 73565-4 | Trenbolone [Presence] in Urine |
| 88205-0 | Lymphocytic choriomeningitis virus IgM Ab [Presence] in Serum by Immunoassay |
| 89043-4 | Zopiclone-N-oxide [Mass/volume] in Urine |
| 41259-3 | Western equine encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid |
| 41639-6 | Ricin toxin IgM Ab [Presence] in Serum by Immunofluorescence |
| 5103-7 | Coxsackievirus B1 neutralizing antibody [Titer] in Serum by Neutralization test |
| 30482-4 | Suberylglycine [Presence] in Urine |
| 42515-7 | Jamestown canyon virus RNA [Presence] in Urine by NAA with probe detection |
| 60197-1 | Triclopyr [Mass/volume] in Serum or Plasma |
| 21288-6 | Gastrin [Mass/volume] in Serum or Plasma --2.5 hours post 0.2 U/kg secretin |
| 3129-4 | Menadione [Mass/volume] in Serum or Plasma |
| 31400-5 | Ganglioside GD1b Ab [Presence] in Serum |
| 31473-2 | Legionella pneumophila atypical Ab [Units/volume] in Serum |
| 31607-5 | Orientia tsutsugamushi Gilliam Ab [Units/volume] in Serum |
| 51198-0 | Manganese [Mass/volume] in Body fluid |
| 42730-2 | Cardiolipin IgA Ab B2GP1 independent [Multiple of the median] in Serum |
| 43027-2 | Herpes simplex virus 2 IgM Ab [Titer] in Body fluid |
| 43057-9 | Chlamydophila psittaci IgM Ab [Titer] in Cerebral spinal fluid |
| 21776-0 | t(1;19)(q23.3;p13.3)(PBX1,TCF3) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 22249-7 | Cytomegalovirus IgM Ab [Titer] in Serum or Plasma |
| 31987-1 | Western equine encephalitis virus Ag [Presence] in Serum |
| 51507-2 | Creatine kinase.MM [Enzymatic activity/volume] in Cerebral spinal fluid by Electrophoresis |
| 5173-0 | Streptococcus pyogenes enzyme Ab [Titer] in Serum by Latex agglutination |
| 51735-9 | Urea nitrogen renal clearance in 24 hour Urine and Serum or Plasma |
| 43283-1 | Myeloid cells/100 cells in Tissue |
| 22393-3 | Legionella pneumophila 7 Ab [Titer] in Serum |
| 22474-1 | Rickettsia spotted fever group Ab [Presence] in Serum |
| 32157-0 | Calcium oxalate/Total in Stone |
| 53060-0 | Butyrylcarnitine (C4) [Moles/volume] in Amniotic fluid |
| 43902-6 | Azinphos-methyl [Presence] in Blood |
| 4407-3 | Primidone [Mass] of Dose |
| 33007-6 | Protoporphyrin.zinc [Mass/volume] in Blood |
| 44736-7 | Asialoganglioside GM1 Ab [Presence] in Serum by Immunoassay |
| 2346-5 | Glucose [Mass/volume] in Pleural fluid |
| 24141-4 | Rough Marsh Elder IgG Ab [Units/volume] in Serum |
| 3432-2 | carBAMazepine [Mass/volume] in Serum or Plasma |
| 34684-1 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor XIII depleted plasma |
| 25462-3 | Lithium [Moles/volume] in Red Blood Cells |
| 35128-8 | Perforin [Units/volume] in Leukocytes |
| 5566-5 | Acetone [Presence] in Exhaled gas |
| 47806-5 | Xylose [Presence] in Urine |
| 25760-0 | Insulin-like growth factor [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge |
| 25886-3 | Creatinine [Moles/volume] in 24 hour Urine |
| 35841-6 | Streptomycin.high potency [Susceptibility] by Gradient strip |
| 3645-9 | FLUoxetine [Presence] in Urine |
| 3740-8 | Medazepam [Mass/volume] in Urine |
| 56581-2 | Insulin [Units/volume] in Serum or Plasma --12 minutes post XXX challenge |
| 48561-5 | Bacteria # 2 identified in Specimen by Respiratory culture |
| 48678-7 | P57 Ag [Presence] in Tissue by Immune stain |
| 48859-3 | Rickettsia akari IgG Ab [Titer] in Serum by Immunofluorescence |
| 38344-8 | Trichloroethylene [Mass/volume] in Water |
| 38536-9 | MLH1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 3877-8 | Ofloxacin [Mass/volume] in Serum or Plasma |
| 58369-0 | Temazepam/Creatinine [Mass Ratio] in Urine |
| 49455-9 | Varicella zoster virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
| 49633-1 | Ethanolamine [Presence] in Urine |
| 58931-7 | Mycobacterium tuberculosis DNA [Presence] in Body fluid by NAA with probe detection |
| 59210-5 | Inosine/Creatinine [Molar ratio] in Urine |
| 50463-9 | C peptide [Moles/volume] in Serum or Plasma --3rd specimen |
| 19425-8 | Dextromethamphetamine [Mass/volume] in Urine by Confirmatory method |
| 19623-8 | Nitrazepam cutoff [Mass/volume] in Urine for Confirmatory method |
| 20566-6 | Colony count [#/volume] in Catheter tip by Culture |
| 12382-8 | Temazepam [Mass/volume] in Urine |
| 101634-4 | HBB gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
| 13271-2 | Neisseria meningitidis serogroup A Ab [Units/volume] in Serum |
| 102052-8 | 1-Deoxysphingosine [Mass/volume] in Serum by LC/MS/MS |
| 103097-2 | Latex recombinant (rHev b) 9 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103179-8 | Haemophilus ducreyi DNA [Presence] in Urine by NAA with probe detection |
| 14837-9 | Methsuximide [Moles/volume] in Serum or Plasma |
| 15036-7 | Catecholamines [Moles/time] in 24 hour Urine |
| 1510-7 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
| 16141-4 | Nitrogen [Mass/time] in 24 hour Stool |
| 12223-4 | Human papilloma virus 16+18 Ag [Presence] in Genital specimen |
| 17257-7 | Mesothelial cells [Presence] in Body fluid by Light microscopy |
| 17824-4 | CD3+CD8+ (T8 suppressor) cells/100 cells in Body fluid |
| 18236-0 | Lead [Presence] in Tissue |
| 19134-6 | Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 91045-5 | Methamphetamine+Methylenedioxymethamphetamine [Presence] in Hair by Screen method |
| 92478-7 | VS Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 61091-5 | Temazepam [Presence] in Gastric fluid |
| 6159-8 | Lemon IgE Ab [Units/volume] in Serum |
| 622-1 | Bacteria identified in Sputum by Aerobe culture |
| 78786-1 | Amitriptyline [Mass/volume] in Blood |
| 94701-0 | Movement disorder autoimmune Ab panel - Serum or Plasma |
| 6392-5 | Echovirus 30 Ab [Titer] in Serum by Complement fixation |
| 66148-8 | Mononuclear cells/100 leukocytes in Pleural fluid from Fetus by Manual count |
| 668-4 | Microscopic observation [Identifier] in Specimen by M'Fadyean stain |
| 6691-0 | Loxapine+8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma |
| 95697-9 | Snowshoe hare virus IgA Ab [Presence] in Specimen by Immunoassay |
| 80620-8 | Zika virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 808-6 | Leukocytes [#/volume] in Pleural fluid by Manual count |
| 966-2 | C sup(x) Ag [Presence] on Red Blood Cells |
| 96652-3 | HLA-DQA1 [Type] in Donor by High resolution |
| 96706-7 | Clot stiffness.platelet contribution (elasticity) in Blood by calculation |
| 97178-8 | Yersinia outer protein P Ab [Presence] in Serum by Line blot |
| 70065-8 | Enterovirus Ag [Presence] in Stool by Immunoassay |
| 82094-4 | Occupational Allergen Mix 6 (Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 974-6 | D Ab [Presence] in Serum or Plasma from Donor |
| 97746-2 | Alpha-1-Fetoprotein [Mass/volume] in Aspirate |
| 97867-6 | Chikungunya virus IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 7134-0 | Mung Bean IgG Ab [Units/volume] in Serum |
| 82853-3 | Prenanediolone+pregnanetriol/Androsterone+etiocholanolone [Molar ratio] in Urine |
| 98198-5 | Erythrosine B IgE Ab [Units/volume] in Serum |
| 9837-6 | HIV 1 proviral DNA [Presence] in Blood by Probe with amplification |
| 85269-9 | X-linked adrenoleukodystrophy newborn screen interpretation |
| 72824-6 | Del(17)(p13) [Identifier] in Blood or Tissue by FISH Nominal |
| 72889-9 | Progesterone Free [Mass/volume] in Serum or Plasma |
| 86334-0 | Adenovirus B(3) DNA [Presence] in Specimen by NAA with probe detection |
| 7301-5 | White Elm triggered histamine release [Units/volume] in Blood |
| 87423-0 | Borrelia burgdorferi IgG and IgM panel - Cerebral spinal fluid by Immunoblot |
| 87602-9 | Bambermycins [Mass/mass] in Specimen |
| 88912-1 | Taenia solium larva DNA [Presence] in Blood by NAA with probe detection |
| 4139-2 | Benzfetamine [Mass] of Dose |
| 41661-0 | Azlocillin [Susceptibility] by Gradient strip |
| 41729-5 | cefoTEtan+Clavulanate [Susceptibility] |
| 59826-8 | Creatinine [Moles/volume] in Blood |
| 50631-1 | Cefepime [Susceptibility] by Method for Slow-growing mycobacteria |
| 51024-8 | Cytoplasmic CD117 blasts/100 cells in Specimen |
| 30550-8 | Pristanate (C15:0(CH3)4)/Phytanate (C16:0(CH3)4) [Molar ratio] in Serum or Plasma |
| 30572-2 | Pyridoxal [Mass/volume] in Serum or Plasma |
| 42588-4 | Bordetella parapertussis DNA [Presence] in Nasopharynx by NAA with probe detection |
| 21199-5 | Chromium [Mass/volume] in Body fluid |
| 31249-6 | Bartonella henselae Ab [Units/volume] in Serum |
| 31285-0 | Canine distemper virus Ab [Presence] in Serum |
| 3128-6 | Viscosity of Serum |
| 31382-5 | Escherichia coli verotoxin 2 Ab [Units/volume] in Stool |
| 31-5 | Ampicillin+Sulbactam [Susceptibility] by Minimum lethal concentration (MLC) |
| 43021-5 | Herpes virus 8 IgG Ab [Units/volume] in Serum |
| 43040-5 | Echovirus 30 Ab [Titer] in Body fluid |
| 22310-7 | Helicobacter pylori Ab [Presence] in Serum |
| 31674-5 | Ganglioside GQ1b Ab [Units/volume] in Serum |
| 31911-1 | Neisseria meningitidis Ag [Units/volume] in Cerebral spinal fluid |
| 4325-7 | Methoxyphenamine [Mass] of Dose |
| 4350-5 | Nicotine [Mass] of Dose |
| 43708-7 | Alkaline phosphatase.liver+bone [Presence] in Serum or Plasma |
| 2232-7 | EPINEPHrine [Mass/time] in 24 hour Urine |
| 32555-5 | Urate [Molar amount] in Urine collected for unspecified duration |
| 5234-0 | Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoassay |
| 23049-0 | Eastern equine encephalitis virus Ag [Presence] in Specimen by Complement fixation |
| 23052-4 | Eastern equine encephalitis virus RNA [Presence] in Tissue by Probe |
| 4453-7 | Trimeperidine [Mass] of Dose |
| 44628-6 | Reason specimen size cannot be determined in Breast tumor |
| 23370-0 | PRRSV Ag [Presence] in Tissue by Immune stain |
| 23483-1 | Theileria sp [Presence] in Tissue by Giemsa stain |
| 2358-0 | Glucose-6-Phosphate dehydrogenase [Presence] in Serum |
| 23591-1 | Western equine encephalitis virus Ag [Presence] in Specimen by Complement fixation |
| 3330-8 | Amiodarone [Mass/volume] in Serum or Plasma |
| 5388-4 | Toxoplasma gondii IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 2385-3 | Glycerate [Mass/volume] in Serum |
| 23967-3 | Chlamydia sp Ab [Titer] in Cerebral spinal fluid |
| 34293-1 | Estriol (E3)/Creatinine [Molar ratio] in Urine |
| 34343-4 | Nickel [Moles/volume] in Urine |
| 34451-5 | Herpes simplex virus DNA [Presence] in Blood by NAA with probe detection |
| 34533-0 | Odor of Urine |
| 55308-1 | Yeast.pseudohyphae [Presence] in Specimen by KOH preparation |
| 55320-6 | Yeast [Presence] in Bronchial specimen by KOH preparation |
| 47148-2 | EPINEPHrine [Moles/volume] in Urine --5th specimen post XXX challenge |
| 34894-6 | Akabane virus Ab [Titer] in Serum |
| 47521-0 | Cytology report of Breast fine needle aspirate Cyto stain |
| 47800-8 | Valine/Amino acids.total in Hair |
| 25665-1 | Glucose [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
| 56343-7 | Papaya (Carica papaya) IgG4 Ab [Mass/volume] in Serum |
| 47997-2 | Genetic variant clinical significance [Interpretation] in Blood or Tissue by Molecular genetics method |
| 56993-9 | Tryptophan/Creatinine [Ratio] in 24 hour Urine |
| 27059-5 | traZODone [Mass/volume] in Urine |
| 48996-3 | Amylase.pancreatic [Enzymatic activity/volume] in Body fluid |
| 49267-8 | Glutathione reductase phenotype [Interpretation] in Red Blood Cells Narrative |
| 27868-9 | Follitropin [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 2866-2 | Alpha 1 globulin [Mass/volume] in Synovial fluid by Electrophoresis |
| 29277-1 | Carbon disulfide [Presence] in Blood |
| 40003-6 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 4006-3 | Pyrilamine [Mass/volume] in Blood |
| 58584-4 | Corticotropin [Moles/volume] in Plasma --30 minutes post dose glucose |
| 49979-8 | Borrelia burgdorferi 35kD IgM Ab [Presence] in Serum by Immunoblot |
| 29905-7 | Entamoeba histolytica Ag [Presence] in Stool by Immunoassay |
| 40412-9 | Barbiturates [Presence] in Meconium |
| 40561-3 | Cytokeratin Cam5.2 Ag [Presence] in Tissue by Immune stain |
| 40613-2 | Brucella sp Ab [Presence] in Serum by Complement fixation |
| 30299-2 | Amprenavir [Susceptibility] |
| 12367-9 | Mesoridazine [Presence] in Urine |
| 12610-2 | Glucose [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 12830-6 | Prolactin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 101490-1 | Piperacillin [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 13063-3 | Drug induced platelet Ab [Units/volume] in Serum |
| 102429-8 | Maple sugar IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13981-6 | Alpha 2 globulin/Protein.total in Serum or Plasma by Electrophoresis |
| 103182-2 | Human papilloma virus 16 DNA [Presence] in Urine by NAA with probe detection |
| 15004-5 | 11-Hydroxyetiocholanolone [Moles/time] in 24 hour Urine |
| 104337-1 | Borna disease virus RNA [Presence] in Brain tissue by NAA with probe detection |
| 16139-8 | Neuronal nuclear Ab [Titer] in Cerebral spinal fluid |
| 16391-5 | Antimony [Presence] in Urine |
| 16681-9 | Coxsackievirus A IgM Ab [Units/volume] in Serum |
| 16684-3 | Coxsackievirus B Ab [Units/volume] in Serum |
| 17321-1 | Neisseria meningitidis serogroups A+Y Ag [Presence] in Urine |
| 17947-3 | Fungus # 2 identified in Specimen by Culture |
| 18974-6 | rifAMPin [Susceptibility] |
| 74535-6 | Neisseria meningitidis serogroup X DNA [Presence] in Specimen by NAA with probe detection |
| 91836-7 | Giardia sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 92641-0 | diphenhydrAMINE [Mass/volume] in Urine by Confirmatory method |
| 75358-2 | Bacteria identified in Bone by Anaerobe+Aerobe culture |
| 6194-5 | Orange IgE Ab [Units/volume] in Serum |
| 62302-5 | Lysosomal storage disorders suspected [Identifier] in DBS |
| 62377-7 | Chromosome copy number change panel |
| 93795-3 | NOP56 gene GGCCTG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 93877-9 | N-Nervonoylsphingosine/N-Lignoceroylsphingosine [Molar ratio] in Plasma |
| 78961-0 | IgG clearance/Albumin clearance [Ratio] in Urine and Serum or Plasma |
| 79233-3 | Naphyrone cutoff [Mass/volume] in Urine for Confirmatory method |
| 79265-5 | Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid --overnight dwell |
| 7947-5 | Legionella pneumophila Ab [Presence] in Serum |
| 9521-6 | Entamoeba histolytica IgA Ab [Units/volume] in Serum by Immunoassay |
| 95540-1 | Carbapenem resistance blaIMP+blaVIM genes [Presence] by Molecular method |
| 66877-2 | Skin Ab pattern [Interpretation] in Serum |
| 66881-4 | Skin IgG Ab [Presence] in Serum by Monkey esophagus substrate |
| 6795-9 | Alpha 2 globulin [Mass/time] in 24 hour Urine by Electrophoresis |
| 69576-7 | Campylobacter fetus Ab [Presence] in Serum |
| 82085-2 | Mold Allergen Mix 4 (Aspergillus fumigatus+Aspergillus niger+Aspergillus terreus+Aspergillus flavus) IgE Ab [Units/volume] in Serum by Multidisk |
| 97254-7 | HYDROcodone Free [Presence] in Cord tissue by Screen method |
| 97648-0 | Iloperidone [Presence] in Urine by Confirmatory method |
| 8256-0 | Service comment 14 |
| 7234-8 | Clove IgE Ab [Units/volume] in Serum |
| 84888-7 | Intramural vein invasion [Presence] in Colorectal cancer specimen by Light microscopy |
| 99462-4 | Sugar Beet Seed (Beta vulgaris seed) IgG Ab [Mass/volume] in Serum |
| 85825-8 | Carbapenem resistance blaOXA-23-like gene [Presence] by Molecular method |
| 72989-7 | Metoprolol induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73138-0 | sulfaSALAzine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73154-7 | Sertraline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86722-6 | Actinobacillus suis DNA [Presence] in Specimen by NAA with probe detection |
| 87480-0 | Bone ash/Bone.total in Bone |
| 73395-6 | Erythromycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73443-4 | Citalopram induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73863-3 | Allo-tetrahydrocortisol [Moles/volume] in Urine |
| 73908-6 | Alloisoleucine/Creatinine [Ratio] in Urine |
| 7398-1 | Hemp IgE Ab [Units/volume] in Serum |
| 41198-3 | Walnut IgE Ab/IgE total in Serum |
| 42523-1 | Molindone [Mass/volume] in Urine |
| 21107-8 | Bendiocarb [Mass/volume] in Urine |
| 21666-3 | EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 31295-9 | Chlamydia trachomatis B IgM Ab [Units/volume] in Serum |
| 51252-5 | CD15 cells/100 cells in Body fluid |
| 51282-2 | CD3+CD57+ cells/100 cells in Tissue |
| 42743-5 | Phosphatidylcholine IgM Ab B2GP1 dependent [Multiple of the median] in Serum |
| 31687-7 | Trichinella sp IgM Ab [Units/volume] in Serum |
| 5152-4 | Epidermis Ab [Titer] in Serum by Immunofluorescence |
| 43304-5 | Chlamydia trachomatis rRNA [Presence] in Specimen by NAA with probe detection |
| 43676-6 | Fatty acid essential (C12-C22) panel - Serum or Plasma |
| 3210-2 | Coagulation factor VIII activity [Units/volume] in Platelet poor plasma by Chromogenic method |
| 32497-0 | CD57 cells/100 cells in Bone marrow |
| 32567-0 | Candida albicans reaction wheal [Diameter] --2 days post 50 ug Candida albicans intradermal |
| 53027-9 | Cyclic citrullinated peptide Ab [Units/volume] in Serum |
| 32654-6 | 6-Methylmercaptopurine [Entitic substance] in Red Blood Cells |
| 53300-0 | Leucine crystals [#/volume] in Urine by Computer assisted method |
| 44643-5 | Gleason pattern.tertiary in Prostate tumor |
| 33261-9 | Thyrotropin [Units/volume] in Serum or Plasma --2 hours post dose TRH |
| 33273-4 | 3-Methylglutaconate [Moles/volume] in Serum or Plasma |
| 33599-2 | Amylase [Enzymatic activity/volume] in Urine collected for unspecified duration |
| 44999-1 | Chlamydia trachomatis IgM Ab [Presence] in Cerebral spinal fluid |
| 45331-6 | NF1 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
| 33740-2 | Venous.large vessel.invasion [Identifier] in Specimen by CAP cancer protocols |
| 3378-7 | Bendroflumethiazide [Presence] in Urine |
| 33966-3 | SARS coronavirus Urbani RNA [Presence] in Nose by NAA with probe detection |
| 53992-4 | Nucleolar nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
| 46982-5 | Liver kidney microsomal IgG Ab [Titer] in Serum by Immunofluorescence |
| 34416-8 | Nucleosome Ab [Units/volume] in Serum by Immunoassay |
| 34455-6 | La Crosse virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 25211-4 | Capreomycin 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25241-1 | Cefpodoxime [Mass/volume] in Specimen |
| 48132-5 | Xylitol/Creatinine [Molar ratio] in Urine |
| 4816-5 | HLA-B18 [Presence] in Donor |
| 48199-4 | Ampicillin triggered leukotriene release [Mass/volume] by Leukocytes |
| 48575-5 | Hepatitis C virus genotype [Identifier] in Specimen by NAA with probe detection |
| 48707-4 | Hemoglobin C crystals [Presence] in Red Blood Cells by Light microscopy |
| 48795-9 | Fibrosis score |
| 26944-9 | 11-Ketoandrosterone [Mass/volume] in Urine |
| 57640-5 | Androsterone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
| 49070-6 | Specimen drawn [Date and time] of Cerebral spinal fluid |
| 49123-3 | Bartonella sp identified in Specimen by Sequencing |
| 27812-7 | Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay |
| 40038-2 | Glucose [Mass/volume] in Serum or Plasma --26 hours post XXX challenge |
| 50017-3 | Hemoglobin.gastrointestinal [Presence] in Sputum or Gastric fluid |
| 29581-6 | Differential panel - Peritoneal fluid |
| 58919-2 | Androstenedione [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 50299-7 | 4-Hydroxyifosfamide [Mass/volume] in Blood --6 hours post dose ifosfamide |
| 30236-4 | 3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in Serum or Plasma |
| 40877-3 | CPT2 gene p.Pro50His+Ser113Leu [Presence] in Blood or Tissue by Molecular genetics method |
| 19218-7 | Oxygen content in Arterial blood |
| 20526-0 | Dimetamphetamine [Mass/volume] in Urine by Confirmatory method |
| 20895-9 | Mycoplasma gallisepticum Ag [Presence] in Tissue by Immune stain |
| 100148-6 | Schistosoma sp Ab bands panel - Serum by Immunoblot |
| 101405-9 | Amyloid protein in Tissue Document |
| 129-7 | Cefsulodin [Susceptibility] by Disk diffusion (KB) |
| 12971-8 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen |
| 13041-9 | C peptide [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 102054-4 | 1-deoxymethylsphingosine [Mass/volume] in Serum by LC/MS/MS |
| 102072-6 | 2-N-Methyl-perfluorooctanesulfonamide acetate [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 102430-6 | Mare milk IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102587-3 | Scallop IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14185-3 | methIMAzole [Mass/volume] in Serum or Plasma |
| 14228-1 | Cells.estrogen receptor/100 cells in Tissue by Immune stain |
| 102915-6 | Cladosporium cladosporioides IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10396-0 | Factor VIII given [Volume] |
| 15081-3 | Prolactin [Units/volume] in Serum or Plasma |
| 15173-8 | Cryoglobulin.IgM [Units/volume] in Serum |
| 104320-7 | Burst forming unit erythroid [#/mass] in Blood |
| 104376-9 | Diphtheria toxin DNA [Presence] in Specimen by NAA with probe detection |
| 10497-6 | Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain |
| 16103-4 | Porcine Gelatin IgE Ab [Units/volume] in Serum |
| 17024-1 | Iodine.inorganic [Mass/volume] in Serum or Plasma |
| 17215-5 | CV lymphocytes/100 lymphocytes in Blood |
| 17357-5 | Neutrophil cytoplasmic Ab.perinuclear [Presence] in Serum by Immunofluorescence |
| 1776-4 | Alkaline phosphatase [Mass/volume] in Urine |
| 18201-4 | Borrelia burgdorferi IgA Ab [Presence] in Serum by Immunoblot |
| 90277-5 | Bacteria identified in Peritoneal dialysis fluid by Anaerobe culture |
| 90446-6 | Pseudoephedrine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 92529-7 | little c Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 93751-6 | Atypical porcine pestivirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 62440-3 | Nucleated erythrocytes/100 leukocytes [Ratio] in Body fluid by Automated count |
| 63209-1 | English plantain IgG Ab [Mass/volume] in Serum |
| 63268-7 | Keratin Ab [Presence] in Serum by Immunofluorescence |
| 63298-4 | Nucleosome Ab [Presence] in Body fluid by Immunoassay |
| 7834-5 | Coxsackievirus A7 Ab [Units/volume] in Serum |
| 78689-7 | Adenylosuccinate/Creatinine [Molar ratio] in Urine |
| 63554-0 | Leukocytes in 24 hour Urine sediment by Microscopy |
| 644-5 | Microscopic observation [Identifier] in Skin by KOH preparation |
| 79488-3 | 3,4-Dihydroxybutyrate [Moles/volume] in Serum or Plasma |
| 6539-1 | Rabies virus identified in Specimen by Organism specific culture |
| 6594-6 | Amoeba identified in Specimen by Organism specific culture |
| 95797-7 | Norfentanyl [Presence] in Urine by Screen method |
| 95826-4 | SARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detection |
| 9650-3 | Methyclothiazide [Mass/volume] in Urine |
| 80544-0 | Nortriptyline [Mass/volume] in DBS |
| 97019-4 | Maximum amplitude ADP induced [Length] in Blood |
| 97190-3 | carBAMazepine [Mass/volume] in Serum or Plasma --peak |
| 81812-0 | TPP1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 97853-6 | Anticomplementary activity [Titer] in Specimen by Complement fixation |
| 9796-4 | Color of Stone |
| 71650-6 | Segmented neutrophils/Leukocytes [Pure number fraction] in Body fluid by Manual count |
| 98262-9 | Distance of tumor from cervical resection margins [Length] in Endometrial cancer specimen |
| 83109-9 | Progesterone [Mass/volume] in Serum or Plasma by Immunoassay |
| 84927-3 | Glial nuclear type 1 Ab [Presence] in Serum by Immunofluorescence |
| 72586-1 | Beta globulin/Protein.total [Pure mass fraction] in Serum or Plasma by Electrophoresis |
| 86592-3 | Varicella zoster virus Ag [Presence] in Tissue by Immunofluorescence |
| 73266-9 | Milrinone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73404-6 | Doxazosin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88208-4 | Parainfluenza virus 1 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 7399-9 | Hemp fiber IgE Ab [Units/volume] in Serum |
| 88703-4 | Bedaquiline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 41620-6 | Xylose [Moles/volume] in Urine --5 hours post 5 g xylose PO |
| 59340-0 | Stiripentol [Mass/volume] in Serum or Plasma |
| 59391-3 | Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum |
| 30455-0 | Neutrophils/100 leukocytes in Pleural fluid |
| 42340-0 | HTLV I p42 Ab [Presence] in Serum by Immunoblot |
| 42371-5 | Neisseria meningitidis serogroup C Ag [Presence] in Isolate by Agglutination |
| 42539-7 | Hydroxyperhexiline/Perhexiline [Mass Ratio] in Serum or Plasma |
| 59962-1 | Propranolol [Moles/volume] in Gastric fluid |
| 21307-4 | Glucose [Mass/time] in 10 hour Urine |
| 51130-3 | CD23 blasts/100 blasts in Bone marrow |
| 22173-9 | Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid |
| 318-6 | Methacycline [Susceptibility] by Minimum lethal concentration (MLC) |
| 51586-6 | Other cells/100 leukocytes in Blood by Manual count |
| 22419-6 | Mumps virus IgM Ab [Titer] in Cerebral spinal fluid |
| 22601-9 | Varicella zoster virus IgG Ab [Titer] in Cerebral spinal fluid |
| 32137-2 | Calcium phosphate/Total in Stone |
| 32370-9 | West Nile virus RNA [Presence] in Tissue by NAA with probe detection |
| 32376-6 | Clinafloxacin [Susceptibility] |
| 51974-4 | Gas panel - Arterial cord blood |
| 52873-7 | CD1a cells/100 cells in Body fluid |
| 4405-7 | Practolol [Mass] of Dose |
| 32793-2 | Parvovirus B19 IgG Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen |
| 44626-0 | Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols |
| 33462-3 | Hepatitis C virus IgG Ab [Presence] in Serum by Immunoblot |
| 3420-7 | Butalbital [Presence] in Serum or Plasma |
| 53963-5 | Blood [Presence] in Urine by Visual |
| 54025-2 | Nuclear pore protein gp210 Ab [Presence] in Serum |
| 54405-6 | Transfuse pooled cryoprecipitate units [#] |
| 24244-6 | Polio virus 1 Ab [Titer] in Serum --2nd specimen |
| 24480-6 | Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab [Units/volume] in Serum by Multidisk |
| 34691-6 | Erythroamino alcohol [Mass/volume] in Serum or Plasma |
| 55377-6 | Mononuclear cells immature/100 leukocytes in Blood by Manual count |
| 55548-2 | metFORMIN [Moles/volume] in Serum or Plasma |
| 47188-8 | Progesterone [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 55646-4 | Cephradine [Susceptibility] by Gradient strip |
| 55958-3 | Oleoylcarnitine (C18:1) [Moles/volume] in Urine |
| 56134-0 | Cholesterol in IDL 1 [Moles/volume] in Serum or Plasma |
| 3562-6 | Digoxin Free [Mass/volume] in Serum or Plasma |
| 2604-7 | Mannitol renal clearance in 24 hour Urine and Serum or Plasma |
| 26739-3 | Xylose [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 3662-4 | Furosemide [Mass/time] in 24 hour Urine |
| 27104-9 | Glutamate [Moles/volume] in Amniotic fluid |
| 38295-2 | Methylene chloride [Mass/volume] in Water |
| 38555-9 | Spermatozoa.head Motile w IgG/100 spermatozoa in Semen by Immunobead |
| 3858-8 | Nitrazepam [Mass/volume] in Serum or Plasma |
| 573-6 | Fungus identified in Nail by Culture |
| 5754-7 | Vanadium [Mass/mass] in Hair |
| 48911-2 | Rickettsia prowazekii IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 2730-0 | Parathyrin.C-terminal [Mass/volume] in Serum or Plasma |
| 3942-0 | Pheniramine [Mass/volume] in Serum or Plasma |
| 39593-9 | Coconut IgE Ab/IgE total in Serum |
| 57931-8 | CFTR+PRSS1+SPINK1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 5819-8 | Waxy casts [#/area] in Urine sediment by Microscopy low power field |
| 49527-5 | Influenza virus A H7 RNA [Presence] in Isolate by NAA with probe detection |
| 58456-5 | Bladder cells [Presence] in Urine sediment by Light microscopy |
| 49841-0 | CD19+IgM+ cells/100 cells in Specimen |
| 40405-3 | Urea [Moles/time] in 24 hour Dialysis fluid |
| 59046-3 | FGB gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 20489-1 | Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid |
| 20866-0 | Lactobacillus acidophilus colony count [#/volume] in Milk by Organism specific culture |
| 101079-2 | DAK Ab [Presence] in Serum or Plasma |
| 101433-1 | Bacterial vaginosis score in Vaginal fluid Qualitative by Nugent |
| 13300-9 | HLA-A+B [Type] |
| 102284-7 | Duck feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102453-8 | Mouse urine proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103031-1 | Shrimp tropomyosin recombinant (rPen a) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14404-8 | Phosphate [Mass/volume] in Pleural fluid |
| 103565-8 | HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hep C RNA+Hep B DNA+Hep E RNA [Presence] in Serum, Plasma or Blood from Donor by NAA with probe detection |
| 15501-0 | Pseudorabies virus Herdcheck gene deletion Ab [Presence] in Serum by Immunoassay |
| 10733-4 | Trypanosoma sp identified in Blood by Wet preparation |
| 10872-0 | Xylose [Mass/volume] in Blood --baseline |
| 16472-3 | Blastomyces dermatitidis rRNA [Presence] in Serum by Probe |
| 16489-7 | Brucella melitensis Ab [Units/volume] in Serum by Latex agglutination |
| 17561-2 | Salmon roe IgE Ab [Units/volume] in Serum |
| 90294-0 | MMP-9 Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 74858-2 | Hepatitis E virus genotypes 1+2+3+4 RNA [Presence] in Serum or Plasma from Donor by NAA with probe detection |
| 92752-5 | Glucopsychosine [Moles/volume] in DBS |
| 75265-9 | Blood group antibody screen [Presence] in Serum or Plasma by Polyethylene glycol (PEG) method |
| 60383-7 | Lobster IgG Ab [Mass/volume] in Serum |
| 92949-7 | Streptococcus pneumoniae DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection |
| 92976-0 | Influenza virus B RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 93362-2 | Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC) |
| 93984-3 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --45 minutes post dose carbohydrate |
| 63224-0 | DNA double strand IgG Ab [Presence] in Body fluid by Immunoassay |
| 94348-0 | Voltage-gated calcium channel N type binding IgG+IgM Ab [Moles/volume] in Serum by Immunoassay |
| 79264-8 | Glucose [Moles/volume] in Peritoneal dialysis fluid --overnight dwell |
| 79416-4 | MLH1 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
| 7949-1 | Legionella pneumophila 2 Ab [Titer] in Serum by Immunofluorescence |
| 80117-5 | 7-Aminoflunitrazepam [Mass/volume] in Body fluid by Confirmatory method |
| 67833-4 | Lymphocytes [#/volume] in Pleural fluid from Fetus |
| 80982-2 | Phytanoyl CoA hydroxlase [Enzymatic activity/mass] in Fibroblast |
| 96794-3 | Hardwood Mix (Oak+Mahogany+West Red Cedar+Abachi) IgE Ab [Units/volume] in Serum by Multidisk |
| 8180-2 | Chlorobenzene [Mass/volume] in Blood |
| 8187-7 | Benzoylecgonine [Presence] in Meconium |
| 82252-8 | Constitutive heterochromatin analysis in Blood or Tissue by Banding |
| 82724-6 | Natural killer cell cytotoxicity.3.13:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
| 82798-0 | Clot formation lag time in Platelet poor plasma |
| 98231-4 | Sorbic acid IgE Ab [Units/volume] in Serum |
| 71771-0 | Marburg virus IgM Ab [Presence] in Serum by Immunoassay |
| 99889-8 | Crystal casts [#/area] in Urine sediment by Computer assisted method |
| 72737-0 | Cocaine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 72941-8 | Terazosin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73364-2 | Gentamicin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73483-0 | Carisoprodol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73560-5 | Mumps virus IgG and IgM [Interpretation] in Serum |
| 88180-5 | Wuchereria bancrofti+Brugia malayi IgG3 Ab [Presence] in Serum by Immunoassay |
| 88199-5 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Aspirate by NAA with probe detection |
| 89312-3 | CD3+CD45+ cells [#/volume] in Blood |
| 59421-8 | Neisseria meningitidis serogroups A+B+C+w135+Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 59567-8 | Netilmicin [Moles/volume] in Serum or Plasma --peak |
| 51017-2 | CD1 blasts [Units/volume] in Specimen |
| 30479-0 | Methylsuccinate [Presence] in Urine |
| 42587-6 | BK virus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection |
| 42602-3 | Tropheryma whipplei DNA [Presence] in Blood by NAA with probe detection |
| 60160-9 | Perphenazine [Mass/volume] in Blood |
| 60189-8 | Tin [Mass/mass] in Nail |
| 51066-9 | CD13 blasts [Units/volume] in Bone marrow |
| 51119-6 | Cytoplasmic CD22 blasts/100 blasts in Blood |
| 31829-5 | Francisella tularensis Ag [Presence] in Specimen |
| 32039-0 | Polymorphonuclear cells [Presence] in Synovial fluid by Wright stain |
| 51634-4 | Reticulocytes.mid [#/volume] in Blood |
| 43426-6 | Bacteria identified in Nasopharynx by Aerobe culture |
| 43580-0 | Complement C4 [Mass/volume] in Pericardial fluid |
| 22425-3 | Mycoplasma pneumoniae Ab [Titer] in Serum |
| 32516-7 | CD3+CD4+ (T4 helper) cells/100 cells in Specimen |
| 33216-3 | Platelets agranular [Presence] in Blood by Light microscopy |
| 53217-6 | Dicarboxypalmitoleylcarnitine (C16:1-DC) [Moles/volume] in DBS |
| 44706-0 | Actin smooth muscle IgG Ab [Units/volume] in Serum |
| 23284-3 | Mycoplasma mycoides ss mycoides large colony Ab [Presence] in Serum by Immunoassay |
| 5367-8 | Streptobacillus moniliformis Ab [Units/volume] in Serum |
| 44880-3 | Staphylococcus aureus enterotoxin B seb gene [Presence] in Specimen by NAA with probe detection |
| 23679-4 | Bovine respiratory syncytial virus Ag [Presence] in Specimen |
| 24044-0 | Acetyl-CoA:glucosamine acetyltransferase [Enzymatic activity/mass] in Leukocytes |
| 33784-0 | Bacterial casts [Presence] in Urine sediment by Light microscopy |
| 33788-1 | Calcitonin [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 5404-9 | Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay |
| 24191-9 | Coxsackievirus B4 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen |
| 24379-0 | Platelet aggregation collagen induced [Presence] in Platelet rich plasma |
| 55392-5 | Insulin [Moles/volume] in Serum or Plasma --1 minute post XXX challenge |
| 55590-4 | Canary feather IgE Ab [Presence] in Serum |
| 47139-1 | EPINEPHrine [Moles/volume] in Plasma --2nd specimen post XXX challenge |
| 25369-0 | Chlamydia sp IgA Ab [Units/volume] in Serum |
| 35309-4 | Trypsin [Enzymatic activity/volume] in Body fluid --4th specimen post Sincalide |
| 5583-0 | Arsenic [Mass/volume] in Blood |
| 55880-9 | Homovanillate [Moles/volume] in Serum |
| 47594-7 | C peptide [Moles/volume] in Serum or Plasma --pre dose glucagon |
| 26017-4 | Cholesterol in HDL 3 [Moles/volume] in Serum or Plasma |
| 35488-6 | Diazinon [Mass/volume] in Serum or Plasma |
| 26769-0 | Endothelin [Mass/volume] in Serum or Plasma |
| 35820-0 | Isepamicin [Susceptibility] by Disk diffusion (KB) |
| 57003-6 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
| 2692-2 | Osmolality of Serum or Plasma |
| 26974-6 | Delta aminolevulinate [Mass/volume] in 24 hour Urine |
| 27075-1 | Lycopene [Moles/volume] in Plasma |
| 5733-1 | Silver [Mass/mass] in Hair |
| 4904-9 | HLA-Dw2 [Presence] in Donor |
| 49092-0 | Second trimester quad maternal screen [Interpretation] in Serum or Plasma Narrative |
| 49217-3 | 2,3-Diphosphoglycerate [Moles/mass] in Red Blood Cells |
| 39531-9 | Acetaldehyde [Presence] in Blood |
| 49672-9 | Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection |
| 2923-1 | Retinol [Mass/volume] in Serum or Plasma |
| 4005-5 | Pseudoephedrine [Mass/time] in 24 hour Urine |
| 40298-2 | Somatotropin [Mass/volume] in Serum or Plasma --pre dose cloNIDine |
| 49962-4 | Urate renal clearance/1.73 sq M in Urine and Serum or Plasma collected for unspecified duration |
| 29659-0 | Bordetella pertussis IgG Ab [Presence] in Serum by Immunoassay |
| 29820-8 | Anaplasma phagocytophilum IgM Ab [Presence] in Serum by Immunoblot |
| 40507-6 | Jamestown canyon virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 30189-5 | Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgE Ab [Units/volume] in Serum by Multidisk |
| 40900-3 | CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Tissue |
| 19275-7 | Barbiturates cutoff [Mass/volume] in Urine for Screen method |
| 20408-1 | Leukocytes [#/volume] in Urine by Test strip |
| 20698-7 | Bluetongue virus serotype [Identifier] in Isolate |
| 20808-2 | Ergot alkaloid [Mass/volume] in Specimen |
| 20849-6 | Bovine herpesvirus 4 Ag [Presence] in Body fluid by Immunofluorescence |
| 101638-5 | TCRB gene and TCRG gene rearrangements in Specimen by Molecular genetics method |
| 13206-8 | Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid by Immunoblot |
| 102039-5 | MET gene amplification in Blood or Tissue by Molgen |
| 13619-2 | Volume of 2 hour Urine |
| 102262-3 | Crawfish IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102612-9 | Tyrophagus putrescentiae IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13942-8 | Spermatozoa Motile [Presence] in Semen by Light microscopy |
| 103106-1 | Giant grouper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15082-1 | Methemoglobin [Mass/volume] in Blood |
| 16151-3 | Dechlorane [Presence] in Serum or Plasma |
| 10814-2 | Microscopic observation [Identifier] in Tissue by Supravital stain |
| 10858-9 | Teichoate Ab [Presence] in Serum |
| 10982-7 | Demeclocycline [Mass/volume] in Serum or Plasma |
| 16383-2 | Androstenedione [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 16593-6 | Chlamydia sp Ag [Presence] in Urine |
| 16682-7 | Coxsackievirus A2 Ab [Titer] in Cerebral spinal fluid |
| 17943-2 | Bacteria # 3 identified in Line specimen by IV Line culture |
| 18902-7 | Cephradine [Susceptibility] |
| 18983-7 | Streptomycin.high potency [Susceptibility] |
| 90804-6 | Levothyroxine absorption in Serum or Plasma by calculation |
| 92491-0 | little c Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 75584-3 | Fetal Prader-Willi syndrome risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
| 61219-2 | Peanut IgE Ab/IgE total in Serum |
| 78537-8 | Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid --4 hour dwell specimen |
| 7854-3 | Dengue virus 1 Ab [Presence] in Serum by Immunoassay |
| 79177-2 | Clostridioides difficile glutamate dehydrogenase and toxins A+B [Presence] in Stool by Rapid immunoassay |
| 9489-6 | Arsenic [Mass/volume] in Body fluid |
| 95077-4 | Glucagon [Mass/volume] in Serum or Plasma --5 hours post meal |
| 96046-8 | B and T cell crossmatch panel - Patient serum and Donor blood by Flow cytometry (FC) |
| 96399-1 | Retinol binding protein panel - 24 hour Urine |
| 96410-6 | Pancreatic polypeptide [Mass/volume] in Serum or Plasma --15M post sham feeding |
| 9641-2 | Catecholamines/Creatinine [Mass Ratio] in Urine |
| 68397-9 | Basophils [#/volume] in Vitreous fluid by Manual count |
| 68965-3 | Rg Ag [Presence] on Red Blood Cells |
| 81273-5 | fentaNYL and Norfentanyl panel - Specimen |
| 96592-1 | Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in DBS |
| 96733-1 | Connective tissue [Presence] in Stool by Light microscopy |
| 82195-9 | Gastrointestinal pathogens DNA and RNA panel - Stool by NAA with non-probe detection |
| 82224-7 | Ribose-5-phosphate isomerase [Enzymatic activity/mass] in Lymphoblasts |
| 71368-5 | Desmosome IgG Ab [Titer] in Serum by Immunofluorescence |
| 98734-7 | SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Units/volume] in Serum or Plasma by Immunoassay |
| 71666-2 | Promyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count |
| 71692-8 | Platelets reticulated [#/volume] in Blood by Automated count |
| 99473-1 | Red Imported Fire Ant IgG Ab [Mass/volume] in Serum |
| 73211-5 | Perphenazine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73371-7 | Fosinopril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87350-5 | Senecavirus A RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73750-2 | RAI1 gene 17p11.2 deletion and duplication mutation analysis [Identifier] in Blood or Tissue by FISH Nominal |
| 4133-5 | Atropine [Mass] of Dose |
| 50931-5 | Uroporphyrin 1 isomer [Moles/mass] in Stool |
| 42258-4 | Shigella flexneri Ag [Presence] in Isolate |
| 59974-6 | Thiocyanate [Moles/volume] in Gastric fluid |
| 31562-2 | PM-SCL extractable nuclear Ab [Units/volume] in Serum |
| 510-8 | Tobramycin [Susceptibility] by Serum bactericidal titer |
| 51217-8 | CD10 cells/100 cells in Body fluid |
| 43034-8 | Feline leukemia virus Ab [Titer] in Serum |
| 51519-7 | Lactate dehydrogenase 4/Lactate dehydrogenase.total in Cerebral spinal fluid by Electrophoresis |
| 43704-6 | Cytomegalovirus [Presence] in Body fluid by Shell vial culture |
| 22527-6 | Salmonella sp Ab [Titer] in Serum |
| 225-3 | Doxycycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 22740-5 | Threonine [Moles/volume] in Specimen |
| 44248-3 | Spermatozoa Immotile [#/area] in Vaginal fluid |
| 22889-0 | Bovine diarrhea virus Ab [Presence] in Milk |
| 22913-8 | Bovine herpesvirus 1 DNA [Presence] in Semen by NAA with probe detection |
| 53150-9 | Alanine+Beta Alanine+Sarcosine [Moles/volume] in DBS |
| 44409-1 | Succinate/Creatinine [Molar ratio] in 24 hour Urine |
| 44478-6 | Herpes simplex virus 1 DNA [Presence] in Amniotic fluid by NAA with probe detection |
| 33582-8 | CD13+CD33+ cells [#/volume] in Blood |
| 3363-9 | Anthraquinone [Mass/volume] in Serum or Plasma |
| 53619-3 | ZAP70 cells [Presence] in Bone marrow |
| 34162-8 | Hepatitis C virus IgG band pattern [Interpretation] in Serum by Immunoblot |
| 53977-5 | Dimagnesium phosphate crystals [Presence] in Urine sediment by Light microscopy |
| 24335-2 | Creatine kinase panel - Serum or Plasma |
| 24401-2 | Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 34482-0 | Blood group antibodies identified in Serum or Plasma by Warm absorption |
| 55315-6 | Yeast [Presence] in Specimen by KOH preparation |
| 47026-0 | Cytoketatin HMW Ag [Presence] in Tissue by Immune stain |
| 35342-5 | Amylase [Enzymatic activity/volume] in Body fluid --5th specimen post Sincalide |
| 2-6 | Almecillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 56511-9 | Calcitonin [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge |
| 26493-7 | Mononuclear cells/100 leukocytes in Body fluid |
| 3677-2 | hydroCHLOROthiazide [Mass/volume] in Urine |
| 5661-4 | Gold [Mass/time] in 24 hour Urine |
| 56770-1 | Neutrophils/100 leukocytes in Bronchial specimen by Flow cytometry (FC) |
| 48850-2 | Ehrlichia chaffeensis IgM Ab [Titer] in Serum by Immunofluorescence |
| 57415-2 | Baker's yeast IgA Ab [Presence] in Serum by Immunoassay |
| 57465-7 | Cortisol [Mass/volume] in Serum or Plasma --10th specimen |
| 49003-7 | Urate [Mass/volume] in Peritoneal dialysis fluid |
| 38759-7 | Aluminum [Mass/volume] in Air |
| 5776-0 | Calcium sulfate crystals [Presence] in Urine sediment by Light microscopy |
| 49666-1 | Darunavir [Susceptibility] by Phenotype method |
| 40261-0 | Glucose [Mass/volume] in Serum or Plasma --13 minutes pre XXX challenge |
| 49950-9 | Somatotropin [Units/volume] in Serum or Plasma --2 AM specimen |
| 40329-5 | Prolactin [Mass/volume] in Serum or Plasma --pre dose triple bolus |
| 40481-4 | Methylenedioxymethamphetamine [Presence] in Specimen |
| 58989-5 | Volume of 18 hour Urine |
| 5041-9 | Adenovirus Ab [Titer] in Serum by Complement fixation |
| 30203-4 | Candida albicans reaction wheal [Diameter] --2 days post 0.1 mL Candida albicans intradermal |
| 1967-9 | Bile acid [Mass/volume] in Serum |
| 20990-8 | APC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 12464-4 | Corticotropin [Mass/volume] in Plasma --8th specimen post XXX challenge |
| 12527-8 | Norepinephrine [Mass/volume] in Plasma --3 hours post XXX challenge |
| 12644-1 | Glucose [Mass/volume] in Serum or Plasma --9 hours post XXX challenge |
| 12784-5 | Codeine Free [Mass/volume] in Serum or Plasma |
| 101419-0 | Human coronavirus 229E RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 102624-4 | Tarragon IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14116-8 | IgG synthesis rate [Mass/time] in Serum and CSF by calculation |
| 14239-8 | Myelin basic protein IgM Ab [Units/volume] in Serum |
| 102711-9 | Cherry IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102870-3 | Chocolate IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103007-1 | Timothy recombinant (rPhl p) 5 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14597-9 | Amitriptyline [Moles/volume] in Serum or Plasma |
| 103662-3 | Campylobacter and Salmonella and Shigella and Yersinia sp identified in Stool by Organism specific culture |
| 10421-6 | Transfuse Pentaspan [Volume] |
| 14973-2 | Mycobacterium sp DNA [Presence] in Sputum by NAA with probe detection |
| 15005-2 | 11-Ketoandrosterone [Moles/time] in 24 hour Urine |
| 15044-1 | Cortisol Free [Moles/volume] in Serum or Plasma |
| 10545-2 | Normephenytoin [Mass/volume] in Serum or Plasma |
| 15478-1 | Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum by Agglutination |
| 16640-5 | Coccidioides reaction wheal [Diameter] |
| 16668-6 | Cortisol Free [Mass/time] in 72 hour Urine |
| 12220-0 | Glucose [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis |
| 18966-2 | Penicillin V [Susceptibility] |
| 90233-8 | Dermatan sulfate [Moles/volume] in DBS |
| 90885-5 | Influenza virus D RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 92729-3 | Tacrolimus [Mass/volume] in Blood --2 hours post dose |
| 75858-1 | Sterols panel [Mass/volume] - Serum or Plasma |
| 77396-0 | Human papilloma virus 16 DNA [Presence] in Anorectal by NAA with probe detection |
| 93979-3 | Chikungunya virus IgG Ab [Presence] in Serum or Plasma |
| 62479-1 | Aspergillus terreus DNA [Presence] in Specimen by NAA with probe detection |
| 6249-7 | Spiny lobster IgE Ab [Units/volume] in Serum |
| 63119-2 | Honey IgG Ab [Mass/volume] in Serum |
| 94343-1 | Neuronal nuclear type 2 IgG Ab [Titer] in Serum by Immunofluorescence |
| 94754-9 | CD21lowCD38- cells/100 CD19 cells in Blood |
| 63488-1 | Epithelial cells.ciliated [Presence] in Bronchoalveolar lavage |
| 95114-5 | Insulin [Units/volume] in Serum or Plasma --2 hours post meal |
| 95224-2 | Myelocytes/100 leukocytes in Stem cell product by Manual count |
| 66736-0 | Normalized silica clotting time of Platelet poor plasma |
| 80353-6 | Herpes simplex virus 1 genome DNA polymerase region B+thymidine kinase region C [Presence] in Anogenital specimen by NAA with probe detection |
| 95801-7 | Immunoglobulin light chains.free and IFE panel - Urine |
| 67569-4 | Streptococcus pyogenes M protein emm gene [Type] in Isolate by Sequencing |
| 68441-5 | Gamma hydroxybutyrate [Moles/volume] in Gastric fluid |
| 6875-9 | Cancer Ag 15-3 [Units/volume] in Serum or Plasma |
| 69815-9 | 2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --4 days post dose ifosfamide |
| 69905-8 | Service comment 78 |
| 81761-9 | F8 gene intron 1 and 22 inversion targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 97922-9 | California encephalitis virus RNA [Presence] in Specimen by NAA with probe detection |
| 7110-0 | Groundsel Tree IgE Ab [Units/volume] in Serum |
| 8230-5 | Phencyclidine [Presence] in Gastric fluid by Screen method |
| 98002-9 | HLA-A and B and C (class I) [Type] by Low resolution |
| 98494-8 | SARS-CoV-2 (COVID-19) ORF1a region [Presence] in Saliva (oral fluid) by NAA with probe detection |
| 98846-9 | SARS coronavirus 2 stimulated gamma interferon release by Helper (CD4+) T-cells [Units/volume] corrected for background in Blood by Immunoassay |
| 99008-5 | Leptospira interrogans sv Djasiman Ab [Titer] in Serum by Agglutination |
| 99079-6 | Acrylfentanyl [Presence] in Urine by Confirmatory method |
| 7295-9 | Egg yolk triggered histamine release [Units/volume] in Blood |
| 73040-8 | Celecoxib induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87477-6 | Calcium in Specimen |
| 73436-8 | Clindamycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73530-8 | amLODIPine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73850-0 | 18-Beta glycyrrhetinate [Mass/volume] in Urine |
| 87942-9 | Bacteria identified in Pleural fluid by Anaerobe culture |
| 88128-4 | Herpes simplex virus 1 DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 88745-5 | Coccidioides immitis IgG and IgM panel - Cerebral spinal fluid |
| 59467-1 | MCHC [Moles/volume] |
| 59697-3 | Iodide [Mass/volume] in Serum or Plasma |
| 50679-0 | First trimester maternal screen with nuchal translucency [Interpretation] |
| 50851-5 | Germanium [Moles/mass] in Hair |
| 59944-9 | Normeperidine [Moles/volume] in Serum or Plasma |
| 21108-6 | Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum |
| 31526-7 | Neisseria meningitidis serogroup A IgG Ab [Units/volume] in Serum |
| 51077-6 | CD14 blasts [Units/volume] in Bone marrow |
| 51379-6 | HLA-DR+ cells/100 cells in Cerebral spinal fluid |
| 51462-0 | Onchocerca sp IgG2 Ab [Units/volume] in Serum |
| 22132-5 | Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid |
| 31979-8 | Trypanosoma evansi Ag [Presence] in Blood |
| 51594-0 | Galactose [Presence] in Stool |
| 51753-2 | Histoplasma capsulatum Ag [Mass/volume] in Serum by Immunoassay |
| 43313-6 | Avian adenovirus 127 Ab [Titer] in Serum by Hemagglutination inhibition |
| 22716-5 | Methionine [Moles/volume] in Specimen |
| 530-6 | Viomycin [Susceptibility] by Serum bactericidal titer |
| 44035-4 | Analgesics Non-narcotic [Presence] in Serum or Plasma |
| 53196-2 | 3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Moles/volume] in DBS |
| 53369-5 | Echinococcus sp IgG1 Ab [Units/volume] in Serum |
| 5374-4 | Taenia saginata Ab [Units/volume] in Serum by Immunoassay |
| 53875-1 | LMX1B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 23769-3 | Porcine influenza virus A Ag [Presence] in Tissue by Immune stain |
| 54144-1 | Trichomonas vaginalis DNA [Presence] in Vaginal fluid by Probe with signal amplification |
| 46091-5 | Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --3rd tube |
| 24193-5 | Coxsackievirus B5 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24303-0 | Coxsackievirus A16 Ab [Titer] in Serum --2nd specimen |
| 24496-2 | Food Allergen Mix C (Oat+Barley+Rice+Rye+Wheat+Corn) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 34308-7 | Fructose [Moles/volume] in Urine |
| 34490-3 | MT-TK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 34571-0 | aPTT.lupus sensitive (LA screen) |
| 3467-8 | Chlorpheniramine [Presence] in Urine |
| 47479-1 | Rickettsia typhi IgG Ab [Titer] in Cerebral spinal fluid |
| 25673-5 | Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose glucose |
| 35603-0 | clonazePAM [Mass/volume] in Serum or Plasma by Screen method |
| 56324-7 | Mucor racemosus IgG4 Ab [Mass/volume] in Serum |
| 56546-5 | Insulin Ab [Units/volume] in Serum by Immunoassay |
| 56557-2 | Renin [Enzymatic activity/volume] in Plasma --10 minutes post XXX challenge |
| 48184-6 | Yellow Jacket triggered leukotriene release [Mass/volume] by Leukocytes |
| 48235-6 | American house dust mite triggered leukotriene release [Mass/volume] by Leukocytes |
| 26590-0 | Beta aminoisobutyrate [Moles/volume] in Cerebral spinal fluid |
| 26685-8 | 3-Hydroxyisovalerate [Presence] in Urine |
| 26772-4 | Mephentermine [Mass/mass] in Stool |
| 4844-7 | HLA-B8 [Presence] in Donor |
| 57611-6 | 6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
| 49661-2 | HIV protease gene mutations by Phenotype method |
| 58733-7 | Mycoplasma pneumoniae IgG and IgM panel - Serum |
| 50075-1 | 11-Deoxycortisol [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
| 29705-1 | Rickettsia rickettsii Ab [Titer] in Serum by Immunofluorescence |
| 29739-0 | Leptospira interrogans sv Kremastos Ab [Presence] in Serum |
| 40560-5 | Cytokeratin AE1/AE3 Ag [Presence] in Tissue by Immune stain |
| 40585-2 | Drugs identified in Specimen by Confirmatory method |
| 19166-8 | Carcinoembryonic Ag [Units/volume] in Serum or Plasma |
| 19282-3 | Benzodiazepines positive [Identifier] in Urine by Confirmatory method |
| 100814-3 | Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge |
| 100993-5 | CD49d cell expression evaluation in Specimen Document by Flow cytometry (FC) |
| 12970-0 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen |
| 102005-6 | Chromium IgE Ab RAST class [Presence] in Serum |
| 13746-3 | Glutamate/Creatinine [Mass Ratio] in Urine |
| 102257-3 | Western Cottonwood IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102334-0 | Bermuda grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14168-9 | Palatinase [Enzymatic activity/mass] in Tissue |
| 102869-5 | Blue Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15112-6 | Leukocyte phosphatase [Units/volume] in Leukocytes |
| 10847-2 | Borrelia burgdorferi DNA [Presence] in Body fluid by Probe with amplification |
| 16591-0 | Chlamydia sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 1190-8 | little k Ab [Presence] in Serum or Plasma from Blood product unit |
| 16787-4 | DOPamine [Mass/volume] in Urine --5th specimen post XXX challenge |
| 17571-1 | Scopolamine [Mass/volume] in Urine |
| 19074-4 | Carnitine esters [Moles/volume] in Serum or Plasma |
| 90844-2 | PCA-Tr Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 91712-0 | F5 gene c.1691G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 91843-3 | Ureaplasma parvum DNA [Presence] in Genital specimen by NAA with probe detection |
| 75047-1 | Sialate [Moles/volume] in Serum or Plasma |
| 6056-6 | Bumble Bee IgE Ab [Units/volume] in Serum |
| 76670-9 | Glucose [Moles/volume] in Cerebral spinal fluid --2nd tube |
| 77022-2 | Respiratory syncytial virus A RNA [Presence] in Nasopharynx by NAA with probe detection |
| 6236-4 | Cultivated Rye IgE Ab [Units/volume] in Serum |
| 62371-0 | FISH probe locus [Identifier] in Laboratory device |
| 63102-8 | Nectarine IgG Ab [Mass/volume] in Serum |
| 63250-5 | Ganglioside GM2 IgM Ab [Presence] in Serum by Immunoassay |
| 94873-7 | Cortisol.free post corticotropin stimulation panel - Serum or Plasma |
| 9530-7 | Histoplasma capsulatum IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 6577-1 | Escherichia coli verotoxin 2 neutralizing antibody [Titer] in Stool by Neutralization test |
| 65789-0 | Mouse lipocain native (nMus m) 1 IgE Ab [Units/volume] in Serum |
| 6727-2 | Honey bee IgG Ab [Units/volume] in Serum |
| 79668-0 | Purine and Pyrimidine panel - Cerebral spinal fluid |
| 7982-2 | Parvovirus B19 Ab [Units/volume] in Serum |
| 68940-6 | Somatotropin [Mass/volume] in Serum or Plasma --90 minutes post exercise |
| 9668-5 | HIV 1 p55 Ab [Presence] in Serum by Immunoblot |
| 81806-2 | Alpha cortolone/Creatinine [Molar ratio] in Urine |
| 82061-3 | Food Allergen Mix 19 (Cucumber+Carrot+Potato+Spinach) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 82092-8 | Occupational Allergen Mix 4 (Amylase+Soybean+Grain weevel+Wheat) IgE Ab [Units/volume] in Serum by Multidisk |
| 97302-4 | Tapentadol [Presence] in Cord tissue by Screen method |
| 9797-2 | Consistency of Stone |
| 70255-5 | Follitropin IgA Ab [Units/volume] in Serum by Immunoassay |
| 71629-0 | Mononuclear cells/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
| 82451-6 | U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot |
| 82518-2 | IVD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 73683-5 | Busulfan [Mass/volume] in Serum or Plasma --trough |
| 7374-2 | Perennial rye grass triggered histamine release [Units/volume] in Blood |
| 88511-1 | Natural killer cell cytotoxicity.0.9:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
| 74420-1 | Parvovirus B19 DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 411-9 | Piperacillin+Tazobactam [Susceptibility] by Minimum lethal concentration (MLC) |
| 41246-0 | Yellow fever virus Ab [Titer] in Serum --2nd specimen |
| 50878-8 | Mercury [Moles/volume] in Red Blood Cells |
| 417-6 | Pivampicillin [Susceptibility] by Disk diffusion (KB) |
| 42192-5 | Nidus [Presence] in Stone |
| 21349-6 | IgA [Presence] in Cerebral spinal fluid by Immunofixation |
| 31523-4 | Myxoma virus Ab [Units/volume] in Serum |
| 31550-7 | Parainfluenza virus 2 Ab [Units/volume] in Body fluid |
| 22409-7 | Lymphocytic choriomeningitis virus IgG Ab [Titer] in Cerebral spinal fluid |
| 22411-3 | Lymphocytic choriomeningitis virus IgM Ab [Titer] in Serum |
| 22429-5 | Mycoplasma synoviae Ab [Presence] in Serum |
| 32621-5 | HLA-DR [Presence] |
| 53345-5 | Cortisol [Mass/volume] in DBS |
| 44693-0 | Tumor infiltrating lymphocytes |
| 23436-9 | Salmonella pullorum rRNA [Presence] in Specimen by Probe |
| 33421-9 | Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma |
| 33507-5 | Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Urine |
| 53510-4 | Dodecanoylcarnitine (C12)/Creatinine [Molar ratio] in Urine |
| 44897-7 | Malignant cells/100 cells in Pericardial fluid by Manual count |
| 45212-8 | HIV 2 p31+p34 Ab [Presence] in Serum by Immunoblot |
| 23660-4 | Aspergillus sp Ab [Titer] in Serum by Immunoassay |
| 23835-2 | Carbon disulfide [Mass/volume] in Urine |
| 23914-5 | Osmotic fragility of Red Blood Cells--0.45% sodium chloride |
| 24056-4 | Alpha-L-iduronidase [Enzymatic activity/mass] in Fibroblast |
| 33742-8 | Tumor border configuration [Type] in Specimen |
| 34161-0 | Cancer Ag 72-4 [Units/volume] in Body fluid |
| 54257-1 | Glucose [Moles/volume] in Serum or Plasma --pre dose insulin IV |
| 24171-1 | Polio virus 2 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen |
| 34671-8 | 8-Dehydrocholesterol [Mass/volume] in Serum or Plasma |
| 34713-8 | Clostridioides difficile toxin A+B [Presence] in Stool |
| 47394-2 | Gliadin peptide IgG Ab [Presence] in Serum by Immunoassay |
| 25123-1 | Para nitrophenol/Creatinine [Molar ratio] in Urine |
| 35031-4 | Metamyelocytes [#/volume] in Body fluid |
| 48232-3 | Tyrophagus putrescentiae triggered leukotriene release [Mass/volume] by Leukocytes |
| 36913-2 | FMR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 38179-8 | Peripheral neuropathy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 48706-6 | Reticulocyte mean volume [Entitic volume] in Reticulocytes |
| 27210-4 | Magnesium [Presence] in Blood |
| 38511-2 | CD19+CD33+ cells/100 cells in Blood |
| 3866-1 | Norfenefrine [Mass/volume] in Urine |
| 57406-1 | CD8+CD57+ cells/100 cells in Body fluid |
| 57473-1 | Calcitriol [Moles/volume] in Serum or Plasma --1 hour post dose calcium |
| 27948-9 | Herpes simplex virus 1+2 IgG Ab [Units/volume] in Serum by Immunoassay |
| 28063-6 | Mercury [Mass/volume] in Dentin --2nd specimen |
| 38723-3 | 1,4-Benzoquinone [Mass/volume] in Air |
| 2867-0 | Alpha 2 globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis |
| 58505-9 | C peptide [Mass/volume] in Serum or Plasma --2.5 hours post dose glucose |
| 58526-5 | Corticotropin [Mass/volume] in Plasma --1.5 hours post dose glucagon |
| 49912-9 | Japanese encephalitis virus Ab [Titer] in Cerebral spinal fluid |
| 50048-8 | Hemicystine [Moles/volume] in Specimen |
| 30323-0 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with normal plasma |
| 30392-5 | Nucleated erythrocytes [#/volume] in Blood |
| 40795-7 | Alkaline phosphatase.liver 2 [Presence] in Serum or Plasma |
| 100384-7 | Rapeseed IgG Ab [Units/volume] in Serum |
| 13087-2 | Complement alternate pathway AH50 [Units/volume] in Serum or Plasma |
| 13263-9 | Leishmania tropica IgM Ab [Units/volume] in Serum |
| 101835-7 | Fludrocortisone [Moles/volume] in Serum or Plasma |
| 102133-6 | Almond IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102141-9 | Anise IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1364-9 | Corticotropin [Mass/volume] in Plasma --45 minutes post 1 ug/kg CRH IV |
| 13907-1 | Norethindrone [Mass/volume] in Serum or Plasma |
| 102766-3 | Macadamia IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1037-1 | G Ab [Presence] in Serum or Plasma from Donor |
| 103959-3 | cycloSERINE [Susceptibility] by Genotype method |
| 14931-0 | Trimipramine [Moles/volume] in Serum or Plasma |
| 15178-7 | Complement factor B [Mass/volume] in Body fluid |
| 104283-7 | DPYD gene.c.2846A>T [Presence] in Blood or Tissue by Molecular genetics method |
| 104315-7 | Sunitinib [Mass/volume] in Serum or Plasma |
| 104446-0 | Rubella virus IgM Ab index [Units/volume] in Serum and CSF |
| 10620-3 | Spermatozoa Nonprogressive/100 spermatozoa in Semen |
| 15241-3 | Food Allergen Mix 10 (Beef+Chicken meat+Egg yolk+Pork+Turkey meat) IgE Ab [Presence] in Serum by Multidisk |
| 11263-1 | Parainfluenza virus 3 IgM Ab [Titer] in Serum |
| 1226-0 | M Ab [Presence] in Serum or Plasma from Blood product unit |
| 17789-9 | Large unstained cells [#/volume] in Blood by Automated count |
| 17860-8 | 3-Methylhistidine [Mass/volume] in 24 hour Urine |
| 1812-7 | Alpha fucosidase [Enzymatic activity/mass] in Tissue |
| 18219-6 | EPINEPHrine [Mass/volume] in Urine --2nd specimen post XXX challenge |
| 19054-6 | Mycoplasma pneumoniae [Presence] in Specimen by Organism specific culture |
| 190-9 | Clarithromycin [Susceptibility] by Disk diffusion (KB) |
| 90425-0 | Microorganism preliminary growth detection panel - Platelets from Blood product unit by Culture |
| 74487-0 | P504S and p63 and Cytokeratin 903 Ag [Identifier] in Tissue by Immune stain |
| 74628-9 | Adipoylcarnitine (C6-DC) [Moles/volume] in DBS |
| 75555-3 | Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
| 92879-6 | Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 936-5 | Blood product unit [Identifier] |
| 77610-4 | C peptide [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 77947-0 | CD9 cells/100 cells in Specimen |
| 79391-9 | Catecholamine metabolites panel - Cerebral spinal fluid |
| 95674-8 | Mayaro virus IgG Ab [Presence] in Specimen by Immunoassay |
| 65340-2 | Micafungin [Susceptibility] |
| 79672-2 | 5-Aminoimidazole-4-carboxamide/Creatinine [Molar ratio] in Urine |
| 69012-3 | 3-Hydroxybenzoylecgonine [Mass/mass] in Meconium by Confirmatory method |
| 8106-7 | CD1 cells/100 cells in Blood |
| 96611-9 | Treponema pallidum and Haemophilus ducreyi and Herpes simplex virus DNA panel - Specimen by NAA with probe detection |
| 69786-2 | 2-Methylacetoacetate [Moles/volume] in Cerebral spinal fluid |
| 81872-4 | SCN5A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 7136-5 | Pinto Bean IgG Ab [Units/volume] in Serum |
| 82297-3 | Chikungunya virus structural proteins (E1+E2) IgG Ab [Presence] in Serum by Immunoassay |
| 82426-8 | Mj Ab [Presence] in Serum by Line blot |
| 82869-9 | 6-Thioguanine and 6-methylmercaptopurine panel - Red Blood Cells |
| 98225-6 | Piperacillin IgE Ab [Units/volume] in Serum |
| 7215-7 | Swiss Cheese IgE Ab [Units/volume] in Serum |
| 7231-4 | Cladosporium herbarum triggered histamine release [Units/volume] in Blood |
| 85766-4 | Streptococcus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 99524-1 | Circumference [Length] of Mitral valve |
| 99766-8 | Interleukin 17 [Mass/volume] in Cerebral spinal fluid |
| 72772-7 | O-desmethylvenlafaxine [Mass/volume] in Urine by Confirmatory method |
| 72798-2 | Methylenedioxypyrovalerone/Creatinine [Mass Ratio] in Urine |
| 72804-8 | JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
| 87339-8 | Porcine circovirus type 2a DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73500-1 | Budesonide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87806-6 | Methylphenidate [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 87831-4 | Yeast [Presence] in Urine |
| 88678-8 | Herpes simplex virus 1 Ag [Presence] in Cornea or Conjunctiva by Immunofluorescence |
| 41252-8 | Xylose [Mass/volume] in Serum or Plasma --5 hours post 25 g xylose PO |
| 41696-6 | Everninomicin [Susceptibility] by Disk diffusion (KB) |
| 59745-0 | Temazepam [Mass/volume] in Blood |
| 30985-6 | Silver Birch recombinant (rBet v) 2 IgE Ab [Units/volume] in Serum |
| 4263-0 | fluPHENAZine [Mass] of Dose |
| 51255-8 | CD16+CD56+ cells/100 cells in Bone marrow |
| 4296-0 | Methotrimeprazine [Mass] of Dose |
| 42961-3 | Salmonella pullorum Ab [Titer] in Serum |
| 22231-5 | Coxsackievirus B4 Ab [Titer] in Cerebral spinal fluid |
| 31668-7 | Sulfatide Ab [Units/volume] in Serum |
| 32029-1 | Monocytes+Macrophages/100 leukocytes in Peritoneal fluid by Manual count |
| 51772-2 | F9 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 32539-9 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
| 53040-2 | Genetic variation's effect on drug metabolism |
| 22867-6 | Bacillus anthracis Ag [Presence] in Specimen by Immunofluorescence |
| 23054-0 | Ehrlichia canis Ab [Presence] in Serum by Immunofluorescence |
| 23114-2 | Foot and mouth disease virus RNA [Presence] in Tissue by Probe |
| 32584-5 | Propionylglycine [Presence] in Urine |
| 329-3 | metroNIDAZOLE [Susceptibility] by Serum bactericidal titer |
| 53371-1 | Echovirus IgG Ab [Titer] in Serum |
| 44467-9 | Herpes simplex virus 1 [Presence] in Cervix by Organism specific culture |
| 44567-6 | Influenza virus A+B Ag [Presence] in Nose |
| 23282-7 | Mycoplasma mycoides ss capri Ab [Presence] in Serum |
| 33414-4 | Lipoprotein.pre-beta/total Lipoprotein in Pleural fluid |
| 44949-6 | Borrelia burgdorferi 34kD IgG Ab [Presence] in Serum by Immunoblot |
| 45053-6 | Glucose [Moles/volume] in Serum or Plasma --8 AM specimen |
| 45124-5 | Vesicular stomatitis Alagoas virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 3381-1 | Benzfetamine [Mass/volume] in Blood |
| 33836-8 | Malignant cells [#/volume] in Blood by Manual count |
| 54440-3 | Newberyite/Total in Stone |
| 46177-2 | Chlamydia trachomatis D+E+F+G+H+I+J+K IgG Ab [Titer] in Serum |
| 34382-2 | Treponema pallidum Ab [Titer] in Serum by Immunofluorescence |
| 3461-1 | Chlormerodrin [Mass/volume] in 24 hour Urine |
| 47277-9 | Erythrocyte distribution width [Ratio] in Cord blood |
| 47357-9 | Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 25313-8 | Amylase.salivary/Amylase.total in Serum or Plasma |
| 55659-7 | Clindamycin.high potency [Susceptibility] by Disk diffusion (KB) |
| 5573-1 | Aluminum [Mass/mass] in Hair |
| 47798-4 | Urea [Moles/volume] in Stool |
| 25732-9 | Pregnanetriolone [Moles/time] in 24 hour Urine |
| 25992-9 | Lipase [Enzymatic activity/volume] in 24 hour Urine |
| 35395-3 | Legionella pneumophila 1 IgM Ab [Presence] in Serum |
| 48267-9 | Benzylpenicilloyl-polylysine triggered leukotriene release [Mass/volume] by Leukocytes |
| 26705-4 | Epstein Barr virus nuclear IgM Ab [Titer] in Serum |
| 27120-5 | Streptococcus pneumoniae Danish serotype 7F Ab [Mass/volume] in Serum --2nd specimen |
| 27127-0 | Arsenic [Mass/mass] in Red Blood Cells |
| 38529-4 | CMTX2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 5717-4 | Polychlorinated biphenyl (PCB) [Mass/volume] in Urine |
| 5749-7 | Titanium [Mass/volume] in Urine |
| 48975-7 | GPR143 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 49074-8 | Influenza virus A IgA Ab [Mass/volume] in Cerebral spinal fluid |
| 39576-4 | Sulfate [Mass/time] in 24 hour Urine |
| 49352-8 | Epstein Barr virus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
| 49564-8 | Epstein Barr virus band pattern [Interpretation] in Specimen by Immunoblot Narrative |
| 2818-3 | Porphyrins [Presence] in Urine |
| 28639-3 | Base excess in Venous cord blood by calculation |
| 49802-2 | Urea [Mass/volume] in Peritoneal fluid |
| 29609-5 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification |
| 58842-6 | Somatotropin [Mass/volume] in Serum or Plasma --25th specimen |
| 58911-9 | Chicken droppings IgG Ab [Mass/volume] in Serum |
| 50398-7 | Narrative diagnostic report [Interpretation] |
| 50591-7 | Adenosine deaminase [Enzymatic activity/mass] in Trophoblasts |
| 30039-2 | Anaplasma phagocytophilum DNA [Presence] in Blood by NAA with probe detection |
| 30371-9 | Promyelocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
| 19396-1 | chlorproMAZINE [Presence] in Urine by Confirmatory method |
| 20479-2 | Measles virus IgG Ab [Presence] in Serum |
| 20666-4 | Echovirus Ab [Interpretation] in Serum |
| 20855-3 | IgG.bovine [Mass/volume] in Serum by Immune diffusion (ID) |
| 100-8 | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 12747-2 | Insulin [Mass/volume] in Serum or Plasma --3.5 hours post XXX challenge |
| 12765-4 | Insulin [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 101665-8 | Protein electrophoresis and M protein isotype panel - 24 hour Urine |
| 13226-6 | Cytomegalovirus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 1336-7 | Xg sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 136-2 | Ceftizoxime [Susceptibility] by Minimum lethal concentration (MLC) |
| 102445-4 | Mint IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102620-2 | Swordfish IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14735-5 | Gastrin [Moles/volume] in Serum or Plasma --10 minutes post 0.2 U/kg secretin |
| 14770-2 | Fasting glucose [Moles/volume] in Capillary blood by Glucometer |
| 103132-7 | Maltose binding protein IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15048-2 | Creatine kinase.BB/Creatine kinase.total in Serum or Plasma by Electrophoresis |
| 10544-5 | Normeperidine [Presence] in Serum or Plasma |
| 16176-0 | Bartonella quintana IgG Ab [Units/volume] in Cerebral spinal fluid |
| 10909-0 | Benzidine [Mass/volume] in Urine |
| 1136-1 | Lu sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 17269-2 | Methyl isobutyl ketone [Mass/volume] in Urine |
| 17343-5 | Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid |
| 1846-5 | Amylo-alpha-1,6-glucosidase [Enzymatic activity/volume] in Red Blood Cells |
| 19049-6 | Metanephrine [Mass/time] in 24 hour Urine |
| 89983-1 | OLANZapine [Presence] in Serum or Plasma by Screen method |
| 90783-2 | F2-Isoprostanes/Creatinine [Mass Ratio] in Urine |
| 75014-1 | t(9;12)(q34.1;p13)(ABL1,ETV6) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
| 92535-4 | Js sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 76544-6 | Breast cancer 10-year risk of distant recurrence score Calculated by Prosigna |
| 76765-7 | Phosphatidylcholine.saturated [Moles/volume] in Amniotic fluid |
| 9343-5 | Coproporphyrin 1 [Mass/volume] in Urine |
| 77132-9 | CDHR1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 7715-6 | Summer Squash IgG Ab [Units/volume] in Serum |
| 77739-1 | Mother's Hepatitis B virus surface Ag status |
| 93923-1 | ABO and Rh group post transfusion reaction panel - Blood |
| 63302-4 | Parathyrin Ab [Titer] in Serum by Immunofluorescence |
| 78796-0 | Atazanavir [Mass/volume] in Amniotic fluid |
| 63480-8 | Pseudomonas aeruginosa.multidrug resistant isolate [Presence] in Specimen by Organism specific culture |
| 64122-5 | Hemoglobins that can be presumptively identified based on available controls in DBS |
| 95164-0 | Infectious bursal disease virus Ab/Positive control in Serum by Immunoassay |
| 95527-8 | Cytomegalovirus IgG Ab [Presence] in Saliva (oral fluid) by Immunoassay |
| 79701-9 | Fatty acids.very long chain.C22:1n9 (Erucate) [Moles/volume] in Serum or Plasma |
| 7992-1 | Respiratory syncytial virus IgM Ab [Units/volume] in Serum |
| 68326-8 | Reptilase time actual/Normal |
| 80552-3 | Trimethoprim [Mass/volume] in DBS |
| 82186-8 | Streptococcus agalactiae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
| 97624-1 | Klebsiella pneumoniae+Klebsiella variicola+Klebsiella quasipneumoniae DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 71377-6 | Legionella sp [Identifier] in Isolate by Agglutination |
| 82425-0 | Mj Ab [Units/volume] in Serum by Line blot |
| 82512-5 | Hepatitis C virus genotype 1 [Type] in Serum or Plasma by NAA with probe detection |
| 82919-2 | Ku IgG Ab [Presence] in Serum by Line blot |
| 7281-9 | Dill IgG Ab [Units/volume] in Serum |
| 86088-2 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum --2nd specimen |
| 86324-1 | Coliform bacteria [#/mass] in Food by Viability count |
| 86563-4 | Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Tissue by NAA with probe detection |
| 73117-4 | Tirofiban induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73228-9 | Oxacillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86716-8 | Actinobacillus pleuropneumoniae DNA [Cycle Threshold #] in Isolate by NAA with probe detection |
| 86865-3 | Dengue virus 1 neutralizing antibody [Presence] in Specimen by Neutralization test |
| 87642-5 | o,p'- DDE [Mass/mass] in Specimen |
| 87744-9 | Carbaryl [Mass/mass] in Specimen |
| 73601-7 | Danofloxacin [Susceptibility] |
| 883-9 | ABO group [Type] in Blood |
| 74085-2 | Isocoproporphyrin [Moles/mass] in Stool |
| 74131-4 | Morphine [Mass/volume] in Serum, Plasma or Blood |
| 74340-1 | MICA*008 IgG Ab [Presence] in Serum |
| 41666-9 | Biapenem [Susceptibility] by Disk diffusion (KB) |
| 50875-4 | Manganese [Moles/volume] in Red Blood Cells |
| 42507-4 | Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid |
| 21408-0 | Myelin IgG Ab [Titer] in Serum |
| 31489-8 | Lumpy skin disease virus Ab [Units/volume] in Serum |
| 51060-2 | CD127 blasts [Units/volume] in Specimen |
| 21704-2 | MT-ATP6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 22078-0 | Acanthamoeba sp Ab [Presence] in Cerebral spinal fluid |
| 31925-1 | Parainfluenza virus 2 Ag [Presence] in Throat |
| 22455-0 | Pseudorabies virus Herdcheck gene deletion Ab [Presence] in Serum |
| 22781-9 | African swine fever virus Ag [Presence] in Specimen by Agglutination |
| 5204-3 | Herpes simplex virus Ab [Titer] in Serum by Complement fixation |
| 52118-7 | Pooled platelets units available [#] |
| 5274-6 | Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay |
| 52999-0 | Leukocytes.disintegrated [#/volume] in Blood |
| 44008-1 | Herpes simplex virus 1 and 2 IgM Ab [Interpretation] in Serum |
| 22820-5 | Avian orthoreovirus Ag [Presence] in Specimen |
| 32617-3 | Ornithine carbamoyltransferase [Enzymatic activity/mass] in Tissue |
| 5348-8 | SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoassay |
| 44458-8 | Brucella abortus IgG+IgM Ab [Units/volume] in Serum |
| 23304-9 | Myxoma virus Ab [Presence] in Serum |
| 23423-7 | Salmonella enteritidis IgG Ab [Presence] in Egg yolk by Immunoassay |
| 33244-5 | Guanidinoacetate [Moles/volume] in Serum or Plasma |
| 33513-3 | Specific gravity of Specimen |
| 45103-9 | Chlamydia sp Ag [Presence] in Anal by Immunofluorescence |
| 4522-9 | Complement iC3 [Mass/volume] in Plasma |
| 23699-2 | Canine parainfluenza virus 2 Ag [Presence] in Tissue by Immunofluorescence |
| 2382-0 | Glutathione.reduced [Mass/volume] in Red Blood Cells |
| 23904-6 | Monocytes+Macrophages/100 leukocytes in Cerebral spinal fluid by Manual count |
| 46755-5 | Carnitine uptake defect/CPT1 deficiency newborn screen interpretation |
| 46760-5 | Other hemoglobinopathies newborn screen interpretation |
| 3434-8 | Carbenicillin [Mass/volume] in Serum or Plasma |
| 55144-0 | Powassan virus RNA [Presence] in Specimen by NAA with probe detection |
| 55650-6 | cefTAZidime+Sulbactam [Susceptibility] by Disk diffusion (KB) |
| 47572-3 | Asparagine [Moles/volume] in DBS |
| 25803-8 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 35619-6 | Methaqualone [Mass/volume] in Serum or Plasma by Screen method |
| 56223-1 | Cinnamon IgG4 Ab [Mass/volume] in Serum |
| 26453-1 | Erythrocytes [#/volume] in Blood |
| 26600-7 | Alpha aminoadipate [Moles/volume] in Serum or Plasma |
| 3601-2 | Etafedrine [Mass/time] in 24 hour Urine |
| 3612-9 | Ethchlorvynol [Mass/volume] in Urine |
| 48731-4 | Complement C4 [Presence] in Serum or Plasma |
| 27133-8 | Citrate [Presence] in Urine |
| 27189-0 | Methylenedioxyamphetamine [Mass/volume] in Vitreous fluid |
| 3833-1 | Moxalactam [Mass/volume] in Serum or Plasma |
| 38562-5 | Spermatozoa.tail Motile w IgM/100 spermatozoa in Semen by Immunobead |
| 38569-0 | Arsenic [Mass/volume] in Air |
| 38591-4 | Dichlorvos [Mass/volume] in Air |
| 5730-7 | Silicate [Mass/mass] in Tissue |
| 49062-3 | Lipid risk factors [Finding] |
| 49238-9 | Patient symptoms [Interpretation] Narrative--30 minutes post dose lactose PO |
| 49265-2 | Gammopathy [Interpretation] in Serum by Electrophoresis Narrative |
| 57692-6 | Cortisol [Mass/volume] in Saliva (oral fluid) --5th specimen |
| 58027-4 | Testolactone [Presence] in Urine |
| 58066-2 | Kn sup(a) Ag [Presence] on Red Blood Cells |
| 49596-0 | Uroporphyrinogen decarboxylase [Units/volume] in Red Blood Cells |
| 40263-6 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 40444-2 | CMV gene mutations detected [Identifier] |
| 40579-5 | Cryoglobulin.IgG [Mass/volume] in Serum by Cold incubation |
| 40651-2 | Metamyelocytes [Presence] in Blood |
| 30336-2 | Echovirus 7 Ab [Presence] in Serum by Complement fixation |
| 4079-0 | Trimethoprim [Presence] in Serum or Plasma |
| 40800-5 | Cannabinoids [Presence] in Hair by Screen method |
| 19258-3 | Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood |
| 19697-2 | Secobarbital cutoff [Mass/volume] in Urine for Confirmatory method |
| 20403-2 | Fibronectin.fetal [Mass/volume] in Vaginal fluid |
| 20462-8 | Streptomycin [Susceptibility] by Method for Slow-growing mycobacteria |
| 100864-8 | Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method |
| 100972-9 | Influenza virus A and Influenza virus B and SARS coronavirus 2 RNA panel - Nose by NAA with non-probe detection |
| 101319-2 | Cortisol and Cortisone panel - 24 hour Urine |
| 101535-3 | Fungal 18s rRNA gene [Nucleotide sequence] in Specimen by Sequencing |
| 13070-8 | Phosphatidate IgG Ab [Units/volume] in Serum |
| 13262-1 | Leishmania tropica IgG Ab [Units/volume] in Serum |
| 1334-2 | V Ag [Presence] on Red Blood Cells |
| 13378-5 | 3-Methylhistidine [Mass/volume] in Cerebral spinal fluid |
| 101818-3 | Herpes virus 6 DNA [Units/volume] in Cerebral spinal fluid by NAA with probe detection |
| 101844-9 | Triamcinolone acetonide [Moles/volume] in Serum or Plasma |
| 13456-9 | IgG synthesis rate [Units/volume] in Serum and CSF |
| 13701-8 | Acetoacetate/Creatinine [Mass Ratio] in Urine |
| 102376-1 | Hornet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14005-3 | Prostaglandin E1 [Mass/time] in 24 hour Urine |
| 14105-1 | Leukocytes [Presence] in Nose by Light microscopy |
| 103070-9 | Peach recombinant (rPru p) 4 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15493-0 | Parainfluenza virus 3 Ab [Titer] in Serum by Hemagglutination inhibition |
| 16355-0 | Amino beta guanidinopropionate [Presence] in Plasma |
| 11147-6 | Myoglobin/Creatinine [Mass Ratio] in Urine |
| 17673-5 | sulfiSOXAZOLE IgE Ab [Units/volume] in Serum |
| 17903-6 | Bacteria # 6 identified in Throat by Aerobe culture |
| 18342-6 | Glucose [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 90847-5 | Zinc finger protein of the cerebellum 4 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
| 90976-2 | Opipramol [Mass/volume] in Serum or Plasma |
| 91109-9 | Cholesterol in LDL 5 [Mass/volume] in Serum or Plasma |
| 74663-6 | Zaleplon [Mass/volume] in Urine |
| 92769-9 | Gram negative bacteria DNA [Presence] by NAA with probe detection in Positive blood culture |
| 60584-0 | t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points [Presence] in Cerebral spinal fluid by Molecular genetics method |
| 76492-8 | Amphetamine+Methamphetamine [Presence] in Urine by Screen method |
| 61344-8 | Sheep epithelium IgE Ab/IgE total in Serum |
| 77148-5 | Albumin [Mass/volume] in Serum, Plasma or Blood by Bromocresol purple (BCP) dye binding method |
| 7716-4 | Yellow Squash IgE Ab [Units/volume] in Serum |
| 7766-9 | English Walnut Pollen IgE Ab [Units/volume] in Serum |
| 93889-4 | Methane/Expired gas [Volume Fraction] in Exhaled gas --15 minutes post dose carbohydrate |
| 94101-3 | Hantavirus seoul IgG Ab [Presence] in Serum or Plasma by Line blot |
| 94214-4 | PRKAR1A gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 63167-1 | Trichophyton mentagrophytes IgG Ab [Mass/volume] in Serum |
| 94714-3 | Beta globulin [Mass/time] in 24 hour Urine by Electrophoresis |
| 9475-5 | Hexane [Mass/volume] in Blood |
| 6477-4 | Mumps virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 79239-0 | Ethyl glucuronide cutoff [Mass/volume] in Urine for Screen method |
| 95680-5 | Snowshoe hare virus IgM Ab [Presence] in Specimen by Immunoassay |
| 65-3 | Cefadroxil [Susceptibility] by Disk diffusion (KB) |
| 6751-2 | Glucose [Presence] in Urine by Test strip --2 hours post 75 g glucose PO |
| 67726-0 | Rickettsia sp DNA [Identifier] in Specimen by NAA with probe detection |
| 6815-5 | Epstein Barr virus nuclear IgM Ab [Presence] in Serum by Immunoassay |
| 80663-8 | 4-Hydroxy 3-Nitrophenylacetate (HNPAA) [Mass/volume] in Urine |
| 8101-8 | CD3+CD8+ (T8 suppressor) cells/100 cells in Blood |
| 96715-8 | Color of Prostatic fluid |
| 82161-1 | Human coronavirus HKU1 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 97931-0 | Mayaro virus RNA [Presence] in Specimen by NAA with probe detection |
| 82301-3 | Salmonella sp [Presence] in Stool by Culture |
| 98250-4 | Neuroendocrine tumor [Type] in Tumor |
| 71848-6 | Oxygen saturation [Pure mass fraction] in Arterial cord blood |
| 72262-9 | Methemoglobin [Moles/volume] in Cerebral spinal fluid |
| 72329-6 | Anucleated bodies/100 round cells in Semen by Manual count |
| 85771-4 | Enterobacteriaceae DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 99269-3 | Clonazolam [Mass/volume] in Urine by Confirmatory method |
| 72781-8 | JWH-018 pentanol (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
| 72924-4 | Barium [Moles/volume] in Urine |
| 86144-3 | Streptococcus pneumoniae Danish serotype 8 Ab [Presence] in Serum by Immunoassay |
| 73343-6 | Hydrocortisone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86743-2 | Surgical margin tumor involvement.deep [Presence] in Skin melanoma by Light microscopy |
| 87323-2 | Porcine circovirus type 1 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 87709-2 | Virus identified in Lower respiratory specimen by Culture |
| 87761-3 | Atomoxetine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 73438-4 | Clavulanate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74462-3 | Basophils/100 leukocytes in Blood from Fetus |
| 88970-9 | RBC casts [#/area] in Urine sediment |
| 41488-8 | Cryptosporidium sp [Presence] in Specimen by Acid fast stain |
| 59754-2 | Titanium [Mass/mass] in Hair |
| 30911-2 | DNA ploidy [Identifier] in Specimen by Flow cytometry (FC) Nominal |
| 30921-1 | Mercury [Mass/volume] in Urine collected for unspecified duration |
| 31063-1 | Polio virus 1 Ab [Titer] in Body fluid by Complement fixation |
| 42520-7 | Methylmalonate [Moles/volume] in 24 hour Urine |
| 51331-7 | CD43 cells/100 cells in Bone marrow |
| 43042-1 | Echovirus 4 Ab [Titer] in Body fluid |
| 22088-9 | Avian adenovirus 2 Ab [Presence] in Serum |
| 51603-9 | Cytochrome B5 reductase [Presence] in Red Blood Cells |
| 51740-9 | 6-monoacetylmorphine free [Mass/volume] in Urine |
| 43274-0 | CD1c+CD22+ cells/100 cells in Specimen |
| 32087-9 | Loxapine [Moles/volume] in Serum or Plasma |
| 52821-6 | Saint Louis encephalitis virus IgG Ab [Presence] in Serum by Immunoassay |
| 22948-4 | Brucella sp Ag [Presence] in Tissue from Fetus by Immune stain |
| 23078-9 | Equine arteritis virus Ag [Presence] in Tissue by Immune stain |
| 32824-5 | Microscopic observation [Identifier] in Specimen by Tartrate-resistant acid phosphatase stain |
| 53439-6 | Argininosuccinate lyase [Enzymatic activity/mass] in Liver from Fetus |
| 44469-5 | Herpes simplex virus 1 Ab [Presence] in Body fluid |
| 44523-9 | Histoplasma capsulatum IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 44607-0 | HIV 1 [Interpretation] in Serum or Plasma by Immunoassay |
| 44869-6 | Histoplasma capsulatum Ab [Presence] in Serum by Counterimmunoelectrophoresis (CIE) |
| 33245-2 | Amylase [Catalytic Activity] in Urine collected for unspecified duration |
| 33316-1 | Salmonella paratyphi A O Ab [Titer] in Serum |
| 33623-0 | Pentacarboxylporphyrin I [Mass/time] in 24 hour Stool |
| 53816-5 | Alpha hydroxytriazolam [Mass/volume] in Serum |
| 45056-9 | Glucose [Moles/volume] in Serum or Plasma --8 PM specimen |
| 45186-4 | Kiwifruit IgE Ab/IgE total in Serum |
| 45343-1 | Sex+stage of tick |
| 24067-1 | Beta mannosidase [Enzymatic activity/mass] in Fibroblast |
| 24079-6 | Cholesterol esterase [Enzymatic activity/mass] in Fibroblast |
| 33908-5 | Prolactin [Moles/volume] in Serum or Plasma --1.5 hours post 200 ug TRH IV |
| 54028-6 | Lamin Ab [Titer] in Serum by Immunofluorescence |
| 54143-3 | Gardnerella vaginalis DNA [Presence] in Vaginal fluid by Probe with signal amplification |
| 34525-6 | Erythrocytes.lytic resistant [Presence] in Blood by Automated count |
| 55358-6 | Osmolality of Urine--2 hours post fluid fast |
| 4709-2 | HLA-A69(28) [Presence] in Donor |
| 55773-6 | Cardiolipin IgM Ab [Multiple of the median] in Serum |
| 55831-2 | Catecholamines [Moles/volume] in Body fluid |
| 35501-6 | Pesticide and Insecticide panel [Mass/volume] - Urine and Serum or Plasma |
| 48125-9 | Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose insulin IV |
| 2609-6 | Metanephrines [Mass/time] in 24 hour Urine |
| 26524-9 | Promyelocytes/100 leukocytes in Blood |
| 3800-0 | Methoxyphenamine [Mass/time] in 24 hour Urine |
| 48493-1 | Beta-trace protein [Mass/volume] in Cerebral spinal fluid |
| 48819-7 | Karyotype [Identifier] in Tissue from Fetus Nominal |
| 26969-6 | Parietal cell Ab [Presence] in Serum by Immunofluorescence |
| 57291-7 | HLA-B [Type] by High resolution |
| 57325-3 | Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 57576-1 | Androstanolone [Moles/volume] in Serum or Plasma --pre dose corticotropin |
| 57899-7 | Triiodothyronine (T3)/Triiodothyronine (T3).reverse [Ratio] in Serum or Plasma |
| 49403-9 | Herpes virus 8 DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 39801-6 | Triglyceride [Moles/volume] in Pleural fluid |
| 40221-4 | Glucose [Moles/volume] in Serum or Plasma --36 hours post XXX challenge |
| 49761-0 | Alpha-1-Fetoprotein [Mass/volume] in Peritoneal fluid |
| 49918-6 | Heptacarboxylporphyrin II [Mass/time] in unspecified time Stool |
| 29777-0 | Coxiella burnetii phase 2 IgG Ab [Presence] in Serum by Immunoassay |
| 4060-0 | Tocainide [Mass/volume] in Serum or Plasma |
| 40601-7 | Alpha-1-acid glycoprotein [Presence] in Serum or Plasma by Immunoelectrophoresis |
| 40956-5 | Yersinia sp Ab [Presence] in Serum by Complement fixation |
| 12589-8 | Creatinine [Mass/time] in 12 hour Urine |
| 1259-1 | N Ag [Presence] on Red Blood Cells from Blood product unit |
| 13483-3 | Oxalate/Creatinine [Mass Ratio] in Urine |
| 102411-6 | Easter lily IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102639-2 | Tuna IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102773-9 | Mustard IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15347-8 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 10800-1 | Microscopic observation [Identifier] in Tissue by Periodic acid-Schiff stain with diatase digestion |
| 11041-1 | Creatinine [Mass/volume] in Serum or Plasma --post dialysis |
| 11048-6 | Glyceraldehyde 3 phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
| 16539-9 | Candida sp Ag [Presence] in Serum |
| 12209-3 | Eosinophils/100 leukocytes in Body fluid by Manual count |
| 1753-3 | Albumin [Presence] in Urine |
| 17728-7 | Treponema pallidum IgM Ab [Units/volume] in Serum by Immunofluorescence |
| 90429-2 | Microorganism preliminary growth [Presence] in Body fluid by Aerobe culture |
| 74825-1 | Saint Louis encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 92-7 | Cefodizime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 75725-2 | CYP1A2 gene c.-729C>T [Presence] in Blood or Tissue by Molecular genetics method |
| 75771-6 | Trifluoperazine [Presence] in Blood or Urine by Screen method |
| 76089-2 | Respiratory syncytial virus RNA [Presence] in Nasopharynx by NAA with probe detection |
| 76678-2 | Appearance of Cerebral spinal fluid--4th tube |
| 77024-8 | Human metapneumovirus RNA [Presence] in Nasopharynx by NAA with probe detection |
| 61320-8 | Scad IgE Ab/IgE total in Serum |
| 616-3 | Bacteria identified in Line specimen by IV Line culture |
| 6195-2 | Cocksfoot IgE Ab [Units/volume] in Serum |
| 77342-4 | Beta 1 globulin [Mass/volume] by Electrophoresis in Urine collected for unspecified duration |
| 63145-7 | Gum arabic IgG Ab [Mass/volume] in Serum |
| 94434-8 | HLA-DPB1 IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC) |
| 9471-4 | Fluoride [Mass/volume] in Water |
| 94753-1 | Psychotropic medication pharmacogenomic analysis in Blood or Tissue by Molecular genetics method |
| 63441-0 | Tissue polypeptide Ag [Units/volume] in Serum or Plasma |
| 79289-5 | Creatine and guanidinoacetate panel - Serum or Plasma |
| 95578-1 | Tetrahydrodeoxycortisol [Z-score] in 24 hour Urine |
| 65357-6 | Proinsulin [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 6682-9 | Microscopic observation [Identifier] in Tissue by Wright Giemsa stain |
| 79695-3 | Octadecatetraenoate (C18:4w3) [Moles/volume] in Serum or Plasma |
| 95964-3 | European gooseberry IgE Ab [Units/volume] in Serum |
| 68989-3 | Performing laboratory [Address] |
| 96970-9 | TP53 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 97228-1 | chlordiazePOXIDE [Presence] in Cord tissue by Screen method |
| 97268-7 | Meperidine [Presence] in Cord tissue by Screen method |
| 8-3 | Amdinocillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 85584-1 | Dengue virus RNA [Presence] in Plasma from Donor by NAA with probe detection |
| 72501-0 | Homocyst(e)ine [Moles/volume] in Serum or Plasma --6 hours post dose methionine |
| 72605-9 | Cytomegalovirus glycoprotein genotype in Specimen by NAA with probe detection |
| 85833-2 | Carbapenem resistance blaGIM gene [Presence] by Molecular method |
| 86014-8 | Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 73030-9 | Clopidogrel induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73370-9 | Fosinopril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87418-0 | Cytolethal distending toxin B Ab [Units/volume] in Serum by Immunoassay |
| 87755-5 | Clostridioides difficile BI-NAP1-027 strain DNA [Presence] in Stool by NAA with probe detection |
| 88714-1 | Dehydroaripiprazole [Mass/volume] in Serum or Plasma by Confirmatory method |
| 88917-0 | Leishmania sp DNA [Identifier] in Bone marrow by NAA with probe detection |
| 88968-3 | Waxy casts [#/area] in Urine sediment |
| 41502-6 | Moxifloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
| 50918-2 | Thallium [Moles/volume] in 24 hour Urine |
| 42177-6 | Fc epsilon RI Ab [Presence] in Serum |
| 59986-0 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 60036-1 | 1-Naphthol [Mass/volume] in Blood |
| 6005-3 | Prekallikrein (Fletcher Factor) [Units/volume] in Platelet poor plasma |
| 60284-7 | Amobarbital [Moles/volume] in Specimen |
| 31470-8 | Legionella pneumophila 9 Ab [Units/volume] in Serum |
| 31837-8 | Haemophilus influenzae D Ag [Presence] in Cerebral spinal fluid |
| 31929-3 | Parainfluenza virus Ag [Presence] in Specimen |
| 31978-0 | Trichomonas vaginalis Ag [Presence] in Genital specimen |
| 51606-2 | Xylose [Moles/volume] in Blood --3 hours post dose xylose PO |
| 43693-1 | Varicella zoster virus identified in Skin by Shell vial culture |
| 22404-8 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum |
| 32148-9 | Toxic substance identified in Urine |
| 3224-3 | Coagulation factor XI inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
| 5269-6 | Parainfluenza virus 2 Ab [Titer] in Serum by Complement fixation |
| 5289-4 | Reagin Ab [Units/volume] in Cerebral spinal fluid by VDRL |
| 52907-3 | Bismuth/Creatinine [Molar ratio] in Urine |
| 53035-2 | DNA marker assessed [Identifier] |
| 442-4 | Rosoxacin [Susceptibility] by Serum bactericidal titer |
| 5340-5 | Salmonella paratyphi A O Ab [Presence] in Serum by Latex agglutination |
| 23269-4 | Mycoplasma capricolum ss capripneumonia Ag [Presence] in Specimen |
| 33926-7 | PCA-Tr Ab [Titer] in Serum |
| 46190-5 | Herpes simplex virus Ab [Presence] in Body fluid |
| 34616-3 | Amino acids [Identifier] in Cerebral spinal fluid |
| 55521-9 | Acebutolol [Moles/volume] in Specimen |
| 2520-5 | Lactate [Moles/volume] in Cerebral spinal fluid |
| 25489-6 | Normetanephrine [Moles/volume] in Serum or Plasma |
| 35023-1 | Monocytes+Macrophages [#/volume] in Peritoneal fluid |
| 47673-9 | Isoleucine/Amino acids.total in Cerebral spinal fluid |
| 25995-2 | Tyrosine [Moles/volume] in 24 hour Urine |
| 35606-3 | Desipramine [Mass/volume] in Serum or Plasma by Screen method |
| 56167-0 | Corticotropin IgG4 Ab [Mass/volume] in Serum |
| 56333-8 | Oat IgG4 Ab [Mass/volume] in Serum |
| 48241-4 | Aspergillus fumigatus triggered leukotriene release [Mass/volume] by Leukocytes |
| 26581-9 | Gamma aminobutyrate/Creatinine [Molar ratio] in Urine |
| 26785-6 | ePHEDrine+Pseudoephedrine [Mass/volume] in Urine |
| 3779-6 | Methamphetamine [Presence] in Urine |
| 57010-1 | Nuclear Ab [Presence] in Pleural fluid by Immunoassay |
| 2722-7 | Pantothenate [Mass/volume] in Serum, Plasma or Blood |
| 38382-8 | Influenza virus B [Presence] in Specimen by Organism specific culture |
| 49067-2 | La Crosse virus IgG and IgM [Interpretation] in Cerebral spinal fluid |
| 27338-3 | 2,4-Dichlorophenoxyacetate [Mass/volume] in Serum or Plasma |
| 2815-9 | Porphyrins [Mass/volume] in Serum or Plasma |
| 2879-5 | Protein [Presence] in Cerebral spinal fluid |
| 2909-0 | Pyruvate carboxylase [Enzymatic activity/mass] in Tissue |
| 293-1 | Kanamycin [Susceptibility] by Serum bactericidal titer |
| 58470-6 | Nucleated cells [#/volume] in Cerebral spinal fluid |
| 58598-4 | Corticotropin [Mass/volume] in Plasma --3 hours post dose insulin IV |
| 4977-5 | HLA-DR1 [Presence] |
| 50101-5 | 3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Cerebral spinal fluid |
| 58866-5 | Somatotropin [Mass/volume] in Serum or Plasma --42nd specimen |
| 58888-9 | Pyruvate [Mass/volume] in Blood --10 minutes post XXX challenge |
| 50229-4 | Fatty casts [Presence] in Urine by Computer assisted method |
| 50365-6 | Platelet glycoprotein IIb/IIIa Ab [Presence] in Serum |
| 50543-8 | Tricyclic antidepressants [Mass/volume] in Urine |
| 19277-3 | Barbiturates screen method [Identifier] in Urine |
| 19290-6 | Cannabinoids positive [Identifier] in Urine by Confirmatory method |
| 20575-7 | Hepatitis A virus Ab [Presence] in Serum |
| 13328-0 | Measles virus Ag [Presence] in Serum or Plasma by Immunofluorescence |
| 1341-7 | Xg sup(a) Ag [Presence] on Red Blood Cells |
| 102150-0 | White Ash IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13568-1 | N-desalkylflurazepam [Presence] in Serum or Plasma |
| 102329-0 | Goldenrod IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103689-6 | Histoplasma sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 1605-5 | Norepinephrine [Mass/volume] in Plasma --3 hours post 300 ug cloNIDine PO |
| 10706-0 | Picornavirus [Identifier] in Stool by Electron microscopy |
| 1101-5 | Kp sup(a) Ag [Presence] on Red Blood Cells from Donor |
| 11100-5 | Tetrachloroethylene [Mass/volume] in Blood |
| 16525-8 | Calcium/Phosphate [Mass Ratio] in Serum or Plasma |
| 16699-1 | Cyclohexanol [Mass/volume] in Urine |
| 1141-1 | Lu sup(ab) Ab [Presence] in Serum or Plasma |
| 17082-9 | Lipoprotein.alpha [Mass/volume] in Body fluid |
| 18864-9 | Ampicillin [Susceptibility] |
| 90073-8 | Lactobacillales identified in Isolate by Organism specific culture |
| 90418-5 | BAFF-R cells/100 CD19 cells in Blood |
| 61045-1 | Methylenedioxyamphetamine [Presence] in Serum or Plasma |
| 61070-9 | 7-Aminoclonazepam [Presence] in Gastric fluid |
| 62203-5 | t(10;11)(p12;q23)(MLLT10,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 93780-5 | Primary mediastinal large B-cell lymphoma [Likelihood] in Tissue |
| 63187-9 | Saltwort IgG Ab [Mass/volume] in Serum |
| 63338-8 | SCL-70 extractable nuclear Ab [Titer] in Serum by Immunoassay |
| 78810-9 | Beryllium [Moles/mass] in Tissue |
| 78887-7 | Trans-3-Hydroxycotinine [Mass/volume] in Saliva (oral fluid) |
| 79322-4 | Lysophosphatidylcholine(26:0) [Moles/volume] in Serum or Plasma |
| 95095-6 | Glucagon [Mass/volume] in Serum or Plasma --2 hours post meal |
| 95181-4 | Mycoplasma synoviae Ab [Titer] in Serum by Immunoassay |
| 95236-6 | Hepatitis B virus DNA [Interpretation] in Serum or Plasma |
| 95522-9 | SARS-CoV-2 (COVID-19) N gene [Log #/volume] (viral load) in Respiratory system specimen by NAA with probe detection |
| 79647-4 | Beta-ureidoisobutyrate/Creatinine [Molar ratio] in Urine |
| 80182-9 | S-adenosylmethionine/Creatinine [Molar ratio] in Urine |
| 6763-7 | Glucose [Presence] in Urine by Test strip --1.5 hours post 75 g glucose PO |
| 96601-0 | Bacilliform bacteria [Presence] in Skin by Light microscopy |
| 6921-1 | Cytomegalovirus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 82084-5 | Mold Allergen Mix 4 (Aspergillus fumigatus+Aspergillus niger+Aspergillus terreus+Aspergillus flavus) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 97733-0 | Influenza virus types A and B and subtypes RNA panel - Specimen by NAA with probe detection |
| 70132-6 | Rickettsia typhus group IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
| 71623-3 | Monocytes/Leukocytes [Pure number fraction] in Synovial fluid by Manual count |
| 82899-6 | Pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
| 82991-1 | Phospholipase A2 receptor IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 71772-8 | Mitogen stimulated gamma interferon [Units/volume] in Blood |
| 72217-3 | t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
| 85513-0 | Hepatitis D virus RNA [log units/volume] (viral load) in Serum by NAA with probe detection |
| 72659-6 | OXcarbazepine [Mass/volume] in Serum or Plasma --trough |
| 72720-6 | Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation |
| 86076-7 | Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum --2nd specimen |
| 73024-2 | Fenofibrate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73286-7 | metFORMIN induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73368-3 | Furosemide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73749-4 | 4p16.3 chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal |
| 88236-5 | Bacteria identified in Cerebral spinal fluid by Aerobe culture |
| 73973-0 | O-nortramadol [Mass/volume] in Blood |
| 4154-1 | Carbromal [Mass] of Dose |
| 41605-7 | Lactose [Mass/volume] in Serum or Plasma --pre fast |
| 59895-3 | Dextromethorphan [Moles/volume] in Urine |
| 30905-4 | Cobalamin (Vitamin B12) [Ratio] in 24 hour Urine --post dose cyanocobalamin+intrinsic factor/post dose cyanocobalamin |
| 4210-1 | Nordoxepin [Mass] of Dose |
| 59935-7 | Naproxen [Moles/volume] in Gastric fluid |
| 60114-6 | PACLitaxel [Mass/volume] in Serum or Plasma |
| 60126-0 | Papaverine [Mass/volume] in Urine |
| 21173-0 | Cephaeline [Mass/volume] in Serum or Plasma |
| 31497-1 | Ganglioside GM1 Ab [Presence] in Serum |
| 51116-2 | CD20 blasts/100 blasts in Specimen |
| 51367-1 | CD79a cells/100 cells in Bone marrow |
| 51375-4 | CD9 cells/100 cells in Cerebral spinal fluid |
| 42929-0 | Lactate dehydrogenase panel - Serum or Plasma |
| 31896-4 | Mumps virus Ag [Presence] in Sputum |
| 22503-7 | Measles virus IgG Ab [Units/volume] in Serum --1st specimen |
| 22699-3 | Alloisoleucine/Creatinine [Molar ratio] in Urine |
| 22765-2 | Adult fly identified in Specimen |
| 32093-7 | Methadone [Presence] in Specimen |
| 43871-3 | Aspergillus sp IgA Ab [Presence] in Serum |
| 44726-8 | HLA-B51 [Presence] |
| 33479-7 | Epstein Barr virus early restricted Ab [Titer] in Serum |
| 33626-3 | Hematoporphyrin [Mass/time] in 24 hour Stool |
| 53750-6 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --15 minutes post XXX challenge |
| 44874-6 | HTLV I+II RNA [Presence] in Serum by NAA with probe detection |
| 45137-7 | IgA.secretory [Mass/volume] in Body fluid |
| 23743-8 | Genistein [Units/volume] in Serum or Plasma |
| 240-2 | Ethambutol [Susceptibility] by Minimum lethal concentration (MLC) |
| 33761-8 | Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols |
| 33952-3 | Immune complex.IgM [Mass/volume] in Serum or Plasma |
| 34059-6 | Glucose [Moles/volume] in Serum or Plasma --pre or post dose glucose |
| 53983-3 | Homogenous nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
| 46417-2 | Prothrombin time (PT) in Capillary blood by Coagulation assay |
| 24377-4 | Platelet aggregation ADP induced [Presence] in Platelet rich plasma |
| 34583-5 | Candida sp IgG Ab [Presence] in Serum |
| 55220-8 | Asialoglycoprotein receptor Ab [Units/volume] in Serum |
| 55401-4 | Warfarin tracking panel - Platelet poor plasma |
| 25361-7 | Caffeine [Moles/volume] in Serum or Plasma |
| 47866-9 | Phosphoribosylpyrophosphate synthetase [Enzymatic activity/mass] in Red Blood Cells |
| 25618-0 | Cortisol [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 25683-4 | Lambda light chains [Presence] in Serum by Immunoelectrophoresis |
| 25796-4 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 25858-2 | Anserine [Moles/volume] in 24 hour Urine |
| 56216-5 | Cheese mold type IgG4 Ab [Mass/volume] in Serum |
| 56289-2 | Horseradish IgG4 Ab [Mass/volume] in Serum |
| 48310-7 | Influenza virus A [Presence] in Specimen by Organism specific culture |
| 26575-1 | 3-Methylhistidine/Creatinine [Molar ratio] in Urine |
| 38177-2 | Kappa light chains.free [Mass/time] in 24 hour Urine |
| 48777-7 | Kappa light chains.free/Albumin in Serum and CSF |
| 27065-2 | Ketones [Presence] in Urine --2 hours post XXX challenge |
| 38348-9 | Herpes virus 6 DNA [Identifier] in Specimen by NAA with probe detection |
| 4899-1 | HLA-Dw24 [Presence] |
| 27346-6 | Benzfetamine [Mass/volume] in Vitreous fluid |
| 49700-8 | Metanephrine Free [Moles/volume] in Serum or Plasma |
| 39968-3 | Creatinine [Mass/volume] in Serum or Plasma --8 hours post XXX challenge |
| 40394-9 | Phencyclidine [Presence] in Hair |
| 40564-7 | Thyroid transcription factor 1 Ag [Presence] in Tissue by Immune stain |
| 30405-5 | Leukocytes [#/volume] in Urine |
| 1956-2 | Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in Serum or Plasma |
| 2083-4 | Cholesterol esterase [Enzymatic activity/volume] in Serum |
| 21016-1 | CD41 cells [#/volume] in Blood |
| 100144-5 | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot |
| 101446-3 | Creatine kinase.MB [Moles/volume] in Serum or Plasma by Immunoassay |
| 101827-4 | Urate crystals [Saturation Fraction] in 24 hour Urine |
| 13904-8 | Meclizine [Mass/volume] in Serum or Plasma |
| 13982-4 | Beta globulin/Protein.total in Serum or Plasma by Electrophoresis |
| 14042-6 | Corticosterone [Mass/time] in 24 hour Urine |
| 14204-2 | Chlamydia trachomatis C IgM Ab [Titer] in Serum by Immunofluorescence |
| 102797-8 | Lodgepole Pine+Pondersosa Pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102955-2 | Aureobasidium pullulans IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103041-0 | Olive pollen native (nOle e) 7 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14685-2 | Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma |
| 14874-2 | PHENobarbital [Moles/volume] in Serum or Plasma |
| 15015-1 | Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma |
| 10540-3 | glyBURIDE [Mass/volume] in Serum or Plasma |
| 1572-7 | Insulin [Mass/volume] in Serum or Plasma --pre 75 g glucose PO |
| 10897-7 | Eastern equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 11479-3 | Microscopic observation [Identifier] in Tissue by Acid fast stain |
| 16952-4 | Herpes simplex virus 1 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 17206-4 | CD9 cells/100 cells in Blood |
| 17635-4 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum |
| 19108-0 | Histoplasma capsulatum Ag [Presence] in Serum |
| 92763-2 | 7-Alpha hydroxy-4-cholesten-3-one [Moles/volume] in DBS |
| 75045-5 | Sialate [Moles/volume] in Amniotic fluid |
| 75263-4 | Blood group antibody screen [Presence] in Serum or Plasma by GEL |
| 76350-8 | Other cells/100 leukocytes in Body fluid |
| 92845-7 | Insulin resistance score in Serum by Calculated.CardioIQ |
| 61249-9 | Cladosporium herbarum IgE Ab/IgE total in Serum |
| 77386-1 | Parainfluenza virus 2 Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
| 93990-0 | Osmolality of Serum or Plasma--1 hour post fluid fast |
| 6308-1 | Adenovirus rRNA [Presence] in Specimen by Probe |
| 78842-2 | JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
| 78855-4 | M-chlorophenylpiperazine [Mass/volume] in Urine |
| 79527-8 | 4-Deoxythreonate/Creatinine [Molar ratio] in Urine |
| 9607-3 | Taenia solium larva 50kD Ab [Presence] in Serum by Immunoblot |
| 96278-7 | Dermatophagoides pteronyssinus recombinant (rDer p) 23 IgE Ab [Units/volume] in Serum |
| 80550-7 | Tacrolimus [Mass/volume] in DBS |
| 96639-0 | HLA-DP and DQ and DR (class II) typing panel - Blood or Tissue from Donor by High resolution |
| 69944-7 | Glucose [Moles/volume] in Serum or Plasma --40 minutes post 50 g lactose PO |
| 8165-3 | Tetrahydrocannabinol [Presence] in Gastric fluid by Screen method |
| 81774-2 | Actin smooth muscle IgG Ab [Presence] in Serum |
| 81846-8 | C9orf72 gene GGGGCC repeat analysis in Blood or Tissue by Molecular genetics method |
| 82249-4 | Chromosome region 8q23.3-24.13 deletion in Blood or Tissue by FISH |
| 97291-9 | Noroxycodone [Presence] in Cord tissue by Confirmatory method |
| 97935-1 | Bourbon virus RNA [Presence] in Specimen by NAA with probe detection |
| 7118-3 | Basil IgE Ab [Units/volume] in Serum |
| 8245-3 | Zinc [Mass/volume] in Blood |
| 82453-2 | Zo Ab [Presence] in Serum by Line blot |
| 82499-5 | TRBV4 gene segments/TRBV gene segments.total in Blood |
| 729-4 | Leukocytes other [#/volume] in Blood by Manual count |
| 72998-8 | Losartan induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73644-7 | Fidaxomicin [Susceptibility] by Disk diffusion (KB) |
| 88027-8 | Rh group Ag [Type] on Red Blood Cells |
| 74280-9 | Mitogen stimulated gamma interferon positive control spot count [#] in Blood |
| 88996-4 | Eicosapentaenoate (C20:5w3)/Arachidonate (C20:4w6) [Molar ratio] in Serum or Plasma |
| 41278-3 | Gross blood [Presence] of Stool Qualitative |
| 41839-2 | Burkholderia pseudomallei IgG and IgM panel - Serum by Immunofluorescence |
| 41871-5 | Voltage-gated potassium channel Ab [Moles/volume] in Serum |
| 60059-3 | Bismuth [Mass/mass] in Tissue |
| 6012-9 | von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 51098-2 | CD179a blasts [Units/volume] in Bone marrow |
| 51143-6 | CD3 blasts/100 blasts in Bone marrow |
| 42748-4 | Phosphatidylethanolamine IgG Ab B2GP1 independent [Multiple of the median] in Serum |
| 31954-1 | Rinderpest virus Ag [Units/volume] in Specimen |
| 51631-0 | Platelet distribution width [Ratio] in Blood |
| 4334-9 | Midazolam [Mass] of Dose |
| 32230-5 | Asparagine [Moles/volume] in Body fluid |
| 32353-5 | Estriol (E3) [Multiple of the median] in Serum or Plasma |
| 44357-2 | Galactomannan Ag [Units/volume] in Serum or Plasma by Immunoassay |
| 23011-0 | Cowdria ruminantium Ab [Presence] in Serum by Immunoassay |
| 23103-5 | Equine influenza virus A2 Ab [Presence] in Serum by Complement fixation |
| 23133-2 | Histoplasma farciminosum Ab [Presence] in Serum by Immunoassay |
| 44832-4 | Glycogen synthase I/Glycogen synthase.total in Blood |
| 23487-2 | Transmissible gastroenteritis virus Ab [Presence] in Serum |
| 23558-0 | Vesicular stomatitis virus Ag [Presence] in Throat by Immunoassay |
| 33351-8 | 11-Dehydro thromboxane beta 2 [Mass/volume] in Urine |
| 45178-1 | Basement membrane zone IgG Ab [Presence] in Serum by Immunofluorescence |
| 45378-7 | Glutathione peroxidase [Enzymatic activity/mass] in Red Blood Cells |
| 33888-9 | aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --1H post incubation with 1:4 normal plasma |
| 4564-1 | Hemoglobin C - Harlem [Presence] in Blood |
| 46737-3 | Galactosemias newborn screen interpretation |
| 2423-2 | Histidine [Mass/volume] in Urine |
| 24292-5 | Influenza virus B Ab [Titer] in Serum --2nd specimen |
| 24314-7 | TORCH 1996 panel - Serum |
| 24511-8 | Western wheatgrass IgE Ab [Units/volume] in Serum |
| 34387-1 | Zinc [Moles/volume] in Urine |
| 34392-1 | Food Allergen Mix 17 (Apple+Banana+Pear+Peach) IgE Ab [Presence] in Serum by Multidisk |
| 25416-9 | Herpes virus 6 IgG Ab [Titer] in Serum by Immunofluorescence |
| 25549-7 | Urea [Moles/volume] in Body fluid |
| 34969-6 | Fractional oxyhemoglobin in Mixed venous blood |
| 35110-6 | Flecainide [Mass/volume] in Serum or Plasma --trough |
| 47603-6 | Citrate synthase [Enzymatic activity/mass] in Fibroblast |
| 47773-7 | Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose insulin IV |
| 47809-9 | 2-Hydroxysebacate/Creatinine [Molar ratio] in Urine |
| 35750-9 | DMPK gene allele 2 CTG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 48058-2 | Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma by Immunoassay |
| 26469-7 | Leukocytes [#/volume] in Synovial fluid |
| 26614-8 | Taurine [Moles/volume] in Cerebral spinal fluid |
| 56972-3 | Prolactin [Mass/volume] in Serum or Plasma --post precipitation |
| 5709-1 | Paraquat [Mass/volume] in Serum or Plasma |
| 48826-2 | Respiratory allergen panel, US - South Atlantic states a - Serum |
| 38285-3 | Erythrocytes [Presence] in Duodenal fluid |
| 38493-3 | Ketones [Titer] in Serum or Plasma |
| 27316-9 | Dioxin [Presence] in Serum or Plasma |
| 27416-7 | SCL-70 extractable nuclear Ab [Units/volume] in Serum |
| 27883-8 | Lutropin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 57710-6 | Amino acidemias newborn screening comment-discussion |
| 57767-6 | Trimipramine and Nortrimipramine panel - Serum or Plasma |
| 57892-2 | Pregnanediol [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
| 28646-8 | pH of Arterial cord blood |
| 2870-4 | Beta globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis |
| 49856-8 | Methyltestosterone [Presence] in Serum or Plasma |
| 29610-3 | Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 59266-7 | Maternal cell contamination [Identifier] in Specimen Nominal |
| 50224-5 | Epithelial casts [Presence] in Urine by Computer assisted method |
| 50442-3 | Cortisol [Mass/volume] in Serum or Plasma --20 minutes post dose insulin IV |
| 50470-4 | Calcitonin [Mass/volume] in Serum or Plasma --2nd specimen |
| 30074-9 | Hemoglobin F [Presence] in Specimen |
| 19197-3 | Prostate specific Ag [Moles/volume] in Serum or Plasma |
| 19437-3 | Propoxyphene + Norpropoxyphene cutoff [Mass/volume] in Urine for Screen method |
| 1989-3 | 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma |
| 20860-3 | Infectious bronchitis virus [Presence] in Tissue by Organism specific culture |
| 100023-1 | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 101398-6 | Monkeypox virus and Orthopoxvirus.non-variola DNA panel - Specimen |
| 101791-2 | Corynebacterium diphtheriae and Clostridium tetani toxoid Ab Panel - Serum or Plasma |
| 102069-2 | Perfluorodecanoate [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 103047-7 | Mugwort native (nArt v) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10929-8 | Fennel Seed IgE Ab [Units/volume] in Serum |
| 16466-5 | Bile acid.trihydroxy [Mass/volume] in Serum or Plasma |
| 16726-2 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 1164-3 | little e Ag [Presence] on Red Blood Cells from Donor |
| 12305-9 | Chlordecone [Presence] in Blood |
| 16933-4 | Hepatitis B virus core Ab [Presence] in Serum |
| 16948-2 | Herpes simplex virus 1 IgG Ab [Units/volume] in Cerebral spinal fluid |
| 17566-1 | Salmonella typhi O Ab [Presence] in Serum |
| 19-0 | Amoxicillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC) |
| 90275-9 | Gardnerella vaginalis [Presence] in Vaginal fluid by Organism specific culture |
| 90302-1 | Trichomonas vaginalis DNA [Presence] in Cervix by NAA with probe detection |
| 74668-5 | Gardnerella vaginalis DNA [Log #/volume] in Vaginal fluid by NAA with probe detection |
| 92003-3 | Spinal muscular atrophy newborn screening comment-discussion |
| 60328-2 | Pentazocine [Moles/volume] in Specimen |
| 765-8 | Neutrophils.hypersegmented [Presence] in Blood by Light microscopy |
| 62368-6 | Cell phase [Type] |
| 77058-6 | CYP17A1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 93744-1 | HTLV I and II IgG panel - Cerebral spinal fluid |
| 94102-1 | Epstein Barr virus early diffuse IgA Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 94237-5 | F2 gene full mutation analysis in Blood or Tissue by Sequencing |
| 64120-9 | Fourth most predominant hemoglobin in DBS |
| 79333-1 | Viscosity of Cervical mucus Qualitative |
| 95068-3 | ADRB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 95274-7 | DNM2 gene full mutation analysis in Blood or Tissue by Sequencing |
| 65777-5 | Japanese Cedar native (nCry j) 1 IgE Ab [Units/volume] in Serum |
| 79521-1 | Lactyl lactate [Moles/volume] in Serum or Plasma |
| 79571-6 | BCHE gene full mutation analysis in Blood or Tissue by Sequencing |
| 95692-0 | Saint Louis encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay |
| 96300-9 | Cell growth [Presence] of Fibroblast in Tissue culture |
| 9631-3 | Viscosity of Semen |
| 68544-6 | HYDROcodone [Mass/mass] in Meconium by Confirmatory method |
| 686-6 | Respiratory Mycoplasma identified in Specimen by Organism specific culture |
| 8082-0 | Myelin basic protein Ab [Titer] in Serum |
| 97009-5 | Activated clotting time.kaolin+tissue factor induced of Blood by calculation |
| 82105-8 | Regional Allergen Mix 2 (Alternaria alternata+Cat dander+American house dust mite+Dog dander+Horse dander) IgE Ab [Units/volume] in Serum by Multidisk |
| 82177-7 | Mycoplasma pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 82218-9 | 3-Methylcrotonyl-CoA carboxylase [Enzymatic activity/mass] in Fibroblast |
| 97317-2 | Escherichia coli enteroaggregative DNA [Presence] in Stool by NAA with probe detection |
| 70667-1 | Cold agglutinin [Presence] in Serum by 28 degree C incubation |
| 8264-4 | Service comment 03 |
| 82878-0 | Dehydroepiandrosterone (DHEA)/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
| 85099-0 | Norescitalopram [Mass/volume] in Serum or Plasma |
| 85781-3 | Candida albicans DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 99279-2 | Alpha-hydroxy flubromazolam [Mass/volume] in Urine by Confirmatory method |
| 99446-7 | Paper wasp recombinant (rPol d) 5 IgG4 Ab [Mass/volume] in Serum |
| 73302-2 | Linezolid induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87638-3 | p,p'- Dichlorodiphenyldichloroethane [Mass/mass] in Specimen |
| 88534-3 | Human metapneumovirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 89536-7 | PM-SCL extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
| 41479-7 | BK virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 59599-1 | Alpha hydroxyalprazolam [Mass/volume] in Blood |
| 50923-2 | Tin [Moles/time] in 24 hour Urine |
| 421-8 | Polymyxin B [Susceptibility] by Disk diffusion (KB) |
| 43159-3 | Formaldehyde [Mass/volume] in Nonbiological fluid |
| 21815-6 | t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 43383-9 | Neisseria sp identified in Throat by Organism specific culture |
| 32233-9 | Carbamoyl phosphate synthetase [Enzymatic activity/mass] in Tissue |
| 32365-9 | Torque teno virus DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 5212-6 | Herpes virus 6 IgM Ab [Units/volume] in Serum |
| 53466-9 | Eicosanoylcarnitine (C20) [Moles/volume] in Cerebral spinal fluid |
| 44423-2 | Herpes virus 7 DNA [Presence] in Specimen by NAA with probe detection |
| 23460-9 | Theileria annulata Ab [Presence] in Serum by Immunofluorescence |
| 23515-0 | Trypanosoma equiperdum Ab [Presence] in Serum |
| 53564-1 | Platelet aggregation ADP induced in Platelet rich plasma --50 umol/mL |
| 45055-1 | Glucose [Moles/volume] in Serum or Plasma --4 PM specimen |
| 23692-7 | Canine distemper virus IgG Ab [Titer] in Serum |
| 33880-6 | Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --2H post incubation with normal plasma |
| 54448-6 | NPM1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 34575-1 | 8-Hydroxyloxapine [Presence] in Serum, Plasma or Blood |
| 55290-1 | Sulopenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 55497-2 | Insulin [Moles/volume] in Serum or Plasma --3 minutes post dose glucose IV |
| 47569-9 | Argininosuccinate lyase [Enzymatic activity/mass] in Liver |
| 25608-1 | Nitroxoline [Susceptibility] |
| 25659-4 | Gastrin [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 25764-2 | Insulin-like growth factor [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 35593-3 | Creatinine renal clearance/1.73 sq M in Urine and Serum or Plasma collected for unspecified duration |
| 48282-8 | Atracurium triggered leukotriene release [Mass/volume] by Leukocytes |
| 48565-6 | Bacteria # 6 identified in Specimen by Respiratory culture |
| 57721-3 | Reason for lab test in Dried blood spot |
| 49600-0 | Hepatitis B virus DNA [log units/volume] (viral load) in Specimen by NAA with probe detection |
| 29512-1 | Beta hydroxybutyrate [Mass/volume] in Serum or Plasma |
| 49886-5 | Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --1st specimen post XXX challenge |
| 29586-5 | Immunoelectrophoresis panel - Serum |
| 29603-8 | CD5 Ag [Presence] in Tissue by Immune stain |
| 29968-5 | Rubidium [Mass/volume] in 24 hour Urine |
| 40465-7 | Glimepride [Mass/volume] in Serum or Plasma |
| 4069-1 | Triazolam [Mass/volume] in Serum or Plasma |
| 58826-9 | Cortisol [Mass/volume] in Serum or Plasma --17th specimen |
| 5887-5 | Virus identified in Throat by Culture |
| 50192-4 | Cholesterol in VLDL 1+2+3 [Mass/volume] in Serum or Plasma |
| 50250-0 | 21-Deoxycortisol [Moles/volume] in Serum or Plasma |
| 19611-3 | Naltrexone [Mass/volume] in Urine |
| 19626-1 | Nordiazepam cutoff [Mass/volume] in Urine for Screen method |
| 19723-6 | Trichlorothiazide cutoff [Mass/volume] in Urine for Confirmatory method |
| 2058-6 | Catecholamines [Mass/time] in 24 hour Urine |
| 100987-7 | Lymphocyte T-cell and B-cell and Natural killer subsets panel - Cerebral spinal fluid |
| 101644-3 | CD3+CD4+ (T4 helper) cells [#/volume] in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
| 13039-3 | C peptide [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 102065-0 | Perfluorohexane sulfonate [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 102234-2 | Chicory IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102456-1 | White mulberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13953-5 | Hepatitis B virus e Ab [Presence] in Serum or Plasma by Immunoassay |
| 14604-3 | Blood group antibodies identified in Serum or Plasma from Blood product unit |
| 103169-9 | Citrobacter freundii DNA [Presence] in Wound by NAA with probe detection |
| 103645-8 | Asenapine [Mass/volume] in Urine by Confirmatory method |
| 14958-3 | Microalbumin/Creatinine [Mass Ratio] in 24 hour Urine |
| 10866-2 | Sulfatide IgG Ab [Titer] in Serum |
| 12303-4 | Theobromine [Presence] in Urine |
| 12326-5 | Diamorphine [Presence] in Unknown substance |
| 16814-6 | Endomysium Ab [Presence] in Serum by Immunofluorescence |
| 16944-1 | Herpes simplex virus IgM Ab [Units/volume] in Serum |
| 1784-8 | Alpha amino acid nitrogen [Mass/volume] in Plasma |
| 17867-3 | Carnitine free (C0)/Creatinine [Ratio] in Urine |
| 18425-9 | Zucchini IgG Ab [Units/volume] in Serum |
| 90263-5 | Microscopic observation [Identifier] in Milk by Gram stain |
| 90910-1 | Omega 6 fatty acids (w6)/Omega 3 fatty acids (w3) [Mass Ratio] in Blood |
| 91033-1 | Methadone+Metabolite [Presence] in Serum, Plasma or Blood by Screen method |
| 74531-5 | Dicarboxytetradecanoylcarnitine (C14-DC) [Moles/volume] in Serum or Plasma |
| 91839-1 | Bordetella sp Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
| 92242-7 | Pyrazinamide [Susceptibility] by Genotype method |
| 92246-8 | Microorganism resistance mutation detected [Presence] by Molecular method |
| 94010-6 | Bicarbonate [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin |
| 94268-0 | CD11a cells [Presence] in Blood |
| 62860-2 | Influenza virus C RNA [Presence] in Specimen by NAA with probe detection |
| 63146-5 | Karaya gum IgG Ab [Mass/volume] in Serum |
| 77763-1 | ALPRAZolam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 78698-8 | Liver fibrosis score panel - Serum or Plasma Calculated by HepaScore |
| 78764-8 | 7-Hydroxyquetiapine [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine |
| 94458-7 | Monomethylarsonate [Mass/volume] in Urine |
| 78991-7 | Flavin adenine dinucleotide [Moles/volume] in Blood |
| 65772-6 | Soybean native (nGly m) 6 IgE Ab [Units/volume] in Serum |
| 6689-4 | Glucose [Mass/volume] in Blood --2 hours post meal |
| 9581-0 | Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence |
| 69004-0 | Immature granulocytes/100 leukocytes in Body fluid |
| 69569-2 | Risk of ovarian malignancy algorithm score in Serum or Plasma --premenopausal |
| 82137-1 | FGFR3 gene p.Gly380Arg targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
| 97588-8 | Dextromethorphan+Levomethorphan [Presence] in Cord tissue by Screen method |
| 82875-6 | Campylobacter jejuni IgA Ab [Titer] in Serum |
| 98964-0 | Brexpiprazole [Presence] in Urine by Confirmatory method |
| 71790-0 | Calcium [Moles/volume] in Urine collected for unspecified duration |
| 99395-6 | Siderocytes/100 Erythroblasts in Blood or Marrow by Prussian blue stain |
| 86738-2 | Toxoplasma gondii IgG Ab [Presence] in Specimen by Immunoassay |
| 87347-1 | Senecavirus A IgG Ab/Positive control in Serum by Immunoassay |
| 87401-6 | Brachyspira pilosicoli DNA [Presence] in Isolate by NAA with probe detection |
| 7351-0 | Grapefruit triggered histamine release [Units/volume] in Blood |
| 59732-8 | Oxazepam [Mass/mass] in Tissue |
| 50737-6 | Serotonin release.heparin.porcine panel - Serum |
| 51008-1 | Wheat native (nTri a) 19 IgE Ab [Units/volume] in Serum |
| 3107-0 | Urobilinogen [Mass/volume] in Urine |
| 42516-5 | Legionella sp Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 31424-5 | Histone H2a+H2b Ab [Presence] in Serum |
| 31831-1 | Giardia lamblia Ag [Presence] in Stool --2nd specimen |
| 43315-1 | Avian paramyxovirus 7 Ab [Titer] in Serum by Hemagglutination inhibition |
| 22356-0 | HIV 1 Ab [Units/volume] in Serum |
| 22481-6 | Rickettsia typhus group IgM Ab [Titer] in Cerebral spinal fluid |
| 22526-8 | Salmonella pullorum Ab [Presence] in Serum |
| 32334-5 | Pipecolate [Moles/volume] in Serum or Plasma |
| 32359-2 | Glucose [Moles/volume] in Serum or Plasma --10 minutes post dose glucose |
| 32515-9 | CD3+CD4+ (T4 helper) cells [#/volume] in Specimen |
| 22839-5 | Avian pox virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 32638-9 | Blood group antibody screen [Presence] in Serum or Plasma by Saline method |
| 53066-7 | Cystathionine [Moles/volume] in DBS |
| 23320-5 | Nairobi sheep disease virus Ag [Presence] in Specimen by Immunoassay |
| 33535-6 | Influenza virus A+B Ag [Presence] in Nasopharynx |
| 53507-0 | Kynurenin/Creatinine [Molar ratio] in Urine |
| 53561-7 | Lactate dehydrogenase/Creatinine [Ratio] in Urine |
| 45295-3 | Acetylcholinesterase/Cholinesterase [Enzymatic activity ratio] in Amniotic fluid |
| 45358-9 | Length of calorie fast |
| 54031-0 | Smith extractable nuclear D Ab [Presence] in Serum |
| 54380-1 | Cystatin C [Mass/volume] in 24 hour Urine |
| 46194-7 | Legionella non-pneumophila Ab [Titer] in Serum |
| 24184-4 | Coxsackievirus B2 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen |
| 24268-5 | Coxsackievirus B5 Ab [Titer] in Serum --2nd specimen |
| 54476-7 | Pimeloylcarnitine (C7-DC) [Moles/volume] in Urine |
| 55560-7 | Orphenadrine [Moles/volume] in Serum or Plasma |
| 25157-9 | Epithelial casts [Presence] in Urine sediment by Light microscopy |
| 25372-4 | Choriogonadotropin [Units/volume] in Urine |
| 25531-5 | Streptococcus pneumoniae Ab [Mass/volume] in Serum |
| 55857-7 | Estradiol (E2) [Mass/volume] in Body fluid |
| 561-1 | Chlamydia sp Ag [Presence] in Specimen by Immunofluorescence |
| 56318-9 | Meadow Foxtail IgG4 Ab [Mass/volume] in Serum |
| 5651-5 | Fluoride [Mass/time] in 24 hour Urine |
| 26751-8 | Adipate [Presence] in Urine |
| 36923-1 | Epstein Barr virus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
| 26928-2 | Vasopressin [Presence] in 24 hour Urine |
| 27256-7 | Aspartate [Moles/volume] in Amniotic fluid |
| 38568-2 | Asbestos [Mass/volume] in Air |
| 5714-1 | Platinum [Mass/volume] in Serum or Plasma |
| 5783-6 | Unidentified crystals [Presence] in Urine sediment by Light microscopy |
| 39987-3 | Creatinine [Mass/volume] in Urine --2.5 hours post XXX challenge |
| 58528-1 | Corticotropin [Mass/volume] in Plasma --1.5 hours post dose glucose |
| 49914-5 | Legionella pneumophila 1+2+3+4+5+6 IgM Ab [Presence] in Serum |
| 50117-1 | 3-Hydroxyoleoylcarnitine (C18:1-OH)/Creatinine [Molar ratio] in Urine |
| 29870-3 | 4-Hydroxyphenyllactate [Presence] in Urine |
| 40399-8 | Thyrotropin [Units/volume] in Serum or Plasma --20 minutes post dose triple bolus |
| 58974-7 | Ganglioside GM2 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 50246-8 | 17-Hydroxycorticosteroids [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
| 50260-9 | Prekeratocytes [Presence] in Blood by Light microscopy |
| 40857-5 | Prealbumin [Mass/volume] in Urine |
| 40928-4 | Cortisol [Mass/volume] in Serum or Plasma --pre dose dexamethasone |
| 41121-5 | ACADS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 41160-3 | Ascaris lumbricoides IgM Ab [Units/volume] in Serum |
| 20399-2 | Nucleolar nuclear Ab pattern [Titer] in Serum |
| 100909-1 | Cronobacter sakazakii [Presence] by Organism specific culture |
| 101070-1 | CEAG Ab [Presence] in Serum or Plasma |
| 1255-9 | Minor crossmatch [Interpretation] |
| 101847-2 | Betamethasone [Moles/volume] in Urine |
| 101880-3 | Osmolality of Venous blood by calculation |
| 13589-7 | Activated protein C resistance [Presence] in Blood by NAA with probe detection |
| 13765-3 | Isoleucine/Creatinine [Mass Ratio] in Urine |
| 102320-9 | Garlic IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102509-7 | Chili Pepper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14022-8 | HTLV I+II p26 Ab [Presence] in Serum by Immunoblot |
| 14317-2 | Microscopic observation [Identifier] in Genital specimen by Wet preparation |
| 14338-8 | Prealbumin [Mass/volume] in Serum or Plasma |
| 10439-8 | CD3 Ag [Presence] in Tissue by Immune stain |
| 10528-8 | Acetophenazine [Mass/volume] in Serum or Plasma |
| 16235-4 | Methamphetamine [Mass/volume] in Urine by Confirmatory method |
| 11012-2 | Reovirus Ab [Titer] in Serum by Complement fixation |
| 16486-3 | Brucella abortus IgA+IgG+IgM Ab [Units/volume] in Serum |
| 16734-6 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --baseline |
| 17306-2 | Myelin IgG Ab [Presence] in Serum |
| 18903-5 | Chloramphenicol [Susceptibility] |
| 90100-9 | Listeria sp identified in Isolate by Organism specific culture |
| 76524-8 | Acetone [Moles/volume] in Blood |
| 9339-3 | Insulin [Mass/volume] in Serum or Plasma --6 hours post 75 g glucose PO |
| 93408-3 | Platelet aggregation EPINEPHrine induced in Platelet rich plasma --10 umol/L |
| 62862-8 | Microsatellite instability [Presence] in Tissue by Immune stain |
| 78355-5 | Abnormal lymphocytes [Presence] in Blood by Manual count |
| 78748-1 | Hemoglobin pattern [Interpretation] in Blood by Capillary electrophoresis (CE) |
| 63412-1 | Thyroid colloidal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 95205-1 | Hepatitis B virus surface Ab panel - Serum or Plasma |
| 95550-0 | ABL1 gene c.944C>T [Presence] in Blood or Marrow by Molecular genetics method |
| 95639-1 | Cache valley virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 65754-4 | Skin Pathology biopsy report |
| 79613-6 | R- and S-beta aminoisobutyrate and D- and L-serine pattern [Interpretation] in Cerebral spinal fluid Narrative |
| 80212-4 | Beta blockers [Presence] in Hair by Screen method |
| 96427-0 | Borrelia burgdorferi IgM Ab [Presence] in Specimen |
| 8067-1 | Cardiolipin IgM Ab [Units/volume] in Serum or Plasma |
| 96591-3 | Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in DBS |
| 96822-2 | Spurge IgE Ab [Units/volume] in Serum |
| 81752-8 | Chromosome region 1q21 duplication in Bone marrow by FISH |
| 97290-1 | Noroxycodone [Presence] in Cord tissue by Screen method |
| 70671-3 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Milk by Immunoassay |
| 7135-7 | Pinto Bean IgE Ab [Units/volume] in Serum |
| 71613-4 | Eosinophils/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
| 71655-5 | Metamyelocytes/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
| 82485-4 | TRBV20-1 gene segment/TRBV gene segments.total in Blood |
| 82524-0 | 6-Beta naltrexol [Mass/volume] in Urine by Confirmatory method |
| 71786-8 | Staphylococcus aureus exfoliative toxin A eta gene [Presence] in Specimen by NAA with probe detection |
| 72318-9 | Centromere protein A IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 72335-3 | NPM1 gene c.956dupTCTG transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
| 738-5 | Macrocytes [Presence] in Blood by Light microscopy |
| 73936-7 | fentaNYL [Presence] in Blood by Screen method |
| 89006-1 | p53 Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 41629-7 | Burkholderia sp DNA [Identifier] in Specimen by NAA with probe detection |
| 59641-1 | clonazePAM [Mass/mass] in Tissue |
| 50815-0 | Arsenic.inorganic [Moles/time] in 24 hour Urine |
| 31254-6 | Basement membrane IgG Ab [Units/volume] in Serum |
| 31513-5 | Mycoplasma hyopneumoniae Ab [Presence] in Serum |
| 51148-5 | CD3 blasts [Units/volume] in Specimen |
| 42922-5 | Ketamine [Presence] in Serum or Plasma |
| 21786-9 | t(2;13)(q36.1;q14.4)(PAX3,FOXO1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 31611-7 | Rickettsia typhi IgM Ab [Units/volume] in Body fluid |
| 31848-5 | Herpes simplex virus 1 Ag [Presence] in Specimen |
| 51694-8 | Carumonam [Susceptibility] |
| 51716-9 | Muscle specific receptor tyrosine kinase Ab [Moles/volume] in Serum |
| 22317-2 | Hepatitis B virus core Ab [Units/volume] in Serum from Donor |
| 32525-8 | CD19 cells/100 cells in Bone marrow |
| 43860-6 | Amphetamine+Methamphetamine [Presence] in Gastric fluid by Screen method |
| 43982-8 | Choriogonadotropin.intact [Multiple of the median] in Serum or Plasma |
| 44293-9 | Albumin/Globulin [Mass Ratio] in Urine by Electrophoresis |
| 23087-0 | Equine herpesvirus 1+4 Ab [Presence] in Serum |
| 32708-0 | Neutrophil cytoplasmic Ab.classic [Titer] in Serum |
| 32791-6 | Cytomegalovirus IgG Ab [Ratio] in Serum or Plasma by Immunoassay --1st specimen/2nd specimen |
| 53157-4 | Citrulline/Phenylalanine [Molar ratio] in DBS |
| 5331-4 | Rubella virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 33464-9 | Hepatitis D virus Ag [Presence] in Serum |
| 33845-9 | Parathyrin.intact [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
| 33938-2 | Interleukin 5 [Mass/volume] in Serum or Plasma |
| 54159-9 | Pancytokeratin Ab [Titer] in Serum by Immunofluorescence |
| 54307-4 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Urine |
| 54465-0 | Alpha 1 globulin/Protein.total in Dialysis fluid by Electrophoresis |
| 24119-0 | Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 24396-4 | Brucella sp IgG Ab [Presence] in Serum |
| 55523-5 | Anileridine [Moles/volume] in Serum or Plasma |
| 47024-5 | Choriogonadotropin.beta subunit Ag [Presence] in Tissue by Immune stain |
| 47090-6 | Indicans/Creatinine [Molar ratio] in 24 hour Urine |
| 47210-0 | Triglyceride [Moles/volume] in Serum or Plasma --fasting |
| 47411-4 | Methadone [Presence] in Serum or Plasma by Confirmatory method |
| 47899-0 | Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post dose propranolol+glucagon |
| 35427-4 | Herpes simplex virus identified in Peritoneal fluid by Organism specific culture |
| 48254-7 | Mugwort triggered leukotriene release [Mass/volume] by Leukocytes |
| 26495-2 | Mononuclear cells/100 leukocytes in Peritoneal fluid |
| 26608-0 | Ethanolamine [Moles/volume] in Serum or Plasma |
| 3737-4 | Maprotiline [Presence] in Urine |
| 2684-9 | Alpha-1-acid glycoprotein [Mass/volume] in Cerebral spinal fluid |
| 26965-4 | Isoleucine [Moles/volume] in Urine |
| 26973-8 | Beta aminoisobutyrate [Moles/volume] in Urine |
| 38480-0 | Carnitine [Moles/volume] in DBS |
| 5743-0 | Thallium [Mass/volume] in Blood |
| 49461-7 | C4d Ag [Presence] in Tissue by Immune stain |
| 49473-2 | CD123 Ag [Presence] in Tissue by Immune stain |
| 2914-0 | Pyruvate oxidase [Enzymatic activity/volume] in Serum or Plasma |
| 40043-2 | Glucose [Mass/volume] in Serum or Plasma --31 hour post XXX challenge |
| 29539-4 | HIV 1 RNA [Log #/volume] (viral load) in Plasma by Probe with signal amplification |
| 29708-5 | Rickettsia akari Ab [Presence] in Serum by Immunofluorescence |
| 58993-7 | Phosphate [Mass/time] in 18 hour Urine |
| 50472-0 | Calcitonin [Mass/volume] in Serum or Plasma --4th specimen |
| 20556-7 | Phenothiazines [Mass/volume] in Urine by Confirmatory method |
| 20634-2 | Alpha aminobutyrate [Moles/volume] in Serum or Plasma |
| 100978-6 | Thyroxine.free.gestational [Moles/volume] in Serum or Plasma by Immunoassay |
| 100985-1 | HIV protease failed codons [Identifier] by Genotype method |
| 12574-0 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --24 hour specimen |
| 12838-9 | Prostaglandin D2 [Mass/volume] in Urine |
| 101120-4 | Candida glabrata+krusei DNA [Presence] in Blood by NAA with probe detection |
| 101396-0 | Preimplantation multigene analysis in Embryo by Molecular genetics method |
| 13470-0 | Aluminum/Creatinine [Mass Ratio] in Urine |
| 102982-6 | Whitefaced Hornet IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102997-4 | Hake IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14447-7 | Triglyceride [Mass/volume] in Peritoneal fluid |
| 10346-5 | Hemoglobin A [Units/volume] in Blood by Electrophoresis |
| 104107-8 | traMADol [Presence] in Serum or Plasma |
| 14876-7 | Phenylpropanolamine [Presence] in Gastric fluid |
| 104323-1 | IDH1 and IDH2 gene full mutation analysis in Blood or Tissue by Molecular genetics method |
| 10611-2 | Spermatozoa Immotile/100 spermatozoa in Semen |
| 16412-9 | Aspartate aminotransferase [Enzymatic activity/volume] in Red Blood Cells |
| 16414-5 | Aspergillus amstelodami Ab [Units/volume] in Serum |
| 1120-5 | Le sup(b) Ag [Presence] on Red Blood Cells from Donor |
| 16945-8 | Herpes simplex virus Ag [Presence] in Specimen |
| 17649-5 | Streptococcus pneumoniae IgG Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen |
| 19145-2 | Referral lab test name |
| 90926-7 | MET gene amplification in Blood or Tissue by FISH |
| 74675-0 | Codeine [Presence] in Saliva (oral fluid) by Confirmatory method |
| 92514-9 | Blood group Ag and Hemoglobin S inferred panel - Blood or Tissue by Molecular genetics method |
| 92537-0 | Jo sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 7519-2 | Blue mussel IgG Ab [Units/volume] in Serum |
| 76076-9 | Haemophilus ducreyi DNA [Presence] in Genital specimen by NAA with probe detection |
| 93845-6 | UGT1A1 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 62420-5 | Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --8th specimen fasting |
| 63161-4 | Latex IgG Ab [Mass/volume] in Serum |
| 63245-5 | Ganglioside GM1 IgM Ab [Presence] in Body fluid by Immunoassay |
| 94587-3 | Germline disorder chromosome analysis in Amniotic fluid or Chorionic villus sample by Mate pair sequencing |
| 63401-4 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 6452-7 | Leptospira interrogans Ag [Presence] in Specimen by Immunofluorescence |
| 95230-9 | Biliary tract neoplasm chromosome aneuploidy and cytology analysis in Tissue |
| 6524-3 | Rabies virus neutralizing antibody [Units/volume] in Serum by Neutralization test |
| 66766-7 | Albumin in peritoneal fluid/Albumin in Serum or Plasma |
| 67151-1 | Troponin T.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method |
| 9633-9 | Epstein Barr virus capsid IgA Ab [Titer] in Serum by Immunofluorescence |
| 68950-5 | Herpes virus 8 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 8114-1 | CD16-CD57+ cells/100 cells in Blood |
| 81173-7 | Duodenum [Length] in Specimen |
| 9672-7 | Salmonella sp IgA Ab [Units/volume] in Serum |
| 96729-9 | Coral fibers [#/volume] in Lower respiratory specimen by Manual count |
| 96809-9 | Cyanocobalamin IgE Ab [Units/volume] in Serum |
| 97162-2 | Titin Ab [Units/volume] in Cerebral spinal fluid by Line blot |
| 86007-2 | Streptococcus pneumoniae Danish serotype 14 Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen |
| 73068-9 | Amiodarone induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73422-8 | diazePAM induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 50845-7 | Cobalt [Moles/mass] in Hair |
| 50927-3 | Tobramycin [Moles/volume] in Serum or Plasma |
| 60181-5 | Tellurium [Mass/mass] in Tissue |
| 60199-7 | Trifluralin [Mass/volume] in Serum or Plasma |
| 21058-3 | Albumin [Mass/volume] in Serum or Plasma --2 hours post peritoneal dialysis |
| 21117-7 | Borrelia burgdorferi 93kD IgM Ab [Presence] in Serum by Immunoblot |
| 51071-9 | CD135 blasts/100 blasts in Specimen |
| 51200-4 | Nickel [Mass/volume] in Body fluid |
| 51266-5 | CD23 cells/100 cells in Tissue |
| 42721-1 | Oxacillin Resistant Staphylococcus sp isolate [Presence] in Isolate by Latex agglutination |
| 4311-7 | Mersalyl [Mass] of Dose |
| 21688-7 | HBA1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 220-4 | Dicloxacillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 31795-8 | Cytomegalovirus Ag [Presence] in Serum or Plasma |
| 51513-0 | Lactate dehydrogenase 2/Lactate dehydrogenase.total in Peritoneal fluid by Electrophoresis |
| 43806-9 | Urease [Presence] in Tissue --20 minutes post incubation |
| 32537-3 | CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Bone marrow |
| 52984-2 | Cytomegalovirus IgG Ab avidity [Ratio] in Serum or Plasma by Immunoassay |
| 32630-6 | MSH2 gene+MLH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 32687-6 | Herpes simplex virus 1 IgM Ab [Presence] in Serum |
| 32722-1 | Lipase [Enzymatic activity/volume] in Peritoneal fluid |
| 233-7 | Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 45171-6 | Pancreatic islet cell Ab [Units/volume] in Serum by Immunofluorescence |
| 23936-8 | Staphylococcus aureus toxic shock syndrome toxin 1 Ab [Presence] in Serum |
| 4610-2 | Hemoglobin M - Saskatoon [Presence] in Blood |
| 46175-6 | Cache valley virus Ab [Titer] in Serum |
| 54927-9 | Tetranychus urticae IgE Ab [Units/volume] in Serum |
| 35024-9 | Monocytes+Macrophages [#/volume] in Synovial fluid |
| 35045-4 | Variant lymphocytes [#/volume] in Body fluid |
| 55851-0 | Androstenediol [Moles/volume] in Serum or Plasma |
| 55941-9 | Mannitol [Mass/volume] in Urine |
| 55962-5 | Oxygen content in Cord blood |
| 47580-6 | Bicarbonate [Moles/volume] in 24 hour Urine |
| 5616-8 | Cesium [Mass/volume] in Serum or Plasma |
| 56362-7 | Poppy Seed IgG4 Ab [Mass/volume] in Serum |
| 56382-5 | Safflower IgG4 Ab [Mass/volume] in Serum |
| 48154-9 | Threo-4,5-Dihydrohexanoate/Creatinine [Molar ratio] in Urine |
| 26678-3 | Bartonella elizabethae Ab [Presence] in Serum |
| 56754-5 | sp100 Ab [Presence] in Serum by Immunoblot |
| 575-1 | Fungus identified in Skin by Culture |
| 57635-5 | Alpha cortolone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
| 27442-3 | Phenylpropanolamine [Mass/mass] in Stool |
| 27821-8 | Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay |
| 27870-5 | Follitropin [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 27932-3 | Neutrophils/100 leukocytes in Sputum |
| 58036-5 | Xanthine/Total in Stone |
| 28596-5 | Anserine/Creatinine [Ratio] in Urine |
| 58437-5 | Microorganisms seen [Type] in Urine sediment by Light microscopy |
| 58600-8 | Corticotropin [Mass/volume] in Plasma --3 hours post XXX challenge |
| 58622-2 | Corticotropin [Mass/volume] in Plasma --pre dose glucagon |
| 40517-5 | Macrophages/100 leukocytes in Peritoneal fluid by Manual count |
| 40574-6 | Platelets [#/volume] in Body fluid by Automated count |
| 59223-8 | Prostate specific Ag [Mass/volume] in Peritoneal fluid |
| 50199-9 | Iron [Mass/volume] in Serum or Plasma --2nd specimen |
| 5020-3 | Legionella sp rRNA [Presence] in Specimen by Probe |
| 30160-6 | Tau protein [Mass/volume] in Cerebral spinal fluid |
| 30194-5 | Fatty acids.very long chain C22:0 (Docosanoate) [Moles/volume] in Serum or Plasma |
| 41051-4 | SPINK1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19165-0 | Cancer Ag 125 [Units/volume] in Pleural fluid |
| 19535-4 | Meperidine cutoff [Mass/volume] in Urine for Confirmatory method |
| 20546-8 | Methylenedioxyamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
| 2078-4 | Chloride [Moles/volume] in Urine |
| 100899-4 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture |
| 13020-3 | Pesticides [Identifier] in Blood |
| 13321-5 | Human papilloma virus IgG Ab [Presence] in Serum |
| 13428-8 | Norepinephrine [Mass/volume] in Plasma --4th specimen post XXX challenge |
| 102544-4 | Prune IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103113-7 | Alaska pollock roe IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103618-5 | Hepatitis B virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 103675-5 | Phosphorylated tau 181 [Mass/volume] in Plasma by Immunoassay |
| 10506-4 | Peanut agglutinin Ag [Presence] in Tissue by Immune stain |
| 10594-0 | Spermatozoa Tapering Head/100 spermatozoa in Semen |
| 16183-6 | Phenolphthalein [Mass/volume] in Stool |
| 10815-9 | Microscopic observation [Identifier] in Tissue by Tetrachrome stain |
| 16625-6 | clomiPRAMINE [Mass/volume] in Milk |
| 16711-4 | Cystine+Homocystine [Presence] in Urine |
| 11562-6 | Acetylcholine receptor modulation Ab [Units/volume] in Serum |
| 17127-2 | CD26 cells/100 cells in Blood |
| 17457-3 | Phosphoethanolamine [Presence] in Urine |
| 17603-2 | Volume of 24 hour Stool |
| 908-4 | Ax Ab [Presence] in Serum or Plasma from Blood product unit |
| 90992-9 | Monoclonal gammopathy panel - Serum or Plasma |
| 75098-4 | Nervonate (C24:1) [Entitic substance] in Red Blood Cells |
| 75552-0 | Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
| 92813-5 | Borrelia afzelii+burgdorferi+garinii IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 9306-2 | Polymorphonuclear cells/100 leukocytes in Body fluid by Manual count |
| 6240-6 | Seminal fluid IgE Ab [Units/volume] in Serum |
| 7757-8 | Veal IgE Ab [Units/volume] in Serum |
| 63165-5 | Dry-rot Fungus IgG Ab [Mass/volume] in Serum |
| 78206-0 | 4q12 chromosome region rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 78366-2 | Goose feather IgG Ab [Mass/volume] in Serum |
| 78742-4 | Yeast [#/area] in Urine by Automated count |
| 94666-5 | High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy |
| 64964-0 | Hazelnut recombinant (rCor a) 1.0401 IgE Ab [Units/volume] in Serum |
| 79297-8 | D- and L-2-hydroxyglutarate panel - Urine |
| 79486-7 | 3,5-Dihydroxybenzoate/Creatinine [Molar ratio] in Urine |
| 9557-0 | CD2 cells [#/volume] in Blood |
| 95643-3 | Tahyna virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 6568-0 | Trichomonas vaginalis rRNA [Presence] in Genital specimen by Probe |
| 65756-9 | Salmonella sp serovar [Type] in Isolate |
| 96458-5 | Coagulation factor V activity and inhibitor panel - Platelet poor plasma by Coagulation assay |
| 80604-2 | Desacetylrifampicin [Mass/volume] in Serum or Plasma |
| 6985-6 | Beta lactamase.usual [Susceptibility] |
| 70045-0 | Polymorphonuclear cells [#/volume] in Pericardial fluid by Automated count |
| 82055-5 | Food Allergen Mix 13 (Carrot+White bean+Peas+Potato) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 9753-5 | Coxsackievirus A2 Ab [Titer] in Serum by Complement fixation |
| 82925-9 | PM-SCL-100 IgG Ab [Presence] in Serum by Line blot |
| 82978-8 | Leucine-rich glioma-inactivated protein 1 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 99065-5 | Ej Ab [Units/volume] in Serum by Line blot |
| 83078-6 | Beta-2-Microglobulin [Mass/volume] in Serum or Plasma by Immunoassay |
| 84881-2 | Polyps [Presence] in Specimen |
| 85095-8 | D-3-phosphoglycerate dehydrogenase IgG Ab [Presence] in Serum by Line blot |
| 99387-3 | Carbon monoxide [Moles/volume] in Blood |
| 99877-3 | Deep transitional cells [#/volume] in Urine sediment by Computer assisted method |
| 72505-1 | Exserohilum rostratum DNA [Presence] in Specimen by NAA with probe detection |
| 72559-8 | HIV integrase inhibitor susceptibility panel by Phenotype method |
| 73174-5 | RABEprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73261-0 | Mirtazapine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73383-2 | fentaNYL induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74136-3 | fentaNYL [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 50644-4 | Tetrahydrocorticosterone/Creatinine [Mass Ratio] in Urine |
| 50898-6 | Phosphate [Moles/mass] in Hair |
| 30903-9 | Neutrophil oxidative burst [Presence] in Blood by Flow cytometry (FC) |
| 4251-5 | Fenetylline [Mass] of Dose |
| 60110-4 | Oxyphenbutazone [Mass/volume] in Blood |
| 21649-9 | CBS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 21665-5 | EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 31233-0 | Aspergillus sp Ab [Units/volume] in Cerebral spinal fluid |
| 42723-7 | OmpC Ab [Units/volume] in Serum |
| 2175-8 | Cystine [Presence] in Blood |
| 22304-0 | Giardia lamblia Ab [Titer] in Serum |
| 31766-9 | Chlamydia sp Ag [Presence] in Stool |
| 31910-3 | Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Specimen |
| 51680-7 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 22573-0 | Thermoactinomyces vulgaris Ab [Presence] in Serum |
| 22624-1 | Xylose [Moles/volume] in Blood --2 hours post 5 g xylose PO |
| 22795-9 | Anaplasma marginale Ab [Presence] in Serum by Immunoassay |
| 2307-7 | Galactose [Mass/volume] in Blood |
| 53108-7 | Decenoylcarnitine (C10:1)/Creatinine [Molar ratio] in Urine |
| 53310-9 | Leucine crystals [#/area] in Urine by Computer assisted method |
| 44566-8 | Influenza virus A+B Ag [Presence] in Bronchial specimen |
| 45368-8 | Lymphocyte proliferation stimulated by 5 ug concanavalin A in Blood |
| 33766-7 | Radioactivity [Presence] in Urine --pre dose radioactive cyanocobalamin |
| 24233-9 | Coxsackievirus A9 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 47180-5 | Parathyrin [Moles/volume] in Serum or Plasma --baseline |
| 55838-7 | Cholesterol/Phospholipid [Molar ratio] in Serum or Plasma |
| 47640-8 | Hematocrit [Volume Fraction] of Dialysis fluid |
| 47701-8 | Methionine/Amino acids.total in Hair |
| 56172-0 | American Cheese IgG4 Ab [Mass/volume] in Serum |
| 2605-4 | Meat fibers [Presence] in Stool by Light microscopy |
| 26592-6 | Cystathionine [Moles/volume] in Cerebral spinal fluid |
| 35879-6 | Escherichia coli O157:H7 IgG Ab [Units/volume] in Serum |
| 5669-7 | Isopropanol [Mass/volume] in Serum or Plasma |
| 57019-2 | Urinalysis dipstick W Reflex Culture panel - Urine |
| 27252-6 | Choriogonadotropin.alpha subunit [Mass/volume] in Serum or Plasma |
| 5762-0 | Zinc [Mass/volume] in Semen |
| 4890-0 | HLA-Dw20 [Presence] in Donor |
| 2754-0 | pH of Synovial fluid |
| 57698-3 | Lipid panel with direct LDL - Serum or Plasma |
| 57876-5 | Honeydew melon IgG4 Ab [Mass/volume] in Serum |
| 49533-3 | Influenza virus B Ab [Presence] in Serum by Immunoassay |
| 58387-2 | Normeperidine/Creatinine [Mass Ratio] in Urine |
| 58631-3 | Cortisol [Mass/volume] in Saliva (oral fluid) --1.5 hours post 1 ug/kg CRH IV |
| 58800-4 | Oligoclonal bands [Interpretation] in 24 hour Urine by Isoelectric focusing |
| 4980-9 | HLA-DR3 [Presence] in Donor |
| 59140-4 | CD13+CD34+ cells/100 cells in Bone marrow |
| 5925-3 | Gastric acid [Volume] in Gastric fluid |
| 41087-8 | Mitochondrial myopathy gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19254-2 | Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood |
| 20430-5 | Culture medium [Type] in Isolate |
| 20982-5 | Western equine encephalitis virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 12954-4 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 13957-6 | Clostridioides difficile toxin A [Presence] in Stool by Immunoassay |
| 14805-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Pyruvate to lactate reaction |
| 103555-9 | Escherichia coli O157:H7 DNA [Presence] in Wound by NAA with probe detection |
| 103787-8 | Influenza A H3N2V RNA [Presence] in Specimen by NAA with probe detection |
| 15088-8 | Parathyrin.C-terminal [Moles/volume] in Serum or Plasma |
| 15441-9 | Infectious bronchitis virus Conn-42 Ab [Titer] in Serum by Hemagglutination inhibition |
| 16693-4 | Cryptococcus sp Ag [Presence] in Urine |
| 17317-9 | N-acetylprocainamide [Mass/volume] in Urine |
| 17792-3 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum |
| 1814-3 | Acid alpha glucosidase [Enzymatic activity/volume] in Semen |
| 18336-8 | Methyl tert-butyl ether [Mass/volume] in Blood |
| 1854-9 | Androstenedione [Mass/volume] in Serum or Plasma |
| 74979-6 | Urate [Moles/volume] in Bronchoalveolar lavage |
| 75012-5 | t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
| 75308-7 | Fetal blood [Volume] in Blood by Flow cytometry (FC) |
| 76078-5 | Influenza virus A RNA [Presence] in Nasopharynx by NAA with probe detection |
| 92930-7 | LPA gene.c.3947+467T>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 62318-1 | Niemann Pick disease A/B newborn screen interpretation |
| 62350-4 | Chromosome analysis panel - Chorionic villus sample by G-banded |
| 774-0 | Ovalocytes [Presence] in Blood by Light microscopy |
| 9386-4 | NIFEdipine [Mass/volume] in Serum or Plasma |
| 6299-2 | Urea nitrogen [Mass/volume] in Blood |
| 63182-0 | White Oak IgG Ab [Mass/volume] in Serum |
| 94505-5 | SARS-CoV-2 (COVID-19) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 6501-1 | Neisseria meningitidis serogroup C Ag [Presence] in Specimen by Immunofluorescence |
| 66139-7 | Neutrophils [#/volume] in Blood from Fetus by Manual count |
| 66884-8 | Skin Ab.IgG pattern [Interpretation] in Serum by Guinea pig esophagus substrate |
| 95844-7 | Epithelial cells.squamous [#/volume] in Sputum by Manual count |
| 96813-1 | Goat milk cheese IgE Ab [Units/volume] in Serum |
| 81645-4 | Clostridium botulinum toxin D botD gene [Presence] in Specimen by NAA with probe detection |
| 82034-0 | Tree Allergen Mix 6 (Boxelder+Silver birch+American beech+White oak+California walnut) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 98268-6 | Adnexal involvement [Presence] in Endometrial cancer specimen |
| 98966-5 | Antipsychotics drug panel - Urine by Confirmatory method |
| 86133-6 | Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 73381-6 | Fexofenadine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73459-0 | Cephalexin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73881-5 | Cortisone free [Moles/volume] in Urine |
| 74125-6 | Mesothelin Ag [Presence] in Tissue by Immune stain |
| 89316-4 | CD4+CD25+CD45RO+CD127Low+ cells [#/volume] in Blood |
| 41200-7 | Voriconazole [Susceptibility] by Disk diffusion (KB) |
| 59746-8 | Temazepam [Mass/volume] in Blood by Confirmatory method |
| 5986-5 | Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method |
| 50950-5 | Phosphoethanolamine IgA Ab [Presence] in Serum or Plasma |
| 51004-0 | Lipoprotein midband C [Mass/volume] in Serum or Plasma |
| 30498-0 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum --1st specimen |
| 31123-3 | CD25 cells [#/volume] in Blood |
| 31141-5 | cefTRIAXone [Susceptibility] for meningitis by Gradient strip |
| 60246-6 | Androstanolone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 60295-3 | Citalopram [Moles/volume] in Specimen |
| 21139-1 | Carbofuran [Mass/volume] in Urine |
| 21375-1 | Kappa lymphocytes/Lymphocytes.lambda [# Ratio] in Blood |
| 31301-5 | Chlamydophila pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid |
| 51069-3 | CD135 blasts/100 blasts in Bone marrow |
| 51343-2 | CD55 cells/100 cells in Cerebral spinal fluid |
| 42985-2 | Neisseria meningitidis serogroup C IgG Ab [Mass/volume] in Serum |
| 31689-3 | Trivittatus virus Ab [Units/volume] in Serum |
| 31882-4 | Measles virus Ag [Presence] in Skin |
| 51730-0 | Herpes virus 6 IgG and IgM [Interpretation] in Serum Narrative |
| 22668-8 | Propylene glycol [Moles/volume] in Serum or Plasma |
| 32172-9 | Ehrlichia chaffeensis Ab [Presence] in Serum |
| 32527-4 | CD2 cells/100 cells in Bone marrow |
| 521-5 | Troleandomycin [Susceptibility] by Disk diffusion (KB) |
| 52825-7 | La Crosse virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 22859-3 | Bacillus anthracis Ab [Titer] in Serum |
| 53153-3 | Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Phenylalanine [Molar ratio] in DBS |
| 53229-1 | Prealbumin [Mass/time] in 24 hour Urine |
| 44755-7 | Hepatitis D virus Ag [Units/volume] in Serum by Immunoassay |
| 53769-6 | CD55+CD59 deficient RBC actual/normal in Blood |
| 45352-2 | Date skin test interpreted |
| 24094-5 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Leukocytes |
| 33979-6 | Voltage-gated calcium channel N type binding Ab [Moles/volume] in Serum |
| 3416-5 | Buprenorphine [Mass/time] in 24 hour Urine |
| 54000-5 | Multiple nuclear dots nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
| 24288-3 | Eastern equine encephalitis virus Ab [Titer] in Serum --2nd specimen |
| 24420-2 | Haemophilus somnus Ab [Titer] in Serum |
| 3429-8 | Canrenone [Mass/volume] in Urine |
| 34567-8 | Cell count and Differential panel - Peritoneal fluid |
| 55352-9 | Glucose [Moles/volume] in Serum or Plasma --45 minutes post 75 g glucose PO |
| 55357-8 | Osmolality of Urine--3 hours post fluid fast |
| 55505-2 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose glucose |
| 4704-3 | HLA-A43 [Presence] |
| 4722-5 | HLA-A25(10) [Presence] in Donor |
| 34992-8 | Smudge cells/100 leukocytes in Blood |
| 47656-4 | Insulin [Units/volume] in Serum or Plasma --1 minute post dose glucose |
| 25829-3 | Glucosylceramidase [Enzymatic activity/mass] in Fibroblast |
| 56188-6 | Basil IgG4 Ab [Mass/volume] in Serum |
| 56234-8 | Cow milk IgG4 Ab [Mass/volume] in Serum |
| 56248-8 | Dog dander IgG4 Ab [Mass/volume] in Serum |
| 26045-5 | Pheneturide [Moles/volume] in Serum or Plasma |
| 26787-2 | Anserine [Moles/volume] in Amniotic fluid |
| 27001-7 | Diethyl ether [Presence] in Blood |
| 27045-4 | Microscopic exam [Interpretation] of Urine by Cytology |
| 38553-4 | Narcolepsy associated Ag [Presence] in Serum or Plasma |
| 48937-7 | Alpha hydroxyalprazolam [Mass/volume] in Specimen |
| 28052-9 | HIV 1 IgG band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot |
| 3913-1 | Penicillin G [Mass/volume] in Serum or Plasma |
| 49583-8 | Trisomy 21 risk cutoff in Fetus |
| 29741-6 | Leptospira interrogans sv Medanensis Ab [Presence] in Serum |
| 29817-4 | Powassan virus IgG Ab [Presence] in Serum by Immunofluorescence |
| 50476-1 | Calcitonin [Mass/volume] in Serum or Plasma --8th specimen |
| 50532-1 | Parathyrin.intact [Mass/volume] in Serum or Plasma --8th specimen |
| 30060-8 | Amino beta guanidinopropionate [Moles/volume] in Serum or Plasma |
| 30173-9 | Cortisol Free [Moles/volume] in Urine |
| 41078-7 | NIPBL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19168-4 | Carcinoembryonic Ag [Units/volume] in Pleural fluid |
| 19343-3 | Amphetamine [Presence] in Urine by Screen method |
| 19364-9 | Bromazepam [Presence] in Urine by Screen method |
| 20882-7 | Microscopic observation [Identifier] in Stool by Electron microscopy negative stain |
| 12345-5 | Cyclothiazide [Presence] in Urine |
| 101087-5 | Ge2 Ag [Presence] on Red Blood Cells |
| 12858-7 | HIV 1 p32 Ab [Presence] in Serum by Immunoblot |
| 101243-4 | Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 101815-9 | Cytomegalovirus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 13450-2 | Creatinine renal clearance/1.73 sq M in 12 hour Urine and Serum or Plasma |
| 13847-9 | Terminal Deoxyribonucleotidyl Transferase blasts/100 blasts in Blood by Immunoperoxidase stain |
| 102565-9 | Rat serum proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102746-5 | Ginger IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103656-5 | Color of Spun Peritoneal fluid |
| 14922-9 | Toxoplasma gondii IgA+IgE Ab [Units/volume] in Serum by Immunoassay |
| 15482-3 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immune diffusion (ID) |
| 16145-5 | Mescaline [Mass/volume] in Serum or Plasma |
| 17519-0 | Respiratory syncytial virus IgM Ab [Titer] in Cerebral spinal fluid |
| 17780-8 | Helicobacter pylori Ag [Presence] in Stool by Immunoassay |
| 17922-6 | Bacteria # 3 identified in Nose by Anaerobe culture |
| 18480-4 | Human papilloma virus 6+11 DNA [Presence] in Tissue by Probe |
| 18869-8 | Bacampicillin [Susceptibility] |
| 18882-1 | Cefodizime [Susceptibility] |
| 7455-9 | Lemon IgG Ab [Units/volume] in Serum |
| 74581-0 | Fumarase [Enzymatic activity/mass] in Fibroblast |
| 74767-5 | Tryptophan [Moles/volume] in Platelet rich plasma |
| 74944-0 | lamoTRIgine [Mass/volume] in Serum or Plasma --trough |
| 75025-7 | Coproporphyrin 3/Porphyrins.total in Stool |
| 75627-0 | Vascular adhesion protein 1 [Mass/volume] in Serum or Plasma |
| 6042-6 | Beta lactoglobulin MF77 IgE Ab [Units/volume] in Serum |
| 93410-9 | Platelet aggregation ristocetin induced in Platelet rich plasma --5 ug/mL |
| 61419-8 | Imipramine [Mass/volume] in Urine by Confirmatory method |
| 77607-0 | Cortisol [Moles/volume] in Serum or Plasma --1 minute post XXX challenge |
| 78755-6 | 1-Hydroxymidazolam [Mass/volume] in Blood |
| 94751-5 | RHCE gene allele Ee [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 95225-9 | Band form neutrophils/100 leukocytes in Stem cell product by Manual count |
| 80094-6 | Glutamylphenylalanine/Creatinine [Molar ratio] in Urine |
| 8055-6 | Yellow fever virus IgG Ab [Units/volume] in Serum |
| 81429-3 | Bismuth [Moles/volume] in Blood |
| 96536-8 | Bunyamwera virus IgM Ab [Presence] in Specimen by Immunoassay |
| 96703-4 | Clot initiation.kaolin induced/Clot initiation.kaolin induced post heparin neutralization [Time Ratio] in Blood by calculation |
| 6939-3 | IgA subclass 2 [Mass/volume] in Serum |
| 69851-4 | 3-Hydroxyglutarate [Moles/volume] in Serum or Plasma |
| 82097-7 | Food Allergen Mix 21 (Kiwi+Pineapple+Melon+Banana+Peach) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 70121-9 | Francisella tularensis IgG Ab [Units/volume] in Serum or Plasma |
| 70666-3 | Cold agglutinin [Presence] in Serum by 22 degree C incubation |
| 82414-4 | Ha Ab [Units/volume] in Serum by Line blot |
| 82894-7 | Pregnanediol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
| 73094-5 | Valdecoxib induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73352-7 | hydroCHLOROthiazide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87444-6 | Electrical conductivity [Fluid Conductance] of Water |
| 73649-6 | Ceftaroline+Avibactam [Susceptibility] by Disk diffusion (KB) |
| 88054-2 | Lipopolysaccharide binding protein [Mass/volume] in Serum or Plasma by Immunoassay |
| 88728-1 | Babesia microti IgG and IgM panel - Serum by Immunofluorescence |
| 89334-7 | CD27-CD45RO+CD62L-CCR7- cells/100 CD3+CD8+ cells in Blood |
| 41403-7 | Atazanavir [Susceptibility] by Genotype method |
| 59615-5 | ALPRAZolam [Mass/volume] in Urine by Confirmatory method |
| 50820-0 | Base excess in Capillary blood from Fetus by calculation |
| 30576-3 | 2-Ethyl-3-Hydroxypropionate [Presence] in Urine |
| 60010-6 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 60060-1 | Boron [Mass/mass] in Tissue |
| 6021-0 | Apple IgE Ab [Units/volume] in Serum |
| 51094-1 | Cytoplasmic CD179a blasts [Units/volume] in Specimen |
| 51213-7 | Acetaminophen crystals [#/area] in Urine sediment by Microscopy high power field |
| 4273-9 | Heptaminol [Mass] of Dose |
| 42856-5 | Benzoylecgonine [Mass/volume] in Blood by Confirmatory method |
| 43211-2 | Human papilloma virus 6+11+42+43+44 DNA [Presence] in Anal by Probe |
| 22346-1 | Histoplasma capsulatum Ab [Presence] in Serum |
| 3209-4 | Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay |
| 32147-1 | Reducing substances [Mass/volume] in Urine |
| 44685-6 | Distance of invasive melanoma to closest deep margin [Length] in Skin melanoma |
| 53550-0 | Fructosamine/Protein [Ratio] in Serum or Plasma |
| 45214-4 | Isoleucine+Leucine [Moles/volume] in DBS |
| 33846-7 | Parathyrin.intact [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
| 33856-6 | Sezary cells [#/volume] in Blood by Manual count |
| 54430-4 | Pooled platelets given [Volume] |
| 46397-6 | Cortisol [Mass/volume] in Serum or Plasma --15 minutes post 1 ug/kg CRH IV |
| 4692-0 | HLA Ag [Units/mass] in Tissue |
| 47206-8 | Corticotropin [Mass] of Dose |
| 25203-1 | rifAMPin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25266-8 | Oxytetracycline [Mass/volume] in Specimen |
| 34931-6 | CD3+CD4+CD45RO-CD45RA- cells/100 cells in Blood |
| 47756-2 | Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose arginine |
| 25656-0 | Gastrin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 25852-5 | 17-Hydroxycorticosteroids [Moles/volume] in 24 hour Urine |
| 56226-4 | Cocklebur IgG4 Ab [Mass/volume] in Serum |
| 47961-8 | ACVRL1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 2652-6 | NADH dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
| 26542-1 | Glucose [Mass/volume] in Urine --5 hours post dose glucose |
| 35814-3 | Gemifloxacin [Susceptibility] by Disk diffusion (KB) |
| 3690-5 | Imipramine [Mass/volume] in Serum or Plasma |
| 56773-5 | CD1a cells/100 cells in Bronchial specimen |
| 49218-1 | Phosphatidylinositol/Surfactant.total in Amniotic fluid |
| 39458-5 | Beta-2-Microglobulin [Moles/volume] in Body fluid |
| 57948-2 | Collagen crosslinked C-telopeptide [Mass/volume] in 24 hour Urine |
| 58494-6 | C peptide [Mass/volume] in Serum or Plasma --1.5 hours post dose glucose |
| 29615-2 | Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 29634-3 | Terbutaline [Presence] in Urine |
| 29648-3 | Rickettsia australis Ab [Titer] in Serum by Immunofluorescence |
| 29958-6 | Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
| 40573-8 | Variant lymphocytes [#/volume] in Body fluid by Manual count |
| 59232-9 | Prostate Specific Ag Free [Mass/volume] in Pleural fluid |
| 50374-8 | Myelocytes.eosinophilic/100 cells in Bone marrow by Manual count |
| 50453-0 | Cortisol [Mass/volume] in Serum or Plasma --1st specimen |
| 50500-8 | Somatotropin [Mass/volume] in Serum or Plasma --8th specimen |
| 40863-3 | Norovirus genogroup I Ag [Presence] in Stool |
| 20665-6 | Echovirus 14 neutralizing antibody [Titer] in Serum by Neutralization test |
| 20991-6 | Antithrombin [Interpretation] in Platelet poor plasma |
| 21054-2 | Adenovirus IgM Ab [Presence] in Serum |
| 12961-9 | Urea nitrogen [Mass/volume] in Arterial blood |
| 12964-3 | Urea nitrogen [Mass/volume] in Blood --baseline |
| 13008-8 | Methyl propyl ketone [Mass/volume] in Blood |
| 13371-0 | Cystine [Mass/volume] in Cerebral spinal fluid |
| 102019-7 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose glucagon |
| 102085-8 | CNS Demyelinating Disease Panel - Serum or Plasma by Flow cytometry (FC) |
| 13857-8 | Androstenedione [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
| 102337-3 | False oat grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102448-8 | Aedes mosquito IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14571-4 | 17-Hydroxyprogesterone [Moles/time] in 24 hour Urine |
| 14716-5 | Estriol (E3) [Moles/volume] in Serum or Plasma |
| 104332-2 | Bordetella pertussis IgA Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 15395-7 | Parainfluenza virus 3 IgM Ab [Presence] in Serum |
| 11010-6 | Epstein Barr virus capsid IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 12308-3 | HYDROcodone [Presence] in Urine |
| 16735-3 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --post XXX challenge |
| 1725-1 | Adenosine monophosphate deaminase [Enzymatic activity/volume] in Serum |
| 17390-6 | Orphenadrine [Mass/volume] in Urine |
| 17517-4 | Respiratory syncytial virus IgG Ab [Titer] in Cerebral spinal fluid |
| 17793-1 | Immunoglobulin light chains [Mass/volume] in 24 hour Urine |
| 17940-8 | Bacteria # 5 identified in Burn by Culture |
| 1863-0 | Anion gap 4 in Serum or Plasma |
| 92130-4 | Rhinovirus RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 75571-0 | Comment on fetal Monosomy X risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 61203-6 | Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab/IgE total in Serum by Multidisk |
| 75983-7 | Fetal Chromosome 21 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
| 92905-9 | Chromosome 7 copy number/nucleus in Blood or Tissue by FISH |
| 9356-7 | busPIRone [Mass/volume] in Serum or Plasma |
| 93749-0 | Mumps virus N gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 93875-3 | Phosphohistone H3 [Presence] in Tissue by Immune stain |
| 63173-9 | Mycogone perniciosa IgG Ab [Mass/volume] in Serum |
| 6502-9 | Neisseria meningitidis serogroup Y Ab [Titer] in Specimen by Immunofluorescence |
| 80131-6 | Amisulpride [Mass/volume] in Urine |
| 95947-8 | Alcuronium IgE Ab [Units/volume] in Serum |
| 68407-6 | Lymphocytes [#/volume] in Vitreous fluid by Manual count |
| 6874-2 | Calcium [Mass/time] in 24 hour Urine |
| 81688-4 | Barmah forest virus RNA [Presence] in Blood by NAA with probe detection |
| 7140-7 | Wax Bean IgE Ab [Units/volume] in Serum |
| 72433-6 | Gamma hydroxybutyrate [Moles/volume] in Cerebral spinal fluid |
| 839-1 | A1 Ab [Presence] in Serum or Plasma from Blood product unit |
| 84884-6 | Distal AndOr proximal margin involvement [Presence] in Colorectal cancer specimen |
| 85743-3 | Streptococcus pneumoniae Danish serotype 23F DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 99437-6 | English walnut recombinant (rJug r) 1 IgG4 Ab [Mass/volume] in Serum |
| 72614-1 | Oxazepam [Presence] in Saliva (oral fluid) |
| 7287-6 | Dog Fennel IgE Ab [Units/volume] in Serum |
| 85960-3 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum --1st specimen |
| 85989-2 | Streptococcus pneumoniae Danish serotype 14 Ab [Mass/volume] in Serum |
| 86090-8 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 7322-1 | Formaldehyde triggered histamine release [Units/volume] in Blood |
| 7328-8 | Fusarium solani IgG Ab [Units/volume] in Serum |
| 87375-2 | Escherichia coli paa gene [Presence] in Isolate by NAA with probe detection |
| 87433-9 | Free hemoglobin and oxyhemoglobin panel - Plasma |
| 87816-5 | 6-Monoacetylmorphine (6-MAM) [Presence] in Saliva (oral fluid) by Screen method |
| 88270-4 | Staphylococcus epidermidis hsp60 gene [Presence] by Probe in Positive blood culture |
| 88732-3 | Mi-2 alpha Ab [Units/volume] in Serum by Line blot |
| 41177-7 | Trichophyton reaction wheal [Diameter] --1 day post dose trichophyton intradermal |
| 41183-5 | Western equine encephalitis virus Ab [Titer] in Serum by Complement fixation |
| 41677-6 | cefOXitin+Clavulanate [Susceptibility] by Gradient strip |
| 59357-4 | Vardenafil [Mass/volume] in Blood |
| 59677-5 | Flurazepam [Mass/volume] in Body fluid by Confirmatory method |
| 31068-0 | Herpes simplex virus 1 IgM Ab [Units/volume] in Body fluid |
| 5990-7 | Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --20 minutes post venistasis |
| 60282-1 | ALPRAZolam [Moles/volume] in Specimen |
| 21295-1 | Gastrin [Mass/volume] in Serum or Plasma --50 minutes post 0.2 U/kg secretin |
| 31313-0 | Coxiella burnetii phase 2 Ab [Units/volume] in Serum |
| 42816-9 | Stachybotrys chartarum IgG Ab [Mass/volume] in Serum |
| 43053-8 | Coccidioides immitis Ab [Titer] in Pleural fluid |
| 31617-4 | Saint Louis encephalitis virus Ab [Units/volume] in Specimen |
| 3188-0 | Coagulation factor IX activity [Units/volume] in Platelet poor plasma by Chromogenic method |
| 32350-1 | Basophils+Eosinophils+Monocytes/100 leukocytes in Blood |
| 51952-0 | UGT1A1 gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 44318-4 | Insulin porcine Ab [Presence] in Serum |
| 4432-1 | sulfiSOXAZOLE [Mass] of Dose |
| 23226-4 | Mareks disease virus Ab [Presence] in Serum by Immunofluorescence |
| 23234-8 | Mycobacterium avium ss avium Ab [Presence] in Blood |
| 2329-1 | Gastrin releasing polypeptide [Mass/volume] in Serum or Plasma |
| 23338-7 | Ovine pulmonary adenomatosis retrovirus RNA [Presence] in Lung tissue by NAA with probe detection |
| 5352-0 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
| 53544-3 | 3,4-Dihydroxyphenylacetate [Moles/volume] in Cerebral spinal fluid |
| 53850-4 | HTC2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 54330-6 | Propionylcarnitine (C3) [Moles/volume] in Cerebral spinal fluid |
| 46256-4 | oxyCODONE Free [Presence] in Serum or Plasma by Screen method |
| 24170-3 | Polio virus 1 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen |
| 34497-8 | SPINK1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 25452-4 | Itraconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 34916-7 | Plasma cell precursor [#/volume] in Blood |
| 55895-7 | Hypoxanthine phosphoribosyltransferase/Adenine phosphoribosyltransferase [Enzymatic activity ratio] in Chorionic villus sample |
| 48291-9 | Potassium metabisulfite triggered leukotriene release [Mass/volume] by Leukocytes |
| 26591-8 | Carnosine [Moles/volume] in Cerebral spinal fluid |
| 36898-5 | West Nile virus NS5 Ab [Presence] in Specimen by Immunoassay |
| 56719-8 | Liver cytosol Ab [Presence] in Serum by Immunoblot |
| 26855-7 | Parainfluenza virus Ab [Titer] in Serum by Immunofluorescence |
| 26885-4 | Ova and parasites identified in Specimen by Concentration |
| 5734-9 | Silver [Mass/volume] in Serum or Plasma |
| 49059-9 | Trisomy 21+Trisomy 18 risk [Likelihood] in Fetus |
| 49081-3 | Beta-2-Microglobulin [Mass/volume] in Dialysis fluid |
| 38893-4 | ARIPiprazole [Mass/volume] in Serum or Plasma |
| 49617-4 | Carbapenem resistance blaKPC gene [Presence] by Molecular method |
| 399-6 | Phenethicillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 3999-0 | Protriptyline [Mass/volume] in Serum or Plasma |
| 58382-3 | Norfentanyl/Creatinine [Mass Ratio] in Urine |
| 58439-1 | Clinical research drug XXX [Mass/volume] in Urine |
| 49756-0 | Norethindrone [Mass/volume] in Urine |
| 29674-9 | Bordetella pertussis IgG Ab [Presence] in Serum |
| 29742-4 | Date last dose |
| 40340-2 | Somatotropin [Mass/volume] in Serum or Plasma --3 hours post dose triple bolus |
| 2998-3 | Thiamine [Mass/volume] in Blood |
| 30001-2 | Microalbumin/Creatinine [Ratio] in Urine by Test strip |
| 40761-9 | Coxsackievirus A Ab [Titer] in Serum --2nd specimen |
| 40792-4 | Coproporphyrin 1 [Moles/time] in 24 hour Urine |
| 20717-5 | Bovine diarrhea virus 2 Ag [Presence] in Tissue by Immunofluorescence |
| 20781-1 | Cryptosporidium sp [Presence] in Stool by Acid fast stain |
| 12839-7 | Prostaglandin D2 [Mass/volume] in Serum or Plasma |
| 101234-3 | Glial nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 13179-7 | English Walnut IgG Ab [Units/volume] in Serum |
| 101681-5 | Leukotriene E4, Random, Urine panel |
| 101806-8 | Beta-Amyloid [Ratio] in Plasma by LC/MS/MS |
| 101937-1 | Candida albicans+glabrata+tropicalis+parapsilosis DNA [Presence] in Specimen by NAA with probe detection |
| 14330-5 | Polymorphonuclear cells/100 leukocytes in Stool by Manual count |
| 102899-2 | Red Currant IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14652-2 | clomiPRAMINE [Moles/volume] in Serum or Plasma |
| 14988-0 | little i-1 subtype [Presence] on Red Blood Cells |
| 104341-3 | Borna disease virus [Presence] in Specimen |
| 10672-4 | Helminth+Arthropod identified in Specimen |
| 10978-5 | Amitriptyline+Nortriptyline [Mass/volume] in Urine |
| 11604-6 | Burkholderia pseudomallei Ab [Units/volume] in Serum |
| 16738-7 | Dengue virus 3 Ab [Titer] in Serum |
| 16925-0 | Haemophilus influenzae A Ag [Presence] in Urine |
| 17001-9 | Hydroxyproline [Presence] in Urine |
| 17180-1 | CD62L cells/100 cells in Blood |
| 17938-2 | Bacteria # 3 identified in Burn by Culture |
| 18226-1 | Erythrocyte size [Morphology] in Blood |
| 18419-2 | Cephalosporine mold IgG Ab [Units/volume] in Serum |
| 19023-1 | Granulocytes/100 leukocytes in Blood by Automated count |
| 90916-8 | Arachidonate (C20:4w6)/Fatty acids.C14-C22 in Blood |
| 75661-9 | Polymorphonuclear cells [#] in Pleural fluid by Manual count |
| 61119-4 | Lymphocytes.cytoplasmic IgM/100 lymphocytes in Body fluid |
| 7573-9 | Chick Pea IgE Ab [Units/volume] in Serum |
| 76034-8 | GAA gene full mutation analysis in Blood or Tissue by Sequencing |
| 76088-4 | Respiratory syncytial virus RNA [Presence] in Bronchoalveolar lavage by NAA with probe detection |
| 92980-2 | Haemophilus influenzae DNA [NCncRange] in Sputum by NAA with non-probe detection |
| 62379-3 | Chromosome band involved start |
| 77341-6 | Anion gap 4 in Serum, Plasma or Blood |
| 77671-6 | Gastrin [Moles/volume] in Serum or Plasma --1 minute post XXX challenge |
| 63246-3 | Ganglioside GM1 IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 94608-7 | Erbovirus A RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 64092-0 | Cells analyzed [#] in Amniotic fluid by Molecular genetics method |
| 79505-4 | 4-Hydroxy-3-Methoxyphenyllactate [Moles/volume] in Serum or Plasma |
| 7957-4 | Legionella sp Ab [Units/volume] in Serum |
| 7983-0 | Parvovirus B19 IgG Ab [Units/volume] in Serum |
| 96403-1 | Renal clearance and Renal plasma flow panel - Urine and Serum or Plasma |
| 67725-2 | Mycobacterium sp identified in Isolate by HPLC |
| 81439-2 | Human papilloma virus 31+33 DNA [Presence] in Tissue by Probe |
| 9689-1 | Carbofuran [Mass/volume] in Serum or Plasma |
| 97517-7 | Rabies virus IgG Ab [Presence] in Specimen by Immunofluorescence |
| 716-1 | Heinz bodies [Presence] in Blood by Light microscopy |
| 85310-1 | Estrogen receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain |
| 99124-0 | Tick-borne encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 72652-1 | Subtelomere analysis.long arm [Interpretation] in Blood or Tissue by FISH Narrative |
| 72873-3 | Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method |
| 86197-1 | Pentylone [Mass/volume] in Urine by Confirmatory method |
| 87923-9 | Rickettsia conorii IgM Ab [Presence] in Serum by Immunoassay |
| 41484-7 | Coxsackievirus A Ab panel [Titer] - Serum by Complement fixation |
| 50609-7 | Nitroblue Tetrazolium Test (NBT) [Units/volume] in Blood |
| 4180-6 | chlorproPAMIDE [Mass] of Dose |
| 41842-6 | Herpes virus 7 IgG and IgM panel [Titer] - Serum by Immunofluorescence |
| 42713-8 | AML/MDS gene CEP 8 trisomy [Presence] in Blood or Tissue by Molecular genetics method |
| 215-4 | cycloSERINE [Susceptibility] by Serum bactericidal titer |
| 51185-7 | CD117 Ag [Presence] in Specimen by Immune stain |
| 51317-6 | CD41 cells/100 cells in Tissue |
| 51435-6 | Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis |
| 42779-9 | BRCA2 Ag [Presence] in Tissue by Immune stain |
| 42937-3 | Acetylcholine receptor blocking Ab/Acetylcholine Ab.total in Serum |
| 43196-5 | Cotinine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 51872-0 | Transfuse platelet concentrate units [#] |
| 22428-7 | Mycoplasma sp Ab [Presence] in Serum |
| 32073-9 | fluvoxaMINE [Moles/volume] in Serum or Plasma |
| 32266-9 | Proline [Moles/volume] in Vitreous fluid |
| 44397-8 | Insulin bovine Ab [Presence] in Serum |
| 2293-9 | Fructokinase [Enzymatic activity/volume] in Serum |
| 53183-0 | Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in DBS |
| 53351-3 | Urinalysis other formed elements panel [#/volume] - Urine by Computer assisted method |
| 23325-4 | Ovine herpesvirus 2 Ab [Presence] in Serum by Immunoassay |
| 23329-6 | Ovine progressive pneumonia virus Ab [Presence] in Serum |
| 33279-1 | Acetylcholine receptor modulation Ab [Moles/volume] in Serum |
| 33665-1 | HTLV I+II Ab band pattern [Interpretation] in Serum by Radioimmunoprecipitation assay (RIPA) |
| 23806-3 | Albumin [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis |
| 24075-4 | Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Leukocytes |
| 33873-1 | DOPamine/Creatinine [Molar ratio] in Urine collected for unspecified duration |
| 34214-7 | 11-Ketoandrosterone [Moles/volume] in Urine |
| 544-7 | Bacteroides fragilis Ag [Presence] in Specimen by Immunofluorescence |
| 4691-2 | Viscosity of Plasma |
| 34577-7 | Apheresis.therapeutic [Interpretation] |
| 34669-2 | Pyrimethamine [Mass/volume] in Serum or Plasma |
| 54472-6 | Amylase.macromolecular/Amylase.total in Serum or Plasma |
| 25409-4 | Filaria Ab [Titer] in Serum by Immunofluorescence |
| 25511-7 | Propafenone [Moles/volume] in Serum or Plasma |
| 47523-6 | Cytology report of Body fluid Cyto stain |
| 2591-6 | Macroamylase [Enzymatic activity/volume] in Serum or Plasma |
| 35570-1 | Renin [Mass/volume] in Plasma |
| 26546-2 | Glucose [Presence] in Urine by Test strip --1 hour post dose glucose |
| 27072-8 | 14-3-3 Ag [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 27391-2 | Candida sp IgM Ab [Units/volume] in Serum by Immunoassay |
| 2741-7 | Pepsins [Enzymatic activity/volume] in Urine |
| 5814-9 | Triple phosphate crystals [Presence] in Urine sediment by Light microscopy |
| 49653-9 | TPMT gene c.719A>G [Presence] in Blood or Tissue by Molecular genetics method |
| 40034-1 | Glucose [Mass/volume] in Serum or Plasma --27 minutes post XXX challenge |
| 587-6 | Helicobacter pylori [Presence] in Specimen by Organism specific culture |
| 49907-9 | IgA Ag [Presence] in Tissue by Immunofluorescence |
| 49980-6 | Borrelia burgdorferi 35kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 40986-2 | Parainfluenza virus 4 Ag [Presence] in Specimen by Immunofluorescence |
| 19530-5 | Lysergate diethylamide cutoff [Mass/volume] in Urine for Screen method |
| 19578-4 | Methylphenidate [Presence] in Urine by Confirmatory method |
| 19752-5 | Pigeon serum IgG Ab [Presence] in Serum |
| 20505-4 | Bilirubin.total [Mass/volume] in Urine by Test strip |
| 12423-0 | Trimeprazine [Mass/volume] in Serum or Plasma |
| 100833-3 | Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 101865-4 | Troponin T. cardiac 2H and 6H 5th generation panel in Serum or Plasma by High sensitivity method |
| 101963-7 | SLC1A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 102153-4 | Aspergillus fumigatus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13495-7 | Volume of 24 hour Dialysis fluid |
| 13889-1 | Lactate dehydrogenase 4/Lactate dehydrogenase.total in Urine by Electrophoresis |
| 14263-8 | Dichlorodiphenyltrichloroethane [Mass/mass] in Tissue |
| 103562-5 | AB-Fubinaca metabolite 3 [Mass/volume] in Urine by Confirmatory method |
| 10452-1 | Xylose [Mass/volume] in Serum or Plasma --1 hour post 25 g xylose PO |
| 16307-1 | Acetate [Mass/volume] in Dialysis fluid |
| 17052-2 | Lead [Presence] in Blood |
| 1744-2 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P |
| 17532-3 | Rheumatoid arthritis nuclear Ab [Presence] in Serum |
| 17888-9 | Bacteria # 2 identified in Nose by Aerobe culture |
| 18341-8 | Propylene glycol [Mass/volume] in Urine |
| 91027-3 | Buprenorphine-3-glucuronide [Presence] in Urine by Screen method |
| 74690-9 | Weak D Ag [Presence] in Cord red blood cells |
| 92739-2 | 7-Alpha,12-alpha dihydroxycholest-4-en-3-one and 7-Alpha hydroxy-4-cholesten-3-one panel - DBS |
| 76077-7 | Influenza virus A RNA [Presence] in Bronchoalveolar lavage by NAA with probe detection |
| 6185-3 | Mustard IgE Ab [Units/volume] in Serum |
| 7736-2 | Termamyl IgE Ab [Units/volume] in Serum |
| 77398-6 | Mumps virus IgG and IgM index panel - Serum |
| 63090-5 | Beta lactoglobulin IgG Ab [Mass/volume] in Serum |
| 78693-9 | Dihydrothymine/Creatinine [Molar ratio] in Urine |
| 79318-2 | L-2-hydroxyglutarate [Moles/volume] in Serum or Plasma |
| 79388-5 | Norovirus genogroup I+II orf1-orf2 junction region [Presence] in Stool by NAA with probe detection |
| 95608-6 | SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with non-probe detection |
| 6575-5 | Escherichia coli verotoxin 1 neutralizing antibody [Titer] in Stool by Neutralization test |
| 6592-0 | Yellow fever virus IgG Ab [Units/volume] in Serum by Immunoassay |
| 80092-0 | Glycyl-4-hydroxyproline/Creatinine [Molar ratio] in Urine |
| 95942-9 | Influenza virus A and B and SARS-CoV+SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay |
| 6752-0 | Glucose [Mass/volume] in Serum or Plasma --3.5 hours post 75 g glucose PO |
| 68427-4 | Neutrophils [#/volume] in Vitreous fluid by Manual count |
| 814-4 | Leukocytes [#/volume] in Synovial fluid by Manual count |
| 96798-4 | Cortisol, glucose, and somatotropin post arginine stimulation panel - Serum or Plasma |
| 97163-0 | Theophylline [Mass/volume] in Serum or Plasma --peak |
| 81655-3 | Respiratory pathogens DNA and RNA identified in Respiratory system specimen by NAA with probe detection |
| 71652-2 | Plasma cells/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
| 98992-1 | Alpha-1-acid glycoprotein/Protein.total in Serum or Plasma by Electrophoresis |
| 85084-2 | Coarse speckled nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
| 72898-0 | Bilirubin [Moles/volume] in Skin |
| 86458-7 | Brucella sp Ab [Titer] in Serum by Rivanol agglutination |
| 86574-1 | Marburg virus RNA [Presence] in Blood by NAA with probe detection |
| 73535-7 | Amiodarone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73668-6 | Bacteria soluble by bile [Presence] in Isolate |
| 73894-8 | Tetrahydrocortisone [Moles/volume] in Urine |
| 73982-1 | Carbapenem resistance blaNDM gene [Presence] by Molecular method |
| 89647-2 | Bartonella sp DNA [Presence] in Implanted device by NAA with probe detection |
| 41428-4 | Trypanosoma brucei rhodesiense Ab [Titer] in Serum by Immunofluorescence |
| 41507-5 | Rabies virus Ab [Presence] in Serum by Immunoassay |
| 59577-7 | Glucagon [Mass/volume] in Serum or Plasma --7th specimen fasting |
| 41876-4 | Rickettsia typhi and Rickettsia spotted fever group IgG and IgM panel - Serum |
| 60044-5 | Acepromazine [Mass/volume] in Urine |
| 60073-4 | Fexofenadine [Mass/volume] in Serum or Plasma |
| 6014-5 | von Willebrand factor (vWf) ristocetin cofactor actual/normal in Platelet poor plasma by Platelet aggregation |
| 2123-8 | Chymotrypsin [Enzymatic activity/volume] in Body fluid |
| 21374-4 | CD8+CD38+ cells [#/volume] in Blood |
| 2145-1 | Cortisol Free [Mass/volume] in Serum or Plasma |
| 21660-6 | CTNNB1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 31563-0 | PM-SCL extractable nuclear Ab [Presence] in Serum |
| 22491-5 | Rickettsia typhus group Ab [Presence] in Serum |
| 32260-2 | Ornithine [Moles/volume] in Body fluid |
| 52912-3 | Copper [Moles/mass] in Tissue |
| 53037-8 | Genetic variation clinical significance [Imp] |
| 4429-7 | Sulbactam [Mass] of Dose |
| 33243-7 | Trichomonas vaginalis [Presence] in Urine by Computer assisted method |
| 53089-9 | Carbon dioxide, total [Moles/volume] in Nonbiological fluid by calculation |
| 23315-5 | Nairobi sheep disease virus Ab [Presence] in Serum by Immunofluorescence |
| 23482-3 | Theileria sp [Presence] in Blood by Giemsa stain |
| 53518-7 | Leukocytes [#/volume] in Dialysis fluid |
| 53958-5 | Choriogonadotropin.tumor marker [Moles/volume] in Serum or Plasma |
| 23955-8 | Bartonella henselae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 34169-3 | Fatty acids.very long chain [Mass/volume] in Serum or Plasma |
| 46094-9 | Plasmodium sp Ag [Presence] in Blood by Immunoassay |
| 46272-1 | Appearance of Urine--after transfusion reaction |
| 34335-0 | Lysozyme [Mass/volume] in 24 hour Urine |
| 55575-5 | Pseudoephedrine [Moles/volume] in Serum or Plasma |
| 47433-8 | Epstein Barr virus capsid IgM Ab [Titer] in Body fluid |
| 25136-3 | Succinate/Creatinine [Molar ratio] in Urine |
| 35292-2 | Chromosome 11 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics |
| 5570-7 | Acetone [Mass/volume] in Urine |
| 47575-6 | Aspartate/Amino acids.total in Cerebral spinal fluid |
| 25948-1 | Lutropin [Units/volume] in Serum or Plasma by 1st IRP --6th specimen post XXX challenge |
| 47937-8 | Somatotropin [Units/volume] in Serum or Plasma --pre dose propranolol+glucagon |
| 3725-9 | LORazepam [Mass/volume] in Urine |
| 487-9 | Temafloxacin [Susceptibility] by Minimum lethal concentration (MLC) |
| 48838-7 | Respiratory allergen panel, US - Intermountain west a - Serum |
| 27028-0 | Ketones [Presence] in Urine by Test strip --2 hours post XXX challenge |
| 38452-9 | CFTR gene c.3120+1G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 38559-1 | Spermatozoa.midpiece Motile w IgM/100 spermatozoa in Semen by Immunobead |
| 57491-3 | 11-Deoxycorticosterone [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin |
| 28077-6 | Hexachlorobutadiene [Presence] in Serum or Plasma |
| 57802-1 | Chromosome analysis.interphase [Interpretation] in Blood or Marrow by FISH Narrative |
| 49615-8 | Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection |
| 49755-2 | Crystals [Presence] in Urine sediment by Light microscopy |
| 58765-9 | Histone Ab [Presence] in Serum by Immunoassay |
| 29863-8 | IgD Ag [Presence] in Tissue by Immune stain |
| 40324-6 | Glucose [Moles/volume] in Serum or Plasma --3 hours post dose triple bolus |
| 40418-6 | Cotinine [Presence] in Meconium |
| 30100-2 | Yersinia enterocolitica O:3 Ab [Titer] in Specimen |
| 40871-6 | CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 40999-5 | Calcium hydrogen phosphate dihydrate [Mass/time] in 24 hour Urine |
| 19680-8 | Prazepam cutoff [Mass/volume] in Urine for Screen method |
| 19738-4 | Dog serum albumin IgE Ab [Units/volume] in Serum |
| 19746-7 | Maleic anhydride IgE Ab [Units/volume] in Serum |
| 20525-2 | Dextroamphetamine [Mass/volume] in Urine by Confirmatory method |
| 100097-5 | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot |
| 100676-6 | Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection |
| 100841-6 | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot |
| 100892-9 | Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 101073-5 | CEST Ab [Presence] in Serum or Plasma |
| 12897-5 | Myelin associated glycoprotein Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 101140-2 | Salmonella sp Ag [Presence] in Stool by Rapid immunoassay |
| 101449-7 | Neurochondrin Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 101537-9 | AGA gene [Interpretation] in Serum |
| 1332-6 | V Ag [Presence] on Red Blood Cells from Blood product unit |
| 101859-7 | Triamcinolone [Moles/volume] in Urine |
| 14353-7 | Microscopic observation [Identifier] in Pleural fluid by Acid fast stain.Kinyoun modified |
| 102949-5 | Tilapia IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103060-0 | Cat recombinant (rFel d) 4 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14639-9 | carBAMazepine [Moles/volume] in Serum or Plasma |
| 14641-5 | Carbonate [Presence] in Stone |
| 15144-9 | Glutamate+Glutamine+Threonine [Presence] in Urine |
| 16188-5 | Creatinine [Mass/volume] in Serum or Plasma --2 hour specimen |
| 10832-4 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post 50 g lactose PO |
| 10855-5 | Ova and parasites identified in Duodenal fluid or Gastric fluid by Light microscopy |
| 16416-0 | Aspergillus terreus Ab [Units/volume] in Serum |
| 16687-6 | Creatine [Mass/volume] in Vitreous fluid |
| 16974-8 | HIV 1 Ab [Presence] in Cerebral spinal fluid |
| 16985-4 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose glucose |
| 17073-8 | Legionella pneumophila 9 Ab [Presence] in Serum |
| 19089-2 | Collection of urine specimen start time |
| 92675-8 | MSH2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 92877-0 | Human coronavirus 229E+HKU1+NL63+OC43 and Parainfluenza virus 1+2+3+4 RNA panel - Upper respiratory specimen by NAA with probe detection |
| 9353-4 | Baclofen [Mass/volume] in Serum or Plasma |
| 61304-2 | Cottonwood IgE Ab/IgE total in Serum |
| 93781-3 | Diffuse large B-cell lymphoma.activated B-cell subtype [Likelihood] in Tissue |
| 6254-7 | Acarus siro IgE Ab [Units/volume] in Serum |
| 7863-4 | Echinococcus sp Ab [Units/volume] in Serum |
| 7948-3 | Legionella pneumophila 1 Ab [Titer] in Serum by Immunofluorescence |
| 9512-5 | Creosol [Presence] in Specimen |
| 79639-1 | N,N'-dimethylarginine/Creatinine [Molar ratio] in Urine |
| 67848-2 | Leukocyte clumps [Presence] in Urine sediment by Light microscopy |
| 8054-9 | Yellow fever virus Ab [Units/volume] in Serum |
| 97149-9 | proPSA isoform 2 [Mass/volume] in Serum or Plasma by Immunoassay |
| 6963-3 | Yersinia enterocolitica Ab [Titer] in Serum |
| 6993-0 | Cefpodoxime [Susceptibility] by Gradient strip |
| 81793-2 | Tetrahydrodeoxycortisol/Creatinine [Molar ratio] in 24 hour Urine |
| 70865-1 | Rabies virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 98128-2 | Neutrophils.immature/Neutrophils.segmented [Ratio] in Bone marrow by Manual count |
| 72375-9 | Microscopic method - Urine |
| 72390-8 | Candida lusitaniae DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 85538-7 | Mycoplasma hyorhinis 16S rRNA gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 99456-6 | Blomia tropicalis IgG Ab [Mass/volume] in Serum |
| 86150-0 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum by Immunoassay |
| 87601-1 | Carbadox [Mass/mass] in Specimen |
| 73846-8 | 16-Alpha hydroxydehydroepiandrosterone [Moles/volume] in 24 hour Urine |
| 87962-7 | HIV 1 subtype identified in Cerebral spinal fluid by NAA with probe detection |
| 88509-5 | Helicobacter pylori 23S rRNA clarithromycin resistance mutation [Identifier] by Molecular method |
| 74133-0 | Volatiles and gases [Presence] in Blood |
| 88596-2 | Influenza virus B RNA [Presence] in Pericardial fluid by NAA with probe detection |
| 89645-6 | Bartonella henselae DNA [Presence] in Implanted device by NAA with probe detection |
| 50920-8 | Thorium [Moles/mass] in Hair |
| 3094-0 | Urea nitrogen [Mass/volume] in Serum or Plasma |
| 31132-4 | Mumps virus soluble Ab [Titer] in Cerebral spinal fluid |
| 41764-2 | SBDS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 42617-1 | Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification |
| 21148-2 | White Cedar IgE Ab [Units/volume] in Serum |
| 21340-5 | HIV 2 p58 Ab [Presence] in Serum by Immunoblot |
| 21424-7 | Nuclear IgG Ab [Presence] in Serum by Immunofluorescence |
| 2147-7 | Cortisol Free [Mass/time] in 24 hour Urine |
| 21550-9 | Synovial lining cells [Presence] in Synovial fluid by Light microscopy |
| 31312-2 | Coxiella burnetii phase 1 IgA Ab [Units/volume] in Serum |
| 42864-9 | CD103 cells/100 cells in Body fluid |
| 4316-6 | Metaraminol [Mass] of Dose |
| 31934-3 | Pneumocystis jiroveci Ag [Presence] in Cerebral spinal fluid |
| 32048-1 | Amitriptyline+Nortriptyline [Presence] in Specimen |
| 51751-6 | Pyruvate [Moles/volume] in Venous blood |
| 43418-3 | Stem cell product given [Volume] |
| 22708-2 | Homovanillate/Creatinine [Molar ratio] in Urine |
| 52114-6 | Direct antiglobulin test.IgG specific reagent [presence] on Cord red blood cells |
| 526-4 | Vancomycin [Susceptibility] by Serum bactericidal titer |
| 44003-2 | Choriogonadotropin.beta subunit free [Multiple of the median] in Amniotic fluid |
| 44333-3 | Lactate/Creatinine [Mass Ratio] in 24 hour Urine |
| 53446-1 | Carnitine palmitoyltransferase 2/Citrate synthase [Enzymatic activity ratio] in Red Blood Cells |
| 44727-6 | HLA-DP2 [Presence] |
| 53828-0 | cycloSPORINE [Mass/volume] in Blood --trough |
| 45184-9 | 11-Deoxycortisol/Cortisol [Mass Ratio] in Serum or Plasma |
| 2373-9 | Glutamine [Mass/volume] in Urine |
| 34227-9 | Acylcarnitine [Moles/time] in 24 hour Urine |
| 3428-0 | Canrenone [Presence] in Urine |
| 54272-0 | Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose ornithine alpha-ketoglutarate |
| 46429-7 | Alpha 1 antitrypsin [Mass/mass] in 24 hour Stool |
| 2483-6 | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma |
| 34379-8 | Teicoplanin [Mass/volume] in Serum or Plasma --trough |
| 55243-0 | HBB gene c.364G>C [Presence] in Blood by Molecular genetics method |
| 47056-7 | Legionella pneumophila 11 IgM Ab [Titer] in Serum by Immunofluorescence |
| 47069-0 | Rickettsia rickettsii IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 34739-3 | NR0B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 4758-9 | HLA-B52(5) [Presence] in Donor |
| 2561-9 | Leucine [Mass/volume] in Urine |
| 25685-9 | Insulin [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 25836-8 | HIV 1 RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 35597-4 | Salicylates [Mass/volume] in Serum or Plasma by Screen method |
| 56147-2 | Parietal cell Ab [Units/volume] in Serum by Immunoassay |
| 2626-0 | Methoxyacetate [Mass/volume] in Serum or Plasma |
| 2630-2 | Methylmalonate [Mass/volume] in Urine |
| 26541-3 | Glucose [Mass/volume] in Serum or Plasma --4 hours post dose glucose |
| 26640-3 | Paracoccidioides brasiliensis Ab [Presence] in Serum |
| 26779-9 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose lactose PO |
| 3669-9 | Haloperidol [Mass/volume] in Serum or Plasma |
| 56667-9 | 3-Methylhistidine/Creatinine [Ratio] in 24 hour Urine |
| 56693-5 | SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot |
| 385-5 | Oxacillin [Susceptibility] by Serum bactericidal titer |
| 3865-3 | Norethandrolone [Mass/time] in 24 hour Urine |
| 27919-0 | Calcium [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 27999-2 | Toxoplasma gondii DNA [Presence] in Amniotic fluid by NAA with probe detection |
| 39604-4 | Mugwort IgE Ab/IgE total in Serum |
| 57858-3 | Normaprotiline [Moles/volume] in Specimen |
| 49607-5 | Hepatitis C virus genotype [Identifier] in Tissue by NAA with probe detection |
| 39802-4 | Creatinine in dialysis fluid/Creatinine in serum or plasma |
| 49879-0 | Hepatitis B virus codon 181 [Identifier] by Genotype method |
| 50153-6 | 5-Methyltetrahydrofolate [Moles/volume] in Serum or Plasma |
| 40700-7 | Aromatic solvents [Identifier] in Serum or Plasma |
| 59037-2 | Phosphate [Mass/volume] in Peritoneal dialysis fluid |
| 50512-3 | Lutropin [Units/volume] in Serum or Plasma --4th specimen |
| 40791-6 | Coproporphyrin 3 [Moles/time] in 24 hour Urine |
| 20755-5 | Chlamydia sp Ag [Presence] in Body fluid by Immunoassay |
| 100359-9 | Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay |
| 100840-8 | IgE [Units/volume] in Body fluid |
| 100998-4 | Cortisol post dose insulin IV panel - Serum or Plasma |
| 12616-9 | Glucose [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 1270-8 | Unidentified Ab [Presence] in Serum or Plasma |
| 101457-0 | Septin-7 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 101673-2 | KPC carbapenemase [Presence] in Isolate by Rapid immunoassay |
| 12972-6 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --1st specimen |
| 14755-3 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g lactose PO |
| 14903-9 | Folate [Interpretation] in Blood |
| 104478-3 | ITpA-Index Serum and CSF |
| 10458-8 | Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain |
| 15252-0 | Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgE Ab [Presence] in Serum by Multidisk |
| 15263-7 | Tree Allergen Mix D (Cottonwood+Elm+Maple+Oak+Pecan tree) IgE Ab [Presence] in Serum by Multidisk |
| 10939-7 | Whiff IgE Ab [Units/volume] in Serum |
| 16427-7 | Babesia microti Ab [Titer] in Serum |
| 1681-6 | Beta hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Blood |
| 17041-5 | Lactate dehydrogenase [Presence] in Urine |
| 17131-4 | CD3+CD69+ cells/100 cells in Blood |
| 18875-5 | Cefadroxil [Susceptibility] |
| 91030-7 | Methadone+Metabolite [Presence] in Meconium by Screen method |
| 74793-1 | Thyroid hormone uptake (T-uptake) in Serum or Plasma |
| 75147-9 | Succinylaminoimidazole carboxamide riboside [Moles/volume] in Cerebral spinal fluid |
| 76090-0 | Erythrocytes.hyperchromic/100 erythrocytes in Blood by Automated count |
| 76599-0 | Enterococcus faecalis cpn60 gene [#/mass] in XXX.tissue by NAA with probe detection |
| 93235-0 | aPTT.lupus sensitive in Platelet poor plasma by Coagulation assay --post heparin neutralization |
| 6154-9 | Kiwifruit IgE Ab [Units/volume] in Serum |
| 62349-6 | Chromosome analysis panel - Blood from Fetus by G-banded |
| 62352-0 | Chromosome analysis panel - Products of Conception by G-banded |
| 93724-3 | Keratan sulfate [Mass/volume] in Serum or Plasma |
| 94196-3 | CTRC gene full mutation analysis in Blood or Tissue by Sequencing |
| 6702-5 | 11-Ketoandrosterone [Mass/time] in 24 hour Urine |
| 95971-8 | SARS-CoV-2 stimulated gamma interferon [Presence] in Blood |
| 96431-2 | Borrelia burgdorferi 49736 IgG bands [Identifier] in Specimen by Immunoblot |
| 67807-8 | Mumps virus Ag [Presence] in Isolate by Immunofluorescence |
| 81171-1 | Lesser curvature of stomach [Length] in Specimen |
| 69419-0 | Cholesterol in LDL [Moles/volume] in Serum or Plasma by Direct assay |
| 6979-9 | Ampicillin [Susceptibility] by Gradient strip |
| 81822-9 | BBS10 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 81852-6 | Chromosome region 7q11.23 deletion and duplication mutation analysis in Blood or Tissue by Molecular genetics method |
| 82083-7 | Mold Allergen Mix 2 (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 97551-6 | Carboxyhemoglobin/Hemoglobin.total in Central venous blood |
| 70210-0 | Morphine [Moles/volume] in Urine by Confirmatory method |
| 7088-8 | Apple IgG Ab [Units/volume] in Serum |
| 9812-9 | Cortisol [Mass/volume] in Serum or Plasma --PM trough specimen |
| 7227-2 | Chocolate triggered histamine release [Units/volume] in Blood |
| 83004-2 | Glutamate decarboxylase 65 IgG Ab [Presence] in Serum or Plasma by Line blot |
| 83122-2 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma by Immunoassay |
| 85292-1 | Surgical margin tumor involvement.distant [Presence] in Colorectal cancer specimen by Light microscopy |
| 85582-5 | Chikungunya virus RNA+Dengue virus RNA [Presence] in Plasma from Donor by NAA with probe detection |
| 99785-8 | Cell-free DNA.donor/Cell-free DNA.total in Plasma cell-free DNA --post cardiac transplant |
| 99883-1 | Free lipid droplets [#/volume] in Urine sediment by Computer assisted method |
| 86666-5 | Location within lymph node [Anatomy] in Skin melanoma by Light microscopy |
| 72987-1 | Montelukast induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7318-9 | Flounder triggered histamine release [Units/volume] in Blood |
| 87565-8 | Zearalenol [Mass/mass] in Specimen |
| 73403-8 | Doxycycline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74366-6 | Clorazepate [Mass/volume] in Serum or Plasma --trough |
| 41207-2 | Wheat IgE Ab/IgE total in Serum |
| 41500-0 | Linezolid [Susceptibility] by Method for Slow-growing mycobacteria |
| 42489-5 | Aureobasidium pullulans Ab [Presence] in Cerebral spinal fluid |
| 21441-1 | Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe |
| 31398-1 | Ganglioside GD1a IgM Ab [Units/volume] in Cerebral spinal fluid |
| 31446-8 | Jamestown canyon virus Ab [Units/volume] in Serum |
| 31474-0 | Legionella sp IgM Ab [Units/volume] in Serum |
| 43085-0 | Babesia duncani Ab [Titer] in Serum |
| 22256-2 | Eastern equine encephalitis virus Ab [Presence] in Serum |
| 22276-0 | Echovirus 4 Ab [Titer] in Cerebral spinal fluid |
| 31989-7 | 14-3-3 Ag [Presence] in Cerebral spinal fluid |
| 51623-7 | Spermatozoa [#/volume] in Semen --post vasectomy |
| 51889-4 | Transfuse factor VIII [#] |
| 4366-1 | Oxandrolone [Mass] of Dose |
| 43710-3 | Alkaline phosphatase.heat stable [Presence] in Serum or Plasma by Heat stability |
| 5199-5 | Hepatitis C virus Ab [Presence] in Serum by Immunoblot |
| 52946-1 | diazePAM [Presence] in Gastric fluid |
| 32703-1 | Cytochrome B5 reductase [Enzymatic activity/mass] in Red Blood Cells |
| 33038-1 | Candida sp identified in Vaginal fluid by Cyto stain |
| 53257-2 | Mycobacterium tuberculosis DNA [#/volume] in Specimen by NAA with probe detection |
| 53276-2 | Urinalysis type of non-squamous epithelial cells panel [#/area] - Urine by Computer assisted method |
| 53347-1 | 11-Deoxycorticosterone [Mass/volume] in DBS |
| 53432-1 | Gamma glutamyl transferase [Enzymatic activity/volume] in Dialysis fluid |
| 23219-9 | Lumpy skin disease virus Ag [Presence] in Specimen by Immunoassay |
| 23479-9 | Theileria parva rRNA [Presence] in Serum by Probe |
| 33688-3 | Yersinia pestis Ag [Presence] in Isolate by Immunofluorescence |
| 53921-3 | Thyroglobulin Ab [Units/volume] in Lymph node fine needle aspirate |
| 33866-5 | HIV 1 Ab [Presence] in Capillary blood by Immunoassay |
| 33889-7 | aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --2H post incubation with 1:4 normal plasma |
| 34275-8 | Creatine/Creatinine [Molar ratio] in Urine |
| 54218-3 | CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood |
| 47006-2 | Spermatozoa IgG Ab/100 spermatozoa in Serum by Immunobead |
| 55490-7 | Insulin [Moles/volume] in Serum or Plasma --45 minutes post dose glucagon |
| 25115-7 | Methylmalonate/Creatinine [Molar ratio] in 24 hour Urine |
| 34889-6 | Akabane virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 55969-0 | Phenylalanine/Amino acids.total in DBS |
| 3752-3 | Meprobamate [Presence] in Serum or Plasma |
| 3830-7 | Morphine [Presence] in Urine |
| 38498-2 | Spermatozoa Nonviable/100 spermatozoa in Semen |
| 38653-2 | Amiben [Mass/volume] in Air |
| 49176-1 | Herpes virus 8 IgM Ab [Titer] in Serum |
| 27287-2 | Flurazepam [Mass/mass] in Stool |
| 57956-5 | Desoxymethyltestosterone [Presence] in Urine |
| 58082-9 | Vel Ag [Presence] on Red Blood Cells |
| 49446-8 | Toxoplasma gondii DNA [#/volume] in Bone marrow by NAA with probe detection |
| 29216-9 | Digoxin [Mass/volume] in Body fluid |
| 40290-9 | Insulin [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 58522-4 | C peptide [Mass/volume] in Serum or Plasma --pre dose glucose |
| 49800-6 | Treponema pallidum Ab [Units/volume] in Cerebral spinal fluid by Hemagglutination |
| 50040-5 | Advanced oxidation protein products [Moles/volume] in Serum or Plasma |
| 59003-4 | Lactoferrin Ab [Units/volume] in Serum by Immunoassay |
| 50316-9 | Galectin 3 Ag [Presence] in Tissue by Immune stain |
| 50404-3 | Other cells/100 leukocytes [Identifier] in Synovial fluid |
| 30118-4 | IgA lymphocytes [#/volume] in Leukocytes |
| 30138-2 | Epstein Barr virus nuclear Ab [Presence] in Serum --2nd specimen |
| 40939-1 | Yersinia sp IgM Ab [Units/volume] in Serum by Immunoassay |
| 40942-5 | Yersinia sp IgM Ab [Titer] in Serum by Immunoassay |
| 40997-9 | Honey bee IgE Ab/IgE total in Serum |
| 19231-0 | Bicarbonate [Moles/volume] standard in Capillary blood |
| 19287-2 | Cannabinoids tested for in Urine by Screen method Nominal |
| 19417-5 | Tetrahydrocannabinol cutoff [Mass/volume] in Urine for Screen method |
| 1998-4 | Calcium [Moles/volume] in Dialysis fluid |
| 20391-9 | Mafenide [Susceptibility] |
| 20450-3 | Alpha-1-Fetoprotein [Multiple of the median] in Serum or Plasma |
| 20998-1 | Cell Fractions/Differential [Interpretation] in Cerebral spinal fluid |
| 101083-4 | Fy5 Ab [Presence] in Serum or Plasma |
| 101152-7 | Mitochondria whole genome analysis in Blood or Tissue by Molecular genetics method |
| 12926-2 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 102278-9 | Dermatophagoides microceras IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102709-3 | Cream Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14481-6 | Diphtheria identified in Nose by Organism specific culture |
| 14612-6 | Nuclear Ab [Titer] in Pericardial fluid |
| 103163-2 | Staphylococcus aureus enterotoxin A + Staphylococcus aureus enterotoxin B DNA [Presence] in Wound by NAA with probe detection |
| 104459-3 | Varicella zoster virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 16205-7 | LORazepam [Presence] in Urine by Confirmatory method |
| 1682-4 | Beta hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
| 16877-3 | Francisella tularensis IgG Ab [Presence] in Serum by Latex agglutination |
| 1693-1 | 5-Hydroxyindoleacetate [Mass/volume] in Serum or Plasma |
| 17579-4 | Ganglioside GQ1b IgG Ab [Presence] in Serum |
| 17587-7 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
| 18276-6 | Blood group antigens absent [Identifier] on Red Blood Cells from Donor |
| 18957-1 | Novobiocin [Susceptibility] |
| 91110-7 | Cholesterol in LDL 6 [Mass/volume] in Serum or Plasma |
| 92548-7 | Di sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 92721-0 | Lipoprotein.pre-beta.subparticle.medium [Moles/volume] in Serum |
| 75077-8 | Quinolinate [Moles/volume] in Serum or Plasma |
| 60367-0 | Cinnamon IgG Ab [Mass/volume] in Serum |
| 6112-7 | Ethylene oxide IgE Ab [Units/volume] in Serum |
| 61167-3 | Hepatitis B virus codon S202C [Presence] by Genotype method |
| 6120-0 | Fusarium culmorum IgE Ab [Units/volume] in Serum |
| 77034-7 | inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript in Blood or Tissue by FISH |
| 77205-3 | Buprenorphine [Presence] in Meconium by Screen method |
| 77645-0 | HLA-DQ IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
| 94079-1 | TYMP gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
| 7846-9 | Taenia solium larva IgG Ab [Presence] in Cerebral spinal fluid |
| 7864-2 | Echovirus 1 Ab [Units/volume] in Serum |
| 94486-8 | Parainfluenza virus 4 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 94674-9 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2/24,25-dihydroxyvitamin D3+24,25-dihydroxyvitamin D2 ratio panel in Serum or Plasma |
| 79479-2 | 3-Hydroxyadipate 3,6-lactone [Moles/volume] in Serum or Plasma |
| 79653-2 | Dihydroorotate [Moles/volume] in Urine |
| 79687-0 | 2,8-dihydroxyadenine/Creatinine [Molar ratio] in Urine |
| 80371-8 | Chitotriosidase [Enzymatic activity/mass] in Serum or Plasma |
| 68387-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid by Lactate to pyruvate reaction |
| 80547-3 | Rilpivirine [Mass/volume] in Serum or Plasma |
| 96640-8 | HLA-DP and DQ and DR (class II) typing panel - Blood or Tissue by Low resolution |
| 97213-3 | 7-Aminoclonazepam [Presence] in Cord tissue by Confirmatory method |
| 69848-0 | 2-Hydroxyisocaproate [Moles/volume] in Cerebral spinal fluid |
| 71426-1 | C reactive protein [Mass/volume] in Blood by High sensitivity method |
| 8240-4 | Phencyclidine [Presence] in Unknown substance |
| 98003-7 | HLA-A and B and C (class I) IgG donor specific [Identifier] in Serum or Plasma |
| 98907-9 | Hemoglobinopathy panel |
| 99879-9 | Lipids [#/area] in Urine sediment by Computer assisted method |
| 72863-4 | Mycobacterium leprae gyrB gene fluoroquinolone resistance mutation [Presence] by Molecular method |
| 87315-8 | Encephalomyocarditis virus RNA [Presence] in Tissue by NAA with probe detection |
| 73570-4 | Testosterone/Epitestosterone [Interpretation] in Urine Qualitative |
| 88258-9 | Escherichia coli oppA gene [Presence] by Probe in Positive blood culture |
| 7415-3 | Cladosporium sphaerospermum IgE Ab [Units/volume] in Serum |
| 41725-3 | Thiamphenicol [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 59709-6 | Midazolam [Mass/volume] in Body fluid |
| 59799-7 | Ganciclovir [Mass/volume] in Plasma --trough |
| 4212-7 | Desipramine [Mass] of Dose |
| 42715-3 | Del(5)(q12-35) deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 60026-2 | Leukocyte esterase [Presence] in Urine by Automated test strip |
| 51244-2 | CD13+CD33+HLA-DR+ cells/100 cells in Body fluid |
| 21672-1 | F8 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 22244-8 | Cytomegalovirus IgG Ab [Presence] in Serum or Plasma |
| 5146-6 | Echovirus 9 neutralizing antibody [Titer] in Serum by Neutralization test |
| 51470-3 | Satratoxin IgM Ab [Units/volume] in Serum |
| 43824-2 | Bilirubin.total [Presence] in Body fluid |
| 22682-9 | Ornithine/Creatinine [Molar ratio] in Urine |
| 52932-1 | Copper/Creatinine [Molar ratio] in 24 hour Urine |
| 44306-9 | Citrate/Creatinine [Mass Ratio] in 24 hour Urine |
| 22923-7 | Brucella abortus IgG1 Ab [Presence] in Milk by Immunoassay |
| 53485-9 | Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose betaxolol |
| 44432-3 | Annexin V IgM Ab [Units/volume] in Serum or Plasma |
| 44625-2 | Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols |
| 4470-1 | Choleglobin/Hemoglobin.total in Blood |
| 23213-2 | Lumpy skin disease virus Ab [Titer] in Serum by Immunofluorescence |
| 23229-8 | Mareks disease virus Ag [Presence] in Specimen by Immunofluorescence |
| 23384-1 | Pseudorabies virus Ag [Presence] in Specimen by Immunoassay |
| 23565-5 | Vesicular stomatitis New Jersey virus Ab [Presence] in Serum |
| 33624-8 | Pentacarboxylporphyrin III [Mass/time] in 24 hour Stool |
| 53863-7 | FLNA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 45114-6 | Chlamydia sp Ag [Presence] in Urethra |
| 23661-2 | Avian paramyxovirus 1 Ab [Titer] in Serum by Immunoassay |
| 23671-1 | Bluetongue virus 10 neutralizing antibody [Titer] in Serum by Neutralization test |
| 54027-8 | Lamin Ab [Presence] in Serum by Immunofluorescence |
| 54469-2 | Cholesterol in HDL 3a/Cholesterol in total HDL in Serum or Plasma by Electrophoresis |
| 46961-9 | TCR gamma delta Ag [Presence] in Tissue by Immune stain |
| 47007-0 | Spermatozoa IgA Ab/100 spermatozoa in Serum by Immunobead |
| 24209-9 | La Crosse virus Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 24263-6 | Coxsackievirus B4 Ab [Titer] in Serum --1st specimen |
| 554-6 | Candida sp identified in Stool by Organism specific culture |
| 47075-7 | Coxiella burnetii phase 1 IgM Ab [Titer] in Serum by Immunofluorescence |
| 2519-7 | Lactate [Moles/volume] in Venous blood |
| 2555-1 | Lecithin cholesterol acyltransferase [Enzymatic activity/volume] in Serum or Plasma |
| 34932-4 | CD3+CD4+CD45RO-CD45RA+ cells/100 cells in Blood |
| 35269-0 | Bartonella henselae Ab [Presence] in Serum by Immunofluorescence |
| 55849-4 | Cryoglobulin.IgM.monoclonal [Presence] in Serum |
| 55866-8 | Choriogonadotropin.beta subunit free [Mass/volume] in Cerebral spinal fluid |
| 47570-7 | Argininosuccinate lyase [Enzymatic activity/mass] in Fibroblast |
| 35374-8 | DMPK gene allele 2 CTG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 35443-1 | HIV 1 p65 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
| 35447-2 | HIV 1 p31 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
| 264-2 | Fusidate [Susceptibility] by Serum bactericidal titer |
| 26634-6 | Legionella gormanii Ab [Presence] in Serum |
| 38233-3 | CD3+CD62L+ cells [#/volume] in Blood |
| 48592-0 | Fibrin+Fibrinogen fragments [Titer] in Platelet poor plasma by Latex agglutination |
| 2693-0 | Osmolality of Stool |
| 38448-7 | CFTR gene p.Ala455Glu [Presence] in Blood or Tissue by Molecular genetics method |
| 4922-1 | HLA-DPw2 [Presence] in Donor |
| 27910-9 | Calcium [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 49435-1 | Parvovirus B19 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
| 58645-3 | Cortisol [Moles/volume] in Saliva (oral fluid) --12 PM specimen |
| 58652-9 | Cortisol [Mass/volume] in Saliva (oral fluid) --1 hour post 1 ug/kg CRH IV |
| 49846-9 | Hepatitis C virus core Ag [Presence] in Blood or Marrow from Donor |
| 29612-9 | ePHEDrine+Pseudoephedrine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 29719-2 | Orientia tsutsugamushi Litchfield Ab [Titer] in Serum by Immunofluorescence |
| 29-9 | Ampicillin [Susceptibility] by Disk diffusion (KB) |
| 40554-8 | CD45 Ag [Presence] in Tissue by Immune stain |
| 58942-4 | Microscopic observation [Identifier] in Pleural fluid by Acid fast stain.Ziehl-Neelsen |
| 59011-7 | Lactate [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 40911-0 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum by Immunoassay |
| 19701-2 | Temazepam cutoff [Mass/volume] in Urine for Confirmatory method |
| 20421-4 | Barbiturates [Presence] in Serum or Plasma by Screen method |
| 20519-5 | Cocaine [Mass/volume] in Urine by Confirmatory method |
| 100669-1 | NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method |
| 100802-8 | 21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge |
| 12548-4 | Tybamate [Mass/volume] in Serum or Plasma |
| 12704-3 | Length of Hair |
| 13178-9 | Wasp venom IgG Ab [Units/volume] in Serum |
| 1335-9 | Whole blood given [Volume] |
| 102291-2 | Elder IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102507-1 | Black Pepper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1447-2 | Cortisol [Mass/volume] in Serum or Plasma --pre 40 ug corticotropin IM 3 day |
| 14564-9 | Hemoglobin.gastrointestinal [Presence] in Stool --2nd specimen |
| 16404-6 | Arsenic [Presence] in Urine |
| 11141-9 | Phosphate/Creatinine [Mass Ratio] in Urine |
| 18220-4 | EPINEPHrine [Mass/volume] in Urine --3rd specimen post XXX challenge |
| 90845-9 | PCA-Tr Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 74491-2 | Cytokeratin 7 and Thyroid transcription factor 1 Ag [Identifier] in Tissue by Immune stain |
| 74788-1 | Lactulose challenge (hydrogen breath test) panel - Exhaled gas |
| 74791-5 | Lactulose challenge (hydrogen breath test) [Interpretation] in Exhaled gas |
| 75382-2 | ATP7B gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 75563-7 | Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 75586-8 | Fetal Angelman syndrome prior risk [Likelihood] based on general population risk |
| 75656-9 | Mononuclear cells [#] in Pericardial fluid by Manual count |
| 60463-7 | Insulin Ab [Moles/volume] in Serum |
| 75982-9 | Fetal Chromosome 18 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
| 76600-6 | Streptococcus pneumoniae nanA gene [#/volume] in XXX.body fluid by NAA with probe detection |
| 92809-3 | Influenza virus A H1 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 77754-0 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) cutoff [Mass/volume] in Urine for Confirmatory method |
| 78858-8 | Methcathinone [Mass/volume] in Urine by Confirmatory method |
| 64137-3 | Pregabalin [Presence] in Urine by Screen method |
| 9570-3 | Para aminobenzoate [Mass/volume] in 6 hour Urine --6 hours post 500 mg bentiromide PO |
| 80831-1 | Pepsin A Panel - Lower respiratory specimen |
| 96635-8 | HLA-C [Type] in Donor |
| 6927-8 | Platelet IgG Ab [Presence] in Serum by Flow cytometry (FC) |
| 81698-3 | Microsatellite instability marker BAT26 in Cancer specimen Qualitative |
| 8181-0 | Chromium [Mass/volume] in Saliva (oral fluid) |
| 97525-0 | Norovirus genogroup I RNA [Presence] in Specimen by NAA with probe detection |
| 7049-0 | Streptomycin.high potency [Susceptibility] by Disk diffusion (KB) |
| 72333-8 | JAK2 gene p.Val617Phe [Presence] in Bone marrow by Molecular genetics method |
| 72797-4 | Methylenedioxypyrovalerone [Mass/volume] in Urine by Confirmatory method |
| 72875-8 | JWH-073 butanol (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
| 72882-4 | CYP2B6 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 86028-8 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum --2nd specimen |
| 73050-7 | carBAMazepine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73547-2 | Acetaminophen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88739-8 | TIF1-gamma Ab [Units/volume] in Serum by Line blot |
| 4155-8 | Carisoprodol [Mass] of Dose |
| 59838-3 | Cytomegalovirus Ab [Presence] in Serum or Plasma by Latex agglutination |
| 50662-6 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 50946-3 | Platelet aggregation ADP induced [Presence] in Platelet rich plasma --4 umol/L |
| 59928-2 | Methaqualone [Moles/volume] in Urine |
| 60153-4 | PENTobarbital [Mass/mass] in Tissue |
| 60234-2 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.75 hours post dose lactose PO |
| 60323-3 | Nordoxepin [Moles/volume] in Specimen |
| 21634-1 | ATP7B gene p.Asn915Ser [Presence] in Blood or Tissue by Molecular genetics method |
| 31410-4 | Herpes simplex virus 1 Ab [Units/volume] in Cerebral spinal fluid |
| 22243-0 | Cytomegalovirus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 51783-9 | Reagin Ab [Presence] in Cord blood by VDRL |
| 51813-4 | Coxiella burnetii phase 2 IgM Ab [Units/volume] in Serum by Immunoassay |
| 43744-2 | COX10 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 22580-5 | Toxoplasma gondii IgG Ab [Presence] in Serum |
| 22630-8 | Xylose/Xylose dose in 5 hour Urine --post 25 g xylose PO |
| 32521-7 | CD10+CD19+ cells/100 cells in Specimen |
| 3252-4 | Fibrin+Fibrinogen fragments [Units/volume] in Serum by Latex agglutination |
| 44022-2 | Bacteria [Presence] in Cervix by Wet preparation |
| 3328-2 | Aminopyrine [Mass/volume] in Serum or Plasma |
| 33991-1 | CD79b cells/100 cells in Specimen |
| 54214-2 | Cortisol [Moles/volume] in Serum or Plasma --5 days post dose dexamethasone |
| 4552-6 | Hemoglobin A2/Hemoglobin.total in Blood by Electrophoresis |
| 46203-6 | Reagin Ab [Titer] in Cerebral spinal fluid |
| 24402-0 | Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Specimen by Probe with amplification |
| 34489-5 | TOR1A gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
| 47405-6 | Ehrlichia chaffeensis IgG Ab [Titer] in Serum by Immunofluorescence |
| 26019-0 | Creatine Kinase.macromolecular type 1/Creatine kinase.total in Serum or Plasma |
| 56449-2 | Baker's yeast IgG4 Ab [Mass/volume] in Serum |
| 26551-2 | Glucose [Presence] in Urine by Test strip --5 hours post dose glucose |
| 48848-6 | Coxiella burnetii phase 1 IgA Ab [Titer] in Serum by Immunofluorescence |
| 26903-5 | Canine distemper virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 2724-3 | Para aminohippurate [Mass/volume] in Urine |
| 38607-8 | Methoxychlor [Mass/volume] in Air |
| 4923-9 | HLA-DPw2 [Presence] |
| 27343-3 | Molybdenum [Mass/mass] in Red Blood Cells |
| 57951-6 | CPVT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 49439-3 | Pneumocystis jiroveci DNA [#/volume] in Cerebral spinal fluid by NAA with probe detection |
| 49576-2 | Phosphatidylethanolamine/Surfactants.total in Amniotic fluid |
| 29505-5 | 2-Hydroxy-3-Methylvalerate/Creatinine [Molar ratio] in Urine |
| 3990-9 | Propranolol [Mass/time] in 24 hour Urine |
| 50169-2 | Aldosterone [Moles/volume] in Serum or Plasma --post XXX challenge |
| 29573-3 | Phenylalanine [Moles/volume] in DBS |
| 2977-7 | Sulfite oxidase [Enzymatic activity/volume] in Plasma |
| 40312-1 | Cortisol [Moles/volume] in Serum or Plasma --30 minutes post dose triple bolus |
| 4039-4 | Streptomycin [Mass/volume] in Serum or Plasma |
| 30259-6 | Insulin [Units/volume] in Serum or Plasma --2.6 hours post XXX challenge |
| 41107-4 | FMR1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 1920-8 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma |
| 19446-4 | Dihydrocodeine [Presence] in Urine by Screen method |
| 2039-6 | Carcinoembryonic Ag [Mass/volume] in Serum or Plasma |
| 21018-7 | CD61 cells [#/volume] in Blood |
| 100995-0 | Laceyella sacchari IgG Ab [Presence] in Serum |
| 12601-1 | Fluoride [Mass/volume] in Dialysis fluid |
| 13027-8 | Ethyl acetate [Mass/volume] in Serum or Plasma |
| 13535-0 | Sucrose hemolysis of Red Blood Cells |
| 13992-3 | Albumin/Protein.total in Urine by Electrophoresis |
| 14162-2 | Gamma melanocyte stimulating hormone [Mass/volume] in Serum or Plasma |
| 14175-4 | Protoporphyrin [Mass/mass] in 24 hour Stool |
| 103108-7 | Cedar elm IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14492-3 | Virus identified in Eye by Immunofluorescence |
| 104117-7 | 11-Hydroxytestosterone [Moles/volume] in Serum or Plasma by LC/MS/MS |
| 104453-6 | Trichinella spiralis IgG Ab [Titer] in Serum by Immunoassay --1st specimen |
| 10851-4 | Escherichia coli O157:H7 [Presence] in Stool by Organism specific culture |
| 10933-0 | Guar gum IgE Ab [Units/volume] in Serum |
| 11074-2 | Norfentanyl [Mass/volume] in Serum or Plasma |
| 11570-9 | Platelet IgG Ab [Units/volume] in Serum |
| 17010-0 | Imipenem [Mass/volume] in Serum or Plasma |
| 17537-2 | Rickettsia spotted fever group RNA [Presence] in Serum by NAA with probe detection |
| 17897-0 | Bacteria # 6 identified in Sputum by Aerobe culture |
| 74633-9 | Dimethylacetal (DMA) panel - Fibroblast |
| 92731-9 | Hepatitis C virus genotype in Serum or Plasma by Sequencing |
| 7538-2 | Oat IgG Ab [Units/volume] in Serum |
| 6033-5 | Avocado IgE Ab [Units/volume] in Serum |
| 60519-6 | Fatty acids.ethyl esters [Moles/mass] in Meconium |
| 60531-1 | Japanese encephalitis virus IgM Ab [Titer] in Serum |
| 61194-7 | Cells Counted Total [#] in Pleural fluid from Fetus |
| 62291-0 | 1,25-Dihydroxyvitamin D2 [Mass/volume] in Serum or Plasma |
| 77182-4 | Niobium [Mass/volume] in Blood |
| 63483-2 | Penicillium notatum Ab [Presence] in Serum by Immune diffusion (ID) |
| 9554-7 | CD10 cells [#/volume] in Blood |
| 66143-9 | Monocytes [#/volume] in Blood from Fetus by Manual count |
| 79565-8 | Mucopolysaccharidosis type I newborn screening comment-discussion |
| 79632-6 | Homocarnosine/Creatinine [Molar ratio] in Urine |
| 961-3 | C sup(x) Ab [Presence] in Serum or Plasma from Blood product unit |
| 6750-4 | Glucose [Presence] in Urine by Test strip --2 hours post 50 g lactose PO |
| 8083-8 | Myocardium Ab [Units/volume] in Serum |
| 96653-1 | HLA-DQA1 [Type] in Donor by Low resolution |
| 9722-0 | Smith extractable nuclear Ab [Titer] in Serum |
| 71760-3 | Rotavirus identified in Stool by Sequencing |
| 99913-6 | Bacilliform bacteria [#/area] in Urine sediment by Automated count |
| 99929-2 | Leukocytes [#/area] in Body fluid by Automated count |
| 87633-4 | Phorate [Mass/mass] in Specimen |
| 87934-6 | Bacteria identified in Bile fluid by Anaerobe culture |
| 7419-5 | Horse epithelium IgE Ab [Units/volume] in Serum |
| 41700-6 | Lincomycin [Susceptibility] by Gradient strip |
| 50623-8 | AS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 50836-6 | Calcium [Moles/mass] in Hair |
| 3064-3 | Trypsin+Trypsinogen [Mass/volume] in Serum or Plasma |
| 31267-8 | Bordetella pertussis secretory IgA Ab [Presence] in Specimen |
| 42994-4 | Leptospira sp Ab [Titer] in Cerebral spinal fluid |
| 22163-0 | Candida albicans Ab [Units/volume] in Serum |
| 51518-9 | Lactate dehydrogenase 4/Lactate dehydrogenase.total in Pleural fluid by Electrophoresis |
| 5163-1 | Fasciola sp Ab [Units/volume] in Serum |
| 51659-1 | Hepatitis B virus surface Ag [Presence] in Body fluid |
| 51911-6 | Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool --3rd specimen |
| 4358-8 | Norfenefrine [Mass] of Dose |
| 43637-8 | Parrot droppings IgG Ab [Presence] in Serum |
| 22333-9 | Herpes simplex virus 1 IgG Ab [Titer] in Cerebral spinal fluid |
| 32075-4 | fluvoxaMINE [Presence] in Specimen |
| 53028-7 | Cyclic citrullinated peptide Ab [Presence] in Serum |
| 23006-0 | Classical swine fever virus Ag [Presence] in Specimen by Immunofluorescence |
| 23126-6 | Francisella tularensis Ag [Presence] in Tissue by Immune stain |
| 32579-5 | Phentermine [Mass/volume] in Serum or Plasma |
| 32778-3 | Fibrin strands [Presence] in Blood by Light microscopy |
| 32814-6 | Microscopic observation [Identifier] in Specimen by Chloracetate esterase stain |
| 53209-3 | Dehydrosuberylcarnitine (C8:1-DC) [Moles/volume] in DBS |
| 23314-8 | Nairobi sheep disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 53623-5 | HRAS gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal |
| 53749-8 | Collection time of Blood--5th specimen |
| 53834-8 | cycloSPORINE [Mass/volume] in Blood --peak |
| 53838-9 | Arsenic.inorganic [Mass/time] in 24 hour Urine |
| 54022-9 | Mutated citrullinated vimentin Ab [Units/volume] in Serum |
| 46221-8 | Glucose [Moles/volume] in Dialysis fluid --2 hour specimen |
| 46418-0 | INR in Capillary blood by Coagulation assay |
| 46717-5 | Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of bovine thrombin |
| 24117-4 | Ross River virus IgG Ab [Presence] in Serum by Immunoassay |
| 2481-0 | Insulin Ab [Presence] in Serum |
| 55493-1 | Insulin [Moles/volume] in Serum or Plasma --3 hours post dose glucose IV |
| 47202-7 | Sincalide [Mass] of Dose |
| 34975-3 | DNA index in Serum or Plasma by Flow cytometry (FC) |
| 3518-8 | Cyclizine [Mass/volume] in Serum or Plasma |
| 48006-1 | Amino acid change [Type] |
| 48167-1 | Prostate specific Ag/Creatinine [Mass Ratio] in Urine |
| 26054-7 | Mitochondria M2 Ab [Presence] in Serum |
| 26597-5 | Phosphoethanolamine [Moles/volume] in Cerebral spinal fluid |
| 26796-3 | Oxalate [Presence] in Urine |
| 35874-7 | Penicillin+Novobiocin [Susceptibility] |
| 3635-0 | Fenproporex [Mass/time] in 24 hour Urine |
| 36915-7 | AS+PWS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 37990-9 | Corticotropin releasing hormone [Moles/volume] in Serum or Plasma |
| 38488-3 | IgG [Units/volume] in Serum |
| 49230-6 | Acetylcholinesterase [Enzymatic activity/mass] in Red Blood Cells |
| 3880-2 | Orphenadrine [Mass/volume] in Serum or Plasma |
| 57775-9 | Valproate.free and Valproate panel - Serum or Plasma |
| 49354-4 | Epstein Barr virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
| 4958-5 | HLA-DR14(6) [Presence] in Donor |
| 58398-9 | Propoxyphene/Creatinine [Mass Ratio] in Urine |
| 58609-9 | Corticotropin [Moles/volume] in Plasma --5th specimen post XXX challenge |
| 58755-0 | Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 29880-2 | 2-Hydroxy-3-Methylvalerate [Presence] in Urine |
| 40471-5 | FBN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 50231-0 | Hyaline casts [Presence] in Urine by Automated |
| 50504-0 | Insulin [Units/volume] in Serum or Plasma --4th specimen |
| 30002-0 | Creatinine [Moles/volume] in Urine by Test strip |
| 30082-2 | IgE [Presence] in Serum by Immunofixation |
| 30195-2 | Fatty acids.very long chain C24:0 (Tetracosanoate) [Moles/volume] in Serum or Plasma |
| 41168-6 | Arginine [Presence] in Blood |
| 21033-6 | Yeast.budding [Presence] in Urine sediment |
| 100819-2 | Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge |
| 101157-6 | Flualprazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 1321-9 | Transfusion duration |
| 13286-0 | Toxoplasma gondii IgG Ab [Units/volume] in Serum --2nd specimen |
| 13317-3 | Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture |
| 13432-0 | DOPamine [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 13486-6 | Testosterone/Creatinine [Mass Ratio] in Urine |
| 13582-2 | Theophylline [Mass/volume] in Body fluid |
| 102318-3 | Fusarium moniliforme IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102354-8 | Guinea pig epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13995-6 | Gamma globulin/Protein.total in Urine by Electrophoresis |
| 14093-9 | Bacteria identified in Water by Culture |
| 1432-4 | Cortisol [Mass/volume] in Serum or Plasma --72 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 14766-0 | Glucose [Moles/volume] in Serum or Plasma --4 hours post dose glucose |
| 10600-5 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa |
| 16241-2 | PHENobarbital [Mass/volume] in Urine by Confirmatory method |
| 11069-2 | Microscopic observation [Identifier] in Gastric fluid by Cyto stain |
| 16250-3 | Codeine [Mass/volume] in Urine by Confirmatory method |
| 11545-1 | Microscopic observation [Identifier] in Specimen by Acid fast stain |
| 17755-0 | Urate [Mass/time] in 2 hour Urine |
| 74872-3 | 21-Deoxycortisol [Mass/volume] in Serum or Plasma |
| 92551-1 | C Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 75057-0 | Sialidase [Enzymatic activity/mass] in Leukocytes |
| 75557-9 | Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 75726-0 | HTR2A gene c.-1438G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 60438-9 | Diamine oxidase [Units/volume] in Serum or Plasma |
| 76607-1 | Enterococcus faecium sodA gene [#/volume] in XXX.body fluid by NAA with probe detection |
| 9305-4 | Mononuclear cells/100 leukocytes in Body fluid by Manual count |
| 77172-5 | KIT gene exon 9 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 77400-0 | Human papilloma virus 18 DNA [Presence] in Cervix by NAA with probe detection |
| 7839-4 | Coxsackievirus B4 Ab [Units/volume] in Serum |
| 7877-4 | Anaplasma phagocytophilum Ab [Presence] in Serum |
| 94553-5 | Isopentacarboxylporphyrin [Mass/time] in 24 hour Stool |
| 79193-9 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post dose arginine+insulin |
| 79201-0 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose arginine+insulin |
| 95568-2 | 5-Pregnenediol [Z-score] in 24 hour Urine |
| 65347-7 | Glucagon [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 79685-4 | 5,6-Dihydrouracil/Creatinine [Molar ratio] in Urine |
| 8038-2 | Toxocara canis Ab [Units/volume] in Serum |
| 9629-7 | TOLAZamide [Mass/volume] in Serum or Plasma |
| 96471-8 | Rho GTPase-activating protein 26 IgG Ab [Presence] in Serum by Immunofluorescence |
| 69050-3 | Toxicologist review of results |
| 96633-3 | HLA-Bw [Type] |
| 70026-0 | Candida glabrata DNA [Presence] in Blood by NAA with probe detection |
| 70138-3 | Amphetamines [Mass/volume] in Urine by Screen method |
| 85320-0 | Foci [Type] in Breast cancer specimen by Light microscopy |
| 73329-5 | Irbesartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86730-9 | Leptospira borgpetersenii sv Hardjo-bovis DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73933-4 | Normeperidine [Mass/volume] in Serum, Plasma or Blood |
| 74104-1 | Alpha-Amanitin + gamma-Amanitin [Mass/volume] in Urine by Immunoassay |
| 59920-9 | lamoTRIgine [Moles/volume] in Gastric fluid |
| 5999-8 | Platelet aggregation serotonin induced in Platelet rich plasma |
| 60047-8 | Acetaldehyde [Mass/mass] in Tissue |
| 6008-7 | Protein C+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 60183-1 | Terazosin [Mass/volume] in Blood |
| 21112-8 | Birth date |
| 31284-3 | Canine distemper virus Ab [Units/volume] in Serum |
| 51344-0 | CD55 cells/100 cells in Bone marrow |
| 51410-9 | Environmental stressors panel - Water |
| 43077-7 | Borrelia burgdorferi Ab [Units/volume] in Specimen |
| 22206-7 | Coccidioides immitis Ab [Units/volume] in Serum |
| 22313-1 | Hepatitis A virus IgG Ab [Units/volume] in Serum |
| 31690-1 | Trivittatus virus Ab [Units/volume] in Specimen |
| 31763-6 | Chlamydia sp Ag [Presence] in Conjunctival specimen |
| 32015-0 | EPINEPHrine [Mass/volume] in 24 hour Urine |
| 5184-7 | Hepatitis A virus Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
| 51908-2 | Efavirenz [Mass/volume] in Serum or Plasma --peak |
| 22447-7 | Polio virus 2 Ab [Titer] in Cerebral spinal fluid |
| 32272-7 | Threonine [Moles/volume] in Vitreous fluid |
| 43845-7 | Chlamydophila pneumoniae Ab [Titer] in Serum by Immunofluorescence |
| 23383-3 | Pseudorabies virus Ag [Presence] in Specimen by Immune stain |
| 33390-6 | Respiratory syncytial virus Ab [Presence] in Serum |
| 33612-3 | Phosphatidylinositol Ab [Units/volume] in Serum |
| 4487-5 | Complement C3 fragment [Mass/volume] in Red Blood Cells |
| 45063-5 | Varicella zoster virus IgG and IgM panel - Serum |
| 45086-6 | Chlamydia trachomatis DNA [Presence] in Nasopharynx by NAA with probe detection |
| 45180-7 | 1p chromosome deletion [Presence] in Blood or Tissue by Molecular genetics method |
| 54206-8 | Cytomegalovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 54352-0 | Nitrogen [Mass/volume] in Urine |
| 455-6 | Spiramycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 46230-9 | Methanolone [Mass/volume] in Urine |
| 46752-2 | Medium chain acyl dehydrogenase Deficiency/Glutaric Acidemia type 2 newborn screen interpretation |
| 548-8 | Bordetella pertussis [Presence] in Throat by Organism specific culture |
| 2526-2 | Lactate [Mass/time] in 24 hour Urine |
| 25272-6 | Tetracycline [Mass/volume] in Specimen |
| 25432-6 | Haemophilus influenzae Ab [Mass/volume] in Serum |
| 35026-4 | Monocytes [#/volume] in Cerebral spinal fluid |
| 35048-8 | Abnormal lymphocytes [#/volume] in Synovial fluid |
| 55855-1 | Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Serum or Plasma |
| 47613-5 | Decanoate (C10:0)/Creatinine [Molar ratio] in Urine |
| 47734-9 | Proline/Amino acids.total in Amniotic fluid |
| 56267-8 | Ginger IgG4 Ab [Mass/volume] in Serum |
| 56465-8 | Salt grass IgG4 Ab [Mass/volume] in Serum |
| 47979-0 | Tranylcypromine [Presence] in Serum or Plasma |
| 48146-5 | Myeloperoxidase [Units/volume] in Serum |
| 38159-0 | levETIRAcetam [Mass/volume] in Urine |
| 38173-1 | Borrelia burgdorferi C6 Ab [Units/volume] in Serum by Immunoassay |
| 56707-3 | Spiramycin IgE Ab [Units/volume] in Serum |
| 48497-2 | Pro-hepcidin [Mass/volume] in Serum or Plasma |
| 4856-1 | HLA-Cw4 [Presence] in Donor |
| 48590-4 | aPTT in Platelet poor plasma by Coagulation assay --after addition of APC |
| 48607-6 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose fructose PO |
| 48812-2 | Spermatozoa morphology panel |
| 26987-8 | Pentachlorophenol/Creatinine [Mass Ratio] in Urine |
| 27050-4 | Mephobarbital [Mass/volume] in Milk |
| 57508-4 | 11-Hydroxyandrosterone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
| 27438-1 | Protein C Ag/Coagulation factor VII Ag [Mass Ratio] in Platelet poor plasma by Immunoassay |
| 38676-3 | Sperm Tail Tip IgA Ab/100 spermatozoa in Specimen by Immunobead |
| 39488-2 | Phensuximide [Moles/volume] in Serum or Plasma |
| 3960-2 | Phenylbutazone [Mass/volume] in Serum or Plasma |
| 57898-9 | Cocaine [Moles/volume] in Specimen |
| 4009-7 | Pyrilamine [Presence] in Urine |
| 40250-3 | Creatinine [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 58553-9 | Corticotropin [Moles/volume] in Plasma --1 hour post 1 ug/kg CRH IV |
| 58666-9 | Cortisol [Mass/volume] in Saliva (oral fluid) --4 AM specimen |
| 29572-5 | Phenylalanine [Mass/volume] in DBS |
| 59056-2 | Glucagon [Mass/volume] in Serum or Plasma --2nd specimen fasting |
| 59168-5 | Urea [Moles/time] in 24 hour Stool |
| 50278-1 | 3-Hydroxymyristoleylcarnitine (C14:1-OH)/Creatinine [Molar ratio] in Urine |
| 40744-5 | Factor inhibitor XXX [Presence] in Platelet poor plasma by Coagulation assay |
| 41088-6 | MERRF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19415-9 | Tetrahydrocannabinol [Presence] in Urine by Screen method |
| 19706-1 | Thioridazine [Presence] in Urine by Screen method |
| 20378-6 | Ceftizoxime [Susceptibility] by Method for Slow-growing mycobacteria |
| 21000-5 | Erythrocyte distribution width [Entitic volume] by Automated count |
| 100996-8 | Neurofilament light chain [Mass/volume] in Cerebral spinal fluid |
| 101305-1 | Plasmodium sp DNA [Presence] in Blood by NAA with non-probe detection |
| 101843-1 | Triamcinolone [Moles/volume] in Serum or Plasma |
| 102211-0 | Catfish IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13452-8 | Iron/Transferrin [Mass Ratio] in Serum or Plasma |
| 102412-4 | Lime IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102463-7 | Nutmeg IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14456-8 | Virus identified in Peritoneal fluid by Culture |
| 14460-0 | Virus identified in Urethra by Culture |
| 15097-9 | Vanillylmandelate [Moles/volume] in Urine |
| 15131-6 | Isoleucine+Leucine [Presence] in Serum or Plasma |
| 10614-6 | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Immunobead |
| 10888-6 | Lipase [Enzymatic activity/volume] in Urine |
| 11115-3 | Neutrophils/100 cells in Bone marrow by Manual count |
| 16599-3 | Chlamydia trachomatis DNA [Presence] in Blood by NAA with probe detection |
| 1133-8 | Lu sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 16795-7 | Echovirus Ab [Units/volume] in Serum |
| 16818-7 | Entamoeba histolytica Ab [Units/volume] in Cerebral spinal fluid |
| 17138-9 | CD31 cells/100 cells in Blood |
| 17290-8 | Morphine [Presence] in Serum or Plasma by Confirmatory method |
| 1761-6 | Aldolase [Enzymatic activity/volume] in Serum or Plasma |
| 74914-3 | Acylglycines panel [Molar ratio] - Urine |
| 60520-4 | Eosinophils [Presence] in Body fluid by Light microscopy |
| 76083-5 | Microscopic observation [Presence] in Bronchoalveolar lavage by Acid fast stain.Ziehl-Neelsen |
| 93426-5 | GABABR IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 61330-7 | Pine Nut IgE Ab/IgE total in Serum |
| 62201-9 | XXX microorganism DNA [Identifier] in Serum or Plasma by NAA with probe detection |
| 93846-4 | Hemoglobin [Moles/volume] in Venous blood |
| 63563-1 | Japanese encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 6455-0 | Leptospira sp identified in Urine by Organism specific culture |
| 9523-2 | Entamoeba histolytica IgM Ab [Units/volume] in Serum by Immunoassay |
| 65764-3 | Kiwi native (nAct d) 5 IgE Ab [Units/volume] in Serum |
| 95719-1 | Flavivirus Ab [Presence] in Serum or Plasma |
| 68437-3 | Smudge cells [#/volume] in Blood by Manual count |
| 81107-5 | Leptospira interrogans sv Shermani Ab [Titer] in Serum by Agglutination |
| 81272-7 | Cell count and Differential panel - Dialysis fluid |
| 81755-1 | Lymphocyte proliferation.Interleukin 2.maximum/CD45 in Blood by Flow cytometry (FC) |
| 97286-9 | Norhydrocodone [Presence] in Cord tissue by Screen method |
| 97582-1 | Buprenorphine free [Presence] in Cord tissue by Screen method |
| 7041-7 | Penicillin G [Susceptibility] by Gradient strip |
| 82964-8 | Cannabidiol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 99092-9 | Neisseria meningitidis DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 7217-3 | Cherry IgG Ab [Units/volume] in Serum |
| 72633-1 | Benzodiazepines [Presence] in Saliva (oral fluid) by Screen method |
| 72951-7 | Simvastatin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86048-6 | Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 73279-2 | Methylphenidate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73333-7 | Imipenem+Cilastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87600-3 | Chlortetracycline [Mass/mass] in Specimen |
| 73615-7 | Ormetroprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 88716-6 | Adenovirus A+B+C+D+E+F DNA [Presence] in Nasopharynx by NAA with probe detection |
| 89527-6 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
| 59463-0 | Lymphocytes/100 leukocytes in Dialysis fluid |
| 31038-3 | Gatifloxacin [Susceptibility] |
| 21110-2 | Beta-N-acetylhexosaminidase.B/Beta-n-acetylhexosaminidase.total in Blood |
| 21207-6 | CCR5 gene mutations found [Identifier] in Blood by Molecular genetics method Nominal |
| 2153-5 | Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma |
| 51127-9 | CD22 blasts [Units/volume] in Bone marrow |
| 51324-2 | CD42 cells/100 cells in Body fluid |
| 42736-9 | CD20+CD23+ cells/100 cells in Blood |
| 51478-6 | Mucus [#/volume] in Urine by Automated count |
| 5164-9 | Fc fragment Ab [Units/volume] in Serum |
| 43389-6 | Streptococcus sp identified in Isolate by Organism specific culture |
| 43745-9 | DYS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 22714-0 | Isoleucine [Moles/volume] in Specimen |
| 22745-4 | Ethanol [Moles/volume] in Urine |
| 22824-7 | Influenza virus A Ab [Titer] in Serum by Hemagglutination inhibition |
| 2316-8 | Galactosylgalactosylglucosylceramidase [Enzymatic activity/mass] in Tissue |
| 32756-9 | CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Bronchial specimen |
| 32818-7 | Microscopic observation [Identifier] in Specimen by Acetate esterase stain |
| 33234-6 | Calcium oxalate crystals [Presence] in Urine by Computer assisted method |
| 33242-9 | Fungi.filamentous [Presence] in Urine by Computer assisted method |
| 53163-2 | Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 44548-6 | Human papilloma virus DNA [Presence] in Urethra by Probe with signal amplification |
| 33412-8 | Blasts/100 leukocytes in Pericardial fluid |
| 23808-9 | Aldosterone free [Mass/time] in 24 hour Urine |
| 34061-2 | Somatotropin [Mass/volume] in Serum or Plasma --pre or post dose arginine |
| 54071-6 | Hemoglobin E/Hemoglobin.total in DBS |
| 54242-3 | Influenza virus identified in Isolate |
| 47094-8 | Calciferol (Vit D2) [Moles/volume] in Serum or Plasma |
| 25192-6 | Clarithromycin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 35134-6 | Thyrotropin Ab [Presence] in Serum |
| 26637-9 | Leishmania brasilensis Ab [Presence] in Serum |
| 27090-0 | Entamoeba histolytica IgA Ab [Presence] in Saliva (oral fluid) |
| 27110-6 | Androsterone [Mass/volume] in Urine |
| 38649-0 | Chloroform [Mass/volume] in Air |
| 27859-8 | Sporothrix schenckii Ab [Titer] in Cerebral spinal fluid |
| 27947-1 | Coxsackievirus A7 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe |
| 27969-5 | Coxsackievirus A9 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe |
| 3945-3 | Phenmetrazine [Mass/volume] in Urine |
| 49546-5 | Age of Blood specimen |
| 40254-5 | Creatinine [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 58440-9 | Classical swine fever virus E2 Ab [Units/volume] in Serum by Immunoassay |
| 50049-6 | Hemicystine/Amino acids.total in Hair |
| 2958-7 | Sodium/Potassium [Molar ratio] in Sweat |
| 29886-9 | Encephalomyocarditis virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 5017-9 | HIV 1 RNA [Presence] in Blood by NAA with probe detection |
| 19660-0 | Phencyclidine cutoff [Mass/volume] in Urine for Screen method |
| 21005-4 | Hepatitis B virus core Ab [Units/volume] in Serum from Donor by Immunoassay |
| 101545-2 | FCGR3A gene.p.Phe158 [Identifier] in Blood by Molecular genetics method Nominal |
| 102035-3 | Anti-hypertensive and Anti-thrombotic drug [Presence] in Serum by LC/MS/MS |
| 102061-9 | 4,8-Dioxa-3H-perfluorononanoate [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 13515-2 | Hemoglobin pattern [Interpretation] in Blood by Electrophesis citrate agar Narrative |
| 138-8 | Ceftizoxime [Susceptibility] by Disk diffusion (KB) |
| 14662-1 | Color of Pleural fluid |
| 14781-9 | Hexacarboxylate [Moles/volume] in Urine |
| 103138-4 | Cat recombinant (rFel d) 7 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103160-8 | Cells.CD33.recipient derived/Cells.CD33 in Blood --post bone marrow transplant |
| 14917-9 | Thioridazine [Moles/volume] in Serum or Plasma |
| 15143-1 | Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Urine |
| 15503-6 | Pseudorabies virus Tolvid gene deletion Ab [Presence] in Serum by Immunoassay |
| 1105-6 | Kp sup(b) Ab [Presence] in Serum or Plasma |
| 16570-4 | Centromere Ab [Presence] in Serum by Immunofluorescence |
| 11468-6 | Bacillus anthracis Ab [Units/volume] in Specimen by Immunofluorescence |
| 16915-1 | Glucose [Mass/volume] in Serum or Plasma --post meal |
| 17590-1 | Smith extractable nuclear Ab [Titer] in Serum by Immunoassay |
| 17863-2 | Calcium.ionized [Mass/volume] in Serum or Plasma |
| 90268-4 | Microscopic observation [Identifier] in Peritoneal fluid by Giemsa stain |
| 74659-4 | oxyMORphone [Presence] in Saliva (oral fluid) by Confirmatory method |
| 75630-4 | Interstitial collagenase [Mass/volume] in Serum or Plasma |
| 61095-6 | Ethanol [Presence] in Gastric fluid by Screen method |
| 767-4 | Neutrophils.hypersegmented/100 leukocytes in Blood by Manual count |
| 76766-5 | Treponema pallidum polA gene [Presence] in Genital specimen by NAA with probe detection |
| 63116-8 | Pumpkin IgG Ab [Mass/volume] in Serum |
| 78692-1 | Pseudouridine/Creatinine [Molar ratio] in Urine |
| 94557-6 | dRVVT in Platelet poor plasma by Coagulation assay --post DOAC neutralization |
| 6373-5 | Taenia solium larva IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 79293-7 | Creatine and guanidinoacetate pattern [Interpretation] in Cerebral spinal fluid Narrative |
| 94855-4 | carBAMazepine hypersensitivity genotype panel - Blood or Tissue |
| 95198-8 | CMV-specific CD8 cells [#/volume] in Blood by Flow cytometry (FC) |
| 66723-8 | Adenovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 80129-0 | Amisulpride [Mass/volume] in Blood |
| 95711-8 | Saint Louis encephalitis virus IgA Ab [Presence] in Specimen by Immunoassay |
| 9603-2 | Taenia solium larva 18kD Ab [Presence] in Serum by Immunoblot |
| 80602-6 | Respiratory pathogens identified [Type] in Nasopharynx by NAA with probe detection |
| 6945-0 | glyBURIDE [Mass/volume] in Specimen |
| 81869-0 | PRNP gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 82201-5 | Vibrio cholerae DNA [Presence] in Stool by NAA with non-probe detection |
| 97321-4 | Cyclospora cayetanensis DNA [Presence] in Stool by NAA with probe detection |
| 97925-2 | Barmah forest virus RNA [Presence] in Specimen by NAA with probe detection |
| 7082-1 | Black Ant IgG Ab [Units/volume] in Serum |
| 82504-2 | Glutarate [Moles/volume] in DBS |
| 82538-0 | CALR gene exon 9 full mutation analysis in Blood or Tissue by Molecular genetics method |
| 82971-3 | Butalbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 85376-2 | Neutrophil.PMA stimulated.DHR/Neutrophil.PMA stimulated.total in Blood by Flow cytometry (FC) |
| 85740-9 | Streptococcus pneumoniae Danish serotype 5 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 72744-6 | Norhydrocodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 86320-9 | Zika virus neutralizing antibody [Presence] in Specimen by Neutralization test |
| 73075-4 | Drug induced neutrophil Ab [Interpretation] in Serum or Plasma by Flow cytometry (FC) Narrative |
| 73322-0 | ISOtretinoin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87605-2 | Warfarin [Mass/mass] in Specimen |
| 73445-9 | Ciprofloxacin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 89510-2 | Ganglioside GM3 IgM Ab [Presence] in Serum by Line blot |
| 41224-7 | West Nile virus Ab [Titer] in Cerebral spinal fluid |
| 59324-4 | Salvinorin A [Mass/volume] in Blood |
| 50635-2 | Monterey cypress IgE Ab [Units/volume] in Serum |
| 50823-4 | Beryllium [Moles/mass] in Hair |
| 3044-5 | Triglyceride+ester in HDL [Mass/volume] in Serum or Plasma |
| 30571-4 | Vanillylmandelate/Creatinine [Mass Ratio] in 24 hour Urine |
| 31126-6 | CD20+CD25- cells/100 cells in Blood |
| 4205-1 | Cyclizine [Mass] of Dose |
| 42664-3 | HLA-Cw [Type] |
| 31413-8 | Herpes simplex virus Ab [Units/volume] in Cerebral spinal fluid |
| 51118-8 | Cytoplasmic CD22 blasts/100 blasts in Bone marrow |
| 5120-1 | Taenia solium larva Ab [Units/volume] in Serum by Hemagglutination |
| 51278-0 | CD3+CD56+ cells/100 cells in Tissue |
| 5141-7 | Echovirus 3 Ab [Titer] in Serum by Complement fixation |
| 51644-3 | Megakaryocytic nuclei [Presence] in Blood by Light microscopy |
| 43231-0 | Histone Ab [Units/volume] in Serum by Immunoassay |
| 2235-0 | Epitestosterone [Mass/volume] in Urine |
| 2257-4 | Estrone (E1) [Mass/volume] in Semen |
| 32100-0 | Morphine [Presence] in Specimen |
| 44066-9 | CD20+FMC7+ cells [#/volume] in Cerebral spinal fluid |
| 44345-7 | Orotate/Creatinine [Molar ratio] in 24 hour Urine |
| 23030-0 | Duck enteritis virus [Presence] in Tissue by Electron microscopy |
| 53181-4 | Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS |
| 53296-0 | Calcium oxalate crystals [#/volume] in Urine by Computer assisted method |
| 44565-0 | Influenza virus A+B Ab [Presence] in Serum |
| 44738-3 | Asialoganglioside GM1 IgG Ab [Presence] in Serum |
| 44917-3 | Cortisol [Moles/volume] in Serum or Plasma --post dose dexamethasone |
| 23785-9 | Trypanosoma cruzi Ab [Presence] in Serum |
| 24035-8 | Bordetella pertussis filamentous hemagglutinin IgM Ab [Units/volume] in Serum by Immunoassay |
| 54246-4 | Protein and Glucose panel [Mass/volume] - Body fluid |
| 47028-6 | Follitropin Ag [Presence] in Tissue by Immune stain |
| 25477-1 | Methionine sulfoxide [Moles/time] in 24 hour Urine |
| 34717-9 | Coxiella burnetii phase 2 IgG Ab [Titer] in Serum by Immunofluorescence |
| 35301-1 | Transferrin.carbohydrate deficient.asialo [Presence] in Cerebral spinal fluid |
| 55675-3 | Flumequine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 55794-2 | Other cells [#] in Cerebral spinal fluid by Manual count |
| 47785-1 | Threonine/Amino acids.total in Hair |
| 47797-6 | Tyrosine/Amino acids.total in Specimen |
| 26001-8 | Valine [Moles/volume] in 24 hour Urine |
| 56542-4 | Ganglioside GD1b IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 48075-6 | Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post dose betaxolol+glucagon |
| 48142-4 | Indole-3-Acetate/Creatinine [Molar ratio] in Urine |
| 48200-0 | Penicillin V triggered leukotriene release [Mass/volume] by Leukocytes |
| 26405-1 | Aspergillus fumigatus IgG4 Ab [Units/volume] in Serum |
| 26658-5 | Treponema sp Ab [Presence] in Serum |
| 3657-4 | Furfenorex [Mass/volume] in Urine |
| 3768-9 | Metenolone [Presence] in Urine |
| 56726-3 | Perennial rye grass recombinant profilin IgE Ab [Units/volume] in Serum |
| 27111-4 | Histidine [Moles/volume] in Amniotic fluid |
| 38606-0 | Maleic anhydride [Mass/volume] in Air |
| 3861-2 | Nordiazepam [Presence] in Urine |
| 27310-2 | Taurine [Moles/volume] in Amniotic fluid |
| 2785-4 | Phosphatidylglycerol [Presence] in Amniotic fluid |
| 5793-5 | Granular casts [#/area] in Urine sediment by Microscopy low power field |
| 58045-6 | SCN4A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2830-8 | Potassium renal clearance in 24 hour Urine and Serum or Plasma |
| 29374-6 | Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum |
| 58403-7 | Tricyclic antidepressants/Creatinine [Mass Ratio] in Urine |
| 40469-9 | Hydroflumethiazide [Presence] in Urine |
| 40577-9 | Yersinia enterocolitica O:3 Ab [Titer] in Serum by Agglutination |
| 40657-9 | Parvovirus B19 IgG Ab [Presence] in Serum by Immunofluorescence |
| 59137-0 | CD5+CD23+ cells/100 cells in Bone marrow |
| 59265-9 | 8-Hydroxydeoxyguanosine/Creatinine [Mass Ratio] in Urine |
| 50181-7 | Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV |
| 30048-3 | Lysine/Creatinine [Ratio] in Urine |
| 40801-3 | Cannabinoids [Presence] in Saliva (oral fluid) by Screen method |
| 40971-4 | XXX microorganism DNA [Presence] in Urine by NAA with probe detection |
| 19176-7 | Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma |
| 1925-7 | Base excess in Arterial blood by calculation |
| 20446-1 | Herpes simplex virus IgG Ab [Interpretation] in Serum by Immunoassay |
| 100685-7 | JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 100806-9 | Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge |
| 101148-5 | CD14+CD16- (Classical) Monocytes/100 Monocytes in Blood |
| 13266-2 | Mumps virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 101947-0 | Cytomegalovirus DNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 102252-4 | Cultivated Cotton IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14358-6 | Microscopic observation [Identifier] in Aspirate by Gram stain |
| 102924-8 | Aspergillus fumigatus IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103006-3 | Timothy recombinant (rPhl p) 7 + 12 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14722-3 | Extractable nuclear Ab [Presence] in Serum |
| 104387-6 | Dengue virus IgM Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 16102-6 | Bovine Gelatin IgE Ab [Units/volume] in Serum |
| 16277-6 | Bartonella quintana DNA [Presence] in Blood by NAA with probe detection |
| 12319-0 | Thioridazine [Presence] in Urine |
| 16938-3 | Heptacarboxylporphyrin [Mass/volume] in Stool |
| 17771-7 | Whitefish roe IgE Ab [Units/volume] in Serum |
| 18196-6 | Beta-N-acetylhexosaminidase.A [Presence] in Tissue |
| 18360-8 | 8-Hydroxyamoxapine [Mass/volume] in Urine |
| 91032-3 | oxyCODONE+oxyMORphone [Presence] in Meconium by Screen method |
| 74735-2 | Health data repository [Identifier] |
| 74943-2 | busPIRone [Mass/volume] in Serum or Plasma --trough |
| 92786-3 | Corynebacterium sp DNA [Presence] by NAA with probe detection in Positive blood culture |
| 76401-9 | Albumin/Creatinine [Ratio] in 24 hour Urine |
| 76771-5 | Respiratory pathogens RNA 8 panel - Specimen by NAA with probe detection |
| 93851-4 | Delamanid [Susceptibility] |
| 9429-2 | Indium [Mass/volume] in Specimen |
| 7790-9 | Burr cells [Presence] in Blood by Light microscopy |
| 94433-0 | HLA-DP and DQ and DR (class II) IgG with prozone effect [Identifier] in Serum or Plasma by Flow cytometry (FC) |
| 79476-8 | Ethylmalonate [Moles/volume] in Serum or Plasma |
| 6518-5 | Pneumocystis jiroveci Ag [Presence] in Serum by Immunofluorescence |
| 80175-3 | S-adenosylhomocysteine [Moles/volume] in Serum or Plasma |
| 96483-3 | Alpha-internexin IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 6797-5 | Cyclobenzaprine [Mass/volume] in Serum or Plasma |
| 68324-3 | von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay |
| 69015-6 | Lymphocyte proliferation.Candida albicans.maximum/CD3 in Blood by Flow cytometry (FC) |
| 6908-8 | Complement C4 [Mass/volume] in Body fluid |
| 8174-5 | Tetrahydrocannabinol [Presence] in Urine by SAMHSA confirm method |
| 82928-3 | Mitochondria M2 IgG Ab [Presence] in Serum by Line blot |
| 98055-7 | Nystatin IgE Ab [Units/volume] in Serum |
| 99521-7 | Weight of Kidney - left |
| 99778-3 | Chlamydia trachomatis rRNA [Presence] in Conjunctival specimen by NAA with probe detection |
| 73751-0 | 5p15.2 (5p-) chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal |
| 87980-9 | Fungus identified in Sinus by Culture |
| 74128-0 | Neuroblastoma 84 Ag [Presence] in Tissue by Immune stain |
| 89486-5 | Mycobacterial susceptibility panel Qualitative by Genotype method |
| 59561-1 | Propofol glucuronide [Mass/volume] in Urine |
| 42186-7 | Number of specimens received |
| 21086-4 | Aspergillus niger Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
| 21464-3 | Plasminogen activator urokinase type [Presence] in Tissue |
| 21767-9 | SCA7 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 43381-3 | Bordetella pertussis Ab [Presence] in Specimen by Immunofluorescence |
| 43876-2 | Antimony [Presence] in 24 hour Urine |
| 44435-6 | Ascaris lumbricoides adult IgG Ab [Units/volume] in Serum by Immunoassay |
| 4451-1 | Triamterene [Mass] of Dose |
| 44659-1 | Dominant nodule additional dimension 2 in Prostate tumor |
| 33517-4 | Hemoglobin [Presence] in Body fluid |
| 33637-0 | Phagocytic index of Blood by Flow cytometry (FC) |
| 33696-6 | Clostridium botulinum toxin [Presence] in Specimen by Mouse bioassay |
| 3370-4 | Barbital [Mass/volume] in Serum or Plasma |
| 45294-6 | Bordetella bronchiseptica DNA [Presence] in Specimen by NAA with probe detection |
| 23937-6 | Trans nonachlor [Mass/volume] in Serum or Plasma |
| 33772-5 | PL-7 Ab [Presence] in Serum |
| 53976-7 | Pseudocasts [Presence] in Urine sediment by Light microscopy |
| 54011-2 | Vimentin Ab [Presence] in Serum by Immunofluorescence |
| 54452-8 | Ferning [Presence] in Cervical mucus |
| 24296-6 | Parainfluenza virus 3 Ab [Titer] in Serum --1st specimen |
| 4761-3 | HLA-B53 [Presence] |
| 3542-8 | Propoxyphene [Presence] in Serum or Plasma |
| 35494-4 | Succinate dehydrogenase [Enzymatic activity/mass] in Tissue |
| 35631-1 | PHENobarbital [Mass/volume] in Serum or Plasma by Screen method |
| 35642-8 | Cotinine [Presence] in Urine by Confirmatory method |
| 56187-8 | Barley IgG4 Ab [Mass/volume] in Serum |
| 56261-1 | Flax IgG4 Ab [Mass/volume] in Serum |
| 26471-3 | Leukocytes other/100 leukocytes in Blood |
| 26571-0 | CD16 cells [#/volume] in Blood |
| 26632-0 | Legionella dumoffii Ab [Presence] in Serum |
| 26673-4 | Echinococcus granulosus Ab [Presence] in Serum |
| 26712-0 | Phenmetrazine [Mass/mass] in Meconium |
| 57011-9 | Ornithine/Creatinine [Ratio] in 24 hour Urine |
| 48505-2 | Platelet glycoprotein IIb/IIIa Ab [Presence] in Serum by Immunoassay |
| 27024-9 | Cannabinoids [Mass/mass] in Meconium |
| 38440-4 | Basement membrane zone Ab [Presence] in Serum |
| 5748-9 | Tin [Mass/volume] in Serum or Plasma |
| 57595-1 | Aldosterone [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
| 49245-4 | Alpha tocopherol and Beta+gamma tocopherol [Interpretation] in Serum or Plasma Narrative |
| 2764-9 | Phenylalanine [Presence] in Serum or Plasma |
| 58080-3 | Penicillin Parenteral [Susceptibility] for meningitis |
| 29158-3 | Opiates [Mass/mass] in Meconium |
| 2926-4 | Ribose [Mass/volume] in Serum |
| 40187-7 | Glucose [Moles/volume] in Serum or Plasma --20 hours post XXX challenge |
| 29689-7 | Orientia tsutsugamushi Karp Ab [Presence] in Serum |
| 4035-2 | Spironolactone [Mass/time] in 24 hour Urine |
| 59036-4 | Triglyceride [Mass/volume] in Peritoneal dialysis fluid |
| 50483-7 | Follitropin [Units/volume] in Serum or Plasma --7th specimen |
| 100675-8 | Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection |
| 101002-4 | Monkeypox virus sequencing panel - Specimen by Sequencing |
| 101850-6 | Fludrocortisone [Moles/volume] in Urine |
| 102145-0 | Apricot IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13648-1 | Morphine [Presence] in Urine by SAMHSA confirm method |
| 13918-8 | Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence |
| 13985-7 | Prealbumin/Protein.total in 24 hour Urine by Electrophoresis |
| 14237-2 | Myelin basic protein IgA Ab [Units/volume] in Serum |
| 14284-4 | Beta glucuronidase [Moles/volume] in Serum or Plasma |
| 15062-3 | Estradiol (E2).unconjugated [Moles/time] in 24 hour Urine |
| 15100-1 | Barbiturates [Moles/volume] in Serum or Plasma |
| 104346-2 | Borna disease virus Ag [Presence] in Specimen by Immune stain |
| 10811-8 | Microscopic observation [Identifier] in Tissue by Silver stain.Grimelius |
| 1098-3 | Kp sup(a) Ab [Presence] in Serum or Plasma from Donor |
| 11586-5 | Brucella abortus Ab [Units/volume] in Serum |
| 16733-8 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 16977-1 | HIV 1 Ag [Presence] in Cerebral spinal fluid |
| 17949-9 | Fungus # 4 identified in Specimen by Culture |
| 18381-4 | Uroporphyrinogen decarboxylase [Enzymatic activity/volume] in Blood |
| 18905-0 | Cinoxacin [Susceptibility] |
| 7466-6 | Linen IgE Ab [Units/volume] in Serum |
| 91774-0 | Varicella zoster virus Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
| 75709-6 | Calcitonin [Mass/volume] in Lymph node fine needle aspirate |
| 61160-8 | Hepatitis B virus codon A181V [Presence] by Genotype method |
| 61175-6 | Polychlorinated biphenyl.Aroclor 1242 [Mass/volume] in Serum or Plasma |
| 76415-9 | Sheep prion protein codon 154 [Type] in Blood by Genotype method |
| 76545-3 | Breast cancer 10-year risk of distant recurrence classification [Interpretation] Qualitative by Prosigna |
| 7670-3 | Brazilian Rubber Tree IgE Ab [Units/volume] in Serum |
| 7687-7 | Annual Saltbush IgE Ab [Units/volume] in Serum |
| 92844-0 | FLT3 gene internal tandem duplication/Normal [Ratio] in Blood or Tissue by Molecular genetics method |
| 93690-6 | BRAF gene V600 mutations [Identifier] in Plasma cell-free DNA by Molecular genetics method Nominal |
| 61216-8 | Pineapple IgE Ab/IgE total in Serum |
| 61376-0 | Human papilloma virus 33 DNA [Presence] in Specimen by NAA with probe detection |
| 62363-7 | Mosaicism detected |
| 77043-8 | ACAD8 gene full mutation analysis in Blood or Tissue by Sequencing |
| 9442-5 | IgG lymphocytes/100 lymphocytes in Leukocytes |
| 94510-5 | SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 63458-4 | Mugwort native (nArt v) 1 IgE Ab [Units/volume] in Serum |
| 63528-4 | Centromere Ab [Presence] in Body fluid by Immunofluorescence |
| 79187-1 | Cells.CD3+CD4+CD8+ (Double positive) [#/volume] in Blood |
| 79376-0 | Microscopic observation [Identifier] in Sputum by Acid fast stain.Ziehl-Neelsen--3rd specimen |
| 95287-9 | TRPV4 gene full mutation analysis in Blood or Tissue by Sequencing |
| 6624-1 | Naegleria fowleri Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 79720-9 | CYP2B6 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
| 80140-7 | Antimony [Moles/volume] in Body fluid |
| 9636-2 | Varicella zoster virus Ab [Presence] in Cerebral spinal fluid |
| 67-9 | Cefamandole [Susceptibility] by Minimum lethal concentration (MLC) |
| 6854-4 | Pumpkin IgE Ab [Units/volume] in Serum |
| 81231-3 | Protein electrophoresis panel - 24 hour Urine |
| 6911-2 | Brucella abortus IgG Ab [Units/volume] in Serum |
| 69381-2 | t(9;22)(q34.1;q11)(ABL1,BCR) b2a2 fusion transcript/control transcript (International Scale) in Blood or Tissue by Molecular genetics method |
| 69956-1 | Human upstream binding factor IgG Ab [Presence] in Serum by Immunoassay |
| 82506-7 | Oligosaccharides pattern [Interpretation] in Fibroblast by Screen method Narrative |
| 98217-3 | Treponema pallidum IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 99063-0 | Free water Clearance in Urine and Serum or Plasma |
| 85147-7 | PD-L1 by clone 22C3 in Tissue by Immune stain Report |
| 7323-9 | Fruit IgE Ab [Units/volume] in Serum |
| 7330-4 | Garlic IgG Ab [Units/volume] in Serum |
| 88188-8 | Dengue virus 1+2+3+4 RNA [Presence] in Urine by NAA with probe detection |
| 73949-0 | JWH-018 (synthetic cannabinoid) [Presence] in Blood |
| 74426-8 | Myelocytes.neutrophilic/100 cells in Bone marrow by Manual count |
| 88707-5 | Moxifloxacin 0.25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 88840-4 | Microbiology CNAMTS panel - Urethra |
| 89040-0 | Rubella virus Ab [Presence] in Serum by Immunofluorescence |
| 41426-8 | Trichinella spiralis Ab [Units/volume] in Serum by Immunoassay |
| 30553-2 | Rabies virus Ab [Presence] in Serum |
| 41859-0 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Specimen |
| 21380-1 | Prolactin [Mass/time] in 24 hour Urine |
| 21526-9 | Sodium [Mass/volume] in 24 hour Urine |
| 21595-4 | Varicella zoster virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 21641-6 | CACNA1S gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 51173-3 | CD36 blasts/100 blasts in Bone marrow |
| 51427-3 | Insulin [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
| 22064-0 | Alpha 1 globulin [Mass/volume] in Urine |
| 51468-7 | Plasmodium ovale IgG Ab [Titer] in Serum |
| 51811-8 | Coxiella burnetii phase 1 IgM Ab [Units/volume] in Serum by Immunoassay |
| 43607-1 | Microalbumin [Mass/time] in 12 hour Urine |
| 3218-5 | Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay |
| 32348-5 | Zinc [Moles/volume] in Cerebral spinal fluid |
| 32506-8 | CD14 cells/100 cells in Tissue |
| 32558-9 | Mumps reaction wheal [Diameter] --1 day post 0.1 mL mumps intradermal |
| 5206-8 | Herpes simplex virus 1 IgG Ab [Units/volume] in Serum by Immunoassay |
| 53041-0 | DNA region of interest panel |
| 32737-9 | Beta 2 globulin/Protein.total in Urine by Electrophoresis |
| 23243-9 | Mycobacterium avium ss paratuberculosis [Presence] in Stool by Acid fast stain.Ziehl-Neelsen |
| 23252-0 | Mycoplasma agalactiae DNA [Presence] in Specimen by NAA with probe detection |
| 33501-8 | Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose lactose PO |
| 53737-3 | HLA-DQA1*01:02 [Presence] |
| 23910-3 | Osmotic fragility of Red Blood Cells--0.0% sodium chloride |
| 46701-9 | Adenosine triphosphate [Moles/volume] in Red Blood Cells |
| 2434-9 | Homovanillate [Mass/volume] in Cerebral spinal fluid |
| 2492-7 | Iodine [Mass/time] in 24 hour Urine |
| 55097-0 | Parainfluenza virus 1 [Presence] in Specimen by Organism specific culture |
| 47191-2 | Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 34983-7 | Unidentified cells/100 leukocytes in Pleural fluid |
| 55867-6 | Choriogonadotropin.beta subunit free [Mass/volume] in Body fluid |
| 47727-3 | Pipecolate/Creatinine [Molar ratio] in Urine |
| 56168-8 | Allspice IgG4 Ab [Mass/volume] in Serum |
| 35810-1 | Fosfomycin [Susceptibility] by Disk diffusion (KB) |
| 26989-4 | Trypanosoma cruzi IgM Ab [Presence] in Serum by Immunofluorescence |
| 3928-9 | Perphenazine [Mass/volume] in Urine |
| 49584-6 | Neural tube defect risk cutoff in Fetus |
| 49612-5 | Salmonella sp DNA [Presence] in Specimen by NAA with probe detection |
| 2921-5 | Retinoate [Mass/volume] in Serum or Plasma |
| 58402-9 | Tapentadol [Mass/volume] in Urine by Confirmatory method |
| 58910-1 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 30269-5 | lamiVUDine [Susceptibility] by Phenotype method |
| 20674-8 | Avian adenovirus 2 Ag [Presence] in Tissue by Immune diffusion (ID) |
| 101217-8 | Hantavirus hantaan IgM Ab [Presence] in Serum or Plasma by Line blot |
| 101360-6 | Bacillus anthracis plasmid pXO1 DNA [Presence] in Blood by NAA with non-probe detection |
| 101588-2 | Histoplasma capsulatum+Blastomyces dermatitidis Ag [Presence] in Serum or Plasma by Immunoassay |
| 101633-6 | MT-RNR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 13293-6 | Colorado tick fever virus IgM Ab [Units/volume] in Serum |
| 101922-3 | Eculizumab Monitoring Panel |
| 13579-8 | Sertraline [Presence] in Serum or Plasma |
| 102462-9 | Nigrospora sphaerica IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102481-9 | Orris root IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102809-1 | Rye IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14418-8 | Calcium [Moles/volume] in Synovial fluid |
| 14551-6 | Mumps virus Ag [Presence] in Cervix by Immunofluorescence |
| 14621-7 | Appearance of Peritoneal fluid |
| 103598-9 | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells from Fetus |
| 1481-1 | Galactose [Mass/volume] in Blood --2 hours post 40 g galactose PO |
| 15006-0 | 11-Ketoetiocholanolone [Moles/time] in 24 hour Urine |
| 16401-2 | Arginine [Presence] in Urine |
| 16606-6 | Chlorine [Mass/volume] in Dialysis fluid |
| 16827-8 | Epstein Barr virus capsid IgG Ab [Presence] in Cerebral spinal fluid |
| 17191-8 | CD3-CD7+cells/100 cells in Blood |
| 17784-0 | Parasite identified in Blood by Light microscopy |
| 17955-6 | Bacteria # 6 identified in Body fluid by Aerobe culture |
| 18338-4 | Nortramadol [Mass/volume] in Urine |
| 18386-3 | Chlorothiazide [Presence] in Serum or Plasma |
| 18914-2 | cycloSERINE [Susceptibility] |
| 92542-0 | Fy sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 75242-8 | Antipsychotics [Presence] in Urine by Screen method |
| 61101-2 | Influenza virus A neuraminidase RNA [Type] in Specimen by Sequencing |
| 7584-6 | Penicillium notatum IgG Ab [Units/volume] in Serum |
| 61233-3 | Cabbage IgE Ab/IgE total in Serum |
| 62261-3 | Vancomycin resistance vanA + vanB genes [Presence] by Molecular method |
| 62348-8 | Chromosome analysis panel - Blood by G-banded |
| 77100-6 | MRPL18A gene full mutation analysis in Blood or Tissue by Sequencing |
| 93912-4 | CE Ag [Presence] on Red Blood Cells |
| 62476-7 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 94538-6 | Hemoglobin HPLC and electrophoresis panel - Blood |
| 63368-5 | Carbapenem resistance genes [Identifier] by NAA with probe detection |
| 9497-9 | Butane [Mass/volume] in Blood |
| 95221-8 | Metamyelocytes/100 leukocytes in Stem cell product by Manual count |
| 6693-6 | Mercury [Mass/time] in 24 hour Urine |
| 79612-8 | L-homoarginine [Moles/volume] in Serum or Plasma |
| 7995-4 | Rickettsia prowazekii Ab [Units/volume] in Serum |
| 96273-8 | HIV 1 RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum, Plasma or Blood from Donor by NAA with probe detection |
| 6841-1 | Grape IgE Ab [Units/volume] in Serum |
| 68411-8 | Macrophages [#/volume] in Synovial fluid by Manual count |
| 96560-8 | Nuclear pore protein gp210 Ab [Units/volume] in Serum by Immunoassay |
| 81796-5 | Tetrahydrocorticosterone/Creatinine [Molar ratio] in Urine |
| 97539-1 | Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Central venous blood |
| 97763-7 | Beta 2 globulin/Protein.total in 24 hour Urine by Electrophoresis |
| 97854-4 | Paracoccidioides sp Ab [Titer] in Specimen by Complement fixation |
| 71696-9 | Polymorphonuclear cells/100 leukocytes in Body fluid by Automated count |
| 50641-0 | CD3+CD8+CD57+ cells [#/volume] in Blood |
| 50903-4 | Selenium [Moles/volume] in Urine |
| 4265-5 | Furfenorex [Mass] of Dose |
| 21226-6 | Cortisol [Mass/volume] in Serum or Plasma --4 PM specimen |
| 21532-7 | Spermatozoa Motile/100 spermatozoa in Semen --2 hours post ejaculation |
| 31216-5 | Actinobacillus pleuropneumoniae Ab [Units/volume] in Serum |
| 31373-4 | Epstein Barr virus nuclear IgG Ab [Units/volume] in Cerebral spinal fluid |
| 31442-7 | Interferon.beta 1 Ab [Units/volume] in Serum or Plasma |
| 51223-6 | CD105 cells/100 cells in Cerebral spinal fluid |
| 5124-3 | Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 51348-1 | CD56+CD57+ cells/100 cells in Body fluid |
| 22303-2 | Equine influenza virus A2 Ab [Titer] in Serum |
| 31796-6 | Cytomegalovirus Ag [Presence] in Urine |
| 22466-7 | Respiratory syncytial virus Ab [Titer] in Serum |
| 52889-3 | Selenium [Moles/mass] in Tissue |
| 52905-7 | Silver/Creatinine [Molar ratio] in Urine |
| 3306-8 | Acetylsalicylate [Mass/volume] in Serum or Plasma |
| 53266-3 | Yeast.budding [#/volume] in Urine by Computer assisted method |
| 44495-0 | Herpes simplex virus 2 Ag [Presence] in Eye |
| 23376-7 | Porcine respiratory coronavirus Ag [Presence] in Specimen by Immune stain |
| 33463-1 | Hepatitis B virus e IgG Ab [Presence] in Serum by Immunoassay |
| 53841-3 | ATRX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 4513-8 | Complement C1r2+C1s2 [Mass/volume] in Serum or Plasma |
| 45164-1 | Asialoganglioside GM2 Ab [Presence] in Serum |
| 34170-1 | Biopterin [Moles/volume] in Urine |
| 5397-5 | Trypanosoma brucei Ab [Units/volume] in Serum |
| 46271-3 | Blood group antibody screen [Presence] in Serum or Plasma --after transfusion reaction |
| 2436-4 | Homovanillate [Mass/time] in 24 hour Urine |
| 34350-9 | Oxalate/Creatinine [Molar ratio] in Urine |
| 34462-2 | California serogroup RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 34496-0 | Chromosome 7 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics |
| 55227-3 | Sapeli IgE Ab [Units/volume] in Serum |
| 47074-0 | PCNA extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 35081-9 | Lymphocytes+Monocytes [#/volume] in Blood |
| 5578-0 | Antimony [Mass/volume] in Blood |
| 25807-9 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 56171-2 | American Beech IgG4 Ab [Mass/volume] in Serum |
| 47929-5 | Somatotropin [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 48215-8 | Crab triggered leukotriene release [Mass/volume] by Leukocytes |
| 2666-6 | Norepinephrine [Mass/volume] in Plasma |
| 26985-2 | Arginine [Moles/volume] in Amniotic fluid |
| 27002-5 | Secobarbital [Mass/mass] in Meconium |
| 3831-5 | Morphine [Mass/volume] in Urine |
| 57543-1 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --6th specimen post dose gonadotropin releasing hormone |
| 57557-1 | 18-Hydroxycortisol [Moles/volume] in Serum or Plasma --pre dose corticotropin |
| 4924-7 | HLA-DPw3 [Presence] in Donor |
| 27848-1 | Lutropin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 49577-0 | Lecithin/Surfactant.total in Amniotic fluid |
| 29255-7 | Linezolid [Susceptibility] by Disk diffusion (KB) |
| 3979-2 | Probenecid [Presence] in Urine |
| 40106-7 | aPTT in Platelet poor plasma by Coagulation assay --4 hours post XXX challenge |
| 40285-9 | Glucose [Moles/volume] in Serum or Plasma --75 minutes post dose glucose |
| 58605-7 | Corticotropin [Moles/volume] in Plasma --45 minutes post 1 ug/kg CRH IV |
| 58679-2 | Cortisol [Moles/volume] in Saliva (oral fluid) --pre 1 ug/kg CRH IV |
| 29773-9 | Coxiella burnetii phase 2 IgM Ab [Presence] in Serum by Immunoassay |
| 59185-9 | Hemoglobin H inclusion bodies [Presence] in Blood |
| 50257-5 | Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --5th specimen fasting |
| 5056-7 | Basement membrane Ab [Presence] in Serum by Immunofluorescence |
| 30207-5 | Coccidioides immitis IgG Ab [Presence] in Cerebral spinal fluid |
| 3036-1 | Transketolase [Enzymatic activity/volume] in Serum |
| 20686-2 | Anaplasma marginale Ab [Presence] in Serum by Complement fixation |
| 21008-8 | HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe |
| 101085-9 | Ge1 Ab [Presence] in Serum or Plasma |
| 101463-8 | Septin-5 IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay |
| 101629-4 | Hypoglycemia evaluation panel - Serum or Plasma |
| 13042-7 | C peptide [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 13426-2 | Norepinephrine [Mass/volume] in Plasma --2nd specimen post XXX challenge |
| 101761-5 | Trichophyton concentricum DNA [Presence] in Specimen by NAA with probe detection |
| 102116-1 | ESR1 gene mutation panel - Tissue by Molecular genetics method |
| 102497-5 | Pea IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13977-4 | Gamma globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
| 10491-9 | IgG Ag [Presence] in Tissue by Immune stain |
| 16199-2 | Methadone [Presence] in Urine by Confirmatory method |
| 11193-0 | Pumpkin Seed IgE Ab [Units/volume] in Serum |
| 11211-0 | Carbon dioxide, total [Moles/volume] in Body fluid |
| 11483-5 | Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection |
| 12267-1 | Urea nitrogen [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis |
| 1675-8 | 2,3-Diphosphoglycerate [Mass/volume] in Red Blood Cells |
| 16765-0 | Dichlorodiphenyltrichloroethane [Mass/volume] in Milk |
| 18390-5 | Opiates [Presence] in Urine by Confirmatory method |
| 89988-0 | Vilazodone [Mass/volume] in Urine by Confirmatory method |
| 90274-2 | Bacteria identified in Catheter tip by Aerobe culture |
| 92541-2 | Hy Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 61187-1 | Spermatozoa bent midpiece/100 spermatozoa in Semen |
| 77637-7 | HLA-A and B and C (class I) IgG panel [Identifier] - Serum or Plasma by Immunoassay |
| 78822-4 | Doxepin cutoff [Mass/volume] in Urine for Confirmatory method |
| 79140-0 | Carisoprodol+Meprobamate [Presence] in Blood by Screen method |
| 95229-1 | Biliary tract neoplasm chromosome analysis in Tissue |
| 66112-4 | Lymph node Pathology biopsy report |
| 8013-5 | Rubella virus Ab [Units/volume] in Serum |
| 6789-2 | Lambda light chains [Presence] in Serum by Electrophoresis |
| 68985-1 | Bacteria antigenic formula [Identifier] in Isolate |
| 80538-2 | Methylphenidate [Mass/mass] in Hair |
| 80549-9 | Sulfamethoxazole [Mass/volume] in DBS |
| 80588-7 | Influenza virus A M gene [Presence] in Nasopharynx by NAA with probe detection |
| 81848-4 | t(1;13)(p36.13;q14.1)(PAX7,FOXO1) and t(2;13)(q36.1;q14.4)(PAX3,FOXO1) fusion transcript in Bone marrow by Molecular genetics method |
| 97642-3 | dRVVT/dRVVT.excess phospholipid [Ratio] normalized in Platelet poor plasma by Coagulation assay |
| 9766-7 | Lymphocytic choriomeningitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 82879-8 | Dehydroepiandrosterone (DHEA)/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
| 98053-2 | Loquat IgE Ab [Units/volume] in Serum |
| 99036-6 | Trimethoprim resistance dfrA7+dfrA17 genes [Presence] by Molecular method |
| 99049-9 | Acidity.titratable [Moles/volume] in 24 hour Urine |
| 7243-9 | Coffee bean IgE Ab [Units/volume] in Serum |
| 72842-8 | Hepatitis B virus codon 233 [Identifier] by Genotype method |
| 7284-3 | Dog dander IgG Ab [Units/volume] in Serum |
| 72962-4 | Ramipril induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86023-9 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum by Immunoassay |
| 86191-4 | Eutylone [Mass/volume] in Urine by Confirmatory method |
| 7336-1 | Ginger IgG Ab [Units/volume] in Serum |
| 73385-7 | Fenofibrate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73440-0 | Clarithromycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73553-0 | Abciximab induced platelet Ab [Interpretation] in Serum or Plasma |
| 73603-3 | cefTAZidime+Avibactam [Susceptibility] |
| 87804-1 | Sulfachloropyridazine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 74362-5 | Lecithin cholesterol acyltransferase actual/normal in Serum or Plasma |
| 59811-0 | Caffeine [Moles/volume] in Serum --peak |
| 50978-6 | Lambda light chains.free [Presence] in Serum by Immunofixation |
| 51041-2 | CD11c blasts/100 blasts in Blood |
| 30568-0 | Toxoplasma gondii IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 3067-6 | Trypsinogen I Free [Mass/volume] in Serum or Plasma |
| 31053-2 | Coxsackievirus B1 Ab [Titer] in Body fluid by Complement fixation |
| 42208-9 | IgM in CSF/IgM in serum |
| 4241-6 | Ethacrynate [Mass] of Dose |
| 42532-2 | Thermoactinomyces candidus Ab [Presence] in Cerebral spinal fluid |
| 21271-2 | Fireweed IgE Ab [Units/volume] in Serum |
| 51153-5 | CD30 blasts/100 blasts in Blood |
| 31880-8 | Measles virus Ag [Presence] in Penis |
| 5167-2 | Francisella tularensis Ab [Titer] in Serum by Latex agglutination |
| 51689-8 | Pregnenolone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 43424-1 | Bartonella sp IgM Ab [Titer] in Cerebral spinal fluid |
| 43817-6 | Androstenedione [Presence] in Serum or Plasma |
| 44327-5 | Iron [Presence] in Body fluid |
| 22950-0 | Brucella suis Ab [Presence] in Serum by Plate agglutination |
| 2308-5 | Galactose [Mass/volume] in Serum or Plasma |
| 33207-2 | CD235a cells/100 cells in Tissue |
| 44468-7 | Herpes simplex virus 1 [Presence] in Anal by Organism specific culture |
| 33509-1 | Hemoglobin [Mass/volume] in Body fluid |
| 33652-9 | CD56 cells/CD38 Cells [# Ratio] in Blood |
| 5369-4 | Streptokinase Ab [Units/volume] in Serum |
| 44907-4 | 5-Hydroxyindoleacetate panel - 24 hour Urine |
| 23665-3 | Babesia divergens Ab [Presence] in Serum by Complement fixation |
| 4669-8 | Prekallikrein (Fletcher Factor) [Mass/volume] in Platelet poor plasma |
| 4700-1 | HLA-A34(10) [Presence] |
| 24124-0 | Casts [Presence] in Urine sediment by Light microscopy |
| 34384-8 | Tryptophan [Moles/volume] in Urine |
| 54475-9 | Pimeloylcarnitine (C7-DC) [Moles/volume] in DBS |
| 55146-5 | Familial long QTS syndrome gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55253-9 | Heparin 10000 U/mL given [Volume] |
| 47297-7 | Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 4740-7 | HLA-A9 [Presence] in Donor |
| 25231-2 | Ethionamide 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25405-2 | Ethanolamine [Moles/time] in 24 hour Urine |
| 25415-1 | Folate [Moles/volume] in Blood |
| 3473-6 | chlorproMAZINE [Mass/volume] in Urine |
| 35130-4 | Salicylates [Presence] in Specimen |
| 55672-0 | Dibekacin [Susceptibility] by Gradient strip |
| 47860-2 | Glutamate dehydrogenase [Enzymatic activity/mass] in Chorionic villus sample |
| 35356-5 | TWIST1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 56942-6 | Insulin [Units/volume] in Serum or Plasma --64 hour post XXX challenge |
| 26862-3 | HYDROmorphone [Mass/mass] in Meconium |
| 26986-0 | Trichoderma viride IgG Ab [Presence] in Serum |
| 27204-7 | Cocaine [Mass/volume] in Vitreous fluid |
| 27209-6 | Histoplasma capsulatum yeast phase Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 57436-8 | Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay |
| 57490-5 | 11-Ketoetiocholanolone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
| 58590-1 | Corticotropin [Moles/volume] in Plasma --30 minutes pre dose glucagon |
| 49891-5 | Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection |
| 50004-1 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3 hours post XXX challenge |
| 29558-4 | Enterovirus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 29701-0 | Leptospira interrogans sv Zanoni Ab [Presence] in Serum |
| 29710-1 | Rickettsia prowazekii Ab [Presence] in Serum by Immunofluorescence |
| 59192-5 | 3-Methyl crotonate/Creatinine [Molar ratio] in Urine |
| 19267-4 | Amphetamines cutoff [Mass/volume] in Urine for Confirmatory method |
| 20429-7 | Phospholipid IgM Ab [Presence] in Serum |
| 12445-3 | Norfluoxetine [Mass/volume] in Urine |
| 1012-4 | E sup(w) Ab [Presence] in Serum or Plasma |
| 1016-5 | E Ab [Presence] in Serum or Plasma from Blood product unit |
| 102075-9 | NASEM Summation Value [Mass/volume] in Serum or Plasma |
| 102562-6 | Rapeseed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14069-9 | Estazolam [Mass/volume] in Serum or Plasma |
| 102720-0 | Coconut IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10333-3 | Appearance of Cerebral spinal fluid |
| 104350-4 | Borrelia recurrentis [Presence] in Specimen by Microscopy |
| 15458-3 | Bordetella avium Ab [Presence] in Serum by Immunoassay |
| 10975-1 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine |
| 11057-7 | Monophosphoglyceromutase [Enzymatic activity/volume] in Red Blood Cells |
| 12257-2 | Spermatozoa Motile/100 spermatozoa in Semen by Microscopy high power field --post vasectomy |
| 16736-1 | Dengue virus 1 Ab [Titer] in Serum |
| 16748-6 | Propoxyphene [Presence] in Serum or Plasma by Confirmatory method |
| 17334-4 | Neopterin/Creatinine [Mass Ratio] in Urine |
| 1851-5 | Androstenedione [Mass/volume] in Amniotic fluid |
| 18889-6 | Cefpirome [Susceptibility] |
| 89984-9 | Molindone [Presence] in Serum or Plasma by Screen method |
| 90471-4 | 9-Hydroxyrisperidone [Presence] in Urine by Screen method |
| 74776-6 | Human papilloma virus 6 DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
| 61041-0 | N-desalkylflurazepam [Presence] in Specimen |
| 93328-3 | Taurochenodeoxycholate [Moles/volume] in Serum or Plasma |
| 77676-5 | Gastrin [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 7777-6 | Wild Rice IgE Ab [Units/volume] in Serum |
| 63568-0 | Neutrophil cytoplasmic Ab pattern [Interpretation] in Cerebral spinal fluid by Immunofluorescence |
| 6372-7 | Cryptosporidium sp Ag [Titer] in Stool by Immunofluorescence |
| 79157-4 | Cold agglutinin [Titer] in Serum by 22 degree C incubation --1 hour post incubation |
| 95188-9 | CD107a+b expressing HLA-B8 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC) |
| 6543-3 | Rickettsia rickettsii Ag [Identifier] in Tissue by Immunofluorescence |
| 79665-6 | Purine and Pyrimidine panel - Serum or Plasma |
| 9637-0 | Toluene [Mass/volume] in Blood |
| 67568-6 | Circulating tumor cells.breast [#/volume] in Blood |
| 6766-0 | 17-Ketosteroids [Mass/time] in 24 hour Urine |
| 68392-0 | Basophils [#/volume] in Peritoneal fluid by Manual count |
| 81860-9 | Hypertrophic cardiomyopathy gene targeted mutation analysis in Blood or Tissue by Sequencing |
| 70096-3 | Thyrotropin releasing hormone [Mass/volume] in Urine |
| 71631-6 | Basophils/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
| 8274-3 | Cefpirome [Susceptibility] by Minimum lethal concentration (MLC) |
| 71869-2 | Hemoglobin C/Hemoglobin.total [Pure mass fraction] in Blood by HPLC |
| 72159-7 | Inulin renal clearance/1.73 sq M in Urine and Serum or Plasma |
| 72312-2 | t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
| 85306-9 | Distance of carcinoma from lateral margin [Length] in Breast cancer specimen by Light microscopy |
| 99532-4 | Volume of Peritoneal space |
| 72780-0 | JWH-018 pentanol (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
| 88345-4 | Microscopic exam panel - Ear by Light microscopy |
| 88533-5 | Adenovirus DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 88726-5 | Glial nuclear type 1 Ab [Units/volume] in Serum by Line blot |
| 88881-8 | Smith extractable nuclear D Ab [Presence] in Serum by Line blot |
| 3113-8 | Uroporphyrin [Mass/time] in 24 hour Urine |
| 31286-8 | Canine parvovirus Ab [Units/volume] in Serum |
| 31287-6 | Canine parvovirus Ab [Presence] in Stool |
| 31594-5 | Rickettsia (Proteus OXK) Ab [Units/volume] in Serum |
| 42980-3 | Polio virus Ab [Titer] in Serum |
| 21785-1 | t(15;17)(q24.1;q21.1)(PML,RARA) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 2193-1 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma |
| 31854-3 | Herpes simplex virus Ag [Presence] in Skin |
| 51524-7 | Silver Birch recombinant (rBet v) 2 + 4 IgE Ab [Units/volume] in Serum |
| 43385-4 | Neisseria sp identified in Cervix by Organism specific culture |
| 2272-3 | Fat [Presence] in Urine |
| 32144-8 | Pathologist review of serum or plasma results |
| 32292-5 | Acetone [Moles/volume] in Specimen |
| 22807-2 | Infectious bronchitis virus Ag [Presence] in Specimen by Immunofluorescence |
| 53140-0 | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Venous blood |
| 33573-7 | Bactericidal permeability increasing protein IgG Ab [Units/volume] in Serum by Immunoassay |
| 5357-9 | Smith extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
| 53807-4 | Basement membrane zone BP230 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 23728-9 | Feline infectious peritonitis virus Ab [Presence] in Serum |
| 23962-4 | Bartonella henselae IgM Ab [Titer] in Cerebral spinal fluid |
| 34635-3 | Citalopram [Mass/volume] in Serum or Plasma |
| 55311-5 | Yeast.pseudohyphae [Presence] in Skin by KOH preparation |
| 25364-1 | Campylobacter jejuni Ab [Titer] in Serum by Complement fixation |
| 34927-4 | Urobilinogen [Moles/volume] in Urine |
| 35044-7 | Variant lymphocytes [#/volume] in Synovial fluid |
| 47508-7 | Streptococcus pneumoniae Danish serotype 9V IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 47871-9 | Prolactin [Units/volume] in Serum or Plasma --30 minutes post dose metoclopramide |
| 25593-5 | Rotavirus IgG Ab [Presence] in Serum |
| 26014-1 | Arbovirus NOS Ab [Titer] in Serum by Complement fixation |
| 47928-7 | Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose betaxolol+glucagon |
| 48301-6 | Patent blue V triggered leukotriene release [Mass/volume] by Leukocytes |
| 26789-8 | Escherichia coli IgM Ab [Units/volume] in Serum |
| 56614-1 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 5740-6 | Strychnine [Mass/volume] in Urine |
| 5765-3 | Zinc [Mass/time] in 24 hour Urine |
| 27383-9 | Feline herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence |
| 28045-3 | Cortisol [Presence] in Saliva (oral fluid) --1st specimen |
| 38997-3 | West Nile virus IgG Ab [Units/volume] in Serum by Immunoassay |
| 57864-1 | Meperidine [Moles/volume] in Specimen |
| 49518-4 | Influenza virus Ab [Titer] in Serum |
| 49581-2 | Referral lab test identifier and name [Identifier] |
| 29211-0 | Caffeine [Mass/volume] in Body fluid |
| 39978-2 | Creatinine [Mass/volume] in Urine --2.25 hours pre XXX challenge |
| 49859-2 | Amphotericin B [Mass/volume] in Specimen |
| 50097-5 | 21-Deoxycortisol [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
| 2985-0 | Testosterone [Mass/volume] in Semen |
| 40509-2 | Snowshoe hare virus IgM Ab [Titer] in Serum by Neutralization test |
| 59065-3 | Chlamydophila psittaci [Presence] in Bronchial brush by Organism specific culture |
| 59242-8 | Reducing substances [Moles/volume] in Stool |
| 5040-1 | Actinomyces sp Ab [Titer] in Serum by Immunofluorescence |
| 30053-3 | Leucine/Creatinine [Ratio] in Urine |
| 30301-6 | Zalcitabine [Susceptibility] |
| 1984-4 | Bromide [Mass/volume] in Serum or Plasma |
| 209-7 | Cyclacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 21034-4 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --evening specimen |
| 100396-1 | Brassica napus IgG Ab [Units/volume] in Serum |
| 127-1 | Cefsulodin [Susceptibility] by Minimum lethal concentration (MLC) |
| 12810-8 | Porphobilinogen deaminase [Enzymatic activity/volume] in Blood |
| 12853-8 | Purkinje cells Ab [Presence] in Serum by Immunoblot |
| 101247-5 | NMDAR Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 101257-4 | Silica clotting time W excess phospholipid actual/normal of Platelet poor plasma |
| 101386-1 | RET gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 101409-1 | Anaplasma phagocytophilum, Babesia microti and Ehrlichia chaffeensis IgG panel - Serum |
| 102026-2 | Cortisol [Mass/volume] in Serum or Plasma --2 hours post dose glucagon |
| 102080-9 | CAR-T cell [Type] in Blood product unit |
| 102115-3 | Epidermal Allergen Mix (Dog dander+Cat epithelium+Horse dander) Ab.IgE panel - Serum or Plasma |
| 13517-8 | Variant lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
| 102391-0 | Isocyanate HDI IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102764-8 | Lime IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14545-8 | Mumps virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 103674-8 | Cells.chromosome region 1q21 duplication in Blood or Marrow by FISH |
| 104395-9 | European tick borne encephalitis virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 10638-5 | Thermophilic Actinomycetes colony count [#/volume] in Specimen by Organism specific culture |
| 1562-8 | Insulin [Mass/volume] in Serum or Plasma --2.5 hours post dose TOLBUTamide IV |
| 16107-5 | CD8+HLA-DR+ cells [#/volume] in Blood |
| 16114-1 | Amitriptyline [Mass/volume] in Urine |
| 10795-3 | Microscopic observation [Identifier] in Tissue by Methyl violet stain |
| 16363-4 | Ammonia [Moles/mass] in Tissue |
| 1650-1 | 1,4-Alpha glucan branching enzyme [Enzymatic activity/volume] in Leukocytes |
| 16750-2 | Dezocine [Mass/volume] in Serum or Plasma |
| 19096-7 | Electrolytes - single valence [Interpretation] in 24 hour Urine Narrative |
| 90432-6 | Microorganism preliminary growth [Presence] in Platelets from Blood product unit by Anaerobe culture |
| 91111-5 | Cholesterol in LDL 7 [Mass/volume] in Serum or Plasma |
| 75143-8 | Deoxyuridine [Moles/volume] in Cerebral spinal fluid |
| 75233-7 | Norsertraline [Presence] in Urine |
| 75514-0 | Lupus anticoagulant two screening tests W Reflex [interpretation] |
| 93387-9 | Proteus mirabilis DNA [Presence] by NAA with probe detection in Positive blood culture |
| 62324-9 | Post-discharge provider name in Provider |
| 7862-6 | Ebola virus Ab [Titer] in Serum by Immunofluorescence |
| 7898-0 | Hantavirus puumala IgM Ab [Units/volume] in Serum |
| 79199-6 | Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post dose arginine+insulin |
| 95655-7 | Western equine encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 80141-5 | Arsenic [Moles/volume] in Body fluid |
| 960-5 | C sup(w) Ag [Presence] on Red Blood Cells |
| 6737-1 | Wheat IgG Ab [Units/volume] in Serum |
| 68124-7 | Circulating tumor cells.colon [#/volume] in Blood |
| 68426-6 | Neutrophils/100 leukocytes in Vitreous fluid by Manual count |
| 80660-4 | Strongyloides sp IgG Ab [Presence] in Serum by Immunoassay |
| 80822-0 | Zika virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 96522-8 | Colorado tick fever virus IgG Ab [Presence] in Specimen by Immunoassay |
| 6933-6 | Streptomycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 82216-3 | 3-Hydroxyisobutyrate dehydrogenase [Enzymatic activity/mass] in Fibroblast |
| 7143-1 | Beef triggered histamine release [Units/volume] in Blood |
| 82772-5 | Lab result date reported |
| 82966-3 | Methamphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 99272-7 | Alpha-hydroxy flualprazolam [Mass/volume] in Urine by Confirmatory method |
| 86033-8 | Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum --1st specimen |
| 73131-5 | Tamoxifen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73299-0 | Loperamide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87408-1 | Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay |
| 87734-0 | cefTAZidime+Avibactam [Susceptibility] by Gradient strip |
| 88012-0 | Sialate.lipid bound/Creatinine [Molar ratio] in Urine |
| 89500-3 | Sulfatide IgG Ab [Presence] in Serum by Line blot |
| 59370-7 | Leptospira interrogans sv Australis Ab [Titer] in Serum by Agglutination |
| 5975-8 | Plasminogen activator inhibitor 1 Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 50847-3 | Cobalt [Moles/volume] in Red Blood Cells |
| 60297-9 | clomiPRAMINE [Moles/volume] in Specimen |
| 42729-4 | Cardiolipin IgA Ab B2GP1 dependent [Multiple of the median] in Serum |
| 22197-8 | Chlamydia trachomatis C IgA Ab [Titer] in Serum |
| 31698-4 | Vibrio cholerae Ab [Units/volume] in Serum |
| 31838-6 | Haemophilus influenzae D Ag [Presence] in Specimen |
| 51695-5 | Chloride [Mass/time] in 24 hour Urine |
| 43720-2 | Acetaminophen+Codeine [Presence] in Serum or Plasma |
| 43819-2 | Beta-2-Microglobulin [Presence] in Urine |
| 22723-1 | Aspartate [Moles/volume] in Specimen |
| 32056-4 | Butalbital [Moles/volume] in Urine |
| 52943-8 | Aluminum/Creatinine [Molar ratio] in Urine |
| 53003-0 | Mitotic spindle apparatus Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 23097-9 | Equine infectious anemia virus Ab [Presence] in Serum by Immunoassay |
| 23201-7 | Leptospira sp IgM Ab [Presence] in Serum by Immunoassay |
| 32863-3 | Osmotic fragility [Interpretation] of Red Blood Cells--fresh |
| 53064-2 | Beta aminoisobutyrate [Moles/volume] in DBS |
| 53224-2 | Hemoglobin M [Presence] in Blood |
| 44594-0 | IgE [Presence] in Serum |
| 23247-0 | Mycobacterium sp DNA [Presence] in Tissue by NAA with probe detection |
| 23401-3 | Rift valley fever virus Ag [Presence] in Tissue by Neutralization test |
| 3337-3 | Amobarbital [Presence] in Serum or Plasma |
| 53653-2 | pH of Bile fluid |
| 23739-6 | Feline syncytial virus Ab [Titer] in Serum |
| 23773-5 | Porcine rotavirus Ag [Presence] in Tissue by Immunofluorescence |
| 23903-8 | Monocytes+Macrophages/100 leukocytes in Specimen by Manual count |
| 33919-2 | Ampicillin [Mass/volume] in Serum or Plasma --trough |
| 54363-7 | Bilirubin.total [Moles/volume] in Blood |
| 46128-5 | Tissue transglutaminase IgA Ab [Units/volume] in Serum by Immunoassay |
| 46708-4 | Food Allergen Mix 1 (Peanut+Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Units/volume] in Serum by Multidisk |
| 24218-0 | Influenza virus B Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 54910-5 | DNA double strand Ab [Units/volume] in Serum by Immunofluorescence |
| 55137-4 | Penicillin Parenteral [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC) |
| 55159-8 | Ursodeoxycholate [Moles/volume] in Serum or Plasma |
| 4705-0 | HLA-A66(10) [Presence] in Donor |
| 47082-3 | Legionella pneumophila 10 IgG Ab [Titer] in Serum by Immunofluorescence |
| 55677-9 | Flumequine [Susceptibility] by Disk diffusion (KB) |
| 5577-2 | Aluminum [Mass/volume] in Urine |
| 47545-9 | 5-Hydroxyindoleacetate/Creatinine [Molar ratio] in 24 hour Urine |
| 25708-9 | Leishmania donovani Ab [Titer] in Serum by Immunofluorescence |
| 25726-1 | OXcarbazepine [Moles/volume] in Serum or Plasma |
| 35487-8 | Fenchlorphos [Mass/volume] in Serum or Plasma |
| 356-6 | Neomycin [Susceptibility] by Disk diffusion (KB) |
| 26625-4 | Coccidioides sp Ab [Presence] in Serum |
| 2669-0 | Normetanephrine [Mass/volume] in Serum or Plasma |
| 56579-6 | Aldosterone [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 56947-5 | Insulin [Units/volume] in Serum or Plasma --60 hour post XXX challenge |
| 48605-0 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose fructose PO |
| 26866-4 | N-desalkylflurazepam [Mass/mass] in Meconium |
| 27220-3 | Histoplasma capsulatum mycelial phase Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 38561-7 | Spermatozoa.tail Motile w IgG/100 spermatozoa in Semen by Immunobead |
| 57102-6 | Lutropin [Units/volume] in Serum or Plasma --2 hours post dose gonadotropin releasing hormone |
| 27839-0 | C peptide [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
| 27911-7 | Gamma aminobutyrate [Moles/volume] in Urine |
| 38685-4 | Sperm Tail IgM Ab/100 spermatozoa in Specimen by Immunobead |
| 39579-8 | Penicillium notatum Ab [Mass/volume] in Serum |
| 49464-1 | CD13 Ag [Presence] in Tissue by Immune stain |
| 4965-0 | HLA-DR17(3) [Presence] |
| 50118-9 | 3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Urine |
| 5016-1 | Histoplasma capsulatum rRNA [Presence] in Specimen by Probe |
| 59006-7 | Lactate [Moles/volume] in Serum or Plasma --3 minutes post XXX challenge |
| 50241-9 | 17-Ketosteroids [Mass/volume] in 24 hour Urine --post high dose dexamethasone |
| 40802-1 | Cocaine [Presence] in Saliva (oral fluid) by Screen method |
| 41122-3 | Treponema pallidum Ab [Units/volume] in Specimen |
| 19465-4 | Ethylmorphine cutoff [Mass/volume] in Urine for Confirmatory method |
| 1951-3 | Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid |
| 20733-2 | Brucella ovis Ab [Presence] in Serum by Complement fixation |
| 20847-0 | Bovine herpesvirus 2 Ag [Presence] in Exudate by Immunofluorescence |
| 2096-6 | Cholesterol/Triglyceride [Mass Ratio] in Serum or Plasma |
| 100915-8 | Burr cells [Presence] in Body fluid by Light microscopy |
| 101526-2 | Tylvalosin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 101853-0 | Fluticasone propionate [Moles/volume] in Urine |
| 101995-9 | Foundation Pain Index Score |
| 1379-7 | Calcitonin [Mass/volume] in Serum or Plasma --pre 2.4 mg/kg calcium short IV |
| 102641-8 | Turnip IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14242-2 | Phosphatidylcholine IgA Ab [Presence] in Serum |
| 103035-2 | Annatto seed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14655-5 | clonazePAM [Moles/volume] in Serum or Plasma |
| 103165-7 | Adenovirus 1 and 2 Alpha DNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 103603-7 | Tick-borne Ab panel [Titer] - Serum |
| 104192-0 | Guanidinoacetate methyltransferase deficiency newborn screen interpretation |
| 15018-5 | Alkaline phosphatase.renal/Alkaline phosphatase.total in Serum or Plasma |
| 10558-5 | Albumin [Moles/volume] in Semen |
| 10619-5 | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Mixed antiglobulin reaction |
| 11024-7 | Benzodiazepines [Mass/volume] in Serum or Plasma |
| 12237-4 | Mumps virus Ag [Presence] in Specimen by Immunofluorescence |
| 16914-4 | Glucose [Mass/volume] in Serum or Plasma --post XXX challenge |
| 17189-2 | CD68 cells/100 cells in Blood |
| 17375-7 | Norflunitrazepam [Mass/volume] in Blood |
| 75383-0 | DMD gene deletion and duplication mutation analysis in Amniotic fluid or Chorionic villus sample by MLPA |
| 61076-6 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Gastric fluid |
| 92795-4 | Candida guilliermondii DNA [Presence] by NAA with probe detection in Positive blood culture |
| 92983-6 | Escherichia coli DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection |
| 62320-7 | T-cell receptor excision circle [#/volume] in DBS by NAA with probe detection |
| 77339-0 | Indocyanine green [Mass/volume] in Plasma --15 minutes post dose indocyanine green |
| 93941-3 | ABO and Rh group during infancy panel - Blood |
| 77956-1 | Yersinia enterocolitica O:3 IgG Ab [Presence] in Serum by Agglutination |
| 7798-2 | Smudge cells [Presence] in Blood by Light microscopy |
| 79478-4 | Salicylurate/Creatinine [Molar ratio] in Urine |
| 95586-4 | Cortisone [Z-score] in 24 hour Urine |
| 65361-8 | Phenytoin [Moles/volume] corrected for albumin in Serum or Plasma |
| 80166-2 | 2-Amino-4-hydroxypteridine [Moles/volume] in Serum or Plasma |
| 68975-2 | IgM.intrathecally synthesized/IgM.total in Cerebral spinal fluid |
| 80718-0 | Lymphocyte TCR gamma delta and alpha beta subsets panel - Blood |
| 81815-3 | CTNS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 82194-2 | Enterovirus RNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
| 97293-5 | O-nortramadol [Presence] in Cord tissue by Confirmatory method |
| 97301-6 | PHENobarbital [Presence] in Cord tissue by Confirmatory method |
| 70145-8 | Cannabinoids [Presence] in Urine by Screen method >50 ng/mL |
| 70200-1 | Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma |
| 70286-0 | t(12;22)(p13;q12.1)(ETV6,MN1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 82508-3 | Ethyl sulfate [Mass/volume] in Saliva (oral fluid) |
| 82990-3 | 3-Hydroxy-3-Methylglutaryl-coenzyme A reductase IgG Ab [Presence] in Serum or Plasma by Line blot |
| 98187-8 | Aspergillus repens IgE Ab [Units/volume] in Serum |
| 98205-8 | Borrelia burgdorferi IgG and IgM and total panel - Serum by Immunoassay |
| 98210-8 | Legionella pneumophila IgM Ab [Presence] in Serum by Immunoassay |
| 83120-6 | Thyroxine (T4) [Moles/volume] in Serum or Plasma by Immunoassay |
| 83132-1 | Pregnanolone [Moles/volume] in Urine |
| 85326-7 | Tissue blocks positive for DCIS [#] in Breast cancer specimen by Light microscopy |
| 85625-2 | Kidney failure 5-year risk [Likelihood] by KFRE |
| 86092-4 | Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 73055-6 | Atenolol induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74406-0 | Basophils [#/volume] in Cord blood |
| 41733-7 | Clavulanate [Susceptibility] |
| 59361-6 | Vardenafil [Mass/volume] in Urine |
| 51039-6 | CD11b blasts/100 blasts in Specimen |
| 21494-0 | Rickettsia spotted fever group IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 51113-9 | CD2 blasts [Units/volume] in Blood |
| 32040-8 | Respiratory syncytial virus Ag [Presence] in Nose by Immunofluorescence |
| 51474-5 | Treponema pallidum Ab [Units/volume] in Cerebral spinal fluid |
| 51642-7 | Reticulocytes.high light scatter/Reticulocytes.total in Blood |
| 43378-9 | Spermatozoa Motile [#/volume] in Semen --post washing |
| 2243-4 | Estradiol (E2) [Mass/volume] in Serum or Plasma |
| 22736-3 | Acetaminophen [Moles/volume] in Specimen |
| 22769-4 | African horse sickness virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 44332-5 | Jo-1 extractable nuclear IgG Ab [Presence] in Serum |
| 32782-5 | Leukocyte esterase+Nitrite [Presence] in Urine by Test strip |
| 44753-2 | Sulfatide IgM Ab [Presence] in Serum |
| 33686-7 | Yersinia pestis [Presence] in Isolate by Organism specific culture |
| 53513-8 | Anthranilate/Creatinine [Molar ratio] in Urine |
| 53751-4 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.75 hours post XXX challenge |
| 5383-5 | Thyroperoxidase Ab [Titer] in Serum or Plasma by Latex agglutination |
| 53-9 | Butirosin [Susceptibility] by Disk diffusion (KB) |
| 23701-6 | Canine parvovirus Ab [Presence] in Serum |
| 23800-6 | Mold Allergen Mix 1 (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk |
| 23922-8 | Osmotic fragility of Red Blood Cells--0.85% sodium chloride |
| 2409-1 | Hexokinase [Enzymatic activity/volume] in Plasma |
| 54251-4 | Glucose [Moles/volume] in Serum or Plasma --20 minutes post dose glucagon |
| 46434-7 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
| 34342-6 | Niacin [Moles/volume] in Serum or Plasma |
| 34368-1 | Pyridinoline [Moles/time] in 24 hour Urine |
| 3469-4 | Chlorphentermine [Presence] in Urine |
| 55428-7 | Drug test kit name [Identifier] in Urine |
| 47196-1 | Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 34722-9 | EGR2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 47585-5 | C peptide [Moles/volume] in Serum or Plasma --15 minutes post dose glucose |
| 35470-4 | Mitochondria Genes deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 48202-6 | Short+Giant Ragweed triggered leukotriene release [Mass/volume] by Leukocytes |
| 56573-9 | Renin [Enzymatic activity/volume] in Plasma --30 minutes post XXX challenge |
| 56708-1 | metroNIDAZOLE IgE Ab [Units/volume] in Serum |
| 48406-3 | Parietal cell IgG Ab [Titer] in Serum |
| 26937-3 | Temazepam [Mass/mass] in Meconium |
| 27226-0 | Cocaethylene [Mass/volume] in Serum or Plasma |
| 27243-5 | PENTobarbital [Mass/mass] in Stool |
| 38544-3 | Spermatozoa [#/volume] in Semen --pre washing |
| 38660-7 | Acetylene [Mass/volume] in Air |
| 5729-9 | Silicate [Mass/volume] in Serum or Plasma |
| 57536-5 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 27261-7 | Polio virus Ab [Titer] in Serum by Complement fixation |
| 27321-9 | Opiates [Mass/volume] in Milk |
| 39538-4 | Finch droppings IgG Ab [Presence] in Serum |
| 57700-7 | Hearing loss newborn screening comment/discussion |
| 5780-2 | Crystals [type] in Duodenal fluid by Light microscopy |
| 58003-5 | Methylandrostenediol [Presence] in Urine |
| 29218-5 | Ethosuximide [Mass/volume] in Body fluid |
| 29369-6 | N-acetylprocainamide/Procainamide [Mass Ratio] in Serum or Plasma |
| 3991-7 | Propranolol [Presence] in Serum or Plasma |
| 58524-0 | Corticosterone [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
| 40310-5 | Cortisol [Moles/volume] in Serum or Plasma --pre dose triple bolus |
| 40494-7 | Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination |
| 40727-0 | Hepatitis D virus Ab [Presence] in Serum by Immunoassay |
| 30006-1 | Transfuse granulocytes [Volume] |
| 4080-8 | Trimethoprim [Presence] in Urine |
| 20853-8 | Equine herpesvirus 1 Ag [Presence] in Tracheal swab by Immunofluorescence |
| 100397-9 | Goat Meat IgG Ab [Units/volume] in Serum |
| 101749-0 | Borrelia miyamotoi DNA [Presence] in Blood by NAA with probe detection |
| 13592-1 | Platelet aggregation XXX induced in Platelet rich plasma |
| 13883-4 | Estradiol (E2).bioavailable/Estradiol (E2).total in Serum or Plasma |
| 14549-0 | Mumps virus Ag [Presence] in Nose by Immunofluorescence |
| 14642-3 | Carotene [Moles/volume] in Serum or Plasma |
| 14841-1 | Microscopic observation [Identifier] in Specimen by Iron hematoxylin stain |
| 15169-6 | Complement total hemolytic C50 [Units/volume] in Serum or Plasma by Immunoassay |
| 104310-8 | Abemaciclib [Mass/volume] in Serum or Plasma |
| 10454-7 | Xylose [Mass/volume] in Serum or Plasma --2 hours post 25 g xylose PO |
| 1582-6 | Lactose [Mass/volume] in Serum or Plasma --1 hour post 50 g lactose PO |
| 1868-9 | Antithrombin Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
| 18951-4 | Nafcillin [Susceptibility] |
| 92508-1 | Do sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 92635-2 | Leukocytes [#/volume] in Buffy Coat |
| 7611-7 | Western White Pine IgE Ab [Units/volume] in Serum |
| 92831-7 | Lymph nodes with metastasis [#] in Cancer specimen |
| 93919-9 | little c Ag [Presence] on Red Blood Cells --after transfusion reaction |
| 94188-0 | APC gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 77939-7 | Corticotropin [Moles/volume] in Plasma --45 minutes post XXX challenge |
| 94579-0 | Clot strength arachidonate induced [Length fraction] in Blood by calculation |
| 79257-2 | Methylenedioxyamphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 95650-8 | Mayaro virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 9592-7 | Borrelia burgdorferi 39kD IgG Ab [Presence] in Serum by Immunoblot |
| 96656-4 | HLA-DQA1 unresolved alleles [Type] by High resolution |
| 96722-4 | Amyloid bodies [#/area] in Prostatic fluid by Light microscopy |
| 81843-5 | GALC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 97518-5 | Paracoccidioides sp Ab band pattern [Identifier] in Specimen by Immune diffusion (ID) |
| 97635-7 | Staphylococcus lugdunensis DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 70111-0 | Number of chromosome 21 present [#] in Amniotic fluid by NAA with probe detection |
| 7121-7 | Bassiai IgE Ab [Units/volume] in Serum |
| 71355-2 | SLC26A5 gene c.-53-2A>G [Presence] in Blood or Tissue by Molecular genetics method |
| 82372-4 | Buprenorphine [Presence] in Gastric fluid by Screen method |
| 9827-7 | Paraquat [Mass/volume] in Urine |
| 72399-9 | Amobarbital [Mass/volume] in Blood by Confirmatory method |
| 72460-9 | JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 85066-9 | Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose lutropin |
| 99469-9 | Horse Bot Fly IgG Ab [Mass/volume] in Serum |
| 72908-7 | Drug induced platelet Ab panel - Serum or Plasma |
| 87731-6 | KIT gene exon 17 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 88132-6 | Varicella zoster virus DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 88209-2 | Parainfluenza virus 2 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 88568-1 | Influenza virus identified in Lower respiratory specimen by Organism specific culture |
| 88573-1 | Onchocerca sp IgG2 Ab [Presence] in Serum by Immunoassay |
| 41182-7 | Histoplasma capsulatum farciminosum reaction wheal [Diameter] --2 days post histoplasmin intradermal |
| 41205-6 | Watermelon IgG Ab [Mass/volume] in Serum |
| 59722-9 | Nordiazepam [Mass/mass] in Stool by Confirmatory method |
| 30478-2 | Malonate [Presence] in Urine |
| 31069-8 | Herpes simplex virus 2 IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 31099-5 | Amikacin [Mass/volume] in Serum or Plasma --random post extended interval dosing |
| 4230-9 | Doxepin [Mass] of Dose |
| 42510-8 | IgD [Mass/volume] in Urine |
| 42577-7 | Ampicillin IgE Ab/IgE total in Serum |
| 6006-1 | Protein C [Units/volume] in Platelet poor plasma by Chromogenic method |
| 21074-0 | Arsenic [Mass/volume] in 24 hour Urine |
| 21476-7 | Potassium [Moles/volume] in 24 hour Urine |
| 31221-5 | Alcelaphine herpesvirus 1 Ab [Units/volume] in Serum |
| 31229-8 | Aspergillus flavus Ab [Presence] in Body fluid |
| 51080-0 | CD15 blasts/100 blasts in Bone marrow |
| 42728-6 | pH of Ocular fluid |
| 4315-8 | Metandienone [Mass] of Dose |
| 43191-6 | FANCC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 21812-3 | t(2;13)(q36.1;q14.4)(PAX3,FOXO1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 31740-4 | Bovine diarrhea virus Ag [Presence] in Blood |
| 31959-0 | Rubella virus Ag [Presence] in Nose |
| 51878-7 | Fresh frozen plasma units given [#] |
| 5251-4 | Muscle sarcolemma Ab [Units/volume] in Serum |
| 52944-6 | Aluminum/Creatinine [Molar ratio] in 24 hour Urine |
| 22861-9 | Bacillus anthracis Ab [Presence] in Serum by Immune diffusion (ID) |
| 22914-6 | Bovine herpesvirus 1 DNA [Presence] in Tissue by NAA with probe detection |
| 32679-3 | Ehrlichia chaffeensis IgM Ab [Presence] in Cerebral spinal fluid |
| 32692-6 | Anaplasma phagocytophilum IgM Ab [Titer] in Serum |
| 33059-7 | Fluorescence polarization [Presence] in Amniotic fluid |
| 4441-2 | Thiopental [Mass] of Dose |
| 44434-9 | Other Antibiotic [Mass/volume] in Serum or Plasma --trough |
| 44672-4 | Invasive carcinoma uninvolved margin distance closest [Length] in Breast tumor |
| 53590-6 | Gamma globulin.abnormal band/Protein.total in Serum or Plasma by Electrophoresis |
| 45144-3 | clomiPRAMINE [Presence] in Urine |
| 23668-7 | Bartonella henselae Ab [Titer] in Serum |
| 53994-0 | Centrosomal nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
| 4542-7 | Haptoglobin [Mass/volume] in Serum or Plasma |
| 34457-2 | Powassan virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 3449-6 | cefTAZidime [Mass/volume] in Serum or Plasma |
| 55225-7 | Okoume IgE Ab [Units/volume] in Serum |
| 47313-2 | Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay |
| 47512-9 | Treponema pallidum IgG Ab [Units/volume] in Cerebral spinal fluid |
| 476-2 | Sulfonamide [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 25700-6 | Immunofixation for Serum or Plasma |
| 25980-4 | Serine/Creatinine [Molar ratio] in 24 hour Urine |
| 2603-9 | Malonate [Mass/volume] in Serum |
| 35717-8 | Chlamydia sp rRNA [Presence] in Vaginal fluid by Probe |
| 35759-0 | Cefditoren [Susceptibility] by Disk diffusion (KB) |
| 56461-7 | Red Alder IgG4 Ab [Mass/volume] in Serum |
| 48306-5 | Coproporphyrin 3/Creatinine [Mass Ratio] in Urine |
| 35853-1 | Trospectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 3617-8 | Ethotoin [Mass/volume] in Serum or Plasma |
| 377-2 | Ofloxacin [Susceptibility] by Serum bactericidal titer |
| 48615-9 | Insulin.free and Insulin.total panel [Units/volume] - Serum or Plasma |
| 26820-1 | Stachybotrys chartarum IgA Ab [Mass/volume] in Serum |
| 2708-6 | Oxygen saturation in Arterial blood |
| 38314-1 | Cyclohexanone [Mass/volume] in Water |
| 38322-4 | Carbon tetrachloride [Mass/volume] in Water |
| 38376-0 | Cryptococcus sp identified in Specimen by Organism specific culture |
| 3839-8 | Nalbuphine [Presence] in Urine |
| 38667-2 | 3,3'-Dimethoxybenzidine [Mass/volume] in Air |
| 27943-0 | Interferon omega [Mass/volume] in Serum or Plasma |
| 3959-4 | Phentermine [Mass/time] in 24 hour Urine |
| 49627-3 | Muscle sarcolemma Ab [Titer] in Serum by Immunofluorescence |
| 5843-8 | Enterovirus identified in Specimen by Organism specific culture |
| 58564-6 | Corticotropin [Moles/volume] in Plasma --2.5 hours post dose glucagon |
| 49773-5 | Galactitol [Moles/volume] in Serum or Plasma |
| 50051-2 | Hemicystine/Amino acids.total in Serum or Plasma |
| 29953-7 | Nuclear Ab [Titer] in Serum |
| 40431-9 | Osmotic fragility [Interpretation] of Red Blood Cells from Control--fresh |
| 40652-0 | Methamphetamine [Presence] in Hair |
| 50479-5 | Follitropin [Units/volume] in Serum or Plasma --3rd specimen |
| 30155-6 | Reticulocytes.punctate/100 erythrocytes in Blood |
| 30368-5 | Myelocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
| 19405-0 | Cocaethylene [Presence] in Urine by Screen method |
| 19580-0 | Methylphenidate cutoff [Mass/volume] in Urine for Confirmatory method |
| 20409-9 | Erythrocytes [#/volume] in Urine by Test strip |
| 20675-5 | Bovine adenovirus 3 Ag [Presence] in Tissue by Immunofluorescence |
| 2074-3 | Chloride [Moles/volume] in Saliva (oral fluid) |
| 100420-9 | Fava bean IgG Ab [Units/volume] in Serum |
| 101799-5 | 2-Oxo-3-Hydroxy-Lysergate diethylamide/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 101866-2 | Gas and electrolytes point of care panel - Venous blood |
| 14309-9 | Amphetamines [Presence] in Urine by Confirm method >200 ng/mL |
| 102754-9 | Shagbark Hickory IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14550-8 | Mumps virus Ag [Presence] in Sputum by Immunofluorescence |
| 1518-0 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
| 16219-8 | Pentazocine [Presence] in Urine by Confirmatory method |
| 11127-8 | Erythrocytes [Morphology] in Bone marrow |
| 16260-2 | Triamterene crystals [Presence] in Stone by Infrared spectroscopy |
| 16571-2 | Cephadrine [Mass/volume] in Serum or Plasma |
| 18491-1 | Chlamydia trachomatis G+F+K IgG Ab [Titer] in Serum by Immunofluorescence |
| 18970-4 | Piperacillin+Tazobactam [Susceptibility] |
| 76629-5 | Fasting glucose [Moles/volume] in Blood |
| 9361-7 | Bartonella quintana IgM Ab [Titer] in Serum |
| 77657-5 | Diploid cells in G1 phase/100 cells in Cells.XXX by Flow cytometry (FC) |
| 93927-2 | E Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant |
| 9401-1 | Silicon [Mass/volume] in Specimen |
| 94107-0 | Oxazepam glucuronide [Presence] in Urine by Screen method |
| 78767-1 | oxyCODONE [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine |
| 64121-7 | Fifth most predominant hemoglobin in DBS |
| 7907-9 | Herpes simplex virus Ab [Units/volume] in Serum |
| 79130-1 | Platelet aggregation ristocetin induced in Platelet rich plasma --500 ug/mL |
| 95121-0 | Coagulation factor VIII activity and inhibitor panel - Platelet poor plasma by Chromogenic method |
| 79609-4 | Glutathione.oxidized [Moles/volume] in Serum or Plasma |
| 6893-2 | Urobilinogen [Mass/time] in 24 hour Stool |
| 69883-7 | Service comment 56 |
| 6989-8 | Cefotaxime [Susceptibility] by Gradient strip |
| 69964-5 | Bicarbonate [Moles/volume] standard in Plasma |
| 82256-9 | Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH |
| 71645-6 | Band form neutrophils/Leukocytes [Pure number fraction] in Body fluid by Manual count |
| 85741-7 | Streptococcus pneumoniae Danish serotype 4 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 86102-1 | Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum --2nd specimen |
| 86611-1 | Chromosome analysis in Amniotic fluid or Chorionic villus sample by Microarray |
| 72986-3 | Mycophenolate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73365-9 | Gentamicin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87370-3 | Escherichia coli fasA gene [Presence] in Isolate by NAA with probe detection |
| 87609-4 | Dicoumarol [Mass/mass] in Specimen |
| 87794-4 | Furazolidone [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 87994-0 | Trypanosoma cruzi IgG Ab [Presence] in Serum by Immunoassay |
| 88228-2 | Mycoplasma genitalium DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 88549-1 | Scedosporium apiospermum DNA [Presence] in Isolate by NAA with probe detection |
| 89303-2 | Noroxycodone [Presence] in Urine by Screen method |
| 5077-3 | Centromere Ab [Titer] in Serum by Immunofluorescence |
| 3079-1 | Tyrosine [Mass/volume] in Serum or Plasma |
| 42001-8 | Nickel/Creatinine [Mass Ratio] in 24 hour Urine |
| 60285-4 | Amoxapine [Moles/volume] in Specimen |
| 21385-0 | Metasystox [Mass/volume] in Urine |
| 3122-9 | Vanillylmandelate [Mass/time] in 24 hour Urine |
| 51052-9 | CD126 blasts [Units/volume] in Bone marrow |
| 43076-9 | Borrelia burgdorferi IgM Ab [Titer] in Cerebral spinal fluid |
| 22124-2 | Borrelia burgdorferi IgA Ab [Presence] in Serum |
| 31808-9 | Eastern equine encephalitis virus Ag [Presence] in Specimen |
| 3193-0 | Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay |
| 22655-5 | Aspartate [Moles/volume] in Cerebral spinal fluid |
| 52891-9 | Chromium [Moles/mass] in Tissue |
| 52959-4 | cloBAZam [Presence] in Urine |
| 4440-4 | Theophylline [Mass] of Dose |
| 22844-5 | Babesia bigemina Ab [Presence] in Serum |
| 23511-9 | Trypanosoma equiperdum Ab [Presence] in Serum by Complement fixation |
| 45140-1 | Phenols [Mass/time] in 24 hour Urine |
| 45188-0 | Basement membrane zone BP180 Ab [Units/volume] in Serum |
| 23776-8 | Rickettsia spotted fever group Ab [Presence] in Serum by Immunofluorescence |
| 34219-6 | 17-Hydroxycorticosteroids/Creatinine [Molar ratio] in Urine |
| 54241-5 | Influenza virus B Ag [Presence] in Isolate |
| 25196-7 | Ethionamide 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 48141-6 | Ferritin [Entitic mass] in Red Blood Cells |
| 48204-2 | Casein triggered leukotriene release [Mass/volume] by Leukocytes |
| 26419-2 | American house dust mite IgG4 Ab [Units/volume] in Serum |
| 27167-6 | Chlamydia trachomatis IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 38384-4 | Cocaine [Presence] in Gastric fluid |
| 38475-0 | Acid alpha glucosidase [Enzymatic activity/volume] in Serum or Plasma |
| 38619-3 | Dioxin [Mass/volume] in Air |
| 5719-0 | Rubidium [Mass/mass] in Hair |
| 57321-2 | Herpes simplex virus 2 IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 5739-8 | Strychnine [Presence] in Urine |
| 48990-6 | Glucose [Mass/volume] in Serum or Plasma --8 PM specimen |
| 49007-8 | Magnesium [Moles/volume] in Peritoneal dialysis fluid |
| 27841-6 | Somatotropin [Mass/volume] in Serum or Plasma --17th specimen post XXX challenge |
| 57751-0 | Hemoglobin [Presence] in Urine by Automated test strip |
| 29226-8 | quiNIDine [Mass/volume] in Body fluid |
| 5845-3 | Herpes simplex virus 1 Ag [Presence] in Skin by Immunofluorescence |
| 58487-0 | Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --6th specimen post XXX challenge |
| 58762-6 | Coxiella burnetii phase 2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 29613-7 | Phendimetrazine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 29763-0 | Protoporphyrin.zinc [Molar ratio] in Red Blood Cells |
| 40384-0 | Morphine [Presence] in Hair |
| 50495-1 | Somatotropin [Mass/volume] in Serum or Plasma --3rd specimen |
| 40845-0 | Turkey meat IgE Ab/IgE total in Serum |
| 19767-3 | Cytologist who read Cyto stain of Cervical or vaginal smear or scraping |
| 101130-3 | Mast cells/100 cells in Bone marrow by Flow cytometry (FC) |
| 13022-9 | Propane [Mass/volume] in Blood |
| 102289-6 | Eggplant IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14249-7 | Purkinje cells Ab [Presence] in Serum by Immunofluorescence |
| 14434-5 | Albumin/Globulin [Mass Ratio] in Pleural fluid |
| 14483-2 | Diphtheria identified in Bronchial specimen by Organism specific culture |
| 14730-6 | Flurazepam+N-desalkylflurazepam [Moles/volume] in Serum or Plasma |
| 103685-4 | Citalopram [Mass/volume] in Urine by LC/MS/MS |
| 10394-5 | Factor IX given [Volume] |
| 1482-9 | Galactose [Mass/volume] in Blood --30 minutes post 40 g galactose PO |
| 14895-7 | Protein Fractions [Interpretation] in Serum or Plasma by Immunofixation |
| 15168-8 | Complement total hemolytic C50 [Units/volume] in Body fluid by Immunoassay |
| 16232-1 | Triazolam [Mass/volume] in Urine by Confirmatory method |
| 12229-1 | Macrophages/100 leukocytes in Cerebral spinal fluid by Manual count |
| 12253-1 | Somatotropin [Mass/volume] in Serum or Plasma --baseline |
| 18383-0 | Alfentanil [Presence] in Urine |
| 90248-6 | Myelin oligodendrocyte glycoprotein IgG1 Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74661-0 | Phosphatidylethanol [Mass/volume] in Blood |
| 75086-9 | Catecholamine metabolites pattern [Interpretation] in Urine Narrative |
| 7572-1 | Black-eye pea IgG Ab [Units/volume] in Serum |
| 6108-5 | Elder IgE Ab [Units/volume] in Serum |
| 76484-5 | Beta-2-Microglobulin [Moles/volume] in Serum or Plasma |
| 76609-7 | Streptococcus pyogenes csrS gene [#/volume] in XXX.body fluid by NAA with probe detection |
| 93321-8 | PT mixing study panel - Platelet poor plasma by Coagulation assay |
| 62243-1 | MCH [Entitic mass] in Blood from Fetus by Automated count |
| 62358-7 | ISCN band level [#] Qualitative |
| 77159-2 | Erythrocytes.ghost cells [Presence] in Blood by Light microscopy |
| 93976-9 | Chikungunya virus Ab.IgM and IgG panel - Serum or Plasma |
| 6298-4 | Potassium [Moles/volume] in Blood |
| 63427-9 | Escherichia coli Stx1 toxin stx1 gene [Presence] in Specimen by NAA with probe detection |
| 95533-6 | Human papilloma virus 56+59+66 DNA [Presence] in Cervix by NAA with probe detection |
| 95685-4 | Ross River virus IgM Ab [Presence] in Specimen by Immunoassay |
| 65325-3 | Ku Ab [Presence] in Serum or Plasma |
| 65794-0 | Shrimp native (nPen m) 1 IgE Ab [Units/volume] in Serum |
| 79584-9 | Beta alanine and Beta aminoisobutyrate and Gamma aminobutyrate panel - Urine |
| 80111-8 | 11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Blood by Confirmatory method |
| 96307-4 | Klebsiella pneumoniae+Klebsiella variicola+Klebsiella quasipneumoniae DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 96751-3 | SARS-CoV-2 (COVID-19) S gene mutation detected [Identifier] in Specimen by Molecular genetics method |
| 9709-7 | Coxiella burnetii phase 2 IgG Ab [Titer] in Serum |
| 97166-3 | Thyroxine (T4) [Mass/time] in 24 hour Urine |
| 97194-5 | Phenytoin [Moles/volume] in Serum or Plasma --peak |
| 69755-7 | Bordetella pertussis.pertussis toxin IgG Ab [Presence] in Serum by Line blot |
| 69935-5 | Mycoplasma genitalium DNA [Presence] in Specimen by NAA with probe detection |
| 81868-2 | PRNP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 82099-3 | Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 97311-5 | Zolpidem [Presence] in Cord tissue by Confirmatory method |
| 72452-6 | Secobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 84907-5 | Cancer pathology panel - Colorectal cancer specimen |
| 86153-4 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum --1st specimen |
| 87466-9 | Molybdenum [Mass/mass] in Specimen |
| 73499-6 | Bumetanide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73928-4 | JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
| 73963-1 | Enterococcus faecalis and other enterococcus sp rRNA [Identifier] by FISH in Positive blood culture |
| 88729-9 | Ganglioside GQ1b IgG+IgM Ab [Units/volume] in Serum by Immunoassay |
| 4119-4 | Amiodarone [Mass] of Dose |
| 41444-1 | Naegleria fowleri DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 59957-1 | Promazine [Moles/volume] in Serum or Plasma |
| 60041-1 | Acebutolol [Mass/mass] in Tissue |
| 21143-3 | Carp IgE Ab [Units/volume] in Serum |
| 51193-1 | Cadmium [Mass/volume] in Body fluid |
| 2176-6 | Cystine [Presence] in Serum or Plasma |
| 22307-3 | Giardia lamblia IgM Ab [Titer] in Serum |
| 51643-5 | Reticulocytes.high light scatter [#/volume] in Blood |
| 4321-6 | Methaqualone [Mass] of Dose |
| 43410-0 | Bacteria identified in Cervix by Culture |
| 43437-3 | Bartonella henselae and Bartonella quintana IgG and IgM panel - Cerebral spinal fluid |
| 22353-7 | Histoplasma capsulatum IgM Ab [Units/volume] in Serum |
| 52779-6 | Maximum clot firmness.extrinsic coagulation system activated.fibrinolysis suppressed [Length] in Blood by Rotational TEG |
| 4393-5 | PHENobarbital [Mass] of Dose |
| 43959-6 | CD3+HLA-DR+ cells [#/volume] in Body fluid |
| 53288-7 | Fatty casts [#/volume] in Urine by Computer assisted method |
| 44448-9 | Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 44531-2 | HIV 1 Ag [Presence] in Serum from Donor |
| 33395-5 | Epstein Barr virus capsid Ab [Presence] in Serum |
| 33728-7 | Size.maximum dimension in Tumor |
| 44898-5 | Malignant cells/100 cells in Peritoneal fluid by Manual count |
| 44980-1 | Chlamydophila pneumoniae Ab [Presence] in Serum --1st specimen |
| 23830-3 | Bordetella pertussis.pertussis toxin IgA Ab [Units/volume] in Serum |
| 3423-1 | Caffeine [Presence] in Urine |
| 54389-2 | Dodecanoylcarnitine (C12) [Moles/volume] in Urine |
| 54407-2 | Transfuse pooled fresh frozen plasma units [#] |
| 54459-3 | Dicarboxypalmitoylcarnitine (C16-DC)/Creatinine [Molar ratio] in Urine |
| 46714-2 | Food Allergen Mix 17 (Apple+Banana+Pear+Peach) IgE Ab [Units/volume] in Serum by Multidisk |
| 47419-7 | Varicella zoster virus Ab [Units/volume] in Serum by Immunoassay |
| 25315-3 | 11-Deoxycortisol [Moles/time] in 24 hour Urine |
| 3510-5 | Prochlorperazine [Presence] in Urine |
| 47793-5 | Tyrosine/Amino acids.total in Cerebral spinal fluid |
| 35363-1 | Triglyceride in Chylomicrons [Mass/volume] in Serum or Plasma |
| 35426-6 | Herpes simplex virus identified in Pleural fluid by Organism specific culture |
| 3545-1 | Propoxyphene [Mass/volume] in Urine |
| 5618-4 | Cesium [Mass/volume] in Urine |
| 56457-5 | Lamb IgG4 Ab [Mass/volume] in Serum |
| 48313-1 | Yersinia enterocolitica O:9 Ab [Titer] in Serum by Agglutination |
| 26669-2 | Absidia corymbifera Ab [Presence] in Serum |
| 56987-1 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 38326-5 | Pentachlorophenol [Mass/volume] in Water |
| 38729-0 | 2,4,5-Trichlorophenol [Mass/volume] in Air |
| 58371-6 | Carisoprodol/Creatinine [Mass Ratio] in Urine |
| 40180-2 | Glucose [Moles/volume] in Serum or Plasma --14 hours post XXX challenge |
| 49929-3 | Protein in pleural fluid/Protein in serum |
| 29589-9 | Heavy metals panel - Urine |
| 40452-5 | Sialate/Creatinine [Ratio] in Urine |
| 40453-3 | Sialooligosaccharides [Presence] in Urine |
| 40646-2 | Leukocytes other/100 leukocytes in Blood by Automated count |
| 40670-2 | Smudge cells/100 leukocytes in Body fluid by Manual count |
| 5894-1 | Prothrombin time (PT) actual/Normal |
| 58996-0 | Potassium [Moles/time] in 18 hour Urine |
| 5902-2 | Prothrombin time (PT) |
| 41008-4 | Human coronavirus OC43 IgG Ab [Presence] in Serum by Immunoassay |
| 20730-8 | Brucella abortus Ab [Presence] in Serum by Immunoassay |
| 20873-6 | Alcelaphine herpesvirus 1 neutralizing antibody [Presence] in Serum by Neutralization test |
| 12705-0 | Strontium [Mass/volume] in Urine |
| 101822-5 | Human papilloma virus cytology and high-risk genotypes panel - Cervix |
| 14516-9 | Pneumocystis jiroveci Ag [Presence] in Semen by Immunofluorescence |
| 103731-6 | Distal weakness multigene analysis in Blood or Tissue by Molecular genetics method |
| 10416-6 | Transfuse blood product other [Volume] |
| 10480-2 | Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain |
| 16273-5 | Calcium [Mass/mass] in Red Blood Cells |
| 11228-4 | Uroporphyrin [Mass/volume] in Urine |
| 119-8 | Cefpodoxime [Susceptibility] by Minimum lethal concentration (MLC) |
| 16806-2 | Echovirus 6+18+30 Ab [Units/volume] in Serum |
| 19128-8 | Bacteria identified in Catheter tip by Culture |
| 74490-4 | PAX5 and BCL2 Ag [Identifier] in Tissue by Immune stain |
| 60534-5 | SARS coronavirus RNA [Presence] in Serum or Plasma by NAA with probe detection |
| 61098-0 | N-desalkylflurazepam [Presence] in Gastric fluid |
| 7587-9 | Bell Pepper IgG Ab [Units/volume] in Serum |
| 7683-6 | California Sagebrush IgE Ab [Units/volume] in Serum |
| 93439-8 | Herpes simplex virus 1 DNA [Presence] in Blood by NAA with non-probe detection |
| 61222-6 | Aspergillus sp IgE Ab/IgE total in Serum |
| 62456-9 | HIV 2 p15 Ab [Presence] in Serum by Immunoblot |
| 78235-9 | Cells.PDGFRB gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 78691-3 | Guanosine/Creatinine [Molar ratio] in Urine |
| 78840-6 | JWH-081 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
| 94412-4 | EPHX1 gene.c.416A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 64428-6 | KIR gene allele 3DL3 [Presence] in Blood or Tissue by Molecular genetics method |
| 95524-5 | HIV 1 and 2 Ab [Identifier] in Serum or Plasma by Immunoassay |
| 66743-6 | CYP2C19 gene c.IVS5+2T>A(*7) [Presence] in Blood or Tissue by Molecular genetics method |
| 95828-0 | T cell product characterization panel - Blood product unit by Flow cytometry (FC) |
| 96112-8 | Moxifloxacin [Susceptibility] by Genotype method |
| 96270-4 | Cyclin-dependent kinase 4 [Presence] in Cancer specimen by Immune stain |
| 8063-0 | Cardiolipin IgA Ab [Units/volume] in Serum or Plasma |
| 8162-0 | Tetrahydrocannabinol [Mass/volume] in Gastric fluid |
| 69358-0 | HPV E6+E7 mRNA cells/cells [Presence] in Cervix by Flow cytometry (FC) |
| 70038-5 | Mononuclear cells/100 leukocytes in Peritoneal fluid by Automated count |
| 70043-5 | Mononuclear cells [#/volume] in Pleural fluid by Automated count |
| 81814-6 | HSD17B4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 71360-2 | Y chromosome AZFb region deletion [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
| 7153-0 | Blueberry IgG Ab [Units/volume] in Serum |
| 82744-4 | CD8+CD45RA+ cells/100 CD8 cells in Blood |
| 98118-3 | Vascular endothelial growth factor C [Mass/volume] in Serum or Plasma |
| 98214-0 | Reagin Ab and Treponema pallidum IgG and IgM and total panel - Cerebral spinal fluid |
| 98232-2 | St. John's wort IgE Ab [Units/volume] in Serum |
| 71881-7 | Methemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood |
| 719-5 | Hemoglobin [Mass/volume] in Cerebral spinal fluid |
| 72942-6 | Terazosin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86073-4 | Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum --1st specimen |
| 73130-7 | Tamoxifen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73225-5 | OXcarbazepine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87460-2 | Nitrite [Mass/mass] in Specimen |
| 73586-0 | Tedizolid [Susceptibility] |
| 87926-2 | Epithelial cells [#/volume] in Urine by Automated |
| 88250-6 | Cephalosporin resistance blaCTX-M gene [Presence] by Molecular method |
| 74223-9 | Immunohistochemical stains in Bone marrow Narrative |
| 41491-2 | Echovirus 30 neutralizing antibody [Titer] in Serum by Neutralization test |
| 41740-2 | Tazobactam [Susceptibility] |
| 59694-0 | Hydroxytriazolam [Mass/mass] in Meconium by Confirmatory method |
| 5091-4 | Chymotrypsin Ab [Units/volume] in Serum |
| 31158-9 | Fibrinogen Ag/Fibrinogen [Mass Ratio] in Platelet poor plasma |
| 41845-9 | Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Agglutination |
| 42365-7 | Streptococcus pneumoniae 4 serotypes IgG panel [Mass/volume] - Serum |
| 60278-9 | Fibrinogen Ag [Presence] in Tissue by Immunofluorescence |
| 31278-5 | Campylobacter fetus Ab [Units/volume] in Serum |
| 3130-2 | Vitronectin [Mass/volume] in Plasma |
| 31308-0 | Clostridioides difficile Ab [Units/volume] in Serum |
| 31540-8 | Nuclear Ab [Units/volume] in Body fluid |
| 51207-9 | Thallium [Mass/volume] in Body fluid |
| 51353-1 | CD19+CD58+ cells/100 cells in Cerebral spinal fluid |
| 43050-4 | Coxiella burnetii phase 1 Ab [Titer] in Serum |
| 51729-2 | Ganglioside GM1 IgG Ab [Units/volume] in Serum by Immunoassay |
| 43428-2 | Bilirubin.microscopic observation [Identifier] in Tissue by Hall's stain |
| 32238-8 | Cystine [Moles/volume] in Vitreous fluid |
| 44292-1 | Microalbumin/Creatinine [Mass Ratio] in 12 hour Urine |
| 22865-0 | Bacillus anthracis Ab [Titer] in Serum by Immune diffusion (ID) |
| 22916-1 | Bovine leukemia virus Ab [Presence] in Milk by Immunoassay |
| 44675-7 | DCIS.uninvolved margin.closest in Breast tumor |
| 23259-5 | Mycoplasma capricolum ss capricolum Ab [Presence] in Serum |
| 23273-6 | Mycoplasma gallisepticum Ab [Presence] in Serum by Hemagglutination |
| 33466-4 | Francisella tularensis IgM Ab [Titer] in Serum |
| 53798-5 | HIV reverse transcriptase+protease gene mutations detected [Identifier] |
| 53851-2 | COL10A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 44879-5 | Staphylococcus aureus enterotoxin E see gene [Presence] in Specimen by NAA with probe detection |
| 45091-6 | Chlamydia trachomatis Ag [Presence] in Genital specimen |
| 23742-0 | Fumonisin [Mass/volume] in Specimen |
| 23750-3 | Leptospira sp Ag [Presence] in Urine by Immunofluorescence |
| 23933-5 | Staphylococcus aureus enterotoxin B [Presence] in Specimen |
| 34206-3 | 11-Deoxycortisol/Creatinine [Molar ratio] in Urine |
| 55326-3 | Kp sup(a) Ab [Titer] in Serum or Plasma |
| 47264-7 | Adenosine monophosphate.cyclic [Moles/volume] in Urine --1st specimen post XXX challenge |
| 25388-0 | Cystathionine [Moles/time] in 24 hour Urine |
| 55809-8 | 11-Deoxycortisol [Mass/volume] in Amniotic fluid |
| 56016-9 | Platelet aggregation collagen induced ATP secretion [Presence] in Blood --1 ug/mL |
| 47588-9 | C peptide [Moles/volume] in Serum or Plasma --2 hours post dose glucose |
| 47891-7 | Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose growth hormone releasing factor |
| 25603-2 | Rickettsia prowazekii IgG Ab [Titer] in Serum |
| 25609-9 | Cochineal extract IgE Ab [Units/volume] in Serum |
| 25892-1 | Cysteine [Moles/time] in 24 hour Urine |
| 48071-5 | Complement total hemolytic CH50 [Titer] in Serum or Plasma |
| 4820-7 | HLA-B27 [Presence] in Donor |
| 26052-1 | Epithelial cells.renal [#/area] in Urine sediment by Microscopy high power field |
| 26563-7 | CD1a cells/100 cells in Specimen |
| 26791-4 | Amphetamine [Mass/mass] in Stool |
| 372-3 | Novobiocin [Susceptibility] by Disk diffusion (KB) |
| 56655-4 | Bromide/Creatinine [Ratio] in Urine |
| 4852-0 | HLA-Cw2 [Presence] in Donor |
| 27003-3 | Mephobarbital [Mass/mass] in Meconium |
| 38494-1 | Metanephrine Free [Mass/volume] in Serum or Plasma |
| 57637-1 | Androsterone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
| 48981-5 | Anaplasma sp [Presence] in Specimen by Light microscopy |
| 49044-1 | diazePAM and Nordiazepam panel - Serum or Plasma |
| 57993-8 | Lepidoglyphus destructor IgE Ab/IgE total in Serum |
| 57996-1 | Leucine+Isoleucine [Mass/volume] in DBS |
| 29256-5 | Fat.microscopic observation [Identifier] in Urine sediment by Sudan IV stain |
| 29285-4 | Methadone [Presence] in Gastric fluid |
| 40041-6 | Glucose [Mass/volume] in Serum or Plasma --29 hours post XXX challenge |
| 40113-3 | Creatinine [Moles/volume] in Serum or Plasma --1.5 hours pre XXX challenge |
| 58813-7 | Renin [Mass/volume] in Plasma --2nd specimen |
| 49862-6 | G6PC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 50043-9 | Protein carbonyl/Protein [Ratio] in Serum or Plasma |
| 40432-7 | Osmotic fragility [Interpretation] of Red Blood Cells from Control--Incubated |
| 40484-8 | Urate crystals amorphous [#/area] in Urine sediment by Microscopy low power field |
| 40513-4 | Powassan virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 29982-6 | Cesium [Mass/volume] in 24 hour Urine |
| 30019-4 | Borrelia burgdorferi 41kD IgM Ab [Presence] in Synovial fluid by Immunoblot |
| 41050-6 | TH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 12348-9 | Quinethazone [Presence] in Urine |
| 100838-2 | Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 12878-5 | Borrelia burgdorferi 29kD Ab [Presence] in Serum by Immunoblot |
| 13244-9 | Filaria IgG Ab [Units/volume] in Serum |
| 1325-0 | U Ab [Presence] in Serum or Plasma |
| 102274-8 | Daphnia (fish feed) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14174-7 | Prostaglandin F2 alpha [Mass/volume] in Serum or Plasma |
| 103149-1 | Total perfluorooctane sulfonic acid isomers [Mass/volume] in Serum or Plasma |
| 14975-7 | Human antimouse Ab [Mass/volume] in Serum |
| 10608-8 | Spermatozoa Cytoplasmic Droplet/100 spermatozoa in Semen |
| 1555-2 | Glucose [Mass/volume] in Urine --12 hours fasting |
| 11112-0 | Monocytes/100 cells in Bone marrow by Manual count |
| 16785-8 | DOPamine [Mass/volume] in Urine --3rd specimen post XXX challenge |
| 17656-0 | Streptococcus pyogenes [Presence] in Specimen by Organism specific culture |
| 18995-1 | Ticarcillin+Clavulanate [Susceptibility] |
| 92702-0 | Lactobacillus crispatus+jensenii + Gardnerella vaginalis + Atopobium vaginae + Bacterial Vaginosis Associated Bacteria-2 + Megasphaera sp type 1 DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 75508-2 | aPTT.lupus sensitive W excess phospholipid actual/Normal (normalized LA confirm) |
| 7632-3 | Privet IgE Ab [Units/volume] in Serum |
| 61283-8 | Macadamia IgE Ab/IgE total in Serum |
| 7745-3 | Trichophyton sp IgE Ab [Units/volume] in Serum |
| 94111-2 | 7-Aminoflunitrazepam [Presence] in Urine by Screen method |
| 63218-2 | Desmoglein 1 Ab [Presence] in Serum by Immunoassay |
| 94436-3 | HLA-DQB1 IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC) |
| 94759-8 | SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection |
| 6357-8 | Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection |
| 95170-7 | Mycoplasma gallisepticum DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 95537-7 | Human papilloma virus 35+39+68 DNA [Presence] in Cervix by NAA with probe detection |
| 66142-1 | Basophils [#/volume] in Blood from Fetus by Manual count |
| 80168-8 | Pterins panel - Cerebral spinal fluid |
| 96115-1 | Level of tumor invasion [Type] in Colorectal cancer specimen by Haggitt |
| 96473-4 | Rho GTPase-activating protein 26 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 69052-9 | Flow cytometry specialist review of results |
| 80702-4 | CD27+CD45RA- cells/100 CD3+CD4+ cells in Blood |
| 81638-9 | Clotting time of Capillary blood by Sukharev method |
| 97538-3 | Carbon dioxide [Partial pressure] in Central venous blood |
| 70204-3 | Cholesterol non HDL [Moles/volume] in Serum or Plasma |
| 82882-2 | Etiocholanolone/Androsterone [Molar ratio] in 24 hour Urine |
| 72219-9 | Lymphocytes [#/area] in Urine sediment by Microscopy high power field |
| 85046-1 | AmpC beta-lactamase by cefoTEtan to cefoTEtan+cloxacillin inhibitory concentration ratio [Presence] by ARD gradient strip |
| 72721-4 | Base excess.100% oxygenated [Moles/volume] standard in Arterial blood by calculation |
| 72979-8 | Pantoprazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86152-6 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum --1st specimen |
| 87383-6 | Porcine hemagglutinating encephalomyelitis virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73515-9 | Atomoxetine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73612-4 | Razupenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 74296-5 | 3-Methylcrotonyl-CoA carboxylase deficiency newborn screen interpretation |
| 74380-7 | HYDROmorphone [Mass/volume] in Unknown substance |
| 88742-2 | U1 small nuclear ribonucleoprotein C Ab [Units/volume] in Serum by Line blot |
| 89502-9 | SCL-70 extractable nuclear Ab [Units/volume] in Serum by Line blot |
| 59344-2 | Tadalafil [Mass/volume] in Urine |
| 50846-5 | Cobalt [Moles/mass] in Tissue |
| 31090-4 | Ethchlorvynol [Presence] in Bile fluid |
| 4220-0 | Dichlorphenamide [Mass] of Dose |
| 59942-3 | Nordoxepin [Moles/volume] in Urine |
| 5998-0 | Platelet aggregation ristocetin induced in Platelet rich plasma |
| 59993-6 | Testosterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 60056-9 | Astemizole [Mass/mass] in Tissue |
| 60102-1 | O-desmethylvenlafaxine [Mass/volume] in Blood |
| 21389-2 | Saccharopolyspora rectivirgula IgE Ab [Units/volume] in Serum |
| 21489-0 | Rickettsia (Proteus OX19) Ab [Titer] in Serum by Latex agglutination |
| 21705-9 | MT-ND4 gene m.11696G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 22070-7 | HP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 22117-6 | Bordetella pertussis Ab [Titer] in Specimen |
| 43358-1 | UNC13D gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2254-1 | Estrogen [Mass/volume] in Serum or Plasma |
| 32085-3 | Isopropanol [Moles/volume] in Urine |
| 32499-6 | CD7-CD13+CD33+ cells/100 cells in Blood |
| 51937-1 | HLA-A+B+Bw+DR [Type] |
| 52135-1 | t(9;22)(q34.1;q11)(ABL1,BCR) transcript detection panel - Blood or Tissue by Molecular genetics method |
| 44295-4 | Aldosterone/Creatinine [Mass Ratio] in 24 hour Urine |
| 22813-0 | Avian infectious laryngotracheitis virus Ab [Titer] in Serum by Immunofluorescence |
| 53530-2 | Microalbumin [Mass/volume] in 24 hour Urine by Detection limit <= 1.0 mg/L |
| 53898-3 | KIAA0196 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 45006-4 | Chlamydia trachomatis IgA Ab [Units/volume] in Serum by Immunoassay |
| 45051-0 | Cortisol [Moles/volume] in Serum or Plasma --8 PM specimen |
| 23663-8 | Babesia bovis Ab [Presence] in Serum by Complement fixation |
| 23689-3 | Canine distemper virus Ab [Presence] in Serum by Immunofluorescence |
| 23761-0 | Neutrophils/100 leukocytes in Blood by Manual count |
| 33964-8 | SARS coronavirus Urbani RNA [Presence] in Specimen by NAA with probe detection |
| 4567-4 | Hemoglobin Constant Spring [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 24352-7 | Protein electrophoresis panel - Cerebral spinal fluid |
| 34463-0 | California serogroup RNA [Presence] in Blood by NAA with probe detection |
| 34588-4 | Tick feeding duration |
| 55163-0 | Streptococcus pyogenes enzyme Ab panel - Serum Qualitative |
| 47465-0 | Legionella pneumophila 13 IgG Ab [Titer] in Serum |
| 55876-7 | Homocitrulline [Moles/volume] in Serum or Plasma |
| 47752-1 | Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose arginine |
| 47901-4 | Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose arginine+insulin |
| 35446-4 | HIV 1 gp41 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
| 56334-6 | Oat pollen IgG4 Ab [Mass/volume] in Serum |
| 26665-0 | Chlamydia trachomatis F Ab [Presence] in Serum |
| 5680-4 | Malathion [Mass/volume] in Serum or Plasma |
| 48724-9 | Bacteria # 3 identified in Blood by Culture |
| 48834-6 | Respiratory allergen panel, US - Rocky mountain states a - Serum |
| 27894-5 | Sulfatide IgG Ab [Presence] in Serum by Immunoassay |
| 3953-7 | Phenothiazines [Presence] in Urine |
| 49538-2 | Influenza virus identified in Specimen by Shell vial culture |
| 49654-7 | TPMT gene c.238G>C [Presence] in Blood or Tissue by Molecular genetics method |
| 49709-9 | predniSONE [Presence] in Serum or Plasma |
| 40073-9 | Calcium [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
| 40183-6 | Glucose [Moles/volume] in Serum or Plasma --17.5 hours post XXX challenge |
| 58608-1 | Corticotropin [Moles/volume] in Plasma --4th specimen post XXX challenge |
| 49852-7 | Oligoclonal bands [#] in Cerebral spinal fluid by Isoelectric focusing |
| 49967-3 | Charcoal [Presence] in Urine sediment by Light microscopy |
| 29799-4 | Jamestown canyon virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 58930-9 | Glutamine+Histidine [Moles/volume] in Serum or Plasma |
| 59066-1 | sp100 Ab [Presence] in Serum by Immunoassay |
| 5022-9 | Mycobacterium avium complex rRNA [Presence] in Specimen by Probe |
| 50435-7 | Corticotropin [Mass/volume] in Plasma --9 AM specimen |
| 29983-4 | Cesium [Mass/time] in 24 hour Urine |
| 40879-9 | Chicken IgE Ab [Units/volume] in Serum |
| 1918-2 | Aspartate aminotransferase [Enzymatic activity/volume] in Cerebral spinal fluid |
| 19564-4 | Methylenediamine cutoff [Mass/volume] in Urine for Confirmatory method |
| 20777-9 | Caprine parapoxvirus Ab [Presence] in Serum by Complement fixation |
| 20891-8 | Mushroom identified |
| 12818-1 | Progesterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 101124-6 | Bacterial carbapenem resistance blaIMI+blaNMC genes [Presence] by Molecular method |
| 12982-5 | Vasopressin [Mass/volume] in Plasma --2nd specimen post XXX challenge |
| 13514-5 | Hemoglobin pattern [Interpretation] in Blood by Electrophoresis Narrative |
| 13536-8 | Globulin [Mass/volume] in Plasma |
| 13550-9 | clonazePAM [Presence] in Serum or Plasma |
| 13824-8 | Arsenic/Creatinine [Mass Ratio] in 24 hour Urine |
| 102467-8 | Gamble Oak IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13936-0 | Diethyl ether [Mass/volume] in Blood |
| 13997-2 | Neuronal nuclear type 1 Ab [Titer] in Serum |
| 102794-5 | Pheasant IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14661-3 | Color of Pericardial fluid |
| 14699-3 | diphenhydrAMINE+dimenhyDRINATE [Presence] in Gastric fluid |
| 104232-4 | Naproxen [Mass/volume] in Urine by Confirmatory method |
| 10560-1 | Carcinoembryonic Ag [Units/volume] in Semen |
| 15389-0 | Parainfluenza virus 1 IgG Ab [Presence] in Serum |
| 1083-5 | Js sup(a) Ag [Presence] on Red Blood Cells from Donor |
| 1657-6 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma |
| 16742-9 | European house dust mite IgG Ab [Presence] in Blood |
| 1691-5 | 5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/volume] in Serum |
| 18923-3 | Floxacillin [Susceptibility] |
| 18949-8 | Miocamycin [Susceptibility] |
| 89996-3 | Pneumocystis jiroveci DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 91051-3 | Methamphetamine+Methylenedioxymethamphetamine [Presence] in Tissue by Screen method |
| 92540-4 | Hemoglobin S inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 92715-2 | Lipoprotein.beta.subparticle.very small-a [Moles/volume] in Serum |
| 7522-6 | Mycogone sp IgE Ab [Units/volume] in Serum |
| 75729-4 | HTR2A gene c.1354C>T [Presence] in Blood or Tissue by Molecular genetics method |
| 77136-0 | Urea [Moles/volume] in Serum, Plasma or Blood |
| 7749-5 | Tuna IgG Ab [Units/volume] in Serum |
| 77626-0 | Pyruvate kinase [Entitic Catalytic Activity] in Red Blood Cells |
| 77655-9 | Diploid cells/100 cells in Cells.XXX by Flow cytometry (FC) |
| 6333-9 | Campylobacter jejuni rRNA [Presence] in Specimen by Probe |
| 77781-3 | Pregabalin cutoff [Mass/volume] in Urine for Confirmatory method |
| 94315-9 | SARS-related coronavirus E gene [Presence] in Specimen by NAA with probe detection |
| 6338-8 | Chlamydophila psittaci Ag [Presence] in Genital specimen by Immunoassay |
| 6347-9 | Chlamydia sp Ag [Presence] in Specimen by Immunoassay |
| 79484-2 | Levulinate [Moles/volume] in Serum or Plasma |
| 9565-3 | Measles virus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 6521-9 | Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection |
| 65348-5 | Glucagon [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 79658-1 | Cytosine/Creatinine [Molar ratio] in Urine |
| 96295-1 | Streptomycin IgE Ab [Units/volume] in Serum |
| 96313-2 | Salmonella sp DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 67809-4 | Parainfluenza virus 2 Ag [Presence] in Isolate by Immunofluorescence |
| 68315-1 | Transcortin and Cortisol.free panel - Serum or Plasma |
| 80959-0 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post meal |
| 97171-3 | Hexacarboxylporphyrin/Creatinine [Molar ratio] in Urine |
| 97230-7 | clonazePAM [Presence] in Cord tissue by Screen method |
| 97562-3 | Signal Recognition Particle (SRP) IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 70246-4 | CCR2 gene p.Val64Ile [Presence] in Blood or Tissue by Molecular genetics method |
| 71427-9 | Fibrin D-dimer FEU [Mass/volume] in Blood by Immunoassay |
| 71611-8 | Leukocytes other/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
| 82418-5 | Human upstream binding factor Ab [Presence] in Serum by Line blot |
| 9833-5 | Cholesterol in HDL 3 [Mass/volume] in Serum or Plasma |
| 71883-3 | Methemoglobin/Hemoglobin.total [Pure mass fraction] in Blood |
| 84922-4 | Cells.chromosome 7 monosomy/Cells counted in Blood or Tissue by FISH |
| 85531-2 | PRRSV whole genome [Nucleotide sequence] in Isolate by Sequencing |
| 86178-1 | Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum --1st specimen |
| 73003-6 | levoFLOXacin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73241-2 | Nitroglycerin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73273-5 | Metoprolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7381-7 | Greasewood IgE Ab [Units/volume] in Serum |
| 88138-3 | Herpes simplex virus DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 73906-0 | HIV 1+2 IgG Ab [Presence] in Blood by Rapid immunoassay |
| 74112-4 | Bromadiolone [Presence] in Specimen by Screen method |
| 74419-3 | Parvovirus B19 DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 41427-6 | Trypanosoma brucei gambiense Ab [Presence] in Serum by Agglutination |
| 41743-6 | BBS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 5065-8 | Borrelia burgdorferi IgM Ab [Titer] in Serum by Immunofluorescence |
| 41763-4 | Rubella virus IgG Ab [Titer] in Serum |
| 59956-3 | Phencyclidine [Moles/volume] in Serum or Plasma |
| 60018-9 | Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid by Pyruvate to lactate reaction |
| 21564-0 | Thiosulfate [Mass/volume] in Serum or Plasma |
| 31538-2 | Neuronal nuclear type 2 Ab [Units/volume] in Cerebral spinal fluid |
| 21798-4 | t(X;18)(q11.2;p11.22)(SS18,SSX2) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 22071-5 | Gaucher 3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 32032-5 | Phosphatidylserine IgG Ab [Units/volume] in Serum by Immunoassay |
| 51482-8 | Crystals [#/volume] in Urine by Automated count |
| 43356-5 | Chlamydia trachomatis D+E+F+G+H+I+J+K IgA Ab [Titer] in Serum by Immunofluorescence |
| 22476-6 | Rickettsia spotted fever group IgG Ab [Titer] in Cerebral spinal fluid |
| 32099-4 | 6-Monoacetylmorphine (6-MAM) [Presence] in Specimen |
| 32498-8 | CD57 cells/100 cells in Specimen |
| 33004-3 | Kelp or Seaweed IgE Ab [Units/volume] in Serum |
| 53452-9 | Gamma 3 globulin.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis |
| 53474-3 | Glucose [Moles/volume] in Serum or Plasma --4 AM specimen |
| 44745-8 | La Crosse virus Ab [Presence] in Serum by Immunoassay |
| 23608-3 | cycloSERINE [Susceptibility] by Method for Slow-growing mycobacteria |
| 53630-0 | Alpha cortol/Creatinine [Mass Ratio] in 24 hour Urine |
| 24445-9 | Valerylglycine/Creatinine [Molar ratio] in Urine |
| 34670-0 | Choriogonadotropin [Mass/volume] in Serum or Plasma |
| 34710-4 | Chlamydia trachomatis Ag [Presence] in Anal |
| 55327-1 | Kp sup(b) Ab [Titer] in Serum or Plasma |
| 25244-5 | cefTRIAXone [Mass/volume] in Specimen |
| 35453-0 | ARSA gene PD allele [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 56706-5 | Doxycycline IgE Ab [Units/volume] in Serum |
| 56894-9 | CD13+HLA-DR+ cells/100 cells in Cerebral spinal fluid |
| 4872-8 | HLA-Dw12 [Presence] in Donor |
| 48797-5 | Organic acids panel - Urine |
| 27129-6 | Lead [Mass/mass] in Red Blood Cells |
| 27188-2 | Methylenedioxymethamphetamine [Mass/volume] in Vitreous fluid |
| 27249-2 | Temazepam [Mass/mass] in Stool |
| 38296-0 | 1,2-Dichloropropane [Mass/volume] in Water |
| 57462-4 | Normetanephrine Free [Mass/volume] in Serum or Plasma |
| 38708-4 | Methyl hydrazine [Mass/volume] in Air |
| 29406-6 | Amitriptyline [Mass/volume] in Gastric fluid |
| 29519-6 | 4-Hydroxyphenylpyruvate/Creatinine [Molar ratio] in Urine |
| 40085-3 | Calcium [Mass/volume] in Serum or Plasma --2 days post XXX challenge |
| 58453-2 | Hemoglobin.gastrointestinal.lower [Mass/volume] in Stool by Immunoassay |
| 4981-7 | HLA-DR3 [Presence] |
| 49982-2 | Borrelia burgdorferi 37kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 40322-0 | Glucose [Moles/volume] in Serum or Plasma --1 hour post dose triple bolus |
| 40474-9 | Volatiles and gases [Identifier] in Specimen |
| 40498-8 | Yersinia enterocolitica Ab [Titer] in Serum by Agglutination |
| 40598-5 | Acetone [Presence] in Gastric fluid |
| 59275-8 | Oxygen capacity [Volume Fraction] in Arterial blood |
| 19373-0 | Butalbital [Presence] in Urine by Screen method |
| 19600-6 | Morphine cutoff [Mass/volume] in Urine for Confirmatory method |
| 100138-7 | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot |
| 100666-7 | NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method |
| 101077-6 | Dr^a Ab [Presence] in Serum or Plasma |
| 101197-2 | Lymph nodes with metastasis/Lymph nodes examined in Colorectal cancer specimen |
| 12928-8 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 101964-5 | HPS3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 14171-3 | Porphyrins [Mass/mass] in 24 hour Stool |
| 14269-5 | Sec-butyl acetate [Mass/volume] in Blood |
| 14310-7 | Phencyclidine [Presence] in Urine by Screen method >25 ng/mL |
| 103021-2 | Staphylococcus aureus TSST-1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14435-2 | Albumin/Globulin [Mass Ratio] in Peritoneal fluid |
| 14517-7 | Pneumocystis jiroveci Ag [Presence] in Stool by Immunofluorescence |
| 14594-6 | Amitriptyline+Nortriptyline [Presence] in Gastric fluid |
| 16182-8 | Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability |
| 11171-6 | Erythromycin IgE Ab [Units/volume] in Serum |
| 12182-2 | Cells [#/volume] in Body fluid by Manual count |
| 1785-5 | Alpha amino acid nitrogen [Mass/time] in 24 hour Urine |
| 1871-3 | Apolipoprotein B-100 [Mass/volume] in Serum or Plasma |
| 1874-7 | Apolipoprotein B/Apolipoprotein A-I [Mass Ratio] in Serum or Plasma |
| 90741-0 | Parathyrin.1-84 [Mass/volume] in Serum or Plasma by Immunoassay |
| 75018-2 | t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 92510-7 | Di sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 92732-7 | Codon AndOr region with poor sequence quality [Identifier] in Isolate or Specimen by Sequencing Nominal |
| 75072-9 | Mandelate [Moles/volume] in Serum or Plasma |
| 6107-7 | Egg yolk IgE Ab [Units/volume] in Serum |
| 93460-4 | AH-7921 [Mass/volume] in Urine by Confirmatory method |
| 77563-5 | Leukocyte esterase [Presence] in Body fluid by Automated test strip |
| 95141-8 | Hepatitis D virus Ab panel - Serum |
| 66720-4 | Adenovirus DNA [Log #/volume] (viral load) in Body fluid by NAA with probe detection |
| 66880-6 | Skin Ab.IgG pattern [Interpretation] in Serum by Monkey esophagus substrate |
| 95972-6 | SARS-CoV-2 stimulated gamma interferon release by T-cells [Units/volume] corrected for background in Blood |
| 6740-5 | Yellow Jacket IgE Ab [Units/volume] in Serum |
| 81189-3 | Tumor regression [Type] in Tumor --post preoperative therapy |
| 81425-1 | Microscopic observation [Identifier] in Bone marrow by Oil red O stain |
| 96649-9 | HLA-DPB1 T-cell epitope match [Type] in Donor+Patient by High resolution |
| 6924-5 | Gliadin IgA Ab [Units/volume] in Serum |
| 69798-7 | 2,5-dimethoxy-4-bromoamphetamine [Presence] in Urine |
| 69931-4 | Food Allergen Mix 13 (Carrot+White bean+Peas+Potato) IgE Ab [Units/volume] in Serum by Multidisk |
| 70024-5 | Candida parapsilosis DNA [Presence] in Blood by NAA with probe detection |
| 70856-0 | Rabies virus Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 82601-6 | Latex recombinant (rHev b) 10 IgE Ab [Units/volume] in Serum |
| 99073-9 | Kelch-like protein 11 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 86091-6 | Streptococcus pneumoniae Danish serotype 3 Ab [Mass/volume] in Serum --1st specimen |
| 72982-2 | Omeprazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87584-9 | Aflatoxin B1 [Mass/mass] in Specimen |
| 879-7 | A,B Ag [Presence] on Red Blood Cells from Donor |
| 74184-3 | Lymphocytes clefted [Presence] in Blood |
| 89542-5 | Centromere protein B Ab [Presence] in Cerebral spinal fluid by Line blot |
| 5097-1 | Cold agglutinin [Presence] in Serum or Plasma by Agglutination |
| 31047-4 | Rubella virus IgM Ab [Units/volume] in Body fluid |
| 42256-8 | Shigella boydii Ag [Presence] in Isolate |
| 51152-7 | CD30 blasts/100 blasts in Bone marrow |
| 51201-2 | Palladium [Mass/volume] in Body fluid |
| 42882-1 | CD3-CD57+ cells/100 cells in Tissue |
| 31865-9 | Influenza virus C Ag [Presence] in Specimen |
| 43247-6 | Catecholamines/Creatinine [Mass Ratio] in 24 hour Urine |
| 43414-2 | Blood product units available [#] |
| 43415-9 | Unidentified cells/100 cells in Bone marrow |
| 43606-3 | Microalbumin [Mass/time] in 4 hour Urine |
| 22661-3 | Coproporphyrin [Moles/volume] in Serum or Plasma |
| 22927-8 | Brucella abortus DNA [Presence] in Specimen by NAA with probe detection |
| 44729-2 | Progesterone/11-Deoxycorticosterone [Mass Ratio] in Serum or Plasma |
| 33656-0 | Beta-N-acetylhexosaminidase.B [Moles/volume] in Leukocytes |
| 53823-1 | Panipenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 33801-2 | E selectin [Mass/volume] in Serum or Plasma |
| 33861-6 | Starch granules [Presence] in Urine sediment by Light microscopy |
| 54070-8 | Hemoglobin D/Hemoglobin.total in DBS |
| 46726-6 | HTR2A gene+HTR2C gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 24156-2 | Maple syrup IgG Ab [Units/volume] in Serum |
| 2452-1 | Hypoxanthine [Mass/volume] in Body fluid |
| 2498-4 | Iron [Mass/volume] in Serum or Plasma |
| 47269-6 | Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --2nd specimen post XXX challenge |
| 25238-7 | Cefotaxime [Mass/volume] in Specimen |
| 3487-6 | cloBAZam [Mass/volume] in Serum or Plasma |
| 47662-2 | Insulin [Units/volume] in Serum or Plasma --3 hours post dose glucose |
| 35461-3 | ELN gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 56250-4 | Duck feather IgG4 Ab [Mass/volume] in Serum |
| 2642-7 | Myoglobin [Mass/time] in 24 hour Urine |
| 26691-6 | Uroporphyrin 1 isomer [Mass/time] in 24 hour Stool |
| 365-7 | Nitrofurantoin [Susceptibility] by Serum bactericidal titer |
| 56741-2 | Ganglioside GQ1b IgG Ab [Presence] in Serum by Immunoblot |
| 57091-1 | HLA-DQB1*02:01 [Presence] |
| 2683-1 | Ornithine carbamoyltransferase [Enzymatic activity/volume] in Serum |
| 38492-5 | Insulin-like growth factor-I [Units/volume] in Serum or Plasma |
| 57437-6 | CD56+CD138+ cells/100 cells in Body fluid |
| 57518-3 | 11-Hydroxyetiocholanolone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
| 27299-7 | Methylenedioxyethylamphetamine [Mass/volume] in Vitreous fluid |
| 3900-8 | Oxyphenbutazone [Mass/volume] in Serum or Plasma |
| 57796-5 | Reducing substances [Presence] in Stool by Post hydrolysis |
| 3975-0 | Pipradrol [Mass/time] in 24 hour Urine |
| 29578-2 | Viral susceptibility panel |
| 50359-9 | Phenyllactate/Creatinine [Molar ratio] in 24 hour Urine |
| 40927-6 | 3-Methylcrotonylglycine [Moles/volume] in Blood |
| 19180-9 | Choriogonadotropin.beta subunit free [Units/volume] in Serum or Plasma |
| 19304-5 | Thiazides tested for in Urine by Screen method Nominal |
| 20487-5 | Neisseria meningitidis serogroups A+Y Ag [Presence] in Cerebral spinal fluid |
| 20642-5 | Glutamate [Moles/volume] in Serum or Plasma |
| 20957-7 | Sarcocystis neurona Ab [Presence] in Serum by Immunoblot |
| 100798-8 | Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge |
| 12576-5 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --1st specimen |
| 12876-9 | HIV 1 p53 Ab [Presence] in Serum by Immunoblot |
| 12902-3 | Renin [Enzymatic activity/volume] in Plasma --4th specimen post XXX challenge |
| 101391-1 | PAH gene full mutation analysis in Blood or Tissue by Molecular genetics method |
| 102109-6 | Oxalate and Glycolate and Glyoxylate and Citrate [Interpretation] in Urine |
| 102386-0 | House dust Hollister Stier IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103105-3 | Phadiatop infant IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14855-1 | Norfluoxetine [Moles/volume] in Serum or Plasma |
| 104280-3 | ABCG2 gene.p.Q141K [Presence] in Blood or Tissue by Molecular genetics method |
| 10615-3 | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Mixed antiglobulin reaction |
| 15246-2 | Food Allergen Mix 15 (Orange+Apple+Banana+Peach) IgE Ab [Presence] in Serum by Multidisk |
| 16130-7 | Herpes simplex virus 1 DNA [Presence] in Specimen by NAA with probe detection |
| 16195-0 | Benzodiazepines [Presence] in Urine by Confirmatory method |
| 16929-2 | Helicobacter pylori Ab [Units/volume] in Serum by Immunofluorescence |
| 188-3 | Clarithromycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 7478-1 | Coastal Maple IgE Ab [Units/volume] in Serum |
| 74892-1 | Medium-chain Acyl CoA dehydrogenase [Enzymatic activity/mass] in Fibroblast |
| 75046-3 | Sialate [Moles/volume] in Cerebral spinal fluid |
| 75226-1 | 8-Hydroxyamoxapine [Presence] in Urine |
| 60526-1 | Pseudo Pelger Huet cells [Presence] in Blood by Light microscopy |
| 76045-4 | Moxifloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 76681-6 | Color of Cerebral spinal fluid--3rd tube |
| 92948-9 | Streptococcus pneumoniae DNA [NCncRange] in Sputum by NAA with non-probe detection |
| 62355-3 | Chromosome analysis panel by Banding |
| 77325-9 | N-desalkylflurazepam [Moles/volume] in Specimen |
| 77943-9 | Schistosoma mansoni+haematobium+intercalatum [Titer] in Serum by Hemagglutination |
| 78817-4 | Cathinone [Mass/volume] in Urine by Confirmatory method |
| 94827-3 | Epstein Barr virus DNA [Presence] in Amniotic fluid by NAA with probe detection |
| 63538-3 | Myeloperoxidase Ab [Units/volume] in Body fluid |
| 6548-2 | Rubella virus identified in Serum by Organism specific culture |
| 6614-2 | Haemophilus influenzae E Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 80383-3 | Influenza virus B Ag [Presence] in Upper respiratory specimen by Rapid immunoassay |
| 68396-1 | Basophils/100 leukocytes in Vitreous fluid by Manual count |
| 69018-0 | Lymphocyte proliferation mitogen panel - Blood by Flow cytometry (FC) |
| 8091-1 | Ribonucleoprotein extractable nuclear Ab [Presence] in Serum |
| 81185-1 | Non-regional lymph nodes positive [#] in Specimen |
| 96629-1 | HLA-A and B and C (class I) typing panel - Blood or Tissue by Low resolution |
| 96662-2 | HLA-DRB1 [Type] in Donor by High resolution |
| 69405-9 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood |
| 69892-8 | Service comment 65 |
| 81652-0 | HIV 2 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 97744-7 | Enolase.neuron specific [Mass/volume] in Aspirate |
| 83135-4 | Allo-pregnanediolone/Creatinine [Molar ratio] in Urine |
| 83140-4 | 17-Hydroxypregnenetriol [Moles/volume] in Urine |
| 85749-0 | Streptococcus pneumoniae Danish serotypes 22A+22F DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 99388-1 | Choriogonadotropin.tumor marker [Units/volume] in Aspirate |
| 89585-4 | Herpes simplex virus 1 DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 89595-3 | Legionella pneumophila Ag [Presence] in Tissue by Immunofluorescence |
| 41193-4 | Whitefaced Hornet IgG4 Ab [Presence] in Serum |
| 3056-9 | Trimethylamine [Mass/volume] in Urine |
| 31089-6 | Acetaminophen [Presence] in Bile fluid |
| 31143-1 | Cefepime [Susceptibility] for meningitis by Gradient strip |
| 41848-3 | Paprika IgG Ab [Units/volume] in Serum |
| 59914-2 | Indomethacin [Moles/volume] in Urine |
| 60232-6 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.75 hours post dose lactose PO |
| 51349-9 | CD56+CD57+ cells/100 cells in Blood |
| 51398-6 | CD65w cells/100 cells in Bone marrow |
| 21726-5 | SERPINA1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 31736-2 | Bordetella parapertussis Ag [Presence] in Specimen |
| 51722-7 | Reticulin Ab [Titer] in Serum by Immunofluorescence |
| 22464-2 | Reagin Ab [Presence] in Specimen |
| 3230-0 | Coagulation factor XII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
| 43931-5 | California encephalitis virus Ab [Titer] in Serum |
| 22884-1 | Border disease virus RNA [Presence] in Tissue by NAA with probe detection |
| 22971-6 | Caprine arthritis encephalitis virus [Presence] in Specimen by Electron microscopy |
| 44511-4 | Herpes simplex virus Ag [Presence] in Eye |
| 23431-0 | Salmonella gallinarum DNA [Presence] in Specimen by NAA with probe detection |
| 33285-8 | Cytomegalovirus IgM Ab [Units/volume] in Body fluid by Immunoassay |
| 53586-4 | HLA-B6 [Presence] |
| 44995-9 | Chlamydia trachomatis B IgG Ab [Presence] in Serum |
| 45046-0 | Bacteria producing X and V factors [Presence] in Isolate |
| 45373-8 | Medication route [Identifier] of Dose |
| 23907-9 | Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Units/volume] in Serum |
| 23974-9 | Bartonella quintana IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 53969-2 | Microcytes [Presence] in Urine sediment by Light microscopy |
| 54468-4 | Cholesterol in HDL 2b/Cholesterol in total HDL in Serum or Plasma by Electrophoresis |
| 4605-2 | Hemoglobin Lepore [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 46187-1 | Equine herpesvirus 2 Ab [Titer] in Serum |
| 47009-6 | BCL6 Ag [Presence] in Tissue by Immune stain |
| 24195-0 | Coxsackievirus B5 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen |
| 25317-9 | 17-Ketosteroids [Moles/volume] in 24 hour Urine |
| 35011-6 | Segmented neutrophils [#/volume] in Cerebral spinal fluid |
| 35298-9 | FXN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 35333-4 | Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
| 55689-4 | Nystatin [Susceptibility] by Gradient strip |
| 5605-1 | Boron [Mass/volume] in Body fluid |
| 25887-1 | Cystathionine [Moles/volume] in 24 hour Urine |
| 35758-2 | Cefdinir [Susceptibility] by Disk diffusion (KB) |
| 56190-2 | Bermuda grass IgG4 Ab [Mass/volume] in Serum |
| 47957-6 | Deoxyuridine [Moles/volume] in Serum or Plasma |
| 48362-8 | O-desmethylvenlafaxine [Moles/volume] in Serum or Plasma |
| 26808-6 | Histidine [Presence] in 24 hour Urine |
| 2753-2 | pH of Serum or Plasma |
| 39023-7 | Vesicular stomatitis Indiana virus RNA [Presence] in Specimen by NAA with probe detection |
| 39317-3 | Influenza virus A N7 neutralizing antibody [Presence] in Serum by Neutralization test |
| 57859-1 | Dextromethorphan [Moles/volume] in Specimen |
| 49371-8 | Hepatitis C virus RNA [#/volume] (viral load) in Tissue by NAA with probe detection |
| 2823-3 | Potassium [Moles/volume] in Serum or Plasma |
| 29149-2 | Mefloquine [Mass/volume] in Serum or Plasma |
| 4016-2 | quiNIDine+Quinine [Presence] in Serum or Plasma |
| 58716-2 | Testosterone.free+weakly bound and total panel - Serum or Plasma |
| 58723-8 | Lymphocyte proliferation stimulated by 10 ug pokeweed mitogen actual/normal in Blood |
| 49985-5 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
| 49988-9 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
| 29723-4 | Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection |
| 40620-7 | Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Capillary blood |
| 58834-3 | Thyrotropin [Units/volume] in Serum or Plasma --15 minutes pre XXX challenge |
| 58881-4 | Somatotropin [Mass/volume] in Serum or Plasma --26th specimen |
| 50242-7 | 17-Ketosteroids [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
| 50530-5 | Parathyrin.intact [Mass/volume] in Serum or Plasma --6th specimen |
| 40856-7 | Chlamydia trachomatis L2 IgM Ab [Titer] in Serum |
| 19728-5 | Beet IgE Ab [Units/volume] in Serum |
| 20706-8 | Clostridium botulinum toxin [Identifier] in Specimen by Animal inoculation |
| 20905-6 | Oleandrin [Mass/volume] in Urine |
| 13402-3 | Isoleucine [Mass/volume] in Amniotic fluid |
| 13440-3 | Immunofixation for Urine |
| 101837-3 | Fluorometholone [Moles/volume] in Serum or Plasma |
| 102175-7 | American Beech IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102710-1 | Roquefort Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102798-6 | Pineapple IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102850-5 | Canary droppings IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103043-6 | Olive pollen recombinant (rOle e) 9 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15387-4 | Leishmania tropica IgM Ab [Titer] in Serum |
| 10900-9 | Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay |
| 18410-1 | Epicoccum purpurascens IgG Ab [Units/volume] in Serum |
| 1886-1 | Apolipoprotein E [Mass/volume] in Serum or Plasma |
| 90422-7 | TACI cells/100 CD19 cells in Blood |
| 74813-7 | Nucleated cells [#/volume] in Dialysis fluid by Manual count |
| 74868-1 | IgG.kappa/IgG.lambda [Mass Ratio] in Serum or Plasma |
| 7510-1 | Mugwort triggered histamine release [Units/volume] in Blood |
| 61044-4 | LORazepam [Presence] in Specimen |
| 75754-2 | Streptobacillus moniliformis DNA [Presence] in Specimen by NAA with probe detection |
| 76408-4 | Monocytes+Macrophages [#] in Body fluid by Manual count |
| 7647-1 | Desert Ragweed IgE Ab [Units/volume] in Serum |
| 76498-5 | Cervical cells.overexpressing HPV E6+E7 mRNA/cervical cells by Flow cytometry (FC) |
| 77179-0 | Niobium [Mass/mass] in Tissue |
| 77364-8 | Tryptophan, kynurenin and 3-hydroxykynurenin panel - Serum or Plasma |
| 77367-1 | Cholinesterase [Enzymatic activity/volume] in Serum or Plasma by calculation --Dibucaine |
| 77609-6 | Aldosterone [Moles/volume] in Serum or Plasma --4 hours post XXX challenge |
| 93713-6 | Epstein Barr virus capsid IgG Ab [Presence] in Serum from Donor by Immunoassay |
| 93718-5 | Francisella tularensis IgG and IgM [Interpretation] in Serum |
| 78440-5 | risperiDONE trough and 9-Hydroxyrisperidone panel - Serum or Plasma |
| 94493-4 | Celiac disease IgA and HLA typing and serology panel - Blood or Tissue |
| 64086-2 | Cells analyzed [#] in Chorionic villus sample by Molecular genetics method |
| 78989-1 | Cryoglobulin [Mass/volume] in Serum |
| 79518-7 | 3-Hydroxybenzoate/Creatinine [Molar ratio] in Urine |
| 80122-5 | Alfentanil [Mass/volume] in Blood by Confirmatory method |
| 9599-2 | Borrelia burgdorferi 39kD IgM Ab [Presence] in Serum by Immunoblot |
| 96514-5 | Cache valley virus IgM Ab [Presence] in Specimen by Immunoassay |
| 96668-9 | HLA-DRB3 and HLA-DRB4 and HLA DRB5 [Type] in Donor by High resolution |
| 69969-4 | Newborn screening report overall laboratory comment |
| 71622-5 | Eosinophils/Leukocytes [Pure number fraction] in Synovial fluid by Manual count |
| 82793-1 | Clot size [Length] in Platelet poor plasma --30 minutes post incubation |
| 97993-0 | Epstein Barr virus early IgM Ab [Titer] in Serum by Immunofluorescence |
| 856-5 | A2 Ag [Presence] on Red Blood Cells |
| 99926-8 | Erythrocytes [Presence] in Body fluid by Automated |
| 72723-0 | Base excess.100% oxygenated [Moles/volume] standard in Venous blood by calculation |
| 73412-9 | Diphenoxylate and Atropine (Lomatil) induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73544-9 | Acyclovir induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73666-0 | Streptococcus.beta-hemolytic [Type] in Isolate by Latex agglutination |
| 42183-4 | Gossypol negative isomer [Mass/volume] in Specimen |
| 42234-5 | Alpha subunit free [Units/volume] in Serum or Plasma |
| 21222-5 | Cortisol [Mass/volume] in Serum or Plasma --11 PM specimen |
| 31279-3 | Campylobacter jejuni Ab [Units/volume] in Serum |
| 5107-8 | Coxsackievirus B3 neutralizing antibody [Titer] in Serum by Neutralization test |
| 31737-0 | Bordetella pertussis Ag [Presence] in Specimen |
| 51683-1 | Pregnenolone [Mass/volume] in Serum or Plasma --baseline |
| 51818-3 | Coxsackievirus B IgM Ab [Units/volume] in Serum by Immunoassay |
| 43439-9 | Bartonella henselae and Bartonella quintana IgG panel [Titer] - Serum |
| 43805-1 | Urease [Presence] in Tissue --1 hour post incubation |
| 32278-4 | Valine [Moles/volume] in Vitreous fluid |
| 44011-5 | Measles virus IgG and IgM [Interpretation] in Cerebral spinal fluid |
| 44366-3 | Glycosaminoglycans/Creatinine [Mass Ratio] in 24 hour Urine |
| 2297-0 | Fructose [Mass/time] in 24 hour Urine |
| 44691-4 | Invasive melanoma.location relative to involved deep margin in Skin melanoma |
| 44807-6 | Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Genital specimen by NAA with probe detection |
| 23289-2 | Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Agglutination |
| 23299-1 | Mycoplasma sp Ag [Presence] in Specimen |
| 2341-6 | Glucose [Mass/volume] in Blood by Test strip manual |
| 23459-1 | Theileria annulata Ab [Presence] in Serum |
| 33699-0 | Microscopic observation [Identifier] in Specimen by Malachite green stain |
| 33794-9 | Calcium [Moles/volume] in Urine --8th specimen post XXX challenge |
| 34220-4 | 17-Hydroxyprogesterone [Moles/volume] in 24 hour Urine |
| 54030-2 | Smith extractable nuclear B Ab [Presence] in Serum |
| 47401-5 | CV2 IgG Ab [Presence] in Serum by Immunoblot |
| 34726-0 | Eosinophils [#/area] in Peritoneal fluid by Microscopy high power field |
| 55630-8 | Cephalothin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 25737-8 | Prolactin [Mass/volume] in Serum or Plasma --20 minutes post 200 ug TRH IV |
| 35469-6 | Transferrin.carbohydrate deficient.disialo/Transferrin.carbohydrate deficient.tetrasialo [Mass Ratio] in Serum or Plasma |
| 56473-2 | Metamyelocytes [#] in Cerebral spinal fluid by Manual count |
| 3627-7 | Fenetylline [Presence] in Urine |
| 38175-6 | Heptacarboxylate/Creatinine [Molar ratio] in Urine |
| 48385-9 | Collagen.injectable Ab [Units/volume] in Serum |
| 48496-4 | Complement total hemolytic CH50 actual/normal in Serum or Plasma |
| 57421-0 | CD34 cells/100 cells in Body fluid |
| 57470-7 | Calcitriol [Mass/volume] in Serum or Plasma --2 hours post dose calcium |
| 49115-9 | Thiamine.free [Mass/volume] in Blood |
| 49191-0 | Clostridium tetani toxoid IgG Ab [Units/volume] in Serum --1st specimen |
| 39021-1 | Abnormal Prion Protein [Presence] in Tissue by Immunoassay |
| 39455-1 | 9-Hydroxyrisperidone [Moles/volume] in Serum or Plasma |
| 3964-4 | Phenylpropanolamine [Mass/volume] in Serum or Plasma |
| 58367-4 | Nordiazepam/Creatinine [Mass Ratio] in Urine |
| 49442-7 | Pneumocystis jiroveci DNA [#/volume] in Bone marrow by NAA with probe detection |
| 49649-7 | CACNA1A gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 49741-2 | Plasmodium malariae IgG Ab [Titer] in Serum by Immunofluorescence |
| 2894-4 | Protoporphyrin.zinc [Presence] in Red Blood Cells |
| 58675-0 | Cortisol [Moles/volume] in Saliva (oral fluid) --8 AM specimen |
| 58691-7 | Cortisol [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge |
| 50089-2 | 2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Urine |
| 29608-7 | Phentermine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 40616-5 | Campylobacter sp IgA Ab [Presence] in Serum by Immunoassay |
| 30401-4 | Leukocytes [#/volume] in Bronchial specimen |
| 20658-1 | Threonine [Moles/volume] in Serum or Plasma |
| 100407-6 | Camembert cheese IgG Ab [Units/volume] in Serum |
| 13236-5 | Epstein Barr virus early diffuse Ab [Presence] in Serum by Immunofluorescence |
| 101938-9 | Candida dubliniensis DNA [Presence] in Specimen by NAA with probe detection |
| 102021-3 | Glucose [Mass/volume] in Serum or Plasma --2.5 hours post dose glucagon |
| 13464-3 | Chromium/Creatinine [Mass Ratio] in Urine |
| 13590-5 | Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay |
| 1409-2 | Cortisol [Mass/volume] in Serum or Plasma --24 hours post 500 ug corticotropin IM |
| 14283-6 | Acylcarnitine [Moles/volume] in Urine |
| 103048-5 | Saltwort native (nSal k) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103193-9 | Mycobacterium ulcerans DNA [Presence] in Wound by NAA with probe detection |
| 103740-7 | Hyper igE syndrome multigene analysis in Specimen by Molecular genetics method |
| 14814-8 | Lipoprotein.beta [Moles/volume] in Serum or Plasma by Electrophoresis |
| 14928-6 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma |
| 10436-4 | CD15 Ag [Presence] in Tissue by Immune stain |
| 11233-4 | Brompheniramine [Mass/volume] in Serum or Plasma |
| 12226-7 | Leukocytes [Presence] in Vaginal fluid by Wet preparation |
| 1688-1 | 4-Pyridoxate [Mass/volume] in Serum or Plasma |
| 17917-6 | Bacteria # 3 identified in Wound shallow by Aerobe culture |
| 18502-5 | Microscopic observation [Identifier] in Deep tissue fine needle aspirate by Cyto stain |
| 19149-4 | Rifabutin [Susceptibility] |
| 74621-4 | 1,1-Dimethoxy-(9Z)octadecene (DMA 18:1)/Oleate (C18:1w9) [Molar ratio] in Red Blood Cells |
| 7485-6 | Burweed marshelder IgG Ab [Units/volume] in Serum |
| 91809-4 | Human metapneumovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 92700-4 | Trichomonas vaginalis DNA [Presence] in Vaginal fluid by Probe |
| 92713-7 | Lipoprotein.beta.subparticle.very small-c [Moles/volume] in Serum |
| 75070-3 | Catechol [Moles/volume] in Serum or Plasma |
| 61040-2 | N-desalkylflurazepam [Presence] in Urine |
| 7668-7 | Rice IgG Ab [Units/volume] in Serum |
| 92818-4 | Glucose [Mass/volume] in Serum or Plasma --20 minutes post dose glucagon |
| 92870-5 | Herpes simplex virus 1 DNA [Presence] in Blood by NAA with probe detection |
| 61321-6 | Trimellitic anhydride (TMA) IgE Ab/IgE total in Serum |
| 61343-0 | Ferret epithelium IgE Ab/IgE total in Serum |
| 63100-2 | Black-eye pea IgG Ab [Mass/volume] in Serum |
| 63378-4 | Erythrocyte clumps [Presence] in Urine sediment by Light microscopy |
| 6418-8 | Haemophilus influenzae F Ag [Presence] in Specimen by Immunofluorescence |
| 79162-4 | chlordiazePOXIDE and Norchlordiazepoxide panel - Serum or Plasma |
| 79395-0 | NADH:ubiquinone reductase [Enzymatic activity/mass] in Fibroblast |
| 9561-2 | CD5+CD19+ cells [#/volume] in Blood |
| 66503-4 | APC gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 96250-6 | Arsenic.inorganic+methylated [Mass/volume] in Urine |
| 67812-8 | Varicella zoster virus Ag [Presence] in Isolate by Immunofluorescence |
| 68543-8 | oxyCODONE [Mass/mass] in Meconium by Confirmatory method |
| 69007-3 | Carboxy tetrahydrocannabinol [Mass/mass] in Meconium by Confirmatory method |
| 96692-9 | Platelet-induced clot retraction.glass bead induced in Blood by Microviscometry |
| 96960-0 | Varicella zoster virus IgM Ab index [Units/volume] in Serum and CSF |
| 81659-5 | Escherichia coli Stx1 and Stx2 toxin stx1 and stx2 genes panel - Stool by NAA with probe detection |
| 97309-9 | Triazolam [Presence] in Cord tissue by Confirmatory method |
| 70244-9 | CFTR gene c.394delTT [Presence] in Blood or Tissue by Molecular genetics method |
| 82785-7 | Lab order date |
| 9836-8 | HIV proviral DNA [Presence] in Blood by Probe with amplification |
| 85551-0 | PRRSV European and North American strains neutralizing antibody panel - Serum by Neutralization test |
| 85772-2 | Enterobacter cloacae complex DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 7257-9 | Cow epithelium IgE Ab [Units/volume] in Serum |
| 72966-5 | quiNIDine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86037-9 | Streptococcus pneumoniae Danish serotype 19F Ab [Mass/volume] in Serum --2nd specimen |
| 73599-3 | Fidaxomicin [Susceptibility] |
| 88452-8 | Babesia microti 18S rRNA gene [Presence] in Blood by NAA with non-probe detection |
| 73943-3 | Cannabinoids synthetic [Presence] in Blood |
| 41754-3 | Fludrocortisone [Mass/volume] in Serum or Plasma |
| 59404-4 | Oxygen capacity [Moles/volume] in Arterial blood |
| 59840-9 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 59849-0 | Lactate [Moles/volume] in Serum or Plasma --post exercise |
| 5064-1 | Borrelia burgdorferi IgM Ab [Units/volume] in Serum by Immunoassay |
| 42605-6 | Peritoneal dialysis bag number |
| 21130-0 | Cadmium [Mass/volume] in 24 hour Urine |
| 31176-1 | Estradiol (E2) [Mass/volume] in Amniotic fluid |
| 31244-7 | Babesia microti IgG Ab [Units/volume] in Serum |
| 21826-3 | t(X;18)(q11.2;p11.22)(SS18,SSX2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 51592-4 | Creatinine [Moles/time] in 12 hour Urine |
| 43636-0 | Plasminogen activator tissue type [Presence] in Platelet poor plasma by Chromogenic method |
| 22506-0 | Measles virus IgM Ab [Titer] in Serum |
| 52981-8 | Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay |
| 53031-1 | Signal Recognition Particle (SRP) Ab [Units/volume] in Serum or Plasma |
| 44395-2 | Lambda light chains [Presence] in 24 hour Urine |
| 32645-4 | Coxiella burnetii phase 1 IgM Ab [Presence] in Serum |
| 33055-5 | Ki-67 nuclear Ag [Presence] in Tissue by Immune stain |
| 5311-6 | Rickettsia spotted fever group Ab [Titer] in Serum by Immunofluorescence |
| 53121-0 | Protein [Mass/time] in 1 hour Urine |
| 44443-0 | Bartonella sp IgG Ab [Units/volume] in Serum by Immunoassay |
| 33470-6 | Salmonella paratyphi A O Ab [Titer] in Serum by Agglutination |
| 45288-8 | Coxsackievirus B5 Ab [Presence] in Body fluid |
| 2402-6 | Guanosine monophosphate.cyclic [Mass/volume] in Serum or Plasma |
| 46431-3 | Alpha 1 antitrypsin [Mass/mass] in 72 hour Stool |
| 2461-2 | IgD.monoclonal [Mass/volume] in Serum |
| 34340-0 | Methionine sulfoxide [Moles/volume] in Urine |
| 55307-3 | Fungus [Presence] in Vaginal fluid by KOH preparation |
| 47194-6 | Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 47321-5 | Baker's yeast IgG Ab [Units/volume] in Serum by Immunoassay |
| 25148-8 | Calcium oxalate crystals [#/area] in Urine sediment by Microscopy high power field |
| 34951-4 | Phosphatidylserine IgG and IgM panel - Serum |
| 35163-5 | Gamma Linolenate (C18:3w6) [Moles/volume] in Serum or Plasma |
| 55708-2 | Piromidate [Susceptibility] by Gradient strip |
| 55959-1 | Ornithine/Amino acids.total in Serum or Plasma |
| 47608-5 | Cortisol [Moles/volume] in Serum or Plasma --pre dose corticotropin |
| 25624-8 | Cortisol [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 25831-9 | Beta-N-acetylhexosaminidase.A [Enzymatic activity/mass] in Fibroblast |
| 35553-7 | Stemphylium botryosum IgG Ab [Mass/volume] in Serum |
| 35790-5 | Difloxacin [Susceptibility] by Disk diffusion (KB) |
| 364-0 | Nitrofurantoin [Susceptibility] by Disk diffusion (KB) |
| 3693-9 | Imipramine [Mass/volume] in Serum or Plasma --trough |
| 3702-8 | Ketobemidone [Presence] in Urine |
| 48360-2 | Borrelia afzelii IgG Ab [Presence] in Serum by Immunoblot |
| 48412-1 | Zygomycete sp Ag [Presence] in Tissue by Immune stain |
| 26988-6 | 18-Hydroxydeoxycorticosterone [Mass/time] in 24 hour Urine |
| 27039-7 | Ammonia [Mass/volume] in 24 hour Urine |
| 38629-2 | Acetamide [Mass/volume] in Air |
| 57620-7 | 5-Alpha tetrahydrocortisol [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
| 57679-3 | Chlamydia sp IgG Ab [Presence] in Serum by Immunoassay --1st specimen |
| 49281-9 | Lipoprotein fractions [Interpretation] in Serum or Plasma Narrative |
| 27408-4 | C peptide [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 57880-7 | Honeydew melon IgG Ab [Units/volume] in Serum |
| 57908-6 | AIRE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 29398-5 | Gastrin [Mass/volume] in Serum or Plasma --1 minute pre XXX challenge |
| 58570-3 | Corticotropin [Moles/volume] in Plasma --1 day post dose metyraPONE |
| 58763-4 | IgA [Mass/time] in 24 hour Urine |
| 49884-0 | Lymphocyte proliferation stimulated by tetanus toxoid [Ratio] in Blood --7 day post incubation |
| 49987-1 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 29584-0 | Differential panel - Cerebral spinal fluid |
| 19394-6 | Chlorpheniramine cutoff [Mass/volume] in Urine for Confirmatory method |
| 20384-4 | Ofloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
| 100673-3 | Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection |
| 12791-0 | Oxalate [Mass/volume] in Urine --3rd specimen post XXX challenge |
| 13030-2 | Xylose [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
| 1317-7 | S Ab [Presence] in Serum or Plasma |
| 101909-0 | Protein monoclonal panel - Urine |
| 102225-0 | Mozzarella Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13732-3 | Dodecanedioate/Creatinine [Mass Ratio] in Urine |
| 102978-4 | Fusarium sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14630-8 | Bilirubin.indirect [Moles/volume] in Serum or Plasma |
| 103199-6 | Treponema pallidum DNA [Presence] in Urine by Probe with amplification |
| 103668-0 | Gabapentin [Presence] in Cord tissue by Screen method |
| 10834-0 | Globulin [Mass/volume] in Serum by calculation |
| 12232-5 | Measles virus Ag [Presence] in Specimen by Immunofluorescence |
| 17768-3 | Vinyl chloride [Mass/volume] in Blood |
| 18298-0 | High titer low avidity Ab [Presence] in Serum or Plasma |
| 74775-8 | Platelets [#/volume] in Platelet rich plasma by Automated count |
| 74790-7 | Glucose challenge (hydrogen breath test) panel - Exhaled gas |
| 91863-1 | Bartonella quintana DNA [Presence] in Aspirate by NAA with probe detection |
| 76352-4 | Testosterone/Cortisol [Molar ratio] in Serum or Plasma |
| 92965-3 | Moraxella catarrhalis DNA [NCncRange] in Sputum by NAA with non-probe detection |
| 77646-8 | HLA-DR IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
| 93809-2 | MDM2 gene copy number/Chromosome 12 copy number in Tissue by FISH |
| 63113-5 | Rabbit IgG Ab [Mass/volume] in Serum |
| 63251-3 | Ganglioside GM3 IgG Ab [Presence] in Serum by Immunoassay |
| 6450-1 | Legionella sp Ab [Titer] in Serum by Immunofluorescence |
| 79276-2 | 7,8-Dihydrobiopterin [Moles/volume] in Cerebral spinal fluid |
| 79278-8 | 8-lathosterol [Moles/volume] in Serum or Plasma |
| 79499-0 | Catecholamine metabolites panel - Serum or Plasma |
| 6665-4 | Microscopic observation [Identifier] in Tissue by Hematoxylin and eosin stain |
| 68466-2 | Epstein-Barr virus-encoded RNA 1 [Presence] in Tissue by Probe |
| 96655-6 | HLA-DQA1 unresolved alleles [Type] in Donor by High resolution |
| 69813-4 | 2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --3 days post dose ifosfamide |
| 69951-2 | Amylase.pancreatic/Creatinine [Ratio] in Urine |
| 97914-6 | Time to thrombin peak in Platelet poor plasma by Chromogenic method |
| 98406-2 | Color.yeast colony [Type] in Isolate by Culture--with Sabouraud Dextrose Agar |
| 99416-0 | Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Immunofixation |
| 99911-0 | Atypical crystals [#/volume] in Urine sediment by Computer assisted method |
| 73307-1 | levoFLOXacin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73532-4 | Amitriptyline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74038-1 | Influenza virus A H1 RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 88737-2 | RNA polymerase III RP11 Ab [Units/volume] in Serum by Line blot |
| 88888-3 | Pancreatic stone protein [Mass/volume] in Serum, Plasma or Blood by Rapid immunoassay |
| 89969-0 | Norolanzapine [Presence] in Urine by Screen method |
| 41454-0 | Human coronavirus identified in Specimen |
| 50632-9 | Cefotaxime [Susceptibility] by Method for Slow-growing mycobacteria |
| 5991-5 | Plasminogen Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 21491-6 | Rickettsia (Proteus OXK) Ab [Titer] in Serum by Latex agglutination |
| 51345-7 | CD56+CD57+ cells/100 cells in Tissue |
| 21676-2 | FGFR3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 22144-0 | Bovine leukemia virus Ab [Presence] in Serum |
| 22174-7 | Chlamydophila pneumoniae IgM Ab [Titer] in Serum |
| 51508-0 | Lactate dehydrogenase 1/Lactate dehydrogenase.total in Pleural fluid by Electrophoresis |
| 4322-4 | Methicillin [Mass] of Dose |
| 43639-4 | Mercaptopurine [Presence] in Blood |
| 4383-6 | Pentazocine [Mass] of Dose |
| 23000-3 | Chlamydophila psittaci Ag [Presence] in Exudate by Immune stain |
| 53212-7 | Sebacylcarnitine (C10-DC) [Moles/volume] in DBS |
| 53265-5 | Yeast.hyphae [#/volume] in Urine by Computer assisted method |
| 33668-5 | Erythrocytes [Presence] in Stool |
| 45042-9 | XXX microorganism Ag [Identifier] in Specimen by Immunofluorescence |
| 23704-0 | Canine parvovirus IgM Ab [Titer] in Serum |
| 23764-4 | Pesticides [Identifier] in Specimen |
| 2394-5 | Glycogen synthase [Enzymatic activity/volume] in Serum |
| 34205-5 | 11-Deoxycortisol [Moles/volume] in Urine |
| 54091-4 | Rubella virus RNA [Presence] in Specimen by NAA with probe detection |
| 46220-0 | Creatinine [Moles/volume] in Dialysis fluid --overnight |
| 463-0 | sulfADIAZINE [Susceptibility] by Minimum lethal concentration (MLC) |
| 24515-9 | Grass Allergen Mix A (Sweet vernal grass+Bermuda grass+Perennial rye grass+Timothy+Johnson grass) IgE Ab [Units/volume] in Serum by Multidisk |
| 34370-7 | Salmonella paratyphi C O Ab [Titer] in Serum by Agglutination |
| 34485-3 | Avian paramyxovirus 1.exotic RNA [Presence] in Specimen by NAA with probe detection |
| 54913-9 | Gentamicin IgE Ab [Units/volume] in Serum |
| 47081-5 | Legionella pneumophila 9 IgM Ab [Titer] in Serum by Immunofluorescence |
| 47104-5 | Doxepin [Moles/volume] in Gastric fluid |
| 47289-4 | IgG and IgG subclass panel [Mass/volume] - Serum |
| 35042-1 | Variant lymphocytes [#/volume] in Pleural fluid |
| 35049-6 | Lymphocytes [#/volume] in Synovial fluid |
| 55772-8 | Cardiolipin IgG Ab [Multiple of the median] in Serum |
| 47633-3 | Glycine [Moles/volume] in DBS |
| 25918-4 | Glutamate/Creatinine [Molar ratio] in 24 hour Urine |
| 35610-5 | FLUoxetine [Mass/volume] in Serum or Plasma by Screen method |
| 35681-6 | Tissue transglutaminase Ab panel - Serum |
| 56420-3 | White Ash IgG4 Ab [Mass/volume] in Serum |
| 47944-4 | Testosterone [Mass/volume] in Serum or Plasma --4 hours post 5000 U HCG IM |
| 38343-0 | Chlorobenzene [Mass/volume] in Water |
| 57614-0 | 5-Alpha tetrahydrocortisol [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
| 48903-9 | Rickettsia africae IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 48983-1 | Glucose [Mass/volume] in Serum or Plasma --20 minutes pre XXX challenge |
| 27326-8 | Alanine [Moles/volume] in Urine |
| 38930-4 | EXT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 58043-1 | American Sycamore IgE Ab/IgE total in Serum |
| 4952-8 | HLA-DR11(5) [Presence] in Donor |
| 29516-2 | 3-Hydroxyvalerate/Creatinine [Molar ratio] in Urine |
| 40139-8 | Creatinine [Moles/volume] in Urine --3 hours post XXX challenge |
| 29733-3 | Leptospira interrogans sv Kremastos Ab [Presence] in Serum by Agglutination |
| 58946-5 | Lutropin [Units/volume] in Serum or Plasma --pre XXX challenge |
| 50364-9 | Black Pepper IgE Ab/IgE total in Serum |
| 30115-0 | Kappa lymphocytes [#/volume] in Blood |
| 3038-7 | Trehalase [Enzymatic activity/volume] in Urine |
| 20457-8 | Fungi.filamentous [Presence] in Urine sediment by Light microscopy |
| 20513-8 | Turbidity [Presence] of Body fluid Qualitative |
| 1008-2 | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma |
| 12594-8 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 13911-3 | HLA-B27 related Ag [Presence] |
| 102479-3 | Orange IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102500-6 | Peach IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14485-7 | Mycoplasma sp and Ureaplasma sp [Identifier] in Vaginal fluid by Organism specific culture |
| 14522-7 | Pneumocystis jiroveci Ag [Presence] in Bronchial specimen by Immunofluorescence |
| 14600-1 | Amoxapine [Moles/volume] in Serum or Plasma |
| 14649-8 | Cimetidine [Presence] in Gastric fluid |
| 14836-1 | Methotrexate [Moles/volume] in Serum or Plasma |
| 15400-5 | Platelet IgG Ab [Presence] in Serum |
| 10924-9 | Starfruit IgE Ab [Units/volume] in Serum |
| 1706-1 | Acetonitrile [Mass/volume] in Blood |
| 17182-7 | CD63 cells/100 cells in Blood |
| 17572-9 | 2-Butanol [Mass/volume] in Blood |
| 90000-1 | Microalbumin [Mass/time] in 24 hour Urine by Detection limit <= 3.0 mg/L |
| 910-0 | Ax Ab [Presence] in Serum or Plasma |
| 60581-6 | TCRB gene rearrangements [Presence] in Body fluid by Molecular genetics method |
| 6103-6 | Echinococcus sp IgE Ab [Units/volume] in Serum |
| 93451-3 | Nor-W-18+Nor-W-15 [Mass/volume] in Urine by Confirmatory method |
| 631-2 | Bacteria identified in Unknown substance by Aerobe culture |
| 94297-9 | Norfluvoxamine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 94338-1 | Chromosome 13+15+16+18+21+22+X+Y aneuploidy in Products of Conception by FISH |
| 944-9 | C Ab [Presence] in Serum or Plasma from Donor |
| 64017-7 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Specimen by NAA with probe detection |
| 64095-3 | Cells counted [#] in Amniotic fluid by Molecular genetics method |
| 95115-2 | Insulin [Units/volume] in Serum or Plasma --3.5 hours post meal |
| 80360-1 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urine by NAA with probe detection |
| 6824-7 | Color of Body fluid |
| 69571-8 | Bacterial vaginosis DNA and score panel - Vaginal fluid by NAA with probe detection |
| 6983-1 | Bacitracin [Susceptibility] by Gradient strip |
| 82068-8 | Citrus Allergen Mix (Orange+Lemon+Grapefruit+Clementine) IgE Ab [Units/volume] in Serum by Multidisk |
| 7162-1 | Buckwheat IgG Ab [Units/volume] in Serum |
| 82411-0 | Ganglioside GT1a IgG Ab [Presence] in Serum by Line blot |
| 97981-5 | Hazelnut recombinant (rCor a) 9 IgG4 Ab [Mass/volume] in Serum |
| 98100-1 | Interleukin 22 [Mass/volume] in Serum or Plasma |
| 98277-7 | Para-aortic lymph nodes positive [#] in Specimen |
| 71852-8 | Oxygen saturation [Pure mass fraction] in Arterial blood |
| 84899-4 | Other nodules greater than 10mm in diameter [Presence] in Prostate tumor |
| 85067-7 | Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose gonadotropin releasing hormone |
| 72948-3 | Sulfamethoxazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 72949-1 | Spironolactone induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 85999-1 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum --2nd specimen |
| 73199-2 | Pravastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73285-9 | Methocarbamol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86927-1 | Porcine respiratory coronavirus Ab/Negative control in Serum by Immunoassay |
| 87462-8 | Nitrate [Mass/mass] in Specimen |
| 73635-5 | Razupenem [Susceptibility] by Disk diffusion (KB) |
| 88274-6 | Streptococcus anginosus group gyrB gene [Presence] by Probe in Positive blood culture |
| 50852-3 | Gold [Moles/volume] in 24 hour Urine |
| 60141-9 | Penciclovir [Mass/volume] in Serum or Plasma |
| 21422-1 | Normetanephrine [Mass/volume] in 24 hour Urine |
| 31185-2 | Platelet IgA Ab [Presence] in Serum |
| 21739-8 | TP53 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 31665-3 | Sulfate-3-Glucuronyl paragloboside IgM Ab [Presence] in Serum |
| 51582-5 | Anisochromasia [Presence] in Blood by Light microscopy |
| 44288-9 | 5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in 24 hour Urine |
| 22976-5 | Caprine arthritis encephalitis virus Ag [Presence] in Specimen by Immunofluorescence |
| 23089-6 | Equine herpesvirus 1+4 neutralizing antibody [Titer] in Serum by Neutralization test |
| 33012-6 | Provolone Cheese IgE Ab [Units/volume] in Serum |
| 44546-0 | Human papilloma virus DNA [Presence] in Vaginal fluid by Probe |
| 44558-5 | Influenza virus A Ag [Presence] in Nasopharynx by Immunofluorescence |
| 23291-8 | Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Specimen by Immunofluorescence |
| 53521-1 | Polymorphonuclear cells [#/volume] in Semen |
| 53710-0 | Hyperoxaluria panel - Urine |
| 53776-1 | Hepatitis A virus Ab [Interpretation] in Serum |
| 53925-4 | Chlamydia trachomatis rRNA [Presence] in Urethra by NAA with probe detection |
| 2390-3 | Glycine [Presence] in Serum or Plasma |
| 24200-8 | Coxsackievirus B6 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen |
| 54932-9 | Centers for Environmental Health abrine and ricinine panel [Mass/volume] - Urine |
| 47115-1 | LORazepam [Moles/volume] in Urine |
| 25455-7 | Lactoglobulin IgA Ab [Units/volume] in Serum |
| 35038-9 | Macrophages [#/volume] in Cerebral spinal fluid |
| 352-5 | Nalidixate [Susceptibility] by Disk diffusion (KB) |
| 47559-0 | Alpha aminobutyrate [Moles/volume] in DBS |
| 35569-3 | Oligoclonal bands [#] in Serum or Plasma |
| 5648-1 | Fluoride [Mass/volume] in Blood |
| 4807-4 | HLA-B13 [Presence] |
| 2617-9 | Methemoglobin/Hemoglobin.total in Venous blood |
| 48404-8 | Myeloperoxidase IgG Ab [Units/volume] in Serum |
| 26852-4 | Amino beta guanidinopropionate [Moles/volume] in Amniotic fluid |
| 38353-9 | Streptococcus sp identified in Specimen by Organism specific culture |
| 57293-3 | HLA-DRB1 [Type] by High resolution |
| 5742-2 | Tellurium [Mass/volume] in Urine |
| 57782-5 | CBC W Ordered Manual Differential panel - Blood |
| 2813-4 | Porphobilinogen synthase [Enzymatic activity/volume] in Red Blood Cells |
| 29217-7 | Disopyramide [Mass/volume] in Body fluid |
| 40006-9 | Glucose [Mass/volume] in Serum or Plasma --8.5 hours post XXX challenge |
| 40300-6 | Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose cloNIDine |
| 58939-0 | CD34 cells [#/volume] in Body fluid |
| 40742-9 | Rabies virus IgG Ab [Presence] in Serum by Immunofluorescence |
| 4108-7 | Adenine [Mass] of Dose |
| 20597-1 | CD24 cells/100 cells in Specimen |
| 20953-6 | Salmonella sp identified in Tissue by Organism specific culture |
| 12430-5 | Cumene [Mass/volume] in Serum or Plasma |
| 100690-7 | Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection |
| 12773-8 | Cholesterol in LDL [Units/volume] in Serum or Plasma by Electrophoresis |
| 12794-4 | Oxalate [Mass/volume] in Urine --6th specimen post XXX challenge |
| 12855-3 | HIV 1 p23 Ab [Presence] in Serum by Immunoblot |
| 13220-9 | Chlamydia trachomatis C IgM Ab [Units/volume] in Serum |
| 13342-1 | CD3+CD26+ cells/100 cells in Blood |
| 102182-3 | Silver Birch IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13646-5 | Methaqualone [Mass/mass] in Hair |
| 13888-3 | Lactate dehydrogenase 3/Lactate dehydrogenase.total in Urine by Electrophoresis |
| 102898-4 | Conalbumin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14508-6 | Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 14701-7 | diphenhydrAMINE+dimenhyDRINATE [Presence] in Urine |
| 14849-4 | Nitrazepam [Moles/volume] in Serum or Plasma |
| 16337-8 | Alkaline phosphatase [Enzymatic activity/volume] in Urine |
| 11196-3 | Orange roughy IgE Ab [Units/volume] in Serum |
| 1228-6 | M Ab [Presence] in Serum or Plasma |
| 17101-7 | CD104 cells/100 cells in Blood |
| 17150-4 | CD42b cells/100 cells in Blood |
| 17404-5 | Human papilloma virus 33 Ag [Presence] in Specimen |
| 17975-4 | Virus # 2 identified in Specimen by Culture |
| 18283-2 | CD11 cells/100 cells in Blood |
| 90-1 | Cefmetazole [Susceptibility] by Serum bactericidal titer |
| 90303-9 | Trichomonas vaginalis [Presence] in Cervix by Light microscopy |
| 91093-5 | Fungal ITS region [Presence] in Lower respiratory specimen by NAA with probe detection |
| 74494-6 | CD34 and Coagulation factor XIII Ag [Identifier] in Tissue by Immune stain |
| 75104-0 | Fatty acids.very long chain C24:0 (Tetracosanoate) [Entitic substance] in Red Blood Cells |
| 61063-4 | Carboxy tetrahydrocannabinol [Presence] in Specimen |
| 76035-5 | ARSA gene full mutation analysis in Blood or Tissue by Sequencing |
| 92956-2 | Rhinovirus+Enterovirus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 7719-8 | Staphylococcus aureus IgE Ab [Units/volume] in Serum |
| 63266-1 | Jo-1 extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
| 63574-8 | Staphylococcus sp.coagulase negative DNA [Presence] in Isolate by NAA with probe detection |
| 78892-7 | Silver [Moles/mass] in Tissue |
| 79307-5 | D-2-hydroxyglutarate [Moles/volume] in Amniotic fluid |
| 95269-7 | HLA-A+B+C (class I) Ab [Presence] in Serum or Plasma by Immunoassay |
| 96484-1 | Neuronal intermediate filament heavy chain IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 68430-8 | Leukocytes other [#/volume] in Pleural fluid by Manual count |
| 81210-7 | clomiPRAMINE and Norclomipramine panel - Gastric fluid |
| 69812-6 | 2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --2 days post dose ifosfamide |
| 7005-2 | Clindamycin [Susceptibility] by Gradient strip |
| 81647-0 | Clostridium botulinum toxin F botF gene [Presence] in Specimen by NAA with probe detection |
| 81699-1 | Microsatellite instability marker NR21 in Cancer specimen Qualitative |
| 82037-3 | Tree Allergen Mix 8 (Boxelder+Silver birch+Hazelnut+White oak+London plane or Maple leaf sycamore) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 71644-9 | Blasts/Leukocytes [Pure number fraction] in Body fluid by Manual count |
| 82907-7 | Tetrahydrocorticosterone/Allo-tetrahydrocorticosterone [Molar ratio] in 24 hour Urine |
| 98208-2 | Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 85091-7 | HBA2 gene alpha 3.7kb triplication [Presence] in Blood by Molecular genetics method |
| 99433-5 | Sugar Beet Seed (Beta vulgaris seed) IgG4 Ab [Mass/volume] in Serum |
| 72578-8 | Prealbumin/Protein.total [Pure mass fraction] in Urine by Electrophoresis |
| 85823-3 | Carbapenem resistance blaGES gene [Presence] by Molecular method |
| 86103-9 | Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 87454-5 | Potassium [Mass/volume] in Specimen |
| 87730-8 | HBA1 and HBA2 gene full mutation analysis in Blood or Tissue by Sequencing |
| 88336-3 | Microscopic observation [Interpretation] of Ear specimen Narrative |
| 73952-4 | AM-2201 (synthetic cannabinoid) [Presence] in Blood |
| 74363-3 | N,N-dimethylarginine [Moles/volume] in Serum or Plasma |
| 4131-9 | Ascorbate.PO [Mass] of Dose |
| 41396-3 | Tenofovir [Susceptibility] by Genotype method |
| 59371-5 | Leptospira interrogans sv Autumnalis Ab [Titer] in Serum by Agglutination |
| 59794-8 | Glucose [Molar concentration difference] in Serum or Plasma --2 hours post XXX challenge |
| 50734-3 | Serotonin release.heparin.porcine in Serum |
| 50977-8 | Echovirus 5 Ab [Titer] in Serum |
| 51033-9 | CD11a blasts/100 blasts in Specimen |
| 3051-0 | Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma |
| 59946-4 | OLANZapine [Moles/volume] in Gastric fluid |
| 60159-1 | Pergolide [Mass/volume] in Urine |
| 21091-4 | Barbiturates present [Identifier] in Serum or Plasma by Screen method |
| 21623-4 | ASPA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 22599-5 | Trypanosoma cruzi Ab [Titer] in Serum |
| 32304-8 | Cadmium [Moles/time] in 24 hour Urine |
| 32501-9 | CD10+CD19+ cells/100 cells in Tissue |
| 4385-1 | PENTobarbital [Mass] of Dose |
| 43951-3 | CD2 cells [#/volume] in Tissue |
| 3292-0 | 2-Pyridone/N'-methylnicotinamide [Mass Ratio] in Serum or Plasma |
| 33226-2 | Coarse Granular Casts [#/area] in Urine sediment by Microscopy high power field |
| 53178-0 | 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC) [Moles/volume] in DBS |
| 44800-1 | Burkholderia sp [Presence] in Specimen by Organism specific culture |
| 23262-9 | Mycoplasma capricolum ss capripneumonia Ab [Titer] in Serum |
| 23268-6 | Mycoplasma capricolum ss capripneumonia Ag [Presence] in Specimen by Immunofluorescence |
| 2345-7 | Glucose [Mass/volume] in Serum or Plasma |
| 23470-8 | Theileria mutans Ab [Presence] in Serum |
| 45301-9 | Nortriptyline [Moles/volume] in Urine |
| 33958-0 | Cholecalciferol (Vit D3) [Moles/volume] in Serum or Plasma |
| 55386-7 | Insulin [Moles/volume] in Serum or Plasma --2 minutes post XXX challenge |
| 47265-4 | Adenosine monophosphate.cyclic [Moles/volume] in Urine --4th specimen post XXX challenge |
| 4782-9 | HLA-B64(14) [Presence] in Donor |
| 47885-9 | Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose arginine+insulin |
| 35590-9 | Aniline [Mass/volume] in Urine |
| 56555-6 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --baseline |
| 48226-5 | Egg white triggered leukotriene release [Mass/volume] by Leukocytes |
| 48341-2 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 35871-3 | Succinate [Moles/volume] in Serum or Plasma |
| 56977-2 | Rheumatoid arthritis nuclear Ab [Titer] in Serum by Immunofluorescence |
| 48711-6 | Free Hemoglobin [Mass/volume] in Plasma --after transfusion reaction |
| 57448-3 | Nuclear Ab pattern [Interpretation] in Synovial fluid by Immunofluorescence |
| 49039-1 | Subtelomere analysis [Identifier] in Blood or Tissue by FISH Nominal |
| 49160-5 | Rickettsia africae IgM Ab [Titer] in Body fluid |
| 27427-4 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 5774-5 | Calcium oxalate crystals [Presence] in Urine sediment by Light microscopy |
| 29215-1 | Digitoxin [Mass/volume] in Body fluid |
| 29336-5 | Mexiletine [Mass/volume] in Gastric fluid |
| 40228-9 | Calcium [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 29764-8 | Iron [Moles/volume] in Body fluid |
| 40456-6 | Beta 2 glycoprotein 1 Ab [Units/volume] in Serum |
| 50505-7 | Insulin [Units/volume] in Serum or Plasma --5th specimen |
| 30303-2 | Abacavir [Susceptibility] |
| 4115-2 | Amikacin [Mass] of Dose |
| 19635-2 | Norpropoxyphene [Mass/volume] in Urine |
| 20484-2 | Cardiolipin IgG Ab [Titer] in Serum |
| 20615-1 | IgD lymphocytes/100 lymphocytes in Specimen |
| 21052-6 | Adenosine monophosphate.cyclic.nephrogenous [Moles/volume] in Urine and Serum or Plasma |
| 12910-6 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 13058-3 | aPTT in Platelet poor plasma by Coagulation assay --2nd specimen |
| 13584-8 | Tobramycin [Mass/volume] in Body fluid |
| 1369-8 | Ascorbate [Mass/time] in 24 hour Urine --post dose PO |
| 13717-4 | Calcium/Creatinine [Mass Ratio] in 24 hour Urine |
| 102314-2 | Formaldehyde IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14102-8 | Strychnine [Mass/volume] in Blood |
| 14240-6 | Neuronal nuclear Ab [Units/volume] in Cerebral spinal fluid |
| 14287-7 | Carnitine [Moles/volume] in Urine |
| 102765-5 | Lobster IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103225-9 | Enterovirus RNA [Log #/volume] (viral load) in Serum by NAA with probe detection |
| 104294-4 | CDH1 gene rearrangements [Interpretation] in Blood or Tissue by Molecular genetics method Narrative |
| 10433-1 | BR-2 Ag [Presence] in Tissue by Immune stain |
| 11082-5 | HIV 2 p68 Ab [Presence] in Serum by Immunoblot |
| 16461-6 | Bicarbonate [Moles/volume] in Red Blood Cells |
| 11556-8 | Oxygen [Partial pressure] in Blood |
| 16947-4 | Herpes simplex virus 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 91028-1 | Barbiturates [Presence] in Body fluid by Screen method |
| 76086-8 | Parainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with probe detection |
| 93388-7 | Neisseria meningitidis DNA [Presence] by NAA with probe detection in Positive blood culture |
| 61294-5 | Avocado IgE Ab/IgE total in Serum |
| 61400-8 | Proteus mirabilis DNA [Presence] in Specimen by NAA with probe detection |
| 62303-3 | Lysosomal storage disorders newborn screening comment-discussion |
| 93760-7 | Influenza virus A PB1 gene [Nucleotide sequence] in Isolate by Sequencing |
| 63196-0 | Alternaria alternata+American house dust mite IgG Ab [Mass/volume] in Serum by Multidisk |
| 63301-6 | Parathyrin Ab [Presence] in Serum by Immunofluorescence |
| 78011-4 | Schistocytes/100 cells in Cord blood |
| 94448-8 | HLA-DP and DQ and DR (class II) IgG intermediate risk [Identifier] in Serum or Plasma by Flow cytometry (FC) |
| 64417-9 | Fragile X protein (FMRP) [Interpretation] in Blood |
| 95563-3 | 16-Alpha hydroxydehydroepiandrosterone [Mass/time] in 24 hour Urine |
| 6643-1 | Cefepime [Susceptibility] by Minimum lethal concentration (MLC) |
| 79500-5 | Furoylglycine/Creatinine [Molar ratio] in Urine |
| 80113-4 | 11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method |
| 80159-7 | 27-Norcholestanehexol/Creatinine [Ratio] in Urine |
| 96262-1 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:1 addition of normal plasma |
| 96418-9 | Cells.CD3-CD14-CD45+CD56+DOCK8+/100 Cells.CD3-CD14-CD45+CD56+ in Blood by Flow cytometry (FC) |
| 68919-0 | Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post exercise |
| 8068-9 | Centromere Ab [Units/volume] in Serum |
| 81770-0 | Tiglylcarnitine (C5:1)/Creatinine [Molar ratio] in Urine |
| 81877-3 | SPG3A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 70262-1 | Amylase in peritoneal fluid/Amylase in serum |
| 7156-3 | Boxelder IgG Ab [Units/volume] in Serum |
| 71709-0 | Lassa virus IgM Ab [Titer] in Serum by Immunoassay |
| 83087-7 | Clostridioides difficile glutamate dehydrogenase [Presence] in Stool by Immunoassay |
| 86116-1 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum --2nd specimen |
| 87737-3 | 3,4,5-trimethylphenyl methylcarbamate [Mass/mass] in Specimen |
| 73725-4 | Bile acid panel - 24 hour Stool |
| 74457-3 | Neutrophils/100 leukocytes in Cord blood |
| 41693-3 | Ethionamide [Susceptibility] by Disk diffusion (KB) |
| 5942-8 | Reptilase time in Control Platelet poor plasma by Coagulation assay |
| 50653-5 | Tree Allergen Mix 8 (Boxelder+Silver birch+Hazelnut+White oak+London plane or Maple leaf sycamore) IgE Ab [Units/volume] in Serum by Multidisk |
| 50657-6 | Food Allergen Mix 25A (Onion+Garlic+Sesame seed+Yeast) IgE Ab [Units/volume] in Serum by Multidisk |
| 31065-6 | Polio virus 3 Ab [Titer] in Body fluid by Complement fixation |
| 212-1 | cycloSERINE [Susceptibility] by Minimum lethal concentration (MLC) |
| 21473-4 | White Poplar IgE Ab [Units/volume] in Serum |
| 31363-5 | Anaplasma phagocytophilum Ab [Units/volume] in Serum |
| 31397-3 | Ganglioside GD1a IgG Ab [Units/volume] in Serum |
| 21766-1 | SCA2 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 31765-1 | Chlamydia sp Ag [Presence] in Genital specimen |
| 51676-5 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 32366-7 | Hepatitis B virus genotype [Identifier] in Serum or Plasma by NAA with probe detection |
| 32503-5 | CD13+CD33+ cells/100 cells in Blood |
| 52818-2 | Nucleated cells [#/volume] in Peritoneal fluid by Automated count |
| 441-6 | Rosoxacin [Susceptibility] by Disk diffusion (KB) |
| 22972-4 | Caprine arthritis encephalitis virus Ab [Presence] in Milk |
| 5332-2 | Rubella virus Ab [Presence] in Serum by Latex agglutination |
| 44653-4 | Tumor quantitation.incidental in Prostate tumor by CAP cancer protocols |
| 44716-9 | Creatinine/Calcium [Mass Ratio] in Urine |
| 23279-3 | Mycoplasma gallisepticum DNA [Presence] in Nose or Trachea by NAA with probe detection |
| 23563-0 | Vesicular stomatitis Indiana virus Ab [Presence] in Serum by Immunoassay |
| 23629-9 | Para aminosalicylate [Susceptibility] |
| 53536-9 | Measles virus IgG Ab [Presence] in Body fluid by Immunoassay |
| 53593-0 | Gamma 2 globulin.abnormal band/Protein.total in Serum or Plasma by Electrophoresis |
| 53617-7 | Bacteria identified in Duodenal fluid by Aerobe culture |
| 23854-3 | Dioxin [Mass/volume] in Serum or Plasma |
| 33796-4 | Cotinine [Moles/volume] in Urine |
| 34185-9 | methIMAzole [Mass/time] in 24 hour Urine |
| 54461-9 | Malonylcarnitine (C3-DC) [Moles/volume] in Amniotic fluid |
| 46455-2 | Shigella sp DNA [Presence] in Specimen by NAA with probe detection |
| 34345-9 | N-methylhistamine [Moles/volume] in Urine |
| 35340-9 | ASPA gene p.Tyr231Ter [Presence] in Blood or Tissue by Molecular genetics method |
| 47735-6 | Proline/Amino acids.total in Serum or Plasma |
| 47783-6 | Myristate (C14:0)/Creatinine [Molar ratio] in Urine |
| 25743-6 | Quinoa IgE Ab [Units/volume] in Serum |
| 26029-9 | Lactoferrin bovine IgE Ab [Units/volume] in Serum |
| 35560-2 | Protein.monoclonal [Mass/volume] in Urine |
| 48298-4 | Pigweed triggered leukotriene release [Mass/volume] by Leukocytes |
| 3588-1 | Emetine [Presence] in Urine |
| 3632-7 | Fenoprofen [Mass/volume] in Serum or Plasma |
| 4850-4 | HLA-Cw1 [Presence] in Donor |
| 48876-7 | Anaplasma phagocytophilum IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 38320-8 | Benzo alpha pyrene [Mass/volume] in Water |
| 57317-0 | Chromosome 13+18+21+X+Y aneuploidy in Amniotic fluid or Chorionic villus sample by FISH Nominal |
| 57472-3 | Calcitriol [Mass/volume] in Serum or Plasma --3 hours post dose calcium |
| 27303-7 | Phendimetrazine [Mass/mass] in Stool |
| 39082-3 | Gentamicin [Mass/volume] in Cerebral spinal fluid --peak |
| 290-7 | Kanamycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 29495-9 | Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection |
| 58567-9 | Corticotropin [Mass/volume] in Plasma --2.5 hours post dose glucose |
| 30305-7 | Delavirdine [Susceptibility] |
| 40784-1 | Streptococcus agalactiae Ag [Presence] in Vaginal fluid |
| 41116-5 | ATP7A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2002-4 | Calcium [Moles/volume] in Stool |
| 100980-2 | BK virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 12459-4 | Corticotropin [Mass/volume] in Plasma --3rd specimen post XXX challenge |
| 12647-4 | Glucose [Mass/volume] in Serum or Plasma --12 hours post XXX challenge |
| 12712-6 | Hemoglobin S+D+G region [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 101670-8 | Protein.monoclonal [Presence] in Urine by MS.MALDI-TOF |
| 102210-2 | Cat dander IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13767-9 | Lactate/Creatinine [Mass Ratio] in Urine |
| 102598-0 | Bermuda grass smut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103148-3 | Steroid drug screening panel - Serum or Plasma by LC/MS/MS |
| 104230-8 | MDMB-Fubinaca [Mass/volume] in Urine by Confirmatory method |
| 16364-2 | Amobarbital [Mass/volume] in Gastric fluid |
| 1658-4 | 11-Hydroxyandrostenedione [Mass/volume] in Serum or Plasma |
| 16691-8 | Cresols [Identifier] in Specimen |
| 12218-4 | Glucose [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis |
| 16825-2 | Epstein Barr virus nuclear IgG Ab [Presence] in Body fluid |
| 17019-1 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 17124-9 | CD2+CD20+ cells/100 cells in Blood |
| 17488-8 | Progesterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 17766-7 | Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunofluorescence |
| 74505-9 | 16-Beta,18-dihydroxydehydroepiandrosterone [Moles/time] in 24 hour Urine |
| 91133-9 | Respiratory syncytial virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 92484-5 | N Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 75517-3 | Protein.monoclonal band 4 [Mass/time] in 24 hour Urine by Electrophoresis |
| 60544-4 | Giardia lamblia DNA [Presence] in Specimen by NAA with probe detection |
| 76617-0 | Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 2-14C-pyruvate substrate |
| 76650-1 | Gadolinium [Mass/mass] in Hair |
| 61256-4 | Cocksfoot IgE Ab/IgE total in Serum |
| 61413-1 | Desipramine [Mass/volume] in Urine by Confirmatory method |
| 77098-2 | MRPL44 gene full mutation analysis in Blood or Tissue by Sequencing |
| 77190-7 | Hepatitis B virus core and surface Ab and surface Ag panel - Serum |
| 77220-2 | Niobium [Moles/mass] in Tissue |
| 7726-3 | Sunflower Pollen IgE Ab [Units/volume] in Serum |
| 77334-1 | Norpropoxyphene [Moles/volume] in Specimen |
| 93779-7 | Large B-cell lymphoma and cell of origin [Type] in Tissue |
| 77924-9 | Enterobacteriaceae.carbapenem resistant [Presence] in Anorectal or stool specimen by Organism specific culture |
| 78245-8 | MYB gene deletion [Presence] in Blood or Tissue by FISH |
| 63373-5 | Ketones [Presence] in Urine by Test strip --4 hours post dose glucose |
| 79188-9 | Platelet aggregation ADP induced in Platelet rich plasma --10 umol/L |
| 79210-1 | FLT3 gene internal tandem duplication [Presence] in Blood or Tissue by Molecular genetics method |
| 95663-1 | Zika virus IgG Ab [Presence] in Specimen by Immunoassay |
| 6560-7 | Plasmodium ovale Ab [Units/volume] in Serum |
| 66109-0 | Brain Pathology biopsy report |
| 66125-6 | Urinary bladder Pathology biopsy report |
| 68978-6 | Pseudomonas aeruginosa exotoxin A Ab [Titer] in Serum by Immunoassay |
| 96520-2 | Ilheus virus IgG Ab [Presence] in Specimen by Immunoassay |
| 69777-1 | Suberylcarnitine (C8-DC) [Moles/volume] in Cerebral spinal fluid |
| 69948-8 | Bordetella parapertussis IgG Ab [Presence] in Serum by Immunoassay |
| 97313-1 | Salmonella sp DNA [Presence] in Stool by NAA with probe detection |
| 97602-7 | Glial fibrillary acidic protein and Ubiquitin carboxyl-terminal hydrolase-L1 panel - Plasma |
| 7031-8 | metroNIDAZOLE [Susceptibility] by Gradient strip |
| 71770-2 | Ebola virus IgG Ab [Presence] in Serum by Immunoassay |
| 83079-4 | Beta-2-Microglobulin [Units/volume] in Urine by Immunoassay |
| 99267-7 | Nifoxipam [Mass/volume] in Urine by Confirmatory method |
| 99544-9 | Stenosis degree [Length fraction] in Proximal right coronary artery by Autopsy |
| 99880-7 | Lipids [#/volume] in Urine sediment by Computer assisted method |
| 73342-8 | Hydrocortisone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87549-2 | 1,25-Dihydroxyvitamin D and 1,25-Dihydroxyvitamin D2 and 1,25-Dihydroxyvitamin D3 panel - Serum or Plasma |
| 73528-2 | amLODIPine+Benazepril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88844-6 | Microbiology CNAMTS panel - Bronchial specimen |
| 89324-8 | Insulin intact [Units/volume] in Serum by LC/MS/MS |
| 5090-6 | Chlamydia trachomatis IgM Ab [Units/volume] in Serum |
| 51013-1 | CD1 blasts/100 blasts in Bone marrow |
| 30516-9 | Bromodiphenhydramine [Mass/volume] in Serum or Plasma |
| 5992-3 | Platelet aggregation ADP induced in Platelet rich plasma |
| 21546-7 | Sulfatide IgM Ab [Titer] in Cerebral spinal fluid |
| 2164-2 | Creatinine renal clearance in 24 hour Urine and Serum or Plasma |
| 43093-4 | Angiostrongylus costaricensis Ab [Presence] in Serum |
| 22441-0 | Plasmodium falciparum Ab [Titer] in Serum |
| 32315-4 | Cortisol [Moles/volume] in Serum or Plasma --baseline |
| 43889-5 | Bile acid [Presence] in Urine |
| 44279-8 | 16-Alpha hydroxypregnenolone/16-Alpha hydroxydehydroepiandrosterone [Mass Ratio] in Urine |
| 4435-4 | Teicoplanin [Mass] of Dose |
| 23117-5 | Foot and mouth disease virus serotype [Identifier] in Serum by Immunoassay |
| 23240-5 | Mycobacterium bovis Ab [Presence] in Serum by Immunoassay |
| 5384-3 | Thyrotropin Ab [Units/volume] in Serum |
| 44950-4 | aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --1H post incubation with normal plasma |
| 45150-0 | Neutrophil Ab [Units/volume] in Serum by Immunoassay |
| 23889-9 | Kanamycin [Mass/volume] in Specimen |
| 24047-3 | Alpha fucosidase [Enzymatic activity/mass] in Leukocytes |
| 33770-9 | Mucin clot [Appearance] in Synovial fluid Qualitative --30 minutes post incubation |
| 54351-2 | Ascorbate+Dehydroascorbate [Mass/volume] in Serum or Plasma |
| 54403-1 | Transfuse 5% plasma protein fraction units [#] |
| 54918-8 | Ma+Ta Ab [Units/volume] in Serum by Immunoassay |
| 47268-8 | Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --6th specimen post XXX challenge |
| 47315-7 | Influenza virus B IgM Ab [Units/volume] in Serum by Immunoassay |
| 47414-8 | Pregabalin [Mass/volume] in Serum or Plasma |
| 25434-2 | Heptacarboxylporphyrin [Moles/time] in 24 hour Urine |
| 2551-0 | Lactoferrin [Mass/volume] in Serum |
| 35146-0 | Decanoate (C10:0) [Moles/volume] in Serum or Plasma |
| 55847-8 | Cryoglobulin.IgG.monoclonal [Presence] in Serum |
| 55909-6 | Alpha-L-iduronidase [Enzymatic activity/volume] in DBS |
| 55936-9 | Lysozyme [Mass/volume] in Cerebral spinal fluid |
| 25793-1 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 56197-7 | Insulin bovine IgG4 Ab [Mass/volume] in Serum |
| 56491-4 | Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay --3rd specimen |
| 48061-6 | Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool by Immunofluorescence |
| 26559-5 | CD38+CD56+ cells/100 cells in Specimen |
| 5686-1 | Mercury [Mass/mass] in Hair |
| 27207-0 | Methadone [Mass/volume] in Vitreous fluid |
| 49086-2 | First trimester maternal screen with nuchal translucency panel |
| 49110-0 | Mycoplasma sp identified in Urine by Organism specific culture |
| 49161-3 | Rickettsia africae IgG Ab [Titer] in Serum |
| 27878-8 | CD14+HLA-DR+ cells/100 cells in Blood |
| 38682-1 | Sperm Head IgM Ab/100 spermatozoa in Specimen by Immunobead |
| 38738-1 | Carbaryl [Mass/volume] in Air |
| 39358-7 | Cholinesterase.RO 020683 inhibited/Cholinesterase in Serum or Plasma |
| 49634-9 | FXN gene allele 1.GAA repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 29227-6 | Salicylates [Mass/volume] in Body fluid |
| 49854-3 | COL5A1 gene+COL5A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 40739-5 | Osmotic fragility of Red Blood Cells--unincubated |
| 50603-0 | HPA-6 [Type] in Blood |
| 41060-5 | SFTPB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 41069-6 | PPT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 20720-9 | Brucella abortus Ab [Presence] in Milk by Serial ring agglutination |
| 21036-9 | 17-Hydroxycorticosteroids [Mass/time] in 24 hour Urine |
| 100047-0 | Cefteram [Susceptibility] |
| 12596-3 | Estradiol (E2) [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 102324-1 | Ginger IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14140-8 | Ketones [Presence] in Urine --5 hours post XXX challenge |
| 14316-4 | Benzodiazepines [Presence] in Urine by Screen method |
| 14339-6 | IgG/Protein.total in Cerebral spinal fluid |
| 103115-2 | Cashew nut recombinant (rAna o) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103644-1 | N-Desmethylasenapine [Mass/volume] in Urine by Confirmatory method |
| 10607-0 | Spermatozoa Coiled Tail/100 spermatozoa in Semen |
| 12236-6 | Mononuclear cells/100 leukocytes in Cerebral spinal fluid by Manual count |
| 17016-7 | Influenza virus B IgM Ab [Units/volume] in Serum |
| 17117-3 | CD15 cells/100 cells in Blood |
| 17230-4 | Lysine [Presence] in Urine |
| 17574-5 | Selenium [Mass/volume] in Body fluid |
| 17874-9 | Bacteria # 3 identified in Bone by Aerobe culture |
| 74815-2 | Ascaris sp IgG Ab [Presence] in Serum by Immunoassay |
| 74840-0 | CD56 cells [#/volume] in Specimen |
| 91141-2 | TPMT activity in RBC by production of 6-MMP |
| 92773-1 | Streptococcus agalactiae DNA [Presence] by NAA with probe detection in Positive blood culture |
| 92774-9 | Streptococcus sp DNA [Presence] by NAA with probe detection in Positive blood culture |
| 60468-6 | PHENobarbital [Mass/volume] in Serum or Plasma by Confirmatory method |
| 9344-3 | Coproporphyrin 1/Coproporphyrin.total [Mass Ratio] in 24 hour Urine |
| 62345-4 | Chromosome analysis.interphase panel - Blood by FISH |
| 776-5 | Platelet mean volume [Entitic volume] in Blood by Rees-Ecker |
| 94087-4 | Chromosome analysis in Blood or Tissue by Microarray |
| 78012-2 | Streptococcus pyogenes Ag [Presence] in Throat by Rapid immunoassay |
| 786-4 | MCHC [Mass/volume] by Automated count |
| 78857-0 | Methadone [Z-score] in Urine |
| 94456-1 | Arsenocholine [Mass/volume] in Urine |
| 94646-7 | SARS-CoV-2 (COVID-19) RdRp gene [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection |
| 95525-2 | Chromium and cobalt panel [Mass/volume] - Synovial fluid |
| 79611-0 | Prolylhydroxyproline/Creatinine [Molar ratio] in Urine |
| 9589-3 | Borrelia burgdorferi 23kD IgG Ab [Presence] in Serum by Immunoblot |
| 6793-4 | Prealbumin [Mass/volume] in Serum or Plasma by Immunoassay |
| 80711-5 | CD38+HLA-DR+ cells/100 CD3+CD4+ cells in Blood |
| 9670-1 | Plasmodium malariae IgG Ab [Units/volume] in Serum |
| 70061-7 | Human papilloma virus 16 and 18 DNA [Presence] in Specimen by NAA with probe detection |
| 8172-9 | Cannabinoids [Presence] in Serum or Plasma by Screen method |
| 8224-8 | Opiates [Presence] in Unknown substance |
| 98095-3 | Cells.FOXP3 Ag/100 cells in Blood |
| 9826-9 | Treponema pallidum Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 72440-1 | 3-Methylglutaconate [Moles/volume] in Cerebral spinal fluid |
| 99538-1 | Stenosis degree [Length fraction] in Proximal left anterior descending artery by Autopsy |
| 99917-7 | Cocci bacteria [#/volume] in Urine sediment by Automated count |
| 72756-0 | ALPRAZolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 73027-5 | Enalapril induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73080-4 | Voriconazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87590-6 | Tetracycline [Mass/mass] in Specimen |
| 87661-5 | Endosulfan I [Mass/mass] in Specimen |
| 88257-1 | Enterococcus faecium hsp60 gene [Presence] by Probe in Positive blood culture |
| 88378-5 | Gamithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 59616-3 | Benzoylecgonine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 30995-5 | Timothy recombinant (rPhl p) 2 IgE Ab [Units/volume] in Serum |
| 42511-6 | IgD [Mass/volume] in Cerebral spinal fluid |
| 21365-2 | Leptin [Mass/volume] in Serum or Plasma |
| 21417-1 | Neurokinin A [Units/volume] in Serum or Plasma |
| 21461-9 | Lodgepole Pine+Pondersosa Pine IgE Ab [Units/volume] in Serum |
| 31593-7 | Rickettsia (Proteus OX19) Ab [Units/volume] in Serum |
| 42969-6 | Rickettsia rickettsii IgM Ab [Presence] in Serum |
| 22248-9 | Cytomegalovirus IgM Ab [Titer] in Cerebral spinal fluid |
| 31811-3 | Entamoeba histolytica Ag [Units/volume] in Stool |
| 51466-1 | Parainfluenza virus 1+2+3 Ab [Titer] in Serum |
| 51859-7 | Pigeon serum proteins+feathers+droppings IgG Ab [Presence] in Serum |
| 44027-1 | Aspergillus fumigatus B Ab [Presence] in Serum by Immune diffusion (ID) |
| 44051-1 | Adenylate kinase [Enzymatic activity/mass] in Red Blood Cells |
| 22860-1 | Bacillus anthracis Ab [Presence] in Serum |
| 22879-1 | Border disease virus Ag [Presence] in Specimen by Immunofluorescence |
| 22895-7 | Bovine diarrhea virus Ab [Presence] in Serum |
| 32738-7 | Beta 1 globulin [Mass/volume] in Body fluid by Electrophoresis |
| 53293-7 | Urinalysis microscopic panel [#/area] - Urine sediment by Automated count |
| 44656-7 | Number of tissue chips CAP cancer protocols |
| 33267-6 | Aspergillus sp IgG Ab [Presence] in Urine |
| 45032-0 | Tyrosine [Mass/volume] in DBS |
| 2393-7 | Glycine [Mass/time] in 24 hour Urine |
| 46136-8 | Transitional cells [#/area] in Urine sediment by Microscopy low power field |
| 2447-1 | Hydroxyproline [Mass/time] in 24 hour Urine |
| 25259-3 | Ketoconazole [Mass/volume] in Specimen |
| 55829-6 | Catalase [Enzymatic activity/mass] in Tissue |
| 55840-3 | Cholesterol esters [Moles/volume] in Serum or Plasma |
| 47753-9 | Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
| 47894-1 | Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose growth hormone releasing factor |
| 25563-8 | Angiotensin II [Moles/volume] in Plasma --upright |
| 25667-7 | Glucose [Mass/volume] in Urine --2 hours post dose glucose |
| 26005-9 | Xylose [Moles/volume] in Serum or Plasma --2 hours post dose xylose PO |
| 56424-5 | Whitefaced Hornet IgG4 Ab [Mass/volume] in Serum |
| 47968-3 | PINK1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 48088-9 | 3-Hydroxytetradecenedioate/Creatinine [Molar ratio] in Urine |
| 48094-7 | Corticotropin [Mass/volume] in Plasma --4 AM specimen |
| 48123-4 | Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose arginine+insulin |
| 26560-3 | CD16 cells/100 cells in Specimen |
| 57288-3 | Chlamydia trachomatis rRNA [Presence] in Nasopharynx by NAA with probe detection |
| 57386-5 | Urate [Mass/volume] in 2 hour Urine |
| 28001-6 | Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 5773-7 | Calcium carbonate crystals [Presence] in Urine sediment by Light microscopy |
| 49525-9 | Influenza virus A H5 Ab [Presence] in Serum |
| 49699-2 | pH of Venous cord blood adjusted to patient's actual temperature |
| 58664-4 | Cortisol [Moles/volume] in Serum or Plasma --30 minutes pre 1 ug/kg CRH IV |
| 40440-0 | XXX microorganism serotype [Identifier] in Isolate by Agglutination |
| 58862-4 | Somatotropin [Mass/volume] in Serum or Plasma --46th specimen |
| 59286-5 | Benzylpiperazine [Mass/volume] in Serum or Plasma |
| 50347-4 | Parvovirus B19 DNA [Presence] in Bone marrow by NAA with probe detection |
| 50525-5 | Parathyrin.intact [Mass/volume] in Serum or Plasma --1st specimen |
| 41030-8 | Listeria monocytogenes O4b Ab [Titer] in Serum |
| 20763-9 | Clostridium novyii Ag [Presence] in Tissue by Immunofluorescence |
| 100132-0 | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot |
| 12588-0 | Creatinine [Mass/time] in 8 hour Urine |
| 12733-2 | Tryptase [Enzymatic activity/volume] in Serum or Plasma |
| 12882-7 | Borrelia burgdorferi 29kD Ab [Presence] in Body fluid by Immunoblot |
| 101504-9 | Tetracycline [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 13006-2 | 1,4-Dichlorobenzene [Mass/volume] in Serum or Plasma |
| 13129-2 | Pancreatic oncofetal Ag [Units/volume] in Serum or Plasma |
| 13398-3 | Histidine [Mass/volume] in Amniotic fluid |
| 13437-9 | DOPamine [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 101754-0 | Trichophyton tonsurans DNA [Presence] in Specimen by NAA with probe detection |
| 101798-7 | 8-Aminoclonazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 1355-7 | 11-Deoxycorticosteroids [Mass/volume] in Plasma --pre 3 g metyraPONE PO overnight |
| 1415-9 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 1 ug/kg CRH IV |
| 14213-3 | Herpes simplex virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 14355-2 | Microscopic observation [Identifier] in Cervix by KOH preparation |
| 102743-2 | Garlic IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102762-2 | Lettuce IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103082-4 | Kiwi native (nAct d) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103112-9 | Inhalant Allergen Mix 7 (Dermatophagoides pteronyssinus+Cat dander+Cat epithelium+Horse dander+Dog dander+Rabbit epithelium) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1449-8 | Cortisol [Mass/volume] in Serum or Plasma --pre 8 mg dexamethasone PO overnight high dose |
| 103575-7 | Cat epithelium IgE panel - Serum or Plasma |
| 103733-2 | Hereditary emery dreifuss multigene analysis in Blood or Tissue by Molecular genetics method |
| 104200-1 | CRLF2 gene rearrangements in Blood or Marrow by FISH |
| 104237-3 | Zopiclone [Mass/volume] in Urine by Confirmatory method |
| 15185-2 | IgM [Mass/volume] in Body fluid |
| 104301-7 | UGT1A9 gene.c.-2152C>T [Presence] in Blood or Tissue by Molecular genetics method |
| 10504-9 | Myelin basic protein Ag [Presence] in Tissue by Immune stain |
| 1585-9 | Lactose [Mass/volume] in Serum or Plasma --pre 12 hour fast |
| 10752-4 | Fat.microscopic observation [Identifier] in Milk by Sudan IV stain |
| 10758-1 | Iron.microscopic observation [Identifier] in Bone by Histomorphometry stain |
| 109-9 | Cefotaxime [Susceptibility] by Disk diffusion (KB) |
| 16527-4 | Calcium/Sodium [Mass Ratio] in Serum or Plasma |
| 17084-5 | Lipoprotein.pre-beta [Mass/volume] in Body fluid |
| 17452-4 | Phosphatidylglycerol IgG Ab [Presence] in Serum |
| 17775-8 | Yersinia sp IgA Ab [Units/volume] in Serum |
| 1805-1 | Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma |
| 18880-5 | Cefixime [Susceptibility] |
| 18907-6 | Clarithromycin [Susceptibility] |
| 92717-8 | Lipoprotein.beta.subparticle.large-a [Moles/volume] in Serum |
| 7657-0 | Raspberry IgG Ab [Units/volume] in Serum |
| 92832-5 | Sentinel lymph nodes with metastasis [#] in Cancer specimen |
| 61266-3 | Strawberry IgE Ab/IgE total in Serum |
| 77355-6 | Non-hematopoietic stem cells/100 leukocytes in Body fluid by Manual count |
| 9398-9 | Reticulin Ab [Titer] in Serum |
| 63305-7 | PCNA extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
| 78009-8 | HIV 1 proviral DNA [Entitic number] (viral load) in Blood mononuclear cells by NAA with probe detection |
| 78514-7 | Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Specimen by Latex agglutination |
| 9468-0 | Chloramines [Mass/volume] in Water |
| 9470-6 | Copper [Mass/volume] in Water |
| 7913-7 | Herpes simplex virus 2 IgM Ab [Units/volume] in Serum |
| 65632-2 | cloZAPine and Norclozapine panel - Serum or Plasma |
| 80142-3 | Atazanavir [Mass/volume] in Cerebral spinal fluid by Confirmatory method |
| 673-4 | Ova and parasites identified in Specimen by Light microscopy |
| 8069-7 | Epidermis Ab [Titer] in Serum |
| 9654-5 | Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma |
| 9680-0 | CD16+CD57+ cells/100 cells in Blood |
| 97760-3 | MLH1 gene methylation analysis in Blood by Molecular genetics method |
| 82444-1 | Glial nuclear type 1 Ab [Presence] in Serum by Line blot |
| 82591-9 | Reticulocytes.low light scatter/Reticulocytes.total in Blood by Automated count |
| 83054-7 | PD-L1 by clone 22C3 [Interpretation] in Tissue by Immune stain Narrative |
| 85316-8 | Extent of superior margin carcinoma involvement in Breast cancer specimen Qualitative by Light microscopy |
| 72654-7 | SNRPN gene 15q11 deletion and duplication mutation analysis [Identifier] in Blood or Tissue by FISH Nominal |
| 73042-4 | cefTRIAXone induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73978-9 | von Willebrand factor (vWf).activity [Units/volume] in Platelet poor plasma by Immunoassay |
| 74443-3 | Sucrose/Creatinine [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO |
| 89302-4 | Noroxymorphone [Presence] in Urine by Screen method |
| 41738-6 | Rosamicin [Susceptibility] |
| 594-2 | Leptospira sp identified in Specimen by Organism specific culture |
| 59569-4 | Calcitonin [Moles/volume] in Serum or Plasma --post XXX challenge |
| 59628-8 | cloBAZam [Mass/volume] in Body fluid |
| 4261-4 | Fluoxymesterone [Mass] of Dose |
| 51272-3 | CD25+CD19+ cells/100 cells in Cerebral spinal fluid |
| 42973-8 | Powassan virus IgG Ab [Titer] in Specimen |
| 43123-9 | Imipramine and Desipramine panel - Serum or Plasma |
| 51657-5 | Hepatitis C virus Ab [Presence] in Body fluid |
| 51797-9 | CV2 Ab [Units/volume] in Serum or Plasma |
| 51800-1 | Homogentisate [Mass/volume] in 24 hour Urine |
| 43326-8 | Classical swine fever virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 43332-6 | Equine herpesvirus 1 neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test |
| 43823-4 | Aspergillus glaucus Ab [Presence] in Serum by Immune diffusion (ID) |
| 44403-4 | Serine/Creatinine [Mass Ratio] in 24 hour Urine |
| 23032-6 | Duck enteritis virus Ag [Presence] in Specimen by Agglutination |
| 33008-4 | Neuronal nuclear type 2 Ab [Presence] in Serum by Immunoblot |
| 4460-2 | Verapamil [Mass] of Dose |
| 23296-7 | Mycoplasma putrefaciens Ab [Presence] in Serum |
| 33375-7 | Chylomicrons [Presence] in Pleural fluid |
| 44887-8 | Malignant cells [#/volume] in Peritoneal fluid by Manual count |
| 45356-3 | Time Rh immune globulin given |
| 23656-2 | Ammonia [Mass/volume] in Specimen |
| 23690-1 | Canine distemper virus Ab [Titer] in Serum |
| 54156-5 | RNA polymerase I Ab [Presence] in Serum by Immunofluorescence |
| 46968-4 | CD122 cells [#/volume] in Blood |
| 34439-0 | Natural killer cell function [Units/volume] in Blood |
| 54938-6 | Ethyl benzene [Mass/volume] in Serum or Plasma |
| 55602-7 | Microscopic observation [Identifier] in Pleural fluid by Cyto stain |
| 47130-0 | Thallium [Moles/volume] in Red Blood Cells |
| 3498-3 | Clorazepate [Mass/volume] in Serum or Plasma |
| 47771-1 | Somatotropin [Units/volume] in Serum or Plasma --3 hours post dose glucose PO |
| 56336-1 | Olive Pollen IgG4 Ab [Mass/volume] in Serum |
| 5634-1 | Cyanide [Mass/volume] in Blood |
| 47988-1 | Progesterone [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 56632-3 | Mitochondria M2 IgG Ab [Titer] in Serum by Immunofluorescence |
| 56720-6 | Ma+Ta Ab [Presence] in Serum by Immunoblot |
| 5682-0 | Manganese [Mass/volume] in Red Blood Cells |
| 56949-1 | Insulin [Units/volume] in Serum or Plasma --40 hours post XXX challenge |
| 56968-1 | Plasmodium sp Ab [Presence] in Serum by Immunofluorescence |
| 48363-6 | Morphine-6-Glucuronide [Moles/volume] in Serum or Plasma |
| 48792-6 | Necroinflammatory activity score |
| 48833-8 | Respiratory allergen panel, US - Southwestern grassland states - Serum |
| 26927-4 | Herpes simplex virus 2 IgM Ab [Titer] in Serum by Immunofluorescence |
| 26971-2 | Smooth muscle Ab [Presence] in Serum by Immunofluorescence |
| 57295-8 | HLA-DRB4 [Type] by High resolution |
| 38894-2 | CD158 cells [#/volume] in Specimen |
| 39573-1 | West Nile virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 49486-4 | Alphapinene [Presence] in Blood |
| 40303-0 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose arginine |
| 58559-6 | Corticotropin [Moles/volume] in Plasma --1 hour post XXX challenge |
| 58715-4 | Adulterants panel - Urine |
| 49843-6 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with 1:4 normal plasma |
| 29587-3 | Toxicology panel - Blood |
| 4046-9 | Tetrahydrocortisone [Mass/volume] in Urine |
| 40675-1 | Toxocara canis IgM Ab [Presence] in Serum by Immunoassay |
| 58987-9 | ITGB3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 30051-7 | Homocystine/Creatinine [Ratio] in Urine |
| 30097-0 | Neisseria meningitidis serogroup w135 Ag [Presence] in Specimen by Latex agglutination |
| 40825-2 | Candida sp IgG Ab [Titer] in Serum |
| 41009-2 | Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection |
| 20557-5 | Phentermine [Mass/volume] in Urine by Confirmatory method |
| 20655-7 | Proline [Moles/volume] in Serum or Plasma |
| 20737-3 | Cadmium [Mass/mass] in Tissue |
| 101099-0 | Km Ab [Presence] in Serum or Plasma |
| 101178-2 | Pneumocystis jiroveci DNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection |
| 13651-5 | 1,4-Dimethylbenzene [Mass/volume] in Blood |
| 102364-7 | Setomelanomma rostrata IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102631-9 | Tomato IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14020-2 | HTLV I+II p19 Ab [Presence] in Serum or Plasma by Immunoblot |
| 102713-5 | Chicken meat IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102835-6 | Trout IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14477-4 | Bacteria identified in Urethra by Aerobe culture |
| 1095-9 | K Ag [Presence] on Red Blood Cells from Donor |
| 11090-8 | Smith extractable nuclear Ab [Units/volume] in Serum |
| 16276-8 | Bartonella henselae DNA [Presence] in Blood by NAA with probe detection |
| 1146-0 | Lu sup(b) Ag [Presence] on Red Blood Cells from Donor |
| 17737-8 | Trichloroethane [Mass/volume] in Urine |
| 17965-5 | Bacteria # 3 identified in Stool by Culture |
| 90330-2 | Porcine parainfluenza virus 1 RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 74582-8 | Fatty acids.very long chain C26:0 (Hexacosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Fibroblast |
| 75393-9 | HTT gene CAG repeats [Presence] in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
| 61162-4 | Hepatitis B virus codon N236T [Presence] by Genotype method |
| 93407-5 | Gram negative blood culture panel by NAA with probe detection in Positive blood culture |
| 61285-3 | Bass, Black IgE Ab/IgE total in Serum |
| 61306-7 | Cherry IgE Ab/IgE total in Serum |
| 77038-8 | t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript in Blood or Tissue by FISH |
| 77656-7 | Diploid cells in S phase/100 cells in Cells.XXX by Flow cytometry (FC) |
| 7767-7 | Walnut IgG Ab [Units/volume] in Serum |
| 9453-2 | Histidine [Moles/volume] in Cerebral spinal fluid |
| 94541-0 | Mycobacterial identification panel - Specimen by Molecular genetics method |
| 94734-1 | Prostate cancer grade group [Score] in Prostate tumor Qualitative |
| 64082-1 | Bilirubin.indirect [Mass/volume] in Cord blood |
| 7904-6 | Hepatitis A virus RNA [Presence] in Serum by NAA with probe detection |
| 79190-5 | Zika virus RNA [Presence] in Specimen by NAA with probe detection |
| 79503-9 | 4-Hydroxyhippurate [Moles/volume] in Serum or Plasma |
| 95949-4 | Glucan 1,4 alpha glucosidase IgE Ab [Units/volume] in Serum |
| 96830-5 | Specimen source [Identifier] from Donor |
| 97026-9 | Phosphatidylserine-prothrombin complex IgG and IgM panel - Serum or Plasma |
| 70014-6 | Parainfluenza virus 1+2+3+4 IgA Ab [Presence] in Serum by Immunoassay |
| 8197-6 | Cocaine [Presence] in Unknown substance by Screen method |
| 72391-6 | Candida tropicalis DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 99960-7 | ADAMTS13 gene full mutation analysis in Blood or Tissue by Sequencing |
| 72562-2 | Creatine kinase.MM/Creatine kinase.total [Pure catalytic fraction] in Serum or Plasma by Electrophoresis |
| 86271-4 | Transferrin.gastrointestinal [Mass/volume] in Stool by Immunoassay |
| 73291-7 | Lovastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7339-5 | Gnat whole body IgE Ab [Units/volume] in Serum |
| 73453-3 | chlorproPAMIDE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74445-8 | Porphyrin fractions panel [Moles/mass] - Stool |
| 88902-2 | Adenovirus [Presence] in Urine by Organism specific culture |
| 89968-2 | Norolanzapine [Mass/volume] in Urine by Confirmatory method |
| 41432-6 | Balamuthia mandrillaris DNA [Presence] in Specimen by NAA with probe detection |
| 41467-2 | Benzodiazepines/Creatinine [Mass Ratio] in Urine |
| 59963-9 | QUEtiapine [Moles/volume] in Urine |
| 60307-6 | hydrOXYzine [Moles/volume] in Specimen |
| 31272-8 | Bovine diarrhea virus Ab [Units/volume] in Serum |
| 51224-4 | CD105 cells/100 cells in Bone marrow |
| 42772-4 | Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Nephelometry |
| 42919-1 | Insulin [Mass/volume] in Serum or Plasma --pre 100 g glucose PO |
| 43018-1 | Histoplasma capsulatum mycelial phase Ab [Titer] in Cerebral spinal fluid |
| 51608-8 | Xylose [Moles/volume] in Blood --30 minutes post dose xylose PO |
| 43364-9 | Enterovirus identified in Specimen by Immunofluorescence |
| 43706-1 | Cytomegalovirus [Presence] in Anal by Shell vial culture |
| 22463-4 | Reagin Ab [Presence] in Serum from Donor |
| 22498-0 | Measles virus Ab [Titer] in Cerebral spinal fluid |
| 22567-2 | Streptococcus pyogenes enzyme Ab [Titer] in Serum |
| 22770-2 | African horse sickness virus Ab [Titer] in Serum |
| 32216-4 | Uroporphyrin [Mass/volume] in 24 hour Urine |
| 32255-2 | Lysine [Moles/volume] in Vitreous fluid |
| 5243-1 | Measles virus Ab [Titer] in Serum by Complement fixation |
| 53055-0 | Creatine [Moles/volume] in Amniotic fluid |
| 44352-3 | Phosphoethanolamine/Creatinine [Mass Ratio] in 24 hour Urine |
| 32840-1 | Parvovirus B19 IgM Ab [Ratio] in Serum --1st specimen/2nd specimen |
| 44498-4 | Herpes simplex virus 2 Ag [Presence] in Anal |
| 44698-9 | Lesion size additional dimension 1 in Skin |
| 44857-1 | Bacteria # 5 identified in Specimen by Anaerobe culture |
| 23371-8 | PRRSV RNA [Presence] in Semen by NAA with probe detection |
| 2355-6 | Glucose-6-Phosphatase [Enzymatic activity/mass] in Tissue |
| 53936-1 | CD3-CD56+ cells [#/volume] in Blood |
| 33819-4 | Insulin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 34155-2 | Guanidinoacetate/Creatinine [Molar ratio] in Urine |
| 54323-1 | Palmitoylcarnitine (C16)/Creatinine [Molar ratio] in Urine |
| 46-3 | Aztreonam [Susceptibility] by Serum bactericidal titer |
| 24177-8 | Coxsackievirus B1 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 34389-7 | Zinc/Creatinine [Molar ratio] in Urine |
| 34423-4 | Salmonella enteritidis H Ab [Titer] in Serum |
| 34666-8 | Carisoprodol+Meprobamate [Mass/volume] in Serum or Plasma |
| 55565-6 | Phenacetin [Moles/volume] in Serum or Plasma |
| 251-9 | Fluconazole [Susceptibility] by Serum bactericidal titer |
| 34957-1 | Eosinophils [#/volume] in Cerebral spinal fluid by Manual count |
| 35119-7 | Chloral hydrate [Presence] in Serum or Plasma |
| 35285-6 | Tissue transglutaminase IgA Ab [Presence] in Serum |
| 47877-6 | Propionyl CoA Carboxylase [Enzymatic activity/mass] in Chorionic villus sample |
| 35601-4 | chlorproMAZINE [Mass/volume] in Serum or Plasma by Screen method |
| 35785-5 | Clinafloxacin [Susceptibility] by Disk diffusion (KB) |
| 56269-4 | Goat milk IgG4 Ab [Mass/volume] in Serum |
| 48116-8 | Insulin [Units/volume] in Serum or Plasma --10 minutes pre dose glucose |
| 48299-2 | New coccine triggered leukotriene release [Mass/volume] by Leukocytes |
| 56753-7 | PML Ab [Presence] in Serum by Immunoblot |
| 56926-9 | Hepatitis C virus c1 Ab [Presence] in Serum by Immunoblot |
| 56961-6 | Nicotinamide [Mass/volume] in Serum or Plasma |
| 57094-5 | Phenol [Mass/volume] adjusted to specific gravity 1.024 in Urine |
| 48430-3 | Carnitine [Molar amount] in unspecified time Semen |
| 27068-6 | Purkinje cells Ab [Units/volume] in Serum |
| 38289-5 | 1,2-Dichlorobenzene [Mass/volume] in Water |
| 4917-1 | HLA-Dw8 [Presence] |
| 2749-0 | pH of Gastric fluid |
| 57755-1 | WAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 29153-4 | Cancer Ag 15-3 [Units/volume] in Body fluid |
| 40053-1 | Albumin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 40306-3 | Somatotropin [Mass/volume] in Serum or Plasma --3 hours post dose arginine |
| 58592-7 | Corticotropin [Mass/volume] in Plasma --30 minutes pre XXX challenge |
| 58670-1 | Cortisol [Mass/volume] in Saliva (oral fluid) --45 minutes post 1 ug/kg CRH IV |
| 5872-7 | Parainfluenza virus 3 Ag [Presence] in Throat by Immunofluorescence |
| 58801-2 | Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid |
| 50062-9 | Tetradecenedioate/Creatinine [Molar ratio] in Urine |
| 40434-3 | APTX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 4073-3 | Tricyclic antidepressants [Presence] in Serum or Plasma |
| 50201-3 | Iron [Mass/volume] in Serum or Plasma --4th specimen |
| 40974-8 | Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum |
| 12462-8 | Corticotropin [Mass/volume] in Plasma --6th specimen post XXX challenge |
| 102229-2 | Chestnut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13819-8 | Uracil/Creatinine [Mass Ratio] in Urine |
| 102242-5 | Clove IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14595-3 | Amitriptyline+Nortriptyline [Presence] in Serum or Plasma |
| 103198-8 | Staphylococcus aureus DNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 103-2 | Ceforanide [Susceptibility] by Minimum lethal concentration (MLC) |
| 103719-1 | Lassa virus RNA [Presence] in Blood by NAA with non-probe detection |
| 103725-8 | Suvorexant [Mass/volume] in Urine by LC/MS/MS |
| 104391-8 | Echinococcus sp [Identifier] in Specimen |
| 10952-0 | Swine urine proteins IgE Ab [Units/volume] in Serum |
| 12178-0 | Bacteria [Presence] in Genital specimen by Wet preparation |
| 16775-9 | Dihydrocodeine Free [Presence] in Serum or Plasma by Confirmatory method |
| 17287-4 | Monocytes/100 leukocytes in Urine by Manual count |
| 17460-7 | Phosphoserine [Presence] in Urine |
| 18876-3 | Cefamandole [Susceptibility] |
| 74619-8 | 1,1-Dimethoxyoctadecane (DMA 18:0) [Moles/mass] in Red Blood Cells |
| 92961-2 | Proteus sp DNA [NCncRange] in Sputum by NAA with non-probe detection |
| 61391-9 | Human papilloma virus 73 DNA [Presence] in Specimen by NAA with probe detection |
| 77078-4 | MTFMT gene full mutation analysis in Blood or Tissue by Sequencing |
| 7742-0 | Tomato triggered histamine release [Units/volume] in Blood |
| 7823-8 | Chlamydia sp Ab [Units/volume] in Serum |
| 94635-0 | Bovine diarrhea virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 63405-5 | Smith extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
| 63476-6 | Soybean recombinant (rGly m) 4 IgE Ab [Units/volume] in Serum |
| 6381-8 | Cytomegalovirus Ag [Presence] in Specimen by Immunofluorescence |
| 66502-6 | HBA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 96120-1 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Lower respiratory specimen by NAA with probe detection |
| 96820-6 | Arugula IgE Ab [Units/volume] in Serum |
| 97645-6 | Parainfluenza virus 1+2+3+4 RNA [Presence] in Specimen by NAA with probe detection |
| 97764-5 | Beta 1 globulin/Protein.total in 24 hour Urine by Electrophoresis |
| 98054-0 | Mouse droppings IgE Ab [Units/volume] in Serum |
| 71700-9 | Rotavirus RNA [Identifier] in Stool by NAA with probe detection |
| 7333-8 | Geotrichum candidum IgE Ab [Units/volume] in Serum |
| 87603-7 | Bacitracin zinc [Mass/mass] in Specimen |
| 73624-9 | Ceftolozane+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 88583-0 | Bordetella sp DNA [Identifier] in Nasopharynx by NAA with probe detection |
| 89310-7 | Codeine-6-glucuronide [Presence] in Urine by Screen method |
| 30501-1 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum --1st specimen |
| 3097-3 | Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma |
| 31118-3 | G2+M phase cells/100 cells in Specimen |
| 42352-5 | cefTAZidime+Clavulanate [Susceptibility] by Gradient strip |
| 21084-9 | Aspergillus flavus Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
| 511-6 | Trimethoprim [Susceptibility] by Minimum lethal concentration (MLC) |
| 4298-6 | Levorphanol [Mass] of Dose |
| 43094-2 | Angiostrongylus cantonensis Ab [Presence] in Specimen |
| 22084-8 | Anaplasma marginale Ab [Presence] in Serum |
| 31972-3 | Swine vesicular disease virus Ag [Presence] in Skin |
| 52919-8 | Tellurium/Creatinine [Molar ratio] in Urine |
| 44301-0 | Asparagine/Creatinine [Mass Ratio] in 24 hour Urine |
| 44378-8 | Homocystine/Creatinine [Mass Ratio] in 24 hour Urine |
| 32761-9 | Leukocytes [Presence] in Specimen by Wet preparation |
| 53469-3 | Kynurenate [Moles/volume] in Serum or Plasma |
| 44660-9 | Tumor involvement by ulceration by CAP cancer protocols |
| 44785-4 | Alanine aminotransferase [Enzymatic activity/volume] (Maximum value during study) in Serum or Plasma by No addition of P-5'-P |
| 53504-7 | Decanoylcarnitine (C10)/Creatinine [Molar ratio] in Urine |
| 53705-0 | Myasthenia gravis evaluation pediatric panel - Serum |
| 45060-1 | Protein and Glucose panel - Urine by Test strip |
| 23708-1 | Caprine arthritis encephalitis virus Ag [Presence] in Specimen |
| 33812-9 | Insulin [Units/volume] in Serum or Plasma --13th specimen post XXX challenge |
| 4543-5 | Haptoglobin [Mass/volume] in Serum or Plasma by Electrophoresis |
| 24111-7 | Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection |
| 24413-7 | Eperythrozoon sp [Presence] in Blood by Giemsa stain |
| 24452-5 | Carnitine free (C0) [Moles/mass] in Tissue |
| 24462-4 | Heptacarboxylporphyrin [Mass/time] in 24 hour Urine |
| 34558-7 | Cell count panel - Peritoneal fluid |
| 54916-2 | Angler IgE Ab [Units/volume] in Serum |
| 55120-0 | Centers for Environmental Health metabolic toxin panel [Mass/volume] - Urine |
| 55394-1 | Protein and Glucose panel - Cerebral spinal fluid |
| 47399-1 | ZAP70+CD19+ cells/100 cells in Blood |
| 253-5 | 5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 25447-4 | Insulin Free [Moles/volume] in Serum or Plasma |
| 55925-2 | IgM [Mass/volume] in Serum by Electrophoresis |
| 47548-3 | Adenosine deaminase [Enzymatic activity/mass] in Fibroblast |
| 35477-9 | Ciliated columnar lining cells/100 leukocytes [# Ratio] in Body fluid |
| 35806-9 | Fleroxacin [Susceptibility] by Disk diffusion (KB) |
| 3646-7 | Fluoxymesterone [Presence] in Urine |
| 3666-5 | Glutethimide [Mass/volume] in Serum or Plasma |
| 26859-9 | Phencyclidine [Mass/mass] in Meconium |
| 26877-1 | Hydroxytriazolam [Mass/mass] in Hair |
| 26933-2 | Oxazepam [Mass/mass] in Meconium |
| 38292-9 | 1,1-Dichloroethylene [Mass/volume] in Water |
| 38422-2 | C peptide [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
| 49028-4 | Microdeletion syndromes [Identifier] in Blood or Tissue by FISH Nominal |
| 57885-6 | Honeydew melon triggered histamine release [Units/volume] in Blood |
| 49335-3 | Adenovirus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
| 49556-4 | p16INK4a Ag [Presence] in Tissue by Immune stain |
| 2843-1 | Proline [Mass/volume] in Cerebral spinal fluid |
| 2869-6 | Alpha 2 globulin [Mass/volume] in Synovial fluid by Electrophoresis |
| 40000-2 | Glucose [Mass/volume] in Serum or Plasma --5 minutes pre XXX challenge |
| 58771-7 | Bactericidal permeability increasing protein Ab [Units/volume] in Serum |
| 4984-1 | HLA-DR5 [Presence] in Donor |
| 50032-2 | China aster IgE Ab [Units/volume] in Serum |
| 2960-3 | Somatostatin [Presence] in Plasma |
| 50198-1 | Iron [Mass/volume] in Serum or Plasma --1st specimen |
| 30286-9 | Stavudine [Susceptibility] by Genotype method |
| 30376-8 | Blasts [#/volume] in Blood |
| 40994-6 | CPEO syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19200-5 | Prostate specific Ag [Moles/volume] in Semen |
| 19270-8 | Barbiturates [Presence] in Urine by Screen method |
| 19757-4 | Sheep whey IgE Ab [Units/volume] in Serum |
| 20497-4 | Histoplasma capsulatum mycelial phase Ab [Units/volume] in Serum by Complement fixation |
| 101093-3 | Hut Ab [Presence] in Serum or Plasma |
| 12840-5 | Prostaglandin F2 alpha [Moles/volume] in Urine |
| 101341-6 | BK virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection |
| 1314-4 | Rh immune globulin screen [interpretation] |
| 13257-1 | Leishmania donovani IgM Ab [Units/volume] in Serum |
| 13325-6 | Bartonella sp identified in Blood by Light microscopy |
| 13327-2 | Parainfluenza virus Ag [Presence] in Specimen by Immunofluorescence |
| 101955-3 | DNAI1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 102505-5 | Penicillium frequentans IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102635-0 | Trichophyton rubrum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14628-2 | Bile acid [Moles/volume] in Serum or Plasma |
| 104284-5 | DPYD gene.c.1679T>G [Presence] in Blood or Tissue by Molecular genetics method |
| 10486-9 | Hemoglobin Ag [Presence] in Tissue by Immune stain |
| 15345-2 | Aldosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 16121-6 | Colorado tick fever virus IgG Ab [Titer] in Serum |
| 11035-3 | Adenylate kinase [Enzymatic activity/volume] in Red Blood Cells |
| 16405-3 | Arylamidase [Presence] in Urine |
| 12331-5 | Phenethylamine [Presence] in Urine |
| 17288-2 | Ganglioside GM1 Ab [Presence] in Serum by Immunofluorescence |
| 17583-6 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 17705-5 | Thyroglobulin IgM Ab [Units/volume] in Serum |
| 17853-3 | Ganglioside GM1b IgG Ab [Titer] in Serum |
| 18944-9 | Methacycline [Susceptibility] |
| 90357-5 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Nasopharynx by NAA with probe detection |
| 74962-2 | Maprotiline [Mass/volume] in Serum or Plasma --trough |
| 74973-9 | carBAMazepine [Mass/volume] in Serum or Plasma --trough |
| 60421-5 | Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum |
| 6148-1 | Insulin human IgE Ab [Units/volume] in Serum |
| 77389-5 | Respiratory syncytial virus Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
| 63044-2 | Cotinine [Presence] in Saliva (oral fluid) by Screen method |
| 7843-6 | Cryptococcus sp Ab [Presence] in Serum |
| 78792-9 | Anakinra [Mass/volume] in Serum or Plasma |
| 95584-9 | 11-Hydroxyandrosterone [Z-score] in 24 hour Urine |
| 79718-3 | UGT1A1 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
| 9617-2 | Chylomicrons [Mass/volume] in Pleural fluid |
| 68371-4 | Nuclear Ab [Presence] in Peritoneal fluid by Immunofluorescence |
| 690-8 | Neisseria gonorrhoeae [Presence] in Endometrium by Organism specific culture |
| 80708-1 | CD27-CD45RA- cells/100 CD3+CD4+ cells in Blood |
| 81322-0 | Glucan 1,4 alpha glucosidase [Enzymatic activity/mass] in Small intestine Tissue |
| 96735-6 | Lipoprotein.beta.subparticle.medium [Moles/volume] in Serum |
| 69359-8 | Amylase [Enzymatic activity/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 69581-7 | National (USA) PFGE cluster code or CDC cluster [Identifier] in Isolate |
| 82109-0 | Regional Allergen Mix 4 (Bermuda grass+Perennial rye grass+Brome+Common ragweed+Mugwort+English plantain) IgE Ab [Units/volume] in Serum by Multidisk |
| 97236-4 | Codeine Free [Presence] in Cord tissue by Screen method |
| 97307-3 | traMADol [Presence] in Cord tissue by Confirmatory method |
| 9760-0 | Coxsackievirus B2 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 7078-9 | Ampicillin IgM Ab [Units/volume] in Serum |
| 85332-5 | Radial position in breast [Angle] in Breast cancer specimen |
| 86327-4 | Bordetella parapertussis IS1001 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 87571-6 | Fumonisin B3 [Mass/mass] in Specimen |
| 88335-5 | Predominant leukocyte identified [Type] in Ear by Light microscopy |
| 50985-1 | Horowitz index in Mixed venous blood |
| 51021-4 | CD10 blasts [Units/volume] in Specimen |
| 4247-3 | Ethylmorphine [Mass] of Dose |
| 60139-3 | Pemoline [Mass/volume] in Blood |
| 60206-0 | Tripelennamine [Mass/volume] in Blood |
| 60306-8 | fluvoxaMINE [Moles/volume] in Specimen |
| 21262-1 | Escherichia coli shiga-like toxin [Presence] in Stool by Immunoassay |
| 21335-5 | HIV 2 gp120 Ab [Presence] in Serum by Immunoblot |
| 31189-4 | Microscopic observation [Identifier] in Neck mass fine needle aspirate by Cyto stain |
| 31191-0 | Microscopic observation [Identifier] in Prostate fine needle aspirate by Cyto stain |
| 31336-1 | Cryptostroma corticale Ab [Presence] in Serum |
| 42966-2 | Saint Louis encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid |
| 43025-6 | Herpes virus 6 IgM Ab [Titer] in Cerebral spinal fluid |
| 22196-0 | Chlamydia trachomatis B IgM Ab [Titer] in Serum |
| 32044-0 | Volatiles and gases [Identifier] in Serum or Plasma |
| 32181-0 | Herpes simplex virus 2 Ab [Units/volume] in Synovial fluid |
| 32339-4 | Serotonin [Moles/time] in 24 hour Urine |
| 52976-8 | Cytomegalovirus Ab [Units/volume] in Serum by Complement fixation |
| 32631-4 | Nitroblue Tetrazolium Test (NBT) [Presence] in Blood |
| 33498-7 | Methane/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose lactose PO |
| 33670-1 | Platelet aggregation collagen induced lag [Time] in Platelet rich plasma --High dose |
| 45225-0 | Pancreatic islet cell complement fixing Ab [Titer] in Serum by Immunofluorescence |
| 45333-2 | Superoxide dismutase [Enzymatic activity/volume] in Blood |
| 24039-0 | Taenia solium larva IgG band pattern [Interpretation] in Serum by Immunoblot |
| 54427-0 | Transfuse frozen erythrocytes newborn units [Volume] |
| 34337-6 | Mercury [Moles/volume] in 24 hour Urine |
| 34464-8 | B Ab [Titer] in Serum or Plasma by Antihuman globulin |
| 55116-8 | Centers for Environmental Health volatile organic compounds panel [Mass/volume] - Serum or Plasma |
| 55774-4 | Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells |
| 47647-3 | Histidine/Amino acids.total in Serum or Plasma |
| 3552-7 | diazePAM [Mass/volume] in Serum or Plasma --trough |
| 56228-0 | Codfish IgG4 Ab [Mass/volume] in Serum |
| 48034-3 | Leukocytes [#/volume] corrected for nucleated erythrocytes in Cerebral spinal fluid |
| 4809-0 | HLA-B14 [Presence] |
| 48278-6 | Mefenamate triggered leukotriene release [Mass/volume] by Leukocytes |
| 3602-0 | Etamivan [Presence] in Urine |
| 3701-0 | Ketamine [Mass/volume] in Serum or Plasma |
| 3797-8 | Methotrexate [Mass/volume] in Serum or Plasma --72 hours post dose |
| 57021-8 | CBC W Auto Differential panel - Blood |
| 4846-2 | HLA-Cw10(w3) [Presence] in Donor |
| 27216-1 | sulfADIAZINE [Mass/volume] in Urine |
| 38330-7 | Toxaphene [Mass/volume] in Water |
| 57534-0 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge |
| 57669-4 | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 274-1 | Hetacillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 27421-7 | C peptide [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 2767-2 | Phenylalanine [Mass/time] in 24 hour Urine |
| 27836-6 | Somatotropin [Mass/volume] in Serum or Plasma --12th specimen post XXX challenge |
| 3869-5 | Normeperidine [Mass/volume] in Urine |
| 57688-4 | Cortisol [Mass/volume] in Saliva (oral fluid) --3rd specimen |
| 58081-1 | Vel Ab [Presence] in Serum or Plasma |
| 49399-9 | Herpes virus 7 DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 49638-0 | HTT gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 4002-2 | Protriptyline [Mass/volume] in Serum or Plasma --trough |
| 29535-2 | West Nile virus IgG Ab [Units/volume] in Serum |
| 29727-5 | Leptospira interrogans sv Djasiman Ab [Presence] in Serum by Agglutination |
| 2984-3 | Testosterone [Mass/volume] in Saliva (oral fluid) |
| 59276-6 | Calcium hydrogen phosphate dihydrate crystals [Presence] in Stone by X-ray diffraction |
| 30146-5 | Mumps virus Ab [Presence] in Serum --2nd specimen |
| 19700-4 | Temazepam cutoff [Mass/volume] in Urine for Screen method |
| 1996-8 | Calcium [Moles/volume] in Blood |
| 20565-8 | Carbon dioxide, total [Moles/volume] in Blood |
| 2079-2 | Chloride [Moles/time] in 24 hour Urine |
| 21024-5 | Pathologist interpretation of Cerebral spinal fluid tests |
| 100743-4 | Lipase.macromolecular [Presence] in Serum or Plasma |
| 1258-3 | N Ab [Presence] in Serum or Plasma |
| 14-1 | Amikacin [Susceptibility] by Serum bactericidal titer |
| 102971-9 | Hazelnut IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14559-9 | Mycobacterium tuberculosis DNA [Presence] in Pleural fluid by NAA with probe detection |
| 103120-2 | Hazelnut recombinant (rCor a) 14 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103188-9 | Morganella morganii DNA [Presence] in Wound by NAA with probe detection |
| 103687-0 | Coccidioides sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 104168-0 | TCL-1A gene rearrangements in Bone marrow by FISH |
| 14994-8 | O group [Presence] on Red Blood Cells |
| 15026-8 | Androstanediol [Moles/volume] in Serum or Plasma |
| 15091-2 | Pregnanediol [Moles/volume] in Urine |
| 1601-4 | Norepinephrine [Mass/volume] in Plasma --supine |
| 16768-4 | Dichlorvos [Mass/volume] in Urine |
| 16972-2 | Histoplasma capsulatum IgE Ab [Presence] in Serum by Immune diffusion (ID) |
| 17573-7 | Secobarbital [Mass/volume] in Gastric fluid |
| 18349-1 | CD8+CD25+ cells [#/volume] in Blood |
| 75736-9 | Lysophosphatidylcholine(16:0) [Moles/volume] in Plasma |
| 76487-8 | IgA [Moles/volume] in Serum or Plasma |
| 7658-8 | Raspberry triggered histamine release [Units/volume] in Blood |
| 93191-5 | HTR2C gene c.-759C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 93335-8 | Glycochenodeoxycholate [Moles/volume] in Serum or Plasma |
| 61245-7 | Cinnamon IgE Ab/IgE total in Serum |
| 6147-3 | Insulin bovine IgE Ab [Units/volume] in Serum |
| 77167-5 | cycloSPORINE [Mass/volume] in Blood --3 hours post dose |
| 9385-6 | Levodopa [Mass/volume] in Serum or Plasma |
| 6247-1 | Silk IgE Ab [Units/volume] in Serum |
| 78365-4 | Imipramine trough, Imipramine+desimipramine trough and Desipramine panell - Serum or Plasma |
| 79329-9 | Trimethyllysine [Moles/volume] in Cerebral spinal fluid |
| 66757-6 | Clot lysis estimate [Percentile] by Thromboelastography |
| 79606-0 | Cysteate [Moles/volume] in Serum or Plasma |
| 8018-4 | Schistosoma japonicum Ab [Units/volume] in Serum |
| 95807-4 | Chylomicrons [Presence] in Urine |
| 8131-5 | CD5+CD19+ cells/100 cells in Blood |
| 81696-7 | Microsatellite instability markers assessed [#] in Cancer specimen |
| 82139-7 | LRRK2 gene Arg1441Gly and Gly2019Ser targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 82240-3 | Chromosome region 16p13.3 deletion in Amniotic fluid or Chorionic villus sample by FISH |
| 9807-9 | Chlordane [Mass/volume] in Serum or Plasma |
| 85342-4 | Lymph node site of origin [Anatomy] in Cancer specimen |
| 99262-8 | Designer benzodiazepines [Presence] in Urine by Confirmatory method |
| 87357-0 | Actinobacillus pleuropneumoniae serotype 2 Ab/Positive control in Serum by Immunoassay |
| 73753-6 | oxyCODONE [Presence] in Hair |
| 88223-3 | Francisella sp DNA [Presence] in Aspirate by NAA with probe detection |
| 74297-3 | Isobutyryl-CoA dehydrogenase deficiency newborn screen interpretation |
| 59471-3 | Calcium.ionized [Mass/volume] in Venous blood |
| 50929-9 | Uranium [Moles/mass] in Hair |
| 21066-6 | Ampicillin [Mass/volume] in Specimen |
| 21176-3 | Cerebroventricular lining cells [Presence] in Cerebral spinal fluid by Light microscopy |
| 31223-1 | Arbovirus NOS Ab [Units/volume] in Serum |
| 51194-9 | Cobalt [Mass/volume] in Body fluid |
| 31781-8 | Classical swine fever virus Ag [Presence] in Specimen |
| 31971-5 | Streptococcus pyogenes Ag [Presence] in Specimen |
| 51510-6 | Lactate dehydrogenase 1/Lactate dehydrogenase.total in Cerebral spinal fluid by Electrophoresis |
| 22729-8 | Valine [Moles/volume] in Specimen |
| 52927-1 | Molybdenum/Creatinine [Molar ratio] in 24 hour Urine |
| 52936-2 | Beryllium/Creatinine [Molar ratio] in 24 hour Urine |
| 2295-4 | Fructose [Mass/volume] in Semen |
| 53067-5 | Argininosuccinate [Moles/volume] in Body fluid |
| 44454-7 | Borrelia burgdorferi Ab [Units/volume] in Synovial fluid |
| 44701-1 | BHD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 23648-9 | Actinobacillus pleuropneumoniae Ab [Titer] in Serum |
| 33632-1 | Cytomegalovirus UL54+UL97 gene mutations detected [Identifier] |
| 53914-8 | Microscopic observation [Identifier] in Endometrium by Rhodamine-auramine fluorochrome stain |
| 44925-6 | Prolactin [Units/volume] in Serum or Plasma --1 hour post dose TRH IV |
| 45195-5 | Cow epithelium+Cow dander IgE Ab [Units/volume] in Serum |
| 23954-1 | Bartonella henselae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 46756-3 | Other fatty acid oxidation disorders newborn screen interpretation |
| 25295-7 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Units/volume] in Serum |
| 3530-3 | Tetrahydrocannabinol [Mass/volume] in Urine |
| 55887-4 | 3-Hydroxyanthranilate [Moles/volume] in Serum or Plasma |
| 47546-7 | 5-Hydroxytryptophan [Moles/volume] in Cerebral spinal fluid |
| 47728-1 | Procollagen type III/Creatinine [Ratio] in Urine |
| 35372-2 | GBA gene p.Leu444Pro [Presence] in Blood or Tissue by Molecular genetics method |
| 35669-1 | Amikacin [Mass/volume] in Serum or Plasma |
| 35688-1 | GBA gene c.1448T>G and 1448T>C [Presence] in Blood or Tissue by Molecular genetics method |
| 56164-7 | CYP2C9 gene allele 2 [Identifier] in Blood by Molecular genetics method Nominal |
| 26746-8 | Magnesium [Mass/volume] in Red Blood Cells |
| 5689-5 | Mercury [Mass/volume] in Urine |
| 26964-7 | Cystathionine [Moles/volume] in Urine |
| 38582-3 | 2,4-Dichlorophenoxyacetate [Mass/volume] in Air |
| 49021-9 | Respiratory allergen panel, US - Greater Ohio valley c - Serum |
| 27440-7 | Candida sp Ag [Units/volume] in Serum or Plasma by Immunoassay |
| 3919-8 | Pentazocine [Mass/time] in 24 hour Urine |
| 49378-3 | Hepatitis C virus RNA [Units/volume] (viral load) in Bone marrow by NAA with probe detection |
| 50044-7 | Glomerular filtration rate/1.73 sq M.predicted among females [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) |
| 59182-6 | C reactive protein [Mass/volume] in Cerebral spinal fluid by High sensitivity method |
| 30062-4 | Arginine/Creatinine [Ratio] in Urine |
| 3027-0 | Thyroxine (T4)/Thyroxine binding globulin [Mass Ratio] in Serum or Plasma |
| 30388-3 | Erythrocytes [#/volume] in Pericardial fluid |
| 19411-8 | Codeine [Presence] in Urine by Screen method |
| 19548-7 | Mesoridazine cutoff [Mass/volume] in Urine for Screen method |
| 20699-5 | Bluetongue virus Ab [Presence] in Serum by Complement fixation |
| 20876-9 | Mercury [Mass/mass] in Feed |
| 100108-0 | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay |
| 12742-3 | Insulin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 101153-5 | Chemokine (C-C motif) ligand 14 [Mass/volume] in Urine by Immunoassay |
| 1313-6 | Rh immune globulin dosage.vials recommended [#] |
| 101769-8 | Trichophyton rubrum DNA [Presence] in Specimen by NAA with probe detection |
| 13474-2 | Magnesium/Creatinine [Mass Ratio] in Urine |
| 102730-9 | Cumin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14410-5 | Aspartate aminotransferase [Enzymatic activity/volume] in Peritoneal fluid |
| 104233-2 | Norcocaine [Mass/volume] in Urine by Confirmatory method |
| 14853-6 | Norepinephrine [Moles/volume] in Urine |
| 10510-6 | S-100 Ag [Presence] in Tissue by Immune stain |
| 10625-2 | Spermatozoa Round Head/100 spermatozoa in Semen |
| 1620-4 | Prolactin [Mass/volume] in Serum or Plasma --pre dose TRH IV |
| 11084-1 | Reagin Ab [Titer] in Serum |
| 16258-6 | Ammonium urate crystals [Presence] in Stone by Infrared spectroscopy |
| 12204-4 | Cryoglobulin [Presence] in Serum by 4 day cold incubation |
| 1674-1 | 18-Hydroxycorticosterone [Mass/volume] in Serum or Plasma |
| 1698-0 | 8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma |
| 1815-0 | Acid alpha glucosidase [Enzymatic activity/mass] in Tissue |
| 19001-7 | Viomycin [Susceptibility] |
| 19147-8 | Referral lab test reference range |
| 74941-6 | Moclobemide [Mass/volume] in Serum or Plasma |
| 6117-6 | Red Imported Fire Ant IgE Ab [Units/volume] in Serum |
| 76031-4 | NPC1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 61383-6 | Human papilloma virus 53 DNA [Presence] in Specimen by NAA with probe detection |
| 77082-6 | FARS2 gene full mutation analysis in Blood or Tissue by Sequencing |
| 77620-3 | Arginase-1 [Mass/volume] in Serum by Immunoassay |
| 94104-7 | Zolpidem [Presence] in Urine by Screen method |
| 63303-2 | Parietal cell Ab [Presence] in Gastric fluid by Immunofluorescence |
| 78433-0 | Soluble liver IgG Ab [Presence] in Serum by Line blot |
| 78819-0 | clomiPRAMINE cutoff [Mass/volume] in Urine for Confirmatory method |
| 94758-0 | SARS-related coronavirus E gene [Presence] in Respiratory system specimen by NAA with probe detection |
| 6431-1 | HIV identified in Specimen by Organism specific culture |
| 95359-6 | Rabbit hemorrhagic disease virus type 1 RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 67126-3 | Cannabinoids synthetic [Presence] in Urine by Confirmatory method |
| 80124-1 | Alminoprofen [Mass/mass] in Hair |
| 9597-6 | Borrelia burgdorferi 93kD IgG Ab [Presence] in Serum by Immunoblot |
| 67810-2 | Parainfluenza virus 3 Ag [Presence] in Isolate by Immunofluorescence |
| 6879-1 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) |
| 96524-4 | Rocio virus IgM Ab [Presence] in Specimen by Immunoassay |
| 69353-1 | HIV 2 RNA [Presence] in Serum or Plasma by NAA with probe detection |
| 6982-3 | Aztreonam [Susceptibility] by Gradient strip |
| 69846-4 | 2-Hydroxyisobutyrate [Moles/volume] in Cerebral spinal fluid |
| 81742-9 | Th-To Ab [Units/volume] in Serum by Line blot |
| 98131-6 | SARS-CoV-2 (COVID-19) ORF1b region [Presence] in Respiratory system specimen by NAA with probe detection |
| 72264-5 | Bilirubin excess and oxyhemoglobin and methemoglobin and xanthochromia and albumin quotient panel - Serum and CSF |
| 72481-5 | Candida sp 6 panel - Vaginal fluid by NAA with probe detection |
| 99452-5 | Silver Birch recombinant (rBet v) 2 IgG4 Ab [Mass/volume] in Serum |
| 86319-1 | Staphylococcus aureus [Presence] in Food by Culture |
| 73041-6 | cefTRIAXone induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73081-2 | Voriconazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86698-8 | Porcine epidemic diarrhea virus RNA [Nucleotide sequence] in Isolate by Sequencing |
| 87620-1 | Candida auris ITS2 gene [Presence] in Specimen by NAA with probe detection |
| 73488-9 | Captopril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88967-5 | Leucine crystals [#/area] in Urine sediment |
| 41247-8 | Yellow fever virus Ab [Titer] in Serum --1st specimen |
| 596-7 | Bacteria identified in Amniotic fluid by Culture |
| 50701-2 | Influenza virus A H1 Ag [Presence] in Isolate by Immunofluorescence |
| 50956-2 | HLA-B*57:01 [Presence] |
| 42005-9 | Saint Louis encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
| 42719-5 | Bilirubin.total [Mass/volume] in Blood |
| 59953-0 | Perphenazine [Moles/volume] in Serum or Plasma |
| 51334-1 | CD19+CD43+ cells/100 cells in Cerebral spinal fluid |
| 43186-6 | Acylcarnitine/Carnitine.free (C0) [Molar ratio] in Urine |
| 222-0 | Dicloxacillin [Susceptibility] by Disk diffusion (KB) |
| 32007-7 | Chlamydia trachomatis G+F+K Ab [Titer] in Serum |
| 32021-8 | HTLV I DNA [Presence] in Serum by NAA with probe detection |
| 53044-4 | DNA marker identified panel |
| 22903-9 | Bovine herpesvirus 1 Ab [Presence] in Milk by Immunoassay |
| 23109-2 | Foot and mouth disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 4466-9 | Vital stain used for semen analysis |
| 44831-6 | Hepatitis C virus c100p+5-1-1 Ab [Presence] in Serum |
| 53628-4 | 20q chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal |
| 45289-6 | Coxsackievirus B4 Ab [Presence] in Body fluid |
| 23861-8 | Ethanol [Mass/mass] in Tissue |
| 23999-6 | Ganglioside GD1b IgG Ab [Titer] in Cerebral spinal fluid by Immunoassay |
| 33890-5 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with normal plasma |
| 54245-6 | Respiratory virus Ag [Identifier] in Specimen by Immunofluorescence |
| 54248-0 | Glucose [Moles/volume] in Serum or Plasma --10 minutes pre dose glucagon |
| 46257-2 | Dihydrocodeine+Hydrocodol [Presence] in Serum or Plasma by Screen method |
| 55292-7 | Linopristin+Flopristin [Susceptibility] |
| 47010-4 | Ber-EP4 Ag [Presence] in Tissue by Immune stain |
| 2521-3 | Lactate [Presence] in Gastric fluid |
| 35126-2 | Hemoglobin O - Arab/Hemoglobin.total in Blood |
| 55627-4 | Cefacetrile [Susceptibility] by Gradient strip |
| 5601-0 | Boldenone [Mass/time] in 24 hour Urine |
| 25638-8 | Eosinophil cationic protein (ECP) [Mass/volume] in Serum |
| 25711-3 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum by Complement fixation |
| 3569-1 | diphenhydrAMINE [Presence] in Serum or Plasma |
| 56549-9 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum by Immunoassay |
| 48089-7 | Cholesterol/Apolipoprotein B [Molar ratio] in Serum or Plasma |
| 48106-9 | 4,5-Dihydroxyhexanolactone/Creatinine [Molar ratio] in Urine |
| 48296-8 | Quinoline yellow triggered leukotriene release [Mass/volume] by Leukocytes |
| 48331-3 | BLM gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 26428-3 | Rice IgG4 Ab [Units/volume] in Serum |
| 26568-6 | CD3+HLA-DR+ cells [#/volume] in Blood |
| 3782-0 | Methapyrilene [Mass/volume] in Serum or Plasma |
| 26819-3 | Alpha aminobutyrate [Moles/volume] in Amniotic fluid |
| 38354-7 | Bartonella sp identified in Specimen by Organism specific culture |
| 49231-4 | Cholinesterase [Enzymatic activity/mass] in Red Blood Cells |
| 39541-8 | Legionella sp Ag [Presence] in Specimen by Immunofluorescence |
| 58046-4 | Strongyloides stercoralis Ab [Titer] in Serum |
| 29143-5 | 1,4-Dimethylbenzene [Mass/volume] in Serum or Plasma |
| 58721-2 | Lymphocyte proliferation stimulated by 0.5 ug concanavalin A actual/normal in Blood |
| 49786-7 | Onchocerca sp IgG3 Ab [Units/volume] in Serum by Immunoassay |
| 40430-1 | TH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 19555-2 | Methamphetamine [Presence] in Urine by Confirmatory method |
| 20390-1 | Silver sulfADIAZINE [Susceptibility] |
| 20753-0 | Chlamydophila psittaci Ag [Presence] in Tissue by Immunofluorescence |
| 100122-1 | Chlamydophila pneumoniae Ab panel - Serum |
| 13059-1 | aPTT in Platelet poor plasma by Coagulation assay --3rd specimen |
| 13247-2 | HTLV I+II Ab [Units/volume] in Cerebral spinal fluid |
| 101832-4 | Betamethasone [Moles/volume] in Serum or Plasma |
| 101991-8 | 3-hydroxypropyl mercapturate [Mass Ratio] in Urine |
| 13513-7 | Iron.microscopic observation [Identifier] in Bone marrow by Potassium ferrocyanide stain |
| 13570-7 | Norclomipramine [Presence] in Serum or Plasma |
| 103161-6 | CD33 cells [#/volume] in Blood from Donor |
| 103576-5 | Horse dander IgE panel - Serum or Plasma |
| 10358-0 | Teichoate Ab [Titer] in Serum by Immune diffusion (ID) |
| 15105-0 | Flecainide [Moles/volume] in Serum or Plasma |
| 15176-1 | Cryoproteins identified in Serum or Plasma |
| 10796-1 | Microscopic observation [Identifier] in Tissue by Mucicarmine stain |
| 16776-7 | dilTIAZem [Mass/volume] in Urine |
| 17208-0 | CD93 cells/100 cells in Blood |
| 17322-9 | Neisseria meningitidis Ab [Presence] in Serum |
| 17377-3 | Norpropoxyphene [Mass/volume] in Urine by Confirmatory method |
| 17497-9 | Alpha 2 globulin [Mass/volume] in Body fluid by Electrophoresis |
| 18214-7 | Delta 5-Pregnanetriol [Mass/volume] in Urine |
| 18405-1 | Arsenate [Mass/volume] in Urine |
| 89990-6 | fluvoxaMINE [Mass/volume] in Urine by Confirmatory method |
| 91078-6 | Zika virus RNA [Presence] in Blood by NAA with probe detection |
| 91851-6 | Human papilloma virus genotype [Identifier] in Genital specimen by NAA with probe detection |
| 92543-8 | Fy sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 75035-6 | Oxytocin [Moles/volume] in Saliva (oral fluid) |
| 75513-2 | dRVVT with 1:1 PNP (LA mix) |
| 6032-7 | Australian pine IgE Ab [Units/volume] in Serum |
| 7646-3 | Common Ragweed IgG Ab [Units/volume] in Serum |
| 7652-1 | Common Ragweed triggered histamine release [Units/volume] in Blood |
| 94197-1 | CYP21A2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 7778-4 | Pussy Willow IgE Ab [Units/volume] in Serum |
| 94349-8 | Voltage-gated calcium channel P/Q type binding IgG+IgM Ab [Moles/volume] in Serum by Immunoassay |
| 94539-4 | Hepatitis A virus IgM and total panel - Serum or Plasma Qualitative |
| 64127-4 | Methylenedioxyethylamphetamine/Creatinine [Mass Ratio] in Urine |
| 78874-5 | oxyMORphone [Z-score] in Urine |
| 8022-6 | Saint Louis encephalitis virus Ab [Units/volume] in Serum by Complement fixation |
| 96424-7 | Testosterone/Cortisol [Mass Ratio] in DBS |
| 8112-5 | CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood |
| 97018-6 | Maximum amplitude activator F induced [Length] in Blood |
| 97191-1 | carBAMazepine [Moles/volume] in Serum or Plasma --peak |
| 97212-5 | 7-Aminoclonazepam [Presence] in Cord tissue by Screen method |
| 69900-9 | Service comment 73 |
| 81626-4 | Methotrexate triglutamate [Moles/volume] in Red Blood Cells |
| 82463-1 | Aluminum [Moles/volume] in Blood |
| 72462-5 | JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 99273-5 | Meclonazepam [Mass/volume] in Urine by Confirmatory method |
| 87577-3 | Ergocryptine [Mass/mass] in Specimen |
| 73548-0 | Acebutolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7380-9 | Grayfish IgE Ab [Units/volume] in Serum |
| 88554-1 | Scedosporium prolificans DNA [Presence] in Tissue by NAA with probe detection |
| 7400-5 | Water Hemp IgE Ab [Units/volume] in Serum |
| 74083-7 | Norolanzapine [Moles/volume] in Serum or Plasma |
| 89300-8 | Tapentadol glucuronide [Presence] in Urine by Screen method |
| 41178-5 | Mumps reaction wheal [Diameter] --2 days post dose mumps intradermal |
| 41424-3 | Schistosoma mansoni Ab [Presence] in Specimen by Immunoblot |
| 59328-5 | Salvinorin A [Mass/volume] in Urine |
| 59610-6 | ALPRAZolam [Mass/mass] in Meconium by Confirmatory method |
| 30512-8 | Pregnanetriol/Creatinine [Mass Ratio] in Urine |
| 30983-1 | Horse Chestnut IgE Ab [Presence] in Serum |
| 31002-9 | Dates IgE Ab [Units/volume] in Serum |
| 42351-7 | Cefepime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 59932-4 | Mexiletine [Moles/volume] in Urine |
| 21618-4 | APC gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 43016-5 | Histoplasma capsulatum yeast phase Ab [Titer] in Cerebral spinal fluid |
| 21781-0 | t(12;16)(q13;p11.2)(DDIT3,FUS) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 43291-4 | HLA-DQB1 [Presence] |
| 22512-8 | Saint Louis encephalitis virus IgG Ab [Titer] in Serum |
| 22702-5 | Ketones [Moles/volume] in Urine by Test strip |
| 52987-5 | Mycoplasma pneumoniae Ab [Units/volume] in Serum by Complement fixation |
| 53005-5 | Fibrillarin Ab [Presence] in Serum by Immunofluorescence |
| 43899-4 | Beta lipotropin [Presence] in Serum or Plasma |
| 23057-3 | Ephemeral fever virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 32574-6 | Zaleplon [Mass/volume] in Serum or Plasma |
| 32790-8 | Herpes simplex virus 2 IgG Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen |
| 53177-2 | Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in DBS |
| 44484-4 | Herpes simplex virus 2 [Presence] in Specimen by Organism specific culture |
| 44505-6 | Herpes simplex virus IgG Ab [Presence] in Cerebral spinal fluid |
| 44694-8 | Tumor regression by CAP cancer protocols |
| 23574-7 | Rabbit hemorrhagic disease virus Ab [Presence] in Serum |
| 5371-0 | Streptolysin O Ab [Titer] in Serum by Latex agglutination |
| 44914-0 | Beta globulin+Gamma globulin/Protein.total in Serum or Plasma by Electrophoresis |
| 45089-0 | Chlamydia trachomatis rRNA [Presence] in Anal by Probe |
| 45193-0 | CD20+CD52+ cells/100 cells in Blood |
| 23778-4 | Salmonella typhimurium Ab [Titer] in Serum by Agglutination |
| 46430-5 | Alpha 1 antitrypsin [Mass/mass] in 48 hour Stool |
| 34361-6 | Pregnanetriol/Creatinine [Molar ratio] in Urine |
| 25440-9 | Histidine [Moles/time] in 24 hour Urine |
| 35099-1 | Monocytes+Macrophages [#/volume] in Body fluid |
| 47537-6 | 3-Hydroxysebacate ( 3-OH-C8)/Creatinine [Molar ratio] in Urine |
| 25696-6 | Insulin [Moles/volume] in Serum or Plasma --7.5 hours post XXX challenge |
| 257-6 | Framycetin [Susceptibility] by Minimum lethal concentration (MLC) |
| 26024-0 | Gastrin [Moles/volume] in Serum or Plasma --post meal |
| 47996-4 | Adenosine deaminase binding protein [Units/volume] in Urine |
| 26478-8 | Lymphocytes/100 leukocytes in Blood |
| 3789-5 | Methocarbamol [Presence] in Serum or Plasma |
| 48596-1 | Activated protein C resistance panel - Platelet poor plasma |
| 2680-7 | Ornithine [Mass/volume] in Urine |
| 57477-2 | 11-Ketoandrosterone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
| 5752-1 | Uranium [Mass/volume] in Urine |
| 48950-0 | Flurazepam [Mass/volume] in Specimen |
| 49045-8 | PT and aPTT and Fibrinogen panel - Platelet poor plasma by Coagulation assay |
| 49167-0 | Orientia tsutsugamushi Karp IgM Ab [Titer] in Serum |
| 27980-2 | Thyroxine binding globulin [Moles/volume] in Serum or Plasma |
| 49368-4 | Hepatitis B virus DNA [Units/volume] (viral load) in Tissue by NAA with probe detection |
| 49648-9 | MJD gene allele 2 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 40184-4 | Glucose [Moles/volume] in Serum or Plasma --18 hours post XXX challenge |
| 40275-0 | Cortisol [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 58620-6 | Corticotropin [Mass/volume] in Plasma --pre dose dexamethasone |
| 49952-5 | Somatotropin [Units/volume] in Serum or Plasma --3 AM specimen |
| 50123-9 | 3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Urine |
| 29783-8 | Saint Louis encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 29787-9 | Jamestown canyon virus IgM Ab [Presence] in Specimen by Immunofluorescence |
| 40549-8 | Hemoglobin F [Mass/volume] in Blood by Electrophoresis |
| 40580-3 | Cryoglobulin.IgA [Mass/volume] in Serum by Cold incubation |
| 5908-9 | Giant platelets [Presence] in Blood by Light microscopy |
| 50277-3 | 3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Serum or Plasma |
| 30181-2 | Lymphocytes clefted [#/volume] in Blood by Manual count |
| 4096-4 | Volatile drugs negative [Identifier] in Urine by Screen method |
| 19234-4 | Base excess in Mixed venous blood by calculation |
| 19456-3 | Ethylamphetamine [Presence] in Urine by Screen method |
| 19761-6 | Thermoactinomyces vulgaris IgG Ab [Presence] in Serum |
| 12497-4 | Butalbital [Presence] in Stool |
| 12512-0 | Calcium hydrogen phosphate dihydrate crystals [Presence] in Urine sediment by Light microscopy |
| 13136-7 | Streptococcus pneumoniae Danish serotype 18C Ab [Units/volume] in Serum |
| 1338-3 | Xg sup(a) Ab [Presence] in Serum or Plasma |
| 101781-3 | Candida guilliermondii DNA [Presence] in Specimen by NAA with probe detection |
| 102514-7 | Phospholipase IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14252-1 | Smooth muscle Ab [Presence] in Serum |
| 102909-9 | Staphylococcus aureus enterotoxin C IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103095-6 | Latex recombinant (rHev b) 6.02 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14443-6 | Cholesterol [Mass/volume] in Synovial fluid |
| 1492-8 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 0.5 g/kg glucose IV |
| 104447-8 | Salmonella paratyphi DNA [Presence] in Isolate by NAA with probe detection |
| 10641-9 | Amoeba identified in Aspirate by Immune stain |
| 16208-1 | Buprenorphine [Presence] in Urine by Confirmatory method |
| 17304-7 | Mycoplasma pneumoniae IgG+IgM Ab [Units/volume] in Serum |
| 17381-5 | Uroporphyrin [Mass/time] in 24 hour Stool |
| 17657-8 | Streptolysin O Ab [Units/volume] in Synovial fluid |
| 17826-9 | CD3 cells/100 cells in Body fluid |
| 18182-6 | Osmolality of Serum or Plasma by calculation |
| 19091-8 | Colony count [#] in Urine by Visual count |
| 75102-4 | Oleate (C18:1w9) [Entitic substance] in Red Blood Cells |
| 60351-4 | Artichoke IgG Ab [Mass/volume] in Serum |
| 76598-2 | Klebsiella pneumoniae phoE gene [#/mass] in XXX.tissue by NAA with probe detection |
| 93339-0 | THSD7A IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 6153-1 | Kentucky blue grass IgE Ab [Units/volume] in Serum |
| 93884-5 | Methane/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose carbohydrate |
| 63138-2 | Hop IgG Ab [Mass/volume] in Serum |
| 94588-1 | Myeloid neoplasm chromosome analysis in Blood or Marrow by Mate pair sequencing |
| 79407-3 | Catecholamine metabolites pattern [Interpretation] in Serum or Plasma Narrative |
| 80130-8 | Amisulpride [Mass/volume] in Body fluid |
| 67709-6 | Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in DBS |
| 8079-6 | Myelin IgA Ab [Units/volume] in Serum |
| 96899-0 | SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection |
| 69811-8 | 2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --2 days post dose ifosfamide |
| 97563-1 | Signal Recognition Particle (SRP) IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 70260-5 | Triglyceride in peritoneal fluid/Triglyceride in serum |
| 72220-7 | Macrophages [#/area] in Urine sediment by Microscopy high power field |
| 99767-6 | Interleukin 1 beta [Mass/volume] in Cerebral spinal fluid |
| 86572-5 | Influenza virus B RNA [Presence] in Tissue by NAA with probe detection |
| 86734-1 | Porcine parvovirus Ab [Titer] in Serum by Hemagglutination inhibition |
| 87467-7 | Manganese [Mass/volume] in Specimen |
| 88202-7 | Respiratory syncytial virus B RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 74454-0 | Normoblasts [#/volume] in Blood from Fetus |
| 41241-1 | Viscosity of Serum Qualitative |
| 59734-4 | Propoxyphene [Presence] in Serum or Plasma by Screen method |
| 5987-3 | Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method |
| 31127-4 | CD20+CD25- cells [#/volume] in Blood |
| 60165-8 | Phensuximide [Mass/volume] in Urine |
| 21642-4 | CACNA1S gene p.Arg1239Gly [Presence] in Blood or Tissue by Molecular genetics method |
| 51156-8 | CD33 blasts/100 blasts in Specimen |
| 31847-7 | Herpes simplex virus 1 Ag [Presence] in Skin |
| 31968-1 | Streptococcus pneumoniae Ag [Presence] in Sputum |
| 32030-9 | Nitrate [Presence] in Urine |
| 51914-0 | Hepatitis B virus core IgG+IgM Ab [Presence] in Serum |
| 43207-0 | Invasive trophoblast Ag [Presence] in Serum or Plasma |
| 43717-8 | Acylcarnitine [Presence] in DBS |
| 43719-4 | Acetaminophen+oxyCODONE [Presence] in Serum or Plasma |
| 3276-3 | Kininogen HMW [Units/volume] in Platelet poor plasma by Coagulation assay |
| 3286-2 | Phospholipid IgG Ab [Units/volume] in Serum by Immunoassay |
| 53339-8 | 11-Deoxycortisol [Moles/volume] in DBS |
| 23570-5 | Vesicular stomatitis virus serotype [Identifier] in Tissue by Complement fixation |
| 33255-1 | Cell Fractions/Differential [Interpretation] in Blood |
| 33676-8 | Francisella tularensis [Presence] in Specimen by Organism specific culture |
| 53616-9 | Bacteria # 4 identified in Duodenal fluid by Aerobe culture |
| 45121-1 | Cocal virus Ag [Presence] in Specimen by Complement fixation |
| 45157-5 | U2 small nuclear ribonucleoprotein IgG Ab [Presence] in Serum |
| 3422-3 | Caffeine [Mass/volume] in Serum or Plasma |
| 46135-0 | Hyaline casts [#/area] in Urine sediment by Microscopy high power field |
| 4622-7 | Hemoglobin S [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 24106-7 | Hairy cells/100 leukocytes in Blood by Manual count |
| 34286-5 | Estradiol (E2) [Moles/volume] in Urine |
| 34301-2 | Etiocholanolone [Moles/volume] in Urine |
| 34378-0 | Teicoplanin [Mass/volume] in Serum or Plasma --peak |
| 34686-6 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor II depleted plasma |
| 25102-5 | Galactose/Creatinine [Molar ratio] in Urine |
| 2540-3 | Lactate dehydrogenase 2 [Enzymatic activity/volume] in Serum or Plasma |
| 47520-2 | Cytology report of Sputum Cyto stain |
| 25824-4 | Staphylococcus aureus enterotoxin C IgE Ab [Units/volume] in Serum |
| 35368-0 | SCA1 gene allele 2 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 35649-3 | Propoxyphene [Mass/volume] in Serum or Plasma by Screen method |
| 56292-6 | Insulin human IgG4 Ab [Mass/volume] in Serum |
| 56312-2 | Malt IgG4 Ab [Mass/volume] in Serum |
| 48237-2 | Flea triggered leukotriene release [Mass/volume] by Leukocytes |
| 48326-3 | glipiZIDE [Presence] in Serum or Plasma |
| 26549-6 | Glucose [Presence] in Urine by Test strip --3 hours post dose glucose |
| 56576-2 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 48703-3 | Hematocrit [Volume Fraction] of Blood by Estimated |
| 26958-9 | IgM [Mass/volume] in 24 hour Urine |
| 57401-2 | CD4+CD8+ cells/100 cells in Body fluid |
| 49318-9 | Alpha-1-Fetoprotein interpretation in Amniotic fluid Narrative |
| 27810-1 | Plasmin inhibitor actual/normal in Platelet poor plasma by Chromogenic method |
| 38689-6 | Dimethyl sulfate [Mass/volume] in Air |
| 38750-6 | Para nitrophenol [Mass/volume] in Air |
| 57850-0 | Mesothelial cells/100 leukocytes in Synovial fluid by Manual count |
| 57895-5 | Influenza virus A H1.neuraminidase inhibitor resistance [Susceptibility] in Specimen by Genotype method |
| 49324-7 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --2 hours post dose metyraPONE |
| 49637-2 | HTT gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 29373-8 | Ethchlorvynol [Presence] in Gastric fluid |
| 58471-4 | Erythrocytes.pitted/Erythrocytes.total in Red Blood Cells |
| 58725-3 | Lymphocyte proliferation stimulated by 1.0 ug pokeweed mitogen actual/normal in Blood |
| 58727-9 | Lymphocyte proliferation stimulated by phytohemagglutinin [Interpretation] in Blood Narrative |
| 29588-1 | Heavy metals panel - Blood |
| 40546-4 | Hemoglobin E [Presence] in Blood by Electrophoresis |
| 40688-4 | Megakaryocytes [Presence] in Bone marrow by Microscopy |
| 58823-6 | Cortisol [Mass/volume] in Serum or Plasma --20th specimen |
| 59021-6 | HLA-DRB4 [Type] |
| 59139-6 | CD19+CD34+ cells/100 cells in Bone marrow |
| 30282-8 | Zidovudine [Susceptibility] by Genotype method |
| 30343-8 | Glomerular basement membrane IgG Ab [Units/volume] in Serum by Immunoassay |
| 19288-0 | Cannabinoids tested for in Urine by Screen method Narrative |
| 19310-2 | Thiazides screen method [Identifier] in Urine |
| 2037-0 | Carcinoembryonic Ag [Mass/volume] in Cerebral spinal fluid |
| 20650-8 | Lysine [Moles/volume] in Serum or Plasma |
| 20936-1 | Pentachlorophenol [Mass/mass] in Tissue |
| 12380-2 | LORazepam [Presence] in Stool |
| 12529-4 | EPINEPHrine [Mass/volume] in Plasma --2 hours post XXX challenge |
| 12893-4 | HIV 1 gp105 Ab [Presence] in Serum by Immunoblot |
| 12947-8 | Thyrotropin [Units/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 13706-7 | Amylase/Creatinine [Mass Ratio] in Urine |
| 13933-7 | Benzodiazepines [Mass/mass] in Hair |
| 102424-9 | Malt IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102459-5 | Mustard IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102516-2 | Pigeon droppings IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13954-3 | Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay |
| 14359-4 | Microscopic observation [Identifier] in Peritoneal fluid by Gram stain |
| 102894-3 | Chicken droppings IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102994-1 | Chinchilla epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103714-2 | Karyotype [Identifier] in Tissue from Fetus Narrative |
| 1486-0 | Gastrin [Mass/volume] in Serum or Plasma --20 minutes post 0.2 U/kg secretin |
| 10548-6 | Phenytoin Free/Phenytoin.total in Serum or Plasma |
| 155-2 | Cephaloglycin [Susceptibility] by Serum bactericidal titer |
| 159-4 | Cephaloridine [Susceptibility] by Serum bactericidal titer |
| 16186-9 | Hydroxyalprazolam [Mass/volume] in Stool |
| 10809-2 | Microscopic observation [Identifier] in Tissue by Silver nitrate stain |
| 120-6 | Cefpodoxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 17552-1 | Rubella virus IgM Ab [Presence] in Cerebral spinal fluid |
| 18364-0 | Chondroitin sulfate [Mass/volume] in Serum |
| 18494-5 | Ova and parasites identified in Stool by Concentration--2nd specimen |
| 18896-1 | Cefuroxime Parenteral [Susceptibility] |
| 74954-9 | Isomaltase [Enzymatic activity/mass] in Small intestine Tissue |
| 60571-7 | Pathology Consult note.synoptic |
| 7672-9 | Wheat Stem Rust IgE Ab [Units/volume] in Serum |
| 61226-7 | Oat IgE Ab/IgE total in Serum |
| 6169-7 | Meadow Fescue IgE Ab [Units/volume] in Serum |
| 6170-5 | Meadow Foxtail IgE Ab [Units/volume] in Serum |
| 7727-1 | Sunflower Seed triggered histamine release [Units/volume] in Blood |
| 62470-0 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
| 943-1 | C Ab [Presence] in Serum or Plasma from Blood product unit |
| 94563-4 | SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 63555-7 | Leukocytes [#/volume] by Microscopy high power field in Urine sediment collected for unspecified duration |
| 64970-7 | London Plane recombinant (rPla a) 3 IgE Ab [Units/volume] in Serum |
| 95073-3 | Histoplasma capsulatum Ag [Mass/volume] in Bronchoalveolar lavage by Immunoassay |
| 7966-5 | Mumps virus IgG Ab [Units/volume] in Serum |
| 80135-7 | Amphetamine [Mass/volume] in Body fluid by Confirmatory method |
| 81700-7 | Microsatellite instability marker NR24 in Cancer specimen Qualitative |
| 82217-1 | 3-Hydroxyisobutyryl-CoA hydrolase [Enzymatic activity/mass] in Fibroblast |
| 71636-5 | Plasma cells/Leukocytes [Pure number fraction] in Body fluid by Manual count |
| 82909-3 | Tetrahydrocortisol/5-Alpha tetrahydrocortisol [Molar ratio] in Urine |
| 72420-3 | Gamma aminobutyrate.free [Moles/volume] in Cerebral spinal fluid |
| 85079-2 | Other nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
| 99428-5 | Dermatophagoides microceras IgG4 Ab [Mass/volume] in Serum |
| 99892-2 | Microorganism casts [#/area] in Urine sediment by Computer assisted method |
| 99930-0 | Nucleated cells [Presence] in Body fluid by Automated |
| 86337-3 | Virus identified in Isolate by Shell vial culture |
| 72988-9 | Montelukast induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88229-0 | Mycoplasma genitalium DNA [Presence] in Anorectal by NAA with probe detection |
| 73984-7 | Hemoglobin.other [Type] in Blood |
| 50782-2 | Cancer Ag 27-29 [Units/volume] in Cerebral spinal fluid |
| 4246-5 | Ethotoin [Mass] of Dose |
| 59952-2 | Pentazocine [Moles/volume] in Gastric fluid |
| 21483-3 | quiNIDine [Mass/volume] in Serum or Plasma --peak |
| 31512-7 | Mycoplasma hominis Ab [Units/volume] in Serum |
| 51192-3 | Barium [Mass/volume] in Body fluid |
| 51464-6 | Onchocerca sp IgG4 Ab [Units/volume] in Serum |
| 42770-8 | Human papilloma virus high and Low risk DNA panel - Cervix |
| 21689-5 | HBB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21712-5 | MTHFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 31799-0 | Dengue virus Ag [Presence] in Specimen |
| 31994-7 | Basophils/100 leukocytes in Pericardial fluid by Manual count |
| 32050-7 | Barbital [Moles/volume] in Serum or Plasma |
| 51705-2 | Homogentisate [Mass/time] in 24 hour Urine |
| 43282-3 | Heterophile Ab [Presence] in Control Serum |
| 43803-6 | Estriol (E3) [Multiple of the median] adjusted in Serum or Plasma |
| 22730-6 | Alloisoleucine [Moles/volume] in Specimen |
| 32741-1 | Beta 2 globulin/Protein.total in Body fluid by Electrophoresis |
| 53456-0 | Iron [Mass/mass] in Specimen |
| 53481-8 | Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose betaxolol |
| 44587-4 | IgA.monoclonal [Presence] in Serum by Immunofixation |
| 45275-5 | Bacteria identified in Blood by Aerobe culture 25 degree C incubation |
| 5402-3 | Varicella zoster virus Ab [Titer] in Serum by Latex agglutination |
| 24448-3 | Carnitine [Moles/time] in 24 hour Urine |
| 24467-3 | CD3+CD4+ (T4 helper) cells [#/volume] in Blood |
| 55531-8 | Cyclobenzaprine [Moles/volume] in Serum or Plasma |
| 25107-4 | Glyoxylate/Creatinine [Molar ratio] in Urine |
| 2513-0 | Ketones [Presence] in Serum or Plasma |
| 25382-3 | Cortisone [Moles/volume] in Serum or Plasma |
| 25494-6 | Pentacarboxylporphyrins [Moles/time] in 24 hour Urine |
| 25520-8 | Secobarbital [Moles/volume] in Serum or Plasma |
| 35670-9 | Tobramycin [Mass/volume] in Serum or Plasma |
| 26636-1 | Candida sp Ab [Presence] in Serum |
| 26702-1 | Clostridioides difficile IgG Ab [Units/volume] in Serum |
| 3676-4 | hydroCHLOROthiazide [Presence] in Urine |
| 56651-3 | Cadmium/Creatinine [Ratio] in Urine |
| 56705-7 | Tobramycin IgE Ab [Units/volume] in Serum |
| 38341-4 | Chlordane [Mass/volume] in Water |
| 38454-5 | CFTR gene p.Gly85Glu [Presence] in Blood or Tissue by Molecular genetics method |
| 38650-8 | Chloromethyl methyl ether [Mass/volume] in Air |
| 57510-0 | 11-Hydroxyandrosterone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
| 49078-9 | Influenza virus B IgM Ab [Mass/volume] in Cerebral spinal fluid |
| 49266-0 | Glucose-6-Phosphate dehydrogenase phenotype [Interpretation] in Red Blood Cells Narrative |
| 27385-4 | Somatotropin [Mass/volume] in Serum or Plasma --18th specimen post XXX challenge |
| 2751-6 | pH of Peritoneal fluid |
| 57873-2 | Thiothixene [Moles/volume] in Specimen |
| 58047-2 | Tetrahydrocannabinol [Presence] in Blood by Confirmatory method |
| 49343-7 | BK virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
| 49379-1 | Hepatitis C virus RNA [Units/volume] (viral load) in Tissue by NAA with probe detection |
| 28612-0 | Legionella sp IgM Ab [Titer] in Serum by Immunofluorescence |
| 3993-3 | Propranolol [Presence] in Urine |
| 40100-0 | aPTT in Platelet poor plasma by Coagulation assay --baseline |
| 58499-5 | C peptide [Moles/volume] in Serum or Plasma --15 minutes post 1 mg glucagon IV |
| 49827-9 | 2-Hydroxyestrone/16-Alpha hydroxyestrone [Mass Ratio] in Serum or Plasma |
| 49935-0 | Calcium.ionized/Calcium.total corrected for albumin in Serum or Plasma |
| 40374-1 | Lutropin [Units/volume] in Serum or Plasma --1 hour post dose triple bolus |
| 40631-4 | Nucleated erythrocytes/100 leukocytes [Ratio] in Cerebral spinal fluid by Manual count |
| 50438-1 | Corticotropin [Mass/volume] in Plasma --9 PM specimen |
| 40833-6 | SOD1 gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 41062-1 | SDHB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 41089-4 | MEN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21001-3 | Coagulation factor VIII [Interpretation] in Specimen |
| 12923-9 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 12930-4 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 102056-9 | Sphingosine [Mass/volume] in Serum by LC/MS/MS |
| 13586-3 | Vancomycin [Mass/volume] in Cerebral spinal fluid |
| 13875-0 | Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma |
| 102451-2 | Mouse epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14422-0 | Bilirubin.total [Mass/volume] in Peritoneal fluid |
| 14464-2 | Chlamydia trachomatis [Presence] in Vaginal fluid by Organism specific culture |
| 14566-4 | Calcitriol [Moles/volume] in Serum or Plasma |
| 14615-9 | Nuclear Ab [Titer] in Peritoneal fluid |
| 14678-7 | Cortisol [Moles/volume] in Serum or Plasma --PM trough specimen |
| 15030-0 | Androsterone [Moles/time] in 24 hour Urine |
| 104476-7 | Zika virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 10475-2 | Corticotropin Ag [Presence] in Tissue by Immune stain |
| 15428-6 | Service comment 37 |
| 1084-3 | Js sup(a) Ag [Presence] on Red Blood Cells |
| 16328-7 | Benzyl alcohol [Presence] in Blood |
| 16465-7 | Bile acid [Mass/volume] in Urine |
| 11600-4 | Shigella flexneri Ab [Units/volume] in Serum |
| 1224-5 | Mg Ag [Presence] on Red Blood Cells from Donor |
| 16732-0 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 16888-0 | Gamma chlordane [Mass/volume] in Urine |
| 17063-9 | Legionella pneumophila 2 IgM Ab [Units/volume] in Serum |
| 17300-5 | Mycoplasma hominis Ab [Titer] in Serum by Complement fixation |
| 17886-3 | Bacteria # 5 identified in Genital specimen by Aerobe culture |
| 18274-1 | Blood group antibody screen [Presence] in Serum or Plasma from Donor |
| 18335-0 | Antihistamines [Presence] in Urine by Confirmatory method |
| 18344-2 | Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Platelets |
| 91842-5 | Ureaplasma urealyticum DNA [Presence] in Genital specimen by NAA with probe detection |
| 92643-6 | Cotinine [Mass/volume] in Urine by Confirmatory method |
| 94377-9 | Haemophilus influenzae DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 63478-2 | Platelet glycoprotein Ib/Ix Ab [Presence] in Blood by Immunoassay |
| 79330-7 | Trimethyllysine [Moles/volume] in DBS |
| 79453-7 | Alcohol dehydrogenase [Enzymatic activity/mass] in Liver |
| 95109-5 | Glucose [Mass/volume] in Serum or Plasma --5 hours post meal |
| 79620-1 | Formiminoglutamate/Creatinine [Molar ratio] in Urine |
| 79693-8 | 5,6-Dihydrouracil [Moles/volume] in Cerebral spinal fluid |
| 7998-8 | Rickettsia spotted fever group IgG Ab [Units/volume] in Serum |
| 80163-9 | Bile alcohols panel - Urine |
| 80177-9 | S-adenosylmethionine [Moles/volume] in Cerebral spinal fluid |
| 96312-4 | Stenotrophomonas maltophilia DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 96718-2 | Leukocytes [#/area] in Prostatic fluid by Light microscopy |
| 97607-6 | POPEth [Mass/volume] in Blood |
| 9779-0 | quiNIDine Free [Mass/volume] in Serum or Plasma |
| 71761-1 | Rotavirus identified in Isolate by Sequencing |
| 85368-9 | HIV 1+2 RNA [Presence] in Serum or Plasma by NAA with probe detection |
| 99528-2 | Thickness [Length] of Interventricular septum |
| 72960-8 | raNITIdine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 85790-4 | CD3+CD8+CD45RO+ cells [#/volume] in Blood |
| 73496-2 | buPROPion induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87982-5 | Toxoplasma gondii [Presence] in Bone marrow by Organism specific culture |
| 88181-3 | Wuchereria bancrofti+Brugia malayi IgG2 Ab [Presence] in Serum by Immunoassay |
| 88548-3 | Scedosporium apiospermum DNA [Presence] in Tissue by NAA with probe detection |
| 74357-5 | Lymphocytes Immunoblastic [Presence] in Blood by Light microscopy |
| 7444-3 | Lactalbumin IgG Ab [Units/volume] in Serum |
| 4156-6 | Cathine [Mass] of Dose |
| 4169-9 | Cefuroxime Parenteral [Mass] of Dose |
| 59323-6 | Rufinamide [Mass/volume] in Serum or Plasma |
| 59629-6 | cloBAZam [Mass/volume] in Body fluid by Confirmatory method |
| 59744-3 | SUMAtriptan [Mass/volume] in Urine |
| 50831-7 | Boron/Creatinine [Molar ratio] in 24 hour Urine |
| 51014-9 | CD1 blasts/100 blasts in Blood |
| 41874-9 | White Birch IgE Ab [Units/volume] in Serum |
| 60066-8 | Cobalt [Mass/volume] in Red Blood Cells |
| 21674-7 | FGFR2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 22181-2 | Chlamydophila psittaci IgM Ab [Titer] in Serum |
| 3179-9 | Bleeding time by Ivy method |
| 43243-5 | Isobutyrylcarnitine (C4) [Moles/volume] in Serum or Plasma |
| 43307-8 | Bacteria identified in Sinus by Culture |
| 32322-0 | Glucose [Moles/volume] in Serum or Plasma --5 hours post 75 g glucose PO |
| 22887-4 | Bordetella bronchiseptica Ab [Presence] in Serum by Agglutination |
| 32666-0 | Borrelia burgdorferi 25kD IgM Ab [Presence] in Serum by Immunoblot |
| 23522-6 | Trypanosoma evansi Ab [Presence] in Serum |
| 53753-0 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.25 hours post XXX challenge |
| 4609-4 | Hemoglobin M - Milwaukee [Presence] in Blood |
| 47004-7 | 6-monoacetylmorphine free [Mass/volume] in Urine by Confirmatory method |
| 24381-6 | Platelet aggregation arachidonate induced [Presence] in Platelet rich plasma |
| 24394-9 | Cortisol [Moles/volume] in Serum or Plasma --17 hours post 1 mg dexamethasone PO overnight |
| 34614-8 | Spermatozoa IgM Ab [Units/volume] in Cervical mucus |
| 47116-9 | Manganese [Moles/volume] in Gastric fluid |
| 47168-0 | Norepinephrine [Moles/volume] in Urine --4th specimen post XXX challenge |
| 25226-2 | sulfiSOXAZOLE 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 55712-4 | rifAMPin 40 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 55901-3 | IgA.monoclonal [Presence] in Serum by Immunoelectrophoresis |
| 55946-8 | Neopterin [Moles/volume] in Urine |
| 47517-8 | Vesicular stomatitis Alagoas virus Ab [Titer] in Serum |
| 35773-1 | Cefotiam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 5626-7 | Cobalt [Mass/mass] in Hair |
| 56884-0 | Somatotropin [Mass/volume] in Serum or Plasma --160 minutes post exercise |
| 48422-0 | Oligoclonal bands [Presence] in Serum or Plasma |
| 48555-7 | Fetal blood [Volume] by Kleihauer-Betke method |
| 38512-0 | CD2+CD3+ cells/100 cells in Specimen |
| 38647-4 | Chlorine [Mass/volume] in Air |
| 57332-9 | Urate [Mass/volume] in 12 hour Urine |
| 57485-5 | 11-Ketoetiocholanolone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
| 57556-3 | 18-Hydroxycorticosterone [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
| 4914-8 | HLA-Dw7 [Presence] in Donor |
| 49312-2 | Acute leukemia markers [Interpretation] in Specimen |
| 27284-9 | Brompheniramine [Mass/volume] in Urine |
| 40287-5 | Glucose [Moles/volume] in Serum or Plasma --1 hour post meal |
| 49874-1 | ABCB4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 29746-5 | Cryoglobulin [Presence] in Serum by 3 day 37 degree C incubation |
| 30358-6 | Hexanoylcarnitine (C6) [Moles/volume] in Serum or Plasma |
| 19207-0 | Squamous cell carcinoma Ag [Units/volume] in Serum or Plasma |
| 19459-7 | Ethylamphetamine [Mass/volume] in Urine |
| 20381-0 | Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria |
| 20561-7 | traMADol [Mass/volume] in Urine by Confirmatory method |
| 100890-3 | Poxvirus DNA panel |
| 10406-7 | little i Ag [Presence] on Red Blood Cells from Blood product unit |
| 10679-9 | Herpes simplex virus 2 Ag [Presence] in Tissue by Immune stain |
| 16180-2 | Zinc [Mass/mass] in Tissue |
| 1708-7 | Acetylcholinesterase [Enzymatic activity/volume] in Amniotic fluid |
| 17366-6 | Nizatidine [Mass/volume] in Serum or Plasma |
| 17610-7 | Spermatozoa Motile [Presence] in Semen --30 minutes post collection |
| 17708-9 | Thyroid stimulating immunoglobulins [Presence] in Serum |
| 17946-5 | Bacteria # 6 identified in Line specimen by IV Line culture |
| 18986-0 | sulfiSOXAZOLE [Susceptibility] |
| 19133-8 | Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 75695-7 | Human papilloma virus 18 DNA [Presence] in Anorectal specimen by Probe and signal amplification method |
| 61168-1 | Hepatitis B virus codon S202I [Presence] by Genotype method |
| 9332-8 | Carbon tetrachloride [Mass/volume] in Blood |
| 6161-4 | Lettuce IgE Ab [Units/volume] in Serum |
| 62435-3 | Saint Louis encephalitis virus IgG Ab [Presence] in Body fluid by Immunoassay |
| 63342-0 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Serum by Immunoassay |
| 63363-6 | Thyrotropin receptor Ab [Units/volume] in Blood from Fetus |
| 63387-5 | Elastase Ab [Presence] in Body fluid by Immunoassay |
| 7890-7 | Francisella tularensis IgM Ab [Presence] in Serum |
| 6661-3 | Microscopic observation [Identifier] in Tissue by Dry mount |
| 8132-3 | CD5 cells/100 cells in Blood |
| 96647-3 | HLA-DPB1 [Type] in Donor by Low resolution |
| 97947-6 | Rocio virus RNA [Presence] in Specimen by NAA with probe detection |
| 7174-6 | Candida sp IgG Ab [Units/volume] in Serum |
| 85763-1 | Listeria monocytogenes DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 72650-5 | Glucose in serum - glucose in pericard fld [Molar concentration difference] |
| 86145-0 | Streptococcus pneumoniae Danish serotype 8 Ab [Units/volume] in Serum |
| 86342-3 | Streptococcus pneumoniae Danish serotype 6A+6B Ab [Mass/volume] in Serum |
| 73072-1 | Alendronate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87389-3 | Porcine sapelovirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73455-8 | chlorproMAZINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 59367-3 | Leptospira interrogans sv Tarassovi Ab [Titer] in Serum by Agglutination |
| 59671-8 | Estazolam [Mass/mass] in Tissue by Confirmatory method |
| 59743-5 | SUMAtriptan [Mass/volume] in Blood |
| 59864-9 | Acetone [Moles/volume] in Gastric fluid |
| 50625-3 | Ova and parasites identified in Blood or Tissue by Wright stain |
| 50672-5 | Leukocyte toxic vacuoles [Presence] in Blood by Light microscopy |
| 51011-5 | CD3-CD16+CD56+CD244+ cells/100 cells in Specimen |
| 42537-1 | Varicella zoster virus IgG Ab [Presence] in Cerebral spinal fluid |
| 60090-8 | Indium [Mass/volume] in Serum or Plasma |
| 31456-7 | Legionella pneumophila 1 IgM Ab [Units/volume] in Cerebral spinal fluid |
| 51089-1 | Cytoplasmic CD179a blasts/100 blasts in Bone marrow |
| 4299-4 | Lidocaine [Mass] of Dose |
| 2214-5 | Dinitrobenzene [Mass/volume] in Urine |
| 31792-5 | Cryptococcus sp Ag [Units/volume] in Specimen |
| 32012-7 | Ehrlichia sp IgM Ab [Titer] in Serum |
| 51796-1 | PCA-Tr Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 51815-9 | Leptospira sp IgG Ab [Units/volume] in Serum by Immunoassay |
| 43613-9 | Adenovirus Ag [Presence] in Trachea by Immunofluorescence |
| 32356-8 | Yeast [Presence] in Urine sediment by Light microscopy |
| 52890-1 | Lead [Moles/mass] in Tissue |
| 4427-1 | Stanozolol [Mass] of Dose |
| 22873-4 | Bluetongue virus Ag [Presence] in Specimen by Immune stain |
| 2299-6 | Aldolase [Enzymatic activity/volume] in Red Blood Cells |
| 32995-3 | Lutropin [Units/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 53145-9 | Lutropin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 53794-4 | RPS6KA3 gene mutations tier 2 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 44895-1 | Malignant cells/100 cells in Pleural fluid by Manual count |
| 33910-1 | Rheumatoid factor [Presence] in Serum |
| 33921-8 | Signal Recognition Particle (SRP) Ab [Presence] in Serum or Plasma |
| 34279-0 | Dehydroepiandrosterone (DHEA) [Moles/volume] in Urine |
| 54067-4 | Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection |
| 2415-8 | Histamine [Mass/volume] in Blood |
| 24326-1 | Electrolytes 1998 panel - Serum or Plasma |
| 24446-7 | Porphobilinogen [Mass/volume] in Urine |
| 55547-4 | Labetalol [Moles/volume] in Serum or Plasma |
| 47391-8 | Sulfonylurea [Presence] in Urine |
| 3499-1 | Clorprenaline [Presence] in Urine |
| 35129-6 | Karyotype [Identifier] in Specimen Nominal |
| 55615-9 | Amoxicillin+Sulbactam [Susceptibility] by Gradient strip |
| 55692-8 | Ornidazole [Susceptibility] by Gradient strip |
| 47742-2 | Serine [Moles/volume] in DBS |
| 35565-1 | HIV 1 p40 Ab [Presence] in Serum by Immunoblot |
| 48213-3 | Tomato triggered leukotriene release [Mass/volume] by Leukocytes |
| 2697-1 | Osteocalcin [Mass/volume] in Serum or Plasma |
| 27046-2 | 3-Methylhistidine [Moles/volume] in Urine |
| 27055-3 | Catecholamines Free [Mass/time] in 24 hour Urine |
| 38633-4 | Benzotrichloride [Mass/volume] in Air |
| 38753-0 | Tetrachloroethane [Mass/volume] in Air |
| 57758-5 | TNFRSF13B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2911-6 | Pyruvate dehydrogenase.lipoamide [Enzymatic activity/mass] in Tissue |
| 29159-1 | Methadone [Mass/mass] in Meconium |
| 4001-4 | Protriptyline [Presence] in Urine |
| 58418-5 | Micafungin [Mass/volume] in Serum or Plasma |
| 50081-9 | 18-Hydroxydeoxycorticosterone [Moles/volume] in Serum or Plasma |
| 58951-5 | Creatinine [Mass/volume] in Urine --2nd specimen |
| 58952-3 | Testosterone free and total panel [Mass/volume] - Serum or Plasma |
| 59038-0 | Cholesterol [Mass/volume] in Peritoneal dialysis fluid |
| 50410-0 | dRVVT/dRVVT W excess phospholipid (screen to confirm ratio) |
| 40809-6 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 2023-0 | Carbon dioxide [Partial pressure] in Body fluid |
| 2025-5 | Carbon dioxide dissolved [Moles/volume] in Red Blood Cells |
| 100055-3 | Optochin [Susceptibility] |
| 12877-7 | Borrelia burgdorferi 47kD Ab [Presence] in Serum by Immunoblot |
| 13404-9 | Lysine [Mass/volume] in Amniotic fluid |
| 13408-0 | Ornithine [Mass/volume] in Amniotic fluid |
| 102000-7 | Maximum amplitude kaolin induced [Length] in Blood by Thromboelastography |
| 102640-0 | Turkey meat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1431-6 | Cortisol [Mass/volume] in Serum or Plasma --5 minutes post 1 ug/kg CRH IV |
| 102832-3 | Tea IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14742-1 | Gastrin [Moles/volume] in Serum or Plasma --pre 0.2 U/kg secretin |
| 103172-3 | Clostridium perfringens DNA [Presence] in Wound by NAA with probe detection |
| 103845-4 | Fat/Total solids [Mass Ratio] in 72 hour Stool |
| 15133-2 | Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Serum or Plasma |
| 104409-8 | Hepatitis A virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen |
| 10468-7 | Calcitonin Ag [Presence] in Tissue by Immune stain |
| 16247-9 | Dextromethorphan [Mass/volume] in Serum or Plasma by Confirmatory method |
| 10993-4 | Nafcillin [Mass/volume] in Serum or Plasma |
| 16390-7 | Antidiuretics [Identifier] in Urine |
| 16475-6 | Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 11577-4 | Sulfamethoxazole [Susceptibility] by Gradient strip |
| 17567-9 | Sasapyrine [Mass/volume] in Serum or Plasma |
| 17937-4 | Bacteria # 2 identified in Burn by Culture |
| 90893-9 | Borrelia burgdorferi bba64 gene [Presence] in Blood by NAA with non-probe detection |
| 74680-0 | Amphetamine [Presence] in Saliva (oral fluid) by Confirmatory method |
| 91763-3 | Mycobacterium tuberculosis DNA [Presence] in Aspirate by NAA with probe detection |
| 75270-9 | Promethazine [Presence] in Serum or Plasma or Urine by Screen method |
| 6106-9 | Egg white IgE Ab [Units/volume] in Serum |
| 61198-8 | Raltegravir [Susceptibility] by Phenotype method |
| 75883-9 | dRVVT W excess hexagonal phospholipid (STA-StaClot confirm) |
| 9338-5 | Rheumatoid factor IgM [Units/volume] in Serum by Immunoassay |
| 93465-3 | 3-Methylfentanyl [Mass/volume] in Urine by Confirmatory method |
| 93689-8 | THSD7A IgG Ab [Titer] in Serum or Plasma by Cell binding immunofluorescent assay |
| 93759-9 | Influenza virus A PB2 gene [Nucleotide sequence] in Isolate by Sequencing |
| 93991-8 | Osmolality of Serum or Plasma--2 hours post fluid fast |
| 62428-8 | Bordetella sp DNA [Identifier] in Specimen by NAA with probe detection |
| 6261-2 | Sweet Vernal grass IgE Ab [Units/volume] in Serum |
| 78789-5 | Amoxapine [Mass/mass] in Hair |
| 95667-2 | Japanese encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay |
| 66136-3 | Myelocytes [#/volume] in Blood from Fetus by Manual count |
| 7971-5 | Naegleria fowleri Ab [Presence] in Cerebral spinal fluid |
| 9585-1 | Babesia sp IgM Ab [Titer] in Serum by Immunofluorescence |
| 96277-9 | carBAMazepine IgE Ab [Units/volume] in Serum |
| 6890-8 | Gamma globulin [Mass/volume] in 24 hour Urine |
| 69013-1 | Lymphocyte proliferation.phytohemagglutinin.maximum/CD3 in Blood by Flow cytometry (FC) |
| 96600-2 | Retinol and Alpha tocopherol panel - Serum or Plasma |
| 6995-5 | cefTAZidime [Susceptibility] by Gradient strip |
| 81771-8 | Myeloperoxidase IgG Ab [Presence] in Serum by Immunoblot |
| 81809-6 | 3-Hydroxydodecanoylcarnitine (C12-OH)/Creatinine [Molar ratio] in Urine |
| 9750-1 | Coxsackievirus A10 Ab [Titer] in Serum by Complement fixation |
| 83131-3 | Pregnanolone [Moles/time] in 24 hour Urine |
| 85501-5 | Carbapenem resistance blaVIM gene [Presence] by Molecular method |
| 72761-0 | Carisoprodol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 73204-0 | Pioglitazone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73276-8 | Methylprednisolone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87548-4 | Anaplasma phagocytophilum and Ehrlichia sp DNA panel - Blood Qualitative by NAA with non-probe detection |
| 41228-8 | Xanthine [Presence] in Serum |
| 5075-7 | Candida albicans Ag [Titer] in Serum by Latex agglutination |
| 42216-2 | Referral lab name [Identifier] |
| 42239-4 | Borrelia burgdorferi 39kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
| 42502-5 | Glycolate [Moles/volume] in Serum or Plasma |
| 21198-7 | Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma |
| 51307-7 | CD4+CD7-CD26- cells/100 cells in Tissue |
| 22183-8 | Chlamydia sp IgG Ab [Units/volume] in Cerebral spinal fluid |
| 51743-3 | Borrelia burgdorferi 49736 IgG Ab [Units/volume] in Serum by Immunoassay |
| 51776-3 | 7-Aminoclonazepam [Mass/volume] in Urine by Confirmatory method |
| 51841-5 | Echovirus IgM Ab [Titer] in Serum by Immunofluorescence |
| 4333-1 | Mezlocillin [Mass] of Dose |
| 22459-2 | Reagin Ab [Presence] in Cerebral spinal fluid |
| 52935-4 | Beryllium/Creatinine [Molar ratio] in Urine |
| 23184-5 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Presence] in Serum by Agglutination |
| 4455-2 | Trimethoprim [Mass] of Dose |
| 44730-0 | Progesterone/Estradiol (E2) [Mass Ratio] in Serum or Plasma |
| 23440-1 | Swine vesicular disease virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 33293-2 | Herpes simplex virus 1+2 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 33514-1 | Volume of Sweat |
| 54021-1 | Actin.filamentous Ab [Units/volume] in Serum or Plasma |
| 54318-1 | Methylmalonylcarnitine (C4-DC) [Moles/volume] in Amniotic fluid |
| 46955-1 | prednisoLONE [Mass/volume] in Urine |
| 47153-2 | EPINEPHrine [Moles/volume] in Plasma --pre 300 ug cloNIDine PO |
| 25199-1 | Rifabutin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 3489-2 | Clobenzorex [Mass/volume] in Urine |
| 35180-9 | Docosapentaenate (C22:5w3) [Moles/volume] in Serum or Plasma |
| 3533-7 | Desipramine [Presence] in Urine |
| 55608-4 | Turkey feather IgE Ab [Presence] in Serum |
| 55792-6 | Nucleated cells [#/volume] in Bone marrow |
| 55938-5 | Magnesium [Moles/volume] in Total parental nutrition |
| 47644-0 | Histidine/Amino acids.total in Hair |
| 47887-5 | Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose ornithine |
| 25996-0 | Tyrosine/Creatinine [Molar ratio] in 24 hour Urine |
| 35545-3 | Rice IgG Ab [Mass/volume] in Serum |
| 3571-7 | diphenhydrAMINE [Presence] in Urine |
| 35762-4 | Cefditoren [Susceptibility] |
| 26721-1 | 6-Monoacetylmorphine (6-MAM) [Mass/mass] in Hair |
| 35856-4 | Tylosin [Susceptibility] by Disk diffusion (KB) |
| 38230-9 | Calcium.ionized [Mass/volume] in Blood |
| 567-8 | Diphtheria identified in Specimen by Organism specific culture |
| 27020-7 | IgM.monoclonal [Presence] in Serum |
| 57328-7 | Influenza virus B IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 48916-1 | Respiratory allergen panel, US - North Atlantic states b - Serum |
| 49296-7 | Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis Narrative |
| 27293-0 | oxyCODONE Free [Mass/mass] in Stool |
| 3873-7 | Nortriptyline [Presence] in Serum or Plasma |
| 58711-3 | Doripenem [Susceptibility] by Gradient strip |
| 50010-8 | Transfusion end time |
| 2967-8 | Starch granules [Presence] in Stool by Light microscopy |
| 40398-0 | Thyrotropin [Units/volume] in Serum or Plasma --1 hour post dose triple bolus |
| 58904-4 | Nucleated cells [#/volume] in Pleural fluid by Manual count |
| 59050-5 | Chromosome analysis.interphase [Interpretation] in Specimen by FISH Narrative |
| 50514-9 | Lutropin [Units/volume] in Serum or Plasma --6th specimen |
| 20445-3 | Herpes virus identified in Specimen by Organism specific culture |
| 20473-5 | Polymorphonuclear cells [Presence] in Specimen by Wright stain |
| 101294-7 | Influenza virus A H3 RNA [Presence] in Throat by NAA with non-probe detection |
| 101447-1 | Contactin-associated protein 1 Ab.IgG and Neurofascin155 Ab.IgG4 panel - Serum or Plasma |
| 13084-9 | Phosphatidylinositol IgA Ab [Units/volume] in Serum |
| 13176-3 | Wasp venom IgE Ab [Units/volume] in Serum |
| 102068-4 | Perfluoroundecanoate [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 13447-8 | Creatinine renal clearance/1.73 sq M in 6 hour Urine and Serum or Plasma |
| 13498-1 | Dextromethamphetamine/Levomethamphetamine [Mass Ratio] in Urine |
| 13614-3 | Etiocholanolone [Mass/volume] in Serum or Plasma |
| 14360-2 | Microscopic observation [Identifier] in Pleural fluid by Gram stain |
| 1027-2 | Fy sup(a) Ag [Presence] on Red Blood Cells |
| 102813-3 | Annual Saltbush IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1445-6 | Cortisol [Mass/volume] in Serum or Plasma --pre 1 mg dexamethasone PO overnight |
| 103158-2 | Cells.CD15.recipient derived/Cells.CD15 in Blood --post bone marrow transplant |
| 103619-3 | Coagulation surface induced.lupus sensitive.buffer (LA control) in Platelet poor plasma by Coagulation assay |
| 10413-3 | Rh immune globulin given [Volume] |
| 14868-4 | Pathologist report of Plasma or RBC tests |
| 15027-6 | Androstenedione [Moles/volume] in Urine |
| 104347-0 | Borrelia recurrentis [Presence] in Cerebral spinal fluid by Organism specific culture |
| 10636-9 | Acanthamoeba sp identified in Eye by Wet preparation |
| 11058-5 | Phosphofructokinase [Enzymatic activity/volume] in Red Blood Cells |
| 17058-9 | Legionella pneumophila Ag [Presence] in Urine by Latex agglutination |
| 17846-7 | Lipoprotein.beta [Presence] in Serum or Plasma |
| 18997-7 | Trimethoprim [Susceptibility] |
| 90427-6 | Microorganism preliminary growth [Presence] in Blood by Anaerobic culture with antimicrobial neutralizer |
| 90806-1 | Candida albicans DNA [Presence] in Serum by NAA with probe detection |
| 74758-4 | Ethyl sulfate+Ethyl glucuronide [Presence] in Urine by Confirmatory method |
| 74989-5 | Pentacarboxylporphyrins [Moles/volume] in Serum or Plasma |
| 75648-6 | Methylenedioxymethamphetamine+Methylenedioxyamphetamine [Presence] in Blood |
| 61034-5 | 7-Aminoflunitrazepam [Presence] in Specimen |
| 61139-2 | Isocyanate TDI IgG Ab [Mass/volume] in Serum |
| 92866-3 | Herpes simplex virus 1 and 2 DNA panel - Serum or Plasma by NAA with probe detection |
| 61361-2 | Klebsiella aerogenes DNA [Presence] in Specimen by NAA with probe detection |
| 77353-1 | Noninvasive colorectal cancer DNA and occult blood screening [Interpretation] in Stool Narrative |
| 93860-5 | Toxoplasma gondii IgG Ab [Units/volume] in Serum from Donor by Immunoassay |
| 94275-5 | Honey bee acid phosphatase recombinant (rApi m) 3 IgE Ab [Units/volume] in Serum |
| 62454-4 | Herpes simplex virus and Varicella zoster virus identified in Specimen by Organism specific culture |
| 63081-4 | Brazil Nut IgG Ab [Mass/volume] in Serum |
| 63127-5 | Dill IgG Ab [Mass/volume] in Serum |
| 63261-2 | Gliadin IgG Ab [Titer] in Cerebral spinal fluid by Immunoassay |
| 78357-1 | Mycobacterium tuberculosis DNA [Presence] in Bronchoalveolar lavage by NAA with probe detection |
| 78752-3 | 11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Body fluid by Screen method |
| 947-2 | C Ag [Presence] on Red Blood Cells from Donor |
| 78879-4 | RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
| 79452-9 | Adenylosuccinate lyase [Enzymatic activity/substance] in Red Blood Cells |
| 9559-6 | CD5 cells [#/volume] in Blood |
| 65343-6 | Oxygen [Partial pressure] saturation adjusted to 0.5 in Blood |
| 80173-8 | Pterins pattern [Interpretation] in Cerebral spinal fluid Narrative |
| 9622-2 | Phytonadione [Mass/volume] in Serum or Plasma |
| 80628-1 | 1,1'-Sulfonylbis-2-Methylthioethane [Mass/volume] in Urine |
| 96557-4 | HIV 1 and 2 RNA panel - Serum or Plasma by NAA with probe detection |
| 96688-7 | Clot formation.diatomaceous earth+clay induced panel - Blood by Microviscometry |
| 97643-1 | Barmah forest virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 97654-8 | SMN2 gene copy number in Blood or Tissue by Molecular genetics method |
| 7108-4 | Acetylsalicylate IgE Ab [Units/volume] in Serum |
| 8227-1 | Phencyclidine [Mass/volume] in Gastric fluid |
| 8250-3 | Microscopic observation [Identifier] in Stool by Electron microscopy |
| 99024-2 | Proteus sp DNA [Presence] in Urine by NAA with probe detection |
| 73220-6 | oxyCODONE+Acetylsalicylate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87336-4 | Porcine circovirus type 2 DNA [Presence] in Specimen by NAA with probe detection |
| 87619-3 | Barium [Mass/mass] in Specimen |
| 74314-6 | PRRSV ORF5 gene RNA pattern [Identifier] in Isolate by RFLP |
| 89362-8 | CD45RO cells/100 CD4 cells in Blood |
| 41616-4 | Platelet Ab [Presence] in Serum by Flow cytometry (FC) |
| 31003-7 | Grass Allergen Mix 6 (Brome+Bermuda grass+Velvet grass+Perennial rye grass+Bahia grass+Johnson grass) IgE Ab [Presence] in Serum by Multidisk |
| 42531-4 | Spermatozoa Motile [#/volume] in Semen |
| 60070-0 | Dichlorvos [Mass/volume] in Blood |
| 6025-1 | Aspergillus fumigatus IgE Ab [Units/volume] in Serum |
| 31297-5 | Chlamydia trachomatis D+K IgG Ab [Units/volume] in Serum |
| 31499-7 | Ganglioside GM1 IgG Ab [Units/volume] in Serum |
| 43162-7 | Monochloramine [Mass/volume] in Water |
| 21734-9 | RET gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 22122-6 | Borrelia burgdorferi Ab [Titer] in Serum |
| 22649-8 | Valine [Moles/volume] in Cerebral spinal fluid |
| 32284-2 | BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 52757-2 | SERPINE1 gene c.-675 4G+5G [Presence] in Blood or Tissue by Molecular genetics method |
| 43837-4 | Influenza virus A IgG Ab [Presence] in Serum |
| 22822-1 | Influenza virus A Ab [Presence] in Serum by Immunoassay |
| 22997-1 | Chlamydophila psittaci Ag [Presence] in Specimen by Immune stain |
| 32712-2 | Giant platelets/100 leukocytes [Ratio] in Blood by Manual count |
| 32775-9 | Clostridium tetani toxoid Ab [Units/volume] in Serum |
| 53162-4 | Propionylcarnitine (C3)/Carnitine.free (C0) [Molar ratio] in DBS |
| 3411-6 | Bumetanide [Mass/time] in 24 hour Urine |
| 34600-7 | HC gene rearrangements [Presence] in Cerebral spinal fluid by Molecular genetics method |
| 4743-1 | HLA-B22 [Presence] |
| 56130-8 | Chikungunya virus IgM Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 47547-5 | 5-Methyltetrahydrofolate [Moles/volume] in Cerebral spinal fluid |
| 47563-2 | Arginine/Amino acids.total in Serum or Plasma |
| 47649-9 | Histidine/Amino acids.total in Specimen |
| 25739-4 | Prolactin [Mass/volume] in Serum or Plasma --30 minutes post 200 ug TRH IV |
| 2592-4 | Macroglobulin [Mass/volume] in Serum or Plasma |
| 56368-4 | Radish IgG4 Ab [Mass/volume] in Serum |
| 26569-4 | CD4+CD29+ cells [#/volume] in Blood |
| 26601-5 | Alpha aminoadipate/Creatinine [Molar ratio] in Urine |
| 57012-7 | Osteoblasts/100 cells in Bone marrow by Manual |
| 48643-1 | Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) |
| 48913-8 | Rickettsia rickettsii IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 40227-1 | Calcium [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 58735-2 | Alpha-1-Fetoprotein panel - Amniotic fluid |
| 49998-8 | Borrelia burgdorferi 83/93kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 59145-3 | CD11c+CD103+ cells [#/volume] in Blood |
| 30036-8 | Aspergillus fumigatus 2 Ab [Presence] in Serum by Immune diffusion (ID) |
| 30262-0 | Insulin [Units/volume] in Serum or Plasma --3.6 hours post XXX challenge |
| 19516-4 | Levorphanol [Presence] in Urine by Screen method |
| 1961-2 | Bicarbonate [Moles/volume] in Capillary blood |
| 19759-0 | Swine serum albumin IgE Ab [Units/volume] in Serum |
| 100893-7 | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma |
| 101536-1 | Salmonella sp whole genome [Nucleotide sequence] in Isolate by Sequencing |
| 13173-0 | Fibronectin aggregate IgA Ab [Units/volume] in Serum |
| 13275-3 | Toxocara canis IgM Ab [Units/volume] in Serum |
| 102081-7 | CAR-T cells total [#] in Blood product unit |
| 102152-6 | Aspen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102264-9 | Cucumber IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14745-4 | Glucose [Moles/volume] in Body fluid |
| 15120-9 | Ethanol [Moles/volume] in Blood |
| 104422-1 | Leptospira sp Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 104465-0 | Yersinia enterocolitica O:3 Ab [Presence] in Stool |
| 16179-4 | Polychlorinated biphenyl (PCB) [Mass/mass] in Tissue |
| 10889-4 | Bisacodyl [Mass/mass] in Stool |
| 11564-2 | Intrinsic factor Ab [Units/volume] in Serum |
| 17087-8 | Loperamide [Mass/volume] in Serum or Plasma |
| 17469-8 | PM-1 Ab [Units/volume] in Serum |
| 1762-4 | Aldosterone [Mass/volume] in Blood |
| 18992-8 | Terbinafine [Susceptibility] |
| 74671-9 | Cocaine [Presence] in Saliva (oral fluid) by Confirmatory method |
| 91896-1 | Mycoplasma pneumoniae Ab [Titer] in Serum by Agglutination |
| 6115-0 | False ragweed IgE Ab [Units/volume] in Serum |
| 6207-5 | Pear IgE Ab [Units/volume] in Serum |
| 77106-3 | SARS2 gene full mutation analysis in Blood or Tissue by Sequencing |
| 94859-6 | Glycerol and glycerol-corrected triglyceride panel - Serum or Plasma |
| 6713-2 | Baker's yeast IgG Ab [Units/volume] in Serum |
| 79579-9 | Alanylproline/Creatinine [Molar ratio] in Urine |
| 79656-5 | N-carbamoyl beta alanine [Moles/volume] in Serum or Plasma |
| 80172-0 | Pterins pattern [Interpretation] in Serum or Plasma Narrative |
| 96285-2 | Indomethacin IgE Ab [Units/volume] in Serum |
| 6881-7 | Ethanolamine [Mass/time] in 24 hour Urine |
| 96802-4 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose arginine |
| 69567-6 | Megasphaera sp type 1 DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 97781-9 | Sodium [Moles/volume] in Dialysis fluid --4 hour specimen |
| 82792-3 | Clot density in Platelet poor plasma |
| 98411-2 | Cryptosporidium sp [Identifier] in Isolate by RFLP.rRNA |
| 85544-5 | PRRSV Ab/Positive control in Serum or Plasma by Immunoassay |
| 99107-5 | Stimulants drug panel - Urine by Screen method |
| 99920-1 | Amorphous sediment [#/volume] in Urine sediment by Automated count |
| 72620-8 | Norpropoxyphene [Presence] in Saliva (oral fluid) |
| 86203-7 | Lawsonia intracellularis Ag [Presence] in Tissue by Immune stain |
| 73305-5 | Lidocaine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87615-1 | Sulfate [Mass/mass] in Specimen |
| 73567-0 | Propoxyphene [Presence] in Meconium by Screen method |
| 88341-3 | Cerumen [Presence] in Ear |
| 73976-3 | CD158b cells/100 cells in Specimen |
| 74438-3 | Lactose/Creatinine [Molar ratio] in Urine |
| 4126-9 | Amphotericin B [Mass] of Dose |
| 41695-8 | Everninomicin [Susceptibility] by Gradient strip |
| 4174-9 | Clorazepate [Mass] of Dose |
| 50651-9 | Food Allergen Mix 26 (Peanut+Cow milk+Egg white+Mustard) IgE Ab [Units/volume] in Serum by Multidisk |
| 50855-6 | Hexacarboxylporphyrin [Moles/mass] in Stool |
| 42200-6 | DNA double strand Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
| 60052-8 | Alphapinene [Mass/volume] in Blood |
| 31547-3 | Pancreatic islet cell Ab [Presence] in Serum |
| 51186-5 | CD15 Ag [Presence] in Bone marrow by Immune stain |
| 42777-3 | AKT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 42970-4 | Pseudallescheria boydii IgG Ab [Presence] in Serum |
| 43111-4 | Herpes simplex virus 1 Ab [Presence] in Serum |
| 31678-6 | Ganglioside GQ1b IgG Ab [Units/volume] in Serum |
| 43584-2 | Bizarre cells [Presence] in Blood by Light microscopy |
| 22381-8 | Legionella pneumophila 1 IgG Ab [Titer] in Serum |
| 32554-8 | Thiamine [Moles/volume] in Blood |
| 52750-7 | Activated protein C resistance [Presence] in Platelet poor plasma by Coagulation assay |
| 44314-3 | D-Lactate/Creatinine [Molar ratio] in Urine |
| 53125-1 | Monocytes+Macrophages/100 leukocytes in Bone marrow |
| 53231-7 | Succinylacetone [Moles/volume] in DBS |
| 4485-9 | Complement C3 [Mass/volume] in Serum or Plasma |
| 23335-3 | Ovine progressive pneumonia virus Ag [Presence] in Specimen by Immune stain |
| 23358-5 | Peste des petits ruminants virus RNA [Presence] in Tissue by Probe |
| 33635-4 | PM-SCL extractable nuclear Ab [Mass/volume] in Serum by Immune diffusion (ID) |
| 53545-0 | Dodeicosanoylcarnitine (C22) [Moles/volume] in Cerebral spinal fluid |
| 45013-0 | Adenosine monophosphate.cyclic [Moles/volume] in Urine --2 hours post XXX challenge |
| 23873-3 | Heptacarboxylporphyrin III [Mass/time] in unspecified time Stool |
| 33960-6 | Immune complex IgE [Units/volume] in Serum or Plasma |
| 24194-3 | Coxsackievirus B5 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 2493-5 | Iodine Free [Mass/volume] in Urine |
| 34478-8 | Blood group antibodies identified in Blood by Chromogenic method |
| 55166-3 | Hepatitis G virus E2 Ab [Presence] in Serum |
| 47237-3 | Treponema pallidum IgM Ab [Presence] in Serum by Immunoassay |
| 34913-4 | Immature eosinophils/100 leukocytes in Blood |
| 25572-9 | C peptide [Moles/volume] in Serum or Plasma --14th specimen post XXX challenge |
| 3566-7 | Dimetamphetamine [Mass/time] in 24 hour Urine |
| 56160-5 | Glucose [Mass/volume] in Peritoneal dialysis fluid --4 hours post peritoneal dialysis |
| 56338-7 | Orange IgG4 Ab [Mass/volume] in Serum |
| 56396-5 | Chestnut IgG4 Ab [Mass/volume] in Serum |
| 56985-5 | Taurine/Creatinine [Ratio] in 24 hour Urine |
| 38361-2 | Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgG Ab [Mass/volume] in Serum by Multidisk |
| 38476-8 | Mullerian inhibiting substance [Mass/volume] in Serum or Plasma |
| 49251-2 | Amylase isoenzymes [Interpretation] in Serum or Plasma Narrative |
| 38994-0 | Histiocytes [Presence] in Urine sediment by Light microscopy |
| 49537-4 | Influenza virus A and B RNA [Identifier] in Isolate by NAA with probe detection |
| 49590-3 | Calcidiol and Calciferol panel - Serum or Plasma |
| 49706-5 | ARSA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2877-9 | Prealbumin [Mass/volume] in Serum or Plasma by Electrophoresis |
| 40190-1 | Glucose [Moles/volume] in Serum or Plasma --22 hours post XXX challenge |
| 58414-4 | Herpes simplex virus 1+2 DNA [Presence] in Amniotic fluid by NAA with probe detection |
| 29564-2 | Powassan virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 29635-0 | Albuterol [Presence] in Urine |
| 40593-6 | Platelet aggregation EPINEPHrine induced [Units/volume] in Platelet rich plasma --50 umol/L |
| 30012-9 | Borrelia burgdorferi 28kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
| 19524-8 | Lormetazepam [Presence] in Urine by Screen method |
| 12604-5 | Hydroxyethylflurazepam [Presence] in Stool |
| 12617-7 | Glucose [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 101772-2 | Microsporum canis DNA [Presence] in Specimen by NAA with probe detection |
| 101977-7 | Cortisol, glucose and somatotropin post glucagon stimulation panel - Serum or Plasma |
| 13891-7 | Motilin [Mass/volume] in Serum or Plasma |
| 102311-8 | Flounder IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102362-1 | Hazelnut Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102515-4 | Phthalic anhydride IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103013-9 | Aspergillus fumigatus recombinant (rAsp f) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15021-9 | Amylase.P2/Amylase.total in Serum or Plasma |
| 10654-2 | Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC) |
| 11087-4 | Insulin Ab [Titer] in Serum |
| 11272-2 | MCV [Entitic volume] in Cord blood by Automated count |
| 17602-4 | Volume of Seminal plasma |
| 91107-3 | Cholesterol in LDL 3 [Mass/volume] in Serum or Plasma |
| 92734-3 | Voxilaprevir [Susceptibility] by Genotype method |
| 75096-8 | Fatty acids.very long chain C26:0 (Hexacosanoate) [Entitic substance] in Red Blood Cells |
| 93697-1 | Liver steatosis interpretation in Serum or Plasma Qualitative |
| 61295-2 | Parsley IgE Ab/IgE total in Serum |
| 77206-1 | Norbuprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method |
| 77649-2 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 93711-0 | Epstein Barr virus Ab panel - Serum from Donor |
| 9380-7 | Heptacarboxylporphyrin [Mass/time] in unspecified time Stool |
| 77764-9 | Buprenorphine cutoff [Mass/volume] in Urine for Confirmatory method |
| 77773-0 | Morphine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 77927-2 | Cortisol [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge |
| 78821-6 | Desipramine cutoff [Mass/volume] in Urine for Confirmatory method |
| 78849-7 | JWH-210 5-Hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
| 9481-3 | pH of Water |
| 9484-7 | Silver [Mass/volume] in Water |
| 95423-0 | Influenza virus A and B and SARS-CoV-2 (COVID-19) identified in Respiratory system specimen by NAA with probe detection |
| 81138-0 | Spermatozoa Aggregated [Presence] in Semen |
| 96651-5 | HLA-DPB1 unresolved alleles [Type] by High resolution |
| 81803-9 | Beta cortolone/Creatinine [Molar ratio] in Urine |
| 82191-8 | Herpes simplex virus 2 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
| 9729-5 | Canary serum proteins IgE Ab [Units/volume] in Serum |
| 98252-0 | Histologic grade in Endometrial cancer specimen Qualitative |
| 98979-8 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021) |
| 99026-7 | Providencia stuartii DNA [Presence] in Urine by NAA with probe detection |
| 72494-8 | Cytomegalovirus DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 72500-2 | Homocyst(e)ine [Moles/volume] in Serum or Plasma --fasting |
| 72843-6 | Hepatitis B virus codon 215 [Identifier] by Genotype method |
| 72934-3 | Vancomycin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73076-2 | Neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87330-7 | Porcine circovirus type 2 neutralizing antibody [Titer] in Serum by Neutralization test |
| 87545-0 | Beta-N-acetylhexosaminidase.A and beta-N-acetylhexosaminidase panel - Serum or Plasma |
| 87722-5 | Complement C1q.functional [Units/volume] in Serum or Plasma |
| 73643-9 | Finafloxacin [Susceptibility] by Disk diffusion (KB) |
| 87787-8 | guaiFENesin/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 87945-2 | Borrelia sp identified in Cerebral spinal fluid by Organism specific culture |
| 73968-0 | Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
| 89044-2 | Basic metabolic and albumin panel - Serum or Plasma |
| 59351-7 | Nortamoxifen [Mass/volume] in Serum or Plasma |
| 59900-1 | Fenoprofen [Moles/volume] in Urine |
| 41840-0 | Coxiella burnetii phase 1 and 2 IgG panel [Titer] - Serum |
| 41994-5 | CD4+CD45RO+ cells/100 cells in Blood |
| 59924-1 | Meperidine [Moles/volume] in Serum or Plasma |
| 60286-2 | Ascorbate [Moles/volume] in Specimen |
| 21289-4 | Gastrin [Mass/volume] in Serum or Plasma --2 hours post 0.2 U/kg secretin |
| 31273-6 | Bovine herpesvirus 1 Ab [Units/volume] in Serum |
| 21737-2 | SNCA gene p.Ala53Thr [Presence] in Blood or Tissue by Molecular genetics method |
| 31886-5 | Measles virus Ag [Presence] in Urethra |
| 51660-9 | Hepatitis A virus IgM Ab [Presence] in Body fluid |
| 43391-2 | Bacterial vaginosis score |
| 43866-3 | Bartonella sp Ab [Presence] in Serum |
| 22845-2 | Babesia bigemina Ab [Presence] in Serum by Immunofluorescence |
| 23096-1 | Equine infectious anemia virus Ab [Presence] in Serum by Immunoblot |
| 32680-1 | Fine Granular Casts [#/area] in Urine sediment by Microscopy low power field |
| 33048-0 | Eosin-5-Maleimide binding [Presence] in Blood by Flow cytometry (FC) |
| 44599-9 | IgG.monoclonal [Presence] in Cerebral spinal fluid by Immunofixation |
| 46998-1 | TCRB and HC gene rearrangements in Blood or Tissue by Molecular genetics method |
| 55549-0 | Methocarbamol [Moles/volume] in Serum or Plasma |
| 47118-5 | Maprotiline [Moles/volume] in Urine |
| 25342-7 | Fasciola sp Ab [Titer] in Serum |
| 25360-9 | Cadmium [Moles/volume] in Urine |
| 35017-3 | Myelocytes [#/volume] in Cerebral spinal fluid |
| 55830-4 | Catecholamines [Moles/volume] in Cerebral spinal fluid |
| 56463-3 | Rough Pigweed IgG4 Ab [Mass/volume] in Serum |
| 47947-7 | Thyrotropin [Units/volume] in Serum or Plasma --1.5 hours post dose luteinizing releasing hormone IV |
| 26520-7 | Polymorphonuclear cells/100 leukocytes in Peritoneal fluid |
| 26667-6 | Chlamydia trachomatis I Ab [Presence] in Serum |
| 35802-8 | Ertapenem [Susceptibility] |
| 48776-9 | Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Cerebral spinal fluid |
| 27118-9 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum |
| 27180-9 | Bisacodyl [Mass/volume] in Urine |
| 3827-3 | Morphine [Mass/volume] in Serum or Plasma |
| 38612-8 | Naphthalene [Mass/volume] in Air |
| 49111-8 | Spermatozoa [#/area] in Urine sediment by Microscopy high power field |
| 277-4 | Hetacillin [Susceptibility] by Serum bactericidal titer |
| 27833-3 | Insulin [Units/volume] in Serum or Plasma --7 hours post 75 g glucose PO |
| 27843-2 | Somatotropin [Mass/volume] in Serum or Plasma --20th specimen post XXX challenge |
| 2796-1 | Phosphofructokinase M subunit/Phosphofructokinase.total in Red Blood Cells |
| 27981-0 | 2-Hydroxyisobutyrate [Presence] in Urine |
| 28072-7 | Dihydrocodeine+Hydrocodeinone [Mass/mass] in Stool |
| 38714-2 | Pentachloronitrobenzene [Mass/volume] in Air |
| 38902-3 | LITAF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 3933-9 | Phenazocine [Mass/time] in 24 hour Urine |
| 49350-2 | Cytomegalovirus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
| 28602-1 | Beta aminoisobutyrate/Creatinine [Ratio] in Urine |
| 2902-5 | Pyrimidine-5'-Nucleotidase [Presence] in Blood |
| 58829-3 | Cortisol [Mass/volume] in Serum or Plasma --15th specimen |
| 59175-0 | QUEtiapine metabolite [Presence] in Urine |
| 50249-2 | 17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
| 50487-8 | Gastrin [Mass/volume] in Serum or Plasma --3rd specimen |
| 29994-1 | Basement membrane IgG Ab [Presence] in Serum by Immunofluorescence |
| 30256-2 | Insulin [Units/volume] in Serum or Plasma --1.3 hours post XXX challenge |
| 19223-7 | Carbon dioxide, total [Moles/volume] in Mixed venous blood |
| 19573-5 | MethylePHEDrine [Presence] in Urine by Screen method |
| 2033-9 | Carbonate [Mass/volume] in Arterial blood |
| 2034-7 | Carbonate [Mass/volume] in Venous blood |
| 20762-1 | Clostridioides difficile [Presence] in Stool by Aerobe culture |
| 20771-2 | Coliform bacteria [#/mass] in Egg by Viability count |
| 20877-7 | Bacteria identified in Isolate by Animal inoculation |
| 20995-7 | Cortisol [Interpretation] in Serum or Plasma--1 hour post dose corticotropin |
| 100107-2 | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay |
| 100872-1 | Bacteria producing polysaccharide from sucrose [Presence] in Isolate |
| 12553-4 | Stimulants [Identifier] in Urine |
| 13560-8 | fluvoxaMINE [Presence] in Serum or Plasma |
| 104174-8 | DPYD gene.c.1679T>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 10648-4 | Babesia sp identified in Blood by Thin film |
| 15444-3 | Influenza virus A Ab [Presence] in Serum by Immune diffusion (ID) |
| 10739-1 | Virus identified in Specimen by Electron microscopy |
| 11262-3 | Parainfluenza virus 3 IgG Ab [Titer] in Serum |
| 17174-4 | CD54 cells/100 cells in Blood |
| 17281-7 | Microscopic observation [Identifier] in Sputum by KOH preparation |
| 17496-1 | Alpha 1 globulin [Mass/volume] in Body fluid by Electrophoresis |
| 17507-5 | quiNIDine [Mass/volume] in Urine |
| 17795-6 | Potassium [Moles/volume] in Hyperal solution |
| 18388-9 | diazePAM [Presence] in Urine by Confirmatory method |
| 18977-9 | Rosoxacin [Susceptibility] |
| 90273-4 | Bacteria identified in Catheter tip by Anaerobe culture |
| 75013-3 | t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
| 91846-6 | Treponema pallidum DNA [Presence] in Genital specimen by NAA with probe detection |
| 75364-0 | Urea [Moles/volume] in Vitreous fluid |
| 7694-3 | Scorpion IgE Ab [Units/volume] in Serum |
| 61346-3 | Rat urine proteins IgE Ab/IgE total in Serum |
| 93702-9 | Platelet aggregation ristocetin induced in Platelet rich plasma --15 ug/mL |
| 78815-8 | Carisoprodol [Mass/volume] in Blood by Confirmatory method |
| 63349-5 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) |
| 63572-2 | Time received in laboratory of Specimen |
| 6604-3 | Influenza virus identified in Specimen by Organism specific culture |
| 66113-2 | Uterus Pathology biopsy report |
| 66760-0 | Coagulation index in Blood by Thromboelastography |
| 79643-3 | 5-S-cysteinyldopa/Creatinine [Molar ratio] in Urine |
| 80128-2 | Amisulpride [Mass/mass] in Hair |
| 8096-0 | Somatotropin Ab [Units/volume] in Serum or Plasma |
| 6941-9 | Albumin [Mass/time] in 24 hour Urine by Electrophoresis |
| 69573-4 | Tiglylcarnitine+methylcrotonylcarnitine (C5:1) [Moles/volume] in Serum or Plasma |
| 81759-3 | Lymphocyte proliferation.anti-CD28.maximum/CD45 in Blood by Flow cytometry (FC) |
| 8191-9 | Cocaine [Presence] in Serum or Plasma by Screen method |
| 82051-4 | Food Allergen Mix 10 (Beef+Chicken meat+Egg yolk+Pork+Turkey meat) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 7016-9 | Gentamicin [Susceptibility] by Gradient strip |
| 8267-7 | Service comment 06 |
| 82924-2 | PL-7 IgG Ab [Presence] in Serum by Immunoassay |
| 98233-0 | Cape gooseberry IgE Ab [Units/volume] in Serum |
| 98961-6 | Lurasidone [Presence] in Urine by Confirmatory method |
| 98981-4 | Urate [Mass/volume] in Blood |
| 72389-0 | Candida krusei DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 72905-3 | Neutrophil Ab and HLA Ab screen panel - Serum or Plasma |
| 87305-9 | Clostridium perfringens cpb2 gene [Presence] in Isolate by NAA with probe detection |
| 87471-9 | Iron [Mass/volume] in Specimen |
| 87785-2 | Oxaprozin/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 88535-0 | Cytomegalovirus DNA [Presence] in DBS by NAA with probe detection |
| 74220-5 | Dabigatran [Mass/volume] in Platelet poor plasma by Coagulation assay |
| 74361-7 | Dehydroepiandrosterone (DHEA) [Moles/volume] in Saliva (oral fluid) |
| 41610-7 | Tube number of Pericardial fluid |
| 41726-1 | ABT492 [Susceptibility] |
| 59611-4 | ALPRAZolam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 59617-1 | chlordiazePOXIDE [Mass/volume] in Blood |
| 51025-5 | CD117 blasts/100 blasts in Bone marrow |
| 51029-7 | CD117 blasts [Units/volume] in Blood |
| 4236-6 | ePHEDrine [Mass] of Dose |
| 42581-9 | Babesia sp IgG Ab [Presence] in Serum |
| 60271-4 | Respiratory syncytial virus RNA [Presence] in Isolate by NAA with probe detection |
| 31253-8 | Basement membrane IgA Ab [Presence] in Serum |
| 31408-8 | Hantavirus sin nombre IgG Ab [Units/volume] in Serum |
| 31506-9 | Mumps virus particle-bound Ab [Units/volume] in Cerebral spinal fluid |
| 51232-7 | CD11c cells/100 cells in Body fluid |
| 4339-8 | N-acetylprocainamide [Mass] of Dose |
| 22719-9 | Leucine [Moles/volume] in Specimen |
| 53039-4 | Genetic disease analysis overall carrier interpretation |
| 43956-2 | CD4+CD45RO+ cells [#/volume] in Specimen |
| 53175-6 | Octanoylcarnitine (C8) [Moles/volume] in DBS |
| 44744-1 | La Crosse virus Ab [Presence] in Serum by Immunofluorescence |
| 53931-2 | Histoplasma capsulatum Ag [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 54074-0 | Hemoglobin F/Hemoglobin.total in DBS |
| 54198-7 | Piperacillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 54268-8 | Glucose [Moles/volume] in Serum or Plasma --pre dose ornithine alpha-ketoglutarate |
| 54443-7 | Echovirus 2 Ab [Titer] in Serum |
| 46216-8 | Mycobacterium tuberculosis tuberculin stimulated gamma interferon/Mitogen stimulated gamma interferon [Units/volume] in Control Blood |
| 46237-4 | Kappa lymphocytes/100 lymphocytes in Bone marrow |
| 3437-1 | Carisoprodol [Mass/volume] in Serum or Plasma |
| 34682-5 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor V depleted plasma |
| 47137-5 | EPINEPHrine [Moles/volume] in Plasma --2 hours post 300 ug cloNIDine PO |
| 55897-3 | Immunoglobulin light chains.free [Presence] in Serum by Immunoelectrophoresis |
| 47799-2 | Valine [Moles/volume] in DBS |
| 25613-1 | Smoky Brown Cockroach IgE Ab [Units/volume] in Serum |
| 35431-6 | Herpes simplex virus identified in Tissue by Organism specific culture |
| 35577-6 | Hypersensitivity pneumonitis panel - Serum |
| 56217-3 | Chick Pea IgG4 Ab [Mass/volume] in Serum |
| 56257-9 | English plantain IgG4 Ab [Mass/volume] in Serum |
| 56344-5 | Paper wasp IgG4 Ab [Mass/volume] in Serum |
| 56471-6 | Direct antiglobulin test.complement C3c specific reagent [Presence] on Red Blood Cells |
| 47949-3 | Thyrotropin [Units/volume] in Serum or Plasma --15 minutes pre dose luteinizing releasing hormone IV |
| 47982-4 | Epstein Barr virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 48087-1 | 3-Hydroxytetradecanedioate/Creatinine [Molar ratio] in Urine |
| 369-9 | Norfloxacin [Susceptibility] by Serum bactericidal titer |
| 56646-3 | Trichloroacetate/Creatinine [Ratio] in Urine |
| 48405-5 | Neuronal nuclear IgG Ab [Presence] in Serum by Immunofluorescence |
| 48773-6 | Kappa light chains/Lambda light chains [Mass Ratio] in Cerebral spinal fluid |
| 27185-8 | Chlamydia trachomatis IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 49048-2 | Protein feed time |
| 49261-1 | Cryoproteins [Interpretation] in Serum by Electrophoresis agarose gel Narrative |
| 3951-1 | PHENobarbital Free [Mass/volume] in Serum or Plasma |
| 5771-1 | Bilirubin crystals [Presence] in Urine sediment by Light microscopy |
| 49359-3 | Hepatitis B virus DNA [Log #/volume] (viral load) in Bone marrow by NAA with probe detection |
| 49582-0 | Trisomy 18 risk cutoff in Fetus |
| 39988-1 | Creatinine [Mass/volume] in Urine --3 hours post XXX challenge |
| 58612-3 | Corticotropin [Mass/volume] in Plasma --75 minutes post dose insulin IV |
| 58705-5 | cefTAZidime [Susceptibility] by Method for Slow-growing mycobacteria |
| 29628-5 | 3-Methylcrotonylglycine [Presence] in Urine |
| 50272-4 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --6 hours post dose ifosfamide |
| 30145-7 | Monocytes [#/volume] in Synovial fluid by Manual count |
| 41123-1 | Toxoplasma gondii HS Ab [Units/volume] in Serum |
| 20392-7 | Sample icteric [Presence] of Serum or Plasma Qualitative |
| 20417-2 | Histoplasma capsulatum mycelial phase Ab [Titer] in Serum |
| 20458-6 | Rubella virus IgG Ab [Interpretation] in Serum |
| 20754-8 | Chlamydophila psittaci Ab [Presence] in Serum by Complement fixation |
| 100406-8 | Butter IgG Ab [Units/volume] in Serum |
| 1323-5 | U Ab [Presence] in Serum or Plasma from Blood product unit |
| 1330-0 | V Ab [Presence] in Serum or Plasma from Donor |
| 13557-4 | Norsertraline [Presence] in Serum or Plasma |
| 13833-9 | Finch feather IgE Ab [Units/volume] in Serum |
| 102348-0 | Sorghum grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104218-3 | Spermatozoa Nonprogressive/100 spermatozoa in Urine --post ejaculation |
| 14998-9 | Thyrotropin [Units/volume] in Serum or Plasma --1 hour post dose TRH IV |
| 10479-4 | CD227 Ag [Presence] in Tissue by Immune stain |
| 15251-2 | Food Allergen Mix 21 (Kiwi+Pineapple+Melon+Banana+Peach) IgE Ab [Presence] in Serum by Multidisk |
| 11043-7 | Cryofibrinogen [Presence] in Plasma |
| 11551-9 | Borrelia burgdorferi DNA [Presence] in Cerebral spinal fluid by Probe with amplification |
| 17341-9 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 1741-8 | Alanine aminotransferase [Enzymatic activity/volume] in Amniotic fluid |
| 17502-6 | Pseudomonas aeruginosa Ab [Units/volume] in Serum |
| 17565-3 | Salmonella typhi H D Ab [Presence] in Serum by Latex agglutination |
| 17609-9 | Weight [Mass/time] of 72 hour Stool |
| 18218-8 | Epidermis IgM Ab [Presence] in Tissue |
| 18263-4 | Cholesterol in HDL [Mass/volume] in Serum or Plasma ultracentrifugate |
| 1865-5 | Anserine [Presence] in Serum or Plasma |
| 18921-7 | Ethambutol [Susceptibility] |
| 90902-8 | HIV 1 RNA reverse transcriptase gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing |
| 74485-4 | CD3 and CD20 Ag [Identifier] in Tissue by Immune stain |
| 74545-5 | Tryptophan-related indole profiling panel - Platelet rich plasma |
| 74759-2 | Yeast [Presence] in Specimen by Gram stain |
| 91790-6 | Trichomonas vaginalis [Presence] in Genital specimen by Organism specific culture |
| 91865-6 | Bacteria identified in Genital specimen by Anaerobe culture |
| 60377-9 | Grapefruit IgG Ab [Mass/volume] in Serum |
| 60402-5 | Sesame Seed IgG Ab [Mass/volume] in Serum |
| 61060-0 | Temazepam [Presence] in Urine |
| 61115-2 | Mitochondria DNA complex IV targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 76347-4 | Dehydroepiandrosterone sulfate (DHEA-S)/Cortisol [Molar ratio] in Serum or Plasma |
| 76587-5 | Streptococcus pneumoniae nanA gene [#/mass] in XXX.tissue by NAA with probe detection |
| 93908-2 | Au sup(b) Ag [Presence] on Red Blood Cells |
| 6259-6 | Chestnut IgE Ab [Units/volume] in Serum |
| 78445-4 | Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay |
| 94567-5 | Valine [Moles/volume] in Serum or Plasma --post therapeutic diet |
| 63482-4 | Methotrimeprazine [Mass/volume] in Serum or Plasma |
| 6405-5 | Ehrlichia sp Ab [Presence] in Serum by Immunoassay |
| 78993-3 | Prolactin isoforms panel - Serum or Plasma |
| 79146-7 | Tapentadol [Presence] in Blood by Screen method |
| 79308-3 | Gamma butyrobetaine [Moles/volume] in Serum or Plasma |
| 95362-0 | Pancreatic exocrine function panel - Body fluid |
| 96362-9 | Dextrorphan [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 6991-4 | cefOXitin [Susceptibility] by Gradient strip |
| 82076-1 | Food Allergen Mix 74 (Herring+Cod+Plaice+Mackerel) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 82780-8 | Borrelia miyamotoi flaB gene [Presence] in Tick by NAA with probe detection |
| 99054-9 | Manual differential comment [Interpretation] in Bronchoalveolar lavage Narrative |
| 83133-9 | Pregnanolone/Creatinine [Molar ratio] in Urine |
| 72635-6 | PENTobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 72901-2 | Insulin [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
| 86046-0 | Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum by Immunoassay |
| 87473-5 | Cobalt [Mass/mass] in Specimen |
| 87591-4 | Sulfathiazole [Mass/mass] in Specimen |
| 88006-2 | Octanoylcarnitine (C8)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma |
| 41279-1 | Borrelia burgdorferi IgG Ab/IgM Ab [Ratio] in Serum |
| 59885-4 | chlorproMAZINE [Moles/volume] in Gastric fluid |
| 50858-0 | Hydrogen ion [Moles/volume] in Mixed venous cord blood |
| 30558-1 | Sodium [Moles/volume] in Total parental nutrition |
| 60079-1 | Germanium [Mass/volume] in Blood |
| 60184-9 | Terazosin [Mass/volume] in Serum or Plasma |
| 21534-3 | Spermatozoa Motile/100 spermatozoa in Semen --4 hours post ejaculation |
| 31484-9 | Leptospira sp IgG Ab [Units/volume] in Cerebral spinal fluid |
| 22246-3 | Cytomegalovirus IgG Ab [Titer] in Serum or Plasma |
| 31691-9 | Trypanosoma cruzi IgG Ab [Units/volume] in Specimen |
| 31710-7 | Adenovirus Ag [Presence] in Conjunctival specimen |
| 31950-9 | Respiratory syncytial virus Ag [Presence] in Specimen |
| 22713-2 | Lysine [Moles/volume] in Specimen |
| 32155-4 | Basophils+Eosinophils+Monocytes/100 leukocytes in Blood by Automated count |
| 52117-9 | Bx Ab [Presence] in Serum or Plasma |
| 52749-9 | Etravirine [Susceptibility] by Genotype method |
| 23107-6 | Foot and mouth disease virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 32731-2 | Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
| 53077-4 | Levodopa [Moles/volume] in Cerebral spinal fluid |
| 44592-4 | IgD [Presence] in Serum |
| 53869-4 | HPRT1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 23789-1 | Vesicular stomatitis Indiana virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 23984-8 | Borrelia burgdorferi IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 24197-6 | Coxsackievirus B6 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24333-7 | Amylase isoenzyme 3 panel - Serum or Plasma |
| 24418-6 | Formononetin [Mass/volume] in Serum or Plasma |
| 2491-9 | Inulin renal clearance in 24 hour Urine and Serum or Plasma |
| 55200-0 | Carnitine [Moles/volume] in Body fluid |
| 47077-3 | Legionella pneumophila 7 IgM Ab [Titer] in Serum by Immunofluorescence |
| 47100-3 | Copper [Moles/volume] in Blood |
| 34944-9 | Cytomegalovirus IgG and IgM panel - Cerebral spinal fluid |
| 5629-1 | Copper [Mass/mass] in Hair |
| 48218-2 | Peanut triggered leukotriene release [Mass/volume] by Leukocytes |
| 48249-7 | Silver Birch triggered leukotriene release [Mass/volume] by Leukocytes |
| 2621-1 | Methionine [Presence] in Serum or Plasma |
| 36914-0 | FMR1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 3783-8 | Methapyrilene [Presence] in Urine |
| 26925-8 | Acetophenazine [Presence] in Serum or Plasma |
| 38272-1 | Influenza virus A H5 RNA [Presence] in Specimen by NAA with probe detection |
| 38336-4 | Ethyl benzene [Mass/volume] in Water |
| 3842-2 | Nalorphine [Mass/volume] in Urine |
| 57289-1 | Neisseria gonorrhoeae rRNA [Presence] in Nasopharynx by NAA with probe detection |
| 2743-3 | pH of Amniotic fluid |
| 39301-7 | Influenza virus A H14 Ab [Titer] in Serum by Hemagglutination inhibition |
| 57901-1 | Clostridioides difficile glutamate dehydrogenase [Presence] in Stool |
| 292-3 | Kanamycin [Susceptibility] by Disk diffusion (KB) |
| 40178-6 | Glucose [Moles/volume] in Serum or Plasma --13 hours post XXX challenge |
| 58775-8 | Peach recombinant (rPru p) 4 IgE Ab [Units/volume] in Serum |
| 29877-8 | Methylmalonate [Presence] in Urine |
| 40618-1 | Cancer Ag 125 [Units/volume] in Peritoneal fluid |
| 40625-6 | Cocaine [Presence] in Specimen |
| 58971-3 | Ganglioside GD1b IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 30347-9 | Glutamate decarboxylase 65 Ab [Moles/volume] in Serum |
| 40991-2 | Rhinovirus+Enterovirus RNA [Presence] in Specimen by NAA with probe detection |
| 41074-6 | NPHS1 gene mutations found [Identifier] in Body fluid by Molecular genetics method Nominal |
| 19217-9 | Oxygen [Partial pressure] saturation adjusted to 0.5 in Mixed venous blood |
| 19321-9 | 6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Screen method |
| 20725-8 | Brucella abortus Ab [Presence] in Milk by Ring agglutination |
| 20977-5 | Urea [Mass/volume] in Blood |
| 1278-1 | P Ab [Presence] in Serum or Plasma from Donor |
| 13148-2 | Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum --2nd specimen |
| 102114-6 | Natural cannabinoids panel - Urine |
| 102140-1 | Anisakis IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1366-4 | Corticotropin [Mass/volume] in Plasma --5 minutes post 1 ug/kg CRH IV |
| 102296-1 | Epicoccum purpurascens IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104271-2 | Primer set [Identifier] in Specimen by Molecular genetics method |
| 10635-1 | Acanthamoeba sp identified in Eye by Organism specific culture |
| 15421-1 | Service comment 30 |
| 10819-1 | Microscopic observation [Identifier] in Tissue by Wade stain |
| 17104-1 | CD107a cells/100 cells in Blood |
| 17504-2 | Psilocybin [Presence] in Urine |
| 18382-2 | Dry weight [Mass/time] of 24 hour Stool |
| 1852-3 | Androstenedione [Mass/volume] in Capillary blood |
| 19073-6 | Cannabinoids cutoff [Mass/volume] in Urine |
| 19123-9 | Magnesium [Mass/volume] in Serum or Plasma |
| 90039-9 | ABO and Rh group [Type] in Blood--after transfusion reaction |
| 74615-6 | Fatty acids.very long chain C22:0 (Docosanoate) [Mass/mass] in Fibroblast |
| 91793-0 | Rhinovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 92517-2 | V Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 92532-1 | Kp sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 60399-3 | Sage IgG Ab [Mass/volume] in Serum |
| 62312-4 | Gaucher disease newborn screen interpretation |
| 94059-3 | Bacterial pncA gene drug resistance mutation [Identifier] by Molecular method |
| 94226-8 | PKHD1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 6277-8 | Cultivated Wheat IgE Ab [Units/volume] in Serum |
| 94691-3 | Dermatan sulfate, heparan sulfate, chondroitin-6-sulfate, keratan sulfate panel - Urine |
| 63375-0 | Cyclic citrullinated peptide IgA+IgG Ab [Presence] in Serum |
| 8032-5 | Streptococcus pneumoniae IgM Ab [Units/volume] in Serum |
| 9705-5 | Coccidioides immitis IgA Ab [Units/volume] in Serum |
| 6970-8 | Purkinje cells Ab [Titer] in Serum |
| 81802-1 | 16-Beta,18-dihydroxydehydroepiandrosterone/Creatinine [Molar ratio] in Urine |
| 82073-8 | Food Allergen Mix 72 (Fennel seed+Basil+Anise+Ginger) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 976-1 | D Ag [Presence] on Red Blood Cells from Blood product unit |
| 71432-9 | Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA - Cervix |
| 71607-6 | Mesothelial cells/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
| 97997-1 | HPA and HLA Ab [Interpretation] in Serum, Plasma or Blood Narrative |
| 71861-9 | Hemoglobin Lepore/Hemoglobin.total [Pure mass fraction] in Blood |
| 85540-3 | PRRSV European strain RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 86566-7 | Influenza virus A IgG Ab [Presence] in Serum by Immunoassay |
| 86897-6 | inFLIXimab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
| 73469-9 | cefTAZidime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73717-1 | Food Allergen Mix 19 (Cucumber+Carrot+Potato+Spinach) IgE Ab [Units/volume] in Serum by Multidisk |
| 87996-5 | Fasciola hepatica Ab [Titer] in Serum by Complement fixation |
| 88444-5 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --50M post dose fructose PO |
| 89520-1 | Actin smooth muscle Ab [Presence] in Serum by Line blot |
| 59332-7 | Sibutramine [Mass/volume] in Blood |
| 598-3 | Bacteria identified in Aspirate by Anaerobe culture |
| 50769-9 | Asialoganglioside GM1 IgG Ab/IgM Ab [Ratio] in Serum by Immunoassay |
| 42536-3 | Tropheryma whipplei DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 42606-4 | Herpes simplex virus 2 IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 59984-5 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 60259-9 | Adenovirus DNA [Presence] in Isolate by NAA with probe detection |
| 21750-5 | MYC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 43715-2 | Acylcarnitine [Presence] in Blood |
| 5205-0 | Herpes simplex virus 1 Ab [Units/volume] in Serum by Immunoassay |
| 43870-5 | Aspergillus sp Ab [Presence] in Serum by Complement fixation |
| 22910-4 | Bovine herpesvirus 1 Ag [Presence] in Specimen by Immunofluorescence |
| 32661-1 | Adrenal Ab [Titer] in Serum |
| 33233-8 | Urate crystals [Presence] in Urine by Computer assisted method |
| 53477-6 | Levodopa/Tyrosine [Molar ratio] in Serum or Plasma |
| 23242-1 | Mycobacterium bovis Ag [Presence] in Blood |
| 33363-3 | Normocytic [Presence] in Blood by Light microscopy |
| 33661-0 | Glucosylceramidase [Entitic Catalytic Activity] in Leukocytes |
| 23677-8 | Bovine leukemia virus Ab [Titer] in Serum by Complement fixation |
| 23719-8 | Feline herpesvirus 1 neutralizing antibody [Presence] in Serum by Neutralization test |
| 34159-4 | Tau protein [Presence] in Body fluid |
| 54180-5 | Miconazole [Susceptibility] by Disk diffusion (KB) |
| 2490-1 | Inulin [Mass/volume] in Serum or Plasma |
| 55513-6 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose cloNIDine |
| 47052-6 | Chlamydophila pneumoniae Ab [Units/volume] in Serum by Immunofluorescence |
| 47427-0 | Aspergillus niger B Ab [Presence] in Serum |
| 35021-5 | Monocytes+Macrophages/100 leukocytes in Pleural fluid |
| 55889-0 | 3-Hydroxyanthranilate [Moles/volume] in Urine |
| 47676-2 | Isoleucine/Amino acids.total in DBS |
| 38234-1 | CD3+CD62L+ cells/100 cells in Blood |
| 5657-2 | Gold [Mass/volume] in Cerebral spinal fluid |
| 48571-4 | Follitropin [Units/volume] in Serum or Plasma --on cycle day 11 |
| 4877-7 | HLA-Dw14 [Presence] |
| 48873-4 | Ehrlichia sp identified in Specimen by Organism specific culture |
| 2701-1 | Oxalate [Mass/time] in 24 hour Urine |
| 27112-2 | Microscopic observation [Identifier] in Body fluid by Gram stain |
| 38457-8 | Immune complex.C3d+IgG [Units/volume] in Serum or Plasma |
| 57296-6 | HLA-DRB5 [Type] by High resolution |
| 27956-2 | Proinsulin [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
| 38704-3 | Isophorone [Mass/volume] in Air |
| 38917-1 | Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection |
| 58061-3 | Go sup(a) Ab [Presence] in Serum or Plasma |
| 49406-2 | Herpes virus 8 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
| 4960-1 | HLA-DR15(2) [Presence] in Donor |
| 49602-6 | Hepatitis B virus DNA [log units/volume] (viral load) in Bone marrow by NAA with probe detection |
| 49618-2 | Atazanavir+Ritonavir [Susceptibility] by Genotype method |
| 40025-9 | Glucose [Mass/volume] in Serum or Plasma --3 minutes post XXX challenge |
| 58415-1 | BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method |
| 49790-9 | Sodium [Moles/volume] in Peritoneal fluid |
| 59218-8 | Beta-2-Microglobulin [Mass/volume] in Pleural fluid |
| 30275-2 | Nevirapine [Susceptibility] by Phenotype method |
| 40768-4 | Cryptococcus sp Ag [Titer] in Serum |
| 40943-3 | Yellow Jacket IgE Ab [Mass/volume] in Serum |
| 19236-9 | Base excess standard in Capillary blood by calculation |
| 19725-1 | Aspergillus flavus IgG Ab [Presence] in Serum |
| 100699-8 | Rifabutin+Ethambutol [Susceptibility] |
| 12504-7 | Hemoglobin.gastrointestinal [Presence] in Stool --5th specimen |
| 12912-2 | Lipids [Mass/volume] in Body fluid |
| 101576-7 | Bacterial gyrB gene drug resistance mutation [Identifier] by Molecular method |
| 101759-9 | Trichophyton schoenleinii DNA [Presence] in Specimen by NAA with probe detection |
| 14079-8 | Brucella canis IgG Ab [Titer] in Serum by Immunofluorescence |
| 14324-8 | Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 102842-2 | Watermelon IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10352-3 | Bacteria identified in Genital specimen by Aerobe culture |
| 10869-6 | Xylose [Mass/volume] in Blood --3 hours post 25 g xylose PO |
| 10956-1 | Short Leaf Pine IgE Ab [Units/volume] in Serum |
| 11015-5 | Somatotropin binding protein [Moles/volume] in Serum or Plasma |
| 16634-8 | Coccidioides immitis Ab [Units/volume] in Cerebral spinal fluid |
| 17372-4 | Norepinephrine [Mass/volume] in Urine --5th specimen post XXX challenge |
| 17422-7 | Parvovirus B19 IgG+IgM Ab [Units/volume] in Serum |
| 1759-0 | Albumin/Globulin [Mass Ratio] in Serum or Plasma |
| 90827-7 | Glial nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 91060-4 | Helicobacter pylori DNA [Presence] in Tissue by NAA with probe detection |
| 74517-4 | Cholesterol sulfate [Moles/volume] in Serum or Plasma |
| 74896-2 | Lactate [Moles/mass] in Stool |
| 74978-8 | Cerebroside sulfatase and N-Acetylgalactosamine-4-Sulfatase panel [Enzymatic activity/mass] - Leukocytes |
| 75060-4 | Pantothenate/Creatinine [Molar ratio] in Urine |
| 75105-7 | Fatty acids.very long chain C26:1 (Hexacosenoate) [Entitic substance] in Red Blood Cells |
| 61188-9 | Clindamycin.induced [Susceptibility] |
| 762-5 | Neutrophils [#/volume] in Urine by Manual count |
| 7627-3 | Sweet potato IgE Ab [Units/volume] in Serum |
| 92875-4 | Herpes simplex virus 2 DNA [Presence] in Anogenital by NAA with probe detection |
| 9328-6 | Carbidopa [Mass/volume] in Serum or Plasma |
| 61250-7 | Coffee IgE Ab/IgE total in Serum |
| 77088-3 | GFM1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 9400-3 | Platinum [Mass/volume] in Specimen |
| 94276-3 | Honey bee dipeptidyl peptidase recombinant (rApi m) 5 IgE Ab [Units/volume] in Serum |
| 94569-1 | Leucine [Moles/volume] in Serum or Plasma --post therapeutic diet |
| 7914-5 | Heterophile Ab after beef cell absorption [Titer] in Serum |
| 94869-5 | Ganglioside GD1b IgM Ab [Titer] in Serum by Immunoassay |
| 65330-3 | MER Ab [Presence] in Serum or Plasma |
| 96114-4 | Streptomycin [Susceptibility] by Genotype method |
| 9644-6 | Cystine [Presence] in Urine |
| 80633-1 | Aldicarb [Mass/volume] in Urine |
| 80981-4 | N,N-dimethylarginine [Mass/volume] in Serum or Plasma |
| 81122-4 | HIV 1 RNA reverse transcriptase and protease gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing |
| 9678-4 | Silicone IgM Ab [Units/volume] in Serum |
| 97012-9 | Reduction in kaolin+tissue factor induced clot strength [Length fraction] in Blood --30 minutes post maximum clot amplitude |
| 97214-1 | Acetyl fentanyl [Presence] in Cord tissue by Screen method |
| 69806-8 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --post dose ifosfamide |
| 81760-1 | Lymphocyte proliferation.anti-CD3.maximum/CD45 in Blood by Flow cytometry (FC) |
| 82033-2 | Tree Allergen Mix 5 (Grey alder+Hazelnut+White elm+Willow+Cottonwood) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 82178-5 | Chlamydophila pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 97857-7 | Histoplasma capsulatum mycelial phase Ab [Titer] in Specimen by Complement fixation |
| 71373-5 | Inhalant Allergen Mix 8 (Mugwort+Common silver birch+Cat dander+C herbarum+Dermatophagoides pteronyssinus+Dog dander+Timothy grass+Rye) IgE Ab [Units/volume] in Serum by Multidisk |
| 82592-7 | Reticulocytes.mid light scatter/Reticulocytes.total in Blood by Automated count |
| 98236-3 | Norfloxacin IgE Ab [Units/volume] in Serum |
| 98393-2 | Candida sp [Identifier] in Isolate by Sequencing |
| 98860-0 | Transforming growth factor beta free [Mass/volume] in Serum or Plasma |
| 99071-3 | Kelch-like protein 11 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 71846-0 | Oxygen saturation [Pure mass fraction] in Mixed venous blood |
| 71864-3 | Hemoglobin F/Hemoglobin.total [Pure mass fraction] in Blood by HPLC |
| 72415-3 | Acetoacetate [Moles/volume] in Blood --post meal |
| 7245-4 | Cola IgG Ab [Units/volume] in Serum |
| 72617-4 | Propoxyphene [Presence] in Saliva (oral fluid) by Screen method |
| 86457-9 | Brucella sp Ab [Presence] in Serum by Fluorescent polarization assay |
| 73160-4 | Rofecoxib induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86714-3 | Carbapenem resistance blaOXA-51-like gene [Presence] by Molecular method |
| 87797-7 | Sulfathiazole [Susceptibility] |
| 73997-9 | Ibuprofen [Mass/volume] in Urine |
| 74031-6 | Arbovirus identified in Serum by Immunofluorescence |
| 74130-6 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum, Plasma or Blood |
| 74432-6 | Cholestanol [Moles/volume] in Serum or Plasma |
| 4142-6 | Bisacodyl [Mass] of Dose |
| 59383-0 | Hydroxyproline/Creatinine [Mass Ratio] in 2 hour Urine |
| 5066-6 | Brucella abortus Ab [Presence] in Serum by Latex agglutination |
| 59981-1 | Zopiclone [Moles/volume] in Urine |
| 60015-5 | Corticotropin [Moles/volume] in Plasma --5 minutes post XXX challenge |
| 21283-7 | Ganglioside GD1a IgG Ab [Titer] in Serum by Immunoassay |
| 31449-2 | La Crosse virus Ab [Presence] in Specimen |
| 31553-1 | Parainfluenza virus 3 IgG Ab [Units/volume] in Serum |
| 31606-7 | Orientia tsutsugamushi IgG Ab [Units/volume] in Serum |
| 51122-0 | Cytoplasmic CD22 blasts [Units/volume] in Blood |
| 42791-4 | Mitogen-Activated protein kinase 3 Ag [Presence] in Tissue by Immune stain |
| 2180-8 | Cystine+Cysteine [Mass/volume] in Serum or Plasma |
| 22195-2 | Chlamydia trachomatis B IgG Ab [Titer] in Serum |
| 31627-3 | Smith extractable nuclear Ab [Presence] in Serum |
| 2263-2 | Ethanolamine [Mass/volume] in Serum or Plasma |
| 3222-7 | Coagulation factor X+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 519-9 | Troleandomycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 44377-0 | Homocysteine/Creatinine [Molar ratio] in 24 hour Urine |
| 44396-0 | Insulin [Presence] in Serum or Plasma |
| 23141-5 | Infectious bursal disease virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 33240-3 | Cystine crystals [Presence] in Urine by Computer assisted method |
| 2344-0 | Glucose [Mass/volume] in Body fluid |
| 23567-1 | Vesicular stomatitis New Jersey virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 53822-3 | Flomoxef [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 53923-9 | HIV 1 tropism [Identifier] in Blood Narrative |
| 34056-2 | Glucose [Moles/volume] in Serum or Plasma --pre or post dose arginine |
| 34238-6 | Androstenediol/Creatinine [Molar ratio] in Urine |
| 46193-9 | Infectious bronchitis virus JMK Ab [Titer] in Serum |
| 46260-6 | HYDROmorphone Free [Presence] in Serum or Plasma by Screen method |
| 24474-9 | Cancer associated serum Ag [Units/volume] in Serum |
| 3438-9 | Cathine [Presence] in Urine |
| 55535-9 | ePHEDrine [Moles/volume] in Serum or Plasma |
| 47445-2 | Influenza virus A H10 Ab [Titer] in Serum |
| 35362-3 | Triglyceride in Chylomicrons [Presence] in Serum or Plasma |
| 35629-5 | Oxazepam [Mass/volume] in Serum or Plasma by Screen method |
| 56231-4 | Corn IgG4 Ab [Mass/volume] in Serum |
| 56265-2 | Garlic IgG4 Ab [Mass/volume] in Serum |
| 56437-7 | Chicken feather IgG4 Ab [Mass/volume] in Serum |
| 47975-8 | tiZANidine [Mass/volume] in Serum or Plasma |
| 48108-5 | Follitropin [Units/volume] in Serum or Plasma --15 minutes pre 100 ug luteinizing releasing hormone IV |
| 26042-2 | Didesmethylcitalopram [Moles/volume] in Serum or Plasma |
| 2678-1 | Ornithine [Presence] in Serum or Plasma |
| 56910-3 | Chlamydia sp IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 38249-9 | C peptide [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 27419-1 | Sodium [Moles/time] in 24 hour Stool |
| 38757-1 | 1,3-Dimethylbenzene [Mass/volume] in Air |
| 49407-0 | Herpes virus 8 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 49628-1 | Remnant lipoprotein [Mass/volume] in Serum or Plasma |
| 50031-4 | Sulfamethoxazole IgE Ab [Units/volume] in Serum |
| 29566-7 | West Nile virus IgG Ab [Presence] in Serum by Immunoassay |
| 29868-7 | Gamma hydroxybutyrate [Presence] in Urine |
| 58889-7 | Pyruvate [Mass/volume] in Blood --3 minutes post XXX challenge |
| 59231-1 | Prostate Specific Ag Free [Mass/volume] in Cerebral spinal fluid |
| 50210-4 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Cystatin C-based formula |
| 50266-6 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --1 day post dose ifosfamide |
| 504-1 | Ticarcillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 50493-6 | Somatotropin [Mass/volume] in Serum or Plasma --1st specimen |
| 30017-8 | Borrelia burgdorferi 58kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
| 4092-3 | Vancomycin [Mass/volume] in Serum or Plasma --trough |
| 41152-0 | Haemophilus paragallinarum Ab [Units/volume] in Serum |
| 19214-6 | Oxygen [Partial pressure] saturation adjusted to 0.5 in Arterial blood |
| 19514-9 | Levomethamphetamine cutoff [Mass/volume] in Urine for Screen method |
| 19719-4 | Trichlorothiazide [Presence] in Urine by Confirmatory method |
| 2040-4 | Cardiolipin [Mass/volume] in Serum |
| 20690-4 | Theileria equi Ab [Presence] in Serum by Complement fixation |
| 20735-7 | Brucella sp identified in Milk by Organism specific culture |
| 20844-7 | Avian infectious laryngotracheitis virus Ag [Presence] in Lung tissue by Immunofluorescence |
| 12410-7 | Pimozide [Mass/volume] in Serum or Plasma |
| 100127-0 | Campylobacter sp Ab panel - Serum |
| 12997-3 | 1,4-Dioxane [Mass/volume] in Serum or Plasma |
| 101809-2 | Xylazine [Presence] in Urine by Confirmatory method |
| 102117-9 | Gastrointestinal stromal tumor multigene mutation panel - Tissue by Molecular genetics method |
| 13472-6 | Nickel/Creatinine [Mass Ratio] in Urine |
| 13662-2 | Ganglioside GD1b IgG Ab [Titer] in Serum |
| 102653-3 | Yellow Jacket IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14038-4 | Pacific Squid IgE Ab [Units/volume] in Serum |
| 14371-9 | Yeast [Presence] in Urethra by Wet preparation |
| 1034-8 | Fetal cell screen [Interpretation] in Blood |
| 103613-6 | Sunitinib total [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose |
| 14888-2 | Procainamide [Moles/volume] in Serum or Plasma |
| 15150-6 | Anisocytosis [Presence] in Blood by Automated count |
| 104452-8 | Toxoplasma gondii IgG Ab [Presence] in Serum by Immunoblot |
| 10627-8 | Spermatozoa Small Oval Head/100 spermatozoa in Semen |
| 1126-2 | Le Ab [Presence] in Serum or Plasma from Donor |
| 1676-6 | 2,3-Diphosphoglycerate [Mass/volume] in Serum |
| 18402-8 | Spermatozoa IgA Ab [Units/volume] in Semen |
| 90450-8 | Herpes simplex virus DNA [Presence] in Aspirate by NAA with probe detection |
| 7464-1 | Lime IgE Ab [Units/volume] in Serum |
| 91685-8 | Glutathione [Mass/volume] in Blood |
| 7523-4 | Nectarine IgE Ab [Units/volume] in Serum |
| 60400-9 | Salmon IgG Ab [Mass/volume] in Serum |
| 76540-4 | Pathology dx ICD code [Identifier] |
| 76656-8 | Phosphate [Mass/mass] in Hair |
| 92824-2 | Source of population allelic frequency data |
| 619-7 | Bacteria identified in Peritoneal fluid by Culture |
| 77076-8 | MRPL40 gene full mutation analysis in Blood or Tissue by Sequencing |
| 77628-6 | PSEN2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 7853-5 | Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma |
| 78846-3 | JWH-200 6-Hydroxyindole (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
| 94729-1 | Cyclobenzaprine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 6364-4 | Clostridioides difficile toxin A+B [Units/volume] in Specimen by Immunoassay |
| 6389-1 | Eastern equine encephalitis virus Ag [Presence] in Serum by Immunofluorescence |
| 79292-9 | Creatine, guanidinoacetate and creatinine pattern [Interpretation] in Urine Narrative |
| 79402-4 | Niacin [Moles/volume] in Blood |
| 96294-4 | Straw dust IgE Ab [Units/volume] in Serum |
| 80558-0 | Amitriptyline [Mass/volume] in DBS |
| 8156-2 | Amphetamines [Presence] in Unknown substance by Screen method |
| 99410-3 | Italian Cypress IgG Ab [Mass/volume] in Serum |
| 85803-5 | Influenza virus A H3 Ag [Titer] in Isolate by Hemagglutination inhibition |
| 73256-0 | Morphine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7327-0 | Fusarium solani IgE Ab [Units/volume] in Serum |
| 87321-6 | Escherichia coli enterotoxigenic sta gene [Presence] in Isolate by NAA with probe detection |
| 88024-5 | Palmitoylcarnitine (C16)/Carnitine.free (C0) [Molar ratio] in DBS |
| 5946-9 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma |
| 5972-5 | Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis |
| 59850-8 | Wuchereria bancrofti Ag [Units/volume] in Serum by Immunoassay |
| 30425-3 | Macrophages/100 leukocytes in Bronchial specimen |
| 31171-2 | 2,5-Hexanedione/Creatinine [Mass Ratio] in Urine |
| 423-4 | Pyrazinamide [Susceptibility] by Minimum lethal concentration (MLC) |
| 31242-1 | Avian paramyxovirus 1 Ab [Units/volume] in Serum |
| 51325-9 | CD42b cells/100 cells in Tissue |
| 43107-2 | Mycoplasma sp and Ureaplasma sp panel - Specimen by Organism specific culture |
| 22305-7 | Giardia lamblia IgA Ab [Titer] in Serum |
| 51698-9 | Dapsone [Susceptibility] |
| 51918-1 | Indinavir [Mass/volume] in Serum or Plasma --trough |
| 43314-4 | Avian paramyxovirus 6 Ab [Titer] in Serum by Hemagglutination inhibition |
| 43335-9 | Fowl adenovirus Ab [Presence] in Serum by Immune diffusion (ID) |
| 32162-0 | Cells [#/volume] in Pleural fluid by Manual count |
| 44274-9 | Clostridium botulinum toxin [Identifier] in Specimen by Immunoassay |
| 22977-3 | Caprine arthritis encephalitis virus DNA [Presence] in Specimen by Polyacrylamide gel electrophoresis (PAGE) |
| 23035-9 | Duck hepatitis virus 1 Ag [Presence] in Specimen by Neutralization test |
| 32575-3 | Bartonella henselae IgG Ab [Presence] in Serum |
| 44805-0 | BK virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 23517-6 | Trypanosoma equiperdum Ab [Titer] in Serum |
| 23547-3 | Venezuelan equine encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
| 53754-8 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --45 minutes post XXX challenge |
| 45018-9 | Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --6 hours post XXX challenge |
| 45364-7 | Lymphocyte proliferation stimulated by 1.0 ug pokeweed mitogen [Units/volume] in Blood |
| 23787-5 | Venezuelan equine encephalitis virus Ab [Titer] in Serum by Complement fixation |
| 35151-0 | Lauroleate (C12:1) [Moles/volume] in Serum or Plasma |
| 4756-3 | HLA-B50(21) [Presence] in Donor |
| 25905-1 | D-Lactate [Moles/volume] in Serum or Plasma --Pre excercise |
| 25970-5 | Phenylalanine/Creatinine [Molar ratio] in 24 hour Urine |
| 56372-6 | Western Ragweed IgG4 Ab [Mass/volume] in Serum |
| 48182-0 | European Hornet triggered leukotriene release [Mass/volume] by Leukocytes |
| 26415-0 | Casein IgG4 Ab [Units/volume] in Serum |
| 56734-7 | Centromere protein B Ab [Presence] in Serum by Immunoblot |
| 48857-7 | Rickettsia africae IgM Ab [Titer] in Serum by Immunofluorescence |
| 27054-6 | Morphine Free [Mass/volume] in Cerebral spinal fluid |
| 57290-9 | HLA-A [Type] by High resolution |
| 57405-3 | CD8+CD56+ cells/100 cells in Body fluid |
| 49057-3 | Blood group antibody score |
| 49271-0 | Immunofixation for Cerebral spinal fluid Narrative |
| 49421-1 | Papova virus SV 40 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 49529-1 | Influenza virus A Ag [Presence] in Isolate by Immunofluorescence |
| 49574-7 | Phosphatidylinositol+Phosphatidylserine/Surfactant.total in Amniotic fluid |
| 2828-2 | Potassium [Moles/volume] in Urine |
| 2916-5 | Renin renal clearance in 24 hour Urine and Serum or Plasma |
| 58569-5 | Corticotropin [Mass/volume] in Plasma --1 day post dose metyraPONE |
| 50070-2 | 11-Hydroxyandrostenedione [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
| 40421-0 | Amphetamine+Methamphetamine [Presence] in Serum or Plasma |
| 40524-1 | Macrophages/100 leukocytes in Pericardial fluid by Manual count |
| 58884-8 | Somatotropin [Mass/volume] in Serum or Plasma --21st specimen |
| 30214-1 | Coxsackievirus A10 Ab [Presence] in Serum |
| 30244-8 | Acetylcholinesterase [Enzymatic activity/volume] in Blood |
| 30261-2 | Insulin [Units/volume] in Serum or Plasma --3.5 hours post XXX challenge |
| 30296-8 | Amprenavir [Susceptibility] by Phenotype method |
| 40757-7 | Amphotericin B [Mass/volume] in Serum or Plasma --trough |
| 41044-9 | UGT1A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 41127-2 | Salmonella gallinarum Ab [Presence] in Blood |
| 19255-9 | Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood |
| 20602-9 | CD34 cells/100 cells in Specimen |
| 20884-3 | Microscopic observation [Identifier] in Stool by Dark field examination |
| 12509-6 | Calcitonin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 101824-1 | Aspartylglucosaminidase [Enzymatic activity/mass] in Serum or Plasma |
| 101849-8 | Dexamethasone [Moles/volume] in Urine |
| 14746-2 | Glucose [Moles/volume] in Peritoneal dialysis fluid |
| 10353-1 | Bacteria identified in Nose by Aerobe culture |
| 10632-8 | Time until next menstrual period |
| 15258-7 | Regional Allergen Mix B (Common ragweed+Goosefoot or Lambs quarters+Bermuda grass+Perennial rye grass+Bahia grass) IgE Ab [Presence] in Serum by Multidisk |
| 16503-5 | C reactive protein [Mass/volume] in Body fluid |
| 11229-2 | 3-O-Methyldopa [Mass/volume] in Serum or Plasma |
| 16833-6 | Escherichia coli K1 Ag [Presence] in Specimen by Immunoassay |
| 17576-0 | Shigella sp identified in Specimen by Organism specific culture |
| 1847-3 | Amyloid associated protein [Mass/volume] in Serum |
| 18868-0 | Aztreonam [Susceptibility] |
| 90329-4 | Porcine deltacoronavirus IgG Ab/Positive control in Specimen by Immunoassay |
| 74672-7 | Carisoprodol+Meprobamate [Mass/volume] in Urine |
| 74870-7 | IgM.kappa/IgM.lambda [Mass Ratio] in Serum or Plasma |
| 76037-1 | GALT gene full mutation analysis in Blood or Tissue by Sequencing |
| 7667-9 | Rhubarb IgE Ab [Units/volume] in Serum |
| 93234-3 | dRVVT in Platelet poor plasma by Coagulation assay --post heparin neutralization |
| 7720-6 | Stemphylium solani IgE Ab [Units/volume] in Serum |
| 63260-4 | Gliadin IgA Ab [Titer] in Cerebral spinal fluid by Immunoassay |
| 94334-0 | Enterocytozoon bieneusi 18S rRNA gene [Presence] in Specimen by NAA with non-probe detection |
| 94765-5 | SARS-related coronavirus E gene [Presence] in Serum or Plasma by NAA with probe detection |
| 63397-4 | Myeloperoxidase Ab [Presence] in Body fluid by Immunoassay |
| 64414-6 | KIR gene allele 2DL2 [Presence] in Blood or Tissue by Molecular genetics method |
| 66127-2 | Amphetamine [Presence] in Serum or Plasma by Confirmatory method |
| 7953-3 | Legionella pneumophila 6 Ab [Titer] in Serum by Immunofluorescence |
| 81430-1 | Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal dialysis fluid by Lactate to pyruvate reaction |
| 6913-8 | Chlamydophila pneumoniae IgG Ab [Titer] in Serum by Immunofluorescence |
| 82077-9 | Food Allergen Mix 8 (Brazil nut+Orange+Hazelnut+Apple+Cocoa) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 97226-5 | Carisoprodol [Presence] in Cord tissue by Screen method |
| 97233-1 | Cocaethylene [Presence] in Cord tissue by Confirmatory method |
| 97541-7 | Oxygen [Partial pressure] adjusted to patient's actual temperature in Central venous blood |
| 70282-9 | t(9;12)(q34.1;p13)(ABL1,ETV6) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 82987-9 | AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 84921-6 | Cells.chromosome region 7q31 deletion/Cells counted in Blood or Tissue by FISH |
| 73132-3 | Tacrolimus induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87582-3 | Aflatoxin G1 [Mass/mass] in Specimen |
| 87743-1 | Bufencarb [Mass/mass] in Specimen |
| 87756-3 | BMPR1A and SMAD4 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 73614-0 | Plazomicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 73667-8 | Bacteria producing hippuricase [Presence] in Isolate |
| 74330-2 | MICA*028 IgG Ab [Presence] in Serum |
| 89599-5 | Toxoplasma gondii [Presence] in Cerebral spinal fluid by Organism specific culture |
| 41283-3 | HLA-DQ8 [Presence] |
| 59664-3 | Estazolam [Mass/volume] in Blood |
| 50761-6 | A IgG Ab [Titer] in Serum or Plasma |
| 21055-9 | Adenovirus DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 2108-9 | Choriogonadotropin.alpha subunit [Presence] in Serum or Plasma |
| 31187-8 | Microscopic observation [Identifier] in Lymph node fine needle aspirate by Cyto stain |
| 31322-1 | Coxsackievirus A9 Ab [Units/volume] in Body fluid |
| 51380-4 | HLA-DR+ cells/100 cells in Bone marrow |
| 43066-0 | Canine distemper virus IgG Ab [Titer] in Cerebral spinal fluid |
| 2224-4 | Enolase [Enzymatic activity/volume] in Serum |
| 22253-9 | Dengue virus 4 Ab [Presence] in Serum |
| 31909-5 | Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Cerebral spinal fluid |
| 32023-4 | Insulin-like growth factor-I [Mass/volume] in Blood |
| 32038-2 | Polymorphonuclear cells [Presence] in Peritoneal fluid by Wright stain |
| 51624-5 | Malignant cells/100 cells in Dialysis fluid by Manual count |
| 43709-5 | Alkaline phosphatase.intestinal+renal [Presence] in Serum or Plasma |
| 32252-9 | Isoleucine [Moles/volume] in Vitreous fluid |
| 51926-4 | Nucleated cells [#/volume] in Peritoneal fluid by Manual count |
| 43969-5 | CD3+CD25+ cells [#/volume] in Tissue |
| 22974-0 | Caprine arthritis encephalitis virus Ab [Presence] in Serum by Agglutination |
| 23085-4 | Equine herpesvirus 1+4 neutralizing antibody [Presence] in Serum by Neutralization test |
| 53097-2 | 3-O-Methyldopa [Moles/time] in 24 hour Urine |
| 44573-4 | Influenza virus B Ag [Presence] in Nose by Immunofluorescence |
| 45279-7 | Influenza virus A+B Ab [Presence] in Body fluid |
| 2406-7 | Heparan sulfate [Mass/volume] in Urine |
| 54077-3 | Thyroid newborn screening panel (SI units) |
| 54458-5 | Granulocyte colony stimulating factor [Mass/volume] in Serum or Plasma |
| 24145-5 | American Sycamore IgG Ab [Units/volume] in Serum |
| 24316-2 | Epstein Barr virus capsid IgG and IgM panel - Serum |
| 34442-4 | Bilirubin.conjugated/Bilirubin.total in Serum or Plasma |
| 47106-0 | ePHEDrine [Presence] in Serum or Plasma |
| 25212-2 | Capreomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 55767-8 | EGFR gene c.2582T>A [Presence] in Blood or Tissue by Molecular genetics method |
| 55961-7 | Oxalate [Moles/volume] in Water |
| 47583-0 | C peptide [Moles/volume] in Serum or Plasma --1.5 hours post dose glucose |
| 47619-2 | Follitropin [Units/volume] in Serum or Plasma --2.5 hours post 100 ug luteinizing releasing hormone IV |
| 25604-0 | Rickettsia prowazekii IgM Ab [Titer] in Serum |
| 25669-3 | Glucose [Moles/volume] in Serum or Plasma --3.5 hours post dose glucose |
| 3577-4 | Disulfiram [Mass/volume] in Serum or Plasma |
| 56227-2 | Coconut IgG4 Ab [Mass/volume] in Serum |
| 56578-8 | Aldosterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 56924-4 | Fasciola hepatica Ab [Titer] in Serum by Hemagglutination |
| 48414-7 | Alpha-1-Microglobulin [Mass/time] in 24 hour Urine |
| 48614-2 | Cryoglobulin [Presence] in Serum by Immune diffusion (ID) |
| 27041-3 | Norpropoxyphene [Mass/mass] in Stool |
| 27181-7 | Hydroxyproline [Moles/volume] in Amniotic fluid |
| 57302-2 | Temazepam [Mass/volume] in Saliva (oral fluid) |
| 2795-3 | Phosphofructokinase L subunit/Phosphofructokinase.total in Red Blood Cells |
| 57746-0 | Gamma hydroxybutyrate [Presence] in Urine by Confirmatory method |
| 49443-5 | Toxoplasma gondii DNA [#/volume] in Urine by NAA with probe detection |
| 49474-0 | CD163 Ag [Presence] in Tissue by Immune stain |
| 2837-3 | Pregnenolone [Mass/volume] in Serum or Plasma |
| 40127-3 | Creatinine [Moles/volume] in Serum or Plasma --4 days post XXX challenge |
| 58484-7 | Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --8th specimen post XXX challenge |
| 58616-4 | Corticotropin [Moles/volume] in Plasma --8 PM specimen |
| 58738-6 | Drugs of abuse [Interpretation] in Meconium |
| 49959-0 | Specific gravity of Urine adjusted to pH 7.4 |
| 29927-1 | Beryllium [Mass/volume] in 24 hour Urine |
| 40353-5 | MT-ND6 gene m.14484T>C [Presence] in Blood or Tissue by Molecular genetics method |
| 59013-3 | Lactate [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 59293-1 | Levamisole [Mass/volume] in Serum or Plasma |
| 50387-0 | Chlamydia trachomatis rRNA [Presence] in Cervix by NAA with probe detection |
| 30161-4 | Citrulline/Creatinine [Ratio] in Urine |
| 407-7 | Piperacillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 4083-2 | Trimipramine [Mass/volume] in Serum or Plasma |
| 19737-6 | Cotton fibers IgE Ab [Units/volume] in Serum |
| 20515-3 | Amitriptyline [Mass/volume] in Urine by Confirmatory method |
| 20791-0 | Eastern equine encephalitis virus Ab [Presence] in Serum by Immunofluorescence |
| 100402-7 | Venison meat IgG Ab [Units/volume] in Serum |
| 100830-9 | Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 102224-3 | Cottage Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102683-0 | Banana IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103125-1 | Latex recombinant (rHev b) 2 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103152-5 | Bone marrow transplant chimerism panel - Plasma cell-free DNA by Sequencing |
| 103677-1 | HMEP-Hemiplegic migraine multigene analysis in Blood or Tissue by Molecular genetics method |
| 104132-6 | Human papilloma virus 16 and 18 and 31 and 45+33+52+58 and 35+39+51+56+59+66+68 DNA [Interpretation] in Cervix by NAA with probe detection |
| 14902-1 | raNITIdine [Presence] in Urine |
| 15197-7 | Lymphocytes clefted/100 leukocytes in Blood by Manual count |
| 16171-1 | Cocaethylene [Mass/mass] in Hair |
| 16583-7 | Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 16666-0 | Corticotropin [Mass/volume] in Plasma --9th specimen post XXX challenge |
| 16706-4 | Taenia solium larva IgM Ab [Units/volume] in Cerebral spinal fluid |
| 1232-8 | Mi sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 17043-1 | Lactose [Mass/volume] in Urine |
| 17379-9 | Propanol [Mass/volume] in Blood |
| 90421-9 | Apolipoprotein CIII-1/Apolipoprotein CIII-2 [Mass Ratio] in Serum or Plasma |
| 92647-7 | diphenhydrAMINE [Presence] in Urine by Confirmatory method |
| 92654-3 | 9-Hydroxyrisperidone [Mass/volume] in Urine by Confirmatory method |
| 75056-2 | Pyridoxal phosphate [Moles/volume] in Cerebral spinal fluid |
| 7507-7 | Mucor racemosus IgG Ab [Units/volume] in Serum |
| 75566-0 | Fetal Monosomy X prior risk [Likelihood] Based on maternal age |
| 60398-5 | Avocado IgG Ab [Mass/volume] in Serum |
| 77192-3 | Prealbumin [Moles/volume] in Serum or Plasma |
| 77770-6 | HYDROmorphone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 78774-7 | Acenocoumarol [Mass/volume] in Blood |
| 94353-0 | Myelopathy autoimmune Ab panel - Cerebral spinal fluid |
| 63416-2 | Pompe disease newborn screening comment-discussion |
| 95355-4 | Convalescent plasma given [Volume] |
| 6667-0 | Microscopic observation [Identifier] in Tissue by KOH preparation |
| 66740-2 | CYP2C19 gene c.636G>A(*3) [Presence] in Blood or Tissue by Molecular genetics method |
| 7959-0 | Leptospira sp Ab [Titer] in Serum |
| 96091-4 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Saliva (oral fluid) by NAA with probe detection |
| 9623-0 | Valine [Presence] in Urine |
| 67832-6 | Neutrophils [#/volume] in Pleural fluid from Fetus |
| 96797-6 | SARS-CoV-2 (COVID-19) RNA [Presence] in Oropharyngeal wash by NAA with probe detection |
| 6950-0 | raNITIdine [Mass/volume] in Serum or Plasma |
| 81778-3 | Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH)/Creatinine [Molar ratio] in Urine |
| 70211-8 | Mycophenolate [Moles/volume] in Serum or Plasma |
| 99021-8 | Klebsiella oxytoca DNA [Presence] in Urine by NAA with probe detection |
| 7169-6 | Cabbage IgE Ab [Units/volume] in Serum |
| 85982-7 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum --2nd specimen |
| 73012-7 | hydroCHLOROthiazide induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73096-0 | valACYclovir induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73191-9 | Propoxyphene induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73234-7 | OLANZapine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73249-5 | Naproxen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88219-1 | Parechovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 74230-4 | Lymphocytes assessment in Bone marrow Narrative |
| 89970-8 | Molindone [Presence] in Urine by Screen method |
| 41407-8 | Cortisol [Mass/volume] in Serum or Plasma --pre dose corticotropin |
| 59331-9 | Dinorsibutramine [Mass/volume] in Blood |
| 50959-6 | Indirect antiglobulin test.unspecified reagent [Presence] in Serum or Plasma |
| 59996-9 | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 60016-3 | Corticotropin [Moles/volume] in Plasma --1.5 hours post XXX challenge |
| 21277-9 | Follitropin [Units/volume] in Serum or Plasma --2 hours post dose gonadotropin releasing hormone |
| 31222-3 | Anaplasma marginale Ab [Units/volume] in Serum |
| 3154-2 | Weight of Specimen |
| 21738-0 | SNCA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 22139-0 | Borrelia hermsii IgM Ab [Titer] in Serum |
| 22187-9 | Chlamydia trachomatis Ab [Titer] in Serum |
| 3161-7 | Volume [Flow] of 24 hour Sputum |
| 31667-9 | Sulfatide Ab [Presence] in Serum |
| 51875-3 | Varicella zoster virus immune globulin units given [#] |
| 43596-6 | Apple IgE Ab/IgE total in Serum |
| 43705-3 | Cytomegalovirus [Presence] in Bone marrow by Shell vial culture |
| 22405-5 | Leptospira interrogans sv Pomona Ab [Titer] in Serum |
| 32088-7 | Meperidine [Presence] in Specimen |
| 52902-4 | Uranium/Creatinine [Molar ratio] in 24 hour Urine |
| 43968-7 | CD3+HLA-DR+ cells/100 cells in Cerebral spinal fluid |
| 23021-9 | Coxiella burnetii Ag [Presence] in Tissue by Immunoassay |
| 44650-0 | Mitotic count per 10 HPF in Breast tumor |
| 23319-7 | Nairobi sheep disease virus Ag [Presence] in Specimen by Immunofluorescence |
| 53529-4 | Microalbumin [Mass/volume] in Body fluid by Detection limit <= 1.0 mg/L |
| 53595-5 | Homovanillate [Mass/volume] in 24 hour Urine |
| 53853-8 | COL4A5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 44981-9 | Chlamydophila pneumoniae IgG Ab [Presence] in Serum |
| 23694-3 | Canine distemper virus IgM Ab [Titer] in Serum |
| 23998-8 | Ganglioside GD1a IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay |
| 53990-8 | Chromosomal nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
| 54097-1 | Organophosphonate nerve agent metabolite panel [Mass/volume] - Urine |
| 4563-3 | Hemoglobin C/Hemoglobin.total in Blood |
| 46179-8 | Chlamydophila sp Ab [Presence] in Serum |
| 24139-8 | Cockroach IgG Ab [Units/volume] in Serum |
| 55514-4 | Somatotropin [Mass/volume] in Serum or Plasma --20 minutes post exercise |
| 47114-4 | LORazepam [Moles/volume] in Gastric fluid |
| 35037-1 | Macrophages [#/volume] in Synovial fluid |
| 55685-2 | Isoniazid 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 55779-3 | Erythrocytes [#/volume] in Amniotic fluid |
| 47852-9 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin |
| 2560-1 | Leucine [Mass/volume] in Serum or Plasma |
| 35463-9 | Telomere analysis [Identifier] in Blood or Tissue Nominal |
| 35781-4 | Ceftiofur [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 35782-2 | Cefuroxime Oral [Susceptibility] by Disk diffusion (KB) |
| 56438-5 | Beef IgG4 Ab [Mass/volume] in Serum |
| 26586-8 | Alpha aminobutyrate [Moles/volume] in Cerebral spinal fluid |
| 56740-4 | Ganglioside GD1b IgM Ab [Presence] in Serum by Immunoblot |
| 57005-1 | Glutathione [Moles/volume] in Serum or Plasma |
| 4851-2 | HLA-Cw1 [Presence] |
| 38316-6 | Dichloroethane [Mass/volume] in Water |
| 38587-2 | Acrylaldehyde [Mass/volume] in Air |
| 3860-4 | Nitrofurantoin [Mass/volume] in Serum or Plasma |
| 57579-5 | Aldosterone [Mass/volume] in Serum or Plasma --post 25 mg captopril PO |
| 49182-9 | Coxiella burnetii phase 2 IgM Ab [Titer] in Body fluid |
| 27325-0 | Glycine [Moles/volume] in Urine |
| 38927-0 | TRPS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 39554-1 | Endomysium IgG Ab [Presence] in Serum |
| 49441-9 | Pneumocystis jiroveci DNA [#/volume] in Specimen by NAA with probe detection |
| 49609-1 | Vibrio sp DNA [Identifier] in Specimen by NAA with probe detection |
| 28659-1 | Prekallikrein (Fletcher Factor) actual/normal in Platelet poor plasma by Chromogenic method |
| 29291-2 | Glutethimide [Mass/volume] in Gastric fluid |
| 29368-8 | Parainfluenza virus 3 Ab [Titer] in Body fluid by Complement fixation |
| 58623-0 | Corticotropin [Moles/volume] in Plasma --pre dose glucagon |
| 49768-5 | Filaria IgG3 Ab [Units/volume] in Serum by Immunoassay |
| 40499-6 | Lymphocytic choriomeningitis virus IgM Ab [Titer] in Serum by Immunoassay |
| 40594-4 | Platelet aggregation EPINEPHrine induced [Units/volume] in Platelet rich plasma --100 umol/L |
| 40689-2 | Erythroid cells/100 cells in Bone marrow by Manual count |
| 5885-9 | Virus identified in Skin by Culture |
| 5050-0 | Aspergillus fumigatus Ab [Units/volume] in Serum |
| 41002-7 | Human coronavirus 229E IgG Ab [Presence] in Serum by Immunoassay |
| 41059-7 | SFTPC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 20413-1 | Cannabinoids [Mass/volume] in Urine by Confirmatory method |
| 20643-3 | Glutamine [Moles/volume] in Serum or Plasma |
| 2070-1 | Chloride [Moles/volume] in Cerebral spinal fluid |
| 13180-5 | Formaldehyde IgG Ab [Units/volume] in Serum |
| 102087-4 | Secretin stimulation/Gastrin XXX challenge panel |
| 13638-2 | Chlordecone [Mass/volume] in Blood |
| 14166-3 | Methane [Mass/volume] in Blood |
| 14231-5 | H2a-H2b DNA IgG Ab [Units/volume] in Serum |
| 14357-8 | Microscopic observation [Identifier] in Cerebral spinal fluid by Gram stain |
| 103071-7 | Peanut recombinant (rAra h) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103078-2 | Soybean native (nGly m) 5 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10376-2 | Oval macrocytes [Presence] in Blood by Light microscopy |
| 14992-2 | O group [Presence] on Red Blood Cells from Blood product unit |
| 1580-0 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --pre 500 ug dexamethasone PO 2.5 day low dose q6h |
| 12323-2 | Trimeprazine [Presence] in Urine |
| 1713-7 | Prostatic acid phosphatase [Enzymatic activity/volume] in Semen |
| 18881-3 | Cefmetazole [Susceptibility] |
| 90798-0 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --3 hours post dose levothyroxine |
| 90839-2 | NMDAR subunit 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 91116-4 | Cholesterol in LDL 5 [Moles/volume] in Serum or Plasma |
| 74918-4 | Fatty acids [Mass/mass] in 24 hour Stool |
| 6080-6 | Cocoa IgE Ab [Units/volume] in Serum |
| 6092-1 | Crab IgE Ab [Units/volume] in Serum |
| 61061-8 | Temazepam [Presence] in Specimen |
| 75768-2 | Prochlorperazine [Presence] in Blood or Urine by Screen method |
| 7628-1 | Sweet potato IgG Ab [Units/volume] in Serum |
| 92819-2 | Glucose [Mass/volume] in Serum or Plasma --10 minutes post dose glucagon |
| 61215-0 | Giant Ragweed IgE Ab/IgE total in Serum |
| 6125-9 | Gluten IgE Ab [Units/volume] in Serum |
| 77162-6 | Anidulafungin [Susceptibility] by Gradient strip |
| 77183-2 | Niobium [Moles/volume] in Urine |
| 77743-3 | Toxocara sp Ab [Presence] in Ocular fluid by Immunoassay |
| 93790-4 | Delafloxacin [Susceptibility] by Gradient strip |
| 95576-5 | Pregnanetriol [Z-score] in 24 hour Urine |
| 95644-1 | Japanese encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 66110-8 | Breast Pathology biopsy report |
| 66135-5 | Promyelocytes [#/volume] in Blood from Fetus by Manual count |
| 7970-7 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum |
| 96264-7 | aPTT.lupus sensitive.factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with 1:1 normal plasma |
| 8065-5 | Cardiolipin IgG Ab [Units/volume] in Serum or Plasma |
| 7065-6 | Alfalfa IgE Ab [Units/volume] in Serum |
| 71603-5 | Eosinophils/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count |
| 98016-9 | Fat [#/area] in Urine sediment by Microscopy high power field |
| 98050-8 | European roe venison IgE Ab [Units/volume] in Serum |
| 98060-7 | Penicillamine IgE Ab [Units/volume] in Serum |
| 98237-1 | Chemokine (C-X-C motif) ligand 1 [Mass/volume] in Serum or Plasma |
| 98847-7 | SARS coronavirus 2 stimulated gamma interferon release by lymphocytes [Units/volume] corrected for background in Blood by Immunoassay |
| 99014-3 | Citrobacter freundii DNA [Presence] in Urine by NAA with probe detection |
| 7182-9 | Casein IgG Ab [Units/volume] in Serum |
| 85682-3 | Haemophilus influenzae ccs gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 99407-9 | Myeloperoxidase [Mass/volume] in Serum by Immunoassay |
| 99460-8 | Rabbit epithelium IgG Ab [Mass/volume] in Serum |
| 99527-4 | Thickness [Length] of Left ventricle |
| 998-5 | DBG Ag [Presence] on Red Blood Cells from Donor |
| 86198-9 | Neisseria meningitidis serogroup Y synF gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73093-7 | valGANciclovir induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73122-4 | Terazosin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87557-5 | Protein S Ag and protein S Ag.free panel - Platelet poor plasma by Immunoassay |
| 87738-1 | GALC gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 73518-3 | Acetylsalicylate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73626-4 | Ceftaroline+Avibactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 88542-6 | HIV 1 RNA integrase gene mutations detected [Identifier] in Cerebral spinal fluid by Sequencing |
| 89041-8 | Lung cancer antibody [Interpretation] in Serum or Plasma by Immunoassay |
| 59315-2 | Ramelteon M-II [Mass/volume] in Body fluid |
| 59614-8 | ALPRAZolam [Mass/mass] in Tissue by Confirmatory method |
| 50646-9 | Latex recombinant (rHev b) 1 IgE Ab [Units/volume] in Serum |
| 5081-5 | Chlamydophila psittaci IgM Ab [Units/volume] in Serum |
| 50941-4 | Mycobacterium sp [Presence] in Specimen by Organism specific culture |
| 31058-1 | Coxsackievirus B6 Ab [Titer] in Body fluid by Complement fixation |
| 31080-5 | Cannabinoids [Presence] in Meconium by Screen method |
| 31152-2 | Immunoglobulin light chains [Presence] in 24 hour Urine |
| 42619-7 | CD28 cells/100 cells in Bone marrow |
| 60198-9 | Trifluralin [Mass/volume] in Blood |
| 60287-0 | Benztropine [Moles/volume] in Specimen |
| 31482-3 | Leptospira interrogans sv Pomona Ab [Units/volume] in Serum |
| 51109-7 | Cytoplasmic CD2 blasts/100 blasts in Specimen |
| 21764-6 | MJD gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 43409-2 | Bacteria identified in Isolate by Culture |
| 22492-3 | Rickettsia typhus group Ab [Titer] in Serum |
| 22718-1 | Glycine [Moles/volume] in Specimen |
| 52769-7 | Clot formation.extrinsic coagulation system activated.fibrinolysis suppressed [Time] in Blood by Rotational TEG |
| 44095-8 | Unidentified cells/100 leukocytes in Blood by Manual count |
| 44287-1 | 5-Hydroxyhexanoate/Creatinine [Mass Ratio] in 24 hour Urine |
| 2315-0 | Galactosylceramidase [Enzymatic activity/mass] in Tissue |
| 32752-8 | CD3 cells/100 cells in Bronchial specimen |
| 53118-6 | Sulfonamide crystals [#/area] in Urine sediment by Microscopy high power field |
| 53147-5 | Follitropin [Units/volume] in Serum or Plasma --2 hours post XXX challenge |
| 5333-0 | Rubella virus Ab [Titer] in Serum by Latex agglutination |
| 23500-2 | Tritrichomonas foetus Ab [Presence] in Genital mucus |
| 23585-3 | Western equine encephalitis virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 33491-2 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose lactose PO |
| 537-1 | Mycobacterium sp identified in Peritoneal fluid by Organism specific culture |
| 4491-7 | Complement C3c [Mass/volume] in Serum or Plasma |
| 23675-2 | Bluetongue virus 2 neutralizing antibody [Titer] in Serum by Neutralization test |
| 23931-9 | Salmonella typhi O D [Titer] in Serum by Immunofluorescence |
| 33759-2 | Deepest extent of invasion [Type] in Specimen |
| 54271-2 | Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose ornithine alpha-ketoglutarate |
| 460-6 | Streptomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 4695-3 | HLA-A19 [Presence] in Donor |
| 2426-5 | Homocarnosine [Mass/volume] in Cerebral spinal fluid |
| 55522-7 | Acetazolamide [Moles/volume] in Serum or Plasma |
| 55844-5 | Cortisol Free [Mass/time] in 24 hour Urine by Radioimmunoassay (RIA) |
| 55967-4 | Palmitoylcarnitine (C16) [Moles/volume] in Urine |
| 47904-8 | Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose growth hormone releasing factor |
| 25788-1 | Streptolysin O Ab [Units/volume] in Serum by Latex agglutination |
| 25880-6 | Copper/Creatinine [Molar ratio] in Urine |
| 35602-2 | clomiPRAMINE [Mass/volume] in Serum or Plasma by Screen method |
| 26728-6 | CD38 cells [#/volume] in Blood |
| 35813-5 | Garenoxacin [Susceptibility] |
| 35837-4 | Salinomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 56716-4 | Nuclear pore protein gp210 Ab [Presence] in Serum by Immunoblot |
| 48680-3 | PAX5 Ag [Presence] in Tissue by Immune stain |
| 48863-5 | Rickettsia sp DNA [Identifier] in Specimen by RFLP |
| 26892-0 | Intrinsic factor blocking IgG Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
| 2694-8 | Osmolality of 24 hour Urine |
| 38552-6 | Acylcarnitine short chain [Moles/volume] in Serum or Plasma |
| 57316-2 | Tropomyosin IgE Ab [Units/volume] in Serum |
| 57385-7 | Urea [Mass/time] in 12 hour Urine |
| 57571-2 | 3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum or Plasma --1 day post dose dexamethasone |
| 57587-8 | Aldosterone [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
| 27423-3 | 1,4-Dioxane [Presence] in Serum or Plasma |
| 27920-8 | Normeperidine [Presence] in Urine |
| 57790-8 | Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
| 57847-6 | Leukocytes [#/volume] in Dialysis fluid by Manual count |
| 49451-8 | Varicella zoster virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 49462-5 | Calponin Ag [Presence] in Tissue by Immune stain |
| 58467-2 | Horse Bot Fly IgG4 Ab [Mass/volume] in Serum |
| 58641-2 | Cortisol [Moles/volume] in Saliva (oral fluid) --11th specimen post XXX challenge |
| 59029-9 | HLA-DRB1*15:01 [Presence] |
| 30221-6 | Coxsackievirus B2 Ab [Presence] in Serum |
| 40854-2 | Chlamydia trachomatis L2 IgG Ab [Titer] in Serum |
| 40882-3 | CD3-CD57+ cells/100 cells in Body fluid |
| 4093-1 | Verapamil [Presence] in Serum or Plasma |
| 20535-1 | Hydroxytriazolam cutoff [Mass/volume] in Urine for Confirmatory method |
| 12398-4 | Diphenoxylate [Mass/volume] in Serum or Plasma |
| 12414-9 | Resperine [Mass/volume] in Urine |
| 100761-6 | PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 101461-2 | Septin-5 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 102294-6 | Chinese Elm IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14067-3 | Dihydrocodeine [Mass/volume] in Blood |
| 103050-1 | English plantain recombinant (rPla l) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103646-6 | clozapine N-oxide [Mass/volume] in Urine by Confirmatory method |
| 15214-0 | Epidermal Allergen Mix 70 (Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) IgE Ab [Presence] in Serum by Multidisk |
| 15398-1 | Neuronal nuclear Ab [Titer] in Serum |
| 10787-0 | Microscopic observation [Identifier] in Tissue by Gridley stain |
| 17213-0 | CD98 cells/100 cells in Blood |
| 17249-4 | Menthol [Mass/volume] in Blood |
| 17410-2 | Human papilloma virus 51 Ag [Presence] in Specimen |
| 19140-3 | Phospholipid Ab [Presence] in Serum |
| 92479-5 | V Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 75397-0 | HNF1A gene full mutation analysis in Blood or Tissue by Sequencing |
| 93434-9 | Busulfan [Mass/volume] in Plasma --2 hours post busulfan infusion completion |
| 62290-2 | 1,25-Dihydroxyvitamin D [Mass/volume] in Serum or Plasma |
| 62353-8 | Chromosome analysis panel - Skin by G-banded |
| 7785-9 | Brewer's yeast triggered histamine release [Units/volume] in Blood |
| 78345-6 | Docosenoate (C22:1) [Entitic substance] in Red Blood Cells |
| 78844-8 | JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
| 94644-2 | SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection |
| 63462-6 | Rubella virus IgG Ab [Presence] in Serum by Latex agglutination |
| 6370-1 | Cryptococcus sp Ab [Presence] in Serum by Immunofluorescence |
| 95172-3 | Mycoplasma iowae DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 6525-0 | Rabies virus neutralizing antibody [Units/volume] in Tissue by Neutralization test |
| 6622-5 | Leishmania sp Ab [Presence] in Serum by Hemagglutination |
| 96331-4 | Streptococcus pyogenes DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection |
| 80541-6 | Nicotine [Mass/mass] in Hair |
| 96621-8 | HLA-C [Type] in Donor by High resolution |
| 96812-3 | Chervil IgE Ab [Units/volume] in Serum |
| 96963-4 | Grimontia holisae and Vibrio fluvialis and Vibrio harveyi DNA [Identifier] in Specimen by NAA with probe detection |
| 97004-6 | Insulin type [Identifier] in Serum or Plasma by LC/MS/MS |
| 69756-5 | Bordetella sp filamentous hemagglutinin and pertussis toxin Ab.IgA and IgG panel - Serum by Line blot |
| 70176-3 | Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Serum or Plasma |
| 98066-4 | Colistin resistance mcr-3+mcr-4+mcr-5 genes [Presence] by Molecular method |
| 99066-3 | PL-12 Ab [Units/volume] in Serum by Line blot |
| 71670-4 | Band form neutrophils/Leukocytes [Pure number fraction] in Blood by Manual count |
| 71702-5 | Rotavirus dsRNA [Identifier] in Isolate by Polyacrylamide gel electrophoresis (PAGE) |
| 84917-4 | Chromosome Y aneuploidy [Presence] in Amniotic fluid or Chorionic villus sample by FISH |
| 85285-5 | Polyp in which invasive carcinoma arose [Type] in Colorectal cancer specimen by Light microscopy |
| 85508-0 | Satellite nodules [#] in Colorectal cancer specimen by Light microscopy |
| 73163-8 | risperiDONE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73509-2 | Aztreonam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73529-0 | amLODIPine+Benazepril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88364-5 | Actinobacillus pleuropneumoniae IgG Ab/Positive control in Saliva (oral fluid) by Immunoassay |
| 7408-8 | Histamine extract triggered histamine release [Units/volume] in Blood |
| 74444-1 | Thiamine pyrophosphate [Moles/volume] in Blood |
| 88866-9 | Other Chemical [Mass/mass] in Specimen |
| 89355-2 | CD21- cells/100 CD19 cells in Blood |
| 41231-2 | Xanthurenate+Kynurenate [Presence] in 24 hour Urine |
| 41607-3 | Methemoglobin/Hemoglobin.total in Mixed venous blood |
| 59348-3 | Nortamoxifen [Mass/volume] in Blood |
| 5071-6 | Brucella suis Ab [Titer] in Serum by Latex agglutination |
| 50796-2 | Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis |
| 50965-3 | Gamma hydroxybutyrate cutoff [Mass/volume] in Serum or Plasma |
| 31026-8 | Dextromethamphetamine/Amphetamines.total in Urine |
| 41861-6 | Yeast.hyphae [#/area] in Urine sediment by Microscopy high power field |
| 60270-6 | Rabies virus RNA [Presence] in Isolate by NAA with probe detection |
| 51144-4 | CD3 blasts/100 blasts in Blood |
| 42996-9 | Leptospira borgpetersenii sv Ballum Ab [Titer] in Serum |
| 43250-0 | Xanthine derivatives [Presence] in Urine |
| 32354-3 | Hematocrit [Volume Fraction] of Arterial blood |
| 53095-6 | Carnitine free (C0)/Carnitine.total in DBS |
| 53394-3 | 5-Oxoproline+Pipecolate/Phenylalanine [Molar ratio] in DBS |
| 44671-6 | Margin involvement by CAP cancer protocols |
| 44864-7 | 6-Alpha hydroxytetrahydro-11-Deoxycortisol/Creatinine [Mass Ratio] in Urine |
| 33406-0 | Candida albicans Ab [Units/volume] in Serum by Complement fixation |
| 33417-7 | pH of Pericardial fluid |
| 5379-3 | Platelet Ab [Units/volume] in Serum |
| 45332-4 | NF2 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
| 34175-0 | Analgesics [Identifier] in Serum or Plasma |
| 54163-1 | Cytomegalovirus DNA [#/volume] (viral load) in Urine by Probe and target amplification method detection limit = 200 copies/ml |
| 4595-5 | Hemoglobin J - Baltimore [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 55520-1 | 6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine |
| 25251-0 | cycloSERINE [Mass/volume] in Specimen |
| 34892-0 | West Nile virus RNA [Presence] in Specimen by NAA with probe detection |
| 55915-3 | Beta 2 globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis |
| 47558-2 | Microalbumin/Protein.total in 24 hour Urine |
| 47645-7 | Histidine/Amino acids.total in Cerebral spinal fluid |
| 47724-0 | Phenylalanine/Amino acids.total in Serum or Plasma |
| 25921-8 | Glycine [Moles/volume] in 24 hour Urine |
| 26003-4 | Vanillylmandelate [Moles/volume] in 24 hour Urine |
| 35760-8 | Cefditoren [Susceptibility] by Gradient strip |
| 5650-7 | Fluoride [Mass/volume] in Urine |
| 4835-5 | HLA-B45(12) [Presence] |
| 484-6 | Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 48892-4 | Coxiella burnetii phase 2 IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 38380-2 | HFE gene.p.Ser65Cys [Presence] in Blood or Tissue by Molecular genetics method |
| 38464-4 | Mountain Juniper IgE Ab/IgE total in Serum |
| 57294-1 | HLA-DRB3 [Type] by High resolution |
| 27396-1 | Hemoglobin.gastrointestinal [Mass/mass] in Stool |
| 39971-7 | Creatinine [Mass/volume] in Serum or Plasma --12 hours post XXX challenge |
| 40137-2 | Creatinine [Moles/volume] in Urine --2 hours post XXX challenge |
| 58381-5 | fentaNYL [Mass/volume] in Urine by Confirmatory method |
| 58518-2 | C peptide [Mass/volume] in Serum or Plasma --5 hours post dose glucose |
| 58647-9 | Cortisol [Moles/volume] in Saliva (oral fluid) --12th specimen post XXX challenge |
| 50395-3 | Adenosine deaminase [Enzymatic activity/mass] in Chorionic villus sample |
| 30373-5 | Basophils/100 leukocytes in Bronchial specimen |
| 41146-2 | Herpes virus 8 IgG Ab [Presence] in Serum |
| 12468-5 | Amino acids [Identifier] in Serum or Plasma |
| 12607-8 | Glucose [Mass/volume] in Peritoneal dialysis fluid --pre dialysis |
| 12760-5 | Insulin [Mass/volume] in Serum or Plasma --4 minutes post XXX challenge |
| 12895-9 | HIV 1 p58 Ab [Presence] in Serum by Immunoblot |
| 101218-6 | Hantavirus dobrava IgM Ab [Presence] in Serum or Plasma by Line blot |
| 101281-4 | Neurofilament light chain [Mass/volume] in Serum or Plasma by Immunoassay |
| 13639-0 | Chlordecone [Mass/volume] in Serum or Plasma |
| 14013-7 | Platelet associated IgM Ab [Units/volume] in Blood by Flow cytometry (FC) |
| 1483-7 | Galactose [Mass/time] in 5 hour Urine --post 40 g dose PO |
| 15221-5 | Food Allergen Mix F (Buckwheat+Soybean+Rice+Sesame seed+Wheat) IgE Ab [Presence] in Serum by Multidisk |
| 104463-5 | Yellow fever virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 11190-6 | Mint IgE Ab [Units/volume] in Serum |
| 11241-7 | Hyoscyamine [Mass/volume] in Serum or Plasma |
| 1192-4 | little k Ab [Presence] in Serum or Plasma |
| 16910-2 | Glucose [Presence] in Urine --7th specimen post XXX challenge |
| 17401-1 | Human papilloma virus 18 Ag [Presence] in Specimen |
| 17575-2 | Serine [Presence] in Urine |
| 18190-9 | Acid phosphatase tartrate resistant [Presence] in Specimen |
| 18259-2 | Vasoactive intestinal peptide [Mass/time] in 24 hour Urine |
| 74912-7 | Primidone [Mass/volume] in Serum or Plasma --trough |
| 74930-9 | 3-Hydroxykynurenin [Moles/volume] in Cerebral spinal fluid |
| 75668-4 | Fetal sex [Likelihood] in Plasma cell-free DNA by Dosage of chromosome specifi cell free (cf) DNA |
| 75755-9 | Methicillin susceptible Staphylococcus aureus DNA [Presence] in Specimen by NAA with probe detection |
| 61292-9 | Oyster IgE Ab/IgE total in Serum |
| 61370-3 | Salmonella enterica DNA [Presence] in Specimen by NAA with probe detection |
| 62313-2 | Gaucher disease newborn screening comment-discussion |
| 94183-1 | Heartland banyangvirus RNA [Presence] in Specimen by NAA with probe detection |
| 63069-9 | TOP2A gene [Interpretation] in Tissue Narrative |
| 78019-7 | Toscana virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 9432-6 | Isobutyl acetate [Mass/volume] in Specimen |
| 78972-7 | CYP2C8 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 78994-1 | Prolactin monomeric [Units/volume] in Serum or Plasma |
| 95204-4 | PMA+ionomycin stimulated gamma interferon producing CD8 Cells/100 CD3+CD8+ cells in Blood by Flow cytometry (FC) |
| 9527-3 | Hexacarboxylporphyrin [Mass/time] in 24 hour Urine |
| 95535-1 | Human papilloma virus 51 DNA [Presence] in Cervix by NAA with probe detection |
| 95675-5 | Yellow fever virus IgG Ab [Presence] in Specimen by Immunoassay |
| 66144-7 | Variant lymphocytes [#/volume] in Blood from Fetus by Manual count |
| 6668-8 | Microscopic observation [Identifier] in Tissue by M'Fadyean stain |
| 80369-2 | Neisseria sp identified in Anorectal by Organism specific culture |
| 96122-7 | SARS-related coronavirus E gene [Presence] in Upper respiratory specimen by NAA with probe detection |
| 68941-4 | Somatotropin [Mass/volume] in Serum or Plasma --110 minutes post exercise |
| 9724-6 | Spermatozoa IgG Ab [Units/volume] in Serum |
| 97253-9 | Flurazepam [Presence] in Cord tissue by Confirmatory method |
| 97933-6 | Sandfly fever Sicilian virus RNA [Presence] in Specimen by NAA with probe detection |
| 99404-6 | CD19+CD38+ cells/100 cells in Bone marrow |
| 99859-1 | Erythrocytes.non-dysmorphic [Presence] in Urine sediment by Computer assisted method |
| 85804-3 | Influenza virus A H5 Ag [Titer] in Isolate by Hemagglutination inhibition |
| 86081-7 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum by Immunoassay |
| 73254-5 | Moxifloxacin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87382-8 | Porcine cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection |
| 87617-7 | Ethylene glycol [Mass/mass] in Specimen |
| 73680-1 | Mycophenolate [Mass/volume] in Serum or Plasma --peak |
| 73747-8 | Keyhole limpet hemocyanin IgM Ab [Mass/volume] in Serum |
| 73967-2 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA |
| 74140-5 | Granulocytes [#/volume] in Peritoneal dialysis fluid |
| 4127-7 | Ampicillin [Mass] of Dose |
| 41497-9 | HIV 1 RNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 50832-5 | Boron/Creatinine [Molar ratio] in Urine |
| 31131-6 | Mumps virus particle-bound Ab [Titer] in Serum |
| 41843-4 | Lymphocytic choriomeningitis virus IgG and IgM panel [Titer] - Cerebral spinal fluid by Immunofluorescence |
| 42225-3 | Thallium [Moles/volume] in Urine |
| 21208-4 | Cobalt [Mass/volume] in 24 hour Urine |
| 21416-3 | Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection |
| 31571-3 | Porcine parvovirus Ab [Units/volume] in Serum |
| 43049-6 | Coxsackievirus A10 Ab [Titer] in Body fluid |
| 5182-1 | Hepatitis A virus IgM Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
| 22692-8 | Valine/Creatinine [Molar ratio] in Urine |
| 22704-1 | Carnitine free (C0)/Creatinine [Molar ratio] in Urine |
| 52978-4 | Varicella zoster virus Ab [Units/volume] in Serum by Complement fixation |
| 23023-5 | Coxiella burnetii Ag [Presence] in Specimen by Immunofluorescence |
| 53223-4 | Hemoglobin G/Hemoglobin.total in Blood |
| 44606-2 | ALOX3+ALOX12B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 23856-8 | Endrin [Mass/volume] in Serum or Plasma |
| 24002-8 | Microscopic observation [Identifier] in Bronchial specimen by Acid fast stain |
| 24103-4 | Plasma cells [#/volume] in Blood by Manual count |
| 34163-6 | Oxygen content in Blood |
| 54164-9 | Cytomegalovirus immediate-early Ag [Presence] in Blood |
| 464-8 | sulfADIAZINE [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 46947-8 | Budesonide [Mass/volume] in Urine |
| 24312-1 | Treponema pallidum Ab [Presence] in Serum by Agglutination |
| 2465-3 | IgG [Mass/volume] in Serum or Plasma |
| 55192-9 | Chromosome analysis.interphase [Interpretation] in Amniotic fluid by FISH Narrative |
| 25309-6 | Amobarbital [Moles/volume] in Serum or Plasma |
| 35007-4 | Nonhematic cells [#/volume] in Cerebral spinal fluid |
| 35120-5 | Dothiepin sulfoxide [Mass/volume] in Serum or Plasma |
| 35145-2 | Octanoate (C8:0) [Moles/volume] in Serum or Plasma |
| 35334-2 | Collagen crosslinked N-telopeptide [Moles/volume] in 24 hour Urine |
| 47733-1 | Proline/Amino acids.total in Hair |
| 25867-3 | Echinococcus sp Ab [Titer] in Serum |
| 35644-4 | Metanephrine/Creatinine [Mass Ratio] in 24 hour Urine |
| 56149-8 | Beta 2 glycoprotein and Cardiolipin Ab and Phosphatidylserine panel - Serum |
| 56470-8 | Blasts [#] in Cerebral spinal fluid by Manual count |
| 48007-9 | Genetic variant allelic state [Type] in Blood or Tissue by Molecular genetics method |
| 26594-2 | Gamma aminobutyrate [Moles/volume] in Cerebral spinal fluid |
| 56973-1 | Proline/Creatinine [Ratio] in 24 hour Urine |
| 38666-4 | Diethylsulfate [Mass/volume] in Air |
| 57106-7 | Lutropin [Units/volume] in Serum or Plasma --20 minutes post dose gonadotropin releasing hormone |
| 27937-2 | Sporothrix schenckii Ab [Titer] in Serum |
| 39306-6 | Influenza virus A H5 Ab [Titer] in Serum by Hemagglutination inhibition |
| 49452-6 | Varicella zoster virus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
| 28608-8 | Tryptophan/Creatinine [Ratio] in Urine |
| 39956-8 | Creatinine [Mass/volume] in Serum or Plasma --1.5 hours pre XXX challenge |
| 58611-5 | Corticotropin [Moles/volume] in Plasma --6th specimen post XXX challenge |
| 5863-6 | Influenza virus A Ag [Presence] in Specimen by Immunofluorescence |
| 29679-8 | Rickettsia sibirica Ab [Titer] in Serum |
| 40621-5 | Carcinoembryonic Ag [Mass/volume] in Pericardial fluid |
| 40706-4 | Colchicine [Mass/volume] in Urine |
| 59053-9 | Glucagon [Mass/volume] in Serum or Plasma --5th specimen fasting |
| 59183-4 | Epstein Barr virus early diffuse IgG Ab [Presence] in Serum |
| 30293-5 | Ritonavir [Susceptibility] by Genotype method |
| 19397-9 | chlorproMAZINE cutoff [Mass/volume] in Urine for Screen method |
| 19542-0 | Mescaline [Presence] in Urine by Screen method |
| 20563-3 | Carboxyhemoglobin/Hemoglobin.total in Blood |
| 20701-9 | Bluetongue virus Ag [Presence] in Tissue by Immunofluorescence |
| 20854-6 | Equine herpesvirus 1 Ag [Presence] in Tissue by Immunofluorescence |
| 100136-1 | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot |
| 100711-1 | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay |
| 100868-9 | Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method |
| 12940-3 | Thyrotropin [Units/volume] in Serum or Plasma --30 minutes pre XXX challenge |
| 101826-6 | Sodium Urate crystals [Saturation Fraction] in 24 hour Urine |
| 101976-9 | Voltage-gated calcium channel P/Q type binding Ab [Mass/volume] in Serum by Immunoassay |
| 102236-7 | Chloramin T IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102691-3 | Soybean dust IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104239-9 | B cell non hodgkin Lymphoma multigene analysis in Blood or Tissue by Molecular genetics method |
| 15083-9 | Normetanephrine [Moles/time] in 24 hour Urine |
| 15126-6 | Alpha 2 globulin/Protein.total in Synovial fluid by Electrophoresis |
| 1566-9 | Insulin [Mass/volume] in Serum or Plasma --3 hours post dose TOLBUTamide IV |
| 10925-6 | Chub Mackerel IgE Ab [Units/volume] in Serum |
| 11102-1 | Charcot-leyden crystals [type] in Specimen by Trichrome stain |
| 16665-2 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --5 minutes post XXX challenge |
| 17050-6 | Latex glove extract buffered IgE Ab [Units/volume] in Blood |
| 18909-2 | Clotrimazole [Susceptibility] |
| 18929-0 | Gentamicin.high potency [Susceptibility] |
| 90436-7 | Microorganism preliminary growth [Presence] in Body fluid by Organism specific culture |
| 74616-4 | 1,1-Dimethoxyoctadecane (DMA 18:0)/Octadecanoate (C18:0) [Mass Ratio] in Fibroblast |
| 75606-4 | Cell-free DNA.fetal/Cell-free DNA.total in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Narrative |
| 61094-9 | Lysergate diethylamide [Presence] in Gastric fluid |
| 77675-7 | Gastrin [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 9375-7 | Glucose [Mass/volume] in Serum or Plasma --2.5 hours post 100 g glucose PO |
| 93882-9 | N-Palmitoylsphingosine [Moles/volume] in Plasma |
| 9426-8 | Barbiturates [Mass/volume] in Urine |
| 94298-7 | O-desmethylvenlafaxine [Presence] in Serum or Plasma by Screen method |
| 94695-4 | Axonal autoimmune Ab panel - Serum or Plasma |
| 6522-7 | Rabies virus Ab [Units/volume] in Cerebral spinal fluid |
| 6632-4 | Strongyloides stercoralis IgG Ab [Presence] in Serum by Immunoassay |
| 66729-5 | Adenovirus DNA [#/volume] (viral load) in Skin by NAA with probe detection |
| 8050-7 | Venezuelan equine encephalitis virus IgG Ab [Units/volume] in Serum |
| 96480-9 | IgLON5 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 96501-2 | TIF1-gamma Ab [Units/volume] in Serum by Immunoassay |
| 81725-4 | Glutamate decarboxylase 65 Ab [Presence] in Serum by Line blot |
| 8207-3 | Nickel [Mass/volume] in Saliva (oral fluid) |
| 97862-7 | Herpes virus 8 IgG and IgM panel - Serum or Plasma |
| 824-3 | Au sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 82980-4 | AMPAR2 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 98193-6 | Wax begonia IgE Ab [Units/volume] in Serum |
| 99093-7 | Streptococcus agalactiae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 72764-4 | Carboxy tetrahydrocannabinol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 86015-5 | Streptococcus pneumoniae Danish serotype 17F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 86131-0 | Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 86176-5 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 73059-8 | Ampicillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87394-3 | Salmonella sp DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 87404-0 | Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay |
| 73400-4 | Enalapril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73671-0 | Legionella pneumophila serogroup [Type] in Isolate by Agglutination |
| 87803-3 | Sulfadimethoxine [Susceptibility] |
| 87827-2 | Casts [Presence] in Urine |
| 73979-7 | Keyhole limpet hemocyanin Ab panel - Serum or Plasma |
| 41681-8 | cefTRIAXone+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 60076-7 | Gallium [Mass/volume] in Red Blood Cells |
| 31237-1 | Infectious bronchitis virus Ark-99 Ab [Units/volume] in Serum |
| 31318-9 | Coxsackievirus A16 Ab [Units/volume] in Body fluid |
| 4278-8 | Hydroxychloroquine [Mass] of Dose |
| 22101-0 | Avian pox virus Ab [Presence] in Serum |
| 31789-1 | Cryptococcus sp Ag [Units/volume] in Cerebral spinal fluid |
| 31917-8 | Neisseria meningitidis serogroup C Ag [Presence] in Specimen |
| 32018-4 | Hepatitis A virus IgG Ab [Presence] in Serum |
| 51702-9 | Ganglioside IgM Ab [Presence] in Serum by Immunoblot |
| 51879-5 | Transfuse packed erythrocytes units [#] |
| 43623-8 | Acetylcholine receptor blocking Ab [Presence] in Serum |
| 22479-0 | Rickettsia spotted fever group IgM Ab [Titer] in Serum |
| 44018-0 | Basophils [Presence] in Body fluid by Light microscopy |
| 4406-5 | Prazepam [Mass] of Dose |
| 22981-5 | Capripox virus [Presence] in Tissue by Animal inoculation |
| 32603-3 | Itraconazole [Susceptibility] |
| 32625-6 | Spermatozoa IgA Ab [Presence] in Serum |
| 32673-6 | Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma |
| 2337-4 | Glucagon [Mass/volume] in Amniotic fluid |
| 23582-0 | Rabbit hemorrhagic disease virus Ag [Presence] in Tissue by Immune stain |
| 33489-6 | Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose lactose PO |
| 53531-0 | Microalbumin [Mass/volume] in Urine by Detection limit <= 1.0 mg/L |
| 2386-1 | Glycerate [Mass/volume] in Urine |
| 33934-1 | Methylmethacrylate IgE Ab [Presence] in Serum |
| 54247-2 | Drug screen comment [Interpretation] in Urine |
| 24245-3 | Polio virus 2 Ab [Titer] in Serum --1st specimen |
| 34548-8 | Sodium and Potassium panel [Moles/volume] - Serum or Plasma |
| 47447-8 | Influenza virus A H12 Ab [Titer] in Serum |
| 35317-7 | Thermoactinomyces vulgaris 1 Ab [Presence] in Serum by Immune diffusion (ID) |
| 55714-0 | Sisomicin [Susceptibility] by Gradient strip |
| 47868-5 | Prolactin [Units/volume] in Serum or Plasma --1.5 hours post dose metoclopramide |
| 56360-1 | Pistachio IgG4 Ab [Mass/volume] in Serum |
| 26451-5 | Eosinophils/100 leukocytes in Cerebral spinal fluid |
| 3715-0 | Lidocaine [Presence] in Serum or Plasma |
| 5660-6 | Gold [Mass/volume] in Urine |
| 26999-3 | Homocystine [Moles/volume] in Urine |
| 38465-1 | Chicken IgE Ab/IgE total in Serum |
| 38589-8 | Ammonia [Mass/volume] in Air |
| 3889-3 | Oxprenolol [Mass/volume] in Serum or Plasma |
| 5818-0 | Urobilinogen [Presence] in Urine by Test strip |
| 2876-1 | Prealbumin [Mass/volume] in Cerebral spinal fluid by Electrophoresis |
| 29296-1 | Dimethylbenzene [Presence] in Blood |
| 3996-6 | Propylhexedrine [Presence] in Urine |
| 58672-7 | Cortisol [Moles/volume] in Serum or Plasma --45 minutes post 1 ug/kg CRH IV |
| 49872-5 | FH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 49947-5 | Somatotropin [Units/volume] in Serum or Plasma --11:30 PM specimen |
| 40864-1 | 11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Serum or Plasma |
| 19402-7 | clonazePAM [Mass/volume] in Urine |
| 20453-7 | Epithelial cells [Presence] in Urine sediment by Light microscopy |
| 20767-0 | Coccidioides immitis [Presence] in Isolate |
| 12814-0 | Potassium [Moles/volume] in Vitreous fluid |
| 101370-5 | Bacillus anthracis plasmid pXO2 DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 101568-4 | Thyroglobulin and Thyroglobulin Ab panel - Tissue fine needle aspirate |
| 13045-0 | C peptide [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
| 101956-1 | COQ4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 14585-4 | Albumin/Creatinine [Molar ratio] in Urine |
| 103653-2 | Ciprofloxacin [Susceptibility] for meningitis |
| 14943-5 | Uroporphyrin 3 isomer [Moles/volume] in Serum or Plasma |
| 15108-4 | Methadone [Moles/volume] in Serum or Plasma |
| 10541-1 | Mepivacaine [Mass/volume] in Serum or Plasma |
| 15489-8 | Mycoplasma synoviae Ab [Presence] in Serum by Immunoassay |
| 1076-9 | Jk sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
| 1154-4 | little c Ab [Presence] in Serum or Plasma from Blood product unit |
| 16956-5 | Herpes simplex virus 2 IgG Ab [Units/volume] in Cerebral spinal fluid |
| 17274-2 | Methylergonovine [Mass/volume] in Serum or Plasma |
| 17442-5 | Phenylephrine [Mass/volume] in Serum or Plasma |
| 183-4 | Cinoxacin [Susceptibility] by Serum bactericidal titer |
| 7499-7 | Monkey epithelium IgE Ab [Units/volume] in Serum |
| 75354-1 | Other cells [#/volume] in Pleural fluid by Manual count |
| 76596-6 | Streptococcus pyogenes csrS gene [#/mass] in XXX.tissue by NAA with probe detection |
| 76671-7 | Glucose [Moles/volume] in Cerebral spinal fluid --3rd tube |
| 92971-1 | Klebsiella pneumoniae+Klebsiella variicola+Klebsiella quasipneumoniae DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
| 61254-9 | Italian Cypress IgE Ab/IgE total in Serum |
| 6190-3 | Oat IgE Ab [Units/volume] in Serum |
| 93839-9 | Histoplasma capsulatum IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 7884-0 | Epstein Barr virus nuclear IgM Ab [Presence] in Serum |
| 64975-6 | Cat recombinant (rFel d) 1 IgE Ab [Units/volume] in Serum |
| 9502-6 | Carbophenothion [Mass/volume] in Specimen |
| 95166-5 | Mycoplasma synoviae Ab/Positive control in Serum by Immunoassay |
| 65759-3 | T-cell subsets CD4 and CD8 panel - Blood |
| 80198-5 | Nonsteroidal antiinflammatory drugs [Presence] in Blood by Screen method |
| 69023-0 | Methylenedioxyamphetamine [Mass/mass] in Meconium by Confirmatory method |
| 81112-5 | Murray Valley encephalitis virus IgG Ab [Titer] in Serum |
| 8142-2 | Amphetamines [Presence] in Gastric fluid by Screen method |
| 82081-1 | Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 97223-2 | Benzoylecgonine [Presence] in Cord tissue by Confirmatory method |
| 97276-0 | Methylone [Presence] in Cord tissue by Screen method |
| 97961-7 | European Ash IgG4 Ab [Mass/volume] in Serum |
| 82904-4 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
| 98280-1 | Optimal tissue block [Identifier] in Cancer specimen |
| 84905-9 | Margin involvement [Type] in Prostate tumor |
| 85312-7 | Extent of inferior margin carcinoma involvement in Breast cancer specimen Qualitative by Light microscopy |
| 99263-6 | Delorazepam [Mass/volume] in Urine by Confirmatory method |
| 99453-3 | Penicillin V IgG Ab [Mass/volume] in Serum |
| 99898-9 | Calcium oxalate dihydrate crystals [#/area] in Urine sediment by Computer assisted method |
| 72503-6 | WT1 gene exon 1+2 transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
| 72627-3 | Barbiturates [Presence] in Saliva (oral fluid) by Screen method |
| 72850-1 | Hepatitis B virus codon 85 [Identifier] by Genotype method |
| 7307-2 | Epidermophyton floccosum IgE Ab [Units/volume] in Serum |
| 73178-6 | quiNIDine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73196-8 | predniSONE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73359-2 | glyBURIDE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86949-5 | Trichomonas vaginalis and Mycoplasma genitalium DNA panel - Specimen |
| 73490-5 | Candesartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73519-1 | Acetylsalicylate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88743-0 | Zinc finger protein of the cerebellum 4 Ab [Units/volume] in Serum by Line blot |
| 41408-6 | Ofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 41466-4 | Methadone/Creatinine [Mass Ratio] in Urine |
| 50885-3 | Naproxen [Moles/volume] in Serum or Plasma |
| 41768-3 | VWF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 21330-6 | Histoplasma capsulatum Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
| 21545-9 | Sulfatide IgG Ab [Titer] in Cerebral spinal fluid |
| 42906-8 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in DBS |
| 43061-1 | Chlamydia trachomatis IgM Ab [Titer] in Cerebral spinal fluid |
| 43072-8 | Brucella canis IgG Ab [Titer] in Cerebral spinal fluid |
| 43169-2 | Bromide [Moles/volume] in Urine |
| 21727-3 | PMP22 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 22184-6 | Chlamydia sp IgG Ab [Titer] in Serum |
| 51533-8 | European house dust mite IgG Ab [Presence] in Serum |
| 43246-8 | PHOX2B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 32188-5 | Microscopic observation [Identifier] in Cerebral spinal fluid by Acid fast stain |
| 5252-2 | Mycoplasma pneumoniae Ab [Units/volume] in Serum by Latex agglutination |
| 43965-3 | CD4+CD45RA+ cells/100 cells in Tissue |
| 23101-9 | Equine influenza virus A1 Ab [Presence] in Serum |
| 3269-8 | Heparin neutralization [Presence] in Platelet poor plasma |
| 32996-1 | HER2 [Mass/volume] in Serum |
| 53237-4 | Acrylylcarnitine (C3:1) [Moles/volume] in DBS |
| 44444-8 | Bartonella sp IgM Ab [Units/volume] in Serum by Immunoassay |
| 23382-5 | Pseudorabies virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 23433-6 | Salmonella pullorum Ab [Presence] in Serum by Immune diffusion (ID) |
| 33506-7 | Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post dose lactose PO |
| 4489-1 | Complement C3b [Mass/volume] in Serum or Plasma |
| 33804-6 | RBC casts [Presence] in Urine sediment by Light microscopy |
| 33923-4 | Hemosiderin [Presence] in Specimen |
| 34239-4 | Androstenedione [Moles/volume] in 24 hour Urine |
| 46401-6 | Corticotropin [Mass/volume] in Plasma --1.5 hours post 1 ug/kg CRH IV |
| 24188-5 | Coxsackievirus B3 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen |
| 24315-4 | Cytomegalovirus IgG and IgM panel - Serum or Plasma |
| 24450-9 | Carnitine esters [Moles/mass] in Tissue |
| 34563-7 | Cell count panel - Cerebral spinal fluid |
| 34709-6 | Chlamydia trachomatis Ag [Presence] in Nasopharynx |
| 55194-5 | Ciprofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 55465-9 | Influenza virus A H1 2009 pandemic RNA [Presence] in Specimen by NAA with probe detection |
| 47453-6 | Influenza virus A H4 Ab [Titer] in Serum |
| 25128-0 | Phosphoserine/Creatinine [Molar ratio] in Urine |
| 35338-3 | Chymotrypsin [Enzymatic activity/volume] in Body fluid --2nd specimen post Sincalide |
| 55919-5 | C peptide [Moles/volume] in Serum or Plasma --post meal |
| 35748-3 | Hydrogen ion [Moles/volume] adjusted to patient's actual temperature in Arterial blood |
| 47980-8 | Mirtazapine [Presence] in Serum or Plasma |
| 26499-4 | Neutrophils [#/volume] in Blood |
| 56697-6 | Thiopental IgE Ab [Units/volume] in Serum |
| 27069-4 | Cisapride [Mass/volume] in Serum or Plasma |
| 57500-1 | 11-Deoxycortisol [Moles/volume] in Serum or Plasma --pre dose metyraPONE |
| 27281-5 | Propoxyphene [Mass/mass] in Stool |
| 57749-4 | Amphiphysin Ab [Presence] in Serum by Immunoblot |
| 5808-1 | Erythrocytes [#/volume] in Urine sediment by Microscopy high power field |
| 49450-0 | Varicella zoster virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
| 2824-1 | Potassium [Moles/volume] in Red Blood Cells |
| 40102-6 | aPTT in Platelet poor plasma by Coagulation assay --1 hour post XXX challenge |
| 40247-9 | Calcium [Moles/volume] in Serum or Plasma --3 days post XXX challenge |
| 49957-4 | Somatotropin [Units/volume] in Serum or Plasma --5:30 AM specimen |
| 29899-2 | Gamma globulin [Presence] in 24 hour Urine |
| 5913-9 | Hemoglobin F/Hemoglobin.total in Amniotic fluid |
| 59203-0 | Adenine/Creatinine [Molar ratio] in Urine |
| 40821-1 | Helicobacter pylori IgM Ab [Titer] in Serum |
| 40932-6 | Yersinia enterocolitica O:3 Ab [Presence] in Serum |
| 40990-4 | Rhinovirus RNA [Identifier] in Specimen by NAA with probe detection |
| 41135-5 | Influenza virus A N8 Ab [Presence] in Serum |
| 19269-0 | Amphetamines confirm method [Identifier] in Urine |
| 12460-2 | Corticotropin [Mass/volume] in Plasma --4th specimen post XXX challenge |
| 13502-0 | Borrelia burgdorferi IgG band pattern [Interpretation] in Serum by Immunoblot |
| 13549-1 | clomiPRAMINE [Presence] in Serum or Plasma |
| 13720-8 | Carnosine/Creatinine [Mass Ratio] in Urine |
| 13881-8 | Deoxypyridinoline Free/Creatinine [Molar ratio] in Urine |
| 14334-7 | Lithium [Moles/volume] in Serum or Plasma |
| 10354-9 | Bacteria identified in Urethra by Culture |
| 103560-9 | Aldosterone/Renin [Ratio] in Serum or Plasma |
| 14833-8 | Metanephrines [Moles/time] in 24 hour Urine |
| 10694-8 | Naegleria sp identified in Tissue by Organism specific culture |
| 1534-7 | Glucose [Mass/volume] in Serum or Plasma --3 minutes post 0.5 g/kg glucose IV |
| 16138-0 | Ganglioside GM1 IgA Ab [Titer] in Serum |
| 10774-8 | Microscopic observation [Identifier] in Tissue by Bielschowsky stain |
| 16697-5 | Cyclohexane [Presence] in Blood |
| 1225-2 | Mg Ag [Presence] on Red Blood Cells |
| 16875-7 | Francisella tularensis Ab [Titer] in Serum |
| 1802-8 | Amylase.P1 [Enzymatic activity/volume] in Serum or Plasma |
| 74681-8 | Amphetamines [Presence] in Saliva (oral fluid) by Confirmatory method |
| 75106-5 | Mead acid (C20:3w9) [Entitic substance] in Red Blood Cells |
| 75351-7 | Other cells [#/volume] in Synovial fluid by Manual count |
| 61056-8 | Pseudoephedrine [Presence] in Serum or Plasma |
| 61141-8 | Isocyanate HDI IgG Ab [Mass/volume] in Serum |
| 76033-0 | HEXA gene full mutation analysis in Blood or Tissue by Sequencing |
| 9308-8 | 2,4-Dinitrophenylhydrazine reacting substances [Presence] in Urine |
| 93980-1 | Iothalamate [Mass/volume] in Serum or Plasma |
| 7868-3 | Echovirus 30 Ab [Titer] in Serum |
| 9480-5 | Nitrate [Mass/volume] in Water |
| 6420-4 | Helicobacter pylori IgA Ab [Units/volume] in Serum by Immunoassay |
| 79449-5 | Formate [Moles/volume] in Urine |
| 95580-7 | 6-Beta-Hydroxycortisol [Z-score] in 24 hour Urine |
| 7961-6 | Measles virus Ab [Units/volume] in Serum |
| 96057-5 | Interferon beta IgG Ab [Presence] in Serum |
| 69020-6 | Lymphocyte proliferation stimulated by pokeweed mitogen/CD3 in Blood by Flow cytometry (FC) |
| 80658-8 | Activated clotting time (ACT) of Blood induced by Diatomaceous earth |
| 81280-0 | Differential panel - Dialysis fluid |
| 8193-5 | Benzoylecgonine [Presence] in Urine by SAMHSA screen method |
| 97656-3 | Hereditary cancer multigene analysis in Blood or Tissue by Molecular genetics method |
| 70852-9 | Burkholderia pseudomallei DNA [Presence] in Specimen by NAA with probe detection |
| 8229-7 | Phencyclidine [Presence] in Gastric fluid by Confirmatory method |
| 9813-7 | Cortisol [Mass/volume] in Serum or Plasma --AM peak specimen |
| 83064-6 | Calcium.ionized [Moles/volume] in Blood drawn from CRRT circuit |
| 72672-9 | traZODone [Mass/volume] in Serum or Plasma --trough |
| 86170-8 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum --1st specimen |
| 87366-1 | Actinobacillus pleuropneumoniae serotypes 1+9+11 Ab/Positive control in Serum by Immunoassay |
| 73606-6 | Besifloxacin [Susceptibility] |
| 73870-8 | Alpha cortolone [Moles/time] in 24 hour Urine |
| 88005-4 | Glutarylcarnitine (C5-DC)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma |
| 88574-9 | Onchocerca sp IgG3 Ab [Presence] in Serum by Immunoassay |
| 41251-0 | Xylose [Mass/volume] in Urine --5 hours post 25 g xylose PO |
| 41482-1 | Chlamydia sp IgG and IgM panel [Titer] - Serum |
| 41648-7 | Carboxyhemoglobin/Hemoglobin.total in Mixed venous blood |
| 5978-2 | Plasminogen activator inhibitor 2 [Units/volume] in Platelet poor plasma by Chromogenic method |
| 508-2 | Tobramycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 31110-0 | Osmotic fragility of Red Blood Cells--0.30% sodium chloride 24 hour 37 degree C incubation |
| 42179-2 | PLP1 gene duplication [Presence] in Blood or Tissue by Molecular genetics method |
| 42321-0 | HTT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 60029-6 | West Nile virus IgG Ab avidity [Presence] in Serum by Immunofluorescence |
| 21482-5 | Protein [Mass/volume] in 24 hour Urine |
| 31404-7 | Ganglioside GM1b IgG Ab [Units/volume] in Serum |
| 51283-0 | CD3+CD57+ cells/100 cells in Cerebral spinal fluid |
| 51299-6 | CD38 cells/100 cells in Body fluid |
| 51578-3 | Chlamydia trachomatis DNA [Presence] in Semen by NAA with probe detection |
| 51717-7 | Normoblasts Orthochromic/100 cells in Blood by Microscopy |
| 22450-1 | Polio virus 3 Ab [Titer] in Serum |
| 32106-7 | Perphenazine [Presence] in Specimen |
| 32189-3 | Microscopic observation [Identifier] in Body fluid by Acid fast stain |
| 32298-2 | Amylase [Enzymatic activity/volume] in Specimen |
| 32351-9 | Alkaline phosphatase.heat labile [Enzymatic activity/volume] in Serum or Plasma by Heat stability |
| 520-7 | Troleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 52785-3 | Maximum lysis.extrinsic coagulation system activated.fibrinolysis suppressed [Length fraction] in Blood by Rotational TEG |
| 5283-7 | Polio virus 2 neutralizing antibody [Titer] in Serum by Neutralization test |
| 43917-4 | Benzene [Presence] in Urine |
| 44300-2 | Arsenic.inorganic/Creatinine [Mass Ratio] in 24 hour Urine |
| 22869-2 | Bluetongue virus Ag [Presence] in Specimen by Immunofluorescence |
| 44552-8 | hydroCHLOROthiazide [Presence] in Serum or Plasma |
| 44700-3 | ACTA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 23572-1 | Vesicular stomatitis virus serotype [Identifier] in Specimen by Immunoassay |
| 33615-6 | Neuronal nuclear type 1 Ab [Presence] in Serum |
| 53708-4 | Glutamate decarboxylase 65 Ab [Moles/volume] in Cerebral spinal fluid |
| 53793-6 | RPS6KA3 gene mutations tier 1 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 34619-7 | Complement C1 esterase inhibitor.functional [Mass/volume] in Body fluid |
| 55344-6 | Platelet aggregation ristocetin induced in Platelet rich plasma --1000 ug/mL |
| 47251-4 | BK virus DNA [Presence] in Specimen by NAA with probe detection |
| 47361-1 | Treponema pallidum IgG Ab [Presence] in Serum from Donor by Immunoassay |
| 2534-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Urine |
| 34950-6 | Parvovirus B19 IgG and IgM panel - Serum |
| 25564-6 | Bilirubin.direct [Moles/volume] in Body fluid |
| 3543-6 | Propoxyphene [Mass/volume] in Serum or Plasma |
| 26534-8 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post dose corticotropin |
| 26643-7 | Clostridium tetani toxoid Ab [Presence] in Serum |
| 26763-3 | Sodium [Mass/time] in 2 hour Urine |
| 35843-2 | Telithromycin [Susceptibility] by Disk diffusion (KB) |
| 48618-3 | Cholesterol in VLDL [Mass/volume] in Serum or Plasma ultracentrifugate |
| 26926-6 | Ganglioside GD1b Ab [Presence] in Serum by Immunoassay |
| 38519-5 | Microscopic observation [Identifier] in Blood or Marrow by Prussian blue stain |
| 57568-8 | 25-hydroxyvitamin D3 [Moles/volume] in Serum or Plasma --3 hours post dose calcium |
| 48947-6 | Cocaine [Presence] in Specimen by Confirmatory method |
| 49041-7 | Testosterone [Mass/volume] in Serum or Plasma by Detection limit <= 1.0 ng/dL |
| 49255-3 | Calculus analysis [Interpretation] in Stone Narrative by Infrared spectroscopy |
| 39463-5 | Bilirubin.indirect [Moles/volume] in Body fluid |
| 57939-1 | Chromium [Mass/volume] in Cerebral spinal fluid |
| 5832-1 | Adenovirus Ag [Presence] in Urine by Immunofluorescence |
| 29363-9 | Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 40023-4 | Glucose [Mass/volume] in Serum or Plasma --23.5 hours post XXX challenge |
| 5876-8 | Respiratory syncytial virus Ag [Presence] in Specimen by Immunoassay |
| 58964-8 | Ganglioside GT1a IgG Ab [Units/volume] in Serum by Immunoassay |
| 50524-8 | Prolactin [Mass/volume] in Serum or Plasma --8th specimen |
| 1940-6 | Beta galactosidase [Enzymatic activity/volume] in Red Blood Cells |
| 19766-5 | Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain Narrative |
| 20407-3 | Nitrite [Mass/volume] in Urine by Test strip |
| 20649-0 | Leucine [Moles/volume] in Serum or Plasma |
| 20663-1 | Tricyclic antidepressants [Mass/volume] in Urine by Screen method |
| 20947-8 | Retinol [Mass/mass] in Feed |
| 100415-9 | Kale IgG Ab [Units/volume] in Serum |
| 100829-1 | Renin [Mass/volume] in Plasma --4th specimen post XXX challenge |
| 101300-2 | Streptococcus pyogenes DNA [Presence] in Throat by NAA with non-probe detection |
| 1015-7 | E sup(w) Ag [Presence] on Red Blood Cells |
| 13038-5 | C peptide [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 13081-5 | Phosphatidylglycerol IgA Ab [Units/volume] in Serum |
| 102027-0 | Cortisol [Mass/volume] in Serum or Plasma --2.5 hours post dose glucagon |
| 102475-1 | Oidiodendrum spp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1462-1 | EPINEPHrine [Mass/volume] in Plasma --2 hours post 300 ug cloNIDine PO |
| 14752-0 | Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose glucose |
| 10377-0 | Pencil cells [Presence] in Blood by Light microscopy |
| 15110-0 | Morphine [Moles/volume] in Serum or Plasma |
| 104475-9 | Zika virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen |
| 15247-0 | Food Allergen Mix H (Pineapple+Lemon+Strawberry+Avocado) IgE Ab [Presence] in Serum by Multidisk |
| 16217-2 | Methyprylon [Presence] in Urine by Confirmatory method |
| 16341-0 | Alpha aminoisobutyrate [Presence] in Plasma |
| 16500-1 | Butyrate (C4) [Mass/volume] in Stool |
| 16840-1 | Ethacrynate [Mass/volume] in Serum or Plasma |
| 16926-8 | Haemophilus influenzae A Ag [Presence] in Cerebral spinal fluid |
| 17166-0 | CD49d cells/100 cells in Blood |
| 18408-5 | CD3+HLA-DR+ cells/100 cells in Blood |
| 74508-3 | 16-Alpha hydroxypregnenolone [Moles/volume] in 24 hour Urine |
| 74577-8 | Pyruvate dehydrogenase complex [Enzymatic activity/mass] in Fibroblast |
| 7536-6 | White Oak IgG Ab [Units/volume] in Serum |
| 60493-4 | Calcidiol+Calciferol [Moles/volume] in Serum or Plasma |
| 7659-6 | Rat hair IgE Ab [Units/volume] in Serum |
| 93428-1 | GABABR IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay |
| 62-0 | Carbenicillin [Susceptibility] by Serum bactericidal titer |
| 6213-3 | Pepper tree IgE Ab [Units/volume] in Serum |
| 77176-6 | Hepatitis B virus little e Ag and Ab panel - Serum |
| 93730-0 | Testosterone [Moles/volume] in Amniotic fluid |
| 94011-4 | Anion gap 3 in Serum or Plasma --2 hours post dose vasopressin |
| 9408-6 | Aminobenzoate [Mass/volume] in Serum or Plasma |
| 63087-1 | Common Millet IgG Ab [Mass/volume] in Serum |
| 63094-7 | Parsley IgG Ab [Mass/volume] in Serum |
| 78527-9 | Platelet aggregation collagen induced in Platelet rich plasma --5 ug/mL |
| 94378-7 | Escherichia coli DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 95096-4 | Glucagon [Mass/volume] in Serum or Plasma --3.5 hours post meal |
| 95129-3 | Dense fine speckled 70 protein IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 6549-0 | Saint Louis encephalitis virus Ag [Units/volume] in Serum |
| 79722-5 | SLCO1B1 gene product functional interpretation in Blood or Tissue Qualitative by Molecular genetics method |
| 95834-8 | Mononuclear cells [#] in Blood product unit |
| 9591-9 | Borrelia burgdorferi 30kD IgG Ab [Presence] in Serum by Immunoblot |
| 95954-4 | Stone pine IgE Ab [Units/volume] in Serum |
| 68974-5 | IgG.intrathecally synthesized/IgG.total in Cerebral spinal fluid |
| 8077-0 | Mitochondria Ab [Units/volume] in Serum |
| 81120-8 | Barmah forest virus Ab [Titer] in Serum |
| 81702-3 | Microsatellite instability marker D2S123 in Cancer specimen Qualitative |
| 97646-4 | Lassa virus RNA [Presence] in Specimen by NAA with probe detection |
| 97758-7 | Fungus and Mycobacterium sp identified in Blood by Organism specific culture |
| 97946-8 | Color.fungal colony [Type] in Isolate by Culture--with Chromogenic agar |
| 70149-0 | Methadone [Presence] in Urine by Screen method >300 ng/mL |
| 7144-9 | Liver beef triggered histamine release [Units/volume] in Blood |
| 82471-4 | Borrelia garinii+afzelii oppA1 gene [Presence] in Blood by NAA with non-probe detection |
| 98117-5 | Fibroblast growth factor 2 [Mass/volume] in Serum or Plasma |
| 72445-0 | 3-Hydroxysuberate [Moles/volume] in Cerebral spinal fluid |
| 72881-6 | UGT2B15 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 72977-2 | PARoxetine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86156-7 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum --2nd specimen |
| 73313-9 | Levalbuterol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86709-3 | Lawsonia intracellularis RNA [#/volume] in Specimen by NAA with probe detection |
| 88377-7 | Tildipirosin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 74294-0 | Isovaleric acidemia newborn screen interpretation |
| 41688-3 | Dalbavancin [Susceptibility] by Disk diffusion (KB) |
| 50814-3 | Arsenic.inorganic [Moles/volume] in Urine |
| 30524-3 | Triglyceride [Moles/volume] in Serum or Plasma --12 hours fasting |
| 42176-8 | 1,3 beta glucan [Mass/volume] in Serum |
| 59999-3 | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 2118-8 | Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma |
| 42765-8 | Tube number of Body fluid |
| 21735-6 | SNCA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 22083-0 | Alcelaphine herpesvirus 1 Ab [Presence] in Serum |
| 22281-0 | Echovirus 9 Ab [Titer] in Serum |
| 43275-7 | CD3 cells/CD4 cells [# Ratio] in Specimen |
| 22418-8 | Mumps virus IgM Ab [Presence] in Serum |
| 51986-8 | niCARdipine [Presence] in Serum or Plasma |
| 22942-7 | Brucella reaction wheal [Diameter] --3 days post 0.1 mL brucellin intradermal |
| 23098-7 | Equine infectious anemia virus Ag [Presence] in Specimen by Immunofluorescence |
| 23105-0 | Fly larvae identified in Specimen |
| 32859-1 | Multiple drug resistance cells/100 cells in Specimen |
| 53131-9 | Calcium oxalate crystals [#/area] in Urine sediment by Microscopy low power field |
| 53321-6 | Mucus [Presence] in Urine by Automated |
| 23531-7 | Trypanosoma sp Ab [Presence] in Serum by Immunoassay |
| 33745-1 | Polyps in Specimen Narrative |
| 34261-8 | Catecholamines [Moles/volume] in Urine |
| 54222-5 | Lymphoma - acute screen markers [Interpretation] in Specimen Narrative |
| 54441-1 | Lipoprotein goals |
| 54450-2 | CYP2C9 and VKORC1 panel - Blood or Tissue by Molecular genetics method |
| 34440-8 | Immunoelectrophoresis for Urine |
| 47019-5 | CD8 Ag [Presence] in Tissue by Immune stain |
| 47179-7 | Parathyrin [Moles/volume] in Serum or Plasma --10 minutes post excision |
| 25469-8 | Meprobamate [Moles/volume] in Serum or Plasma |
| 47664-8 | Insulin [Units/volume] in Serum or Plasma --3 minutes post dose glucose |
| 56460-9 | Pepper tree IgG4 Ab [Mass/volume] in Serum |
| 48203-4 | Celery triggered leukotriene release [Mass/volume] by Leukocytes |
| 35811-9 | Garenoxacin [Susceptibility] by Disk diffusion (KB) |
| 38189-7 | Alpha 2 globulin [Mass/volume] in 24 hour Urine by Electrophoresis |
| 57035-8 | Cow milk Ab [Presence] in Serum by Immune diffusion (ID) |
| 48368-5 | trans-Octadecanoate (C18:0) [Moles/volume] in Serum or Plasma |
| 27032-2 | Zirconium [Mass/volume] in Serum or Plasma |
| 27131-2 | Phencyclidine [Presence] in Vitreous fluid |
| 38360-4 | Isobutyrylglycine/Creatinine [Mass Ratio] in Urine |
| 38659-9 | Acetophenone [Mass/volume] in Air |
| 57443-4 | Spermatozoa Progressive Grade 3/100 spermatozoa in Semen --post concentration |
| 48949-2 | Estazolam [Mass/volume] in Specimen |
| 27349-0 | Cystathionine [Presence] in 24 hour Urine |
| 3954-5 | Phenothiazines [Mass/volume] in Urine |
| 57748-6 | Liver cytosol Ab [Presence] in Serum by Immunoassay |
| 49366-8 | Hepatitis B virus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
| 29288-8 | Orphenadrine [Presence] in Urine |
| 40019-2 | Glucose [Mass/volume] in Serum or Plasma --20 hours post XXX challenge |
| 58568-7 | Corticotropin [Moles/volume] in Plasma --2.5 hours post dose glucose |
| 50074-4 | 11-Deoxycortisol [Moles/volume] in Serum or Plasma --45 minutes post 250 ug corticotropin |
| 29611-1 | Ethchlorvynol [Presence] in Specimen |
| 40788-2 | Japanese cypress IgE Ab [Units/volume] in Serum |
| 40869-0 | Carnitine esters/Carnitine.free (C0) [Molar ratio] in Serum or Plasma |
| 40875-7 | Glucose [Mass/volume] in Specimen --3rd specimen |
| 40949-0 | Yersinia enterocolitica O:5 Ab [Presence] in Cerebral spinal fluid |
| 41136-3 | Influenza virus A N7 Ab [Presence] in Serum |
| 20469-3 | Acetone [Presence] in Serum or Plasma by Screen method |
| 12545-0 | Zomepirac [Mass/volume] in Serum or Plasma |
| 12550-0 | Papaverine [Mass/volume] in Serum or Plasma |
| 12611-0 | Glucose [Mass/volume] in Serum or Plasma --4 hour specimen |
| 12767-0 | Insulin [Mass/volume] in Serum or Plasma --50 minutes post XXX challenge |
| 101467-9 | Septin-7 IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay |
| 102372-0 | Honey IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102403-3 | Latex glove extract buffered IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14373-5 | Leukocytes [#/volume] in Gastric fluid by Manual count |
| 14376-8 | Polymorphonuclear cells/100 leukocytes in Synovial fluid by Manual count |
| 14421-2 | Bilirubin.total [Mass/volume] in Pleural fluid |
| 103836-3 | Noroxycodone [Presence] in Meconium |
| 15270-2 | Tree Allergen Mix 8 (Boxelder+Silver birch+Hazelnut+White oak+London plane or Maple leaf sycamore) IgE Ab [Presence] in Serum by Multidisk |
| 10935-5 | Horse serum proteins IgE Ab [Units/volume] in Serum |
| 16433-5 | Basement membrane Ab [Presence] in Serum |
| 114-9 | cefoTEtan [Susceptibility] by Serum bactericidal titer |
| 11569-1 | Phosphatidylserine IgM Ab [Presence] in Serum |
| 11601-2 | Echovirus 7 Ab [Units/volume] in Serum |
| 17085-2 | Lipoproteins [Presence] in Serum or Plasma |
| 17162-9 | CD48 cells/100 cells in Blood |
| 17303-9 | Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid |
| 17459-9 | Phospholipid IgA Ab [Units/volume] in Serum by Immunoassay |
| 19110-6 | HIV 1 gp41+gp43 Ab [Presence] in Serum by Immunoblot |
| 75231-1 | Nefazodone [Presence] in Urine |
| 60388-6 | Oyster IgG Ab [Mass/volume] in Serum |
| 93386-1 | Pseudomonas aeruginosa DNA [Presence] by NAA with probe detection in Positive blood culture |
| 94206-0 | MMACHC gene full mutation analysis in Blood or Tissue by Sequencing |
| 94373-8 | Moraxella catarrhalis DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 94398-5 | Ethyl sulfate [Mass/mass] in Meconium by Confirmatory method |
| 9478-9 | Magnesium [Mass/volume] in Water |
| 63470-9 | Ganglioside GM4 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 6482-4 | Mycoplasma pneumoniae rRNA [Presence] in Sputum by Probe |
| 79184-8 | Last name of Guardian or legally authorized representative |
| 7946-7 | Lassa virus Ag [Presence] in Serum by Immunoassay |
| 95087-3 | C peptide [Mass/volume] in Serum or Plasma --3 hours post meal |
| 95571-6 | 11-Deoxytetrahydrocorticosterone [Mass/time] in 24 hour Urine |
| 65327-9 | Lu 14 Ab [Presence] in Serum or Plasma |
| 6709-0 | Hippurate [Mass/volume] in Urine |
| 80139-9 | Antimony [Moles/mass] in Tissue |
| 6739-7 | Yellow Hornet IgG Ab [Units/volume] in Serum |
| 68381-3 | pH of Synovial fluid by Test strip |
| 69037-0 | Lymphocyte proliferation.pokeweed mitogen.maximum/CD19 in Blood by Flow cytometry (FC) |
| 80699-2 | CD4-CD8-/100 CD3+TCR alpha beta+ cells in Blood |
| 81212-3 | clomiPRAMINE and Norclomipramine panel - Specimen |
| 6943-5 | Acetohexamide [Mass/volume] in Specimen |
| 69844-9 | 2-Hydroxyglutarate [Moles/volume] in Cerebral spinal fluid |
| 97257-0 | HYDROmorphone Free [Presence] in Cord tissue by Confirmatory method |
| 97590-4 | Norbuprenorphine free [Presence] in Cord tissue by Screen method |
| 97780-1 | Sodium [Moles/volume] in Dialysis fluid --2 hour specimen |
| 97949-2 | Semliki Forest virus RNA [Presence] in Specimen by NAA with probe detection |
| 82532-3 | SDHB and SDHC and SDHD gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 98483-1 | Apolipoprotein E phenotype [Identifier] in Cerebral spinal fluid |
| 85042-0 | Staphylococcus aureus glycopeptide resistant identified [Type] in Isolate |
| 72799-0 | Norketamine [Mass/volume] in Urine by Confirmatory method |
| 86235-9 | Neisseria meningitidis serogroup B synD gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73533-2 | Amitriptyline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88148-2 | Microscopic observation [Identifier] in Genital specimen by Acid fast stain |
| 88302-5 | Lambda light chains.free [Presence] in 24 hour Urine by Immunofixation |
| 88304-1 | Kappa light chains [Presence] in 24 hour Urine by Immunofixation |
| 73950-8 | JWH-250 (synthetic cannabinoid) [Presence] in Blood |
| 74395-5 | Blasts [#/volume] in Cord blood |
| 74429-2 | Metamyelocytes.eosinophilic/100 cells in Bone marrow by Manual count |
| 74437-5 | Galactokinase [Enzymatic activity/mass] in Leukocytes |
| 50804-4 | Amitriptyline [Moles/volume] in Urine |
| 30577-1 | 2-methyl-3-hydroxybutyrate (C5-OH) [Presence] in Urine |
| 42189-1 | CD3+CD16+CD56+ cells/100 cells in Blood |
| 6023-6 | Aspergillus amstelodami IgE Ab [Units/volume] in Serum |
| 31213-2 | Actinobacillus pleuropneumoniae serotype 3 Ab [Presence] in Serum |
| 42741-9 | Phosphatidylcholine IgG Ab B2GP1 dependent [Multiple of the median] in Serum |
| 21760-4 | FRAXE gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 31724-8 | Avian leukosis virus Ag [Units/volume] in Serum |
| 22414-7 | Mumps virus Ab [Titer] in Serum |
| 52940-4 | Arsenic.inorganic/Creatinine [Molar ratio] in 24 hour Urine |
| 32736-1 | Beta 1 globulin/Protein.total in Urine by Electrophoresis |
| 33210-6 | Transferrin receptor.soluble [Moles/volume] in Serum or Plasma |
| 53281-2 | Urinalysis type of cast panel [#/volume] - Urine by Computer assisted method |
| 44722-7 | Histiocytes [Presence] in Body fluid by Light microscopy |
| 44732-6 | Transferrin.carbohydrate deficient.monosialo/Transferrin.carbohydrate deficient.disialo [Mass Ratio] in Serum or Plasma |
| 44816-7 | Trypanosoma cruzi IgG Ab [Presence] in Serum by Immunofluorescence |
| 23341-1 | Pasteurella multocida Ab [Titer] in Serum by Immunoassay |
| 23596-0 | Dermatophilus congolensis [Presence] in Exudate by Carbol-fuchsin stain |
| 53743-1 | Cocaine metabolites.other [Mass/volume] in Urine |
| 4555-9 | Hemoglobin A3/Hemoglobin.total in Blood |
| 4641-7 | Hemolysin warm [Mass/volume] in Plasma |
| 54925-3 | Selenium [Mass/volume] in Semen |
| 47101-1 | Copper [Moles/volume] in Body fluid |
| 2545-2 | Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis |
| 25521-6 | Selenium [Moles/volume] in Serum or Plasma |
| 55801-5 | Platelet aggregation ristocetin induced [Presence] in Platelet rich plasma --500 mg/L |
| 55968-2 | pH of Total parental nutrition |
| 47601-0 | Choriogonadotropin.beta subunit free [Units/volume] in Body fluid |
| 47636-6 | Glycine/Amino acids.total in Cerebral spinal fluid |
| 47641-6 | Palmitate (C16:0)/Creatinine [Molar ratio] in Urine |
| 25661-0 | Gastrin [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 25955-6 | Metanephrine [Moles/volume] in 24 hour Urine |
| 25961-4 | Nickel [Moles/volume] in 24 hour Urine |
| 26023-2 | Extractable nuclear Ab identified in Serum |
| 56305-6 | Lenscale IgG4 Ab [Mass/volume] in Serum |
| 48214-1 | Shrimp triggered leukotriene release [Mass/volume] by Leukocytes |
| 48273-7 | Lysine acetylsalicylate triggered leukotriene release [Mass/volume] by Leukocytes |
| 26039-8 | Norflunitrazepam [Moles/volume] in Serum or Plasma |
| 57015-0 | Lactulose.PO [Mass] of Dose |
| 48889-0 | Coxiella burnetii phase 1 IgA Ab [Titer] in Body fluid by Immunofluorescence |
| 271-7 | Gramicidin D [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 38415-6 | MTHFR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 38489-1 | Insulin bovine Ab [Titer] in Serum |
| 38611-0 | Methyl isobutyl ketone [Mass/volume] in Air |
| 49248-8 | Amino acid pattern [Interpretation] in Urine Narrative |
| 28075-0 | Sildenafil citrate [Mass/volume] in Serum or Plasma |
| 39615-0 | Benzoylcarnitine (BzCn) [Moles/volume] in Serum or Plasma |
| 49425-2 | Papova virus SV 40 DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 49498-9 | Leukocytes [#/volume] in Blood by Estimate |
| 49663-8 | HIV nucleoside reverse transcriptase susceptibility panel by Phenotype method |
| 28649-2 | Oxygen [Partial pressure] in Venous cord blood |
| 29236-7 | Herpes simplex virus 2 Ab [Units/volume] in Body fluid |
| 40204-0 | Glucose [Moles/volume] in Serum or Plasma --12 minutes post XXX challenge |
| 58583-6 | Corticotropin [Mass/volume] in Plasma --30 minutes post dose glucose |
| 40404-6 | Tripelennamine [Presence] in Gastric fluid |
| 40433-5 | Sucrose hemolysis of Red Blood Cells from Control |
| 40641-3 | Ketones [Presence] in Vitreous fluid |
| 59303-8 | Memantine [Mass/volume] in Body fluid |
| 30031-9 | Alternaria alternata+American house dust mite IgG Ab [Presence] in Serum by Multidisk |
| 30220-8 | Coxsackievirus B1 Ab [Presence] in Serum |
| 30386-7 | Erythrocyte mean corpuscular diameter [Length] |
| 19204-7 | Prostate Specific Ag Free [Units/volume] in Semen |
| 19403-5 | clonazePAM cutoff [Mass/volume] in Urine for Screen method |
| 19442-3 | Diamorphine cutoff [Mass/volume] in Urine for Confirmatory method |
| 20592-2 | CD19 cells [#/volume] in Specimen |
| 20939-5 | Phosphide [Mass/mass] in Gastrointestinal content |
| 12353-9 | Methaqualone [Presence] in Stool |
| 100345-8 | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection |
| 1252-6 | Major crossmatch [Interpretation] --post immediate spin |
| 12530-2 | Chloride [Moles/volume] in Water |
| 101127-9 | Bacterial carbapenem resistance blaSIM gene [Presence] by Molecular method |
| 101735-9 | Urate crystals [Energy Difference] in 24 hour Urine |
| 102002-3 | Clot formation.kaolin induced [Time] in Blood by Thromboelastography^after addition of heparinase |
| 13678-8 | Alpha ketoglutarate/Creatinine [Mass Ratio] in Urine |
| 13937-8 | Ethyl acetate [Mass/volume] in Blood |
| 13973-3 | Prealbumin/Protein.total in Cerebral spinal fluid by Electrophoresis |
| 102674-9 | Alternaria alternata IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102724-2 | Corn IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 11184-9 | Scad IgE Ab [Units/volume] in Serum |
| 11258-1 | Hepatitis B virus DNA [Units/volume] in Serum |
| 16995-3 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --6 hours post dose glucose |
| 17522-4 | Reticulin IgA Ab [Titer] in Serum by Immunofluorescence |
| 17591-9 | Smith extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 91140-4 | Brucella sp IgG and IgM panel - Serum Qualitative |
| 75657-7 | Mononuclear cells [#] in Pleural fluid by Manual count |
| 76606-3 | Pseudomonas aeruginosa regA gene [#/volume] in XXX.body fluid by NAA with probe detection |
| 62249-8 | Reticulocytes [#/volume] in Blood from Fetus by Automated count |
| 62370-2 | FISH probe gene name [Identifier] in Laboratory device |
| 77382-0 | Adenovirus Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
| 63331-3 | Baker's yeast IgA Ab [Presence] in Serum by Immunofluorescence |
| 78768-9 | Morphine [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine |
| 94826-5 | Parvovirus B19 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 63396-6 | Myelin associated glycoprotein Ab [Presence] in Body fluid by Immunoblot |
| 79420-6 | Miscellaneous allergen IgE Ab [Units/volume] in Serum |
| 653-6 | Microscopic observation [Identifier] in Urine by Gram stain |
| 6547-4 | Rotavirus identified in Specimen by Organism specific culture |
| 6706-6 | buPROPion [Mass/volume] in Serum or Plasma |
| 96319-9 | Escherichia coli DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection |
| 96358-7 | Bovine parainfluenza virus 3 [Presence] in Specimen by Organism specific culture |
| 68364-9 | Pincer cells [Presence] in Blood by Light microscopy |
| 69017-2 | Immature granulocytes/100 leukocytes in Synovial fluid |
| 80957-4 | cefTRIAXone free [Mass/volume] in Serum or Plasma |
| 82114-0 | Inhalant Allergen Mix 7 (Dermatophagoides pteronyssinus+Cat dander+Cat epithelium+Horse dander+Dog dander+Rabbit epithelium) IgE Ab [Units/volume] in Serum |
| 97557-3 | Gastrointestinal dysmotility autoimmune Ab panel - Serum |
| 70178-9 | 11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Blood |
| 7090-4 | Apple Tree IgE Ab [Units/volume] in Serum |
| 82731-1 | Zika virus IgM Ab [Presence] in Serum by Immunofluorescence |
| 82986-1 | Contactin-associated protein 2 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 72162-1 | Erythrocytes [Presence] in Specimen by Gram stain |
| 99436-8 | Peach recombinant (rPru p) 3 IgG4 Ab [Mass/volume] in Serum |
| 99539-9 | Stenosis degree [Length fraction] in Mid left anterior descending artery by Autopsy |
| 86099-9 | Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum by Immunoassay |
| 73280-0 | Methyldopa induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87346-3 | Senecavirus A Ab [Titer] in Serum by Immunofluorescence |
| 7354-4 | Bermuda grass triggered histamine release [Units/volume] in Blood |
| 73879-9 | Catecholamine metabolites and creatinine panel - Urine |
| 7404-7 | Shagbark Hickory IgE Ab [Units/volume] in Serum |
| 7424-5 | House dust Greer IgG Ab [Units/volume] in Serum |
| 89317-2 | CD4+CD25-CD127+ cells [#/volume] in Blood |
| 89522-7 | Ganglioside GM3 IgG Ab [Presence] in Serum by Line blot |
| 41646-1 | Calcium.ionized [Moles/volume] in Mixed venous blood |
| 50908-3 | Silver [Moles/mass] in Hair |
| 30520-1 | Deoxycholate [Moles/volume] in Serum or Plasma |
| 60117-9 | Palladium [Mass/volume] in Blood |
| 60144-3 | Pendimethalin [Mass/volume] in Urine |
| 60176-5 | Sulfamethizole [Mass/volume] in Serum or Plasma |
| 60200-3 | Trifluralin [Mass/volume] in Urine |
| 31208-2 | Specimen source identified |
| 31290-0 | Centromere IgG Ab [Units/volume] in Serum |
| 31514-3 | Mycoplasma mycoides ss mycoides large colony Ab [Presence] in Serum |
| 43080-1 | Bluetongue virus 13 Ab [Titer] in Serum |
| 22224-0 | Coxsackievirus B IgM Ab [Units/volume] in Serum |
| 31805-5 | Duck hepatitis virus 3 Ag [Presence] in Specimen |
| 51629-4 | Macroblasts/100 cells in Bone marrow by Manual count |
| 51777-1 | 7-Aminoflunitrazepam [Mass/volume] in Urine by Confirmatory method |
| 51801-9 | Myeloperoxidase Ab [Titer] in Serum by Immunofluorescence |
| 44272-3 | Cache valley virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 44579-1 | Influenza virus C Ab [Presence] in Serum |
| 23275-1 | Mycoplasma gallisepticum Ab [Titer] in Serum |
| 53535-1 | Varicella zoster virus IgM Ab [Presence] in Body fluid by Immunoassay |
| 23950-9 | Adenovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 24052-3 | Alpha mannosidase [Enzymatic activity/mass] in Fibroblast |
| 33806-1 | HIV 2 IgG Ab [Presence] in Serum by Immunoblot |
| 3387-8 | Benzodiazepines positive [Identifier] in Urine |
| 34281-6 | Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in 24 hour Urine |
| 55165-5 | Echinococcus sp IgG4 Ab [Presence] in Serum |
| 55472-5 | Cortisol [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 55532-6 | Diethylpropion [Moles/volume] in Serum or Plasma |
| 47395-9 | Kanamycin [Mass/volume] in Serum or Plasma |
| 55874-2 | Histidine [Moles/mass] in Hair |
| 55885-8 | Hydroxocobalamin [Mass/volume] in Urine |
| 48140-8 | Erythro-4-Deoxytetronate/Creatinine [Molar ratio] in Urine |
| 26056-2 | Pyridoxine [Moles/volume] in Serum or Plasma --post 250 mg pyridoxine PO |
| 3679-8 | HYDROcodone [Presence] in Serum or Plasma |
| 3745-7 | Meperidine [Mass/volume] in Serum or Plasma |
| 56690-1 | Insulin [Mass/volume] in Serum or Plasma --16 hours post XXX challenge |
| 48803-1 | Neural tube defect risk [Likelihood] in Fetus |
| 38656-5 | Chlorobenzilate [Mass/volume] in Air |
| 39465-0 | Carbon dioxide, total [Moles/volume] in Venous cord blood |
| 57754-4 | TNFRSF13B gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 49347-8 | Cytomegalovirus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
| 49659-6 | HIV reverse transcriptase susceptibility panel by Genotype method |
| 29365-4 | Magnesium [Mass/volume] in Body fluid |
| 40075-4 | Calcium [Mass/volume] in Serum or Plasma --6.5 hours post XXX challenge |
| 58450-8 | Bilirubin [Presence] in Urine by Confirmatory method |
| 58520-8 | C peptide [Moles/volume] in Serum or Plasma --5 minutes post 1 mg glucagon IV |
| 58591-9 | Corticotropin [Moles/volume] in Plasma --30 minutes pre dose insulin IV |
| 29771-3 | Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay |
| 50256-7 | Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --4th specimen fasting |
| 503-3 | Ticarcillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC) |
| 50445-6 | Corticotropin [Mass/volume] in Plasma --1st specimen |
| 40895-5 | CD3+CD56+ cells [#/volume] in Bone marrow |
| 41119-9 | APTX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19199-9 | Prostate specific Ag [Mass/volume] in Semen |
| 19727-7 | Aspergillus niger IgG Ab [Presence] in Serum |
| 1980-2 | Biotin [Mass/volume] in Serum or Plasma |
| 101166-7 | Metonitazene [Mass/volume] in Urine by Confirmatory method |
| 101168-3 | Metonitazene [Presence] in Urine by Confirmatory method |
| 101169-1 | 2-methyl AP-237 [Mass/volume] in Urine by Confirmatory method |
| 101177-4 | Metanephrine Free/Creatinine [Molar ratio] in Serum or Plasma |
| 13303-3 | HLA-A+B+C (class I) [Type] |
| 13480-9 | 18-Hydroxydeoxycortisol/Creatinine [Mass Ratio] in Urine |
| 102343-1 | Quack grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102723-4 | Cilantro IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102747-3 | Gluten IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102948-7 | Gerbil epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1463-9 | EPINEPHrine [Mass/volume] in Plasma --3 hours post 300 ug cloNIDine PO |
| 14670-4 | Coproporphyrin 1/Porphyrins.total in Urine |
| 104111-0 | Legionella pneumophila DNA [Presence] in Upper respiratory specimen by NAA with non-probe detection |
| 14844-5 | 6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma |
| 15224-9 | Food Allergen Mix 71 (Caraway+Cardamon+Mace+Clove) IgE Ab [Presence] in Serum by Multidisk |
| 104248-0 | Pepsinogen I/Pepsinogen II [Mass Ratio] in Serum |
| 10483-6 | Gastrin Ag [Presence] in Tissue by Immune stain |
| 15408-8 | Thallium [Mass/mass] in Hair |
| 15443-5 | Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 16115-8 | Doxepin [Mass/mass] in Tissue |
| 10957-9 | Slash Pine IgE Ab [Units/volume] in Serum |
| 16858-3 | fentaNYL [Mass/volume] in Body fluid |
| 17316-1 | Myeloperoxidase Ab [Presence] in Serum |
| 17512-5 | Redfish IgE Ab [Units/volume] in Serum |
| 18370-7 | Nitrite [Mass/volume] in Blood |
| 90246-0 | Bacterial whole genome [Nucleotide sequence] in Isolate by Sequencing |
| 90993-7 | Iothalamate clearance panel - Urine and Serum or Plasma |
| 74991-1 | Amino acids panel [Molar ratio] - Urine |
| 75591-8 | Comment on fetal Angelman syndrome risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 93390-3 | Carbapenem resistance blaOXA-23-like+blaOXA-48-like genes [Presence] in Isolate or Specimen by Molecular method |
| 61425-5 | Noroxycodone [Mass/volume] in Urine by Confirmatory method |
| 93859-7 | Toxoplasma gondii IgG Ab [Presence] in Serum from Donor by Immunoassay |
| 93953-8 | Villous lymphocytes [Presence] in Blood by Light microscopy |
| 63291-9 | Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 77767-2 | Codeine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 7789-1 | Acanthocytes [Presence] in Blood by Light microscopy |
| 63570-6 | Nuclear Ab pattern [Interpretation] in Pleural fluid by Immunofluorescence |
| 65758-5 | T-cell helper (CD4) subset panel - Blood |
| 66722-0 | Adenovirus DNA [Log #/volume] (viral load) in Tissue by NAA with probe detection |
| 8039-0 | Toxoplasma gondii IgG Ab [Units/volume] in Serum |
| 95709-2 | Venezuelan equine encephalitis virus IgA Ab [Presence] in Specimen by Immunoassay |
| 96459-3 | Coagulation factor IX activity and inhibitor panel - Platelet poor plasma by Coagulation assay |
| 80828-7 | Pepsin A+Pepsinogen A [Mass/volume] in Lower respiratory specimen by Immunoassay |
| 81108-3 | Leptospira interrogans sv Szwajizak Ab [Titer] in Serum by Agglutination |
| 6925-2 | Ganglioside GM1 IgG Ab [Titer] in Serum |
| 69564-3 | Bacterial vaginosis score in Vaginal fluid Qualitative by NAA with probe detection |
| 97243-0 | Dihydrocodeine Free+Hydrocodol Free [Presence] in Cord tissue by Confirmatory method |
| 97999-7 | HLA-DP and DQ and DR (class II) IgG donor specific [Identifier] in Serum or Plasma |
| 72507-7 | VKORC1 gene c.1173C>T [Presence] in Blood or Tissue by Molecular genetics method |
| 72914-5 | HNA 1c Ab [Presence] in Serum by Immunoassay |
| 73118-2 | Timolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86-9 | Cefaclor [Susceptibility] by Serum bactericidal titer |
| 87334-9 | Porcine circovirus type 2 DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 87377-8 | Escherichia coli Stx2 toxin stx2 gene [Presence] in Isolate by NAA with probe detection |
| 4134-3 | Azlocillin [Mass] of Dose |
| 59400-2 | RNA Ab [Units/volume] in Serum by Immunoassay |
| 59626-2 | cloBAZam [Mass/volume] in Blood |
| 59742-7 | sulfADIAZINE [Mass/volume] in Blood |
| 30432-9 | Mesothelial cells/100 leukocytes in Peritoneal fluid |
| 30534-2 | Linoleoylcarnitine (C18:2) [Moles/volume] in Serum or Plasma |
| 43172-6 | Triiodothyronine (T3) Ab [Presence] in Serum |
| 22171-3 | Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid |
| 22186-1 | Chlamydia sp IgM Ab [Titer] in Serum |
| 22299-2 | Equine arteritis virus Ab [Titer] in Serum |
| 31758-6 | Candida albicans Ag [Presence] in Serum |
| 3180-7 | Cardiolipin Ab [Units/volume] in Serum by Immunoassay |
| 43752-5 | Aquaporin 4 water channel IgG Ab [Units/volume] in Serum or Plasma by Immunofluorescence |
| 22439-4 | Parainfluenza virus 3 Ab [Titer] in Serum |
| 32082-0 | Ibuprofen [Moles/volume] in Serum or Plasma |
| 44077-6 | Brucella canis IgG and IgM [Interpretation] in Serum |
| 22973-2 | Caprine arthritis encephalitis virus Ab [Presence] in Milk by Immunoassay |
| 53082-4 | Cholesterol [Moles/volume] in Dialysis fluid |
| 53222-6 | Coagulation factor XI activated [Units/volume] in Platelet poor plasma by Coagulation assay |
| 23352-8 | Peste des petits ruminants virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 33294-0 | Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 33359-1 | Branched chain keto-acid dehydrogenase complex [Identifier] in Blood |
| 33689-1 | Yersinia pestis Ab [Presence] in Serum by Hemagglutination inhibition |
| 53803-3 | Transferrin.carbohydrate deficient panel - Serum or Plasma |
| 53859-5 | Fatty acids.very long chain C22:0 (Docosanoate) [Mass/volume] in Serum or Plasma |
| 53933-8 | Lactate dehydrogenase in pericardial fluid/Lactate dehydrogenase in serum |
| 44872-0 | HIV 1 p24 Ag [Presence] in Serum or Plasma from Donor by Immunoassay |
| 4532-8 | Complement total hemolytic CH50 [Units/volume] in Serum or Plasma |
| 23975-6 | Bartonella quintana IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 33747-7 | Number of fragmented pieces |
| 24174-5 | Polio virus 3 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen |
| 34405-1 | Escitalopram [Mass/volume] in Serum or Plasma |
| 34633-8 | Hypoglycemics.sulfonyluric [Identifier] in Urine |
| 34674-2 | Tripeptide aminopeptidase [Enzymatic activity/volume] in Serum or Plasma |
| 47013-8 | CD1a Ag [Presence] in Tissue by Immune stain |
| 47141-7 | EPINEPHrine [Moles/volume] in Plasma --3 hours post 300 ug cloNIDine PO |
| 35288-0 | MEN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 25851-7 | Ammonia/Creatinine [Molar ratio] in 24 hour Urine |
| 25862-4 | Asparagine [Moles/volume] in 24 hour Urine |
| 35424-1 | Herpes simplex virus identified in Penis by Organism specific culture |
| 56263-7 | Flounder IgG4 Ab [Mass/volume] in Serum |
| 48072-3 | Synthetic glucocorticoid drug [Mass/volume] in Unknown substance |
| 26479-6 | Lymphocytes/100 leukocytes in Cerebral spinal fluid |
| 3735-8 | Maprotiline [Mass/volume] in Serum or Plasma |
| 3819-0 | Mexiletine [Mass/volume] in Serum or Plasma |
| 56640-6 | Aspartate/Creatinine [Ratio] in 24 hour Urine |
| 26812-8 | Xylose [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 38567-4 | Aniline [Mass/volume] in Air |
| 57520-9 | 11-Hydroxyetiocholanolone [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
| 57531-6 | 17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --1 day post dose dexamethasone |
| 27394-6 | Lambda light chains [Mass/volume] in Urine |
| 39103-7 | Influenza virus A neuraminidase cDNA [Identifier] in Specimen by NAA with probe detection |
| 57887-2 | Pregnanediol [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
| 49475-7 | CD41-Bf Ag [Presence] in Tissue by Immune stain |
| 287-3 | Isoniazid [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 29329-0 | Glucose [Mass/volume] in Serum or Plasma --3.5 hours post XXX challenge |
| 29354-8 | Reovirus Ab [Titer] in Cerebral spinal fluid |
| 40081-2 | Calcium [Mass/volume] in Serum or Plasma --16 hours post XXX challenge |
| 40146-3 | Creatinine [Moles/volume] in Urine --8 hours post XXX challenge |
| 40175-2 | Glucose [Moles/volume] in Serum or Plasma --11.5 hours post XXX challenge |
| 58773-3 | Dog recombinant (rCan f) 1 IgE Ab [Units/volume] in Serum |
| 4994-0 | Coccidioides immitis rRNA [Presence] in Specimen by Probe |
| 49986-3 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Body fluid by NAA with probe detection |
| 50036-3 | Dengue virus neutralizing antibody [Presence] in Specimen by Neutralization test |
| 29947-9 | Alpha 2 globulin [Presence] in 24 hour Urine by Electrophoresis |
| 40372-5 | Isopropanol [Presence] in Gastric fluid |
| 58890-5 | Pyruvate [Mass/volume] in Blood --1 minute post XXX challenge |
| 59171-9 | Norclozapine [Presence] in Urine |
| 50284-9 | 3-Hydroxytetradecanoylcarnitine (C14-OH)/Creatinine [Molar ratio] in Urine |
| 40892-2 | CD3-CD16+ cells/100 cells in Bone marrow |
| 19604-8 | Morphine Free cutoff [Mass/volume] in Urine for Confirmatory method |
| 20501-3 | Hydroxytriazolam [Mass/volume] in Urine by Confirmatory method |
| 20785-2 | Drugs identified in Serum or Plasma by Screen method |
| 12360-4 | Barbital [Presence] in Urine |
| 100048-8 | Clarithromycin+Ethambutol [Susceptibility] |
| 100134-6 | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot |
| 12591-4 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 101345-7 | Candida krusei DNA [Presence] in Specimen by NAA with probe detection |
| 13028-6 | Xylose [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 13029-4 | Xylose [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 13298-5 | HLA-A [Type] |
| 13650-7 | 1,2-Dimethylbenzene [Mass/volume] in Blood |
| 13958-4 | Arsenic [Presence] in 24 hour Urine |
| 102862-0 | European Hornet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103110-3 | Olive pollen native (nOle e) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14684-5 | Creatinine [Moles/time] in 24 hour Urine |
| 10351-5 | HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification |
| 14871-8 | Pentacarboxylate [Moles/volume] in Stool |
| 104265-4 | Ethanol cutoff [Volume Fraction] in Exhaled gas |
| 104416-3 | Lassa virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen |
| 10494-3 | IgM.heavy chain Ag [Presence] in Tissue by Immune stain |
| 15343-7 | Blood group antibody screen [Titer] in Serum or Plasma |
| 15470-8 | Equine influenza virus A2 Ab [Presence] in Serum |
| 11055-1 | Melatonin [Mass/volume] in Serum or Plasma |
| 16344-4 | Alpha aminoisobutyrate [Mass/volume] in Amniotic fluid |
| 16673-6 | Cortisol [Mass/volume] in Serum or Plasma --50 minutes post XXX challenge |
| 16966-4 | Hexachloroethane [Mass/volume] in Blood |
| 7458-3 | Lentils IgE Ab [Units/volume] in Serum |
| 74839-2 | CD3-CD4+ cells/100 cells in Specimen |
| 75711-2 | Date of autopsy |
| 60379-5 | Halibut IgG Ab [Mass/volume] in Serum |
| 76397-9 | Lymph node involvement |
| 93242-6 | 11-Ketotestosterone [Mass/volume] in Serum or Plasma |
| 6168-9 | Maple IgE Ab [Units/volume] in Serum |
| 6226-5 | Rat urine proteins IgE Ab [Units/volume] in Serum |
| 6319-8 | Borrelia burgdorferi Ab [Units/volume] in Body fluid by Immunoassay |
| 7837-8 | Coxsackievirus B2 Ab [Units/volume] in Serum |
| 78524-6 | Platelet aggregation EPINEPHrine induced in Platelet rich plasma --6 umol/L |
| 94755-6 | CD21lowCD38- cells [#/volume] in Blood |
| 79405-7 | 1,4-Alpha glucan branching enzyme [Enzymatic activity/mass] in Fibroblast |
| 95223-4 | Mononuclear cells/100 leukocytes in Stem cell product by Manual count |
| 96317-3 | Acinetobacter calcoaceticus-baumannii complex DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection |
| 80624-0 | Zika virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test --1st specimen |
| 80630-7 | 1,2-Dichloroethane [Mass/volume] in Blood |
| 81114-1 | Murray Valley encephalitis virus IgM Ab [Titer] in Serum |
| 8161-2 | Bismuth [Mass/volume] in Blood |
| 97104-4 | SARS-CoV-2 (COVID-19) ORF1ab region [Units/volume] (viral load) in Upper respiratory specimen by NAA with probe detection |
| 81788-2 | Hazelnut recombinant (rCor a) 14 IgE Ab [Units/volume] in Serum |
| 70280-3 | t(6;11)(q27;q23)(MLLT4,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 82458-1 | Alaska pollock roe IgE Ab [Units/volume] in Serum |
| 71854-4 | Deoxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial blood |
| 72429-4 | 4-Hydroxyphenyllactate [Moles/volume] in Cerebral spinal fluid |
| 84-4 | Cefaclor [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 72897-2 | Xanthine [Moles/volume] in Urine |
| 86225-0 | clonazePAM/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 88572-3 | Fetal 22q11.2 deletion risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative |
| 41473-0 | Carbamazepine 10,11-Epoxide [Mass/volume] in DBS |
| 59393-9 | Trypanosoma cruzi IgG Ab [Titer] in Serum by Immunofluorescence |
| 59565-2 | Netilmicin [Moles/volume] in Serum or Plasma --trough |
| 59825-0 | Phenols [Presence] in Urine |
| 30411-3 | Leukocytes Left Shift [Presence] in Blood |
| 31100-1 | Hematocrit [Volume Fraction] of Blood by Impedance |
| 60322-5 | Norclomipramine [Moles/volume] in Specimen |
| 21197-9 | Cholesterol esters/Cholesterol.total in Serum or Plasma |
| 31271-0 | Bovine diarrhea virus 2 Ab [Units/volume] in Serum |
| 31283-5 | Canine coronavirus Ab [Presence] in Serum |
| 51135-2 | CD25 blasts/100 blasts in Blood |
| 21762-0 | FXN gene GAA repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 31717-2 | Alcelaphine herpesvirus 1 Ag [Presence] in Specimen |
| 31732-1 | Bluetongue virus Ag [Presence] in Specimen |
| 31869-1 | Legionella pneumophila Ag [Presence] in Sputum |
| 51668-2 | Streptococcus pneumoniae DNA and Haemophilus influenza DNA and Pseudomonas aeruginosa DNA [Identifier] in Unspecified specimen by NAA with probe detection |
| 22-4 | Amoxicillin+Clavulanate [Susceptibility] by Serum bactericidal titer |
| 22518-5 | Salmonella paratyphi A H Ab [Titer] in Serum |
| 5218-3 | Histoplasma capsulatum Ab [Presence] in Serum by Immune diffusion (ID) |
| 44311-9 | Cotinine/Creatinine [Mass Ratio] in Urine |
| 23134-0 | Histoplasma farciminosum Ab [Presence] in Serum by Hemagglutination |
| 33010-0 | Colby Cheese IgE Ab [Units/volume] in Serum |
| 44541-1 | HTLV II DNA [Presence] in Blood by Probe |
| 23244-7 | Mycobacterium avium ss paratuberculosis [Presence] in Tissue by Acid fast stain.Ziehl-Neelsen |
| 23363-5 | Porcine enterovirus Ab [Presence] in Serum by Immunoassay |
| 23639-8 | Grepafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 33631-3 | Cytomegalovirus UL54 gene mutations detected [Identifier] |
| 5359-5 | Somatotropin Ab [Units/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
| 23930-1 | Salmonella typhi O D Ab [Titer] in Serum by Agglutination |
| 53989-0 | Chromosomal nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
| 54355-3 | Beta-2-Microglobulin in CSF/Beta-2-Microglobulin in serum |
| 24301-4 | Coxsackievirus A10 Ab [Titer] in Serum --2nd specimen |
| 55512-8 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose glucagon |
| 55616-7 | Amoxicillin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
| 47579-8 | Bicarbonate [Moles/time] in 24 hour Urine |
| 4781-1 | HLA-B63(15) [Presence] |
| 25716-2 | Lutropin [Units/volume] in Urine by 1st IRP |
| 25901-0 | D-Lactate [Moles/volume] in Serum or Plasma --3rd specimen post excercise |
| 35380-5 | HEXA gene c.IVS7+1G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 56524-2 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 4819-9 | HLA-B21 [Presence] |
| 26606-4 | Carnosine [Moles/volume] in Serum or Plasma |
| 26610-6 | Hydroxylysine [Moles/volume] in Serum or Plasma |
| 26718-7 | HYDROmorphone [Mass/mass] in Hair |
| 48558-1 | HIV genotype [Susceptibility] |
| 48600-1 | VPS13B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 5720-8 | Rubidium [Mass/volume] in Serum or Plasma |
| 57597-7 | 6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
| 49058-1 | aPTT in Blood drawn from CRRT circuit by Coagulation assay |
| 49224-9 | Leukocytes [#/area] in Semen by Microscopy high power field |
| 38734-0 | Vinyl bromide [Mass/volume] in Air |
| 39090-6 | Clam IgE Ab/IgE total in Serum |
| 58004-3 | Methasterone [Presence] in Urine |
| 58057-1 | Cs sup(a) Ab [Presence] in Serum or Plasma |
| 58060-5 | Do sup(b) Ag [Presence] on Red Blood Cells |
| 58092-8 | Acylcarnitine newborn screen panel |
| 49331-2 | Renin [Enzymatic activity/volume] in Plasma --2 hours post XXX challenge |
| 58409-4 | Other cells/100 leukocytes in Blood by Automated count |
| 40454-1 | Clot Lysis [Presence] in Platelet poor plasma by Coagulation assay |
| 58828-5 | Cortisol [Mass/volume] in Serum or Plasma --14th specimen |
| 30014-5 | Borrelia burgdorferi 21kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
| 40893-0 | CD3-CD16+ cells/100 cells in Tissue |
| 19583-4 | Methyprylon cutoff [Mass/volume] in Urine for Screen method |
| 2054-5 | Catalase [Enzymatic activity/volume] in Red Blood Cells |
| 20640-9 | Citrulline [Moles/volume] in Serum or Plasma |
| 12565-8 | Cortisol [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 12600-3 | Pristanate (C15:0(CH3)4)/Phytanate (C16:0(CH3)4) [Mass Ratio] in Serum or Plasma |
| 101533-8 | Porcine reproductive and respiratory syndrome virus ORF5 gene sequence homology to RespPRRS in Isolate by Sequencing |
| 13567-3 | Mexiletine [Presence] in Serum or Plasma |
| 102281-3 | Yellow Dock IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102621-0 | American Sycamore IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1410-0 | Cortisol [Mass/volume] in Serum or Plasma --24 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 102921-4 | Canary serum proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14570-6 | 17-Hydroxyprogesterone [Moles/volume] in Urine |
| 103784-5 | Chemokine (C-C motif) ligand 26 [Mass/volume] in Serum or Plasma by Immunoassay |
| 15122-5 | Lipoprotein.beta/total Lipoprotein in Serum or Plasma |
| 104275-3 | Hematopoietic progenitor cells/Cells.total in Blood by Automated count |
| 10730-0 | Trypanosoma sp identified in Blood by Organism specific culture |
| 1668-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma |
| 12241-6 | Osmotic fragility of Red Blood Cells by Diluted RBC |
| 16920-1 | Glycoproteins [Presence] in Serum or Plasma |
| 17157-9 | CD45RA cells/100 cells in Blood |
| 17285-8 | Mitochondria Ab [Units/volume] in Serum by Immunofluorescence |
| 18322-8 | Norketamine [Mass/volume] in Urine |
| 18926-6 | Framycetin [Susceptibility] |
| 91043-0 | Opiates [Presence] in Body fluid by Screen method |
| 91118-0 | Cholesterol in LDL 7 [Moles/volume] in Serum or Plasma |
| 75355-8 | Other cells/100 leukocytes in Synovial fluid by Manual count |
| 75642-9 | Urate/Creatinine [Molar ratio] in 24 hour Urine |
| 61030-3 | 7-Aminoclonazepam [Presence] in Urine |
| 92880-4 | Human metapneumovirus and Respiratory syncytial virus RNA panel - Lower respiratory specimen by NAA with probe detection |
| 93324-2 | Taurolithocholate [Moles/volume] in Serum or Plasma |
| 77371-3 | Brassicasterol [Moles/volume] in Serum or Plasma |
| 77750-8 | DLD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 94201-1 | GNPTAB gene full mutation analysis in Blood or Tissue by Sequencing |
| 63318-0 | Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
| 9482-1 | Potassium [Mass/volume] in Water |
| 649-4 | Microscopic observation [Identifier] in Stool by Gram stain |
| 95234-1 | Hepatitis B virus surface Ag [Interpretation] in Serum or Plasma |
| 95245-7 | Platelet aggregation ristocetin induced in Platelet rich plasma --375 ug/mL |
| 80143-1 | Atazanavir [Mass/volume] in Cord blood |
| 68958-8 | Microscopic observation [Identifier] in Urine by KOH preparation |
| 81154-7 | Dengue and Chikungunya and Zika virus panel by NAA with probe detection |
| 97008-7 | Clot initiation.kaolin+tissue factor induced [Time] in Blood |
| 97049-1 | p53 Ab [Mass/volume] in Serum or Plasma by Immunoassay |
| 81694-2 | Mismatch repair endonuclease PMS2 [Presence] in Cancer specimen by Immune stain |
| 82250-2 | Chromosome region 1p subtelomere and 1p36 deletion and 1q25 rearrangement in Blood or Tissue by FISH |
| 97264-6 | Methylenedioxyethylamphetamine [Presence] in Cord tissue by Screen method |
| 99309-7 | Acid alpha glucosidase cross-reactive immunologic material (CRIM) [Presence] in Tissue by Immunoblot |
| 99415-2 | Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Immunofixation |
| 86331-6 | Adenovirus B(14) DNA [Presence] in Specimen by NAA with probe detection |
| 73484-8 | Carbidopa induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87770-4 | Topiramate/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 74002-7 | Tungsten/Creatinine [Mass Ratio] in 24 hour Urine |
| 74224-7 | Disease category [Interpretation] in Bone marrow |
| 74369-0 | Nitric oxide [Moles/volume] in Exhaled gas |
| 88994-9 | Arachidonate (C20:4w6)/Fatty acids.C14-C24 in Serum or Plasma |
| 59753-4 | Titanium [Mass/volume] in Blood |
| 59871-4 | Benztropine [Moles/volume] in Gastric fluid |
| 31112-6 | Reticulocytes/100 erythrocytes in Blood by Manual |
| 31355-1 | Echovirus 4 Ab [Units/volume] in Body fluid |
| 51396-0 | CD65w cells/100 cells in Tissue |
| 43163-5 | Quaternary ammonium compound [Mass/volume] in Specimen |
| 31919-4 | Neisseria meningitidis serogroup w135 Ag [Presence] in Serum or Plasma |
| 51636-9 | Immature reticulocytes [#/volume] in Blood |
| 52113-8 | Blood product unit 1 expiration [Date and time] |
| 43932-3 | Rheumatoid factor [Titer] in Body fluid |
| 53251-5 | Influenza virus B RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 23238-9 | Mycobacterium avium ss avium serotype [Identifier] in Specimen |
| 23324-7 | Ovine herpesvirus 2 Ab [Presence] in Serum by Immunofluorescence |
| 23528-3 | Trypanosoma evansi Ag [Presence] in Blood by Immunoassay |
| 23561-4 | Vesicular stomatitis Indiana virus Ab [Presence] in Serum |
| 33657-8 | Beta-N-acetylhexosaminidase.A [Moles/volume] in Leukocytes |
| 53811-6 | Triple phosphate [Saturation Fraction] in 24 hour Urine |
| 44947-0 | Borrelia burgdorferi 31kD IgM Ab [Presence] in Serum by Immunoblot |
| 450-7 | Sisomicin [Susceptibility] by Serum bactericidal titer |
| 23880-8 | Immune complex [Units/volume] in Body fluid by Raji cell assay |
| 24058-0 | Aspartylglucosaminidase [Enzymatic activity/mass] in Fibroblast |
| 54087-2 | Toxoplasma gondii IgG Ab [Presence] in DBS |
| 4589-8 | Hemoglobin Hasharon [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 46710-0 | Food Allergen Mix 23 (Beef+Chicken meat+Pork+Turkey meat) IgE Ab [Units/volume] in Serum by Multidisk |
| 24481-4 | Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 54471-8 | Cholesterol in HDL 3c/Cholesterol in total HDL in Serum or Plasma by Electrophoresis |
| 55219-0 | Antioxidants [Moles/volume] in Serum or Plasma |
| 47022-9 | CD11c+CD19+ cells/100 cells in Specimen |
| 55940-1 | Malonylcarnitine (C3-DC) [Moles/volume] in Serum or Plasma |
| 35400-1 | Varicella zoster virus DNA [Presence] in Tissue by NAA with probe detection |
| 35701-2 | Acetylcholinesterase [Enzymatic activity/volume] in Specimen |
| 56434-4 | Yellow Jacket IgG4 Ab [Mass/volume] in Serum |
| 56507-7 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 3757-2 | Mersalyl [Mass/volume] in Urine |
| 376-4 | Ofloxacin [Susceptibility] by Disk diffusion (KB) |
| 56885-7 | Somatotropin [Mass/volume] in Serum or Plasma --3 hours post exercise |
| 26936-5 | Hydroxyethylflurazepam [Mass/mass] in Meconium |
| 38408-1 | PEO gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 49032-6 | Second trimester penta maternal screen [Interpretation] in Serum or Plasma |
| 49095-3 | Saint Louis encephalitis virus IgG and IgM [Interpretation] in Serum |
| 57900-3 | Age of Specimen |
| 49414-6 | JC virus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
| 58709-7 | Gliadin peptide IgA Ab [Units/volume] in Serum |
| 50046-2 | Hemicystine [Moles/volume] in Serum or Plasma |
| 4041-0 | Sulfonamide [Presence] in Serum or Blood |
| 40505-0 | Chikungunya virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 59034-9 | Ganglioside GD2 IgG Ab [Units/volume] in Serum by Immunoassay |
| 59225-3 | Squamous cell carcinoma Ag [Mass/volume] in Peritoneal fluid |
| 50308-6 | Caldesmon Ag [Presence] in Tissue by Immune stain |
| 19314-4 | Tricyclic antidepressants tested for in Urine by Screen method Narrative |
| 19552-9 | Methadone cutoff [Mass/volume] in Urine for Screen method |
| 19662-6 | Phenmetrazine [Presence] in Urine by Screen method |
| 20533-6 | Hydroxytriazolam [Presence] in Urine by Confirmatory method |
| 20889-2 | Monensin [Mass/mass] in Gastric fluid |
| 100394-6 | Astacoidea IgG Ab [Units/volume] in Serum |
| 12572-4 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen |
| 101175-8 | 3-Methoxytyramine.free/Creatinine [Molar ratio] in Serum or Plasma |
| 102188-0 | Boxelder IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102304-3 | Ferret epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14010-3 | Phosphatidylcholine IgA Ab [Units/volume] in Serum by Immunoassay |
| 14186-1 | Methylprednisolone [Mass/volume] in Serum or Plasma |
| 102726-7 | Cottonseed IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102890-1 | Thermoactinomyces vulgaris IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102931-3 | American house dust mite IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102936-2 | Timothy IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102941-2 | Lovage IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103607-8 | Paroxetine metabolite III [Mass/volume] in Urine by Confirmatory method |
| 104296-9 | DPYD gene.c.1905+1G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 15426-0 | Service comment 35 |
| 10901-7 | HIV 2 gp125 Ab [Presence] in Serum by Immunoblot |
| 16717-1 | Cytomegalovirus Ag [Presence] in Urine by Immunoassay |
| 17881-4 | Bacteria # 5 identified in Bronchial specimen by Aerobe culture |
| 19053-8 | Brucella sp Ab [Titer] in Serum by Agglutination |
| 90299-9 | Giardia sp DNA [Presence] in Stool by NAA with probe detection |
| 91590-0 | Mycobacterium preliminary growth [Presence] in Body fluid by Organism specific culture |
| 92714-5 | Lipoprotein.beta.subparticle.very small-b [Moles/volume] in Serum |
| 60435-5 | CD10+CD19+ cells [#/volume] in Blood |
| 60528-7 | Enterovirus subtype in Specimen by NAA with probe detection |
| 76497-7 | Polymorphonuclear cells [#] in Cerebral spinal fluid by Manual count |
| 61416-4 | Doxepin [Mass/volume] in Urine by Confirmatory method |
| 77660-9 | Aneuploid cell population 2 in G2 phase/100 cells in Cells.XXX by Flow cytometry (FC) |
| 94570-9 | Alloisoleucine [Moles/volume] in Serum or Plasma --post therapeutic diet |
| 63388-3 | Extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
| 6498-0 | Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 95138-4 | Epstein Barr virus DNA panel - Amniotic fluid by NAA with probe detection |
| 95682-1 | Japanese encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay |
| 79576-5 | Allocystathionine [Moles/volume] in Serum or Plasma |
| 6906-2 | Sertraline [Mass/volume] in Serum or Plasma |
| 69779-7 | Suberylcarnitine (C8-DC) [Moles/volume] in Urine |
| 97591-2 | Norbuprenorphine free [Presence] in Cord tissue by Confirmatory method |
| 97773-6 | Base excess standard in Arterial cord blood by calculation |
| 70109-4 | Number of chromosome 13 present [#] in Amniotic fluid by NAA with probe detection |
| 8273-5 | Cefepime [Susceptibility] by Serum bactericidal titer |
| 82796-4 | Stationary clot growth mean [Velocity] Platelet poor plasma |
| 97986-4 | Common wasp recombinant (rVes v) 5 IgG4 Ab [Mass/volume] in Serum |
| 9821-0 | HIV 1 p24 Ag [Presence] in Serum |
| 98400-5 | Fungus identified in Isolate by Sequencing |
| 71678-7 | Lymphocytes/Leukocytes [Pure number fraction] in Blood by Automated count |
| 84916-6 | Cells.chromosome region 17p13.1 deletion/Cells counted in Blood or Tissue by FISH |
| 85284-8 | Peritumoral lymphocytic response in Cancer specimen Qualitative by Light microscopy |
| 72564-8 | Creatine kinase.MB/Creatine kinase.total [Pure catalytic fraction] in Serum or Plasma by calculation |
| 85987-6 | Streptococcus pneumoniae Danish serotype 12F Ab [Mass/volume] in Serum --2nd specimen |
| 73331-1 | Ipratropium induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73430-1 | Clopidogrel induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88045-0 | P sup(k) Ab [Presence] in Serum or Plasma from Donor |
| 4148-3 | Butabarbital [Mass] of Dose |
| 50687-3 | Plasmodium sp Ag [Presence] in Blood |
| 4204-4 | Cyclacillin [Mass] of Dose |
| 42594-2 | White Ash IgE Ab/IgE total in Serum |
| 5993-1 | Platelet aggregation arachidonate induced in Platelet rich plasma |
| 60006-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 60215-1 | ZOLMitriptan [Mass/volume] in Urine |
| 43129-6 | Brucella abortus IgG and IgM panel - Serum |
| 22167-1 | Caprine parapoxvirus Ab [Presence] in Tissue |
| 22193-7 | Chlamydia trachomatis IgM Ab [Titer] in Serum |
| 31620-8 | Salmonella pullorum Ab [Units/volume] in Serum |
| 22746-2 | Gentamicin [Moles/volume] in Serum or Plasma --peak |
| 23090-4 | Equine herpesvirus 1+4 Ab [Titer] in Serum by Complement fixation |
| 44638-5 | Histologic type in Breast tumor |
| 23310-6 | Myxoma virus Ag [Presence] in Skin by Immune diffusion (ID) |
| 33484-7 | Patient symptoms [Interpretation] --30 minutes post dose lactose PO |
| 33576-0 | Francisella tularensis IgA Ab [Titer] in Serum |
| 45374-6 | Specimen expiration date of Blood |
| 23885-7 | Isoheptacarboxylporphyrin [Mass/time] in unspecified time Stool |
| 34197-4 | Salicylamide [Mass/volume] in Serum or Plasma --trough |
| 54098-9 | Isopropyl methylphosphonate [Mass/volume] in Urine |
| 54429-6 | 5% plasma protein fraction given [Volume] |
| 54442-9 | Carnitine esters/Carnitine.free (C0) [Molar ratio] in Urine |
| 4665-6 | Lysozyme [Enzymatic activity/volume] in Serum or Plasma |
| 24238-8 | Chlamydia sp IgG Ab [Units/volume] in Serum --1st specimen |
| 24443-4 | Suberylglycine/Creatinine [Molar ratio] in Urine |
| 5567-3 | Acetone [Presence] in Serum or Plasma |
| 56020-1 | Platelet aggregation thrombin induced ATP secretion in Blood --5 U/mL |
| 47930-3 | Somatotropin [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 48260-4 | Timothy triggered leukotriene release [Mass/volume] by Leukocytes |
| 48309-9 | BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 48342-0 | Ethanol+Methanol+Isopropyl alcohol+Acetone [Moles/volume] in Serum or Plasma |
| 26646-0 | Powassan virus Ab [Presence] in Serum |
| 56739-6 | Ganglioside GD1b IgG Ab [Presence] in Serum by Immunoblot |
| 27173-4 | Propylthiouracil [Mass/volume] in Urine |
| 38276-2 | aPTT in Pooled Platelet poor plasma by Coagulation assay --1 hour post incubation |
| 38490-9 | Insulin porcine Ab [Titer] in Serum |
| 49269-4 | Homovanillate and Creatinine [Interpretation] in Urine Narrative |
| 38900-7 | HEXA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 39542-6 | Almond IgE Ab/IgE total in Serum |
| 39567-3 | TOLAZamide [Mass/volume] in 24 hour Urine |
| 57769-2 | Salmonella typhi O Vi Ab [Presence] in Serum |
| 57978-9 | HIV 2 p34 Ab [Presence] in Serum by Immunoblot |
| 5800-8 | Lipids [#/area] in Urine sediment by Microscopy high power field |
| 49476-5 | Cyclooxygenase 2 Ag [Presence] in Tissue by Immune stain |
| 29504-8 | 2-Hydroxyisovalerate/Creatinine [Molar ratio] in Urine |
| 39786-9 | Pyridoxine [Moles/volume] in Serum or Plasma |
| 4022-0 | Salicylamide [Mass/volume] in Serum or Plasma |
| 40294-1 | Insulin [Moles/volume] in Serum or Plasma --pre or post dose glucose |
| 58640-4 | Cortisol [Mass/volume] in Saliva (oral fluid) --11th specimen post XXX challenge |
| 29823-2 | Highlands J virus Ab [Titer] in Specimen |
| 3011-4 | Thromboxane alpha 2 [Mass/volume] in Serum |
| 30132-5 | Coxsackievirus Ab [Presence] in Serum --1st specimen |
| 30208-3 | Coccidioides immitis IgM Ab [Presence] in Cerebral spinal fluid |
| 20647-4 | Hydroxyproline [Moles/volume] in Serum or Plasma |
| 12411-5 | Promazine [Mass/volume] in Serum or Plasma |
| 101297-0 | Parainfluenza virus 1+2+3+4 RNA [Presence] in Throat by NAA with non-probe detection |
| 13074-0 | Phosphatidylcholine IgM Ab [Units/volume] in Serum |
| 101846-4 | Beclomethasone dipropionate [Moles/volume] in Urine |
| 13442-9 | Creatinine renal clearance in 6 hour Urine and Serum or Plasma |
| 13566-5 | Mesoridazine [Presence] in Serum or Plasma |
| 14732-2 | Folate [Moles/volume] in Serum or Plasma |
| 104330-6 | Bacillus anthracis protective antigen Ab [Presence] in Serum by Immunoassay |
| 16119-0 | Brucella abortus IgG Ab [Titer] in Serum |
| 16330-3 | Aldosterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 11276-3 | Tubular cells [Presence] in Urine sediment by Light microscopy |
| 12262-2 | Toxoplasma gondii IgM Ab [Titer] in Serum by Immunoassay |
| 1673-3 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine |
| 17282-5 | Minoxidil [Mass/volume] in Serum or Plasma |
| 17364-1 | Nitrophenol [Presence] in Urine |
| 17455-7 | Phosphatidylinositol IgG Ab [Presence] in Serum |
| 17814-5 | Alpha 2 globulin/Protein.total in Body fluid by Electrophoresis |
| 18203-0 | Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum by Immunoblot |
| 18968-8 | Pipemidate [Susceptibility] |
| 90748-5 | Atomoxetine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 90831-9 | Leucine-rich glioma-inactivated protein 1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 92531-3 | Lu sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 7644-8 | Radish IgG Ab [Units/volume] in Serum |
| 92995-0 | THBD gene full mutation analysis in Blood or Tissue by Sequencing |
| 6199-4 | Pellitory (Parietaria judaica) IgE Ab [Units/volume] in Serum |
| 62256-3 | Aminoglycoside resistance aacA gene [Presence] by Molecular method |
| 77307-7 | Lead [Mass/volume] in Venous blood |
| 62467-6 | Galactomannan Ag [Units/volume] in Specimen by Immunoassay |
| 63295-0 | Nuclear Ab [Presence] in Cerebral spinal fluid by Hep2 substrate |
| 78526-1 | Platelet aggregation collagen induced in Platelet rich plasma --1.25 ug/ml |
| 6337-0 | Candida albicans Ag [Presence] in Serum by Immune diffusion (ID) |
| 95124-4 | Sarcoma targeted gene fusion transcript analysis in Tissue by Sequencing |
| 95199-6 | HLA-B35 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC) |
| 95203-6 | PMA+ionomycin stimulated CD107a+b expressing CD8 cells/100 CD3+CD8+ cells in Blood by Flow cytometry (FC) |
| 9541-4 | Legionella pneumophila 1 IgG Ab [Titer] in Serum by Immunofluorescence |
| 95673-0 | Dengue virus 1+2+3+4 IgG Ab [Presence] in Specimen by Immunoassay |
| 6705-8 | Androsterone [Mass/time] in 24 hour Urine |
| 79637-5 | Glutathione.oxidized/Creatinine [Molar ratio] in Urine |
| 95959-3 | Black salsify IgE Ab [Units/volume] in Serum |
| 69835-7 | 3-Hydroxyadipate [Moles/volume] in Cerebral spinal fluid |
| 82103-3 | Regional Allergen Mix 1 (Mugwort+Silver birch+Pellitory+Timothy+English plantain) IgE Ab [Units/volume] in Serum by Multidisk |
| 97596-1 | CD3+CD8+ (T8 suppressor) cells/100 lymphocytes in Lower respiratory specimen by Flow cytometry (FC) |
| 82461-5 | Influenza virus A and B and H1 2009 pandemic RNA [Identifier] in Upper respiratory specimen by NAA with probe detection |
| 82906-9 | Tetrahydrocorticosterone/Allo-tetrahydrocorticosterone [Molar ratio] in Urine |
| 98904-6 | Osmotic fragility panel of Red Blood Cells |
| 7203-3 | Blue Cheese IgE Ab [Units/volume] in Serum |
| 85683-1 | Haemophilus influenzae bcs gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 99116-6 | Bourbon virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 99431-9 | Goat epithelium IgG4 Ab [Mass/volume] in Serum |
| 72601-8 | Beta hydroxybutyrate + Acetoacetate [Moles/volume] in Blood --pre-meal |
| 72848-5 | Hepatitis B virus codon 184 [Identifier] by Genotype method |
| 86001-5 | Streptococcus pneumoniae Danish serotype 14 Ab [Mass/volume] in Serum --1st specimen |
| 73809-6 | B cell+T cell crossmatch [Interpretation] Qualitative by Complement dependent cytotoxicity |
| 88529-3 | Parainfluenza virus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 7389-0 | Hay IgE Ab [Units/volume] in Serum |
| 74459-9 | Immature granulocytes/100 leukocytes in Blood from Fetus |
| 89644-9 | Bacteria identified in Lower respiratory specimen by Anaerobe culture |
| 59583-5 | Coxsackievirus A16 IgG Ab [Titer] in Serum by Immunofluorescence |
| 30414-7 | Abnormal lymphocytes/100 leukocytes in Cerebral spinal fluid |
| 31083-9 | Lead [Mass/time] in 8 hour Urine |
| 42668-4 | Fatty acids [Presence] in Stool |
| 42673-4 | Calcium hydrogen phosphate dihydrate [Saturation Fraction] in 24 hour Urine |
| 60298-7 | cloZAPine [Moles/volume] in Specimen |
| 60320-9 | Nicotine [Moles/volume] in Specimen |
| 21062-5 | Allobarbital [Mass/volume] in Serum or Plasma |
| 21394-2 | Monocytes+Macrophages/100 leukocytes in Body fluid by Manual count |
| 42862-3 | Carbofuran [Presence] in Urine |
| 42936-5 | Intercellular substance IgA Ab [Presence] in Serum by Immunofluorescence |
| 43006-6 | Jamestown canyon virus Ab [Titer] in Serum |
| 22188-7 | Chlamydia trachomatis IgA Ab [Titer] in Cerebral spinal fluid |
| 32017-6 | Hemoglobin.other/Hemoglobin.total in Blood by Electrophoresis |
| 43230-2 | Benzoylecgonine [Mass/volume] in Specimen |
| 43355-7 | Chlamydia trachomatis D+E+F+G+H+I+J+K IgG Ab [Titer] in Serum by Immunofluorescence |
| 51931-4 | Rubella virus Ab [Units/volume] in Serum by Immunoassay |
| 4438-8 | Tetrahydrocannabinol [Mass] of Dose |
| 32846-8 | Herpes simplex virus 1 IgG Ab [Ratio] in Serum --1st specimen/2nd specimen |
| 53226-7 | Leukocytes [#/area] in Urethra by Wet preparation |
| 44431-5 | Annexin V IgG Ab [Units/volume] in Serum or Plasma |
| 44509-8 | Herpes simplex virus Ag [Presence] in Penis |
| 44633-6 | Tumor pigmentation |
| 33552-1 | Platelet aggregation ristocetin induced in Platelet rich plasma --900 ug/mL |
| 53819-9 | Thiopurine methyltransferase [Enzymatic activity/volume] in Blood |
| 45149-2 | Ej Ab [Presence] in Serum |
| 23850-1 | Creosol [Mass/volume] in Urine |
| 23913-7 | Osmotic fragility of Red Blood Cells--0.40% sodium chloride |
| 54075-7 | Endocrine newborn screening panel (SI units) |
| 34449-9 | Eastern equine encephalitis virus RNA [Presence] in Blood by NAA with probe detection |
| 55244-8 | HPFH-6 gene [Presence] in Blood by Molecular genetics method |
| 47409-8 | Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 34925-8 | Immature monocytes/100 leukocytes in Blood |
| 35289-8 | Peroxide hemolysis of Red Blood Cells |
| 55651-4 | cefTAZidime+Sulbactam [Susceptibility] by Gradient strip |
| 47573-1 | Aspartate [Moles/volume] in DBS |
| 25626-3 | Cortisol [Moles/volume] in Serum or Plasma --8 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 56699-2 | Bupivacaine IgE Ab [Units/volume] in Serum |
| 56952-5 | Leptospira interrogans Ab [Titer] in Serum by Agglutination |
| 48350-3 | Venlafaxine+O-desmethylvenlafaxine [Moles/volume] in Serum or Plasma |
| 27208-8 | Drugs identified in Stool by Screen method |
| 27239-3 | Nordiazepam [Mass/mass] in Stool |
| 49034-2 | Microorganism identified in Cervical or vaginal smear or scraping by Cyto stain |
| 4910-6 | HLA-Dw5 [Presence] in Donor |
| 49116-7 | Trichosporon sp DNA [Units/volume] in Serum by NAA with probe detection |
| 49174-6 | Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Body fluid |
| 49194-4 | California encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid |
| 27372-2 | Insulin [Units/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 3909-9 | Pemoline [Mass/volume] in Urine |
| 49632-3 | ATN1 gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 29208-6 | Streptolysin O Ab [Units/volume] in Body fluid |
| 29224-3 | Phenytoin [Mass/volume] in Body fluid |
| 58514-1 | C peptide [Mass/volume] in Serum or Plasma --45 minutes post dose glucose |
| 58536-4 | Corticotropin [Mass/volume] in Plasma --105 minutes post dose insulin IV |
| 40368-3 | Hexacarboxylate [Moles/time] in 24 hour Urine |
| 40640-5 | Lambda light chains.free [Presence] in Urine |
| 58992-9 | Protein [Mass/time] in 18 hour Urine |
| 59249-3 | Acylcarnitine/Acylcarnitine+Carnitine Free (C0) [Molar ratio] in DBS |
| 50584-2 | Lactose challenge (hydrogen breath test) panel - Exhaled gas |
| 40934-2 | Yersinia enterocolitica O:8 Ab [Presence] in Serum |
| 20999-9 | Cell Fractions/Differential [Interpretation] in Body fluid |
| 12520-3 | Catecholamines [Mass/volume] in Urine --6th specimen post XXX challenge |
| 12744-9 | Insulin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 1277-3 | P Ab [Presence] in Serum or Plasma from Blood product unit |
| 101231-9 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 13346-2 | CD35 cells/100 cells in Blood |
| 101907-4 | AP-3 complex IgG Ab [Presence] in Specimen |
| 102007-2 | Heterophile ACTH Interpretation in Plasma Narrative |
| 102032-0 | Glucose [Mass/volume] in Serum or Plasma --2 hours post dose insulin IV |
| 14411-3 | Aspartate aminotransferase [Enzymatic activity/volume] in Synovial fluid |
| 15014-4 | Alkaline phosphatase.intestinal/Alkaline phosphatase.total in Serum or Plasma |
| 15425-2 | Service comment 34 |
| 11129-4 | Pronormoblasts [#/volume] in Blood |
| 1644-4 | Triglyceride [Mass/volume] in Serum or Plasma --12 hours fasting |
| 12197-0 | Cryofibrinogen [Presence] in Plasma by 1 day cold incubation |
| 17889-7 | Bacteria # 3 identified in Nose by Aerobe culture |
| 18472-1 | Organophosphate pesticides [Identifier] in Urine |
| 1870-5 | Apolipoprotein A-II [Mass/volume] in Serum or Plasma |
| 90889-7 | Porcine circovirus type 2 IgG Ab [Titer] in Specimen by Immunofluorescence |
| 91773-2 | Herpes simplex virus identified in Aspirate by Organism specific culture |
| 92703-8 | Vaginal pathogens panel - Vaginal fluid by NAA with probe detection |
| 7528-3 | Black Oak IgE Ab [Units/volume] in Serum |
| 60441-3 | Oseltamivir+Zanamivir [Susceptibility] by Genotype method |
| 93316-8 | Platelet CD42b actual/normal in Blood by Flow cytometry (FC) |
| 77123-8 | GPR98 gene full mutation analysis in Blood or Tissue by Sequencing |
| 7761-0 | Walleye Pike IgE Ab [Units/volume] in Serum |
| 77652-6 | C peptide [Moles/volume] in Serum or Plasma --5 hours post XXX challenge |
| 7768-5 | Yellow Jacket IgG Ab [Units/volume] in Serum |
| 93978-5 | Complement C4.functional [Units/volume] in Serum or Plasma |
| 63189-5 | Rough Pigweed IgG Ab [Mass/volume] in Serum |
| 63320-6 | Ribosomal Ab [Presence] in Body fluid by Immunofluorescence |
| 79202-8 | Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose arginine+insulin |
| 95108-7 | Glucose [Mass/volume] in Serum or Plasma --4 hours post meal |
| 9544-8 | Legionella pneumophila 2 IgG Ab [Titer] in Serum by Immunofluorescence |
| 79648-2 | D-serine [Moles/volume] in Cerebral spinal fluid |
| 80097-9 | Glycyl-4-hydroxyproline [Moles/volume] in Serum or Plasma |
| 8016-8 | Saint Louis encephalitis virus IgG Ab [Units/volume] in Serum |
| 96697-8 | Rate of fibrin formation.glass bead induced [Units] in Blood by Microviscometry --post heparin neutralization |
| 69809-2 | 2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --1 day post dose ifosfamide |
| 82225-4 | Ribose-5-phosphate isomerase [Enzymatic activity/mass] in Fibroblast |
| 97304-0 | Temazepam [Presence] in Cord tissue by Screen method |
| 97776-9 | Urea [Moles/volume] in Dialysis fluid --1 hour specimen |
| 9794-9 | Cathepsin D [Moles/mass] in Tissue |
| 7236-3 | Clover IgE Ab [Units/volume] in Serum |
| 85308-5 | Distance of carcinoma from posterior margin [Length] in Breast cancer specimen by Light microscopy |
| 85758-1 | Streptococcus pneumoniae Danish serotypes 12A+12F+44+46 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 99360-0 | Bovine serum albumin (BSA) IgG Ab [Mass/volume] in Serum |
| 72865-9 | Mycobacterium tuberculosis ethB gene ethionamide resistance mutation [Presence] by Molecular method |
| 730-2 | Leukocytes other/100 leukocytes in Blood by Manual count |
| 73382-4 | fentaNYL induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87610-2 | Chlorophacinone [Mass/mass] in Specimen |
| 73561-3 | Insulin-like growth factor-I [Z-score] in Serum or Plasma |
| 88106-0 | Parathyrin.intact [Mass/volume] in Tissue fine needle aspirate |
| 73917-7 | JWH-250 4/5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 74117-3 | Adalimumab [Mass/volume] in Serum or Plasma |
| 41209-8 | VWF gene.p.Arg854Gln [Presence] in Blood or Tissue by Molecular genetics method |
| 59318-6 | Ramelteon [Mass/volume] in Serum or Plasma |
| 31027-6 | Ritonavir [Mass/volume] in Serum or Plasma |
| 31586-1 | Rhodococcus equi Ab [Units/volume] in Serum |
| 43004-1 | Jamestown canyon virus IgG Ab [Titer] in Specimen |
| 43022-3 | Herpes virus 7 IgM Ab [Titer] in Serum |
| 43079-3 | Bluetongue virus 17 Ab [Titer] in Serum |
| 22114-3 | Bordetella avium Ab [Presence] in Serum |
| 31715-6 | African horse sickness virus Ag [Presence] in Specimen |
| 22482-4 | Rickettsia rickettsii IgG Ab [Titer] in Serum |
| 22680-3 | Mercury/Creatinine [Molar ratio] in Urine |
| 32063-0 | Cimetidine [Presence] in Specimen |
| 4404-0 | Pipradrol [Mass] of Dose |
| 23086-2 | Equine herpesvirus 1+4 Ab [Titer] in Serum by Immunoassay |
| 32602-5 | HIV 1+2 Ab [Presence] in Cerebral spinal fluid |
| 53346-3 | Cortisol [Moles/volume] in DBS |
| 53425-5 | Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --pre XXX challenge |
| 23432-8 | Salmonella gallinarum rRNA [Presence] in Specimen by Probe |
| 33350-0 | Lysergate diethylamide [Mass/volume] in Urine by Screen method |
| 33374-0 | Blasts/100 leukocytes in Synovial fluid |
| 33644-6 | A1 Ab [Titer] in Serum or Plasma |
| 45156-7 | Rheumatoid factor [Presence] in Body fluid by Latex agglutination |
| 45268-0 | Immunodeficiency panel - Blood by Flow cytometry (FC) |
| 23852-7 | Deuteroporphyrin [Mass/time] in unspecified time Stool |
| 33739-4 | Lymphatic.small vessel.invasion [Identifier] in Specimen by CAP cancer protocols |
| 54235-7 | Cortisol challenge panel - Saliva (oral fluid) |
| 54250-6 | Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose glucagon |
| 4671-4 | Protein C [Mass/volume] in Plasma |
| 24229-7 | Coxsackievirus A16 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 34344-2 | N-methylhistamine [Moles/volume] in 24 hour Urine |
| 34419-2 | Reticulocytes.mature/Reticulocytes.total in Blood |
| 55155-6 | Flunitrazepam and 7-Aminoflunitrazepam panel [Mass/volume] - Urine |
| 55489-9 | Insulin [Moles/volume] in Serum or Plasma --1.5 hours post dose glucagon |
| 55570-6 | predniSONE [Moles/volume] in Serum or Plasma |
| 25177-7 | Amikacin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 55804-9 | Leukocyte phosphatase [Presence] in Leukocytes |
| 47939-4 | Sulfocysteine [Moles/volume] in Serum or Plasma |
| 48080-6 | 3,6-Epoxyoctanedioate/Creatinine [Molar ratio] in Urine |
| 48319-8 | glipiZIDE [Presence] in Specimen |
| 2663-3 | Nitrogen.nonprotein [Mass/volume] in Serum or Plasma |
| 26783-1 | Glucose [Mass/volume] in Serum or Plasma --5 hours post dose lactose PO |
| 56668-7 | Alpha aminoadipate/Creatinine [Ratio] in 24 hour Urine |
| 56775-0 | CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Tissue |
| 48508-6 | Measles virus RNA [Presence] in Specimen by NAA with probe detection |
| 48700-9 | Thyrotropin releasing hormone [Mass] of Dose |
| 27029-8 | Norpropoxyphene [Mass/mass] in Meconium |
| 27247-6 | Hydroxyethylflurazepam [Mass/mass] in Stool |
| 27965-3 | Babesia microti IgM Ab [Presence] in Serum |
| 49643-0 | SCA10 gene allele 1.ATTCT repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 28552-8 | Cladosporium herbarum IgM Ab [Units/volume] in Serum |
| 5846-1 | Herpes simplex virus 1 Ag [Presence] in Specimen by Immunofluorescence |
| 29691-3 | Orientia tsutsugamushi Kato Ab [Presence] in Serum |
| 40687-6 | Myeloid cells/100 cells in Bone marrow by Manual count |
| 50288-0 | 3-Dechloroethylifosfamide [Mass/volume] in Blood --4 days post dose ifosfamide |
| 50447-2 | Corticotropin [Mass/volume] in Plasma --3rd specimen |
| 50596-6 | HPA-1a [Type] in Blood |
| 41114-0 | CATCH22 syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 1982-8 | Biotinidase [Enzymatic activity/volume] in Serum or Plasma |
| 20510-4 | Lipoprotein fractions [Interpretation] in Serum or Plasma by Electrophoresis |
| 20591-4 | CD16+CD57- cells/100 cells in Specimen |
| 12377-8 | Demoxepam [Mass/volume] in Serum or Plasma |
| 101119-6 | Leukemia and lymphoma immunophenotyping in Specimen Document by Flow cytometry (FC) |
| 101415-8 | Blastomyces sp and Blastomyces dermatitidis Ag panel |
| 101444-8 | Solitary lung nod malignancy risk [Scale] Qualitative by Calculated.Nodify XL2 |
| 13066-6 | Nuclear Ab [Units/volume] in Body fluid by Immunofluorescence |
| 101954-6 | SLC35A3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 1424-1 | Cortisol [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV |
| 103602-9 | 6-Hydroxychlorzoxazone [Mass/volume] in Urine |
| 104171-4 | DPYD gene.c.2846A>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 15077-1 | Glucose [Moles/time] in 24 hour Urine |
| 10776-3 | Microscopic observation [Identifier] in Tissue by Bodian stain |
| 11071-8 | Butalbital [Mass/volume] in Urine |
| 16418-6 | Azatadine [Presence] in Urine |
| 11238-3 | Hydroxyalprazolam [Mass/volume] in Urine |
| 12203-6 | Cryoglobulin [Presence] in Serum by 3 day cold incubation |
| 18300-4 | IgA [Presence] in Urine by Immunofixation |
| 74884-8 | Valine [Moles/volume] in DBS --post therapeutic diet |
| 74897-0 | Lithocholate [Moles/volume] in Serum or Plasma |
| 91791-4 | Varicella zoster virus DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 75515-7 | Lupus anticoagulant aPTT and dRVVT screening panel W Reflex |
| 75628-8 | Vascular endothelial growth factor A [Mass/volume] in Serum or Plasma |
| 60546-9 | Polio virus identified [Type] in Isolate by Organism specific culture |
| 76080-1 | Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection |
| 93797-9 | MYCN gene copy number/Chromosome 2 copy number in Tissue by FISH |
| 6265-3 | Timothy IgE Ab [Units/volume] in Serum |
| 63103-6 | Swiss Cheese IgG Ab [Mass/volume] in Serum |
| 63174-7 | Spondylocladium sp IgG Ab [Mass/volume] in Serum |
| 94450-4 | HLA-A and B and C (class I) IgG intermediate risk [Identifier] in Serum or Plasma by Flow cytometry (FC) |
| 94503-0 | SARS-CoV-2 (COVID-19) Ab panel - Serum, Plasma or Blood by Rapid immunoassay |
| 94583-2 | Herpes simplex virus 1 and 2 DNA panel - Cerebral spinal fluid by NAA with non-probe detection |
| 95176-4 | Avian metapneumovirus Ab [Titer] in Serum by Immunoassay |
| 66118-1 | Spleen Pathology biopsy report |
| 80151-4 | Brucella abortus IgG Ab [Titer] in Serum by Agglutination |
| 6774-4 | Desethylamiodarone [Mass/volume] in Serum or Plasma |
| 67831-8 | Erythrocytes [#/volume] in Pleural fluid from Fetus |
| 68391-2 | Volume of Vitreous fluid |
| 81233-9 | Influenza virus types A and B and subtypes RNA panel - Respiratory system specimen by NAA with probe detection |
| 96599-6 | Neisseria gonorrhoeae DNA [Presence] in Cervix by NAA with probe detection |
| 97761-1 | MLH1 gene methylation analysis in Tumor by Molecular genetics method |
| 70254-8 | Follitropin IgG Ab [Units/volume] in Serum by Immunoassay |
| 70568-1 | Plasmodium knowlesi DNA [Presence] in Blood by NAA with probe detection |
| 99002-8 | Leptospira santarosai sv Alexi Ab [Titer] in Serum by Agglutination |
| 72937-6 | Trimethoprim induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86339-9 | Streptococcus pneumoniae Danish serotype 6A+6B IgG Ab [Units/volume] in Serum |
| 73263-6 | Minoxidil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87492-5 | AB-PINACA pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 73688-4 | Danazol [Presence] in Urine by Screen method |
| 88110-2 | OXcarbazepine [Moles/volume] in Serum or Plasma --trough |
| 74124-9 | Blood group 8 (BG8) Ag [Presence] in Tissue by Immune stain |
| 74405-2 | Eosinophils/100 leukocytes in Cord blood |
| 41659-4 | ABT492 [Susceptibility] by Disk diffusion (KB) |
| 50627-9 | HC gene rearrangements in Blood or Tissue by Molecular genetics method Narrative |
| 50795-4 | Osmotic fragility full hemolysis of Red Blood Cells |
| 59910-0 | Ibuprofen [Moles/volume] in Urine |
| 60120-3 | Palladium [Mass/volume] in Urine |
| 21655-6 | CFTR gene.p.Phe508del [Presence] in Blood or Tissue by Molecular genetics method |
| 51070-1 | CD135 blasts/100 blasts in Blood |
| 51196-4 | Hemoglobin A1/Hemoglobin.total in Blood by Electrophoresis |
| 42783-1 | ERBB2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 42958-9 | Salmonella typhimurium Ab [Titer] in Serum |
| 43217-9 | Cortisol [Mass/volume] in Serum or Plasma --15 minutes post dose corticotropin IM |
| 22727-2 | Arginine [Moles/volume] in Specimen |
| 22779-3 | African swine fever virus Ab [Presence] in Serum |
| 32059-8 | chlordiazePOXIDE [Moles/volume] in Serum or Plasma |
| 52784-6 | Maximum lysis [Length fraction] in Blood by Thromboelastography |
| 43918-2 | Babesia microti Ab [Presence] in Serum |
| 44083-4 | Extractable nuclear Ab [Interpretation] in Serum |
| 23566-3 | Vesicular stomatitis New Jersey virus Ab [Presence] in Serum by Immunoassay |
| 44929-8 | Prolactin [Units/volume] in Serum or Plasma --15 minutes post dose TRH IV |
| 45209-4 | Heptacarboxylporphyrin [Moles/volume] in DBS |
| 24011-9 | Hepatitis C virus Ab band pattern [Interpretation] in Serum by Immunoblot |
| 54309-0 | Lactate/Pyruvate [Molar ratio] in Cerebral spinal fluid |
| 54392-6 | Glucose [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 46183-0 | Coccidioides sp IgM Ab [Presence] in Serum |
| 35339-1 | Chymotrypsin [Enzymatic activity/volume] in Body fluid --1st specimen post Sincalide |
| 55667-0 | cycloSERINE [Susceptibility] by Gradient strip |
| 25898-8 | Deoxypyridinoline [Moles/volume] in 24 hour Urine |
| 35355-7 | PABPN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 35481-1 | Terbufos [Mass/volume] in Serum or Plasma |
| 26527-2 | Cortisol Free [Mass/volume] in 24 hour Urine --72 hours post dose corticotropin |
| 3625-1 | Fencamfamin [Mass/volume] in Urine |
| 375-6 | Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 56963-2 | pH of Saliva (oral fluid) |
| 57085-3 | Organic acid newborn screen panel |
| 48395-8 | Coproporphyrin/Creatinine [Molar ratio] in Urine |
| 26951-4 | Alternaria alternata IgG Ab [Mass/volume] in Serum |
| 38325-7 | Oxamyl [Mass/volume] in Water |
| 57392-3 | Urea [Mass/volume] in Body fluid |
| 49187-8 | Coxiella burnetii phase 1 IgA Ab [Titer] in Body fluid |
| 49256-1 | Catecholamines [Interpretation] in Urine Narrative |
| 57842-7 | Erythrocytes [#/volume] in Pericardial fluid by Automated count |
| 57869-0 | Phencyclidine [Moles/volume] in Specimen |
| 50110-6 | 3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Cerebral spinal fluid |
| 29858-8 | Alpha hydroxybutyrate/Creatinine [Molar ratio] in Urine |
| 59257-6 | Cell count and Differential panel - Pericardial fluid |
| 50564-4 | Urinalysis panel - Urine by Auto |
| 41142-1 | Influenza virus A N1 Ab [Presence] in Serum |
| 20782-9 | Cyanide [Mass/mass] in Plant |
| 20787-8 | Drugs identified in Specimen by Screen method |
| 100124-7 | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay |
| 101647-6 | Ehrlichiosis and Anaplasmosis and Babesiosis and Borrelia miyamotoi DNA panel - Serum, Plasma or Blood by NAA with probe detection |
| 13025-2 | Trichlorotrifluoroethane [Mass/volume] in Blood |
| 13248-0 | Hepatitis D virus Ab [Presence] in Serum |
| 101833-2 | Budesonide [Moles/volume] in Serum or Plasma |
| 10232-7 | Oxygen content in Aorta root |
| 13948-5 | Coccidioides immitis IgM Ab [Presence] in Serum by Immunoassay |
| 14340-4 | Gammopathy [Interpretation] in Serum or Plasma by Electrophoresis |
| 102907-3 | Blue vetch IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103025-3 | Honeydew melon IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103629-2 | Monkeypox virus IgG Ab [Titer] in Serum by Immunoassay |
| 103640-9 | 4-hydroxy Xylazine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 103730-8 | Hereditary spastic paraplegia multigene analysis in Blood or Tissue by Molecular genetics method |
| 104326-4 | Adenovirus sp identified [Type] in Specimen by Sequencing |
| 10639-3 | Thermophilic Actinomycetes identified in Specimen by Organism specific culture |
| 10707-8 | Toxic Plant identified in Plant specimen by Inspection |
| 10770-6 | Microscopic observation [Identifier] in Tissue by Argentaffin stain |
| 16280-0 | Human papilloma virus DNA [Presence] in Specimen by Probe with amplification |
| 16737-9 | Dengue virus 2 Ab [Titer] in Serum |
| 17427-6 | Penicillium sp Ab [Units/volume] in Serum |
| 175-0 | Chloramphenicol [Susceptibility] by Serum bactericidal titer |
| 17531-5 | Rh [Type] in Amniotic fluid |
| 1829-1 | Alpha 1 antitrypsin SS [Mass/volume] in Serum or Plasma |
| 18952-2 | Nalidixate [Susceptibility] |
| 90824-4 | Dipeptidyl aminopeptidase-like protein 6 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 91804-5 | Mycoplasma pneumoniae DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 60342-3 | Borrelia burgdorferi IgG bands panel - Serum by Immunoblot |
| 6267-9 | Trichoderma viride IgE Ab [Units/volume] in Serum |
| 94614-5 | Bovine parainfluenza virus 3 RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 79209-3 | t(2;3)(q13;p25)(PAX8,PPARG) fusion transcript [Presence] in Tissue by Molecular genetics method |
| 79338-0 | Hypoglycemics.oral [Presence] in Urine by Screen method |
| 65788-2 | Horse serum albumin native (nEqu c) 3 IgE Ab [Units/volume] in Serum |
| 80138-1 | Antimony [Mass/mass] in Tissue |
| 8040-8 | Toxoplasma gondii IgM Ab [Units/volume] in Serum |
| 95913-0 | Coccidioides sp DNA [Presence] in Tissue by NAA with probe detection |
| 6865-0 | 1-Methylhistidine [Mass/time] in 24 hour Urine |
| 80713-1 | TCR alpha beta cells/100 CD3 cells in Blood |
| 96814-9 | Sheep milk cheese IgE Ab [Units/volume] in Serum |
| 69484-4 | FBN1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 97963-3 | Silver Birch IgG4 Ab [Mass/volume] in Serum |
| 70088-0 | Interleukin 7 [Mass/volume] in Body fluid |
| 702-1 | Anisocytosis [Presence] in Blood by Light microscopy |
| 82400-3 | Ganglioside GD2 IgG+IgM Ab [Presence] in Serum by Line blot |
| 98081-3 | Cytomegalovirus DNA [#/volume] (viral load) in Saliva (oral fluid) by NAA with probe detection |
| 98963-2 | Cariprazine [Mass/volume] in Urine by Confirmatory method |
| 83126-3 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma by Immunoassay |
| 7265-2 | Crawfish IgE Ab [Units/volume] in Serum |
| 72693-5 | Insulin-like growth factor-II.high molecular weight [Mass/volume] in Serum or Plasma |
| 72884-0 | CYP1A2 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 86512-1 | Adenovirus DNA [Presence] in Urine by NAA with probe detection |
| 86864-6 | Dengue virus 2 neutralizing antibody [Presence] in Specimen by Neutralization test |
| 87788-6 | Milnacipran/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 88876-8 | Measles virus genotype A vaccine strain N gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 41617-2 | Neutrophil Ab [Presence] in Serum by Flow cytometry (FC) |
| 50843-2 | clonazePAM [Moles/volume] in Urine |
| 60062-7 | buPROPion [Mass/volume] in Body fluid |
| 2163-4 | Creatinine renal clearance in 12 hour Urine and Serum or Plasma |
| 31589-5 | Ribosomal Ab [Units/volume] in Serum |
| 51205-3 | Sodium [Mass/mass] in Hair |
| 42861-5 | Carbaryl [Presence] in Urine |
| 42872-2 | CD138 cells/100 cells in Tissue |
| 2203-8 | Dermatan sulfate [Mass/volume] in Serum or Plasma |
| 31748-7 | Bovine herpesvirus 2 Ag [Presence] in Exudate |
| 32343-6 | Urate [Moles/volume] in Specimen |
| 32526-6 | CD2 cells [#/volume] in Bone marrow |
| 52124-5 | Osmotic fragility of Red Blood Cells--0.90% sodium chloride |
| 32627-2 | Argininosuccinate lyase [Enzymatic activity/mass] in Red Blood Cells |
| 23488-0 | Transmissible gastroenteritis virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 23581-2 | Rabbit hemorrhagic disease virus Ag [Presence] in Tissue by Agglutination |
| 33714-7 | Francisella tularensis Ab [Presence] in Specimen by Slide agglutination |
| 23826-1 | Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection |
| 3417-3 | Butabarbital [Presence] in Serum or Plasma |
| 53987-4 | Atypic speckled nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
| 46762-1 | Congenital hypothyroidism newborn screen interpretation |
| 24344-4 | Gas and Carbon monoxide panel - Venous blood |
| 24373-3 | Ferritin [Mass/volume] in Blood |
| 34541-3 | ACTH stimulation test using IM corticosteroids in Serum or Plasma |
| 34587-6 | Palmitoyl protein thioesterase [Enzymatic activity/volume] in Serum or Plasma |
| 47296-9 | Clostridium tetani toxoid Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 25111-6 | Isocitrate/Creatinine [Molar ratio] in Urine |
| 34911-8 | Immature basophils/100 leukocytes in Blood |
| 55666-2 | Cyclacillin [Susceptibility] by Gradient strip |
| 25670-1 | Glucose [Mass/volume] in Urine --30 minutes post dose glucose |
| 47963-4 | JAK3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 3821-6 | Midazolam [Mass/volume] in Serum or Plasma |
| 56938-4 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose lactulose |
| 27016-5 | Xylose [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 57371-7 | Enolase.neuron specific [Mass/volume] in Serum or Plasma by Immunoassay |
| 57528-2 | 17-Hydroxycorticosteroids [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
| 38746-4 | 4,4'-Methylene bis(2-Chloroaniline) [Mass/volume] in Air |
| 49483-1 | HIV 1 [Interpretation] in Serum or Plasma by Immunoassay Narrative |
| 2945-4 | Sialidase [Enzymatic activity/volume] in Serum |
| 40080-4 | Calcium [Mass/volume] in Serum or Plasma --14 hours post XXX challenge |
| 58722-0 | Lymphocyte proliferation stimulated by pokeweed mitogen [Interpretation] in Blood |
| 49844-4 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with 1:4 normal plasma |
| 49905-3 | HIV 1 Ab [Presence] in Specimen by Rapid immunoassay |
| 40490-5 | Macrophages/100 leukocytes in Synovial fluid by Manual count |
| 58991-1 | Urea [Mass/time] in 18 hour Urine |
| 5026-0 | Mycobacterium kansasii rRNA [Presence] in Specimen by Probe |
| 50546-1 | Bacterial susceptibility panel by Disk diffusion (KB) |
| 40746-0 | Fragments [Presence] in Blood by Automated count |
| 100154-4 | Specimen collection supervision level |
| 100742-6 | Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma |
| 101144-4 | Ustekinumab and Ustekinumab Ab panel - Serum or Plasma |
| 101986-8 | Candida krusei DNA [Presence] in Body fluid by Probe.amp.tar |
| 13561-6 | Gentamicin [Mass/volume] in Cerebral spinal fluid |
| 102300-1 | Euroglyphus maynei IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102864-6 | Western wheatgrass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10839-9 | Troponin I.cardiac [Mass/volume] in Serum or Plasma |
| 16446-7 | Benzoylecgonine [Presence] in Serum or Plasma by Confirmatory method |
| 1186-6 | little i Ab [Presence] in Serum or Plasma |
| 18326-9 | Microscopic observation [Identifier] in Cervix by Other stain |
| 74906-9 | Bilirubin.total [Moles/volume] in Cerebral spinal fluid |
| 91838-3 | Bordetella sp DNA [Identifier] in Lower respiratory specimen by NAA with probe detection |
| 7543-2 | Oidiodendrum spp IgE Ab [Units/volume] in Serum |
| 75647-8 | Meperidine [Presence] in Meconium |
| 75722-9 | CYP1A2 gene c.-163C>A [Presence] in Blood or Tissue by Molecular genetics method |
| 60492-6 | Hypertrophic cardiomyopathy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 76026-4 | Phosphomannomutase 2 [Enzymatic activity/mass] in Fibroblast |
| 7654-7 | Slender Ragweed IgE Ab [Units/volume] in Serum |
| 92991-9 | F13A1 and F13B gene full mutation analysis in Blood or Tissue by Sequencing |
| 77210-3 | Salivary gland protein 1 IgG Ab [Units/volume] in Serum by Immunoassay |
| 77324-2 | Flurazepam [Moles/volume] in Specimen |
| 9371-6 | Chlorpyrifos [Mass/volume] in Blood |
| 78342-3 | MYB gene deletion [Interpretation] in Blood or Tissue by FISH Narrative |
| 63447-7 | CD3+CD5- cells [#/volume] in Cerebral spinal fluid |
| 64134-0 | Phentermine/Creatinine [Mass Ratio] in Urine |
| 65356-8 | Proinsulin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 6723-1 | Corn IgG Ab [Units/volume] in Serum |
| 79712-6 | HLA-A*31:01 [Presence] in Blood or Tissue |
| 69771-4 | Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Amniotic fluid |
| 81780-9 | Tetradecenoylcarnitine (C14:1)/Creatinine [Molar ratio] in Urine |
| 97640-7 | Thyroglobulin [Moles/volume] in Tissue fine needle aspirate |
| 7009-4 | Erythromycin [Susceptibility] by Gradient strip |
| 70291-0 | inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 7117-5 | Oat+Barley IgE Ab [Units/volume] in Serum |
| 85549-4 | PRRSV European strain neutralizing antibody [Presence] in Serum by Neutralization test |
| 99623-1 | Influenza virus A N1 RNA [Presence] in Specimen by NAA with probe detection |
| 99966-4 | KIT gene exon 17 full mutation analysis in Blood or Tissue by Sequencing |
| 73033-3 | Clindamycin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87752-2 | O-Ethyl O-(p-nitrophenyl) phenylphosphonothionate [Mass/mass] in Specimen |
| 73661-1 | Methadone panel - Saliva (oral fluid) by Screen method |
| 88166-4 | Mycobacterium tuberculosis DNA [Presence] in Ocular fluid by NAA with probe detection |
| 88528-5 | Respiratory syncytial virus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 74143-9 | Granulocytes/100 leukocytes in Body fluid |
| 89351-1 | CD19+CD27+IgD+IgM+ cells [#/volume] in Blood |
| 41406-0 | Meropenem [Mass/volume] in Serum or Plasma |
| 59755-9 | Titanium [Mass/volume] in Red Blood Cells |
| 6026-9 | Aspergillus terreus IgE Ab [Units/volume] in Serum |
| 2125-3 | Chymotrypsin [Mass/mass] in Stool |
| 31215-7 | Actinobacillus pleuropneumoniae serotype 7 Ab [Presence] in Serum |
| 31529-1 | Neospora caninum Ab [Units/volume] in Serum |
| 51208-7 | Tin [Mass/volume] in Body fluid |
| 5131-8 | DNA double strand Ab [Presence] in Serum by Immunofluorescence |
| 42782-3 | Epidermal growth factor receptor.phosphorylated Ag [Presence] in Tissue by Immune stain |
| 42880-5 | CD3-CD57+ cells [#/volume] in Bone marrow |
| 2185-7 | Cytochrome C oxidase [Enzymatic activity/volume] in Platelets |
| 31633-1 | Sporothrix schenckii Ab [Units/volume] in Cerebral spinal fluid |
| 43423-3 | Sodium urate [Saturation Fraction] in 24 hour Urine |
| 43725-1 | 2,4-Dichlorophenol [Presence] in Urine |
| 43750-9 | SURF1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 32118-2 | TOLBUTamide [Moles/volume] in Serum or Plasma |
| 5209-2 | Herpes simplex virus 2 IgG Ab [Units/volume] in Serum by Immunoassay |
| 23010-2 | Cowdria ruminantium Ab [Presence] in Serum by Immunofluorescence |
| 32710-6 | Nitrite [Presence] in Urine |
| 53230-9 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:4 addition of normal plasma |
| 53264-8 | Urinalysis yeast variants panel [#/volume] - Urine by Computer assisted method |
| 33757-6 | Polyp size additional dimensions |
| 3392-8 | Benzoylecgonine [Mass/volume] in Serum or Plasma |
| 34233-7 | Alternaria sp IgG Ab [Presence] in Serum by Immune diffusion (ID) |
| 54101-1 | 2-Methylpropyl methylphosphonate [Mass/volume] in Urine |
| 4577-3 | Hemoglobin F - Texas [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 24331-1 | Lipid 1996 panel - Serum or Plasma |
| 34524-9 | Band form neutrophils [Presence] in Blood by Automated count |
| 34661-9 | Actin IgG Ab [Units/volume] in Serum or Plasma |
| 55589-6 | Budgerigar feather IgE Ab [Presence] in Serum |
| 47020-3 | CD99 Ag [Presence] in Tissue by Immune stain |
| 47448-6 | Influenza virus A H13 Ab [Titer] in Serum |
| 2538-7 | Lactate dehydrogenase 2 [Enzymatic activity/volume] in Serum or Plasma by Chemical separation |
| 47577-2 | Aspartate/Amino acids.total in Serum or Plasma |
| 47820-6 | 3-Hydroxyvalerate [Moles/volume] in Plasma |
| 25601-6 | Rotavirus IgM Ab [Presence] in Serum |
| 2571-8 | Triglyceride [Mass/volume] in Serum or Plasma |
| 25804-6 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 35381-3 | HEXA gene c.IVS12+1G>C [Presence] in Blood or Tissue by Molecular genetics method |
| 35827-5 | Orbifloxacin [Susceptibility] |
| 35836-6 | Salinomycin [Susceptibility] by Disk diffusion (KB) |
| 3791-1 | Methocarbamol [Presence] in Urine |
| 56941-8 | Insulin [Units/volume] in Serum or Plasma --8 hours post XXX challenge |
| 27034-8 | Drugs identified in Hair by Screen method |
| 27171-8 | Chlorphentermine [Mass/volume] in Milk |
| 38481-8 | Carnitine free (C0) [Moles/volume] in DBS |
| 38503-9 | Spermatozoa Progressive Grade 3/100 spermatozoa in Semen |
| 5731-5 | Silicate [Mass/volume] in Urine |
| 57524-1 | 17-Ketogenic steroids [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
| 57563-9 | 21-Deoxycortisol [Moles/volume] in Serum or Plasma --pre dose dexamethasone |
| 49076-3 | Influenza virus B IgA Ab [Mass/volume] in Cerebral spinal fluid |
| 49594-5 | Trichothecene IgG Ab [Units/volume] in Serum by Immunoassay |
| 49603-4 | Hepatitis C virus RNA [log units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 2922-3 | Retinol [Mass/volume] in Blood |
| 4990-8 | Blastomyces dermatitidis rRNA [Presence] in Specimen by Probe |
| 2953-8 | Sodium [Molar amount] in 72 hour Stool |
| 29884-4 | 2-Methylbutyrylglycine [Presence] in Urine |
| 29949-5 | Sjogrens syndrome-B extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) |
| 40439-2 | HIV 1 gp120+gp160 Ab [Presence] in Serum or Plasma by Immunoassay |
| 40704-9 | Maternal cell contamination [Identifier] in Blood Nominal |
| 59030-7 | CD45+CD103+ Cells/100 cells in Tissue |
| 50519-8 | Prolactin [Mass/volume] in Serum or Plasma --3rd specimen |
| 41130-6 | Mycobacterium avium ss paratuberculosis Ab [Units/volume] in Serum |
| 41140-5 | Influenza virus A N3 Ab [Presence] in Serum |
| 1919-0 | Aspartate aminotransferase [Enzymatic activity/volume] in Body fluid |
| 19193-2 | Enolase.neuron specific [Units/volume] in Serum or Plasma |
| 12526-0 | Norepinephrine [Mass/volume] in Plasma --2 hours post XXX challenge |
| 13554-1 | Cyclobenzaprine [Presence] in Serum or Plasma |
| 13789-3 | Phosphoethanolamine/Creatinine [Mass Ratio] in Urine |
| 10245-9 | Oxygen content in Main pulmonary artery |
| 14130-9 | Estrogen receptor [Moles/mass] in Tissue |
| 1434-0 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 1 mg dexamethasone PO overnight |
| 102679-8 | Ascaris lumbricoides IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14624-1 | Barbiturates [Presence] in Gastric fluid |
| 15016-9 | Alkaline phosphatase.placental/Alkaline phosphatase.total in Serum or Plasma |
| 15084-7 | Osteocalcin [Moles/volume] in Serum or Plasma |
| 15086-2 | Oxalate [Moles/volume] in Urine |
| 15142-3 | Alanine+Ethanolamine [Presence] in Urine |
| 104342-1 | Borna disease virus RNA [Presence] in Specimen by NAA with probe detection |
| 16716-3 | Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay --2nd specimen |
| 11475-1 | Microorganism identified in Specimen by Culture |
| 18323-6 | Smith extractable nuclear IgG Ab [Units/volume] in Serum |
| 18863-1 | Amphotericin B [Susceptibility] |
| 18878-9 | ceFAZolin [Susceptibility] |
| 90819-4 | Aquaporin 4 water channel IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 90979-6 | Vortioxetine [Mass/volume] in Serum or Plasma |
| 76405-0 | Metamyelocytes [#] in Body fluid by Manual count |
| 93196-4 | Warfarin response genotype panel - Blood or Tissue by Molecular genetics method |
| 93389-5 | Gram positive bacteria DNA [Presence] by NAA with probe detection in Positive blood culture |
| 93437-2 | Lurasidone [Mass/volume] in Serum or Plasma |
| 93694-8 | Nonalcoholic steatohepatitis interpretation in Serum or Plasma Qualitative |
| 77140-2 | Creatinine [Moles/volume] in Serum, Plasma or Blood |
| 7740-4 | Tobacco triggered histamine release [Units/volume] in Blood |
| 93836-5 | Coccidioides sp IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 63105-1 | Rhubarb IgG Ab [Mass/volume] in Serum |
| 63198-6 | Weed Allergen Mix 6 (English plantain+Goosefoot or Lambs quarters+Saltwort+Sheep sorrel) IgE Ab [Units/volume] in Serum by Multidisk |
| 78234-2 | Cells.MLL gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 78522-0 | Platelet aggregation ADP induced in Platelet rich plasma --5 umol/L |
| 78804-2 | Barbital [Mass/volume] in Blood |
| 94839-8 | Calcium [Mass/volume] in Urine from Fetus |
| 64088-8 | Karyotype [Identifier] in Chorionic villus sample Narrative |
| 64094-6 | Karyotype [Identifier] in Amniotic fluid Narrative |
| 79223-4 | Atenolol [Mass/volume] in Body fluid |
| 95163-2 | Infectious bronchitis virus Ab/Positive control in Serum by Immunoassay |
| 66107-4 | Lung Pathology biopsy report |
| 80368-4 | Neisseria gonorrhoeae [Presence] in Anorectal by Organism specific culture |
| 6787-6 | Kappa light chains [Presence] in Serum by Immunoassay |
| 69035-4 | Eastern equine encephalitis virus IgG and IgM panel - Cerebral spinal fluid by Immunofluorescence |
| 9694-1 | Propoxur [Mass/volume] in Serum or Plasma |
| 69368-9 | Bordetella pertussis IgM Ab [Presence] in Serum by Immunoblot |
| 69787-0 | 2-Methylacetoacetate [Moles/volume] in Serum or Plasma |
| 6984-9 | Beta lactamase.extended spectrum [Susceptibility] |
| 81839-3 | CLN8 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 81881-5 | TNNT3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 97306-5 | traMADol [Presence] in Cord tissue by Screen method |
| 97617-5 | Enterococcus faecalis DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 70173-0 | JC virus Ab [Presence] in Serum or Plasma by Immunoassay |
| 7159-7 | Broccoli IgG Ab [Units/volume] in Serum |
| 82931-7 | Nuclear pore protein gp210 IgG Ab [Presence] in Serum by Line blot |
| 71804-9 | Serotonin [Entitic substance] in Platelets |
| 72441-9 | 3-Methylcrotonylglycine [Moles/volume] in Amniotic fluid |
| 85327-5 | Foci [#] in Breast cancer specimen by Light microscopy |
| 99477-2 | Sheep Sorrel IgG Ab [Mass/volume] in Serum |
| 88043-5 | P sup(k) Ab [Presence] in Serum or Plasma |
| 88835-4 | Influenza virus A swine origin RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 88918-8 | Filaria DNA [Presence] in Blood by NAA with probe detection |
| 89966-6 | Norquetiapine [Mass/volume] in Urine by Confirmatory method |
| 41611-5 | Tube number of Peritoneal fluid |
| 42370-7 | Neisseria meningitidis serogroup B Ag [Presence] in Isolate by Agglutination |
| 21356-1 | Ketones [Presence] in Urine --3.5 hours post XXX challenge |
| 31193-6 | Microscopic observation [Identifier] in Pancreas fine needle aspirate by Cyto stain |
| 31419-5 | Heterophile Ab [Presence] in Synovial fluid |
| 31439-3 | Insulin receptor Ab [Units/volume] in Serum |
| 31469-0 | Legionella pneumophila 8 Ab [Units/volume] in Serum |
| 43184-1 | 6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Confirmatory method |
| 22074-9 | FGFR3 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 22127-5 | Borrelia burgdorferi IgG Ab [Units/volume] in Body fluid |
| 2229-3 | Epiandrosterone [Mass/volume] in Serum or Plasma |
| 51491-9 | Cortisol [Mass/volume] in Saliva (oral fluid) --4th specimen post XXX challenge |
| 51807-6 | Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum by Immunoassay |
| 43212-0 | Albumin [Mass/volume] in Body fluid by Electrophoresis |
| 43234-4 | Liver kidney microsomal 1 IgG Ab [Presence] in Serum |
| 4348-9 | Nicomorphine [Mass] of Dose |
| 22325-5 | Hepatitis C virus 22-3 Ab [Presence] in Serum |
| 53025-3 | Gliadin Ab [Presence] in Serum |
| 44313-5 | Delta aminolevulinate/Creatinine [Mass Ratio] in 24 hour Urine |
| 44364-8 | Glutarate/Creatinine [Molar ratio] in 24 hour Urine |
| 22825-4 | Influenza virus A Ag [Presence] in Specimen by Immune diffusion (ID) |
| 22883-3 | Border disease virus RNA [Presence] in Tissue from Fetus by NAA with probe detection |
| 23063-1 | Epizootic hemorrhagic disease virus Alberta Ab [Presence] in Serum |
| 23110-0 | Foot and mouth disease virus Ag [Presence] in Tissue by Immunoassay |
| 23157-1 | Leishmania sp Ab [Presence] in Serum by Agglutination |
| 44593-2 | IgE [Presence] in Urine by Immunofixation |
| 33372-4 | Blasts/100 leukocytes in Peritoneal fluid |
| 33585-1 | Uroporphyrin 3 isomer [Mass/time] in 24 hour Stool |
| 53799-3 | Major crossmatch [Interpretation] by Electronic |
| 45128-6 | Vesicular stomatitis New Jersey virus Ag [Presence] in Specimen by Complement fixation |
| 24045-7 | Alpha fucosidase [Enzymatic activity/volume] in Serum or Plasma |
| 34142-0 | Paraneoplastic Ab [Presence] in Serum by Immunoblot |
| 4625-0 | Hemoglobin S/Hemoglobin.total in Blood |
| 3444-7 | Cefonicid [Mass/volume] in Serum or Plasma |
| 34471-3 | Calcium bilirubinate crystals [Presence] in Bile fluid by Light microscopy |
| 3450-4 | Ceftizoxime [Mass/volume] in Serum or Plasma |
| 55580-5 | Sulfapyridine [Moles/volume] in Serum or Plasma |
| 4741-5 | HLA-A9 [Presence] |
| 25208-0 | cycloSERINE 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25258-5 | Itraconazole [Mass/volume] in Specimen |
| 55904-7 | IgE.monoclonal [Presence] in Serum by Immunoelectrophoresis |
| 56010-2 | Platelet aggregation ristocetin induced in Blood --250 ug/mL |
| 35588-3 | Ethylene glycol dinitrate [Mass/volume] in Blood |
| 48109-3 | Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose glucose |
| 48191-1 | Monosodium glutamate (MSG) triggered leukotriene release [Mass/volume] by Leukocytes |
| 2662-5 | Nitrogen.nonprotein [Mass/volume] in Blood |
| 38357-0 | B cell crossmatch [Interpretation] |
| 38502-1 | Spermatozoa Progressive Grade 4/100 spermatozoa in Semen |
| 57478-0 | 11-Ketoandrosterone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
| 49006-0 | Phosphate [Moles/volume] in Peritoneal dialysis fluid |
| 28006-5 | Hemoglobin F [Presence] in Vomitus |
| 2822-5 | Potassium [Moles/volume] in Gastric fluid |
| 29405-8 | Maprotiline [Mass/volume] in Gastric fluid |
| 49770-1 | Filaria IgG1 Ab [Units/volume] in Serum by Immunoassay |
| 49860-0 | Sporothrix schenckii Ab [Presence] in Cerebral spinal fluid by Latex agglutination |
| 29682-2 | Rickettsia prowazekii Ab [Titer] in Serum |
| 59022-4 | HLA-DRB3 [Type] |
| 4086-5 | Valproate [Mass/volume] in Serum or Plasma |
| 20559-1 | Temazepam [Mass/volume] in Urine by Confirmatory method |
| 20616-9 | IgM lymphocytes/100 lymphocytes in Specimen |
| 20826-4 | Gallotannin [Mass/volume] in Serum or Plasma |
| 100381-3 | Mentha balsamea Wild IgG Ab [Units/volume] in Serum |
| 101933-0 | Hydroxyapatite crystals [Energy Difference] in Urine |
| 102158-3 | Banana IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102202-9 | Candida albicans IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13606-9 | Glucose [Mass/volume] in Serum or Plasma --3 hours post 50 g lactose PO |
| 102342-3 | Cocksfoot IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102398-5 | Lamb IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14222-4 | HTLV I p36 Ab [Presence] in Serum |
| 14364-4 | Microscopic observation [Identifier] in Eye by Gram stain |
| 1452-2 | Creatinine [Mass/volume] in 24 hour Urine --24 hours post 40 ug corticotropin IM BID 3 day |
| 14620-9 | Appearance of Pleural fluid |
| 103621-9 | Small lymphocytic lymphoma chromosome deletions AndOr rearrangements in Blood or Tissue by FISH |
| 1488-6 | Gastrin [Mass/volume] in Serum or Plasma --30 minutes post 0.2 U/kg secretin |
| 1059-5 | I Ab [Presence] in Serum or Plasma from Donor |
| 10656-7 | Coccidia identified in Stool by Acid fast stain |
| 15384-1 | Leishmania mexicana IgG Ab [Titer] in Serum |
| 11160-9 | Beta lactoglobulin IgG Ab [Units/volume] in Serum |
| 1752-5 | Albumin [Mass/volume] in Synovial fluid |
| 17878-0 | Bacteria # 2 identified in Bronchial specimen by Aerobe culture |
| 17936-6 | Bacteria # 3 identified in Blood by Anaerobe culture |
| 18497-8 | Microscopic observation [Identifier] in Thyroid fine needle aspirate by Cyto stain |
| 74885-5 | ERBB2 gene (HER2) duplication associated observations panel - Tissue by FISH |
| 91679-1 | F8 gene intron 22 inversion targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 91708-8 | Corticotropin [Mass/volume] in Plasma --10 minutes post 1 ug/kg CRH IV |
| 91765-8 | Entamoeba sp DNA [Identifier] in Aspirate by Sequencing |
| 92741-8 | Cholestane-3-beta, 5-alpha, 6-beta triol and Lyso-sphingomyelin panel - DBS |
| 75123-0 | Hypoxanthine [Moles/volume] in Cerebral spinal fluid |
| 60677-2 | Alpha hydroxytriazolam [Mass/volume] in Urine |
| 76139-5 | Reticulocyte hemoglobin distribution width [Mass/volume] in Blood by calculation |
| 76655-0 | Tungsten [Mass/mass] in Hair |
| 9314-6 | Western equine encephalitis virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 93474-5 | Synthetic opioids panel - Urine by Confirmatory method |
| 93507-2 | Hexacarboxylporphyrin I [Moles/time] in 24 hour Urine |
| 61319-0 | Cocoa IgE Ab/IgE total in Serum |
| 61333-1 | Dog dander IgE Ab/IgE total in Serum |
| 9372-4 | Cotinine [Mass/volume] in Specimen |
| 63107-7 | Flax IgG Ab [Mass/volume] in Serum |
| 94421-5 | Candida glabrata RNA [Presence] in Vaginal fluid by NAA with probe detection |
| 81421-0 | Baker's yeast IgG Ab [Presence] in Serum by Immunoassay |
| 81813-8 | F11 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 81876-5 | SPG11 gene deletion+duplication and mutation analysis in Blood or Tissue by Molecular genetics method |
| 97965-8 | Dermatophagoides pteronyssinus recombinant (rDer p) 1 IgG4 Ab [Mass/volume] in Serum |
| 82401-1 | Ganglioside GD2 IgM Ab [Presence] in Serum by Line blot |
| 98211-6 | Salmonella species antibody panel - Serum by Agglutination |
| 98213-2 | Treponema pallidum IgG and IgM and bands panel - Serum by Immunoblot |
| 98257-9 | MELF invasion pattern [Presence] in Endometrial cancer specimen |
| 85988-4 | Streptococcus pneumoniae Danish serotype 12F Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 86925-5 | Lawsonia intracellularis Ab [Presence] in Serum by Immunoassay |
| 87735-7 | Ceftolozane+Tazobactam [Susceptibility] by Gradient strip |
| 87802-5 | Sulfachloropyridazine [Susceptibility] |
| 88259-7 | Gram negative bacteria identified [Interpretation] by Probe in Positive blood culture |
| 73969-8 | Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
| 88880-0 | Monocyte distribution width [Entitic volume] in Blood by Automated |
| 50810-1 | Antimony [Moles/mass] in Hair |
| 42631-2 | Glucose [Mass/volume] in Urine --5 hours post dose lactose PO |
| 59979-5 | Warfarin [Moles/volume] in Urine |
| 60267-2 | Influenza virus C RNA [Presence] in Isolate by NAA with probe detection |
| 31262-9 | Bluetongue virus 13 Ab [Units/volume] in Serum |
| 51423-2 | Corticotropin [Moles/volume] in Plasma --pre or post XXX challenge |
| 43035-5 | Feline immunodeficiency virus Ab [Titer] in Serum |
| 31908-7 | Neisseria meningitidis serogroup A Ag [Presence] in Specimen |
| 51598-1 | Lactose [Presence] in Stool |
| 5165-6 | Filaria Ab [Units/volume] in Serum by Hemagglutination |
| 43438-1 | Bartonella henselae and Bartonella quintana IgG and IgM panel - Serum |
| 52762-2 | Intrinsic coagulation system thromboelastography panel - Blood |
| 5284-5 | Polio virus 2 Ab [Titer] in Serum by Complement fixation |
| 44028-9 | Aspergillus fumigatus H Ab [Presence] in Serum by Immune diffusion (ID) |
| 32854-2 | 17-Hydroxyprogesterone [Presence] in DBS |
| 531-4 | Zidovudine [Susceptibility] |
| 53161-6 | Propionylcarnitine (C3)/Methionine [Molar ratio] in DBS |
| 53484-2 | Glucose [Moles/volume] in Serum or Plasma --30 minutes pre dose betaxolol |
| 44477-8 | Herpes simplex virus 1 Ag [Presence] in Vaginal fluid |
| 44499-2 | Herpes simplex virus 2 Ag [Presence] in Urethra |
| 33588-5 | Phosphatidylethanolamine Ab [Units/volume] in Serum by Immunoassay |
| 45073-4 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Tissue by Probe |
| 45130-2 | Chlamydia trachomatis Ab [Presence] in Body fluid |
| 33847-5 | Parathyrin.intact [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 34057-0 | Glucose [Moles/volume] in Serum or Plasma --pre or post dose cloNIDine |
| 34157-8 | little e Ab [Titer] in Serum or Plasma |
| 34662-7 | Mephenytoin+Normephenytoin [Mass/volume] in Serum or Plasma |
| 54500-4 | Aspartate aminotransferase.macromolecular/Aspartate aminotransferase.total in Serum or Plasma |
| 55193-7 | Chromosome analysis.interphase [Interpretation] in Chorionic villus sample by FISH Narrative |
| 47147-4 | EPINEPHrine [Moles/volume] in Plasma --5th specimen post XXX challenge |
| 25228-8 | Vancomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25924-2 | Hexacarboxylporphyrin [Moles/volume] in 24 hour Urine |
| 56526-7 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post exercise |
| 48276-0 | Indomethacin triggered leukotriene release [Mass/volume] by Leukocytes |
| 3810-9 | Methylphenidate [Mass/time] in 24 hour Urine |
| 27091-8 | Calcium [Mass/time] in 4 hour Urine |
| 38318-2 | Acrylamide [Mass/volume] in Water |
| 38403-2 | Cyclospora sp Ag [Presence] in Stool by Immunoassay |
| 38614-4 | Pentachlorophenol [Mass/volume] in Air |
| 49038-3 | Riboflavin [Moles/volume] in Serum or Plasma |
| 27298-9 | Protein [Units/volume] in Urine |
| 27432-4 | Glucose [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 38740-7 | Dimethylcarbamoyl chloride [Mass/volume] in Air |
| 40701-5 | Arsenic [Mass/volume] in Dialysis fluid |
| 59025-7 | Neutrophil Ab [Units/volume] in Serum by Flow cytometry (FC) |
| 59241-0 | Chromogranin A [Units/volume] in Body fluid |
| 30109-3 | Ecgonine methyl ester [Mass/volume] in Gastric fluid |
| 19280-7 | Benzodiazepines tested for in Urine by Screen method Narrative |
| 2018-0 | Carbon dioxide [Partial pressure] in Amniotic fluid |
| 20416-4 | Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 20852-0 | Duck enteritis virus Ag [Presence] in Tissue by Immunofluorescence |
| 21010-4 | CD1 cells [#/volume] in Blood |
| 100413-4 | Fennel Fresh IgG Ab [Units/volume] in Serum |
| 101654-2 | Neonatal ABO, Rh and DAT panel - Blood from Newborn |
| 13343-9 | CD4+HLA-DR+ cells/100 cells in Blood |
| 102530-3 | Pineapple IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102606-1 | Squash IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13955-0 | Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay |
| 14109-3 | CD16C+CD56+ cells/100 cells in Blood |
| 1421-7 | Cortisol [Mass/volume] in Serum or Plasma --32 hours post 40 ug corticotropin IM BID 3 day |
| 10481-0 | Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain |
| 10647-6 | Babesia sp identified in Blood by Thick film |
| 15279-3 | Cardamon IgE Ab [Units/volume] in Serum |
| 16192-7 | PHENobarbital [Presence] in Urine by Confirmatory method |
| 10991-8 | metroNIDAZOLE [Mass/volume] in Serum or Plasma |
| 11054-4 | Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma |
| 16838-5 | Estriol (E3) [Mass/volume] in Body fluid |
| 17478-9 | Porphyrins [Presence] in Body fluid |
| 18288-1 | Donath Landsteiner Ab [Titer] in Control Serum and RBC |
| 74902-8 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/mass] in Leukocytes |
| 91683-3 | Histoplasma capsulatum H and M and Blastomyces dermatitidis Ab panel - Cerebral spinal fluid |
| 75039-8 | Biopterin [Moles/volume] in Serum or Plasma |
| 75113-1 | Alpha linolenate (C18:3w3) [Entitic substance] in Red Blood Cells |
| 76411-8 | Neutrophils [#] in Body fluid by Manual count |
| 77061-0 | HPD gene full mutation analysis in Blood or Tissue by Sequencing |
| 7828-7 | Coxiella burnetii Ab [Units/volume] in Serum |
| 6427-9 | Histoplasma capsulatum Ab [Presence] in Serum by Latex agglutination |
| 79291-1 | Creatine and guanidinoacetate pattern [Interpretation] in Serum or Plasma Narrative |
| 95190-5 | CD107a+b expressing HLA-A2 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC) |
| 95603-7 | AMPAR2 Ab [Titer] in Serum by Cell binding immunofluorescent assay |
| 7987-1 | Polio virus 3 Ab [Units/volume] in Serum |
| 9714-7 | Shigella flexneri Ab [Titer] in Serum by Complement fixation |
| 6978-1 | Amphotericin B [Susceptibility] by Gradient strip |
| 69850-6 | 3-Hydroxyglutarate [Moles/volume] in Amniotic fluid |
| 9738-6 | Gabapentin [Mass/volume] in Serum, Plasma or Blood |
| 97651-4 | Pigeon serum IgG Ab [Mass/volume] in Serum |
| 97967-4 | Chicken droppings IgG4 Ab [Mass/volume] in Serum |
| 98018-5 | Megakaryoblasts/100 cells in Bone marrow by Manual count |
| 71874-2 | Hemoglobin A2/Hemoglobin.total [Pure mass fraction] in Blood by Electrophoresis |
| 72367-6 | Influenza virus A+B Ag [Presence] in Nose by Rapid immunoassay |
| 72416-1 | Beta hydroxybutyrate [Moles/volume] in Blood --post meal |
| 99787-4 | Cell-free DNA.donor/Cell-free DNA.total in Plasma cell-free DNA --post kidney transplant |
| 72810-5 | Gabapentin [Mass/volume] in Urine by Confirmatory method |
| 86065-0 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum --1st specimen |
| 87833-0 | Protein.monoclonal band 3 [Mass/volume] in Urine by Immunofixation |
| 74360-9 | Cortisone [Moles/volume] in Saliva (oral fluid) |
| 50723-6 | CD38+ Lambda+ cells [#/volume] in Blood |
| 5082-3 | Chlamydia sp Ab [Units/volume] in Serum by Immunoassay |
| 3089-0 | Urate/Creatinine [Mass Ratio] in Urine |
| 3106-2 | Urobilinogen [Mass/volume] in Stool |
| 4224-2 | diphenhydrAMINE [Mass] of Dose |
| 60154-2 | Pentoxifylline [Mass/volume] in Blood |
| 21350-4 | IgG [Presence] in Cerebral spinal fluid by Immunofixation |
| 31274-4 | Bovine leukemia virus Ab [Units/volume] in Serum |
| 5117-7 | Cryoglobulin [Presence] in Serum |
| 42993-6 | Mycoplasma pneumoniae Ab [Titer] in Cerebral spinal fluid |
| 2171-7 | Cobalamin (Vitamin B12).unsaturated Binding Capacity [Mass/volume] in Serum or Plasma |
| 31722-2 | Avian infectious laryngotracheitis virus Ag [Presence] in Specimen |
| 51789-6 | Histoplasma capsulatum mycelial phase Ab [Titer] in Serum by Immune diffusion (ID) |
| 22348-7 | Histoplasma capsulatum IgA Ab [Presence] in Serum |
| 32064-8 | Clorazepate [Moles/volume] in Serum or Plasma |
| 32128-1 | risperiDONE [Presence] in Serum or Plasma |
| 32221-4 | Alanine [Moles/volume] in Vitreous fluid |
| 32505-0 | CD13+CD33+ cells/100 cells in Tissue |
| 43864-8 | Blastomyces dermatitidis IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 44058-6 | CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Body fluid |
| 22848-6 | Babesia bovis Ab [Presence] in Serum by Immunoassay |
| 23477-3 | Theileria parva Ab [Presence] in Serum by Immunoassay |
| 23576-2 | Rabbit hemorrhagic disease virus Ab [Titer] in Serum by Immunoassay |
| 53930-4 | Histoplasma capsulatum Ag [Units/volume] in Bronchoalveolar lavage by Immunoassay |
| 45109-6 | Chlamydia sp Ag [Presence] in Body fluid by Immunofluorescence |
| 23943-4 | Xylose [Mass/volume] in Blood --2 hours post dose xylose PO |
| 34187-5 | DNA double strand Ab [Titer] in Serum by Immunofluorescence (IF) Crithidia luciliae |
| 54289-4 | Hemoglobin [Mass/volume] in Blood from Blood product unit |
| 46969-2 | Asialoganglioside GM1 IgG Ab [Titer] in Serum by Immunoassay |
| 2503-1 | Iron.chelated [Mass/volume] in Urine |
| 35320-1 | Protein [Mass/volume] in Body fluid --4th specimen post Sincalide |
| 55807-2 | Mycophenolate glucuronide [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 55905-4 | Alpha cortol [Mass/volume] in 24 hour Urine |
| 3557-6 | Dichlorphenamide [Mass/time] in 24 hour Urine |
| 56520-0 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 3755-6 | Meprobamate [Mass/volume] in Urine |
| 57095-2 | Anidulafungin [Susceptibility] |
| 48581-3 | Lutropin [Units/volume] in Serum or Plasma --on cycle day 11 |
| 57529-0 | 17-Hydroxycorticosteroids [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
| 48995-5 | N-acetyl-beta-glucosaminidase/Creatinine [Ratio] in Urine |
| 39486-6 | pH of Venous blood adjusted to patient's actual temperature |
| 57942-5 | Cladosporium sp IgG4 Ab [Mass/volume] in Serum |
| 49531-7 | Influenza virus A RNA [Presence] in Isolate by NAA with probe detection |
| 40033-3 | Glucose [Mass/volume] in Serum or Plasma --25 minutes post XXX challenge |
| 40236-2 | Calcium [Moles/volume] in Serum or Plasma --6.5 hours post XXX challenge |
| 58729-5 | Lymphocyte proliferation stimulated by 2.5 ug phytohemagglutin actual/normal in Blood |
| 49858-4 | Peptide YY [Mass/volume] in Serum or Plasma |
| 49954-1 | Somatotropin [Units/volume] in Serum or Plasma --4 AM specimen |
| 49999-6 | Platelet aggregation collagen induced [Identifier] in Platelet rich plasma |
| 29979-2 | Tin [Mass/volume] in 24 hour Urine |
| 30276-0 | Delavirdine [Susceptibility] by Phenotype method |
| 19175-9 | Choriogonadotropin.beta subunit [Moles/volume] in Amniotic fluid |
| 1929-9 | Immunoglobulin light chains [Mass/volume] in Urine |
| 19350-8 | Aprobarbital [Presence] in Urine by Confirmatory method |
| 20893-4 | Mycobacterium avium ss paratuberculosis [Presence] in Stool by Organism specific culture |
| 2097-4 | Cholinesterase [Enzymatic activity/volume] in Amniotic fluid |
| 21020-3 | Bacteria identified in Specimen by Anaerobe+Aerobe culture |
| 100049-6 | Eravacycline [Susceptibility] |
| 100974-5 | Influenza virus B RNA [Presence] in Nose by NAA with non-probe detection |
| 13015-3 | Diisobutylketone [Mass/volume] in Blood |
| 14567-2 | 11-Deoxycortisol [Moles/volume] in Serum or Plasma |
| 10330-9 | Monocytes/100 leukocytes in Body fluid by Manual count |
| 15401-3 | Drugs identified in Blood by Screen method |
| 16189-3 | Creatinine [Mass/volume] in Serum or Plasma --4 hour specimen |
| 11197-1 | Sardine (pilchard) IgE Ab [Units/volume] in Serum |
| 17148-8 | CD41 cells/100 cells in Blood |
| 17671-9 | Sulfatide IgM Ab [Units/volume] in Serum by Immunoassay |
| 19122-1 | CD42 cells/100 cells in Blood |
| 91086-9 | Fungal BT2 gene [Presence] in Specimen by NAA with probe detection |
| 92487-8 | LW sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 75075-2 | 4-Hydroxybenzoate [Moles/volume] in Serum or Plasma |
| 75559-5 | Comment on fetal Trisomy 18 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 61353-9 | Lymphocyte proliferation stimulated by 10 ug phytohemagglutinin in Blood |
| 6202-6 | Parrot feather IgE Ab [Units/volume] in Serum |
| 77651-8 | C peptide [Moles/volume] in Serum or Plasma --75 minutes post XXX challenge |
| 77661-7 | Aneuploid cell population 2 in S phase/100 cells in Cells.XXX by Flow cytometry (FC) |
| 77679-9 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 94076-7 | Mutations/Megabase [# Ratio] in Tumor |
| 62453-6 | Fatty acids.ethyl esters [Moles/mass] in Hair |
| 63249-7 | Ganglioside GM2 IgG+IgM Ab [Presence] in Serum by Immunoassay |
| 77772-2 | Methylenedioxyethylamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
| 78516-2 | Lactose [Moles/volume] in Serum or Plasma --45 minutes post dose lactose PO |
| 94495-9 | HLA-DQA1 [Type] |
| 6434-5 | Influenza virus A+B Ab [Titer] in Serum by Immunofluorescence |
| 94864-6 | Transthyretin-associated familial amyloidosis panel - Blood |
| 9501-8 | Candida sp Ag [Titer] in Serum |
| 96461-9 | Gastrin releasing polypeptide prohormone [Mass/volume] in Serum or Plasma by Immunoassay |
| 6746-2 | Prolymphocytes/100 leukocytes in Blood by Manual count |
| 68327-6 | Egg donor age |
| 8103-4 | CD45+CD14+ cells/100 cells in Blood |
| 7098-7 | White Ash triggered histamine release [Units/volume] in Blood |
| 98224-9 | Treponema pallidum IgM bands [Identifier] in Cerebral spinal fluid by Immunoblot |
| 7239-7 | Cocklebur triggered histamine release [Units/volume] in Blood |
| 72485-6 | Tapentadol [Presence] in Urine by Screen method |
| 85289-7 | Signet ring cells/100 cells in Colorectal cancer specimen by Light microscopy |
| 99266-9 | Deschloroetizolam [Mass/volume] in Urine by Confirmatory method |
| 72851-9 | Hepatitis B virus codon 84 [Identifier] by Genotype method |
| 72893-1 | Doripenem [Susceptibility] by Disk diffusion (KB) |
| 73013-5 | Gentamicin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 884-7 | ABO and Rh group [Type] in Capillary blood |
| 74217-1 | Fondaparinux [Mass/volume] in Platelet poor plasma by Chromogenic method |
| 89277-8 | Oxygen saturation in Arterial blood by Pulse oximetry --during anesthesia |
| 41602-4 | Bacteria [Presence] in Cerebral spinal fluid by Light microscopy |
| 59587-6 | Homovanillate [Mass/volume] in Urine collected for unspecified duration |
| 59827-6 | Bilirubin.total [Mass/volume] in Arterial blood |
| 506-6 | Ticarcillin+Clavulanate [Susceptibility] by Serum bactericidal titer |
| 30916-1 | Euploid+Aneuploid cells/100 cells in Specimen |
| 42522-3 | Mitochondria Ab [Titer] in Cerebral spinal fluid |
| 59994-4 | Testosterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 60216-9 | Zomepirac [Mass/volume] in Blood |
| 31298-3 | Chlamydia trachomatis D+K IgM Ab [Units/volume] in Serum |
| 31412-0 | Herpes simplex virus 2 IgM Ab [Units/volume] in Body fluid |
| 43060-3 | Chlamydia trachomatis D+K IgA Ab [Titer] in Serum |
| 31889-9 | Mumps virus Ag [Presence] in Cervix |
| 43631-1 | 6-Methylmercaptopurine metabolite [Presence] in Red Blood Cells |
| 22383-4 | Legionella pneumophila 2 IgG Ab [Titer] in Serum |
| 22497-2 | Rubella virus Ab [Titer] in Serum |
| 32305-5 | Calcium [Moles/volume] in Specimen |
| 52783-8 | Maximum clot firmness.extrinsic coagulation system activated [Length] in Blood by Rotational TEG |
| 43854-9 | Mycobacterium sp rRNA [Presence] in Specimen by Probe |
| 3301-9 | Acetazolamide [Presence] in Urine |
| 33235-3 | Calcium phosphate crystals [Presence] in Urine by Computer assisted method |
| 44784-7 | Creatinine [Mass/volume] (Maximum value during study) in Serum or Plasma |
| 23442-7 | Swine vesicular disease virus Ab [Presence] in Serum by Immunoassay |
| 33352-6 | Glucose/Creatinine [Mass Ratio] in Urine |
| 33379-9 | Coccidioides sp Ab [Presence] in Serum by Complement fixation |
| 5356-1 | Smith extractable nuclear Ab [Presence] in Serum by Immunoassay |
| 45007-2 | Chlamydia trachomatis Ab [Units/volume] in Serum by Immunoassay |
| 2401-8 | Guanine deaminase [Enzymatic activity/volume] in Serum |
| 33865-7 | Staphylococcus aureus enterotoxin [Identifier] in Specimen |
| 33939-0 | Interleukin 2 [Mass/volume] in Serum or Plasma |
| 34235-2 | Amylase/Creatinine [Ratio] in Urine |
| 54425-4 | Weak D Ag [Presence] on Red Blood Cells from Fetus |
| 24324-6 | Hepatic function 1996 panel - Serum or Plasma |
| 34363-2 | Pregnanetriolone [Moles/volume] in Urine |
| 34438-2 | Apolipoprotein E phenotype [Identifier] in Blood |
| 54478-3 | Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Amniotic fluid |
| 55359-4 | Osmolality of Urine--1 hour post fluid fast |
| 47356-1 | Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum by Immunoassay |
| 55670-4 | Dibekacin [Susceptibility] |
| 47648-1 | Histidine/Amino acids.total in DBS |
| 47826-3 | Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma |
| 25986-1 | Testosterone [Moles/volume] in 24 hour Urine |
| 35744-2 | TP73L gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 56144-9 | CHIC2 gene 4q12 deletion in Blood or Tissue by FISH |
| 4804-1 | HLA-B12 [Presence] in Donor |
| 4824-9 | HLA-B37 [Presence] in Donor |
| 48626-6 | Creatinine [Mass/volume] in Peritoneal fluid --24 hours post peritoneal dialysis |
| 5753-9 | Vanadium [Mass/volume] in Blood |
| 48902-1 | Rickettsia africae IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 48912-0 | Rickettsia rickettsii IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 48932-8 | Respiratory allergen panel, US - Alaska b - Serum |
| 49303-1 | Amino acid pattern [Interpretation] in Cerebral spinal fluid Narrative |
| 27443-1 | DOPamine [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 38675-5 | Sperm Midpiece IgA Ab/100 spermatozoa in Specimen by Immunobead |
| 38989-0 | Clostridium botulinum toxin A+B+E+F+G [Presence] in Specimen by Mouse bioassay neutralization |
| 39594-7 | Pecan or Hickory Nut IgE Ab/IgE total in Serum |
| 49375-9 | Hepatitis C virus RNA [Log #/volume] (viral load) in Tissue by NAA with probe detection |
| 4946-0 | HLA-DQ8(3) [Presence] in Donor |
| 58527-3 | Corticotropin [Moles/volume] in Plasma --1.5 hours post dose glucagon |
| 29673-1 | Bordetella pertussis IgM Ab [Presence] in Serum |
| 29814-1 | Jamestown canyon virus IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 29956-0 | Lysozyme [Mass/volume] in Body fluid |
| 40355-0 | Cotinine [Presence] in Hair |
| 40544-9 | Monocytes/100 leukocytes in Bronchial specimen by Manual count |
| 58895-4 | Pyruvate [Mass/volume] in Blood --post exercise |
| 58994-5 | Sodium [Moles/time] in 18 hour Urine |
| 29986-7 | Barium/Creatinine [Mass Ratio] in 24 hour Urine |
| 30211-7 | Collection duration of Specimen |
| 30227-3 | Histoplasma capsulatum farciminosum reaction wheal [Diameter] --2 days post 0.1 mL histoplasmin intradermal |
| 40883-1 | CD19+CD103+ cells/100 cells in Bone marrow |
| 20919-7 | Organophosphate pesticides [Presence] in Gastric fluid by Screen method |
| 100101-5 | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot |
| 100844-0 | Liver fibrosis score in Serum or Plasma by Calculated.Agile4 |
| 12467-7 | Amino acids [Identifier] in Urine |
| 12511-2 | Calcium [Mass/volume] in 4 hour Urine |
| 12734-0 | Soluble liver Ab [Units/volume] in Serum |
| 101202-0 | Mumps virus IgG Ab index [Units/volume] in Serum and CSF |
| 101284-8 | Bordetella pertussis DNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 101400-0 | Metanephrine, Normetanephrine, 3-Methoxytyramine panel - 24 hour Urine |
| 12959-3 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 101734-2 | Sodium Urate crystals [Energy Difference] in 24 hour Urine |
| 14021-0 | HTLV I+II p24 Ab [Presence] in Serum or Plasma by Immunoblot |
| 14629-0 | Bilirubin.direct [Moles/volume] in Serum or Plasma |
| 1607-1 | Osmolality of Urine--12 hours post fluid fast |
| 10870-4 | Xylose [Mass/volume] in Blood --4 hours post 25 g xylose PO |
| 16314-7 | Acetylsalicylate [Presence] in Urine |
| 16754-4 | Diamorphine [Mass/volume] in Unknown substance |
| 16987-0 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post dose glucose |
| 17703-0 | Thorium [Mass/volume] in Urine |
| 90794-9 | Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma |
| 74860-8 | ERBB2 gene copy number/nucleus in Tissue by FISH |
| 91132-1 | Measles virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 7551-5 | Orange Tree IgE Ab [Units/volume] in Serum |
| 93510-6 | Pentacarboxylporphyrin III [Moles/time] in 24 hour Urine |
| 61218-4 | Celery IgE Ab/IgE total in Serum |
| 6251-3 | Sporobolomyces roseus IgE Ab [Units/volume] in Serum |
| 63203-4 | Smooth Alder IgG Ab [Mass/volume] in Serum |
| 63539-1 | Proteinase 3 Ab [Units/volume] in Body fluid |
| 95648-2 | Sindbis virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 9600-8 | Taenia solium larva Ab [Presence] in Serum by Immunoblot |
| 68454-8 | Phenylbutazone [Moles/volume] in Gastric fluid |
| 68924-0 | Cancer Ag 72-4 [Units/volume] in Peritoneal fluid |
| 80706-5 | CD27+IgD- cells/100 CD19+CD20+ cells in Blood |
| 97010-3 | Clot formation kaolin+tissue factor induced [Time] in Blood |
| 97050-9 | Acinetobacter calcoaceticus-baumannii complex DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 69888-6 | Service comment 61 |
| 97599-5 | CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Lower respiratory specimen by Flow cytometry (FC) |
| 70275-3 | t(X;11)(q13.1;q23)(FOXO4,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 70855-2 | Burkholderia pseudomallei Ag [Presence] in Specimen by Immunofluorescence |
| 82852-5 | Prenanediolone+pregnanetriol/Androsterone+etiocholanolone [Molar ratio] in 24 hour Urine |
| 99096-0 | Mycoplasma pneumoniae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 72745-3 | Norfentanyl [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 73341-0 | HYDROmorphone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87574-0 | Ergovaline [Mass/mass] in Specimen |
| 73536-5 | ALPRAZolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88159-9 | Microscopic observation [Identifier] in Aspirate by Acid fast stain |
| 74170-2 | Ceftaroline [Susceptibility] by Gradient strip |
| 7418-7 | Horse dander triggered histamine release [Units/volume] in Blood |
| 88884-2 | Fatty acid omega-3 and omega-6 panel - Serum or Plasma |
| 89360-2 | CD45RA cells/100 CD4 cells in Blood |
| 41707-1 | Oritavancin [Susceptibility] by Disk diffusion (KB) |
| 593-4 | Legionella sp identified in Specimen by Organism specific culture |
| 59647-8 | N-desalkylflurazepam [Mass/volume] in Blood |
| 50622-0 | Miscellaneous allergen IgG Ab [Identifier] in Serum |
| 50669-1 | Transfuse antithrombin [Volume] |
| 50670-9 | Erythrocyte agglutination [Presence] in Blood |
| 60085-8 | Hydroxybupropion [Mass/mass] in Tissue |
| 60194-8 | Triamterene [Mass/volume] in Blood |
| 60264-9 | Hantavirus Ab [Titer] in Serum |
| 21458-5 | Phosphate [Mass/volume] in 24 hour Urine |
| 21620-0 | STS gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
| 31360-1 | Echovirus 9 Ab [Presence] in Serum |
| 31519-2 | Myelin associated glycoprotein Ab [Presence] in Cerebral spinal fluid |
| 31618-2 | Salmonella paratyphi B H Ab [Units/volume] in Serum |
| 31856-8 | Histoplasma capsulatum Ag [Units/volume] in Urine |
| 51549-4 | Pigeon feather IgG Ab [Presence] in Serum |
| 2277-2 | Ferrochelatase [Enzymatic activity/volume] in Serum |
| 32373-3 | Arbekacin [Susceptibility] |
| 51961-1 | Genetic variation's effect on drug efficacy |
| 22793-4 | Aleutian disease virus Ab [Presence] in Serum |
| 22833-8 | Avian paramyxovirus 1 [Units/volume] in Specimen by Bioassay |
| 23142-3 | Infectious bursal disease virus Ag [Presence] in Specimen by Neutralization test |
| 32598-5 | Sertraline [Mass] of Dose |
| 32610-8 | Amino acids [Moles/volume] in Cerebral spinal fluid |
| 44472-9 | Herpes simplex virus 1 Ag [Presence] in Eye |
| 33280-9 | Amphetamine+Methamphetamine [Mass/volume] in Urine by Screen method |
| 3346-4 | Diethylpropion [Mass/volume] in Urine |
| 44934-8 | Thymidine kinase [Enzymatic activity/volume] in Serum |
| 45061-9 | Spermatozoa IgA and IgG and IgM panel - Serum |
| 23845-1 | Coproporphyrin 1 [Mass/time] in 24 hour Stool |
| 46991-6 | BLM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 34290-7 | Estradiol (E2).unconjugated/Creatinine [Molar ratio] in Urine |
| 34620-5 | Camphor [Mass/volume] in Body fluid |
| 55090-5 | CD3-CD56+ cells/100 cells in Blood |
| 55507-8 | Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose glucose |
| 55524-3 | Atropine [Moles/volume] in Serum or Plasma |
| 2509-8 | Isoleucine [Mass/volume] in Urine |
| 35097-5 | Lymphocytes [#/volume] in Peritoneal fluid |
| 55730-6 | Fetal blood [Volume] in Blood |
| 47687-9 | Lutropin [Units/volume] in Serum or Plasma --15 minutes post 100 ug luteinizing releasing hormone IV |
| 26037-2 | Trichophyton mentagrophytes var goetzii IgE Ab [Units/volume] in Serum |
| 35413-4 | Coxsackievirus A4+A16 Ab [Titer] in Serum |
| 56182-9 | Aspergillus versicolor IgG4 Ab [Mass/volume] in Serum |
| 3636-8 | fentaNYL [Mass/volume] in Serum or Plasma |
| 3734-1 | Maprotiline [Presence] in Serum or Plasma |
| 48880-9 | Bartonella elizabethae IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 27232-8 | Lead [Mass/volume] in Milk |
| 38371-1 | Xanthine/Creatinine [Molar ratio] in Urine |
| 57619-9 | 5-Alpha tetrahydrocortisol [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
| 39318-1 | Influenza virus A N8 neutralizing antibody [Presence] in Serum by Neutralization test |
| 49707-3 | KCNQ2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 58489-6 | Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --4th specimen post XXX challenge |
| 58540-6 | Corticotropin [Mass/volume] in Plasma --11th specimen post XXX challenge |
| 58713-9 | Streptococcal DNAse B and ASO antibodies panel - Serum |
| 49953-3 | Somatotropin [Units/volume] in Serum or Plasma --3:30 AM specimen |
| 2962-9 | Somatotropin [Mass/volume] in Amniotic fluid |
| 29654-1 | Temazepam [Moles/volume] in Serum or Plasma |
| 29656-6 | Sympathomimetics [Presence] in Urine |
| 5929-5 | Candida albicans reaction wheal [Diameter] --3 days post 50 ug Candida albicans intradermal |
| 50452-2 | Corticotropin [Mass/volume] in Plasma --8th specimen |
| 30055-8 | Phenylalanine/Creatinine [Ratio] in Urine |
| 19664-2 | Phenmetrazine cutoff [Mass/volume] in Urine for Screen method |
| 20872-8 | Magnesium [Mass/volume] in Ocular fluid |
| 101066-9 | Cr^a Ab [Presence] in Serum or Plasma |
| 12719-1 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 101525-4 | Valnemulin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 102478-5 | Onion IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14064-0 | Diethylstilbestrol [Mass/volume] in Serum or Plasma |
| 102714-3 | Chocolate IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103104-6 | Phadiatop IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14377-6 | Polymorphonuclear cells/100 leukocytes in Semen by Manual count |
| 14378-4 | Polymorphonuclear cells/100 leukocytes in Urine by Manual count |
| 103963-5 | Zika virus lineage [Identifier] in Specimen by Molecular genetics method |
| 14812-2 | Lidocaine [Moles/volume] in Serum or Plasma |
| 14940-1 | Uroporphyrin 1 isomer [Moles/volume] in Serum or Plasma |
| 10697-1 | Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 10705-2 | Human papilloma virus Ag [Presence] in Tissue by Immune stain |
| 10727-6 | Toxoplasma gondii identified in Tissue |
| 11169-0 | Deer hair IgE Ab [Units/volume] in Serum |
| 16809-6 | Anaplasma phagocytophilum IgM Ab [Units/volume] in Serum |
| 17467-2 | Plasminogen activator inhibitor 2 Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 18213-9 | Complement C1 esterase inhibitor free IgM Ab [Mass/volume] in Serum or Plasma |
| 19109-8 | Histoplasma capsulatum Ag [Presence] in Specimen |
| 91853-2 | Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Genital specimen by NAA with probe detection |
| 75230-3 | M-chlorophenylpiperazine [Presence] in Urine |
| 75239-4 | Albumin.ischemia modified [Units/volume] in Serum |
| 75666-8 | HIV 1+2 Ab and HIV1 p24 Ag [Identifier] in Serum, Plasma or Blood by Rapid immunoassay |
| 60397-7 | Radish IgG Ab [Mass/volume] in Serum |
| 93433-1 | Busulfan [Mass/volume] in Plasma --4 hours post busulfan infusion completion |
| 62242-3 | MCV [Entitic volume] in Blood from Fetus by Automated count |
| 77030-5 | t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript in Blood or Tissue by FISH |
| 9384-9 | Benztropine [Mass/volume] in Serum or Plasma |
| 94040-3 | Adenovirus A+B+C+D+E DNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 94185-6 | Borrelia miyamotoi glpQ gene [Presence] in Specimen by NAA with probe detection |
| 63133-3 | Goat milk IgG Ab [Mass/volume] in Serum |
| 94417-3 | SLC6A4 gene 5-HTTLPR variant [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 64427-8 | KIR gene allele 3DL2 [Presence] in Blood or Tissue by Molecular genetics method |
| 80354-4 | Herpes simplex virus 1 and 2 DNA panel - Anogenital specimen by Probe and target amplification method |
| 9647-9 | Thiosulfate [Mass/volume] in Blood |
| 67818-5 | Parainfluenza virus 4a RNA [Presence] in Specimen by NAA with probe detection |
| 6799-1 | Tricyclic antidepressants [Presence] in Urine by Immunoassay |
| 8094-5 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum |
| 81748-6 | Chromosome region Yp11.3 deletion AndOr rearrangement in Blood or Tissue by FISH |
| 82211-4 | Norovirus genogroup I+II RNA [Presence] in Stool by NAA with non-probe detection |
| 70201-9 | Cholesterol in IDL [Moles/volume] in Serum or Plasma |
| 7122-5 | Basswood IgE Ab [Units/volume] in Serum |
| 7124-1 | Bayberry Pollen IgE Ab [Units/volume] in Serum |
| 7138-1 | Soybean dust IgE Ab [Units/volume] in Serum |
| 82914-3 | Dothiepin [Mass/volume] in Serum or Plasma --trough |
| 71701-7 | Rotavirus dsRNA [Identifier] in Stool by Polyacrylamide gel electrophoresis (PAGE) |
| 72859-2 | Boceprevir [Susceptibility] by Genotype method |
| 73000-2 | Loratadine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87664-9 | Dimethoate [Mass/mass] in Specimen |
| 73578-7 | Anion gap 4 in Venous blood |
| 88598-8 | Toscana virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 88681-2 | Herpes simplex virus Ag [Presence] in Cornea or Conjunctiva by Immunofluorescence |
| 4118-6 | Aminosalicylate [Mass] of Dose |
| 59312-9 | Milnacipran [Mass/volume] in Urine |
| 50981-0 | Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Mixed venous blood |
| 31046-6 | Rheumatoid factor [Presence] in Body fluid |
| 42002-6 | Pentacarboxylporphyrins [Mass/volume] in 24 hour Urine |
| 21056-7 | Alanine+Cystine+Histidine+Homocysteine+Leucine+Phenylalanine+Tyrosine [Presence] in Urine |
| 21611-9 | Age estimated |
| 51368-9 | CD79a cells/100 cells in Body fluid |
| 42939-9 | CFTR gene allele 2 [Presence] in Blood or Tissue by Molecular genetics method |
| 43155-1 | Spermatozoa Motile/100 spermatozoa in Semen by Microscopy high power field --post concentration |
| 31685-1 | Toxoplasma gondii IgG Ab [Presence] in Cerebral spinal fluid |
| 51919-9 | Lettuce IgG Ab [Mass/volume] in Serum |
| 2304-4 | Fumarylacetoacetate [Mass/volume] in Serum |
| 53377-8 | Herpes simplex virus IgG Ab [Titer] in Serum |
| 53463-6 | Beta aminoisobutyrate [Moles/volume] in Body fluid |
| 53494-1 | Eicosanoylcarnitine (C20) [Moles/volume] in Urine |
| 33248-6 | Diabetes status [Identifier] |
| 33679-2 | Francisella tularensis DNA [Presence] in Specimen by NAA with probe detection |
| 45158-3 | Immune complex [Units/volume] in Serum or Plasma by C3d binding assay |
| 34184-2 | Gamma globulin/Protein.total in 24 hour Urine |
| 54398-3 | Glucose [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 46406-5 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post 1 g/kg glucose PO |
| 34648-6 | Weight of unspecified time Stool |
| 47434-6 | Epstein Barr virus early diffuse Ab [Presence] in Serum |
| 47436-1 | Epstein Barr virus early IgG Ab [Titer] in Body fluid |
| 25336-9 | Coxiella burnetii IgM Ab [Titer] in Serum |
| 34926-6 | Promonocytes [#/volume] in Blood |
| 55643-1 | Ceforanide [Susceptibility] by Gradient strip |
| 55886-6 | 3-Hydroxyanthranilate/Creatinine [Molar ratio] in Urine |
| 55955-9 | Oleoylcarnitine (C18:1)/Creatinine [Molar ratio] in Urine |
| 56129-0 | Chikungunya virus IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 47658-0 | Insulin [Units/volume] in Serum or Plasma --1.5 hours post dose glucose |
| 56399-9 | Swiss Cheese IgG4 Ab [Mass/volume] in Serum |
| 48144-0 | Mannose [Presence] in Urine |
| 26055-4 | Pyridoxine [Moles/volume] in Serum or Plasma --pre 250 mg pyridoxine PO |
| 2618-7 | Methemoglobin/Hemoglobin.total in Red Blood Cells |
| 26611-4 | Phosphoethanolamine [Moles/time] in 24 hour Urine |
| 48358-6 | Herpes virus 8 IgM Ab [Titer] in Serum by Immunofluorescence |
| 48620-9 | Cholesterol [Mass/volume] in Serum or Plasma ultracentrifugate |
| 48732-2 | NCF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 49054-0 | 25-hydroxyvitamin D2 [Mass/volume] in Serum or Plasma |
| 38920-5 | MFN2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 57729-6 | Lactate [Mass/volume] in Serum or Plasma --6 minutes post XXX challenge |
| 39782-8 | Delta aminolevulinate/Creatinine [Molar ratio] in Urine |
| 50000-9 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post XXX challenge |
| 2975-1 | Sulfate [Mass/volume] in Urine |
| 29849-7 | Jamestown canyon virus IgM Ab [Units/volume] in Serum |
| 29865-3 | 2-Oxoisocaproate [Presence] in Urine |
| 50300-3 | 6-Hydroxyheptanoate [Moles/volume] in Urine |
| 50369-8 | White Oak IgE Ab/IgE total in Serum |
| 30254-7 | Insulin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 19577-6 | Methylphenidate [Presence] in Urine by Screen method |
| 19678-2 | Prazepam [Presence] in Urine by Screen method |
| 2020-6 | Carbon dioxide [Partial pressure] in Capillary blood |
| 20485-9 | Cardiolipin IgM Ab [Titer] in Serum |
| 100989-3 | Phosphoglucomutase [Enzymatic activity/volume] in Leukocytes |
| 12507-0 | Calcitonin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 12542-7 | N-methylacetamide [Mass/volume] in Urine |
| 12585-6 | Creatinine [Mass/time] in 2 hour Urine |
| 12708-4 | Tin [Mass/volume] in Urine |
| 101554-4 | Campylobacter jejuni DNA [Presence] in Stool by NAA with probe detection |
| 1319-3 | S Ag [Presence] on Red Blood Cells from Donor |
| 102282-1 | Dog dander IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102359-7 | Halibut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102651-7 | California Walnut Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13998-0 | Neuronal nuclear type 2 Ab [Titer] in Serum |
| 102834-9 | Tree of Heaven IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103063-4 | Peanut recombinant (rAra h) 8 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10408-3 | little i Ag [Presence] on Red Blood Cells |
| 150-3 | Cephalexin [Susceptibility] by Disk diffusion (KB) |
| 15266-0 | Tree Allergen Mix 5 (Grey alder+Hazelnut+White elm+Willow+Cottonwood) IgE Ab [Presence] in Serum by Multidisk |
| 15354-4 | Bombesin Ag [Presence] in Tissue by Immune stain |
| 15403-9 | Isopropanol [Presence] in Meconium |
| 16201-6 | Oxazepam [Mass/volume] in Urine by Confirmatory method |
| 16587-8 | Chlamydophila psittaci IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 16703-1 | cycloSPORINE [Mass/volume] in Plasma |
| 11192-2 | Protamine IgE Ab [Units/volume] in Serum |
| 12254-9 | Volume of Body fluid |
| 16819-5 | Entamoeba histolytica Ab [Units/volume] in Serum by Immunofluorescence |
| 16905-2 | Glucose [Presence] in Urine --2nd specimen post XXX challenge |
| 17079-5 | Fatty acids.long chain [Identifier] in Serum or Plasma |
| 18222-0 | EPINEPHrine [Mass/volume] in Urine --5th specimen post XXX challenge |
| 90076-1 | Staphylococcus sp identified in Isolate by Organism specific culture |
| 91075-2 | Rabies virus Ag [Presence] in Saliva (oral fluid) by Immunoassay |
| 60496-7 | MAP2K2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 7593-7 | Chili Pepper triggered histamine release [Units/volume] in Blood |
| 7616-6 | English plantain triggered histamine release [Units/volume] in Blood |
| 6138-2 | Setomelanomma rostrata IgE Ab [Units/volume] in Serum |
| 77685-6 | HIV 1 and 2 IgG Ab [Identifier] in Serum or Plasma by Immunoblot |
| 93808-4 | MDM2 gene amplification in Tissue by FISH |
| 63125-9 | Thyme IgG Ab [Mass/volume] in Serum |
| 6408-9 | Francisella tularensis Ag [Presence] in Specimen by Immunofluorescence |
| 80207-4 | Leishmania infantum+donovani IgM Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 69360-6 | Amylase [Enzymatic activity/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 69579-1 | Local PFGE event description in Isolate |
| 70070-8 | Streptococcus anginosus DNA [Presence] in Specimen by NAA with probe detection |
| 82110-8 | Tree Allergen Mix 10 (Grey alder+Silver birch+Hazelnut+White ash) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 97556-5 | Hemoglobin [Mass/volume] in Capillary blood by Oximetry |
| 71356-0 | TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
| 82905-1 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript [Log Number Ratio] in Bone marrow by Molecular genetics method |
| 71775-1 | Mycobacterium tuberculosis stimulated gamma interferon panel - Blood |
| 72336-1 | NPM1 gene c.960insCCTG transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
| 83055-4 | PD-L1 by clone 28-8 [Presence] in Tissue by Immune stain |
| 72849-3 | Hepatitis B virus codon 169 [Identifier] by Genotype method |
| 86900-8 | Plasma cells monotypic population [Identifier] in Blood by Flow cytometry (FC) |
| 87551-8 | Neutrophil cytoplasmic Ab.IgG and Saccharomyces cerevisiae IgA and IgG in Serum |
| 87563-3 | Antimony [Mass/mass] in Specimen |
| 87673-0 | Retinal+retinol+retinoic acid [Mass/mass] in Specimen |
| 73461-6 | Celecoxib induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88575-6 | Onchocerca sp IgG4 Ab [Presence] in Serum by Immunoassay |
| 73902-9 | CD3-CD57+ cells [#/volume] in Blood by Flow cytometry (FC) |
| 74326-0 | MICA*036 IgG Ab [Presence] in Serum |
| 3084-1 | Urate [Mass/volume] in Serum or Plasma |
| 60035-3 | 10-Hydroxycarbazepine [Mass/volume] in Blood |
| 60124-5 | Pancuronium [Mass/volume] in Urine |
| 60233-4 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.25 hours post dose lactose PO |
| 31235-5 | Aureobasidium pullulans IgG Ab [Units/volume] in Serum |
| 31569-7 | Polio virus 3 Ab [Units/volume] in Body fluid |
| 51159-2 | CD33 blasts [Units/volume] in Specimen |
| 51382-0 | Erythrocytes [#/area] in Synovial fluid by Light microscopy |
| 42789-8 | Mitogen-Activated protein kinase 14 Ag [Presence] in Tissue by Immune stain |
| 43055-3 | Clostridioides difficile toxin Ab [Titer] in Serum |
| 31662-0 | Sulfate-3-Glucuronyl paragloboside Ab [Units/volume] in Serum |
| 31693-5 | Unidentified extractable nuclear Ab [Presence] in Serum |
| 51710-2 | Leishmania sp identified in Specimen by Organism specific culture |
| 32328-7 | Lutropin [Units/volume] in Serum or Plasma --baseline |
| 32377-4 | Cefetamet [Susceptibility] |
| 44263-2 | Influenza virus A RNA [Units/volume] (viral load) in Specimen by NAA with probe detection |
| 53132-7 | Epithelial cells.non-squamous [#/area] in Urine sediment by Microscopy low power field |
| 53291-1 | Epithelial casts [#/area] in Urine by Computer assisted method |
| 53383-6 | Plasmodium sp IgG Ab [Titer] in Serum |
| 23419-5 | Salmonella abortus equi Ab [Presence] in Serum |
| 23645-5 | Actinobacillus pleuropneumoniae serotype 3 Ab [Presence] in Serum by Immunoassay |
| 5358-7 | Smooth muscle Ab [Titer] in Serum by Immunofluorescence |
| 53636-7 | Beta cortol/Creatinine [Mass Ratio] in Urine |
| 44876-1 | Influenza virus A Ab [Presence] in Cerebral spinal fluid |
| 4521-1 | Complement factor P [Mass/volume] in Plasma |
| 46232-5 | ZAP70 cells/100 cells in Specimen |
| 2456-2 | Iduronate-2-Sulfatase [Enzymatic activity/mass] in Tissue |
| 55354-5 | Osmolality of Urine--4 hours post fluid fast |
| 47468-4 | Legionella pneumophila 14 IgM Ab [Titer] in Serum |
| 2514-8 | Ketones [Presence] in Urine by Test strip |
| 56002-9 | Platelet aggregation ADP induced ATP secretion in Blood --5 umol/L |
| 25675-0 | Glucose [Mass/volume] in Urine --4 hours post dose glucose |
| 25973-9 | Phosphate [Moles/volume] in 24 hour Urine |
| 48193-7 | Succinylcholine triggered leukotriene release [Mass/volume] by Leukocytes |
| 2624-5 | Methionine [Mass/time] in 24 hour Urine |
| 56625-7 | Methylene chloride [Moles/volume] in Blood |
| 48573-0 | Follitropin [Units/volume] in Serum or Plasma --on cycle day 3 |
| 26890-4 | Canine distemper virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 5713-3 | Platinum [Mass/mass] in Hair |
| 57322-0 | Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 28035-4 | Escherichia coli shiga-like toxin [Units/volume] in Specimen by Immunoassay |
| 58375-7 | Ethyl glucuronide [Presence] in Urine by Screen method |
| 40293-3 | Insulin [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
| 58686-7 | C peptide [Mass/volume] in Serum or Plasma --2 hours post dose glucose |
| 49941-8 | Sepiapterin [Moles/volume] in Cerebral spinal fluid |
| 50115-5 | 3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Amniotic fluid |
| 29999-0 | Xylose [Mass/volume] in Serum or Plasma |
| 3007-2 | Threonine [Presence] in Serum or Plasma |
| 41169-4 | Valine [Presence] in Blood |
| 19666-7 | PHENobarbital [Presence] in Urine by Screen method |
| 20768-8 | Coccidioides immitis Ab [Presence] in Serum by Complement fixation |
| 20790-2 | Eastern equine encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 12388-5 | Phenylethylmalonamide [Mass/volume] in Serum or Plasma |
| 100846-5 | Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 12561-7 | Cortisol [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 12817-3 | Progesterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 101767-2 | Trichophyton verrucosum DNA [Presence] in Specimen by NAA with probe detection |
| 14032-7 | Ciprofloxacin [Mass/volume] in Serum or Plasma --trough |
| 14203-4 | Chlamydia trachomatis C IgG Ab [Titer] in Serum by Immunofluorescence |
| 14705-8 | Doxepin [Moles/volume] in Serum or Plasma |
| 103227-5 | Testosterone Free [Mass/volume] in Serum or Plasma by Calculation |
| 15280-1 | Mace IgE Ab [Units/volume] in Serum |
| 15372-6 | Nordiazepam [Mass/volume] in Urine |
| 1612-1 | Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
| 10899-3 | Eastern equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 12273-9 | Xanthochromia [Presence] of Body fluid Qualitative |
| 17205-6 | CD88 cells/100 cells in Blood |
| 17761-8 | Urobilinogen [Mass/time] in 48 hour Stool |
| 18941-5 | Lymecycline [Susceptibility] |
| 18947-2 | Mezlocillin [Susceptibility] |
| 90803-8 | Post-challenge peak - baseline concentration increment [Mass concentration difference] in Serum or Plasma by calculation |
| 91138-8 | ITPA gene g.9381A>C [Type] in Serum or Plasma by Molecular genetics method |
| 92244-3 | Microorganism resistance mutation nucleic acid change type by Molecular method |
| 92499-3 | Jo sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 60540-2 | HBA2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 61083-2 | Methylenedioxymethamphetamine [Presence] in Gastric fluid |
| 76590-9 | Bacterial 16S rRNA [#/mass] in XXX.tissue by NAA with probe detection |
| 92979-4 | Human coronavirus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 93360-6 | Monotypic plasma cell DNA index in Bone marrow by Flow cytometry (FC) |
| 93385-3 | Salmonella sp DNA [Presence] by NAA with probe detection in Positive blood culture |
| 77090-9 | TFB1M gene full mutation analysis in Blood or Tissue by Sequencing |
| 77361-4 | Triglyceride [Mass/time] in 24 hour Stool |
| 93982-7 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose carbohydrate |
| 94001-5 | Bicarbonate [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin |
| 94212-8 | PKLR gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 78784-6 | Amiodarone [Mass/volume] in Urine |
| 78829-9 | Gamma hydroxybutyrate [Mass/mass] in Hair |
| 79132-7 | 4-Hydroxymidazolam [Mass/volume] in Body fluid |
| 79524-5 | P-cresol [Moles/volume] in Serum or Plasma |
| 79716-7 | CYP2C9 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
| 80176-1 | S-adenosylhomocysteine/Creatinine [Molar ratio] in Urine |
| 96316-5 | AMPAR1+AMPAR2 IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay |
| 68993-5 | Human RNase P RNA [Presence] in Specimen by NAA with probe detection |
| 81096-0 | West Nile virus Kunjin strain IgM Ab [Presence] in Serum |
| 96603-6 | SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Presence] in Serum or Plasma by sVNT |
| 96721-6 | Macrophages [#/area] in Prostatic fluid by Light microscopy |
| 69546-0 | DNA region of interest stop [Identifier] |
| 8182-8 | Benzoylecgonine [Mass/volume] in Gastric fluid |
| 97271-1 | Meprobamate [Presence] in Cord tissue by Confirmatory method |
| 71669-6 | Blasts/Leukocytes [Pure number fraction] in Blood by Manual count |
| 99117-4 | Toscana virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 99275-0 | Phenazepam [Mass/volume] in Urine by Confirmatory method |
| 72727-1 | Del(13)(q14) and del(17)(p13) in Blood or Tissue |
| 85959-5 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum --1st specimen |
| 86546-9 | Herpes virus 8 DNA [Presence] in Tissue by NAA with probe detection |
| 87340-6 | Porcine circovirus type 2b DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 88232-4 | Trypanosoma cruzi DNA [Presence] in Tissue by NAA with probe detection |
| 74346-8 | MICA*001 IgG Ab [Presence] in Serum |
| 7436-9 | Jute IgE Ab [Units/volume] in Serum |
| 74399-7 | Monocytes [#/volume] in Cord blood |
| 88993-1 | Acute kidney injury risk [Likelihood] by Calculated by NephroCheck |
| 41414-4 | Babesia microti Ab [Titer] in Serum by Immunofluorescence |
| 59352-5 | Tapentadol [Mass/volume] in Blood |
| 59389-7 | Androstanolone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 31170-4 | 2,5-Hexanedione [Mass/volume] in Urine |
| 41759-2 | Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Urine |
| 42521-5 | Saccharopolyspora rectivirgula Ab [Presence] in Cerebral spinal fluid |
| 5995-6 | Platelet aggregation collagen induced in Platelet rich plasma |
| 3136-9 | Xylulose [Mass/volume] in Serum |
| 31463-3 | Legionella pneumophila 5 Ab [Units/volume] in Serum |
| 51452-1 | Coccidioides immitis Ab [Titer] in Body fluid |
| 4293-7 | Ketobemidone [Mass] of Dose |
| 43059-5 | Chlamydia trachomatis D+K IgG Ab [Titer] in Serum |
| 22520-1 | Salmonella paratyphi B Ab [Presence] in Serum |
| 53015-4 | Nucleosome Ab [Presence] in Serum |
| 43901-8 | Barium [Presence] in 24 hour Urine |
| 23-2 | Amphotericin B [Susceptibility] by Minimum lethal concentration (MLC) |
| 32688-4 | Herpes simplex virus 2 IgM Ab [Presence] in Serum |
| 53253-1 | Parainfluenza virus 2 RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 23438-5 | Swine influenza virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 33307-0 | Phosphatidylcholine Ab [Presence] in Serum |
| 33486-2 | Patient symptoms [Interpretation] --1.5 hours post dose lactose PO |
| 44936-3 | Thyrotropin [Units/volume] in Serum or Plasma --15 minutes pre dose TRH IV |
| 24099-4 | Sialidase [Enzymatic activity/mass] in Fibroblast |
| 33842-6 | Immature monocytes/100 leukocytes in Blood by Manual count |
| 46700-1 | 7-Dehydrocholesterol [Moles/volume] in Amniotic fluid |
| 34433-3 | Bartonella henselae Ab [Titer] in Serum by Flow cytometry (FC) |
| 34689-0 | Sulfatidase [Enzymatic activity/volume] in Leukocytes |
| 55294-3 | Linopristin+Flopristin [Susceptibility] by Disk diffusion (KB) |
| 55540-9 | Furosemide [Moles/volume] in Serum or Plasma |
| 25300-5 | Toxoplasma gondii IgG Ab [Ratio] in Serum --1st specimen/2nd specimen |
| 55728-0 | Yersinia sp IgG and IgM panel - Serum |
| 25637-0 | Econazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 56541-6 | Ganglioside GD1b IgG Ab [Units/volume] in Serum by Immunoassay |
| 3732-5 | Lysergate diethylamide [Presence] in Urine |
| 37983-4 | Eastern equine encephalitis virus RNA [Presence] in Specimen by Probe |
| 48382-6 | Omega 6 fatty acids (w6)/Omega 3 fatty acids (w3) [Molar ratio] in Serum or Plasma |
| 48504-5 | Platelet glycoprotein IIb/IIIa IgG Ab [Presence] in Blood by Immunoassay |
| 48602-7 | TGM1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 38634-2 | Benzyl chloride [Mass/volume] in Air |
| 5756-2 | Vanadium [Mass/volume] in Serum or Plasma |
| 27263-3 | Amphetamines [Mass/volume] in Vitreous fluid |
| 49370-0 | Hepatitis C virus RNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
| 28637-7 | Base deficit in Venous cord blood |
| 49757-8 | Minocycline [Mass/volume] in Specimen |
| 50069-4 | 11-Hydroxyandrostenedione [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
| 50174-2 | Alloisoleucine [Moles/volume] in Amniotic fluid |
| 29645-9 | Echovirus+Coxsackievirus IgA Ab [Presence] in Serum by Immunoassay |
| 40348-5 | MT-TL1 gene m.3252T>C [Presence] in Blood or Tissue by Molecular genetics method |
| 40619-9 | Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Venous blood |
| 5893-3 | Protein S [Units/volume] in Platelet poor plasma by Chromogenic method |
| 58936-6 | Hepatitis E virus Ab [Presence] in Serum by Immunoassay |
| 59009-1 | Fractional excretion of urea [Ratio] in Urine and Serum or Plasma collected for unspecified duration |
| 59235-2 | Prostate Specific Ag Free/Prostate specific Ag.total in Cerebral spinal fluid |
| 59239-4 | Prostate Specific Ag Free [Mass/volume] in Body fluid |
| 2028-9 | Carbon dioxide, total [Moles/volume] in Serum or Plasma |
| 20598-9 | CD3 cells [#/volume] in Specimen |
| 100672-5 | Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection |
| 12470-1 | Homocysteine [Mass/volume] in Urine |
| 1331-8 | V Ab [Presence] in Serum or Plasma |
| 13326-4 | Pneumocystis sp identified in Specimen by Light microscopy |
| 101677-3 | NDM Carbapenemase [Presence] in Isolate by Rapid immunoassay |
| 101790-4 | Platelet function profile in plasma |
| 101862-1 | 4F-MDMB-BUTICA [Presence] in Urine by Confirmatory method |
| 101987-6 | Candida glabrata DNA [Presence] in Body fluid by Probe.amp.tar |
| 102091-6 | HBA1 and HBA2 gene full mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
| 13825-5 | Arsenic.inorganic/Creatinine [Mass Ratio] in Urine |
| 14034-3 | Rheumatoid factor [Units/volume] in Cerebral spinal fluid |
| 102685-5 | Black Bean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14430-3 | Globulin [Mass/volume] in Synovial fluid |
| 14729-8 | Flurazepam [Moles/volume] in Serum or Plasma |
| 14811-4 | Leukocytes [#/volume] in Pericardial fluid by Manual count |
| 14899-9 | quiNIDine [Moles/volume] in Serum or Plasma |
| 15028-4 | Androstenedione [Moles/time] in 24 hour Urine |
| 15264-5 | Tree Allergen Mix 3 (Mountain juniper+White oak+White elm+Cottonwood+Mesquite) IgE Ab [Presence] in Serum by Multidisk |
| 10860-5 | Varicella zoster virus [Presence] in Specimen by Organism specific culture |
| 10921-5 | Blomia tropicalis IgE Ab [Units/volume] in Serum |
| 16451-7 | Beryllium [Presence] in Urine |
| 1652-7 | 1-Methylhistidine [Mass/volume] in Serum or Plasma |
| 17179-3 | CD62E cells/100 cells in Blood |
| 17259-3 | Methadone.long acting metabolite [Mass/volume] in Serum or Plasma |
| 17724-6 | Treponema pallidum Ab [Units/volume] in Serum by Immunofluorescence |
| 18936-5 | Kanamycin.high potency [Susceptibility] |
| 75095-0 | Docosahexaenoate (C22:6w3) [Entitic substance] in Red Blood Cells |
| 75224-6 | Chediak-Higashi cells [Presence] in Blood |
| 9321-1 | Calcium/Creatinine [Mass Ratio] in Urine |
| 61396-8 | Human papilloma virus 56 DNA [Presence] in Specimen by NAA with probe detection |
| 77636-9 | HLA-C [Type] by High resolution typing |
| 94225-0 | TTR gene full mutation analysis in Blood or Tissue by Sequencing |
| 77878-7 | Ziprasidone cutoff [Mass/volume] in Urine for Confirmatory method |
| 94383-7 | Glial nuclear type 1 IgG Ab [Presence] in Cerebral spinal fluid by Line blot |
| 94763-0 | SARS-CoV-2 (COVID-19) [Presence] in Specimen by Organism specific culture |
| 7919-4 | HIV 2 Ab [Presence] in Serum |
| 79398-4 | Prolactin isoforms pattern [Interpretation] in Serum or Plasma Narrative |
| 6627-4 | Schistosoma mansoni Ab [Presence] in Serum by Immunoassay |
| 79706-8 | Octadecatetraenoate (C18:4w3) [Entitic substance] in Red Blood Cells |
| 7974-9 | Norovirus RNA [Presence] in Stool by NAA with probe detection |
| 802-9 | Spherocytes [Presence] in Blood by Light microscopy |
| 95701-9 | Ross River virus IgA Ab [Presence] in Specimen by Immunoassay |
| 96429-6 | Borrelia burgdorferi G39/40 IgG bands [Identifier] in Specimen by Immunoblot |
| 9649-5 | Hydroflumethiazide [Mass/volume] in Urine |
| 6861-9 | Vanilla IgG Ab [Units/volume] in Serum |
| 80653-9 | Spermatozoa Normal chromatin/100 spermatozoa in Semen by Romanowsky stain |
| 81318-8 | Spermatozoa.normal morphology [#] in Semen by Automated count |
| 97629-0 | Peptostreptococcus anaerobius DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 83106-5 | Myoglobin [Mass/volume] in Serum or Plasma by Immunoassay |
| 84913-3 | Cells.chromosome 12 trisomy/Cells counted in Blood or Tissue by FISH |
| 992-8 | Do sup(a) Ab [Presence] in Serum or Plasma from Donor |
| 99868-2 | Acanthocytes [#/volume] in Urine sediment by Computer assisted method |
| 73389-9 | Ezetimibe induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86950-3 | Thymus IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 87490-9 | ADB-PINACA pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 73684-3 | Atovaquone [Mass/volume] in Serum or Plasma |
| 41745-1 | Betamethasone [Mass/volume] in Serum or Plasma |
| 42496-0 | Echinococcus sp Ab [Presence] in Cerebral spinal fluid |
| 21186-2 | Chlamydia sp IgM Ab [Presence] in Serum |
| 51136-0 | CD25 blasts/100 blasts in Specimen |
| 5116-9 | Corynebacterium diphtheriae Ab [Units/volume] in Serum by Immunoassay |
| 51171-7 | CD34+CD117+ blasts [Units/volume] in Blood |
| 3167-4 | Volume of 24 hour Urine |
| 43322-7 | Avian metapneumovirus C Ab [Presence] in Serum by Immunofluorescence |
| 43945-5 | CD4+CD45RO+ cells/100 cells in Body fluid |
| 22919-5 | Bovine leukemia virus RNA [Presence] in Tissue by NAA with probe detection |
| 32815-3 | Microscopic observation [Identifier] in Specimen by Sudan black B stain |
| 53151-7 | Valine/Phenylalanine [Molar ratio] in DBS |
| 53207-7 | Nonanoylcarnitine (C9) [Moles/volume] in DBS |
| 23469-0 | Theileria mutans Ab [Presence] in Serum by Immunofluorescence |
| 23471-6 | Theileria mutans Ab [Titer] in Serum |
| 5360-3 | Spermatozoa Ab [Units/volume] in Cervical mucus |
| 44888-6 | Malignant cells [#/volume] in Synovial fluid |
| 44979-3 | Chlamydophila pneumoniae Ab [Presence] in Serum --2nd specimen |
| 45293-8 | Choriogonadotropin.beta subunit.free multiple of the median [Percentile] |
| 34277-4 | Cysteine [Moles/volume] in Urine |
| 54169-8 | Thiamphenicol [Susceptibility] |
| 46759-7 | Hb SS, Hb SC, Hb SB thal newborn screen interpretation |
| 24405-3 | Aeromonas salmonicida [Presence] in Specimen |
| 25140-5 | Uracil/Creatinine [Molar ratio] in Urine |
| 25402-9 | Estrogen [Moles/time] in 24 hour Urine |
| 47708-3 | Methylmalonate/Urea [Molar ratio] in Serum or Plasma |
| 25864-0 | Aspartate [Moles/volume] in 24 hour Urine |
| 35674-1 | Creatinine [Mass/volume] in Urine collected for unspecified duration |
| 48322-2 | Acetohexamide [Presence] in Specimen |
| 48335-4 | Aspergillus sp Ag [Presence] in Tissue by Immune stain |
| 48377-6 | Mullerian inhibiting substance [Moles/volume] in Serum or Plasma |
| 26984-5 | Helicobacter pylori IgG Ab [Units/volume] in Saliva (oral fluid) |
| 27160-1 | Hydrastine [Presence] in Serum or Plasma |
| 38575-7 | Bromoform [Mass/volume] in Air |
| 38720-9 | Beta-propiolactone [Mass/volume] in Air |
| 57879-9 | Cantaloupe IgG Ab [Units/volume] in Serum |
| 5811-5 | Specific gravity of Urine by Test strip |
| 29395-1 | Gastrin [Mass/volume] in Serum or Plasma --fasting |
| 3988-3 | Promethazine [Mass/volume] in Serum or Plasma |
| 40119-0 | Creatinine [Moles/volume] in Serum or Plasma --4 hours post XXX challenge |
| 49853-5 | Transforming growth factor beta 1 [Mass/volume] in Serum or Plasma |
| 40596-9 | Prothrombin IgM Ab [Units/volume] in Serum or Plasma |
| 30009-5 | Fibrin+Fibrinogen fragments [Mass/volume] in Serum |
| 300-4 | Lincomycin [Susceptibility] by Disk diffusion (KB) |
| 41043-1 | VHL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19362-3 | Cocaine cutoff [Mass/volume] in Urine for Screen method |
| 100692-3 | Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 101820-9 | Preimplantation targeted mutation analysis in Embryo by Molecular genetics method |
| 13600-2 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin |
| 102613-7 | Strawberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102661-6 | Willow IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103028-7 | Coffee bean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14515-1 | Pneumocystis jiroveci Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 103655-7 | Color of Spun Pleural fluid |
| 14829-6 | Mesothelial cells/100 leukocytes in Pleural fluid by Manual count |
| 1507-3 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
| 104302-5 | UGT1A9 gene.c.-275T>A [Presence] in Blood or Tissue by Molecular genetics method |
| 10574-2 | Fructose [Moles/volume] in Semen |
| 15464-1 | Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immunoassay |
| 10734-2 | Varicella zoster virus identified in Skin by Electron microscopy |
| 10931-4 | Daphnia (fish feed) IgE Ab [Units/volume] in Serum |
| 16490-5 | Brucella suis Ab [Units/volume] in Serum by Latex agglutination |
| 11188-0 | Cayenne IgE Ab [Units/volume] in Serum |
| 1227-8 | M Ab [Presence] in Serum or Plasma from Donor |
| 17363-3 | Nitrazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 17741-0 | Trichlorophenoxyacetate [Mass/volume] in Serum or Plasma |
| 185-9 | Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 90250-2 | Vanillylmandelate and Homovanillate panel - Urine |
| 75087-7 | Adipate [Moles/volume] in Serum or Plasma |
| 75134-7 | Deoxyguanosine [Moles/volume] in Serum or Plasma |
| 75144-6 | Xanthine [Moles/volume] in Serum or Plasma |
| 7520-0 | Blue mussel triggered histamine release [Units/volume] in Blood |
| 75568-6 | Fetal Monosomy X prior risk [Likelihood] Based on maternal age Narrative |
| 60548-5 | 11-Oxo-Etiocholanolone/Creatinine [Mass Ratio] in Urine |
| 77046-1 | ACADSB gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77083-4 | FARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 93926-4 | little c Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant |
| 7818-8 | Borrelia burgdorferi IgM Ab [Units/volume] in Serum |
| 94293-8 | Citalopram+Escitalopram [Mass/volume] in Serum or Plasma by Confirmatory method |
| 63536-7 | Jo-1 extractable nuclear Ab [Presence] in Body fluid |
| 79489-1 | Salicylurate [Moles/volume] in Serum or Plasma |
| 95532-8 | Human papilloma virus high-risk genotypes panel - Cervix by NAA with probe detection |
| 6663-9 | Microscopic observation [Identifier] in Tissue by Gimenez stain |
| 79676-3 | 5,6-Dihydrouridine [Moles/volume] in Cerebral spinal fluid |
| 68378-9 | Leukocytes.disintegrated/100 leukocytes in Blood |
| 68413-4 | Macrophages [#/volume] in Vitreous fluid by Manual count |
| 80829-5 | Pepsin A+Pepsinogen A [Interpretation] in Lower respiratory specimen Narrative |
| 96554-1 | Eutylone [Mass/volume] in Serum or Plasma |
| 9712-1 | Shigella boydii Ab [Titer] in Serum by Complement fixation |
| 9730-3 | Pentacarboxylporphyrins [Mass/time] in 24 hour Urine |
| 7053-2 | Ticarcillin [Susceptibility] by Gradient strip |
| 98239-7 | CD154 expression and function panel - T cells by Flow cytometry (FC) |
| 85355-6 | PEDV S INDEL strain S gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 99386-5 | Adenovirus DNA [Log #/volume] (viral load) in Cornea or Conjunctiva by NAA with probe detection |
| 99902-9 | Triple phosphate crystals [#/volume] in Urine sediment by Computer assisted method |
| 72957-4 | risperiDONE induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 41245-2 | Viscosity of Pericardial fluid Qualitative |
| 41425-0 | Toxocara canis Ab [Titer] in Specimen by Immunoassay |
| 50835-8 | Cadmium/Creatinine [Molar ratio] in 24 hour Urine |
| 30448-5 | Neutrophils [#/volume] in Urine |
| 60316-7 | Methaqualone [Moles/volume] in Specimen |
| 42724-5 | OmpC Ab [Presence] in Serum by Immunoassay |
| 2217-8 | DOPamine [Mass/volume] in Urine |
| 22189-5 | Chlamydia trachomatis IgA Ab [Titer] in Serum |
| 31864-2 | Influenza virus B Ag [Presence] in Specimen |
| 51880-3 | Packed erythrocytes units given [#] |
| 43746-7 | KCNQ1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 22422-0 | Mycoplasma gallisepticum Ab [Presence] in Serum |
| 22453-5 | Pseudorabies virus Ab [Titer] in Serum |
| 22717-3 | Histidine [Moles/volume] in Specimen |
| 52916-4 | Tin/Creatinine [Molar ratio] in 24 hour Urine |
| 43926-5 | Babesia sp Ab [Presence] in Serum |
| 3293-8 | Acebutolol [Presence] in Urine |
| 3295-3 | Acebutolol [Mass/time] in 24 hour Urine |
| 53113-7 | Spermatids/100 spermatozoa in Semen |
| 23360-1 | Porcine enterovirus Ag [Presence] in Specimen by Neutralization test |
| 53893-4 | RNA polymerase III Ab [Units/volume] in Serum |
| 33972-1 | SARS coronavirus Urbani Ab [Presence] in Serum |
| 53996-5 | Nuclear matrix Ab pattern [Presence] in Serum by Immunofluorescence |
| 24178-6 | Coxsackievirus B1 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 34967-0 | Osmotic fragility of Red Blood Cells--0.20% sodium chloride 24 hour 37 degree C incubation |
| 5571-5 | Acrylonitrile [Mass/volume] in Blood |
| 25927-5 | Histidine/Creatinine [Molar ratio] in 24 hour Urine |
| 26035-6 | Serotonin [Moles/volume] in Plasma |
| 35460-5 | Platelet genotype [Identifier] in Amniotic fluid |
| 5624-2 | Chromium [Mass/time] in 24 hour Urine |
| 56276-9 | Olive IgG4 Ab [Mass/volume] in Serum |
| 48117-6 | Isovalerylglycine/Urea [Molar ratio] in Plasma |
| 26403-6 | Alternaria alternata IgG4 Ab [Units/volume] in Serum |
| 3678-0 | hydroCHLOROthiazide [Mass/time] in 24 hour Urine |
| 3801-8 | Methsuximide [Mass/volume] in Serum or Plasma |
| 38331-5 | 2,4,5-Trichlorophenoxyacetate [Mass/volume] in Water |
| 27359-9 | Somatotropin [Mass/volume] in Serum or Plasma --15th specimen post XXX challenge |
| 27979-4 | 17-Ketogenic steroids [Moles/time] in 24 hour Urine |
| 39580-6 | Phoma herbarum Ab [Mass/volume] in Serum |
| 49876-6 | Alpha hydroxytriazolam [Mass/volume] in Urine by Confirmatory method |
| 29929-7 | Titanium [Mass/time] in 24 hour Urine |
| 40557-1 | Progesterone receptor Ag [Presence] in Tissue by Immune stain |
| 30239-8 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P |
| 41171-0 | Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma |
| 19230-2 | Bicarbonate [Moles/volume] standard in Arterial blood |
| 19659-2 | Phencyclidine [Presence] in Urine by Screen method |
| 2075-0 | Chloride [Moles/volume] in Serum or Plasma |
| 12391-9 | dimenhyDRINATE [Mass/volume] in Serum or Plasma |
| 12440-4 | Midazolam [Presence] in Stool |
| 100734-3 | traMADol and Metabolites Panel - Urine by Confirmatory method |
| 13283-7 | Measles virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 101962-9 | DHDDS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 102050-2 | Diabetic diagnosis [Identifier] |
| 102389-4 | Insulin porcine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102441-3 | Common Millet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103001-4 | Timothy recombinant (rPhl p) 6 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14444-4 | Cholesterol [Mass/volume] in Urine |
| 103171-5 | Clostridioides difficile toxin A+B DNA [Presence] in Wound by NAA with probe detection |
| 14935-1 | Urate [Moles/time] in 24 hour Urine |
| 14978-1 | cycloSPORINE [Mass/volume] in Blood by Immunoassay |
| 1514-9 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO |
| 15209-0 | Saccharomonospora viridis Ab [Presence] in Serum by Immune diffusion (ID) |
| 104343-9 | Borna disease virus [Presence] in Specimen by Organism specific culture |
| 10591-6 | Primary Spermatocytes [#/volume] in Semen |
| 10805-0 | Microscopic observation [Identifier] in Tissue by Safranin stain |
| 1648-5 | Tuberculosis reaction wheal [Diameter] --3 days post 5 TU intradermal |
| 12251-5 | Rubella virus Ag [Presence] in Specimen by Immunofluorescence |
| 17449-0 | Phosphatidylethanolamine IgG Ab [Presence] in Serum |
| 74538-0 | Neisseria meningitidis serogroup B DNA [Presence] in Specimen by NAA with probe detection |
| 74859-0 | Ethanol [Mass/volume] in Blood Estimated from serum or plasma level |
| 75716-1 | CYP1A2 gene c.2499A>T [Presence] in Blood or Tissue by Molecular genetics method |
| 6046-7 | Black Walnut Pollen IgE Ab [Units/volume] in Serum |
| 92938-0 | Catecholamines 3 panel - Urine |
| 931-6 | Blood product source [Type] |
| 9352-6 | Amphetamines [Mass/mass] in Hair |
| 61269-7 | Gelatin IgE Ab/IgE total in Serum |
| 78439-7 | Phenytoin free and total trough panel - Serum or Plasma |
| 6536-7 | Rabies virus identified in Tissue by Organism specific culture |
| 66133-0 | Mononuclear cells atypical/100 leukocytes in Body fluid by Manual count |
| 6748-8 | Glucose [Presence] in Urine by Test strip --1 hour post 75 g glucose PO |
| 67813-6 | Fatty casts [#/area] in Urine sediment by Microscopy high power field |
| 68434-0 | Leukocytes [#/volume] in Vitreous fluid by Automated count |
| 6866-8 | 17-Hydroxycorticosteroids [Mass/volume] in 24 hour Urine |
| 80650-5 | Tin [Moles/volume] in Blood |
| 7000-3 | Cephalothin [Susceptibility] by Gradient strip |
| 97315-6 | Vibrio parahaemolyticus DNA [Presence] in Stool by NAA with probe detection |
| 85505-6 | Presumptive Rh [Type] in Saliva (oral fluid) by Molecular genetics method |
| 99872-4 | Superficial transitional cells [Presence] in Urine sediment by Computer assisted method |
| 72870-9 | Mycobacterium leprae rpoB gene rifAMPin resistance mutation [Presence] by Molecular method |
| 86086-6 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum --1st specimen |
| 86575-8 | Measles virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 73134-9 | Sulindac induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73334-5 | Imipenem induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86861-2 | Dengue virus 4 neutralizing antibody [Titer] in Specimen by Neutralization test |
| 87716-7 | Influenza virus A NA gene [Nucleotide sequence] in Isolate by Sequencing |
| 736-9 | Lymphocytes/100 leukocytes in Blood by Automated count |
| 73901-1 | CD3- CD8- CD57+ Cells/100 lymphocytes in Blood by Flow cytometry (FC) |
| 88864-4 | Microbiology CNAMTS panel - Cornea or Conjunctiva |
| 89535-9 | Ribonucleoprotein extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
| 41716-2 | Sulbactam [Susceptibility] by Disk diffusion (KB) |
| 59668-4 | Estazolam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 50675-8 | Calcium-phosphorus product [(Mass/volume)*2] in Serum or Plasma |
| 4194-7 | clonazePAM [Mass] of Dose |
| 42368-1 | Neisseria meningitidis serogroup w135 Ag [Presence] in Isolate by Agglutination |
| 424-2 | Pyrazinamide [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 42506-6 | Hepatitis C virus Ab [Presence] in Cerebral spinal fluid |
| 4264-8 | Flurazepam [Mass] of Dose |
| 60081-7 | Germanium [Mass/volume] in Serum or Plasma |
| 2107-1 | Choriogonadotropin [Moles/volume] in Urine |
| 51210-3 | Titanium [Mass/volume] in Body fluid |
| 43087-6 | Babesia canis Ab [Titer] in Serum |
| 43126-2 | Cortisol.free panel - 24 hour Urine |
| 31733-9 | Border disease virus Ag [Presence] in Blood |
| 31904-6 | Nairobi sheep disease virus Ag [Presence] in Specimen |
| 32025-9 | Malignin Ab [Presence] in Serum |
| 51528-8 | Citrus Allergen Mix (Orange+Lemon+Grapefruit+Clementine) IgE Ab [Presence] in Serum by Multidisk |
| 22358-6 | HIV 2 Ab [Units/volume] in Serum |
| 22681-1 | Methionine/Creatinine [Molar ratio] in Urine |
| 32300-6 | Base excess in Cord blood by calculation |
| 53032-9 | U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum |
| 44309-3 | Cortisol Free/Creatinine [Mass Ratio] in Urine |
| 44347-3 | Phenol/Creatinine [Molar ratio] in 24 hour Urine |
| 4447-9 | TOLBUTamide [Mass] of Dose |
| 44862-1 | 5-Alpha tetrahydro-11-Dehydrocorticosterone/Creatinine [Mass Ratio] in Urine |
| 33325-2 | Trypsin [Mass/volume] in Serum or Plasma |
| 33611-5 | Phosphatidylethanolamine Ab [Units/volume] in Serum |
| 53526-0 | Triglyceride in VLDL [Moles/volume] in Serum or Plasma |
| 45075-9 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urethra by Probe |
| 34397-0 | Amilsulpride [Mass/volume] in Serum or Plasma |
| 35170-0 | Nervonate (C24:1) [Moles/volume] in Serum or Plasma |
| 4784-5 | HLA-B65(14) [Presence] in Donor |
| 25894-7 | Cystine/Creatinine [Molar ratio] in 24 hour Urine |
| 35839-0 | Sparfloxacin [Susceptibility] by Disk diffusion (KB) |
| 57038-2 | Chromosome 12 aneuploidy in Amniotic fluid or Chorionic villus sample by FISH Nominal |
| 57346-9 | Creatinine [Mass/volume] in 12 hour Urine |
| 57413-7 | Mitochondria Ab [Presence] in Serum by Immunoblot |
| 38764-7 | Eastern equine encephalitis virus IgG Ab [Units/volume] in Specimen |
| 58016-7 | Octreotide [Mass/volume] in Serum or Plasma |
| 28605-4 | Ethanolamine/Creatinine [Ratio] in Urine |
| 58753-5 | Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum |
| 2995-9 | Tetrahydrocortisol [Mass/time] in 24 hour Urine |
| 40506-8 | Jamestown canyon virus Ab [Titer] in Serum by Immunofluorescence |
| 59261-8 | Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol |
| 50415-9 | Cortisol [Mass/volume] in Serum or Plasma --pre 2 mg dexamethasone PO overnight |
| 40750-2 | Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunofluorescence |
| 40945-8 | Yersinia enterocolitica IgA Ab [Presence] in Serum |
| 19692-3 | Secobarbital [Presence] in Urine by Screen method |
| 20673-0 | Actinobacillus pleuropneumoniae Ab [Presence] in Serum |
| 20766-2 | Clostridium sordellii Ag [Presence] in Tissue by Immunofluorescence |
| 20851-2 | Bovine herpesvirus 5 Ag [Presence] in Tissue by Immunofluorescence |
| 20927-0 | Oxalate [Mass/mass] in Tissue |
| 100044-7 | Cefcapene [Susceptibility] |
| 12857-9 | HIV 1 p28 Ab [Presence] in Serum by Immunoblot |
| 101158-4 | Flualprazolam [Presence] in Urine by Confirmatory method |
| 102198-9 | Burweed marshelder IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13510-3 | Microscopic observation [Identifier] in Bone marrow by Myeloperoxidase stain |
| 102856-2 | Parakeet droppings IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14523-5 | Rubella virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 14795-9 | Immunoglobulin light chains [Interpretation] in Urine |
| 103664-9 | Dehydronorketamine [Mass/volume] in Urine by LC/MS/MS |
| 1498-5 | Glucose [Mass/volume] in Serum or Plasma --10 minutes post 0.5 g/kg glucose IV |
| 15492-2 | Neospora caninum Ab [Presence] in Serum by Immunoassay |
| 10766-4 | Microscopic observation [Identifier] in Tissue by Alcian blue stain |
| 1092-6 | K Ab [Presence] in Serum or Plasma from Donor |
| 11086-6 | Streptococcus pneumoniae Ag [Presence] in Serum |
| 16674-4 | Cortisol [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge |
| 1195-7 | little k Ag [Presence] on Red Blood Cells |
| 16870-8 | Fluconazole [Mass/volume] in Urine |
| 17090-2 | Loxapine+8-Hydroxyloxapine [Mass/volume] in Serum or Plasma |
| 17428-4 | Pentacarboxylporphyrins [Mass/time] in 24 hour Stool |
| 17899-6 | Bacteria # 2 identified in Throat by Aerobe culture |
| 1823-4 | Alpha tocopherol [Mass/volume] in Serum or Plasma |
| 90906-9 | Father's ABO and Rh group Type |
| 91088-5 | Fungal BT2 gene [Presence] in Dermatologic specimen by NAA with probe detection |
| 74526-5 | Delta aminolevulinate, porphobilinogen and creatinine panel - 24 hour Urine |
| 74822-8 | Clostridioides difficile toxin B tcdB gene [Presence] in Stool by NAA with probe detection |
| 74843-4 | Baylisascaris sp IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 60373-8 | Flounder IgG Ab [Mass/volume] in Serum |
| 93325-9 | Taurohyodeoxycholate [Moles/volume] in Serum or Plasma |
| 77057-8 | CYP17A1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 77168-3 | cycloSPORINE [Mass/volume] in Blood --4 hours post dose |
| 63169-7 | Aspergillus nidulans IgG Ab [Mass/volume] in Serum |
| 78787-9 | amLODIPine [Mass/volume] in Blood |
| 79180-6 | Somatotropin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 79448-7 | Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus panel - Nose by NAA with probe detection |
| 6683-7 | Reptilase time |
| 95767-0 | Cefiderocol [Susceptibility] by Disk diffusion (KB) |
| 95774-6 | MSH6 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 68936-4 | Baker's yeast Ab [Units/volume] in Serum by Immunoassay |
| 8061-4 | Nuclear Ab [Presence] in Serum |
| 80645-5 | Maprotiline+normaprotiline [Mass/volume] in Serum or Plasma |
| 80690-1 | HIV 1 proviral DNA tropism [Identifier] in Blood mononuclear cells |
| 96517-8 | Bourbon virus IgG Ab [Presence] in Specimen by Immunoassay |
| 69791-2 | Tetradecadienoylcarnitine (C14:2)/Creatinine [Molar ratio] in Urine |
| 69957-9 | Proteinase 3 IgG Ab [Presence] in Serum by Immunoassay |
| 97751-2 | Amiodarone+Desethylamiodarone [Moles/volume] in Serum or Plasma |
| 70241-5 | HIV 1 RNA [#/volume] (viral load) in Plasma by Probe and target amplification method detection limit = 20 copies/mL |
| 71648-0 | Monocytes/Leukocytes [Pure number fraction] in Body fluid by Manual count |
| 82295-7 | Chromosome region Xp22.33 AndOr Yp11.32 deletion and duplication mutation analysis in Blood or Tissue by FISH |
| 82900-2 | Pregnanetriolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
| 97978-1 | Apple recombinant (rMal d) 1 IgG4 Ab [Mass/volume] in Serum |
| 7204-1 | Cheese cheddar type IgG Ab [Units/volume] in Serum |
| 72459-1 | JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Urine by Confirmatory method |
| 84903-4 | Extraprostatic extension extent [Type] of Prostate tumor |
| 85329-1 | Cells.estrogen receptor/100 cells in Breast cancer specimen by Immune stain |
| 99370-9 | Horse Fly IgG Ab [Mass/volume] in Serum |
| 99443-4 | Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgG4 Ab [Mass/volume] in Serum |
| 72825-3 | Phencyclidine [Mass/volume] in Urine by Screen method |
| 85994-2 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum by Immunoassay |
| 86003-1 | Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum --1st specimen |
| 86159-1 | Streptococcus pneumoniae Danish serotype 8 Ab [Units/volume] in Serum --1st specimen |
| 73101-8 | Trimethoprim induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73300-6 | Lisinopril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73393-1 | Escitalopram induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73641-3 | Marbofloxacin [Susceptibility] by Disk diffusion (KB) |
| 74329-4 | MICA*029 IgG Ab [Presence] in Serum |
| 74344-3 | MICA*004 IgG Ab [Presence] in Serum |
| 88690-3 | Pneumocystis jiroveci DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 41419-3 | Leishmania brasilensis Ab [Titer] in Serum by Immunofluorescence |
| 41494-6 | Gatifloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
| 59793-0 | Glucose [Molar concentration difference] in Serum or Plasma --1.5 hours post XXX challenge |
| 42534-8 | Thermoactinomyces vulgaris Ab [Presence] in Cerebral spinal fluid |
| 51174-1 | CD36 blasts/100 blasts in Blood |
| 43019-9 | Histoplasma capsulatum Ab [Presence] in Pleural fluid |
| 4317-4 | Metenolone [Mass] of Dose |
| 21724-0 | SERPINA1 gene p.Glu264Val [Presence] in Blood or Tissue by Molecular genetics method |
| 22215-8 | Coxsackievirus A16 Ab [Titer] in Serum |
| 31834-5 | Haemophilus influenzae B Ag [Presence] in Specimen |
| 3194-8 | Coagulation factor V Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 43743-4 | Variant lymphocytes [#/volume] in Blood by Automated count |
| 43811-9 | Propoxyphene [Presence] in Specimen |
| 43814-3 | Basement membrane IgG Ab [Presence] in Serum by Immunoassay |
| 22583-9 | Toxoplasma gondii IgM Ab [Titer] in Cerebral spinal fluid |
| 51951-2 | UGT1A1 gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 53020-4 | Complement C1q Ab [Presence] in Serum |
| 43840-8 | Influenza virus B IgM Ab [Presence] in Serum |
| 43975-2 | Aprobarbital [Presence] in Specimen |
| 44405-9 | Sodium/Creatinine [Molar ratio] in 24 hour Urine |
| 53323-2 | Casts type not specified [#/volume] in Urine by Computer assisted method |
| 44518-9 | Herpes simplex virus DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 44533-8 | HIV 1+2 Ab [Presence] in Serum from Donor |
| 23510-1 | Trypanosoma equiperdum Ab [Titer] in Serum by Complement fixation |
| 53552-6 | Dodeicosanoylcarnitine (C22)/Creatinine [Molar ratio] in Urine |
| 53563-3 | Platelet aggregation ADP induced in Platelet rich plasma --20 umol/mL |
| 5381-9 | Thyroglobulin Ab [Titer] in Serum by Latex agglutination |
| 23786-7 | Urea [Mass/volume] in Specimen |
| 54288-6 | Guanidinoacetate [Moles/volume] in Amniotic fluid |
| 24159-6 | White+Black Pepper IgE Ab [Units/volume] in Serum |
| 24502-7 | Parakeet serum Ab [Presence] in Serum by Immune diffusion (ID) |
| 34325-1 | Lead [Moles/volume] in 24 hour Urine |
| 55367-7 | Cholesterol crystals [#/area] in Urine by Computer assisted method |
| 55696-9 | Oxolinate [Susceptibility] |
| 47628-3 | Glutamate/Amino acids.total in DBS |
| 56458-3 | Wattle IgG4 Ab [Mass/volume] in Serum |
| 26504-1 | Neutrophils [#/volume] in Synovial fluid |
| 26684-1 | Mycoplasma pneumoniae IgA Ab [Presence] in Serum by Immunoassay |
| 56715-6 | Bacteria identified in Pericardial fluid by Culture |
| 26909-2 | Alpha aminoadipate [Moles/volume] in Amniotic fluid |
| 27217-9 | Beta aminoisobutyrate [Moles/volume] in Amniotic fluid |
| 38557-5 | Spermatozoa.midpiece Motile w IgA/100 spermatozoa in Semen by Immunobead |
| 38665-6 | Diethanolamine [Mass/volume] in Air |
| 49009-4 | Norepinephrine [Moles/volume] in Plasma --7th specimen post XXX challenge |
| 49206-6 | Bartonella elizabethae IgG Ab [Titer] in Body fluid |
| 27415-9 | Interferon gamma [Mass/volume] in Serum or Plasma |
| 27874-7 | Insulin [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 40205-7 | Glucose [Moles/volume] in Serum or Plasma --14 minutes post XXX challenge |
| 50012-4 | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma by Polyethylene glycol (PEG) method |
| 50125-4 | 3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in DBS |
| 29837-2 | Jamestown canyon virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 40396-4 | Porphyrins [Moles/time] in 24 hour Urine |
| 59151-1 | Vancomycin resistant enterococcus [Presence] in Urine by Organism specific culture |
| 50298-9 | 4-Hydroxyifosfamide [Mass/volume] in Blood --3 hours post dose ifosfamide |
| 50405-0 | Patient symptoms [Interpretation] Narrative--after transfusion reaction |
| 30199-4 | Alpha subunit [Mass/volume] in Serum or Plasma |
| 19628-7 | Norfluoxetine [Presence] in Urine by Screen method |
| 20659-9 | Tryptophan [Moles/volume] in Serum or Plasma |
| 20751-4 | Chicken anemia virus Ab [Presence] in Serum by Immunoassay |
| 100714-5 | Guanfacine [Mass/volume] in Serum or Plasma |
| 12847-0 | Protein [Mass/volume] in Peritoneal dialysis fluid --5th specimen |
| 101293-9 | Influenza virus A H1 2009 pandemic RNA [Presence] in Throat by NAA with non-probe detection |
| 102285-4 | Echinococcus sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102378-7 | Yellow Hornet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102557-6 | Desert Ragweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102904-0 | Quinoa IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15205-8 | Rheumatoid factor [Units/volume] in Serum by Nephelometry |
| 104290-2 | ROS proto-oncogene 1 mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 104305-8 | Regorafenib N-oxide [Mass/volume] in Serum or Plasma |
| 10721-9 | Terbinafine [Susceptibility] by Minimum lethal concentration (MLC) |
| 10783-9 | Microscopic observation [Identifier] in Tissue by Crystal violet stain |
| 10916-5 | Platinum [Mass/volume] in Blood |
| 16320-4 | Acyclovir [Susceptibility] by Serum bactericidal titer |
| 16409-5 | Ascorbate [Mass/volume] in Serum or Plasma --post dose |
| 167-7 | Cephapirin [Susceptibility] by Serum bactericidal titer |
| 18284-0 | CD198 cells/100 cells in Blood |
| 1838-2 | Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Tissue |
| 18404-4 | Spermatozoa IgM Ab [Units/volume] in Semen |
| 74810-3 | Acetyl fentanyl [Presence] in Urine by Confirmatory method |
| 75008-3 | Dog native (nCan f) 1 IgE Ab [Units/volume] in Serum |
| 91876-3 | Brucella sp Ab [Titer] in Serum by Immunocapture agglutination |
| 75112-3 | Docosatetraenoate (C22:4w6) [Entitic substance] in Red Blood Cells |
| 78035-3 | Fibers [Presence] in Body fluid |
| 63418-8 | Lactalbumin alpha IgG Ab [Mass/volume] in Serum |
| 6435-2 | Influenza virus A+B Ag [Presence] in Throat by Immunoassay |
| 64416-1 | KIR gene allele 2DL4 [Presence] in Blood or Tissue by Molecular genetics method |
| 68317-7 | Metanephrine, Normetanephrine and Creatinine panel - Urine |
| 81170-3 | Greater curvature of stomach [Length] in Specimen |
| 96613-5 | HLA-A [Type] in Donor by High resolution |
| 82098-5 | Food Allergen Mix 21 (Kiwi+Pineapple+Melon+Banana+Peach) IgE Ab [Units/volume] in Serum by Multidisk |
| 97227-3 | Carisoprodol [Presence] in Cord tissue by Confirmatory method |
| 70263-9 | Cholesterol in pericardial fluid/Cholesterol in serum |
| 71615-9 | Lymphocytes/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
| 72339-5 | Lecithin [Presence] in Prostatic fluid by Light microscopy |
| 85304-4 | Distance of carcinoma from anterior margin [Length] in Breast cancer specimen by Light microscopy |
| 72512-7 | VKORC1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 85843-1 | Beta-lactam resistance AmpC blaFOX gene [Presence] by Molecular method |
| 86550-1 | HTLV I+II RNA [Presence] in Blood by NAA with probe detection |
| 73105-9 | Triamterene induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87274-7 | Borrelia afzelii+burgdorferi+garinii IgG and IgM panel - Serum by Line blot |
| 87417-2 | Cytolethal distending toxin B and Vinculin Ab panel - Serum by Immunoassay |
| 73478-0 | Casanthranol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73875-7 | Androstenetriol [Moles/volume] in Urine |
| 88457-7 | Herpes simplex virus 1 IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 89371-9 | MTB complex DNA and rpoB RIF resistance mutation panel [Presence] |
| 89650-6 | Tropheryma whipplei DNA [Presence] in Implanted device by NAA with probe detection |
| 4141-8 | Benzthiazide [Mass] of Dose |
| 41465-6 | Opiates/Creatinine [Mass Ratio] in Urine |
| 41623-0 | Bacillus anthracis DNA [Presence] in Specimen by NAA with probe detection |
| 31081-3 | Benzodiazepines [Presence] in Meconium by Screen method |
| 42251-9 | Methadone+Metabolite [Presence] in Urine by Screen method |
| 60099-9 | Loxapine [Mass/volume] in Blood |
| 21247-2 | DMD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 51102-2 | CD19 blasts/100 blasts in Specimen |
| 51147-7 | CD3 blasts [Units/volume] in Blood |
| 5136-7 | Echovirus 1 neutralizing antibody [Titer] in Serum by Neutralization test |
| 51411-7 | Environmental stressors panel - Air |
| 4309-1 | Mephobarbital [Mass] of Dose |
| 22068-1 | MXI1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 43279-9 | Hepatitis B Virus YMDD [Presence] in Serum or Plasma by NAA with probe detection |
| 43798-8 | Alpha-1-Fetoprotein [Presence] in Amniotic fluid |
| 22420-4 | Mumps virus IgM Ab [Titer] in Serum |
| 44335-8 | Lysine/Creatinine [Mass Ratio] in 24 hour Urine |
| 2306-9 | Galactose [Presence] in Blood |
| 53370-3 | Echinococcus sp IgG4 Ab [Units/volume] in Serum |
| 53454-5 | Iron [Mass/volume] in Urine --post dose deferoxamine |
| 44482-8 | Herpes simplex virus 1+2 IgG Ab [Presence] in Body fluid |
| 23533-3 | Trypanosoma sp Ab [Presence] in Serum |
| 33407-8 | Protein [Mass/volume] in Pericardial fluid |
| 33410-2 | Chlamydia sp IgG Ab [Units/volume] in Serum by Immunoassay |
| 23884-0 | Interleukin 2 receptor [Presence] in Tissue by Immunocytochemical assay |
| 24491-3 | Tree Allergen Mix 4 (White oak+White elm+London plane or Maple leaf sycamore+Willow+Cottonwood) IgE Ab [Units/volume] in Serum by Multidisk |
| 54907-1 | Alkaline phosphatase [Enzymatic activity/volume] in Amniotic fluid |
| 55380-0 | West Nile virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 4703-5 | HLA-A43 [Presence] in Donor |
| 35116-3 | Sulforidazine [Mass/volume] in Serum or Plasma |
| 5584-8 | Arsenic [Mass/mass] in Hair |
| 47691-1 | Lysine/Amino acids.total in Cerebral spinal fluid |
| 25816-0 | Vigabatrin [Moles/volume] in Serum or Plasma |
| 2593-2 | Magnesium [Moles/volume] in Blood |
| 35727-7 | Chlamydia sp DNA [Presence] in Urethra by NAA with probe detection |
| 56377-5 | Red top grass IgG4 Ab [Mass/volume] in Serum |
| 48300-8 | Erythrosine triggered leukotriene release [Mass/volume] by Leukocytes |
| 36906-6 | Complement C1 esterase inhibitor [Mass/volume] in Body fluid |
| 3761-4 | Mesterolone [Presence] in Urine |
| 56683-6 | Histidine/Creatinine [Ratio] in 24 hour Urine |
| 48660-5 | Ganglioside GM1 Ab [Units/volume] in Serum by Immunoassay |
| 26945-6 | Triazolam [Mass/mass] in Hair |
| 38509-6 | Viscosity of Semen Qualitative--30 minutes post collection |
| 48925-2 | Respiratory allergen panel, US - Central midwest b - Serum |
| 27850-7 | Somatotropin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 28038-8 | Gamma hydroxybutyrate [Mass/volume] in Blood |
| 39457-7 | Beta aminobutyrate [Moles/volume] in Serum or Plasma |
| 57916-9 | Borrelia burgdorferi C6 Ab [Presence] in Serum |
| 58083-7 | Vw Ag [Presence] on Red Blood Cells |
| 49322-1 | Hemoglobin pattern [Interpretation] in Blood by HPLC |
| 4939-5 | HLA-DQ4 [Presence] |
| 2875-3 | Gamma globulin [Mass/volume] in Synovial fluid by Electrophoresis |
| 29245-8 | Zinc [Mass/mass] in Nail |
| 39961-8 | Creatinine [Mass/volume] in Serum or Plasma --3.5 hours post XXX challenge |
| 5844-6 | Herpes simplex virus 1 Ag [Presence] in Genital specimen by Immunofluorescence |
| 58463-1 | Tau protein/Protein.total in Cerebral spinal fluid |
| 58561-2 | Corticotropin [Mass/volume] in Plasma --2 PM specimen |
| 50119-7 | 3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Cerebral spinal fluid |
| 295-6 | Ketoconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 40436-8 | Parainfluenza virus identified in Specimen by Organism specific culture |
| 59229-5 | Testosterone [Moles/volume] in Peritoneal fluid |
| 30107-7 | Ecgonine methyl ester [Mass/volume] in Serum or Plasma |
| 19491-0 | Hydroxyalprazolam cutoff [Mass/volume] in Urine for Screen method |
| 12405-7 | Nabumetone [Mass/volume] in Serum or Plasma |
| 100738-4 | Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma |
| 12449-5 | Ketones [Mass/volume] in Urine by Test strip --1 hour post XXX challenge |
| 12629-2 | Glucose [Mass/volume] in 24 hour Peritoneal dialysis fluid |
| 12635-9 | Glucose [Mass/volume] in Peritoneal dialysis fluid --6th specimen |
| 12720-9 | Hydroxyproline [Mass/volume] in 2 hour Urine |
| 12754-8 | Insulin [Mass/volume] in Serum or Plasma --10 hours post XXX challenge |
| 101246-7 | NMDAR Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 101564-3 | Gliadin peptide IgA+IgG Ab [Units/volume] in Serum by Immunoassay |
| 101671-6 | Hereditary Wilms tumor multigene analysis in Blood or Tissue by Molecular genetics method |
| 13264-7 | Leptospira sp IgG Ab [Titer] in Serum |
| 102216-9 | Red Cedar IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13542-6 | Phosphate [Mass/volume] in Cerebral spinal fluid |
| 13759-6 | Homocystine/Creatinine [Mass Ratio] in Urine |
| 102355-5 | Gum arabic IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102719-2 | Cockatiel feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102969-3 | Miscellaneous allergen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14541-7 | Measles virus Ag [Presence] in Vaginal fluid by Immunofluorescence |
| 15362-7 | aPTT.inhibitor sensitive in Platelet poor plasma by Coagulation assay |
| 16590-2 | Chlamydia sp Ab [Units/volume] in Serum by Complement fixation |
| 11230-0 | Amobarbital [Mass/volume] in Urine |
| 12256-4 | Spermatozoa [#/area] in Semen by Microscopy high power field --post vasectomy |
| 16932-6 | Hemoglobin A3/Hemoglobin.total in Blood by Electrophoresis |
| 18431-7 | Amphetamines [Presence] in Stool by Screen method |
| 1901-8 | Arylsulfatase [Enzymatic activity/volume] in Serum or Plasma |
| 90909-3 | Arachidonate (C20:4w6)/Eicosapentaenoate (C20:5w3) [Mass Ratio] in Blood |
| 91135-4 | Acanthocytes [Presence] in Urine sediment by Light microscopy |
| 92249-2 | Microorganism gene tested for [Identifier] by Molecular method |
| 75649-4 | Mitragynine+7-Hydroxymitragynine [Presence] in Urine by Confirmatory method |
| 60474-4 | Reticulocytes [#/volume] in Blood by Automated count |
| 61106-1 | 16p11.2 chromosome region deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 6116-8 | Ficus sp IgE Ab [Units/volume] in Serum |
| 7617-4 | Plum IgG Ab [Units/volume] in Serum |
| 7653-9 | Short+Giant Ragweed IgG Ab [Units/volume] in Serum |
| 77023-0 | Respiratory syncytial virus B RNA [Presence] in Nasopharynx by NAA with probe detection |
| 92822-6 | Genomic coordinate system [Type] |
| 93812-6 | 1,3 beta glucan [Presence] in Serum |
| 63159-8 | Flea IgG Ab [Mass/volume] in Serum |
| 79287-9 | Carnitine biosynthesis intermediates panel - Urine |
| 79346-3 | Alpha-aminoadipic semialdehyde/Creatinine [Molar ratio] in Urine |
| 68970-3 | Gamma hydroxybutyrate [Moles/volume] in Specimen |
| 80685-1 | Clostridioides difficile toxin A+B tcdA+tcdB genes [Presence] in Stool by NAA with probe detection |
| 81190-1 | Histologic type of Stomach cancer by WHO Classification |
| 69773-0 | Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Urine |
| 81865-8 | MYBPC3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 97219-0 | ALPRAZolam [Presence] in Cord tissue by Confirmatory method |
| 7013-6 | Fluconazole [Susceptibility] by Gradient strip |
| 7023-5 | Kanamycin.high potency [Susceptibility] by Disk diffusion (KB) |
| 7045-8 | rifAMPin [Susceptibility] by Gradient strip |
| 82588-5 | Erythrocytes [#/volume] in Bone marrow by Automated count |
| 99047-3 | Metanephrine Free [Moles/time] in 24 hour Urine |
| 72381-7 | ALPRAZolam [Mass/volume] in Saliva (oral fluid) |
| 87451-1 | Sodium [Mass/volume] in Specimen |
| 73824-5 | Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative |
| 88339-7 | Bacilliform bacteria [Presence] in Ear by Light microscopy |
| 88513-7 | Natural killer cell cytotoxicity.7.5:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
| 74120-7 | PDGFR-alpha Ag [Presence] in Tissue by Immune stain |
| 88615-0 | Human coronavirus NL63 RNA [Presence] in Aspirate by NAA with probe detection |
| 41286-6 | Uranium 235/Uranium 238 [Mass Ratio] in Urine |
| 4186-3 | Ciprofloxacin [Mass] of Dose |
| 42360-8 | Streptococcus pneumoniae 14 serotypes IgG panel A [Mass/volume] - Serum |
| 21188-8 | Chlamydia trachomatis rRNA [Presence] in Conjunctival specimen by Probe |
| 31441-9 | Intercellular substance Ab [Units/volume] in Serum |
| 31542-4 | Nuclear Ab [Units/volume] in Pleural fluid |
| 51440-6 | Protein.monoclonal band 3 [Mass/volume] in Urine by Electrophoresis |
| 21756-2 | ATN1 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 31975-6 | Taenia sp Ag [Presence] in Stool |
| 51547-8 | Canary feather IgG Ab [Presence] in Serum |
| 5181-3 | Hepatitis A virus IgM Ab [Units/volume] in Serum by Immunoassay |
| 43245-0 | Erythrocytes [#/volume] in Semen by Light microscopy |
| 4360-4 | Normetanephrine [Mass] of Dose |
| 22536-7 | Schistosoma mansoni Ab [Presence] in Serum |
| 32243-8 | Glutamine [Moles/volume] in Body fluid |
| 22856-9 | Babesia sp rRNA [Presence] in Tissue by Probe |
| 23074-8 | Equine arteritis virus Ag [Presence] in Specimen by Immunofluorescence |
| 2311-9 | Galactose renal clearance in 24 hour Urine and Serum or Plasma |
| 53103-8 | Decenoylcarnitine (C10:1) [Moles/volume] in Urine |
| 53172-3 | 3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS |
| 44476-0 | Herpes simplex virus 1 Ag [Presence] in Urethra |
| 53499-0 | Creatinine [Moles/volume] in 12 hour Urine |
| 53865-2 | Galactomannan Ag [Units/volume] in Cerebral spinal fluid |
| 44910-8 | Alpha-1-Fetoprotein [Units/volume] in Body fluid |
| 23994-7 | Epstein Barr virus nuclear IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 24083-8 | Galactosylceramidase [Enzymatic activity/mass] in Fibroblast |
| 46988-2 | GBA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 24148-9 | Kentucky blue grass IgG Ab [Units/volume] in Serum |
| 34500-9 | SHOX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 25354-2 | Wheat Bran IgG Ab [Units/volume] in Serum |
| 25362-5 | Calcium [Moles/volume] in 24 hour Urine |
| 35299-7 | PSEN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 35300-3 | GJB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55814-8 | 25-hydroxyvitamin D3 [Moles/volume] in Cord blood |
| 47574-9 | Aspartate/Amino acids.total in Hair |
| 47699-4 | Metanephrine/Creatinine [Molar ratio] in 24 hour Urine |
| 56286-8 | Honey bee IgG4 Ab [Mass/volume] in Serum |
| 48016-0 | Genechip kit panel - Blood or Tissue by Molecular genetics method |
| 26589-2 | Beta alanine [Moles/volume] in Cerebral spinal fluid |
| 3718-4 | Lithium [Mass/mass] in Hair |
| 56637-2 | Mi-2 Ab [Units/volume] in Serum by Immunoassay |
| 57476-4 | 11-Ketoandrosterone [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
| 49113-4 | ZAP70 Ag [Presence] in Tissue by Immune stain |
| 49140-7 | California encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 49214-0 | Anaplasma phagocytophilum IgM Ab [Titer] in Body fluid |
| 28005-7 | MTHFR gene c.677C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 5786-9 | Epithelial casts [#/area] in Urine sediment by Microscopy low power field |
| 58457-3 | Sulfites [Presence] in Urine by Test strip |
| 58668-5 | Cortisol [Mass/volume] in Saliva (oral fluid) --4 PM specimen |
| 29698-8 | Leptospira interrogans sv Javanica Ab [Presence] in Serum |
| 58852-5 | Osmolality of Urine--1.5 hours post fluid fast |
| 59062-0 | Lipoprofile panel - Serum or Plasma |
| 59161-0 | Phosphate [Moles/volume] in Stool |
| 50386-2 | Parakeet+Parrot droppings IgE Ab/IgE total in Serum |
| 30015-2 | Borrelia burgdorferi 41kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
| 41048-0 | TPMT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 41163-7 | Treponema pallidum DNA [Presence] in Specimen by NAA with probe detection |
| 19292-2 | Cannabinoids cutoff [Mass/volume] in Urine for Confirmatory method |
| 19734-3 | Chicken droppings IgE Ab [Units/volume] in Serum |
| 101514-8 | Equine herpesvirus 1 non-neuropathogenic A2254 variant DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 101935-5 | Sodium urate crystals [Energy Difference] in Urine |
| 13539-2 | Phosphate [Moles/volume] in Urine |
| 102657-4 | Cultivated Wheat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13990-7 | Alpha 1 globulin/Protein.total in Urine by Electrophoresis |
| 102807-5 | Rice IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102889-3 | Clostridium tetani toxoid IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103101-2 | Aspergillus flavus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1193-2 | little k Ag [Presence] on Red Blood Cells from Blood product unit |
| 16793-2 | Drugs identified in Unknown substance by Screen method |
| 17611-5 | Stimulants [Identifier] in Serum or Plasma |
| 91137-0 | ITPA gene g.9330C>A [Type] in Serum or Plasma by Molecular genetics method |
| 75223-8 | Dengue virus IgG and IgM [Identifier] in Serum, Plasma or Blood by Rapid immunoassay |
| 60364-7 | Cheese mold type IgG Ab [Mass/volume] in Serum |
| 60428-0 | Toxoplasma gondii IgA Ab [Titer] in Serum |
| 6067-3 | Cheese cheddar type IgE Ab [Units/volume] in Serum |
| 61173-1 | Hepatitis B virus codon L80I [Presence] by Genotype method |
| 76413-4 | Sheep prion protein codon 112 [Type] in Blood by Genotype method |
| 9335-1 | Appearance of Body fluid |
| 63272-9 | Liver kidney microsomal 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 9465-6 | Benzene [Mass/volume] in Urine |
| 6396-6 | Entamoeba histolytica DNA [Presence] in Specimen by NAA with probe detection |
| 7892-3 | Giardia lamblia IgM Ab [Units/volume] in Serum |
| 9558-8 | CD20 cells [#/volume] in Blood |
| 80169-6 | Pterins panel - Serum or Plasma |
| 96283-7 | Gliadin IgE Ab [Units/volume] in Serum |
| 96521-0 | Cache valley virus IgG Ab [Presence] in Specimen by Immunoassay |
| 96713-3 | Microscopic observation [Identifier] in Body fluid by Light microscopy |
| 70037-7 | Mononuclear cells/100 leukocytes in Pericardial fluid by Automated count |
| 81797-3 | 11-Dehydrotetrahydrocorticosterone/Creatinine [Molar ratio] in Urine |
| 97644-9 | Barmah forest virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 82560-4 | Food Allergen Mix 76 (Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Presence] in Serum by Multidisk |
| 9804-6 | Weight of Stone |
| 98245-4 | Spermatozoa motility [Score] in Urine Qualitative by Light microscopy --post ejaculation |
| 85322-6 | Adjacent structure invaded by tumor [Anatomy] in Breast cancer specimen by Light microscopy |
| 85330-9 | Cells.Ki-67 nuclear Ag/100 cells in Breast cancer specimen by Immune stain |
| 85769-8 | Streptococcus pyogenes DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 99314-7 | SARS-CoV-2 (COVID-19) RdRp gene mutation detected [Identifier] in Specimen by Molecular genetics method |
| 73197-6 | predniSONE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73816-1 | Heparin induced platelet IgG Ab [Interpretation] in Serum Narrative |
| 87981-7 | Fungus identified in Burn by Culture |
| 7405-4 | Shellbark Hickory IgE Ab [Units/volume] in Serum |
| 59621-3 | chlordiazePOXIDE [Mass/mass] in Meconium by Confirmatory method |
| 59738-5 | Silver [Mass/volume] in Body fluid |
| 59739-3 | Silver [Mass/mass] in Nail |
| 30510-2 | Estriol (E3)/Creatinine [Mass Ratio] in Urine |
| 43043-9 | Echovirus 11 Ab [Titer] in Body fluid |
| 22201-8 | Chlamydia trachomatis G+F+K IgG Ab [Titer] in Serum |
| 31769-3 | Chlamydia trachomatis Ag [Presence] in Conjunctival specimen |
| 51638-5 | Erythrocyte aggregates [Presence] in Blood by Light microscopy |
| 22572-2 | Saccharomonospora viridis Ab [Presence] in Serum |
| 22666-2 | Busulfan [Moles/volume] in Serum or Plasma |
| 32318-8 | Glucose [Moles/volume] in Specimen |
| 32371-7 | West Nile virus Ag [Presence] in Tissue by Immune stain |
| 44370-5 | Hippurate/Creatinine [Mass Ratio] in 24 hour Urine |
| 44387-9 | Hypnotics [Presence] in Gastric fluid by Screen method |
| 2283-0 | Folate [Mass/volume] in Red Blood Cells |
| 32718-9 | Spermatozoa IgA Ab [Presence] in Semen |
| 32838-5 | Parvovirus B19 IgG Ab [Ratio] in Serum --1st specimen/2nd specimen |
| 33056-3 | Sezary cells [Presence] in Specimen by Light microscopy |
| 53392-7 | Proline/Phenylalanine [Molar ratio] in DBS |
| 44867-0 | Iron.microscopic observation [Presence] in Body fluid by Other stain |
| 23529-1 | Trypanosoma evansi DNA [Presence] in Specimen by NAA with probe detection |
| 23592-9 | African swine fever virus Ab [Presence] in Serum by Immune stain |
| 23688-5 | Canine coronavirus Ag [Presence] in Tissue by Immunofluorescence |
| 33769-1 | Mucin clot [Appearance] in Synovial fluid Qualitative --15 minutes post incubation |
| 46733-2 | Amino acidemias newborn screen interpretation |
| 4696-1 | HLA-A19 [Presence] |
| 24523-3 | Norepinephrine/Creatinine [Molar ratio] in Urine |
| 3431-4 | carBAMazepine [Presence] in Serum or Plasma |
| 47223-3 | Fetal Trisomy 18 risk [Likelihood] Based on maternal age |
| 55931-0 | Lactate [Moles/volume] in Dialysis fluid |
| 4778-7 | HLA-B62(15) [Presence] in Donor |
| 25697-4 | Insulin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 35547-9 | Tomato IgG Ab [Mass/volume] in Serum |
| 3579-0 | Doxepin [Mass/volume] in Serum or Plasma |
| 26868-0 | Phenolphthalein [Presence] in Stool |
| 26991-0 | Phenylpropanolamine [Mass/volume] in Milk |
| 27066-0 | Ketones [Presence] in Urine --3 hours post XXX challenge |
| 27081-9 | Itraconazole+Hydroxyitraconazole [Mass/volume] in Serum or Plasma |
| 38406-5 | PABPN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 5750-5 | Toluene [Mass/volume] in Serum or Plasma |
| 49202-5 | Bartonella quintana IgG Ab [Titer] in Body fluid |
| 49259-5 | Creatine kinase isoenzymes [Interpretation] in Serum or Plasma Narrative |
| 27368-0 | Chlamydia trachomatis B Ab [Titer] in Serum by Immunofluorescence |
| 28071-9 | E selectin [Mass/volume] in Blood |
| 58357-5 | Amphetamine/Creatinine [Mass Ratio] in Urine |
| 49708-1 | TTR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 29294-6 | Methadone [Mass/volume] in Gastric fluid |
| 58573-7 | Corticotropin [Moles/volume] in Plasma --2 hours post dose glucagon |
| 29891-9 | Helicobacter pylori [Presence] in Stomach by urea breath test |
| 59254-3 | Acylcarnitine/Acylcarnitine+Carnitine Free (C0) [Molar ratio] in Serum or Plasma |
| 50233-6 | Leukocyte clumps [#/area] in Urine sediment by Automated count |
| 5031-0 | Parvovirus B19 RNA [Presence] in Tissue by NAA with probe detection |
| 30397-4 | Hairy cells [#/volume] in Blood |
| 100426-6 | Squalene [Mass/volume] in Serum or Plasma |
| 12544-3 | Nefazodone [Mass/volume] in Serum or Plasma |
| 12752-2 | Insulin [Mass/volume] in Serum or Plasma --8 hours post XXX challenge |
| 101304-4 | Dengue virus 1+2+3+4 RNA [Presence] in Blood by NAA with non-probe detection |
| 101499-2 | Tigecycline [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 13167-2 | Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum |
| 13518-6 | Variant lymphocytes/100 leukocytes in Body fluid by Manual count |
| 13827-1 | Beryllium/Creatinine [Mass Ratio] in Urine |
| 102279-7 | European house dust mite IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14343-8 | Eosinophils/100 leukocytes in Peritoneal fluid by Manual count |
| 10417-4 | Transfuse cryoprecipitate [Volume] |
| 15154-8 | Blasts [Presence] in Blood by Automated count |
| 15377-5 | Cytomegalovirus Ab [Presence] in Serum by Latex agglutination |
| 16099-4 | Ethionamide [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 11021-3 | Microscopic observation [Identifier] in Blood or Marrow by Terminal deoxynucleotidyl transferase stain |
| 16476-4 | Borrelia burgdorferi Ab [Presence] in Body fluid by Immunoassay |
| 1659-2 | 11-Hydroxyandrosterone [Mass/volume] in Urine |
| 1663-4 | 11-Oxycorticosterone [Mass/volume] in Serum |
| 11161-7 | Wheat Bran IgE Ab [Units/volume] in Serum |
| 17484-7 | Progesterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 17750-1 | Trypsinogen [Enzymatic activity/volume] in Serum or Plasma |
| 18251-9 | Polychlorinated biphenyl (PCB) [Presence] in Tissue |
| 91048-9 | Cannabinoids [Presence] in Tissue by Screen method |
| 74960-6 | valGANciclovir [Mass/volume] in Plasma --trough |
| 61072-5 | Alpha hydroxyalprazolam [Presence] in Gastric fluid |
| 75860-7 | Hepatitis A virus RNA and Parvovirus B19 DNA panel - Plasma from Donor by NAA with probe detection |
| 61241-6 | Casein IgE Ab/IgE total in Serum |
| 61290-3 | Oregano IgE Ab/IgE total in Serum |
| 6187-9 | Neurospora sitophila IgE Ab [Units/volume] in Serum |
| 94203-7 | GSN gene full mutation analysis in Blood or Tissue by Sequencing |
| 77775-5 | Norfentanyl cutoff [Mass/volume] in Urine for Confirmatory method |
| 78773-9 | Abacavir [Mass/volume] in Serum or Plasma |
| 94606-1 | Equine herpesvirus 4 RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 79238-2 | Methylenedioxypyrovalerone cutoff [Mass/volume] in Urine for Confirmatory method |
| 66878-0 | Skin Ab [Titer] in Serum |
| 96061-7 | HLA donor match status [Type] |
| 683-3 | Genital Mycoplasma identified in Genital specimen by Organism specific culture |
| 68986-9 | Influenza virus A H5a RNA [Presence] in Specimen by NAA with probe detection |
| 80968-1 | Teicoplanin free [Mass/volume] in Serum or Plasma |
| 9665-1 | HIV 1 p24 Ag [Units/volume] in Serum |
| 972-0 | Weak D Ag [Presence] on Red Blood Cells |
| 6940-1 | Potassium [Moles/time] in unspecified time Stool |
| 6981-5 | Azithromycin [Susceptibility] by Gradient strip |
| 69826-6 | 2-Ethylhydracrylate [Moles/volume] in Serum or Plasma |
| 7003-7 | Clarithromycin [Susceptibility] by Gradient strip |
| 82069-6 | Food Allergen Mix 3 (Oat+Buckwheat+Sesame seed+Wheat+Corn) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 9757-6 | Coxsackievirus A9 Ab [Titer] in Serum by Complement fixation |
| 70270-4 | Amylase.pancreatic [Enzymatic activity/volume] in Pleural fluid |
| 708-8 | Blasts [#/volume] in Blood by Manual count |
| 98965-7 | Brexpiprazole [Mass/volume] in Urine by Confirmatory method |
| 85089-1 | Dothiepin and nordothiepin and dothiepin sulfoxide panel - Serum or Plasma |
| 99368-3 | Gliadin IgG Ab [Mass/volume] in Serum |
| 99969-8 | PLG gene full mutation analysis in Blood or Tissue by Sequencing |
| 73089-5 | Valsartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73289-1 | Meropenem induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73479-8 | Casanthranol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88711-7 | Beta-2-Microglobulin [Mass/volume] in Peritoneal dialysis fluid |
| 88988-1 | Melperone [Mass/volume] in Serum or Plasma |
| 59795-5 | Glucose [Molar concentration difference] in Serum or Plasma --3 hours post XXX challenge |
| 59980-3 | Warfarin [Moles/volume] in Gastric fluid |
| 31487-2 | Leptospira sp IgM Ab [Units/volume] in Serum |
| 51237-6 | CD13 cells/100 cells in Bone marrow |
| 51416-6 | Tiglylcarnitine (C5:1) [Moles/volume] in Serum or Plasma |
| 21693-7 | HP gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 22109-3 | Bacillus anthracis Ab [Units/volume] in Specimen |
| 22161-4 | Cache valley virus Ab [Presence] in Serum |
| 31709-9 | Adenovirus 40+41 Ag [Presence] in Stool |
| 31835-2 | Haemophilus influenzae C Ag [Presence] in Cerebral spinal fluid |
| 5158-1 | Epstein Barr virus capsid IgG Ab [Titer] in Serum by Immunofluorescence |
| 51617-9 | Color of Dialysis fluid |
| 22369-3 | Japanese encephalitis virus Ab [Presence] in Cerebral spinal fluid |
| 22382-6 | Legionella pneumophila 1 IgM Ab [Titer] in Serum |
| 22417-0 | Mumps virus IgG Ab [Titer] in Serum |
| 3205-2 | Coagulation factor VIII Ab [Units/volume] in Platelet poor plasma by Immunoassay |
| 43885-3 | Beryllium [Presence] in Specimen |
| 44038-8 | Bacteria [Presence] in Specimen |
| 44068-5 | CD20+FMC7+ cells [#/volume] in Tissue |
| 23158-9 | Leishmania sp rRNA [Identifier] in Specimen by Probe |
| 23163-9 | Leptospira interrogans sv Australis Ab [Presence] in Serum by Agglutination |
| 32586-0 | Follitropin [Units/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 53311-7 | Urate crystals [#/area] in Urine by Computer assisted method |
| 44737-5 | Asialoganglioside GM1 Ab [Units/volume] in Serum by Immunoassay |
| 2342-4 | Glucose [Mass/volume] in Cerebral spinal fluid |
| 33586-9 | CD2+CD7+ cells [#/volume] in Blood |
| 53600-3 | pH of Blood product unit |
| 44924-9 | Normetanephrine/Creatinine [Molar ratio] in 24 hour Urine |
| 45120-3 | Vesicular stomatitis Indiana virus Ag [Presence] in Specimen by Immunoassay |
| 23652-1 | Aeromonas salmonicida DNA [Presence] in Tissue by NAA with probe detection |
| 23820-4 | Aspergillus flavus Ab [Presence] in Serum by Immune diffusion (ID) |
| 23980-6 | Borrelia burgdorferi IgG Ab [Presence] in Body fluid by Immunoblot |
| 2398-6 | Glycosaminoglycans [Presence] in Urine |
| 24049-9 | Alpha galactosidase A [Enzymatic activity/mass] in Leukocytes |
| 33816-0 | Insulin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 33844-2 | Norepinephrine [Moles/volume] in Plasma --supine |
| 24408-7 | Babesia canis [Presence] in Blood by Giemsa stain |
| 4718-3 | HLA-A1 [Presence] |
| 47226-6 | Fetal lung maturity [Interpretation] in Amniotic fluid |
| 254-3 | 5-Fluorocytosine [Susceptibility] by Disk diffusion (KB) |
| 25486-2 | Nickel [Moles/volume] in Serum or Plasma |
| 35474-6 | Gene XXX targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 35509-9 | Amino acids panel [Moles/time] - 24 hour Urine |
| 26557-9 | CD11b+CD56+ cells/100 cells in Specimen |
| 48357-8 | Testosterone [Moles/volume] in Saliva (oral fluid) |
| 26946-4 | Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 57615-7 | 5-Alpha tetrahydrocortisol [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
| 48952-6 | Histoplasma capsulatum Ag [Mass/volume] in Urine |
| 27938-0 | Salmonella paratyphi B O Ab [Titer] in Serum by Agglutination |
| 27960-4 | Coxsackievirus B5 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe |
| 3868-7 | Norfluoxetine [Mass/volume] in Serum or Plasma |
| 38906-4 | MSH6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 40066-3 | Calcium [Mass/volume] in Serum or Plasma --15 minutes pre XXX challenge |
| 58458-1 | Mitochondria Ab pattern [Interpretation] in Serum by Immunofluorescence |
| 5854-5 | Herpes simplex virus Ag [Presence] in Specimen by Immunoassay |
| 58566-1 | Corticotropin [Moles/volume] in Plasma --2.5 hours post dose insulin IV |
| 4989-0 | HLA-DR9 [Presence] |
| 50146-0 | Gamma aminobutyrate [Moles/volume] in DBS |
| 40632-2 | Gamma globulin/Beta globulin [Mass Ratio] in Cerebral spinal fluid by Electrophoresis |
| 50408-4 | Protein.abnormal band/Protein.total in Urine by Electrophoresis |
| 40941-7 | Yersinia enterocolitica Ab [Presence] in Serum |
| 19216-1 | Oxygen [Partial pressure] saturation adjusted to 0.5 in Venous blood |
| 19470-4 | FLUoxetine [Presence] in Urine by Screen method |
| 20918-9 | Organophosphate pesticides [Presence] in Specimen by Screen method |
| 100897-8 | Staphylococcus aureus [Presence] in Specimen by Organism specific culture |
| 12739-9 | Insulin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 13347-0 | RNA polymerase I+II+III Ab [Presence] in Serum |
| 13379-3 | Ornithine [Mass/volume] in Cerebral spinal fluid |
| 13395-9 | Glutamate [Mass/volume] in Amniotic fluid |
| 13436-1 | DOPamine [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 102074-2 | Perfluorooctane Sulfonamide [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 13575-6 | Normaprotiline [Presence] in Serum or Plasma |
| 15011-0 | Aldosterone [Moles/volume] in Serum or Plasma --supine |
| 10592-4 | Secondary Spermatocytes [#/volume] in Semen |
| 16664-5 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --45 minutes post XXX challenge |
| 12295-2 | Hallucinogens [Identifier] in Urine |
| 16896-3 | Gastrin [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge |
| 17313-8 | Myelin associated glycoprotein IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 74484-7 | Argininosuccinate [Moles/volume] in Urine |
| 60473-6 | Lymphocytes.vacuolated [Presence] in Blood by Light microscopy |
| 61206-9 | Boxelder IgE Ab/IgE total in Serum |
| 77035-4 | t(14;18)(q32;q21)(IGH,MALT1) fusion transcript in Blood or Tissue by FISH |
| 77202-0 | Laboratory comment [Text] in Report Narrative |
| 94283-9 | Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 63141-6 | Yogurt IgG Ab [Mass/volume] in Serum |
| 63199-4 | Food Allergen Mix 46 (Cashew+Pecan or Hickory nut+Chestnut+Walnut+Pistachio) IgE Ab [Units/volume] in Serum by Multidisk |
| 77948-8 | FLAER cells/100 cells in Specimen |
| 94624-4 | Tritrichomonas foetus DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 6361-0 | Clostridioides difficile toxin A+B [Units/volume] in Serum by Immunoassay |
| 7909-5 | Herpes simplex virus 1 IgG Ab [Units/volume] in Serum |
| 95175-6 | Avian encephalomyelitis virus Ab [Titer] in Serum by Immunoassay |
| 95235-8 | Hepatitis B virus Ab [Interpretation] in Serum or Plasma |
| 6724-9 | Cucumber IgE Ab [Units/volume] in Serum |
| 95723-3 | Glycine receptor Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 68453-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid by Lactate to pyruvate reaction |
| 68944-8 | Listeria monocytogenes IgG Ab [Titer] in Serum by Agglutination |
| 96911-3 | Delta aminolevulinate and porphobilinogen panel - Serum or Plasma |
| 9716-2 | Streptococcal hyaluronidase Ab [Titer] in Serum |
| 97231-5 | clonazePAM [Presence] in Cord tissue by Confirmatory method |
| 97608-4 | Joint pathogens panel - Synovial fluid by NAA with non-probe detection |
| 70170-6 | Nucleated erythrocytes/100 cells in Pleural fluid |
| 7017-7 | Gentamicin.high potency [Susceptibility] by Disk diffusion (KB) |
| 7024-3 | Kanamycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 82482-1 | TRBV27 gene segment/TRBV gene segments.total in Blood |
| 82552-1 | Food Allergen Mix 32 (Carob+Lentil+White bean+Pea) IgE Ab [Units/volume] in Serum by Multidisk |
| 99764-3 | Interferon gamma [Mass/volume] in Cerebral spinal fluid |
| 99768-4 | Interleukin 2 Receptor Soluble [Mass/volume] in Cerebral spinal fluid |
| 99906-0 | Urate crystals amorphous [#/area] in Urine sediment by Computer assisted method |
| 72621-6 | Propoxyphene [Mass/volume] in Saliva (oral fluid) |
| 72782-6 | JWH-018 pentanoate (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
| 86171-6 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum --1st specimen |
| 73010-1 | Ibuprofen induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73077-0 | Neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73294-1 | LORazepam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73633-0 | Sarafloxacin [Susceptibility] by Disk diffusion (KB) |
| 88201-9 | Herpes simplex virus 1 Ag [Presence] in Tissue by Immunofluorescence |
| 73971-4 | Methylenedioxymethamphetamine(MDMA)+Methylenedioxyethylamphetamine (MDEA)+Methylenedioxyamphetamine(MDA) [Interpretation] in Urine Qualitative |
| 89354-5 | CD19+21- cells [#/volume] in Blood |
| 50710-3 | Influenza virus susceptibility panel |
| 50739-2 | Serotonin release.heparin.porcine and low molecular weight panel - Serum |
| 4252-3 | Fenfluramine [Mass] of Dose |
| 2140-2 | Corticotropin [Mass/volume] in Amniotic fluid |
| 31555-6 | Parainfluenza virus Ab [Units/volume] in Serum |
| 51074-3 | CD135 blasts [Units/volume] in Specimen |
| 51212-9 | Vanadium [Mass/volume] in Body fluid |
| 51287-1 | CD30 cells/100 cells in Tissue |
| 51517-1 | Lactate dehydrogenase 4/Lactate dehydrogenase.total in Peritoneal fluid by Electrophoresis |
| 43419-1 | Tuberculosis reaction wheal [Diameter] --3 days post 1 TU intradermal |
| 22504-5 | Measles virus IgG Ab [Units/volume] in Serum --2nd specimen |
| 23153-0 | Leishmania sp Ab [Presence] in Serum by Immunoassay |
| 53094-9 | Glucose [Moles/volume] in Serum or Plasma --post meal |
| 53355-4 | Trichomonas sp [#/volume] in Urine by Computer assisted method |
| 53391-9 | Trichothecene IgM Ab [Units/volume] in Serum |
| 44850-6 | Bacteria # 8 identified in Specimen by Culture |
| 23790-9 | Vesicular stomatitis New Jersey virus Ab [Titer] in Serum by Complement fixation |
| 23851-9 | Cyclohexanone [Mass/volume] in Serum or Plasma |
| 33737-8 | Distance of tumor from closest margin |
| 54286-0 | Glycolate [Moles/volume] in Cerebral spinal fluid |
| 54367-8 | Calcium.ionized [Moles/volume] in Cord blood |
| 54929-5 | Tissue transglutaminase Ab [Titer] in Serum by Immunofluorescence |
| 55139-0 | SCN5A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55298-4 | Human papilloma virus 6+11+42+43+44 DNA [Presence] in Urethra by Probe with signal amplification |
| 47063-3 | Treponema pallidum IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 4710-0 | HLA-A69(28) [Presence] |
| 25133-0 | Sarcosine/Creatinine [Molar ratio] in Urine |
| 25446-6 | IgM [Presence] in Urine by Immunoelectrophoresis |
| 47599-6 | Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Cord blood |
| 25717-0 | Lutropin [Units/volume] in Serum or Plasma --1.5 hours post 100 ug luteinizing releasing hormone IV |
| 2595-7 | Magnesium [Moles/volume] in Dialysis fluid |
| 35661-8 | JC virus DNA [Presence] in Urine by NAA with probe detection |
| 56379-1 | Rice IgG4 Ab [Mass/volume] in Serum |
| 56426-0 | White Oak IgG4 Ab [Mass/volume] in Serum |
| 48263-8 | Cocksfoot triggered leukotriene release [Mass/volume] by Leukocytes |
| 26725-2 | Alpha aminoadipate [Moles/volume] in Urine |
| 48813-0 | Methicillin resistance mecA gene [Presence] by Molecular method |
| 38366-1 | Hypoxanthine/Creatinine [Molar ratio] in Urine |
| 48989-8 | Glucose [Mass/volume] in Serum or Plasma --6 PM specimen |
| 4926-2 | HLA-DPw4 [Presence] in Donor |
| 28059-4 | 7-Aminoclonazepam [Mass/volume] in Serum or Plasma |
| 3929-7 | Phenacetin [Mass/volume] in Serum or Plasma |
| 39610-1 | Neisseria meningitidis serogroup w135 Ab [Mass/volume] in Serum |
| 49472-4 | Mammaglobin Ag [Presence] in Tissue by Immune stain |
| 4045-1 | Tetracycline [Mass/volume] in Serum or Plasma |
| 40691-8 | Volume of Semen--post washing |
| 50237-7 | Trichomonas sp [Presence] in Urine by Computer assisted method |
| 30369-3 | Fractional oxyhemoglobin in Venous cord blood |
| 19525-5 | Lormetazepam [Presence] in Urine by Confirmatory method |
| 20713-4 | Bovine diarrhea virus Ag [Presence] in Blood by Immunofluorescence |
| 20848-8 | Bovine herpesvirus 2 Ag [Presence] in Tissue by Immunofluorescence |
| 21022-9 | Microscopic observation [Identifier] in Dialysis fluid by Gram stain |
| 100104-9 | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot |
| 1010-8 | E sup(w) Ab [Presence] in Serum or Plasma from Blood product unit |
| 12716-7 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 12837-1 | Prostaglandin E1 [Mass/volume] in 24 hour Urine |
| 13214-2 | Brucella canis IgG Ab [Units/volume] in Cerebral spinal fluid |
| 101727-6 | JC virus DNA [log units/volume] (viral load) in Urine by NAA with probe detection |
| 13820-6 | Urate/Creatinine [Mass Ratio] in 24 hour Urine |
| 13830-5 | Phenylglyoxylate/Creatinine [Mass Ratio] in Urine |
| 14046-7 | D-Lactate [Moles/volume] in Urine |
| 102867-9 | Silver Birch IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102905-7 | Stachybotrys chartarum IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14465-9 | Chlamydia trachomatis [Presence] in Urethra by Organism specific culture |
| 103633-4 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis [Presence] in Genital fluid by NAA with probe detection |
| 104389-2 | Ebola virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen |
| 10492-7 | IgG.heavy chain Ag [Presence] in Tissue by Immune stain |
| 11003-1 | Ticlopidine [Mass/volume] in Serum or Plasma |
| 16478-0 | Borrelia burgdorferi IgA Ab [Presence] in Serum by Immunoassay |
| 1114-8 | Le sup(a) Ag [Presence] on Red Blood Cells from Donor |
| 17491-2 | Proinsulin [Mass/volume] in Serum or Plasma --baseline |
| 17698-2 | Tetraethyl lead [Mass/volume] in Blood |
| 18345-9 | Protein S Ag/Coagulation factor VII Ag [Mass Ratio] in Platelet poor plasma by Coagulation assay |
| 18353-3 | Glucose [Mass/volume] in Serum or Plasma --6 hours post 50 g lactose PO |
| 90282-5 | Microscopic observation [Identifier] in Catheter tip by Gram stain |
| 903-5 | Blood group antibody screen [Presence] in Serum or Plasma by RESt absorption |
| 90911-9 | Eicosapentaenoate (C20:5w3)+Docosapentaenate (C22:5w3)+Docosahexaenoate (C22:6w3)/Fatty acids.C14-C22 in Blood |
| 74521-6 | Complement total hemolytic CH50 actual/normal in Serum by Immunoassay |
| 92145-2 | Legionella pneumophila DNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 92753-3 | Globotriaosylsphingosine [Moles/volume] in Blood |
| 92793-9 | Candida famata DNA [Presence] by NAA with probe detection in Positive blood culture |
| 75049-7 | Thiosulfate [Moles/volume] in Urine |
| 9309-6 | Ammonia [Mass/time] in 24 hour Urine |
| 61279-6 | English Walnut IgE Ab/IgE total in Serum |
| 61390-1 | Human papilloma virus 70 DNA [Presence] in Specimen by NAA with probe detection |
| 7763-6 | Black Walnut IgE Ab [Units/volume] in Serum |
| 77668-2 | Calcitonin [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge |
| 9396-3 | SUFentanil [Mass/volume] in Urine |
| 63233-1 | DNA double strand IgM Ab [Units/volume] in Body fluid by Immunoassay |
| 94698-8 | Epilepsy autoimmune Ab panel - Serum or Plasma |
| 94760-6 | SARS-CoV-2 (COVID-19) N gene [Presence] in Nasopharynx by NAA with probe detection |
| 79240-8 | Tapentadol cutoff [Mass/volume] in Urine for Screen method |
| 79384-4 | Vibrio cholerae+parahaemolyticus rfbL+trkH+tnaA genes [Presence] in Stool by NAA with probe detection |
| 952-2 | C little e Ag [Presence] on Red Blood Cells from Blood product unit |
| 79622-7 | R-beta aminoisobutyrate/Creatinine [Molar ratio] in Urine |
| 7969-9 | Mycoplasma pneumoniae Ab [Units/volume] in Serum |
| 80115-9 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Blood by Confirmatory method |
| 80220-7 | NMDAR IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 96372-8 | Imipenem+Relebactam [Susceptibility] |
| 67838-3 | Mephedrone [Presence] in Urine by Confirmatory method |
| 68962-0 | Phenylbutazone [Moles/volume] in Specimen |
| 97754-6 | Oxalate [Moles/volume] in Body fluid |
| 82730-3 | GlycA [Moles/volume] in Serum or Plasma |
| 71707-4 | Marburg virus IgG Ab [Titer] in Serum by Immunoassay |
| 844-1 | A1 Ag [Presence] on Red Blood Cells |
| 84908-3 | Cancer pathology panel - Prostate cancer |
| 85534-6 | Influenza virus A avian origin nucleoprotein Ab/Negative control in Serum by Immunoassay |
| 72596-0 | Albumin/Protein.total [Pure mass fraction] in 24 hour Urine by Electrophoresis |
| 72626-5 | Methadone [Presence] in Saliva (oral fluid) by Screen method |
| 72679-4 | Bile acid [Moles/time] in 24 hour Stool |
| 86605-3 | Alpha hydroxytriazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 73930-0 | RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
| 4140-0 | Benzoylecgonine [Mass] of Dose |
| 59872-2 | Bromazepam [Moles/volume] in Urine |
| 50681-6 | Thyroxine binding protein pattern [Interpretation] in Serum or Plasma by Electrophoresis |
| 42575-1 | Amoxicillin IgE Ab/IgE total in Serum |
| 42623-9 | Coxsackievirus A3 Ab [Titer] in Serum |
| 21310-8 | Glucose [Mass/volume] in Serum or Plasma --75 minutes post XXX challenge |
| 31567-1 | Polio virus 2 Ab [Units/volume] in Body fluid |
| 22263-8 | Ebola virus Ab [Titer] in Serum |
| 51492-7 | Cortisol [Mass/volume] in Saliva (oral fluid) --3rd specimen post XXX challenge |
| 22375-0 | La Crosse virus IgM Ab [Titer] in Cerebral spinal fluid |
| 22457-6 | Pseudorabies virus Tolvid gene deletion Ab [Presence] in Serum |
| 51978-5 | Coxsackievirus A Ab [Titer] in Serum |
| 5279-5 | Plasmodium sp Ab [Units/volume] in Serum |
| 52795-2 | Ova and parasites identified in Specimen by Light microscopy--2nd specimen |
| 43896-0 | Bordetella pertussis [Presence] in Pleural fluid by Organism specific culture |
| 53443-8 | Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Control Leukocytes |
| 45284-7 | DPYD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 24048-1 | Alpha galactosidase A [Enzymatic activity/mass] in Fibroblast |
| 3415-7 | Buprenorphine [Mass/volume] in Urine |
| 34260-0 | Catecholamines [Moles/volume] in 24 hour Urine |
| 46087-3 | Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --2nd tube |
| 46222-6 | Glucose [Moles/volume] in Dialysis fluid --4 hour specimen |
| 24142-2 | Red mulberry IgG Ab [Units/volume] in Serum |
| 24163-8 | Food Allergen Mix fx73 (Beef+Chicken+Pork) IgE Ab [Presence] in Serum by Multidisk |
| 34393-9 | Food Allergen Mix 28 (Kiwi+Beef+Shrimp+Sesame seed) IgE Ab [Presence] in Serum by Multidisk |
| 34585-0 | Inner ear 68kD Ab [Presence] in Serum or Plasma |
| 47459-3 | Legionella pneumophila 10 IgG Ab [Titer] in Serum |
| 34918-3 | Sezary cells [#/volume] in Blood |
| 34946-4 | Herpes virus 6 IgG and IgM panel - Cerebral spinal fluid |
| 47784-4 | Threonine [Moles/volume] in DBS |
| 35652-7 | Epithelial cells/100 cells in Body fluid |
| 56516-8 | C peptide [Mass/volume] in Serum or Plasma --6 minutes post XXX challenge |
| 48339-6 | Sporothrix schenckii Ag [Presence] in Tissue by Immune stain |
| 38171-5 | CD3-CD19+ cells/100 cells in Specimen |
| 57018-4 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose lactulose |
| 26914-2 | Estazolam [Mass/mass] in Meconium |
| 27116-3 | Methamphetamine [Mass/volume] in Milk |
| 49138-1 | California encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 49544-0 | Newborn screening recommended follow-up [Interpretation] |
| 49620-8 | lamiVUDine or Emtricitabine [Susceptibility] by Genotype method |
| 58653-7 | Cortisol [Moles/volume] in Saliva (oral fluid) --1 hour post 1 ug/kg CRH IV |
| 49885-7 | Lymphocyte proliferation.beryllium stimulation panel - Blood |
| 29602-0 | Chlorphentermine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 50406-8 | Cannabinoids [Presence] in Meconium by Confirmatory method |
| 30363-6 | Insulin [Units/volume] in Serum or Plasma --12 hours fasting |
| 100694-9 | SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method |
| 100901-8 | Enterobacteriaceae.carbapenemase resistance phenotype [Identifier] in Anal by Organism specific culture |
| 12656-5 | Glucose [Mass/volume] in Serum or Plasma --4 minutes post XXX challenge |
| 101626-0 | Thyroglobulin heterophile Ab interference panel - Serum |
| 101742-5 | Mitochondria M2-3E Ab [Presence] in Serum |
| 14177-0 | Growth hormone-releasing hormone [Mass/volume] in Serum or Plasma |
| 102929-7 | Casein IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103614-4 | Gefitinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose |
| 14887-4 | Primidone [Moles/volume] in Serum or Plasma |
| 16283-4 | Escherichia coli verotoxin [Presence] in Specimen |
| 1159-3 | little c Ag [Presence] on Red Blood Cells |
| 1705-3 | Acetoacetate [Mass/volume] in Serum or Plasma |
| 17485-4 | Progesterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 17560-4 | Salicylates [Presence] in Gastric fluid |
| 17658-6 | Strontium/Creatinine [Mass Ratio] in Urine |
| 1821-8 | Alpha naphthylesterase [Enzymatic activity/volume] in Serum |
| 19144-5 | Reason for drug test [Interpretation] |
| 91053-9 | oxyCODONE+oxyMORphone [Presence] in Tissue by Screen method |
| 91080-2 | Zika virus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 91551-2 | Other cells/100 leukocytes in Dialysis fluid by Manual count |
| 6093-9 | Oat pollen IgE Ab [Units/volume] in Serum |
| 61174-9 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --20 minutes pre XXX challenge |
| 76403-5 | Blasts [#] in Body fluid by Manual count |
| 61411-5 | Desipramine/Creatinine [Mass Ratio] in Urine |
| 61418-0 | Imipramine [Presence] in Urine by Confirmatory method |
| 77120-4 | RPGR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77363-0 | N-tau methylimidazoleacetate/Creatinine [Molar ratio] in Urine |
| 6273-7 | Walnut IgE Ab [Units/volume] in Serum |
| 78228-4 | IGH gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 94480-1 | Human coronavirus HKU1 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 64432-8 | KIR3DP1 gene deletion variant [Presence] in Blood or Tissue by Molecular genetics method |
| 64960-8 | Celery recombinant (rApi g) 1 IgE Ab [Units/volume] in Serum |
| 79237-4 | Mephedrone cutoff [Mass/volume] in Urine for Confirmatory method |
| 7930-1 | Influenza virus A+B Ab [Units/volume] in Serum |
| 95207-7 | Hepatitis E virus RNA panel - Serum or Plasma |
| 9537-2 | Intrinsic factor blocking Ab [Presence] in Serum by Radioimmunoassay (RIA) |
| 66446-6 | Carrot recombinant (rDau c) 1 IgE Ab [Units/volume] in Serum |
| 66755-0 | Maximum clot firmness [Length] in Blood by Thromboelastography --after addition of heparinase |
| 79619-3 | S-beta aminoisobutyrate/Creatinine [Molar ratio] in Urine |
| 80174-6 | S-adenosylhomocysteine [Moles/volume] in Cerebral spinal fluid |
| 68937-2 | Acetylcholine receptor Ab [Moles/volume] in Serum by Immunoassay |
| 69545-2 | DNA region of interest start [Identifier] |
| 70044-3 | Polymorphonuclear cells [#/volume] in Pleural fluid by Automated count |
| 81695-9 | Microsatellite instability [Interpretation] in Cancer specimen Qualitative |
| 8178-6 | Cannabinoids [Presence] in Unknown substance by Confirmatory method |
| 97527-6 | Acanthamoeba sp Ag [Presence] in Specimen by Immunofluorescence |
| 71359-4 | Y chromosome AZFa region deletion [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
| 72400-5 | Methadone [Presence] in Blood by Screen method |
| 85761-5 | Klebsiella pneumoniae DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 72673-7 | Theophylline [Mass/volume] in Serum or Plasma --trough |
| 86560-0 | Human papilloma virus 16 DNA [Presence] in Tissue by NAA with probe detection |
| 73309-7 | Levodopa induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86928-9 | Porcine epidemic diarrhea virus whole genome [Nucleotide sequence] in Isolate by Sequencing |
| 73507-6 | Benazepril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73677-7 | Valproate [Mass/volume] in Serum or Plasma --peak |
| 88183-9 | Mycobacterium sp identified in Isolate by Sequencing |
| 88448-6 | Necroinflammatory activity interpretation in Serum Qualitative |
| 41634-7 | Clostridium botulinum toxin E [Presence] in Specimen by Immunofluorescence |
| 41718-8 | Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 59675-9 | Flurazepam [Mass/volume] in Blood by Confirmatory method |
| 59822-7 | Tacrolimus [Mass/volume] in Serum or Plasma --4 hours post dose |
| 50619-6 | Karyotype [Identifier] in Blood or Tissue Narrative |
| 41862-4 | Viscosity of Semen--20 minutes post collection |
| 42597-5 | Corticotropin [Mass/volume] in Plasma --1.5 hours post XXX challenge |
| 2109-7 | Choriogonadotropin.alpha subunit [Moles/volume] in Serum or Plasma |
| 21322-3 | Hantavirus puumala IgG Ab [Titer] in Serum by Immunofluorescence |
| 31288-4 | Canine parvovirus IgG Ab [Units/volume] in Serum |
| 21719-0 | NRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21778-6 | t(11;19)(q23;p13.3)(MLL,MLLT1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 51769-8 | Glucose [Mass/volume] in Serum or Plasma --2 hours post dose fructose PO |
| 51988-4 | Ureaplasma urealyticum DNA [Presence] in Specimen by NAA with probe detection |
| 52913-1 | Selenium [Moles/volume] in Red Blood Cells |
| 44871-2 | HIV 1 proviral DNA [Presence] in Blood by NAA with probe detection |
| 23264-5 | Mycoplasma capricolum ss capripneumonia Ab [Presence] in Blood by Agglutination |
| 23349-4 | Pasteurella multocida toxin [Presence] in Specimen by Immunoassay |
| 23562-2 | Vesicular stomatitis Indiana virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 33711-3 | Clostridium botulinum toxin F [Presence] in Specimen |
| 53752-2 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.75 hours post XXX challenge |
| 53877-7 | NAGS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 33732-9 | Histology grade [Identifier] in Cancer specimen |
| 34148-7 | Borrelia burgdorferi IgG+IgM Ab [Units/volume] in Serum |
| 5409-8 | Yersinia enterocolitica O:9 Ab [Units/volume] in Serum |
| 54444-5 | Echovirus 8 Ab [Titer] in Serum |
| 46261-4 | HYDROcodone Free [Presence] in Serum or Plasma |
| 46996-5 | HLA Ab positive cells [#] in Serum |
| 24236-2 | Mycoplasma pneumoniae Ab [Titer] in Serum by Complement fixation --1st specimen |
| 55595-3 | Finch feather IgE Ab [Presence] in Serum |
| 3519-6 | cycloSERINE [Mass/volume] in Serum or Plasma |
| 55908-8 | Alpha galactosidase A [Enzymatic activity/volume] in DBS |
| 55930-2 | Isovalerylglycine [Moles/volume] in Plasma |
| 5599-6 | Boldenone [Presence] in Urine |
| 47526-9 | Cytology report of Specimen Cyto stain |
| 47652-3 | Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Placenta |
| 25954-9 | Magnesium [Moles/volume] in 24 hour Urine |
| 35442-3 | HIV 1 p66 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
| 35582-6 | Hydrazine [Mass/volume] in Blood |
| 35594-1 | Creatinine renal clearance/1.73 sq M in 2 hour Urine and Serum or Plasma |
| 48148-1 | Osmolality of Urine by calculation |
| 2607-0 | Melanin [Mass/volume] in Urine |
| 26788-0 | Carnitine [Units/mass] in Tissue |
| 3587-3 | Dyphylline [Mass/volume] in Serum or Plasma |
| 56613-3 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 56621-6 | Coxsackievirus A9 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 56680-2 | Glutamine/Creatinine [Ratio] in 24 hour Urine |
| 48612-6 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --45 minutes post dose lactose PO |
| 26981-1 | Phenylalanine [Moles/volume] in Amniotic fluid |
| 38247-3 | Brucella sp IgG Ab [Titer] in Serum |
| 38402-4 | Parasite identified in Tissue |
| 57105-9 | Lutropin [Units/volume] in Serum or Plasma --30 minutes post dose gonadotropin releasing hormone |
| 27944-8 | C peptide [Mass/time] in 24 hour Urine |
| 39571-5 | Herpes simplex virus 1+2 IgM Ab [Titer] in Cerebral spinal fluid |
| 57731-2 | Osmolality of Urine--2nd specimen |
| 57787-4 | Dehydroepiandrosterone (DHEA) [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
| 5806-5 | Pyrophosphate crystals [Presence] in Urine sediment by Light microscopy |
| 58090-2 | Glucose-6-Phosphate dehydrogenase newborn screening comment-discussion |
| 40086-1 | Calcium [Mass/volume] in Serum or Plasma --3 days post XXX challenge |
| 49778-4 | Immune complex [Mass/volume] in Serum or Plasma |
| 29776-2 | Microscopic observation [Identifier] in Blood by Brilliant cresyl blue |
| 29906-5 | Haemophilus influenzae A DNA [Presence] in Specimen by NAA with probe detection |
| 40379-0 | Maprotiline [Presence] in Gastric fluid |
| 40408-7 | Uroporphyrin 3 isomer [Moles/time] in 24 hour Urine |
| 58892-1 | Calcitonin [Mass/volume] in Serum or Plasma --baseline |
| 58986-1 | Shrimp tropomyosin recombinant (rPen a) 1 IgE Ab [Units/volume] in Serum |
| 40862-5 | Methylparaben IgE Ab [Units/volume] in Serum |
| 19170-0 | Carcinoembryonic Ag [Moles/volume] in Pleural fluid |
| 19315-1 | Tricyclic antidepressants [Presence] in Urine by Confirmatory method |
| 20703-5 | Border disease virus Ag [Presence] in Tissue by Immunofluorescence |
| 12343-0 | Thiazides [Identifier] in Urine |
| 100388-8 | Cocoa IgG Ab [Units/volume] in Serum |
| 12723-3 | Insulin-like growth factor binding protein 2 [Mass/volume] in Serum or Plasma |
| 101566-8 | Human coronavirus RNA in Specimen Document |
| 13351-2 | Leukocytes other [#/volume] in Cerebral spinal fluid by Manual count |
| 101990-0 | Xanthurenate [Mass Ratio] in Urine |
| 102533-7 | Plaice IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102906-5 | Trichophyton mentagrophytes var interdigitale IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102981-8 | Honey bee IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103594-8 | Acetyl norfentanyl [Mass/volume] in Cord tissue by Confirmatory method |
| 10629-4 | Spermatozoa Vacuolated Head/100 spermatozoa in Semen |
| 1069-4 | Jk sup(a) Ab [Presence] in Serum or Plasma |
| 15242-1 | Food Allergen Mix 11 (Broccoli+Carrot+White bean+Peas+Corn) IgE Ab [Presence] in Serum by Multidisk |
| 15349-4 | Alkaline phosphatase.liver 2/Alkaline phosphatase.total in Serum or Plasma |
| 10703-7 | Ova and parasites identified in Stool by Kinyoun iron hematoxylin stain |
| 10904-1 | La Crosse virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 10984-3 | Dicloxacillin [Mass/volume] in Serum or Plasma |
| 16379-0 | Androstenedione [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 16425-1 | Babesia sp IgM Ab [Units/volume] in Serum by Immunofluorescence |
| 16690-0 | Creatinine [Mass/time] in 72 hour Urine |
| 17030-8 | Isopropyl ether [Presence] in Blood |
| 1715-2 | Acid phosphatase [Enzymatic activity/volume] in Serum or Plasma |
| 17588-5 | Sjogrens syndrome-B extractable nuclear IgG Ab [Presence] in Serum by Immunoassay |
| 18229-5 | Heparan sulfate [Presence] in Serum or Plasma |
| 18886-2 | Cefotaxime [Susceptibility] |
| 18908-4 | Clindamycin [Susceptibility] |
| 90331-0 | PRRSV IgA+IgM/Positive control in Specimen by Immunoassay |
| 92498-5 | Js sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 60455-3 | Bizarre platelets [Presence] in Blood by Light microscopy |
| 61122-8 | CD8-CD57+ cells [#/volume] in Blood |
| 61192-1 | Color of Pleural fluid from Fetus |
| 7608-3 | Loblolly Pine IgE Ab [Units/volume] in Serum |
| 76605-5 | Staphylococcus aureus sau3AI gene [#/volume] in XXX.body fluid by NAA with probe detection |
| 92825-9 | Renin [Units/volume] in Plasma --upright |
| 77577-5 | Chlamydia trachomatis and Neisseria gonorrhoeae DNA panel - Urethra by NAA with probe detection |
| 93838-1 | Histoplasma capsulatum IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 94105-4 | Alpha hydroxytriazolam [Presence] in Urine by Screen method |
| 94233-4 | FECH gene full mutation analysis in Blood or Tissue by Sequencing |
| 63543-3 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Body fluid |
| 95100-4 | Glucagon [Mass/volume] in Serum or Plasma --4 hours post meal |
| 68395-3 | Basophils [#/volume] in Synovial fluid by Manual count |
| 68915-8 | Spermatozoa Progressive/100 spermatozoa in Semen --post concentration |
| 9715-4 | Shigella sonnei Ab [Titer] in Serum by Complement fixation |
| 81648-8 | Clostridium botulinum toxin G botG gene [Presence] in Specimen by NAA with probe detection |
| 97267-9 | Methylenedioxymethamphetamine [Presence] in Cord tissue by Confirmatory method |
| 7068-0 | Algae IgE Ab [Units/volume] in Serum |
| 71365-1 | Alkaline phosphatase.intestinal 2 [Enzymatic activity/volume] in Serum or Plasma |
| 82612-3 | Grass Allergen Mix 7 (Bermuda grass+Meadow fescue+Rye grass+Timothy grass+Cultivated rye) IgE Ab [Units/volume] in Serum by Multidisk |
| 98410-4 | Cryptococcus molecular type in Isolate by Sequencing |
| 99086-1 | p40 Ag [Presence] in Tissue by Immune stain |
| 83074-5 | Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid by Immunoassay |
| 85503-1 | Carbapenem resistance blaOXA-48 gene [Presence] by Molecular method |
| 72738-8 | Temazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 86061-9 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum by Immunoassay |
| 73423-6 | diazePAM induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73836-9 | Bacteria.fluoroquinolone resistant identified in Anal by Organism specific culture |
| 88458-5 | Mumps virus Ab.IgG and IgM panel - Cerebral spinal fluid by Immunofluorescence |
| 74279-1 | Gamma interferon negative control spot count [#] in Blood |
| 41239-5 | Yellow fever virus Ab [Presence] in Cerebral spinal fluid |
| 4147-5 | Buprenorphine [Mass] of Dose |
| 41702-2 | Mezlocillin [Susceptibility] by Gradient strip |
| 5070-8 | Brucella sp IgM Ab [Units/volume] in Serum |
| 30476-6 | Glyoxylate [Presence] in Urine |
| 30536-7 | Magnesium [Mass/volume] in Total parental nutrition |
| 60080-9 | Germanium [Mass/volume] in Red Blood Cells |
| 3157-5 | Volume of Blood |
| 5112-8 | Coxsackievirus B5 Ab [Titer] in Serum by Complement fixation |
| 51245-9 | CD13+CD33+HLA-DR+ cells/100 cells in Blood |
| 51247-5 | CD14 cells/100 cells in Cerebral spinal fluid |
| 51269-9 | CD23 cells/100 cells in Body fluid |
| 51451-3 | Bartonella quintana IgG Ab [Units/volume] in Serum or Plasma |
| 22292-7 | Epstein Barr virus capsid IgM Ab [Titer] in Cerebral spinal fluid |
| 32016-8 | Glucose [Mass/volume] in Capillary blood |
| 51760-7 | Ehrlichia chaffeensis IgG+IgM Ab [Presence] in Serum or Plasma |
| 2249-1 | Estriol (E3).unconjugated [Mass/volume] in Amniotic fluid |
| 32535-7 | CD3+CD8+ (T8 suppressor) cells/100 cells in Bone marrow |
| 32557-1 | Candida albicans reaction wheal [Diameter] --1 day post 50 ug Candida albicans intradermal |
| 52782-0 | Maximum clot firmness.intrinsic coagulation system activated.heparin insensitive [Length] in Blood by Rotational TEG |
| 52995-8 | Cytoplasmic CD79a cells/100 cells in Tissue |
| 44086-7 | ABO and Rh group [Interpretation] in Blood from Newborn |
| 44353-1 | Porphyrins/Creatinine [Mass Ratio] in 24 hour Urine |
| 22940-1 | Brucella ovis Ab [Presence] in Serum by Immune diffusion (ID) |
| 33041-5 | Hypnotics [Presence] in Urine by Screen method |
| 33042-3 | Immunofixation for 24 hour Urine |
| 53437-0 | Carnitine palmitoyltransferase 1 [Enzymatic activity/mass] in Fibroblast |
| 45298-7 | Glucose [Moles/volume] in Serum or Plasma --2.5 hours post 50 g lactose PO |
| 23751-1 | Metaldehyde [Mass/volume] in Specimen |
| 33810-3 | Insulin [Units/volume] in Serum or Plasma --11th specimen post XXX challenge |
| 34602-3 | E Ab [Titer] in Serum or Plasma |
| 55374-3 | Hemoglobin N+I/Hemoglobin.total in Blood |
| 47471-8 | Legionella pneumophila 8 IgG Ab [Titer] in Serum |
| 25524-0 | Serotonin [Moles/volume] in Blood |
| 35003-3 | Polymorphonuclear cells [#/volume] in Blood |
| 35124-7 | Dysferlin [Presence] in Leukocytes |
| 55964-1 | Palmitoleylcarnitine (C16:1) [Moles/volume] in Cerebral spinal fluid |
| 47867-7 | Phosphoribosylpyrophosphate synthetase [Enzymatic activity/mass] in Fibroblast |
| 25809-5 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 25872-3 | C peptide [Moles/volume] in 24 hour Urine |
| 26628-8 | Legionella polyvalent B Ab [Presence] in Serum |
| 56599-4 | Epstein Barr virus capsid IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 56642-2 | Serine/Creatinine [Ratio] in 24 hour Urine |
| 56788-3 | Insulin [Units/volume] in Serum or Plasma --28 hours post XXX challenge |
| 57086-1 | Congenital adrenal hyperplasia newborn screening panel |
| 4837-1 | HLA-B49(21) [Presence] |
| 49120-9 | Immunodeficiency follow-up panel - Specimen by Flow cytometry (FC) |
| 57902-9 | Bg sup(a) Ab [Presence] in Serum or Plasma |
| 57944-1 | Cobalt [Mass/volume] in Cerebral spinal fluid |
| 49416-1 | JC virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
| 29314-2 | Adenovirus Ab [Titer] in Body fluid by Complement fixation |
| 29515-4 | 3-Hydroxypropionate (3-OH-C3)/Creatinine [Molar ratio] in Urine |
| 40028-3 | Glucose [Mass/volume] in Serum or Plasma --12 minutes post XXX challenge |
| 58383-1 | Norfentanyl [Mass/volume] in Urine by Confirmatory method |
| 5871-9 | Parainfluenza virus 2 Ag [Presence] in Specimen by Immunofluorescence |
| 50063-7 | Urea renal clearance/1.73 sq M in Urine and Serum or Plasma collected for unspecified duration |
| 50138-7 | 3-Methoxy-4-Hydroxyphenylglycol/Creatinine [Molar ratio] in Urine |
| 29580-8 | Differential panel - Body fluid |
| 29717-6 | Orientia tsutsugamushi Kato Ab [Titer] in Serum by Immunofluorescence |
| 29889-3 | Encephalomyocarditis virus Ab [Titer] in Serum |
| 40881-5 | CD3-CD57+ cells/100 cells in Bone marrow |
| 41064-7 | PYGM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19546-1 | Mesoridazine [Presence] in Urine by Screen method |
| 19617-0 | N-desalkylflurazepam [Mass/volume] in Urine |
| 101489-3 | Meropenem+Vaborbactam [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 12937-9 | Thyrotropin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 13243-1 | Sporothrix schenckii IgA Ab [Units/volume] in Serum |
| 14499-8 | Human papilloma virus Ag [Presence] in Cervix |
| 14942-7 | Uroporphyrin 1 isomer [Moles/volume] in Urine |
| 104372-8 | Corynebacterium pseudotuberculosis [Presence] in Upper respiratory specimen by Organism specific culture |
| 104474-2 | Yersinia pseudotuberculosis 3 Ab [Presence] in Stool |
| 16513-4 | Calcium.ionized [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 16633-0 | Cocaine [Presence] in Blood |
| 12191-3 | Creatinine [Mass/volume] in Peritoneal fluid |
| 17159-5 | CD45RO cells/100 cells in Blood |
| 17279-1 | Bacteria identified in Pleural fluid by Aerobe culture |
| 17777-4 | Yersinia sp IgM Ab [Units/volume] in Serum |
| 17909-3 | Bacteria identified in Wound deep by Aerobe culture |
| 18260-0 | Zinc [Presence] in Tissue |
| 90044-9 | Epithelial cells.renal [Presence] in Urine sediment |
| 90324-5 | Mycoplasma hyopneumoniae DNA [Presence] in Specimen by NAA with probe detection |
| 74527-3 | Delta aminolevulinate, porphobilinogen and creatinine panel - Urine |
| 91840-9 | Bordetella holmesii DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 61031-1 | 7-Aminoclonazepam [Presence] in Specimen |
| 61073-3 | ALPRAZolam [Presence] in Gastric fluid |
| 76483-7 | Apolipoprotein A-I [Moles/volume] in Serum or Plasma |
| 9322-9 | Cholesterol.total/Cholesterol in HDL [Percentile] |
| 6210-9 | Penicillin V IgE Ab [Units/volume] in Serum |
| 77776-3 | Norhydrocodone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 77877-9 | Ziprasidone [Mass/volume] in Urine by Confirmatory method |
| 78347-2 | Docosapentaenate (C22:5w3) [Entitic substance] in Red Blood Cells |
| 7835-2 | Coxsackievirus A9 Ab [Units/volume] in Serum |
| 63425-3 | Bacterial heat-labile enterotoxin LT gene [Presence] in Specimen by NAA with probe detection |
| 6416-2 | Haemophilus influenzae D Ag [Presence] in Specimen by Immunofluorescence |
| 79280-4 | Alpha-aminoadipic semialdehyde [Moles/volume] in Cerebral spinal fluid |
| 955-5 | C sup(w) Ab [Presence] in Serum or Plasma from Blood product unit |
| 95587-2 | Tetrahydrocortisone [Z-score] in 24 hour Urine |
| 8019-2 | Schistosoma mansoni Ab [Units/volume] in Serum |
| 95800-9 | Immunoglobulin light chains.free panel - Urine |
| 96360-3 | Dextromethorphan [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 96504-6 | Protein/Osmolality [Ratio] in Urine |
| 68939-8 | Enolase.neuron specific [Mass/volume] in Pleural fluid |
| 8118-2 | CD2 cells/100 cells in Blood |
| 69355-6 | Parvovirus B19 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 82066-2 | Food Allergen Mix 28 (Kiwi+Beef+Shrimp+Sesame seed) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 98274-4 | Right pelvic lymph nodes examined [#] in Specimen |
| 98955-8 | Burkholderia pseudomallei Ab [Titer] in Specimen by Hemagglutination inhibition |
| 99097-8 | Blastomyces dermatitidis IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 71844-5 | Oxygen saturation [Pure mass fraction] Calculated from oxygen partial pressure in Blood |
| 71866-8 | Hemoglobin E/Hemoglobin.total [Pure mass fraction] in Blood by HPLC |
| 72348-6 | Leukocytes [#/volume] in Prostatic fluid by Manual count |
| 85351-5 | Lymph node metastatic deposit.max dimension [Length] in Cancer specimen by Light microscopy |
| 7266-0 | Cricket IgE Ab [Units/volume] in Serum |
| 72763-6 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 72909-5 | Drug induced neutrophil Ab panel - Serum or Plasma |
| 85975-1 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum |
| 86132-8 | Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum --1st specimen |
| 86285-4 | Erythrocyte deformability [Interpretation] in Red Blood Cells Narrative |
| 86699-6 | Rotavirus C RNA [Nucleotide sequence] in Isolate by Sequencing |
| 74327-8 | MICA*033 IgG Ab [Presence] in Serum |
| 74378-1 | Meperidine [Mass/volume] in Unknown substance |
| 7442-7 | Firebush IgA Ab [Units/volume] in Serum |
| 88978-2 | Fat [Presence] in Urine sediment |
| 41656-0 | Potassium [Moles/volume] in Mixed venous blood |
| 4267-1 | Galactose.PO [Mass] of Dose |
| 60028-8 | West Nile virus IgG Ab avidity [Presence] in Serum by Immunoassay |
| 6007-9 | Protein C [Units/volume] in Platelet poor plasma by Coagulation assay |
| 60101-3 | Molybdenum [Mass/mass] in Nail |
| 31511-9 | Mycoplasma gallisepticum Ab [Units/volume] in Serum |
| 31561-4 | Phospholipid IgA Ab [Units/volume] in Serum |
| 51120-4 | Cytoplasmic CD22 blasts/100 blasts in Specimen |
| 4318-2 | Methadone [Mass] of Dose |
| 31688-5 | Trivittatus virus Ab [Units/volume] in Cerebral spinal fluid |
| 51621-1 | Macrophages/100 leukocytes in Dialysis fluid by Manual count |
| 51661-7 | Hepatitis A virus Ab [Presence] in Body fluid |
| 2273-1 | Fatty acids.esterified [Mass/volume] in Blood |
| 51975-1 | Individual allele results panel |
| 524-9 | Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 22901-3 | Bovine herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence |
| 2320-0 | Gamma glutamyl cysteine synthetase [Enzymatic activity/volume] in Red Blood Cells |
| 23215-7 | Lumpy skin disease virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 23377-5 | Porcine respiratory coronavirus Ag [Presence] in Small intestine Tissue by Immune stain |
| 53516-1 | Basophils/100 leukocytes in Dialysis fluid by Manual count |
| 45213-6 | Isobutyrylcarnitine (C4) [Moles/volume] in DBS |
| 54003-9 | Human upstream binding factor Ab [Presence] in Serum by Immunofluorescence |
| 54462-7 | Malonylcarnitine (C3-DC) [Moles/volume] in DBS |
| 46749-8 | 3-Methylcrotonic/Hydroxymethylglutaric/Methylglutaconic newborn screen interpretation |
| 34494-5 | SCA10 gene ATTCT repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 34651-0 | CYP21A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 47217-5 | Immune Complex C3d [Mass/volume] in Serum or Plasma |
| 25210-6 | Capreomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 35005-8 | Polymorphonuclear cells [#/volume] in Peritoneal fluid |
| 35176-7 | Monounsaturated fatty acids [Moles/volume] in Serum or Plasma |
| 47848-7 | Cortisol [Mass/volume] in Serum or Plasma --post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 25582-8 | C peptide [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 26013-3 | 17-Hydroxycorticosteroids [Moles/time] in 24 hour Urine --2 days post XXX challenge |
| 26544-7 | Glucose [Mass/volume] in Serum or Plasma --6 hours post dose glucose |
| 3687-1 | Ibuprofen [Mass/volume] in Serum or Plasma |
| 56890-7 | CD13+HLA-DR+ cells/100 cells in Aspirate |
| 48501-1 | HLA Ab [Presence] in Serum by Immunoassay |
| 48599-5 | CLCN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 572-8 | Fungus identified in Bone marrow by Culture |
| 38672-2 | P-cresol [Mass/volume] in Air |
| 38688-8 | 1,1-Dimethylhydrazine [Mass/volume] in Air |
| 38707-6 | Trichloroethane [Mass/volume] in Air |
| 49463-3 | CD1 Ag [Presence] in Tissue by Immune stain |
| 49679-4 | CD36 cells/100 cells in Bone marrow |
| 49718-0 | HIV 1 p24 Ag [Presence] in Cerebral spinal fluid |
| 2839-9 | Progesterone [Mass/volume] in Serum or Plasma |
| 28541-1 | Metamyelocytes/100 leukocytes in Blood |
| 29340-7 | CD71 cells [#/volume] in Blood |
| 40149-7 | Glucose [Moles/volume] in Serum or Plasma --30 minutes pre XXX challenge |
| 58619-8 | Corticotropin [Moles/volume] in Plasma --pre 1 ug/kg CRH IV |
| 49772-7 | Fructose [Mass/volume] in Urine |
| 29713-5 | Orientia tsutsugamushi Gilliam Ab [Titer] in Serum by Immunofluorescence |
| 40523-3 | Histiocytes/100 cells in Pericardial fluid by Manual count |
| 19208-8 | Squamous cell carcinoma Ag [Moles/volume] in Serum or Plasma |
| 19687-3 | Psilocybin [Presence] in Urine by Confirmatory method |
| 20587-2 | CD10 cells/100 cells in Specimen |
| 20716-7 | Bovine diarrhea virus [Presence] in Serum by Organism specific culture |
| 20803-3 | Epizootic hemorrhagic disease virus Ab [Presence] in Serum |
| 20979-1 | Urea [Mass/mass] in Feed |
| 100997-6 | Respiratory Allergen Panel, Area 5 - Serum |
| 12586-4 | Creatinine [Mass/time] in 4 hour Urine |
| 101787-0 | B-cell lymphoma chromosome analysis in Tissue by FISH |
| 102237-5 | Chortoglyphus arcuatus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14900-5 | raNITIdine [Presence] in Gastric fluid |
| 14960-9 | Estradiol (E2) Free/Estradiol (E2).total in Serum or Plasma |
| 15049-0 | Creatine kinase.MM/Creatine kinase.total in Serum or Plasma by Electrophoresis |
| 10651-8 | Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial |
| 15373-4 | Phenyltoloxamine [Mass/volume] in Blood |
| 16160-4 | Gastrin [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 16612-4 | Chlorthalidone [Mass/volume] in Serum or Plasma |
| 16918-5 | Glutathione [Mass/volume] in Serum or Plasma |
| 17556-2 | Measles virus Ab [Units/volume] in Serum --2nd specimen |
| 17715-4 | Toxocara canis Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 17941-6 | Bacteria # 6 identified in Burn by Culture |
| 18392-1 | Phencyclidine [Presence] in Urine by Confirmatory method |
| 18871-4 | Butirosin [Susceptibility] |
| 18984-5 | sulfADIAZINE [Susceptibility] |
| 75052-1 | Adenosine deaminase [Enzymatic activity/volume] in DBS |
| 6047-5 | Bloodworm IgE Ab [Units/volume] in Serum |
| 61107-9 | SLC25A13 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 76597-4 | Streptococcus agalactiae cfb gene [#/mass] in XXX.tissue by NAA with probe detection |
| 93352-3 | Neutrophils.CD64/100 Neutrophils in Blood by Flow cytometry (FC) |
| 93489-3 | AMPAR2 IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay |
| 62946-9 | Jamestown canyon virus IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 63238-0 | Extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
| 94347-2 | Metabotropic glutamate receptor 1 IgG Ab [Presence] in Serum by Immunofluorescence |
| 9438-3 | Morphine [Presence] in Gastric fluid |
| 7933-5 | Japanese encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 95072-5 | 1,3 beta glucan [Mass/volume] in Cerebral spinal fluid |
| 95588-0 | Alpha cortolone [Z-score] in 24 hour Urine |
| 95609-4 | SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory system specimen by Sequencing |
| 68412-6 | Macrophages/100 leukocytes in Vitreous fluid by Manual count |
| 97168-9 | Vasopressin [Mass/time] in 24 hour Urine |
| 85750-8 | Streptococcus pneumoniae Danish serotype 23A DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 99264-4 | Etizolam [Mass/volume] in Urine by Confirmatory method |
| 73207-3 | Phenytoin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86729-1 | Haemophilus parasuis DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73444-2 | Ciprofloxacin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87793-6 | Nitrofurazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 88920-4 | Taenia solium larva Ag [Presence] in Serum by Immunoassay |
| 59718-7 | Nordiazepam [Mass/volume] in Body fluid |
| 59762-5 | Triazolam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 31075-5 | Legionella pneumophila 1 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 31165-4 | Methyl butyl ketone [Mass/volume] in Urine |
| 59991-0 | Testosterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 51374-7 | CD9 cells/100 cells in Tissue |
| 31686-9 | Transmissible gastroenteritis virus Ab [Units/volume] in Serum |
| 31706-5 | Western equine encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 32031-7 | Phosphatidylserine IgA Ab [Units/volume] in Serum by Immunoassay |
| 51762-3 | Helicobacter pylori IgA and IgG and IgM [Interpretation] in Serum or Plasma |
| 32254-5 | Leucine [Moles/volume] in Body fluid |
| 52885-1 | Cytoplasmic CD3 cells/100 cells in Tissue |
| 22900-5 | Bovine diarrhea virus RNA [Presence] in Specimen by NAA with probe detection |
| 22937-7 | Brucella ovis Ab [Units/volume] in Serum by Complement fixation |
| 32763-5 | Bacteria [Presence] in Specimen by Wet preparation |
| 32777-5 | Escherichia coli O157:H7 Ag [Presence] in Stool |
| 32998-7 | Tissue transglutaminase IgG Ab [Units/volume] in Serum |
| 3311-8 | Alphaprodine [Mass/time] in 24 hour Urine |
| 53221-8 | dRVVT in Control Platelet poor plasma by Coagulation assay |
| 44473-7 | Herpes simplex virus 1 Ag [Presence] in Penis |
| 44789-6 | Amylase and Creatinine clearance panel - Urine and Serum or Plasma |
| 23467-4 | Theileria mutans Ab [Titer] in Serum by Immunofluorescence |
| 3327-4 | Aminopyrine [Mass/volume] in Exhaled gas |
| 33525-7 | Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma |
| 45035-3 | Bacterial virulence [Presence] in Specimen by Mouse bioassay |
| 45153-4 | HLA Ab in Serum |
| 54263-9 | Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose insulin IV |
| 54280-3 | Glutarylcarnitine (C5-DC) [Moles/volume] in Cerebral spinal fluid |
| 24267-7 | Coxsackievirus B5 Ab [Titer] in Serum --1st specimen |
| 24334-5 | Amylase isoenzyme 7 panel - Serum |
| 24351-9 | Protein electrophoresis panel - Serum or Plasma |
| 34385-5 | Urate/Creatinine [Molar ratio] in Urine |
| 34732-8 | APOE gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method |
| 55639-9 | Cefatrizine [Susceptibility] by Gradient strip |
| 55791-8 | Neutrophils [#] in Cerebral spinal fluid by Manual count |
| 25944-0 | Lutropin [Units/volume] in Serum or Plasma by 1st IRP --2nd specimen post XXX challenge |
| 35646-9 | Deoxypyridinoline/Creatinine [Molar ratio] in Urine collected for unspecified duration |
| 47981-6 | Phenylalanine/Creatinine [Ratio] in 24 hour Urine |
| 48265-3 | Dust Allergen Mix B (Acarus siro+Lepidoglyphus destructor+Tyrophagus putrescentiae+Glycyphagus domesticus) triggered leukotriene release [Mass/volume] by Leukocytes |
| 26465-5 | Leukocytes [#/volume] in Cerebral spinal fluid |
| 35817-6 | Gentamicin.high potency [Susceptibility] by Gradient strip |
| 56918-6 | Coxiella burnetii IgM Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 26841-7 | N-desalkylflurazepam [Mass/mass] in Hair |
| 27989-3 | Thyroxine (T4) free [Units/volume] in Serum or Plasma --1 hour post XXX challenge |
| 57763-5 | Activated partial thromboplastin time (aPTT).factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma/pre addition of normal plasma |
| 49735-4 | FBN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 40049-9 | Albumin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 49781-8 | Mitochondria M2 Ab [Units/volume] in Serum |
| 29537-8 | West Nile virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 29801-8 | Jamestown canyon virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 29973-5 | Strontium/Creatinine [Mass Ratio] in 24 hour Urine |
| 40660-3 | Promyelocytes/100 leukocytes in Body fluid by Manual count |
| 410-1 | Piperacillin [Susceptibility] by Serum bactericidal titer |
| 20904-9 | Neospora caninum Ab [Presence] in Serum by Immunofluorescence |
| 12453-7 | Phosphate crystals amorphous [Presence] in Urine sediment by Light microscopy |
| 12501-3 | PHENobarbital [Presence] in Stool |
| 102253-2 | Cotton fibers IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102455-3 | Mugwort IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102466-0 | Coastal Oak IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14118-4 | Lactate [Mass/volume] in Serum or Plasma |
| 102812-5 | California Sagebrush IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1444-9 | Cortisol [Mass/volume] in Serum or Plasma --pre 12 hour fast |
| 1041-3 | G Ag [Presence] on Red Blood Cells |
| 15068-0 | Follitropin [Units] in 24 hour Urine |
| 15093-8 | Protoporphyrin Free [Moles/volume] in Blood |
| 15138-1 | Isoleucine+Leucine [Presence] in Urine |
| 1548-7 | Glucose [Mass/volume] in Serum or Plasma --pre 0.5 g/kg glucose IV |
| 10873-8 | Beta-2-Microglobulin [Mass/time] in 24 hour Urine |
| 16558-9 | Catecholamines [Mass/volume] in Plasma --2 hours post XXX challenge |
| 11181-5 | Lycopodium spp IgE Ab [Units/volume] in Serum |
| 11561-8 | Acetylcholine receptor blocking Ab [Units/volume] in Serum |
| 17280-9 | Plasmodium sp identified in Tissue by Thick film |
| 18423-4 | Phthalic anhydride IgG Ab [Units/volume] in Serum |
| 1875-4 | Apolipoprotein C-I [Mass/volume] in Serum or Plasma |
| 18950-6 | Moxalactam [Susceptibility] |
| 91047-1 | Barbiturates [Presence] in Hair by Screen method |
| 91848-2 | Mycoplasma hominis DNA [Presence] in Genital specimen by NAA with probe detection |
| 61265-5 | Fennel Seed IgE Ab/IgE total in Serum |
| 77103-0 | NARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 94145-0 | Crotonylglycine/Creatinine [Molar ratio] in Urine |
| 63207-5 | False ragweed IgG Ab [Mass/volume] in Serum |
| 94610-3 | Bovine diarrhea virus subtype [Identifier] in Specimen by NAA with probe detection |
| 63474-1 | Microalbumin [Mass/time] in 18 hour Urine |
| 6467-5 | Microscopic observation [Identifier] in Genital fluid by Gram stain |
| 78921-4 | Bordetella pertussis and Bordetella parapertussis DNA and culture panel - Nasopharynx |
| 80244-7 | Mycoplasma hyopneumoniae DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 95848-8 | Somatotropin [Mass/volume] in Serum by Immunoassay --60 minutes post dose macimorelin |
| 80969-9 | Methotrexate free [Mass/volume] in Serum or Plasma |
| 97187-9 | Urea/Creatinine [Mass Ratio] in Urine |
| 69923-1 | European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
| 97757-9 | Androstenedione [Moles/volume] in Body fluid |
| 7195-1 | Red Cedar IgE Ab [Units/volume] in Serum |
| 72260-3 | Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay |
| 72965-7 | quiNIDine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73091-1 | Valproate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73277-6 | Methylprednisolone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87378-6 | Isotopic Tubular extraction rate/1.73 sq M [Volume Rate/Area] in Serum or Blood |
| 88053-4 | Cells.CD4-CD8-CD45R+TCR alpha beta+ [#/volume] in Blood by Flow cytometry (FC) |
| 73919-3 | MAM-2201 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood |
| 88897-4 | Adenovirus Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
| 89514-4 | Glomerular basement membrane Ab [Presence] in Serum by Line blot |
| 31105-0 | Osmotic fragility of Red Blood Cells--0.55% sodium chloride 24 hour 37 degree C incubation |
| 60071-8 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Serum or Plasma |
| 60131-0 | Paraoxon [Mass/mass] in Tissue |
| 60177-3 | Sulfamethizole [Mass/volume] in Urine |
| 21383-5 | Mercury [Mass/volume] in 24 hour Urine |
| 21597-0 | Varicella zoster virus IgM Ab [Presence] in Serum |
| 31319-7 | Coxsackievirus A7 Ab [Units/volume] in Cerebral spinal fluid |
| 31379-1 | Equine influenza virus A1 Ab [Units/volume] in Serum |
| 31502-8 | Ganglioside GM1 IgM Ab [Units/volume] in Serum |
| 51107-1 | CD1a blasts/100 blasts in Blood |
| 51455-4 | Filaria IgG1 Ab [Units/volume] in Serum |
| 4291-1 | Kanamycin [Mass] of Dose |
| 42930-8 | CD11+CD18+ cells [Presence] in Blood |
| 43073-6 | Bovine leukemia virus Ab [Titer] in Serum |
| 21774-5 | Chromosome 9 trisomy [Presence] in Blood or Tissue by Cytogenetics |
| 31814-7 | Equine adenovirus Ag [Presence] in Lung |
| 51502-3 | Estradiol (E2) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 51697-1 | CV2 Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 43828-3 | Benzodiazepines [Presence] in Specimen |
| 32055-6 | Butalbital [Moles/volume] in Serum or Plasma |
| 32213-1 | Salmonella paratyphi B Ab [Titer] in Serum |
| 3223-5 | Coagulation factor X+Acarboxy Ag actual/normal in Platelet poor plasma by Immunoassay |
| 53008-9 | PM-SCL extractable nuclear Ab [Titer] in Serum by Immunofluorescence |
| 43974-5 | Coccidioides sp Ab [Presence] in Serum by Immune diffusion (ID) |
| 43996-8 | Alpha-1-Fetoprotein [Multiple of the median] adjusted for diabetes+weight in Serum or Plasma |
| 23155-5 | Leishmania sp Ab [Presence] in Serum by Immunoelectrophoresis |
| 32662-9 | Afipia felis IgG Ab [Presence] in Serum |
| 32798-1 | Microscopic observation [Identifier] in Specimen by Oil red O stain |
| 53255-6 | Mycoplasma pneumoniae DNA [#/volume] in Specimen by NAA with probe detection |
| 44682-3 | Invasive melanoma in situ.uninvolved margin.closest in Skin melanoma |
| 53883-5 | OCRL1 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 45190-6 | CASR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 3414-0 | Buprenorphine [Presence] in Urine |
| 34257-6 | Carnitine [Moles/volume] in 24 hour Urine |
| 46176-4 | Chlamydia trachomatis D+E+F+G+H+I+J+K IgA Ab [Titer] in Serum |
| 46423-0 | Hemoglobin distribution width [Mass/volume] in Blood |
| 34448-1 | Cache valley virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 34559-5 | Cell count panel - Synovial fluid |
| 55592-0 | Cockatiel feather IgE Ab [Presence] in Serum |
| 34959-7 | Microscopic observation [Identifier] in Blood by Myeloperoxidase stain |
| 35028-0 | Monocytes [#/volume] in Pleural fluid |
| 55768-6 | EGFR gene c.2303G>T [Presence] in Blood or Tissue by Molecular genetics method |
| 5580-6 | Antimony [Mass/volume] in Serum or Plasma |
| 47696-0 | Malonate/Creatinine [Molar ratio] in Urine |
| 56414-6 | Walnut IgG4 Ab [Mass/volume] in Serum |
| 48229-9 | Dog epithelium triggered leukotriene release [Mass/volume] by Leukocytes |
| 2632-8 | Methyltestosterone [Presence] in Urine |
| 26577-7 | Asparagine/Creatinine [Molar ratio] in Urine |
| 26813-6 | Acidity.titratable [Moles/volume] in Gastric fluid |
| 2699-7 | Oxalate [Mass/volume] in Serum or Plasma |
| 27137-9 | Antimony [Mass/mass] in Red Blood Cells |
| 38270-5 | Influenza virus A H7 RNA [Presence] in Specimen by NAA with probe detection |
| 38420-6 | Soluble liver IgG Ab [Units/volume] in Serum by Immunoassay |
| 27822-6 | Protein S actual/normal in Platelet poor plasma by Coagulation assay |
| 27984-4 | SCA8 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 28074-3 | Tritium [Presence] in Urine |
| 49740-4 | Yellow Hornet IgG Ab [Mass/volume] in Serum |
| 28638-5 | Base excess in Arterial cord blood by calculation |
| 29390-2 | Parathyrin.mid molecule [Moles/volume] in Serum or Plasma |
| 40018-4 | Glucose [Mass/volume] in Serum or Plasma --19.5 hours post XXX challenge |
| 50165-0 | Adenine phosphoribosyltransferase [Enzymatic activity/mass] in Amniotic fluid cells |
| 40476-4 | PARK2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 59292-3 | Levamisole [Mass/volume] in Body fluid |
| 5045-0 | Ancylostoma sp Ab [Units/volume] in Serum |
| 50554-5 | Urinalysis microscopic panel [#/volume] - Urine by Automated count |
| 30086-3 | Coagulation factor IX inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
| 30102-8 | Yersinia enterocolitica O:8 Ab [Titer] in Specimen |
| 30191-1 | Acetylcarnitine (C2) [Moles/volume] in Serum or Plasma |
| 30192-9 | Acetylcholine receptor modulation Ab/Acetylcholine Ab.total in Serum |
| 3019-7 | Thyrotropin.long acting [Presence] in Serum or Plasma |
| 1939-8 | Beta fructofuranosidase [Enzymatic activity/volume] in Serum |
| 19644-4 | oxyCODONE cutoff [Mass/volume] in Urine for Screen method |
| 20829-8 | Glycol [Mass/mass] in Tissue |
| 12913-0 | Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Leukocytes |
| 101174-1 | 17-Hydroxyprogesterone [Mass/volume] in Saliva (oral fluid) |
| 101434-9 | 2-Ketobutyrate [Moles/volume] in Serum or Plasma |
| 101719-3 | Nickel IgE Ab [Units/volume] in Serum |
| 13643-2 | Lindane [Mass/volume] in Urine |
| 13772-9 | Methionine/Creatinine [Mass Ratio] in Urine |
| 102673-1 | Almond IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14976-5 | Lecithin/Sphingomyelin [Ratio] in Amniotic fluid |
| 15226-4 | Food Allergen Mix G (Beef+Chicken meat+Pork+Plaice) IgE Ab [Presence] in Serum by Multidisk |
| 104381-9 | Coxiella burnetii IgM Ab [Titer] in Serum by Immunoassay --1st specimen |
| 10476-0 | Desmin Ag [Presence] in Tissue by Immune stain |
| 10666-6 | Fungus identified in Tissue by Fontana-Masson stain |
| 15433-6 | Anaplasma marginale Ab [Presence] in Serum by Agglutination |
| 16867-4 | Fibronectin aggregate IgG Ab [Mass/volume] in Serum |
| 172-7 | Chloramphenicol [Susceptibility] by Minimum lethal concentration (MLC) |
| 17275-9 | Methylfentanyl [Mass/volume] in Serum or Plasma |
| 17942-4 | Bacteria # 2 identified in Line specimen by IV Line culture |
| 89972-4 | Loxapine [Mass/volume] in Urine by Confirmatory method |
| 91665-0 | Ascorbate oxidase IgE Ab [Units/volume] in Serum |
| 91769-0 | Enterovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 92638-6 | Sertraline [Mass/volume] in Urine by Confirmatory method |
| 76407-6 | Eosinophils [#] in Body fluid by Manual count |
| 76603-0 | Bacterial 16S rRNA [#/volume] in XXX.body fluid by NAA with probe detection |
| 7696-8 | Sesame Seed IgG Ab [Units/volume] in Serum |
| 93412-5 | SLCO1B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 61217-6 | Sweet Vernal grass IgE Ab/IgE total in Serum |
| 77158-4 | Microalbumin [Moles/volume] in Urine by Detection limit <= 3.0 mg/L |
| 77452-1 | Bilirubin [Presence] in Peritoneal fluid |
| 77664-1 | Aneuploid G1 phase cell population 2 peak channel [#] in Cells.XXX by Flow cytometry (FC) |
| 63088-9 | Perch IgG Ab [Mass/volume] in Serum |
| 63253-9 | Ganglioside GM3 IgM Ab [Presence] in Serum by Immunoassay |
| 77768-0 | Ethanol cutoff [Mass/volume] in Urine for Confirmatory method |
| 94372-0 | Proteus sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 64984-8 | Cockroach recombinant (rBla g) 5 IgE Ab [Units/volume] in Serum |
| 79183-0 | First name of Guardian or legally authorized representative |
| 95222-6 | Monocytes/100 leukocytes in Stem cell product by Manual count |
| 66115-7 | Pancreas Pathology biopsy report |
| 6625-8 | Naegleria fowleri Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 80126-6 | Aluminum [Moles/volume] in Body fluid |
| 6903-9 | Norverapamil [Mass/volume] in Serum or Plasma |
| 80533-3 | Methamphetamine [Mass/mass] in Hair |
| 96664-8 | HLA-DRB1 [Type] by Low resolution |
| 9686-7 | Cadmium [Mass/volume] in Cerebral spinal fluid |
| 82408-6 | Ganglioside GM4 IgG+IgM Ab [Presence] in Serum by Line blot |
| 82491-2 | TRBV13 gene segments/TRBV gene segments.total in Blood |
| 9816-0 | Actinomyces sp identified in Specimen by Organism specific culture |
| 98394-0 | Candida sp [Identifier] in Isolate by MS.MALDI-TOF |
| 72841-0 | Hepatitis B virus codon 237 [Identifier] by Genotype method |
| 86229-2 | HYDROcodone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 87475-0 | Chloride [Mass/volume] in Specimen |
| 87667-2 | Alpha benzene hexachloride [Mass/mass] in Specimen |
| 73543-1 | Albuterol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73625-6 | cefTAZidime+Avibactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 73658-7 | HIV 1 subtype in Specimen by NAA with probe detection |
| 73835-1 | Bacteria.extended spectrum beta lactamase resistance [Identifier] in Anal by Organism specific culture |
| 88344-7 | Intracellular bacteria [Presence] in Ear by Light microscopy |
| 41442-5 | Entamoeba dispar DNA [Presence] in Specimen by NAA with probe detection |
| 41458-1 | SARS coronavirus RNA [Presence] in Specimen by NAA with probe detection |
| 59354-1 | Tapentadol [Mass/volume] in Serum or Plasma |
| 59420-0 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe with signal amplification |
| 41850-9 | Lidocaine IgE Ab [Units/volume] in Serum |
| 2128-7 | Citrate [Mass/volume] in Urine |
| 21292-8 | Gastrin [Mass/volume] in Serum or Plasma --40 minutes post 0.2 U/kg secretin |
| 31236-3 | Infectious bronchitis virus Ab [Units/volume] in Serum |
| 51172-5 | CD34+CD117+ blasts in Specimen |
| 5140-9 | Echovirus 3 neutralizing antibody [Titer] in Serum by Neutralization test |
| 42954-8 | Sindbis virus Ab [Titer] in Serum |
| 43119-7 | Extractable nuclear Ab panel - Serum |
| 31745-3 | Bovine herpesvirus 1 Ag [Presence] in Nose |
| 3191-4 | Coagulation factor V inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
| 51834-0 | Tryptase [Moles/volume] in Serum or Plasma |
| 43216-1 | Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Throat by NAA with probe detection |
| 43427-4 | Microscopic observation [Identifier] in Tissue by Rapid stain |
| 43707-9 | Cytomegalovirus [Presence] in Tissue by Shell vial culture |
| 32566-2 | Coxiella burnetii Ab [Titer] in Cerebral spinal fluid |
| 52906-5 | Bismuth/Creatinine [Molar ratio] in 24 hour Urine |
| 43936-4 | CD55 cells/100 cells in Tissue |
| 23072-2 | Equine arteritis virus Ab [Presence] in Serum by Immunofluorescence |
| 32614-0 | Glutamate [Moles/volume] in Body fluid |
| 44556-9 | Influenza virus A Ab [Presence] in Serum by Complement fixation |
| 53890-0 | PLOD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 45019-7 | Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --2 hours post XXX challenge |
| 23691-9 | Canine distemper virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 24006-9 | Eastern equine encephalitis virus IgG and IgM [Interpretation] in Serum |
| 54012-0 | Vimentin Ab [Titer] in Serum by Immunofluorescence |
| 5410-6 | Yersinia pseudotuberculosis Ab [Units/volume] in Serum |
| 46099-8 | Calcium [Mass/volume] corrected for albumin in Serum or Plasma |
| 2501-5 | Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma |
| 34322-8 | Iron/Creatinine [Molar ratio] in Urine |
| 34418-4 | Protoporphyrin [Mass/mass] in Red Blood Cells |
| 34586-8 | JC virus DNA [Presence] in Tissue by NAA with probe detection |
| 55250-5 | HBA2 gene THAI+FIL+MED+alpha 20.5 deletion [Presence] in Blood by Molecular genetics method |
| 47158-1 | Norepinephrine [Moles/volume] in Plasma --2 hours post 300 ug cloNIDine PO |
| 3512-1 | Cropropamide [Mass/volume] in Urine |
| 55727-2 | Tissue transglutaminase IgA and IgG panel - Serum |
| 2563-5 | Leukocyte esterase [Enzymatic activity/volume] in Leukocytes |
| 35778-0 | Ceftibuten [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 56340-3 | Oregano IgG4 Ab [Mass/volume] in Serum |
| 47954-3 | Tiglylglycine [Moles/volume] in Plasma |
| 48139-0 | Erythro-4,5-Dihydroxyhexanoate/Creatinine [Molar ratio] in Urine |
| 48143-2 | LDL.oxidized Ab [Units/volume] in Serum |
| 38407-3 | PAX3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 49177-9 | Hepatitis B virus surface IgG Ab [Presence] in Serum |
| 2746-6 | pH of Venous blood |
| 39017-9 | Mycobacterium tuberculosis tuberculin stimulated gamma interferon/Mitogen stimulated gamma interferon in Blood |
| 58545-5 | Corticotropin [Moles/volume] in Plasma --12th specimen post XXX challenge |
| 58615-6 | Corticotropin [Moles/volume] in Plasma --8 AM specimen |
| 29709-3 | Rickettsia prowazekii Ab [Titer] in Serum by Immunofluorescence |
| 29726-7 | Leptospira interrogans sv Cynopteri Ab [Presence] in Serum by Agglutination |
| 59026-5 | U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum |
| 50550-3 | Malondialdehyde.free [Moles/volume] in Plasma |
| 100813-5 | Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge |
| 101071-9 | CELO Ab [Presence] in Serum or Plasma |
| 12918-9 | Monoamine oxidase [Enzymatic activity/volume] in Platelet rich plasma |
| 101571-8 | Candida glabrata+krusei DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 13348-8 | Monoclonal band observed [Identifier] in Serum or Plasma |
| 102119-5 | Skeletal muscle channelopathy multigene panel - Blood or Tissue by Molecular genetics method |
| 102208-6 | Casein IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102209-4 | Cashew nut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13890-9 | Lactate dehydrogenase 5/Lactate dehydrogenase.total in Urine by Electrophoresis |
| 14019-4 | HTLV I+II gp46 Ab [Presence] in Serum or Plasma by Immunoblot |
| 14861-9 | Oxalate [Presence] in Stone |
| 104444-5 | Rickettsia prowazekii IgG Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 104467-6 | Yersinia enterocolitica O:8 Ab [Presence] in Stool |
| 16471-5 | Blastomyces dermatitidis Ab [Units/volume] in Serum |
| 1651-9 | 1-Methylhistidine [Presence] in Serum or Plasma |
| 12300-0 | Polythiazide [Presence] in Urine |
| 16892-2 | Gastrin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 17031-6 | Jo-1 extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 17132-2 | CD3+IL2R1+ cells/100 cells in Blood |
| 17229-6 | Lymphocytic choriomeningitis virus IgM Ab [Titer] in Cerebral spinal fluid |
| 1756-6 | Albumin in CSF/Albumin in Serum or Plasma |
| 18241-0 | cefOXitin IgE Ab [Units/volume] in Serum |
| 89997-1 | SUMF1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 74639-6 | Monoclonal band 2 observed [Identifier] in Urine by Immunofixation |
| 74818-6 | Desomorphine [Presence] in Urine by Screen method |
| 74867-3 | IgM.lambda [Mass/volume] in Serum or Plasma |
| 917-5 | B variant subtype Ab [Presence] in Serum or Plasma from Blood product unit |
| 75713-8 | CYP1A2 gene c.125C>G [Presence] in Blood or Tissue by Molecular genetics method |
| 60530-3 | Influenza virus A H9 RNA [Presence] in Isolate by NAA with probe detection |
| 6072-3 | Chloramin T IgE Ab [Units/volume] in Serum |
| 61049-3 | Methylenedioxyethylamphetamine [Presence] in Specimen |
| 92890-3 | Hepatitis A and B and C virus immunity AndOr previous exposure panel - Serum or Plasma |
| 62292-8 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma |
| 77122-0 | DFNB31 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77349-9 | Everolimus [Mass/volume] in Blood by LC/MS/MS --trough |
| 77745-8 | HTLV I p19-I Ab [Presence] in Serum or Plasma by Immunoblot |
| 93788-8 | F5 gene HR2 haplotype [Genotype] in Blood by Molecular genetics method Nominal |
| 78757-2 | 2-Oxo-3-Hydroxy-Lysergate diethylamide [Presence] in Urine by Screen method |
| 63407-1 | Thyroid colloidal Ab [Presence] in Serum by Immunofluorescence |
| 6403-0 | Anaplasma phagocytophilum Ab [Presence] in Serum by Immunoassay |
| 6410-5 | Gardnerella vaginalis rRNA [Presence] in Genital specimen by Probe |
| 78868-7 | Norhydrocodone cutoff [Mass/volume] in Urine for Confirmatory method |
| 95103-8 | Glucose [Mass/volume] in Serum or Plasma --2.5 hours post meal |
| 95105-3 | Glucose [Mass/volume] in Serum or Plasma --30 min post meal |
| 80146-4 | Tricyclic antidepressants [Presence] in Blood by Screen method |
| 8123-2 | CD3+CD4+ (T4 helper) cells/100 cells in Blood |
| 9684-2 | Bendiocarb [Mass/volume] in Serum or Plasma |
| 70049-2 | Polymorphonuclear cells [#/volume] in Synovial fluid by Automated count |
| 81798-1 | Pregnanediolone/Creatinine [Molar ratio] in Urine |
| 82172-8 | Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 97288-5 | Normeperidine [Presence] in Cord tissue by Screen method |
| 9747-7 | Dapsone [Mass/volume] in Serum or Plasma |
| 82771-7 | Lab test location performed [Type] |
| 98056-5 | Oxacillin IgE Ab [Units/volume] in Serum |
| 71763-7 | Rotavirus IgA Ab [Titer] in Serum by Immunoassay |
| 72212-4 | t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
| 72397-3 | Secobarbital [Mass/volume] in Blood by Confirmatory method |
| 85757-3 | Streptococcus pneumoniae Danish serotypes 15A+15F DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 99771-8 | SARS coronavirus 2 spike and nucleocapsid protein stimulated gamma interferon panel - Blood |
| 72790-9 | Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Urine by Confirmatory method |
| 86689-7 | Rotavirus A [Presence] in Specimen by Organism specific culture |
| 87348-9 | Senecavirus A RNA [Presence] in Specimen by NAA with probe detection |
| 87362-0 | Actinobacillus pleuropneumoniae serotypes 1+2+9+11 Ab/Positive control in Serum by Immunoassay |
| 87456-0 | Phosphate [Mass/volume] in Specimen |
| 73659-5 | HIV 2 subtype in Specimen by NAA with probe detection |
| 74229-6 | Megakaryopoiesis assessment in Bone marrow Narrative |
| 88706-7 | Linezolid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 88847-9 | Microbiology CNAMTS panel - Stool |
| 89358-6 | CD27 cells/100 CD19 cells in Blood |
| 41-4 | Azlocillin [Susceptibility] by Disk diffusion (KB) |
| 59720-3 | Nordiazepam [Mass/mass] in Meconium by Confirmatory method |
| 31086-2 | Morphine Free [Mass/volume] in Bile fluid |
| 31159-7 | Heparin anti Xa [Units/volume] in Nonbiological fluid |
| 42486-1 | Aspergillus fumigatus 1 Ab [Presence] in Cerebral spinal fluid |
| 42573-6 | 18-Hydroxycorticosterone [Mass/volume] in Urine |
| 21493-2 | Rickettsia conorii IgM Ab [Titer] in Serum |
| 21563-2 | Thiopurine methyltransferase [Enzymatic activity/volume] in Red Blood Cells |
| 21606-9 | Xylose [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 51378-8 | HLA-DR+ cells/100 cells in Tissue |
| 31619-0 | Salmonella paratyphi B O Ab [Units/volume] in Serum |
| 31728-9 | Bacteroides melaninogenicus Ag [Presence] in Specimen |
| 31867-5 | Lassa virus Ag [Presence] in Serum |
| 31878-2 | Measles virus Ag [Presence] in Vaginal fluid |
| 51903-3 | Chromium [Mass/volume] in Air |
| 51909-0 | Ependymal cells/100 cells in Cerebral spinal fluid |
| 4361-2 | Nortriptyline [Mass] of Dose |
| 32072-1 | FLUoxetine [Presence] in Specimen |
| 43987-7 | Clarithromycin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 44275-6 | Coxiella burnetii [Presence] in Specimen by Light microscopy |
| 44385-3 | Hydroflumethiazide [Presence] in 24 hour Urine |
| 23119-1 | Foot and mouth disease virus serotype [Identifier] in Tissue by Complement fixation |
| 44440-6 | Aspergillus fumigatus 6 Ab [Units/volume] in Serum |
| 2324-2 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma |
| 45155-9 | Heparin induced platelet Ab [Units/volume] in Serum |
| 33981-2 | TBP gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 46219-2 | Creatinine [Moles/volume] in Dialysis fluid --4 hour specimen |
| 34320-2 | Iodine [Moles/volume] in Urine |
| 34679-1 | PTPN11 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 47134-2 | Trimipramine [Moles/volume] in Urine |
| 25129-8 | Pyridinoline/Creatinine [Molar ratio] in Urine |
| 55878-3 | Homocysteine [Moles/volume] in 24 hour Urine |
| 47703-4 | Methionine/Amino acids.total in Amniotic fluid |
| 56183-7 | Australian pine IgG4 Ab [Mass/volume] in Serum |
| 48330-5 | MCOLN1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 26519-9 | Polymorphonuclear cells/100 leukocytes in Pleural fluid |
| 2670-8 | Normetanephrine [Mass/volume] in Urine |
| 35831-7 | Pirlimycin [Susceptibility] |
| 56585-3 | Cortisol [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 56689-3 | Isoleucine/Creatinine [Ratio] in 24 hour Urine |
| 4848-8 | HLA-Cw11 [Presence] in Donor |
| 48785-0 | Prostaglandin D2 [Mass/volume] in Body fluid |
| 48822-1 | Tubular basement membrane IgG Ab [Units/volume] in Serum by Immunoassay |
| 26913-4 | Triazolam [Mass/mass] in Meconium |
| 3857-0 | Nikethamide [Mass/time] in 24 hour Urine |
| 39481-7 | Glucose [Moles/volume] in Arterial blood |
| 5813-1 | Trichomonas vaginalis [Presence] in Urine sediment by Light microscopy |
| 2859-7 | Protein kinase [Enzymatic activity/volume] in Serum |
| 58596-8 | Corticotropin [Mass/volume] in Plasma --3 hours post dose glucose |
| 40427-7 | FGF23 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 40477-2 | L1CAM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 58861-6 | Somatotropin [Mass/volume] in Serum or Plasma --47th specimen |
| 59163-6 | Sodium [Moles/volume] in 24 hour Stool |
| 59196-6 | 3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Serum or Plasma |
| 30223-2 | Coxsackievirus B4 Ab [Presence] in Serum |
| 40772-6 | Heavy metals [Presence] in Urine |
| 40876-5 | AMPD1 gene p.Gln12Ter and p.Pro48Leu [Presence] in Blood or Tissue by Molecular genetics method |
| 20467-7 | Blood bank alert |
| 101214-5 | Hantavirus IgM panel - Serum or Plasma by Line blot |
| 13092-2 | Endomysium Ab [Units/volume] in Serum |
| 13738-0 | Estrogen/Creatinine [Mass Ratio] in 24 hour Urine |
| 102312-6 | Black Fly IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102542-8 | Privet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13991-5 | Prealbumin/Protein.total in Urine by Electrophoresis |
| 14137-4 | Glucose [Mass/volume] in Serum or Plasma --5.5 hours post 75 g glucose PO |
| 14314-9 | Benzoylecgonine [Presence] in Urine by Screen method |
| 104231-6 | N-Ethylpentylone [Mass/volume] in Urine by Confirmatory method |
| 15193-6 | CD3-CD16+ cells [#/volume] in Blood |
| 10863-9 | Endomysium IgA Ab [Titer] in Serum |
| 16285-9 | Creatinine/Protein [Mass Ratio] in Urine |
| 16698-3 | Cyclohexanol [Mass/volume] in Blood |
| 11145-0 | 5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in Urine |
| 1158-5 | little c Ag [Presence] on Red Blood Cells from Donor |
| 16815-3 | Endomysium Ab [Units/volume] in Serum by Immunofluorescence |
| 16958-1 | Herpes simplex virus 2 IgG Ab [Units/volume] in Serum --2nd specimen |
| 17492-0 | Proline [Presence] in Urine |
| 18922-5 | Ethionamide [Susceptibility] |
| 18963-9 | Pefloxacin [Susceptibility] |
| 90223-9 | Neutrophils.immature/Neutrophils.total [Pure number fraction] in Blood |
| 90812-9 | AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 75378-0 | Hepatitis B virus core Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 61172-3 | Hepatitis B virus codon M250L [Presence] by Genotype method |
| 76043-9 | Moxifloxacin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 92947-1 | Streptococcus pyogenes DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection |
| 92969-5 | Legionella pneumophila DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 93499-2 | Metabotropic glutamate receptor 1 IgG Ab [Titer] in Serum by Immunofluorescence |
| 9368-2 | Boron [Mass/volume] in Specimen |
| 93844-9 | UGT1A1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 94110-4 | 2-Hydroxyethylflurazepam [Presence] in Urine by Screen method |
| 78740-8 | Pathologic casts [#/area] in Urine by Automated count |
| 94423-1 | Lysosomal enzymes screen [Interpretation] in Urine Narrative |
| 6359-4 | Clostridioides difficile toxin A [Units/volume] in Stool by Immunoassay |
| 64131-6 | Dihydrocodeine/Creatinine [Mass Ratio] in Urine |
| 95083-2 | C peptide [Mass/volume] in Serum or Plasma --2.5 hours post meal |
| 954-8 | C little e Ag [Presence] on Red Blood Cells |
| 65774-2 | Wheat native (nTri a) aA/TI IgE Ab [Units/volume] in Serum |
| 95700-1 | Murray Valley encephalitis virus IgA Ab [Presence] in Specimen by Immunoassay |
| 9682-6 | 2-Butanol [Mass/volume] in Specimen |
| 8222-2 | Opiates [Presence] in Urine by SAMHSA screen method |
| 9727-9 | Eosinophils/100 leukocytes in Nose by Manual count |
| 71612-6 | Basophils/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
| 82846-7 | 11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Androsterone+etiocholanolone [Molar ratio] in 24 hour Urine |
| 9834-3 | HYDROmorphone [Presence] in Urine |
| 7199-3 | Cephalosporine mold IgE Ab [Units/volume] in Serum |
| 72366-8 | Influenza virus A and B Ag [Identifier] in Nose by Rapid immunoassay |
| 72479-9 | Drugs of abuse panel - Blood by Screen method |
| 83080-2 | Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 83093-5 | Digoxin [Mass/volume] in Serum or Plasma by Immunoassay |
| 85087-5 | Hexanoate (C6:0) [Moles/volume] in Serum or Plasma |
| 85287-1 | Radial position of closest mucosal margin involved by invasive carcinoma [Angle] in Colorectal cancer specimen by Light microscopy |
| 72981-4 | Omeprazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73200-8 | Piperacillin+Tazobactam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73487-1 | carBAMazepine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73494-7 | busPIRone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74347-6 | Leukocyte aggregates [Presence] in Blood by Light microscopy |
| 59682-5 | Hydroxyethylflurazepam [Mass/volume] in Blood |
| 59699-9 | LORazepam [Mass/volume] in Blood |
| 50645-1 | Tetrahydrocortisol/Creatinine [Mass Ratio] in Urine |
| 30408-9 | Leukocytes other/100 leukocytes in Pleural fluid |
| 30513-6 | Pregnanetriolone/Creatinine [Mass Ratio] in Urine |
| 31050-8 | Coxsackievirus A9 Ab [Titer] in Body fluid by Complement fixation |
| 60106-2 | OLANZapine [Mass/volume] in Body fluid |
| 51162-6 | CD34 blasts/100 blasts in Bone marrow |
| 43052-0 | Coccidioides sp Ab [Presence] in Specimen |
| 43065-2 | Canine distemper virus IgM Ab [Titer] in Cerebral spinal fluid |
| 43109-8 | Leishmania sp IgG and IgM panel - Serum |
| 22214-1 | Coxsackievirus A16 Ab [Titer] in Cerebral spinal fluid |
| 51506-4 | Creatine kinase.MB [Enzymatic activity/volume] in Cerebral spinal fluid by Electrophoresis |
| 51707-8 | Inner ear 68kD Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 43690-7 | Triamterene/Total in Stone |
| 43830-9 | Nicotine [Presence] in Specimen |
| 43834-1 | Tetrahydrocannabinol [Presence] in Specimen |
| 22359-4 | HTLV I Ab [Presence] in Serum |
| 22653-0 | Cystine [Moles/volume] in Cerebral spinal fluid |
| 52110-4 | Blood product unit 4 expiration [Date and time] |
| 53045-1 | Reference sequence alteration [Identifier] |
| 44099-0 | Galactomannan Ag [Presence] in Serum or Plasma by Immunoassay |
| 23115-9 | Foot and mouth disease virus serotype [Identifier] in Specimen by Complement fixation |
| 32789-0 | Viscosity of Semen Qualitative |
| 33035-7 | Reason for lab test in Semen |
| 5309-0 | Rickettsia spotted fever group Ab [Units/volume] in Serum by Immunoassay |
| 53195-4 | Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 53249-9 | Human metapneumovirus RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 53292-9 | Erythrocytes [Presence] in Urine by Automated |
| 4448-7 | TOLBUTamide.IV [Mass] of Dose |
| 4462-8 | Xylose.PO [Mass] of Dose |
| 23450-0 | Taenia sp Ag [Presence] in Stool by Immunoassay |
| 23540-8 | Turkey enteritis coronavirus [Presence] in Serum by Immunofluorescence |
| 2354-9 | Glucose-6-Phosphatase [Enzymatic activity/volume] in Serum |
| 33258-5 | Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post dose TRH |
| 3352-2 | Amphetaminil [Mass/time] in 24 hour Urine |
| 53825-6 | HIV 1+Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection |
| 23993-9 | Echovirus 7 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 33774-1 | Karyotype [Identifier] in Chorionic villus sample Nominal |
| 54017-9 | Elastase Ab [Presence] in Serum |
| 54385-0 | Dehydroascorbate/Ascorbate in Serum or Plasma |
| 24388-1 | Brucella sp IgM Ab [Presence] in Serum by Immunoassay |
| 34319-4 | Inhibin B [Mass/volume] in Serum or Plasma |
| 55563-1 | Paraldehyde [Moles/volume] in Serum or Plasma |
| 25488-8 | Nicotinamide [Moles/volume] in Serum or Plasma |
| 55648-0 | cefTAZidime+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 47556-6 | Alanine/Amino acids.total in DBS |
| 48039-2 | Fibronectin.fetal [Presence] in Specimen |
| 48073-1 | Thyroxine binding globulin panel [Mass/volume] - Serum or Plasma by Electrophoresis |
| 35855-6 | Trovafloxacin [Susceptibility] by Disk diffusion (KB) |
| 48623-3 | Bilirubin.direct [Mass/volume] in Cord blood |
| 4871-0 | HLA-Dw11(w7) [Presence] |
| 27172-6 | Calcium [Mass/mass] in 24 hour Stool |
| 4921-3 | HLA-DPw1 [Presence] |
| 49239-7 | Patient symptoms [Interpretation] Narrative--3 hours post dose lactose PO |
| 38747-2 | Methyl isocyanate [Mass/volume] in Air |
| 50313-6 | Cyclospora sp identified in Stool by Safranin stain |
| 40799-9 | Amphetamines [Presence] in Saliva (oral fluid) by Screen method |
| 4100-4 | 2-Oxoisocaproate [Mass] of Dose |
| 19286-4 | Benzodiazepines confirm method [Identifier] in Urine |
| 19556-0 | Methamphetamine cutoff [Mass/volume] in Urine for Screen method |
| 20541-9 | Lormetazepam [Mass/volume] in Urine by Confirmatory method |
| 21045-0 | 5-Hydroxytryptophan [Mass/time] in 24 hour Urine |
| 1245-0 | M1 Ab [Presence] in Serum or Plasma from Donor |
| 12785-2 | Dihydrocodeine Free [Mass/volume] in Serum or Plasma |
| 101335-8 | Etizolam [Presence] in Urine by Confirmatory method |
| 13218-3 | Chlamydia trachomatis C Ab [Units/volume] in Serum |
| 101744-1 | Toxoplasma gondii DNA [Presence] in Plasma by NAA with probe detection |
| 102584-0 | Saltbush IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14114-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
| 1422-5 | Cortisol [Mass/volume] in Serum or Plasma --3 days post 500 ug corticotropin IM |
| 14323-0 | Streptococcus agalactiae Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 14480-8 | Diphtheria identified in Sputum by Organism specific culture |
| 14503-7 | Human papilloma virus 16+18 Ag [Presence] in Cervix |
| 103134-3 | Ascorbate oxidase IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10405-9 | Inject varicella zoster virus immune globulin [Volume] |
| 1523-0 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst |
| 15375-9 | Valproate Free [Mass/volume] in Saliva (oral fluid) |
| 15414-6 | Service comment 23 |
| 16223-0 | Thiopental [Presence] in Urine by Confirmatory method |
| 12322-4 | Triflupromazine [Presence] in Urine |
| 17465-6 | Pigeon serum IgE Ab [Presence] in Serum |
| 17906-9 | Bacteria # 4 identified in Tissue by Aerobe culture |
| 1803-6 | Amylase.P2 [Enzymatic activity/volume] in Serum or Plasma |
| 18227-9 | Glucose [Mass/time] in 6 hour Urine |
| 18255-0 | Sulfonylurea [Mass/volume] in Serum or Plasma |
| 74513-3 | Alpha tocopherol [Entitic substance] in Red Blood Cells |
| 74907-7 | Beta sitosterol [Moles/volume] in Serum or Plasma |
| 91824-3 | Pneumocystis jiroveci Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
| 75267-5 | Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 75600-7 | Fetal 1p36 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
| 60353-0 | Green Bean IgG Ab [Mass/volume] in Serum |
| 93019-8 | Plasma cells [#] in Bone marrow by Flow cytometry (FC) |
| 61299-4 | Eastern White Pine IgE Ab/IgE total in Serum |
| 62323-1 | Post-discharge provider ID [Identifier] |
| 77622-9 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Peritoneal dialysis fluid by Immunoassay |
| 77757-3 | 7-Hydroxyquetiapine [Mass/volume] in Urine by Confirmatory method |
| 63162-2 | Curvularia lunata IgG Ab [Mass/volume] in Serum |
| 78515-4 | Lactose [Moles/volume] in Serum or Plasma --15 minutes post dose lactose PO |
| 63434-5 | Coxsackievirus A Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 6464-2 | Microscopic observation [Identifier] in Cervix by Gram stain |
| 95657-3 | Flavivirus identified in Specimen by Neutralization test |
| 65359-2 | Sex hormone binding globulin [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
| 6675-3 | Microscopic observation [Identifier] in Tissue by Periodic acid-Schiff stain |
| 79572-4 | Folate and tryptophan and metabolites panel - Cerebral spinal fluid |
| 9572-9 | Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection |
| 80830-3 | pH of Lower respiratory specimen |
| 97189-5 | Alpha-2-Macroglobulin [Mass/volume] in Urine |
| 69547-8 | Genomic ref allele [ID] |
| 9733-7 | Porphyrins [Mass/time] in 24 hour Stool |
| 82531-5 | SDHC gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 82883-0 | Lysosomal acid lipase [Enzymatic activity/mass] in Leukocytes by 4-MU-palmitate substrate |
| 9818-6 | Cryptococcus sp Ag [Titer] in Serum by Immunoassay |
| 98227-2 | Prilocaine IgE Ab [Units/volume] in Serum |
| 72365-0 | Influenza virus A and B Ag [Identifier] in Nose by Immunofluorescence |
| 86465-2 | AST to platelet ratio index in Serum and Blood by calculation |
| 87393-5 | Salmonella sp Ab/Positive control in Serum by Immunoassay |
| 88275-3 | Streptococcus pneumoniae gryB gene [Presence] by Probe in Positive blood culture |
| 74416-9 | Measles virus IgM Ab [Units/volume] in Body fluid by Immunoassay |
| 59624-7 | chlordiazePOXIDE [Mass/mass] in Tissue |
| 5104-5 | Coxsackievirus B1 Ab [Titer] in Serum by Complement fixation |
| 30555-7 | Rickettsia typhus group IgG Ab [Presence] in Serum |
| 31005-2 | Epidermal Allergen Mix B (Budgerigar feather+Canary feather+Parrot feather+Finch feather) IgE Ab [Presence] in Serum by Multidisk |
| 42630-4 | Cannabinoids [Presence] in Blood |
| 59940-7 | Norclomipramine [Moles/volume] in Urine |
| 31309-8 | Coccidioides immitis Ab [Presence] in Body fluid |
| 31405-4 | Ganglioside GM1b IgM Ab [Units/volume] in Serum |
| 22233-1 | Coxsackievirus B5 Ab [Titer] in Cerebral spinal fluid |
| 51758-1 | POMT2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 51784-7 | Lot number of Rh immune globulin |
| 52924-8 | Platinum/Creatinine [Molar ratio] in 24 hour Urine |
| 44061-0 | CD20+FMC7+ cells/100 cells in Bone marrow |
| 44346-5 | Phenol/Creatinine [Molar ratio] in Urine |
| 44367-1 | Glycosaminoglycans/Creatinine [Molar ratio] in Urine |
| 32684-3 | LMW Heparin [Units/volume] in Platelet poor plasma |
| 33009-2 | Chylomicrons [Presence] in Body fluid |
| 3313-4 | ALPRAZolam [Mass/volume] in Urine |
| 53083-2 | Bilirubin.conjugated [Moles/volume] in Dialysis fluid |
| 44990-0 | Chlamydia trachomatis D+K IgA Ab [Presence] in Serum |
| 45031-2 | HLA-C SBT [Type] by High resolution |
| 2374-7 | Glutamine [Mass/time] in 24 hour Urine |
| 23981-4 | Borrelia burgdorferi IgG band pattern [Interpretation] in Body fluid by Immunoblot |
| 33778-2 | SmIg Ag [Presence] in Tissue by Immune stain |
| 55488-1 | Insulin [Moles/volume] in Serum or Plasma --1 hour post dose glucagon |
| 47103-7 | Copper [Moles/mass] in Hair |
| 25234-6 | Aztreonam [Mass/volume] in Specimen |
| 2535-3 | Lactate dehydrogenase 1 [Enzymatic activity/volume] in Serum or Plasma by Chemical separation |
| 35075-1 | Basophils [#/volume] in Pleural fluid |
| 35263-3 | Phosphate [Mass or Moles] in 24 hour Urine |
| 4753-0 | HLA-B48 [Presence] |
| 47721-6 | Phenylalanine/Amino acids.total in Hair |
| 25936-6 | Iodine [Moles/volume] in 24 hour Urine |
| 3578-2 | Doxepin [Presence] in Serum or Plasma |
| 48159-8 | Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay |
| 26517-3 | Polymorphonuclear cells/100 leukocytes in Cerebral spinal fluid |
| 26661-9 | Trichinella sp Ab [Presence] in Serum |
| 35861-4 | Virginiamycin [Susceptibility] |
| 5662-2 | Heavy metals [Presence] in Urine by Reinsch |
| 48679-5 | Pancytokeratin Ag [Presence] in Tissue by Immune stain |
| 48708-2 | Erythrocytes.fresh/100 erythrocytes in Cerebral spinal fluid by Manual count |
| 386-3 | Oxytetracycline [Susceptibility] by Minimum lethal concentration (MLC) |
| 57301-4 | Benzoylecgonine [Mass/volume] in Saliva (oral fluid) |
| 27946-3 | Lactate [Mass/volume] in Blood --1 hour post XXX challenge |
| 5778-6 | Color of Urine |
| 29356-3 | fentaNYL [Presence] in Serum or Plasma |
| 40009-3 | Glucose [Mass/volume] in Serum or Plasma --12.5 hours post XXX challenge |
| 40132-3 | Creatinine [Moles/volume] in Urine --30 minutes pre XXX challenge |
| 29669-9 | Rickettsia australis Ab [Presence] in Serum |
| 29909-9 | Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection |
| 58912-7 | Pigeon feather IgG Ab [Mass/volume] in Serum |
| 58949-9 | Somatotropin [Mass/volume] in Serum or Plasma --12th specimen |
| 50293-0 | 4-Hydroxyifosfamide [Mass/volume] in Blood --1 day post dose ifosfamide |
| 29984-2 | Cesium/Creatinine [Mass Ratio] in 24 hour Urine |
| 40930-0 | PYGM gene p.Arg50Ter+Gly205Ser [Presence] in Blood or Tissue by Molecular genetics method |
| 40983-9 | Parainfluenza virus 1 IgG Ab [Presence] in Serum by Immunoassay |
| 19163-5 | Cancer Ag 19-9 [Units/volume] in Pleural fluid |
| 19225-2 | Deoxyhemoglobin/Hemoglobin.total in Arterial blood |
| 1992-7 | Calcitonin [Mass/volume] in Serum or Plasma |
| 20942-9 | Plant identified [Type] in Plant |
| 21027-8 | Platelet aggregation [Interpretation] in Platelet poor plasma |
| 12890-0 | Borrelia burgdorferi 45kD Ab [Presence] in Serum by Immunoblot |
| 101165-9 | Brorphine [Presence] in Urine by Confirmatory method |
| 101501-5 | levoFLOXacin [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 13299-3 | HLA-B [Type] |
| 13423-9 | EPINEPHrine [Mass/volume] in Plasma --5th specimen post XXX challenge |
| 102148-4 | Ascaris sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13790-1 | Para nitrophenol/Creatinine [Mass Ratio] in Urine |
| 13919-6 | Hepatitis B virus core IgG Ab [Units/volume] in Serum by Immunoassay |
| 102414-0 | Liver beef IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102425-6 | Mango IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102965-1 | Perch IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103734-0 | Dyserythropoietic anemia multigene analysis in Specimen by Sequencing |
| 10580-9 | Liquefaction [Time] in Semen |
| 1610-5 | Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose L-dopa PO |
| 11068-4 | Microscopic observation [Identifier] in Body fluid by Cyto stain |
| 11183-1 | Macadamia IgE Ab [Units/volume] in Serum |
| 1121-3 | Le sup(b) Ag [Presence] on Red Blood Cells |
| 12227-5 | Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood |
| 16751-0 | Dezocine [Mass/volume] in Blood |
| 17349-2 | Neutrophil IgG Ab [Units/volume] in Serum |
| 18930-8 | Gramicidin D [Susceptibility] |
| 74525-7 | Dehydrosebacylcarnitine (C10:1-DC) [Moles/volume] in Serum or Plasma |
| 74536-4 | Neisseria meningitidis serogroup w135 DNA [Presence] in Specimen by NAA with probe detection |
| 74910-1 | Porphyrin fractions and creatinine panel [Molar ratio] - 24 hour Urine |
| 91862-3 | Bartonella sp DNA [Presence] in Aspirate by NAA with probe detection |
| 76622-0 | Lysosomal acid lipase [Interpretation] in Fibroblast Narrative |
| 93195-6 | NUDT15 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
| 93475-2 | Busulfan clearance from plasma over study |
| 6204-2 | Pea IgE Ab [Units/volume] in Serum |
| 77142-8 | Potassium [Moles/volume] in Serum, Plasma or Blood |
| 93992-6 | Osmolality of Serum or Plasma--3 hours post fluid fast |
| 78233-4 | Cells.ALK gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 94379-5 | Enterobacter cloacae complex DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 6457-6 | DNA double strand Ab [Presence] in Serum by Immunofluorescence (IF) Crithidia luciliae |
| 79178-0 | 4-Hydroxycyclohexylacetate/Creatinine [Molar ratio] in Urine |
| 95071-7 | Chromosome region 14q32 rearrangements in Bone marrow by FISH |
| 95202-8 | HLA-A2 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC) |
| 79651-6 | Dihydrothymine [Moles/volume] in Cerebral spinal fluid |
| 96404-9 | Para aminohippurate renal clearance/1.73 sq M in Urine and Serum or Plasma |
| 80529-1 | Everolimus [Mass/volume] in DBS |
| 815-1 | A Ab [Presence] in Serum or Plasma from Blood product unit |
| 96967-5 | CD79B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 97157-2 | Human papilloma virus 6+11+42+43+44 DNA [Presence] in Genital specimen by Probe with signal amplification |
| 69739-1 | Drugs of abuse panel - Urine by Screen method |
| 81762-7 | F8 gene intron 1 inversion targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 82180-1 | Meningitis+Encephalitis pathogens panel - Cerebral spinal fluid by NAA with non-probe detection |
| 9732-9 | Phosphoserine [Mass/time] in 24 hour Urine |
| 9781-6 | Acanthamoeba sp identified in Specimen by Organism specific culture |
| 9790-7 | Methyl bromide [Mass/volume] in Serum or Plasma |
| 71599-5 | Mesothelial cells/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count |
| 8238-8 | Phencyclidine [Presence] in Urine by SAMHSA screen method |
| 82541-4 | Cetuximab IgE Ab [Units/volume] in Serum |
| 82975-4 | Desmosome IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 990-2 | Di sup(b) Ag [Presence] on Red Blood Cells |
| 99548-0 | Gas and electrolytes panel - Arterial blood |
| 72973-1 | PHENobarbital induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86143-5 | Streptococcus pneumoniae Danish serotype 8 Ab [Presence] in Serum |
| 73640-5 | Nitazoxanide [Susceptibility] by Disk diffusion (KB) |
| 73972-2 | Morphine Free [Mass/volume] in Blood |
| 74087-8 | Hexacarboxylporphyrin III [Moles/mass] in Stool |
| 50718-6 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 42247-7 | Hemoglobin pattern [Interpretation] in Blood by HPLC Narrative |
| 21662-2 | CYP2D6 gene c.2637delA [Presence] in Blood or Tissue by Molecular genetics method |
| 51376-2 | CD9 cells/100 cells in Bone marrow |
| 22394-1 | Legionella pneumophila 8 Ab [Titer] in Serum |
| 32058-0 | carBAMazepine free [Moles/volume] in Serum or Plasma |
| 3254-0 | Fibrin.soluble [Units/volume] in Serum by Coagulation assay |
| 22834-6 | Avian metapneumovirus Ab [Presence] in Serum |
| 22995-5 | Chlamydophila psittaci Ab [Presence] in Serum by Immune diffusion (ID) |
| 23037-5 | Duck hepatitis virus 2 neutralizing antibody [Presence] in Serum by Neutralization test |
| 44642-7 | Gleason pattern.secondary in Prostate tumor |
| 23532-5 | Trypanosoma sp Ab [Presence] in Serum by Agglutination |
| 53711-8 | Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid |
| 53715-9 | Paraneoplastic Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 53731-6 | Posaconazole [Mass/volume] in Serum or Plasma |
| 45369-6 | Lymphocyte proliferation stimulated by 0.5 ug phytohemagglutinin in Blood |
| 54431-2 | Pooled cryoprecipitate given [Volume] |
| 46126-9 | Endomysium IgA Ab [Presence] in Serum by Immunofluorescence |
| 46981-7 | Silicon [Mass/volume] in Urine |
| 4699-5 | HLA-A34(10) [Presence] in Donor |
| 24300-6 | Coxsackievirus A10 Ab [Titer] in Serum --1st specimen |
| 24343-6 | Gas and Carbon monoxide panel - Blood |
| 34477-0 | Blood group antibodies identified in Serum or Plasma by Elution |
| 54933-7 | Abrine [Mass/volume] in Urine |
| 54940-2 | Styrene [Mass/volume] in Serum or Plasma |
| 55395-8 | Phospholipid IgA and IgG and IgM panel - Serum |
| 35736-8 | Chlamydia sp rRNA [Presence] in Nasopharynx by Probe |
| 26051-3 | Epithelial cells.extrarenal [#/area] in Urine sediment by Microscopy high power field |
| 26566-0 | CD19+Lambda+ cells/100 cells in Specimen |
| 26629-6 | Legionella polyvalent C Ab [Presence] in Serum |
| 3583-2 | Doxepin+Metabolites [Mass/volume] in Serum or Plasma |
| 4863-7 | HLA-Cw7 [Presence] |
| 48757-9 | 3-Hydroxyoctanoate (3-OH-C8:0) [Moles/volume] in Serum or Plasma |
| 48896-5 | Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 38245-7 | Brucella canis IgG Ab [Presence] in Serum |
| 38277-0 | Lymphocyte proliferation stimulated by 0.5 ug/mL Candida albicans [Units/volume] in Blood |
| 57107-5 | Lutropin [Units/volume] in Serum or Plasma --10 minutes pre dose gonadotropin releasing hormone |
| 27312-8 | HYDROcodone Free [Mass/mass] in Stool |
| 3950-3 | PHENobarbital [Mass/volume] in Urine |
| 58058-9 | Cs sup(a) Ag [Presence] in Serum or Plasma |
| 49332-0 | Vasopressin [Mass/volume] in Plasma --30 minutes post XXX challenge |
| 28644-3 | Carbon dioxide [Partial pressure] in Arterial cord blood |
| 40155-4 | Glucose [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 58541-4 | Corticotropin [Moles/volume] in Plasma --11th specimen post XXX challenge |
| 29664-0 | Chlamydia sp IgA Ab [Presence] in Serum by Immunoassay |
| 29921-4 | Boron [Mass/time] in 24 hour Urine |
| 4038-6 | Stanozolol [Mass/time] in 24 hour Urine |
| 50498-5 | Somatotropin [Mass/volume] in Serum or Plasma --6th specimen |
| 30230-7 | Segmented neutrophils/100 leukocytes in Body fluid by Manual count |
| 30374-3 | Basophils/100 leukocytes in Cerebral spinal fluid |
| 4094-9 | Verapamil [Mass/volume] in Serum or Plasma |
| 41148-8 | Herpes virus 6 IgG Ab [Presence] in Serum |
| 20466-9 | Estriol (E3).unconjugated [Multiple of the median] in Serum or Plasma |
| 100654-3 | Pyruvate kinase M2 [Presence] in Stool |
| 100885-3 | Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection |
| 12517-9 | Catecholamines [Mass/volume] in Urine --3rd specimen post XXX challenge |
| 101834-0 | Dexamethasone [Moles/volume] in Serum or Plasma |
| 13558-2 | Disopyramide [Presence] in Serum or Plasma |
| 13573-1 | Nordoxepin [Presence] in Serum or Plasma |
| 13894-1 | Pregnenolone [Mass/time] in 24 hour Urine |
| 14303-2 | Transfuse plateletpheresis [Volume] |
| 103744-9 | Other cells/100 leukocytes in Bronchoalveolar lavage by Manual count |
| 14835-3 | Methanol [Moles/volume] in Serum or Plasma |
| 14981-5 | A variant subtype Ab [Presence] in Serum or Plasma from Donor |
| 104299-3 | UGT1A9 gene.1b-118(dT)9>10 [Presence] in Blood or Tissue by Molecular genetics method |
| 10602-1 | Spermatozoa Abnormal Head/100 spermatozoa in Semen |
| 10674-0 | Hepatitis B virus surface Ag [Presence] in Tissue by Immune stain |
| 10895-1 | Clostridioides difficile toxin B [Presence] in Stool |
| 16613-2 | Cholesterol crystals [Presence] in Stone by Infrared spectroscopy |
| 12248-1 | Epithelial cells.renal [Presence] in Urine sediment by Light microscopy |
| 176-8 | Chlortetracycline [Susceptibility] by Minimum lethal concentration (MLC) |
| 17735-2 | Trichinella spiralis IgM Ab [Presence] in Serum |
| 18205-5 | Carbon disulfide [Presence] in Urine |
| 18243-6 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid |
| 19076-9 | Cells Counted Total [#] in Specimen |
| 74654-5 | Morphine [Presence] in Saliva (oral fluid) by Confirmatory method |
| 91855-7 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Genital specimen by NAA with probe detection |
| 60497-5 | SLC22A5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 75735-1 | BMPR1A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 93244-2 | Complement Sc5b-9 [Mass/volume] in Serum or Plasma by Immunoassay |
| 6229-9 | Rhizopus nigricans IgE Ab [Units/volume] in Serum |
| 77213-7 | Carbonic anhydrase 6 IgM Ab [Units/volume] in Serum by Immunoassay |
| 77216-0 | Parotid secretory protein IgM Ab [Units/volume] in Serum by Immunoassay |
| 7850-1 | Taenia solium larva Ab [Units/volume] in Serum |
| 63381-8 | DNA double strand IgG Ab [Titer] in Serum |
| 64415-3 | KIR gene allele 2DL3 [Presence] in Blood or Tissue by Molecular genetics method |
| 95085-7 | C peptide [Mass/volume] in Serum or Plasma --3.5 hours post meal |
| 95165-7 | Mycoplasma gallisepticum Ab/Positive control in Serum by Immunoassay |
| 95174-9 | Ornithobacterium rhinotracheale RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 95601-1 | Leucine-rich glioma-inactivated protein 1 Ab [Titer] in Serum by Cell binding immunofluorescent assay |
| 95681-3 | Tahyna virus IgM Ab [Presence] in Specimen by Immunoassay |
| 66737-8 | CYP2C19 gene c.1A>G(*4) [Presence] in Blood or Tissue by Molecular genetics method |
| 79659-9 | Purine and Pyrimidine pattern [Interpretation] in Serum or Plasma Narrative |
| 80121-7 | Acyclovir [Mass/volume] in Cerebral spinal fluid |
| 97161-4 | Amphetamines panel - Urine by Confirmatory method |
| 69769-8 | Dicarboxyoleylcarnitine (C18:1-DC)/Creatinine [Molar ratio] in Urine |
| 7105-0 | Aspergillus nidulans IgE Ab [Units/volume] in Serum |
| 82299-9 | Escherichia coli shiga-like toxin 1+2 [Presence] in Stool by Immunoassay |
| 97991-4 | Herpes virus 6 IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 98201-7 | Fuchsia spp IgE Ab [Units/volume] in Serum |
| 98273-6 | Left pelvic lymph nodes positive [#] in Specimen |
| 7185-2 | Cat dander triggered histamine release [Units/volume] in Blood |
| 85311-9 | Extent of anterior margin carcinoma involvement in Breast cancer specimen Qualitative by Light microscopy |
| 72502-8 | Homocyst(e)ine [Molar concentration difference] in Serum or Plasma --6 hours post dose methionine - post CFst |
| 72774-3 | Venlafaxine [Mass/volume] in Urine by Confirmatory method |
| 73019-2 | Fluconazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73121-6 | Tetracycline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87479-2 | Boron [Mass/mass] in Specimen |
| 87924-7 | Rickettsia conorii IgG Ab [Presence] in Serum by Immunoassay |
| 74375-7 | 2,2',3,5'-Tetrachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
| 31111-8 | Reticulocyte production index |
| 31129-0 | CD11c-CD20+ cells [#/volume] in Blood |
| 42188-3 | CD3+CD16+CD56+ cells [#/volume] in Blood |
| 4256-4 | Flecainide [Mass] of Dose |
| 60142-7 | Pendimethalin [Mass/volume] in Blood |
| 31444-3 | Intrinsic factor blocking Ab [Presence] in Serum |
| 51160-0 | CD33+CD34+ blasts/100 blasts in Specimen |
| 4285-3 | Insulin Lente [Mass] of Dose |
| 42883-9 | CD52 cells/100 cells in Tissue |
| 42974-6 | Powassan virus IgG Ab [Titer] in Serum |
| 21742-2 | WT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 31912-9 | Neisseria meningitidis Ag [Presence] in Specimen |
| 22641-5 | Glutamine [Moles/volume] in Cerebral spinal fluid |
| 22720-7 | Glutamine [Moles/volume] in Specimen |
| 32813-8 | Pathologist interpretation of Bronchial specimen tests |
| 44480-2 | Herpes simplex virus 1+2 Ab [Presence] in Serum |
| 44728-4 | HLA-DQA1 [Presence] |
| 23345-2 | Pasteurella multocida serotype [Identifier] in Specimen by Agglutination |
| 33383-1 | Influenza virus A Bangkok Ab [Titer] in Cerebral spinal fluid |
| 33575-2 | Chlamydia trachomatis I Ab [Titer] in Serum by Immunofluorescence |
| 33664-4 | CD59 cells [Presence] in Blood |
| 33671-9 | Platelet aggregation collagen induced lag [Time] in Control Platelet rich plasma --High dose |
| 53570-8 | aPTT.lupus insensitive in Platelet poor plasma by Coagulation assay |
| 34223-8 | 17-Ketosteroids/Creatinine [Molar ratio] in Urine |
| 4657-3 | Kallikrein [Enzymatic activity/volume] in Plasma |
| 24126-5 | Adenovirus type [Identifier] in Specimen by Neutralization test |
| 34375-6 | Streptokinase Ab [Titer] in Serum |
| 47449-4 | Influenza virus A H14 Ab [Titer] in Serum |
| 25176-9 | Amikacin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 56928-5 | Hepatitis C virus E2 Ab [Presence] in Serum by Immunoblot |
| 48402-2 | Latex IgE Ab/IgE total in Serum |
| 48717-3 | Leishmania mexicana IgM Ab [Units/volume] in Serum by Immunofluorescence |
| 27049-6 | Secobarbital [Mass/volume] in Milk |
| 57339-4 | Citrate [Mass/time] in 12 hour Urine |
| 49282-7 | Metanephrine and Normetanephrine [Interpretation] in Serum or Plasma Narrative |
| 2772-2 | Phenylpyruvate [Presence] in Urine |
| 27826-7 | Insulin [Units/volume] in Serum or Plasma --2 hours post XXX challenge |
| 27888-7 | Somatotropin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 38690-4 | 4,6-Dinitro-O-Cresol [Mass/volume] in Air |
| 49495-5 | Hepatitis B virus surface Ab actual/Negative control in Serum or Plasma |
| 29284-7 | Leucine [Presence] in Blood |
| 49777-6 | Hepatitis G virus Ab [Units/volume] in Serum |
| 58816-0 | C peptide [Mass/volume] in Serum or Plasma --2nd specimen |
| 59267-5 | Karyotype [Identifier] in Blood or Tissue by FISH Narrative |
| 50312-8 | Clusterin Ag [Presence] in Tissue by Immune stain |
| 30359-4 | Histone Ab [Units/volume] in Serum |
| 4102-0 | 5-Fluorocytosine [Mass] of Dose |
| 19363-1 | Cocaine cutoff [Mass/volume] in Urine for Confirmatory method |
| 12339-8 | Diquat [Presence] in Urine |
| 12-5 | Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 12651-6 | Glucose [Mass/volume] in Serum or Plasma --10 minutes pre XXX challenge |
| 13324-9 | Herpes simplex virus 1 Ab [Units/volume] in Serum by Immunofluorescence |
| 101810-0 | Xylazine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 101851-4 | Flunisolide [Moles/volume] in Urine |
| 101867-0 | Ma2 Antibody [Presence] in Cerebral spinal fluid by Immunoassay |
| 102082-5 | Alpha-1-Antitrypsin Proteotype Panel - Serum or Plasma |
| 14546-6 | Mumps virus Ag [Presence] in Throat by Immunofluorescence |
| 15232-2 | Regional Allergen Mix A (Common ragweed+Mugwort+Japanese cedar+Orchard grass+Timothy) IgE Ab [Presence] in Serum by Multidisk |
| 104404-9 | Giardia lamblia cysts [Presence] in Stool by Microscopy |
| 10976-9 | 6-Monoacetylmorphine (6-MAM) [Presence] in Urine |
| 1160-1 | little e Ab [Presence] in Serum or Plasma from Blood product unit |
| 16817-9 | Entamoeba histolytica Ab [Presence] in Serum by Immune diffusion (ID) |
| 17407-8 | Human papilloma virus 44 Ag [Presence] in Specimen |
| 17901-0 | Bacteria # 4 identified in Throat by Aerobe culture |
| 17919-2 | Bacteria # 5 identified in Wound shallow by Aerobe culture |
| 91090-1 | Fungal ITS region [Presence] in Specimen by NAA with probe detection |
| 74857-4 | West Nile virus RNA [Presence] in Serum or Plasma from Donor by NAA with probe detection |
| 91822-7 | Adenovirus Ag [Presence] in Upper respiratory specimen by Immunoassay |
| 91871-4 | Bordetella sp DNA [Identifier] in Throat by NAA with probe detection |
| 60486-8 | MED12 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 75811-0 | Antipsychotics [Interpretation] in Blood or Urine Qualitative by Screen method |
| 92820-0 | Glucose post glucagon stimulation panel - Serum or Plasma |
| 621-3 | Bacteria identified in Synovial fluid by Culture |
| 62359-5 | Chromosome banding method - |
| 77174-1 | CALR gene exon 9 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 77193-1 | Bacteria identified in Uterus by Culture |
| 63193-7 | Common Sagebrush IgG Ab [Mass/volume] in Serum |
| 63335-4 | SCL-70 extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
| 7813-9 | Babesia sp Ab [Units/volume] in Serum |
| 94491-8 | Protoporphyrin Free [Mass/volume] in Red Blood Cells |
| 63451-9 | CD3+CD8+ (T8 suppressor) cells [#/volume] in Cerebral spinal fluid |
| 63534-2 | DNA double strand IgG Ab [Units/volume] in Body fluid |
| 95279-6 | HSPB8 gene full mutation analysis in Blood or Tissue by Sequencing |
| 95545-0 | Loprazolam [Mass/volume] in Serum by Confirmatory method |
| 6608-4 | Virus identified in Isolate by Culture |
| 6719-9 | Cherry IgE Ab [Units/volume] in Serum |
| 79510-4 | 3-Hydroxyhippurate [Moles/volume] in Serum or Plasma |
| 80193-6 | Ecgonine methyl ester [Mass/volume] in Blood by Confirmatory method |
| 96355-3 | Equine herpesvirus 1 [Presence] in Specimen by Organism specific culture |
| 96491-6 | Neuronal intermediate filament IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 68903-4 | Erythrocytes by Light microscopy in Urine sediment collected for unspecified duration |
| 80601-8 | Bordetella pertussis+parapertussis+bronchiseptica gidA gene [Presence] in Nasopharynx by NAA with probe detection |
| 96741-4 | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by Sequencing |
| 97176-2 | Yersinia outer protein D Ab [Presence] in Serum by Line blot |
| 69356-4 | oxyCODONE [Presence] in Saliva (oral fluid) by Screen method |
| 71630-8 | Leukocytes other/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
| 82421-9 | Ks Ab [Units/volume] in Serum by Line blot |
| 98101-9 | Interleukin 23 [Mass/volume] in Serum or Plasma |
| 99028-3 | Serratia marcescens DNA [Presence] in Urine by NAA with probe detection |
| 721-1 | Free Hemoglobin [Mass/volume] in Plasma |
| 99470-7 | Paper wasp recombinant (rPol d) 5 IgG Ab [Mass/volume] in Serum |
| 85820-9 | Clot firmness reduction [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude + heparinase |
| 866-4 | A3 Ag [Presence] on Red Blood Cells from Blood product unit |
| 73262-8 | Minoxidil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88171-4 | Microscopic observation [Presence] in Cornea or Conjunctiva by Acid fast stain |
| 74410-2 | Polychlorinated biphenyl (PCB) panel - Serum or Plasma by Confirmatory method |
| 41287-4 | Epithelial cells.parabasal [Presence] in Vaginal fluid by Light microscopy |
| 4138-4 | Bendroflumethiazide [Mass] of Dose |
| 5950-1 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --20M post incubation with normal plasma |
| 59802-9 | Protein.monoclonal band 4/Protein.total in Urine by Electrophoresis |
| 60078-3 | Ganciclovir [Mass/volume] in Urine |
| 60125-2 | Papaverine [Mass/volume] in Blood |
| 213-9 | cycloSERINE [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 21465-0 | Plasmodium falciparum Ab [Titer] in Serum by Immunofluorescence |
| 2159-2 | Creatinine [Mass/volume] in Amniotic fluid |
| 31188-6 | Microscopic observation [Identifier] in Kidney fine needle aspirate by Cyto stain |
| 51356-4 | CD19+CD58+ cells/100 cells in Blood |
| 42942-3 | Yersinia sp IgM Ab [Titer] in Serum |
| 21733-1 | RET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2213-7 | Dimethadione [Mass/volume] in Serum or Plasma |
| 3181-5 | Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay |
| 43221-1 | Chloride/Creatinine [Ratio] in Urine |
| 32069-7 | ePHEDrine+Pseudoephedrine [Presence] in Specimen |
| 32159-6 | Carbonated calcium phosphate/Total in Stone |
| 32509-2 | CD3-CD16+CD56+ (Natural killer) cells/100 cells in Tissue |
| 5227-4 | Streptococcal hyaluronidase Ab [Presence] in Serum |
| 52788-7 | Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG |
| 43884-6 | Ampicillin [Presence] in Urine |
| 44064-4 | CD20+FMC7+ cells/100 cells in Tissue |
| 44079-2 | Chlamydia trachomatis IgA and IgG and IgM [Interpretation] in Serum |
| 44264-0 | Influenza virus A H5 RNA [Units/volume] (viral load) in Specimen by NAA with probe detection |
| 22830-4 | Avian paramyxovirus 1 Ab [Titer] in Serum by Agglutination |
| 5323-1 | Orientia tsutsugamushi Ab [Titer] in Serum by Complement fixation |
| 44596-5 | IgG Ag [Presence] in Skin by Immunofluorescence |
| 23441-9 | Swine vesicular disease virus Ab [Presence] in Serum |
| 23461-7 | Theileria annulata Ab [Titer] in Serum |
| 3336-5 | Amitriptyline [Mass/volume] in Serum or Plasma --trough >12 hours post dose |
| 53815-7 | Platelet glycoprotein IIb/IIIa Ab [Units/volume] in Blood |
| 53909-8 | Mycobacterium sp identified in Pleural fluid by Organism specific culture |
| 23986-3 | Brucella abortus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 54033-6 | Rickettsia spotted fever group Ag [Presence] in Tissue by Immune stain |
| 4580-7 | Hemoglobin F1/Hemoglobin.total in Blood |
| 34697-3 | Alpha 1 antitrypsin actual/normal in Serum or Plasma |
| 34711-2 | Cholinesterase [Presence] in Serum or Plasma |
| 47122-7 | Methyprylon [Moles/volume] in Gastric fluid |
| 47316-5 | Inner ear 68kD Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 25433-4 | Free Hemoglobin [Moles/volume] in Plasma |
| 34718-7 | CFTR gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
| 3522-0 | cycloSPORINE+Metabolites [Mass/volume] in Blood |
| 3528-7 | Tetrahydrocannabinol [Mass/volume] in Serum or Plasma |
| 35312-8 | Trypsin [Enzymatic activity/volume] in Body fluid --1st specimen post Sincalide |
| 47571-5 | Argininosuccinate synthase [Enzymatic activity/mass] in Fibroblast |
| 4780-3 | HLA-B63(15) [Presence] in Donor |
| 25619-8 | Cortisol [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 25849-1 | Alpha aminobutyrate/Creatinine [Molar ratio] in 24 hour Urine |
| 56374-2 | Rat epithelium IgG4 Ab [Mass/volume] in Serum |
| 56503-6 | Somatotropin [Units/volume] in Serum or Plasma --8 hours post XXX challenge |
| 56530-9 | CV2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 48275-2 | Ibuprofen triggered leukotriene release [Mass/volume] by Leukocytes |
| 35844-0 | Telithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 35852-3 | Trospectinomycin [Susceptibility] by Disk diffusion (KB) |
| 56920-2 | Coxiella burnetii IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 38356-2 | Thyroxine (T4) Ab [Presence] in Serum |
| 3847-1 | Neopterin [Mass/volume] in Urine |
| 57391-5 | Eosinophils/100 leukocytes in Synovial fluid by Manual count |
| 57580-3 | Aldosterone [Mass/volume] in Serum or Plasma --post XXX challenge |
| 48934-4 | 11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Specimen |
| 49024-3 | Differential cell count method - Blood |
| 49112-6 | Borna disease virus Ab [Units/volume] in Serum |
| 57739-5 | Centromere Ab [Presence] in Serum by Immunoblot |
| 49419-5 | Papova virus SV 40 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
| 49681-0 | CD36 cells/100 cells in Body fluid |
| 39792-7 | Sodium [Moles/volume] in Capillary blood |
| 40059-8 | Albumin [Mass/volume] in Serum or Plasma --12 hours post XXX challenge |
| 58574-5 | Corticotropin [Mass/volume] in Plasma --2 hours post dose glucose |
| 29867-9 | 3-Hydroxy,3-Methylglutarate [Presence] in Urine |
| 40685-0 | Immunoelectrophoresis for Cerebral spinal fluid |
| 59166-9 | Bilirubin.total [Moles/time] in 24 hour Stool |
| 3006-4 | Threonine [Mass/volume] in Cerebral spinal fluid |
| 19167-6 | Carcinoembryonic Ag [Moles/volume] in Serum or Plasma |
| 20705-0 | Clostridium botulinum toxin [Identifier] in Serum by Animal inoculation |
| 20734-0 | Brucella sp identified in Tissue by Organism specific culture |
| 20800-9 | Clostridium perfringens enterotoxin [Presence] in Small intestine Fixed |
| 12394-3 | Butorphanol [Mass/volume] in Serum or Plasma |
| 101219-4 | Legionella sp DNA [Presence] in Specimen by NAA with probe detection |
| 101639-3 | PDGFB gene rearrangements in Blood or Tissue by FISH |
| 13120-1 | Ovary Ab [Units/volume] in Serum |
| 13601-0 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
| 13776-0 | Methylmalonate/Creatinine [Mass Ratio] in Urine |
| 13856-0 | Androstenedione [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin IM |
| 13865-1 | Glucose [Mass/volume] in Serum or Plasma --2.5 hours post 50 g lactose PO |
| 102245-8 | Cockroach IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102750-7 | Grapefruit IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14593-8 | Aluminum [Moles/volume] in Serum or Plasma |
| 14863-5 | oxyCODONE [Presence] in Gastric fluid |
| 16197-6 | Codeine [Presence] in Urine by Confirmatory method |
| 10700-3 | Orthopoxvirus [Identifier] in Skin by Electron microscopy |
| 16421-0 | Azithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 17421-9 | Parrot serum Ab [Units/volume] in Serum |
| 17904-4 | Bacteria # 2 identified in Tissue by Aerobe culture |
| 18492-9 | Chlamydia trachomatis G+F+K IgM Ab [Titer] in Serum by Immunofluorescence |
| 18872-2 | Capreomycin [Susceptibility] |
| 90249-4 | Natural killer cell cytotoxicity.IL-stimulated 7.5:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
| 90416-9 | Lymphocyte subset and B-cell phenotyping panel - Blood |
| 75268-3 | Leucine/Phenylalanine [Molar ratio] in DBS |
| 75633-8 | Rheumatoid arthritis disease activity score Calculated by VectraDA |
| 75643-7 | 7-Hydroxymitragynine [Presence] in Urine by Confirmatory method |
| 62486-6 | Herpes virus 6B DNA [Presence] in Specimen by NAA with probe detection |
| 94369-6 | Staphylococcus aureus DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 94713-5 | Aspartylglycosamine [Moles/volume] in Cerebral spinal fluid |
| 94733-3 | Anticonvulsants [Presence] in Saliva (oral fluid) by Confirmatory method |
| 63540-9 | Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid |
| 95075-8 | Cannabidiol/Tetrahydrocannabinol [Ratio] in Urine by Confirmatory method |
| 6579-7 | Vibrio sp identified in Stool by Organism specific culture |
| 96466-8 | Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 67835-9 | Eosinophils [#/volume] in Pleural fluid from Fetus |
| 6825-4 | Crystals [type] in Body fluid by Light microscopy |
| 68366-4 | Bacteria identified in Blood product unit by Culture |
| 68452-2 | Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid by Pyruvate to lactate reaction |
| 80892-3 | Heparin unfractionated [Units/volume] in Blood by Heparin protamine titration |
| 81321-2 | Influenza virus A H5 Asian RNA [Cycle Threshold #] in Respiratory system specimen by Nucleic acid amplification using primer-probe set H5b |
| 96538-4 | Rocio virus IgG Ab [Presence] in Specimen by Immunoassay |
| 69936-3 | Gardnerella vaginalis DNA [Presence] in Specimen by NAA with probe detection |
| 97638-1 | Streptococcus pyogenes DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 703-9 | Basophilic stippling [Presence] in Blood by Light microscopy |
| 98045-8 | Flaxseed IgE Ab [Units/volume] in Serum |
| 72209-0 | inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
| 72393-2 | Cell count and Differential panel - Vitreous fluid by Manual count |
| 86005-6 | Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 72983-0 | OLANZapine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73402-0 | Doxycycline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88701-8 | Norovirus genogroups I and II RNA panel - Stool by NAA with probe detection |
| 89579-7 | Troponin I.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method |
| 51042-0 | CD11c blasts/100 blasts in Specimen |
| 4237-4 | Erythromycin [Mass] of Dose |
| 42525-6 | Mycoplasma pneumoniae IgM Ab [Titer] in Pleural fluid by Immunofluorescence |
| 512-4 | Trimethoprim [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 51292-1 | CD33 cells/100 cells in Cerebral spinal fluid |
| 21681-2 | G6PD gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 2178-2 | Cystine [Mass/volume] in Urine |
| 51902-5 | Cadmium [Mass/volume] in Air |
| 43329-2 | Eastern equine encephalitis virus Ab [Titer] in Serum by Complement fixation |
| 32206-5 | Plasmodium sp identified in Blood by Light microscopy |
| 52895-0 | Tellurium [Moles/volume] in Urine |
| 22816-3 | Avian infectious laryngotracheitis virus Ag [Presence] in Specimen by Neutralization test |
| 23003-7 | Classical swine fever virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 53483-4 | Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose betaxolol |
| 44461-2 | American house dust mite Ab [Presence] in Serum by Immune diffusion (ID) |
| 53829-8 | Casein IgG Ab [Mass/volume] in Serum |
| 23696-8 | Canine distemper virus Ag [Presence] in Conjunctival specimen |
| 54283-7 | Glycerol [Mass/volume] in Body fluid |
| 4582-3 | Hemoglobin G - Coushatta [Units/volume] in Blood by Electrophoresis alkaline (pH 8.9) |
| 54486-6 | Glucose [Mass/volume] in Water |
| 55440-2 | Cholesterol.in LDL (real) [Mass/volume] in Serum or Plasma by VAP |
| 47107-8 | Ethanol [Moles/volume] in Gastric fluid |
| 35010-8 | Segmented neutrophils [#/volume] in Peritoneal fluid |
| 35068-6 | Blasts [#/volume] in Cerebral spinal fluid |
| 350-9 | Nalidixate [Susceptibility] by Minimum lethal concentration (MLC) |
| 35142-9 | Amphiphysin Ab [Titer] in Cerebral spinal fluid |
| 55842-9 | Corticosterone [Moles/time] in 24 hour Urine |
| 25956-4 | Methionine [Moles/volume] in 24 hour Urine |
| 35544-6 | Potato IgG Ab [Mass/volume] in Serum |
| 56384-1 | Sardine (pilchard) IgG4 Ab [Mass/volume] in Serum |
| 56422-9 | White Birch IgG4 Ab [Mass/volume] in Serum |
| 4799-3 | HLA-B75(15) [Presence] |
| 3738-2 | Maprotiline [Mass/volume] in Urine |
| 48552-4 | HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 2.6 log copies/mL |
| 27184-1 | Alpha 1 globulin [Presence] in Urine |
| 38577-3 | Carbon disulfide [Mass/volume] in Air |
| 49168-8 | Orientia tsutsugamushi Karp IgM Ab [Titer] in Body fluid |
| 27941-4 | Lactate [Mass/volume] in Cerebral spinal fluid |
| 5782-8 | Crystals [type] in Urine sediment by Light microscopy |
| 5785-1 | Eosinophils [#/area] in Urine sediment by Microscopy high power field |
| 29343-1 | Rubella virus IgG Ab [Units/volume] in Body fluid |
| 58563-8 | Corticotropin [Mass/volume] in Plasma --2.5 hours post dose glucagon |
| 29976-8 | Molybdenum/Creatinine [Mass Ratio] in 24 hour Urine |
| 40713-0 | Giardia lamblia IgG Ab [Presence] in Serum by Immunoassay |
| 3004-9 | Thiocyanate [Mass/volume] in Urine |
| 19464-7 | Ethylmorphine cutoff [Mass/volume] in Urine for Screen method |
| 20850-4 | Bovine herpesvirus 4 Ag [Presence] in Tissue by Immunofluorescence |
| 100702-0 | Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection |
| 12465-1 | Ethanol [Mass/volume] in Vitreous fluid |
| 12485-9 | Amobarbital [Presence] in Gastric fluid |
| 13221-7 | Chlamydia trachomatis G+F+K IgM Ab [Units/volume] in Serum |
| 13273-8 | Sporothrix schenckii Ab [Presence] in Serum |
| 13280-3 | Rubella virus IgG Ab [Units/volume] in Serum --2nd specimen |
| 13414-8 | Serine [Mass/volume] in Amniotic fluid |
| 13477-5 | Orthocresol/Creatinine [Mass Ratio] in Urine |
| 102548-5 | Pumpkin Seed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13987-3 | Alpha 2 globulin/Protein.total in 24 hour Urine by Electrophoresis |
| 14043-4 | Cortisol Free [Mass/time] in 12 hour Urine |
| 102859-6 | White Pepper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103127-7 | Honey bee recombinant (rApi m) 10 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10368-9 | Lead [Mass/volume] in Capillary blood |
| 10418-2 | Transfuse factor IX [Volume] |
| 104461-9 | Yellow fever virus IgG Ab [Titer] in Serum by Immunoassay |
| 15336-1 | Other Antibiotic [Susceptibility] by Serum bactericidal titer |
| 10848-0 | Chlamydia sp IgG Ab [Titer] in Serum by Immunofluorescence |
| 1100-7 | Kp sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 16319-6 | Acrylamide [Mass/volume] in Serum or Plasma |
| 11585-7 | Bordetella pertussis Ab [Units/volume] in Serum |
| 1726-9 | Adenosine monophosphate.cyclic [Mass/volume] in Serum or Plasma |
| 1773-1 | Fatty acids.very long chain C24:0 (Tetracosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Serum or Plasma |
| 90781-6 | N,N'-dimethylarginine [Mass/volume] in Serum or Plasma |
| 74648-7 | Methylenedioxyamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method |
| 74756-8 | Soluble fms-like tyrosine kinase-1 [Mass/volume] in Serum |
| 74983-8 | Phenytoin Free [Mass/volume] in Serum or Plasma --trough |
| 6100-2 | Duck feather IgE Ab [Units/volume] in Serum |
| 61238-2 | Candida albicans IgE Ab/IgE total in Serum |
| 6232-3 | Rough Marsh Elder IgE Ab [Units/volume] in Serum |
| 9415-1 | Carbamazepine 10,11-Epoxide [Mass/volume] in Serum or Plasma |
| 63190-3 | Rough Marsh Elder IgG Ab [Mass/volume] in Serum |
| 7866-7 | Echovirus 19 Ab [Units/volume] in Serum |
| 94342-3 | Neuronal nuclear type 1 IgG Ab [Titer] in Serum by Immunofluorescence |
| 94483-5 | Parainfluenza virus 1 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 6785-0 | Kappa light chains [Presence] in Serum by Electrophoresis |
| 8070-5 | Gliadin IgM Ab [Units/volume] in Serum |
| 96510-3 | Heartland banyangvirus IgG Ab [Presence] in Specimen by Immunoassay |
| 96586-3 | Alanine aminotransferase [Enzymatic activity/volume] in DBS |
| 96617-6 | HLA-A unresolved alleles [Type] by High resolution |
| 96634-1 | HLA-C [Type] in Donor by Low resolution |
| 69825-8 | 2-Ethylhydracrylate [Moles/volume] in Cerebral spinal fluid |
| 69925-6 | European tick borne encephalitis virus IgM Ab index [Units/volume] in Serum and CSF by Immunoassay |
| 70068-2 | Streptococcus dysgalactiae subspecies equisimilis DNA [Presence] in Specimen by NAA with probe detection |
| 70069-0 | Streptococcus intermedius DNA [Presence] in Specimen by NAA with probe detection |
| 9742-8 | Chloride [Moles/time] in 24 hour Stool |
| 70136-7 | Rickettsia spotted fever group IgM Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
| 71601-9 | Leukocytes other/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count |
| 72157-1 | Apo-transcobalamin II [Moles/volume] in Serum |
| 85621-1 | Zika virus RNA [Presence] in Amniotic fluid by NAA with probe detection |
| 99603-3 | Band form neutrophils/100 leukocytes in Peritoneal fluid by Manual count |
| 725-2 | Hemoglobin [Presence] in Urine |
| 85782-1 | Candida glabrata DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 73078-8 | Warfarin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74321-1 | MICA*046 IgG Ab [Presence] in Serum |
| 74334-4 | MICA*017 IgG Ab [Presence] in Serum |
| 88843-8 | Metabolic panel.dialysis patient - Serum or Plasma |
| 89597-9 | Mycoplasma genitalium DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 59790-6 | Hexacarboxylporphyrin [Moles/volume] in Serum or Plasma |
| 50628-7 | Heptacarboxylporphyrin/Creatinine [Molar ratio] in Urine |
| 30460-0 | Polymorphonuclear cells/100 leukocytes in Gastric fluid |
| 31119-1 | CD227 cells/100 cells in Blood |
| 21118-5 | Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid by Immunoassay |
| 21290-2 | Gastrin [Mass/volume] in Serum or Plasma --3.5 hours post 0.2 U/kg secretin |
| 31516-8 | Mycoplasma pneumoniae IgM Ab [Units/volume] in Cerebral spinal fluid |
| 31581-2 | Reovirus Ab [Units/volume] in Cerebral spinal fluid |
| 21690-3 | HBB gene p.Glu6Val [Presence] in Blood or Tissue by Molecular genetics method |
| 22240-6 | Cytomegalovirus Ab [Titer] in Cerebral spinal fluid |
| 43598-2 | Indicans [Presence] in 24 hour Urine |
| 5235-7 | Jo-1 extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
| 22877-5 | Border disease virus Ab [Titer] in Serum |
| 53159-0 | Tryptophan [Moles/volume] in DBS |
| 44588-2 | IgA.monoclonal [Presence] in Urine by Immunofixation |
| 5354-6 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
| 53567-4 | Platelet aggregation EPINEPHrine induced in Platelet rich plasma --0.1 ug/mL |
| 23770-1 | Porcine parvovirus Ab [Titer] in Serum |
| 23829-5 | Bordetella pertussis filamentous hemagglutinin IgM Ab [Units/volume] in Serum |
| 33928-3 | Efavirenz [Mass/volume] in Serum or Plasma |
| 54149-0 | Homogenous nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
| 54319-9 | Methylmalonylcarnitine (C4-DC) [Moles/volume] in Urine |
| 54383-5 | Cytochrome C oxidase [Enzymatic activity/mass] in Fibroblast |
| 34292-3 | Estriol (E3) [Moles/volume] in 24 hour Urine |
| 34488-7 | Avian paramyxovirus 1 subtype [Identifier] in Isolate by NAA with probe detection |
| 34545-4 | carBAMazepine free and total panel [Mass/volume] - Serum or Plasma |
| 47175-5 | Norepinephrine [Moles/volume] in Plasma --pre 300 ug cloNIDine PO |
| 25138-9 | Taurine/Creatinine [Molar ratio] in Urine |
| 25562-0 | Angiotensin II [Moles/volume] in Plasma --supine |
| 35022-3 | Monocytes+Macrophages [#/volume] in Pleural fluid |
| 35281-5 | Toxoplasma gondii IgG Ab [Presence] in Serum by Immunofluorescence |
| 25625-5 | Cortisol [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 47990-7 | Progesterone [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 26663-5 | Chlamydia trachomatis D Ab [Presence] in Serum |
| 3787-9 | Methaqualone [Mass/volume] in Urine |
| 38183-0 | Parainfluenza virus 2 IgG Ab [Units/volume] in Serum |
| 48494-9 | Complement C1 esterase inhibitor actual/normal in Serum or Plasma |
| 48578-9 | HFE gene c.187G>C [Presence] in Blood or Tissue by Molecular genetics method |
| 48655-5 | Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 38315-8 | Dichlorobenzene [Mass/volume] in Water |
| 38385-1 | Coccidioides immitis Ag [Presence] in Cerebral spinal fluid |
| 3871-1 | Norpropoxyphene [Presence] in Urine |
| 3891-9 | Oxprenolol [Mass/volume] in Urine |
| 57913-6 | White Bean IgE Ab/IgE total in Serum |
| 58361-7 | Norbuprenorphine/Creatinine [Mass Ratio] in Urine |
| 49349-4 | Cytomegalovirus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
| 49575-4 | Sphingomyelin/Surfactant.total in Amniotic fluid |
| 2863-9 | Albumin [Mass/volume] in Synovial fluid by Electrophoresis |
| 39985-7 | Creatinine [Mass/volume] in Urine --1.5 hours post XXX challenge |
| 29624-4 | 3-Hydroxyglutarate [Presence] in Urine |
| 29897-6 | Styrene [Mass/volume] in Urine |
| 40328-7 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --2 hours post dose triple bolus |
| 50205-4 | Iron [Mass/volume] in Serum or Plasma --8th specimen |
| 50244-3 | 17-Ketosteroids [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
| 30175-4 | Jamestown canyon virus neutralizing antibody [Presence] in Specimen by Neutralization test |
| 30225-7 | Coxsackievirus B6 Ab [Presence] in Serum |
| 30260-4 | Insulin [Units/volume] in Serum or Plasma --3.3 hours post XXX challenge |
| 30345-3 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 1.2 g/kg lactose PO |
| 40935-9 | Yersinia enterocolitica O:9 Ab [Presence] in Serum |
| 41162-9 | Adenovirus IgG Ab [Presence] in Serum |
| 19188-2 | Mucin-like carcinoma associated Ag [Units/volume] in Pleural fluid |
| 20478-4 | CD61 cells/100 cells in Blood |
| 2072-7 | Chloride [Moles/volume] in Body fluid |
| 20978-3 | Urea [Mass/volume] in Gastric fluid |
| 100096-7 | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot |
| 100418-3 | Liquorice IgG Ab [Units/volume] in Serum |
| 13412-2 | Proline [Mass/volume] in Amniotic fluid |
| 102213-6 | Italian Cedar IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102731-7 | Deer hair IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15029-2 | Androsterone [Moles/volume] in Serum or Plasma |
| 10490-1 | IgE Ag [Presence] in Tissue by Immune stain |
| 15340-3 | Italian Cedar IgE Ab [Units/volume] in Serum |
| 1536-2 | Glucose [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV |
| 10818-3 | Microscopic observation [Identifier] in Tissue by Trichrome stain.Masson modified |
| 10949-6 | Malassezia furfur IgE Ab [Units/volume] in Serum |
| 11189-8 | Jalepeno Pepper IgE Ab [Units/volume] in Serum |
| 11194-8 | Rape Pollen IgE Ab [Units/volume] in Serum |
| 16826-0 | Epstein Barr virus capsid IgG Ab [Units/volume] in Cerebral spinal fluid |
| 18892-0 | Cefsulodin [Susceptibility] |
| 90818-6 | Aquaporin 4 water channel IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 92695-6 | Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection |
| 75594-2 | Fetal 5p deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
| 77327-5 | Triazolam [Moles/volume] in Specimen |
| 94078-3 | PDX1 gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
| 94096-5 | Collagen type VII IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 94290-4 | Saint Louis encephalitis virus neutralizing antibody [Presence] in Specimen by Neutralization test |
| 62455-1 | Coccidioides sp F Ab [Presence] in Serum by Immune diffusion (ID) |
| 63292-7 | Neutrophil cytoplasmic Ab [Titer] in Body fluid by Immunofluorescence |
| 77779-7 | Noroxycodone cutoff [Mass/volume] in Urine for Confirmatory method |
| 684-1 | Respiratory Mycoplasma identified in Sputum by Organism specific culture |
| 80965-7 | Topiramate free [Mass/volume] in Serum or Plasma |
| 69551-0 | Genomic alt allele [ID] |
| 81763-5 | Phytanate and pristanate panel - Serum or Plasma |
| 8221-4 | Opiates [Presence] in Urine by SAMHSA confirm method |
| 97774-4 | Base excess standard in Venous cord blood by calculation |
| 70162-3 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Urethra by NAA with probe detection |
| 70288-6 | t(17;19)(q22;p13.3)(HLF,TCF3) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 7086-2 | Black Imported Fire Ant IgE Ab [Units/volume] in Serum |
| 82373-2 | Buprenorphine [Presence] in Specimen by Screen method |
| 82981-2 | NMDAR IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 71779-3 | Rift valley fever virus IgM Ab [Titer] in Serum by Immunoassay |
| 83125-5 | Triiodothyronine (T3) [Moles/volume] in Serum or Plasma by Immunoassay |
| 994-4 | Do sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 7262-9 | Cranberry IgE Ab [Units/volume] in Serum |
| 72956-6 | Sertraline induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73104-2 | Triamterene induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87711-8 | Rotavirus B VP7 gene [Nucleotide sequence] in Isolate by Sequencing |
| 73431-9 | Clopidogrel induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7346-0 | Grain dust IgE Ab [Units/volume] in Serum |
| 87810-8 | Methylenedioxymethamphetamine [Presence] in Saliva (oral fluid) by Screen method |
| 73886-4 | Steroid fractions panel - Urine |
| 88839-6 | Microbiology CNAMTS panel - Pus |
| 50621-2 | HTT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 30556-5 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Titer] in Serum by Immunofluorescence |
| 3099-9 | Uridine diphosphate glucose-4-Epimerase [Enzymatic activity/volume] in Plasma |
| 21614-3 | CDKN2A gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
| 31231-4 | Aspergillus nidulans Ab [Presence] in Serum |
| 51129-5 | CD22 blasts [Units/volume] in Specimen |
| 42767-4 | Borrelia burgdorferi IgG and IgM [Interpretation] in Cerebral spinal fluid |
| 22250-5 | Dengue virus 1 Ab [Presence] in Serum |
| 22288-5 | Entamoeba histolytica IgG Ab [Units/volume] in Serum |
| 31970-7 | Streptococcus pyogenes Ag [Presence] in Serum |
| 51837-3 | Bordetella parapertussis IgG Ab [Titer] in Serum by Immunofluorescence |
| 22613-4 | Western equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid |
| 3212-8 | Coagulation factor VIII Activity.Xa activator [Units/volume] in Platelet poor plasma by Chromogenic method |
| 22876-7 | Border disease virus Ab [Units/volume] in Serum |
| 53155-8 | Asparagine+Ornithine [Moles/volume] in DBS |
| 53218-4 | Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in DBS |
| 44710-2 | Carnitine/Acylcarnitine [Molar ratio] in Serum or Plasma |
| 33568-7 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot |
| 336-8 | Minocycline [Susceptibility] by Disk diffusion (KB) |
| 53588-0 | Beta globulin+Gamma globulin.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis |
| 53723-3 | SLC26A4 gene.p.Leu236Pro [Presence] in Blood by Molecular genetics method |
| 45360-5 | Lymphocyte proliferation stimulated by 0.125 ug pokeweed mitogen in Blood |
| 33760-0 | Surgical margin tumor involvement.mucosal in Specimen by CAP cancer protocols |
| 33780-8 | Galactose 1 phosphate uridyl transferase phenotype [Type] in Blood |
| 34210-5 | 11-Hydroxyetiocholanolone [Moles/volume] in 24 hour Urine |
| 46706-8 | Clostridium perfringens toxin gene [Identifier] in Specimen by NAA with probe detection |
| 46958-5 | Triamcinolone acetonide [Mass/volume] in Urine |
| 55151-5 | Aldosterone and renin activity panel - Plasma |
| 55568-0 | Phenolphthalein [Moles/volume] in Serum or Plasma |
| 2543-7 | Lactate dehydrogenase 3 [Enzymatic activity/volume] in Serum or Plasma |
| 34963-9 | CD3+TCR alpha beta+ cells [#/volume] in Blood |
| 35040-5 | Lymphocytes Immunoblastic [#/volume] in Blood |
| 55709-0 | Pristinamycin [Susceptibility] by Gradient strip |
| 35554-5 | Chocolate IgG Ab [Mass/volume] in Serum |
| 35556-0 | Trichophyton rubrum IgG Ab [Mass/volume] in Serum |
| 3563-4 | Digoxin>12 hours post dose [Mass/volume] in Serum or Plasma |
| 26755-9 | Streptococcus pneumoniae Danish serotype 18C Ab [Mass/volume] in Serum |
| 35877-0 | Rickettsia sp IgG Ab [Units/volume] in Serum |
| 38-0 | Azithromycin [Susceptibility] by Serum bactericidal titer |
| 56696-8 | Cloxacillin IgE Ab [Units/volume] in Serum |
| 56768-5 | Protein.monoclonal.beta/Protein.total in Urine by Electrophoresis |
| 26949-8 | Thermoactinomyces IgG Ab [Mass/volume] in Serum |
| 26993-6 | Benzfetamine [Mass/volume] in Milk |
| 27079-3 | Methylenedioxyethylamphetamine [Mass/mass] in Stool |
| 27917-4 | Coxsackievirus B3 Ab [Presence] in Cerebral spinal fluid |
| 38998-1 | HIV 1+Hepatitis C virus RNA [Presence] in Serum or Plasma from Blood product unit by NAA with probe detection |
| 57716-3 | State printed on filter paper card [Identifier] in NBS card |
| 57733-8 | Beta-trace protein [Mass/volume] in Body fluid |
| 57982-1 | HYDROmorphone [Presence] in Meconium |
| 49361-9 | Hepatitis B virus DNA [Log #/volume] (viral load) in Tissue by NAA with probe detection |
| 49623-2 | Amprenavir or Fosamprenavir [Susceptibility] by Genotype method |
| 49677-8 | Lymphocyte proliferation stimulated by 1 umol beryllium [Ratio] in Blood --7 day post incubation |
| 4004-8 | Pseudoephedrine [Mass/volume] in Urine |
| 40103-4 | aPTT in Platelet poor plasma by Coagulation assay --1.5 hours post XXX challenge |
| 40259-4 | Glucose [Mass/volume] in Serum or Plasma --10.5 hours post XXX challenge |
| 40268-5 | Creatinine [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
| 58548-9 | Corticotropin [Moles/volume] in Plasma --15 minutes post dose insulin IV |
| 29540-2 | E-cadherin [Presence] in Tissue by Immune stain |
| 29938-8 | Thallium/Creatinine [Mass Ratio] in 24 hour Urine |
| 4050-1 | Thiopental [Mass/volume] in Serum or Plasma |
| 40588-6 | Inulin [Mass/volume] in Control Serum |
| 40626-4 | Codeine [Presence] in Specimen |
| 40679-3 | Treponema pallidum IgG Ab [Presence] in Serum by Immunoblot |
| 59238-6 | Prostate Specific Ag Free/Prostate specific Ag.total in Body fluid |
| 50325-0 | MUM-1 Ag [Presence] in Tissue by Immune stain |
| 30134-1 | Echovirus Ab [Presence] in Serum --1st specimen |
| 40820-3 | Helicobacter pylori IgA Ab [Titer] in Serum |
| 2030-5 | Carboxyhemoglobin/Hemoglobin.total in Arterial blood |
| 101470-3 | HBA1+2 gene THAI deletion [Presence] in Blood by Molecular genetics method |
| 101562-7 | Sapovirus genogroups I+II+IV RNA [Presence] in Stool by NAA with probe detection |
| 103002-2 | Timothy recombinant (rPhl p) 7 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103606-0 | Paroxetine M-II [Mass/volume] in Urine by Confirmatory method |
| 15071-4 | Galactose [Moles/time] in 24 hour Urine |
| 104457-7 | Varicella zoster virus IgA Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 16979-7 | HIV 1 p24 Ag [Units/volume] in Cerebral spinal fluid |
| 17228-8 | Lymphocytic choriomeningitis virus Ab [Titer] in Cerebral spinal fluid |
| 17926-7 | Bacteria # 2 identified in Wound deep by Anaerobe culture |
| 18969-6 | Piperacillin [Susceptibility] |
| 90840-0 | NMDAR subunit 1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 90841-8 | PCA-1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 91071-1 | Hepatitis E virus RNA [Presence] in Stool by NAA with probe detection |
| 74757-6 | Soluble fms-like tyrosine kinase-1/placental growth factor [Ratio] in Serum |
| 75007-5 | Aspergillus restrictus native (nAsp r) 1 IgE Ab [Units/volume] in Serum |
| 75225-3 | Glutarylcarnitine (C5-DC)/Carnitine (C0) [Molar ratio] in DBS |
| 605-6 | Bacteria identified in Cannula specimen by Aerobe culture |
| 7640-6 | Pyrethrum triggered histamine release [Units/volume] in Blood |
| 76649-3 | Germanium [Mass/mass] in Hair |
| 93315-0 | Platelet CD49b actual/normal in Blood by Flow cytometry (FC) |
| 62251-4 | Leukocytes [#/volume] in Pleural fluid from Fetus by Automated count |
| 7728-9 | Swordfish IgE Ab [Units/volume] in Serum |
| 77331-7 | Nortrimipramine [Moles/volume] in Specimen |
| 63297-6 | Nuclear Ab [Titer] in Cerebral spinal fluid by Hep2 substrate |
| 94568-3 | Isoleucine [Moles/volume] in Serum or Plasma --post therapeutic diet |
| 63384-2 | Asialoganglioside GM1 IgM Ab [Presence] in Serum by Immunoassay |
| 6365-1 | Clostridioides difficile toxin B [Units/volume] in Stool by Immunoassay |
| 6454-3 | Leptospira sp identified in Cerebral spinal fluid by Organism specific culture |
| 79135-0 | Acebutolol [Mass/volume] in Body fluid |
| 79200-2 | Somatotropin [Mass/volume] in Serum or Plasma --2.5 hours post dose arginine+insulin |
| 654-4 | Microscopic observation [Identifier] in Specimen by Acid fast stain.Kinyoun |
| 6555-7 | Streptococcus pneumoniae Ag [Presence] in Specimen by Immunofluorescence |
| 65763-5 | Neisseria meningitidis Ag [Presence] in Tissue by Immune stain |
| 7999-6 | Rickettsia spotted fever group IgM Ab [Units/volume] in Serum |
| 95917-1 | Histoplasma capsulatum DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 9674-3 | Salmonella sp IgM Ab [Units/volume] in Serum |
| 81842-7 | BCKDHB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 82238-7 | Chromosome region 15q11-13 deletion and duplication mutation analysis in Amniotic fluid or Chorionic villus sample by FISH |
| 7158-9 | Brazil Nut triggered histamine release [Units/volume] in Blood |
| 98993-9 | Alpha 1 antitrypsin/Protein.total in Serum or Plasma by Electrophoresis |
| 84912-5 | Cells.chromosome region 5q31 deletion/Cells counted in Bone marrow by FISH |
| 99376-6 | Olive Pollen IgG Ab [Mass/volume] in Serum |
| 86518-8 | Ebola virus RNA [Presence] in Blood by NAA with probe detection |
| 73557-1 | Thyroxine (T4) free [Mass/volume] in Cord blood |
| 73594-4 | Omadacycline [Susceptibility] |
| 88215-9 | Rabies virus RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |
| 88908-9 | Parainfluenza virus 3 Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
| 89042-6 | Eszopiclone [Mass/volume] in Urine |
| 89533-4 | SCL-70 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
| 89634-0 | Actinomyces sp identified in Implanted device by Organism specific culture |
| 59652-8 | N-desalkylflurazepam [Mass/mass] in Tissue |
| 31120-9 | CD227 cells [#/volume] in Blood |
| 42361-6 | Streptococcus pneumoniae 12 serotypes IgG panel [Mass/volume] - Serum |
| 425-9 | Pyrazinamide [Susceptibility] by Disk diffusion (KB) |
| 51051-1 | CD126 blasts/100 blasts in Specimen |
| 51056-0 | CD127 blasts/100 blasts in Blood |
| 51182-4 | CD10 blasts [Units/volume] in Bone marrow |
| 42885-4 | CD52 cells/100 cells in Body fluid |
| 22259-6 | Eastern equine encephalitis virus IgG Ab [Titer] in Serum |
| 51581-7 | Other cells/100 cells in Bone marrow |
| 51957-9 | Placer DNA analysis test identifier [Identifier] |
| 43920-8 | Bartonella sp IgG Ab [Presence] in Serum |
| 22959-1 | Burkholderia mallei Ab [Presence] in Serum by Complement fixation |
| 53308-3 | Triple phosphate crystals [#/area] in Urine by Computer assisted method |
| 44589-0 | IgA.monoclonal [Presence] in Cerebral spinal fluid by Immunofixation |
| 33698-2 | Bacillus anthracis [Presence] in Isolate by Phage lysis |
| 536-3 | Mycobacterium sp identified in Bone marrow by Organism specific culture |
| 5375-1 | Taenia solium adult Ab [Units/volume] in Serum by Immunoassay |
| 23976-4 | Blastomyces dermatitidis Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 53978-3 | Epithelial cells.non-squamous [Presence] in Urine sediment by Light microscopy |
| 24165-3 | Sugar Beet Seed (Beta vulgaris seed) IgE Ab [Units/volume] in Serum |
| 34693-2 | GALOP Ab [Titer] in Serum or Plasma |
| 47138-3 | EPINEPHrine [Moles/volume] in Plasma --2 hours post XXX challenge |
| 34922-5 | Lymphoblasts/100 leukocytes in Blood |
| 35270-8 | Candida sp Ab [Presence] in Serum by Immune diffusion (ID) |
| 55871-8 | Heptanoylcarnitine (C7) [Moles/volume] in Serum or Plasma |
| 25928-3 | Homocystine [Moles/volume] in 24 hour Urine |
| 35456-3 | Y chromosome deletion [Identifier] in Blood or Tissue Nominal |
| 35756-6 | Avilamycin [Susceptibility] |
| 56300-7 | Lepidoglyphus destructor IgG4 Ab [Mass/volume] in Serum |
| 26511-6 | Neutrophils/100 leukocytes in Blood |
| 3634-3 | Fenproporex [Mass/volume] in Urine |
| 371-5 | Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 38610-2 | Methylene chloride [Mass/volume] in Air |
| 57370-9 | Sodium [Moles/volume] in 12 hour Urine |
| 48915-3 | Rickettsia typhi IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 48984-9 | Glucose [Mass/volume] in Serum or Plasma --10 minutes post dose glucose |
| 27882-0 | Proinsulin [Moles/volume] in Serum or Plasma |
| 38913-0 | TBX5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 49490-6 | BCR-ABL1 b2a2 fusion protein [Presence] in Blood or Tissue by Molecular genetics method |
| 2811-8 | Porphobilinogen [Moles/volume] in Urine |
| 58428-4 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Confirmatory method |
| 58479-7 | Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --7th specimen fasting |
| 50171-8 | Aldosterone [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin IM |
| 2956-1 | Sodium [Moles/time] in 24 hour Urine |
| 59213-9 | Alloisoleucine [Moles/time] in Urine collected for unspecified duration |
| 59294-9 | Levamisole [Mass/mass] in Tissue |
| 3005-6 | Thiosulfate renal clearance in 24 hour Urine and Serum or Plasma |
| 302-0 | Lomefloxacin [Susceptibility] by Minimum lethal concentration (MLC) |
| 30287-7 | Abacavir [Susceptibility] by Genotype method |
| 1941-4 | Beta galactosidase [Enzymatic activity/volume] in Serum or Plasma |
| 19676-6 | Phentermine cutoff [Mass/volume] in Urine for Screen method |
| 20622-7 | Cortisol [Mass/volume] in 24 hour Urine |
| 20807-4 | Equine arteritis virus [Presence] in Blood by Organism specific culture |
| 20868-6 | Leptospira sp [Presence] in Tissue by Immunofluorescence |
| 100851-5 | Other cells [#/volume] in Amniotic fluid by Manual count |
| 12513-8 | Bicarbonate [Moles/volume] in Water |
| 101406-7 | Sudan virus RNA [Presence] in Blood by NAA with probe detection |
| 13337-1 | CD8+HLA-DR+ cells/100 cells in Blood |
| 101795-3 | Tianeptine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 13741-4 | Ethylmalonate/Creatinine [Mass Ratio] in Urine |
| 13963-4 | Orotate [Moles/volume] in Urine |
| 14654-8 | clomiPRAMINE+Norclomipramine [Moles/volume] in Serum or Plasma |
| 14785-0 | Hydroxyproline [Moles/time] in 24 hour Urine |
| 10400-0 | I Ag [Presence] on Red Blood Cells |
| 10526-2 | Microscopic observation [Identifier] in Sputum by Cyto stain |
| 106-5 | Ceforanide [Susceptibility] by Serum bactericidal titer |
| 15376-7 | Spermatozoa Abnormal/100 spermatozoa in Semen |
| 12298-6 | Erythromycin [Presence] in Urine |
| 16993-8 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --5.5 hours post dose glucose |
| 17015-9 | Influenza virus B IgG Ab [Units/volume] in Serum |
| 18202-2 | Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 18272-5 | RNA Ab [Units/volume] in Serum |
| 18891-2 | Cefprozil [Susceptibility] |
| 1892-9 | Arginine [Presence] in Serum or Plasma |
| 90833-5 | Ma+Ta Ab [Units/volume] in Cerebral spinal fluid by Line blot |
| 75386-3 | MEN1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 75689-0 | Iron panel - Serum or Plasma |
| 60390-2 | Peach IgG Ab [Mass/volume] in Serum |
| 7625-7 | Potato IgG Ab [Units/volume] in Serum |
| 92810-1 | Borrelia afzelii+burgdorferi+garinii IgG Ab [Units/volume] in Serum by Immunoassay |
| 93319-2 | Platelet CD41 actual/normal in Blood by Flow cytometry (FC) |
| 6155-6 | Lamb IgE Ab [Units/volume] in Serum |
| 6162-2 | Lilac IgE Ab [Units/volume] in Serum |
| 62260-5 | Tetracycline resistance tetK + tetM genes [Presence] by Molecular method |
| 77672-4 | Gastrin [Moles/volume] in Serum or Plasma --3 minutes post XXX challenge |
| 94009-8 | Chloride [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin |
| 63166-3 | Aspergillus terreus IgG Ab [Mass/volume] in Serum |
| 63230-7 | DNA double strand IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 63329-7 | RNA polymerase III Ab [Units/volume] in Serum by Immunoassay |
| 9440-9 | IgA lymphocytes/100 lymphocytes in Leukocytes |
| 94621-0 | Mycobacterium avium ss paratuberculosis Ab/Positive control in Specimen by Immunoassay |
| 6441-0 | Influenza virus A+B+C Ag [Presence] in Specimen by Immunoassay |
| 78870-3 | OPC3373 (Metabolite of Ariprazole) [Mass/volume] in Urine by Confirmatory method |
| 79172-3 | Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 79232-5 | Naphyrone [Mass/volume] in Urine by Confirmatory method |
| 95200-2 | HLA-B8 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC) |
| 95534-4 | Human papilloma virus 52 DNA [Presence] in Cervix by NAA with probe detection |
| 6776-9 | Estrone (E1) [Mass/time] in 24 hour Urine |
| 68318-5 | Hypoglycemics panel - Serum or Plasma |
| 6848-6 | Mushroom IgE Ab [Units/volume] in Serum |
| 69024-8 | Methylenedioxyethylamphetamine [Mass/mass] in Meconium by Confirmatory method |
| 97263-8 | Methylenedioxyamphetamine [Presence] in Cord tissue by Confirmatory method |
| 70296-9 | Plesiomonas shigelloides DNA [Presence] in Stool by NAA with probe detection |
| 98279-3 | DNA mismatch repair in Cancer specimen by Immune stain Narrative |
| 98407-0 | Conidia morphology [Interpretation] in Isolate by Light microscopy |
| 99270-1 | 8-Aminoclonazolam [Mass/volume] in Urine by Confirmatory method |
| 99465-7 | Velvet grass IgG Ab [Mass/volume] in Serum |
| 72823-8 | Staphylococcus aureus enterotoxin C sec gene [Presence] in Specimen by NAA with probe detection |
| 86333-2 | Adenovirus E(4) DNA [Presence] in Specimen by NAA with probe detection |
| 86459-5 | Brucella sp Ab [Titer] in Serum by Plate agglutination |
| 873-0 | A3 B Ag [Presence] on Red Blood Cells from Donor |
| 87432-1 | Mycophenolate and mycophenolate glucuronide panel - Serum or Plasma |
| 73471-5 | Cefepime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7349-4 | Grape raisin triggered histamine release [Units/volume] in Blood |
| 87777-9 | 8-Hydroxyloxapine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 74103-3 | Neutrophil gelatinase-associated lipocalin [Mass/volume] in Serum or Plasma by Rapid immunoassay |
| 74122-3 | Ubiquitin Ag [Presence] in Tissue by Immune stain |
| 89346-1 | IgM cells/100 CD19 cells in Blood |
| 41714-7 | Rosamicin [Susceptibility] by Gradient strip |
| 59702-1 | LORazepam [Mass/volume] in Body fluid by Confirmatory method |
| 50818-4 | Barium [Moles/mass] in Hair |
| 42943-1 | Yersinia enterocolitica O:5,27 Ab [Titer] in Serum |
| 21773-7 | Chromosome 8 trisomy [Presence] in Blood or Tissue by Cytogenetics |
| 22202-6 | Chlamydia trachomatis G+F+K IgM Ab [Titer] in Serum |
| 43363-1 | Cardiolipin IgM Ab [Mass/volume] in Serum |
| 52761-4 | Prothrombin time (PT) PIVKA sensitive actual/normal in Platelet poor plasma by Coagulation assay |
| 22804-9 | Infectious bronchitis virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 3285-4 | Phospholipid Ab [Units/volume] in Serum by Immunoassay |
| 53457-8 | Gamma 3 globulin.abnormal band/Protein.total in Serum or Plasma by Electrophoresis |
| 33397-1 | Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Serum by Latex agglutination |
| 53744-9 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells by 5 minute RT incubation |
| 44986-8 | Chlamydia trachomatis G+F+K IgM Ab [Presence] in Serum |
| 45376-1 | Date of transfusion reaction |
| 34264-2 | Chlamydia sp IgA Ab [Titer] in Serum by Immunofluorescence |
| 5411-4 | Yersinia sp Ab [Units/volume] in Serum |
| 54326-4 | Phosphoethanolamine [Moles/volume] in DBS |
| 54417-1 | ABO and Rh group [Type] in Blood from Fetus |
| 54423-9 | Transfuse plateletpheresis half units [#] |
| 55235-6 | Abnormal hemoglobin gene panel - Blood by Molecular genetics method |
| 55324-8 | Jk sup(b) Ab [Titer] in Serum or Plasma |
| 55536-7 | Fenoprofen [Moles/volume] in Serum or Plasma |
| 47120-1 | Meprobamate [Moles/volume] in Urine |
| 47135-9 | Ascorbate [Moles/volume] in Serum or Plasma --post dose |
| 55891-6 | Hydroxylysine [Moles/mass] in Hair |
| 47819-8 | 3-Hydroxysuberate/Creatinine [Molar ratio] in Urine |
| 25699-0 | Insulin [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 25856-6 | 3-Methylhistidine [Moles/volume] in 24 hour Urine |
| 26012-5 | 17-Hydroxycorticosteroids [Moles/time] in 24 hour Urine --1 day post XXX challenge |
| 35420-9 | Herpes simplex virus identified in Cervix by Organism specific culture |
| 48327-1 | glyBURIDE [Presence] in Serum or Plasma |
| 56596-0 | Latex recombinant (rHev b) 5 IgE Ab [Units/volume] in Serum |
| 56897-2 | CD3-CD56+ cells/100 cells in Cerebral spinal fluid |
| 26825-0 | Eastern equine encephalitis virus RNA [Presence] in Cerebral spinal fluid by Probe |
| 27190-8 | Propoxyphene [Mass/volume] in Vitreous fluid |
| 38364-6 | Haloperidol reduced [Mass/volume] in Serum or Plasma |
| 5727-3 | Selenium [Mass/time] in 24 hour Urine |
| 57673-6 | Coxiella burnetii IgM Ab [Presence] in Serum by Immunofluorescence --1st specimen |
| 39474-2 | Creatinine [Moles/volume] in Peritoneal fluid |
| 5826-3 | Adenovirus Ag [Presence] in Stool by Immunofluorescence |
| 29345-6 | 6-Monoacetylmorphine (6-MAM) [Mass/mass] in Meconium |
| 2952-0 | Sodium [Molar amount] in 24 hour Stool |
| 49896-4 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Specimen by NAA with probe detection |
| 49906-1 | Hydroxydecanedioate/Creatinine [Molar ratio] in 24 hour Urine |
| 40724-7 | Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay |
| 59057-0 | Glucagon [Mass/volume] in Serum or Plasma --1st specimen fasting |
| 19560-2 | Methaqualone cutoff [Mass/volume] in Urine for Confirmatory method |
| 101500-7 | Ciprofloxacin [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 101875-3 | GABAAR IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay |
| 13530-1 | Nucleated erythrocytes [#/volume] in Body fluid by Manual count |
| 1370-6 | Carotene [Mass/volume] in Serum --post 15000 U carotene QDx3 for 3 day poly |
| 13971-7 | Histoplasma capsulatum Ag [Units/volume] in Urine by Immunoassay |
| 102799-4 | Plum IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14774-4 | Haloperidol [Moles/volume] in Serum or Plasma |
| 14882-5 | Porphobilinogen [Moles/time] in 24 hour Urine |
| 104437-9 | Polio virus 1 Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 16152-1 | Gastrin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 10763-1 | Microscopic observation [Identifier] in Body fluid by Sudan black stain |
| 1671-7 | 17-Ketogenic steroids [Mass/volume] in Blood |
| 11264-9 | Salmonella paratyphi A Ab [Presence] in Serum by Agglutination |
| 12271-3 | Varicella zoster virus Ab [Presence] in Serum by Latex agglutination |
| 16919-3 | Glycine [Presence] in Urine |
| 16922-7 | Wild rye grass IgE Ab [Units/volume] in Serum |
| 1694-9 | 5-Hydroxyindoleacetate [Mass/volume] in Urine |
| 17250-2 | Mephobarbital [Mass/volume] in Urine by Confirmatory method |
| 17849-1 | Reticulocytes/100 erythrocytes in Blood by Automated count |
| 74489-6 | Melan-A and Ki67 Ag [Identifier] in Tissue by Immune stain |
| 74678-4 | Carboxy tetrahydrocannabinol [Presence] in Saliva (oral fluid) by Confirmatory method |
| 91709-6 | Corticotropin [Mass/volume] in Plasma --2 minutes post 1 ug/kg CRH IV |
| 7764-4 | Black Western Walnut IgE Ab [Units/volume] in Serum |
| 78739-0 | Platelet aggregation ristocetin induced [Units/volume] in Blood --Low dose |
| 63357-8 | Smooth muscle Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 9550-5 | Legionella pneumophila 5 IgG Ab [Titer] in Serum by Immunofluorescence |
| 79580-7 | R- and S-beta aminoisobutyrate and D- and L-serine pattern [Interpretation] in Urine Narrative |
| 796-3 | Erythrocytes [#/volume] in Synovial fluid by Automated count |
| 79699-5 | cis-11-Eicosenoate (cis 11 C20:1w9) [Moles/volume] in Serum or Plasma |
| 79703-5 | cis-13-Eicosenoate (cis 13 C20:1w7) [Moles/volume] in Serum or Plasma |
| 80691-9 | HIV 1 proviral DNA integrase gene mutations detected [Identifier] in Blood mononuclear cells by Sequencing |
| 96644-0 | HLA-DPA1 unresolved alleles [Type] in Donor by High resolution |
| 97277-8 | Methylone [Presence] in Cord tissue by Confirmatory method |
| 70134-2 | Rickettsia typhus group IgM Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
| 82386-4 | 2-Methylcitrate [Moles/volume] in DBS |
| 85-1 | Cefaclor [Susceptibility] by Disk diffusion (KB) |
| 73597-7 | Iclaprim [Susceptibility] |
| 73856-7 | Allo-pregnanediol [Moles/volume] in Urine |
| 87988-2 | Acanthamoeba sp DNA [Presence] in Contact lens by NAA with probe detection |
| 73988-8 | 2,2',4,5,5'-Pentachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
| 41240-3 | Xanthurenate [Presence] in Serum or Plasma |
| 59736-9 | Salicylamide [Mass/volume] in Urine |
| 50904-2 | Selenium [Moles/mass] in Hair |
| 3042-9 | Chloral hydrate [Mass/volume] in Serum or Plasma |
| 3110-4 | Uronate [Mass/volume] in Urine |
| 422-6 | Polymyxin B [Susceptibility] by Serum bactericidal titer |
| 6013-7 | von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot |
| 5129-2 | Deoxyribonuclease Ab [Units/volume] in Serum |
| 21821-4 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 22170-5 | Chlamydophila pneumoniae IgA Ab [Titer] in Serum |
| 31721-4 | Avian infectious laryngotracheitis virus Ag [Presence] in Trachea |
| 31961-6 | Rubella virus Ag [Presence] in Skin |
| 51486-9 | Epithelial cells.squamous [#/volume] in Urine by Automated count |
| 5177-1 | Helicobacter pylori IgM Ab [Units/volume] in Serum by Immunoassay |
| 51860-5 | Parrot serum proteins+feathers+droppings IgG Ab [Presence] in Serum |
| 43412-6 | Blood product units issued [#] |
| 22752-0 | Tobramycin [Moles/volume] in Serum or Plasma --trough |
| 23044-1 | Eastern equine encephalitis virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 33220-5 | Transitional cells [#/area] in Urine by Computer assisted method |
| 44655-9 | Number of carcinoma positive tissue chips CAP cancer protocols |
| 53771-2 | Alpha 2 globulin [Presence] in Urine by Electrophoresis |
| 45191-4 | CAPN3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 23727-1 | Feline infectious peritonitis virus Ab [Presence] in Serum by Immunofluorescence |
| 23811-3 | Alpha-1-Fetoprotein [Multiple of the median] adjusted in Serum or Plasma |
| 54006-2 | Nuclear membrane pores nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
| 54298-5 | Hexanoylcarnitine (C6) [Moles/volume] in Urine |
| 4568-2 | Hemoglobin Constant Spring [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 34323-6 | Lactate [Moles/volume] in 24 hour Urine |
| 34641-1 | Protein Fractions [Interpretation] in Serum or Plasma |
| 470-5 | Sulfamethoxazole [Susceptibility] by Serum bactericidal titer |
| 47142-5 | EPINEPHrine [Moles/volume] in Plasma --3rd specimen post XXX challenge |
| 47304-1 | Borrelia burgdorferi IgG Ab index [Units/volume] in Serum and CSF |
| 47469-2 | Legionella pneumophila 7 IgG Ab [Titer] in Serum |
| 25094-4 | Decenedioate/Creatinine [Molar ratio] in Urine |
| 25346-8 | Beta alanine [Moles/time] in 24 hour Urine |
| 34962-1 | CD3+TCR alpha beta+ cells/100 cells in Blood |
| 55688-6 | Nitroxoline [Susceptibility] by Gradient strip |
| 55877-5 | Homocysteine [Moles/volume] in Body fluid |
| 56012-8 | Platelet aggregation arachidonate induced ATP secretion [Presence] in Blood --500 umol/L |
| 35598-2 | Butalbital [Mass/volume] in Serum or Plasma by Screen method |
| 26490-3 | Mononuclear cells [#/volume] in Body fluid |
| 56664-6 | Methylmalonate/Creatinine [Ratio] in Urine |
| 56925-1 | Fractional excretion of phosphate [Ratio] in 24 hour Urine and Serum or Plasma |
| 48417-0 | Staphylolysin Ab [Units/volume] in Body fluid |
| 48500-3 | Borrelia burgdorferi 18kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 38543-5 | Spermatozoa [#/volume] in Semen --post washing |
| 38624-3 | 1,1,2-Trichloroethane [Mass/volume] in Air |
| 38635-9 | Biphenyl [Mass/volume] in Air |
| 57350-1 | Glucose [Mass/volume] in Serum or Plasma --1 minute post XXX challenge |
| 48997-1 | Immune complex.IgG [Mass/volume] in Body fluid by C1q binding assay |
| 27913-3 | Calcium [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 3905-7 | Paraldehyde [Mass/volume] in Serum or Plasma |
| 40083-8 | Calcium [Mass/volume] in Serum or Plasma --1 day post XXX challenge |
| 4023-8 | Salicylates [Presence] in Serum or Plasma |
| 40493-9 | Methylenedioxymethamphetamine [Presence] in Serum or Plasma |
| 40512-6 | Semliki Forest virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 40548-0 | Mononuclear cells atypical [#/volume] in Blood by Manual count |
| 59138-8 | CD7+CD34+ cells/100 cells in Bone marrow |
| 5028-6 | Neisseria gonorrhoeae rRNA [Presence] in Specimen by Probe |
| 30072-3 | Cortisone [Mass/volume] in 24 hour Urine by HPLC |
| 301-2 | Lincomycin [Susceptibility] by Serum bactericidal titer |
| 30212-5 | Coxiella burnetii IgG Ab [Presence] in Serum |
| 4087-3 | Valproate Free [Mass/volume] in Serum or Plasma |
| 19162-7 | Varicella zoster virus IgG Ab [Presence] in Serum |
| 1932-3 | Beta alanine [Mass/volume] in Serum or Plasma |
| 19463-9 | Ethylmorphine [Presence] in Urine by Confirmatory method |
| 19640-2 | Oxazepam cutoff [Mass/volume] in Urine for Screen method |
| 20428-9 | Phospholipid IgG Ab [Presence] in Serum |
| 20974-2 | Sulfate [Mass/volume] in Serum or Plasma |
| 100913-3 | Staph aureus and MRSA screening panel - Specimen by Organism specific culture |
| 101583-3 | ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [Interpretation] by based on lab data in Positive blood culture Qualitative |
| 102171-6 | Pinto Bean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102227-6 | Swiss Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14009-5 | Phosphatidylcholine IgM Ab [Units/volume] in Serum by Immunoassay |
| 14276-0 | Hemoglobin F distribution [Interpretation] in Blood by Kleihauer-Betke method |
| 102769-7 | Monkey epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14772-8 | Gold [Moles/volume] in Serum or Plasma |
| 15435-1 | Avian adenovirus 2 Ab [Presence] in Serum by Immune diffusion (ID) |
| 10944-7 | Octopus IgE Ab [Units/volume] in Serum |
| 16572-0 | Cephaloridine [Mass/volume] in Serum or Plasma |
| 1209-6 | little s Ab [Presence] in Serum or Plasma from Donor |
| 1710-3 | Acetylcholinesterase [Enzymatic activity/volume] in Serum or Plasma |
| 17312-0 | Myelin associated glycoprotein IgG Ab [Units/volume] in Serum |
| 173-5 | Chloramphenicol [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 90445-8 | ePHEDrine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 74765-9 | Bordetella pertussis.pertussis toxin IgA Ab [Presence] in Serum by Line blot |
| 92523-0 | M Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 75664-3 | Human papilloma virus 16 DNA [Presence] in Anorectal specimen by Probe and signal amplification method |
| 60518-8 | Creatinine [Moles/time] in 24 hour Stool |
| 75980-3 | Fetal Chromosome 13+18+21+X+Y aneuploidy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
| 76685-7 | Platelet dry mass distribution width [Entitic mass] in Blood by calculation |
| 92967-9 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 93734-2 | Creatinine [Moles/time] in 5 hour Urine |
| 78382-9 | CFTR gene mutations found [Identifier] in Blood or Tissue by MS.MALDI-TOF Nominal |
| 78801-8 | Atropine [Mass/volume] in Blood |
| 7882-4 | Epstein Barr virus early Ab [Presence] in Serum |
| 64971-5 | Goosefoot recombinant (rChe a) 1 IgE Ab [Units/volume] in Serum |
| 6506-0 | Neisseria meningitidis serogroup w135 Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 66452-4 | Wheat native (nTri a) 18 IgE Ab [Units/volume] in Serum |
| 6690-2 | Leukocytes [#/volume] in Blood by Automated count |
| 79578-1 | N6-Acetyl-L-lysine [Moles/volume] in Serum or Plasma |
| 9624-8 | Vanillylmandelate [Mass/volume] in Urine |
| 69016-4 | Lymphocyte proliferation.tetanus toxoid.maximum/CD45 in Blood by Flow cytometry (FC) |
| 96687-9 | Clot formation.diatomaceous earth induced panel - Blood by Microviscometry |
| 96922-0 | Spindle fibers nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 69834-0 | 3-Hydroxy,3-Methylglutarate [Moles/volume] in Serum or Plasma |
| 69922-3 | Food Allergen Mix fx73 (Beef+Chicken+Pork) IgE Ab [Units/volume] in Serum by Multidisk |
| 9728-7 | CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood |
| 9746-9 | Dantrolene [Mass/volume] in Serum or Plasma |
| 97766-0 | IgG subclass 2 [Mass/volume] in Body fluid |
| 97973-2 | Peanut recombinant (rAra h) 1 IgG4 Ab [Mass/volume] in Serum |
| 82407-8 | Ganglioside GM4 IgG Ab [Presence] in Serum by Line blot |
| 82465-6 | Mosquito identified [Type] in Environmental specimen |
| 99520-9 | Weight of Kidney - right |
| 72814-7 | DULoxetine [Mass/volume] in Urine by Confirmatory method |
| 72950-9 | Spironolactone induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 72968-1 | QUEtiapine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7332-0 | Gelatin IgE Ab [Units/volume] in Serum |
| 7407-0 | White Hickory IgE Ab [Units/volume] in Serum |
| 74323-7 | MICA*042 IgG Ab [Presence] in Serum |
| 59865-6 | Amobarbital [Moles/volume] in Urine |
| 50947-1 | Platelet aggregation collagen induced [Presence] in Platelet rich plasma --190 ug/mL |
| 31087-0 | Thioridazine [Mass/volume] in Gastric fluid |
| 42538-9 | Hydroxyperhexiline [Mass/volume] in Serum or Plasma |
| 60017-1 | Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Pyruvate to lactate reaction |
| 21276-1 | Follitropin [Units/volume] in Serum or Plasma --1 hour post XXX challenge |
| 31471-6 | Legionella pneumophila Ab [Units/volume] in Serum |
| 51426-5 | Glucose [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
| 5143-3 | Echovirus 4 Ab [Titer] in Serum by Complement fixation |
| 42982-9 | Parainfluenza virus Ab [Titer] in Serum |
| 31701-6 | West Nile virus IgG Ab [Presence] in Serum |
| 32169-5 | Cystine [Mass/volume] in 24 hour Urine |
| 4420-6 | quiNINE [Mass] of Dose |
| 44402-6 | Selenium/Creatinine [Molar ratio] in 24 hour Urine |
| 23066-4 | Epizootic hemorrhagic disease virus New Jersey Ab [Presence] in Serum by Immune diffusion (ID) |
| 3289-6 | Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay |
| 44489-3 | Herpes simplex virus 2 [Presence] in Cervix by Organism specific culture |
| 44868-8 | Herpes simplex virus 1+2 DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 23415-3 | Rinderpest virus Ag [Presence] in Exudate by Immune diffusion (ID) |
| 5353-8 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoassay |
| 53627-6 | Chloride [Moles/volume] in Pleural fluid |
| 53778-7 | Arsenic organic [Mass/volume] in Urine |
| 45029-6 | HLA-DQB1 SBT [Type] by High resolution |
| 4644-1 | Hemosiderin [Presence] in Urine |
| 24284-2 | La Crosse virus Ab [Titer] in Serum --2nd specimen |
| 246-9 | Floxacillin [Susceptibility] by Disk diffusion (KB) |
| 249-3 | Fluconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 3430-6 | Canrenone [Mass/time] in 24 hour Urine |
| 47429-6 | Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum --1st specimen |
| 47654-9 | Insulin [Units/volume] in Serum or Plasma --10 minutes post dose glucose |
| 47666-3 | Insulin [Units/volume] in Serum or Plasma --5 minutes pre dose glucose |
| 35775-6 | cefTAZidime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 47956-8 | CNR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 47959-2 | GFAP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 48131-7 | Somatotropin [Units/volume] in Serum or Plasma --30 minutes pre dose TRH |
| 26671-8 | Ascaris sp Ab [Presence] in Serum |
| 48828-8 | Respiratory allergen panel, US - Greater Ohio valley a - Serum |
| 27064-5 | Opiates [Mass/mass] in Stool |
| 38616-9 | Propoxur [Mass/volume] in Air |
| 57628-0 | Alpha cortol [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
| 48909-6 | Rickettsia parkeri IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 48959-1 | Nordiazepam [Mass/volume] in Specimen |
| 38721-7 | Propionaldehyde [Mass/volume] in Air |
| 29249-0 | Varicella zoster virus IgG Ab [Units/volume] in Body fluid |
| 4013-9 | Pyrovalerone [Mass/time] in 24 hour Urine |
| 40292-5 | Insulin [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 49789-1 | Potassium [Moles/volume] in Peritoneal fluid |
| 40751-0 | Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunofluorescence |
| 20486-7 | Haemophilus influenzae B Ag [Units/volume] in Cerebral spinal fluid |
| 20507-0 | Reagin Ab [Presence] in Serum by RPR |
| 20529-4 | FLUoxetine [Mass/volume] in Urine by Confirmatory method |
| 12463-6 | Corticotropin [Mass/volume] in Plasma --7th specimen post XXX challenge |
| 13292-8 | Colorado tick fever virus IgG Ab [Units/volume] in Serum |
| 101870-4 | GABAAR IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 102974-3 | Dermatophagoides sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14534-2 | Measles virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 104276-1 | ALK gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 15445-0 | Avian leukosis virus Ag [Titer] in Serum by Immunoassay |
| 15476-5 | Leptospira interrogans sv Bratislava Ab [Titer] in Serum by Agglutination |
| 16161-2 | Gastrin [Mass/volume] in Serum or Plasma --post XXX challenge |
| 11045-2 | Enolase [Enzymatic activity/volume] in Red Blood Cells |
| 11271-4 | Hematocrit [Volume Fraction] of Cord blood by Automated count |
| 11550-1 | Borrelia burgdorferi [Presence] in Specimen by Organism specific culture |
| 115-6 | cefOXitin [Susceptibility] by Minimum lethal concentration (MLC) |
| 11566-7 | Liver kidney microsomal Ab [Units/volume] in Serum |
| 12179-8 | Basophils/100 leukocytes in Body fluid by Manual count |
| 1754-1 | Albumin [Mass/volume] in Urine |
| 17859-0 | Helicobacter pylori IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 18354-1 | Glucose [Mass/volume] in Serum or Plasma --12 hours post 50 g lactose PO |
| 184-2 | Ciprofloxacin [Susceptibility] by Minimum lethal concentration (MLC) |
| 90415-1 | B-cell TACI and BAFF-R subsets panel - Blood |
| 75032-3 | CEBPA gene full mutation analysis in Bone marrow by Sequencing |
| 7603-4 | Pigeon droppings IgG Ab [Units/volume] in Serum |
| 76063-7 | MSH2 gene+MLH1 gene+MSH6 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 76142-9 | Immature lymphocytes [Presence] in Blood by Manual count |
| 7692-7 | Scallop IgG Ab [Units/volume] in Serum |
| 61372-9 | Human papilloma virus 16 DNA [Presence] in Specimen by NAA with probe detection |
| 772-4 | Nucleated erythrocytes [#/volume] in Blood by Manual count |
| 7771-9 | Watermelon IgG Ab [Units/volume] in Serum |
| 9414-4 | Phosphoserine [Moles/volume] in 24 hour Urine |
| 63154-9 | Cultivated Rye IgG Ab [Mass/volume] in Serum |
| 63270-3 | Liver kidney microsomal 1 Ab [Presence] in Body fluid by Immunofluorescence |
| 7791-7 | Dacrocytes [Presence] in Blood by Light microscopy |
| 78826-5 | Ethyl acetate [Mass/volume] in Urine |
| 94761-4 | SARS-CoV-2 (COVID-19) IgG Ab [Presence] in DBS by Immunoassay |
| 95201-0 | HLA-B7 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC) |
| 79614-4 | N-monomethylarginine [Moles/volume] in Serum or Plasma |
| 80825-3 | Zika virus envelope E gene [Presence] in Serum by NAA with probe detection |
| 82078-7 | Food Allergen Mix 8 (Brazil nut+Orange+Hazelnut+Apple+Cocoa) IgE Ab [Units/volume] in Serum by Multidisk |
| 82242-9 | Chromosome region 17p13.3 deletion in Amniotic fluid or Chorionic villus sample by FISH |
| 70207-6 | Estrogen [Moles/volume] in Serum or Plasma |
| 7164-7 | Burrobrush IgE Ab [Units/volume] in Serum |
| 98276-9 | Para-aortic lymph nodes examined [#] in Specimen |
| 71689-4 | Mononuclear cells [#/volume] in Body fluid by Automated count |
| 71765-2 | Rotavirus Ab [Presence] in Serum by Immunoassay |
| 84894-5 | Dimension [Length] of Specimen |
| 73202-4 | Piperacillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86894-3 | Adalimumab [Mass/volume] in Serum or Plasma by Immunoassay |
| 87431-3 | Herpes simplex virus 1 and 2 DNA panel - Specimen Qualitative by NAA with probe detection |
| 87651-6 | 2,3,5-trimethylphenyl methylcarbamate [Mass/mass] in Specimen |
| 88454-4 | Mumps virus IgG+IgM Ab [Interpretation] in Cerebral spinal fluid Qualitative by Immunofluorescence |
| 74333-6 | MICA*018 IgG Ab [Presence] in Serum |
| 59609-8 | ALPRAZolam [Mass/volume] in Body fluid by Confirmatory method |
| 30480-8 | Orotate [Presence] in Urine |
| 3077-5 | Tyrosine [Mass/volume] in Blood |
| 42222-0 | Manganese [Moles/time] in 24 hour Urine |
| 42375-6 | Neisseria meningitidis serogroup Z Ag [Presence] in Isolate by Agglutination |
| 42678-3 | Urate [Saturation Fraction] in 24 hour Urine |
| 31573-9 | Powassan virus IgG Ab [Units/volume] in Serum |
| 51318-4 | CD41 cells/100 cells in Cerebral spinal fluid |
| 43031-4 | Herpes simplex virus 1 Ab [Titer] in Serum |
| 22098-8 | Avian paramyxovirus 1 Ab [Titer] in Serum |
| 22123-4 | Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid |
| 22236-4 | Coxsackievirus B6 Ab [Titer] in Serum |
| 31681-0 | Theileria mutans Ab [Units/volume] in Serum |
| 3175-7 | Antithrombin Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 31806-3 | Eastern equine encephalitis virus Ag [Presence] in Brain |
| 51748-2 | PCA-Tr Ab [Titer] in Cerebral spinal fluid |
| 3211-0 | Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation.2 stage |
| 32269-3 | Serine [Moles/volume] in Vitreous fluid |
| 23069-8 | Equine arteritis virus Ab [Titer] in Serum by Complement fixation |
| 32593-6 | Eosinophils/100 leukocytes in Specimen |
| 4442-0 | Thioridazine [Mass] of Dose |
| 23233-0 | Mite identified in Skin by Parasite sedimentation |
| 3365-4 | Antipyrine renal clearance in 24 hour Urine and Serum or Plasma |
| 33660-2 | HIV 1 p24 Ag [Presence] in Serum or Plasma by Neutralization test |
| 53795-1 | STK11 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 5386-8 | Toxocara canis Ab [Units/volume] in Serum by Immunoassay |
| 23738-8 | Feline herpesvirus 1 Ab [Titer] in Serum |
| 3396-9 | Cocaine [Mass/volume] in Serum or Plasma |
| 54335-5 | Stearoylcarnitine (C18) [Moles/volume] in Amniotic fluid |
| 24495-4 | Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 55385-9 | Insulin [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 25425-0 | Gabapentin [Moles/volume] in Serum or Plasma |
| 25461-5 | Lithium, [Moles/volume] in Blood |
| 34990-2 | Unidentified cells [#/volume] in Peritoneal fluid |
| 3513-9 | Cropropamide [Mass/time] in 24 hour Urine |
| 55790-0 | Band form neutrophils [#] in Cerebral spinal fluid by Manual count |
| 56140-7 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Anal by Probe with signal amplification |
| 5636-6 | Cyanide [Mass/mass] in Tissue |
| 56453-4 | Cow dander IgG4 Ab [Mass/volume] in Serum |
| 26948-0 | Saccharopolyspora rectivirgula IgG Ab [Mass/volume] in Serum |
| 57604-1 | 6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
| 48993-0 | Glucose [Mass/volume] in Serum or Plasma --3 AM specimen |
| 4906-4 | HLA-Dw3 [Presence] in Donor |
| 28053-7 | Borrelia burgdorferi 30kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 38760-5 | Dibenzofuran [Mass/volume] in Air |
| 29237-5 | Herpes simplex virus 1 Ab [Units/volume] in Body fluid |
| 58681-8 | Temperature of Urine |
| 29559-2 | Haemophilus ducreyi DNA [Presence] in Specimen by NAA with probe detection |
| 29883-6 | 2-Hydroxyphenylacetate [Presence] in Urine |
| 40558-9 | Cytokeratin 20 Ag [Presence] in Tissue by Immune stain |
| 30231-5 | Rheumatoid factor [Units/volume] in Body fluid |
| 30249-7 | Barbiturates [Mass/volume] in Serum or Plasma by Screen method |
| 41011-8 | Human metapneumovirus IgG Ab [Presence] in Serum |
| 20772-0 | Coliform colony count [#/volume] in Milk |
| 20796-9 | Endophyte identified in Plant |
| 100088-4 | Taenia solium larva Ab bands panel - Serum by Immunoblot |
| 100151-0 | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma |
| 100689-9 | Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection |
| 12821-5 | Progesterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 101625-2 | Spermatozoa.motility [Score] in Semen Qualitative by Light microscopy |
| 101667-4 | Protein.monoclonal [Presence] in 24 hour Urine by MS.MALDI-TOF |
| 1327-6 | U Ag [Presence] on Red Blood Cells from Donor |
| 102793-7 | White Pepper IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103087-3 | House dust Bencard IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103103-8 | Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103952-8 | Muscular dystrophy multigene analysis in Specimen by Molecular genetics method |
| 14832-0 | Metanephrines [Moles/volume] in Urine |
| 104272-0 | IgH and IgK gene rearrangement status [Identifier] in Specimen by Molecular genetics method Nominal |
| 1573-5 | Insulin [Mass/volume] in Serum or Plasma --12 hours fasting |
| 10967-8 | Glucose [Presence] in Urine by Test strip --3.5 hours post 75 g glucose PO |
| 17328-6 | Neisseria meningitidis serogroup B Ag [Presence] in Urine by Latex agglutination |
| 18503-3 | Microscopic observation [Identifier] in Superficial tissue fine needle aspirate by Cyto stain |
| 19066-0 | Blood bank comment |
| 91783-1 | Cytomegalovirus [Presence] in Lower respiratory specimen by Organism specific culture |
| 75604-9 | Fetal sex in Cell-free+Maternal WBC DNA by Dosage of chromosome specific circulating cell free (ccf) DNA |
| 75605-6 | Cell-free DNA.fetal/Cell-free DNA.total in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
| 61237-4 | Budgerigar feather IgE Ab/IgE total in Serum |
| 62252-2 | CD79 cells/100 cells in Blood |
| 93911-6 | little cE Ag [Presence] on Red Blood Cells |
| 9423-5 | Nuclear Ab [Units/volume] in Serum by Immunofluorescence |
| 94273-0 | Muscle specific receptor tyrosine kinase IgG Ab [Moles/volume] in Serum by Immunoassay |
| 94632-7 | Escherichia coli K99 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 63565-6 | Prothionamide [Susceptibility] by Method for Slow-growing mycobacteria |
| 80160-5 | 5-beta-cholestane-3-alpha,7-alpha,12-alpha,23-tetrol/Creatinine [Ratio] in Urine |
| 95833-0 | Nucleated cells [#] in Blood product unit |
| 96324-9 | Klebsiella pneumoniae+Klebsiella variicola+Klebsiella quasipneumoniae DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection |
| 68325-0 | Thrombin time actual/Normal |
| 96720-8 | Epithelial cells [#/area] in Prostatic fluid by Light microscopy |
| 69754-0 | Bordetella pertussis+Bordetella parapertussis filamentous hemagglutinin IgG Ab [Presence] in Serum by Line blot |
| 6986-4 | Cefaclor [Susceptibility] by Gradient strip |
| 9740-2 | Neopterin [Moles/volume] in Serum or Plasma |
| 97631-6 | Pseudomonas aeruginosa DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 70863-6 | Rabies virus IgM Ab [Presence] in Serum by Immunofluorescence |
| 87608-6 | Difenacoum [Mass/mass] in Specimen |
| 87949-4 | Chlamydia trachomatis DNA [Presence] in Tissue by NAA with probe detection |
| 87986-6 | Leishmania sp identified in Bone marrow by Organism specific culture |
| 88552-5 | Scedosporium prolificans DNA [Presence] in Specimen by NAA with probe detection |
| 74118-1 | P27 Ag [Presence] in Tissue by Immune stain |
| 74461-5 | Lymphocytes/100 leukocytes in Blood from Fetus |
| 88893-3 | Prothrombin time (PT) PIVKA sensitive in Platelet poor plasma |
| 41429-2 | Acanthamoeba sp DNA [Presence] in Specimen by NAA with probe detection |
| 41668-5 | Carbenicillin [Susceptibility] by Gradient strip |
| 59424-2 | Influenza virus A hemagglutinin type RNA [Identifier] in Isolate by NAA with probe detection |
| 50802-8 | Amikacin [Moles/volume] in Serum or Plasma --peak |
| 3046-0 | Triglyceride+ester in LDL [Mass/volume] in Serum or Plasma |
| 30502-9 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum --2nd specimen |
| 30562-3 | Surfactant/Albumin [Mass Ratio] in Amniotic fluid |
| 21088-0 | Azinphos-methyl [Mass/volume] in Urine |
| 21481-7 | Propranolol [Mass/volume] in Gastric fluid |
| 31427-8 | Histoplasma capsulatum yeast phase Ab [Units/volume] in Cerebral spinal fluid |
| 43205-4 | Parainfluenza virus 3 Ab [Presence] in Cerebral spinal fluid by Complement fixation |
| 31826-1 | Feline infectious peritonitis virus Ag [Presence] in Small intestine Tissue |
| 5159-9 | Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay |
| 3213-6 | Coagulation factor VIII Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 32372-5 | Fleroxacin [Susceptibility] |
| 51934-8 | Spermatozoa Slow/100 spermatozoa in Semen --1 hour post ejaculation |
| 44406-7 | Sodium/Potassium [Molar ratio] in 24 hour Urine |
| 22836-1 | Avian pox virus [Presence] in Tissue by Electron microscopy |
| 32611-6 | Amino acids [Moles/volume] in Amniotic fluid |
| 32721-3 | Tacrolimus [Mass/volume] in Serum or Plasma |
| 3291-2 | 2-Pyridone [Mass/volume] in Serum or Plasma |
| 2338-2 | Glucagon [Mass/volume] in Serum or Plasma |
| 23468-2 | Theileria mutans Ab [Presence] in Serum by Immunoassay |
| 23507-7 | Trypanosoma brucei DNA [Presence] in Blood by NAA with probe detection |
| 33526-5 | Reptilase time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma |
| 53520-3 | Neutrophils/100 leukocytes in Dialysis fluid |
| 45283-9 | Echovirus 11 Ab [Presence] in Body fluid |
| 5399-1 | Trypanosoma sp Ab [Units/volume] in Serum |
| 46096-4 | Arsenic [Moles/mass] in Hair |
| 24349-3 | Drugs of abuse 5 panel - Urine |
| 34605-6 | Collagen type 2 Ab [Units/volume] in Serum |
| 55300-8 | JAK2 gene exon 12 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 25393-0 | Desethylamiodarone [Moles/volume] in Serum or Plasma |
| 35173-4 | Eicosapentaenoate (C20:5w3) [Moles/volume] in Serum or Plasma |
| 55783-5 | Hemoglobin Barts [Presence] in Blood by HPLC |
| 35614-7 | Ibuprofen [Mass/volume] in Serum or Plasma by Screen method |
| 56357-7 | Perennial rye grass IgG4 Ab [Mass/volume] in Serum |
| 56386-6 | Sesame Seed IgG4 Ab [Mass/volume] in Serum |
| 56656-2 | Fluoride/Creatinine [Ratio] in Urine |
| 56701-6 | Diclofenac IgE Ab [Units/volume] in Serum |
| 48790-0 | Creatinine [Mass/time] in unspecified time Peritoneal dialysis fluid |
| 38580-7 | Cresols [Mass/volume] in Air |
| 57394-9 | CD19+CD34+ cells/100 cells in Body fluid |
| 57601-7 | 6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
| 49310-6 | Nuclear Ab pattern [Interpretation] in Serum Narrative |
| 27337-5 | Amino beta guanidinopropionate [Moles/volume] in Cerebral spinal fluid |
| 57990-4 | KRIT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 49595-2 | Trichothecene IgM Ab [Units/volume] in Serum by Immunoassay |
| 49723-0 | Tea IgG Ab [Mass/volume] in Serum |
| 28585-8 | 4-Hydroxyphenylacetate/Creatinine [Ratio] in Urine |
| 40199-2 | Glucose [Moles/volume] in Serum or Plasma --3 minutes post XXX challenge |
| 58397-1 | Phencyclidine/Creatinine [Mass Ratio] in Urine |
| 58786-5 | Herpes simplex virus 1 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 50135-3 | 3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in Serum or Plasma |
| 50280-7 | 3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Cerebral spinal fluid |
| 50328-4 | PMS-2 Ag [Presence] in Tissue by Immune stain |
| 50539-6 | Thyrotropin [Units/volume] in Serum or Plasma --7th specimen |
| 50545-3 | Bacterial susceptibility panel by Minimum inhibitory concentration (MIC) |
| 41141-3 | Influenza virus A N2 Ab [Presence] in Serum |
| 19652-7 | Para hydroxyamphetamine [Presence] in Urine by Confirmatory method |
| 12338-0 | Pentachlorophenol [Presence] in Serum or Plasma |
| 100378-9 | Sheep cheese IgG Ab [Units/volume] in Serum |
| 100749-1 | Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection |
| 13213-4 | Brucella abortus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13291-0 | Trypanosoma cruzi IgG Ab [Units/volume] in Serum |
| 13779-4 | N-acetyl-L-aspartate/Creatinine [Mass Ratio] in Urine |
| 1387-0 | Catecholamines Free fractionated [Mass/volume] in Plasma --3 hours post 300 ug cloNIDine PO |
| 102658-2 | Wheat Stem Rust IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103669-8 | Mitragynine [Presence] in Cord tissue by Screen method |
| 103711-8 | Nickel IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10381-2 | Target cells [Presence] in Blood by Light microscopy |
| 15010-2 | Aldosterone [Moles/volume] in Urine |
| 104307-4 | Letrozole [Mass/volume] in Serum or Plasma |
| 10749-0 | Collagen fibers.microscopic observation [Identifier] in Tissue by Van Gieson stain |
| 16595-1 | Chlamydia trachomatis IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 16859-1 | Fibrinogen [Presence] in Platelet poor plasma |
| 17035-7 | Ketorolac [Mass/volume] in Serum or Plasma |
| 17236-1 | Magnesium [Moles/volume] in Stool |
| 17332-8 | Neisseria meningitidis polyvalent Ag [Presence] in Cerebral spinal fluid |
| 17862-4 | Calcium [Mass/volume] in Urine |
| 92549-5 | Co sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 75079-4 | Succinylacetone [Moles/volume] in Serum or Plasma |
| 75402-8 | GCDH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 61103-8 | Prochlorperazine [Moles/volume] in Urine |
| 62354-6 | Chromosome analysis.metaphase panel - Amniotic fluid by FISH |
| 93999-1 | Creatinine [Mass/volume] in Serum or Plasma --1 hour post dose vasopressin |
| 63312-3 | Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 77888-6 | OLANZapine [Mass/volume] in Urine by Confirmatory method |
| 63438-6 | MAPT gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 63446-9 | CD3+CD5- cells/100 cells in Cerebral spinal fluid |
| 7901-2 | Helicobacter pylori IgA Ab [Units/volume] in Serum |
| 79225-9 | Barbital [Mass/volume] in Body fluid |
| 95155-8 | PRRSV ORF5 gene sequence homology to Prevacent in Isolate by Sequencing |
| 95195-4 | Interferon-gamma producing HLA-B7 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC) |
| 6558-1 | Streptococcus pyogenes Ag [Presence] in Specimen by Immunoassay |
| 79516-1 | Octenedioate (C8:1) [Moles/volume] in Serum or Plasma |
| 79696-1 | cis-11-Eicosenoate (cis 11 C20:1w9) [Entitic substance] in Red Blood Cells |
| 79714-2 | CYP2C19 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
| 80424-5 | Inosine triphosphate pyrophosphatase [Enzymatic activity/substance] in Red Blood Cells |
| 9609-9 | Hepatitis C virus 22-3 Ab [Presence] in Serum by Immunoblot |
| 6741-3 | Erythrocytes [#/volume] in Body fluid by Manual count |
| 97052-5 | Chemokine (C-C motif) ligand 2 [Mass/volume] in Serum or Plasma |
| 69357-2 | Amylase [Enzymatic activity/volume] in Serum or Plasma --fasting |
| 69479-4 | BTK gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 70009-6 | Enterovirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 82088-6 | Occupational Allergen Mix 2 (Acarus siro+Lepidoglyphus destructor+Horse bot fly+Grain weevel) IgE Ab [Units/volume] in Serum by Multidisk |
| 82196-7 | Campylobacter coli+jejuni+upsaliensis DNA [Presence] in Stool by NAA with non-probe detection |
| 82527-3 | 6-Beta naltrexol/Creatinine [Mass Ratio] in Urine |
| 82658-6 | Glutamate decarboxylase Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 98390-8 | Percent epithelial component of carcinosarcoma |
| 98416-1 | traZODone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 71877-5 | Hemoglobin A/Hemoglobin.total [Pure mass fraction] in Blood by HPLC |
| 85488-5 | Sc2 Ag [Presence] on Red Blood Cells |
| 85747-4 | Streptococcus pneumoniae Danish serotype 1 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 99894-8 | Calcium oxalate monohydrate crystals [Presence] in Urine sediment by Computer assisted method |
| 72582-0 | Gamma globulin/Protein.total [Pure mass fraction] in Serum or Plasma by Electrophoresis |
| 87656-5 | Carbofuran [Mass/mass] in Specimen |
| 87751-4 | Endosulfan II [Mass/mass] in Specimen |
| 73439-2 | Clavulanate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73726-2 | Lysergate diethylamide [Presence] in Hair |
| 88451-0 | Babesia duncani 18S rRNA gene [Presence] in Blood by NAA with non-probe detection |
| 74099-3 | Neutrophil gelatinase-associated lipocalin [Mass/volume] in Urine by Rapid immunoassay |
| 50967-9 | Hepatitis B virus surface Ag [Presence] in Blood from Donor by Neutralization test |
| 59930-8 | Methotrimeprazine [Moles/volume] in Urine |
| 60180-7 | Tellurium [Mass/volume] in Red Blood Cells |
| 60195-5 | Trichlormethiazide [Mass/volume] in Blood |
| 60225-0 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose fructose PO |
| 21652-3 | CDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 51114-7 | CD2 blasts [Units/volume] in Specimen |
| 51421-6 | Testosterone [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
| 4283-8 | Imipramine [Mass] of Dose |
| 43084-3 | Blastomyces dermatitidis Ab [Titer] in Pleural fluid |
| 43101-5 | Phosphatidylserine IgA and IgG and IgM panel - Serum |
| 22166-3 | Caprine parapoxvirus Ab [Presence] in Serum |
| 31863-4 | Influenza virus B Ag [Presence] in Throat |
| 22384-2 | Legionella pneumophila 2 IgM Ab [Titer] in Serum |
| 32246-1 | Histidine [Moles/volume] in Body fluid |
| 43941-4 | Red top grass IgE Ab/IgE total in Serum |
| 4416-4 | Protriptyline [Mass] of Dose |
| 22966-6 | Campylobacter fetus Ag [Presence] in Tissue by Immunofluorescence |
| 32583-7 | Phenyllactate [Presence] in Urine |
| 23220-7 | Lumpy skin disease virus Ag [Presence] in Specimen |
| 23257-9 | Mycoplasma capricolum ss capricolum Ab [Presence] in Serum by Immunoassay |
| 23374-2 | Porcine respiratory coronavirus Ab [Presence] in Serum by Immunoassay |
| 3338-1 | Amobarbital [Mass/volume] in Serum or Plasma |
| 23726-3 | Feline infectious peritonitis virus Ab [Presence] in Serum by Immunoassay |
| 24028-3 | Toxocara canis IgA Ab [Presence] in Serum |
| 34221-2 | 17-Hydroxyprogesterone/Creatinine [Molar ratio] in Urine |
| 55092-1 | PDGFRA gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 47156-5 | Norepinephrine [Moles/volume] in Plasma --1 hour post 300 ug cloNIDine PO |
| 25245-2 | Cefuroxime Parenteral [Mass/volume] in Specimen |
| 35277-3 | Myocardium IgG Ab [Presence] in Serum |
| 35354-0 | COL1A1+COL1A2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 354-1 | Neomycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 35440-7 | HIV 1 gp160 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
| 56192-8 | Bass, Black IgG4 Ab [Mass/volume] in Serum |
| 56195-1 | Black-eye pea IgG4 Ab [Mass/volume] in Serum |
| 5621-8 | Chromium [Mass/volume] in Red Blood Cells |
| 56279-3 | Guinea pig epithelium IgG4 Ab [Mass/volume] in Serum |
| 48344-6 | Activated clotting time.kaolin induced of Platelet poor plasma |
| 2633-6 | Methyltestosterone [Mass/volume] in Urine |
| 3670-7 | Haloperidol [Presence] in Urine |
| 56597-8 | Latex recombinant (rHev b) 8 IgE Ab [Units/volume] in Serum |
| 2698-9 | Osteonectin [Mass/volume] in Plasma |
| 38758-9 | 1,4-Dimethylbenzene [Mass/volume] in Air |
| 57950-8 | Cow whey IgE Ab/IgE total in Serum |
| 49413-8 | JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 49573-9 | HIV genotype [Susceptibility] in Isolate by Genotype method Narrative |
| 58480-5 | Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --6th specimen fasting |
| 50073-6 | 11-Deoxycortisol [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
| 30059-0 | Glutamate/Creatinine [Ratio] in Urine |
| 30130-9 | Brucella sp Ab [Presence] in Serum --2nd specimen |
| 19328-4 | Alpha hydroxyalprazolam [Mass/volume] in Urine |
| 20578-1 | Vancomycin [Mass/volume] in Serum or Plasma |
| 101515-5 | Equine herpesvirus 1 neuropathogenic G2254 variant DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 13249-8 | Herpes simplex virus 1+2 IgG Ab [Units/volume] in Cerebral spinal fluid |
| 13285-2 | Salmonella typhi O D Ab [Presence] in Serum |
| 102120-3 | Carbapenemase [Type] in Isolate by Immunoassay |
| 1416-7 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM rapid |
| 102803-4 | Pork IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1614-7 | Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose TRH IV |
| 1119-7 | Le sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
| 12172-3 | 5-Hydroxyindoleacetate [Presence] in 24 hour Urine |
| 16836-9 | Escherichia coli verotoxic identified in Stool by Organism specific culture |
| 17825-1 | CD41a cells/100 cells in Blood |
| 17924-2 | Bacteria # 3 identified in Tissue by Anaerobe culture |
| 89971-6 | 8-Hydroxyloxapine [Presence] in Urine by Screen method |
| 89975-7 | Norclozapine [Mass/volume] in Urine by Confirmatory method |
| 90443-3 | Coxiella burnetii aroE gene [Presence] in Serum, Plasma or Blood by NAA with non-probe detection |
| 7498-9 | Chrysonilia sitophila IgE Ab [Units/volume] in Serum |
| 7635-6 | Psyllium seed IgE Ab [Units/volume] in Serum |
| 76699-8 | Filaria identified in Skin by Light microscopy |
| 92847-3 | Herpes simplex virus 1 and 2 and Varicella zoster virus DNA panel - Blood by NAA with probe detection |
| 92989-3 | Acinetobacter calcoaceticus-baumannii complex DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
| 9430-0 | Isobutylcarbinol [Mass/volume] in Blood |
| 63380-0 | Methionine [Presence] in DBS |
| 95213-5 | Basophils/100 leukocytes in Stem cell product by Manual count |
| 6615-9 | Haemophilus influenzae F Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 96465-0 | Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Titer] in Serum by Immunofluorescence |
| 80687-7 | CYP1A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 96532-7 | Rift valley fever virus IgM Ab [Presence] in Specimen by Immunoassay |
| 692-4 | Neisseria gonorrhoeae [Presence] in Genital lochia by Organism specific culture |
| 9756-8 | Coxsackievirus A7 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 7038-3 | Ofloxacin [Susceptibility] by Gradient strip |
| 70569-9 | Plasmodium sp Ag [Identifier] in Blood by Rapid immunoassay |
| 98265-2 | Involvement of peritoneal biopsy specimen [Presence] in Endometrial cancer specimen |
| 72332-0 | Nucleated cells/100 round cells in Prostatic fluid by Manual count |
| 85586-6 | PRRSV European and North American strains IgG panel - Serum by Immunofluorescence |
| 99908-6 | Phosphate crystals amorphous [#/volume] in Urine sediment by Computer assisted method |
| 86128-6 | Streptococcus pneumoniae Danish serotype 11A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 86590-7 | Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid by Rapid immunoassay |
| 73111-7 | Topiramate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74332-8 | MICA*019 IgG Ab [Presence] in Serum |
| 59820-1 | Coproporphyrin 1/Creatinine [Molar ratio] in 24 hour Urine |
| 50825-9 | Bile acid [Moles/volume] in Body fluid |
| 50840-8 | Cholesterol in HDL [Moles/volume] in Body fluid |
| 60235-9 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.25 hours post dose lactose PO |
| 21291-0 | Gastrin [Mass/volume] in Serum or Plasma --3 hours post 0.2 U/kg secretin |
| 51092-5 | Cytoplasmic CD179a blasts [Units/volume] in Bone marrow |
| 51371-3 | CD8+HLA-DR+ cells/100 cells in Cerebral spinal fluid |
| 42795-5 | Retinoblastoma protein [Presence] in Tissue by Immune stain |
| 43104-9 | Paraneoplastic Ab panel - Serum |
| 21721-6 | OTC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21740-6 | TRAF3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 22182-0 | Chlamydia sp Ab [Titer] in Serum |
| 51647-6 | Rabies virus RNA [Presence] in Specimen by Probe |
| 43233-6 | OTC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 43582-6 | Complement C4 [Mass/volume] in Pleural fluid |
| 43585-9 | TYMP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 22616-7 | Western equine encephalitis virus IgM Ab [Titer] in Serum |
| 52116-1 | Date blood unit received |
| 43983-6 | Amphetamines [Presence] in Urine by Screen method >500 ng/mL |
| 32667-8 | Borrelia burgdorferi DNA [Presence] in Blood by NAA with probe detection |
| 53084-0 | Glucose [Moles/volume] in Nonbiological fluid |
| 5316-5 | Rickettsia typhus group Ab [Presence] in Serum by Immunoassay |
| 23534-1 | Trypanosoma sp Ab [Presence] in Serum by Immunofluorescence |
| 33323-7 | Theophylline [Presence] in Urine by Screen method |
| 33343-5 | Leukotriene E4/Creatinine [Mass Ratio] in Urine |
| 45034-6 | Bacteria producing catalase [Presence] in Isolate |
| 23753-7 | Mycoplasma hyopneumoniae Ab [Presence] in Serum by Immunofluorescence |
| 34218-8 | 17-Hydroxycorticosteroids [Moles/volume] in Urine |
| 54295-1 | Hexanoylcarnitine (C6)/Creatinine [Molar ratio] in Urine |
| 4551-8 | Hemoglobin A2/Hemoglobin.total in Blood |
| 4597-1 | Hemoglobin J - Capetown [Presence] in Blood |
| 55494-9 | Insulin [Moles/volume] in Serum or Plasma --5 minutes post dose glucose IV |
| 55550-8 | Methsuximide+Normethsuximide [Moles/volume] in Serum or Plasma |
| 55553-2 | Metoprolol [Moles/volume] in Serum or Plasma |
| 25179-3 | Amikacin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 5575-6 | Aluminum [Mass/volume] in Red Blood Cells |
| 55782-7 | Hemoglobin [Mass/volume] in Blood by Oximetry |
| 55821-3 | Allo-pregnanediol [Mass/volume] in 24 hour Urine |
| 55976-5 | pH of Nonbiological fluid |
| 4750-6 | HLA-B47 [Presence] in Donor |
| 25674-3 | Glucose [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 2573-4 | Lipoprotein.alpha [Mass/volume] in Serum or Plasma |
| 35698-0 | metFORMIN [Mass/volume] in Serum or Plasma |
| 35718-6 | Chlamydia sp rRNA [Presence] in Nose by Probe |
| 56366-8 | Rabbit IgG4 Ab [Mass/volume] in Serum |
| 56531-7 | Amphiphysin Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 48077-2 | Thyrotropin [Units/volume] in Serum or Plasma --2.5 hours post dose luteinizing releasing hormone IV |
| 48149-9 | Osmolality.urine/Osmolality.serum |
| 26444-0 | Basophils [#/volume] in Blood |
| 48407-1 | Pregnancy associated plasma protein A [Mass/volume] in Serum or Plasma |
| 26912-6 | Hydroxytriazolam [Mass/mass] in Meconium |
| 39295-1 | Influenza virus A Ab [Presence] in Egg yolk by Immune diffusion (ID) |
| 2808-4 | Porphobilin [Mass/volume] in Serum |
| 50005-8 | Methaqualone [Presence] in Body fluid by Screen method |
| 50245-0 | 17-Hydroxycorticosteroids [Mass/time] in 24 hour Urine --post high dose dexamethasone |
| 50411-8 | Chlamydia trachomatis rRNA [Presence] in Specimen from Donor by NAA with probe detection |
| 41010-0 | Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection |
| 41110-8 | CSTB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 1923-2 | Base deficit in Capillary blood |
| 19239-3 | Lactate [Moles/volume] in Capillary blood |
| 19272-4 | Barbiturates tested for in Urine by Screen method Narrative |
| 19630-3 | Norfluoxetine cutoff [Mass/volume] in Urine for Screen method |
| 20395-0 | Sample integrity [Type] of Serum or Plasma |
| 20398-4 | Homogenous nuclear Ab pattern [Titer] in Serum |
| 20584-9 | Leukocytes [#/volume] in Specimen by Automated count |
| 2100-6 | Cholylglycine [Mass/volume] in Serum |
| 12352-1 | Benzoylecgonine [Presence] in Stool |
| 100674-1 | BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 12711-8 | Hemoglobin A region [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 13064-1 | Platelet associated IgA Ab [Units/volume] in Blood |
| 13605-1 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
| 13763-8 | Hydroxyproline/Creatinine [Mass Ratio] in Urine |
| 102244-1 | Cocklebur IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102307-6 | Douglas Fir IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14208-3 | Filaria IgG4 Ab [Units/volume] in Serum |
| 102800-0 | Pollock IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102868-7 | Wheat Bran IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14644-9 | chlorproMAZINE [Presence] in Gastric fluid |
| 103647-4 | Cortisol [Mass/volume] in Serum or Plasma --2 hour post dose corticotropin |
| 104223-3 | Spermatozoa.progressive.slow+rapid/100 spermatozoa in Urine --post ejaculation |
| 104224-1 | HLA-DPB1+DPA1 Typing panel - Blood or Tissue from Donor |
| 10691-4 | Mushroom.toxic identified by Inspection |
| 15240-5 | Occupational Allergen Mix 6 (Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) IgE Ab [Presence] in Serum by Multidisk |
| 15245-4 | Food Allergen Mix 14 (Cabbage+Paprika+Tomato+Spinach) IgE Ab [Presence] in Serum by Multidisk |
| 10938-9 | Mediterranean flour moth IgE Ab [Units/volume] in Serum |
| 113-1 | cefoTEtan [Susceptibility] by Disk diffusion (KB) |
| 17267-6 | Methoxychlor [Mass/volume] in Urine |
| 17292-4 | Mumps virus Ab [Units/volume] in Cerebral spinal fluid |
| 17685-9 | Testosterone Free [Mass/volume] in Dialysis fluid |
| 18333-5 | Echovirus 7 Ab [Units/volume] in Cerebral spinal fluid |
| 187-5 | Ciprofloxacin [Susceptibility] by Serum bactericidal titer |
| 90912-7 | Eicosapentaenoate (C20:5w3)/Fatty acids.C14-C22 in Blood |
| 75151-1 | Acadesine/Creatinine [Molar ratio] in Urine |
| 6069-9 | Chestnut Pollen IgE Ab [Units/volume] in Serum |
| 77623-7 | Thyrotropin [Units/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 93716-9 | Francisella tularensis IgM Ab [Presence] in Serum by Immunoassay |
| 94397-7 | Sulfocysteine, Hypoxanthine, Xanthine, Urate and Creatinine panel - Urine |
| 65332-9 | Rh32 Ab [Presence] in Serum or Plasma |
| 9571-1 | Parvovirus B19 DNA [Presence] in Specimen by NAA with probe detection |
| 9614-9 | Cortisol [Mass/volume] in Serum or Plasma --45 minutes post 250 ug corticotropin IM |
| 68946-3 | SERPINA10 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 80662-0 | Volume of Peritoneal dialysis fluid |
| 96519-4 | Semliki Forest virus IgG Ab [Presence] in Specimen by Immunoassay |
| 81622-3 | Hydroxyapatite [Energy Difference] in 24 hour Urine |
| 81691-8 | DNA mismatch repair protein Mlh1 [Presence] in Cancer specimen by Immune stain |
| 81708-0 | Microsatellite markers exhibiting instability/Microsatellite instability markers assessed in Cancer specimen |
| 81810-4 | 3-Hydroxydecanoylcarnitine (C10-OH)/Creatinine [Molar ratio] in Urine |
| 97910-4 | Endogenous thrombin potential [Area under the curve] in Platelet poor plasma by Chromogenic method |
| 988-6 | Di sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
| 99083-8 | Blastomyces sp Ag [Mass/volume] in Body fluid by Immunoassay |
| 99897-1 | Calcium oxalate dihydrate crystals [Presence] in Urine sediment by Computer assisted method |
| 72773-5 | O-desmethylvenlafaxine/Creatinine [Mass Ratio] in Urine |
| 85801-9 | Influenza virus B Yamagata lineage Ag [Titer] in Isolate by Hemagglutination inhibition |
| 73007-7 | Lansoprazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87614-4 | Thallium [Mass/mass] in Specimen |
| 73587-8 | Solithromycin [Susceptibility] |
| 73899-7 | CD3- CD8- CD57+ Cells [#/volume] in Blood by Flow cytometry (FC) |
| 88850-3 | Microbiology CNAMTS panel - Blood |
| 88924-6 | Microsporidia DNA [Presence] in Tissue by NAA with probe detection |
| 41262-7 | Viscosity of Peritoneal fluid Qualitative |
| 31142-3 | Cefepime [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC) |
| 42376-4 | Neisseria meningitidis serogroup Z' Ag [Presence] in Isolate by Agglutination |
| 60164-1 | Phensuximide [Mass/volume] in Blood |
| 31324-7 | Coxsackievirus B1 Ab [Units/volume] in Body fluid |
| 31501-0 | Ganglioside GM1 IgG+IgM Ab [Presence] in Serum |
| 51084-2 | CD15 blasts [Units/volume] in Blood |
| 42747-6 | Phosphatidylethanolamine IgG Ab B2GP1 dependent [Multiple of the median] in Serum |
| 22131-7 | Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum |
| 3160-9 | Volume of Semen |
| 31774-3 | Chlamydia trachomatis Ag [Presence] in Stool |
| 43334-2 | Equine herpesvirus 3 neutralizing antibody [Titer] in Serum by Neutralization test |
| 43586-7 | Yersinia pseudotuberculosis Ab [Presence] in Cerebral spinal fluid |
| 43600-6 | Ganglioside GD1b IgM Ab [Presence] in Serum |
| 52128-6 | Cefotaxime [Susceptibility] for meningitis |
| 43872-1 | Aspergillus sp IgG Ab [Presence] in Serum |
| 44244-2 | Trichomonas vaginalis [#/area] in Vaginal fluid by Wet preparation |
| 33666-9 | Erythrocytes.dysmorphic [#/volume] in Urine by Light microscopy |
| 45344-9 | Tick mouth intact [Identifier] |
| 4598-9 | Hemoglobin J - Oxford [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 24127-3 | Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum by Immunoassay |
| 24149-7 | Food Allergen Mix D (Cauliflower+Cabbage+Brussel sprouts+Broccoli) IgG Ab [Units/volume] in Serum by Multidisk |
| 55506-0 | Somatotropin [Mass/volume] in Serum or Plasma --10 minutes post exercise |
| 55582-1 | Timolol [Moles/volume] in Serum or Plasma |
| 55594-6 | Duck feather IgE Ab [Presence] in Serum |
| 47060-9 | Legionella pneumophila 13 IgM Ab [Titer] in Serum by Immunofluorescence |
| 35361-5 | Triglyceride in Lipoprotein a [Presence] in Serum or Plasma |
| 358-2 | Netilmicin [Susceptibility] by Minimum lethal concentration (MLC) |
| 56731-3 | Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot |
| 27135-3 | Tryptophan [Moles/volume] in Amniotic fluid |
| 38563-3 | Spermatozoa.tail tip Motile w IgA/100 spermatozoa in Semen by Immunobead |
| 57983-9 | IDUA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 57991-2 | Lactalbumin IgE Ab/IgE total in Serum |
| 58038-1 | Gestrinone [Presence] in Urine |
| 49558-0 | TAU 3 Ag [Presence] in Tissue by Immune stain |
| 29409-0 | Desipramine [Mass/volume] in Gastric fluid |
| 50139-5 | 3-Methoxytyramine [Moles/volume] in Cerebral spinal fluid |
| 59219-6 | Testosterone [Moles/volume] in Pleural fluid |
| 59304-6 | Memantine [Mass/volume] in Serum or Plasma |
| 3000-7 | Thiamine pyrophosphate [Mass/volume] in Serum |
| 30089-7 | Transitional cells [#/area] in Urine sediment by Microscopy high power field |
| 30119-2 | IgM lymphocytes [#/volume] in Leukocytes |
| 30210-9 | Coccidioides reaction wheal [Diameter] --2 days post 0.1 mL coccidioidin intradermal |
| 30328-9 | Decenoylcarnitine (C10:1) [Moles/volume] in Serum or Plasma |
| 19527-1 | Lormetazepam cutoff [Mass/volume] in Urine for Confirmatory method |
| 20679-7 | Alkaloid identified in Plant by Thin layer chromatography (TLC) |
| 101164-2 | Brorphine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 101497-6 | Aztreonam [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 13585-5 | Trifluoperazine [Presence] in Serum or Plasma |
| 1426-6 | Cortisol [Mass/volume] in Serum or Plasma --48 hours post 40 ug corticotropin IM BID 3 day |
| 102912-3 | Penicillium roqueforti IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14482-4 | Diphtheria identified in Skin by Organism specific culture |
| 15151-4 | Aspergillus fumigatus 3 Ab [Presence] in Serum by Immune diffusion (ID) |
| 15418-7 | Service comment 27 |
| 10780-5 | Microscopic observation [Identifier] in Tissue by Chloracetate esterase stain |
| 16532-4 | Campylobacter lari rRNA [Presence] in Serum by Probe |
| 16739-5 | Dengue virus 4 Ab [Titer] in Serum |
| 17744-4 | Trimellitic anhydride (TMA) IgG Ab [Units/volume] in Serum |
| 17915-0 | Bacteria identified in Wound shallow by Aerobe culture |
| 90947-3 | Pathology case identifier [Identifier] |
| 91775-7 | Bordetella sp identified in Lower respiratory specimen by Organism specific culture |
| 75148-7 | Orotidine [Moles/volume] in Cerebral spinal fluid |
| 75346-7 | Promethazine [Mass/volume] in Blood by Confirmatory method |
| 76692-3 | Fungus identified [#/volume] in Mouth by Culture |
| 92901-8 | Noninvasive prenatal fetal aneuploidy and microdeletion panel - Plasma cell-free DNA by Sequencing |
| 93192-3 | HTR2C gene c.551-3008C>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 77208-7 | Salivary gland protein 1 IgA Ab [Units/volume] in Serum by Immunoassay |
| 94204-5 | HMBS gene full mutation analysis in Blood or Tissue by Sequencing |
| 6356-0 | Chlamydia trachomatis DNA [Presence] in Genital specimen by NAA with probe detection |
| 63-8 | Cefadroxil [Susceptibility] by Minimum lethal concentration (MLC) |
| 64799-0 | Oxygen content in Capillary blood by calculation |
| 78969-3 | Neurofilament heavy chain Ab [Mass/volume] in Cerebral spinal fluid |
| 79447-9 | Staphylococcus aureus capsular polysaccharide enzyme cpe gene [Presence] in Nose by NAA with probe detection |
| 95180-6 | Mycoplasma gallisepticum Ab [Titer] in Serum by Immunoassay |
| 95283-8 | PARK7 gene deletion in Blood or Tissue by Molecular genetics method |
| 95354-7 | Transfuse convalescent plasma [Volume] |
| 6639-9 | Influenza virus A Bangkok Ab [Units/volume] in Serum by Hemagglutination inhibition |
| 79594-8 | Glycylproline/Creatinine [Molar ratio] in Urine |
| 67805-2 | Cytomegalovirus Ag [Presence] in Isolate by Immunofluorescence |
| 80557-2 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/mass] in Hair |
| 80688-5 | HIV 1 RNA tropism [Identifier] in Plasma |
| 8078-8 | Mycoplasma pneumoniae IgM Ab [Units/volume] in Serum |
| 8223-0 | Opiates [Mass/volume] in Unknown substance |
| 97943-5 | Color.yeast colony [Type] in Isolate by Culture |
| 82343-5 | F8 gene intron 1 and 22 inversion targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
| 99003-6 | Leptospira santarosai sv Georgia Ab [Titer] in Serum by Agglutination |
| 71778-5 | Rift valley fever virus Ag [Presence] in Serum by Immunoassay |
| 99400-4 | CD19+CD23+ cells/100 cells in Bone marrow |
| 72662-0 | Extrinsic coagulation factor activity 4 panel - Platelet poor plasma |
| 7272-8 | Bald Cypress IgE Ab [Units/volume] in Serum |
| 861-5 | A2 B Ag [Presence] on Red Blood Cells from Donor |
| 73189-3 | Propoxyphene+Acetaminophen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87733-2 | KIT gene exon 8 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 73890-6 | Tetrahydrocortisol [Moles/volume] in Urine |
| 73994-6 | Polychlorinated biphenyl (PCB) [Presence] in Serum or Plasma by Screen method |
| 7439-3 | Karaya gum IgE Ab [Units/volume] in Serum |
| 88682-0 | Leishmania sp IgM Ab [Titer] in Serum by Immunofluorescence |
| 88928-7 | Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection |
| 41483-9 | Clostridium tetani toxoid Ab [Units/volume] in Serum by Immunoassay |
| 50664-2 | CD19+Kappa+ cells [#/volume] in Blood |
| 50698-0 | Influenza virus A.adamantane resistance [Presence] by Phenotype method |
| 50966-1 | Flunitrazepam [Presence] in Serum, Plasma or Blood |
| 31071-4 | Histoplasma capsulatum mycelial phase Ab [Titer] in Body fluid by Complement fixation |
| 41877-2 | Bordetella pertussis IgA and IgG and IgM panel [Units/volume] - Serum by Immunoassay |
| 60313-4 | Maprotiline [Moles/volume] in Specimen |
| 51449-7 | Paragonimus sp Ab [Titer] in Serum by Immunoassay |
| 42899-5 | Cytomegalovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 22267-9 | Echovirus 11 Ab [Titer] in Cerebral spinal fluid |
| 51706-0 | Hyaluronate [Mass/volume] in Pleural fluid |
| 51825-8 | Bordetella parapertussis Ab [Units/volume] in Serum by Immunoassay |
| 43583-4 | Lipoprotein a [Moles/volume] in Serum or Plasma |
| 22665-4 | Bilirubin.delta [Moles/volume] in Serum or Plasma |
| 32195-0 | Monocytes+Macrophages [Presence] in Peritoneal fluid by Light microscopy |
| 44536-1 | HTLV I DNA [Presence] in Blood by Probe |
| 23306-4 | Myxoma virus Ab [Titer] in Serum by Immunofluorescence |
| 23519-2 | Trypanosoma evansi [Presence] in Aspirate by Thin film |
| 23605-9 | Tritrichomonas foetus [Presence] in Placenta by Organism specific culture |
| 45097-3 | Chlamydia sp identified in Anal by Organism specific culture |
| 54422-1 | Frozen erythrocytes pediatric units given [#] |
| 46180-6 | Classical swine fever virus Ab [Titer] in Serum |
| 46218-4 | 5-Fluorocytosine [Moles/volume] in Serum or Plasma |
| 2504-9 | Iron [Mass/volume] in Urine |
| 2600-5 | Magnesium Ionized [Moles/volume] in Serum or Plasma |
| 35389-6 | Cholesterol.in chylomicrons [Presence] in Serum or Plasma |
| 35541-2 | Onion IgG Ab [Mass/volume] in Serum |
| 56404-7 | Tobacco IgG4 Ab [Mass/volume] in Serum |
| 3753-1 | Meprobamate [Mass/volume] in Serum or Plasma |
| 3758-0 | Mersalyl [Mass/time] in 24 hour Urine |
| 56785-9 | Baker's yeast Ab [Units/volume] in Serum |
| 48556-5 | Erythrocytes.fetal/1000 erythrocytes [Ratio] in Blood by Kleihauer-Betke method |
| 48878-3 | Bartonella bacilliformis IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 38638-3 | Boron oxide [Mass/volume] in Air |
| 57375-8 | Oxalate [Mass/time] in 12 hour Urine |
| 57377-4 | Pyruvate [Mass/volume] in Blood --5 minutes post XXX challenge |
| 49237-1 | Patient symptoms [Interpretation] Narrative--2 hours post dose lactose PO |
| 49254-6 | Bile acid pattern [Interpretation] in Urine Narrative |
| 49307-2 | Myocardium Ab pattern [Interpretation] in Serum Narrative |
| 38701-9 | Hexachlorocyclopentadiene [Mass/volume] in Air |
| 38713-4 | N-nitrosomorpholine [Mass/volume] in Air |
| 49377-5 | Hepatitis C virus RNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 49743-8 | Plasmodium falciparum IgG Ab [Titer] in Serum by Immunofluorescence |
| 2882-9 | Protein [Mass/volume] in Pleural fluid |
| 5877-6 | Respiratory syncytial virus Ag [Presence] in Specimen by Immunofluorescence |
| 50133-8 | 3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Amniotic fluid |
| 50604-8 | HPA panel [Type] in Blood |
| 4078-2 | Trimethadione [Mass/volume] in Serum or Plasma |
| 41118-1 | AR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19367-2 | Bromazepam cutoff [Mass/volume] in Urine for Confirmatory method |
| 19460-5 | Ethylamphetamine cutoff [Mass/volume] in Urine for Screen method |
| 20512-0 | Turbidity [Presence] of Cerebral spinal fluid Qualitative |
| 12369-5 | Sympathomimetics [Identifier] in Urine |
| 100150-2 | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma |
| 100891-1 | Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 12789-4 | oxyCODONE Free [Mass/volume] in Serum or Plasma |
| 13422-1 | EPINEPHrine [Mass/volume] in Plasma --4th specimen post XXX challenge |
| 102053-6 | 1-deoxymethylsphinganine [Mass/volume] in Serum by LC/MS/MS |
| 102269-8 | Bald Cypress IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14525-0 | Rubella virus Ag [Presence] in Skin by Immunofluorescence |
| 103634-2 | Coccidioides sp IgG and IgM [Units/volume] in Serum and CSF Qualitative by Immunoassay |
| 14858-5 | Leukocytes other/100 leukocytes in Pleural fluid by Manual count |
| 10434-9 | Complement C3 Ag [Presence] in Tissue by Immune stain |
| 10493-5 | IgM Ag [Presence] in Tissue by Immune stain |
| 16562-1 | Cathartic laxatives [Identifier] in Urine |
| 11225-0 | Porphyrins [Mass/volume] in Urine |
| 11259-9 | Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection |
| 17668-5 | Sulfatide IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 18367-3 | Iodine Free [Mass/volume] in Serum or Plasma |
| 90470-6 | Norfluvoxamine [Presence] in Urine by Screen method |
| 90995-2 | Iothalamate renal clearance/Body surface area |
| 74805-3 | Penicillium sp IgG Ab [Mass/volume] in Serum or Plasma by Immunoassay |
| 92719-4 | Lipoprotein.broad beta.subparticle.large [Moles/volume] in Serum |
| 92784-8 | Enterococcus sp DNA [Presence] by NAA with probe detection in Positive blood culture |
| 6076-4 | Clam IgE Ab [Units/volume] in Serum |
| 7700-8 | Shrimp IgG Ab [Units/volume] in Serum |
| 61394-3 | Human papilloma virus 11 DNA [Presence] in Specimen by NAA with probe detection |
| 77081-8 | SERPINF1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77447-1 | Nordiazepam [Moles/volume] in Specimen |
| 62483-3 | Herpes virus 6A DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 63310-7 | Proteinase 3 Ab [Presence] in Serum by Immunoassay |
| 77930-6 | Cortisol [Moles/volume] in Serum or Plasma --4 hours post XXX challenge |
| 94431-4 | Dilution factor [Titer] in Serum or Plasma |
| 78884-4 | Lurasidone [Mass/volume] in Urine by Confirmatory method |
| 79125-1 | Hawkinsin [Moles/volume] in Serum or Plasma |
| 7944-2 | Lassa virus IgM Ab [Presence] in Serum by Immunoassay |
| 6595-3 | Klebsiella granulomatis [Presence] in Isolate by Organism specific culture |
| 79517-9 | Desaminotyrosine/Creatinine [Molar ratio] in Urine |
| 79636-7 | Aspartylglycosamine/Creatinine [Molar ratio] in Urine |
| 7967-3 | Mumps virus IgM Ab [Units/volume] in Serum |
| 80152-2 | N-methylhistamine/Creatinine [Molar ratio] in 24 hour Urine |
| 96265-4 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with 1:1 normal plasma |
| 96276-1 | Blackcurrant IgE Ab [Units/volume] in Serum |
| 80597-8 | Respiratory syncytial virus A 5' UTR RNA [Presence] in Nasopharynx by NAA with probe detection |
| 96645-7 | HLA-DPA1 unresolved alleles [Type] by High resolution |
| 69788-8 | 2-methyl-3-hydroxybutyrate (C5-OH) [Moles/volume] in Cerebral spinal fluid |
| 82104-1 | Regional Allergen Mix 2 (Alternaria alternata+Cat dander+American house dust mite+Dog dander+Horse dander) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 82163-7 | Human coronavirus 229E RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 70247-2 | CCR5 gene c.794_825del [Presence] in Blood or Tissue by Molecular genetics method |
| 99455-8 | Amoxicillin IgG Ab [Mass/volume] in Serum |
| 99876-5 | Deep transitional cells [#/area] in Urine sediment by Computer assisted method |
| 72658-8 | PARoxetine [Mass/volume] in Serum or Plasma --trough |
| 72680-2 | Macroprolactin [Presence] in Serum or Plasma |
| 7370-0 | Perennial rye grass IgG Ab [Units/volume] in Serum |
| 74036-5 | Abnormal Prion Protein [Identifier] in Tissue by Immunoblot |
| 7417-9 | Whitefaced Hornet IgG Ab [Units/volume] in Serum |
| 88604-4 | Human coronavirus HKU1 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 88697-8 | Electrolytes and Osmolality panel - Stool |
| 41643-8 | West Nile virus Ag [Presence] in Specimen by Immunofluorescence |
| 51036-2 | CD11a blasts [Units/volume] in Specimen |
| 3072-6 | Tryptophan [Mass/volume] in Urine |
| 3104-7 | Urobilin [Mass/volume] in Urine |
| 21639-0 | BRCA1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 31533-3 | Neuronal Ab [Presence] in Serum |
| 51288-9 | CD30 cells/100 cells in Cerebral spinal fluid |
| 4276-2 | HYDROcodone [Mass] of Dose |
| 43197-3 | Gamma hydroxybutyrate [Presence] in Urine by Screen method |
| 2182-4 | Cytochrome B reductase [Enzymatic activity/volume] in Amniotic fluid |
| 22275-2 | Echovirus 30 Ab [Titer] in Cerebral spinal fluid |
| 31828-7 | Francisella tularensis Ag [Presence] in Serum |
| 31942-6 | Pneumocystis jiroveci Ag [Presence] in Urine |
| 22385-9 | Legionella pneumophila 3 IgG Ab [Titer] in Serum |
| 32259-4 | Methylmalonate [Mass/volume] in Cerebral spinal fluid |
| 5215-9 | Heterophile Ab [Titer] in Serum by Latex agglutination |
| 527-2 | Viomycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 52918-0 | Thallium/Creatinine [Molar ratio] in 24 hour Urine |
| 53022-0 | U1 small nuclear ribonucleoprotein Ab [Presence] in Serum |
| 43928-1 | Coxiella burnetii phase 2 IgM Ab [Presence] in Serum by Immunofluorescence |
| 43991-9 | Clarithromycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 22962-5 | Campylobacter fetus Ab [Presence] in Genital mucus |
| 23002-9 | Classical swine fever virus Ab [Presence] in Serum by Immunoassay |
| 44445-5 | Basement membrane IgA Ab [Units/volume] in Serum |
| 44751-6 | Nuclear Ab [Presence] in Serum by Immunofluorescence (IF) rat kidney |
| 53620-1 | KRAS gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal |
| 53951-0 | HPA 1b/1b+HPA 3a/3a [Presence] in Blood |
| 44992-6 | Chlamydia trachomatis C IgG Ab [Presence] in Serum |
| 45207-8 | Glutarylcarnitine (C5-DC) [Moles/volume] in DBS |
| 23664-6 | Babesia canis Ab [Titer] in Serum by Immunofluorescence |
| 24084-6 | Galactosylceramidase [Enzymatic activity/mass] in Leukocytes |
| 33891-3 | aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --2H post incubation with normal plasma |
| 54201-9 | Griseofulvin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 24248-7 | Polio virus 3 Ab [Titer] in Serum --2nd specimen |
| 34531-4 | Blood type and Crossmatch panel - Blood |
| 55469-1 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin |
| 2522-1 | Lactate [Moles/volume] in Pleural fluid |
| 34933-2 | CD3+CD8+CD45RO+CD45RA- cells/100 cells in Blood |
| 35307-8 | TTR gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 35326-8 | pH of Body fluid--5th specimen post Sincalide |
| 55868-4 | Choriogonadotropin.beta subunit [Multiple of the median] in Serum or Plasma |
| 47637-4 | Glycine/Amino acids.total in Amniotic fluid |
| 47915-4 | Somatotropin [Units/volume] in Serum or Plasma --3 hours post dose betaxolol+glucagon |
| 35568-5 | Oligoclonal bands [#] in Cerebral spinal fluid by Electrophoresis |
| 56381-7 | Cultivated Rye IgG4 Ab [Mass/volume] in Serum |
| 47962-6 | JAG1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 26501-7 | Neutrophils [#/volume] in Pleural fluid |
| 26548-8 | Glucose [Presence] in Urine by Test strip --30 minutes post dose glucose |
| 35829-1 | Pirlimycin [Susceptibility] by Disk diffusion (KB) |
| 3596-4 | ePHEDrine+Pseudoephedrine [Presence] in Urine |
| 3619-4 | Ethylmorphine [Mass/volume] in Urine |
| 56604-2 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 56944-2 | Insulin [Units/volume] in Serum or Plasma --3 days post XXX challenge |
| 48799-1 | Second trimester penta maternal screen panel - Serum or Plasma |
| 38539-3 | Spermatozoa Motile/100 spermatozoa in Semen --post washing |
| 48936-9 | Acylcarnitine pattern [Interpretation] in Tissue |
| 27818-4 | Protein C actual/normal in Platelet poor plasma by Chromogenic method |
| 57854-2 | Thyrotropin [Units/volume] in Serum or Plasma --5 minutes post XXX challenge |
| 49503-6 | Neutrophil cytoplasmic Ab.perinuclear.atypical [Titer] in Serum by Immunofluorescence |
| 49604-2 | Hepatitis C virus RNA [log units/volume] (viral load) in Bone marrow by NAA with probe detection |
| 49964-0 | Siderocytes [#/volume] in Blood |
| 40682-7 | Urate crystals [Presence] in Body fluid by Light microscopy |
| 41079-5 | NEFL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 20590-6 | CD15 cells/100 cells in Specimen |
| 20773-8 | Colony count [#/volume] in Milk by Culture Standard Plate Count |
| 20932-0 | Parasite identified in Specimen by Inspection |
| 101170-9 | Soluble urokinase plasminogen activator receptor [Mass/volume] in Serum or Plasma |
| 12981-7 | Urea nitrogen [Mass Ratio] in Peritoneal dialysis fluid --post dialysis/pre dialysis |
| 13694-5 | 3-Methylhistidine/Creatinine [Mass Ratio] in Urine |
| 13728-1 | Delta aminolevulinate/Creatinine [Mass Ratio] in Urine |
| 102655-8 | Grain weevel IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14253-9 | Somatotropin Ab [Presence] in Serum or Plasma |
| 103061-8 | Cat recombinant (rFel d) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15065-6 | Etiocholanolone [Moles/time] in 24 hour Urine |
| 15269-4 | Tree Allergen Mix 9 (Grey alder+Silver birch+Hazelnut+White oak+Willow) IgE Ab [Presence] in Serum by Multidisk |
| 15494-8 | Pasteurella multocida Ab [Presence] in Serum by Immunoassay |
| 16117-4 | Babesia microti IgG Ab [Titer] in Serum |
| 10738-3 | Virus identified in Tissue by Electron microscopy |
| 16718-9 | Cytomegalovirus Ag [Presence] in Blood |
| 1142-9 | Lu sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
| 17305-4 | Myelin IgA Ab [Presence] in Serum |
| 17355-9 | Neutrophil cytoplasmic IgG Ab [Presence] in Serum |
| 901-9 | Blood group antibody screen.cells I+II+III [Presence] in Serum or Plasma by Prewarmed |
| 914-2 | B Ag [Presence] on Red Blood Cells from Blood product unit |
| 93200-4 | Ehlers-Danlos syndrome multigene analysis in Blood or Tissue by Molecular genetics method |
| 77077-6 | MRPL40 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 94151-8 | Bacteria.carbapenem resistant identified in Specimen by Organism specific culture |
| 94677-2 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine and Cystatin C-based formula (CKD-EPI) |
| 63429-5 | Bacterial beta-glucuronidase uidA gene [Presence] in Specimen by NAA with probe detection |
| 64976-4 | Cat recombinant (rFel d) 4 IgE Ab [Units/volume] in Serum |
| 65349-3 | Glucagon [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 79690-4 | Guanine [Moles/volume] in Serum or Plasma |
| 68954-7 | Streptococcus pyogenes rRNA [Presence] in Throat by Probe |
| 698-1 | Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture |
| 69840-7 | 2-Hydroxyadipate [Moles/volume] in Cerebral spinal fluid |
| 81644-7 | Clostridium botulinum toxin C botC gene [Presence] in Specimen by NAA with probe detection |
| 82477-1 | Erythrocyte sedimentation rate by Photometric method |
| 7229-8 | Cinnamon IgG Ab [Units/volume] in Serum |
| 85361-4 | HIV 1+2 RNA [Presence] in Blood by NAA with probe detection |
| 85796-1 | Rubella virus E1 gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 87764-7 | Pregabalin/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 73468-1 | cefTAZidime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73845-0 | 16-Alpha hydroxydehydroepiandrosterone [Moles/time] in 24 hour Urine |
| 88142-5 | Bacteria identified in Cornea or Conjunctiva by Aerobe culture |
| 88343-9 | Leukocytes [Presence] in Ear by Light microscopy |
| 211-3 | Cyclacillin [Susceptibility] by Serum bactericidal titer |
| 21529-3 | Volume of 8 hour Urine |
| 31315-5 | Coxiella burnetii phase 2 IgM Ab [Presence] in Serum |
| 31595-2 | Rickettsia akari Ab [Units/volume] in Serum |
| 22308-1 | Hantavirus puumala IgG Ab [Titer] in Serum |
| 31924-4 | Parainfluenza virus 1 Ag [Presence] in Specimen |
| 51615-3 | Hemoglobin A2+C/Hemoglobin.total in Blood |
| 43716-0 | Acylcarnitine [Presence] in Urine |
| 22334-7 | Herpes simplex virus 1 IgM Ab [Titer] in Cerebral spinal fluid |
| 32307-1 | Chloride [Moles/volume] in Specimen |
| 32637-1 | Urease [Presence] in Tissue |
| 33193-4 | Viable cells/100 cells in Blood |
| 53164-0 | Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 53403-2 | Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBS |
| 44519-7 | Herpes virus 6 Ab [Presence] in Serum |
| 23822-0 | Azinphos-methyl [Mass/volume] in Blood |
| 24014-3 | Herpes simplex virus 2 IgG Ab [Titer] in Serum |
| 54285-2 | Glycerol [Moles/volume] in Urine |
| 54327-2 | Pipecolate [Moles/volume] in Cerebral spinal fluid |
| 46746-4 | Phenylketonuria and variants/Biopterin defects newborn screen interpretation |
| 46949-4 | Fludrocortisone [Mass/volume] in Urine |
| 24210-7 | La Crosse virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
| 47080-7 | Legionella pneumophila 9 IgG Ab [Titer] in Serum by Immunofluorescence |
| 47312-4 | Influenza virus A IgM Ab [Units/volume] in Serum by Immunoassay |
| 348-3 | Nafcillin [Susceptibility] by Disk diffusion (KB) |
| 47659-8 | Insulin [Units/volume] in Serum or Plasma --2 hours post dose glucose |
| 47794-3 | Tyrosine/Amino acids.total in Amniotic fluid |
| 47920-4 | Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose glucagon |
| 25765-9 | Insulin-like growth factor [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 26021-6 | Nordiazepam [Moles/volume] in Serum or Plasma |
| 56207-4 | Casein IgG4 Ab [Mass/volume] in Serum |
| 56256-1 | Eggplant IgG4 Ab [Mass/volume] in Serum |
| 56349-4 | Parsnip IgG4 Ab [Mass/volume] in Serum |
| 48004-6 | DNA change (c.HGVS) |
| 48027-7 | MT-ND4 gene c.G15257A [Presence] in Blood or Tissue by Molecular genetics method |
| 56648-9 | Phenylglyoxylate/Creatinine [Ratio] in 24 hour Urine |
| 56930-1 | Hepatitis C virus NS4 Ab [Presence] in Serum by Immunoblot |
| 27017-3 | Allyl alcohol [Presence] in Serum or Plasma |
| 27100-7 | Probenecid [Mass/volume] in Serum or Plasma |
| 57333-7 | Calcium.ionized [Mass/volume] adjusted to pH 7.4 in Serum or Plasma by Ion-selective membrane electrode (ISE) |
| 49046-6 | Drugs of abuse panel - Meconium |
| 58354-2 | Human antihuman Ab [Moles/volume] in Plasma |
| 49598-6 | Natalizumab Ab [Presence] in Serum by Immunoassay |
| 49793-3 | t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Bone marrow by Molecular genetics method |
| 50028-0 | Escherichia coli IgE Ab [Units/volume] in Serum |
| 29852-1 | La Crosse virus IgG Ab [Presence] in Serum |
| 40567-0 | Myelocytes [#/volume] in Body fluid by Manual count |
| 58820-2 | Cortisol [Mass/volume] in Serum or Plasma --24th specimen |
| 58924-2 | LCT gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 50243-5 | 17-Ketosteroids [Mass/time] in 24 hour Urine --post dose dexamethasone |
| 50356-5 | Canary grass IgE Ab/IgE total in Serum |
| 30090-5 | Burkholderia pseudomallei IgG Ab [Titer] in Specimen by Immunofluorescence |
| 41007-6 | Human coronavirus OC43 Ag [Presence] in Specimen by Immunofluorescence |
| 41053-0 | SMN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 41174-4 | Waxy Casts Broad [Presence] in Urine sediment by Light microscopy |
| 19438-1 | Propoxyphene + Norpropoxyphene cutoff [Mass/volume] in Urine for Confirmatory method |
| 19622-0 | Nitrazepam cutoff [Mass/volume] in Urine for Screen method |
| 20901-5 | Mycoplasma sp Ag [Presence] in Isolate by Immune stain |
| 20983-3 | Western equine encephalitis virus Ab [Presence] in Serum by Immunofluorescence |
| 100305-2 | IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method |
| 100380-5 | Red cabbage IgG Ab [Units/volume] in Serum |
| 12834-8 | Prolactin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 13945-1 | Erythrocytes [#/area] in Urine sediment by Microscopy high power field |
| 14469-1 | Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid by Immunoassay |
| 14753-8 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 100 g glucose PO |
| 14813-0 | Lipoprotein.alpha [Moles/volume] in Serum or Plasma by Electrophoresis |
| 14939-3 | Urea nitrogen [Moles/time] in 24 hour Urine |
| 10588-2 | Spermatogonia [#/volume] in Semen |
| 16316-2 | Acid phosphatase tartrate resistant [Enzymatic activity/volume] in Blood |
| 11606-1 | Leptospira interrogans Ab [Units/volume] in Serum |
| 17804-6 | Promonocytes/100 leukocytes in Body fluid |
| 18398-8 | Polio virus 2 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 90892-1 | Borrelia sp panel - Blood by NAA with non-probe detection |
| 91875-5 | Streptococcus agalactiae DNA [Presence] in Vag+Rectum by NAA with probe detection |
| 92757-4 | Cholestane-3-beta, 5-alpha, 6-beta triol [Moles/volume] in DBS |
| 75728-6 | HTR2A gene c.74C>A [Presence] in Blood or Tissue by Molecular genetics method |
| 7663-8 | Redwood Dust IgE Ab [Units/volume] in Serum |
| 92896-0 | Aldosterone [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
| 9317-9 | Platelet adequacy [Presence] in Blood by Light microscopy |
| 94242-5 | BTD gene full mutation analysis in Blood or Tissue by Sequencing |
| 63239-8 | Extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 94427-2 | Dengue virus 1+2+3+4 3' UTR RNA [Presence] in Serum by NAA with probe detection |
| 63471-7 | Ganglioside GD2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 79480-0 | 3,4-Dihydroxyhydrocinnamate [Moles/volume] in Serum or Plasma |
| 95605-2 | NMDAR subunit 1 Ab [Titer] in Serum by Cell binding immunofluorescent assay |
| 96253-0 | Arsenic fractions panel - 24 hour Urine |
| 6768-6 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma |
| 81305-5 | Influenza virus A H1 2009 pandemic RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection |
| 96595-4 | Hemoglobin A1c/Hemoglobin.total in DBS |
| 69361-4 | PCA3 score in Urine by Molecular genetics method |
| 69485-1 | LDLR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 81864-1 | KCNQ1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 82112-4 | Regional Allergy Mix 5 (Aspergillus fumigatus+Cockroach+Cat dander+European house dust mite) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 70107-8 | SERPINC1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 71657-1 | Band form neutrophils/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
| 82375-7 | Norbuprenorphine [Presence] in Specimen by Screen method |
| 99035-8 | Trimethoprim resistance dfrA5 gene [Presence] by Molecular method |
| 72103-5 | Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method |
| 7276-9 | American house dust mite IgG Ab [Units/volume] in Serum |
| 86027-0 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 73353-5 | hydroCHLOROthiazide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87786-0 | Bupivacaine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 87820-7 | Zolpidem [Presence] in Saliva (oral fluid) by Screen method |
| 73910-2 | PAX8 Ag [Presence] in Tissue by Immune stain |
| 41402-9 | Emtricitabine [Susceptibility] by Genotype method |
| 59399-6 | PM-1 Ab [Titer] in Serum by Immunofluorescence |
| 59423-4 | Influenza virus A hemagglutinin type RNA [Identifier] in Specimen by NAA with probe detection |
| 50821-8 | Beryllium [Moles/volume] in Urine |
| 50850-7 | Fluoride/Creatinine [Molar ratio] in Urine |
| 41993-7 | Atazanavir [Susceptibility] |
| 42341-8 | Neisseria meningitidis serogroups A+w135 Ag [Presence] in Body fluid |
| 60034-6 | PIK3CA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 60250-8 | Androstanolone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 21345-4 | HTLV I+II Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 31260-3 | Bluetongue virus 10 Ab [Units/volume] in Serum |
| 31436-9 | Infectious bursal disease virus Ab [Units/volume] in Serum |
| 51377-0 | CD9 cells/100 cells in Body fluid |
| 427-5 | rifAMPin [Susceptibility] by Minimum lethal concentration (MLC) |
| 21682-0 | Gaucher 1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 22089-7 | Avian adenovirus Ab [Presence] in Serum |
| 31890-7 | Mumps virus Ag [Presence] in Eye |
| 32242-0 | Glutamine [Moles/volume] in Vitreous fluid |
| 32530-8 | CD3+CD25+ cells [#/volume] in Bone marrow |
| 5254-8 | Mycoplasma pneumoniae Ab [Titer] in Serum by Complement fixation |
| 4421-4 | rifAMPin [Mass] of Dose |
| 22787-6 | Alcelaphine herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence |
| 23020-1 | Coxiella burnetii Ab [Presence] in Serum |
| 23029-2 | Dirofilaria immitis Ag [Presence] in Blood |
| 23094-6 | Equine herpesvirus 4 DNA [Presence] in Tissue by NAA with probe detection |
| 33045-6 | Respiratory syncytial virus Ag [Presence] in Nose |
| 53475-0 | Glucose [Moles/volume] in Serum or Plasma --pre dose betaxolol |
| 23294-2 | Mycoplasma putrefaciens Ab [Presence] in Serum by Immunoassay |
| 23373-4 | Porcine respiratory coronavirus neutralizing antibody [Presence] in Serum by Neutralization test |
| 33534-9 | Coccidioides immitis IgM Ab [Presence] in Specimen |
| 53781-1 | Acetaminophen and Propoxyphene panel [Mass/volume] - Urine |
| 34630-4 | Substance P [Mass/volume] in Cerebral spinal fluid |
| 3463-7 | Chloroquine [Mass/volume] in Serum or Plasma |
| 47053-4 | Enolase.neuron specific [Mass/volume] in Cerebral spinal fluid by Immunoassay |
| 47157-3 | Norepinephrine [Moles/volume] in Plasma --1 hour post XXX challenge |
| 2546-0 | Lactate dehydrogenase 4 [Enzymatic activity/volume] in Serum or Plasma |
| 47705-9 | Methionine/Amino acids.total in DBS |
| 47732-3 | Proline [Moles/volume] in DBS |
| 47738-0 | Prostate specific Ag [Mass/volume] in Body fluid |
| 35697-2 | La Crosse virus Ab [Titer] in Serum by Complement fixation |
| 26564-5 | CD30 cells [#/volume] in Specimen |
| 26587-6 | Alpha aminoadipate [Moles/volume] in Cerebral spinal fluid |
| 3656-6 | Furfenorex [Presence] in Urine |
| 3816-6 | Metoprolol [Presence] in Urine |
| 56976-4 | Renin [Mass/volume] in Plasma --upright+1 hour post XXX challenge |
| 4860-3 | HLA-Cw6 [Presence] in Donor |
| 27191-6 | PHENobarbital [Mass/volume] in Vitreous fluid |
| 38294-5 | Trans-1,2-Dichloroethylene [Mass/volume] in Water |
| 38439-6 | Barbiturates [Presence] in Meconium by Confirmatory method |
| 57535-7 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --12th specimen post XXX challenge |
| 49042-5 | Testosterone Free [Mass/volume] in Serum or Plasma by Detection limit <= 1.0 ng/dL |
| 27353-2 | Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin |
| 3966-9 | Phenylpropanolamine [Mass/time] in 24 hour Urine |
| 57974-8 | HIV 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 58067-0 | Kn sup(a) Ab [Presence] in Serum or Plasma |
| 29323-3 | Cocaine [Mass/volume] in Gastric fluid |
| 40051-5 | Albumin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 58496-1 | C peptide [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 58512-5 | C peptide [Mass/volume] in Serum or Plasma --4.5 hours post dose glucose |
| 49930-1 | Lactate dehydrogenase in pleural fluid/Lactate dehydrogenase in serum |
| 29714-3 | Orientia tsutsugamushi Gilliam Ab [Presence] in Serum by Immunofluorescence |
| 5047-6 | Nuclear Ab [Units/volume] in Serum by Immunoassay |
| 50593-3 | 3-Hydroxybenzoylecgonine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 41096-9 | KEL gene allele [Genotype] in Amniotic fluid by Molecular genetics method Nominal |
| 20823-1 | Escherichia coli O157:H7 [Presence] in Raw milk by Organism specific culture |
| 100417-5 | Vitis sp leaf IgG Ab [Units/volume] in Serum |
| 101128-7 | Theoretical limit of detection [#] in Specimen by calculation |
| 12931-2 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 13623-4 | Dextromethorphan [Mass/volume] in Serum or Plasma |
| 13949-3 | Cytomegalovirus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 14312-3 | Tetrahydrocannabinol [Presence] in Urine by Screen method >50 ng/mL |
| 103684-7 | Vortioxetine [Presence] in Urine by LC/MS/MS |
| 104435-3 | Norovirus genogroup II Ag [Presence] in Stool |
| 10570-0 | Consistency of Cervical mucus |
| 15430-2 | Service comment 39 |
| 10953-8 | Timothy IgG Ab [Units/volume] in Serum |
| 16331-1 | Aldosterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 16654-6 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --1.5 hours post XXX challenge |
| 12321-6 | Trifluoperazine [Presence] in Urine |
| 17008-4 | IgG/Beta tubulin [Mass Ratio] in Serum |
| 75352-5 | Other cells/100 leukocytes in Pericardial fluid by Manual count |
| 75507-4 | aPTT.lupus sensitive W excess phospholipid percent correction |
| 7678-6 | Sage IgE Ab [Units/volume] in Serum |
| 92888-7 | Varicella zoster virus DNA [Presence] in Skin by NAA with probe detection |
| 93326-7 | Taurodeoxycholate [Moles/volume] in Serum or Plasma |
| 93509-8 | Pentacarboxylporphyrin I [Moles/time] in 24 hour Urine |
| 93883-7 | Ceramide panel - Plasma |
| 78377-9 | Epipregnanolone [Moles/volume] in 24 hour Urine |
| 63391-7 | Extractable nuclear Ab [Presence] in Serum by Immunoassay |
| 63449-3 | CD3 cells [#/volume] in Cerebral spinal fluid |
| 6395-8 | Echovirus 40 neutralizing antibody [Units/volume] in Serum by Neutralization test |
| 79196-2 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose arginine+insulin |
| 95523-7 | HIV 1 and 2 Ab panel - Serum or Plasma by Immunoassay |
| 6628-2 | Schistosoma sp Ab [Presence] in Serum by Immunofluorescence |
| 96492-4 | CD3+CD8+CD27+CD45RO+CD62L+ cells [#/volume] in Blood |
| 68959-6 | Specimen condition [Interpretation] of Urine Narrative |
| 69022-2 | Methamphetamine [Mass/mass] in Meconium by Confirmatory method |
| 96726-5 | Epithelial cells.ciliated [#/volume] in Lower respiratory specimen by Manual count |
| 97182-0 | Carnitine free and total and acylcarnitine panel - Serum or Plasma |
| 70071-6 | Streptococcus constellatus DNA [Presence] in Specimen by NAA with probe detection |
| 9778-2 | Phenelzine [Mass/volume] in Serum or Plasma |
| 82450-8 | U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot |
| 98190-2 | Bromhexine IgE Ab [Units/volume] in Serum |
| 71868-4 | Hemoglobin D/Hemoglobin.total [Pure mass fraction] in Blood |
| 72273-6 | Blood product ordered [Volume] in Blood product unit |
| 72482-3 | BK virus subtype in Tissue by NAA with probe detection |
| 84904-2 | Gleason score at positive margin in Prostate tumor Qualitative |
| 72868-3 | Mycobacterium leprae folP1 gene dapsone resistance mutation [Presence] by Molecular method |
| 72928-5 | Secobarbital [Moles/volume] in Urine |
| 73116-6 | Tirofiban induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7341-1 | Goat milk IgG Ab [Units/volume] in Serum |
| 73868-2 | Alpha cortol [Moles/volume] in Urine |
| 73992-0 | 2,2',5-Trichlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
| 88744-8 | inv(2)(p21;p23)(EML4,ALK) fusion transcript [Presence] in Tissue by Molecular genetics method |
| 41642-0 | West Nile virus IgM Ab [Presence] in Specimen by Immunofluorescence |
| 41657-8 | Sodium [Moles/volume] in Mixed venous blood |
| 59579-3 | Coxsackievirus A24 IgM Ab [Titer] in Serum by Immunofluorescence |
| 59618-9 | chlordiazePOXIDE [Mass/volume] in Blood by Confirmatory method |
| 50703-8 | Influenza virus A.neuraminidase inhibitor resistance [Susceptibility] Qualitative by Phenotype method |
| 30477-4 | Hexanoylglycine [Presence] in Urine |
| 31093-8 | Gentamicin [Mass/volume] in Serum or Plasma --random post extended interval dosing |
| 60094-0 | Ketoprofen [Mass/volume] in Urine |
| 60213-6 | Zolazepam [Mass/volume] in Urine |
| 2116-2 | Choriogonadotropin.intact [Presence] in Serum or Plasma |
| 21572-3 | Transferrin.carbohydrate deficient.asialo/Transferrin.total in Serum or Plasma |
| 4306-7 | Mefenorex [Mass] of Dose |
| 21736-4 | SNCA gene p.Ala30Pro [Presence] in Blood or Tissue by Molecular genetics method |
| 21751-3 | TCRB gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 21819-8 | t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 22178-8 | Chlamydophila psittaci IgA Ab [Titer] in Serum |
| 51469-5 | Plasmodium vivax IgG Ab [Titer] in Serum |
| 51497-6 | Estradiol (E2) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 22690-2 | Proline/Creatinine [Molar ratio] in Urine |
| 53024-6 | Baker's yeast Ab [Presence] in Serum |
| 44094-1 | Epithelial cells.squamous [#/area] in Vaginal fluid by Light microscopy |
| 44322-6 | Interleukin 6 [Presence] in Serum or Plasma |
| 33014-2 | Romano Cheese IgE Ab [Units/volume] in Serum |
| 33205-6 | CD235a cells/100 cells in Peritoneal fluid |
| 53315-8 | Urinalysis microscopic panel - Urine Qualitative by Automated |
| 44724-3 | HLA-A29 [Presence] |
| 44735-9 | Urea nitrogen/Creatinine [Mass Ratio] in Body fluid |
| 2333-3 | Gastrin [Mass/volume] in Serum or Plasma |
| 23443-5 | Swine vesicular disease virus Ab [Presence] in Serum by Immunoelectrophoresis |
| 33260-1 | Thyrotropin [Units/volume] in Serum or Plasma --1.5 hours post dose TRH |
| 33326-0 | Turbidity [Presence] of Amniotic fluid Qualitative |
| 4488-3 | Complement C3a [Mass/volume] in Serum or Plasma |
| 33932-5 | Borrelia burgdorferi Ab [Titer] in Cerebral spinal fluid |
| 4586-4 | Hemoglobin G - Philadelphia [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 46197-0 | Measles virus Ab [Presence] in Serum |
| 46255-6 | Methyl ethyl ketone [Mass/volume] in Serum or Plasma |
| 46269-7 | 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma |
| 24271-9 | Coxsackievirus B6 Ab [Titer] in Serum --1st specimen |
| 34617-1 | Other Antibiotic [Mass/volume] in Specimen |
| 55509-4 | Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose cloNIDine |
| 25098-5 | Ethanolamine/Creatinine [Molar ratio] in Urine |
| 34909-2 | Cortisol Free [Mass/volume] in 24 hour Urine by HPLC |
| 35141-1 | Purine nucleoside phosphorylase [Enzymatic activity/volume] in Cerebral spinal fluid |
| 4771-2 | HLA-B58(17) [Presence] |
| 47762-0 | Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose insulin IV |
| 25750-1 | Rickettsia conorii IgM Ab [Titer] in Serum by Immunofluorescence |
| 25834-3 | Cancer associated retinopathy Ab [Presence] in Serum by Immunoblot |
| 36919-9 | ELN gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 36920-7 | PROP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 27053-8 | Morphine [Mass/volume] in Cerebral spinal fluid |
| 48999-7 | Urea [Mass/time] in 24 hour Urine |
| 49150-6 | Rickettsia parkeri IgM Ab [Titer] in Body fluid |
| 38680-5 | Sperm Tail Tip IgG Ab/100 spermatozoa in Specimen by Immunobead |
| 57886-4 | Pregnanediol [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
| 49493-0 | Leukemia markers [Interpretation] in Blood Narrative |
| 29259-9 | Monocytes Abnormal/100 leukocytes in Blood by Manual count |
| 40159-6 | Glucose [Moles/volume] in Serum or Plasma --70 minutes post XXX challenge |
| 4975-9 | HLA-DR8 [Presence] |
| 49933-5 | Adipate.unsaturated/Creatinine [Molar ratio] in Urine |
| 2955-3 | Sodium [Moles/volume] in Urine |
| 40335-2 | Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post dose triple bolus |
| 20380-2 | Erythromycin [Susceptibility] by Method for Slow-growing mycobacteria |
| 20704-3 | Border disease virus Ag [Presence] in Blood by Immunofluorescence |
| 21028-6 | Protein [Interpretation] in 24 hour Urine |
| 101172-5 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis rRNA panel - Specimen by NAA with probe detection |
| 13739-8 | Estrone (E1)/Creatinine [Mass Ratio] in 24 hour Urine |
| 102540-2 | Sweet potato IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102675-6 | Black Ant IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14484-0 | Mycoplasma sp and Ureaplasma sp [Identifier] in Cervix by Organism specific culture |
| 103728-2 | Hereditary motor and sensory neuropathy multigene analysis in Blood or Tissue by Molecular genetics method |
| 15411-2 | Ergosterol [Mass/volume] in Serum or Plasma |
| 10824-1 | Myelin+Myelin breakdown products.microscopic observation [Identifier] in Tissue by Luxol fast blue/Periodic acid-Schiff stain |
| 10977-7 | ALPRAZolam [Mass/volume] in Blood |
| 16410-3 | Asparagine [Presence] in Urine |
| 16484-8 | Boysenberry IgE Ab [Units/volume] in Serum |
| 16841-9 | Ethambutol+rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 17193-4 | CD73 cells/100 cells in Blood |
| 17429-2 | Pentachlorophenol [Mass/volume] in Blood |
| 1766-5 | Aldosterone receptors [#] in Leukocytes |
| 179-2 | Chlortetracycline [Susceptibility] by Serum bactericidal titer |
| 1881-2 | Apolipoprotein LPA [Mass/volume] in Serum or Plasma |
| 75121-4 | Thymine [Moles/volume] in Serum or Plasma |
| 75215-4 | Ornithine/Citrulline [Molar ratio] in DBS |
| 60547-7 | 11-Oxo-Androsterone/Creatinine [Mass Ratio] in Urine |
| 6087-1 | Corn IgE Ab [Units/volume] in Serum |
| 75730-2 | HTR2C gene c.796G>C [Presence] in Blood or Tissue by Molecular genetics method |
| 75734-4 | AXIN2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 77678-1 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 94494-2 | Celiac disease serology panel - Serum |
| 94572-5 | Alloisoleucine [Moles/volume] in DBS |
| 63463-4 | European house dust mite recombinant (rDer p) 10 IgE Ab [Units/volume] in Serum |
| 6429-5 | HIV identified in Blood by Organism specific culture |
| 64980-6 | American house dust mite recombinant (rDer f) 2 IgE Ab [Units/volume] in Serum |
| 7950-9 | Legionella pneumophila 3 Ab [Titer] in Serum by Immunofluorescence |
| 6896-5 | cloZAPine [Mass/volume] in Serum or Plasma |
| 69565-0 | Atopobium vaginae DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 81624-9 | Methotrexate pentaglutamate [Moles/volume] in Red Blood Cells |
| 81783-3 | Chicken feather IgG Ab [Mass/volume] in Serum |
| 82202-3 | Yersinia enterocolitica DNA [Presence] in Stool by NAA with non-probe detection |
| 70214-2 | Oxazepam [Moles/volume] in Urine by Confirmatory method |
| 99099-4 | Procalcitonin [Moles/volume] in Serum or Plasma |
| 99442-6 | Barley Pollen IgG4 Ab [Mass/volume] in Serum |
| 72845-1 | Hepatitis B virus codon 202 [Identifier] by Genotype method |
| 85810-0 | Adenovirus serotype DNA panel - Specimen by NAA with probe detection |
| 7309-8 | Weeping Fig IgE Ab [Units/volume] in Serum |
| 87441-2 | Dengue virus 1+2+3+4 and Zika virus IgA+IgG+IgM panel - Specimen by Immunoassay |
| 87476-8 | Chloride [Mass/mass] in Specimen |
| 87496-6 | Gabapentin [Presence] in Serum, Plasma or Blood by Screen method |
| 73434-3 | clonazePAM induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87779-5 | Pimozide/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 88143-3 | Fungus identified in Cornea or Conjunctiva by Culture |
| 88441-1 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --20M post dose fructose PO |
| 41289-0 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --post dose metyraPONE |
| 41737-8 | Ramoplanin [Susceptibility] |
| 59670-0 | Estazolam [Mass/mass] in Tissue |
| 59711-2 | Midazolam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 50699-8 | Influenza virus A.adamantane resistance [Presence] |
| 50984-4 | Horowitz index in Arterial blood |
| 3054-4 | Triiodothyronine (T3).true [Mass/volume] in Serum or Plasma |
| 60166-6 | Platinum [Mass/mass] in Nail |
| 60228-4 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose fructose PO |
| 2151-9 | Creatine kinase [Enzymatic activity/volume] in Cerebral spinal fluid |
| 51170-9 | CD34+CD117+ blasts [Units/volume] in Bone marrow |
| 42988-6 | Mycoplasma synoviae Ab [Titer] in Serum |
| 31868-3 | Legionella pneumophila 1 Ag [Presence] in Urine |
| 32009-3 | Cortisol Free/Creatinine [Mass Ratio] in 24 hour Urine |
| 51527-0 | Tree Allergen Mix 4 (White oak+White elm+London plane or Maple leaf sycamore+Willow+Cottonwood) IgE Ab [Presence] in Serum by Multidisk |
| 51538-7 | Cladosporium herbarum IgG Ab [Presence] in Serum |
| 51861-3 | Mold Allergen Mix 6 (Alternaria alternata+Cladosporium herbarum+Mucor racemosus+Penicillium notatum) IgG Ab [Presence] in Serum by Multidisk |
| 43285-6 | Spermatozoa IgM Ab/100 spermatozoa in Serum |
| 43306-0 | Chromosome 21 trisomy [Percentile] by Cytogenetics |
| 43625-3 | Acetylcholine receptor Ab [Presence] in Serum |
| 22771-0 | African horse sickness virus Ab [Presence] in Serum |
| 32215-6 | Thyroxine (T4) free index in Serum or Plasma by calculation |
| 44030-5 | Aspergillus nidulans H Ab [Presence] in Serum by Immune diffusion (ID) |
| 22990-6 | Capripox virus Ag [Presence] in Tissue by Immunoassay |
| 32810-4 | Bacteria identified in Bronchial specimen |
| 44553-6 | Hydroxyitraconazole [Presence] in Serum or Plasma |
| 23590-3 | Western equine encephalitis virus Ag [Presence] in Specimen by Immunofluorescence |
| 33341-9 | Granular casts [#/area] in Urine by Computer assisted method |
| 53954-4 | HPA 5a/5b+Gp Ia/IIa [Presence] in Blood |
| 4500-5 | Complement C4 CH50 [Mass/volume] in Cerebral spinal fluid |
| 54253-0 | Glucose [Moles/volume] in Serum or Plasma --4 minutes post dose glucagon |
| 4569-0 | Hemoglobin D/Hemoglobin.total in Blood |
| 2437-2 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post 50 g glucose PO |
| 55091-3 | Darunavir [Susceptibility] by Genotype method |
| 47475-9 | Powassan virus polyvalent E Ab [Presence] in Specimen |
| 55884-1 | Hydroxocobalamin [Moles/volume] in Urine |
| 47781-0 | Sulfocysteine [Moles/volume] in Amniotic fluid |
| 25736-0 | Prolactin [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 35575-0 | Pigeon antibody panel - Serum |
| 35685-7 | Carbon dioxide [Moles/volume] in Urine collected for unspecified duration |
| 56405-4 | Tomato IgG4 Ab [Mass/volume] in Serum |
| 48020-2 | Forward primer [Nucleotide sequence] in Blood or Tissue by Molecular genetics method Nominal |
| 48059-0 | Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool by Immunoassay |
| 366-5 | Norfloxacin [Susceptibility] by Minimum lethal concentration (MLC) |
| 56971-5 | Potassium/Creatinine [Ratio] in 24 hour Urine |
| 48752-0 | 3-Hydroxymyristate.free (3-OH-C14:0) [Moles/volume] in Serum or Plasma |
| 26799-7 | Fumarate [Presence] in Urine |
| 57453-3 | Chromosome 18 aneuploidy in Amniotic fluid or Chorionic villus sample by FISH Nominal |
| 49002-9 | Albumin [Mass/time] in Urine collected for unspecified duration |
| 4932-0 | HLA-DQ1 [Presence] in Donor |
| 38731-6 | Triethylamine [Mass/volume] in Air |
| 581-9 | Streptococcus agalactiae [Presence] in Cervix by Organism specific culture |
| 49516-8 | Topiramate [Mass/volume] in Serum or Plasma --peak |
| 40218-0 | Glucose [Moles/volume] in Serum or Plasma --29 hours post XXX challenge |
| 29562-6 | Jamestown canyon virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 59277-4 | Cystine crystals [Presence] in Stone by X-ray diffraction |
| 41102-5 | GJB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19385-4 | chlordiazePOXIDE [Presence] in Urine by Screen method |
| 19576-8 | MethylePHEDrine cutoff [Mass/volume] in Urine for Confirmatory method |
| 19615-4 | N-desalkylflurazepam [Presence] in Urine by Confirmatory method |
| 12344-8 | Antipsychotics [Identifier] in Serum or Plasma |
| 100100-7 | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay |
| 101482-8 | cefTAZidime+Clavulanate [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 1343-3 | Yt sup(a) Ab [Presence] in Serum or Plasma from Donor |
| 13540-0 | Carbon dioxide, total [Moles/volume] in Cerebral spinal fluid |
| 1360-7 | Corticotropin [Mass/volume] in Plasma --1 hour post dose insulin IV |
| 102259-9 | Cow epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14191-1 | Prazosin [Mass/volume] in Serum or Plasma |
| 102843-0 | Wheat IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14609-2 | Nuclear Ab [Presence] in Peritoneal fluid |
| 15114-2 | Arsenic [Moles/volume] in Blood |
| 10425-7 | Transfuse Rh immune globulin [Volume] |
| 104344-7 | Borna disease virus RNA [Presence] in Specimen by Sequencing |
| 11077-5 | Hepatitis C virus superoxide dismutase Ab [Presence] in Serum by Immunoblot |
| 17252-8 | Mercaptopurine [Presence] in Serum or Plasma |
| 17494-6 | Prostaglandin F2 alpha [Mass/volume] in Urine |
| 17736-0 | Trichloroacetate [Mass/volume] in Blood |
| 74965-5 | Haloperidol [Mass/volume] in Serum or Plasma --trough |
| 91771-6 | Influenza virus A subtype [Identifier] in Upper respiratory specimen by NAA with probe detection |
| 75974-6 | KRAS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 92899-4 | Fetal Chromosome region 11q23 deletion [Presence] based on Plasma cell-free DNA by Sequencing |
| 92929-9 | Measles, Mumps and Rubella virus IgG panel [Units/volume] - Serum or Plasma |
| 77728-4 | Serotonin release 0.2 IU/mL heparin.unfractionated [Units/volume] in Serum |
| 6305-7 | Plasmodium malariae Ab [Units/volume] in Serum |
| 94672-3 | 24,25-dihydroxyvitamin D3+24,25-dihydroxyvitamin D2 [Mass/volume] in Serum or Plasma |
| 79401-6 | HBB gene full mutation analysis [Identifier] in Blood or Tissue by Sequencing |
| 9540-6 | La Crosse virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 664-3 | Microscopic observation [Identifier] in Specimen by Gram stain |
| 95776-1 | GNS gene full mutation analysis in Blood or Tissue by Sequencing |
| 69021-4 | Amphetamines panel - Meconium by Confirmatory method |
| 69782-1 | 2-Hydroxyphenylacetate [Moles/volume] in Cerebral spinal fluid |
| 69818-3 | 2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --5 days post dose ifosfamide |
| 71643-1 | Metamyelocytes/Leukocytes [Pure number fraction] in Body fluid by Manual count |
| 9817-8 | Cryptococcus sp Ag [Titer] in Cerebral spinal fluid by Immunoassay |
| 9828-5 | House dust Greer IgE Ab [Units/volume] in Serum |
| 7216-5 | Swiss Cheese IgG Ab [Units/volume] in Serum |
| 7224-9 | Chicken feather IgG Ab [Units/volume] in Serum |
| 83073-7 | Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma by Immunoassay |
| 84879-6 | Tumor perforation [Presence] by Macroscopy |
| 99786-6 | Cell-free DNA.donor/Cell-free DNA.total in Plasma cell-free DNA --post lung transplant |
| 87583-1 | Aflatoxin B2 [Mass/mass] in Specimen |
| 7391-6 | Hazelnut IgG Ab [Units/volume] in Serum |
| 73935-9 | Tetrahydrocannabinol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 74387-2 | Normirtazapine [Mass/volume] in Urine |
| 88704-2 | Bedaquiline [Susceptibility] by Method for Slow-growing mycobacteria |
| 41501-8 | Measles virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 50683-2 | Staphylococcus aureus toxic shock syndrome toxin 1+Staphylococcus aureus enterotoxin B Ab [Presence] in Serum |
| 50712-9 | Influenza virus.neuraminidase inhibitor resistance [Susceptibility] Qualitative |
| 50916-6 | Sucrose [Moles/volume] in Urine |
| 30566-4 | Tetradecenoylcarnitine (C14:1) [Moles/volume] in Serum or Plasma |
| 31107-6 | Osmotic fragility of Red Blood Cells--0.45% sodium chloride 24 hour 37 degree C incubation |
| 31133-2 | Mumps virus particle-bound Ab [Titer] in Cerebral spinal fluid |
| 4181-4 | Chlorprothixene [Mass] of Dose |
| 42332-7 | Alpha-1-Fetoprotein L3/Alpha-1-fetoprotein.total in Serum or Plasma |
| 51436-4 | Protein.monoclonal [Mass/volume] in 24 hour Urine by Electrophoresis |
| 43131-2 | Bacterial Ag panel - Cerebral spinal fluid |
| 21791-9 | t(6;9)(p22;q34)(DEK,NUP214) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 22301-6 | Equine infectious anemia virus Ab [Presence] in Serum |
| 43434-0 | Bacterial Ag panel - Serum |
| 43801-0 | Choriogonadotropin.intact [Units/volume] in Amniotic fluid |
| 22676-1 | 7-Dehydrocholesterol [Presence] in Serum or Plasma |
| 22735-5 | Bicarbonate [Moles/volume] in Specimen |
| 44009-9 | Herpes simplex virus 1 and 2 IgG Ab [Interpretation] in Serum by Immunoassay |
| 22790-0 | Alcelaphine herpesvirus 1 Ag [Presence] in Specimen by Immune stain |
| 23122-5 | Francisella tularensis A DNA [Presence] in Tissue by NAA with probe detection |
| 32628-0 | ACADM gene c.985A>G [Presence] in Blood or Tissue by Molecular genetics method |
| 54185-4 | Caspofungin [Susceptibility] by Gradient strip |
| 34436-6 | Diethylene glycol [Mass/volume] in Serum or Plasma |
| 55371-9 | Hemoglobin A2+E+O/Hemoglobin.total in Blood |
| 47212-6 | Chlamydia trachomatis DNA [Identifier] in Specimen by NAA with probe detection |
| 47876-8 | Propionyl CoA Carboxylase [Enzymatic activity/mass] in Placenta |
| 25721-2 | Mianserin [Moles/volume] in Serum or Plasma |
| 25969-7 | Phenylalanine [Moles/volume] in 24 hour Urine |
| 25971-3 | 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine |
| 35423-3 | Herpes simplex virus identified in Vaginal fluid by Organism specific culture |
| 35579-2 | Tetrahydrofuran [Mass/volume] in Urine |
| 48264-6 | Bermuda grass triggered leukotriene release [Mass/volume] by Leukocytes |
| 373-1 | Novobiocin [Susceptibility] by Serum bactericidal titer |
| 3773-9 | Methadone [Presence] in Urine |
| 3811-7 | Methyprylon [Presence] in Serum or Plasma |
| 3851-3 | Nicomorphine [Mass/volume] in Urine |
| 48955-9 | LORazepam [Mass/volume] in Specimen |
| 48974-0 | MDCR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 48982-3 | Ehrlichia sp [Presence] in Specimen by Light microscopy |
| 27990-1 | Fibrinogen fragments [Mass/volume] in Platelet poor plasma by Latex agglutination |
| 3870-3 | Norpropoxyphene [Presence] in Serum or Plasma |
| 39471-8 | Creatinine [Moles/volume] in 24 hour Peritoneal dialysis fluid |
| 49968-1 | Cortisol [Molar concentration difference] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
| 50029-8 | Mahogany wood dust IgE Ab [Units/volume] in Serum |
| 29629-3 | 3-Methylglutaconate [Presence] in Urine |
| 40468-1 | SLC26A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 40487-1 | Urea/Creatinine [Ratio] in Urine |
| 4068-3 | Triamterene [Presence] in Urine |
| 40697-5 | Toxoplasma gondii IgM Ab index [Units/volume] in Serum and CSF |
| 58824-4 | Cortisol [Mass/volume] in Serum or Plasma --19th specimen |
| 58901-0 | Spermatozoa Progressive [#/volume] in Semen |
| 30063-2 | Methionine/Creatinine [Ratio] in Urine |
| 30222-4 | Coxsackievirus B3 Ab [Presence] in Serum |
| 30309-9 | Nelfinavir [Susceptibility] |
| 41014-2 | Human coronavirus NL63 IgG Ab [Presence] in Serum |
| 19186-6 | Cancer Ag 15-3 [Units/volume] in Pleural fluid |
| 19489-4 | Hydroxyalprazolam [Presence] in Urine by Screen method |
| 20491-7 | Epstein Barr virus capsid IgM Ab [Titer] in Serum |
| 101420-8 | Human coronavirus HKU1 RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 101556-9 | Candida krusei DNA [Presence] in Urine by NAA with probe detection |
| 1320-1 | S Ag [Presence] on Red Blood Cells |
| 13421-3 | EPINEPHrine [Mass/volume] in Plasma --3rd specimen post XXX challenge |
| 101812-6 | 2,6-dimethylaniline/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 102219-3 | Acremonium sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13544-2 | 4-Hydroxyglutethimide [Presence] in Serum or Plasma |
| 13562-4 | Gentamicin [Mass/volume] in Body fluid |
| 102238-3 | Chymopapain IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102473-6 | Oat pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14182-0 | Thrombin antithrombin complex Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
| 14728-0 | FLUoxetine [Moles/volume] in Serum or Plasma |
| 15198-5 | Macrocytes [Presence] in Blood by Automated count |
| 104456-9 | Varicella zoster virus Ab.IgA index in Serum and CSF |
| 10861-3 | Progesterone receptor [Mass/mass] in Tissue |
| 10981-9 | cloNIDine [Mass/volume] in Urine |
| 11176-5 | Lactalbumin alpha IgG Ab [Units/volume] in Serum |
| 16937-5 | Hepatitis G virus RNA [Presence] in Serum by NAA with probe detection |
| 17197-5 | CD79b cells/100 cells in Blood |
| 17210-6 | CD95 cells/100 cells in Blood |
| 17535-6 | Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 74806-1 | Lithium [Moles/volume] in Serum or Plasma --trough |
| 7484-9 | Burweed marshelder IgE Ab [Units/volume] in Serum |
| 91128-9 | Clot strength ADP receptor inhibited [Length fraction] in Blood by calculation |
| 92525-5 | LW sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 6219-0 | Pork IgE Ab [Units/volume] in Serum |
| 93977-7 | Complement C2.functional [Units/volume] in Serum or Plasma |
| 94247-4 | Borrelia burgdorferi oppA2 gene [Presence] in Blood by NAA with non-probe detection |
| 63269-5 | Ku Ab [Presence] in Body fluid by Immunoassay |
| 79498-2 | 4-Hydroxyhippurate/Creatinine [Molar ratio] in Urine |
| 95243-2 | Platelet aggregation EPINEPHrine induced in Platelet rich plasma --0.5 umol/L |
| 95544-3 | HTLV I DNA [#/volume] in Specimen by NAA with probe detection |
| 95689-6 | Mayaro virus IgM Ab [Presence] in Specimen by Immunoassay |
| 8107-5 | CD10 cells/100 cells in Blood |
| 97011-1 | Clot angle kaolin+tissue factor induced in Blood |
| 97285-1 | Norfentanyl [Presence] in Cord tissue by Confirmatory method |
| 9743-6 | Isoleucine [Mass/volume] in Cerebral spinal fluid |
| 70125-0 | Yeast.hyphae [Presence] in Specimen by KOH preparation |
| 70202-7 | Cholesterol in IDL+Cholesterol in VLDL 3 [Moles/volume] in Serum or Plasma |
| 70969-1 | Glomerular filtration rate/1.73 sq M.predicted among males [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) |
| 99091-1 | Listeria monocytogenes DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 85478-6 | Influenza virus B RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 85537-9 | Mycoplasma hyosynoviae 16S rRNA gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 85547-8 | PRRSV North American strain neutralizing antibody [Titer] in Serum by Neutralization test |
| 72490-6 | 17-Hydroxyprogesterone [Moles/volume] in Saliva (oral fluid) |
| 72524-2 | Myelin Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 72671-1 | Everolimus [Mass/volume] in Plasma --trough |
| 7275-1 | Date Palm Pollen IgE Ab [Units/volume] in Serum |
| 86070-0 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 73653-8 | Apramycin [Susceptibility] by Disk diffusion (KB) |
| 7426-0 | House dust Hollister Stier IgG Ab [Units/volume] in Serum |
| 88709-1 | Albumin/Globulin [Mass Ratio] in Body fluid by Electrophoresis |
| 41416-9 | Echinococcus sp Ab [Presence] in Serum by Immunoblot |
| 41636-2 | Ebola virus RNA [Presence] in Specimen by NAA with probe detection |
| 50880-4 | Methyl ethyl ketone [Moles/volume] in Serum or Plasma |
| 50913-3 | Strontium [Moles/mass] in Hair |
| 31029-2 | Stenbolone [Mass/volume] in Urine |
| 41999-4 | Lipoprotein.pre-beta [Presence] in Body fluid |
| 42372-3 | Neisseria meningitidis serogroup D Ag [Presence] in Isolate by Agglutination |
| 60095-7 | Loperamide [Mass/volume] in Blood |
| 31348-6 | DNA double strand Ab [Presence] in Serum |
| 4295-2 | Labetalol [Mass] of Dose |
| 21822-2 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript major break points [Presence] in Blood or Tissue by Molecular genetics method |
| 31680-2 | Theileria annulata Ab [Units/volume] in Serum |
| 435-8 | Rolitetracycline [Susceptibility] by Minimum lethal concentration (MLC) |
| 32167-9 | Clarity of Urine |
| 44024-8 | Boldenone [Presence] in Specimen |
| 44040-4 | Basophils [Presence] in Cerebral spinal fluid by Light microscopy |
| 22843-7 | Avian pox virus DNA [Presence] in Tissue by Probe |
| 22931-0 | Brucella melitensis Ab [Presence] in Serum |
| 32626-4 | Spermatozoa IgG Ab [Presence] in Serum |
| 32796-5 | Parvovirus B19 IgM Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen |
| 23499-7 | Trichinella spiralis [Presence] in Tissue by Light microscopy |
| 33532-3 | Platelet aggregation ristocetin induced in Control Platelet rich plasma --High dose |
| 53735-7 | Barbiturates.other [Mass/volume] in Urine |
| 53940-3 | CD4 stimulated ATP immune response [Presence] in Blood |
| 23973-1 | Burkholderia pseudomallei IgM Ab [Titer] in Serum |
| 54205-0 | Legionella pneumophila 7+8+9+10+11+12+13+14 Ab [Titer] in Serum |
| 34694-0 | Vascular endothelial growth factor [Mass/volume] in Serum or Plasma |
| 34989-4 | Unidentified cells [#/volume] in Pleural fluid |
| 35108-0 | Normaprotiline [Mass/volume] in Serum or Plasma |
| 35174-2 | Docosahexaenoate (C22:6w3) [Moles/volume] in Serum or Plasma |
| 47846-1 | Cortisol [Mass/volume] in Serum or Plasma --post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 25687-5 | Insulin [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge |
| 3550-1 | diazePAM [Presence] in Urine |
| 56205-8 | Careless Weed IgG4 Ab [Mass/volume] in Serum |
| 56361-9 | Plum IgG4 Ab [Mass/volume] in Serum |
| 48056-6 | Human bocavirus Ag [Presence] in Specimen by Immunofluorescence |
| 48189-5 | Formaldehyde triggered leukotriene release [Mass/volume] by Leukocytes |
| 26505-8 | Segmented neutrophils/100 leukocytes in Blood |
| 26516-5 | Platelets [#/volume] in Plasma |
| 2676-5 | Organic acids [Presence] in Urine |
| 3599-8 | Etafedrine [Presence] in Urine |
| 3675-6 | hydroCHLOROthiazide [Mass/volume] in Serum or Plasma |
| 56879-0 | Lactose IgE Ab [Units/volume] in Serum |
| 38630-0 | Acrylate [Mass/volume] in Air |
| 57412-9 | Desmoglein 3 Ab [Units/volume] in Serum by Immunoassay |
| 48923-7 | Respiratory allergen panel, US - Greater Ohio valley b - Serum |
| 28058-6 | Borrelia burgdorferi 21kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 57742-9 | Phadiatop infant IgE Ab [Units/volume] in Serum |
| 49356-9 | Epstein Barr virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
| 28-1 | Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2834-0 | Pregnanediol [Mass/time] in 24 hour Urine |
| 2845-6 | Proline [Mass/volume] in Serum or Plasma |
| 39784-4 | Porphyrins [Moles/volume] in Red Blood Cells |
| 3998-2 | Propylhexedrine [Mass/time] in 24 hour Urine |
| 40064-8 | Calcium [Mass/volume] in Serum or Plasma --pre XXX challenge |
| 50045-4 | Hemicystine [Moles/volume] in Amniotic fluid |
| 2992-6 | Testosterone [Mass/volume] in Amniotic fluid |
| 40673-6 | Thyrotropin binding inhibitory immunoglobulins [Units/volume] in Serum |
| 58954-9 | Deoxypyridinoline/Pyridinoline [Molar ratio] in Urine |
| 58966-3 | Ganglioside GM4 IgG Ab [Units/volume] in Serum by Immunoassay |
| 50599-0 | HPA-1 [Type] in Blood |
| 41128-0 | Rabies virus IgG Ab [Presence] in Serum |
| 19263-3 | Amphetamines tested for in Urine by Screen method Narrative |
| 19650-1 | oxyMORphone cutoff [Mass/volume] in Urine for Confirmatory method |
| 1986-9 | C peptide [Mass/volume] in Serum or Plasma |
| 20439-6 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose glucose |
| 20596-3 | CD22 cells/100 cells in Specimen |
| 100801-0 | 21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge |
| 12643-3 | Glucose [Mass/volume] in Serum or Plasma --8 hours post XXX challenge |
| 101569-2 | Semen and urine analysis fertility panel - Specimen |
| 101914-0 | Troponin T.cardiac delta [Interpretation] in 2 hour Serum or Plasma Qualitative |
| 102333-2 | Bahia grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1459-7 | Creatinine [Mass/volume] in 24 hour Urine --pre 2 mg dexamethasone PO 2.5 day high dose q6h |
| 14631-6 | Bilirubin.total [Moles/volume] in Serum or Plasma |
| 14686-0 | Cystine [Presence] in Stone |
| 103200-2 | Vibrio cholerae+parahaemolyticus+vulnificus DNA [Presence] in Wound by NAA with probe detection |
| 14963-3 | CD14 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 15451-8 | Avian pox virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 1606-3 | Norepinephrine [Mass/volume] in Plasma --pre 300 ug cloNIDine PO |
| 10963-7 | Spondylocladium citrovirens IgE Ab [Units/volume] in Serum |
| 11052-8 | Ketamine [Mass/volume] in Urine |
| 17020-9 | Intercellular substance Ab [Presence] in Serum by Immunofluorescence |
| 17029-0 | Isoleucine [Presence] in Urine |
| 17037-3 | La Crosse virus Ab [Titer] in Cerebral spinal fluid |
| 17164-5 | CD49b cells/100 cells in Blood |
| 17235-3 | Magnesium [Moles/volume] in Leukocytes |
| 17527-3 | Retinol Free [Mass/volume] in Serum or Plasma |
| 17816-0 | Beta globulin/Protein.total in Body fluid by Electrophoresis |
| 1843-2 | Ammonia nitrogen [Mass/time] in 24 hour Urine |
| 18894-6 | Ceftizoxime [Susceptibility] |
| 18958-9 | Nystatin [Susceptibility] |
| 90290-8 | Alpha-1-Fetoprotein Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 75010-9 | inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
| 61151-7 | Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method |
| 92872-1 | Herpes simplex virus 1 DNA [Presence] in Anogenital by NAA with probe detection |
| 93698-9 | Gram negative bacterial resistance panel by Molecular genetics method |
| 77079-2 | MTFMT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 78348-0 | Docosapentaenate (C22:5w6) [Entitic substance] in Red Blood Cells |
| 78762-2 | 7-Aminoflunitrazepam [Mass/mass] in Hair |
| 95150-9 | Avian infectious laryngotracheitis virus RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 9516-6 | Echovirus 11 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 95216-8 | Eosinophils/100 leukocytes in Stem cell product by Manual count |
| 95363-8 | Bicarbonate post secretin stimulation panel - Body fluid |
| 66448-2 | Latex recombinant (rHev b) 6 IgE Ab [Units/volume] in Serum |
| 66731-1 | Adenovirus DNA [Log #/volume] (viral load) in Sputum or Bronchial by NAA with probe detection |
| 66748-5 | Clot angle in Blood by Thromboelastography |
| 7973-1 | Norovirus [Presence] in Stool by Electron microscopy |
| 68328-4 | Previous fetus defect |
| 81277-6 | fentaNYL and Norfentanyl panel - Gastric fluid |
| 81282-6 | Spermatozoa Motile [#] in Semen by Automated count |
| 70035-1 | Siderophages/100 leukocytes in Cerebral spinal fluid by Manual count |
| 97564-9 | Nuclear antibody panel - Serum |
| 70146-6 | Benzoylecgonine [Mass/volume] in Urine by Screen method |
| 82380-7 | Hepatitis C virus genotype 1 NS5a gene mutations detected [Identifier] |
| 82424-3 | MDA5 Ab [Presence] in Serum by Line blot |
| 71870-0 | Hemoglobin C/Hemoglobin.total [Pure mass fraction] in Blood |
| 85352-3 | Lymph nodes with isolated tumor cells [#] in Cancer specimen by Light microscopy |
| 72493-0 | Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 86130-2 | Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum |
| 86565-9 | Influenza virus A Ag [Presence] in Tissue by Immunofluorescence |
| 86692-1 | Rotavirus A RNA [Presence] in Specimen by NAA with probe detection |
| 86863-8 | Dengue virus 3 neutralizing antibody [Presence] in Specimen by Neutralization test |
| 87402-4 | Escherichia coli aidA-I gene [Presence] in Isolate by NAA with probe detection |
| 73686-8 | Methylone [Presence] in Urine by Screen method |
| 88111-0 | Gentamicin [Moles/volume] in Serum or Plasma --random post extended interval dosing |
| 41270-0 | Drugs identified in Urine |
| 41430-0 | Angiostrongylus cantonensis DNA [Presence] in Specimen by NAA with probe detection |
| 59386-3 | Starch [Mass/mass] in Stool by Infrared spectroscopy |
| 50767-3 | Ganglioside GD1a IgG Ab/IgM Ab [Ratio] in Serum by Immunoassay |
| 30926-0 | Aluminum [Mass/volume] in Urine collected for unspecified duration |
| 419-2 | Polymyxin B [Susceptibility] by Minimum lethal concentration (MLC) |
| 4271-3 | Gonadotropin releasing hormone [Mass] of Dose |
| 31178-7 | Toxoplasma gondii IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 31504-4 | Mumps virus soluble Ab [Units/volume] in Cerebral spinal fluid |
| 51285-5 | CD3+CD57+ cells/100 cells in Body fluid |
| 21683-8 | Gaucher 2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 51622-9 | Mesothelial cells/100 leukocytes in Dialysis fluid by Manual count |
| 51738-3 | HYDROcodone Free [Mass/volume] in Urine |
| 51907-4 | Efavirenz [Mass/volume] in Serum or Plasma --trough |
| 32160-4 | Carboxyhemoglobin [Presence] in Blood by Screen method |
| 32208-1 | Platelets Small [Presence] in Blood by Light microscopy |
| 4403-2 | Piperacillin [Mass] of Dose |
| 23022-7 | Coxiella burnetii Ag [Presence] in Placenta by Immunofluorescence |
| 32714-8 | Rickettsia typhus group IgM Ab [Presence] in Serum |
| 32808-8 | Leukocytes other/100 leukocytes in Bronchial specimen |
| 53236-6 | Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline [Molar ratio] in DBS |
| 53557-5 | Nucleated cells [#/volume] in Synovial fluid by Manual count |
| 45351-4 | Date of skin test |
| 54436-1 | Urate dihydrate/Total in Stone |
| 46970-0 | BK virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 345-9 | Moxalactam [Susceptibility] by Serum bactericidal titer |
| 25124-9 | Phenylacetate/Creatinine [Molar ratio] in Urine |
| 25146-2 | Bilirubin crystals [#/area] in Urine sediment by Microscopy high power field |
| 25412-8 | Flunitrazepam [Moles/volume] in Serum or Plasma |
| 3496-7 | Clopenthixol [Mass/volume] in Serum or Plasma |
| 5568-1 | Acetone [Mass/volume] in Serum or Plasma |
| 47541-8 | 4-Hydroxybenzoate/Creatinine [Molar ratio] in Urine |
| 25958-0 | Methionine sulfoxide/Creatinine [Molar ratio] in 24 hour Urine |
| 26007-5 | Echinococcus sp Ab [Presence] in Serum by Hemagglutination |
| 48261-2 | Perennial rye grass triggered leukotriene release [Mass/volume] by Leukocytes |
| 48328-9 | Repaglinide [Presence] in Serum or Plasma |
| 26043-0 | HLA-B27 [Presence] by NAA with probe detection |
| 2648-4 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Leukocytes |
| 35798-8 | Enrofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 56620-8 | Elastase Ab [Units/volume] in Serum by Immunoassay |
| 56889-9 | CD13+HLA-DR+ cells/100 cells in Tissue |
| 48862-7 | Rickettsia parkeri IgG Ab [Titer] in Serum by Immunofluorescence |
| 27099-1 | Riboflavin [Presence] in Blood |
| 38466-9 | Chicken serum proteins IgG Ab [Presence] in Serum |
| 57435-0 | Myeloperoxidase cells [Presence] in Body fluid |
| 4011-3 | Pyrovalerone [Presence] in Urine |
| 5879-2 | Rotavirus Ag [Presence] in Stool by Agglutination |
| 29621-0 | 3-Hydroxyadipate [Presence] in Urine |
| 5033-6 | Staphylococcus aureus rRNA [Presence] in Specimen by Probe |
| 50507-3 | Insulin [Units/volume] in Serum or Plasma --7th specimen |
| 30104-4 | Trypanosoma cruzi IgG Ab [Titer] in Specimen |
| 30241-4 | Lactate [Mass/volume] in Venous blood |
| 40745-2 | Filaria identified in Blood |
| 4114-5 | Amdinocillin [Mass] of Dose |
| 19164-3 | Cancer Ag 72-4 [Units/volume] in Pleural fluid |
| 19198-1 | Prostate specific Ag [Units/volume] in Semen |
| 19205-4 | Prostate Specific Ag Free [Mass/volume] in Semen |
| 19347-4 | Amphetamine cutoff [Mass/volume] in Urine for Screen method |
| 19482-9 | HYDROcodone [Presence] in Urine by Screen method |
| 12390-1 | sulfaSALAzine [Mass/volume] in Serum or Plasma |
| 102023-9 | Cortisol [[Mass/volume] in Serum or Plasma --30 minutes post dose glucagon |
| 14529-2 | Rubella virus Ag [Presence] in Cervix by Immunofluorescence |
| 104172-2 | DPYD gene.c.1236G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 16369-1 | Amphetamines [Presence] in Urine by Confirmatory method |
| 11593-1 | Coxsackievirus A4 Ab [Units/volume] in Serum |
| 12291-1 | Mephentermine [Presence] in Urine |
| 17211-4 | CD96 cells/100 cells in Blood |
| 1879-6 | Apolipoprotein E2 [Mass/volume] in Serum or Plasma |
| 90237-9 | Phenylacetylcarnitine (PheC2) [Moles/volume] in Serum or Plasma |
| 90364-1 | Cholesterol.in LDL.small dense [Mass/volume] in Serum or Plasma |
| 90442-5 | Coxiella burnetii aroE gene [Presence] in Tissue by NAA with non-probe detection |
| 60376-1 | Grape IgG Ab [Mass/volume] in Serum |
| 6105-1 | Eel IgE Ab [Units/volume] in Serum |
| 92988-5 | Acinetobacter calcoaceticus-baumannii complex DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
| 93343-2 | Treatment to which interaction between genetic variants confers synergy [Identifier] in Blood or Tissue Nominal |
| 77091-7 | TFB1M gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 7724-8 | Sugar Cane IgG Ab [Units/volume] in Serum |
| 77749-0 | CLRN1 gene c.144T>G [Presence] in Blood or Tissue by Molecular genetics method |
| 62421-3 | Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --9th specimen fasting |
| 62480-9 | Adenovirus DNA [Presence] in Bronchoalveolar lavage by NAA with probe detection |
| 6276-0 | Wheat IgE Ab [Units/volume] in Serum |
| 78992-5 | Melatonin [Mass/volume] in Saliva (oral fluid) |
| 79306-7 | D-2-hydroxyglutarate [Moles/volume] in DBS |
| 66761-8 | Lymphocytes/100 leukocytes in Dialysis fluid by Manual count |
| 79522-9 | 2,5-Furandicarboxylate/Creatinine [Molar ratio] in Urine |
| 6784-3 | IgM [Mass/volume] in Urine by Immunoassay |
| 6794-2 | Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis |
| 68981-0 | Argatroban [Units/volume] in Platelet poor plasma by Chromogenic method |
| 80680-2 | Vibrio cholerae toxin ctxA gene [Presence] in Stool by NAA with probe detection |
| 80697-6 | Mycophenolate acyl-glucuronide [Mass/volume] in Serum or Plasma |
| 69580-9 | Local assigning authority [Identifier] in Isolate |
| 70213-4 | Nordiazepam [Moles/volume] in Urine by Confirmatory method |
| 83137-0 | OJ IgG Ab [Presence] in Serum by Line blot |
| 99276-8 | 3-Hydroxyphenazepam [Mass/volume] in Urine by Confirmatory method |
| 99537-3 | Stenosis degree [Length fraction] in Left main coronary artery by Autopsy |
| 72515-0 | Myeloperoxidase IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 72813-9 | FLUoxetine/Creatinine [Mass Ratio] in Urine |
| 72913-7 | HNA 2 Ab [Presence] in Serum by Immunoassay |
| 73144-8 | Spironolactone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73295-8 | LORazepam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 89512-8 | Ganglioside GD3 IgG+IgM Ab [Presence] in Serum by Line blot |
| 59466-3 | Hematologist review of results |
| 50797-0 | Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis |
| 51006-5 | Direct antiglobulin test.unspecified reagent [Presence] on Red Blood Cells |
| 42651-0 | Isoniazid 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 31977-2 | Transmissible gastroenteritis virus Ag [Presence] in Specimen |
| 51613-8 | Hemoglobin J/Hemoglobin.total in Blood |
| 43835-8 | Apolipoprotein E [Presence] in Serum or Plasma |
| 22397-4 | Legionella pneumophila IgG Ab [Titer] in Serum |
| 32083-8 | Imipramine+Desipramine [Presence] in Specimen |
| 3215-1 | Coagulation factor VIII Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
| 52766-3 | aPTT in Platelet poor plasma by Coagulation assay -- after addition of protein C activator + Factor V depleted plasma/aPTT |
| 2279-8 | Fibrinopeptide A [Mass/volume] in Peritoneal fluid |
| 2347-3 | Glucose [Mass/volume] in Peritoneal fluid |
| 23603-4 | Taylorella equigenitalis [Presence] in Genital specimen by Organism specific culture |
| 33500-0 | Methane/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose lactose PO |
| 53512-0 | Eicosanoylcarnitine (C20)/Creatinine [Molar ratio] in Urine |
| 45040-3 | Francisella tularensis Ab [Presence] in Serum by Microagglutination |
| 23731-3 | Feline leukemia provirus [Presence] in Specimen |
| 23805-5 | 5-Fluorocytosine [Mass/volume] in Specimen |
| 54269-6 | Glucose [Moles/volume] in Serum or Plasma --2 hour post dose ornithine alpha-ketoglutarate |
| 46080-8 | CD55 RBC/100 erythrocytes in Blood |
| 34608-0 | Leishmania sp IgG Ab [Titer] in Serum |
| 47309-0 | Haemophilus influenzae B IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 47462-7 | Legionella pneumophila 11 IgM Ab [Titer] in Serum |
| 25250-2 | Cloxacillin [Mass/volume] in Specimen |
| 34921-7 | Lymphocytes Plasmacytoid/100 leukocytes in Blood |
| 55697-7 | Oxolinate [Susceptibility] by Disk diffusion (KB) |
| 25651-1 | Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --8th specimen post XXX challenge |
| 35397-9 | Epstein Barr virus DNA [Presence] in Bone marrow by NAA with probe detection |
| 56346-0 | Parmesan Cheese IgG4 Ab [Mass/volume] in Serum |
| 26409-3 | Silver Birch IgG4 Ab [Units/volume] in Serum |
| 2645-0 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Amniotic fluid |
| 26538-9 | Glucose [Presence] in Urine by Test strip --3.5 hours post dose glucose |
| 26615-5 | CD55 RBC [Presence] in Blood |
| 26704-7 | Isospora belli [Presence] in Stool by Immunofluorescence |
| 3763-0 | Mesterolone [Mass/time] in 24 hour Urine |
| 38238-2 | CD4+CD28+ cells/100 cells in Blood |
| 27257-5 | Sodium [Moles/mass] in 24 hour Stool |
| 27436-5 | N-desalkylflurazepam [Mass/mass] in Stool |
| 27828-3 | Insulin [Units/volume] in Serum or Plasma --3 hours post XXX challenge |
| 27933-1 | Calcium [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 49725-5 | Melatonin [Mass/volume] in Cerebral spinal fluid |
| 40252-9 | Creatinine [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 58501-8 | C peptide [Mass/volume] in Serum or Plasma --15 minutes pre XXX challenge |
| 49851-9 | Cholinesterase [Enzymatic activity/volume] in Peritoneal fluid |
| 49925-1 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells by Glock and McLean |
| 29600-4 | Benzfetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 58874-9 | Somatotropin [Mass/volume] in Serum or Plasma --33rd specimen |
| 59296-4 | Lacosamide [Mass/volume] in Blood |
| 50424-1 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 100 ug CRH IV |
| 40786-6 | Toxoplasma gondii IgG Ab [Titer] in Serum --2nd specimen |
| 40962-3 | SFTPC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 19487-8 | HYDROmorphone cutoff [Mass/volume] in Urine for Screen method |
| 19684-0 | Psilocin cutoff [Mass/volume] in Urine for Screen method |
| 20795-1 | Eastern equine encephalitis virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 101068-5 | Cs^b Ag [Presence] on Red Blood Cells |
| 13007-0 | Ethane [Mass/volume] in Blood |
| 13231-6 | Saint Louis encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 101740-9 | 3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab in Serum by Immunoassay |
| 101879-5 | Osmolality of Arterial blood by calculation |
| 102520-4 | Spiny Pigweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102593-1 | Sheep wool IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14247-1 | Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 15130-8 | Methionine+Tryptophan [Presence] in Serum or Plasma |
| 11008-0 | Cytomegalovirus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 11581-6 | Ebola virus Ab [Units/volume] in Serum |
| 18204-8 | Caffeine renal clearance in 24 hour Urine and Serum or Plasma |
| 18299-8 | IgA [Presence] in Serum by Immunofixation |
| 75229-5 | DULoxetine [Presence] in Urine |
| 61036-0 | Alpha hydroxyalprazolam [Presence] in Urine |
| 76404-3 | Promyelocytes [#] in Body fluid by Manual count |
| 92854-9 | Adenovirus DNA [#/volume] (viral load) in Cornea or Conjunctiva by NAA with probe detection |
| 9323-7 | Sarcosine [Moles/volume] in 24 hour Urine |
| 94265-6 | CD18 cells [Presence] in Blood |
| 6334-7 | Campylobacter lari rRNA [Presence] in Specimen by Probe |
| 78758-0 | 4-Hydroxymidazolam [Mass/volume] in Urine |
| 94358-9 | Neuronal nuclear type 3 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 94828-1 | Epstein Barr virus DNA [Units/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 79186-3 | Cells.CD3+CD4+CD8+ (Double positive)/100 cells in Blood |
| 80209-0 | Barium [Moles/volume] in Body fluid |
| 9612-3 | Cortisol [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin IM |
| 6770-2 | Alpha 1 antitrypsin phenotype [Identifier] in Serum or Plasma by Immunofixation |
| 68403-5 | Eosinophils/100 leukocytes in Vitreous fluid by Manual count |
| 69053-7 | Endocrinologist review of results |
| 96754-7 | Mycobacterium tuberculosis stimulated gamma interferon release by T-cells [Units/volume] corrected for background in Blood |
| 97299-2 | Phencyclidine [Presence] in Cord tissue by Confirmatory method |
| 97506-0 | Glucose management indicator |
| 97921-1 | Bunyamwera virus RNA [Presence] in Specimen by NAA with probe detection |
| 70181-3 | Alpha aminobutyrate [Moles/volume] in Serum or Plasma from Fetus |
| 71894-0 | Cortisone free [Moles/time] in 24 hour Urine |
| 85086-7 | Elastase IgG Ab [Presence] in Serum by Immunoassay |
| 86926-3 | Transmissible gastroenteritis virus Ab/Negative control in Serum by Immunoassay |
| 87570-8 | Narasin [Mass/mass] in Specimen |
| 73563-9 | 7-Aminoclonazepam [Mass/mass] in Meconium by Confirmatory method |
| 88570-7 | Acanthamoeba sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 74134-8 | Ezogabine [Mass/volume] in Plasma |
| 89314-9 | Bacterial 23S rRNA gene azithromycin resistance mutation [Presence] by Molecular method |
| 50784-8 | CD16 cells actual/normal in Blood |
| 50957-0 | Manual differential performed [Presence] in Blood |
| 3095-7 | Urea nitrogen [Mass/volume] in Urine |
| 42600-7 | HIV 1+2 Ab [Presence] in Specimen by Immunoassay |
| 31321-3 | Coxsackievirus A9 Ab [Units/volume] in Cerebral spinal fluid |
| 51046-1 | CD123 blasts [Units/volume] in Bone marrow |
| 22075-6 | DMD gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 31613-3 | Rinderpest virus Ab [Units/volume] in Serum |
| 43754-1 | Sulfate [Mass/volume] in Urine collected for unspecified duration |
| 43962-0 | CD4+CD45RA+ cells/100 cells in Bone marrow |
| 32615-7 | Homocysteine cysteine disulfide [Moles/volume] in Serum or Plasma |
| 53124-4 | Calcium [Moles/time] in 1 hour Urine |
| 44474-5 | Herpes simplex virus 1 Ag [Presence] in Throat |
| 44543-7 | Human papilloma virus 31+33 Ag [Presence] in Specimen |
| 44794-6 | Aquaporin 4 water channel IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 23388-2 | Rabies virus [Presence] in Brain by Light microscopy |
| 33634-7 | Mycobacterium tuberculosis rifAMPin resistance gene [Identifier] in Sputum by NAA with probe detection |
| 53562-5 | Rheumatoid factor [Units/volume] in Pleural fluid |
| 45003-1 | Chlamydia trachomatis IgG Ab [Titer] in Serum by Immunoassay |
| 45206-0 | Glucose [Mass/volume] in Urine by Test strip --5th specimen post XXX challenge |
| 23700-8 | Canine parvovirus Ab [Presence] in Serum by Immunofluorescence |
| 33885-5 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with 1:4 normal plasma |
| 34156-0 | Insulin.bound [Units/volume] in Serum or Plasma |
| 5401-5 | Varicella zoster virus Ab [Titer] in Serum by Complement fixation |
| 54328-0 | Pipecolate [Moles/volume] in DBS |
| 2482-8 | Insulin Ab [Mass/volume] in Serum |
| 55196-0 | Terconazole [Susceptibility] |
| 4738-1 | HLA-A3 [Presence] in Donor |
| 34978-7 | Volume of Peritoneal fluid |
| 35331-8 | OXcarbazepine [Mass/volume] in Serum or Plasma |
| 25903-6 | D-Lactate [Moles/volume] in Serum or Plasma --5th specimen post excercise |
| 26028-1 | HLA-B27 [Presence] by Flow cytometry (FC) |
| 35508-1 | Amino acids panel [Moles/volume] - Amniotic fluid |
| 4803-3 | HLA-B77(15) [Presence] |
| 48112-7 | Glutathione.reduced [Units/mass] in Red Blood Cells |
| 48164-8 | Enolase.neuron specific [Mass/volume] in Body fluid |
| 48398-2 | Hepatitis B virus DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 26980-3 | Coccidioides immitis Ab [Titer] in Serum by Immune diffusion (ID) |
| 57506-8 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin |
| 57538-1 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1st specimen post dose gonadotropin releasing hormone |
| 28036-2 | Borrelia burgdorferi 39kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 49554-9 | Beta F1 Ag [Presence] in Tissue by Immune stain |
| 2907-4 | Pyruvate [Mass/volume] in Cerebral spinal fluid |
| 29503-0 | 2-Hydroxyisocaproate/Creatinine [Molar ratio] in Urine |
| 40032-5 | Glucose [Mass/volume] in Serum or Plasma --22 minutes post XXX challenge |
| 58572-9 | Corticotropin [Mass/volume] in Plasma --2 hours post dose glucagon |
| 50006-6 | Human antimouse Ab [Presence] in Serum |
| 29592-3 | Amphetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 40314-7 | Cortisol [Moles/volume] in Serum or Plasma --1 hour post dose triple bolus |
| 29990-9 | Spermatozoa [Presence] in Semen by Light microscopy --post vasectomy |
| 30087-1 | Cow hair+Cow dander IgE Ab [Units/volume] in Serum |
| 40961-5 | SFTPB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 20830-6 | Glycol [Mass/volume] in Urine |
| 100763-2 | Mycobacterium sp comparative reaction interpretation Narrative |
| 100831-7 | Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 12593-0 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 12819-9 | Progesterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 101948-8 | Cytomegalovirus DNA [Presence] in Stool by NAA with probe detection |
| 13938-6 | Trichloroethane [Mass/volume] in Blood |
| 14453-5 | Virus identified in Vaginal fluid by Culture |
| 103750-6 | Hemoglobin [Moles/volume] in Venous cord blood |
| 14846-0 | N-acetylprocainamide [Moles/volume] in Serum or Plasma |
| 1579-2 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --pre 50 ug corticotropin IM 3 day |
| 16144-8 | Droperidol [Presence] in Serum or Plasma |
| 1211-2 | little s Ag [Presence] on Red Blood Cells from Blood product unit |
| 17608-1 | Weight [Mass/time] of 48 hour Stool |
| 18486-1 | Methylenediamine [Presence] in Urine |
| 18954-8 | Netilmicin [Susceptibility] |
| 90365-8 | Chlamydia trachomatis L1 Ab.IgG+IgA+IgM Interpretation in Serum by Immunoassay |
| 74856-6 | HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum or Plasma from Donor by NAA with probe detection |
| 74949-9 | Perphenazine [Mass/volume] in Serum or Plasma --trough |
| 74985-3 | ALPRAZolam [Mass/volume] in Serum or Plasma --trough |
| 92143-7 | Respiratory pathogens DNA and RNA panel - Respiratory system specimen by NAA with probe detection |
| 60384-5 | Mustard IgG Ab [Mass/volume] in Serum |
| 76490-2 | IgG [Moles/volume] in Urine |
| 6144-0 | Horse Fly IgE Ab [Units/volume] in Serum |
| 62326-4 | Post-discharge provider practice name |
| 9441-7 | IgD lymphocytes/100 lymphocytes in Leukocytes |
| 94573-3 | Tyrosinemia newborn screening follow-up and therapeutic monitoring panel - DBS |
| 6666-2 | Microscopic observation [Identifier] in Tissue by India ink prep |
| 68408-4 | Macrophages [#/volume] in Pericardial fluid by Manual count |
| 6901-3 | Insulin Free [Units/volume] in Serum or Plasma |
| 96894-1 | SARS-CoV-2 (COVID-19) sequencing and identification panel - Specimen by Molecular genetics method |
| 82577-8 | Food Allergen Mix 31 (Apple+Cherry+Plum+Peach+Pear) IgE Ab [Presence] in Serum by Multidisk |
| 82859-0 | 11-Deoxytetrahydrocorticosterone [Moles/time] in 24 hour Urine |
| 82867-3 | Allo-pregnanediolone [Moles/volume] in 24 hour Urine |
| 98063-1 | Beta-lactam resistance ESBL blaCTX-M-15 gene [Presence] by Molecular method |
| 98412-0 | Retrograde ejaculation evaluation panel - Urine |
| 99077-0 | Alpha-1-Fetoprotein L3 [Mass/volume] in Serum or Plasma by Immunoassay |
| 83119-8 | Thyroxine (T4) [Mass/volume] in Serum or Plasma by Immunoassay |
| 72765-1 | Phencyclidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 72899-8 | Isoleucine+Leucine [Moles/volume] in Serum or Plasma |
| 86243-3 | Color of Sputum |
| 73230-5 | Ondansetron induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73358-4 | glyBURIDE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87363-8 | Actinobacillus pleuropneumoniae serotypes 3+6+8+15 Ab/Positive control in Serum by Immunoassay |
| 73486-3 | carBAMazepine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73864-1 | Allo-tetrahydrocortisol [Moles/volume] in 24 hour Urine |
| 87790-2 | Carbadox [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 74232-0 | Cellularity assessment in Bone marrow Narrative |
| 74442-5 | Pyridoxal phosphate [Moles/volume] in Blood |
| 88613-5 | Human bocavirus DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 50948-9 | Vanillylmandelate and Creatinine [Interpretation] in 24 hour Urine Narrative |
| 3047-8 | Triglyceride+ester in VLDL [Mass/volume] in Serum or Plasma |
| 31072-2 | HIV 1 p41 Ab [Presence] in Serum by Immunoblot |
| 21514-5 | Salmonella paratyphi B H Ab [Titer] in Serum by Immunofluorescence |
| 31181-1 | Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid |
| 31202-5 | Mycoplasma pneumoniae Ab [Titer] in Serum by Immunofluorescence |
| 31570-5 | Porcine influenza virus A Ab [Units/volume] in Serum |
| 31583-8 | Respiratory syncytial virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 51253-3 | CD16+CD56+ cells/100 cells in Tissue |
| 31827-9 | Foot and mouth disease virus Ag [Presence] in Throat |
| 51475-2 | Treponema pallidum Ab [Titer] in Cerebral spinal fluid |
| 43265-8 | Benztropine [Presence] in Urine |
| 43344-1 | Avian adenovirus 127 Ab [Titer] in Serum |
| 32313-9 | Cortisol [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 32338-6 | Pyruvate [Moles/volume] in Serum or Plasma |
| 5268-8 | Parainfluenza virus 1 Ab [Titer] in Serum by Complement fixation |
| 52945-3 | LORazepam [Presence] in Gastric fluid |
| 52991-7 | Cytoplasmic CD79a cells/100 cells in Blood |
| 43877-0 | Bile acid [Presence] in Serum |
| 4410-7 | Prolintane [Mass] of Dose |
| 4481-8 | Complement C1r [Mass/volume] in Serum or Plasma |
| 33338-5 | Zolpidem [Presence] in Urine |
| 24001-0 | Ganglioside GQ1b IgG Ab [Titer] in Cerebral spinal fluid by Immunoassay |
| 54265-4 | Glucose [Moles/volume] in Serum or Plasma --1 hour post dose insulin IV |
| 24281-8 | Rickettsia spotted fever group IgG Ab [Titer] in Serum --1st specimen |
| 56131-6 | Chikungunya virus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 47620-0 | Glucose [Moles/volume] in Stool |
| 47745-5 | Serine/Amino acids.total in Amniotic fluid |
| 25740-2 | Prolactin [Mass/volume] in Serum or Plasma --40 minutes post 200 ug TRH IV |
| 56380-9 | Saltwort IgG4 Ab [Mass/volume] in Serum |
| 48582-1 | Lutropin [Units/volume] in Serum or Plasma --on cycle day 3 |
| 2704-5 | Oxygen [Partial pressure] in Capillary blood |
| 38499-0 | Spermatozoa Progressive [Presence] in Semen --4 hours post ejaculation |
| 57521-7 | 11-Hydroxyetiocholanolone [Mass/time] in 24 hour Urine --pre dose dexamethasone |
| 57540-7 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --3rd specimen post dose gonadotropin releasing hormone |
| 49106-8 | Phenols [Mass/volume] in Specimen |
| 49170-4 | Orientia tsutsugamushi Karp IgG Ab [Titer] in Body fluid |
| 2739-1 | Pepsinogen [Mass/volume] in Serum or Plasma |
| 39000-5 | 3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Serum or Plasma |
| 57695-9 | Cortisol [Mass/volume] in Saliva (oral fluid) --8th specimen |
| 49580-4 | HIV 1+2 Ab [Presence] in Specimen by Rapid immunoassay |
| 49629-9 | Citrulline [Presence] in Urine |
| 49721-4 | Haemophilus influenzae type [Identifier] in Isolate |
| 28556-9 | Chlamydia trachomatis D+K IgG Ab [Titer] in Serum by Immunofluorescence |
| 39788-5 | Urate [Moles/volume] in Synovial fluid |
| 40154-7 | Glucose [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 49813-9 | 2-Hydroxyisocaproate/Creatinine [Molar ratio] in 24 hour Urine |
| 40367-5 | Heptacarboxylate [Moles/time] in 24 hour Urine |
| 50468-8 | C peptide [Moles/volume] in Serum or Plasma --8th specimen |
| 30228-1 | Mumps reaction wheal [Diameter] --2 days post 0.1 mL mumps intradermal |
| 19248-4 | Lactate dehydrogenase 2 [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis |
| 101785-4 | CYP2C Cluster Allele [Genotype] in Blood or Tissue by Molecular genetics method |
| 102616-0 | Sunflower Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102767-1 | Malt IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102840-6 | Venison IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14531-8 | Rubella virus Ag [Presence] in Urine sediment by Immunofluorescence |
| 14759-5 | Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose |
| 103194-7 | Proteus mirabilis DNA [Presence] in Urine by NAA with probe detection |
| 15051-6 | Creatinine [Moles/volume] in Dialysis fluid |
| 11128-6 | Segmented neutrophils/100 cells in Bone marrow |
| 16537-3 | Candida albicans Ab [Units/volume] in Serum by Immune diffusion (ID) |
| 11243-3 | Methadone [Mass/mass] in Hair |
| 16863-3 | Fibrinopeptide B beta (1-14) Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 1690-7 | 5'-Nucleotidase [Enzymatic activity/volume] in Serum or Plasma |
| 16921-9 | St. Augustine grass IgE Ab [Units/volume] in Serum |
| 17147-0 | CD40 cells/100 cells in Blood |
| 18895-3 | cefTRIAXone [Susceptibility] |
| 90838-4 | Neuronal nuclear type 3 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
| 61128-5 | Cotinine [Presence] in Serum or Plasma |
| 75757-5 | Chlamydia sp Ab [Presence] in Serum by Complement fixation |
| 76580-0 | Candida albicans its gene [Presence] in Swab specimen by NAA with probe detection |
| 92876-2 | Human coronavirus 229E+HKU1+NL63+OC43 and Parainfluenza virus 1+2+3+4 RNA panel - Lower respiratory specimen by NAA with probe detection |
| 93454-7 | W-18 [Mass/volume] in Urine by Confirmatory method |
| 93935-5 | little e Ag [Presence] on Red Blood Cells --during infancy |
| 62463-5 | Enterovirus RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 7857-6 | Dengue virus 3 Ab [Presence] in Serum by Immunoassay |
| 94432-2 | HLA-DP and DQ and DR (class II) IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC) |
| 64084-7 | Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood |
| 79175-6 | Somatotropin [Units/volume] in Serum or Plasma --1 hour post XXX challenge |
| 6699-3 | Delta 5-Pregnanetriol [Mass/time] in 24 hour Urine |
| 79523-7 | 3-(3-Hydroxyphenyl)propanoate [Moles/volume] in Serum or Plasma |
| 80093-8 | Glucosamine [Moles/volume] in Serum or Plasma |
| 96256-3 | Copper free [Moles/volume] in Serum or Plasma |
| 96359-5 | 7-Aminoclonazepam [Presence] in Saliva (oral fluid) by Confirmatory method |
| 80532-5 | Methadone [Mass/volume] in Blood |
| 8090-3 | Platelet associated IgM Ab [Units/volume] in Blood |
| 8121-6 | CD25 cells/100 cells in Blood |
| 96731-5 | Curschmann's spirals and crystals [type] in Lower respiratory specimen by Light microscopy |
| 69559-3 | Ma1 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 82521-6 | Paritaprevir [Susceptibility] by Genotype method |
| 98098-7 | Interleukin 17F [Mass/volume] in Serum or Plasma |
| 9831-9 | Gamma globulin [Mass/time] in 24 hour Urine |
| 83069-5 | Zika virus non-structural protein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 85552-8 | Influenza virus A porcine origin nucleoprotein IgA Ab/Positive control in Specimen by Immunoassay |
| 99384-0 | Creatinine [Moles/time] in 6 hour Urine |
| 99905-2 | Urate crystals [#/volume] in Urine sediment by Computer assisted method |
| 72818-8 | AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
| 86058-5 | Streptococcus pneumoniae Danish serotype 22F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 86194-8 | 3,4-Dimethylmethcathinone [Mass/volume] in Urine by Confirmatory method |
| 73139-8 | sulfaSALAzine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73245-3 | NIFEdipine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73390-7 | Esomeprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87465-1 | Monensin [Mass/mass] in Specimen |
| 73470-7 | Cefepime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88007-0 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma |
| 89504-5 | Ribosomal Ab [Presence] in Serum by Line blot |
| 41255-1 | Xylose [Mass/volume] in Urine --3 hours post 25 g xylose PO |
| 59684-1 | Hydroxyethylflurazepam [Mass/volume] in Body fluid |
| 5067-4 | Brucella abortus Ab [Titer] in Serum by Latex agglutination |
| 42-2 | Azlocillin [Susceptibility] by Serum bactericidal titer |
| 21326-4 | Herpes simplex virus 1 IgM Ab [Titer] in Serum |
| 31317-1 | Coxsackievirus A10 Ab [Units/volume] in Body fluid |
| 31357-7 | Echovirus 7 Ab [Presence] in Serum |
| 31520-0 | Myelin associated glycoprotein Ab [Units/volume] in Serum |
| 5134-2 | Eastern equine encephalitis virus Ab [Units/volume] in Serum |
| 42731-0 | Cardiolipin IgG Ab B2GP1 dependent [Multiple of the median] in Serum |
| 42798-9 | Age at menarche |
| 43033-0 | Herpes simplex virus 1+2 Ab [Titer] in Cerebral spinal fluid |
| 22142-4 | Bovine herpesvirus 1 Ab [Presence] in Serum |
| 22153-1 | Brucella canis IgG Ab [Units/volume] in Serum |
| 22230-7 | Coxsackievirus B3 Ab [Titer] in Serum |
| 3184-9 | Activated clotting time (ACT) of Blood by Coagulation assay |
| 51654-2 | Hepatitis D virus Ab [Presence] in Body fluid |
| 51812-6 | Coxiella burnetii phase 2 IgG Ab [Units/volume] in Serum by Immunoassay |
| 43214-6 | Bacteria identified in Nasopharynx by Culture |
| 22461-8 | Reagin Ab [Presence] in Serum |
| 32234-7 | Citrulline [Moles/volume] in Vitreous fluid |
| 32572-0 | Tilapia IgE Ab [Units/volume] in Serum |
| 32803-9 | Appearance of Bronchial specimen |
| 33214-8 | Taurine [Moles/volume] in Vitreous fluid |
| 53180-6 | Decadienoylcarnitine (C10:2) [Moles/volume] in DBS |
| 44501-5 | Herpes simplex virus 2 Ag [Presence] in Throat |
| 23380-9 | Abnormal Prion Protein [Presence] in Brain by Immune stain |
| 33701-4 | Clostridium botulinum toxin A [Presence] in Specimen by Mouse bioassay neutralization |
| 53591-4 | Gamma globulin.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis |
| 2366-3 | Glutamate [Mass/time] in 24 hour Urine |
| 24041-6 | Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by Probe with signal amplification |
| 24057-2 | Alpha-L-iduronidase [Enzymatic activity/mass] in Leukocytes |
| 24081-2 | Dihydroxyacetone phosphate acylcoa acyl transferase [Enzymatic activity/mass] in Fibroblast |
| 54160-7 | Ki Ab [Presence] in Serum |
| 54349-6 | Ammonia [Mass/volume] in Dialysis fluid |
| 4553-4 | Hemoglobin A2/Hemoglobin.total in Blood by Electrophoresis acid (pH 6.3) |
| 3436-3 | Carboxy tetrahydrocannabinol [Mass/volume] in Urine |
| 55330-5 | Lu sup(a) Ab [Titer] in Serum or Plasma |
| 55342-0 | Sd sup(a) Ag [Presence] on Red Blood Cells |
| 47754-7 | Somatotropin [Units/volume] in Serum or Plasma --10 minutes post dose TRH |
| 48121-8 | Quinolinate/Creatinine [Molar ratio] in Urine |
| 48147-3 | Oligosaccharides/Creatinine [Molar ratio] in Urine |
| 48194-5 | Lidocaine triggered leukotriene release [Mass/volume] by Leukocytes |
| 3776-2 | Methamphetamine [Mass/volume] in Blood |
| 48831-2 | Respiratory allergen panel, US - Central midwest a - Serum |
| 38411-5 | TOR1A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 57129-9 | Full newborn screening summary report for display or printing |
| 57182-8 | HIV 1 RNA tropism [Identifier] in Plasma Narrative |
| 57395-6 | CD19+CD38+ cells/100 cells in Body fluid |
| 57582-9 | Aldosterone [Mass/volume] in Serum or Plasma --pre 25 mg captopril PO |
| 49065-6 | Eastern equine encephalitis virus IgG and IgM [Interpretation] in Cerebral spinal fluid |
| 49127-4 | Rickettsia sp identified in Specimen by Sequencing |
| 27824-2 | Prothrombin Fragment 1.2 Ag [Moles/volume] in Serum or Plasma by Immunoassay |
| 38691-2 | 1,2-Diphenylhydrazine [Mass/volume] in Air |
| 57727-0 | Norolanzapine [Mass/volume] in Serum or Plasma |
| 57857-5 | Chlorpheniramine [Moles/volume] in Specimen |
| 49467-4 | CD22 Ag [Presence] in Tissue by Immune stain |
| 49727-1 | Homocysteine [Moles/volume] in Cerebral spinal fluid |
| 2899-3 | Purine nucleoside phosphorylase [Enzymatic activity/mass] in Tissue |
| 40179-4 | Glucose [Moles/volume] in Serum or Plasma --13.5 hours post XXX challenge |
| 58515-8 | C peptide [Moles/volume] in Serum or Plasma --45 minutes post dose glucose |
| 58707-1 | ePHEDrine+Pseudoephedrine [Mass/volume] in Urine by Confirmatory method |
| 58795-6 | Glomerular basement membrane IgG Ab [Titer] in Serum by Immunofluorescence |
| 58810-3 | Testosterone [Mass/volume] in Serum or Plasma --2nd specimen |
| 29964-4 | Sjogrens syndrome-A extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
| 40360-0 | Follitropin [Units/volume] in Serum or Plasma --15 minutes post dose triple bolus |
| 30238-0 | 3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Serum or Plasma |
| 40929-2 | Parathyrin.intact [Mass/volume] in Serum or Plasma --10 minutes post excision |
| 41042-3 | WFS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 1960-4 | Bicarbonate [Moles/volume] in Arterial blood |
| 2045-3 | Carnitine [Presence] in Serum or Plasma |
| 100744-2 | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis |
| 12515-3 | Carcinoembryonic Ag [Mass/volume] in Body fluid |
| 12622-7 | Glucose [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 1289-8 | P1 Ag [Presence] on Red Blood Cells from Blood product unit |
| 101163-4 | Brorphine [Mass/volume] in Urine by Confirmatory method |
| 13016-1 | Nitrophenol [Units/volume] in Blood |
| 13576-4 | oxyCODONE [Presence] in Serum or Plasma |
| 102556-8 | Common Ragweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14375-0 | Polymorphonuclear cells/100 leukocytes in Peritoneal fluid by Manual count |
| 14468-3 | Chlamydia trachomatis Ag [Presence] in Blood by Immunoassay |
| 14548-2 | Mumps virus Ag [Presence] in Eye by Immunofluorescence |
| 14972-4 | Mycobacterium sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 10649-2 | Calicivirus [Identifier] in Stool by Electron microscopy |
| 18976-1 | Rolitetracycline [Susceptibility] |
| 90258-5 | LDLR gene full mutation analysis in Blood or Tissue by Sequencing |
| 90975-4 | Clomethiazole [Mass/volume] in Serum or Plasma |
| 74975-4 | Nordiazepam [Mass/volume] in Serum or Plasma --trough |
| 76348-2 | Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma |
| 76588-3 | Moraxella catarrhalis g1b gene [#/mass] in XXX.tissue by NAA with probe detection |
| 61289-5 | Trout IgE Ab/IgE total in Serum |
| 62247-2 | Erythrocyte distribution width [Ratio] in Blood from Fetus by Automated count |
| 77184-0 | Niobium/Creatinine [Molar ratio] in Urine |
| 93720-1 | traMADol [Mass/mass] in Meconium by Confirmatory method |
| 94005-6 | Osmolality of Urine--1 hour post dose vasopressin |
| 94240-9 | CDH1 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 77881-1 | risperiDONE cutoff [Mass/volume] in Urine for Confirmatory method |
| 94737-4 | Intraductal carcinoma of prostate [Presence] in Specimen by Microscopy |
| 6437-8 | Influenza virus A+B Ag [Presence] in Specimen by Immunoassay |
| 96050-0 | B cell median channel shift in Patient serum and Donor blood by Flow cytometry (FC) |
| 6756-1 | Glucose [Mass/volume] in Serum or Plasma --4.5 hours post 75 g glucose PO |
| 681-7 | Microscopic observation [Identifier] in Specimen by Wright stain |
| 69420-8 | Heterophile Ab [Presence] in Blood by Immunoassay |
| 69827-4 | 2-Methylglutarate [Moles/volume] in Serum or Plasma |
| 82887-1 | Ortho methylhippurate [Moles/volume] in Urine |
| 98029-2 | Crystals [type] in Stool by Light microscopy |
| 71831-2 | Hematocrit [Pure volume fraction] of Capillary blood |
| 72606-7 | Hepatitis D virus genotype [Identifier] in Specimen by NAA with probe detection |
| 86158-3 | Streptococcus pneumoniae Danish serotype 8 Ab [Mass/volume] in Serum --1st specimen |
| 87360-4 | Actinobacillus pleuropneumoniae serotypes 4+5+7 Ab/Positive control in Serum by Immunoassay |
| 73497-0 | buPROPion induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73737-9 | Phospholipase A2 receptor IgG Ab [Units/volume] in Serum by Immunoassay |
| 87809-0 | Benzoylecgonine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 4132-7 | Atenolol [Mass] of Dose |
| 41650-3 | Chloride [Moles/volume] in Arterial blood |
| 597-5 | Bacteria identified in Aspirate by Aerobe culture |
| 59803-7 | Cortisol [Molar concentration difference] in Serum or Plasma --30 minutes post XXX challenge |
| 59821-9 | Coproporphyrin 3/Creatinine [Molar ratio] in 24 hour Urine |
| 50750-9 | F13A1 gene p.Val34Leu [Presence] in Blood or Tissue by Molecular genetics method |
| 50788-9 | Cytokeratin cells/100 cells in Blood |
| 42682-5 | Succinyladenosine [Moles/volume] in Cerebral spinal fluid |
| 60321-7 | Norclobazam [Moles/volume] in Specimen |
| 21362-9 | Legionella pneumophila IgG Ab [Titer] in Serum by Immunofluorescence |
| 51108-9 | CD1a blasts/100 blasts in Specimen |
| 51246-7 | CD138 cells/100 cells in Cerebral spinal fluid |
| 21669-7 | F5 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 2172-5 | Cystathionine [Presence] in Serum or Plasma |
| 31849-3 | Herpes simplex virus 2 Ag [Presence] in Genital specimen |
| 31992-1 | Aldosterone [Mass/volume] in 24 hour Urine |
| 4357-0 | Norethandrolone [Mass] of Dose |
| 43603-0 | Androstenedione [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 22396-6 | Legionella pneumophila Ab [Titer] in Serum |
| 22507-8 | Saint Louis encephalitis virus Ab [Presence] in Cerebral spinal fluid |
| 2269-9 | Complement factor B [Mass/volume] in Serum or Plasma |
| 32079-6 | Gold [Moles/volume] in Urine |
| 32114-1 | Thallium [Presence] in Blood |
| 32228-9 | Argininosuccinate [Moles/volume] in Amniotic fluid |
| 32302-2 | Beta-2-Microglobulin [Moles/volume] in Urine |
| 51967-8 | Genetic disease assessed [ID] |
| 22796-7 | Anaplasma marginale Ag [Presence] in Tissue by Immunofluorescence |
| 33021-7 | Tyrosine crystals [#/area] in Urine sediment by Microscopy low power field |
| 53074-1 | Creatine [Moles/volume] in Cerebral spinal fluid |
| 53104-6 | Dodecenoylcarnitine (C12:1) [Moles/volume] in Urine |
| 53440-4 | Argininosuccinate synthase [Enzymatic activity/mass] in Liver from Fetus |
| 44641-9 | Gleason pattern.primary in Prostate tumor |
| 44648-4 | Histologic grade [Score] in Breast cancer specimen by Nottingham |
| 23640-6 | Quinupristin+Dalfopristin [Susceptibility] |
| 33529-9 | Platelet aggregation ADP induced in Control Platelet rich plasma --Low dose |
| 5390-0 | Toxoplasma gondii IgM Ab [Units/volume] in Serum by Immunoassay |
| 44877-9 | Insulin dependent diabetes mellitus [Presence] |
| 23779-2 | Selenium [Mass/volume] in Specimen |
| 24046-5 | Alpha fucosidase [Enzymatic activity/mass] in Fibroblast |
| 54336-3 | Sulfocysteine [Moles/volume] in Cerebral spinal fluid |
| 34479-6 | Blood group antibodies identified in Serum or Plasma by Cold absorption |
| 55158-0 | Tigecycline [Susceptibility] by Method for Slow-growing mycobacteria |
| 47221-7 | Cholesterol in HDL 1+2 [Mass/volume] in Serum or Plasma |
| 34960-5 | HLA Ab [Identifier] in Serum or Plasma |
| 55717-3 | Ticarcillin+Sulbactam [Susceptibility] |
| 5585-5 | Arsenic [Mass/volume] in Serum or Plasma |
| 35458-9 | Ma+Ta Ab [Presence] in Serum |
| 56150-6 | Candida albicans IgM Ab [Units/volume] in Serum |
| 56320-5 | Mesquite IgG4 Ab [Mass/volume] in Serum |
| 56490-6 | Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay --2nd specimen |
| 48251-3 | Pellitory (Parietaria officinalis) triggered leukotriene release [Mass/volume] by Leukocytes |
| 56983-0 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post resting |
| 27085-0 | Methylenedioxyethylamphetamine [Mass/volume] in Urine |
| 57599-3 | 6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
| 49184-5 | Coxiella burnetii phase 2 IgA Ab [Titer] in Body fluid |
| 57893-0 | Pregnanediol [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
| 49329-6 | Interferon alpha Ab [Presence] in Serum or Plasma by Immunoassay |
| 39980-8 | Creatinine [Mass/volume] in Urine --1 hour pre XXX challenge |
| 4015-4 | quiNIDine [Presence] in Urine |
| 4021-2 | rifAMPin [Mass/volume] in Serum or Plasma |
| 5839-6 | Enterovirus identified in Cerebral spinal fluid by Organism specific culture |
| 58546-3 | Corticotropin [Moles/volume] in Plasma --15 minutes post 1 ug/kg CRH IV |
| 58595-0 | Corticotropin [Moles/volume] in Plasma --3 hours post dose glucagon |
| 58737-8 | Parvovirus B19 IgG and IgM [Interpretation] in Serum |
| 49920-2 | Isopropyl ether [Presence] in Serum or Plasma |
| 29935-4 | Manganese/Creatinine [Mass Ratio] in 24 hour Urine |
| 40556-3 | Estrogen receptor Ag [Presence] in Tissue by Immune stain |
| 50366-4 | Prolactin monomeric/Prolactin.total in Serum or Plasma |
| 5044-3 | Adrenal cortex Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
| 50469-6 | Calcitonin [Mass/volume] in Serum or Plasma --1st specimen |
| 50480-3 | Follitropin [Units/volume] in Serum or Plasma --4th specimen |
| 41072-0 | PANK2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 20812-4 | Escherichia coli 987P [Presence] in Small intestine Tissue by Immunofluorescence |
| 12843-9 | Protein [Mass/volume] in Peritoneal dialysis fluid |
| 13295-1 | Coxsackievirus A10 Ab [Units/volume] in Cerebral spinal fluid |
| 13503-8 | Borrelia burgdorferi IgM band pattern [Interpretation] in Serum by Immunoblot |
| 1361-5 | Corticotropin [Mass/volume] in Plasma --1 minute post 1 ug/kg CRH IV |
| 13811-5 | Suberylglycine/Creatinine [Mass Ratio] in Urine |
| 102571-7 | Rhizopus nigricans IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103077-4 | Kiwi recombinant (rAct d) 8 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103089-9 | European paper wasp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15099-5 | Amiodarone [Moles/volume] in Serum or Plasma |
| 15134-0 | Glutamate+Glutamine+Threonine [Presence] in Serum or Plasma |
| 15337-9 | Other Antibiotic [Susceptibility] by Serum bactericidal titer --peak |
| 15488-0 | Mycoplasma meleagridis Ab [Presence] in Serum by Agglutination |
| 10822-5 | Mucin.microscopic observation [Identifier] in Tissue by Mucicarmine stain.Mayer |
| 16642-1 | Cockatiel droppings IgG Ab [Units/volume] in Serum |
| 12217-6 | Globulin [Mass/volume] in Body fluid |
| 17039-9 | La Crosse virus IgM Ab [Titer] in Serum |
| 1853-1 | Androstenedione [Mass/volume] in Semen |
| 90431-8 | Microorganism preliminary growth [Presence] in Body fluid by Anaerobic culture with antimicrobial neutralizer |
| 74691-7 | Round cells [#/area] in Semen by Microscopy high power field |
| 74826-9 | Semliki Forest virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 74835-0 | Porphyrin fractions panel - Stool |
| 924-1 | Blood product dispensed [Volume] |
| 75097-6 | Eicosapentaenoate (C20:5w3) [Entitic substance] in Red Blood Cells |
| 60361-3 | Cauliflower IgG Ab [Mass/volume] in Serum |
| 60374-6 | Garlic IgG Ab [Mass/volume] in Serum |
| 61171-5 | Hepatitis B virus codon M250I [Presence] by Genotype method |
| 76679-0 | Color of Cerebral spinal fluid--1st tube |
| 61282-0 | Perennial rye grass IgE Ab/IgE total in Serum |
| 93709-4 | Hexacarboxylporphyrin I/Creatinine [Molar ratio] in Urine |
| 93726-8 | Dermatan sulfate and heparan sulfate and keratan sulfate panel - Serum or Plasma |
| 63341-2 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 94593-1 | Multiplex allergen panel - Serum or Plasma |
| 65783-3 | Mugwort native (nArt v) 3 IgE Ab [Units/volume] in Serum |
| 6585-4 | Western equine encephalitis virus Ag [Presence] in Serum by Immunoassay |
| 95783-7 | ETV6 gene rearrangements in Blood or Marrow by FISH |
| 96493-2 | T-cell naive and memory and activated subsets panel - Blood |
| 68388-8 | DNA double strand IgG Ab [Units/volume] in Peritoneal fluid by Immunoassay |
| 80964-0 | Acetaminophen free [Mass/volume] in Serum or Plasma |
| 81310-5 | Carbonic anhydrase 2 Ab [Presence] in Serum by Immunoassay |
| 81317-0 | Additional pathological findings [Identifier] in Specimen |
| 9692-5 | Isobutanol [Mass/volume] in Specimen |
| 82298-1 | Yersinia enterocolitica [Presence] in Specimen by Culture |
| 9830-1 | Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma |
| 71705-8 | Rotavirus Ab [Units/volume] in Serum by Immunoassay |
| 71776-9 | Gamma interferon background [Units/volume] in Blood by Immunoassay |
| 72309-8 | NPM1 gene c.960insCCTG transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
| 83113-1 | Prostate Specific Ag Free [Mass/volume] in Serum or Plasma by Immunoassay |
| 84885-3 | Surgical margin tumor involvement.circumferential [Presence] in Colorectal cancer specimen |
| 84929-9 | AMPAR1 Ab [Presence] in Serum by Immunofluorescence |
| 99414-5 | Gamma globulin [Mass/volume] in Serum or Plasma by Immunofixation |
| 72516-8 | Glucose [Moles/volume] in Blood by Automated test strip |
| 85993-4 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum |
| 86667-3 | Level of tumor invasion in Skin melanoma Qualitative by Clark |
| 86732-5 | Leptospira sp identified [Type] in Isolate by Sequencing |
| 88011-2 | Tetradecenoylcarnitine (C14:1)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma |
| 88177-1 | Coxiella burnetii DNA [Presence] in Blood by NAA with probe detection |
| 88923-8 | 1,3 beta glucan [Mass/volume] in Lower respiratory specimen |
| 89490-7 | Aminoglycoside [Susceptibility] by Genotype method |
| 41208-0 | Viscosity+Liquefaction [Identifier] of Semen |
| 5068-2 | Brucella canis Ab [Titer] in Serum by Latex agglutination |
| 30987-2 | Chinchilla epithelium IgE Ab [Units/volume] in Serum |
| 4188-9 | Clavulanate [Mass] of Dose |
| 42487-9 | Aspergillus fumigatus 6 Ab [Presence] in Cerebral spinal fluid |
| 6000-4 | Platelet aggregation thrombin induced [Units threshold] in Platelet rich plasma |
| 21496-5 | Rickettsia typhus group IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 51190-7 | Albumin [Mass/volume] in 24 hour Urine by Electrophoresis |
| 43012-4 | HIV 1 gp41 Ab [Presence] in Serum |
| 22211-7 | Coxiella burnetii Ab [Titer] in Serum |
| 22247-1 | Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma --2nd specimen |
| 31810-5 | Entamoeba histolytica Ag [Units/volume] in Serum |
| 52882-8 | Cytoplasmic CD3 cells/100 cells in Body fluid |
| 32595-1 | Topiramate [Mass] of Dose |
| 3315-9 | Alprenolol [Presence] in Urine |
| 33253-6 | Nuclear Ab [Titer] in Serum by Hep2 substrate |
| 33269-2 | Thyrotropin [Units/volume] in Serum or Plasma --pre dose TRH |
| 53718-3 | Acylglycines [Interpretation] in Urine Narrative |
| 53953-6 | HPA 5a/5a+Gp Ia/IIa [Presence] in Blood |
| 44938-9 | Hepatitis D virus IgM Ab [Presence] in Serum by Immunoassay |
| 23703-2 | Canine parvovirus IgG Ab [Titer] in Serum |
| 33781-6 | Alpha-1-acid glycoprotein [Moles/volume] in Serum or Plasma |
| 34231-1 | Aldosterone/Creatinine [Molar ratio] in Urine |
| 54219-1 | Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:4 addition of normal plasma |
| 24243-8 | Polio virus 1 Ab [Titer] in Serum --1st specimen |
| 2455-4 | Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Tissue |
| 25184-3 | rifAMPin 14 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25327-8 | Aspartate [Moles/time] in 24 hour Urine |
| 25392-2 | Dengue virus IgM Ab [Presence] in Serum by Immunoblot |
| 34938-1 | Phosphate [Moles/volume] in Dialysis fluid |
| 55635-7 | Cefamandole+Sulbactam [Susceptibility] |
| 56014-4 | Platelet aggregation collagen induced ATP secretion in Blood --5 ug/mL |
| 47688-7 | Lutropin [Units/volume] in Serum or Plasma --pre 100 ug luteinizing releasing hormone IV |
| 25640-4 | Follitropin [Units/volume] in Serum or Plasma --1.5 hours post 100 ug luteinizing releasing hormone IV |
| 2576-7 | Lipoproteins [Mass/volume] in Serum or Plasma |
| 56410-4 | Vanilla IgG4 Ab [Mass/volume] in Serum |
| 48234-9 | Acarus siro triggered leukotriene release [Mass/volume] by Leukocytes |
| 26780-7 | Glucose [Mass/volume] in Serum or Plasma --2 hours post dose lactose PO |
| 36910-8 | S-phase cells/100 cells in Blood |
| 3756-4 | Mersalyl [Presence] in Urine |
| 38200-2 | Volume of Sputum |
| 5706-7 | Opiates [Identifier] in Urine |
| 57096-0 | HPA 1a/1a+HPA 3a/3a [Presence] in Blood |
| 48656-3 | Ganglioside GD1a Ab [Units/volume] in Serum by Immunoassay |
| 38432-1 | Ibuprofen [Mass/volume] in Serum or Plasma --2 hours post dose |
| 57542-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --5th specimen post dose gonadotropin releasing hormone |
| 49205-8 | Bartonella elizabethae IgM Ab [Titer] in Body fluid |
| 27290-6 | Phenmetrazine [Mass/mass] in Stool |
| 5827-1 | Adenovirus Ag [Presence] in Throat by Immunoassay |
| 4945-2 | HLA-DQ7(3) [Presence] |
| 49686-9 | CPT2 gene p.Arg631Cys [Presence] in Blood by Molecular genetics method |
| 58399-7 | Norpropoxyphene/Creatinine [Mass Ratio] in Urine |
| 40345-1 | MT-TK gene m.8356T>C [Presence] in Blood or Tissue by Molecular genetics method |
| 40451-7 | Lead [Presence] in Stool |
| 58990-3 | Urate [Mass/time] in 18 hour Urine |
| 50215-3 | Glucose [Mass/volume] in Serum or Plasma --5th specimen |
| 41031-6 | Lopinavir [Susceptibility] by Genotype method |
| 19733-5 | Cefaclor IgE Ab [Units/volume] in Serum |
| 12404-0 | Nitroglycerin [Mass/volume] in Serum or Plasma |
| 1251-8 | Major crossmatch [Interpretation] by Immediate spin |
| 12709-2 | Norastemizole [Mass/volume] in Serum or Plasma |
| 12868-6 | Borrelia burgdorferi 47kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 12873-6 | Borrelia burgdorferi 88kD Ab [Presence] in Serum by Immunoblot |
| 101445-5 | Solitary lung nod malignancy risk [Scale] Qualitative by Calculated.Nodify CDT |
| 102130-2 | Alfalfa IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13459-3 | Cholesterol in LDL/Cholesterol.total [Mass Ratio] in Serum or Plasma |
| 13851-1 | CD5+CD25+ cells/100 cells in Blood |
| 102488-4 | Parakeet feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10420-8 | Transfuse immune serum globulin [Volume] |
| 14866-8 | Parathyrin.intact [Moles/volume] in Serum or Plasma |
| 10563-5 | Cells other than spermatozoa [#/volume] in Semen |
| 15363-5 | Busulfan [Mass/volume] in Serum or Plasma |
| 12228-3 | Triglyceride [Mass/volume] in Body fluid |
| 171-9 | Cephradine [Susceptibility] by Serum bactericidal titer |
| 74816-0 | Bacteria identified in Eye by Anaerobe+Aerobe culture |
| 92684-0 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA panel - Urine by NAA with probe detection |
| 76406-8 | Basophils [#] in Body fluid by Manual count |
| 61332-3 | Cow milk IgE Ab/IgE total in Serum |
| 93708-6 | Heptacarboxylporphyrin I/Creatinine [Molar ratio] in Urine |
| 93915-7 | Rh antigens and K Ag panel - Blood from Blood product unit |
| 78688-9 | Platelet aggregation adenosine diphosphate+prostaglandin E1 induced [Units/volume] in Blood |
| 7880-8 | Entamoeba histolytica Ab [Units/volume] in Serum |
| 94332-4 | Microsporidia sp 18S rRNA gene panel - Specimen by NAA with non-probe detection |
| 94732-5 | DULoxetine [Presence] in Saliva (oral fluid) by Confirmatory method |
| 94818-2 | Paraneoplastic Ab panel - Cerebral spinal fluid by Immunofluorescence |
| 95123-6 | Gene fusion transcript details in Blood or Tissue by Molecular genetics method Narrative |
| 6642-3 | Influenza virus A Leningrad Ab [Units/volume] in Serum by Hemagglutination inhibition |
| 95704-3 | Sindbis virus IgA Ab [Presence] in Specimen by Immunoassay |
| 80637-2 | Bedaquiline [Mass/volume] in Serum or Plasma |
| 96587-1 | Aspartate aminotransferase [Enzymatic activity/volume] in DBS |
| 69379-6 | Vancomycin resistance vanA and vanB and vanC1 and vanC2 genes [Identifier] by Molecular method |
| 69384-6 | AGXT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 70076-5 | Interleukin 1 alpha [Mass/volume] in Body fluid |
| 975-3 | D Ab [Presence] in Serum or Plasma |
| 9774-1 | Metoclopramide [Mass/volume] in Serum or Plasma |
| 97864-3 | Parainfluenza virus 1 and 2 and 3 Ab panel - Serum or Plasma |
| 82468-0 | Edoxaban [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 82797-2 | Initial clot growth [Velocity] in Platelet poor plasma |
| 98104-3 | Interleukin 15 [Mass/volume] in Serum or Plasma |
| 85553-6 | Mycoplasma flocculare 16S rRNA gene [Presence] in Specimen by NAA with probe detection |
| 99621-5 | Omega 6 fatty acids (w6) [Moles/volume] in RBC.lysate |
| 86149-2 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum |
| 86332-4 | Adenovirus B(7) DNA [Presence] in Specimen by NAA with probe detection |
| 73216-4 | Papaverine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87459-4 | Nitrite [Mass/volume] in Specimen |
| 87552-6 | IgA, IgA1 and IgA2 panel - Serum or Plasma |
| 87953-6 | Helicobacter pylori [Presence] in Tissue by Organism specific culture |
| 59380-6 | Tobramycin [Mass/volume] in Serum or Plasma --post dialysis |
| 59394-7 | Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay |
| 59619-7 | chlordiazePOXIDE [Mass/volume] in Body fluid |
| 42603-1 | Coxsackievirus A6 Ab [Titer] in Serum |
| 31240-5 | Avian infectious laryngotracheitis virus Ab [Units/volume] in Serum |
| 31252-0 | Basement membrane Ab [Units/volume] in Serum |
| 31307-2 | Chlamydophila psittaci IgG Ab [Units/volume] in Cerebral spinal fluid |
| 31343-7 | Dengue virus Ab [Presence] in Specimen |
| 51131-1 | CD23 blasts/100 blasts in Blood |
| 42931-6 | Chlamydia trachomatis rRNA [Presence] in Urine by NAA with probe detection |
| 2226-9 | Enteroglucagon [Mass/volume] in Serum |
| 31634-9 | Stachybotrys chartarum IgA Ab [Units/volume] in Serum |
| 31982-2 | Varicella zoster virus Ag [Presence] in Specimen |
| 4376-0 | Paraldehyde [Mass] of Dose |
| 528-0 | Viomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 44055-2 | Pyrimidine-5'-Nucleotidase [Enzymatic activity/mass] in Blood |
| 23046-6 | Eastern equine encephalitis virus IgM Ab [Presence] in Serum |
| 23127-4 | Francisella tularensis Ag [Presence] in Tissue by Immunofluorescence |
| 4469-3 | Cellano Ag [Presence] on Red Blood Cells |
| 44801-9 | Aldolase [Enzymatic activity/volume] in Pleural fluid |
| 33583-6 | Sjogrens syndrome-A extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot |
| 45183-1 | Neisseria meningitidis [Identifier] in Isolate by Agglutination |
| 45297-9 | Glucose [Moles/volume] in 24 hour Dialysis fluid |
| 23676-0 | Borrelia burgdorferi Ab [Presence] in Serum by Immunofluorescence |
| 23740-4 | Florfenicol [Susceptibility] |
| 33777-4 | SmIg cells/100 cells in Specimen |
| 46217-6 | Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] in Blood |
| 46974-2 | oxyMORphone Free [Mass/volume] in Serum or Plasma by Confirmatory method |
| 34458-0 | Saint Louis encephalitis virus RNA [Presence] in Blood by NAA with probe detection |
| 34624-7 | Cystine Free [Moles/volume] in Serum or Plasma |
| 54926-1 | t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript [#/volume] in Blood or Tissue by Molecular genetics method |
| 35076-9 | Monocytes [#/volume] in Body fluid |
| 56007-8 | Platelet aggregation arachidonate induced in Blood --500 umol/L |
| 4791-0 | HLA-B70 [Presence] |
| 25573-7 | C peptide [Moles/volume] in Serum or Plasma --15th specimen post XXX challenge |
| 25677-6 | Glucose [Moles/volume] in Serum or Plasma --6 hours post dose glucose |
| 256-8 | Foscarnet [Susceptibility] |
| 25766-7 | Insulin-like growth factor [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 25923-4 | Heptacarboxylporphyrin [Moles/volume] in 24 hour Urine |
| 3785-3 | Methaqualone [Mass/volume] in Serum or Plasma |
| 38235-8 | CD3+TCR gamma delta+ cells [#/volume] in Blood |
| 27105-6 | Amphetamines [Mass/volume] in Milk |
| 38244-0 | Brucella abortus IgM Ab [Presence] in Serum |
| 38260-6 | Cells Counted Total [#] in Synovial fluid |
| 3864-6 | Norethandrolone [Mass/volume] in Urine |
| 57523-3 | 11-Hydroxyetiocholanolone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
| 57530-8 | 17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --pre dose dexamethasone |
| 49211-6 | Bartonella bacilliformis IgM Ab [Titer] in Serum |
| 27285-6 | Estazolam [Mass/mass] in Stool |
| 58358-3 | Methamphetamine/Creatinine [Mass Ratio] in Urine |
| 49338-7 | Adenovirus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 39805-7 | Rabbit hair IgE Ab [Units/volume] in Serum |
| 58430-0 | oxyCODONE+oxyMORphone [Presence] in Urine by Screen method |
| 58504-2 | C peptide [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 5858-6 | Herpes simplex virus identified in Skin by Organism specific culture |
| 58731-1 | Lymphocyte proliferation stimulated by 0.5 ug phytohemagglutinin actual/normal in Blood |
| 5008-8 | Hepatitis B virus DNA [Presence] in Tissue by NAA with probe detection |
| 29879-4 | Dehydroepiandrosterone (DHEA)/Creatinine [Mass Ratio] in 24 hour Urine |
| 40331-1 | Prolactin [Mass/volume] in Serum or Plasma --20 minutes post dose triple bolus |
| 40545-6 | Hemoglobin C [Presence] in Blood by Electrophoresis |
| 5058-3 | Blastomyces dermatitidis Ab [Presence] in Serum by Immune diffusion (ID) |
| 40773-4 | Histoplasma capsulatum IgM Ab [Titer] in Cerebral spinal fluid --1st specimen |
| 41125-6 | Strongyloides sp IgG Ab [Units/volume] in Serum |
| 19338-3 | Amitriptyline+Nortriptyline cutoff [Mass/volume] in Urine for Confirmatory method |
| 2087-5 | Cholesterol in IDL [Mass/volume] in Serum or Plasma |
| 100988-5 | Phosphoglucomutase [Enzymatic activity/volume] in Fibroblast |
| 12816-5 | Progesterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 101131-1 | B-cell precursors in Bone marrow by Flow cytometry (FC) |
| 101161-8 | p-Fluorofentanyl/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 13572-3 | Nordiazepam [Presence] in Serum or Plasma |
| 102298-7 | Ethylene oxide IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104407-2 | Hantavirus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 10688-0 | Microscopic observation [Identifier] in Hair by KOH preparation |
| 10961-1 | Rabbit urine proteins IgE Ab [Units/volume] in Serum |
| 16677-7 | Coxiella burnetii IgG Ab [Units/volume] in Serum |
| 12189-7 | Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by calculation |
| 18237-8 | Legionella pneumophila atypical IgM Ab [Presence] in Serum |
| 18415-0 | Psilocin [Mass/volume] in Urine |
| 18961-3 | Oxacillin [Susceptibility] |
| 90800-4 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --6 hours post dose levothyroxine |
| 91543-9 | Myelin oligodendrocyte glycoprotein Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 75119-8 | Gamma Linolenate (C18:3w6) [Entitic substance] in Red Blood Cells |
| 92973-7 | Klebsiella oxytoca DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection |
| 93239-2 | dRVVT excess phospholipid actual/normal in Platelet poor plasma by Coagulation assay --post heparin neutralization |
| 93491-9 | AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 61369-5 | Listeria monocytogenes DNA [Presence] in Specimen by NAA with probe detection |
| 93733-4 | Creatinine [Mass/time] in 5 hour Urine |
| 93750-8 | Mumps virus RNA and N gene panel - Specimen |
| 94113-8 | Norclobazam [Presence] in Urine by Screen method |
| 63155-6 | Cultivated Wheat IgG Ab [Mass/volume] in Serum |
| 63304-0 | Parietal cell Ab [Titer] in Gastric fluid by Immunofluorescence |
| 7780-0 | Winterfat IgE Ab [Units/volume] in Serum |
| 63426-1 | Bacterial heat-stable enterotoxin ST gene [Presence] in Specimen by NAA with probe detection |
| 79412-3 | Mianserin trough and Normianserin panel - Serum or Plasma |
| 79660-7 | Guanosine [Moles/volume] in Cerebral spinal fluid |
| 80187-8 | JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 80-2 | Cefixime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 68548-7 | Aquaporin 4 water channel IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 68938-0 | Cytokeratin 19 [Mass/volume] in Pleural fluid |
| 68979-4 | Rivaroxaban [Units/volume] in Platelet poor plasma by Chromogenic method |
| 97020-2 | Maximum amplitude arachidonate induced [Length] in Blood |
| 8189-3 | Benzoylecgonine [Presence] in Meconium by Screen method |
| 7081-3 | Anise IgE Ab [Units/volume] in Serum |
| 82369-0 | Buprenorphine [Presence] in Serum or Plasma by Screen method |
| 98022-7 | Abnormal lymphocytes [Presence] in Body fluid by Manual count |
| 71699-3 | Flavivirus Ag [Presence] in Specimen by Immune stain |
| 85350-7 | Extranodal extension of carcinoma [Presence] in Cancer specimen by Light microscopy |
| 7258-7 | Cow milk IgE Ab [Units/volume] in Serum |
| 72770-1 | Zolpidem [Mass/volume] in Urine by Confirmatory method |
| 41226-2 | Viscosity of Water |
| 59759-1 | Triazolam [Mass/volume] in Blood by Confirmatory method |
| 21503-8 | Measles virus IgM Ab [Presence] in Serum |
| 3123-7 | Vanillylmandelate/Creatine [Mass Ratio] in Urine |
| 31546-5 | Ovary IgG Ab [Units/volume] in Serum |
| 51065-1 | CD13 blasts/100 blasts in Specimen |
| 21703-4 | KRAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 43597-4 | Inner ear 68kD Ab [Presence] in Serum or Plasma by Immunoblot |
| 32081-2 | HYDROmorphone [Presence] in Specimen |
| 44093-3 | Neisseria meningitidis [Identifier] in Isolate by Organism specific culture |
| 23274-4 | Mycoplasma gallisepticum Ab [Titer] in Serum by Hemagglutination |
| 5349-6 | SCL-70 extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
| 45286-2 | Cytomegalovirus IgA Ab [Presence] in Body fluid |
| 34152-9 | Herpes simplex virus 1+2 IgM Ab [Titer] in Serum |
| 34250-1 | Silver Birch recombinant (rBet v) 4 IgE Ab [Units/volume] in Serum |
| 46178-0 | Chlamydia trachomatis D+E+F+G+H+I+J+K IgM Ab [Titer] in Serum |
| 46262-2 | Codeine Free [Presence] in Serum or Plasma by Screen method |
| 2459-6 | IgA.monoclonal [Mass/volume] in Serum |
| 47406-4 | Entamoeba histolytica Ab [Presence] in Cerebral spinal fluid |
| 34941-5 | Bordetella pertussis IgG and IgM panel - Serum |
| 34945-6 | Herpes virus 6 IgG and IgM panel - Serum |
| 35313-6 | Lipase [Enzymatic activity/volume] in Body fluid --5th specimen post Sincalide |
| 35468-8 | FLAER cells [Presence] in Blood |
| 4825-6 | HLA-B37 [Presence] |
| 35869-7 | 2-Oxo,3-Methylvalerate [Moles/volume] in Serum or Plasma |
| 3642-6 | Fluorouracil [Mass/volume] in Serum or Plasma |
| 56934-3 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.5 hour post dose lactulose |
| 48369-3 | trans-Vaccenate (C18:1w7) [Moles/volume] in Serum or Plasma |
| 2679-9 | Ornithine [Mass/volume] in Serum or Plasma |
| 4894-2 | HLA-Dw22 [Presence] in Donor |
| 48978-1 | CDKL5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 49149-8 | Rickettsia parkeri IgG Ab [Titer] in Body fluid |
| 27819-2 | Protein C actual/normal in Platelet poor plasma by Coagulation assay |
| 3910-7 | Pemoline [Mass/time] in 24 hour Urine |
| 3924-8 | PENTobarbital [Mass/volume] in Serum or Plasma |
| 49578-8 | Aminocaproate cutoff [Mass/volume] in Serum or Plasma |
| 49732-1 | Interleukin 6 [Mass/volume] in Body fluid |
| 28586-6 | 4-Hydroxyphenyllactate/Creatinine [Ratio] in Urine |
| 2892-8 | Protoporphyrin Free [Mass/volume] in Blood |
| 40234-7 | Calcium [Moles/volume] in Serum or Plasma --4 hours post XXX challenge |
| 58772-5 | Dog recombinant (rCan f) 2 IgE Ab [Units/volume] in Serum |
| 50173-4 | Aldosterone [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
| 29640-0 | Isomaltase [Enzymatic activity/mass] in Tissue |
| 40410-3 | Alkaline phosphatase [Enzymatic activity/volume] in Peritoneal fluid |
| 59027-3 | Asialoganglioside GM1 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 30232-3 | Trichophyton reaction wheal [Diameter] --2 days post 0.1ml trichophyton intradermal |
| 19232-8 | Bicarbonate [Moles/volume] standard in Venous blood |
| 20741-5 | Canarypox virus Ag [Presence] in Serum by Immunofluorescence |
| 20926-2 | Ova and parasites identified in Stool by Baermann concentration |
| 12523-7 | Catecholamines [Mass/volume] in Plasma --3rd specimen post XXX challenge |
| 101223-6 | Normorphine/Creatinine [Mass Ratio] in Urine |
| 13240-7 | Phoma herbarum IgE Ab [Units/volume] in Serum |
| 13258-9 | Leishmania brasilensis IgG Ab [Units/volume] in Serum |
| 101755-7 | Trichophyton equinum DNA [Presence] in Specimen by NAA with probe detection |
| 102006-4 | von Willebrand factor.platelet binding activity without ristocetin [Units/volume] in Platelet poor plasma by Latex agglutination |
| 13684-6 | Beta hydroxybutyrate/Creatinine [Mass Ratio] in Urine |
| 102336-5 | Brome IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102617-8 | Sunflower Seed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13967-5 | Sex hormone binding globulin [Moles/volume] in Serum or Plasma |
| 102926-3 | Silver Birch IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14645-6 | chlorproMAZINE [Moles/volume] in Serum or Plasma |
| 14682-9 | Creatinine [Moles/volume] in Serum or Plasma |
| 14944-3 | Uroporphyrin 3 isomer [Moles/volume] in Stool |
| 104318-1 | Common myeloid progenitor cell [#/mass] in Blood |
| 15273-6 | Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab [Presence] in Serum by Multidisk |
| 1552-9 | Glucose [Mass/volume] in Serum or Plasma --pre 75 g glucose PO |
| 16108-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --45 minutes post 250 ug corticotropin IM |
| 16713-0 | Cytomegalovirus Ab [Units/volume] in Cerebral spinal fluid |
| 18286-5 | Donath Landsteiner Ab [Presence] in Blood |
| 74644-6 | HYDROcodone [Presence] in Saliva (oral fluid) by Confirmatory method |
| 74677-6 | 6-Monoacetylmorphine (6-MAM) [Presence] in Saliva (oral fluid) by Confirmatory method |
| 92485-2 | M Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 92750-9 | Glucopsychosine [Moles/volume] in Serum or Plasma |
| 75389-7 | CDKN1B gene full mutation analysis in Blood or Tissue by Sequencing |
| 75396-2 | AIP gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 60387-8 | Oregano IgG Ab [Mass/volume] in Serum |
| 77097-4 | MRPS22 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 78223-5 | TRA+TRD gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 7830-3 | Coxiella burnetii phase 2 IgG Ab [Units/volume] in Serum |
| 94443-9 | HLA-C IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC) |
| 94716-8 | AGTR1 gene c.1166A>C [Genotype] in Blood by Molecular genetics method Nominal |
| 79258-0 | Meprobamate cutoff [Mass/volume] in Urine for Confirmatory method |
| 95591-4 | 11-Ketoetiocholanolone [Z-score] in 24 hour Urine |
| 68374-8 | Nuclear Ab [Titer] in Pleural fluid by Immunofluorescence |
| 69913-2 | Basophils+Mast cells/100 leukocytes in Cerebral spinal fluid |
| 8171-1 | Cannabinoids [Presence] in Serum or Plasma by Confirmatory method |
| 8183-6 | Benzoylecgonine [Presence] in Gastric fluid |
| 82184-3 | Listeria monocytogenes DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
| 70133-4 | Rickettsia typhus group IgM Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 82535-6 | KRAS gene full mutation analysis in Blood or Tissue by Sequencing |
| 82916-8 | Flurazepam [Mass/volume] in Serum or Plasma --trough |
| 98014-4 | Plasma cell proliferation analysis in Bone marrow by FISH |
| 72160-5 | Holo-transcobalamin II [Moles/volume] in Serum |
| 85581-7 | Mycobacterium avium and Mycobacterium intracellulare DNA [Identifier] in Sputum or Bronchial by NAA with probe detection |
| 72618-2 | Propoxyphene + Norpropoxyphene [Presence] in Saliva (oral fluid) |
| 72872-5 | MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 85978-5 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum --1st specimen |
| 86135-1 | Streptococcus pneumoniae Danish serotype 5 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 73288-3 | Meropenem induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86742-4 | Growth phase [Type] in Skin melanoma by Light microscopy |
| 73841-9 | Tetrahydrodeoxycortisol [Moles/volume] in Urine |
| 88133-4 | Herpes simplex virus 2 DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 88146-6 | Microscopic observation [Identifier] in Placenta by Gram stain |
| 73940-9 | HYDROmorphone Free [Mass/volume] in Blood |
| 74463-1 | Normoblasts/100 leukocytes in Blood from Fetus |
| 5078-1 | Chlamydophila pneumoniae Ab [Units/volume] in Serum |
| 3116-1 | Valine [Mass/volume] in Cerebral spinal fluid |
| 21138-3 | Carbaryl [Mass/volume] in Urine |
| 3119-5 | Valine [Mass/volume] in Urine |
| 51360-6 | CD61 cells/100 cells in Cerebral spinal fluid |
| 21759-6 | FMR1 gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 43399-5 | JAK2 gene p.Val617Phe [Presence] in Blood or Tissue by Molecular genetics method |
| 22339-6 | Herpes simplex virus Ab [Presence] in Serum |
| 44070-1 | CD20+CD52+ cells/100 cells in Bone marrow |
| 23036-7 | Duck hepatitis virus 2 Ab [Presence] in Serum |
| 53173-1 | 3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBS |
| 44516-3 | Herpes simplex virus Ag [Presence] in Cervix by Immunofluorescence |
| 44739-1 | Beta tubulin IgM Ab [Presence] in Serum |
| 53522-9 | Microscopic observation [Identifier] in Bronchial specimen by Rhodamine-auramine fluorochrome stain |
| 53625-0 | Leishmania sp identified in Tissue |
| 53836-3 | ABCD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 45039-5 | Clostridium botulinum toxin [Presence] in Specimen by Immunoassay |
| 23841-0 | Choriogonadotropin.beta subunit [Multiple of the median] adjusted in Serum or Plasma |
| 24059-8 | Aspartylglucosaminidase [Enzymatic activity/mass] in Leukocytes |
| 34064-6 | Somatotropin [Mass/volume] in Serum or Plasma --pre or post dose insulin |
| 34146-1 | Neopterin [Moles/volume] in Cerebral spinal fluid |
| 34177-6 | Opiates [Presence] in Specimen |
| 46195-4 | Legionella pneumophila 2+3+4+5+6+8 Ab [Titer] in Serum |
| 24385-7 | Cardiolipin IgG Ab [Presence] in Serum by Immunoassay |
| 24485-5 | Mold Allergen Mix 1 (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 34316-0 | Histamine [Moles/volume] in Serum or Plasma |
| 55529-2 | Clopenthixol [Moles/volume] in Serum or Plasma |
| 55593-8 | Creatinine [Moles/volume] in Urine collected for unspecified duration |
| 47149-0 | EPINEPHrine [Moles/volume] in Plasma --6th specimen post XXX challenge |
| 47183-9 | Progesterone [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 47283-7 | Platelet mean volume [Entitic volume] in Cord blood |
| 47364-5 | Hepatitis B virus surface Ag [Presence] in Serum from Donor by Immunoassay |
| 47415-5 | Propoxyphene + Norpropoxyphene [Mass/volume] in Serum or Plasma by Confirmatory method |
| 25220-5 | cefOXitin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25426-8 | Galactose [Moles/volume] in Serum or Plasma |
| 3501-4 | Clorprenaline [Mass/time] in 24 hour Urine |
| 47813-1 | 2-Methylglutarate/Creatinine [Molar ratio] in Urine |
| 47888-3 | Somatotropin [Units/volume] in Serum or Plasma --1.75 hours post dose arginine+insulin |
| 47909-7 | Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose arginine+insulin |
| 25595-0 | Econazole [Susceptibility] |
| 25841-8 | HIV 2 proviral DNA [Presence] in Blood by NAA with probe detection |
| 35450-6 | HIV 1 p18 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
| 35530-5 | Candida albicans IgG Ab [Mass/volume] in Serum |
| 49252-0 | Calculus analysis [Interpretation] in Stone Narrative |
| 27851-5 | Lutropin [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 57853-4 | Snowshoe hare virus IgG Ab [Presence] in Serum by Immunoassay |
| 5790-1 | Fungi.filamentous [#/area] in Urine sediment by Microscopy high power field |
| 49374-2 | Hepatitis C virus RNA [Log #/volume] (viral load) in Bone marrow by NAA with probe detection |
| 49469-0 | CD33 Ag [Presence] in Tissue by Immune stain |
| 49697-6 | Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous cord blood |
| 40240-4 | Calcium [Moles/volume] in Serum or Plasma --13 hours post XXX challenge |
| 49889-9 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --pre dose corticotropin |
| 50054-6 | Hemicystine/Creatinine [Molar ratio] in Urine |
| 50120-5 | 3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Amniotic fluid |
| 50161-9 | Organic acids pattern [Interpretation] in Specimen |
| 58907-7 | Liver kidney microsomal 1 Ab [Presence] in Serum by Immunofluorescence |
| 5029-4 | Neisseria meningitidis rRNA [Presence] in Specimen by Probe |
| 19685-7 | Psilocin cutoff [Mass/volume] in Urine for Confirmatory method |
| 20554-2 | Para hydroxyamphetamine [Mass/volume] in Urine by Confirmatory method |
| 100435-7 | Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay |
| 12741-5 | Insulin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 101103-0 | C^G Ab [Presence] in Serum or Plasma |
| 101286-3 | Adenovirus DNA [Presence] in Throat by NAA with non-probe detection |
| 101635-1 | USP6 gene rearrangements in Blood or Tissue by FISH |
| 13080-7 | Phosphatidylglycerol IgM Ab [Units/volume] in Serum |
| 102022-1 | Glucose [Mass/volume] in Serum or Plasma --3 hours post dose glucagon |
| 13835-4 | Monocytes/100 leukocytes in Peritoneal fluid by Manual count |
| 102247-4 | Codfish IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102361-3 | Hazelnut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102594-9 | Shrimp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14183-8 | Aprobarbital [Mass/volume] in Urine |
| 102712-7 | Chicken IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103085-7 | Food Allergen Mix 25A (Onion+Garlic+Sesame seed+Yeast) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103958-5 | Ofloxacin [Susceptibility] by Genotype method |
| 1487-8 | Gastrin [Mass/volume] in Serum or Plasma --25 minutes post 0.2 U/kg secretin |
| 15346-0 | Aldosterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 10698-9 | Nystatin [Susceptibility] by Minimum lethal concentration (MLC) |
| 16707-2 | Taenia solium larva IgM Ab [Units/volume] in Serum |
| 11546-9 | Microscopic observation [Identifier] in Specimen by Other stain |
| 11553-5 | Microscopic exam [Interpretation] of Sputum by Cytology |
| 16861-7 | Fibrinopeptide A Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 17218-9 | Cytoplasmic Ig mu cells/100 cells in Blood |
| 1813-5 | Alpha galactosidase A [Enzymatic activity/volume] in Serum or Plasma |
| 91058-8 | Kingella kingae DNA [Presence] in Synovial fluid by NAA with probe detection |
| 74630-5 | Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Serum or Plasma |
| 74636-2 | Protein.monoclonal band 3 [Mass/time] in 24 hour Urine by Electrophoresis |
| 74986-1 | Hydroxychloroquine [Mass/volume] in Serum or Plasma --trough |
| 92687-3 | Giardia lamblia DNA [Presence] in Stool by NAA with probe detection |
| 76480-3 | Albumin [Moles/volume] in Cerebral spinal fluid |
| 92960-4 | Pseudomonas aeruginosa DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection |
| 7746-1 | Trimellitic anhydride (TMA) IgE Ab [Units/volume] in Serum |
| 7822-0 | Chlamydophila psittaci Ab [Units/volume] in Serum |
| 94310-0 | SARS-related coronavirus N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N3 |
| 7918-6 | HIV 1+2 Ab [Presence] in Serum |
| 79226-7 | ARIPiprazole [Mass/volume] in Body fluid |
| 95219-2 | Variant lymphocytes/100 leukocytes in Stem cell product by Manual count |
| 65776-7 | Silver birch native (nBet v) 1 IgE Ab [Units/volume] in Serum |
| 6680-3 | Microscopic observation [Identifier] in Tissue by Wet preparation |
| 7993-9 | Rhinovirus RNA [Presence] in Specimen by NAA with probe detection |
| 95951-0 | Azalea spp IgE Ab [Units/volume] in Serum |
| 96119-3 | SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay |
| 96275-3 | Ammonium persulfate IgE Ab [Units/volume] in Serum |
| 96354-6 | Platelets Large [#/volume] in Blood by Automated count |
| 6836-1 | Chicken serum proteins IgE Ab [Units/volume] in Serum |
| 68949-7 | Ehrlichia chaffeensis Ab [Titer] in Serum by Immunofluorescence |
| 68973-7 | IgA.intrathecally synthesized/IgA.total in Cerebral spinal fluid |
| 8093-7 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum |
| 96561-6 | Citrullinated alpha enolase peptide 1 Ab [Units/volume] in Serum by Immunoassay |
| 69794-6 | Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Urine |
| 82193-4 | Parechovirus A RNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
| 8225-5 | Opiates [Presence] in Unknown substance by Confirmatory method |
| 97584-7 | Carboxy tetrahydrocannabinol [Presence] in Cord tissue by Screen method |
| 97620-9 | Finegoldia magna DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 82965-5 | Methylenedioxyethylamphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 83086-9 | Choriogonadotropin [Units/volume] in Serum or Plasma by Immunoassay |
| 85294-7 | Surgical margin tumor involvement.mucosal [Identifier] in Colorectal cancer specimen by Light microscopy |
| 99775-9 | Leukocytes [#/volume] in Peritoneal dialysis fluid by Automated count |
| 99964-9 | MPL gene exon 10 full mutation analysis in Blood or Tissue by Sequencing |
| 72919-4 | HNA 3 genotype in Blood |
| 73166-1 | rifAMPin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73531-6 | amLODIPine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 41253-6 | Xylose [Mass/volume] in Urine --4 hours post 25 g xylose PO |
| 4130-1 | Antipyrine [Mass] of Dose |
| 41730-3 | cefOXitin+Clavulanate [Susceptibility] |
| 59602-3 | Alpha hydroxyalprazolam [Mass/volume] in Body fluid by Confirmatory method |
| 509-0 | Tobramycin [Susceptibility] by Disk diffusion (KB) |
| 4213-5 | Nordiazepam [Mass] of Dose |
| 42255-0 | Salmonella and Shigella sp identified in Specimen by Organism specific culture |
| 42504-1 | Hepatitis B virus surface Ab [Presence] in Cerebral spinal fluid |
| 59990-2 | Testosterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 60257-3 | Bacteria identified in Cornea by Culture |
| 31780-0 | Chlamydophila psittaci Ag [Presence] in Specimen |
| 31874-1 | Mareks disease virus Ag [Presence] in Specimen |
| 43405-0 | Chlamydia trachomatis and Neisseria gonorrhoeae DNA [Identifier] in Specimen by Probe with signal amplification |
| 43442-3 | Bacteria identified in Bronchial brush by Aerobe culture |
| 22525-0 | Salmonella paratyphi C O Ab [Presence] in Serum |
| 22687-8 | Cystine/Creatinine [Molar ratio] in Urine |
| 525-6 | Vancomycin [Susceptibility] by Disk diffusion (KB) |
| 53047-7 | Chromogranin A [Mass/volume] in Body fluid |
| 44041-2 | Basophils [Presence] in Synovial fluid by Light microscopy |
| 22838-7 | Avian pox virus Ab [Presence] in Serum by Immunofluorescence |
| 32787-4 | Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum |
| 53418-0 | Fibroblast growth factor 23.intact [Mass/volume] in Plasma --pre XXX challenge |
| 4498-2 | Complement C4 [Mass/volume] in Serum or Plasma |
| 23754-5 | Mycoplasma sp Ab [Titer] in Serum |
| 33807-9 | HIV 2 IgG Ab [Presence] in Serum |
| 54167-2 | Cefoperazone+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 54193-8 | Cefotaxime+Sulbactam [Susceptibility] by Disk diffusion (KB) |
| 46125-1 | Cardiolipin Ab [Presence] in Serum by Immunoassay |
| 24375-8 | Platelet Ab [Presence] in Serum |
| 24376-6 | von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoassay |
| 34395-4 | Food Allergen Mix 27 (Hazelnut+Codfish+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk |
| 34435-8 | Protein Fractions [Interpretation] in Specimen by Immunofixation |
| 55463-4 | Influenza virus A swine origin RNA [Identifier] in Specimen by NAA with probe detection |
| 5559-0 | RFD9 [Units/volume] in Leukocytes |
| 25144-7 | Ammonium urate crystals [#/area] in Urine sediment by Microscopy high power field |
| 25506-7 | Potassium [Moles/mass] in Stool |
| 34939-9 | Tumor necrosis factor.alpha [Moles/volume] in Serum or Plasma |
| 55843-7 | Corticosterone [Moles/volume] in 24 hour Urine |
| 25691-7 | Insulin [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 35549-5 | Mucor racemosus IgG Ab [Mass/volume] in Serum |
| 56311-4 | Locust tree IgG4 Ab [Mass/volume] in Serum |
| 56435-1 | Yogurt IgG4 Ab [Mass/volume] in Serum |
| 56539-0 | Intrinsic factor Ab [Units/volume] in Serum by Immunoassay |
| 48231-5 | Glycyphagus domesticus triggered leukotriene release [Mass/volume] by Leukocytes |
| 3589-9 | Encainide [Mass/volume] in Serum or Plasma |
| 3661-6 | Furosemide [Mass/volume] in Urine |
| 26880-5 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoassay |
| 4892-6 | HLA-Dw21 [Presence] in Donor |
| 48929-4 | Respiratory allergen panel, US - Cascade Pacific northwest b - Serum |
| 27847-3 | Somatotropin [Mass/volume] in Serum or Plasma --25th specimen post XXX challenge |
| 3923-0 | PENTobarbital [Presence] in Serum or Plasma |
| 39585-5 | Tritium [Presence] in 24 hour Urine |
| 397-0 | Penicillin V [Susceptibility] by Disk diffusion (KB) |
| 29212-8 | carBAMazepine [Mass/volume] in Body fluid |
| 29327-4 | HIV 1 Ab [Presence] in Body fluid |
| 39772-9 | Sulfamethoxazole [Moles/volume] in Serum or Plasma |
| 40200-8 | Glucose [Moles/volume] in Serum or Plasma --4 minutes post XXX challenge |
| 50041-3 | Bilirubin+Urobilinogen [Presence] in Urine |
| 50164-3 | Acylcarnitine pattern [Interpretation] in Specimen |
| 297-2 | Ketoconazole [Susceptibility] by Serum bactericidal titer |
| 4054-3 | Ticarcillin [Mass/volume] in Serum or Plasma |
| 30265-3 | Glucose [Moles/volume] in Serum or Plasma --1.3 hours post dose glucose |
| 40874-0 | Glucose [Mass/volume] in Specimen --1st specimen |
| 20931-2 | Parasites [#/volume] in Gastric fluid |
| 100121-3 | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay |
| 100143-7 | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot |
| 13068-2 | Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence |
| 13861-0 | C peptide [Mass/volume] in Serum or Plasma --5 minutes post 1 mg glucagon IV |
| 102664-0 | Wingscale IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14197-8 | Blastomyces dermatitidis exoantigen [Identifier] in Isolate |
| 102732-5 | Echinococcus granulosus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103049-3 | Mugwort native (nArt v) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14386-7 | Glucose [Mass/volume] in Gastric fluid |
| 14486-5 | Mycoplasma sp and Ureaplasma sp [Identifier] in Penis by Organism specific culture |
| 103604-5 | Carbamazepine 10,11-Epoxide [Mass/volume] in Urine |
| 10361-4 | DNA single strand IgM Ab [Units/volume] in Serum |
| 14890-8 | Progesterone [Moles/volume] in Serum or Plasma |
| 15034-2 | Bromide [Moles/volume] in Serum or Plasma |
| 10617-9 | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Mixed antiglobulin reaction |
| 16261-0 | Calcium bilirubinate crystals [Presence] in Stone by Infrared spectroscopy |
| 16669-4 | Cortisol [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 12195-4 | Creatinine renal clearance/1.73 sq M in 24 hour Urine and Serum or Plasma |
| 17791-5 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum |
| 17928-3 | Bacteria identified in Blood by Aerobe culture |
| 1880-4 | Beta 2 glycoprotein 1 [Mass/volume] in Serum or Plasma |
| 18879-7 | Cefepime [Susceptibility] |
| 89989-8 | Vilazodone [Presence] in Urine by Screen method |
| 90286-6 | Trichomonas vaginalis [Presence] in Vaginal fluid by Light microscopy |
| 74934-1 | fluPHENAZine [Mass/volume] in Serum or Plasma --trough |
| 92782-2 | Enterococcus faecium DNA [Presence] by NAA with probe detection in Positive blood culture |
| 75138-8 | Succinylaminoimidazole carboxamide riboside/Creatinine [Molar ratio] in Urine |
| 75159-4 | Uridine [Moles/volume] in Serum or Plasma |
| 60-4 | Carbenicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 60587-3 | Cell count and Differential panel - Peritoneal dialysis fluid |
| 61161-6 | Hepatitis B virus codon A181T [Presence] by Genotype method |
| 7639-8 | Pyrethrum IgE Ab [Units/volume] in Serum |
| 93459-6 | U-47700 [Mass/volume] in Urine by Confirmatory method |
| 93488-5 | Guanidinoacetate [Moles/volume] in DBS |
| 94080-9 | RRM2B gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
| 94500-6 | SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 94712-7 | Movement disorder autoimmune Ab panel - Cerebral spinal fluid |
| 64412-0 | Mycobacterium sp [Presence] in Blood by Organism specific culture |
| 78872-9 | OPC3373 (Metabolite of Ariprazole) [Z-score] in Urine |
| 79575-7 | Metanephrine, Normetanephrine, 3-Methoxytyramine and Creatinine panel - 24 hour Urine |
| 79698-7 | Docosadienoate (C22:2w6) [Moles/volume] in Serum or Plasma |
| 8009-3 | Bartonella quintana IgG Ab [Units/volume] in Serum |
| 68414-2 | Mesothelial cells [#/volume] in Pericardial fluid by Manual count |
| 6858-5 | Squid IgE Ab [Units/volume] in Serum |
| 68969-5 | Relative activated clotting time (ACT) of Platelet poor plasma by Kaolin induced method |
| 8145-5 | Amphetamines [Presence] in Meconium by Confirmatory method |
| 8158-8 | Arsenic [Mass/mass] in Tissue |
| 8163-8 | Tetrahydrocannabinol [Presence] in Gastric fluid |
| 81867-4 | NOTCH3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 82197-5 | Clostridioides difficile toxin A+B tcdA+tcdB genes [Presence] in Stool by NAA with non-probe detection |
| 9791-5 | Organochlorine pesticides [Type] in Serum or Plasma |
| 70850-3 | Burkholderia mallei [Presence] in Specimen by Organism specific culture |
| 82497-9 | TRBV6 gene segments/TRBV gene segments.total in Blood |
| 72223-1 | Yeast [Presence] in Urine by Automated |
| 83121-4 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Immunoassay |
| 84923-2 | PCA-1 Ab [Units/volume] in Serum by Immunoblot |
| 85688-0 | Streptococcus pneumoniae lytA gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 72751-1 | oxyCODONE [Mass/volume] in Saliva (oral fluid) by Screen method |
| 73243-8 | Nitrofurantoin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73269-3 | Midazolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73344-4 | HYDROcodone+Chlorpheniramine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87547-6 | Borrelia burgdorferi Ab and Anaplasma phagocytophilum, Babesia microti and Ehrlichia chaffeensis IgG panel - Serum |
| 73467-3 | Ceftizoxime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87811-6 | Meprobamate [Presence] in Saliva (oral fluid) by Screen method |
| 88578-0 | Clostridium botulinum toxin [Identifier] in Stool by Mouse bioassay neutralization |
| 73941-7 | 6-monoacetylmorphine free [Mass/volume] in Blood |
| 88904-8 | Influenza virus A Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
| 89590-4 | Zika virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 59325-1 | Salvinorin B [Mass/volume] in Blood |
| 59672-6 | Estazolam [Mass/volume] in Urine by Confirmatory method |
| 31022-7 | Filaria identified in Specimen by Concentration |
| 4184-8 | Cilastatin [Mass] of Dose |
| 42490-3 | Blastomyces dermatitidis Ab [Titer] in Pleural fluid by Complement fixation |
| 60173-2 | Strontium [Mass/volume] in Red Blood Cells |
| 60227-6 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose fructose PO |
| 21631-7 | ATP7B gene p.Gly1267Arg [Presence] in Blood or Tissue by Molecular genetics method |
| 31182-9 | 7-Aminonitrazepam [Mass/volume] in Serum or Plasma |
| 31197-7 | Microscopic observation [Identifier] in Pelvis fine needle aspirate by Cyto stain |
| 31300-7 | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum |
| 51408-3 | Streptococcus pneumoniae capsular polysaccharide IgG2 Ab [Mass/volume] in Serum by Immunoassay |
| 51591-6 | Cholesterol [Moles/volume] in Synovial fluid |
| 51759-9 | RAI1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 22555-7 | Streptococcus pneumoniae Danish serotype 7F Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 5220-9 | HIV 1 Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 52934-7 | Chromium/Creatinine [Molar ratio] in 24 hour Urine |
| 44078-4 | Catecholamines [Interpretation] in Urine |
| 44284-8 | 2-Methylcitrate/Creatinine [Molar ratio] in 24 hour Urine |
| 32591-0 | Heavy metals [Presence] in 24 hour Urine |
| 32733-8 | Beta 2 globulin/Protein.total in Serum or Plasma by Electrophoresis |
| 44618-7 | Total linear mm of carcinoma |
| 33254-4 | pH of Arterial blood adjusted to patient's actual temperature |
| 33265-0 | Toxoplasma gondii IgA Ab [Units/volume] in Cerebral spinal fluid |
| 33313-8 | Rheumatoid factor IgA [Units/volume] in Serum |
| 33496-1 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose lactose PO |
| 33706-3 | Yersinia pestis Ab [Presence] in Serum |
| 53873-6 | IRF6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 3421-5 | Butalbital [Presence] in Urine |
| 47174-8 | Norepinephrine [Moles/volume] in Urine --7th specimen post XXX challenge |
| 25321-1 | Antimony [Moles/volume] in Serum or Plasma |
| 25460-7 | Leucine [Moles/time] in 24 hour Urine |
| 25551-3 | Urobilinogen [Presence] in Body fluid |
| 35315-1 | Lipase [Enzymatic activity/volume] in Body fluid --3rd specimen post Sincalide |
| 55775-1 | Direct antiglobulin test.IgA specific reagent [Presence] on Red Blood Cells |
| 35404-3 | Leishmania brasilensis IgG Ab [Presence] in Serum |
| 26582-7 | Homocysteine/Creatinine [Molar ratio] in Urine |
| 38370-3 | Voriconazole [Mass/volume] in Serum or Plasma |
| 49022-7 | Respiratory allergen panel, US - Northern midwest states c - Serum |
| 49314-8 | Immunodeficiency markers [Interpretation] in Specimen |
| 2777-1 | Phosphate [Mass/volume] in Serum or Plasma |
| 3887-7 | Oxazepam [Mass/volume] in Urine |
| 28544-5 | Mesothelial cells/100 leukocytes in Body fluid |
| 58629-7 | Corticotropin [Mass/volume] in Plasma --pre XXX challenge |
| 49921-0 | Lymphocyte proliferation stimulated by concanavalin A in Blood |
| 58856-6 | Somatotropin [Mass/volume] in Serum or Plasma --10th specimen |
| 58918-4 | Androstanolone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 58927-5 | Glutamine+Histidine/Creatinine [Ratio] in Urine |
| 59204-8 | Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma |
| 3002-3 | Thiocyanate [Mass/volume] in Serum or Plasma |
| 41025-8 | Ribonucleoprotein extractable nuclear Ab [Mass/volume] in Serum |
| 19323-5 | 6-Monoacetylmorphine (6-MAM) cutoff [Mass/volume] in Urine for Screen method |
| 19646-9 | oxyMORphone [Presence] in Urine by Screen method |
| 101236-8 | Titin Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 101464-6 | Septin-7 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 102028-8 | Cortisol [Mass/volume] in Serum or Plasma --3 hours post dose glucagon |
| 14044-2 | Cortisone [Mass/time] in 24 hour Urine |
| 102987-5 | Cephalosporine mold IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14415-4 | Calcium [Moles/volume] in Amniotic fluid |
| 14526-8 | Rubella virus Ag [Presence] in Eye by Immunofluorescence |
| 16210-7 | Diethylpropion [Presence] in Urine by Confirmatory method |
| 16226-3 | Benzoylecgonine [Mass/volume] in Urine by Confirmatory method |
| 10826-6 | Nissel.microscopic observation [Identifier] in Tissue by Cresyl echt violet stain |
| 11103-9 | Band form neutrophils/100 cells in Bone marrow by Manual count |
| 1638-6 | Testosterone [Mass/volume] in Serum or Plasma --96 hours post 5000 U HCG IM |
| 16822-9 | Epithelial cells [Presence] in Nose by Light microscopy |
| 17930-9 | Bacteria # 3 identified in Blood by Aerobe culture |
| 18935-7 | Kanamycin [Susceptibility] |
| 90040-7 | Alpha globin gene cluster and HS-40 region deletion and duplication mutation analysis in Blood or Tissue by Molecular genetics method |
| 91781-5 | Neisseria gonorrhoeae [Presence] in Aspirate by Organism specific culture |
| 92779-8 | Micrococcus sp DNA [Presence] by NAA with probe detection in Positive blood culture |
| 7534-1 | Red Oak IgE Ab [Units/volume] in Serum |
| 75710-4 | Coccidioides immitis+posadasii IgM Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
| 60389-4 | Pea IgG Ab [Mass/volume] in Serum |
| 60588-1 | t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 6095-4 | American house dust mite IgE Ab [Units/volume] in Serum |
| 76684-0 | Mean platelet dry mass [Entitic mass] in Blood by calculation |
| 92958-8 | Respiratory pathogens DNA and RNA panel - Lower respiratory specimen by NAA with non-probe detection |
| 93406-7 | Acinetobacter baumannii DNA [Presence] by NAA with probe detection in Positive blood culture |
| 9362-5 | Bordetella pertussis IgA Ab [Units/volume] in Serum |
| 93995-9 | Osmolality of Serum or Plasma--6 hours post fluid fast |
| 94284-7 | Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 95143-4 | UGT1A1 gene TA repeats [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 95151-7 | Infectious bronchitis virus RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 79502-1 | 4-Hydroxyvalerate [Moles/volume] in Serum or Plasma |
| 79675-5 | Cytidine [Moles/volume] in Serum or Plasma |
| 8005-1 | Rickettsia rickettsii RNA [Presence] in Serum by NAA with probe detection |
| 9608-1 | Hepatitis C virus 100-3 Ab [Presence] in Serum by Immunoblot |
| 96468-4 | Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 80599-4 | Bordetella holmesii fumC gene [Presence] in Nasopharynx by NAA with probe detection |
| 97007-9 | Clot initiation.kaolin induced [Time] in Blood by Resonance TEG --post heparin neutralization |
| 97535-9 | Gas panel - Central venous blood |
| 82556-2 | Inhalant Allergen Mix 6 (Alternaria tenuis+Mugwort+Silver birch+Cladosporium herbarum+Timothy grass) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 82920-0 | Legionella pneumophila IgA Ab [Units/volume] in Serum by Immunoassay |
| 98048-2 | Levothyroxine IgE Ab [Units/volume] in Serum |
| 98220-7 | Treponema pallidum IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 85539-5 | PRRSV North American strain RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 99871-6 | Erythrocytes.ghost cells [#/volume] in Urine sediment by Computer assisted method |
| 72911-1 | HNA 4b/4b Ab [Presence] in Serum by Immunoassay |
| 86161-7 | Streptococcus pneumoniae Danish serotype 8 Ab [Units/volume] in Serum --2nd specimen |
| 73340-2 | HYDROmorphone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87450-3 | Sulfur [Mass/mass] in Specimen |
| 73607-4 | Tizoxanide [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 87801-7 | Ormetoprim+Sulfadimethoxine [Susceptibility] |
| 73945-8 | UR-144 (synthetic cannabinoid) [Presence] in Blood |
| 74389-8 | Normirtazapine [Mass/volume] in Blood |
| 89356-0 | CD21 cells/100 CD19 cells in Blood |
| 59756-7 | Titanium [Mass/mass] in Tissue |
| 50629-5 | Liver kidney microsomal IgG Ab [Titer] in Serum |
| 50759-0 | Beta-N-acetylhexosaminidase.A [Enzymatic activity/mass] in Leukocytes |
| 51019-8 | CD10 blasts/100 blasts in Specimen |
| 60204-5 | Trimethadione [Mass/volume] in Blood |
| 22103-6 | Reticuloendotheliosis virus Ab [Presence] in Serum |
| 3183-1 | Clotting time of Blood by Lee White method |
| 51477-8 | Coccidioides sp IgM Ab [Presence] in Specimen by Immune diffusion (ID) |
| 22437-8 | Parainfluenza virus 1 Ab [Titer] in Serum |
| 22686-0 | Protoporphyrin [Moles/time] in 24 hour Urine |
| 32529-0 | CD3 cells/100 cells in Bone marrow |
| 32542-3 | Chloride [Molar amount] in Urine collected for unspecified duration |
| 22870-0 | Bluetongue virus Ag [Presence] in Specimen by Immunoassay |
| 22965-8 | Campylobacter fetus Ag [Presence] in Specimen by Immunofluorescence |
| 53362-0 | Borrelia burgdorferi 49736 IgA Ab [Units/volume] in Serum |
| 23451-8 | Taenia sp eggs [Presence] in Stool by Probe |
| 23553-1 | Venezuelan equine encephalitis virus subtype [Identifier] in Specimen by NAA with probe detection |
| 33471-4 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post XXX challenge |
| 44909-0 | 5-Hydroxyindoleacetate and Creatinine [Interpretation] in Urine |
| 3408-2 | Brompheniramine [Presence] in Urine |
| 34248-5 | Ascorbate/Creatinine [Molar ratio] in Urine |
| 24129-9 | Bordetella pertussis.pertussis toxin IgM Ab [Units/volume] in Serum by Immunoassay |
| 55584-7 | Trimethoprim [Moles/volume] in Serum or Plasma |
| 25481-3 | Molybdenum [Moles/volume] in Serum or Plasma |
| 34935-7 | CD3+CD8+CD45RO-CD45RA- cells/100 cells in Blood |
| 34968-8 | Osmotic fragility of Red Blood Cells--0.20% sodium chloride |
| 35106-4 | Norcitalopram [Mass/volume] in Serum or Plasma |
| 47514-5 | Treponema pallidum IgM Ab [Units/volume] in Cerebral spinal fluid |
| 47713-3 | Oleate (C18:1w9)/Creatinine [Molar ratio] in Urine |
| 25694-1 | Insulin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 25706-3 | Ketones [Mass/volume] in Urine by Test strip --2 hours post dose glucose |
| 48280-2 | Dipyrone triggered leukotriene release [Mass/volume] by Leukocytes |
| 56786-7 | Beta-2-Microglobulin.tumor marker [Mass/volume] in Serum |
| 57676-9 | Legionella pneumophila IgG Ab [Presence] in Serum by Immunofluorescence --2nd specimen |
| 38925-4 | RS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 57896-3 | Influenza virus A 2009 H1N1v.neuraminidase inhibitor resistance [Susceptibility] in Specimen by Genotype method |
| 58807-9 | Conalbumin native (nGal d) 3 IgE Ab [Units/volume] in Serum |
| 29765-5 | Cholesterol [Moles/volume] in Body fluid |
| 2986-8 | Testosterone [Mass/volume] in Serum or Plasma |
| 40571-2 | Basophils [#/volume] in Body fluid by Manual count |
| 40583-7 | Invasive trophoblast Ag [Mass/volume] in Serum or Plasma |
| 58948-1 | Somatotropin [Mass/volume] in Serum or Plasma --pre XXX challenge |
| 59191-7 | 2-Ketobutyrate/Creatinine [Molar ratio] in Urine |
| 30201-8 | B Ab [Titer] in Serum or Plasma |
| 30304-0 | Adefovir [Susceptibility] |
| 20937-9 | Pentachlorophenol [Mass/mass] in Fat |
| 2094-1 | Cholesterol.non-esterified [Mass/volume] in Serum or Plasma |
| 12871-0 | HIV 1 p26 Ab [Presence] in Serum by Immunoblot |
| 101283-0 | Speciociliatine [Presence] in Cord tissue |
| 101523-9 | Bovine parainfluenza virus 3 neutralizing antibody [Titer] in Serum by Neutralization test |
| 13742-2 | Formate/Creatinine [Mass Ratio] in Urine |
| 1390-4 | Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post 40 ug corticotropin IM BID 3 day |
| 14127-5 | Neisseria gonorrhoeae [Presence] in Anal by Organism specific culture |
| 10364-8 | Cotinine [Mass/mass] in Hair |
| 14984-9 | I (intermediate) subtype [Presence] on Red Blood Cells from Donor |
| 104285-2 | UGT1A1 gene.p.G71R [Presence] in Blood or Tissue by Molecular genetics method |
| 15432-8 | Testosterone Free/Testosterone.total in Serum or Plasma |
| 11568-3 | Phosphatidylserine IgG Ab [Presence] in Serum |
| 17163-7 | CD49a cells/100 cells in Blood |
| 17419-3 | Parathion [Mass/volume] in Urine |
| 17454-0 | Phosphatidylinositol IgA Ab [Presence] in Serum |
| 1883-8 | Apolipoprotein A [Mass/volume] in Serum or Plasma |
| 19150-2 | Specimen creatinine acceptable [Presence] in Urine |
| 74999-4 | 5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/mass] in Leukocytes |
| 61153-3 | Glucose [Mass/volume] in Peritoneal dialysis fluid --baseline |
| 92802-8 | Cryptococcus neoformans DNA [Presence] by NAA with probe detection in Positive blood culture |
| 9411-0 | Hydrocorticosterone [Mass/time] in 24 hour Urine |
| 94604-6 | Equine arteritis virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 6609-2 | Listeria sp identified in Specimen by Organism specific culture |
| 79583-1 | R- and S-beta aminoisobutyrate and D- and L-serine panel - Serum or Plasma |
| 797-1 | Erythrocytes [#/volume] in Synovial fluid by Manual count |
| 95726-6 | 3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 81141-4 | Spermatozoa motility [Score] in Semen by Automated |
| 97258-8 | Hydroxytriazolam [Presence] in Cord tissue by Screen method |
| 97969-0 | Ovomucoid IgG4 Ab [Mass/volume] in Serum |
| 7026-8 | levoFLOXacin [Susceptibility] by Gradient strip |
| 82719-6 | Enfuvirtide [Susceptibility] by Phenotype method |
| 71781-9 | Rift valley fever virus IgM Ab [Presence] in Serum by Immunoassay |
| 71841-1 | Oxygen saturation [Pure mass fraction] Calculated from oxygen partial pressure in Venous blood |
| 7226-4 | Chinese Tallow Tree IgE Ab [Units/volume] in Serum |
| 99108-3 | ePHEDrine [Presence] in Urine by Screen method |
| 85808-4 | Mumps virus RNA and SH gene panel - Specimen by NAA with probe detection |
| 86025-4 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum --1st specimen |
| 86125-2 | Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 87325-7 | Porcine circovirus type 2 Ab [Titer] in Serum by Immunoassay |
| 73655-3 | Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method |
| 87965-0 | Microscopic observation [Identifier] in Cerebral spinal fluid by Giemsa stain |
| 73897-1 | Chronic lyme disease panel - Blood by Flow cytometry (FC) |
| 88907-1 | Parainfluenza virus 2 Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
| 41422-7 | Schistosoma haematobium Ab [Presence] in Serum by Immunoblot |
| 59313-7 | Ramelteon M-II [Mass/volume] in Blood |
| 42716-1 | Mycobacterium sp rRNA [Identifier] in Isolate by NAA with probe detection |
| 60083-3 | Hydroxybupropion [Mass/volume] in Blood |
| 51402-6 | CD81 cells/100 cells in Cerebral spinal fluid |
| 42971-2 | Powassan virus IgM Ab [Titer] in Specimen |
| 31739-6 | Borrelia sp Ag [Presence] in Specimen |
| 31900-4 | Mumps virus Ag [Presence] in Specimen |
| 43320-1 | Avian metapneumovirus B Ab [Presence] in Serum by Immunofluorescence |
| 4335-6 | Minocycline [Mass] of Dose |
| 22618-3 | Yellow fever virus Ab [Titer] in Serum |
| 52767-1 | Activated partial thromboplastin time (aPTT) in Platelet poor plasma by Coagulation assay -- after addition of protein C activator/Activated partial thromboplastin time (aPTT) |
| 52772-1 | Clot formation.intrinsic coagulation system activated.heparin insensitive [Time] in Blood by Rotational TEG |
| 43873-9 | Aspergillus sp IgM Ab [Presence] in Serum |
| 44001-6 | Choriogonadotropin [Units/volume] in Cerebral spinal fluid |
| 23159-7 | Leishmania sp DNA [Identifier] in Specimen by NAA with probe detection |
| 32685-0 | Hepatitis B virus core IgG Ab [Presence] in Serum |
| 32743-7 | CD138 cells/100 cells in Specimen |
| 5339-7 | Salmonella paratyphi A H Ab [Presence] in Serum by Latex agglutination |
| 44449-7 | Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 44859-7 | Bacteria # 7 identified in Specimen by Anaerobe culture |
| 2331-7 | Gastrin.17 residue fragment [Mass/volume] in Serum or Plasma |
| 23346-0 | Pasteurella multocida serotype [Identifier] in Specimen by Immunoelectrophoresis |
| 23794-1 | Food Allergen Mix C (Oat+Barley+Rice+Rye+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk |
| 23797-4 | Tree Allergen Mix 2 (Boxelder+White oak+White elm+Cottonwood+Pecan/Hickory) IgE Ab [Presence] in Serum by Multidisk |
| 4603-7 | Hemoglobin Koln [Presence] in Blood |
| 46730-8 | Bacterial vaginosis whiff test [Presence] in Vaginal fluid |
| 34315-2 | Hexacarboxylporphyrins [Mass/mass] in Stool |
| 25082-9 | 2-methyl-3-hydroxybutyrate (C5-OH)/Creatinine [Molar ratio] in Urine |
| 25218-9 | Isoniazid 0.2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25243-7 | Ceftizoxime [Mass/volume] in Specimen |
| 56128-2 | Chikungunya virus IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 25985-3 | Taurine/Creatinine [Molar ratio] in 24 hour Urine |
| 56233-0 | Cottonwood IgG4 Ab [Mass/volume] in Serum |
| 56888-1 | HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay |
| 4839-7 | HLA-B51(5) [Presence] |
| 27060-3 | Melatonin [Presence] in Saliva (oral fluid) |
| 38286-1 | 2,4-Dichlorophenoxyacetate [Mass/volume] in Water |
| 38471-9 | Karyotype [Identifier] in Urine Nominal |
| 38530-2 | BRCA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 57569-6 | 25-hydroxyvitamin D3 [Moles/volume] in Serum or Plasma --1 hour post dose calcium |
| 48914-6 | Rickettsia typhi IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 4916-3 | HLA-Dw8 [Presence] in Donor |
| 4920-5 | HLA-DPw1 [Presence] in Donor |
| 3902-4 | Para hydroxyamphetamine [Mass/volume] in Urine |
| 39611-9 | Silicone IgG Ab [Units/volume] in Serum by Immunoassay |
| 57719-7 | Conditions tested for in this newborn screening study [Identifier] in DBS |
| 49641-4 | SCA1 gene allele 1 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 2889-4 | Protein [Mass/time] in 24 hour Urine |
| 29738-2 | Leptospira interrogans sv Robinsoni Ab [Presence] in Serum |
| 40532-4 | Methanol [Presence] in Gastric fluid |
| 5021-1 | Listeria monocytogenes rRNA [Presence] in Specimen by Probe |
| 50542-0 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine |
| 20662-3 | Allergens tested for in Serum |
| 12543-5 | Methyl formamide [Mass/volume] in Urine |
| 13898-2 | Trichloroacetate [Mass/volume] in Serum or Plasma |
| 102351-4 | Velvet grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102434-8 | Cajeput tree IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102597-2 | Silver IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102833-1 | Tomato IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14955-9 | Zinc [Moles/volume] in Serum or Plasma |
| 104327-2 | Bacillus anthracis Ab [Titer] in Serum by Immunoassay --1st specimen |
| 10918-1 | Zinc [Mass/volume] in Specimen |
| 1711-1 | Acid phosphatase [Enzymatic activity/volume] in Blood |
| 17717-0 | Toxoplasma gondii IgG+IgM Ab [Presence] in Serum |
| 17760-0 | Urea nitrogen [Mass/volume] in Venous blood --pre dialysis |
| 18253-5 | Serotonin [Mass/time] in 24 hour Urine |
| 18395-4 | Aspergillus niger Ab [Presence] in Cerebral spinal fluid |
| 18399-6 | Polio virus 3 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 904-3 | Blood group antibody screen [Presence] in Serum or Plasma by Warm absorption |
| 74916-8 | Metoprolol [Mass/volume] in Serum or Plasma --trough |
| 75377-2 | Dengue virus NS1 Ag [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 60331-6 | Propranolol [Moles/volume] in Specimen |
| 93450-5 | Coagulation factor VIII inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method |
| 770-8 | Neutrophils/100 leukocytes in Blood by Automated count |
| 94116-1 | ALPRAZolam [Presence] in Urine by Screen method |
| 63206-7 | Common Ragweed IgG Ab [Mass/volume] in Serum |
| 94720-0 | SARS-CoV-2 (COVID-19) IgA Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 78984-2 | Macroprolactin/Prolactin in Serum or Plasma |
| 66116-5 | Ovary Pathology biopsy report |
| 66875-6 | FMR1 gene methylation/methylated+unmethylated in Blood by Molecular genetics method |
| 79577-3 | Levodopa/Creatinine [Molar ratio] in Urine |
| 95691-2 | Venezuelan equine encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay |
| 8117-4 | CD19 cells/100 cells in Blood |
| 96559-0 | Testosterone Free [Moles/volume] in Serum or Plasma by calculation |
| 69780-5 | 2-Hydroxyisovalerate [Moles/volume] in Cerebral spinal fluid |
| 6990-6 | cefoTEtan [Susceptibility] by Gradient strip |
| 97548-2 | Base deficit in Central venous blood |
| 85583-3 | Chikungunya virus RNA [Presence] in Plasma from Donor by NAA with probe detection |
| 72579-6 | Prealbumin/Protein.total [Pure mass fraction] in Cerebral spinal fluid by Electrophoresis |
| 72791-7 | Alpha-Phenyl-2-Piperidine acetate/Creatinine [Mass Ratio] in Urine |
| 73324-6 | Isosorbide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 733-6 | Variant lymphocytes [Presence] in Blood by Light microscopy |
| 87491-7 | ADBICA N-4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 73827-8 | Gamma hydroxybutyrate [Mass/volume] in Serum, Plasma or Blood |
| 74100-9 | Nitrate+Nitrite [Moles/volume] in Serum or Plasma |
| 74135-5 | N-acetyl ezogabine [Mass/volume] in Plasma |
| 7420-3 | Horseradish IgE Ab [Units/volume] in Serum |
| 88887-5 | Isavuconazole [Susceptibility] |
| 88903-0 | Influenza virus B IgG Ab [Presence] in Serum by Immunoassay |
| 4135-0 | Aztreonam [Mass] of Dose |
| 59379-8 | Gentamicin [Mass/volume] in Serum or Plasma --post dialysis |
| 5958-4 | Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --20M post incubation with normal plasma |
| 50630-3 | Gentamicin [Susceptibility] by Method for Slow-growing mycobacteria |
| 59912-6 | Imipramine [Moles/volume] in Urine |
| 21284-5 | Gardnerella vaginalis [Presence] in Genital specimen by Organism specific culture |
| 3118-7 | Valine [Mass/volume] in Serum or Plasma |
| 31535-8 | Neuronal nuclear Ab [Units/volume] in Serum |
| 42780-7 | CCND1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 42893-8 | Cladosporium herbarum IgG Ab [Mass/volume] in Serum |
| 21757-0 | DMPK gene CTG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 51884-5 | Transfuse pooled platelets units [#] |
| 43300-3 | HTLV I+II p24 Ab [Presence] in Serum |
| 43608-9 | Adrenal cortex Ab [Presence] in Serum |
| 22448-5 | Polio virus 2 Ab [Titer] in Serum |
| 22712-4 | Adenosine monophosphate.cyclic [Moles/volume] in Urine |
| 32347-7 | Xylose [Moles/volume] in Serum or Plasma |
| 44265-7 | Influenza virus A H6 RNA [Units/volume] (viral load) in Specimen by NAA with probe detection |
| 53200-2 | Argininosuccinate/Arginine [Molar ratio] in DBS |
| 53428-9 | Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --3rd specimen post XXX challenge |
| 4484-2 | Complement C2 [Mass/volume] in Serum or Plasma |
| 23300-7 | Mycoplasma sp rRNA [Presence] in Specimen by Probe |
| 23368-4 | PRRSV neutralizing antibody [Presence] in Serum by Neutralization test |
| 23579-6 | Rabbit hemorrhagic disease virus Ag [Presence] in Tissue by Immunofluorescence |
| 53614-4 | Bacteria # 2 identified in Duodenal fluid by Aerobe culture |
| 23877-4 | Anaplasma phagocytophilum IgG Ab [Titer] in Serum by Immunofluorescence |
| 33775-8 | CD41a cells/100 cells in Specimen |
| 54199-5 | Piperacillin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
| 24476-4 | F2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 34636-1 | Ciprofloxacin [Mass/volume] in Cerebral spinal fluid |
| 47195-3 | Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 47229-0 | Herpes simplex virus Ag [Presence] in Cerebral spinal fluid |
| 3486-8 | Clindamycin [Mass/volume] in Serum or Plasma |
| 35283-1 | Hepatitis D virus IgG Ab [Presence] in Serum |
| 47883-4 | Renin [Mass/volume] in Plasma --upright |
| 25611-5 | Oriental Cockroach IgE Ab [Units/volume] in Serum |
| 25652-9 | Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --9th specimen post XXX challenge |
| 25819-4 | Xylose [Moles/volume] in Serum or Plasma --baseline |
| 56232-2 | Corn smut IgG4 Ab [Mass/volume] in Serum |
| 56450-0 | Black Pepper IgG4 Ab [Mass/volume] in Serum |
| 26795-5 | Alanine [Presence] in 24 hour Urine |
| 56649-7 | Hippurate/Creatinine [Ratio] in 24 hour Urine |
| 56883-2 | BCHE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 48771-0 | Kappa light chains [Mass/volume] in Cerebral spinal fluid |
| 4886-8 | HLA-Dw19(w6) [Presence] in Donor |
| 27132-0 | Acetoacetate [Presence] in Urine |
| 27161-9 | Interleukin 4 [Mass/volume] in Serum or Plasma |
| 38651-6 | 2-Chloro-1,3-Butadiene [Mass/volume] in Air |
| 2761-5 | Phenylketones [Presence] in Blood |
| 39570-7 | Alternaria sp IgG Ab [Mass/volume] in Serum |
| 5812-3 | Sulfonamide crystals [Presence] in Urine sediment by Light microscopy |
| 49339-5 | Adenovirus DNA [#/volume] (viral load) in Stool by NAA with probe detection |
| 2934-8 | Serine [Mass/volume] in Cerebral spinal fluid |
| 29526-1 | Azelate/Creatinine [Molar ratio] in Urine |
| 40017-6 | Glucose [Mass/volume] in Serum or Plasma --18.5 hours post XXX challenge |
| 40074-7 | Calcium [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
| 40117-4 | Creatinine [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 29966-9 | Centromere IgG Ab [Titer] in Serum by Immunofluorescence |
| 40428-5 | NIPBL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 59164-4 | Alkaline phosphatase [Enzymatic activity/volume] in Dialysis fluid |
| 59202-2 | Deoxyinosine/Creatinine [Molar ratio] in Urine |
| 59248-5 | Cholesterol esterase [Enzymatic activity/mass] in Tissue |
| 40842-7 | Galactose 1 phosphate [Mass/volume] in DBS |
| 19708-7 | Thioridazine cutoff [Mass/volume] in Urine for Screen method |
| 19717-8 | Triazolam cutoff [Mass/volume] in Urine for Confirmatory method |
| 20938-7 | Phenols [Mass/volume] in Gastric fluid |
| 12461-0 | Corticotropin [Mass/volume] in Plasma --5th specimen post XXX challenge |
| 12581-5 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --6th specimen |
| 12725-8 | IgA.secretory [Units/volume] in Serum or Plasma |
| 102191-4 | Bromelin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10243-4 | Oxygen content in Inferior vena cava |
| 102700-2 | Carageenan IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102753-1 | Helminthosporium sativum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102911-5 | Methyltetrahydrophthalic anhydride (MTHPA) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10372-1 | Blister cells [Presence] in Blood by Light microscopy |
| 10555-1 | Acrosin [Entitic Catalytic Activity] in Spermatozoa |
| 11202-9 | Tarragon IgE Ab [Units/volume] in Serum |
| 1222-9 | Mg Ab [Presence] in Serum or Plasma |
| 16770-0 | Dicoumarol [Mass/volume] in Urine |
| 17895-4 | Bacteria # 4 identified in Sputum by Aerobe culture |
| 19056-1 | Mercury [Presence] in Urine |
| 92653-5 | traZODone [Presence] in Urine by Confirmatory method |
| 75063-8 | Glycerate [Moles/volume] in Serum or Plasma |
| 60583-2 | TCRB gene rearrangements [Presence] in Bone marrow by Molecular genetics method |
| 7576-2 | Peach triggered histamine release [Units/volume] in Blood |
| 76024-9 | Sialate/Creatinine [Molar ratio] in Urine |
| 77045-3 | ACADSB gene full mutation analysis in Blood or Tissue by Sequencing |
| 77362-2 | N-tau methylimidazoleacetate/Creatinine [Molar ratio] in 24 hour Urine |
| 77365-5 | Nitrogen panel - 24 hour Stool |
| 63222-4 | DNA double strand Ab [Units/volume] in Pleural fluid by Immunoassay |
| 63445-1 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Serum by Immunoblot |
| 63487-3 | Epithelial cells.squamous [Presence] in Bronchoalveolar lavage |
| 658-5 | Microscopic observation [Identifier] in Specimen by Calcofluor white |
| 95831-4 | Lymphocyte dose in hematopoietic progenitor cell transfusion [#/mass] |
| 96059-1 | Mitragynine [Mass/volume] in Urine by Screen method |
| 80958-2 | Fractional excretion of magnesium [Ratio] in Urine and Serum or Plasma |
| 9669-3 | HIV 1 p66 Ab [Presence] in Serum by Immunoblot |
| 9717-0 | Toxocara canis IgA Ab [Units/volume] in Serum by Immunoassay |
| 69895-1 | Service comment 68 |
| 81781-7 | Saccharopine [Moles/volume] in Cerebral spinal fluid |
| 82038-1 | Tree Allergen Mix 9 (Grey alder+Silver birch+Hazelnut+White oak+Willow) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 7042-5 | Penicillin V [Susceptibility] by Gradient strip |
| 82422-7 | Ks Ab [Presence] in Serum by Line blot |
| 72398-1 | Butalbital [Mass/volume] in Blood by Confirmatory method |
| 72404-7 | 3-epi-25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma |
| 85764-9 | Staphylococcus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 72488-0 | Beta 2 glycoprotein 1 IgG and IgM panel - Serum |
| 7249-6 | Cornish hen triggered histamine release [Units/volume] in Blood |
| 88294-4 | Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) |
| 74325-2 | MICA*037 IgG Ab [Presence] in Serum |
| 88607-7 | Human coronavirus 229E RNA [Presence] in Aspirate by NAA with probe detection |
| 50671-7 | Corticotropin releasing hormone [Mass] of Dose |
| 30452-7 | Segmented neutrophils [#/volume] in Body fluid |
| 21619-2 | APOE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 51249-1 | CD15 cells/100 cells in Tissue |
| 43010-8 | HIV 1+2 Ab [Presence] in Specimen |
| 43605-5 | Microalbumin [Mass/volume] in 4 hour Urine |
| 22693-6 | Leucine/Creatinine [Molar ratio] in Urine |
| 32306-3 | Carbon dioxide [Partial pressure] in Urine |
| 32757-7 | BCL2 cells/100 cells in Specimen |
| 33019-1 | Pseudocasts [#/area] in Urine sediment by Microscopy low power field |
| 44719-3 | Methylmalonate/Homocysteine [Mass Ratio] in Serum or Plasma |
| 33357-5 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --1 hour post incubation |
| 33569-5 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
| 33598-4 | Sjogrens syndrome-B extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot |
| 53820-7 | Cefozopran [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 45318-3 | Uroporphyrin 3 isomer/Creatinine [Molar ratio] in Urine |
| 24015-0 | Influenza virus A+B Ag [Presence] in Specimen |
| 34230-3 | Adenosine monophosphate.cyclic [Moles/volume] in 24 hour Urine |
| 54176-3 | Caspofungin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 54279-5 | Glutarylcarnitine (C5-DC)/Creatinine [Molar ratio] in Urine |
| 54372-8 | Cholesterol in HDL [Mass/volume] in Body fluid |
| 54460-1 | Malonylcarnitine (C3-DC) [Moles/volume] in Cerebral spinal fluid |
| 247-7 | Floxacillin [Susceptibility] by Serum bactericidal titer |
| 34554-6 | Electrolytes 1998 and Venous pH panel - Serum or Plasma + Blood venous |
| 35035-5 | Mesothelial cells [#/volume] in Synovial fluid |
| 47668-9 | Insulin [Units/volume] in Serum or Plasma --pre dose glucose |
| 25630-5 | Parvovirus B19 IgG Ab [Titer] in Serum |
| 25813-7 | Trypanosoma cruzi Ab [Titer] in Serum by Immunofluorescence |
| 25869-9 | Beta alanine/Creatinine [Molar ratio] in 24 hour Urine |
| 25891-3 | Cysteine [Moles/volume] in 24 hour Urine |
| 35434-0 | Herpes simplex virus identified in Wound by Organism specific culture |
| 3560-0 | Digitoxin [Mass/volume] in Urine |
| 56388-2 | Shrimp IgG4 Ab [Mass/volume] in Serum |
| 36-4 | Azithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 56652-1 | Arsenic/Creatinine [Ratio] in Urine |
| 56902-0 | Amylase/Creatinine [Ratio] in 24 hour Urine |
| 27134-6 | Argininosuccinate [Presence] in Urine |
| 5715-8 | Platinum [Mass/volume] in Urine |
| 57400-4 | CD34 cells/100 cells in Bone marrow |
| 57456-6 | Spermatozoa Progressive [#/volume] in Semen --post concentration |
| 57625-6 | Alpha cortol [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
| 48906-2 | Rickettsia conorii IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 49154-8 | Rickettsia conorii IgG Ab [Titer] in Body fluid |
| 39563-2 | Glucose [Mass/volume] in Serum or Plasma --3rd specimen post dose lactose |
| 57992-0 | Legionella pneumophila 1+3+4+5+6+8 Ab [Presence] in Serum |
| 29525-3 | Aconitate/Creatinine [Molar ratio] in Urine |
| 4991-6 | Borrelia burgdorferi DNA [Presence] in Specimen by NAA with probe detection |
| 49923-6 | Lymphocyte proliferation stimulated by pokeweed mitogen in Blood |
| 4062-6 | Tranylcypromine [Mass/volume] in Urine |
| 40672-8 | Sucrose [Presence] in Stool |
| 30056-6 | Glutamine/Creatinine [Ratio] in Urine |
| 30078-0 | Weight of Stool |
| 30267-9 | Glucose [Moles/volume] in Serum or Plasma --2.3 hours post dose glucose |
| 19177-5 | Alpha-1-Fetoprotein [Moles/volume] in Serum or Plasma |
| 20516-1 | Amitriptyline+Nortriptyline [Mass/volume] in Urine by Confirmatory method |
| 20571-6 | Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by Probe with signal amplification |
| 100871-3 | Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method |
| 12533-6 | Thiazolidine-2-Thione-4-Carboxylic acid [Mass/volume] in Urine |
| 12899-1 | Acetylene [Mass/volume] in Serum or Plasma |
| 101993-4 | Kynurenate [Mass Ratio] in Urine |
| 102179-9 | Berlin Beetle IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102648-3 | Black Walnut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14113-5 | CD56 cells [#/volume] in Blood |
| 14372-7 | Erythrocytes [#/volume] in Gastric fluid by Manual count |
| 14656-3 | cloZAPine [Moles/volume] in Serum or Plasma |
| 14676-1 | Cortisol Free [Moles/time] in 24 hour Urine |
| 103141-8 | Staphylococcus aureus MLVA complex [Type] in Isolate or Specimen by Molecular genetics method |
| 15053-2 | Dehydroepiandrosterone sulfate (DHEA-S) [Moles/time] in 24 hour Urine |
| 10511-4 | Serotonin Ag [Presence] in Tissue by Immune stain |
| 10610-4 | Spermatozoa Duplicate Tail/100 spermatozoa in Semen |
| 15397-3 | Trypanosoma cruzi IgM Ab [Titer] in Serum |
| 10958-7 | Virginia Scrub Pine IgE Ab [Units/volume] in Serum |
| 1110-6 | Le sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 17158-7 | CD45RB cells/100 cells in Blood |
| 18920-9 | Erythromycin+Sulfisoxazole [Susceptibility] |
| 90326-0 | Porcine circovirus type 2d DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 7554-9 | Oregano triggered histamine release [Units/volume] in Blood |
| 76075-1 | Galactomannan Ag [Units/volume] in Bronchoalveolar lavage |
| 7618-2 | Plum Pollen IgE Ab [Units/volume] in Serum |
| 76625-3 | Alanine aminotransferase [Enzymatic activity/volume] in Blood |
| 77133-7 | LCA5 gene full mutation analysis in Blood or Tissue by Sequencing |
| 7760-2 | Wall pellitory IgE Ab [Units/volume] in Serum |
| 6328-9 | Brucella sp Ab [Titer] in Serum by Immunofluorescence |
| 7824-6 | Chlamydia trachomatis Ab [Units/volume] in Serum |
| 63385-9 | DNA double strand IgG Ab [Units/volume] in Body fluid by Flow cytometry (FC) |
| 63562-3 | Japanese encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
| 64961-6 | Apple recombinant (rMal d) 1 IgE Ab [Units/volume] in Serum |
| 79165-7 | OXcarbazepine trough and 10-hydroxycarbazepine panel - Serum or Plasma |
| 79317-4 | L-2-hydroxyglutarate [Moles/volume] in Cerebral spinal fluid |
| 95169-9 | Infectious bronchitis virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 9551-3 | Legionella pneumophila 5 IgM Ab [Titer] in Serum by Immunofluorescence |
| 96274-6 | American Beech wood dust IgE Ab [Units/volume] in Serum |
| 96567-3 | Toxocara sp IgG Ab [Presence] in Ocular fluid by Immunoassay |
| 69354-9 | HIV 2 RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 69380-4 | t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method |
| 69926-4 | European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay |
| 6996-3 | Ceftibuten [Susceptibility] by Gradient strip |
| 81716-3 | DNA double strand Ab [Presence] in Serum by Line blot |
| 97589-6 | Dextromethorphan+Levomethorphan [Presence] in Cord tissue by Confirmatory method |
| 7070-6 | Almond IgG Ab [Units/volume] in Serum |
| 71628-2 | Macrophages/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
| 99458-2 | Rabbit urine proteins IgG Ab [Mass/volume] in Serum |
| 85991-8 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum |
| 7316-3 | Flounder IgE Ab [Units/volume] in Serum |
| 86721-8 | Actinobacillus pleuropneumoniae serotype identified in Isolate by NAA with probe detection |
| 87442-0 | Turbidity of Water |
| 73513-4 | Atorvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73905-2 | HIV 1+2 IgG Ab [Presence] in Serum or Plasma by Rapid immunoassay |
| 88913-9 | Strongyloides stercoralis DNA [Presence] in Stool by NAA with probe detection |
| 41277-5 | Gross blood [Presence] of Body fluid Qualitative |
| 59634-6 | cloBAZam [Mass/mass] in Tissue by Confirmatory method |
| 50772-3 | Ganglioside GQ1b IgG Ab/IgM Ab [Ratio] in Serum by Immunoassay |
| 50994-3 | CMT demyelinating gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 51010-7 | CD3-CD16+CD56+CD244+ cells/100 cells in Blood |
| 30474-1 | Glutarate [Presence] in Urine |
| 21536-8 | Acid sphingomyelinase [Enzymatic activity/volume] in Blood |
| 31194-4 | Microscopic observation [Identifier] in Submandibular fine needle aspirate by Cyto stain |
| 31421-1 | Highlands J virus Ab [Units/volume] in Serum |
| 5128-4 | Neutrophil cytoplasmic Ab [Units/volume] in Serum |
| 43166-8 | Carbon.organic [Mass/volume] in Specimen |
| 43182-5 | Smith extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
| 22298-4 | Epstein Barr virus nuclear IgG Ab [Titer] in Serum |
| 51467-9 | Plasmodium falciparum IgG Ab [Titer] in Serum |
| 51723-5 | Fungus [Presence] in Specimen by Organism specific culture |
| 22659-7 | Isoleucine [Moles/volume] in Cerebral spinal fluid |
| 52814-1 | Appearance of Spun Peritoneal fluid |
| 23068-0 | Equine arteritis virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 53115-2 | Immature granulocytes [#/volume] in Blood by Automated count |
| 53233-3 | Carnitine free (C0)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 23583-8 | Western equine encephalitis virus Ab [Presence] in Serum by Agglutination |
| 33292-4 | Herpes simplex virus 1+2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 33370-8 | Variant lymphocytes/100 leukocytes in Pleural fluid |
| 44933-0 | Specific gravity of 24 hour Urine by Refractometry |
| 45208-6 | Hemoglobin A [Presence] in Blood by Electrophoresis |
| 4566-6 | Hemoglobin Chesapeake [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 34351-7 | Pentacarboxylporphyrins [Mass/mass] in Stool |
| 34672-6 | Immunoelectrophoresis panel - 24 hour Urine |
| 55419-6 | Home drug screening panel - Urine |
| 55429-5 | Short blood count panel - Blood |
| 56214-0 | Acremonium sp IgG4 Ab [Mass/volume] in Serum |
| 56322-1 | Aedes mosquito IgG4 Ab [Mass/volume] in Serum |
| 56443-5 | Rye IgG4 Ab [Mass/volume] in Serum |
| 56464-1 | Sage IgG4 Ab [Mass/volume] in Serum |
| 2643-5 | N-acetyl-beta-glucosaminidase [Enzymatic activity/volume] in Serum |
| 26631-2 | Borrelia hermsii Ab [Presence] in Serum |
| 26717-9 | Phosphoethanolamine [Moles/volume] in Blood |
| 35793-9 | Dirithromycin [Susceptibility] by Disk diffusion (KB) |
| 35847-3 | Tiamulin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 3686-3 | hydrOXYzine [Mass/volume] in Serum or Plasma |
| 37424-9 | Perchlorate [Mass/volume] in Specimen by HPLC |
| 56575-4 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 38416-4 | Parasite identified in Body fluid by Inspection |
| 4905-6 | HLA-Dw2 [Presence] |
| 49228-0 | Porphobilinogen deaminase [Enzymatic activity/mass] in Red Blood Cells |
| 39084-9 | Rough Marsh Elder IgE Ab/IgE total in Serum |
| 57861-7 | HYDROcodone [Moles/volume] in Specimen |
| 49728-9 | Neurokinin A [Mass/volume] in Serum or Plasma |
| 49752-9 | Buprenorphine [Mass/volume] in Urine by Confirmatory method |
| 40115-8 | Creatinine [Moles/volume] in Serum or Plasma --45 minutes pre XXX challenge |
| 40172-9 | Glucose [Moles/volume] in Serum or Plasma --9.5 hours post XXX challenge |
| 5880-0 | Rotavirus Ag [Presence] in Stool by Immunoassay |
| 29651-7 | Rickettsia honei Ab [Presence] in Serum by Immunofluorescence |
| 29760-6 | Bilirubin.conjugated [Moles/volume] in Serum or Plasma |
| 40562-1 | Actin muscle specific Ag [Presence] in Tissue by Immune stain |
| 40709-8 | Polio virus Ab [Units/volume] in Cerebral spinal fluid |
| 30044-2 | Dirofilaria immitis Ab [Titer] in Serum |
| 40749-4 | Echinococcus sp Ab [Presence] in Serum by Complement fixation |
| 1995-0 | Calcium.ionized [Moles/volume] in Serum or Plasma |
| 100677-4 | Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 12859-5 | HIV 1 p18 Ab [Presence] in Serum by Immunoblot |
| 1316-9 | S Ab [Presence] in Serum or Plasma from Donor |
| 102078-3 | CAR-T therapy panel - Specimen |
| 1375-5 | Calcitonin [Mass/volume] in Serum or Plasma --4 hours post 15 mg/kg calcium gluconate IV |
| 13915-4 | Adenovirus IgM Ab [Titer] in Serum |
| 102501-4 | Peanut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1438-1 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 40 ug corticotropin IM BID 3 day |
| 14388-3 | Amylase [Enzymatic activity/volume] in Synovial fluid |
| 14651-4 | cloBAZam [Moles/volume] in Serum or Plasma |
| 104322-3 | Lambda lymphocytes/100 lymphocytes in Bone marrow |
| 15449-2 | Avian paramyxovirus 2 Ab [Titer] in Serum by Hemagglutination inhibition |
| 16468-1 | Bismuth [Presence] in Urine |
| 11164-1 | Cream Cheese IgE Ab [Units/volume] in Serum |
| 11174-0 | Grain weevel IgE Ab [Units/volume] in Serum |
| 17414-4 | Parainfluenza virus 1+2+3 Ag [Presence] in Specimen |
| 17693-3 | Testosterone [Mass/volume] in Serum or Plasma --4 days post XXX challenge |
| 90737-8 | CD24-FLAER- cells/100 cells.CD15 (Neutrophils) in Blood |
| 91049-7 | Cocaine+Benzoylecgonine [Presence] in Tissue by Screen method |
| 91684-1 | Histoplasma capsulatum H and M Ab panel - Cerebral spinal fluid |
| 92696-4 | Gastrointestinal viral pathogens panel - Stool by NAA with probe detection |
| 92758-2 | 7-Alpha,12-alpha dihydroxycholest-4-en-3-one [Moles/volume] in Serum or Plasma |
| 60461-1 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 6088-9 | Cultivated Cotton IgE Ab [Units/volume] in Serum |
| 76042-1 | levoFLOXacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 92906-7 | MET gene copy number/nucleus in Blood or Tissue by FISH |
| 77344-0 | Colony count [#/volume] in Implanted device by Culture |
| 77635-1 | C9orf72 gene GGGGCC repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 6280-2 | Whitefaced Hornet IgE Ab [Units/volume] in Serum |
| 9447-4 | Heptacarboxylporphyrin [Mass/volume] in Serum or Plasma |
| 94475-1 | Borrelia burgdorferi IgA and IgG and IgM [Interpretation] in Cerebral spinal fluid |
| 94506-3 | SARS-CoV-2 (COVID-19) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 95125-1 | SARS-CoV-2 (COVID-19) IgA+IgM [Presence] in Serum or Plasma by Immunoassay |
| 8043-2 | Trichinella spiralis IgG Ab [Presence] in Serum |
| 9618-0 | Cholesterol [Mass/volume] in Pleural fluid |
| 9640-4 | Androstanediol [Mass/volume] in Serum or Plasma |
| 68421-7 | Monocytes [#/volume] in Peritoneal fluid by Manual count |
| 68902-6 | Erythrocytes [#/volume] by Light microscopy in Urine sediment collected for unspecified duration |
| 96535-0 | Tick-borne encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay |
| 69770-6 | Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Cerebral spinal fluid |
| 7004-5 | Clinafloxacin [Susceptibility] by Gradient strip |
| 817-7 | A Ab [Presence] in Serum or Plasma |
| 82063-9 | Food Allergen Mix 24 (Kiwi+Hazelnut+Banana+Shrimp) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 71604-3 | Monocytes/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count |
| 85548-6 | PRRSV European strain neutralizing antibody [Titer] in Serum by Neutralization test |
| 99542-3 | Stenosis degree [Length fraction] in Middle left circumflex artery by Autopsy |
| 72518-4 | CHEK2 gene c.470C>T and 1100delC [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 73571-2 | Osmol gap of Stool |
| 88563-2 | Parainfluenza virus 1 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 73957-3 | UR-144 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood |
| 50879-6 | Methyl ethyl ketone [Moles/volume] in Body fluid |
| 30552-4 | Pyridoxal phosphate [Mass/volume] in Serum or Plasma |
| 31137-3 | Cocaine [Mass/volume] in Bile fluid |
| 42493-7 | Catecholamines Free fractionated [Mass/volume] in Plasma |
| 5110-2 | Coxsackievirus B4 Ab [Titer] in Serum by Complement fixation |
| 32022-6 | Hydroxyproline Free [Moles/volume] in 24 hour Urine |
| 51888-6 | Rh immune globulin units given [#] |
| 43621-2 | Actinomyces bovis Ab [Presence] in Serum |
| 32136-4 | Antidepressants [Presence] in Urine |
| 32363-4 | JC virus DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 52754-9 | Kininogen HMW activity actual/normal in Platelet poor plasma by Coagulation assay |
| 23188-6 | Leptospira interrogans Ab [Presence] in Serum by Agglutination |
| 44619-5 | Length of tissue core(s) |
| 44814-2 | Coxiella burnetii phase 2 IgM Ab [Titer] in Serum by Immunofluorescence |
| 23424-5 | Salmonella enteritidis IgG Ab [Presence] in Serum by Immunoassay |
| 53763-9 | Cytomegalovirus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
| 53810-8 | Lymphocyte proliferation [Interpretation] in Blood |
| 53902-3 | Voriconazole [Mass/volume] in Cerebral spinal fluid |
| 54178-9 | Econazole [Susceptibility] by Disk diffusion (KB) |
| 54211-8 | Cortisol [Moles/volume] in Serum or Plasma --24 hours post dose dexamethasone |
| 46253-1 | Bordetella pertussis filamentous hemagglutinin IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 46956-9 | predniSONE [Mass/volume] in Urine |
| 34476-2 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
| 47464-3 | Legionella pneumophila 12 IgM Ab [Titer] in Serum |
| 255-0 | 5-Fluorocytosine [Susceptibility] by Serum bactericidal titer |
| 55652-2 | Ceftiofur [Susceptibility] by Gradient strip |
| 55913-8 | Aspartate [Moles/mass] in Hair |
| 56040-9 | Methemoglobin [Moles/volume] in Blood |
| 47553-3 | Alanine/Amino acids.total in Cerebral spinal fluid |
| 47858-6 | Gentisate/Creatinine [Molar ratio] in Urine |
| 26004-2 | Vanillylmandelate/Creatinine [Molar ratio] in 24 hour Urine |
| 48272-9 | Ciprofloxacin triggered leukotriene release [Mass/volume] by Leukocytes |
| 26585-0 | 3-Methylhistidine [Moles/volume] in Cerebral spinal fluid |
| 26766-6 | Bacteroides fragilis IgG Ab [Units/volume] in Serum |
| 56880-8 | TCRB gene+TCRD gene+TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 26916-7 | Cobalamin (Vitamin B12) [Presence] in Blood |
| 38640-9 | Bromine [Mass/volume] in Air |
| 4971-8 | HLA-DR53 [Presence] |
| 2857-1 | Prostate specific Ag [Mass/volume] in Serum or Plasma |
| 28588-2 | Beta alanine/Creatinine [Ratio] in Urine |
| 2900-9 | Pyridoxine [Mass/volume] in Serum or Plasma |
| 29147-6 | Carbamazepine 10,11-Epoxide.bound [Mass/volume] in Serum or Plasma |
| 40208-1 | Glucose [Moles/volume] in Serum or Plasma --22 minutes post XXX challenge |
| 58542-2 | Corticotropin [Moles/volume] in Plasma --12 AM specimen |
| 58760-0 | Epstein Barr virus capsid IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 50594-1 | 3-Hydroxybenzoylecgonine [Mass/volume] in Urine by Confirmatory method |
| 29981-8 | Tin/Creatinine [Mass Ratio] in 24 hour Urine |
| 30018-6 | Borrelia burgdorferi 30kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
| 30205-9 | Chlamydophila pneumoniae Ab [Presence] in Serum |
| 20608-6 | CD41 cells/100 cells in Specimen |
| 20789-4 | Escherichia coli serotype [Identifier] in Isolate |
| 100393-8 | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum |
| 12827-2 | Prolactin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 101664-1 | in Blood or Tissue by FISH |
| 13629-1 | Interleukin 1 beta [Mass/volume] in Serum or Plasma |
| 13983-2 | Gamma globulin/Protein.total in Serum or Plasma by Electrophoresis |
| 1030-6 | Fy sup(b) Ab [Presence] in Serum or Plasma |
| 14640-7 | Carbon dioxide, total [Moles/volume] in Dialysis fluid |
| 14771-0 | Fasting glucose [Moles/volume] in Serum or Plasma |
| 16162-0 | Parathyrin.intact [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 10947-0 | Persimmon IgE Ab [Units/volume] in Serum |
| 16720-5 | Dechlorane [Presence] in Blood |
| 16843-5 | Ethanol [Mass/volume] in Body fluid |
| 16967-2 | Hexokinase 1 [Enzymatic activity/volume] in Red Blood Cells |
| 17323-7 | Neisseria meningitidis Ag [Presence] in Urine |
| 17551-3 | Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 74846-7 | Snowshoe hare virus IgM Ab [Presence] in Serum by Immunofluorescence |
| 75381-4 | TTR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 92968-7 | Methicillin resistance mecA+mecC genes [Presence] in Isolate or Specimen by Molecular genetics method |
| 61381-0 | Human papilloma virus 51 DNA [Presence] in Specimen by NAA with probe detection |
| 61429-7 | Tapentadol/Creatinine [Mass Ratio] in Urine |
| 62468-4 | 1,3 beta glucan [Mass/volume] in Specimen |
| 78751-5 | 11-Hydroxy delta-9 tetrahydrocannabinol [Mass/mass] in Hair |
| 94400-9 | Protein.monoclonal [Presence] in Serum or Plasma |
| 94402-5 | ANKK1 gene c.2137G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 94478-5 | Bordetella pertussis.pertussis toxin promoter region [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 94663-2 | Coccidioides immitis IgM Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
| 78883-6 | Triazolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 79252-3 | Nordiazepam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 9496-1 | Brucella canis IgM Ab [Units/volume] in Serum by Immunoassay |
| 95285-3 | RAB7A gene full mutation analysis in Blood or Tissue by Sequencing |
| 95553-4 | 5p15.2 (5p-) chromosome deletion [Identifier] in Blood or Tissue by FISH |
| 95702-7 | Powassan virus IgA Ab [Presence] in Specimen by Immunoassay |
| 9587-7 | Borrelia burgdorferi 41kD IgM Ab [Presence] in Serum by Immunoblot |
| 6778-5 | IgA [Mass/volume] in Urine by Electrophoresis |
| 6905-4 | Propafenone [Mass/volume] in Serum or Plasma |
| 96730-7 | Calcified elastic fibers [#/volume] in Lower respiratory specimen by Manual count |
| 69953-8 | PCA-1 IgG Ab [Presence] in Serum by Immunoassay |
| 82173-6 | Parainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 70147-4 | Methadone [Mass/volume] in Urine by Screen method |
| 7147-2 | Sugar Beet IgE Ab [Units/volume] in Serum |
| 98196-9 | Echinacea IgE Ab [Units/volume] in Serum |
| 98414-6 | lamoTRIgine [Presence] in Urine by Confirmatory method |
| 99463-2 | Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgG Ab [Mass/volume] in Serum |
| 99529-0 | Volume of Pleural space - right |
| 7286-8 | Dog epithelium triggered histamine release [Units/volume] in Blood |
| 86094-0 | Streptococcus pneumoniae Danish serotype 3 Ab [Mass/volume] in Serum --2nd specimen |
| 86165-8 | Streptococcus pneumoniae Danish serotype 9N Ab [Presence] in Serum |
| 73048-1 | ceFAZolin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73853-4 | Aldosterone-18-glucuronide [Moles/volume] in 24 hour Urine |
| 74127-2 | Akt1 phosphate Ag [Presence] in Tissue by Immune stain |
| 89635-7 | Mycobacterium tuberculosis DNA [Presence] in Implanted device by NAA with probe detection |
| 41225-4 | West Nile virus Ab [Titer] in Serum |
| 59601-5 | Alpha hydroxyalprazolam [Mass/volume] in Body fluid |
| 59631-2 | cloBAZam [Mass/mass] in Meconium by Confirmatory method |
| 59643-7 | Cocaethylene [Mass/volume] in Serum or Plasma by Confirmatory method |
| 42353-3 | Cefepime+Clavulanate [Susceptibility] |
| 59926-6 | Mesoridazine [Moles/volume] in Gastric fluid |
| 21190-4 | Chlamydia trachomatis DNA [Presence] in Cervix by NAA with probe detection |
| 31200-9 | Histoplasma capsulatum IgG Ab [Presence] in Serum |
| 31257-9 | Beta tubulin IgG Ab [Units/volume] in Serum |
| 51310-1 | CD4+CD7-CD26- cells/100 cells in Body fluid |
| 31782-6 | Coccidioides immitis Ag [Presence] in Isolate |
| 51750-8 | Pyruvate [Moles/volume] in Arterial blood |
| 22354-5 | Histoplasma capsulatum mycelial phase Ab [Units/volume] in Serum |
| 22505-2 | Measles virus IgM Ab [Titer] in Cerebral spinal fluid |
| 22538-3 | Shigella dysenteriae Ab [Titer] in Serum |
| 51964-5 | Drug efficacy analysis overall interpretation |
| 23139-9 | Infectious bursal disease virus Ab [Titer] in Serum |
| 44411-7 | Taurine/Creatinine [Mass Ratio] in 24 hour Urine |
| 33590-1 | Neuronal nuclear IgG Ab [Units/volume] in Cerebral spinal fluid |
| 5372-8 | Striated muscle Ab [Titer] in Serum by Immunofluorescence |
| 53805-8 | LDL apheresis procedure [Type] |
| 53830-6 | CD55 deficient Granulocytes/100 cells in Blood |
| 23963-2 | Brucella abortus IgG Ab [Titer] in Cerebral spinal fluid |
| 34254-3 | Cadmium [Moles/volume] in 24 hour Urine |
| 54343-9 | 3-Methoxytyramine/Creatinine [Mass Ratio] in 24 hour Urine |
| 54361-1 | Bicarbonate [Moles/volume] in Pleural fluid |
| 54463-5 | Malonylcarnitine (C3-DC) [Moles/volume] in Urine |
| 24422-8 | Hydrocarbons.chlorinated [Identifier] in Specimen |
| 2463-8 | IgE.monoclonal [Mass/volume] in Serum |
| 34287-3 | Estradiol (E2) [Moles/volume] in 24 hour Urine |
| 55388-3 | Insulin [Moles/volume] in Serum or Plasma --4 hours post XXX challenge |
| 25285-8 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 55826-2 | Allo-tetrahydrocortisol [Mass/volume] in 24 hour Urine |
| 47682-0 | Leucine/Amino acids.total in Amniotic fluid |
| 47916-2 | Somatotropin [Units/volume] in Serum or Plasma --3 hours post dose glucagon |
| 48187-9 | Chloramin T triggered leukotriene release [Mass/volume] by Leukocytes |
| 48285-1 | Propofol triggered leukotriene release [Mass/volume] by Leukocytes |
| 48751-2 | 3-Hydroxypalmitate.free (3-OH-C16:0) [Moles/volume] in Serum or Plasma |
| 48887-4 | Bartonella vinsonii berkhoffii IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 27196-5 | HYDROmorphone Free [Mass/volume] in Vitreous fluid |
| 27206-2 | Morphine Free [Mass/volume] in Vitreous fluid |
| 27211-2 | Norpropoxyphene [Mass/mass] in Hair |
| 38398-4 | Crystals [type] in Pericardial fluid by Light microscopy |
| 38434-7 | Ibuprofen [Mass/volume] in Serum or Plasma --3 hours post dose |
| 38516-1 | Terminal deoxyribonucleotidyl transferase cells/100 cells in Specimen by Immunoassay |
| 57639-7 | Androsterone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
| 38699-5 | 1,1-Dichloroethane [Mass/volume] in Air |
| 57953-2 | Ethisterone [Presence] in Urine |
| 29381-1 | Meprobamate [Mass/volume] in Gastric fluid |
| 39960-0 | Creatinine [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 40123-2 | Creatinine [Moles/volume] in Serum or Plasma --12 hours post XXX challenge |
| 40129-9 | Creatinine [Moles/volume] in Urine --pre XXX challenge |
| 40162-0 | Glucose [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
| 49831-1 | Normorphine [Mass/volume] in Urine |
| 49948-3 | Somatotropin [Units/volume] in Serum or Plasma --12 PM specimen |
| 2978-5 | Superoxide dismutase [Enzymatic activity/volume] in Plasma |
| 50186-6 | Wine vinegar IgE Ab [Units/volume] in Serum |
| 30352-9 | Hemoglobin [Mass/volume] in Capillary blood |
| 19308-6 | Thiazides cutoff [Mass/volume] in Urine for Screen method |
| 20892-6 | Mycobacterium avium ss paratuberculosis [Presence] in Tissue by Organism specific culture |
| 21026-0 | Pathologist interpretation of Blood tests |
| 21037-7 | 17-Hydroxypregnenolone [Mass/time] in 24 hour Urine |
| 100886-1 | Orf virus DNA [Presence] in Specimen by NAA with probe detection |
| 101354-9 | Borrelia afzelii+burgdorferi+garinii IgG+IgM Ab [Presence] in Serum by Immunoassay |
| 13840-4 | CD19 blasts/100 blasts in Blood |
| 102861-2 | Aspergillus fumigatus IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14520-1 | Pneumocystis jiroveci Ag [Presence] in Nose by Immunofluorescence |
| 103615-1 | Erlotinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose |
| 103627-6 | Streptococcus pyogenes DNA [Presence] in Specimen by NAA with probe detection |
| 103828-0 | 1-Hydroxymidazolam [Presence] in Meconium |
| 15204-1 | Rheumatoid factor [Titer] in Serum by Nephelometry |
| 10451-3 | Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting |
| 15237-1 | Occupational Allergen Mix 3 (Alternaria alternata+Aspergillus fumigatus+rye pollen+wheat pollen) IgE Ab [Presence] in Serum by Multidisk |
| 1619-6 | Prolactin [Mass/volume] in Serum or Plasma --pre dose L-dopa PO |
| 11070-0 | Microscopic observation [Identifier] in Urine by Cyto stain |
| 16362-6 | Ammonia [Moles/volume] in Plasma |
| 16917-7 | Glutamine [Presence] in Urine |
| 18266-7 | CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Body fluid |
| 90001-9 | Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Nose by NAA with probe detection |
| 90078-7 | Yeast identified in Isolate by Organism specific culture |
| 90232-0 | Histoplasma capsulatum Ab [Identifier] in Serum or Plasma by Immune diffusion (ID) |
| 90463-1 | Adenovirus DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 74755-0 | Placental growth factor [Mass/volume] in Serum |
| 75000-0 | Coproporphyrin 3/Coproporphyrin.total in 24 hour Urine |
| 751-8 | Neutrophils [#/volume] in Blood by Automated count |
| 76085-0 | Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with probe detection |
| 77189-9 | Zirconium/Creatinine [Molar ratio] in Urine |
| 93986-8 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --15 minutes post dose carbohydrate |
| 62427-0 | Bordetella holmesii DNA [Presence] in Specimen by NAA with probe detection |
| 63257-0 | Ganglioside GT1b IgG Ab [Presence] in Serum by Immunoassay |
| 6352-9 | Chlamydia trachomatis Ag [Presence] in Stool by Immunofluorescence |
| 6397-4 | Entamoeba histolytica Ag [Units/volume] in Serum by Immunoassay |
| 79406-5 | IgM clearance/Albumin clearance [Ratio] in Serum and CSF |
| 95429-7 | SARS-CoV-2 (COVID-19) IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 7996-2 | Rickettsia prowazekii RNA [Presence] in Serum by NAA with probe detection |
| 9569-5 | Nocardia sp IgG Ab [Units/volume] in Serum |
| 95786-0 | Gene XXX mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 80589-5 | Influenza virus A H1 HA gene [Presence] in Nasopharynx by NAA with probe detection |
| 80704-0 | CD27+CD45RA+ cells/100 CD3+CD4+ cells in Blood |
| 80967-3 | Theophylline free [Mass/volume] in Serum or Plasma |
| 81104-2 | Leptospira interrogans sv Medanensis Ab [Titer] in Serum by Agglutination |
| 97314-9 | Vibrio cholerae DNA [Presence] in Stool by NAA with probe detection |
| 71-1 | Cefatrizine [Susceptibility] by Minimum lethal concentration (MLC) |
| 82440-9 | SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot |
| 85047-9 | MBL by meropenem to meropenem-EDTA IC ratio [Presence] by ARD gradient strip |
| 85759-9 | Streptococcus pneumoniae Danish serotypes 11A+11D DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 99706-4 | Hepatocellular carcinoma screening [Interpretation] based on clinical and lab data |
| 73259-4 | Montelukast induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86700-2 | Rotavirus C RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 87337-2 | Porcine circovirus type 2 RFLP pattern [Type] in Isolate by RFLP |
| 73991-2 | 2,2',5,5'-Tetrachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
| 895-3 | Blood group antibody screen.cells I+II+III [Presence] in Serum or Plasma |
| 41236-1 | West Nile virus IgG Ab [Presence] in Cerebral spinal fluid |
| 59663-5 | Diclofenac [Mass/volume] in Urine |
| 59836-7 | Mycoplasma sp+Ureaplasma urealyticum DNA [Presence] in Specimen by NAA with probe detection |
| 42244-4 | Hemoglobin A/Hemoglobin.total in Blood by HPLC |
| 21320-7 | Haemophilus influenzae B Ag [Presence] in Specimen by Latex agglutination |
| 31452-6 | Lassa virus IgG Ab [Units/volume] in Serum |
| 51329-1 | CD43 cells/100 cells in Tissue |
| 4288-7 | Insulin semilente [Mass] of Dose |
| 43044-7 | Eastern equine encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid |
| 4328-1 | MethylePHEDrine [Mass] of Dose |
| 22603-5 | Varicella zoster virus IgG Ab [Units/volume] in Serum --1st specimen |
| 53016-2 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Serum |
| 43946-3 | CD4+CD45RO+ cells/100 cells in Cerebral spinal fluid |
| 22847-8 | Babesia bovis Ab [Presence] in Serum |
| 22951-8 | Brucella suis Ab [Presence] in Serum |
| 53194-7 | Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in DBS |
| 44686-4 | Invasive melanoma.location relative to closest uninvolved lateral margin in Skin melanoma |
| 33647-9 | Protein.monoclonal/Protein.total in Serum or Plasma by Electrophoresis |
| 4503-9 | Complement C4b binding protein [Mass/volume] in Serum or Plasma |
| 23988-9 | Burkholderia pseudomallei IgG Ab [Titer] in Serum by Immunofluorescence |
| 4612-8 | Hemoglobin Malmo [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 46236-6 | HLA-B*51 [Type] in Leukocytes |
| 46946-0 | Betamethasone [Mass/volume] in Urine |
| 2472-9 | IgM [Mass/volume] in Serum or Plasma |
| 34399-6 | Buccal mucosa Ab [Titer] in Serum by Immunofluorescence |
| 34417-6 | Protoporphyrin.zinc [Mass/mass] in Red Blood Cells |
| 55100-2 | Respiratory syncytial virus [Presence] in Specimen by Organism specific culture |
| 47055-9 | Legionella pneumophila 11 IgG Ab [Titer] in Serum by Immunofluorescence |
| 47349-6 | Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum by Immunoassay |
| 25404-5 | Ethambutol [Presence] in Serum or Plasma |
| 3494-2 | clonazePAM [Mass/volume] in Serum or Plasma |
| 4755-5 | HLA-B w4 [Presence] |
| 35564-4 | HIV 1 p31+p32 Ab [Presence] in Serum by Immunoblot |
| 26576-9 | Anserine/Creatinine [Molar ratio] in Urine |
| 35826-7 | Orbifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 3607-9 | Ethambutol [Mass/volume] in Serum or Plasma |
| 3610-3 | Ethchlorvynol [Mass/volume] in Serum or Plasma |
| 36922-3 | TPMT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 3724-2 | LORazepam [Mass/volume] in Serum or Plasma |
| 27242-7 | Secobarbital [Mass/mass] in Stool |
| 3841-4 | Nalbuphine [Mass/time] in 24 hour Urine |
| 38625-0 | Trichloroethylene [Mass/volume] in Air |
| 27909-1 | Calcium [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 27958-8 | Proinsulin [Moles/volume] in Serum or Plasma --4 hours post XXX challenge |
| 57962-3 | FECH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2880-3 | Protein [Mass/volume] in Cerebral spinal fluid |
| 40169-5 | Glucose [Moles/volume] in Serum or Plasma --8 hours post XXX challenge |
| 58565-3 | Corticotropin [Mass/volume] in Plasma --2.5 hours post dose insulin IV |
| 58613-1 | Corticotropin [Moles/volume] in Plasma --75 minutes post dose insulin IV |
| 50105-6 | 3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Amniotic fluid |
| 50140-3 | 3-Methoxytyramine [Moles/volume] in Serum or Plasma |
| 2957-9 | Sodium renal clearance in 24 hour Urine and Serum or Plasma |
| 40576-1 | Yersinia enterocolitica O:8 Ab [Titer] in Serum by Agglutination |
| 40684-3 | Acinetobacter sp multidrug resistant identified in Specimen by Organism specific culture |
| 58818-6 | Estrogen [Mass/volume] in Serum or Plasma --2nd specimen |
| 50516-4 | Lutropin [Units/volume] in Serum or Plasma --8th specimen |
| 30185-3 | Epidermal Allergen Mix 1 (Cat dander+Cow dander+Dog dander+Horse dander) IgE Ab [Units/volume] in Serum by Multidisk |
| 41144-7 | HIV 1 Ab [Presence] in Saliva (oral fluid) |
| 19497-7 | Hydroxytriazolam [Presence] in Urine by Screen method |
| 12466-9 | Alpha 1 antitrypsin [Mass/volume] in Amniotic fluid by Nephelometry |
| 101542-9 | Bacterial versus viral etiology indicator panel - Serum, Plasma or Blood |
| 13381-9 | Tyrosine [Mass/volume] in Cerebral spinal fluid |
| 102458-7 | Blue mussel IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102550-1 | Rabbit meat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13959-2 | Calcium.ionized [Moles/volume] in Serum or Plasma by calculation |
| 14351-1 | Specific gravity of Stool by Refractometry |
| 14626-6 | Beta-2-Microglobulin [Moles/volume] in Serum |
| 14702-5 | Disopyramide [Moles/volume] in Serum or Plasma |
| 14721-5 | Ethylene glycol [Moles/volume] in Serum or Plasma |
| 103659-9 | Cells.chromosome Y deletion/Cells counted in Blood or Marrow by FISH |
| 10910-8 | Borate [Mass/volume] in Urine |
| 11529-5 | Surgical pathology study |
| 1842-4 | Ammonia [Moles/volume] in Urine |
| 90801-2 | Thyrotropin [Units/volume] in Serum or Plasma --6 hours post dose levothyroxine |
| 7488-0 | Mayfly triggered histamine release [Units/volume] in Blood |
| 92520-6 | Sc1 Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 92699-8 | Candida sp DNA [Presence] in Vaginal fluid by Probe |
| 7508-5 | Mucor racemosus triggered histamine release [Units/volume] in Blood |
| 75115-6 | Palmitate (C16:0) [Entitic substance] in Red Blood Cells |
| 7515-0 | Mushroom IgG Ab [Units/volume] in Serum |
| 75214-7 | Arginine/Ornithine [Molar ratio] in DBS |
| 60362-1 | Asparagus IgG Ab [Mass/volume] in Serum |
| 60406-6 | Spinach IgG Ab [Mass/volume] in Serum |
| 60408-2 | Mandarin IgG Ab [Mass/volume] in Serum |
| 92974-5 | Klebsiella aerogenes DNA [NCncRange] in Sputum by NAA with non-probe detection |
| 93393-7 | Proteus sp DNA [Presence] by NAA with probe detection in Positive blood culture |
| 62316-5 | Acid sphingomyelinase [Enzymatic activity/volume] in DBS |
| 77735-9 | Mycobacterium abscessus complex clarithromycin resistance erm(41) truncated gene [Presence] by Molecular method |
| 78016-3 | HLA-DRB [Type] by Low resolution |
| 78699-6 | Liver fibrosis score panel - Serum or Plasma Calculated by FibroMeter |
| 94307-6 | SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N1 |
| 63399-0 | Ribonucleoprotein extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 6424-6 | Heterophile Ab [Titer] in Serum by Agglutination |
| 95965-0 | Ethylparaben IgE Ab [Units/volume] in Serum |
| 96311-6 | Staphylococcus lugdunensis DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 96402-3 | Retinol binding protein/Creatinine [Mass Ratio] in Urine |
| 96474-2 | Rho GTPase-activating protein 26 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 68429-0 | Leukocytes other [#/volume] in Peritoneal fluid by Manual count |
| 8122-4 | CD3 cells [#/volume] in Blood |
| 8134-9 | CD57 cells/100 cells in Blood |
| 69366-3 | Bordetella pertussis IgA Ab [Presence] in Serum by Immunoblot |
| 69563-5 | Candida glabrata DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 6956-7 | Coxsackievirus A21 Ab [Titer] in Serum by Complement fixation |
| 69784-7 | 2-Hydroxysebacate [Moles/volume] in Cerebral spinal fluid |
| 70083-1 | Interleukin 4 [Mass/volume] in Cerebral spinal fluid |
| 82041-5 | Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab [Units/volume] in Serum by Multidisk |
| 7010-2 | Ethambutol [Susceptibility] by Gradient strip |
| 70257-1 | Sjogrens syndrome-A extractable nuclear 52kD IgG Ab [Units/volume] in Serum by Immunoassay |
| 82371-6 | Norbuprenorphine [Presence] in Urine by Screen method |
| 98997-0 | Haptoglobin/Protein.total in Serum or Plasma by Electrophoresis |
| 72431-0 | 4-Hydroxyphenylacetate [Moles/volume] in Cerebral spinal fluid |
| 7271-0 | Curvularia sp IgE Ab [Units/volume] in Serum |
| 7290-0 | Egg white triggered histamine release [Units/volume] in Blood |
| 85995-9 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 86057-7 | Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 87575-7 | Ergotamine [Mass/mass] in Specimen |
| 74401-1 | Lymphocytes [#/volume] in Cord blood |
| 89491-5 | Ethambutol [Susceptibility] by Genotype method |
| 41692-5 | Enoxacin [Susceptibility] by Gradient strip |
| 59687-4 | Hydroxyethylflurazepam [Mass/mass] in Stool by Confirmatory method |
| 50673-3 | Insulin XXX challenge panel - Serum |
| 50860-6 | Hydrogen ion [Moles/volume] in Arterial cord blood |
| 42187-5 | Number of specimens tested |
| 59959-7 | Promazine [Moles/volume] in Gastric fluid |
| 60192-2 | Topiramate [Mass/volume] in Blood |
| 31510-1 | Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum |
| 42786-4 | HER3 Ag [Presence] in Tissue by Immune stain |
| 43026-4 | Herpes simplex virus 2 IgM Ab [Presence] in Cerebral spinal fluid |
| 31735-4 | Bordetella bronchiseptica Ag [Presence] in Specimen |
| 31862-6 | Influenza virus A+B+C Ag [Presence] in Specimen |
| 31888-1 | Mumps virus Ag [Presence] in Cerebral spinal fluid |
| 31967-3 | Streptococcus agalactiae Ag [Presence] in Throat |
| 51522-1 | Lactate dehydrogenase 5/Lactate dehydrogenase.total in Cerebral spinal fluid by Electrophoresis |
| 51922-3 | Malt IgG Ab [Mass/volume] in Serum |
| 43387-0 | Neisseria sp identified in Specimen by Organism specific culture |
| 43620-4 | Actinomyces israelii Ab [Presence] in Serum |
| 32277-6 | Tyrosine [Moles/volume] in Body fluid |
| 5258-9 | Mycoplasma pneumoniae IgM Ab [Titer] in Serum by Immunofluorescence |
| 44097-4 | Unidentified cells/100 leukocytes in Blood |
| 22898-1 | Bovine diarrhea virus Ag [Presence] in Specimen by Immunofluorescence |
| 33002-7 | Spelt IgE Ab [Units/volume] in Serum |
| 53320-8 | Casts [Presence] in Urine by Automated |
| 44749-0 | Ganglioside GM1 IgA Ab [Presence] in Serum |
| 2362-2 | Glutamate [Mass/volume] in Cerebral spinal fluid |
| 53960-1 | Alpha-1-fetoprotein.tumor marker [Moles/volume] in Serum or Plasma |
| 45355-5 | Date Rh immune globulin given |
| 239-4 | Erythromycin+Sulfisoxazole [Susceptibility] by Serum bactericidal titer |
| 33771-7 | PL-12 Ab [Presence] in Serum |
| 4604-5 | Hemoglobin Lepore [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 46976-7 | Benzodiazepines [Presence] in Serum or Plasma by Screen method |
| 34415-0 | Normirtazapine [Mass/volume] in Serum or Plasma |
| 3443-9 | ceFAZolin [Mass/volume] in Serum or Plasma |
| 34493-7 | PRF1 gene targeted mutation analysis in Amniotic fluid by Molecular genetics method |
| 55197-8 | Transfusion status Qualitative |
| 55248-9 | HBB gene c.79G>A [Presence] in Blood by Molecular genetics method |
| 56029-2 | CD3-CD56+ cells/100 cells in Body fluid |
| 47679-6 | Leucine [Moles/volume] in DBS |
| 47898-2 | Somatotropin [Units/volume] in Serum or Plasma --2.25 hours post dose arginine+insulin |
| 25633-9 | Leishmania donovani Ab [Titer] in Serum |
| 56766-9 | Protein.monoclonal band 1/Protein.total in Serum or Plasma by Electrophoresis |
| 48511-0 | HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 copies/mL |
| 26861-5 | Gamma aminobutyrate [Moles/volume] in Amniotic fluid |
| 27114-8 | Cocaine [Mass/mass] in Hair |
| 57495-4 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --pre dose dexamethasone |
| 27300-3 | Mephentermine [Mass/volume] in Vitreous fluid |
| 57690-0 | Cortisol [Mass/volume] in Saliva (oral fluid) --10th specimen |
| 5822-2 | Yeast [#/area] in Urine sediment by Microscopy high power field |
| 5829-7 | Adenovirus Ag [Presence] in Tissue by Immunoassay |
| 58362-5 | Norbuprenorphine [Presence] in Urine by Confirmatory method |
| 40260-2 | Glucose [Mass/volume] in Serum or Plasma --10.75 hours post XXX challenge |
| 29692-1 | Orientia tsutsugamushi Litchfield Ab [Titer] in Serum |
| 29715-0 | Orientia tsutsugamushi Karp Ab [Titer] in Serum by Immunofluorescence |
| 40653-8 | Myelocytes/100 leukocytes in Body fluid by Manual count |
| 50232-8 | Leucine crystals [Presence] in Urine by Computer assisted method |
| 50423-3 | Cortisol [Mass/volume] in Serum or Plasma --40 minutes post 100 ug CRH IV |
| 50520-6 | Prolactin [Mass/volume] in Serum or Plasma --4th specimen |
| 41133-0 | Jamestown canyon virus Ab [Presence] in Specimen |
| 19436-5 | Propoxyphene + Norpropoxyphene [Mass/volume] in Urine |
| 19523-0 | LORazepam cutoff [Mass/volume] in Urine for Confirmatory method |
| 19741-8 | Hake IgE Ab [Units/volume] in Serum |
| 20805-8 | Epizootic hemorrhagic disease virus Ag [Units/mass] in Lung Qualitative by Immunofluorescence |
| 20838-9 | Herbicide [Presence] in Gastric fluid by Screen method |
| 125-5 | Cefprozil [Susceptibility] by Disk diffusion (KB) |
| 12579-9 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --4th specimen |
| 12903-1 | Renin [Enzymatic activity/volume] in Plasma --5th specimen post XXX challenge |
| 101641-9 | Myeloid sarcoma analysis in Blood or Tissue by FISH |
| 12986-6 | 2,5-Hexanedione [Mass/volume] in Blood |
| 13446-0 | Creatinine renal clearance/1.73 sq M in 4 hour Urine and Serum or Plasma |
| 13736-4 | Estradiol (E2)/Creatinine [Mass Ratio] in 24 hour Urine |
| 102239-1 | Cinnamon IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102585-7 | Sardine (pilchard) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102687-1 | Red Kidney Bean IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14568-0 | 17-Hydroxycorticosteroids [Moles/time] in 24 hour Urine |
| 10690-6 | Microsporidia identified in Duodenal fluid by Trichrome stain modified |
| 15271-0 | Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab [Presence] in Serum by Multidisk |
| 16140-6 | Tellurium [Mass/volume] in Blood |
| 10806-8 | Microscopic observation [Identifier] in Tissue by Schmorl stain |
| 11007-2 | Borrelia burgdorferi Ag [Units/volume] in Urine |
| 11059-3 | Phosphoglycerate kinase [Enzymatic activity/volume] in Red Blood Cells |
| 16380-8 | Androstenedione [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 16389-9 | Antidepressants [Identifier] in Serum or Plasma |
| 17128-0 | CD27 cells/100 cells in Blood |
| 17842-6 | Cancer Ag 27-29 [Units/volume] in Serum or Plasma |
| 1888-7 | Aquacobalamin [Mass/volume] in Serum or Plasma |
| 90461-5 | Herpes simplex virus 1+2 IgG Ab [Presence] in Serum by Immunoassay |
| 74880-6 | Hydroxyproline [Moles/volume] in DBS --post therapeutic diet |
| 75737-7 | Lysophosphatidylcholine(18:0) [Moles/volume] in Plasma |
| 75761-7 | Doxylamine [Presence] in Serum or Plasma or Urine by Screen method |
| 77621-1 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay |
| 77725-0 | Factor VIII+von Willebrand factor (vWf) ristocetin cofactor given [Units/volume] by vWF dosing |
| 63211-7 | Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence |
| 78830-7 | HYDROcodone [Z-score] in Urine |
| 94396-9 | Influenza virus A H1 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 94496-7 | Cell suspension [Volume] of Specimen |
| 78893-5 | Tricyclic antidepressants [Presence] in Gastric fluid |
| 7916-0 | Histoplasma capsulatum Ab [Units/volume] in Serum |
| 79461-0 | Hypoxanthine phosphoribosyltransferase [Enzymatic activity/substance] in Red Blood Cells |
| 95092-3 | Glucagon [Mass/volume] in Serum or Plasma --1.5 hours post meal |
| 6572-2 | Venezuelan equine encephalitis virus Ag [Presence] in Serum by Immunoassay |
| 95781-1 | ATP7B gene full mutation analysis in Blood or Tissue by Sequencing |
| 81873-2 | Chromosome region Xp22.33 AndOr Yp11.32 deletion and duplication mutation analysis in Blood or Tissue by MLPA |
| 82175-1 | Rhinovirus+Enterovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 70174-8 | Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Cerebral spinal fluid |
| 71654-8 | Myelocytes/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
| 98272-8 | Left pelvic lymph nodes examined [#] in Specimen |
| 71694-4 | Hemoglobin [Entitic mass] in Reticulocytes by Automated count |
| 85065-1 | Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose follitropin |
| 99543-1 | Stenosis degree [Length fraction] in Distal left circumflex artery by Autopsy |
| 86570-9 | Influenza virus B IgM Ab [Presence] in Serum by Immunoassay |
| 88735-6 | PM-SCL-100 Ab [Units/volume] in Serum by Line blot |
| 4160-8 | Cefonicid [Mass] of Dose |
| 59741-9 | Silver [Mass/mass] in Tissue |
| 3066-8 | Trypsinogen [Mass/volume] in Serum or Plasma |
| 31007-8 | Food Allergen Mix 23 (Beef+Chicken meat+Pork+Turkey meat) IgE Ab [Presence] in Serum by Multidisk |
| 31102-7 | Protein S actual/normal in Platelet poor plasma by Chromogenic method |
| 42248-5 | Hemoglobin.other/Hemoglobin.total in Blood by HPLC |
| 51294-7 | CD33 cells/100 cells in Body fluid |
| 43132-0 | California encephalitis virus Ab [Units/volume] in Serum Qualitative |
| 31851-9 | Herpes simplex virus 2 Ag [Presence] in Specimen |
| 22617-5 | Wuchereria bancrofti Ab [Presence] in Serum |
| 33478-9 | Fatty acids.very long chain pattern [Interpretation] in Serum or Plasma |
| 53556-7 | Erythrocytes.Plasmodium sp infected/100 erythrocytes in Blood |
| 53646-6 | Aldicarb [Presence] in Gastric fluid |
| 53916-3 | Microscopic observation [Identifier] in Gastric fluid by Rhodamine-auramine fluorochrome stain |
| 5392-6 | Treponema pallidum Ab [Units/volume] in Serum by Immobilization |
| 45068-4 | Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Cervix by NAA with probe detection |
| 53973-4 | Erythrocytes.ghost cells [Presence] in Urine sediment by Light microscopy |
| 54177-1 | Clotrimazole [Susceptibility] by Disk diffusion (KB) |
| 4587-2 | Hemoglobin H/Hemoglobin.total in Blood by Electrophoresis |
| 24128-1 | Bordetella pertussis.pertussis toxin IgA Ab [Units/volume] in Serum by Immunoassay |
| 34557-9 | Cell count and Differential panel - Body fluid |
| 54474-2 | Pimeloylcarnitine (C7-DC) [Moles/volume] in Amniotic fluid |
| 56365-0 | Queen Palm IgG4 Ab [Mass/volume] in Serum |
| 26523-1 | Promyelocytes [#/volume] in Blood |
| 3788-7 | Methicillin [Mass/volume] in Serum or Plasma |
| 38180-6 | Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 56749-5 | Estradiol (E2) [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 56901-2 | Amino acid pattern [Interpretation] in Body fluid |
| 56999-6 | European Hornet IgG4 Ab [Units/volume] in Serum |
| 26963-9 | Methionine [Moles/volume] in Urine |
| 27369-8 | Somatotropin [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 2752-4 | pH of Semen |
| 57905-2 | Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay --1st specimen |
| 49515-0 | Bisacodyl [Mass/volume] in Stool |
| 28601-3 | Hydroxyproline/Creatinine [Ratio] in Urine |
| 50092-6 | 2-Methylcitrate [Moles/volume] in Cerebral spinal fluid |
| 58958-0 | Fusarium oxysporum IgG Ab [Mass/volume] in Serum |
| 59302-0 | Memantine [Mass/volume] in Blood |
| 30099-6 | Neisseria gonorrhoeae [Presence] in Conjunctival specimen by Organism specific culture |
| 40770-0 | Ethosuximide [Mass/volume] in Serum or Plasma --trough |
| 19174-2 | Choriogonadotropin.beta subunit [Units/volume] in Amniotic fluid |
| 19299-7 | Opiates cutoff [Mass/volume] in Urine for Screen method |
| 19480-3 | Haloperidol cutoff [Mass/volume] in Urine for Screen method |
| 2011-5 | Cancer Ag 242 [Presence] in Serum or Plasma |
| 20599-7 | CD3 cells/100 cells in Specimen |
| 20969-2 | Strychnine [Presence] in Gastric fluid |
| 1011-6 | E sup(w) Ab [Presence] in Serum or Plasma from Donor |
| 13091-4 | Deoxyribonucleoprotein Ab [Units/volume] in Serum |
| 102258-1 | Cow dander IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14299-2 | Cryoprecipitate units available [#] |
| 10380-4 | Stomatocytes [Presence] in Blood by Light microscopy |
| 104182-1 | Clostridium tetani toxin [Presence] in Serum or Plasma by Immunoassay |
| 14923-7 | Toxoplasma gondii Ab [Units/volume] in Specimen |
| 1540-4 | Glucose [Mass/volume] in Serum or Plasma --5 hours post 100 g glucose PO |
| 10971-0 | Lysozyme [Mass/volume] in Urine |
| 12173-1 | Non prostatic acid phosphatase [Enzymatic activity/volume] in Serum or Plasma |
| 17061-3 | Legionella pneumophila 1 IgM Ab [Units/volume] in Serum |
| 17091-0 | Lumpfish roe IgE Ab [Units/volume] in Serum |
| 17284-1 | Mitochondria Ab [Presence] in Serum by Immunofluorescence |
| 17335-1 | Neostigmine [Mass/volume] in Serum or Plasma |
| 17688-3 | Testosterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 17952-3 | Bacteria # 3 identified in Body fluid by Aerobe culture |
| 18948-0 | Minocycline [Susceptibility] |
| 19146-0 | Referral lab test results |
| 74519-0 | Complement activity panel - Serum |
| 7468-2 | Liver IgE Ab [Units/volume] in Serum |
| 74958-0 | clomiPRAMINE [Mass/volume] in Serum or Plasma --trough |
| 75401-0 | GCDH gene full mutation analysis in Blood or Tissue by Sequencing |
| 75667-6 | Electrolytes 3 panel - 24 hour Urine |
| 61213-5 | Lactalbumin alpha IgE Ab/IgE total in Serum |
| 77049-5 | SUGCT gene full mutation analysis in Blood or Tissue by Sequencing |
| 9383-1 | 9-Hydroxyrisperidone [Mass/volume] in Serum or Plasma |
| 62477-5 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
| 7805-5 | Adenovirus Ab [Units/volume] in Serum |
| 78444-7 | Hepatitis A virus IgG+IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 79137-6 | Benzylpiperazine [Mass/volume] in Body fluid |
| 65329-5 | McC sup(c) Ab [Presence] in Serum or Plasma |
| 65751-0 | Muscle Pathology biopsy report |
| 66765-9 | Albumin in pericardial fld/Albumin in Serum or Plasma |
| 80534-1 | Methylenedioxyamphetamine [Mass/mass] in Hair |
| 6922-9 | Echovirus 7 Ab [Titer] in Serum by Complement fixation |
| 69875-3 | Service comment 48 |
| 97532-6 | Norovirus genogroup II RNA [Presence] in Specimen by NAA with probe detection |
| 7040-9 | Pefloxacin [Susceptibility] by Gradient strip |
| 71606-8 | Neutrophils/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count |
| 71634-0 | Lymphocytes/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
| 82973-9 | Amobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 71697-7 | Mononuclear cells/100 leukocytes in Body fluid by Automated count |
| 71774-4 | Mitogen stimulated gamma interferon [Units/volume] corrected for background in Blood |
| 71871-8 | Hemoglobin Barts/Hemoglobin.total [Pure mass fraction] in Blood |
| 99265-1 | Alpha hydroxyetizolam [Mass/volume] in Urine by Confirmatory method |
| 99540-7 | Stenosis degree [Length fraction] in Distal left anterior descending artery by Autopsy |
| 99963-1 | JAK2 gene exon 14 full mutation analysis in Blood or Tissue by Sequencing |
| 7261-1 | Crab triggered histamine release [Units/volume] in Blood |
| 72801-4 | Ketamine/Creatinine [Mass Ratio] in Urine |
| 7319-7 | Deer Fly IgE Ab [Units/volume] in Serum |
| 73232-1 | Omeprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73357-6 | Haloperidol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87331-5 | Porcine circovirus type 2 Ab/Negative control in Serum by Immunoassay |
| 87604-5 | Ampicillin [Mass/mass] in Specimen |
| 73428-5 | Colchicine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88151-6 | Microscopic observation [Identifier] in Wound by Acid fast stain |
| 59470-5 | Calcium.ionized [Mass/volume] in Arterial blood |
| 59654-4 | diazePAM [Mass/volume] in Blood |
| 59706-2 | MethylePHEDrine [Mass/volume] in Serum or Plasma |
| 50736-8 | Serotonin release.heparin.unfractionated panel - Serum |
| 50979-4 | CBir1 Ab [Units/volume] in Serum by Immunoassay |
| 3102-1 | Urobilin [Mass/volume] in Stool |
| 42494-5 | Coccidioides immitis Ab [Titer] in Pleural fluid by Complement fixation |
| 60174-0 | Strontium [Mass/mass] in Tissue |
| 21409-8 | Myelin IgM Ab [Titer] in Serum |
| 2162-6 | Creatinine [Mass/time] in 24 hour Urine |
| 31479-9 | Leptospira interrogans sv Grippotyphosa Ab [Units/volume] in Serum |
| 2198-0 | Delta aminolevulinate [Mass/volume] in Plasma |
| 22151-5 | Brucella abortus IgM Ab [Units/volume] in Serum |
| 22160-6 | Brucella suis Ab [Titer] in Serum |
| 22235-6 | Coxsackievirus B6 Ab [Titer] in Cerebral spinal fluid |
| 51496-8 | Estradiol (E2) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 43581-8 | Complement C4 [Mass/volume] in Peritoneal fluid |
| 22343-8 | Herpes simplex virus IgM Ab [Titer] in Serum |
| 32295-8 | Aluminum [Moles/time] in 24 hour Urine |
| 52794-5 | Ova and parasites identified in Specimen by Light microscopy--3rd specimen |
| 32632-2 | HEXA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 53227-5 | Leukocytes [#/area] in Cervix by Wet preparation |
| 44695-5 | Mitotic index by CAP cancer protocols |
| 23355-1 | Peste des petits ruminants virus Ag [Presence] in Tissue by Immunoassay |
| 33610-7 | Sjogrens syndrome-A extractable nuclear IgG Ab [Units/volume] in Serum |
| 33730-3 | Resection completeness in Mesorectum Qualitative by Macroscopy |
| 54228-2 | Lymphoma - CLL screen panel - Specimen by Flow cytometry (FC) |
| 54266-2 | Glucose [Moles/volume] in Serum or Plasma --1.3 hours post dose insulin IV |
| 46711-8 | Food Allergen Mix 11 (Broccoli+Carrot+White bean+Peas+Corn) IgE Ab [Units/volume] in Serum by Multidisk |
| 24410-3 | Brucella canis Ab [Presence] in Serum by Plate agglutination |
| 55360-2 | Osmolality of Urine--6 hours post fluid fast |
| 5574-9 | Aluminum [Mass/volume] in Serum or Plasma |
| 5590-5 | Barium [Mass/volume] in Urine |
| 47681-2 | Leucine/Amino acids.total in Cerebral spinal fluid |
| 4768-8 | HLA-B57(17) [Presence] in Donor |
| 25945-7 | Lutropin [Units/volume] in Serum or Plasma by 1st IRP --3rd specimen post XXX challenge |
| 35639-4 | Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Tissue by NAA with probe detection |
| 35686-5 | GBA gene c.1226A>G [Presence] in Blood or Tissue by Molecular genetics method |
| 56191-0 | Cherry IgG4 Ab [Mass/volume] in Serum |
| 56206-6 | Carrot IgG4 Ab [Mass/volume] in Serum |
| 3694-7 | Indomethacin [Mass/volume] in Serum or Plasma |
| 56563-0 | Somatotropin [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge |
| 56571-3 | Somatotropin [Mass/volume] in Serum or Plasma --post exercise |
| 5673-9 | Lead [Mass/mass] in Hair |
| 56927-7 | Hepatitis C virus c2 Ab [Presence] in Serum by Immunoblot |
| 4870-2 | HLA-Dw11(w7) [Presence] in Donor |
| 2687-2 | Orotate phosphoribosyltransferase [Enzymatic activity/volume] in Serum |
| 49294-2 | Oligoclonal bands [Interpretation] in Serum or Plasma Narrative |
| 27815-0 | Coagulation factor XIII activity actual/normal in Platelet poor plasma by Chromogenic method |
| 39545-9 | Crab IgE Ab/IgE total in Serum |
| 4943-7 | HLA-DQ6(1) [Presence] |
| 49812-1 | 2-Hydroxyglutarate/Creatinine [Molar ratio] in 24 hour Urine |
| 49861-8 | Toxocara canis Ab [Units/volume] in Specimen by Immunoassay |
| 49937-6 | Calcium/Oxalate [Molar ratio] in Urine |
| 29574-1 | Thyrotropin [Presence] in DBS |
| 29625-1 | 3-Hydroxypropionate (3-OH-C3) [Presence] in Urine |
| 29974-3 | Molybdenum [Mass/volume] in 24 hour Urine |
| 40424-4 | Methotrimeprazine [Presence] in Serum or Plasma |
| 40623-1 | CD3+CD4+ (T4 helper) cells/100 cells in Bronchial specimen |
| 40634-8 | HYDROcodone [Presence] in Gastric fluid |
| 50371-4 | Protoporphyrin [Mass/volume] in Urine |
| 41018-3 | Testosterone.free+weakly bound [Moles/volume] in Serum or Plasma |
| 19212-0 | Carbon dioxide [Partial pressure] in Mixed venous blood |
| 19408-4 | Cocaethylene [Mass/volume] in Urine |
| 20545-0 | Methylenedioxyamphetamine [Mass/volume] in Urine by Confirmatory method |
| 12866-0 | Borrelia burgdorferi 18kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 101814-2 | BK virus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 101863-9 | Complement factor H Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 14370-1 | Yeast [Presence] in Vaginal fluid by Wet preparation |
| 14769-4 | Glucose [Moles/volume] in Serum or Plasma --pre 12 hour fast |
| 151-1 | Cephalexin [Susceptibility] by Serum bactericidal titer |
| 15132-4 | Beta aminoisobutyrate+Proline [Presence] in Serum or Plasma |
| 1528-9 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
| 16645-4 | Colistin [Mass/volume] in Serum or Plasma |
| 1727-7 | Adenosine monophosphate.cyclic [Mass/time] in 24 hour Urine |
| 18411-9 | Rhizopus nigricans IgG Ab [Units/volume] in Serum |
| 91796-3 | Parvovirus B19 DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 76025-6 | Arylsulfatase C [Enzymatic activity/mass] in Fibroblast |
| 76349-0 | clonazePAM [Mass/mass] in Meconium by Confirmatory method |
| 9469-8 | Chromium [Mass/volume] in Water |
| 79394-3 | Hepatocyte growth factor [Mass/volume] in Serum or Plasma |
| 6599-5 | Haemophilus influenzae B Ag [Presence] in Specimen by Immunofluorescence |
| 66126-4 | Cholesterol in VLDL [Moles/volume] in Serum or Plasma by calculation |
| 66132-2 | Mononuclear+Mesothelial cells/100 leukocytes in Body fluid by Manual count |
| 67127-1 | Cellularity assessment [Interpretation] in Specimen by Flow cytometry (FC) Narrative |
| 9578-6 | Saint Louis encephalitis virus Ab [Titer] in Serum by Immunofluorescence |
| 9588-5 | Borrelia burgdorferi 18kD IgG Ab [Presence] in Serum by Immunoblot |
| 8072-1 | Insulin Ab [Units/volume] in Serum |
| 97021-0 | Reduction in kaolin induced clot strength [Length fraction] in Blood --30 minutes post maximum clot amplitude |
| 7014-4 | 5-Fluorocytosine [Susceptibility] by Gradient strip |
| 82385-6 | Methylmalonate [Moles/volume] in DBS |
| 98004-5 | HLA-A and B and C (class I) and HLA-DP and DQ and DR (class II) [Type] |
| 98113-4 | Chemokine (C-C motif) ligand 5 [Mass/volume] in Serum or Plasma |
| 98125-8 | Intravascular coagulation and fibrinolysis panel |
| 98194-4 | Hibiscus tea IgE Ab [Units/volume] in Serum |
| 71858-5 | Hemoglobin S/Hemoglobin.total [Pure mass fraction] in Blood by HPLC |
| 72311-4 | NPM1 gene c.956dupTCTG transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
| 72521-8 | p-ANCA formalin sensitive IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 72619-0 | Norpropoxyphene [Mass/volume] in Saliva (oral fluid) |
| 86121-1 | Streptococcus pneumoniae Danish serotype 4 Ab [Units/volume] in Serum --2nd specimen |
| 86509-7 | Varicella zoster virus clade [Type] in Specimen by Molecular genetics method |
| 87317-4 | Escherichia coli [#/volume] in Water by Viability count |
| 87662-3 | Fonofos [Mass/mass] in Specimen |
| 73462-4 | Cefuroxime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87772-0 | lamoTRIgine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 30997-1 | Timothy native (nPhl p) 4 IgE Ab [Units/volume] in Serum |
| 60191-4 | Tin [Mass/mass] in Tissue |
| 43081-9 | Bluetongue virus 11 Ab [Titer] in Serum |
| 22148-1 | Brucella abortus Ab [Presence] in Semen |
| 31885-7 | Measles virus Ag [Presence] in Urine sediment |
| 32014-3 | Eosinophils/100 leukocytes in Urine by Manual count |
| 51724-3 | Cefuroxime [Susceptibility] |
| 51823-3 | Adenovirus IgM Ab [Units/volume] in Serum by Immunoassay |
| 43290-6 | HLA-DRB1 [Presence] |
| 43729-3 | Lipoprotein.alpha.subparticle.large [Moles/volume] in Serum or Plasma |
| 22368-5 | Influenza virus C Ab [Titer] in Serum |
| 32335-2 | Pipecolate [Moles/volume] in Urine |
| 53059-2 | Dodecenoylcarnitine (C12:1) [Moles/volume] in Amniotic fluid |
| 4408-1 | Probenecid [Mass] of Dose |
| 22896-5 | Bovine diarrhea virus Ag [Presence] in Blood by Immunoassay |
| 32724-7 | Trichomonas sp [Presence] in Urine by Light microscopy |
| 53076-6 | Decenoylcarnitine (C10:1) [Moles/volume] in Cerebral spinal fluid |
| 5315-7 | Rickettsia spotted fever group IgM Ab [Titer] in Serum by Immunofluorescence |
| 44426-5 | 3-Hydroxyphenylacetate/Creatinine [Molar ratio] in Urine |
| 44793-8 | Immunoglobulin light chains panel [Mass/volume] - Serum |
| 2321-8 | Gamma glutamyl cysteine synthetase [Enzymatic activity/volume] in Serum |
| 23560-6 | Vesicular stomatitis virus Ag [Presence] in Throat by Complement fixation |
| 53654-0 | pH of Dialysis fluid |
| 45030-4 | HLA-DRB1 SBT [Type] by High resolution |
| 4539-3 | Erythrocyte sedimentation rate Zeta by Zetafuge |
| 245-1 | Floxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 34547-0 | Complement profile panel [Mass/volume] - Serum or Plasma |
| 47222-5 | Trisomy 21 risk based on maternal age+Alpha-1-Fetoprotein+Choriogonadotropin+Estriol.unconjugated [Likelihood] in Fetus |
| 55722-3 | Tinidazole [Susceptibility] by Gradient strip |
| 47767-9 | Somatotropin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 47884-2 | Ribitol/Creatinine [Molar ratio] in Urine |
| 25666-9 | Glucose [Moles/volume] in Serum or Plasma --2.5 hours post dose glucose |
| 25959-8 | Methionine/Creatinine [Molar ratio] in 24 hour Urine |
| 25964-8 | Normetanephrine [Moles/volume] in 24 hour Urine |
| 35399-5 | Varicella zoster virus DNA [Presence] in Eye by NAA with probe detection |
| 56158-9 | PCSK9 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 56480-7 | Taenia solium larva Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 26060-4 | European tick borne encephalitis virus IgM Ab [Units/volume] in Serum by Immunoassay |
| 26481-2 | Lymphocytes/100 leukocytes in Pleural fluid |
| 3622-8 | Etilefrine [Mass/volume] in Urine |
| 56711-5 | Sodium benzoate IgE Ab [Units/volume] in Serum |
| 48419-6 | Immune complex.IgG [Mass/volume] in Serum or Plasma by C1q binding assay |
| 27013-2 | Alanine [Moles/volume] in Amniotic fluid |
| 27187-4 | Methohexital [Mass/volume] in Urine |
| 38446-1 | Catecholamines [Mass/time] in 72 hour Urine |
| 38617-7 | 1,2-Dichloropropane [Mass/volume] in Air |
| 57533-2 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 27270-8 | 4-Hydroxyphenylacetate [Presence] in Urine |
| 27297-1 | Leukocyte esterase [Units/volume] in Urine |
| 387-1 | Oxytetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 39309-0 | Influenza virus A H8 Ab [Titer] in Serum by Hemagglutination inhibition |
| 28548-6 | Mycoplasma pneumoniae Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 40133-1 | Creatinine [Moles/volume] in Urine --baseline |
| 40274-3 | Cortisol [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 58808-7 | Aspergillus sp Ab [Titer] in Serum by Hemagglutination |
| 49927-7 | Amylase in fluid/Amylase in serum |
| 29924-8 | Scandium [Mass/time] in 24 hour Urine |
| 30073-1 | Voltage-gated calcium channel Ab [Presence] in Serum |
| 41157-9 | Chlamydia trachomatis IgM Ab [Presence] in Serum |
| 19608-9 | Nalbuphine cutoff [Mass/volume] in Urine for Confirmatory method |
| 20532-8 | Hydroxyethylflurazepam [Mass/volume] in Urine by Confirmatory method |
| 101092-5 | Hr^B Ab [Presence] in Serum or Plasma |
| 101094-1 | In^a Ab [Presence] in Serum or Plasma |
| 124-8 | Cefprozil [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 12554-2 | Narcotics and opioids [Identifier] in Urine |
| 12652-4 | Glucose [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge |
| 13254-8 | Legionella pneumophila atypical Ab [Presence] in Serum |
| 102125-2 | Abalone IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13506-1 | Urea nitrogen renal clearance in Urine and Serum or Plasma |
| 13531-9 | Fat.microscopic observation [Presence] in Sputum by Sudan III stain |
| 102543-6 | Protamine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14003-8 | Carbon dioxide [Partial pressure] in Cord blood |
| 14147-3 | Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 102703-6 | Carrot IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103042-8 | Japanese cypress IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104229-0 | Carfentanil [Mass/volume] in Urine by Confirmatory method |
| 104351-2 | Borrelia recurrentis [Presence] in Specimen by Organism specific culture |
| 10676-5 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification |
| 10747-4 | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Lawson-Van Gieson stain |
| 1091-8 | K Ab [Presence] in Serum or Plasma from Blood product unit |
| 16639-7 | Coccidioides immitis IgM Ab [Units/volume] in Cerebral spinal fluid |
| 1166-8 | little f Ab [Presence] in Serum or Plasma from Blood product unit |
| 16999-5 | Hydroquinone [Mass/volume] in Urine |
| 17154-6 | CD43 cells/100 cells in Blood |
| 17444-1 | Phenytoin [Mass/volume] in Urine |
| 17546-3 | Bartonella quintana rRNA [Presence] in Specimen by Probe |
| 17700-6 | Theophylline [Mass/volume] in Urine |
| 17788-1 | Large unstained cells/100 leukocytes in Blood by Automated count |
| 18416-8 | Aspergillus nidulans IgG Ab [Units/volume] in Serum |
| 1849-9 | Androstanolone [Mass/volume] in Semen |
| 18924-1 | Fluconazole [Susceptibility] |
| 74541-4 | Surfactant pulmonary-associated protein D [Mass/volume] in Serum |
| 75005-9 | Food Allergen Mix 14 (Cabbage+Paprika+Tomato+Spinach) IgE Ab [Units/volume] in Serum by Multidisk |
| 92546-1 | Do sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 75631-2 | Stromelysin-1 [Mass/volume] in Serum or Plasma |
| 7567-1 | Parrot serum IgE Ab [Units/volume] in Serum |
| 60337-3 | Venlafaxine [Moles/volume] in Specimen |
| 76145-2 | Prulifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 7699-2 | Sheep Sorrel triggered histamine release [Units/volume] in Blood |
| 93020-6 | Polyclonal plasma cells/Total plasma cells in Bone marrow by Flow cytometry (FC) |
| 93403-4 | Citrobacter sp DNA [Presence] by NAA with probe detection in Positive blood culture |
| 77032-1 | t(8;14)(q24;q32)(MYC,IGH) fusion transcript in Blood or Tissue by FISH |
| 77379-6 | Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Interpretation] in Cervix |
| 77778-9 | Noroxycodone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 7902-0 | Helicobacter pylori IgG Ab [Units/volume] in Serum |
| 6598-7 | Troponin T.cardiac [Mass/volume] in Serum or Plasma |
| 6673-8 | Microscopic observation [Identifier] in Tissue by Neisser stain |
| 95724-1 | Glycine receptor Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 9762-6 | Coxsackievirus B4 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 97959-1 | Silver Birch recombinant (rBet v) 1 IgG4 Ab [Mass/volume] in Serum |
| 71618-3 | Macrophages/Leukocytes [Pure number fraction] in Synovial fluid by Manual count |
| 97987-2 | Honey bee recombinant (rApi m) 10 IgG4 Ab [Mass/volume] in Serum |
| 99032-5 | Streptococcus agalactiae DNA [Presence] in Urine by NAA with probe detection |
| 83138-8 | 17-Hydroxypregnenetriol [Moles/time] in 24 hour Urine |
| 99863-3 | Erythrocytes.dysmorphic [Presence] in Urine sediment by Computer assisted method |
| 86019-7 | Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum |
| 73264-4 | Minocycline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87826-4 | t(11;18)(q21;q21)(BIRC3,MALT1) fusion transcript in Blood or Tissue by Molecular genetics method |
| 74306-2 | PRRSV ORF5 gene sequence homology to Fostera in Isolate by Sequencing |
| 88593-9 | Human bocavirus DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 89301-6 | oxymorphone-3-glucuronide [Presence] in Urine by Screen method |
| 59750-0 | Temazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 5061-7 | Borrelia burgdorferi Ab [Titer] in Serum by Immunofluorescence |
| 50905-9 | Silicon [Moles/mass] in Hair |
| 31302-3 | Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum |
| 51445-5 | CD41a cells [Units/volume] in Blood |
| 43118-9 | Fat panel - Stool |
| 43176-7 | Lithium [Moles/volume] in Saliva (oral fluid) |
| 31775-0 | Chlamydia trachomatis Ag [Presence] in Urine sediment |
| 31903-8 | Myxoma virus Ag [Presence] in Specimen |
| 22362-8 | HTLV I+II Ab [Presence] in Serum |
| 3243-3 | Thrombin time |
| 522-3 | Troleandomycin [Susceptibility] by Serum bactericidal titer |
| 43955-4 | CD4+CD45RO+ cells [#/volume] in Tissue |
| 23120-9 | Foot and mouth disease virus serotype [Identifier] in Specimen by Immunoassay |
| 32774-2 | Chlamydia sp DNA [Presence] in Genital specimen by NAA with probe detection |
| 5317-3 | Rickettsia typhus group Ab [Presence] in Serum by Latex agglutination |
| 53333-1 | Urinalysis other formed elements panel - Urine by Computer assisted method |
| 53356-2 | Fat [#/volume] in Urine by Computer assisted method |
| 23286-8 | Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Immunoblot |
| 2335-8 | Hemoglobin.gastrointestinal [Presence] in Stool |
| 23495-5 | Transmissible gastroenteritis virus Ag [Presence] in Specimen by Immune stain |
| 33365-8 | Mesothelial cells/100 leukocytes in Synovial fluid |
| 33683-4 | Francisella tularensis Ab [Titer] in Serum by Microagglutination |
| 449-9 | Sisomicin [Susceptibility] by Disk diffusion (KB) |
| 23734-7 | Feline leukemia virus Ab [Presence] in Serum |
| 33930-9 | aPTT W excess hexagonal phospholipid (StaClot LA confirm) |
| 33988-7 | Thymidine phosphorylase [Enzymatic activity/mass] in Leukocytes |
| 54035-1 | Ehrlichia chaffeensis Ag [Presence] in Tissue by Immune stain |
| 54153-2 | Nuclear mitotic apparatus Ab [Titer] in Serum by Immunofluorescence |
| 54225-8 | Immune response panel - Specimen by Flow cytometry (FC) |
| 54416-3 | Rh [Type] in Blood from Fetus |
| 45391-0 | Epithelial cells.renal [#/area] in Urine sediment by Microscopy low power field |
| 46134-3 | Granular casts [#/area] in Urine sediment by Microscopy high power field |
| 34284-0 | Delta aminolevulinate [Moles/volume] in Urine |
| 55242-2 | HBB gene c.20A>T [Presence] in Blood by Molecular genetics method |
| 47058-3 | Legionella pneumophila 12 IgM Ab [Titer] in Serum by Immunofluorescence |
| 47764-6 | Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose arginine |
| 47815-6 | 3,4-Hydroxymandelate/Creatinine [Molar ratio] in Urine |
| 4786-0 | HLA-B67 [Presence] in Donor |
| 35367-2 | SCA2 gene allele 1 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 48127-5 | Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose TRH |
| 3815-8 | Metoprolol [Mass/volume] in Serum or Plasma |
| 48381-8 | 3-Methoxytyramine/Creatinine [Molar ratio] in 24 hour Urine |
| 48651-4 | Borrelia burgdorferi IgM Ab index [Units/volume] in Body fluid |
| 48666-2 | IgG.intrathecally synthesized [Mass/volume] in Serum and CSF |
| 26809-4 | Homocystine [Presence] in 24 hour Urine |
| 27048-8 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum |
| 49107-6 | Rubella virus IgM Ab [Titer] in Serum |
| 278-2 | Imipenem [Susceptibility] by Minimum lethal concentration (MLC) |
| 27846-5 | Somatotropin [Mass/volume] in Serum or Plasma --24th specimen post XXX challenge |
| 28547-8 | Neisseria meningitidis serogroup C IgG Ab [Mass/volume] in Serum by Immunoassay |
| 29142-7 | Metanephrines [Mass/volume] in Serum or Plasma |
| 40112-5 | Creatinine [Moles/volume] in Serum or Plasma --pre XXX challenge |
| 29970-1 | Rubidium/Creatinine [Mass Ratio] in 24 hour Urine |
| 40438-4 | HIV 1 gp41 Ab [Presence] in Serum or Plasma by Immunoassay |
| 40692-6 | Volume of Semen--pre washing |
| 40712-2 | Coccidioides immitis Ab [Presence] in Serum by Immunoassay |
| 29989-1 | Uranium/Creatinine [Mass Ratio] in 24 hour Urine |
| 40914-4 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 19404-3 | clonazePAM cutoff [Mass/volume] in Urine for Confirmatory method |
| 19522-2 | LORazepam cutoff [Mass/volume] in Urine for Screen method |
| 2062-8 | Cerebroside sulfatase [Presence] in Leukocytes |
| 20984-1 | Western equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 1000-9 | DBG Ab [Presence] in Serum or Plasma from Blood product unit |
| 12457-8 | Volume of Dialysis fluid |
| 102535-2 | Plum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102552-7 | Rabbit epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102604-6 | Spondylocladium citrovirens IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102952-9 | Colby Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14383-4 | Mononuclear cells/100 leukocytes in Semen by Manual count |
| 14399-0 | Creatinine [Mass/volume] in Pleural fluid |
| 103122-8 | Silver Birch recombinant (rBet v) 6 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14965-8 | CD2 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 14982-3 | A variant subtype Ab [Presence] in Serum or Plasma |
| 10746-6 | Calcium.microscopic observation [Identifier] in Tissue by Von Kossa stain |
| 10930-6 | Fish Feed IgE Ab [Units/volume] in Serum |
| 16441-8 | Benzene ring IgG Ab [Units/volume] in Serum |
| 17726-1 | Treponema pallidum IgG Ab [Presence] in Serum by Immunofluorescence |
| 18483-8 | Yeast [Presence] in Genital specimen by Organism specific culture |
| 18901-9 | Cephapirin [Susceptibility] |
| 91761-7 | Giardia sp Ag [Presence] in Stool by Rapid immunoassay |
| 92253-4 | Microorganism identified in Isolate or Specimen by Molecular genetics method |
| 75103-2 | Myristate (C14:0) [Entitic substance] in Red Blood Cells |
| 75111-5 | Palmitoleate (C16:1w7) [Entitic substance] in Red Blood Cells |
| 75394-7 | Chromosome uniparental disomy [Identifier] in Amniotic fluid or Chorionic villus sample by Molecular genetics method Narrative |
| 75650-2 | Sulfonamide [Moles/volume] in Serum or Plasma |
| 60678-0 | Protein/Creatinine [Mass Ratio] in 12 hour Urine |
| 75892-0 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript break points [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 7674-5 | Rye IgE Ab [Units/volume] in Serum |
| 93398-6 | Klebsiella oxytoca DNA [Presence] by NAA with probe detection in Positive blood culture |
| 77039-6 | t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript in Blood or Tissue by FISH |
| 93904-1 | Transfusion reaction panel |
| 63120-0 | Walnut IgG Ab [Mass/volume] in Serum |
| 6331-3 | Campylobacter sp identified in Stool by Organism specific culture |
| 78201-1 | 4q12 chromosome region rearrangements [Identifier] in Blood or Tissue by FISH Nominal |
| 64116-7 | Hemoglobin observations newborn screening panel |
| 94871-1 | Aldosterone and sodium panel - 24 hour Urine |
| 65793-2 | Cockroach native (nBla g) 7 IgE Ab [Units/volume] in Serum |
| 6718-1 | Cashew nut IgE Ab [Units/volume] in Serum |
| 80164-7 | Bile alcohols pattern [Interpretation] in Urine Narrative |
| 80221-5 | NMDAR IgG Ab [Titer] in Serum by Immunofluorescence |
| 96306-6 | Enterobacterales DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 80612-5 | B IgG Ab [Presence] in Serum or Plasma |
| 81117-4 | Ross River virus RNA [Presence] in Serum by NAA with probe detection |
| 6966-6 | Yersinia enterocolitica IgM Ab [Units/volume] in Serum by Immunoassay |
| 81853-4 | Chromosome 15 and 16 and 22 aneuploidy in Blood or Tissue by Molecular genetics method |
| 82207-2 | Entamoeba histolytica DNA [Presence] in Stool by NAA with non-probe detection |
| 978-7 | D Ag [Presence] on Red Blood Cells |
| 98-4 | Cefonicid [Susceptibility] by Serum bactericidal titer |
| 98733-9 | Percent neutralization by SARS coronavirus 2 spike protein RBD neutralizing antibody in Serum or Plasma by Immunoassay |
| 85307-7 | Distance of carcinoma from medial margin [Length] in Breast cancer specimen by Light microscopy |
| 85348-1 | Procedure used to obtain tumor specimen [Type] in Specimen |
| 85685-6 | Mycoplasma hyopneumoniae P146 gene [Nucleotide sequence] in Specimen by Sequencing |
| 85799-5 | Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73058-0 | Acetylsalicylate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73240-4 | Nitroglycerin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73332-9 | Imipenem+Cilastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73959-9 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+66 DNA [Presence] in Tissue by Probe |
| 74353-4 | Sodium and Potassium panel [Moles/volume] - Blood |
| 88608-5 | Human coronavirus 229E RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 88865-1 | Other Chemical [Identifier] in Specimen |
| 59358-2 | Desethylvardenafil [Mass/volume] in Serum or Plasma |
| 59382-2 | Aspergillus versicolor IgG Ab [Mass/volume] in Serum |
| 5988-1 | Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis |
| 50660-0 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 30925-2 | Cadmium [Mass/volume] in Urine collected for unspecified duration |
| 42204-8 | Hairy cells/100 leukocytes in Bone marrow |
| 60258-1 | Bacteria identified in Bone marrow by Culture |
| 31493-0 | Lymphocytic choriomeningitis virus IgG Ab [Units/volume] in Serum |
| 51057-8 | CD127 blasts/100 blasts in Specimen |
| 22126-7 | Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid |
| 22156-4 | Brucella canis IgM Ab [Titer] in Serum |
| 3176-5 | Antithrombin [Moles/volume] in Platelet poor plasma by Chromogenic method |
| 51620-3 | Creatinine [Moles/volume] in Serum or Plasma --post dialysis |
| 43421-7 | Thiopurine methyltransferase [Enzymatic activity/mass] in Red Blood Cells |
| 43815-0 | Arsenic [Presence] in Specimen |
| 32253-7 | Leucine [Moles/volume] in Vitreous fluid |
| 32275-0 | Tryptophan [Moles/volume] in Body fluid |
| 32540-7 | Glucosylceramidase [Enzymatic activity/mass] in Leukocytes |
| 22936-9 | Brucella melitensis DNA [Presence] in Specimen by NAA with probe detection |
| 22938-5 | Brucella ovis Ab [Presence] in Serum by Agglutination |
| 33050-6 | Pseudocholinesterase phenotype [Identifier] in Serum or Plasma |
| 23650-5 | Actinobacillus pleuropneumoniae serotype [Identifier] in Specimen by Agglutination |
| 33519-0 | Platelet aggregation ADP induced in Platelet rich plasma --Low dose |
| 3368-8 | Azlocillin [Mass/volume] in Serum or Plasma |
| 53642-5 | Glutathione.reduced/glutathione.oxidized [Molar ratio] in Blood |
| 53713-4 | PCA-1 Ab [Titer] in Cerebral spinal fluid |
| 45216-9 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in DBS |
| 23992-1 | Dengue virus IgM Ab [Units/volume] in Serum by Immunoassay |
| 45385-2 | Hippurate crystals [#/area] in Urine sediment by Microscopy low power field |
| 34628-8 | Methotrexate [Moles/volume] in Cerebral spinal fluid |
| 55296-8 | CAV3 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method |
| 47140-9 | EPINEPHrine [Moles/volume] in Urine --2nd specimen post XXX challenge |
| 25246-0 | Cephalothin [Mass/volume] in Specimen |
| 35009-0 | Segmented neutrophils [#/volume] in Synovial fluid |
| 55890-8 | Hydroxylysine/Amino acids.total in Hair |
| 47591-3 | C peptide [Moles/volume] in Serum or Plasma --3 minutes post dose glucose |
| 4774-6 | HLA-B60(40) [Presence] in Donor |
| 35625-3 | Normeperidine [Mass/volume] in Serum or Plasma by Screen method |
| 56518-4 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 48104-4 | Cortisol [Mass/volume] in Serum or Plasma --8 AM specimen |
| 48119-2 | Pentadecanoate/Creatinine [Molar ratio] in Urine |
| 48165-5 | Squamous cell carcinoma Ag [Mass/volume] in Body fluid |
| 26472-1 | Leukocytes other/100 leukocytes in Cerebral spinal fluid |
| 26747-6 | Cannabinoids/Creatinine [Mass Ratio] in Urine |
| 48754-6 | 3-Hydroxydodecanoate (3-OH-C12:0) [Moles/volume] in Serum or Plasma |
| 2691-4 | Osmolality of Peritoneal fluid |
| 57298-2 | HLA-DRB1 [Type] |
| 2758-1 | Phenol [Mass/volume] in Urine |
| 27814-3 | Coagulation factor VII+Coagulation factor X actual/normal in Platelet poor plasma by Coagulation assay |
| 49447-6 | Toxoplasma gondii DNA [#/volume] in Blood by NAA with probe detection |
| 49742-0 | Plasmodium vivax IgG Ab [Titer] in Serum by Immunofluorescence |
| 29232-6 | Coxsackievirus B3 Ab [Titer] in Body fluid |
| 40005-1 | Glucose [Mass/volume] in Serum or Plasma --110 minutes post XXX challenge |
| 40192-7 | Glucose [Moles/volume] in Serum or Plasma --1 day post XXX challenge |
| 58642-0 | Cortisol [Mass/volume] in Saliva (oral fluid) --12 AM specimen |
| 50273-2 | 3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Urine |
| 30391-7 | Erythrocytes [#/volume] in Urine |
| 40984-7 | Parainfluenza virus 2 IgG Ab [Presence] in Serum by Immunoassay |
| 41023-3 | Aldosterone [Molar amount] in Urine collected for unspecified duration |
| 19266-6 | Amphetamines cutoff [Mass/volume] in Urine for Screen method |
| 19589-1 | Midazolam cutoff [Mass/volume] in Urine for Screen method |
| 12556-7 | Copper [Mass/volume] in Blood |
| 101149-3 | Borrelia burgdorferi IgM Ab index [Units/volume] in Serum and CSF |
| 13255-5 | Legionella longbeachae 1+2 Ab [Presence] in Serum |
| 13375-1 | Lysine [Mass/volume] in Cerebral spinal fluid |
| 101877-9 | Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay |
| 102083-3 | Arginine stimulation challenge panel - Serum or Plasma by Immunoassay |
| 102136-9 | Alternaria alternata IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13760-4 | Homovanillate/Creatinine [Mass Ratio] in 24 hour Urine |
| 102588-1 | Scotch broom IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102608-7 | Pacific Squid IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102768-9 | Saccharopolyspora rectivirgula IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14720-7 | Ethosuximide [Moles/volume] in Serum or Plasma |
| 104112-8 | Mucopolysaccharidosis [Enzymatic activity/volume] in DBS |
| 10428-1 | Varicella zoster virus immune globulin given [Volume] |
| 10660-9 | Cytomegalovirus Ag [Presence] in Tissue by Immune stain |
| 10960-3 | Rabbit serum proteins IgE Ab [Units/volume] in Serum |
| 16616-5 | Cholesterol in HDL/Cholesterol in LDL [Mass Ratio] in Serum or Plasma |
| 11157-5 | Leukocytes [Morphology] in Bone marrow |
| 11203-7 | Trichosporon pullulans IgE Ab [Units/volume] in Serum |
| 1217-9 | LW Ag [Presence] on Red Blood Cells from Blood product unit |
| 12287-9 | Drugs identified in Gastric fluid by Screen method |
| 12297-8 | Chlorate [Presence] in Blood |
| 17188-4 | CD66e cells/100 cells in Blood |
| 17217-1 | Cytoplasmic CD79 cells/100 cells in Blood |
| 17226-2 | SmIg-Cd79 cells/100 cells in Blood |
| 1724-4 | Adenosine diphosphate [Mass/volume] in Serum |
| 1730-1 | Adenosine triphosphatase [Enzymatic activity/volume] in Semen |
| 17962-2 | Bacteria # 5 identified in Peritoneal fluid by Culture |
| 90230-4 | Myeloperoxidase Ab.IgG and Proteinase 3 Ab.IgG Panel - Serum |
| 7489-8 | Cajeput tree triggered histamine release [Units/volume] in Blood |
| 75131-3 | Adenine [Moles/volume] in Serum or Plasma |
| 60335-7 | traZODone [Moles/volume] in Specimen |
| 6054-1 | Buckwheat IgE Ab [Units/volume] in Serum |
| 61043-6 | Ketamine [Presence] in Specimen |
| 61176-4 | Polychlorinated biphenyl.Aroclor 1248 [Mass/volume] in Serum or Plasma |
| 92972-9 | Klebsiella oxytoca DNA [NCncRange] in Sputum by NAA with non-probe detection |
| 61385-1 | Human papilloma virus 59 DNA [Presence] in Specimen by NAA with probe detection |
| 77377-0 | Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Interpretation] in Specimen |
| 93794-6 | Glucose tolerance and insulin sensitivity 2 hour panel - Serum or Plasma |
| 63177-0 | Acremonium sp IgG Ab [Mass/volume] in Serum |
| 63443-6 | Fasciola hepatica Ab [Presence] in Serum by Hemagglutination |
| 79169-9 | Cherry recombinant (rPru av) 3 IgE Ab [Units/volume] in Serum |
| 79467-7 | Purine nucleoside phosphorylase [Enzymatic activity/volume] in DBS |
| 6613-4 | Haemophilus influenzae D Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 68420-9 | Monocytes [#/volume] in Pericardial fluid by Manual count |
| 81144-8 | Cerium [Mass/volume] in Blood |
| 81319-6 | Spermatozoa Progressive [#] in Semen by Automated count |
| 696-5 | Neisseria gonorrhoeae [Presence] in Throat by Organism specific culture |
| 69810-0 | 2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --1 day post dose ifosfamide |
| 70023-7 | Candida tropicalis DNA [Presence] in Blood by NAA with probe detection |
| 70036-9 | Polymorphonuclear cells/100 leukocytes in Pericardial fluid by Automated count |
| 9793-1 | Trichloroethylene [Mass/volume] in Urine |
| 7076-3 | Alternaria alternata IgG Ab [Units/volume] in Serum |
| 7161-3 | Brussel Sprouts IgG Ab [Units/volume] in Serum |
| 98226-4 | prednisoLONE IgE Ab [Units/volume] in Serum |
| 85797-9 | Neisseria meningitidis serogroup DNA panel - Specimen by NAA with probe detection |
| 86087-4 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 73209-9 | PHENobarbital induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73271-9 | metroNIDAZOLE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87410-7 | Thymidine synthase activity interpretation in Blood or Tissue Qualitative |
| 87413-1 | Brachyspira sp [Type] in Isolate by Sequencing |
| 73406-1 | Donepezil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87812-4 | Flunitrazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 87955-1 | Bacteria identified in Cord blood by Anaerobe culture |
| 88194-6 | Influenza virus B Ag [Presence] in Tissue by Immunofluorescence |
| 59801-1 | Protein.monoclonal band 3/Protein.total in Urine by Electrophoresis |
| 30490-7 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum --1st specimen |
| 42338-4 | Herpes simplex virus 2 glycoprotein G IgG Ab [Units/volume] in Serum |
| 31438-5 | Influenza virus A IgM Ab [Units/volume] in Serum |
| 31454-2 | Legionella pneumophila 1 Ab [Units/volume] in Serum |
| 51271-5 | CD25 cells/100 cells in Body fluid |
| 51277-2 | CD3+CD16+ cells/100 cells in Body fluid |
| 42771-6 | Streptococcus pneumoniae serotype IgG Ab [Interpretation] in Serum Narrative |
| 22219-0 | Coxsackievirus A7 Ab [Titer] in Cerebral spinal fluid |
| 31844-4 | Hepatitis B virus e Ag [Presence] in Serum |
| 43674-1 | Fatty acid comprehensive (C8-C26) panel - Serum or Plasma |
| 52775-4 | Clotting time.intrinsic coagulation system activated.heparin insensitive of Blood by Rotational TEG |
| 52965-1 | clonazePAM [Presence] in Gastric fluid |
| 44374-7 | Homocysteine [Presence] in Serum or Plasma |
| 23031-8 | Duck enteritis virus Ag [Presence] in Specimen by Neutralization test |
| 23178-7 | Leptospira interrogans sv Grippotyphosa Ab [Presence] in Serum by Agglutination |
| 23400-5 | Rift valley fever virus Ab [Titer] in Serum |
| 23408-8 | Rinderpest virus Ab [Titer] in Serum |
| 23543-2 | Venezuelan equine encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 33483-9 | Patient symptoms [Interpretation] --pre dose lactose PO |
| 53741-5 | HLA-DRB1*7 [Presence] |
| 45090-8 | Chlamydia trachomatis DNA [Presence] in Anal by NAA with probe detection |
| 339-2 | Miocamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 34183-4 | Beta globulin/Protein.total in 24 hour Urine |
| 34268-3 | Cobalt [Moles/volume] in Urine |
| 54019-5 | Lysozyme Ab [Presence] in Serum |
| 54224-1 | Lymphoma - T-cell markers [Interpretation] in Specimen Narrative |
| 54371-0 | Cholesterol [Moles/volume] in Peritoneal fluid |
| 54470-0 | Cholesterol in HDL 3b/Cholesterol in total HDL in Serum or Plasma by Electrophoresis |
| 24465-7 | Urea nitrogen [Mass/time] in 12 hour Urine |
| 55483-2 | Insulin [Moles/volume] in Serum or Plasma --1.5 hours post dose glucose IV |
| 47190-4 | Proinsulin [Moles/volume] in Serum or Plasma --baseline |
| 47199-5 | Methionine [Mass] of Dose |
| 47254-8 | Coproporphyrin 3 [Mass/volume] in 24 hour Urine |
| 35345-8 | Amylase [Enzymatic activity/volume] in Body fluid --2nd specimen post Sincalide |
| 55873-4 | Palmitate (C16:0)/Laurate (C12:0) [Molar ratio] in Serum or Plasma |
| 35391-2 | Taenia solium larva IgG Ab [Units/volume] in Cerebral spinal fluid |
| 35483-7 | Mevinphos [Mass/volume] in Serum or Plasma |
| 35635-2 | traZODone [Mass/volume] in Serum or Plasma by Screen method |
| 5641-6 | Ethanol [Mass/volume] in Exhaled gas |
| 5653-1 | Formaldehyde [Mass/volume] in Urine |
| 56591-1 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 48829-6 | Respiratory allergen panel, US - South central states - Serum |
| 48841-1 | Respiratory allergen panel, US - Alaska a - Serum |
| 27076-9 | Dextromethorphan+Levorphanol [Presence] in Urine |
| 38501-3 | Spermatozoa Progressive Grade 2/100 spermatozoa in Semen |
| 57644-7 | Androsterone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
| 27411-8 | Iron/Creatinine [Mass Ratio] in Urine |
| 2789-6 | Phosphoethanolamine [Mass/volume] in Serum or Plasma |
| 3947-9 | PHENobarbital [Presence] in Serum or Plasma |
| 49750-3 | Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma |
| 29290-4 | Carbon disulfide [Mass/volume] in Blood |
| 29295-3 | Phenylethylmalonamide [Mass/volume] in Urine |
| 3986-7 | Prolintane [Mass/time] in 24 hour Urine |
| 40176-0 | Glucose [Moles/volume] in Serum or Plasma --12 hours post XXX challenge |
| 49771-9 | Onchocerca sp IgG Ab [Units/volume] in Serum by Immunoassay |
| 49996-2 | Borrelia burgdorferi 83/93kD IgG Ab [Presence] in Serum by Immunoblot |
| 29711-9 | Rickettsia typhi Ab [Titer] in Serum by Immunofluorescence |
| 40483-0 | Phosphate crystals amorphous [#/area] in Urine sediment by Microscopy low power field |
| 50178-3 | Lymphocyte proliferation stimulated by 100 umol beryllium [Ratio] in Blood --6 days post incubation |
| 50263-3 | 17-Ketosteroids [Mass/time] in 24 hour Urine --post high dose dexamethasone |
| 20506-2 | Specimen drawn from |
| 20920-5 | Organophosphate pesticides [Presence] in Tissue by Screen method |
| 100421-7 | Chick Pea IgG Ab [Units/volume] in Serum |
| 12500-5 | Secobarbital [Presence] in Stool |
| 1260-9 | N Ag [Presence] on Red Blood Cells from Donor |
| 101502-3 | Cefepime [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 101589-0 | Histoplasma capsulatum+Blastomyces dermatitidis Ag [Mass/volume] in Serum or Plasma by Immunoassay |
| 101642-7 | Cardiovascular risk panel - Serum or Plasma |
| 13075-7 | Phosphatidylcholine IgA Ab [Units/volume] in Serum |
| 13-3 | Amikacin [Susceptibility] by Disk diffusion (KB) |
| 101940-5 | Candida glabrata DNA [Presence] in Specimen by NAA with probe detection |
| 1345-8 | Yt sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 102313-4 | Horse Fly IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102335-7 | Canadian blue grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102405-8 | Lemon IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102521-2 | Austrian Pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14158-0 | Cortisol [Mass/time] in 24 hour Urine |
| 14327-1 | Epithelial cells.squamous [Presence] in Sputum by Light microscopy |
| 14336-2 | Ethanol [Mass/volume] in Serum or Plasma by Gas chromatography |
| 102792-9 | Jalepeno Pepper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102985-9 | Japanese hop IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1441-5 | Cortisol [Mass/volume] in Serum or Plasma --9 hours post 3 g metyraPONE PO overnight |
| 147-9 | Cefuroxime Parenteral [Susceptibility] by Serum bactericidal titer |
| 104105-2 | Ethyl glucuronide [Presence] in Serum or Plasma |
| 14938-5 | Urea nitrogen [Moles/volume] in Urine |
| 15075-5 | Glucose [Moles/volume] in Dialysis fluid |
| 10546-0 | Normethsuximide [Mass/volume] in Serum or Plasma |
| 10753-2 | Fat.microscopic observation [Identifier] in Stool by Sudan IV stain |
| 17136-3 | CD3+DR+ cells/100 cells in Blood |
| 17374-0 | Norepinephrine [Mass/volume] in Urine --7th specimen post XXX challenge |
| 90245-2 | Natural killer cell cytotoxicity.IL-stimulated 3.75:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
| 76705-3 | Trichomonas vaginalis [Presence] in Specimen by Gram stain |
| 92826-7 | Renin [Units/volume] in Plasma --supine |
| 93240-0 | dRVVT factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:1 addition of normal plasma and heparin neutralization |
| 9333-6 | Chloroform [Mass/volume] in Blood |
| 61247-3 | Grapefruit IgE Ab/IgE total in Serum |
| 7723-0 | Sugar Cane IgE Ab [Units/volume] in Serum |
| 7738-8 | Timothy triggered histamine release [Units/volume] in Blood |
| 93943-9 | little e Ag [Presence] in Cord red blood cells |
| 62442-9 | Nucleated erythrocytes/100 leukocytes [Ratio] in Synovial fluid by Automated count |
| 94628-5 | Mycoplasma bovis DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 94629-3 | Mycobacterium avium ss paratuberculosis DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 78860-4 | Mirtazapine cutoff [Mass/volume] in Urine for Confirmatory method |
| 79599-7 | Cysteate/Creatinine [Molar ratio] in Urine |
| 79605-2 | R- and S-beta aminoisobutyrate and D- and L-serine panel - Urine |
| 6765-2 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma |
| 6842-9 | Halibut IgE Ab [Units/volume] in Serum |
| 80518-4 | Clostridium baratii toxin F bont gene [Presence] in Specimen by NAA with probe detection |
| 69549-4 | Genetic knowledge reference [Identifier] |
| 97520-1 | Histoplasma capsulatum mycelial phase Ab band pattern [Identifier] in Specimen by Immune diffusion (ID) |
| 710-4 | Blood smear finding positive [Identifier] in Blood by Light microscopy |
| 82309-6 | Basis for allelic phase [Type] |
| 99780-9 | Multidrug resistant gram-negative organism classification [Type] |
| 72612-5 | ALPRAZolam [Presence] in Saliva (oral fluid) |
| 7268-6 | Cucumber IgG Ab [Units/volume] in Serum |
| 86120-3 | Streptococcus pneumoniae Danish serotype 4 Ab [Mass/volume] in Serum --2nd specimen |
| 73164-6 | Risedronate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87338-0 | Porcine circovirus type 2 strain identified [Type] in Isolate by Sequencing |
| 73588-6 | Sarafloxacin [Susceptibility] |
| 74396-3 | Large unstained cells/100 leukocytes in Cord blood by Automated count |
| 88740-6 | Titin Ab [Units/volume] in Serum by Line blot |
| 41194-2 | West Nile virus Ab [Units/volume] in Serum by Immunoassay |
| 41393-0 | Collection date of Body fluid |
| 41721-2 | Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 59347-5 | Tamoxifen [Mass/volume] in Blood |
| 59669-2 | Estazolam [Mass/mass] in Stool by Confirmatory method |
| 50640-2 | CD3+CD57+ cells [#/volume] in Blood |
| 30435-2 | Monocytes [#/volume] in Synovial fluid |
| 31124-1 | CD20+CD25+ cells/100 cells in Blood |
| 31386-6 | Feline herpesvirus 1 Ab [Presence] in Serum |
| 51254-1 | CD16+CD56+ cells/100 cells in Cerebral spinal fluid |
| 4289-5 | Insulin ultralente [Mass] of Dose |
| 42976-1 | PRRSV Ab [Titer] in Serum |
| 31612-5 | Rift valley fever virus Ab [Units/volume] in Serum |
| 32113-3 | Sertraline [Presence] in Specimen |
| 43979-4 | Aspergillus sp identified in Specimen by Organism specific culture |
| 43981-0 | Choriogonadotropin.intact [Multiple of the median] adjusted in Serum or Plasma |
| 44057-8 | CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Cerebral spinal fluid |
| 32640-5 | BLM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 4478-4 | Complement C1q [Mass/volume] in Serum or Plasma |
| 23494-8 | Transmissible gastroenteritis virus Ag [Presence] in Stool by Immunoassay |
| 33592-7 | CD10+HLA-DR+ cells [#/volume] in Blood |
| 33685-9 | Yersinia pestis [Presence] in Specimen by Organism specific culture |
| 53578-1 | Alkaline phosphatase.intestinal 2/Alkaline phosphatase.total in Serum or Plasma |
| 45292-0 | Coxsackievirus B1 Ab [Presence] in Body fluid |
| 3409-0 | Bumetanide [Presence] in Urine |
| 34174-3 | Hemoglobin casts [Presence] in Urine sediment by Light microscopy |
| 54100-3 | Monocyclohexyl methylphosphonate [Mass/volume] in Urine |
| 2458-8 | IgA [Mass/volume] in Serum or Plasma |
| 3454-6 | Cephalothin [Mass/volume] in Serum or Plasma |
| 25373-2 | Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma |
| 35144-5 | Neuronal nuclear type 3 Ab [Titer] in Cerebral spinal fluid |
| 55684-5 | Isoconazole [Susceptibility] by Gradient strip |
| 5572-3 | Aluminum [Mass/volume] in Dialysis fluid |
| 4764-7 | HLA-B55(22) [Presence] in Donor |
| 47855-2 | Fibroblast growth factor 23.C-terminal [Units/volume] in Plasma |
| 35707-9 | Alkaline phosphatase.macrohepatic/Alkaline phosphatase.total in Serum or Plasma |
| 35783-0 | Cefuroxime Oral [Susceptibility] |
| 56302-3 | Beta lactoglobulin IgG4 Ab [Mass/volume] in Serum |
| 48122-6 | Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose TRH |
| 56622-4 | Echovirus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 4859-5 | HLA-Cw5 [Presence] |
| 2725-0 | Para methylhippurate [Mass/volume] in Urine |
| 27831-7 | Immune complex [Units/volume] in Serum or Plasma by C1q binding assay |
| 27982-8 | Borrelia burgdorferi 66kD Ab [Presence] in Serum by Immunoblot |
| 27994-3 | Ehrlichia chaffeensis DNA [Presence] in Blood by NAA with probe detection |
| 58059-7 | Do sup(b) Ab [Presence] in Serum or Plasma |
| 2826-6 | Potassium [Moles/time] in 72 hour Stool |
| 3977-6 | Prazepam [Mass/volume] in Serum or Plasma |
| 40040-8 | Glucose [Mass/volume] in Serum or Plasma --28 hours post XXX challenge |
| 29569-1 | West Nile virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 29988-3 | Gold/Creatinine [Mass Ratio] in 24 hour Urine |
| 40858-3 | Glucose [Mass/volume] in Capillary blood --baseline |
| 40992-0 | Rhinovirus+Enterovirus Ag [Presence] in Specimen by Immunofluorescence |
| 1934-9 | Beta aminoisobutyrate [Presence] in Plasma |
| 19493-6 | Hydroxyethylflurazepam [Presence] in Urine by Screen method |
| 1964-6 | Bicarbonate [Moles/volume] in Urine |
| 19744-2 | Jackfruit IgE Ab [Units/volume] in Serum |
| 20538-5 | Methotrimeprazine [Mass/volume] in Urine by Confirmatory method |
| 20700-1 | Bluetongue virus RNA [Presence] in Tissue by NAA with probe detection |
| 20888-4 | Molybdenum [Mass/mass] in Feed |
| 20996-5 | Coxsackievirus B1+B2+B3+B4+B5+B6 Ab [Interpretation] in Serum |
| 101115-4 | Leukotriene E4/Creatinine [Mass Ratio] in 24 hour Urine |
| 101184-0 | 4F-MDMB-BINACA [Mass/volume] in Urine by Confirmatory method |
| 101493-5 | Amikacin [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 13556-6 | Demoxepam [Presence] in Serum or Plasma |
| 14278-6 | Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence |
| 102760-6 | Lamb IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102780-4 | Oregano IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102940-4 | Stachybotrys chartarum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103830-6 | Gabapentin [Presence] in Meconium |
| 14913-8 | Testosterone [Moles/volume] in Serum or Plasma |
| 10466-1 | Anion gap 3 in Serum or Plasma |
| 10737-5 | Virus identified in Stool by Electron microscopy |
| 10790-4 | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Mayers progressive stain |
| 16265-1 | Triple phosphate crystals [Presence] in Stone by Infrared spectroscopy |
| 16350-1 | Amantadine [Susceptibility] by Serum bactericidal titer |
| 1218-7 | LW Ag [Presence] on Red Blood Cells from Donor |
| 12211-9 | Epithelial cells [Presence] in Vaginal fluid by Wet preparation |
| 16907-8 | Glucose [Presence] in Urine --4th specimen post XXX challenge |
| 17021-7 | Intercellular substance Ab [Units/volume] in Serum by Immunofluorescence |
| 17302-1 | Mycoplasma pneumoniae Ab [Presence] in Serum |
| 91784-9 | Varicella zoster virus [Presence] in Lower respiratory specimen by Organism specific culture |
| 92572-7 | Sodium [Molar amount] in 24 hour Dialysis fluid |
| 75740-1 | Lathosterol [Mass/volume] in Serum or Plasma |
| 75977-9 | Fetal Chromosome X and Y aneuploidy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
| 76546-1 | Breast cancer 10-year risk of distant recurrence panel by Prosigna |
| 7685-1 | Salmon IgG Ab [Units/volume] in Serum |
| 92863-0 | Herpes simplex virus 1 and 2 DNA panel - Skin by NAA with probe detection |
| 92867-1 | Herpes simplex virus 1 and 2 DNA panel - Blood by NAA with probe detection |
| 92934-9 | 9p21 g.22124478A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 93336-6 | Bile acid [Moles/time] in 48 hour Stool |
| 93351-5 | HLA-DR Ag [Entitic number] on Monocyte by Flow cytometry (FC) |
| 77063-6 | TAT gene full mutation analysis in Blood or Tissue by Sequencing |
| 9420-1 | Entamoeba histolytica Ab [Titer] in Serum by Complement fixation |
| 63296-8 | Nuclear Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 77957-9 | Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination |
| 78376-1 | Epipregnanolone [Moles/time] in 24 hour Urine |
| 94872-9 | Cholesterol and triglyceride panel - Body fluid |
| 66-1 | Cefadroxil [Susceptibility] by Serum bactericidal titer |
| 66879-8 | Skin IgG Ab [Titer] in Serum by Guinea pig esophagus substrate |
| 81283-4 | Spermatozoa Nonprogressive [#] in Semen by Microscopy |
| 96986-5 | SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with non-probe detection |
| 69906-6 | Service comment 79 |
| 82064-7 | Food Allergen Mix 26 (Peanut+Cow milk+Egg white+Mustard) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 70086-4 | Interleukin 7 [Mass/volume] in Serum or Plasma |
| 70098-9 | Methotrexate [Moles/volume] in Serum or Plasma --10th specimen |
| 82550-5 | Food Allergen Mix 32 (Carob+Lentil+White bean+Pea) IgE Ab [Presence] in Serum by Multidisk |
| 827-6 | Am Ag [Presence] on Red Blood Cells from Blood product unit |
| 98057-3 | Penicillium digitatum IgE Ab [Units/volume] in Serum |
| 98127-4 | Normoblasts oxyphilic+polychromatophilic/Normoblasts.total in Bone marrow by Manual count |
| 99074-7 | Calcium/Creatinine [Mass Ratio] in Urine from Fetus |
| 71714-0 | Brucella abortus Ab [Presence] in Milk by Heat-inactivation ring test |
| 85956-1 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum |
| 73323-8 | ISOtretinoin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73379-0 | Finasteride induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 41752-7 | Ehrlichia chaffeensis Ab [Titer] in Serum |
| 51000-8 | Leishmania tropica IgG and IgM [Interpretation] in Serum Narrative |
| 42233-7 | Acetylcholine receptor ganglionic neuronal Ab [Moles/volume] in Serum |
| 42574-4 | 1-Naphthol [Presence] in Urine |
| 60319-1 | Naproxen [Moles/volume] in Specimen |
| 21420-5 | Nitrate [Mass/volume] in Urine |
| 31184-5 | Methyl amyl ketone [Mass/volume] in Urine |
| 51124-6 | CD22 blasts/100 blasts in Bone marrow |
| 51157-6 | CD33 blasts [Units/volume] in Bone marrow |
| 51309-3 | CD4+CD7-CD26- cells/100 cells in Bone marrow |
| 51332-5 | CD43 cells/100 cells in Body fluid |
| 51338-2 | CD45 (Lymphs) cells/100 cells in Tissue |
| 42952-2 | Snowshoe hare virus Ab [Titer] in Serum |
| 21699-4 | HRAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 31879-0 | Measles virus Ag [Presence] in Nose |
| 5148-2 | Echovirus NOS neutralizing antibody [Titer] in Serum by Neutralization test |
| 43587-5 | Grape IgE Ab/IgE total in Serum |
| 43726-9 | 17-Ketogenic steroids [Presence] in 24 hour Urine |
| 22392-5 | Legionella pneumophila 6 IgM Ab [Titer] in Serum |
| 22768-6 | African horse sickness virus Ab [Presence] in Serum by Complement fixation |
| 52792-9 | Father's Rh Type |
| 5280-3 | Plasmodium vivax Ab [Units/volume] in Serum |
| 23725-5 | Feline immunodeficiency virus Ab [Titer] in Serum by Immunofluorescence |
| 46223-4 | Glucose [Moles/volume] in Dialysis fluid --overnight |
| 24395-6 | Cortisol [Moles/volume] in Serum or Plasma --24 hours post 1 mg dexamethasone PO overnight |
| 55518-5 | Testosterone [Moles/volume] in Serum or Plasma --4 hours post dose gonadotropin releasing hormone |
| 25134-8 | Sebacate (C8)/Creatinine [Molar ratio] in Urine |
| 25381-5 | Corticosterone [Moles/volume] in Serum or Plasma |
| 34966-2 | Osmotic fragility of Red Blood Cells--0.10% sodium chloride |
| 34972-0 | DNA index 3 in Specimen by Flow cytometry (FC) |
| 47918-8 | Somatotropin [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 25648-7 | Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --5th specimen post XXX challenge |
| 25741-0 | Prolactin [Mass/volume] in Serum or Plasma --50 minutes post 200 ug TRH IV |
| 25791-5 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 25838-4 | Herpes simplex virus 1 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 35612-1 | fluvoxaMINE [Mass/volume] in Serum or Plasma by Screen method |
| 35712-9 | Chlamydia sp rRNA [Presence] in Conjunctival specimen by Probe |
| 562-9 | Clostridioides difficile [Presence] in Stool by Organism specific culture |
| 56481-5 | Lambda light chains.free [Presence] in Urine by Immunofixation |
| 2613-8 | Methemoglobin [Presence] in Blood |
| 3713-5 | Levorphanol [Mass/time] in 24 hour Urine |
| 3796-0 | Methotrexate [Mass/volume] in Serum or Plasma --48 hours post dose |
| 26824-3 | Phosphoserine [Moles/volume] in Amniotic fluid |
| 2713-6 | Oxygen saturation Calculated from oxygen partial pressure in Blood |
| 57439-2 | Terminal deoxyribonucleotidyl transferase cells [Presence] in Body fluid |
| 48-9 | Bacampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 49180-3 | Ehrlichia chaffeensis IgG Ab [Titer] in Body fluid |
| 3965-1 | Phenylpropanolamine [Presence] in Urine |
| 49376-7 | Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection |
| 40014-3 | Glucose [Mass/volume] in Serum or Plasma --16 hours post XXX challenge |
| 40021-8 | Glucose [Mass/volume] in Serum or Plasma --21.5 hours post XXX challenge |
| 50149-4 | 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma |
| 29731-7 | Leptospira interrogans sv Zanoni Ab [Presence] in Serum by Agglutination |
| 29975-0 | Molybdenum [Mass/time] in 24 hour Urine |
| 50302-9 | Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Amniotic fluid |
| 50595-8 | Pathologist interpretation of Specimen tests |
| 19389-6 | Chlorpheniramine [Presence] in Urine by Screen method |
| 19443-1 | diazePAM [Presence] in Urine by Screen method |
| 19492-8 | Hydroxyalprazolam cutoff [Mass/volume] in Urine for Confirmatory method |
| 19501-6 | Ketamine cutoff [Mass/volume] in Urine for Screen method |
| 20426-3 | Alkaline phosphatase.bile [Enzymatic activity/volume] in Serum or Plasma |
| 101061-0 | Be^a Ab [Presence] in Serum or Plasma |
| 101373-9 | Francisella tularensis DNA [Presence] in Sputum by NAA with non-probe detection |
| 13340-5 | CD3+CD38+ cells/100 cells in Blood |
| 102073-4 | Perfluorododecanoate [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 13496-5 | Triple phosphate crystals [type] in Stone by Light microscopy |
| 1350-8 | Yt sup(b) Ab [Presence] in Serum or Plasma |
| 14341-2 | Globulin/Protein.total in 24 hour Urine by Electrophoresis |
| 102789-5 | Cayenne IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102913-1 | Sheep milk IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102947-9 | Australian pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15233-0 | Mold Allergen Mix A (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk |
| 10525-4 | Microscopic observation [Identifier] in Specimen by Cyto stain |
| 160-2 | Cephalothin [Susceptibility] by Minimum lethal concentration (MLC) |
| 16225-5 | Amitriptyline [Presence] in Urine by Confirmatory method |
| 16429-3 | Barbiturates [Presence] in Urine by Confirmatory method |
| 16444-2 | Benzophenone [Mass/volume] in Serum or Plasma |
| 16456-6 | Beta hydroxybutyrate [Moles/volume] in Urine |
| 1220-3 | Mg Ab [Presence] in Serum or Plasma from Blood product unit |
| 12268-9 | Urea nitrogen [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis |
| 16911-0 | Glucose [Presence] in Urine --8th specimen post XXX challenge |
| 17044-9 | Lamellar bodies [Presence] in Amniotic fluid |
| 17198-3 | CD8+CD28+ cells/100 cells in Blood |
| 17430-0 | Pentane [Mass/volume] in Blood |
| 18249-3 | Para aminobenzoate [Mass/volume] in Serum or Plasma |
| 18870-6 | Bacitracin [Susceptibility] |
| 91787-2 | Mumps virus [Presence] in Upper respiratory specimen by Organism specific culture |
| 60332-4 | QUEtiapine [Moles/volume] in Specimen |
| 60385-2 | Nutmeg IgG Ab [Mass/volume] in Serum |
| 76618-8 | Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 1-14C-glutamate substrate |
| 77021-4 | Fetal Y chromosome [Presence] based on Plasma cell-free DNA by Sequencing |
| 93317-6 | Platelet CD42a actual/normal in Blood by Flow cytometry (FC) |
| 93345-7 | Genetic variant effect on drug resistance in Blood or Tissue Narrative |
| 93834-0 | Coccidioides sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 9412-8 | Leucine [Moles/volume] in Cerebral spinal fluid |
| 63324-8 | Ribosomal IgG Ab [Presence] in Serum by Immunoassay |
| 9445-8 | 11-Oxopregnanetriol [Mass/time] in 24 hour Urine |
| 79616-9 | S-beta aminoisobutyrate [Moles/volume] in Cerebral spinal fluid |
| 95796-9 | Opioids panel - Urine by Screen method |
| 96361-1 | Dextromethorphan [Presence] in Saliva (oral fluid) by Confirmatory method |
| 68948-9 | Candida albicans Ab [Titer] in Serum by Immunofluorescence |
| 96606-9 | Treated sheep wool IgE Ab [Units/volume] in Serum |
| 70060-9 | Hantavirus seoul IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 81849-2 | t(1;13)(p36.13;q14.1)(PAX7,FOXO1) and t(2;13)(q36.1;q14.4)(PAX3,FOXO1) fusion transcript in Blood or Tissue by Molecular genetics method |
| 82043-1 | Weed Allergen Mix 6 (English plantain+Goosefoot or Lambs quarters+Saltwort+Sheep sorrel) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 97552-4 | Fractional oxyhemoglobin in Central venous blood |
| 82305-4 | Gastrointestinal pathogens panel - Stool by Culture |
| 823-5 | Au sup(a) Ab [Presence] in Serum or Plasma |
| 82517-4 | LAMA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 99011-9 | Leptospira sp Ab panel - Serum by Agglutination |
| 99027-5 | Pseudomonas aeruginosa DNA [Presence] in Urine by NAA with probe detection |
| 85626-0 | Kidney failure 2-year and 5-year risk panel by KFRE |
| 99363-4 | Spelt IgG Ab [Mass/volume] in Serum |
| 99531-6 | Volume of Pericardial space |
| 72587-9 | Beta globulin/Protein.total [Pure mass fraction] in Cerebral spinal fluid by Electrophoresis |
| 7267-8 | Cryptococcus terreus IgE Ab [Units/volume] in Serum |
| 73303-0 | Linezolid induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86896-8 | inFLIXimab [Mass/volume] in Serum or Plasma by Immunoassay |
| 74440-9 | Pemptoporphyrin [Moles/mass] in Stool |
| 41216-3 | Yellow fever virus IgM Ab [Presence] in Serum |
| 30469-1 | Unspecified cells/100 leukocytes in Body fluid |
| 30525-0 | Age |
| 30548-2 | Polio virus 3 Ab [Presence] in Serum |
| 42181-8 | Myocardium Ab [Presence] in Serum by Immunofluorescence |
| 59923-3 | Mefenamate [Moles/volume] in Gastric fluid |
| 6027-7 | Aspergillus versicolor IgE Ab [Units/volume] in Serum |
| 312-9 | Lymecycline [Susceptibility] by Disk diffusion (KB) |
| 31358-5 | Echovirus 9 Ab [Units/volume] in Cerebral spinal fluid |
| 51111-3 | CD2 blasts/100 blasts in Specimen |
| 51250-9 | CD15 cells/100 cells in Cerebral spinal fluid |
| 51372-1 | CD8+HLA-DR+ cells/100 cells in Bone marrow |
| 43192-4 | Legionella pneumophila 2+3+4+5+6+8 Ab [Titer] in Serum by Immunofluorescence |
| 32051-5 | Barbital [Presence] in Specimen |
| 5166-4 | Francisella tularensis Ab [Presence] in Serum by Latex agglutination |
| 43219-5 | traMADol [Presence] in Urine |
| 32170-3 | Cytomegalovirus Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 44331-7 | Isovalerylglycine/Creatinine [Mass Ratio] in 24 hour Urine |
| 44348-1 | Phenylalanine/Creatinine [Mass Ratio] in 24 hour Urine |
| 22817-1 | Avian infectious laryngotracheitis virus Ag [Presence] in Trachea by Immune diffusion (ID) |
| 23038-3 | Duck hepatitis virus 2 Ag [Presence] in Specimen by Neutralization test |
| 23132-4 | Histoplasma farciminosum Ab [Presence] in Serum by Immunofluorescence |
| 23147-2 | Japanese encephalitis virus Ab [Titer] in Serum |
| 23161-3 | Leishmania sp identified in Tissue by Electrophoresis |
| 32601-7 | CD59 cells/100 cells in Specimen |
| 3275-5 | Heparin unfractionated [Mass/time] in 24 hour Urine |
| 53240-8 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Propionylcarnitine (C3) [Molar ratio] in DBS |
| 44713-6 | Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Specimen by Immunoassay |
| 23249-6 | Mycoplasma agalactiae Ab [Presence] in Serum by Complement fixation |
| 33408-6 | Complement C2 [Units/volume] in Serum or Plasma |
| 53498-2 | Anthranilate [Moles/volume] in Urine |
| 53716-7 | levoFLOXacin [Susceptibility] by Method for Slow-growing mycobacteria |
| 54183-9 | Rifabutin [Susceptibility] by Disk diffusion (KB) |
| 54401-5 | Glucose [Moles/volume] in Serum or Plasma --10 minutes post dose glucagon |
| 46414-9 | Lutropin [Units/volume] in Serum or Plasma --15 minutes post dose gonadotropin releasing hormone |
| 24180-2 | Coxsackievirus B1 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen |
| 55496-4 | Insulin [Moles/volume] in Serum or Plasma --2 hours post dose glucose IV |
| 47051-8 | Treponema pallidum IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 47442-9 | Herpes virus 8 IgG Ab [Titer] in Serum |
| 35030-6 | Metamyelocytes [#/volume] in Cerebral spinal fluid |
| 55614-2 | Amoxicillin+Sulbactam [Susceptibility] |
| 47900-6 | Somatotropin [Units/volume] in Serum or Plasma --20 minutes post dose TRH |
| 4815-7 | HLA-B17 [Presence] |
| 26462-2 | Large unstained cells [#/volume] in Blood |
| 26540-5 | Glucose [Mass/volume] in Urine --3 hours post dose glucose |
| 38239-0 | CD4+CD95+ cells [#/volume] in Blood |
| 27123-9 | Phosphate [Mass/mass] in Red Blood Cells |
| 38564-1 | Spermatozoa.tail tip Motile w IgG/100 spermatozoa in Semen by Immunobead |
| 38623-5 | 1,2,4-Trichlorobenzene [Mass/volume] in Air |
| 57378-2 | Porphyrins/Creatinine [Molar ratio] in Urine |
| 49278-5 | Immunoelectrophoresis for Urine Narrative |
| 39483-3 | Normethsuximide [Moles/volume] in Serum or Plasma |
| 57720-5 | Newborn conditions with equivocal markers [Identifier] in DBS |
| 57863-3 | HYDROmorphone [Moles/volume] in Specimen |
| 5787-7 | Epithelial cells [#/area] in Urine sediment by Microscopy high power field |
| 5825-5 | Adenovirus Ag [Presence] in Stool by Immunoassay |
| 49412-0 | JC virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 28642-7 | Oxygen saturation in Arterial cord blood |
| 49909-5 | Interleukin 10 [Mass/volume] in Cerebral spinal fluid |
| 29902-4 | Chlorobenzene [Mass/volume] in Urine |
| 58821-0 | Cortisol [Mass/volume] in Serum or Plasma --23rd specimen |
| 59195-8 | 3-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in Serum or Plasma |
| 5034-4 | Streptococcus agalactiae rRNA [Presence] in Specimen by Probe |
| 50372-2 | Protoporphyrin [Mass/time] in 24 hour Urine |
| 100693-1 | Pneumocystis jiroveci DNA [Log #/volume] in Respiratory system specimen by NAA with probe detection |
| 101064-4 | Co3 Ag Ag [Presence] on Red Blood Cells |
| 12549-2 | Turpentine [Mass/volume] in Serum or Plasma |
| 101473-7 | Gas and electrolytes panel - Venous blood |
| 13868-5 | Renin [Enzymatic activity/volume] in Plasma --2 hours post 25 mg captopril PO |
| 13895-8 | Sodium [Moles/volume] in Milk |
| 10411-7 | Plasma given [Volume] |
| 10568-4 | Clarity of Semen |
| 15412-0 | Service comment 21 |
| 15423-7 | Service comment 32 |
| 15477-3 | Leptospira interrogans sv Canicola Ab [Titer] in Serum by Agglutination |
| 16120-8 | Brucella abortus IgM Ab [Titer] in Serum |
| 162-8 | Cephalothin [Susceptibility] by Disk diffusion (KB) |
| 1646-9 | Xylose [Mass/time] in 5 hour Urine --post dose PO |
| 11591-5 | Coxsackievirus A2 Ab [Units/volume] in Serum |
| 16853-4 | Fat [Mass] in Stool |
| 17451-6 | Phosphatidylglycerol IgA Ab [Presence] in Serum |
| 90288-2 | Norovirus genogroup I RNA [Presence] in Vomitus by NAA with probe detection |
| 90805-3 | Vedolizumab [Mass/volume] in Serum or Plasma by LC/MS/MS --trough |
| 91062-0 | Bacteria identified in Platelets from Blood product unit by Anaerobe culture |
| 7452-6 | Latex Bencard triggered histamine release [Units/volume] in Blood |
| 74777-4 | Human papilloma virus 6 DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 75019-0 | t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method |
| 91817-7 | Bordetella holmesii DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 92645-1 | Citalopram [Presence] in Urine by Confirmatory method |
| 7525-9 | Nigrospora oryzae IgE Ab [Units/volume] in Serum |
| 76651-9 | Zinc transporter 8 Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 93477-8 | Busulfan given [Mass] of Dose |
| 9416-9 | Acyclovir [Mass/volume] in Serum or Plasma |
| 63252-1 | Ganglioside GM3 IgG+IgM Ab [Presence] in Serum by Immunoassay |
| 77879-5 | Tapentadol cutoff [Mass/volume] in Urine for Confirmatory method |
| 94416-5 | SCN1A gene.c.603-91G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 94533-7 | SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory system specimen by NAA with probe detection |
| 63529-2 | Centromere Ab [Titer] in Body fluid by Immunofluorescence |
| 79126-9 | Uroporphyrin 1 isomer [Mass/time] in 24 hour Urine |
| 79417-2 | PMS2 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
| 95111-1 | Insulin [Units/volume] in Serum or Plasma --1.5 hours post meal |
| 6511-0 | Human papilloma virus Ab [Presence] in Genital specimen by Immunoblot |
| 95948-6 | Aloe vera IgE Ab [Units/volume] in Serum |
| 6974-0 | Zirconium [Mass/volume] in Specimen |
| 69830-8 | 3,4-Dihydroxyphenylacetate [Moles/volume] in 24 hour Urine |
| 69928-0 | European tick borne encephalitis virus IgG Ab index [Units/volume] in Serum and CSF by Immunoassay |
| 69965-2 | Clinical cytogeneticist review of results |
| 82205-6 | Cryptosporidium sp DNA [Presence] in Stool by NAA with non-probe detection |
| 9767-5 | Lymphocytic choriomeningitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 7080-5 | Anchovy IgG Ab [Units/volume] in Serum |
| 8232-1 | Phencyclidine [Presence] in Meconium |
| 7183-7 | Cashew nut IgG Ab [Units/volume] in Serum |
| 85476-0 | Influenza virus A and B and Respiratory syncytial virus RNA panel - Upper respiratory specimen by NAA with probe detection |
| 85512-2 | Hepatitis D virus RNA [Units/volume] (viral load) in Serum by NAA with probe detection |
| 99900-3 | Triple phosphate crystals [Presence] in Urine sediment by Computer assisted method |
| 72525-9 | Raltegravir [Susceptibility] by Genotype method |
| 72613-3 | Oxazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 72910-3 | HNA 4a/4b Ab [Presence] in Serum by Immunoassay |
| 867-2 | A3 Ag [Presence] on Red Blood Cells from Donor |
| 87352-1 | Senecavirus A whole genome [Nucleotide sequence] in Isolate by Sequencing |
| 87708-4 | Beta-2-Microglobulin [Mass/volume] in Serum or Plasma --post dialysis |
| 87754-8 | Terbufos [Mass/mass] in Specimen |
| 73473-1 | ceFAZolin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73736-1 | ACADVL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 73840-1 | 11-Dehydrotetrahydrocorticosterone [Moles/time] in 24 hour Urine |
| 74236-1 | Unidentified cells/100 leukocytes in Pericardial fluid by Manual count |
| 41644-6 | Calcium.ionized [Moles/volume] in Capillary blood |
| 50626-1 | DMD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 42214-7 | Speckled nuclear Ab pattern [Titer] in Body fluid |
| 59947-2 | OXcarbazepine [Moles/volume] in Urine |
| 60190-6 | Tin [Mass/volume] in Red Blood Cells |
| 603-1 | Bacteria identified in Burn by Culture |
| 21200-1 | Chromium [Mass/mass] in Nail |
| 42860-7 | Cannabinoids [Mass/volume] in Urine |
| 22175-4 | Chlamydophila psittaci Ab [Presence] in Serum |
| 31624-0 | Schistosoma sp IgG Ab [Units/volume] in Cerebral spinal fluid |
| 3201-1 | Coagulation factor VII Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 43380-5 | Coccidioides immitis IgG Ab [Units/volume] in Specimen |
| 32309-7 | Cholesterol.total/Cholesterol in HDL [Molar ratio] in Serum or Plasma |
| 51984-3 | Meperidine+Normeperidine [Presence] in Serum or Plasma by Screen method |
| 22837-9 | Avian pox virus Ab [Presence] in Serum by Agglutination |
| 53277-0 | Urinalysis type of cast panel - Urine by Computer assisted method |
| 53344-8 | Androstenedione [Moles/volume] in DBS |
| 53358-8 | Erythrocyte clumps [#/area] in Urine by Computer assisted method |
| 53459-4 | Decadienoylcarnitine (C10:2) [Moles/volume] in Amniotic fluid |
| 44602-1 | IgM.monoclonal [Presence] in Urine by Immunofixation |
| 53926-2 | Chlamydia trachomatis rRNA [Presence] in Vaginal fluid by NAA with probe detection |
| 45058-5 | cycloSPORINE Monoclonal and Polyclonal panel [Mass/volume] - Blood |
| 53971-8 | Spherocytes [Presence] in Urine sediment by Light microscopy |
| 54438-7 | Cholesterol/Total in Stone |
| 46410-7 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose arginine |
| 24382-4 | Neutrophil associated Ab [Identifier] in Serum |
| 34495-2 | TOR1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 25391-4 | Dehydroepiandrosterone (DHEA) [Moles/time] in 24 hour Urine |
| 56127-4 | CD38 Ag [Presence] in Tissue by Immune stain |
| 47650-7 | Homogentisate/Creatinine [Molar ratio] in Urine |
| 35605-5 | N-desalkylflurazepam [Mass/volume] in Serum or Plasma by Screen method |
| 35679-0 | Varicella zoster virus IgG and IgM panel - Cerebral spinal fluid |
| 56285-0 | Honey IgG4 Ab [Mass/volume] in Serum |
| 26487-9 | Monocytes/100 leukocytes in Body fluid |
| 56792-5 | Telbivudine [Susceptibility] by Genotype method |
| 38483-4 | Creatinine [Mass/volume] in Blood |
| 57555-5 | 18-Hydroxycorticosterone [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin |
| 49203-3 | Bartonella henselae IgG Ab [Titer] in Body fluid |
| 27916-6 | Calcium [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 3898-4 | Oxymetholone [Mass/volume] in Urine |
| 57725-4 | Corticotropin [Mass/volume] in Plasma --20 minutes post XXX challenge |
| 49642-2 | SCA1 gene allele 2 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 29331-6 | Glucose [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
| 29828-1 | La Crosse virus IgG Ab [Presence] in Specimen |
| 40656-1 | Parasite identified in Blood by Thick film |
| 50226-0 | Erythrocyte clumps [Presence] in Urine by Computer assisted method |
| 30384-2 | Erythrocyte distribution width [Entitic volume] |
| 100401-9 | Rabbit meat IgG Ab [Units/volume] in Serum |
| 12552-6 | Propylene glycol [Mass/volume] in Serum or Plasma |
| 12738-1 | Insulin [Mass/volume] in Serum or Plasma --pre XXX challenge |
| 101221-0 | PM-SCL-100 extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
| 101484-4 | Ceftolozane+Tazobactam [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 12966-8 | Urea nitrogen [Mass/volume] in Serum or Plasma --2 hour specimen |
| 102589-9 | Sericin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102774-7 | Nutmeg IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102824-0 | Zucchini IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14587-0 | Aldosterone [Moles/time] in 24 hour Urine |
| 103189-7 | Mycobacterium abscessus DNA [Presence] in Wound by NAA with probe detection |
| 104278-7 | BRAF gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 10443-0 | CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain |
| 10979-3 | Carisoprodol [Mass/volume] in Urine |
| 16600-9 | Chlamydia trachomatis rRNA [Presence] in Genital specimen by Probe |
| 11167-4 | Cockatiel feather IgE Ab [Units/volume] in Serum |
| 17017-5 | Insulin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 1855-6 | Androstenedione [Mass/volume] in Urine |
| 1899-4 | Argininosuccinate synthase [Enzymatic activity/mass] in Tissue |
| 90279-1 | Bacteria identified in Semen by Aerobe culture |
| 90749-3 | 4-Hydroxyatomoxetine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 74823-6 | Jamestown canyon virus Ab [Presence] in Serum by Immunoassay |
| 91136-2 | Lipoprotein metabolism panel - Serum or Plasma |
| 91542-1 | Myelin oligodendrocyte glycoprotein Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 75109-9 | Fatty acids.very long chain.C22:1n9 (Erucate) [Entitic substance] in Red Blood Cells |
| 61046-9 | Methylenedioxyamphetamine [Presence] in Specimen |
| 93018-0 | Polyclonal plasma cells [#] in Bone marrow by Flow cytometry (FC) |
| 77125-3 | PCDH15 gene full mutation analysis in Blood or Tissue by Sequencing |
| 94470-2 | VEGFA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 6353-7 | Chlamydia trachomatis Ag [Presence] in Tissue by Immunofluorescence |
| 64091-2 | Cells karyotyped.total [#] in Amniotic fluid |
| 78964-4 | N-acetylaspartylglutamate [Moles/volume] in Cerebral spinal fluid |
| 95278-8 | HSPB1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 66111-6 | Peritoneum Pathology biopsy report |
| 79683-9 | Cytosine [Moles/volume] in Cerebral spinal fluid |
| 80194-4 | Ecgonine methyl ester [Mass/volume] in Body fluid by Confirmatory method |
| 6888-2 | Alpha 2 globulin [Mass/volume] in Urine |
| 96926-1 | PCNA extractable nuclear Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 82303-9 | Escherichia coli O157 [Presence] in Stool by Culture |
| 82304-7 | Plesiomonas shigelloides [Presence] in Stool by Culture |
| 82536-4 | SOS1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 98489-8 | FLT3 gene internal tandem duplication length [#] in Blood or Tissue by Molecular genetics method |
| 83114-9 | S100 calcium binding protein B [Mass/volume] in Serum by Immunoassay |
| 85045-3 | Staphylococcus aureus glycopeptide resistant based on vancomycin and teicoplanin IC [Identifier] by ARD gradient strip |
| 85526-2 | Influenza virus D PB2 gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 72504-4 | CV2 Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 72648-9 | Glucose in serum - glucose in synovial fluid [Molar concentration difference] |
| 86547-7 | HIV 2 RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 87745-6 | Carbophenothion [Mass/mass] in Specimen |
| 73574-6 | Acyclovir [Susceptibility] by Genotype method |
| 88590-5 | Legionella pneumophila DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 31161-3 | Epidermal Allergen Mix 73 (Chicken feather+Duck feather+Goose feather+Parrot feather) IgE Ab [Units/volume] in Serum by Multidisk |
| 42320-2 | Glutathione reductase phenotype [Interpretation] in Red Blood Cells |
| 42627-0 | HIV 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 59927-4 | Methanol [Moles/volume] in Gastric fluid |
| 21215-9 | Collagen crosslinked N-telopeptide [Moles/volume] in Serum |
| 31369-2 | Epstein Barr virus capsid IgA Ab [Units/volume] in Serum |
| 31415-3 | Herpes virus 6 IgM Ab [Units/volume] in Cerebral spinal fluid |
| 21675-4 | FGFR2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 21697-8 | HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 21816-4 | t(5;12)(q33.1;p13)(PDGFRB,ETV6) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 31683-6 | Thermoactinomyces IgG Ab [Units/volume] in Serum |
| 43615-4 | Adenovirus Ag [Presence] in Genital specimen |
| 22715-7 | Homocystine [Moles/volume] in Specimen |
| 32518-3 | CD3+CD8+ (T8 suppressor) cells/100 cells in Specimen |
| 52770-5 | Clot formation.extrinsic coagulation system activated [Time] in Blood by Rotational TEG |
| 53011-3 | Signal Recognition Particle (SRP) Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 22986-4 | Capripox virus Ag [Presence] in Specimen by Immune diffusion (ID) |
| 23203-3 | Leptospira sp Ag [Presence] in Tissue by Immunofluorescence |
| 33037-3 | Anion gap in Serum or Plasma |
| 53170-7 | Tiglylcarnitine (C5:1) [Moles/volume] in DBS |
| 44507-2 | Herpes simplex virus IgM Ab [Presence] in Serum by Immunofluorescence |
| 44537-9 | HTLV I DNA [Presence] in Blood by NAA with probe detection |
| 2364-8 | Glutamate [Mass/volume] in Serum or Plasma |
| 33335-1 | Diphenylmethoxyacetate [Presence] in Urine by Screen method |
| 33415-1 | IgG [Mass/volume] in Urine |
| 53908-0 | Bacteria identified in Esophageal brushing by Culture |
| 45215-1 | Isoniazid 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 45353-0 | Date of analysis of unspecified specimen |
| 2376-2 | Glutathione peroxidase [Enzymatic activity/volume] in Serum or Plasma |
| 23836-0 | Carbon disulfide [Mass/volume] in Serum or Plasma |
| 33736-0 | Surgical margin tumor involvement.circumferential by CAP cancer protocols |
| 33764-2 | Shiga toxin stx gene [Identifier] in Specimen by NAA with probe detection |
| 33851-7 | Progesterone [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 46712-6 | Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Units/volume] in Serum by Multidisk |
| 24227-1 | Coxsackievirus A10 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24328-7 | Electrolytes 3 panel - Stool |
| 34328-5 | Levodopa [Moles/volume] in Serum or Plasma |
| 35059-5 | Granulocytes [#/volume] in Cerebral spinal fluid |
| 55942-7 | Methemoglobin/Hemoglobin.total in Cord blood |
| 47803-2 | Valine/Amino acids.total in Serum or Plasma |
| 25581-0 | C peptide [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 25952-3 | Lysine [Moles/volume] in 24 hour Urine |
| 35497-7 | NADH cytochrome C reductase [Enzymatic activity/mass] in Tissue |
| 35682-4 | Trypanosoma cruzi IgG and IgM panel - Serum |
| 5646-5 | Ethylene glycol [Mass/volume] in Serum, Plasma or Blood |
| 3616-0 | Ethosuximide [Mass/volume] in Serum or Plasma |
| 48564-9 | Bacteria # 5 identified in Specimen by Respiratory culture |
| 49064-9 | Gamma 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
| 27273-2 | Chlamydia sp Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 49624-0 | Cholesterol in VLDL 1+2 [Mass/volume] in Serum or Plasma |
| 39962-6 | Creatinine [Mass/volume] in Serum or Plasma --3.75 hours post XXX challenge |
| 40237-0 | Calcium [Moles/volume] in Serum or Plasma --7.5 hours post XXX challenge |
| 49798-2 | Taenia solium larva Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 49830-3 | Norcodeine [Mass/volume] in Serum or Plasma |
| 50151-0 | 5-Hydroxytryptophan [Moles/volume] in Urine |
| 29695-4 | Leptospira interrogans sv Bulgarica Ab [Presence] in Serum |
| 40569-6 | Eosinophils [#/volume] in Body fluid by Manual count |
| 50509-9 | Lutropin [Units/volume] in Serum or Plasma --1st specimen |
| 19276-5 | Barbiturates cutoff [Mass/volume] in Urine for Confirmatory method |
| 20956-9 | Sarcocystis neurona Ab [Presence] in Body fluid by Immunoblot |
| 100395-3 | Carob IgG Ab [Units/volume] in Serum |
| 100990-1 | Fathers Blood group antigens panel |
| 12532-8 | Meclizine [Presence] in Serum or Plasma |
| 101141-0 | NAT2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 101648-4 | 14-3-3 Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay |
| 13270-4 | Mycoplasma pneumoniae IgA Ab [Units/volume] in Serum |
| 101911-6 | Troponin T. cardiac [Mass/volume] in 2 hour 5th generation Serum or Plasma |
| 102020-5 | Glucose [Mass/volume] in Serum or Plasma --2 hours post dose glucagon |
| 13793-5 | Phenylpropionylglycine/Creatinine [Mass Ratio] in Urine |
| 102440-5 | Milk powder IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102554-3 | Rabbit urine proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14365-1 | Microscopic observation [Identifier] in Ear by Gram stain |
| 102718-4 | Cockatiel droppings IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103601-1 | Staphylococcus aureus MLVA type in Isolate or Specimen by Molecular genetics method |
| 103652-4 | 4-Hydroxyatomoxetine [Mass/volume] in Urine by Confirmatory method |
| 153-7 | Cephaloglycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 15455-9 | Bluetongue virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 1656-8 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma |
| 16893-0 | Gastrin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 17004-3 | Hypoxanthine [Mass/volume] in Urine |
| 17261-9 | Methapyrilene [Mass/volume] in Urine |
| 1835-8 | Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma |
| 18368-1 | Magnesium [Moles/time] in 2 hour Urine |
| 189-1 | Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 89998-9 | Microalbumin/Creatinine [Ratio] in Urine by Detection limit <= 3.0 mg/L |
| 91072-9 | Influenza virus A subtype [Identifier] in Lower respiratory specimen by NAA with probe detection |
| 74787-3 | Influenza virus B Victoria and Yamagata lineage RNA panel - Specimen |
| 7626-5 | Potato triggered histamine release [Units/volume] in Blood |
| 93693-0 | Nonalcoholic steatohepatitis grade in Serum or Plasma Qualitative |
| 61264-8 | Meadow Fescue IgE Ab/IgE total in Serum |
| 61273-9 | Barley IgE Ab/IgE total in Serum |
| 93924-9 | K Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant |
| 6270-3 | Tuna IgE Ab [Units/volume] in Serum |
| 6327-1 | Brucella canis Ab [Units/volume] in Serum by Immunoassay |
| 77774-8 | Norbuprenorphine cutoff [Mass/volume] in Urine for Confirmatory method |
| 9434-2 | Isopropanol [Mass/volume] in Urine |
| 94706-9 | CV2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 9477-1 | Lead [Mass/volume] in Water |
| 95182-2 | Ornithobacterium rhinotracheale Ab [Titer] in Serum by Immunoassay |
| 65773-4 | Buckwheat native (nFag e) 2 IgE Ab [Units/volume] in Serum |
| 6711-6 | Acetaminophen IgE Ab [Units/volume] in Serum |
| 80223-1 | CD4 cells/100 lymphocytes in Specimen |
| 6735-5 | Soybean IgG Ab [Units/volume] in Serum |
| 80553-1 | Voriconazole [Mass/volume] in DBS |
| 96979-0 | Trisomy 13, trisomy 18 or triploidy risk [Interpretation] in Plasma cell-free+WBC DNA Qualitative by calculation |
| 69553-6 | Lactose tolerance [Interpretation] in Serum or Plasma Narrative |
| 69795-3 | Dicarboxytetradecenoylcarnitine (C14:1-DC)/Creatinine [Molar ratio] in Urine |
| 81875-7 | SPAST gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 97756-1 | Androstenedione [Mass/volume] in Body fluid |
| 70248-0 | GALT gene p.Gln188Arg [Presence] in Blood or Tissue by Molecular genetics method |
| 70258-9 | Amylase.pancreatic [Enzymatic activity/volume] in Peritoneal fluid |
| 8249-5 | Transitional cells [Presence] in Urine sediment by Light microscopy |
| 72200-9 | Influenza virus A neuraminidase segment sequence identifier |
| 72257-9 | Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood |
| 73598-5 | Finafloxacin [Susceptibility] |
| 88041-9 | little p phenotype [Presence] on Red Blood Cells from Blood product unit |
| 88217-5 | Parechovirus RNA [Presence] in Aspirate by NAA with probe detection |
| 88277-9 | Streptococcus sp tuf gene [Presence] by Probe in Positive blood culture |
| 88510-3 | Natural killer cell cytotoxicity.30:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
| 74141-3 | Granulocytes/100 leukocytes in Peritoneal dialysis fluid |
| 88741-4 | U1 small nuclear ribonucleoprotein A Ab [Units/volume] in Serum by Line blot |
| 89525-0 | Ganglioside GM2 IgG Ab [Presence] in Serum by Line blot |
| 41223-9 | Waxy casts [#/area] in Urine sediment by Microscopy high power field |
| 50685-7 | Somatotropin [Mass/time] in 24 hour Urine |
| 308-7 | Loracarbef [Susceptibility] by Disk diffusion (KB) |
| 60048-6 | Acetaminophen [Mass/volume] in Blood |
| 21193-8 | chlordiazePOXIDE+Norchlordiazepoxide [Mass/volume] in Serum or Plasma |
| 2137-8 | Coproporphyrin [Mass/time] in 24 hour Urine |
| 21625-9 | ATM gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 31192-8 | Microscopic observation [Identifier] in Liver fine needle aspirate by Cyto stain |
| 31407-0 | Haemophilus somnus Ab [Units/volume] in Serum |
| 43105-6 | Acetaldehyde and Paraldehyde panel [Mass/volume] - Serum or Plasma |
| 31622-4 | Salmonella typhi O D Ab [Units/volume] in Serum |
| 31749-5 | Bovine herpesvirus 4 Ag [Presence] in Body fluid |
| 31751-1 | Bovine respiratory syncytial virus Ag [Presence] in Lung |
| 22605-0 | Varicella zoster virus IgM Ab [Titer] in Cerebral spinal fluid |
| 32149-7 | Urate/Total in Stone |
| 32531-6 | CD3+CD25+ cells/100 cells in Bone marrow |
| 23166-2 | Leptospira interrogans sv Autumnalis Ab [Presence] in Serum |
| 2360-6 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Leukocytes |
| 33252-8 | Monocytes [#/volume] in Cerebral spinal fluid by Manual count |
| 45045-2 | Yersinia pestis Ab [Presence] in Specimen by Hemagglutination |
| 23693-5 | Canine distemper virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 34244-4 | Arsenic [Moles/time] in 24 hour Urine |
| 53981-7 | Centromere protein B Ab [Presence] in Serum |
| 54154-0 | Intercellular bridge nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
| 46243-2 | Urea [Moles/volume] in Dialysis fluid --overnight |
| 34300-4 | Ethanolamine [Moles/volume] in Urine |
| 34640-3 | Bile acid [Mass/volume] in Body fluid |
| 47176-3 | Parathyrin.intact [Moles/volume] in Serum or Plasma --10 minutes post excision |
| 47358-7 | Hepatitis B virus core Ab [Presence] in Serum from Donor by Immunoassay |
| 55713-2 | Rosoxacin [Susceptibility] by Gradient strip |
| 25957-2 | Methionine sulfoxide [Moles/volume] in 24 hour Urine |
| 35473-8 | HEXA gene 7.6kb deletion [Presence] in Blood or Tissue by Molecular genetics method |
| 56245-4 | Deer Fly IgG4 Ab [Mass/volume] in Serum |
| 56246-2 | Dill IgG4 Ab [Mass/volume] in Serum |
| 48100-2 | Cortisol [Mass/volume] in Serum or Plasma --15 minutes pre 1 ug/kg CRH IV |
| 26670-0 | Rhizomucor pusillus Ab [Presence] in Serum |
| 26790-6 | chlordiazePOXIDE [Mass/mass] in Hair |
| 3663-2 | Gentamicin [Mass/volume] in Serum or Plasma --peak |
| 56662-0 | Beta-2-Microglobulin [Moles/time] in 24 hour Urine |
| 57098-6 | Follitropin [Units/volume] in Serum or Plasma --1.5 hours post dose gonadotropin releasing hormone |
| 48424-6 | Protein Fractions [Interpretation] in Body fluid |
| 48709-0 | Burr cells/100 erythrocytes in Cerebral spinal fluid by Manual count |
| 38297-8 | Di(2-Ethylhexyl) phthalate [Mass/volume] in Water |
| 57488-9 | 11-Ketoetiocholanolone [Mass/time] in 24 hour Urine --pre dose dexamethasone |
| 27280-7 | Tripelennamine [Mass/volume] in Urine |
| 27963-8 | Pyruvate [Mass/volume] in Blood --1 hour post XXX challenge |
| 27987-7 | Thyroxine (T4) free [Units/volume] in Serum or Plasma --baseline |
| 39612-7 | Silicone IgA Ab [Units/volume] in Serum by Immunoassay |
| 57781-7 | Chromosome breakage [Identifier] in Blood by Diepoxybutane Narrative |
| 5795-0 | Hippurate crystals [Presence] in Urine sediment by Light microscopy |
| 40060-6 | Albumin [Mass/volume] in Serum or Plasma --1 day post XXX challenge |
| 40189-3 | Glucose [Moles/volume] in Serum or Plasma --21.5 hours post XXX challenge |
| 40191-9 | Glucose [Moles/volume] in Serum or Plasma --23.5 hours post XXX challenge |
| 40308-9 | Somatotropin [Mass/volume] in Serum or Plasma --4 hours post dose arginine |
| 29791-1 | Powassan virus IgG Ab [Presence] in Specimen by Immunofluorescence |
| 29926-3 | Boron [Mass/volume] in 24 hour Urine |
| 58831-9 | Urea [Moles/volume] in Cerebral spinal fluid |
| 30395-8 | Granulocytes/100 leukocytes in Blood |
| 40798-1 | Amphetamines [Presence] in Hair by Screen method |
| 40870-8 | Cystine Free [Presence] in Serum or Plasma |
| 19550-3 | Methadone [Presence] in Urine by Screen method |
| 19755-8 | Saffron IgE Ab [Units/volume] in Serum |
| 20373-7 | Amikacin [Susceptibility] by Method for Slow-growing mycobacteria |
| 12944-5 | Thyrotropin [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 13251-4 | Herpes simplex virus 1 IgM Ab [Units/volume] in Cerebral spinal fluid |
| 1347-4 | Yt sup(a) Ag [Presence] on Red Blood Cells |
| 14681-1 | Creatinine [Moles/volume] in Peritoneal dialysis fluid |
| 103715-9 | GABAAR IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 15073-0 | Glucagon [Moles/volume] in Serum or Plasma |
| 16174-5 | Bartonella henselae IgG Ab [Presence] in Cerebral spinal fluid |
| 16349-3 | Aluminum [Mass/volume] in Body fluid |
| 16694-2 | Cumene [Presence] in Blood |
| 16909-4 | Glucose [Presence] in Urine --6th specimen post XXX challenge |
| 75395-4 | AIP gene full mutation analysis in Blood or Tissue by Sequencing |
| 7557-2 | Ovomucoid IgE Ab [Units/volume] in Serum |
| 76576-8 | Serratia marcescens gyrB gene [Presence] in Swab specimen by NAA with probe detection |
| 6189-5 | White Oak IgE Ab [Units/volume] in Serum |
| 62343-9 | Chromosome analysis copy number change panel by Microarray |
| 77639-3 | HLA class I and II IgG panel - Serum or Plasma by Immunoassay |
| 78212-8 | Cells.9q34 chromosome region deletion/Cells counted in Blood or Tissue by FISH |
| 94600-4 | Equine influenza virus [Presence] in Specimen by Organism specific culture |
| 94640-0 | SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory system specimen by NAA with probe detection |
| 94697-0 | Encephalopathy autoimmune Ab panel - Serum or Plasma |
| 94841-4 | Potassium [Moles/volume] in Urine from Fetus |
| 6479-0 | Mumps virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 95206-9 | Hepatitis C virus Ab panel - Serum or Plasma |
| 65322-0 | Gy sup(a) Ab [Presence] in Serum or Plasma |
| 9574-5 | Respiratory syncytial virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 96286-0 | Ketoprofen IgE Ab [Units/volume] in Serum |
| 80674-5 | Adenovirus 40+41 fiber protein gene [Presence] in Stool by NAA with probe detection |
| 9653-7 | Trichlormethiazide [Mass/volume] in Urine |
| 9658-6 | Giardia lamblia IgA Ab [Units/volume] in Serum |
| 69371-3 | B Ab [Presence] in Cord blood |
| 69916-5 | Basophils+Mast cells/100 leukocytes in Synovial fluid |
| 8219-8 | Opiates [Presence] in Serum or Plasma by Screen method |
| 97259-6 | Hydroxytriazolam [Presence] in Cord tissue by Confirmatory method |
| 97587-0 | Tetrahydrocannabinol [Presence] in Cord tissue by Confirmatory method |
| 97938-5 | Color.reverse pigment [Type] in Isolate by Culture |
| 70130-0 | Rickettsia typhus group and Rickettsia spotted fever group acute and convalescent IgG and IgM panel - Serum by Immunofluorescence |
| 7075-5 | Alternaria sp IgG Ab [Units/volume] in Serum |
| 82448-2 | TIF1-gamma Ab [Presence] in Serum by Line blot |
| 98186-0 | Aspartame IgE Ab [Units/volume] in Serum |
| 71851-0 | Oxygen saturation [Pure mass fraction] in Capillary blood |
| 83101-6 | HIV 1+2 Ab and HIV1 p24 Ag panel - Serum or Plasma by Immunoassay |
| 99967-2 | Atypical hemolytic uremic syndrome multigene analysis in Blood or Tissue by Molecular genetics method |
| 86179-9 | Streptococcus pneumoniae Danish serotype 9N Ab [Mass/volume] in Serum --1st specimen |
| 73304-8 | Lidocaine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87484-2 | BB-22 3-carboxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 87644-1 | Ethoprop [Mass/mass] in Specimen |
| 88008-8 | Palmitoylcarnitine (C16)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma |
| 74390-6 | Baclofen [Mass/mass] in Specimen |
| 30420-4 | Large granular lymphocytes/100 leukocytes in Blood |
| 30485-7 | Uracil [Presence] in Urine |
| 30575-5 | Xylose [Mass/volume] in Serum or Plasma --baseline |
| 42217-0 | Striated muscle IgG Ab [Titer] in Serum |
| 2117-0 | Choriogonadotropin.intact [Moles/volume] in Serum or Plasma |
| 31201-7 | HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay |
| 31392-4 | Feline panleukopenia virus IgM Ab [Units/volume] in Serum |
| 51487-7 | Leukocytes [#/volume] in Urine by Automated count |
| 51500-7 | Estradiol (E2) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 51757-3 | POMT1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 43813-5 | Reagin Ab [Presence] in Cord blood |
| 22330-5 | Hepatitis D virus Ab [Units/volume] in Serum |
| 2252-5 | Estriol (E3) [Mass/volume] in Urine |
| 22734-8 | Ethylene glycol [Moles/volume] in Specimen |
| 32344-4 | Urobilin [Presence] in Stool |
| 32495-4 | CD25 cells/100 cells in Specimen |
| 52129-4 | INR in Platelet poor plasma by Coagulation assay --post heparin neutralization |
| 44050-3 | Glucose phosphate isomerase [Enzymatic activity/mass] in Red Blood Cells |
| 44073-5 | CD20+CD52+ cells/100 cells in Tissue |
| 44294-7 | Albumin/Globulin [Mass Ratio] in 24 hour Urine by Electrophoresis |
| 53198-8 | Palmitoleylcarnitine (C16:1) [Moles/volume] in DBS |
| 44590-8 | IgA.secretory [Presence] in Saliva (oral fluid) |
| 4461-0 | Warfarin [Mass] of Dose |
| 23357-7 | Peste des petits ruminants virus Ag [Presence] in Tissue by Immune diffusion (ID) |
| 33681-8 | Francisella tularensis [Presence] in Specimen by Cell wall fatty acid analysis |
| 53846-2 | Buprenorphine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 23774-3 | Pseudorabies virus Ag [Presence] in Tissue by Immunofluorescence |
| 24295-8 | Parainfluenza virus 2 Ab [Titer] in Serum --2nd specimen |
| 47410-6 | Herpes virus 6 DNA [Identifier] in Serum or Plasma by NAA with probe detection |
| 25099-3 | Ethylmalonate/Creatinine [Molar ratio] in Urine |
| 55603-5 | Microscopic observation [Identifier] in Synovial fluid by Cyto stain |
| 55818-9 | Organic acids [Moles/mass] in Stool |
| 56253-8 | Egg white IgG4 Ab [Mass/volume] in Serum |
| 48103-6 | Cortisol [Moles/volume] in Serum or Plasma --4 AM specimen |
| 26553-8 | Glucose [Presence] in Urine by Test strip --1.5 hours post dose glucose |
| 48827-0 | Respiratory allergen panel, US - Subtropical Florida - Serum |
| 26844-1 | Methionine [Moles/volume] in Amniotic fluid |
| 38531-0 | BRCA2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 38654-0 | Chloroacetate [Mass/volume] in Air |
| 57699-1 | Biotinidase deficiency newborn screening comment-discussion |
| 57824-5 | Cortisol Free [Mass/volume] in Serum or Plasma --AM peak specimen |
| 49404-7 | Herpes virus 8 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 49542-4 | Date and time of pheresis procedure |
| 28584-1 | 2-Oxoadipate/Creatinine [Ratio] in Urine |
| 2881-1 | Protein [Mass/volume] in Body fluid |
| 50056-1 | Nutritional risk index |
| 29570-9 | West Nile virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test |
| 40376-6 | Lutropin [Units/volume] in Serum or Plasma --2 hours post dose triple bolus |
| 30046-7 | Legionella pneumophila Ab [Units/volume] in Serum by Immunoassay |
| 41005-0 | Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection |
| 20389-3 | Mupirocin [Susceptibility] |
| 20411-5 | Barbiturates [Mass/volume] in Urine by Confirmatory method |
| 20897-5 | Mycoplasma sp serotype [Identifier] in Isolate |
| 100385-4 | Corn salad IgG Ab [Units/volume] in Serum |
| 12444-6 | Nortrimipramine [Mass/volume] in Urine |
| 101782-1 | Fusarium solani DNA [Presence] in Specimen by NAA with probe detection |
| 13564-0 | Ibuprofen [Presence] in Serum or Plasma |
| 14133-3 | Silver Maple IgE Ab [Units/volume] in Serum |
| 14207-5 | Streptococcal DNAse B [Titer] in Serum |
| 103118-6 | English walnut recombinant (rJug r) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103129-3 | Peanut recombinant (rAra h) 6 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10398-6 | I Ag [Presence] on Red Blood Cells from Blood product unit |
| 14864-3 | Oxygen [Partial pressure] in Cord blood |
| 10435-6 | C5B-9 Ag [Presence] in Tissue by Immune stain |
| 10523-9 | Fibrinogen Ag [Presence] in Tissue by Immune stain |
| 10954-6 | Pine Nut IgE Ab [Units/volume] in Serum |
| 16617-3 | Choriogonadotropin.intact [Moles/volume] in Semen |
| 16757-7 | diazePAM+Nordiazepam [Mass/volume] in Serum or Plasma |
| 17251-0 | Mepivacaine [Presence] in Serum or Plasma |
| 17320-3 | Nefazodone [Mass/volume] in Urine |
| 19141-1 | Propoxyphene [Presence] in Urine |
| 90328-6 | Porcine circovirus type 3 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 90468-0 | Hydroxyaripiprazole [Presence] in Urine by Screen method |
| 90920-0 | Lysophosphatidylcholine(20:0) [Mass/volume] in DBS |
| 7472-4 | Locust tree IgE Ab [Units/volume] in Serum |
| 92636-0 | APOL1 inferred genotype [Identifier] in Plasma from Donor |
| 75888-8 | HCV RNA screening tests - Meaningful Use set |
| 93467-9 | Butyrylfentanyl [Mass/volume] in Urine by Confirmatory method |
| 77933-0 | Cortisol [Moles/volume] in Serum or Plasma --9 hours post XXX challenge |
| 94598-0 | Equine herpesvirus 2 RNA [Presence] in Specimen by NAA with probe detection |
| 79284-6 | Carnitine biosynthesis intermediates panel - DBS |
| 79390-1 | Gastrointestinal pathogens identified in Stool by NAA with probe detection |
| 95835-5 | CD34 cells [#] in Blood product unit |
| 96806-5 | Ginseng IgE Ab [Units/volume] in Serum |
| 96815-6 | Piper gurnard IgE Ab [Units/volume] in Serum |
| 81657-9 | Salmonella sp spaO gene [Presence] in Stool by NAA with probe detection |
| 9726-1 | Mescaline [Mass/volume] in Urine |
| 71626-6 | Mesothelial cells/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
| 97982-3 | Cultivated Corn IgG4 Ab [Mass/volume] in Serum |
| 83070-3 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma by Immunoassay |
| 99380-8 | Mercury [Moles/volume] in Cerebral spinal fluid |
| 99903-7 | Urate crystals [Presence] in Urine sediment by Computer assisted method |
| 72666-1 | Nitrazepam [Mass/volume] in Serum or Plasma --trough |
| 72959-0 | raNITIdine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 85964-5 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 73247-9 | Niacin+Lovastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87313-3 | Clostridium perfringens iota toxin DNA [Presence] in Isolate by NAA with probe detection |
| 87403-2 | Platelet aggregation ristocetin induced in Platelet rich plasma --750 ug/mL |
| 73693-4 | African swine fever virus DNA [Cycle Threshold #] in Tissue by NAA with probe detection |
| 88559-0 | Parainfluenza virus 2 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 59385-5 | Nitrogen [Mass/mass] in Stool by Infrared spectroscopy |
| 59703-9 | LORazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 30934-4 | Natriuretic peptide B [Mass/volume] in Serum or Plasma |
| 31014-4 | Corynebacterium diphtheriae Ab [Units/volume] in Serum --2nd specimen |
| 42211-3 | Myelin associated glycoprotein/Sulfated glucuronic paragloboside Ab [Titer] in Serum |
| 42513-2 | IgE [Units/volume] in Cerebral spinal fluid |
| 31557-2 | Parvovirus B19 IgG Ab [Units/volume] in Cerebral spinal fluid |
| 43195-7 | Nicotine [Presence] in Urine by Confirmatory method |
| 22092-1 | Infectious bronchitis virus Ark-99 Ab [Titer] in Serum |
| 22138-2 | Borrelia hermsii IgG Ab [Titer] in Serum |
| 436-6 | Rolitetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 43740-0 | Glucose/Insulin [Mass Ratio] in Serum or Plasma |
| 43950-5 | CD2 cells [#/volume] in Body fluid |
| 32600-9 | Felbamate [Mass] of Dose |
| 32768-4 | Trichinella sp IgG Ab [Units/volume] in Serum |
| 53171-5 | 3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0) [Molar ratio] in DBS |
| 44697-1 | Lesion size.maximum dimension in Skin |
| 44718-5 | Lipoprotein.pre-beta/Triglyceride [Mass Ratio] in Serum or Plasma |
| 44824-1 | Leishmania donovani IgG Ab [Titer] in Serum by Immunofluorescence |
| 33724-6 | Collection method - |
| 44996-7 | Chlamydia trachomatis B IgA Ab [Presence] in Serum |
| 23918-6 | Osmotic fragility of Red Blood Cells--0.60% sodium chloride 24 hour 37 degree C incubation |
| 34194-1 | Fructose [Mass/volume] in Body fluid |
| 34262-6 | Catecholamines/Creatinine [Molar ratio] in Urine |
| 24278-4 | Legionella pneumophila Ab [Titer] in Serum --2nd specimen |
| 54922-0 | Phosphate [Mass/time] in 12 hour Urine |
| 25161-1 | Hippurate crystals [#/area] in Urine sediment by Microscopy high power field |
| 25476-3 | Methionine [Moles/time] in 24 hour Urine |
| 35046-2 | Abnormal lymphocytes [#/volume] in Body fluid |
| 35177-5 | Polyunsaturated fatty acids [Moles/volume] in Serum or Plasma |
| 26009-1 | Treponema pallidum Ab [Titer] in Serum by Hemagglutination |
| 35437-3 | HIV 1 Ab [Presence] in Saliva (oral fluid) by Immunoassay |
| 35482-9 | Para nitrophenol [Mass/volume] in Serum or Plasma |
| 56143-1 | Potassium/Creatinine [Molar ratio] in 24 hour Urine |
| 48188-7 | Latex triggered leukotriene release [Mass/volume] by Leukocytes |
| 48343-8 | Hemoglobin.other/Hemoglobin.total in Blood |
| 2611-2 | Methcoproporphyrin [Mass/volume] in Serum or Plasma |
| 38163-2 | Heptacarboxylporphyrin/Creatinine [Mass Ratio] in Urine |
| 48370-1 | Dihomogammalinolenate (C20:3n-6) [Moles/volume] in Serum or Plasma |
| 48380-0 | 3-Methoxytyramine [Moles/volume] in 24 hour Urine |
| 48791-8 | Urea nitrogen peritoneal dialysis clearance/1.73 sq M |
| 27074-4 | Methylenedioxyethylamphetamine [Mass/volume] in Milk |
| 38458-6 | Crystals [Presence] in Synovial fluid by Light microscopy |
| 5751-3 | Uranium [Mass/volume] in Blood |
| 5759-6 | Dimethylbenzene [Mass/volume] in Serum or Plasma |
| 49179-5 | Ehrlichia chaffeensis IgM Ab [Titer] in Body fluid |
| 4929-6 | HLA-DPw5 [Presence] |
| 27871-3 | Interferon beta IgG Ab [Units/volume] in Serum or Plasma |
| 49340-3 | Adenovirus DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 29387-8 | Norpropoxyphene [Mass/volume] in Gastric fluid |
| 29413-2 | Reovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 40008-5 | Glucose [Mass/volume] in Serum or Plasma --11.5 hours post XXX challenge |
| 29585-7 | Immunoelectrophoresis panel - Urine |
| 2963-7 | Somatotropin [Mass/volume] in Serum or Plasma |
| 29795-2 | Trivittatus virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test |
| 40392-3 | Pentacarboxylate [Moles/time] in 24 hour Urine |
| 58849-1 | Somatotropin [Mass/volume] in Serum or Plasma --15th specimen |
| 59020-8 | HLA-DRB5 [Type] |
| 59157-8 | Glucose [Moles/volume] in Serum or Plasma --pre dose lactose PO |
| 30322-2 | aPTT.factor substitution in Platelet poor plasma --1 hour post incubation |
| 20955-1 | Salmonella sp identified in Stool by Organism specific culture |
| 2101-4 | Cholylglycine.conjugated [Mass/volume] in Serum |
| 100371-4 | Titin Ab [Units/volume] in Serum by Immunoassay |
| 101494-3 | Gentamicin [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 101586-6 | Cortisol [Moles/volume] in Serum or Plasma by LC/MS/MS |
| 13301-7 | HLA-A+B+Bw [Type] |
| 101852-2 | Fluorometholone [Moles/volume] in Urine |
| 13545-9 | ALPRAZolam [Presence] in Serum or Plasma |
| 102600-4 | Escargot IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14075-6 | Sulfapyridine [Mass/volume] in Serum or Plasma |
| 14154-9 | Cholesterol sulfate [Mass/volume] in Serum |
| 102717-6 | Clove IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103084-0 | Yam IgE Ab in Serum by Radioallergosorbent test (RAST) |
| 14553-2 | Mumps virus Ag [Presence] in Urine sediment by Immunofluorescence |
| 103612-8 | N-Desethyl Sunitinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose |
| 15394-0 | Parainfluenza virus 3 IgG Ab [Presence] in Serum |
| 1547-9 | Glucose [Mass/volume] in Serum or Plasma --baseline |
| 10894-4 | Aspergillus niger Ab [Presence] in Serum by Immune diffusion (ID) |
| 10998-3 | oxyCODONE [Presence] in Urine |
| 11093-2 | Dichlorodiphenyldichloroethylene [Mass/volume] in Serum or Plasma |
| 11139-3 | Metanephrine [Mass/volume] in Urine |
| 16522-5 | Calcium [Moles/volume] in Urine --4th specimen post XXX challenge |
| 16568-8 | Cefuroxime IgE Ab [Units/volume] in Serum |
| 16727-0 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 11150-0 | Blasts/100 cells in Bone marrow |
| 17706-3 | Thyroperoxidase Ab [Titer] in Cerebral spinal fluid by Latex agglutination |
| 17743-6 | Triiodothyronine resin uptake (T3RU) in Serum or Plasma --1 hour post XXX challenge |
| 18351-7 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 7504-4 | Mouse hair IgE Ab [Units/volume] in Serum |
| 7537-4 | White Oak triggered histamine release [Units/volume] in Blood |
| 60324-1 | Nortriptyline [Moles/volume] in Specimen |
| 613-0 | Fungal strain [Type] in Isolate by Fungus subtyping |
| 77048-7 | ACSF3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77135-2 | Glucose [Moles/volume] in Serum, Plasma or Blood |
| 77378-8 | Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA - Specimen |
| 93803-5 | Chromosome 19 polysomy [Presence] in Tissue by FISH |
| 65326-1 | LAN Ab [Presence] in Serum or Plasma |
| 7991-3 | Respiratory syncytial virus IgG Ab [Units/volume] in Serum |
| 95912-2 | Pneumocystis jiroveci DNA [Presence] in Tissue by NAA with probe detection |
| 96555-8 | Eutylone [Presence] in Urine |
| 81737-9 | RNA polymerase III RP11 Ab [Presence] in Serum by Line blot |
| 82255-1 | Marker and derivative chromosome analysis in Blood or Tissue Document by Cytogenetics |
| 97244-8 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Cord tissue by Screen method |
| 97265-3 | Methylenedioxyethylamphetamine [Presence] in Cord tissue by Confirmatory method |
| 71627-4 | Polymorphonuclear cells/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
| 8272-7 | Cefepime [Susceptibility] by Disk diffusion (KB) |
| 98207-4 | Borrelia burgdorferi IgG and IgM panel - Cerebral spinal fluid by Immunoassay |
| 71845-2 | Oxygen saturation [Pure mass fraction] in Venous blood |
| 71886-6 | Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Venous cord blood |
| 72277-7 | Trichomonas vaginalis [Presence] in Prostatic fluid by Light microscopy |
| 85421-6 | Bacterial identification and susceptibility panel - Isolate |
| 72816-2 | DOPamine [Mass/volume] in Urine by Confirmatory method |
| 72827-9 | dic(9;20)(p11-13;q11)(wcp9+,wcp20+) [Identifier] in Blood or Tissue by FISH Nominal |
| 73808-8 | B cell+T cell crossmatch [Interpretation] Qualitative by Flow cytometry (FC) |
| 73912-8 | DOG1 Ag [Presence] in Tissue by Immune stain |
| 73916-9 | 1,3-Dimethylamylamine [Mass/volume] in Urine by Confirmatory method |
| 416-8 | Pivampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 50766-5 | Fungus # 8 identified in Specimen by Culture |
| 51002-4 | Lipoprotein midband A [Mass/volume] in Serum or Plasma |
| 30933-6 | Nickel [Mass/volume] in Urine collected for unspecified duration |
| 31023-5 | Myelin associated glycoprotein IgM Ab [Presence] in Serum by Immunoblot |
| 31136-5 | Carboxy tetrahydrocannabinol [Mass/mass] in Meconium |
| 42720-3 | Clindamycin.induced [Susceptibility] by Disk diffusion (KB) |
| 21555-8 | Testosterone [Mass/volume] adjusted for sex hormone binding globulin in Serum or Plasma |
| 43595-8 | Methadone [Presence] in Meconium |
| 43609-7 | Adipate [Presence] in 24 hour Urine |
| 22742-1 | Propylene glycol [Moles/volume] in Specimen |
| 5226-6 | HTLV I+II Ab [Units/volume] in Serum by Immunoassay |
| 52899-2 | Beryllium [Moles/volume] in Serum or Plasma |
| 43915-8 | Beta 2 glycoprotein 1 IgA Ab [Presence] in Serum |
| 43927-3 | Arginine [Presence] in DBS |
| 23129-0 | Francisella tularensis B rRNA [Presence] in Tissue by Probe |
| 33230-4 | Waxy casts [#/area] in Urine by Computer assisted method |
| 44696-3 | Inflammation type in Prostate tumor |
| 44826-6 | Hepatitis D virus IgM Ab [Units/volume] in Serum by Immunoassay |
| 23550-7 | Venezuelan equine encephalitis virus Ag [Presence] in Specimen by Hemagglutination inhibition |
| 33510-9 | Coccidioides immitis IgM Ab [Presence] in Specimen by Immunoassay |
| 4514-6 | Complement decay accelerating factor [Entitic number] in Red Blood Cells |
| 23883-2 | Inhibin A [Mass/volume] in Serum or Plasma |
| 24061-4 | Beta galactosidase [Enzymatic activity/mass] in Leukocytes |
| 34263-4 | Cefaclor IgG Ab [Units/volume] in Serum |
| 24118-2 | Barmah forest virus IgM Ab [Presence] in Serum by Immunoassay |
| 34285-7 | Ehrlichia sp Ab [Titer] in Serum by Complement fixation |
| 47186-2 | Progesterone [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 47444-5 | Influenza virus A H1 Ab [Titer] in Serum |
| 47511-1 | Treponema pallidum Ab [Units/volume] in Body fluid |
| 47748-9 | Serine/Amino acids.total in Specimen |
| 56513-5 | Hepatitis E virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 48185-3 | Honey bee triggered leukotriene release [Mass/volume] by Leukocytes |
| 26041-4 | Normephenytoin [Moles/volume] in Serum or Plasma |
| 2647-6 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Tissue |
| 48586-2 | Collagen crosslinked C-telopeptide [Mass/volume] in Urine |
| 3848-9 | Netilmicin [Mass/volume] in Serum or Plasma --peak |
| 57606-6 | 6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
| 49018-5 | Respiratory allergen panel, US - Intermountain west c - Serum |
| 49099-5 | Codfish IgG Ab [Mass/volume] in Serum |
| 38875-1 | INR in Platelet poor plasma or blood by Coagulation assay |
| 40153-9 | Glucose [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge |
| 29565-9 | Powassan virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 40332-9 | Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose triple bolus |
| 58827-7 | Cortisol [Mass/volume] in Serum or Plasma --16th specimen |
| 50420-9 | Corticotropin [Mass/volume] in Plasma --post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 50588-3 | Glucose tolerance 5 hours panel - Serum or Plasma |
| 50589-1 | Glucose tolerance 6 hours panel - Serum or Plasma |
| 30137-4 | Epstein Barr virus capsid IgM Ab [Presence] in Serum --2nd specimen |
| 30353-7 | Hemoglobin [Mass/volume] in Venous cord blood |
| 19311-0 | Thiazides confirm method [Identifier] in Urine |
| 20661-5 | Valine [Moles/volume] in Serum or Plasma |
| 20865-2 | Iodine [Mass/mass] in Liver |
| 12389-3 | OLANZapine [Mass/volume] in Serum or Plasma |
| 101118-8 | Sezary syndrome diagnosis in Blood Document by Flow cytometry (FC) |
| 101376-2 | Megakaryocytes [Presence] in Blood by Light microscopy |
| 102527-9 | Slash Pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102599-8 | Johnson grass smut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14169-7 | Peptide histidine isoleucine [Mass/volume] in Plasma |
| 14180-4 | Uroporphyrin [Mass/volume] in Red Blood Cells |
| 102966-9 | Rhizopus nigricans IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14416-2 | Calcium [Moles/volume] in Pleural fluid |
| 103135-0 | Honey bee acid phosphatase recombinant (rApi m) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10355-6 | Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain |
| 15162-1 | Complement C1q [Mass/volume] in Body fluid |
| 15442-7 | Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immunoassay |
| 1089-2 | Js sup(b) Ag [Presence] on Red Blood Cells from Donor |
| 11133-6 | Catecholamines Free [Mass/volume] in Urine |
| 16585-2 | Chlamydophila pneumoniae rRNA [Presence] in Serum or Plasma by Probe |
| 12201-0 | Cryoglobulin [Presence] in Serum by 1 day cold incubation |
| 12292-9 | Dimethyltryptamine [Presence] in Urine |
| 92544-6 | E Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 92665-9 | Growth and differentiation factor 15 [Mass/volume] in Serum or Plasma by Immunoassay |
| 7524-2 | Nectarine IgG Ab [Units/volume] in Serum |
| 60401-7 | Scallop IgG Ab [Mass/volume] in Serum |
| 61118-6 | Lymphocytes.cytoplasmic IgG/100 lymphocytes in Body fluid |
| 76496-9 | Complement C4 [Moles/volume] in Serum or Plasma |
| 63340-4 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Titer] in Body fluid by Immunoassay |
| 77791-2 | Benzoylecgonine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 94501-4 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 94507-1 | SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 79610-2 | D-serine [Moles/volume] in Serum or Plasma |
| 691-6 | Neisseria gonorrhoeae [Presence] in Genital specimen by Organism specific culture |
| 81799-9 | 16-Alpha hydroxypregnenolone/Creatinine [Molar ratio] in Urine |
| 97218-2 | ALPRAZolam [Presence] in Cord tissue by Screen method |
| 97593-8 | Lymphocyte T-cell and B-cell and Natural killer subsets panel - Lower respiratory specimen by Flow cytometry (FC) |
| 7051-6 | Teicoplanin [Susceptibility] by Gradient strip |
| 70664-8 | Parathyrin.intact intraoperative percent change in Serum or Plasma |
| 7129-0 | Red Kidney Bean IgE Ab [Units/volume] in Serum |
| 82478-9 | 3-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in Serum or Plasma |
| 9825-1 | Mycobacterium sp identified in Isolate |
| 7242-1 | Codfish triggered histamine release [Units/volume] in Blood |
| 99620-7 | Omega 3 fatty acids (w3) [Moles/volume] in RBC.lysate |
| 99881-5 | Free lipid droplets [Presence] in Urine sediment by Computer assisted method |
| 72939-2 | Topiramate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87494-1 | AB-CHMINACA hydroxycyclohexyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 87714-2 | Influenza virus A M gene [Nucleotide sequence] in Isolate by Sequencing |
| 7359-3 | Meadow Fescue triggered histamine release [Units/volume] in Blood |
| 7437-7 | Kapok IgE Ab [Units/volume] in Serum |
| 89329-7 | CD3+CD4+CD27+CD45RO+CD62L+ cells [#/volume] in Blood |
| 89483-2 | Capreomycin [Susceptibility] by Genotype method |
| 41625-5 | Brucella sp DNA [Identifier] in Specimen by NAA with probe detection |
| 50776-4 | Cancer Ag 15-3 [Units/volume] in Cerebral spinal fluid |
| 30481-6 | Pyruvate [Presence] in Urine |
| 59998-5 | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 31383-3 | European tick borne encephalitis virus Ab [Units/volume] in Serum |
| 31490-6 | Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum |
| 51189-9 | 4-Hydroxybupivacaine [Mass/volume] in Serum or Plasma |
| 43099-1 | Vanillylmandelate and Creatinine panel - 24 hour Urine |
| 4330-7 | Methyprylon [Mass] of Dose |
| 22679-5 | Lysine/Creatinine [Molar ratio] in Urine |
| 22766-0 | African horse sickness virus Ab [Presence] in Serum by Immunoassay |
| 32248-7 | Homocitrulline/Creatinine [Ratio] in Urine |
| 3238-3 | Coagulation factor XIII Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 43953-9 | CD4+CD45RO+ cells [#/volume] in Cerebral spinal fluid |
| 22970-8 | Campylobacter fetus ss venerealis IgA Ab [Presence] in Genital mucus |
| 32779-1 | Glucose-6-Phosphatase [Enzymatic activity/volume] in Red Blood Cells |
| 3307-6 | Alfentanil [Mass/volume] in Serum or Plasma |
| 33211-4 | Interleukin 8 [Mass/volume] in Serum or Plasma |
| 33215-5 | Neutrophils.agranular [Presence] in Blood by Light microscopy |
| 53152-5 | Alloisoleucine+Isoleucine+Leucine+Hydroxyproline [Moles/volume] in DBS |
| 53386-9 | Toxocara canis Ab [Units/volume] in Specimen |
| 23217-3 | Lumpy skin disease virus Ab [Titer] in Serum |
| 23649-7 | Actinobacillus pleuropneumoniae biovar 2 serotype [Identifier] in Specimen by Agglutination |
| 332-7 | Mezlocillin [Susceptibility] by Disk diffusion (KB) |
| 33649-5 | Cryoglobulin.IgG [Mass/volume] in Serum |
| 44886-0 | Malignant cells [#/volume] in Pericardial fluid by Manual count |
| 2407-5 | Heptacarboxylporphyrin [Mass/volume] in Urine |
| 33733-7 | Sites of distant metastasis |
| 54369-4 | Chloride [Moles/volume] in Serum or Plasma --post dialysis |
| 46088-1 | Leukocytes [#/volume] in Cerebral spinal fluid --2nd tube |
| 46110-3 | Rubella virus IgG Ab [Titer] in Cerebral spinal fluid |
| 24350-1 | Volatiles panel - Urine |
| 24497-0 | Canary serum proteins Ab [Presence] in Serum by Immune diffusion (ID) |
| 34295-6 | Estrogen [Moles/volume] in Urine |
| 55329-7 | Le sup(b) Ab [Titer] in Serum or Plasma |
| 25087-8 | 3-Methylglutaconate/Creatinine [Molar ratio] in Urine |
| 35113-0 | Nelfinavir M8 [Mass/volume] in Serum or Plasma |
| 55655-5 | Chlortetracycline [Susceptibility] by Gradient strip |
| 55769-4 | EGFR gene c.2369C>T [Presence] in Blood or Tissue by Molecular genetics method |
| 56358-5 | Pineapple IgG4 Ab [Mass/volume] in Serum |
| 48262-0 | Meadow Fescue triggered leukotriene release [Mass/volume] by Leukocytes |
| 26062-0 | European tick borne encephalitis virus IgG Ab [Units/volume] in Serum |
| 26737-7 | Phosphoserine [Moles/volume] in Cerebral spinal fluid |
| 35799-6 | Ertapenem [Susceptibility] by Disk diffusion (KB) |
| 3648-3 | Fluoxymesterone [Mass/time] in 24 hour Urine |
| 56669-5 | Carotene.alpha [Mass/volume] in Serum |
| 56917-8 | Coxiella burnetii IgM Ab [Presence] in Serum by Immunofluorescence |
| 48502-9 | Platelet glycoprotein Ia/IIa IgG Ab [Presence] in Blood by Immunoassay |
| 38661-5 | Aldrin [Mass/volume] in Air |
| 57344-4 | Creatinine [Mass/volume] in 2 hour Urine |
| 57373-3 | Oxalate [Mass/volume] in 12 hour Urine |
| 57442-6 | Volume of Semen--post concentration |
| 27986-9 | Borrelia burgdorferi 28kD Ab [Presence] in Serum by Immunoblot |
| 39083-1 | Herpes virus 8 Ab [Presence] in Serum |
| 57726-2 | Creatinine [Mass/volume] in 24 hour Peritoneal dialysis fluid |
| 49337-9 | Adenovirus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
| 29391-0 | Gastrin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 40089-5 | Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --30 minutes post XXX challenge |
| 40214-9 | Glucose [Moles/volume] in Serum or Plasma --25 hours post XXX challenge |
| 49936-8 | Calcium.ionized/Calcium.total corrected for albumin in Blood |
| 59176-8 | Zopiclone [Presence] in Urine |
| 50373-0 | Eosinophils.band form/100 cells in Bone marrow by Manual count |
| 30169-7 | Chromogranin A [Units/volume] in Serum or Plasma by Immunoassay |
| 30338-8 | Anaplasma phagocytophilum Ab [Titer] in Serum by Immunofluorescence |
| 41058-9 | SH2D1A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 20764-7 | Clostridium perfringens genotype [Identifier] in Isolate |
| 100436-5 | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay |
| 100709-5 | Hepatocellular carcinoma risk [Score] by GAAD |
| 12769-6 | 17-Ketosteroids.total neutral [Mass/time] in 24 hour Urine |
| 101179-0 | Immunoglobulin light chains.free/Protein.total in 24 hour Urine |
| 101672-4 | Carbapenemase enzyme panel - Isolate by Rapid immunoassay |
| 137-0 | Ceftizoxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 102474-4 | Octopus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102761-4 | Lemon IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14380-0 | Mononuclear cells/100 leukocytes in Pleural fluid by Manual count |
| 1443-1 | Cortisol [Mass/volume] in Serum or Plasma --pre 1 ug/kg CRH IV |
| 103590-6 | Bacterial vaginosis RNA [Presence] in Vagina by Probe with amplification |
| 15052-4 | Cobalamin (Vitamin B12).unsaturated Binding Capacity [Moles/volume] in Serum or Plasma |
| 104291-0 | KIT gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 10501-5 | Lutropin [Units/volume] in Serum or Plasma |
| 10609-6 | Spermatozoa Duplicate Head/100 spermatozoa in Semen |
| 10693-0 | Mushroom.toxic identified in Vomitus by Light microscopy |
| 15380-9 | Leishmania brasilensis IgG Ab [Titer] in Serum |
| 10742-5 | Amyloid.microscopic observation [Identifier] in Tissue by Bennhold stain.Putchler modified |
| 10813-4 | Microscopic observation [Identifier] in Tissue by Sudan black stain |
| 11029-6 | Consistency of Stool |
| 11038-7 | Beta+gamma tocopherol [Mass/volume] in Serum or Plasma |
| 16560-5 | Catecholamines [Mass/volume] in Plasma --5th specimen post XXX challenge |
| 16705-6 | Cystathionine [Presence] in Urine |
| 16773-4 | Dieldrin [Mass/volume] in Blood |
| 17009-2 | IgM [Presence] in Serum |
| 17025-8 | Iron [Mass/volume] in Water |
| 92644-4 | Phentermine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 75565-2 | Comment on fetal Trisomy 21 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 60419-9 | Dengue virus 3 RNA [Presence] in Serum by NAA with probe detection |
| 60521-2 | Babesia microti IgG+IgM Ab [Presence] in Serum |
| 61154-1 | Hepatitis B virus codon L180M [Presence] by Genotype method |
| 92800-2 | Candida tropicalis DNA [Presence] by NAA with probe detection in Positive blood culture |
| 92803-6 | Fusarium sp DNA [Presence] by NAA with probe detection in Positive blood culture |
| 77663-3 | Aneuploid G1 phase cell population peak channel [#] in Cells.XXX by Flow cytometry (FC) |
| 93939-7 | Rh antigens and K Ag during infancy panel - Blood |
| 7811-3 | Astrovirus RNA [Presence] in Serum by NAA with probe detection |
| 78747-3 | Peritoneal equilibration test panel - Peritoneal dialysis fluid |
| 6432-9 | HTLV I Ab [Presence] in Serum by Immunoblot |
| 64986-3 | Anisakis recombinant (rAni s) 3 IgE Ab [Units/volume] in Serum |
| 95119-4 | Insulin [Units/volume] in Serum or Plasma --4 hours post meal |
| 95280-4 | MTMR2 gene full mutation analysis in Blood or Tissue by Sequencing |
| 95427-1 | SARS-CoV-2 (COVID-19) IgA Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 80133-2 | Amoxicillin [Mass/volume] in Cerebral spinal fluid |
| 95699-5 | Highlands J virus IgA Ab [Presence] in Specimen by Immunoassay |
| 805-2 | Leukocytes [#/volume] in Cerebral spinal fluid by Automated count |
| 9707-1 | Coxiella burnetii phase 2 IgA Ab [Titer] in Serum |
| 81641-3 | HIV 2 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 70171-4 | Nucleated erythrocytes/100 cells in Peritoneal fluid |
| 705-4 | Basophils [#/volume] in Blood by Manual count |
| 7104-3 | Aspergillus fumigatus triggered histamine release [Units/volume] in Blood |
| 82566-1 | Grass Allergen Mix 5 (Sweet Vernal grass+Bermuda grass+Cocksfoot+Timothy+Common Reed) IgE Ab [Presence] in Serum by Multidisk |
| 98259-5 | Vessels involved in lymphovascular invasion [#] in Cancer specimen |
| 99111-7 | Dengue virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 99391-5 | Progesterone [Mass/volume] in Ovarian aspirate |
| 99402-0 | Cells.CD19+CD79b+/100 cells in Bone marrow |
| 86737-4 | Toxoplasma gondii Ag [Presence] in Tissue by Immune stain |
| 87390-1 | Porcine sapelovirus RNA [Presence] in Specimen by NAA with probe detection |
| 74090-2 | Hexacarboxylporphyrin III/Creatinine [Molar ratio] in Urine |
| 74304-7 | PRRSV neutralizing antibody [Titer] in Serum by Neutralization test |
| 88985-7 | Alpha-Amanitin + gamma-Amanitin [Mass/volume] in Serum or Plasma |
| 89526-8 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
| 59349-1 | Endoxifen [Mass/volume] in Serum or Plasma |
| 59356-6 | Desethylvardenafil [Mass/volume] in Blood |
| 59381-4 | Vancomycin [Mass/volume] in Serum or Plasma --post dialysis |
| 50608-9 | Glucose tolerance 3 hours gestational panel - Serum or Plasma |
| 5076-5 | Cardiolipin IgA Ab [Units/volume] in Serum by Immunoassay |
| 60097-3 | Loratadine [Mass/volume] in Blood |
| 42881-3 | CD3-CD57+ cells [#/volume] in Tissue |
| 43000-9 | Leishmania brasilensis Ab [Titer] in Serum |
| 22207-5 | Coccidioides immitis Ab [Titer] in Cerebral spinal fluid |
| 51618-7 | Potassium [Moles/volume] in Serum or Plasma --pre dialysis |
| 5169-8 | Giardia lamblia Ab [Units/volume] in Serum |
| 51785-4 | Dengue virus IgG and IgM [Interpretation] in Serum |
| 43617-0 | Adenovirus Ab [Presence] in Cerebral spinal fluid |
| 22540-9 | Shigella sonnei Ab [Titer] in Serum |
| 32324-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Specimen |
| 51939-7 | Escherichia coli shiga-like toxin 2 [Presence] in Stool by Immunoassay |
| 52764-8 | Extrinsic coagulation system with fibrinolysis inhibition thromboelastography panel - Blood |
| 2281-4 | Flavin adenine dinucleotide [Mass/volume] in Serum |
| 53073-3 | Ceruloplasmin [Moles/volume] in Cerebral spinal fluid |
| 23402-1 | Rift valley fever virus Ag [Presence] in Blood by Neutralization test |
| 33264-3 | Osmol gap of Serum or Plasma |
| 33354-2 | N-acetyl-beta-glucosaminidase [Enzymatic activity/volume] in Urine |
| 33499-5 | Methane/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose lactose PO |
| 23869-1 | Hepatitis B virus DNA [Mass/volume] (viral load) in Serum by Probe |
| 33935-8 | Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma |
| 53998-1 | Nuclear dots nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
| 54332-2 | Propionylglycine [Moles/volume] in Cerebral spinal fluid |
| 543-9 | Mycobacterium sp identified in Specimen by Organism specific culture |
| 54424-7 | Plateletpheresis half units given [#] |
| 34307-9 | Fructose [Moles/volume] in 24 hour Urine |
| 25135-5 | Suberate/Creatinine [Molar ratio] in Urine |
| 25201-5 | Rifabutin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 55723-1 | Virginiamycin [Susceptibility] by Gradient strip |
| 47865-1 | Malondialdehyde [Moles/volume] in Plasma |
| 47903-0 | Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose glucagon |
| 25908-5 | EPINEPHrine [Moles/volume] in 24 hour Urine |
| 25937-4 | Iron [Moles/volume] in 24 hour Urine |
| 47950-1 | Thyrotropin [Units/volume] in Serum or Plasma --1 hour post dose luteinizing releasing hormone IV |
| 5693-7 | Methanol [Mass/volume] in Serum or Plasma |
| 38599-7 | Hexachlorobutadiene [Mass/volume] in Air |
| 57670-2 | Brucella melitensis IgG Ab [Units/volume] in Serum by Immunoassay |
| 48969-0 | DCX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 27271-6 | Alpha ketoglutarate [Presence] in Urine |
| 27835-8 | Somatotropin [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge |
| 39595-4 | Halibut IgE Ab/IgE total in Serum |
| 57766-8 | Histoplasma capsulatum Ag [Mass/volume] in Body fluid |
| 57862-5 | Hydrocortisone [Moles/volume] in Specimen |
| 58056-3 | Co sup(b) Ag [Presence] on Red Blood Cells |
| 4942-9 | HLA-DQ6(1) [Presence] in Donor |
| 49702-4 | Nateglinide [Mass/volume] in Serum or Plasma |
| 2814-2 | Porphyrins [Mass/volume] in Red Blood Cells |
| 29397-7 | Gastrin [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge |
| 40010-1 | Glucose [Mass/volume] in Serum or Plasma --13 hours post XXX challenge |
| 5890-9 | Protein S+Acarboxy Free Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 58920-0 | CD4+CD45RO+ cells/CD3+CD4+ (T4 helper) cells [# Ratio] in Blood |
| 50558-6 | Nitrite [Presence] in Urine by Automated test strip |
| 50587-5 | Glucose tolerance 4 hours panel - Serum or Plasma |
| 40853-4 | Leishmania sp IgG Ab [Units/volume] in Cerebral spinal fluid |
| 41167-8 | Listeria monocytogenes H Ab [Titer] in Serum |
| 20745-6 | Carbamates [Presence] in Gastric fluid by Screen method |
| 20886-8 | Molybdenum [Mass/volume] in Specimen |
| 12887-6 | Borrelia burgdorferi 41kD Ab [Presence] in Body fluid by Immunoblot |
| 12894-2 | HIV 1 p68 Ab [Presence] in Serum by Immunoblot |
| 101227-7 | Recoverin Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 101358-0 | Borrelia burgdorferi Ab [Interpretation] in Serum by IA.MTTT |
| 101485-1 | cefTRIAXone [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 101555-1 | Campylobacter upsaliensis DNA [Presence] in Stool by NAA with probe detection |
| 101913-2 | Troponin T.cardiac delta/Troponin T.cardiac in 2 hour Serum or Plasma --baseline |
| 102108-8 | Glycerate [Moles/volume] in Urine by Gas chromatography-mass spectrometry |
| 14030-1 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
| 14040-0 | Carbon dioxide, total [Moles/volume] in Stool |
| 102816-6 | Sesame Seed IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1479-5 | Galactose [Mass/volume] in Blood --1.5 hours post 40 g galactose PO |
| 103736-5 | Erythrocytosis focused multigene analysis in Specimen by Sequencing |
| 10409-1 | Pentaspan given [Volume] |
| 14884-1 | Porphyrins [Interpretation] in Stool |
| 14921-1 | Thyroxine (T4) [Moles/volume] in Serum or Plasma |
| 15163-9 | Complement C2 [Mass/volume] in Body fluid |
| 15498-9 | Pseudorabies virus Ab [Presence] in Serum by Latex agglutination |
| 1624-6 | Retinol [Mass/volume] in Serum or Plasma --3 hours post 5000 units |
| 16417-8 | Aspergillus versicolor Ab [Units/volume] in Serum |
| 1219-5 | LW Ag [Presence] on Red Blood Cells |
| 90923-4 | Lysophosphatidylcholine(26:0) [Mass/volume] in DBS |
| 91772-4 | Influenza virus identified in Upper respiratory specimen by Organism specific culture |
| 75059-6 | Transaldolase [Enzymatic activity/mass] in Fibroblast |
| 7509-3 | Mucor sp IgG Ab [Units/volume] in Serum |
| 60405-8 | Sole IgG Ab [Mass/volume] in Serum |
| 76074-4 | Enterovirus RNA [Presence] in Nasopharynx by NAA with probe detection |
| 935-7 | Blood product unit expiration [Date and time] |
| 93695-5 | Liver steatosis score in Serum or Plasma |
| 6182-0 | Mucor racemosus IgE Ab [Units/volume] in Serum |
| 62382-7 | Base pair end coordinate [#] |
| 9405-2 | Albumin/Globulin [Mass Ratio] in Urine |
| 6302-4 | Prothrombin index in Platelet poor plasma by Coagulation assay |
| 63158-0 | House dust Hollister Stier IgG Ab [Mass/volume] in Serum |
| 63205-9 | Aspen IgG Ab [Mass/volume] in Serum |
| 63294-3 | Nuclear Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 78808-3 | Benzodiazepines [Presence] in Serum or Plasma by Screen method >200 ng/mL |
| 78839-8 | JWH-073 butanoate (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
| 94424-9 | Staphylococcus aureus methicillin resistance SCCmec+orfX junction [Presence] by Molecular method |
| 94571-7 | Branched chain amino acid panel - DBS |
| 6493-1 | Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid by Immunoassay |
| 79138-4 | Buprenorphine [Presence] in Blood by Confirmatory method |
| 95137-6 | Parvovirus B19 DNA panel - Amniotic fluid by NAA with probe detection |
| 9648-7 | Chlorothiazide [Mass/volume] in Urine |
| 6780-1 | IgG [Mass/volume] in Urine by Electrophoresis |
| 68377-1 | Ribonucleoprotein extractable nuclear 63kD Ab [Presence] in Serum or Plasma |
| 96631-7 | HLA-B [Type] in Donor |
| 96752-1 | SARS-CoV-2 (COVID-19) S gene mutation [Presence] in Specimen by Molecular genetics method |
| 6988-0 | Cefodizime [Susceptibility] by Gradient strip |
| 69899-3 | Service comment 72 |
| 70179-7 | 1-Methylhistidine [Moles/volume] in Serum or Plasma from Fetus |
| 82567-9 | Grass Allergen Mix 5 (Sweet Vernal grass+Bermuda grass+Cocksfoot+Timothy+Common Reed) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 82995-2 | TIF1-gamma IgG Ab [Presence] in Serum by Line blot |
| 72327-0 | Amphiphysin IgG Ab [Presence] in Serum by Immunoassay |
| 7269-4 | Cucumber triggered histamine release [Units/volume] in Blood |
| 85996-7 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum --1st specimen |
| 73596-9 | Marbofloxacin [Susceptibility] |
| 88227-4 | Mycoplasma genitalium DNA [Presence] in Cervix by NAA with probe detection |
| 74115-7 | Difenacoum [Presence] in Specimen by Screen method |
| 89480-8 | Azithromycin [Susceptibility] by Genotype method |
| 59899-5 | Ethylene glycol [Moles/volume] in Gastric fluid |
| 31012-8 | Vancomycin [Moles/volume] in Serum or Plasma |
| 31067-2 | Herpes simplex virus 2 IgG Ab [Units/volume] in Body fluid |
| 59960-5 | Propoxyphene [Moles/volume] in Urine |
| 42870-6 | CD138 cells/100 cells in Bone marrow |
| 42908-4 | Hematocrit [Volume Fraction] of Capillary blood |
| 42999-3 | Leishmania sp Ab [Presence] in Cerebral spinal fluid |
| 43117-1 | FLUoxetine and Norfluoxetine panel [Mass/volume] - Serum or Plasma |
| 43174-2 | Chlamydia trachomatis L2 IgA Ab [Titer] in Serum by Immunofluorescence |
| 4344-8 | Nandrolone [Mass] of Dose |
| 22468-3 | Rickettsia (Proteus OX19) Ab [Presence] in Serum |
| 22629-0 | Xylose [Moles/time] in 5 hour Urine --post 5 g xylose PO |
| 22694-4 | Citrulline/Creatinine [Molar ratio] in Urine |
| 32092-9 | Meprobamate [Presence] in Specimen |
| 32508-4 | CD3-CD16+CD56+ (Natural killer) cells/100 cells in Bone marrow |
| 53019-6 | Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum |
| 43900-0 | Blastomyces dermatitidis Ab [Presence] in Cerebral spinal fluid by Complement fixation |
| 23145-6 | Japanese encephalitis virus Ab [Titer] in Serum by Complement fixation |
| 53430-5 | Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --5th specimen post XXX challenge |
| 33275-9 | 7-Dehydrocholesterol [Mass/volume] in Serum or Plasma |
| 53538-5 | Herpes simplex virus IgM Ab [Presence] in Body fluid by Immunoassay |
| 5363-7 | Spirillum minus Ab [Units/volume] in Serum |
| 23827-9 | Bordetella pertussis filamentous hemagglutinin IgA Ab [Units/volume] in Serum |
| 54166-4 | Cefoperazone+Sulbactam [Susceptibility] |
| 46986-6 | Cholesterol in VLDL 3 [Mass/volume] in Serum or Plasma |
| 54905-5 | Norovirus genogroup I RNA [Presence] in Stool by NAA with probe detection |
| 25474-8 | Metanephrines [Moles/volume] in Serum or Plasma |
| 55726-4 | Borrelia burgdorferi IgA and IgG and IgM panel - Cerebral spinal fluid |
| 4759-7 | HLA-B52(5) [Presence] |
| 35772-3 | Cefotiam [Susceptibility] by Disk diffusion (KB) |
| 3608-7 | Ethchlorvynol [Mass/volume] in Blood |
| 56958-2 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 48566-4 | Bacteria # 7 identified in Specimen by Respiratory culture |
| 27169-2 | Butyrate (C4) [Mass/mass] in Stool |
| 57368-3 | Magnesium [Mass/time] in 12 hour Urine |
| 57671-0 | Brucella melitensis IgM Ab [Units/volume] in Serum by Immunoassay |
| 49082-1 | Western equine encephalitis virus IgG and IgM [Interpretation] in Serum |
| 38898-3 | Fibrin D-dimer [Titer] in Platelet poor plasma |
| 39010-4 | Methylmalonylcarnitine (C4-DC) [Moles/volume] in Serum or Plasma |
| 39012-0 | Mycoplasma pneumoniae Ab [Presence] in Body fluid |
| 58359-1 | Buprenorphine+Norbuprenorphine [Presence] in Urine by Screen method |
| 29145-0 | 1,3-Dimethylbenzene [Mass/volume] in Serum or Plasma |
| 40278-4 | Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose lactose PO |
| 30052-5 | Isoleucine/Creatinine [Ratio] in Urine |
| 30064-0 | Valine/Creatinine [Ratio] in Urine |
| 30094-7 | Neisseria meningitidis serogroup A Ag [Presence] in Specimen by Latex agglutination |
| 19709-5 | Thioridazine cutoff [Mass/volume] in Urine for Confirmatory method |
| 100793-9 | Testosterone [Mass/volume] in Body fluid |
| 12917-1 | Porphobilinogen synthase [Enzymatic activity/volume] in Serum or Plasma |
| 12960-1 | Alpha 1 antitrypsin fecal clearance |
| 101984-3 | Candida albicans DNA [Presence] in Body fluid by Probe.amp.tar |
| 102042-9 | Lung cancer panel |
| 13622-6 | Acetaminophen [Mass/volume] in Urine |
| 102499-1 | Chick Pea IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102576-6 | Rose Hip IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14119-2 | Lactate dehydrogenase 1/Lactate dehydrogenase 2 [Enzymatic activity ratio] in Serum or Plasma |
| 14396-6 | Urea nitrogen [Mass/volume] in Synovial fluid |
| 15012-8 | Aldosterone [Moles/volume] in Serum or Plasma --upright |
| 15136-5 | Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Serum or Plasma |
| 104401-5 | Francisella tularensis Ab [Titer] in Serum by Immunoassay --1st specimen |
| 16177-8 | Bartonella quintana IgM Ab [Units/volume] in Cerebral spinal fluid |
| 16206-5 | Temazepam [Presence] in Urine by Confirmatory method |
| 1623-8 | Renin [Enzymatic activity/volume] in Plasma --pre 600 ug furosemide PO |
| 10934-8 | Guava IgE Ab [Units/volume] in Serum |
| 10983-5 | Norparamethadione [Mass/volume] in Serum or Plasma |
| 1699-8 | Alpha-L-iduronidase [Enzymatic activity/mass] in Tissue |
| 17118-1 | CD16B cells/100 cells in Blood |
| 17135-5 | CD3+CD56+ cells/100 cells in Blood |
| 17851-7 | Herpes simplex virus 2 IgG Ab [Presence] in Serum |
| 18401-0 | Spermatozoa IgG Ab [Units/volume] in Cervical mucus |
| 1876-2 | Apolipoprotein C-II [Mass/volume] in Serum or Plasma |
| 90236-1 | Keratan sulfate [Moles/volume] in DBS |
| 90420-1 | Transferrin.carbohydrate deficient.trisialo/Transferrin.carbohydrate deficient.tetrasialo [Mass Ratio] in Serum or Plasma |
| 91055-4 | Drugs of abuse panel - Tissue |
| 74588-5 | Succinate cytochrome C reductase [Enzymatic activity/mass] in Fibroblast |
| 91131-3 | Rhinovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 60409-0 | Trout IgG Ab [Mass/volume] in Serum |
| 60514-7 | 6-Acetylcodeine [Mass/volume] in Urine by Confirmatory method |
| 60554-3 | CD59 deficient monocytes/100 cells in Blood |
| 6119-2 | Formaldehyde IgE Ab [Units/volume] in Serum |
| 76140-3 | Reticulocytes.hypochromic/100 erythrocytes in Blood by Automated count |
| 76772-3 | Plasmodium falciparum Ag [Presence] in Blood by Rapid immunoassay |
| 92829-1 | Location of metastasis within sentinel lymph node [Anatomy] in Cancer specimen |
| 7751-1 | Turkey IgG Ab [Units/volume] in Serum |
| 7772-7 | Wheat triggered histamine release [Units/volume] in Blood |
| 94000-7 | Chloride [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin |
| 63237-2 | DNA double strand IgM Ab [Units/volume] in Serum by Immunoassay |
| 63255-4 | Ganglioside GQ1b IgM Ab [Presence] in Serum by Immunoassay |
| 6368-5 | Coccidioides immitis Ab [Titer] in Serum by Latex agglutination |
| 6478-2 | Mumps virus IgM Ab [Presence] in Serum by Immunoassay |
| 79248-1 | Methylenedioxyethylamphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 95218-4 | Leukocytes [#/volume] in Stem cell product |
| 79563-3 | Mucopolysaccharidosis type I newborn screening panel |
| 69005-7 | Malignant cells/100 cells in Body fluid |
| 9652-9 | N-desalkylflurazepam [Mass/volume] in Serum or Plasma |
| 9655-2 | Campylobacter jejuni Ab [Titer] in Serum |
| 6997-1 | Ceftizoxime [Susceptibility] by Gradient strip |
| 97247-1 | Ethylone [Presence] in Cord tissue by Confirmatory method |
| 97771-0 | Protein.monoclonal band 1 [Mass/volume] in 24 hour Urine by Electrophoresis |
| 97923-7 | Sandfly fever Naples virus RNA [Presence] in Specimen by NAA with probe detection |
| 71867-6 | Hemoglobin D/Hemoglobin.total [Pure mass fraction] in Blood by HPLC |
| 7235-5 | Clove IgG Ab [Units/volume] in Serum |
| 72646-3 | Albumin in serum - albumin in pericardial fluid [Mass concentration difference] |
| 85840-7 | Beta-lactam resistance ESBL blaVEB gene [Presence] by Molecular method |
| 86093-2 | Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum --1st specimen |
| 86114-6 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 87952-8 | Helicobacter pylori [Presence] in Stool by Organism specific culture |
| 73913-6 | Glycine in CSF/Glycine in plasma |
| 88602-8 | Adenovirus Ag [Presence] in Nasopharynx by Immunoassay |
| 89632-4 | Toxoplasma gondii [Presence] in Placenta by Organism specific culture |
| 41614-9 | Tube number of Synovial fluid |
| 50773-1 | ABO and Rh group [Type] in Blood from Newborn--after transfusion reaction |
| 51040-4 | CD11c blasts/100 blasts in Bone marrow |
| 59982-9 | Zopiclone [Moles/volume] in Gastric fluid |
| 60299-5 | Cotinine [Moles/volume] in Specimen |
| 21151-6 | cefTAZidime [Mass/volume] in Specimen |
| 51418-2 | Domperidone [Moles/volume] in Body fluid |
| 21797-6 | t(X;18)(q11.2;p11.23)(SS18,SSX1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 51754-0 | Histoplasma capsulatum Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay |
| 51832-4 | Brucella abortus Ab [Presence] in Cerebral spinal fluid by Acidified buffered plate agglutination |
| 43604-8 | Aldosterone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 52998-2 | Terminal deoxyribonucleotidyl transferase cells/100 cells in Tissue by Flow cytometry (FC) |
| 22831-2 | Avian paramyxovirus 1 Ag [Presence] in Specimen by Hemagglutination inhibition |
| 23179-5 | Leptospira interrogans sv Hardjo Ab [Presence] in Serum by Immunoassay |
| 53204-4 | Heptanoylcarnitine (C7) [Moles/volume] in DBS |
| 53271-3 | Epithelial cells.renal [Presence] in Urine by Computer assisted method |
| 3341-5 | Amoxapine [Mass/volume] in Serum or Plasma |
| 53539-3 | Alpha globulin.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis |
| 53759-7 | Natural killer cell panel - Blood by Flow cytometry (FC) |
| 45226-8 | Ribosomal P IgG Ab [Presence] in Serum |
| 3-4 | Almecillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 46731-6 | RHCE gene allele Cc [Genotype] in Amniotic fluid by Molecular genetics method Nominal |
| 2410-9 | Hexokinase [Enzymatic activity/volume] in Red Blood Cells |
| 24415-2 | Feline panleukopenia virus Ag [Presence] in Tissue by Immunofluorescence |
| 34642-9 | Thyroid colloidal Ab [Titer] in Serum |
| 55164-8 | Paroxysmal nocturnal panel - Blood |
| 55495-6 | Insulin [Moles/volume] in Serum or Plasma --45 minutes post dose glucose IV |
| 55528-4 | Chloral hydrate [Moles/volume] in Serum or Plasma |
| 4735-7 | HLA-A31(19) [Presence] |
| 25335-1 | Coxiella burnetii IgG Ab [Titer] in Serum |
| 34910-0 | Immature basophils [#/volume] in Blood |
| 35029-8 | Monoblasts [#/volume] in Blood |
| 35272-4 | Centromere IgG Ab [Presence] in Serum |
| 55872-6 | Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Serum or Plasma |
| 47533-5 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM |
| 4766-2 | HLA-B56(22) [Presence] in Donor |
| 47831-3 | Argininosuccinate synthase [Enzymatic activity/mass] in Amniotic fluid cells |
| 4790-2 | HLA-B70 [Presence] in Donor |
| 25988-7 | Threonine [Moles/volume] in 24 hour Urine |
| 35542-0 | Peanut IgG Ab [Mass/volume] in Serum |
| 48155-6 | Threo-4,5-Dihydrohexanolactone/Creatinine [Molar ratio] in Urine |
| 48170-5 | Capreomycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 3650-9 | fluPHENAZine [Mass/volume] in Serum or Plasma |
| 3781-2 | Methapyrilene [Presence] in Serum or Plasma |
| 56892-3 | CD13+HLA-DR+ cells/100 cells in Blood |
| 4891-8 | HLA-Dw20 [Presence] |
| 38694-6 | Chloroethane [Mass/volume] in Air |
| 29330-8 | Glucose [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
| 50067-8 | 11-Hydroxyandrostenedione [Moles/volume] in Body fluid |
| 29658-2 | Bordetella pertussis IgM Ab [Presence] in Serum by Immunoassay |
| 40527-4 | Cocaine [Presence] in Meconium |
| 59305-3 | Memantine [Mass/mass] in Tissue |
| 50311-0 | Chlamydia trachomatis DNA [Presence] in Specimen from Donor by NAA with probe detection |
| 30234-9 | 3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Serum or Plasma |
| 30389-1 | Erythrocytes [#/volume] in Seminal plasma |
| 20714-2 | Bovine diarrhea virus Ag [Presence] in Stool by Immunofluorescence |
| 100123-9 | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay |
| 100358-1 | Phentermine [Presence] in Cord tissue by Screen method |
| 12883-5 | Borrelia burgdorferi 18kD Ab [Presence] in Body fluid by Immunoblot |
| 1303-7 | Reverse ABO group [Type] |
| 102636-8 | Trichosporon spp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14012-9 | Platelet associated IgG Ab [Units/volume] in Blood by Flow cytometry (FC) |
| 14225-7 | HTLV II g46 Ab [Presence] in Serum |
| 14233-1 | Beta tubulin IgG Ab [Titer] in Serum |
| 102702-8 | Carp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103117-8 | Dog recombinant (rCan f) 4 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14452-7 | Virus identified in Cervix by Culture |
| 103639-1 | 4-hydroxy Xylazine [Presence] in Urine by Confirmatory method |
| 104217-5 | Additional treatment [Identifier] in Urine |
| 104292-8 | PDGFRA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 1526-3 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 50 g lactose PO |
| 1537-0 | Glucose [Mass/volume] in Serum or Plasma --4 hours post 100 g glucose PO |
| 16923-5 | guaiFENesin [Mass/volume] in Serum or Plasma |
| 17738-6 | Chloral hydrate [Presence] in Urine |
| 17820-2 | Albumin/Protein.total in Body fluid by Electrophoresis |
| 1797-0 | Amylase [Enzymatic activity/volume] in Peritoneal fluid |
| 1832-5 | Alpha-1-Fetoprotein [Mass/volume] in Amniotic fluid |
| 18365-7 | Cortisol Free [Mass/volume] in Saliva (oral fluid) |
| 7453-4 | Latex Greer triggered histamine release [Units/volume] in Blood |
| 75269-1 | Bacteria identified in Genital specimen by Anaerobe+Aerobe culture |
| 75546-2 | Fetal Trisomy 13 prior risk [Likelihood] Based on maternal age |
| 60840-6 | Base excess in Extracellular fluid by calculation |
| 6090-5 | Cottonwood IgE Ab [Units/volume] in Serum |
| 76071-0 | Aspergillus sp DNA [Presence] in Bronchoalveolar lavage by NAA with probe detection |
| 92897-8 | Aldosterone [Mass/volume] in Serum or Plasma by Immunoassay |
| 93359-8 | Monotypic plasma cell DNA ploidy [Type] in Bone marrow by Flow cytometry (FC) |
| 77641-9 | HLA-A IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
| 93907-4 | Lu 20 Ag [Presence] on Red Blood Cells |
| 62489-0 | Sulfate.inorganic [Moles/time] in 24 hour Urine |
| 63243-0 | Ganglioside GM1 IgG Ab [Presence] in Serum by Immunoassay |
| 77790-4 | Cocaine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 94301-9 | Vortioxetine [Presence] in Serum or Plasma by Screen method |
| 94549-3 | Isoheptacarboxylporphyrin [Mass/time] in 24 hour Stool |
| 94831-5 | Varicella zoster virus DNA [Units/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 640-3 | Microscopic observation [Identifier] in Gastric fluid by Acid fast stain.Kinyoun |
| 79153-3 | Alfentanil [Mass/volume] in Body fluid |
| 663-5 | Microscopic observation [Identifier] in Specimen by Gimenez stain |
| 66719-6 | Adenovirus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection |
| 79697-9 | Docosadienoate (C22:2w6) [Entitic substance] in Red Blood Cells |
| 6767-8 | 18-Hydroxycorticosteroids [Mass/volume] in Serum |
| 6826-2 | Crystals [type] in Pleural fluid by Light microscopy |
| 80608-3 | Cefuroxime [Mass/volume] in Serum or Plasma |
| 6961-7 | Yersinia enterocolitica O:8 Ab [Titer] in Serum |
| 81630-6 | Methotrexate polyglutamates 1-5 and total panel - Red Blood Cells |
| 97255-4 | HYDROcodone Free [Presence] in Cord tissue by Confirmatory method |
| 97275-2 | Methamphetamine [Presence] in Cord tissue by Confirmatory method |
| 9783-2 | Ehrlichia chaffeensis IgG Ab [Titer] in Serum |
| 7125-8 | Bayleaf IgE Ab [Units/volume] in Serum |
| 71594-6 | Macrophages/Leukocytes [Pure number fraction] in Bronchial specimen by Manual count |
| 82455-7 | Ganglioside Ab panel - Serum |
| 82603-2 | Latex recombinant (rHev b) 2 IgE Ab [Units/volume] in Serum |
| 82982-0 | Exocrine pancreas IgA+IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 98069-8 | SARS-CoV-2 (COVID-19) Ab [Presence] in Saliva (oral fluid) by Rapid immunoassay |
| 83100-8 | Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 85370-5 | Neutrophil.fMLP stimulated.DHR mean fluorescence intensity in Blood by Flow cytometry (FC) |
| 86084-1 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 73028-3 | Enalapril induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 731-0 | Lymphocytes [#/volume] in Blood by Automated count |
| 73376-6 | Fluconazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87750-6 | Dichlorvos [Mass/mass] in Specimen |
| 73581-1 | Anion gap 4 in Arterial blood |
| 73685-0 | Streptococcus pneumoniae Ag [Presence] in Isolate by Latex agglutination |
| 87985-8 | Trichinella spiralis DNA [Presence] in Tissue by NAA with probe detection |
| 88046-8 | P sup(k) Ag [Presence] on Red Blood Cells |
| 88256-3 | Enterococcus faecalis hsp60 gene [Presence] by Probe in Positive blood culture |
| 88977-4 | Epithelial casts [#/area] in Urine sediment |
| 89485-7 | Clarithromycin [Susceptibility] by Genotype method |
| 41176-9 | Trichophyton reaction wheal [Diameter] --2 days post dose trichophyton intradermal |
| 59665-0 | Estazolam [Mass/volume] in Blood by Confirmatory method |
| 59791-4 | Glucose [Molar concentration difference] in Serum or Plasma --30 minutes post XXX challenge |
| 30559-9 | Spermatozoa Ab [Units/volume] in Specimen |
| 59925-8 | Mesoridazine [Moles/volume] in Urine |
| 51177-4 | CD36 blasts in Blood |
| 21702-6 | KRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 3173-2 | aPTT in Blood by Coagulation assay |
| 31986-3 | Vesicular stomatitis virus Ag [Presence] in Throat |
| 51612-0 | Sucrose [Presence] in Urine |
| 22398-2 | Legionella pneumophila IgM Ab [Titer] in Serum |
| 22678-7 | Ethylene glycol [Moles/volume] in Urine |
| 44388-7 | IgA [Presence] in 24 hour Urine by Immunofixation |
| 53093-1 | Glucose [Moles/volume] in Serum or Plasma --post XXX challenge |
| 33947-3 | Clostridioides difficile toxin neutralizing antibody [Titer] in Serum by Neutralization test |
| 33951-5 | Sodium/Creatinine [Molar ratio] in Urine |
| 54259-7 | Glucose [Moles/volume] in Serum or Plasma --2.5 hours post dose insulin IV |
| 24483-0 | Epidermal Allergen Mix 1 (Cat dander+Cow dander+Dog dander+Horse dander) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 55798-3 | Platelet aggregation ADP induced [Presence] in Platelet rich plasma --5 umol/L |
| 47843-8 | Corticotropin [Mass/volume] in Plasma --post dose dexamethasone |
| 47906-3 | Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose propranolol+glucagon |
| 25631-3 | Parvovirus B19 IgM Ab [Titer] in Serum |
| 25989-5 | Threonine/Creatinine [Molar ratio] in 24 hour Urine |
| 56339-5 | Cocksfoot IgG4 Ab [Mass/volume] in Serum |
| 56556-4 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 5694-5 | Methanol [Presence] in Urine |
| 48879-1 | Bartonella bacilliformis IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 5726-5 | Selenium [Mass/volume] in Urine |
| 49066-4 | Western equine encephalitis virus IgG and IgM [Interpretation] in Cerebral spinal fluid |
| 49134-0 | Glucose [Mass/volume] in Blood --2 hours post dose glucose |
| 27272-4 | 3-Hydroxyisobutyrate [Presence] in Urine |
| 28039-6 | Borrelia burgdorferi 66kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 38692-0 | 1-Butene oxide [Mass/volume] in Air |
| 5797-6 | Ketones [Mass/volume] in Urine by Test strip |
| 49454-2 | Varicella zoster virus DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 29280-5 | Fibrin D-dimer [Presence] in Platelet poor plasma by Latex agglutination |
| 39973-3 | Creatinine [Mass/volume] in Serum or Plasma --18 hours post XXX challenge |
| 40131-5 | Creatinine [Moles/volume] in Urine --1 hour pre XXX challenge |
| 40164-6 | Glucose [Moles/volume] in Serum or Plasma --5 hours post XXX challenge |
| 40219-8 | Glucose [Moles/volume] in Serum or Plasma --30 hours post XXX challenge |
| 40245-3 | Calcium [Moles/volume] in Serum or Plasma --36 hours post XXX challenge |
| 40297-4 | Somatotropin [Mass/volume] in Serum or Plasma --3.5 hours post XXX challenge |
| 585-0 | Streptococcus agalactiae [Presence] in Throat by Organism specific culture |
| 58625-5 | Corticotropin [Moles/volume] in Plasma --pre dose glucose |
| 58658-6 | Cortisol [Moles/volume] in Saliva (oral fluid) --2 hours post 1 ug/kg CRH IV |
| 50113-0 | 3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in DBS |
| 29882-8 | 2-Hydroxyisovalerate [Presence] in Urine |
| 58860-8 | Somatotropin [Mass/volume] in Serum or Plasma --48th specimen |
| 58915-0 | Parakeet feather IgG Ab [Mass/volume] in Serum |
| 40760-1 | Coxsackievirus A Ab [Titer] in Cerebral spinal fluid --2nd specimen |
| 19227-8 | Deoxyhemoglobin/Hemoglobin.total in Venous blood |
| 19690-7 | Psilocybin cutoff [Mass/volume] in Urine for Screen method |
| 199-0 | Cloxacillin [Susceptibility] by Serum bactericidal titer |
| 20801-7 | Encephalitozoon cuniculi Ab [Presence] in Serum |
| 100898-6 | Lipid panel - Serum or Plasma |
| 13174-8 | Immunofixation for Cerebral spinal fluid |
| 102071-8 | Linear PFOS Isomer [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 102737-4 | Erythromycin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1439-9 | Cortisol [Mass/volume] in Serum or Plasma --9.5 hours post 8 mg dexamethasone PO overnight high dose |
| 15186-0 | IgM [Presence] in Serum by Immunoelectrophoresis |
| 16347-7 | Alpha chlordane [Mass/volume] in Blood |
| 16792-4 | Doxylamine [Mass/volume] in Urine |
| 17168-6 | CD49f cells/100 cells in Blood |
| 18982-9 | Streptomycin [Susceptibility] |
| 90333-6 | PRRSV IgM Ab/Positive control in Specimen by Immunoassay |
| 906-8 | Blood group antigens present [Identifier] in Blood |
| 90796-4 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --1 hours post dose levothyroxine |
| 92775-6 | Staphylococcus lugdunensis DNA [Presence] by NAA with probe detection in Positive blood culture |
| 75228-7 | Carisoprodol+Meprobamate [Mass/volume] in Urine by Confirmatory method |
| 6206-7 | Peanut IgE Ab [Units/volume] in Serum |
| 77608-8 | Androstenedione [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 93728-4 | Copper [Moles/volume] in Dialysis fluid |
| 93768-0 | Acarboxyprothrombin [Units/volume] in Serum or Plasma |
| 93847-2 | Aspergillus oryzae IgE Ab [Units/volume] in Serum |
| 6264-6 | Tea IgE Ab [Units/volume] in Serum |
| 77762-3 | Alpha hydroxyalprazolam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 78765-5 | oxyMORphone [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine |
| 94581-6 | Herpes simplex virus 1 DNA [Presence] in Specimen by NAA with non-probe detection |
| 79283-8 | C29 dicarboxylate [Moles/volume] in Serum or Plasma |
| 94867-9 | Ganglioside GD1b IgG Ab [Titer] in Serum by Immunoassay |
| 95212-7 | Neospora caninum Ab/Negative control in Serum by Immunoassay |
| 6725-6 | Egg white IgG Ab [Units/volume] in Serum |
| 80355-1 | Herpes simplex virus 2 genome glycoprotein B 3' end region+thymidine kinase region C [Presence] in Anogenital specimen by NAA with probe detection |
| 68917-4 | Parathyrin.intact [Mass/volume] in Serum or Plasma --20 minutes post excision |
| 69562-7 | Candida albicans DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 81627-2 | Methotrexate diglutamate [Moles/volume] in Red Blood Cells |
| 9725-3 | Spermatozoa IgM Ab [Units/volume] in Serum |
| 82851-7 | Androsterone+etiocholanolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
| 82862-4 | 11-Deoxytetrahydrocortisol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
| 98903-8 | Hemolytic anemia panel |
| 99000-2 | Dysautonomia autoimmune Ab panel - Serum |
| 99519-1 | Volume of Gallbladder |
| 72844-4 | Hepatitis B virus codon 214 [Identifier] by Genotype method |
| 72918-6 | HNA 4 genotype in Blood |
| 86020-5 | Streptococcus pneumoniae Danish serotype 19F Ab [Mass/volume] in Serum |
| 73031-7 | cloNIDine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73248-7 | Naproxen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73600-9 | Faropenem [Susceptibility] |
| 73619-9 | Iclaprim [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 87933-8 | Bacteria identified in Amniotic fluid by Anaerobe culture |
| 88571-5 | Fetal Monosomy X risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative |
| 41724-6 | Thiamphenicol [Susceptibility] by Gradient strip |
| 41739-4 | Sulbactam [Susceptibility] |
| 50694-9 | Rubella virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 30450-1 | Neutrophils.hypersegmented/100 leukocytes in Blood |
| 21748-9 | Kappa LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 51479-4 | Spermatozoa [#/volume] in Urine by Automated count |
| 43226-0 | 2-Hydroxyisocaproate [Presence] in Urine |
| 43379-7 | HLA-DRB3 [Presence] |
| 22341-2 | Herpes simplex virus Ab [Titer] in Serum |
| 32067-1 | Digoxin Free [Moles/volume] in Serum or Plasma |
| 53048-5 | Ferritin [Mass/volume] in Body fluid |
| 43916-6 | Beta 2 glycoprotein 1 IgM Ab [Presence] in Serum |
| 23146-4 | Japanese encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 32781-7 | Legionella sp Ag [Presence] in Urine |
| 33345-0 | Histrelin [Mass/volume] in Urine |
| 45036-1 | Bacteria producing oxidase [Presence] in Isolate |
| 45309-2 | Hexacarboxylate [Moles/mass] in Stool |
| 23951-7 | Asialoganglioside GM1 IgG Ab [Titer] in Cerebral spinal fluid by Immunoassay |
| 555-3 | Candida sp identified in Specimen by Organism specific culture |
| 474-7 | sulfiSOXAZOLE [Susceptibility] by Serum bactericidal titer |
| 35297-1 | LMNA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 47590-5 | C peptide [Moles/volume] in Serum or Plasma --3 hours post dose glucose |
| 25926-7 | Histidine [Moles/volume] in 24 hour Urine |
| 25939-0 | Isoleucine/Creatinine [Molar ratio] in 24 hour Urine |
| 35373-0 | Platelet aggregation XXX induced in Platelet rich plasma from Donor |
| 56373-4 | Raspberry IgG4 Ab [Mass/volume] in Serum |
| 26454-9 | Erythrocytes [#/volume] in Cerebral spinal fluid |
| 3652-5 | Flurazepam [Presence] in Serum or Plasma |
| 48788-4 | Creatinine peritoneal dialysis clearance |
| 48810-6 | Glucose [Mass/volume] in Serum or Plasma --5 hours post 50 g glucose PO |
| 38622-7 | Toxaphene [Mass/volume] in Air |
| 38644-1 | Caprolactam [Mass/volume] in Air |
| 27259-1 | Estriol (E3).unconjugated [Presence] in Serum or Plasma |
| 57930-0 | CFTR gene p.Asp1152His [Presence] in Blood or Tissue by Molecular genetics method |
| 2883-7 | Protein [Mass/volume] in Peritoneal fluid |
| 40140-6 | Creatinine [Moles/volume] in Urine --3.5 hours post XXX challenge |
| 5851-1 | Herpes simplex virus Ag [Presence] in Genital specimen by Immunofluorescence |
| 58523-2 | Corticosterone [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
| 58776-6 | Peach recombinant (rPru p) 1 IgE Ab [Units/volume] in Serum |
| 29606-1 | Appearance of Gastric fluid |
| 29824-0 | Eastern equine encephalitis virus IgG Ab [Presence] in Specimen |
| 50194-0 | Cholesterol in IDL+Cholesterol in VLDL 3 [Mass/volume] in Serum or Plasma |
| 30131-7 | Complement total hemolytic CH50 [Mass/volume] in Serum or Plasma |
| 30237-2 | 3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Serum or Plasma |
| 30362-8 | Insulin [Units/volume] in Serum or Plasma --30 minutes post 75 g glucose PO |
| 40995-3 | Mitochondria Genes mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 41175-1 | Western equine encephalitis virus Ab [Titer] in Body fluid |
| 19512-3 | Levomethamphetamine [Mass/volume] in Urine by Confirmatory method |
| 100741-8 | Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma |
| 100834-1 | Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 12510-4 | Calcitonin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 101375-4 | Troponin I.cardiac [Mass concentration difference] in Serum or Plasma by Calculation --2H post baseline measurement |
| 13012-0 | Methyl isoamyl ketone [Mass/volume] in Blood |
| 13438-7 | Protein Fractions [Interpretation] in Urine by Electrophoresis |
| 102063-5 | Linear PFOA Isomer [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 102064-3 | Total perfluorohexanoic acid isomers [Mass/volume] in Serum or Plasma |
| 13666-3 | Alpha aminoadipate/Creatinine [Mass Ratio] in Urine |
| 102406-6 | Lenscale IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102419-9 | Lycopodium spp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102472-8 | Oat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102645-9 | Veal IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13989-9 | Gamma globulin/Protein.total in 24 hour Urine by Electrophoresis |
| 14104-4 | Barley smut+Wheat smut IgE Ab [Units/volume] in Serum |
| 102778-8 | Orange IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1440-7 | Cortisol [Mass/volume] in Serum or Plasma --9 hours post 1 mg dexamethasone PO overnight |
| 103174-9 | Enterobacter spp DNA [Presence] in Wound by NAA with probe detection |
| 10367-1 | Ethanol [Mass/volume] in Gastric fluid |
| 10508-0 | Prostate specific Ag [Presence] in Tissue by Immune stain |
| 10628-6 | Spermatozoa Tail Swelling/100 spermatozoa in Semen |
| 16222-2 | Phentermine [Presence] in Urine by Confirmatory method |
| 10745-8 | Bile.microscopic observation [Identifier] in Tissue by Fouchet stain |
| 10874-6 | Bombesin [Mass/volume] in Plasma |
| 16442-6 | Benzene ring IgM Ab [Units/volume] in Serum |
| 16708-0 | Taenia solium larva Ab [Units/volume] in Cerebral spinal fluid |
| 11572-5 | Rheumatoid factor [Units/volume] in Serum or Plasma |
| 1169-2 | little f Ag [Presence] on Red Blood Cells from Blood product unit |
| 12192-1 | Creatinine [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis |
| 17434-2 | Phenazopyridine [Mass/volume] in Serum or Plasma |
| 17549-7 | Rubella virus Ab [Units/volume] in Cerebral spinal fluid |
| 181-8 | Cinoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 74665-1 | Monoclonal band observed [Identifier] in Serum or Plasma by Immunofixation |
| 75091-9 | Catechol/Creatinine [Molar ratio] in Urine |
| 6178-8 | Mountain Juniper IgE Ab [Units/volume] in Serum |
| 62342-1 | Borrelia burgdorferi IgG and IgM [Interpretation] in Serum by Immunoblot |
| 62383-5 | Flanking normal region before start |
| 77333-3 | Imipramine+Desipramine [Moles/volume] in Specimen |
| 63153-1 | Johnson grass IgG Ab [Mass/volume] in Serum |
| 632-0 | Bacteria identified in Wound by Aerobe culture |
| 78833-1 | Hydroxylurasidone [Mass/volume] in Urine by Confirmatory method |
| 9437-5 | Methylhippurate [Mass/time] in Urine |
| 94699-6 | Glutamate decarboxylase 65 Ab [Moles/volume] in Serum by Immunoassay |
| 64087-0 | ISCN band level [#] in Chorionic villus sample Qualitative by Molecular genetics method |
| 79466-9 | Purine nucleoside phosphorylase [Enzymatic activity/substance] in Red Blood Cells |
| 95358-8 | Rabbit hemorrhagic disease virus RNA panel - Specimen by NAA with probe detection |
| 6732-2 | Peanut IgG Ab [Units/volume] in Serum |
| 95961-9 | House dust Japan IgE Ab [Units/volume] in Serum |
| 6771-0 | Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma by Nephelometry |
| 8215-6 | Opiates [Presence] in Meconium by Confirmatory method |
| 82534-9 | CASR gene full mutation analysis in Blood or Tissue by Sequencing |
| 82985-3 | Leucine-rich glioma-inactivated protein 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 85069-3 | Lab test method [Type] |
| 72630-7 | PENTobarbital [Presence] in Saliva (oral fluid) by Confirmatory method |
| 85965-2 | Streptococcus pneumoniae Danish serotype 1 Ab [Mass/volume] in Serum --1st specimen |
| 31061-5 | Echovirus 11 Ab [Titer] in Body fluid by Complement fixation |
| 31154-8 | Coccidioides sp IgG Ab [Presence] in Specimen by Immunoassay |
| 2122-0 | Chymopapain [Mass/volume] in Serum |
| 21246-4 | Dimethoate [Mass/volume] in Urine |
| 51257-4 | CD16+CD57+ cells/100 cells in Cerebral spinal fluid |
| 51384-6 | Mononuclear cells/100 leukocytes in Blood by Manual count |
| 43020-7 | Heterophile Ab [Titer] in Serum |
| 3177-3 | Antithrombin Ag [Moles/volume] in Platelet poor plasma by Immunoassay |
| 31830-3 | Giardia lamblia Ag [Presence] in Stool |
| 51821-7 | Bartonella quintana IgM Ab [Units/volume] in Serum by Immunoassay |
| 43422-5 | Rabbit dander IgE Ab [Units/volume] in Serum |
| 22774-4 | African horse sickness virus RNA [Presence] in Tissue by NAA with probe detection |
| 3207-8 | Coagulation factor VIII inhibitor [Presence] in Platelet poor plasma by Chromogenic method |
| 53002-2 | Fine speckled nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
| 43933-1 | Cathine [Mass/mass] in Meconium |
| 44351-5 | Phosphoethanolamine/Creatinine [Molar ratio] in 24 hour Urine |
| 23162-1 | Leishmania sp identified in Tissue by Polyacrylamide gel electrophoresis (PAGE) |
| 32795-7 | Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 44810-0 | HTLV I gp21e Ab [Presence] in Serum |
| 23297-5 | Mycoplasma sp Ab [Presence] in Serum by Complement fixation |
| 23427-8 | Salmonella gallinarum Ab [Presence] in Serum |
| 3360-5 | Atenolol [Presence] in Urine |
| 33715-4 | Francisella tularensis Ab [Presence] in Isolate by Slide agglutination |
| 23702-4 | Canine parvovirus Ab [Titer] in Serum |
| 33746-9 | Pathologic findings |
| 54170-6 | Imipenem+EDTA [Susceptibility] |
| 54229-0 | Lymphoma - T-cell screen panel - Specimen by Flow cytometry (FC) |
| 54365-2 | Calcium [Moles/volume] in Cord blood |
| 4547-6 | Hemoglobin A1/Hemoglobin.total in Blood |
| 456-4 | Spiramycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 46133-5 | Epithelial cells [#/area] in Urine sediment by Microscopy low power field |
| 46160-8 | Blastomyces dermatitidis IgG Ab [Presence] in Cerebral spinal fluid |
| 4698-7 | HLA-A33(19) [Presence] |
| 24185-1 | Coxsackievirus B3 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 34401-0 | Complement C3d [Mass/volume] in Serum or Plasma |
| 34723-7 | Eastern equine encephalitis virus Ab [Titer] in Cerebral spinal fluid |
| 35041-3 | Variant lymphocytes [#/volume] in Peritoneal fluid |
| 25735-2 | Prolactin [Mass/volume] in Serum or Plasma --1 hour post 200 ug TRH IV |
| 25876-4 | Citrate [Moles/volume] in 24 hour Urine |
| 35725-1 | Chlamydia sp rRNA [Presence] in Throat by Probe |
| 5625-9 | Cobalt [Mass/volume] in Blood |
| 5645-7 | Ethanol [Mass/volume] in Urine |
| 4818-1 | HLA-B21 [Presence] in Donor |
| 48206-7 | Lactalbumin alpha triggered leukotriene release [Mass/volume] by Leukocytes |
| 35878-8 | Escherichia coli O157:H7 IgM Ab [Units/volume] in Serum |
| 57633-0 | Alpha cortolone [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
| 27858-0 | Lutropin [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 39305-8 | Influenza virus A H4 Ab [Titer] in Serum by Hemagglutination inhibition |
| 58376-5 | Ethyl glucuronide/Creatinine [Mass Ratio] in Urine |
| 40031-7 | Glucose [Mass/volume] in Serum or Plasma --19 minutes post XXX challenge |
| 298-0 | Lincomycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 40526-6 | Plasma cells/100 leukocytes in Pericardial fluid by Manual count |
| 4072-5 | Chloral hydrate [Mass/volume] in Urine |
| 5891-7 | Protein S+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 50334-2 | Acylglycines panel [Mass Ratio] - Urine |
| 40894-8 | CD3-CD16+ cells/100 cells in Body fluid |
| 12396-8 | chlorproPAMIDE [Mass/volume] in Urine |
| 101142-8 | NAT2 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 101195-6 | Depth of invasion beyond muscularis propria [Length] in Colorectal cancer specimen |
| 101222-8 | Meropenem+Vaborbactam [Susceptibility] by Disk diffusion (KB) |
| 101428-1 | Varicella zoster virus DNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 13926-1 | Glutamate decarboxylase 65 Ab [Units/volume] in Serum |
| 1406-8 | Cortisol [Mass/volume] in Serum or Plasma --1 minute post 1 ug/kg CRH IV |
| 15228-0 | Grass Allergen Mix 4 (Sweet vernal grass+Velvet grass+Perennial rye grass+Common reed+Rye) IgE Ab [Presence] in Serum by Multidisk |
| 15459-1 | Bovine herpesvirus 1 neutralizing antibody [Titer] in Serum by Neutralization test |
| 16166-1 | Glucose [Mass/volume] in Serum or Plasma --11 AM specimen |
| 11117-9 | Plasma cells immature/100 cells in Bone marrow by Manual count |
| 16487-1 | Brucella abortus IgG Ab [Units/volume] in Serum by Agglutination |
| 1215-3 | LW Ab [Presence] in Serum or Plasma from Donor |
| 12208-5 | Eosinophils/100 leukocytes in Cerebral spinal fluid by Manual count |
| 17121-5 | CD18 cells/100 cells in Blood |
| 17518-2 | Respiratory syncytial virus IgG Ab [Titer] in Serum |
| 17806-1 | N-acetylprocainamide [Mass/volume] in Body fluid |
| 17837-6 | Acid phosphatase tartrate resistant [Enzymatic activity/volume] in Serum |
| 91764-1 | Nocardia sp identified in Aspirate by Organism specific culture |
| 6118-4 | Firebush IgE Ab [Units/volume] in Serum |
| 94228-4 | MUTYH gene full mutation analysis in Blood or Tissue by Sequencing |
| 63136-6 | Allspice IgG Ab [Mass/volume] in Serum |
| 6329-7 | Campylobacter coli rRNA [Presence] in Specimen by Probe |
| 94313-4 | SARS-related coronavirus N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N3 |
| 94392-8 | Bordetella pertussis+parapertussis+bronchiseptica gidA gene [Presence] in Lower respiratory specimen by NAA with probe detection |
| 94479-3 | Human coronavirus 229E RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 94582-4 | Herpes simplex virus 2 DNA [Presence] in Specimen by NAA with non-probe detection |
| 7910-3 | Herpes simplex virus 1 IgM Ab [Units/volume] in Serum |
| 79259-8 | fentaNYL cutoff [Mass/volume] in Urine for Confirmatory method |
| 68394-6 | Basophils [#/volume] in Pleural fluid by Manual count |
| 97024-4 | aPTT mixing study panel - Platelet poor plasma |
| 69823-3 | 2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --7 days post dose ifosfamide |
| 70081-5 | Interleukin 3 [Mass/volume] in Body fluid |
| 98007-8 | B cell+T cell crossmatch [Interpretation] Narrative |
| 72270-2 | Urea nitrogen [Mass/volume] in Serum or Plasma --pre contrast |
| 72427-8 | 4-Hydroxyphenylpyruvate [Moles/volume] in Cerebral spinal fluid |
| 73084-6 | Venlafaxine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73221-4 | oxyCODONE+Acetylsalicylate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87365-3 | Actinobacillus pleuropneumoniae serotypes 4+7 Ab/Positive control in Serum by Immunoassay |
| 73819-5 | Heparin induced platelet IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 41274-2 | Alpha-1-Fetoprotein interpretation in Serum or Plasma |
| 4136-8 | Barbital [Mass] of Dose |
| 4162-4 | Cefotaxime [Mass] of Dose |
| 41685-9 | Clavulanate [Susceptibility] by Gradient strip |
| 5982-4 | Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis |
| 60137-7 | PARoxetine [Mass/volume] in Body fluid |
| 60140-1 | Penciclovir [Mass/volume] in Blood |
| 51168-3 | CD34+CD117+ blasts/100 blasts in Blood |
| 42892-0 | Citrulline [Moles/volume] in DBS |
| 4310-9 | Meprobamate [Mass] of Dose |
| 22079-8 | Actinomyces sp Ab [Titer] in Serum |
| 22212-5 | Coxsackievirus A10 Ab [Titer] in Cerebral spinal fluid |
| 51671-6 | Brucella sp Ab [Titer] in Serum by Tube agglutination |
| 51787-0 | Blastomyces dermatitidis Ab [Titer] in Serum by Immune diffusion (ID) |
| 51829-0 | Lactate [Mass/volume] in Capillary blood |
| 4327-3 | Methyldopa [Mass] of Dose |
| 52816-6 | Nucleated cells [#/volume] in Cerebral spinal fluid by Automated count |
| 23154-8 | Leishmania sp Ab [Titer] in Serum by Hemagglutination |
| 23204-1 | Leptospira sp Ag [Presence] in Tissue by Immune stain |
| 53080-8 | Cystine [Moles/mass] in Chorionic villus sample |
| 53238-2 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0) [Molar ratio] in DBS |
| 44812-6 | Yeast.hyphae [Presence] in Specimen by Wet preparation |
| 53587-2 | Beta globulin.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis |
| 44902-5 | Malignant cells/100 cells in Pleural fluid |
| 23853-5 | Dimethylformamide/Creatinine [Mass Ratio] in Urine |
| 33882-2 | Collection date of Specimen |
| 54337-1 | Sulfocysteine [Moles/volume] in DBS |
| 46769-6 | Cystic fibrosis newborn screen interpretation |
| 47005-4 | Spermatozoa IgM Ab/100 spermatozoa in Serum by Immunobead |
| 34426-7 | cycloSPORINE.monoclonal [Mass/volume] in Serum or Plasma |
| 34498-6 | ACADS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 47216-7 | Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 200 copies/ml |
| 25106-6 | Glycolate/Creatinine [Molar ratio] in Urine |
| 34971-2 | Neutrophil associated Ab [Presence] in Blood |
| 55704-1 | Piperacillin+Sulbactam [Susceptibility] by Gradient strip |
| 56489-8 | Acidity.titratable [Moles/time] in 24 hour Urine |
| 48192-9 | Sunset yellow FCF triggered leukotriene release [Mass/volume] by Leukocytes |
| 36900-9 | West Nile virus polyvalent E Ab [Presence] in Specimen |
| 56644-8 | Glutamate/Creatinine [Ratio] in 24 hour Urine |
| 48371-9 | Docosapentaenoate (C22:5 n-3) [Moles/volume] in Serum or Plasma |
| 48849-4 | Coxiella burnetii phase 2 IgA Ab [Titer] in Serum by Immunofluorescence |
| 27213-8 | Carboxy tetrahydrocannabinol [Mass/volume] in Vitreous fluid |
| 57304-8 | Codeine [Mass/volume] in Saliva (oral fluid) |
| 57665-2 | Oligoclonal Bands IgG [Presence] in Serum or Plasma by Isoelectric focusing |
| 27315-1 | Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid |
| 3922-2 | Pentetrazol [Mass/time] in 24 hour Urine |
| 39605-1 | Goose feather IgE Ab/IgE total in Serum |
| 57906-0 | 9p21 chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal |
| 58355-9 | Plasma cells immature [#/volume] in Blood |
| 49470-8 | CD35 Ag [Presence] in Tissue by Immune stain |
| 58462-3 | Complement functional activity [Units/volume] in Serum or Plasma by Immunoassay |
| 50084-3 | Alpha aminoadipate [Moles/volume] in Body fluid |
| 1917-4 | Aspartate aminotransferase [Enzymatic activity/volume] in Amniotic fluid |
| 1938-0 | Beta fructofuranosidase [Enzymatic activity/volume] in Red Blood Cells |
| 1988-5 | C reactive protein [Mass/volume] in Serum or Plasma |
| 2031-3 | Carboxyhemoglobin/Hemoglobin.total in Capillary blood |
| 20822-3 | Escherichia coli K99 [Presence] in Small intestine Tissue by Immunofluorescence |
| 100061-1 | Tosufloxacin [Susceptibility] |
| 100368-0 | Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS |
| 100705-3 | Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection |
| 100745-9 | Chloride [Moles/volume] in Mixed venous blood |
| 101776-3 | Nannizzia gypsea DNA [Presence] in Specimen by NAA with probe detection |
| 101802-7 | Brucella sp IgA Ab [Presence] in Serum |
| 102151-8 | Asparagus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13487-4 | Phenol/Creatinine [Mass Ratio] in Urine |
| 1353-2 | Yt sup(b) Ag [Presence] on Red Blood Cells |
| 102250-8 | Corn IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102399-3 | Goosefoot IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102958-6 | Fusarium moniliforme IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103081-6 | Apple recombinant (rMal d) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14496-4 | Virus identified in Sputum by Immunofluorescence |
| 15227-2 | Food Allergen Mix 74 (Herring+Cod+Plaice+Mackerel) IgE Ab [Presence] in Serum by Multidisk |
| 1563-6 | Insulin [Mass/volume] in Serum or Plasma --2 hours post dose TOLBUTamide IV |
| 16657-9 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --1 hour post XXX challenge |
| 1212-0 | little s Ag [Presence] on Red Blood Cells from Donor |
| 12314-1 | Clorazepate [Presence] in Urine |
| 16984-7 | Hydrastine [Presence] in Urine |
| 17109-0 | CD11a cells/100 cells in Blood |
| 17227-0 | Lymphocytes/100 leukocytes in Synovial fluid by Automated count |
| 17545-5 | Bartonella quintana IgM Ab [Presence] in Cerebral spinal fluid |
| 1873-9 | Apolipoprotein B-48 [Mass/volume] in Serum or Plasma |
| 18989-4 | Teicoplanin [Susceptibility] |
| 74982-0 | FLUoxetine [Mass/volume] in Serum or Plasma --trough |
| 75560-3 | Fetal Trisomy 21 prior risk [Likelihood] Based on maternal age |
| 92903-4 | Fetal Chromosome region 15q11 deletion [Presence] based on Plasma cell-free DNA by Sequencing |
| 6129-1 | Goose feather IgE Ab [Units/volume] in Serum |
| 94250-8 | Borrelia burgdorferi oppA2 gene [Presence] in Specimen by NAA with non-probe detection |
| 63134-1 | Sardine (pilchard) IgG Ab [Mass/volume] in Serum |
| 9520-8 | Echovirus 9 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 66114-0 | Stomach Pathology biopsy report |
| 7962-4 | Measles virus IgG Ab [Units/volume] in Serum |
| 79666-4 | Purine and Pyrimidine pattern [Interpretation] in Cerebral spinal fluid Narrative |
| 95922-1 | Tocilizumab [Mass/volume] in Serum |
| 6755-3 | Glucose [Presence] in Urine by Test strip --3 hours post 75 g glucose PO |
| 6820-5 | Streptococcus sp Ab [Titer] in Serum |
| 6862-7 | Black Willow IgE Ab [Units/volume] in Serum |
| 81186-9 | Gastric cancer pathology panel |
| 8130-7 | CD45 (Lymphs) cells/100 cells in Blood |
| 96612-7 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA panel - Specimen by NAA with probe detection |
| 96630-9 | HLA-B [Type] in Donor by Low resolution |
| 96642-4 | HLA-DPA1 [Type] in Donor by Low resolution |
| 82107-4 | Regional Allergen Mix 3 (Common Ragweed+Goosefoot+Bermuda grass+Perennial rye grass+English Plantain+Bahia grass) IgE Ab [Units/volume] in Serum by Multidisk |
| 71371-9 | Tree Allergen Mix 9 (Grey alder+Silver birch+Hazelnut+White oak+Willow) IgE Ab [Units/volume] in Serum by Multidisk |
| 71711-6 | Ebola virus IgM Ab [Titer] in Serum by Immunoassay |
| 72411-2 | Monocytes+Macrophages [#] in Cerebral spinal fluid by Manual count |
| 99886-4 | Hyaline-granular casts [#/area] in Urine sediment by Computer assisted method |
| 86196-3 | Alpha pyrrolidinovalerophenone [Mass/volume] in Urine by Confirmatory method |
| 73662-9 | Benzodiazepines panel - Saliva (oral fluid) by Screen method |
| 88206-8 | Lymphocytic choriomeningitis virus IgG Ab [Presence] in Serum by Immunoassay |
| 41492-0 | Echovirus 7 neutralizing antibody [Titer] in Serum by Neutralization test |
| 59359-0 | Vardenafil [Mass/volume] in Serum or Plasma |
| 42718-7 | Alkaline phosphatase.heat labile/Alkaline phosphatase.total in Serum or Plasma by Heat stability |
| 2105-5 | Choriogonadotropin [Moles/volume] in Semen |
| 21622-6 | ASPA gene p.Glu285Ala [Presence] in Blood or Tissue by Molecular genetics method |
| 51199-8 | Molybdenum [Mass/volume] in Body fluid |
| 51385-3 | Plasma cells/100 leukocytes in Cerebral spinal fluid by Manual count |
| 42903-5 | Enterovirus NOS Ab [Titer] in Cerebral spinal fluid |
| 21720-8 | NRAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 21807-3 | t(12;22)(q13;q12.2)(ATF1,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 22152-3 | Brucella canis Ab [Titer] in Serum |
| 31694-3 | Varicella zoster virus Ab [Units/volume] in Cerebral spinal fluid |
| 31699-2 | Rabbit hemorrhagic disease virus Ab [Units/volume] in Serum |
| 51616-1 | Hemoglobin A2+E/Hemoglobin.total in Blood |
| 22426-1 | Mycoplasma pneumoniae IgG Ab [Titer] in Serum |
| 22509-4 | Saint Louis encephalitis virus Ab [Titer] in Cerebral spinal fluid |
| 22772-8 | African horse sickness virus Ag [Presence] in Tissue by Immunoassay |
| 32321-2 | Glucose [Moles/volume] in Serum or Plasma --4 hours post 75 g glucose PO |
| 52758-0 | SERPINE1 gene c.-844A>G [Presence] in Blood or Tissue by Molecular genetics method |
| 52953-7 | Cocaine [Moles/volume] in Urine |
| 22918-7 | Bovine leukemia virus RNA [Presence] in Blood by NAA with probe detection |
| 23043-3 | Eastern equine encephalitis virus Ab [Presence] in Serum by Agglutination |
| 32577-9 | Bartonella quintana IgG Ab [Presence] in Serum |
| 53429-7 | Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --4th specimen post XXX challenge |
| 53442-0 | Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Leukocytes |
| 44825-8 | Bartonella quintana IgM Ab [Titer] in Serum by Immunofluorescence |
| 53524-5 | Alkaline phosphatase.bile/Alkaline phosphatase.total in Serum or Plasma |
| 4519-5 | Complement factor H [Mass/volume] in Serum or Plasma |
| 24097-8 | N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Fibroblast |
| 33894-7 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with 1:4 normal plasma |
| 24114-1 | Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunoassay |
| 24252-9 | Coxsackievirus B1 Ab [Titer] in Serum --2nd specimen |
| 47211-8 | Chlamydia trachomatis L2 DNA [Presence] in Specimen by NAA with probe detection |
| 47431-2 | Echinococcus granulosus IgG Ab [Units/volume] in Serum |
| 47472-6 | Legionella pneumophila 8 IgM Ab [Titer] in Serum |
| 34981-1 | Volume of Pericardial fluid |
| 35013-2 | Band form neutrophils [#/volume] in Synovial fluid |
| 3504-8 | Clostebol [Mass/time] in 24 hour Urine |
| 4785-2 | HLA-B65(14) [Presence] |
| 25755-0 | Rotavirus IgM Ab [Presence] in Serum by Immunoassay |
| 35680-8 | Hepatitis E virus Ab panel - Serum |
| 48082-2 | 3-Hydroxyadipate 3,6-lactone/Creatinine [Molar ratio] in Urine |
| 48175-4 | Mycobacterium tuberculosis katG + inhA gene isoniazid resistance mutation [Presence] by Molecular method |
| 26835-9 | Sebacate (C8) [Presence] in Urine |
| 26889-6 | Sulfate [Moles/time] in 24 hour Urine |
| 26978-7 | Protriptyline [Mass/volume] in Urine |
| 27195-7 | Hydroxylysine [Moles/volume] in Amniotic fluid |
| 57559-7 | 18-Hydroxycortisol [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
| 2847-2 | Proline [Mass/time] in 24 hour Urine |
| 4000-6 | Protriptyline [Presence] in Serum or Plasma |
| 40015-0 | Glucose [Mass/volume] in Serum or Plasma --17.5 hours post XXX challenge |
| 49833-7 | Specimen drawn [Date and time] of Serum or Plasma--2nd specimen |
| 49955-8 | Somatotropin [Units/volume] in Serum or Plasma --4:30 AM specimen |
| 29912-3 | Magnesium [Mass/time] in Stool |
| 59288-1 | Bisphenol A [Mass/volume] in Urine |
| 40764-3 | Coxsackievirus B IgG Ab [Titer] in Serum --2nd specimen |
| 19575-0 | MethylePHEDrine cutoff [Mass/volume] in Urine for Screen method |
| 20570-8 | Hematocrit [Volume Fraction] of Blood |
| 20802-5 | Epizootic hemorrhagic disease virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 100433-2 | Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) |
| 12797-7 | Oxalate [Mass/volume] in Urine --9th specimen post XXX challenge |
| 12874-4 | Borrelia burgdorferi 93kD Ab [Presence] in Serum by Immunoblot |
| 101739-1 | Platelet aggregation ristocetin induced in Platelet rich plasma --125 ug/mL |
| 13497-3 | Dextroamphetamine/Levoamphetamine [Mass Ratio] in Urine |
| 13850-3 | CD5+CD25+ cells [#/volume] in Blood |
| 102656-6 | Wheat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102976-8 | Pellitory (Parietaria officinalis) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14500-3 | Human papilloma virus Ag [Presence] in Vaginal fluid |
| 14658-9 | Cold agglutinin [Titer] in Serum or Plasma |
| 104173-0 | DPYD gene.c.1905+1G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 15003-7 | 11-Hydroxyandrosterone [Moles/time] in 24 hour Urine |
| 15008-6 | 3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum |
| 104250-6 | Platelet aggregation collagen induced in Platelet rich plasma --2 ug/mL |
| 10552-8 | Tricyclic antidepressants [Mass/volume] in Serum or Plasma |
| 17877-2 | Bacteria # 6 identified in Bone by Aerobe culture |
| 18479-6 | Human papilloma virus 31+35+51 DNA [Presence] in Tissue by Probe |
| 90276-7 | Bacteria identified in Semen by Anaerobe culture |
| 75078-6 | 3-Hydroxydodecanoate (3-OH-C12:0)/Creatinine [Molar ratio] in Urine |
| 60467-8 | oxyMORphone [Mass/volume] in Serum or Plasma |
| 61165-7 | Hepatitis B virus codon T184I [Presence] by Genotype method |
| 763-3 | Band form neutrophils [#/volume] in Blood by Manual count |
| 92954-7 | Serratia marcescens DNA [NCncRange] in Sputum by NAA with non-probe detection |
| 7739-6 | Tobacco IgG Ab [Units/volume] in Serum |
| 77759-9 | 9-Hydroxyrisperidone cutoff [Mass/volume] in Urine for Confirmatory method |
| 94215-1 | PRSS1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 63306-5 | PCNA extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 78695-4 | Guanine/Creatinine [Molar ratio] in Urine |
| 78856-2 | Meprobamate [Mass/volume] in Blood by Confirmatory method |
| 94564-2 | SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 63475-8 | BK virus DNA [Presence] in Blood |
| 95646-6 | Ross River virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 65844-3 | Date of observation (non-patient) |
| 66758-4 | Clot firmness reduction [Length fraction] in Blood by Thromboelastography --60M post maximum clot amplitude |
| 79601-1 | L-serine [Moles/volume] in Cerebral spinal fluid |
| 79641-7 | Glutathione.reduced/Creatinine [Molar ratio] in Urine |
| 803-7 | Toxic granules [Presence] in Blood by Light microscopy |
| 95712-6 | Eastern equine encephalitis virus IgA Ab [Presence] in Specimen by Immunoassay |
| 80696-8 | 2-Chlorovinyl arsonous acid [Mass/volume] in Urine |
| 96704-2 | Clot initiation.kaolin induced [Time] in Blood by US --post heparin neutralization |
| 96765-3 | SARS-CoV-2 (COVID-19) S gene [Presence] in Saliva (oral fluid) by NAA with probe detection |
| 82106-6 | Regional Allergen Mix 3 (Common Ragweed+Goosefoot+Bermuda grass+Perennial rye grass+English Plantain+Bahia grass) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 97269-5 | Meperidine [Presence] in Cord tissue by Confirmatory method |
| 7025-0 | Ketoconazole [Susceptibility] by Gradient strip |
| 70857-8 | Rabies virus Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 85423-2 | Eravacycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 72558-0 | Etravirine [Susceptibility] by Phenotype method |
| 85969-4 | Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 86544-4 | Herpes virus 7 DNA [Presence] in Blood by NAA with probe detection |
| 73186-9 | Propranolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87243-2 | Microscopic observation [Presence] in Specimen by Auramine fluorochrome stain |
| 73731-2 | Transaldolase [Enzymatic activity/mass] in Lymphoblasts |
| 88567-3 | Cytomegalovirus DNA [Presence] in Bone marrow by NAA with probe detection |
| 88684-6 | Microscopic observation [Identifier] in Aspirate by Giemsa stain |
| 41431-8 | Angiostrongylus costaricensis DNA [Presence] in Specimen by NAA with probe detection |
| 59650-2 | N-desalkylflurazepam [Mass/mass] in Meconium by Confirmatory method |
| 31088-8 | Narcotics and opioids [Identifier] in Bile fluid |
| 60260-7 | Chikungunya virus RNA [Presence] in Serum or Plasma by NAA with probe detection |
| 21282-9 | Ganglioside GD1a IgM Ab [Titer] in Serum by Immunoassay |
| 21557-4 | Tetrahydrocannabinol [Presence] in Urine by Screen method >100 ng/mL |
| 2225-1 | Enolase.neuron specific [Enzymatic activity/volume] in Serum or Plasma |
| 31778-4 | Chlamydophila pneumoniae Ag [Presence] in Specimen |
| 4381-0 | Penicillin G procaine [Mass] of Dose |
| 22595-3 | Trichinella spiralis Ab [Presence] in Serum |
| 32556-3 | Urea [Molar amount] in Urine collected for unspecified duration |
| 5202-7 | Herpes simplex virus Ab [Units/volume] in Serum by Immunoassay |
| 5247-2 | Mitochondria Ab [Titer] in Serum by Immunofluorescence |
| 5281-1 | Polio virus 1 neutralizing antibody [Titer] in Serum by Neutralization test |
| 23175-3 | Leptospira interrogans sv Copenhageni Ab [Presence] in Serum |
| 23187-8 | Leptospira interrogans Ab [Presence] in Serum |
| 32642-1 | Dextroamphetamine/Levoamphetamine [Mass Ratio] in Serum or Plasma |
| 53352-1 | Oval fat bodies (globules) [#/volume] in Urine by Computer assisted method |
| 5342-1 | Salmonella paratyphi B O Ab [Presence] in Serum by Latex agglutination |
| 53448-7 | Cycloguanil [Mass/volume] in Serum or Plasma |
| 44527-0 | Histoplasma capsulatum H Ab [Presence] in Serum |
| 23241-3 | Mycobacterium bovis Ag [Presence] in Tissue by Immune stain |
| 23425-2 | Salmonella enteritidis IgG Ab [Presence] in Egg yolk |
| 33473-0 | Bile acid pattern [Interpretation] in Urine |
| 33548-9 | Abnormal lymphocytes/100 leukocytes in Body fluid by Manual count |
| 53755-5 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.25 hours post XXX challenge |
| 45179-9 | Herpes gestationis IgG Ab complement fixing [Presence] in Serum by Immunofluorescence |
| 45350-6 | Tick identification panel |
| 23759-4 | Neospora caninum Ag [Presence] in Tissue by Immune stain |
| 33945-7 | Brucella abortus Ab [Titer] in Cerebral spinal fluid |
| 34145-3 | Human antichimeric Ab [Mass/volume] in Serum |
| 5405-6 | Vibrio cholerae Ab [Mass/volume] in Serum |
| 4697-9 | HLA-A33(19) [Presence] in Donor |
| 34634-6 | CD11+CD18+ cells [#/volume] in Leukocytes |
| 34687-4 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor XI depleted plasma |
| 25153-8 | Cholesterol crystals [#/area] in Urine sediment by Microscopy high power field |
| 25378-1 | Cobalt [Moles/volume] in Serum or Plasma |
| 34727-8 | DMPK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 34936-5 | CD3+CD8+CD45RO-CD45RA+ cells/100 cells in Blood |
| 35101-5 | Intrathecal pressure |
| 55822-1 | Allo-tetrahydrodeoxycortisol [Mass/time] in 24 hour Urine |
| 35449-8 | HIV 1 p17 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
| 35683-2 | Burkholderia pseudomallei IgG and IgM panel - Serum |
| 56283-5 | Hazelnut IgG4 Ab [Mass/volume] in Serum |
| 4795-1 | HLA-B72(70) [Presence] |
| 3594-9 | ePHEDrine+Pseudoephedrine [Presence] in Serum or Plasma |
| 56771-9 | Eosinophils/100 leukocytes in Bronchial specimen by Flow cytometry (FC) |
| 38389-3 | Coxiella burnetii phase 2 Ab [Titer] in Serum |
| 49222-3 | Food allergen panel - Serum |
| 27900-0 | Lactobacillus sp IgG Ab [Units/volume] in Serum |
| 49444-3 | Toxoplasma gondii DNA [#/volume] in Amniotic fluid by NAA with probe detection |
| 40253-7 | Creatinine [Mass/volume] in Serum or Plasma --2.25 hours post XXX challenge |
| 58451-6 | Glutamate decarboxylase 65 Ab [Mass/volume] in Serum |
| 58661-0 | Cortisol [Mass/volume] in Saliva (oral fluid) --30 minutes pre 1 ug/kg CRH IV |
| 49870-9 | Coagulation factor VII Ag actual/normal in Platelet poor plasma by Immunoassay |
| 50127-0 | 3-Hydroxypalmitoylcarnitine (C16-OH)/Creatinine [Molar ratio] in Urine |
| 29703-6 | Rickettsia sibirica Ab [Titer] in Serum by Immunofluorescence |
| 40638-9 | Lambda light chains [Presence] in Urine by Immunofixation |
| 40650-4 | Mesothelial cells/100 leukocytes in Blood by Manual count |
| 50477-9 | Follitropin [Units/volume] in Serum or Plasma --1st specimen |
| 30224-0 | Coxsackievirus B5 Ab [Presence] in Serum |
| 41046-4 | TWIST1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 41111-6 | COL5A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19296-3 | Opiates tested for in Urine by Screen method Nominal |
| 19366-4 | Bromazepam cutoff [Mass/volume] in Urine for Screen method |
| 19421-7 | Dextroamphetamine cutoff [Mass/volume] in Urine for Screen method |
| 20588-0 | CD13 cells/100 cells in Specimen |
| 13010-4 | Methyl amyl ketone [Mass/volume] in Blood |
| 13073-2 | Phosphatidylcholine IgG Ab [Units/volume] in Serum |
| 13086-4 | C3 nephritic factor [Mass/volume] in Serum or Plasma |
| 13377-7 | 1-Methylhistidine [Mass/volume] in Cerebral spinal fluid |
| 101916-5 | Troponin T.cardiac delta [Mass concentration difference] in 6 hour Serum or Plasma |
| 102545-1 | Psyllium seed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102854-7 | Mattress dust IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104339-7 | Borna disease virus RNA [Presence] in Brain tissue by Sequencing |
| 15339-5 | Berlin Beetle IgE Ab [Units/volume] in Serum |
| 15361-9 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:4 addition of normal plasma |
| 1541-2 | Glucose [Mass/volume] in Urine --5 hours post 100 g glucose PO |
| 15474-0 | Infectious bursal disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 10732-6 | Trypanosoma sp identified in Blood by Thin film |
| 11092-4 | Barbiturates [Mass/mass] in Hair |
| 16332-9 | Aldosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 1214-6 | LW Ab [Presence] in Serum or Plasma from Blood product unit |
| 17672-7 | Sulfide [Mass/volume] in Urine |
| 90251-0 | Bartonella henselae and Bartonella quintana IgG and IgM panel [Titer] - Serum |
| 74590-1 | NADH cytochrome C reductase/Citrate synthase [Enzymatic activity ratio] in Tissue |
| 6057-4 | Chamomile IgE Ab [Units/volume] in Serum |
| 609-8 | Bacteria identified in Eye by Aerobe culture |
| 61195-4 | Albumin [Mass/volume] in Serum or Plasma from Fetus |
| 761-7 | Neutrophils [#/volume] in Urine by Automated count |
| 61308-3 | Rhizopus nigricans IgE Ab/IgE total in Serum |
| 6193-7 | Onion IgE Ab [Units/volume] in Serum |
| 62310-8 | Galactosylceramidase [Enzymatic activity/volume] in DBS |
| 77118-8 | RPGRIP1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 93706-0 | Ethyl sulfate+Ethyl glucuronide [Mass/volume] in Urine by Screen method |
| 9404-5 | Adenosine deaminase [Enzymatic activity/volume] in Body fluid |
| 94058-5 | Bacterial embB gene drug resistance mutation [Identifier] by Molecular method |
| 63183-8 | Cottonwood IgG Ab [Mass/volume] in Serum |
| 78036-1 | Fibers [Presence] in Urine |
| 94833-1 | Varicella zoster virus DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 63393-3 | Jo-1 extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
| 64972-3 | English plantain recombinant (rPla l) 1 IgE Ab [Units/volume] in Serum |
| 78864-6 | Naloxone cutoff [Mass/volume] in Urine for Confirmatory method |
| 79319-0 | L-2-hydroxyglutarate [Moles/volume] in Amniotic fluid |
| 79341-4 | Carnitine biosynthesis intermediates pattern [Interpretation] in Serum or Plasma Narrative |
| 79446-1 | Pericyazine [Mass/volume] in Serum or Plasma |
| 95178-0 | Bordetella avium Ab [Titer] in Serum by Immunoassay |
| 95183-0 | Clostridioides difficile toxin and BI-NAP1-027 strain DNA panel - Stool by NAA with probe detection |
| 95641-7 | Barmah forest virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 65358-4 | Proinsulin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 66146-2 | Reticulocytes [#/volume] in Blood from Fetus by Manual count |
| 79525-2 | 3-Hydroxysebacate (3-OH-C8) unsaturated [Moles/volume] in Serum or Plasma |
| 95841-3 | Monocytes+Macrophages/100 leukocytes in Sputum by Manual count |
| 69002-4 | Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection |
| 81106-7 | Leptospira interrogans sv Robinsoni Ab [Titer] in Serum by Agglutination |
| 69837-3 | 3-Hydroxyglutarate [Moles/volume] in Cerebral spinal fluid |
| 97861-9 | HIV 2 Ab panel - Serum or Plasma by Immunoblot |
| 8236-2 | Phencyclidine [Presence] in Serum or Plasma by Screen method |
| 82845-9 | Campylobacter jejuni IgA and IgG and IgM panel - Serum |
| 83327-7 | HIV 1 RNA phenotype in Isolate |
| 849-0 | A1 B Ag [Presence] on Red Blood Cells from Donor |
| 85535-3 | Influenza virus A RNA TCID50 [#/volume] in Specimen |
| 85627-8 | Haemophilus influenzae hpd gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 99450-9 | Botrytis cinerea IgG4 Ab [Mass/volume] in Serum |
| 72511-9 | CYP2B6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 72833-7 | Cytomegalovirus UL97 gene mutations detected [Identifier] |
| 86219-3 | Porcine epidemic diarrhea virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 87373-7 | Escherichia coli K88 DNA [Presence] in Isolate by NAA with probe detection |
| 87578-1 | Ergocristine [Mass/mass] in Specimen |
| 88182-1 | Wuchereria bancrofti+Brugia malayi IgG1 Ab [Presence] in Serum by Immunoassay |
| 73993-8 | Polychlorinated biphenyl (PCB) [Presence] in Serum or Plasma by Confirmatory method |
| 74226-2 | Plasma cells assessment in Bone marrow Narrative |
| 74227-0 | Other observations in Bone marrow Narrative |
| 41410-2 | Ofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 4150-9 | Caffeine [Mass] of Dose |
| 50890-3 | Norclozapine [Moles/volume] in Urine |
| 30454-3 | Neutrophils/100 leukocytes in Pericardial fluid |
| 41769-1 | Neuronal nuclear type 1 Ab [Presence] in Serum by Immunoblot |
| 42596-7 | Corticotropin [Mass/volume] in Plasma --30 minutes post XXX challenge |
| 31234-8 | Aspergillus terreus Ab [Presence] in Serum |
| 22129-1 | Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid |
| 22157-2 | Brucella melitensis Ab [Titer] in Serum |
| 31788-3 | Cryptococcus sp Ag [Presence] in Cerebral spinal fluid |
| 31921-0 | Neisseria meningitidis serogroup Y Ag [Presence] in Specimen |
| 51906-6 | Collection of air specimen start time |
| 22744-7 | Copper [Moles/volume] in Specimen |
| 32237-0 | Cystine [Moles/volume] in Body fluid |
| 44059-4 | CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Tissue |
| 33237-9 | Sulfonamide crystals [Presence] in Urine by Computer assisted method |
| 53219-2 | Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in DBS |
| 53306-7 | Calcium oxalate crystals [#/area] in Urine by Computer assisted method |
| 23564-8 | Vesicular stomatitis Indiana virus Ab [Presence] in Serum by Complement fixation |
| 45170-8 | Myelin associated glycoprotein Ab [Units/volume] in Serum by Immunofluorescence |
| 34196-6 | C Ab [Titer] in Serum or Plasma |
| 54331-4 | Propionylcarnitine (C3) [Moles/volume] in Amniotic fluid |
| 458-0 | Spiramycin [Susceptibility] by Serum bactericidal titer |
| 4618-5 | Hemoglobin O - Arab [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 46403-2 | Cortisol [Mass/volume] in Serum or Plasma --2 hours post dose insulin IV |
| 46979-1 | Flurazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 2435-6 | Homovanillate [Mass/volume] in Serum |
| 55325-5 | Js sup(a) Ab [Titer] in Serum or Plasma |
| 47308-2 | Echinococcus granulosus IgG Ab [Units/volume] in Serum by Immunoassay |
| 47446-0 | Influenza virus A H11 Ab [Titer] in Serum |
| 3534-5 | Desipramine [Mass/volume] in Urine |
| 55649-8 | cefTAZidime+Sulbactam [Susceptibility] |
| 55952-6 | Octenoylcarnitine (C8:1) [Moles/volume] in Cerebral spinal fluid |
| 2556-9 | Lecithin phosphorus [Mass/volume] in Amniotic fluid |
| 25770-9 | Insulin-like growth factor [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 25909-3 | EPINEPHrine/Creatinine [Molar ratio] in 24 hour Urine |
| 56194-4 | Blackberry IgG4 Ab [Mass/volume] in Serum |
| 48320-6 | glyBURIDE [Presence] in Specimen |
| 26468-9 | Leukocytes [#/volume] in Peritoneal fluid |
| 26741-9 | Serine [Moles/volume] in Urine |
| 35823-4 | Mupirocin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 48762-9 | 3-Hydroxymyristate (3-OH-C14:0) [Moles/volume] in Serum or Plasma |
| 26952-2 | Phoma herbarum IgG Ab [Mass/volume] in Serum |
| 27246-8 | Butalbital [Mass/mass] in Stool |
| 57308-9 | CYP11B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 57315-4 | Sulphonamide IgE Ab [Units/volume] in Serum |
| 57572-0 | 3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum or Plasma --2 days post dose dexamethasone |
| 49190-2 | Coccidioides sp Ab [Presence] in Body fluid |
| 39461-9 | Bilirubin.total [Moles/volume] in Peritoneal fluid |
| 39543-4 | Hazelnut IgE Ab/IgE total in Serum |
| 49501-0 | Calcium oxalate monohydrate/Total in Stone by Infrared spectroscopy |
| 58726-1 | Lymphocyte proliferation stimulated by 0.50 ug pokeweed mitogen actual/normal in Blood |
| 49818-8 | 2-Oxoisovalerate/Creatinine [Molar ratio] in 24 hour Urine |
| 50068-6 | 11-Hydroxyandrostenedione [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin |
| 29770-5 | Karyotype [Identifier] in Blood or Tissue Nominal |
| 40535-7 | Leukocytes other/100 leukocytes in Peritoneal dialysis fluid by Manual count |
| 58864-0 | Somatotropin [Mass/volume] in Serum or Plasma --44th specimen |
| 59000-0 | Calcium [Mass/time] in 18 hour Urine |
| 50179-1 | Calcitonin Calcium and Pentagastrin challenge panel - Serum or Plasma |
| 50189-0 | Neonatal bilirubin panel [Mass/volume] - Serum or Plasma |
| 50292-2 | 4-Hydroxyifosfamide [Mass/volume] in Blood --pre dose ifosfamide |
| 30154-9 | Protein/Creatinine [Mass Ratio] in Serum or Plasma |
| 40765-0 | Coxsackievirus B Ab [Titer] in Cerebral spinal fluid |
| 41170-2 | Phenylalanine+Tyrosine [Presence] in Blood |
| 20637-5 | Arginine [Moles/volume] in Serum or Plasma |
| 12519-5 | Catecholamines [Mass/volume] in Urine --5th specimen post XXX challenge |
| 12710-0 | Hemoglobin pattern [Interpretation] in Blood |
| 12841-3 | Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma |
| 101204-6 | Varicella zoster virus IgA Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 101362-2 | Bacillus anthracis DNA [Presence] in Blood by NAA with non-probe detection |
| 13198-7 | Thermoactinomyces Ab [Units/volume] in Serum |
| 13521-0 | Blasts/100 leukocytes in Cerebral spinal fluid by Manual count |
| 102241-7 | Clam IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102287-0 | Whole Egg IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14061-6 | Cyclobenzaprine [Mass/volume] in Urine |
| 14368-5 | Trichomonas vaginalis [Presence] in Urethra by Wet preparation |
| 1506-5 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g lactose PO |
| 15463-3 | Bovine diarrhea virus 2 neutralizing antibody [Titer] in Serum by Neutralization test |
| 11124-5 | Pronormoblasts/100 cells in Bone marrow by Manual count |
| 11467-8 | Bacillus anthracis Ab [Units/volume] in Serum by Immunoblot |
| 11565-9 | Jo-1 extractable nuclear Ab [Units/volume] in Serum |
| 12221-8 | Heterophile Ab [Presence] in Serum by Sheep Cell Agglutination |
| 17424-3 | 1,4-Dichlorobenzene [Mass/volume] in Blood |
| 18361-6 | Adenosine monophosphate.cyclic/Creatinine [Mass Ratio] in Urine |
| 90224-7 | Thyroxine and Thyroxine.free panel - Serum or Plasma |
| 60429-8 | Enterovirus 71 RNA [Presence] in Isolate by NAA with probe detection |
| 92862-2 | Herpes simplex virus 1 and 2 and Varicella zoster virus DNA panel - Serum or Plasma by NAA with probe detection |
| 93500-7 | Metabotropic glutamate receptor 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 77169-1 | cycloSPORINE [Mass/volume] in Blood --1 hour post dose |
| 77667-4 | Calcitonin [Moles/volume] in Serum or Plasma --2 minutes post XXX challenge |
| 94292-0 | Citalopram+Escitalopram [Presence] in Serum or Plasma by Screen method |
| 6371-9 | Cryptosporidium sp Ag [Presence] in Stool by Immunoassay |
| 6374-3 | Taenia solium larva IgG Ab [Presence] in Serum by Immunoblot |
| 79487-5 | Lactyl lactate/Creatinine [Molar ratio] in Urine |
| 9490-4 | Aspergillus flavus Ab [Presence] in Serum |
| 9518-2 | Echovirus 30 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 9552-1 | Legionella pneumophila 6 IgG Ab [Titer] in Serum by Immunofluorescence |
| 95672-2 | Chikungunya virus IgG Ab [Presence] in Specimen by Immunoassay |
| 6636-5 | Influenza virus A Port Chalmers Ab [Units/volume] in Serum by Hemagglutination inhibition |
| 6640-7 | Influenza virus A Phillipines Ab [Units/volume] in Serum by Hemagglutination inhibition |
| 6757-9 | Glucose [Presence] in Urine by Test strip --4 hours post 75 g glucose PO |
| 69036-2 | Western equine encephalitis virus IgG and IgM panel - Cerebral spinal fluid by Immunofluorescence |
| 8058-0 | Acetylcholine receptor Ab [Units/volume] in Serum |
| 81232-1 | Supersaturation panel - 24 hour Urine |
| 9720-4 | Reticulin IgA Ab [Titer] in Serum |
| 70058-3 | Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 82257-7 | SRY gene deletion in Blood or Tissue by FISH |
| 97305-7 | Temazepam [Presence] in Cord tissue by Confirmatory method |
| 70123-5 | Epithelial cells.ciliated [Presence] in Body fluid |
| 8247-9 | Mucus [Presence] in Urine sediment by Light microscopy |
| 98240-5 | CD154 cells [Presence] in T cells |
| 99072-1 | Kelch-like protein 11 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 72474-0 | JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 84915-8 | Cells.chromosome region 11q22.3 deletion/Cells counted in Blood or Tissue by FISH |
| 85530-4 | PRRSV European strain IgG Ab [Presence] in Serum by Immunofluorescence |
| 85980-1 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 87354-7 | Actinobacillus pleuropneumoniae Ab/Positive control in Serum or Plasma by Immunoassay |
| 874-8 | A3 B Ag [Presence] on Red Blood Cells |
| 87645-8 | Dechlorane [Mass/mass] in Specimen |
| 7340-3 | Goat milk IgE Ab [Units/volume] in Serum |
| 7361-9 | Johnson grass triggered histamine release [Units/volume] in Blood |
| 87939-5 | Bacteria identified in Pericardial fluid by Anaerobe culture |
| 88519-4 | KIT gene c.2447A>T [Presence] in Blood or Tissue by Molecular genetics method |
| 74415-1 | Rubella virus IgG Ab [Presence] in Body fluid by Immunoassay |
| 88679-6 | Herpes simplex virus 2 Ag [Presence] in Cornea or Conjunctiva by Immunofluorescence |
| 88998-0 | Omega-3 (EPA+DHA) index in Serum or Plasma |
| 59464-8 | Microbiologist review of results |
| 59689-0 | Hydroxyethylflurazepam [Mass/mass] in Tissue by Confirmatory method |
| 50689-9 | Treponema pallidum Ab [Presence] in Cerebral spinal fluid by Hemagglutination |
| 31091-2 | Gentamicin [Mass/volume] in Serum or Plasma --peak post extended interval dosing |
| 42323-6 | HLA-DR Ag [Type] in Tissue |
| 59971-2 | Sulfamethoxazole [Moles/volume] in Urine |
| 60051-0 | Acetophenazine [Mass/volume] in Blood |
| 21174-8 | Cephaeline [Mass/volume] in Urine |
| 51456-2 | Filaria IgG2 Ab [Units/volume] in Serum |
| 42904-3 | Epicoccum purpurascens IgG Ab [Mass/volume] in Serum |
| 42944-9 | Vesicular stomatitis New Jersey virus Ab [Titer] in Serum |
| 43183-3 | Cyanide [Mass/volume] in Blood by Confirmatory method |
| 51816-7 | Bartonella quintana IgG Ab [Units/volume] in Serum by Immunoassay |
| 43323-5 | Avian metapneumovirus C Ab [Titer] in Serum by Immunoassay |
| 51994-2 | Homovanillate/Creatinine [Mass Ratio] in Urine collected for unspecified duration |
| 5229-0 | Influenza virus A Ab [Titer] in Serum by Complement fixation |
| 52914-9 | Boron [Moles/volume] in Serum or Plasma |
| 52963-6 | Flurazepam [Presence] in Gastric fluid |
| 43967-9 | CD3+CD25+ cells/100 cells in Cerebral spinal fluid |
| 22902-1 | Bovine herpesvirus 1 Ab [Presence] in Serum by Immune diffusion (ID) |
| 23084-7 | Equine herpesvirus 1 DNA [Presence] in Tissue by NAA with probe detection |
| 32717-1 | Sodium [Moles/volume] in Arterial blood |
| 232-9 | Erythromycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 3356-3 | Anileridine [Mass/volume] in Serum or Plasma |
| 33642-0 | Lymphocyte Ab [Units/volume] in Serum by Flow cytometry (FC) |
| 45123-7 | Cocal virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 45187-2 | Other Antibiotic [Susceptibility] by Disk diffusion (KB) |
| 4616-9 | Hemoglobin N - Seattle [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 46174-9 | Borrelia burgdorferi IgA Ab [Units/volume] in Serum |
| 4632-6 | Hemoglobin F [Presence] in Blood by Alkali denaturation |
| 24221-4 | Parainfluenza virus 2 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 34551-2 | Catecholamines 3 panel [Mass/volume] - Plasma |
| 55376-8 | Megaloblasts/100 leukocytes in Blood by Manual count |
| 55865-0 | Glycolate [Moles/volume] in Urine |
| 47811-5 | 2-Methyl-3-Oxobutyrate/Creatinine [Molar ratio] in Urine |
| 47879-2 | Pyruvate carboxylase [Enzymatic activity/mass] in Amniotic fluid cells |
| 25680-0 | Glucose [Moles/volume] in Serum or Plasma --pre 50 g glucose PO |
| 35498-5 | Succinate cytochrome C reductase [Enzymatic activity/mass] in Tissue |
| 47994-9 | Bilirubin.total [Moles/volume] in Cord blood |
| 48090-5 | Cholesterol in HDL/Cholesterol in HDL+VLDL [Molar ratio] in Serum or Plasma |
| 48097-0 | Corticotropin [Mass/volume] in Plasma --8 PM specimen |
| 48178-8 | Reference change value 0.99 [#] in unspecified time Population |
| 48288-5 | Vecuronium triggered leukotriene release [Mass/volume] by Leukocytes |
| 3726-7 | Lormetazepam [Mass/volume] in Urine |
| 57007-7 | Insulin [Units/volume] in Serum or Plasma --52 hours post XXX challenge |
| 48710-8 | Eosinophils [Presence] in Specimen by Light microscopy |
| 48854-4 | Orientia tsutsugamushi Karp IgM Ab [Titer] in Serum by Immunofluorescence |
| 38584-9 | Acetaldehyde [Mass/volume] in Air |
| 49319-7 | Beta glucosidase activator [Interpretation] in Fibroblast Narrative |
| 58034-0 | Bermuda grass smut IgE Ab/IgE total in Serum |
| 49341-1 | Adenovirus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
| 49517-6 | Topiramate [Mass/volume] in Serum or Plasma --trough |
| 294-9 | Ketoconazole [Susceptibility] by Minimum lethal concentration (MLC) |
| 58445-8 | Manual differential comment [Interpretation] in Blood Narrative |
| 49871-7 | Codeine IgE Ab [Units/volume] in Serum |
| 50547-9 | Eastern equine encephalitis virus RNA [Presence] in Specimen by NAA with probe detection |
| 40747-8 | Complement C2 [Presence] in Serum or Plasma |
| 40756-9 | Amiodarone [Mass/volume] in Serum or Plasma --trough |
| 20418-0 | Histoplasma capsulatum yeast phase Ab [Titer] in Serum |
| 20488-3 | Streptococcus agalactiae Ag [Presence] in Cerebral spinal fluid |
| 1256-7 | N Ab [Presence] in Serum or Plasma from Blood product unit |
| 101122-0 | Mephobarbital [Mass/volume] in Blood by Confirmatory method |
| 101487-7 | Imipenem [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 101627-8 | Thyroglobulin heterophile Ab interference [Presence] in Serum |
| 102400-9 | Latex IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14135-8 | CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood |
| 15358-5 | Macroamylase [Presence] in Serum or Plasma |
| 16213-1 | Levorphanol [Presence] in Urine by Confirmatory method |
| 11104-7 | Normoblasts Basophilic/100 cells in Bone marrow by Manual count |
| 16655-3 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --10 minutes post XXX challenge |
| 1156-9 | little c Ab [Presence] in Serum or Plasma |
| 16778-3 | Dinitrophenol [Presence] in Serum or Plasma |
| 16992-0 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --4 hours post dose glucose |
| 17892-1 | Bacteria # 6 identified in Nose by Aerobe culture |
| 18308-7 | Pneumocystis sp identified in Lung tissue by Immune stain |
| 90003-5 | Acinetobacter sp identified in Specimen by Organism specific culture |
| 90240-3 | Eculizumab [Mass/volume] in Serum |
| 74641-2 | Monoclonal band 2 observed [Identifier] in Serum or Plasma by Immunofixation |
| 75027-3 | Mesoporphyrin/Porphyrins.total in Stool |
| 60412-4 | Vanilla IgG Ab [Mass/volume] in Serum |
| 60517-0 | Iron/Transferrin [Ratio] in Serum or Plasma |
| 61050-1 | Methylphenidate [Presence] in Specimen |
| 61112-9 | HTLV [Type] in Serum or Plasma |
| 75979-5 | Fetal Chromosome 13 trisomy [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative |
| 92891-1 | INR goal in Platelet poor plasma by Coagulation assay |
| 92982-8 | Escherichia coli DNA [NCncRange] in Sputum by NAA with non-probe detection |
| 9311-2 | Albuterol [Mass/volume] in Serum or Plasma |
| 93190-7 | HTR2A gene c.614-2211T>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 93353-1 | CD64 Ag [Entitic number] on Neutrophil by Flow cytometry (FC) |
| 6122-6 | Garlic IgE Ab [Units/volume] in Serum |
| 61297-8 | Phthalic anhydride IgE Ab/IgE total in Serum |
| 61387-7 | Human papilloma virus 67 DNA [Presence] in Specimen by NAA with probe detection |
| 77027-1 | Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with probe detection |
| 9450-8 | Hexacarboxylporphyrin [Mass/volume] in Red Blood Cells |
| 94844-8 | Creatinine [Mass/volume] in Urine from Fetus |
| 9494-6 | Blastomyces dermatitidis IgG Ab [Units/volume] in Serum |
| 80112-6 | 11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Body fluid by Confirmatory method |
| 80134-0 | Amphetamine [Mass/mass] in Hair by Confirmatory method |
| 95696-1 | Barmah forest virus IgA Ab [Presence] in Specimen by Immunoassay |
| 96719-0 | Erythrocytes [#/area] in Prostatic fluid by Light microscopy |
| 8260-2 | Service comment 18 |
| 99001-0 | Leptospira weilii sv Celledoni Ab [Titer] in Serum by Agglutination |
| 83092-7 | Creatine kinase.MB [Mass/volume] in Serum or Plasma by Immunoassay |
| 85301-0 | Adjacent structure invaded by tumor [Anatomy] in Breast cancer specimen by Macroscopy |
| 85358-0 | Phosphatidylserine-prothrombin complex IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 72779-2 | JWH-073 butanoate (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
| 73097-8 | valACYclovir induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73388-1 | Ezetimibe induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87335-6 | Porcine circovirus type 2 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73550-6 | Acarbose induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73690-0 | Nateglinide [Mass/volume] in Urine |
| 739-3 | Metamyelocytes [#/volume] in Blood by Manual count |
| 41238-7 | Viscosity of Synovial fluid |
| 41627-1 | Burkholderia sp Ag [Presence] in Specimen by Immunofluorescence |
| 59623-9 | chlordiazePOXIDE [Mass/mass] in Stool by Confirmatory method |
| 51059-4 | CD127 blasts [Units/volume] in Blood |
| 51181-6 | CD1 blasts in Bone marrow |
| 514-0 | Trimethoprim [Susceptibility] by Serum bactericidal titer |
| 51446-3 | CD64 cells [Units/volume] in Blood |
| 42876-3 | CD25+CD19+ cells/100 cells in Bone marrow |
| 42959-7 | Salmonella typhi O Ab [Titer] in Serum |
| 43612-1 | Adenovirus Ag [Presence] in Nose by Immunofluorescence |
| 3261-5 | Fibrinopeptide B beta (1-42) Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
| 32745-2 | CD62E cells/100 cells in Specimen |
| 32820-3 | Glucose [Mass/volume] in Serum or Plasma --45 minutes post dose lactose PO |
| 32844-3 | Epstein Barr virus capsid IgG Ab [Units/volume] in Serum --2nd specimen |
| 32999-5 | Rickettsia spotted fever group IgG Ab [Presence] in Serum |
| 33036-5 | Fatty acids.very long chain C26:1 (Hexacosenoate) [Moles/volume] in Serum or Plasma |
| 53225-9 | Leukocytes [#/area] in Specimen by Wet preparation |
| 53465-1 | Sebacylcarnitine (C10-DC) [Moles/volume] in Cerebral spinal fluid |
| 44652-6 | Total number of cores in Tissue core |
| 23239-7 | Mycobacterium bovis Ab [Presence] in Serum |
| 23260-3 | Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum by Agglutination |
| 23503-6 | Tritrichomonas foetus Ag [Presence] in Placenta by Immune stain |
| 33574-5 | Chlamydia trachomatis I IgM Ab [Titer] in Serum by Immunofluorescence |
| 53497-4 | 5-Hydroxytryptophan [Moles/volume] in 24 hour Urine |
| 23888-1 | Isopropanol [Mass/volume] in Gastric fluid |
| 33918-4 | Acetoacetate [Moles/volume] in Urine |
| 46270-5 | ABO group [Type] in Blood--after transfusion reaction |
| 24463-2 | Keratan sulfate [Presence] in Urine |
| 34359-0 | Pregnanediol/Creatinine [Molar ratio] in Urine |
| 54917-0 | Lysozyme [Mass/volume] in Pleural fluid |
| 4730-8 | HLA-A2 [Presence] in Donor |
| 34956-3 | Western equine encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 35018-1 | Mononuclear cells [#/volume] in Pleural fluid |
| 35086-8 | Second trimester triple maternal screen panel - Serum or Plasma |
| 35274-0 | Histone IgG Ab [Presence] in Serum by Immunoassay |
| 55950-0 | Octanoylcarnitine (C8) [Moles/volume] in Urine |
| 47730-7 | Prolactin [Mass/volume] in Serum or Plasma --15 minutes post dose TRH IV |
| 25574-5 | C peptide [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 25904-4 | D-Lactate [Moles/volume] in Serum or Plasma --6th specimen post excercise |
| 56204-1 | Candida albicans IgG4 Ab [Mass/volume] in Serum |
| 56359-3 | Pinto Bean IgG4 Ab [Mass/volume] in Serum |
| 26539-7 | Glucose [Mass/volume] in Serum or Plasma --45 minutes post dose glucose |
| 26652-8 | Banzi virus Ab [Presence] in Serum |
| 26657-7 | Schistosoma haematobium Ab [Presence] in Serum |
| 26770-8 | Trichloroacetate/Creatinine [Mass Ratio] in Urine |
| 57683-5 | Plasmodium falciparum IgM Ab [Presence] in Serum by Immunoassay |
| 48927-8 | Respiratory allergen panel, US - Rocky mountain states b - Serum |
| 38703-5 | Hexamethylphosphoramide [Mass/volume] in Air |
| 2809-2 | Porphobilinogen [Presence] in Urine |
| 28603-9 | Asparagine/Creatinine [Ratio] in Urine |
| 29375-3 | Methanol [Mass/volume] in Unknown substance |
| 29527-9 | Citrate/Creatinine [Molar ratio] in Urine |
| 40091-1 | Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --1.5 hours post XXX challenge |
| 58680-0 | Cortisol [Moles/volume] in Serum or Plasma --pre 2 mg dexamethasone PO 2.5 day high dose q6h |
| 49928-5 | Leukocytes [#/volume] in Peritoneal dialysis fluid |
| 49960-8 | Suberate.unsaturated/Creatinine [Molar ratio] in Urine |
| 50077-7 | 17-Ketosteroids [Mass/volume] in Urine --2 days post dose dexamethasone |
| 29696-2 | Leptospira interrogans sv Cynopteri Ab [Presence] in Serum |
| 29963-6 | Parietal cell IgG Ab [Presence] in Serum by Immunofluorescence |
| 58999-4 | Chloride [Moles/time] in 18 hour Urine |
| 5919-6 | Creatinine [Mass/volume] in Dialysis fluid |
| 50259-1 | Aldosterone [Moles/volume] in Serum or Plasma --pre 25 mg captopril PO |
| 30226-5 | Fibrin+Fibrinogen fragments [Mass/volume] in Platelet poor plasma |
| 30250-5 | Benzodiazepines [Mass/volume] in Serum or Plasma by Screen method |
| 40785-8 | Toxoplasma gondii IgM Ab [Titer] in Serum --1st specimen |
| 19539-6 | Mephobarbital [Mass/volume] in Urine |
| 19627-9 | Nordiazepam cutoff [Mass/volume] in Urine for Confirmatory method |
| 21017-9 | CD57 cells [#/volume] in Blood |
| 1249-2 | M1 Ag [Presence] on Red Blood Cells |
| 101348-1 | Palmitoyl protein thioesterase and Tripeptidyl peptidase I panel - DBS |
| 101520-5 | Avian reovirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 102502-2 | Pear IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1398-7 | Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
| 14592-0 | Aluminum [Moles/volume] in 24 hour Urine |
| 14743-9 | Glucose [Moles/volume] in Capillary blood by Glucometer |
| 10339-0 | FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma |
| 103667-2 | Cells.chromosome region 1p32 deletion/Cells counted in Blood or Marrow by FISH |
| 103712-6 | Entamoeba hartmanni DNA [Presence] in Stool by NAA with probe detection |
| 14827-0 | Mesoporphyrin [Moles/volume] in Stool |
| 14915-3 | Theophylline [Moles/volume] in Serum or Plasma |
| 10579-1 | Leukocytes [#/volume] in Semen |
| 10768-0 | Microscopic observation [Identifier] in Tissue by Alcian blue stain.with periodic acid-Schiff |
| 10833-2 | Insulin [Mass/volume] in Serum or Plasma --7 hours post 75 g glucose PO |
| 16535-7 | Canary droppings IgE Ab [Units/volume] in Serum |
| 12174-9 | Albumin/Globulin [Mass Ratio] in Body fluid |
| 17098-5 | CD100 cells/100 cells in Blood |
| 17931-7 | Bacteria # 4 identified in Blood by Aerobe culture |
| 756-7 | Neutrophils [#/volume] in Pleural fluid by Automated count |
| 7637-2 | Pullularia sp IgE Ab [Units/volume] in Serum |
| 92881-2 | Human metapneumovirus and Respiratory syncytial virus RNA panel - Upper respiratory specimen by NAA with probe detection |
| 93422-4 | Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 6214-1 | Perch IgE Ab [Units/volume] in Serum |
| 62244-9 | Platelets [#/volume] in Blood from Fetus by Automated count |
| 77650-0 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 77876-1 | Phencyclidine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 77937-1 | Cortisol [Moles/volume] in Serum or Plasma --12 hours post XXX challenge |
| 6348-7 | Chlamydia sp identified in Sputum by Organism specific culture |
| 6412-1 | Giardia lamblia Ag [Presence] in Stool by Immunoassay |
| 79203-6 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose arginine+insulin |
| 79408-1 | cloBAZam and norclobazam panel - Serum or Plasma |
| 80095-3 | Galactosamine/Creatinine [Molar ratio] in Urine |
| 68314-4 | Meperidine and Normeperidine panel - Serum or Plasma |
| 81281-8 | Heparin dose response panel - Blood |
| 96636-6 | HLA-C [Type] by Low resolution |
| 70055-9 | Hantavirus dobrova IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 82393-0 | Fibrillarin Ab [Units/volume] in Serum by Line blot |
| 82747-7 | Babesia microti IgG Ab [Presence] in Serum by Immunoblot |
| 82866-5 | Allo-pregnanediolone [Moles/time] in 24 hour Urine |
| 9822-8 | Bacteria identified in Dialysis fluid by Culture |
| 99088-7 | Cryptococcus gattii+neoformans DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 71838-7 | Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood |
| 72259-5 | Adefovir [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 72465-8 | JWH-073 butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 85333-3 | DCIS.additional dimension 1 [Length] in Breast cancer specimen by Light microscopy |
| 99268-5 | Diclazepam [Mass/volume] in Urine by Confirmatory method |
| 86047-8 | Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum --1st specimen |
| 86329-0 | Adenovirus B(16) DNA [Presence] in Specimen by NAA with probe detection |
| 73065-5 | Amitriptyline induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88271-2 | Staphylococcus lugdunensis sodA gene [Presence] by Probe in Positive blood culture |
| 73931-8 | Propanol [Mass/volume] in Urine |
| 74302-1 | Tyrosine [Moles/volume] in DBS --post therapeutic diet |
| 74343-5 | MICA*005 IgG Ab [Presence] in Serum |
| 88734-9 | PCA-Tr Ab [Units/volume] in Serum by Line blot |
| 89304-0 | Norhydrocodone [Presence] in Urine by Screen method |
| 41673-5 | cefoTEtan+Clavulanate [Susceptibility] by Disk diffusion (KB) |
| 59869-8 | Benztropine [Moles/volume] in Serum or Plasma |
| 50719-4 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 3063-5 | Trypsin [Enzymatic activity/volume] in Stool |
| 4193-9 | clomiPRAMINE [Mass] of Dose |
| 31902-0 | Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Specimen |
| 31933-5 | Pneumocystis jiroveci Ag [Presence] in Bronchial specimen |
| 31940-0 | Pneumocystis jiroveci Ag [Presence] in Stool |
| 51790-4 | RBC casts [#/area] in Urine sediment by Microscopy high power field |
| 51882-9 | Cryoprecipitate units given [#] |
| 3245-8 | Clot Retraction [Time] in Blood by Coagulation assay |
| 52812-5 | Appearance of Spun Dialysis fluid |
| 44075-0 | Bilirubin casts [Presence] in Urine sediment by Light microscopy |
| 44246-7 | Yeast [#/area] in Vaginal fluid by Wet preparation |
| 23192-8 | Leptospira interrogans sv Pomona Ab [Presence] in Serum by Agglutination |
| 53102-0 | Decanoylcarnitine (C10) [Moles/volume] in Urine |
| 53107-9 | Kynurenate/Creatinine [Molar ratio] in Urine |
| 33596-8 | CD10+CD20+ cells [#/volume] in Blood |
| 53728-2 | WS2A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 44978-5 | Chlamydophila psittaci IgA Ab [Presence] in Serum |
| 34242-8 | Androsterone [Moles/volume] in Urine |
| 342-6 | Moxalactam [Susceptibility] by Minimum lethal concentration (MLC) |
| 53966-8 | Erythrocytes.dysmorphic G1/100 erythrocytes in Urine sediment by Light microscopy |
| 54362-9 | Bilirubin.total [Moles/volume] in Dialysis fluid |
| 46973-4 | oxyCODONE Free [Mass/volume] in Urine by Confirmatory method |
| 34394-7 | Food Allergen Mix 26 (Peanut+Cow milk+Egg white+Mustard) IgE Ab [Presence] in Serum by Multidisk |
| 55240-6 | HBB gene c.251G>A [Presence] in Blood by Molecular genetics method |
| 47273-8 | Creatinine [Mass/volume] in Urine --5th specimen post XXX challenge |
| 35169-2 | Arachidate (C20:0) [Moles/volume] in Serum or Plasma |
| 55664-7 | Cloxacillin [Susceptibility] by Gradient strip |
| 47542-6 | Gamma hydroxybutyrate/Creatinine [Molar ratio] in Urine |
| 48021-0 | Reverse primer [Nucleotide sequence] in Blood or Tissue by Molecular genetics method Nominal |
| 26650-2 | Hantavirus sin nombre IgM Ab [Presence] in Serum |
| 5656-4 | Gold [Mass/volume] in Blood |
| 4847-0 | HLA-Cw10(w3) [Presence] |
| 27103-1 | Procyclidine [Mass/volume] in Urine |
| 38508-8 | Uroporphyrin/Creatinine [Mass Ratio] in Urine |
| 57420-2 | CD27 cells/100 cells in Body fluid |
| 49145-6 | Rickettsia rickettsii IgG Ab [Titer] in Body fluid |
| 27282-3 | Carbinoxamine [Mass/volume] in Urine |
| 27970-3 | Pyruvate [Mass/volume] in Blood --3 hours post XXX challenge |
| 28043-8 | Borrelia burgdorferi 41kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 5804-0 | Protein [Mass/volume] in Urine by Test strip |
| 58068-8 | Kn sup (b) Ab [Presence] in Serum or Plasma |
| 49353-6 | Epstein Barr virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
| 58550-5 | Corticotropin [Moles/volume] in Plasma --15 minutes pre 1 ug/kg CRH IV |
| 58682-6 | Sulfatides [Mass/volume] in Urine |
| 58761-8 | Coxiella burnetii phase 2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 50079-3 | 17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
| 50114-8 | 3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Cerebral spinal fluid |
| 40320-4 | Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose triple bolus |
| 40607-4 | Ascaris lumbricoides IgG Ab [Units/volume] in Serum by Immunoassay |
| 59017-4 | HLA-DPB1 [Type] by High resolution |
| 50432-4 | Cortisol [Mass/volume] in Serum or Plasma --9 PM specimen |
| 20595-5 | CD20 cells/100 cells in Specimen |
| 12371-1 | Isopropyl ether [Mass/volume] in Blood |
| 13241-5 | Sporothrix schenckii IgG Ab [Units/volume] in Serum |
| 102357-1 | Hackberry tree IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103052-7 | Pholcodine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14502-9 | Human papilloma virus Ag [Presence] in Urethra |
| 103962-7 | 11-Ketotestosterone [Moles/volume] in Serum or Plasma by LC/MS/MS |
| 10424-0 | Transfuse erythrocytes [Volume] |
| 14946-8 | Valproate [Moles/volume] in Serum or Plasma |
| 15272-8 | Weed Allergen Mix 2 (Western ragweed+Mugwort+Lenscale+Goosefoot or Lambs quarters+English plantain) IgE Ab [Presence] in Serum by Multidisk |
| 10751-6 | Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain |
| 10970-2 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in Blood |
| 16565-4 | Cefadroxil [Mass/volume] in Serum or Plasma |
| 17209-8 | CD94 cells/100 cells in Blood |
| 17358-3 | Neutrophil Cytoplasmic Ab atypical [Units/volume] in Serum |
| 17676-8 | Sulindac sulfide metabolite [Mass/volume] in Serum or Plasma |
| 17801-2 | Metamyelocytes/100 leukocytes in Body fluid |
| 17905-1 | Bacteria # 3 identified in Tissue by Aerobe culture |
| 90337-7 | Cryptococcus sp rRNA gene [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 90994-5 | Iothalamate renal clearance |
| 91061-2 | Helicobacter pylori DNA [Presence] in Stool by NAA with probe detection |
| 74926-7 | PHENobarbital [Mass/volume] in Serum or Plasma --trough |
| 74967-1 | Adrenal cortex IgG Ab [Presence] in Serum by Immunofluorescence |
| 75405-1 | Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose triple bolus |
| 60545-1 | Cryptosporidium sp DNA [Presence] in Specimen by NAA with probe detection |
| 60569-1 | Pathology Report addendum.synoptic Document |
| 76491-0 | IgM [Moles/volume] in Serum or Plasma |
| 61362-0 | Enterococcus faecalis DNA [Presence] in Specimen by NAA with probe detection |
| 61374-5 | Human papilloma virus 26 DNA [Presence] in Specimen by NAA with probe detection |
| 94187-2 | Platelet aggregation [Interpretation] in Platelet rich plasma |
| 6245-5 | Sheep wool IgE Ab [Units/volume] in Serum |
| 63085-5 | Blue mussel IgG Ab [Mass/volume] in Serum |
| 78530-3 | Vesicular stomatitis New Jersey virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 78803-4 | Barbital [Mass/mass] in Hair |
| 79285-3 | Carnitine biosynthesis intermediates panel - Serum or Plasma |
| 9485-4 | Sodium [Mass/volume] in Water |
| 95194-7 | Interferon-gamma producing HLA-B8 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC) |
| 6515-1 | Human papilloma virus rRNA [Presence] in Tissue by NAA with probe detection |
| 65364-2 | Cortisol Free/Cortisol.total in Serum or Plasma |
| 66117-3 | Prostate Pathology biopsy report |
| 95690-4 | Yellow fever virus IgM Ab [Presence] in Specimen by Immunoassay |
| 67701-3 | Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 6788-4 | Kappa light chains/Lambda light chains [Mass Ratio] in Serum by Immunoassay |
| 6839-5 | Cryptostroma corticale IgE Ab [Units/volume] in Serum |
| 80712-3 | CD38+HLA-DR+ cells/100 CD3+CD8+ cells in Blood |
| 8164-6 | Tetrahydrocannabinol [Presence] in Gastric fluid by Confirmatory method |
| 97232-3 | Cocaethylene [Presence] in Cord tissue by Screen method |
| 97502-9 | Prion disease biomarker panel - Cerebral spinal fluid |
| 82376-5 | Elbasvir [Susceptibility] by Genotype method |
| 82431-8 | Platelet-derived growth factor receptor Ab [Units/volume] in Serum by Line blot |
| 7240-5 | Coconut IgG Ab [Units/volume] in Serum |
| 72487-2 | TF gene full mutation analysis in Blood or Tissue by Sequencing |
| 72803-0 | JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
| 86862-0 | Dengue virus 4 neutralizing antibody [Presence] in Specimen by Neutralization test |
| 88002-1 | Kanamycin 2.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 88262-1 | Gram positive blood culture panel by Probe in Positive blood culture |
| 73960-7 | Bacteria identified in Mouth by Culture |
| 59603-1 | Alpha hydroxyalprazolam [Mass/mass] in Meconium by Confirmatory method |
| 59812-8 | Glucose [Moles/volume] in Serum or Plasma --11 AM specimen |
| 30475-8 | Glycerate [Presence] in Urine |
| 42252-7 | Methaqualone+Metabolite [Presence] in Urine by Screen method |
| 60115-3 | 9-Hydroxyrisperidone [Mass/volume] in Blood |
| 43108-0 | Metanephrine and Normetanephrine panel [Mass/volume] - Serum or Plasma |
| 31616-6 | Rubella virus IgM Ab [Presence] in Serum |
| 51687-2 | Pregnenolone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 43403-5 | Neisseria gonorrhoeae DNA [Presence] in Specimen by Probe with signal amplification |
| 22581-3 | Toxoplasma gondii IgG Ab [Titer] in Cerebral spinal fluid |
| 22672-0 | Cystine [Moles/volume] in Serum or Plasma |
| 51933-0 | Rye IgG Ab [Mass/volume] in Serum |
| 44096-6 | Unidentified cells/100 leukocytes in Blood by Automated count |
| 44334-1 | Leucine/Creatinine [Mass Ratio] in 24 hour Urine |
| 22968-2 | Campylobacter fetus ss venerealis Ab [Presence] in Genital mucus by Agglutination |
| 23088-8 | Equine herpesvirus 1+4 Ab [Titer] in Serum |
| 32580-3 | Chromatin IgG Ab [Units/volume] in Serum or Plasma |
| 32664-5 | Ammonia [Mass/volume] in Blood |
| 44835-7 | Acid phosphatase tartrate resistant [Presence] in Blood |
| 3355-5 | Ampicillin [Mass/volume] in Serum or Plasma |
| 53519-5 | Monocytes/100 leukocytes in Dialysis fluid |
| 53849-6 | HTC2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 45112-0 | Chlamydia sp Ag [Presence] in Urine by Immunofluorescence |
| 45196-3 | Cytokines [Presence] in Specimen |
| 23755-2 | Mycoplasma synoviae Ab [Titer] in Serum by Hemagglutination |
| 24053-1 | Alpha mannosidase [Enzymatic activity/mass] in Leukocytes |
| 53980-9 | Actin Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 54174-8 | Cefmenoxime [Susceptibility] by Disk diffusion (KB) |
| 46226-7 | SGCA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 47016-1 | CD4 Ag [Presence] in Tissue by Immune stain |
| 25186-8 | Pyrazinamide 25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25235-3 | ceFAZolin [Mass/volume] in Specimen |
| 55777-7 | Direct antiglobulin test.IgM specific reagent [Presence] on Red Blood Cells |
| 55850-2 | Cobalamin (Vitamin B12) [Mass/volume] in Urine |
| 55933-6 | Leucine [Moles/mass] in Hair |
| 25644-6 | Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --2nd specimen post XXX challenge |
| 25931-7 | Homovanillate/Creatinine [Molar ratio] in 24 hour Urine |
| 48256-2 | Common Ragweed triggered leukotriene release [Mass/volume] by Leukocytes |
| 48340-4 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 48639-9 | Urea nitrogen [Mass/volume] in Peripheral blood --post dialysis |
| 27214-6 | Purkinje cells Ab [Presence] in Serum |
| 38535-1 | LAMA2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 57479-8 | 11-Ketoandrosterone [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
| 57548-0 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --1 day post dose dexamethasone |
| 57551-4 | 18-Hydroxydeoxycorticosterone [Moles/volume] in Serum or Plasma --pre dose corticotropin |
| 57605-8 | 6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
| 48968-2 | PKHD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 27838-2 | Somatotropin [Mass/volume] in Serum or Plasma --14th specimen post XXX challenge |
| 27991-9 | Fibrinogen fragments [Mass/volume] in Urine by Latex agglutination |
| 39296-9 | Influenza virus A H1 Ab [Titer] in Serum by Hemagglutination inhibition |
| 3937-0 | Phencyclidine [Mass/volume] in Urine |
| 58377-3 | Ethyl glucuronide [Presence] in Urine by Confirmatory method |
| 49587-9 | Protein.abnormal band [Mass/volume] in Serum |
| 49660-4 | HIV susceptibility panel by Genotype method |
| 29282-1 | Glutethimide [Presence] in Gastric fluid |
| 39989-9 | Creatinine [Mass/volume] in Urine --3.5 hours post XXX challenge |
| 4998-1 | Cytomegalovirus DNA [Presence] in Tissue by NAA with probe detection |
| 29842-2 | Powassan virus IgG Ab [Presence] in Cerebral spinal fluid |
| 29846-3 | Trivittatus virus Ab [Titer] in Serum |
| 40317-0 | Cortisol [Moles/volume] in Serum or Plasma --3 hours post dose triple bolus |
| 40422-8 | Methotrimeprazine [Presence] in Urine |
| 40655-3 | Nuclear Ab [Titer] in Serum by Immunoassay |
| 58956-4 | Direct antiglobulin test.complement C3b+C4d specific reagent [Presence] on Red Blood Cells |
| 50285-6 | 3-Dechloroethylifosfamide [Mass/volume] in Blood --1 day post dose ifosfamide |
| 50484-5 | Follitropin [Units/volume] in Serum or Plasma --8th specimen |
| 30255-4 | Insulin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 30316-4 | Alpha subunit free [Mass/volume] in Serum or Plasma |
| 4075-8 | Trimeperidine [Presence] in Urine |
| 1969-5 | Bilirubin.total renal clearance in 24 hour Urine and Serum or Plasma |
| 20740-7 | Campylobacter sp identified in Tissue by Organism specific culture |
| 20811-6 | Escherichia coli [Presence] in Specimen by Culture FDA method |
| 2104-8 | Choriomammotropin [Mass/volume] in Serum |
| 1002-5 | DBG Ab [Presence] in Serum or Plasma |
| 12829-8 | Prolactin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 13189-6 | English plantain IgG Ab [Units/volume] in Serum |
| 13449-4 | Creatinine renal clearance/1.73 sq M in 8 hour Urine and Serum or Plasma |
| 14062-4 | Dexamethasone [Mass/volume] in Serum or Plasma |
| 102999-0 | Timothy recombinant (rPhl p) 2 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15382-5 | Leishmania donovani IgG Ab [Titer] in Serum |
| 16991-2 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --4.5 hours post dose glucose |
| 17212-2 | CD97 cells/100 cells in Blood |
| 17463-1 | Pigeon droppings Ab [Units/volume] in Serum |
| 18348-3 | Toxoplasma gondii IgM Ab [Units/volume] in Cerebral spinal fluid |
| 18358-2 | Methylenedioxymethamphetamine [Mass/volume] in Urine by Confirmatory method |
| 18916-7 | Dicloxacillin [Susceptibility] |
| 89977-3 | 7-Hydroxychlorpromazine [Presence] in Urine by Screen method |
| 91776-5 | Respiratory Mycoplasma identified in Lower respiratory specimen by Organism specific culture |
| 75232-9 | Norcitalopram [Presence] in Urine |
| 60485-0 | Interferon gamma [Mass/volume] in Body fluid |
| 61047-7 | Methylenedioxyethylamphetamine [Presence] in Serum or Plasma |
| 76592-5 | Staphylococcus aureus sau3AI gene [#/mass] in XXX.tissue by NAA with probe detection |
| 62234-0 | Albumin [Moles/volume] in Serum or Plasma by Bromocresol purple (BCP) dye binding method |
| 7747-9 | Trout IgG Ab [Units/volume] in Serum |
| 7770-1 | Watermelon IgE Ab [Units/volume] in Serum |
| 93910-8 | Fy3 Ag [Presence] on Red Blood Cells |
| 77953-8 | West Nile virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 78238-3 | Chromosome 3 copy number/nucleus in Blood or Tissue by FISH |
| 78749-9 | Glycolate [Mass/volume] in Serum or Plasma by Gas chromatography |
| 94340-7 | Amphiphysin IgG Ab [Titer] in Serum by Immunofluorescence |
| 63459-2 | Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay |
| 78982-6 | D-3-phosphoglycerate dehydrogenase [Enzymatic activity/mass] in Fibroblast |
| 79211-9 | Fetal Chromosome X and Y aneuploidy risk [interpretation] in Plasma cell-free DNA Qualitative by Sequencing |
| 661-9 | Microscopic observation [Identifier] in Specimen by Dry mount |
| 95809-0 | Carbapenem resistance genes [Presence] by Molecular method |
| 96327-2 | Proteus sp DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection |
| 96414-8 | Pancreatic polypeptide sham feeding panel - Serum or Plasma |
| 6829-6 | Amoxicillin IgE Ab [Units/volume] in Serum |
| 80556-4 | cloZAPine [Mass/volume] in DBS |
| 96637-4 | HLA-DP and DQ and DR (class II) typing panel - Blood or Tissue by High resolution |
| 69845-6 | 2-Hydroxyglutarate [Moles/volume] in Serum or Plasma |
| 81749-4 | Chromosome region 13q14 deletion in Bone marrow by FISH |
| 7116-7 | Barley Pollen IgE Ab [Units/volume] in Serum |
| 826-8 | Au sup(a) Ag [Presence] on Red Blood Cells |
| 98995-4 | Transferrin/Protein.total in Serum or Plasma by Electrophoresis |
| 83001-8 | Glial nuclear type 1 IgG Ab [Presence] in Serum or Plasma by Line blot |
| 84897-8 | Dominant nodule quadrant [Anatomy] in Prostate tumor |
| 99515-9 | Weight of Heart |
| 99777-5 | Erythrocytes [#/volume] in Bronchoalveolar lavage by Automated count |
| 86239-1 | Cells.chromosome 3 monosomy/Cells counted in Cancer specimen by FISH |
| 86587-3 | Rabies virus IgG Ab [Presence] in Serum by Immunoassay |
| 86669-9 | Mitotic figures [#/area] in Cancer specimen by Light microscopy |
| 87463-6 | Nickel [Mass/mass] in Specimen |
| 7376-7 | Sudan grass IgE Ab [Units/volume] in Serum |
| 87815-7 | fentaNYL [Presence] in Saliva (oral fluid) by Screen method |
| 878-9 | A,B Ag [Presence] on Red Blood Cells from Blood product unit |
| 88157-3 | Microscopic observation [Identifier] in Semen by Acid fast stain |
| 74086-0 | Pentacarboxylporphyrin III [Moles/mass] in Stool |
| 89521-9 | Ganglioside GM1 IgG Ab [Presence] in Serum by Line blot |
| 89591-2 | Zika virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 41237-9 | Xylose [Mass/volume] in Urine --5 hours post dose xylose PO |
| 4167-3 | Ceftizoxime [Mass] of Dose |
| 4233-3 | Emetine [Mass] of Dose |
| 60023-9 | Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid by Pyruvate to lactate reaction |
| 60211-0 | Zolazepam [Mass/volume] in Blood |
| 31342-9 | Dengue virus Ab [Units/volume] in Specimen |
| 51369-7 | CD79b cells/100 cells in Cerebral spinal fluid |
| 4304-2 | Maprotiline [Mass] of Dose |
| 43141-1 | Synthetic glucocorticoid panel [Mass/volume] - Serum or Plasma |
| 21679-6 | FGFR3 gene p.Lys650Glu [Presence] in Blood or Tissue by Molecular genetics method |
| 22532-6 | Sarcocystis neurona Ab [Presence] in Blood |
| 3248-2 | Fibrin fragments Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 51954-6 | oxyCODONE Free [Mass/volume] in Urine |
| 33212-2 | N-acetyl-L-aspartate [Mass/volume] in Body fluid |
| 44559-3 | Influenza virus A Ag [Presence] in Bronchial specimen by Immunofluorescence |
| 33524-0 | Clot Lysis [Time] in Control Platelet poor plasma by Coagulation assay |
| 23757-8 | Neospora caninum Ab [Titer] in Serum by Immunofluorescence |
| 540-5 | Mycobacterium sp identified in Tissue by Organism specific culture |
| 46254-9 | Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 3453-8 | Cephalexin [Mass/volume] in Serum or Plasma |
| 34609-8 | Transketolase [Enzymatic activity/mass] in Blood |
| 55437-8 | Neoplastic cells/100 leukocytes in Cerebral spinal fluid by Manual count |
| 47205-0 | metyraPONE [Mass] of Dose |
| 47460-1 | Legionella pneumophila 10 IgM Ab [Titer] in Serum |
| 25170-2 | Mercury [Moles/volume] in Blood |
| 25229-6 | Pyrazinamide 100 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 34952-2 | Rubella virus IgG and IgM panel - Serum |
| 35015-7 | Band form neutrophils [#/volume] in Cerebral spinal fluid |
| 35074-4 | Basophils [#/volume] in Synovial fluid |
| 47763-8 | Somatotropin [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 47769-5 | Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose glucose PO |
| 25972-1 | Adenosine monophosphate.cyclic/Creatinine [Molar ratio] in 24 hour Urine |
| 35352-4 | Mycobacterium tuberculosis genotype [Identifier] in Isolate |
| 56317-1 | Meadow Fescue IgG4 Ab [Mass/volume] in Serum |
| 48074-9 | Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post dose arginine+insulin |
| 26804-5 | Gamma aminobutyrate [Presence] in 24 hour Urine |
| 26871-4 | IgA [Mass/volume] in 24 hour Urine |
| 48987-2 | Pyridinoline.free/Creatinine [Molar ratio] in Urine |
| 27283-1 | Methadone [Mass/mass] in Stool |
| 27845-7 | Somatotropin [Mass/volume] in Serum or Plasma --23rd specimen post XXX challenge |
| 39312-4 | Influenza virus A N2 neutralizing antibody [Presence] in Serum by Neutralization test |
| 58031-6 | Treponema pallidum IgG Ab [Presence] in Cerebral spinal fluid |
| 49545-7 | JC virus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 29357-1 | Cyanide [Mass/volume] in Gastric fluid |
| 58417-7 | dilTIAZem [Presence] in Urine |
| 5007-0 | Hepatitis B virus DNA [Presence] in Blood by NAA with probe detection |
| 50106-4 | 3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in DBS |
| 29835-6 | Highlands J virus Ab [Titer] in Cerebral spinal fluid |
| 50385-4 | Alpha-1-Microglobulin.placental [Presence] in Vaginal fluid |
| 50413-4 | Corticotropin [Mass/volume] in Plasma --pre 1 mg dexamethasone PO overnight |
| 30233-1 | 3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in Serum or Plasma |
| 40834-4 | Herpes virus 8 IgG Ab [Presence] in Serum by Immunofluorescence |
| 20943-7 | Bovine respiratory syncytial virus Ag [Presence] in Lung by Immune stain |
| 100739-2 | Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma |
| 100973-7 | Influenza virus A RNA [Presence] in Nose by NAA with non-probe detection |
| 12768-8 | Insulin [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge |
| 101336-6 | Wr sup(b) Ag [Presence] on Red Blood Cells |
| 101450-5 | Neurochondrin Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay |
| 101794-6 | Tianeptine [Presence] in Urine by Confirmatory method |
| 101830-8 | Medazepam [Mass/volume] in Serum or Plasma |
| 13526-9 | Nonhematic cells/100 leukocytes in Body fluid by Manual count |
| 13748-9 | Glutarate/Creatinine [Mass Ratio] in Urine |
| 102319-1 | Fusarium solani IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14199-4 | Chlamydia trachomatis B IgA Ab [Titer] in Serum by Immunofluorescence |
| 104235-7 | Dibutylone [Mass/volume] in Urine by Confirmatory method |
| 14892-4 | Propranolol [Moles/volume] in Urine |
| 15096-1 | Uroporphyrin [Moles/time] in 24 hour Urine |
| 104295-1 | ESR1 gene mutation [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 11121-1 | Prolymphocytes/100 cells in Bone marrow by Manual count |
| 17092-8 | Lupus erythematosus factor [Presence] in Serum by Latex agglutination |
| 17753-5 | Tungsten [Mass/volume] in Serum or Plasma |
| 89991-4 | Citalopram+Escitalopram [Presence] in Urine by Screen method |
| 7513-5 | White mulberry IgG Ab [Units/volume] in Serum |
| 75659-3 | Polymorphonuclear cells [#] in Pericardial fluid by Manual count |
| 60359-7 | Cantaloupe IgG Ab [Mass/volume] in Serum |
| 61286-1 | White mulberry IgE Ab/IgE total in Serum |
| 61291-1 | Rice IgE Ab/IgE total in Serum |
| 62457-7 | Coccidioides sp TP Ab [Presence] in Serum by Immune diffusion (ID) |
| 94439-7 | HLA-DRB1 IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC) |
| 79149-1 | Trimeprazine [Mass/volume] in Body fluid |
| 80963-2 | Salicylates free [Mass/volume] in Serum or Plasma |
| 81102-6 | Leptospira interrogans sv Cynopteri Ab [Titer] in Serum by Agglutination |
| 81187-7 | Non-regional lymph nodes examined [#] in Specimen |
| 8136-4 | CD71 cells/100 cells in Blood |
| 97148-1 | Guanidinoacetate [Moles/volume] in Urine |
| 70042-7 | Mononuclear cells/100 leukocytes in Synovial fluid by Automated count |
| 81767-6 | Eicosatrienoate (C20:3w3) [Moles/volume] in Serum or Plasma |
| 97319-8 | Escherichia coli enterotoxigenic DNA [Presence] in Stool by NAA with probe detection |
| 7029-2 | Meropenem [Susceptibility] by Gradient strip |
| 84891-1 | Tumor response to neoadjuvant therapy |
| 85297-0 | Tumor buds [#/area] in Cancer specimen by Light microscopy |
| 72629-9 | Secobarbital [Presence] in Saliva (oral fluid) by Confirmatory method |
| 86112-0 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum --1st specimen |
| 86224-3 | ALPRAZolam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 86519-6 | European tick borne encephalitis virus RNA [Presence] in Serum by NAA with probe detection |
| 73004-4 | levoFLOXacin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73171-1 | Ramipril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87607-8 | Difethialone [Mass/mass] in Specimen |
| 73542-3 | Albuterol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 41195-9 | West Nile virus IgM Ab [Titer] in Body fluid |
| 59372-3 | Leptospira interrogans sv Ballum Ab [Titer] in Serum by Agglutination |
| 2150-1 | Creatine [Mass/time] in 24 hour Urine |
| 31590-3 | Ribosomal Ab [Presence] in Serum |
| 51296-2 | CD38 cells/100 cells in Tissue |
| 22100-2 | Avian paramyxovirus 3 Ab [Titer] in Serum |
| 31937-6 | Pneumocystis jiroveci Ag [Presence] in Serum |
| 51744-1 | Borrelia burgdorferi 49736 IgA Ab [Units/volume] in Serum by Immunoassay |
| 32219-8 | Soluble liver Ab [Units/volume] in Serum by Immunoassay |
| 32317-0 | Follitropin [Units/volume] in Serum or Plasma --baseline |
| 32507-6 | CD14 cells/100 cells in Bone marrow |
| 52960-2 | cloNIDine [Presence] in Urine |
| 44398-6 | Proline/Creatinine [Mass Ratio] in 24 hour Urine |
| 23135-7 | Histoplasma farciminosum Ab [Presence] in Serum |
| 32686-8 | Hepatitis B virus DNA [Mass/volume] in Serum |
| 23595-2 | Dermatophilus congolensis [Presence] in Exudate by Giemsa stain |
| 33246-0 | Ovary Ab [Titer] in Serum |
| 33308-8 | Phosphatidylethanolamine Ab [Presence] in Serum |
| 53609-4 | Parasite identified in Bone marrow by Light microscopy |
| 23960-8 | Bartonella quintana IgM Ab [Titer] in Cerebral spinal fluid |
| 4629-2 | Hemoglobin Zurich [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 24151-3 | Giant Ragweed IgG Ab [Units/volume] in Serum |
| 24519-1 | Phosphate [Moles/volume] in Blood |
| 34526-4 | Sialooligosaccharides/Creatinine [Ratio] in Urine |
| 34658-5 | MCOLN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 34677-5 | Mitotic spindle apparatus Ab [Titer] in Serum or Plasma |
| 34680-9 | Ceramide trihexoside [Presence] in Urine |
| 47031-0 | Melan-A Ag [Presence] in Tissue by Immune stain |
| 2518-9 | Lactate [Moles/volume] in Arterial blood |
| 55917-9 | Glucosylceramidase [Enzymatic activity/volume] in DBS |
| 47886-7 | Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose betaxolol+glucagon |
| 25686-7 | Insulin [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge |
| 56323-9 | Mountain Juniper IgG4 Ab [Mass/volume] in Serum |
| 4808-2 | HLA-B14 [Presence] in Donor |
| 26864-9 | Sporothrix schenckii Ab [Units/volume] in Serum by Latex agglutination |
| 26961-3 | Valine [Moles/volume] in Urine |
| 38293-7 | cis-1,2-Dichloroethylene [Mass/volume] in Water |
| 38352-1 | Interleukin 2 receptor [Units/volume] in Specimen |
| 4919-7 | HLA-Dw9 [Presence] |
| 49232-2 | Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool by Rapid, less than 30 minutes |
| 27823-4 | Protein S Ag actual/normal in Platelet poor plasma by Immunoassay |
| 27832-5 | Insulin [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 38730-8 | 2,4,6-Trichlorophenol [Mass/volume] in Air |
| 49326-2 | Aldosterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 2816-7 | Porphyrins [Presence] in Stool |
| 40058-0 | Albumin [Mass/volume] in Serum or Plasma --8 hours post XXX challenge |
| 4043-6 | Teicoplanin [Mass/volume] in Serum or Plasma |
| 58871-5 | Somatotropin [Mass/volume] in Serum or Plasma --37th specimen |
| 59285-7 | Benzylpiperazine [Mass/volume] in Blood |
| 50228-6 | Oval fat bodies (globules) [Presence] in Urine by Computer assisted method |
| 3018-9 | Thyrotropin releasing hormone [Mass/volume] in Plasma |
| 30378-4 | Eosinophils/100 leukocytes in Nose |
| 19603-0 | Morphine Free cutoff [Mass/volume] in Urine for Screen method |
| 19720-2 | Trichlorothiazide [Mass/volume] in Urine by Confirmatory method |
| 19762-4 | General categories [Interpretation] of Cervical or vaginal smear or scraping by Cyto stain |
| 20388-5 | Nitrofurazone [Susceptibility] |
| 20424-8 | Cardiolipin IgG Ab [Interpretation] in Serum |
| 100410-0 | Curd cheese IgG Ab [Units/volume] in Serum |
| 101636-9 | TCRB gene and TCRG gene rearrangements in Bone marrow by Molecular genetics method |
| 102510-5 | Green Pepper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102693-9 | Beef IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14695-1 | Nordoxepin [Moles/volume] in Serum or Plasma |
| 14854-4 | Norepinephrine [Moles/time] in 24 hour Urine |
| 10460-4 | Lactalbumin alpha Ag [Presence] in Tissue by Immune stain |
| 1626-1 | Retinol [Mass/volume] in Serum or Plasma --pre 5000 units |
| 17839-2 | Alpha fucosidase [Enzymatic activity/volume] in Blood |
| 19072-8 | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma |
| 91079-4 | Zika virus RNA [Presence] in Placenta by NAA with probe detection |
| 75100-8 | Fatty acids [Entitic substance] in Red Blood Cells |
| 75575-1 | Fetal 22q11.2 deletion prior risk [Likelihood] based on general population risk Narrative |
| 60465-2 | Neisseria meningitidis serogroup w135 IgG Ab [Mass/volume] in Serum by Immunoassay |
| 93121-2 | Gabapentin [Presence] in Tissue by Screen method |
| 6166-3 | Malt IgE Ab [Units/volume] in Serum |
| 77171-7 | KIT gene exon 11 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 93784-7 | Diffuse large B-Cell lymphoma cell of origin subclassification panel - Tissue |
| 63323-0 | Ribosomal Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 78004-9 | Staphylococcus aureus.vancomycin resistance [Susceptibility] Qualitative |
| 94364-7 | PCA-2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 94708-5 | Encephalopathy autoimmune Ab panel - Cerebral spinal fluid |
| 63352-9 | Smith extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) |
| 63466-7 | Ganglioside GM3 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 64083-9 | MGMT gene methylation score in Tissue by Molecular genetics method |
| 95148-3 | Hepatitis B virus surface Ag and Hepatitis B virus e Ab and Ag panel - Serum or Plasma |
| 95551-8 | Chromosome region 17p11.2 deletion in Blood or Tissue by FISH |
| 65766-8 | English Walnut native (nJug r) 1 IgE Ab [Units/volume] in Serum |
| 79520-3 | 4-Deoxythreonate [Moles/volume] in Serum or Plasma |
| 795-5 | Erythrocytes [#/volume] in Peritoneal fluid by Manual count |
| 7989-7 | Burkholderia pseudomallei IgM Ab [Units/volume] in Serum |
| 80154-8 | Monolysocardiolipin/Cardiolipin [Molar ratio] in DBS |
| 96428-8 | Borrelia burgdorferi IgA Ab [Presence] in Specimen |
| 68923-2 | Cancer Ag 125 [Units/volume] in Pericardial fluid |
| 6907-0 | sulfADIAZINE [Mass/volume] in Serum or Plasma |
| 69930-6 | Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 81828-6 | SLC37A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 82059-7 | Food Allergen Mix 16 (Pineapple+Lemon+Strawberry+Pear) IgE Ab [Units/volume] in Serum by Multidisk |
| 82072-0 | Food Allergen Mix 71 (Caraway+Cardamon+Mace+Clove) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 82208-0 | Giardia lamblia DNA [Presence] in Stool by NAA with non-probe detection |
| 82970-5 | PHENobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 83326-9 | HIV 1 RNA genotype and phenotype in Isolate |
| 84886-1 | Satellite nodules [Presence] in Colorectal cancer specimen |
| 85684-9 | Bordetella pertussis.pertussis toxin IgG Ab [Presence] in Serum by Immunoassay |
| 85807-6 | Mumps virus genotype in Specimen |
| 85984-3 | Streptococcus pneumoniae Danish serotype 12F Ab [Units/volume] in Serum --1st specimen |
| 87307-5 | Clostridium perfringens etx gene [Presence] in Isolate by NAA with probe detection |
| 73838-5 | 11-Dehydrotetrahydrocorticosterone [Moles/volume] in Urine |
| 88211-8 | Rabies virus Ag [Presence] in Cerebral spinal fluid by Immunoassay |
| 88266-2 | Mycobacterium sp rRNA [Identifier] by Probe in Positive blood culture |
| 89201-8 | Molecular lab test method used to determine resistance [Identifier] in Isolate or Specimen |
| 41230-4 | Xanthine [Presence] in Specimen |
| 59809-4 | Lymphoma cells [Presence] in Blood |
| 50668-3 | Microscopic observation in Specimen by Electron microscopy Narrative |
| 31134-0 | Nuclear matrix protein 22 [Units/volume] in Urine |
| 42628-8 | CD9+CD41+ cells/100 cells in Blood |
| 42637-9 | Natriuretic peptide B [Mass/volume] in Blood |
| 60182-3 | Temephos [Mass/volume] in Urine |
| 31507-7 | Mumps virus particle-bound Ab [Units/volume] in Serum |
| 31531-7 | Neuronal Ab [Presence] in Cerebral spinal fluid |
| 5113-6 | Coxsackievirus B6 neutralizing antibody [Titer] in Serum by Neutralization test |
| 51341-6 | CD5+CD19+ cells/100 cells in Cerebral spinal fluid |
| 42991-0 | Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid |
| 31957-4 | Rubella virus Ag [Presence] in Eye |
| 51755-7 | CD3+CD4-CD8-CD45+ cells/100 cells in Blood |
| 437-4 | Rolitetracycline [Susceptibility] by Disk diffusion (KB) |
| 22592-0 | Treponema pallidum IgG Ab [Units/volume] in Serum |
| 2313-5 | Galactose 1 phosphate uridyl transferase [Presence] in Red Blood Cells |
| 53187-1 | Methylglutarylcarnitine (C6-DC) [Moles/volume] in DBS |
| 53197-0 | 3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in DBS |
| 23309-8 | Myxoma virus Ab [Presence] in Serum by Immunofluorescence |
| 23518-4 | Trypanosoma evansi [Presence] in Aspirate by Thick film |
| 23549-9 | Venezuelan equine encephalitis virus Ag [Presence] in Specimen by Immunofluorescence |
| 33857-4 | Sezary cells/100 leukocytes in Blood by Manual count |
| 34186-7 | Para aminobenzoate [Mass/time] in 24 hour Urine |
| 54374-4 | Creatinine/Body weight [Moles/kg/time] in 24 hour Urine |
| 24505-0 | Pigeon droppings Ab [Presence] in Serum by Immune diffusion (ID) |
| 34430-9 | Timothy recombinant (rPhl p) 7 + 12 IgE Ab [Units/volume] in Serum |
| 55121-8 | Multiple sclerosis panel - Serum and CSF |
| 25326-0 | Asparagine [Moles/time] in 24 hour Urine |
| 25429-2 | Glutamate [Moles/time] in 24 hour Urine |
| 25464-9 | Lysine [Moles/time] in 24 hour Urine |
| 34961-3 | Rh [Type] in Blood by Confirmatory method |
| 34977-9 | Platelet genotype [Identifier] in Blood |
| 351-7 | Nalidixate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 55802-3 | Platelets [#/volume] in Cord blood by Estimate |
| 55893-2 | Hypoxanthine phosphoribosyltransferase/Adenine phosphoribosyltransferase [Enzymatic activity ratio] in Red Blood Cells |
| 55918-7 | C peptide [Mass/volume] in Serum or Plasma --post meal |
| 47780-2 | Sulfate [Moles/volume] in Urine |
| 25663-6 | Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose glucose |
| 35531-3 | Sugar Cane IgG Ab [Mass/volume] in Serum |
| 4823-1 | HLA-B35 [Presence] |
| 26525-6 | Cortisol Free [Mass/volume] in 24 hour Urine --24 hours post dose corticotropin |
| 56569-7 | Somatotropin [Mass/volume] in Serum or Plasma --11 hour post XXX challenge |
| 48802-3 | Alpha-1-Fetoprotein panel - Serum or Plasma |
| 26934-0 | LORazepam [Mass/mass] in Meconium |
| 38307-5 | Heptachlorepoxide [Mass/volume] in Water |
| 38586-4 | Acetonitrile [Mass/volume] in Air |
| 57449-1 | Tubular basement membrane Ab [Units/volume] in Serum |
| 49157-1 | Rickettsia akari IgG Ab [Titer] in Serum |
| 49258-7 | Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis Narrative |
| 27302-9 | Midazolam [Mass/mass] in Meconium |
| 57770-0 | Toxoplasma gondii IgG and IgM panel - Serum |
| 2833-2 | Pregnanediol [Mass/volume] in Urine |
| 2895-1 | Protoporphyrin.zinc [Mass/volume] in Red Blood Cells |
| 29151-8 | Somatotropin [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
| 29246-6 | Lactate [Mass/volume] in Body fluid |
| 29316-7 | Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 5856-0 | Herpes simplex virus identified in Genital specimen by Organism specific culture |
| 50148-6 | Gamma hydroxybutyrate [Moles/volume] in Amniotic fluid |
| 59051-3 | Bacteria # 4 identified in Tissue by Anaerobe culture |
| 59247-7 | Tetrahydrobiopterin [Moles/volume] in Cerebral spinal fluid |
| 50281-5 | 3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in DBS |
| 40886-4 | CD19+CD103+ cells/100 cells in Body fluid |
| 40905-2 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum by Immunoassay |
| 21007-0 | HIV 1 Ab [Presence] in Serum from Donor |
| 101344-0 | Acute febrile illness global pathogens panel - Blood by NAA with non-probe detection |
| 101868-8 | Ma2 Antibody [Presence] in Serum or Plasma by Immunoassay |
| 102135-1 | Lactalbumin alpha IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13750-5 | Glycine/Creatinine [Mass Ratio] in Urine |
| 102678-0 | Apricot IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1544-6 | Glucose [Mass/volume] in Serum or Plasma --6 hours post 100 g glucose PO |
| 1583-4 | Lactose [Mass/volume] in Serum or Plasma --2 hours post 50 g lactose PO |
| 16714-8 | Cytomegalovirus Ab [Units/volume] in Serum by Latex agglutination |
| 1687-3 | 3-Methylhistidine [Mass/volume] in Urine |
| 17547-1 | Rotavirus Ag [Presence] in Stool |
| 17607-3 | Volume of Cerebral spinal fluid |
| 17709-7 | Ticlopidine [Presence] in Urine |
| 18199-0 | Blastomyces dermatitidis IgG Ab [Presence] in Serum |
| 18328-5 | Microscopic observation [Identifier] in Body fluid by Other stain |
| 60344-9 | Lipoprotein a/total Lipoprotein in Serum or Plasma |
| 60472-8 | Complement C5.functional [Units/volume] in Serum or Plasma |
| 60523-8 | Carbromal [Mass/volume] in Serum or Plasma |
| 93430-7 | Blastomyces sp Ag [Mass/volume] in Serum or Plasma by Immunoassay |
| 77145-1 | Fasting glucose [Moles/volume] in Serum, Plasma or Blood |
| 77958-7 | Dengue virus 1 and 2 and 3 and 4 RNA [Identifier] in Cerebral spinal fluid by NAA with probe detection |
| 78438-9 | Sertraline trough and Norsertraline panel - Serum or Plasma |
| 94428-0 | HLA class I and II IgG panel - Serum or Plasma by Flow cytometry (FC) |
| 94435-5 | HLA-DPA1 IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC) |
| 94620-2 | Bovine diarrhea virus [Presence] in Specimen by Organism specific culture |
| 79181-4 | Somatotropin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 79255-6 | oxyCODONE cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 79454-5 | Alpha fucosidase [Enzymatic activity/volume] in DBS |
| 95598-9 | Mucus strands [Presence] in Semen by Microscopy |
| 95666-4 | Tahyna virus IgG Ab [Presence] in Specimen by Immunoassay |
| 66492-0 | Urease [Presence] in Tissue --3rd specimen |
| 8017-6 | Saint Louis encephalitis virus IgM Ab [Units/volume] in Serum |
| 8034-1 | Strongyloides sp Ab [Units/volume] in Serum |
| 9590-1 | Borrelia burgdorferi 28kD IgG Ab [Presence] in Serum by Immunoblot |
| 96450-2 | Hepatotocellular carcinoma risk [Score] GALAD |
| 96727-3 | Erythrocytes [#/volume] in Lower respiratory specimen by Manual count |
| 97203-4 | Lipemic interference index of Urine |
| 69766-4 | Mumps virus IgM Ab [Presence] in Body fluid by Immunoassay |
| 81744-5 | Submitter's laboratory test method [Type] in Specimen |
| 81784-1 | Canary droppings IgG Ab [Mass/volume] in Serum |
| 81792-4 | Dermatophagoides pteronyssinus native (nDer p) 2 IgE Ab [Units/volume] in Serum |
| 82070-4 | Food Allergen Mix 7 (Onion+Garlic+Celery+Tomato+Yeast) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 9771-7 | CD5+CD20+ cells [#/volume] in Leukocytes |
| 97749-6 | Cancer Ag 15-3 [Units/volume] in Aspirate |
| 82877-2 | Cytochrome C oxidase [Enzymatic activity/mass] in Leukocytes |
| 71788-4 | Neisseria meningitidis DNA [Identifier] in Specimen by NAA with probe detection |
| 72213-2 | t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
| 72476-5 | Methadone panel - Saliva (oral fluid) by Confirmatory method |
| 87931-2 | Bacteria identified in Implanted device by Aerobe culture |
| 88532-7 | Human metapneumovirus identified in Cornea or Conjunctiva by Organism specific culture |
| 59646-0 | Cotinine [Presence] in Urine by Screen method |
| 59674-2 | Flurazepam [Mass/volume] in Blood |
| 51023-0 | Cytoplasmic CD117 blasts/100 cells in Blood |
| 4245-7 | Ethosuximide [Mass] of Dose |
| 31269-4 | Borrelia burgdorferi IgM Ab [Presence] in Body fluid |
| 31380-9 | Equine influenza virus A2 Ab [Units/volume] in Serum |
| 31596-0 | Rickettsia australis Ab [Units/volume] in Serum |
| 31599-4 | Rickettsia prowazekii IgG Ab [Units/volume] in Serum |
| 21687-9 | HBA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 22080-6 | Adenovirus Ab [Titer] in Serum |
| 31697-6 | Vesicular stomatitis New Jersey virus Ab [Units/volume] in Serum |
| 31777-6 | Chlamydia trachomatis Ag [Presence] in Specimen |
| 317-8 | Meclocycline [Susceptibility] by Serum bactericidal titer |
| 31842-8 | Haemophilus influenzae F Ag [Presence] in Specimen |
| 32033-3 | Phosphatidylserine IgM Ab [Units/volume] in Serum by Immunoassay |
| 43229-4 | Cryptococcus sp Ag [Titer] in Specimen by Latex agglutination |
| 22485-7 | Orientia tsutsugamushi Ab [Titer] in Serum |
| 22486-5 | Rickettsia typhi Ab [Units/volume] in Serum |
| 32125-7 | Propoxyphene [Moles/volume] in Serum or Plasma |
| 44383-8 | Hyaluronate [Presence] in Pleural fluid |
| 23177-9 | Leptospira interrogans sv Grippotyphosa Ab [Presence] in Serum |
| 53492-5 | Decadienoylcarnitine (C10:2) [Moles/volume] in Urine |
| 44575-9 | Influenza virus B Ag [Presence] in Nose by Immunoassay |
| 4486-7 | Complement C3 fragment [Presence] in Red Blood Cells |
| 23326-2 | Ovine herpesvirus 2 Ab [Presence] in Serum by Immune stain |
| 45104-7 | Chlamydia sp Ag [Presence] in Anal by Immunoassay |
| 33879-8 | Protein.monoclonal [Mass/volume] in Specimen by Immunofixation |
| 4649-0 | Interferon [Units/volume] in Serum |
| 24504-3 | Pullularia sp Ab [Presence] in Serum by Immune diffusion (ID) |
| 3452-0 | Cefuroxime Parenteral [Mass/volume] in Serum or Plasma |
| 34589-2 | von Willebrand factor (vWf) cleaving protease [Presence] in Platelet poor plasma |
| 55310-7 | Yeast.pseudohyphae [Presence] in Nail by KOH preparation |
| 55375-0 | Megaloblasts [#/volume] in Blood by Manual count |
| 47066-6 | Epstein Barr virus capsid IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 47099-7 | Chromium [Moles/volume] in 24 hour Urine |
| 47285-2 | Heparin cofactor II Ag [Units/volume] in Platelet poor plasma |
| 25270-0 | Pyrazinamide [Mass/volume] in Specimen |
| 35115-5 | Pipamperone [Mass/volume] in Serum or Plasma |
| 55862-7 | Glycine [Moles/mass] in Hair |
| 5609-3 | Cadmium [Mass/volume] in Blood |
| 56259-5 | Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgG4 Ab [Mass/volume] in Serum |
| 26413-5 | Candida albicans IgG4 Ab [Units/volume] in Serum |
| 35800-2 | Ertapenem [Susceptibility] by Gradient strip |
| 56767-7 | Protein.monoclonal.beta [Mass/volume] in Urine by Electrophoresis |
| 57404-6 | CD45RO cells/100 cells in Body fluid |
| 57558-9 | 18-Hydroxycortisol [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin |
| 27380-5 | DOPamine [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
| 49705-7 | LMNA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 2835-7 | Pregnanetriol [Mass/volume] in Urine |
| 28606-2 | 1-Methylhistidine/Creatinine [Ratio] in Urine |
| 40296-6 | Xylose [Moles/volume] in Serum or Plasma --fasting |
| 58544-8 | Corticotropin [Mass/volume] in Plasma --12th specimen post XXX challenge |
| 49949-1 | Somatotropin [Units/volume] in Serum or Plasma --12:30 PM specimen |
| 40334-5 | Somatotropin [Mass/volume] in Serum or Plasma --pre dose triple bolus |
| 58832-7 | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 59147-9 | CD19+CD38+ cells [#/volume] in Blood |
| 59278-2 | Calcium oxalate dihydrate crystals [Presence] in Stone by X-ray diffraction |
| 41013-4 | Human coronavirus 229E IgG Ab [Presence] in Serum |
| 41104-1 | GBA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 1930-7 | Benzoate [Mass/volume] in Serum or Plasma |
| 19354-0 | Barbital [Presence] in Urine by Confirmatory method |
| 20620-1 | CD16+CD56+ cells/100 cells in Specimen |
| 100020-7 | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100376-3 | Bambusa vulgaris IgG Ab [Units/volume] in Serum |
| 101469-5 | HBA1+2 gene FIL deletion [Presence] in Blood by Molecular genetics method |
| 102984-2 | House dust Hollister Stier IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14763-7 | Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose |
| 14784-3 | Hydroxyproline Free [Moles/time] in 24 hour Urine |
| 14847-8 | Neutrophils/100 leukocytes in Pericardial fluid by Manual count |
| 16116-6 | Tetrahydrocortisone [Mass/time] in 24 hour Urine |
| 10850-6 | Cyclospora cayetanensis [Presence] in Specimen |
| 11482-7 | Rickettsia rickettsii RNA [Presence] in Tissue by NAA with probe detection |
| 17365-8 | Nitroprusside [Mass/volume] in Serum or Plasma |
| 17417-7 | Parakeet droppings IgG Ab [Units/volume] in Serum |
| 1903-4 | Ascorbate [Mass/volume] in Serum or Plasma |
| 90041-5 | Specimen collection setting type |
| 91767-4 | Giardia sp DNA [Presence] in Duodenal fluid by NAA with probe detection |
| 91832-6 | Human bocavirus Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
| 92718-6 | Lipoprotein.broad beta.subparticle.small [Moles/volume] in Serum |
| 75211-3 | Propionylcarnitine (C3)+Palmitoylcarnitine (C16) [Moles/volume] in DBS |
| 60532-9 | Japanese encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid |
| 60589-9 | t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 61057-6 | Pseudoephedrine [Presence] in Specimen |
| 76495-1 | Titanium [Moles/volume] in Blood |
| 929-0 | Blood product release time |
| 77309-3 | Acylcarnitine pattern [Interpretation] in Serum or Plasma Narrative |
| 7752-9 | Turkey triggered histamine release [Units/volume] in Blood |
| 93710-2 | Pentacarboxylporphyrin I/Creatinine [Molar ratio] in Urine |
| 93811-8 | F9 gene full mutation analysis in Blood or Tissue by Sequencing |
| 63337-0 | SCL-70 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 95099-8 | Glucagon [Mass/volume] in Serum or Plasma --4.5 hours post meal |
| 95664-9 | Jamestown canyon virus IgG Ab [Presence] in Specimen by Immunoassay |
| 96494-0 | ABL1 and ABL2 and PDGFRB gene rearrangements in Blood or Tissue by FISH |
| 68961-2 | HIV 1 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 8144-8 | Amphetamines [Presence] in Meconium |
| 81768-4 | U1 small nuclear ribonucleoprotein 70kD IgG Ab [Units/volume] in Serum by Immunoassay |
| 82074-6 | Food Allergen Mix 72 (Fennel seed+Basil+Anise+Ginger) IgE Ab [Units/volume] in Serum by Multidisk |
| 97855-1 | Blastomyces sp Ab [Titer] in Specimen by Complement fixation |
| 70292-8 | Blastocystis hominis DNA [Presence] in Stool by NAA with probe detection |
| 7148-0 | Berry IgE Ab [Units/volume] in Serum |
| 82937-4 | SAP and XIAP [Interpretation] in Leukocytes by Flow cytometry (FC) |
| 9801-2 | Shape of Stone |
| 85053-7 | MBL by imipenem to imipenem-EDTA IC ratio [Presence] by ARD gradient strip |
| 85356-4 | PEDV prototype strain S gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 99383-2 | Copper [Moles/volume] in Water |
| 7280-1 | Dill IgE Ab [Units/volume] in Serum |
| 72940-0 | Topiramate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 72958-2 | risperiDONE induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 72963-2 | quiNINE induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73127-3 | Tazobactam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88586-3 | Shigella sp identified in Stool by Organism specific culture |
| 88715-8 | Norquetiapine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 89349-5 | CD19+CD27+IgD-IgM- cells [#/volume] in Blood |
| 50853-1 | Heptacarboxylporphyrin [Moles/mass] in Stool |
| 30410-5 | Leukocytes other/100 leukocytes in Synovial fluid |
| 31057-3 | Coxsackievirus B5 Ab [Titer] in Body fluid by Complement fixation |
| 41868-1 | Waxy casts [#/volume] in Urine by Computer assisted method |
| 60188-0 | Thiethylperazine [Mass/volume] in Urine |
| 31378-3 | Equine herpesvirus 1+4 Ab [Units/volume] in Serum |
| 51115-4 | CD20 blasts/100 blasts in Bone marrow |
| 51355-6 | CD19+CD58+ cells/100 cells in Body fluid |
| 4274-7 | Hippurate [Mass] of Dose |
| 42964-7 | Salmonella paratyphi B O Ab [Titer] in Serum |
| 21825-5 | t(X;18)(q11.2;p11.23)(SS18,SSX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 22081-4 | Afipia felis IgG Ab [Titer] in Serum |
| 31623-2 | Salmonella typhimurium Ab [Units/volume] in Serum |
| 31804-8 | Duck hepatitis virus 2 Ag [Presence] in Specimen |
| 43312-8 | Desmoglein 3 Ab [Units/volume] in Serum |
| 4396-8 | Phentermine [Mass] of Dose |
| 33249-4 | Hyperchromia [Presence] in Blood by Light microscopy |
| 33356-7 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with normal plasma |
| 33550-5 | Platelet aggregation ristocetin induced in Platelet rich plasma --1500 ug/mL |
| 5351-2 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoassay |
| 23886-5 | Isohexacarboxylporphyrin [Mass/time] in unspecified time Stool |
| 53962-7 | Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma |
| 54437-9 | Sodium urate/Total in Stone by Infrared spectroscopy |
| 46987-4 | Helicobacter pylori IgM Ab [Presence] in Serum by Immunoassay |
| 24363-4 | Acute hepatitis 2000 panel - Serum |
| 25323-7 | Arsenic [Moles/volume] in Serum or Plasma |
| 25547-1 | Tyrosine [Moles/time] in 24 hour Urine |
| 55856-9 | Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Urine |
| 55944-3 | Neopterin [Moles/time] in 24 hour Urine |
| 56006-0 | Platelet aggregation ADP induced in Blood --10 umol/L |
| 25678-4 | Glucose [Mass/volume] in Urine --1.5 hours post dose glucose |
| 25965-5 | Ornithine [Moles/volume] in 24 hour Urine |
| 26010-9 | Alkaline phosphatase.other fractions/Alkaline phosphatase.total in Serum or Plasma |
| 35715-2 | Chlamydia sp rRNA [Presence] in Genital specimen by Probe |
| 56391-6 | Spinach IgG4 Ab [Mass/volume] in Serum |
| 48138-2 | Enolase.neuron specific [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
| 3814-1 | Methyprylon [Mass/volume] in Urine |
| 48646-4 | Yersinia sp DNA [Identifier] in Specimen by NAA with probe detection |
| 26870-6 | Ganglioside GD1b Ab [Units/volume] in Serum by Immunoassay |
| 26977-9 | Coproporphyrin 1 [Presence] in Stool |
| 57410-3 | Actin.filamentous Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 49047-4 | Globulin [Mass/volume] in Urine by Electrophoresis |
| 49192-8 | Clostridium tetani toxoid IgG Ab [Units/volume] in Serum --2nd specimen |
| 49242-1 | Acylcarnitine pattern [Interpretation] in Urine Narrative |
| 38912-2 | Succinylacetone [Moles/volume] in Amniotic fluid |
| 57707-2 | Cystic fibrosis newborn screening comment-discussion |
| 57884-9 | Honeydew melon IgE Ab [Units/volume] in Serum |
| 58353-4 | Human antihuman Ab [Mass/volume] in Plasma |
| 29396-9 | Gastrin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 3981-8 | Probenecid [Mass/time] in 24 hour Urine |
| 58830-1 | Cortisol [Mass/volume] in Serum or Plasma --13th specimen |
| 50350-8 | Mustard IgE Ab/IgE total in Serum |
| 50526-3 | Parathyrin.intact [Mass/volume] in Serum or Plasma --2nd specimen |
| 40805-4 | Opiates [Presence] in Hair by Screen method |
| 19336-7 | Amitriptyline+Nortriptyline [Presence] in Urine by Confirmatory method |
| 19392-0 | Chlorpheniramine [Mass/volume] in Urine |
| 19543-8 | Mescaline [Presence] in Urine by Confirmatory method |
| 100735-0 | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes |
| 100991-9 | CD52 cell expression evaluation in Specimen Document by Flow cytometry (FC) |
| 101003-2 | Monkeypox virus clade [Type] in Specimen by Sequencing |
| 12634-2 | Glucose [Mass/volume] in Peritoneal dialysis fluid --5th specimen |
| 101183-2 | MDMB-4en-PINACA [Presence] in Urine by Confirmatory method |
| 13599-6 | Promonocytes/100 leukocytes in Blood by Manual count |
| 13781-0 | N-methylhistamine/Creatinine [Mass Ratio] in Urine |
| 13826-3 | Barium/Creatinine [Mass Ratio] in Urine |
| 14346-1 | Specific gravity of Cerebral spinal fluid by Refractometry |
| 103091-5 | Latex recombinant (rHev b) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15187-8 | Lambda light chains [Mass/volume] in 24 hour Urine |
| 15475-7 | Infectious bursal disease virus Ab [Presence] in Serum by Immunoassay |
| 16146-3 | Psilocin [Mass/volume] in Serum or Plasma |
| 10781-3 | Microscopic observation [Identifier] in Tissue by Churukian-Schenk stain |
| 16510-0 | Calcitonin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 16518-3 | Calcium [Mass/time] in 2 hour Urine |
| 11592-3 | Aspergillus fumigatus 6 Ab [Presence] in Serum |
| 18187-5 | LORazepam [Presence] in Urine |
| 18270-9 | Carbamazepine 10,11-Epoxide [Moles/volume] in Serum or Plasma |
| 90002-7 | Candida auris [Presence] in Specimen by Organism specific culture |
| 74634-7 | Dimethylacetal (DMA) panel - Red Blood Cells |
| 75264-2 | Blood group antibody screen [Presence] in Serum or Plasma by Low ionic strength saline (LISS) |
| 61090-7 | Alpha-Phenyl-2-Piperidine acetate [Presence] in Gastric fluid |
| 76616-2 | Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 1-14C-pyruvate substrate |
| 77310-1 | Measles virus IgG associated observations panel - Serum |
| 7755-2 | Upholstery dust IgE Ab [Units/volume] in Serum |
| 93983-5 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose carbohydrate |
| 94221-9 | SMN1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 63131-7 | Papaya (Carica papaya) IgG Ab [Mass/volume] in Serum |
| 94337-3 | Desmoglein 3 IgG Ab [Units/volume] in Serum by Immunoassay |
| 94609-5 | Bovine leukemia virus Ab [Units/volume] in Serum by Immunoassay |
| 6363-6 | Clostridioides difficile toxin A+B [Units/volume] in Stool by Immunoassay |
| 95583-1 | Beta cortol [Z-score] in 24 hour Urine |
| 95669-8 | Murray Valley encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay |
| 79597-1 | N-monomethylarginine/Creatinine [Molar ratio] in Urine |
| 95799-3 | O-nortramadol [Presence] in Urine by Screen method |
| 68976-0 | Pseudomonas aeruginosa alkaline protease Ab [Titer] in Serum by Immunoassay |
| 68983-6 | National (USA) PFGE pattern [Identifier] in Isolate |
| 69887-8 | Service comment 60 |
| 69921-5 | Herpes simplex virus 1 IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 82067-0 | Citrus Allergen Mix (Orange+Lemon+Grapefruit+Clementine) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 7033-4 | Mupirocin [Susceptibility] by Gradient strip |
| 82857-4 | Tetrahydrocortisol+allo-tetrahydrocortisol/Tetrahydrocortisone [Molar ratio] in 24 hour Urine |
| 9808-7 | Phenothiazines [Presence] in Gastric fluid |
| 71675-3 | Basophils/Leukocytes [Pure number fraction] in Blood by Manual count |
| 72867-5 | Mycobacterium tuberculosis gyrB gene fluoroquinolone resistance mutation [Presence] by Molecular method |
| 72931-9 | Venlafaxine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73044-0 | cefTAZidime induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 89327-1 | CD3+CD8+CD27-CD45RO+CD62L- cells [#/volume] in Blood |
| 89482-4 | Kanamycin [Susceptibility] by Genotype method |
| 41767-5 | Triamcinolone acetonide [Mass/volume] in Serum or Plasma |
| 42533-0 | Saccharomonospora viridis Ab [Presence] in Cerebral spinal fluid |
| 60069-2 | Dantrolene [Mass/volume] in Blood |
| 6019-4 | Almond IgE Ab [Units/volume] in Serum |
| 21511-1 | Salmonella paratyphi A H Ab [Titer] in Serum by Agglutination |
| 3153-4 | Weight of 24 hour Specimen |
| 31559-8 | Pasteurella multocida Ab [Units/volume] in Serum |
| 51141-0 | Cytoplasmic CD3 blasts [Units/volume] in Blood |
| 42901-9 | Dihydrocodeine [Mass/volume] in Serum or Plasma |
| 21796-8 | t(9;22)(q22;q12.2)(NR4A3,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 31836-0 | Haemophilus influenzae C Ag [Presence] in Specimen |
| 43365-6 | Nocardia sp identified in Specimen by Organism specific culture |
| 51989-2 | Vasoactive intestinal peptide [Presence] in Serum or Plasma |
| 53007-1 | PM-SCL extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 22920-3 | Brucella abortus Ab [Presence] in Serum by Immunofluorescence |
| 22944-3 | Brucella sp Ag [Presence] in Vaginal fluid by Immune stain |
| 23125-8 | Francisella tularensis Ab [Titer] in Serum by Agglutination |
| 33213-0 | Glycine in plasma/Glycine in CSF |
| 44463-8 | Herpes simplex virus 1 [Presence] in Vaginal fluid by Organism specific culture |
| 44475-2 | Herpes simplex virus 1 Ag [Presence] in Tissue |
| 23235-5 | Mycobacterium avium ss avium Ab [Presence] in Blood by Agglutination |
| 23266-0 | Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum by Complement fixation |
| 33404-5 | Platelet associated IgG Ab/IgM Ab [Ratio] in Blood |
| 3362-1 | Atenolol [Mass/time] in 24 hour Urine |
| 53817-3 | Carnosine [Presence] in Cerebral spinal fluid |
| 45037-9 | Bacteria producing urease [Presence] in Isolate |
| 53968-4 | Erythrocytes.non-dysmorphic [Presence] in Urine sediment by Light microscopy |
| 24146-3 | Western Water Hemp IgG Ab [Units/volume] in Serum |
| 24187-7 | Coxsackievirus B3 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen |
| 24451-7 | Carnitine [Moles/mass] in Tissue |
| 34683-3 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor IX depleted plasma |
| 47185-4 | Progesterone [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
| 35125-4 | Hemoglobin Lepore/Hemoglobin.total in Blood |
| 55841-1 | Corticosterone [Mass/volume] in 24 hour Urine |
| 47810-7 | 2-Methyl-3-Hydroxyvalerate [Moles/volume] in Plasma |
| 47889-1 | Somatotropin [Units/volume] in Serum or Plasma --1.75 hours post dose ornithine |
| 35714-5 | Chlamydia sp rRNA [Presence] in Cervix by Probe |
| 35768-1 | Cefoperazone+Sulbactam [Susceptibility] by Gradient strip |
| 56141-5 | MPL gene p.Ser505Asn [Presence] in Blood or Tissue by Molecular genetics method |
| 48029-3 | PKLR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 26452-3 | Eosinophils/100 leukocytes in Body fluid |
| 382-2 | Oxacillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 26827-6 | Testosterone/Creatinine [Mass Ratio] in 24 hour Urine |
| 57361-8 | Lactate [Mass/volume] in Serum or Plasma --3 minutes post XXX challenge |
| 27972-9 | Histidine [Units/volume] in Serum or Plasma |
| 39008-8 | Hepatitis C virus Ab [Presence] in Body fluid by Immunoblot |
| 39462-7 | Bilirubin.conjugated [Moles/volume] in Body fluid |
| 29350-6 | CD42 cells [#/volume] in Blood |
| 29501-4 | 2-Hydroxyisobutyrate/Creatinine [Molar ratio] in Urine |
| 39787-7 | Sodium [Moles/volume] in Peritoneal dialysis fluid |
| 40105-9 | aPTT in Platelet poor plasma by Coagulation assay --3 hours post XXX challenge |
| 40213-1 | Glucose [Moles/volume] in Serum or Plasma --5.5 hours post XXX challenge |
| 58396-3 | oxyMORphone/Creatinine [Mass Ratio] in Urine |
| 58449-0 | Erythrocyte clumps [#/area] in Urine sediment by Microscopy high power field |
| 58635-4 | Cortisol [Mass/volume] in Serum or Plasma --10 PM specimen |
| 58673-5 | Cortisol [Moles/volume] in Saliva (oral fluid) --4th specimen post XXX challenge |
| 50158-5 | Acetylcarnitine (C2) [Moles/volume] in Urine |
| 58839-2 | Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 30148-1 | Respiratory syncytial virus Ab [Presence] in Serum --2nd specimen |
| 30215-8 | Coxsackievirus A16 Ab [Presence] in Serum |
| 30310-7 | Saquinavir [Susceptibility] |
| 40860-9 | Cytokines [Presence] in Serum or Plasma |
| 19335-9 | Amitriptyline+Nortriptyline [Presence] in Urine by Screen method |
| 19455-5 | Dimetamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
| 19773-1 | Recommended follow-up [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
| 12355-4 | Phencyclidine [Presence] in Stool |
| 100379-7 | Leeks IgG Ab [Units/volume] in Serum |
| 100845-7 | Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC) |
| 101315-0 | Cortisol and Cortisone panel - Urine |
| 13011-2 | Methyl ethyl ketone [Mass/volume] in Blood |
| 101788-8 | Chronic lymphocytic leukemia gene rearrangements in Blood or Marrow by FISH |
| 101918-1 | Troponin T.cardiac delta [Interpretation] in 6 hour Serum or Plasma Qualitative |
| 101980-1 | Glucose, somatotropin and cortisol post insulin administration in Serum or Plasma |
| 104119-3 | Breast Cancer recurrence risk multigene analysis [Presence] in Tissue by Molecular genetics method |
| 15104-3 | Digitoxin [Moles/volume] in Serum or Plasma |
| 1067-8 | Jk sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 10828-2 | Urate crystals.microscopic observation [type] in Tissue by De Galantha stain |
| 1099-1 | Kp sup(a) Ab [Presence] in Serum or Plasma |
| 1113-0 | Le sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 1637-8 | Somatotropin [Mass/volume] in Serum or Plasma --pre dose insulin IV |
| 16454-1 | Beta galactosidase [Enzymatic activity/volume] in Blood |
| 1168-4 | little f Ab [Presence] in Serum or Plasma |
| 16908-6 | Glucose [Presence] in Urine --5th specimen post XXX challenge |
| 17817-8 | Gamma globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
| 90784-0 | Cystinuria panel - Urine |
| 74667-7 | Atopobium vaginae DNA [Log #/volume] in Vaginal fluid by NAA with probe detection |
| 91841-7 | Adenovirus Ag [Presence] in Lower respiratory specimen by Rapid immunoassay |
| 923-3 | Blood collection bag lot [Identifier] |
| 75567-8 | Fetal Monosomy X risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
| 60403-3 | Shrimp IgG Ab [Mass/volume] in Serum |
| 76150-2 | Cefquinome [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 77114-7 | FBN1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 77146-9 | Amylase [Enzymatic activity/volume] in Serum, Plasma or Blood |
| 77320-0 | Benzoylecgonine [Moles/volume] in Specimen |
| 77737-5 | Mycobacterium abscessus complex clarithromycin resistance erm(41) gene panel by Molecular genetics method |
| 94127-8 | Clarity of Body fluid |
| 7800-6 | Phospholipid Ab [Units/volume] in Serum |
| 78346-4 | Hexadecenoate (C16:1w9) [Entitic substance] in Red Blood Cells |
| 7849-3 | Taenia solium larva IgM Ab [Presence] in Serum |
| 78521-2 | Platelet aggregation ADP induced in Platelet rich plasma --4 umol/L |
| 94693-9 | Heparan sulfate/Creatinine [Ratio] in Urine |
| 63481-6 | Urea [Mass/volume] in 24 hour Urine |
| 79144-2 | Methcathinone [Presence] in Urine by Screen method |
| 6586-2 | Western equine encephalitis virus Ag [Presence] in Serum by Immunofluorescence |
| 66767-5 | Vanillylmandelate/Body weight [Moles/kg/time] in 24 hour Urine |
| 96297-7 | Cobalamin (Vitamin B12) IgE Ab [Units/volume] in Serum |
| 80675-2 | Rotavirus A VP6 gene [Presence] in Stool by NAA with probe detection |
| 80821-2 | Zika virus neutralizing antibody [Presence] in Cerebral spinal fluid by Neutralization test |
| 81316-2 | Trichomonas vaginalis [Presence] in Urine sediment by Organism specific culture |
| 97503-7 | Abnormal Prion Protein [Presence] in Cerebral spinal fluid |
| 97565-6 | B-cell primary immunodeficiency multigene analysis in Blood or Tissue by Molecular genetics method |
| 70163-1 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Cervix by NAA with probe detection |
| 82746-9 | Varicella zoster virus strain [Type] in Isolate |
| 7188-6 | Catfish triggered histamine release [Units/volume] in Blood |
| 72279-3 | Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab [Units/volume] in Serum by Multidisk |
| 84914-1 | Cells.chromosome region 13q14 deletion/Cells counted in Blood or Tissue by FISH |
| 85768-0 | Streptococcus pneumoniae DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 72729-7 | 7-Hydroxymitragynine/Creatinine [Mass Ratio] in Urine |
| 73021-8 | Fexofenadine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73306-3 | levoFLOXacin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87380-2 | Escherichia coli Stx2e toxin stx2e gene [Presence] in Isolate by NAA with probe detection |
| 87817-3 | Propoxyphene [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 87930-4 | Bacteria identified in Burn by Aerobe culture |
| 73951-6 | RCS-4 (synthetic cannabinoid) [Presence] in Blood |
| 74365-8 | Palmitoyl protein thioesterase [Enzymatic activity/mass] in Fibroblast |
| 88973-3 | Crystals.amorphous [#/area] in Urine sediment |
| 41197-5 | Xylose [Mass/volume] in Serum or Plasma --30 minutes post dose xylose PO |
| 59338-4 | Sibutramine [Mass/volume] in Urine |
| 50771-5 | Ganglioside GM2 IgG Ab/IgM Ab [Ratio] in Serum by Immunoassay |
| 50841-6 | Chromium [Moles/volume] in Red Blood Cells |
| 3060-1 | Trypsin [Enzymatic activity/volume] in Serum or Plasma |
| 42518-1 | Leptospira sp Ab [Titer] in Cerebral spinal fluid by Agglutination |
| 21219-1 | Copper [Mass/volume] in 24 hour Urine |
| 31209-0 | Islet cell 512 Ab [Units/volume] in Serum |
| 21803-2 | t(11;22)(q24;q12.2)(FLI1,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 31859-2 | Influenza virus A Ag [Presence] in Specimen |
| 31964-0 | Rubella virus Ag [Presence] in Urine sediment |
| 43331-8 | Ehrlichia risticii Ab [Titer] in Serum by Immunofluorescence |
| 43436-5 | Bartonella henselae and Bartonella quintana IgG panel - Cerebral spinal fluid |
| 22502-9 | Measles virus IgG Ab [Titer] in Serum |
| 32534-0 | CD3+CD8+ (T8 suppressor) cells [#/volume] in Bone marrow |
| 2310-1 | Galactose [Mass/volume] in Urine |
| 32831-0 | Herpes simplex virus 1 IgG Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen |
| 53262-2 | Carnitine newborn screen panel |
| 23506-9 | Tritrichomonas foetus reaction wheal [Diameter] --post 0.1 mL tricin intradermal |
| 45313-4 | Coproporphyrin 1/Creatinine [Molar ratio] in Urine |
| 45347-2 | Date tick attached |
| 33813-7 | Insulin [Units/volume] in Serum or Plasma --14th specimen post XXX challenge |
| 34274-1 | Creatine [Moles/volume] in 24 hour Urine |
| 54399-1 | Glucose [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 45-5 | Aztreonam [Susceptibility] by Disk diffusion (KB) |
| 4558-3 | Hemoglobin Barts [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 34505-8 | NPDC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 34663-5 | Hemoglobin S [Presence] in Amniotic fluid |
| 54491-6 | Alanine aminotransferase [Enzymatic activity/volume] in Peritoneal fluid |
| 55373-5 | Hemoglobin D+G/Hemoglobin.total in Blood |
| 47088-0 | Delta aminolevulinate [Moles/volume] in Serum |
| 47275-3 | S100 calcium binding protein B [Mass/volume] in Serum |
| 47432-0 | Epstein Barr virus capsid IgG Ab [Titer] in Body fluid |
| 25534-9 | Teicoplanin [Moles/volume] in Serum or Plasma --peak |
| 25538-0 | Thermoactinomyces vulgaris IgG Ab [Units/volume] in Serum |
| 55781-9 | Hematocrit [Volume Fraction] of Bone marrow |
| 55833-8 | Cathepsin L [Mass/volume] in Serum or Plasma |
| 56031-8 | Doripenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 47610-1 | Creatinine [Moles/volume] in Stool |
| 56240-5 | Squid IgG4 Ab [Mass/volume] in Serum |
| 56249-6 | Douglas Fir IgG4 Ab [Mass/volume] in Serum |
| 2636-9 | Mianserin [Mass/volume] in Urine |
| 48353-7 | Chlorprothixene [Moles/volume] in Serum or Plasma |
| 27087-6 | Herpes simplex virus 2 Ab [Units/volume] in Cerebral spinal fluid |
| 57132-3 | CYP2C19 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 57584-5 | Aldosterone [Moles/volume] in Serum or Plasma --3 hours post 25 mg captopril PO |
| 48924-5 | Respiratory allergen panel, US - Northern midwest states b - Serum |
| 28056-0 | Borrelia burgdorferi 28kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 49458-3 | Annexin 1 Ag [Presence] in Tissue by Immune stain |
| 49591-1 | Calcidiol and Calciferol [Interpretation] in Serum or Plasma Narrative |
| 2864-7 | Alpha 1 globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis |
| 29378-7 | Insulin [Units/volume] in Serum or Plasma --4 hours post XXX challenge |
| 40246-1 | Calcium [Moles/volume] in Serum or Plasma --2 days post XXX challenge |
| 49769-3 | Filaria IgG4 Ab [Units/volume] in Serum by Immunoassay |
| 49816-2 | 2-Oxo,3-Methylvalerate/Creatinine [Molar ratio] in 24 hour Urine |
| 49997-0 | Borrelia burgdorferi 83/93kD IgM Ab [Presence] in Serum by Immunoblot |
| 59072-9 | Liver kidney microsomal 1 Ab [Presence] in Serum by Immunoblot |
| 19607-1 | Nalbuphine cutoff [Mass/volume] in Urine for Screen method |
| 19669-1 | PHENobarbital cutoff [Mass/volume] in Urine for Confirmatory method |
| 19772-3 | Preparation techniques [Type] in Cervical or vaginal smear or scraping by Cyto stain |
| 20476-8 | CD1a cells/100 cells in Blood |
| 12570-8 | Cortisol [Mass/volume] in Serum or Plasma --post XXX challenge |
| 12856-1 | HIV 1 p65 Ab [Presence] in Serum by Immunoblot |
| 12969-2 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --baseline |
| 12973-4 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --4th specimen |
| 12983-3 | Volatiles and gases [Identifier] in Urine |
| 13276-1 | Toxocara canis IgA Ab [Units/volume] in Serum |
| 13363-7 | Collection duration of Stool |
| 1407-6 | Cortisol [Mass/volume] in Serum or Plasma --24 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 103076-6 | Hazelnut recombinant (rCor a) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14561-5 | Mycobacterium tuberculosis DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 103650-8 | Lutropin [Units/volume] in Serum or Plasma --4 hours post dose gonadotropin releasing hormone |
| 14906-2 | Rh [Type] in Cord blood |
| 104371-0 | Corynebacterium pseudotuberculosis [Presence] in Specimen by Organism specific culture |
| 15356-9 | Globulin [Mass/time] in 24 hour Urine |
| 1613-9 | Prolactin [Mass/volume] in Serum or Plasma --2 hours post dose L-dopa PO |
| 10853-0 | Isospora belli [Presence] in Specimen by Acid fast stain.Kinyoun modified |
| 16329-5 | Aldosterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 16342-8 | Alpha aminoisobutyrate [Mass/volume] in Plasma |
| 16506-8 | Calcitonin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 16557-1 | Carnosine [Presence] in Urine |
| 1660-0 | 11-Hydroxyetiocholanolone [Mass/volume] in Serum |
| 11611-1 | Shigella sonnei Ab [Units/volume] in Serum |
| 17336-9 | Neuronal Ab [Presence] in Serum by Immunofluorescence |
| 17589-3 | Smith extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) |
| 17861-6 | Calcium [Mass/volume] in Serum or Plasma |
| 17879-8 | Bacteria # 3 identified in Bronchial specimen by Aerobe culture |
| 17968-9 | Bacteria # 6 identified in Stool by Culture |
| 18256-8 | Sulfonylurea [Mass/volume] in Urine |
| 61116-0 | Mitochondria rRNA targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 77581-7 | Alpha 2 globulin [Mass/volume] by Electrophoresis in Urine collected for unspecified duration |
| 94065-0 | Bacterial rpoB gene drug resistance mutation [Identifier] by Molecular method |
| 63287-7 | Myelin Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 94361-3 | Metabotropic glutamate receptor 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 94700-2 | Liver diseases autoimmune Ab panel - Serum or Plasma |
| 9479-7 | Mercury [Mass/volume] in Water |
| 63553-2 | Succinylaminoimidazole carboxamide riboside [Presence] in Urine |
| 63561-5 | aPTT actual/normal in Platelet poor plasma by Coagulation assay |
| 79251-5 | diazePAM cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 95-0 | Cefonicid [Susceptibility] by Minimum lethal concentration (MLC) |
| 65768-4 | English Walnut native (nJug r) 3 IgE Ab [Units/volume] in Serum |
| 65809-6 | Kingella kingae DNA [Presence] in Specimen by NAA with probe detection |
| 66128-0 | chlordiazePOXIDE/Creatinine [Mass Ratio] in Urine |
| 97201-8 | Hemolysis interference index of Urine |
| 69421-6 | Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum |
| 69897-7 | Service comment 70 |
| 97505-2 | Glucose standard deviation Calculated |
| 70124-3 | Erythrocytes [Presence] in Specimen by Wet preparation |
| 82523-2 | Grazoprevir [Susceptibility] by Genotype method |
| 82559-6 | Food Allergen Mix 75 (Cow milk+Egg white+Cod+Wheat) IgE Ab [Units/volume] in Serum |
| 98223-1 | Treponema pallidum IgM bands [Identifier] in Serum by Immunoblot |
| 85282-2 | Mucinous fraction [Area Fraction] in Colorectal cancer specimen by Light microscopy |
| 86174-0 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum --2nd specimen |
| 73223-0 | oxyCODONE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73377-4 | Fluconazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87364-6 | Haemophilus parasuis Ab/Positive control in Serum by Immunoassay |
| 87606-0 | Diphacinone [Mass/mass] in Specimen |
| 73909-4 | D2-40 Ag [Presence] in Tissue by Immune stain |
| 89484-0 | Amikacin [Susceptibility] by Genotype method |
| 89657-1 | Microscopic observation [Identifier] in Lower respiratory specimen by Toluidine blue O stain |
| 3081-7 | Tyrosine [Mass/time] in 24 hour Urine |
| 6024-4 | Aspergillus flavus IgE Ab [Units/volume] in Serum |
| 31527-5 | Neisseria meningitidis serogroup C IgG Ab [Units/volume] in Serum |
| 31575-4 | Powassan virus IgM Ab [Units/volume] in Serum |
| 31576-2 | Powassan virus IgM Ab [Units/volume] in Specimen |
| 51123-8 | Cytoplasmic CD22 blasts [Units/volume] in Specimen |
| 43032-2 | Herpes simplex virus 1 Ab [Titer] in Cerebral spinal fluid |
| 43038-9 | Enterovirus NOS Ab [Titer] in Serum |
| 31915-2 | Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Specimen |
| 32003-6 | Chlamydia sp Ag [Presence] in Peritoneal fluid by Immunoassay |
| 51602-1 | Methotrexate [Moles/volume] in Serum or Plasma --72 hours post dose |
| 43695-6 | Herpes virus identified in Specimen by Shell vial culture |
| 22443-6 | Plasmodium ovale Ab [Titer] in Serum |
| 22514-4 | Saint Louis encephalitis virus IgM Ab [Titer] in Serum |
| 32296-6 | Amino acid pattern [Interpretation] in Urine |
| 5299-3 | Rheumatoid factor [Titer] in Serum by Latex agglutination |
| 5305-8 | Rickettsia (Proteus OXK) Ab [Presence] in Serum by Latex agglutination |
| 44071-9 | CD20+CD52+ cells/100 cells in Cerebral spinal fluid |
| 23137-3 | Histoplasma capsulatum farciminosum reaction wheal [Diameter] --2 days post dose intradermal |
| 23472-4 | Theileria mutans rRNA [Presence] in Serum by Probe |
| 33288-2 | Galactose 1 phosphate uridyl transferase [Presence] in DBS |
| 23991-3 | Dengue virus IgG Ab [Units/volume] in Serum by Immunoassay |
| 24070-5 | Beta-N-acetylhexosaminidase.B/Beta-n-acetylhexosaminidase.total in Fibroblast |
| 5408-0 | Yersinia enterocolitica O:8 Ab [Units/volume] in Serum |
| 54358-7 | Beta globulin/Protein.total in Dialysis fluid by Electrophoresis |
| 54455-1 | Blastomyces dermatitidis Ag [Units/volume] in Body fluid |
| 4592-2 | Hemoglobin Hope [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 24386-5 | Cardiolipin IgM Ab [Presence] in Serum by Immunoassay |
| 34289-9 | Estradiol (E2).unconjugated [Moles/volume] in Urine |
| 34597-5 | Hepatitis D virus IgM Ab [Presence] in Serum |
| 34696-5 | Collection method - Semen |
| 47017-9 | CD68 Ag [Presence] in Tissue by Immune stain |
| 47443-7 | Influenza virus A Ab [Presence] in Egg yolk |
| 25375-7 | Chymotrypsin [Enzymatic activity/mass] in Stool |
| 2584-1 | Lysine [Presence] in Serum or Plasma |
| 4806-6 | HLA-B13 [Presence] in Donor |
| 26621-3 | Legionella sp Ag [Presence] in Specimen |
| 48976-5 | POLG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 49025-0 | CD25+CD127Low cells/CD4 cells [# Ratio] in Specimen |
| 49169-6 | Orientia tsutsugamushi Karp IgG Ab [Titer] in Serum |
| 49305-6 | Cervical Mucus Penetration Test [Interpretation] in Semen Narrative |
| 2791-2 | Phosphofructokinase [Enzymatic activity/volume] in Blood |
| 28068-5 | Beta aminobutyrate [Moles/volume] in Amniotic fluid |
| 39556-6 | Coagulation factor X inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
| 57971-4 | Glucose [Mass/volume] in Serum or Plasma --4th specimen post lactose |
| 49626-5 | Muscle sarcolemma Ab [Titer] in Pleural fluid by Immunofluorescence |
| 39977-4 | Creatinine [Mass/volume] in Urine --pre XXX challenge |
| 40283-4 | Lactose [Moles/volume] in Serum or Plasma --1.5 hours post dose lactose PO |
| 58511-7 | C peptide [Mass/volume] in Serum or Plasma --3 hours post dose glucose |
| 5002-1 | Epstein Barr virus DNA [Presence] in Blood by NAA with probe detection |
| 29685-5 | Rickettsia typhi Ab [Presence] in Serum |
| 58869-9 | Somatotropin [Mass/volume] in Serum or Plasma --39th specimen |
| 3013-0 | Thyroglobulin [Mass/volume] in Serum or Plasma |
| 40947-4 | Zinc [Presence] in Hair |
| 41073-8 | NR0B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 1922-4 | Base deficit in Arterial blood |
| 19691-5 | Psilocybin cutoff [Mass/volume] in Urine for Confirmatory method |
| 2052-9 | Carotene [Mass/volume] in Blood |
| 20774-6 | Colony count [Units/volume] in Specimen by Visual count |
| 2084-2 | Cholesterol esters [Mass/volume] in Serum or Plasma |
| 100983-6 | HIV reverse transcriptase failed codons [Identifier] by Genotype method |
| 12584-9 | Creatinine [Mass/volume] in Vitreous fluid |
| 13411-4 | Phosphoserine [Mass/volume] in Amniotic fluid |
| 102003-1 | Reduction in kaolin induced clot strength [Length fraction] in Blood by Thromboelastography ^30 min p max clot amplitude + heparinase |
| 13559-0 | Flecainide [Presence] in Serum or Plasma |
| 13782-8 | Norepinephrine/Creatinine [Mass Ratio] in Urine |
| 10239-2 | Oxygen content in Right ventricular outflow tract |
| 102933-9 | Egg white IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103023-8 | Sugar Beet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14436-0 | Albumin/Globulin [Mass Ratio] in Semen |
| 14605-0 | Blood group antibodies identified in Serum or Plasma from Donor |
| 14668-8 | Coproporphyrin 1 [Moles/volume] in Stool |
| 14669-6 | Coproporphyrin 1 [Moles/volume] in Urine |
| 14677-9 | Cortisol [Moles/volume] in Serum or Plasma --24 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 14697-7 | diazePAM [Moles/volume] in Serum or Plasma |
| 14733-0 | Folate+Cyanocobalamin [Interpretation] in Serum or Blood |
| 10370-5 | Phencyclidine [Mass/mass] in Hair |
| 10441-4 | CD34 Ag [Presence] in Tissue by Immune stain |
| 10524-7 | Microscopic observation [Identifier] in Cervix by Cyto stain |
| 17605-7 | Volume of 24 hour Specimen |
| 18475-4 | Phenylalanine/Creatinine [Molar ratio] in Urine |
| 92496-9 | K Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 60575-8 | HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method |
| 76486-0 | C reactive protein [Moles/volume] in Serum or Plasma by High sensitivity method |
| 93729-2 | Beta-2-Microglobulin/Creatinine [Ratio] in 24 hour Urine |
| 94063-5 | Bacterial rpsL gene drug resistance mutation [Identifier] by Molecular method |
| 6332-1 | Campylobacter sp identified in Specimen by Organism specific culture |
| 78222-7 | MYC gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 95590-6 | Beta cortolone [Z-score] in 24 hour Urine |
| 6832-0 | Oregon Ash IgE Ab [Units/volume] in Serum |
| 68419-1 | Mesothelial cells [#/volume] in Vitreous fluid by Manual count |
| 9667-7 | HIV 1 p51 Ab [Presence] in Serum by Immunoblot |
| 97229-9 | chlordiazePOXIDE [Presence] in Cord tissue by Confirmatory method |
| 70099-7 | Methotrexate [Moles/volume] in Serum or Plasma --2nd specimen |
| 99023-4 | Morganella morganii DNA [Presence] in Urine by NAA with probe detection |
| 72417-9 | Beta hydroxybutyrate [Moles/volume] in Blood --pre-meal |
| 83053-9 | Cells.programmed cell death ligand 1/100 viable tumor cells in Tissue by Immune stain |
| 85765-6 | Staphylococcus aureus DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 73109-1 | traMADol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87427-1 | Neutrophil cytoplasmic Ab panel - Serum by Immunofluorescence |
| 73694-2 | Microscopic observation [Identifier] in Blood by KOH preparation |
| 7383-3 | Hackberry tree IgE Ab [Units/volume] in Serum |
| 88683-8 | Bacteria identified in Bronchoalveolar lavage by Anaerobe culture |
| 88927-9 | Cryptosporidium sp DNA [Presence] in Tissue by NAA with probe detection |
| 41649-5 | Chloride [Moles/volume] in Venous blood |
| 50611-3 | Felbamate [Mass/volume] in Serum or Plasma by Confirmatory method |
| 50749-1 | Protein [Interpretation] in Urine |
| 5095-5 | Coccidioides immitis Ab [Presence] in Serum by Immune diffusion (ID) |
| 41863-2 | Yeast.pseudohyphae [Presence] in Urine sediment by Light microscopy |
| 41872-3 | PDCD10 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 4269-7 | Glucose.PO [Mass] of Dose |
| 59950-6 | PARoxetine [Moles/volume] in Gastric fluid |
| 42750-0 | Phosphatidylethanolamine IgM Ab B2GP1 independent [Multiple of the median] in Serum |
| 42912-6 | Hemoglobin.gastrointestinal [Presence] in Specimen --2nd specimen |
| 4294-5 | Levodopa.PO [Mass] of Dose |
| 22106-9 | Babesia sp Ab [Titer] in Serum |
| 43700-4 | Cytomegalovirus [Presence] in Urine by Shell vial culture |
| 51927-2 | Other cells/100 leukocytes in Bronchial specimen by Manual count |
| 52107-0 | Bacterial capsule [Identifier] in Specimen by Light microscopy |
| 5240-7 | Listeria monocytogenes Ab [Units/volume] in Serum |
| 5250-6 | Mumps virus Ab [Titer] in Serum by Immunofluorescence |
| 53012-1 | Neutrophil Cytoplasmic Ab atypical [Titer] in Serum by Immunofluorescence |
| 230-3 | Enoxacin [Susceptibility] by Disk diffusion (KB) |
| 23055-7 | Ehrlichia risticii Ab [Presence] in Serum by Immunofluorescence |
| 5328-0 | Rotavirus Ab [Units/volume] in Serum |
| 44420-8 | CACNA1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 23228-0 | Mareks disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 33559-6 | Kappa light chains/Lambda light chains [Mass Ratio] in Urine |
| 53607-8 | Haemophilus influenzae B DNA [Presence] in Blood by NAA with probe detection |
| 33773-3 | Karyotype [Identifier] in Amniotic fluid Nominal |
| 33795-6 | Calcium [Moles/volume] in Urine --9th specimen post XXX challenge |
| 54216-7 | Insulin-like growth factor binding protein 1 [Mass/volume] in Serum or Plasma --pre or post XXX challenge |
| 2422-4 | Histidine [Presence] in Urine |
| 47109-4 | Gentamicin [Moles/volume] in Serum or Plasma |
| 55883-3 | Hydroxocobalamin [Mass/volume] in Body fluid |
| 47596-2 | Calcium.ionized [Moles/volume] in Blood by Ion-selective membrane electrode (ISE) |
| 56325-4 | Mugwort IgG4 Ab [Mass/volume] in Serum |
| 56326-2 | Mushroom IgG4 Ab [Mass/volume] in Serum |
| 48022-8 | aPTT.lupus sensitive actual/normal (normalized LA screen) |
| 48076-4 | Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post dose glucagon |
| 48128-3 | Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose arginine+insulin |
| 48205-9 | Beta lactoglobulin triggered leukotriene release [Mass/volume] by Leukocytes |
| 48415-4 | Alpha-1-Microglobulin/Creatinine [Mass Ratio] in Urine |
| 48716-5 | La Crosse virus IgG Ab [Units/volume] in Serum by Immunoassay |
| 48726-4 | JAK2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 57318-8 | Chromosome 13+18+21+X+Y aneuploidy in Blood or Tissue by FISH Nominal |
| 5741-4 | Strychnine [Mass/time] in 24 hour Urine |
| 48941-9 | Benzodiazepines [Mass/volume] in Specimen |
| 27278-1 | Phosphoethanolamine [Moles/volume] in Amniotic fluid |
| 38899-1 | fluPHENAZine [Presence] in Serum or Plasma |
| 39614-3 | Silicone IgE Ab [Units/volume] in Serum by Immunoassay |
| 58018-3 | Oxabolone [Presence] in Urine |
| 2924-9 | Riboflavin [Mass/volume] in Serum or Plasma |
| 58695-8 | Cortisol [Mass/volume] in Saliva (oral fluid) --8th specimen post XXX challenge |
| 58784-0 | Herpes simplex virus 1 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 59236-0 | Prostate Specific Ag Free/Prostate specific Ag.total in Peritoneal fluid |
| 30124-2 | Amylase [Enzymatic activity/time] in 1 hour Urine |
| 19478-7 | Haloperidol [Presence] in Urine by Screen method |
| 12782-9 | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Electrophoresis |
| 12848-8 | Protein [Mass/volume] in Peritoneal dialysis fluid --6th specimen |
| 101132-9 | Glucose post XXX challenge panel - Serum or Plasma |
| 101216-0 | Hantavirus sin nombre IgM Ab [Presence] in Serum or Plasma by Line blot |
| 13192-0 | Adenovirus Ab [Units/volume] in Cerebral spinal fluid |
| 13338-9 | CD8+CD57+ cells/100 cells in Blood |
| 102684-8 | Barley IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102801-8 | Pomegranate IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103065-9 | Brazil Nut recombinant (rBer e) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103628-4 | Monkeypox virus neutralizing antibody [Titer] in Serum by Immunoassay |
| 10395-2 | Factor VIII given [Type] |
| 16136-4 | Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum |
| 11044-5 | Diphosphoglycerate mutase [Enzymatic activity/volume] in Red Blood Cells |
| 11111-2 | Metamyelocytes/100 cells in Bone marrow by Manual count |
| 16828-6 | Erythrocytes [#/volume] in Seminal plasma by Manual count |
| 90067-0 | Enterobacteriaceae identified in Isolate by Organism specific culture |
| 92545-3 | Do sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 75399-6 | HNF4A gene full mutation analysis in Blood or Tissue by Sequencing |
| 75697-3 | Bilirubin fractions panel [Moles/volume] - Serum or Plasma |
| 6038-4 | American Beech IgE Ab [Units/volume] in Serum |
| 60393-6 | Green Pepper IgG Ab [Mass/volume] in Serum |
| 61086-5 | Norfentanyl [Presence] in Gastric fluid |
| 61236-6 | Budgerigar droppings IgE Ab/IgE total in Serum |
| 6179-6 | Mouse epithelium IgE Ab [Units/volume] in Serum |
| 77185-7 | Uranium [Mass/mass] in Dentin |
| 93755-7 | Porcine circovirus type 3 DNA [Presence] in Specimen by NAA with probe detection |
| 94251-6 | Borrelia mayonii oppA2 gene [Presence] in Specimen by NAA with non-probe detection |
| 6256-2 | Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum |
| 77887-8 | OLANZapine cutoff [Mass/volume] in Urine for Confirmatory method |
| 78215-1 | MYC gene rearrangements [Presence] in Blood or Tissue by FISH |
| 78685-5 | Platelet aggregation collagen induced [Units/volume] in Blood |
| 787-2 | MCV [Entitic volume] by Automated count |
| 78848-9 | JWH-210 5-Hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
| 94707-7 | Dementia autoimmune Ab panel - Cerebral spinal fluid |
| 63383-4 | Amphiphysin Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 79595-5 | N,N'-dimethylarginine [Moles/volume] in Serum or Plasma |
| 79642-5 | Beta alanine and Beta aminoisobutyrate and Gamma aminobutyrate pattern [Interpretation] in Cerebral spinal fluid Narrative |
| 95916-3 | Blastomyces sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 96321-5 | Haemophilus influenzae DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection |
| 96684-6 | Activated clotting time.kaolin induced of Blood by Microviscometry |
| 97167-1 | Thyroxine (T4) [Moles/time] in 24 hour Urine |
| 69483-6 | F9 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 70084-9 | Interleukin 5 [Mass/volume] in Cerebral spinal fluid |
| 97283-6 | Nordiazepam [Presence] in Cord tissue by Confirmatory method |
| 7071-4 | Almond triggered histamine release [Units/volume] in Blood |
| 70859-4 | Rabies virus neutralizing antibody [Presence] in Cerebral spinal fluid by Neutralization test |
| 7230-6 | Cladosporium herbarum IgG Ab [Units/volume] in Serum |
| 85375-4 | Neutrophil.PMA stimulated.DHR mean fluorescence instensity in Control Blood by Flow cytometry (FC) |
| 99375-8 | Hazelnut Pollen IgG Ab [Mass/volume] in Serum |
| 99393-1 | Siderocytes panel - Blood or Marrow by Prussian blue stain |
| 72904-6 | Formate [Moles/volume] in Blood |
| 86108-8 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum by Immunoassay |
| 88016-1 | Glutarylcarnitine (C5-DC)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 88439-5 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --10M post dose fructose PO |
| 89359-4 | Hepatitis C virus IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 50789-7 | Cytokeratin cells [#/volume] in Blood |
| 42316-0 | RHD gene allele [Genotype] in Amniotic fluid by Molecular genetics method Nominal |
| 60269-8 | Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection |
| 31245-4 | Babesia microti IgM Ab [Units/volume] in Serum |
| 42972-0 | Powassan virus IgM Ab [Titer] in Serum |
| 4300-0 | Lithium [Mass] of Dose |
| 31891-5 | Mumps virus Ag [Presence] in Vaginal fluid |
| 51686-4 | Pregnenolone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 51822-5 | Adenovirus IgG Ab [Units/volume] in Serum by Immunoassay |
| 43348-2 | Avian paramyxovirus 9 Ab [Titer] in Serum |
| 22471-7 | Rickettsia (Proteus OX2) Ab [Titer] in Serum |
| 32122-4 | Choriogonadotropin.beta subunit free [Multiple of the median] in Serum or Plasma |
| 53036-0 | Filler DNA analysis test identifier [Identifier] |
| 43939-8 | Alkaline phosphatase.liver [Presence] in Serum or Plasma |
| 44241-8 | Clue cells [#/area] in Vaginal fluid by Microscopy low power field |
| 44285-5 | 3-Methylcrotonylglycine/Creatinine [Mass Ratio] in 24 hour Urine |
| 22949-2 | Brucella sp Ag [Presence] in Placenta by Immune stain |
| 22963-3 | Campylobacter fetus Ab [Presence] in Genital mucus by Agglutination |
| 53167-3 | Butyrylcarnitine+Isobutyrylcarnitine (C4)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 5326-4 | Bartonella henselae IgG Ab [Units/volume] in Serum |
| 53419-8 | Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --1st specimen post XXX challenge |
| 44419-0 | CIAS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 33251-0 | Monocytes [#/volume] in Body fluid by Manual count |
| 33460-7 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Presence] in Serum |
| 33461-5 | Candida albicans Ab [Presence] in Cerebral spinal fluid |
| 53736-5 | Benzodiazepines.other [Mass/volume] in Urine |
| 45339-9 | Tick # 4 identified in Specimen |
| 23714-9 | Fat [Mass/volume] in Milk |
| 23858-4 | Epstein Barr virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 34062-0 | Somatotropin [Mass/volume] in Serum or Plasma --pre or post dose cloNIDine |
| 34251-9 | Borrelia garinii IgG Ab [Presence] in Serum by Immunoblot |
| 54446-0 | Fatty acids.very long chain C26:1 (Hexacosenoate) [Mass/volume] in Serum or Plasma |
| 54457-7 | Biotinidase [Enzymatic activity/volume] in Serum or Plasma from Normal control |
| 46095-6 | Anabolic steroids [Moles/volume] in Serum or Plasma |
| 46409-9 | Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post dose arginine |
| 24277-6 | Legionella pneumophila Ab [Titer] in Serum --1st specimen |
| 47704-2 | Methionine/Amino acids.total in Serum or Plasma |
| 47744-8 | Serine/Amino acids.total in Cerebral spinal fluid |
| 3547-7 | Diamorphine [Mass/volume] in Urine |
| 5615-0 | Cesium [Mass/mass] in Hair |
| 56236-3 | Cranberry IgG4 Ab [Mass/volume] in Serum |
| 56392-4 | Spiny Pigweed IgG4 Ab [Mass/volume] in Serum |
| 48161-4 | PROS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 38194-7 | Antidepressants [Identifier] in Gastric fluid |
| 56721-4 | PM-SCL extractable nuclear Ab [Presence] in Serum by Immunoblot |
| 57090-3 | HLA-DQA1*05:01 [Presence] |
| 48619-1 | Apolipoprotein E1 [Presence] in Blood |
| 26839-1 | Oxazepam [Mass/mass] in Hair |
| 4931-2 | HLA-DPw6 [Presence] |
| 29263-1 | Fibrin degradation products [Presence] in Blood by Agglutination |
| 58395-5 | oxyCODONE/Creatinine [Mass Ratio] in Urine |
| 4985-8 | HLA-DR5 [Presence] |
| 29803-4 | La Crosse virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 40495-4 | Yersinia pseudotuberculosis 3 Ab [Titer] in Serum |
| 40522-5 | Plasma cells/100 leukocytes in Pleural fluid by Manual count |
| 30016-0 | Borrelia burgdorferi 66kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
| 19185-8 | Tissue polypeptide specific Ag [Units/volume] in Pleural fluid |
| 19365-6 | Bromazepam [Presence] in Urine by Confirmatory method |
| 19571-9 | Methylenedioxymethamphetamine cutoff [Mass/volume] in Urine for Screen method |
| 19732-7 | Cat serum albumin IgE Ab [Units/volume] in Serum |
| 20404-0 | Fibronectin.fetal [Presence] in Vaginal fluid |
| 20555-9 | Phenmetrazine [Mass/volume] in Urine by Confirmatory method |
| 2059-4 | Cerebroside sulfatase [Presence] in Serum or Plasma |
| 20610-2 | CD45 (Lymphs) cells/100 cells in Specimen |
| 20968-4 | Staphylococcus sp identified in Cheese by Organism specific culture |
| 100434-0 | Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection |
| 100683-2 | Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 12575-7 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --baseline |
| 101645-0 | CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
| 101731-8 | JC virus DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 13897-4 | Thyrotropin.beta subunit [Mass/volume] in Serum or Plasma |
| 102566-7 | Rat urine proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1403-5 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
| 102836-4 | Turkey IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14391-7 | Amylase [Enzymatic activity/volume] in Gastric fluid |
| 103790-2 | Renal calculus risk assessment [Likelihood] in 24 hour Urine Narrative |
| 10446-3 | Leukocyte common Ag [Presence] in Tissue by Immune stain |
| 10469-5 | Carcinoembryonic Ag [Presence] in Tissue by Immune stain |
| 10495-0 | Insulin Ag [Presence] in Tissue by Immune stain |
| 15260-3 | Tree Allergen Mix 10 (Grey alder+Silver birch+Hazelnut+White ash) IgE Ab [Presence] in Serum by Multidisk |
| 15341-1 | Black Fly IgE Ab [Units/volume] in Serum |
| 10712-8 | Pneumocystis sp identified in Lung tissue |
| 10784-7 | Microscopic observation [Identifier] in Tissue by Esterase stain.non-specific |
| 1662-6 | 11-Ketoetiocholanolone [Mass/volume] in Serum |
| 12244-0 | Polymorphonuclear cells/100 leukocytes in Cerebral spinal fluid by Manual count |
| 17354-2 | Neutrophil cytoplasmic IgA Ab [Presence] in Serum |
| 18245-1 | Nickel [Mass/volume] in Specimen |
| 19127-0 | Bacteria identified in Sputum by Acute Respiratoy Distress (ARDS) culture |
| 75009-1 | CEBPA gene full mutation analysis in Blood or Tissue by Sequencing |
| 75021-6 | OLANZapine panel - Serum or Plasma |
| 91681-7 | F9 gene mutation analysis limited to known familial mutations in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
| 92689-9 | Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection |
| 75550-4 | Fetal Trisomy 13 prior risk [Likelihood] Based on maternal age Narrative |
| 75635-3 | Rheumatoid arthritis disease activity panel - Serum or Plasma by VectraDA |
| 60422-3 | Measles virus genotype [Identifier] in Specimen by NAA with probe detection |
| 76032-2 | SGSH gene full mutation analysis in Blood or Tissue by Sequencing |
| 7688-5 | Sardine IgG Ab [Units/volume] in Serum |
| 77014-9 | Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Sequencing Qualitative |
| 92966-1 | Moraxella catarrhalis DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection |
| 61313-3 | Sesame Seed IgE Ab/IgE total in Serum |
| 78850-5 | JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
| 63464-2 | Treponema pallidum Ab [Units/volume] in Serum by Immunoassay |
| 79344-8 | Pyridoxal phosphate and pyridoxal and pyridoxine pattern [Interpretation] in Serum or Plasma Narrative |
| 79464-4 | Phosphorylase [Enzymatic activity/mass] in Red Blood Cells |
| 6845-2 | Latex glove extract ammoniated IgE Ab [Units/volume] in Serum |
| 68458-9 | Trichomonas sp identified in Specimen by Organism specific culture |
| 80586-1 | Adenovirus hexon gene [Presence] in Nasopharynx by NAA with probe detection |
| 96819-8 | Roxithromycin IgE Ab [Units/volume] in Serum |
| 97153-1 | Primidone [Presence] in Urine by Confirmatory method |
| 6998-9 | cefTRIAXone [Susceptibility] by Gradient strip |
| 9736-0 | Allopurinol [Mass/volume] in Serum or Plasma |
| 82613-1 | Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum |
| 99012-7 | Urinary tract pathogens panel - Urine by NAA with probe detection |
| 7207-4 | Cottage Cheese IgG Ab [Units/volume] in Serum |
| 72271-0 | Creatinine [Mass/volume] in Serum or Plasma --pre contrast |
| 85527-0 | Mycoplasma hyopneumoniae P146 gene sequence and phylogenetic analysis in Specimen Document |
| 72577-0 | Protein.monoclonal/Protein.total [Pure mass fraction] in 24 hour Urine by Electrophoresis |
| 73275-0 | Metoclopramide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73354-3 | hydrALAZINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73378-2 | Finasteride induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87406-5 | Golimumab [Mass/volume] in Serum or Plasma by Immunoassay |
| 87544-3 | Beta-N-acetylhexosaminidase.A and beta-N-acetylhexosaminidase panel [Enzymatic activity/mass] - Leukocytes |
| 73602-5 | Ceftolozane+Tazobactam [Susceptibility] |
| 73861-7 | Allo-tetrahydrocorticosterone [Moles/time] in 24 hour Urine |
| 88051-8 | P2 phenotype [Presence] on Red Blood Cells from Donor |
| 7388-2 | Ham triggered histamine release [Units/volume] in Blood |
| 88842-0 | Microbiology CNAMTS panel - Cerebral spinal fluid |
| 59954-8 | Perphenazine [Moles/volume] in Urine |
| 60119-5 | Palladium [Mass/volume] in Serum or Plasma |
| 21287-8 | Gastrin [Mass/volume] in Serum or Plasma --1 hour post 0.2 U/kg secretin |
| 21562-4 | Thiocyanate/Creatinine [Mass Ratio] in Urine |
| 51363-0 | CD64 cells/100 cells in Tissue |
| 51424-0 | Cortisol [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
| 42894-6 | Clindamycin IgE Ab [Units/volume] in Serum |
| 43011-6 | HIV 1 p24 Ab [Presence] in Serum |
| 43134-6 | Calcidiol and Calciferol and Calcitriol panel [Mass/volume] - Serum or Plasma |
| 31707-3 | Yersinia enterocolitica O:5 Ab [Units/volume] in Specimen |
| 51626-0 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --with 1:4 normal plasma 1H post incubation separate tubes |
| 51693-0 | Albumin [Mass/volume] in Pericardial fluid |
| 43337-5 | Goose parvovirus RNA [Presence] in Specimen by NAA with probe detection |
| 32528-2 | CD3 cells [#/volume] in Bone marrow |
| 52773-9 | Clotting time.extrinsic coagulation system activated of Blood by Rotational TEG |
| 43906-7 | Anserine [Presence] in Urine |
| 43971-1 | CD3+CD8+ (T8 suppressor) cells/100 cells in Cerebral spinal fluid |
| 44269-9 | Bacillus anthracis cell wall Ag [Presence] in Specimen by Immunofluorescence |
| 22815-5 | Avian infectious laryngotracheitis virus Ab [Titer] in Serum |
| 23193-6 | Leptospira borgpetersenii sv Sejroe Ab [Presence] in Serum |
| 32804-7 | Neutrophils/100 leukocytes in Bronchial specimen by Manual count |
| 33017-5 | Parasites [#/area] in Urine sediment by Microscopy low power field |
| 44-8 | Aztreonam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 33718-8 | Cytology report of Tissue fine needle aspirate Cyto stain |
| 53523-7 | Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma |
| 53742-3 | Legionella pneumophila 2+3+4+5+6+8 Ab [Presence] in Serum |
| 45324-1 | Ethyl glucuronide [Mass/volume] in Urine |
| 4536-9 | Deoxyhemoglobin/Hemoglobin.total in Blood |
| 23801-4 | Food Allergen Mix 5 (Peanut+Cow milk+Egg white+Cod+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk |
| 33789-9 | Calcium [Moles/volume] in Urine --10th specimen post XXX challenge |
| 4643-3 | Hemosiderin [Mass/volume] in Serum |
| 24226-3 | Coxsackievirus A10 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24439-2 | Isobutyrylglycine/Creatinine [Molar ratio] in Urine |
| 55515-1 | Somatotropin [Mass/volume] in Serum or Plasma --2.5 hours post dose glucagon |
| 25233-8 | Azithromycin [Mass/volume] in Specimen |
| 25312-0 | Amylase.pancreatic/Amylase.total in Serum or Plasma |
| 34716-1 | Coxiella burnetii phase 1 IgG Ab [Titer] in Serum by Immunofluorescence |
| 3472-8 | chlorproMAZINE [Presence] in Urine |
| 35104-9 | Acyclovir [Mass/volume] in Serum or Plasma --peak |
| 35311-0 | Trypsin [Enzymatic activity/volume] in Body fluid --2nd specimen post Sincalide |
| 55957-5 | Oleoylcarnitine (C18:1) [Moles/volume] in Amniotic fluid |
| 47672-1 | Isoleucine/Amino acids.total in Hair |
| 35455-5 | X chromosome inactivation [Identifier] in Blood or Tissue Narrative |
| 35774-9 | cefTAZidime+Clavulanate [Susceptibility] by Disk diffusion (KB) |
| 56427-8 | Eastern White Pine IgG4 Ab [Mass/volume] in Serum |
| 48303-2 | Brilliant black BN triggered leukotriene release [Mass/volume] by Leukocytes |
| 56729-7 | Cladosporium cladosporioides IgE Ab [Units/volume] in Serum |
| 38537-7 | ARX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 38545-0 | Methylmercury [Mass/mass] in Tissue |
| 48919-5 | Respiratory allergen panel, US - Central Florida - Serum |
| 49077-1 | Influenza virus B IgG Ab [Mass/volume] in Cerebral spinal fluid |
| 49225-6 | Heptacarboxylate/Creatinine [Molar ratio] in 24 hour Urine |
| 2748-2 | pH of Body fluid |
| 57687-6 | Cortisol [Mass/volume] in Saliva (oral fluid) --1st specimen |
| 579-3 | Fungus identified in Wound by Culture |
| 580-1 | Fungus identified in Specimen by Culture |
| 49325-4 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 28555-1 | Nicotine+Cotinine [Presence] in Urine by Confirmatory method |
| 58736-0 | Manganese panel - Urine |
| 49797-4 | t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method |
| 50163-5 | Acylcarnitine [Moles/volume] in Cerebral spinal fluid |
| 2987-6 | Testosterone [Presence] in Urine |
| 59061-2 | Adulterants [Interpretation] in Urine |
| 50381-3 | Creatinine renal clearance/1.73 sq M.predicted among males by Cockcroft-Gault formula, BSA formula |
| 30150-7 | Streptolysin O Ab [Units/volume] in Serum --2nd specimen |
| 30218-2 | Coxsackievirus A7 Ab [Presence] in Serum |
| 30356-0 | Palmitoylcarnitine (C16) [Moles/volume] in Serum or Plasma |
| 41112-4 | CMT axonal gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19554-5 | Methamphetamine [Presence] in Urine by Screen method |
| 20530-2 | Haloperidol [Mass/volume] in Urine by Confirmatory method |
| 20664-9 | Barbiturates [Mass/volume] in Urine by Screen method |
| 100905-9 | Gram positive bacteria identified in Isolate by Organism specific culture |
| 101078-4 | Dw Ab [Presence] in Serum or Plasma |
| 13217-5 | Chlamydia trachomatis B Ab [Units/volume] in Serum |
| 1349-0 | Yt sup(b) Ab [Presence] in Serum or Plasma from Donor |
| 13940-2 | Dimethylbenzene [Mass/volume] in Blood |
| 14092-1 | HIV 1 Ab [Presence] in Serum by Immunofluorescence |
| 1456-3 | Creatinine [Mass/volume] in 24 hour Urine --72 hours post 40 ug corticotropin IM BID 3 day |
| 15111-8 | Tricyclic antidepressants [Moles/volume] in Serum or Plasma |
| 1517-2 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 50 g lactose PO |
| 11075-9 | Norfentanyl [Mass/volume] in Urine |
| 1635-2 | Somatotropin [Mass/volume] in Serum or Plasma --pre 1 g/kg glucose PO |
| 16395-6 | Antipsychotics [Identifier] in Urine |
| 17333-6 | Neisseria meningitidis serogroup w135 Ag [Presence] in Serum or Plasma by Latex agglutination |
| 18424-2 | Phthalic anhydride IgM Ab [Units/volume] in Serum |
| 92251-8 | Microorganism gene detected [Presence] by Molecular method |
| 75099-2 | Laurate (C12:0) [Entitic substance] in Red Blood Cells |
| 61096-4 | Barbiturates [Presence] in Gastric fluid by Screen method |
| 6133-3 | Green Nimitti IgE Ab [Units/volume] in Serum |
| 61382-8 | Human papilloma virus 52 DNA [Presence] in Specimen by NAA with probe detection |
| 6203-4 | Parsley IgE Ab [Units/volume] in Serum |
| 7713-1 | Squash IgE Ab [Units/volume] in Serum |
| 77348-1 | Tacrolimus [Mass/volume] in Blood --trough |
| 93763-1 | Influenza virus A NS1 gene [Nucleotide sequence] in Isolate by Sequencing |
| 93810-0 | SS18 gene rearrangements in Tissue by FISH |
| 62857-8 | Micromegakaryocytes [#/volume] in Blood by Manual count |
| 63109-3 | Cashew nut IgG Ab [Mass/volume] in Serum |
| 63453-5 | Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay |
| 95573-2 | Pregnanediol [Z-score] in 24 hour Urine |
| 651-0 | Microscopic observation [Identifier] in Urine by Acid fast stain.Kinyoun modified |
| 6544-1 | Rickettsia sp identified in Genital specimen by Organism specific culture |
| 6811-4 | Dengue virus IgG Ab [Titer] in Serum |
| 68373-0 | Nuclear Ab [Titer] in Pericardial fluid by Immunofluorescence |
| 81172-9 | Esophagus [Length] in Specimen |
| 96516-0 | Toscana virus IgG Ab [Presence] in Specimen by Immunoassay |
| 96622-6 | HLA-C unresolved alleles [Type] in Donor by High resolution |
| 96920-4 | Nucleolar nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 69959-5 | Tree Allergen Mix 5 (Grey alder+Hazelnut+White elm+Willow+Cottonwood) IgE Ab [Units/volume] in Serum by Multidisk |
| 81823-7 | SACS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 818-5 | A Ag [Presence] on Red Blood Cells from Blood product unit |
| 82031-6 | Tree Allergen Mix 2 (Boxelder+White oak+White elm+Cottonwood+Pecan/Hickory) IgE Ab [Units/volume] in Serum by Multidisk |
| 9792-3 | Organophosphate pesticides [Identifier] in Blood |
| 82510-9 | Mycobacterium bovis tuberculin stimulated gamma interferon [Interpretation] in Blood Qualitative |
| 82516-6 | LAMC2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 98990-5 | Methotrexate [Moles/volume] in Serum or Plasma --18 hour post dose |
| 71663-9 | Plasma cells/Leukocytes [Pure number fraction] in Blood |
| 99127-3 | BIRC3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 72925-1 | Bilirubin.total [Moles/volume] in Amniotic fluid |
| 86018-9 | Streptococcus pneumoniae Danish serotype 18F Ab [Units/volume] in Serum --1st specimen |
| 86536-0 | Hantavirus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 73155-4 | Sertraline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87554-2 | Epstein Barr virus Ab panel - Serum |
| 73987-0 | 2,2',3,4,4',5-Hexachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
| 41215-5 | Yeast [#/area] in Urine sediment by Microscopy low power field |
| 41250-2 | Xylose [Mass/volume] in Urine --baseline |
| 30542-5 | Oleoylcarnitine (C18:1) [Moles/volume] in Serum or Plasma |
| 3096-5 | Urea nitrogen [Mass/time] in 24 hour Urine |
| 2113-9 | Choriogonadotropin.beta subunit [Mass/time] in 24 hour Urine |
| 21588-9 | Urobilinogen [Mass/mass] in Stool |
| 22128-3 | Borrelia burgdorferi IgG Ab [Presence] in Serum |
| 22162-2 | Candida albicans Ab [Presence] in Serum |
| 31846-9 | Herpes simplex virus 1 Ag [Presence] in Genital specimen |
| 51920-7 | Legionella sp Ab [Titer] in Serum --2nd specimen |
| 43702-0 | Cytomegalovirus [Presence] in Cerebral spinal fluid by Shell vial culture |
| 3231-8 | Coagulation factor XII activated [Units/volume] in Platelet poor plasma by Coagulation assay |
| 3253-2 | Fibrin.soluble [Units/volume] in Platelet poor plasma by Chromogenic method |
| 43869-7 | Antithrombin Ag [Presence] in Platelet poor plasma by Immunoassay |
| 32689-2 | Herpes simplex virus identified in Eye by Organism specific culture |
| 53087-3 | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Nonbiological fluid |
| 44771-4 | Varicella zoster virus Ab [Titer] in Serum by Immunofluorescence |
| 3326-6 | Aminocaproate [Mass/volume] in Serum or Plasma --trough |
| 53571-6 | Yeast identified in Genital specimen by Organism specific culture |
| 45023-9 | HLA typing for celiac disease panel - Blood or Tissue |
| 24239-6 | Chlamydia sp IgG Ab [Units/volume] in Serum --2nd specimen |
| 34638-7 | Clarithromycin [Mass/volume] in Cerebral spinal fluid |
| 54473-4 | Pimeloylcarnitine (C7-DC) [Moles/volume] in Cerebral spinal fluid |
| 55303-2 | Fungus [Presence] in Skin by KOH preparation |
| 55492-3 | Insulin [Moles/volume] in Serum or Plasma --30 minutes post dose glucose IV |
| 3481-9 | Cimetidine [Presence] in Serum or Plasma |
| 35275-7 | Measles virus IgG Ab [Presence] in Serum by Immunoassay |
| 35347-4 | Microscopic observation [Identifier] in Specimen by Immunofluorescence |
| 5632-5 | Copper [Mass/volume] in Urine |
| 48019-4 | DNA change type |
| 48304-0 | Glutamate triggered leukotriene release [Mass/volume] by Leukocytes |
| 3654-1 | Flurazepam [Presence] in Urine |
| 3780-4 | Methamphetamine [Mass/volume] in Urine |
| 38165-7 | Uroporphyrin/Creatinine [Mass Ratio] in 24 hour Urine |
| 26865-6 | Codeine [Mass/mass] in Meconium |
| 27122-1 | Magnesium [Mass/mass] in Red Blood Cells |
| 38395-0 | Parainfluenza virus 1 Ag [Presence] in Nasopharynx by Immunofluorescence |
| 384-8 | Oxacillin [Susceptibility] by Disk diffusion (KB) |
| 49196-9 | Brucella abortus Ab [Presence] in Cerebral spinal fluid |
| 27275-7 | diazePAM [Mass/mass] in Stool |
| 28070-1 | Vegetable fibers [#/area] in Stool by Light microscopy |
| 39478-3 | Glucose [Moles/volume] in Vitreous fluid |
| 49394-0 | Herpes virus 7 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
| 58390-6 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP)/Creatinine [Mass Ratio] in Urine |
| 58614-9 | Corticotropin [Moles/volume] in Plasma --7th specimen post XXX challenge |
| 49758-6 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 5 iU/mL |
| 49776-8 | Hepatitis E virus Ab [Units/volume] in Serum by Immunoassay |
| 40497-0 | Yersinia pseudotuberculosis 1 Ab [Titer] in Serum |
| 58896-2 | C peptide [Mass/volume] in Serum or Plasma --post XXX challenge |
| 50184-1 | Calcitonin [Mass/volume] in Serum or Plasma --pre 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV |
| 50389-6 | Microscopic observation [Identifier] in Bronchial brush by Cyto stain.thin prep |
| 19653-5 | Para hydroxyamphetamine cutoff [Mass/volume] in Urine for Screen method |
| 20819-9 | Escherichia coli K99 [Presence] in Isolate by Agglutination |
| 20899-1 | Mycoplasma sp [Presence] in Exudate by Organism specific culture |
| 20911-4 | Organochlorine pesticides [Identifier] in Tissue |
| 12358-8 | Barbiturates [Presence] in Stool |
| 101086-7 | Ge2 Ab [Presence] in Serum or Plasma |
| 1250-0 | Major crossmatch [Interpretation] |
| 101738-3 | Platelet aggregation ristocetin induced in Platelet rich plasma --250 ug/mL |
| 13613-5 | Ethanolamine [Mass/volume] in Cerebral spinal fluid |
| 13841-2 | CD2 blasts/100 blasts in Blood |
| 102483-5 | Ovomucoid IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102729-1 | Cucumber IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1513-1 | Glucose [Mass/volume] in Serum or Plasma --20 minutes post 0.5 g/kg glucose IV |
| 15180-3 | Hypochromia [Presence] in Blood by Automated count |
| 10444-8 | CD57 Ag [Presence] in Tissue by Immune stain |
| 10522-1 | Coagulation factor XIII Ag [Presence] in Tissue by Immune stain |
| 1072-8 | Jk sup(a) Ag [Presence] on Red Blood Cells |
| 11135-1 | Appearance of Spun Cerebral spinal fluid |
| 12269-7 | Urobilinogen [Presence] in 24 hour Urine |
| 17064-7 | Legionella pneumophila 3 Ab [Titer] in Serum |
| 17536-4 | Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
| 92711-1 | Lipoprotein.alpha.subparticle.small [Moles/volume] in Serum |
| 7516-8 | Mushroom triggered histamine release [Units/volume] in Blood |
| 60352-2 | Banana IgG Ab [Mass/volume] in Serum |
| 77104-8 | HARS2 gene full mutation analysis in Blood or Tissue by Sequencing |
| 77654-2 | Diploid cells in G2 phase/100 cells in Cells.XXX by Flow cytometry (FC) |
| 63180-4 | Tobacco IgG Ab [Mass/volume] in Serum |
| 78519-6 | Platelet aggregation ADP induced in Platelet rich plasma --2 umol/L |
| 78760-6 | 6-Monoacetylmorphine (6-MAM) [Presence] in Body fluid by Screen method |
| 9444-1 | House dust Hausstaub IgE Ab [Units/volume] in Serum |
| 94816-6 | Voltage-gated potassium channel Ab [Moles/volume] in Serum by Immunoassay |
| 94842-2 | Sodium [Moles/volume] in Urine from Fetus |
| 7911-1 | Herpes simplex virus 2 Ab [Units/volume] in Serum |
| 7931-9 | Influenza virus B Ab [Units/volume] in Serum |
| 95078-2 | Glucose [Mass/volume] in Serum or Plasma --15 min post meal |
| 95135-0 | Noroxycodone [Mass/volume] in Urine |
| 66883-0 | Skin IgG Ab [Titer] in Serum by Monkey esophagus substrate |
| 8097-8 | Striated muscle Ab [Titer] in Serum |
| 96691-1 | Coagulation viscoelastic tracing in Blood Document |
| 96962-6 | Bordetella pertussis.pertussis toxin promoter region [Presence] in Lower respiratory specimen by NAA with probe detection |
| 69582-5 | PFGE restriction enzyme [Identifier] in Isolate |
| 69832-4 | 3-Hydroxy,3-Methylglutarate [Moles/volume] in Cerebral spinal fluid |
| 81858-3 | GJB1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 70851-1 | Burkholderia pseudomallei [Presence] in Specimen by Organism specific culture |
| 71363-6 | Alkaline phosphatase.placental 2/Alkaline phosphatase.total in Serum or Plasma |
| 8254-5 | Service comment 12 |
| 82586-9 | Nucleated cells [#] in Bone marrow by Automated count |
| 82659-4 | Thyrotropin receptor Ab [Presence] in Serum |
| 98996-2 | Transferrin [Mass/volume] in Serum or Plasma by Electrophoresis |
| 99016-8 | Enterobacter cloacae complex DNA [Presence] in Urine by NAA with probe detection |
| 7170-4 | Cabbage IgG Ab [Units/volume] in Serum |
| 72328-8 | HLA-A+B+C (class I) IgG Ab [Presence] in Serum by Flow cytometry (FC) |
| 99763-5 | Clot formation.kaolin induced [Time] in Blood by Resonance TEG |
| 72785-9 | PARoxetine/Creatinine [Mass Ratio] in Urine |
| 72864-2 | Mycobacterium tuberculosis rpsL+rrs genes aminoglycoside resistance mutation [Presence] by Molecular method |
| 86582-4 | Parechovirus A RNA [Presence] in Blood by NAA with probe detection |
| 73226-3 | Oxaliplatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87485-9 | ADBICA N-pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 87622-7 | Zika virus IgM Ab [Presence] in Specimen by Immunoassay |
| 73534-0 | Amiodarone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 737-7 | Lymphocytes/100 leukocytes in Blood by Manual count |
| 88210-0 | Parainfluenza virus 3 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 74032-4 | Arbovirus IgM panel - Serum |
| 74312-0 | PRRSV [Presence] in Specimen by Organism specific culture |
| 74322-9 | MICA*043 IgG Ab [Presence] in Serum |
| 88609-3 | Human coronavirus 229E RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 88685-3 | Microscopic observation [Identifier] in Lower respiratory specimen by KOH preparation |
| 89000-4 | Ethyl glucuronide [Mass/mass] in Hair by Confirmatory method |
| 3062-7 | Trypsin [Enzymatic activity/time] in 24 hour Stool |
| 31097-9 | Amikacin [Mass/volume] in Serum or Plasma --peak post extended interval dosing |
| 42492-9 | Carboxy tetrahydrocannabinol [Presence] in Blood |
| 4259-8 | Fluorouracil [Mass] of Dose |
| 6022-8 | Ascaris sp IgE Ab [Units/volume] in Serum |
| 60272-2 | Rickettsia typhus group DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 51184-0 | CD117 Ag [Presence] in Blood by Immune stain |
| 51197-2 | Iron [Mass/volume] in Body fluid |
| 42877-1 | CD3-CD16+ cells [#/volume] in Body fluid |
| 42963-9 | Salmonella paratyphi C H Ab [Titer] in Serum |
| 43007-4 | HTLV I+II Ab [Titer] in Serum |
| 31824-6 | Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid |
| 51601-3 | Methotrexate [Moles/volume] in Serum or Plasma --4 hours post dose |
| 51891-0 | Transfuse factor IX units [#] |
| 43432-4 | Escherichia coli K1 Ag [Presence] in Urine |
| 22315-6 | Hepatitis A virus IgM Ab [Units/volume] in Serum |
| 22524-3 | Salmonella paratyphi C H Ab [Presence] in Serum |
| 22755-3 | Haemophilus influenzae B Ab [Mass/volume] in Serum |
| 32209-9 | Protein [Presence] in 24 hour Urine by Test strip |
| 22853-6 | Babesia caballi rRNA [Presence] in Blood by Probe |
| 33229-6 | RBC casts [#/area] in Urine by Computer assisted method |
| 44528-8 | Histoplasma capsulatum M Ab [Presence] in Serum |
| 33680-0 | Francisella tularensis DNA [Presence] in Isolate by NAA with probe detection |
| 45211-0 | Hexanoylcarnitine (C6) [Moles/volume] in DBS |
| 2369-7 | Glutamate dehydrogenase.NADP [Enzymatic activity/volume] in Serum or Plasma |
| 3398-5 | Cocaine [Mass/volume] in Urine |
| 54226-6 | Lymphoma panel - Specimen by Flow cytometry (FC) |
| 46415-6 | Lutropin [Units/volume] in Serum or Plasma --45 minutes post dose gonadotropin releasing hormone |
| 3445-4 | Cefoperazone [Mass/volume] in Serum or Plasma |
| 55237-2 | HBA2 gene c.427T>C [Presence] in Blood by Molecular genetics method |
| 55554-0 | Mirtazapine [Moles/volume] in Serum or Plasma |
| 25423-5 | Trichinella spiralis IgG Ab [Units/volume] in Serum by Immunoassay |
| 34998-5 | Prolymphocytes [#/volume] in Body fluid |
| 25709-7 | Leptospira interrogans sv Canicola Ab [Titer] in Serum by Complement fixation |
| 48005-3 | Amino acid change (pHGVS) |
| 2651-8 | NADH dehydrogenase [Enzymatic activity/volume] in Plasma |
| 26793-0 | Methylenedioxymethamphetamine [Mass/mass] in Stool |
| 56687-7 | Pancreatic islet cell IgG Ab [Titer] in Serum by Immunofluorescence |
| 38399-2 | Crystals [type] in Peritoneal fluid by Light microscopy |
| 2802-7 | Phosphoserine [Mass/volume] in Urine |
| 57890-6 | Pregnanediol [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
| 40026-7 | Glucose [Mass/volume] in Serum or Plasma --6 minutes post XXX challenge |
| 5866-9 | Influenza virus B Ag [Presence] in Specimen by Immunoassay |
| 49780-0 | Leishmania sp DNA [Presence] in Blood by NAA with probe detection |
| 49795-8 | t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 29735-8 | Leptospira interrogans sv Medanensis Ab [Presence] in Serum by Agglutination |
| 50320-1 | Helicobacter pylori Ag [Presence] in Tissue by Immune stain |
| 50551-1 | Bilirubin.total [Presence] in Urine by Automated test strip |
| 19370-6 | Butabarbital [Mass/volume] in Urine |
| 100664-2 | NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method |
| 12577-3 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --2nd specimen |
| 13708-3 | Arginine/Creatinine [Mass Ratio] in Urine |
| 102611-1 | Acarus siro IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103086-5 | Bermuda grass native (nCyn d) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14724-9 | Ferritin [Interpretation] in Blood |
| 14750-4 | Glucose [Moles/volume] in Synovial fluid |
| 14765-2 | Glucose [Moles/volume] in Serum or Plasma --3 hours post dose glucose |
| 103735-7 | Erythrocytosis multigene analysis in Specimen by Sequencing |
| 16373-3 | Amyl ether [Presence] in Blood |
| 17505-9 | Psilocybin/Psilocin [Mass Ratio] in Serum or Plasma |
| 18186-7 | Calcium [Mass/time] in 12 hour Urine |
| 74492-0 | PAX5 and CD43 Ag [Identifier] in Tissue by Immune stain |
| 74613-1 | Fatty acids.very long chain C24:0 (Tetracosanoate) [Mass/mass] in Fibroblast |
| 75050-5 | Coenzyme Q10 [Moles/volume] in Serum or Plasma |
| 93371-3 | von Willebrand factor (vWf) cleaving protease activity [Enzymatic activity/volume] in Platelet poor plasma by Chromogenic method |
| 93438-0 | Herpes simplex virus 2 DNA [Presence] in Blood by NAA with non-probe detection |
| 7748-7 | Tryptase IgE Ab [Units/volume] in Serum |
| 9421-9 | Entamoeba histolytica Ab [Units/volume] in Serum by Immune diffusion (ID) |
| 95683-9 | Highlands J virus IgM Ab [Presence] in Specimen by Immunoassay |
| 6513-6 | Human papilloma virus Ab [Presence] in Tissue by Immunoblot |
| 96449-4 | Cell growth [Presence] of Tumor in Tissue culture |
| 6792-6 | Potassium [Moles/time] in 24 hour Stool |
| 6851-0 | Penicillin G IgE Ab [Units/volume] in Serum |
| 6856-9 | Spinach IgE Ab [Units/volume] in Serum |
| 81420-2 | KRAS and NRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 96658-0 | HLA-DQB1 [Type] in Donor by Low resolution |
| 96674-7 | HLA-DRB3 and HLA-DRB4 and HLA DRB5 unresolved alleles [Type] in Donor by High resolution |
| 81821-1 | RMRP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 82050-6 | Food Allergen Mix 1 (Peanut+Brazil nut+Coconut+Hazelnut+Almond) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 97260-4 | LORazepam [Presence] in Cord tissue by Screen method |
| 82374-0 | Norbuprenorphine [Presence] in Serum or Plasma by Screen method |
| 82848-3 | 11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
| 98058-1 | Penicillium expansum IgE Ab [Units/volume] in Serum |
| 72322-1 | HLA-A+B+C (class I) IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 84901-8 | Other nodule plane [Anatomy] in Prostate tumor |
| 85369-7 | Neutrophils [#/volume] in Control Blood by Flow cytometry (FC) |
| 99962-3 | JAK2 gene exon 12 full mutation analysis in Blood or Tissue by Sequencing |
| 86111-2 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 73179-4 | quiNIDine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73187-7 | Propranolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87430-5 | Cystatin C and Glomerular filtration rate by Cystatin C-based formula panel - Serum or Plasma |
| 87658-1 | Famphur [Mass/mass] in Specimen |
| 73525-8 | Amoxicillin+Clavulanate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74097-7 | Tacrolimus [Mass/volume] in Blood by LC/MS/MS |
| 89583-9 | Cytomegalovirus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 41220-5 | Xanthurenate [Presence] in 24 hour Urine |
| 42354-1 | Tigecycline [Susceptibility] by Gradient strip |
| 60240-9 | Common wasp recombinant (rVes v) 5 IgE Ab [Units/volume] in Serum |
| 51447-1 | CD79a cells [Units/volume] in Blood |
| 22105-1 | Theileria equi Ab [Presence] in Serum |
| 2228-5 | Enterotoxin [Mass/volume] in Serum |
| 3250-8 | Fibrin monomer [Units/volume] in Platelet poor plasma by Latex agglutination |
| 32541-5 | Calcium [Molar amount] in Urine collected for unspecified duration |
| 23018-5 | Coxiella burnetii Ab [Presence] in Serum by Immunofluorescence |
| 33218-9 | Bacteria [#/area] in Urine sediment by Automated count |
| 5373-6 | Strongyloides sp Ab [Units/volume] in Serum by Hemagglutination |
| 33782-4 | Retinol binding protein [Mass/volume] in Urine |
| 33790-7 | Calcium [Moles/volume] in Urine --1st specimen post XXX challenge |
| 34249-3 | Asialoganglioside GM2 Ab [Units/volume] in Serum |
| 54024-5 | sp100 Ab [Presence] in Serum |
| 34460-6 | West Nile virus RNA [Presence] in Blood by NAA with probe detection |
| 34491-1 | PRF1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 47166-4 | Norepinephrine [Moles/volume] in Plasma --4 hours post XXX challenge |
| 25194-2 | Ethambutol 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25430-0 | Glutamine [Moles/time] in 24 hour Urine |
| 5592-1 | Benzene [Mass/volume] in Serum or Plasma |
| 47528-5 | Cytology report of Cervical or vaginal smear or scraping Cyto stain |
| 2557-7 | Lecithin/Sphingomyelin [Mass Ratio] in Amniotic fluid |
| 35592-5 | Creatinine renal clearance/1.73 sq M.predicted by Cockcroft-Gault formula, BSA formula |
| 56487-2 | Androsterone [Mass/volume] in 24 hour Urine |
| 48242-2 | Cladosporium herbarum triggered leukotriene release [Mass/volume] by Leukocytes |
| 48338-8 | Histoplasma capsulatum Ag [Presence] in Tissue by Immune stain |
| 36916-5 | Kappa light chains.free [Mass/volume] in Serum |
| 56682-8 | Homocystine/Creatinine [Ratio] in 24 hour Urine |
| 27047-0 | Anserine [Moles/volume] in Urine |
| 27183-3 | Cardiolipin IgG Ab [Presence] in Serum |
| 57539-9 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --2nd specimen post dose gonadotropin releasing hormone |
| 49185-2 | Coxiella burnetii phase 1 IgM Ab [Titer] in Body fluid |
| 492-9 | Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 38684-7 | Sperm Tail Tip IgM Ab/100 spermatozoa in Specimen by Immunobead |
| 39016-1 | Age at death |
| 49358-5 | Hepatitis B virus DNA [Units/volume] (viral load) in Bone marrow by NAA with probe detection |
| 49408-8 | Herpes virus 8 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
| 29866-1 | 2-Oxoisovalerate [Presence] in Urine |
| 50555-2 | Glucose [Presence] in Urine by Automated test strip |
| 30013-7 | Borrelia burgdorferi 23kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
| 40823-7 | HTLV II Ab [Presence] in Cerebral spinal fluid |
| 19307-8 | Thiazides positive [Identifier] in Urine by Confirmatory method |
| 197-4 | Cloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2017-2 | Carbamoyl phosphate synthetase (ammonia) [Enzymatic activity/mass] in Tissue |
| 20806-6 | Saint Louis encephalitis virus Ab [Presence] in Serum |
| 100405-0 | Kefir IgG Ab [Units/volume] in Serum |
| 100756-6 | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing |
| 12450-3 | Ketones [Mass/volume] in Urine by Test strip --2 hours post XXX challenge |
| 12567-4 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 12999-9 | Epichlorohydrin [Mass/volume] in Serum or Plasma |
| 13085-6 | C4 nephritic factor [Mass/volume] in Serum or Plasma |
| 13212-6 | Brucella abortus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 13976-6 | Beta globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
| 14198-6 | Chlamydophila psittaci Ab [Titer] in Serum by Immunofluorescence |
| 102740-8 | Flax IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14427-9 | Globulin [Mass/volume] in Pleural fluid |
| 103729-0 | Hereditary sensory neuropathy multigene analysis in Blood or Tissue by Molecular genetics method |
| 104072-4 | Mucopolysaccharidosis enzymes panel - Leukocytes |
| 14983-1 | I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit |
| 104432-0 | Mycobacterium leprae Ab. anti-PGL-1 Ab [Titer] in Serum |
| 10530-4 | Aprobarbital [Mass/volume] in Serum or Plasma |
| 15483-1 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immunoassay |
| 1557-8 | Fasting glucose [Mass/volume] in Venous blood |
| 1569-3 | Insulin [Mass/volume] in Serum or Plasma --5 hours post 75 g glucose PO |
| 16237-0 | Butalbital [Mass/volume] in Urine by Confirmatory method |
| 11019-7 | Microscopic observation [Identifier] in Blood or Marrow by Sudan black B stain |
| 17161-1 | CD47 cells/100 cells in Blood |
| 17767-5 | Verapamil [Mass/volume] in Urine |
| 18931-6 | Hetacillin [Susceptibility] |
| 19071-0 | Blood removed from patient [Volume] |
| 90747-7 | MDMB-FUBINACA-M1 [Mass/volume] in Urine by Confirmatory method |
| 74676-8 | Carbapenemase [Type] in Isolate by Carba NP |
| 74686-7 | Glucose [Moles/time] in 12 hour Urine |
| 7482-3 | Maple sugar IgE Ab [Units/volume] in Serum |
| 92692-3 | Norovirus genogroup I+II RNA [Presence] in Stool by NAA with probe detection |
| 7532-5 | California Live Oak IgE Ab [Units/volume] in Serum |
| 75385-5 | DMD gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
| 7698-4 | Sheep epithelium triggered histamine release [Units/volume] in Blood |
| 63344-6 | Sjogrens syndrome-A extractable nuclear 60kD Ab [Titer] in Body fluid by Immunoassay |
| 94665-7 | Granulomatous prostatitis [Presence] in Specimen by Microscopy |
| 79145-9 | Tapentadol [Presence] in Blood by Confirmatory method |
| 95055-0 | DOPamine [Mass/volume] in Plasma --standing |
| 6630-8 | Schistosoma sp Ab [Presence] in Serum by Hemagglutination |
| 66447-4 | Euroglyphus maynei recombinant (rEur m) 2 IgE Ab [Units/volume] in Serum |
| 80655-4 | Hemoglobin G - Philadelphia/Hemoglobin.total in Blood |
| 80974-9 | Sulfamethoxazole free [Mass/volume] in Serum or Plasma |
| 81856-7 | FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method |
| 97246-3 | Ethylone [Presence] in Cord tissue by Screen method |
| 97550-8 | Hemoglobin [Mass/volume] in Central venous blood by calculation |
| 82551-3 | Food Allergen Mix 32 (Carob+Lentil+White bean+Pea) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 72387-4 | Methadone [Presence] in Saliva (oral fluid) by Confirmatory method |
| 86234-2 | Neisseria meningitidis serogroup A sacB gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73367-5 | Gabapentin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87398-4 | Brachyspira sp DNA [Presence] in Isolate by NAA with probe detection |
| 87616-9 | Gossypol [Mass/mass] in Specimen |
| 87966-8 | Microscopic observation [Identifier] in Bone marrow by Giemsa stain |
| 7416-1 | Horn beam IgE Ab [Units/volume] in Serum |
| 89524-3 | Ganglioside GM2 IgM Ab [Presence] in Serum by Line blot |
| 41606-5 | Lactose [Mass/volume] in Serum or Plasma --3 hours post dose lactose PO |
| 59378-0 | Amikacin [Mass/volume] in Serum or Plasma --post dialysis |
| 59882-1 | Chlorpheniramine [Moles/volume] in Urine |
| 21573-1 | Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma |
| 31396-5 | Francisella tularensis Ab [Units/volume] in Serum |
| 51055-2 | CD127 blasts/100 blasts in Bone marrow |
| 51450-5 | Paragonimus sp Ab [Titer] in Pleural fluid by Immunoassay |
| 43096-7 | Eastern equine encephalitis virus IgM Ab [Presence] in Specimen |
| 31901-2 | Mycoplasma gallisepticum Ag [Presence] in Specimen |
| 51605-4 | Triglyceride [Moles/volume] in Synovial fluid |
| 22700-9 | Urea [Moles/volume] in Urine |
| 22778-5 | African swine fever virus Ab [Presence] in Body fluid |
| 32107-5 | Phencyclidine [Presence] in Specimen |
| 32193-5 | Monocytes+Macrophages [Presence] in Pericardial fluid by Light microscopy |
| 32293-3 | Albumin [Mass/volume] in Specimen |
| 32545-6 | Fat [Moles/time] in 72 hour Stool |
| 52971-9 | Immune complex [Mass/volume] in Serum or Plasma by Immunoassay |
| 53010-5 | Signal Recognition Particle (SRP) Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 44019-8 | Bordetella parapertussis Ab [Presence] in Body fluid |
| 44813-4 | Hepatitis C virus c22p Ab [Presence] in Serum by Immunoblot |
| 23628-1 | Sparfloxacin [Susceptibility] |
| 53915-5 | Microscopic observation [Identifier] in Pericardial fluid by Rhodamine-auramine fluorochrome stain |
| 45044-5 | Bacteria producing indole [Presence] in Isolate |
| 45166-6 | Corynebacterium diphtheriae IgG Ab [Presence] in Serum |
| 45345-6 | Tick engorgement [presence] |
| 3376-1 | Barbiturates [Presence] in Serum, Plasma or Blood |
| 54282-9 | Glutarylcarnitine (C5-DC) [Moles/volume] in Urine |
| 46244-0 | Mycobacterium tuberculosis complex rpoB gene rifAMPin resistance mutation identified by Molecular method |
| 2462-0 | IgE [Mass/volume] in Serum |
| 54945-1 | Monochloroacetate [Mass/volume] in Urine |
| 47087-2 | Angiotensinogen [Moles/volume] in Plasma |
| 25163-7 | Leucine crystals [#/area] in Urine sediment by Microscopy high power field |
| 25239-5 | cefoTEtan [Mass/volume] in Specimen |
| 25242-9 | Cefsulodin [Mass/volume] in Specimen |
| 35102-3 | Acenocoumarol [Mass/volume] in Serum or Plasma |
| 35325-0 | PMP22 gene allele 2 [Presence] in Blood or Tissue by Molecular genetics method |
| 55633-2 | Cephalothin+Sulbactam [Susceptibility] by Gradient strip |
| 56025-0 | Ethambutol 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 35739-2 | Brucella sp IgG and IgM panel - Serum |
| 5738-0 | Strychnine [Mass/volume] in Serum or Plasma |
| 49208-2 | Bartonella elizabethae IgG Ab [Titer] in Serum |
| 38990-8 | Escherichia coli O157:H7 DNA [Presence] in Specimen by NAA with probe detection |
| 39014-6 | Suberylcarnitine (C8-DC) [Moles/volume] in Serum or Plasma |
| 57734-6 | Ketones [Presence] in Urine by Automated test strip |
| 57741-1 | Lymphocyte proliferation stimulated by OKT3 in Blood |
| 58708-9 | Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunofluorescence |
| 49946-7 | Somatotropin [Units/volume] in Serum or Plasma --11 PM specimen |
| 40515-9 | Dengue virus Ab [Titer] in Serum by Complement fixation |
| 40603-3 | Alpha 1 antitrypsin [Presence] in Serum or Plasma by Immunoelectrophoresis |
| 59069-5 | Nuclear Ab [Presence] in Serum by Hep2 substrate |
| 50352-4 | Papain IgE Ab/IgE total in Serum |
| 50367-2 | Propionylglycine/Creatinine [Molar ratio] in 24 hour Urine |
| 50455-5 | Cortisol [Mass/volume] in Serum or Plasma --3rd specimen |
| 30042-6 | Vigabatrin [Mass/volume] in Serum or Plasma |
| 40837-7 | Alternaria sp IgG Ab [Presence] in Serum |
| 19588-3 | Midazolam [Mass/volume] in Urine |
| 20415-6 | Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma by Immunoassay (EIA) 3rd IS |
| 20551-8 | Nalbuphine [Mass/volume] in Urine by Confirmatory method |
| 20742-3 | Canine distemper virus Ag [Presence] in Conjunctival specimen by Immunofluorescence |
| 20761-3 | Clostridioides difficile [Presence] in Stool by Agglutination |
| 21048-4 | Acetaldehyde [Mass/volume] in Urine |
| 100022-3 | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 12609-4 | Glucose [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen |
| 101924-9 | Transforming growth factor beta 1 [Mass/volume] in Urine by Immunoassay |
| 13473-4 | Zinc/Creatinine [Mass Ratio] in Urine |
| 13649-9 | Nickel [Mass/volume] in Water |
| 1373-0 | Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post 2.4 mg/kg calcium short IV |
| 13775-2 | Methylmalonate/Creatinine [Mass Ratio] in 24 hour Urine |
| 1454-8 | Creatinine [Mass/volume] in 24 hour Urine --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 104225-8 | HLA-DPB1+DPA1 Typing panel - Blood or Tissue |
| 14842-9 | Microscopic observation [Identifier] in Specimen by Kinyoun iron hematoxylin stain |
| 15094-6 | Testosterone [Moles/volume] in Urine |
| 15107-6 | Imipramine [Moles/volume] in Serum or Plasma |
| 10683-1 | Hydatid cyst identified in Aspirate by Immune stain |
| 15402-1 | Ethanol [Presence] in Meconium |
| 16134-9 | Neisseria meningitidis [Presence] in Specimen by Organism specific culture |
| 163-6 | Cephalothin [Susceptibility] by Serum bactericidal titer |
| 12190-5 | Creatinine [Mass/volume] in Body fluid |
| 18490-3 | Chlamydia trachomatis G+F+K IgA Ab [Titer] in Serum by Immunofluorescence |
| 18500-9 | Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep |
| 74865-7 | IgA.lambda [Mass/volume] in Serum or Plasma |
| 74984-6 | 5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/mass] in Lymphoblasts |
| 76654-3 | Beryllium [Mass/mass] in Hair |
| 94062-7 | Bacterial rrs gene drug resistance mutation [Identifier] by Molecular method |
| 9425-0 | Acetone [Mass/volume] in Blood |
| 62471-8 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
| 63112-7 | Blackberry IgG Ab [Mass/volume] in Serum |
| 94371-2 | Pseudomonas aeruginosa DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 7900-4 | Helicobacter pylori Ab [Units/volume] in Serum |
| 68455-5 | Appearance of Spun Vitreous fluid |
| 81148-9 | Zika virus envelope E gene [Presence] in Urine by NAA with probe detection |
| 96757-0 | SARS-CoV-2 (COVID-19) S gene codon N501Y [Presence] in Specimen by Molecular genetics method |
| 97621-7 | Haemophilus influenzae DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 97966-6 | European house dust mite recombinant (rDer p) 2 IgG4 Ab [Mass/volume] in Serum |
| 71649-8 | Lymphocytes/Leukocytes [Pure number fraction] in Body fluid by Manual count |
| 82901-0 | Pregnanetriolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
| 85276-4 | Closest surgical margin when all margins are uninvolved [Type] in Colorectal cancer specimen by Light microscopy |
| 72523-4 | Glutamate decarboxylase 65 Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 72657-0 | Procainamide [Mass/volume] in Serum or Plasma --trough |
| 73252-9 | Mycophenolate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73713-0 | Epidermal Allergen Mix 72 (Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) IgE Ab [Units/volume] in Serum by Multidisk |
| 73995-3 | Mitragynine [Presence] in Urine by Confirmatory method |
| 7432-8 | Juniper IgE Ab [Units/volume] in Serum |
| 41203-1 | Yellow Jacket IgE Ab/IgE total in Serum |
| 59648-6 | N-desalkylflurazepam [Mass/volume] in Body fluid |
| 50912-5 | Sodium [Moles/mass] in Hair |
| 30514-4 | Tetrahydrocortisone/Creatinine [Mass Ratio] in Urine |
| 3093-2 | Urea nitrogen [Mass/volume] in Body fluid |
| 21250-6 | Doxycycline [Mass/volume] in Specimen |
| 3133-6 | Xanthurenate [Mass/volume] in Urine |
| 43090-0 | Aspergillus flavus Ab [Titer] in Serum |
| 22227-3 | Coxsackievirus B2 Ab [Titer] in Cerebral spinal fluid |
| 51924-9 | Neutrophil cytoplasmic Ab [Titer] in Serum by Immunofluorescence |
| 22460-0 | Reagin Ab [Units/volume] in Cerebral spinal fluid |
| 22473-3 | Rickettsia (Proteus OXK) Ab [Titer] in Serum |
| 22607-6 | Venezuelan equine encephalitis virus Ab [Titer] in Serum |
| 22724-9 | Alanine [Moles/volume] in Specimen |
| 32-3 | Ampicillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 43851-5 | Influenza virus A IgA Ab [Presence] in Serum |
| 53213-5 | Dicarboxydodecenoylcarnitine (C12:1-DC) [Moles/volume] in DBS |
| 44465-3 | Herpes simplex virus 1 [Presence] in Genital specimen by Organism specific culture |
| 33347-6 | 17-Ketosteroids/Creatinine [Mass Ratio] in Urine |
| 33682-6 | Francisella tularensis [Presence] in Isolate by Cell wall fatty acid analysis |
| 53777-9 | Cortisone free [Mass/volume] in Urine |
| 45327-4 | FMR1 gene targeted mutation analysis in Amniotic fluid by Molecular genetics method |
| 54275-3 | Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose ornithine alpha-ketoglutarate |
| 46699-5 | Fibroblast growth factor 23 [Units/volume] in Plasma |
| 34339-2 | Metanephrine [Moles/volume] in Urine |
| 34406-9 | Exocrine pancreas Ab [Titer] in Serum by Immunofluorescence |
| 55149-9 | BCR-ABL1 e1a2 fusion protein [Presence] in Blood or Tissue by Molecular genetics method |
| 55337-0 | P1 Ab [Titer] in Serum or Plasma |
| 55368-5 | Crystals.amorphous [#/area] in Urine sediment by Microscopy high power field |
| 47050-0 | Herpes virus 8 IgG Ab [Titer] in Serum by Immunofluorescence |
| 34741-9 | RHCE gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 35448-0 | HIV 1 p24 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
| 48070-7 | Hepatitis B virus surface IgG Ab [Presence] in Serum by Immunoassay |
| 48686-0 | Salmonella paratyphi C Ab [Titer] in Serum |
| 38470-1 | chlorproPAMIDE [Mass/volume] in 24 hour Urine |
| 28004-0 | HIV 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 28600-5 | Phosphoserine/Creatinine [Ratio] in Urine |
| 39981-6 | Creatinine [Mass/volume] in Urine --30 minutes pre XXX challenge |
| 58448-2 | Microalbumin ug/min [Mass/time] in 24 hour Urine |
| 49880-8 | Hepatitis B virus codon 204 [Identifier] by Genotype method |
| 29971-9 | Strontium [Mass/volume] in 24 hour Urine |
| 50548-7 | Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection |
| 30158-0 | Toxoplasma gondii [Presence] in Stool |
| 409-3 | Piperacillin [Susceptibility] by Disk diffusion (KB) |
| 1974-5 | Bilirubin.total [Mass/volume] in Body fluid |
| 20528-6 | Flunitrazepam [Mass/volume] in Urine by Confirmatory method |
| 20618-5 | Lambda lymphocytes/100 lymphocytes in Specimen |
| 100054-6 | Gamithromycin [Susceptibility] |
| 101390-3 | GP9 gene full mutation analysis in Blood or Tissue by Molecular genetics method |
| 101762-3 | Trichophyton bullosum DNA [Presence] in Specimen by NAA with probe detection |
| 102105-4 | Pecan or Hickory Tree IgG Ab [Mass/volume] in Serum by Immunoassay |
| 102387-8 | Insulin bovine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14121-8 | Pyruvate [Moles/volume] in Blood |
| 14236-4 | Mitochondria Ab [Presence] in Serum |
| 14448-5 | Triglyceride [Mass/volume] in Semen |
| 144-6 | Cefuroxime Parenteral [Susceptibility] by Minimum lethal concentration (MLC) |
| 10868-8 | Bacitracin [Susceptibility] by Disk diffusion (KB) |
| 11105-4 | Basophils/100 cells in Bone marrow by Manual count |
| 1116-3 | Le sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
| 1134-6 | Lu sup(a) Ab [Presence] in Serum or Plasma from Donor |
| 11587-3 | Brucella canis Ab [Units/volume] in Serum |
| 16954-0 | Herpes simplex virus 2 Ab [Presence] in Serum |
| 17774-1 | Yellow dye IgE Ab [Units/volume] in Serum |
| 18320-2 | Globulin [Mass/volume] in Urine by calculation |
| 91544-7 | Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay |
| 92670-9 | Glucose [Mass/volume] in Serum or Plasma --2 hours post dose cloNIDine |
| 75372-3 | Hexane [Mass/volume] in Serum or Plasma by Screen method |
| 60424-9 | Parainfluenza virus 4 Ag [Presence] in Specimen |
| 93370-5 | Anaplasma phagocytophilum and Ehrlichia chaffeensis IgG and IgM panel - Serum |
| 9341-9 | Cerebroside sulfatase [Mass/time] in 24 hour Urine |
| 6145-7 | House dust IgE Ab [Units/volume] in Serum |
| 6158-0 | Latex IgE Ab [Units/volume] in Serum |
| 77170-9 | PDGFRA gene p.Asp842Val [Presence] in Blood or Tissue by Molecular genetics method |
| 7769-3 | Water Chestnut IgE Ab [Units/volume] in Serum |
| 77741-7 | Streptavidin [Presence] in Serum or Plasma by Immunoblot |
| 78528-7 | Platelet aggregation ristocetin induced in Platelet rich plasma --1.25 mg/ml |
| 94769-7 | SARS-CoV-2 (COVID-19) Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 94847-1 | Reason specimen not collected |
| 95424-8 | SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by Sequencing |
| 65786-6 | Shrimp native (nPen m) 2 IgE Ab [Units/volume] in Serum |
| 66123-1 | Pleura Pathology biopsy report |
| 79582-3 | Beta-ureidoisobutyrate [Moles/volume] in Serum or Plasma |
| 79717-5 | CYP3A5 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
| 80636-4 | Alpha-amanitin [Mass/volume] in Urine |
| 8086-1 | Pancreatic islet cell Ab [Units/volume] in Serum |
| 96925-3 | Nuclear dots nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 97625-8 | Morganella morganii DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 71637-3 | Unspecified cells/Leukocytes [Pure number fraction] in Body fluid by Manual count |
| 99059-8 | N-acetylglycine/Creatinine [Mass Ratio] in Urine |
| 72338-7 | Erythrocytes [Presence] in Prostatic fluid by Light microscopy |
| 72424-5 | 3-Methylhistidine/Amino acids.total in Serum or Plasma |
| 85343-2 | Lymph nodes with macrometastases [#] in Cancer specimen by Light microscopy |
| 85532-0 | Influenza virus A whole genome [Nucleotide sequence] in Isolate by Sequencing |
| 99271-9 | Flualprazolam [Mass/volume] in Urine by Confirmatory method |
| 99895-5 | Calcium oxalate monohydrate crystals [#/area] in Urine sediment by Computer assisted method |
| 72857-6 | Dolutegravir [Susceptibility] by Genotype method |
| 86216-9 | Porcine epidemic diarrhea virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 73405-3 | Doxazosin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73495-4 | busPIRone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73621-5 | Fidaxomicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 74446-6 | Stone analysis panel |
| 41258-5 | Xylose [Mass/volume] in Urine --1 hour post 25 g xylose PO |
| 59695-7 | Hydroxytriazolam [Mass/mass] in Tissue |
| 30557-3 | Smooth muscle IgG Ab [Presence] in Serum |
| 3075-9 | Tyramine [Mass/volume] in Cerebral spinal fluid |
| 42199-0 | Soluble liver Ab [Presence] in Serum by Immunoassay |
| 21280-3 | Fonofos [Mass/volume] in Urine |
| 51308-5 | CD4+CD7-CD26- cells/100 cells in Cerebral spinal fluid |
| 22082-2 | Afipia felis IgM Ab [Titer] in Serum |
| 51890-2 | Factor VIII units given [#] |
| 52119-5 | Apheresis available [#] in Blood product unit |
| 52901-6 | Vanadium/Creatinine [Molar ratio] in Urine |
| 44360-6 | Glutamate+Glutamine/Creatinine [Molar ratio] in Urine |
| 44847-2 | Bacteria # 7 identified in Urine by Culture |
| 23589-5 | Western equine encephalitis virus Ag [Presence] in Specimen by Neutralization test |
| 33675-0 | Microscopic observation [Identifier] in Specimen by Esterase stain.combined |
| 53569-0 | Platelet aggregation ristocetin induced in Platelet rich plasma --800 ug/mL |
| 23793-3 | Canine parvovirus Ag [Presence] in Stool by Immunoassay |
| 2408-3 | Hexachlorophene [Mass/volume] in Blood |
| 33896-2 | Orientia tsutsugamushi IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 5406-4 | Western equine encephalitis virus Ab [Units/volume] in Serum |
| 54381-9 | Cystatin C [Mass/time] in 24 hour Urine |
| 46745-6 | Other amino acidopathies newborn screen interpretation |
| 2421-6 | Histidine [Presence] in Serum or Plasma |
| 24464-0 | Chondroitin sulfate [Presence] in Urine |
| 55232-3 | Genetic analysis summary panel |
| 25449-0 | Iodine [Moles/time] in 24 hour Urine |
| 55720-7 | Tinidazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 47825-5 | 7-Hydroxyoctanoate/Creatinine [Molar ratio] in Urine |
| 25681-8 | Kappa light chains [Presence] in Serum by Immunoelectrophoresis |
| 25999-4 | Urea/Creatinine [Molar ratio] in 24 hour Urine |
| 35696-4 | California encephalitis virus Ab [Titer] in Cerebral spinal fluid |
| 56309-8 | Lime IgG4 Ab [Mass/volume] in Serum |
| 56451-8 | Chymopapain IgG4 Ab [Mass/volume] in Serum |
| 4812-4 | HLA-B16 [Presence] in Donor |
| 26668-4 | Chlamydia trachomatis L1 Ab [Presence] in Serum |
| 26710-4 | Leucine [Moles/volume] in Amniotic fluid |
| 57037-4 | Chromosome 13+18+21+X+Y aneuploidy in Amniotic fluid by Molecular genetics method Nominal |
| 4878-5 | HLA-Dw15 [Presence] in Donor |
| 38317-4 | Hexane [Mass/volume] in Water |
| 38392-7 | Legionella sp Ab [Presence] in Serum |
| 38486-7 | Homocystine [Presence] in DBS |
| 27890-3 | Somatotropin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 39092-2 | Vancomycin [Mass/volume] in Cerebral spinal fluid --peak |
| 57921-9 | Carbon dioxide, total [Moles/volume] in Arterial cord blood by calculation |
| 49434-4 | Parvovirus B19 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 49720-6 | Meadow Fescue IgG Ab [Mass/volume] in Serum |
| 29247-4 | Sirolimus [Mass/volume] in Blood |
| 29529-5 | Acetaminophen [Presence] in Specimen |
| 5850-3 | Herpes simplex virus Ag [Presence] in Genital specimen by Immunoassay |
| 58581-0 | Corticotropin [Mass/volume] in Plasma --30 minutes post dose glucagon |
| 5875-0 | Respiratory syncytial virus Ag [Presence] in Throat by Immunofluorescence |
| 40311-3 | Cortisol [Moles/volume] in Serum or Plasma --15 minutes post dose triple bolus |
| 50556-0 | Urinalysis dipstick panel - Urine by Automated test strip |
| 29991-7 | Fibrin+Fibrinogen fragments [Mass/volume] in Serum by Latex agglutination |
| 30159-8 | HTLV I+II DNA [Presence] in Blood by NAA with probe detection |
| 3034-6 | Transferrin [Mass/volume] in Serum or Plasma |
| 30351-1 | Hemoglobin [Mass/volume] in Mixed venous blood |
| 40741-1 | Platelet clump [Presence] in Blood by Automated count |
| 40861-7 | CD103 cells/100 cells in Tissue |
| 40973-0 | Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum |
| 19240-1 | Lactate [Moles/volume] in Mixed venous blood |
| 19729-3 | Blue vetch IgE Ab [Units/volume] in Serum |
| 100092-6 | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot |
| 100684-0 | Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 100704-6 | Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection |
| 12758-9 | Insulin [Mass/volume] in Serum or Plasma --15 minutes pre XXX challenge |
| 12786-0 | HYDROcodone Free [Mass/volume] in Serum or Plasma |
| 101159-2 | Flubromazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 101417-4 | Pediatric autoimmune central nervous system disorders evaluation panel - Serum or Plasma |
| 13434-6 | DOPamine [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 101943-9 | Candida parapsilosis DNA [Presence] in Specimen by NAA with probe detection |
| 13511-1 | Cyanide ascorbate screen [Presence] in Blood |
| 13844-6 | CD34 blasts/100 blasts in Blood |
| 102468-6 | Jerusalem oak IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102665-7 | Wormwood IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13979-0 | Prealbumin/Protein.total in Serum or Plasma by Electrophoresis |
| 14257-0 | Tetrachlorodiphenylethane [Mass/volume] in Serum or Plasma |
| 10344-0 | Tranylcypromine [Mass/volume] in Serum or Plasma |
| 14834-6 | Methamphetamine [Presence] in Gastric fluid |
| 14838-7 | Toxoplasma gondii [Presence] in Tissue by Organism specific culture |
| 15368-4 | Hypoglycemics.sulfonyluric [Identifier] in Serum or Plasma |
| 1538-8 | Glucose [Mass/volume] in Urine --4 hours post 100 g glucose PO |
| 16221-4 | Phenothiazines [Presence] in Urine by Confirmatory method |
| 1108-0 | Kp sup(b) Ag [Presence] on Red Blood Cells |
| 16628-0 | Cloxacillin [Mass/volume] in Serum or Plasma |
| 11249-0 | Phenacemide [Mass/volume] in Serum or Plasma |
| 12329-9 | chlorproPAMIDE [Presence] in Urine |
| 17307-0 | Myelin IgM Ab [Presence] in Serum |
| 17395-5 | oxyMORphone [Mass/volume] in Urine by Confirmatory method |
| 17458-1 | Phosphoethanolamine [Presence] in Serum or Plasma |
| 18197-4 | Blastomyces dermatitidis Ab [Presence] in Cerebral spinal fluid |
| 18470-5 | Norclomipramine [Mass/volume] in Urine |
| 90905-1 | Mother's ABO and Rh group Type |
| 90917-6 | Linoleate (C18:2w6)/Fatty acids.C14-C22 in Blood |
| 74773-3 | Immunoglobulin light chains and heavy chains panel - Serum or Plasma |
| 74871-5 | Rivaroxaban [Mass/volume] in Platelet poor plasma by Chromogenic method |
| 7546-5 | Olive IgG Ab [Units/volume] in Serum |
| 6050-9 | Brazil Nut IgE Ab [Units/volume] in Serum |
| 76572-7 | Streptococcus pneumoniae nanA gene [Presence] in Swab specimen by NAA with probe detection |
| 92886-1 | Torque teno virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 61339-8 | Egg yolk IgE Ab/IgE total in Serum |
| 6167-1 | Mango IgE Ab [Units/volume] in Serum |
| 93714-4 | Epstein Barr virus capsid IgM Ab [Presence] in Serum from Donor by Immunoassay |
| 93950-4 | D variant Ag [Presence] on Red Blood Cells |
| 63299-2 | Nucleosome Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 78434-8 | carBAMazepine free and total trough and 10,11-Epoxide panel - Serum or Plasma |
| 63398-2 | Ribonucleoprotein extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
| 9580-2 | Thyroxine (T4) Ab [Units/volume] in Serum |
| 96304-1 | Enterococcus faecalis DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 96357-9 | Equine herpesvirus 4 [Presence] in Specimen by Organism specific culture |
| 6835-3 | Cauliflower IgE Ab [Units/volume] in Serum |
| 81424-4 | Microscopic observation [Identifier] in Bone marrow by Toluidine blue O stain |
| 69890-2 | Service comment 63 |
| 69902-5 | Service comment 75 |
| 97281-0 | Morphine Free [Presence] in Cord tissue by Confirmatory method |
| 9772-5 | Xylose [Mass/volume] in Blood --1 hour post 25 g xylose PO |
| 7044-1 | Piperacillin+Tazobactam [Susceptibility] by Gradient strip |
| 82582-8 | Food Allergen Mix 25B (Garlic, Celery, Sesame seed, Yeast) IgE Ab [Units/volume] in Serum by Multidisk |
| 85044-6 | Staphylococcus aureus glycopeptide resistance panel |
| 85374-7 | Neutrophil.PMA stimulated.DHR mean fluorescence instensity in Blood by Flow cytometry (FC) |
| 85800-1 | Mumps virus SH gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 85841-5 | Beta-lactam resistance AmpC blaACC gene [Presence] by Molecular method |
| 73457-4 | chlordiazePOXIDE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74349-2 | Lactose [Moles/volume] in Serum or Plasma --fasting |
| 88713-3 | Phosphate [Mass/volume] in Stool |
| 88724-0 | Ganglioside GD1a IgG+IgM Ab [Units/volume] in Serum by Immunoassay |
| 41757-6 | Fluticasone propionate [Mass/volume] in Serum or Plasma |
| 59657-7 | diazePAM [Mass/volume] in Body fluid by Confirmatory method |
| 60118-7 | Palladium [Mass/volume] in Red Blood Cells |
| 31496-3 | Ganglioside GM1 Ab [Units/volume] in Serum |
| 51304-4 | CD4+CD7- cells/100 cells in Bone marrow |
| 5185-4 | Hepatitis B virus core IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 43687-3 | Powassan virus polyvalent E Ab [Presence] in Specimen by Immunoassay |
| 22562-3 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum --1st specimen |
| 32261-0 | Ornithine [Moles/volume] in Vitreous fluid |
| 32553-0 | Sodium [Molar amount] in Urine collected for unspecified duration |
| 52121-1 | Biopsy [Interpretation] in Specimen Narrative |
| 43973-7 | Zinc [Moles/volume] in Specimen |
| 23167-0 | Leptospira borgpetersenii sv Ballum Ab [Presence] in Serum |
| 23189-4 | Leptospira interrogans sv Mitis Ab [Presence] in Serum |
| 23205-8 | Leptospira sp DNA [Presence] in Body fluid by NAA with probe detection |
| 44515-5 | Herpes simplex virus Ag [Presence] in Cervix by Immunoassay |
| 23444-3 | Swine vesicular disease virus Ag [Presence] in Specimen by Immunoassay |
| 34147-9 | Treponema pallidum IgG+IgM Ab [Presence] in Serum |
| 55498-0 | Insulin [Moles/volume] in Serum or Plasma --7 minutes pre dose glucose |
| 47450-2 | Influenza virus A H15 Ab [Titer] in Serum |
| 55668-8 | Dicloxacillin [Susceptibility] by Gradient strip |
| 55972-4 | Phosphate [Moles/volume] in Serum or Plasma --post dialysis |
| 47776-0 | Somatotropin [Units/volume] in Serum or Plasma --pre dose glucose PO |
| 47805-7 | Valine/Amino acids.total in Specimen |
| 4822-3 | HLA-B35 [Presence] in Donor |
| 48271-1 | Tetracycline triggered leukotriene release [Mass/volume] by Leukocytes |
| 26607-2 | Cystathionine [Moles/volume] in Serum or Plasma |
| 568-6 | Fungus identified in Aspirate by Culture |
| 4868-6 | HLA-Dw10 [Presence] in Donor |
| 38309-1 | Asbestos [Mass/volume] in Water |
| 38423-0 | C peptide [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 28048-7 | Borrelia burgdorferi 58kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 38737-3 | O-anisidine [Mass/volume] in Air |
| 57732-0 | Osmolality of Urine--3rd specimen |
| 57975-5 | HIV 1+O+2 Ab [Presence] in Body fluid |
| 2856-3 | Prostaglandin [Mass/volume] in Serum or Plasma |
| 5012-0 | Hepatitis C virus RNA [Presence] in Specimen by NAA with probe detection |
| 59206-3 | Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in Serum or Plasma |
| 5018-7 | HIV 1 RNA [Presence] in Specimen by NAA with probe detection |
| 19473-8 | FLUoxetine cutoff [Mass/volume] in Urine for Confirmatory method |
| 20656-5 | Serine [Moles/volume] in Serum or Plasma |
| 100906-7 | Bacteria [#/volume] in Urine by Culture |
| 12865-2 | Borrelia burgdorferi 29kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 101211-1 | Hantavirus sin nombre IgG Ab [Presence] in Serum or Plasma by Line blot |
| 13282-9 | Rubella virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13405-6 | Methionine [Mass/volume] in Amniotic fluid |
| 101816-7 | Cytomegalovirus DNA [Units/volume] (viral load) in Urine by NAA with probe detection |
| 1382-1 | Calcium [Moles/volume] in Serum or Plasma --5 minutes post 2.4 mg/kg calcium short IV |
| 102353-0 | Guava IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102866-1 | Red Beet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14384-2 | Mononuclear cells/100 leukocytes in Urine sediment by Manual count |
| 103642-5 | Herpes virus 6B DNA [Units/volume] (viral load) in Serum or Plasma by NAA with non-probe detection |
| 10422-4 | Transfuse plasma [Volume] |
| 15072-2 | Gastrin [Moles/volume] in Serum or Plasma |
| 15080-5 | Lutropin [Units] in 24 hour Urine |
| 15344-5 | little i Ab [Titer] in Serum or Plasma |
| 15495-5 | PRRSV Ab [Presence] in Serum by Immunoassay |
| 16106-7 | CD8+CD28+ cells [#/volume] in Blood |
| 16234-7 | Amphetamine [Mass/volume] in Urine by Confirmatory method |
| 16302-2 | 1-Methylhistidine [Presence] in Urine |
| 89978-1 | ARIPiprazole [Presence] in Urine by Screen method |
| 90261-9 | Microscopic observation [Identifier] in Bile fluid by Giemsa stain |
| 91035-6 | Phencyclidine [Presence] in Tissue by Screen method |
| 74761-8 | Microcytes/100 erythrocytes in Blood |
| 91556-1 | Fibrin D-dimer DDU [Mass/volume] in Blood by Immunoassay |
| 92146-0 | Human coronavirus 229E+NL63 RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 92247-6 | Microorganism resistance mutation amino acid change type by Molecular method |
| 60395-1 | Plum IgG Ab [Mass/volume] in Serum |
| 75981-1 | Fetal Chromosome 13 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
| 76065-2 | 6p25 and 6q23 and 11q and 8q24 and 9p21 chromosome partial aneuploidy in Blood or Tissue by FISH |
| 76091-8 | Respiratory pathogens DNA and RNA 4 panel - Nasopharynx by NAA with probe detection |
| 6139-0 | Herring IgE Ab [Units/volume] in Serum |
| 77066-9 | AHCY gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77215-2 | Parotid secretory protein IgG Ab [Units/volume] in Serum by Immunoassay |
| 9374-0 | Character of Cerebral spinal fluid |
| 62432-0 | La Crosse virus IgM Ab [Presence] in Body fluid by Immunoassay |
| 781-5 | Promyelocytes [#/volume] in Blood by Manual count |
| 78217-7 | RARA gene rearrangements [Presence] in Blood or Tissue by FISH |
| 9436-7 | Lead [Mass/volume] in Body fluid |
| 7891-5 | Giardia lamblia IgG Ab [Units/volume] in Serum |
| 79158-2 | Cold agglutinin [Titer] in Serum by 4 deg C incubation --1 hour post incubation |
| 79235-8 | Butylone cutoff [Mass/volume] in Urine for Confirmatory method |
| 9493-8 | Bismuth [Mass/volume] in Body fluid |
| 95241-6 | Platelet aggregation ADP induced in Platelet rich plasma --0.6 umol/L |
| 9584-4 | Babesia sp IgG Ab [Titer] in Serum by Immunofluorescence |
| 95941-1 | Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection |
| 68402-7 | Eosinophils [#/volume] in Vitreous fluid by Manual count |
| 8120-8 | CD21 cells/100 cells in Blood |
| 96564-0 | Inner ear Ab [Units/volume] in Serum by Immunoassay |
| 70012-0 | Coxsackievirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 70092-2 | Prostaglandin E1 [Mass/volume] in Body fluid |
| 8262-8 | Service comment 02 |
| 83103-2 | Lutropin [Units/volume] in Serum or Plasma by Immunoassay |
| 85805-0 | Influenza virus A H7 Ag [Titer] in Isolate by Hemagglutination inhibition |
| 86009-8 | Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum |
| 73092-9 | valGANciclovir induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73583-7 | Molybdenum/Creatinine [Mass Ratio] in Urine |
| 87970-0 | Microscopic observation [Identifier] in Amniotic fluid by Giemsa stain |
| 74414-4 | Varicella zoster virus IgM Ab [Units/volume] in Body fluid by Immunoassay |
| 74460-7 | Blasts/100 leukocytes in Blood from Fetus |
| 88905-5 | Influenza virus B Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
| 89315-6 | CD4+CD25+CD45RA+CD127Low+ cells [#/volume] in Blood |
| 89633-2 | Actinomyces sp identified in Lower respiratory specimen by Organism specific culture |
| 4157-4 | Cefamandole [Mass] of Dose |
| 50638-6 | Annatto seed IgE Ab [Units/volume] in Serum |
| 50891-1 | OLANZapine [Moles/volume] in Urine |
| 59968-8 | Strychnine [Moles/volume] in Serum or Plasma |
| 43070-2 | Burkholderia pseudomallei IgG Ab [Titer] in Specimen |
| 22164-8 | Caprine arthritis encephalitis virus Ab [Presence] in Serum |
| 22274-5 | Echovirus 3 Ab [Titer] in Serum |
| 22421-2 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum |
| 22469-1 | Rickettsia (Proteus OX19) Ab [Titer] in Serum |
| 22511-0 | Saint Louis encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid |
| 22531-8 | Salmonella typhimurium Ab [Presence] in Serum |
| 2260-8 | Estrone (E1).unconjugated [Mass/volume] in Amniotic fluid |
| 22628-2 | Xylose [Moles/time] in 5 hour Urine --post 25 g xylose PO |
| 32053-1 | Bupivacaine [Moles/volume] in Serum or Plasma |
| 32060-6 | Chloroquine [Moles/volume] in Serum or Plasma |
| 32264-4 | Phenylalanine [Moles/volume] in Vitreous fluid |
| 5237-3 | Legionella pneumophila Ab [Titer] in Serum by Immunofluorescence |
| 23480-7 | Theileria parva DNA [Presence] in Serum by NAA with probe detection |
| 33361-7 | Band form neutrophils/100 leukocytes in Synovial fluid |
| 5389-2 | Toxoplasma gondii IgG Ab [Titer] in Serum by Immunofluorescence |
| 53937-9 | HLA-B w4+w6 [Type] in Leukocytes |
| 53941-1 | Vibrio cholerae toxin Ag [Presence] in Isolate |
| 53945-2 | Escherichia coli adherence pattern [Identifier] in Isolate by Hep2 substrate |
| 34167-7 | Platelets Large [Presence] in Blood by Automated count |
| 54018-7 | Lactoferrin Ab [Presence] in Serum |
| 4600-3 | Hemoglobin Kansas [Presence] in Blood |
| 46259-8 | Morphine Free [Presence] in Serum or Plasma by Screen method |
| 55432-9 | Immature cells [#/volume] in Blood |
| 55657-1 | Clindamycin.high potency [Susceptibility] |
| 47530-1 | Cytology report of Breast ductal lavage Cyto stain |
| 25981-2 | Serotonin [Moles/volume] in 24 hour Urine |
| 56510-1 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 35834-1 | Pristinamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 5664-8 | Heavy metals negative [Identifier] in Urine by Screen method |
| 56732-1 | Ribosomal P Ab [Presence] in Serum by Immunoblot |
| 38442-0 | Bilirubin crystals [#/area] in Urine sediment by Microscopy low power field |
| 38522-9 | Complement C4b binding protein actual/normal in Serum or Plasma |
| 57501-9 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --pre dose metyraPONE |
| 57645-4 | C peptide [Moles/volume] in Serum or Plasma --10 minutes pre XXX challenge |
| 49085-4 | First and Second trimester integrated maternal screen panel |
| 57935-9 | Chocolate IgE Ab/IgE total in Serum |
| 49691-9 | Nortrimipramine [Presence] in Serum or Plasma |
| 29412-4 | Glucose [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
| 39999-8 | Glucose [Mass/volume] in Serum or Plasma --15 minutes pre XXX challenge |
| 50052-0 | Hemicystine/Amino acids.total in DBS |
| 50304-5 | Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in DBS |
| 30333-9 | Echovirus 11 Ab [Presence] in Serum by Complement fixation |
| 20624-3 | Creatinine [Mass/volume] in 24 hour Urine |
| 20867-8 | Lead [Mass/mass] in Bone |
| 12631-8 | Glucose [Mass/volume] in Peritoneal dialysis fluid --2nd specimen |
| 102034-6 | Pathology report microscopic observation in Specimen |
| 13725-7 | Cystine/Creatinine [Mass Ratio] in Urine |
| 102350-6 | Sweet Vernal grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102404-1 | Legume IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102423-1 | Scad IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14115-0 | Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Urine |
| 14535-9 | Measles virus Ag [Presence] in Throat by Immunofluorescence |
| 14611-8 | Nuclear Ab pattern [Interpretation] in Serum |
| 103786-0 | Macrophage derived chemokine [Mass/volume] in Serum or Plasma by Immunoassay |
| 14869-2 | Pathologist review of Blood tests |
| 104317-3 | Common myeloid progenitor cell [#/volume] in Blood by Visual count |
| 10455-4 | Xylose [Mass/volume] in Serum or Plasma --30 minutes post 25 g xylose PO |
| 15238-9 | Occupational Allergen Mix 4 (Amylase+Soybean+Grain weevel+Wheat) IgE Ab [Presence] in Serum by Multidisk |
| 11091-6 | Alpha chlordane [Mass/volume] in Serum or Plasma |
| 17258-5 | Metandienone [Mass/volume] in Serum or Plasma |
| 19051-2 | Saquinavir [Mass/volume] in Serum or Plasma |
| 90742-8 | Bovine Mullerian inhibiting substance [Mass/volume] in Serum or Plasma by Immunoassay |
| 91829-2 | Mycobacterium tuberculosis DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 926-6 | Blood product.other given [Volume] |
| 75234-5 | O-desmethylvenlafaxine [Presence] in Urine |
| 75548-8 | Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
| 60349-8 | Apple IgG Ab [Mass/volume] in Serum |
| 7574-7 | Pea triggered histamine release [Units/volume] in Blood |
| 62351-2 | Chromosome analysis panel - Amniotic fluid by G-banded |
| 62472-6 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 63171-3 | Neurospora sitophila IgG Ab [Mass/volume] in Serum |
| 63347-9 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
| 94441-3 | HLA-A and B and C (class I) IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC) |
| 94703-6 | PCA-2 Ab [Titer] in Serum by Immunofluorescence |
| 79161-6 | Nortriptyline and E-10-hydroxynortriptyline and Z-10-hydroxynortriptyline panel - Serum or Plasma |
| 79445-3 | Fluspirilene [Mass/volume] in Serum or Plasma |
| 95226-7 | Segmented neutrophils/100 leukocytes in Stem cell product by Manual count |
| 79615-1 | R-beta aminoisobutyrate [Moles/volume] in Serum or Plasma |
| 6873-4 | Beta hydroxybutyrate [Moles/volume] in Serum or Plasma |
| 69014-9 | Lymphocyte proliferation.Candida albicans.maximum/CD45 in Blood by Flow cytometry (FC) |
| 80631-5 | 1,3-Dimethylbenzene+1,4-Dimethylbenzene [Mass/volume] in Blood |
| 81113-3 | Murray Valley encephalitis virus IgM Ab [Presence] in Serum |
| 81307-1 | Influenza virus A H7 Eurasia RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection |
| 96525-1 | Semliki Forest virus IgM Ab [Presence] in Specimen by Immunoassay |
| 9660-2 | HIV 1 gp160 Ab [Presence] in Serum by Immunoblot |
| 70028-6 | Megakaryocytic nuclei/100 leukocytes in Blood by Manual count |
| 97512-8 | Rabies virus IgM Ab [Presence] in Specimen by Immunofluorescence |
| 82396-3 | Ganglioside GD1a IgG+IgM Ab [Presence] in Serum by Line blot |
| 98185-2 | Ambroxol IgE Ab [Units/volume] in Serum |
| 7168-8 | Buttermilk triggered histamine release [Units/volume] in Blood |
| 71887-4 | Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial cord blood |
| 7194-4 | Mountain Juniper triggered histamine release [Units/volume] in Blood |
| 7223-1 | Chicken triggered histamine release [Units/volume] in Blood |
| 83065-3 | Cytomegalovirus DNA [Presence] in Saliva (oral fluid) by NAA with probe detection |
| 83107-3 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma by Immunoassay |
| 99129-9 | SF3B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 73318-8 | Lansoprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86718-4 | Actinobacillus pleuropneumoniae serotype 3 Ab [Titer] in Serum by Complement fixation |
| 87276-2 | Borrelia afzelii+burgdorferi+garinii IgG band pattern [Interpretation] in Serum by Line blot |
| 87556-7 | Thyroglobulin and thyroperoxidase Ab panel - Serum or Plasma |
| 41179-3 | Mumps reaction wheal [Diameter] --1 day post dose mumps intradermal |
| 41434-2 | Cryptosporidium parvum DNA [Presence] in Specimen by NAA with probe detection |
| 41641-2 | Ricin toxin [Presence] in Specimen by Immunofluorescence |
| 41698-2 | Josamycine [Susceptibility] by Disk diffusion (KB) |
| 50747-5 | Platelet factor 4 Ag [Presence] in Platelet poor plasma by Immunoassay |
| 4183-0 | Chlorthalidone [Mass] of Dose |
| 418-4 | Pivampicillin [Susceptibility] by Serum bactericidal titer |
| 31391-6 | Feline panleukopenia virus IgG Ab [Units/volume] in Serum |
| 51425-7 | EPINEPHrine [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
| 51441-4 | Macroprolactin/Prolactin [Mass] in Serum or Plasma |
| 42863-1 | Cedar IgE Ab/IgE total in Serum |
| 2206-1 | Dicarboxylate, C6-C8-C10 [Mass/volume] in Serum |
| 22085-5 | Aspergillus fumigatus 3 Ab [Presence] in Serum |
| 51588-2 | Granulocytes [#/volume] in Blood by Manual count |
| 5178-9 | Haemophilus influenzae Ab [Units/volume] in Serum by Immunoassay |
| 43630-3 | 6-Thioguanine [Presence] in Red Blood Cells |
| 3214-4 | Coagulation factor VIII Ag [Units/volume] in Platelet poor plasma by Immunoelectrophoresis |
| 5267-0 | Paragonimus sp Ab [Titer] in Serum by Complement fixation |
| 53034-5 | Allelic state |
| 32785-8 | Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method |
| 32799-9 | Glycosaminoglycans/Creatinine [Mass Ratio] in Urine |
| 32828-6 | Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 53179-8 | 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS |
| 44534-6 | HLA Ab [Presence] in Serum |
| 44796-1 | Clostridium botulinum toxin [Identifier] in Specimen |
| 23387-4 | Pseudorabies virus DNA [Presence] in Specimen by NAA with probe detection |
| 33472-2 | Acylcarnitine pattern [Interpretation] in Urine |
| 53515-3 | Citrate synthase [Enzymatic activity/mass] in Control Fibroblast |
| 53948-6 | Donated egg [Presence] |
| 45096-5 | Chlamydia trachomatis [Presence] in Nasopharynx by Organism specific culture |
| 33783-2 | Atrial natriuretic factor [Moles/volume] in Plasma |
| 3424-9 | Caffeine [Mass/volume] in Urine |
| 46225-9 | ABCA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 24217-2 | Influenza virus B Ab [Titer] in Serum by Complement fixation --1st specimen |
| 55201-8 | KIT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55949-2 | Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Serum or Plasma |
| 47880-0 | Pyruvate carboxylase [Enzymatic activity/mass] in Fibroblast |
| 47882-6 | Pyruvate carboxylase [Enzymatic activity/mass] in Placenta |
| 25753-5 | Rotavirus IgG Ab [Presence] in Serum by Immunoassay |
| 25949-9 | Lutropin [Units/volume] in Serum or Plasma by 1st IRP --7th specimen post XXX challenge |
| 35632-9 | Phenytoin [Mass/volume] in Serum or Plasma by Screen method |
| 56316-3 | Rough Marsh Elder IgG4 Ab [Mass/volume] in Serum |
| 56462-5 | Red Pepper IgG4 Ab [Mass/volume] in Serum |
| 26423-4 | Egg white IgG4 Ab [Units/volume] in Serum |
| 362-4 | Nitrofurantoin [Susceptibility] by Minimum lethal concentration (MLC) |
| 56943-4 | Insulin [Units/volume] in Serum or Plasma --68 hour post XXX challenge |
| 5700-0 | Nickel [Mass/volume] in Blood |
| 27018-1 | IgG.monoclonal [Presence] in Serum |
| 27245-0 | Amobarbital [Mass/mass] in Stool |
| 3859-6 | Nitrazepam [Mass/volume] in Urine |
| 57471-5 | Calcitriol [Moles/volume] in Serum or Plasma --3 hours post dose calcium |
| 48904-7 | Rickettsia akari IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 27313-6 | Aspergillus niger Ab [Titer] in Serum by Immune diffusion (ID) |
| 27924-0 | Ascaris sp Ab [Titer] in Serum by Immunoassay |
| 28002-4 | Borrelia burgdorferi 39kD Ab [Presence] in Serum by Immunoblot |
| 38710-0 | Nitrobenzene [Mass/volume] in Air |
| 49395-7 | Herpes virus 7 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
| 4972-6 | HLA-DR6 [Presence] in Donor |
| 29207-8 | Amiodarone [Mass/volume] in Body fluid |
| 58624-8 | Corticotropin [Mass/volume] in Plasma --pre dose glucose |
| 58782-4 | Mycoplasma pneumoniae IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 2970-2 | Streptomyces proteinase [Presence] in Serum |
| 29872-9 | 5-Oxoproline [Presence] in Urine |
| 40375-8 | Lutropin [Units/volume] in Serum or Plasma --20 minutes post dose triple bolus |
| 50397-9 | Molecular diagnostic overall interpretation [Presence] in Blood or Tissue by Molecular genetics method |
| 50401-9 | Blood group antibody titered [Identifier] in Serum or Plasma |
| 50436-5 | Corticotropin [Mass/volume] in Plasma --3 PM specimen |
| 50441-5 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes pre dose insulin IV |
| 30204-2 | Chlamydia trachomatis Ab [Presence] in Serum |
| 30213-3 | Coxiella burnetii IgM Ab [Presence] in Serum |
| 30360-2 | Histoplasma capsulatum mycelial phase Ab [Presence] in Serum by Complement fixation |
| 40959-9 | MUTYH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 41138-9 | Influenza virus A N5 Ab [Presence] in Serum |
| 20441-2 | Glucose [Mass/volume] in Serum or Plasma --post 50 g glucose |
| 20517-9 | Aprobarbital [Mass/volume] in Urine by Confirmatory method |
| 20858-7 | Infectious bronchitis virus genotype [Identifier] in Isolate by Polyacrylamide gel electrophoresis (PAGE) |
| 12900-7 | Renin [Enzymatic activity/volume] in Plasma --2nd specimen post XXX challenge |
| 13062-5 | Platelet IgA Ab [Units/volume] in Serum |
| 101915-7 | Troponin T.cardiac [Mass/volume] in 6 hour Serum or Plasma |
| 13644-0 | 1,3-Dimethylbenzene [Mass/volume] in Blood |
| 102293-8 | White Elm IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102322-5 | Geotrichum candidum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102470-2 | Red Oak IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102536-0 | Black Cottonwood IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103016-2 | Silver Birch recombinant (rBet v) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14886-6 | Pregnanetriol [Moles/time] in 24 hour Urine |
| 11095-7 | Dieldrin [Mass/volume] in Serum or Plasma |
| 16385-7 | Androstenedione [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 16670-2 | Cortisol [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 12318-2 | Spironolactone [Presence] in Urine |
| 18482-0 | Yeast [Presence] in Specimen by Organism specific culture |
| 90267-6 | Microscopic observation [Identifier] in Pericardial fluid by Giemsa stain |
| 74638-8 | Monoclonal band 3 observed [Identifier] in Urine by Immunofixation |
| 91825-0 | Parechovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 75370-7 | Norbuprenorphine [Mass/volume] in Serum, Plasma or Blood |
| 6081-4 | Coconut IgE Ab [Units/volume] in Serum |
| 61309-1 | Sheep Sorrel IgE Ab/IgE total in Serum |
| 6289-3 | Lysozyme [Moles/volume] in Serum or Plasma |
| 78364-7 | Amphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 64962-4 | Cashew nut recombinant (rAna o) 2 IgE Ab [Units/volume] in Serum |
| 79460-2 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/substance] in Red Blood Cells |
| 95582-3 | 5-Alpha tetrahydrocortisol [Z-score] in 24 hour Urine |
| 95953-6 | Aminoglycoside Mix (Gentamycin+Lincomycin+Neomycin+Streptomycin+Tobramycin) IgE Ab [Units/volume] in Serum |
| 70046-8 | Mononuclear cells [#/volume] in Pericardial fluid by Automated count |
| 82507-5 | Oligosaccharides pattern [Interpretation] in Leukocytes by Screen method Narrative |
| 98258-7 | Distance of myoinvasive tumor from serosa [Length] in Endometrial cancer specimen |
| 85756-5 | Streptococcus pneumoniae Danish serotypes 18A+18B+18C+18F DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 99396-4 | Siderocytes.Type 1/100 Erythroblasts in Blood or Marrow by Prussian blue stain |
| 99916-9 | Cocci bacteria [#/area] in Urine sediment by Automated count |
| 72906-1 | HNA Ab panel - Serum or Plasma |
| 86581-6 | Neisseria meningitidis [Presence] in Cerebral spinal fluid by Organism specific culture |
| 73523-3 | Ampicillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88515-2 | Natural killer cell cytotoxicity.3.75:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
| 74129-8 | Transforming growth factor alpha Ag [Presence] in Tissue by Immune stain |
| 74311-2 | PRRSV ORF5 gene sequence [Nucleotide sequence] in Isolate by Sequencing |
| 89653-0 | Parainfluenza virus identified in Lower respiratory specimen by Organism specific culture |
| 5955-0 | Thrombin time in Control Platelet poor plasma by Coagulation assay |
| 59841-7 | Vendor name [Identifier] in Specimen |
| 5098-9 | Cold agglutinin [Titer] in Serum or Plasma by Agglutination |
| 30991-4 | Aspergillus fumigatus recombinant (rAsp f) 3 IgE Ab [Units/volume] in Serum |
| 21658-0 | COL2A1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 31303-1 | Chlamydophila pneumoniae IgM Ab [Units/volume] in Cerebral spinal fluid |
| 51243-4 | CD13+CD33+HLA-DR+ cells/100 cells in Bone marrow |
| 51267-3 | CD23 cells/100 cells in Cerebral spinal fluid |
| 42740-1 | Phosphatidylcholine IgA Ab B2GP1 independent [Multiple of the median] in Serum |
| 42742-7 | Phosphatidylcholine IgG Ab B2GP1 independent [Multiple of the median] in Serum |
| 42868-0 | CD11c+CD19+ cells/100 cells in Bone marrow |
| 21728-1 | PMP22 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 21779-4 | t(11;22)(q24;q12.2)(FLI1,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 31887-3 | Measles virus Ag [Presence] in Specimen |
| 5151-6 | Entamoeba histolytica Ab [Units/volume] in Serum by Hemagglutination |
| 51630-2 | Schistocytes/1000 erythrocytes in Blood by Light microscopy |
| 4364-6 | Ouabain [Mass] of Dose |
| 32564-7 | CD3+CD7+ cells/100 cells in Blood |
| 43919-0 | Beta-2-Microglobulin [Presence] in Cerebral spinal fluid |
| 22850-2 | Babesia caballi Ab [Presence] in Serum by Immunoassay |
| 22935-1 | Brucella melitensis Ab [Presence] in Serum by Complement fixation |
| 23004-5 | Classical swine fever virus Ab [Presence] in Serum |
| 32665-2 | Anticonvulsants [Identifier] in Serum or Plasma |
| 33001-9 | Rickettsia typhi IgM Ab [Presence] in Serum |
| 2336-6 | Globulin [Mass/volume] in Serum |
| 3342-3 | Amoxapine [Presence] in Urine |
| 457-2 | Spiramycin [Susceptibility] by Disk diffusion (KB) |
| 46127-7 | Haptoglobin [Mass/volume] in Serum or Plasma by Nephelometry |
| 46258-0 | oxyMORphone Free [Presence] in Serum or Plasma by Screen method |
| 47203-5 | Pyridoxine [Mass] of Dose |
| 25389-8 | Taenia solium larva IgG Ab [Units/volume] in Serum by Immunoassay |
| 25552-1 | Uroporphyrin [Moles/time] in 24 hour Stool |
| 56039-1 | Lysozyme [Units/volume] in Urine |
| 47653-1 | Insulin [Units/volume] in Serum or Plasma --10 minutes post dose glucagon |
| 35724-4 | Chlamydia sp DNA [Presence] in Throat by NAA with probe detection |
| 56219-9 | Chicory IgG4 Ab [Mass/volume] in Serum |
| 56314-8 | Maple syrup IgG4 Ab [Mass/volume] in Serum |
| 48067-3 | Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma by Immunoassay |
| 26532-2 | Cortisol [Mass/volume] in Serum or Plasma --48 hours post dose corticotropin |
| 3597-2 | Erythromycin [Mass/volume] in Serum or Plasma |
| 57002-8 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --4 days post XXX challenge |
| 48881-7 | Bartonella elizabethae IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 27193-2 | Tetrahydrocannabinol [Mass/volume] in Vitreous fluid |
| 49043-3 | Testosterone Free/Testosterone.total in Serum or Plasma by Detection limit <= 1.0 ng/dL |
| 27330-0 | Insulin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 38728-2 | 2-Aminotoluene [Mass/volume] in Air |
| 3875-2 | Nortriptyline [Mass/volume] in Urine |
| 49388-2 | Herpes virus 6 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 49540-8 | Acid citrate dextrose [Volume] in Blood product unit |
| 49557-2 | PDGFR-beta Ag [Presence] in Tissue by Immune stain |
| 49745-3 | Whitefaced Hornet IgG Ab [Mass/volume] in Serum |
| 58420-1 | Anidulafungin [Mass/volume] in Serum or Plasma |
| 49939-2 | Dodecenedioate/Creatinine [Molar ratio] in Urine |
| 50100-7 | Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Cerebral spinal fluid |
| 50150-2 | 5-Hydroxytryptophan [Moles/volume] in Serum or Plasma |
| 29652-5 | Dothiepin [Mass/volume] in Serum or Plasma |
| 40388-1 | Nitrogen [Moles/time] in 24 hour Urine |
| 50310-2 | CD7 Ag [Presence] in Tissue by Immune stain |
| 30079-8 | Renal tubular casts [#/area] in Urine by Light microscopy |
| 41003-5 | Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection |
| 4105-3 | Acetaminophen [Mass] of Dose |
| 19568-5 | Methylenedioxymethamphetamine [Presence] in Urine by Screen method |
| 20933-8 | Parasite identified in Serum by Light microscopy |
| 101538-7 | SMA residual risk [Interpretation] in Blood by Molecular genetics method Narrative |
| 13037-7 | C peptide [Mass/volume] in Serum or Plasma --fasting |
| 101760-7 | Trichophyton simii DNA [Presence] in Specimen by NAA with probe detection |
| 102218-5 | Celery IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13457-7 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation |
| 13859-4 | C peptide [Mass/volume] in Serum or Plasma --10 minutes post 1 mg glucagon IV |
| 13943-6 | Fructose [Presence] in Semen |
| 14078-0 | Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 102736-6 | Endive IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102995-8 | Fox epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14623-3 | Barbital [Presence] in Serum or Plasma |
| 104464-3 | Yersinia enterocolitica biotype [Presence] in Stool |
| 11013-0 | DNA double strand Ab [Titer] in Serum |
| 1636-0 | Somatotropin [Mass/volume] in Serum or Plasma --pre 250 ug L-dopa TID 2day PO |
| 16548-0 | carBAMazepine [Mass/volume] in Urine |
| 11247-4 | oxyMORphone [Presence] in Urine |
| 1804-4 | Amylase.P3 [Enzymatic activity/volume] in Serum or Plasma |
| 90301-3 | Toxoplasma gondii [Presence] in Amniotic fluid by Organism specific culture |
| 919-1 | B variant subtype Ab [Presence] in Serum or Plasma |
| 92652-7 | Sertraline [Presence] in Urine by Confirmatory method |
| 75349-1 | Other cells [#/volume] in Peritoneal fluid by Manual count |
| 75387-1 | INS gene full mutation analysis in Blood or Tissue by Sequencing |
| 608-0 | Bacteria identified in Ear by Aerobe culture |
| 7585-3 | Penicillium notatum triggered histamine release [Units/volume] in Blood |
| 7638-0 | Pullularia sp IgG Ab [Units/volume] in Serum |
| 92797-0 | Candida krusei DNA [Presence] by NAA with probe detection in Positive blood culture |
| 61274-7 | House dust Greer IgE Ab/IgE total in Serum |
| 61342-2 | Mouse urine proteins IgE Ab/IgE total in Serum |
| 6163-0 | Lime Tree (Citrus aurantifolia tree) IgE Ab [Units/volume] in Serum |
| 6222-4 | Queen Palm IgE Ab [Units/volume] in Serum |
| 6284-4 | Wild Silk IgE Ab [Units/volume] in Serum |
| 6321-4 | Borrelia burgdorferi IgM Ab [Presence] in Serum by Immunoblot |
| 94391-0 | Respiratory viral pathogens DNA and RNA panel - Lower respiratory specimen by NAA with probe detection |
| 94719-2 | Plazomicin [Susceptibility] by Gradient strip |
| 79197-0 | Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose arginine+insulin |
| 7928-5 | Influenza virus A Texas Ab [Units/volume] in Serum |
| 79410-7 | Penfluridol [Mass/volume] in Serum or Plasma --trough |
| 66739-4 | CYP2C19 gene c.395G>A(*6) [Presence] in Blood or Tissue by Molecular genetics method |
| 6681-1 | Microscopic observation [Identifier] in Tissue by Wright stain |
| 79507-0 | P-cresol/Creatinine [Molar ratio] in Urine |
| 79602-9 | Homocarnosine [Moles/volume] in Serum or Plasma |
| 6744-7 | Lymphocytes [#/volume] in Body fluid by Manual count |
| 80551-5 | Tetrahydrocannabinol [Mass/mass] in Hair |
| 8115-8 | CD16 cells/100 cells in Blood |
| 81312-1 | Cryoglobulin.IgM [Presence] in Serum |
| 96638-2 | HLA-DP and DQ and DR (class II) typing panel - Blood or Tissue from Donor by Low resolution |
| 7087-0 | Red Ant IgE Ab [Units/volume] in Serum |
| 82972-1 | Butabarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 98234-8 | Quail meat IgE Ab [Units/volume] in Serum |
| 99029-1 | Staphylococcus aureus DNA [Presence] in Urine by NAA with probe detection |
| 99058-0 | DHCR7 gene full mutation analysis in Blood or Tissue by Sequencing |
| 72394-0 | Cell count panel - Vitreous fluid by Manual count |
| 99887-2 | Hyaline-granular casts [#/volume] in Urine sediment by Computer assisted method |
| 86192-2 | 4-Methylethcathinone [Mass/volume] in Urine by Confirmatory method |
| 73239-6 | Nizatidine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86696-2 | Rotavirus B RNA [Nucleotide sequence] in Isolate by Sequencing |
| 73399-8 | Erythropoietin (EPO) induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87978-3 | Fungus identified in Peritoneal dialysis fluid by Culture |
| 87984-1 | Toxoplasma gondii DNA [Presence] in Tissue by NAA with probe detection |
| 73953-2 | JWH-073 (synthetic cannabinoid) [Presence] in Blood |
| 50612-1 | Chlamydophila pneumoniae IgA and IgG and IgM [Interpretation] in Serum |
| 30406-3 | Leukocytes other [#/volume] in Blood |
| 31266-0 | Bordetella pertussis Ab [Units/volume] in Specimen |
| 31492-2 | Lymphocytic choriomeningitis virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 51058-6 | CD127 blasts [Units/volume] in Bone marrow |
| 51204-6 | Silicon [Mass/mass] in Hair |
| 22119-2 | Borrelia burgdorferi Ab [Units/volume] in Cerebral spinal fluid |
| 51916-5 | Herpes simplex virus 1 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 43235-1 | Acrylylcarnitine (C3:1) [Moles/volume] in Serum or Plasma |
| 22424-6 | Mycoplasma meleagridis Ab [Presence] in Serum |
| 22462-6 | Reagin Ab [Units/volume] in Serum |
| 32104-2 | PENTobarbital [Presence] in Specimen |
| 52922-2 | Strontium/Creatinine [Molar ratio] in Urine |
| 44342-4 | Normetanephrine/Creatinine [Mass Ratio] in 24 hour Urine |
| 53120-2 | Creatinine [Moles/time] in 1 hour Urine |
| 4443-8 | Ticarcillin [Mass] of Dose |
| 33334-4 | Quinupristin+Dalfopristin [Susceptibility] by Gradient strip |
| 33339-3 | Zolpidem [Mass/volume] in Urine |
| 33600-8 | Neuronal nuclear Ab [Units/volume] in Serum by Immunofluorescence |
| 53950-2 | HPA 1a/1a+Gp IIb/IIIa [Presence] in Blood |
| 44916-5 | Cortisol [Moles/volume] in Serum or Plasma --pre XXX challenge |
| 45375-3 | Time of analysis of unspecified specimen |
| 54179-7 | Itraconazole [Susceptibility] by Disk diffusion (KB) |
| 46729-0 | Weight container+Specimen of Stool |
| 24272-7 | Coxsackievirus B6 Ab [Titer] in Serum --2nd specimen |
| 34644-5 | Tenofovir [Susceptibility] by Phenotype method |
| 25120-7 | Octanoate (C8:0)/Creatinine [Molar ratio] in Urine |
| 25185-0 | Streptomycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25463-1 | Lithium [Moles/volume] in Urine |
| 56033-4 | Androstenediol [Mass/time] in 24 hour Urine |
| 35478-7 | Cytosol aminopeptidase [Enzymatic activity/time] in 24 hour Urine |
| 56442-7 | Pork IgG4 Ab [Mass/volume] in Serum |
| 26497-8 | Mononuclear cells/100 leukocytes in Synovial fluid |
| 5675-4 | Lead [Presence] in Urine |
| 57022-6 | CBC W Reflex Manual Differential panel - Blood |
| 38429-7 | Ibuprofen [Mass/volume] in Serum or Plasma --30 minutes post dose |
| 57320-4 | Trypanosoma cruzi Ab [Presence] in Serum or Plasma by Immunoassay |
| 57636-3 | Alpha cortolone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
| 27905-9 | Bacteroides fragilis IgM Ab [Units/volume] in Serum |
| 38926-2 | Macroprolactin [Mass/volume] in Serum or Plasma |
| 577-7 | Fungus identified in Sputum by Culture |
| 4944-5 | HLA-DQ7(3) [Presence] in Donor |
| 49622-4 | Tipranavir+Ritonavir [Susceptibility] by Genotype method |
| 29509-7 | Beta hydroxybutyrate/Creatinine [Molar ratio] in Urine |
| 40165-3 | Glucose [Moles/volume] in Serum or Plasma --6 hours post XXX challenge |
| 40194-3 | Glucose [Moles/volume] in Serum or Plasma --20 minutes pre XXX challenge |
| 58442-5 | Other elements [Identifier] in Urine sediment by Light microscopy |
| 58537-2 | Corticotropin [Moles/volume] in Plasma --105 minutes post dose insulin IV |
| 50047-0 | Hemicystine [Moles/volume] in DBS |
| 29965-1 | Sjogrens syndrome-B extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
| 40559-7 | Cytokeratin 7 Ag [Presence] in Tissue by Immune stain |
| 58835-0 | Testosterone [Mass/volume] in Serum or Plasma --baseline |
| 59040-6 | Cancer Ag 125 [Units/volume] in Peritoneal dialysis fluid |
| 30206-7 | Choriogonadotropin.alpha subunit free [Units/volume] in Serum or Plasma |
| 30246-3 | Cytomegalovirus DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 19450-6 | Dihydrocodeine cutoff [Mass/volume] in Urine for Screen method |
| 2016-4 | Carbamoyl phosphate synthetase [Enzymatic activity/volume] in Serum |
| 100788-9 | Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum |
| 101249-1 | Delta-8-tetrahydrocannabinol [Mass/volume] in Urine by LC/MS/MS |
| 13184-7 | Cottonwood IgG Ab [Units/volume] in Serum |
| 13354-6 | Band form neutrophils/100 leukocytes in Body fluid by Manual count |
| 101678-1 | Blood group antibody screen [Presence] in Blood from Newborn |
| 101764-9 | Trichophyton benhamiae (white) DNA [Presence] in Specimen by NAA with probe detection |
| 13754-7 | Hippurate/Creatinine [Mass Ratio] in Urine |
| 13909-7 | Tamoxifen [Mass/volume] in Serum or Plasma |
| 13941-0 | Lymphocytes/100 leukocytes in Body fluid by Manual count |
| 103114-5 | Apple recombinant (rMal d) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14408-9 | Phosphate [Mass/volume] in Amniotic fluid |
| 103654-0 | Meropenem [Susceptibility] for meningitis |
| 10390-3 | Blood product special preparation [Type] |
| 10621-1 | Spermatozoa Normal Head/100 spermatozoa in Semen |
| 16597-7 | Chlamydia trachomatis B IgG Ab [Units/volume] in Serum |
| 11219-3 | Immunoglobulin light chains [Presence] in Serum |
| 11590-7 | Coxsackievirus A10 Ab [Units/volume] in Serum |
| 17152-0 | CD42d cells/100 cells in Blood |
| 17260-1 | Methamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 17420-1 | Parrot droppings Ab [Units/volume] in Serum |
| 18897-9 | Cephalexin [Susceptibility] |
| 90413-6 | T-cell regulatory (Treg) subsets panel - Blood |
| 91105-7 | Cholesterol in LDL 1 [Mass/volume] in Serum or Plasma |
| 75717-9 | CYP1A2 gene c.3497G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 60533-7 | Mycoplasma pneumoniae Ab [Titer] in Serum by Latex agglutination |
| 76041-3 | levoFLOXacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 93440-6 | Herpes simplex virus 1 and 2 DNA panel - Blood by NAA with non-probe detection |
| 6217-4 | Pigeon droppings IgE Ab [Units/volume] in Serum |
| 6220-8 | Potato IgE Ab [Units/volume] in Serum |
| 6223-2 | Rabbit epithelium IgE Ab [Units/volume] in Serum |
| 93725-0 | Heparan sulfate [Mass/volume] in Serum or Plasma |
| 7779-2 | Wingscale IgE Ab [Units/volume] in Serum |
| 77925-6 | Cortisol [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 79242-4 | Methylone cutoff [Mass/volume] in Urine for Confirmatory method |
| 79310-9 | Gamma butyrobetaine [Moles/volume] in DBS |
| 95106-1 | Glucose [Mass/volume] in Serum or Plasma --3 hours post meal |
| 6605-0 | Leptospira interrogans Ag [Presence] in Tissue by Immunofluorescence |
| 68385-4 | Glomerular basement membrane Ab [Presence] in Serum |
| 81143-0 | Galactokinase [Enzymatic activity/mass] in Red Blood Cells |
| 9780-8 | Spermatozoa [#/volume] in Semen |
| 97955-9 | European Hornet IgG4 Ab [Mass/volume] in Serum |
| 71595-3 | Basophils/Leukocytes [Pure number fraction] in Bronchial specimen by Manual count |
| 82484-7 | TRBV24-1 gene segment/TRBV gene segments.total in Blood |
| 9803-8 | Texture of Stone |
| 99022-6 | Klebsiella pneumoniae DNA [Presence] in Urine by NAA with probe detection |
| 84872-1 | Epstein Barr virus nuclear 1 IgG Ab [Presence] in Serum by Rapid immunoassay |
| 85338-2 | LCIS [Presence] in Breast cancer specimen by Light microscopy |
| 86063-5 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum by Immunoassay |
| 86148-4 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum by Immunoassay |
| 73029-1 | Clopidogrel induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87464-4 | Monensin [Mass/volume] in Specimen |
| 87766-2 | 10-Hydroxycarbazepine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 88152-4 | Microscopic observation [Identifier] in Cervix by Acid fast stain.Kinyoun |
| 74231-2 | Erythropoiesis assessment in Bone marrow Narrative |
| 7428-6 | Iodinebush IgE Ab [Units/volume] in Serum |
| 59893-8 | Desipramine [Moles/volume] in Gastric fluid |
| 50780-6 | Cancer Ag 19-9 [Units/volume] in Pericardial fluid |
| 60072-6 | Fexofenadine [Mass/volume] in Blood |
| 4282-0 | Imipenem [Mass] of Dose |
| 22284-4 | Ehrlichia chaffeensis IgG Ab [Units/volume] in Serum |
| 51619-5 | Creatinine [Moles/volume] in Serum or Plasma --pre dialysis |
| 43722-8 | 5-Ethyl-5-Phenylhydantoin [Presence] in Specimen |
| 22577-1 | Toxoplasma gondii Ab [Presence] in Serum |
| 5270-4 | Parainfluenza virus 3 Ab [Titer] in Serum by Complement fixation |
| 53298-6 | Triple phosphate crystals [#/volume] in Urine by Computer assisted method |
| 4479-2 | Complement C1q Ag [Moles/volume] in Serum or Plasma |
| 23302-3 | Mycoplasma synoviae Ab [Presence] in Serum by Hemagglutination |
| 33667-7 | Prostate specific Ag.protein bound [Mass/volume] in Serum or Plasma |
| 53942-9 | Vibrio cholerae toxin ctx gene [Presence] in Specimen by NAA with probe detection |
| 2403-4 | Hemopexin [Mass/volume] in Serum |
| 34181-8 | Methanol [Presence] in Urine by Confirmatory method |
| 54377-7 | Cobalamin (Vitamin B12) [Mass/volume] in Body fluid |
| 24430-1 | Streptococcus suis serotype [Identifier] in Isolate by Agglutination |
| 34357-4 | Porphobilinogen/Creatinine [Molar ratio] in Urine |
| 34590-0 | von Willebrand factor (vWf) cleaving protease inhibitor [Presence] in Platelet poor plasma |
| 55299-2 | Human papilloma virus 6+11+42+43+44 DNA [Presence] in Specimen by Probe with signal amplification |
| 47201-9 | Bentiromide [Mass] of Dose |
| 4725-8 | HLA-A26(10) [Presence] |
| 34954-8 | Treponema pallidum IgG and IgM panel - Serum |
| 35321-9 | Protein [Mass/volume] in Body fluid --3rd specimen post Sincalide |
| 55863-5 | Glycolate [Mass/volume] in Body fluid |
| 25623-0 | Cortisol [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 2581-7 | Gonadotropin releasing hormone [Moles/volume] in Serum or Plasma |
| 35433-2 | Herpes simplex virus identified in Urethra by Organism specific culture |
| 56180-3 | Aspergillus fumigatus IgG4 Ab [Mass/volume] in Serum |
| 56291-8 | Dust Allergen Mix 2 (Cockroach+American house dust mite+European house dust mite+House dust Hollister Stier) IgG4 Ab [Mass/volume] in Serum |
| 3651-7 | fluPHENAZine [Mass/volume] in Urine |
| 36901-7 | West Nile virus NS5 Ab [Presence] in Specimen |
| 5658-0 | Gold [Mass/mass] in Hair |
| 48399-0 | Herpes simplex virus 1 glycoprotein G IgG Ab [Units/volume] in Cerebral spinal fluid |
| 48598-7 | BBS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 48823-9 | Tubular basement membrane IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 38560-9 | Spermatozoa.tail Motile w IgA/100 spermatozoa in Semen by Immunobead |
| 48928-6 | Respiratory allergen panel, US - Inland northwest b - Serum |
| 5835-4 | Cytomegalovirus [Presence] in Blood by Organism specific culture |
| 29241-7 | Mumps virus IgG Ab [Units/volume] in Body fluid |
| 40037-4 | Glucose [Mass/volume] in Serum or Plasma --25 hours post XXX challenge |
| 58803-8 | Acetone/Creatinine [Mass Ratio] in Urine |
| 59071-1 | Tropheryma whipplei Ab [Presence] in Serum |
| 50223-7 | Cholesterol crystals [Presence] in Urine by Computer assisted method |
| 19503-2 | Methotrimeprazine [Presence] in Urine by Confirmatory method |
| 13147-4 | Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum --1st specimen |
| 13158-1 | Streptococcus pneumoniae Danish serotype 18C Ab [Units/volume] in Serum --2nd specimen |
| 13396-7 | Glutamine [Mass/volume] in Amniotic fluid |
| 102126-0 | Wattle IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13914-7 | Adenovirus IgG Ab [Units/volume] in Serum |
| 102255-7 | Cottonseed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14101-0 | Strychnine [Mass/volume] in Gastric fluid |
| 102851-3 | Chicken serum proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103201-0 | Yersinia enterocolitica DNA [Presence] in Wound by NAA with probe detection |
| 104238-1 | Chronic and low grade B cell lymphoid neoplasm multigene analysis in Blood or Tissue by Molecular genetics method |
| 10488-5 | IgA Ag [Presence] in Tissue by Immune stain |
| 10692-2 | Mushroom.toxic identified in Food by Light microscopy |
| 16295-8 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --post XXX challenge |
| 16543-1 | Cannabinoids [Mass/volume] in Unknown substance by Confirmatory method |
| 16622-3 | Clindamycin [Mass/volume] in Serum or Plasma --trough |
| 16959-9 | Herpes simplex virus 2 DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 17319-5 | Nalidixate [Mass/volume] in Serum or Plasma |
| 17356-7 | Neutrophil cytoplasmic IgM Ab [Presence] in Serum |
| 17957-2 | Bacteria # 2 identified in Body fluid by Anaerobe culture |
| 19088-4 | Collection of urine specimen start date |
| 75596-7 | Fetal 5p deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
| 63143-2 | Catfish IgG Ab [Mass/volume] in Serum |
| 94547-7 | SARS-CoV-2 (COVID-19) IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 78889-3 | Tricyclic antidepressants [Presence] in Urine by Screen method >300 ng/mL |
| 94857-0 | Microscopic observation [Presence] in Sputum by Acid fast stain --3rd specimen |
| 79512-0 | Vanilloylglycine [Moles/volume] in Serum or Plasma |
| 79573-2 | Riboflavin and flavin mononucleotide and flavin adenine dinucleotide panel - Serum or Plasma |
| 7964-0 | Measles virus RNA [Presence] in Nose by NAA with probe detection |
| 80120-9 | Acenocoumarol [Mass/mass] in Hair |
| 68372-2 | Nuclear Ab [Presence] in Synovial fluid by Immunofluorescence |
| 80560-6 | Citalopram [Mass/volume] in DBS |
| 80629-9 | 1,2,2-Trimethylpropyl methylphosphonate [Mass/volume] in Blood |
| 69952-0 | Liver kidney microsomal 1 IgG Ab [Presence] in Serum by Immunoassay |
| 81884-9 | NIPA1 and REEP1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 82047-2 | Epidermal Allergen Mix 2 (Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) IgE Ab [Units/volume] in Serum by Multidisk |
| 97300-8 | PHENobarbital [Presence] in Cord tissue by Screen method |
| 98115-9 | Chemokine (C-X-C motif) ligand 9 [Mass/volume] in Serum or Plasma |
| 72208-2 | t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
| 72447-6 | 3-Hydroxysebacate ( 3-OH-C8) [Moles/volume] in Cerebral spinal fluid |
| 85286-3 | Promoter methylation testing method [Type] in Cancer specimen |
| 99278-4 | Flubromazolam [Mass/volume] in Urine by Confirmatory method |
| 99306-3 | Choriogonadotropin.beta subunit heterophile Ab interference panel - Serum |
| 99772-6 | SARS-CoV-2 stimulated gamma interferon [Interpretation] in Blood Qualitative |
| 86341-5 | Streptococcus pneumoniae Danish serotype 6A+6B Ab [Units/volume] in Serum --1st specimen |
| 73194-3 | Primidone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87424-8 | Cytomegalovirus IgG and IgM panel - Serum or Plasma Qualitative |
| 87621-9 | Bordetella parapertussis IS1001 DNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 73527-4 | Amoxicillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73903-7 | CD3-CD57+ cells/100 leukocytes in Blood by Flow cytometry (FC) |
| 4149-1 | Butalbital [Mass] of Dose |
| 5933-7 | Lead [Mass/volume] in Dialysis fluid |
| 50907-5 | Silicon [Moles/time] in 24 hour Urine |
| 30437-8 | Monocytes+Macrophages/100 leukocytes in Body fluid |
| 30461-8 | Polymorphonuclear cells/100 leukocytes in Stool |
| 3057-7 | Triokinase [Enzymatic activity/volume] in Plasma |
| 30932-8 | Manganese [Mass/volume] in Urine collected for unspecified duration |
| 31117-5 | Euploid+Aneuploid cells population 2/100 cells in Specimen |
| 59975-3 | traZODone [Moles/volume] in Urine |
| 60067-6 | Cobalt [Mass/mass] in Tissue |
| 21327-2 | Herpes simplex virus 2 IgM Ab [Titer] in Serum |
| 21351-2 | IgM [Presence] in Cerebral spinal fluid by Immunofixation |
| 31368-4 | Epidermis Ab [Units/volume] in Serum |
| 5127-6 | Cytomegalovirus IgM Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 21768-7 | SCA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 22135-8 | Borrelia burgdorferi IgM Ab [Presence] in Serum |
| 31614-1 | Ross River virus IgG Ab [Presence] in Serum |
| 32036-6 | Polymorphonuclear cells [Presence] in Pericardial fluid by Wright stain |
| 51625-2 | Malignant cells/100 cells in Body fluid by Manual count |
| 22496-4 | Rubella virus Ab [Presence] in Serum |
| 32352-7 | Alkaline phosphatase.heat stable [Enzymatic activity/volume] in Serum or Plasma by Heat stability |
| 51968-6 | Discrete variation analysis overall interpretation |
| 51982-7 | lamoTRIgine [Presence] in Serum or Plasma |
| 5293-6 | Reovirus Ab [Units/volume] in Serum |
| 44036-2 | Analgesics Non-narcotic [Presence] in Urine |
| 22841-1 | Avian pox virus Ab [Presence] in Serum by Immunoassay |
| 53100-4 | Calcium [Moles/volume] in Total parental nutrition |
| 23452-6 | Taenia sp eggs [Presence] in Stool by NAA with probe detection |
| 33495-3 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post dose lactose PO |
| 33603-2 | Bactericidal permeability increasing protein IgG Ab [Units/volume] in Serum |
| 33906-9 | Prolactin [Moles/volume] in Serum or Plasma --30 minutes post 200 ug TRH IV |
| 33936-6 | Homocystine Free [Moles/volume] in Urine |
| 33963-0 | Granulocytes/100 leukocytes in Cerebral spinal fluid |
| 33978-8 | BK virus DNA [Presence] in Urine by NAA with probe detection |
| 34199-0 | Neutrophils.hypersegmented [Presence] in Blood by Automated count |
| 45384-5 | Leucine crystals [#/area] in Urine sediment by Microscopy low power field |
| 24302-2 | Coxsackievirus A16 Ab [Titer] in Serum --1st specimen |
| 34705-4 | Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood |
| 55096-2 | Nocardia sp identified in Isolate |
| 47071-6 | Babesia microti IgG Ab [Titer] in Cerebral spinal fluid |
| 4716-7 | HLA-A11 [Presence] |
| 47236-5 | Treponema pallidum IgG+IgM Ab [Presence] in Serum by Immunoassay |
| 47458-5 | Influenza virus A H9 Ab [Titer] in Serum |
| 3497-5 | Clopenthixol [Mass/volume] in Urine |
| 35436-5 | Spermatozoa [Presence] in Semen by Light microscopy --post reanastomosis |
| 48113-5 | Heptadecenoate/Creatinine [Molar ratio] in Urine |
| 26723-7 | Varicella zoster virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 35846-5 | Tiamulin [Susceptibility] by Disk diffusion (KB) |
| 3747-3 | Meperidine [Mass/volume] in Urine |
| 48729-8 | CYBA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 48772-8 | Lambda light chains [Mass/volume] in Cerebral spinal fluid |
| 38355-4 | Chitotriosidase [Enzymatic activity/volume] in Serum or Plasma |
| 57660-3 | Ganglioside GQ1b IgG Ab [Units/volume] in Serum by Immunoassay |
| 49297-5 | Protein Fractions [Interpretation] in Serum or Plasma by Immunofixation Narrative |
| 27820-0 | Protein C Ag actual/normal in Platelet poor plasma by Immunoassay |
| 27967-9 | Progesterone [Mass/volume] in Serum or Plasma --baseline |
| 38922-1 | PTCH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 57703-1 | Hemoglobin disorders newborn screening comment-discussion |
| 58032-4 | White Elm IgG Ab [Mass/volume] in Serum |
| 4934-6 | HLA-DQ2 [Presence] in Donor |
| 49400-5 | Herpes virus 7 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 49726-3 | Endomysium IgG Ab [Titer] in Serum |
| 40084-6 | Calcium [Mass/volume] in Serum or Plasma --36 hours post XXX challenge |
| 58706-3 | OmpC IgA Ab [Presence] in Serum by Immunoassay |
| 50024-9 | Virus identified in Specimen by Shell vial culture |
| 58870-7 | Somatotropin [Mass/volume] in Serum or Plasma --38th specimen |
| 50342-5 | Ependymal+Choroid plexus cells/100 leukocytes [Ratio] in Cerebral spinal fluid |
| 41065-4 | PTPN11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 20540-1 | Levorphanol [Mass/volume] in Urine by Confirmatory method |
| 20542-7 | Lysergate diethylamide [Mass/volume] in Urine by Confirmatory method |
| 20814-0 | Escherichia coli F41 [Presence] in Small intestine Tissue by Immunofluorescence |
| 100706-1 | Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection |
| 12812-4 | Potassium [Moles/volume] in Serum or Plasma --2nd specimen |
| 13200-1 | Rickettsia conorii IgM Ab [Units/volume] in Serum |
| 101936-3 | Candida albicans DNA [Presence] in Specimen by NAA with probe detection |
| 101958-7 | ADAMTS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 101983-5 | Influenza virus A+B RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 13547-5 | Butriptyline [Presence] in Serum or Plasma |
| 102303-5 | Fennel Seed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102561-8 | Western Ragweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14524-3 | Rubella virus Ag [Presence] in Throat by Immunofluorescence |
| 1458-9 | Creatinine [Mass/volume] in 24 hour Urine --pre 500 ug dexamethasone PO 2.5 day low dose q6h |
| 10350-7 | Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay |
| 14920-3 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma |
| 15223-1 | Food Allergen Mix B (Tarragon+Lovage+Marjoram) IgE Ab [Presence] in Serum by Multidisk |
| 104287-8 | SLCO1B1 gene.c.521T>C [Presence] in Blood or Tissue by Molecular genetics method |
| 10502-3 | Lutropin Ag [Presence] in Tissue by Immune stain |
| 10644-3 | Arthropod identified in Specimen |
| 15491-4 | Mycoplasma synoviae rRNA [Presence] in Serum by Probe |
| 1575-0 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --48 hours post 40 ug corticotropin IM BID 3 day |
| 11098-1 | Malaoxon [Mass/volume] in Serum or Plasma |
| 16547-2 | Carbamate pesticides [Type] in Urine |
| 1230-2 | M Ag [Presence] on Red Blood Cells from Donor |
| 16964-9 | Hexacarboxylporphyrin [Mass/volume] in Stool |
| 17170-2 | CD50 cells/100 cells in Blood |
| 17254-4 | Mercury [Mass/volume] in Food |
| 17667-7 | Sulfate.organic/Sulfate.total in Urine |
| 19113-0 | IgE [Units/volume] in Serum or Plasma |
| 90243-7 | Natural killer cell cytotoxicity.IL-stimulated 1.88:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
| 90809-5 | Candida parapsilosis DNA [Presence] in Serum by NAA with probe detection |
| 92694-9 | Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection |
| 75029-9 | Zanamivir [Susceptibility] by Genotype method |
| 60333-2 | Sulfamethoxazole [Moles/volume] in Specimen |
| 93496-8 | Nortriptyline [Presence] in Urine by Screen method |
| 77644-3 | HLA-DP IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
| 77666-6 | Methicillin resistance mecA mRNA [Presence] by FISH in Positive blood culture |
| 78525-3 | Platelet aggregation arachidonate induced in Platelet rich plasma --1.6 mmol/L |
| 94387-8 | Neuronal nuclear type 2 IgG Ab [Presence] in Serum by Line blot |
| 6476-6 | Mumps virus IgG Ab [Presence] in Serum by Immunoassay |
| 68404-3 | Lymphocytes [#/volume] in Pericardial fluid by Manual count |
| 68464-7 | Insulin [Units/volume] in Serum or Plasma --1.25 hours post XXX challenge |
| 81651-2 | Murray Valley encephalitis virus RNA [Presence] in Specimen by NAA with probe detection |
| 97870-0 | Zika virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 7058-1 | Trovafloxacin [Susceptibility] by Gradient strip |
| 82502-6 | Ethylmalonate [Moles/volume] in DBS |
| 82520-8 | Velpatasvir [Susceptibility] by Genotype method |
| 862-3 | A2 B Ag [Presence] on Red Blood Cells |
| 86516-2 | Coxsackievirus A Ab [Titer] in Serum by Complement fixation |
| 87374-5 | Escherichia coli K99 DNA [Presence] in Isolate by NAA with probe detection |
| 73613-2 | Premafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 73729-6 | Meperidine [Presence] in Hair |
| 88909-7 | Respiratory syncytial virus Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
| 59368-1 | Leptospira interrogans sv Bataviae Ab [Titer] in Serum by Agglutination |
| 59596-7 | 7-Aminoclonazepam [Mass/mass] in Tissue |
| 3058-5 | Triosephosphate isomerase [Enzymatic activity/volume] in Serum |
| 42638-7 | Prothrombin time (PT) in Platelet poor plasma by Coagulation 1:1 saline |
| 6020-2 | Alternaria alternata IgE Ab [Units/volume] in Serum |
| 21294-4 | Gastrin [Mass/volume] in Serum or Plasma --4 hours post 0.2 U/kg secretin |
| 51105-5 | CD19 blasts [Units/volume] in Specimen |
| 51336-6 | CD19+CD43+ cells/100 cells in Body fluid |
| 42900-1 | Carrot IgE Ab/IgE total in Serum |
| 42965-4 | Saint Louis encephalitis virus IgM Ab [Presence] in Serum |
| 51768-0 | Glucose [Mass/volume] in Serum or Plasma --3 hours post dose fructose PO |
| 22386-7 | Legionella pneumophila 3 IgM Ab [Titer] in Serum |
| 32249-5 | Hydroxyproline [Moles/volume] in Body fluid |
| 53063-4 | Beta alanine [Moles/volume] in DBS |
| 22814-8 | Avian infectious laryngotracheitis virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 32576-1 | Bartonella henselae IgM Ab [Presence] in Serum |
| 33353-4 | Alanine aminopeptidase [Enzymatic activity/volume] in Urine |
| 45147-6 | Propiomazine [Presence] in Serum or Plasma |
| 33818-6 | Insulin [Units/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 4683-9 | Sulfhemoglobin [Mass/volume] in Blood |
| 47428-8 | Aspergillus niger H Ab [Presence] in Serum |
| 25540-6 | Threonine [Moles/time] in 24 hour Urine |
| 35122-1 | MTM1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55920-3 | C peptide [Mass/volume] in 24 hour Urine |
| 56119-1 | Cellular material [Mass/mass] of Stone by Estimated |
| 56133-2 | Cholesterol in HDL 2b [Moles/volume] in Serum or Plasma |
| 3538-6 | Dextromethorphan [Presence] in Serum or Plasma |
| 5628-3 | Cobalt [Mass/volume] in Urine |
| 56436-9 | Zucchini IgG4 Ab [Mass/volume] in Serum |
| 56512-7 | Porphyrins [Mass/mass] in Stool |
| 47974-1 | THRB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 48207-5 | Egg yolk triggered leukotriene release [Mass/volume] by Leukocytes |
| 26733-6 | Butabarbital [Mass/mass] in Stool |
| 35840-8 | Spectinomycin [Susceptibility] by Gradient strip |
| 359-0 | Netilmicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 56595-2 | Latex recombinant (rHev b) 3 IgE Ab [Units/volume] in Serum |
| 56957-4 | Methionine/Creatinine [Ratio] in 24 hour Urine |
| 4862-9 | HLA-Cw7 [Presence] in Donor |
| 48733-0 | NCF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 26960-5 | Trypsin [Presence] in Stool |
| 5722-4 | Selenium [Mass/volume] in Blood |
| 57685-0 | Cortisol [Mass/volume] in Saliva (oral fluid) --2nd specimen |
| 490-3 | Temafloxacin [Susceptibility] by Serum bactericidal titer |
| 27318-5 | Mycoplasma pneumoniae Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 3963-6 | Phenylpropanolamine [Presence] in Serum or Plasma |
| 49351-0 | Cytomegalovirus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
| 49676-0 | Lymphocyte proliferation stimulated by 1 umol beryllium [Ratio] in Blood --5 days post incubation |
| 50008-2 | Mixing studies [Interpretation] in Platelet poor plasma Narrative |
| 40455-8 | Ceruloplasmin actual/normal in Serum or Plasma |
| 50358-1 | Phenylacetate/Creatinine [Molar ratio] in 24 hour Urine |
| 41100-9 | GJB6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19233-6 | Bicarbonate [Moles/volume] standard in Mixed venous blood |
| 19528-9 | Lysergate diethylamide [Presence] in Urine by Screen method |
| 19643-6 | oxyCODONE [Presence] in Urine by Confirmatory method |
| 20482-6 | Granulocytes [#/volume] in Blood by Automated count |
| 20748-0 | Carbamates [Presence] in Tissue by Screen method |
| 2099-0 | Cholinesterase [Enzymatic activity/volume] in Red Blood Cells |
| 12775-3 | Mercury [Mass/volume] in Dentin |
| 13195-3 | Ehrlichia chaffeensis Ab [Units/volume] in Serum |
| 102129-4 | Smooth Alder IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102629-3 | Timothy IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14098-8 | Dimethylsulfoxide [Mass/volume] in Serum or Plasma |
| 1433-2 | Cortisol [Mass/volume] in Serum or Plasma --72 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 14650-6 | Citrate [Moles/time] in 24 hour Urine |
| 10357-2 | Microscopic observation [Identifier] in Wound by Gram stain |
| 15024-3 | Amylase S2/Amylase.total in Serum or Plasma |
| 10723-5 | Toxoplasma gondii IgA Ab [Units/volume] in Serum by Immunoassay |
| 1820-0 | Alpha melanocyte stimulating hormone [Mass/volume] in Serum or Plasma |
| 18877-1 | Cefatrizine [Susceptibility] |
| 90068-8 | Gram negative bacilli identified in Isolate by Organism specific culture |
| 90306-2 | Mycobacterium sp identified in Specimen by Sequencing |
| 90886-3 | Influenza virus B RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 7555-6 | Orris root IgE Ab [Units/volume] in Serum |
| 60392-8 | Black Pepper IgG Ab [Mass/volume] in Serum |
| 61202-8 | Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab/IgE total in Serum by Multidisk |
| 7656-2 | Raspberry IgE Ab [Units/volume] in Serum |
| 93409-1 | Platelet aggregation EPINEPHrine induced in Platelet rich plasma --5 umol/L |
| 61284-6 | Cajeput tree IgE Ab/IgE total in Serum |
| 61365-3 | Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection |
| 62305-8 | Fabry disease newborn screen interpretation |
| 77044-6 | ACAD8 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 93933-0 | ABO and Rh group post hematopoietic stem cell transplant panel - Blood |
| 93974-4 | Iohexol [Mass/volume] in Serum or Plasma |
| 94003-1 | Urea nitrogen [Mass/volume] in Serum or Plasma --1 hour post dose vasopressin |
| 78378-7 | PON1 gene c.575A>G [Presence] in Blood or Tissue by Molecular genetics method |
| 78811-7 | Buprenorphine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 945-6 | C Ab [Presence] in Serum or Plasma |
| 63545-8 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Body fluid |
| 7887-3 | Filaria Ab [Units/volume] in Serum |
| 79677-1 | Purine and Pyrimidine pattern [Interpretation] in Urine Narrative |
| 6781-9 | IgG [Mass/volume] in Urine by Immunoassay |
| 80638-0 | Beta-amanitin [Mass/volume] in Urine |
| 96900-6 | SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection |
| 8217-2 | Opiates [Mass/volume] in Serum or Plasma |
| 70268-8 | Cholesterol in pleural fluid/Cholesterol in serum |
| 83084-4 | Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay |
| 85090-9 | Citalopram and norcitalopram and didesmethylcitalopram panel - Serum or Plasma |
| 85427-3 | Meropenem+Vaborbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 86622-8 | MRSA SCCmec and mecA+mecC genes panel - Nose |
| 87343-0 | Pseudorabies virus glycoprotein 1 Ab/Negative control in Serum by Immunoassay |
| 74216-3 | Fondaparinux [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 59585-0 | GSTP1 gene+APC gene methylation [Presence] in Tissue by Molecular genetics method |
| 59749-2 | Temazepam [Mass/mass] in Meconium by Confirmatory method |
| 50748-3 | Alpha-2-Macroglobulin/Creatinine [Mass Ratio] in Urine |
| 3105-4 | Urobilinogen [Presence] in Stool |
| 420-0 | Polymyxin B [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 42226-1 | Thallium/Creatinine [Molar ratio] in Urine |
| 60013-0 | Cortisol [Moles/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 51133-7 | CD24 blasts/100 blasts in Specimen |
| 51218-6 | CD10+CD19+ cells/100 cells in Cerebral spinal fluid |
| 5133-4 | Streptococcal DNAse B [Units/volume] in Serum |
| 42734-4 | Cardiolipin IgM Ab B2GP1 independent [Multiple of the median] in Serum |
| 31646-3 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum --2nd specimen |
| 51542-9 | Aspergillus versicolor IgG Ab [Presence] in Serum |
| 51886-0 | Autologous whole blood units given [#] |
| 51895-1 | Lot number of Blood product unit |
| 438-2 | Rolitetracycline [Susceptibility] by Serum bactericidal titer |
| 52892-7 | Aluminum [Moles/mass] in Tissue |
| 53254-9 | Parainfluenza virus 3 RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 53451-1 | Uracil arabinoside [Mass/volume] in Serum or Plasma |
| 4456-0 | Trimipramine [Mass] of Dose |
| 23271-0 | Mycoplasma capricolum ss capripneumonia rRNA [Presence] in Specimen by Probe |
| 23428-6 | Salmonella gallinarum Ab [Presence] in Serum by Immunoassay |
| 23606-7 | Tritrichomonas foetus [Presence] in Genital fluid by Organism specific culture |
| 23614-1 | Trimethoprim [Susceptibility] by Method for Slow-growing mycobacteria |
| 23849-3 | Creosol [Mass/volume] in Serum or Plasma |
| 23920-2 | Osmotic fragility of Red Blood Cells--0.65% sodium chloride 24 hour 37 degree C incubation |
| 54315-7 | Methylmalonate [Moles/volume] in Cerebral spinal fluid |
| 46435-4 | Rheumatoid factor and Cyclic citrullinated peptide IgG Ab [Interpretation] in Serum |
| 55095-4 | Adenovirus [Presence] in Specimen by Organism specific culture |
| 55519-3 | Testosterone [Moles/volume] in Serum or Plasma --baseline |
| 47182-1 | Progesterone [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 25139-7 | Tryptophan/Creatinine [Molar ratio] in Urine |
| 55681-1 | Isoconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 5606-9 | Boron [Mass/volume] in Red Blood Cells |
| 47766-1 | Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose insulin IV |
| 35438-1 | HIV 1 Ab [Units/volume] in Saliva (oral fluid) by Immunoassay |
| 35499-3 | Pesticide and Insecticide panel [Mass/volume] - Serum or Plasma |
| 56400-5 | Mandarin IgG4 Ab [Mass/volume] in Serum |
| 4813-2 | HLA-B16 [Presence] |
| 2656-7 | Niacin [Mass/time] in 24 hour Urine |
| 56772-7 | Macrophages/100 leukocytes in Bronchial specimen by Flow cytometry (FC) |
| 57036-6 | Phadiatop inhalant allergen IgE Ab [Units/volume] in Serum |
| 48583-9 | Lutropin [Units/volume] in Serum or Plasma --on cycle day 21 |
| 26848-2 | Interleukin 10 [Mass/volume] in Serum or Plasma |
| 38482-6 | Creatine kinase.MB [Presence] in Serum or Plasma |
| 5710-9 | Pentachlorophenol [Mass/volume] in Serum or Plasma |
| 4897-5 | HLA-Dw23 [Presence] |
| 4927-0 | HLA-DPw4 [Presence] |
| 40233-9 | Calcium [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
| 29543-6 | Beta-N-acetylhexosaminidase.A/Beta-n-acetylhexosaminidase.total in Amniotic fluid cells |
| 50362-3 | Phoma betae IgE Ab/IgE total in Serum |
| 50392-0 | 3-Keto n-Valerate [Moles/volume] in Cerebral spinal fluid |
| 50473-8 | Calcitonin [Mass/volume] in Serum or Plasma --5th specimen |
| 50510-7 | Lutropin [Units/volume] in Serum or Plasma --2nd specimen |
| 30196-0 | Fatty acids.very long chain C24:0 (Tetracosanoate)/C22:0 (Docosanoate) [Molar ratio] in Serum or Plasma |
| 12364-6 | Benzodiazepines [Presence] in Gastric fluid |
| 12415-6 | Selegiline [Mass/volume] in Serum or Plasma |
| 100387-0 | Poppy Seed IgG Ab [Units/volume] in Serum |
| 12771-2 | Cholesterol in HDL [Presence] in Serum or Plasma by Electrophoresis |
| 12822-3 | Progesterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 12844-7 | Protein [Mass/volume] in Peritoneal dialysis fluid --2nd specimen |
| 101878-7 | Metabotropic glutamate receptor 1 IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay |
| 101930-6 | Crystals panel - Urine |
| 102102-1 | Vitamin B3 and metabolites panel - Serum or Plasma by LC/MS/MS |
| 13512-9 | Microscopic observation [Identifier] in Bone marrow by Butyrate esterase stain |
| 13604-4 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
| 13946-9 | Complement+Immunoglobulin [Presence] in Red Blood Cells |
| 103680-5 | TP53 gene full mutation analysis in Blood or Tissue by Molecular genetics method |
| 10604-7 | Spermatozoa Abnormal Tail/100 spermatozoa in Semen |
| 1609-7 | Prolactin [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
| 1082-7 | Js sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 10856-3 | Microscopic observation [Identifier] in Genital mucus by Gram stain |
| 11064-3 | Urea nitrogen [Mass/volume] in Serum or Plasma --post dialysis |
| 16686-8 | Coxsackievirus B IgM Ab [Units/volume] in Serum by Neutralization test |
| 17185-0 | CD66b cells/100 cells in Blood |
| 18938-1 | Lincomycin [Susceptibility] |
| 90262-7 | Microscopic observation [Identifier] in Bile fluid by Gram stain |
| 91667-6 | Aspergillus clavatus Ab [Units/volume] in Serum |
| 60394-4 | Pineapple IgG Ab [Mass/volume] in Serum |
| 6041-8 | Bermuda grass IgE Ab [Units/volume] in Serum |
| 93687-2 | Psychosine [Moles/mass] in Red Blood Cells |
| 61210-1 | Onion IgE Ab/IgE total in Serum |
| 93758-1 | Erysipelothrix sp [Presence] in Tissue by Immune stain |
| 93989-2 | Carbohydrate challenge panel - Exhaled gas |
| 63277-8 | Mitochondria Ab [Presence] in Body fluid by Immunofluorescence |
| 78003-1 | Nucleated cell dose in hematopoietic progenitor cell transfusion [#/mass] per recipient body mass |
| 78518-8 | Cholesterol [Moles/volume] in Pericardial fluid |
| 78836-4 | JWH-018 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
| 94709-3 | Epilepsy autoimmune Ab panel - Cerebral spinal fluid |
| 64433-6 | Fragile X protein (FMRP) panel - Blood |
| 79393-5 | Flavin mononucleotide [Moles/volume] in Serum or Plasma |
| 95184-8 | Cytomegalovirus T-cell immunodeficiency panel - Blood by Flow cytometry (FC) |
| 95214-3 | Blasts/100 leukocytes in Stem cell product by Manual count |
| 79630-0 | R- and S-beta aminoisobutyrate and D- and L-serine pattern [Interpretation] in Serum or Plasma Narrative |
| 79661-5 | Dihydroorotate [Moles/volume] in Cerebral spinal fluid |
| 68368-0 | Leukocytes [#/volume] in Dialysis fluid by Automated count |
| 69008-1 | Cocaine panel - Meconium by Confirmatory method |
| 80656-2 | Hemoglobin Hope/Hemoglobin.total in Blood |
| 81157-0 | Coenzyme Q10.reduced [Mass/volume] in Serum or Plasma |
| 81209-9 | clomiPRAMINE and Norclomipramine panel - Urine |
| 96511-1 | Bwamba virus IgG Ab [Presence] in Specimen by Immunoassay |
| 96893-3 | ERBB2 gene duplication in Tumor by FISH |
| 9693-3 | Mercury [Mass/volume] in Cerebral spinal fluid |
| 82125-6 | Respiratory pathogens DNA and RNA tested for in Pleural fluid by NAA with probe detection |
| 70243-1 | CLN3 gene exon 7+8 deletion [Presence] in Blood or Tissue by Molecular genetics method |
| 82568-7 | Grass Allergen Mix 5 (Sweet Vernal grass+Bermuda grass+Cocksfoot+Timothy+Common Reed) IgE Ab [Units/volume] in Serum by Multidisk |
| 98958-2 | Periostin [Moles/volume] in Serum or Plasma by Immunoassay |
| 72321-3 | HLA-DP+DQ+DR (class II) IgG Ab [Presence] in Serum by Immunoassay |
| 83063-8 | PTEN gene [VCF] in Cancer specimen by Sequencing |
| 99372-5 | London Plane IgG Ab [Mass/volume] in Serum |
| 72749-5 | Meperidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 72854-3 | Ganciclovir [Susceptibility] by Genotype method |
| 86036-1 | Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum --2nd specimen |
| 86127-8 | Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 73085-3 | Venlafaxine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73114-1 | Tobramycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73284-2 | Methocarbamol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87342-2 | Pseudorabies virus DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 88746-3 | Toxoplasma gondii IgG and IgM panel - Serum or Plasma by Immunoassay |
| 41405-2 | Parainfluenza virus 2 IgG Ab [Units/volume] in Serum by Immunoassay |
| 41451-6 | Plasmodium stage [Identifier] in Blood by Light microscopy |
| 41663-6 | Aztreonam+Clavulanate [Susceptibility] by Disk diffusion (KB) |
| 50808-5 | Antimony [Moles/volume] in 24 hour Urine |
| 50866-3 | Indicans/Creatinine [Molar ratio] in Urine |
| 3080-9 | Tyrosine [Mass/volume] in Urine |
| 30913-8 | S-phase cells/100 cells in Specimen by Flow cytometry (FC) |
| 31016-9 | Levoamphetamine/Amphetamines.total in Urine |
| 21333-0 | HIV 1 RNA [#/volume] in Serum |
| 22268-7 | Echovirus 11 Ab [Titer] in Serum |
| 32024-2 | Magnesium [Mass/volume] in 24 hour Urine |
| 516-5 | Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 22323-0 | Hepatitis B virus surface Ab [Units/volume] in Serum from Donor |
| 22775-1 | African horse sickness virus serotype [Identifier] in Serum by Neutralization test |
| 52875-2 | CD1a cells/100 cells in Cerebral spinal fluid |
| 32619-9 | Biotinidase [Presence] in Serum or Plasma |
| 32655-3 | Metanephrines/Creatinine [Mass Ratio] in 24 hour Urine |
| 53467-7 | 3-Keto n-Valerate [Moles/volume] in Serum or Plasma |
| 44769-8 | Neuronal nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 45217-7 | Linoleoylcarnitine (C18:2) [Moles/volume] in DBS |
| 24008-5 | Echovirus 14 Ab [Titer] in Serum by Complement fixation |
| 3382-9 | Benzfetamine [Presence] in Urine |
| 3383-7 | Benzfetamine [Mass/volume] in Urine |
| 34229-5 | Acylcarnitine/Creatinine [Molar ratio] in Urine |
| 24144-8 | Brome IgG Ab [Units/volume] in Serum |
| 2416-6 | Histamine [Mass/volume] in Serum or Plasma |
| 55133-3 | Influenza virus A hemagglutinin cDNA [Identifier] in Isolate by NAA with probe detection |
| 47300-9 | Phosphatidate IgM Ab [Units/volume] in Serum by Immunoassay |
| 34729-4 | CFTR gene.p.Arg117His+5T variant [Presence] in Blood or Tissue by Molecular genetics method |
| 35149-4 | Octadecanoate (C18:0) [Moles/volume] in Serum or Plasma |
| 35332-6 | Band form neutrophils/100 leukocytes in Blood by Automated count |
| 55729-8 | Erythrocytes.fetal/100 erythrocytes [Ratio] in Blood by Flow cytometry (FC) |
| 5591-3 | Benzene [Presence] in Serum or Plasma |
| 56015-1 | Platelet aggregation collagen induced ATP secretion in Blood --1 ug/mL |
| 47788-5 | Threonine/Amino acids.total in Serum or Plasma |
| 47851-1 | Cortisol [Mass/volume] in Serum or Plasma --post dose dexamethasone |
| 25994-5 | Tryptophan/Creatinine [Molar ratio] in 24 hour Urine |
| 35706-1 | Albumin/Protein.total in Serum or Plasma |
| 56407-0 | Trout IgG4 Ab [Mass/volume] in Serum |
| 26593-4 | Ethanolamine [Moles/volume] in Cerebral spinal fluid |
| 26745-0 | Citrulline [Moles/volume] in Amniotic fluid |
| 38184-8 | Basophils/100 leukocytes in Amniotic fluid by Manual count |
| 38237-4 | CD4+CD28+ cells [#/volume] in Blood |
| 26857-3 | Mephentermine [Mass/mass] in Meconium |
| 38367-9 | N-octanoylglycine/Creatinine [Mass Ratio] in Urine |
| 57359-2 | Lactate [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 27409-2 | Methylenedianiline [Mass/volume] in Urine |
| 3943-8 | Phenmetrazine [Mass/volume] in Serum or Plasma |
| 395-4 | Penicillin V [Susceptibility] by Minimum lethal concentration (MLC) |
| 57744-5 | Striated muscle Ab [Presence] in Serum by Immunofluorescence |
| 5789-3 | Fatty casts [#/area] in Urine sediment by Microscopy low power field |
| 57949-0 | Complement C4c [Mass/volume] in Serum or Plasma |
| 5816-4 | Urate crystals [Presence] in Synovial fluid by Light microscopy |
| 2896-9 | Protoporphyrin [Mass/volume] in Blood |
| 29332-4 | Glucose [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 40182-8 | Glucose [Moles/volume] in Serum or Plasma --16 hours post XXX challenge |
| 58429-2 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine by Confirmatory method |
| 29793-7 | Anaplasma phagocytophilum IgG Ab [Presence] in Specimen by Immunoblot |
| 59289-9 | Iloperidone [Mass/volume] in Blood |
| 50268-2 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --3 days post dose ifosfamide |
| 30174-7 | Jamestown canyon virus IgG Ab [Titer] in Specimen by Immunofluorescence |
| 40989-6 | Respiratory syncytial virus IgG Ab [Presence] in Serum by Immunoassay |
| 41027-4 | Tau protein/Amyloid beta 42 peptide [Ratio] in Cerebral spinal fluid |
| 19153-6 | Volume in Urine collected for unspecified duration |
| 19262-5 | Amphetamines tested for in Urine by Screen method Nominal |
| 2071-9 | Chloride [Moles/volume] in Dialysis fluid |
| 20729-0 | Brucella abortus Ab [Titer] in Serum by Plate agglutination |
| 101123-8 | Bacterial carbapenem resistance blaIMI gene [Presence] by Molecular method |
| 101230-1 | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 101544-5 | Bacterial versus viral infection likelihood [Score] by calculation |
| 13026-0 | Orthocresol [Mass/volume] in Urine |
| 13048-4 | Sezary cells [Presence] in Blood by Light microscopy |
| 101784-7 | Scopulariopsis brevicaulis DNA [Presence] in Specimen by NAA with probe detection |
| 101872-0 | Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 14205-9 | Coccidioides immitis Ag [Presence] in Isolate by Immune diffusion (ID) |
| 102858-8 | Bell Pepper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102863-8 | Maple syrup IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103058-4 | Dog recombinant 5 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103960-1 | Prothionamide [Susceptibility] by Genotype method |
| 14966-6 | CD20 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 10613-8 | Spermatozoa Viable/100 spermatozoa in Semen |
| 11006-4 | Borrelia burgdorferi Ab [Presence] in Serum |
| 16564-7 | Cefaclor [Mass/volume] in Serum or Plasma |
| 16771-8 | Dicyclomine [Mass/volume] in Serum or Plasma |
| 17445-8 | Phoma herbarum IgG Ab [Units/volume] in Serum |
| 18422-6 | Microcytes [Presence] in Urine by Light microscopy |
| 74766-7 | Bordetella pertussis.pertussis toxin 100 IgG Ab [Presence] in Serum by Line blot |
| 74942-4 | Kynurenin [Moles/volume] in Cerebral spinal fluid |
| 92489-4 | little k Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 92519-8 | Sc2 Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 7503-6 | Moth triggered histamine release [Units/volume] in Blood |
| 7531-7 | Jerusalem oak IgE Ab [Units/volume] in Serum |
| 75593-4 | Fetal 5p deletion prior risk [Likelihood] based on general population risk Narrative |
| 60488-4 | NPHS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 61163-2 | Hepatitis B virus codon A194T [Presence] by Genotype method |
| 7590-3 | Cayenne IgG Ab [Units/volume] in Serum |
| 61228-3 | Silver Birch IgE Ab/IgE total in Serum |
| 61288-7 | Basil IgE Ab/IgE total in Serum |
| 77166-7 | Chlamydia sp IgG and IgM panel [Titer] - Serum by Immunofluorescence |
| 63225-7 | DNA double strand IgG Ab [Presence] in Body fluid by Immunofluorescence |
| 78367-0 | Pigeon serum proteins+feathers+droppings IgG Ab [Mass/volume] in Serum |
| 78867-9 | Norfentanyl cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 949-8 | C little e Ab [Presence] in Serum or Plasma from Blood product unit |
| 9529-9 | Histoplasma capsulatum IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 96255-5 | Saint Louis encephalitis virus IgG and IgM panel - Serum |
| 96464-3 | Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Presence] in Serum by Immunofluorescence |
| 68405-0 | Lymphocytes [#/volume] in Pleural fluid by Manual count |
| 69034-7 | Eastern equine encephalitis virus IgG and IgM panel - Serum by Immunofluorescence |
| 80634-9 | Aldicarb sulfone [Mass/volume] in Urine |
| 97158-0 | Cytokeratin 8 Ag [Presence] in Tissue by Immune stain |
| 69-5 | Cefamandole [Susceptibility] by Disk diffusion (KB) |
| 6969-0 | Myeloperoxidase Ab [Units/volume] in Serum |
| 81743-7 | Th-To Ab [Presence] in Serum by Line blot |
| 81862-5 | Karyotype in Blood or Tissue --post mitogen stimulation |
| 81871-6 | PSEN2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 97775-1 | Base excess standard in Cord blood by calculation |
| 70219-1 | Basic metabolic 2008 panel with ionized calcium - Serum or Plasma |
| 7032-6 | Minocycline [Susceptibility] by Gradient strip |
| 82903-6 | t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
| 98249-6 | Cancer pathology panel - Endometrial cancer specimen |
| 98260-3 | Lymphovascular invasion extent in Cancer specimen Qualitative |
| 98954-1 | KCNN4 gene full mutation analysis in Blood or Tissue by Sequencing |
| 71888-2 | Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood |
| 7222-3 | Chicken IgG Ab [Units/volume] in Serum |
| 72446-8 | 3-Hydroxysuberate [Moles/volume] in Serum or Plasma |
| 99971-4 | Hemophagocytic lymphohistiocytosis multigene analysis in Blood or Tissue by Molecular genetics method |
| 73229-7 | Oxacillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7344-5 | Goose feather IgG Ab [Units/volume] in Serum |
| 73851-8 | 18-Beta glycyrrhetinate [Mass/volume] in 24 hour Urine |
| 59384-8 | Acetaminophen [Presence] in Urine by Screen method |
| 5966-7 | Plasmin inhibitor Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
| 59715-3 | Nitrous oxide [Mass/volume] in Serum or Plasma |
| 50768-1 | Ganglioside GD1b IgG Ab/IgM Ab [Ratio] in Serum by Immunoassay |
| 50932-3 | Uroporphyrin/Porphyrins.total in 24 hour Urine |
| 30543-3 | Osmotic fragility of Red Blood Cells--0.75% sodium chloride |
| 21576-4 | Transferrin.carbohydrate deficient.tetrasialo/Transferrin.total in Serum or Plasma |
| 31855-0 | Histoplasma capsulatum Ag [Units/volume] in Serum |
| 31999-6 | Broad casts [Presence] in Urine sediment by Light microscopy |
| 32001-0 | Chlamydia sp Ag [Presence] in Vaginal fluid by Immunoassay |
| 51485-1 | Epithelial cells.non-squamous [#/volume] in Urine by Automated count |
| 22646-4 | Phenylalanine [Moles/volume] in Cerebral spinal fluid |
| 5221-7 | HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot |
| 52763-0 | Extrinsic coagulation system thromboelastography panel - Blood |
| 5298-5 | Rheumatoid factor [Presence] in Serum by Sheep Cell Agglutination |
| 23191-0 | Leptospira interrogans sv Pomona Ab [Presence] in Serum |
| 32830-2 | Epstein Barr virus capsid IgG Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen |
| 32860-9 | TCR alpha beta cells/100 cells in Specimen |
| 53065-9 | Butyrylcarnitine (C4) [Moles/volume] in DBS |
| 53142-6 | Nitrogen [Moles/time] in 24 hour Stool |
| 53285-3 | RBC casts [#/volume] in Urine by Computer assisted method |
| 23521-8 | Trypanosoma evansi Ab [Units/volume] in Serum |
| 2352-3 | Glucose in CSF/Glucose plas |
| 23597-8 | Dermatophilus congolensis [Presence] in Exudate by Methylene blue stain |
| 24102-6 | Corynebacterium toxin [Presence] in Specimen by Immune diffusion (ID) |
| 24289-1 | Influenza virus A Ab [Titer] in Serum --1st specimen |
| 2525-4 | Lactate [Moles/volume] in Synovial fluid |
| 25358-3 | C peptide [Moles/time] in 24 hour Urine |
| 34725-2 | Echovirus 7 Ab [Presence] in Cerebral spinal fluid |
| 55683-7 | Isoconazole [Susceptibility] by Disk diffusion (KB) |
| 35421-7 | Herpes simplex virus identified in Ear by Organism specific culture |
| 35422-5 | Herpes simplex virus identified in Body fluid by Organism specific culture |
| 56496-3 | Prolactin [Units/volume] in Serum or Plasma --2 hours post XXX challenge |
| 48032-7 | THRB gene p.Ala317Thr [Presence] in Blood or Tissue by Molecular genetics method |
| 26656-9 | HTLV II Ab [Presence] in Serum |
| 2677-3 | Organochloride [Mass/volume] in Blood |
| 3793-7 | Methotrexate [Mass/volume] in Serum or Plasma |
| 5678-8 | Lysergate diethylamide [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
| 26845-8 | Sialate.lipid bound [Mass/volume] in Serum or Plasma |
| 48998-9 | 6-Phosphogluconate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells |
| 27893-7 | CD19+CD23+ cells/100 cells in Blood |
| 27985-1 | Borrelia burgdorferi 18kD Ab [Presence] in Serum by Immunoblot |
| 38727-4 | 2,4 toluenediamine [Mass/volume] in Air |
| 39578-0 | Alternaria alternata Ab [Mass/volume] in Serum |
| 57967-2 | Galactitol [Presence] in Urine |
| 58022-5 | Prostanozol [Presence] in Urine |
| 49731-3 | Herpes simplex virus 1+2 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 40301-4 | Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose cloNIDine |
| 40349-3 | MT-TK gene m.8363G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 40480-6 | Virus identified in Genital specimen by Culture |
| 40703-1 | Lactoferrin [Presence] in Stool by Immunoassay |
| 30085-5 | Legionella pneumophila IgG Ab [Units/volume] in Serum |
| 4084-0 | Trimipramine [Presence] in Urine |
| 40859-1 | SOD1 gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19526-3 | Lormetazepam cutoff [Mass/volume] in Urine for Screen method |
| 12469-3 | Cystine crystals [type] in Stone by Light microscopy |
| 101287-1 | Chlamydophila pneumoniae DNA [Presence] in Throat by NAA with non-probe detection |
| 13078-1 | Phosphatidylethanolamine IgA Ab [Units/volume] in Serum |
| 102049-4 | Hereditary sensory and autonomic neuropathy type 1 panel - Serum by LC/MS/MS |
| 102164-1 | Bayberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13462-7 | Apolipoprotein A-I/Apolipoprotein B [Mass Ratio] in Serum or Plasma |
| 10235-0 | Oxygen content in High right atrium |
| 102990-9 | Dipyrone IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14521-9 | Pneumocystis jiroveci Ag [Presence] in Urine by Immunofluorescence |
| 103649-0 | Lutropin [Units/volume] in Serum or Plasma --10 minutes post dose gonadotropin releasing hormone |
| 15182-9 | IgA [Presence] in Serum by Immunoelectrophoresis |
| 10711-0 | Plasmodium vivax Ag [Units/volume] in Blood by Immunofluorescence |
| 16423-6 | Aztreonam [Mass/volume] in Urine |
| 16667-8 | Cortisol Free [Mass/time] in 48 hour Urine |
| 16755-1 | Diamorphine [Mass/volume] in Urine by Confirmatory method |
| 18301-2 | IgG [Presence] in Serum by Immunofixation |
| 75006-7 | Food Allergen Mix E (Crab+Buckwheat+Shrimp+Sesame seed+Corn) IgE Ab [Units/volume] in Serum by Multidisk |
| 91680-9 | F8 gene intron 22 inversion targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
| 75216-2 | Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC) [Molar ratio] in DBS |
| 75580-1 | Fetal Prader-Willi syndrome prior risk [Likelihood] based on general population risk |
| 75653-6 | Manual differential comment [Interpretation] in Body fluid Narrative |
| 76044-7 | Moxifloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 7613-3 | Pistachio IgE Ab [Units/volume] in Serum |
| 7614-1 | Pitosporium triggered histamine release [Units/volume] in Blood |
| 9359-1 | Tacrine [Mass/volume] in Serum or Plasma |
| 7753-7 | Turkey feather IgE Ab [Units/volume] in Serum |
| 77605-4 | Influenza virus A H5 RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 93876-1 | Ceramide risk score in Plasma by calculation |
| 626-2 | Bacteria identified in Throat by Culture |
| 78230-0 | Cells.RARA gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 78374-6 | American house dust mite native (nDer f) 2 IgE Ab [Units/volume] in Serum |
| 63533-4 | Centromere protein B Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 6459-2 | Bacteria identified in Food by Culture |
| 79128-5 | Uroporphyrin 3 isomer [Mass/time] in 24 hour Urine |
| 79321-6 | Lysophosphatidylcholine(26:0) [Moles/volume] in DBS |
| 95677-1 | Saint Louis encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay |
| 6674-6 | Ova and parasites identified in Tissue by Light microscopy |
| 9639-6 | 18-Hydroxycorticosterone [Mass/time] in 24 hour Urine |
| 6791-8 | Lambda light chains [Presence] in Serum by Immunoassay |
| 97990-6 | von Willebrand factor (vWf) cleaving protease actual/normal in Platelet poor plasma by Immunoassay |
| 9829-3 | Beta globulin [Mass/time] in 24 hour Urine |
| 9840-0 | CD11+CD20+ cells [#/volume] in Leukocytes |
| 83091-9 | Cortisol [Moles/volume] in 24 hour Urine by Immunoassay |
| 83096-8 | Estradiol (E2) [Mass/volume] in Serum or Plasma by Immunoassay |
| 85080-0 | Nucleolar nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
| 99474-9 | Amylase IgG Ab [Mass/volume] in Serum |
| 72822-0 | Staphylococcus aureus enterotoxin D sed gene [Presence] in Specimen by NAA with probe detection |
| 86034-6 | Streptococcus pneumoniae Danish serotype 19F Ab [Mass/volume] in Serum --1st specimen |
| 86124-5 | Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum --1st specimen |
| 73099-4 | Ursodeoxycholate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73410-3 | Dipyridamole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7350-2 | Grapefruit IgG Ab [Units/volume] in Serum |
| 87778-7 | Molindone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 88135-9 | Varicella zoster virus [Presence] in Cornea or Conjunctiva by Organism specific culture |
| 88565-7 | Varicella zoster virus DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 41417-7 | Filaria Ab [Units/volume] in Serum by Immunoassay |
| 59581-9 | Coxsackievirus A7 IgM Ab [Titer] in Serum by Immunofluorescence |
| 59712-0 | Midazolam [Mass/mass] in Tissue |
| 30419-6 | Lymphocytes clefted/100 leukocytes in Blood |
| 30515-1 | Tetrahydroaldosterone/Creatinine [Mass Ratio] in Urine |
| 31020-1 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Amniotic fluid |
| 42491-1 | Cannabinoids [Presence] in Blood by Screen method |
| 60157-5 | Perfluorooctanoate [Mass/volume] in Serum or Plasma |
| 21239-9 | Desalkylhalazepam [Mass/volume] in Serum or Plasma |
| 51330-9 | CD43 cells/100 cells in Cerebral spinal fluid |
| 4307-5 | Meperidine [Mass] of Dose |
| 21794-3 | t(9;11)(p22;q23)(MLLT3,MLL) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 21808-1 | t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 2191-5 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma |
| 32047-3 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+68+70 DNA [Presence] in Tissue by Probe |
| 51607-0 | Xylose [Moles/volume] in Blood --3 hours post XXX challenge |
| 43610-5 | Adenovirus Ag [Presence] in Nasopharynx by Immunofluorescence |
| 22412-1 | Saccharopolyspora rectivirgula Ab [Presence] in Serum |
| 32152-1 | 17-Hydroxyketosteroids [Mass/time] in 24 hour Urine |
| 32262-8 | Orotate/Creatinine [Ratio] in Urine |
| 5246-4 | Saccharopolyspora rectivirgula Ab [Units/volume] in Serum |
| 52760-6 | Prothrombin time (PT) PIVKA sensitive actual/normal in Capillary blood by Coagulation assay |
| 52787-9 | Maximum lysis.intrinsic coagulation system activated [Length fraction] in Blood by Rotational TEG |
| 52887-7 | Bismuth [Moles/time] in 24 hour Urine |
| 43888-7 | Bile acid [Presence] in Bile fluid |
| 43964-6 | CD4+CD45RA+ cells/100 cells in Body fluid |
| 44047-9 | Bordetella pertussis Yamaguchi Ab [Presence] in Serum |
| 53190-5 | Tetradecadienoylcarnitine (C14:2) [Moles/volume] in DBS |
| 53487-5 | Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose betaxolol |
| 44561-9 | Influenza virus A Ag [Presence] in Trachea by Immunofluorescence |
| 53551-8 | 3,4-Dihydroxyphenylacetate/Creatinine [Molar ratio] in 24 hour Urine |
| 53833-0 | Myoglobin [Mass/volume] in Blood |
| 33824-4 | Iron [Moles/volume] in Urine |
| 33956-4 | cycloSPORINE.polyclonal [Mass/volume] in Blood |
| 54395-9 | Glucose [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge |
| 24521-7 | EPINEPHrine [Moles/volume] in Urine |
| 55585-4 | Tripelennamine [Moles/volume] in Serum or Plasma |
| 25331-0 | Bordetella pertussis IgG Ab [Titer] in Serum |
| 35158-5 | Myristoleate (C14:1) [Moles/volume] in Serum or Plasma |
| 55638-1 | Cephapirin [Susceptibility] by Gradient strip |
| 25818-6 | Xylose [Moles/volume] in Serum or Plasma --1 hour post dose xylose PO |
| 35693-1 | GBA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 37-2 | Azithromycin [Susceptibility] by Disk diffusion (KB) |
| 48882-5 | Bartonella henselae IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 26801-1 | Protein [Mass/time] in 12 hour Urine |
| 26829-2 | Phencyclidine [Mass/mass] in Meconium by Screen method |
| 38368-7 | Pigeon droppings IgG Ab [Mass/volume] in Serum |
| 48910-4 | Rickettsia prowazekii IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 49153-0 | Rickettsia conorii IgM Ab [Titer] in Body fluid |
| 27939-8 | Collagen crosslinked N-telopeptide [Moles/volume] in Urine |
| 38687-0 | 2-Acetylaminofluorene [Mass/volume] in Air |
| 49639-8 | Protein C/Coagulation factor X [Mass Ratio] in Platelet poor plasma |
| 49711-5 | Listeria sp Ab [Titer] in Serum by Complement fixation |
| 29371-2 | cloZAPine [Mass/volume] in Serum or Plasma --peak |
| 3987-5 | Promazine [Mass/volume] in Urine |
| 40282-6 | Lactose [Moles/volume] in Serum or Plasma --1 hour post dose lactose PO |
| 49970-7 | Collection time of Blood--4th specimen |
| 30067-3 | Proline/Creatinine [Ratio] in Urine |
| 3033-8 | Transcortin [Mass/volume] in Serum |
| 41086-0 | MLH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19302-9 | Opiates confirm method [Identifier] in Urine |
| 19476-1 | Flurazepam cutoff [Mass/volume] in Urine for Screen method |
| 20776-1 | Caprine parapoxvirus Ab [Presence] in Tissue by Immunofluorescence |
| 100836-6 | Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 12790-2 | Oxalate [Mass/volume] in Urine --2nd specimen post XXX challenge |
| 101210-3 | Hantavirus puumala IgG Ab [Presence] in Serum or Plasma by Line blot |
| 14017-8 | CD22 cells/100 cells in Blood |
| 14354-5 | Microscopic observation [Identifier] in Wound by Acid fast stain.Kinyoun modified |
| 14803-1 | Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction |
| 10389-5 | Blood product.other [Type] |
| 15019-3 | Alpha-1-Fetoprotein [Moles/volume] in Amniotic fluid |
| 15119-1 | Cobalt [Moles/volume] in Blood |
| 15137-3 | Alanine+Ethanolamine [Presence] in Serum or Plasma |
| 104428-8 | Measles virus IgG Ab avidity [Ratio] in Serum by Immunoassay |
| 10478-6 | Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain |
| 16638-9 | Coccidioides immitis IgG Ab [Units/volume] in Cerebral spinal fluid |
| 17237-9 | Magnesium [Moles/mass] in Hair |
| 1728-5 | Adenosine monophosphate.cyclic/Creatinine [Mass Ratio] in Serum or Plasma |
| 17584-4 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
| 17707-1 | Thyroperoxidase IgM Ab [Units/volume] in Serum or Plasma |
| 91085-1 | Fungal 18s rRNA gene [Presence] in Lower respiratory specimen by NAA with probe detection |
| 74626-3 | 1,1-Dimethoxyhexadecane (DMA 16:0) [Mass/mass] in Fibroblast |
| 74662-8 | Sertraline [Mass/volume] in Urine |
| 927-4 | Blood product.pooled [Identifier] |
| 92749-1 | Lyso-sphingomyelin [Moles/volume] in DBS |
| 75588-4 | Fetal Angelman syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
| 93224-4 | Coccidioides sp Ag [Mass/volume] in Bronchoalveolar lavage by Immunoassay |
| 93722-7 | N-nortramadol [Mass/mass] in Meconium by Confirmatory method |
| 6285-1 | Willow IgE Ab [Units/volume] in Serum |
| 77761-5 | ARIPiprazole [Mass/volume] in Urine by Confirmatory method |
| 78356-3 | Bacteria identified in Implanted device by Culture |
| 94403-3 | CHRNA3 gene c.645C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 7895-6 | Hantavirus hantaan IgG Ab [Units/volume] in Serum |
| 79463-6 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in DBS |
| 95232-5 | Microalbumin [Presence] in Urine by Test strip |
| 67823-5 | Borrelia burgdorferi IgG bands [#] in Cerebral spinal fluid by Immunoblot |
| 68913-3 | Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid |
| 68943-0 | Voltage-gated potassium channel Ab [Units/volume] in Serum |
| 6899-9 | Felbamate [Mass/volume] in Serum or Plasma |
| 8151-3 | Amphetamines [Presence] in Urine by SAMHSA confirm method |
| 96711-7 | Erythrocytes [#/area] in Body fluid by Light microscopy |
| 97743-9 | Cancer Ag 125 [Units/volume] in Aspirate |
| 979-5 | Di sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 7095-3 | Arizona Ash IgE Ab [Units/volume] in Serum |
| 82539-8 | Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum |
| 85774-8 | Klebsiella oxytoca DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 72570-5 | Cholinesterase.chloride inhibited/Cholinesterase [Pure catalytic fraction] in Serum or Plasma |
| 72974-9 | PHENobarbital induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86113-8 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum --1st specimen |
| 86723-4 | Actinobacillus suis DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 87411-5 | Brachyspira hyodysenteriae DNA [Presence] in Specimen by NAA with probe detection |
| 87527-8 | Fasting duration |
| 73872-4 | Alpha cortolone [Moles/volume] in 24 hour Urine |
| 87813-2 | Flurazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 88130-0 | Cytomegalovirus DNA [#/volume] (viral load) in Ocular fluid by NAA with probe detection |
| 74393-0 | Immature reticulocytes/100 erythrocytes in Cord blood by Automated count |
| 74447-4 | Sugars and polyols panel [Molar ratio] - Urine |
| 41604-0 | Fasting glucose [Mass/volume] in Capillary blood by Glucometer |
| 5085-6 | Chlamydia sp IgG Ab [Units/volume] in Serum |
| 50993-5 | Laxatives [Mass/mass] in Stool |
| 59905-0 | fluPHENAZine [Moles/volume] in Gastric fluid |
| 2135-2 | Coproporphyrin [Mass/time] in 24 hour Stool |
| 21633-3 | ATP7B gene p.His714Gln [Presence] in Blood or Tissue by Molecular genetics method |
| 51260-8 | CD16B cells/100 cells in Tissue |
| 43112-2 | Herpes simplex virus Ab panel - Serum |
| 51473-7 | Streptococcus pneumoniae capsular polysaccharide IgG2 Ab [Mass/volume] in Serum |
| 51826-6 | Herpes virus 8 IgG Ab [Units/volume] in Serum by Immunoassay |
| 43431-6 | Escherichia coli K1 Ag [Presence] in Serum |
| 22710-8 | Glutamine/Creatinine [Molar ratio] in Urine |
| 32265-1 | Phenylalanine/Tyrosine [Molar ratio] in Serum or Plasma |
| 44363-0 | Glutarate/Creatinine [Mass Ratio] in 24 hour Urine |
| 327-7 | metroNIDAZOLE [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 53263-0 | Urinalysis yeast variants panel - Urine by Computer assisted method |
| 53441-2 | Carnitine palmitoyltransferase 1 [Enzymatic activity/mass] in Leukocytes |
| 44688-0 | Invasive melanoma.location relative to involved lateral margin in Skin melanoma |
| 33299-9 | N-acetyl-L-aspartate [Presence] in Urine |
| 33521-6 | Platelet aggregation collagen induced in Platelet rich plasma --Low dose |
| 33617-2 | HLA-DR+ cells [#/volume] in Blood |
| 45322-5 | FMR1 gene allele 2 CGG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 23655-4 | Aflatoxin [Mass/mass] in Tissue |
| 24066-3 | Beta mannosidase [Enzymatic activity/volume] in Serum or Plasma |
| 33731-1 | Histology type in Cancer specimen Narrative |
| 34276-6 | Cysteate [Moles/volume] in Urine |
| 54303-3 | Hydroxylysine [Moles/volume] in DBS |
| 55338-8 | Sd sup(a) Ab [Presence] in Serum or Plasma |
| 55485-7 | Insulin [Moles/volume] in Serum or Plasma --1 hour post dose glucose IV |
| 47407-2 | Fibers [#/area] in Stool by Light microscopy |
| 25376-5 | Citrulline [Moles/time] in 24 hour Urine |
| 2550-2 | Lactate/Pyruvate [Molar ratio] in Blood |
| 349-1 | Nafcillin [Susceptibility] by Serum bactericidal titer |
| 47907-1 | Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose TRH |
| 25747-7 | Ribosomal Ab [Presence] in Serum by Immunoassay |
| 4792-8 | HLA-B71(70) [Presence] in Donor |
| 48197-8 | Cefuroxime triggered leukotriene release [Mass/volume] by Leukocytes |
| 48284-4 | Pancuronium triggered leukotriene release [Mass/volume] by Leukocytes |
| 26467-1 | Leukocytes [#/volume] in Pleural fluid |
| 5708-3 | Paraquat [Mass/volume] in Blood |
| 26891-2 | Nordiazepam [Mass/mass] in Meconium |
| 38460-2 | Legionella sp Ag [Presence] in Bronchial specimen by Immunofluorescence |
| 57590-2 | Aldosterone [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 49101-9 | Helicobacter pylori DNA [Presence] in Specimen by NAA with probe detection |
| 49199-3 | Bartonella vinsonii berkhoffii IgG Ab [Titer] in Serum |
| 49304-9 | Uranium dose assessment [Interpretation] in Urine Narrative |
| 39313-2 | Influenza virus A N3 neutralizing antibody [Presence] in Serum by Neutralization test |
| 49614-1 | Campylobacter sp DNA [Identifier] in Specimen by NAA with probe detection |
| 29235-9 | Coxsackievirus B6 Ab [Titer] in Body fluid |
| 39798-4 | Warfarin [Moles/volume] in Serum or Plasma |
| 5005-4 | Epstein Barr virus DNA [Presence] in Specimen by NAA with probe detection |
| 29693-9 | Orientia tsutsugamushi Litchfield Ab [Presence] in Serum |
| 59005-9 | Lactate [Moles/volume] in Serum or Plasma --1 minute post XXX challenge |
| 59290-7 | Iloperidone [Mass/volume] in Serum or Plasma |
| 50439-9 | Corticotropin [Mass/volume] in Plasma --3 AM specimen |
| 50508-1 | Insulin [Units/volume] in Serum or Plasma --8th specimen |
| 30149-9 | Streptolysin O Ab [Units/volume] in Serum --1st specimen |
| 41095-1 | L1CAM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 41113-2 | Chronic lymphocytic leukemia gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 41149-6 | Herpes simplex virus 1+2 IgM Ab [Presence] in Serum |
| 1946-3 | Beta hydroxybutyrate [Mass/volume] in Cerebral spinal fluid |
| 19748-3 | Methyltetrahydrophthalic anhydride (MTHPA) IgE Ab [Units/volume] in Serum |
| 12356-2 | Methadone [Presence] in Stool |
| 101365-5 | Coxiella burnetii DNA [Presence] in Blood by NAA with non-probe detection |
| 101448-9 | Contactin-associated protein 1 IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay |
| 101488-5 | Meropenem [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 13552-5 | cloZAPine [Presence] in Serum or Plasma |
| 102755-6 | House dust Greer IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14406-3 | Phosphate [Mass/volume] in Synovial fluid |
| 104383-5 | Dengue virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen |
| 15283-5 | Silver Birch IgE Ab [Units/volume] in Serum |
| 10907-4 | Saint Louis encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 16388-1 | Anticonvulsants [Identifier] in Urine |
| 16407-9 | Asbestos identified in Sputum by Light microscopy |
| 16605-8 | Chlorocycline [Mass/volume] in Urine |
| 11268-0 | Streptococcus pyogenes [Presence] in Throat by Organism specific culture |
| 17742-8 | Trichlorothiazide [Presence] in Urine |
| 18254-3 | Silicate [Mass/volume] in Body fluid |
| 90424-3 | Microorganism preliminary growth detection panel - Body fluid by Culture |
| 90467-2 | Hydroxyaripiprazole [Mass/volume] in Urine by Confirmatory method |
| 91844-1 | Trichomonas vaginalis DNA [Presence] in Genital specimen by NAA with probe detection |
| 92736-8 | CD3+CD4+ (T4 helper) cells [#/volume] in Blood by Rapid immunoassay |
| 76399-5 | Troponin I.cardiac [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 62439-5 | Nucleated erythrocytes [#/volume] in Body fluid by Automated count |
| 78207-8 | 9q34 chromosome region deletion [Interpretation] in Blood or Tissue by FISH Narrative |
| 94300-1 | Vilazodone [Mass/volume] in Serum or Plasma by Confirmatory method |
| 94365-4 | Bordetella pertussis DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 6504-5 | Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 79477-6 | 5-Hydroxymethyl-2-Furoate/Creatinine [Molar ratio] in Urine |
| 9492-0 | Aspergillus sp IgM Ab [Units/volume] in Serum |
| 96044-3 | Human epididymis protein 4 [Mass/volume] in Serum or Plasma |
| 685-8 | Respiratory Mycoplasma identified in Throat by Organism specific culture |
| 68911-7 | Lactate [Mass/volume] in Serum or Plasma --post exercise |
| 69009-9 | Cocaine [Mass/mass] in Meconium by Confirmatory method |
| 96643-2 | HLA-DPA1 [Type] by Low resolution |
| 97295-0 | oxyCODONE Free [Presence] in Cord tissue by Screen method |
| 97323-0 | oxyCODONE Free [Presence] in Cord tissue by Confirmatory method |
| 71361-0 | Y chromosome AZFc region deletion [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
| 71872-6 | Hemoglobin A2/Hemoglobin.total [Pure mass fraction] in Blood |
| 72793-3 | Methylone [Mass/volume] in Urine by Confirmatory method |
| 86043-7 | Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum --2nd specimen |
| 86079-1 | Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum |
| 86141-9 | Streptococcus pneumoniae Danish serotype 7A IgG Ab [Units/volume] in Serum |
| 73158-8 | Rosiglitazone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73346-9 | HYDROcodone+Acetaminophen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73703-1 | Pathology report preliminary diagnosis [Interpretation] in Specimen |
| 7385-8 | Haddock IgG Ab [Units/volume] in Serum |
| 87935-3 | Bacteria identified in Blood product unit by Anaerobe culture |
| 41438-3 | Cyclospora papionis DNA [Presence] in Specimen by NAA with probe detection |
| 4144-2 | Bromazepam [Mass] of Dose |
| 59608-0 | ALPRAZolam [Mass/volume] in Body fluid |
| 59708-8 | Midazolam [Mass/volume] in Blood by Confirmatory method |
| 50954-7 | Phosphoethanolamine IgG Ab [Presence] in Serum or Plasma |
| 30993-0 | Aspergillus fumigatus recombinant (rAsp f) 6 IgE Ab [Units/volume] in Serum |
| 31094-6 | Tobramycin [Mass/volume] in Serum or Plasma --peak post extended interval dosing |
| 60217-7 | Chloride [Moles/volume] in Mother's milk |
| 22302-4 | Equine influenza virus A1 Ab [Titer] in Serum |
| 43734-3 | aPTT in Platelet poor plasma by Coagulation 1:1 saline |
| 22435-2 | Paracoccidioides brasiliensis Ab [Titer] in Serum |
| 22658-9 | Alloisoleucine [Moles/volume] in Cerebral spinal fluid |
| 32320-4 | Glucose [Moles/volume] in Serum or Plasma --3 hours post 75 g glucose PO |
| 4395-0 | Phensuximide [Mass] of Dose |
| 44797-9 | Brucella sp [Presence] in Specimen by Organism specific culture |
| 33295-7 | JC virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 33570-3 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunoblot |
| 44998-3 | Chlamydia trachomatis Ab [Presence] in Serum --1st specimen |
| 54373-6 | Cholesterol.non-esterified [Moles/volume] in Serum or Plasma |
| 54408-0 | Pooled fresh frozen plasma units given [#] |
| 46454-5 | Shigella sp [Presence] in Specimen by Organism specific culture |
| 24348-5 | Free T4 and TSH panel - Serum or Plasma |
| 55476-6 | Estradiol (E2) [Moles/volume] in Serum or Plasma --baseline |
| 25344-3 | Filaria Ab [Titer] in Serum |
| 25550-5 | Urea [Moles/time] in 24 hour Urine |
| 35006-6 | Plasma cells [#/volume] in Body fluid |
| 56011-0 | Platelet aggregation ADP induced ATP secretion in Blood --10 umol/L |
| 47706-7 | Methionine/Amino acids.total in Specimen |
| 47844-6 | Cortisol [Mass/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight |
| 25565-3 | Bougainvillea IgE Ab [Units/volume] in Serum |
| 4802-5 | HLA-B77(15) [Presence] in Donor |
| 26719-5 | HYDROcodone [Mass/mass] in Hair |
| 3671-5 | Haloperidol [Mass/volume] in Urine |
| 3766-3 | Metandienone [Mass/time] in 24 hour Urine |
| 48872-6 | Anaplasma phagocytophilum [Presence] in Specimen by Organism specific culture |
| 27102-3 | Phendimetrazine [Mass/volume] in Milk |
| 27151-0 | Streptococcus pneumoniae Danish serotype 18C Ab [Mass/volume] in Serum --1st specimen |
| 38430-5 | Ibuprofen [Mass/volume] in Serum or Plasma --1 hour post dose |
| 48918-7 | Respiratory allergen panel, US - NC, PA, SC, VA, WV - Serum |
| 49000-3 | Free Hemoglobin [Presence] in Cerebral spinal fluid |
| 28066-9 | Celecoxib [Mass/volume] in Serum or Plasma |
| 57800-5 | Oxygen content in Blood by calculation |
| 57874-0 | Cantaloupe triggered histamine release [Units/volume] in Blood |
| 2939-7 | Serotonin [Mass/volume] in Blood |
| 40156-2 | Glucose [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 40173-7 | Glucose [Moles/volume] in Serum or Plasma --10 hours post XXX challenge |
| 40347-7 | MT-TL1 gene m.3256C>T [Presence] in Blood or Tissue by Molecular genetics method |
| 59010-9 | Fractional excretion of potassium [Ratio] in Urine and Serum or Plasma collected for unspecified duration |
| 59295-6 | Levamisole [Mass/volume] in Urine |
| 50218-7 | Glucose [Mass/volume] in Serum or Plasma --9th specimen |
| 50265-8 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --pre dose ifosfamide |
| 3035-3 | Transferrin [Mass/volume] in Urine |
| 19502-4 | Methotrimeprazine [Presence] in Urine by Screen method |
| 12908-0 | Sodium [Moles/volume] in Vitreous fluid |
| 102186-4 | Blueberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102590-7 | Sesame Seed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14536-7 | Measles virus Ag [Presence] in Skin by Immunofluorescence |
| 10337-4 | Procollagen type I [Mass/volume] in Serum |
| 14848-6 | Neutrophils/100 leukocytes in Pleural fluid by Manual count |
| 15159-7 | Coagulation factor extrinsic pathway [Interpretation] in Platelet poor plasma Narrative |
| 10760-7 | Iron.microscopic observation [Identifier] in Tissue by Gomori stain |
| 17014-2 | Influenza virus B Ab [Units/volume] in Cerebral spinal fluid |
| 1732-7 | Adenylosuccinate lyase [Enzymatic activity/volume] in Serum |
| 17353-4 | Neutrophil cytoplasmic Ab.classic [Presence] in Serum by Immunofluorescence |
| 17578-6 | Ganglioside GQ1b Ab [Presence] in Serum |
| 90283-3 | Mycobacterium tuberculosis DNA [Presence] in Bile fluid by NAA with probe detection |
| 90904-4 | HIV 1 RNA protease gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing |
| 6070-7 | Chicken feather IgE Ab [Units/volume] in Serum |
| 61075-8 | diphenhydrAMINE [Presence] in Gastric fluid |
| 92882-0 | Influenza virus types A and B panel - Upper respiratory specimen by NAA with probe detection |
| 6156-4 | Goosefoot IgE Ab [Units/volume] in Serum |
| 77178-2 | Boron [Mass/mass] in Hair |
| 7732-1 | Mandarin IgG Ab [Units/volume] in Serum |
| 78802-6 | Baclofen [Mass/mass] in Hair |
| 7885-7 | Epstein Barr virus capsid IgG Ab [Units/volume] in Serum |
| 94823-2 | Cytomegalovirus DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 9533-1 | Influenza virus A IgM Ab [Titer] in Serum |
| 95570-8 | Tetrahydro-11-corticosterone [Z-score] in 24 hour Urine |
| 65785-8 | Chicken CSA serum albumin native (nGal d) 5 IgE Ab [Units/volume] in Serum |
| 6672-0 | Microscopic observation [Identifier] in Tissue by Methylene blue stain.Loeffler |
| 68399-5 | Eosinophils [#/volume] in Peritoneal fluid by Manual count |
| 81184-4 | Distance of tumor from circumferential resection margin [Length] by Microscopy |
| 81324-6 | Glucose tolerance 2 hours gestational panel - Serum or Plasma |
| 96512-9 | Rift valley fever virus IgG Ab [Presence] in Specimen by Immunoassay |
| 82192-6 | Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
| 70215-9 | oxyCODONE [Moles/volume] in Urine by Confirmatory method |
| 82454-0 | Ganglioside Ab panel - Serum by Immunoblot |
| 82501-8 | TRBV2 gene segments/TRBV gene segments.total in Blood |
| 98039-1 | Preconception AndOr prenatal carrier screening multigene analysis in Blood or Tissue by Molecular genetics method |
| 98242-1 | Spermatozoa Motile [#/volume] in Urine by Light microscopy --post ejaculation |
| 85623-7 | Zika virus RNA [Presence] in Urine by NAA with probe detection |
| 99601-7 | Beta 2 globulin [Mass/volume] in 24 hour Urine by Electrophoresis |
| 99921-9 | Schistosoma haematobium [Presence] in Urine sediment by Computer assisted method |
| 72594-5 | Alpha 1 globulin/Protein.total [Pure mass fraction] in Serum or Plasma by Electrophoresis |
| 72651-3 | Glucose in serum - glucose in pleural fluid [Molar concentration difference] |
| 72757-8 | Benzodiazepines [Mass/volume] in Saliva (oral fluid) by Screen method |
| 86201-1 | Porcine epidemic diarrhea virus gene sequence and phylogenetic analysis in Specimen Document |
| 73213-1 | Penicillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87566-6 | Deoxynivalenol [Mass/mass] in Specimen |
| 73572-0 | Magnesium Ionized [Moles/volume] in Blood by Ion-selective membrane electrode (ISE) |
| 73944-1 | MAM-2201 (synthetic cannabinoid) [Presence] in Blood |
| 74305-4 | PRRSV Ag [Presence] in Specimen by Immunofluorescence |
| 88719-0 | Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Nasopharynx by NAA with probe detection |
| 41699-0 | Josamycine [Susceptibility] by Gradient strip |
| 41744-4 | Beclomethasone dipropionate [Mass/volume] in Serum or Plasma |
| 5985-7 | Plasminogen activator urokinase type [Units/volume] in Platelet poor plasma |
| 41865-7 | Yeast.hyphae [Presence] in Urine sediment by Light microscopy |
| 59918-3 | Ketoprofen [Moles/volume] in Gastric fluid |
| 21636-6 | BRCA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 31248-8 | Barmah forest virus IgM Ab [Presence] in Serum |
| 31275-1 | Brush border Ab [Presence] in Serum |
| 31923-6 | Parainfluenza virus 1 Ag [Presence] in Throat |
| 43227-8 | Ova and parasites identified in Stool by Trichrome stain |
| 22367-7 | Influenza virus B Ab [Titer] in Serum |
| 51970-2 | Individual allele identifier [Identifier] |
| 5238-1 | Leishmania sp Ab [Units/volume] in Serum |
| 4399-2 | Phenylpropanolamine [Mass] of Dose |
| 53235-8 | Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in DBS |
| 53338-0 | 11-Deoxycortisol [Mass/volume] in DBS |
| 3357-1 | Anileridine [Presence] in Urine |
| 53596-3 | Laminaribioside IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 34171-9 | Histoplasma capsulatum Ag [Units/volume] in Specimen |
| 54384-3 | Cytochrome C oxidase [Enzymatic activity/mass] in Amniotic fluid |
| 45387-8 | Cystine crystals [#/area] in Urine sediment by Microscopy low power field |
| 47002-1 | Varicella zoster virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 47259-7 | Creatinine [Mass/volume] in Urine --4th specimen post XXX challenge |
| 2549-4 | Lactate dehydrogenase 5 [Enzymatic activity/volume] in Serum or Plasma |
| 55606-8 | Parrot feather IgE Ab [Presence] in Serum |
| 47614-3 | Decenoate (C10:1)/Creatinine [Molar ratio] in Urine |
| 35479-5 | Diazinon [Mass/volume] in Urine |
| 56495-5 | Lutropin [Units/volume] in Serum or Plasma --3 hours post XXX challenge |
| 5652-3 | Formaldehyde [Mass/volume] in Blood |
| 3731-7 | Lysergate diethylamide [Mass/volume] in Serum or Plasma |
| 56997-0 | Urea/Creatinine [Mass Ratio] in Serum or Plasma |
| 57030-9 | Chromosome 13+18+21+X+Y aneuploidy in Blood by Molecular genetics method Nominal |
| 48672-0 | Clinical cytogeneticist [Identifier] in Specimen |
| 38605-2 | Lindane [Mass/volume] in Air |
| 48966-6 | Triazolam [Mass/volume] in Specimen |
| 49126-6 | Orientia tsutsugamushi identified in Specimen by Sequencing |
| 27935-6 | Calcium [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 3890-1 | Oxprenolol [Presence] in Urine |
| 3899-2 | Oxymetholone [Mass/time] in 24 hour Urine |
| 39577-2 | Leishmania sp IgM Ab [Titer] in Serum |
| 58013-4 | Norclomipramine [Presence] in Urine |
| 58372-4 | Meprobamate/Creatinine [Mass Ratio] in Urine |
| 28587-4 | Benzoate/Creatinine [Ratio] in Urine |
| 29358-9 | Cortisol [Mass/volume] in Serum or Plasma --pre XXX challenge |
| 29376-1 | Narcotics and opioids [Identifier] in Blood |
| 58547-1 | Corticotropin [Mass/volume] in Plasma --15 minutes post dose insulin IV |
| 58610-7 | Corticotropin [Moles/volume] in Plasma --6 PM specimen |
| 50155-1 | Acetylcarnitine (C2) [Moles/volume] in Cerebral spinal fluid |
| 29699-6 | Leptospira interrogans sv Panama Ab [Presence] in Serum |
| 58988-7 | FGB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 59215-4 | Thymidine/Creatinine [Molar ratio] in Urine |
| 30170-5 | American Cockroach IgE Ab [Units/volume] in Serum |
| 40780-9 | Mexiletine [Mass/volume] in Serum or Plasma --peak |
| 40975-5 | Adenovirus DNA [Identifier] in Specimen by RFLP |
| 41103-3 | Gene XXX mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19383-9 | Carboxy tetrahydrocannabinol cutoff [Mass/volume] in Urine for Screen method |
| 20432-1 | Epstein Barr virus nuclear Ab [Presence] in Serum by Immunofluorescence |
| 20633-4 | 1-Methylhistidine [Moles/volume] in Serum or Plasma |
| 20946-0 | Retinol [Mass/mass] in Liver |
| 100141-1 | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot |
| 100383-9 | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection |
| 100847-3 | Gas and ammonia panel - Arterial blood |
| 12781-1 | Borrelia burgdorferi Ab band pattern [Interpretation] in Serum by Immunoblot |
| 12788-6 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum or Plasma |
| 12801-7 | Methdilazine [Mass/volume] in Serum or Plasma |
| 101288-9 | Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Throat by NAA with non-probe detection |
| 13000-5 | Mandelate [Mass/volume] in Urine |
| 102365-4 | Eastern Hemlock IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102660-8 | Whitefish IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13962-6 | Beta glucuronidase [Enzymatic activity/volume] in Serum or Plasma |
| 14037-6 | Fox IgE Ab [Units/volume] in Serum |
| 10503-1 | Lysozyme Ag [Presence] in Tissue by Immune stain |
| 15278-5 | Lovage IgE Ab [Units/volume] in Serum |
| 11011-4 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 1104-9 | Kp sup(b) Ab [Presence] in Serum or Plasma from Donor |
| 16586-0 | Chlamydophila psittaci IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 17351-8 | Neutrophil cytoplasmic Ab [Presence] in Serum |
| 17360-9 | Heptane [Mass/volume] in Blood |
| 17701-4 | Thiazides [Mass/volume] in Urine |
| 90454-0 | Herpes simplex virus 2 DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 74507-5 | 16-Alpha hydroxypregnenolone [Moles/volume] in Urine |
| 6068-1 | Cheese mold type IgE Ab [Units/volume] in Serum |
| 61065-9 | Lysergate diethylamide [Presence] in Specimen |
| 9313-8 | Butorphanol [Mass/volume] in Body fluid |
| 62378-5 | Chromosome copy number change [Type] |
| 77372-1 | 3-Methoxytyramine.free [Moles/volume] in Serum or Plasma |
| 94248-2 | Borrelia mayonii oppA2 gene [Presence] in Blood by NAA with non-probe detection |
| 77886-0 | Nortriptyline cutoff [Mass/volume] in Urine for Confirmatory method |
| 78229-2 | Cells.MYC gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 95117-8 | Insulin [Units/volume] in Serum or Plasma --3 hours post meal |
| 65338-6 | WES sup(b) Ab [Presence] in Serum or Plasma |
| 6596-1 | Diphtheria identified in Isolate by Organism specific culture |
| 66481-3 | Protein.monoclonal band 2 [Mass/time] in Urine collected for unspecified duration |
| 667-6 | Microscopic observation [Identifier] in Specimen by KOH preparation |
| 80531-7 | Itraconazole [Mass/volume] in DBS |
| 80625-7 | Zika virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test --2nd specimen |
| 81825-2 | MAN2B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 98000-3 | HLA-A and B and C (class I) and HLA-DP and DQ and DR (class II) [Type] by High resolution |
| 98732-1 | SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Titer] in Serum or Plasma by Immunoassay |
| 72403-9 | 3-epi-25-Hydroxyvitamin D3 [Mass/volume] in Serum or Plasma |
| 99441-8 | Cocoa IgG4 Ab [Mass/volume] in Serum |
| 72767-7 | Influenza virus A hemagglutinin segment sequence identifier |
| 72887-3 | Staphylococcus aureus methicillin resistance SCCmec [Presence] in Nose by NAA with probe detection |
| 86026-2 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum --1st specimen |
| 86142-7 | Streptococcus pneumoniae Danish serotype 7A IgG Ab [Units/volume] in Serum by Immunoassay |
| 73020-0 | Fluconazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73435-0 | clonazePAM induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73732-0 | Human papilloma virus 26+31+33+35+39+45+51+52+53+56+58+59+66+68+73+82 DNA [Presence] in Genital specimen by NAA with probe detection |
| 73821-1 | Fetal Chromosome X and Y aneuploidy risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
| 89311-5 | CD3-CD45+ cells/100 cells in Blood |
| 41619-8 | Unstable Hemoglobin [Presence] in Red Blood Cells by Isopropanol stability |
| 59830-0 | Erythrocytes in 3 hour Urine sediment by Light microscopy |
| 30517-7 | Carbinoxamine [Mass/volume] in Serum or Plasma |
| 21617-6 | APC gene p.Ile1307Lys [Presence] in Blood or Tissue by Molecular genetics method |
| 31928-5 | Parainfluenza virus 3 Ag [Presence] in Specimen |
| 5172-2 | Streptococcus pyogenes enzyme Ab [Presence] in Serum by Latex agglutination |
| 5188-8 | Hepatitis B virus core Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
| 43210-4 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68+70 DNA [Presence] in Anal by NAA with probe detection |
| 52908-1 | Selenium [Moles/time] in 24 hour Urine |
| 43986-9 | Clofazimine 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 23196-9 | Leptospira sp Ab [Presence] in Serum |
| 53350-5 | Thyroxine (T4) free [Moles/volume] in DBS |
| 44455-4 | Borrelia burgdorferi Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 44799-5 | Coxiella burnetii [Presence] in Specimen by Organism specific culture |
| 44808-4 | Histoplasma capsulatum H Ab band pattern [Interpretation] in Serum by Immunoblot |
| 45278-9 | Lymphocytic choriomeningitis virus IgG Ab [Presence] in Body fluid |
| 23705-7 | Canine parvovirus Ag [Presence] in Tissue by Immunofluorescence |
| 33946-5 | Ziprasidone [Mass/volume] in Serum or Plasma |
| 46085-7 | Gamma hydroxybutyrate [Presence] in Serum or Plasma |
| 24110-9 | Treponema pallidum Ab [Presence] in Serum by Immunoassay |
| 2524-7 | Lactate [Moles/volume] in Serum or Plasma |
| 25247-8 | Chloramphenicol [Mass/volume] in Specimen |
| 35175-9 | Saturated fatty acids [Moles/volume] in Serum or Plasma |
| 55795-9 | Phosphatidylserine IgG Ab [Multiple of the median] in Serum |
| 56024-3 | Influenza virus A N1 RNA [Units/volume] (viral load) in Specimen by NAA with probe detection |
| 35412-6 | Chlamydia sp DNA [Presence] in Nose by NAA with probe detection |
| 47924-6 | Somatotropin [Units/volume] in Serum or Plasma --5 minutes post dose arginine |
| 56685-1 | Hydroxyproline Free [Moles/volume] in Serum or Plasma |
| 49087-0 | Maternal screen clinical predictors panel |
| 27336-7 | Amino acids [Identifier] in Blood |
| 27951-3 | Coxiella burnetii phase 1 Ab [Titer] in Serum by Immunofluorescence |
| 58077-9 | Urinalysis complete W Reflex Culture panel - Urine |
| 29404-1 | Thiothixene [Mass/volume] in Gastric fluid |
| 40118-2 | Creatinine [Moles/volume] in Serum or Plasma --3.5 hours post XXX challenge |
| 58461-5 | Intestinal goblet cell Ab [Titer] in Serum |
| 58543-0 | Corticotropin [Moles/volume] in Plasma --12 PM specimen |
| 59049-7 | Coccidioides sp IgG and IgM panel - Specimen |
| 59306-1 | Memantine [Mass/volume] in Urine |
| 50437-3 | Corticotropin [Mass/volume] in Plasma --6 PM specimen |
| 50540-4 | Thyrotropin [Units/volume] in Serum or Plasma --8th specimen |
| 19285-6 | Benzodiazepines screen method [Identifier] in Urine |
| 12436-2 | Naphthol [Mass/volume] in Serum or Plasma |
| 12602-9 | Hydroxyethylflurazepam [Mass/volume] in Urine |
| 101675-7 | IMP Carbapenemase [Presence] in Isolate by Rapid immunoassay |
| 13403-1 | Leucine [Mass/volume] in Amniotic fluid |
| 102098-1 | Acute myeloid leukemia minimal residual disease in Bone marrow by Flow cytometry (FC) Narrative |
| 102232-6 | Chicken feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13620-0 | Volume of 12 hour Urine |
| 13682-0 | 3-Hydroxy,3-Methylglutarate/Creatinine [Mass Ratio] in Urine |
| 102352-2 | Guar gum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102450-4 | Mediterranean flour moth IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14049-1 | Epidermal growth factor [Mass/volume] in Serum or Plasma |
| 14094-7 | Trypanosoma cruzi IgG Ab [Titer] in Serum |
| 102699-6 | Cabbage IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102734-1 | Egg yolk IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103055-0 | European house dust mite recombinant (rDer p) 10 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103718-3 | Ebolavirus Bundibugyo+Reston+Sudan+Taï Forest+Zaire RNA [Presence] in Blood by NAA with non-probe detection |
| 104127-6 | Cytokeratin 19 mRNA for cancer metastasis [Presence] in Lymph node by NAA with non-probe detection |
| 1629-5 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
| 12310-9 | Phenytoin [Presence] in Urine |
| 16927-6 | Haemophilus influenzae B IgG Ab [Units/volume] in Serum |
| 17003-5 | Serotonin [Mass/volume] in Urine |
| 17167-8 | CD49e cells/100 cells in Blood |
| 17690-9 | Testosterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 90750-1 | O-nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 74623-0 | 1,1-Dimethoxy-(9Z)octadecene (DMA 18:1) [Moles/mass] in Red Blood Cells |
| 74814-5 | Plasma cells.centroblasts/100 leukocytes in Blood by Manual count |
| 74829-3 | Snowshoe hare virus IgG Ab [Presence] in Serum by Immunofluorescence |
| 9336-9 | IgA subclass 1/IgA.total in Serum |
| 93479-4 | Observation interpretation |
| 62474-2 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
| 63179-6 | Johnson grass smut IgG Ab [Mass/volume] in Serum |
| 7847-7 | Taenia solium larva IgG Ab [Presence] in Serum |
| 94394-4 | Influenza virus A H3 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 94446-2 | HLA-A and B and C (class I) IgG panel - Serum or Plasma by Flow cytometry (FC) |
| 80149-8 | Tricyclic antidepressants [Presence] in Urine by Screen method >1000 ng/mL |
| 9602-4 | Taenia solium larva 14kD Ab [Presence] in Serum by Immunoblot |
| 96252-2 | Arsenic.methylated [Mass/volume] in 24 hour Urine |
| 69047-9 | Geneticist review of results |
| 96626-7 | HLA-A [Type] in Donor by Low resolution |
| 96724-0 | Alveolar macrophages [#/volume] in Lower respiratory specimen by Manual count |
| 9782-4 | Adenovirus sp identified in Specimen by Organism specific culture |
| 70100-3 | Methotrexate [Moles/volume] in Serum or Plasma --3rd specimen |
| 98132-4 | SARS-CoV-2 (COVID-19) ORF1a region [Presence] in Respiratory system specimen by NAA with probe detection |
| 85366-3 | Neutrophil membrane IgM Ab [Presence] in Serum by Immunofluorescence |
| 72972-3 | Phenytoin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87438-8 | Dengue virus 1+2+3+4 and Zika virus IgA+IgG+IgM Ab [Interpretation] in Specimen by Immunoassay |
| 88039-3 | little p phenotype [Presence] on Red Blood Cells |
| 88584-8 | Corynebacterium diphtheriae [Presence] in Upper respiratory specimen by Organism specific culture |
| 89038-4 | CHEK2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 41409-4 | Ofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 50960-4 | Rabbit Ab [Presence] in Serum |
| 41841-8 | Coxiella burnetii phase 1 and 2 IgM panel [Titer] - Serum |
| 6004-6 | Prekallikrein (Fletcher Factor) [Mass/volume] in Platelet poor plasma by Chromogenic method |
| 21233-2 | Cryptosporidium sp Ag [Presence] in Stool |
| 51187-3 | CD15 Ag [Presence] in Blood by Immune stain |
| 42753-4 | Phosphatidylserine IgG Ab B2GP1 dependent [Multiple of the median] in Serum |
| 21713-3 | MT-TK gene m.8344A>G [Presence] in Blood or Tissue by Molecular genetics method |
| 21731-5 | RB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2194-9 | Dehydroepiandrosterone (DHEA) [Presence] in Urine |
| 31985-5 | Vesicular stomatitis virus Ag [Presence] in Skin |
| 5155-7 | Epstein Barr virus nuclear IgG Ab [Presence] in Serum by Immunofluorescence |
| 5157-3 | Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay |
| 51649-2 | Hepatitis C virus c100p+5-1-1 Ab [Presence] in Serum by Immunoblot |
| 51761-5 | Giardia lamblia IgA and IgG and IgM [Interpretation] in Serum or Plasma |
| 51809-2 | Chlamydophila psittaci IgM Ab [Units/volume] in Serum by Immunoassay |
| 52938-8 | Barium/Creatinine [Molar ratio] in Urine |
| 43999-2 | Choriogonadotropin [Multiple of the median] in Amniotic fluid |
| 44308-5 | Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in 24 hour Urine by Immunoassay |
| 44394-5 | Kappa light chains [Presence] in 24 hour Urine |
| 22805-6 | Infectious bronchitis virus Ag [Presence] in Specimen by Neutralization test |
| 32629-8 | Protein.monoclonal/Protein.total in Specimen by Immunofixation |
| 44494-3 | Herpes simplex virus 2 IgM Ab [Presence] in Serum by Immunoassay |
| 44786-2 | Aspartate aminotransferase [Enzymatic activity/volume] (Maximum value during study) in Serum or Plasma |
| 53918-9 | Microscopic observation [Identifier] in Bone marrow by Rhodamine-auramine fluorochrome stain |
| 44922-3 | Hemoglobin E/Hemoglobin.total in Blood by HPLC |
| 45049-4 | Cortisol [Moles/volume] in Serum or Plasma --4 PM specimen |
| 45122-9 | Cocal virus Ag [Presence] in Specimen by Immunoassay |
| 23681-0 | Brucella canis Ab [Presence] in Serum by Immunofluorescence |
| 34065-3 | Cortisol [Moles/volume] in Serum or Plasma --pre or post dose corticotropin |
| 34291-5 | Estradiol (E2)/Creatinine [Molar ratio] in Urine |
| 34445-7 | Leukocytes [Presence] in Body fluid |
| 54931-1 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Creatinine [Molar ratio] in Urine |
| 25419-3 | Mumps virus IgM Ab [Units/volume] in Serum by Immunoassay |
| 2553-6 | Lactose [Presence] in Urine |
| 35001-7 | Polymorphonuclear cells [#/volume] in Cerebral spinal fluid |
| 35039-7 | Lymphocytes Plasmacytoid [#/volume] in Blood |
| 25806-1 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 35728-5 | Chlamydia sp rRNA [Presence] in Urethra by Probe |
| 48268-7 | Minor determinant mixture triggered leukotriene release [Mass/volume] by Leukocytes |
| 48294-3 | Food colorant mix I triggered leukotriene release [Mass/volume] by Leukocytes |
| 57004-4 | Glucose/Creatinine [Mass Ratio] in 24 hour Urine |
| 48401-4 | Herpes simplex virus 2 glycoprotein G IgG Ab [Units/volume] in Cerebral spinal fluid |
| 48673-8 | EBV-LMP Ag [Presence] in Tissue by Immune stain |
| 48725-6 | Hemoglobin [Mass/volume] in Blood --pre therapeutic phlebotomy |
| 48888-2 | Coxiella burnetii phase 1 IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 27225-2 | Estriol (E3) [Mass/volume] in Saliva (oral fluid) |
| 38469-3 | Chlamydia trachomatis rRNA [Presence] in Blood by Probe |
| 57424-4 | CD56 cells/100 cells in Body fluid |
| 57451-7 | CV2 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 48994-8 | Glucose [Mass/volume] in Serum or Plasma --6 AM specimen |
| 27371-4 | Chlamydia trachomatis G+F+K Ab [Titer] in Serum by Immunofluorescence |
| 39011-2 | Mumps virus IgG Ab [Presence] in Cerebral spinal fluid |
| 57743-7 | ABO group [Type] in Blood by Confirmatory method |
| 49487-2 | Nateglinide [Presence] in Serum or Plasma |
| 49586-1 | First and Second trimester integrated maternal screen [Interpretation] |
| 29141-9 | Metanephrine [Mass/volume] in Serum or Plasma |
| 29520-4 | 5-Hydroxyindoleacetate/Creatinine [Molar ratio] in Urine |
| 29521-2 | 5-Hydroxyhexanoate/Creatinine [Molar ratio] in Urine |
| 40007-7 | Glucose [Mass/volume] in Serum or Plasma --9.5 hours post XXX challenge |
| 40136-4 | Creatinine [Moles/volume] in Urine --1.5 hours post XXX challenge |
| 58495-3 | C peptide [Moles/volume] in Serum or Plasma --10 minutes post 1 mg glucagon IV |
| 58525-7 | Corticosterone [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin |
| 49864-2 | Procaine IgE Ab [Units/volume] in Serum |
| 29626-9 | 3-Hydroxysebacate ( 3-OH-C8) [Presence] in Urine |
| 2965-2 | Specific gravity of Urine |
| 2966-0 | Specific gravity of 24 hour Urine |
| 40738-7 | Mumps virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 50290-6 | 3-Dechloroethylifosfamide [Mass/volume] in Blood --3 hours post dose ifosfamide |
| 40787-4 | Calculus analysis [Interpretation] in Stone by Infrared spectroscopy |
| 40887-2 | CD11c+CD19+ cells/100 cells in Tissue |
| 19511-5 | Levomethamphetamine [Presence] in Urine by Confirmatory method |
| 20621-9 | Albumin/Creatinine [Presence] in Urine by Test strip |
| 12357-0 | Propoxyphene [Presence] in Stool |
| 100372-2 | Abiraterone [Mass/volume] in Serum or Plasma |
| 12486-7 | Butabarbital [Presence] in Gastric fluid |
| 12564-1 | Cortisol [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 102226-8 | Parmesan Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103558-3 | NR4A3 gene rearrangements in Blood or Tissue by FISH |
| 14967-4 | CD33 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 15217-3 | Food Allergen Mix 1 (Peanut+Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Presence] in Serum by Multidisk |
| 1525-5 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 100 g glucose PO |
| 1551-1 | Glucose [Mass/volume] in Serum or Plasma --pre 50 g lactose PO |
| 11028-8 | Zinc [Mass/volume] in Body fluid |
| 16251-1 | Morphine [Mass/volume] in Urine by Confirmatory method |
| 16567-0 | Cefixime [Mass/volume] in Serum or Plasma |
| 1124-7 | Le sup(x) Ab [Presence] in Serum or Plasma |
| 16763-5 | Dichlorodiphenyldichloroethylene [Mass/volume] in Urine |
| 17934-1 | Bacteria identified in Blood by Anaerobe culture |
| 19022-3 | Neisseria meningitidis serogroups C+w135 Ag [Presence] in Cerebral spinal fluid |
| 19099-1 | Events counted [#] in Specimen |
| 91068-7 | Enterovirus RNA [Presence] in Stool by NAA with probe detection |
| 74807-9 | Transferrin receptor.soluble/log Ferritin index [Mass Ratio] in Serum or Plasma |
| 74873-1 | Metabolic disorder being monitored [Identifier] in DBS |
| 6040-0 | House dust Bencard IgE Ab [Units/volume] in Serum |
| 6101-0 | Duck meat IgE Ab [Units/volume] in Serum |
| 75738-5 | Campesterol [Mass/volume] in Serum or Plasma |
| 93458-8 | AH-8533 [Mass/volume] in Urine by Confirmatory method |
| 9346-8 | Lipoprotein.beta [Mass/volume] in Serum or Plasma by calculation |
| 9358-3 | Lithium [Mass/volume] in Saliva (oral fluid) |
| 61328-1 | Ginger IgE Ab/IgE total in Serum |
| 6211-7 | Penicillium brevicompactum IgE Ab [Units/volume] in Serum |
| 77397-8 | ABO and Rh group [Type] in Blood by Confirmatory method |
| 94756-4 | SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory system specimen by Nucleic acid amplification using CDC primer-probe set N1 |
| 64424-5 | KIR2DS4 gene deletion variant [Presence] in Blood or Tissue by Molecular genetics method |
| 79377-8 | Naltrexol [Mass/volume] in Urine by Confirmatory method |
| 79469-3 | Uridine diphosphate glucose-4-Epimerase [Enzymatic activity/mass] in Red Blood Cells |
| 65750-2 | Drugs of abuse 5 panel - Urine by Screen method |
| 6638-1 | Influenza virus A Texas Ab [Units/volume] in Serum by Hemagglutination inhibition |
| 7980-6 | Parainfluenza virus 3 Ab [Units/volume] in Serum |
| 96499-9 | La Crosse virus Ab.IgG and IgM panel - Serum |
| 68952-1 | Enolase.neuron specific [Mass/volume] in Pericardial fluid |
| 80540-8 | Moxifloxacin [Mass/volume] in DBS |
| 96527-7 | Bourbon virus IgM Ab [Presence] in Specimen by Immunoassay |
| 96808-1 | Thiamine IgE Ab [Units/volume] in Serum |
| 97583-9 | Buprenorphine free [Presence] in Cord tissue by Confirmatory method |
| 70166-4 | Trichomonas vaginalis rRNA [Presence] in Cervix by NAA with probe detection |
| 7054-0 | Ticarcillin+Clavulanate [Susceptibility] by Gradient strip |
| 70907-1 | Cryptococcus sp rRNA gene [Identifier] in Specimen by Sequencing |
| 82378-1 | Ombitasvir [Susceptibility] by Genotype method |
| 82842-6 | Liver kidney microsomal IgG Ab [Presence] in Serum by Immunofluorescence |
| 72347-8 | Neutrophils [#/volume] in Prostatic fluid by Manual count |
| 72386-6 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Saliva (oral fluid) by Confirmatory method |
| 72470-8 | MAM-2201 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 85779-7 | Neisseria meningitidis DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 99434-3 | Quinoa IgG4 Ab [Mass/volume] in Serum |
| 7264-5 | Cranberry triggered histamine release [Units/volume] in Blood |
| 72861-8 | Ganciclovir [Susceptibility] by Phenotype method |
| 86055-1 | Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 73319-6 | Lansoprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87284-6 | Brachyspira hyodysenteriae DNA [Presence] in Isolate by NAA with probe detection |
| 87395-0 | West Nile virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73433-5 | cloNIDine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 41398-9 | Alloisoleucine [Presence] in Serum or Plasma |
| 4159-0 | ceFAZolin [Mass] of Dose |
| 59713-8 | Midazolam [Mass/mass] in Tissue by Confirmatory method |
| 59808-6 | Large granular lymphocytes [Presence] in Blood |
| 59894-6 | Dextromethorphan [Moles/volume] in Serum or Plasma |
| 50682-4 | PRKCG gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 3100-5 | Uridyl transferase [Enzymatic activity/volume] in Red Blood Cells |
| 42193-3 | CD3 cells/100 cells in Cerebral spinal fluid |
| 6018-6 | House dust Allergopharma IgE Ab [Units/volume] in Serum |
| 60229-2 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose fructose PO |
| 21245-6 | Diisobutylketone [Mass/volume] in Urine |
| 31387-4 | Feline herpesvirus Ab [Units/volume] in Serum |
| 43202-1 | Liver kidney microsomal 1 IgG Ab [Units/volume] in Serum |
| 21802-4 | t(11;19)(q23;p13.3)(MLL,MLLT1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 22300-8 | Equine herpesvirus 1 Ab [Titer] in Serum |
| 3170-8 | Volume [Flow] of 24 hour Specimen |
| 43349-0 | Avian metapneumovirus A Ab [Presence] in Serum |
| 43575-0 | Complement C3 [Mass/volume] in Pericardial fluid |
| 32178-6 | Hepatitis B virus e Ag [Titer] in Serum |
| 32511-8 | CD5+CD19+ cells/100 cells in Tissue |
| 44081-8 | Chlamydophila psittaci IgA and IgG and IgM [Interpretation] in Serum |
| 22788-4 | Alcelaphine herpesvirus 1 neutralizing antibody [Titer] in Serum by Neutralization test |
| 53395-0 | Asparagine+Ornithine/Serine [Molar ratio] in DBS |
| 44560-1 | Influenza virus A Ag [Presence] in Nose by Immunofluorescence |
| 23298-3 | Mycoplasma sp Ag [Presence] in Specimen by Immunofluorescence |
| 33480-5 | Methane/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose lactose PO |
| 45197-1 | Decanoylcarnitine (C10) [Moles/volume] in DBS |
| 33820-2 | Interferon alpha [Mass/volume] in Serum or Plasma |
| 46399-2 | Cortisol [Mass/volume] in Serum or Plasma --2 hours post 1 ug/kg CRH IV |
| 35079-3 | Mesothelial cells [#/volume] in Body fluid |
| 35318-5 | Laceyella sacchari Ab [Presence] in Serum by Immune diffusion (ID) |
| 47531-9 | Wet mount panel - Vaginal fluid |
| 25942-4 | Leucine/Creatinine [Molar ratio] in 24 hour Urine |
| 35694-9 | California encephalitis virus IgG Ab [Titer] in Serum |
| 56327-0 | Blue mussel IgG4 Ab [Mass/volume] in Serum |
| 56425-2 | White mulberry IgG4 Ab [Mass/volume] in Serum |
| 48052-5 | Leukocytes [#/volume] corrected for nucleated erythrocytes in Body fluid |
| 2612-0 | Methemalbumin [Mass/volume] in Serum or Plasma |
| 26476-2 | Lymphocytes [#/volume] in Body fluid |
| 35794-7 | Dirithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 35850-7 | Tilmicosin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 4858-7 | HLA-Cw5 [Presence] in Donor |
| 2718-5 | Oxytocin [Mass/volume] in Serum or Plasma |
| 57382-4 | Sodium [Moles/volume] in 2 hour Urine |
| 48948-4 | diazePAM [Mass/volume] in Specimen |
| 2947-0 | Sodium [Moles/volume] in Blood |
| 49824-6 | 3-Hydroxypropionate (3-OH-C3)/Creatinine [Molar ratio] in 24 hour Urine |
| 29670-7 | Rickettsia honei Ab [Titer] in Serum |
| 29821-6 | Trivittatus virus Ab [Titer] in Specimen |
| 29831-5 | Powassan virus IgM Ab [Presence] in Specimen |
| 29874-5 | Isovalerylglycine [Presence] in Urine |
| 58891-3 | Calcitonin [Mass/volume] in Serum or Plasma --1 minute post XXX challenge |
| 59015-8 | Carbohydrates [Mass/mass] in Stool by Infrared spectroscopy |
| 30165-5 | Phosphatidylcholine/Albumin [Mass Ratio] in Amniotic fluid |
| 41155-3 | Cytomegalovirus IgM Ab [Units/volume] in Body fluid |
| 1947-1 | Beta hydroxybutyrate [Mass/volume] in Urine |
| 19621-2 | Nitrazepam [Presence] in Urine by Confirmatory method |
| 2013-1 | Cancer Ag 50 [Presence] in Serum or Plasma |
| 20828-0 | Gallotannin [Mass/mass] in Plant |
| 12480-0 | Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid |
| 12587-2 | Creatinine [Mass/time] in 6 hour Urine |
| 14347-9 | Specific gravity of Gastric fluid by Refractometry |
| 14572-2 | 17-Ketosteroids [Moles/time] in 24 hour Urine |
| 14693-6 | Norclobazam [Moles/volume] in Serum or Plasma |
| 14937-7 | Urea nitrogen [Moles/volume] in Serum or Plasma |
| 14989-8 | little i-2 subtype [Presence] on Red Blood Cells from Blood product unit |
| 104308-2 | Palbociclib [Mass/volume] in Serum or Plasma |
| 16248-7 | 6-monoacetylmorphine free [Mass/volume] in Serum or Plasma by Confirmatory method |
| 17027-4 | Isocyanate IgG Ab [Units/volume] in Serum |
| 18355-8 | Methylenedioxyamphetamine [Mass/volume] in Urine |
| 19055-3 | Carboxy tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine |
| 90298-1 | Entamoeba sp DNA [Identifier] in Stool by Sequencing |
| 90795-6 | Levothyroxine absorption panel - Serum or Plasma |
| 7471-6 | Lobster IgG Ab [Units/volume] in Serum |
| 91807-8 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 92833-3 | Lymph nodes examined [#] in Cancer specimen by Light microscopy |
| 92978-6 | Human metapneumovirus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 93346-5 | Genetic variant effect on drug sensitivity in Blood or Tissue Narrative |
| 6134-1 | Guinea pig epithelium IgE Ab [Units/volume] in Serum |
| 62386-8 | Chromosome analysis summary panel |
| 77682-3 | Staphylococcus aureus methicillin resistance SCCmec+orfX junction [Presence] in Nose by NAA with probe detection |
| 63200-0 | Goldenrod IgG Ab [Mass/volume] in Serum |
| 94591-5 | Chromosome rearrangement [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
| 63552-4 | Macrophages/100 cells in Bone marrow by Manual count |
| 6390-9 | Echinococcus sp Ab [Units/volume] in Serum by Complement fixation |
| 6417-0 | Haemophilus influenzae E Ag [Presence] in Specimen by Immunofluorescence |
| 80218-1 | Mycoplasma hyopneumoniae Ab sample/Buffer control in Serum by Immunoassay |
| 6734-8 | Pork IgG Ab [Units/volume] in Serum |
| 68416-7 | Mesothelial cells [#/volume] in Pleural fluid by Manual count |
| 68417-5 | Mesothelial cells [#/volume] in Synovial fluid by Manual count |
| 69961-1 | Hepatitis E virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 70022-9 | Candida albicans DNA [Presence] in Blood by NAA with probe detection |
| 97762-9 | Parathyrin.intact [Moles/volume] in Body fluid |
| 7030-0 | Methicillin [Susceptibility] by Gradient strip |
| 82926-7 | Phospholipase A2 receptor IgG Ab [Presence] in Serum by Line blot |
| 98001-1 | HLA-DP and DQ and DR (class II) [Type] by Low resolution |
| 99050-7 | Erythrocytes [#/volume] in Bronchoalveolar lavage by Manual count |
| 83085-1 | Carcinoembryonic Ag [Mass/volume] in Serum or Plasma by Immunoassay |
| 85778-9 | Haemophilus influenzae DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 86119-5 | Streptococcus pneumoniae Danish serotype 4 Ab [Units/volume] in Serum --1st specimen |
| 86140-1 | Streptococcus pneumoniae Danish serotype 6A Ab [Mass/volume] in Serum --2nd specimen |
| 88462-7 | Carbapenem [Susceptibility] |
| 74114-0 | Coumatetralyl [Presence] in Specimen by Screen method |
| 74431-8 | Acetoacetate [Moles/volume] in Blood |
| 41206-4 | West Nile virus Ab [Units/volume] in Cerebral spinal fluid |
| 41713-9 | Rosamicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 59314-5 | Ramelteon [Mass/volume] in Blood |
| 59678-3 | Flurazepam [Mass/mass] in Tissue |
| 50849-9 | diazePAM+Nordiazepam [Moles/volume] in Serum or Plasma |
| 41858-2 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine |
| 60022-1 | Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction |
| 60092-4 | Ketoconazole [Mass/volume] in Urine |
| 21502-0 | Measles virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 5135-9 | Echinococcus sp Ab [Units/volume] in Serum by Hemagglutination |
| 21695-2 | HFE gene.p.Cys282Tyr [Presence] in Blood or Tissue by Molecular genetics method |
| 21709-1 | MTHFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 22245-5 | Cytomegalovirus IgG Ab [Titer] in Cerebral spinal fluid |
| 22260-4 | Eastern equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid |
| 4351-3 | Nikethamide [Mass] of Dose |
| 22477-4 | Rickettsia spotted fever group IgG Ab [Titer] in Serum |
| 5210-0 | Herpes simplex virus 2 IgM Ab [Units/volume] in Serum by Immunoassay |
| 53056-8 | Decanoylcarnitine (C10) [Moles/volume] in Amniotic fluid |
| 44326-7 | Iron [Presence] in Serum or Plasma |
| 44328-3 | Isocitrate [Presence] in 24 hour Urine |
| 22975-7 | Caprine arthritis encephalitis virus Ag [Presence] in Specimen by Immune stain |
| 32759-3 | Myeloperoxidase cells/100 cells in Specimen |
| 33224-7 | Fine Granular Casts [#/area] in Urine sediment by Microscopy high power field |
| 53348-9 | 11-Deoxycorticosterone [Moles/volume] in DBS |
| 23465-8 | Theileria equi rRNA [Presence] in Blood by Probe |
| 45009-8 | Chlamydia trachomatis Ab [Presence] in Serum by Immunofluorescence |
| 3394-4 | Benzoylecgonine [Mass/volume] in Urine |
| 34234-5 | Ampicillin IgG Ab [Units/volume] in Serum |
| 4560-9 | Hemoglobin Bethesda [Presence] in Blood |
| 46422-2 | Trichomonas vaginalis [#/area] in Urine sediment by Microscopy high power field |
| 46977-5 | Benzodiazepines [Mass/volume] in Serum or Plasma by Confirmatory method |
| 55350-3 | Fenfluramine [Presence] in Urine |
| 47219-1 | Cholesterol in VLDL 5+6 [Mass/volume] in Serum or Plasma |
| 25172-8 | Fluoride [Moles/volume] in Blood |
| 25188-4 | Ciprofloxacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25299-9 | Measles virus IgG Ab [Ratio] in Serum --1st specimen/2nd specimen |
| 25503-4 | Phosphoserine [Moles/time] in 24 hour Urine |
| 55634-0 | Cefamandole+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 55707-4 | Piromidate [Susceptibility] by Disk diffusion (KB) |
| 55921-1 | IgG.monoclonal [Presence] in Serum by Immunoelectrophoresis |
| 55971-6 | Alkaline phosphatase [Enzymatic activity/volume] in Cord blood |
| 3536-0 | Norclomipramine [Mass/volume] in Serum or Plasma |
| 56282-7 | Hazelnut Pollen IgG4 Ab [Mass/volume] in Serum |
| 5638-2 | Diazinon [Mass/volume] in Blood |
| 3700-2 | Kanamycin [Mass/volume] in Serum or Plasma --trough |
| 56590-3 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 48383-4 | Collagen.bovine type 1 Ab [Units/volume] in Serum |
| 48647-2 | Ej Ab [Presence] in Serum by Radioimmunoprecipitation assay (RIPA) |
| 48851-0 | Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Serum by Immunofluorescence |
| 38455-2 | CFTR gene c.621+1G>T [Presence] in Blood or Tissue by Molecular genetics method |
| 5716-6 | Polychlorinated biphenyl (PCB) [Mass/volume] in Serum or Plasma |
| 27306-0 | Testosterone [Presence] in Saliva (oral fluid) |
| 27365-6 | Kappa light chains [Mass/volume] in Urine |
| 38724-1 | Quinoline [Mass/volume] in Air |
| 39536-8 | Influenza virus A Ab [Units/volume] in Serum by Complement fixation |
| 57717-1 | Newborn screen card data panel |
| 49668-7 | Atazanavir [Susceptibility] by Phenotype method |
| 49713-1 | Parainfluenza virus Ab [Titer] in Serum by Complement fixation |
| 58446-6 | Creatinine 24H renal clearance adjusted for body surface area panel |
| 49868-3 | Ibuprofen IgE Ab [Units/volume] in Serum |
| 40740-3 | Osmotic fragility of Red Blood Cells--Incubated |
| 19157-7 | Tube number of Cerebral spinal fluid |
| 20379-4 | Doxycycline [Susceptibility] by Method for Slow-growing mycobacteria |
| 20385-1 | rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria |
| 2076-8 | Chloride [Moles/mass] in Stool |
| 12438-8 | Nortramadol [Mass/volume] in Serum or Plasma |
| 100344-1 | Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |
| 100800-2 | 21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge |
| 101371-3 | Yersinia pestis DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 1378-9 | Calcitonin [Mass/volume] in Serum or Plasma --pre 0.5 ug/kg pentagastrin IV |
| 14738-9 | Gastrin [Moles/volume] in Serum or Plasma --25 minutes post 0.2 U/kg secretin |
| 103624-3 | Klebsiella pneumoniae oxytoca DNA [Presence] in Specimen by NAA with probe detection |
| 10884-5 | Phosphate [Mass/mass] in Stool |
| 91873-0 | Chlamydia trachomatis Ag [Presence] in Throat by Immunofluorescence |
| 75110-7 | Arachidonate (C20:4w6) [Entitic substance] in Red Blood Cells |
| 60487-6 | NPHP1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 6060-8 | Careless Weed IgE Ab [Units/volume] in Serum |
| 6082-2 | Codfish IgE Ab [Units/volume] in Serum |
| 61062-6 | Carboxy tetrahydrocannabinol [Presence] in Gastric fluid |
| 92852-3 | Adenovirus and Bocavirus DNA panel - Lower respiratory specimen by NAA with probe detection |
| 77052-9 | IFITM5 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 7776-8 | Whitefish IgG Ab [Units/volume] in Serum |
| 78210-2 | ALK gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 6446-9 | Legionella pneumophila Ag [Presence] in Sputum by Latex agglutination |
| 95215-0 | CBC W Differential panel - Stem cell product |
| 67790-6 | Thromboelastography panel - Blood |
| 6962-5 | Yersinia enterocolitica O:9 Ab [Titer] in Serum |
| 8212-3 | Opiates [Presence] in Gastric fluid by Screen method |
| 97522-7 | Giardia sp [Presence] in Water by Immunofluorescence |
| 70261-3 | Cholesterol in peritoneal fluid/Cholesterol in serum |
| 82737-8 | Beta tubulin IgG Ab [Titer] in Serum by Immunoassay |
| 98028-4 | Crystals [type] in Semen by Light microscopy |
| 85334-1 | Surgical margin DCIS involvement [Presence] in Breast cancer specimen by Light microscopy |
| 855-7 | A2 Ag [Presence] on Red Blood Cells from Donor |
| 99466-5 | Oat pollen IgG Ab [Mass/volume] in Serum |
| 86173-2 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum --2nd specimen |
| 86898-4 | Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay |
| 7342-9 | Goldenrod IgG Ab [Units/volume] in Serum |
| 73652-0 | Apramycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 73796-5 | Infant activity during preductal oxygen saturation measurement |
| 73887-2 | Tetrahydrocorticosterone [Moles/volume] in 24 hour Urine |
| 89967-4 | Norquetiapine [Presence] in Urine by Screen method |
| 41248-6 | Xanthurenate [Presence] in Urine |
| 41599-2 | Bacteria [Presence] in Body fluid by Light microscopy |
| 50940-6 | Zinc/Creatinine [Molar ratio] in 24 hour Urine |
| 30422-0 | Lymphoma cells [#/volume] in Blood |
| 30453-5 | Segmented neutrophils/100 leukocytes in Body fluid |
| 60005-6 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 21661-4 | CYP2D6 gene deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 31508-5 | Mycoplasma capricolum ss capripneumonia Ab [Presence] in Blood |
| 51178-2 | CD36 blasts in Specimen |
| 51403-4 | CD81 cells/100 cells in Bone marrow |
| 42967-0 | Rubella virus Ab [Titer] in Cerebral spinal fluid |
| 22523-5 | Salmonella paratyphi B O Ab [Presence] in Serum |
| 2268-1 | Etiocholanolone [Mass/time] in 24 hour Urine |
| 44031-3 | Aspergillus niger B Ab [Presence] in Serum by Immune diffusion (ID) |
| 32652-0 | Fenthion [Mass/volume] in Serum or Plasma |
| 44792-0 | Immunoglobulin light chains panel - Urine |
| 44827-4 | Bartonella quintana IgG Ab [Titer] in Serum by Immunofluorescence |
| 23221-5 | Lumpy skin disease virus Ag [Presence] in Specimen by Immunofluorescence |
| 53808-2 | Oligosaccharides pattern [Interpretation] in Serum or Plasma Narrative |
| 53818-1 | Arbekacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 53949-4 | HPA 1a/1a+HPA 3b/3b [Presence] in Blood |
| 33800-4 | DNA double strand IgG Ab [Units/volume] in Serum |
| 5398-3 | Trypanosoma cruzi Ab [Titer] in Serum by Complement fixation |
| 46082-4 | Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay |
| 46398-4 | Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post 1 ug/kg CRH IV |
| 46952-8 | Fluticasone propionate [Mass/volume] in Urine |
| 47233-2 | Influenza virus A Ab [Presence] in Serum --2nd specimen |
| 35343-3 | Amylase [Enzymatic activity/volume] in Body fluid --4th specimen post Sincalide |
| 55975-7 | IgG [Mass/volume] in Body fluid by Immune diffusion (ID) |
| 47609-3 | Cortisol [Moles/volume] in Serum or Plasma --pre 1 ug/kg CRH IV |
| 35535-4 | Egg white IgG Ab [Mass/volume] in Serum |
| 35567-7 | Parathyrin [Mass/volume] in Serum or Plasma --10 minutes post excision |
| 35716-0 | Chlamydia sp DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 56213-2 | Celery IgG4 Ab [Mass/volume] in Serum |
| 3611-1 | Ethchlorvynol [Presence] in Urine |
| 3769-7 | Metenolone [Mass/volume] in Urine |
| 3778-8 | Methamphetamine [Mass/volume] in Serum or Plasma |
| 38176-4 | Kappa light chains.free [Mass/volume] in Urine |
| 56612-5 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 26932-4 | Sarcosine [Moles/volume] in Amniotic fluid |
| 38500-5 | Spermatozoa Progressive Grade 1/100 spermatozoa in Semen |
| 4901-5 | HLA-Dw25 [Presence] |
| 49301-5 | Protein Fractions [Interpretation] in 24 hour Urine by Electrophoresis Narrative |
| 2750-8 | pH of Pleural fluid |
| 28069-3 | Meat fibers [#/area] in Stool by Light microscopy |
| 57972-2 | Glucose [Mass/volume] in Serum or Plasma --5th specimen post lactose |
| 49521-8 | Influenza virus A H1 RNA [Presence] in Specimen by NAA with probe detection |
| 29328-2 | Xylose [Mass/volume] in Blood --2.5 hours post dose xylose PO |
| 29514-7 | 3-Hydroxyisovalerate/Creatinine [Molar ratio] in Urine |
| 40143-0 | Creatinine [Moles/volume] in Urine --5 hours post XXX challenge |
| 40302-2 | Somatotropin [Mass/volume] in Serum or Plasma --pre dose arginine |
| 58650-3 | Cortisol [Mass/volume] in Saliva (oral fluid) --15 minutes pre 1 ug/kg CRH IV |
| 29571-7 | Phenylalanine [Presence] in DBS |
| 29946-1 | Albumin [Presence] in 24 hour Urine by Electrophoresis |
| 40414-5 | Benzodiazepines [Presence] in Meconium |
| 40501-9 | Candida sp Ab [Titer] in Serum by Latex agglutination |
| 19471-2 | FLUoxetine [Presence] in Urine by Confirmatory method |
| 19677-4 | Phentermine cutoff [Mass/volume] in Urine for Confirmatory method |
| 1976-0 | Bilirubin.total [Presence] in Stool |
| 1994-3 | Calcium.ionized [Moles/volume] in Blood |
| 20648-2 | Isoleucine [Moles/volume] in Serum or Plasma |
| 20677-1 | Equine adenovirus Ag [Presence] in Lung by Immunofluorescence |
| 100021-5 | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100043-9 | Azithromycin+Ethambutol [Susceptibility] |
| 12563-3 | Cortisol [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 102066-8 | Perfluorononanoate [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 13749-7 | Glycerate/Creatinine [Mass Ratio] in Urine |
| 13882-6 | Androstanolone Free/Androstanolone.total in Serum or Plasma |
| 102495-9 | Parsnip IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102513-9 | Phoma betae IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14138-2 | Ketones [Presence] in Urine --30 minutes post XXX challenge |
| 102855-4 | Wild Oats IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103710-0 | Chenodeoxycholate+Cholate/Bile acid.total in Stool |
| 10404-2 | Inject Rh immune globulin [Volume] |
| 14809-8 | Lead [Moles/time] in 24 hour Urine |
| 104261-3 | Eosinophil derived neurotoxin [Mass/volume] in Serum by Immunoassay |
| 16254-5 | Phencyclidine [Mass/volume] in Urine by Confirmatory method |
| 16297-4 | 17-Hydroxypregnenolone [Mass/volume] in Urine |
| 16531-6 | Campylobacter lari rRNA [Units/volume] in Serum by Probe |
| 16536-5 | Canary serum proteins Ab [Units/volume] in Serum |
| 17394-8 | Oxychlordane [Mass/volume] in Urine |
| 90071-2 | Gram positive non-catalase producing cocci identified in Isolate by Organism specific culture |
| 90339-3 | Aspergillus sp DNA [Presence] in Tissue by NAA with probe detection |
| 90881-4 | Inhalant Allergen Mix 6 (Alternaria tenuis+Mugwort+Silver birch+Cladosporium herbarum+Timothy grass) IgE Ab [Presence] in Serum by Multidisk |
| 74789-9 | Fructose challenge (hydrogen breath test) panel - Exhaled gas |
| 92794-7 | Candida glabrata DNA [Presence] by NAA with probe detection in Positive blood culture |
| 60415-7 | Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection |
| 60680-6 | Cortisol Free [Mass/volume] in Serum or Plasma --30 minutes post dose corticotropin |
| 61104-6 | Prochlorperazine [Moles/volume] in Specimen |
| 76669-1 | Glucose [Moles/volume] in Cerebral spinal fluid --1st tube |
| 92861-4 | Herpes simplex virus 1 and 2 and Varicella zoster virus DNA panel - Skin by NAA with probe detection |
| 93237-6 | aPTT.lupus sensitive.excess phospholipid actual/normal in Platelet poor plasma by Coagulation assay --post heparin neutralization |
| 93501-5 | Metabotropic glutamate receptor 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 93506-4 | Heptacarboxylporphyrin III [Moles/time] in 24 hour Urine |
| 61211-9 | Garlic IgE Ab/IgE total in Serum |
| 62307-4 | Krabbe disease newborn screening panel |
| 771-6 | Nucleated erythrocytes [#/volume] in Blood by Automated count |
| 77496-8 | Clostridium perfringens [Presence] in Specimen by Organism specific culture |
| 93707-8 | Porphyrin fractions panel - Urine |
| 94256-5 | Magnesium [Mass/volume] in Sweat |
| 79148-3 | traMADol [Presence] in Blood by Screen method |
| 95220-0 | Lymphocytes/100 leukocytes in Stem cell product by Manual count |
| 6526-8 | Rabies virus Ab [Units/volume] in Specimen |
| 6895-7 | Butalbital [Mass/volume] in Serum or Plasma |
| 68966-1 | Respiratory syncytial virus Ag [Presence] in Nasopharynx by Immunoassay |
| 8126-5 | CD38 cells/100 cells in Blood |
| 96588-9 | Cholesterol [Mass/volume] in DBS |
| 81837-7 | GRHPR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 82160-3 | Adenovirus DNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 8220-6 | Opiates [Mass/volume] in Urine |
| 97270-3 | Meprobamate [Presence] in Cord tissue by Screen method |
| 8242-0 | Phencyclidine [Presence] in Unknown substance by Screen method |
| 82795-6 | Clot growth mean [Velocity] Platelet poor plasma |
| 71792-6 | Procollagen type III.N-terminal propeptide [Mass/volume] in Serum |
| 87407-3 | Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
| 73730-4 | Lysergate diethylamide [Presence] in Meconium |
| 88048-4 | P sup(k) Ag [Presence] on Red Blood Cells from Donor |
| 742-7 | Monocytes [#/volume] in Blood by Automated count |
| 88610-1 | Human coronavirus 229E RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 89370-1 | Zika virus non-structural protein 1 IgM Ab [Interpretation] in Serum by Immunoassay |
| 59681-7 | Gamma hydroxybutyrate [Presence] in Serum or Plasma by Screen method |
| 4203-6 | Cyanocobalamin.PO [Mass] of Dose |
| 4232-5 | Dyphylline [Mass] of Dose |
| 426-7 | Pyrazinamide [Susceptibility] by Serum bactericidal titer |
| 21352-0 | Intercellular substance IgG Ab [Interpretation] in Serum by Immunofluorescence |
| 31280-1 | Canary serum proteins Ab [Presence] in Serum |
| 31554-9 | Parainfluenza virus 3 IgM Ab [Units/volume] in Serum |
| 31604-2 | Rickettsia rickettsii Ab [Presence] in Serum |
| 51054-5 | CD126 blasts [Units/volume] in Specimen |
| 51083-4 | CD15 blasts [Units/volume] in Bone marrow |
| 43009-0 | HIV 1+2 IgG Ab [Presence] in Serum |
| 43237-7 | Thrombopoietin [Mass/volume] in Platelet poor plasma by Immunoassay |
| 22395-8 | Legionella pneumophila 9 Ab [Titer] in Serum |
| 32358-4 | Oligoclonal bands [Presence] in Cerebral spinal fluid |
| 5197-9 | Hepatitis B virus surface Ag [Presence] in Serum by Radioimmunoassay (RIA) |
| 52109-6 | Co sup(a) Ab [Presence] in Serum or Plasma |
| 52910-7 | Zinc [Moles/mass] in Tissue |
| 44310-1 | Cortisol/Creatinine [Mass Ratio] in 24 hour Urine |
| 32676-9 | Diuretics [Mass/volume] in Urine |
| 32797-3 | Drugs identified in Meconium by Screen method |
| 532-2 | Mycobacterium sp identified in Aspirate by Organism specific culture |
| 44820-9 | Leishmania brasilensis IgM Ab [Titer] in Serum by Immunofluorescence |
| 53582-3 | Echovirus Ab [Units/volume] in Serum by Immunoassay |
| 44889-4 | Malignant cells [#/volume] in Pleural fluid |
| 44892-8 | Malignant cells/100 cells in Cerebral spinal fluid |
| 45328-2 | Glutathione peroxidase [Enzymatic activity/volume] in Blood |
| 45337-3 | Bacterial biochemical profile [Identifier] in Isolate by Culture |
| 23772-7 | PRRSV Ab [Titer] in Serum by Immunofluorescence |
| 54432-0 | Pooled fresh frozen plasma given [Volume] |
| 46196-2 | Leptospira interrogans IgG Ab [Titer] in Serum |
| 55136-6 | Penicillin Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 55526-8 | Brompheniramine [Moles/volume] in Serum or Plasma |
| 47012-0 | Cancer Ag 72-4 [Presence] in Tissue by Immune stain |
| 47073-2 | Babesia microti IgM Ab [Titer] in Cerebral spinal fluid |
| 4720-9 | HLA-A23(9) [Presence] |
| 47257-1 | Creatinine [Mass/volume] in Urine --1st specimen post XXX challenge |
| 25303-9 | Alpha 1 antitrypsin [Mass/mass] in Stool |
| 34721-1 | Dengue virus IgM Ab [Presence] in Cerebral spinal fluid |
| 34953-0 | Rubella virus IgG and IgM panel - Cerebral spinal fluid |
| 55661-3 | Clofazimine [Susceptibility] by Disk diffusion (KB) |
| 55835-3 | Vegetable fibers [Presence] in Stool by Light microscopy |
| 55923-7 | IgG [Mass/time] in 24 hour Urine |
| 47796-8 | Tyrosine/Amino acids.total in DBS |
| 25759-2 | Insulin-like growth factor [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge |
| 35359-9 | AR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 35726-9 | Chlamydia sp rRNA [Presence] in Urine by Probe |
| 35776-4 | cefTAZidime+Clavulanate [Susceptibility] |
| 56148-0 | Smith extractable nuclear Ab and Ribonucleoprotein extractable nuclear Ab panel - Serum |
| 35862-2 | Voriconazole [Susceptibility] by Gradient strip |
| 3613-7 | Ethoheptazine [Presence] in Urine |
| 3683-0 | HYDROmorphone [Mass/volume] in Serum or Plasma |
| 3770-5 | Metenolone [Mass/time] in 24 hour Urine |
| 27223-7 | Serine [Moles/volume] in Amniotic fluid |
| 3931-3 | Phenazocine [Presence] in Urine |
| 3949-5 | PHENobarbital [Presence] in Urine |
| 40077-0 | Calcium [Mass/volume] in Serum or Plasma --8 hours post XXX challenge |
| 58478-9 | Bombus sp IgG Ab [Mass/volume] in Serum |
| 29790-3 | La Crosse virus IgM Ab [Presence] in Specimen by Immunofluorescence |
| 30095-4 | Neisseria meningitidis serogroup B Ag [Presence] in Specimen by Latex agglutination |
| 2021-4 | Carbon dioxide [Partial pressure] in Venous blood |
| 101474-5 | Adenovirus DNA and Human Metapneumovirus and Rhinovirus RNA panel - Respiratory specimen by NAA with probe detection |
| 101506-4 | Phosphatidylethanol panel - Blood |
| 102187-2 | Botrytis cinerea IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13475-9 | Fluoride/Creatinine [Mass Ratio] in Urine |
| 1372-2 | Calcitonin [Mass/volume] in Serum or Plasma --90 seconds post 0.5 ug/kg pentagastrin IV |
| 102477-7 | Olive Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102546-9 | Aureobasidium pullulans IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102567-5 | Redwood IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14057-4 | carBAMazepine free [Mass/volume] in Saliva (oral fluid) |
| 102857-0 | Parakeet serum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14387-5 | Protein [Mass/volume] in Gastric fluid |
| 103143-4 | Genetic disease DNA and RNA analysis [Presence] in Blood or Tissue by Molecular genetics method |
| 10363-0 | Barbiturates [Presence] in Specimen |
| 104433-8 | Mycobacterium leprae DNA [Presence] in Specimen by NAA with probe detection |
| 16431-9 | Barium [Presence] in Urine |
| 17176-9 | CD58 cells/100 cells in Blood |
| 17534-9 | Rheumatoid factor [Units/volume] in Body fluid by Immunoassay |
| 17961-4 | Bacteria # 4 identified in Peritoneal fluid by Culture |
| 18473-9 | HYDROmorphone [Presence] in Urine by Confirmatory method |
| 19106-4 | Herpes simplex virus IgG Ab [Presence] in Serum |
| 90439-1 | Atypical pneumonia pathogens panel - Respiratory system specimen by NAA with probe detection |
| 90825-1 | GABABR Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 74964-8 | Gabapentin [Mass/volume] in Serum or Plasma --trough |
| 91143-8 | TPMT activity in RBC by production of 6-MTG riboside |
| 61033-7 | 7-Aminoflunitrazepam [Presence] in Urine |
| 62311-6 | Gaucher disease newborn screening panel |
| 77769-8 | Ethyl glucuronide cutoff [Mass/volume] in Urine for Confirmatory method |
| 77882-9 | Dehydroaripiprazole cutoff [Mass/volume] in Urine for Confirmatory method |
| 783-1 | Promyelocytes/100 leukocytes in Blood by Manual count |
| 6512-8 | Human papilloma virus Ab [Presence] in Tissue by Immunoassay |
| 65345-1 | Glucagon [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 7958-2 | Leishmania sp Ab [Presence] in Serum |
| 79710-0 | Potassium [Mass/mass] in Hair |
| 79711-8 | HLA-B*58:01 [Presence] in Blood or Tissue |
| 8147-1 | Amphetamines [Mass/volume] in Serum or Plasma |
| 96528-5 | Toscana virus IgM Ab [Presence] in Specimen by Immunoassay |
| 96673-9 | HLA-DRB3 and HLA-DRB4 and HLA DRB5 [Type] |
| 6967-4 | Yersinia pseudotuberculosis Ab [Titer] in Serum |
| 97856-9 | Histoplasma capsulatum yeast phase Ab [Titer] in Specimen by Complement fixation |
| 7145-6 | Beet IgG Ab [Units/volume] in Serum |
| 82383-1 | Dengue virus 2+4 RNA [Presence] in Serum by NAA with probe detection |
| 8266-9 | Service comment 05 |
| 98218-1 | Treponema pallidum IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 9835-0 | HYDROmorphone [Mass/volume] in Urine |
| 72930-1 | Warfarin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7308-0 | Esterase IgE Ab [Units/volume] in Serum |
| 88015-3 | Palmitoylcarnitine (C16)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 88050-0 | P2 phenotype [Presence] on Red Blood Cells from Blood product unit |
| 88167-2 | Mycobacterium sp identified in Cornea or Conjunctiva by Organism specific culture |
| 88906-3 | Parainfluenza virus 1 Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
| 88992-3 | Ustekinumab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
| 41653-7 | Glucose [Mass/volume] in Capillary blood by Glucometer |
| 59365-7 | Leptospira interrogans sv Mini Ab [Titer] in Serum by Agglutination |
| 59376-4 | 3-Keto, 2-Methylvalerate/Creatinine [Molar ratio] in Urine |
| 50983-6 | Horowitz index in Capillary blood |
| 43092-6 | Arbovirus NOS Ab [Titer] in Serum |
| 2202-0 | Deoxycholylglycine [Mass/volume] in Serum |
| 3204-5 | Coagulation factor VIII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
| 32329-5 | Magnesium [Moles/volume] in Specimen |
| 5228-2 | Immune complex [Units/volume] in Serum or Plasma |
| 44010-7 | Influenza virus A and B Ab [Interpretation] in Body fluid |
| 53331-5 | Crystals.amorphous [#/volume] in Urine by Computer assisted method |
| 44821-7 | Leishmania brasilensis IgG Ab [Titer] in Serum by Immunofluorescence |
| 44854-8 | Mycobacterium sp # 4 identified in Specimen by Organism specific culture |
| 23311-4 | Myxoma virus Ag [Presence] in Specimen by Immunofluorescence |
| 23359-3 | Peste des petits ruminants virus RNA [Presence] in Tissue by NAA with probe detection |
| 53724-1 | SLC26A4 gene p.Thr416Pro [Presence] in Blood by Molecular genetics method |
| 44994-2 | Chlamydia trachomatis B IgM Ab [Presence] in Serum |
| 45008-0 | Chlamydia trachomatis Ab [Presence] in Serum by Complement fixation |
| 45349-8 | Condition of tick [Identifier] |
| 24092-9 | Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Leukocytes |
| 34352-5 | Pentacarboxylporphyrins [Moles/volume] in Urine |
| 55150-7 | Anaplasma phagocytophilum IgG and IgM panel - Serum Qualitative |
| 25222-1 | Cefmetazole 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 55641-5 | Cefmenoxime [Susceptibility] by Gradient strip |
| 56009-4 | Platelet aggregation collagen induced in Blood --5 ug/mL |
| 56018-5 | Platelet aggregation thrombin induced ATP secretion [Presence] in Blood --5 U/mL |
| 47864-4 | Lutropin [Units/volume] in Serum or Plasma --2.5 hours post 100 ug luteinizing releasing hormone IV |
| 25615-6 | Conalbumin IgE Ab [Units/volume] in Serum |
| 25688-3 | Insulin [Moles/volume] in Serum or Plasma --13th specimen post XXX challenge |
| 56428-6 | White Poplar IgG4 Ab [Mass/volume] in Serum |
| 5644-0 | Ethanol [Presence] in Urine |
| 56521-8 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 47938-6 | Specimen source [Identifier] of Body fluid |
| 26724-5 | Sarcosine [Moles/volume] in Urine |
| 35867-1 | Acetoacetate [Moles/volume] in Serum or Plasma |
| 3750-7 | Mephobarbital [Mass/volume] in Serum or Plasma |
| 37987-5 | Dust Allergen Mix 2 (Cockroach+American house dust mite+European house dust mite+House dust Hollister Stier) IgE Ab [Units/volume] in Serum by Multidisk |
| 56964-0 | Phosphate/Creatinine [Ratio] in Urine |
| 57492-1 | 11-Deoxycorticosterone [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
| 49276-9 | Immunofixation for Urine Narrative |
| 39087-2 | Myelin associated glycoprotein IgM Ab [Titer] in Serum by Immunoassay |
| 39529-3 | Acetone [Presence] in Blood |
| 29150-0 | Mefloquine [Mass/volume] in Urine |
| 40244-6 | Calcium [Moles/volume] in Serum or Plasma --1 day post XXX challenge |
| 40267-7 | Creatinine [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 58498-7 | C peptide [Mass/volume] in Serum or Plasma --12th specimen post XXX challenge |
| 4063-4 | traZODone [Presence] in Serum or Plasma |
| 5922-0 | Gastric acid [Moles/volume] in Gastric fluid |
| 50418-3 | Corticotropin [Mass/volume] in Plasma --post 2 mg dexamethasone PO overnight |
| 50422-5 | Cortisol [Mass/volume] in Serum or Plasma --20 minutes post 100 ug CRH IV |
| 19368-0 | Butabarbital [Presence] in Urine by Screen method |
| 101139-4 | Hro Ab [Presence] in Serum or Plasma |
| 13079-9 | Phosphatidylglycerol IgG Ab [Units/volume] in Serum |
| 102967-7 | Stemphylium botryosum IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104106-0 | Pregabalin [Presence] in Serum or Plasma |
| 104114-4 | Alpha-N-acetylglucosaminidase [Enzymatic activity/volume] in DBS |
| 10659-1 | Cyclospora sp identified in Stool by Acid fast stain |
| 1550-3 | Glucose [Mass/volume] in Serum or Plasma --pre 12 hour fast |
| 1118-9 | Le sup(b) Ab [Presence] in Serum or Plasma |
| 11279-7 | Urine sediment comments by Light microscopy Narrative |
| 12296-0 | Mescaline [Presence] in Urine |
| 1679-0 | 24r-Hydroxycalcidiol [Mass/volume] in Serum or Plasma |
| 1686-5 | 3-Methylhistidine [Mass/volume] in Serum or Plasma |
| 17013-4 | Influenza virus A+B Ab [Units/volume] in Serum by Immunofluorescence |
| 1702-0 | Acetoacetate [Mass/volume] in Urine |
| 17648-7 | Streptococcus pneumoniae Ab [Units/volume] in Serum by Immunoassay |
| 18257-6 | Coproporphyrin [Mass/volume] in Blood |
| 18485-3 | Mi-2 Ab [Presence] in Serum |
| 19104-9 | Glucose [Interpretation] in Serum or Plasma--1 hour post dose glucose |
| 90888-9 | Porcine circovirus type 3 DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 74920-0 | Gamma hydroxybutyrate [Moles/volume] in Blood |
| 92737-6 | 7-Alpha,12-alpha dihydroxycholest-4-en-3-one and 7-Alpha hydroxy-4-cholesten-3-one panel - Blood |
| 6062-4 | Casein IgE Ab [Units/volume] in Serum |
| 61089-9 | Pseudoephedrine [Presence] in Gastric fluid |
| 76626-1 | Measles virus [Presence] in Specimen by Organism specific culture |
| 77357-2 | Nitrogen [Moles/mass] in 24 hour Stool |
| 77374-7 | clomiPRAMINE trough, clomiPRAMINE+Norclomipramine trough and Norclomipramine panel - Serum or Plasma |
| 93769-8 | Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma |
| 62485-8 | Herpes virus 6A DNA [Presence] in Specimen by NAA with probe detection |
| 77760-7 | ARIPiprazole cutoff [Mass/volume] in Urine for Confirmatory method |
| 94393-6 | Respiratory pathogens DNA and RNA panel - Lower respiratory specimen by NAA with probe detection |
| 95196-2 | Interferon-gamma producing HLA-A2 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC) |
| 6619-1 | Acanthamoeba sp Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 7975-6 | Human papilloma virus Ab [Presence] in Genital specimen |
| 80684-4 | Campylobacter coli+jejuni+lari 16S rRNA [Presence] in Stool by NAA with probe detection |
| 81174-5 | Tumor type in Stomach cancer by Macroscopy |
| 96957-6 | SARS-CoV-2 (COVID-19) M gene [Presence] in Upper respiratory specimen by NAA with probe detection |
| 8203-2 | Manganese [Mass/time] in 24 hour Urine |
| 82044-9 | Weed Allergen Mix 7 (Ox-eye daisy+Dandelion+English plantain+Goosefoot or Lambs quarters+Goldenrod) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 97919-5 | Bwamba virus RNA [Presence] in Specimen by NAA with probe detection |
| 71680-3 | Basophils/Leukocytes [Pure number fraction] in Blood by Automated count |
| 72272-8 | Amylase and triacylglycerol lipase panel - Serum or Plasma |
| 72280-1 | Rh immune globulin expiration [Date and time] |
| 99875-7 | Deep transitional cells [Presence] in Urine sediment by Computer assisted method |
| 85998-3 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 86060-1 | Streptococcus pneumoniae Danish serotype 23F Ab [Mass/volume] in Serum |
| 73350-1 | hydroCHLOROthiazide+Losartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87455-2 | Potassium [Mass/mass] in Specimen |
| 87613-6 | Urea [Mass/mass] in Specimen |
| 87663-1 | Disulfoton [Mass/mass] in Specimen |
| 87807-4 | Naloxone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 73923-5 | JWH-018 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood |
| 88614-3 | Human coronavirus RNA [Presence] in Aspirate by NAA with probe detection |
| 88999-8 | Omega-3 (EPA+DHA) index risk in Serum or Plasma |
| 89325-5 | CD3+CD8+CD28+HLA DR+ cells [#/volume] in Blood |
| 89341-2 | CD38+IgM+ cells/100 CD19 cells in Blood |
| 89368-5 | Zika virus non-structural protein 1 IgM panel - Serum or Plasma by Immunoassay |
| 89488-1 | Isoniazid [Susceptibility] by Genotype method |
| 41187-6 | Waxy casts [#/volume] in Urine sediment |
| 41263-5 | Viscosity of Pleural fluid Qualitative |
| 41719-6 | Tazobactam [Susceptibility] by Disk diffusion (KB) |
| 30897-3 | Total Erythrocyte Volume by Scintigraphy |
| 42497-8 | Epstein Barr virus early Ab [Titer] in Cerebral spinal fluid |
| 42655-1 | Rifabutin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 21579-8 | Trichloroethylene [Mass/volume] in Blood |
| 31414-6 | Herpes virus 6 IgG Ab [Units/volume] in Cerebral spinal fluid |
| 31525-9 | Neisseria gonorrhoeae Ab [Units/volume] in Cerebral spinal fluid |
| 51251-7 | CD15 cells/100 cells in Bone marrow |
| 51259-0 | CD16+CD57+ cells/100 cells in Body fluid |
| 21722-4 | OTC gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 22095-4 | Avian infectious laryngotracheitis virus Ab [Presence] in Serum |
| 22210-9 | Coccidioides immitis IgM Ab [Presence] in Serum |
| 31704-0 | West Nile virus IgM Ab [Presence] in Serum |
| 51516-3 | Lactate dehydrogenase 3/Lactate dehydrogenase.total in Cerebral spinal fluid by Electrophoresis |
| 43354-0 | Avian metapneumovirus C Ab [Titer] in Serum |
| 22399-0 | Legionella sp Ab [Titer] in Serum |
| 53021-2 | Salivary gland Ab [Titer] in Serum by Immunofluorescence |
| 43875-4 | Basement membrane IgM Ab [Presence] in Serum |
| 32635-5 | Coagulation factor II inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
| 53393-5 | Alloisoleucine+Isoleucine+Leucine+Hydroxyproline+Valine/Phenylalanine+Tyrosine [Molar ratio] in DBS |
| 44526-2 | Histoplasma capsulatum H Ab [Presence] in Cerebral spinal fluid |
| 44601-3 | IgM.monoclonal [Presence] in Serum by Immunofixation |
| 44863-9 | 6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone/Creatinine [Mass Ratio] in Urine |
| 23473-2 | Theileria mutans DNA [Presence] in Serum by NAA with probe detection |
| 23512-7 | Trypanosoma equiperdum Ab [Presence] in Serum by Immunoassay |
| 33333-6 | Colistin [Susceptibility] by Gradient strip |
| 33413-6 | Lipoprotein.beta/total Lipoprotein in Pleural fluid |
| 53527-8 | Triglyceride in HDL 2 [Moles/volume] in Serum or Plasma |
| 54366-0 | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Cord blood |
| 46266-3 | Myeloperoxidase Ab [Units/volume] in Serum by Immunoassay |
| 24208-1 | Rickettsia spotted fever group IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
| 24297-4 | Parainfluenza virus 3 Ab [Titer] in Serum --2nd specimen |
| 34467-1 | Cholesterol.in chylomicrons [Mass/volume] in Serum or Plasma |
| 47256-3 | Creatinine [Mass/volume] in Urine --2nd specimen post XXX challenge |
| 25548-9 | Urate [Moles/volume] in Body fluid |
| 34920-9 | Lymphocytes Immunoblastic/100 leukocytes in Blood |
| 55636-5 | Cefamandole+Sulbactam [Susceptibility] by Disk diffusion (KB) |
| 55806-4 | Mycophenolate [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 47760-4 | Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose arginine |
| 25941-6 | Leucine [Moles/volume] in 24 hour Urine |
| 35417-5 | Herpes simplex virus identified in Anal by Organism specific culture |
| 47946-9 | Testosterone [Mass/volume] in Serum or Plasma --pre dose corticotropin |
| 38164-0 | Hexacarboxylporphyrin/Creatinine [Mass Ratio] in Urine |
| 56751-1 | Glucose [Mass/volume] in Serum or Plasma --2.17 hours post XXX challenge |
| 56900-4 | Terminal deoxyribonucleotidyl transferase cells/100 cells in Cerebral spinal fluid by Flow cytometry (FC) |
| 48676-1 | HER2 [Interpretation] in Tissue |
| 2696-3 | Osmolality of Specimen |
| 27089-2 | Asparagine [Moles/volume] in Amniotic fluid |
| 38350-5 | Herpes virus 6 DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
| 3843-0 | Nandrolone [Presence] in Urine |
| 28044-6 | Gamma hydroxybutyrate [Mass/volume] in Urine |
| 39468-4 | Cholesterol [Moles/volume] in Pleural fluid |
| 49621-6 | Saquinavir+Ritonavir [Susceptibility] by Genotype method |
| 2846-4 | Proline [Mass/volume] in Urine |
| 40257-8 | Creatinine [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
| 58588-5 | Corticotropin [Moles/volume] in Plasma --30 minutes pre 1 ug/kg CRH IV |
| 29716-8 | Orientia tsutsugamushi Karp Ab [Presence] in Serum by Immunofluorescence |
| 29774-7 | Coxiella burnetii phase 1 Ab [Titer] in Serum by Complement fixation |
| 29804-2 | Powassan virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 40316-2 | Cortisol [Moles/volume] in Serum or Plasma --2 hours post dose triple bolus |
| 5888-3 | Virus identified in Tissue by Culture |
| 58914-3 | Aspergillus niger IgG Ab [Mass/volume] in Serum |
| 59023-2 | Adenosine deaminase [Enzymatic activity/volume] in Peritoneal dialysis fluid |
| 5905-5 | Monocytes/100 leukocytes in Blood by Automated count |
| 50291-4 | 3-Dechloroethylifosfamide [Mass/volume] in Blood --6 hours post dose ifosfamide |
| 30007-9 | Transfuse cryoprecipitate poor plasma [Volume] |
| 19342-5 | Amobarbital cutoff [Mass/volume] in Urine for Confirmatory method |
| 19413-4 | Codeine cutoff [Mass/volume] in Urine for Screen method |
| 20440-4 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose glucose |
| 100748-3 | Legionella spp [Presence] in Specimen by NAA with probe detection |
| 100896-0 | Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge |
| 12992-4 | Isobutane [Mass/volume] in Blood |
| 1299-7 | Platelets given [Volume] |
| 14272-9 | Liver kidney microsomal Ab [Presence] in Serum |
| 102698-8 | Brussel Sprouts IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14801-5 | Iron saturation [Molar fraction] in Serum or Plasma |
| 103622-7 | Enterobacter spp DNA [Presence] in Specimen by NAA with probe detection |
| 14859-3 | Leukocytes other/100 leukocytes in Peritoneal fluid by Manual count |
| 15031-8 | Angiotensin I [Moles/volume] in Plasma |
| 15032-6 | Angiotensin II [Moles/volume] in Plasma |
| 15256-1 | Regional Allergen Mix 1 (Mugwort+Silver birch+Pellitory+Timothy+English plantain) IgE Ab [Presence] in Serum by Multidisk |
| 16233-9 | Midazolam [Mass/volume] in Urine by Confirmatory method |
| 11014-8 | Somatotropin Ab [Titer] in Serum or Plasma |
| 1703-8 | Acetoacetate [Mass/volume] in Cerebral spinal fluid |
| 18262-6 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay |
| 18281-6 | Calcium [Moles/volume] corrected for total protein in Serum or Plasma |
| 19077-7 | Cells identified in Body fluid |
| 74685-9 | Sodium [Moles/volume] in 4 hour Urine |
| 74809-5 | von Willebrand factor (vWf).activity actual/normal in Control Platelet poor plasma by Immunoassay |
| 92642-8 | Dextromethorphan [Mass/volume] in Urine by Confirmatory method |
| 75222-0 | Microscopic observation [Identifier] in Throat by Alberts stain |
| 7571-3 | Black-eye pea IgE Ab [Units/volume] in Serum |
| 6083-0 | Coffee IgE Ab [Units/volume] in Serum |
| 92885-3 | Rhinovirus+Enterovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 93401-8 | Escherichia coli DNA [Presence] by NAA with probe detection in Positive blood culture |
| 93476-0 | Busulfan [Area under the curve] in Plasma |
| 62360-3 | Cells analyzed [#] |
| 77130-3 | CERKL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77388-7 | Cytomegalovirus Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
| 77732-6 | oxyCODONE+oxyMORphone [Presence] in Serum, Plasma or Blood by Screen method |
| 94346-4 | Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Serum by Immunofluorescence |
| 94735-8 | Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy |
| 6411-3 | Giardia lamblia IgG Ab [Titer] in Serum by Immunofluorescence |
| 79426-3 | Plasma cells/100 leukocytes in Blood by Manual count |
| 94870-3 | Ganglioside GD1b IgM Ab [Presence] in Serum by Immunoassay |
| 96455-1 | Coagulation factor II activity and inhibitor panel - Platelet poor plasma by Coagulation assay |
| 96463-5 | Copper free/Total copper in Serum or Plasma by calculation |
| 6878-3 | Coproporphyrin 3 [Mass/time] in 24 hour Urine |
| 812-8 | Leukocytes [#/volume] in Semen by Manual count |
| 96959-2 | Cholesterol.in LDL.small dense [Moles/volume] in Serum or Plasma |
| 69898-5 | Service comment 71 |
| 97312-3 | Campylobacter coli+jejuni+upsaliensis DNA [Presence] in Stool by NAA with probe detection |
| 973-8 | D Ab [Presence] in Serum or Plasma from Blood product unit |
| 9788-1 | Streptolysin O Ab [Presence] in Serum |
| 7132-4 | Lima Bean IgG Ab [Units/volume] in Serum |
| 71386-7 | Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma |
| 7149-8 | Bipolanis curvularia IgE Ab [Units/volume] in Serum |
| 98906-1 | Band 3 [Presence] in Red Blood Cells by Flow cytometry (FC) |
| 72978-0 | PARoxetine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87950-2 | Chlamydia trachomatis [Presence] in Tissue by Organism specific culture |
| 88616-8 | Human coronavirus NL63 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 50868-9 | Iodine [Moles/mass] in Hair |
| 42185-9 | Number of specimens obtained |
| 60247-4 | Androstanolone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 21531-9 | Spermatozoa Motile/100 spermatozoa in Semen --1 hour post ejaculation |
| 21668-9 | F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method |
| 51442-2 | Domperidone [Moles/volume] in Serum or Plasma |
| 42874-8 | CD18 cells/100 cells in Bone marrow |
| 21790-1 | t(5;12)(q33.1;p13)(PDGFRB,ETV6) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 31741-2 | Bovine diarrhea virus Ag [Presence] in Nose |
| 22366-9 | Influenza virus A+B Ab [Titer] in Serum |
| 22483-2 | Rickettsia rickettsii IgM Ab [Titer] in Serum |
| 5245-6 | Measles virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 23183-7 | Leptospira interrogans sv Hebdomadis Ab [Presence] in Serum |
| 3264-9 | Fibrinopeptide A Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
| 53169-9 | Butyrylcarnitine+Isobutyrylcarnitine (C4)/Octanoylcarnitine (C8) [Molar ratio] in DBS |
| 53417-2 | Alpha naphthylesterase [Enzymatic activity/volume] in Bone marrow |
| 44503-1 | Herpes simplex virus 2 DNA [Presence] in Amniotic fluid by NAA with probe detection |
| 44629-4 | Specimen size.maximum dimension in Breast tumor |
| 4477-6 | Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma |
| 53496-6 | 3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in 24 hour Urine |
| 53721-7 | Amino acid marker assessed [Identifier] |
| 44915-7 | Cholesterol in LDL/Cholesterol in HDL [Molar ratio] in Serum or Plasma |
| 45221-9 | Lymphocytic choriomeningitis virus IgM Ab [Presence] in Cerebral spinal fluid |
| 23990-5 | Chlamydia sp Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 3412-4 | Bupivacaine [Mass/volume] in Serum or Plasma |
| 54005-4 | Nuclear membrane pores nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
| 54210-0 | Hepatitis B virus basal core promoter mutation [Identifier] in Serum by NAA with probe detection |
| 4549-2 | Hemoglobin A1c/Hemoglobin.total in Blood by Electrophoresis |
| 46704-3 | Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma by Screen method |
| 242-8 | Ethambutol [Susceptibility] by Disk diffusion (KB) |
| 47322-3 | SCL-70 extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
| 25158-7 | Oval fat bodies (globules) [Presence] in Urine sediment by Light microscopy |
| 35062-9 | Eosinophils [#/volume] in Pleural fluid |
| 55703-3 | Pipemidate [Susceptibility] by Gradient strip |
| 3539-4 | Dextromethorphan [Presence] in Urine |
| 35757-4 | Cefdinir [Susceptibility] by Gradient strip |
| 56173-8 | American Cockroach IgG4 Ab [Mass/volume] in Serum |
| 48245-5 | Japanese Cedar triggered leukotriene release [Mass/volume] by Leukocytes |
| 26053-9 | N-methylhistamine [Moles/time] in 24 hour Urine |
| 26619-7 | Campylobacter sp Ab [Presence] in Serum |
| 26664-3 | Chlamydia trachomatis E Ab [Presence] in Serum |
| 26792-2 | Methylenedioxyamphetamine [Mass/mass] in Stool |
| 56658-8 | Delta aminolevulinate/Creatinine [Ratio] in Urine |
| 57028-3 | Iron [Mass/mass] in Liver |
| 48567-2 | Bacteria # 3 identified in Specimen by Aerobe culture |
| 48681-1 | Plasma cell Ag [Presence] in Tissue by Immune stain |
| 26881-3 | Interleukin 6 [Mass/volume] in Serum or Plasma |
| 27014-0 | Inhibin A [Presence] in Serum or Plasma |
| 38427-1 | Thiocyanate [Mass/time] in 24 hour Urine |
| 57128-1 | Newborn Screening Report summary panel |
| 57130-7 | Newborn screening report - overall interpretation |
| 57389-9 | Urea [Mass/volume] in 12 hour Urine |
| 57627-2 | Alpha cortol [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
| 49315-5 | Hemolytic disease of newborn screen [Interpretation] in Blood Narrative |
| 3904-0 | Paraldehyde [Mass/volume] in Blood |
| 39316-5 | Influenza virus A N6 neutralizing antibody [Presence] in Serum by Neutralization test |
| 29248-2 | Varicella zoster virus DNA [Presence] in Blood by NAA with probe detection |
| 2925-6 | Ribonuclease [Enzymatic activity/volume] in Serum |
| 40163-8 | Glucose [Moles/volume] in Serum or Plasma --4 hours post XXX challenge |
| 50035-5 | Colorado tick fever virus neutralizing antibody [Presence] in Specimen by Neutralization test |
| 40370-9 | Imipramine [Presence] in Gastric fluid |
| 40385-7 | Nicotine [Presence] in Meconium |
| 40662-9 | Protein [Mass/time] in 12 hour Urine --resting |
| 4067-5 | Triamterene [Mass/time] in 24 hour Urine |
| 50368-0 | Protoporphyrin [Mass/volume] in 24 hour Urine |
| 19247-6 | Doxepin+Metabolites [Mass/volume] in Urine |
| 194-1 | Clindamycin [Susceptibility] by Disk diffusion (KB) |
| 19466-2 | Flunitrazepam [Presence] in Urine by Screen method |
| 20552-6 | Nitrazepam [Mass/volume] in Urine by Confirmatory method |
| 100708-7 | Plasma cells/100 leukocytes in Synovial fluid |
| 12492-5 | Thiamylal [Presence] in Serum or Plasma |
| 101292-1 | Influenza virus A RNA [Presence] in Throat by NAA with non-probe detection |
| 12962-7 | Urea nitrogen [Mass/volume] in Venous blood |
| 133-9 | cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 102159-1 | Barley IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14457-6 | Virus identified in Urine by Culture |
| 15124-1 | Albumin/Protein.total in Synovial fluid by Electrophoresis |
| 16238-8 | Secobarbital [Mass/volume] in Urine by Confirmatory method |
| 10699-7 | Onchocerca sp identified in Tissue by Wet preparation |
| 10896-9 | Eastern equine encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 12266-3 | Urea nitrogen [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis |
| 17639-6 | Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 18937-3 | Ketoconazole [Susceptibility] |
| 90891-3 | Estradiol (E2) [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 92125-4 | Streptococcus pneumoniae DNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 75150-3 | Inosine [Moles/volume] in Serum or Plasma |
| 75213-9 | Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Decanoylcarnitine (C10) [Molar ratio] in DBS |
| 60375-3 | Ginger IgG Ab [Mass/volume] in Serum |
| 61078-2 | Flunitrazepam [Presence] in Gastric fluid |
| 76341-7 | Protoporphyrin [Moles/volume] in Blood |
| 77013-1 | Fetal Chromosome 13 trisomy [Presence] based on Plasma cell-free DNA by Sequencing |
| 93472-9 | 4-Methylphenethylacetylfentanyl [Mass/volume] in Urine by Confirmatory method |
| 61360-4 | Acinetobacter baumannii DNA [Presence] in Specimen by NAA with probe detection |
| 6175-4 | Common Millet IgE Ab [Units/volume] in Serum |
| 77053-7 | MTR gene full mutation analysis in Blood or Tissue by Sequencing |
| 9377-3 | Glucose [Mass/volume] in Serum or Plasma --4.5 hours post 100 g glucose PO |
| 63293-5 | Neutrophil cytoplasmic Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 94299-5 | Vilazodone [Presence] in Serum or Plasma by Screen method |
| 94488-4 | Acid alpha glucosidase [Enzymatic activity/mass] in Leukocytes by Confirmatory method |
| 6366-9 | Clostridioides difficile toxin B [Units/volume] in Specimen by Immunoassay |
| 79315-8 | Gamma butyrobetaine/Trimethyllysine [Molar ratio] in Cerebral spinal fluid |
| 79379-4 | HIV 1 RNA+proviral DNA [Presence] in Plasma by NAA with probe detection |
| 95080-8 | C peptide post fasting and meal stimulation panel - Serum or Plasma |
| 8045-7 | Trypanosoma cruzi Ab [Units/volume] in Serum |
| 96470-0 | Rho GTPase-activating protein 26 IgG Ab [Titer] in Serum by Immunofluorescence |
| 69422-4 | Carnitine free (C0) [Moles/volume] in Semen |
| 6944-3 | glipiZIDE [Mass/volume] in Specimen |
| 6946-8 | Imipramine [Mass/volume] in Specimen |
| 82052-2 | Food Allergen Mix 10 (Beef+Chicken meat+Egg yolk+Pork+Turkey meat) IgE Ab [Units/volume] in Serum by Multidisk |
| 97531-8 | Balamuthia mandrillaris Ab [Presence] in Specimen by Immunofluorescence |
| 97544-1 | Bicarbonate [Moles/volume] standard in Central venous blood |
| 98097-9 | Thymic stromal lymphopoietin [Mass/volume] in Serum or Plasma |
| 99373-3 | Grey Alder IgG Ab [Mass/volume] in Serum |
| 99860-9 | Erythrocytes.non-dysmorphic [#/area] in Urine sediment by Computer assisted method |
| 72784-2 | PARoxetine [Mass/volume] in Urine by Confirmatory method |
| 73149-7 | Simvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73394-9 | Erythromycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73526-6 | Amoxicillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88112-8 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P |
| 7412-0 | Honey IgE Ab [Units/volume] in Serum |
| 41748-5 | CAPN3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 31025-0 | Dextroamphetamine/Amphetamines.total in Urine |
| 4216-8 | Diamorphine [Mass] of Dose |
| 6011-1 | Protein C cofactor [Units/volume] in Platelet poor plasma |
| 51117-0 | CD21 blasts/100 blasts in Specimen |
| 42865-6 | CD117 cells/100 cells in Tissue |
| 31696-8 | Vesicular stomatitis Indiana virus Ab [Units/volume] in Serum |
| 43232-8 | Saint Louis encephalitis virus IgG Ab [Presence] in Serum |
| 43328-4 | Duck enteritis virus Ab [Presence] in Serum by Immunofluorescence |
| 43408-4 | Bacteria identified in Tissue by Culture |
| 22449-3 | Polio virus 3 Ab [Titer] in Cerebral spinal fluid |
| 44271-5 | Brucella sp Ag [Identifier] in Specimen by Immunofluorescence |
| 22930-2 | Brucella canis Ab [Presence] in Serum by Agglutination |
| 23014-4 | Cowdria ruminantium DNA [Presence] in Specimen by NAA with probe detection |
| 23019-3 | Coxiella burnetii Ab [Presence] in Serum by Immunoassay |
| 53099-8 | Chloride [Moles/volume] in Total parental nutrition |
| 53372-9 | Echovirus IgM Ab [Titer] in Serum |
| 53471-9 | Decadienoylcarnitine (C10:2) [Moles/volume] in Serum or Plasma |
| 33697-4 | Bacillus anthracis Ag [Presence] in Isolate by Immunofluorescence |
| 45134-4 | Campylobacter jejuni IgM Ab [Titer] in Serum |
| 23915-2 | Osmotic fragility of Red Blood Cells--0.50% sodium chloride |
| 24095-2 | N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Fibroblast |
| 34215-4 | 11-Ketoandrosterone/Creatinine [Molar ratio] in Urine |
| 34217-0 | 11-Ketoetiocholanolone [Moles/volume] in Urine |
| 454-9 | Spectinomycin [Susceptibility] by Serum bactericidal titer |
| 24241-2 | Mumps virus IgG Ab [Units/volume] in Serum --2nd specimen |
| 55179-6 | Sodium urate crystals [Presence] in Specimen by Light microscopy |
| 55239-8 | HBB gene c.441_442insAC [Presence] in Blood by Molecular genetics method |
| 47143-3 | EPINEPHrine [Moles/volume] in Urine --3rd specimen post XXX challenge |
| 25417-7 | Herpes virus 6 IgM Ab [Titer] in Serum by Immunofluorescence |
| 35319-3 | Protein [Mass/volume] in Body fluid --5th specimen post Sincalide |
| 55937-7 | Magnesium [Moles/volume] in Serum or Plasma --post dialysis |
| 560-3 | Chlamydia sp identified in Specimen by Organism specific culture |
| 56120-9 | Amphetamine+Methamphetamine [Mass/volume] in Urine |
| 25920-0 | Glutamine/Creatinine [Molar ratio] in 24 hour Urine |
| 25930-9 | Homovanillate [Moles/volume] in 24 hour Urine |
| 260-0 | Framycetin [Susceptibility] by Serum bactericidal titer |
| 48274-5 | Diclofenac triggered leukotriene release [Mass/volume] by Leukocytes |
| 26771-6 | ePHEDrine+Pseudoephedrine [Mass/mass] in Stool |
| 38169-9 | Lambda light chains.free [Mass/time] in 24 hour Urine |
| 56564-8 | Somatotropin [Mass/volume] in Serum or Plasma --8 hours post XXX challenge |
| 26935-7 | diazePAM [Mass/mass] in Meconium |
| 57416-0 | Thyrotropin receptor Ab [Units/volume] in Serum by Immunoassay |
| 57458-2 | Neisseria gonorrhoeae rRNA [Presence] in Anal by NAA with probe detection |
| 49234-8 | Patient symptoms [Interpretation] Narrative--1.5 hours post dose lactose PO |
| 49275-1 | Immunofixation for Serum or Plasma Narrative |
| 27402-7 | Norparamethadione [Mass/volume] in Urine |
| 49484-9 | Phenylalanine [Presence] in Blood |
| 49550-7 | CD59 Deficient leukocytes/100 cells in Blood |
| 58687-5 | Corticotropin [Moles/volume] in Plasma --9th specimen post XXX challenge |
| 40597-7 | 7-Dehydrocholesterol [Presence] in Amniotic fluid |
| 58922-6 | Vasopressin [Mass/volume] in Plasma --2 hours post XXX challenge |
| 50459-7 | Cortisol [Mass/volume] in Serum or Plasma --7th specimen |
| 30283-6 | lamiVUDine [Susceptibility] by Genotype method |
| 30341-2 | Erythrocyte sedimentation rate |
| 40759-3 | Coxsackievirus A IgM Ab [Titer] in Serum --1st specimen |
| 40891-4 | CD3-CD57+ cells [#/volume] in Body fluid |
| 20644-1 | Glycine [Moles/volume] in Serum or Plasma |
| 12346-3 | Methyclothiazide [Presence] in Urine |
| 12419-8 | Terfenadine [Mass/volume] in Urine |
| 101084-2 | FPTT Ab [Presence] in Serum or Plasma |
| 101836-5 | Flunisolide [Moles/volume] in Serum or Plasma |
| 13656-4 | Phosphate crystals amorphous [#/volume] in Urine sediment |
| 102607-9 | Squid IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102739-0 | Fireweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14449-3 | Triglyceride [Mass/volume] in Synovial fluid |
| 14507-8 | Chlamydia trachomatis Ag [Presence] in Blood by Immunofluorescence |
| 103609-4 | Imatinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose |
| 15118-3 | Chromium [Moles/volume] in Blood |
| 15135-7 | Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Serum or Plasma |
| 15413-8 | Service comment 22 |
| 10893-6 | Trenbolone [Mass/volume] in Urine |
| 10932-2 | Tetramin IgE Ab [Units/volume] in Serum |
| 1106-4 | Kp sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
| 12230-9 | Macrophages/100 leukocytes in Body fluid by Manual count |
| 18309-5 | Nucleated erythrocytes/100 leukocytes [Ratio] in Blood by Manual count |
| 74622-2 | 1,1-Dimethoxy-(9Z)octadecene (DMA 18:1) [Mass/mass] in Fibroblast |
| 74827-7 | Snowshoe hare virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 91837-5 | Francisella sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 75026-5 | Deuteroporphyrin/Porphyrins.total in Stool |
| 75033-1 | MPL gene mutations tested for in Bone marrow by Molecular genetics method Nominal |
| 75553-8 | Comment on fetal Trisomy 13 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 757-5 | Neutrophils [#/volume] in Pleural fluid by Manual count |
| 75812-8 | Antihistamines [Interpretation] in Serum or Plasma or Urine Qualitative by Screen method |
| 92981-0 | Haemophilus influenzae DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection |
| 77643-5 | HLA-C IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
| 77742-5 | HTLV I and II panel - Serum or Plasma by Immunoblot |
| 6311-5 | Babesia microti Ab [Units/volume] in Serum by Immunoassay |
| 7781-8 | Wormwood IgG Ab [Units/volume] in Serum |
| 7792-5 | Dohle body [Presence] in Blood by Light microscopy |
| 78966-9 | S-adenosylmethionine [Moles/volume] in Serum or Plasma |
| 79494-1 | Pimelate/Creatinine [Molar ratio] in Urine |
| 66751-9 | Clot strength in Blood by Thromboelastography |
| 8041-6 | Treponema pallidum Ab [Presence] in Serum by Hemagglutination |
| 9605-7 | Taenia solium larva 24kD Ab [Presence] in Serum by Immunoblot |
| 8052-3 | Western equine encephalitis virus IgG Ab [Units/volume] in Serum |
| 80530-9 | Fluconazole [Mass/volume] in DBS |
| 97240-6 | diazePAM [Presence] in Cord tissue by Screen method |
| 97559-9 | Acetylcholine receptor ganglionic neuronal IgG+IgM Ab [Moles/volume] in Serum by Immunoassay |
| 71602-7 | Basophils/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count |
| 82489-6 | TRBV15 gene segments/TRBV gene segments.total in Blood |
| 99031-7 | Staphylococcus saprophyticus DNA [Presence] in Urine by NAA with probe detection |
| 71706-6 | Marburg virus IgM Ab [Titer] in Serum by Immunoassay |
| 72315-5 | Platelet-derived growth factor receptor IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 85319-2 | HER2 [Presence] in Breast cancer specimen by Immune stain |
| 85528-8 | PRRSV European strain IgG Ab [Titer] in Serum by Immunofluorescence |
| 72996-2 | metFORMIN induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73417-8 | dilTIAZem induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73537-3 | ALPRAZolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88216-7 | Hantavirus puumala RNA [Presence] in Urine by NAA with probe detection |
| 88263-9 | Klebsiella oxytoca ompA gene [Presence] by Probe in Positive blood culture |
| 88566-5 | Cytomegalovirus Ag [Presence] in Bone marrow by Immunofluorescence |
| 89501-1 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Line blot |
| 41411-0 | Angiostrongylus cantonensis Ab [Presence] in Specimen by Immunoblot |
| 59721-1 | Nordiazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 5083-1 | Chlamydia sp Ab [Titer] in Serum by Complement fixation |
| 31049-0 | Coxsackievirus A7 Ab [Titer] in Body fluid by Complement fixation |
| 42203-0 | Ganglioside GM1 Ab [Titer] in Serum |
| 60045-2 | Acetaldehyde [Mass/volume] in Body fluid |
| 21443-7 | Paraoxon [Mass/volume] in Urine |
| 31371-8 | Epstein Barr virus early IgG Ab [Units/volume] in Cerebral spinal fluid |
| 31494-8 | Lymphocytic choriomeningitis virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 51434-9 | Somatotropin [Mass/volume] in Serum or Plasma --pre or post XXX challenge |
| 21789-3 | t(4;11)(q21.3;q23)(AFF1,MLL) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 2275-6 | Fatty acids [Mass/volume] in Serum or Plasma |
| 32177-8 | Granulocytes/100 leukocytes in Vaginal fluid |
| 43879-6 | Bordetella parapertussis [Presence] in Nasopharynx by Organism specific culture |
| 44273-1 | Classical swine fever virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection |
| 44302-8 | Aspartate/Creatinine [Mass Ratio] in 24 hour Urine |
| 32740-3 | Beta 1 globulin/Protein.total in Body fluid by Electrophoresis |
| 32851-8 | Neisseria meningitidis serogroups A+Y Ag [Presence] in Specimen by Latex agglutination |
| 44430-7 | Alpha cortolone/Creatinine [Mass Ratio] in Urine |
| 44578-3 | Influenza virus C Ab [Presence] in Serum by Complement fixation |
| 44848-0 | Bacteria # 7 identified in Specimen by Culture |
| 23453-4 | Taylorella equigenitalis Ab [Presence] in Serum by Complement fixation |
| 2349-9 | Glucose [Presence] in Urine |
| 23627-3 | Clofazimine [Susceptibility] |
| 53959-3 | Choriogonadotropin.tumor marker [Units/volume] in Serum or Plasma |
| 54023-7 | U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum |
| 54317-3 | Methylmalonylcarnitine (C4-DC) [Moles/volume] in Cerebral spinal fluid |
| 54356-1 | Beta-2-Microglobulin [Mass/volume] in 24 hour Urine |
| 24306-3 | Coxsackievirus A9 Ab [Titer] in Serum --1st specimen |
| 34653-6 | GJB1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55119-2 | Centers for Environmental Health nitrogen mustard metabolite panel [Mass/volume] - Urine |
| 25088-6 | 4-Hydroxyphenylacetate/Creatinine [Molar ratio] in Urine |
| 25237-9 | Cefonicid [Mass/volume] in Specimen |
| 25478-9 | Methyprylon [Moles/volume] in Serum or Plasma |
| 34731-0 | APOE gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method |
| 3476-9 | Chlorprothixene [Mass/volume] in Serum or Plasma |
| 3516-2 | Crotethamide [Mass/time] in 24 hour Urine |
| 55810-6 | 18-Hydroxycortisol [Moles/volume] in Serum or Plasma |
| 47587-1 | C peptide [Moles/volume] in Serum or Plasma --1 minute post dose glucose |
| 47627-5 | Glutamate/Amino acids.total in Serum or Plasma |
| 4763-9 | HLA-B54(22) [Presence] |
| 25571-1 | C peptide [Moles/volume] in Serum or Plasma --13th specimen post XXX challenge |
| 3555-0 | Dichlorphenamide [Presence] in Urine |
| 56986-3 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 26807-8 | Glycine [Presence] in 24 hour Urine |
| 57499-6 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --2 days post dose dexamethasone |
| 57566-2 | 25-hydroxyvitamin D3 [Moles/volume] in Serum or Plasma --pre dose calcium |
| 57591-0 | Aldosterone [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
| 275-8 | Hetacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 38673-0 | Dimethylphthalate [Mass/volume] in Air |
| 3948-7 | PHENobarbital [Mass/volume] in Serum or Plasma |
| 57998-7 | Magnesium [Mass/volume] in Nonbiological fluid |
| 5805-7 | Pyrophosphate crystals [Presence] in Synovial fluid by Light microscopy |
| 49657-0 | HIV nonnucleoside reverse transcriptase susceptibility panel by Genotype method |
| 28643-5 | Oxygen saturation in Venous cord blood |
| 29283-9 | Hydrogen sulfide [Presence] in Blood |
| 40138-0 | Creatinine [Moles/volume] in Urine --2.5 hours post XXX challenge |
| 50015-7 | West Nile virus Ag [Presence] in Blood or Marrow from Donor |
| 50093-4 | 21-Deoxycortisol [Moles/volume] in Amniotic fluid |
| 50121-3 | 3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in DBS |
| 5013-8 | Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 29560-0 | Anaplasma phagocytophilum DNA [Presence] in Specimen by NAA with probe detection |
| 2969-4 | Stercobilin [Presence] in Stool |
| 2982-7 | Taurine [Mass/volume] in Urine |
| 40581-1 | Cryoglobulin.IgM [Mass/volume] in Serum by 37 degree C incubation |
| 58882-2 | Somatotropin [Mass/volume] in Serum or Plasma --23rd specimen |
| 58885-5 | Urea [Mass/volume] in Peritoneal dialysis fluid |
| 50196-5 | Occult blood panel - Stool |
| 50333-4 | Tetradecanedioate/Creatinine [Mass Ratio] in Urine |
| 30121-8 | Colony count [#/volume] in Dialysis fluid |
| 1937-2 | Beta endorphin [Mass/volume] in Serum or Plasma |
| 19382-1 | Carboxy tetrahydrocannabinol [Presence] in Urine by Confirmatory method |
| 19763-2 | Specimen source [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
| 20639-1 | Aspartate [Moles/volume] in Serum or Plasma |
| 20786-0 | Drugs identified in Tissue by Screen method |
| 20896-7 | Mycoplasma sp [Presence] in Tissue by Culture NPIP (National Poultry Improvement Plan) |
| 20963-5 | Serpulina hyodysenteria [Presence] in Stool by Organism specific culture |
| 12787-8 | HYDROmorphone Free [Mass/volume] in Serum or Plasma |
| 101653-4 | Prenatal hepatitis B and C panel - Serum or Plasma |
| 13854-5 | Aldosterone [Mass/volume] in Serum or Plasma --2 hours post 25 mg captopril PO |
| 102315-9 | Fox IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102715-0 | Cinnamon IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14680-3 | Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis |
| 15013-6 | Alkaline phosphatase.bone/Alkaline phosphatase.total in Serum or Plasma |
| 10471-1 | Chromogranin A Ag [Presence] in Tissue by Immune stain |
| 10564-3 | Cervical mucus [Volume] |
| 10603-9 | Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen |
| 10606-2 | Spermatozoa Amorphous Head/100 spermatozoa in Semen |
| 15416-1 | Service comment 25 |
| 1561-0 | Insulin [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
| 12315-8 | Mephobarbital [Presence] in Urine |
| 17781-6 | 21-Hydroxylase Ab [Units/volume] in Serum |
| 74819-4 | Promazine [Presence] in Urine by Screen method |
| 91545-4 | Myelin oligodendrocyte glycoprotein Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 915-9 | B Ag [Presence] on Red Blood Cells from Donor |
| 75708-8 | Bruton tyrosine kinase [Interpretation] in B cells+monocytes by Flow cytometry (FC) Narrative |
| 61422-2 | Norhydrocodone [Mass/volume] in Urine by Confirmatory method |
| 6165-5 | Lobster IgE Ab [Units/volume] in Serum |
| 93994-2 | Osmolality of Serum or Plasma--5 hours post fluid fast |
| 78007-2 | HIV 1 proviral DNA [Logarithmic entitic number] (viral load) in Blood mononuclear cells by NAA with probe detection |
| 94611-1 | Pasteurella multocida toxin toxA gene [Presence] in Specimen by NAA with probe detection |
| 79266-3 | Lead [Mass/mass] in Dentin |
| 6527-6 | Rabies virus neutralizing antibody [Units/volume] in Specimen by Neutralization test |
| 66484-7 | DNA single strand Ab [Units/volume] in Serum by Immunoassay |
| 95958-5 | Italian chicory Radicchio IgE Ab [Units/volume] in Serum |
| 96048-4 | T cell median channel shift in Patient serum and Donor blood by Flow cytometry (FC) |
| 96251-4 | Arsenic.inorganic+methylated [Mass/volume] in 24 hour Urine |
| 96328-0 | Staphylococcus aureus DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection |
| 96405-6 | Filtration Fraction in Urine and Serum or Plasma |
| 68990-1 | Performing laboratory medical director [Identifier] |
| 69048-7 | Immunologist review of results |
| 81116-6 | Hepatitis C virus core Ab+Ag [Presence] in Serum |
| 96529-3 | Sandfly fever Sicilian virus IgM Ab [Presence] in Specimen by Immunoassay |
| 82045-6 | Weed Allergen Mix 7 (Ox-eye daisy+Dandelion+English plantain+Goosefoot or Lambs quarters+Goldenrod) IgE Ab [Units/volume] in Serum by Multidisk |
| 82049-8 | Epidermal Allergen Mix 72 (Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 98222-3 | Treponema pallidum IgG bands [Identifier] in Cerebral spinal fluid by Immunoblot |
| 72953-3 | Sildenafil citrate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86162-5 | Streptococcus pneumoniae Danish serotype 9N Ab [Presence] in Serum by Immunoassay |
| 73222-2 | oxyCODONE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87461-0 | Nitrate [Mass/volume] in Specimen |
| 88547-5 | Chlamydophila pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 89641-5 | Chlamydophila pneumoniae IgG Ab [Presence] in Serum by Immunoassay |
| 59366-5 | Leptospira interrogans sv Sejroe Ab [Titer] in Serum by Agglutination |
| 50614-7 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --4.5 hours post XXX challenge |
| 50817-6 | Arsenic/Creatinine [Molar ratio] in 24 hour Urine |
| 50865-5 | Hydrogen ion [Moles/volume] in Serum or Plasma |
| 30445-1 | Myeloblasts/100 leukocytes in Blood |
| 42350-9 | Cefepime+Clavulanate [Susceptibility] by Disk diffusion (KB) |
| 60311-8 | Ketoprofen [Moles/volume] in Specimen |
| 21396-7 | Mononuclear cells [#/volume] in Cerebral spinal fluid by Manual count |
| 2158-4 | Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma |
| 42946-4 | Trypanosoma brucei rhodesiense Ab [Titer] in Serum |
| 43023-1 | Herpes virus 7 IgG Ab [Titer] in Serum |
| 43179-1 | Asialoganglioside GM1 IgM Ab [Titer] in Serum by Immunoassay |
| 21718-2 | NF1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 5244-9 | Measles virus IgG Ab [Units/volume] in Serum by Immunoassay |
| 52904-0 | Silver/Creatinine [Molar ratio] in 24 hour Urine |
| 53018-8 | Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Serum |
| 43852-3 | Influenza virus B IgA Ab [Presence] in Serum |
| 44076-8 | Alpha tocopherol and Beta+gamma tocopherol [Interpretation] in Serum or Plasma |
| 22928-6 | Brucella canis Ab [Presence] in Serum |
| 53088-1 | Calcium.ionized [Moles/volume] in Nonbiological fluid by Ion-selective membrane electrode (ISE) |
| 44460-4 | Cladosporium herbarum Ab [Presence] in Serum by Immune diffusion (ID) |
| 33662-8 | Erythrocytes.CD59 deficient/100 erythrocytes in Blood |
| 53796-9 | Interferon drug given [Identifier] |
| 45043-7 | Microscopic observation [Identifier] in Specimen by Tzanck smear |
| 2375-4 | Glutaryl CoA dehydrogenase [Enzymatic activity/mass] in Tissue |
| 54296-9 | Hexanoylcarnitine (C6) [Moles/volume] in Cerebral spinal fluid |
| 54320-7 | Octanoylcarnitine (C8)/Creatinine [Molar ratio] in Urine |
| 46782-9 | Argininemia newborn screen interpretation |
| 24223-0 | Parainfluenza virus 3 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 25154-6 | Unidentified crystals [#/area] in Urine sediment by Microscopy high power field |
| 25398-9 | Echinococcus sp Ab [Units/volume] in Serum by Counterimmunoelectrophoresis (CIE) |
| 25514-1 | Rubella virus IgG Ab [Presence] in Serum |
| 35065-2 | Blasts [#/volume] in Peritoneal fluid |
| 55718-1 | Ticarcillin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
| 47560-8 | Androstenedione [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM |
| 4773-8 | HLA-B59 [Presence] |
| 25695-8 | Insulin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 35418-3 | Herpes simplex virus identified in Bronchial specimen by Organism specific culture |
| 56278-5 | Green Pepper IgG4 Ab [Mass/volume] in Serum |
| 56440-1 | Clove IgG4 Ab [Mass/volume] in Serum |
| 48252-1 | Saltwort triggered leukotriene release [Mass/volume] by Leukocytes |
| 5704-2 | Nickel [Presence] in Urine |
| 26818-5 | Campylobacter jejuni Ab [Units/volume] in Serum by Immunoassay |
| 27237-7 | LORazepam [Mass/mass] in Stool |
| 3893-5 | oxyCODONE [Mass/volume] in Serum or Plasma |
| 39091-4 | Johnson grass IgE Ab/IgE total in Serum |
| 58230-4 | Maple syrup urine disease newborn screening comment-discussion |
| 29251-6 | Brucella sp Ab [Titer] in Serum --2nd specimen |
| 4028-7 | Secobarbital [Mass/volume] in Serum or Plasma |
| 49822-0 | 3-Hydroxyisobutyrate/Creatinine [Molar ratio] in 24 hour Urine |
| 4036-0 | Stanozolol [Presence] in Urine |
| 40406-1 | Urea [Moles/time] in 24 hour Body fluid |
| 30198-6 | Fatty acids.very long chain C26:0 (Hexacosanoate)/C22:0 (Docosanoate) [Molar ratio] in Serum or Plasma |
| 40855-9 | Chlamydia trachomatis L2 IgA Ab [Titer] in Serum |
| 41024-1 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 50 g glucose PO |
| 20731-6 | Brucella abortus Ab [Presence] in Serum by Immunoassay (EIA) RST |
| 100142-9 | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot |
| 100374-8 | Aloe vera IgG Ab [Units/volume] in Serum |
| 100414-2 | Gourd IgG Ab [Units/volume] in Serum |
| 100430-8 | Cells.LRBA+/100 Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC) |
| 12619-3 | Glucose [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 12849-6 | Protein [Mass/volume] in Peritoneal dialysis fluid --7th specimen |
| 101380-4 | ETV6 gene rearrangements in Tissue by FISH |
| 101411-7 | Dupilumab [Mass/volume] in Serum or Plasma by LC/MS/MS --trough |
| 130-5 | Cefsulodin [Susceptibility] by Serum bactericidal titer |
| 13252-2 | Herpes simplex virus 2 IgM Ab [Units/volume] in Cerebral spinal fluid |
| 101931-4 | Calcium oxalate crystals [Energy Difference] in Urine |
| 102486-8 | Papaya (Carica papaya) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14008-7 | Phosphatidylcholine IgG Ab [Units/volume] in Serum by Immunoassay |
| 103164-0 | Cryptococcus neoformans DNA [Presence] in Specimen by NAA with probe detection |
| 14910-4 | Serotonin [Moles/volume] in Serum |
| 15009-4 | 5-Hydroxyindoleacetate [Moles/volume] in Urine |
| 12193-9 | Creatinine [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis |
| 17330-2 | Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid |
| 17838-4 | Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma |
| 17856-6 | Hemoglobin A1c/Hemoglobin.total in Blood by HPLC |
| 75135-4 | Hypoxanthine [Moles/volume] in Serum or Plasma |
| 75770-8 | Thioridazine [Presence] in Blood or Urine by Screen method |
| 76346-6 | Microorganism identified in Isolate by MS.MALDI-TOF |
| 63244-8 | Ganglioside GM1 IgG+IgM Ab [Presence] in Serum by Immunoassay |
| 94717-6 | SLC25A15 gene c.562_564delTTC [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 94767-1 | SARS-CoV-2 (COVID-19) S gene [Presence] in Serum or Plasma by NAA with probe detection |
| 63454-3 | TPMT gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 63535-9 | DNA double strand IgG Ab [Units/volume] in Cerebral spinal fluid |
| 64085-4 | Cells karyotyped.total [#] in Chorionic villus sample |
| 78877-8 | QUEtiapine [Mass/volume] in Urine by Confirmatory method |
| 65810-4 | SEPT9 gene methylation [Presence] in Plasma by Molecular genetics method |
| 80646-3 | Monocyclohexyl methylphosphonate [Mass/volume] in Blood |
| 8152-1 | Amphetamines [Presence] in Urine by SAMHSA screen method |
| 69870-4 | Service comment 43 |
| 70293-6 | Entamoeba histolytica+Entamoeba dispar+Entamoeba ecuadoriensis+Entamoeba nuttalli DNA [Presence] in Specimen by NAA with probe detection |
| 82410-2 | Ganglioside GQ1b IgG+IgM Ab [Presence] in Serum by Line blot |
| 82992-9 | SUMO-activating enzyme subunit 1 IgG Ab [Presence] in Serum by Line blot |
| 97980-7 | Hazelnut recombinant (rCor a) 14 IgG4 Ab [Mass/volume] in Serum |
| 981-1 | Di sup(a) Ab [Presence] in Serum or Plasma |
| 7192-8 | Cedar dust IgE Ab [Units/volume] in Serum |
| 99113-3 | Ilheus virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 99467-3 | Cultivated Corn IgG Ab [Mass/volume] in Serum |
| 72628-1 | PHENobarbital [Presence] in Saliva (oral fluid) by Confirmatory method |
| 86064-3 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum |
| 73904-5 | CD3-CD57+ cells/100 lymphocytes in Blood by Flow cytometry (FC) |
| 74316-1 | PRRSV ORF5 gene RNA [Presence] in Specimen by NAA with probe detection |
| 74392-2 | Zopiclone [Mass/mass] in Hair |
| 89345-3 | CD19+IgM+ cells [#/volume] in Blood |
| 41275-9 | Amino acids intense band position [Identifier] in Urine |
| 41412-8 | Angiostrongylus costaricensis Ab [Presence] in Serum by Agglutination |
| 59786-4 | Urea/Creatinine [Molar ratio] in Urine |
| 50949-7 | Albumin [Presence] in Urine by Test strip |
| 60057-7 | Bismuth [Mass/mass] in Hair |
| 21224-1 | Cortisol [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 21612-7 | Age - Reported |
| 31832-9 | Giardia lamblia Ag [Presence] in Stool --3rd specimen |
| 31969-9 | Streptococcus pneumoniae Ag [Presence] in Specimen |
| 51548-6 | Parrot feather IgG Ab [Presence] in Serum |
| 51589-0 | Dyserythropoiesis [Presence] in Blood by Light microscopy |
| 5170-6 | Gliadin IgG Ab [Units/volume] in Serum |
| 43319-3 | Avian metapneumovirus A Ab [Titer] in Serum by Immunoassay |
| 22761-1 | Pristanate (C15:0(CH3)4) [Moles/volume] in Serum or Plasma |
| 22840-3 | Avian pox virus Ab [Presence] in Serum by Immune stain |
| 22952-6 | Brucella suis Ab [Presence] in Serum by Immunoassay |
| 32709-8 | Neutrophils [#/volume] in Body fluid |
| 23548-1 | Venezuelan equine encephalitis virus Ag [Presence] in Specimen by Neutralization test |
| 33385-6 | Segmented neutrophils/100 leukocytes in Pleural fluid |
| 24068-9 | Beta mannosidase [Enzymatic activity/mass] in Leukocytes |
| 33937-4 | Homocystine Free [Moles/volume] in Serum or Plasma |
| 46109-5 | Rubella virus IgM Ab [Titer] in Cerebral spinal fluid |
| 46138-4 | Urate crystals [#/area] in Urine sediment by Microscopy high power field |
| 46995-7 | HLA-DP+DQ+DR (class II) Ab in Serum |
| 34372-3 | Salmonella typhi O Ab [Titer] in Serum by Agglutination |
| 34428-3 | Timothy recombinant (rPhl p) 12 IgE Ab [Units/volume] in Serum |
| 55571-4 | Prilocaine [Moles/volume] in Serum or Plasma |
| 47076-5 | Legionella pneumophila 7 IgG Ab [Titer] in Serum by Immunofluorescence |
| 47278-7 | MCH [Entitic mass] in Cord blood |
| 25557-0 | Zinc [Moles/volume] in Red Blood Cells |
| 35103-1 | Acyclovir [Mass/volume] in Serum or Plasma --trough |
| 35465-4 | RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 35595-8 | Acetaminophen [Mass/volume] in Serum or Plasma by Screen method |
| 48173-9 | levoFLOXacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 26536-3 | Cortisol [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
| 48718-1 | Leishmania mexicana IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 38485-9 | Galactose 1 phosphate [Moles/mass] in Red Blood Cells |
| 57376-6 | C peptide [Mass/volume] in Serum or Plasma --baseline |
| 48930-2 | Respiratory allergen panel, US - Intermountain west b - Serum |
| 27320-1 | Parietal cell Ab [Titer] in Serum |
| 2905-8 | Pyruvate [Mass/volume] in Blood |
| 29402-5 | Trimipramine [Mass/volume] in Gastric fluid |
| 29492-6 | Methicillin [Mass/volume] in Specimen |
| 49811-3 | 2-Hydroxyadipate/Creatinine [Molar ratio] in 24 hour Urine |
| 50099-1 | Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Blood |
| 29860-4 | Cardiolipin Ab [Presence] in Serum |
| 40361-8 | Follitropin [Units/volume] in Serum or Plasma --1 hour post dose triple bolus |
| 40578-7 | Cryoglobulin.IgM [Mass/volume] in Serum by Cold incubation |
| 40628-0 | Cryoglobulin.IgA [Mass/volume] in Serum by 37 degree C incubation |
| 50338-3 | Cannabinoids [Mass/volume] in Dialysis fluid |
| 30037-6 | Alternaria alternata+American house dust mite IgE Ab [Presence] in Serum by Multidisk |
| 30047-5 | Histidine/Creatinine [Ratio] in Urine |
| 40951-6 | Yersinia enterocolitica O:9 Ab [Presence] in Cerebral spinal fluid |
| 101090-9 | Ge4 Ab [Presence] in Serum or Plasma |
| 13246-4 | Haemophilus influenzae B Ab [Units/volume] in Serum |
| 101845-6 | Sweat analysis specialist review of results |
| 102170-8 | Lima Bean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102178-1 | Sugar Beet Seed (Beta vulgaris seed) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13569-9 | Norchlordiazepoxide [Presence] in Serum or Plasma |
| 14103-6 | Epithelial cells [Presence] in Stool by Light microscopy |
| 102925-5 | Honey bee IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102980-0 | Aspergillus sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14580-5 | ABO group [Type] in Blood from Newborn |
| 14689-4 | Delta aminolevulinate [Moles/time] in 24 hour Urine |
| 10347-3 | Babesia microti identified in Blood by Light microscopy |
| 104109-4 | Zolpidem [Presence] in Serum or Plasma |
| 15141-5 | Beta aminoisobutyrate+Proline [Presence] in Urine |
| 104279-5 | ERBB2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 104319-9 | Burst forming unit erythroid [#/volume] in Blood by Visual count |
| 10565-0 | Choriogonadotropin [Units/volume] in Semen |
| 161-0 | Cephalothin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 11000-7 | Promethazine [Presence] in Urine |
| 16515-9 | Calcium.ionized [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 11232-6 | Bromocriptine [Mass/volume] in Serum or Plasma |
| 90227-0 | Histoplasma capsulatum H and M Ab panel - Serum |
| 74631-3 | Glycosaminoglycans/Creatinine [Ratio] in 24 hour Urine |
| 75016-6 | t(9;22)(q34.1;q11)(ABL1,BCR) b3a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method |
| 60339-9 | Zopiclone [Moles/volume] in Specimen |
| 61155-8 | Hepatitis B virus codon L80V [Presence] by Genotype method |
| 76674-1 | Leukocytes [#/volume] in Cerebral spinal fluid --1st tube |
| 92865-5 | Herpes simplex virus 1 and 2 DNA panel - Cerebral spinal fluid by NAA with probe detection |
| 93483-6 | Cortisol [Mass/volume] in Serum or Plasma --2 minutes post 1 ug/kg CRH IV |
| 61243-2 | Goosefoot IgE Ab/IgE total in Serum |
| 7743-8 | Tragacanth IgE Ab [Units/volume] in Serum |
| 77665-8 | Dexamethasone [Mass] of Dose |
| 77669-0 | Calcitonin [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 93743-3 | HTLV I and II IgG band [Type] in Cerebral spinal fluid by Line blot |
| 93764-9 | Porcine astrovirus type 3 RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 62466-8 | BK virus IgG Ab [Presence] in Serum or Plasma |
| 78361-3 | Fatty acid and triglyceride panel - 24 hour Stool |
| 7838-6 | Coxsackievirus B3 Ab [Units/volume] in Serum |
| 94357-1 | Neuronal nuclear type 2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 63437-8 | Brucella abortus Ab [Titer] in Serum by Antihuman globulin |
| 7903-8 | Helicobacter pylori IgM Ab [Units/volume] in Serum |
| 79389-3 | Rotavirus A nsp5 gene [Presence] in Stool by NAA with probe detection |
| 9505-9 | Chlorobenzene [Mass/volume] in Serum or Plasma |
| 95658-1 | Influenza virus A H7 Eurasia RNA [Presence] in Specimen by NAA with probe detection |
| 66738-6 | CYP2C19 gene c.358T>C(*8) [Presence] in Blood or Tissue by Molecular genetics method |
| 79667-2 | 5,6-Dihydrouridine [Moles/volume] in Serum or Plasma |
| 95768-8 | Parathyrin.1-84 [Moles/volume] in Serum or Plasma by Immunoassay |
| 81276-8 | Doxepin and Nordoxepin panel - Urine |
| 6976-5 | Amoxicillin [Susceptibility] by Gradient strip |
| 98221-5 | Treponema pallidum IgG bands [Identifier] in Serum by Immunoblot |
| 72921-0 | HNA 1 genotype in Blood |
| 86024-7 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum |
| 73175-2 | RABEprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73735-3 | ACADVL gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
| 73867-4 | Alpha cortol [Moles/time] in 24 hour Urine |
| 73877-3 | Beta cortolone [Moles/time] in 24 hour Urine |
| 88226-6 | Mycoplasma genitalium DNA [Presence] in Urine by NAA with probe detection |
| 7425-2 | House dust Hollister Stier IgE Ab [Units/volume] in Serum |
| 89531-8 | Smith extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
| 89588-8 | Herpes simplex virus 2 Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 89649-8 | Coxiella burnetii DNA [Presence] in Implanted device by NAA with probe detection |
| 41268-4 | VWF gene.p.Thr791Met [Presence] in Blood by Molecular genetics method |
| 59686-6 | Hydroxyethylflurazepam [Mass/mass] in Meconium by Confirmatory method |
| 50663-4 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
| 31092-0 | Gentamicin [Mass/volume] in Serum or Plasma --trough post extended interval dosing |
| 42253-5 | Methylenedioxyamphetamine [Presence] in Urine |
| 42324-4 | I group phenotype [Identifier] in Blood |
| 21656-4 | CFTR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 51529-6 | Mold Allergen Mix 4 (Aspergillus fumigatus+Aspergillus niger+Aspergillus terreus+Aspergillus flavus) IgE Ab [Presence] in Serum by Multidisk |
| 51685-6 | Pregnenolone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 43628-7 | Acetaminophen crystals [Presence] in Urine sediment by Light microscopy |
| 22703-3 | Histidine/Creatinine [Molar ratio] in Urine |
| 32111-7 | Secobarbital [Presence] in Specimen |
| 32227-1 | Argininosuccinate [Moles/volume] in Serum or Plasma |
| 529-8 | Viomycin [Susceptibility] by Disk diffusion (KB) |
| 4436-2 | Tetracaine [Mass] of Dose |
| 23202-5 | Leptospira sp IgM Ab [Presence] in Serum |
| 32681-9 | Hemoglobin C/Hemoglobin.total in Blood by Electrophoresis |
| 5322-3 | Rickettsia typhus group IgM Ab [Titer] in Serum by Immunofluorescence |
| 53319-0 | Crystals [Presence] in Urine by Automated |
| 53378-6 | Herpes virus 6 Ab [Units/volume] in Serum |
| 53509-6 | Sebacylcarnitine (C10-DC)/Creatinine [Molar ratio] in Urine |
| 53641-7 | OCT2 Ag [Presence] in Tissue by Immune stain |
| 53746-4 | Barbiturates panel - Urine |
| 23900-4 | Methanol [Mass/mass] in Tissue |
| 34236-0 | Androstenediol [Moles/volume] in Urine |
| 46975-9 | oxyMORphone Free [Mass/volume] in Urine by Confirmatory method |
| 2412-5 | Hexokinase 3/Hexokinase.total in Red Blood Cells |
| 34362-4 | Pregnanetriolone [Moles/volume] in 24 hour Urine |
| 34386-3 | Venlafaxine [Moles/volume] in Serum or Plasma |
| 54911-3 | Giant grouper IgE Ab [Units/volume] in Serum |
| 55482-4 | Insulin [Moles/volume] in Serum or Plasma --4 hours post dose glucose IV |
| 4712-6 | HLA-A74(19) [Presence] |
| 55680-3 | Isepamicin [Susceptibility] by Gradient strip |
| 47550-9 | Adenosine deaminase [Entitic Catalytic Activity] in Leukocytes |
| 25754-3 | Rotavirus IgG Ab [Units/volume] in Serum by Immunoassay |
| 25801-2 | Trichophyton mentagrophytes var interdigitale IgE Ab [Units/volume] in Serum |
| 56199-3 | Brewer's yeast IgG4 Ab [Mass/volume] in Serum |
| 56262-9 | Flea IgG4 Ab [Mass/volume] in Serum |
| 56418-7 | Cultivated Wheat IgG4 Ab [Mass/volume] in Serum |
| 56475-7 | Salmonella sp antigenic formula [Identifier] in Isolate by Agglutination |
| 48198-6 | Amoxicillin triggered leukotriene release [Mass/volume] by Leukocytes |
| 26776-5 | QUEtiapine [Mass/volume] in Serum or Plasma |
| 3689-7 | Imipramine [Presence] in Serum or Plasma |
| 2688-0 | Orotidine-5'-Phosphate decarboxylase [Enzymatic activity/volume] in Serum |
| 38404-0 | CFTR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 49204-1 | Bartonella henselae IgM Ab [Titer] in Body fluid |
| 27444-9 | Insulin [Units/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 27926-5 | Hemoglobin.gastrointestinal [Presence] in Stool --8th specimen |
| 57957-3 | Difenacoum [Mass/volume] in Serum or Plasma |
| 58015-9 | Nortrimipramine [Presence] in Urine |
| 49592-9 | Satratoxin IgM Ab [Units/volume] in Serum by Immunoassay |
| 49655-4 | TPMT gene c.460G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 49710-7 | SOD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 29210-2 | Bilirubin.indirect [Mass/volume] in Body fluid |
| 58532-3 | Corticotropin [Mass/volume] in Plasma --10 AM specimen |
| 4992-4 | Campylobacter sp rRNA [Presence] in Specimen by Probe |
| 49993-9 | Borrelia burgdorferi 18/20kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 50124-7 | 3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Cerebral spinal fluid |
| 2974-4 | Sucrose [Mass/volume] in Specimen |
| 40555-5 | CD66e Ag [Presence] in Tissue by Immune stain |
| 30021-0 | Borrelia burgdorferi 23kD IgM Ab [Presence] in Synovial fluid by Immunoblot |
| 19300-3 | Opiates cutoff [Mass/volume] in Urine for Confirmatory method |
| 2006-5 | Cancer Ag 125 [Presence] in Serum or Plasma |
| 21053-4 | Adenovirus IgG Ab [Titer] in Serum |
| 12433-9 | Bufotenine [Mass/volume] in Serum or Plasma |
| 100024-9 | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 12745-6 | Insulin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 12772-0 | Cholesterol in HDL [Units/volume] in Serum or Plasma by Electrophoresis |
| 101097-4 | JAHK Ab [Presence] in Serum or Plasma |
| 12967-6 | Urea nitrogen [Mass/volume] in 24 hour Urine |
| 12968-4 | Urea nitrogen [Mass/volume] in Dialysis fluid --4 hour specimen |
| 101961-1 | PHGDH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 13815-6 | Threonine/Creatinine [Mass Ratio] in Urine |
| 13893-3 | Phenylalanine [Presence] in Urine |
| 102395-1 | Juniper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102583-2 | Salmon IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102756-4 | Western Juniper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14872-6 | Pentacarboxylate [Moles/volume] in Urine |
| 15061-5 | Erythropoietin (EPO) [Units/volume] in Serum or Plasma |
| 15115-9 | Arsenic [Moles/volume] in Urine |
| 10438-0 | CD20 Ag [Presence] in Tissue by Immune stain |
| 15438-5 | Avian hemorrhagic enteritis virus Ab [Presence] in Serum by Immunoassay |
| 10762-3 | Microscopic observation [Identifier] in Blood by Hemosiderin stain |
| 12277-0 | DNA double strand Ab [Presence] in Serum by Farr method |
| 12278-8 | Band form neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count |
| 16829-4 | Erythromycin [Mass/volume] in Urine |
| 6039-2 | Beef IgE Ab [Units/volume] in Serum |
| 611-4 | Bacteria identified in Body fluid by Culture |
| 766-6 | Neutrophils.hypersegmented [#/volume] in Blood by Manual count |
| 93-5 | Cefodizime [Susceptibility] by Disk diffusion (KB) |
| 93738-3 | Cooked cauliflower IgE Ab [Units/volume] in Serum |
| 94195-5 | CPT2 gene full mutation analysis in Blood or Tissue by Sequencing |
| 63160-6 | Castor Bean IgG Ab [Mass/volume] in Serum |
| 78533-7 | Creatinine [Moles/volume] in Peritoneal dialysis fluid --4 hour dwell specimen |
| 78845-5 | JWH-200 6-Hydroxyindole (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
| 94616-0 | Bovine coronavirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 64130-8 | diazePAM/Creatinine [Mass Ratio] in Urine |
| 6712-4 | Ampicillin IgE Ab [Units/volume] in Serum |
| 69738-3 | Differential panel, method unspecified - Blood |
| 69772-2 | Orotate [Moles/volume] in Serum or Plasma |
| 81851-8 | Chromosome region 11p15 methylation and deletion+duplication in Blood or Tissue by Molecular genetics method |
| 82039-9 | Weed Allergen Mix 209 (Common ragweed+Western ragweed+Giant ragweed) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 82168-6 | Influenza virus A H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 82187-6 | Streptococcus pneumoniae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
| 98017-7 | Megakaryocytes [#/volume] in Bone marrow by Manual count |
| 9811-1 | Chromogranin A [Mass/volume] in Serum or Plasma |
| 72104-3 | Acute and chronic leukemia fusion transcript per control transcript panel - Blood or Tissue by Molecular genetics method |
| 85279-8 | Excised length [Length] of Colon by Macroscopy |
| 99970-6 | Hereditary thrombocytopenia multigene analysis in Blood or Tissue by Molecular genetics method |
| 72837-8 | Vancomycin resistance vanC1 gene [Presence] by Molecular method |
| 73143-0 | Sucralfate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73339-4 | hydrOXYzine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87324-0 | Porcine circovirus type 2 [Presence] in Specimen by Organism specific culture |
| 73593-6 | Ormetroprim+Sulfamethoxazole [Susceptibility] |
| 73642-1 | Iclaprim [Susceptibility] by Disk diffusion (KB) |
| 87791-0 | Carbadox [Susceptibility] |
| 88197-9 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Nasopharynx by NAA with probe detection |
| 50676-6 | Calcium-phosphorus product panel - Serum or Plasma |
| 5072-4 | Brush border Ab [Units/volume] in Serum |
| 30428-7 | MCV [Entitic volume] |
| 31135-7 | Cocaethylene [Mass/volume] in Bile fluid |
| 42580-1 | Babesia sp IgM Ab [Presence] in Serum |
| 59987-8 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 21134-2 | Calcitonin [Mass/volume] in Serum or Plasma --3 minutes post 0.5 ug/kg pentagastrin IV |
| 21680-4 | G6PD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21755-4 | CACNA1A gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 22290-1 | Epstein Barr virus capsid IgA Ab [Titer] in Serum |
| 3166-6 | Volume [Flow] of 24 hour Sweat |
| 4377-8 | Pefloxacin [Mass] of Dose |
| 32524-1 | CD19 cells [#/volume] in Bone marrow |
| 52824-0 | La Crosse virus IgM Ab [Presence] in Serum by Immunoassay |
| 52893-5 | Vanadium [Moles/volume] in Serum or Plasma |
| 22854-4 | Babesia divergens Ab [Presence] in Serum by Immunofluorescence |
| 22874-2 | Bluetongue virus serotype [Identifier] in Specimen by NAA with probe detection |
| 23073-0 | Equine arteritis virus Ab [Presence] in Serum |
| 33058-9 | Ketones [Mass/volume] in Serum or Plasma |
| 53278-8 | RBC casts [Presence] in Urine by Computer assisted method |
| 23489-8 | Transmissible gastroenteritis virus Ab [Titer] in Serum |
| 33321-1 | Toxoplasma gondii IgM Ab [Units/volume] in Body fluid |
| 53547-6 | 3,4-Dihydroxyphenylacetate [Moles/volume] in Serum or Plasma |
| 53584-9 | Loa loa DNA [Presence] in Blood by NAA with probe detection |
| 33785-7 | Immature basophils [#/volume] in Blood by Manual count |
| 3400-9 | Benzthiazide [Mass/volume] in Urine |
| 46191-3 | Histoplasma capsulatum IgG Ab [Presence] in Cerebral spinal fluid |
| 46721-7 | Barley smut IgE Ab [Units/volume] in Serum |
| 24231-3 | Coxsackievirus A7 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 34515-7 | GLA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 34572-8 | aPTT.lupus sensitive in Control Platelet poor plasma by Coagulation assay |
| 34665-0 | TORCH panel - Cerebral spinal fluid |
| 55346-1 | cloBAZam+Norclobazam [Moles/volume] in Serum or Plasma |
| 55468-3 | 11-Deoxycortisol [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
| 25143-9 | 5-Fluorocytosine [Mass/volume] in Serum or Plasma --trough |
| 25297-3 | Parainfluenza virus 1 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 34737-7 | Nuclear mitotic apparatus Ab [Interpretation] in Serum or Plasma |
| 26016-6 | Cholesterol in HDL 2 [Mass/volume] in Serum or Plasma ultracentrifugate |
| 35415-9 | Oxytocin [Units/volume] in Serum or Plasma |
| 35466-2 | AS+PWS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 35492-8 | Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Specimen by NAA with probe detection |
| 56452-6 | Cottonseed IgG4 Ab [Mass/volume] in Serum |
| 56493-0 | Lutropin [Units/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 26482-0 | Lymphocytes/100 leukocytes in Peritoneal fluid |
| 26483-8 | Lymphocytes/100 leukocytes in Synovial fluid |
| 26496-0 | Mononuclear cells/100 leukocytes in Semen |
| 35866-3 | Organic acids panel - Serum or Plasma |
| 36907-4 | Chromosome 8 trisomy [Percentile] by Cytogenetics |
| 379-8 | Oleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 56764-4 | Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing |
| 56922-8 | Entamoeba histolytica IgG Ab [Presence] in Serum by Immunoassay |
| 48359-4 | Echinococcus granulosus Ab [Titer] in Serum by Hemagglutination |
| 48649-8 | OJ Ab [Presence] in Serum by Radioimmunoprecipitation assay (RIPA) |
| 38542-7 | Repaglinide [Mass/volume] in Serum or Plasma |
| 57327-9 | Influenza virus A IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 49098-7 | Cryptococcus neoformans rRNA [Units/volume] in Specimen by NAA with probe detection |
| 27348-2 | DOPamine [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 39537-6 | Influenza virus B Ab [Units/volume] in Serum by Hemagglutination inhibition |
| 40239-6 | Calcium [Moles/volume] in Serum or Plasma --12 hours post XXX challenge |
| 40286-7 | Glucose [Moles/volume] in Serum or Plasma --105 minutes post dose glucose |
| 58757-6 | Parvovirus B19 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 49765-1 | Calcium [Mass/volume] in Blood |
| 49961-6 | Urate renal clearance in Urine and Serum or Plasma collected for unspecified duration |
| 49971-5 | Collection time of Blood--3rd specimen |
| 50057-9 | Fractional excretion of phosphate [Ratio] in Urine and Serum or Plasma collected for unspecified duration |
| 29591-5 | Enterovirus RNA [Presence] in Specimen by NAA with probe detection |
| 29595-6 | Alpha-1-Fetoprotein [Multiple of the median] in Amniotic fluid |
| 29718-4 | Orientia tsutsugamushi Kato Ab [Presence] in Serum by Immunofluorescence |
| 58848-3 | Somatotropin [Mass/volume] in Serum or Plasma --16th specimen |
| 58980-4 | Ganglioside GD2 IgM Ab [Units/volume] in Serum by Immunoassay |
| 50471-2 | Calcitonin [Mass/volume] in Serum or Plasma --3rd specimen |
| 19294-8 | Cannabinoids confirm method [Identifier] in Urine |
| 19356-5 | Barbital cutoff [Mass/volume] in Urine for Confirmatory method |
| 20881-9 | Microscopic observation [Identifier] in Tissue by Electron microscopy thin sectiion |
| 101226-9 | Recoverin Ab [Presence] in Serum by Immunoblot |
| 101318-4 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin |
| 13199-5 | Rickettsia conorii IgG Ab [Units/volume] in Serum |
| 13290-2 | Trypanosoma cruzi IgM Ab [Units/volume] in Serum |
| 101860-5 | 4F-MDMB-BUTICA [Mass/volume] in Urine by Confirmatory method |
| 13978-2 | Alpha 1 globulin/Protein.total in Serum or Plasma by Electrophoresis |
| 14060-8 | Cyclobenzaprine [Presence] in Urine |
| 10553-6 | Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid |
| 11004-9 | Tricyclic antidepressants [Presence] in Urine |
| 16881-5 | Gallium [Mass/volume] in Blood |
| 18194-1 | Barium [Mass/time] in 24 hour Urine |
| 18939-9 | Lomefloxacin [Susceptibility] |
| 90736-0 | CD14-FLAER- cells/100 cells.CD33 (Monocytes) in Blood |
| 74532-3 | Energy content [Energy/mass] of 24 hour Stool.wet |
| 75663-5 | Prolymphocytes [Presence] in Blood |
| 92959-6 | Pseudomonas aeruginosa DNA [NCncRange] in Sputum by NAA with non-probe detection |
| 61235-8 | Brome IgE Ab/IgE total in Serum |
| 61351-3 | Lymphocyte proliferation stimulated by 0.6 ug pokeweed mitogen in Blood |
| 94004-9 | Osmolality of Serum or Plasma--1 hour post dose vasopressin |
| 6317-2 | Bordetella sp identified in Specimen by Organism specific culture |
| 7842-8 | Cryptococcus neoformans Ab [Units/volume] in Serum |
| 78851-3 | M-chlorophenylpiperazine [Mass/mass] in Hair |
| 64425-2 | KIR gene allele 2DS5 [Presence] in Blood or Tissue by Molecular genetics method |
| 79253-1 | Oxazepam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 7978-0 | Parainfluenza virus 1 Ab [Units/volume] in Serum |
| 68370-6 | Nuclear Ab [Presence] in Pleural fluid by Immunofluorescence |
| 68947-1 | ATP1A2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 97017-8 | Maximum amplitude kaolin induced [Length] in Blood --after addition of heparinase |
| 97869-2 | Zika virus Ab panel - Serum or Plasma |
| 97930-2 | Sindbis virus RNA [Presence] in Specimen by NAA with probe detection |
| 82525-7 | Hepatitis C virus genotype and drug resistance panel |
| 82996-0 | Mi-2 beta IgG Ab [Presence] in Serum by Line blot |
| 83139-6 | 17-Hydroxypregnenetriol/Creatinine [Molar ratio] in Urine |
| 85739-1 | Bombay phenotype [Presence] on Red Blood Cells from Donor |
| 72567-1 | Cholinesterase.RO 020683 inhibited/Cholinesterase [Pure catalytic fraction] in Serum or Plasma |
| 72923-6 | Specimen source [Identifier] of Synovial fluid |
| 86163-3 | Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum |
| 73345-1 | HYDROcodone+Chlorpheniramine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73691-8 | Glimepride [Mass/volume] in Urine |
| 74000-1 | 25I-NBOMe [Presence] in Urine by Confirmatory method |
| 74456-5 | Plasma cells/100 leukocytes in Cord blood |
| 88632-5 | Microscopic observation [Identifier] in Lower respiratory specimen by Gram stain |
| 89004-6 | MAGE A4 Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 89363-6 | Cholinesterase [Enzymatic activity/volume] in Body fluid |
| 59311-1 | Milnacipran [Mass/volume] in Serum or Plasma |
| 5959-2 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma |
| 42616-3 | Magnesium [Mass/volume] in Dialysis fluid |
| 2110-5 | Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Serum or Plasma |
| 21267-0 | O-Ethyl O-(p-nitrophenyl) phenylphosphonothionate [Mass/volume] in Urine |
| 3158-3 | Volume [Mass/time] of 24 hour Body fluid |
| 5109-4 | Coxsackievirus B4 neutralizing antibody [Titer] in Serum by Neutralization test |
| 51231-9 | CD11c cells/100 cells in Cerebral spinal fluid |
| 42987-8 | Neisseria gonorrhoeae Ab [Titer] in Cerebral spinal fluid |
| 43067-8 | Candida sp Ab [Titer] in Serum |
| 21824-8 | t(9;22)(q22;q12.2)(NR4A3,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 51666-6 | Japanese encephalitis virus RNA [Presence] in Specimen by NAA with probe detection |
| 51715-1 | Mitochondria M2 Ab [Units/volume] in Serum by Immunoassay |
| 3235-9 | Coagulation factor XII Ag actual/normal in Platelet poor plasma by Immunoassay |
| 32560-5 | Trichophyton reaction wheal [Diameter] --2 days post 50 ug trichophyton intradermal |
| 52786-1 | Maximum lysis.extrinsic coagulation system activated [Length fraction] in Blood by Rotational TEG |
| 22862-7 | Bacillus anthracis Ab [Presence] in Serum by Agglutination |
| 33031-6 | Sodium urate crystals [#/area] in Urine sediment by Microscopy low power field |
| 23635-6 | Erythropoietin (EPO) given [Units/mass] of Dose |
| 23642-2 | Trovafloxacin [Susceptibility] |
| 33726-1 | Macroscopic tumor configuration |
| 45131-0 | Chlamydia sp Ag [Presence] in Nasopharynx by Immunofluorescence |
| 34432-5 | Salmonella typhimurium H Ab [Titer] in Serum by Agglutination |
| 56215-7 | Cheese cheddar type IgG4 Ab [Mass/volume] in Serum |
| 48044-2 | Phenolphthalein cutoff [Mass/mass] in Stool |
| 35872-1 | Penicillin+Novobiocin [Susceptibility] by Disk diffusion (KB) |
| 48870-0 | Rickettsia spotted fever group DNA [Presence] in Specimen by NAA with probe detection |
| 38447-9 | CFTR gene c.711+1G>T [Presence] in Blood or Tissue by Molecular genetics method |
| 3845-5 | Nandrolone [Mass/time] in 24 hour Urine |
| 4898-3 | HLA-Dw24 [Presence] in Donor |
| 49279-3 | Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma Narrative |
| 58356-7 | Ethanol/Creatinine [Mass Ratio] in Urine |
| 49420-3 | Papova virus SV 40 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
| 49662-0 | HIV nonnucleoside reverse transcriptase susceptibility panel by Phenotype method |
| 29767-1 | Bilirubin.total [Moles/volume] in Body fluid |
| 40553-0 | CD19 Ag [Presence] in Tissue by Immune stain |
| 59041-4 | BRCA1+BRCA2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 19483-7 | HYDROcodone [Presence] in Urine by Confirmatory method |
| 19665-9 | Phenmetrazine cutoff [Mass/volume] in Urine for Confirmatory method |
| 20386-9 | Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria |
| 20396-8 | levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 20696-1 | Bifidobacterium sp [#/volume] in Milk by Organism specific culture |
| 20727-4 | Brucella abortus Ab [Presence] in Serum by Acidified buffered plate agglutination |
| 13822-2 | Valine/Creatinine [Mass Ratio] in Urine |
| 102822-4 | Blue Spruce IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102964-4 | Penicillium notatum IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103605-2 | Paroxetine metabolite I [Mass/volume] in Urine by Confirmatory method |
| 15229-8 | Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgE Ab [Presence] in Serum by Multidisk |
| 104300-9 | UGT1A9 gene.p.M33T [Presence] in Blood or Tissue by Molecular genetics method |
| 104410-6 | Hepatitis A virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 15243-9 | Food Allergen Mix 12 (Mushroom+Pumpkin+Rice+Rye+Potato) IgE Ab [Presence] in Serum by Multidisk |
| 10985-0 | Doxapram [Mass/volume] in Serum or Plasma |
| 16303-0 | 2-Hexanol [Mass/volume] in Urine |
| 16688-4 | Creatine kinase [Enzymatic activity/volume] in Body fluid |
| 17244-5 | Manganese [Mass/mass] in Hair |
| 17951-5 | Bacteria # 2 identified in Body fluid by Aerobe culture |
| 90849-1 | Cefpodoxime 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 74509-1 | 3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in Serum or Plasma |
| 91786-4 | Measles virus [Presence] in Upper respiratory specimen by Organism specific culture |
| 75592-6 | Fetal 5p deletion prior risk [Likelihood] based on general population risk |
| 60369-6 | Clove IgG Ab [Mass/volume] in Serum |
| 7609-1 | Pine IgE Ab [Units/volume] in Serum |
| 9307-0 | Insulin [Mass/volume] in Serum or Plasma --30 minutes post 75 g glucose PO |
| 61302-6 | London Plane IgE Ab/IgE total in Serum |
| 6221-6 | Primrose IgE Ab [Units/volume] in Serum |
| 94061-9 | Bacterial gidB gene drug resistance mutation [Identifier] by Molecular method |
| 94191-4 | BRCA1+BRCA2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 63186-1 | Goosefoot IgG Ab [Mass/volume] in Serum |
| 78225-0 | BCL2 gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 63523-5 | Carboxyhemoglobin/Hemoglobin.total in Arterial cord blood |
| 6360-2 | Clostridioides difficile toxin A [Units/volume] in Specimen by Immunoassay |
| 79163-2 | Z-10-Hydroxynortriptyline [Mass/volume] in Serum or Plasma |
| 79167-3 | Honey bee recombinant (rApi m) 2 IgE Ab [Units/volume] in Serum |
| 95272-1 | Aquaporin 4 water channel IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 6573-0 | Venezuelan equine encephalitis virus Ag [Presence] in Serum by Immunofluorescence |
| 65779-1 | Olive pollen native (nOle e) 7 IgE Ab [Units/volume] in Serum |
| 66496-1 | Spermatozoa Abnormal head size/100 spermatozoa in Semen |
| 96049-2 | B cell crossmatch [Presence] in Patient serum and Donor blood by Flow cytometry (FC) |
| 96605-1 | Sugar cane pollen IgE Ab [Units/volume] in Serum |
| 69901-7 | Service comment 74 |
| 69954-6 | Neuronal nuclear type 2 IgG Ab [Presence] in Serum by Immunoassay |
| 7103-5 | Aspergillus fumigatus IgG Ab [Units/volume] in Serum |
| 71425-3 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Blood by Immunoassay |
| 72337-9 | Protein S Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 85148-5 | PD-L1 by clone 28-8 in Tissue by Immune stain Report |
| 72769-3 | Zolpidem phenyl-4-carboxylate/Creatinine [Mass Ratio] in Urine |
| 86226-8 | Codeine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 7302-3 | Chinese Elm IgE Ab [Units/volume] in Serum |
| 87282-0 | Brachyspira hyodysenteriae DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73755-1 | Adenovirus B+E DNA [Presence] in Nasopharynx by NAA with probe detection |
| 74472-2 | Middle East respiratory syndrome coronavirus (MERS-CoV) N3 gene RNA [Presence] in Specimen by NAA with probe detection |
| 88722-4 | Streptococcus pneumoniae serotype [Type] in Isolate |
| 41423-5 | Schistosoma japonicum Ab [Presence] in Serum by Immunoblot |
| 41736-0 | Oritavancin [Susceptibility] |
| 59818-5 | Uroporphyrin 3 isomer/Creatinine [Molar ratio] in 24 hour Urine |
| 50828-3 | Boron [Moles/mass] in Hair |
| 50867-1 | Insulin [Moles/volume] in Body fluid |
| 42481-2 | Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe with signal amplification |
| 42498-6 | Epstein Barr virus nuclear Ab [Titer] in Cerebral spinal fluid |
| 42576-9 | Amphetamine [Mass/volume] in Blood by Confirmatory method |
| 51429-9 | Norepinephrine [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
| 43074-4 | Borrelia burgdorferi C6 Ab [Units/volume] in Cerebral spinal fluid |
| 43384-7 | Neisseria sp identified in Urethra by Organism specific culture |
| 53051-9 | Beta globulin+Gamma globulin/Protein.total in Body fluid by Electrophoresis |
| 23197-7 | Leptospira sp Ab [Presence] in Serum by Agglutination |
| 32701-5 | Microsporidia identified in Stool by Trichrome stain modified |
| 3271-4 | LMW Heparin [Units/volume] in Platelet poor plasma by Chromogenic method |
| 32715-5 | SCL-70 extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) |
| 23362-7 | Porcine enterovirus neutralizing antibody [Presence] in Serum by Neutralization test |
| 33259-3 | Thyrotropin [Units/volume] in Serum or Plasma --1 hour post dose TRH |
| 33561-2 | Cannabinoids [Mass/volume] in Gastric fluid |
| 53633-4 | BCL1 Ag [Presence] in Tissue by Immune stain |
| 33752-7 | Distance of carcinoma from closest lateral margin [Length] in Specimen |
| 33949-9 | Potassium/Creatinine [Molar ratio] in Urine |
| 54236-5 | Cortisol [Mass/volume] in Serum or Plasma --9 AM 2nd day specimen |
| 46437-0 | Rheumatoid Factor and Cyclic Citrullinated Peptide IgG panel [Units/volume] - Serum |
| 34518-1 | SMPD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55466-7 | Influenza virus A H1 2009 pandemic RNA panel - Specimen by NAA with probe detection |
| 55557-3 | Nicotine [Moles/volume] in Serum or Plasma |
| 47213-4 | Cholesterol in LDL real size pattern [Identifier] in Serum or Plasma |
| 4742-3 | HLA-B22 [Presence] in Donor |
| 5565-7 | Terminal deoxyribonucleotidyl transferase [Units/volume] in Leukocytes |
| 557-9 | Chlamydia sp identified in Genital specimen by Organism specific culture |
| 5581-4 | Antimony [Mass/volume] in Urine |
| 5588-9 | Barium [Presence] in Serum or Plasma |
| 35439-9 | HIV 1 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
| 56500-2 | Somatotropin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 56547-3 | Tubular basement membrane IgG Ab [Titer] in Serum by Immunofluorescence |
| 48096-2 | Corticotropin [Mass/volume] in Plasma --8 AM specimen |
| 26567-8 | IgA lymphocytes/100 lymphocytes in Specimen |
| 56967-3 | Plasmodium falciparum Ab [Presence] in Serum by Immunoassay |
| 38590-6 | 1,4-Dichlorobenzene [Mass/volume] in Air |
| 5721-6 | Rubidium [Mass/volume] in Urine |
| 49148-0 | Rickettsia prowazekii IgG Ab [Titer] in Body fluid |
| 49209-0 | Bartonella bacilliformis IgM Ab [Titer] in Body fluid |
| 49293-4 | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Electrophoresis Narrative |
| 2731-8 | Parathyrin.intact [Mass/volume] in Serum or Plasma |
| 28064-4 | amLODIPine [Mass/volume] in Serum or Plasma |
| 38763-9 | Eastern equine encephalitis virus IgM Ab [Units/volume] in Specimen |
| 58063-9 | In sup (b) Ab [Presence] in Serum or Plasma |
| 49466-6 | CD2 Ag [Presence] in Tissue by Immune stain |
| 49553-1 | Kappa light chains.free/Lambda light chains.free [Mass Ratio] in 24 hour Urine |
| 40181-0 | Glucose [Moles/volume] in Serum or Plasma --15.5 hours post XXX challenge |
| 40248-7 | Creatinine [Mass/volume] in Serum or Plasma --baseline |
| 58447-4 | Microalbumin/Creatinine panel in 24H Urine |
| 5849-5 | Herpes simplex virus 2 Ag [Presence] in Specimen by Immunofluorescence |
| 58781-6 | Calcium [Mass/volume] in Peritoneal dialysis fluid |
| 4059-2 | Tobramycin [Mass/volume] in Serum or Plasma --trough |
| 40693-4 | RET gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 58965-5 | Ganglioside GM4 IgM Ab [Units/volume] in Serum by Immunoassay |
| 59149-5 | Creatine kinase.macromolecular [Presence] in Serum or Plasma |
| 59167-7 | Phosphate [Moles/time] in 24 hour Stool |
| 59244-4 | Arylsulfatase C [Enzymatic activity/mass] in Leukocytes |
| 50416-7 | Cortisol [Mass/volume] in Serum or Plasma --post 2 mg dexamethasone PO overnight |
| 30065-7 | Cystine/Creatinine [Ratio] in Urine |
| 41094-4 | LAMA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2103-0 | Choriomammotropin [Mass/volume] in Amniotic fluid |
| 12337-2 | Dimethylsulfoxide [Presence] in Serum or Plasma |
| 12402-4 | Griseofulvin [Mass/volume] in Serum or Plasma |
| 100213-8 | Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method |
| 12653-2 | Glucose [Mass/volume] in Serum or Plasma --8 minutes post XXX challenge |
| 12842-1 | Protein [Mass/volume] in 12 hour Urine |
| 12889-2 | Borrelia burgdorferi 30kD Ab [Presence] in Body fluid by Immunoblot |
| 1318-5 | S Ag [Presence] on Red Blood Cells from Blood product unit |
| 101741-7 | Nonspermatozoal cells [#/area] in Semen by Microscopy high power field |
| 102008-0 | ACTH heterophile Ab interference panel - Plasma |
| 13522-8 | Blasts/100 leukocytes in Body fluid by Manual count |
| 13533-5 | Acid hemolysis [Presence] of Blood |
| 13707-5 | Anserine/Creatinine [Mass Ratio] in Urine |
| 13986-5 | Albumin/Protein.total in 24 hour Urine by Electrophoresis |
| 14190-3 | Phenytoin Free [Mass/volume] in Saliva (oral fluid) |
| 10527-0 | Microscopic observation [Identifier] in Tissue by Cyto stain |
| 17819-4 | Albumin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
| 18311-1 | Pelger Huet cells [Presence] in Blood by Light microscopy |
| 1856-4 | Androsterone [Mass/volume] in Serum or Plasma |
| 89981-5 | QUEtiapine [Presence] in Serum or Plasma by Screen method |
| 90254-4 | Measles virus IgG and IgM panel [Titer] - Cerebral spinal fluid |
| 90296-5 | Microscopic observation [Identifier] in Skin by Gram stain |
| 90807-9 | Candida glabrata DNA [Presence] in Serum by NAA with probe detection |
| 92133-8 | Chlamydophila pneumoniae DNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 6094-7 | Curvularia lunata IgE Ab [Units/volume] in Serum |
| 61067-5 | Barbiturates [Presence] in Specimen by Screen method |
| 61085-7 | Nordiazepam [Presence] in Gastric fluid |
| 75732-8 | HTR2C gene c.-759C>T [Presence] in Blood or Tissue by Molecular genetics method |
| 92796-2 | Candida kefyr DNA [Presence] by NAA with probe detection in Positive blood culture |
| 6176-2 | Mimosa IgE Ab [Units/volume] in Serum |
| 62255-5 | Lipoprotein insulin resistance score in Serum or Plasma |
| 77127-9 | USH1C gene full mutation analysis in Blood or Tissue by Sequencing |
| 7735-4 | Tea IgG Ab [Units/volume] in Serum |
| 94077-5 | Tumor mutation burden [Interpretation] |
| 94236-7 | F5 gene full mutation analysis in Blood or Tissue by Sequencing |
| 63132-5 | Chestnut IgG Ab [Mass/volume] in Serum |
| 63150-7 | Parsnip IgG Ab [Mass/volume] in Serum |
| 63213-3 | Bactericidal permeability increasing protein Ab [Units/volume] in Serum by Immunoassay |
| 94314-2 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Specimen by NAA with probe detection |
| 946-4 | C Ag [Presence] on Red Blood Cells from Blood product unit |
| 6400-6 | Ehrlichia canis Ab [Presence] in Serum by Immunoassay |
| 64978-0 | Cladosporium herbarum recombinant (rCla h) 8 IgE Ab [Units/volume] in Serum |
| 953-0 | C little e Ag [Presence] on Red Blood Cells from Donor |
| 95661-5 | Barmah forest virus IgG Ab [Presence] in Specimen by Immunoassay |
| 6679-5 | Microscopic observation [Identifier] in Tissue by Warthin-Starry stain |
| 79682-1 | 5,6-Dihydrouracil [Moles/volume] in Serum or Plasma |
| 95843-9 | Neutrophils/100 leukocytes in Sputum by Manual count |
| 9643-8 | Creatine kinase.MM/Creatine kinase.total in Serum or Plasma |
| 6869-2 | Allo-tetrahydrocortisol [Mass/time] in 24 hour Urine |
| 69026-3 | Opiates panel - Meconium by Confirmatory method |
| 96597-0 | Cholesterol in LDL [Mass/volume] in DBS by Direct assay |
| 69373-9 | Passive D Ab [Presence] in Serum or Plasma |
| 97868-4 | Yellow fever virus Ab panel - Serum or Plasma |
| 97957-5 | Anisakis IgG4 Ab [Mass/volume] in Serum |
| 70970-9 | Cryoglobulin [Presence] in Serum by Hypotonic dilution |
| 85362-2 | Mycobacterium tuberculosis complex DNA [Presence] in Sputum or Bronchial by NAA with probe detection |
| 72835-2 | Raltegravir [Mass/volume] in Serum or Plasma |
| 86517-0 | Cytomegalovirus Ag [Presence] in Tissue by Immunofluorescence |
| 73267-7 | Milrinone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87481-8 | Arsenic [Mass/volume] in Specimen |
| 87647-4 | Methoxychlor [Mass/mass] in Specimen |
| 88049-2 | P2 phenotype [Presence] on Red Blood Cells |
| 74427-6 | Myelocytes.eosinophilic/100 leukocytes in Blood by Manual count |
| 5970-9 | Plasminogen [Units/volume] in Platelet poor plasma by Chromogenic method |
| 59889-6 | clomiPRAMINE [Moles/volume] in Gastric fluid |
| 50863-0 | Hydrogen ion [Moles/volume] in Blood |
| 42221-2 | Manganese [Moles/volume] in Urine |
| 42317-8 | Foscarnet [Susceptibility] by Genotype method |
| 42517-3 | Leishmania sp Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 59931-6 | Methotrimeprazine [Moles/volume] in Gastric fluid |
| 21216-7 | Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in 24 hour Urine |
| 31464-1 | Legionella pneumophila 5 IgG Ab [Units/volume] in Serum |
| 42778-1 | BRCA1 Ag [Presence] in Tissue by Immune stain |
| 22285-1 | Entamoeba histolytica Ab [Presence] in Serum |
| 31958-2 | Rubella virus Ag [Presence] in Vaginal fluid |
| 51640-1 | Platelet anisocytosis [Presence] in Blood by Light microscopy |
| 51665-8 | Flavivirus RNA [Presence] in Specimen by NAA with probe detection |
| 51905-8 | Collection of air specimen end time |
| 43220-3 | Nucleated erythrocytes [#/volume] in Synovial fluid by Manual count |
| 4378-6 | Pemoline [Mass] of Dose |
| 32086-1 | Lidocaine [Presence] in Specimen |
| 51980-1 | Glomerular basement membrane Ab [Mass/volume] in Serum |
| 4415-6 | Propylhexedrine [Mass] of Dose |
| 53075-8 | Decanoylcarnitine (C10) [Moles/volume] in Cerebral spinal fluid |
| 53138-4 | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Arterial blood |
| 33376-5 | Macrophages/100 leukocytes in Synovial fluid |
| 33663-6 | CD59 deficient cells/100 cells in Blood |
| 23848-5 | Creosol [Mass/volume] in Specimen |
| 23968-1 | Dengue virus IgM Ab [Units/volume] in Serum |
| 33931-7 | Lymphocyte proliferation stimulated by Borrelia burgdorferi [Ratio] in Blood |
| 34266-7 | Citrate [Moles/volume] in Urine |
| 4599-7 | Hemoglobin J - Oxford [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 4611-0 | Hemoglobin Malmo [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 46229-1 | Furazabol [Mass/volume] in Urine |
| 47038-5 | Villin Ag [Presence] in Tissue by Immune stain |
| 25089-4 | 4-Hydroxyphenyllactate/Creatinine [Molar ratio] in Urine |
| 35157-7 | Myristate (C14:0) [Moles/volume] in Serum or Plasma |
| 55926-0 | Interleukin 1 receptor alpha chain [Mass/volume] in Serum or Plasma |
| 47892-5 | Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose ornithine |
| 25676-8 | Glucose [Moles/volume] in Serum or Plasma --5.5 hours post dose glucose |
| 47923-8 | Somatotropin [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 48036-8 | Glucose [Mass/volume] in Stool |
| 26561-1 | CD16+CD56+ cells [#/volume] in Specimen |
| 26674-2 | Legionella longbeachae 1 Ab [Presence] in Serum |
| 56750-3 | Estradiol (E2) [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 48668-8 | Protein fractions.oligoclonal bands.intrathecal [Presence] in Serum and CSF |
| 57634-8 | Alpha cortolone [Mass/time] in 24 hour Urine --pre dose dexamethasone |
| 49001-1 | Osmolality of Sweat |
| 49386-6 | Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
| 49428-6 | Parvovirus B19 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
| 2885-2 | Protein [Mass/volume] in Serum or Plasma |
| 40284-2 | Lactose [Moles/volume] in Serum or Plasma --2 hours post dose lactose PO |
| 49762-8 | Alpha-1-Fetoprotein [Mass/volume] in Pleural fluid |
| 29582-4 | Differential panel - Synovial fluid |
| 59159-4 | Microalbumin/Creatinine [Ratio] in 24 hour Urine |
| 29978-4 | Silver/Creatinine [Mass Ratio] in 24 hour Urine |
| 30375-0 | Basophils/100 leukocytes in Sputum |
| 19441-5 | Diamorphine cutoff [Mass/volume] in Urine for Screen method |
| 100050-4 | Erythromycin+Ethambutol [Susceptibility] |
| 100716-0 | Prostate specific Ag [Mass/volume] in DBS |
| 101075-0 | Crawford Ab [Presence] in Serum or Plasma |
| 12640-9 | Glucose [Mass/volume] in Serum or Plasma --6.5 hours post XXX challenge |
| 101147-7 | Monocytes/100 leukocytes in Blood by Flow cytometry (FC) |
| 101171-7 | 2-methyl AP-237/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 12976-7 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --6th specimen |
| 13358-7 | Collection time of Semen |
| 102251-6 | Cultivated Corn IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102547-7 | Pumpkin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14590-4 | Alpha tocopherol [Moles/volume] in Serum or Plasma |
| 10430-7 | AE 3 Ag [Presence] in Tissue by Immune stain |
| 10456-2 | Xylose [Mass/volume] in Serum or Plasma --6 hours fasting |
| 10461-2 | Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain |
| 16172-9 | Magnesium [Mass/mass] in Hair |
| 10772-2 | Microscopic observation [Identifier] in Tissue by Azure-eosin stain |
| 110-7 | Cefotaxime [Susceptibility] by Serum bactericidal titer |
| 16620-7 | Clarithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 11142-7 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post 100 g glucose PO |
| 12265-5 | Urea nitrogen [Mass/volume] in Peritoneal fluid |
| 17220-5 | FMC7 cells/100 cells in Blood |
| 18359-0 | Methylenedioxyamphetamine [Mass/volume] in Blood |
| 18979-5 | Sisomicin [Susceptibility] |
| 74833-5 | ACAT1 gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
| 74952-3 | Lymphocyte proliferation [Interpretation] in Blood Narrative |
| 75117-2 | Linoleate (C18:2w6) [Entitic substance] in Red Blood Cells |
| 75136-2 | Adenosine [Moles/volume] in Cerebral spinal fluid |
| 7560-6 | Oyster triggered histamine release [Units/volume] in Blood |
| 75715-3 | CYP1A2 gene c.2473G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 60330-8 | Propoxyphene [Moles/volume] in Specimen |
| 77017-2 | CFTR gene mutation analysis [interpretation] in Blood or Tissue Qualitative by MS.MALDI |
| 61324-0 | Vanilla IgE Ab/IgE total in Serum |
| 93918-1 | little e Ag [Presence] on Red Blood Cells --after transfusion reaction |
| 9397-1 | Color of Stool |
| 94106-2 | Temazepam glucuronide [Presence] in Urine by Screen method |
| 77935-5 | Cortisol [Moles/volume] in Serum or Plasma --10 hours post XXX challenge |
| 7871-7 | Echovirus 6 Ab [Units/volume] in Serum |
| 63569-8 | Nuclear Ab pattern [Interpretation] in Cerebral spinal fluid by Immunofluorescence |
| 9524-0 | Giardia lamblia Ab [Titer] in Serum by Immunofluorescence |
| 6561-5 | Treponema pallidum IgG Ab [Presence] in Serum |
| 79654-0 | Dihydroorotate [Moles/volume] in Serum or Plasma |
| 95919-7 | Fungal pathogens panel - Lower respiratory specimen by NAA with probe detection |
| 9627-1 | Imipramine+Desipramine [Mass/volume] in Serum or Plasma |
| 80595-2 | Parainfluenza virus 4 P gene [Presence] in Nasopharynx by NAA with probe detection |
| 80679-4 | Escherichia coli Stx1 and Stx2 toxin stx1+stx2 genes [Presence] in Stool by NAA with probe detection |
| 80714-9 | TCR gamma delta cells/100 CD3 cells in Blood |
| 80720-6 | T-cell naive and memory and effector (CD27 and CD45RA) subsets panel - Blood |
| 80722-2 | Lymphocyte T-cell and B-cell and Natural killer subsets [Interpretation] in Blood Narrative |
| 9663-6 | HIV 1 p17 Ab [Presence] in Serum by Immunoblot |
| 9687-5 | Cadmium [Mass/volume] in Specimen |
| 82065-4 | Food Allergen Mix 27 (Hazelnut+Codfish+Soybean+Wheat) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 97547-4 | Base excess standard in Central venous blood |
| 97633-2 | Serratia marcescens DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 97777-7 | Creatinine [Moles/volume] in Dialysis fluid --1 hour specimen |
| 72943-4 | Tazobactam induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73161-2 | Rofecoxib induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73312-1 | Levalbuterol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73421-0 | Dicyclomine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73502-7 | Bivalirudin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7369-2 | Perennial rye grass IgE Ab [Units/volume] in Serum |
| 88456-9 | California encephalitis virus IgG+IgM Ab [Interpretation] in Serum Qualitative by Immunofluorescence |
| 88560-8 | Parainfluenza virus 3 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 89539-1 | Mitochondria M2 Ab [Presence] in Cerebral spinal fluid by Line blot |
| 59640-3 | clonazePAM [Mass/volume] in Serum or Plasma by Confirmatory method |
| 59767-4 | Ziprasidone [Mass/volume] in Blood |
| 42598-3 | Corticotropin [Mass/volume] in Plasma --baseline |
| 60209-4 | Venlafaxine [Mass/volume] in Body fluid |
| 3117-9 | Valine [Presence] in Serum or Plasma |
| 5114-4 | Coxsackievirus B6 Ab [Titer] in Serum by Complement fixation |
| 51354-9 | CD19+CD58+ cells/100 cells in Bone marrow |
| 31873-3 | Mareks disease virus Ag [Presence] in Feather |
| 51732-6 | Oxygen saturation Calculated from oxygen partial pressure in Capillary blood |
| 44382-0 | Hyaline casts.broad [Presence] in Urine sediment by Light microscopy |
| 32732-0 | Beta 1 globulin/Protein.total in Serum or Plasma by Electrophoresis |
| 23267-8 | Mycoplasma capricolum ss capripneumonia Ag [Presence] in Specimen by Neutralization test |
| 44875-3 | IgM Ag [Presence] in Skin by Immunofluorescence |
| 45361-3 | Lymphocyte proliferation stimulated by 0.25 ug pokeweed mitogen in Blood |
| 53965-0 | Brickdust deposit [Presence] in Urine by Visual |
| 46084-0 | Immunoglobulin light chains [Mass/time] in 24 hour Urine |
| 4640-9 | Hemolysin cold [Mass/volume] in Plasma |
| 34452-3 | Jamestown canyon virus RNA [Presence] in Blood by NAA with probe detection |
| 54912-1 | Fosfomycin IgE Ab [Units/volume] in Serum |
| 47161-5 | Norepinephrine [Moles/volume] in Urine --2nd specimen post XXX challenge |
| 35114-8 | Nordothiepin [Mass/volume] in Serum or Plasma |
| 35336-7 | Chymotrypsin [Enzymatic activity/volume] in Body fluid --4th specimen post Sincalide |
| 55854-4 | Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Amniotic fluid |
| 47746-3 | Serine/Amino acids.total in Serum or Plasma |
| 3540-2 | Dextromoramide [Presence] in Urine |
| 35663-4 | Protein [Mass/volume] in Urine collected for unspecified duration |
| 56906-1 | Bilirubin.direct [Mass/volume] in Peritoneal fluid |
| 5691-1 | Methanol [Presence] in Exhaled gas |
| 27038-9 | Endomysium IgA Ab [Titer] in Serum by Immunofluorescence |
| 38491-7 | Insulin-like growth factor binding protein 3.acid labile [Mass/volume] in Serum or Plasma |
| 49040-9 | Subtelomere analysis [Interpretation] in Blood or Tissue by FISH Narrative |
| 27332-6 | Feline panleukopenia virus IgG Ab [Titer] in Serum |
| 39568-1 | TOLBUTamide [Mass/volume] in 24 hour Urine |
| 2936-3 | Serine [Mass/volume] in Serum or Plasma |
| 40157-0 | Glucose [Moles/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 5862-8 | Influenza virus A Ag [Presence] in Specimen by Immunoassay |
| 29724-2 | Leptospira interrogans sv Celledoni Ab [Presence] in Serum by Agglutination |
| 40674-4 | Toxocara canis IgG Ab [Presence] in Serum by Immunoassay |
| 59028-1 | Ganglioside GM1 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 20869-4 | Leptospira sp [Presence] in Tissue by Organism specific culture |
| 12354-7 | Opiates [Presence] in Stool |
| 100028-0 | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 12811-6 | Uroporphyrinogen III synthase [Enzymatic activity/volume] in Blood |
| 101316-8 | Cortisol and 17-Hydroxyprogesterone post corticotropin stimulation panel - Serum or Plasma |
| 101471-1 | Alpha globin gene deletion panel - Blood |
| 101745-8 | Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 139-6 | Ceftizoxime [Susceptibility] by Serum bactericidal titer |
| 14232-3 | Adrenal Ab [Presence] in Serum |
| 102682-2 | Aspergillus terreus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102829-9 | Sunflower Seed IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14461-8 | Chlamydia trachomatis [Presence] in Blood by Organism specific culture |
| 14828-8 | Mesothelial cells/100 leukocytes in Pericardial fluid by Manual count |
| 1070-2 | Jk sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 16310-5 | Acetone [Presence] in Body fluid |
| 16769-2 | Dicloxacillin [Mass/volume] in Urine |
| 17207-2 | CD91 cells/100 cells in Blood |
| 18267-5 | CD16+CD56+ cells/100 cells in Blood |
| 18898-7 | Cephaloglycin [Susceptibility] |
| 89999-7 | Microalbumin [Mass/volume] in Urine by Detection limit <= 3.0 mg/L |
| 90438-3 | Mycobacterium preliminary growth [Presence] in Tissue by Organism specific culture |
| 91785-6 | Respiratory syncytial virus [Presence] in Upper respiratory specimen by Organism specific culture |
| 92516-4 | VS Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 93471-1 | Acetyl norfentanyl [Mass/volume] in Urine by Confirmatory method |
| 78350-6 | Decenoate (C10:1) [Entitic substance] in Red Blood Cells |
| 78368-8 | Parrot serum proteins+feathers+droppings IgG Ab [Mass/volume] in Serum |
| 63551-6 | Pituitary Ab [Titer] in Serum by Immunofluorescence |
| 63564-9 | Giardia lamblia Ag and Cryptosporidium parvum Ag and Entamoeba histolytica/dispar Ag [Identifier] in Stool |
| 791-4 | Erythrocytes [#/volume] in Cerebral spinal fluid by Automated count |
| 79587-2 | L-homoarginine/Creatinine [Molar ratio] in Urine |
| 80153-0 | Soluble CD27 [Units/volume] in Cerebral spinal fluid |
| 96094-8 | SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory system specimen by NAA with probe detection |
| 6753-8 | Glucose [Presence] in Urine by Test strip --30 minutes post 50 g lactose PO |
| 68415-9 | Mesothelial cells [#/volume] in Peritoneal fluid by Manual count |
| 96766-1 | GISAID sequence accession number |
| 96961-8 | Varicella zoster virus IgG Ab index [Units/volume] in Serum and CSF |
| 97169-7 | Vasopressin [Moles/time] in 24 hour Urine |
| 6929-4 | Aluminum [Mass/volume] in 24 hour Urine |
| 97778-5 | Glucose [Moles/volume] in Dialysis fluid --1 hour specimen |
| 8259-4 | Service comment 17 |
| 99034-1 | Trimethoprim resistance dfrA1 gene [Presence] by Molecular method |
| 71764-5 | Rotavirus Ab [Titer] in Serum by Immunoassay |
| 86071-8 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 73472-3 | ceFAZolin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73492-1 | Butalbital+Acetylsalicylate+Caffeine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 89340-4 | CD27+CD62L+ cells/100 CD3+CD4+ cells in Blood |
| 89964-1 | Ziprasidone [Presence] in Urine by Screen method |
| 4152-5 | carBAMazepine [Mass] of Dose |
| 31149-8 | P53 protein Ag/100 cells in Tissue by Immune stain |
| 42326-9 | Drugs identified in Mother's milk by Screen method |
| 59934-0 | Naproxen [Moles/volume] in Urine |
| 3148-4 | Oxygen [Partial pressure] in Gas |
| 51420-8 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
| 22225-7 | Coxsackievirus B1 Ab [Titer] in Cerebral spinal fluid |
| 31621-6 | Salmonella typhi H D Ab [Units/volume] in Serum |
| 31956-6 | Rubella virus Ag [Presence] in Cervix |
| 51767-2 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose fructose PO |
| 51770-6 | Leukocytes [#/area] in Stool by Microscopy high power field |
| 32066-3 | cloZAPine [Presence] in Specimen |
| 51977-7 | Chromium [Presence] in Urine |
| 52952-9 | Opiates [Moles/volume] in Urine |
| 43909-1 | Bordetella pertussis Ag [Presence] in Nasopharynx |
| 22791-8 | Alcelaphine herpesvirus 1 DNA [Presence] in Tissue by NAA with probe detection |
| 23040-9 | Duck hepatitis virus 3 neutralizing antibody [Presence] in Serum by Neutralization test |
| 32862-5 | Osmotic fragility [Interpretation] of Red Blood Cells--Incubated |
| 44803-5 | GNE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 33487-0 | Patient symptoms [Interpretation] --2 hours post dose lactose PO |
| 24-0 | Amphotericin B [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 34228-7 | Acylcarnitine [Moles/volume] in 24 hour Urine |
| 34346-7 | N-methylhistamine/Creatinine [Molar ratio] in Urine |
| 34692-4 | Threoamino alcohol [Mass/volume] in Serum or Plasma |
| 55207-5 | Genetic analysis discrete result panel |
| 55588-8 | OXcarbazepine + 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma |
| 4727-4 | HLA-A28 [Presence] |
| 47390-0 | Toxoplasma gondii IgG Ab [Units/volume] in Serum by Sabin dye test |
| 25399-7 | Endomysium Ab [Titer] in Serum by Immunofluorescence |
| 25484-7 | Nefazodone [Moles/volume] in Serum or Plasma |
| 25523-2 | Serine [Moles/time] in 24 hour Urine |
| 34715-3 | Cocaine [Presence] in Hair by Screen method |
| 35027-2 | Monocytes [#/volume] in Peritoneal fluid |
| 55623-3 | Capreomycin [Susceptibility] by Gradient strip |
| 47684-6 | Leucine/Amino acids.total in DBS |
| 48240-6 | Candida albicans triggered leukotriene release [Mass/volume] by Leukocytes |
| 56629-9 | Myelin Ab [Titer] in Serum by Immunofluorescence |
| 48509-4 | Influenza virus A and B RNA [Identifier] in Specimen by NAA with probe detection |
| 27201-3 | Zinc/Creatinine [Mass Ratio] in 24 hour Urine |
| 38374-5 | Tenofovir [Mass/volume] in Serum or Plasma |
| 38436-2 | Colony count [#/mass] in Specimen by Visual count |
| 57326-1 | Influenza virus A IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 57602-5 | 6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/time] in 24 hour Urine --pre dose dexamethasone |
| 27861-4 | Insulin [Units/volume] in Serum or Plasma --3 hours post 75 g glucose PO |
| 3883-6 | Oxandrolone [Presence] in Urine |
| 39005-4 | Hepatitis B virus core Ab [Presence] in Body fluid |
| 57964-9 | Formebolone metabolite [Presence] in Urine |
| 58024-1 | Saquinavir+Ritonavir [Susceptibility] by Phenotype method |
| 493-7 | Temocillin [Susceptibility] by Disk diffusion (KB) |
| 2817-5 | Porphyrins [Mass/volume] in Stool |
| 40210-7 | Glucose [Moles/volume] in Serum or Plasma --27 minutes post XXX challenge |
| 58604-0 | Corticotropin [Moles/volume] in Plasma --4 PM specimen |
| 29908-1 | Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection |
| 40318-8 | Glucose [Moles/volume] in Serum or Plasma --pre dose triple bolus |
| 40629-8 | Doxepin [Presence] in Specimen |
| 3021-3 | Thyroxine binding globulin [Mass/volume] in Serum or Plasma |
| 30324-8 | Cryptococcus sp Ag [Presence] in Serum by Latex agglutination |
| 41032-4 | Uroporphyrin [Mass/time] in unspecified time Stool |
| 2057-8 | Catecholamines [Mass/volume] in Urine |
| 20835-5 | Herbicide [Identifier] in Ingesta |
| 20845-4 | Bovine herpesvirus 1 Ab [Presence] in Serum by Immunoassay |
| 13194-6 | Aspergillus glaucus Ab [Units/volume] in Serum |
| 13216-7 | Candida albicans immune complex [Units/volume] in Serum or Plasma |
| 101797-9 | 8-Aminoclonazolam [Presence] in Urine by Confirmatory method |
| 101928-0 | SARS-CoV-2 Ag [Presence] in Nasopharynx by Immunofluorescence |
| 102310-0 | Flea IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14039-2 | Neutrophils/100 leukocytes in Cerebral spinal fluid by Microscopy |
| 14144-0 | Somatotropin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 14319-8 | Microscopic observation [Identifier] in Vaginal fluid by Wet preparation |
| 14768-6 | Glucose [Moles/volume] in Serum or Plasma --baseline |
| 10397-8 | Hepatitis B immune globulin given [Volume] |
| 14919-5 | Thyrotropin binding inhibitory immunoglobulins [Presence] in Serum |
| 15188-6 | Kappa light chains [Mass/volume] in 24 hour Urine |
| 104316-5 | N-Desethyl Sunitinib [Mass/volume] in Serum or Plasma |
| 10519-7 | Vimentin Ag [Presence] in Tissue by Immune stain |
| 17558-8 | Saint Louis encephalitis virus Ab [Units/volume] in Cerebral spinal fluid |
| 1830-9 | Alpha 1 antitrypsin SZ [Mass/volume] in Serum or Plasma |
| 18960-5 | Oleandomycin [Susceptibility] |
| 91065-3 | 14-3-3 protein [Presence] in Tissue by NAA with probe detection |
| 74970-5 | Acetylsalicylate [Mass/volume] in Serum or Plasma --trough |
| 60343-1 | Borrelia burgdorferi IgM bands panel - Serum by Immunoblot |
| 93338-2 | Bile acid panel - 48 hour Stool |
| 9342-7 | Cholesterol [Percentile] |
| 61287-9 | Banana IgE Ab/IgE total in Serum |
| 77335-8 | Propoxyphene + Norpropoxyphene [Moles/volume] in Specimen |
| 93754-0 | Encephalomyocarditis virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 93888-6 | Methane/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose carbohydrate |
| 62429-6 | Eastern equine encephalitis virus IgM Ab [Presence] in Body fluid by Immunofluorescence |
| 94419-9 | Candida auris [Presence] in Isolate by MS.MALDI-TOF |
| 95113-7 | Insulin [Units/volume] in Serum or Plasma --2.5 hours post meal |
| 95569-0 | Tetrahydro-11-corticosterone [Mass/time] in 24 hour Urine |
| 79657-3 | Pseudouridine [Moles/volume] in Serum or Plasma |
| 80170-4 | Pterins panel - Urine |
| 80912-9 | Gadolinium [Mass/volume] in Serum or Plasma |
| 70078-1 | Interleukin 2 [Mass/volume] in Body fluid |
| 70137-5 | Sample icteric [Presence] of Cerebral spinal fluid Qualitative by Spectrophotometry |
| 8268-5 | Service comment 07 |
| 71855-1 | Hemoglobin.other/Hemoglobin.total [Pure mass fraction] in Blood by Electrophoresis |
| 72207-4 | t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
| 83072-9 | Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma by Immunoassay |
| 85097-4 | Meta methylhippurate and ortho methylhippurate and para methylhippurate and creatinine panel - Urine |
| 85424-0 | Imipenem+Relebactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 72858-4 | Enfuvirtide [Susceptibility] by Genotype method |
| 87349-7 | Senecavirus A VP1 gene [Nucleotide sequence] in Isolate by Sequencing |
| 73687-6 | Methylenedioxypyrovalerone [Presence] in Urine by Screen method |
| 87819-9 | Tapentadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 88624-2 | Cytomegalovirus [Presence] in Amniotic fluid by Shell vial culture |
| 88890-9 | Parainfluenza virus 1+2+3+4 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 59719-5 | Nordiazepam [Mass/volume] in Body fluid by Confirmatory method |
| 50700-4 | Influenza virus A.adamantane resistant RNA [Presence] by NAA with probe detection |
| 31147-2 | Reagin Ab [Titer] in Serum by RPR |
| 42484-6 | Protein.monoclonal/Protein.total in 24 hour Urine by Electrophoresis |
| 60086-6 | Hydroxybupropion [Mass/volume] in Urine |
| 21341-3 | HLA-DR locus [Type] |
| 51053-7 | CD126 blasts [Units/volume] in Blood |
| 42911-8 | Hemoglobin.gastrointestinal [Presence] in Gastric fluid --3rd specimen |
| 42978-7 | Polio virus 2 Ab [Titer] in Body fluid |
| 4305-9 | Medazepam [Mass] of Dose |
| 21787-7 | t(2;5)(p23;q35.1)(ALK,NPM1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 51893-6 | Transfuse cryoprecipitate poor plasma units [#] |
| 32381-6 | Isepamicin [Susceptibility] |
| 51979-3 | Donepezil [Mass/volume] in Serum or Plasma |
| 52955-2 | Benzodiazepines [Moles/volume] in Urine |
| 3298-7 | Acetaminophen [Mass/volume] in Serum or Plasma |
| 53098-0 | 3-Methoxy-4-Hydroxyphenylglycol [Moles/time] in 24 hour Urine |
| 53491-7 | Kynurenin [Moles/time] in 24 hour Urine |
| 33639-6 | Lymphocyte proliferation stimulated by Candida albicans [Units/volume] in Blood |
| 53615-1 | Bacteria # 3 identified in Duodenal fluid by Aerobe culture |
| 53871-0 | HRAS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 4492-5 | Complement C3d [Entitic number] in Red Blood Cells |
| 33899-6 | Bilirubin.conjugated+indirect [Moles/volume] in Serum or Plasma |
| 55321-4 | C sup(w) Ab [Titer] in Serum or Plasma |
| 47365-2 | Hepatitis C virus Ab [Presence] in Serum from Donor by Immunoassay |
| 2537-9 | Lactate dehydrogenase 1 [Enzymatic activity/volume] in Serum or Plasma |
| 25384-9 | Coxiella burnetii IgG Ab [Titer] in Serum by Immunofluorescence |
| 4751-4 | HLA-B47 [Presence] |
| 35432-4 | Herpes simplex virus identified in Urine by Organism specific culture |
| 35532-1 | Chicken IgG Ab [Mass/volume] in Serum |
| 56251-2 | Duck meat IgG4 Ab [Mass/volume] in Serum |
| 56303-1 | Goosefoot IgG4 Ab [Mass/volume] in Serum |
| 56413-8 | Virginia Live Oak IgG4 Ab [Mass/volume] in Serum |
| 56519-2 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 2649-2 | N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Tissue |
| 26622-1 | Babesia duncani Ab [Presence] in Serum |
| 35863-0 | Voriconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 5685-3 | Mercury [Mass/volume] in Blood |
| 48572-2 | Follitropin [Units/volume] in Serum or Plasma --on cycle day 21 |
| 48654-8 | Corynebacterium diphtheriae toxin IgG Ab [Units/volume] in Serum by Immunoassay |
| 48701-7 | Luteinizing releasing hormone [Mass] of Dose |
| 26810-2 | Hydroxyproline [Presence] in 24 hour Urine |
| 26992-8 | Mephentermine [Mass/volume] in Milk |
| 38251-5 | Calcium oxalate [Mass/time] in 24 hour Urine |
| 38282-0 | Lymphocyte proliferation stimulated by 4.83 ug/mL tetanus toxoid [Units/volume] in Blood |
| 57494-7 | 11-Deoxycortisol [Moles/volume] in Serum or Plasma --pre dose dexamethasone |
| 49030-0 | Trisomy 21 risk based on maternal age+Pregnancy associated plasma protein A+Choriogonadotropin+Nuchal translucency [Likelihood] in Fetus |
| 2759-9 | Phenols [Mass/volume] in Urine |
| 27978-6 | Metanephrines/Creatinine [Molar ratio] in 24 hour Urine |
| 49373-4 | Hepatitis C virus RNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 49380-9 | Hepatitis C virus RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 29511-3 | 3-Hydroxyisobutyrate/Creatinine [Molar ratio] in Urine |
| 39969-1 | Creatinine [Mass/volume] in Serum or Plasma --9 hours post XXX challenge |
| 40177-8 | Glucose [Moles/volume] in Serum or Plasma --12.5 hours post XXX challenge |
| 58551-3 | Corticotropin [Mass/volume] in Plasma --15 minutes pre dose insulin IV |
| 497-8 | Tetracycline [Susceptibility] by Disk diffusion (KB) |
| 29788-7 | Jamestown canyon virus IgG Ab [Units/volume] in Specimen by Immunofluorescence |
| 30030-1 | Iron [Mass/volume] in 24 hour Urine |
| 3016-3 | Thyrotropin [Units/volume] in Serum or Plasma |
| 30247-1 | Cytomegalovirus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 40867-4 | 11-Oxo-Etiocholanolone [Mass/time] in 24 hour Urine |
| 19432-4 | Propoxyphene cutoff [Mass/volume] in Urine for Confirmatory method |
| 1959-6 | Bicarbonate [Moles/volume] in Blood |
| 20449-5 | Borrelia burgdorferi Ab [Presence] in Serum by Immunoassay |
| 20568-2 | Prolactin [Mass/volume] in Serum or Plasma by Immunoassay |
| 100409-2 | Processed cheese IgG Ab [Units/volume] in Serum |
| 12568-2 | Cortisol [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 101495-0 | Trimethoprim+Sulfamethoxazole [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 12949-4 | Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma |
| 13054-2 | Fibrin+Fibrinogen fragments [Units/volume] in Urine |
| 13265-4 | Leptospira sp IgM Ab [Titer] in Serum |
| 101750-8 | Adeno-associated virus (AAV) serotype Rh74 [Presence] in Serum by Immunoassay |
| 102201-1 | Canary feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102260-7 | Crab IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102619-4 | Swine urine proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102742-4 | Fusarium oxysporum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102923-0 | Alternaria alternata IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103059-2 | Horse recombinant (rEqu c) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14528-4 | Rubella virus Ag [Presence] in Sputum by Immunofluorescence |
| 10341-6 | Norpropoxyphene [Mass/volume] in Serum or Plasma |
| 14810-6 | Leukocytes [#/volume] in Bronchial specimen by Manual count |
| 14817-1 | LORazepam [Moles/volume] in Serum or Plasma |
| 15166-2 | Complement C5 [Mass/volume] in Body fluid |
| 104361-1 | Brucella sp Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 10633-6 | Zinc [Moles/volume] in Semen |
| 10757-3 | Hematologic+Nuclear elements.microscopic observation [Identifier] in Tissue by Giemsa stain.May-Grunwald |
| 1111-4 | Le sup(a) Ab [Presence] in Serum or Plasma from Donor |
| 16434-3 | Basement membrane Ab [Units/volume] in Serum by Immunofluorescence |
| 11146-8 | Homovanillate/Creatinine [Mass Ratio] in Urine |
| 17294-0 | Mushroom toxins [Identifier] in Urine |
| 90414-4 | B-cell phenotyping panel - Blood |
| 91042-2 | Methamphetamine+Methylenedioxymethamphetamine [Presence] in Body fluid by Screen method |
| 7491-4 | Mexican Firebush IgE Ab [Units/volume] in Serum |
| 7492-2 | Multiple inhalant allergen IgE Ab [Units/volume] in Serum |
| 75152-9 | Uracil [Moles/volume] in Serum or Plasma |
| 75392-1 | FXN gene GAA repeats [Presence] in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
| 60356-3 | Broccoli IgG Ab [Mass/volume] in Serum |
| 61055-0 | Oxazepam [Presence] in Specimen |
| 92799-6 | Candida parapsilosis DNA [Presence] by NAA with probe detection in Positive blood culture |
| 92884-6 | Parainfluenza virus 1+2+3+4 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 93997-5 | Sodium [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin |
| 9417-7 | Anthraquinone [Mass/mass] in Stool |
| 62426-2 | Bordetella sp DNA panel - Specimen by NAA with probe detection |
| 94824-0 | Parvovirus B19 DNA [Units/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 95574-0 | 17 Alpha-hydroxypregnanolone [Mass/time] in 24 hour Urine |
| 95579-9 | Cortisol [Z-score] in 24 hour Urine |
| 66950-7 | MALT1 18q21 gene rearrangements in Blood or Tissue by FISH |
| 8003-6 | Rickettsia rickettsii IgG Ab [Units/volume] in Serum |
| 95962-7 | Tree Allergen Oak Mix (White oak+Red oak+Black Oak) IgE Ab [Units/volume] in Serum |
| 68457-1 | Enterovirus and Parechovirus A RNA [Identifier] in Specimen by NAA with probe detection |
| 6867-6 | 3-Methylhistidine [Mass/time] in 24 hour Urine |
| 68931-5 | Catecholamines Free [Mass/volume] in 24 hour Urine |
| 68945-5 | CD3+CD5+ cells [#/volume] in Cerebral spinal fluid |
| 80617-4 | Cefuroxime free [Mass/volume] in Serum or Plasma |
| 96632-5 | HLA-Bw [Type] in Donor |
| 96716-6 | Odor of Prostatic fluid |
| 97014-5 | Maximum amplitude tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited [Length] in Blood by Resonance TEG |
| 970-4 | Weak D Ag [Presence] on Red Blood Cells from Blood product unit |
| 7066-4 | Alfalfa IgG Ab [Units/volume] in Serum |
| 82998-6 | Dense fine speckled 70 protein IgG Ab [Presence] in Serum or Plasma by Line blot |
| 98254-6 | Depth of myometrial invasion [Length] in Endometrial cancer specimen |
| 72611-7 | diazePAM [Presence] in Saliva (oral fluid) |
| 85789-6 | CD3+CD8+CD45RO+ cells/100 CD3 cells in Blood |
| 86069-2 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum --2nd specimen |
| 73049-9 | carBAMazepine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87400-8 | Brachyspira sp Ag [Presence] in Tissue by Immune stain |
| 87405-7 | Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 88265-4 | Listeria sp tuf gene [Presence] by Probe in Positive blood culture |
| 74364-1 | Oxytocin [Mass/volume] in Saliva (oral fluid) |
| 50643-6 | Pregnanetriolone [Mass/time] in 24 hour Urine |
| 50658-4 | Basophils.band form/100 leukocytes in Bone marrow |
| 50974-5 | CD38+CD138+ cells/100 cells in Blood |
| 60075-9 | Finasteride [Mass/volume] in Serum or Plasma |
| 60169-0 | Rubidium [Mass/volume] in Red Blood Cells |
| 2126-1 | Citrate [Mass/volume] in Semen |
| 31299-1 | Chlamydophila pneumoniae IgA Ab [Units/volume] in Cerebral spinal fluid |
| 4292-9 | Ketamine [Mass] of Dose |
| 43013-2 | HIV 1 gp120+gp160 Ab [Presence] in Serum |
| 22309-9 | Hantavirus puumala IgM Ab [Titer] in Serum |
| 31670-3 | Sulfatide IgG Ab [Presence] in Serum |
| 51509-8 | Lactate dehydrogenase 1/Lactate dehydrogenase.total in Peritoneal fluid by Electrophoresis |
| 32532-4 | CD3+CD4+ (T4 helper) cells [#/volume] in Bone marrow |
| 43911-7 | Aspergillus versicolor Ab [Presence] in Serum |
| 23093-8 | Equine herpesvirus 4 DNA [Presence] in Nose by NAA with probe detection |
| 23214-0 | Lumpy skin disease virus Ab [Presence] in Serum by Immunoblot |
| 23646-3 | Actinobacillus pleuropneumoniae serotype 5 Ab [Presence] in Serum by Immunoassay |
| 33336-9 | Toxoplasma gondii IgM Ab [Presence] in Serum by Agglutination |
| 53559-1 | Beta-2 transferrin [Mass/volume] in Cerebral spinal fluid |
| 53572-4 | Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture |
| 45335-7 | Bacteria Identification [Presence] in Isolate by Culture |
| 2381-2 | Glutathione.oxidized [Mass/volume] in Red Blood Cells |
| 33833-5 | Lymphocytes Immunoblastic/100 leukocytes in Blood by Manual count |
| 33852-5 | Progesterone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 34173-5 | Mixed cellular casts [Presence] in Urine sediment by Light microscopy |
| 54195-3 | Mezlocillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 54203-5 | Cefmenoxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 24391-5 | Cortisol [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
| 25182-7 | Kanamycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 35054-6 | Leukocytes other [#/volume] in Peritoneal fluid |
| 47856-0 | Follitropin [Units/volume] in Serum or Plasma --pre 100 ug luteinizing releasing hormone IV |
| 25794-9 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 56235-5 | Crab IgG4 Ab [Mass/volume] in Serum |
| 56270-2 | Hamster epithelium IgG4 Ab [Mass/volume] in Serum |
| 48026-9 | ITGA2B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 48180-4 | Reference change value 0.95 in unspecified time Population |
| 26613-0 | Sarcosine [Moles/volume] in Serum or Plasma |
| 26742-7 | Methylenedioxyamphetamine [Mass/volume] in Milk |
| 3818-2 | Metoprolol [Mass/time] in 24 hour Urine |
| 27150-2 | Streptococcus pneumoniae Danish serotype 7F Ab [Mass/volume] in Serum --1st specimen |
| 38271-3 | Influenza virus A H6 RNA [Presence] in Specimen by NAA with probe detection |
| 38518-7 | Immature granulocytes/100 leukocytes in Blood |
| 57305-5 | Tropomyosin IgE Ab [Mass/volume] in Serum |
| 57357-6 | Lactate [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 57428-5 | FMC7 cells/100 cells in Body fluid |
| 27976-0 | Lactate [Mass/volume] in Blood --fasting |
| 39584-8 | Mercury [Presence] in Nail |
| 57923-5 | Carbon dioxide, total [Moles/volume] in Venous cord blood by calculation |
| 29326-6 | Carboxy tetrahydrocannabinol [Mass/volume] in Gastric fluid |
| 29998-2 | Striated muscle IgG Ab [Titer] in Serum by Immunofluorescence |
| 41001-9 | Human coronavirus RNA [Presence] in Specimen by NAA with probe detection |
| 19567-7 | Methylenedioxyamphetamine cutoff [Mass/volume] in Urine for Screen method |
| 19629-5 | Norfluoxetine [Presence] in Urine by Confirmatory method |
| 20680-5 | Alkaloid identified in Ingesta by Thin layer chromatography (TLC) |
| 1003-3 | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma |
| 100869-7 | Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method |
| 101513-0 | Mycoplasma flocculare DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 101998-3 | Clot formation.kaolin induced [Time] in Blood by Thromboelastography |
| 13766-1 | Isovalerylglycine/Creatinine [Mass Ratio] in Urine |
| 13817-2 | Tryptophan/Creatinine [Mass Ratio] in Urine |
| 13853-7 | Aldosterone [Mass/volume] in Serum or Plasma --1 hour post 25 mg captopril PO |
| 10238-4 | Oxygen content in Left ventricle |
| 102541-0 | Povertyweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102659-0 | Cow whey IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13993-1 | Alpha 2 globulin/Protein.total in Urine by Electrophoresis |
| 142-0 | cefTRIAXone [Susceptibility] by Disk diffusion (KB) |
| 14274-5 | Uroporphyrin [Mass/volume] in Serum or Plasma |
| 1451-4 | Cortisol [Mass/volume] in Serum or Plasma --pre dose insulin IV |
| 14664-7 | Color of Synovial fluid |
| 14711-6 | EPINEPHrine [Moles/volume] in Plasma |
| 10345-7 | Trihexyphenidyl [Mass/volume] in Urine |
| 14986-4 | little i-1 subtype [Presence] on Red Blood Cells from Blood product unit |
| 15222-3 | Food Allergen Mix E (Crab+Buckwheat+Shrimp+Sesame seed+Corn) IgE Ab [Presence] in Serum by Multidisk |
| 10589-0 | Spermatids [#/volume] in Semen by Streptoavidin-biotin method (SAB) |
| 15351-0 | Apolipoprotein E2 [Presence] in Blood |
| 17283-3 | Mirtazapine [Mass/volume] in Serum or Plasma |
| 17550-5 | Rubella virus Ab [Units/volume] in Serum by Latex agglutination |
| 1763-2 | Aldosterone [Mass/volume] in Serum or Plasma |
| 74503-4 | 16-Beta,18-dihydroxydehydroepiandrosterone [Moles/volume] in Urine |
| 7451-8 | Latex ALK triggered histamine release [Units/volume] in Blood |
| 91779-9 | Yeast identified in Upper respiratory specimen by Organism specific culture |
| 92505-7 | Fy sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 94222-7 | SERPINA1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 94252-4 | Borrelia garinii+afzelii oppA2 gene [Presence] in Specimen by NAA with non-probe detection |
| 7814-7 | Bacillus anthracis Ab [Units/volume] in Serum |
| 6460-0 | Bacteria identified in Sputum by Culture |
| 78985-9 | Prolactin.dimeric [Units/volume] in Serum or Plasma |
| 79496-6 | Hydantoin-5-propionate [Moles/volume] in Serum or Plasma |
| 95139-2 | Varicella zoster virus DNA panel - Amniotic fluid by NAA with probe detection |
| 65363-4 | Glutathione [Moles/volume] in Blood |
| 65775-9 | Bermuda grass native (nCyn d) 1 IgE Ab [Units/volume] in Serum |
| 96121-9 | SARS-related coronavirus E gene [Presence] in Lower respiratory specimen by NAA with probe detection |
| 676-7 | Microscopic observation [Identifier] in Specimen by Rhodamine-auramine fluorochrome stain |
| 69006-5 | Immature granulocytes/100 leukocytes in Cerebral spinal fluid |
| 80683-6 | Giardia lamblia 18S rRNA [Presence] in Stool by NAA with probe detection |
| 80826-1 | Zika virus envelope E gene [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 97106-9 | Hepatitis A virus cellular receptor 1 [Mass/volume] in Urine by Immunoassay |
| 97165-5 | Triiodothyronine (T3) [Moles/time] in 24 hour Urine |
| 97196-0 | quiNIDine [Moles/volume] in Serum or Plasma --peak |
| 69847-2 | 2-Hydroxyisobutyrate [Moles/volume] in Serum or Plasma |
| 69872-0 | Service comment 45 |
| 81650-4 | West Nile virus Kunjin strain RNA [Presence] in Specimen by NAA with probe detection |
| 81818-7 | PMM2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 97537-5 | pH of Central venous blood adjusted to patient's actual temperature |
| 97916-1 | Coccidioides sp DNA [Presence] in Specimen by NAA with probe detection |
| 71863-5 | Hemoglobin F/Hemoglobin.total [Pure mass fraction] in Blood by Kleihauer-Betke method |
| 85345-7 | Dermal lymph-vascular invasion in Cancer specimen Qualitative by Light microscopy |
| 99392-3 | Sulfocysteine [Moles/volume] in Urine |
| 86082-5 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum |
| 86107-0 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum |
| 86227-6 | Dihydrocodeine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 86562-6 | Human papilloma virus 18 DNA [Presence] in Tissue by NAA with probe detection |
| 73414-5 | diphenhydrAMINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88564-0 | Cytomegalovirus [Presence] in Bone marrow by Organism specific culture |
| 74345-0 | MICA*002 IgG Ab [Presence] in Serum |
| 88867-7 | Other Chemical [Mass/volume] in Specimen |
| 41514-1 | HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 2.6 log copies/mL |
| 5984-0 | Plasminogen activator urokinase type [Units/volume] in Urine |
| 4197-0 | Clorprenaline [Mass] of Dose |
| 42319-4 | Glucose-6-Phosphate dehydrogenase phenotype [Interpretation] in Red Blood Cells |
| 21653-1 | CDH1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 51240-0 | CD13+CD33+ cells/100 cells in Body fluid |
| 42855-7 | 11-Deoxycorticosterone [Mass/volume] in Urine |
| 4302-6 | Lormetazepam [Mass] of Dose |
| 22120-0 | Borrelia burgdorferi Ab [Units/volume] in Body fluid |
| 22168-9 | Chicken anemia virus Ab [Presence] in Serum |
| 51604-7 | Phosphate [Moles/time] in 12 hour Urine |
| 51865-4 | Plasmodium sp Ag [Identifier] in Blood |
| 43330-0 | Eastern equine encephalitis virus IgM Ab [Titer] in Serum by Immunoassay |
| 22423-8 | Mycoplasma hominis Ab [Titer] in Serum |
| 32091-1 | Meprobamate [Moles/volume] in Specimen |
| 51985-0 | Modafinil [Mass/volume] in Serum or Plasma |
| 4422-2 | Salicylamide [Mass] of Dose |
| 23124-1 | Francisella tularensis Ab [Presence] in Serum by Immunoassay |
| 33203-1 | Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid |
| 23599-4 | Leptospira sp identified in Tissue by Organism specific culture |
| 33268-4 | Bordetella pertussis.pertussis toxin IgG Ab [Mass/volume] in Serum |
| 4561-7 | Hemoglobin C/Hemoglobin.total in Blood by Electrophoresis acid (pH 6.3) |
| 4574-0 | Hemoglobin E/Hemoglobin.total in Blood by Electrophoresis alkaline (pH 8.9) |
| 46723-3 | Alpha-1-Microglobulin [Mass/volume] in Urine |
| 24294-1 | Parainfluenza virus 2 Ab [Titer] in Serum --1st specimen |
| 24412-9 | Coccidia identified in Small intestine Tissue by Giemsa stain |
| 47123-5 | Nickel [Moles/mass] in Hair |
| 25166-0 | Uroporphyrin [Moles/volume] in Urine |
| 55902-1 | IgA [Mass/volume] in Serum by Electrophoresis |
| 47774-5 | Somatotropin [Units/volume] in Serum or Plasma --pre dose arginine |
| 56185-2 | Bahia grass IgG4 Ab [Mass/volume] in Serum |
| 56394-0 | Sugar Cane IgG4 Ab [Mass/volume] in Serum |
| 56544-0 | Ganglioside GM2 IgM Ab [Units/volume] in Serum by Immunoassay |
| 48266-1 | Grass Allergen Mix E (Cocksfoot+Meadow Fescue+Velvet grass+Perennial rye grass+Timothy+Kentucky blue grass ) triggered leukotriene release [Mass/volume] by Leukocytes |
| 2619-5 | Methemoglobin [Presence] in Red Blood Cells |
| 56580-4 | Renin [Enzymatic activity/volume] in Plasma --20 minutes post XXX challenge |
| 56673-7 | Beta aminoisobutyrate/Creatinine [Ratio] in 24 hour Urine |
| 56921-0 | Entamoeba histolytica Ab [Presence] in Serum by Immunofluorescence |
| 27998-4 | Estrone (E1) [Mass/volume] in Saliva (oral fluid) |
| 3921-4 | Pentetrazol [Mass/volume] in Urine |
| 49749-5 | 6-monoacetylmorphine free [Mass/volume] in Serum or Plasma |
| 2848-0 | Proline dipeptidase [Enzymatic activity/mass] in Tissue |
| 50109-8 | 3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in DBS |
| 29942-0 | Copper/Creatinine [Mass Ratio] in 24 hour Urine |
| 40364-2 | Follitropin [Units/volume] in Serum or Plasma --30 minutes post dose triple bolus |
| 58903-6 | Neomycin IgE Ab [Units/volume] in Serum |
| 58940-8 | Bacteria identified in Total parental nutrition by Culture |
| 30381-8 | Eosinophils/100 leukocytes in Sputum |
| 40954-0 | Yersinia enterocolitica O:8 Ab [Titer] in Serum by Complement fixation |
| 41097-7 | HADHA gene c.1528G>C [Presence] in Blood or Tissue by Molecular genetics method |
| 19331-8 | Amitriptyline [Presence] in Urine by Screen method |
| 100119-7 | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot |
| 100342-5 | Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry |
| 100733-5 | Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a) |
| 12487-5 | Butalbital [Presence] in Gastric fluid |
| 101145-1 | Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay --trough |
| 102332-4 | Grapefruit IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102586-5 | Savinase IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14081-4 | Coliform bacteria [Presence] in Water |
| 14083-0 | Epstein Barr virus early Ab [Titer] in Serum by Immunofluorescence |
| 14262-0 | Dichlorodiphenyldichloroethylene [Mass/mass] in Tissue |
| 14270-3 | Tert-butyl acetate [Mass/volume] in Blood |
| 102992-5 | Spondylocladium sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103226-7 | Fibrin+Fibrinogen fragments [Mass/volume] in Platelet poor plasma by Latex agglutination |
| 16635-5 | Coccidioides immitis IgA Ab [Units/volume] in Serum by Immunoassay |
| 11558-4 | pH of Blood |
| 11559-2 | Fractional oxyhemoglobin in Blood |
| 168-5 | Cephradine [Susceptibility] by Minimum lethal concentration (MLC) |
| 17509-1 | Marsh Ragweed IgE Ab [Units/volume] in Serum |
| 18337-6 | Hydroxyitraconazole [Mass/volume] in Serum or Plasma |
| 7450-0 | Goosefoot triggered histamine release [Units/volume] in Blood |
| 92723-6 | Yersinia enterocolitica DNA [Presence] in Stool by NAA with probe detection |
| 75569-4 | Fetal Monosomy X risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 60566-7 | Respiratory pathogens DNA and RNA 12b panel - Specimen by NAA with probe detection |
| 93425-7 | GABABR IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 61336-4 | Cochineal extract IgE Ab/IgE total in Serum |
| 62380-1 | Chromosome band involved end |
| 77625-2 | ENG gene full mutation analysis in Blood or Tissue by Sequencing |
| 77633-6 | TARDBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 9382-3 | Coproporphyrin [Mass/time] in unspecified time Stool |
| 94241-7 | BTK gene full mutation analysis in Blood or Tissue by Sequencing |
| 95543-5 | Aspergillus terreus IgG Ab [Presence] in Serum |
| 95647-4 | Powassan virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 79511-2 | Suberylglycine [Moles/volume] in Serum or Plasma |
| 79650-8 | Beta alanine and Beta aminoisobutyrate and Gamma aminobutyrate panel - Serum or Plasma |
| 95823-1 | SARS-related coronavirus E gene [Presence] in Saliva (oral fluid) by NAA with probe detection |
| 96117-7 | Resection adequacy of non-malignant polyp in Specimen Qualitative |
| 96186-2 | Dermatology autoimmune Ab panel - Serum or Plasma |
| 96799-2 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose arginine |
| 82111-6 | Tree Allergen Mix 10 (Grey alder+Silver birch+Hazelnut+White ash) IgE Ab [Units/volume] in Serum by Multidisk |
| 70101-1 | Methotrexate [Moles/volume] in Serum or Plasma --4th specimen |
| 70197-9 | 6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine by Confirmatory method |
| 8233-9 | Phencyclidine [Presence] in Meconium by Confirmatory method |
| 98051-6 | Microsporum canis IgE Ab [Units/volume] in Serum |
| 72469-0 | RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 84918-2 | Chromosome X aneuploidy [Presence] in Amniotic fluid or Chorionic villus sample by FISH |
| 99503-5 | Cefiderocol [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 86078-3 | Streptococcus pneumoniae Danish serotype 3 Ab [Mass/volume] in Serum |
| 87355-4 | Actinobacillus pleuropneumoniae serotype 10 Ab/Positive control in Serum by Immunoassay |
| 88207-6 | Lymphocytic choriomeningitis virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 88337-1 | Mite identified in Ear by Light microscopy |
| 41461-5 | Virus identified in Specimen |
| 59724-5 | Cathine [Mass/volume] in Serum or Plasma |
| 59819-3 | Pentacarboxylporphyrins/Creatinine [Molar ratio] in 24 hour Urine |
| 42315-2 | APOE gene alleles e2 and e3 and e4 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 42712-0 | AML/MDS gene 7q31 deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 59908-4 | hydrOXYzine [Moles/volume] in Urine |
| 21498-1 | Orientia tsutsugamushi IgG Ab [Titer] in Serum |
| 51431-5 | Gastrin [Mass/volume] in Serum or Plasma --pre or post XXX challenge |
| 31676-0 | Ganglioside GQ1b IgG Ab [Units/volume] in Cerebral spinal fluid |
| 31750-3 | Bovine inner ear Ag [Presence] in Serum or Plasma |
| 31756-0 | Campylobacter fetus Ag [Presence] in Specimen |
| 51641-9 | Mean sphered cell volume [Entitic volume] in Red Blood Cells |
| 51874-6 | Varicella zoster virus immune globulin ordered [#] in Blood product unit |
| 43730-1 | Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 3208-6 | Coagulation factor VIII activated [Units/volume] in Platelet poor plasma by Coagulation assay |
| 3234-2 | Coagulation factor XII Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 22958-3 | Burkholderia mallei Ab [Presence] in Serum by Immunoassay |
| 22967-4 | Campylobacter fetus ss venerealis Ab [Presence] in Genital mucus |
| 32596-9 | Trifluoperazine [Mass] of Dose |
| 32634-8 | Metanephrine Free [Mass/time] in 24 hour Urine |
| 44413-3 | Threonine/Creatinine [Mass Ratio] in 24 hour Urine |
| 33386-4 | Segmented neutrophils/100 leukocytes in Synovial fluid |
| 53732-4 | GCK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 45054-4 | Glucose [Moles/volume] in Serum or Plasma --12 PM specimen |
| 45125-2 | Vesicular stomatitis Alagoas virus Ag [Presence] in Specimen by Complement fixation |
| 34404-4 | Cytoskeleton Ab [Titer] in Serum by Immunofluorescence |
| 55335-4 | little s Ab [Titer] in Serum or Plasma |
| 34987-8 | Unidentified cells [#/volume] in Cerebral spinal fluid |
| 25583-6 | Calcium [Moles/volume] in Red Blood Cells |
| 35489-4 | Chlorpyrifos [Mass/volume] in Serum or Plasma |
| 56535-8 | 8-Dehydrocholesterol [Moles/volume] in Serum or Plasma |
| 2623-7 | Methionine [Mass/volume] in Urine |
| 38168-1 | Major crossmatch [Interpretation] by Low ionic strength saline (LISS) |
| 48355-2 | traMADol [Moles/volume] in Serum or Plasma |
| 4840-5 | HLA-B5 [Presence] in Donor |
| 38642-5 | 1,3-Butadiene [Mass/volume] in Air |
| 38657-3 | Diazomethane [Mass/volume] in Air |
| 28007-3 | Urobilinogen [Units] in 24 hour Urine |
| 38995-7 | Mixed cellular casts [#/area] in Urine sediment by Microscopy low power field |
| 39530-1 | Isopropanol [Presence] in Blood |
| 39591-3 | PARoxetine [Mass/volume] in Urine |
| 57917-7 | Budgerigar droppings IgG Ab [Units/volume] in Serum |
| 58069-6 | Kn sup (b) Ag [Presence] on Red Blood Cells |
| 28545-2 | Mucus [#/area] in Urine sediment by Microscopy low power field |
| 49940-0 | Glutamate dehydrogenase [Enzymatic activity/mass] in Leukocytes |
| 40339-4 | Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose triple bolus |
| 4049-3 | Theophylline [Mass/volume] in Serum or Plasma |
| 58853-3 | Osmolality of Urine--30 minutes post fluid fast |
| 58985-3 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --pre XXX challenge |
| 59193-3 | Deoxyuridine/Creatinine [Molar ratio] in Urine |
| 59273-3 | Cortisol [Mass/volume] in Serum or Plasma --post 6 mg dexamethasone PO overnight |
| 50370-6 | Queen Palm IgE Ab/IgE total in Serum |
| 30092-1 | Brucella canis IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 40940-9 | Yersinia sp Ab [Titer] in Serum |
| 40969-8 | Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum |
| 41092-8 | MAPT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19352-4 | Aprobarbital cutoff [Mass/volume] in Urine for Confirmatory method |
| 19519-8 | Levorphanol cutoff [Mass/volume] in Urine for Confirmatory method |
| 12341-4 | Mazindol [Presence] in Serum or Plasma |
| 100662-6 | Cortisol free and total panel - Serum or Plasma |
| 100848-1 | Cell count and Differential panel - Amniotic fluid by Manual count |
| 12654-0 | Glucose [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 101200-4 | Protein.monoclonal band 6/Protein.total in Serum or Plasma by Electrophoresis |
| 101854-8 | Megestrol acetate [Moles/volume] in Urine |
| 102131-0 | Alkalase IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13769-5 | Lysine/Creatinine [Mass Ratio] in Urine |
| 102654-1 | Watermelon IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14125-9 | Entamoeba histolytica [Presence] in Stool by Trichrome stain |
| 14304-0 | Measles virus IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 102676-4 | Red Ant IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1442-3 | Cortisol [Mass/volume] in Serum or Plasma --9 hours post 8 mg dexamethasone PO overnight high dose |
| 10415-8 | Transfuse blood exchange transfusion [Volume] |
| 14997-1 | Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post dose TRH IV |
| 10731-8 | Trypanosoma sp identified in Blood by Thick film |
| 10829-0 | Silicon [Mass/volume] in Serum or Plasma |
| 10974-4 | 5-Fluorocytosine [Mass/volume] in Urine |
| 11477-7 | Microscopic observation [Identifier] in Sputum by Acid fast stain |
| 11599-8 | Coxsackievirus A21 Ab [Units/volume] in Serum |
| 16803-9 | Echovirus 4 Ab [Units/volume] in Serum by Complement fixation |
| 16950-8 | Herpes simplex virus 1 IgG Ab [Units/volume] in Serum --2nd specimen |
| 17493-8 | Prostaglandin E [Mass/volume] in Serum or Plasma |
| 17783-2 | Hemosiderin [Presence] in Urine by Light microscopy |
| 17869-9 | Orotate/Creatinine [Molar ratio] in Urine |
| 1791-3 | Alpha aminoadipate [Presence] in Plasma |
| 90281-7 | Bacteria identified in Peritoneal fluid by Aerobe culture |
| 74624-8 | 1,1-Dimethoxyhexadecane (DMA 16:0)/palmitate (C16:0) [Mass Ratio] in Fibroblast |
| 74879-8 | Galactose 1 phosphate [Mass/volume] in DBS --post therapeutic diet |
| 74948-1 | FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma --trough |
| 91816-9 | Bordetella parapertussis DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 7517-6 | Oyster Mushroom IgE Ab [Units/volume] in Serum |
| 75356-6 | Other cells/100 leukocytes in Pleural fluid by Manual count |
| 75574-4 | Fetal 22q11.2 deletion prior risk [Likelihood] based on general population risk |
| 75714-6 | CYP1A2 gene c.-2467delT [Presence] in Blood or Tissue by Molecular genetics method |
| 61123-6 | Lymphocytes/100 leukocytes in Specimen by Flow cytometry (FC) |
| 9354-2 | Benztropine [Mass/volume] in Urine |
| 61373-7 | Human papilloma virus 18 DNA [Presence] in Specimen by NAA with probe detection |
| 77075-0 | C12orf65 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77394-5 | Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Anorectal by NAA with probe detection |
| 94449-6 | HLA-A and B and C (class I) IgG high risk [Identifier] in Serum or Plasma by Flow cytometry (FC) |
| 63370-1 | Gamma tocopherol [Mass/volume] in Serum or Plasma |
| 794-8 | Erythrocytes [#/volume] in Pleural fluid by Automated count |
| 666-8 | Microscopic observation [Identifier] in Specimen by India ink prep |
| 95779-5 | TFE3 gene rearrangements in Tissue by FISH |
| 809-4 | Leukocytes [#/volume] in Peritoneal fluid by Automated count |
| 96734-9 | Fatty acid salts [Presence] in Stool by Light microscopy |
| 69370-5 | A1 Ab [Presence] in Cord blood |
| 69668-2 | HIV 1 and 2 Ab [Identifier] in Serum or Plasma by Rapid immunoassay |
| 82467-2 | riTUXimab [Mass/volume] in Serum or Plasma by Immunoassay |
| 71834-6 | Cryoglobulin/Serum.total [Pure volume fraction] in Serum by Spun Westergren |
| 85344-0 | Lymph nodes with micrometastases [#] in Cancer specimen by Light microscopy |
| 72622-4 | Propoxyphene [Presence] in Saliva (oral fluid) |
| 72732-1 | Mitragynine [Mass/volume] in Urine by Confirmatory method |
| 86022-1 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum |
| 87328-1 | Porcine circovirus type 2 IgG+IgM Ab [Presence] in Serum by Immunofluorescence |
| 88449-4 | Coagulation factor IX activity actual/normal in Platelet poor plasma by Chromogenic method |
| 74371-6 | Cotinine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 89651-4 | Human metapneumovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 41632-1 | Clostridium botulinum toxin B [Presence] in Specimen by Immunofluorescence |
| 50971-1 | Cytology report of Bronchial brush Cyto stain |
| 3108-8 | Urobilinogen [Mass/time] in 24 hour Urine |
| 21373-6 | Abnormal lymphocytes/100 leukocytes in Synovial fluid by Manual count |
| 21582-2 | Tryptase [Mass/volume] in Serum or Plasma |
| 31370-0 | Epstein Barr virus capsid IgM Ab [Units/volume] in Cerebral spinal fluid |
| 51358-0 | CD59 cells/100 cells in Bone marrow |
| 2177-4 | Cystine [Mass/volume] in Serum or Plasma |
| 22125-9 | Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid |
| 51844-9 | Cortisol [Moles/volume] in Saliva (oral fluid) |
| 51935-5 | Trypsinogen I Free [Presence] in DBS |
| 53042-8 | DNA marker assessed panel |
| 43942-2 | Insulin Free [Mass/volume] in Serum or Plasma |
| 22998-9 | Chlamydophila psittaci Ag [Presence] in Tissue by Immune stain |
| 23083-9 | Equine herpesvirus 1 DNA [Presence] in Specimen by NAA with probe detection |
| 32861-7 | TCR gamma delta cells/100 cells in Specimen |
| 53106-1 | Butyrylcarnitine (C4) [Moles/volume] in Urine |
| 53361-2 | Bordetella parapertussis IgG Ab [Titer] in Serum |
| 44580-9 | HTLV I+II p21 env Ab [Presence] in Serum by Immunoblot |
| 23361-9 | Porcine enterovirus Ab [Presence] in Serum |
| 2391-1 | Glycine [Mass/volume] in Serum or Plasma |
| 34201-4 | Cytomegalovirus [Presence] in Amniotic fluid by Organism specific culture |
| 54404-9 | Pooled platelet concentrate units given [#] |
| 46416-4 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 8 mg dexamethasone PO overnight high dose |
| 24282-6 | Rickettsia spotted fever group IgG Ab [Titer] in Serum --2nd specimen |
| 24341-0 | Gas and Carbon monoxide panel - Arterial blood |
| 34611-4 | Prostate specific Ag [Mass/volume] in Urine |
| 34934-0 | CD3+CD8+CD45RO+CD45RA+ cells/100 cells in Blood |
| 35052-0 | Leukocytes other [#/volume] in Pleural fluid |
| 47709-1 | Methylmalonate/Urea [Molar ratio] in Urine |
| 35630-3 | PENTobarbital [Mass/volume] in Serum or Plasma by Screen method |
| 56532-5 | Asialoglycoprotein receptor Ab [Units/volume] in Serum by Immunoassay |
| 56545-7 | Ganglioside GQ1b IgM Ab [Units/volume] in Serum by Immunoassay |
| 56552-3 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --baseline |
| 56717-2 | Histone Ab [Presence] in Serum by Immunoblot |
| 38450-3 | CFTR gene c.2184delA [Presence] in Blood or Tissue by Molecular genetics method |
| 57444-2 | Spermatozoa Progressive Grade 2/100 spermatozoa in Semen --post concentration |
| 57469-9 | Calcitriol [Moles/volume] in Serum or Plasma --2 hours post dose calcium |
| 57648-8 | C peptide [Moles/volume] in Serum or Plasma --5 minutes pre XXX challenge |
| 48939-3 | Amphetamines [Mass/volume] in Specimen |
| 49090-4 | Fetal Trisomy 21 risk [Likelihood] Based on maternal age |
| 49233-0 | Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool by Rapid, less than 30 minutes |
| 39015-3 | Treponema pallidum Ab [Units/volume] in Body fluid by Hemagglutination |
| 39102-9 | Influenza virus A hemagglutinin cDNA [Identifier] in Specimen by NAA with probe detection |
| 578-5 | Fungus identified in Tissue by Culture |
| 49673-7 | Lymphocyte proliferation stimulated by 100 umol beryllium [Ratio] in Blood --7 day post incubation |
| 4970-0 | HLA-DR53 [Presence] in Donor |
| 39958-4 | Creatinine [Mass/volume] in Serum or Plasma --45 minutes pre XXX challenge |
| 4027-9 | Secobarbital [Presence] in Serum or Plasma |
| 58562-0 | Corticotropin [Moles/volume] in Plasma --2 PM specimen |
| 58897-0 | Methyl ethyl ketone/Creatinine [Mass Ratio] in Urine |
| 59226-1 | Chromogranin A [Units/volume] in Peritoneal fluid |
| 5043-5 | Adrenal Ab [Titer] in Serum by Immunofluorescence |
| 50580-0 | Maternal screen for fetal abnormalities such as Open Neural Tube Defects, Trisomy 21 or Trisomy 18 panel - Serum or Plasma |
| 29995-8 | Basement membrane IgA Ab [Presence] in Serum by Immunofluorescence |
| 30348-7 | Glutamate [Moles/volume] in Urine |
| 12884-3 | Borrelia burgdorferi 39kD Ab [Presence] in Body fluid by Immunoblot |
| 101547-8 | Hepatocyte Ag by paraffin 1 in Blood or Tissue Qualitative by Immune stain |
| 101570-0 | Spermatozoa Normal chromatin/100 spermatozoa in Semen |
| 13061-7 | Platelet IgM Ab [Units/volume] in Serum |
| 13602-8 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
| 13879-2 | Collagen type 2 IgG Ab [Units/volume] in Serum |
| 102465-2 | California Black Oak IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102601-2 | Red Snapper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103046-9 | Common ragweed native (nAmb a) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14414-7 | Aspartate aminotransferase [Enzymatic activity/volume] in Dialysis fluid |
| 10342-4 | Sulfamethoxazole [Mass/volume] in Serum or Plasma |
| 103660-7 | Entamoeba coli DNA [Presence] in Stool by NAA with probe detection |
| 104414-8 | Hepatitis E virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 1622-0 | Renin [Enzymatic activity/volume] in Plasma --5 hours post 600 ug furosemide PO |
| 16680-1 | Coxsackievirus A IgG Ab [Units/volume] in Serum |
| 16730-4 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 16779-1 | Dinitrophenol [Mass/volume] in Urine |
| 17224-7 | Lambda lymphocytes/100 lymphocytes in Blood |
| 17921-8 | Bacteria # 2 identified in Nose by Anaerobe culture |
| 18352-5 | Volume of 4 hour Urine |
| 18403-6 | Spermatozoa IgG Ab [Units/volume] in Semen |
| 91052-1 | Opiates [Presence] in Tissue by Screen method |
| 91803-7 | Neisseria meningitidis DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 93232-7 | Imipenem+Relebactam [Susceptibility] by Gradient strip |
| 93466-1 | Valerylfentanyl [Mass/volume] in Urine by Confirmatory method |
| 61234-1 | Broccoli IgE Ab/IgE total in Serum |
| 61364-6 | Echovirus+Coxsackievirus RNA [Presence] in Specimen by NAA with probe detection |
| 94339-9 | Myelopathy autoimmune Ab panel - Serum |
| 94562-6 | SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay |
| 79475-0 | 2,5-Furandicarboxylate [Moles/volume] in Serum or Plasma |
| 95577-3 | Pregnanetriolone [Z-score] in 24 hour Urine |
| 79526-0 | 3,5-Dihydroxybenzoate [Moles/volume] in Serum or Plasma |
| 79673-0 | Purine and Pyrimidine panel - Urine |
| 80363-5 | Chlamydia trachomatis DNA [Presence] in Anorectal by NAA with probe detection |
| 96047-6 | T cell crossmatch [Presence] in Patient serum and Donor blood by Flow cytometry (FC) |
| 674-2 | Microscopic observation [Identifier] in Specimen by Periodic acid-Schiff stain |
| 9673-5 | Salmonella sp IgG Ab [Units/volume] in Serum |
| 9691-7 | Cobalt [Mass/volume] in Specimen |
| 69894-4 | Service comment 67 |
| 81697-5 | Microsatellite instability marker BAT25 in Cancer specimen Qualitative |
| 81829-4 | SDHA gene full mutation analysis in Blood or Tissue by Sequencing |
| 8184-4 | Benzoylecgonine [Presence] in Gastric fluid by Confirmatory method |
| 81844-3 | IVD gene full mutation analysis in Blood or Tissue by Sequencing |
| 97614-2 | Clostridium perfringens [Presence] in Synovial fluid by NAA with non-probe detection |
| 97652-2 | Mold Allergen Mix 6 (Alternaria alternata+Cladosporium herbarum+Mucor racemosus+Penicillium notatum) IgG Ab [Mass/volume] in Serum by Multidisk |
| 98202-5 | Ginkgo IgE Ab [Units/volume] in Serum |
| 99075-4 | Alpha-1-Microglobulin/Creatinine [Mass Ratio] in 24 hour Urine |
| 72384-1 | Meperidine+Normeperidine [Presence] in Urine by Confirmatory method |
| 72473-2 | JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 73136-4 | sulfiSOXAZOLE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73168-7 | raNITIdine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86728-3 | Erysipelothrix tonsillarum DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 74132-2 | Aromatic solvents [Presence] in Blood |
| 89589-6 | Varicella zoster virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 41397-1 | Beta lactoglobulin IgE Ab [Units/volume] in Serum |
| 59568-6 | Orotate [Moles/time] in 24 hour Urine |
| 5084-9 | Chlamydia sp Ab [Titer] in Serum by Immunofluorescence |
| 21075-7 | Ascaris lumbricoides IgE Ab [Units/volume] in Serum |
| 21442-9 | Parainfluenza virus identified in Nose by Organism specific culture |
| 21487-4 | Ribosomal P Ab [Units/volume] in Cerebral spinal fluid |
| 31174-6 | Terbufos [Mass/volume] in Blood |
| 3120-3 | Valine [Mass/time] in 24 hour Urine |
| 31552-3 | Parainfluenza virus 3 Ab [Units/volume] in Body fluid |
| 43041-3 | Echovirus 9 Ab [Titer] in Body fluid |
| 43110-6 | Immunoglobulin light chains panel - 24 hour Urine |
| 31852-7 | Herpes simplex virus Ag [Presence] in Genital specimen |
| 31951-7 | Rift valley fever virus Ag [Presence] in Specimen |
| 5192-0 | Hepatitis B virus e Ag [Presence] in Serum by Radioimmunoassay (RIA) |
| 22992-2 | Chlamydophila psittaci [Presence] in Specimen by Giemsa stain |
| 32620-7 | Corynebacterium diphtheriae Ab [Presence] in Serum |
| 5319-9 | Rickettsia typhus group IgG Ab [Units/volume] in Serum by Immunoassay |
| 44459-6 | C peptide/Creatinine [Mass Ratio] in Urine --2nd specimen post XXX challenge |
| 23644-8 | Actinobacillus pleuropneumoniae serotype 1 Ab [Presence] in Serum by Immunoassay |
| 23917-8 | Osmotic fragility of Red Blood Cells--0.60% sodium chloride |
| 33940-8 | Herpes virus 6 DNA [Presence] in Tissue by NAA with probe detection |
| 54255-5 | Glucose [Moles/volume] in Serum or Plasma --6 minutes post dose glucagon |
| 4690-4 | Viscosity of Blood |
| 46971-8 | HYDROmorphone Free [Mass/volume] in Urine by Confirmatory method |
| 24339-4 | Gas panel - Venous blood |
| 34550-4 | Immunoglobulin panel [Mass/volume] - Serum |
| 34698-1 | CSTB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55467-5 | 11-Deoxycortisol [Moles/volume] in Serum or Plasma --baseline |
| 55533-4 | dilTIAZem [Moles/volume] in Serum or Plasma |
| 55534-2 | Doxylamine [Moles/volume] in Serum or Plasma |
| 34984-5 | Unidentified cells/100 leukocytes in Synovial fluid |
| 55663-9 | Clotrimazole [Susceptibility] by Gradient strip |
| 55764-5 | EGFR gene exon 19 deletion [Presence] in Blood or Tissue by Molecular genetics method |
| 55827-0 | Acid alpha glucosidase [Enzymatic activity/volume] in DBS |
| 47538-4 | 3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in Cerebral spinal fluid |
| 47549-1 | Adenosine deaminase [Enzymatic activity/mass] in Red Blood Cells |
| 47692-9 | Lysine/Amino acids.total in Amniotic fluid |
| 25888-9 | Cystathionine/Creatinine [Molar ratio] in 24 hour Urine |
| 35375-5 | DMPK gene allele 1 CTG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 35621-2 | Norclomipramine [Mass/volume] in Serum or Plasma by Screen method |
| 56459-1 | Oat smut IgG4 Ab [Mass/volume] in Serum |
| 262-6 | Fusidate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 26417-6 | Cladosporium herbarum IgG4 Ab [Units/volume] in Serum |
| 3591-5 | ePHEDrine [Mass/volume] in Serum or Plasma |
| 3803-4 | MethylePHEDrine [Presence] in Urine |
| 56782-6 | Amylase S4/Amylase.total in Serum or Plasma |
| 56789-1 | Insulin [Units/volume] in Serum or Plasma --32 hours post XXX challenge |
| 56960-8 | Segmented neutrophils/100 leukocytes in Bone marrow by Manual count |
| 48793-4 | Necroinflammatory activity grade |
| 26898-7 | Temazepam [Mass/volume] in Vitreous fluid |
| 27051-2 | PHENobarbital [Mass/volume] in Milk |
| 38303-4 | Epichlorohydrin [Mass/volume] in Water |
| 38431-3 | Ibuprofen [Mass/volume] in Serum or Plasma --1.5 hours post dose |
| 4902-3 | HLA-Dw26 [Presence] in Donor |
| 49114-2 | Flavivirus rRNA [Units/volume] (viral load) in Blood by NAA with probe detection |
| 27344-1 | Aspartate aminotransferase [Presence] in Serum or Plasma |
| 39596-2 | Blue mussel IgE Ab/IgE total in Serum |
| 49342-9 | BK virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
| 49437-7 | Pneumocystis jiroveci DNA [#/volume] in Tissue by NAA with probe detection |
| 28599-9 | Cystathionine/Creatinine [Ratio] in Urine |
| 2917-3 | Renin [Mass/volume] in Plasma --supine |
| 39963-4 | Creatinine [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
| 58587-7 | Corticotropin [Mass/volume] in Plasma --30 minutes pre 1 ug/kg CRH IV |
| 49839-4 | Eosinophils [Presence] in Urine sediment by Wright stain |
| 29596-4 | CD25 Ag [Presence] in Tissue by Immune stain |
| 40552-2 | CD117 Ag [Presence] in Tissue by Immune stain |
| 59059-6 | Inflammatory bowel disease Ab 7 panel - Serum |
| 59262-6 | Leukocyte esterase [Presence] in Cerebral spinal fluid by Test strip |
| 59307-9 | Metaxalone [Mass/volume] in Blood |
| 50195-7 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript [Log Number Ratio] in Blood or Tissue by Molecular genetics method |
| 12400-8 | Emetine [Mass/volume] in Urine |
| 101173-3 | Melatonin [Moles/volume] in Saliva (oral fluid) |
| 101193-1 | Sphincter excision plane [Anatomy] in Colorectal cancer specimen |
| 1017-3 | E Ab [Presence] in Serum or Plasma from Donor |
| 101858-9 | Triamcinolone acetonide [Moles/volume] in Urine |
| 102452-0 | Mouse serum proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14047-5 | Androstanolone Free [Mass/volume] in Serum or Plasma |
| 14216-6 | HTLV 1 gp46 Ab [Presence] in Serum |
| 102845-5 | Whitefish IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103032-9 | European Ash IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15500-2 | Pseudorabies virus Clinease gene deletion Ab [Presence] in Serum by Immunoassay |
| 10840-7 | Atropine [Mass/volume] in Urine |
| 10905-8 | La Crosse virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 16470-7 | Blastomyces dermatitidis Ab [Presence] in Serum by Complement fixation |
| 12240-8 | Orotidine [Moles/volume] in Urine |
| 17184-3 | CD66a cells/100 cells in Blood |
| 17520-8 | Respiratory syncytial virus identified in Specimen by Organism specific culture |
| 17932-5 | Bacteria # 5 identified in Blood by Aerobe culture |
| 90325-2 | Mycoplasma suis DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 74540-6 | Hexenoylcarnitine (C6:1) [Moles/volume] in Serum or Plasma |
| 75576-9 | Fetal 22q11.2 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
| 60579-0 | TCRG gene rearrangements [Presence] in Cerebral spinal fluid by Molecular genetics method |
| 76478-7 | Acetylcholinesterase panel - Amniotic fluid |
| 92986-9 | Chlamydophila pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 9331-0 | Boron [Mass/volume] in Urine |
| 61421-4 | Norhydrocodone [Presence] in Urine by Confirmatory method |
| 62301-7 | Lysosomal storage disorders newborn screen interpretation |
| 6263-8 | American Sycamore IgE Ab [Units/volume] in Serum |
| 78523-8 | Platelet aggregation EPINEPHrine induced in Platelet rich plasma --100 umol/L |
| 94366-2 | Streptococcus pyogenes DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 94487-6 | Galactosylceramidase [Enzymatic activity/mass] in Leukocytes by Confirmatory method |
| 94671-5 | Tetanus reaction wheal [Diameter] --2 day post tetanus toxoid intradermal |
| 63411-3 | Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Serum by Immunoassay |
| 6465-9 | Microscopic observation [Identifier] in Duodenal fluid by Trichrome stain |
| 64963-2 | Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum |
| 95193-9 | Interferon-gamma producing HLA-B35 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC) |
| 8012-7 | Rotavirus dsRNA [Presence] in Stool by NAA with probe detection |
| 96266-2 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with 1:1 normal plasma |
| 68436-5 | Appearance of Vitreous fluid |
| 80618-2 | Zika virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 80703-2 | CD27+CD45RA- cells/100 CD3+CD8+ cells in Blood |
| 96693-7 | Platelet-induced clot retraction.glass bead induced in Blood by Microviscometry --post heparin neutralization |
| 9677-6 | Silicone IgG Ab [Units/volume] in Serum |
| 96984-0 | Chromosome analysis in Products of Conception by Microarray |
| 69802-7 | Alpha ketoglutarate [Moles/volume] in Cerebral spinal fluid |
| 97292-7 | O-nortramadol [Presence] in Cord tissue by Screen method |
| 97536-7 | pH of Central venous blood |
| 97779-3 | Sodium [Moles/volume] in Dialysis fluid --1 hour specimen |
| 71885-8 | Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Mixed venous blood |
| 72376-7 | Hepatitis C virus Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 83081-0 | Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum by Immunoassay |
| 836-7 | Ax Ag [Presence] on Red Blood Cells from Blood product unit |
| 99909-4 | Atypical crystals [Presence] in Urine sediment by Computer assisted method |
| 86134-4 | Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum --2nd specimen |
| 86561-8 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Tissue by NAA with probe detection |
| 73061-4 | Amoxicillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73126-5 | Tazobactam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73310-5 | levETIRAcetam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87359-6 | Actinobacillus pleuropneumoniae serotypes 3+6+8 Ab/Positive control in Serum by Immunoassay |
| 88272-0 | Staphylococcus sp tuf gene [Presence] by Probe in Positive blood culture |
| 73947-4 | JWH-398 (synthetic cannabinoid) [Presence] in Blood |
| 88730-7 | Ganglioside GD1b IgG+IgM Ab [Units/volume] in Serum by Immunoassay |
| 89308-1 | Morphine-6-Glucuronide [Presence] in Urine by Screen method |
| 41710-5 | Ramoplanin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 50842-4 | Chromium [Moles/mass] in Hair |
| 21184-7 | Chlamydophila pneumoniae [Presence] in Specimen by Organism specific culture |
| 21303-3 | Giardia lamblia Ag [Presence] in Stool by Immunoassay --3rd specimen |
| 31367-6 | Enterovirus NOS Ab [Units/volume] in Serum |
| 42951-4 | Taylorella equigenitalis Ab [Titer] in Serum |
| 21814-9 | t(21;22)(q22.3;q12.2)(ERG,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 22112-7 | Blastomyces dermatitidis Ab [Titer] in Serum |
| 31692-7 | Trypanosoma equiperdum Ab [Units/volume] in Serum |
| 31716-4 | African swine fever virus Ag [Presence] in Specimen |
| 4329-9 | Methylphenidate [Mass] of Dose |
| 43619-6 | Actinomyces sp Ab [Presence] in Serum |
| 22378-4 | Lassa virus IgG Ab [Titer] in Serum |
| 2248-3 | Estriol (E3) [Mass/volume] in Amniotic fluid |
| 32061-4 | chlorproMAZINE [Presence] in Specimen |
| 32187-7 | Microscopic observation [Identifier] in Skin by Tzanck smear |
| 4419-8 | quiNIDine [Mass] of Dose |
| 22864-3 | Bacillus anthracis Ab [Presence] in Serum by Complement fixation |
| 53343-0 | Androstenedione [Mass/volume] in DBS |
| 53399-2 | Citrulline/Tyrosine [Molar ratio] in DBS |
| 44680-7 | Margin(s) involved by melanoma in situ |
| 33380-7 | Coccidioides sp Ab [Titer] in Serum by Complement fixation |
| 53844-7 | BRAF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 53964-3 | Leukocytes [Presence] in Urine by Visual |
| 24298-2 | Respiratory syncytial virus Ab [Titer] in Serum --1st specimen |
| 55189-5 | Cefotaxime [Susceptibility] for meningitis by Disk diffusion (KB) |
| 55304-0 | Fungus [Presence] in Sputum by KOH preparation |
| 47288-6 | CBC WO Differential panel - Cord blood |
| 2511-4 | Keratan sulfate [Mass/volume] in Blood |
| 2536-1 | Lactate dehydrogenase 1/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis |
| 55710-8 | Pyrazinamide [Susceptibility] by Gradient strip |
| 25868-1 | Beta alanine [Moles/volume] in 24 hour Urine |
| 35753-3 | Mitochondrial myopathy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 47970-9 | SGCB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 26411-9 | Wheat Bran IgG4 Ab [Units/volume] in Serum |
| 26642-9 | Jamestown canyon virus Ab [Presence] in Serum |
| 26726-0 | Proline [Moles/volume] in Urine |
| 26736-9 | Promethazine [Presence] in Serum or Plasma |
| 26767-4 | Clostridium perfringens IgG Ab [Units/volume] in Serum |
| 3692-1 | Imipramine [Mass/volume] in Urine |
| 56709-9 | Tartrazine IgE Ab [Units/volume] in Serum |
| 56905-3 | Bilirubin.direct [Mass/volume] in Pleural fluid |
| 48378-4 | Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Serum |
| 49071-4 | Urea nitrogen [Mass ratio] in Serum or Plasma--post dialysis/pre dialysis |
| 57704-9 | Galactosemias newborn screening comment-discussion |
| 57752-8 | Urea [Mass/volume] in Peritoneal dialysis fluid --overnight |
| 57918-5 | CACNA1S+SCN4A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 29335-7 | Mexiletine [Mass/volume] in Urine |
| 29506-3 | 2-Oxoadipate/Creatinine [Molar ratio] in Urine |
| 4029-5 | Secobarbital [Presence] in Urine |
| 50018-1 | Cytomegalovirus IgG Ab [Presence] in Body fluid |
| 50156-9 | Acetylcarnitine (C2) [Moles/volume] in Amniotic fluid |
| 2971-0 | Substance P [Mass/volume] in Serum or Plasma |
| 40622-3 | Carcinoembryonic Ag [Mass/volume] in Peritoneal fluid |
| 30040-0 | Dirofilaria immitis Ab [Units/volume] in Serum |
| 30098-8 | Neisseria meningitidis serogroup Y Ag [Presence] in Specimen by Latex agglutination |
| 30164-8 | Nut Allergen Mix (Cashew+Pecan or Hickory nut+English walnut) IgE Ab [Presence] in Serum by Multidisk |
| 30190-3 | 3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in Serum or Plasma |
| 40944-1 | Yohimbine [Mass/volume] in Serum or Plasma |
| 40977-1 | Adenovirus IgG Ab [Presence] in Serum by Immunoassay |
| 41068-8 | PRF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 205-5 | Colistin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 20824-9 | Freezing point of Milk |
| 100432-4 | Cells.LRBA+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) |
| 13227-4 | Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum |
| 13245-6 | Filaria IgM Ab [Units/volume] in Serum |
| 101905-8 | Follitropin and lutropin post leuprolide stimulation panel - Serum |
| 10234-3 | Oxygen content in Right atrium |
| 102377-9 | Whitefaced Hornet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14791-8 | Imipramine+Desipramine [Presence] in Gastric fluid |
| 14945-0 | Uroporphyrin 3 isomer [Moles/volume] in Urine |
| 15037-5 | Chymotrypsin [Moles/mass] in Stool |
| 15174-6 | Cryocrit of Serum by Spun Westergren |
| 15215-7 | Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab [Presence] in Serum by Multidisk |
| 104335-5 | Bordetella pertussis.pertussis toxin IgG Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 15504-4 | Salmonella arizonae Ab [Presence] in Serum by Agglutination |
| 158-6 | Cephaloridine [Susceptibility] by Disk diffusion (KB) |
| 10741-7 | Amyloid.microscopic observation [Identifier] in Brain by Thioflavine-S stain |
| 10992-6 | Norclozapine [Mass/volume] in Serum or Plasma |
| 16520-9 | Calcium [Moles/volume] in Urine --2nd specimen post XXX challenge |
| 11168-2 | Arizona Cypress IgE Ab [Units/volume] in Serum |
| 169-3 | Cephradine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 17350-0 | Neutrophil IgM Ab [Units/volume] in Serum |
| 17681-8 | Tellurium [Presence] in Urine |
| 18428-3 | Epstein Barr virus nuclear IgG Ab [Presence] in Cerebral spinal fluid |
| 19126-2 | Bacteria identified in Bone marrow by Aerobe culture |
| 90256-9 | CFTR gene full mutation analysis in Blood or Tissue by Sequencing |
| 74589-3 | Succinate dehydrogenase/Citrate synthase [Enzymatic activity ratio] in Tissue |
| 91895-3 | Bacterial strain [Type] in Isolate by Sequencing |
| 92748-3 | Lyso-sphingomyelin [Moles/volume] in Blood |
| 7597-8 | White Pepper IgG Ab [Units/volume] in Serum |
| 92977-8 | Influenza virus A RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 93498-4 | Metabotropic glutamate receptor 1 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 93775-5 | 2-Octenoate/Creatinine [Molar ratio] in Urine |
| 93842-3 | HOGA1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 6257-0 | Strawberry IgE Ab [Units/volume] in Serum |
| 6262-0 | Swine epithelium IgE Ab [Units/volume] in Serum |
| 63231-5 | DNA double strand IgG Ab [Units/volume] in Pleural fluid by Immunoassay |
| 77954-6 | Yellow fever virus IgG Ab [Presence] in Serum by Immunofluorescence |
| 779-9 | Poikilocytosis [Presence] in Blood by Light microscopy |
| 7801-4 | Phospholipid IgG Ab [Units/volume] in Serum |
| 78686-3 | Platelet aggregation ristocetin induced [Units/volume] in Blood --High dose |
| 94584-0 | Varicella zoster virus DNA [Presence] in Specimen by NAA with non-probe detection |
| 63415-4 | Pompe disease newborn screen interpretation |
| 79323-2 | 7-Isobiopterin/Creatinine [Molar ratio] in Urine |
| 95122-8 | Coagulation factor VIII inhibitor [Interpretation] in Platelet poor plasma by Chromogenic method |
| 95585-6 | 11-Hydroxyetiocholanolone [Z-score] in 24 hour Urine |
| 66882-2 | Skin IgG Ab [Presence] in Serum by Guinea pig esophagus substrate |
| 68432-4 | Leukocytes other/100 leukocytes in Vitreous fluid by Manual count |
| 80593-7 | Parainfluenza virus 2 L gene [Presence] in Nasopharynx by NAA with probe detection |
| 81155-4 | Islet cell 512 Ab [Moles/volume] in Serum |
| 96509-5 | Tick-borne encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay |
| 81703-1 | Microsatellite instability marker D5S346 in Cancer specimen Qualitative |
| 8196-8 | Cocaine [Presence] in Unknown substance by Confirmatory method |
| 97529-2 | Naegleria fowleri [Presence] in Specimen by Organism specific culture |
| 97741-3 | Estradiol (E2) [Moles/volume] in Aspirate |
| 98197-7 | EPINEPHrine IgE Ab [Units/volume] in Serum |
| 72265-2 | Influenza virus B IgA Ab [Units/volume] in Serum by Immunoassay |
| 83112-3 | Prostate specific Ag [Mass/volume] in Serum or Plasma by Immunoassay |
| 99119-0 | Sandfly fever Naples virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 72610-9 | diazePAM [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 72856-8 | Cidofovir [Susceptibility] by Genotype method |
| 73250-3 | Nafcillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87784-5 | Naproxen/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 88055-9 | Liver fibrosis score in Serum or Plasma by Calculated by ELF |
| 74421-9 | Mumps virus IgM Ab [Units/volume] in Body fluid by Immunoassay |
| 88592-1 | Influenza virus B RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 50659-2 | Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative |
| 59916-7 | Isopropanol [Moles/volume] in Gastric fluid |
| 60170-8 | Silicon [Mass/volume] in Body fluid |
| 6029-3 | Aureobasidium pullulans IgE Ab [Units/volume] in Serum |
| 21312-4 | Gold [Mass/volume] in Body fluid |
| 21457-7 | Phorate [Mass/volume] in Urine |
| 31264-5 | Bluetongue virus 2 Ab [Units/volume] in Serum |
| 51346-5 | CD56+CD57+ cells/100 cells in Cerebral spinal fluid |
| 43001-7 | Legionella sp Ab [Titer] in Cerebral spinal fluid |
| 43039-7 | Ehrlichia sp Ab [Titer] in Serum |
| 21692-9 | PRSS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 22239-8 | Cytomegalovirus Ab [Presence] in Serum or Plasma |
| 22283-6 | Ehrlichia chaffeensis IgG Ab [Presence] in Serum |
| 43694-9 | Inner ear 68kD Ab [Presence] in Body fluid |
| 52115-3 | D Ab [Presence] in Serum or Plasma by Antihuman globulin |
| 52123-7 | aPTT in Platelet poor plasma by Coagulation assay --post heparin neutralization |
| 3294-6 | Acebutolol [Mass/volume] in Urine |
| 33027-4 | Herpes simplex virus+Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection |
| 5330-6 | Rubella virus Ab [Units/volume] in Serum by Hemagglutination inhibition |
| 53314-1 | Tyrosine crystals [#/area] in Urine by Computer assisted method |
| 44851-4 | Mycobacterium sp # 2 identified in Specimen by Organism specific culture |
| 23458-3 | Taylorella equigenitalis DNA [Presence] in Genital specimen by NAA with probe detection |
| 53604-5 | Brucella sp DNA [Identifier] in Serum by NAA with probe detection |
| 44983-5 | Chlamydia trachomatis L2 IgM Ab [Presence] in Serum |
| 45222-7 | Methylmalonylcarnitine (C4-DC) [Moles/volume] in DBS |
| 24029-1 | Toxocara canis IgG Ab [Presence] in Serum |
| 24042-4 | Ehrlichia chaffeensis DNA [Presence] in Specimen by NAA with probe detection |
| 54261-3 | Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose insulin IV |
| 46238-2 | Kappa lymphocytes/100 lymphocytes in Body fluid |
| 46252-3 | Acylcarnitine pattern [Interpretation] in Serum or Plasma |
| 46428-9 | Xylose [Mass/volume] in Serum or Plasma --15 minutes post 25 g xylose PO |
| 25145-4 | Bacteria [Presence] in Urine sediment by Light microscopy |
| 25479-7 | Saccharopolyspora rectivirgula IgG Ab [Units/volume] in Serum |
| 56013-6 | Platelet aggregation arachidonate induced ATP secretion in Blood --500 umol/L |
| 47667-1 | Insulin [Units/volume] in Serum or Plasma --6 minutes post dose glucagon |
| 47972-5 | TGFBR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 48003-8 | DNA sequence variation identifier [Identifier] |
| 26565-2 | CD19+Kappa+ cells/100 cells in Specimen |
| 5692-9 | Methanol [Presence] in Serum or Plasma |
| 48389-1 | Macroprolactin/Prolactin [Moles] in Serum or Plasma |
| 48714-0 | Leishmania tropica IgM Ab [Units/volume] in Serum by Immunofluorescence |
| 26959-7 | Amphetamine [Mass/mass] in Meconium |
| 38246-5 | Brucella canis IgM Ab [Presence] in Serum |
| 28060-2 | MTHFR gene c.1298A>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 57708-0 | Organic acidemias defects newborn screening comment-discussion |
| 57797-3 | Glucose [Mass/volume] in Stool by Post hydrolysis |
| 57851-8 | Microscopic observation [Identifier] in Urethra by Wet preparation |
| 49593-7 | Trichothecene IgA Ab [Units/volume] in Serum by Immunoassay |
| 49692-7 | Striated muscle IgG Ab [Presence] in Serum by Immunofluorescence |
| 49748-7 | Lipoprotein.alpha [Moles/volume] in Serum or Plasma |
| 29225-0 | Primidone [Mass/volume] in Body fluid |
| 39803-2 | inFLIXimab [Mass/volume] in Serum or Plasma |
| 40242-0 | Calcium [Moles/volume] in Serum or Plasma --16 hours post XXX challenge |
| 58557-0 | Corticotropin [Moles/volume] in Plasma --1 hour post dose glucose |
| 58639-6 | Cortisol [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 5867-7 | Influenza virus B Ag [Presence] in Specimen by Immunofluorescence |
| 49931-9 | 3-Hydroxysebacate (3-OH-C8) unsaturated/Creatinine [Molar ratio] in Urine |
| 40411-1 | Amitriptyline [Presence] in Gastric fluid |
| 40702-3 | Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination |
| 59058-8 | Cow whey IgG Ab [Mass/volume] in Serum |
| 5906-3 | Neutrophils [#/volume] in Synovial fluid by Automated count |
| 30058-2 | Serine/Creatinine [Ratio] in Urine |
| 41173-6 | Xylose [Mass/volume] in Serum or Plasma --2 hours post dose xylose PO |
| 20382-8 | Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria |
| 100842-4 | Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST |
| 12495-8 | Barbital [Presence] in Stool |
| 13608-5 | Insulin [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO |
| 102491-8 | Parrot droppings IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102681-4 | Asparagus IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14618-3 | Appearance of Stone |
| 103641-7 | Herpes virus 6A DNA [#/volume] (viral load) in Serum or Plasma by NAA with non-probe detection |
| 15342-9 | European Hornet IgE Ab [Units/volume] in Serum |
| 11113-8 | Myeloblasts/100 cells in Bone marrow by Manual count |
| 16432-7 | Barium [Mass/volume] in Blood |
| 16618-1 | Cladosporium herbarum Ab [Units/volume] in Serum |
| 16632-2 | Cocaethylene [Mass/volume] in Urine by Confirmatory method |
| 11201-1 | Succinylcholine IgE Ab [Units/volume] in Serum |
| 11269-8 | Streptococcus pyogenes Ag [Presence] in Serum by Agglutination |
| 17032-4 | Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
| 90927-5 | RET gene rearrangements in Blood or Tissue by FISH |
| 91860-7 | Chlamydia trachomatis Ag [Presence] in Genital specimen by Immunofluorescence |
| 61152-5 | Albumin [Mass/volume] in Serum or Plasma by Bromocresol purple (BCP) dye binding method |
| 76611-3 | Klebsiella pneumoniae phoE gene [#/volume] in XXX.body fluid by NAA with probe detection |
| 92804-4 | Rhodotorula spp DNA [Presence] by NAA with probe detection in Positive blood culture |
| 777-3 | Platelets [#/volume] in Blood by Automated count |
| 93774-8 | Trans-cinnamoylglycine/Creatinine [Molar ratio] in Urine |
| 94207-8 | MMADHC gene full mutation analysis in Blood or Tissue by Sequencing |
| 9424-3 | Intercellular substance Ab [Titer] in Serum |
| 63076-4 | Cat dander IgG Ab [Mass/volume] in Serum |
| 63117-6 | Safflower IgG Ab [Mass/volume] in Serum |
| 7788-3 | Yogurt IgG Ab [Units/volume] in Serum |
| 9463-1 | Arsenic [Mass/volume] in Water |
| 79331-5 | Trimethyllysine/Creatinine [Molar ratio] in Urine |
| 95686-2 | Sindbis virus IgM Ab [Presence] in Specimen by Immunoassay |
| 66451-6 | Shrimp native (nPen i) 11 IgE Ab [Units/volume] in Serum |
| 96113-6 | Rifabutin [Susceptibility] by Genotype method |
| 68933-1 | IgA.secretory [Mass/volume] in Sweat |
| 6923-7 | Adrenal cortex Ab [Units/volume] in Serum by Immunofluorescence |
| 82209-8 | Adenovirus 40+41 DNA [Presence] in Stool by NAA with non-probe detection |
| 7139-9 | Bean string IgG Ab [Units/volume] in Serum |
| 828-4 | Am Ag [Presence] on Red Blood Cells from Donor |
| 98983-0 | Methocarbamol [Mass/volume] in Urine by Confirmatory method |
| 71782-7 | Yellow fever virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 7191-0 | Cauliflower triggered histamine release [Units/volume] in Blood |
| 72468-2 | RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 85313-5 | Extent of lateral margin carcinoma involvement in Breast cancer specimen Qualitative by Light microscopy |
| 86139-3 | Streptococcus pneumoniae Danish serotype 6A Ab [Units/volume] in Serum --2nd specimen |
| 73208-1 | PHENobarbital induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73218-0 | Pantoprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86715-0 | Actinobacillus pleuropneumoniae Ab [Titer] in Serum by Complement fixation |
| 87546-8 | Dengue virus IgG and IgM panel - Serum Qualitative |
| 87597-1 | Lincomycin [Mass/mass] in Specimen |
| 87669-8 | Chlorinated hydrocarbon panel - Specimen |
| 73549-8 | Acebutolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87941-1 | Bacteria identified in Placenta by Anaerobe culture |
| 41630-5 | Clostridium botulinum toxin A [Presence] in Specimen by Immunofluorescence |
| 5938-6 | Benzoylecgonine [Presence] in Hair |
| 59655-1 | diazePAM [Mass/volume] in Blood by Confirmatory method |
| 59896-1 | Dextromethorphan [Moles/volume] in Gastric fluid |
| 42202-2 | GALOP IgM Ab [Titer] in Serum or Plasma |
| 21191-2 | Chlamydia trachomatis DNA [Presence] in Urethra by NAA with probe detection |
| 3124-5 | Vanillylmandelate/Creatinine [Mass Ratio] in Urine |
| 31374-2 | Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum |
| 31465-8 | Legionella pneumophila 6 Ab [Units/volume] in Serum |
| 31588-7 | Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum |
| 51104-8 | CD19 blasts [Units/volume] in Blood |
| 42722-9 | OmpC Ab [Presence] in Serum |
| 21715-8 | MXI1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 22176-2 | Chlamydophila psittaci Ab [Titer] in Serum |
| 31794-1 | Cryptosporidium sp Ag [Presence] in Specimen |
| 32005-1 | Chlamydia trachomatis B Ab [Titer] in Serum |
| 51739-1 | Codeine Free [Mass/volume] in Urine |
| 22380-0 | Lassa virus IgM Ab [Titer] in Serum |
| 22517-7 | Salmonella paratyphi A H Ab [Presence] in Serum |
| 32536-5 | CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Bone marrow |
| 51971-0 | Gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
| 534-8 | Mycobacterium sp identified in Cerebral spinal fluid by Organism specific culture |
| 33554-7 | Platelet aggregation ristocetin induced in Platelet rich plasma --300 ug/mL |
| 53560-9 | Herpes simplex virus IgM Ab [Units/volume] in Serum by Immunoassay |
| 53608-6 | Rickettsia sp DNA [Presence] in Blood by NAA with probe detection |
| 53639-1 | CD52 Ag [Presence] in Tissue by Immune stain |
| 23654-7 | Aflatoxin [Mass/mass] in Feed |
| 23687-7 | Canine coronavirus Ab [Presence] in Serum by Immunofluorescence |
| 23695-0 | Canine distemper virus Ag [Presence] in Tissue by Immunofluorescence |
| 54099-7 | 1,2,2-Trimethylpropyl methylphosphonate [Mass/volume] in Urine |
| 54172-2 | Imipenem+EDTA [Susceptibility] by Disk diffusion (KB) |
| 54301-7 | Homocysteine [Moles/volume] in DBS |
| 24327-9 | Electrolytes 3 panel - Body fluid |
| 24347-7 | Parathyrin.mid molecule and Calcium panel - Serum or Plasma |
| 24356-8 | Urinalysis complete panel - Urine |
| 34410-1 | Saccharopolyspora rectivirgula IgG Ab [Presence] in Serum by Immune diffusion (ID) |
| 34465-5 | B Ab [Titer] in Serum or Plasma by Immediate spin |
| 34625-4 | Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum |
| 55153-1 | Biotinidase panel - Serum or Plasma |
| 25168-6 | Perhexiline [Mass/volume] in Serum or Plasma |
| 34949-8 | Measles virus IgG and IgM panel - Cerebral spinal fluid |
| 35123-9 | Chromosome 14 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics |
| 5630-9 | Copper [Mass/volume] in Red Blood Cells |
| 26782-3 | Glucose [Mass/volume] in Serum or Plasma --4 hours post dose lactose PO |
| 3668-1 | Glutethimide [Mass/volume] in Urine |
| 37988-3 | Regional Allergy Mix 5 (Aspergillus fumigatus+Cockroach+Cat dander+European house dust mite) IgE Ab [Units/volume] in Serum by Multidisk |
| 48495-6 | Transferrin.carbohydrate deficient/Transferrin.total in Serum or Plasma |
| 27254-2 | Amino beta guanidinopropionate/Creatinine [Molar ratio] in Urine |
| 38301-8 | Endothall [Mass/volume] in Water |
| 57487-1 | 11-Ketoetiocholanolone [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
| 48900-5 | Orientia tsutsugamushi Kato IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 38923-9 | SDHC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 40108-3 | aPTT in Platelet poor plasma by Coagulation assay --8 hours post XXX challenge |
| 4012-1 | Pyrovalerone [Mass/volume] in Urine |
| 40141-4 | Creatinine [Moles/volume] in Urine --4 hours post XXX challenge |
| 58493-8 | Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay |
| 58756-8 | Parvovirus B19 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 49848-5 | Herpes simplex virus 1+2 IgG Ab [Presence] in Serum by Immunoblot |
| 40359-2 | Dextromethorphan [Presence] in Specimen |
| 40470-7 | Lymphocytes [#/area] in Semen by Microscopy high power field |
| 59016-6 | Water [Mass/mass] in Stool by Infrared spectroscopy |
| 59070-3 | Paraquat [Presence] in Serum or Plasma |
| 30366-9 | Metamyelocytes/100 leukocytes in Cerebral spinal fluid |
| 19306-0 | Thiazides [Presence] in Urine by Confirmatory method |
| 19312-8 | Tricyclic antidepressants [Presence] in Urine by Screen method |
| 19355-7 | Barbital cutoff [Mass/volume] in Urine for Screen method |
| 19714-5 | Triazolam [Presence] in Urine by Screen method |
| 20436-2 | Glucose [Mass/volume] in Serum or Plasma --2 hours post dose glucose |
| 20756-3 | Chlamydia sp Ag [Presence] in Stool by Immunoassay |
| 100750-9 | Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection |
| 101125-3 | Bacterial carbapenem resistance blaOXA-235-like gene [Presence] by Molecular method |
| 101252-5 | Urea [Mass/volume] in Dialysis fluid |
| 101385-3 | NF1 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 101813-4 | 2,6-dimethylaniline [Mass/volume] in Urine by Confirmatory method |
| 102196-3 | Bumble Bee IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13461-9 | Monoacetyldapsone/Dapsone [Mass Ratio] in Serum or Plasma |
| 13625-9 | Methoxsalen [Mass/volume] in Serum or Plasma |
| 14050-9 | Epidermal growth factor receptor [Moles/mass] in Tissue |
| 14192-9 | Triazolam [Presence] in Urine |
| 14790-0 | Helminth identified in Specimen by Permanent mount |
| 10915-7 | Phencyclidine [Mass/volume] in Specimen |
| 16408-7 | Ascorbate [Mass/volume] in Urine |
| 16660-3 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --20 minutes post XXX challenge |
| 11552-7 | Microscopic exam [Interpretation] of Tissue fine needle aspirate by Cytology |
| 17418-5 | Parakeet serum Ab [Units/volume] in Serum |
| 17453-2 | Phosphatidylglycerol IgM Ab [Presence] in Serum |
| 17907-7 | Bacteria # 5 identified in Tissue by Aerobe culture |
| 74730-3 | Oligosaccharides pattern [Interpretation] in 24 hour Urine Narrative |
| 60365-4 | Cherry IgG Ab [Mass/volume] in Serum |
| 60414-0 | Zucchini IgG Ab [Mass/volume] in Serum |
| 6075-6 | Cladosporium herbarum IgE Ab [Units/volume] in Serum |
| 93327-5 | Taurocholate [Moles/volume] in Serum or Plasma |
| 61371-1 | Vibrio cholerae DNA [Presence] in Specimen by NAA with probe detection |
| 6227-3 | Red Pepper IgE Ab [Units/volume] in Serum |
| 93841-5 | Epstein Barr virus DNA [log units/volume] (viral load) in Blood by NAA with probe detection |
| 93949-6 | ABO and Rh group panel - Cord blood |
| 78017-1 | HLA-DQB1 [Type] by Low resolution |
| 78794-5 | ARIPiprazole [Mass/volume] in Blood |
| 94715-0 | Gamma globulin [Mass/time] in 24 hour Urine by Electrophoresis |
| 63371-9 | Ketones [Presence] in Urine by Test strip --1 hour post dose glucose |
| 6471-7 | Microscopic observation [Identifier] in Tissue by Other stain |
| 95428-9 | SARS-CoV-2 (COVID-19) IgM Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 95676-3 | Venezuelan equine encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay |
| 79633-4 | L-leucyl-L-proline [Moles/volume] in Serum or Plasma |
| 80348-6 | Escherichia coli enteropathogenic eae gene [Presence] in Stool by NAA with non-probe detection |
| 80648-9 | N-monodesmethyl bedaquiline [Mass/volume] in Serum or Plasma |
| 82554-7 | Food Allergen Mix 6 (Buckwheat+Rice+Sesame seed+Wheat+Corn) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 82599-2 | Chum salmon roe IgE Ab [Units/volume] in Serum |
| 98037-5 | Jewish descent preconception AndOr prenatal carrier screening multigene analysis in Blood or Tissue by Molecular genetics method |
| 71884-1 | Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Venous blood |
| 85497-6 | clozapine N-oxide [Mass/volume] in Serum or Plasma |
| 85542-9 | PRRSV Ingelvac ATP strain ORF5 gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 99923-5 | Schistosoma haematobium [#/volume] in Urine sediment by Computer assisted method |
| 72557-2 | Rilpivirine [Susceptibility] by Phenotype method |
| 72847-7 | Hepatitis B virus codon 191 [Identifier] by Genotype method |
| 85957-9 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum by Immunoassay |
| 73673-6 | Yersinia enterocolitica serotype [Type] in Isolate by Agglutination |
| 73834-4 | Bacteria.carbapenem resistant identified in Anal by Organism specific culture |
| 87951-0 | Escherichia coli eaeA gene [Presence] in Stool by NAA with probe detection |
| 88540-0 | Enterovirus RNA [Presence] in Aspirate by NAA with probe detection |
| 88545-9 | Cytomegalovirus DNA [#/volume] (viral load) in DBS by NAA with probe detection |
| 73934-2 | Meperidine [Mass/volume] in Serum, Plasma or Blood |
| 74034-0 | MAML2 11q21 gene rearrangements in Tissue by FISH |
| 88869-3 | Veterinary toxicology panel [Presence] - Specimen |
| 4145-9 | Brompheniramine [Mass] of Dose |
| 42669-2 | Fatty acids [Presence] in Pleural fluid |
| 21236-5 | Cyclohexanone [Mass/volume] in Urine |
| 21323-1 | Hantavirus puumala IgM Ab [Titer] in Serum by Immunofluorescence |
| 31325-4 | Coxsackievirus B2 Ab [Units/volume] in Cerebral spinal fluid |
| 51235-0 | CD13 cells/100 cells in Tissue |
| 42962-1 | Salmonella paratyphi C O Ab [Titer] in Serum |
| 43017-3 | Histoplasma capsulatum mycelial phase Ab [Titer] in Body fluid |
| 31615-8 | Ross River virus IgM Ab [Presence] in Serum |
| 31629-9 | Smooth muscle Ab [Units/volume] in Serum |
| 31798-2 | Dengue virus Ag [Presence] in Serum |
| 43295-5 | HTLV I+II p53 Ab [Presence] in Serum |
| 43298-9 | HTLV I+II rgp21 Ab [Presence] in Serum |
| 43327-6 | Classical swine fever virus Ag [Presence] in Specimen by Immune stain |
| 43732-7 | 4-Hydroxybenzoate [Presence] in Urine |
| 23396-5 | Rift valley fever virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 53546-8 | Dodeicosanoylcarnitine (C22) [Moles/volume] in Serum or Plasma |
| 53717-5 | PCA-1 Ab [Titer] in Serum |
| 45319-1 | Uroporphyrin/Creatinine [Molar ratio] in Urine |
| 23678-6 | Bovine parainfluenza virus 3 Ag [Presence] in Tissue by Immunofluorescence |
| 2372-1 | Glutamine [Mass/volume] in Serum or Plasma |
| 23893-1 | Malaoxon [Mass/volume] in Blood |
| 24013-5 | HIV 1 RNA [Interpretation] in Serum |
| 33802-0 | Immature eosinophils [#/volume] in Blood by Manual count |
| 34712-0 | Clostridioides difficile [Presence] in Stool |
| 55339-6 | Sd sup(a) Ab [Titer] in Serum or Plasma |
| 55502-9 | Prolactin [Mass/volume] in Serum or Plasma --20 minutes post dose TRH IV |
| 55564-9 | Pentazocine [Moles/volume] in Serum or Plasma |
| 25147-0 | Calcium carbonate crystals [#/area] in Urine sediment by Microscopy high power field |
| 35308-6 | Trypsin [Enzymatic activity/volume] in Body fluid --5th specimen post Sincalide |
| 25800-4 | Tobramycin [Susceptibility] by Method for Slow-growing mycobacteria |
| 25897-0 | Delta aminolevulinate/Creatinine [Molar ratio] in 24 hour Urine |
| 35392-0 | Hantavirus IgG Ab [Units/volume] in Serum |
| 35428-2 | Herpes simplex virus identified in Synovial fluid by Organism specific culture |
| 56378-3 | Rhubarb IgG4 Ab [Mass/volume] in Serum |
| 48230-7 | Cat dander triggered leukotriene release [Mass/volume] by Leukocytes |
| 4830-6 | HLA-B40 [Presence] in Donor |
| 26047-1 | Phytate [Moles/volume] in Serum or Plasma |
| 26430-9 | Timothy IgG4 Ab [Units/volume] in Serum |
| 26734-4 | Methamphetamine [Mass/mass] in Stool |
| 35803-6 | Bambermycins [Susceptibility] by Disk diffusion (KB) |
| 5687-9 | Mercury [Mass/volume] in Serum or Plasma |
| 48392-5 | Coccidioides immitis Ab [Titer] in Body fluid by Complement fixation |
| 26831-8 | Suberate [Presence] in Urine |
| 27101-5 | Phenmetrazine [Mass/volume] in Milk |
| 27149-4 | Thiamine [Presence] in Blood |
| 38288-7 | 1,2-Dibromo-3-Chloropropane [Mass/volume] in Water |
| 3850-5 | Netilmicin [Mass/volume] in Serum or Plasma --trough |
| 38570-8 | Azinphos-methyl [Mass/volume] in Air |
| 57546-4 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --pre dose dexamethasone |
| 48942-7 | Cannabinoids [Mass/volume] in Specimen |
| 48991-4 | Glucose [Mass/volume] in Serum or Plasma --10 PM specimen |
| 2774-8 | Phosphate [Mass/volume] in Blood |
| 57765-0 | Disaccharidases panel - Small intestine Tissue |
| 58005-0 | Methylnortestosterone [Presence] in Urine |
| 49719-8 | Kentucky blue grass IgG Ab [Mass/volume] in Serum |
| 2964-5 | Specific gravity of Body fluid |
| 29818-2 | Powassan virus IgM Ab [Presence] in Serum by Immunofluorescence |
| 40599-3 | Albumin [Mass/volume] in Peritoneal dialysis fluid |
| 58973-9 | Ganglioside GM2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 58979-6 | Ganglioside GD3 IgG Ab [Units/volume] in Serum by Immunoassay |
| 59148-7 | Calcium [Moles/volume] in Serum or Plasma --post dialysis |
| 5057-5 | Blastomyces dermatitidis Ab [Titer] in Serum by Complement fixation |
| 30364-4 | Lymphocytes [#/volume] in Blood by Flow cytometry (FC) |
| 19655-0 | PENTobarbital [Presence] in Urine by Screen method |
| 19679-0 | Prazepam [Presence] in Urine by Confirmatory method |
| 203-0 | Colistimethate [Susceptibility] by Serum bactericidal titer |
| 100347-4 | Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG |
| 100375-5 | Anise IgG Ab [Units/volume] in Serum |
| 100419-1 | Snow pea IgG Ab [Units/volume] in Serum |
| 100904-2 | Urinary tract pathogens panel - Urine by Culture |
| 12750-6 | Insulin [Mass/volume] in Serum or Plasma --7 hours post XXX challenge |
| 12888-4 | Borrelia burgdorferi 25kD Ab [Presence] in Body fluid by Immunoblot |
| 12898-3 | Chloride [Moles/volume] in Vitreous fluid |
| 12909-8 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 101254-1 | Herpes virus 6 DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 101383-8 | FUS gene rearrangements in Blood or Tissue by FISH |
| 1391-2 | Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 102301-9 | Dog Fennel IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102630-1 | Tobacco IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102638-4 | Trout IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14132-5 | Color of Gastric fluid |
| 14187-9 | OKT3 [Mass/volume] in Serum or Plasma |
| 103029-5 | White mulberry IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103073-3 | Peanut recombinant (rAra h) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1450-6 | Cortisol [Mass/volume] in Serum or Plasma --pre 2 mg dexamethasone PO 2.5 day high dose q6h |
| 14643-1 | Catecholamines Free [Moles/time] in 24 hour Urine |
| 103173-1 | Enterobacter aerogenes+Enterobacter cloacae DNA [Presence] in Specimen by NAA with probe detection |
| 103666-4 | Cells.CD200/100 cells in Bone marrow by Flow cytometry (FC) |
| 149-5 | Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 15092-0 | Pregnanetriol [Moles/volume] in Urine |
| 15165-4 | Complement C4 [Mass/volume] in Synovial fluid |
| 10616-1 | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Immunobead |
| 11001-5 | Pyrazinamide [Mass/volume] in Serum or Plasma |
| 16292-5 | 1,4-Dioxane [Mass/volume] in Urine |
| 1157-7 | little c Ag [Presence] on Red Blood Cells from Blood product unit |
| 17347-6 | Neutrophil Ab [Units/volume] in Serum by Immunofluorescence |
| 75518-1 | Bacteria identified in Cerebral spinal fluid by Latex agglutination |
| 60372-0 | Eggplant IgG Ab [Mass/volume] in Serum |
| 9329-4 | Basement membrane Ab [Units/volume] in Serum by Immunoassay |
| 61314-1 | Sheep wool IgE Ab/IgE total in Serum |
| 77332-5 | Morphine [Moles/volume] in Specimen |
| 77729-2 | oxyMORphone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 93762-3 | Influenza virus A NP gene [Nucleotide sequence] in Isolate by Sequencing |
| 62462-7 | Influenza virus A+B RNA [Presence] in Specimen by NAA with probe detection |
| 77885-2 | Ethyl sulfate cutoff [Mass/volume] in Urine for Confirmatory method |
| 63527-6 | Centromere Ab [Presence] in Body fluid by Immunoassay |
| 79127-7 | Uroporphyrin 1 isomer/Creatinine [Mass Ratio] in Urine |
| 94862-0 | Transthyretin peak 2 [Mass] in Blood |
| 6589-6 | Yellow fever virus Ab [Titer] in Serum by Immunofluorescence |
| 96257-1 | Copper free [Mass/volume] in Serum or Plasma |
| 6934-4 | RAST class [Presence] in Serum |
| 69955-3 | Intestinal goblet cell Ab [Presence] in Serum by Immunoassay |
| 81692-6 | DNA mismatch repair protein Msh2 [Presence] in Cancer specimen by Immune stain |
| 97745-4 | Alpha-1-Fetoprotein [Units/volume] in Aspirate |
| 98490-6 | FLT3 gene.p.Asp835+Ile836 mutations/Normal in Blood or Tissue by Molecular genetics method |
| 7179-5 | Carob IgE Ab [Units/volume] in Serum |
| 7201-7 | American Cheese IgE Ab [Units/volume] in Serum |
| 72423-7 | 3-Methylhistidine [Moles/volume] in Blood from Fetus |
| 84887-9 | Apical lymph node involvement of Colorectal cancer |
| 84926-5 | PCA-Tr Ab [Presence] in Serum by Immunofluorescence |
| 85377-0 | Neutrophil.PMA stimulated.DHR/Neutrophil.PMA stimulated.total in Control Blood by Flow cytometry (FC) |
| 73491-3 | Candesartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73878-1 | Beta cortolone [Moles/volume] in 24 hour Urine |
| 87969-2 | Microscopic observation [Identifier] in Blood by Gram stain |
| 74398-9 | Neutrophils [#/volume] in Cord blood |
| 41288-2 | Whole Egg IgE Ab/IgE total in Serum |
| 41469-8 | Ribavirin [Mass/volume] in Serum or Plasma |
| 4163-2 | cefoTEtan [Mass] of Dose |
| 59625-4 | chlordiazePOXIDE [Mass/mass] in Tissue by Confirmatory method |
| 30467-5 | Promyelocytes/100 leukocytes in Cerebral spinal fluid |
| 31125-8 | CD20+CD25+ cells [#/volume] in Blood |
| 4279-6 | Hydroxymethoxyphenamine [Mass] of Dose |
| 42947-2 | Trypanosoma brucei Ab [Titer] in Serum |
| 22758-7 | Plasminogen activator inhibitor 1 Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
| 32084-6 | Isopropanol [Moles/volume] in Specimen |
| 32549-8 | Norepinephrine/Creatinine [Molar ratio] in Urine collected for unspecified duration |
| 51940-5 | Escherichia coli shiga-like toxin 1 [Presence] in Stool by Immunoassay |
| 52894-3 | Titanium [Moles/volume] in Red Blood Cells |
| 52930-5 | Manganese/Creatinine [Molar ratio] in 24 hour Urine |
| 43923-2 | Beta hydroxybutyrate [Presence] in Serum or Plasma |
| 44048-7 | Basophils [Presence] in Nose by Light microscopy |
| 23149-8 | Japanese encephalitis virus Ag [Presence] in Specimen by Hemagglutination inhibition |
| 33223-9 | Hyaline casts [#/area] in Urine sediment by Automated count |
| 33232-0 | Spermatozoa [Presence] in Urine by Automated |
| 44630-2 | Specimen size additional dimension 1 in Breast tumor |
| 44791-2 | Menorrhagia coagulation panel - Platelet poor plasma |
| 33503-4 | Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose lactose PO |
| 53956-9 | Salmonella typhi [Identifier] in Isolate by Agglutination |
| 44905-8 | Malignant cells/100 cells in Peritoneal fluid |
| 24089-5 | Iduronate-2-Sulfatase [Enzymatic activity/mass] in Leukocytes |
| 33911-9 | Complement C1r actual/normal in Serum or Plasma |
| 33943-2 | Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 24196-8 | Coxsackievirus B5 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen |
| 55387-5 | Insulin [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 47235-7 | Reagin Ab [Titer] in Specimen by VDRL |
| 47402-3 | CV2 Ab [Presence] in Serum or Plasma by Immunoblot |
| 25116-5 | Methylmalonate/Creatinine [Molar ratio] in Urine |
| 25333-6 | Campylobacter fetus Ab [Titer] in Serum |
| 47743-0 | Serine/Amino acids.total in Hair |
| 25871-5 | Beta aminoisobutyrate/Creatinine [Molar ratio] in 24 hour Urine |
| 3537-8 | Nordiazepam [Mass/volume] in Serum or Plasma |
| 56550-7 | PCA-Tr Ab [Titer] in Serum by Immunofluorescence |
| 4810-8 | HLA-B15 [Presence] in Donor |
| 26526-4 | Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post dose corticotropin |
| 26784-9 | diazePAM [Mass/volume] in Serum or Plasma by Confirmatory method |
| 3626-9 | Fencamfamin [Mass/time] in 24 hour Urine |
| 38351-3 | Herpes virus 6 DNA panel - Specimen by NAA with probe detection |
| 38449-5 | CFTR gene c.1078delT [Presence] in Blood or Tissue by Molecular genetics method |
| 57468-1 | Calcitriol [Moles/volume] in Serum or Plasma --pre dose calcium |
| 5766-1 | Ammonium urate crystals [Presence] in Urine sediment by Light microscopy |
| 57789-0 | Dehydroepiandrosterone (DHEA) [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
| 58033-2 | Nettle IgE Ab/IgE total in Serum |
| 49423-7 | Papova virus SV 40 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
| 49534-1 | Influenza virus B Ag [Presence] in Isolate by Immunofluorescence |
| 49645-5 | SCA2 gene allele 1 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 29161-7 | Barbiturates [Mass/mass] in Meconium |
| 58576-0 | Corticotropin [Mass/volume] in Plasma --2 hours post dose insulin IV |
| 58777-4 | Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum |
| 40462-4 | GJB1 gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 406-9 | Pipemidate [Susceptibility] by Serum bactericidal titer |
| 50317-7 | CD235a Ag [Presence] in Tissue by Immune stain |
| 50426-6 | Corticotropin [Mass/volume] in Plasma --20 minutes post 100 ug CRH IV |
| 40872-4 | CBS gene c.833T>C [Presence] in Blood or Tissue by Molecular genetics method |
| 40873-2 | CBS gene c.919G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 41026-6 | Fungus identified in Genital specimen by Culture |
| 2007-3 | Cancer Ag 15-3 [Presence] in Serum or Plasma |
| 20732-4 | Brucella ovis Ab [Presence] in Serum by Immunoassay |
| 20900-7 | Mycoplasma sp Ab [Presence] in Serum by Immunoassay |
| 100717-8 | FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method |
| 1253-4 | Major crossmatch [Interpretation] by Prewarmed |
| 13311-6 | MNS group Ag [Type] on Red Blood Cells |
| 1337-5 | Xg sup(a) Ab [Presence] in Serum or Plasma from Donor |
| 102233-4 | Chicken meat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102338-1 | Gramma grass (Bouteloua gracilis) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102407-4 | Lentils IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14157-2 | Coproporphyrin [Mass/volume] in Serum or Plasma |
| 14217-4 | HTLV I p19 Ab [Presence] in Serum |
| 103096-4 | Latex recombinant (rHev b) 8 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103184-8 | Human Rhinovirus 1 and 2 RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 10392-9 | Cryoprecipitate given [Volume] |
| 10593-2 | Spermatozoa Pyriform Head/100 spermatozoa in Semen |
| 16300-6 | 17-Ketogenic steroids [Mass/time] in 72 hour Urine |
| 16692-6 | Cryptococcus sp Ag [Presence] in Body fluid |
| 16791-6 | Doxylamine [Mass/volume] in Serum or Plasma |
| 16832-8 | Escherichia coli enterotoxic identified in Stool by Organism specific culture |
| 16913-6 | Fasting glucose [Presence] in Urine |
| 16949-0 | Herpes simplex virus 1 IgG Ab [Units/volume] in Serum --1st specimen |
| 17076-1 | Lidocaine [Mass/volume] in Body fluid |
| 17544-8 | Bartonella quintana IgG Ab [Presence] in Cerebral spinal fluid |
| 1862-2 | Aniline [Mass/volume] in Serum or Plasma |
| 90457-3 | Influenza virus types A and B panel - Tissue by NAA with probe detection |
| 90919-2 | Coagulation factor VIII.recombinant.bound/von Willebrand factor (vWf) Ag in Plasma by Immunoassay |
| 74580-2 | Fumarase [Enzymatic activity/mass] in Tissue |
| 74660-2 | Phencyclidine [Presence] in Saliva (oral fluid) by Confirmatory method |
| 92762-4 | 7-Alpha hydroxy-4-cholesten-3-one [Moles/volume] in Blood |
| 75129-7 | Xanthine [Moles/volume] in Cerebral spinal fluid |
| 60552-7 | Interferon.beta 1b Ab [Titer] in Serum or Plasma |
| 61180-6 | Hemoglobin [Mass/volume] in Blood from Fetus |
| 6233-1 | Rough Pigweed IgE Ab [Units/volume] in Serum |
| 77040-4 | t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript in Blood or Tissue by FISH |
| 94380-3 | Acinetobacter baumannii DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 95785-2 | FOXL2 gene targeted mutation analysis in Tissue by Molecular genetics method |
| 96035-1 | Microscopic observation [Identifier] in Tissue by Alcian blue stain.with hyaluronidase |
| 67834-2 | Macrophages [#/volume] in Pleural fluid from Fetus |
| 68991-9 | Epidemiologically important information for public health reporting panel |
| 8084-6 | Neutrophil cytoplasmic Ab.classic [Units/volume] in Serum |
| 96625-9 | HLA typing comment [Interpretation] Narrative |
| 96695-2 | Rate of fibrin formation.diatomaceous earth+clay induced [Units] in Blood by Microviscometry |
| 9690-9 | Chromium [Mass/volume] in Specimen |
| 6931-0 | Silver [Mass/time] in 24 hour Urine |
| 70239-9 | Testosterone [Moles/volume] in Serum or Plasma by Detection limit <= 3.47 pmol/L |
| 7047-4 | Sparfloxacin [Susceptibility] by Gradient strip |
| 71610-0 | Mononuclear cells/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
| 85275-6 | Adjacent structure invaded by tumor [Anatomy] in Colorectal cancer specimen by Light microscopy |
| 73167-9 | rifAMPin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87367-9 | Erysipelothrix rhusiopathiae Ab/Positive control in Serum by Immunoassay |
| 88185-4 | IgG+IgM.porcine [Presence] in Serum from Fetus by Immune diffusion (ID) |
| 88303-3 | Lambda light chains [Presence] in 24 hour Urine by Immunofixation |
| 74382-3 | Bupivacaine [Mass/volume] in Unknown substance |
| 88846-1 | Urinary cell count CNAMTS panel - 3 hour Urine |
| 890-4 | Blood group antibody screen [Presence] in Serum or Plasma |
| 59813-6 | Glucose [Moles/volume] in Capillary blood by Glucometer --7 AM specimen |
| 5074-0 | Candida albicans Ab [Presence] in Serum by Immune diffusion (ID) |
| 50805-1 | Amitriptyline [Moles/volume] in Gastric fluid |
| 30931-0 | Lead [Mass/volume] in Urine collected for unspecified duration |
| 42599-1 | Corticotropin [Mass/volume] in Plasma --1 hour post XXX challenge |
| 42634-6 | 1p and 19q chromosome deletion [Presence] in Fixed tissue by Molecular genetics method |
| 60093-2 | Ketoprofen [Mass/volume] in Blood |
| 2143-6 | Cortisol [Mass/volume] in Serum or Plasma |
| 51048-7 | CD123 blasts [Units/volume] in Specimen |
| 42764-1 | Crystals [type] in Vitreous fluid by Light microscopy |
| 42769-0 | HTLV I+II Ab [Interpretation] in Serum Narrative |
| 51596-5 | Glucose [Moles/volume] in Capillary blood |
| 22416-2 | Mumps virus IgG Ab [Titer] in Cerebral spinal fluid |
| 32203-2 | Unidentified cells [#/volume] in Pleural fluid by Manual count |
| 53029-5 | Neutrophil cytoplasmic Ab.perinuclear.atypical [Presence] in Serum by Immunofluorescence |
| 43997-6 | Alpha-1-Fetoprotein [Multiple of the median] adjusted for weight in Serum or Plasma |
| 440-8 | Rosoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 23190-2 | Leptospira interrogans sv Mitis Ab [Presence] in Serum by Agglutination |
| 23200-9 | Leptospira sp IgG Ab [Presence] in Serum |
| 44470-3 | Herpes simplex virus 1 Ag [Presence] in Anal |
| 44604-7 | Kappa light chains.free [Presence] in Urine by Immunofixation |
| 33508-3 | HIV 1 p65+p66 Ab [Presence] in Serum by Immunoblot |
| 44982-7 | Chlamydophila pneumoniae IgA Ab [Presence] in Serum |
| 33982-0 | California Walnut Pollen IgE Ab [Units/volume] in Serum |
| 34198-2 | Salicylamide [Mass/volume] in Serum or Plasma --peak |
| 46092-3 | Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --4th tube |
| 4635-9 | Free Hemoglobin [Mass/volume] in Serum |
| 46736-5 | Fatty acid oxidation defects newborn screen interpretation |
| 47091-4 | Methylmalonate [Moles/time] in 24 hour Urine |
| 47225-8 | Bilirubin.total [Interpretation] in Amniotic fluid |
| 25187-6 | Ethambutol 7.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25195-9 | Ethambutol 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25279-1 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Units/volume] in Serum --1st specimen |
| 3503-0 | Clostebol [Mass/volume] in Urine |
| 47615-0 | Dermatan sulfate [Presence] in Urine |
| 47795-0 | Tyrosine/Amino acids.total in Serum or Plasma |
| 25873-1 | Calcium [Moles/volume] in Urine --pre 500 mg calcium PO |
| 25874-9 | Carnosine [Moles/volume] in 24 hour Urine |
| 35377-1 | MJD gene allele 1 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 56281-9 | Halibut IgG4 Ab [Mass/volume] in Serum |
| 5635-8 | Cyanide [Mass/volume] in Serum or Plasma |
| 56397-3 | Sweet potato IgG4 Ab [Mass/volume] in Serum |
| 26552-0 | Glucose [Presence] in Urine by Test strip --6 hours post dose glucose |
| 3749-9 | Mephenytoin [Mass/volume] in Serum or Plasma |
| 2681-5 | Ornithine [Mass/time] in 24 hour Urine |
| 38520-3 | Capillary fragility [Presence] |
| 48953-4 | Hydroxyethylflurazepam [Mass/volume] in Specimen |
| 2735-9 | Pepsinogen [Mass/volume] in Blood |
| 27918-2 | Coxsackievirus B4 Ab [Presence] in Cerebral spinal fluid |
| 28009-9 | Volume of Urine |
| 3944-6 | Phenmetrazine [Presence] in Urine |
| 2910-8 | Pyruvate dehydrogenase.cytochrome [Enzymatic activity/volume] in Serum or Plasma |
| 3971-9 | Pindolol [Mass/volume] in Serum or Plasma |
| 50255-9 | Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --3rd specimen fasting |
| 50276-5 | 3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Cerebral spinal fluid |
| 50449-8 | Corticotropin [Mass/volume] in Plasma --5th specimen |
| 41105-8 | FSHD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 20576-5 | Galactose 1 phosphate uridyl transferase [Presence] in Blood |
| 12780-3 | Nickel [Mass/volume] in Red Blood Cells |
| 12985-8 | 2,6 toluenediamine [Mass/volume] in Blood |
| 101758-1 | Trichophyton quinckeanum DNA [Presence] in Specimen by NAA with probe detection |
| 13901-4 | Tyrosine [Presence] in Urine |
| 103724-1 | Suvorexant [Presence] in Urine by LC/MS/MS |
| 10393-7 | Factor IX given [Type] |
| 104074-0 | Gas and Lactate panel - Arterial blood |
| 15379-1 | Haemophilus influenzae B Ag [Presence] in Urine |
| 16338-6 | Alpha aminoadipate [Presence] in Urine |
| 16382-4 | Androstenedione [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 1665-9 | 17-Hydroxycorticosteroids [Mass/volume] in Plasma |
| 16764-3 | Dichlorodiphenyldichloroethylene [Mass/volume] in Blood |
| 16940-9 | Heptachlorepoxide [Mass/volume] in Urine |
| 16975-5 | HIV 1 IgG Ab [Presence] in Serum |
| 17012-6 | Influenza virus A Ab [Units/volume] in Cerebral spinal fluid |
| 90924-2 | BK virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection |
| 91668-4 | Aspergillus oryzae Ab [Units/volume] in Serum |
| 7529-1 | California Black Oak IgE Ab [Units/volume] in Serum |
| 75398-8 | HNF1B gene full mutation analysis in Blood or Tissue by Sequencing |
| 60439-7 | Large granular lymphocytes/100 leukocytes in Blood by Flow cytometry (FC) |
| 6111-9 | Epicoccum purpurascens IgE Ab [Units/volume] in Serum |
| 75884-7 | aPTT.lupus sensitive/aPTT.lupus sensitive W excess phospholipid (screen to confirm ratio) |
| 76069-4 | Erythrocytes.hypochromic/100 erythrocytes in Blood by Automated count |
| 93482-8 | Cortisol [Mass/volume] in Serum or Plasma --1 minute pre 1 ug/kg CRH IV |
| 61301-8 | English plantain IgE Ab/IgE total in Serum |
| 62309-0 | Krabbe disease newborn screening comment-discussion |
| 77086-7 | TYROBP gene full mutation analysis in Blood or Tissue by Sequencing |
| 77350-7 | Erythropoietin (EPO) Ab [Presence] in Serum |
| 77395-2 | Human papilloma virus 18 DNA [Presence] in Anorectal by NAA with probe detection |
| 94220-1 | SPINK1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 6287-7 | Baker's yeast IgE Ab [Units/volume] in Serum |
| 6300-8 | Glucose [Mass/volume] in Amniotic fluid |
| 63080-6 | Hazelnut IgG Ab [Mass/volume] in Serum |
| 78001-5 | Cytomegalovirus pp65 Ag/100000 PMN cells in Blood by Immunofluorescence |
| 96056-7 | Borrelia sp DNA [Presence] in Blood by NAA with probe detection |
| 6889-0 | Beta globulin [Mass/volume] in 24 hour Urine |
| 80823-8 | Zika virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 8089-5 | Platelet associated IgG Ab [Units/volume] in Blood |
| 81-0 | Cefixime [Susceptibility] by Disk diffusion (KB) |
| 97025-1 | BRAF gene V600 mutations [Identifier] in Tissue by Molecular genetics method Nominal |
| 97173-9 | Yersinia outer protein M Ab [Presence] in Serum by Line blot |
| 69775-5 | Stearoylcarnitine (C18) [Moles/volume] in Urine |
| 71600-1 | Macrophages/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count |
| 85349-9 | Lymph node response to neoadjuvant therapy in Cancer specimen by CAP cancer protocols |
| 85780-5 | Pseudomonas aeruginosa DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 99765-0 | Interleukin 12 [Mass/volume] in Cerebral spinal fluid |
| 72860-0 | Telaprevir [Susceptibility] by Genotype method |
| 86513-9 | Adenovirus IgM Ab [Presence] in Serum by Immunoassay |
| 87569-0 | Nivalenol [Mass/mass] in Specimen |
| 73555-5 | Abciximab induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73579-5 | Anion gap 4 in Mixed venous blood |
| 73866-6 | Catecholamines 3 and creatinine panel [Molar ratio] - Urine |
| 41664-4 | Aztreonam+Clavulanate [Susceptibility] by Gradient strip |
| 59594-2 | 7-Aminoclonazepam [Mass/volume] in Body fluid by Confirmatory method |
| 50648-5 | Latex recombinant (rHev b) 6.01 IgE Ab [Units/volume] in Serum |
| 50869-7 | Iron [Moles/mass] in Hair |
| 4218-4 | Dibenzepin [Mass] of Dose |
| 59978-7 | Venlafaxine [Moles/volume] in Gastric fluid |
| 21440-3 | Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe |
| 21632-5 | ATP7B gene p.His1070Gln [Presence] in Blood or Tissue by Molecular genetics method |
| 31250-4 | Bartonella henselae IgG Ab [Units/volume] in Cerebral spinal fluid |
| 31362-7 | Ehrlichia chaffeensis IgM Ab [Units/volume] in Serum |
| 51236-8 | CD13 cells/100 cells in Cerebral spinal fluid |
| 42869-8 | CD138 cells/100 cells in Blood |
| 2188-1 | Cytosol aminopeptidase [Presence] in Urine |
| 32043-2 | Uroporphyrin/Creatinine [Molar ratio] in 24 hour Urine |
| 43321-9 | Avian metapneumovirus B Ab [Titer] in Serum by Immunoassay |
| 53001-4 | Mitochondria M9 Ab [Units/volume] in Serum |
| 44006-5 | Coxiella burnetii phase 1 and 2 IgG and IgM [Interpretation] in Serum |
| 53304-2 | Tyrosine crystals [#/volume] in Urine by Computer assisted method |
| 44506-4 | Herpes simplex virus Ab [Presence] in Cerebral spinal fluid |
| 4471-9 | Complement Activity Cell Surface Induced [Units/volume] in Serum or Plasma |
| 44754-0 | Hepatitis D virus Ag [Presence] in Serum by Immunoassay |
| 23336-1 | Ovine progressive pneumonia virus DNA [Presence] in Specimen by Polyacrylamide gel electrophoresis (PAGE) |
| 33645-3 | A2 Ab [Titer] in Serum or Plasma |
| 53867-8 | GYS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 45200-3 | Dodecenoylcarnitine (C12:1) [Moles/volume] in DBS |
| 23697-6 | Canine herpesvirus neutralizing antibody [Presence] in Serum by Neutralization test |
| 33841-8 | Immature monocytes [#/volume] in Blood by Manual count |
| 34053-9 | Xylose [Moles/volume] in Serum or Plasma --2 hours post 5 g xylose PO |
| 24143-0 | Sheep Sorrel IgG Ab [Units/volume] in Serum |
| 2506-4 | Isocitrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
| 55662-1 | Clofazimine [Susceptibility] by Gradient strip |
| 47895-8 | Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose ornithine |
| 56543-2 | Ganglioside GM2 IgG Ab [Units/volume] in Serum by Immunoassay |
| 47991-5 | Progesterone [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 48083-0 | 3-Hydroxydodecanedienedioate/Creatinine [Molar ratio] in Urine |
| 26729-4 | Ovary IgG Ab [Titer] in Serum by Immunofluorescence |
| 3673-1 | Heptaminol [Mass/volume] in Urine |
| 48570-6 | Follitropin [Units/volume] in Serum or Plasma --on cycle day 10 |
| 57581-1 | Aldosterone [Mass/volume] in Serum or Plasma --pre XXX challenge |
| 49125-8 | Ehrlichia sp identified in Specimen by Sequencing |
| 39022-9 | Sarcocystis neurona Ab [Presence] in Serum by Immunofluorescence |
| 49646-3 | SCA2 gene allele 2 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 58460-7 | Endothelial cell Ab [Titer] in Serum or Plasma |
| 58805-3 | Leukocytes [#/volume] in Urine by Automated test strip |
| 49897-2 | Insulin [Units/volume] in Serum or Plasma --pre XXX challenge |
| 50217-9 | Glucose [Mass/volume] in Serum or Plasma --8th specimen |
| 41083-7 | MTM1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19201-3 | Prostate Specific Ag Free [Units/volume] in Serum or Plasma |
| 19293-0 | Cannabinoids screen method [Identifier] in Urine |
| 19375-5 | Butalbital cutoff [Mass/volume] in Urine for Screen method |
| 19469-6 | Flunitrazepam cutoff [Mass/volume] in Urine for Confirmatory method |
| 20831-4 | Glycolate [Mass/mass] in Tissue |
| 20986-6 | Western equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Complement fixation |
| 12441-2 | Tolmetin [Mass/volume] in Serum or Plasma |
| 100746-7 | Glucose [Moles/volume] in Mixed venous blood |
| 1246-8 | M1 Ab [Presence] in Serum or Plasma |
| 101425-7 | Respiratory syncytial virus A RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 101841-5 | prednisoLONE [Moles/volume] in Serum or Plasma |
| 13722-4 | Citrate/Creatinine [Mass Ratio] in Urine |
| 13795-0 | Phosphate/Creatinine [Mass Ratio] in 24 hour Urine |
| 102286-2 | Egg white IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14086-3 | Herpes simplex virus 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 14210-9 | Giardia lamblia Ag [Presence] in Stool by Immunofluorescence |
| 14402-2 | Creatinine [Mass/volume] in Gastric fluid |
| 14438-6 | Cholesterol [Mass/volume] in Amniotic fluid |
| 103834-8 | Norbuprenorphine [Presence] in Meconium |
| 10386-1 | Albumin given [Volume] |
| 15452-6 | Avian reovirus Ab [Presence] in Serum by Immune diffusion (ID) |
| 1087-6 | Js sup(b) Ab [Presence] in Serum or Plasma |
| 10883-7 | Phenolphthalein [Mass/mass] in Stool |
| 10989-2 | Itraconazole [Mass/volume] in Serum or Plasma |
| 11252-4 | Scopolamine [Mass/volume] in Serum or Plasma |
| 16821-1 | EPINEPHrine [Mass/volume] in Plasma --4 hours post XXX challenge |
| 17548-9 | Rotavirus RNA [Presence] in Specimen by Probe |
| 17652-9 | Streptococcus pneumoniae Ag [Presence] in Specimen by Latex agglutination |
| 18275-8 | Blood group antigens present [Identifier] on Red Blood Cells from Donor |
| 7501-0 | Spanish Moss IgE Ab [Units/volume] in Serum |
| 92144-5 | Moraxella catarrhalis DNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 92760-8 | 7-Alpha,12-alpha dihydroxycholest-4-en-3-one [Moles/volume] in DBS |
| 75373-1 | Erythrocytes.fetal/2000 erythrocytes in Blood by Kleihauer-Betke method |
| 75585-0 | Comment on fetal Prader-Willi syndrome risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 92816-8 | Phencyclidine [Mass/mass] in Meconium by Confirmatory method |
| 93495-0 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Screen method |
| 77632-8 | ANG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 78221-9 | IGH gene rearrangements [Presence] in Blood or Tissue by FISH |
| 9443-3 | IgM lymphocytes/100 lymphocytes in Leukocytes |
| 6377-6 | Cytomegalovirus Ag [Presence] in Serum or Plasma by Immunofluorescence |
| 79249-9 | Methadone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 65807-0 | Tapentadol [Mass/volume] in Urine |
| 6656-3 | Microscopic observation [Identifier] in Tissue by Acid fast stain.Kinyoun modified |
| 95718-3 | Anion gap 3 in Blood |
| 96430-4 | Borrelia burgdorferi G39/40 IgG bands [#] in Specimen by Immunoblot |
| 8071-3 | Histone Ab [Presence] in Serum |
| 810-2 | Leukocytes [#/volume] in Peritoneal fluid by Manual count |
| 96921-2 | Speckled nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 69880-3 | Service comment 53 |
| 7007-8 | Dirithromycin [Susceptibility] by Gradient strip |
| 81640-5 | Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count |
| 97940-1 | Cryptococcus sp [Presence] in Isolate by Organism specific culture |
| 7131-6 | Lima Bean IgE Ab [Units/volume] in Serum |
| 82368-2 | Thyroid secretory capacity [Moles/time] in Serum or Plasma by Calculated.SPINA |
| 72878-2 | UGT2B15 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
| 72955-8 | Sertraline induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 85997-5 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum --1st specimen |
| 87742-3 | Adalimumab Ab [Units/volume] in Serum or Plasma |
| 73398-0 | Erythropoietin (EPO) induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88557-4 | Scedosporium apiospermum DNA [Presence] in Specimen by NAA with probe detection |
| 741-9 | Microcytes [Presence] in Blood by Light microscopy |
| 89364-4 | Free Hemoglobin [Mass/volume] in Body fluid |
| 41218-9 | Xipamid [Presence] in Urine |
| 41267-6 | Xylose [Mass/volume] in Serum or Plasma --post dose xylose PO |
| 41292-4 | Soluble mesothelin related proteins [Moles/volume] in Serum or Plasma |
| 41689-1 | Dalbavancin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 50720-2 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 30567-2 | Thyroid stimulating immunoglobulins [Units/volume] in Serum |
| 30570-6 | Triglyceride [Percentile] |
| 4196-2 | Clopenthixol [Mass] of Dose |
| 42508-2 | Herpes virus 8 IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 42582-7 | Barbiturates [Mass/volume] in Blood by Confirmatory method |
| 21561-6 | Laceyella sacchari Ab [Presence] in Serum |
| 3126-0 | Vasopressin [Mass/volume] in Serum or Plasma |
| 31375-9 | Epstein Barr virus nuclear IgM Ab [Units/volume] in Serum |
| 31602-6 | Rickettsia typhus group IgM Ab [Units/volume] in Cerebral spinal fluid |
| 51701-1 | Ganglioside IgG Ab [Presence] in Serum by Immunoblot |
| 43599-0 | HIV 1 Ab [Units/volume] in Serum by Immunofluorescence |
| 32130-7 | risperiDONE [Presence] in Specimen |
| 32308-9 | Cholesterol [Moles/volume] in Specimen |
| 52878-6 | Cytoplasmic CD22 cells/100 cells in Body fluid |
| 43957-0 | CD3+HLA-DR+ cells [#/volume] in Bone marrow |
| 32730-4 | Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
| 32747-8 | CD64 cells/100 cells in Specimen |
| 53303-4 | Cystine crystals [#/volume] in Urine by Computer assisted method |
| 53364-6 | Borrelia burgdorferi 49736 IgM Ab [Units/volume] in Serum |
| 53581-5 | Angiotensin converting enzyme [Enzymatic activity/volume] in Peritoneal fluid |
| 45024-7 | HLA typing for narcolepsy panel - Blood |
| 23672-9 | Bluetongue virus 11 neutralizing antibody [Titer] in Serum by Neutralization test |
| 23788-3 | Vesicular stomatitis Indiana virus Ab [Titer] in Serum by Complement fixation |
| 33805-3 | Fructosamine [Mass/volume] in Serum or Plasma |
| 24472-3 | Platelet function (closure time) collagen+ADP induced [Time] in Blood |
| 54492-4 | Alanine aminotransferase [Enzymatic activity/volume] in Pleural fluid |
| 252-7 | 5-Fluorocytosine [Susceptibility] by Minimum lethal concentration (MLC) |
| 2541-1 | Lactate dehydrogenase 3 [Enzymatic activity/volume] in Serum or Plasma by Chemical separation |
| 55654-8 | Cefuroxime [Susceptibility] by Gradient strip |
| 56036-7 | Apolipoprotein B/Cholesterol in LDL [Mass Ratio] in Serum or Plasma |
| 25822-8 | Staphylococcus aureus enterotoxin B IgE Ab [Units/volume] in Serum |
| 25835-0 | HIV 1 RNA [Presence] in Serum or Plasma by NAA with probe detection |
| 56210-8 | Cat dander IgG4 Ab [Mass/volume] in Serum |
| 56258-7 | Gum-Tree IgG4 Ab [Mass/volume] in Serum |
| 56274-4 | Grapefruit IgG4 Ab [Mass/volume] in Serum |
| 4800-9 | HLA-B76(15) [Presence] in Donor |
| 48158-0 | Vanillate/Creatinine [Molar ratio] in Urine |
| 3710-1 | Levorphanol [Mass/volume] in Serum or Plasma |
| 2690-6 | Osmolality of Pleural fluid |
| 26976-1 | Hydroxytriazolam [Mass/mass] in Stool |
| 57480-6 | 11-Ketoandrosterone [Mass/time] in 24 hour Urine --pre dose dexamethasone |
| 57586-0 | Aldosterone [Moles/volume] in Serum or Plasma --1 hour post 25 mg captopril PO |
| 57589-4 | Aldosterone [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 49011-0 | Platelet aggregation arachidonate induced [Units/volume] in Platelet rich plasma |
| 49243-9 | Alkaline phosphatase isoenzymes [Interpretation] in Serum or Plasma Narrative |
| 27347-4 | Methaqualone [Mass/volume] in Vitreous fluid |
| 27921-6 | Alpha hydroxyalprazolam [Mass/volume] in Serum or Plasma |
| 49367-6 | Hepatitis B virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 4953-6 | HLA-DR11(5) [Presence] |
| 280-8 | Imipenem [Susceptibility] by Disk diffusion (KB) |
| 40167-9 | Glucose [Moles/volume] in Serum or Plasma --7 hours post XXX challenge |
| 29642-6 | Neutrophil cytoplasmic Ab.classic.atypical [Presence] in Serum by Immunofluorescence |
| 50326-8 | Neisseria gonorrhoeae DNA [Presence] in Specimen from Donor by NAA with probe detection |
| 30027-7 | Dimethoate [Mass/volume] in Serum or Plasma |
| 20536-9 | Hydroxytriazolam cutoff [Mass/volume] in Urine for Screen method |
| 12489-1 | Secobarbital [Presence] in Gastric fluid |
| 12645-8 | Glucose [Mass/volume] in Serum or Plasma --10 hours post XXX challenge |
| 101343-2 | Erythrocytes.parasite sp infected/100 cells in Blood |
| 101992-6 | Quinolinate [Mass Ratio] in Urine |
| 102162-5 | Bass, Black IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102436-3 | Mexican tea IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102494-2 | Parsley IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14238-0 | Myelin basic protein IgG Ab [Units/volume] in Serum |
| 102705-1 | Cauliflower IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102838-0 | Barley smut+Wheat smut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103092-3 | Latex recombinant (rHev b) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103630-0 | Monkeypox virus IgM Ab [Titer] in Serum by Immunoassay |
| 104178-9 | Clostridium tetani toxin [Presence] in Specimen by Immunoassay |
| 14934-4 | Urate [Moles/volume] in Urine |
| 14964-1 | CD19 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 15446-8 | Avian leukosis virus Ag [Titer] in Egg yolk by Immunoassay |
| 1080-1 | Js sup(a) Ab [Presence] in Serum or Plasma from Donor |
| 1090-0 | Js sup(b) Ag [Presence] on Red Blood Cells |
| 16872-4 | Fluorocarbons [Identifier] in Serum or Plasma |
| 17151-2 | CD42c cells/100 cells in Blood |
| 19050-4 | Metanephrines [Mass/volume] in 24 hour Urine |
| 91069-5 | Enterovirus RNA [Presence] in Urine by NAA with probe detection |
| 61087-3 | Normeperidine [Presence] in Gastric fluid |
| 92868-9 | Herpes simplex virus 1 and 2 DNA panel - Upper respiratory specimen by NAA with probe detection |
| 61312-5 | Rye IgE Ab/IgE total in Serum |
| 62253-0 | Lipoprotein.alpha [Entitic length] in Serum or Plasma |
| 94186-4 | Origin of germline genetic variant [Type] |
| 94254-0 | CYP1A2 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
| 79229-1 | Amitriptyline [Mass/volume] in Body fluid |
| 9564-6 | Lymphocytic choriomeningitis virus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 6517-7 | Parvovirus B19 IgM Ab [Presence] in Serum by Immunoblot |
| 9628-9 | O-desmethylvenlafaxine [Mass/volume] in Serum or Plasma |
| 96292-8 | Quinoline IgE Ab [Units/volume] in Serum |
| 81123-2 | Coagulation factor VII inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
| 96690-3 | Clot formation.kaolin induced panel - Blood by Microviscometry |
| 69839-9 | 2-Hydroxy-3-Methylvalerate [Moles/volume] in Serum or Plasma |
| 81807-0 | Alpha cortol/Creatinine [Molar ratio] in Urine |
| 97606-8 | PLPEth [Mass/volume] in Blood |
| 97932-8 | Colorado tick fever virus RNA [Presence] in Specimen by NAA with probe detection |
| 87561-7 | Ehrlichia muris eauclairensis groEL gene [Presence] in Blood by NAA with non-probe detection |
| 7355-1 | Annual blue grass IgE Ab [Units/volume] in Serum |
| 88721-6 | Rhinovirus+Enterovirus RNA [Presence] in Nasopharynx by NAA with probe detection |
| 59346-7 | 4-Hydroxy-Tamoxifen [Mass/volume] in Blood |
| 3043-7 | Triglyceride [Mass/volume] in Blood |
| 30531-8 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Serum or Plasma |
| 31064-9 | Polio virus 2 Ab [Titer] in Body fluid by Complement fixation |
| 43187-4 | Neuronal nuclear type 2 Ab [Presence] in Serum by Immunofluorescence |
| 51733-4 | Oxygen saturation Calculated from oxygen partial pressure in Arterial blood |
| 43311-0 | Desmoglein 1 Ab [Units/volume] in Serum |
| 22365-1 | Influenza virus A Ab [Titer] in Serum |
| 22444-4 | Plasmodium vivax Ab [Titer] in Serum |
| 52909-9 | Platinum [Moles/time] in 24 hour Urine |
| 44297-0 | Androsterone/Creatinine [Mass Ratio] in 24 hour Urine |
| 22806-4 | Infectious bronchitis virus Ag [Presence] in Tissue by Immune stain |
| 23042-5 | Eastern equine encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 53290-3 | Broad casts [#/area] in Urine by Computer assisted method |
| 23422-9 | Salmonella enteritidis IgG Ab [Presence] in Serum |
| 33633-9 | Hepatitis B virus precore TAG [Presence] in Serum by NAA with probe detection |
| 53764-7 | Prostate specific Ag panel - Serum or Plasma |
| 24120-8 | Ross River virus IgM Ab [Presence] in Serum by Immunoassay |
| 24132-3 | Grass Allergen Mix B (Sweet vernal grass+Perennial rye grass+Common reed+Rye+Velvet grass) IgE Ab [Presence] in Serum by Multidisk |
| 24435-0 | 2-Methylbutyrylglycine/Creatinine [Molar ratio] in Urine |
| 34347-5 | Normetanephrine [Moles/volume] in Urine |
| 34995-1 | Promyelocytes [#/volume] in Cerebral spinal fluid |
| 56023-5 | Foot and mouth disease virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection |
| 47757-0 | Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose arginine |
| 47905-5 | Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose ornithine |
| 25947-3 | Lutropin [Units/volume] in Serum or Plasma by 1st IRP --5th specimen post XXX challenge |
| 35485-2 | Metasystox [Mass/volume] in Serum or Plasma |
| 47927-9 | Somatotropin [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 48009-5 | Genechip manufacturer ID [Identifier] in Blood or Tissue by Molecular genetics method |
| 48225-7 | Cow milk triggered leukotriene release [Mass/volume] by Leukocytes |
| 48293-5 | Tartrazine triggered leukotriene release [Mass/volume] by Leukocytes |
| 26731-0 | Tetrahydrocannabinol [Mass/mass] in Stool |
| 361-6 | Netilmicin [Susceptibility] by Serum bactericidal titer |
| 56919-4 | Coxiella burnetii IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
| 56945-9 | Insulin [Units/volume] in Serum or Plasma --56 hours post XXX challenge |
| 48606-8 | Glucose [Mass/volume] in Serum or Plasma --pre dose fructose PO |
| 48868-4 | Rickettsia rickettsii DNA [Presence] in Specimen by NAA with probe detection |
| 38513-8 | CD2+CD3+ cells [#/volume] in Specimen |
| 38581-5 | Cumene [Mass/volume] in Air |
| 49016-9 | Streptococcus sp exoenzyme Ab [Units/volume] in Serum |
| 49122-5 | Anaplasma sp identified in Specimen by Sequencing |
| 49270-2 | Immunoglobulin light chains [Interpretation] in Urine Narrative |
| 27950-5 | Saint Louis encephalitis virus RNA [Presence] in Cerebral spinal fluid by Probe |
| 39009-6 | Isovalerylcarnitine (C5) [Moles/volume] in Serum or Plasma |
| 29348-0 | ALPRAZolam [Mass/volume] in Gastric fluid |
| 58638-8 | Cortisol [Moles/volume] in Saliva (oral fluid) --10th specimen post XXX challenge |
| 49915-2 | Legionella sp IgG Ab [Presence] in Serum |
| 50126-2 | 3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Amniotic fluid |
| 29805-9 | Powassan virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 50222-9 | Broad casts [Presence] in Urine by Computer assisted method |
| 30081-4 | IgD [Presence] in Serum by Immunofixation |
| 30248-9 | Transferrin receptor.soluble [Mass/volume] in Serum or Plasma |
| 30337-0 | Echovirus 9 Ab [Presence] in Serum by Complement fixation |
| 40806-2 | Opiates [Presence] in Saliva (oral fluid) by Screen method |
| 40814-6 | 11-Ketoandrosterone/Creatinine [Mass Ratio] in 24 hour Urine |
| 1950-5 | Beta melanocyte stimulating hormone [Mass/volume] in Serum or Plasma |
| 100156-9 | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection |
| 1384-7 | Calcium [Moles/volume] in Blood --post calcium infusion |
| 102349-8 | Sudan grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102569-1 | Common Reed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14212-5 | Hepatitis E virus IgM Ab [Presence] in Serum |
| 14250-5 | Purkinje cells IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 14267-9 | Methylenedioxymethamphetamine [Presence] in Urine |
| 102744-0 | Bovine Gelatin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103588-0 | Etizolam [Presence] in Cord tissue by Confirmatory method |
| 103837-1 | O-desmethyltraMADol [Presence] in Meconium |
| 1493-6 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting |
| 10531-2 | Bretylium [Mass/volume] in Serum or Plasma |
| 11156-7 | Leukocyte morphology finding [Identifier] in Blood |
| 11274-8 | Elliptocytes [Presence] in Blood by Light microscopy |
| 11474-4 | Hydatid cyst identified in Specimen by Wet preparation |
| 1161-9 | little e Ab [Presence] in Serum or Plasma from Donor |
| 16802-1 | Echovirus 30 Ab [Units/volume] in Serum |
| 17187-6 | CD66d cells/100 cells in Blood |
| 17483-9 | Progesterone [Mass/volume] in Urine |
| 17599-2 | Volume of 24 hour Peritoneal dialysis fluid |
| 90451-6 | Herpes simplex virus 1 DNA [Presence] in Aspirate by NAA with probe detection |
| 74674-3 | Chlorinated solvents [Presence] in Urine |
| 92745-9 | Hepatosplenomegaly due to lysosomal storage disorders screening panel - DBS |
| 76040-5 | levoFLOXacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 76135-3 | Inositol Free/Creatinine [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO |
| 6128-3 | Goldenrod IgE Ab [Units/volume] in Serum |
| 61322-4 | White Elm IgE Ab/IgE total in Serum |
| 61363-8 | Adenovirus 3+4+7+21 DNA [Presence] in Specimen by NAA with probe detection |
| 93776-3 | Babesia duncani IgG Ab [Titer] in Serum by Immunofluorescence |
| 93858-9 | Toxoplasma gondii IgG panel - Serum from Donor |
| 63170-5 | Helminthosporium interseminatum IgG Ab [Mass/volume] in Serum |
| 94768-9 | SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 63353-7 | Smith extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
| 63422-0 | t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2+e1a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 95104-6 | Glucose [Mass/volume] in Serum or Plasma --3.5 hours post meal |
| 95161-6 | Avian reovirus Ab/Positive control in Serum by Immunoassay |
| 95706-8 | Dengue virus IgA Ab [Presence] in Specimen by Immunoassay |
| 9615-6 | Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post 250 ug corticotropin IM |
| 69019-8 | Lymphocyte proliferation stimulated by pokeweed mitogen/CD45 in Blood by Flow cytometry (FC) |
| 80827-9 | Clostridium botulinum and Clostridium baratii toxins gene panel - Specimen by NAA with probe detection |
| 81124-0 | Coagulation factor V inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
| 69555-1 | Lactose tolerance panel [Mass/volume] in Serum or Plasma |
| 70041-9 | FSHB gene c.-211G>T [Presence] in Blood or Tissue by Molecular genetics method |
| 97545-8 | Carbon dioxide, total [Moles/volume] in Central venous blood |
| 72378-3 | Oxazepam [Mass/volume] in Saliva (oral fluid) |
| 99600-9 | Beta 1 globulin [Mass/volume] in 24 hour Urine by Electrophoresis |
| 99968-0 | Thrombotic microangiopathy multigene analysis in Blood or Tissue by Molecular genetics method |
| 72735-4 | Methamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 86238-3 | Neisseria meningitidis serogroup X xcbB gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73201-6 | Piperacillin+Tazobactam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86713-5 | Carbapenem resistance blaOXA-134-like gene [Presence] by Molecular method |
| 73582-9 | Anion gap 4 in Blood |
| 74402-9 | Lymphocytes/100 leukocytes in Cord blood |
| 89528-4 | Nucleosome Ab [Presence] in Cerebral spinal fluid by Line blot |
| 50666-7 | Nuclear matrix protein 22 [Presence] in Urine |
| 50955-4 | Phosphoserine IgM Ab [Presence] in Serum or Plasma |
| 3073-4 | Tryptophan Free [Mass/volume] in Serum or Plasma |
| 42254-3 | Nuclear Ab [Presence] in Serum by Immunofluorescence |
| 21468-4 | Plasmodium vivax Ab [Titer] in Serum by Immunofluorescence |
| 51333-3 | CD19+CD43+ cells/100 cells in Tissue |
| 42895-3 | Colorado tick fever virus IgG Ab [Presence] in Serum by Immunofluorescence |
| 4303-4 | Loxapine [Mass] of Dose |
| 43165-0 | Dissolved solids [Mass/volume] in Water |
| 2169-1 | Cobalamin (Vitamin B12) renal clearance in 24 hour Urine and Serum or Plasma |
| 31682-8 | Theileria parva Ab [Units/volume] in Serum |
| 51664-1 | Chikungunya virus RNA [Presence] in Specimen by NAA with probe detection |
| 22338-8 | Herpes simplex virus 2 IgM Ab [Titer] in Cerebral spinal fluid |
| 22696-9 | Cadmium/Creatinine [Molar ratio] in Urine |
| 32135-6 | Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma by Heat stability |
| 32142-2 | Leukocytes [Presence] in Synovial fluid by Light microscopy |
| 32176-0 | Fine Granular Casts [Presence] in Urine sediment by Light microscopy |
| 32550-6 | Potassium [Molar amount] in Urine collected for unspecified duration |
| 5224-1 | HIV 2 Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 52817-4 | Nucleated cells [#/volume] in Dialysis fluid by Automated count |
| 52941-2 | Antimony/Creatinine [Molar ratio] in Urine |
| 22911-2 | Bovine herpesvirus 1 Ag [Presence] in Genital specimen by Immunofluorescence |
| 23102-7 | Equine influenza virus A1 Ag [Titer] in Specimen by Hemagglutination inhibition |
| 53182-2 | 3-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in DBS |
| 44544-5 | Human papilloma virus 35 Ag [Presence] in Specimen |
| 23283-5 | Mycoplasma mycoides ss mycoides large colony Ab [Presence] in Serum by Complement fixation |
| 23594-5 | Brucella sp identified in Semen by Organism specific culture |
| 33620-6 | Tricarboxylporphyrin 1 [Mass/time] in 24 hour Stool |
| 45000-7 | Chlamydia trachomatis IgM Ab [Titer] in Serum by Immunoassay |
| 2389-5 | Glycine [Mass/volume] in Cerebral spinal fluid |
| 54072-4 | Hemoglobin A/Hemoglobin.total in DBS |
| 54158-1 | Pancytokeratin Ab [Presence] in Serum by Immunofluorescence |
| 46709-2 | Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab [Mass/volume] in Serum by Multidisk |
| 24216-4 | Influenza virus A Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 55317-2 | Yeast [Presence] in Skin by KOH preparation |
| 55766-0 | EGFR gene c.2573T>G [Presence] in Blood or Tissue by Molecular genetics method |
| 25881-4 | Coproporphyrin [Moles/volume] in 24 hour Urine |
| 25902-8 | D-Lactate [Moles/volume] in Serum or Plasma --4th specimen post excercise |
| 35638-6 | Borrelia burgdorferi DNA [Presence] in Tissue by NAA with probe detection |
| 35690-7 | GBA gene c.IVS2(+1)G>A and IVS2(+1)G>T [Presence] in Blood or Tissue by Molecular genetics method |
| 38166-5 | West Nile virus IgM Ab [Units/volume] in Serum by Immunoassay |
| 56672-9 | Arginine/Creatinine [Ratio] in 24 hour Urine |
| 56694-3 | Chicken droppings Ab [Presence] in Serum by Immune diffusion (ID) |
| 48875-9 | Orientia tsutsugamushi [Presence] in Specimen by Organism specific culture |
| 38645-8 | Captan [Mass/volume] in Air |
| 27341-7 | Alpha aminobutyrate [Moles/volume] in Urine |
| 57711-4 | Unique bar code number of Initial sample |
| 495-2 | Tetracycline [Susceptibility] by Minimum lethal concentration (MLC) |
| 29234-2 | Coxsackievirus B5 Ab [Titer] in Body fluid |
| 29497-5 | Platelet associated IgG Ab [Presence] in Blood by Flow cytometry (FC) |
| 58419-3 | Caspofungin [Mass/volume] in Serum or Plasma |
| 2954-6 | Sodium [Moles/volume] in Sweat |
| 40333-7 | Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose triple bolus |
| 4037-8 | Stanozolol [Mass/volume] in Urine |
| 40658-7 | Parvovirus B19 IgM Ab [Presence] in Serum by Immunoassay |
| 590-0 | Legionella sp identified in Sputum by Organism specific culture |
| 59067-9 | ALAS2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 59162-8 | Potassium [Moles/volume] in 24 hour Stool |
| 59260-0 | Hemoglobin [Moles/volume] in Blood |
| 50209-6 | Albumin [Mass/time] in Urine collected for unspecified duration --supine |
| 3010-6 | Threonine [Mass/time] in 24 hour Urine |
| 4101-2 | 2-Pyridone [Mass] of Dose |
| 41081-1 | MUTYH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19518-0 | Levorphanol cutoff [Mass/volume] in Urine for Screen method |
| 20420-6 | Prostatic acid phosphatase [Mass/volume] in Serum |
| 20543-5 | Mescaline [Mass/volume] in Urine by Confirmatory method |
| 20861-1 | Infectious bronchitis virus genotype [Identifier] in Isolate by NAA with probe detection |
| 20902-3 | Mycoplasma sp+Ureaplasma sp [Presence] in Tissue by Organism specific culture |
| 12429-7 | Succinylcholine [Mass/volume] in Urine |
| 12869-4 | Borrelia burgdorferi 30kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 101906-6 | Noninvasive esophageal cancer DNA and esophageal cell screening [Presence] in Esophagus by Sequencing |
| 102157-5 | Bamboo shoot IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102558-4 | False ragweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102595-6 | Silk IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14122-6 | Pyruvate [Moles/volume] in Cerebral spinal fluid |
| 14181-2 | Uroporphyrin [Mass/mass] in 24 hour Stool |
| 102970-1 | Wasp venom IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14379-2 | Polymorphonuclear cells/100 leukocytes in Gastric fluid by Manual count |
| 14606-8 | Blood group antibody screen [Presence] in Serum or Plasma by Prewarmed |
| 14799-1 | Iron [Moles/time] in 24 hour Urine |
| 104118-5 | CD34 recipient derived/CD34 cells in Bone marrow by Molecular genetics method --post stem cell transplant |
| 14904-7 | Reagin Ab [Presence] in Specimen by VDRL |
| 15195-1 | CD3-CD19+ cells [#/volume] in Blood |
| 10582-5 | pH of Cervical mucus |
| 10765-6 | Microscopic observation [Identifier] in Tissue by Acetate esterase stain |
| 11118-7 | Plasma cells/100 cells in Bone marrow by Manual count |
| 11166-6 | Chortoglyphus arcuatus IgE Ab [Units/volume] in Serum |
| 1125-4 | Le Ab [Presence] in Serum or Plasma from Blood product unit |
| 11254-0 | Chlamydophila pneumoniae Ab [Titer] in Serum |
| 11579-0 | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L |
| 16924-3 | Haemophilus influenzae IgG Ab [Units/volume] in Serum |
| 18378-0 | Transcortin [Mass/volume] in Cerebral spinal fluid |
| 18427-5 | Epstein Barr virus early Ab [Presence] in Body fluid |
| 91074-5 | Phlebovirus sp RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 7465-8 | Lime IgG Ab [Units/volume] in Serum |
| 91818-5 | Bacteria identified in Upper respiratory specimen by Anaerobe culture |
| 92783-0 | Enterococcus faecalis DNA [Presence] by NAA with probe detection in Positive blood culture |
| 92946-3 | Streptococcus pyogenes DNA [NCncRange] in Sputum by NAA with non-probe detection |
| 77347-3 | Beta-2 transferrin panel - Serum or Plasma and CSF |
| 6295-0 | Complement C3d [Presence] in Red Blood Cells |
| 6350-3 | Chlamydia trachomatis Ag [Presence] in Conjunctival specimen by Immunoassay |
| 64967-3 | Black Alder recombinant (rAln g) 1 IgE Ab [Units/volume] in Serum |
| 65324-6 | Jk3 Ab [Presence] in Serum or Plasma |
| 65334-5 | Sc2 Ab [Presence] in Serum or Plasma |
| 95970-0 | SARS-CoV-2 (COVID-19) specific TCRB gene rearrangements [Presence] in Blood by Sequencing |
| 68422-5 | Monocytes [#/volume] in Pleural fluid by Manual count |
| 8056-4 | Yellow fever virus IgM Ab [Units/volume] in Serum |
| 80651-3 | Voriconazole N-oxide [Mass/volume] in Serum or Plasma |
| 96669-7 | HLA-DRB3 and HLA-DRB4 and HLA DRB5 [Type] in Donor by Low resolution |
| 97752-0 | Herpes virus 6 DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 82500-0 | TRBV3-1 gene segment/TRBV gene segments.total in Blood |
| 82580-2 | Food Allergen Mix 25B (Garlic, Celery, Sesame seed, Yeast) IgE Ab [Presence] in Serum by Multidisk |
| 7225-6 | Chicory IgE Ab [Units/volume] in Serum |
| 72345-2 | Neutrophils/100 round cells in Prostatic fluid by Manual count |
| 7237-1 | Cockatoo IgE Ab [Units/volume] in Serum |
| 99409-5 | Acetaminophen-cysteine adduct [Moles/volume] in Serum or Plasma by LC/MS/MS |
| 72604-2 | Insulin [Units/volume] in Serum or Plasma --4.5 hours post 75 g glucose PO |
| 7279-3 | European house dust mite triggered histamine release [Units/volume] in Blood |
| 87358-8 | Actinobacillus pleuropneumoniae serotype 5 Ab/Positive control in Serum by Immunoassay |
| 87940-3 | Bacteria identified in Peritoneal fluid by Anaerobe culture |
| 74121-5 | Perforin Ag [Presence] in Tissue by Immune stain |
| 89861-9 | BRAF gene p.Val600Lys [Presence] in Tissue by Molecular genetics method |
| 41439-1 | Encephalitozoon cuniculi DNA [Presence] in Specimen by NAA with probe detection |
| 59877-1 | Chloral hydrate [Moles/volume] in Urine |
| 3078-3 | Tyrosine [Presence] in Serum or Plasma |
| 31139-9 | Cefotaxime [Susceptibility] for meningitis by Gradient strip |
| 59983-7 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 60116-1 | 9-Hydroxyrisperidone [Mass/volume] in Urine |
| 60130-2 | Paraoxon [Mass/volume] in Body fluid |
| 60178-1 | Tellurium [Mass/mass] in Hair |
| 21229-0 | Coumaphos [Mass/volume] in Urine |
| 31337-9 | Cytotoxic percent reactive Ab [Presence] in Serum |
| 31544-0 | Nuclear Ab [Units/volume] in Synovial fluid |
| 43170-0 | Human papilloma virus 31+33 DNA [Presence] in Tissue by Probe with signal amplification |
| 43171-8 | Interleukin 2 receptor [Units/volume] in Serum or Plasma |
| 21725-7 | SERPINA1 gene p.Glu342Lys [Presence] in Blood or Tissue by Molecular genetics method |
| 31630-7 | Spermatozoa Ab [Presence] in Cervical mucus |
| 22619-1 | Yersinia enterocolitica IgA Ab [Units/volume] in Serum |
| 32197-6 | Myoglobin [Mass/volume] in 24 hour Urine |
| 32222-2 | Alanine [Moles/volume] in Body fluid |
| 51965-2 | Pharmacogenetic analysis report Document |
| 43937-2 | CD59 cells/100 cells in Tissue |
| 43985-1 | Benzoylecgonine [Presence] in Urine by Screen method >300 ng/mL |
| 44479-4 | Herpes simplex virus 1+2 Ab [Presence] in Cerebral spinal fluid |
| 44605-4 | Kappa light chains [Presence] in Cerebral spinal fluid by Immunofixation |
| 33476-3 | Organic acids pattern [Interpretation] in Cerebral spinal fluid |
| 53506-2 | Citrulline/Amino acids.total in Plasma |
| 23752-9 | Mite identified in Skin |
| 23874-1 | Hexacarboxylporphyrin I [Mass/time] in unspecified time Stool |
| 54068-2 | Hemoglobin O - Arab/Hemoglobin.total in DBS |
| 24409-5 | Brachyspira sp identified in Specimen by Organism specific culture |
| 553-8 | Candida sp identified in Saliva (oral fluid) by Organism specific culture |
| 47159-9 | Norepinephrine [Moles/volume] in Plasma --2 hours post XXX challenge |
| 47255-5 | Procollagen type I.N-terminal propeptide [Mass/volume] in Serum |
| 25431-8 | Glycine [Moles/time] in 24 hour Urine |
| 25509-1 | Progesterone [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 5595-4 | Beryllium [Mass/volume] in Urine |
| 47631-7 | Glutathione.oxidized [Moles/mass] in Red Blood Cells |
| 2570-0 | Fat [Mass/volume] in Stool |
| 56202-5 | Buckwheat IgG4 Ab [Mass/volume] in Serum |
| 48068-1 | Heinz bodies [Presence] in Blood |
| 26530-6 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post dose corticotropin |
| 26580-1 | Carnosine/Creatinine [Molar ratio] in Urine |
| 26781-5 | Glucose [Mass/volume] in Serum or Plasma --3 hours post dose lactose PO |
| 35845-7 | Telithromycin [Susceptibility] |
| 3742-4 | Mefenorex [Mass/volume] in Urine |
| 38196-2 | Appearance of Blood |
| 26930-8 | Secobarbital [Mass/mass] in Hair |
| 2721-9 | Pancreatic polypeptide [Mass/volume] in Serum or Plasma |
| 57366-7 | Lactate [Mass/volume] in Serum or Plasma --pre XXX challenge |
| 38892-6 | Anisocytosis [Presence] in Blood |
| 38911-4 | SDHC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 57866-6 | PENTobarbital [Moles/volume] in Specimen |
| 58011-8 | Myelin IgG Ab [Presence] in Serum by Immunofluorescence |
| 58037-3 | Zinc [Mass/volume] in Cerebral spinal fluid |
| 58062-1 | In sup (b) Ag [Presence] on Red Blood Cells |
| 49549-9 | Referral lab test method |
| 28589-0 | Carnitine esters/Creatinine [Ratio] in Urine |
| 2872-0 | Beta globulin [Mass/volume] in Synovial fluid by Electrophoresis |
| 29399-3 | clonazePAM [Mass/volume] in Gastric fluid |
| 40111-7 | aPTT in Platelet poor plasma by Coagulation assay --18 hours post XXX challenge |
| 49759-4 | Adenosine deaminase [Enzymatic activity/volume] in Peritoneal fluid |
| 5011-2 | Hepatitis C virus RNA [Presence] in Tissue by NAA with probe detection |
| 59141-2 | CD11c-CD103+ cells/100 cells in Blood |
| 59208-9 | Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in Serum or Plasma |
| 50523-0 | Prolactin [Mass/volume] in Serum or Plasma --7th specimen |
| 20914-8 | Organochlorine pesticides [Presence] in Gastric fluid by Screen method |
| 100126-2 | Bordetella pertussis Ab.IgG panel - Serum |
| 101126-1 | Bacterial carbapenem resistance blaOXA-24+blaOXA-40 genes [Presence] by Molecular method |
| 101397-8 | Copy number variation analysis in Blood or Tissue by Sequencing |
| 12965-0 | Urea nitrogen [Mass/volume] in Serum or Plasma --70 minute specimen |
| 14107-7 | Segmented neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count |
| 14265-3 | Isobutyl acetate [Mass/volume] in Blood |
| 14392-5 | Amylase [Enzymatic activity/volume] in Amniotic fluid |
| 14839-5 | Trypanosoma sp identified in Buffy Coat by Light microscopy |
| 15067-2 | Follitropin [Units/volume] in Serum or Plasma |
| 104413-0 | Hepatitis E virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen |
| 10576-7 | Germ cells.immature [#/volume] in Semen |
| 16340-2 | Alpha aminoisobutyrate [Mass/volume] in Urine |
| 16361-8 | Amitriptyline [Mass/volume] in Serum or Plasma --trough |
| 16724-7 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 11240-9 | hydrOXYzine [Mass/volume] in Urine |
| 11255-7 | Haemophilus ducreyi [Presence] in Specimen by Organism specific culture |
| 1194-0 | little k Ag [Presence] on Red Blood Cells from Donor |
| 12235-8 | Microscopic observation [Identifier] in Urine sediment by Light microscopy |
| 17678-4 | Taurine [Presence] in Urine |
| 17799-8 | Promyelocytes/100 leukocytes in Body fluid |
| 1783-0 | Alkaline phosphatase [Enzymatic activity/volume] in Blood |
| 74957-2 | Succinylacetone [Moles/volume] in Plasma |
| 92839-0 | Breslow thickness [Length] of Skin melanoma |
| 93453-9 | W-15 [Mass/volume] in Urine by Confirmatory method |
| 93920-7 | E Ag [Presence] on Red Blood Cells --after transfusion reaction |
| 62481-7 | Herpes virus 6A DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 62487-4 | Urobilinogen [Presence] in Urine by Automated test strip |
| 7816-2 | Blastomyces dermatitidis Ab [Presence] in Serum |
| 94565-9 | SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 64038-3 | Adenovirus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
| 64426-0 | KIR gene allele 3DL1 [Presence] in Blood or Tissue by Molecular genetics method |
| 78995-8 | Prolactin monomeric/Prolactin in Serum or Plasma |
| 79339-8 | Carnitine biosynthesis intermediates pattern newborn screen interpretation |
| 6519-3 | Pneumocystis jiroveci Ag [Presence] in Sputum by Immunofluorescence |
| 65320-4 | Fy3 Ab [Presence] in Serum or Plasma |
| 95832-2 | CD3 dose in hematopoietic progenitor cell transfusion [#/mass] |
| 81275-0 | fentaNYL and Norfentanyl panel - Serum or Plasma |
| 8153-9 | Amphetamines [Mass/volume] in Unknown substance |
| 9701-4 | sulfiSOXAZOLE [Mass/volume] in Serum or Plasma |
| 97097-0 | SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay |
| 81751-0 | Chromosome 17p13.1 deletion and 14q32 rearrangements in Bone marrow by FISH |
| 82095-1 | Food Allergen Mix 11 (Broccoli+Carrot+White bean+Peas+Corn) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 9754-3 | Coxsackievirus A4 Ab [Titer] in Serum by Complement fixation |
| 9795-6 | Composition in Stone |
| 71617-5 | Polymorphonuclear cells/Leukocytes [Pure number fraction] in Synovial fluid by Manual count |
| 98209-0 | Legionella pneumophila IgG and IgM panel - Serum |
| 71768-6 | Ebola virus Ag [Presence] in Specimen by Immunoassay |
| 72407-0 | Benzoylecgonine [Presence] in Blood by Screen method |
| 72456-7 | Benzodiazepines [Presence] in Saliva (oral fluid) by Confirmatory method |
| 83325-1 | HIV 1 RNA genotype in Isolate |
| 85479-4 | Respiratory syncytial virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 99864-1 | Erythrocytes.dysmorphic [#/volume] in Urine sediment by Computer assisted method |
| 72649-7 | Glucose in serum - glucose in peritoneal fluid [Molar concentration difference] |
| 72725-5 | t(11;14)(q13.2;q32)(MYEOV,IGH) fusion transcript [Identifier] in Blood or Tissue by FISH Nominal |
| 86038-7 | Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum by Immunoassay |
| 73180-2 | Quinapril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73327-9 | Irbesartan+hydroCHLOROthiazide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74408-6 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA panel - Specimen |
| 89350-3 | CD27+IgD-IgM- cells/100 CD19 cells in Blood |
| 4117-8 | Aminopyrine [Mass] of Dose |
| 41249-4 | Yellow fever virus Ab [Presence] in Serum |
| 41437-5 | Cyclospora colobi DNA [Presence] in Specimen by NAA with probe detection |
| 41732-9 | cefTRIAXone+Clavulanate [Susceptibility] |
| 50754-1 | aPTT in Pooled Platelet poor plasma by Coagulation assay |
| 60226-8 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post dose fructose PO |
| 21415-5 | Neisseria gonorrhoeae DNA [Presence] in Urethra by NAA with probe detection |
| 31458-3 | Legionella pneumophila 2 IgG Ab [Units/volume] in Serum |
| 51090-9 | Cytoplasmic CD179a blasts/100 blasts in Blood |
| 43206-2 | Tetrachloroethylene [Mass/volume] in Urine |
| 21714-1 | MT-TL1 gene m.3243A>G [Presence] in Blood or Tissue by Molecular genetics method |
| 22199-4 | Chlamydia trachomatis C IgM Ab [Titer] in Serum |
| 43288-0 | Spermatozoa IgA Ab/100 spermatozoa in Serum |
| 43362-3 | Cardiolipin IgG Ab [Mass/volume] in Serum |
| 43832-5 | quiNIDine [Presence] in Specimen |
| 2305-1 | Galactokinase [Enzymatic activity/volume] in Red Blood Cells |
| 44678-1 | Margin(s) involved by invasive carcinoma in Prostate tumor |
| 23530-9 | Trypanosoma evansi rRNA [Presence] in Specimen by Probe |
| 53870-2 | HPS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 45167-4 | IgE [Mass/volume] in Specimen |
| 23733-9 | Feline leukemia virus Ab [Presence] in Serum by Immunofluorescence |
| 24101-8 | Acid sphingomyelinase [Enzymatic activity/mass] in Leukocytes |
| 33848-3 | Plasma cell precursor [#/volume] in Blood by Manual count |
| 33850-9 | Plasma cells immature [#/volume] in Bone marrow by Manual count |
| 54386-8 | Dehydroascorbate [Moles/volume] in Serum or Plasma |
| 46201-0 | Porcine adenovirus Ab [Presence] in Serum |
| 2440-6 | Hydroxocobalamin [Mass/volume] in Serum or Plasma |
| 34516-5 | SPAST gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55624-1 | Cefacetrile [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 47935-2 | Somatotropin [Units/volume] in Serum or Plasma --pre dose growth hormone releasing factor |
| 48014-5 | Sequence variation panel - Blood or Tissue by Molecular genetics method |
| 26543-9 | Glucose [Mass/volume] in Serum or Plasma --5 hours post dose glucose |
| 48366-9 | Pentadecanoate [Moles/volume] in Serum or Plasma |
| 48410-5 | Yersinia sp IgM Ab [Presence] in Serum by Immunoblot |
| 48611-8 | Antibiotic tested [Identifier] against isolate |
| 48653-0 | Clostridium tetani toxoid IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 57623-1 | Alpha cortol [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
| 28660-9 | Plasminogen actual/normal in Platelet poor plasma by Chromogenic method |
| 29366-2 | Parainfluenza virus 1 Ab [Titer] in Body fluid by Complement fixation |
| 29414-0 | Parainfluenza virus 3 Ab [Titer] in Body fluid |
| 39974-1 | Creatinine [Mass/volume] in Serum or Plasma --2 days post XXX challenge |
| 39992-3 | Creatinine [Mass/volume] in Urine --5 hours post XXX challenge |
| 40097-8 | Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --12 hours post XXX challenge |
| 49829-5 | Norcodeine [Mass/volume] in Urine |
| 50042-1 | Basal metabolic rate index |
| 29944-6 | Alpha-2-Macroglobulin [Mass/volume] in Specimen |
| 40699-1 | Mycobacterium sp identified in Specimen |
| 58937-4 | F12 gene mutations found [Type] in Blood or Tissue by Molecular genetics method |
| 59197-4 | Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in Serum or Plasma |
| 50490-2 | Gastrin [Mass/volume] in Serum or Plasma --6th specimen |
| 30004-6 | Creatinine [Mass/volume] in Urine by Test strip |
| 30070-7 | Cystathionine [Moles/volume] in Amniotic fluid |
| 30361-0 | HIV 2 Ab [Presence] in Serum or Plasma by Immunoassay |
| 4116-0 | aMILoride [Mass] of Dose |
| 100811-9 | Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge |
| 100865-5 | Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection |
| 12481-8 | Arsenic.inorganic [Mass/volume] in Urine |
| 12835-5 | Prolactin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 13009-6 | Methyl ethyl ketone [Mass/volume] in Urine |
| 13597-0 | Neutrophils/100 leukocytes in Nose |
| 14149-9 | Corticotropin Big Fragment [Mass/volume] in Serum or Plasma |
| 102725-9 | Cotton linters IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14698-5 | Digoxin [Moles/volume] in Serum or Plasma |
| 14856-9 | Nortriptyline [Moles/volume] in Serum or Plasma |
| 10846-4 | Borrelia burgdorferi DNA [Presence] in Blood by Probe with amplification |
| 10942-1 | Cockspur IgE Ab [Units/volume] in Serum |
| 16317-0 | Prostatic acid phosphatase [Presence] in Vaginal fluid |
| 16394-9 | Nuclear Ab [Presence] in Body fluid by Immunofluorescence |
| 16511-8 | Calcitonin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 16663-7 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --3 hours post XXX challenge |
| 17089-4 | Lorcainide [Mass/volume] in Serum or Plasma |
| 17398-9 | Human papilloma virus 11 Ag [Presence] in Specimen |
| 1828-3 | Alpha 1 antitrypsin MZ [Mass/volume] in Serum or Plasma |
| 18890-4 | Cefpodoxime [Susceptibility] |
| 18928-2 | Gentamicin [Susceptibility] |
| 1907-5 | Asparagine [Presence] in Serum or Plasma |
| 90821-0 | Contactin-associated protein 2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 75391-3 | FGFR3 gene targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
| 60325-8 | OLANZapine [Moles/volume] in Specimen |
| 6091-3 | Cow dander IgE Ab [Units/volume] in Serum |
| 76621-2 | Lysosomal acid lipase panel - Fibroblast |
| 61345-5 | Flounder IgE Ab/IgE total in Serum |
| 62250-6 | Immature reticulocytes/Reticulocytes.total in Blood from Fetus by Automated count |
| 7708-1 | Wheat smut IgE Ab [Units/volume] in Serum |
| 7721-4 | Strawberry IgG Ab [Units/volume] in Serum |
| 77642-7 | HLA-B IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
| 6286-9 | Wormwood IgE Ab [Units/volume] in Serum |
| 63098-8 | Venison IgG Ab [Mass/volume] in Serum |
| 63142-4 | Bass, Black IgG Ab [Mass/volume] in Serum |
| 63484-0 | Actin.filamentous Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 79305-9 | D-2-hydroxyglutarate [Moles/volume] in Serum or Plasma |
| 79670-6 | Guanosine [Moles/volume] in Serum or Plasma |
| 79721-7 | CYP4F2 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
| 95770-4 | GALT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 80707-3 | CD27+IgD+ cells/100 CD19+CD20+ cells in Blood |
| 96-8 | Cefonicid [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 9718-8 | Toxocara canis IgG Ab [Units/volume] in Serum by Immunoassay |
| 69882-9 | Service comment 55 |
| 69946-2 | Treponema pallidum IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 70059-1 | Hantavirus puumala IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 81656-1 | Campylobacter coli+jejuni tuf gene [Presence] in Stool by NAA with probe detection |
| 82578-6 | Food Allergen Mix 31 (Apple+Cherry+Plum+Peach+Pear) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 99365-9 | Sheep milk IgG Ab [Mass/volume] in Serum |
| 99405-3 | Cells.CD19+FMC7+/100 cells in Blood |
| 99932-6 | Bacteria [Presence] in Body fluid by Automated |
| 72811-3 | Gabapentin/Creatinine [Mass Ratio] in Urine |
| 86169-0 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum |
| 73083-8 | Verapamil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73153-9 | Sildenafil citrate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87581-5 | Aflatoxin G2 [Mass/mass] in Specimen |
| 88042-7 | little p phenotype [Presence] on Red Blood Cells from Donor |
| 88293-6 | Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) |
| 88342-1 | Malassezia sp [Presence] in Ear by Light microscopy |
| 41217-1 | Yellow fever virus IgG Ab [Presence] in Serum |
| 59636-1 | clonazePAM [Mass/volume] in Blood |
| 5969-1 | Plasmin-plasmin inhibitor complex [Mass/volume] in Platelet poor plasma by Immunoassay |
| 50781-4 | Cancer Ag 19-9 [Units/volume] in Peritoneal fluid |
| 50964-6 | Liley Zone [Presence] in Amniotic fluid by Spectrophotometry |
| 4191-3 | Clobenzorex [Mass] of Dose |
| 4198-8 | Clostebol [Mass] of Dose |
| 31451-8 | La Crosse virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 31605-9 | Rickettsia sibirica Ab [Units/volume] in Serum |
| 51460-4 | Influenza virus A H16 Ab [Titer] in Serum |
| 2200-4 | Delta aminolevulinate [Mass/time] in 24 hour Urine |
| 22625-8 | Xylose [Moles/volume] in Blood --2 hours post dose xylose PO |
| 22642-3 | Tyrosine [Moles/volume] in Cerebral spinal fluid |
| 32151-3 | Microscopic observation [Identifier] in Vaginal fluid by Non-gynecological cytology method |
| 43938-0 | CD59 cells/100 cells in Body fluid |
| 33239-5 | Ammonium urate crystals [Presence] in Urine by Computer assisted method |
| 53122-8 | Sodium [Moles/time] in 1 hour Urine |
| 53282-0 | Granular casts [#/volume] in Urine by Computer assisted method |
| 44582-5 | IgA [Presence] in Skin by Immunofluorescence |
| 2343-2 | Glucose [Mass/volume] in Dialysis fluid |
| 33467-2 | Prealbumin [Mass/volume] in Cord blood |
| 3369-6 | Aztreonam [Mass/volume] in Serum or Plasma |
| 53602-9 | Taenia solium larva Ag [Units/volume] in Serum |
| 3406-6 | Bromazepam [Mass/volume] in Urine |
| 54221-7 | Lymphoma markers [Interpretation] in Specimen Narrative |
| 54244-9 | Influenza virus identified in Specimen |
| 4594-8 | Hemoglobin I [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 24487-1 | Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 34629-6 | CISplatin [Mass/volume] in Urine |
| 55396-6 | Beta 2 glycoprotein 1 IgA and IgG panel - Serum |
| 47301-7 | Ribosomal P Ab [Units/volume] in Serum by Immunoassay |
| 25304-7 | Alpha aminoadipate [Moles/time] in 24 hour Urine |
| 367-3 | Norfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 38197-0 | Bordetella parapertussis Ag [Presence] in Nasopharynx by Immunofluorescence |
| 48778-5 | Nucleated erythrocytes/100 cells in Cerebral spinal fluid |
| 27080-1 | Methylenedioxyethylamphetamine [Mass/mass] in Meconium |
| 2714-4 | Fractional oxyhemoglobin in Arterial blood |
| 49164-7 | Orientia tsutsugamushi Kato IgM Ab [Titer] in Body fluid |
| 27354-0 | Toxoplasma gondii IgE Ab [Presence] in Serum |
| 38915-5 | Zinc finger protein of the cerebellum 4 Ab [Presence] in Serum |
| 57697-5 | Protein Z Ag [Mass/volume] in Plasma by Immunoassay |
| 49504-4 | CMT demyelinating gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 58752-7 | Wheat recombinant (rTri a) 19 IgE Ab [Units/volume] in Serum |
| 58764-2 | IgM [Mass/time] in 24 hour Urine |
| 29740-8 | Leptospira interrogans sv Szwajizak Ab [Presence] in Serum |
| 59154-5 | Base deficit in Cord blood |
| 50258-3 | Aldosterone [Moles/volume] in Serum or Plasma --post 25 mg captopril PO |
| 50499-3 | Somatotropin [Mass/volume] in Serum or Plasma --7th specimen |
| 30034-3 | Bovine herpesvirus 1 Ab [Presence] in Serum by Complement fixation |
| 30280-2 | Nelfinavir [Susceptibility] by Phenotype method |
| 41084-5 | MSH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19637-8 | Norpropoxyphene cutoff [Mass/volume] in Urine for Confirmatory method |
| 20682-1 | Ammonia [Mass/volume] in Urine |
| 20693-8 | Bacteria identified in Litter by Aerobe culture |
| 100416-7 | Savoy cabbage IgG Ab [Units/volume] in Serum |
| 100789-7 | Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum |
| 12755-5 | Insulin [Mass/volume] in Serum or Plasma --11 hour post XXX challenge |
| 1288-0 | P1 Ab [Presence] in Serum or Plasma |
| 13196-1 | Ehrlichia sp IgG Ab [Presence] in Serum |
| 101942-1 | Candida lusitaniae DNA [Presence] in Specimen by NAA with probe detection |
| 13665-5 | 1-Methylhistidine/Creatinine [Mass Ratio] in Urine |
| 13887-5 | Lactate dehydrogenase 2/Lactate dehydrogenase.total in Urine by Electrophoresis |
| 102787-9 | Pear IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14557-3 | Mycobacterium tuberculosis DNA [Presence] in Bronchial specimen by NAA with probe detection |
| 14789-2 | Helminth identified in Specimen by Macro/micro identification |
| 14816-3 | Lipoprotein.pre-beta [Moles/volume] in Serum or Plasma by Electrophoresis |
| 10562-7 | Cells [#/volume] in Cervical mucus |
| 16647-0 | Collagen Ab [Units/volume] in Serum |
| 11220-1 | Iodine Free [Mass/time] in 24 hour Urine |
| 12181-4 | Calcium [Moles/volume] in Body fluid |
| 12307-5 | Dichloroethane [Mass/volume] in Blood |
| 17272-6 | Methylenedianiline [Mass/volume] in Blood |
| 1839-0 | Ammonia [Moles/volume] in Blood |
| 18435-8 | SUFentanil [Presence] in Urine |
| 18987-8 | Sulfonamide [Susceptibility] |
| 90440-9 | BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection |
| 61066-7 | Ethanol [Presence] in Specimen by Screen method |
| 61114-5 | Mitochondria DNA complex III targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 92817-6 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose glucagon |
| 6225-7 | Rat serum proteins IgE Ab [Units/volume] in Serum |
| 77201-2 | Buprenorphine+Norbuprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method |
| 77203-8 | Smut fungi (Ustilago nuda+Ustilago tritici+Ustilago maydis+Tilletia tritici) IgE Ab [Units/volume] in Serum |
| 93905-8 | ABO group [Type] in Blood--during infancy |
| 78232-6 | Cells.BCL2 gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 94627-7 | Neospora caninum DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 63541-7 | Ribosomal P Ab [Presence] in Body fluid |
| 63567-2 | Neutrophil cytoplasmic Ab pattern [Interpretation] in Body fluid by Immunofluorescence |
| 7921-0 | Influenza virus A Bangkok Ab [Units/volume] in Serum |
| 79309-1 | Gamma butyrobetaine [Moles/volume] in Cerebral spinal fluid |
| 9491-2 | Aspergillus sp IgA Ab [Units/volume] in Serum |
| 6600-1 | Haemophilus sp identified in Specimen by Organism specific culture |
| 66725-3 | Adenovirus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 8042-4 | Trichinella spiralis Ab [Units/volume] in Serum |
| 80715-6 | FSHR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 80972-3 | Amikacin free [Mass/volume] in Serum or Plasma |
| 96801-6 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post dose arginine |
| 81754-4 | Nortapentadol [Mass/volume] in Urine by Confirmatory method |
| 97248-9 | fentaNYL [Presence] in Cord tissue by Screen method |
| 97303-2 | Tapentadol [Presence] in Cord tissue by Confirmatory method |
| 97324-8 | Carbapenem resistant bacteria identification and resistance panel by Molecular genetics method |
| 97641-5 | dRVVT/dRVVT.excess phospholipid [Ratio] normalized in Platelet poor plasma by Coagulation assay --post DOAC neutralization |
| 97769-4 | Nucleated erythrocytes [#/volume] in Cord blood |
| 82543-0 | Dog recombinant (rCan f) 4 IgE Ab [Units/volume] in Serum |
| 71780-1 | Rift valley fever virus IgG Ab [Presence] in Serum by Immunoassay |
| 85283-0 | Organ tumor is adherent to [Anatomy] in Colorectal cancer specimen by Light microscopy |
| 72886-5 | CYP2D6 gene and CYP2C19 gene targeted mutation analysis panel - Blood or Tissue by Molecular genetics method |
| 86502-2 | Varicella zoster virus strain DNA [Type] in Specimen by NAA with probe detection |
| 73005-1 | levETIRAcetam induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87332-3 | Porcine circovirus type 2 Ag [Presence] in Tissue by Immune stain |
| 87936-1 | Bacteria identified in Burn by Anaerobe culture |
| 87938-7 | Bacteria identified in Implanted device by Anaerobe culture |
| 88000-5 | Microscopic observation [Identifier] in Pleural fluid by Giemsa stain |
| 89007-9 | SOX-2 Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 89876-7 | MTB complex rifAMPin and isoniazid resistance panel by Molecular genetics method |
| 59607-2 | ALPRAZolam [Mass/volume] in Blood by Confirmatory method |
| 30446-9 | Myelocytes [#/volume] in Blood |
| 30540-9 | Octanoylcarnitine (C8) [Moles/volume] in Serum or Plasma |
| 51637-7 | Plateletcrit [Volume Fraction] in Blood |
| 22406-3 | Listeria monocytogenes Ab [Titer] in Serum |
| 22725-6 | Ornithine [Moles/volume] in Specimen |
| 5253-0 | Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay |
| 53357-0 | Trichomonas sp [#/area] in Urine by Computer assisted method |
| 44408-3 | Suberate/Creatinine [Molar ratio] in 24 hour Urine |
| 44783-9 | Sodium [Moles/volume] (Maximum value during study) in Serum or Plasma |
| 23462-5 | Theileria annulata Ab [Titer] in Serum by Immunofluorescence |
| 24003-6 | Brucella sp identified in Bone marrow by Organism specific culture |
| 24071-3 | Beta-N-acetylhexosaminidase.B/Beta-n-acetylhexosaminidase.total in Leukocytes |
| 34200-6 | Nucleated erythrocytes [Presence] in Blood by Automated count |
| 24393-1 | Cortisol [Moles/volume] in Serum or Plasma --10 hours post 1 mg dexamethasone PO overnight |
| 55499-8 | Insulin [Moles/volume] in Serum or Plasma --15 minutes post dose glucose IV |
| 47218-3 | Cholesterol in VLDL 3+4 [Mass/volume] in Serum or Plasma |
| 25471-4 | Mercury [Moles/time] in 24 hour Urine |
| 25555-4 | Wuchereria bancrofti Ag [Presence] in Serum |
| 35262-5 | Creatinine [Mass or Moles] in 24 hour Urine |
| 55793-4 | Nucleated cells [#/volume] in Body fluid |
| 47807-3 | 2-Deoxytetronate/Creatinine [Molar ratio] in Urine |
| 25974-7 | Phosphoserine/Creatinine [Molar ratio] in 24 hour Urine |
| 35536-2 | Egg yolk IgG Ab [Mass/volume] in Serum |
| 48145-7 | Mevalonolactone/Creatinine [Molar ratio] in Urine |
| 3729-1 | Loxapine [Presence] in Urine |
| 57032-5 | Treponema pallidum Ab [Presence] in Serum by Immunoblot |
| 27222-9 | Oxalate [Mass/volume] in 24 hour Urine |
| 57364-2 | Lactate [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 57517-5 | 11-Hydroxyetiocholanolone [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
| 48972-4 | FGFR2 gene+FGFR3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 5775-2 | Calcium phosphate crystals [Presence] in Urine sediment by Light microscopy |
| 49360-1 | Hepatitis B virus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection |
| 49652-1 | SCA7 gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 28542-9 | Platelet mean volume [Entitic volume] in Blood |
| 2854-8 | Prostaglandin F [Mass/volume] in Plasma |
| 29260-7 | Monocytes Abnormal [#/volume] in Blood by Manual count |
| 3978-4 | Primidone [Mass/volume] in Serum or Plasma |
| 50037-1 | Powassan virus neutralizing antibody [Presence] in Specimen by Neutralization test |
| 40420-2 | Amphetamine+Methamphetamine [Presence] in Specimen |
| 588-4 | Legionella pneumophila Ag [Presence] in Specimen by Immunofluorescence |
| 58962-2 | Ganglioside GT1b IgG Ab [Units/volume] in Serum by Immunoassay |
| 50428-2 | Corticotropin [Mass/volume] in Plasma --1 hour post 100 ug CRH IV |
| 40775-9 | Histoplasma capsulatum IgM Ab [Titer] in Serum --1st specimen |
| 40847-6 | Brome IgG4 Ab [Mass/volume] in Serum |
| 21015-3 | CD33 cells [#/volume] in Blood |
| 100110-6 | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot |
| 101117-0 | Sezary syndrome monitoring in Blood Document by Flow cytometry (FC) |
| 13269-6 | Mycoplasma pneumoniae Ab [Units/volume] in Serum --2nd specimen |
| 101873-8 | Metabotropic glutamate receptor 1 IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 1351-6 | Yt sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
| 14048-3 | Elastase.pancreatic [Mass/volume] in Serum |
| 14672-0 | Coproporphyrin 3 [Moles/volume] in Stool |
| 10335-8 | Color of Cerebral spinal fluid |
| 15467-4 | Equine herpesvirus 1 neutralizing antibody [Titer] in Serum by Neutralization test |
| 15472-4 | Equine influenza virus Ag [Presence] in Nose by Immunoassay |
| 16649-6 | Coproporphyrinogen oxidase [Enzymatic activity/volume] in Red Blood Cells |
| 17-4 | Amoxicillin [Susceptibility] by Disk diffusion (KB) |
| 17785-7 | Radioactive iodine.thyroid/Radioactive iodine dose [Ratio] |
| 91114-9 | Cholesterol in LDL 3 [Moles/volume] in Serum or Plasma |
| 91858-1 | Herpes simplex virus 2 DNA [Presence] in Genital specimen by NAA with probe detection |
| 75124-8 | Deoxyadenosine [Moles/volume] in Cerebral spinal fluid |
| 9347-6 | pH combined acid of Gastric fluid |
| 94210-2 | ARSB gene full mutation analysis in Blood or Tissue by Sequencing |
| 6304-0 | Budgerigar droppings IgE Ab [Units/volume] in Serum |
| 94667-3 | Delayed hypersensitivity anergy intradermal panel |
| 64798-2 | Oxygen content in Mixed venous blood by calculation |
| 79340-6 | Carnitine biosynthesis intermediates pattern [Interpretation] in Cerebral spinal fluid Narrative |
| 80123-3 | Alizapride [Mass/mass] in Hair |
| 80214-0 | Beta blockers [Presence] in Serum or Plasma by Screen method |
| 95795-1 | HBG1 and HBG2 genes full mutation analysis in Blood or Tissue by Sequencing |
| 958-9 | C sup(w) Ag [Presence] on Red Blood Cells from Blood product unit |
| 96421-3 | Testosterone [Mass/volume] in DBS |
| 96488-2 | Neuronal intermediate filament heavy chain IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 6801-5 | Complement C3 [Mass/volume] in Body fluid |
| 81631-4 | Methotrexate polyglutamates [Interpretation] in Red Blood Cells Narrative |
| 82253-6 | JAG1 gene deletion in Blood or Tissue by FISH |
| 97235-6 | Cocaine [Presence] in Cord tissue by Confirmatory method |
| 7100-1 | Asparagus IgG Ab [Units/volume] in Serum |
| 82404-5 | Ganglioside GD3 IgM Ab [Presence] in Serum by Line blot |
| 82579-4 | Food Allergen Mix 31 (Apple+Cherry+Plum+Peach+Pear) IgE Ab [Units/volume] in Serum by Multidisk |
| 98020-1 | Leukocytes [#/volume] in Lower respiratory specimen by Manual count |
| 98027-6 | Lecithin [Presence] in Semen by Light microscopy |
| 99090-3 | Haemophilus influenzae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 72453-4 | PHENobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 72655-4 | Aldolase [Enzymatic activity/mass] in Red Blood Cells |
| 85832-4 | Beta-lactam resistance ESBL blaCTX-M-1 Group gene [Presence] by Molecular method |
| 86323-3 | Enterovirus Ag [Presence] in Specimen by Immunofluorescence |
| 73238-8 | Nizatidine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73257-8 | Morphine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87469-3 | Magnesium [Mass/volume] in Specimen |
| 73506-8 | Benazepril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7366-8 | Cocksfoot triggered histamine release [Units/volume] in Blood |
| 87998-1 | Amoeba identified in Stool by Wet preparation |
| 88889-1 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 41399-7 | Herpes simplex virus 1+2 IgM Ab [Units/volume] in Serum by Immunoassay |
| 59350-9 | 4-Hydroxy-Tamoxifen [Mass/volume] in Serum or Plasma |
| 59395-4 | Latex recombinant (rHev b) 9 IgE Ab [Units/volume] in Serum |
| 5957-6 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --20M post incubation with normal plasma |
| 50991-9 | Horowitz index adjusted to patients actual temperature in Venous blood |
| 30491-5 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum --2nd specimen |
| 60312-6 | lamoTRIgine [Moles/volume] in Specimen |
| 21096-3 | Black Bean IgE Ab [Units/volume] in Serum |
| 21121-9 | Borrelia hermsii IgG Ab [Titer] in Serum by Immunofluorescence |
| 31247-0 | Barmah forest virus IgG Ab [Presence] in Serum |
| 31524-2 | Nairobi sheep disease virus Ab [Units/volume] in Serum |
| 51268-1 | CD23 cells/100 cells in Bone marrow |
| 51412-5 | 3-Hydroxyisovalerylcarnitine+2-Methyl,3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma |
| 42867-2 | CD117 cells/100 cells in Body fluid |
| 51764-9 | Trypanosoma cruzi IgG and IgM [Interpretation] in Serum or Plasma |
| 4343-0 | Nalorphine [Mass] of Dose |
| 22361-0 | HTLV I+II Ab [Presence] in Cerebral spinal fluid |
| 32191-9 | Monocytes+Macrophages [Presence] in Cerebral spinal fluid by Light microscopy |
| 32547-2 | Ketones [Moles/volume] in Serum or Plasma by Test strip |
| 5207-6 | Herpes simplex virus 1 IgM Ab [Units/volume] in Serum by Immunoassay |
| 23033-4 | Duck hepatitis virus 1 neutralizing antibody [Presence] in Serum by Neutralization test |
| 3260-7 | Fibrinopeptide B beta (1-14) Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
| 32842-7 | HIV 1 p17+p18 Ab [Presence] in Serum |
| 53148-3 | DNA double strand Ab [Presence] in Body fluid |
| 53210-1 | Suberylcarnitine (C8-DC) [Moles/volume] in DBS |
| 44717-7 | Lipoprotein.beta/Lipoprotein.alpha [Mass Ratio] in Serum or Plasma |
| 44845-6 | Bacteria # 5 identified in Specimen by Culture |
| 45025-4 | HLA-A SBT [Type] by High resolution |
| 4613-6 | Hemoglobin N - Baltimore [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 24508-4 | Aspergillus nidulans Ab [Presence] in Serum by Immune diffusion (ID) |
| 34699-9 | HIV 2 proviral DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 55464-2 | Influenza virus A swine origin RNA [Presence] in Specimen by NAA with probe detection |
| 55487-3 | Insulin [Moles/volume] in Serum or Plasma --2.5 hours post dose glucose IV |
| 55538-3 | Flupenthixol [Moles/volume] in Serum or Plasma |
| 25397-1 | Echinococcus sp Ab [Presence] in Serum by Immunoassay |
| 55693-6 | Ornidazole [Susceptibility] by Disk diffusion (KB) |
| 55934-4 | Lipase [Enzymatic activity/volume] in Dialysis fluid |
| 56454-2 | Cumin IgG4 Ab [Mass/volume] in Serum |
| 47995-6 | Glucose [Moles/volume] in Cord blood |
| 2629-4 | Methylmalonate [Mass/volume] in Serum or Plasma |
| 48750-4 | 3-Hydroxy fatty acids pattern [Interpretation] in Serum or Plasma |
| 27037-1 | Calcium/Creatinine [Mass Ratio] in 2 hour Urine |
| 38648-2 | Chlorobenzene [Mass/volume] in Air |
| 5747-1 | Tin [Mass/volume] in Blood |
| 4941-1 | HLA-DQ5(1) [Presence] |
| 4986-6 | HLA-DR7 [Presence] in Donor |
| 4987-4 | HLA-DR7 [Presence] |
| 50094-2 | 21-Deoxycortisol [Moles/volume] in Serum or Plasma --45 minutes post 250 ug corticotropin |
| 29838-0 | Jamestown canyon virus IgM Ab [Presence] in Cerebral spinal fluid |
| 40705-6 | Brodifacoum [Mass/volume] in Blood |
| 59055-4 | Glucagon [Mass/volume] in Serum or Plasma --3rd specimen fasting |
| 50515-6 | Lutropin [Units/volume] in Serum or Plasma --7th specimen |
| 50528-9 | Parathyrin.intact [Mass/volume] in Serum or Plasma --4th specimen |
| 30298-4 | lamiVUDine [Susceptibility] |
| 19316-9 | Tricyclic antidepressants positive [Identifier] in Urine by Confirmatory method |
| 20402-4 | CD16+CD56+ cells [#/volume] in Blood |
| 101651-8 | MYC and BCL2 rearrangements in Tissue by FISH |
| 12990-8 | Polychlorinated biphenyl.Aroclor 1260 [Mass/volume] in Serum or Plasma |
| 13925-3 | Soluble liver Ab [Presence] in Serum |
| 14006-1 | Prostaglandin E2 [Mass/time] in 24 hour Urine |
| 14740-5 | Gastrin [Moles/volume] in Serum or Plasma --30 minutes post 0.2 U/kg secretin |
| 104183-9 | Adenovirus DNA [Presence] in Conjunctival specimen by NAA with probe detection |
| 14959-1 | Microalbumin/Creatinine [Mass Ratio] in Urine |
| 104440-3 | Polio virus 3 Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 10713-6 | Prototheca identified in Specimen by Culture |
| 1103-1 | Kp sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
| 11237-5 | hydrALAZINE [Mass/volume] in Serum or Plasma |
| 1147-8 | Lu sup(b) Ag [Presence] on Red Blood Cells |
| 17811-1 | Alpha 1 globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
| 18874-8 | Cefaclor [Susceptibility] |
| 90417-7 | Transferrin.carbohydrate deficient and Apolipoprotein C-III panel - Serum or Plasma |
| 74875-6 | Alloisoleucine [Moles/volume] in DBS --post therapeutic diet |
| 93047-9 | Specimen condition [Type] |
| 77204-6 | Buprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method |
| 93705-2 | Ethyl sulfate and Ethyl glucuronide panel - Urine |
| 6288-5 | Yellow Hornet IgE Ab [Units/volume] in Serum |
| 77961-1 | cloZAPine [Mass/volume] in Urine by Confirmatory method |
| 94440-5 | HLA-DP and DQ and DR (class II) IgG panel - Serum or Plasma by Flow cytometry (FC) |
| 66445-8 | Cyprinus carpio recombinant (rCyp c) 1 IgE Ab [Units/volume] in Serum |
| 6650-6 | Cefpirome [Susceptibility] by Serum bactericidal titer |
| 80201-7 | Alizapride [Mass/volume] in Urine |
| 96330-6 | Streptococcus pneumoniae DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection |
| 68956-2 | DNA double strand IgG Ab [Units/volume] in Pericardial fluid by Immunoassay |
| 81313-9 | Cryoglobulin.complement C3 [Presence] in Serum |
| 9676-8 | Silicone IgE Ab [Units/volume] in Serum |
| 69364-8 | ATP1A2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 82057-1 | Food Allergen Mix 15 (Orange+Apple+Banana+Peach) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 9737-8 | Propoxyphene [Mass/volume] in Gastric fluid |
| 97928-6 | Highlands J virus RNA [Presence] in Specimen by NAA with probe detection |
| 825-0 | Au sup(a) Ag [Presence] on Red Blood Cells from Donor |
| 85293-9 | Surgical margin tumor involvement.mesenteric [Presence] in Colorectal cancer specimen by Light microscopy |
| 85381-2 | Isavuconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 99115-8 | Onyong-nyong virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 99866-6 | Acanthocytes/100 erythrocytes in Urine sediment by Computer assisted method |
| 85798-7 | Measles virus N gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 85827-4 | Carbapenem resistance bla OXA-48-like gene [Presence] by Molecular method |
| 86067-6 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 73448-3 | Cilastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73591-0 | Premafloxacin [Susceptibility] |
| 73595-1 | Nitazoxanide [Susceptibility] |
| 88004-7 | Trisomy 18 risk based on maternal age + Pregnancy associated plasma protein A + Choriogonadotropin + Nuchal translucency [Likelihood] in Fetus |
| 88633-3 | Microscopic observation [Identifier] in Lower respiratory specimen by Giemsa stain |
| 59604-9 | Alpha hydroxyalprazolam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 3068-4 | Tryptophan [Mass/volume] in Cerebral spinal fluid |
| 31051-6 | Coxsackievirus A10 Ab [Titer] in Body fluid by Complement fixation |
| 31168-8 | Mesityl oxide [Mass/volume] in Urine |
| 4234-1 | Encainide [Mass] of Dose |
| 60305-0 | fluPHENAZine [Moles/volume] in Specimen |
| 21120-1 | Borrelia burgdorferi DNA [Presence] in Urine by NAA with probe detection |
| 21166-4 | CD56 cells/100 cells in Specimen |
| 21626-7 | ATP7B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 31366-8 | Endomysium IgA Ab [Units/volume] in Serum |
| 22133-3 | Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid |
| 3165-8 | Volume [Flow] of 72 hour Stool |
| 51627-8 | Lymphocytes [#/volume] in Peritoneal fluid by Manual count |
| 43366-4 | Parainfluenza virus Ag [Identifier] in Specimen by Immunofluorescence |
| 3240-9 | Coagulation factor XIII coagulum dissolution [Units/volume] in Platelet poor plasma by Coagulation assay |
| 22945-0 | Brucella sp Ag [Presence] in Tissue by Immune stain |
| 23152-2 | Leishmania sp Ab [Titer] in Serum |
| 33217-1 | Spermatozoa Agglutinated [Presence] in Semen |
| 53256-4 | Enterovirus RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 23502-8 | Tritrichomonas foetus Ag [Presence] in Tissue from Fetus by Immune stain |
| 33515-8 | Clarity of Specimen |
| 33528-1 | Platelet aggregation ADP induced in Control Platelet rich plasma --High dose |
| 33622-2 | Isotricarboxylporphyrin [Mass/time] in 24 hour Stool |
| 45172-4 | Purkinje cells Ab [Units/volume] in Serum by Immunofluorescence |
| 23711-5 | Ehrlichia canis Ab [Titer] in Serum |
| 23890-7 | Lead [Mass/mass] in Specimen |
| 4631-8 | Hemoglobin F [Presence] in Stool by Apt-Downey method |
| 24189-3 | Coxsackievirus B4 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24321-2 | Basic metabolic 2000 panel - Serum or Plasma |
| 34461-4 | West Nile virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 54939-4 | Meta methylhippurate+Para methylhippurate [Mass/volume] in Serum or Plasma |
| 55202-6 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --5 minutes post incubation after addition of normal plasma |
| 34985-2 | Unidentified cells/100 leukocytes in Body fluid |
| 47902-2 | Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose betaxolol+glucagon |
| 35615-4 | Lidocaine [Mass/volume] in Serum or Plasma by Screen method |
| 56389-0 | Sole IgG4 Ab [Mass/volume] in Serum |
| 47945-1 | Testosterone [Mass/volume] in Serum or Plasma --3 days post 5000 U HCG IM |
| 48281-0 | Sulfamethoxazole triggered leukotriene release [Mass/volume] by Leukocytes |
| 26599-1 | Anserine [Moles/volume] in Serum or Plasma |
| 56907-9 | CD3+CD45+ cells/100 cells in Blood |
| 48713-2 | Bartonella quintana IgG Ab [Units/volume] in Serum or Plasma by Immunofluorescence |
| 27925-7 | Hemoglobin.gastrointestinal [Presence] in Stool --7th specimen |
| 38674-8 | Sperm Head IgA Ab/100 spermatozoa in Specimen by Immunobead |
| 57997-9 | Lopinavir+Ritonavir [Susceptibility] by Phenotype method |
| 58348-4 | MethylePHEDrine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 49415-3 | JC virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
| 2908-2 | Pyruvate [Mass/volume] in Urine |
| 50065-2 | 1-Methylhistidine [Moles/volume] in DBS |
| 5009-6 | Hepatitis B virus DNA [Presence] in Specimen by NAA with probe detection |
| 5046-8 | Hantavirus Ab [Units/volume] in Serum |
| 30380-0 | Eosinophils/100 leukocytes in Peritoneal fluid |
| 41019-1 | Beta endorphin [Moles/volume] in Serum or Plasma |
| 20958-5 | Sarcocystis neurona Ab [Presence] in Blood by Immunoblot |
| 1007-4 | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells |
| 12522-9 | Catecholamines [Mass/volume] in Plasma --2nd specimen post XXX challenge |
| 12831-4 | Prolactin [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 13145-8 | Streptococcus pneumoniae Danish serotype 6B Ab [Units/volume] in Serum --1st specimen |
| 102215-1 | Mountain Juniper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13797-6 | Porphobilinogen/Creatinine [Mass Ratio] in Urine |
| 13801-6 | Protein/Creatinine [Mass Ratio] in 24 hour Urine |
| 14027-7 | HTLV I+II rgp21 Ab [Presence] in Serum or Plasma by Immunoblot |
| 103094-9 | Latex recombinant (rHev b) 6.01 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1464-7 | EPINEPHrine [Mass/volume] in Plasma --pre 300 ug cloNIDine PO |
| 14667-0 | Coproporphyrin 1 [Moles/volume] in Serum or Plasma |
| 14726-4 | Fluoride [Moles/volume] in Serum or Plasma |
| 10338-2 | Barbiturates [Mass/volume] in Serum or Plasma |
| 15121-7 | Lipoprotein.alpha/total Lipoprotein in Serum or Plasma |
| 104268-8 | UBA1 gene mutation in Specimen by Molecular genetics method |
| 1102-3 | Kp sup(a) Ag [Presence] on Red Blood Cells |
| 16538-1 | Candida sp IgA Ab [Units/volume] in Saliva (oral fluid) |
| 17141-3 | CD36 cells/100 cells in Blood |
| 18959-7 | Ofloxacin [Susceptibility] |
| 90047-2 | Spermatozoa.excess residual cytoplasm/100 spermatozoa in Semen |
| 61054-3 | Normeperidine [Presence] in Specimen |
| 7662-0 | Red Snapper IgG Ab [Units/volume] in Serum |
| 61253-1 | Arizona Cypress IgE Ab/IgE total in Serum |
| 77330-9 | Protriptyline [Moles/volume] in Specimen |
| 93879-5 | N-Palmitoylsphingosine/N-Lignoceroylsphingosine [Molar ratio] in Plasma |
| 63202-6 | White mulberry IgG Ab [Mass/volume] in Serum |
| 7874-1 | Ehrlichia canis Ab [Presence] in Serum |
| 94295-3 | DULoxetine [Presence] in Serum or Plasma by Screen method |
| 94592-3 | Chromosome rearrangement [Identifier] in Blood or Tissue by Mate pair sequencing Nominal |
| 95640-9 | Colorado tick fever virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 95684-7 | Murray Valley encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay |
| 66721-2 | Adenovirus DNA [#/volume] (viral load) in Body fluid by NAA with probe detection |
| 9699-0 | PARoxetine [Mass/volume] in Serum or Plasma |
| 97102-8 | Phosphorylated tau 181/Amyloid beta 42 peptide [Ratio] in Cerebral spinal fluid |
| 69568-4 | Bacterial vaginosis [Interpretation] in Vaginal fluid Qualitative |
| 97604-3 | Glial fibrillary acidic protein [Mass/volume] in Plasma by Immunoassay |
| 97964-1 | Pellitory (Parietaria judaica) IgG4 Ab [Mass/volume] in Serum |
| 70217-5 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis |
| 82723-8 | Cocaine+Benzoylecgonine+Cocaethylene [Presence] in Urine by Confirmatory method |
| 85068-5 | Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose dexamethasone |
| 99761-9 | Clot initiation.kaolin induced [Time] in Blood by Resonance TEG |
| 72492-2 | Paraoxonase-arylesterase 1 (PON1) [Enzymatic activity/volume] in Serum |
| 86559-2 | Human bocavirus DNA [Presence] in Tissue by NAA with probe detection |
| 87989-0 | Toxoplasma gondii DNA [Presence] in Bone marrow by NAA with probe detection |
| 88538-4 | Enterovirus RNA [Presence] in Pericardial fluid by NAA with probe detection |
| 50642-8 | Human papilloma virus 6+11+42+43+44 DNA [Presence] in Anal by Probe with signal amplification |
| 41864-0 | Yeast.hyphae [Presence] in Urine by Computer assisted method |
| 4192-1 | Clofibrate [Mass] of Dose |
| 42604-9 | Glucose [Mass/volume] in Urine --3 hours post dose lactose PO |
| 60068-4 | Colchicine [Mass/volume] in Blood |
| 60196-3 | Trichlormethiazide [Mass/volume] in Serum or Plasma |
| 21368-6 | levoFLOXacin [Mass/volume] in Serum or Plasma |
| 31341-1 | Dengue virus 4 Ab [Units/volume] in Serum |
| 43037-1 | Fasciola hepatica Ab [Titer] in Serum |
| 31720-6 | Avian infectious laryngotracheitis virus Ag [Presence] in Lung tissue |
| 31881-6 | Measles virus Ag [Presence] in Serum or Plasma |
| 31941-8 | Pneumocystis jiroveci Ag [Presence] in Throat |
| 51782-1 | Drugs of abuse 7 and Alcohol and Tricyclics panel - Urine by Screen method |
| 43309-4 | Desmoglein 1 and Desmoglein 3 Ab panel [Units/volume] - Serum |
| 43696-4 | Herpes simplex virus identified in Cerebral spinal fluid by Shell vial culture |
| 32224-8 | Alpha aminobutyrate [Moles/volume] in Vitreous fluid |
| 32226-3 | Arginine [Moles/volume] in Vitreous fluid |
| 51962-9 | Pharmacogenetic DNA analysis panel |
| 52962-8 | Tobramycin [Mass/volume] in Cerebral spinal fluid |
| 44020-6 | Borrelia burgdorferi Ab [Presence] in Synovial fluid by Immunoblot |
| 22785-0 | African swine fever virus DNA [Presence] in Tissue by NAA with probe detection |
| 33208-0 | CD235a cells/100 cells in Bone marrow |
| 23410-4 | Rinderpest virus Ab [Presence] in Serum by Immunoassay |
| 53603-7 | Mumps virus RNA [Presence] in Serum by NAA with probe detection |
| 44890-2 | Malignant cells [#/volume] in Cerebral spinal fluid |
| 23709-9 | Ceftiofur [Susceptibility] |
| 23782-6 | Swine influenza virus Ag [Presence] in Tissue by Immune stain |
| 34190-9 | Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum |
| 34253-5 | C peptide [Moles/volume] in Urine |
| 54230-8 | Cell count and Diff panel with Gluc and Prot - Cerebral spinal fluid |
| 4554-2 | Hemoglobin A2/Hemoglobin.total in Blood by Electrophoresis alkaline (pH 8.9) |
| 24206-5 | Rickettsia typhi IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
| 24477-2 | F2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 2471-1 | IgM [Mass/volume] in Cerebral spinal fluid |
| 34302-0 | Etiocholanolone [Moles/volume] in 24 hour Urine |
| 3455-3 | Chloramphenicol [Mass/volume] in Serum or Plasma |
| 47437-9 | Epstein Barr virus early restricted Ab [Presence] in Serum |
| 25332-8 | Bordetella pertussis IgM Ab [Titer] in Serum |
| 47635-8 | Glycine/Amino acids.total in Hair |
| 35435-7 | Histoplasma capsulatum yeast phase Ab [Presence] in Serum by Complement fixation |
| 48631-6 | Bicarbonate [Moles/volume] in Serum --post dialysis |
| 27000-9 | Thyroxine (T4) [Mass/volume] in Saliva (oral fluid) |
| 57299-0 | HLA-DQB1 [Type] by High resolution |
| 57945-8 | Cocaethylene [Presence] in Meconium |
| 58065-4 | Jr sup(a) Ab [Presence] in Serum or Plasma |
| 58079-5 | JMH Ab [Presence] in Serum or Plasma |
| 4933-8 | HLA-DQ1 [Presence] |
| 29349-8 | Potassium [Moles/volume] in Serum or Plasma --post dialysis |
| 49809-7 | 2-Ethyl-3-Hydroxypropionate/Creatinine [Molar ratio] in 24 hour Urine |
| 40797-3 | Alkaline phosphatase.bone [Presence] in Serum or Plasma |
| 19357-3 | Benzoylecgonine cutoff [Mass/volume] in Urine for Screen method |
| 100135-3 | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot |
| 12823-1 | Prolactin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 101800-1 | Lysergate diethylamide/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 102118-7 | Rhabdomyolysis and Metabolic myopathy multigene panel - Blood or Tissue by Molecular genetics method |
| 102189-8 | Brazil Nut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102493-4 | Parrot serum proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14033-5 | 1,4-Dioxane [Mass/volume] in Blood by Gas chromatography |
| 146-1 | Cefuroxime Parenteral [Susceptibility] by Disk diffusion (KB) |
| 15208-2 | Taurine [Presence] in Nose |
| 16112-5 | Estrogen receptor [Interpretation] in Tissue |
| 11017-1 | Microscopic observation [Identifier] in Blood or Marrow by Chloracetate esterase stain |
| 16345-1 | Alpha aminobutyrate [Presence] in Urine |
| 16549-8 | Carbinoxamine [Presence] in Urine |
| 11578-2 | sulfiSOXAZOLE [Susceptibility] by Gradient strip |
| 12185-5 | aPTT in Control Blood by Coagulation assay |
| 16978-9 | HIV 1 p24 Ab [Units/volume] in Serum |
| 17324-5 | Neisseria meningitidis Ag [Units/volume] in Cerebral spinal fluid by Latex agglutination |
| 17697-4 | Tetrachloroethane [Mass/volume] in Blood |
| 17843-4 | Cancer Ag 72-4 [Units/volume] in Serum or Plasma |
| 90746-9 | 5F-ADB-M7 (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
| 75002-6 | Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk |
| 92648-5 | Gabapentin [Presence] in Urine by Confirmatory method |
| 75767-4 | Mesoridazine [Presence] in Blood or Urine by Screen method |
| 76340-9 | Porcine deltacoronavirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 76579-2 | Enterococcus faecium sodA gene [Presence] in Swab specimen by NAA with probe detection |
| 61407-3 | Amitriptyline/Creatinine [Mass Ratio] in Urine |
| 7722-2 | Strawberry triggered histamine release [Units/volume] in Blood |
| 7731-3 | Mandarin IgE Ab [Units/volume] in Serum |
| 77659-1 | Aneuploid cell population in S phase/100 cells in Cells.XXX by Flow cytometry (FC) |
| 77748-2 | PCDH15 gene c.733C>T [Presence] in Blood or Tissue by Molecular genetics method |
| 7782-6 | Yam IgE Ab in Serum |
| 7858-4 | Dengue virus 4 Ab [Presence] in Serum by Immunoassay |
| 94641-8 | SARS-CoV-2 (COVID-19) S gene [Presence] in Specimen by NAA with probe detection |
| 7925-1 | Influenza virus A Mississippi Ab [Units/volume] in Serum |
| 95112-9 | Insulin [Units/volume] in Serum or Plasma --1 hour post meal |
| 79626-8 | L-leucyl-L-proline/Creatinine [Molar ratio] in Urine |
| 79768-8 | Platelet dense bodies [Presence] in Blood by Electron microscopy |
| 96460-1 | Thyroglobulin [Mass/volume] in Serum or Plasma by Immunoassay --post thyroglobulin antibody neutralization |
| 68460-5 | Picornavirus Ag [Presence] in Isolate by Immunofluorescence |
| 80824-6 | Zika virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 8141-4 | Amphetamines [Presence] in Gastric fluid by Confirmatory method |
| 6987-2 | Cefepime [Susceptibility] by Gradient strip |
| 8185-1 | Benzoylecgonine [Presence] in Gastric fluid by Screen method |
| 9741-0 | Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid |
| 71376-8 | Inhalant Allergen Mix 7 (Dermatophagoides pteronyssinus+Cat dander+Cat epithelium+Horse dander+Dog dander+Rabbit epithelium) IgE Ab [Units/volume] in Serum by Multidisk |
| 7154-8 | Blueberry triggered histamine release [Units/volume] in Blood |
| 82548-9 | Food Allergen Mix 30A (Kiwi+Papaya+Mango+Banana+Avocado) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 83111-5 | Prolactin [Units/volume] in Serum or Plasma by Immunoassay |
| 85821-7 | Influenza virus B Victoria lineage Ag [Presence] in Isolate by Hemagglutination inhibition |
| 85972-8 | Streptococcus pneumoniae Danish serotype 12F Ab [Units/volume] in Serum |
| 73053-1 | Atorvastatin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73112-5 | Tolterodine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87327-3 | Porcine circovirus type 2 IgG+IgM Ab [Titer] in Serum by Immunofluorescence |
| 7365-0 | Cocksfoot IgG Ab [Units/volume] in Serum |
| 74214-8 | Apixaban [Mass/volume] in Platelet poor plasma by Chromogenic method |
| 89313-1 | CD3-CD45+ cells [#/volume] in Blood |
| 59683-3 | Hydroxyethylflurazepam [Mass/volume] in Blood by Confirmatory method |
| 59922-5 | Mefenamate [Moles/volume] in Urine |
| 60214-4 | ZOLMitriptan [Mass/volume] in Blood |
| 5108-6 | Coxsackievirus B3 Ab [Titer] in Serum by Complement fixation |
| 5144-1 | Echovirus 6 neutralizing antibody [Titer] in Serum by Neutralization test |
| 2179-0 | Cystine [Mass/time] in 24 hour Urine |
| 3197-1 | Coagulation factor VII activated [Units/volume] in Platelet poor plasma by Coagulation assay |
| 51546-0 | Chicken feather IgG Ab [Presence] in Serum |
| 51804-3 | Rickettsia conorii IgG Ab [Units/volume] in Serum by Immunoassay |
| 43347-4 | Avian paramyxovirus 8 Ab [Titer] in Serum |
| 22320-6 | Hepatitis B virus e Ab [Presence] in Serum |
| 32552-2 | Pyruvate kinase [Enzymatic activity/mass] in Red Blood Cells |
| 52931-3 | Lead/Creatinine [Molar ratio] in 24 hour Urine |
| 52958-6 | Methadone [Moles/volume] in Urine |
| 43836-6 | Beta globulin [Presence] in Serum or Plasma by Electrophoresis |
| 23463-3 | Theileria annulata rRNA [Presence] in Serum by Probe |
| 235-2 | Erythromycin [Susceptibility] by Serum bactericidal titer |
| 24065-5 | Beta glucuronidase [Enzymatic activity/mass] in Leukocytes |
| 34060-4 | Glucose [Moles/volume] in Serum or Plasma --pre or post dose insulin |
| 46950-2 | Flunisolide [Mass/volume] in Urine |
| 2441-4 | Hydroxylysine [Presence] in Serum or Plasma |
| 34280-8 | Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Urine |
| 34618-9 | Hemoglobin [Presence] in Specimen |
| 55099-6 | Parainfluenza virus 3 [Presence] in Specimen by Organism specific culture |
| 47119-3 | Meprobamate [Moles/volume] in Gastric fluid |
| 25165-2 | CD23 cells [#/volume] in Blood |
| 47589-7 | C peptide [Moles/volume] in Serum or Plasma --30 minutes post dose glucose |
| 47605-1 | Cortisol [Moles/volume] in Serum or Plasma --15 minutes post 1 ug/kg CRH IV |
| 47655-6 | Insulin [Units/volume] in Serum or Plasma --15 minutes post dose glucagon |
| 25693-3 | Insulin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 2601-3 | Magnesium [Moles/volume] in Serum or Plasma |
| 35574-3 | Fatty acid oxidation [Identifier] in Fibroblast |
| 35647-7 | Pyridinoline+Deoxypyridinoline/Creatinine [Molar ratio] in Urine collected for unspecified duration |
| 35766-5 | Cefixime [Susceptibility] by Gradient strip |
| 56165-4 | CYP2C9 gene allele 3 [Identifier] in Blood by Molecular genetics method Nominal |
| 56297-5 | Red Kidney Bean IgG4 Ab [Mass/volume] in Serum |
| 56508-5 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 26748-4 | Osmium [Mass/volume] in Blood |
| 3820-8 | Mezlocillin [Mass/volume] in Serum or Plasma |
| 569-4 | Fungus identified in Cerebral spinal fluid by Culture |
| 48874-2 | Neorickettsia sp [Presence] in Specimen by Organism specific culture |
| 38373-7 | Buprenorphine+Norbuprenorphine [Presence] in Urine |
| 57466-5 | Cortisol [Mass/volume] in Serum or Plasma --9th specimen |
| 57574-6 | 3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin |
| 57603-3 | 6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
| 5763-8 | Zinc [Mass/volume] in Serum or Plasma |
| 49300-7 | Protein Fractions [Interpretation] in Urine by Immunofixation Narrative |
| 39569-9 | Trichoderma viride Ab [Mass/volume] in Serum |
| 29267-2 | Protoporphyrin [Moles/mass] in Stool |
| 58730-3 | Lymphocyte proliferation stimulated by 1.0 ug phytohemagglutinin actual/normal in Blood |
| 40460-8 | Phenytoin.bound [Mass/volume] in Serum or Plasma |
| 59169-3 | buPROPion [Presence] in Urine |
| 59308-7 | Metaxalone [Mass/volume] in Serum or Plasma |
| 30167-1 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification |
| 40846-8 | Homovanillate [Moles/volume] in Cerebral spinal fluid |
| 19220-3 | Oxygen content in Venous blood |
| 19454-8 | Dimetamphetamine cutoff [Mass/volume] in Urine for Screen method |
| 19581-8 | Methyprylon [Presence] in Urine by Screen method |
| 100091-8 | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay |
| 13013-8 | Methyl isobutyl ketone [Mass/volume] in Blood |
| 101941-3 | Candida glabrata DNA [Presence] in Urine by NAA with probe detection |
| 102137-7 | Amoxicillin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102266-4 | Curvularia lunata IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102582-4 | Saline fish feed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103072-5 | Peanut recombinant (rAra h) 2 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10704-5 | Ova and parasites identified in Stool by Light microscopy |
| 16259-4 | Urate dihydrate crystals [Presence] in Stone by Infrared spectroscopy |
| 16402-0 | Aromatic solvents [Identifier] in Blood |
| 16621-5 | Clindamycin [Mass/volume] in Serum or Plasma --peak |
| 11607-9 | Junin virus Ab [Units/volume] in Serum |
| 16862-5 | Fibrinopeptide B Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 17528-1 | Retinol [Mass/volume] in Serum or Plasma --3 hours post dose |
| 17651-1 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 1834-1 | Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma |
| 7526-7 | Nigrospora sphaerica IgE Ab [Units/volume] in Serum |
| 7553-1 | Oregano IgG Ab [Units/volume] in Serum |
| 77011-5 | Fetal Chromosome 21 trisomy [Presence] based on Plasma cell-free DNA by Sequencing |
| 77151-9 | Energy content panel - 24 hour Stool |
| 77381-2 | Protein electrophoresis panel in Urine collected for unspecified duration |
| 78385-2 | Budgerigar serum proteins+feathers+droppings IgG Ab [Mass/volume] in Serum |
| 9472-2 | Heptachlor [Mass/volume] in Serum or Plasma |
| 950-6 | C little e Ab [Presence] in Serum or Plasma from Donor |
| 6701-7 | 11-Hydroxyandrosterone [Mass/time] in 24 hour Urine |
| 96478-3 | IgLON5 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 68942-2 | Somatotropin [Mass/volume] in Serum or Plasma --130 minutes post exercise |
| 81422-8 | GATA1 gene exon 2 targeted mutation analysis in Blood or Tissue by Sequencing |
| 96675-4 | HLA-DRB3 and HLA-DRB4 and HLA DRB5 unresolved alleles [Type] by High resolution |
| 97164-8 | Triiodothyronine (T3) [Mass/time] in 24 hour Urine |
| 97601-9 | Microorganism of interest sequence [Presence] in Specimen |
| 82932-5 | sp100 IgG Ab [Presence] in Serum by Line blot |
| 99051-5 | Leukocytes [#/volume] in Bronchoalveolar lavage by Manual count |
| 71859-3 | Hemoglobin S/Hemoglobin.total [Pure mass fraction] in Blood by Electrophoresis |
| 99476-4 | Aspergillus flavus IgG Ab [Mass/volume] in Serum |
| 72728-9 | Del(13)(q14) [Identifier] in Blood or Tissue by FISH Nominal |
| 72907-9 | HNA genotype panel - Serum or Plasma |
| 73051-5 | buPROPion induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73060-6 | Ampicillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73090-3 | Valproate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73540-7 | Alendronate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88047-6 | P sup(k) Ag [Presence] on Red Blood Cells from Blood product unit |
| 41213-0 | Xanthan gum IgE Ab [Units/volume] in Serum |
| 59387-1 | Trypanosoma cruzi IgG Ab [Units/volume] in Serum by Immunoassay |
| 59705-4 | Methadone [Presence] in Serum or Plasma by Screen method |
| 5088-0 | Chlamydia trachomatis Ab [Titer] in Serum by Immunofluorescence |
| 50922-4 | Tin [Moles/mass] in Hair |
| 50992-7 | IgM [Mass/volume] in Cord blood |
| 30533-4 | levoFLOXacin [Mass/volume] in Serum or Plasma --trough |
| 30918-7 | Gold [Mass/volume] in Urine collected for unspecified duration |
| 31070-6 | Histoplasma capsulatum yeast phase Ab [Titer] in Body fluid by Complement fixation |
| 60020-5 | Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid by Pyruvate to lactate reaction |
| 60248-2 | Androstanolone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 51191-5 | Antimony [Mass/volume] in Body fluid |
| 42744-3 | Phosphatidylcholine IgM Ab B2GP1 independent [Multiple of the median] in Serum |
| 22067-3 | NB gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 22091-3 | Avian hemorrhagic enteritis virus Ab [Presence] in Serum |
| 22155-6 | Brucella canis IgM Ab [Units/volume] in Serum |
| 3174-0 | Antithrombin [Units/volume] in Platelet poor plasma by Chromogenic method |
| 31803-0 | Duck hepatitis virus 1 Ag [Presence] in Specimen |
| 31892-3 | Mumps virus Ag [Presence] in Nose |
| 51887-8 | Transfuse Rh immune globulin units [#] |
| 32287-5 | Methylmalonate [Moles/volume] in Urine |
| 51959-5 | Range(s) of DNA sequence examined |
| 52112-0 | Blood product unit 2 expiration [Date and time] |
| 44266-5 | Influenza virus A H7 RNA [Units/volume] (viral load) in Specimen by NAA with probe detection |
| 22988-0 | Capripox virus Ag [Presence] in Specimen by Immunoassay |
| 32609-0 | Amino acids [Moles/volume] in Body fluid |
| 53327-3 | Bilirubin.total [Mass/volume] in Urine by Automated test strip |
| 53434-7 | Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Amniotic fluid cells |
| 23224-9 | Mareks disease virus Ab [Presence] in Serum |
| 3367-0 | Atropine [Mass/volume] in Serum or Plasma |
| 53580-7 | Galactosylceramidase [Enzymatic activity/mass] in Amniotic fluid cells |
| 53635-9 | Beta cortol/Creatinine [Mass Ratio] in 24 hour Urine |
| 33811-1 | Insulin [Units/volume] in Serum or Plasma --12th specimen post XXX challenge |
| 54428-8 | Frozen packed erythrocytes given [Volume] |
| 46732-4 | Francisella tularensis subtype [Identifier] in Specimen by NAA with probe detection |
| 24494-7 | Weed Allergen Mix 2 (Western ragweed+Mugwort+Lenscale+Goosefoot or Lambs quarters+English plantain) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 34579-3 | Basophils [#/area] in Peritoneal fluid by Microscopy high power field |
| 55503-7 | Prolactin [Mass/volume] in Serum or Plasma --40 minutes post dose TRH IV |
| 47440-3 | Hepatitis B virus core Ab [Presence] in Serum from Donor |
| 25097-7 | Dodecanedioate/Creatinine [Molar ratio] in Urine |
| 34982-9 | Unidentified cells/100 leukocytes in Peritoneal fluid |
| 35305-2 | Toxoplasma gondii AC Ab [Units/volume] in Serum by Agglutination |
| 55852-8 | Dicarboxydodecanoylcarnitine (C12-DC)/Creatinine [Molar ratio] in Urine |
| 56284-3 | Herring IgG4 Ab [Mass/volume] in Serum |
| 56306-4 | Lentils IgG4 Ab [Mass/volume] in Serum |
| 48302-4 | Indigo carmine triggered leukotriene release [Mass/volume] by Leukocytes |
| 38186-3 | Beta globulin [Mass/volume] in 24 hour Urine by Electrophoresis |
| 56593-7 | Follitropin [Units/volume] in Serum or Plasma --3 hours post XXX challenge |
| 56954-1 | Leucine/Creatinine [Ratio] in 24 hour Urine |
| 4888-4 | HLA-Dw1 [Presence] in Donor |
| 57464-0 | Cortisol [Mass/volume] in Serum or Plasma --11th specimen |
| 5817-2 | Urate crystals [Presence] in Urine sediment by Light microscopy |
| 5823-0 | Adenovirus Ag [Presence] in Conjunctival specimen by Immunoassay |
| 49348-6 | Cytomegalovirus DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 3982-6 | Procainamide [Mass/volume] in Serum or Plasma |
| 58530-7 | Corticotropin [Moles/volume] in Plasma --1.5 hours post 1 ug/kg CRH IV |
| 30326-3 | Cytomegalovirus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 41106-6 | FXN gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 20438-8 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose glucose |
| 20459-4 | Streptococcus agalactiae Ag [Presence] in Specimen by Latex agglutination |
| 100059-5 | Rifapentine [Susceptibility] |
| 100112-2 | Fasciola sp Ab bands panel - Serum by Immunoblot |
| 12892-6 | Borrelia burgdorferi 30kD Ab [Presence] in Serum by Immunoblot |
| 102070-0 | Branched PFOS Isomers [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 13808-1 | Serine/Creatinine [Mass Ratio] in Urine |
| 102821-6 | Spinach IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103608-6 | Sulbactam+Durlobactam [Susceptibility] by Gradient strip |
| 15007-8 | 2,3-Diphosphoglycerate [Moles/volume] in Red Blood Cells |
| 15189-4 | Kappa light chains/Lambda light chains [Mass Ratio] in Serum |
| 16530-8 | Campylobacter jejuni rRNA [Presence] in Serum by Probe |
| 16789-0 | DOPamine [Mass/volume] in Urine --7th specimen post XXX challenge |
| 17199-1 | CD80 cells/100 cells in Blood |
| 17585-1 | Sjogrens syndrome-A extractable nuclear IgG Ab [Presence] in Serum by Immunoassay |
| 74618-0 | 1,1-Dimethoxyoctadecane (DMA 18:0) [Mass/mass] in Fibroblast |
| 7479-9 | Red Maple IgE Ab [Units/volume] in Serum |
| 92650-1 | PARoxetine [Presence] in Urine by Confirmatory method |
| 75608-0 | Citation [Bibliographic Citation] in Referral lab test Narrative |
| 77322-6 | Amitriptyline+Nortriptyline [Moles/volume] in Specimen |
| 94057-7 | Bacterial ahpC gene drug resistance mutation [Identifier] by Molecular method |
| 62947-7 | MPL gene p.Trp515Leu+Trp515Lys+Ser505Asn [Presence] in Blood or Tissue by Molecular genetics method |
| 94836-4 | Herpes simplex virus 2 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 78916-4 | FGFR1 gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 78987-5 | Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay |
| 79208-5 | BRCA2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 66140-5 | Lymphocytes [#/volume] in Blood from Fetus by Manual count |
| 95830-6 | Hematopoietic progenitor cell product characterization panel - Blood product unit by Flow cytometry (FC) |
| 68545-3 | Nucleated erythrocytes/100 leukocytes [Ratio] in Synovial fluid |
| 81097-8 | West Nile virus Kunjin strain Ab [Presence] in Serum |
| 81183-6 | Distance of tumor from closest distal margin [Length] in Specimen by Light microscopy |
| 816-9 | A Ab [Presence] in Serum or Plasma from Donor |
| 9731-1 | Phosphoethanolamine [Mass/time] in 24 hour Urine |
| 97623-3 | Klebsiella aerogenes DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 7034-2 | Nalidixate [Susceptibility] by Gradient strip |
| 71708-2 | Marburg virus Ag [Presence] in Specimen by Immunoassay |
| 72800-6 | Norketamine/Creatinine [Mass Ratio] in Urine |
| 72933-5 | Vancomycin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86010-6 | Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum by Immunoassay |
| 88629-1 | Chikungunya virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 89691-0 | Pseudocasts [#/area] in Urine by Computer assisted method |
| 4121-0 | Amobarbital [Mass] of Dose |
| 59701-3 | LORazepam [Mass/volume] in Body fluid |
| 50811-9 | Antimony [Moles/volume] in Red Blood Cells |
| 50893-7 | Paraquat [Moles/volume] in Serum or Plasma |
| 30564-9 | Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Serum or Plasma |
| 42184-2 | Gossypol posiitve isomer [Mass/volume] in Specimen |
| 42218-8 | Sulfatide IgG and IgM panel - Serum |
| 42615-5 | Glucose [Mass/volume] in Urine --30 minutes post dose lactose PO |
| 60255-7 | Neisseria gonorrhoeae rRNA [Presence] in Throat by NAA with probe detection |
| 60265-6 | Human coronavirus RNA [Presence] in Serum or Plasma by NAA with probe detection |
| 31199-3 | Microscopic observation [Identifier] in Lung fine needle aspirate by Cyto stain |
| 31381-7 | Escherichia coli verotoxin 1 Ab [Units/volume] in Stool |
| 31453-4 | Lassa virus IgM Ab [Units/volume] in Serum |
| 42804-5 | Fungus identified in Isolate |
| 42897-9 | Coxiella burnetii phase 1 IgM Ab [Units/volume] in Serum by Immunofluorescence |
| 43113-0 | Hemoglobin electrophoresis panel in Blood |
| 22177-0 | Chlamydophila psittaci IgA Ab [Titer] in Cerebral spinal fluid |
| 22277-8 | Echovirus 4 Ab [Titer] in Serum |
| 31609-1 | Orientia tsutsugamushi Kato Ab [Units/volume] in Serum |
| 43345-8 | Avian paramyxovirus 6 Ab [Titer] in Serum |
| 44305-1 | Chloral hydrate/Creatinine [Mass Ratio] in Urine |
| 44319-2 | Insulin.bound [Presence] in Serum or Plasma |
| 32769-2 | Alpha 1 antitrypsin phenotype [Interpretation] in Serum or Plasma |
| 32784-1 | Mean peroxidase activity index [Presence] in Blood |
| 33320-3 | Toxoplasma gondii IgG Ab [Units/volume] in Body fluid |
| 33330-2 | West Nile virus IgM Ab [Titer] in Cerebral spinal fluid |
| 53534-4 | Varicella zoster virus IgG Ab [Presence] in Body fluid by Immunoassay |
| 53730-8 | Borrelia burgdorferi G39/40 IgG Ab [Units/volume] in Serum or Plasma |
| 45224-3 | Mycoplasma pneumoniae IgG Ab [Presence] in Serum by Immunoassay |
| 2392-9 | Glycine [Mass/volume] in Urine |
| 54302-5 | Homocystine [Moles/volume] in DBS |
| 46182-2 | Coccidioides sp IgG Ab [Presence] in Serum |
| 24479-8 | Tree Allergen Mix 1 (Boxelder+Silver birch+White oak+White elm+California walnut) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 34654-4 | MPZ gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 34703-9 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 500 IU/mL |
| 55180-4 | Human epididymis protein 4 [Moles/volume] in Serum or Plasma |
| 47306-6 | Cartilage oligomeric matrix protein [Units/volume] in Serum by Immunoassay |
| 35070-2 | Basophils/100 leukocytes in Pleural fluid |
| 55947-6 | Nitrite [Mass/volume] in Dialysis fluid |
| 47790-1 | Threonine/Amino acids.total in Specimen |
| 25830-1 | Beta glucosidase activator [Interpretation] in Fibroblast |
| 35624-6 | Norfluoxetine [Mass/volume] in Serum or Plasma by Screen method |
| 35786-3 | Clinafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 56252-0 | Eel IgG4 Ab [Mass/volume] in Serum |
| 4793-6 | HLA-B71(70) [Presence] |
| 48062-4 | Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool by Immunofluorescence |
| 48115-0 | Homocysteine.free/Creatinine [Molar ratio] in Urine |
| 4826-4 | HLA-B38(16) [Presence] in Donor |
| 26687-4 | Amobarbital [Mass/volume] in Vitreous fluid |
| 56666-1 | 1-Methylhistidine/Creatinine [Ratio] in 24 hour Urine |
| 2682-3 | Ornithine carbamoyltransferase [Enzymatic activity/volume] in Amniotic fluid |
| 57314-7 | SRY gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 5736-4 | Strontium [Mass/volume] in Serum or Plasma |
| 38677-1 | Sperm Tail IgA Ab/100 spermatozoa in Specimen by Immunobead |
| 57968-0 | Ganglioside GD1a IgG Ab [Presence] in Serum |
| 4025-3 | Salicylates [Presence] in Urine |
| 5852-9 | Herpes simplex virus Ag [Presence] in Skin by Immunoassay |
| 49760-2 | Adenosine deaminase [Enzymatic activity/volume] in Pericardial fluid |
| 29881-0 | 2-Hydroxyglutarate [Presence] in Urine |
| 40606-6 | Appearance of Peritoneal dialysis fluid |
| 5039-3 | Acetylcholine receptor modulation Ab [Titer] in Serum by Immunofluorescence |
| 30114-3 | Lambda lymphocytes [#/volume] in Blood |
| 30279-4 | Ritonavir [Susceptibility] by Phenotype method |
| 19648-5 | oxyMORphone [Mass/volume] in Urine |
| 21039-3 | 18-Hydroxycortisol [Mass/volume] in 24 hour Urine |
| 12569-0 | Cortisol [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 12706-8 | Tellurium [Mass/volume] in Serum or Plasma |
| 13277-9 | Schistosoma sp IgG Ab [Units/volume] in Serum |
| 102193-0 | Bovine serum albumin (BSA) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13860-2 | C peptide [Mass/volume] in Serum or Plasma --15 minutes post 1 mg glucagon IV |
| 102672-3 | Alfalfa IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102805-9 | Radish IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102945-3 | Pellitory (Parietaria judaica) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14625-8 | Basophils/100 leukocytes in Bronchial specimen by Manual count |
| 1079-3 | Js sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 16701-5 | Cyclopropane [Presence] in Blood |
| 11182-3 | Lysozyme IgE Ab [Units/volume] in Serum |
| 1171-8 | little f Ag [Presence] on Red Blood Cells |
| 16900-3 | Gliadin Ab [Units/volume] in Saliva (oral fluid) |
| 17301-3 | Mycoplasma hominis Ab [Presence] in Serum |
| 18321-0 | Benzidine [Mass/volume] in Serum or Plasma |
| 18334-3 | Naltrexone [Presence] in Urine by Confirmatory method |
| 92771-5 | Streptococcus pneumoniae DNA [Presence] by NAA with probe detection in Positive blood culture |
| 76619-6 | Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 2,3-14C-succinate substrate |
| 76687-3 | Mycobacterium sp identified in Bronchoalveolar lavage by Organism specific culture |
| 92993-5 | PROCR gene full mutation analysis in Blood or Tissue by Sequencing |
| 77630-2 | ALS2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 9376-5 | Glucose [Mass/volume] in Serum or Plasma --3.5 hours post 100 g glucose PO |
| 94194-8 | CPOX gene full mutation analysis in Blood or Tissue by Sequencing |
| 63176-2 | Algae IgG Ab [Mass/volume] in Serum |
| 63220-8 | DNA double strand Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 63281-0 | Mitochondria M2 Ab [Presence] in Body fluid by Immunoassay |
| 78214-4 | Cells.CCND1 gene duplication/Cells counted in Blood or Tissue by FISH |
| 78701-0 | Cedar elm IgE Ab [Units/volume] in Serum |
| 94490-0 | Protoporphyrin fractions panel - Red Blood Cells |
| 94540-2 | Mycobacterial stain and culture panel - Specimen |
| 94601-2 | Listeria monocytogenes Ag [Presence] in Tissue by Immune stain |
| 6495-6 | Neisseria meningitidis serogroup A Ag [Presence] in Specimen by Immunofluorescence |
| 78885-1 | traZODone cutoff [Mass/volume] in Urine for Confirmatory method |
| 95118-6 | Insulin [Units/volume] in Serum or Plasma --4.5 hours post meal |
| 80970-7 | Lithium free [Moles/volume] in Serum or Plasma |
| 9765-9 | Lymphocytic choriomeningitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 70153-2 | Sample hemolyzed [Presence] of Cerebral spinal fluid Qualitative |
| 82911-9 | Vascular endothelial growth factor D [Mass/volume] in Serum or Plasma |
| 99004-4 | Leptospira santarosai sv Borincana Ab [Titer] in Serum by Agglutination |
| 99052-3 | Epithelial cells [Presence] in Bronchoalveolar lavage by Light microscopy |
| 72663-8 | Bisphosphoglycerate mutase [Enzymatic activity/mass] in Red Blood Cells |
| 72992-1 | Metoclopramide induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73011-9 | hydroCHLOROthiazide induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87372-9 | Escherichia coli FimF41a gene [Presence] in Isolate by NAA with probe detection |
| 87386-9 | Porcine parainfluenza virus 1 RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73551-4 | Acarbose induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73623-1 | Danofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 87783-7 | Ketoprofen/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 41703-0 | Moxalactam [Susceptibility] by Gradient strip |
| 51005-7 | Testosterone.free+weakly bound [Mass/volume] in Serum or Plasma by High sensitivity method |
| 5101-1 | Coxsackievirus A7 neutralizing antibody [Titer] in Serum by Neutralization test |
| 31042-5 | Gatifloxacin [Susceptibility] by Gradient strip |
| 60091-6 | Ketoconazole [Mass/volume] in Blood |
| 60122-9 | Pancuronium [Mass/volume] in Serum or Plasma |
| 51234-3 | CD11c+CD19+ cells/100 cells in Blood |
| 42737-7 | CD4+CD7+ cells/100 cells in Blood |
| 31894-9 | Mumps virus Ag [Presence] in Serum |
| 43270-8 | Ceftobiprole [Susceptibility] by Minimum lethal concentration (MLC) |
| 22590-4 | Treponema pallidum Ab [Titer] in Serum |
| 325-1 | Methicillin [Susceptibility] by Serum bactericidal titer |
| 22994-8 | Chlamydophila psittaci Ab [Presence] in Serum by Agglutination |
| 32683-5 | Hemoglobin S/Hemoglobin.total in Blood by Electrophoresis |
| 33000-1 | Rickettsia spotted fever group IgM Ab [Presence] in Serum |
| 23364-3 | Porcine enterovirus Ag [Presence] in Specimen by Immunofluorescence |
| 23421-1 | Salmonella abortus ovis Ab [Presence] in Serum |
| 53858-7 | EXT1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 53943-7 | Bacterial cytolethal distending toxin cdt gene [Presence] in Specimen by NAA with probe detection |
| 23718-0 | Feline coronavirus Ab [Titer] in Serum |
| 46108-7 | 18q chromosome deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 46945-2 | Beclomethasone dipropionate [Mass/volume] in Urine |
| 24138-0 | Johnson grass IgG Ab [Units/volume] in Serum |
| 34578-5 | Barbiturates [Presence] in Meconium by Screen method |
| 25339-3 | Echinococcus sp Ab [Presence] in Serum |
| 55622-5 | Butirosin [Susceptibility] by Gradient strip |
| 55948-4 | Nitrite [Moles/volume] in Serum or Plasma |
| 47772-9 | Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose arginine |
| 25646-1 | Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --3rd specimen post XXX challenge |
| 25820-2 | Cysteate [Moles/time] in 24 hour Urine |
| 25875-6 | Carnosine/Creatinine [Molar ratio] in 24 hour Urine |
| 35462-1 | SMN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 3559-2 | Digitoxin [Mass/volume] in Serum or Plasma |
| 5627-5 | Cobalt [Mass/volume] in Serum or Plasma |
| 47951-9 | Thyrotropin [Units/volume] in Serum or Plasma --2 hours post dose luteinizing releasing hormone IV |
| 48183-8 | Paper wasp triggered leukotriene release [Mass/volume] by Leukocytes |
| 26509-0 | Band form neutrophils/100 leukocytes in Cerebral spinal fluid |
| 26513-2 | Neutrophils/100 leukocytes in Body fluid |
| 3623-6 | Etilefrine [Mass/time] in 24 hour Urine |
| 48804-9 | Taenia solium Ag [Presence] in Stool |
| 26938-1 | chlordiazePOXIDE [Mass/mass] in Meconium |
| 27071-0 | CD45 (Lymphs) cells [#/volume] in Blood |
| 38291-1 | 1,2-Dichloroethane [Mass/volume] in Water |
| 49159-7 | Rickettsia africae IgG Ab [Titer] in Body fluid |
| 27880-4 | Follitropin [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 3867-9 | Norfloxacin [Mass/volume] in Serum or Plasma |
| 39555-8 | West Nile virus Ab [Units/volume] in Serum |
| 57932-6 | Cheese cheddar type IgE Ab/IgE total in Serum |
| 29524-6 | Acetoacetate/Creatinine [Molar ratio] in Urine |
| 39804-0 | Lipoprotein associated phospholipase A2 [Mass/volume] in Serum or Plasma |
| 40069-7 | Calcium [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 58412-8 | Cefepime [Susceptibility] for meningitis by Disk diffusion (KB) |
| 58465-6 | DNA double strand IgG Ab [Presence] in Serum by Immunoassay |
| 58628-9 | Corticotropin [Moles/volume] in Plasma --pre dose metyraPONE |
| 50129-6 | 3-Hydroxypropionate (3-OH-C3) [Moles/volume] in Amniotic fluid |
| 30274-5 | Adefovir [Susceptibility] by Phenotype method |
| 30284-4 | Didanosine [Susceptibility] by Genotype method |
| 4098-0 | Warfarin [Mass/volume] in Serum or Plasma |
| 19710-3 | traMADol [Presence] in Urine by Screen method |
| 20836-3 | Herbicide [Identifier] in Tissue |
| 12372-9 | Dimethylacetamide [Mass/volume] in Urine |
| 100815-0 | Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge |
| 12724-1 | Voltage-gated calcium channel IgG Ab [Units/volume] in Serum |
| 101225-1 | Hemosiderin [Presence] in Blood or Marrow by Prussian blue stain |
| 12951-0 | Triglyceride [Mass/volume] in Serum or Plasma by calculation |
| 101960-3 | PEX2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 13751-3 | Glycolate/Creatinine [Mass Ratio] in Urine |
| 102553-5 | Rabbit serum proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14243-0 | Phosphatidylcholine IgG Ab [Presence] in Serum |
| 14308-1 | Amphetamines [Presence] in Urine by Screen method >1000 ng/mL |
| 14647-2 | Cholesterol [Moles/volume] in Serum or Plasma |
| 14764-5 | Glucose [Moles/volume] in Serum or Plasma --3 hours post 100 g glucose PO |
| 1031-4 | Fy sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
| 103716-7 | Yersina pestis DNA [Presence] in Blood by NAA with non-probe detection |
| 15216-5 | Epidermal Allergen Mix 72 (Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk |
| 15276-9 | Weed Allergen Mix 7 (Ox-eye daisy+Dandelion+English plantain+Goosefoot or Lambs quarters+Goldenrod) IgE Ab [Presence] in Serum by Multidisk |
| 15465-8 | Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 17002-7 | Hydroxytriazolam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 17396-3 | Oxytetracycline [Mass/volume] in Serum or Plasma |
| 17689-1 | Testosterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 18873-0 | Carbenicillin [Susceptibility] |
| 61088-1 | Oxazepam [Presence] in Gastric fluid |
| 76620-4 | Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 1-14C-leucine substrate |
| 62235-7 | Albumin [Moles/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method |
| 77634-4 | FUS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 9391-4 | Quazepam [Mass/volume] in Serum or Plasma |
| 94109-6 | LORazepam glucuronide [Presence] in Urine by Screen method |
| 62478-3 | Aspergillus fumigatus DNA [Presence] in Specimen by NAA with probe detection |
| 63546-6 | Smith extractable nuclear Ab [Presence] in Body fluid |
| 6475-8 | Mobiluncus sp rRNA [Presence] in Specimen by Probe |
| 79166-5 | Peach natural (nPru p) 3 IgE Ab [Units/volume] in Serum |
| 65866-6 | Methacholine [Mass] of Dose |
| 6631-6 | Schistosoma sp Ab [Presence] in Serum by Complement fixation |
| 79686-2 | 5-Hydroxymethyluracil [Moles/volume] in Cerebral spinal fluid |
| 79715-9 | CYP2D6 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
| 95693-8 | Western equine encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay |
| 6790-0 | Lambda light chains [Presence] in Urine by Electrophoresis |
| 80686-9 | CYP2C9 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 96619-2 | HLA-B unresolved alleles [Type] in Donor by High resolution |
| 97174-7 | Yersinia outer protein H Ab [Presence] in Serum by Line blot |
| 97242-2 | Dihydrocodeine Free+Hydrocodol Free [Presence] in Cord tissue by Screen method |
| 97326-3 | Staphylococcus aureus identification and resistance panel by Molecular genetics method |
| 82872-3 | AnWj Ab [Presence] in Serum or Plasma |
| 82934-1 | clonazePAM [Mass/volume] in Serum or Plasma --trough |
| 97976-5 | Codfish recombinant (rGad c) 1 IgG4 Ab [Mass/volume] in Serum |
| 98241-3 | CD154 function (binding to CD40) [Presence] in T cells |
| 72466-6 | JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 85050-3 | ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [Presence] by ARD gradient strip |
| 85428-1 | Penicillin [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC) |
| 7278-5 | European house dust mite IgG Ab [Units/volume] in Serum |
| 86077-5 | Streptococcus pneumoniae Danish serotype 23F Ab [Mass/volume] in Serum --2nd specimen |
| 73362-6 | Glimepride induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73366-7 | Gabapentin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87468-5 | Manganese [Mass/mass] in Specimen |
| 87824-9 | 6-Beta naltrexol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 88569-9 | Ocular pathogens panel - Cornea or Conjunctiva Qualitative by NAA with probe detection |
| 88611-9 | Human coronavirus HKU1 RNA [Presence] in Aspirate by NAA with probe detection |
| 89305-7 | Norbuprenorphine-3-glucuronide [Presence] in Urine by Screen method |
| 41609-9 | Prolactin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 59327-7 | Salvinorin B [Mass/volume] in Serum or Plasma |
| 59364-0 | Leptospira interrogans sv Pyrogenes Ab [Titer] in Serum by Agglutination |
| 59676-7 | Flurazepam [Mass/volume] in Body fluid |
| 30424-6 | Macrocytes [Presence] in Blood |
| 31060-7 | Echovirus 9 Ab [Titer] in Body fluid by Complement fixation |
| 42578-5 | Artifact [Presence] in Urine sediment by Light microscopy |
| 60218-5 | Potassium [Moles/volume] in Mother's milk |
| 60318-3 | Mexiletine [Moles/volume] in Specimen |
| 3147-6 | Oxygen [Partial pressure] in Exhaled gas |
| 42754-2 | Phosphatidylserine IgG Ab B2GP1 independent [Multiple of the median] in Serum |
| 4287-9 | Insulin regular [Mass] of Dose |
| 51593-2 | Fructose [Presence] in Stool |
| 43401-9 | Cryofibrinogen [Presence] in Plasma by 1 week 37 degree C incubation |
| 22357-8 | HIV 1+2 Ab [Units/volume] in Serum |
| 52921-4 | Strontium/Creatinine [Molar ratio] in 24 hour Urine |
| 44365-5 | Glycine/Creatinine [Mass Ratio] in 24 hour Urine |
| 44384-6 | hydroCHLOROthiazide [Presence] in 24 hour Urine |
| 23080-5 | Equine herpesvirus 1 Ag [Presence] in Specimen by Immunofluorescence |
| 53126-9 | Monocytes+Macrophages/100 leukocytes in Blood |
| 53297-8 | Crystals unspecified [#/volume] in Urine by Computer assisted method |
| 23307-2 | Myxoma virus Ab [Presence] in Serum by Complement fixation |
| 33497-9 | Methane/Expired gas [Volume Fraction] in Exhaled gas --pre dose lactose PO |
| 33527-3 | Methadone.long acting metabolite [Mass/volume] in Urine |
| 34246-9 | Ascorbate [Moles/volume] in 24 hour Urine |
| 4570-8 | Hemoglobin D - Punjab [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 55247-1 | HBA1 gene c.223G>C [Presence] in Blood by Molecular genetics method |
| 47318-1 | Liver kidney microsomal 1 IgG Ab [Units/volume] in Serum by Immunoassay |
| 25319-5 | 3-Methylhistidine [Moles/time] in 24 hour Urine |
| 47561-6 | Anion gap in Body fluid |
| 47612-7 | Cystatin C [Mass/volume] in Urine |
| 47791-9 | Tocopherols [Mass/volume] in Serum or Plasma |
| 56241-3 | American house dust mite IgG4 Ab [Mass/volume] in Serum |
| 56341-1 | Ox-eye daisy IgG4 Ab [Mass/volume] in Serum |
| 56417-9 | Wheat IgG4 Ab [Mass/volume] in Serum |
| 56419-5 | Cow whey IgG4 Ab [Mass/volume] in Serum |
| 48190-3 | Phthalic anhydride triggered leukotriene release [Mass/volume] by Leukocytes |
| 48221-6 | Barley triggered leukotriene release [Mass/volume] by Leukocytes |
| 2610-4 | Methane [Mass/volume] in Exhaled gas |
| 26535-5 | Cortisol [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin |
| 26956-3 | Cocaine [Mass/mass] in Meconium |
| 38604-5 | Hydroquinone [Mass/volume] in Air |
| 38620-1 | Tetrachloroethylene [Mass/volume] in Air |
| 49229-8 | Nucleated erythrocytes/100 leukocytes [Ratio] in Body fluid |
| 39597-0 | Pumpkin IgE Ab/IgE total in Serum |
| 58002-7 | Mestanolone metabolite [Presence] in Urine |
| 49477-3 | CXCL13 Ag [Presence] in Tissue by Immune stain |
| 28559-3 | Hemoglobin A2 [Presence] in Blood |
| 29146-8 | Alpha 1 antitrypsin [Mass/volume] in Body fluid |
| 39775-2 | Protoporphyrin Free [Moles/volume] in Red Blood Cells |
| 39966-7 | Creatinine [Mass/volume] in Serum or Plasma --5.5 hours post XXX challenge |
| 58423-5 | Ethyl sulfate/Creatinine [Mass Ratio] in Urine |
| 49873-3 | POU3F4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 19749-1 | Saccharopolyspora rectivirgula IgG Ab [Presence] in Serum |
| 20719-1 | Brucella abortus Ab [Titer] in Serum by Tube agglutination |
| 20843-9 | Avian infectious laryngotracheitis virus Ag [Presence] in Trachea by Immunofluorescence |
| 100306-0 | IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method |
| 101239-2 | Mean chromosome banding resolution [#] in Blood or Tissue by Banding |
| 102041-1 | Carboxy tetrahydrocannabinol Delta 9/Creatinine [Mass Ratio] in Urine |
| 102235-9 | Chinchilla IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102647-5 | Walnut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14148-1 | 18-Hydroxycortisol [Mass/time] in 24 hour Urine |
| 14160-6 | Estrone (E1).unconjugated/Estrone (E1).total in Serum or Plasma |
| 102881-0 | Saccharopolyspora rectivirgula IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14403-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Gastric fluid |
| 14723-1 | Ferritin [Moles/volume] in Serum or Plasma |
| 103154-1 | Single nucleotide polymorphisms.recipient derived cf.dna/Single nucleotide polymorphisms.total cf dna in Plasma cell-free DNA by Sequencing --post bone marrow transplant |
| 1489-4 | Gastrin [Mass/volume] in Serum or Plasma --5 minutes post 0.2 U/kg secretin |
| 16154-7 | Gastrin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 11031-2 | Lymphocytes/100 leukocytes in Body fluid |
| 16504-3 | Calcitonin [Mass/volume] in Serum or Plasma --1.5 minutes post XXX challenge |
| 12194-7 | Creatinine [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis |
| 17597-6 | Somatotropin [Mass/volume] in Serum or Plasma --52 hours post XXX challenge |
| 17765-9 | Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 17803-8 | Plasma cells/100 leukocytes in Body fluid |
| 91130-5 | Hantavirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 92755-8 | Cholestane-3-beta, 5-alpha, 6-beta triol [Moles/volume] in Serum or Plasma |
| 6150-7 | Ispaghula laxative IgE Ab [Units/volume] in Serum |
| 62341-3 | Borrelia burgdorferi IgG+IgM with reflex to immune blot panel - Serum |
| 77354-9 | Noninvasive colorectal cancer DNA and occult blood screening [Presence] in Stool |
| 93742-5 | HTLV I and II Ab band pattern [Interpretation] in Cerebral spinal fluid by Line blot |
| 93807-6 | FOXO1 gene rearrangements in Tissue by FISH |
| 78218-5 | BCL2 gene rearrangements [Presence] in Blood or Tissue by FISH |
| 78852-1 | M-chlorophenylpiperazine [Mass/volume] in Blood |
| 94617-8 | Anaplasma marginale DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 63376-8 | Lactoferrin [Presence] in Stool |
| 64125-8 | Pregabalin [Mass/volume] in Urine by Confirmatory method |
| 64413-8 | KIR gene allele 2DL1 [Presence] in Blood or Tissue by Molecular genetics method |
| 64429-4 | KIR gene allele 3DS1 [Presence] in Blood or Tissue by Molecular genetics method |
| 7932-7 | Influenza virus C Ab [Units/volume] in Serum |
| 95089-9 | C peptide [Mass/volume] in Serum or Plasma --4 hours post meal |
| 66752-7 | Clot strength in Blood by Thromboelastography --after addition of heparinase |
| 6700-9 | 11-Hydroxyetiocholanolone [Mass/time] in 24 hour Urine |
| 80144-9 | Ecgonine methyl ester [Presence] in Urine by Screen method |
| 69010-7 | Benzoylecgonine [Mass/mass] in Meconium by Confirmatory method |
| 96615-0 | HLA-A and B and C (class I) typing panel - Blood or Tissue by High resolution |
| 96659-8 | HLA-DQB1 [Type] in Donor |
| 9703-0 | Trihexyphenidyl [Mass/volume] in Serum or Plasma |
| 69478-6 | AGXT gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
| 81824-5 | SLC12A6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 82101-7 | Grass Allergen Mix 6 (Brome+Bermuda grass+Velvet grass+Perennial rye grass+Bahia grass+Johnson grass) IgE Ab [Units/volume] in Serum by Multidisk |
| 97650-6 | Desmethylcyclobenzaprine [Presence] in Urine by Confirmatory method |
| 70104-5 | Methotrexate [Moles/volume] in Serum or Plasma --7th specimen |
| 7048-2 | Streptomycin [Susceptibility] by Gradient strip |
| 82528-1 | VHL gene full mutation analysis in Blood or Tissue by Sequencing |
| 98065-6 | Carbapenem resistance blaOXA-143 gene [Presence] by Molecular method |
| 71661-3 | Eosinophils/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
| 85681-5 | Haemophilus influenzae dcs gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73045-7 | Cefepime induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87653-2 | Hexachlorobenzene [Mass/mass] in Specimen |
| 88562-4 | Parainfluenza virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 73924-3 | JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Presence] in Blood |
| 89319-8 | CD25+CD45RA+CD127Low+ cells/100 CD4 cells in Blood |
| 59693-2 | Hydroxytriazolam [Mass/volume] in Body fluid by Confirmatory method |
| 50997-6 | Complement C8.functional [Units/volume] in Serum or Plasma |
| 31108-4 | Osmotic fragility of Red Blood Cells--0.40% sodium chloride 24 hour 37 degree C incubation |
| 59939-9 | Norclobazam [Moles/volume] in Gastric fluid |
| 21372-8 | Abnormal lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
| 21580-6 | Trimethobenzamide [Mass/volume] in Specimen |
| 31440-1 | Intercalated disk Ab [Units/volume] in Serum |
| 51-3 | Butirosin [Susceptibility] by Minimum lethal concentration (MLC) |
| 42910-0 | Hemoglobin.gastrointestinal [Presence] in Gastric fluid --2nd specimen |
| 2211-1 | Dihydrolipoamide dehydrogenase [Enzymatic activity/mass] in Tissue |
| 22232-3 | Coxsackievirus B4 Ab [Titer] in Serum |
| 31861-8 | Influenza virus A+B+C Ag [Presence] in Throat |
| 51871-2 | Direct antiglobulin test.polyspecific reagent [presence] on Cord red blood cells |
| 43361-5 | Cardiolipin IgA Ab [Mass/volume] in Serum |
| 43367-2 | Trichomonas sp [#/area] in Urine sediment by Microscopy low power field |
| 43416-7 | Hematocrit [Volume Fraction] of Stem cell product |
| 22608-4 | Escherichia coli verotoxin 1 Ab [Titer] in Stool |
| 3239-1 | Coagulation factor XIII Ag actual/normal in Platelet poor plasma by Immunoassay |
| 33392-2 | Coxsackievirus A8 Ab [Presence] in Serum |
| 53839-7 | Arsenic organic [Mass/time] in 24 hour Urine |
| 5393-4 | Treponema pallidum Ab [Presence] in Serum by Immunofluorescence |
| 44894-4 | Malignant cells/100 cells in Cerebral spinal fluid by Manual count |
| 45092-4 | Chlamydia trachomatis Ag [Presence] in Nasopharynx by Immunoassay |
| 238-6 | Erythromycin+Sulfisoxazole [Susceptibility] by Disk diffusion (KB) |
| 34247-7 | Ascorbate [Moles/volume] in Urine |
| 34540-5 | Phenytoin free and total panel - Serum or Plasma |
| 55236-4 | HBA2 gene alpha 4.2kb deletion [Presence] in Blood by Molecular genetics method |
| 3474-4 | chlorproPAMIDE [Mass/volume] in Serum or Plasma |
| 35284-9 | Histone IgG Ab [Presence] in Serum |
| 35394-6 | Legionella pneumophila 1 IgG Ab [Presence] in Serum |
| 56319-7 | Cajeput tree IgG4 Ab [Mass/volume] in Serum |
| 38190-5 | Alpha 2 globulin [Mass/volume] in Urine by Electrophoresis |
| 56643-0 | Asparagine/Creatinine [Ratio] in 24 hour Urine |
| 4843-9 | HLA-B7 [Presence] |
| 48657-1 | Ganglioside GM2 Ab [Units/volume] in Serum by Immunoassay |
| 38412-3 | FGFR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 571-0 | Fungus identified in Hair by Culture |
| 57643-9 | Androsterone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
| 5767-9 | Appearance of Urine |
| 49280-1 | Lipoprotein fractions [Interpretation] in Serum or Plasma by Electrophoresis Narrative |
| 49321-3 | Cerebroside sulfatase activator [Interpretation] in Fibroblast Narrative |
| 57846-8 | Leukocytes [#/volume] in Pericardial fluid by Automated count |
| 58365-8 | 7-Aminoclonazepam [Presence] in Urine by Confirmatory method |
| 3985-9 | Prolintane [Mass/volume] in Urine |
| 58431-8 | Microalbumin panel - 24 hour Urine |
| 58646-1 | Cortisol [Mass/volume] in Saliva (oral fluid) --12th specimen post XXX challenge |
| 50078-5 | 17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin |
| 29619-4 | Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 29745-7 | Cryoglobulin [Presence] in Serum by 3 day RT incubation |
| 40391-5 | Para aminobenzoate free [Mass/volume] in Serum or Plasma |
| 40645-4 | Leptospira borgpetersenii sv Tarrasovi Ab [Titer] in Serum by Agglutination |
| 5024-5 | Mycobacterium gordonae rRNA [Presence] in Specimen by Probe |
| 50460-5 | Cortisol [Mass/volume] in Serum or Plasma --8th specimen |
| 5052-6 | Aspergillus sp Ab [Presence] in Serum by Immune diffusion (ID) |
| 30168-9 | Oneseed Juniper IgE Ab [Units/volume] in Serum |
| 40901-1 | 3-Hydroxybenzoylecgonine [Mass/mass] in Meconium |
| 19451-4 | Dihydrocodeine cutoff [Mass/volume] in Urine for Confirmatory method |
| 19461-3 | Ethylamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
| 19565-1 | Methylenedioxyamphetamine [Presence] in Urine by Screen method |
| 1966-1 | Bile acid [Mass/volume] in Exhaled gas |
| 1977-8 | Bilirubin.total [Presence] in Urine |
| 20652-4 | Ornithine [Moles/volume] in Serum or Plasma |
| 20687-0 | Arsenic [Mass/volume] in Gastric fluid |
| 100109-8 | Leishmania sp Ab bands panel - Serum by Immunoblot |
| 12879-3 | Borrelia burgdorferi 25kD Ab [Presence] in Serum by Immunoblot |
| 12901-5 | Renin [Enzymatic activity/volume] in Plasma --3rd specimen post XXX challenge |
| 101238-4 | Spermatozoa Immotile/100 spermatozoa in Semen --post vasectomy |
| 13253-0 | Legionella non-pneumophila Ab [Presence] in Serum |
| 102036-1 | Abnormal Prion Protein [Interpretation] in Cerebral spinal fluid Document by RT-QuIC |
| 102111-2 | Gastrin 34 [Moles/volume] in Serum or Plasma by LC/MS/MS |
| 1357-3 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --post 750 mg metyraPONE q4h X 6 |
| 103121-0 | Mahi mahi IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14996-3 | Glucose [Moles/volume] in Serum or Plasma --pre 75 g glucose PO |
| 10667-4 | Fungus identified in Specimen by Animal inoculation |
| 16533-2 | Helicobacter pylori Ab [Titer] in Serum |
| 11179-9 | Linden IgE Ab [Units/volume] in Serum |
| 11244-1 | Morphine Free [Mass/volume] in Serum or Plasma |
| 1216-1 | LW Ab [Presence] in Serum or Plasma |
| 12274-7 | Xylose [Mass/time] in 5 hour Urine |
| 17890-5 | Bacteria # 4 identified in Nose by Aerobe culture |
| 18918-3 | Enoxacin [Susceptibility] |
| 74620-6 | 1,1-Dimethoxy-(9Z)octadecene (DMA 18:1)/Oleate (C18:1w9) [Mass Ratio] in Fibroblast |
| 91777-3 | Bordetella sp identified in Upper respiratory specimen by Organism specific culture |
| 75101-6 | Fatty acids.very long chain C22:0 (Docosanoate) [Entitic substance] in Red Blood Cells |
| 61197-0 | oxyCODONE+oxyMORphone [Presence] in Urine by Confirmatory method |
| 93227-7 | Coccidioides sp Ag [Mass/volume] in Urine by Immunoassay |
| 61384-4 | Human papilloma virus 58 DNA [Presence] in Specimen by NAA with probe detection |
| 77072-7 | ATP5A1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 77345-7 | Enterobius vermicularis [Presence] in Anal by Pinworm exam --2nd specimen |
| 6309-9 | Arbovirus identified in Blood by Organism specific culture |
| 63333-9 | Baker's yeast IgG Ab [Presence] in Serum by Immunofluorescence |
| 94306-8 | SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection |
| 94537-8 | Hemoglobin panel - Blood by HPLC |
| 633-8 | Bacteria identified in Wound by Anaerobe culture |
| 79236-6 | Methcathinone cutoff [Mass/volume] in Urine for Confirmatory method |
| 95186-3 | CD107a+b expressing CMV-specific CD8 cells [#/volume] in Blood by Flow cytometry (FC) |
| 79704-3 | Homo-gamma Linolenate (C20:3w6) [Entitic substance] in Red Blood Cells |
| 96310-8 | Staphylococcus epidermidis DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 68502-4 | Treponema pallidum IgG and IgM panel - Serum Qualitative by Immunofluorescence |
| 81140-6 | CYP3A5 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 81326-1 | Human RNase P RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection |
| 81817-9 | MPI gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 97742-1 | Estradiol (E2) [Mass/volume] in Aspirate |
| 70208-4 | Glucose [Moles/volume] in Serum or Plasma --pre 100 g glucose PO |
| 7021-9 | Itraconazole [Susceptibility] by Gradient strip |
| 71367-7 | Alkaline phosphatase.placental 2 [Enzymatic activity/volume] in Serum or Plasma |
| 82735-2 | AMPAR1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 98267-8 | Parametrial involvement [Presence] in Endometrial cancer specimen |
| 98270-2 | Background endometrium findings in Endometrial cancer specimen |
| 98486-4 | Apolipoprotein E [Mass/volume] in Cerebral spinal fluid |
| 85367-1 | Neutrophil membrane IgG Ab [Presence] in Serum by Immunofluorescence |
| 86030-4 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 73314-7 | Leuprolide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86712-7 | Carbapenem resistance blaOXA gene [Presence] by Molecular method |
| 87648-2 | Malathion [Mass/mass] in Specimen |
| 73876-5 | Beta cortolone [Moles/volume] in Urine |
| 87979-1 | Fungus identified in Pleural fluid by Culture |
| 88539-2 | Adenovirus DNA [Presence] in Stool by NAA with probe detection |
| 74355-9 | Bacteria identified in Bartholin cyst by Aerobe culture |
| 59572-8 | Triglyceride [Moles/volume] in Urine |
| 59761-7 | Triazolam [Mass/volume] in Body fluid by Confirmatory method |
| 59868-0 | Amoxapine [Moles/volume] in Gastric fluid |
| 50764-0 | B IgG Ab [Titer] in Serum or Plasma |
| 50822-6 | Beryllium [Moles/time] in 24 hour Urine |
| 4199-6 | Codeine [Mass] of Dose |
| 42593-4 | Calcium [Moles/volume] in Capillary blood |
| 60123-7 | Pancuronium [Mass/mass] in Tissue |
| 60171-6 | Silicon [Mass/volume] in Red Blood Cells |
| 21435-3 | Osteocalcin.bovine [Mass/volume] in Serum or Plasma |
| 42925-8 | Myeloid cells/100 cells in Body fluid |
| 43748-3 | SCO1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 22364-4 | Infectious bursal disease virus Ab [Presence] in Serum |
| 22434-5 | Human papilloma virus Ab [Presence] in Tissue |
| 51950-4 | Calcium [Mass/volume] in Serum or Plasma --post dialysis |
| 43905-9 | Arbovirus IgG Ab [Presence] in Serum |
| 44242-6 | Erythrocytes [#/area] in Vaginal fluid by Wet preparation |
| 22941-9 | Brucella reaction wheal [Diameter] --2 days post 0.1 mL brucellin intradermal |
| 23059-9 | Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Immunoassay |
| 44429-9 | Albumin/Globulin [Mass Ratio] in Serum or Plasma by Electrophoresis |
| 44563-5 | Influenza virus A Ag [Presence] in Nose |
| 53774-6 | Epstein Barr virus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
| 2380-4 | Glutathione synthase [Enzymatic activity/volume] in Red Blood Cells |
| 34222-0 | 17-Ketosteroids [Moles/volume] in Urine |
| 34224-6 | 3-Alpha-Androstanediol glucuronide [Moles/volume] in 24 hour Urine |
| 54445-2 | Fatty acids.very long chain.C22:1n9 (Erucate) [Mass/volume] in Serum or Plasma |
| 46715-9 | B cell crossmatch [Presence] in Blood |
| 24116-6 | Rubella virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 2420-8 | Histidine [Mass/volume] in Serum or Plasma |
| 34521-5 | Carnitine acyltransferase [Enzymatic activity/mass] in Tissue |
| 34621-3 | Liver cytosol Ab [Units/volume] in Serum |
| 47021-1 | CDX2 Ag [Presence] in Tissue by Immune stain |
| 25320-3 | Anserine [Moles/time] in 24 hour Urine |
| 25453-2 | Lactalbumin alpha IgA Ab [Units/volume] in Serum |
| 25689-1 | Insulin [Moles/volume] in Serum or Plasma --14th specimen post XXX challenge |
| 25810-3 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 35618-8 | Methadone [Mass/volume] in Serum or Plasma by Screen method |
| 35691-5 | XXX microorganism DNA [Presence] in Specimen by NAA with probe detection |
| 56208-2 | Cashew nut IgG4 Ab [Mass/volume] in Serum |
| 26040-6 | Norcitalopram [Moles/volume] in Serum or Plasma |
| 26533-0 | Cortisol [Mass/volume] in Serum or Plasma --56 hours post dose corticotropin |
| 56953-3 | Leptospira interrogans IgM Ab [Presence] in Serum by Immunoassay |
| 48670-4 | IgVH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 27170-0 | TOLBUTamide [Mass/volume] in Urine |
| 49132-4 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by Electrophoresis |
| 49236-3 | Patient symptoms [Interpretation] Narrative--2.5 hours post dose lactose PO |
| 49247-0 | Amino acid pattern [Interpretation] in Serum or Plasma Narrative |
| 27357-3 | HYDROcodone Free [Mass/volume] in Vitreous fluid |
| 27401-9 | Hemoglobin.gastrointestinal [Presence] in Stool --6th specimen |
| 27424-1 | Deoxypyridinoline [Moles/volume] in Urine |
| 38671-4 | M-cresol [Mass/volume] in Air |
| 39561-6 | Glucose [Mass/volume] in Serum or Plasma --1st specimen post dose lactose |
| 5769-5 | Bacteria [#/area] in Urine sediment by Microscopy high power field |
| 3973-5 | Pipradrol [Presence] in Urine |
| 40220-6 | Glucose [Moles/volume] in Serum or Plasma --31 hour post XXX challenge |
| 40279-2 | Glucose [Moles/volume] in Serum or Plasma --2 hours post dose lactose PO |
| 49956-6 | Somatotropin [Units/volume] in Serum or Plasma --5 AM specimen |
| 29996-6 | Histone IgG Ab [Units/volume] in Serum by Immunoassay |
| 20816-5 | Escherichia coli K88 [Presence] in Isolate by Agglutination |
| 20885-0 | Microscopic observation [Identifier] in Gastric fluid by Dark field examination |
| 101480-2 | Cefotaxime+Clavulanate [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 1324-3 | U Ab [Presence] in Serum or Plasma from Donor |
| 13315-7 | Bacteria identified in 24 hour Urine by Culture |
| 13429-6 | Norepinephrine [Mass/volume] in Plasma --5th specimen post XXX challenge |
| 13818-0 | Tyrosine/Creatinine [Mass Ratio] in Urine |
| 102339-9 | Johnson grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102498-3 | Black-eye pea IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14301-6 | Platelet concentrate units available [#] |
| 14397-4 | Urea nitrogen [Mass/volume] in Gastric fluid |
| 104370-2 | Clostridium butyricum [Presence] in Specimen |
| 1532-1 | Glucose [Mass/volume] in Urine --3 hours post 100 g glucose PO |
| 1546-1 | Glucose [Mass/volume] in Urine --6 hours post 100 g glucose PO |
| 17435-9 | Pheniramine [Mass/volume] in Urine |
| 19124-7 | Magnesium [Mass/volume] in Urine |
| 74888-9 | Sterols panel [Moles/volume] - Serum or Plasma |
| 75024-0 | Coproporphyrin 1/Porphyrins.total in Stool |
| 75094-3 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in DBS --post therapeutic diet |
| 60524-6 | Helicobacter pylori IgG Ab [Presence] in Serum by Immunoblot |
| 60577-4 | SERPINE1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 61185-5 | Spermatozoa thick midpiece/100 spermatozoa in Semen |
| 92808-5 | Influenza virus A H3 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 62238-1 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) |
| 63091-3 | Gluten IgG Ab [Mass/volume] in Serum |
| 6325-5 | Brucella abortus Ab [Titer] in Serum by Complement fixation |
| 63314-9 | Rheumatoid factor IgA [Units/volume] in Body fluid by Immunoassay |
| 78785-3 | Amitriptyline [Mass/mass] in Hair |
| 63361-0 | Thyroperoxidase Ab [Units/volume] in Body fluid by Immunoassay |
| 79425-5 | Bacteria identified in Lower respiratory specimen by Cystic fibrosis respiratory culture |
| 95127-7 | Mycobacterium tuberculosis lipoarabinomannan Ag [Presence] in Urine by Rapid immunoassay |
| 95281-2 | NDRG1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 65791-6 | Honey bee native (nApi m) 4 IgE Ab [Units/volume] in Serum |
| 79604-5 | S-beta aminoisobutyrate [Moles/volume] in Serum or Plasma |
| 9632-1 | Aspergillus fumigatus Ab [Presence] in Serum |
| 6810-6 | Aureobasidium pullulans Ab [Presence] in Serum by Immune diffusion (ID) |
| 80594-5 | Parainfluenza virus 3 NP gene [Presence] in Nasopharynx by NAA with probe detection |
| 81637-1 | Glucose meter to reference method correlation [Ratio] in Serum, Plasma or Blood by calculation |
| 97970-8 | Turkey meat IgG4 Ab [Mass/volume] in Serum |
| 82487-0 | TRBV18 gene segments/TRBV gene segments.total in Blood |
| 86008-0 | Streptococcus pneumoniae Danish serotype 14 Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 87277-0 | Borrelia afzelii+burgdorferi+garinii IgM Ab [Presence] in Serum by Line blot |
| 87666-4 | Diazinon [Mass/mass] in Specimen |
| 88014-6 | Octanoylcarnitine (C8)/Carnitine.free (C0) [Molar ratio] in DBS |
| 88154-0 | Microscopic observation [Identifier] in Sinus by Acid fast stain |
| 59661-9 | diazePAM [Mass/mass] in Tissue by Confirmatory method |
| 50921-6 | Tin [Moles/volume] in Urine |
| 51003-2 | Lipoprotein midband B [Mass/volume] in Serum or Plasma |
| 30507-8 | Cumene [Mass/volume] in Urine |
| 30563-1 | Taurine [Moles/volume] in Urine |
| 42483-8 | Protein.monoclonal/Protein.total in Urine by Electrophoresis |
| 60210-2 | Venlafaxine [Mass/mass] in Tissue |
| 21651-5 | CCR5 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 42725-2 | Bromide [Mass/volume] in Blood |
| 42738-5 | CD7+CD8+ cells/100 cells in Blood |
| 32241-2 | Glutamate [Moles/volume] in Vitreous fluid |
| 32281-8 | Carnitine free (C0)/Carnitine.total in Serum or Plasma |
| 52108-8 | Co sup(b) Ab [Presence] in Serum or Plasma |
| 22906-2 | Bovine herpesvirus 1 Ag [Presence] in Specimen by Immunoassay |
| 23150-6 | Leishmania donovani Ag [Presence] in Tissue by Immune stain |
| 3287-0 | Phospholipid IgM Ab [Units/volume] in Serum by Immunoassay |
| 44571-8 | Influenza virus B Ag [Presence] in Nasopharynx by Immunofluorescence |
| 44747-4 | La Crosse virus Ab [Presence] in Serum |
| 5366-0 | Staphylolysin Ab [Units/volume] in Serum |
| 53855-3 | DNAI1+DNAH5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 23912-9 | Osmotic fragility of Red Blood Cells--0.35% sodium chloride |
| 3446-2 | Cefotaxime [Mass/volume] in Serum or Plasma |
| 34701-3 | Heparin induced platelet Ab [Presence] in Serum |
| 25528-1 | Insulin-like growth factor [Moles/volume] in Serum or Plasma |
| 25839-2 | Herpes simplex virus 2 Ab [Titer] in Serum by Immunofluorescence |
| 25946-5 | Lutropin [Units/volume] in Serum or Plasma by 1st IRP --4th specimen post XXX challenge |
| 35751-7 | DMPK gene allele 1 CTG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 56220-7 | Chili Pepper IgG4 Ab [Mass/volume] in Serum |
| 48258-8 | Cultivated Rye triggered leukotriene release [Mass/volume] by Leukocytes |
| 48635-7 | Cholesterol in LDL pattern A [Presence] in Serum or Plasma |
| 48869-2 | Rickettsia sp DNA [Presence] in Specimen by NAA with probe detection |
| 38639-1 | Boron trifluoride [Mass/volume] in Air |
| 5760-4 | Zinc [Mass/volume] in Dialysis fluid |
| 2762-3 | Phenylalanine [Mass/volume] in Blood |
| 38909-8 | PTCH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 49479-9 | FOXP3 Ag [Presence] in Tissue by Immune stain |
| 49990-5 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 40521-7 | Monocytes/100 leukocytes in Pleural fluid by Manual count |
| 40565-4 | Promyelocytes [#/volume] in Body fluid by Manual count |
| 40730-4 | Herpes virus 6 IgG Ab [Presence] in Serum by Immunoassay |
| 4074-1 | Trifluoperazine [Mass/volume] in Serum or Plasma |
| 58836-8 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 5901-4 | Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay |
| 59134-7 | ePHEDrine [Mass/volume] in Urine by Confirmatory method |
| 5923-8 | Gastric acid free [Moles/volume] in Gastric fluid |
| 40754-4 | 17-Hydroxyprogesterone [Mass/volume] in Amniotic fluid |
| 40918-5 | Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 19376-3 | Butalbital cutoff [Mass/volume] in Urine for Confirmatory method |
| 19612-1 | Naltrexone cutoff [Mass/volume] in Urine for Screen method |
| 12590-6 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 12759-7 | Insulin [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge |
| 101160-0 | Flubromazolam [Presence] in Urine by Confirmatory method |
| 101466-1 | Septin-7 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 13261-3 | Leishmania mexicana IgM Ab [Units/volume] in Serum |
| 13872-7 | 11-Deoxycortisol [Mass/time] in 24 hour Urine |
| 13935-2 | Dichlorodifluoromethane [Mass/volume] in Blood |
| 14129-1 | Respiratory syncytial virus [Presence] in Nose by Organism specific culture |
| 14657-1 | cloZAPine+Norclozapine [Moles/volume] in Serum or Plasma |
| 103559-1 | Rhinovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 104221-7 | Spermatozoa.progressive.rapid/100 spermatozoa in Urine --post ejaculation |
| 15192-8 | Variant lymphocytes [Presence] in Blood by Automated count |
| 104281-1 | ABCB1 gene.c.1236C>T [Presence] in Blood or Tissue by Molecular genetics method |
| 104454-4 | Trichinella spiralis IgG Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 1608-9 | Osmolality of Urine--8 hours post fluid fast |
| 10892-8 | Pentoxifylline [Mass/volume] in Serum or Plasma |
| 11282-1 | Cells Counted Total [#] in Blood |
| 1138-7 | Lu sup(a) Ag [Presence] on Red Blood Cells |
| 11582-4 | Wuchereria bancrofti Ab [Units/volume] in Serum |
| 17293-2 | Mumps virus IgG+IgM Ab [Units/volume] in Serum |
| 17346-8 | Neutrophil Ab [Presence] in Serum by Immunofluorescence |
| 17871-5 | Hemoglobin H [Presence] in Blood by Heat denaturation |
| 18409-3 | Curvularia lunata IgG Ab [Units/volume] in Serum |
| 90292-4 | Liver cancer antibodies and AFP [Interpretation] in Serum or Plasma Qualitative |
| 90305-4 | t(2;5)(p23;q35.1)(ALK,NPM1) fusion transcript in Blood or Tissue by Molecular genetics method |
| 90323-7 | Influenza virus A Ab/Positive control in Serum by Immunoassay |
| 92724-4 | Candida sp and Gardnerella vaginalis and Trichomonas vaginalis DNA panel - Vaginal fluid by Probe |
| 75125-5 | Orotidine [Moles/volume] in Serum or Plasma |
| 75570-2 | Fetal Monosomy X risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
| 61199-6 | HIV 1 integrase gene mutations detected [Identifier] |
| 76023-1 | N-acetyl-L-aspartate/Creatinine [Molar ratio] in Urine |
| 76604-8 | Serratia marcescens gyrB gene [#/volume] in XXX.body fluid by NAA with probe detection |
| 76647-7 | Strontium [Mass/mass] in Hair |
| 93468-7 | Acrylfentanyl [Mass/volume] in Urine by Confirmatory method |
| 77062-8 | HPD gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 93925-6 | little e Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant |
| 94381-1 | 2,3-dinor 11 beta-Prostaglandin F2 alpha/Creatinine [Mass Ratio] in 24 hour Urine |
| 94385-2 | Amphiphysin IgG Ab [Presence] in Serum by Line blot |
| 94612-9 | Mycoplasma bovis Ag [Presence] in Tissue by Immune stain |
| 9466-4 | Cadmium [Mass/volume] in Water |
| 63524-3 | Carboxyhemoglobin/Hemoglobin.total in Venous cord blood |
| 641-1 | Microscopic observation [Identifier] in Gastric fluid by Acid fast stain.Kinyoun modified |
| 6509-4 | Neisseria meningitidis rRNA [Presence] in Cerebral spinal fluid by Probe |
| 79222-6 | Benzodiazepines [Presence] in Body fluid by Screen method |
| 94865-3 | Triglyceride [Mass/volume] corrected for glycerol in Serum |
| 6958-3 | Western equine encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 69938-9 | Astrovirus RNA [Presence] in Specimen by NAA with probe detection |
| 8170-3 | Cannabinoids [Mass/volume] in Serum or Plasma |
| 81795-7 | Tetrahydrocortisone/Creatinine [Molar ratio] in Urine |
| 82174-4 | Parainfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 97767-8 | IgG subclass 4 [Mass/volume] in Body fluid |
| 70198-7 | Acetaminophen [Moles/volume] in Serum or Plasma by Screen method |
| 71667-0 | Myelocytes/Leukocytes [Pure number fraction] in Blood by Manual count |
| 83089-3 | Cortisol [Mass/volume] in 24 hour Urine by Immunoassay |
| 86593-1 | Varicella zoster virus DNA [Presence] in Amniotic fluid by NAA with probe detection |
| 87564-1 | Zearalenone [Mass/mass] in Specimen |
| 73911-0 | SOX10 Ag [Presence] in Tissue by Immune stain |
| 89582-1 | Microscopic observation [Identifier] in Cervix by Acid fast stain |
| 89643-1 | Bacteria identified in Lower respiratory specimen by Aerobe culture |
| 41686-7 | Clavulanate [Susceptibility] by Disk diffusion (KB) |
| 50727-7 | Serotonin release 100 IU/mL heparin.unfractionated [Units/volume] in Serum |
| 50876-2 | Mercury [Moles/mass] in Hair |
| 42362-4 | Streptococcus pneumoniae 7 serotypes IgG panel B [Mass/volume] - Serum |
| 4250-7 | Fencamfamin [Mass] of Dose |
| 42585-0 | Bendiocarb [Presence] in Urine |
| 42609-8 | Glucose [Mass/volume] in Urine --6 hours post dose lactose PO |
| 31361-9 | Ehrlichia canis Ab [Units/volume] in Serum |
| 31528-3 | Neisseria meningitidis serogroup Y Ab [Units/volume] in Specimen |
| 51457-0 | Filaria IgG3 Ab [Units/volume] in Serum |
| 51461-2 | Listeria sp Ab [Titer] in Serum |
| 43200-5 | Norfentanyl [Presence] in Urine by Confirmatory method |
| 31955-8 | Rubella virus Ag [Presence] in Cerebral spinal fluid |
| 51663-3 | Alphavirus RNA [Presence] in Specimen by NAA with probe detection |
| 51802-7 | Phosphatidylserine IgM Ab [Titer] in Serum by Immunofluorescence |
| 43800-2 | Choriogonadotropin.beta subunit [Presence] in Cerebral spinal fluid |
| 22470-9 | Rickettsia (Proteus OX2) Ab [Presence] in Serum |
| 22705-8 | Glucose [Moles/volume] in Urine by Test strip |
| 5230-8 | Influenza virus B Ab [Titer] in Serum by Complement fixation |
| 43839-0 | Influenza virus B IgG Ab [Presence] in Serum |
| 43868-9 | Chlamydophila psittaci IgG Ab [Presence] in Serum |
| 44067-7 | CD20+FMC7+ cells [#/volume] in Body fluid |
| 22878-3 | Border disease virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 32997-9 | cycloSPORINE [Mass/volume] in Blood --2 hours post dose |
| 4510-4 | Complement C9 [Mass/volume] in Serum or Plasma |
| 3405-8 | Bromazepam [Mass/volume] in Serum or Plasma |
| 54274-6 | Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose ornithine alpha-ketoglutarate |
| 34568-6 | Alkaline phosphatase [Presence] in Body fluid |
| 55171-3 | Cytoplasmic Ab pattern [Interpretation] in Serum by Immunofluorescence |
| 25236-1 | Cefixime [Mass/volume] in Specimen |
| 25533-1 | Taurine [Moles/time] in 24 hour Urine |
| 34714-6 | INR in Blood by Coagulation assay |
| 34915-9 | Malignant cells/100 leukocytes in Blood |
| 353-3 | Nalidixate [Susceptibility] by Serum bactericidal titer |
| 55656-3 | Cinoxacin [Susceptibility] by Gradient strip |
| 47584-8 | C peptide [Moles/volume] in Serum or Plasma --10 minutes post dose glucose |
| 47967-5 | NSD1 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method |
| 48037-6 | pH of Vaginal fluid |
| 3641-8 | Flunitrazepam [Mass/volume] in Urine |
| 56675-2 | Carnosine/Creatinine [Ratio] in 24 hour Urine |
| 48642-3 | Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) |
| 38658-1 | Acetate [Mass/volume] in Air |
| 49096-1 | Chlamydia trachomatis DNA [Units/volume] in Specimen by NAA with probe detection |
| 2780-5 | Phosphate [Presence] in Urine |
| 3882-8 | Oxacillin [Mass/volume] in Serum or Plasma |
| 39476-7 | diphenhydrAMINE [Moles/volume] in Serum or Plasma |
| 57780-9 | Thyroglobulin and Thyroglobulin Ab panel - Serum or Plasma |
| 57856-7 | Carisoprodol [Moles/volume] in Specimen |
| 2841-5 | Prolactin [Mass/volume] in Semen |
| 2878-7 | Protein [Mass/volume] in Amniotic fluid |
| 29258-1 | Linezolid [Susceptibility] |
| 58579-4 | Corticotropin [Moles/volume] in Plasma --2nd specimen post XXX challenge |
| 5010-4 | Hepatitis C virus RNA [Presence] in Blood by NAA with probe detection |
| 29605-3 | Appearance of Synovial fluid |
| 50427-4 | Corticotropin [Mass/volume] in Plasma --40 minutes post 100 ug CRH IV |
| 40781-7 | Polio virus IgM Ab [Titer] in Serum --1st specimen |
| 41164-5 | Uranium depleted [Presence] in Urine |
| 20651-6 | Methionine [Moles/volume] in Serum or Plasma |
| 100804-4 | Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge |
| 13183-9 | White Elm IgG Ab [Units/volume] in Serum |
| 101778-9 | Nannizzia persicolor DNA [Presence] in Specimen by NAA with probe detection |
| 102471-0 | Valley Oak IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13972-5 | Alpha 1 globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
| 102788-7 | Black Pepper IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14603-5 | Androstenedione [Moles/volume] in Serum or Plasma |
| 104375-1 | Corynebacterium ulcerans DNA [Presence] in Specimen by NAA with probe detection |
| 10561-9 | Carnitine [Moles/volume] in Semen |
| 15359-3 | dRVVT actual/normal (normalized LA screen) |
| 16311-3 | Acetone [Mass/volume] in Body fluid |
| 121-4 | Cefpodoxime [Susceptibility] by Disk diffusion (KB) |
| 17436-7 | PHENobarbital [Mass/volume] in Gastric fluid |
| 17911-9 | Bacteria # 3 identified in Wound deep by Aerobe culture |
| 18332-7 | Thyroperoxidase IgG Ab [Units/volume] in Serum or Plasma |
| 90300-5 | Helminth identified in Specimen by NAA with probe detection |
| 90797-2 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --2 hours post dose levothyroxine |
| 90820-2 | Contactin-associated protein 2 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 74940-8 | Moclobemide [Mass/volume] in Serum or Plasma --trough |
| 75410-1 | Hepatitis B virus surface Ag [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 61039-4 | clonazePAM [Presence] in Specimen |
| 61053-5 | Norfentanyl [Presence] in Specimen |
| 93194-9 | NUDT15 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 93497-6 | Moxifloxacin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 61252-3 | Pumpkin Seed IgE Ab/IgE total in Serum |
| 7795-8 | Pappenheimer bodies [Presence] in Blood by Light microscopy |
| 63433-7 | Microscopic observation [Identifier] in Synovial fluid by Acid fast stain.Ziehl-Neelsen |
| 64118-3 | Second most predominant hemoglobin in DBS |
| 79207-7 | BRCA1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 79298-6 | D- and L-2-hydroxyglutarate panel - DBS |
| 79301-8 | D- and L-2-hydroxyglutarate pattern newborn screen interpretation |
| 79470-1 | Uridine monophosphate synthetase [Enzymatic activity/mass] in Red Blood Cells |
| 95276-2 | GARS gene full mutation analysis in Blood or Tissue by Sequencing |
| 65769-2 | Peanut native (nAra h) 1 IgE Ab [Units/volume] in Serum |
| 66718-8 | Rickettsia typhi and Rickettsia spotted fever group IgG and IgM [Interpretation] in Specimen |
| 68501-6 | Serotonin release.heparin.unfractionated and low molecular weight panel - Serum |
| 80607-5 | 14-Hydroxyclarithromycin [Mass/volume] in DBS |
| 96518-6 | Onyong-nyong virus IgG Ab [Presence] in Specimen by Immunoassay |
| 69889-4 | Service comment 62 |
| 97241-4 | diazePAM [Presence] in Cord tissue by Confirmatory method |
| 97962-5 | Grey Alder IgG4 Ab [Mass/volume] in Serum |
| 82721-2 | Intravenous lipid emulsion [Mass/volume] in Serum by Nephelometry |
| 82910-1 | Thromboxane beta 2 [Moles/volume] in Serum or Plasma |
| 98230-6 | Corn starch IgE Ab [Units/volume] in Serum |
| 72426-0 | 5-Hydroxyhexanoate [Moles/volume] in Serum or Plasma |
| 83068-7 | Chikungunya virus structural proteins (E1+E2) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 99931-8 | Nucleated cells [#/area] in Body fluid by Automated count |
| 72743-8 | Normeperidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 86045-2 | Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum |
| 86052-8 | Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum |
| 86123-7 | Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum by Immunoassay |
| 86520-4 | Hantavirus RNA [Presence] in Blood by NAA with probe detection |
| 73054-9 | Atorvastatin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73311-3 | levETIRAcetam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73335-2 | Imipenem induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87487-5 | MAB-CHMINACA butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 88136-7 | Varicella zoster virus [Presence] in Ocular fluid by Organism specific culture |
| 89332-1 | CD28+HLA DR+ cells/100 CD3+CD8+ cells in Blood |
| 41214-8 | Volatiles and gases [Identifier] in Gastric fluid by Screen method |
| 59764-1 | Triazolam [Mass/mass] in Tissue by Confirmatory method |
| 50633-7 | cefTRIAXone [Susceptibility] for meningitis |
| 50901-8 | Porphyrins [Moles/volume] in 24 hour Urine |
| 50972-9 | CD138 cells [#/volume] in Blood |
| 42339-2 | HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay |
| 4254-9 | Fenproporex [Mass] of Dose |
| 21428-8 | Olive IgE Ab [Units/volume] in Serum |
| 21-6 | Amoxicillin+Clavulanate [Susceptibility] by Disk diffusion (KB) |
| 31333-8 | Coxsackievirus B6 Ab [Units/volume] in Cerebral spinal fluid |
| 51142-8 | Cytoplasmic CD3 blasts [Units/volume] in Specimen |
| 51312-7 | CD4+CD7-CD49D- cells/100 cells in Tissue |
| 51327-5 | CD42b cells/100 cells in Bone marrow |
| 21671-3 | F7 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 21678-8 | FGFR3 gene p.Gly380Arg [Presence] in Blood or Tissue by Molecular genetics method |
| 22146-5 | Brucella abortus Ab [Presence] in Milk |
| 22185-3 | Chlamydia sp IgM Ab [Units/volume] in Cerebral spinal fluid |
| 22286-9 | Entamoeba histolytica Ab [Titer] in Serum |
| 31936-8 | Pneumocystis jiroveci Ag [Presence] in Nose |
| 51831-6 | Beta-2 transferrin [Mass/volume] in Body fluid |
| 2262-4 | Estrone (E1).unconjugated [Mass/time] in 24 hour Urine |
| 3227-6 | Coagulation factor XI activity [Units/volume] in Platelet poor plasma by Chromogenic method |
| 52126-0 | Acid glycerol lysis [Time] in Red Blood Cells |
| 5276-1 | PCNA extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
| 32744-5 | CD55 cells/100 cells in Specimen |
| 53284-6 | Broad casts [#/volume] in Urine by Computer assisted method |
| 53423-0 | Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --5th specimen post XXX challenge |
| 53709-2 | Glial nuclear type 1 Ab [Titer] in Serum |
| 53791-0 | PTPN11 gene mutations tier 1 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 53824-9 | Paromomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 53835-5 | 1,5-Anhydroglucitol [Mass/volume] in Serum or Plasma |
| 53881-9 | Norbuprenorphine [Mass/volume] in Serum or Plasma |
| 45365-4 | Lymphocyte proliferation stimulated by 10 ug concanavalin A in Blood |
| 54147-4 | Autoantibodies [Interpretation] in Serum by Immunofluorescence (IF) rat liver+stomach+kidney substrate Narrative |
| 54447-8 | FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method |
| 4645-8 | Hemosiderin [Mass/volume] in Urine |
| 24140-6 | White Ash IgG Ab [Units/volume] in Serum |
| 24264-4 | Coxsackievirus B4 Ab [Titer] in Serum --2nd specimen |
| 54498-1 | Glucose [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 47112-8 | Gold [Moles/time] in 24 hour Urine |
| 47126-8 | Protriptyline [Moles/volume] in Gastric fluid |
| 25422-7 | Schistosoma sp Ab [Titer] in Serum by Immunofluorescence |
| 35139-5 | Interferon beta Ab [Titer] in Serum or Plasma |
| 35161-9 | Palmitate (C16:0) [Moles/volume] in Serum or Plasma |
| 5611-9 | Cadmium [Mass/volume] in Urine |
| 47532-7 | Mumps virus RNA [Presence] in Specimen by NAA with probe detection |
| 35771-5 | Cefotaxime+Clavulanate [Susceptibility] |
| 47977-4 | Smooth muscle IgG Ab [Titer] in Serum |
| 48002-0 | Genomic source class [Type] |
| 26044-8 | Pepsin IgE Ab [Units/volume] in Serum |
| 26856-5 | Cannabinoids [Mass/mass] in Stool |
| 57593-6 | Aldosterone [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge |
| 49103-5 | WBC casts [#/area] in Urine sediment by Microscopy high power field |
| 39796-8 | Vancomycin [Moles/volume] in Serum or Plasma --peak |
| 49764-4 | Calcium [Mass/volume] in Amniotic fluid |
| 29683-0 | Rickettsia prowazekii Ab [Presence] in Serum |
| 29748-1 | Protein [Mass/mass] in Tissue |
| 29843-0 | Powassan virus IgM Ab [Presence] in Cerebral spinal fluid |
| 40319-6 | Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose triple bolus |
| 58947-3 | Follitropin [Units/volume] in Serum or Plasma --pre XXX challenge |
| 5035-1 | Streptococcus pneumoniae rRNA [Presence] in Specimen by Probe |
| 30083-0 | Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
| 40839-3 | fentaNYL [Presence] in Urine by Confirmatory method |
| 4111-1 | ALPRAZolam [Mass] of Dose |
| 1931-5 | Beta alanine [Presence] in Serum or Plasma |
| 19486-0 | HYDROmorphone [Presence] in Urine by Screen method |
| 19672-5 | Phenothiazines cutoff [Mass/volume] in Urine for Screen method |
| 20681-3 | Alpha tocopherol [Mass/mass] in Tissue |
| 20890-0 | Monensin [Mass/mass] in Feed |
| 20976-7 | Tritrichomonas foetus [Presence] in Preputial wash by Organism specific culture |
| 12562-5 | Cortisol [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 12805-8 | Alkaline phosphatase isoenzyme [Units/volume] in Serum or Plasma |
| 128-9 | Cefsulodin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 13555-8 | D-pseudoephedrine [Presence] in Serum or Plasma |
| 1395-3 | Cortisol Free [Mass/volume] in 24 hour Urine --pre 500 ug dexamethasone PO 2.5 day low dose q6h |
| 1427-4 | Cortisol [Mass/volume] in Serum or Plasma --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 14607-6 | Nuclear Ab [Presence] in Body fluid |
| 103167-3 | Blastomyces dermatitidis DNA [Presence] in Specimen by NAA with probe detection |
| 103831-4 | Midazolam [Presence] in Meconium |
| 14936-9 | Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid |
| 104399-1 | European tick borne encephalitis virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 16249-5 | oxyCODONE [Mass/volume] in Urine by Confirmatory method |
| 16482-2 | Borrelia burgdorferi IgM Ab [Units/volume] in Body fluid by Immunoassay |
| 11208-6 | Atrial natriuretic factor [Mass/volume] in Plasma |
| 12259-8 | Streptococcus pyogenes enzyme Ab [Presence] in Serum by Sheep Cell Agglutination |
| 17234-6 | Magnesium.plasma/Magnesium.RBC [Molar ratio] in Blood |
| 1734-3 | Aldosterone renal clearance in 24 hour Urine and Serum or Plasma |
| 17447-4 | Phosphate [Presence] in Stool |
| 17462-3 | Picloram [Mass/volume] in Urine |
| 17827-7 | CD2 cells/100 cells in Body fluid |
| 18282-4 | Cannabinoids [Presence] in Urine by Screen method |
| 18999-3 | Troleandomycin [Susceptibility] |
| 74898-8 | Lanosterol [Moles/volume] in Serum or Plasma |
| 91129-7 | Clot strength ADP induced [Length fraction] in Blood by calculation |
| 75411-9 | Ebola Zaire virus RNA [Presence] in Plasma or Blood by NAA with probe detection |
| 60495-9 | MAP2K1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 76677-4 | Appearance of Cerebral spinal fluid--3rd tube |
| 93400-0 | Enterobacter aerogenes+Enterobacter amnigenus+Enterobacter gergoviae DNA [Presence] by NAA with probe detection in Positive blood culture |
| 612-2 | Bacterial strain [Type] in Isolate by Bacteria subtyping |
| 77253-3 | Microalbumin/Creatinine [Ratio] in Urine by Detection limit <= 1.0 mg/L |
| 62493-2 | Streptococcus pneumoniae DNA and Haemophilus influenza DNA and Streptococcus agalactiae DNA [Identifier] in Unspecified specimen by NAA with probe detection |
| 78213-6 | Cells.BCL6 gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 94294-6 | Norcitalopram [Presence] in Serum or Plasma by Screen method |
| 94363-9 | PCA-1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 94634-3 | Coxiella burnetii DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 94638-4 | Bovine respiratory syncytial virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 94704-4 | Voltage-gated calcium channel N type binding Ab [Moles/volume] in Serum by Immunoassay |
| 63477-4 | Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum |
| 79204-4 | Somatotropin [Mass/volume] in Serum or Plasma --1.25 hours post dose arginine+insulin |
| 80361-9 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Cervix by NAA with probe detection |
| 6847-8 | Mexican tea IgE Ab [Units/volume] in Serum |
| 9708-9 | Coxiella burnetii phase 1 IgG Ab [Titer] in Serum |
| 81845-0 | PALB2 gene full mutation analysis in Blood or Tissue by Sequencing |
| 97605-0 | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Plasma by Immunoassay |
| 7019-3 | Imipenem [Susceptibility] by Gradient strip |
| 7043-3 | Piperacillin [Susceptibility] by Gradient strip |
| 8244-6 | Titanium [Mass/volume] in Serum or Plasma |
| 82492-0 | TRBV12 gene segments/TRBV gene segments.total in Blood |
| 98215-7 | Treponema pallidum Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 71793-4 | Treponema pallidum Ab [Titer] in Serum or Plasma by Agglutination |
| 7214-0 | Roquefort Cheese IgE Ab [Units/volume] in Serum |
| 72343-7 | Monocytes/100 round cells in Semen by Manual count |
| 85543-7 | PRRSV IgG Ab/Positive control in Saliva (oral fluid) by Immunoassay |
| 72752-9 | Morphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 86175-7 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 86573-3 | JC virus DNA [Presence] in Blood by NAA with probe detection |
| 86580-8 | Mumps virus RNA [Presence] in Urine by NAA with probe detection |
| 73185-1 | Pseudoephedrine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73212-3 | Penicillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87725-8 | Cytomegalovirus IgM Ab [Presence] in Serum or Plasma from Donor by Immunoassay |
| 88144-1 | Microscopic observation [Identifier] in Peritoneal fluid by Acid fast stain |
| 89652-2 | Human metapneumovirus identified in Lower respiratory specimen by Organism specific culture |
| 41676-8 | cefOXitin+Clavulanate [Susceptibility] by Disk diffusion (KB) |
| 5079-9 | Chlamydophila psittaci Ab [Titer] in Serum by Complement fixation |
| 5089-8 | Chlamydia trachomatis IgG Ab [Units/volume] in Serum |
| 30468-3 | Unidentified cells/100 leukocytes in Cerebral spinal fluid |
| 30518-5 | Cholate [Moles/volume] in Serum or Plasma |
| 59958-9 | Promazine [Moles/volume] in Urine |
| 60212-8 | Zolazepam [Mass/volume] in Serum or Plasma |
| 31327-0 | Coxsackievirus B3 Ab [Units/volume] in Cerebral spinal fluid |
| 31345-2 | Ganglioside GD1b Ab [Units/volume] in Serum |
| 51088-3 | CD16 blasts/100 blasts in Specimen |
| 51415-8 | Methylmalonylcarnitine+Succinylcarnitine (C4-DC) [Moles/volume] in Serum or Plasma |
| 31705-7 | Western equine encephalitis virus Ab [Units/volume] in Cerebral spinal fluid |
| 31708-1 | Yersinia enterocolitica Ab [Units/volume] in Serum |
| 31914-5 | Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid |
| 51580-9 | Macrophages/100 leukocytes in Bone marrow by Manual count |
| 43589-1 | Shigella sp Ab [Presence] in Serum |
| 22767-8 | African horse sickness virus Ab [Presence] in Serum by Immunoblot |
| 32200-8 | Segmented neutrophils/100 leukocytes in Blood by Automated count |
| 32229-7 | Argininosuccinate/Creatinine [Ratio] in Urine |
| 32504-3 | CD13+CD33+ cells/100 cells in Bone marrow |
| 5292-8 | Reagin Ab [Presence] in Serum by VDRL |
| 44074-3 | Arbovirus Ab [Interpretation] in Serum by Immunofluorescence |
| 4426-3 | Spironolactone [Mass] of Dose |
| 44421-6 | PKD1 gene+PKD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 44576-7 | Influenza virus B Ag [Presence] in Bronchial specimen |
| 3348-0 | Amphetamines [Presence] in Serum or Plasma |
| 53577-3 | Reason for study |
| 44977-7 | Chlamydophila psittaci IgM Ab [Presence] in Serum |
| 45280-5 | Echovirus 9 Ab [Presence] in Body fluid |
| 23792-5 | Western equine encephalitis virus Ab [Presence] in Specimen |
| 23833-7 | Borrelia burgdorferi Ab index [Presence] in Serum and CSF |
| 53982-5 | Centromere protein B Ab [Units/volume] in Serum |
| 53995-7 | Nuclear matrix Ab pattern [Titer] in Serum by Immunofluorescence |
| 54344-7 | 3-Methoxytyramine [Mass/volume] in 24 hour Urine |
| 4677-1 | Protein S Free Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 2468-7 | IgG subclass 3 [Mass/volume] in Serum |
| 34466-3 | Carbohydrates [Presence] in Specimen |
| 55379-2 | Snowshoe hare virus IgM Ab [Presence] in Serum by Immunoassay |
| 55511-0 | Somatotropin [Mass/volume] in Serum or Plasma --3 hours post dose glucagon |
| 47113-6 | Gold/Creatinine [Molar ratio] in 24 hour Urine |
| 34724-5 | Echovirus 4 Ab [Presence] in Cerebral spinal fluid |
| 34964-7 | Osmotic fragility [Interpretation] of Red Blood Cells |
| 55771-0 | Basophils [#] in Cerebral spinal fluid by Manual count |
| 55888-2 | 3-Hydroxyanthranilate [Moles/time] in 24 hour Urine |
| 56121-7 | IgA [Mass/volume] in Urine |
| 25597-6 | Josamycine [Susceptibility] |
| 35385-4 | CV2 IgG Ab [Titer] in Cerebral spinal fluid |
| 35611-3 | Flurazepam [Mass/volume] in Serum or Plasma by Screen method |
| 56363-5 | Insulin porcine IgG4 Ab [Mass/volume] in Serum |
| 48017-8 | Sequencing methodology panel - Blood or Tissue by Molecular genetics method |
| 26450-7 | Eosinophils/100 leukocytes in Blood |
| 26797-1 | Alpha hydroxybutyrate [Presence] in Urine |
| 26906-8 | Mephobarbital [Mass/mass] in Hair |
| 27040-5 | Ketones [Presence] in Urine by Test strip --1 hour post XXX challenge |
| 27106-4 | Zinc [Presence] in Blood |
| 57379-0 | Potassium [Moles/volume] in 2 hour Urine |
| 49165-4 | Orientia tsutsugamushi Kato IgG Ab [Titer] in Serum |
| 27370-6 | Chlamydia trachomatis C Ab [Titer] in Serum by Immunofluorescence |
| 38719-1 | 1,3-Propane sultone [Mass/volume] in Air |
| 49448-4 | Toxoplasma gondii DNA [#/volume] in Specimen by NAA with probe detection |
| 58694-1 | Cortisol [Moles/volume] in Saliva (oral fluid) --7th specimen post XXX challenge |
| 29700-2 | Leptospira interrogans sv Shermani Ab [Presence] in Serum |
| 40541-5 | Plasma cells/100 leukocytes in Cerebral spinal fluid by Microscopy |
| 58908-5 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 50327-6 | Neu-N Ag [Presence] in Tissue by Immune stain |
| 50-5 | Bacampicillin [Susceptibility] by Serum bactericidal titer |
| 30133-3 | Coxsackievirus Ab [Presence] in Serum --2nd specimen |
| 30243-0 | Choriogonadotropin.intact [Units/volume] in Serum or Plasma |
| 30266-1 | Glucose [Moles/volume] in Serum or Plasma --1.6 hours post dose glucose |
| 19423-3 | Dextromethamphetamine [Presence] in Urine by Screen method |
| 19602-2 | Morphine Free [Presence] in Urine by Confirmatory method |
| 19657-6 | PENTobarbital cutoff [Mass/volume] in Urine for Screen method |
| 20818-1 | Escherichia coli K99 [Presence] in Small intestine Tissue by Agglutination |
| 12406-5 | Nadolol [Mass/volume] in Serum or Plasma |
| 12776-1 | Mucin-like carcinoma associated Ag [Units/volume] in Serum or Plasma |
| 12875-1 | HIV 1 p64 Ab [Presence] in Serum by Immunoblot |
| 12956-9 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 13427-0 | Norepinephrine [Mass/volume] in Plasma --3rd specimen post XXX challenge |
| 102231-8 | Chestnut Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13469-2 | Thallium/Creatinine [Mass Ratio] in Urine |
| 14273-7 | Reticulin IgA Ab [Presence] in Serum |
| 102841-4 | English Walnut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103014-7 | Aspergillus fumigatus recombinant (rAsp f) 4 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103075-8 | Peanut recombinant (rAra h) 9 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14588-8 | Alkaline phosphatase isoenzymes [Interpretation] in Serum or Plasma |
| 103136-8 | Honey bee dipeptidyl peptidase recombinant (rApi m) 5 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15160-5 | Coagulation factor Intrinsic Factor [Interpretation] in Platelet poor plasma Narrative |
| 10474-5 | Collagen type 4 Ag [Presence] in Tissue by Immune stain |
| 16224-8 | Triazolam [Presence] in Urine by Confirmatory method |
| 10808-4 | Microscopic observation [Identifier] in Tissue by Silver impregnation stain.Dieterle |
| 10838-1 | Phosphoserine [Mass/volume] in Serum or Plasma |
| 11050-2 | Kappa light chains [Mass/volume] in Serum or Plasma |
| 16264-4 | Calcium oxalate monohydrate crystals [Presence] in Stone by Infrared spectroscopy |
| 12205-1 | Cryoglobulin [Presence] in Serum by 5 day cold incubation |
| 17000-1 | Hydroxylysine [Presence] in Urine |
| 17858-2 | Gamma glutamyl transferase [Enzymatic activity/volume] in Body fluid |
| 19080-1 | Choriogonadotropin [Units/volume] in Serum or Plasma |
| 74763-4 | Human papilloma virus E6+E7 mRNA [Presence] in Anal by NAA with probe detection |
| 74997-8 | Alpha 1 antitrypsin [Mass/mass] in Stool.dried |
| 60327-4 | PARoxetine [Moles/volume] in Specimen |
| 60430-6 | Hepatitis E virus genotype [Identifier] in Blood by NAA with probe detection |
| 60535-2 | Doripenem [Susceptibility] |
| 61100-4 | Collection date of Stool--2nd specimen |
| 75731-0 | HTR2A gene c.102T>C [Presence] in Blood or Tissue by Molecular genetics method |
| 76072-8 | Enterovirus D68 RNA [Presence] in Specimen by NAA with probe detection |
| 61262-2 | Buckwheat IgE Ab/IgE total in Serum |
| 61310-9 | Willow IgE Ab/IgE total in Serum |
| 620-5 | Bacteria identified in Skin by Aerobe culture |
| 62325-6 | Post-discharge provider practice ID |
| 93869-6 | AMPAR1 Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 93873-8 | Borrelia miyamotoi IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 62433-8 | La Crosse virus IgG Ab [Presence] in Body fluid by Immunoassay |
| 94499-1 | Respiratory viral pathogens DNA and RNA panel - Respiratory system specimen Qualitative by NAA with probe detection |
| 63468-3 | Ganglioside GT1a IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 79411-5 | Creatine transport protein [Enzymatic activity/mass] in Fibroblast by Creatine uptake assay |
| 95239-0 | Hepatitis D virus IgM panel - Serum |
| 95286-1 | SBF2 gene full mutation analysis in Blood or Tissue by Sequencing |
| 8030-9 | Streptococcus pneumoniae Ab [Presence] in Serum |
| 80381-7 | Influenza virus A and B Ag panel - Upper respiratory specimen by Rapid immunoassay |
| 95698-7 | Tahyna virus IgA Ab [Presence] in Specimen by Immunoassay |
| 96409-8 | Pancreatic polypeptide [Mass/volume] in Serum or Plasma --20M post sham feeding |
| 687-4 | Mycoplasma sp and Ureaplasma sp [Identifier] in Specimen by Organism specific culture |
| 97210-9 | 6-monoacetylmorphine free [Presence] in Cord tissue by Screen method |
| 69805-0 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --12 hours post dose ifosfamide |
| 9776-6 | Norchlordiazepoxide [Mass/volume] in Serum or Plasma |
| 715-3 | Normoblasts [#/volume] in Blood |
| 82306-2 | Chlamydia trachomatis rRNA [Presence] in Throat by NAA with probe detection |
| 82457-3 | Human papilloma virus 16 and 18+45 E6+E7 mRNA panel - Cervix by NAA with probe detection |
| 82773-3 | Lab result time reported |
| 82794-9 | Spontaneous clot formation [Time] in Platelet poor plasma |
| 82983-8 | Ma+Ta IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 98266-0 | Uterine serosa involvement [Presence] in Endometrial cancer specimen |
| 85746-6 | Streptococcus pneumoniae Danish serotype 14 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 72731-3 | 7-Hydroxymitragynine [Mass/volume] in Urine by Confirmatory method |
| 72999-6 | Loratadine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86719-2 | Actinobacillus pleuropneumoniae serotype 5 Ab [Titer] in Serum by Complement fixation |
| 73670-2 | Bacteria producing coagulase and protein A [Presence] in Isolate by Latex agglutination |
| 73932-6 | traMADol [Mass/volume] in Blood |
| 7397-3 | Eastern Hemlock IgE Ab [Units/volume] in Serum |
| 74381-5 | Midazolam [Mass/volume] in Unknown substance |
| 89489-9 | rifAMPin [Susceptibility] by Genotype method |
| 41495-3 | Haemophilus influenzae B Ag [Presence] in Body fluid |
| 30569-8 | Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 42624-7 | Gastrin [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge |
| 2148-5 | Creatine [Mass/volume] in Serum or Plasma |
| 43188-2 | Neuronal nuclear type 2 Ab [Titer] in Serum by Immunofluorescence |
| 43721-0 | Acetaldehyde+Paraldehyde [Presence] in Serum or Plasma |
| 224-6 | Doxycycline [Susceptibility] by Minimum lethal concentration (MLC) |
| 44312-7 | Cystine/Creatinine [Mass Ratio] in 24 hour Urine |
| 2292-1 | Formate [Mass/volume] in Serum or Plasma |
| 32694-2 | Legionella longbeachae 1+2 Ab [Titer] in Serum |
| 3323-3 | aMILoride [Presence] in Urine |
| 2334-1 | Hemoglobin.gastrointestinal [Presence] in Gastric fluid |
| 23416-1 | Rinderpest virus Ag [Units/volume] in Specimen by Immunoassay |
| 33703-0 | Clostridium botulinum toxin F [Presence] in Specimen by Mouse bioassay neutralization |
| 53772-0 | Beta globulin [Presence] in Urine by Electrophoresis |
| 33808-7 | Insulin-like growth factor binding protein 3 [Moles/volume] in Serum or Plasma |
| 34192-5 | Beta galactosidase [Presence] in Amniotic fluid cells |
| 4668-0 | Plasminogen Ag [Mass/volume] in Platelet poor plasma |
| 24251-1 | Coxsackievirus B1 Ab [Titer] in Serum --1st specimen |
| 24486-3 | Grass Allergen Mix 2 (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass+Bahia grass) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 47129-2 | Silver [Moles/time] in 24 hour Urine |
| 4734-0 | HLA-A31(19) [Presence] in Donor |
| 25216-3 | Para aminosalicylate 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 2542-9 | Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis |
| 25441-7 | Homocystine [Moles/time] in 24 hour Urine |
| 34917-5 | Plasma cell precursor/100 leukocytes in Blood |
| 55660-5 | Clindamycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 55812-2 | 18-Hydroxycortisol [Moles/volume] in 24 hour Urine |
| 47787-7 | Threonine/Amino acids.total in Amniotic fluid |
| 35730-1 | Chlamydia sp rRNA [Presence] in Specimen by Probe |
| 56299-1 | Firebush IgG4 Ab [Mass/volume] in Serum |
| 48114-3 | Hexadecanedioate/Creatinine [Molar ratio] in Urine |
| 48346-1 | HIV 1+O+2 Ab [Units/volume] in Serum or Plasma |
| 2640-1 | Myoglobin [Presence] in Urine |
| 5667-1 | Isopropanol [Mass/volume] in Blood |
| 56791-7 | Entecavir [Susceptibility] by Genotype method |
| 48894-0 | Ehrlichia chaffeensis IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 57545-6 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --pre dose dexamethasone |
| 57588-6 | Aldosterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 2776-3 | Phosphate renal clearance in 24 hour Urine and Serum or Plasma |
| 38695-3 | 1,2-Dichloroethane [Mass/volume] in Air |
| 3903-2 | Para hydroxyamphetamine [Mass/time] in 24 hour Urine |
| 58500-0 | C peptide [Mass/volume] in Serum or Plasma --15 minutes post dose glucose |
| 40415-2 | Benzodiazepines [Presence] in Hair |
| 40624-9 | CD3+CD8+ (T8 suppressor) cells/100 cells in Bronchial specimen |
| 59188-3 | Alkaline phosphatase.placental [Enzymatic activity/volume] in Cerebral spinal fluid |
| 30140-8 | IgA [Presence] in 24 hour Urine by Immunoelectrophoresis |
| 30156-4 | Reticulocytes.aggregate/100 erythrocytes in Blood |
| 40868-2 | 11-Oxo-Etiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine |
| 2024-8 | Carbon dioxide dissolved [Moles/volume] in Plasma |
| 12408-1 | Oxybutynin [Mass/volume] in Serum or Plasma |
| 12514-6 | Bicarbonate [Moles/volume] in Dialysis fluid |
| 12648-2 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post dose lactose PO |
| 101459-6 | Septin-5 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 101530-4 | Porcine epidemic diarrhea virus IgG Ab [Units/volume] in Specimen by Immunoassay |
| 12958-5 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 13855-2 | Aldosterone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
| 102614-5 | Succinylcholine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14002-0 | IgM [Units/volume] in Cord blood |
| 14071-5 | Ibuprofen [Presence] in Urine |
| 1425-8 | Cortisol [Mass/volume] in Serum or Plasma --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 14295-0 | Organic acids/Creatinine [Molar ratio] in Urine |
| 14352-9 | Specific gravity of Water by Refractometry |
| 102953-7 | Provolone Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14547-4 | Mumps virus Ag [Presence] in Skin by Immunofluorescence |
| 14779-3 | Hexacarboxylate [Moles/volume] in Plasma |
| 16268-5 | Calcium phosphate crystals [Presence] in Stone by Infrared spectroscopy |
| 16981-3 | HTLV I DNA [Presence] in Specimen by NAA with probe detection |
| 17060-5 | Legionella pneumophila 1 Ab [Titer] in Serum |
| 17116-5 | CD128 cells/100 cells in Blood |
| 17194-2 | CD74 cells/100 cells in Blood |
| 17953-1 | Bacteria # 4 identified in Body fluid by Aerobe culture |
| 18277-4 | Hemoglobin F [Presence] in Gastric fluid by Apt-Downey method |
| 18910-0 | Cloxacillin [Susceptibility] |
| 90898-8 | HIV 1 proviral DNA reverse transcriptase and protease and integrase gene [Nucleotide sequence] in Blood mononuclear cells by Sequencing |
| 75011-7 | t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
| 913-4 | B Ab [Presence] in Serum or Plasma |
| 91788-0 | Neisseria meningitidis [Presence] in Upper respiratory specimen by Organism specific culture |
| 76064-5 | Rheumatoid arthritis disease activity score confidence interval by VectraDA |
| 76474-6 | Ghrelin [Mass/volume] in Serum or Plasma |
| 76574-3 | Haemophilus influenzae lex2 gene [Presence] in Swab specimen by NAA with probe detection |
| 76660-0 | Phosphatidylethanol [Presence] in Blood by Screen method |
| 76682-4 | Color of Cerebral spinal fluid--4th tube |
| 77141-0 | Alkaline phosphatase [Enzymatic activity/volume] in Serum, Plasma or Blood |
| 77683-1 | Thrombin activatable fibrinolysis inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method |
| 94014-8 | Osmolality of Urine--2 hours post dose vasopressin |
| 63262-0 | Glomerular basement membrane Ab [Presence] in Serum by Immunoassay |
| 63308-1 | PM-SCL extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 78231-8 | Cells.TRA+TRD gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 78763-0 | OPC3373 (Metabolite of Ariprazole) [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine |
| 6523-5 | Rabies virus neutralizing antibody [Units/volume] in Cerebral spinal fluid by Neutralization test |
| 66108-2 | Bone Pathology biopsy report |
| 79513-8 | 1,4-Cyclohexanediol [Moles/volume] in Serum or Plasma |
| 7997-0 | Rickettsia spotted fever group Ab [Units/volume] in Serum |
| 96254-8 | Saint Louis encephalitis virus IgG and IgM panel - Cerebral spinal fluid |
| 67819-3 | Parainfluenza virus 4b RNA [Presence] in Specimen by NAA with probe detection |
| 68398-7 | Eosinophils [#/volume] in Pericardial fluid by Manual count |
| 80980-6 | Frataxin [Mass/volume] in DBS |
| 8110-9 | CD13 cells/100 cells in Blood |
| 81327-9 | Influenza virus B Victoria lineage RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection |
| 9700-6 | Procaine [Mass/volume] in Serum or Plasma |
| 97016-0 | Fibrinogen [Mass/volume] in Blood by calculation |
| 7001-1 | Chloramphenicol [Susceptibility] by Gradient strip |
| 81704-9 | Microsatellite instability marker D17S250 in Cancer specimen Qualitative |
| 8194-3 | Cocaine [Mass/volume] in Unknown substance |
| 97274-5 | Methamphetamine [Presence] in Cord tissue by Screen method |
| 82860-8 | 11-Deoxytetrahydrocorticosterone [Moles/volume] in 24 hour Urine |
| 98271-0 | Cyclic hormonal phase of endometrium [Type] in Endometrial cancer specimen |
| 99067-1 | PL-7 Ab [Units/volume] in Serum by Line blot |
| 83-6 | Cefaclor [Susceptibility] by Minimum lethal concentration (MLC) |
| 85094-1 | Escitalopram and norescitalopram panel - Serum or Plasma |
| 72520-0 | FLT3 gene.p.Asp835+Ile836 mutations [Presence] in Blood or Tissue by Molecular genetics method |
| 72759-4 | Codeine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 86515-4 | Chikungunya virus RNA [Presence] in Urine by NAA with probe detection |
| 73079-6 | Warfarin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87437-0 | Oxyhemoglobin [Mass/volume] in Plasma |
| 73590-2 | Razupenem [Susceptibility] |
| 7382-5 | Gum arabic IgE Ab [Units/volume] in Serum |
| 41613-1 | Tube number of Semen |
| 59562-9 | DNA index by Automated image cytometry |
| 59584-3 | Coxsackievirus A7 IgG Ab [Titer] in Serum by Immunofluorescence |
| 59901-9 | Fenoprofen [Moles/volume] in Gastric fluid |
| 5099-7 | Coronavirus Ab [Units/volume] in Serum |
| 51044-6 | CD123 blasts/100 blasts in Blood |
| 30999-7 | Timothy recombinant (rPhl p) 7 IgE Ab [Units/volume] in Serum |
| 31015-1 | Ethylestrenol [Mass/volume] in Urine |
| 42579-3 | Aspergillus fumigatus IgM Ab [Units/volume] in Serum |
| 2156-8 | Creatine kinase [Enzymatic activity/volume] in Amniotic fluid |
| 51230-1 | CD11b cells/100 cells in Body fluid |
| 51286-3 | CD3+CD57+ cells/100 cells in Blood |
| 43005-8 | Jamestown canyon virus IgG Ab [Titer] in Serum |
| 21686-1 | HADHB gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 31768-5 | Chlamydia trachomatis Ag [Presence] in Blood |
| 32011-9 | Ehrlichia sp IgG Ab [Titer] in Serum |
| 4320-8 | Methapyrilene [Mass] of Dose |
| 43616-2 | Adenovirus Ab [Presence] in Serum |
| 32124-0 | Bromazepam [Moles/volume] in Serum or Plasma |
| 32231-3 | Aspartate [Moles/volume] in Vitreous fluid |
| 51955-3 | Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Urine |
| 5249-8 | Mumps virus Ab [Titer] in Serum by Complement fixation |
| 5263-9 | Nocardia sp Ab [Units/volume] in Serum |
| 5286-0 | Polio virus 3 Ab [Titer] in Serum by Complement fixation |
| 43977-8 | Anabolic steroids [Presence] in Urine |
| 44281-4 | 17-Ketosteroids/Creatinine [Mass Ratio] in 24 hour Urine |
| 23136-5 | Histoplasma capsulatum farciminosum reaction wheal [Diameter] --1 day post dose intradermal |
| 23165-4 | Leptospira interrogans sv Autumnalis Ab [Presence] in Serum by Agglutination |
| 32677-7 | DNA double strand Ab [Units/volume] in Serum by Immunoassay |
| 33025-8 | Hemoglobin [Mass/volume] in Venous cord blood by calculation |
| 53202-8 | Oleoylcarnitine (C18:1) [Moles/volume] in DBS |
| 4465-1 | Hamster Ova Penetration Test [Interpretation] in Semen |
| 44748-2 | La Crosse virus Ab [Units/volume] in Serum by Immunoassay |
| 23290-0 | Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Specimen by Immune diffusion (ID) |
| 23313-0 | Nairobi sheep disease virus Ab [Titer] in Serum |
| 33396-3 | Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Serum |
| 3366-2 | Atenolol [Mass/volume] in Serum or Plasma |
| 4533-6 | Complement+Immunoglobulin [Units/volume] in Red Blood Cells |
| 23784-2 | Toxoplasma gondii Ab [Titer] in Serum by Hemagglutination |
| 33970-5 | SARS coronavirus Urbani Ab [Presence] in Serum by Immunofluorescence |
| 34063-8 | Somatotropin [Mass/volume] in Serum or Plasma --pre or post dose glucagon |
| 24374-1 | Platelet associated Ab [Presence] in Blood |
| 34601-5 | Drugs identified in Body fluid |
| 55974-0 | IgG [Mass/volume] in Serum by Immune diffusion (ID) |
| 35529-7 | Beef IgG Ab [Mass/volume] in Serum |
| 48008-7 | Allele name [Identifier] |
| 48066-5 | Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma |
| 48277-8 | Acetaminophen triggered leukotriene release [Mass/volume] by Leukocytes |
| 48286-9 | Rocuronium triggered leukotriene release [Mass/volume] by Leukocytes |
| 3660-8 | Furosemide [Presence] in Urine |
| 3767-1 | Metaraminol [Mass/volume] in Urine |
| 56939-2 | Hydroxyproline/Creatinine [Ratio] in 24 hour Urine |
| 48758-7 | 3-Hydroxyhexanoate.free (3-OH-C6:0) [Moles/volume] in Serum or Plasma |
| 49188-6 | Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum --2nd specimen |
| 49291-8 | Porphyrins [Interpretation] in Urine Narrative |
| 2862-1 | Albumin [Mass/volume] in Serum or Plasma by Electrophoresis |
| 39776-0 | Urea [Moles/volume] in Serum or Plasma --post dialysis |
| 49908-7 | Kappa light chains/Lambda light chains [Mass Ratio] in 24 hour Urine |
| 29930-5 | Titanium/Creatinine [Mass Ratio] in 24 hour Urine |
| 29943-8 | Lead/Creatinine [Mass Ratio] in 24 hour Urine |
| 40648-8 | Measles virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 58906-9 | Nucleated cells [#/volume] in Cerebral spinal fluid by Manual count |
| 59155-2 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 50221-1 | Bacteria [Presence] in Urine by Automated |
| 50414-2 | Corticotropin [Mass/volume] in Plasma --post 1 mg dexamethasone PO overnight |
| 30404-8 | Leukocytes [#/volume] in Stool |
| 1972-9 | Bilirubin.total [Mass/volume] in Amniotic fluid |
| 20574-0 | Histoplasma capsulatum yeast phase Ab [Titer] in Serum by Complement fixation |
| 100423-3 | Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum |
| 1247-6 | M1 Ag [Presence] on Red Blood Cells from Blood product unit |
| 12476-8 | Bilirubin.total [Mass/volume] in Amniotic fluid by Spectrophotometry direct |
| 12503-9 | Hemoglobin.gastrointestinal [Presence] in Stool --4th specimen |
| 13019-5 | Pesticides [Identifier] in Serum or Plasma |
| 102084-1 | B-Cell lymphoblastic leukemia monitoring minimal residual disease detection in Blood or Marrow by Flow cytometry (FC) |
| 102099-9 | B-cell acute lymphocytic leukemia in Blood or Tissue by FISH |
| 1021-5 | E Ag [Presence] on Red Blood Cells |
| 102230-0 | Horse Chestnut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102243-3 | Clover IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102609-5 | Stemphylium botryosum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102704-4 | Casein IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102897-6 | Smoky Brown Cockroach IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103617-7 | Helicobacter pylori IgG Ab [Presence] in Blood by Immunoassay |
| 104449-4 | Salmonella paratyphi DNA [Presence] in Blood by NAA with probe detection |
| 1088-4 | Js sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
| 11484-3 | Virus identified in Amniotic fluid by Culture |
| 17276-7 | 2-Methylpentane [Mass/volume] in Blood |
| 17513-3 | Renin [Enzymatic activity/volume] in Plasma --5 hours post XXX challenge |
| 1859-8 | Angiotensin II [Mass/volume] in Cerebral spinal fluid |
| 91678-3 | Zika virus IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 75651-0 | Tetrahydrocannabivarin [Mass/volume] in Urine |
| 75720-3 | CYP1A2 gene c.5090C>T [Presence] in Blood or Tissue by Molecular genetics method |
| 76021-5 | Delta aPTT [Time] in Platelet poor plasma by Coagulation assay |
| 61408-1 | Cyclobenzaprine/Creatinine [Mass Ratio] in Urine |
| 7762-8 | Walnut triggered histamine release [Units/volume] in Blood |
| 93703-7 | Palmitoyl protein thioesterase 1 and Tripeptidyl peptidase 1 panel - Fibroblast |
| 784-9 | Erythrocyte mean corpuscular diameter [Length] by Automated count |
| 7002-9 | Ciprofloxacin [Susceptibility] by Gradient strip |
| 82889-7 | Meta methylhippurate+Ortho methylhippurate+Para methylhippurate [Moles/volume] in Urine |
| 82915-0 | Fibrillarin IgG Ab [Presence] in Serum by Line blot |
| 71662-1 | Basophils/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
| 71837-9 | Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Mixed venous blood |
| 99379-0 | Mercury [Moles/volume] in Milk |
| 72740-4 | traMADol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 86105-4 | Streptococcus pneumoniae Danish serotype 4 Ab [Mass/volume] in Serum |
| 86166-6 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum by Immunoassay |
| 7304-9 | Endive IgE Ab [Units/volume] in Serum |
| 7331-2 | Garlic triggered histamine release [Units/volume] in Blood |
| 87368-7 | Actinobacillus pleuropneumoniae serotypes 10+12 Ab/Positive control in Serum by Immunoassay |
| 73556-3 | Platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87832-2 | Fibroblast growth factor 21.intact [Mass/volume] in Serum or Plasma |
| 88544-2 | HIV 1 RNA reverse transcriptase gene mutations detected [Identifier] in Cerebral spinal fluid by Sequencing |
| 740-1 | Metamyelocytes/100 leukocytes in Blood by Manual count |
| 74298-1 | Short-chain acyl-CoA dehydrogenase deficiency newborn screen interpretation |
| 74458-1 | Large unstained cells/100 leukocytes in Blood from Fetus by Automated count |
| 88926-1 | Histoplasma capsulatum DNA [Presence] in Tissue by NAA with probe detection |
| 41463-1 | Wuchereria bancrofti+Brugia malayi Ag [Presence] in Serum by Immunoassay |
| 59597-5 | 7-Aminoclonazepam [Mass/mass] in Tissue by Confirmatory method |
| 59606-4 | Alpha hydroxyalprazolam [Mass/mass] in Tissue by Confirmatory method |
| 59891-2 | Cotinine [Moles/volume] in Serum or Plasma |
| 4223-4 | HYDROmorphone [Mass] of Dose |
| 42249-3 | levETIRAcetam [Presence] in Urine by Screen method |
| 42369-9 | Neisseria meningitidis serogroup A Ag [Presence] in Isolate by Agglutination |
| 42618-9 | Naloxone [Presence] in Urine by Screen method |
| 4270-5 | Glutethimide [Mass] of Dose |
| 21142-5 | Carisoprodol [Presence] in Urine |
| 21397-5 | Mononuclear cells [#/volume] in Body fluid by Manual count |
| 21559-0 | Theophylline [Mass/volume] in Gastric fluid |
| 21596-2 | Varicella zoster virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 31218-1 | Afipia felis IgG Ab [Units/volume] in Serum |
| 31574-7 | Powassan virus IgG Ab [Units/volume] in Specimen |
| 42794-8 | MYC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2190-7 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Amniotic fluid |
| 22269-5 | Echovirus 14 Ab [Titer] in Serum |
| 51658-3 | Hepatitis B virus core IgM Ab [Presence] in Body fluid |
| 22643-1 | Threonine [Moles/volume] in Cerebral spinal fluid |
| 32095-2 | Methanol [Moles/volume] in Urine |
| 32182-8 | Herpes virus 6 IgM Ab [Titer] in Serum |
| 43858-0 | Beta-2 transferrin [Presence] in Specimen |
| 44072-7 | CD20+CD52+ cells/100 cells in Body fluid |
| 44270-7 | Bacillus anthracis spore Ag [Presence] in Specimen by Immunofluorescence |
| 22894-0 | Bovine diarrhea virus Ab [Presence] in Serum by Immunoassay |
| 33039-9 | Fungus identified in Body fluid by Fungus stain |
| 53279-6 | WBC casts [Presence] in Urine by Computer assisted method |
| 23276-9 | Mycoplasma gallisepticum Ag [Presence] in Specimen by Immunofluorescence |
| 33602-4 | Myelin associated glycoprotein IgG Ab [Titer] in Serum |
| 33684-2 | Francisella tularensis Ab [Titer] in Serum by Tube agglutination |
| 53579-9 | Alkaline phosphatase.intestinal 3/Alkaline phosphatase.total in Serum or Plasma |
| 45177-3 | Herpes gestationis IgG Ab non-complement fixing [Presence] in Serum by Immunofluorescence |
| 24038-2 | Cryoglobulin type [Identifier] in Serum by Electrophoresis |
| 34149-5 | N-acetyl-L-aspartate [Moles/volume] in Amniotic fluid |
| 54402-3 | 4-Hydroxymidazolam [Mass/volume] in Serum or Plasma |
| 54406-4 | Pooled cryoprecipitate units given [#] |
| 4584-9 | Hemoglobin G - Georgia [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 24389-9 | Cortisol [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin IM |
| 55479-0 | Insulin [Moles/volume] in Serum or Plasma --7 minutes post dose glucose IV |
| 55581-3 | sulfaSALAzine [Moles/volume] in Serum or Plasma |
| 47105-2 | ePHEDrine [Presence] in Gastric fluid |
| 47128-4 | Salicylates [Moles/volume] in Gastric fluid |
| 25130-6 | Pyridinoline/Creatinine [Molar ratio] in 24 hour Urine |
| 25439-1 | Histamine [Moles/time] in 24 hour Urine |
| 25501-8 | Phosphate [Moles/volume] in Body fluid |
| 34736-9 | Calcium oxalate index in 24 hour Urine |
| 55846-0 | Cryoglobulin.IgA.monoclonal [Presence] in Serum |
| 55943-5 | Methionine [Moles/mass] in Hair |
| 47518-6 | Yersinia pestis Ab [Presence] in Specimen |
| 47568-1 | Arginine/Amino acids.total in Specimen |
| 47715-8 | Oxalate [Moles/volume] in Dialysis fluid |
| 35388-8 | Cholesterol. in Lipoprotein (a) [Mass/volume] in Serum or Plasma |
| 35608-9 | diphenhydrAMINE [Mass/volume] in Serum or Plasma by Screen method |
| 35684-0 | Colorado tick fever virus IgG and IgM panel - Serum |
| 26715-3 | Chlamydia trachomatis IgG Ab [Units/volume] in Serum by Immunoassay |
| 26722-9 | oxyCODONE [Mass/mass] in Hair |
| 3658-2 | Furfenorex [Mass/time] in 24 hour Urine |
| 3774-7 | Methadone [Mass/volume] in Urine |
| 57084-6 | Fatty acid oxidation newborn screen panel |
| 48562-3 | Bacteria # 3 identified in Specimen by Respiratory culture |
| 27035-5 | Dihydrocodeine+Hydrocodeinone [Mass/mass] in Meconium |
| 38253-1 | Carbon dioxide, total [Moles/volume] in Specimen |
| 38319-0 | Alachlor [Mass/volume] in Water |
| 38444-6 | Bromide [Presence] in 24 hour Urine |
| 38588-0 | Acrylonitrile [Mass/volume] in Air |
| 57570-4 | 3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum or Plasma --pre dose dexamethasone |
| 27849-9 | Aldosterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 38679-7 | Sperm Midpiece IgG Ab/100 spermatozoa in Specimen by Immunobead |
| 57977-1 | HIV 2 p16 Ab [Presence] in Serum by Immunoblot |
| 49430-2 | Parvovirus B19 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 3976-8 | Practolol [Mass/volume] in Urine |
| 40161-2 | Glucose [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 40197-6 | Glucose [Moles/volume] in Serum or Plasma --3 minutes pre XXX challenge |
| 40291-7 | Insulin [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
| 58490-4 | Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --3rd specimen post XXX challenge |
| 58509-1 | C peptide [Moles/volume] in Serum or Plasma --3.5 hours post dose glucose |
| 40341-0 | MT-ATP6 gene m.8993T>G [Presence] in Blood or Tissue by Molecular genetics method |
| 40366-7 | Glucose [Moles/time] in 24 hour Body fluid |
| 40520-9 | Macrophages/100 leukocytes in Pleural fluid by Manual count |
| 50382-1 | Glutathione reductase [Enzymatic activity/mass] in Red Blood Cells |
| 50531-3 | Parathyrin.intact [Mass/volume] in Serum or Plasma --7th specimen |
| 30319-8 | Beta galactosidase [Enzymatic activity/mass] in Small intestine Tissue |
| 12383-6 | Hydroxytriazolam [Presence] in Stool |
| 100103-1 | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot |
| 12832-2 | Prolactin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 12851-2 | Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis |
| 101307-7 | Plasmodium vivax+ovale DNA [Presence] in Blood by NAA with non-probe detection |
| 13083-1 | Phosphatidylinositol IgM Ab [Units/volume] in Serum |
| 101978-5 | Glucose and somatotropin post glucagon stimulation panel - Serum or Plasma |
| 13588-9 | Venlafaxine [Presence] in Serum or Plasma |
| 13839-6 | CD14 blasts/100 blasts in Blood |
| 102394-4 | Ispaghula laxative IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14311-5 | Phencyclidine [Presence] in Urine by Confirm method >20 ng/mL |
| 1029-8 | Fy sup(b) Ab [Presence] in Serum or Plasma from Donor |
| 14778-5 | Heptacarboxylate [Moles/volume] in Urine |
| 10687-2 | Leishmania sp identified in Tissue by Organism specific culture |
| 15259-5 | Regional Allergen Mix 4 (Bermuda grass+Perennial rye grass+Brome+Common ragweed+Mugwort+English plantain) IgE Ab [Presence] in Serum by Multidisk |
| 1543-8 | Glucose [Mass/volume] in Serum or Plasma --5 minutes post 0.5 g/kg glucose IV |
| 15462-5 | Bovine diarrhea virus 1 neutralizing antibody [Titer] in Serum by Neutralization test |
| 16676-9 | Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture |
| 17028-2 | Isocyanate IgM Ab [Units/volume] in Serum |
| 17046-4 | Latex IgG Ab [Units/volume] in Serum |
| 1729-3 | Adenosine triphosphatase [Enzymatic activity/volume] in Red Blood Cells |
| 17464-9 | Pigeon feather IgE Ab [Presence] in Serum |
| 18471-3 | Metoclopramide [Mass/volume] in Urine |
| 90297-3 | Entamoeba histolytica Ab [Presence] in Serum by Immunoassay |
| 92142-9 | Influenza virus A RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 92776-4 | Staphylococcus epidermidis DNA [Presence] by NAA with probe detection in Positive blood culture |
| 7565-5 | Parakeet feather IgE Ab [Units/volume] in Serum |
| 92834-1 | Tumor regression at peripheral margin [Presence] in Skin melanoma |
| 61268-9 | Codfish IgG Ab/IgE total in Serum |
| 6136-6 | Hazelnut IgE Ab [Units/volume] in Serum |
| 77207-9 | Naloxone [Mass/volume] in Urine by Confirmatory method |
| 93731-8 | Androstenedione [Moles/volume] in Amniotic fluid |
| 93837-3 | Coccidioides sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 93998-3 | Potassium [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin |
| 94149-2 | Heterophile Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 63423-8 | Escherichia coli eaeA gene [Presence] in Specimen by NAA with probe detection |
| 79311-7 | Gamma butyrobetaine/Creatinine [Molar ratio] in Urine |
| 95140-0 | Herpes simplex virus 1 and 2 DNA panel - Amniotic fluid by NAA with probe detection |
| 79671-4 | Cytidine [Moles/volume] in Cerebral spinal fluid |
| 80385-8 | Choriogonadotropin (pregnancy test) [Presence] in Serum by Rapid immunoassay |
| 95798-5 | Normeperidine [Presence] in Urine by Screen method |
| 95840-5 | Microscopic exam [Interpretation] in Sputum by Microscopy Narrative |
| 6857-7 | Spruce IgE Ab [Units/volume] in Serum |
| 68960-4 | Myoglobin [Presence] in 24 hour Urine |
| 68980-2 | Dabigatran [Units/volume] in Platelet poor plasma by Chromogenic method |
| 80627-3 | Coagulation factor X activated inhibitor [Mass/volume] in Platelet poor plasma |
| 96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
| 97154-9 | Ecgonine methyl ester [Presence] in Urine by Confirmatory method |
| 69554-4 | Lactose tolerance panel [Moles/volume] in Serum or Plasma |
| 70080-7 | Interleukin 3 [Mass/volume] in Cerebral spinal fluid |
| 8209-9 | Opiates [Mass/volume] in Gastric fluid |
| 7094-6 | Artichoke IgE Ab [Units/volume] in Serum |
| 71378-4 | Leptospira sp [Identifier] in Isolate by Agglutination |
| 98403-9 | Yeast identified in Isolate by MS.MALDI-TOF |
| 99070-5 | Kelch-like protein 11 IgG Ab [Titer] in Serum by Immunofluorescence |
| 71879-1 | Methemoglobin/Hemoglobin.total [Pure mass fraction] in Venous blood |
| 72455-9 | Amobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 83127-1 | Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Immunoassay |
| 85624-5 | Kidney failure 2-year risk [Likelihood] by KFRE |
| 72495-5 | Candida parapsilosis DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 72944-2 | Tazobactam induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73183-6 | QUEtiapine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73219-8 | Pantoprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7345-2 | Grain IgE Ab [Units/volume] in Serum |
| 87805-8 | Methylphenidate [Presence] in Saliva (oral fluid) by Screen method |
| 88273-8 | Streptococcus agalactiae hsp60 gene [Presence] by Probe in Positive blood culture |
| 74324-5 | MICA*041 IgG Ab [Presence] in Serum |
| 88710-9 | Amylase.pancreatic [Enzymatic activity/volume] in Peritoneal dialysis fluid |
| 41441-7 | Encephalitozoon intestinalis DNA [Presence] in Specimen by NAA with probe detection |
| 41680-0 | Cefpodoxime+Clavulanate [Susceptibility] by Disk diffusion (KB) |
| 59729-4 | Oxazepam [Mass/mass] in Meconium by Confirmatory method |
| 59763-3 | Triazolam [Mass/mass] in Tissue |
| 507-4 | Tobramycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 50963-8 | XXX blood group IgM Ab [Titer] in Serum or Plasma |
| 30989-8 | Sardine (Sardinops melanosticta) IgE Ab [Units/volume] in Serum |
| 60007-2 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 21237-3 | Cytomegalovirus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 31541-6 | Nuclear Ab [Units/volume] in Pericardial fluid |
| 42955-5 | Semliki Forest virus Ab [Titer] in Serum |
| 22271-1 | Echovirus 16 Ab [Titer] in Serum |
| 22272-9 | Echovirus 18 Ab [Titer] in Serum |
| 43241-9 | Ganglioside GM1 IgM Ab [Titer] in Serum by Immunoassay |
| 43351-6 | Avian metapneumovirus B Ab [Presence] in Serum |
| 22489-9 | Rickettsia typhi IgG Ab [Titer] in Serum |
| 2271-5 | Fat [Mass/time] in 72 hour Stool |
| 32236-2 | Cystathionine [Moles/volume] in Vitreous fluid |
| 22893-2 | Bovine diarrhea virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 53215-0 | Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in DBS |
| 44496-8 | Herpes simplex virus 2 Ag [Presence] in Penis |
| 44746-6 | La Crosse virus Ab [Units/volume] in Serum by Immunofluorescence |
| 23301-5 | Mycoplasma sp DNA [Presence] in Specimen by NAA with probe detection |
| 33405-2 | Glucose [Mass/volume] in Pericardial fluid |
| 53913-0 | Microscopic observation [Identifier] in Synovial fluid by Rhodamine-auramine fluorochrome stain |
| 53961-9 | Alpha-1-fetoprotein.tumor marker [Units/volume] in Serum or Plasma |
| 24017-6 | Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid |
| 33756-8 | Polyp size greatest dimension |
| 33835-0 | Lymphocytes Plasmacytoid/100 leukocytes in Blood by Manual count |
| 54434-6 | Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma |
| 46081-6 | Theophylline [Moles/volume] in Urine |
| 4662-3 | Lymphocytes+Monocytes/100 leukocytes in Blood |
| 4680-5 | von Willebrand factor (vWf) ristocetin cofactor [Units/volume] in Platelet poor plasma |
| 34420-0 | Reticulocytes.mid/Reticulocytes.total in Blood |
| 34532-2 | Blood type and Indirect antibody screen panel - Blood |
| 4701-9 | HLA-A36 [Presence] in Donor |
| 47231-6 | IgM Ab [Presence] in Serum or Plasma |
| 55698-5 | Oxolinate [Susceptibility] by Gradient strip |
| 25746-9 | Rheumatoid factor [Titer] in Body fluid by Sheep Cell Agglutination |
| 56498-9 | Androstenedione [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 2638-5 | Myelin basic protein [Mass/volume] in Cerebral spinal fluid |
| 26703-9 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Titer] in Serum by Immunoassay |
| 56912-9 | Cholesterol [Mass/volume] in Pericardial fluid |
| 48682-9 | Smooth muscle myosin heavy chain Ag [Presence] in Tissue by Immune stain |
| 48843-7 | Bartonella bacilliformis IgM Ab [Titer] in Serum by Immunofluorescence |
| 26904-3 | 2-Methylcitrate [Moles/volume] in Serum or Plasma |
| 26915-9 | Pyridoxine [Presence] in Blood |
| 57303-0 | 7-Aminonitrazepam [Mass/volume] in Saliva (oral fluid) |
| 57433-5 | CD19+Lambda+ cells/100 cells in Body fluid |
| 57457-4 | Immunoelectrophoresis for 24 hour Urine |
| 49137-3 | Hemoglobin [Mass/volume] in Urine by Test strip |
| 49183-7 | Coxiella burnetii phase 2 IgG Ab [Titer] in Body fluid |
| 49193-6 | California encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid |
| 38993-2 | Calcium oxalate dihydrate crystals [Presence] in Urine sediment |
| 49355-1 | Epstein Barr virus DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 29522-0 | 5-Oxoproline/Creatinine [Molar ratio] in Urine |
| 40666-0 | Rubella virus Ab [Presence] in Cerebral spinal fluid by Latex agglutination |
| 58984-6 | Bromelin MUXF3 IgE Ab [Units/volume] in Serum |
| 50380-5 | Creatinine renal clearance/1.73 sq M.predicted among females by Cockcroft-Gault formula, BSA formula |
| 50496-9 | Somatotropin [Mass/volume] in Serum or Plasma --4th specimen |
| 40896-3 | CD3+CD56+ cells [#/volume] in Tissue |
| 41076-1 | NPDC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19237-7 | Base excess standard in Venous blood by calculation |
| 20625-0 | Lead [Mass/volume] in 24 hour Urine |
| 13211-8 | Brucella sp IgA Ab [Units/volume] in Serum |
| 13419-7 | Valine [Mass/volume] in Amniotic fluid |
| 1376-3 | Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post 0.5 ug/kg pentagastrin IV |
| 14117-6 | IgG clearance/Albumin clearance [Ratio] in Serum and CSF |
| 14159-8 | Cortisone [Mass/volume] in Serum or Plasma |
| 14506-0 | Human papilloma virus 16+18 Ag [Presence] in Urethra |
| 14575-5 | Blood group antibody investigation [Interpretation] in Plasma or RBC |
| 104451-0 | SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen |
| 11051-0 | Lambda light chains [Mass/volume] in Serum or Plasma |
| 16422-8 | Azlocillin [Mass/volume] in Urine |
| 16656-1 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --15 minutes post XXX challenge |
| 17122-3 | CD19+Kappa+ cells/100 cells in Blood |
| 17263-5 | Methemalbumin [Presence] in Serum or Plasma |
| 1824-2 | Alpha-1-Antichymotrypsin [Mass/volume] in Serum |
| 18865-6 | Ampicillin+Sulbactam [Susceptibility] |
| 91106-5 | Cholesterol in LDL 2 [Mass/volume] in Serum or Plasma |
| 74981-2 | Pimozide [Mass/volume] in Serum or Plasma --trough |
| 6109-3 | White Elm IgE Ab [Units/volume] in Serum |
| 7660-4 | Rat muliialgro IgE Ab [Units/volume] in Serum |
| 7675-2 | Rye IgG Ab [Units/volume] in Serum |
| 93504-9 | Cholesterol crystals [Presence] in Stone by X-ray diffraction |
| 93692-2 | Nonalcoholic steatohepatitis score in Serum or Plasma |
| 77614-6 | Calcitonin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 94675-6 | Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Titer] in Serum by Immunofluorescence |
| 79269-7 | 3-Hydroxytrimethyl-L-lysine [Moles/volume] in Cerebral spinal fluid |
| 94860-4 | Transthyretin [Mass] in Blood |
| 6634-0 | Influenza virus A Hong Kong Ab [Units/volume] in Serum by Hemagglutination inhibition |
| 79585-6 | Aspartylglycine [Moles/volume] in Serum or Plasma |
| 79688-8 | 5-Hydroxymethyluracil [Moles/volume] in Serum or Plasma |
| 96282-9 | Coagulation factor XII inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
| 6897-3 | Norsertraline [Mass/volume] in Serum or Plasma |
| 80600-0 | Bordetella pertussis.pertussis toxin promoter region [Presence] in Nasopharynx by NAA with probe detection |
| 81101-8 | Leptospira interrogans sv Copenhageni Ab [Titer] in Serum by Agglutination |
| 97051-7 | Interferon beta [Mass/volume] in Serum or Plasma |
| 97298-4 | Phencyclidine [Presence] in Cord tissue by Screen method |
| 70854-5 | Burkholderia mallei Ag [Presence] in Specimen by Immunofluorescence |
| 82530-7 | SDHB gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 98025-0 | Fungus [Identifier] in Prostatic fluid by Fungus stain |
| 98126-6 | Zimnitsky urine concentration panel - Urine |
| 98397-3 | Color.aspergillus colony [Type] in Isolate by Culture |
| 72442-7 | 3-Methylcrotonylglycine [Moles/volume] in Cerebral spinal fluid |
| 85088-3 | Maprotiline and normaprotiline panel - Serum or Plasma |
| 997-7 | DBG Ag [Presence] on Red Blood Cells from Blood product unit |
| 72915-2 | HNA 1a/1b Ab [Presence] in Serum by Immunoassay |
| 7292-6 | Whole Egg IgG Ab [Units/volume] in Serum |
| 86693-9 | Porcine epidemic diarrhea virus IgA Ab/Positive control in Specimen by Immunoassay |
| 86710-1 | Porcine epidemic diarrhea virus RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 73675-1 | Adenosine triphosphate/Adenosine diphosphate [Entitic molar ratio] in Platelets |
| 87830-6 | Epithelial cells [Presence] in Urine |
| 74142-1 | Granulocytes [#/volume] in Body fluid |
| 41704-8 | Nafcillin [Susceptibility] by Gradient strip |
| 51001-6 | Iodide [Mass/volume] in Urine |
| 30539-1 | Neutrophil cytoplasmic Ab.perinuclear [Presence] in Serum |
| 3092-4 | Urea [Mass/volume] in Urine |
| 42373-1 | Neisseria meningitidis serogroup X Ag [Presence] in Isolate by Agglutination |
| 60077-5 | Ganciclovir [Mass/volume] in Blood |
| 21594-7 | Varicella zoster virus Ab [Titer] in Serum |
| 31416-1 | Herpes virus 7 IgG Ab [Units/volume] in Serum |
| 31428-6 | Histoplasma capsulatum yeast phase Ab [Units/volume] in Body fluid |
| 31578-8 | Pullularia sp Ab [Presence] in Serum |
| 51226-9 | CD117 cells/100 cells in Cerebral spinal fluid |
| 22280-2 | Echovirus 9 Ab [Titer] in Cerebral spinal fluid |
| 3178-1 | Bleeding time by Duke method |
| 51628-6 | Morphology [Interpretation] in Bone marrow Narrative |
| 4341-4 | Nadolol [Mass] of Dose |
| 43677-4 | Fatty acid very long chain (C22-C26) panel - Serum or Plasma |
| 43827-5 | Barbiturates [Mass/volume] in Specimen |
| 22436-0 | Paragonimus sp Ab [Titer] in Serum |
| 32098-6 | Mexiletine [Moles/volume] in Serum or Plasma |
| 22823-9 | Influenza virus A Ab [Titer] in Serum by Agglutination |
| 53309-1 | Calcium phosphate crystals [#/area] in Urine by Computer assisted method |
| 53312-5 | Calcium carbonate crystals [#/area] in Urine by Computer assisted method |
| 44483-6 | Herpes simplex virus 1+2 IgM Ab [Presence] in Body fluid |
| 44855-5 | Mycobacterium sp # 5 identified in Specimen by Organism specific culture |
| 33346-8 | Cortisol Free [Mass/volume] in 24 hour Urine |
| 33654-5 | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 53952-8 | HPA 1b/1b+Gp IIb/IIa [Presence] in Blood |
| 45151-8 | Neutrophil cytoplasmic Ab [Units/volume] in Serum by Immunoassay |
| 33900-2 | Fetal cell screen [Presence] in Blood by Rosette test |
| 54418-9 | Transfuse fresh frozen plasma pediatric units [#] |
| 4627-6 | Hemoglobin Yoshizuka [Presence] in Blood |
| 46724-1 | CYP2C9 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 24468-1 | CD14+CD16+CD59+ cells [Presence] in Serum |
| 55572-2 | Procaine [Moles/volume] in Serum or Plasma |
| 47181-3 | Progesterone [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 35162-7 | Palmitoleate (C16:1w7) [Moles/volume] in Serum or Plasma |
| 55823-9 | Allo-tetrahydrodeoxycortisol [Mass/volume] in 24 hour Urine |
| 47841-2 | Citrate synthase [Enzymatic activity/mass] in Amniotic fluid cells |
| 25919-2 | Glutamine [Moles/volume] in 24 hour Urine |
| 35563-6 | Rickettsia rickettsii IgG and IgM panel - Serum |
| 3640-0 | Flunitrazepam [Mass/volume] in Blood |
| 36897-7 | West Nile virus Ab [Presence] in Specimen by Immunoassay |
| 48617-5 | Phosphate [Mass/volume] in Serum or Plasma --post dialysis |
| 48891-6 | Coxiella burnetii phase 2 IgA Ab [Titer] in Body fluid by Immunofluorescence |
| 2689-8 | Osmolality of Amniotic fluid |
| 57514-2 | 11-Hydroxyandrosterone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
| 27886-1 | Follitropin [Units/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 49563-0 | Troponin I.cardiac [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL |
| 40255-2 | Creatinine [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 5838-8 | Cytomegalovirus [Presence] in Specimen by Organism specific culture |
| 29959-4 | Ganglioside GM1 IgG Ab [Mass/volume] in Serum by Immunoassay |
| 40365-9 | Follitropin [Units/volume] in Serum or Plasma --pre dose triple bolus |
| 59301-2 | Desloratadine [Mass/volume] in Urine |
| 50552-9 | Clarity in Urine by Refractometry automated |
| 3008-0 | Threonine [Mass/volume] in Serum or Plasma |
| 30398-2 | Hematocrit [Volume Fraction] of Cerebral spinal fluid |
| 19570-1 | Methylenedioxymethamphetamine [Mass/volume] in Urine |
| 12757-1 | Insulin [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge |
| 12896-7 | Borrelia burgdorferi 58kD Ab [Presence] in Serum by Immunoblot |
| 101560-1 | Rotavirus B RNA [Presence] in Stool by NAA with probe detection |
| 101655-9 | Basic metabolic and hematocrit panel - Blood |
| 102217-7 | Saltcedar IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13528-5 | Unidentified cells/100 leukocytes in Body fluid by Manual count |
| 1381-3 | Calcium [Moles/volume] in Serum or Plasma --10 minutes post 2.4 mg/kg calcium short IV |
| 102490-0 | Budgerigar serum proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13974-1 | Albumin/Protein.total in Cerebral spinal fluid by Electrophoresis |
| 1408-4 | Cortisol [Mass/volume] in Serum or Plasma --24 hours post 40 ug corticotropin IM BID 3 day |
| 14479-0 | Diphtheria identified in Throat by Organism specific culture |
| 14727-2 | FLUoxetine [Presence] in Gastric fluid |
| 16524-1 | Calcium [Moles/volume] in Serum or Plasma --6 hours post XXX challenge |
| 1144-5 | Lu sup(b) Ab [Presence] in Serum or Plasma |
| 16856-7 | Fat.microscopic observation [Identifier] in Synovial fluid by Sudan IV stain |
| 17142-1 | CD37 cells/100 cells in Blood |
| 17405-2 | Human papilloma virus 42 Ag [Presence] in Specimen |
| 17718-8 | traMADol [Presence] in Urine by Confirmatory method |
| 17822-8 | CD3+CD4+ (T4 helper) cells/100 cells in Body fluid |
| 19101-5 | Fungus colony count [#/volume] in Specimen by Culture |
| 90921-8 | Lysophosphatidylcholine(22:0) [Mass/volume] in DBS |
| 91034-9 | Methamphetamine+Methylenedioxymethamphetamine [Presence] in Serum, Plasma or Blood by Screen method |
| 74830-1 | Toxoplasma gondii IgA Ab [Presence] in Serum by Immunoassay |
| 92691-5 | Astrovirus RNA [Presence] in Stool by NAA with probe detection |
| 75506-6 | aPTT.lupus sensitive W excess phospholipid (LA confirm) |
| 92990-1 | F10 gene full mutation analysis in Blood or Tissue by Sequencing |
| 61240-8 | Pecan or Hickory Tree IgE Ab/IgE total in Serum |
| 61260-6 | Erythromycin IgE Ab/IgE total in Serum |
| 61354-7 | Lymphocyte proliferation stimulated by 40 ug phytohemagglutinin in Blood |
| 6205-9 | Peach IgE Ab [Units/volume] in Serum |
| 94738-2 | Biopsy site [Anatomy] |
| 6503-7 | Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid by Immunoassay |
| 7942-6 | Lassa virus IgG Ab [Presence] in Serum by Immunoassay |
| 95091-5 | Glucagon post fasting and meal stimulation panel - Serum or Plasma |
| 9513-3 | Cytomegalovirus Ab [Titer] in Serum by Complement fixation |
| 65818-7 | Medication [Mass/volume] Dose |
| 80219-9 | Mycoplasma hyopneumoniae Ab sample/Positive control in Serum by Immunoassay |
| 69033-9 | Buprenorphine and Norbuprenorphine panel - Urine |
| 96562-4 | Cytosolic 5'-nucleotidase 1A Ab [Units/volume] in Serum by Immunoassay |
| 97183-8 | Mephobarbital and PHENobarbital panel - Serum or Plasma |
| 97185-3 | West Nile virus RNA [Presence] in Urine by NAA with probe detection |
| 69424-0 | Nitrogen [Mass/time] in 72 hour Stool |
| 81642-1 | CYP3A4 and CYP3A5 gene targeted mutation analysis panel - Blood or Tissue by Molecular genetics method |
| 8204-0 | Mercury [Mass/mass] in Nail |
| 82505-9 | 3-Hydroxyglutarate [Moles/volume] in DBS |
| 97996-3 | Myeloperoxidase IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 98216-5 | Treponema pallidum Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 98255-3 | Depth of myometrial invasion/Myometrial thickness [Length fraction] in Endometrial cancer specimen |
| 72664-6 | Phosphofructokinase [Enzymatic activity/mass] in Red Blood Cells |
| 86545-1 | Herpes virus 8 DNA [Presence] in Blood by NAA with probe detection |
| 73120-8 | Tetracycline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7334-6 | Gerbil epithelium IgE Ab [Units/volume] in Serum |
| 87446-1 | Zinc [Mass/mass] in Specimen |
| 87753-0 | Propoxur [Mass/mass] in Specimen |
| 88873-5 | Sympathomimetics [Presence] in Serum, Plasma or Blood by Confirmatory method |
| 89336-2 | CD45RO cells/100 CD3+CD8+ cells in Blood |
| 41400-3 | Yersinia sp IgA Ab [Presence] in Serum by Immunoblot |
| 41490-4 | Echovirus 16 neutralizing antibody [Titer] in Serum by Neutralization test |
| 4153-3 | Carbenicillin [Mass] of Dose |
| 59890-4 | cloZAPine [Moles/volume] in Gastric fluid |
| 42591-8 | Botrytis cinerea IgG Ab [Mass/volume] in Serum |
| 59995-1 | Testosterone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 60100-5 | Loxapine [Mass/volume] in Urine |
| 6031-9 | Budgerigar serum proteins IgE Ab [Units/volume] in Serum |
| 31198-5 | Microscopic observation [Identifier] in Parotid fine needle aspirate by Cyto stain |
| 3121-1 | Vanillylmandelate [Mass/volume] in Serum or Plasma |
| 31566-3 | Polio virus 2 Ab [Units/volume] in Cerebral spinal fluid |
| 51747-4 | Borrelia burgdorferi IgA and IgG and IgM [Interpretation] in Serum by Immunoassay |
| 51820-9 | Listeria monocytogenes IgG Ab [Units/volume] in Serum by Immunoassay |
| 22587-0 | Treponema pallidum Ab [Presence] in Serum |
| 32646-2 | Nevirapine [Mass/volume] in Serum or Plasma |
| 32771-8 | Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood |
| 44485-1 | Herpes simplex virus 2 [Presence] in Vaginal fluid by Organism specific culture |
| 23305-6 | Myxoma virus Ab [Titer] in Serum |
| 33389-8 | Monocytes/100 leukocytes in Pericardial fluid |
| 53882-7 | O-desmethylvenlafaxine [Mass/volume] in Urine |
| 4505-4 | Complement C5 [Mass/volume] in Serum or Plasma |
| 33821-0 | Interleukin 1 alpha [Mass/volume] in Serum or Plasma |
| 54092-2 | Citrulline/Arginine [Molar ratio] in DBS |
| 46275-4 | Major crossmatch [Interpretation] --after transfusion reaction |
| 3456-1 | chlordiazePOXIDE [Presence] in Serum or Plasma |
| 25263-5 | Netilmicin [Mass/volume] in Specimen |
| 25353-4 | Bordetella pertussis IgM Ab [Titer] in Serum by Immunofluorescence |
| 55973-2 | Phosphate [Moles/volume] in Peritoneal fluid |
| 4767-0 | HLA-B56(22) [Presence] |
| 35587-5 | 2-Ethoxyacetate [Mass/volume] in Urine |
| 48093-9 | Corticotropin [Mass/volume] in Plasma --15 minutes pre 1 ug/kg CRH IV |
| 2634-4 | Methyltestosterone [Mass/time] in 24 hour Urine |
| 26531-4 | Cortisol [Mass/volume] in Serum or Plasma --32 hours post dose corticotropin |
| 3691-3 | Imipramine [Presence] in Urine |
| 48671-2 | Prostate cancer risk [Likelihood] by Estimated |
| 26900-1 | chlordiazePOXIDE [Mass/volume] in Vitreous fluid |
| 38425-5 | C peptide [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 38472-7 | 17-Hydroxycorticosteroids/Creatinine [Mass Ratio] in Urine |
| 57419-4 | CD21 cells/100 cells in Body fluid |
| 48960-9 | Norpropoxyphene [Mass/volume] in Specimen |
| 49223-1 | Colony count [#/volume] in Specimen by Visual count |
| 49287-6 | Organic acids pattern [Interpretation] in Urine Narrative |
| 58076-1 | Yk sup(a) Ab [Presence] in Serum or Plasma |
| 28539-5 | MCH [Entitic mass] |
| 40126-5 | Creatinine [Moles/volume] in Serum or Plasma --2 days post XXX challenge |
| 58710-5 | Gliadin peptide IgG Ab [Units/volume] in Serum |
| 49981-4 | Borrelia burgdorferi 37kD IgG Ab [Presence] in Serum by Immunoblot |
| 40378-2 | Lutropin [Units/volume] in Serum or Plasma --pre dose triple bolus |
| 40551-4 | CD10 Ag [Presence] in Tissue by Immune stain |
| 58955-6 | Pyridinoline and Deoxypyridinoline [Interpretation] in Urine |
| 58972-1 | Ganglioside GM1 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 40898-9 | CD3+CD4+ (T4 helper) cells [#/volume] in Tissue |
| 4104-6 | Acepromazine [Mass] of Dose |
| 19351-6 | Aprobarbital cutoff [Mass/volume] in Urine for Screen method |
| 2095-8 | Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma |
| 12439-6 | FLUoxetine [Mass/volume] in Urine |
| 100026-4 | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 101121-2 | Candida albicans and tropicalis DNA [Presence] in Blood by NAA with probe detection |
| 101384-6 | MYC gene amplification in Tissue by FISH |
| 13553-3 | Cocaethylene [Presence] in Serum or Plasma |
| 13852-9 | Aldosterone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
| 102422-3 | Chub Mackerel IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102492-6 | Parrot feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102643-4 | Barley smut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102668-1 | Fish Feed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102939-6 | Eel IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14776-9 | Heptacarboxylate [Moles/volume] in Plasma |
| 103690-4 | Fungal pathogens panel - Cerebral spinal fluid by NAA with probe detection |
| 15486-4 | Mycoplasma gallisepticum rRNA [Presence] in Nose or Trachea by Probe |
| 1553-7 | Glucose [Mass/volume] in Serum or Plasma --pre dose insulin IV |
| 16127-3 | Helicobacter pylori IgM Ab [Presence] in Serum |
| 10994-2 | Naltrexone [Mass/volume] in Serum or Plasma |
| 16678-5 | Coxiella burnetii IgM Ab [Units/volume] in Serum |
| 16747-8 | Dextromoramide [Presence] in Serum or Plasma |
| 17062-1 | Legionella pneumophila 2 Ab [Titer] in Serum |
| 17380-7 | Nuclear Ab.histone reactive [Presence] in Serum |
| 17902-8 | Bacteria # 5 identified in Throat by Aerobe culture |
| 90241-1 | Natural killer cell cytotoxicity.IL-2 stimulated 30:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
| 90260-1 | Rickettsia spotted fever group Ab.IgG and IgM panel [Titer] - Serum |
| 74514-1 | Amino acids panel [Moles/volume] - Urine |
| 74689-1 | Nucleated cells [#/volume] in Body fluid by Manual count |
| 75003-4 | Food Allergen Mix 7A (Peanut+Cow milk+Egg white+Soybean+Wheat+Rice) IgE Ab [Units/volume] in Serum by Multidisk |
| 6099-6 | Dog epithelium IgE Ab [Units/volume] in Serum |
| 92807-7 | Rhinovirus+Enterovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 93361-4 | Monotypic plasma cells in S phase/100 cells in Bone marrow by Flow cytometry (FC) |
| 77751-6 | TMEM216 gene c.218G>T [Presence] in Blood or Tissue by Molecular genetics method |
| 77964-5 | Cholesterol crystals [#/area] in Urine sediment by Microscopy low power field |
| 7831-1 | Coxiella burnetii phase 1 IgM Ab [Units/volume] in Serum |
| 94603-8 | Bacterial 16S rRNA gene [Nucleotide sequence] in Isolate by Sequencing |
| 94702-8 | PCA-1 Ab [Titer] in Serum by Immunofluorescence |
| 63439-4 | Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 79261-4 | HYDROcodone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 7941-8 | La Crosse virus IgM Ab [Units/volume] in Serum |
| 94854-7 | West Nile virus IgG and IgM panel - Serum Qualitative |
| 95231-7 | Chromosome aneuploidy details in Blood or Tissue by Molecular genetics method Narrative |
| 79621-9 | Phenylalanine and Tyrosine panel - DBS |
| 80204-1 | Influenza virus A and B identified in Nasopharynx by Shell vial culture |
| 80222-3 | CD8 cells/100 lymphocytes in Specimen |
| 80971-5 | Gentamicin free [Mass/volume] in Serum or Plasma |
| 81208-1 | Amitriptyline and Nortriptyline panel - Urine |
| 81211-5 | Amitriptyline and Nortriptyline panel - Specimen |
| 69817-5 | 2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --5 days post dose ifosfamide |
| 69852-2 | 3-Hydroxyisobutyrate [Moles/volume] in Cerebral spinal fluid |
| 97759-5 | Magnesium and phosphate and lactate panel - Serum or Plasma |
| 82387-2 | Mycobacterium avium tuberculin stimulated gamma interferon [Units/volume] in Blood |
| 72436-9 | Phenylpyruvate [Moles/volume] in Serum or Plasma |
| 83002-6 | Zinc finger protein of the cerebellum 4 IgG Ab [Presence] in Serum or Plasma by Line blot |
| 72722-2 | Base excess.100% oxygenated [Moles/volume] standard in Mixed venous blood by calculation |
| 72883-2 | CYP2E1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 7297-5 | Eggplant IgG Ab [Units/volume] in Serum |
| 87727-4 | Complement C9.functional [Units/volume] in Serum or Plasma |
| 73822-9 | Chromosome X and Y aneuploidy in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Nominal |
| 74001-9 | NBOMe [Presence] in Urine by Screen method |
| 88990-7 | Sertindole [Mass/volume] in Serum or Plasma |
| 41612-3 | Tube number of Pleural fluid |
| 41753-5 | FKRP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 50654-3 | Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgE Ab [Units/volume] in Serum by Multidisk |
| 51020-6 | CD10 blasts [Units/volume] in Blood |
| 31021-9 | Interferon.beta 1 neutralizing antibody [Titer] in Serum or Plasma by Neutralization test |
| 42501-7 | Glutamate decarboxylase 65 Ab [Units/volume] in Cerebral spinal fluid |
| 60109-6 | Oxychlordane [Mass/mass] in Tissue |
| 31296-7 | Chlamydia trachomatis D+K IgA Ab [Units/volume] in Serum |
| 42915-9 | Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid |
| 21747-1 | HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 31669-5 | Sulfatide IgG Ab [Units/volume] in Serum |
| 43299-7 | HTLV I+II p19 Ab [Presence] in Serum |
| 22390-9 | Legionella pneumophila 5 IgM Ab [Titer] in Serum |
| 22495-6 | Rotavirus Ab [Titer] in Serum |
| 32153-9 | Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Serum or Plasma |
| 44025-5 | Aspergillus flavus B Ab [Presence] in Serum by Immune diffusion (ID) |
| 4424-8 | Secobarbital [Mass] of Dose |
| 22809-8 | Infectious bronchitis virus RNA [Presence] in Specimen by Probe |
| 23636-4 | Cefdinir [Susceptibility] |
| 33270-0 | Microscopic observation [Identifier] in Buffy Coat by Light microscopy |
| 23720-6 | Feline herpesvirus 1 Ag [Presence] in Tissue by Immunofluorescence |
| 55390-9 | Insulin [Moles/volume] in Serum or Plasma --6 hours post XXX challenge |
| 47064-1 | Epstein Barr virus capsid IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 25207-2 | cycloSERINE 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 35032-2 | Mesothelial cells [#/volume] in Peritoneal fluid |
| 55861-9 | Glutamate [Moles/mass] in Hair |
| 4762-1 | HLA-B54(22) [Presence] in Donor |
| 47854-5 | Fibroblast growth factor 23.intact [Units/volume] in Plasma |
| 48118-4 | Lutropin [Units/volume] in Serum or Plasma --15 minutes pre 100 ug luteinizing releasing hormone IV |
| 26620-5 | Hantavirus IgG Ab [Presence] in Serum |
| 26754-2 | Streptococcus pneumoniae Danish serotype 7F Ab [Mass/volume] in Serum |
| 3717-6 | Lidocaine [Mass/volume] in Serum or Plasma -->45 minutes post bolus dose |
| 56758-6 | Renin [Enzymatic activity/volume] in Plasma --70 minutes post XXX challenge |
| 56989-7 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 48855-1 | Orientia tsutsugamushi Kato IgG Ab [Titer] in Serum by Immunofluorescence |
| 38387-7 | C3 nephritic factor [Presence] in Serum or Plasma |
| 49152-2 | Rickettsia parkeri IgM Ab [Titer] in Serum |
| 2744-1 | pH of Arterial blood |
| 27830-9 | Insulin [Units/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
| 27904-2 | Histidine [Moles/volume] in Urine |
| 58029-0 | Tipranavir+Ritonavir [Susceptibility] by Phenotype method |
| 29221-9 | Mercury [Mass/volume] in Body fluid |
| 40050-7 | Albumin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 40098-6 | Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --1 day post XXX challenge |
| 58698-2 | Cortisol [Moles/volume] in Saliva (oral fluid) --9th specimen post XXX challenge |
| 49974-9 | Borrelia burgdorferi 31kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 50038-9 | Snowshoe hare virus neutralizing antibody [Presence] in Specimen by Neutralization test |
| 29568-3 | West Nile virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 58950-7 | Somatotropin [Mass/volume] in Serum or Plasma --11th specimen |
| 59205-5 | Gamma tocopherol [Moles/volume] in Serum or Plasma |
| 50492-8 | Gastrin [Mass/volume] in Serum or Plasma --8th specimen |
| 40763-5 | Coxsackievirus B IgM Ab [Titer] in Serum --1st specimen |
| 40822-9 | HTLV I Ab [Presence] in Cerebral spinal fluid |
| 19209-6 | Squamous cell carcinoma Ag [Units/volume] in Pleural fluid |
| 2032-1 | Carboxyhemoglobin/Hemoglobin.total in Venous blood |
| 20641-7 | Cysteine [Moles/volume] in Serum or Plasma |
| 20879-3 | Bacteria identified in Milk by Aerobe culture |
| 12632-6 | Glucose [Mass/volume] in Peritoneal dialysis fluid --3rd specimen |
| 12957-7 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 13057-5 | Platelets [Units/volume] in Dialysis fluid |
| 13169-8 | Immunoelectrophoresis for Serum or Plasma |
| 102508-9 | Cayenne IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102745-7 | Porcine Gelatin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14501-1 | Human papilloma virus Ag [Presence] in Penis |
| 103589-8 | Flualprazolam [Presence] in Cord tissue by Confirmatory method |
| 1484-5 | Gastrin [Mass/volume] in Serum or Plasma --10 minutes post 0.2 U/kg secretin |
| 1496-9 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO |
| 15079-7 | Lutropin [Units/volume] in Urine |
| 104397-5 | European tick borne encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay |
| 16109-1 | Prolactin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 10756-5 | Glial fibers.microscopic observation [Identifier] in Tissue by Holzer stain |
| 16400-4 | Appearance of Seminal plasma |
| 16528-2 | Campylobacter coli rRNA [Units/volume] in Serum by Probe |
| 11-7 | Amikacin [Susceptibility] by Minimum lethal concentration (MLC) |
| 12288-7 | Diuretics [Identifier] in Urine |
| 16848-4 | Ethoheptazine [Mass/volume] in Serum or Plasma |
| 17057-1 | Legionella pneumophila Ag [Presence] in Specimen |
| 17515-8 | Renin [Enzymatic activity/volume] in Plasma --baseline |
| 17898-8 | Bacteria identified in Throat by Aerobe culture |
| 18306-1 | Hydatid cyst identified in Aspirate by Iron hematoxylin stain |
| 90453-2 | Herpes simplex virus 2 DNA [Presence] in Aspirate by NAA with probe detection |
| 75564-5 | Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
| 75577-7 | Fetal 22q11.2 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 75719-5 | CYP1A2 gene c.-3860G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 61178-0 | CD79 cells/100 cells in Specimen |
| 75765-8 | Triprolidine [Presence] in Serum or Plasma or Urine by Screen method |
| 61315-8 | Red Imported Fire Ant IgE Ab/IgE total in Serum |
| 77042-0 | t(6;9)(p22;q34)(DEK,NUP214) fusion transcript in Blood or Tissue by FISH |
| 7712-3 | Spondylocladium atrovirens IgE Ab [Units/volume] in Serum |
| 77733-4 | Gamma hydroxybutyrate [Presence] in Specimen by Screen method |
| 93736-7 | Creatinine panel - 5 hour Urine |
| 94097-3 | Cytosolic 5'-nucleotidase 1A IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 62948-5 | MPL gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 63194-5 | Alfalfa IgG Ab [Mass/volume] in Serum |
| 63240-6 | Ganglioside GD3 IgG+IgM Ab [Presence] in Serum by Immunoassay |
| 63279-4 | Mitochondria Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 7872-5 | Echovirus 9 Ab [Units/volume] in Serum |
| 78756-4 | 2-Oxo-3-Hydroxy-Lysergate diethylamide [Presence] in Blood by Screen method |
| 94830-7 | Epstein Barr virus DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 79381-0 | Gastrointestinal pathogens panel - Stool by NAA with probe detection |
| 95189-7 | CD107a+b expressing HLA-B7 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC) |
| 95554-2 | Pancreatic exocrine cell Ab [Presence] in Serum by Immunofluorescence |
| 69881-1 | Service comment 54 |
| 70034-4 | Lipophages/100 leukocytes in Cerebral spinal fluid by Manual count |
| 71375-0 | Inhalant Allergen Mix 6 (Alternaria tenuis+Mugwort+Silver birch+Cladosporium herbarum+Timothy grass) IgE Ab [Units/volume] in Serum by Multidisk |
| 82553-9 | Food Allergen Mix 6 (Buckwheat+Rice+Sesame seed+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk |
| 98998-8 | Hematocrit [Pure volume fraction] of Cord blood by Automated count |
| 83118-0 | Thyroperoxidase IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 85550-2 | PRRSV North American strain neutralizing antibody [Presence] in Serum by Neutralization test |
| 85680-7 | Haemophilus influenzae ecs gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 99776-7 | Leukocytes [#/volume] in Bronchoalveolar lavage by Automated count |
| 86694-7 | Porcine epidemic diarrhea virus IgG Ab/Positive control in Specimen by Immunoassay |
| 86857-0 | Flavivirus neutralizing antibody [Presence] in Specimen by Neutralization test |
| 86931-3 | Metanephrine, Normetanephrine and Creatinine panel - 24 hour Urine |
| 73634-8 | rifAXIMin [Susceptibility] by Disk diffusion (KB) |
| 88214-2 | Rabies virus RNA [Presence] in Tissue by NAA with probe detection |
| 59632-0 | cloBAZam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 59792-2 | Glucose [Molar concentration difference] in Serum or Plasma --1 hour post XXX challenge |
| 59815-1 | Glucose [Moles/volume] in Serum or Plasma --3 PM specimen |
| 59837-5 | Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma |
| 3090-8 | Urea [Mass/volume] in Amniotic fluid |
| 60008-0 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 21412-2 | Myocardium Ab pattern [Interpretation] in Serum |
| 31505-1 | Mumps virus soluble Ab [Units/volume] in Serum |
| 22147-3 | Brucella abortus Ab [Presence] in Serum |
| 31647-1 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum --1st specimen |
| 31664-6 | Sulfate-3-Glucuronyl paragloboside IgM Ab [Units/volume] in Cerebral spinal fluid |
| 31870-9 | Legionella pneumophila Ag [Presence] in Urine |
| 51635-1 | Reticulocytes.mature [#/volume] in Blood |
| 51667-4 | Lymphocytic choriomeningitis virus RNA [Presence] in Specimen by NAA with probe detection |
| 43429-0 | Haemophilus influenzae B Ag [Presence] in Serum |
| 51969-4 | Genetic analysis report |
| 44583-3 | IgA Ab [Presence] in Serum or Plasma by Hemagglutination inhibition |
| 33455-7 | Appearance of Sputum |
| 53880-1 | Norbuprenorphine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 4507-0 | Complement C6 [Mass/volume] in Serum or Plasma |
| 45115-3 | Chlamydia sp Ag [Presence] in Urethra by Immunofluorescence |
| 23651-3 | Actinobacillus suis serotype [Identifier] in Isolate by Agglutination |
| 24078-8 | Cerebroside sulfatase [Enzymatic activity/mass] in Leukocytes |
| 33971-3 | SARS coronavirus Urbani Ab [Titer] in Serum by Immunofluorescence |
| 3402-5 | Bolasterone [Presence] in Urine |
| 4602-9 | Hemoglobin Kempsey [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 46716-7 | Ceruloplasmin [Mass/volume] in DBS |
| 24440-0 | Isovalerylglycine/Creatinine [Molar ratio] in Urine |
| 34380-6 | Testosterone/Creatinine [Molar ratio] in Urine |
| 34400-2 | Colon Ab [Titer] in Serum by Immunofluorescence |
| 34660-1 | Hemoglobin A2/Hemoglobin.total in Blood by Chromatography column |
| 545-4 | Bacteroides melaninogenicus Ag [Presence] in Specimen by Immunofluorescence |
| 55384-2 | Insulin [Moles/volume] in Serum or Plasma --3 minutes post XXX challenge |
| 35322-7 | Protein [Mass/volume] in Body fluid --2nd specimen post Sincalide |
| 56034-2 | Hydroxylysine [Moles/volume] in Body fluid |
| 25884-8 | Cortisol Free [Moles/time] in 24 hour Urine by Radioimmunoassay (RIA) |
| 35551-1 | Phoma betae IgG Ab [Mass/volume] in Serum |
| 48107-7 | Erythritol/Creatinine [Molar ratio] in Urine |
| 56654-7 | Nickel/Creatinine [Ratio] in Urine |
| 5666-3 | Indium [Mass/volume] in Urine |
| 5703-4 | Nickel [Mass/time] in 24 hour Stool |
| 48702-5 | Spermatozoa Immature/100 spermatozoa in Semen |
| 26911-8 | ALPRAZolam [Mass/mass] in Meconium |
| 3853-9 | Nicotine [Mass/volume] in Serum or Plasma |
| 2734-2 | Pentoses [Mass/time] in 24 hour Urine |
| 38700-1 | Formaldehyde [Mass/volume] in Air |
| 38742-3 | 2,4-Dinitrotoluene [Mass/volume] in Air |
| 39590-5 | HTLV I+II p19 Ab [Units/volume] in Serum |
| 49539-0 | Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 59001-8 | Amylase [Enzymatic activity/time] in 18 hour Urine |
| 59221-2 | Prostate specific Ag [Mass/volume] in Pleural fluid |
| 59245-1 | Alanine glyoxylate aminotransferase [Enzymatic activity/mass] in Tissue |
| 30127-5 | Gerbil hair IgE Ab [Units/volume] in Serum |
| 41038-1 | Codeine [Mass/volume] in Blood |
| 20-8 | Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 12625-0 | Glucose [Mass/volume] in Serum or Plasma --13th specimen post XXX challenge |
| 101209-5 | Hantavirus IgG panel - Serum or Plasma by Line blot |
| 13190-4 | Formaldehyde IgM Ab [Units/volume] in Serum or Plasma |
| 14398-2 | Creatinine [Mass/volume] in Cerebral spinal fluid |
| 14787-6 | Arthropod identified in Specimen by Permanent mount |
| 103651-6 | Atomoxetine [Presence] in Urine by Confirmatory method |
| 103743-1 | Autoimmune lymphoproliferative syndrome multigene analysis in Specimen by Molecular genetics method |
| 10403-4 | Inject immune serum globulin [Volume] |
| 104259-7 | Fibroblast growth factor 23 [Presence] in Tissue by FISH |
| 10457-0 | Actin Ag [Presence] in Tissue by Immune stain |
| 10681-5 | Herpes simplex virus identified in Tissue by Electron microscopy |
| 10695-5 | Naegleria sp identified in Tissue by Wet preparation |
| 15484-9 | Mycoplasma gallisepticum Ab [Presence] in Serum by Agglutination |
| 111-5 | cefoTEtan [Susceptibility] by Minimum lethal concentration (MLC) |
| 11236-7 | Gemfibrozil [Mass/volume] in Serum or Plasma |
| 1731-9 | Adenylate kinase [Enzymatic activity/volume] in Serum |
| 17691-7 | Testosterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 91040-6 | Phencyclidine [Presence] in Body fluid by Screen method |
| 7580-4 | Pecan or Hickory Nut IgG Ab [Units/volume] in Serum |
| 6123-4 | Geranium IgE Ab [Units/volume] in Serum |
| 61388-5 | Human papilloma virus 68 DNA [Presence] in Specimen by NAA with probe detection |
| 6152-3 | Johnson grass IgE Ab [Units/volume] in Serum |
| 77326-7 | LORazepam [Moles/volume] in Specimen |
| 6296-8 | Complement C3b-C4b receptor [Presence] in Red Blood Cells |
| 78772-1 | Abacavir [Mass/volume] in Amniotic fluid |
| 80099-5 | L-2-hydroxyglutarate/Creatinine [Molar ratio] in Urine |
| 6884-1 | Homocystine [Mass/time] in 24 hour Urine |
| 81153-9 | Chikungunya virus non-structural protein 1 (nsP1) RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 96694-5 | Rate of fibrin formation.diatomaceous earth induced [Units] in Blood by Microviscometry |
| 96919-6 | Homogenous nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 69807-6 | 2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --pre dose ifosfamide |
| 81758-5 | Lymphocyte proliferation.anti-CD28.maximum/CD3 in Blood by Flow cytometry (FC) |
| 82188-4 | Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
| 97634-0 | Staphylococcus aureus DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 71673-8 | Lymphocytes/Leukocytes [Pure number fraction] in Blood by Manual count |
| 71676-1 | Neutrophils/Leukocytes [Pure number fraction] in Blood by Automated count |
| 85149-3 | PD-L1 by clone SP142 in Tissue by Immune stain Report |
| 85357-2 | PEDV prototype and S INDEL strain S gene panel - Specimen by NAA with probe detection |
| 7335-3 | Ginger IgE Ab [Units/volume] in Serum |
| 73665-2 | Optochin [Susceptibility] by Disk diffusion (KB) |
| 87789-4 | Theophylline/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 41219-7 | Paper wasp IgG Ab [Mass/volume] in Serum |
| 41449-0 | Plasmodium ovale DNA [Presence] in Blood by NAA with probe detection |
| 41691-7 | DAPTOmycin [Susceptibility] by Gradient strip |
| 42223-8 | Manganese/Creatinine [Molar ratio] in Urine |
| 59997-7 | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 51291-3 | CD33 cells/100 cells in Tissue |
| 51298-8 | CD38 cells/100 cells in Bone marrow |
| 22306-5 | Giardia lamblia IgG Ab [Titer] in Serum |
| 51786-2 | HIV 2 Ab Signal/Cutoff in Serum or Plasma by Immunoassay |
| 22401-4 | Leptospira interrogans sv Canicola Ab [Titer] in Serum |
| 32327-9 | Lutropin [Units/volume] in Serum or Plasma --1 hour post XXX challenge |
| 43842-4 | Borrelia burgdorferi Ab [Titer] in Serum by Immunoassay |
| 22890-8 | Bovine diarrhea virus Ab [Presence] in Milk by Immunoassay |
| 22999-7 | Chlamydophila psittaci Ag [Presence] in Stool by Immune stain |
| 23405-4 | Rift valley fever virus Ag [Presence] in Tissue by Immune diffusion (ID) |
| 23541-6 | Venezuelan equine encephalitis virus Ab [Presence] in Serum by Complement fixation |
| 23828-7 | Bordetella pertussis filamentous hemagglutinin IgG Ab [Units/volume] in Serum |
| 34593-4 | Epstein Barr virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 54488-2 | Pimeloylcarnitine (C7-DC)/Creatinine [Molar ratio] in Urine |
| 4714-2 | HLA-A10 [Presence] |
| 35138-7 | MEFV gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 47719-0 | Parathyrin [Mass/volume] in Serum or Plasma --pre dose calcium |
| 25655-2 | Gastrin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 35491-0 | Leptospira sp DNA [Presence] in Specimen by NAA with probe detection |
| 4814-0 | HLA-B17 [Presence] in Donor |
| 26676-7 | Bartonella henselae Ab [Presence] in Serum |
| 35880-4 | Tissue transglutaminase IgM Ab [Units/volume] in Serum |
| 56577-0 | Renin [Enzymatic activity/volume] in Plasma --1.5 hours post XXX challenge |
| 56628-1 | Amikacin [Moles/volume] in Serum or Plasma |
| 56722-2 | Soluble liver Ab [Presence] in Serum by Immunoblot |
| 57622-3 | Alpha cortol [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
| 27266-6 | Histoplasma capsulatum Ab [Titer] in Serum by Immune diffusion (ID) |
| 27323-5 | Leucine [Moles/volume] in Urine |
| 27426-6 | Trichinella sp IgM Ab [Units/volume] in Serum by Immunoassay |
| 27955-4 | Lactate [Mass/volume] in Blood --2 hours post XXX challenge |
| 583-5 | Streptococcus agalactiae [Presence] in Genital lochia by Organism specific culture |
| 29403-3 | Thiothixene [Mass/volume] in Urine |
| 2950-4 | Sodium [Moles/volume] in Body fluid |
| 58508-3 | C peptide [Mass/volume] in Serum or Plasma --3.5 hours post dose glucose |
| 40488-9 | Glucose/Creatinine [Ratio] in Urine |
| 3026-2 | Thyroxine (T4) [Mass/volume] in Serum or Plasma |
| 41047-2 | TSC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19215-3 | Oxygen [Partial pressure] saturation adjusted to 0.5 in Capillary blood |
| 19414-2 | Codeine cutoff [Mass/volume] in Urine for Confirmatory method |
| 20619-3 | Lymphocytes/100 leukocytes in Specimen by Automated count |
| 100992-7 | CD20 cell expression evaluation in Specimen Document by Flow cytometry (FC) |
| 101679-9 | Neonate blood type and indirect antibody screen panel - Specimen |
| 1346-6 | Yt sup(a) Ag [Presence] on Red Blood Cells from Donor |
| 14760-3 | Glucose [Moles/volume] in Capillary blood --2 hours post meal |
| 10385-3 | Albumin concentration given |
| 10429-9 | AE 1 Ag [Presence] in Tissue by Immune stain |
| 104338-9 | Borna disease virus RNA [Presence] in Brain tissue by Probe |
| 104448-6 | Salmonella paratyphi [Identifier] in Isolate by Agglutination |
| 15460-9 | Bovine leukemia virus Ab [Presence] in Serum by Immunoassay |
| 11108-8 | Lymphocytes/100 cells in Bone marrow by Manual count |
| 12280-4 | Alanine [Mass/volume] in Amniotic fluid |
| 1840-8 | Ammonia [Moles/volume] in Cerebral spinal fluid |
| 18862-3 | Amoxicillin+Clavulanate [Susceptibility] |
| 90735-2 | PNH GPI-Linked WBC and RBC Ag Panel - Blood |
| 7486-4 | Mattress dust IgE Ab [Units/volume] in Serum |
| 61110-3 | ACSL4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 9367-4 | Borate [Mass/volume] in Specimen |
| 61311-7 | Saltwort IgE Ab/IgE total in Serum |
| 93987-6 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose carbohydrate |
| 7922-8 | Influenza virus A England Ab [Units/volume] in Serum |
| 9563-8 | CD7 cells [#/volume] in Blood |
| 66764-2 | Nucleated erythrocytes/100 leukocytes [Ratio] in Cord blood |
| 79663-1 | Guanine [Moles/volume] in Cerebral spinal fluid |
| 81118-2 | Legionella sp IgM Ab [Presence] in Serum |
| 8146-3 | Amphetamines [Presence] in Meconium by Screen method |
| 81653-8 | Blastomyces dermatitidis drk1 and Histoplasma capsulatum gapdh genes [Identifier] in Specimen by NAA with probe detection |
| 82254-4 | Marker and derivative chromosome analysis in Amniotic fluid or Chorionic villus sample Document by Cytogenetics |
| 97287-7 | Norhydrocodone [Presence] in Cord tissue by Confirmatory method |
| 97513-6 | Campylobacter sp [Presence] in Specimen by Organism specific culture |
| 97960-9 | Olive pollen native (nOle e) 1 IgG4 Ab [Mass/volume] in Serum |
| 98107-6 | Macrophage colony-stimulating factor [Mass/volume] in Serum or Plasma |
| 98485-6 | Amyloid beta 42 peptide/Amyloid beta 40 peptide [Mass Ratio] in Cerebral spinal fluid |
| 71830-4 | Hematocrit [Pure volume fraction] of Mixed venous blood |
| 7202-5 | American Cheese IgG Ab [Units/volume] in Serum |
| 72308-0 | Brucella sp IgG Ab [Titer] in Serum --1st specimen |
| 99307-1 | Choriogonadotropin.beta subunit heterophile Ab interference [Presence] in Serum |
| 99362-6 | Euroglyphus maynei IgG Ab [Mass/volume] in Serum |
| 72526-7 | Elvitegravir [Susceptibility] by Genotype method |
| 7347-8 | Grain mill dust IgE Ab [Units/volume] in Serum |
| 73651-2 | Besifloxacin [Susceptibility] by Disk diffusion (KB) |
| 87997-3 | Trypanosoma cruzi IgM Ab [Presence] in Serum by Immunoassay |
| 74218-9 | Apixaban [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 88997-2 | Eicosapentaenoate (C20:5w3)/Fatty acids.C14-C24 in Serum or Plasma |
| 89516-9 | Ganglioside GT1b IgG+IgM Ab [Presence] in Serum by Line blot |
| 51037-0 | CD11b blasts/100 blasts in Bone marrow |
| 42366-5 | Streptococcus pneumoniae 23 serotypes IgG panel [Mass/volume] - Serum |
| 60186-4 | Thiethylperazine [Mass/volume] in Blood |
| 31311-4 | Coxiella burnetii phase 1 Ab [Units/volume] in Serum |
| 31388-2 | Feline immunodeficiency virus Ab [Units/volume] in Serum |
| 31467-4 | Legionella pneumophila 6 IgM Ab [Units/volume] in Serum |
| 51458-8 | Hepatitis D virus IgG Ab [Units/volume] in Serum |
| 42755-9 | Phosphatidylserine IgM Ab B2GP1 dependent [Multiple of the median] in Serum |
| 42768-2 | HIV 1 and 2 Ab [Interpretation] in Serum Narrative |
| 43095-9 | Anaplasma marginale Ab [Titer] in Serum |
| 2212-9 | Dihydropteridine reductase [Enzymatic activity/volume] in Serum |
| 31966-5 | Rubella virus Ag [Presence] in Specimen |
| 51595-7 | Glucose [Presence] in Stool |
| 43576-8 | Acylcarnitine/Carnitine.free (C0) [Ratio] in Urine |
| 43809-3 | Arsenic [Presence] in Tissue |
| 22777-7 | African swine fever virus Ab [Presence] in Body fluid by Immunoassay |
| 44337-4 | Metanephrine Free/Creatinine [Mass Ratio] in Urine |
| 44349-9 | Phenylalanine/Creatinine [Mass Ratio] in Urine |
| 32604-1 | Leptospira sp Ab [Titer] in Serum --1st specimen |
| 3299-5 | Acetaminophen [Presence] in Urine |
| 33636-2 | IgA.secretory [Units/volume] in Saliva (oral fluid) |
| 33948-1 | IgG/Creatinine [Mass Ratio] in Urine |
| 54237-3 | Corticotropin [Mass/volume] in Plasma --9 AM 2nd day specimen |
| 4626-8 | Hemoglobin Yakima [Presence] in Blood |
| 2444-8 | Hydroxymethylglutaryl CoA lyase [Enzymatic activity/volume] in Serum |
| 2494-3 | Iodine [Mass/volume] in Serum or Plasma |
| 34591-8 | HIV 1 Ab [Presence] in Body fluid by Immunoassay |
| 25428-4 | Glucose [Presence] in Urine by Test strip |
| 55711-6 | Pyrazinamide 200 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 35722-8 | Chlamydia sp DNA [Presence] in Serum by NAA with probe detection |
| 357-4 | Neomycin [Susceptibility] by Serum bactericidal titer |
| 56635-6 | Thyroglobulin IgG Ab [Units/volume] in Serum |
| 56742-0 | Ganglioside GQ1b IgM Ab [Presence] in Serum by Immunoblot |
| 5681-2 | Manganese [Mass/volume] in Blood |
| 27179-1 | Threonine [Moles/volume] in Amniotic fluid |
| 5761-2 | Zinc [Mass/volume] in Red Blood Cells |
| 48905-4 | Rickettsia akari IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 27356-5 | Phencyclidine [Mass/volume] in Vitreous fluid |
| 27364-9 | Aspergillus niger Ab [Presence] in Body fluid by Immune diffusion (ID) |
| 27912-5 | Butalbital [Mass/mass] in Hair |
| 5831-3 | Adenovirus Ag [Presence] in Urine by Immunoassay |
| 49432-8 | Parvovirus B19 DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 2819-1 | Potassium [Moles/volume] in Cerebral spinal fluid |
| 29945-3 | Alpha 1 globulin [Presence] in 24 hour Urine by Electrophoresis |
| 29948-7 | Sjogrens syndrome-A extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) |
| 59280-8 | Urate dihydrate crystals [Presence] in Stone by X-ray diffraction |
| 30108-5 | Ecgonine methyl ester [Mass/mass] in Meconium |
| 20451-1 | Thyroxine (T4) [Presence] in Blood |
| 12428-9 | Flurbiprofen [Mass/volume] in Serum or Plasma |
| 100281-5 | D Ab [Units/volume] in Serum or Plasma |
| 12508-8 | Calcitonin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 101359-8 | Bioterrorism agent panel - Specimen by NAA with non-probe detection |
| 101394-5 | Sex [Type] in Embryo by Molecular genetics method |
| 13362-9 | Collection duration of Urine |
| 13612-7 | Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine |
| 102480-1 | Oregano IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102528-7 | Virginia Scrub Pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14563-1 | Hemoglobin.gastrointestinal [Presence] in Stool --1st specimen |
| 14737-1 | Gastrin [Moles/volume] in Serum or Plasma --20 minutes post 0.2 U/kg secretin |
| 10365-5 | Cotinine [Mass/volume] in Serum or Plasma |
| 10402-6 | Immune serum globulin given [Volume] |
| 1578-4 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --72 hours post 40 ug corticotropin IM BID 3 day |
| 10950-4 | Reindeer epithelium IgE Ab [Units/volume] in Serum |
| 16589-4 | Chlamydia sp Ab [Units/volume] in Serum by Immunofluorescence |
| 16614-0 | Cholesterol crystals [Presence] in Body fluid by Light microscopy |
| 1878-8 | Apolipoprotein A-III [Mass/volume] in Serum or Plasma |
| 91073-7 | Human papilloma virus genotype [Identifier] in Tissue by NAA with probe detection |
| 7476-5 | Malt IgG Ab [Units/volume] in Serum |
| 74874-9 | Metabolic disorder therapy monitoring panel - DBS |
| 92252-6 | Microorganism molecular resistance panel by Molecular genetics method |
| 92686-5 | Vibrio cholerae+parahaemolyticus+vulnificus DNA [Presence] in Stool by NAA with probe detection |
| 75130-5 | Uridine [Moles/volume] in Cerebral spinal fluid |
| 75375-6 | Other cells/100 leukocytes in Sputum by Manual count |
| 75407-7 | Hepatitis B virus e Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 7559-8 | Oyster IgG Ab [Units/volume] in Serum |
| 61105-3 | Prochlorperazine [Moles/volume] in Gastric fluid |
| 92830-9 | Sentinel lymph node extranodal extension [Presence] in Cancer specimen |
| 61349-7 | Cockatiel feather IgE Ab/IgE total in Serum |
| 63078-0 | Buckwheat IgG Ab [Mass/volume] in Serum |
| 7797-4 | Rouleaux [Presence] in Blood by Light microscopy |
| 64013-6 | Escherichia coli shiga-like toxin 1 and 2 [Identifier] in Stool by Immunoassay |
| 64430-2 | KIR gene allele 2DP1 [Presence] in Blood or Tissue by Molecular genetics method |
| 7889-9 | Francisella tularensis IgG Ab [Presence] in Serum |
| 95082-4 | C peptide [Mass/volume] in Serum or Plasma --1 hour post meal |
| 95116-0 | Insulin [Units/volume] in Serum or Plasma --30 min post meal |
| 6607-6 | Microscopic observation [Identifier] in Tissue by Dark field examination |
| 6637-3 | Influenza virus A Victoria Ab [Units/volume] in Serum by Hemagglutination inhibition |
| 6657-1 | Microscopic observation [Identifier] in Tissue by Acid fast stain.Ziehl-Neelsen |
| 66727-9 | Adenovirus DNA [#/volume] (viral load) in Genital specimen by NAA with probe detection |
| 6694-4 | quiNIDine [Mass/volume] in Serum or Plasma |
| 9598-4 | Borrelia burgdorferi 23kD IgM Ab [Presence] in Serum by Immunoblot |
| 96043-5 | Uracil [Mass/volume] in Serum or Plasma |
| 96249-8 | Artifact [#/area] in Urine by Computer assisted method |
| 6954-2 | Bartonella henselae IgG Ab [Titer] in Serum by Immunofluorescence |
| 97622-5 | Kingella kingae DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 70180-5 | Alpha aminoadipate [Moles/volume] in Serum or Plasma from Fetus |
| 71366-9 | Alkaline phosphatase.intestinal 3 [Enzymatic activity/volume] in Serum or Plasma |
| 98006-0 | HLA-A and B and C (class I) and HLA-DP and DQ and DR (class II) Ab [Identifier] in Serum or Plasma |
| 9810-3 | quiNINE [Presence] in Gastric fluid |
| 98396-5 | Aspergillus sp CYP51 gene [Identifier] in Isolate by Sequencing |
| 72425-2 | 7-Hydroxyoctanoate [Moles/volume] in Serum or Plasma |
| 99280-0 | Cefiderocol [Susceptibility] |
| 99598-5 | Erythrocytes.dysmorphic/100 erythrocytes in Urine by Automated count |
| 72862-6 | Hepatitis C virus resistance panel by Genotype method |
| 73176-0 | quiNINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87320-8 | Escherichia coli enterotoxigenic heat-labile toxin DNA [Presence] in Isolate by NAA with probe detection |
| 876-3 | A,B Ab [Presence] in Serum or Plasma from Donor |
| 73828-6 | Flunitrazepam [Mass/volume] in Serum, Plasma or Blood |
| 87995-7 | Strongyloides sp identified in Stool by Organism specific culture |
| 74372-4 | Acetyl fentanyl [Mass/volume] in Urine |
| 88617-6 | Human coronavirus NL63 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 89338-8 | CD27+CD45RO+CD62L+CCR7+ cells/100 CD3+CD4+ cells in Blood |
| 50656-8 | Food Allergen Mix 27 (Hazelnut+Codfish+Soybean+Wheat) IgE Ab [Units/volume] in Serum by Multidisk |
| 3083-3 | Urate [Mass/volume] in Amniotic fluid |
| 42006-7 | Saint Louis encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 5996-4 | Platelet aggregation EPINEPHrine induced in Platelet rich plasma |
| 60251-6 | Androstanolone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 21638-2 | BRCA1 gene c.5382insC [Presence] in Blood or Tissue by Molecular genetics method |
| 5105-2 | Coxsackievirus B2 neutralizing antibody [Titer] in Serum by Neutralization test |
| 51779-7 | CFH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 43296-3 | HTLV I+II gp46 Ab [Presence] in Serum |
| 22689-4 | Zinc [Moles/time] in 24 hour Urine |
| 23064-9 | Epizootic hemorrhagic disease virus Alberta Ab [Presence] in Serum by Immune diffusion (ID) |
| 23128-2 | Francisella tularensis B DNA [Presence] in Tissue by NAA with probe detection |
| 3282-1 | aPTT W excess hexagonal phase phospholipid in Platelet poor plasma by Coagulation assay |
| 33227-0 | Coarse Granular Casts [#/area] in Urine sediment by Automated count |
| 53274-7 | Epithelial cells.renal [#/volume] in Urine by Computer assisted method |
| 53436-2 | Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Chorionic villus sample |
| 23340-3 | Paratuberculosis reaction wheal [Diameter] --3 days post 0.1 mL johnin intradermal |
| 33250-2 | CD55 cells [Presence] in Blood |
| 45185-6 | 2-Oxo-3-Hydroxy-Lysergate diethylamide [Mass/volume] in Urine |
| 54338-9 | Tetradecanoylcarnitine (C14)/Creatinine [Molar ratio] in Urine |
| 461-4 | Streptomycin [Susceptibility] by Disk diffusion (KB) |
| 24287-5 | Eastern equine encephalitis virus Ab [Titer] in Serum --1st specimen |
| 34517-3 | CATCH22 syndrome gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 34673-4 | Propofol [Mass/volume] in Serum or Plasma |
| 55142-4 | Cache valley virus RNA [Presence] in Specimen by NAA with probe detection |
| 55238-0 | HBA2 gene c.429A>T [Presence] in Blood by Molecular genetics method |
| 55626-6 | Cefacetrile [Susceptibility] by Disk diffusion (KB) |
| 35464-7 | CMT axonal gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 3723-4 | Lithium [Mass/volume] in Serum or Plasma --trough |
| 27006-6 | Xylose [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 27176-7 | 3-Methylhistidine [Moles/volume] in Amniotic fluid |
| 38349-7 | Herpes virus 6 DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 38377-8 | Cryptococcus neoformans [Presence] in Specimen by Organism specific culture |
| 3840-6 | Nalbuphine [Mass/volume] in Urine |
| 57675-1 | Legionella pneumophila IgG Ab [Presence] in Serum by Immunofluorescence --1st specimen |
| 27856-4 | Proinsulin [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
| 57870-8 | Phenylpropanolamine [Moles/volume] in Specimen |
| 5834-7 | Adenovirus Ag [Presence] in Specimen by Immunofluorescence |
| 49497-1 | Platelets [#/volume] in Blood by Estimate |
| 29364-7 | Magnesium [Mass/volume] in Cerebral spinal fluid |
| 29388-6 | Methaqualone [Mass/volume] in Gastric fluid |
| 58643-8 | Cortisol [Moles/volume] in Saliva (oral fluid) --12 AM specimen |
| 58812-9 | Renin [Mass/volume] in Plasma --3rd specimen |
| 19305-2 | Thiazides tested for in Urine by Screen method Narrative |
| 1952-1 | Beta-2-Microglobulin [Mass/volume] in Serum or Plasma |
| 2067-7 | Chenodeoxycholylglycine.conjugated [Mass/volume] in Serum |
| 100356-5 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection |
| 101486-9 | Ertapenem [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 13645-7 | Manganese [Mass/volume] in Water |
| 14218-2 | HTLV I p24 Ab [Presence] in Serum |
| 102770-5 | Paper Mulberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10543-7 | Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma |
| 10663-3 | Filaria identified in Blood by Thick film |
| 11009-8 | Epstein Barr virus capsid IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 16262-8 | Newberyite crystals [Presence] in Stone by Infrared spectroscopy |
| 16420-2 | Azithromycin [Mass/volume] in Serum or Plasma |
| 12301-8 | Procaine [Presence] in Urine |
| 12302-6 | Theobromine [Presence] in Serum or Plasma |
| 1677-4 | Alpha hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
| 1750-9 | Albumin [Mass/volume] in Semen |
| 18268-3 | CD16+CD56+ cells/100 cells in Body fluid |
| 18946-4 | metroNIDAZOLE [Susceptibility] |
| 90811-1 | AMPAR1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 74574-5 | Macroscopic observation [Interpretation] in Specimen Narrative |
| 92237-7 | Lab observation sub-type |
| 7511-9 | California Mugwort IgE Ab [Units/volume] in Serum |
| 75511-6 | dRVVT W excess phospholipid percent correction |
| 60396-9 | Sweet potato IgG Ab [Mass/volume] in Serum |
| 93461-2 | 4-Methoxybutyrylfentanyl [Mass/volume] in Urine by Confirmatory method |
| 62327-2 | Post-discharge provider practice address |
| 93813-4 | NTRK1, NTRK2 and NTRK3 gene rearrangements in Tissue by Molecular genetics method |
| 93881-1 | N-Stearoylsphingosine [Moles/volume] in Plasma |
| 6253-9 | Midge stinging IgE Ab [Units/volume] in Serum |
| 63263-8 | Histone Ab [Presence] in Body fluid by Immunoassay |
| 78006-4 | Isotopic Glomerular filtration rate/1.73 sq M [Volume Rate/Area] in Urine and Serum or Plasma |
| 78783-8 | AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
| 94376-1 | Klebsiella aerogenes DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 94597-2 | Equine adenovirus 1 RNA [Presence] in Specimen by NAA with probe detection |
| 6428-7 | Histoplasma capsulatum Ag [Units/volume] in Serum by Immunoassay |
| 79221-8 | Steroid fractions panel - Serum or Plasma |
| 66119-9 | Bone marrow Pathology biopsy report Narrative |
| 8024-2 | Saint Louis encephalitis virus Ab [Presence] in Serum by Immunofluorescence |
| 9579-4 | Tetrahydrocorticosterone [Mass/time] in 24 hour Urine |
| 80535-8 | Methylenedioxyethylamphetamine [Mass/mass] in Hair |
| 81728-8 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
| 820-1 | A Ag [Presence] on Red Blood Cells |
| 97279-4 | Midazolam [Presence] in Cord tissue by Confirmatory method |
| 70862-8 | Rabies virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 8263-6 | Service comment 20 |
| 99454-1 | Clostridium tetani toxoid IgG Ab [Mass/volume] in Serum |
| 99961-5 | Myeloproliferative neoplasm multigene analysis in Blood or Tissue by Molecular genetics method |
| 72497-1 | Dihydropteridine reductase [Enzymatic activity/mass] in DBS |
| 72932-7 | Venlafaxine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74102-5 | Matrix metallopeptidase 2 [Mass/volume] in Serum |
| 414-3 | Piperacillin+Tazobactam [Susceptibility] by Serum bactericidal titer |
| 41440-9 | Encephalitozoon hellem DNA [Presence] in Specimen by NAA with probe detection |
| 4168-1 | cefTRIAXone [Mass] of Dose |
| 50930-7 | Uranium [Moles/time] in 24 hour Urine |
| 4258-0 | Flunitrazepam [Mass] of Dose |
| 2119-6 | Choriogonadotropin [Moles/volume] in Serum or Plasma |
| 51406-7 | Immunoglobulin light chains.free [Mass/time] in 24 hour Urine |
| 51432-3 | Prolactin [Mass/volume] in Serum or Plasma --pre or post XXX challenge |
| 3195-5 | Coagulation factor V Ag actual/normal in Platelet poor plasma by Immunoassay |
| 43240-1 | Ganglioside GM1 IgG Ab [Titer] in Serum by Immunoassay |
| 22427-9 | Mycoplasma pneumoniae IgM Ab [Titer] in Serum |
| 32112-5 | Sertraline [Presence] in Urine |
| 32163-8 | Cells [#/volume] in Peritoneal fluid by Manual count |
| 3217-7 | Coagulation factor X activated [Units/volume] in Platelet poor plasma by Coagulation assay |
| 32379-0 | Voriconazole [Susceptibility] |
| 51930-6 | Ritonavir [Mass/volume] in Serum or Plasma --trough |
| 44012-3 | Measles virus IgG and IgM [Interpretation] in Serum |
| 44069-3 | CD20+FMC7+ cells [#/volume] in Specimen |
| 22996-3 | Chlamydophila psittaci Ab [Presence] in Serum by Immunoassay |
| 231-1 | Enoxacin [Susceptibility] by Serum bactericidal titer |
| 32658-7 | Aflatoxin IgM Ab [Units/volume] in Serum or Plasma |
| 3277-1 | Kininogen HMW [Mass/volume] in Platelet poor plasma by Immunoassay |
| 44634-4 | Reason invasive component size cannot be determined in Breast tumor Narrative |
| 23212-4 | Lumpy skin disease virus [Presence] in Tissue by Electron microscopy |
| 23497-1 | Transmissible gastroenteritis virus Ag [Presence] in Small intestine Tissue by Immunofluorescence |
| 33274-2 | 5-Methyltetrahydrofolate [Presence] in Cerebral spinal fluid |
| 33311-2 | Porphyrins [Moles/volume] in Serum or Plasma |
| 3335-7 | Amitriptyline+Nortriptyline [Mass/volume] in Serum or Plasma |
| 53874-4 | Jamestown canyon virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection |
| 45300-1 | Glycerol [Moles/volume] in Serum or Plasma |
| 45340-7 | Tick # 3 identified in Specimen |
| 2367-1 | Glutamate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
| 23862-6 | Famotidine [Mass/volume] in Serum or Plasma |
| 33779-0 | IgG+IgM+IgA heavy chain Ag [Presence] in Tissue by Immune stain |
| 54213-4 | Cortisol [Moles/volume] in Serum or Plasma --4 days post dose corticotropin |
| 24442-6 | Propionylglycine/Creatinine [Molar ratio] in Urine |
| 34560-3 | Cell count and Differential panel - Synovial fluid |
| 34561-1 | Cell count panel - Pleural fluid |
| 3462-9 | Chlormerodrin [Mass/volume] in Urine |
| 346-7 | Nafcillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 47398-3 | Beta mannosidase actual/normal in Leukocytes |
| 47457-7 | Influenza virus A H8 Ab [Titer] in Serum |
| 47552-5 | Alanine/Amino acids.total in Hair |
| 26057-0 | Pyridoxine [Mass/volume] in Serum or Plasma --post pyridoxine PO |
| 2655-9 | Neurotensin [Mass/volume] in Plasma |
| 48595-3 | von Willebrand evaluation [Interpretation] in Platelet poor plasma |
| 4885-0 | HLA-Dw18(w6) [Presence] |
| 27255-9 | Magnesium [Moles/mass] in 24 hour Stool |
| 3852-1 | Nicotinamide [Mass/volume] in Urine |
| 38626-8 | Vinyl chloride [Mass/volume] in Air |
| 48958-3 | Midazolam [Mass/volume] in Specimen |
| 27417-5 | Candida sp IgA Ab [Units/volume] in Serum by Immunoassay |
| 27441-5 | Potassium [Moles/mass] in 24 hour Stool |
| 27816-8 | von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay |
| 57793-2 | Amino acidemia disorder suspected [Identifier] in DBS |
| 49431-0 | Parvovirus B19 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
| 49716-4 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Saliva (oral fluid) |
| 291-5 | Kanamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 40109-1 | aPTT in Platelet poor plasma by Coagulation assay --12 hours post XXX challenge |
| 58692-5 | Cortisol [Moles/volume] in Saliva (oral fluid) --5th specimen post XXX challenge |
| 49815-4 | 2-methyl-3-hydroxybutyrate (C5-OH)/Creatinine [Molar ratio] in 24 hour Urine |
| 29533-7 | Cryptococcus sp Ag [Presence] in Specimen |
| 29649-1 | Rickettsia australis Ab [Presence] in Serum by Immunofluorescence |
| 29667-3 | Parainfluenza virus 2 IgM Ab [Presence] in Serum |
| 50193-2 | Cholesterol in LDL.narrow density [Mass/volume] in Serum or Plasma |
| 50289-8 | 3-Dechloroethylifosfamide [Mass/volume] in Blood --6 days post dose ifosfamide |
| 30288-5 | Adefovir [Susceptibility] by Genotype method |
| 19479-5 | Haloperidol [Presence] in Urine by Confirmatory method |
| 20454-5 | Protein [Presence] in Urine by Test strip |
| 20549-2 | Methyprylon [Mass/volume] in Urine by Confirmatory method |
| 20804-1 | Epizootic hemorrhagic disease virus Ag [Presence] in Blood by Immunofluorescence |
| 101478-6 | Ampicillin+Sulbactam [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 101563-5 | Sapovirus genogroup V RNA [Presence] in Stool by NAA with probe detection |
| 101949-6 | Mycoplasma genitalium+hominis DNA [Presence] in Wound by NAA with probe detection |
| 102103-9 | Acute myeloid leukemia panel - Blood or Tissue by FISH |
| 102172-4 | Soybean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13565-7 | LORazepam [Presence] in Serum or Plasma |
| 103005-5 | Timothy recombinant (rPhl p) 1 + 5b IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14538-3 | Measles virus Ag [Presence] in Nose by Immunofluorescence |
| 14775-1 | Hemoglobin [Mass/volume] in Arterial blood by Oximetry |
| 1480-3 | Galactose [Mass/volume] in Blood --1 hour post 40 g galactose PO |
| 1490-2 | Gastrin [Mass/volume] in Serum or Plasma --pre 0.2 U/kg secretin |
| 14962-5 | CD13 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 15020-1 | Amylase.P1/Amylase.total in Serum or Plasma |
| 104314-0 | Lenvatinib [Mass/volume] in Serum or Plasma |
| 15429-4 | Service comment 38 |
| 1611-3 | Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose TRH IV |
| 16128-1 | Hepatitis C virus Ab [Presence] in Serum |
| 11234-2 | Propoxyphene [Mass/mass] in Hair |
| 18189-1 | Acetone [Mass/time] in 24 hour Urine |
| 18211-3 | Complement C1 esterase inhibitor bound IgM Ab [Mass/volume] in Serum or Plasma |
| 19086-8 | Collection of urine specimen end date |
| 7469-0 | Liver calf IgE Ab [Units/volume] in Serum |
| 74795-6 | Total thyroxine binding capacity in Serum or Plasma |
| 75374-9 | Other cells/100 leukocytes in Cerebral spinal fluid by Manual count |
| 76627-9 | Rifapentine [Susceptibility] by Method for Slow-growing mycobacteria |
| 77080-0 | SERPINF1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 77734-2 | Mycobacterium abscessus complex clarithromycin resistance erm(41) full length gene [Presence] by Molecular method |
| 94108-8 | 1-Hydroxymidazolam [Presence] in Urine by Screen method |
| 7807-1 | Aspergillus sp Ab [Units/volume] in Serum |
| 78441-3 | Bilirubin.conjugated [Moles/volume] in Peritoneal fluid |
| 78781-2 | ALPRAZolam cutoff [Mass/volume] in Urine for Confirmatory method |
| 94602-0 | West Nile virus IgM Ab/Positive control in Serum by Immunoassay |
| 79337-2 | Hypoglycemics.oral [Presence] in Body fluid by Screen method |
| 79418-0 | EPCAM gene exons 8 and 9 deletion and duplication mutation analysis in Blood or Tissue by MLPA |
| 95837-1 | Mononuclear cell dose in hematopoietic progenitor cell transfusion [#/mass] |
| 8157-0 | Arsenic [Mass/mass] in Nail |
| 96910-5 | Acanthamoeba sp and Naegleria fowleri and Balamuthia mandrillaris DNA panel - Specimen |
| 69907-4 | Service comment 80 |
| 6994-8 | Cefprozil [Susceptibility] by Gradient strip |
| 70073-2 | Amyloid beta 40 peptide [Mass/volume] in Plasma |
| 70265-4 | Protein in pericardial fluid/Protein in serum |
| 7072-2 | Almond Tree IgE Ab [Units/volume] in Serum |
| 99068-9 | Ku Ab [Units/volume] in Serum by Line blot |
| 72454-2 | Butalbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 99120-8 | Oropouche virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 99426-9 | Amoxicillin IgG4 Ab [Mass/volume] in Serum |
| 99901-1 | Triple phosphate crystals [#/area] in Urine sediment by Computer assisted method |
| 86129-4 | Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum by Immunoassay |
| 86199-7 | Rotavirus A Ag [Presence] in Tissue by Immune stain |
| 86578-2 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Blood by NAA with probe detection |
| 86705-1 | Lawsonia intracellularis Ab [Titer] in Serum by Immunoassay |
| 7411-2 | Honey IgG Ab [Units/volume] in Serum |
| 4129-3 | Anthraquinone [Mass] of Dose |
| 41450-8 | Plasmodium vivax DNA [Presence] in Blood by NAA with probe detection |
| 50746-7 | Hirudin [Units/volume] in Platelet poor plasma by Chromogenic method |
| 31085-4 | Methaqualone [Mass/volume] in Bile fluid |
| 21501-2 | Measles virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 31177-9 | Estrone (E1) [Mass/volume] in Amniotic fluid |
| 31179-5 | Lopinavir [Mass/volume] in Serum or Plasma |
| 31372-6 | Epstein Barr virus nuclear Ab [Units/volume] in Serum |
| 42975-3 | Powassan virus Ab [Titer] in Serum |
| 22115-0 | Bordetella avium Ab [Titer] in Serum |
| 22228-1 | Coxsackievirus B2 Ab [Titer] in Serum |
| 32164-6 | Cells [#/volume] in Synovial fluid by Manual count |
| 5256-3 | Mycoplasma pneumoniae IgM Ab [Units/volume] in Serum by Immunoassay |
| 2309-3 | Galactose [Presence] in Urine |
| 53374-5 | Francisella tularensis Ab [Presence] in Specimen |
| 44684-9 | Distance of melanoma in situ to closest lateral margin |
| 23223-1 | Lumpy skin disease virus DNA [Presence] in Specimen by RFLP |
| 23435-1 | Salmonella pullorum DNA [Presence] in Specimen by NAA with probe detection |
| 4509-6 | Complement C8 [Mass/volume] in Serum or Plasma |
| 23749-5 | Lead [Mass/volume] in Specimen |
| 46184-8 | Echinococcus granulosus Ab [Units/volume] in Serum |
| 4694-6 | HLA Ag present [Identifier] |
| 546-2 | Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture |
| 55351-1 | Glucose [Moles/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO |
| 55-4 | Capreomycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 47124-3 | PHENobarbital [Moles/volume] in Gastric fluid |
| 4737-3 | HLA-A32(19) [Presence] |
| 25215-5 | Para aminosalicylate 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 3480-1 | Chlorthalidone [Mass/time] in 24 hour Urine |
| 47737-2 | Proline/Amino acids.total in Specimen |
| 47779-4 | Octadecanoate (C18:0)/Creatinine [Molar ratio] in Urine |
| 25799-8 | Tissue polypeptide specific Ag [Units/volume] in Urine |
| 25826-9 | Staphylococcus aureus enterotoxin D IgE Ab [Units/volume] in Serum |
| 25860-8 | Arginine [Moles/volume] in 24 hour Urine |
| 26008-3 | Echinococcus sp Ab [Titer] in Serum by Hemagglutination |
| 35664-2 | Ethanol [Mass/volume] in Urine collected for unspecified duration |
| 35767-3 | Cefoperazone [Susceptibility] by Gradient strip |
| 56152-2 | Beta 2 glycoprotein 1 Ab IgA and IgG and IgM panel - Serum |
| 56523-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 48031-9 | SCA10 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 3790-3 | Methocarbamol [Mass/volume] in Serum or Plasma |
| 38342-2 | Hexachlorobenzene [Mass/volume] in Water |
| 38595-5 | Ethylene dibromide [Mass/volume] in Air |
| 27971-1 | Catecholamines [Mass/volume] in Plasma --4 hours post XXX challenge |
| 5828-9 | Adenovirus Ag [Presence] in Throat by Immunofluorescence |
| 49492-2 | Leukemia markers [Interpretation] in Cerebral spinal fluid Narrative |
| 2821-7 | Potassium [Moles/volume] in Body fluid |
| 2850-6 | Propionyl CoA Carboxylase [Enzymatic activity/mass] in Tissue |
| 4026-1 | Salicylates [Mass/volume] in Urine |
| 50103-1 | 3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Amniotic fluid |
| 29531-1 | diphenhydrAMINE [Presence] in Specimen |
| 29575-8 | Thyrotropin [Units/volume] in DBS |
| 40510-0 | Snowshoe hare virus Ab [Titer] in Serum by Immunofluorescence |
| 58880-6 | Somatotropin [Mass/volume] in Serum or Plasma --27th specimen |
| 50329-2 | Respiratory syncytial virus Ag [Presence] in Tissue by Immune stain |
| 30229-9 | Band form neutrophils [#/volume] in Blood by Automated count |
| 19353-2 | Barbital [Presence] in Urine by Screen method |
| 12422-2 | Triflupromazine [Mass/volume] in Serum or Plasma |
| 100025-6 | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100346-6 | Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG |
| 12456-0 | Histoplasma capsulatum mycelial phase Ab [Presence] in Cerebral spinal fluid |
| 12558-3 | Cortisol [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 12828-0 | Prolactin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 101401-8 | Tapentadol and Nortapentadol panel - Urine |
| 13005-4 | 2,4,5-Trichlorophenoxyacetate [Type] in Serum or Plasma |
| 13171-4 | Immune complex [Units/volume] in Serum or Plasma by Polyethylene glycol (PEG) assay |
| 101770-6 | Trichophyton violaceum DNA [Presence] in Specimen by NAA with probe detection |
| 102382-9 | Horseradish IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14106-9 | Lymphocytes [#/volume] in Cerebral spinal fluid by Manual count |
| 103162-4 | Escherichia coli enteropathogenic DNA [Presence] in Wound by NAA with probe detection |
| 104193-8 | Guanidinoacetate methyltransferase deficiency comment [Text] in DBS Narrative |
| 14850-2 | Nitrazepam [Moles/volume] in Urine |
| 15155-5 | Calcium [Mass/volume] in Body fluid |
| 10599-9 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test |
| 10764-9 | Microscopic observation [Identifier] in Sputum by Silver stain |
| 10996-7 | Normeperidine [Mass/volume] in Serum or Plasma |
| 16322-0 | Biperiden [Mass/volume] in Serum or Plasma |
| 16348-5 | Alpha hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method |
| 16374-1 | Amyl nitrite [Mass/volume] in Serum or Plasma |
| 16534-0 | Campylobacter sp rRNA [Presence] in Serum by Probe |
| 11224-3 | Phosphoethanolamine [Mass/volume] in Cerebral spinal fluid |
| 16906-0 | Glucose [Presence] in Urine --3rd specimen post XXX challenge |
| 17446-6 | Phoma sp IgE Ab [Units/volume] in Serum |
| 1795-4 | Amylase [Enzymatic activity/volume] in Body fluid |
| 1857-2 | Angiotensin converting enzyme [Enzymatic activity/volume] in Blood |
| 74894-7 | Mannitol [Moles/time] in 5 hour Urine --post XXX g sugar solution PO |
| 75652-8 | Immature lymphocytes [Presence] in Blood |
| 61159-0 | Hepatitis B virus codon M204S [Presence] by Genotype method |
| 9351-8 | ALPRAZolam [Presence] in Urine |
| 61331-5 | Beef IgE Ab/IgE total in Serum |
| 77662-5 | Diploid G1 phase cell population peak channel [#] in Cells.XXX by Flow cytometry (FC) |
| 93996-7 | Osmolality of Serum or Plasma--7 hours post fluid fast |
| 94413-2 | GRIK4 gene c.83-10039T>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 79156-6 | Cold agglutinin [Titer] in Serum by 37 degree C incubation --1 hour post incubation |
| 79303-4 | D- and L-2-hydroxyglutarate pattern [Interpretation] in Urine Narrative |
| 657-7 | Microscopic observation [Identifier] in Specimen by Acridine orange stain |
| 79506-2 | Desaminotyrosine [Moles/volume] in Serum or Plasma |
| 96272-0 | DNA mismatch repair protein Mlh3 [Presence] in Cancer specimen by Immune stain |
| 96417-1 | Cells.CD3-CD14-CD19+CD45+DOCK8+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) |
| 81234-7 | Varicella zoster virus IgG and IgM panel - Serum or Plasma Qualitative |
| 69950-4 | Hemoglobin [Mass/volume] in Pericardial fluid |
| 82058-9 | Food Allergen Mix 16 (Pineapple+Lemon+Strawberry+Pear) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 70110-2 | Number of chromosome 18 present [#] in Amniotic fluid by NAA with probe detection |
| 82891-3 | Para methylhippurate [Moles/volume] in Urine |
| 72346-0 | Round cells [#/volume] in Prostatic fluid by Manual count |
| 7296-7 | Eggplant IgE Ab [Units/volume] in Serum |
| 86054-4 | Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum --1st specimen |
| 7315-5 | Flea triggered histamine release [Units/volume] in Blood |
| 73233-9 | Omeprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87568-2 | Ochratoxin A [Mass/mass] in Specimen |
| 73604-1 | Ceftaroline+Avibactam [Susceptibility] |
| 73630-6 | Telavancin [Susceptibility] by Disk diffusion (KB) |
| 73669-4 | Bacteria producing DNAse [Presence] in Isolate |
| 88038-5 | Hy Ab [Presence] in Serum or Plasma |
| 88140-9 | Tropheryma whipplei DNA [Presence] in Ocular fluid by NAA with probe detection |
| 73915-1 | 1,3-Dimethylamylamine [Presence] in Urine by Screen method |
| 74383-1 | fentaNYL [Mass/volume] in Unknown substance |
| 88919-6 | Taenia solium larva IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 59839-1 | Urate crystals [Presence] in Tissue by Light microscopy |
| 50806-9 | Antimony [Moles/time] in 24 hour Urine |
| 307-9 | Loracarbef [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 4178-0 | Chlorpheniramine [Mass] of Dose |
| 59904-3 | fluPHENAZine [Moles/volume] in Urine |
| 60050-2 | Acetaminophen [Mass/mass] in Tissue |
| 21804-0 | t(11;22)(p13;q12.2)(WT1,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 31672-9 | Taylorella equigenitalis Ab [Units/volume] in Serum |
| 43833-3 | quiNINE [Presence] in Specimen |
| 3229-2 | Coagulation factor XI Ag actual/normal in Platelet poor plasma by Immunoassay |
| 52903-2 | Uranium/Creatinine [Molar ratio] in Urine |
| 43891-1 | Bordetella pertussis Ag [Presence] in Sputum by Immunofluorescence |
| 4390-1 | Phendimetrazine [Mass] of Dose |
| 22792-6 | Aleutian disease virus Ab [Presence] in Serum by Counterimmunoelectrophoresis (CIE) |
| 32594-4 | Tacrolimus [Mass] of Dose |
| 44437-2 | Ascaris sp IgG Ab [Units/volume] in Serum |
| 44645-0 | Nuclear pleomorphism in Breast tumor by Nottingham |
| 23347-8 | Pasteurella multocida serotype [Identifier] in Specimen by Immunofluorescence |
| 23609-1 | Kanamycin [Susceptibility] by Method for Slow-growing mycobacteria |
| 53597-1 | Mannobioside IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 53837-1 | ACVRL1 gene+ENG gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 45310-0 | Mesoporphyrin [Moles/mass] in Stool |
| 45311-8 | Pentacarboxylate [Moles/mass] in Stool |
| 23736-2 | Feline leukemia virus Ag [Presence] in Tissue by Immunofluorescence |
| 34055-4 | Lutropin [Units/volume] in Serum or Plasma --pre or post XXX challenge |
| 54390-0 | Fibroblast growth factor 23.intact [Mass/volume] in Serum or Plasma |
| 24433-5 | IgG.equine [Mass/volume] in Serum |
| 24447-5 | Magnesium [Mass/time] in 24 hour Urine |
| 549-6 | Bordetella pertussis [Presence] in Specimen by Organism specific culture |
| 55676-1 | Flumequine [Susceptibility] |
| 25653-7 | Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2599-9 | Magnesium [Moles/time] in 24 hour Urine |
| 56538-2 | Beta 2 glycoprotein 1 Ab [Units/volume] in Serum by Immunoassay |
| 48269-5 | Cefamandole triggered leukotriene release [Mass/volume] by Leukocytes |
| 26626-2 | Chlamydia trachomatis L2 Ab [Presence] in Serum |
| 3598-0 | Estazolam [Mass/volume] in Urine |
| 56617-4 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 26838-3 | LORazepam [Mass/mass] in Hair |
| 26849-0 | IgA.secretory [Mass/volume] in Saliva (oral fluid) |
| 26968-8 | Beta alanine [Moles/volume] in Urine |
| 49017-7 | Respiratory allergen panel, US - North Atlantic states c - Serum |
| 27879-6 | CD33+HLA-DR+ cells/100 cells in Blood |
| 3876-0 | Nortriptyline [Mass/volume] in Serum or Plasma --trough >12 hours post dose |
| 38928-8 | FAH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 57709-8 | Fatty acid oxidation defects newborn screening comment-discussion |
| 5784-4 | Cystine crystals [Presence] in Urine sediment by Light microscopy |
| 57919-3 | Calcium [Mass/volume] in Nonbiological fluid |
| 4963-5 | HLA-DR16(2) [Presence] |
| 2868-8 | Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
| 2938-9 | Serine [Mass/time] in 24 hour Urine |
| 39965-9 | Creatinine [Mass/volume] in Serum or Plasma --5.25 hours post XXX challenge |
| 29593-1 | Cells.Ki-67 nuclear Ag/100 cells in Tissue by Immune stain |
| 29668-1 | Rickettsia australis Ab [Titer] in Serum |
| 58858-2 | Parathyrin.intact [Mass/volume] in Serum or Plasma --post XXX challenge |
| 59170-1 | Citalopram [Presence] in Urine |
| 3024-7 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma |
| 19515-6 | Levomethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
| 1954-7 | Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Serum or Plasma |
| 20456-0 | Fungi.yeastlike [Presence] in Urine sediment by Light microscopy |
| 12863-7 | Borrelia burgdorferi 41kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 101233-5 | Glutamate decarboxylase 65 Ab [Presence] in Serum by Immunoblot |
| 13499-9 | HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot |
| 13702-6 | Aconitate/Creatinine [Mass Ratio] in Urine |
| 102893-5 | Cat serum albumin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103003-0 | Timothy recombinant (rPhl p) 11 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14932-8 | Urate [Presence] in Stone |
| 104417-1 | Lassa virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 10499-2 | Lambda light chains Ag [Presence] in Tissue by Immune stain |
| 10880-3 | Magnesium [Mass/mass] in Stool |
| 11076-7 | Hepatitis C virus 5-1-1 Ab [Presence] in Serum by Immunoblot |
| 11218-5 | Microalbumin [Mass/volume] in Urine by Test strip |
| 12180-6 | Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE) |
| 16857-5 | Fenclorvos [Presence] in Blood |
| 17123-1 | CD19+Lambda+ cells/100 cells in Blood |
| 17666-9 | Sulfate [Mass/volume] in Dialysis fluid |
| 17757-6 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid |
| 1826-7 | Alpha 1 antitrypsin MM [Mass/volume] in Serum or Plasma |
| 19057-9 | ABO and Rh group [Type] in Blood from Newborn |
| 74838-4 | CD34 cells [#/volume] in Specimen |
| 74862-4 | IgG.kappa [Mass/volume] in Serum or Plasma |
| 92522-2 | N Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 75347-5 | Tapentadol [Mass/volume] in Serum, Plasma or Blood |
| 75541-3 | Parvovirus B19 DNA [log units/volume] (viral load) in Plasma from Donor by NAA with probe detection |
| 76664-2 | Fetal Chromosome X and Y aneuploidy [interpretation] based on dosage of chromosome-specific cell-free DNA in Maternal plasma |
| 93201-2 | Coronary heart disease multigene analysis in Blood or Tissue by Molecular genetics method |
| 93490-1 | AMPAR2 IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 93772-2 | 4-hydroxyglutamate/Creatinine [Molar ratio] in Urine |
| 63123-4 | Cumin IgG Ab [Mass/volume] in Serum |
| 77936-3 | Cortisol [Moles/volume] in Serum or Plasma --10.5 hours post XXX challenge |
| 94437-1 | HLA-DQA1 IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC) |
| 6385-9 | Dengue virus Ag [Presence] in Specimen by Immunofluorescence |
| 79342-2 | Carnitine biosynthesis intermediates pattern [Interpretation] in Urine Narrative |
| 65767-6 | English Walnut native (nJug r) 2 IgE Ab [Units/volume] in Serum |
| 6729-8 | Cow milk IgG Ab [Units/volume] in Serum |
| 80202-5 | Clotting time of depleted plasma with 1:1 phospholipid by Coagulation assay --after addition of factor X activated |
| 6915-3 | Chlamydophila psittaci IgA Ab [Titer] in Serum by Immunofluorescence |
| 69383-8 | AGXT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 69776-3 | Suberylcarnitine (C8-DC)/Creatinine [Molar ratio] in Urine |
| 81785-8 | Duck feather IgG Ab [Mass/volume] in Serum |
| 81850-0 | Chromosome region 11p15 methylation and deletion+duplication in Amniotic fluid by Molecular genetics method |
| 97649-8 | 2-Amino-5-chloropyridine [Presence] in Urine by Confirmatory method |
| 97860-1 | HIV 1 Ab panel - Serum or Plasma by Immunoblot |
| 82300-5 | Shigella sp [Presence] in Stool by Culture |
| 8255-2 | Service comment 13 |
| 82997-8 | Mi-2 alpha IgG Ab [Presence] in Serum by Line blot |
| 72266-0 | Influenza virus A IgA Ab [Units/volume] in Serum by Immunoassay |
| 85364-8 | Muscarinic acetylcholine receptor M3 Ab [Presence] in Serum |
| 72496-3 | DNA double strand [Mass/volume] in Specimen |
| 87636-7 | Crufomate [Mass/mass] in Specimen |
| 87746-4 | Chlordane [Mass/mass] in Specimen |
| 73628-0 | Besifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 88026-0 | Glutarylcarnitine (C5-DC)/Propionylcarnitine (C3) [Molar ratio] in Serum or Plasma |
| 88446-0 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --20 minutes post dose lactose PO |
| 7410-4 | Swine epithelium IgG Ab [Units/volume] in Serum |
| 4122-8 | Amoxapine [Mass] of Dose |
| 41652-9 | Glucose [Mass/volume] in Venous blood |
| 31040-9 | Gatifloxacin [Susceptibility] by Disk diffusion (KB) |
| 4179-8 | chlorproMAZINE [Mass] of Dose |
| 21467-6 | Plasmodium ovale Ab [Titer] in Serum by Immunofluorescence |
| 31476-5 | Leptospira borgpetersenii sv Sejroe Ab [Units/volume] in Serum |
| 22116-8 | Bordetella pertussis Ab [Titer] in Serum |
| 518-1 | Trimethoprim+Sulfamethoxazole [Susceptibility] by Serum bactericidal titer |
| 32285-9 | BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection |
| 52813-3 | Appearance of Spun Pleural fluid |
| 52883-6 | Cytoplasmic CD3 cells/100 cells in Bone marrow |
| 23017-7 | Coxiella burnetii Ab [Presence] in Serum by Complement fixation |
| 32760-1 | Cell type in Specimen |
| 53105-3 | 3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Urine |
| 53426-3 | Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --1st specimen post XXX challenge |
| 53493-3 | Sebacylcarnitine (C10-DC) [Moles/volume] in Urine |
| 44520-5 | Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid |
| 23250-4 | Mycoplasma agalactiae Ab [Presence] in Serum by Immunoassay |
| 23334-6 | Ovine progressive pneumonia virus Ag [Presence] in Specimen by Immunofluorescence |
| 33364-1 | Normochromic [Presence] in Blood by Light microscopy |
| 33830-1 | Lymphoblasts [#/volume] in Blood by Manual count |
| 33875-6 | Oligosaccharides pattern [Interpretation] in Urine |
| 54375-1 | Creatinine [Moles/volume] in Pleural fluid |
| 24198-4 | Coxsackievirus B6 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 2508-0 | Isoleucine [Mass/volume] in Serum or Plasma |
| 54483-3 | Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Amniotic fluid |
| 47084-9 | Platelet glycoprotein Ia/IIa Ab [Presence] in Serum by Immunoassay |
| 25261-9 | Nalidixate [Mass/volume] in Specimen |
| 55716-5 | Ticarcillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2559-3 | Leucine [Presence] in Serum or Plasma |
| 3548-5 | diazePAM [Mass/volume] in Serum or Plasma |
| 35533-9 | Coffee IgG Ab [Mass/volume] in Serum |
| 35700-4 | Acetaminophen [Mass/volume] in Gastric fluid |
| 56355-1 | Penicillium notatum IgG4 Ab [Mass/volume] in Serum |
| 26522-3 | Polymorphonuclear cells/100 leukocytes in Synovial fluid |
| 56936-8 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hour post dose lactulose |
| 48665-4 | IgA.intrathecally synthesized [Mass/volume] in Serum and CSF |
| 4884-3 | HLA-Dw18(w6) [Presence] in Donor |
| 27007-4 | Acetohexamide [Mass/volume] in Serum or Plasma |
| 38643-3 | Calcium cyanamide [Mass/volume] in Air |
| 57666-0 | Oligoclonal Bands IgM [Presence] in Serum or Plasma by Isoelectric focusing |
| 48945-0 | chlordiazePOXIDE [Mass/volume] in Specimen |
| 49189-4 | Corynebacterium diphtheriae toxin IgG Ab [Units/volume] in Serum |
| 27813-5 | Prothrombin Ag actual/normal in Platelet poor plasma by Immunoassay |
| 58093-6 | Acylcarnitine newborn screening comment-discussion |
| 49363-5 | Hepatitis B virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 496-0 | Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 40061-4 | Albumin [Mass/volume] in Serum or Plasma --2 days post XXX challenge |
| 40270-1 | Creatinine [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
| 58606-5 | Corticotropin [Moles/volume] in Plasma --45 minutes post dose insulin IV |
| 4976-7 | HLA-DR1 [Presence] in Donor |
| 50014-0 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Blood or Tissue by Molecular genetics method |
| 29577-4 | Fungal susceptibility panel |
| 29636-8 | Appearance of Stool |
| 40643-9 | Leptospira borgpetersenii sv Ballum Ab [Titer] in Serum by Agglutination |
| 40686-8 | Platelet factor 3 [Units/volume] in Platelet rich plasma |
| 58928-3 | HLA-DQA1*03:01 [Presence] |
| 30321-4 | aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --1 hour post incubation |
| 2035-4 | Carbonate [Mass/volume] in Plasma |
| 20377-8 | Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
| 100792-1 | Forsythia IgE Ab [Units/volume] in Serum |
| 101340-8 | Aeromonas sp DNA [Presence] in Stool by NAA with probe detection |
| 13297-7 | Coxsackievirus A1 Ab [Units/volume] in Serum |
| 101952-0 | MTTP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 102228-4 | Cherry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14053-3 | Homocystine [Presence] in Urine |
| 15156-3 | Cancer Ag 125 [Units/volume] in Body fluid by Dilution |
| 15505-1 | Salmonella pullorum Ab [Presence] in Serum by Agglutination |
| 10999-1 | Paramethadione [Mass/volume] in Serum or Plasma |
| 11610-3 | Heterophile Ab [Units/volume] in Serum |
| 1827-5 | Alpha 1 antitrypsin MS [Mass/volume] in Serum or Plasma |
| 7-5 | Amdinocillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 91670-0 | Orexin-A [Mass/volume] in Cerebral spinal fluid |
| 92521-4 | S Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 60459-5 | Complement C6.functional [Units/volume] in Serum or Plasma |
| 7591-1 | Chili Pepper IgE Ab [Units/volume] in Serum |
| 75975-3 | Fetal Chromosome 13+18+21 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
| 76028-0 | IDUA gene full mutation analysis in Blood or Tissue by Sequencing |
| 7606-7 | Pigweed triggered histamine release [Units/volume] in Blood |
| 76149-4 | Tulathromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 76410-0 | Band form neutrophils [#] in Body fluid by Manual count |
| 62375-1 | Microarray platform [Identifier] Narrative |
| 77254-1 | Microalbumin/Creatinine [Ratio] in 24 hour Urine by Detection limit <= 1.0 mg/L |
| 7758-6 | Veal triggered histamine release [Units/volume] in Blood |
| 77611-2 | C peptide [Moles/volume] in Serum or Plasma --4 hours post XXX challenge |
| 6315-6 | Bordetella pertussis Ab [Titer] in Serum by Agglutination |
| 63309-9 | Proteinase 3 Ab [Presence] in Body fluid by Immunoassay |
| 6449-3 | Legionella pneumophila Ag [Presence] in Specimen by Latex agglutination |
| 95110-3 | Insulin post fasting and meal stimulation panel - Serum or Plasma |
| 95146-7 | Hepatitis B virus core IgM panel - Serum or Plasma |
| 6516-9 | Human papilloma virus rRNA [Presence] in Specimen by NAA with probe detection |
| 6-7 | Amantadine [Susceptibility] |
| 8002-8 | Rickettsia typhus group IgM Ab [Units/volume] in Serum |
| 95769-6 | BMPR1A gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 9582-8 | Afipia felis IgG Ab [Titer] in Serum by Immunofluorescence |
| 96477-5 | IgLON5 IgG Ab [Titer] in Serum by Immunofluorescence |
| 96725-7 | Xanthoma cells [#/volume] in Lower respiratory specimen by Manual count |
| 96965-9 | CARD11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 69943-9 | Glucose [Moles/volume] in Serum or Plasma --20 minutes post 50 g lactose PO |
| 81764-3 | Docosatrienoate (C22:3w9) [Moles/volume] in Serum or Plasma |
| 97974-0 | Peanut recombinant (rAra h) 2 IgG4 Ab [Mass/volume] in Serum |
| 709-6 | Blasts/100 leukocytes in Blood by Manual count |
| 82399-7 | Ganglioside GD2 IgG Ab [Presence] in Serum by Line blot |
| 99904-5 | Urate crystals [#/area] in Urine sediment by Computer assisted method |
| 99925-0 | Artifact [#/volume] in Urine sediment by Computer assisted method |
| 72815-4 | DULoxetine/Creatinine [Mass Ratio] in Urine |
| 72874-1 | JWH-073 butanol (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
| 73018-4 | Furosemide induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73032-5 | cloNIDine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73150-5 | Simethicone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73711-4 | Food Allergen Mix 18 (Peanut+Soybean+Peas) IgE Ab [Units/volume] in Serum by Multidisk |
| 73837-7 | Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum |
| 88461-9 | Babesia microti and B. divergens+MO-1 and B. duncani 18S rRNA gene panel - Blood by NAA with non-probe detection |
| 74317-9 | PRRSV European strain RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 50793-9 | Protein.monoclonal band 4/Protein.total in Serum or Plasma by Electrophoresis |
| 31059-9 | Echovirus 4 Ab [Titer] in Body fluid by Complement fixation |
| 214-7 | cycloSERINE [Susceptibility] by Disk diffusion (KB) |
| 31437-7 | Influenza virus A IgG Ab [Units/volume] in Serum |
| 31953-3 | Rinderpest virus Ag [Presence] in Specimen |
| 43591-7 | Peach IgE Ab/IgE total in Serum |
| 22615-9 | Western equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid |
| 51963-7 | Medication assessed [ID] |
| 43887-9 | Bilirubin.total [Presence] in Amniotic fluid by Spectrophotometry direct |
| 44299-6 | Arginine/Creatinine [Mass Ratio] in 24 hour Urine |
| 23176-1 | Leptospira interrogans sv Copenhageni Ab [Presence] in Serum by Agglutination |
| 33046-4 | Tranquilizers [Presence] in Serum or Plasma by Screen method |
| 53387-7 | Trichinella spiralis IgG Ab [Titer] in Serum |
| 23369-2 | PRRSV Ag [Presence] in Specimen by Immune stain |
| 23501-0 | Tritrichomonas foetus Ab [Presence] in Genital mucus by Agglutination |
| 54413-0 | Transfuse leukocyte-poor plateletpheresis units [#] |
| 34424-2 | Salmonella typhimurium H Ab [Titer] in Serum |
| 55223-2 | Mycobacterium tuberculosis A60 IgM Ab [Presence] in Serum by Immunoassay |
| 47266-2 | Adenosine monophosphate.cyclic [Moles/volume] in Urine --5th specimen post XXX challenge |
| 55914-6 | Beta 1 globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis |
| 47616-8 | Estradiol (E2) [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin |
| 35671-7 | Galactomannan Ag [Units/volume] in Specimen |
| 35779-8 | Ceftibuten [Susceptibility] |
| 56222-3 | Chocolate IgG4 Ab [Mass/volume] in Serum |
| 4797-7 | HLA-B73 [Presence] |
| 48040-0 | Nucleated erythrocytes/100 leukocytes [Ratio] in Synovial fluid by Manual count |
| 26485-3 | Monocytes/100 leukocytes in Blood |
| 360-8 | Netilmicin [Susceptibility] by Disk diffusion (KB) |
| 3649-1 | Flupenthixol [Mass/volume] in Urine |
| 4887-6 | HLA-Dw19(w6) [Presence] |
| 26990-2 | Phentermine [Mass/volume] in Milk |
| 38252-3 | Calcium oxalate monohydrate/Total in Stone |
| 38646-6 | Catechol [Mass/volume] in Air |
| 57426-9 | CD71 cells/100 cells in Body fluid |
| 27853-1 | Lutropin [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 27887-9 | Follitropin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 39575-6 | Fungus.microscopic observation [Identifier] in Specimen by Periodic acid-Schiff stain |
| 58028-2 | Tetrahydrogestrinone [Presence] in Urine |
| 40044-0 | Glucose [Mass/volume] in Serum or Plasma --36 hours post XXX challenge |
| 40079-6 | Calcium [Mass/volume] in Serum or Plasma --13 hours post XXX challenge |
| 4008-9 | Pyrilamine [Mass/volume] in Serum or Plasma |
| 58384-9 | 6-Monoacetylmorphine (6-MAM)/Creatinine [Mass Ratio] in Urine |
| 40566-2 | Neutrophils [#/volume] in Body fluid by Manual count |
| 59039-8 | Amylase [Enzymatic activity/volume] in Peritoneal dialysis fluid |
| 50225-2 | Epithelial cells.non-squamous [Presence] in Urine by Automated |
| 30057-4 | Threonine/Creatinine [Ratio] in Urine |
| 30200-0 | Asialoganglioside GM1 IgM Ab [Presence] in Serum |
| 19169-2 | Carcinoembryonic Ag [Mass/volume] in Pleural fluid |
| 19754-1 | Red Currant IgE Ab [Units/volume] in Serum |
| 12482-6 | Ascorbate [Mass/volume] in Leukocytes |
| 12806-6 | Alkaline phosphatase.lung [Enzymatic activity/volume] in Serum or Plasma |
| 12993-2 | Hydrocarbons.chlorinated [Identifier] in Blood |
| 13372-8 | Homocystine [Mass/volume] in Cerebral spinal fluid |
| 101856-3 | prednisoLONE [Moles/volume] in Urine |
| 13711-7 | Aspartate/Creatinine [Mass Ratio] in Urine |
| 10233-5 | Oxygen content in Left atrium |
| 102401-7 | Latex glove extract IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102428-0 | Silver Maple IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1026-4 | Fy sup(a) Ag [Presence] on Red Blood Cells from Donor |
| 102686-3 | Green Bean IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103057-6 | Dog recombinant (rCan f) 2 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14948-4 | Vanillylmandelate/Creatinine [Molar ratio] in Urine |
| 15499-7 | Pseudorabies virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 11088-2 | Neuronal nuclear Ab [Presence] in Serum |
| 16439-2 | Benzene [Presence] in Blood |
| 16756-9 | Diamorphine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 17315-3 | Myelin basic protein Ab [Mass/volume] in Serum |
| 17368-2 | Norepinephrine [Mass/volume] in Plasma --standing |
| 1836-6 | Retinol binding protein [Mass/volume] in Serum or Plasma |
| 19064-5 | Benzodiazepines cutoff [Mass/volume] in Urine |
| 92764-0 | 7-Ketocholesterol [Moles/volume] in Serum or Plasma |
| 60413-2 | Brewer's yeast IgG Ab [Mass/volume] in Serum |
| 6065-7 | Celery IgE Ab [Units/volume] in Serum |
| 6078-0 | Cockroach IgE Ab [Units/volume] in Serum |
| 7598-6 | Perch IgG Ab [Units/volume] in Serum |
| 92932-3 | KIF6 gene.c.2155T>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 93363-0 | Plasma cell DNA content and proliferation panel - Bone marrow by Flow cytometry (FC) |
| 62304-1 | Fabry disease newborn screening panel |
| 77095-8 | MRPS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 93727-6 | Insulin [Moles/volume] in Serum or Plasma --post meal |
| 93973-6 | Iohexol [Mass/volume] in Urine |
| 94189-8 | APOA2 gene full mutation analysis in Blood or Tissue by Sequencing |
| 94473-6 | VEGFA gene c.-2578A>C and c.-2578A>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 79168-1 | Cherry recombinant (rPru av) 4 IgE Ab [Units/volume] in Serum |
| 7936-8 | Japanese encephalitis virus RNA [Presence] in Serum by NAA with probe detection |
| 95156-6 | Hepatitis E virus RNA [Presence] in Specimen by NAA with probe detection |
| 79625-0 | Aspartylglycine/Creatinine [Molar ratio] in Urine |
| 80210-8 | Beryllium [Mass/volume] in Body fluid |
| 80613-3 | Bicarbonate [Moles/volume] in Urine collected for unspecified duration |
| 80644-8 | Isopropyl methylphosphonate [Mass/volume] in Blood |
| 80894-9 | 2-Methyltyrosine/Creatinine [Molar ratio] in Urine |
| 81789-0 | English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum |
| 97297-6 | oxyMORphone Free [Presence] in Cord tissue by Confirmatory method |
| 82897-0 | Pregnanediolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
| 829-2 | Am Ag [Presence] on Red Blood Cells |
| 98238-9 | Platelet-derived growth factor B+BB [Mass/volume] in Serum or Plasma |
| 98488-0 | Liver fibrosis score in Serum Calculated by FIB4 |
| 98956-6 | Coccidioides immitis IgM Ab [Units/volume] in Specimen by Immunoassay |
| 99101-8 | Cancer Ag 242 [Units/volume] in Serum or Plasma |
| 99102-6 | Gastrin releasing polypeptide [Units/volume] in Serum or Plasma |
| 85341-6 | Pathology report reviewed [Identifier] in Specimen |
| 85371-3 | Neutrophil.fMLP stimulated.DHR mean fluorescence intensity in Control Blood by Flow cytometry (FC) |
| 99770-0 | Tumor necrosis factor.alpha [Mass/volume] in Cerebral spinal fluid |
| 99899-7 | Calcium oxalate dihydrate crystals [#/volume] in Urine sediment by Computer assisted method |
| 72589-5 | Alpha 2 globulin/Protein.total [Pure mass fraction] in Urine by Electrophoresis |
| 85792-0 | CD3+CD4+CD45RO+ cells [#/volume] in Blood |
| 86137-7 | Streptococcus pneumoniae Danish serotype 6A IgG Ab [Units/volume] in Serum |
| 86138-5 | Streptococcus pneumoniae Danish serotype 6A IgG Ab [Mass/volume] in Serum by Immunoassay |
| 73190-1 | Propoxyphene induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87587-2 | Tylosin [Mass/mass] in Specimen |
| 88198-7 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 74303-9 | Phenylalanine [Moles/volume] in DBS --post therapeutic diet |
| 74391-4 | Baclofen [Mass/volume] in Blood |
| 88600-2 | Influenza virus A RNA [Presence] in Pericardial fluid by NAA with probe detection |
| 88868-5 | Veterinary toxicology quantitative panel - Unspecified specimen |
| 89367-7 | von Willebrand factor.ristocetin cofactor inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
| 41508-3 | Streptococcus agalactiae Ag [Presence] in Body fluid |
| 41690-9 | Dalbavancin [Susceptibility] by Gradient strip |
| 59835-9 | Parathyrin.intact [Mass/volume] in Body fluid |
| 50799-6 | 7-Dehydrocholesterol [Moles/volume] in Body fluid |
| 50871-3 | Lead [Moles/mass] in Hair |
| 50953-9 | Phosphoethanolamine IgM Ab [Presence] in Serum or Plasma |
| 60002-3 | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 31238-9 | Infectious bronchitis virus Conn-42 Ab [Units/volume] in Serum |
| 31356-9 | Echovirus 4 Ab [Presence] in Serum |
| 51350-7 | CD57 cells/100 cells in Cerebral spinal fluid |
| 51400-0 | CD65w cells/100 cells in Blood |
| 51670-8 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --baseline |
| 43435-7 | Bartonella henselae and Bartonella quintana IgM panel - Cerebral spinal fluid |
| 43638-6 | Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma |
| 22432-9 | Neospora caninum Ab [Presence] in Serum |
| 22465-9 | Reovirus Ab [Titer] in Serum |
| 22487-3 | Rickettsia typhi IgA Ab [Units/volume] in Serum |
| 22773-6 | African horse sickness virus Ag [Presence] in Specimen by Immunoassay |
| 32316-2 | Follitropin [Units/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 52951-1 | Phencyclidine [Moles/volume] in Urine |
| 53061-8 | Ketones [Moles/volume] in Blood |
| 22956-7 | Burkholderia mallei Ab [Presence] in Serum |
| 32663-7 | Afipia felis IgM Ab [Presence] in Serum |
| 5347-0 | Schistosoma sp Ab [Units/volume] in Serum |
| 44585-8 | IgA IgG Ab [Presence] in Serum or Plasma |
| 53906-4 | Microscopic observation [Identifier] in Cerebral spinal fluid by Rhodamine-auramine fluorochrome stain |
| 44904-1 | Malignant cells/100 cells in Pericardial fluid |
| 23945-9 | Xylose [Moles/volume] in Blood --1 hour post 5 g xylose PO |
| 54032-8 | U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum |
| 54329-8 | Propionylcarnitine (C3)/Creatinine [Molar ratio] in Urine |
| 4619-3 | Hemoglobin Ranier [Presence] in Blood |
| 24498-8 | Chicken serum Ab [Presence] in Serum by Immune diffusion (ID) |
| 34468-9 | Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay |
| 3459-5 | chlordiazePOXIDE [Mass/volume] in Urine |
| 54914-7 | Hepatitis C virus core Ag [Units/volume] in Serum by Immunoassay |
| 54941-0 | Tungsten [Mass/volume] in Urine |
| 55361-0 | Osmolality of Urine--baseline |
| 35282-3 | Toxoplasma gondii IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 55879-1 | Homocystine [Moles/volume] in Body fluid |
| 47912-1 | Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose growth hormone releasing factor |
| 25805-3 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 25821-0 | Staphylococcus aureus enterotoxin A IgE Ab [Units/volume] in Serum |
| 2596-5 | Magnesium [Moles/volume] in Body fluid |
| 35705-3 | Adenovirus Ag [Presence] in Nasopharynx |
| 56145-6 | CD55+CD59 deficient RBC+Granulocytes [Interpretation] in Blood Narrative |
| 56156-3 | Candida albicans IgA and IgG and IgM Ab panel - Serum |
| 56176-1 | Apple IgG4 Ab [Mass/volume] in Serum |
| 56189-4 | Bayleaf IgG4 Ab [Mass/volume] in Serum |
| 56456-7 | Horse dander IgG4 Ab [Mass/volume] in Serum |
| 47953-5 | Thyrotropin [Units/volume] in Serum or Plasma --pre dose luteinizing releasing hormone IV |
| 47964-2 | MVK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 481-2 | Talampicillin [Susceptibility] by Disk diffusion (KB) |
| 48257-0 | Velvet grass triggered leukotriene release [Mass/volume] by Leukocytes |
| 26645-2 | BK virus Ab [Presence] in Serum |
| 56686-9 | Hydroxyproline Free/Creatinine [Ratio] in 24 hour Urine |
| 57092-9 | IgE [Units/volume] in Nasal fluid |
| 26882-1 | Homocystine [Moles/volume] in Amniotic fluid |
| 27093-4 | Leptospira sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 38306-7 | Heptachlor [Mass/volume] in Water |
| 38409-9 | SERPINA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 38443-8 | Blastomyces dermatitidis IgM Ab [Presence] in Serum by Immunoassay |
| 3863-8 | Norethandrolone [Presence] in Urine |
| 57329-5 | Influenza virus B IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 57403-8 | CD45RA cells/100 cells in Body fluid |
| 57677-7 | Mycoplasma pneumoniae IgG Ab [Presence] in Serum by Immunoassay --1st specimen |
| 57888-0 | Pregnanediol [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
| 57984-7 | Indinavir+Ritonavir [Susceptibility] by Phenotype method |
| 49647-1 | MJD gene allele 1 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 49650-5 | CACNA1A gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 28546-0 | Neisseria meningitidis serogroup A IgG Ab [Mass/volume] in Serum by Immunoassay |
| 39997-2 | Glucose [Mass/volume] in Serum or Plasma --pre XXX challenge |
| 40030-9 | Glucose [Mass/volume] in Serum or Plasma --16 minutes post XXX challenge |
| 40677-7 | Toxoplasma gondii IgG Ab [Presence] in Serum by Immunoassay |
| 50581-8 | Adenosine monophosphate.cyclic stimulation panel - Urine |
| 30251-3 | Glucose [Moles/volume] in Serum or Plasma --2.6 hours post dose glucose |
| 41045-6 | TYR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 20498-2 | Histoplasma capsulatum yeast phase Ab [Units/volume] in Serum by Complement fixation |
| 100051-2 | Ethambutol+rifAMPin [Susceptibility] |
| 100790-5 | Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum |
| 100805-1 | Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge |
| 100818-4 | Renin [Mass/volume] in Plasma --1st specimen post XXX challenge |
| 100982-8 | Varicella zoster virus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
| 12846-2 | Protein [Mass/volume] in Peritoneal dialysis fluid --4th specimen |
| 101100-6 | Ku Ag [Presence] on Red Blood Cells |
| 101302-8 | Leptospira sp DNA [Presence] in Blood by NAA with non-probe detection |
| 101455-4 | Mitochondrial metabolites panel - Serum or Plasma |
| 13088-0 | Complement total hemolytic CH100 [Units/volume] in Serum or Plasma |
| 101783-9 | Fusarium oxysporum DNA [Presence] in Specimen by NAA with probe detection |
| 13532-7 | Xanthochromia [Presence] of Cerebral spinal fluid Qualitative |
| 13892-5 | Nitrosonaphthol [Presence] in Urine |
| 102526-1 | Short Leaf Pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14362-8 | Microscopic observation [Identifier] in Throat by Gram stain |
| 103068-3 | Peach recombinant (rPru p) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103789-4 | Aeromonas and plesiomonas sp identified in Stool by Organism specific culture |
| 103791-0 | Infliximab and Infliximab Ab Panel - Serum or Plasma |
| 103832-2 | Naloxone [Presence] in Meconium |
| 103840-5 | Tapentadol [Presence] in Meconium |
| 104134-2 | Dementia evaluation panel - Cerebral spinal fluid |
| 104236-5 | 3-fluorophenmetrazine [Mass/volume] in Urine by Confirmatory method |
| 104374-4 | Corynebacterium ulcerans [Presence] in Upper respiratory specimen by Organism specific culture |
| 16529-0 | Campylobacter jejuni rRNA [Units/volume] in Serum by Probe |
| 1653-5 | 1-Methylhistidine [Mass/volume] in Urine |
| 12335-6 | Halothane [Presence] in Blood |
| 18945-6 | Methicillin [Susceptibility] |
| 74483-9 | Homocitrulline [Moles/volume] in Urine |
| 74924-2 | Nortriptyline [Mass/volume] in Serum or Plasma --trough |
| 92255-9 | Methicillin [Susceptibility] by Genotype method |
| 7681-0 | Common Sagebrush IgE Ab [Units/volume] in Serum |
| 92864-8 | Herpes simplex virus 1 and 2 DNA panel - Lower respiratory specimen by NAA with probe detection |
| 77107-1 | SARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77180-8 | Niobium [Mass/volume] in Urine |
| 63164-8 | Penicillium brevicompactum IgG Ab [Mass/volume] in Serum |
| 78818-2 | Citalopram cutoff [Mass/volume] in Urine for Confirmatory method |
| 94368-8 | Streptococcus agalactiae DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 79504-7 | Levulinate/Creatinine [Molar ratio] in Urine |
| 68934-9 | Heat shock protein 60 Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 96928-7 | Fodrin alpha subunit IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 69868-8 | Service comment 41 |
| 81710-6 | PTEN gene [Presence] in Cancer specimen by FISH |
| 82080-3 | Food Allergen Mix 9 (Kiwi+Melon+Banana+Almond+Grape) IgE Ab [Units/volume] in Serum by Multidisk |
| 7020-1 | Isoniazid [Susceptibility] by Gradient strip |
| 70853-7 | Burkholderia mallei DNA [Presence] in Specimen by NAA with probe detection |
| 712-0 | Eosinophils [#/volume] in Blood by Manual count |
| 82564-6 | Food Allergen Mix 77 (Kiwi+Cashew nut+Hazel nut+Tomato+Sesame seed) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 82739-4 | Dopamine receptor D1 IgG Ab [Titer] in Serum by Immunoassay |
| 82858-2 | 11-Deoxytetrahydrocorticosterone [Moles/volume] in Urine |
| 82890-5 | Meta methylhippurate+Ortho methylhippurate+Para methylhippurate/Creatinine [Molar ratio] in Urine |
| 82979-6 | Contactin-associated protein 2 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 98041-7 | Cortisone IgE Ab [Units/volume] in Serum |
| 72413-8 | BK virus subtype in Specimen by NAA with probe detection |
| 85844-9 | Beta-lactam resistance ESBL blaCTX-M-2 Group gene [Presence] by Molecular method |
| 86039-5 | Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum |
| 73682-7 | CYP2D6 gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 74373-2 | cloNIDine [Mass/volume] in Unknown substance |
| 41212-2 | West Nile virus RNA [Presence] in Serum from Donor by NAA with probe detection |
| 41222-1 | Yeast [Presence] in Body fluid by Light microscopy |
| 41712-1 | Ramoplanin [Susceptibility] by Disk diffusion (KB) |
| 59731-0 | Oxazepam [Mass/mass] in Stool by Confirmatory method |
| 50862-2 | Hydrogen ion [Moles/volume] in Cord blood |
| 59951-4 | Pentazocine [Moles/volume] in Urine |
| 21264-7 | Estriol (E3).unconjugated [Multiple of the median] adjusted in Serum or Plasma |
| 51305-1 | CD4+CD7- cells/100 cells in Body fluid |
| 31744-6 | Bovine herpesvirus 1 Ag [Presence] in Genital specimen |
| 31813-9 | Epizootic hemorrhagic disease virus Ag [Presence] in Lung |
| 31926-9 | Parainfluenza virus 2 Ag [Presence] in Specimen |
| 43402-7 | Erythrocyte sedimentation rate by 15 minute reading |
| 32076-2 | Glutethimide [Moles/volume] in Serum or Plasma |
| 32250-3 | Hydroxyproline [Moles/volume] in Vitreous fluid |
| 52993-3 | Cytoplasmic CD79a cells/100 cells in Bone marrow |
| 43978-6 | Varicella zoster virus Ab [Presence] in Serum by Immunoassay |
| 2302-8 | Fumarase [Enzymatic activity/volume] in Serum |
| 44514-8 | Herpes simplex virus Ag [Presence] in Cerebral spinal fluid by Immunoassay |
| 4483-4 | Complement C1s [Mass/volume] in Serum or Plasma |
| 53845-4 | BTD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 23723-0 | Feline immunodeficiency virus Ab [Presence] in Serum by Immunoassay |
| 2387-9 | Glycerol [Mass/volume] in Serum or Plasma |
| 23952-5 | Asialoganglioside GM1 IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay |
| 34208-9 | 11-Hydroxyandrosterone [Moles/volume] in Urine |
| 2414-1 | Hippurate [Mass/time] in 24 hour Urine |
| 25232-0 | Nafcillin [Mass/volume] in Specimen |
| 35087-6 | Amino acids panel - Urine |
| 25844-2 | Alanine/Creatinine [Molar ratio] in 24 hour Urine |
| 26031-5 | Sialate.lipid bound [Moles/volume] in Serum or Plasma |
| 47966-7 | NCF2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 35815-0 | Gemifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 48411-3 | Fungus identified in Tissue by Immune stain |
| 38280-4 | Lymphocyte proliferation stimulated by 5.0 ug/mL Candida albicans [Units/volume] in Blood |
| 3838-0 | Nadolol [Mass/time] in 24 hour Urine |
| 38641-7 | Ethyl bromide [Mass/volume] in Air |
| 489-5 | Temafloxacin [Susceptibility] by Disk diffusion (KB) |
| 4911-4 | HLA-Dw5 [Presence] |
| 49136-5 | Creatine kinase.MB/Creatine kinase.total [Ratio] in Serum or Plasma |
| 49262-9 | Fatty acids pattern [Interpretation] in Serum or Plasma Narrative |
| 39487-4 | PHENobarbital [Moles/volume] in Urine |
| 57772-6 | Metanephrine.free and Normetanephrine.free panel [Moles/volume] - Serum or Plasma |
| 40135-6 | Creatinine [Moles/volume] in Urine --1 hour post XXX challenge |
| 58632-1 | Cortisol [Moles/volume] in Saliva (oral fluid) --1.5 hours post 1 ug/kg CRH IV |
| 58649-5 | Cortisol [Moles/volume] in Saliva (oral fluid) --15 minutes post 1 ug/kg CRH IV |
| 40715-5 | Immature granulocytes [Presence] in Blood |
| 19346-6 | Amphetamine [Mass/volume] in Urine |
| 20965-0 | Somatic cells [#/volume] in Milk |
| 12783-7 | Oligoclonal bands [Interpretation] in Serum or Plasma |
| 12919-7 | Monoamine oxidase [Enzymatic activity/volume] in Blood |
| 13755-4 | Histamine/Creatinine [Mass Ratio] in Urine |
| 102427-2 | Red Maple IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102791-1 | Green Pepper IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102944-6 | London Plane IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14454-3 | Virus identified in Nose by Culture |
| 14542-5 | Measles virus Ag [Presence] in Urine sediment by Immunofluorescence |
| 14690-2 | N-desalkylflurazepam [Moles/volume] in Serum or Plasma |
| 104175-5 | Clostridium tetani toxin TeNT gene [Presence] in Specimen by NAA with non-probe detection |
| 10684-9 | Hydatid cyst identified in Liver by Wet preparation |
| 16569-6 | cefTRIAXone IgE Ab [Mass/volume] in Serum |
| 16679-3 | Coxsackievirus A Ab [Units/volume] in Serum |
| 11584-0 | Aureobasidium pullulans Ab [Presence] in Serum |
| 12258-0 | Epithelial cells.squamous [Presence] in Urine sediment by Light microscopy |
| 16898-9 | Giardia lamblia 65 Ag [Presence] in Stool |
| 17557-0 | Saccharomonospora viridis IgG Ab [Units/volume] in Serum |
| 1757-4 | Albumin renal clearance in 24 hour Urine and Serum or Plasma |
| 17812-9 | Alpha 1 globulin/Protein.total in Body fluid by Electrophoresis |
| 17939-0 | Bacteria # 4 identified in Burn by Culture |
| 17945-7 | Bacteria # 5 identified in Line specimen by IV Line culture |
| 18943-1 | Meropenem [Susceptibility] |
| 91869-8 | Bordetella pertussis DNA [Presence] in Throat by NAA with probe detection |
| 60476-9 | Stage [Type] in Tick |
| 6058-2 | Canary grass IgE Ab [Units/volume] in Serum |
| 7642-2 | Rabbit meat IgE Ab [Units/volume] in Serum |
| 61338-0 | Egg white IgE Ab/IgE total in Serum |
| 6160-6 | Lepidoglyphus destructor IgE Ab [Units/volume] in Serum |
| 6188-7 | Nutmeg IgE Ab [Units/volume] in Serum |
| 77624-5 | SMAD4 gene full mutation analysis in Blood or Tissue by Sequencing |
| 93874-6 | Borrelia miyamotoi IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 6278-6 | White Ash IgE Ab [Units/volume] in Serum |
| 78353-0 | Hexadecadienoate (C16:2) [Entitic substance] in Red Blood Cells |
| 94639-2 | SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Specimen by NAA with probe detection |
| 7937-6 | Junin virus Ab [Presence] in Serum by Immunoassay |
| 95662-3 | Japanese encephalitis virus IgA Ab [Presence] in Specimen by Immunoassay |
| 6633-2 | Wuchereria bancrofti Ab [Presence] in Serum by Immunoassay |
| 79638-3 | Beta alanine and Beta aminoisobutyrate and Gamma aminobutyrate pattern [Interpretation] in Serum or Plasma Narrative |
| 95950-2 | Arnica montana IgE Ab [Units/volume] in Serum |
| 96367-8 | Pregabalin [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 69801-9 | 2-Oxoadipate [Moles/volume] in Cerebral spinal fluid |
| 81801-3 | 16-Alpha hydroxydehydroepiandrosterone/Creatinine [Molar ratio] in Urine |
| 8211-5 | Opiates [Presence] in Gastric fluid by Confirmatory method |
| 97934-4 | Toscana virus RNA [Presence] in Specimen by NAA with probe detection |
| 7093-8 | Arrowroot IgE Ab [Units/volume] in Serum |
| 82464-9 | Mosquito count [#] in Environmental specimen |
| 82480-5 | TRBV29 gene segments/TRBV gene segments.total in Blood |
| 97994-8 | Platelets Large/Platelets in Blood by Automated count.optical |
| 842-5 | A1 Ag [Presence] on Red Blood Cells from Blood product unit |
| 73034-1 | Clindamycin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73308-9 | Levodopa induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86930-5 | Carbapenemase [Presence] in Isolate |
| 7377-5 | Sweet Vernal grass triggered histamine release [Units/volume] in Blood |
| 74233-8 | Blasts assessment in Bone marrow Narrative |
| 893-8 | Blood group antibody screen.autologous [Interpretation] in Serum or Plasma |
| 89530-0 | Histone Ab [Presence] in Cerebral spinal fluid by Line blot |
| 41750-1 | COCH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 50837-4 | Calcium.ionized [Moles/volume] in Body fluid |
| 50872-1 | Lithium [Moles/mass] in Hair |
| 4266-3 | Furosemide [Mass] of Dose |
| 42676-7 | Spermatozoa Normal Motile [#/volume] in Semen |
| 21328-0 | Beta-N-acetylhexosaminidase A and B [Interpretation] in Blood |
| 21518-6 | SCL-70 extractable nuclear IgG Ab [Presence] in Serum |
| 51274-9 | CD3+CD16+ cells/100 cells in Tissue |
| 51381-2 | HLA-DR+ cells/100 cells in Body fluid |
| 5139-1 | Echovirus 19 Ab [Titer] in Serum by Complement fixation |
| 218-8 | Demeclocycline [Susceptibility] by Disk diffusion (KB) |
| 22255-4 | Eastern equine encephalitis virus Ab [Presence] in Cerebral spinal fluid |
| 31625-7 | Sjogrens syndrome-A extractable nuclear IgG Ab [Presence] in Serum |
| 43225-2 | Toxocara sp Ab [Units/volume] in Serum by Immunoassay |
| 22522-7 | Salmonella paratyphi B H Ab [Titer] in Serum |
| 22529-2 | Salmonella typhi H Ab [Presence] in Serum |
| 22688-6 | Threonine/Creatinine [Molar ratio] in Urine |
| 22866-8 | Bacillus anthracis Ag [Presence] in Tissue by Immunofluorescence |
| 32776-7 | Erythrocytes [Presence] in Urine sediment by Light microscopy |
| 33221-3 | Epithelial cells.renal [#/area] in Urine by Computer assisted method |
| 533-0 | Mycobacterium sp identified in Blood by Organism specific culture |
| 23475-7 | Theileria parva Ab [Presence] in Serum by Immunofluorescence |
| 44919-9 | Glucose [Moles/volume] in Serum or Plasma --1.5 hours post meal |
| 45059-3 | Ehrlichia chaffeensis IgG and IgM panel [Titer] - unspecified time Serum by Immunofluorescence |
| 45315-9 | Coproporphyrin 3/Creatinine [Molar ratio] in Urine |
| 33803-8 | Immature eosinophils/100 leukocytes in Blood by Manual count |
| 54208-4 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor V depleted plasma+APC |
| 46402-4 | Corticotropin [Mass/volume] in Plasma --2 hours post 1 ug/kg CRH IV |
| 4658-1 | Kallikrein Tissue type [Units/volume] in Plasma |
| 466-3 | sulfADIAZINE [Susceptibility] by Serum bactericidal titer |
| 55314-9 | Yeast [Presence] in Nail by KOH preparation |
| 47098-9 | Chromium [Moles/volume] in Body fluid |
| 47108-6 | Furosemide [Presence] in Gastric fluid |
| 25108-2 | Hydroxydecanedioate/Creatinine [Molar ratio] in Urine |
| 3525-3 | cycloSPORINE [Mass/volume] in Blood --24 hours post dose |
| 556-1 | Chlamydia sp identified in Conjunctival specimen by Organism specific culture |
| 48177-0 | Streptomycin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 48305-7 | Coproporphyrin 1/Creatinine [Mass Ratio] in Urine |
| 56982-2 | Somatotropin [Mass/volume] in Serum or Plasma --90 minutes post resting |
| 56984-8 | Taenia solium larva Ab [Presence] in Serum by Immunoassay |
| 48877-5 | Anaplasma phagocytophilum IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 27052-0 | Methadone [Mass/volume] in Milk |
| 27107-2 | Lysine [Moles/volume] in Amniotic fluid |
| 3856-2 | Nikethamide [Mass/volume] in Urine |
| 57578-7 | Androstanolone [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
| 28061-0 | Naloxone [Mass/volume] in Serum or Plasma |
| 39583-0 | Mercury [Presence] in Hair |
| 4019-6 | quiNINE [Mass/volume] in Serum or Plasma |
| 58589-3 | Corticotropin [Mass/volume] in Plasma --30 minutes pre dose glucagon |
| 49842-8 | CD19+IgA+ cells/100 cells in Specimen |
| 40382-4 | Methaqualone [Presence] in Gastric fluid |
| 58933-3 | Endothelial cell Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 58981-2 | Timothy recombinant (rPhl p) 5b IgE Ab [Units/volume] in Serum |
| 40827-8 | Histoplasma capsulatum Ab [Presence] in Body fluid |
| 19303-7 | Thiazides [Presence] in Urine by Screen method |
| 1235-1 | Mi sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 100153-6 | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |
| 12862-9 | Borrelia burgdorferi 66kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 12880-1 | Borrelia burgdorferi 58kD Ab [Presence] in Body fluid by Immunoblot |
| 101255-8 | Herpes virus 6 DNA [Units/volume] (viral load) in Blood by NAA with probe detection |
| 101481-0 | cefTAZidime [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 13260-5 | Leishmania mexicana IgG Ab [Units/volume] in Serum |
| 13433-8 | DOPamine [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 13439-5 | Protein Fractions [Interpretation] in Cerebral spinal fluid by Electrophoresis |
| 102090-8 | Ceruloplasmin [Mass/volume] in 24 hour Urine |
| 102317-5 | Fusarium culmorum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1025-6 | Fy sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 1051-2 | Hemolytic disease of newborn screen [Interpretation] in Blood |
| 1568-5 | Insulin [Mass/volume] in Serum or Plasma --4 hours post 75 g glucose PO |
| 16184-4 | Temazepam [Mass/volume] in Stool |
| 1630-3 | Somatotropin [Mass/volume] in Serum or Plasma --2 hours post 1 g/kg glucose PO |
| 1742-6 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma |
| 90743-6 | CYBB gene full and NCF1 gene c.75_76delGT analysis in Blood or Tissue by Molecular genetics method |
| 74586-9 | Coenzyme Q cytochrome C reductase (Complex III) [Enzymatic activity/mass] in Tissue |
| 92637-8 | traZODone [Mass/volume] in Urine by Confirmatory method |
| 92646-9 | Dextromethorphan [Presence] in Urine by Confirmatory method |
| 7570-5 | Pea IgG Ab [Units/volume] in Serum |
| 76134-6 | Sucrose [Moles/time] in 5 hour Urine --post XXX g sugar solution PO |
| 92828-3 | Adenovirus B+E DNA [Presence] in Specimen by NAA with probe detection |
| 93022-2 | Multiple myeloma minimal residual disease panel - Bone marrow by Flow cytometry (FC) |
| 93391-1 | Stenotrophomonas maltophilia DNA [Presence] by NAA with probe detection in Positive blood culture |
| 61229-1 | Silver Birch recombinant (rBet v) 1 IgE Ab/IgE total in Serum |
| 61305-9 | Mesquite IgE Ab/IgE total in Serum |
| 6174-7 | Milk IgE Ab [Units/volume] in Serum |
| 6239-8 | Lenscale IgE Ab [Units/volume] in Serum |
| 7869-1 | Echovirus 4 Ab [Units/volume] in Serum |
| 94577-4 | Maximum amplitude arachidonate induced [Length] in Blood by Resonance TEG |
| 94613-7 | Bovine respiratory syncytial virus Ag [Presence] in Tissue by Immune stain |
| 78873-7 | oxyCODONE [Z-score] in Urine |
| 7940-0 | La Crosse virus IgG Ab [Units/volume] in Serum |
| 79482-6 | 3-(3-Hydroxyphenyl)propanoate/Creatinine [Molar ratio] in Urine |
| 95142-6 | Hepatitis A virus IgM panel - Serum |
| 6578-9 | Vibrio sp identified in Blood by Organism specific culture |
| 67561-1 | Corynebacterium diphtheriae DNA [Presence] in Specimen by NAA with probe detection |
| 80693-5 | HIV 1 proviral DNA reverse transcriptase and protease and integrase gene mutations detected [Identifier] in Blood mononuclear cells by Sequencing |
| 81142-2 | PTPN22 gene.c.1858C>T [Presence] in Blood or Tissue by Molecular genetics method |
| 81179-4 | Histologic type of Stomach cancer by Lauren classification |
| 81878-1 | Subtelomere analysis in Blood or Tissue by Molecular genetics method |
| 8192-7 | Benzoylecgonine [Presence] in Urine by SAMHSA confirm method |
| 82138-9 | GJB2 gene c.35delG targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 97612-6 | Candida sp DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 97956-7 | Lysozyme IgG4 Ab [Mass/volume] in Serum |
| 82870-7 | Au sup(b) Ab [Presence] in Serum or Plasma |
| 9824-4 | Mycobacterium sp identified in Gastric fluid by Organism specific culture |
| 71833-8 | Hematocrit [Pure volume fraction] of Blood by Automated count |
| 723-7 | Hemoglobin [Mass/volume] in Peritoneal fluid |
| 99439-2 | Cashew nut recombinant (rAna o) 3 IgG4 Ab [Mass/volume] in Serum |
| 99461-6 | Rat epithelium, serum proteins + urine proteins IgG Ab [Mass/volume] in Serum |
| 72834-5 | Foscarnet [Susceptibility] by Phenotype method |
| 87361-2 | Toxoplasma gondii Ab/Negative control in Serum or Plasma by Immunoassay |
| 73702-3 | Neisseria meningitidis serosubtype [Type] in Isolate by Immunoassay |
| 87928-8 | Macroscopic observation [Interpretation] in Stool Narrative |
| 7433-6 | Juniper triggered histamine release [Units/volume] in Blood |
| 74374-0 | 2,4,4'-Trichlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
| 74388-0 | Normirtazapine [Mass/volume] in Body fluid |
| 892-0 | Blood group antibody screen.cell III [Presence] in Serum or Plasma |
| 41257-7 | Xylose [Mass/volume] in Urine --2 hours post 25 g xylose PO |
| 30522-7 | C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method |
| 31096-1 | Tobramycin [Mass/volume] in Serum or Plasma --random post extended interval dosing |
| 21242-3 | Protoporphyrin [Mass/time] in unspecified time Stool |
| 51097-4 | CD179a blasts/100 blasts in Specimen |
| 43711-1 | Albumin [Presence] in Cerebral spinal fluid |
| 22410-5 | Lymphocytic choriomeningitis virus IgG Ab [Titer] in Serum |
| 43924-0 | azaTHIOprine [Presence] in Serum or Plasma |
| 22798-3 | Anaplasma marginale rRNA [Presence] in Tissue by Probe |
| 22802-3 | Infectious bronchitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 23050-8 | Eastern equine encephalitis virus Ag [Presence] in Specimen by Neutralization test |
| 32643-9 | Dextromethamphetamine/Levomethamphetamine [Mass Ratio] in Serum or Plasma |
| 33062-1 | Blood group antigens tested for on Red Blood Cells |
| 5344-7 | Salmonella paratyphi C O Ab [Presence] in Serum by Latex agglutination |
| 4446-1 | Tocainide [Mass] of Dose |
| 2328-3 | Gastrin releasing polypeptide [Moles/volume] in Cerebral spinal fluid |
| 23332-0 | Ovine progressive pneumonia virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 3347-2 | Diethylpropion [Mass/time] in 24 hour Urine |
| 33723-8 | Specimen length |
| 45116-1 | Mycobacterium gordonae rRNA [Presence] in Specimen by NAA with probe detection |
| 23737-0 | Feline panleukopenia virus Ab [Titer] in Serum |
| 33755-0 | Distance of carcinoma from deep margin [Length] in Specimen |
| 33957-2 | Normoblasts/100 blasts in Blood |
| 33990-3 | Normoblasts/100 leukocytes in Blood |
| 46130-1 | Prealbumin [Mass/volume] in Serum or Plasma by Nephelometry |
| 4614-4 | Hemoglobin N - Baltimore [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 46992-4 | DYS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 3441-3 | Cefamandole [Mass/volume] in Serum or Plasma |
| 4713-4 | HLA-A10 [Presence] in Donor |
| 34919-1 | Sezary cells/100 leukocytes in Blood |
| 35341-7 | ASPA gene p.Ala305Glu [Presence] in Blood or Tissue by Molecular genetics method |
| 47686-1 | Linoleate (C18:2w6)/Creatinine [Molar ratio] in Urine |
| 25650-3 | Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --7th specimen post XXX challenge |
| 35695-6 | California encephalitis virus IgM Ab [Titer] in Serum |
| 3584-0 | Doxepin [Mass/volume] in Serum or Plasma --trough |
| 56594-5 | Thyrotropin [Units/volume] in Serum or Plasma --3 hours post XXX challenge |
| 2706-0 | Oxygen [Partial pressure] in Body fluid |
| 39546-7 | Lobster IgE Ab/IgE total in Serum |
| 5788-5 | Oval fat bodies (globules) [#/area] in Urine sediment by Microscopy high power field |
| 49528-3 | Influenza virus A H9 RNA [Presence] in Specimen by NAA with probe detection |
| 29257-3 | Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection |
| 5874-3 | Respiratory syncytial virus Ag [Presence] in Throat by Immunoassay |
| 4053-5 | Thioridazine [Mass/volume] in Urine |
| 40718-9 | Heinz bodies/100 erythrocytes in Blood |
| 58925-9 | Dextromethamphetamine [Presence] in Urine |
| 5019-5 | HTLV I+II RNA [Presence] in Specimen by NAA with probe detection |
| 50254-2 | Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --2nd specimen fasting |
| 50379-7 | Creatinine dialysis fluid clearance/1.73 sq M |
| 30128-3 | Borrelia burgdorferi Ab [Units/volume] in Serum --2nd specimen |
| 30372-7 | Sucrase [Enzymatic activity/mass] in Small intestine Tissue |
| 20758-9 | Cholinesterase [Enzymatic activity/mass] in Brain |
| 20775-3 | Colony count [Units/volume] in Specimen by Viability count FDA method |
| 100437-3 | Norsufentanil [Mass/volume] in Urine by Confirmatory method |
| 12496-6 | Butabarbital [Presence] in Stool |
| 12763-9 | Insulin [Mass/volume] in Serum or Plasma --19 minutes post XXX challenge |
| 13374-4 | Hydroxyproline [Mass/volume] in Cerebral spinal fluid |
| 102031-2 | Ki-67 Nuclear Ag and p16INK4a Ag Ag [Presence] in Cervix by Immune stain |
| 102076-7 | Insulin [Units/volume] in Serum or Plasma --3.5 hours post 75 g glucose PO |
| 13610-1 | 3-Beta-Androstanediol [Mass/volume] in Serum or Plasma |
| 102782-0 | Papain IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102814-1 | Scallop IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10336-6 | Gonadotropin peptide [Mass/volume] in Urine |
| 1503-2 | Glucose [Mass/volume] in Urine --1 hour post 100 g glucose PO |
| 15058-1 | DOPamine [Moles/volume] in Urine |
| 104436-1 | Polio virus 1 Ab [Titer] in Serum by Immunoassay --1st specimen |
| 10778-9 | Microscopic observation [Identifier] in Tissue by Butyrate esterase stain |
| 10788-8 | Microscopic observation [Identifier] in Tissue by Hansel stain |
| 10997-5 | O-desmethylencainide [Mass/volume] in Serum or Plasma |
| 17367-4 | Nomifensine [Mass/volume] in Serum or Plasma |
| 19152-8 | Specimen specific gravity acceptable [Presence] in Urine |
| 90070-4 | Gram positive catalase producing cocci identified in Isolate by Organism specific culture |
| 90295-7 | RalA Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 90321-1 | Aichivirus C RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 90899-6 | HIV 1 proviral DNA reverse transcriptase and protease gene [Nucleotide sequence] in Blood mononuclear cells by Sequencing |
| 7447-6 | Lactoglobulin IgG Ab [Units/volume] in Serum |
| 91792-2 | Rubella virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 7579-6 | Pear Pollen IgE Ab [Units/volume] in Serum |
| 768-2 | Segmented neutrophils [#/volume] in Blood by Manual count |
| 77069-3 | AGA gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 93936-3 | little c Ag [Presence] on Red Blood Cells --during infancy |
| 94218-5 | UBE3A gene full mutation analysis in Blood or Tissue by Sequencing |
| 95366-1 | Date of first positive specimen collection |
| 80398-1 | Unique identifier for Current sample |
| 68389-6 | DNA double strand IgG Ab [Units/volume] in Synovial fluid by Immunoassay |
| 97098-8 | SARS-CoV-2 (COVID-19) Nsp2 gene [Presence] in Upper respiratory specimen by NAA with probe detection |
| 82056-3 | Food Allergen Mix 14 (Cabbage+Paprika+Tomato+Spinach) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 82246-0 | Chromosome region 22q11.2 deletion and duplication mutation analysis in Blood or Tissue by FISH |
| 97611-8 | Candida albicans DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 9768-3 | Lymphocytic choriomeningitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 97859-3 | Fungal Ab panel - Specimen by Complement fixation |
| 71638-1 | Unidentified cells/Leukocytes [Pure number fraction] in Body fluid by Manual count |
| 9842-6 | Casts [#/area] in Urine sediment by Microscopy low power field |
| 71693-6 | Platelets reticulated/100 platelets in Blood by Automated count |
| 72201-7 | Influenza virus A matrix protein segment sequence identifier |
| 83071-1 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay |
| 85545-2 | PRRSV North American strain RNA [Presence] in Specimen by NAA with probe detection |
| 99366-7 | Chicken meat IgG Ab [Mass/volume] in Serum |
| 73418-6 | Digoxin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88139-1 | Bacteria identified in Ocular fluid by Anaerobe culture |
| 88723-2 | Asialoganglioside GM1 IgG+IgM Ab [Units/volume] in Serum by Immunoassay |
| 41746-9 | Blastomyces dermatitidis Ag [Presence] in Urine by Immunoassay |
| 30990-6 | Aspergillus fumigatus recombinant (rAsp f) 2 IgE Ab [Units/volume] in Serum |
| 60155-9 | Pentoxifylline [Mass/volume] in Urine |
| 60161-7 | Phenacemide [Mass/volume] in Blood |
| 21586-3 | Uranium [Mass/time] in 24 hour Urine |
| 51139-4 | Cytoplasmic CD3 blasts/100 blasts in Specimen |
| 2199-8 | Delta aminolevulinate [Mass/volume] in Serum |
| 31628-1 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Serum |
| 31943-4 | Pneumocystis jiroveci Ag [Presence] in Specimen |
| 32004-4 | Chlamydia sp Ag [Presence] in Urine by Immunoassay |
| 43336-7 | Goose parvovirus Ab [Presence] in Serum by Immunofluorescence |
| 321-0 | Methacycline [Susceptibility] by Serum bactericidal titer |
| 52982-6 | Echinococcus sp IgG1 Ab [Units/volume] in Serum by Immunoassay |
| 44043-8 | Basophils [Presence] in Pleural fluid by Light microscopy |
| 44085-9 | Xylose absorption [Interpretation] in Urine and Serum or Plasma |
| 22892-4 | Bovine diarrhea virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 23168-8 | Leptospira borgpetersenii sv Ballum Ab [Presence] in Serum by Agglutination |
| 53141-8 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 53341-4 | 21-Deoxycortisol [Mass/volume] in DBS |
| 44830-8 | Phosphorylase [Enzymatic activity/volume] in Blood |
| 2325-9 | Gamma glutamyl transferase/Aspartate aminotransferase [Enzymatic activity ratio] in Serum or Plasma |
| 23446-8 | Swine vesicular disease virus Ag [Presence] in Specimen by Complement fixation |
| 23447-6 | Swine vesicular disease virus Ag [Presence] in Skin by Immunoassay |
| 23476-5 | Theileria parva Ab [Titer] in Serum by Immunofluorescence |
| 33640-4 | Lymphocyte proliferation stimulated by tetanus toxoid [Units/volume] in Blood |
| 44912-4 | Beta 2 globulin+Gamma globulin/Protein.total in Serum or Plasma by Electrophoresis |
| 45154-2 | Phenylalanine hydroxylase Ab [Units/volume] in Serum |
| 45269-8 | Chronic leukemia panel - Specimen by Flow cytometry (FC) |
| 45308-4 | Heptacarboxylate [Moles/mass] in Stool |
| 45336-5 | Bacteria producing hemolysis [Presence] in Isolate |
| 23744-6 | Giardia lamblia Ag [Presence] in Specimen by Immunofluorescence |
| 34166-9 | Microscopic observation [Identifier] in Specimen by Electron microscopy |
| 54291-0 | Heptanoylcarnitine (C7) [Moles/volume] in Cerebral spinal fluid |
| 24322-0 | Comprehensive metabolic 1998 panel - Serum or Plasma |
| 47397-5 | BCS1L gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 34924-1 | Immature monocytes [#/volume] in Blood |
| 25940-8 | Leptospira borgpetersenii sv Sejroe Ab [Titer] in Serum by Complement fixation |
| 35537-0 | Wheat IgG Ab [Mass/volume] in Serum |
| 3565-9 | Dimetamphetamine [Mass/volume] in Urine |
| 26707-0 | Aluminum [Mass/time] in 24 hour Urine |
| 3581-6 | Doxepin [Mass/volume] in Urine |
| 56698-4 | Atropine IgE Ab [Units/volume] in Serum |
| 26899-5 | Midazolam [Mass/volume] in Vitreous fluid |
| 27166-8 | TOLAZamide [Mass/volume] in Urine |
| 38608-6 | Methyl bromide [Mass/volume] in Air |
| 2729-2 | Parathyrin related protein [Mass/volume] in Serum or Plasma |
| 27296-3 | Arginine [Moles/volume] in Urine |
| 27945-5 | Coxiella burnetii phase 2 Ab [Titer] in Serum by Immunofluorescence |
| 49665-3 | HIV susceptibility panel by Phenotype method |
| 5857-8 | Herpes simplex virus identified in Isolate by Immunofluorescence |
| 49976-4 | Borrelia burgdorferi 34kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 40489-7 | Histiocytes/100 cells in Synovial fluid by Manual count |
| 40502-7 | Saint Louis encephalitis virus Ab [Titer] in Serum by Complement fixation |
| 59230-3 | Prostate specific Ag [Mass/volume] in Cerebral spinal fluid |
| 30290-1 | Delavirdine [Susceptibility] by Genotype method |
| 40866-6 | 11-Oxo-Androsterone/Creatinine [Mass Ratio] in 24 hour Urine |
| 40952-4 | Yellow Jacket IgG4 Ab [Presence] in Serum |
| 41080-3 | Myotonic dystrophy gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2026-3 | Carbon dioxide, total [Moles/volume] in Arterial blood |
| 21004-7 | Glucose tolerance [Interpretation] in Serum or Plasma |
| 12365-3 | dimenhyDRINATE [Presence] in Urine |
| 13583-0 | Thioridazine [Presence] in Serum or Plasma |
| 13799-2 | Proline/Creatinine [Mass Ratio] in Urine |
| 14277-8 | Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence |
| 102844-8 | Wheat dust IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102882-8 | Neurospora sitophila IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103069-1 | Peach recombinant (rPru p) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15175-3 | Cryoproteins [Interpretation] in Serum or Plasma by Electrophoresis agarose gel |
| 15184-5 | IgG [Presence] in Serum by Immunoelectrophoresis |
| 10653-4 | Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 12234-1 | Mesothelial cells/100 leukocytes in Body fluid by Manual count |
| 16800-5 | Echovirus 19 Ab [Units/volume] in Serum by Complement fixation |
| 16804-7 | Echovirus 40 Ab [Units/volume] in Serum |
| 18860-7 | Amikacin [Susceptibility] |
| 90234-6 | Globotriaosylsphingosine [Mass/volume] in Serum or Plasma |
| 90462-3 | Zika virus RNA [Presence] in Cord blood by NAA with probe detection |
| 90843-4 | PCA-2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 91050-5 | Methadone+Metabolite [Presence] in Tissue by Screen method |
| 74853-3 | HIV 1 proviral DNA [Presence] in Specimen by NAA with probe detection |
| 76584-2 | Enterococcus faecalis cpn60 gene [Presence] in Swab specimen by NAA with probe detection |
| 9326-0 | Phosphatidylserine IgG Ab [Presence] in Serum by Immunoassay |
| 77037-0 | t(11;14)(q13;q32)(CCND1,IGH) fusion transcript in Blood or Tissue by FISH |
| 93880-3 | N-Nervonoylsphingosine [Moles/volume] in Plasma |
| 7860-0 | Eastern equine encephalitis virus IgG Ab [Units/volume] in Serum |
| 63486-5 | Nut allergen panel - Serum |
| 95157-4 | Salmonella gallinarum+Salmonella pullorum Ab [Presence] in Serum, Plasma or Blood by Agglutination |
| 79501-3 | 3-Hydroxyhippurate/Creatinine [Molar ratio] in Urine |
| 96289-4 | Morphine IgE Ab [Units/volume] in Serum |
| 80537-4 | Methylenedioxymethamphetamine [Mass/mass] in Hair |
| 9671-9 | Plasmodium malariae IgM Ab [Units/volume] in Serum |
| 69821-7 | 2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --6 days post dose ifosfamide |
| 71651-4 | Macrophages/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
| 98251-2 | Stage [Type] in Endometrial cancer specimen by FIGO |
| 85339-0 | Progesterone receptor Ag [Presence] in Breast cancer specimen by Immune stain |
| 85546-0 | PRRSV European strain RNA [Presence] in Specimen by NAA with probe detection |
| 99128-1 | PLCG2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 99367-5 | Cocoa IgG Ab [Mass/volume] in Serum |
| 72595-2 | Alpha 1 globulin/Protein.total [Pure mass fraction] in Cerebral spinal fluid by Electrophoresis |
| 86328-2 | Adenovirus B(21) DNA [Presence] in Specimen by NAA with probe detection |
| 86564-2 | Human papilloma virus DNA [Presence] in Tissue by NAA with probe detection |
| 86704-4 | Lawsonia intracellularis RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73559-7 | Herpes simplex virus 1 IgG Ab [Titer] in Serum by Immunofluorescence |
| 74370-8 | Cotinine [Presence] in Saliva (oral fluid) by Confirmatory method |
| 41460-7 | SARS coronavirus IgG Ab [Presence] in Serum by Immunoassay |
| 59892-0 | Cotinine [Moles/volume] in Gastric fluid |
| 31140-7 | cefTRIAXone [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC) |
| 42364-0 | Streptococcus pneumoniae 6 serotypes IgG panel [Mass/volume] - Serum |
| 60043-7 | Acepromazine [Mass/volume] in Blood |
| 43198-1 | Gamma hydroxybutyrate [Mass/volume] in Urine by Confirmatory method |
| 31809-7 | Echinococcus sp Ag [Presence] in Stool |
| 43289-8 | Methylcrotonylcarnitine (C5:1) [Moles/volume] in Serum or Plasma |
| 2267-3 | Etiocholanolone [Mass/volume] in Urine |
| 32245-3 | Glycine [Moles/volume] in Body fluid |
| 32517-5 | CD3+CD8+ (T8 suppressor) cells [#/volume] in Specimen |
| 52752-3 | Prothrombin time (PT) PIVKA insensitive actual/normal in Capillary blood by Coagulation assay |
| 44317-6 | Insulin human Ab [Presence] in Serum |
| 22803-1 | Infectious bronchitis virus Ab [Titer] in Serum by Immunoassay |
| 3278-9 | Kininogen HMW actual/normal in Platelet poor plasma by Immunoassay |
| 53332-3 | Crystals.amorphous [#/area] in Urine by Computer assisted method |
| 5341-3 | Salmonella paratyphi B H Ab [Presence] in Serum by Latex agglutination |
| 44637-7 | Invasive component size additional dimension 2 [Length] in Breast tumor |
| 44811-8 | Coccidioides sp IgA Ab [Presence] in Serum by Immunoassay |
| 23411-2 | Rinderpest virus Ab [Presence] in Serum |
| 23445-0 | Swine vesicular disease virus Ag [Presence] in Skin by Complement fixation |
| 45341-5 | Tick # 2 identified in Specimen |
| 23667-9 | Bacteria identified in Specimen |
| 23795-8 | Dust Allergen Mix 2 (Cockroach+American house dust mite+European house dust mite+House dust Hollister Stier) IgE Ab [Presence] in Serum by Multidisk |
| 24192-7 | Coxsackievirus B4 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen |
| 24205-7 | Rickettsia typhi IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 24246-1 | Polio virus 2 Ab [Titer] in Serum --2nd specimen |
| 34511-6 | SDHD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 34685-8 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor X depleted plasma |
| 25492-0 | Oxipurinol [Moles/volume] in Serum or Plasma |
| 34738-5 | K Ab [Titer] in Serum or Plasma |
| 34980-3 | Volume of Synovial fluid |
| 55621-7 | Bambermycins [Susceptibility] by Gradient strip |
| 56027-6 | Platelet aggregation ristocetin induced in Blood --1.0 mg/mL |
| 47524-4 | Cytology report of Thyroid fine needle aspirate Cyto stain |
| 35454-8 | MLL gene rearrangements in Blood or Tissue by Molecular genetics method |
| 35496-9 | NADH dehydrogenase [Enzymatic activity/mass] in Tissue |
| 482-0 | Talampicillin [Susceptibility] by Serum bactericidal titer |
| 48201-8 | Penicillin G triggered leukotriene release [Mass/volume] by Leukocytes |
| 26732-8 | Carboxy tetrahydrocannabinol [Mass/mass] in Stool |
| 3786-1 | Methaqualone [Presence] in Urine |
| 38185-5 | Beta galactosidase [Presence] in Blood |
| 56787-5 | Cytokeratin 19 [Units/volume] in Urine |
| 56975-6 | Renin [Mass/volume] in Plasma --upright+30 minutes post XXX challenge |
| 48420-4 | Complement C3c [Mass/volume] in Body fluid |
| 38256-4 | Cells Counted Total [#] in Body fluid |
| 48944-3 | Carboxy tetrahydrocannabinol [Mass/volume] in Specimen |
| 27884-6 | Lutropin [Units/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 27997-6 | Beta aminoadipate/Creatinine [Molar ratio] in Urine |
| 57835-1 | Appearance of Dialysis fluid |
| 57871-6 | quiNINE [Moles/volume] in Specimen |
| 57970-6 | Glucose [Mass/volume] in Urine --3 hours post 75 g glucose PO |
| 2861-3 | Albumin [Mass/volume] in Cerebral spinal fluid by Electrophoresis |
| 4007-1 | Pyrilamine [Presence] in Serum or Plasma |
| 58516-6 | C peptide [Mass/volume] in Serum or Plasma --4 hours post dose glucose |
| 50085-0 | 2-Methyl-3-Hydroxyvalerate/Creatinine [Molar ratio] in Urine |
| 29616-0 | Stachybotrys chartarum IgE Ab [Units/volume] in Serum |
| 29704-4 | Rickettsia sibirica Ab [Presence] in Serum by Immunofluorescence |
| 40371-7 | Isoniazid [Presence] in Urine |
| 40416-0 | Caffeine [Presence] in Gastric fluid |
| 40459-0 | Hepatitis B virus DNA [Log #/volume] (viral load) in Serum by Probe with signal amplification |
| 58879-8 | Somatotropin [Mass/volume] in Serum or Plasma --28th specimen |
| 50319-3 | HBME-1 Ag [Presence] in Tissue by Immune stain |
| 40889-8 | CD25+CD19+ cells/100 cells in Tissue |
| 19339-1 | Amobarbital [Presence] in Urine by Screen method |
| 20966-8 | Staphylococcus sp identified in Specimen by Organism specific culture |
| 12418-0 | Terfenadine [Mass/volume] in Serum or Plasma |
| 100900-0 | Enterobacteriaceae.carbapenem resistance panel - Anal by Organism specific culture |
| 101072-7 | CENR Ab [Presence] in Serum or Plasma |
| 101311-9 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --30 minutes post dose corticotropin |
| 13695-2 | Gamma aminobutyrate/Creatinine [Mass Ratio] in Urine |
| 13931-1 | Striated muscle Ab [Presence] in Serum |
| 10226-9 | Oxygen content in Intravascular space |
| 14016-0 | Thyroxine.thyroxine binding globulin bound [Mass/volume] in Serum or Plasma |
| 14325-5 | Bacteria identified in Specimen by Environmental culture |
| 102689-7 | Pinto Bean IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14653-0 | clomiPRAMINE [Moles/volume] in Urine |
| 14762-9 | Glucose [Moles/volume] in Serum or Plasma --30 minutes post 50 g lactose PO |
| 15109-2 | Midazolam [Moles/volume] in Serum or Plasma |
| 104340-5 | Borna disease virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 10827-4 | Reticulum.microscopic observation [Identifier] in Tissue by Gomori stain |
| 11065-0 | Urea nitrogen [Mass/volume] in Serum or Plasma --pre dialysis |
| 11073-4 | Despropionylfentanyl [Mass/volume] in Urine |
| 1625-3 | Retinol [Mass/volume] in Serum or Plasma --6 hours post 5000 units |
| 166-9 | Cephapirin [Susceptibility] by Disk diffusion (KB) |
| 11158-3 | Appearance of Serum |
| 12260-6 | Sucrose hemolysis [Presence] of Red Blood Cells |
| 16849-2 | Ethyl benzene [Mass/volume] in Urine |
| 17069-6 | Legionella pneumophila 5 IgM Ab [Units/volume] in Serum |
| 17487-0 | Progesterone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 1765-7 | Aldosterone [Mass/time] in 24 hour Urine |
| 1822-6 | Alpha thymosin [Mass/volume] in Serum |
| 18302-0 | IgG [Presence] in Urine by Immunofixation |
| 90242-9 | Natural killer cell cytotoxicity.IL-stimulated 0.9:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
| 91126-3 | Maximum amplitude activator F induced [Length] in Blood by Resonance TEG |
| 92727-7 | Tacrolimus [AUC] in Blood |
| 75556-1 | Fetal Trisomy 18 prior risk [Likelihood] Based on maternal age Narrative |
| 75762-5 | Methapyrilene [Presence] in Serum or Plasma or Urine by Screen method |
| 76138-7 | Reticulocyte distribution width [Ratio] in Blood by calculation |
| 7664-6 | Redwood IgE Ab [Units/volume] in Serum |
| 76658-4 | Zirconium [Mass/mass] in Hair |
| 6127-5 | Goat epithelium IgE Ab [Units/volume] in Serum |
| 9407-8 | Alpha 1 antitrypsin [Mass/volume] in Stool |
| 63181-2 | Mountain Juniper IgG Ab [Mass/volume] in Serum |
| 63276-0 | Mi-2 Ab [Presence] in Body fluid by Immunoassay |
| 94633-5 | Cryptosporidium parvum DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 63395-8 | Liver cytosol Ab [Titer] in Serum by Immunofluorescence |
| 63532-6 | Centromere protein B Ab [Presence] in Body fluid by Immunoassay |
| 64119-1 | Third most predominant hemoglobin in DBS |
| 6458-4 | Lymphocytic choriomeningitis virus Ab [Titer] in Serum by Immunofluorescence |
| 79147-5 | traMADol [Presence] in Blood by Confirmatory method |
| 792-2 | Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count |
| 95044-4 | Patient refused specimen collection |
| 9508-3 | Chlorothiazide [Presence] in Urine |
| 95152-5 | Mycoplasma synoviae DNA [#/volume] in Specimen by NAA with probe detection |
| 95167-3 | Ornithobacterium rhinotracheale Ab/Positive control in Serum by Immunoassay |
| 66147-0 | Polymorphonuclear cells/100 leukocytes in Pleural fluid from Fetus by Manual count |
| 95707-6 | Mayaro virus IgA Ab [Presence] in Specimen by Immunoassay |
| 96318-1 | Enterobacter cloacae complex DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection |
| 6800-7 | Spermatozoa Motile/100 spermatozoa in Semen |
| 811-0 | Leukocytes [#/volume] in Semen by Automated count |
| 96663-0 | HLA-DRB1 [Type] in Donor by Low resolution |
| 97197-8 | quiNIDine [Moles/volume] in Serum or Plasma --trough |
| 81625-6 | Methotrexate tetraglutamate [Moles/volume] in Red Blood Cells |
| 7027-6 | Loracarbef [Susceptibility] by Gradient strip |
| 70867-7 | Rabies virus strain identified in Specimen by Sequencing |
| 82977-0 | GABABR IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 982-9 | Di sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 71665-4 | Variant lymphocytes/Leukocytes [Pure number fraction] in Blood by Manual count |
| 72215-7 | t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
| 72771-9 | Zolpidem/Creatinine [Mass Ratio] in Urine |
| 86895-0 | Adalimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
| 73480-6 | Carvedilol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73566-2 | Dextrorphan [Mass/volume] in Urine |
| 74092-8 | Acidity.titratable [Moles/volume] in Urine |
| 88591-3 | Scedosporium prolificans DNA [Presence] in Aspirate by NAA with probe detection |
| 88605-1 | Human coronavirus OC43 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 50962-0 | XXX blood group IgG Ab [Titer] in Serum or Plasma |
| 30521-9 | Inhibin B [Units/volume] in Serum or Plasma |
| 30541-7 | Octenoylcarnitine (C8:1) [Moles/volume] in Serum or Plasma |
| 31095-3 | Tobramycin [Mass/volume] in Serum or Plasma --trough post extended interval dosing |
| 311-1 | Lymecycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 41846-7 | Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Urine by Agglutination |
| 60014-8 | Corticotropin [Moles/volume] in Plasma --baseline |
| 42879-7 | CD3-CD16+ cells [#/volume] in Tissue |
| 43158-5 | Chlorine.free [Mass/volume] in Water |
| 43180-9 | Herpes simplex virus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 21696-0 | HFE gene p.His63Asp [Presence] in Blood or Tissue by Molecular genetics method |
| 22345-3 | Histoplasma capsulatum Ab [Presence] in Cerebral spinal fluid |
| 43855-6 | Urease [Presence] in Tissue --2 hours post incubation |
| 44060-2 | CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Specimen |
| 23082-1 | Equine herpesvirus 1 DNA [Presence] in Nose by NAA with probe detection |
| 23144-9 | Japanese encephalitis virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 23496-3 | Transmissible gastroenteritis virus Ag [Presence] in Small intestine Tissue by Immune stain |
| 53548-4 | 3,4-Dihydroxyphenylacetate [Moles/time] in 24 hour Urine |
| 44945-4 | Australian cervix cytology code [Interpretation] of Specimen |
| 23724-8 | Feline immunodeficiency virus Ab [Presence] in Serum |
| 23964-0 | Brucella abortus IgM Ab [Titer] in Cerebral spinal fluid |
| 34245-1 | Arsenic [Moles/volume] in 24 hour Urine |
| 54016-1 | Cathepsin G Ab [Presence] in Serum |
| 46993-2 | HLA Ab panel - Serum |
| 24307-1 | Coxsackievirus A9 Ab [Titer] in Serum --2nd specimen |
| 24390-7 | Cortisol [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
| 55438-6 | Dengue virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 47155-7 | Norepinephrine [Moles/volume] in Plasma --10 minutes post standing |
| 47451-0 | Influenza virus A H2 Ab [Titer] in Serum |
| 25100-9 | Formate/Creatinine [Molar ratio] in Urine |
| 3511-3 | Cropropamide [Presence] in Urine |
| 4770-4 | HLA-B58(17) [Presence] in Donor |
| 47707-5 | Methylmalonate/Urea [Molar ratio] in Amniotic fluid |
| 25723-8 | Nitroxoline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2575-9 | Lipoprotein.pre-beta [Mass/volume] in Serum or Plasma |
| 25890-5 | Cysteate/Creatinine [Molar ratio] in 24 hour Urine |
| 25896-2 | Delta aminolevulinate [Moles/volume] in 24 hour Urine |
| 35687-3 | GBA gene c.1297G>T [Presence] in Blood or Tissue by Molecular genetics method |
| 35710-3 | Chlamydia sp DNA [Presence] in Conjunctival specimen by NAA with probe detection |
| 56211-6 | Catfish IgG4 Ab [Mass/volume] in Serum |
| 48152-3 | Sorbitol/Creatinine [Molar ratio] in Urine |
| 2661-7 | Nitrogen.nonprotein [Presence] in Blood |
| 26716-1 | Chlorphentermine [Mass/mass] in Meconium |
| 48507-8 | Saint Louis encephalitis virus IgM Ab [Presence] in Body fluid by Immunoassay |
| 48510-2 | HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 1.7 log copies/mL |
| 27124-7 | Copper [Mass/mass] in Red Blood Cells |
| 38592-2 | Dimethylformamide [Mass/volume] in Air |
| 48985-6 | Glucose [Mass/volume] in Serum or Plasma --20 minutes post dose glucose |
| 27366-4 | Somatotropin [Mass/volume] in Serum or Plasma --22nd specimen post XXX challenge |
| 2740-9 | Pepsins [Enzymatic activity/volume] in Gastric fluid |
| 27906-7 | Immature lymphocytes/100 leukocytes in Amniotic fluid |
| 39001-3 | 3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma |
| 396-2 | Penicillin V [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 49675-2 | Lymphocyte proliferation stimulated by 10 umol beryllium [Units/volume] in Blood --7 day post incubation |
| 2812-6 | Porphobilinogen deaminase [Enzymatic activity/volume] in Red Blood Cells |
| 58785-7 | Herpes simplex virus 2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 50168-4 | Alanine aminotransferase [Enzymatic activity/volume] in Dialysis fluid |
| 4052-7 | Thioridazine [Mass/volume] in Serum or Plasma |
| 40570-4 | Blasts [#/volume] in Body fluid by Manual count |
| 50354-0 | Bahia grass IgE Ab/IgE total in Serum |
| 5054-2 | Babesia sp Ab [Titer] in Serum by Immunofluorescence |
| 30281-0 | Saquinavir [Susceptibility] by Phenotype method |
| 30285-1 | Zalcitabine [Susceptibility] by Genotype method |
| 40812-0 | 11-Hydroxyandrosterone/Creatinine [Mass Ratio] in 24 hour Urine |
| 20961-9 | Selenium [Mass/mass] in Feed |
| 100816-8 | Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 101548-6 | P63 protein [Interpretation] in Blood or Tissue Qualitative |
| 13014-6 | Methyl butyl ketone [Mass/volume] in Blood |
| 102370-4 | Shellbark Hickory IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14000-4 | Urea nitrogen [Mass/volume] in Cerebral spinal fluid |
| 14051-7 | Estrogen binding protein [Mass/volume] in Serum or Plasma |
| 10375-4 | Irregularly contracted cells [Presence] in Blood by Light microscopy |
| 1040-5 | G Ag [Presence] on Red Blood Cells from Donor |
| 104358-7 | Spirochete [Identifier] in Specimen by Microscopy |
| 12225-9 | Leukocytes [#/area] in Sputum by Microscopy high power field |
| 12320-8 | Thiothixene [Presence] in Urine |
| 16834-4 | Escherichia coli K1 Ag [Presence] in Specimen by Latex agglutination |
| 17762-6 | Valproate [Mass/volume] in Urine |
| 17875-6 | Bacteria # 4 identified in Bone by Aerobe culture |
| 18467-1 | Venlafaxine [Mass/volume] in Urine |
| 902-7 | Blood group antibody screen.autologous [Presence] in Serum or Plasma by Prewarmed |
| 90918-4 | Fatty acid omega-3 and omega-6 panel - Blood |
| 74679-2 | Benzoylecgonine [Presence] in Saliva (oral fluid) by Confirmatory method |
| 92243-5 | Microorganism resistance mutation tested for by Molecular method |
| 92248-4 | Microorganism resistance mutation amino acid change by Molecular method |
| 75366-5 | Lactate [Moles/volume] in Capillary blood from Fetus by Test strip |
| 76586-7 | ENT microorganism gene identification panel by NAA with probe detection |
| 61352-1 | Lymphocyte proliferation stimulated by 2.5 ug pokeweed mitogen in Blood |
| 77055-2 | CYP11B1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 7765-1 | English Walnut IgE Ab [Units/volume] in Serum |
| 94205-2 | LYZ gene full mutation analysis in Blood or Tissue by Sequencing |
| 78853-9 | M-chlorophenylpiperazine [Mass/volume] in Body fluid |
| 94336-5 | Desmoglein 1 IgG Ab [Units/volume] in Serum by Immunoassay |
| 94669-9 | Reaction wheal [Diameter] --2 day post dose control intradermal |
| 6406-3 | Flavivirus identified in Specimen by Organism specific culture |
| 64979-8 | Blomia tropicalis recombinant (rBlo t) 5 IgE Ab [Units/volume] in Serum |
| 79129-3 | Uroporphyrin 3 isomer/Creatinine [Mass Ratio] in Urine |
| 65787-4 | Shrimp native (nPen m) 4 IgE Ab [Units/volume] in Serum |
| 69482-8 | ENG gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 82220-5 | Alkyl-dihydroxyacetonephosphate synthase [Enzymatic activity/mass] in Fibroblast |
| 70093-0 | Prostaglandin E1 [Mass/volume] in Cerebral spinal fluid |
| 70212-6 | Nordiazepam [Moles/volume] in Serum or Plasma by Screen method |
| 82565-3 | Food Allergen Mix 77 (Kiwi+Cashew nut+Hazel nut+Tomato+Sesame seed) IgE Ab [Units/volume] in Serum by Multidisk |
| 82871-5 | Adenosine diphosphate [Entitic substance] in Platelets |
| 98415-3 | Sertraline/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 99064-8 | PD-L1 by clone SP263 in Tissue Document |
| 72762-8 | Buprenorphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 85967-8 | Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum --1st specimen |
| 86097-3 | Streptococcus pneumoniae Danish serotype 3 Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 86608-7 | Norcodeine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 73660-3 | Propoxyphene panel - Saliva (oral fluid) |
| 73829-4 | 7-Aminoflunitrazepam [Mass/volume] in Serum, Plasma or Blood |
| 87987-4 | Leishmania sp identified in Blood by Organism specific culture |
| 88010-4 | Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma |
| 88989-9 | Perazine [Mass/volume] in Serum or Plasma |
| 89576-3 | Troponin T.cardiac panel - Serum or Plasma by High sensitivity method |
| 41635-4 | Clostridium botulinum toxin F [Presence] in Specimen by Immunofluorescence |
| 4166-5 | cefTAZidime [Mass] of Dose |
| 30451-9 | Segmented neutrophils [#/volume] in Blood |
| 42180-0 | C peptide [Moles/volume] in Serum or Plasma --fasting |
| 42325-1 | RHD and RHCE gene alleles [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 59906-8 | fluvoxaMINE [Moles/volume] in Urine |
| 60032-0 | Bacteria identified in Peritoneal dialysis fluid by Culture |
| 21587-1 | Urate [Mass/volume] in 24 hour Urine |
| 51413-3 | Butyrylcarnitine+Isobutyrylcarnitine (C4) [Moles/volume] in Serum or Plasma |
| 42746-8 | Phosphatidylethanolamine IgA Ab B2GP1 independent [Multiple of the median] in Serum |
| 51734-2 | Chlamydia trachomatis L2 IgA and IgG and IgM [Interpretation] in Serum |
| 22314-9 | Hepatitis A virus IgM Ab [Presence] in Serum |
| 51976-9 | Bacillus anthracis capsule Ag [Presence] in Specimen by Immunofluorescence |
| 52820-8 | Appearance of Spun Pericardial fluid |
| 32623-1 | Platelet mean volume [Entitic volume] in Blood by Automated count |
| 3316-7 | Alprenolol [Mass/volume] in Urine |
| 33225-4 | Fine Granular Casts [#/area] in Urine sediment by Automated count |
| 53322-4 | Crystals [#/area] in Urine sediment by Automated count |
| 33594-3 | Platelet factor 4 [Presence] in Platelet poor plasma |
| 53900-7 | C10orf2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 23745-3 | Gossypol [Mass/volume] in Specimen |
| 23767-7 | Porcine circovirus Ag [Presence] in Tissue by Immune stain |
| 3410-8 | Bumetanide [Mass/volume] in Urine |
| 54084-9 | Galactose [Mass/volume] in DBS |
| 46965-0 | MCOLN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55208-3 | DNA analysis discrete sequence variation panel |
| 55291-9 | Sulopenem [Susceptibility] by Disk diffusion (KB) |
| 25495-3 | Phenylalanine [Moles/time] in 24 hour Urine |
| 25649-5 | Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --6th specimen post XXX challenge |
| 3551-9 | diazePAM [Mass/volume] in Urine |
| 35654-3 | Creatinine/Body weight [Mass/kg/time] in 24 hour Urine |
| 56467-4 | Horse Fly IgG4 Ab [Mass/volume] in Serum |
| 26811-0 | 2-Methylcitrate [Moles/volume] in Urine |
| 57678-5 | Mycoplasma pneumoniae IgG Ab [Presence] in Serum by Immunoassay --2nd specimen |
| 49129-0 | Creatine kinase.MiMi/Creatine kinase.total in Serum or Plasma |
| 27862-2 | Insulin [Units/volume] in Serum or Plasma --4 hours post 75 g glucose PO |
| 3884-4 | Oxandrolone [Mass/volume] in Urine |
| 38903-1 | Lymphocytes [Presence] in Stool by Light microscopy |
| 38996-5 | Neutrophils [Presence] in Urine by Light microscopy |
| 39356-1 | Cholinesterase.scoline inhibited/Cholinesterase in Serum or Plasma |
| 57745-2 | Adrenal Ab [Presence] in Serum by Immunofluorescence |
| 58006-8 | Mibolerone [Presence] in Urine |
| 49747-9 | Cocaine+Benzoylecgonine [Presence] in Serum or Plasma by Screen method |
| 40095-2 | Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --6 hours post XXX challenge |
| 58676-8 | Cortisol [Mass/volume] in Saliva (oral fluid) --8 PM specimen |
| 50087-6 | 2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Amniotic fluid |
| 29590-7 | Cytomegalovirus DNA [Mass/volume] (viral load) in Blood by Probe |
| 29712-7 | Rickettsia typhi Ab [Presence] in Serum by Immunofluorescence |
| 29875-2 | Lactate [Presence] in Urine |
| 29940-4 | Bismuth/Creatinine [Mass Ratio] in 24 hour Urine |
| 5909-7 | Blood smear finding [Identifier] in Blood by Light microscopy |
| 40829-4 | Ornithine [Presence] in Blood |
| 19619-6 | N-desalkylflurazepam cutoff [Mass/volume] in Urine for Confirmatory method |
| 20425-5 | Cardiolipin IgM Ab [Interpretation] in Serum |
| 12731-6 | Interferon alpha [Units/volume] in Serum or Plasma |
| 13448-6 | Calcium/Osmolality [Ratio] in Serum or Plasma |
| 14090-5 | Herpes simplex virus 2 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 14230-7 | Cells.progesterone receptor/100 cells in Tissue by Immune stain |
| 102701-0 | Cardamon IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104362-9 | Brucella sp DNA [Identifier] in Specimen by NAA with non-probe detection |
| 1043-9 | H Ab [Presence] in Serum or Plasma from Donor |
| 104470-0 | Yersinia pestis IgG Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 157-8 | Cephaloridine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 16118-2 | Babesia microti IgM Ab [Titer] in Serum |
| 10767-2 | Microscopic observation [Identifier] in Tissue by Alcian blue stain.sulfated |
| 16603-3 | Chloramphenicol [Mass/volume] in Serum or Plasma --peak |
| 16723-9 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 118-0 | cefOXitin [Susceptibility] by Serum bactericidal titer |
| 16788-2 | DOPamine [Mass/volume] in Urine --6th specimen post XXX challenge |
| 17255-1 | Mercury [Mass/volume] in Dialysis fluid |
| 18248-5 | Nordiazepam [Mass/volume] in Stool |
| 18887-0 | cefoTEtan [Susceptibility] |
| 19107-2 | Histoplasma capsulatum Ag [Units/volume] in Serum by Radioimmunoassay (RIA) |
| 90340-1 | Aspergillus sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 74729-5 | Adrenoleukodystrophy protein (ALDP) [Presence] in Fibroblast by Immune stain |
| 74752-7 | Porcine epidemic diarrhea virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 92049-6 | Staphylococcus species methicillin resistant identified in Isolate or Specimen by Molecular genetics method |
| 92127-0 | Haemophilus influenzae DNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 75053-9 | Alpha-L-iduronidase [Enzymatic activity/volume] in Serum or Plasma |
| 75543-9 | Parvovirus B19 DNA [Presence] in Plasma from Donor by NAA with probe detection |
| 92806-9 | Keratan sulfate/Creatinine [Ratio] in Urine |
| 6137-4 | Hazelnut Pollen IgE Ab [Units/volume] in Serum |
| 61402-4 | Serratia marcescens DNA [Presence] in Specimen by NAA with probe detection |
| 6173-9 | Mesquite IgE Ab [Units/volume] in Serum |
| 62365-2 | Diagnostic impression [Interpretation] in Specimen Narrative |
| 6274-5 | California Walnut IgE Ab [Units/volume] in Serum |
| 78828-1 | fentaNYL [Z-score] in Urine |
| 63419-6 | PIK3CA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 6480-8 | Mumps virus Ag [Presence] in Serum by Immunofluorescence |
| 78915-6 | FGFR1 gene rearrangements [Presence] in Blood or Tissue by FISH |
| 94861-2 | Transthyretin - transthyretin peak 2 [Mass difference] in Blood |
| 95158-2 | Avian encephalomyelitis virus Ab/Positive control in Serum by Immunoassay |
| 95179-8 | Infectious bursal disease virus Ab [Titer] in Serum by Immunoassay |
| 7990-5 | Respiratory syncytial virus Ab [Units/volume] in Serum |
| 96111-0 | Linezolid [Susceptibility] by Genotype method |
| 80832-9 | Protein [Mass/volume] in Lower respiratory specimen |
| 69570-0 | Risk of ovarian malignancy algorithm score in Serum or Plasma --postmenopausal |
| 70051-8 | Multiple inhalant allergen IgE Ab [Presence] in Serum by Immunoassay |
| 81786-6 | Chemokine (C-C motif) ligand 17 [Mass/volume] in Serum by Immunoassay |
| 7127-4 | Green Bean IgG Ab [Units/volume] in Serum |
| 82441-7 | SUMO-activating enzyme subunit 2 Ab [Units/volume] in Serum by Line blot |
| 82456-5 | Human papilloma virus 16 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection |
| 82533-1 | VHL gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 98043-3 | 5-Aminosalicylate IgE Ab [Units/volume] in Serum |
| 7193-6 | Mountain Juniper IgG Ab [Units/volume] in Serum |
| 99398-0 | Siderocytes.Type 3/100 Erythroblasts in Blood or Marrow by Prussian blue stain |
| 99475-6 | Penicillium frequentans IgG Ab [Mass/volume] in Serum |
| 99599-3 | Protein.monoclonal band 1/Protein.total in Urine by Electrophoresis |
| 85977-7 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum |
| 86236-7 | Neisseria meningitidis serogroup C synE gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 87381-0 | Porcine adenovirus Ab [Titer] in Serum by Immunoassay |
| 7421-1 | House dust AP IgE Ab [Units/volume] in Serum |
| 89039-2 | MSH2 gene deletion+duplication and full mutation analysis and EPCAM gene exons 8 and 9 deletion and duplication mutation analysis in Blood or Tissue by Molecular genetics method |
| 41192-6 | Yellow Hornet IgG4 Ab [Presence] in Serum |
| 41651-1 | Glucose [Mass/volume] in Arterial blood |
| 41705-5 | Neomycin [Susceptibility] by Gradient strip |
| 59-6 | Carbenicillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 59662-7 | Diclofenac [Mass/volume] in Blood |
| 50794-7 | Osmotic fragility beginning hemolysis of Red Blood Cells |
| 42207-1 | IgG in CSF/IgG in serum |
| 59929-0 | Methaqualone [Moles/volume] in Gastric fluid |
| 2127-9 | Citrate [Mass/volume] in Serum or Plasma |
| 31347-8 | Ganglioside GD1b IgM Ab [Units/volume] in Serum |
| 31460-9 | Legionella pneumophila 3 IgG Ab [Units/volume] in Serum |
| 51100-6 | CD179a blasts [Units/volume] in Specimen |
| 43-0 | Aztreonam [Susceptibility] by Minimum lethal concentration (MLC) |
| 43102-3 | Neuronal nuclear type 3 Ab [Presence] in Serum |
| 21809-9 | t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Blood or Tissue by Molecular genetics method |
| 22237-2 | Cryptococcus neoformans Ab [Titer] in Serum |
| 22265-3 | Echinococcus sp IgG Ab [Units/volume] in Serum |
| 51476-0 | ABCB4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 51532-0 | Casein IgG Ab [Presence] in Serum |
| 22759-5 | Platelet Ab [Titer] in Serum |
| 32294-1 | Albumin/Creatinine [Ratio] in Urine |
| 32569-6 | Corynebacterium diphtheriae Ab [Units/volume] in Serum --1st specimen |
| 44017-2 | Blasts [Presence] in Blood by Light microscopy |
| 32825-2 | Leukocytes [Presence] in Semen |
| 44441-4 | Aspergillus niger Ab [Units/volume] in Serum by Complement fixation |
| 23449-2 | Taenia hydatigena Ag [Presence] in Stool by Immunoassay |
| 33331-0 | West Nile virus IgM Ab [Titer] in Serum |
| 33355-9 | Urea nitrogen [Moles/volume] in 24 hour Urine |
| 3359-7 | Anileridine [Moles/volume] in 24 hour Urine |
| 33614-9 | Transferrin.carbohydrate deficient.XXX/Transferrin.total in Serum or Plasma |
| 53797-7 | Neutrophils.immature/100 leukocytes in Blood |
| 45041-1 | Francisella tularensis Ag [Presence] in Specimen by Slide agglutination |
| 4516-1 | Complement factor Ba [Mass/volume] in Serum or Plasma |
| 45169-0 | Ganglioside GM1 IgG Ab [Presence] in Serum |
| 23865-9 | FLUoxetine+Norfluoxetine [Presence] in Urine |
| 2469-5 | IgG subclass 4 [Mass/volume] in Serum |
| 34562-9 | Cell count and Differential panel - Pleural fluid |
| 55157-2 | risperiDONE and 9-Hydroxyrisperidone panel - Serum or Plasma |
| 34907-6 | Calcium [Mass/volume] corrected for total protein in Serum or Plasma |
| 35118-9 | Acetaldehyde [Presence] in Serum or Plasma |
| 55939-3 | Malondialdehyde [Moles/mass] in Red Blood Cells |
| 47611-9 | Crystals [type] in Tissue by Light microscopy |
| 56412-0 | Venison IgG4 Ab [Mass/volume] in Serum |
| 56485-6 | Taenia solium IgG Ab [Presence] in Serum by Immunoassay |
| 48048-3 | Neutrophils [Presence] in Nose by Wright stain |
| 2625-2 | Methionine adenosyltransferase [Enzymatic activity/volume] in Serum |
| 380-6 | Oleandomycin [Susceptibility] by Disk diffusion (KB) |
| 48418-8 | Staphylolysin Ab [Titer] in Serum |
| 48884-1 | Bartonella quintana IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 49010-2 | Platelet aggregation ADP induced [Units/volume] in Platelet rich plasma |
| 28041-2 | Gamma hydroxybutyrate [Mass/volume] in Serum or Plasma |
| 38891-8 | ABCC8 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 4951-0 | HLA-DR10 [Presence] |
| 29209-4 | Benzodiazepines [Mass/volume] in Body fluid |
| 2937-1 | Serine [Mass/volume] in Urine |
| 40243-8 | Calcium [Moles/volume] in Serum or Plasma --20 hours post XXX challenge |
| 50162-7 | Acylcarnitine [Moles/volume] in Amniotic fluid |
| 2991-8 | Testosterone Free [Mass/volume] in Serum or Plasma |
| 40346-9 | MT-CO1 gene m.7445A>G [Presence] in Blood or Tissue by Molecular genetics method |
| 40604-1 | Alpha-2-Macroglobulin [Presence] in Urine by Immunoelectrophoresis |
| 40719-7 | Hemoglobin [Mass/volume] in Cord blood |
| 59012-5 | Lactate [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 59048-9 | Lactate/Pyruvate [Mass Ratio] in Blood |
| 50271-6 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --3 hours post dose ifosfamide |
| 50296-3 | 4-Hydroxyifosfamide [Mass/volume] in Blood --4 days post dose ifosfamide |
| 30193-7 | Acylcarnitine/Carnitine.free (C0) [Molar ratio] in Serum or Plasma |
| 30396-6 | Granulocytes/100 leukocytes in Bronchial specimen |
| 20689-6 | Babesia caballi Ab [Presence] in Serum by Complement fixation |
| 20694-6 | Bacteria identified in Embryo by Aerobe culture |
| 20778-7 | Copper [Mass/volume] in Specimen |
| 20908-0 | Organochlorine pesticides [Identifier] in Specimen |
| 12420-6 | Thiosulfate [Mass/volume] in Urine |
| 100377-1 | Goat cheese IgG Ab [Units/volume] in Serum |
| 12939-5 | Thyrotropin [Units/volume] in Serum or Plasma --2 hours post XXX challenge |
| 12994-0 | Oxychlordane [Mass/volume] in Blood |
| 13077-3 | Phosphatidylethanolamine IgM Ab [Units/volume] in Serum |
| 1333-4 | V Ag [Presence] on Red Blood Cells from Donor |
| 101968-6 | Circulating tumor cells [#/volume] in Plasma or Blood by Sequencing |
| 13905-5 | Meclofenamate [Mass/volume] in Serum or Plasma |
| 102267-2 | Curvularia specifera IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102649-1 | Black Walnut Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13980-8 | Albumin/Protein.total in Serum or Plasma by Electrophoresis |
| 14394-1 | Urea nitrogen [Mass/volume] in Pleural fluid |
| 14493-1 | Virus identified in Cervix by Immunofluorescence |
| 14539-1 | Measles virus Ag [Presence] in Sputum by Immunofluorescence |
| 10388-7 | Autologous whole blood given [Volume] |
| 15393-2 | Parainfluenza virus 2 IgM Ab [Titer] in Serum |
| 16105-9 | Pheasant IgE Ab [Units/volume] in Serum |
| 16360-0 | Amitriptyline [Mass/volume] in Serum or Plasma --peak |
| 16462-4 | Bicarbonate [Moles/volume] in Amniotic fluid |
| 11151-8 | Hematocrit [Volume Fraction] of Cord blood |
| 12184-8 | Choriogonadotropin [Presence] in Body fluid |
| 17473-0 | Polymyxin B [Mass/volume] in Serum or Plasma |
| 1799-6 | Amylase [Enzymatic activity/volume] in Urine |
| 74666-9 | Monoclonal band observed [Identifier] in Urine by Immunofixation |
| 7474-0 | Mackerel IgE Ab [Units/volume] in Serum |
| 7622-4 | White Poplar triggered histamine release [Units/volume] in Blood |
| 76659-2 | Antipsychotics drug panel - Urine by Screen method |
| 93348-1 | Available treatment related to genetic variant and to patient diagnosis [Identifier] in Blood or Tissue Nominal |
| 93429-9 | Blastomyces sp Ag [Mass/volume] in Urine by Immunoassay |
| 77099-0 | MRPL44 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77390-3 | Respiratory syncytial virus Ag [Presence] in Nasopharynx by Immunofluorescence |
| 63156-4 | Bahia grass IgG Ab [Mass/volume] in Serum |
| 7802-2 | Phospholipid IgM Ab [Units/volume] in Serum |
| 64132-4 | PENTobarbital/Creatinine [Mass Ratio] in Urine |
| 95074-1 | Bacteria [Presence] in Bronchoalveolar lavage by Light microscopy |
| 95561-7 | Etiocholanolone [Z-score] in 24 hour Urine |
| 80367-6 | Chlamydia trachomatis [Presence] in Anorectal by Organism specific culture |
| 80370-0 | Biotinidase [Enzymatic activity/mass] in Serum or Plasma |
| 679-1 | Microscopic observation [Identifier] in Specimen by Warthin-Starry stain |
| 68929-9 | Cytokeratin 19 [Mass/volume] in Pericardial fluid |
| 81109-1 | Leptospira interrogans sv Zanoni Ab [Titer] in Serum by Agglutination |
| 81325-3 | Influenza virus B Yamagata lineage RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection |
| 96686-1 | Clot formation and Platelet function.glass bead induced panel - Blood by Microviscometry |
| 96817-2 | Thermoactinomyces candidus IgE Ab [Units/volume] in Serum |
| 69742-5 | CBC W Differential panel, method unspecified - Blood |
| 70053-4 | Hantavirus hantaan IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 8168-7 | Tetrahydrocannabinol [Presence] in Meconium by Confirmatory method |
| 81808-8 | Androstenetriol/Creatinine [Molar ratio] in Urine |
| 97950-0 | Onyong-nyong virus RNA [Presence] in Specimen by NAA with probe detection |
| 7064-9 | White Alder IgE Ab [Units/volume] in Serum |
| 98212-4 | Reagin Ab and Treponema pallidum IgG and IgM and total panel - Serum |
| 85325-9 | Cells.progesterone receptor/100 cells in Breast cancer specimen by Immune stain |
| 99105-9 | Chlamydia trachomatis Ag [Presence] in Serum or Plasma by Immunoassay |
| 99429-3 | Tyrophagus putrescentiae IgG4 Ab [Mass/volume] in Serum |
| 7253-8 | Cottonseed IgG Ab [Units/volume] in Serum |
| 72696-8 | SLC40A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 86002-3 | Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 86068-4 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum --2nd specimen |
| 86338-1 | Streptococcus pneumoniae Danish serotype 6A+6B Ab [Units/volume] in Serum |
| 86606-1 | Cocaethylene/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 87434-7 | Protein and creatinine panel - Urine |
| 7413-8 | Honeysuckle IgE Ab [Units/volume] in Serum |
| 41180-1 | Candida albicans reaction wheal [Diameter] --2 days post Candida albicans intradermal |
| 41631-3 | Clostridium botulinum toxin A botA gene [Presence] in Specimen by NAA with probe detection |
| 50665-9 | CD19+Lambda+ cells [#/volume] in Blood |
| 50762-4 | A IgM Ab [Titer] in Serum or Plasma |
| 50838-2 | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Body fluid |
| 30449-3 | Neutrophils.hypersegmented [#/volume] in Blood |
| 30483-2 | Succinylacetone [Presence] in Urine |
| 30574-8 | Acetoacetate+Acetone [Mass/volume] in Serum or Plasma |
| 42526-4 | Mycoplasma pneumoniae IgG Ab [Titer] in Pleural fluid |
| 60025-4 | Urobilinogen [Moles/volume] in Urine by Automated test strip |
| 60046-0 | Acetaldehyde [Mass/volume] in Red Blood Cells |
| 21603-6 | Wheat dust IgE Ab [Units/volume] in Serum |
| 51337-4 | CD19+CD43+ cells/100 cells in Blood |
| 51437-2 | Protein.monoclonal band 2 [Mass/volume] in Urine by Electrophoresis |
| 43826-7 | Androstanolone [Presence] in Serum or Plasma |
| 2240-0 | Estradiol (E2) Free [Mass/volume] in Serum or Plasma |
| 22415-4 | Mumps virus IgG Ab [Presence] in Serum |
| 32205-7 | Unidentified cells [#/volume] in Synovial fluid by Manual count |
| 3312-6 | ALPRAZolam [Mass/volume] in Serum or Plasma |
| 44490-1 | Herpes simplex virus 2 [Presence] in Anal by Organism specific culture |
| 4454-5 | Trimethadione [Mass] of Dose |
| 34193-3 | SMPD1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 54085-6 | Galactose [Moles/volume] in DBS |
| 54435-3 | Aspergillus fumigatus Ab [Titer] in Serum |
| 24520-9 | Phosphate [Moles/volume] in Red Blood Cells |
| 34336-8 | Lysozyme/Creatinine [Ratio] in Urine |
| 54499-9 | Glucose [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 550-4 | Bordetella pertussis Ag [Presence] in Specimen by Immunofluorescence |
| 4711-8 | HLA-A74(19) [Presence] in Donor |
| 47163-1 | Norepinephrine [Moles/volume] in Plasma --3 hours post XXX challenge |
| 47299-3 | DNA double strand Ab [Units/volume] in Serum by Farr method |
| 47307-4 | Cytomegalovirus IgG Ab index [Units/volume] in Serum and CSF |
| 47461-9 | Legionella pneumophila 11 IgG Ab [Titer] in Serum |
| 35014-0 | Band form neutrophils [#/volume] in Body fluid |
| 4775-3 | HLA-B60(40) [Presence] |
| 25569-5 | C peptide [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge |
| 25668-5 | Glucose [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
| 25710-5 | Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum by Complement fixation |
| 47931-1 | Somatotropin [Units/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 48150-7 | Perseitol/Creatinine [Molar ratio] in Urine |
| 26506-6 | Segmented neutrophils/100 leukocytes in Cerebral spinal fluid |
| 26547-0 | Glucose [Presence] in Urine by Test strip --2 hours post dose glucose |
| 3714-3 | Lidocaine [Mass/volume] in Serum or Plasma |
| 56688-5 | IgD [Units/volume] in Serum |
| 56940-0 | Inhibin B [Mass/volume] in Serum or Plasma by Immunoassay |
| 38414-9 | Iron [Moles/mass] in Tissue |
| 38441-2 | Benzodiazepines [Presence] in Meconium by Confirmatory method |
| 2775-5 | Phosphate [Mass/volume] in Dialysis fluid |
| 2792-0 | Phosphofructokinase [Enzymatic activity/volume] in Serum |
| 27930-7 | Neutrophils/100 leukocytes in Bronchial specimen |
| 2794-6 | Phosphofructokinase F subunit/Phosphofructokinase.total in Leukocytes |
| 39357-9 | Cholinesterase.chloride inhibited/Cholinesterase in Serum or Plasma |
| 49635-6 | FXN gene allele 2.GAA repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 29518-8 | 3-Methylglutarate/Creatinine [Molar ratio] in Urine |
| 40188-5 | Glucose [Moles/volume] in Serum or Plasma --20.5 hours post XXX challenge |
| 29632-7 | N-acetyltyrosine [Presence] in Urine |
| 29853-9 | La Crosse virus IgM Ab [Presence] in Serum |
| 40356-8 | Creatinine [Moles/time] in 24 hour Dialysis fluid |
| 58841-8 | C peptide [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge |
| 58944-0 | Microscopic observation [Identifier] in Body fluid by Acid fast stain.Ziehl-Neelsen |
| 59007-5 | Lactate [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge |
| 59178-4 | Chloride [Moles/volume] in Gastric fluid |
| 50341-7 | Eosinophils [Presence] in Sputum by Hansel stain |
| 30277-8 | Efavirenz [Susceptibility] by Phenotype method |
| 20738-1 | Campylobacter sp identified in Isolate by Organism specific culture |
| 100691-5 | Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 100812-7 | Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge |
| 101377-0 | inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript in Blood or Marrow by Molecular genetics method |
| 101546-0 | FCGR3A gene.p.Val158 [Identifier] in Blood by Molecular genetics method Nominal |
| 14045-9 | D-Lactate [Moles/volume] in Serum or Plasma |
| 14393-3 | Urea nitrogen [Mass/volume] in Amniotic fluid |
| 1455-5 | Creatinine [Mass/volume] in 24 hour Urine --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 103688-8 | Blastomyces sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 1494-4 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 100 g glucose PO |
| 16101-8 | Cumin IgE Ab [Units/volume] in Serum |
| 10959-5 | Plaice IgE Ab [Units/volume] in Serum |
| 16312-1 | Acetonitrile [Mass/volume] in Serum or Plasma |
| 1664-2 | 17-Hydroxycorticosteroids [Mass/volume] in Amniotic fluid |
| 17809-5 | Hematocrit [Volume Fraction] of Urine |
| 18373-1 | Protein [Mass/time] in 6 hour Urine |
| 18384-8 | Butabarbital [Mass/volume] in Serum or Plasma by Confirmatory method |
| 89994-8 | Trypanosoma cruzi IgG Ab [Presence] in Serum or Plasma from Donor by Rapid immunoassay |
| 74682-6 | Trichloroethanol.free [Mass/volume] in Blood |
| 75158-6 | Allantoine [Moles/volume] in Serum or Plasma |
| 75554-6 | Fetal Trisomy 18 prior risk [Likelihood] Based on maternal age |
| 60404-1 | Red Snapper IgG Ab [Mass/volume] in Serum |
| 75815-1 | Antipsychotics drug panel - Blood or Urine by Screen method |
| 77616-1 | Liver fibrosis score in Serum or Plasma Calculated by FibroMeter |
| 93717-7 | Francisella tularensis IgG Ab [Presence] in Serum by Immunoassay |
| 93798-7 | MYCN gene copy number/nucleus in Tissue by FISH |
| 62861-0 | Enterovirus 71 RNA [Presence] in Specimen by NAA with probe detection |
| 63311-5 | Proteinase 3 Ab [Presence] in Serum by Immunofluorescence |
| 94509-7 | SARS-related coronavirus E gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 789-8 | Erythrocytes [#/volume] in Blood by Automated count |
| 95556-7 | Adrenal cancer risk assessment and urine steroid fractions panel |
| 6620-9 | Acanthamoeba sp Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 80362-7 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by NAA with probe detection |
| 95766-2 | Candida auris DNA [Presence] in Blood by NAA with non-probe detection |
| 96280-3 | European Ash wood dust IgE Ab [Units/volume] in Serum |
| 68546-1 | Mycoplasma hominis DNA [Presence] in Specimen by NAA with probe detection |
| 69808-4 | 2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --pre dose ifosfamide |
| 81747-8 | Chromosome region 6q22 rearrangements in Tissue by FISH |
| 97918-7 | Rift valley fever virus RNA [Presence] in Specimen by NAA with probe detection |
| 70148-2 | Methadone [Presence] in Urine by Screen method >150 ng/mL |
| 97989-8 | Culex mosquito IgG4 Ab [Mass/volume] in Serum |
| 99112-5 | Rocio virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 72677-8 | Salicylates [Mass/volume] in Serum or Plasma --trough |
| 72970-7 | Piperacillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86231-8 | Midazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 88023-7 | XLR-11 N-(4-hydroxypentyl) (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 74430-0 | 3-Hydroxykynurenin [Moles/volume] in Serum or Plasma |
| 89511-0 | Ganglioside GM3 IgG+IgM Ab [Presence] in Serum by Line blot |
| 41436-7 | Cyclospora cayetanensis DNA [Presence] in Specimen by NAA with probe detection |
| 59804-5 | Cortisol [Molar concentration difference] in Serum or Plasma --1 hour post XXX challenge |
| 59883-9 | Chlorpheniramine [Moles/volume] in Gastric fluid |
| 50624-6 | HIV 1 RNA panel (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 43124-7 | Cystine panel - Urine |
| 51912-4 | Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool --2nd specimen |
| 3226-8 | Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay |
| 52929-7 | Mercury/Creatinine [Molar ratio] in 24 hour Urine |
| 44046-1 | Bordetella pertussis Higashi-Hama Ab [Units/volume] in Serum |
| 32755-1 | CD19 cells/100 cells in Bronchial specimen |
| 53324-0 | Spermatozoa [#/area] in Urine sediment by Automated count |
| 44491-9 | Herpes simplex virus 2 Ab [Presence] in Body fluid |
| 44705-2 | ALS4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 45182-3 | HIV phenotype [Susceptibility] |
| 45204-5 | Glucose [Mass/volume] in Urine by Test strip --3rd specimen post XXX challenge |
| 33838-4 | Mannitol [Moles/volume] in Serum or Plasma |
| 46159-0 | Bartonella sp IgM Ab [Units/volume] in Serum |
| 46436-2 | Histamine [Moles/volume] in Blood |
| 24518-3 | Calcium/Creatinine [Molar ratio] in Urine |
| 55800-7 | Platelet aggregation ristocetin induced [Presence] in Platelet rich plasma --1000 mg/L |
| 25690-9 | Insulin [Moles/volume] in Serum or Plasma --15th specimen post XXX challenge |
| 25769-1 | Insulin-like growth factor [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 35702-0 | Acid hemolysis fraction in Blood |
| 56218-1 | Chicken IgG4 Ab [Mass/volume] in Serum |
| 2635-1 | Mianserin [Mass/volume] in Serum or Plasma |
| 3592-3 | ePHEDrine [Presence] in Urine |
| 36918-1 | ALDOB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 3743-2 | Mefenorex [Mass/time] in 24 hour Urine |
| 3777-0 | Methamphetamine [Presence] in Serum or Plasma |
| 48426-1 | Troponin T.cardiac [Presence] in Blood |
| 48632-4 | Heptacarboxylporphyrin [Mass/time] in 24 hour Stool |
| 48720-7 | Coxiella burnetii phase 1 IgG Ab [Presence] in Serum by Immunofluorescence |
| 48840-3 | Respiratory allergen panel, US - Cascade Pacific northwest a - Serum |
| 48864-3 | Bartonella sp DNA [Presence] in Specimen by NAA with probe detection |
| 38248-1 | Brucella sp IgM Ab [Titer] in Serum |
| 38467-7 | Chlamydia sp IgG Ab [Presence] in Body fluid |
| 48897-3 | Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 39480-9 | Glucose [Moles/volume] in Venous blood |
| 49684-4 | CPT2 gene p.Arg503Cys [Presence] in Blood by Molecular genetics method |
| 39771-1 | Porphyrins [Moles/volume] in Urine |
| 49869-1 | Camel dander IgE Ab [Units/volume] in Serum |
| 40409-5 | 3-Methoxytyramine [Moles/time] in 24 hour Urine |
| 40516-7 | Histiocytes/100 cells in Peritoneal fluid by Manual count |
| 4070-9 | Triazolam [Mass/volume] in Urine |
| 5881-8 | Varicella zoster virus Ag [Presence] in Skin by Immunofluorescence |
| 59201-4 | Deoxyguanosine/Creatinine [Molar ratio] in Urine |
| 50251-8 | 3-Hydroxybutyrylcarnitine (C4-OH)/Creatinine [Molar ratio] in Urine |
| 50332-6 | Hexadecanedioate/Creatinine [Mass Ratio] in Urine |
| 19265-8 | Amphetamines [Identifier] in Urine by Confirmatory method |
| 19428-2 | Dextromethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
| 19624-6 | Nordiazepam [Presence] in Urine by Screen method |
| 19721-0 | Trichlorothiazide [Mass/volume] in Urine |
| 2022-2 | Carbon dioxide [Partial pressure] in Cerebral spinal fluid |
| 12437-0 | traMADol [Mass/volume] in Serum or Plasma |
| 100431-6 | Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) |
| 100663-4 | TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method |
| 12603-7 | N-desalkylflurazepam [Presence] in Stool |
| 13177-1 | Russian olive IgE Ab [Units/volume] in Serum |
| 101957-9 | RTEL1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 13538-4 | Carbon dioxide, total [Moles/volume] in Urine |
| 13667-1 | Alpha aminobutyrate/Creatinine [Mass Ratio] in Urine |
| 14139-0 | Ketones [Presence] in Urine --4 hours post XXX challenge |
| 102758-0 | Lactalbumin alpha IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14800-7 | Iron binding capacity [Moles/volume] in Serum or Plasma |
| 103166-5 | Adenovirus 1 and 2 Beta DNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 103620-1 | Lupus anticoagulant aPTT screening panel - Platelet poor plasma by Coagulation assay |
| 10675-7 | Hepatitis B virus surface Ag [Presence] in Tissue by Orcein stain |
| 15366-8 | Dextroamphetamine [Mass/volume] in Urine |
| 15424-5 | Service comment 33 |
| 16243-8 | Cannabinoids [Mass/volume] in Blood by Confirmatory method |
| 17650-3 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 18191-7 | Amino acids [Identifier] in 24 hour Urine |
| 18212-1 | Complement C1 esterase inhibitor free IgG Ab [Mass/volume] in Serum or Plasma |
| 74652-9 | Methylenedioxymethamphetamine [Mass/volume] in Serum, Plasma or Blood |
| 74882-2 | Leucine [Moles/volume] in DBS --post therapeutic diet |
| 75516-5 | Cortisol Free [Moles/volume] in 24 hour Urine |
| 7558-0 | Oyster IgE Ab [Units/volume] in Serum |
| 60391-0 | Pear IgG Ab [Mass/volume] in Serum |
| 76769-9 | Hemoglobin [Mass/volume] in Venous blood by Oximetry |
| 93344-0 | Treatment to which genetic variant confers resistance [Identifier] in Blood or Tissue Nominal |
| 61410-7 | Cyclobenzaprine [Mass/volume] in Urine by Confirmatory method |
| 6171-3 | Cajeput tree IgE Ab [Units/volume] in Serum |
| 7709-9 | Sole IgE Ab [Units/volume] in Serum |
| 93937-1 | E Ag [Presence] on Red Blood Cells --during infancy |
| 63096-2 | Mango IgG Ab [Mass/volume] in Serum |
| 78520-4 | Platelet aggregation ADP induced in Platelet rich plasma --2.5 umol/L |
| 78854-7 | M-chlorophenylpiperazine [Mass/volume] in Serum or Plasma |
| 94425-6 | Human papilloma virus E6+E7 mRNA [Presence] in Specimen by NAA with probe detection |
| 64139-9 | Butalbital/Creatinine [Mass Ratio] in Urine |
| 6414-7 | Haemophilus influenzae A Ag [Presence] in Specimen by Immunofluorescence |
| 95562-5 | Dehydroepiandrosterone (DHEA) [Z-score] in 24 hour Urine |
| 6554-0 | Streptococcus pneumoniae Ag [Presence] in Sputum by Immunofluorescence |
| 66450-8 | Olive native (nOle e) 2 IgE Ab [Units/volume] in Serum |
| 8046-5 | Varicella zoster virus Ab [Units/volume] in Serum |
| 9656-0 | Echinococcus sp IgG Ab [Units/volume] in Serum by Immunoassay |
| 9688-3 | Carbaryl [Mass/volume] in Serum or Plasma |
| 9695-8 | 3-Methoxy-4-Hydroxyphenylglycol [Mass/time] in 24 hour Urine |
| 98493-0 | SARS-CoV-2 (COVID-19) ORF1b region [Presence] in Saliva (oral fluid) by NAA with probe detection |
| 7213-2 | Parmesan Cheese triggered histamine release [Units/volume] in Blood |
| 7246-2 | Cola nut triggered histamine release [Units/volume] in Blood |
| 83095-0 | Epstein Barr virus capsid+early IgG Ab [Presence] in Serum by Immunoassay |
| 85043-8 | ESBL by cefepime to cefepime-clavulanate IC ratio [Presence] by ARD gradient strip |
| 85828-2 | Carbapenem resistance blaOXA-58-like gene [Presence] by Molecular method |
| 73326-1 | Irbesartan+hydroCHLOROthiazide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73441-8 | Clarithromycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88189-6 | Dengue virus 1+2+3+4 RNA [Presence] in Blood by NAA with probe detection |
| 59355-8 | Tapentadol [Mass/mass] in Tissue |
| 21355-3 | Ketones [Presence] in Urine --2.5 hours post XXX challenge |
| 21640-8 | BRCA2 gene c.6174delT [Presence] in Blood or Tissue by Molecular genetics method |
| 31417-9 | Herpes virus 7 IgM Ab [Units/volume] in Serum |
| 31816-2 | Equine herpesvirus 1 Ag [Presence] in Tracheal swab |
| 51675-7 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 5282-9 | Polio virus 1 Ab [Titer] in Serum by Complement fixation |
| 52950-3 | Barbital [Presence] in Gastric fluid |
| 52956-0 | Barbiturates [Moles/volume] in Urine |
| 32783-3 | Leucine+Isoleucine+Valine [Identifier] in Serum or Plasma |
| 33043-1 | Ketones [Presence] in 24 hour Urine |
| 33053-0 | Protoporphyrin [Molar ratio] in Red Blood Cells |
| 53388-5 | Trichothecene IgA Ab [Units/volume] in Serum |
| 44577-5 | Influenza virus B Ag [Presence] in Nose |
| 53932-0 | Streptococcus pneumoniae 14 serotypes and Corynebacterium diphtheriae toxin and Clostridium tetani toxin Ab.IgG panel - Serum |
| 45002-3 | Chlamydia trachomatis IgG Ab [Presence] in Cerebral spinal fluid |
| 45303-5 | Urea [Moles/volume] in Dialysis fluid --2 hour specimen |
| 23870-9 | Hepatitis C virus 100+5-1-1 Ab [Presence] in Serum by Immunoblot |
| 33898-8 | Bilirubin.conjugated+indirect [Mass/volume] in Serum or Plasma |
| 24500-1 | Parrot serum Ab [Presence] in Serum by Immune diffusion (ID) |
| 24513-4 | Tree Allergen Mix C (Berry juniper+Oneseed juniper+Rocky mountain juniper) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 34487-9 | Influenza virus A RNA [Presence] in Specimen by NAA with probe detection |
| 55118-4 | Centers for Environmental Health trace metals panel [Mass/volume] - Urine |
| 55369-3 | Dengue virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 47280-3 | Erythrocytes [#/volume] in Cord blood |
| 4733-2 | HLA-A30(19) [Presence] |
| 47441-1 | Hepatitis C virus Ab [Presence] in Serum from Donor |
| 55705-8 | Piromidate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 55912-0 | Arylsulfatase [Enzymatic activity/volume] in DBS |
| 25621-4 | Cortisol [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 2587-4 | Lysine [Mass/time] in 24 hour Urine |
| 35480-3 | 1-Naphthol [Mass/volume] in Urine |
| 47925-3 | Somatotropin [Units/volume] in Serum or Plasma --5 minutes post dose arginine+insulin |
| 48283-6 | Mivacurium triggered leukotriene release [Mass/volume] by Leukocytes |
| 56674-5 | Beta alanine/Creatinine [Ratio] in 24 hour Urine |
| 56681-0 | Glycine/Creatinine [Ratio] in 24 hour Urine |
| 48663-9 | YKL-40 [Mass/volume] in Serum |
| 27159-3 | Herpes virus 6 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 2799-5 | Phosphoglyceromutase [Enzymatic activity/volume] in Serum |
| 57960-7 | Erythrocytes [Morphology] in Body fluid by Light microscopy |
| 58053-0 | Ch sup(a) Ag [Presence] on Red Blood Cells |
| 49572-1 | Second trimester triple maternal screen [Interpretation] in Serum or Plasma Narrative |
| 40258-6 | Creatinine [Mass/volume] in Serum or Plasma --1 day post XXX challenge |
| 49945-9 | Somatotropin [Units/volume] in Serum or Plasma --10:30 PM specimen |
| 5004-7 | Epstein Barr virus DNA [Presence] in Tissue by NAA with probe detection |
| 40390-7 | OLANZapine [Presence] in Urine |
| 40614-0 | Brucella sp Ab [Presence] in Serum by Agglutination |
| 59150-3 | Vancomycin resistant enterococcus [Presence] in Anal by Organism specific culture |
| 50202-1 | Iron [Mass/volume] in Serum or Plasma --5th specimen |
| 50247-6 | 17-Hydroxycorticosteroids [Mass/time] in 24 hour Urine --post dose dexamethasone |
| 20470-1 | Ethanol [Presence] in Serum or Plasma by Screen method |
| 20780-3 | Cryptosporidium sp [Presence] in Large intestine or small intestine Tissue by Acid fast stain |
| 12427-1 | Chlormezanone [Mass/volume] in Serum or Plasma |
| 100740-0 | Amylase.macromolecular [Presence] in Serum or Plasma |
| 100866-3 | Febrile antibody profile in Serum |
| 12446-1 | Halogenated organic molecules [Identifier] in Urine |
| 101404-2 | Borrelia afzelii+burgdorferi+garinii Ab.IgG and IgM panel - Serum or Plasma by Immunoassay |
| 13047-6 | Plasma cells/100 leukocytes in Blood |
| 13157-3 | Streptococcus pneumoniae Danish serotype 18C Ab [Units/volume] in Serum --1st specimen |
| 13306-6 | HLA-DR beta [Type] |
| 13587-1 | Vancomycin [Mass/volume] in Body fluid |
| 10240-0 | Oxygen content in Right ventricle |
| 103000-6 | Timothy native (nPhl p) 4 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14433-7 | Albumin/Globulin [Mass Ratio] in Cerebral spinal fluid |
| 14731-4 | Folate [Moles/volume] in Red Blood Cells |
| 1042-1 | H Ab [Presence] in Serum or Plasma from Blood product unit |
| 10465-3 | Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain |
| 10867-0 | Sulfatide IgM Ab [Titer] in Serum |
| 11119-5 | Normoblasts Polychromatophilic/100 cells in Bone marrow by Manual count |
| 16636-3 | Coccidioides immitis IgA Ab [Units/volume] in Cerebral spinal fluid |
| 12246-5 | Porphyrins [Presence] in 24 hour Urine |
| 16805-4 | Echovirus 6 Ab [Units/volume] in Serum by Complement fixation |
| 17325-2 | Neisseria meningitidis serogroups C+w135 Ag [Presence] in Urine |
| 18246-9 | Nitrogen [Mass/volume] in Stool |
| 74794-9 | Thyroid hormone binding ratio (THBR) in Serum or Plasma |
| 92740-0 | Oxysterols panel - Serum or Plasma |
| 75120-6 | Octanoate (C8:0) [Entitic substance] in Red Blood Cells |
| 60489-2 | Streptococcus pyogenes DNA [Presence] in Throat by NAA with probe detection |
| 60525-3 | Parechovirus RNA [Presence] in Specimen by NAA with probe detection |
| 76038-9 | Tripeptidyl peptidase I [Enzymatic activity/mass] in Leukocytes |
| 61263-0 | American Beech IgE Ab/IgE total in Serum |
| 94231-8 | G6PD gene full mutation analysis in Blood or Tissue by Sequencing |
| 6258-8 | Sunflower Seed IgE Ab [Units/volume] in Serum |
| 78008-0 | HIV 1 proviral DNA [Entitic number] (viral load) in Mononuclear cells from unspecified specimen by NAA with probe detection |
| 64982-2 | Cockroach recombinant (rBla g) 1 IgE Ab [Units/volume] in Serum |
| 79316-6 | Isoxanthopterin [Moles/volume] in Serum or Plasma |
| 79324-0 | Pyridoxal phosphate and pyridoxal and pyridoxine panel - Cerebral spinal fluid |
| 9638-8 | Toluene [Mass/volume] in Urine |
| 67820-1 | Human metapneumovirus A RNA [Presence] in Specimen by NAA with probe detection |
| 81201-6 | Phospholipase A2 receptor IgG Ab [Titer] in Serum by Immunofluorescence |
| 82164-5 | Human coronavirus OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 9784-0 | Ehrlichia chaffeensis IgM Ab [Titer] in Serum |
| 83099-2 | Galectin 3 [Mass/volume] in Serum or Plasma by Immunoassay |
| 72573-9 | Uroporphyrin/Porphyrins.total [Pure substance fraction] in 24 hour Urine |
| 72976-4 | Penicillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86096-5 | Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum --2nd specimen |
| 73082-0 | Verapamil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87595-5 | Oxytetracycline [Mass/mass] in Specimen |
| 88244-9 | Acinetobacter sp rpsA gene [Presence] by Probe in Positive blood culture |
| 88688-7 | Pneumocystis jiroveci DNA [#/volume] in Lower respiratory specimen by NAA with probe detection |
| 89586-2 | Herpes simplex virus 1 Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 4123-6 | Amoxicillin [Mass] of Dose |
| 59667-6 | Estazolam [Mass/volume] in Body fluid by Confirmatory method |
| 50884-6 | Molybdenum [Moles/time] in 24 hour Urine |
| 42198-2 | Curvularia specifera IgE Ab [Units/volume] in Serum |
| 42206-3 | IgA in CSF/IgA in serum |
| 21667-1 | F5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 51126-1 | CD22 blasts/100 blasts in Specimen |
| 22154-9 | Brucella canis IgG Ab [Titer] in Serum |
| 51731-8 | Oxygen saturation Calculated from oxygen partial pressure in Venous blood |
| 22521-9 | Salmonella paratyphi B H Ab [Presence] in Serum |
| 22571-4 | Teichoate Ab [Titer] in Serum |
| 2265-7 | Ethylmalonate [Mass/volume] in Urine |
| 32291-7 | Acetone [Moles/volume] in Urine |
| 32319-6 | Glucose [Moles/volume] in Serum or Plasma --30 minutes post 75 g glucose PO |
| 5242-3 | Measles virus Ab [Units/volume] in Serum by Immunoassay |
| 43874-7 | Influenza virus A Ag [Presence] in Nasopharynx |
| 23076-3 | Equine arteritis virus Ag [Presence] in Specimen by Neutralization test |
| 23091-2 | Equine herpesvirus 1+4 Ag [Presence] in Body fluid by Immunofluorescence |
| 53070-9 | Butyrylcarnitine (C4) [Moles/volume] in Cerebral spinal fluid |
| 23255-3 | Mycoplasma bovis Ab [Presence] in Serum |
| 23588-7 | Western equine encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
| 33625-5 | Isocoproporphyrin [Mass/time] in 24 hour Stool |
| 33729-5 | Size additional dimension in Tumor |
| 44923-1 | Hemoglobin S/Hemoglobin.total in Blood by HPLC |
| 46707-6 | Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgE Ab [Units/volume] in Serum by Multidisk |
| 24484-8 | Food Allergen Mix 5 (Peanut+Cow milk+Egg white+Cod+Soybean+Wheat) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 55362-8 | Thyrotropin [Units/volume] in Serum or Plasma --pre XXX challenge |
| 47228-2 | Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma |
| 34908-4 | Neopterin [Mass/volume] in Serum or Plasma |
| 35278-1 | Neuronal nuclear Ab [Presence] in Serum by Immunoblot |
| 5596-2 | Beryllium [Mass/time] in 24 hour Urine |
| 47729-9 | Prolactin [Mass/volume] in Serum or Plasma --1.5 hours post dose TRH IV |
| 25998-6 | Urea [Moles/volume] in 24 hour Urine |
| 26750-0 | Carnosine [Moles/volume] in Amniotic fluid |
| 5670-5 | Isopropanol [Presence] in Urine |
| 56979-8 | Sodium [Moles/volume] in Saliva (oral fluid) |
| 4876-9 | HLA-Dw14 [Presence] in Donor |
| 26942-3 | Mumps virus Ab [Presence] in Serum by Immunoassay |
| 27360-7 | Myelin basic protein Ab [Units/volume] in Serum |
| 38991-6 | Amylase [Enzymatic activity/volume] in 12 hour Urine |
| 39592-1 | Brazil Nut IgE Ab/IgE total in Serum |
| 4937-9 | HLA-DQ3 [Presence] |
| 49385-8 | Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 5841-2 | Enterovirus identified in Isolate by Neutralization test |
| 58696-6 | Cortisol [Moles/volume] in Saliva (oral fluid) --8th specimen post XXX challenge |
| 58767-5 | Erythrocytes [#/area] in Semen by Microscopy high power field |
| 50061-1 | Tetradecanedioate/Creatinine [Molar ratio] in Urine |
| 50108-0 | 3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Urine |
| 29599-8 | Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 40425-1 | CYP2D6 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 50586-7 | Glucose tolerance 3 hours panel - Serum or Plasma |
| 29987-5 | Gold [Mass/volume] in 24 hour Urine |
| 40767-6 | Coxsackievirus B IgG Ab [Titer] in Cerebral spinal fluid --2nd specimen |
| 20784-5 | Cyanide [Mass/volume] in Specimen |
| 12493-3 | Hexobarbital [Mass/volume] in Serum or Plasma |
| 12756-3 | Insulin [Mass/volume] in Serum or Plasma --12 hours post XXX challenge |
| 101460-4 | Septin-5 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 101950-4 | Streptococcus pyogenes DNA [Presence] in Wound by NAA with probe detection |
| 13715-8 | C peptide/Creatinine [Mass Ratio] in 24 hour Urine |
| 14142-4 | Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 14226-5 | Nocardia sp identified in Isolate by Organism specific culture |
| 103011-3 | Aspergillus fumigatus recombinant (rAsp f) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14596-1 | Amitriptyline+Nortriptyline [Presence] in Urine |
| 103128-5 | Honey bee recombinant (rApi m) 2 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103673-0 | Isavuconazole [Susceptibility] in Isolate by Gradient strip |
| 14909-6 | Salicylates [Moles/volume] in Serum or Plasma |
| 15113-4 | Aluminum [Moles/volume] in Dialysis fluid |
| 1556-0 | Fasting glucose [Mass/volume] in Capillary blood |
| 16339-4 | Alpha aminoisobutyrate [Presence] in Urine |
| 16619-9 | Clarithromycin [Mass/volume] in Serum or Plasma |
| 11608-7 | Japanese encephalitis virus Ab [Units/volume] in Serum |
| 17495-3 | Prostaglandins [Mass/volume] in Urine |
| 17601-6 | Volume of 24 hour Sputum |
| 17912-7 | Bacteria # 4 identified in Wound deep by Aerobe culture |
| 18866-4 | Azithromycin [Susceptibility] |
| 7448-4 | Lamb IgG Ab [Units/volume] in Serum |
| 74917-6 | CXCL13 Ag [Mass/volume] in Cerebral spinal fluid |
| 75880-5 | 14-3-3 eta Ag [Mass/volume] in Serum by Immunoassay |
| 93329-1 | Hyodeoxycholate [Moles/volume] in Serum or Plasma |
| 6268-7 | Trout IgE Ab [Units/volume] in Serum |
| 63195-2 | Sunflower Pollen IgG Ab [Mass/volume] in Serum |
| 63226-5 | DNA double strand IgG Ab [Units/volume] in Body fluid by Immunoassay |
| 78211-0 | Cells.4q12 chromosome region rearrangements/Cells counted in Blood or Tissue by FISH |
| 78823-2 | DULoxetine [Presence] in Urine by Confirmatory method |
| 6398-2 | Entamoeba histolytica Ag [Units/volume] in Stool by Immunoassay |
| 95090-7 | C peptide [Mass/volume] in Serum or Plasma --5 hours post meal |
| 95416-4 | SARS-CoV-2 (COVID-19) IgM Ab [Presence] in DBS by Immunoassay |
| 6708-2 | Echovirus 11 Ab [Titer] in Serum by Complement fixation |
| 69028-9 | oxyMORphone [Mass/mass] in Meconium by Confirmatory method |
| 80581-2 | Specimen incubation date and time range |
| 81841-9 | MLC1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 9758-4 | Coxsackievirus A9 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 97637-3 | Streptococcus pneumoniae DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 97948-4 | Ilheus virus RNA [Presence] in Specimen by NAA with probe detection |
| 7012-8 | Fleroxacin [Susceptibility] by Gradient strip |
| 72472-4 | UR-144 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 99123-2 | Heartland banyangvirus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 99377-4 | Pellitory (Parietaria judaica) IgG Ab [Mass/volume] in Serum |
| 86576-6 | Measles virus RNA [Presence] in Serum by NAA with probe detection |
| 86726-7 | Erysipelothrix rhusiopathiae DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73656-1 | Varicella zoster virus ORF28 genotype [Identifier] |
| 88018-7 | Alanine/Lysine [Mass Ratio] in DBS |
| 88995-6 | Docosahexaenoate (C22:6w3)/Fatty acids.C14-C24 in Serum or Plasma |
| 50697-2 | Influenza virus A Ag [Identifier] in Isolate |
| 50812-7 | Arsenic [Moles/volume] in Red Blood Cells |
| 42201-4 | DNA single strand IgG Ab [Units/volume] in Serum by Immunoassay |
| 59989-4 | Testosterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 21169-8 | CD71 cells/100 cells in Specimen |
| 2144-4 | Cortisol [Mass/volume] in Urine |
| 21629-1 | ATP7B gene c.2487insT [Presence] in Blood or Tissue by Molecular genetics method |
| 21813-1 | t(2;5)(p23;q35.1)(ALK,NPM1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 22130-9 | Borrelia burgdorferi IgG Ab [Titer] in Serum |
| 31872-5 | Leptospira sp Ag [Presence] in Urine |
| 51870-4 | Frozen erythrocytes given [Volume] |
| 22337-0 | Herpes simplex virus 2 IgG Ab [Titer] in Cerebral spinal fluid |
| 22519-3 | Salmonella paratyphi A O Ab [Presence] in Serum |
| 32097-8 | Methyprylon [Presence] in Specimen |
| 32367-5 | Bacteria identified in Isolate by Aerobe culture |
| 32510-0 | CD5+CD19+ cells/100 cells in Bone marrow |
| 52968-5 | Streptococcus agalactiae [Presence] in Anal by Organism specific culture |
| 52989-1 | Leptospira sp DNA [Presence] in Blood by NAA with probe detection |
| 44044-6 | Basophils [Presence] in Peritoneal fluid by Light microscopy |
| 44063-6 | CD20+FMC7+ cells/100 cells in Body fluid |
| 443-2 | Roxithromycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 23492-2 | Transmissible gastroenteritis virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 33332-8 | Linezolid [Susceptibility] by Gradient strip |
| 33725-3 | Tumor site |
| 53650-8 | Methyl parathion [Mass/volume] in Gastric fluid |
| 45017-1 | Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --baseline |
| 45362-1 | Lymphocyte proliferation stimulated by 0.50 ug pokeweed mitogen in Blood |
| 24009-3 | Fungus identified in Bronchial specimen by Culture |
| 4546-8 | Hemoglobin A/Hemoglobin.total in Blood |
| 24320-4 | Basic metabolic 1998 panel - Serum or Plasma |
| 35067-8 | Blasts [#/volume] in Body fluid |
| 35112-2 | Floxacillin [Mass/volume] in Serum or Plasma |
| 35166-8 | Oleate (C18:1w9) [Moles/volume] in Serum or Plasma |
| 55686-0 | Miconazole [Susceptibility] by Gradient strip |
| 47677-0 | Isoleucine/Amino acids.total in Specimen |
| 47755-4 | Somatotropin [Units/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 35398-7 | Epstein Barr virus DNA [Presence] in Mouth by NAA with probe detection |
| 56466-6 | Swordfish IgG4 Ab [Mass/volume] in Serum |
| 48227-3 | Human serum albumin triggered leukotriene release [Mass/volume] by Leukocytes |
| 26448-1 | Blasts/100 leukocytes in Body fluid |
| 3704-4 | Labetalol [Mass/volume] in Serum or Plasma |
| 38172-3 | Organic acids [Moles/volume] in Serum or Plasma |
| 48824-7 | Respiratory allergen panel, US - North Atlantic states a - Serum |
| 26803-7 | Ethanolamine [Presence] in 24 hour Urine |
| 27219-5 | Ornithine [Moles/volume] in Amniotic fluid |
| 57349-3 | Phosphate [Mass/volume] in 2 hour Urine |
| 57661-1 | Tubular basement membrane Ab [Titer] in Serum by Immunofluorescence |
| 49736-2 | Clarity of Cerebral spinal fluid |
| 29286-2 | Methamphetamine [Presence] in Meconium |
| 49779-2 | Ketones [Mass/volume] in Urine |
| 501-7 | Ticarcillin [Susceptibility] by Disk diffusion (KB) |
| 40354-3 | MT-ND1 gene m.3460G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 50433-2 | Cortisol [Mass/volume] in Serum or Plasma --3 AM specimen |
| 30080-6 | Cathepsin D [Presence] in Tissue by Immune stain |
| 20442-0 | Hepatitis B virus DNA [#/volume] (viral load) in Serum by Probe with signal amplification |
| 20712-6 | Bovine diarrhea virus Ag [Presence] in Tissue by Immunofluorescence |
| 21035-1 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --morning specimen |
| 100090-0 | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot |
| 12541-9 | Meta methylhippurate+Para methylhippurate [Mass/volume] in Urine |
| 12606-0 | Dolichol [Mass/volume] in Serum or Plasma |
| 101295-4 | Influenza virus B RNA [Presence] in Throat by NAA with non-probe detection |
| 101378-8 | Lung cancer targeted gene fusion transcript analysis in Tissue by Sequencing |
| 13046-8 | Variant lymphocytes/100 leukocytes in Blood |
| 13631-7 | Immune complex [Mass/volume] in Serum or Plasma by Polyethylene glycol (PEG) assay |
| 14428-7 | Globulin [Mass/volume] in Peritoneal fluid |
| 14576-3 | Blood group antibody investigation [Interpretation] in Plasma or RBC by Senior review |
| 103723-3 | Leishmania spp DNA [Presence] in Blood by NAA with non-probe detection |
| 103746-4 | Human papilloma virus 16 and 18+45 mRNA [Presence] in Anorectal by NAA with probe detection |
| 104115-1 | heparan-alpha-glucosaminide N-acetyltransferase [Enzymatic activity/volume] in DBS |
| 14999-7 | Thyrotropin [Units/volume] in Serum or Plasma --baseline |
| 104378-5 | Coxiella burnetii IgG Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 105-7 | Ceforanide [Susceptibility] by Disk diffusion (KB) |
| 11198-9 | Shark IgE Ab [Units/volume] in Serum |
| 11221-9 | Pentacarboxylporphyrins [Mass/volume] in Urine |
| 91766-6 | Entamoeba histolytica DNA [Presence] in Aspirate by NAA with probe detection |
| 75051-3 | Xylose/Creatinine [Molar ratio] in Urine |
| 6077-2 | Cocklebur IgE Ab [Units/volume] in Serum |
| 77126-1 | PCDH15 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 93732-6 | IgE [Units/volume] in Tear |
| 93756-5 | Mycoplasma hyorhinis IgG Ab/Positive control in Serum by Immunoassay |
| 93761-5 | Influenza virus A PA gene [Nucleotide sequence] in Isolate by Sequencing |
| 93891-0 | Methane/Expired gas [Volume Fraction] in Exhaled gas --post dose carbohydrate |
| 78015-5 | HLA-B [Type] by Low resolution |
| 7829-5 | Coxiella burnetii phase 1 IgG Ab [Units/volume] in Serum |
| 94-3 | Cefodizime [Susceptibility] by Serum bactericidal titer |
| 64233-0 | Benzylpiperazine [Presence] in Urine by Confirmatory method |
| 66494-6 | Spermatozoa Acrosome defects/100 spermatozoa in Semen |
| 7976-4 | Paracoccidioides brasiliensis Ab [Units/volume] in Serum |
| 96415-5 | DOCK8 expression panel - Blood by Flow cytometry (FC) |
| 8062-2 | Cardiolipin Ab [Units/volume] in Serum |
| 8124-0 | CD3 cells/100 cells in Blood |
| 69934-8 | Ureaplasma urealyticum+Ureaplasma parvum DNA [Presence] in Specimen by NAA with probe detection |
| 82908-5 | Tetrahydrocortisol/5-Alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
| 98182-9 | Thyroxine (T4) free [Moles/volume] in Cord blood |
| 98192-8 | Cephalothin IgE Ab [Units/volume] in Serum |
| 984-5 | Di sup(a) Ag [Presence] on Red Blood Cells |
| 98989-7 | Band form neutrophils/Leukocytes [Pure number fraction] in Blood by Automated count |
| 86589-9 | Rubella virus RNA [Presence] in Urine by NAA with probe detection |
| 73115-8 | Tobramycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87304-2 | Clostridium perfringens cpa gene [Presence] in Isolate by NAA with probe detection |
| 87322-4 | Escherichia coli enterotoxigenic stb gene [Presence] in Isolate by NAA with probe detection |
| 73721-3 | Rocuronium IgE Ab [Units/volume] in Serum |
| 88131-8 | Cytomegalovirus DNA [Presence] in Ocular fluid by NAA with probe detection |
| 74222-1 | Reviewed material and summary of stains in Bone marrow Narrative |
| 74425-0 | Myelocytes.neutrophilic/100 leukocytes in Blood by Manual count |
| 886-2 | Am Ab [Presence] in Serum or Plasma from Donor |
| 41199-1 | Voriconazole [Susceptibility] by Minimum lethal concentration (MLC) |
| 4120-2 | Amitriptyline [Mass] of Dose |
| 41211-4 | West Nile virus IgG+IgM Ab [Presence] in Serum |
| 41678-4 | Cefpodoxime+Clavulanate [Susceptibility] by Gradient strip |
| 50785-5 | CD18 cells actual/normal in Blood |
| 4262-2 | Flupenthixol [Mass] of Dose |
| 2106-3 | Choriogonadotropin (pregnancy test) [Presence] in Urine |
| 21260-5 | Epstein Barr virus nuclear Ab [Titer] in Serum by Immunofluorescence |
| 31224-9 | Ascaris sp Ab [Units/volume] in Serum |
| 22073-1 | Gaucher 1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 22179-6 | Chlamydophila psittaci IgG Ab [Titer] in Cerebral spinal fluid |
| 2223-6 | Elastase.leukocyte [Enzymatic activity/volume] in Plasma |
| 31713-1 | Adenovirus Ag [Presence] in Urine |
| 32378-2 | Caspofungin [Susceptibility] |
| 5239-9 | Leptospira sp Ab [Titer] in Serum by Latex agglutination |
| 53043-6 | DNA marker analysis test coverage panel |
| 22969-0 | Campylobacter fetus ss venerealis IgA Ab [Presence] in Genital mucus by Immunoassay |
| 3259-9 | Fibrinogen fragments Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 5336-3 | Saccharomonospora viridis Ab [Units/volume] in Serum |
| 44860-5 | Methoxyacetate/Creatinine [Mass Ratio] in Urine |
| 53847-0 | CACT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 53892-6 | Ribosomal P IgG Ab [Units/volume] in Serum |
| 4537-7 | Erythrocyte sedimentation rate by Westergren method |
| 24043-2 | Acetyl-CoA:glucosamine acetyltransferase [Enzymatic activity/mass] in Fibroblast |
| 24082-0 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/mass] in Red Blood Cells |
| 24286-7 | Western equine encephalitis virus Ab [Titer] in Serum --2nd specimen |
| 24411-1 | Canine parvovirus Ab [Presence] in Serum by Hemagglutination inhibition |
| 34469-7 | Leukocytes [Presence] in Bile fluid by Light microscopy |
| 47127-6 | Protriptyline [Moles/volume] in Urine |
| 25310-4 | Amoxicillin+Clavulanate [Susceptibility] by Method for Slow-growing mycobacteria |
| 35147-8 | Decenoate (C10:1) [Moles/volume] in Serum or Plasma |
| 55906-2 | Alpha cortolone [Mass/time] in 24 hour Urine |
| 47722-4 | Phenylalanine/Amino acids.total in Cerebral spinal fluid |
| 35713-7 | Chlamydia sp DNA [Presence] in Cervix by NAA with probe detection |
| 47969-1 | PTEN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 35822-6 | Mupirocin [Susceptibility] by Disk diffusion (KB) |
| 35828-3 | Pefloxacin [Susceptibility] by Disk diffusion (KB) |
| 56574-7 | Renin [Enzymatic activity/volume] in Plasma --1 hour post XXX challenge |
| 5683-8 | Manganese [Mass/volume] in Serum or Plasma |
| 48719-9 | Coxiella burnetii phase 2 IgG Ab [Presence] in Serum by Immunofluorescence |
| 57104-2 | Lutropin [Units/volume] in Serum or Plasma --1 hour post dose gonadotropin releasing hormone |
| 48946-8 | Cocaethylene [Mass/volume] in Specimen |
| 49013-6 | Pancreastatin [Mass/volume] in Serum or Plasma |
| 27811-9 | Antithrombin actual/normal in Platelet poor plasma by Chromogenic method |
| 27855-6 | Lutropin [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 39088-0 | Scallop IgE Ab/IgE total in Serum |
| 57920-1 | Carbon dioxide, total [Moles/volume] in Mixed venous blood by calculation |
| 281-6 | Imipenem [Susceptibility] by Serum bactericidal titer |
| 50013-2 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post XXX challenge |
| 50159-3 | Acetylcarnitine (C2)/Creatinine [Molar ratio] in Urine |
| 58913-5 | Parrot feather IgG Ab [Mass/volume] in Serum |
| 50600-6 | HPA-3 [Type] in Blood |
| 30011-1 | Borrelia burgdorferi 45kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
| 41067-0 | PRF1 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
| 191-7 | Clarithromycin [Susceptibility] by Serum bactericidal titer |
| 19337-5 | Amitriptyline+Nortriptyline cutoff [Mass/volume] in Urine for Screen method |
| 20523-7 | chlorproMAZINE [Mass/volume] in Urine by Confirmatory method |
| 20739-9 | Campylobacter sp identified in Body fluid by Organism specific culture |
| 21038-5 | 17-Ketosteroids [Mass/volume] in 24 hour Urine |
| 100703-8 | Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection |
| 12618-5 | Glucose [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 101334-1 | Etizolam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 102100-5 | B-cell acute lymphoblastic leukemia in Blood or Tissue by FISH |
| 102149-2 | Arizona Ash IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13481-7 | Gonadotropin peptide/Creatinine [Mass Ratio] in Urine |
| 102632-7 | Tragacanth IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102642-6 | Ulocladium chartarum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14530-0 | Rubella virus Ag [Presence] in Vaginal fluid by Immunofluorescence |
| 15102-7 | Codeine [Moles/volume] in Serum or Plasma |
| 1559-4 | Insulin [Mass/volume] in Serum or Plasma --1.5 hours post dose TOLBUTamide IV |
| 17400-3 | Human papilloma virus 16+18 Ag [Presence] in Specimen |
| 17885-5 | Bacteria # 4 identified in Genital specimen by Aerobe culture |
| 18499-4 | Microscopic observation [Identifier] in Nipple discharge by Cyto stain |
| 18932-4 | Imipenem [Susceptibility] |
| 90272-6 | Streptococcus agalactiae DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 90444-1 | Diethylpropion [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 91108-1 | Cholesterol in LDL 4 [Mass/volume] in Serum or Plasma |
| 91117-2 | Cholesterol in LDL 6 [Moles/volume] in Serum or Plasma |
| 93243-4 | 11-Hydroxytestosterone [Mass/volume] in Serum or Plasma |
| 62202-7 | XXX microorganism DNA [Identifier] in Isolate by NAA with probe detection |
| 93792-0 | Insulin sensitivity index in Serum or Plasma by calculation |
| 94002-3 | Anion gap 3 in Serum or Plasma --1 hour post dose vasopressin |
| 62431-2 | Eastern equine encephalitis virus IgG Ab [Presence] in Body fluid by Immunoassay |
| 63221-6 | DNA double strand Ab [Presence] in Pleural fluid by Immunofluorescence |
| 63354-5 | Smith extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 6469-1 | Microscopic observation [Identifier] in Stool by Trichrome stain |
| 95581-5 | Tetrahydrocortisol [Z-score] in 24 hour Urine |
| 962-1 | C sup(x) Ab [Presence] in Serum or Plasma from Donor |
| 96268-8 | Monocytes.PD-L1/100 Monocytes in Blood by Flow cytometry (FC) |
| 96302-5 | Candida auris DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 96322-3 | Klebsiella oxytoca DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection |
| 96401-5 | Retinol binding protein panel - Urine |
| 96503-8 | Adenovirus DNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 81328-7 | Cytomegalovirus [Presence] in Lower respiratory specimen by Shell vial culture |
| 8149-7 | Amphetamines [Presence] in Serum or Plasma by Screen method |
| 81689-2 | Hendra virus RNA [Presence] in Specimen by NAA with probe detection |
| 82799-8 | Spatial clot growth analysis panel - Platelet poor plasma |
| 9839-2 | Rheumatoid arthritis nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
| 72168-8 | Ofloxacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 99614-0 | Emicizumab [Mass/volume] in Platelet poor plasma by Coagulation assay |
| 73017-6 | Furosemide induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 868-0 | A3 Ag [Presence] on Red Blood Cells |
| 73584-5 | Norcitalopram [Mass/volume] in Urine |
| 73678-5 | Topotecan [Mass/volume] in Serum or Plasma --trough |
| 88134-2 | Varicella zoster virus DNA [Presence] in Ocular fluid by NAA with probe detection |
| 74412-8 | CBC W Differential panel - Cord blood |
| 41601-6 | Bacteria [Presence] in Peritoneal fluid by Light microscopy |
| 59644-5 | Cocaine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 50774-9 | Nucleated cells [#/volume] in Blood |
| 50894-5 | Pentacarboxylporphyrins [Moles/mass] in Stool |
| 30519-3 | Chenodeoxycholate [Moles/volume] in Serum or Plasma |
| 30544-1 | Phosphate [Mass/volume] in Total parental nutrition |
| 42663-5 | HLA-Cw locus [Type] |
| 60039-5 | Acebutolol [Mass/volume] in Blood |
| 60300-1 | Desipramine [Moles/volume] in Specimen |
| 21135-9 | Canrenone [Mass/volume] in Serum or Plasma |
| 31256-1 | Beta 2 glycoprotein 1 Ab [Presence] in Serum |
| 51137-8 | Cytoplasmic CD3 blasts/100 blasts in Bone marrow |
| 51206-1 | Strontium [Mass/volume] in Body fluid |
| 51284-8 | CD3+CD57+ cells/100 cells in Bone marrow |
| 43088-4 | Aspergillus sp Ab [Titer] in Pleural fluid |
| 43173-4 | Chlamydia trachomatis L2 IgG Ab [Titer] in Serum by Immunofluorescence |
| 32037-4 | Polymorphonuclear cells [Presence] in Pleural fluid by Wright stain |
| 4326-5 | Methsuximide [Mass] of Dose |
| 43333-4 | Equine herpesvirus 2 neutralizing antibody [Titer] in Serum by Neutralization test |
| 43394-6 | Cholesterol in LDL acylated [Mass/volume] in Serum or Plasma |
| 43703-8 | Cytomegalovirus [Presence] in Blood by Shell vial culture |
| 22656-3 | Arginine [Moles/volume] in Cerebral spinal fluid |
| 32101-8 | oxyCODONE [Presence] in Specimen |
| 32139-8 | Haemophilus influenzae Ag [Presence] in Cerebral spinal fluid |
| 32263-6 | Phenylalanine [Moles/volume] in Body fluid |
| 43890-3 | Bordetella pertussis [Presence] in Sputum by Organism specific culture |
| 23557-2 | Vesicular stomatitis virus Ag [Presence] in Skin by Immunoassay |
| 23637-2 | Cefdinir [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 44908-2 | Homovanillate and Creatinine [Interpretation] in Urine |
| 45194-8 | Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma |
| 54339-7 | Tetradecanoylcarnitine (C14) [Moles/volume] in Cerebral spinal fluid |
| 54410-6 | Direct antiglobulin test.complement C3 specific reagent [Presence] on Red Blood Cells |
| 55152-3 | Amiodarone and Desethylamiodarone panel [Mass/volume] - Serum or Plasma |
| 25543-0 | Lipase [Enzymatic activity/time] in 24 hour Urine |
| 55611-8 | Follitropin [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 55658-9 | Clindamycin.high potency [Susceptibility] by Gradient strip |
| 55836-1 | Chitotriosidase [Enzymatic activity/volume] in DBS |
| 56135-7 | Cholesterol in IDL 2 [Moles/volume] in Serum or Plasma |
| 47670-5 | Insulin [Units/volume] in Serum or Plasma --pre-meal |
| 47833-9 | C peptide [Moles/volume] in Serum or Plasma --6 minutes post dose glucagon |
| 47875-0 | Propionyl CoA Carboxylase [Enzymatic activity/mass] in Leukocytes |
| 35403-5 | Leishmania donovani IgM Ab [Presence] in Serum |
| 48186-1 | Amylase triggered leukotriene release [Mass/volume] by Leukocytes |
| 48336-2 | Candida sp Ag [Presence] in Tissue by Immune stain |
| 26584-3 | 1-Methylhistidine [Moles/volume] in Cerebral spinal fluid |
| 26618-9 | Trypanosoma brucei rhodesiense Ab [Presence] in Serum |
| 26679-1 | Secobarbital [Mass/volume] in Vitreous fluid |
| 56935-0 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3.5 hour post dose lactose |
| 26822-7 | Lipoprotein.alpha [Presence] in Body fluid |
| 27174-2 | Inhibin [Units/volume] in Serum or Plasma |
| 38507-0 | Urobilinogen [Units/mass] in Stool |
| 49381-7 | Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 39975-8 | Creatinine [Mass/volume] in Serum or Plasma --4 days post XXX challenge |
| 40231-3 | Calcium [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
| 58552-1 | Corticotropin [Moles/volume] in Plasma --15 minutes pre dose insulin IV |
| 29732-5 | Leptospira interrogans sv Robinsoni Ab [Presence] in Serum by Agglutination |
| 29951-1 | Beta globulin [Presence] in 24 hour Urine |
| 58843-4 | Somatotropin [Mass/volume] in Serum or Plasma --24th specimen |
| 5059-1 | Bordetella pertussis Ab [Units/volume] in Serum by Immunoassay |
| 3025-4 | Thyroxine (T4) [Mass/volume] in Blood |
| 40815-3 | 11-Ketoetiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine |
| 193-3 | Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 20945-2 | Bovine respiratory syncytial virus Ag [Presence] in Lung by Immunofluorescence |
| 12361-2 | Oxazepam [Presence] in Urine |
| 100343-3 | Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |
| 101491-9 | Piperacillin+Tazobactam [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 13234-0 | Coxsackievirus A4 Ab [Units/volume] in Cerebral spinal fluid |
| 102001-5 | Clot initiation.kaolin induced [Time] in Blood by Thromboelastography^after addition of heparinase |
| 14063-2 | Dezocine [Presence] in Urine |
| 14413-9 | Aspartate aminotransferase [Enzymatic activity/volume] in Urine |
| 14488-1 | Virus identified in Cerebral spinal fluid by Immunofluorescence |
| 14804-9 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction |
| 15268-6 | Tree Allergen Mix 7 (Olive+Willow+Eastern white pine+Eucalyptus spp+Wattle+Cajeput) IgE Ab [Presence] in Serum by Multidisk |
| 16473-1 | Bordetella parapertussis Ab [Units/volume] in Serum |
| 1722-8 | Adenosine deaminase [Enzymatic activity/volume] in Blood |
| 17764-2 | Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 18330-1 | Neutrophil cytoplasmic IgG Ab [Units/volume] in Serum |
| 74629-7 | Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma |
| 92495-1 | Kp sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 92524-8 | LW sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 75089-3 | 5-Oxoproline [Moles/volume] in Serum or Plasma |
| 75583-5 | Fetal Prader-Willi syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 92811-9 | Borrelia afzelii+burgdorferi+garinii IgG Ab index [Units/volume] in Serum and CSF by Immunoassay |
| 92814-3 | Borrelia afzelii+burgdorferi+garinii IgG Ab [Presence] in Serum by Immunoassay |
| 61246-5 | Lemon IgE Ab/IgE total in Serum |
| 61415-6 | Doxepin [Presence] in Urine by Confirmatory method |
| 6241-4 | Dry-rot Fungus IgE Ab [Units/volume] in Serum |
| 6250-5 | Spiny Pigweed IgE Ab [Units/volume] in Serum |
| 63403-0 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
| 63450-1 | CD3+CD4+ (T4 helper) cells [#/volume] in Cerebral spinal fluid |
| 64969-9 | London Plane recombinant (rPla a) 1 IgE Ab [Units/volume] in Serum |
| 78875-2 | PARoxetine cutoff [Mass/volume] in Urine for Confirmatory method |
| 7926-9 | Influenza virus A Phillipines Ab [Units/volume] in Serum |
| 79427-1 | Platelets [#/area] in Blood by Microscopy high power field |
| 95240-8 | Hepatitis E virus Ab [Interpretation] in Serum or Plasma |
| 66756-8 | Clot initiation [Time] in Blood by Thromboelastography --after addition of heparinase |
| 96045-0 | Osmotic fragility of Red Blood Cells--10% glucose 48 hour 37 degree C incubation |
| 96368-6 | Pregabalin [Presence] in Saliva (oral fluid) by Confirmatory method |
| 96568-1 | Toxocara sp IgG Ab [Presence] in Serum by Immunoassay |
| 96756-2 | SARS-CoV-2 (COVID-19) S gene codon N501= [Presence] in Specimen by Molecular genetics method |
| 6912-0 | Chlamydophila pneumoniae IgA Ab [Titer] in Serum by Immunofluorescence |
| 70159-9 | Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in DBS |
| 71430-3 | oxyCODONE+oxyMORphone [Presence] in Saliva (oral fluid) by Screen method |
| 83061-2 | BRAF gene [VCF] in Cancer specimen by Sequencing |
| 843-3 | A1 Ag [Presence] on Red Blood Cells from Donor |
| 99602-5 | Glucose/Creatinine [Molar ratio] in 24 hour Urine |
| 72506-9 | ABCB1 gene c.3435C>T [Presence] in Blood or Tissue by Molecular genetics method |
| 72632-3 | Butalbital [Presence] in Saliva (oral fluid) by Confirmatory method |
| 86021-3 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum by Immunoassay |
| 73015-0 | Gabapentin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73859-1 | Allo-tetrahydrocorticosterone [Moles/volume] in Urine |
| 87829-8 | Bacteria [Presence] in Urine |
| 88276-1 | Streptococcus pyogenes hsp60 gene [Presence] by Probe in Positive blood culture |
| 7440-1 | Kiwifruit IgG Ab [Units/volume] in Serum |
| 59329-3 | Salvinorin B [Mass/volume] in Urine |
| 59472-1 | Calcium.ionized [Mass/volume] adjusted to pH 7.4 in Arterial blood by Ion-selective membrane electrode (ISE) |
| 50661-8 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
| 50779-8 | Cancer Ag 19-9 [Units/volume] in Cerebral spinal fluid |
| 50783-0 | CD15 cells actual/normal in Blood |
| 50887-9 | Nickel [Moles/volume] in Red Blood Cells |
| 4206-9 | cycloSERINE [Mass] of Dose |
| 60310-0 | Indomethacin [Moles/volume] in Specimen |
| 21627-5 | ATP7B gene c.2010_2016del [Presence] in Blood or Tissue by Molecular genetics method |
| 31228-0 | Aspergillus clavatus Ab [Presence] in Serum |
| 31500-2 | Ganglioside GM1 IgG+IgM Ab [Units/volume] in Serum |
| 22213-3 | Coxsackievirus A10 Ab [Titer] in Serum |
| 31797-4 | Cytomegalovirus Ag [Presence] in Specimen |
| 22747-0 | Gentamicin [Moles/volume] in Serum or Plasma --trough |
| 32174-5 | Glucose [Presence] in 24 hour Urine |
| 44089-1 | Escherichia coli O157:H7 [Identifier] in Specimen by Organism specific culture |
| 44321-8 | Interleukin 5 [Presence] in Serum or Plasma |
| 22786-8 | Alcelaphine herpesvirus 1 Ab [Titer] in Serum |
| 227-9 | Doxycycline [Susceptibility] by Serum bactericidal titer |
| 33040-7 | Hypnotics [Presence] in Serum or Plasma by Screen method |
| 3350-6 | Amphetaminil [Presence] in Urine |
| 33672-7 | Platelet aggregation.ristocetin+Control PPP induced in Platelet rich plasma |
| 3372-0 | Barbiturate screen absent [Identifier] in Urine |
| 53758-9 | HLA-DRB1 SBT [Type] in Specimen by High resolution |
| 45334-0 | Tryptase [Mass/volume] in Body fluid |
| 45366-2 | Lymphocyte proliferation stimulated by 2.0 ug phytohemagglutinin in Blood |
| 46404-0 | Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose insulin IV |
| 46420-6 | Leukocyte clumps [#/area] in Urine sediment by Microscopy high power field |
| 46740-7 | Hemoglobin disorders newborn screen interpretation |
| 25255-1 | Fluconazole [Mass/volume] in Specimen |
| 2554-4 | Lactose [Mass/time] in 24 hour Urine |
| 34943-1 | Borrelia burgdorferi IgG and IgM panel - Cerebral spinal fluid |
| 35063-7 | Eosinophils [#/volume] in Body fluid |
| 35346-6 | Amylase [Enzymatic activity/volume] in Body fluid --1st specimen post Sincalide |
| 55784-3 | Leukocytes [#/volume] corrected for nucleated erythrocytes in Bone marrow |
| 47808-1 | 2-Ethylhydracrylate/Creatinine [Molar ratio] in Urine |
| 47817-2 | 3-Hydroxy,4-Methoxybenzoate/Creatinine [Molar ratio] in Urine |
| 47829-7 | Arabitol/Creatinine [Molar ratio] in Urine |
| 25978-8 | Sarcosine/Creatinine [Molar ratio] in 24 hour Urine |
| 3564-2 | Dimetamphetamine [Presence] in Urine |
| 35672-5 | Bilirubin.direct/Bilirubin.total in Serum or Plasma |
| 56423-7 | White Hickory IgG4 Ab [Mass/volume] in Serum |
| 48023-6 | HIV 1 proviral DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 48124-2 | Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose glucagon |
| 48211-7 | Beef triggered leukotriene release [Mass/volume] by Leukocytes |
| 56783-4 | Trichloroethane [Moles/volume] in Blood |
| 56990-5 | Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay |
| 38462-8 | Legionella sp Ag [Presence] in Sputum by Immunofluorescence |
| 27908-3 | Coxsackievirus B1 Ab [Presence] in Cerebral spinal fluid |
| 39007-0 | Hepatitis B virus e Ag [Presence] in Specimen |
| 57936-7 | Cholesterol in HDL 2a [Mass/volume] in Serum or Plasma |
| 49734-7 | 11-Dehydro thromboxane beta 2/Creatinine [Mass Ratio] in Urine |
| 29289-6 | Phenylethylmalonamide [Presence] in Urine |
| 2941-3 | Serotonin [Mass/volume] in Platelets |
| 40012-7 | Glucose [Mass/volume] in Serum or Plasma --14 hours post XXX challenge |
| 58427-6 | Carisoprodol [Mass/volume] in Urine by Confirmatory method |
| 58788-1 | Campylobacter jejuni IgM Ab [Titer] in Serum by Immunofluorescence |
| 29736-6 | Rickettsia sibirica Ab [Presence] in Serum |
| 40605-8 | Alpha-2-Macroglobulin [Presence] in Serum by Immunoelectrophoresis |
| 40753-6 | Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 40884-9 | CD19+CD103+ cells/100 cells in Tissue |
| 19211-2 | Oxygen [Partial pressure] in Mixed venous blood |
| 1927-3 | Base excess in Venous blood by calculation |
| 1971-1 | Bilirubin.indirect [Mass/volume] in Serum or Plasma |
| 20875-1 | Manganese [Mass/mass] in Feed |
| 21032-8 | Thrombin time [Interpretation] in Blood |
| 12498-2 | Metharbital [Presence] in Stool |
| 12836-3 | Prostaglandin E2 [Mass/volume] in 24 hour Urine |
| 13052-6 | Protein S/Coagulation factor IX [Mass Ratio] in Platelet poor plasma by Coagulation assay |
| 13435-3 | DOPamine [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 102-4 | Cefoperazone [Susceptibility] by Serum bactericidal titer |
| 102487-6 | Paprika IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102532-9 | Malassezia furfur IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14163-0 | IgA.secretory [Mass/volume] in Serum or Plasma |
| 14636-5 | Calcium [Presence] in Stone |
| 14704-1 | Doxepin [Presence] in Gastric fluid |
| 104312-4 | Rucaparib [Mass/volume] in Serum or Plasma |
| 15471-6 | Equine influenza virus A2 Ab [Titer] in Serum by Hemagglutination inhibition |
| 17289-0 | Monosodium glutamate (MSG) IgE Ab [Units/volume] in Serum |
| 18350-9 | CD8+CD57+ cells [#/volume] in Blood |
| 74750-1 | Lymphocytes clefted [Presence] in Blood or Tissue by Light microscopy |
| 74848-3 | Lymphocytes/100 cells in Lymph node by Manual count |
| 74915-0 | Sulpiride [Mass/volume] in Serum or Plasma --trough |
| 92509-9 | Di sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 60427-2 | Norovirus RNA [Presence] in Isolate by NAA with probe detection |
| 75913-4 | dRVVT W excess hexagonal phospholipid/Normal (StaClot LA confirm) |
| 77020-6 | Fetal Y chromosome [Interpretation] based on Plasma cell-free DNA by Sequencing |
| 93505-6 | Heptacarboxylporphyrin I [Moles/time] in 24 hour Urine |
| 93843-1 | Primary hyperoxaluria multigene analysis in Blood or Tissue by Molecular genetics method |
| 94117-9 | Benzodiazepines panel [Presence] - Urine by Screen method |
| 63099-6 | American Cheese IgG Ab [Mass/volume] in Serum |
| 6316-4 | Bordetella pertussis Ab [Titer] in Serum by Complement fixation |
| 63290-1 | Myelin associated glycoprotein Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 94512-1 | Staphylococcus aureus and Methicillin Resistant Staphylococcus aureus identified in Isolate or Specimen by Molecular genetics method |
| 63394-1 | Jo-1 extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 6569-8 | Varicella zoster virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 79709-2 | Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 80096-1 | Glutamylphenylalanine [Moles/volume] in Serum or Plasma |
| 8015-0 | Rubella virus IgM Ab [Units/volume] in Serum |
| 6883-3 | Glucose.protein bound [Mass/volume] in Serum or Plasma |
| 69042-0 | Lymphocyte proliferation antigen panel - Blood by Flow cytometry (FC) |
| 80555-6 | Diamorphine [Mass/mass] in Hair |
| 80678-6 | Salmonella sp invA+fliC genes [Presence] in Stool by NAA with probe detection |
| 69560-1 | Enolase.neuron specific [Mass/volume] in Peritoneal fluid |
| 82093-6 | Occupational Allergen Mix 5 (Isocyanate HDI+MDI+TDI+Phthalic anhydride) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 97222-4 | Benzoylecgonine [Presence] in Cord tissue by Screen method |
| 97560-7 | Voltage-gated potassium channel IgG+IgM Ab [Moles/volume] in Serum by Immunoassay |
| 701-3 | Yersinia sp identified in Specimen by Organism specific culture |
| 9815-2 | Lithium [Mass/volume] in Red Blood Cells |
| 72379-1 | Cannabinoids synthetic [Presence] in Specimen by Screen method |
| 84920-8 | Cells.chromosome region 5q31 deletion/Cells counted in Blood or Tissue by FISH |
| 99869-0 | Erythrocytes.ghost cells [Presence] in Urine sediment by Computer assisted method |
| 86004-9 | Streptococcus pneumoniae Danish serotype 14 Ab [Mass/volume] in Serum --2nd specimen |
| 86062-7 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum |
| 86167-4 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum |
| 88191-2 | Crimean-Congo hemorrhagic fever virus IgG Ab [Presence] in Serum by Immunoassay |
| 73907-8 | Polio virus identified in Specimen by Organism specific culture |
| 89200-0 | Phenotypic lab test method used to determine resistance [Identifier] in Isolate |
| 59419-2 | HIV 1 RNA [#/volume] (viral load) in Plasma by Probe with signal amplification |
| 50834-1 | Cadmium [Moles/volume] in Red Blood Cells |
| 3087-4 | Urate [Mass/time] in 24 hour Urine |
| 41991-1 | SARS coronavirus IgM Ab [Presence] in Serum by Immunoassay |
| 4208-5 | Dantron [Mass] of Dose |
| 42626-2 | Toxoplasma gondii DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 60136-9 | PARoxetine [Mass/volume] in Blood |
| 21167-2 | CD61 cells/100 cells in Specimen |
| 21466-8 | Plasmodium malariae Ab [Titer] in Serum by Immunofluorescence |
| 21635-8 | ATP7B gene p.Arg778Leu [Presence] in Blood or Tissue by Molecular genetics method |
| 43115-5 | Hexacarboxylporphyrin [Presence] in 24 hour Urine |
| 219-6 | Demeclocycline [Susceptibility] by Serum bactericidal titer |
| 2197-2 | Dehydroepiandrosterone (DHEA).unconjugated [Mass/time] in 24 hour Urine |
| 51806-8 | Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay |
| 43325-0 | Chicken anemia virus Ab [Presence] in Serum by Immunofluorescence |
| 43430-8 | Neisseria meningitidis serogroup B Ag [Presence] in Serum |
| 43807-7 | Urease [Presence] in Tissue --4 hours post incubation |
| 3206-0 | Coagulation factor VIII inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
| 44243-4 | Bacteria [#/area] in Vaginal fluid by Wet preparation |
| 23008-6 | Classical swine fever virus RNA [Presence] in Specimen by NAA with probe detection |
| 23081-3 | Equine herpesvirus 1 Ag [Presence] in Tissue by Immune stain |
| 33219-7 | Epithelial cells.squamous [#/area] in Urine sediment by Automated count |
| 44834-0 | Acid phosphatase tartrate resistant [Presence] in Bone marrow |
| 53621-9 | NRAS gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal |
| 53649-0 | Parathion [Mass/volume] in Gastric fluid |
| 53788-6 | Sodium urate crystals [Presence] in Urine sediment by Light microscopy |
| 45100-5 | Chlamydia sp identified in Vaginal fluid by Organism specific culture |
| 23997-0 | Ganglioside GD1a IgG Ab [Titer] in Cerebral spinal fluid by Immunoassay |
| 241-0 | Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 33791-5 | Calcium [Moles/volume] in Urine --5th specimen post XXX challenge |
| 34267-5 | Cladosporium sp IgG Ab [Presence] in Serum by Immune diffusion (ID) |
| 54297-7 | Hexanoylcarnitine (C6) [Moles/volume] in Amniotic fluid |
| 54391-8 | Gamma globulin/Protein.total in Dialysis fluid by Electrophoresis |
| 24219-8 | Parainfluenza virus 1 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24290-9 | Influenza virus A Ab [Titer] in Serum --2nd specimen |
| 2495-0 | Iodine [Mass/volume] in Urine |
| 2500-7 | Iron binding capacity [Mass/volume] in Serum or Plasma |
| 47480-9 | Rickettsia typhi IgM Ab [Titer] in Cerebral spinal fluid |
| 25112-4 | Lactate/Creatinine [Molar ratio] in Urine |
| 25169-4 | Nickel [Moles/volume] in Blood |
| 34988-6 | Unidentified cells [#/volume] in Body fluid |
| 35008-2 | Nonhematic cells [#/volume] in Body fluid |
| 35100-7 | Enterovirus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 35276-5 | Measles virus IgM Ab [Presence] in Serum by Immunoassay |
| 25725-3 | Ovary Ab [Titer] in Serum by Immunofluorescence |
| 35769-9 | Cefotaxime+Clavulanate [Susceptibility] by Disk diffusion (KB) |
| 56537-4 | Tissue transglutaminase IgG Ab [Units/volume] in Serum by Immunoassay |
| 35789-7 | DAPTOmycin [Susceptibility] |
| 35804-4 | Bambermycins [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 35849-9 | Tilmicosin [Susceptibility] by Disk diffusion (KB) |
| 3695-4 | Insulin [Mass/volume] in Serum or Plasma |
| 37992-5 | Neutrophil cytoplasmic Ab.classic [Units/volume] in Serum by Immunoassay |
| 26907-6 | Listeria sp Ab [Titer] in Cerebral spinal fluid |
| 27098-3 | Methionine [Presence] in 24 hour Urine |
| 2720-1 | Palmitoylphosphatidyl choline [Mass/volume] in Plasma |
| 49309-8 | Nuclear Ab pattern [Interpretation] in Body fluid by Immunofluorescence Narrative |
| 3917-2 | Pentazocine [Presence] in Urine |
| 3955-2 | Phensuximide [Mass/volume] in Serum or Plasma |
| 57740-3 | CD3+HLA-DR+ cells/100 cells in Body fluid |
| 49383-3 | Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
| 5000-5 | Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection |
| 58859-0 | Homocyst(e)ine [Moles/volume] in Serum or Plasma --post XXX challenge |
| 40926-8 | Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum by Immunoassay |
| 41049-8 | TNFRSF1A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19319-3 | Tricyclic antidepressants screen method [Identifier] in Urine |
| 100019-9 | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 12582-3 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --7th specimen |
| 12845-4 | Protein [Mass/volume] in Peritoneal dialysis fluid --3rd specimen |
| 101652-6 | Somatotropin and glucose post glucose stimulation panel - Serum or Plasma |
| 101668-2 | Protein electrophoresis and M protein isotype panel - Urine |
| 13334-8 | CD8+CD25+ cells/100 cells in Blood |
| 101829-0 | Tetrazepam [Mass/volume] in Serum or Plasma |
| 101994-2 | Foundation pain index Document by based on lab data |
| 13609-3 | Insulin [Mass/volume] in Serum or Plasma --2.5 hours post 75 g glucose PO |
| 13823-0 | Antimony/Creatinine [Mass Ratio] in Urine |
| 14245-5 | Phosphatidylserine IgG Ab [Units/volume] in Serum |
| 102790-3 | Chili Pepper IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102877-8 | Lactalbumin alpha IgA Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103137-6 | Dog recombinant 6 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103190-5 | Mycobacterium fortuitum+chelonae DNA [Presence] in Wound by NAA with probe detection |
| 10348-1 | Bordetella parapertussis Ab [Presence] in Serum |
| 15046-6 | Creatine [Moles/volume] in Urine |
| 104353-8 | Borrelia recurrentis DNA [Presence] in Blood by Sequencing |
| 1549-5 | Glucose [Mass/volume] in Serum or Plasma --pre 100 g glucose PO |
| 16272-7 | Calcium [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 16683-5 | Coxsackievirus A4 Ab [Titer] in Cerebral spinal fluid |
| 1135-3 | Lu sup(a) Ab [Presence] in Serum or Plasma |
| 16874-0 | Formate+Formaldehyde [Mass/volume] in Blood |
| 17362-5 | Nicotinamide [Presence] in Urine |
| 18429-1 | Rickettsia rickettsii IgG Ab [Units/volume] in Cerebral spinal fluid |
| 91850-8 | Microscopic observation [Identifier] in Genital specimen by Giemsa stain |
| 75073-7 | Suberate [Moles/volume] in Serum or Plasma |
| 75367-3 | Buprenorphine [Mass/mass] in Meconium by Confirmatory method |
| 7602-6 | Pickleweed IgE Ab [Units/volume] in Serum |
| 76591-7 | Serratia marcescens gyrB gene [#/mass] in XXX.tissue by NAA with probe detection |
| 77026-3 | Influenza virus A H1 RNA [Presence] in Nasopharynx by NAA with probe detection |
| 93786-2 | Varicella zoster virus Ab.IgM+total [Presence] in Cerebral spinal fluid |
| 6301-6 | INR in Platelet poor plasma by Coagulation assay |
| 63126-7 | Fennel Fresh IgG Ab [Mass/volume] in Serum |
| 6330-5 | Campylobacter sp identified in Blood by Organism specific culture |
| 63332-1 | Baker's yeast IgG Ab [Units/volume] in Body fluid by Immunoassay |
| 77884-5 | Dehydroaripiprazole [Mass/volume] in Urine by Confirmatory method |
| 78219-3 | MLL gene rearrangements [Presence] in Blood or Tissue by FISH |
| 63526-8 | Centromere Ab [Presence] in Body fluid |
| 64135-7 | Secobarbital/Creatinine [Mass Ratio] of Urine |
| 79136-8 | Acepromazine [Mass/volume] in Body fluid |
| 79326-5 | Squalene [Moles/volume] in Serum or Plasma |
| 95093-1 | Glucagon [Mass/volume] in Serum or Plasma --1 hour post meal |
| 96281-1 | European pigeon tick IgE Ab [Units/volume] in Serum |
| 81285-9 | Escherichia coli Stx1 and Stx2 toxin stx1 and stx2 genes [Identifier] in Stool by NAA with probe detection |
| 8190-1 | Cocaine [Presence] in Serum or Plasma by Confirmatory method |
| 97600-1 | CD45 (Lymphs) cells [#/volume] in Lower respiratory specimen by Flow cytometry (FC) |
| 97636-5 | Streptococcus agalactiae DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 70264-7 | Creatinine in pleural fluid/Creatinine in serum |
| 97998-9 | HPA Ab [Identifier] in Serum or Plasma |
| 99862-5 | Erythrocytes.dysmorphic [#/area] in Urine sediment by Computer assisted method |
| 72734-7 | Methadone [Mass/volume] in Saliva (oral fluid) by Screen method |
| 86183-1 | Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum --2nd specimen |
| 86202-9 | Porcine epidemic diarrhea virus [Presence] in Tissue by Immune stain |
| 7312-2 | Flax IgE Ab [Units/volume] in Serum |
| 73274-3 | Metoclopramide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87488-3 | AM694 N-5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 73692-6 | Escitalopram [Mass/volume] in Urine |
| 88260-5 | Gram negative blood culture panel by Probe in Positive blood culture |
| 89330-5 | CD3+CD8+CD27+CD62L+ cells [#/volume] in Blood |
| 89871-8 | Bilirubin.total [Moles/volume] in Venous blood |
| 59345-9 | Endoxifen [Mass/volume] in Blood |
| 50684-0 | Chromosome analysis.interphase [Interpretation] in Blood by FISH Narrative |
| 42505-8 | Hepatitis B virus surface Ag [Presence] in Cerebral spinal fluid |
| 59915-9 | Indomethacin [Moles/volume] in Gastric fluid |
| 21410-6 | Myelin associated glycoprotein IgM Ab [Titer] in Serum |
| 31332-0 | Coxsackievirus B5 Ab [Units/volume] in Body fluid |
| 22140-8 | Bovine diarrhea virus 1 Ab [Titer] in Serum |
| 22190-3 | Chlamydia trachomatis IgG Ab [Units/volume] in Cerebral spinal fluid |
| 31725-5 | Avian paramyxovirus 1 Ag [Presence] in Specimen |
| 31734-7 | Border disease virus Ag [Presence] in Specimen |
| 51677-3 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 22582-1 | Toxoplasma gondii IgG Ab [Titer] in Serum |
| 22722-3 | Citrulline [Moles/volume] in Specimen |
| 22748-8 | Cholesterol in LDL [Moles/volume] in Serum or Plasma |
| 23131-6 | Francisella tularensis rRNA [Presence] in Tissue by Probe |
| 3305-0 | Acetylsalicylate [Presence] in Serum or Plasma |
| 53261-4 | Amino acid newborn screen panel |
| 44603-9 | IgM.monoclonal [Presence] in Cerebral spinal fluid by Immunofixation |
| 23593-7 | Bovine leukemia virus [Presence] in Blood by Organism specific culture |
| 33707-1 | Yersinia pestis Ab [Titer] in Serum |
| 53899-1 | TGFBR1 gene+TGFBR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 45205-2 | Glucose [Mass/volume] in Urine by Test strip --4th specimen post XXX challenge |
| 23763-6 | Pasteurella multocida serotype [Identifier] in Isolate |
| 24000-2 | Ganglioside GD1b IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay |
| 34154-5 | Influenza virus B Ab [Units/volume] in Specimen |
| 24105-9 | Lymphoma cells [#/volume] in Blood by Manual count |
| 34355-8 | Phosphoethanolamine [Moles/volume] in 24 hour Urine |
| 55434-5 | Insulin [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 47033-6 | Myogenin Ag [Presence] in Tissue by Immune stain |
| 47146-6 | EPINEPHrine [Moles/volume] in Plasma --4th specimen post XXX challenge |
| 35344-1 | Amylase [Enzymatic activity/volume] in Body fluid --3rd specimen post Sincalide |
| 47862-8 | Insulin [Units/volume] in Serum or Plasma --post meal |
| 25647-9 | Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --4th specimen post XXX challenge |
| 35572-7 | Phenylalanine/Tyrosine [Molar ratio] in DBS |
| 56296-7 | Kentucky blue grass IgG4 Ab [Mass/volume] in Serum |
| 56528-3 | Androstenedione [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 2639-3 | Myoglobin [Mass/volume] in Serum or Plasma |
| 26786-4 | Mephentermine [Mass/volume] in Urine |
| 3643-4 | FLUoxetine [Presence] in Serum or Plasma |
| 4880-1 | HLA-Dw16 [Presence] in Donor |
| 57512-6 | 11-Hydroxyandrosterone [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
| 48961-7 | Opiates [Mass/volume] in Specimen |
| 49201-7 | Bartonella quintana IgM Ab [Titer] in Body fluid |
| 49207-4 | Bartonella elizabethae IgM Ab [Titer] in Serum |
| 3957-8 | Phentermine [Presence] in Urine |
| 5807-3 | RBC casts [#/area] in Urine sediment by Microscopy low power field |
| 49670-3 | Uranium.depleted panel - 24 hour Urine |
| 28595-7 | Taurine/Creatinine [Ratio] in Urine |
| 29415-7 | Reovirus Ab [Titer] in Body fluid |
| 58597-6 | Corticotropin [Moles/volume] in Plasma --3 hours post dose glucose |
| 5878-4 | Rickettsia sp identified in Blood by Organism specific culture |
| 29859-6 | Adipate/Creatinine [Molar ratio] in Urine |
| 50440-7 | Corticotropin [Mass/volume] in Plasma --6 AM specimen |
| 30077-2 | Amylase/Creatinine renal clearance [Ratio] in Urine and Serum or Plasma |
| 3015-5 | Thyrotropin [Units/volume] in Blood |
| 19206-2 | Prostate Specific Ag Free [Moles/volume] in Semen |
| 20419-8 | Lutropin [Units/volume] in Serum or Plasma by 1st IRP |
| 21031-0 | Saint Louis encephalitis virus [Interpretation] in Specimen |
| 12613-6 | Glucose [Mass/volume] in Dialysis fluid --4 hour specimen |
| 12872-8 | HIV 1 p15 Ab [Presence] in Serum by Immunoblot |
| 101146-9 | Monocyte subsets panel - Blood by Flow cytometry (FC) |
| 101207-9 | Hepatitis E virus IgG Ab [Presence] in Serum or Plasma by Line blot |
| 101953-8 | COL4A3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 13507-9 | Lupus erythematosus cells [Presence] in Blood |
| 1393-8 | Cortisol Free [Mass/volume] in 24 hour Urine --72 hours post 40 ug corticotropin IM BID 3 day |
| 102680-6 | Green Ash IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102935-4 | Rice IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103610-2 | Pazopanib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose |
| 10442-2 | CD56 Ag [Presence] in Tissue by Immune stain |
| 15262-9 | Tree Allergen Mix 1 (Boxelder+Silver birch+White oak+White elm+California walnut) IgE Ab [Presence] in Serum by Multidisk |
| 16167-9 | Glucose [Mass/volume] in Serum or Plasma --2 PM specimen |
| 17747-7 | Trimethoprim [Mass/volume] in Urine |
| 90046-4 | Spermatozoa.abnormal principal pieces/100 spermatozoa in Semen |
| 74544-8 | Tocopherols [Entitic substance] in Red Blood Cells |
| 92480-3 | U Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 6044-2 | Black Ant IgE Ab [Units/volume] in Serum |
| 77138-6 | Chloride [Moles/volume] in Serum, Plasma or Blood |
| 6281-0 | White mulberry IgE Ab [Units/volume] in Serum |
| 6326-3 | Brucella abortus IgM Ab [Units/volume] in Serum by Immunoassay |
| 63307-3 | PM-SCL extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
| 63392-5 | Herpes gestationis Ab [Titer] in Serum by Immunofluorescence |
| 79304-2 | D-2-hydroxyglutarate [Moles/volume] in Cerebral spinal fluid |
| 95653-2 | La Crosse virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 66145-4 | Leukocytes other [#/volume] in Blood from Fetus by Manual count |
| 8006-9 | Orientia tsutsugamushi Ab [Units/volume] in Serum |
| 8021-8 | Saint Louis encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 95725-8 | Glycine receptor Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 95968-4 | Gerbera spp IgE Ab [Units/volume] in Serum |
| 97175-4 | Yersinia LcrV protein Ab [Presence] in Serum by Line blot |
| 6942-7 | Albumin [Mass/volume] in Urine by Electrophoresis |
| 9761-8 | Coxsackievirus B3 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 7115-9 | Barley triggered histamine release [Units/volume] in Blood |
| 82884-8 | MAOA gene upstream VNTR repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 82967-1 | Amphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 98409-6 | Mold identified in Isolate by NAA with probe detection |
| 85340-8 | DCIS necrosis [Type] in Breast cancer specimen by Light microscopy |
| 72592-9 | Alpha 1 globulin/Protein.total [Pure mass fraction] in 24 hour Urine by Electrophoresis |
| 72754-5 | LORazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 86321-7 | Zika virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 86741-6 | Porcine parvovirus type 2 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 89373-5 | Hepatitis A virus genotype in Specimen by NAA with probe detection |
| 41273-4 | Alpha-1-Fetoprotein interpretation in Amniotic fluid |
| 41766-7 | Triamcinolone [Mass/volume] in Serum or Plasma |
| 42004-2 | Eastern equine encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 21129-2 | Cadmium [Mass/volume] in Serum or Plasma |
| 21363-7 | Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection |
| 51417-4 | Coproporphyrin/Porphyrins.total in 24 hour Urine |
| 51422-4 | Aldosterone [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
| 31819-6 | Equine herpesvirus 4 Ag [Presence] in Specimen |
| 43236-9 | Streptococcus pneumoniae IgG Ab [Mass/volume] in Serum by Immunoassay |
| 43271-6 | Ceftobiprole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 4336-4 | Morazone [Mass] of Dose |
| 43810-1 | Rubella virus Ab [Presence] in Serum by Immunoassay |
| 5222-5 | HIV 1 Ag [Presence] in Serum or Plasma by Immunoassay |
| 43961-2 | CD3+HLA-DR+ cells [#/volume] in Specimen |
| 53116-0 | Base deficit in Mixed venous blood |
| 53134-3 | Amylase isoenzymes [Interpretation] in Body fluid Narrative |
| 53220-0 | Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in DBS |
| 53330-7 | Urinalysis type of cast panel [#/area] - Urine by Computer assisted method |
| 53389-3 | Trichothecene IgE Ab [Units/volume] in Serum |
| 4452-9 | Triazolam [Mass] of Dose |
| 53876-9 | LRRK2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 4523-7 | Complement iC3b receptors [Entitic number] in Leukocytes |
| 24060-6 | Beta galactosidase [Enzymatic activity/mass] in Fibroblast |
| 33887-1 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with normal plasma |
| 54325-6 | Palmitoylcarnitine (C16) [Moles/volume] in Amniotic fluid |
| 24490-5 | Tree Allergen Mix 3 (Mountain juniper+White oak+White elm+Cottonwood+Mesquite) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 34613-0 | Herpes simplex virus 1+2 IgG Ab [Titer] in Serum |
| 55246-3 | HBA2 gene c.84G>C [Presence] in Blood by Molecular genetics method |
| 55600-1 | Microscopic observation [Identifier] in Peritoneal fluid by Cyto stain |
| 47189-6 | Progesterone [Moles/volume] in Serum or Plasma --baseline |
| 47311-6 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 47869-3 | Prolactin [Units/volume] in Serum or Plasma --1 hour post dose metoclopramide |
| 2572-6 | Lipoprotein lipase [Enzymatic activity/volume] in Serum or Plasma |
| 25917-6 | Glutamate [Moles/volume] in 24 hour Urine |
| 35502-4 | Mitochondrial myopathy enzyme panel [Enzymatic activity/mass] - Tissue |
| 35620-4 | Metoprolol [Presence] in Serum or Plasma by Screen method |
| 3647-5 | Fluoxymesterone [Mass/volume] in Urine |
| 3705-1 | Labetalol [Presence] in Urine |
| 27078-5 | Carotene.alpha [Moles/volume] in Plasma |
| 38528-6 | Protein.abnormal band [Mass/time] in 24 hour Urine |
| 574-4 | Fungus identified in Peritoneal fluid by Culture |
| 27857-2 | Proinsulin [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
| 29233-4 | Coxsackievirus B4 Ab [Titer] in Body fluid |
| 29383-7 | Warfarin [Mass/volume] in Gastric fluid |
| 50022-3 | Ethanol+Methanol+Isopropyl alcohol+Acetone [Presence] in Serum, Plasma or Blood |
| 29830-7 | Powassan virus IgG Ab [Presence] in Specimen |
| 5037-7 | Acetylcholine receptor binding Ab [Titer] in Serum by Immunofluorescence |
| 30093-9 | Brucella canis IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 19686-5 | Psilocybin [Presence] in Urine by Screen method |
| 20455-2 | Leukocytes [Presence] in Urine sediment by Light microscopy |
| 2085-9 | Cholesterol in HDL [Mass/volume] in Serum or Plasma |
| 100386-2 | Rosemary IgG Ab [Units/volume] in Serum |
| 100964-6 | Dengue virus IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 12774-6 | Mercury [Mass/volume] in Red Blood Cells |
| 101565-0 | Electrolytes panel - Venous blood |
| 101808-4 | Xylazine [Mass/volume] in Urine by Confirmatory method |
| 102025-4 | Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post dose glucagon |
| 13525-1 | Nonhematic cells/100 leukocytes in Cerebral spinal fluid by Manual count |
| 13637-4 | Trichloroethane [Mass/volume] in Serum or Plasma |
| 102518-8 | Common Pigweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103083-2 | Hazelnut native (nCor a) 9 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103088-1 | Paper wasp recombinant (rPol d) 5 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103638-3 | 4-hydroxy Xylazine [Mass/volume] in Urine by Confirmatory method |
| 103665-6 | CD4+ CD26- Cells/100 CD4 cells in Blood by Flow cytometry (FC) |
| 10473-7 | Chymotrypsin Ag [Presence] in Tissue by Immune stain |
| 10513-0 | Somatotropin Ag [Presence] in Tissue by Immune stain |
| 15456-7 | Bluetongue virus Ab [Presence] in Serum by Immunoassay |
| 16244-6 | Methaqualone [Mass/volume] in Urine by Confirmatory method |
| 10928-0 | Fennel Fresh IgE Ab [Units/volume] in Serum |
| 16381-6 | Androstenedione [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 12176-4 | Amino acids [Moles/volume] in Serum or Plasma |
| 16868-2 | Finch droppings IgE Ab [Presence] in Serum |
| 17264-3 | Methionine [Presence] in Urine |
| 17661-0 | Succinylcholine [Mass/volume] in Serum or Plasma |
| 18942-3 | Meclocycline [Susceptibility] |
| 74804-6 | Fructose challenge (hydrogen breath test) [Interpretation] in Exhaled gas |
| 75126-3 | Orotate [Moles/volume] in Cerebral spinal fluid |
| 7564-8 | Parakeet droppings IgE Ab [Units/volume] in Serum |
| 60378-7 | Haddock IgG Ab [Mass/volume] in Serum |
| 60529-5 | Influenza virus A H1 2009 pandemic Ab [Titer] in Serum |
| 61158-2 | Hepatitis B virus codon M204I [Presence] by Genotype method |
| 61166-5 | Hepatitis B virus codon S202G [Presence] by Genotype method |
| 7575-4 | Peach IgG Ab [Units/volume] in Serum |
| 76686-5 | Reticulocyte cellular hemoglobin distribution width [Entitic mass] in Blood by calculation |
| 92871-3 | Herpes simplex virus 1 DNA [Presence] in Skin by NAA with probe detection |
| 77068-5 | AGA gene full mutation analysis in Blood or Tissue by Sequencing |
| 93981-9 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose carbohydrate |
| 94253-2 | Borrelia sp panel - Specimen by NAA with non-probe detection |
| 6297-6 | Complement C1q Ag [Units/volume] in Serum |
| 6324-8 | Brucella abortus Ab [Titer] in Serum by Agglutination |
| 63288-5 | Myelin associated glycoprotein Ab [Presence] in Body fluid by Immunoassay |
| 63322-2 | Ribosomal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 94590-7 | Oncologic chromosome analysis in Tissue by Mate pair sequencing |
| 63566-4 | Basement membrane Ab pattern [Interpretation] in Serum by Immunofluorescence |
| 7963-2 | Measles virus IgM Ab [Units/volume] in Serum |
| 9619-8 | Triglyceride [Mass/volume] in Pleural fluid |
| 68542-0 | Codeine [Mass/mass] in Meconium by Confirmatory method |
| 9675-0 | Silicone IgA Ab [Units/volume] in Serum |
| 96981-6 | Trisomy 13, trisomy 18 or triploidy risk [Likelihood] in Plasma cell-free+WBC DNA by calculation |
| 6916-1 | Chlamydophila psittaci IgG Ab [Titer] in Serum by Immunofluorescence |
| 82239-5 | Chromosome region 16p13.3 deletion in Blood or Tissue by FISH |
| 9752-7 | Coxsackievirus A16 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 70858-6 | Rabies virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 82547-1 | Food Allergen Mix 30A (Kiwi+Papaya+Mango+Banana+Avocado) IgE Ab [Presence] in Serum by Multidisk |
| 82896-2 | Pregnanediolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
| 72583-8 | Gamma globulin/Protein.total [Pure mass fraction] in Cerebral spinal fluid by Electrophoresis |
| 72869-1 | Mycobacterium leprae gyrA gene fluoroquinolone resistance mutation [Presence] by Molecular method |
| 72920-2 | HNA 1c genotype [Presence] in Blood |
| 72997-0 | Losartan induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73073-9 | Acetaminophen induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73145-5 | Spironolactone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87483-4 | Aluminum [Mass/mass] in Specimen |
| 73396-4 | Eptifibatide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73489-7 | Captopril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87821-5 | Zolpidem [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 87967-6 | Microscopic observation [Identifier] in Bone marrow by Gram stain |
| 88556-6 | Scedosporium prolificans DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 7402-1 | Pecan or Hickory Nut triggered histamine release [Units/volume] in Blood |
| 74041-5 | BCR-ABL1 p210 Major Molecular Response (MMR) [Presence] in Blood or Tissue by Molecular genetics method --post treatment |
| 59766-6 | Tungsten [Mass/volume] in Red Blood Cells |
| 31036-7 | Gatifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 4243-2 | Ethchlorvynol [Mass] of Dose |
| 21131-8 | Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post 0.5 ug/kg pentagastrin IV |
| 51112-1 | CD2 blasts [Units/volume] in Bone marrow |
| 42797-1 | Age at first pregnancy |
| 43178-3 | Phentermine [Presence] in Hair by Screen method |
| 52915-6 | Aluminum [Moles/volume] in Urine |
| 43861-4 | Asialoganglioside GM1 Ab [Presence] in Serum |
| 4425-5 | Sotalol [Mass] of Dose |
| 44320-0 | Interferon alpha [Presence] in Serum or Plasma |
| 22801-5 | Infectious bronchitis virus Ab [Titer] in Serum |
| 32590-2 | Granulocytes units available [#] |
| 32616-5 | Homocysteine cysteine disulfide/Creatinine [Ratio] in Urine |
| 33049-8 | Hypertonic cryohemolysis of Red Blood Cells |
| 44711-0 | Cholesterol in LDL/Apolipoprotein B [Mass Ratio] in Serum or Plasma |
| 44856-3 | Bacteria # 4 identified in Specimen by Anaerobe culture |
| 23225-6 | Mareks disease virus Ab [Presence] in Serum by Immunoassay |
| 45011-4 | Chlamydia sp Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 33799-8 | DNA double strand IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 33969-7 | SARS coronavirus Urbani Ab [Units/volume] in Serum by Immunoassay |
| 53988-2 | Atypic speckled nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
| 54078-1 | Cystic fibrosis newborn screening panel |
| 4538-5 | Erythrocyte sedimentation rate by Wintrobe method |
| 46997-3 | HLA Ab cells tested [#] in Serum |
| 24123-2 | Epithelial cells [#/volume] in Urine by Manual count |
| 24213-1 | Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 2451-3 | Hydroxyproline [Mass/volume] in Urine |
| 4708-4 | HLA-A68(28) [Presence] |
| 47253-0 | Coproporphyrin 1 [Mass/volume] in 24 hour Urine |
| 34882-1 | Ethanol [Mass/volume] in Saliva (oral fluid) |
| 47643-2 | Histidine [Moles/volume] in DBS |
| 25639-6 | Follitropin [Units/volume] in Urine by 2nd IRP |
| 35650-1 | Lymphocytic choriomeningitis virus IgG and IgM panel - Cerebral spinal fluid |
| 35651-9 | Synovial lining cells/100 cells in Synovial fluid |
| 56157-1 | HOXB13 gene/IL17BR gene [Ratio] in Tissue by Molecular genetics method |
| 56178-7 | Artichoke IgG4 Ab [Mass/volume] in Serum |
| 4794-4 | HLA-B72(70) [Presence] in Donor |
| 2608-8 | Metanephrines [Mass/volume] in Urine |
| 26502-5 | Neutrophils [#/volume] in Peritoneal fluid |
| 3667-3 | Glutethimide [Presence] in Urine |
| 38167-3 | Major crossmatch [Interpretation] by Polyethylene glycol (PEG) method |
| 38195-4 | Antihistamines [Presence] in Gastric fluid |
| 570-2 | Fungus identified in Body fluid by Culture |
| 48712-4 | Microscopic observation [Identifier] in Genital specimen by Gram stain |
| 26830-0 | Prochlorperazine [Presence] in Serum or Plasma |
| 27015-7 | Polychlorinated biphenyl (PCB) [Mass/volume] in Body fluid |
| 57624-9 | Alpha cortol [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
| 4950-2 | HLA-DR10 [Presence] in Donor |
| 28551-0 | Bladder tumor Ag [Units/volume] in Urine by Immunoassay |
| 58636-2 | Cortisol [Moles/volume] in Serum or Plasma --10 PM specimen |
| 58697-4 | Cortisol [Mass/volume] in Saliva (oral fluid) --9th specimen post XXX challenge |
| 29646-7 | Parainfluenza virus 2 IgM Ab [Presence] in Serum by Immunoassay |
| 40533-2 | Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count |
| 58917-6 | Androstanolone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 59240-2 | Testosterone [Moles/volume] in Body fluid |
| 30179-6 | Powassan virus IgM Ab [Titer] in Specimen by Immunofluorescence |
| 41029-0 | Listeria monocytogenes H1 Ab [Titer] in Serum |
| 19268-2 | Amphetamines screen method [Identifier] in Urine |
| 20973-4 | Sulfate [Mass/volume] in Gastric fluid |
| 12524-5 | Catecholamines [Mass/volume] in Plasma --4th specimen post XXX challenge |
| 12718-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 101240-0 | Contactin-associated protein 2 Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 13312-4 | IgA IgG Ab [Units/volume] in Serum or Plasma |
| 13712-5 | Azelate/Creatinine [Mass Ratio] in Urine |
| 13747-1 | Glutamine/Creatinine [Mass Ratio] in Urine |
| 14195-2 | Complement C3b Inactive [Mass/volume] in Plasma |
| 102972-7 | Dog dander+Dog epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103015-4 | Aspergillus fumigatus recombinant (rAsp f) 6 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14555-7 | Mumps virus Ag [Presence] in Urethra by Immunofluorescence |
| 103168-1 | Campylobacter coli+jejuni DNA [Presence] in Wound by NAA with probe detection |
| 15128-2 | Gamma globulin/Protein.total in Synovial fluid by Electrophoresis |
| 1631-1 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
| 16505-0 | Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 11260-7 | HTLV I Ab [Presence] in Serum by Immunoassay |
| 17165-2 | CD49c cells/100 cells in Blood |
| 17270-0 | Methylacrylate [Mass/volume] in Serum or Plasma |
| 17352-6 | Neutrophil cytoplasmic Ab [Interpretation] in Serum |
| 1808-5 | Amylase S3 [Enzymatic activity/volume] in Serum or Plasma |
| 90247-8 | Trypanosoma cruzi IgG Ab [Presence] in Serum from Donor by Immunoassay |
| 74764-2 | Soluble fms-like tyrosine kinase-1 and placental growth factor panel - Serum or Plasma |
| 74866-5 | IgM.kappa [Mass/volume] in Serum or Plasma |
| 92772-3 | Streptococcus anginosus group DNA [Presence] by NAA with probe detection in Positive blood culture |
| 61127-7 | Whitefish IgG Ab [Mass/volume] in Serum |
| 7612-5 | Pineapple IgG Ab [Units/volume] in Serum |
| 76146-0 | Tosufloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 93021-4 | Plasma cells with abnormal marker pattern/Cells counted in Bone marrow by Flow cytometry (FC) |
| 6216-6 | Phoma betae IgE Ab [Units/volume] in Serum |
| 62362-9 | Colonies counted [#] |
| 78838-0 | JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
| 6369-3 | Cryptococcus neoformans Ab [Titer] in Serum by Agglutination |
| 6473-3 | Microscopic observation [Identifier] in Tissue by Trichrome stain |
| 79189-7 | Hepatitis C virus core Ag [Presence] in Serum or Plasma by Immunoassay |
| 65360-0 | Thyrotropin [Units/volume] in Serum or Plasma --pre or post XXX challenge |
| 80200-9 | Nonsteroidal antiinflammatory drugs [Presence] in Urine by Screen method |
| 96116-9 | Anterior surgical resection [Type] in Lower GI tract |
| 96486-6 | Neuronal intermediate filament IgG Ab [Presence] in Serum by Immunofluorescence |
| 6838-7 | Cockatiel droppings IgE Ab [Units/volume] in Serum |
| 81181-0 | Serosal surface involvement [Presence] in Tumor by Light microscopy |
| 69550-2 | Genetic knowledge reference [Type] |
| 69962-9 | Respiratory syncytial virus IgM Ab [Presence] in Serum by Immunoassay |
| 82086-0 | Occupational Allergen Mix 1 (Chicken feather+Cow dander+Goose feather+Horse dander) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 70085-6 | Interleukin 5 [Mass/volume] in Body fluid |
| 82748-5 | Erythrocytes.Babesia sp infected/100 erythrocytes in Blood |
| 72385-8 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 837-5 | Ax Ag [Presence] on Red Blood Cells from Donor |
| 99430-1 | Euroglyphus maynei IgG4 Ab [Mass/volume] in Serum |
| 99530-8 | Volume of Pleural space - left |
| 72855-0 | Cidofovir [Susceptibility] by Phenotype method |
| 85784-7 | Candida parapsilosis DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 73855-9 | Aldosterone-18-glucuronide [Moles/volume] in Urine |
| 87957-7 | Legionella sp identified in Water by Organism specific culture |
| 88184-7 | IgG+IgM.porcine [Presence] in Pleural fluid from Fetus by Immune diffusion (ID) |
| 41188-4 | Xylose [Mass/volume] in Urine --fasting |
| 50906-7 | Silicon [Moles/volume] in Urine |
| 31258-7 | Beta tubulin IgM Ab [Units/volume] in Serum |
| 51281-4 | CD3+CD56+ cells/100 cells in Body fluid |
| 31650-5 | Streptococcus pneumoniae Danish serotype 9V IgG Ab [Units/volume] in Serum |
| 31997-0 | Biotin [Presence] in Blood |
| 51521-3 | Lactate dehydrogenase 5/Lactate dehydrogenase.total in Pleural fluid by Electrophoresis |
| 51749-0 | Jo-1 extractable nuclear Ab [Presence] in Cerebral spinal fluid |
| 51843-1 | Malonate/Creatinine [Mass Ratio] in Urine |
| 22319-8 | Hepatitis B virus core IgM Ab [Units/volume] in Serum |
| 53026-1 | Tissue transglutaminase IgG Ab [Presence] in Serum |
| 44034-7 | Bile canalicular Ab [Presence] in Serum |
| 44092-5 | Leukocytes [#/area] in Vaginal fluid by Wet preparation |
| 22983-1 | Capripox virus Ab [Presence] in Serum by Immunoblot |
| 33032-4 | Spermatozoa Progressive [Presence] in Semen |
| 33033-2 | CD45 positive events [#] in Specimen |
| 53188-9 | 3-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in DBS |
| 53239-0 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 44540-3 | HTLV II IgG Ab [Presence] in Serum by Immunoassay |
| 44562-7 | Influenza virus A Ag [Presence] in Bronchial specimen |
| 23386-6 | Pseudorabies virus Ag [Presence] in Specimen by Neutralization test |
| 23474-0 | Theileria parva Ab [Presence] in Serum |
| 23478-1 | Theileria parva Ab [Titer] in Serum |
| 23887-3 | Isopentacarboxylporphyrin [Mass/time] in unspecified time Stool |
| 33855-8 | Promonocytes [#/volume] in Blood by Manual count |
| 54411-4 | Rh immune globulin given Qualitative |
| 4544-3 | Hematocrit [Volume Fraction] of Blood by Automated count |
| 24444-2 | Tiglylglycine/Creatinine [Molar ratio] in Urine |
| 47412-2 | Mumps virus Ab [Units/volume] in Serum by Immunoassay |
| 25085-2 | 2-Oxoisovalerate/Creatinine [Molar ratio] in Urine |
| 25298-1 | Rubella virus IgG Ab [Ratio] in Serum --1st specimen/2nd specimen |
| 47567-3 | Arginine/Amino acids.total in DBS |
| 25672-7 | Glucose [Moles/volume] in Serum or Plasma --4.5 hours post dose glucose |
| 35571-9 | Tyrosine [Moles/volume] in DBS |
| 56260-3 | Red Imported Fire Ant IgG4 Ab [Mass/volume] in Serum |
| 56514-3 | Legionella pneumophila IgG Ab [Presence] in Serum by Immunofluorescence |
| 26421-8 | European house dust mite IgG4 Ab [Units/volume] in Serum |
| 2654-2 | Neurophysin [Mass/volume] in Serum or Plasma |
| 26765-8 | Antimony [Presence] in Hair |
| 26832-6 | Aconitate [Presence] in Urine |
| 2705-2 | Oxygen [Partial pressure] in Venous blood |
| 38514-6 | CD33+CD34+ cells/100 cells in Blood |
| 49163-9 | Orientia tsutsugamushi Kato IgM Ab [Titer] in Serum |
| 27934-9 | Echovirus 11 RNA [Presence] in Cerebral spinal fluid by Probe |
| 28054-5 | Borrelia burgdorferi 93kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 39606-9 | Rabbit epithelium IgE Ab/IgE total in Serum |
| 57940-9 | Watermelon IgE Ab/IgE total in Serum |
| 49640-6 | Protein S Ag/Coagulation factor X Ag [Mass Ratio] in Platelet poor plasma by Coagulation assay |
| 39799-2 | risperiDONE [Moles/volume] in Serum or Plasma |
| 40013-5 | Glucose [Mass/volume] in Serum or Plasma --15.5 hours post XXX challenge |
| 40101-8 | aPTT in Platelet poor plasma by Coagulation assay --30 minutes post XXX challenge |
| 29778-8 | West Nile virus IgM Ab [Presence] in Specimen by Immunoassay |
| 29952-9 | Borrelia burgdorferi Ag [Mass/volume] in Urine by Immunoassay |
| 59018-2 | HLA-DPA1 [Type] by High resolution |
| 59177-6 | Beta-2-Microglobulin/Creatinine [Ratio] in Urine |
| 5920-4 | Protein [Mass/volume] in Dialysis fluid |
| 50330-0 | SLC6A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 19178-3 | Choriogonadotropin.beta subunit free [Units/volume] in Amniotic fluid |
| 20437-0 | Glucose [Mass/volume] in Serum or Plasma --3 hours post dose glucose |
| 2053-7 | Carotene [Mass/volume] in Serum or Plasma |
| 20607-8 | CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen |
| 100137-9 | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot |
| 100707-9 | Polymorphonuclear cells [#/volume] in Peritoneal dialysis fluid by Automated count |
| 101088-3 | Ge3 Ab [Presence] in Serum or Plasma |
| 12650-8 | Glucose [Mass/volume] in Serum or Plasma --3.5 hours post dose lactose PO |
| 13172-2 | Complement C1q Ag [Units/volume] in Serum or Plasma by Raji cell assay |
| 13235-7 | Coxsackievirus A16 Ab [Units/volume] in Cerebral spinal fluid |
| 13333-0 | CD3+CD25+ cells/100 cells in Blood |
| 102067-6 | Perfluoroheptane sulfonate [Mass/volume] in Serum or Plasma |
| 102190-6 | Broccoli IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13593-9 | Platelet aggregation prostaglandin induced in Platelet rich plasma |
| 102371-2 | White Hickory IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102555-0 | Radish IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102579-0 | Safflower IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1418-3 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
| 102810-9 | Safflower IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102875-2 | Horse Bot Fly IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104220-9 | Spermatozoa Viable/100 spermatozoa in Urine --post ejaculation |
| 104249-8 | Platelet aggregation ADP induced ATP secretion in Blood --2 umol/L |
| 104328-0 | Bacillus anthracis Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 15261-1 | Weed Allergen Mix 209 (Common ragweed+Western ragweed+Giant ragweed) IgE Ab [Presence] in Serum by Multidisk |
| 15348-6 | Alkaline phosphatase.liver 1/Alkaline phosphatase.total in Serum or Plasma |
| 10913-2 | 4,4'-Methylene bis(2-Chloroaniline) [Mass/volume] in Urine |
| 16327-9 | Allyl alcohol [Mass/volume] in Blood |
| 11187-2 | Penicillium frequentans IgE Ab [Units/volume] in Serum |
| 16797-3 | Echovirus 1 Ab [Units/volume] in Serum by Complement fixation |
| 17146-2 | CD4+CD8+ cells/100 cells in Blood |
| 17840-0 | Alpha-L-iduronidase [Enzymatic activity/volume] in Blood |
| 18319-4 | Neutrophils.vacuolated [Presence] in Blood by Light microscopy |
| 75028-1 | Protoporphyrin/Porphyrins.total in Stool |
| 7505-1 | Mouse multi IgE Ab [Units/volume] in Serum |
| 75357-4 | Bacteria identified in Abscess by Anaerobe+Aerobe culture |
| 93396-0 | Fusobacterium nucleatum DNA [Presence] by NAA with probe detection in Positive blood culture |
| 77116-2 | FKBP10 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 78014-8 | HLA-A [Type] by Low resolution |
| 94375-3 | Klebsiella oxytoca DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 94727-5 | Gabapentin [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 6343-8 | Chlamydia sp Ag [Presence] in Conjunctival specimen by Immunoassay |
| 64981-4 | Lepidoglyphus destructor recombinant (rLep d) 2 IgE Ab [Units/volume] in Serum |
| 95173-1 | Mycoplasma meleagridis DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 65780-9 | Olive pollen recombinant (rOle e) 9 IgE Ab [Units/volume] in Serum |
| 68375-5 | Nuclear Ab [Titer] in Peritoneal fluid by Immunofluorescence |
| 97054-1 | Granulocyte macrophage colony stimulating factor [Mass/volume] in Serum or Plasma |
| 97152-3 | HBc+HBe+p22cr Ag [Units/volume] in Serum or Plasma by Immunoassay |
| 82885-5 | Meta methylhippurate [Moles/volume] in Urine |
| 7173-8 | Candida albicans triggered histamine release [Units/volume] in Blood |
| 83066-1 | Mycobacterium tuberculosis complex immunogenic protein MPB64 [Presence] in Isolate by Immunoassay |
| 85360-6 | Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 85755-7 | Streptococcus pneumoniae Danish serotypes 33A+33F+37 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 99468-1 | Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgG Ab [Mass/volume] in Serum |
| 72498-9 | Tripeptidyl peptidase I [Enzymatic activity/volume] in DBS |
| 85962-9 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum --2nd specimen |
| 72984-8 | OLANZapine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87576-5 | Ergosine [Mass/mass] in Specimen |
| 88017-9 | Glutarylcarnitine (C5-DC)/Propionylcarnitine (C3) [Molar ratio] in DBS |
| 73891-4 | Tetrahydrocortisol [Moles/volume] in 24 hour Urine |
| 41645-3 | Calcium.ionized [Moles/volume] in Venous blood |
| 59874-8 | Brompheniramine [Moles/volume] in Urine |
| 30547-4 | Polio virus 2 Ab [Presence] in Serum |
| 31048-2 | Coccidioides immitis Ab [Presence] in Body fluid by Complement fixation |
| 4229-1 | Disulfiram [Mass] of Dose |
| 60309-2 | Imipramine [Moles/volume] in Specimen |
| 21338-9 | HIV 2 p31 Ab [Presence] in Serum by Immunoblot |
| 21423-9 | Nuclear Ab [Titer] in Serum by Immunofluorescence (IF) rat liver |
| 51145-1 | CD3 blasts/100 blasts in Specimen |
| 51444-8 | CD19+CD38+ cells [Units/volume] in Blood |
| 43154-4 | Spermatozoa [Presence] in Semen by Light microscopy --post concentration |
| 43177-5 | Phenmetrazine [Presence] in Hair by Screen method |
| 22252-1 | Dengue virus 3 Ab [Presence] in Serum |
| 51584-1 | Immature granulocytes [#/volume] in Blood |
| 43739-2 | Blood group Ag [Interpretation] on Red Blood Cells from Blood product unit |
| 22373-5 | La Crosse virus IgG Ab [Titer] in Cerebral spinal fluid |
| 22458-4 | Rabies virus Ab [Units/volume] in Tissue |
| 32311-3 | Cortisol [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
| 43863-0 | Benzthiazide [Presence] in 24 hour Urine |
| 22888-2 | Bordetella bronchiseptica Ag [Presence] in Specimen by Agglutination |
| 32589-4 | Gabapentin [Mass] of Dose |
| 53468-5 | Anthranilate [Moles/volume] in Serum or Plasma |
| 44464-6 | Herpes simplex virus 1 [Presence] in Skin by Organism specific culture |
| 44471-1 | Herpes simplex virus 1 Ag [Presence] in Cervix |
| 535-5 | Mycobacterium sp identified in Body fluid by Organism specific culture |
| 33837-6 | Malignant cells/100 leukocytes in Blood by Manual count |
| 54086-4 | HIV 1+2 IgG Ab [Presence] in DBS |
| 4578-1 | Hemoglobin F - Texas [Units/volume] in Blood by Electrophoresis alkaline (pH 8.9) |
| 46720-9 | T cell crossmatch [Presence] in Blood |
| 34321-0 | Iodine/Creatinine [Molar ratio] in Urine |
| 34446-5 | Erythrocytes [Presence] in Body fluid |
| 54489-0 | Phosphoserine [Moles/volume] in DBS |
| 55471-7 | Aldosterone [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
| 55504-5 | Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose glucagon |
| 55556-5 | Nadolol [Moles/volume] in Serum or Plasma |
| 35004-1 | Polymorphonuclear cells [#/volume] in Synovial fluid |
| 55910-4 | Alpha mannosidase [Enzymatic activity/volume] in DBS |
| 55924-5 | IgM.monoclonal [Presence] in Serum by Immunoelectrophoresis |
| 55927-8 | Interleukin 1 receptor alpha chain soluble [Mass/volume] in Serum or Plasma |
| 56028-4 | CD3-CD56+ cells/100 cells in Bone marrow |
| 35490-2 | Azinphos-methyl [Mass/volume] in Serum or Plasma |
| 4805-8 | HLA-B12 [Presence] |
| 48111-9 | Glutathione.reduced [Moles/mass] in Red Blood Cells |
| 48216-6 | Hazelnut triggered leukotriene release [Mass/volume] by Leukocytes |
| 35842-4 | Sulfonamide [Susceptibility] by Gradient strip |
| 38240-8 | CD4+CD95+ cells/100 cells in Blood |
| 56735-4 | Mitochondria M2 Ab [Presence] in Serum by Immunoblot |
| 48761-1 | 3-Hydroxypalmitate (3-OH-C16:0) [Moles/volume] in Serum or Plasma |
| 38328-1 | Simazine [Mass/volume] in Water |
| 27276-5 | Azatadine [Mass/volume] in Urine |
| 28049-5 | 1,2,4-Trichlorobenzene [Mass/volume] in Serum or Plasma |
| 57904-5 | Bg sup(a) Ag [Presence] on Red Blood Cells |
| 58019-1 | Phosphate [Mass/volume] in Nonbiological fluid |
| 49396-5 | Herpes virus 7 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
| 49552-3 | Epinephrine+Norepinephrine [Mass/volume] in Urine |
| 39797-6 | Vancomycin [Moles/volume] in Serum or Plasma --trough |
| 40249-5 | Creatinine [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 58539-8 | Corticotropin [Moles/volume] in Plasma --10th specimen post XXX challenge |
| 50170-0 | Aldosterone [Moles/volume] in Serum or Plasma --pre XXX challenge |
| 58934-1 | Fat [Mass/mass] in 72 hour Stool |
| 59181-8 | Interferon beta given [Type] |
| 40938-3 | Yersinia sp IgG Ab [Units/volume] in Serum by Immunoassay |
| 206-3 | Colistin [Susceptibility] by Disk diffusion (KB) |
| 20840-5 | Herbicide [Presence] in Ingesta by Screen method |
| 101076-8 | Dh^a Ab [Presence] in Serum or Plasma |
| 12620-1 | Glucose [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 12795-1 | Oxalate [Mass/volume] in Urine --7th specimen post XXX challenge |
| 12907-2 | Sodium [Moles/volume] in Red Blood Cells |
| 101181-6 | MDMB-4en-PINACA [Mass/volume] in Urine by Confirmatory method |
| 13863-6 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
| 14077-2 | Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 14123-4 | Thyroxine (T4).albumin bound/Albumin [Mass Ratio] in Serum or Plasma |
| 103056-8 | Dog recombinant (rCan f) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103175-6 | Enterococcus faecalis+Enterococcus faecium DNA [Presence] in Wound by NAA with probe detection |
| 103556-7 | PLA2G7 and PLAC8 gene expression level [Score] in Blood by Molecular genetics method |
| 15059-9 | DOPamine [Moles/time] in 24 hour Urine |
| 10448-9 | T-cell Ag [Presence] in Tissue by Immune stain |
| 10462-0 | Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain |
| 10535-3 | Digoxin [Mass/volume] in Serum or Plasma |
| 10797-9 | Microscopic observation [Identifier] in Tissue by Neutral red stain |
| 11072-6 | Despropionylfentanyl [Mass/volume] in Serum or Plasma |
| 1696-4 | 5-Methyltetrahydrofolate homocysteine methyltransferase [Enzymatic activity/volume] in Serum |
| 17242-9 | Prolactin [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 18417-6 | Black Bean IgG Ab [Units/volume] in Serum |
| 18489-5 | Valproate.protein bound [Mass/volume] in Serum or Plasma |
| 90469-8 | Norfluvoxamine [Mass/volume] in Urine by Confirmatory method |
| 74481-3 | Tyrosine/Phenylalanine [Molar ratio] in DBS |
| 92550-3 | Co sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 60368-8 | Clam IgG Ab [Mass/volume] in Serum |
| 76666-7 | Protein [Mass/volume] in Cerebral spinal fluid --2nd tube |
| 93746-6 | Protein catabolic rate based on 24 hour Urine [Calculated] |
| 93922-3 | Rh antigens and K Ag post transfusion reaction panel - Blood |
| 6303-2 | dRVVT (LA screen) |
| 63079-8 | White Bean IgG Ab [Mass/volume] in Serum |
| 63247-1 | Ganglioside GM1 IgM Ab [Presence] in Serum by Immunoassay |
| 78344-9 | Fatty acid comprehensive (C8-C26) panel - Red Blood Cells |
| 7841-0 | Coxsackievirus B6 Ab [Units/volume] in Serum |
| 66121-5 | Tissue Pathology biopsy report |
| 8000-2 | Rickettsia typhus group Ab [Units/volume] in Serum |
| 80548-1 | Sirolimus [Mass/volume] in DBS |
| 9661-0 | HIV 1 gp120 Ab [Presence] in Serum by Immunoblot |
| 69767-2 | La Crosse virus RNA [Presence] in Specimen by NAA with probe detection |
| 81775-9 | Epipregnanolone/Creatinine [Molar ratio] in Urine |
| 82200-7 | Vibrio cholerae+parahaemolyticus+vulnificus DNA [Presence] in Stool by NAA with non-probe detection |
| 70144-1 | Cannabinoids [Presence] in Urine by Screen method >20 ng/mL |
| 7120-9 | Bass, Black IgE Ab [Units/volume] in Serum |
| 82509-1 | Gamma interferon.negative control [Units/volume] in Blood |
| 99078-8 | Thyrotropin blocking Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 72344-5 | Monocytes/100 round cells in Prostatic fluid by Manual count |
| 83098-4 | Follitropin [Units/volume] in Serum or Plasma by Immunoassay |
| 85100-6 | FLT3 gene internal tandem duplication [Presence] in Bone marrow by Molecular genetics method |
| 993-6 | Do sup(a) Ab [Presence] in Serum or Plasma |
| 86035-3 | Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 73102-6 | Triazolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88895-8 | Perampanel [Mass/volume] - Serum or Plasma |
| 50988-5 | Horowitz index adjusted to patients actual temperature in Capillary blood |
| 30896-5 | Referral lab test [Identifier] |
| 42178-4 | Lipoprotein.X [Presence] in Serum or Plasma |
| 59949-8 | PARoxetine [Moles/volume] in Urine |
| 21085-6 | Aspergillus fumigatus Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
| 21610-1 | Zinc [Mass/volume] in 24 hour Urine |
| 31314-8 | Coxiella burnetii phase 2 IgG Ab [Presence] in Serum |
| 31483-1 | Leptospira sp Ab [Units/volume] in Serum |
| 51319-2 | CD41 cells/100 cells in Bone marrow |
| 43046-2 | Coxsackievirus A16 Ab [Titer] in Body fluid |
| 2184-0 | Cytochrome C oxidase [Enzymatic activity/volume] in Plasma |
| 22254-7 | Duck enteritis virus Ab [Presence] in Serum |
| 51494-3 | Cortisol [Mass/volume] in Saliva (oral fluid) --1st specimen post XXX challenge |
| 51756-5 | ATP7B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 4352-1 | Nitrazepam [Mass] of Dose |
| 32065-5 | cloZAPine [Presence] in Urine |
| 32096-0 | Methaqualone [Presence] in Specimen |
| 32331-1 | Myoglobin [Presence] in Serum or Plasma |
| 51990-0 | Basic metabolic panel - Blood |
| 43865-5 | Blastomyces dermatitidis IgG Ab [Presence] in Serum by Immunoassay |
| 4411-5 | Promazine [Mass] of Dose |
| 22886-6 | Bordetella bronchiseptica Ab [Presence] in Serum |
| 32794-0 | Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 32821-1 | Immunofixation for Body fluid |
| 5334-8 | Rubella virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 53480-0 | Glucose [Moles/volume] in Serum or Plasma --2.5 hours post dose betaxolol |
| 44493-5 | Herpes simplex virus 2 Ab [Presence] in Cerebral spinal fluid |
| 44798-7 | Burkholderia sp identified in Specimen by Organism specific culture |
| 23513-5 | Trypanosoma equiperdum Ab [Presence] in Serum by Immunofluorescence |
| 33505-9 | Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose lactose PO |
| 33531-5 | Platelet aggregation arachidonate induced in Control Platelet rich plasma |
| 33584-4 | Gastrin [Mass/volume] in Serum or Plasma --10 minutes pre XXX challenge |
| 45052-8 | Glucose [Moles/volume] in Serum or Plasma --12 AM specimen |
| 45314-2 | Coproporphyrin 3/Coproporphyrin 1 [Molar ratio] in Urine |
| 54357-9 | Beta 2 globulin+Gamma globulin/Protein.total in Urine by Electrophoresis |
| 45388-6 | Calcium phosphate crystals [#/area] in Urine sediment by Microscopy low power field |
| 45390-2 | Epithelial cells.squamous [#/area] in Urine sediment by Microscopy low power field |
| 46090-7 | Leukocytes [#/volume] in Cerebral spinal fluid --4th tube |
| 46100-4 | Pregnenolone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
| 2485-1 | Insulin-like growth factor-II [Mass/volume] in Serum or Plasma |
| 34413-5 | Moclobemide [Moles/volume] in Serum or Plasma |
| 55289-3 | Sulopenem [Susceptibility] |
| 35111-4 | Flecainide [Mass/volume] in Serum or Plasma --peak |
| 35267-4 | Age at pathology Dx |
| 55695-1 | Oxolinate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 47598-8 | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood |
| 35623-8 | Nordoxepin [Mass/volume] in Serum or Plasma by Screen method |
| 479-6 | Talampicillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 48307-3 | Didanosine [Mass/volume] in Serum or Plasma |
| 35808-5 | Florfenicol [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 56723-0 | Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot |
| 56724-8 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot |
| 48429-5 | Lavender IgE Ab [Units/volume] in Serum |
| 26921-7 | CD2+CD26+ cells [#/volume] in Blood |
| 57513-4 | 11-Hydroxyandrosterone [Mass/time] in 24 hour Urine --pre dose dexamethasone |
| 49311-4 | Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence Narrative |
| 3912-3 | Penicillin [Mass/volume] in Urine |
| 58350-0 | Plasma cells immature/100 cells in Blood |
| 49346-0 | BK virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
| 40266-9 | Creatinine [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
| 58577-8 | Corticotropin [Moles/volume] in Plasma --2 hours post dose insulin IV |
| 58754-3 | Olive pollen native (nOle e) 1 IgE Ab [Units/volume] in Serum |
| 49801-4 | Trypanosoma cruzi DNA [Presence] in Blood by NAA with probe detection |
| 49926-9 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells by WHO method |
| 2979-3 | Taurine [Mass/volume] in Cerebral spinal fluid |
| 29841-4 | La Crosse virus IgM Ab [Presence] in Cerebral spinal fluid |
| 58846-7 | Somatotropin [Mass/volume] in Serum or Plasma --18th specimen |
| 58899-6 | Aldosterone [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
| 59252-7 | Homocysteine cysteine disulfide [Moles/volume] in Cerebral spinal fluid |
| 59279-0 | Urate crystals [Presence] in Stone by X-ray diffraction |
| 30219-0 | Coxsackievirus A9 Ab [Presence] in Serum |
| 41021-7 | Cocaine [Presence] in Hair |
| 19219-5 | Oxygen content in Capillary blood |
| 19641-0 | Oxazepam cutoff [Mass/volume] in Urine for Confirmatory method |
| 19765-7 | Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
| 20949-4 | Rickettsia sp [Presence] in Blood by Light microscopy |
| 100053-8 | Fluoroquinolone [Susceptibility] |
| 1326-8 | U Ag [Presence] on Red Blood Cells from Blood product unit |
| 13319-9 | Ova and parasites identified in Stool by Light microscopy--2nd specimen |
| 13923-8 | Trichinella spiralis IgM Ab [Presence] in Serum by Immunoassay |
| 102388-6 | Insulin human IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14084-8 | Herpes simplex virus 1 [Presence] in Isolate by Immunofluorescence |
| 102827-3 | Sugar Cane IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1033-0 | Fy sup(b) Ag [Presence] on Red Blood Cells |
| 10449-7 | Glucose [Mass/volume] in Serum or Plasma --1 hour post meal |
| 16133-1 | Legionella pneumophila IgM Ab [Titer] in Serum by Immunofluorescence |
| 10965-2 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
| 16275-0 | Bartonella sp DNA [Presence] in Blood by NAA with probe detection |
| 17971-3 | Bacteria # 3 identified in Urine by Culture |
| 90815-2 | Amphiphysin Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 7475-7 | Mackerel triggered histamine release [Units/volume] in Blood |
| 75114-9 | Fatty acids pattern [Interpretation] in Red Blood Cells Narrative |
| 75127-1 | Deoxyinosine [Moles/volume] in Serum or Plasma |
| 75236-0 | Crystals [#/area] in Body fluid by Light microscopy |
| 76485-2 | C reactive protein [Moles/volume] in Serum or Plasma |
| 93367-1 | Variant of unknown significance [Identifier] in Blood or Tissue Nominal |
| 61341-4 | Gerbil epithelium IgE Ab/IgE total in Serum |
| 77369-7 | HIV 1 RNA [Presence] in Semen by NAA with probe detection |
| 93913-2 | VS Ag [Presence] on Red Blood Cells |
| 62858-6 | Micromegakaryocytes/100 leukocytes in Blood by Manual count |
| 63110-1 | Pistachio IgG Ab [Mass/volume] in Serum |
| 63285-1 | Mitochondria M5 Ab [Titer] in Serum by Immunofluorescence |
| 7844-4 | Taenia solium larva IgA Ab [Presence] in Cerebral spinal fluid |
| 94333-2 | Encephalitozoon sp 18S rRNA gene [Presence] in Specimen by NAA with non-probe detection |
| 94457-9 | Dimethylarsinate [Mass/volume] in Urine |
| 63479-0 | Platelet glycoprotein Ia/IIa Ab [Presence] in Blood by Immunoassay |
| 6462-6 | Bacteria identified in Wound by Culture |
| 6468-3 | Microscopic observation [Identifier] in Sputum by Calcofluor white |
| 78962-8 | IgG clearance/Transferrin clearance [Ratio] in Urine and Serum or Plasma |
| 79387-7 | Escherichia coli Stx2 toxin stx2 gene [Presence] in Stool by NAA with probe detection |
| 662-7 | Microscopic observation [Identifier] in Specimen by Giemsa stain |
| 96284-5 | Hay dust IgE Ab [Units/volume] in Serum |
| 96323-1 | Klebsiella aerogenes DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection |
| 96451-0 | Alpha-1-Fetoprotein and Alpha-1-Fetoprotein.L3 panel - Serum or Plasma |
| 80554-9 | Zopiclone [Mass/volume] in Serum or Plasma |
| 70013-8 | Coxsackievirus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 82075-3 | Food Allergen Mix fx73 (Beef+Chicken+Pork) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 9745-1 | Gamma globulin [Mass/volume] in Urine by Electrophoresis |
| 70277-9 | t(3;5)(q25.1;q35.1)(MLF1,NPM1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 82574-5 | Staphylococcus aureus enterotoxin E IgE Ab [Units/volume] in Serum |
| 71660-5 | Lymphocytes/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
| 86157-5 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 88588-9 | Legionella sp DNA [Identifier] in Lower respiratory specimen by NAA with probe detection |
| 88708-3 | Dermatophagoides pteronyssinus recombinant (rDer p) 1 IgE Ab [Units/volume] in Serum |
| 41516-6 | HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 1.9 log copies/mL |
| 41662-8 | Aztreonam+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 50777-2 | Cancer Ag 15-3 [Units/volume] in Pericardial fluid |
| 31076-3 | Rickettsia typhi IgG Ab [Titer] in Body fluid |
| 42584-3 | Beet IgG Ab [Mass/volume] in Serum |
| 60128-6 | Paramethadione [Mass/volume] in Urine |
| 60266-4 | Human metapneumovirus RNA [Presence] in Isolate by NAA with probe detection |
| 51239-2 | CD13+CD33+ cells/100 cells in Cerebral spinal fluid |
| 2187-3 | Cytosol aminopeptidase [Enzymatic activity/volume] in Serum or Plasma |
| 51766-4 | Glucose [Mass/volume] in Serum or Plasma --2.5 hours post dose fructose PO |
| 22579-7 | Toxoplasma gondii IgA+IgE Ab [Units/volume] in Serum |
| 32349-3 | Basophils+Eosinophils+Monocytes [#/volume] in Blood |
| 51966-0 | Genetic disease DNA analysis panel |
| 52896-8 | Silver [Moles/volume] in Red Blood Cells |
| 53092-3 | Collagen crosslinked C-telopeptide [Moles/volume] in Serum or Plasma |
| 44442-2 | Bartonella henselae Ab [Units/volume] in Serum by Immunoassay |
| 44723-5 | Histiocytes [Presence] in Bone marrow by Light microscopy |
| 23328-8 | Ovine progressive pneumonia virus Ab [Presence] in Milk |
| 53706-8 | Myasthenia grav eval adult rflx panel - Serum |
| 33826-9 | Lutropin [Units/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 54333-0 | Stearoylcarnitine (C18)/Creatinine [Molar ratio] in Urine |
| 54426-2 | Fresh frozen plasma pediatric units given [#] |
| 4606-0 | Hemoglobin M - Boston [Presence] in Blood |
| 46157-4 | Aspergillus glaucus Ab [Presence] in Serum |
| 46198-8 | Mycoplasma pneumoniae IgG Ab [Presence] in Serum |
| 3440-5 | Cathine [Mass/time] in 24 hour Urine |
| 34555-3 | Creatinine 24H renal clearance panel |
| 25390-6 | Cytokeratin 19 [Mass/volume] in Serum or Plasma |
| 25444-1 | IgA [Presence] in Urine by Immunoelectrophoresis |
| 25475-5 | Methaqualone [Moles/volume] in Serum or Plasma |
| 3485-0 | CISplatin [Mass/volume] in Serum or Plasma |
| 55848-6 | Cryoglobulin.IgG [Presence] in Serum |
| 55932-8 | Lactate [Moles/volume] in Cord blood |
| 47847-9 | Cortisol [Moles/volume] in Serum or Plasma --post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 48129-1 | Somatotropin [Units/volume] in Serum or Plasma --30 minutes pre dose betaxolol+glucagon |
| 26635-3 | Legionella micdadei Ab [Presence] in Serum |
| 3719-2 | Lithium [Mass/volume] in Serum or Plasma |
| 3754-9 | Meprobamate [Presence] in Urine |
| 48817-1 | Donath Landsteiner Ab [Titer] in Control Serum |
| 48847-8 | Bartonella vinsonii berkhoffii IgG Ab [Titer] in Serum by Immunofluorescence |
| 26884-7 | Ketones [Presence] in Urine by Test strip --3 hours post XXX challenge |
| 38287-9 | 2,2-Dichloropropionate [Mass/volume] in Water |
| 57452-5 | Ma+Ta Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 57544-9 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --7th specimen post dose gonadotropin releasing hormone |
| 49146-4 | Rickettsia rickettsii IgM Ab [Titer] in Body fluid |
| 27329-2 | Feline panleukopenia virus IgM Ab [Titer] in Serum |
| 273-3 | Gramicidin D [Susceptibility] by Serum bactericidal titer |
| 3962-8 | Phenylephrine [Mass/volume] in Urine |
| 5809-9 | Reducing substances [Presence] in Urine |
| 49589-5 | Bacterial susceptibility panel by Gradient strip |
| 29339-9 | Flecainide [Mass/volume] in Gastric fluid |
| 29341-5 | CD11b cells [#/volume] in Blood |
| 40011-9 | Glucose [Mass/volume] in Serum or Plasma --13.5 hours post XXX challenge |
| 40496-2 | Yersinia pseudotuberculosis 2 Ab [Titer] in Serum |
| 40731-2 | Herpes virus 6 IgM Ab [Presence] in Serum by Immunoassay |
| 50340-9 | Eosinophils [Presence] in Nose by Hansel stain |
| 41166-0 | Uranium depleted/Creatinine [Mass Ratio] in Urine |
| 19661-8 | Phencyclidine cutoff [Mass/volume] in Urine for Confirmatory method |
| 20813-2 | Escherichia coli F41 [Presence] in Isolate by Agglutination |
| 100412-6 | Chinese cabbage IgG Ab [Units/volume] in Serum |
| 12746-4 | Insulin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 101143-6 | NAT2 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
| 13056-7 | Platelets [#/volume] in Plasma by Automated count |
| 13119-3 | Myelin associated glycoprotein Ab [Presence] in Serum by Immunoblot |
| 101965-2 | NDUFAF5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 102079-1 | CAR-T dose [#/mass] |
| 102297-9 | Epidermophyton floccosum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102347-2 | Salt grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102496-7 | Passion fruit IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102784-6 | Pea IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15045-8 | Creatine [Moles/volume] in Serum or Plasma |
| 16588-6 | Chlamydophila psittaci IgM Ab [Units/volume] in Cerebral spinal fluid |
| 1231-0 | M Ag [Presence] on Red Blood Cells |
| 16957-3 | Herpes simplex virus 2 IgG Ab [Units/volume] in Serum --1st specimen |
| 17169-4 | CD5+CD2- cells/100 cells in Blood |
| 18285-7 | CDA cells/100 cells in Blood |
| 18981-1 | Spiramycin [Susceptibility] |
| 74664-4 | Zolpidem [Mass/volume] in Blood |
| 74792-3 | Fructose.PO [Mass] in Dose |
| 92673-3 | Hydroxyglutarates and glutarate and ethylmalonate and methylsuccinate panel - Serum or Plasma |
| 75064-6 | Vanillylmandelate [Moles/volume] in Serum or Plasma |
| 77358-0 | Nitrogen [Mass/mass] in 24 hour Stool |
| 93700-3 | Beta-lactam resistance AmpC blaDHA gene [Presence] by Molecular method |
| 94304-3 | OxyCODONE and metabolites panel - Urine by Confirmatory method |
| 79345-5 | Pyridoxal phosphate and pyridoxal and pyridoxine pattern [Interpretation] in Cerebral spinal fluid Narrative |
| 65335-2 | Sw sup(a) Ab [Presence] in Serum or Plasma |
| 79607-8 | Saccharopine [Moles/volume] in Serum or Plasma |
| 675-9 | Enterobius vermicularis [Presence] in Specimen by Pinworm exam |
| 67806-0 | Measles virus Ag [Presence] in Isolate by Immunofluorescence |
| 8102-6 | CD33 cells/100 cells in Blood |
| 96624-2 | Donor HLA typing comment [Interpretation] Narrative |
| 96708-3 | Clot stiffness.tissue factor induced (elasticity) in Blood by US --post heparin neutralization |
| 6919-5 | Chlamydia trachomatis IgG Ab [Titer] in Serum by Immunofluorescence |
| 71653-0 | Promyelocytes/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
| 97995-5 | Platelets [#/volume] in Blood by Automated count.optical |
| 98109-2 | Chemokine (C-C motif) ligand 8 [Mass/volume] in Serum or Plasma |
| 7172-0 | Candida albicans IgG Ab [Units/volume] in Serum |
| 7180-3 | Carrot IgG Ab [Units/volume] in Serum |
| 72449-2 | 3-Hydroxyisovalerate [Moles/volume] in Cerebral spinal fluid |
| 840-9 | A1 Ab [Presence] in Serum or Plasma from Donor |
| 72522-6 | p-ANCA formalin resistant IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 85834-0 | Beta-lactam resistance ESBL blaCTX-M-9 Group gene [Presence] by Molecular method |
| 85904-1 | Cancer pathology panel - Breast cancer specimen by CAP cancer protocols |
| 86168-2 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum by Immunoassay |
| 73119-0 | Timolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88150-8 | Microscopic observation [Identifier] in Ocular fluid by Giemsa stain |
| 88162-3 | Acanthamoeba sp identified in Cornea or Conjunctiva by Organism specific culture |
| 41404-5 | 17-Hydroxycorticosteroids/Creatinine [Mass Ratio] in 24 hour Urine |
| 41670-1 | ceFAZolin [Susceptibility] by Gradient strip |
| 31045-8 | Creatinine/Urea nitrogen [Mass Ratio] in Serum or Plasma |
| 4200-2 | Prochlorperazine [Mass] of Dose |
| 60065-0 | Cobalt [Mass/mass] in Nail |
| 315-2 | Meclocycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 5138-3 | Echovirus 19 neutralizing antibody [Titer] in Serum by Neutralization test |
| 42918-3 | Hydroflumethiazide [Mass/volume] in Serum or Plasma |
| 31983-0 | Venezuelan equine encephalitis virus Ag [Presence] in Serum |
| 51610-4 | Calcium [Moles/time] in 12 hour Urine |
| 51703-7 | Ganglioside GM1 IgM Ab [Units/volume] in Serum by Immunoassay |
| 32303-0 | Bilirubin.total [Moles/volume] in Specimen |
| 5194-6 | Hepatitis B virus surface Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
| 52988-3 | Leptospira sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 4388-5 | Phenazocine [Mass] of Dose |
| 32650-4 | Norflunitrazepam [Mass/volume] in Serum or Plasma |
| 3279-7 | Kininogen LMW [Mass/volume] in Platelet poor plasma by Immunoassay |
| 53146-7 | Follitropin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 44674-0 | Invasive carcinoma uninvolved margin closest in Breast tumor |
| 33282-5 | Cannabinoids [Mass/mass] in Meconium by Confirmatory method |
| 3364-7 | Antipyrine [Mass/volume] in Serum or Plasma |
| 33674-3 | Platelet aggregation.ristocetin+Control PRP induced in Platelet poor plasma |
| 44918-1 | DOPamine/Creatinine [Molar ratio] in 24 hour Urine |
| 23823-8 | Basophils/100 leukocytes in Specimen by Manual count |
| 34283-2 | Dehydroepiandrosterone (DHEA)/Creatinine [Molar ratio] in Urine |
| 47293-6 | Bacteria # 7 identified in Genital specimen by Aerobe culture |
| 25248-6 | Ciprofloxacin [Mass/volume] in Specimen |
| 25265-0 | Oxacillin [Mass/volume] in Specimen |
| 35349-0 | Taenia solium larva Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 47786-9 | Threonine/Amino acids.total in Cerebral spinal fluid |
| 35357-3 | PEO gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 35609-7 | Doxepin [Mass/volume] in Serum or Plasma by Screen method |
| 35752-5 | Escherichia coli O157:H7 IgG and IgM panel - Serum |
| 5642-4 | Ethanol [Presence] in Serum or Plasma |
| 3586-5 | Doxylamine [Presence] in Urine |
| 27182-5 | Calcium [Presence] in Blood |
| 3832-3 | Morphine [Mass/time] in 24 hour Urine |
| 57505-0 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --2 days post dose metyraPONE |
| 29367-0 | Parainfluenza virus 2 Ab [Titer] in Body fluid by Complement fixation |
| 49814-7 | 2-Hydroxyisovalerate/Creatinine [Molar ratio] in 24 hour Urine |
| 29796-0 | Saint Louis encephalitis virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test |
| 40575-3 | Yersinia enterocolitica O:5,27 Ab [Titer] in Serum by Agglutination |
| 4064-2 | traZODone [Mass/volume] in Serum or Plasma |
| 40708-0 | Polio virus IgG Ab [Titer] in Serum --2nd specimen |
| 59187-5 | Urea renal clearance/1.73 sq M in 24 hour Urine and Serum or Plasma |
| 5930-3 | Mumps reaction wheal [Diameter] --3 days post 0.1 mL mumps intradermal |
| 50513-1 | Lutropin [Units/volume] in Serum or Plasma --5th specimen |
| 40789-0 | Japanese hop IgE Ab [Units/volume] in Serum |
| 101137-8 | MNS29 [Presence] in Serum or Plasma |
| 13302-5 | HLA-C [Type] |
| 14108-5 | CD16C+CD56+ cells [#/volume] in Blood |
| 14255-4 | Thyrotropin blocking Ab [Units/volume] in Serum |
| 14258-8 | 1,4-Dioxane [Mass/volume] in Blood |
| 102983-4 | Horse hair+Horse dander IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103022-0 | Malassezia sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104-0 | Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 15234-8 | Mold Allergen Mix 2 (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk |
| 15431-0 | Service comment 40 |
| 16216-4 | MethylePHEDrine [Presence] in Urine by Confirmatory method |
| 11106-2 | Eosinophils/100 cells in Bone marrow by Manual count |
| 16403-8 | Arsenic [Presence] in Serum or Plasma |
| 1685-7 | 3-Methylhistidine [Presence] in Serum or Plasma |
| 17359-1 | Neutrophils [#/volume] in Semen by Manual count |
| 17412-8 | Human papilloma virus 6+11 Ag [Presence] in Specimen |
| 17720-4 | Trans nonachlor [Mass/volume] in Urine |
| 17910-1 | Bacteria # 2 identified in Wound deep by Aerobe culture |
| 90259-3 | NAT2 gene full mutation analysis in Blood or Tissue by Sequencing |
| 74524-0 | Decatrienoylcarnitine (C10:3) [Moles/volume] in Serum or Plasma |
| 92502-4 | Hemoglobin S inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 75597-5 | Comment on fetal 5p deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 7641-4 | Rabbit Bush IgE Ab [Units/volume] in Serum |
| 62422-1 | Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --10th specimen fasting |
| 62461-9 | Trichomonas vaginalis DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 63254-7 | Ganglioside GQ1b IgG Ab [Presence] in Serum by Immunoassay |
| 79335-6 | Hypoglycemics.oral [Presence] in Blood by Screen method |
| 6606-8 | Brugia malayi Ab [Presence] in Serum by Immunoassay |
| 66485-4 | Brucella sp IgG and IgM [Interpretation] in Serum |
| 95720-9 | Glycine receptor Ab [Titer] in Serum or Plasma by Immunoassay |
| 96523-6 | Ilheus virus IgM Ab [Presence] in Specimen by Immunoassay |
| 96909-7 | Cenobamate [Mass/volume] in Serum or Plasma by Confirmatory method |
| 81857-5 | GDAP1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 81861-7 | Karyotype in Bone marrow |
| 8199-2 | Ethyl benzene [Mass/volume] in Blood |
| 82495-3 | TRBV9 gene segments/TRBV gene segments.total in Blood |
| 82874-9 | Calprotectin [Mass/volume] in Stool |
| 98988-9 | Prolactin [Moles/volume] in Serum or Plasma --45 minutes post dose TRH IV |
| 71710-8 | Lassa virus IgG Ab [Titer] in Serum by Immunoassay |
| 72269-4 | pH of Vaginal fluid by Test strip |
| 99378-2 | Vasopressin [Moles/volume] in Urine |
| 99427-7 | Blomia tropicalis IgG4 Ab [Mass/volume] in Serum |
| 86117-9 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 86548-5 | HIV 2 RNA [#/volume] (viral load) in Plasma by NAA with probe detection |
| 73192-7 | Procainamide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73464-0 | cefTRIAXone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88147-4 | Microscopic observation [Identifier] in Pericardial fluid by Gram stain |
| 88261-3 | Gram positive bacteria identified [Interpretation] by Probe in Positive blood culture |
| 59757-5 | tiZANidine [Mass/volume] in Blood |
| 30427-9 | Macrophages/100 leukocytes in Body fluid |
| 41992-9 | Arsenic.inorganic [Mass/volume] in 24 hour Urine |
| 4231-7 | Doxylamine [Mass] of Dose |
| 21346-2 | HTLV I+II Ab band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot |
| 21381-9 | Prolactin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 31481-5 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Units/volume] in Serum |
| 51134-5 | CD25 blasts/100 blasts in Bone marrow |
| 51463-8 | Onchocerca sp IgG3 Ab [Units/volume] in Serum |
| 42926-6 | Myeloid cells/100 cells in Blood |
| 21677-0 | FGFR3 gene p.Gly375Cys [Presence] in Blood or Tissue by Molecular genetics method |
| 2183-2 | Cytochrome B5 reductase [Enzymatic activity/volume] in Serum |
| 22180-4 | Chlamydophila psittaci IgG Ab [Titer] in Serum |
| 22238-0 | Taenia solium larva Ab [Presence] in Serum |
| 3169-0 | Volume of Specimen |
| 31815-4 | Equine arteritis virus Ag [Presence] in Specimen |
| 31841-0 | Haemophilus influenzae F Ag [Presence] in Cerebral spinal fluid |
| 31962-4 | Rubella virus Ag [Presence] in Sputum |
| 51682-3 | Pregnenolone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 22478-2 | Rickettsia spotted fever group IgM Ab [Titer] in Cerebral spinal fluid |
| 43966-1 | CD4+CD45RA+ cells/100 cells in Specimen |
| 23058-1 | Ephemeral fever virus Ab [Presence] in Serum |
| 53733-2 | Color of Spun Body fluid |
| 53842-1 | Basement membrane zone BP180 IgG Ab [Units/volume] in Serum or Plasma |
| 44920-7 | Hemoglobin C/Hemoglobin.total in Blood by HPLC |
| 23666-1 | Babesia sp Ab [Titer] in Serum by Complement fixation |
| 24051-5 | Acid alpha glucosidase [Enzymatic activity/mass] in Leukocytes |
| 54254-8 | Glucose [Moles/volume] in Serum or Plasma --5 minutes pre dose glucagon |
| 46426-3 | Icteric interference index of Serum or Plasma |
| 24211-5 | Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 34367-3 | Pyridinoline [Moles/volume] in Urine |
| 34622-1 | CD4+CD25+ cells/100 cells in Specimen |
| 55398-2 | Short Fibrin D-dimer FEU and DDU panel - Platelet poor plasma |
| 47193-8 | Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 47208-4 | Arginine [Mass] of Dose |
| 25508-3 | Progesterone [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 34742-7 | Chromosome breakage [Units/volume] in Blood by Diepoxybutane |
| 35020-7 | Monocytes+Macrophages/100 leukocytes in Peritoneal fluid |
| 35324-3 | PMP22 gene allele 1 [Presence] in Blood or Tissue by Molecular genetics method |
| 47685-3 | Leucine/Amino acids.total in Specimen |
| 47695-2 | Lysine/Amino acids.total in Specimen |
| 25757-6 | Schistosoma sp IgG Ab [Units/volume] in Serum by Immunoassay |
| 56277-7 | Pea IgG4 Ab [Mass/volume] in Serum |
| 48195-2 | Trimethoprim triggered leukotriene release [Mass/volume] by Leukocytes |
| 26492-9 | Mononuclear cells/100 leukocytes in Cerebral spinal fluid |
| 26743-5 | Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma |
| 35838-2 | Salinomycin [Susceptibility] |
| 38231-7 | CD11b+HLA-DR+ cells/100 cells in Blood |
| 56911-1 | Chlamydia sp IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 48789-2 | Creatinine peritoneal dialysis clearance/1.73 sq M |
| 26953-0 | Dichlorodiphenyltrichloroethane [Presence] in Serum or Plasma |
| 27200-5 | Nuclear Ab [Units/volume] in Serum |
| 38664-9 | Bis(2-Chloroethyl) ether [Mass/volume] in Air |
| 38907-2 | NIPA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 39982-4 | Creatinine [Mass/volume] in Urine --baseline |
| 40029-1 | Glucose [Mass/volume] in Serum or Plasma --14 minutes post XXX challenge |
| 58391-4 | Codeine/Creatinine [Mass Ratio] in Urine |
| 58586-9 | Corticotropin [Moles/volume] in Plasma --30 minutes post XXX challenge |
| 58683-4 | Complement C5 [Presence] in Serum or Plasma |
| 49883-2 | Hepatitis B virus resistance panel by Genotype method |
| 58963-0 | Ganglioside GT1a IgM Ab [Units/volume] in Serum by Immunoassay |
| 5051-8 | Aspergillus niger Ab [Units/volume] in Serum |
| 200-6 | Colistimethate by Minimum lethal concentration (MLC) |
| 12413-1 | Resperine [Mass/volume] in Serum or Plasma |
| 100809-3 | Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge |
| 100867-1 | Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay |
| 12649-0 | Glucose [Mass/volume] in Serum or Plasma --6th specimen post dose lactose |
| 101291-3 | Rhinovirus+Enterovirus RNA [Presence] in Throat by NAA with non-probe detection |
| 101476-0 | Fasting glucose [Moles/volume] in Venous blood |
| 102166-6 | Castor Bean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1430-8 | Cortisol [Mass/volume] in Serum or Plasma --56 hours post 40 ug corticotropin IM BID 3 day |
| 14356-0 | Microscopic observation [Identifier] in Vaginal fluid by KOH preparation |
| 14719-9 | Ethanol [Moles/volume] in Serum or Plasma |
| 14971-6 | Estrone (E1).bioavailable/Estrone (E1).total in Serum or Plasma |
| 15453-4 | Avian reovirus Ab [Presence] in Serum by Immunoassay |
| 15506-9 | Salmonella typhimurium Ab [Presence] in Serum by Agglutination |
| 16209-9 | Chlorpheniramine [Presence] in Urine by Confirmatory method |
| 11257-3 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay |
| 17756-8 | Urate [Mass/time] in 4 hour Urine |
| 90228-8 | Extractable nuclear antigen Ab.IgG panel - Serum |
| 74518-2 | Clara cell protein 16 [Mass/volume] in Serum |
| 74670-1 | Cocaine+Metabolites [Presence] in Saliva (oral fluid) by Confirmatory method |
| 92781-4 | Lactobacillus sp DNA [Presence] by NAA with probe detection in Positive blood culture |
| 75065-3 | Benzoate [Moles/volume] in Serum or Plasma |
| 61032-9 | 7-Aminoflunitrazepam [Presence] in Serum or Plasma |
| 76615-4 | Lysosomal acid lipase [Enzymatic activity/mass] in Fibroblast by 4-MU-palmitate substrate |
| 769-0 | Segmented neutrophils/100 leukocytes in Blood by Manual count |
| 63274-5 | Liver kidney microsomal 2 Ab [Presence] in Serum by Immunofluorescence |
| 94481-9 | Human coronavirus NL63 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 94596-4 | Equine infectious anemia virus Ab [Units/volume] in Serum by Immunoassay |
| 6339-6 | Chlamydophila psittaci Ag [Presence] in Genital specimen by Immunofluorescence |
| 63402-2 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 647-8 | Microscopic observation [Identifier] in Sputum by Acid fast stain.Ziehl-Neelsen |
| 80165-4 | 2-Amino-4-hydroxypteridine [Moles/volume] in Cerebral spinal fluid |
| 96329-8 | Serratia marcescens DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection |
| 81423-6 | Microscopic observation [Identifier] in Bone marrow by Acetate esterase stain |
| 97177-0 | Yersinia outer protein N Ab [Presence] in Serum by Line blot |
| 7011-0 | Ethionamide [Susceptibility] by Gradient strip |
| 70283-7 | t(11;17)(q23;q21)(MLL,MLLT6) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 7089-6 | Apple triggered histamine release [Units/volume] in Serum |
| 82483-9 | TRBV25 gene segments/TRBV gene segments.total in Blood |
| 98264-5 | Omental involvement [Presence] in Endometrial cancer specimen |
| 7196-9 | Saltcedar IgE Ab [Units/volume] in Serum |
| 85314-3 | Extent of medial margin carcinoma involvement in Breast cancer specimen Qualitative by Light microscopy |
| 99878-1 | Lipids [Presence] in Urine sediment by Computer assisted method |
| 7289-2 | Duck feather IgG Ab [Units/volume] in Serum |
| 72971-5 | Phenytoin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86237-5 | Neisseria meningitidis serogroup w135 synG gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73347-7 | HYDROcodone+Acetaminophen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73485-5 | Carbidopa induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 41235-3 | Paper wasp IgE Ab [Mass/volume] in Serum |
| 41715-4 | Rosamicin [Susceptibility] by Disk diffusion (KB) |
| 59630-4 | cloBAZam [Mass/mass] in Meconium |
| 50620-4 | Opiates cutoff [Mass/mass] in Meconium for Confirmatory method |
| 42592-6 | Brucella abortus IgG Ab [Presence] in Cerebral spinal fluid |
| 21269-6 | Fenthion [Mass/volume] in Urine |
| 51103-0 | CD19 blasts [Units/volume] in Bone marrow |
| 5111-0 | Coxsackievirus B5 neutralizing antibody [Titer] in Serum by Neutralization test |
| 51279-8 | CD3+CD56+ cells/100 cells in Cerebral spinal fluid |
| 42884-7 | CD52 cells/100 cells in Specimen |
| 21793-5 | t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 2192-3 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/time] in 24 hour Urine |
| 22134-1 | Borrelia burgdorferi IgM Ab [Units/volume] in Body fluid |
| 22282-8 | Echovirus NOS Ab [Titer] in Serum |
| 31783-4 | Coxiella burnetii Ag [Presence] in Placenta |
| 3203-7 | Coagulation factor VII+Acarboxy Ag activity actual/normal in Platelet poor plasma by Immunoassay |
| 51579-1 | Normoblasts/100 cells in Bone marrow by Manual count |
| 32102-6 | PARoxetine [Presence] in Specimen |
| 32120-8 | Venlafaxine [Presence] in Urine |
| 32190-1 | Microscopic observation [Identifier] in Cerebral spinal fluid |
| 32258-6 | Methionine [Moles/volume] in Body fluid |
| 43921-6 | Bartonella sp IgM Ab [Presence] in Serum |
| 2296-2 | Fructose [Mass/volume] in Serum |
| 23123-3 | Francisella tularensis A rRNA [Presence] in Tissue by Probe |
| 32644-7 | Coxiella burnetii phase 1 IgG Ab [Presence] in Serum |
| 32670-2 | Cells Counted Total [#] in Amniotic fluid |
| 53453-7 | Cyclophosphamide [Mass/volume] in Urine |
| 4450-3 | traZODone [Mass] of Dose |
| 44547-8 | Human papilloma virus DNA [Presence] in Specimen by Probe with signal amplification |
| 44667-4 | Site of distant metastasis in Breast tumor |
| 23413-8 | Rinderpest virus Ag [Presence] in Specimen by Immunofluorescence |
| 33641-2 | Lymphocyte proliferation stimulated by tuberculin [Units/volume] in Blood |
| 53553-4 | Glucose mean value [Moles/volume] in Blood Estimated from glycated hemoglobin |
| 23977-2 | Borrelia burgdorferi Ag [Presence] in Specimen by Immunofluorescence |
| 34232-9 | Pseudallescheria boydii IgG Ab [Presence] in Serum by Immune diffusion (ID) |
| 46994-0 | HLA-A+B+C (class I) Ab in Serum |
| 24279-2 | Rickettsia typhi IgG Ab [Titer] in Serum --1st specimen |
| 47018-7 | CD79a Ag [Presence] in Tissue by Immune stain |
| 25435-9 | Herpes simplex virus IgM Ab [Presence] in Serum |
| 48120-0 | Prolactin [Mass/volume] in Serum or Plasma --15 minutes pre dose TRH IV |
| 56570-5 | Somatotropin [Mass/volume] in Serum or Plasma --11.5 hours post XXX challenge |
| 56776-8 | Amylase S3+S4/Amylase.total in Serum or Plasma |
| 56937-6 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose glucose |
| 48361-0 | Borrelia valaisiana IgG Ab [Presence] in Serum by Immunoblot |
| 48628-2 | Insulin-like growth factor binding protein 3 [Presence] in Urine |
| 5737-2 | Strychnine [Presence] in Serum or Plasma |
| 57425-1 | CD7 cells/100 cells in Body fluid |
| 57630-6 | Alpha cortolone [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
| 49298-3 | Protein Fractions [Interpretation] in Serum or Plasma Narrative |
| 27308-6 | PENTobarbital [Mass/mass] in Meconium |
| 27869-7 | Follitropin [Units/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 39548-3 | Salmon IgE Ab/IgE total in Serum |
| 57798-1 | Progesterone [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 57961-5 | Etravirine [Mass/volume] in Serum or Plasma |
| 5824-8 | Adenovirus Ag [Presence] in Conjunctival specimen by Immunofluorescence |
| 2858-9 | Protein in CSF/Protein in serum |
| 2886-0 | Protein [Mass/volume] in Synovial fluid |
| 29144-3 | 1,2-Dimethylbenzene [Mass/volume] in Serum or Plasma |
| 40276-8 | Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose lactose PO |
| 5006-2 | Haemophilus influenzae rRNA [Presence] in Specimen by Probe |
| 40486-3 | Protein/Creatinine [Ratio] in 24 hour Urine |
| 58875-6 | Somatotropin [Mass/volume] in Serum or Plasma --32nd specimen |
| 5910-5 | Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma |
| 59227-9 | Chromogranin A [Units/volume] in Cerebral spinal fluid |
| 40782-5 | Polio virus IgM Ab [Titer] in Cerebral spinal fluid --1st specimen |
| 20798-5 | Clostridium perfringens enterotoxin [Presence] in Tissue |
| 100837-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 12885-0 | Borrelia burgdorferi 88kD Ab [Presence] in Body fluid by Immunoblot |
| 102048-6 | SARS coronavirus 2 and Respiratory syncytial virus Ag [Presence] in Nasopharynx by Immunofluorescence |
| 102147-6 | Artichoke IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13913-9 | Adenovirus Ab [Titer] in Serum by Immunofluorescence |
| 102418-1 | Lupin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102446-2 | Cheese mold type IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14196-0 | Reticulocytes [#/volume] in Blood |
| 103737-3 | CYB5 and CYB5 Reductase multigene analysis in Specimen by Sequencing |
| 10407-5 | little i Ag [Presence] on Red Blood Cells from Donor |
| 104177-1 | Clostridium tetani toxin [Presence] in Specimen by Mouse bioassay neutralization |
| 104439-5 | Polio virus 3 Ab [Titer] in Serum by Immunoassay --1st specimen |
| 15469-0 | Equine influenza virus A1 Ab [Titer] in Serum by Hemagglutination inhibition |
| 10801-9 | Microscopic observation [Identifier] in Tissue by Phosphotungstic acid Hematoxylin (PTAH) Stain |
| 10911-6 | Dichlorobenzidine [Mass/volume] in Urine |
| 11061-9 | 11-Dehydro thromboxane beta 2 [Mass/time] in 24 hour Urine |
| 1628-7 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post 1 g/kg glucose PO |
| 1733-5 | Adipate [Mass/volume] in Urine |
| 17540-6 | Rickettsia typhi IgA Ab [Units/volume] in Serum by Immunofluorescence |
| 19138-7 | Opiates cutoff [Mass/volume] in Urine |
| 90836-8 | Neuronal nuclear type 3 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 91113-1 | Cholesterol in LDL 2 [Moles/volume] in Serum or Plasma |
| 74515-8 | Bile acid [Moles/mass] in 24 hour Stool |
| 74656-0 | Opiates [Presence] in Saliva (oral fluid) by Confirmatory method |
| 6063-2 | Castor Bean IgE Ab [Units/volume] in Serum |
| 6114-3 | Euroglyphus maynei IgE Ab [Units/volume] in Serum |
| 75759-1 | Chlorpheniramine [Presence] in Serum or Plasma or Urine by Screen method |
| 76594-1 | Enterococcus faecium sodA gene [#/mass] in XXX.tissue by NAA with probe detection |
| 61397-6 | Enterococcus faecium DNA [Presence] in Specimen by NAA with probe detection |
| 7710-7 | Sole IgG Ab [Units/volume] in Serum |
| 62849-5 | Venlafaxine+O-desmethylvenlafaxine [Mass/volume] in Serum or Plasma |
| 77960-3 | Penicillin Parenteral [Susceptibility] by Disk diffusion (KB) |
| 64418-7 | KIR genotyping panel - Blood or Tissue |
| 79404-0 | Adenosine deaminase [Enzymatic activity/substance] in Red Blood Cells |
| 79413-1 | Dothiepin+Nordothiepin [Mass/volume] in Serum or Plasma --trough |
| 95101-2 | Glucagon [Mass/volume] in Serum or Plasma --fasting |
| 80384-1 | Choriogonadotropin (pregnancy test) [Presence] in Urine by Rapid immunoassay |
| 96326-4 | Pseudomonas aeruginosa DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection |
| 69041-2 | Western equine encephalitis virus IgG and IgM panel - Serum by Immunofluorescence |
| 97205-9 | Tropheryma whipplei DNA [Presence] in Blood by NAA with non-probe detection |
| 69480-2 | CFTR gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
| 6977-3 | Amoxicillin+Clavulanate [Susceptibility] by Gradient strip |
| 81769-2 | Adipoylcarnitine (C6-DC)/Creatinine [Molar ratio] in Urine |
| 97515-1 | Entamoeba bangladeshi DNA [Presence] in Specimen by NAA with probe detection |
| 7062-3 | Red Alder IgE Ab [Units/volume] in Serum |
| 70908-9 | Cryptococcus sp Ag [Presence] in Tissue by Immunofluorescence |
| 71647-2 | Basophils/Leukocytes [Pure number fraction] in Body fluid by Manual count |
| 82398-9 | Ganglioside GD1b IgG+IgM Ab [Presence] in Serum by Line blot |
| 8253-7 | Service comment 11 |
| 71860-1 | Hemoglobin M/Hemoglobin.total [Pure mass fraction] in Blood |
| 72341-1 | Amyloid bodies [Presence] in Prostatic fluid by Light microscopy |
| 72362-7 | Starch granules [#/area] in Urine sediment by Microscopy low power field |
| 85754-0 | Streptococcus pneumoniae Danish serotypes 6A+6B+6C+6D DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 7313-0 | Flea IgE Ab [Units/volume] in Serum |
| 87567-4 | T-2 toxin [Mass/mass] in Specimen |
| 73585-2 | Tizoxanide [Susceptibility] |
| 73611-6 | rifAXIMin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 74341-9 | MICA*007 IgG Ab [Presence] in Serum |
| 89369-3 | Zika virus non-structural protein 1 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 89532-6 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Cerebral spinal fluid by Line blot |
| 41202-3 | Baker's yeast IgE Ab/IgE total in Serum |
| 59580-1 | Coxsackievirus A16 IgM Ab [Titer] in Serum by Immunofluorescence |
| 59707-0 | Midazolam [Mass/volume] in Blood |
| 50726-9 | Reticulum cell/100 cells in Bone marrow by Gomori stain |
| 50807-7 | Antimony [Moles/volume] in Urine |
| 30416-2 | Variant lymphocytes/100 leukocytes in Cerebral spinal fluid |
| 30912-0 | DNA index in Specimen by Flow cytometry (FC) |
| 31054-0 | Coxsackievirus B2 Ab [Titer] in Body fluid by Complement fixation |
| 41849-1 | Curry IgG Ab [Units/volume] in Serum |
| 60064-3 | buPROPion [Mass/volume] in Urine |
| 21436-1 | Ovary Ab [Presence] in Serum by Immunofluorescence |
| 31466-6 | Legionella pneumophila 6 IgG Ab [Units/volume] in Serum |
| 31585-3 | Reticulin IgG Ab [Presence] in Serum |
| 42898-7 | Cyclic citrullinated peptide IgG Ab [Presence] in Serum |
| 31871-7 | Leptospira interrogans Ag [Presence] in Specimen |
| 22494-9 | Rickettsia typhus group IgM Ab [Titer] in Serum |
| 22602-7 | Varicella zoster virus IgG Ab [Titer] in Serum |
| 22738-9 | Urea [Moles/volume] in Specimen |
| 44338-2 | Methionine/Creatinine [Mass Ratio] in 24 hour Urine |
| 23156-3 | Leishmania sp Ab [Titer] in Serum by Immunofluorescence |
| 23160-5 | Leishmania sp identified in Tissue by Immunofluorescence |
| 32695-9 | Legionella pneumophila atypical Ab [Titer] in Serum |
| 5314-0 | Rickettsia spotted fever group IgM Ab [Units/volume] in Serum by Immunoassay |
| 44451-3 | Blastomyces dermatitidis Ab [Units/volume] in Serum by Complement fixation |
| 44598-1 | IgG.monoclonal [Presence] in Urine by Immunofixation |
| 53872-8 | Iodine [Mass/volume] in Urine collected for unspecified duration |
| 44900-9 | Malignant cells/100 cells in Bone marrow by Manual count |
| 44913-2 | Beta globulin+Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
| 44988-4 | Chlamydia trachomatis D+K IgM Ab [Presence] in Serum |
| 23732-1 | Feline leukemia virus Ab [Presence] in Serum by Immunoassay |
| 23842-8 | Cobalt [Mass/volume] in Synovial fluid |
| 24032-5 | Rifabutin [Mass/volume] in Serum or Plasma |
| 24055-6 | Alpha-N-acetylgalactosaminidase [Enzymatic activity/mass] in Leukocytes |
| 33822-8 | Interleukin 13 [Mass/volume] in Serum or Plasma |
| 33827-7 | Lutropin [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 54142-5 | Candida sp DNA [Presence] in Vaginal fluid by Probe with signal amplification |
| 46224-2 | Thrombin time in Platelet poor plasma by Coagulation assay --after addition of heparinase |
| 2460-4 | IgD [Mass/volume] in Serum |
| 3439-7 | Cathine [Mass/volume] in Urine |
| 55402-2 | West Nile virus IgG and IgM panel - Serum |
| 25296-5 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum |
| 3491-8 | clomiPRAMINE [Mass/volume] in Serum or Plasma |
| 35136-1 | Patient symptoms [Interpretation] --3 hours post dose lactose PO |
| 35168-4 | Arachidonate (C20:4w6) [Moles/volume] in Serum or Plasma |
| 47578-0 | Aspartate/Amino acids.total in DBS |
| 47634-1 | Glycine/Amino acids.total in Serum or Plasma |
| 56229-8 | Coffee IgG4 Ab [Mass/volume] in Serum |
| 56335-3 | Okra IgG4 Ab [Mass/volume] in Serum |
| 5639-0 | Ethanol [Presence] in Blood |
| 56439-3 | Chub Mackerel IgG4 Ab [Mass/volume] in Serum |
| 48217-4 | Soybean triggered leukotriene release [Mass/volume] by Leukocytes |
| 48314-9 | Leishmania mexicana IgG Ab [Titer] in Serum by Immunofluorescence |
| 2637-7 | Mucoprotein [Mass/volume] in Serum |
| 36909-0 | G0+G1 phase cells/100 cells in Blood |
| 56744-6 | PL-7 Ab [Presence] in Serum by Immunoblot |
| 27031-4 | Oxyphenisatin [Mass/volume] in Urine |
| 49285-0 | Organic acids pattern [Interpretation] in Cerebral spinal fluid Narrative |
| 58732-9 | Porphyrin fractions panel [Mass/volume] - Serum or Plasma |
| 29601-2 | Phenylpropanolamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 29702-8 | Rickettsia conorii Ab [Presence] in Serum by Immunofluorescence |
| 29825-7 | Jamestown canyon virus IgM Ab [Units/volume] in Specimen |
| 30111-9 | Thermoactinomyces vulgaris 2 Ab [Presence] in Serum |
| 40948-2 | Yersinia enterocolitica O:3 Ab [Presence] in Cerebral spinal fluid |
| 40957-3 | Zinc [Presence] in Urine |
| 19435-7 | Propoxyphene + Norpropoxyphene [Mass/volume] in Urine by Confirmatory method |
| 12573-2 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen |
| 12658-1 | Glucose [Mass/volume] in Serum or Plasma --50 minutes post XXX challenge |
| 12911-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 12978-3 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --7th specimen |
| 102055-1 | Sphinganine [Mass/volume] in Serum by LC/MS/MS |
| 13922-0 | Trichinella spiralis IgA Ab [Presence] in Serum by Immunoassay |
| 10237-6 | Oxygen content in Mid right atrium |
| 14463-4 | Chlamydia trachomatis [Presence] in Cervix by Organism specific culture |
| 14558-1 | Mycobacterium tuberculosis DNA [Presence] in Gastric fluid by NAA with probe detection |
| 14806-4 | Lactose.PO [Mass] of Dose |
| 103186-3 | Klebsiella pneumoniae oxytoca DNA [Presence] in Wound by NAA with probe detection |
| 104180-5 | Clostridium tetani toxin [Presence] in Serum or Plasma by Endopeptidase Assay |
| 15060-7 | Enolase.neuron specific [Mass/volume] in Serum or Plasma |
| 15070-6 | Fructose [Moles/time] in 24 hour Urine |
| 15078-9 | Lactate [Moles/time] in 24 hour Urine |
| 15466-6 | Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 16159-6 | Gastrin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 16178-6 | Beryllium [Mass/mass] in Tissue |
| 16187-7 | ALPRAZolam [Mass/volume] in Stool |
| 10759-9 | Iron.microscopic observation [Identifier] in Sputum by Gomori stain |
| 16499-6 | Butorphanol [Mass/volume] in Urine by Confirmatory method |
| 165-1 | Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 18206-3 | Catecholamines [Mass/volume] in Plasma --7th specimen post XXX challenge |
| 1837-4 | Alpha-N-acetylglucosaminidase [Enzymatic activity/volume] in Serum or Plasma |
| 74647-9 | Methylenedioxyamphetamine [Mass/volume] in Serum, Plasma or Blood |
| 74692-5 | MT-ND6 gene m.14459G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 6074-9 | Chymopapain IgE Ab [Units/volume] in Serum |
| 61208-5 | Aedes mosquito IgE Ab/IgE total in Serum |
| 61318-2 | Dandelion IgE Ab/IgE total in Serum |
| 61347-1 | Pork IgE Ab/IgE total in Serum |
| 7704-0 | Bermuda grass smut IgE Ab [Units/volume] in Serum |
| 93871-2 | Borrelia miyamotoi IgG+IgM Ab [Interpretation] in Serum or Plasma |
| 94129-4 | Water deprivation challenge panel - Urine and Serum or Plasma |
| 63118-4 | Lentils IgG Ab [Mass/volume] in Serum |
| 78779-6 | Alizapride [Mass/volume] in Blood |
| 7923-6 | Influenza virus A Hong Kong Ab [Units/volume] in Serum |
| 79392-7 | Catecholamine metabolites pattern [Interpretation] in Cerebral spinal fluid Narrative |
| 66129-8 | fentaNYL+Norfentanyl [Presence] in Urine by Confirmatory method |
| 6758-7 | Glucose [Presence] in Urine by Test strip --5 hours post 75 g glucose PO |
| 96923-8 | Smooth nuclear envelope nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 69423-2 | Rosner index in Platelet poor plasma by Coagulation assay |
| 82167-8 | Influenza virus A H1 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 83136-2 | Allo-pregnanediol/Creatinine [Molar ratio] in Urine |
| 85748-2 | Streptococcus pneumoniae Danish serotypes 7A+7F DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73387-3 | Famotidine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87559-1 | Ehrlichia chaffeensis groEL gene [Presence] in Blood by NAA with non-probe detection |
| 87668-0 | Aldrin [Mass/mass] in Specimen |
| 87767-0 | Primidone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 73450-9 | Chlorthalidone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73681-9 | CYP2D6 gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 88179-7 | Wuchereria bancrofti+Brugia malayi IgG4 Ab [Presence] in Serum by Immunoassay |
| 74336-9 | MICA*015 IgG Ab [Presence] in Serum |
| 74433-4 | Cholestanol/Cholesterol in Serum or Plasma |
| 59588-4 | 1-Hydroxymidazolam [Mass/mass] in Meconium |
| 50882-0 | Molybdenum [Moles/volume] in Urine |
| 30409-7 | Leukocytes other/100 leukocytes in Peritoneal fluid |
| 30429-5 | Mesothelial cells/100 leukocytes in Cerebral spinal fluid |
| 31104-3 | Osmotic fragility of Red Blood Cells--0.85% sodium chloride 24 hour 37 degree C incubation |
| 41873-1 | Smooth Alder IgG Ab [Units/volume] in Serum |
| 60030-4 | West Nile virus IgG Ab [Presence] in Serum by Immunofluorescence |
| 21077-3 | Black Ash IgE Ab [Units/volume] in Serum |
| 31457-5 | Legionella pneumophila 2 Ab [Units/volume] in Serum |
| 31477-3 | Leptospira interrogans sv Bratislava Ab [Units/volume] in Serum |
| 51140-2 | Cytoplasmic CD3 blasts [Units/volume] in Bone marrow |
| 4314-1 | Mesterolone [Mass] of Dose |
| 22234-9 | Coxsackievirus B5 Ab [Titer] in Serum |
| 31753-7 | Brucella sp Ag [Presence] in Vaginal fluid |
| 51763-1 | Muscle specific receptor tyrosine kinase Ab [Titer] in Serum or Plasma |
| 2278-0 | Fibrinopeptide B [Mass/volume] in Serum |
| 32052-3 | Benzodiazepines [Moles/volume] in Serum or Plasma |
| 32121-6 | Venlafaxine [Presence] in Specimen |
| 52776-2 | Clotting time.intrinsic coagulation system activated of Blood by Rotational TEG |
| 43892-9 | Borate [Presence] in Blood |
| 43903-4 | Azinphos-methyl [Presence] in Serum or Plasma |
| 43935-6 | CD55 cells/100 cells in Body fluid |
| 32834-4 | Herpes simplex virus 2 IgG Ab [Ratio] in Serum --1st specimen/2nd specimen |
| 53211-9 | Dehydrosebacylcarnitine (C10:1-DC) [Moles/volume] in DBS |
| 53464-4 | Decadienoylcarnitine (C10:2) [Moles/volume] in Cerebral spinal fluid |
| 33263-5 | Metamyelocytes/100 leukocytes in Body fluid by Manual count |
| 33271-8 | Microscopic observation [Identifier] in Blood by Malaria thin smear |
| 44893-6 | Malignant cells/100 cells in Synovial fluid |
| 4520-3 | Complement factor I [Mass/volume] in Serum or Plasma |
| 23715-6 | Feline calicivirus Ab [Titer] in Serum |
| 33768-3 | Leukocyte clumps [#/volume] in Urine by Automated count |
| 459-8 | Streptomycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 24461-6 | Fatty acids [Moles/volume] in Serum or Plasma |
| 24478-0 | Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 34371-5 | Salmonella typhi H Ab [Titer] in Serum by Agglutination |
| 54493-2 | Allantoine [Moles/time] in 24 hour Urine by Electrophoresis |
| 35072-8 | Basophils [#/volume] in Cerebral spinal fluid |
| 47534-3 | 2-Hydroxyphenylacetate/Creatinine [Molar ratio] in Urine |
| 56354-4 | Pecan or Hickory Tree IgG4 Ab [Mass/volume] in Serum |
| 48295-0 | Food colorant mix II triggered leukotriene release [Mass/volume] by Leukocytes |
| 5665-5 | Indium [Mass/volume] in Blood |
| 48563-1 | Bacteria # 4 identified in Specimen by Respiratory culture |
| 48705-8 | Leukocytes+Platelets [Morphology] in Blood |
| 4874-4 | HLA-Dw13 [Presence] in Donor |
| 38381-0 | Influenza virus A cDNA [Presence] in Specimen by NAA with probe detection |
| 49023-5 | Microalbumin [Mass/time] in Urine collected for unspecified duration |
| 49075-5 | Influenza virus A IgM Ab [Mass/volume] in Cerebral spinal fluid |
| 58044-9 | RYR1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 4962-7 | HLA-DR16(2) [Presence] in Donor |
| 39976-6 | Creatinine [Mass/volume] in Serum or Plasma --7 days post XXX challenge |
| 40093-7 | Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --3 hours post XXX challenge |
| 49894-9 | Somatotropin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 49943-4 | Somatotropin [Units/volume] in Serum or Plasma --1:30 am specimen |
| 29538-6 | West Nile virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 40681-9 | Turbidity [Presence] of Serum or Plasma Qualitative |
| 40723-9 | Heparin Ab [Presence] in Platelet poor plasma by Platelet aggregation |
| 58997-8 | Glucose [Mass/time] in 18 hour Urine |
| 5921-2 | Lactate dehydrogenase [Enzymatic activity/volume] in Dialysis fluid |
| 50275-7 | 3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in DBS |
| 50475-3 | Calcitonin [Mass/volume] in Serum or Plasma --7th specimen |
| 50592-5 | Ecgonine methyl ester [Mass/volume] in Urine by Confirmatory method |
| 1928-1 | Immunoglobulin light chains [Presence] in Urine |
| 19297-1 | Opiates tested for in Urine by Screen method Narrative |
| 19668-3 | PHENobarbital cutoff [Mass/volume] in Urine for Screen method |
| 100140-3 | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot |
| 100794-7 | Follitropin [Units/volume] in Body fluid |
| 12477-6 | Dextromethamphetamine [Mass/volume] in Urine |
| 13197-9 | Ehrlichia sp IgM Ab [Presence] in Serum |
| 1020-7 | E Ag [Presence] on Red Blood Cells from Donor |
| 102163-3 | Fivehook Bassia IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13478-3 | Tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine |
| 102646-7 | Wall pellitory IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102692-1 | Yellow Bean IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102777-0 | Onion IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102920-6 | Trichophyton mentagrophytes var goetzii IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102950-3 | Spelt IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14633-2 | C peptide [Moles/volume] in Serum or Plasma |
| 14725-6 | [Type] of Body fluid |
| 14881-7 | Phosphate [Moles/time] in 24 hour Urine |
| 104324-9 | Acinetobacter sp identified [Type] in Specimen by Sequencing |
| 1535-4 | Glucose [Mass/volume] in Serum or Plasma --40 minutes post 0.5 g/kg glucose IV |
| 1558-6 | Fasting glucose [Mass/volume] in Serum or Plasma |
| 17403-7 | Human papilloma virus 31+33+35 Ag [Presence] in Specimen |
| 174-3 | Chloramphenicol [Susceptibility] by Disk diffusion (KB) |
| 17805-3 | Procainamide [Mass/volume] in Body fluid |
| 90270-0 | Bacteria identified in Bile fluid by Aerobe culture |
| 74820-2 | Plasma cells.centrocytes/100 leukocytes in Blood by Manual count |
| 92738-4 | Cholestane-3-beta, 5-alpha, 6-beta triol and Lyso-sphingomyelin panel - Blood |
| 75545-4 | Noninvasive prenatal testing comment [Text] |
| 75644-5 | Amphetamine+Methamphetamine [Presence] in Blood by Confirmatory method |
| 75881-3 | Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex |
| 76585-9 | Wound microorganism gene identification panel by NAA with probe detection |
| 62258-9 | Erythromyin+clindamycin resistance ermA + ermC genes [Presence] by Molecular method |
| 7703-2 | Corn smut IgE Ab [Units/volume] in Serum |
| 77134-5 | LCA5 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77329-1 | Temazepam [Moles/volume] in Specimen |
| 77653-4 | Microscopic observation [Identifier] in Anorectal Cyto stain.thin prep |
| 93767-2 | Eravacycline [Susceptibility] by Gradient strip |
| 94269-8 | Platelet aggregation EPINEPHrine induced in Platelet rich plasma --50 umol/L |
| 62458-5 | Coccidioides immitis IgM Ab [Presence] in Serum by Immune diffusion (ID) |
| 6307-3 | Adenovirus rRNA [Presence] in Tissue by Probe |
| 63106-9 | Lima Bean IgG Ab [Mass/volume] in Serum |
| 6425-3 | Heterophile Ab [Presence] in Serum or Plasma by Immunoassay |
| 95593-0 | 25-hydroxyvitamin D2 [Mass/volume] in Capillary blood |
| 8037-4 | Taenia solium adult Ab [Units/volume] in Serum |
| 68971-1 | Color of Vitreous fluid |
| 82032-4 | Tree Allergen Mix 3 (Mountain juniper+White oak+White elm+Cottonwood+Mesquite) IgE Ab [Units/volume] in Serum by Multidisk |
| 82159-5 | Respiratory pathogens DNA and RNA panel - Nasopharynx by NAA with non-probe detection |
| 97937-7 | Thermotolerance in Isolate by Culture |
| 8234-7 | Phencyclidine [Presence] in Meconium by Screen method |
| 98417-9 | Eutylone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 989-4 | Di sup(b) Ag [Presence] on Red Blood Cells from Donor |
| 98991-3 | Methotrexate [Moles/volume] in Serum or Plasma --5 minutes post dose |
| 71759-5 | Rotavirus RNA [Identifier] in Isolate by NAA with probe detection |
| 7197-7 | Celery IgG Ab [Units/volume] in Serum |
| 7220-7 | Horse Chestnut IgE Ab [Units/volume] in Serum |
| 85422-4 | ceFAZolin [Susceptibility] for UTI by Minimum inhibitory concentration (MIC) |
| 72676-0 | Sirolimus [Mass/volume] in Plasma --trough |
| 72902-0 | Insulin [Moles/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
| 72952-5 | Simvastatin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73792-4 | Infant activity during postductal oxygen saturation measurement |
| 87814-0 | Midazolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 73954-0 | JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
| 74409-4 | MICA IgG panel - Serum |
| 89374-3 | HIV 1 Ab [Presence] in Specimen by Immunoassay |
| 51022-2 | Cytoplasmic CD117 blasts/100 cells in Bone marrow |
| 31113-4 | HLA-DR+ cells/100 cells in Blood |
| 31155-5 | Borrelia burgdorferi Ab [Units/volume] in Specimen by Immunoassay |
| 4242-4 | Ethambutol [Mass] of Dose |
| 60279-7 | IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method |
| 31340-3 | Dengue virus 3 Ab [Units/volume] in Serum |
| 31390-8 | Feline panleukopenia virus Ab [Units/volume] in Serum |
| 42878-9 | CD3-CD16+ cells [#/volume] in Bone marrow |
| 43078-5 | Bluetongue virus 2 Ab [Titer] in Serum |
| 51489-3 | Cortisol [Mass/volume] in Saliva (oral fluid) --7th specimen post XXX challenge |
| 51881-1 | Transfuse cryoprecipitate units [#] |
| 43622-0 | Aconitate [Presence] in 24 hour Urine |
| 32546-4 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells |
| 53085-7 | Base excess in Nonbiological fluid by calculation |
| 53268-9 | Yeast.hyphae [#/area] in Urine by Computer assisted method |
| 33348-4 | Pemoline [Mass/volume] in Urine by Screen method |
| 53525-2 | Protein [Presence] in Urine by SSA method |
| 53800-9 | Platelets panel - Blood by Automated count |
| 24034-1 | Bordetella pertussis filamentous hemagglutinin IgA Ab [Units/volume] in Serum by Immunoassay |
| 24077-0 | Cerebroside sulfatase [Enzymatic activity/mass] in Fibroblast |
| 33913-5 | pH of Capillary blood from Fetus |
| 33965-5 | SARS coronavirus Urbani RNA [Presence] in Stool by NAA with probe detection |
| 34269-1 | Cobalt [Moles/volume] in 24 hour Urine |
| 4565-8 | Hemoglobin Chesapeake [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 4588-0 | Hemoglobin H/Hemoglobin.total in Blood |
| 46205-1 | Streptococcus pneumoniae IgG Ab [Mass/volume] in Serum |
| 46277-0 | RhoGam given by provider [Identifier] |
| 24364-2 | Obstetric 1996 panel - Serum and Blood |
| 24493-9 | Weed Allergen Mix 2 (Western ragweed+Mugwort+Lenscale+Goosefoot or Lambs quarters+English plantain) IgE Ab [Units/volume] in Serum by Multidisk |
| 34506-6 | EGR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 54921-2 | Neuronal nuclear type 2 Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 47347-0 | Streptococcus pneumoniae Danish serotype 15B IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 25500-0 | Phenylbutazone [Moles/volume] in Serum or Plasma |
| 35098-3 | Lymphocytes [#/volume] in Pleural fluid |
| 35117-1 | Sulpiride [Mass/volume] in Serum or Plasma |
| 5569-9 | Acetone [Presence] in Urine |
| 55960-9 | Osmolality of Dialysis fluid |
| 56005-2 | Platelet aggregation ADP induced in Blood --5 umol/L |
| 47669-7 | Insulin [Units/volume] in Serum or Plasma --pre dose glucagon |
| 47802-4 | Valine/Amino acids.total in Amniotic fluid |
| 35411-8 | Trienoate (C20:3w9)/Arachidonate (C20:4w6) [Molar ratio] in Serum or Plasma |
| 35486-0 | Fonofos [Mass/volume] in Serum or Plasma |
| 56331-2 | Food Allergen Mix 46 (Cashew+Pecan or Hickory nut+Chestnut+Walnut+Pistachio) IgG4 Ab [Mass/volume] in Serum |
| 56592-9 | Follitropin [Units/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 48427-9 | Erythrocytes.Plasmodium sp infected/1000 erythrocytes in Blood |
| 26975-3 | SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
| 38401-6 | Protozoa identified in Specimen |
| 38418-0 | Pigeon droppings IgG Ab [Presence] in Serum |
| 38445-3 | Calprotectin [Mass/mass] in Stool |
| 38550-0 | MSH2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 38637-5 | Bis(Chloromethyl) Ether [Mass/volume] in Air |
| 57649-6 | C peptide [Moles/volume] in Serum or Plasma --1 hour pre XXX challenge |
| 49128-2 | Rickettsia typhus group identified in Specimen by Sequencing |
| 27837-4 | Somatotropin [Mass/volume] in Serum or Plasma --13th specimen post XXX challenge |
| 3934-7 | Phencyclidine [Mass/volume] in Serum or Plasma |
| 3935-4 | Phencyclidine [Presence] in Serum or Plasma |
| 57958-1 | DPYD2A gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method |
| 289-9 | Isoniazid [Susceptibility] by Serum bactericidal titer |
| 29287-0 | Morphine [Presence] in Meconium |
| 58769-1 | Trisomy 13 risk [Likelihood] in Fetus |
| 29781-2 | West Nile virus Ab [Titer] in Specimen |
| 40665-2 | Reticulocytes [#/volume] in Blood by Manual count |
| 58873-1 | Somatotropin [Mass/volume] in Serum or Plasma --35th specimen |
| 50309-4 | CD138 Ag [Presence] in Tissue by Immune stain |
| 303-8 | Lomefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 40852-6 | Leishmania sp IgG Ab [Units/volume] in Serum |
| 4088-1 | Valproate [Mass/volume] in Serum or Plasma --trough |
| 41090-2 | MELAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19559-4 | Methaqualone cutoff [Mass/volume] in Urine for Screen method |
| 21021-1 | Microscopic observation [Identifier] in Bronchial specimen by Gram stain |
| 12455-2 | Histoplasma capsulatum yeast phase Ab [Presence] in Cerebral spinal fluid |
| 101203-8 | Herpes simplex virus 1+2 IgG Ab index [Units/volume] in Serum and CSF |
| 101242-6 | Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 102128-6 | White Alder IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13516-0 | Neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count |
| 1392-0 | Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 102432-2 | Maxatase IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14072-3 | Monoacetyldapsone [Mass/volume] in Serum or Plasma |
| 103180-6 | Herpes simplex virus 1 DNA [Presence] in Urine by NAA with probe detection |
| 10412-5 | Platelets given [Type] |
| 104170-6 | Human papilloma virus 31+33+52+58 DNA [Presence] in Cervix by NAA with probe detection |
| 10496-8 | Kappa light chains Ag [Presence] in Tissue by Immune stain |
| 15447-6 | Avian paramyxovirus 1 Ab [Presence] in Serum by Immunoassay |
| 16501-9 | C peptide [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 16725-4 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 11152-6 | Eosinophils/100 cells in Bone marrow |
| 11480-1 | Microscopic observation [Identifier] in Urine by Acid fast stain |
| 12177-2 | Amino acids/Creatinine [Ratio] in Urine |
| 1701-2 | Acetaldehyde [Mass/volume] in Serum or Plasma |
| 17338-5 | Neuronal Ab [Units/volume] in Serum by Immunofluorescence |
| 17525-7 | Retinoate esters [Mass/volume] in Serum or Plasma |
| 17929-1 | Bacteria # 2 identified in Blood by Aerobe culture |
| 18407-7 | Leukocytes in 12 hour Urine sediment by Light microscopy |
| 19090-0 | Colony count [#/volume] in Urine |
| 90430-0 | Microorganism preliminary growth [Presence] in Body fluid by Anaerobe culture |
| 60457-9 | CD4+ CD26- Cells [#/volume] in Blood |
| 76770-7 | Trace elements panel - Hair |
| 6208-3 | Pecan or Hickory Nut IgE Ab [Units/volume] in Serum |
| 93804-3 | Chromosome 12 copy number/nucleus in Tissue by FISH |
| 94219-3 | VWF gene full mutation analysis in Blood or Tissue by Sequencing |
| 7836-0 | Coxsackievirus B1 Ab [Units/volume] in Serum |
| 6387-5 | Dengue virus DNA [Presence] in Specimen by Probe |
| 79458-6 | Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in DBS |
| 95088-1 | C peptide [Mass/volume] in Serum or Plasma --4.5 hours post meal |
| 65808-8 | Nortapentadol [Mass/volume] in Urine |
| 96290-2 | predniSONE IgE Ab [Units/volume] in Serum |
| 68363-1 | Oxygen saturation in Cord blood |
| 80587-9 | Human metapneumovirus A+B L+N genes [Presence] in Nasopharynx by NAA with probe detection |
| 97926-0 | Snowshoe hare virus RNA [Presence] in Specimen by NAA with probe detection |
| 98005-2 | HLA-A and B and C (class I) and HLA-DP and DQ and DR (class II) [Type] by Low resolution |
| 98030-0 | Natural killer cell cytotoxicity.IL-2 stimulated panel - Blood mononuclear cells by Flow cytometry (FC) |
| 72224-9 | Pathologic casts [Presence] in Urine by Automated |
| 85525-4 | PRRSV North American strain IgG Ab [Titer] in Serum by Immunofluorescence |
| 72569-7 | Cholinesterase [Pure catalytic fraction] in Serum or Plasma --dibucaine/Cholinesterase |
| 72900-4 | Insulin [Moles/volume] in Serum or Plasma --3 hours post 75 g glucose PO |
| 72912-9 | HNA 4a/4a Ab [Presence] in Serum by Immunoassay |
| 85793-8 | Specimen source subject [Type] |
| 73360-0 | glipiZIDE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86695-4 | Porcine epidemic diarrhea virus Ab/Positive control in Serum by Immunoassay |
| 74116-5 | Adalimumab Ab [Mass/volume] in Serum or Plasma |
| 74215-5 | Rivaroxaban [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 74448-2 | Sugars and polyols pattern [Interpretation] in Urine |
| 59810-2 | Caffeine [Moles/volume] in Serum --trough |
| 59870-6 | Benztropine [Moles/volume] in Urine |
| 50809-3 | Antimony [Moles/volume] in Blood |
| 50989-3 | Horowitz index adjusted to patients actual temperature in Arterial blood |
| 60074-2 | Fexofenadine [Mass/volume] in Urine |
| 21630-9 | ATP7B gene c.1711G>C [Presence] in Blood or Tissue by Molecular genetics method |
| 31306-4 | Chlamydophila psittaci IgA Ab [Units/volume] in Serum |
| 31320-5 | Coxsackievirus A7 Ab [Units/volume] in Body fluid |
| 31522-6 | Myelin associated glycoprotein IgM Ab [Presence] in Serum |
| 42983-7 | Parainfluenza virus 4 IgG Ab [Presence] in Serum |
| 42998-5 | Leishmania tropica Ab [Titer] in Serum |
| 430-9 | rifAMPin [Susceptibility] by Serum bactericidal titer |
| 31918-6 | Neisseria meningitidis serogroup w135 Ag [Presence] in Cerebral spinal fluid |
| 51857-1 | Malassezia sp IgE Ab [Units/volume] in Serum |
| 43369-8 | PlA1 Ab [Presence] in Platelet rich plasma |
| 22438-6 | Parainfluenza virus 2 Ab [Titer] in Serum |
| 22731-4 | Triglyceride [Moles/volume] in Specimen |
| 53023-8 | Tissue transglutaminase Ab [Presence] in Serum |
| 43846-5 | Chlamydophila sp Ab [Interpretation] in Serum |
| 43857-2 | Benztropine [Presence] in Serum or Plasma |
| 23026-8 | Dermatophilus congolensis Ab [Presence] in Serum |
| 23095-3 | Equine herpesvirus 4 DNA [Presence] in Specimen by NAA with probe detection |
| 32739-5 | Beta 2 globulin [Mass/volume] in Body fluid by Electrophoresis |
| 53241-6 | Stearoylcarnitine (C18) [Moles/volume] in DBS |
| 3329-0 | Aminosalicylate [Mass/volume] in Serum or Plasma |
| 53738-1 | HLA-DQB1*2 [Presence] |
| 44906-6 | Homovanillate panel - 24 hour Urine |
| 23798-2 | Epidermal Allergen Mix 1 (Cat dander+Cow dander+Dog dander+Horse dander) IgE Ab [Presence] in Serum by Multidisk |
| 34164-4 | N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Tissue |
| 34168-5 | Sulfocysteine/Creatinine [Ratio] in Urine |
| 55295-0 | Protein electrophoresis and Immunoglobulins panel - Serum |
| 55305-7 | Fungus [Presence] in Specimen by KOH preparation |
| 55475-8 | Dehydroepiandrosterone (DHEA) [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
| 35171-8 | Homo-gamma Linolenate (C20:3w6) [Moles/volume] in Serum or Plasma |
| 35181-7 | Docosapentaenate (C22:5w6) [Moles/volume] in Serum or Plasma |
| 55870-0 | Choriogonadotropin [Units/volume] in Cord blood |
| 47917-0 | Somatotropin [Units/volume] in Serum or Plasma --3 hours post dose propranolol+glucagon |
| 25811-1 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 35366-4 | SCA2 gene allele 2 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 56295-9 | Karaya gum IgG4 Ab [Mass/volume] in Serum |
| 56332-0 | Nutmeg IgG4 Ab [Mass/volume] in Serum |
| 48030-1 | RHCE gene allele Ee [Genotype] in Amniotic fluid by Molecular genetics method Nominal |
| 48255-4 | Giant Ragweed triggered leukotriene release [Mass/volume] by Leukocytes |
| 26049-7 | Cedar IgE Ab [Units/volume] in Serum |
| 2614-6 | Methemoglobin/Hemoglobin.total in Blood |
| 35819-2 | Imipenem+EDTA [Susceptibility] by Gradient strip |
| 27192-4 | diazePAM [Mass/volume] in Vitreous fluid |
| 49008-6 | Clot Retraction [Volume Fraction] in Blood |
| 38709-2 | Methyl iodide [Mass/volume] in Air |
| 39600-2 | Fusarium moniliforme IgE Ab/IgE total in Serum |
| 39618-4 | Neisseria meningitidis serogroup Y Ab [Mass/volume] in Serum |
| 57868-2 | Perphenazine [Moles/volume] in Specimen |
| 29155-9 | Follitropin/Creatinine [Ratio] in 24 hour Urine |
| 29230-0 | Coxsackievirus B1 Ab [Titer] in Body fluid |
| 58404-5 | traMADol/Creatinine [Mass Ratio] in Urine |
| 58599-2 | Corticotropin [Moles/volume] in Plasma --3 hours post dose insulin IV |
| 29561-8 | Jamestown canyon virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 40531-6 | Methylenedioxyamphetamine [Presence] in Gastric fluid |
| 50536-2 | Thyrotropin [Units/volume] in Serum or Plasma --4th specimen |
| 30096-2 | Neisseria meningitidis serogroup C Ag [Presence] in Specimen by Latex agglutination |
| 40850-0 | Glucose [Mass/volume] in Urine by Test strip --2nd specimen post XXX challenge |
| 19284-9 | Benzodiazepines cutoff [Mass/volume] in Urine for Confirmatory method |
| 19448-0 | Dihydrocodeine [Mass/volume] in Urine by Confirmatory method |
| 20672-2 | Actinobacillus pleuropneumoniae serotype [Identifier] in Isolate |
| 20793-6 | Eastern equine encephalitis virus Ab [Presence] in Serum by Complement fixation |
| 21014-6 | CD24 cells [#/volume] in Blood |
| 21051-8 | Acrylaldehyde [Mass/volume] in Serum or Plasma |
| 12546-8 | Quinethazone [Presence] in Serum or Plasma |
| 12886-8 | Borrelia burgdorferi 66kD Ab [Presence] in Body fluid by Immunoblot |
| 13341-3 | CD3+CD25+ cells/100 cells in Tissue |
| 13416-3 | Threonine [Mass/volume] in Amniotic fluid |
| 101773-0 | Microsporum audouinii DNA [Presence] in Specimen by NAA with probe detection |
| 16269-3 | Urate crystals [Presence] in Stone by Infrared spectroscopy |
| 11191-4 | Pollock IgE Ab [Units/volume] in Serum |
| 11209-4 | Beta glucuronidase [Enzymatic activity/volume] in Cerebral spinal fluid |
| 17129-8 | CD28 cells/100 cells in Blood |
| 17506-7 | Quinacrine [Mass/volume] in Serum or Plasma |
| 91066-1 | Enterovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 91134-7 | Sexually transmitted pathogens panel - Specimen by NAA with probe detection |
| 91780-7 | Measles virus [Presence] in Lower respiratory specimen by Organism specific culture |
| 92685-7 | Trichomonas vaginalis DNA [Presence] in Urine by NAA with probe detection |
| 60551-9 | Interferon.beta 1a Ab [Titer] in Serum or Plasma |
| 75758-3 | Brompheniramine [Presence] in Serum or Plasma or Urine by Screen method |
| 7619-0 | Poison ivy IgE Ab [Units/volume] in Serum |
| 61207-7 | Acremonium sp IgE Ab/IgE total in Serum |
| 61296-0 | Timothy IgE Ab/IgE total in Serum |
| 62381-9 | Base pair start coordinate [#] |
| 7737-0 | Thyme IgE Ab [Units/volume] in Serum |
| 93942-1 | K Ag [Presence] in Cord red blood cells |
| 78362-1 | Imipramine+Desipramine [Mass/volume] in Serum or Plasma --trough |
| 7881-6 | Enterovirus RNA [Presence] in Nose by NAA with probe detection |
| 94447-0 | HLA-DP and DQ and DR (class II) IgG high risk [Identifier] in Serum or Plasma by Flow cytometry (FC) |
| 95120-2 | Insulin [Units/volume] in Serum or Plasma --5 hours post meal |
| 660-1 | Microscopic observation [Identifier] in Specimen by Dark field examination |
| 6644-9 | Cefepime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 80189-4 | Galactosamine [Moles/volume] in Serum or Plasma |
| 95966-8 | Aspergillus glaucus IgE Ab [Units/volume] in Serum |
| 6819-7 | Streptococcus sp Ab [Presence] in Serum |
| 82840-0 | Mitochondria IgG Ab [Presence] in Serum by Immunofluorescence |
| 72203-3 | Parathyrin.intact intraoperative panel - Serum or Plasma |
| 72388-2 | Methadone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 83058-8 | Nucleoprotein expression [Presence] in Control Tissue by Immune stain |
| 85502-3 | Carbapenemase resistance genes panel by Molecular genetics method |
| 7273-6 | Dahlia IgE Ab [Units/volume] in Serum |
| 72929-3 | Warfarin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87391-9 | Porcine teschovirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 88115-1 | Round cells [Presence] in Semen by Light microscopy |
| 88-5 | Cefmetazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 88516-0 | Gastrointestinal pathogens identified in Specimen by NAA with probe detection |
| 59733-6 | Potassium [Mass/mass] in Tissue |
| 50888-7 | Nitrogen [Moles/time] in 24 hour Body fluid |
| 50945-5 | Platelet aggregation ADP induced [Presence] in Platelet rich plasma --2 umol/L |
| 3052-8 | Triiodothyronine (T3).reverse [Mass/volume] in Serum or Plasma |
| 6016-0 | Corticotropin IgE Ab [Units/volume] in Serum |
| 51085-9 | CD15 blasts [Units/volume] in Specimen |
| 51297-0 | CD38 cells/100 cells in Cerebral spinal fluid |
| 51639-3 | Acanthocytes/1000 erythrocytes in Blood by Light microscopy |
| 43727-7 | Lipoprotein.beta.subparticle.small [Moles/volume] in Serum or Plasma |
| 5232-4 | Insulin Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
| 52753-1 | Prothrombin time (PT) PIVKA insensitive actual/normal in Platelet poor plasma by Coagulation assay |
| 32772-6 | CD14 cells [Presence] in Blood |
| 33060-5 | chlordiazePOXIDE+Metabolites [Mass/volume] in Serum or Plasma |
| 44535-3 | HTLV I Ab [Presence] in Serum from Donor |
| 44574-2 | Influenza virus B Ag [Presence] in Trachea by Immunofluorescence |
| 33485-4 | Patient symptoms [Interpretation] --1 hour post dose lactose PO |
| 33560-4 | Benzodiazepines [Mass/volume] in Gastric fluid |
| 33563-8 | Pancreatic islet cell IgG Ab [Units/volume] in Serum |
| 44885-2 | Malignant cells [#/volume] in Synovial fluid by Manual count |
| 23712-3 | Enrofloxacin [Susceptibility] |
| 33834-3 | Lymphocytes Plasmacytoid [#/volume] in Blood by Manual count |
| 46189-7 | Goose parvovirus Ab [Presence] in Serum |
| 34530-6 | ABO and Rh group panel - Blood |
| 3471-0 | chlorproMAZINE [Mass/volume] in Serum or Plasma |
| 55586-2 | Verapamil [Moles/volume] in Serum or Plasma |
| 35121-3 | E-10-Hydroxynortriptyline [Mass/volume] in Serum or Plasma |
| 55617-5 | Other Antibiotic [Susceptibility] by Gradient strip |
| 55776-9 | Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells |
| 47557-4 | Alanine/Amino acids.total in Specimen |
| 4772-0 | HLA-B59 [Presence] in Donor |
| 47789-3 | Threonine/Amino acids.total in DBS |
| 56169-6 | Almond IgG4 Ab [Mass/volume] in Serum |
| 56401-3 | Tea IgG4 Ab [Mass/volume] in Serum |
| 3674-9 | Heptaminol [Mass/time] in 24 hour Urine |
| 36917-3 | Chromosome uniparental disomy [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
| 56670-3 | Adrenal cortex IgG Ab [Units/volume] in Serum |
| 5688-7 | Mercury [Presence] in Urine by Visual.Reinsch |
| 57409-5 | CD3+TCR alpha beta+ cells/100 cells in Body fluid |
| 48921-1 | Respiratory allergen panel, US - Southeast coast - Serum |
| 48963-3 | Propoxyphene [Mass/volume] in Specimen by Confirmatory method |
| 49050-8 | Microscopic observation [Identifier] in Endocervical brush by Cyto stain |
| 38744-9 | Hydrogen fluoride [Mass/volume] in Air |
| 39466-8 | Carbon dioxide, total [Moles/volume] in Arterial cord blood |
| 57735-3 | Protein [Presence] in Urine by Automated test strip |
| 5821-4 | Leukocytes [#/area] in Urine sediment by Microscopy high power field |
| 29493-4 | Colistin [Mass/volume] in Specimen |
| 58796-4 | Glomerular basement membrane IgG Ab [Presence] in Serum by Immunofluorescence |
| 49792-5 | Somatostatin [Moles/volume] in Plasma |
| 50058-7 | Phosphate renal clearance in Urine and Serum or Plasma collected for unspecified duration |
| 29633-5 | CD122 Ag [Presence] in Tissue by Immune stain |
| 40309-7 | Somatotropin [Mass/volume] in Serum or Plasma --pre or post dose glucose |
| 59298-0 | Lacosamide [Mass/volume] in Urine |
| 50206-2 | Glucose [Mass/volume] in Serum or Plasma --1st specimen |
| 50563-6 | Urobilinogen [Mass/volume] in Urine by Automated test strip |
| 30139-0 | Hydroxyproline Free [Presence] in 24 hour Urine |
| 41000-1 | Human coronavirus RNA [Identifier] in Specimen by NAA with probe detection |
| 19406-8 | Cocaethylene [Presence] in Urine by Confirmatory method |
| 19670-9 | Phenothiazines [Presence] in Urine by Screen method |
| 12370-3 | Thiopental [Mass/volume] in Urine |
| 100422-5 | Chicory IgG Ab [Units/volume] in Serum |
| 100737-6 | Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma |
| 101081-8 | Es^a Ab [Presence] in Serum or Plasma |
| 12551-8 | Isocarboxazid [Mass/volume] in Serum or Plasma |
| 12559-1 | Cortisol [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 101624-5 | Spermatozoa Agglutinated [Score] in Urine Qualitative by Light microscopy --post ejaculation |
| 101910-8 | Protein monoclonal panel 24Hr Urine |
| 13744-8 | Galactose/Creatinine [Mass Ratio] in Urine |
| 10244-2 | Oxygen content in Left pulmonary artery |
| 102476-9 | Okra IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14361-0 | Microscopic observation [Identifier] in Vaginal fluid by Gram stain |
| 102928-9 | Candida albicans IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102937-0 | Wasp venom IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1446-4 | Cortisol [Mass/volume] in Serum or Plasma --pre 3 g metyraPONE PO overnight |
| 14494-9 | Virus identified in Vaginal fluid by Immunofluorescence |
| 14773-6 | Granulocytes/100 leukocytes in Bronchial specimen by Manual count |
| 1512-3 | Glucose [Mass/volume] in Serum or Plasma --1 minute post 0.5 g/kg glucose IV |
| 104368-6 | Chlamydophila psittaci Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 15275-1 | Weed Allergen Mix 6 (English plantain+Goosefoot or Lambs quarters+Saltwort+Sheep sorrel) IgE Ab [Presence] in Serum by Multidisk |
| 10943-9 | Mink epithelium IgE Ab [Units/volume] in Serum |
| 11266-4 | Streptococcus agalactiae Ag [Presence] in Specimen |
| 11555-0 | Base excess in Blood by calculation |
| 16878-1 | Francisella tularensis IgM Ab [Units/volume] in Serum |
| 17181-9 | CD62P cells/100 cells in Blood |
| 17238-7 | Malignin Ab [Units/volume] in Serum |
| 18418-4 | Casein IgA Ab [Units/volume] in Serum |
| 1884-6 | Apolipoprotein B [Mass/volume] in Serum or Plasma |
| 18975-3 | Ristocetin [Susceptibility] |
| 90890-5 | Benzodiazepines panel - Urine by Confirmatory method |
| 74534-9 | Neisseria meningitidis serogroup Y DNA [Presence] in Specimen by NAA with probe detection |
| 91830-0 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 75058-8 | Thymidine phosphorylase [Enzymatic activity/volume] in DBS |
| 754-2 | Neutrophils [#/volume] in Cerebral spinal fluid by Automated count |
| 764-1 | Band form neutrophils/100 leukocytes in Blood by Manual count |
| 76612-1 | Enterococcus faecalis cpn60 gene [#/volume] in XXX.body fluid by NAA with probe detection |
| 76614-7 | Lysosomal acid lipase [Enzymatic activity/mass] in Fibroblast by 4-MU-oleate substrate |
| 92827-5 | Mycobacterium tuberculosis complex species identified in Specimen by Sequencing |
| 94264-9 | Brucella sp Ab [Titer] in Cerebral spinal fluid by Immunocapture agglutination |
| 628-8 | Bacteria identified in Tissue by Anaerobe culture |
| 63093-9 | Kiwifruit IgG Ab [Mass/volume] in Serum |
| 63139-0 | Wine vinegar IgG Ab [Mass/volume] in Serum |
| 78696-2 | Selenium [Moles/volume] in Blood |
| 94731-7 | Narcotics and opioids [Presence] in Saliva (oral fluid) by Confirmatory method |
| 95098-0 | Glucagon [Mass/volume] in Serum or Plasma --3 hours post meal |
| 95411-5 | SARS-CoV-2 (COVID-19) neutralizing antibody [Presence] in Serum by pVNT |
| 6654-8 | Meropenem [Susceptibility] by Serum bactericidal titer |
| 8001-0 | Rickettsia typhus group IgG Ab [Units/volume] in Serum |
| 80657-0 | Hemoglobin Q/Hemoglobin.total in Blood |
| 81314-7 | Palatinase [Enzymatic activity/mass] in Small intestine Tissue |
| 98413-8 | lamoTRIgine [Mass/volume] in Urine by Confirmatory method |
| 7221-5 | Chewing gum IgE Ab [Units/volume] in Serum |
| 72463-3 | AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 73297-4 | Loratadine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73372-5 | Fluvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87758-9 | Naegleria fowleri DNA [Presence] in Specimen by NAA with probe detection |
| 73610-8 | Sarafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 73679-3 | SORAfenib [Mass/volume] in Serum or Plasma |
| 88443-7 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --40M post dose fructose PO |
| 74338-5 | MICA*011 IgG Ab [Presence] in Serum |
| 89509-4 | Ganglioside GT1a IgG+IgM Ab [Presence] in Serum by Line blot |
| 59696-5 | Hydroxytriazolam [Mass/mass] in Tissue by Confirmatory method |
| 51032-1 | CD11a blasts/100 blasts in Blood |
| 59911-8 | Ibuprofen [Moles/volume] in Gastric fluid |
| 21232-4 | Creatinine [Mass/volume] in Arterial blood |
| 51047-9 | CD123 blasts [Units/volume] in Blood |
| 51303-6 | CD4+CD7- cells/100 cells in Cerebral spinal fluid |
| 22086-3 | Aspergillus niger Ab [Presence] in Serum |
| 3185-6 | Coagulation factor IX inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
| 51472-9 | Streptococcus pneumoniae capsular polysaccharide IgG Ab [Mass/volume] in Serum |
| 5150-8 | Entamoeba histolytica Ab [Units/volume] in Serum by Immunoassay |
| 51611-2 | Methotrexate [Moles/volume] in Serum or Plasma --48 hours post dose |
| 22671-2 | Phytanate (C16:0(CH3)4) [Moles/volume] in Serum or Plasma |
| 32858-3 | IgG cells/100 cells in Specimen |
| 53072-5 | Carnitine free (C0) [Moles/volume] in Cerebral spinal fluid |
| 53232-5 | 5-Oxoproline+Pipecolate [Moles/volume] in DBS |
| 44433-1 | Other Antibiotic [Mass/volume] in Serum or Plasma --peak |
| 2351-5 | Glucose [Mass/time] in 24 hour Urine |
| 53612-8 | Urate [Mass/volume] in Body fluid |
| 45028-8 | HLA-B SBT [Type] by High resolution |
| 54267-0 | Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
| 54313-2 | Linoleoylcarnitine (C18:2) [Moles/volume] in Urine |
| 54449-4 | SMN2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 46719-1 | Streptomycin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 2449-7 | Hydroxyproline Free [Mass/volume] in Urine |
| 2487-7 | Inter alpha trypsin inhibitor [Mass/volume] in Serum |
| 47392-6 | chlorproPAMIDE [Mass/volume] in Specimen |
| 34948-0 | Measles virus IgG and IgM Qn panel - Serum |
| 55956-7 | Oleoylcarnitine (C18:1) [Moles/volume] in Cerebral spinal fluid |
| 47749-7 | Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose glucagon |
| 25577-8 | C peptide [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 25763-4 | Insulin-like growth factor [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 35742-6 | SH2D1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 56275-1 | Green Bean IgG4 Ab [Mass/volume] in Serum |
| 56350-2 | Peach IgG4 Ab [Mass/volume] in Serum |
| 48035-0 | Hemoglobin [Presence] in Cerebral spinal fluid |
| 56633-1 | Myocardium IgG Ab [Titer] in Serum by Immunofluorescence |
| 56679-4 | Gamma aminobutyrate/Creatinine [Ratio] in 24 hour Urine |
| 48644-9 | Vanillylmandelate, Homovanillate and Creatinine panel - 24 hour Urine |
| 26816-9 | Nordiazepam [Mass/volume] in Vitreous fluid |
| 27042-1 | Methohexital [Mass/volume] in Serum or Plasma |
| 48986-4 | Glucose [Mass/volume] in Serum or Plasma --8 AM specimen |
| 49417-9 | JC virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
| 39959-2 | Creatinine [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge |
| 40001-0 | Glucose [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge |
| 49787-5 | Polymorphonuclear cells/100 leukocytes in Pericardial fluid |
| 49791-7 | Sodium [Moles/volume] in Amniotic fluid |
| 19439-9 | Diamorphine [Presence] in Urine by Screen method |
| 19458-9 | Ethylamphetamine [Mass/volume] in Urine by Confirmatory method |
| 2004-0 | Calcium [Moles/volume] in Urine |
| 20589-8 | CD14 cells/100 cells in Specimen |
| 20750-6 | Chicken anemia virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 100400-1 | Quail meat IgG Ab [Units/volume] in Serum |
| 100968-7 | Bovine tuberculosis comparative cervical test panel - Skin |
| 12860-3 | Borrelia burgdorferi 39kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 13430-4 | Norepinephrine [Mass/volume] in Plasma --6th specimen post XXX challenge |
| 13463-5 | Arsenic/Creatinine [Mass Ratio] in Urine |
| 102270-6 | Italian Cypress IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102344-9 | Red top grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14031-9 | Ciprofloxacin [Mass/volume] in Serum or Plasma --peak |
| 102763-0 | Licorice IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14556-5 | Mycobacterium tuberculosis DNA [Presence] in Sputum by NAA with probe detection |
| 14794-2 | Imipramine+Desipramine [Moles/volume] in Serum or Plasma |
| 10362-2 | Endomysium IgA Ab [Presence] in Serum |
| 1038-9 | G Ab [Presence] in Serum or Plasma |
| 11126-0 | Platelets [Morphology] in Bone marrow |
| 16672-8 | Cortisol [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 16963-1 | Hexacarboxylporphyrin [Mass/volume] in Blood |
| 17125-6 | CD22+CD19+ cells/100 cells in Blood |
| 18265-9 | Acetaminophen [Presence] in Body fluid |
| 1850-7 | Androstanediol [Mass/volume] in Urine |
| 90437-5 | Microorganism preliminary growth [Presence] in Blood by Anaerobe culture |
| 74753-5 | Blood group antigens present [Identifier] in Blood by IAT |
| 74760-0 | HYDROcodone and metabolites panel - Urine by Confirmatory method |
| 74811-1 | Dihydrocodeine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 61037-8 | Alpha hydroxyalprazolam [Presence] in Specimen |
| 61184-8 | Spermatozoa broken tail/100 spermatozoa in Semen |
| 61-2 | Carbenicillin [Susceptibility] by Disk diffusion (KB) |
| 93349-9 | Treatment to which interaction between genetic variants confers resistance [Identifier] in Blood or Tissue Nominal |
| 77200-4 | SI gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 7744-6 | Tree of Heaven IgE Ab [Units/volume] in Serum |
| 94200-3 | FTCD gene full mutation analysis in Blood or Tissue by Sequencing |
| 94370-4 | Serratia marcescens DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 63382-6 | Fasting glucose [Mass/volume] in Urine |
| 64423-7 | KIR2DS4 gene full variant [Presence] in Blood or Tissue by Molecular genetics method |
| 64968-1 | Hazelnut recombinant (rCor a) 1.0101 IgE Ab [Units/volume] in Serum |
| 6563-1 | Trichinella spiralis IgG Ab [Presence] in Serum by Immunoassay |
| 66498-7 | Spermatozoa Multiple defects/100 spermatozoa in Semen |
| 79538-5 | Formate [Moles/volume] in Serum or Plasma by Confirmatory method |
| 81274-3 | Doxepin and Nordoxepin panel - Gastric fluid |
| 96537-6 | California encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay |
| 70052-6 | Hantavirus hantaan IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 81880-7 | TNNT2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 97322-2 | Oxazepam [Presence] in Cord tissue by Screen method |
| 71642-3 | Promyelocytes/Leukocytes [Pure number fraction] in Body fluid by Manual count |
| 98188-6 | Bacampicillin IgE Ab [Units/volume] in Serum |
| 85504-9 | Presumptive ABO group [Type] in Saliva (oral fluid) by Molecular genetics method |
| 99526-6 | Thickness [Length] of Right ventricle |
| 86688-9 | Rotavirus C [Presence] in Specimen by Organism specific culture |
| 7387-4 | Halibut triggered histamine release [Units/volume] in Blood |
| 73999-5 | 2C-C-NBOMe [Presence] in Urine by Confirmatory method |
| 88900-6 | Adenovirus [Presence] in Upper respiratory specimen by Organism specific culture |
| 88916-2 | Leishmania sp DNA [Identifier] in Tissue by NAA with probe detection |
| 88966-7 | Hyaline casts [#/area] in Urine sediment |
| 59341-8 | Stiripentol [Mass/volume] in Urine |
| 59866-4 | Amobarbital [Moles/volume] in Gastric fluid |
| 30930-2 | Zinc [Mass/volume] in Urine collected for unspecified duration |
| 31077-1 | Rickettsia typhi IgM Ab [Titer] in Body fluid |
| 4227-5 | Dipipanone [Mass] of Dose |
| 60134-4 | Parathion [Mass/mass] in Tissue |
| 21556-6 | Tetrahydrocannabinol [Presence] in Urine by Screen method >20 ng/mL |
| 31401-3 | Ganglioside GD1b IgG Ab [Units/volume] in Cerebral spinal fluid |
| 31420-3 | Highlands J virus Ab [Units/volume] in Cerebral spinal fluid |
| 51405-9 | CD81 cells/100 cells in Blood |
| 21783-6 | t(12;22)(q13;q12.2)(ATF1,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 31764-4 | Chlamydia sp Ag [Presence] in Body fluid |
| 31801-4 | Dirofilaria immitis Ag [Presence] in Serum |
| 51910-8 | Erythrocytes [#/area] in Bronchoalveolar lavage by Microscopy high power field |
| 22446-9 | Polio virus 1 Ab [Titer] in Serum |
| 32158-8 | Klebsiella granulomatis [Presence] in Genital specimen by Light microscopy |
| 53214-3 | Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in DBS |
| 23448-4 | Swine vesicular disease virus RNA [Presence] in Tissue by NAA with probe detection |
| 44891-0 | Malignant cells [#/volume] in Pericardial fluid |
| 23657-0 | Anaplasma marginale Ab [Titer] in Serum by Complement fixation |
| 23983-0 | Borrelia burgdorferi IgM band pattern [Interpretation] in Body fluid by Immunoblot |
| 53970-0 | Macrocytes [Presence] in Urine sediment by Light microscopy |
| 54004-7 | Human upstream binding factor Ab [Titer] in Serum by Immunofluorescence |
| 54453-6 | Semen analysis test method |
| 24346-9 | Parathyrin.intact and Calcium panel - Serum or Plasma |
| 34603-1 | I Ab [Titer] in Serum or Plasma |
| 47029-4 | HIV 2 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 25385-6 | Coxiella burnetii IgM Ab [Titer] in Serum by Immunofluorescence |
| 25473-0 | Metanephrine [Moles/volume] in Serum or Plasma |
| 3488-4 | Clobenzorex [Presence] in Urine |
| 34999-3 | Polymorphonuclear cells/100 leukocytes in Blood |
| 35064-5 | Blasts [#/volume] in Synovial fluid |
| 35137-9 | MECP2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 55951-8 | Octenoylcarnitine (C8:1)/Creatinine [Molar ratio] in Urine |
| 47565-7 | Arginine/Amino acids.total in Cerebral spinal fluid |
| 4777-9 | HLA-B61(40) [Presence] |
| 25847-5 | Alpha aminoadipate/Creatinine [Molar ratio] in 24 hour Urine |
| 56237-1 | Crawfish IgG4 Ab [Mass/volume] in Serum |
| 48043-4 | Oxyphenisatin cutoff [Mass/mass] in Stool |
| 36908-2 | Gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 27011-6 | CD14 cells [#/volume] in Blood |
| 27061-1 | Butabarbital [Mass/mass] in Meconium |
| 272-5 | Gramicidin D [Susceptibility] by Disk diffusion (KB) |
| 38321-6 | Carbofuran [Mass/volume] in Water |
| 49019-3 | Respiratory allergen panel, US - Puerto Rico - Serum |
| 39540-0 | Uranium/Creatinine [Mass Ratio] in Urine |
| 39582-2 | Amino beta guanidinopropionate/Creatinine [Molar ratio] in 24 hour Urine |
| 4935-3 | HLA-DQ2 [Presence] |
| 49-7 | Bacampicillin [Susceptibility] by Disk diffusion (KB) |
| 2884-5 | Protein [Mass/volume] in Semen |
| 40072-1 | Calcium [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
| 40122-4 | Creatinine [Moles/volume] in Serum or Plasma --10 hours post XXX challenge |
| 58799-8 | Legionella pneumophila 1 IgG Ab [Units/volume] in Serum by Immunoassay |
| 49938-4 | Citrate synthase [Enzymatic activity/mass] in Amniotic fluid |
| 29690-5 | Orientia tsutsugamushi Kato Ab [Titer] in Serum |
| 30032-7 | Phoma betae IgG Ab [Units/volume] in Serum |
| 30308-1 | Ritonavir [Susceptibility] |
| 19427-4 | Dextromethamphetamine cutoff [Mass/volume] in Urine for Screen method |
| 19520-6 | LORazepam [Presence] in Urine by Screen method |
| 19618-8 | N-desalkylflurazepam cutoff [Mass/volume] in Urine for Screen method |
| 2093-3 | Cholesterol [Mass/volume] in Serum or Plasma |
| 1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells |
| 12641-7 | Glucose [Mass/volume] in Serum or Plasma --7 hours post XXX challenge |
| 101182-4 | MDMB-4en-PINACA/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 101310-1 | Somatotropin post insulin stimulation panel - Serum or Plasma |
| 14957-5 | Microalbumin [Mass/volume] in Urine |
| 11083-3 | Human papilloma virus identified in Cervix |
| 16384-0 | Androstenedione [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 16781-7 | Disulfiram [Presence] in Urine |
| 17344-3 | Neuronal nuclear type 2 Ab [Units/volume] in Serum by Immunofluorescence |
| 18371-5 | Methyl parathion [Mass/volume] in Urine |
| 18978-7 | Roxithromycin [Susceptibility] |
| 1905-9 | Ascorbate [Mass/time] in 24 hour Urine |
| 9-1 | Amdinocillin [Susceptibility] by Disk diffusion (KB) |
| 91046-3 | Methadone+Metabolite [Presence] in Hair by Screen method |
| 74584-4 | Cytochrome C oxidase/Citrate synthase [Enzymatic activity ratio] in Tissue |
| 92135-3 | Human bocavirus 1+2+3 DNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 92671-7 | Basement membrane zone BP180 and BP230 IgG panel - Serum or Plasma |
| 75237-8 | Erythrocytes [#/area] in Synovial fluid by Microscopy high power field |
| 75388-9 | CDKN1B gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 75739-3 | Desmosterol [Mass/volume] in Serum or Plasma |
| 7589-5 | Black Pepper triggered histamine release [Units/volume] in Blood |
| 76143-7 | Cefcapene [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 9325-2 | Tryptophan [Moles/volume] in 24 hour Urine |
| 94060-1 | Bacterial gyrA gene drug resistance mutation [Identifier] by Molecular method |
| 62430-4 | Eastern equine encephalitis virus IgM Ab [Presence] in Body fluid by Immunoassay |
| 7833-7 | Coxsackievirus A16 Ab [Units/volume] in Serum |
| 64421-1 | KIR gene allele 2DS2 [Presence] in Blood or Tissue by Molecular genetics method |
| 79224-2 | Baclofen [Mass/volume] in Body fluid |
| 9534-9 | Influenza virus B Ab [Titer] in Cerebral spinal fluid |
| 80132-4 | amLODIPine [Mass/mass] in Hair |
| 95963-5 | Quince IgE Ab [Units/volume] in Serum |
| 70072-4 | Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid |
| 81705-6 | BRAF protein [Presence] in Cancer specimen by Immune stain |
| 97296-8 | oxyMORphone Free [Presence] in Cord tissue by Screen method |
| 97915-3 | Thrombin generation test panel - Platelet poor plasma |
| 7056-5 | Trimethoprim [Susceptibility] by Gradient strip |
| 82445-8 | Sulfatide Ab [Presence] in Serum by Line blot |
| 82470-6 | Etanercept [Mass/volume] in Serum or Plasma by Immunoassay |
| 98123-3 | Neutrophil.fMLP stimulated DHR panel by Flow cytometry (FC) |
| 72374-2 | Virus identified in Lung tissue by Culture |
| 86013-0 | Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum --2nd specimen |
| 73184-4 | Pseudoephedrine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7324-7 | Fusarium culmorum IgG Ab [Units/volume] in Serum |
| 87495-8 | AB-CHMINACA butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 87749-8 | Crotoxyphos [Mass/mass] in Specimen |
| 73397-2 | Eptifibatide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73451-7 | Chlorthalidone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88699-4 | Procainamide and N-acetylprocainamide panel - Serum or Plasma |
| 88901-4 | Adenovirus [Presence] in Stool by Organism specific culture |
| 41675-0 | cefOXitin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 30472-5 | Ethylmalonate [Presence] in Urine |
| 41844-2 | Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Serum by Agglutination |
| 60179-9 | Tellurium [Mass/mass] in Nail |
| 21382-7 | Manganese [Mass/volume] in 24 hour Urine |
| 2138-6 | Coproporphyrinogen oxidase [Enzymatic activity/volume] in Serum |
| 21419-7 | Neutrophil cytoplasmic Ab pattern [Interpretation] in Serum by Immunofluorescence |
| 21567-3 | TOLBUTamide [Presence] in Serum or Plasma |
| 31364-3 | Encephalomyocarditis virus Ab [Units/volume] in Serum |
| 51357-2 | CD59 cells/100 cells in Cerebral spinal fluid |
| 42945-6 | Vesicular stomatitis Indiana virus Ab [Titer] in Serum |
| 22102-8 | Avian reovirus Ab [Presence] in Serum |
| 51709-4 | Leishmania sp identified in Specimen by Giemsa stain |
| 43376-3 | Spermatozoa Progressive [Presence] in Semen --post washing |
| 43382-1 | Alkaline phosphatase.heat stable/Alkaline phosphatase.total in Serum or Plasma by Heat stability |
| 22789-2 | Alcelaphine herpesvirus 1 Ag [Presence] in Specimen by Immunofluorescence |
| 53462-8 | Eicosanoylcarnitine (C20) [Moles/volume] in DBS |
| 44457-0 | Borrelia sp Ab [Units/volume] in Serum |
| 44624-5 | Additional pathological findings in Tumor |
| 44852-2 | Mycobacterium sp # 3 identified in Specimen by Organism specific culture |
| 23568-9 | Vesicular stomatitis New Jersey virus Ab [Presence] in Serum by Complement fixation |
| 33328-6 | West Nile virus IgG Ab [Titer] in Cerebral spinal fluid |
| 33399-7 | Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Serum |
| 33547-1 | Creatine Kinase aberrant band/Creatine kinase.total in Serum or Plasma by Electrophoresis |
| 24093-7 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Fibroblast |
| 33767-5 | Acidity.total [Moles/volume] in Gastric fluid |
| 33859-0 | Somatotropin/Creatinine [Ratio] in 12 hour Urine |
| 33871-5 | Xylose [Moles/volume] in Serum or Plasma --1 hour post 5 g xylose PO |
| 33901-0 | Gestational age of fetus by Amniocentesis |
| 54155-7 | Intercellular bridge nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
| 54249-8 | Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose glucagon |
| 54378-5 | Cobalamin (Vitamin B12) [Moles/volume] in Urine |
| 45381-1 | Basophilic stippling coarse [Presence] in Blood by Light microscopy |
| 34627-0 | Methylmalonate [Moles/volume] in Amniotic fluid |
| 34702-1 | Mycoplasma sp [Presence] in Specimen by Hoechst stain |
| 47215-9 | Lipoprotein.beta.subparticle.medium [Entitic length] in Serum or Plasma |
| 47258-9 | Creatinine [Mass/volume] in Urine --3rd specimen post XXX challenge |
| 25491-2 | Ornithine [Moles/time] in 24 hour Urine |
| 35546-1 | Soybean IgG Ab [Mass/volume] in Serum |
| 56-2 | Capreomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 26494-5 | Mononuclear cells/100 leukocytes in Pleural fluid |
| 48704-1 | Unidentified cells [#/volume] in Blood |
| 48763-7 | 3-Hydroxydecanoate (3-OH-C10:0) [Moles/volume] in Serum or Plasma |
| 38308-3 | Antimony [Mass/volume] in Water |
| 49147-2 | Rickettsia prowazekii IgM Ab [Titer] in Body fluid |
| 27363-1 | DOPamine [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 3946-1 | Phenmetrazine [Mass/time] in 24 hour Urine |
| 40144-8 | Creatinine [Moles/volume] in Urine --5.5 hours post XXX challenge |
| 58677-6 | Cortisol [Moles/volume] in Saliva (oral fluid) --8 PM specimen |
| 50055-3 | Iohexol renal clearance in Urine and Serum or Plasma |
| 50122-1 | 3-Hydroxypalmitoleylcarnitine (C16:1-OH)/Creatinine [Molar ratio] in Urine |
| 40387-3 | Nicotine [Presence] in Gastric fluid |
| 40534-0 | Erythrocytes [#/volume] in Peritoneal dialysis fluid by Manual count |
| 5882-6 | Varicella zoster virus Ag [Presence] in Specimen by Immunofluorescence |
| 50227-8 | Fat [Presence] in Urine by Computer assisted method |
| 50541-2 | Thyrotropin [Units/volume] in Serum or Plasma --20 minutes post dose TRH |
| 30020-2 | Borrelia burgdorferi 39kD IgM Ab [Presence] in Synovial fluid by Immunoblot |
| 20628-4 | Terminal Deoxyribonucleotidyl Transferase blasts/100 blasts in Specimen by Immunoperoxidase stain |
| 20711-8 | Bovine diarrhea virus Ag [Presence] in Nose by Immunofluorescence |
| 100145-2 | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot |
| 13024-5 | Trichlorofluoroethane [Mass/volume] in Blood |
| 102818-2 | Shrimp IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103004-8 | Timothy recombinant (rPhl p) 12 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14796-7 | Insulin [Moles/volume] in Serum or Plasma |
| 104166-4 | Apolipoprotein E phenotype [Identifier] in Plasma by LC/MS/MS |
| 15171-2 | Cryoglobulin.IgA [Units/volume] in Serum |
| 15231-4 | Dust Allergen Mix A (Cockroach+American house dust mite+European house dust mite+House dust Greer) IgE Ab [Presence] in Serum by Multidisk |
| 15248-8 | Food Allergen Mix 18 (Peanut+Soybean+Peas) IgE Ab [Presence] in Serum by Multidisk |
| 15440-1 | Infectious bronchitis virus Mass-41 Ab [Titer] in Serum by Hemagglutination inhibition |
| 16170-3 | Glucose [Mass/volume] in Serum or Plasma --5 PM specimen |
| 16190-1 | Amobarbital [Presence] in Urine by Confirmatory method |
| 16196-8 | Morphine [Presence] in Urine by Confirmatory method |
| 16218-0 | Nalbuphine [Presence] in Urine by Confirmatory method |
| 10710-2 | Plasmodium sp identified in Blood by Thin film |
| 16772-6 | Dieldrin [Mass/volume] in Urine |
| 17426-8 | Penicillium roqueforti IgE Ab [Units/volume] in Serum |
| 17562-0 | Salmonella sp Ab [Presence] in Serum |
| 17893-9 | Bacteria # 2 identified in Sputum by Aerobe culture |
| 18224-6 | EPINEPHrine [Mass/volume] in Urine --7th specimen post XXX challenge |
| 18242-8 | Methyprylon [Mass/time] in 24 hour Urine |
| 92669-1 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose cloNIDine |
| 92676-6 | MLH1 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 75376-4 | Siderocytes per HPF [Presence] in Blood by Light microscopy |
| 60568-3 | Pathology synoptic report |
| 75914-2 | aPTT W hexagonal phospholipid/Normal (StaClot LA confirm) |
| 93356-4 | Cells with cytogenetic abnormality [#] in Blood or Tissue by Molecular genetics method |
| 93484-4 | Cortisol [Mass/volume] in Serum or Plasma --5 minutes pre 1 ug/kg CRH IV |
| 77212-9 | Carbonic anhydrase 6 IgG Ab [Units/volume] in Serum by Immunoassay |
| 94100-5 | Hantavirus seoul IgM Ab [Presence] in Serum or Plasma by Line blot |
| 63083-0 | Raspberry IgG Ab [Mass/volume] in Serum |
| 94303-5 | Pregnenolone and 17-Hydroxypregnenolone panel - Serum or Plasma |
| 94484-3 | Parainfluenza virus 2 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 9464-9 | Barium [Mass/volume] in Water |
| 64965-7 | Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum |
| 79134-3 | Abacavir [Mass/volume] in Cerebral spinal fluid |
| 79273-9 | 3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in DBS |
| 79347-1 | Sulfate.total/Creatinine [Molar ratio] in Urine |
| 79451-1 | Adenosine deaminase [Enzymatic activity/mass] in Leukocytes |
| 66491-2 | Urease [Presence] in Tissue --2nd specimen |
| 67830-0 | Leukocytes other [#/volume] in Pericardial fluid |
| 6822-1 | Nuclear Ab [Titer] in Synovial fluid by Immunofluorescence |
| 82258-5 | Subtelomere analysis in Bone marrow by FISH |
| 97647-2 | Asenapine [Presence] in Urine by Confirmatory method |
| 7052-4 | Tetracycline [Susceptibility] by Gradient strip |
| 82868-1 | Allo-pregnanediolone [Moles/volume] in Urine |
| 7238-9 | Cocklebur IgG Ab [Units/volume] in Serum |
| 83076-0 | Beta-2-Microglobulin [Units/volume] in Serum or Plasma by Immunoassay |
| 99865-8 | Acanthocytes [Presence] in Urine sediment by Computer assisted method |
| 7293-4 | Whole Egg triggered histamine release [Units/volume] in Blood |
| 72935-0 | Valproate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 85795-3 | Rubella virus E1 gene and genotype panel - Specimen |
| 87341-4 | Pseudorabies virus [Presence] in Specimen by Organism specific culture |
| 73522-5 | Ampicillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87958-5 | Neisseria meningitidis [Presence] in Throat by Organism specific culture |
| 88203-5 | Dengue virus 1 and 2 and 3 and 4 RNA [Identifier] in Serum or Blood by NAA with probe detection |
| 88254-8 | Citrobacter sp ompA+mrkC genes [Presence] by Probe in Positive blood culture |
| 73892-2 | Tetrahydrocortisol [Moles/time] in 24 hour Urine |
| 41186-8 | Yeast [Presence] in Stool |
| 5931-1 | Trichophyton reaction wheal [Diameter] --3 days post 50 ug trichophyton intradermal |
| 59651-0 | N-desalkylflurazepam [Mass/mass] in Stool by Confirmatory method |
| 59805-2 | Epstein Barr virus DNA [Presence] in Body fluid by NAA with probe detection |
| 50677-4 | Semen analysis post vasectomy panel |
| 4268-9 | Gentamicin [Mass] of Dose |
| 60063-5 | buPROPion [Mass/mass] in Tissue |
| 60224-3 | Beta-trace protein [Mass/volume] in Nasal fluid |
| 602-3 | Bacteria identified in Bone by Aerobe culture |
| 21081-5 | ASPA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 31564-8 | Polio virus 1 Ab [Units/volume] in Cerebral spinal fluid |
| 51238-4 | CD13 cells/100 cells in Body fluid |
| 51373-9 | CD8+HLA-DR+ cells/100 cells in Body fluid |
| 22158-0 | Brucella ovis Ab [Presence] in Serum |
| 22293-5 | Epstein Barr virus early Ab [Units/volume] in Serum |
| 22490-7 | Rickettsia typhi IgM Ab [Titer] in Serum |
| 43914-1 | Beta 2 glycoprotein 1 IgG Ab [Presence] in Serum |
| 32770-0 | Transfusion band number |
| 32836-9 | Parvovirus B19 IgG Ab [Units/volume] in Serum --1st specimen |
| 5313-2 | Rickettsia spotted fever group IgG Ab [Titer] in Serum by Immunofluorescence |
| 44704-5 | NEB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 23245-4 | Mycobacterium avium ss paratuberculosis DNA [Presence] in Specimen by NAA with probe detection |
| 33511-7 | Appearance of Specimen |
| 53605-2 | Treponema pallidum DNA [Presence] in Blood by NAA with probe detection |
| 53895-9 | SH3BP2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 4531-0 | Complement total hemolytic [Units/volume] in Blood |
| 45346-4 | Date tick removed |
| 46227-5 | DULoxetine [Mass/volume] in Serum or Plasma |
| 24400-4 | Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 34305-3 | Flupenthixol [Mass/volume] in Serum or Plasma |
| 34434-1 | Lutropin/Follitropin [Ratio] in Serum or Plasma |
| 34470-5 | Giardia lamblia Ag [Presence] in Bile fluid |
| 55328-9 | Le sup(a) Ab [Titer] in Serum or Plasma |
| 47078-1 | Legionella pneumophila 8 IgG Ab [Titer] in Serum by Immunofluorescence |
| 47363-7 | Cytomegalovirus Ab [Presence] in Serum from Donor by Hemagglutination |
| 47413-0 | Plasma cells/100 leukocytes in Cerebral spinal fluid |
| 47418-9 | Lipase [Enzymatic activity/volume] in Pleural fluid |
| 25090-2 | Benzoate/Creatinine [Molar ratio] in Urine |
| 35182-5 | Docosatetraenoate (C22:4w6) [Moles/volume] in Serum or Plasma |
| 55631-6 | Cephalothin+Sulbactam [Susceptibility] |
| 47606-9 | Cortisol [Moles/volume] in Serum or Plasma --1 hour post 1 ug/kg CRH IV |
| 47651-5 | Hydroxyproline [Moles/volume] in DBS |
| 56177-9 | Apricot IgG4 Ab [Mass/volume] in Serum |
| 48025-1 | Gene mutations tested for [#] in Blood or Tissue by Molecular genetics method |
| 48081-4 | 3,6-Epoxytetradecanedioate/Creatinine [Molar ratio] in Urine |
| 36902-5 | Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection |
| 3739-0 | Medazepam [Mass/volume] in Blood |
| 56560-6 | Somatotropin [Mass/volume] in Serum or Plasma --4.5 hours post XXX challenge |
| 56946-7 | Insulin [Units/volume] in Serum or Plasma --2 days post XXX challenge |
| 26847-4 | Haloperidol [Presence] in Serum or Plasma |
| 38456-0 | CFTR gene c.3849+10kbC>T [Presence] in Blood or Tissue by Molecular genetics method |
| 38579-9 | Chlordane [Mass/volume] in Air |
| 4928-8 | HLA-DPw5 [Presence] in Donor |
| 38762-1 | Iso-octane [Mass/volume] in Air |
| 39024-5 | Vesicular stomatitis New Jersey virus RNA [Presence] in Specimen by NAA with probe detection |
| 39957-6 | Creatinine [Mass/volume] in Serum or Plasma --1 hour pre XXX challenge |
| 3995-8 | Propylhexedrine [Mass/volume] in Blood |
| 40004-4 | Glucose [Mass/volume] in Serum or Plasma --100 minutes post XXX challenge |
| 29833-1 | Anaplasma phagocytophilum IgM Ab [Presence] in Specimen |
| 58967-1 | Ganglioside GM3 IgM Ab [Units/volume] in Serum by Immunoassay |
| 30340-4 | Epstein Barr virus capsid IgM Ab [Presence] in Serum |
| 30365-1 | Lymphocytes/100 leukocytes in Blood by Flow cytometry (FC) |
| 40913-6 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum by Immunoassay |
| 41037-3 | Cocaine [Presence] in Meconium by Confirmatory method |
| 19344-1 | Amphetamine [Presence] in Urine by Confirmatory method |
| 19445-6 | diazePAM cutoff [Mass/volume] in Urine for Confirmatory method |
| 20376-0 | Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria |
| 20414-9 | Thiazides [Mass/volume] in Urine by Confirmatory method |
| 20839-7 | Herbicide [Presence] in Specimen by Screen method |
| 12417-2 | Sulindac [Mass/volume] in Serum or Plasma |
| 100732-7 | Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum |
| 12813-2 | Potassium [Moles/volume] in Serum or Plasma --3rd specimen |
| 101298-8 | Respiratory syncytial virus RNA [Presence] in Throat by NAA with non-probe detection |
| 102384-5 | House dust Greer IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102444-7 | Mink epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14014-5 | Thyroxine (T4).prealbumin bound [Mass/volume] in Serum or Plasma |
| 14256-2 | Tetrachlorodiphenylethane [Mass/mass] in Tissue |
| 14431-1 | Globulin [Mass/volume] in Urine |
| 14818-9 | Lymphocytes/100 leukocytes in Pericardial fluid by Manual count |
| 15023-5 | Amylase S1/Amylase.total in Serum or Plasma |
| 104429-6 | Measles virus IgM Ab [Ratio] in Serum by Immunoassay |
| 104468-4 | Yersinia enterocolitica O:9 Ab [Presence] in Stool |
| 10464-6 | Amyloid P component Ag [Presence] in Tissue by Immune stain |
| 10696-3 | Norovirus [Identifier] in Stool by Electron microscopy |
| 15468-2 | Equine infectious anemia virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 10927-2 | Elk or Moose Meat IgE Ab [Units/volume] in Serum |
| 1633-7 | Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV |
| 16598-5 | Chlamydia trachomatis C IgG Ab [Units/volume] in Serum |
| 11178-1 | Beta galactosidase IgE Ab [Units/volume] in Serum |
| 1221-1 | Mg Ab [Presence] in Serum or Plasma from Donor |
| 74635-4 | Bacterial vaginosis DNA panel - Vaginal fluid by NAA with probe detection |
| 75054-7 | Glutaryl CoA dehydrogenase [Enzymatic activity/mass] in Leukocytes |
| 77684-9 | Legionella pneumophila 1 Ag [Presence] in Urine by Rapid immunoassay |
| 93801-9 | Chromosome 1 polysomy [Presence] in Tissue by FISH |
| 6275-2 | Western Ragweed IgE Ab [Units/volume] in Serum |
| 63212-5 | Asialoganglioside GM1 IgG Ab [Presence] in Serum by Immunoassay |
| 78805-9 | Barium [Moles/mass] in Tissue |
| 78835-6 | Imipramine cutoff [Mass/volume] in Urine for Confirmatory method |
| 63457-6 | European house dust mite recombinant (rDer p) 2 IgE Ab [Units/volume] in Serum |
| 64012-8 | CEBPA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 6421-2 | Hepatitis B virus rRNA [Presence] in Specimen by Probe |
| 94866-1 | 7-Alpha hydroxy-4-cholesten-3-one [Mass/volume] in Serum or Plasma |
| 8020-0 | Schistosoma sp Ab [Presence] in Serum |
| 80351-0 | Escherichia coli enterotoxigenic ltA+st1a+st1b genes [Presence] in Stool by NAA with non-probe detection |
| 80386-6 | Bladder tumor Ag [Presence] in Urine by Rapid immunoassay |
| 96308-2 | Klebsiella aerogenes DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 96365-2 | Naltrexol [Presence] in Saliva (oral fluid) by Confirmatory method |
| 963-9 | C sup(x) Ab [Presence] in Serum or Plasma |
| 97627-4 | Parvimonas micra DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 70216-7 | Salicylates [Moles/volume] in Serum or Plasma by Screen method |
| 82442-5 | SUMO-activating enzyme subunit 2 Ab [Presence] in Serum by Line blot |
| 98980-6 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine and Cystatin C-based formula (CKD-EPI 2021) |
| 99013-5 | Acinetobacter baumannii DNA [Presence] in Urine by NAA with probe detection |
| 72377-5 | Nordiazepam [Mass/volume] in Saliva (oral fluid) |
| 72486-4 | Laboratory director name in Provider |
| 86690-5 | Rotavirus C RNA [Presence] in Specimen by NAA with probe detection |
| 7314-8 | Flea IgG Ab [Units/volume] in Serum |
| 73292-5 | Losartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73380-8 | Fexofenadine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73554-8 | Abciximab induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87925-4 | Reagin Ab [Titer] in Cerebral spinal fluid by RPR |
| 59875-5 | Brompheniramine [Moles/volume] in Gastric fluid |
| 50933-1 | Vanadium [Moles/volume] in Blood |
| 30998-9 | Timothy recombinant (rPhl p) 6 IgE Ab [Units/volume] in Serum |
| 31162-1 | Sulfate-3-Glucuronyl paragloboside Ab [Titer] in Serum |
| 42336-8 | Cytomegalovirus Ag [#/area] in Specimen |
| 60230-0 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose fructose PO |
| 42808-6 | Virus identified in Isolate |
| 43089-2 | Aspergillus niger Ab [Titer] in Serum |
| 43120-5 | Echovirus Ab panel - Serum |
| 43395-3 | Cholesterol in VLDL acylated [Mass/volume] in Serum or Plasma |
| 4342-2 | Nalbuphine [Mass] of Dose |
| 2234-3 | Epitestosterone [Presence] in Urine |
| 22537-5 | Shigella boydii Ab [Titer] in Serum |
| 22568-0 | Streptolysin O Ab [Titer] in Serum |
| 32165-3 | Cells Counted Total [#] in Pericardial fluid |
| 51938-9 | HLA-A+B+Bw+DR [Type] in Donor |
| 43882-0 | Bordetella pertussis filamentous hemagglutinin IgM Ab [Presence] in Serum |
| 43895-2 | Influenza virus B Ag [Presence] in Nasopharynx |
| 44267-3 | Avian paramyxovirus 1 RNA [Units/volume] (viral load) in Specimen by NAA with probe detection |
| 44289-7 | Adenovirus Ab [Units/volume] in Serum by Complement fixation |
| 53329-9 | Crystals.amorphous [Presence] in Urine by Computer assisted method |
| 2323-4 | Gamma glutamyl transferase [Enzymatic activity/volume] in Semen |
| 53610-2 | Erythroid cells [#/volume] in Blood or Marrow |
| 23653-9 | Aflatoxin [Mass/volume] in Specimen |
| 33961-4 | Sulthiame [Mass/volume] in Serum or Plasma |
| 53985-8 | Coarse speckled nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
| 54083-1 | CFTR gene mutations found [Identifier] in DBS by Molecular genetics method Nominal |
| 541-3 | Mycobacterium sp identified in Urine by Organism specific culture |
| 54252-2 | Glucose [Moles/volume] in Serum or Plasma --2 minutes post dose glucagon |
| 24183-6 | Coxsackievirus B2 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen |
| 34501-7 | HADHA gene c.1528G>C [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
| 3465-2 | Chlorpheniramine [Presence] in Serum or Plasma |
| 34655-1 | Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 35061-1 | Eosinophils [#/volume] in Peritoneal fluid |
| 26020-8 | Creatine Kinase.macromolecular type 2/Creatine kinase.total in Serum or Plasma |
| 56155-5 | Date referral lab test results received in unspecified time Referral lab test |
| 56193-6 | Black Willow IgG4 Ab [Mass/volume] in Serum |
| 3644-2 | FLUoxetine [Mass/volume] in Serum or Plasma |
| 3727-5 | Loxapine [Presence] in Serum or Plasma |
| 56713-1 | Dog dander+Dog epithelium IgE Ab [Units/volume] in Serum |
| 56714-9 | Bacteria identified in Contact lens by Culture |
| 26836-7 | Hydroxyethylflurazepam [Mass/mass] in Hair |
| 26998-5 | Thyrotropin [Units/volume] in Saliva (oral fluid) |
| 57338-6 | Citrate [Mass/volume] in 2 hour Urine |
| 48907-0 | Rickettsia conorii IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 4907-2 | HLA-Dw3 [Presence] |
| 49171-2 | Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Serum |
| 3968-5 | Phenytoin [Mass/volume] in Serum or Plasma |
| 3969-3 | Phenytoin Free [Mass/volume] in Serum or Plasma |
| 57911-0 | Basement membrane zone BP230 Ab [Units/volume] in Serum or Plasma |
| 39964-2 | Creatinine [Mass/volume] in Serum or Plasma --4.5 hours post XXX challenge |
| 58416-9 | MLH1 gene methylation [Presence] in Blood or Tissue by Molecular genetics method |
| 59309-5 | Metaxalone [Mass/volume] in Urine |
| 40849-2 | Glucose [Mass/volume] in Urine by Test strip --1st specimen post XXX challenge |
| 40993-8 | Rhinovirus Ag [Identifier] in Specimen by Neutralization test |
| 19475-3 | Flurazepam [Presence] in Urine by Confirmatory method |
| 1990-1 | Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma |
| 20825-6 | Fumonisin [Mass/mass] in Feed |
| 21002-1 | Fibrinogen [Interpretation] in Platelet poor plasma |
| 12412-3 | Pyridine [Mass/volume] in Serum or Plasma |
| 100701-2 | Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection |
| 101062-8 | BARC Ab [Presence] in Serum or Plasma |
| 12659-9 | Glucose [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge |
| 12728-2 | Alpha subunit [Units/volume] in Serum or Plasma |
| 101557-7 | Clostridioides difficile DNA [Presence] in Stool by NAA with probe detection |
| 13653-1 | Epithelial cells.renal [#/volume] in Urine sediment |
| 1374-8 | Calcitonin [Mass/volume] in Serum or Plasma --3 hours post 15 mg/kg calcium gluconate IV |
| 102295-3 | Endive IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102460-3 | Nectarine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14305-7 | Measles virus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 102830-7 | Sweet potato IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14703-3 | DOPamine [Moles/volume] in Serum or Plasma |
| 103838-9 | oxyMORphone [Presence] in Meconium |
| 104348-8 | Borrelia recurrentis [Presence] in Blood by Microscopy |
| 104469-2 | Yersinia pestis IgG Ab [Titer] in Serum by Immunoassay --1st specimen |
| 16169-5 | Glucose [Mass/volume] in Serum or Plasma --4 PM specimen |
| 16903-7 | Glucose [Mass/volume] in Vitreous fluid |
| 17299-9 | Mycoplasma fermentans Ab [Presence] in Serum |
| 17526-5 | Retinyl esters [Mass/volume] in Serum or Plasma |
| 91039-8 | Methadone+Metabolite [Presence] in Body fluid by Screen method |
| 74537-2 | Neisseria meningitidis serogroup C DNA [Presence] in Specimen by NAA with probe detection |
| 7454-2 | Latex Stallerg triggered histamine release [Units/volume] in Blood |
| 91794-8 | Respiratory syncytial virus B RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 6089-7 | Cottonseed IgE Ab [Units/volume] in Serum |
| 760-9 | Neutrophils [#/volume] in Synovial fluid by Manual count |
| 93778-9 | Human papilloma virus 6+11 E6+E7 mRNA [Presence] in Tissue by Probe |
| 95270-5 | Platelet and HLA glycoprotein antibody panel - Blood |
| 9553-9 | Legionella pneumophila 6 IgM Ab [Titer] in Serum by Immunofluorescence |
| 95784-5 | FGFR2 gene rearrangements in Tissue by FISH |
| 95955-1 | Butylparaben IgE Ab [Units/volume] in Serum |
| 95974-2 | SARS-CoV-2 stimulated gamma interferon panel - Blood |
| 96364-5 | Gabapentin [Presence] in Saliva (oral fluid) by Confirmatory method |
| 96506-1 | Oropouche virus IgG Ab [Presence] in Specimen by Immunoassay |
| 69003-2 | Mononuclear cells atypical/100 leukocytes in Blood by Manual count |
| 8099-4 | Thyroperoxidase Ab [Units/volume] in Serum or Plasma |
| 97172-1 | Yersinia outer protein Ab panel - Serum by Line blot |
| 70047-6 | Mononuclear cells [#/volume] in Peritoneal fluid by Automated count |
| 82245-2 | Chromosome region 22q11.2 deletion and duplication mutation analysis in Amniotic fluid or Chorionic villus sample by FISH |
| 9744-4 | Beta globulin [Mass/volume] in Urine by Electrophoresis |
| 9755-0 | Coxsackievirus A7 Ab [Titer] in Serum by Complement fixation |
| 71593-8 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/substance] in Red Blood Cells |
| 82488-8 | TRBV16 gene segments/TRBV gene segments.total in Blood |
| 98402-1 | Mold [Morphology] in Isolate by Light microscopy |
| 986-0 | Di sup(b) Ab [Presence] in Serum or Plasma from Donor |
| 71767-8 | Ebola virus IgG Ab [Titer] in Serum by Immunoassay |
| 7218-1 | Cherry triggered histamine release [Units/volume] in Blood |
| 86180-7 | Streptococcus pneumoniae Danish serotype 9N Ab [Ratio] in Serum --1st specimen/2nd specimen |
| 88168-0 | Mycobacterium sp identified in Ocular fluid by Organism specific culture |
| 74139-7 | Mononuclear cells [#/volume] in Peritoneal dialysis fluid |
| 7435-1 | Western Juniper IgE Ab [Units/volume] in Serum |
| 5947-7 | aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --20M post incubation with normal plasma |
| 50926-5 | Titanium [Moles/mass] in Hair |
| 30417-0 | Variant lymphocytes/100 leukocytes in Body fluid |
| 3069-2 | Tryptophan [Presence] in Serum or Plasma |
| 3098-1 | Urea renal clearance in 24 hour Urine and Serum or Plasma |
| 42527-2 | Parietal cell Ab [Titer] in Cerebral spinal fluid |
| 42735-1 | CD20+CD117+ cells/100 cells in Blood |
| 42889-6 | CD79b cells/100 cells in Bone marrow |
| 42990-2 | Mycoplasma pneumoniae IgM Ab [Titer] in Pleural fluid |
| 31658-8 | Streptococcus pyogenes enzyme Ab [Units/volume] in Serum |
| 43228-6 | Cryptococcus sp Ag [Presence] in Specimen by Latex agglutination |
| 43305-2 | Neisseria gonorrhoeae rRNA [Presence] in Specimen by NAA with probe detection |
| 22695-1 | Carnitine/Creatinine [Molar ratio] in Urine |
| 51929-8 | Ritonavir [Mass/volume] in Serum or Plasma --peak |
| 51958-7 | Transcript reference sequence [ID] |
| 43908-3 | Avian encephalomyelitis virus Ab [Presence] in Cerebral spinal fluid |
| 44088-3 | Escherichia coli O157:H7 DNA [Identifier] in Specimen by NAA with probe detection |
| 44268-1 | Avian paramyxovirus 1.exotic RNA [Units/volume] (viral load) in Specimen by NAA with probe detection |
| 22934-4 | Brucella melitensis Ab [Units/volume] in Serum by Complement fixation |
| 3270-6 | LMW Heparin [Units/volume] in Platelet poor plasma by Coagulation assay |
| 32766-8 | Trichomonas vaginalis [Presence] in Specimen by Wet preparation |
| 53079-0 | Dodecenoylcarnitine (C12:1) [Moles/volume] in Cerebral spinal fluid |
| 44795-3 | Influenza virus A H5 Asian RNA [Presence] in Specimen by NAA with probe detection |
| 33474-8 | Glycosaminoglycans pattern [Interpretation] in Urine |
| 53624-3 | Carnitine esters [Moles/volume] in DBS |
| 53727-4 | SOS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 34259-2 | Carnitine free (C0) [Moles/time] in 24 hour Urine |
| 54082-3 | Infectious diseases newborn screening panel |
| 54190-4 | Temocillin [Susceptibility] by Gradient strip |
| 24407-9 | Androstenedione [Mass/volume] in Serum or Plasma --baseline |
| 24503-5 | Parakeet droppings Ab [Presence] in Serum by Immune diffusion (ID) |
| 54485-8 | Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Urine |
| 55365-1 | CD138+Kappa+ Cells/100 cells in Blood |
| 25507-5 | Pregnenolone [Moles/volume] in Serum or Plasma |
| 34914-2 | Malignant cells [#/volume] in Blood |
| 47507-9 | Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum --2nd specimen |
| 56421-1 | White Bean IgG4 Ab [Mass/volume] in Serum |
| 5643-2 | Ethanol [Mass/volume] in Serum or Plasma |
| 35801-0 | Ertapenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 38158-2 | Parathyrin.intact [Mass/volume] in Serum or Plasma --baseline |
| 48593-8 | von Willebrand panel - Platelet poor plasma |
| 38273-9 | Influenza virus A Ab [Units/volume] in Serum by Immunoassay |
| 49069-8 | Epstein Barr virus Ab [Titer] in Serum |
| 57865-8 | oxyCODONE [Moles/volume] in Specimen |
| 57979-7 | HLA-B*15:02 [Presence] |
| 58030-8 | Tranylcypromine [Presence] in Urine |
| 49410-4 | JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 2893-6 | Protoporphyrin.zinc [Presence] in Blood |
| 58472-2 | Other cells [#] in Body fluid by Manual count |
| 5860-2 | Influenza virus A Ag [Presence] in Throat by Immunoassay |
| 29896-8 | Cryptococcus sp Ag [Presence] in Cerebral spinal fluid by Immunoassay |
| 29922-2 | Boron/Creatinine [Mass Ratio] in 24 hour Urine |
| 40330-3 | Prolactin [Mass/volume] in Serum or Plasma --15 minutes post dose triple bolus |
| 58894-7 | Vasopressin [Mass/volume] in Plasma --baseline |
| 50318-5 | Granzyme B Ag [Presence] in Tissue by Immune stain |
| 40972-2 | XXX microorganism DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 19536-2 | Mephobarbital [Presence] in Urine by Screen method |
| 19561-0 | Methylenediamine [Presence] in Urine by Screen method |
| 12637-5 | Glucose [Mass/volume] in Peritoneal dialysis fluid --8th specimen post XXX challenge |
| 102277-1 | American house dust mite IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102360-5 | Hamster epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102435-5 | Mesquite IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14089-7 | Herpes simplex virus 2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 14582-1 | Acetone [Moles/volume] in Serum or Plasma |
| 104222-5 | Spermatozoa.progressive.slow/100 spermatozoa in Urine --post ejaculation |
| 104227-4 | Rizatriptan [Mass/volume] in Urine by Confirmatory method |
| 14824-7 | Magnesium [Presence] in Stone |
| 14951-8 | Volatile drugs positive [Identifier] in Serum or Plasma by Screen method |
| 1058-7 | I Ab [Presence] in Serum or Plasma from Blood product unit |
| 16158-8 | Gastrin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 16324-6 | Alanine aminotransferase [Enzymatic activity/volume] in Red Blood Cells |
| 1115-5 | Le sup(a) Ag [Presence] on Red Blood Cells |
| 1162-7 | little e Ab [Presence] in Serum or Plasma |
| 17883-0 | Bacteria # 2 identified in Genital specimen by Aerobe culture |
| 91038-0 | Cocaine+Benzoylecgonine [Presence] in Body fluid by Screen method |
| 92137-9 | Parainfluenza virus 4 RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 60420-7 | Dengue virus 2 RNA [Presence] in Serum by NAA with probe detection |
| 6110-1 | English plantain IgE Ab [Units/volume] in Serum |
| 7633-1 | Privet IgG Ab [Units/volume] in Serum |
| 62475-9 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
| 78778-8 | Alfentanil [Presence] in Blood by Screen method |
| 78813-3 | Cannabicyclohexanol [Mass/volume] in Urine by Confirmatory method |
| 94386-0 | PCA-Tr IgG Ab [Presence] in Cerebral spinal fluid by Line blot |
| 6401-4 | Ehrlichia chaffeensis IgG Ab [Presence] in Serum by Immunoassay |
| 6409-7 | Fungus identified in Sputum tracheal aspirate by Culture |
| 78871-1 | OPC3373 (Metabolite of Ariprazole) cutoff [Mass/volume] in Urine for Confirmatory method |
| 79272-1 | 3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in Cerebral spinal fluid |
| 66741-0 | CYP2C19 gene c.681G>A(*2) [Presence] in Blood or Tissue by Molecular genetics method |
| 6720-7 | Chocolate IgG Ab [Units/volume] in Serum |
| 96058-3 | Mitragynine [Presence] in Urine by Screen method |
| 80643-0 | Gadolinium [Mass/mass] in Tissue |
| 821-9 | Au sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 97555-7 | Hemoglobin [Mass/volume] in Central venous blood by Oximetry |
| 707-0 | Basophils/100 leukocytes in Blood by Manual count |
| 82729-5 | Natural killer cell cytotoxicity.100:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
| 82768-3 | Lab order priority [Type] |
| 72263-7 | Oxyhemoglobin [Moles/volume] in Cerebral spinal fluid |
| 84882-0 | Histologic type in Colorectal cancer specimen by WHO classification |
| 72584-6 | Beta globulin/Protein.total [Pure mass fraction] in 24 hour Urine by Electrophoresis |
| 86607-9 | Cocaine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 87748-0 | Coumaphos [Mass/mass] in Specimen |
| 87976-7 | Fungus identified in Implanted device by Culture |
| 88160-7 | Microsporidia DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 74469-8 | Glucose-6-Phosphate dehydrogenase/Pyruvate kinase [Ratio] in Blood |
| 59564-5 | Alpha-1-Fetoprotein [Units/volume] in Cerebral spinal fluid |
| 59714-6 | Nitrous oxide [Mass/volume] in Blood |
| 59831-8 | Gastrin [Mass/volume] in Serum or Plasma --baseline |
| 3076-7 | Tyramine [Mass/volume] in Urine |
| 30900-5 | Cold agglutinin [Titer] in Serum or Plasma by Adult RBC Agglutination |
| 30927-8 | Selenium [Mass/volume] in Urine collected for unspecified duration |
| 42530-6 | Smooth muscle Ab [Titer] in Cerebral spinal fluid |
| 59907-6 | fluvoxaMINE [Moles/volume] in Gastric fluid |
| 601-5 | Fungus identified in Blood by Culture |
| 51050-3 | CD126 blasts/100 blasts in Blood |
| 21694-5 | HFE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21744-8 | CCND1 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 21772-9 | Chromosome 7 trisomy [Presence] in Blood or Tissue by Cytogenetics |
| 3198-9 | Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay |
| 51652-6 | SLC14A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 22440-2 | Pasteurella multocida Ab [Presence] in Serum |
| 32217-2 | von Willebrand factor (vWf) multimers [Presence] in Platelet poor plasma |
| 51928-0 | Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
| 52933-9 | Cobalt/Creatinine [Molar ratio] in 24 hour Urine |
| 43838-2 | Influenza virus A IgM Ab [Presence] in Serum |
| 43912-5 | Bisacodyl [Presence] in Urine |
| 22917-9 | Bovine leukemia virus Ag [Presence] in Specimen |
| 32597-7 | Natamycin [Susceptibility] |
| 32817-9 | Microscopic observation [Identifier] in Specimen by Myeloperoxidase stain |
| 53328-1 | Glucose [Mass/volume] in Urine by Automated test strip |
| 33290-8 | Histamine [Moles/volume] in Urine |
| 34212-1 | 11-Hydroxyetiocholanolone/Creatinine [Molar ratio] in Urine |
| 24240-4 | Mumps virus IgG Ab [Units/volume] in Serum --1st specimen |
| 47111-0 | Glutethimide [Moles/volume] in Urine |
| 25096-9 | Deoxypyridinoline/Creatinine [Molar ratio] in 2 hour Urine |
| 25424-3 | Trypanosoma sp Ab [Units/volume] in Serum by Immunofluorescence |
| 34888-8 | Aino virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 35280-7 | Tissue transglutaminase IgA Ab [Presence] in Serum by Immunoassay |
| 55911-2 | Arginine [Moles/mass] in Hair |
| 25812-9 | Trimipramine+Nortrimipramine [Moles/volume] in Serum or Plasma |
| 3721-8 | Lithium [Mass/volume] in Urine |
| 37984-2 | Saint Louis encephalitis virus RNA [Presence] in Specimen by Probe |
| 38192-1 | Amylase [Enzymatic activity/volume] in 2 hour Urine |
| 56568-9 | Somatotropin [Mass/volume] in Serum or Plasma --10.5 hours post XXX challenge |
| 48933-6 | Respiratory allergen panel, US - Hawaii - Serum |
| 38918-9 | ABCC8 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 39469-2 | Cholesterol in LDL [Moles/volume] in Serum or Plasma by calculation |
| 39551-7 | Cow dander IgE Ab/IgE total in Serum |
| 58352-6 | Connective tissue growth factor [Moles/volume] in Urine |
| 2825-8 | Potassium [Moles/volume] in Saliva (oral fluid) |
| 29293-8 | Leucine [Mass/volume] in Blood |
| 29384-5 | diazePAM [Mass/volume] in Gastric fluid |
| 29499-1 | Selenium [Mass/mass] in Hair |
| 3980-0 | Probenecid [Mass/volume] in Urine |
| 3997-4 | Propylhexedrine [Mass/volume] in Urine |
| 58571-1 | Corticotropin [Moles/volume] in Plasma --2 hours post 1 ug/kg CRH IV |
| 58814-5 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --3rd specimen |
| 49836-0 | Platelet function (closure time) [Interpretation] in Blood Narrative |
| 50001-7 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post XXX challenge |
| 50098-3 | 3-Hydroxyvalerate [Moles/volume] in Cerebral spinal fluid |
| 40671-0 | Volume of 72 hour Urine |
| 50177-5 | Hemicystine [Moles/volume] in Cerebral spinal fluid |
| 50486-0 | Gastrin [Mass/volume] in Serum or Plasma --2nd specimen |
| 50497-7 | Somatotropin [Mass/volume] in Serum or Plasma --5th specimen |
| 30264-6 | Glucose [Moles/volume] in Serum or Plasma --40 minutes post dose glucose |
| 30311-5 | Nevirapine [Susceptibility] |
| 12416-4 | Sotalol [Mass/volume] in Serum or Plasma |
| 100695-6 | Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative |
| 132-1 | cefTAZidime [Susceptibility] by Minimum lethal concentration (MLC) |
| 101840-7 | Methylprednisolone [Moles/volume] in Serum or Plasma |
| 102093-2 | HLA-ABDR typing panel - Blood or Tissue from Donor |
| 102183-1 | Blackberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13944-4 | Leukocyte phosphatase [Enzymatic activity/volume] in Control Leukocytes by Light microscopy |
| 14172-1 | Potassium [Moles/volume] in Synovial fluid |
| 14202-6 | Chlamydia trachomatis C IgA Ab [Titer] in Serum by Immunofluorescence |
| 14321-4 | Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 102721-8 | Codfish IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102781-2 | Oyster IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103648-2 | Follitropin [Units/volume] in Serum or Plasma --4 hours post dose gonadotropin releasing hormone |
| 104176-3 | Clostridium tetani toxin TeNT gene [Presence] in Specimen by NAA with probe detection |
| 10521-3 | Coagulation factor VIII Ag [Presence] in Tissue by Immune stain |
| 10585-8 | Round cells [#/volume] in Semen |
| 16157-0 | Gastrin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 1649-3 | Calcitriol [Mass/volume] in Serum or Plasma |
| 16497-0 | Butabarbital [Mass/volume] in Gastric fluid |
| 16542-3 | Cannabinoids [Mass/volume] in Serum or Plasma by Confirmatory method |
| 19078-5 | CD23 cells/100 cells in Specimen |
| 90834-3 | Myelin Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 74754-3 | Blood group antigens present [Identifier] in Blood by Immediate spin |
| 91797-1 | Parvovirus B19 DNA [#/volume] (viral load) in Upper respiratory specimen by NAA with probe detection |
| 92712-9 | Lipoprotein.beta.subparticle.very small-d [Moles/volume] in Serum |
| 7568-9 | Parsley IgG Ab [Units/volume] in Serum |
| 61182-2 | Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood from Fetus |
| 75814-4 | Antihistamines panel - Serum or Plasma or Urine by Screen method |
| 92953-9 | Staphylococcus aureus DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection |
| 93368-9 | Summary of interaction between genetic variants [Interpretation] in Blood or Tissue Narrative |
| 6130-9 | Goose meat IgE Ab [Units/volume] in Serum |
| 77041-2 | inv(3)(q21;q26.2)+t(3;3)(q21;q26.2)(PSMD2,MECOM) fusion transcript in Blood or Tissue by FISH |
| 63082-2 | Cayenne IgG Ab [Mass/volume] in Serum |
| 6402-2 | Ehrlichia chaffeensis IgM Ab [Presence] in Serum by Immunoassay |
| 79262-2 | Methamphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 95084-0 | C peptide [Mass/volume] in Serum or Plasma --2 hours post meal |
| 95154-1 | PRRSV ORF5 gene sequence homology to Prime Pac in Isolate by Sequencing |
| 6629-0 | Schistosoma sp Ab [Presence] in Serum by Immunoassay |
| 6653-0 | Meropenem [Susceptibility] by Disk diffusion (KB) |
| 670-0 | Microscopic observation [Identifier] in Specimen by Methenamine silver nitrate stain |
| 79593-0 | Allocystathionine/Creatinine [Molar ratio] in Urine |
| 95851-2 | Somatotropin post macimorelin stimulation panel - Serum by Immunoassay |
| 6868-4 | Adenosine monophosphate.cyclic [Mass/volume] in Urine |
| 80973-1 | Trimethoprim free [Mass/volume] in Serum or Plasma |
| 70067-4 | Polymorphonuclear cells/100 leukocytes in Pleural fluid by Automated count |
| 70074-0 | Angiotensin II [Mass/volume] in Plasma --supine |
| 82046-4 | Epidermal Allergen Mix 2 (Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 82210-6 | Astrovirus subtypes 1-8 RNA [Presence] in Stool by NAA with non-probe detection |
| 70091-4 | Prostaglandin E2 [Mass/volume] in Cerebral spinal fluid |
| 70251-4 | Pyruvate dehydrogenase IgG Ab [Units/volume] in Serum by Immunoassay |
| 7114-2 | Barley IgG Ab [Units/volume] in Serum |
| 714-6 | Eosinophils/100 leukocytes in Blood by Manual count |
| 8251-1 | Service comment |
| 98200-9 | Paraphenylenediamine IgE Ab [Units/volume] in Serum |
| 99390-7 | Progesterone [Moles/volume] in Ovarian aspirate |
| 72817-0 | AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
| 86232-6 | Norsufentanil [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 73193-5 | Procainamide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73839-3 | 11-Dehydrotetrahydrocorticosterone [Moles/volume] in 24 hour Urine |
| 882-1 | ABO and Rh group [Type] in Blood |
| 88224-1 | Neisseria gonorrhoeae DNA [Presence] in Anorectal by NAA with probe detection |
| 88625-9 | Cytomegalovirus [Presence] in Ocular fluid by Organism specific culture |
| 5981-6 | Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay |
| 42665-0 | Dantron [Mass/mass] in Stool |
| 42909-2 | Hemoglobin.gastrointestinal [Presence] in Gastric fluid --1st specimen |
| 42950-6 | Toxocara canis Ab [Titer] in Specimen |
| 32080-4 | HYDROcodone [Presence] in Specimen |
| 22993-0 | Chlamydophila psittaci [Presence] in Placenta by Electron microscopy |
| 23104-3 | Equine influenza virus A2 Ag [Titer] in Specimen by Hemagglutination inhibition |
| 44481-0 | Herpes simplex virus 1+2 IgG Ab [Presence] in Cerebral spinal fluid |
| 44635-1 | Invasive component size.maximum dimension [Length] in Breast tumor |
| 44790-4 | Iodide [Mass/volume] in Specimen |
| 23607-5 | Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria |
| 53745-6 | Benzodiazepines panel - Urine |
| 4508-8 | Complement C7 [Mass/volume] in Serum or Plasma |
| 54243-1 | Influenza virus RNA [Identifier] in Specimen by Probe |
| 24181-0 | Coxsackievirus B2 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24190-1 | Coxsackievirus B4 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24220-6 | Parainfluenza virus 2 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 55381-8 | Glucose [Moles/volume] in Serum or Plasma --2.5 hours post 75 g glucose PO |
| 35143-7 | PCA-2 Ab [Titer] in Cerebral spinal fluid |
| 47626-7 | Glutamate/Amino acids.total in Amniotic fluid |
| 25703-0 | Jujube IgE Ab [Units/volume] in Serum |
| 25840-0 | Herpes simplex virus 2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 2589-0 | Lysozyme [Mass/volume] in Serum or Plasma |
| 35711-1 | Chlamydia sp DNA [Presence] in Anal by NAA with probe detection |
| 57013-5 | Phosphoserine/Creatinine [Ratio] in 24 hour Urine |
| 48365-1 | Methadone.R [Moles/volume] in Serum or Plasma |
| 48821-3 | t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
| 49060-7 | Fondaparinux [Mass/volume] in Serum or Plasma |
| 279-0 | Imipenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 39300-9 | Influenza virus A H13 Ab [Titer] in Serum by Hemagglutination inhibition |
| 57933-4 | Cheese mold type IgE Ab/IgE total in Serum |
| 49524-2 | Influenza virus A H3 RNA [Presence] in Specimen by NAA with probe detection |
| 49733-9 | Interleukin 10 [Mass/volume] in Body fluid |
| 29310-0 | Treponema pallidum [Presence] in Specimen by Immunofluorescence |
| 40035-8 | Glucose [Mass/volume] in Serum or Plasma --4.5 hours post XXX challenge |
| 40198-4 | Glucose [Moles/volume] in Serum or Plasma --2 minutes post XXX challenge |
| 58644-6 | Cortisol [Mass/volume] in Saliva (oral fluid) --12 PM specimen |
| 2989-2 | Testosterone [Mass/time] in 24 hour Urine |
| 5900-6 | Prothrombin Fragment 1.2 [Units/volume] in Serum or Plasma |
| 59008-3 | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 59165-1 | Carbon dioxide [Partial pressure] in Dialysis fluid |
| 50322-7 | MLH-1 Ag [Presence] in Tissue by Immune stain |
| 30331-3 | Dodecanoylcarnitine (C12) [Moles/volume] in Serum or Plasma |
| 19221-1 | Oxygen content in Mixed venous blood |
| 19544-6 | Mescaline cutoff [Mass/volume] in Urine for Screen method |
| 20940-3 | Phosphide [Mass/mass] in Feed |
| 21023-7 | Neutrophil cytoplasmic Ab [Titer] in Serum |
| 21046-8 | 7-Aminoflunitrazepam [Mass/volume] in Serum or Plasma |
| 100984-4 | HIV 1 group M RNA genotype [Identifier] by Genotype method |
| 100994-3 | B-cell CD19 and CD20 subsets panel - Blood by Flow cytometry (FC) |
| 12624-3 | Glucose [Mass/volume] in Serum or Plasma --12th specimen post XXX challenge |
| 13313-2 | IgM IgM Ab [Units/volume] in Serum or Plasma |
| 101811-8 | 2,6-dimethylaniline [Presence] in Urine by Confirmatory method |
| 102207-8 | Carrot IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13581-4 | Theophylline [Mass/volume] in Cerebral spinal fluid |
| 102538-6 | Pork IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14266-1 | Methoxyflurane [Mass/volume] in Blood |
| 102903-2 | Palo verde IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103131-9 | Staphylococcus aureus enterotoxin E IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103742-3 | Viral Susceptibility multigene analysis in Specimen by Molecular genetics method |
| 16968-0 | Hexokinase 3 [Enzymatic activity/volume] in Red Blood Cells |
| 17891-3 | Bacteria # 5 identified in Nose by Aerobe culture |
| 18307-9 | Ova and parasites identified in Stool by Iron hematoxylin stain |
| 1861-4 | Angiotensinogen [Mass/volume] in Plasma |
| 1869-7 | Apolipoprotein A-I [Mass/volume] in Serum or Plasma |
| 911-8 | B Ab [Presence] in Serum or Plasma from Blood product unit |
| 75371-5 | Bartlett score of Sputum Qualitative by Light microscopy |
| 60417-3 | Parainfluenza virus 2 RNA [Presence] in Isolate by NAA with probe detection |
| 77016-4 | Fetal RhD antigen in Plasma cell-free DNA by MS.MALDI-TOF |
| 77627-8 | HBB gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
| 93917-3 | K Ag [Presence] on Red Blood Cells --after transfusion reaction |
| 94266-4 | CD11a, CD11b, and CD18 phenotyping panel - Blood Qualitative |
| 63328-9 | RNA polymerase III Ab [Presence] in Serum by Immunoassay |
| 78795-2 | Arsenic [Moles/mass] in Tissue |
| 642-9 | Microscopic observation [Identifier] in Gastric fluid by Acid fast stain.Ziehl-Neelsen |
| 79205-1 | Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose arginine+insulin |
| 6695-1 | Riboflavin [Mass/volume] in Blood |
| 80425-2 | Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in DBS |
| 95921-3 | Hydroxychloroquine [Mass/volume] in Blood |
| 9620-6 | Lipoprotein.beta [Mass/volume] in Pleural fluid |
| 80709-9 | CD27-CD45RA+ cells/100 CD3+CD4+ cells in Blood |
| 8080-4 | Myelin IgG Ab [Units/volume] in Serum |
| 70209-2 | Haptoglobin [Moles/volume] in Serum or Plasma |
| 70281-1 | t(9;9)(q34;q34)(NUP214,SET) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 7141-5 | White Bean IgG Ab [Units/volume] in Serum |
| 82728-7 | Natural killer cell cytotoxicity.50:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
| 97977-3 | Peanut recombinant (rAra h) 9 IgG4 Ab [Mass/volume] in Serum |
| 97983-1 | Timothy recombinant (rPhl p) 1 IgG4 Ab [Mass/volume] in Serum |
| 98184-5 | Acetylcysteine IgE Ab [Units/volume] in Serum |
| 99060-6 | Cerebroventricular lining cells/100 leukocytes in Cerebral spinal fluid |
| 72421-1 | Vancomycin resistance vanB gene [Presence] by Molecular method |
| 84924-0 | PCA-1 Ab [Presence] in Serum by Immunofluorescence |
| 99109-1 | Pseudoephedrine [Presence] in Urine by Screen method |
| 99513-4 | Weight of Lung - left |
| 86106-2 | Streptococcus pneumoniae Danish serotype 4 Ab [Units/volume] in Serum |
| 86164-1 | Streptococcus pneumoniae Danish serotype 9N Ab [Mass/volume] in Serum |
| 73330-3 | Ipratropium induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86740-8 | Streptococcus suis Ag [Presence] in Specimen by Immune stain |
| 87458-6 | Mean diameter [Length] of Feed particles |
| 87760-5 | N-nortramadol/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 73446-7 | Cimetidine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88220-9 | Hantavirus puumala RNA [Presence] in Blood by NAA with probe detection |
| 74377-3 | Baclofen [Mass/volume] in Unknown substance |
| 59326-9 | Salvinorin A [Mass/volume] in Serum or Plasma |
| 51012-3 | BCLXL cells/100 cells in Specimen |
| 41853-3 | Orthopoxvirus DNA [Presence] in Specimen by NAA with probe detection |
| 4238-2 | Estazolam [Mass] of Dose |
| 4255-6 | fentaNYL [Mass] of Dose |
| 21140-9 | Carbophenothion [Mass/volume] in Urine |
| 21268-8 | Fenchlorphos [Mass/volume] in Urine |
| 5154-0 | Epstein Barr virus early Ab [Presence] in Serum by Immunofluorescence |
| 43804-4 | Amino acid pattern [Interpretation] in Cerebral spinal fluid |
| 32212-3 | Salmonella paratyphi A Ab [Titer] in Serum |
| 32513-4 | CD3+CD25+ cells [#/volume] in Specimen |
| 43898-6 | Beta hydroxybutyrate [Presence] in 24 hour Urine |
| 23045-8 | Eastern equine encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
| 44640-1 | Histologic type in Skin melanoma |
| 44873-8 | HIV 1+2 Ab [Presence] in Serum by Immunoblot |
| 23868-3 | Hantavirus sin nombre IgM Ab [Titer] in Serum |
| 33915-0 | Anabasine [Mass/volume] in Urine |
| 33989-5 | quiNINE induced platelet Ab [Presence] in Serum |
| 34211-3 | 11-Hydroxyetiocholanolone [Moles/volume] in Urine |
| 46089-9 | Leukocytes [#/volume] in Cerebral spinal fluid --3rd tube |
| 46951-0 | Fluorometholone [Mass/volume] in Urine |
| 2445-5 | Hydroxyproline [Presence] in Serum or Plasma |
| 34643-7 | Lopinavir [Susceptibility] by Phenotype method |
| 55167-1 | Mycoplasma sp Ab [Presence] in Cerebral spinal fluid |
| 55318-0 | Fungus [Presence] in Bronchial specimen by KOH preparation |
| 47034-4 | Neurofilament Ag [Presence] in Tissue by Immune stain |
| 47204-3 | glipiZIDE [Presence] in Urine |
| 34719-5 | Cytomegalovirus DNA [Presence] in Amniotic fluid by NAA with probe detection |
| 3475-1 | Chlorprothixene [Mass/volume] in Blood |
| 55817-1 | Amino acids [Moles/mass] in Hair |
| 55825-4 | Allo-tetrahydrocorticosterone [Mass/volume] in 24 hour Urine |
| 47914-7 | Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose TRH |
| 35648-5 | C reactive protein [Quintile] in Serum or Plasma by High sensitivity method |
| 35689-9 | GBA gene c.84insG [Presence] in Blood or Tissue by Molecular genetics method |
| 56225-6 | Clam IgG4 Ab [Mass/volume] in Serum |
| 26488-7 | Monocytes/100 leukocytes in Peritoneal fluid |
| 26666-8 | Chlamydia trachomatis H Ab [Presence] in Serum |
| 35876-2 | Rickettsia sp IgM Ab [Units/volume] in Serum |
| 36925-6 | MEFV gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 57-0 | Capreomycin [Susceptibility] by Disk diffusion (KB) |
| 48356-0 | Prazepam [Moles/volume] in Serum or Plasma |
| 48633-2 | Trypsinogen I Free [Mass/volume] in DBS |
| 4909-8 | HLA-Dw4 [Presence] |
| 2784-7 | Phosphatidylcholine.saturated [Mass/volume] in Amniotic fluid |
| 39603-6 | Guinea pig epithelium IgE Ab/IgE total in Serum |
| 57785-8 | Dehydroepiandrosterone (DHEA) [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
| 5799-2 | Leukocyte esterase [Presence] in Urine by Test strip |
| 49465-8 | CD14 Ag [Presence] in Tissue by Immune stain |
| 4956-9 | HLA-DR13(6) [Presence] in Donor |
| 4974-2 | HLA-DR8 [Presence] in Donor |
| 29370-4 | cloZAPine [Mass/volume] in Serum or Plasma --trough |
| 5873-5 | Parainfluenza virus 3 Ag [Presence] in Specimen by Immunofluorescence |
| 40608-2 | Ascaris lumbricoides IgM Ab [Units/volume] in Serum by Immunoassay |
| 40732-0 | HIV 1 IgG Ab [Presence] in Serum by Immunoblot |
| 50336-7 | Beta cortolone/Cortisol [Mass Ratio] in Urine |
| 50343-3 | Ethanol [Presence] in Saliva (oral fluid) by Screen method |
| 40752-8 | Epstein Barr virus early IgG Ab [Presence] in Serum by Immunoassay |
| 40769-2 | Ethosuximide [Mass/volume] in Serum or Plasma --peak |
| 19229-4 | Bicarbonate [Moles/volume] in Mixed venous blood |
| 20878-5 | Bacteria identified in Isolate by Anaerobe culture |
| 1234-4 | Mi sup(a) Ag [Presence] on Red Blood Cells |
| 100671-7 | Aspergillus sp DNA [Presence] in Blood by NAA with probe detection |
| 12557-5 | Cortisol [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 101656-7 | Lactate and pyruvate panel - Serum, Plasma or Blood |
| 101676-5 | VIM Carbapenemase [Presence] in Isolate by Rapid immunoassay |
| 102168-2 | Green Bean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102358-9 | Haddock IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102644-2 | Vanilla IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102895-0 | Cochineal extract IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14914-6 | Testosterone Free [Moles/volume] in Serum or Plasma |
| 15085-4 | Oxalate [Moles/volume] in Serum or Plasma |
| 15502-8 | Pseudorabies virus Omnimark gene deletion Ab [Presence] in Serum by Immunoassay |
| 16142-2 | Fat [Mass/time] in 24 hour Stool |
| 16306-3 | 3-Methylhistidine [Presence] in Urine |
| 16392-3 | Nuclear Ab [Presence] in Serum by Rodent substrate |
| 16584-5 | Chlamydophila pneumoniae rRNA [Presence] in Sputum by Probe |
| 12293-7 | Cotinine [Presence] in Urine |
| 16762-7 | Dichlorobenzene [Mass/volume] in Blood |
| 16939-1 | Heptachlor [Mass/volume] in Urine |
| 18216-2 | Dezocine [Presence] in Urine by Confirmatory method |
| 18304-6 | IgM [Presence] in Urine by Immunofixation |
| 18426-7 | Aspergillus sp Ab [Presence] in Cerebral spinal fluid |
| 18998-5 | Trimethoprim+Sulfamethoxazole [Susceptibility] |
| 19137-9 | Neuronal nuclear Ab [Units/volume] in Serum by Immunoblot |
| 90925-9 | HBB gene full mutation analysis in Amniotic fluid or Chorionic villus sample by Sequencing |
| 74992-9 | Amylase [Enzymatic activity/volume] in Saliva (oral fluid) |
| 92004-1 | Spinal muscular atrophy newborn screen interpretation |
| 75022-4 | Fat.microscopic observation [Presence] in Urine sediment by Oil red O stain |
| 75641-1 | Electrolytes 3 panel - Cerebral spinal fluid |
| 60347-2 | Viable CD34 cells [#/volume] in Body fluid |
| 6097-0 | Dandelion IgE Ab [Units/volume] in Serum |
| 76351-6 | Methotrexate polyglutamates [Moles/volume] in Red Blood Cells |
| 76767-3 | Schistosoma sp identified in Semen by Light microscopy |
| 92992-7 | FGA, FGB, and FGG gene full mutation analysis in Blood or Tissue by Sequencing |
| 93357-2 | Monotypic plasma cell identification and risk stratification panel - Bone marrow by Molecular genetics method |
| 7734-7 | Tapioca IgG Ab [Units/volume] in Serum |
| 94270-6 | Coenzyme Q10 [Moles/mass] in Leukocytes |
| 63280-2 | Mitochondria Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 78816-6 | Carisoprodol+Meprobamate [Presence] in Blood by Confirmatory method |
| 94489-2 | Lysosomal storage disorders panel - Leukocytes |
| 78865-3 | Naltrexol cutoff [Mass/volume] in Urine for Confirmatory method |
| 79474-3 | 3,4-Dihydroxybutyrate/Creatinine [Molar ratio] in Urine |
| 95282-0 | PARK2 gene deletion and duplication mutation analysis in Blood or Tissue by Molecular genetics method |
| 95539-3 | Human papilloma virus 31 DNA [Presence] in Cervix by NAA with probe detection |
| 65755-1 | Rectum Pathology biopsy report |
| 96425-4 | Cortisol/Cortisone [Mass Ratio] in DBS |
| 68928-1 | Cytokeratin 19 [Mass/volume] in Cerebral spinal fluid |
| 9651-1 | metOLazone [Mass/volume] in Urine |
| 96660-6 | HLA-DQB1 unresolved alleles [Type] in Donor by High resolution |
| 97015-2 | Maximum amplitude tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited [Length] in Blood |
| 69362-2 | PCA3 score in Urine Qualitative by Molecular genetics method |
| 69429-9 | Metabolic rate --resting |
| 97519-3 | Blastomyces sp Ab band pattern [Identifier] in Specimen by Immune diffusion (ID) |
| 70156-5 | inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [Log Number Ratio] in Blood or Tissue |
| 70199-5 | Bilirubin.total [Moles/volume] in Urine |
| 82675-0 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection |
| 72171-2 | Glucose tolerance 2 hours panel - Serum or Plasma |
| 73014-3 | Gentamicin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73296-6 | Loratadine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73442-6 | Citalopram induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87781-1 | ARIPiprazole/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 89577-1 | Troponin I.cardiac panel - Serum or Plasma by High sensitivity method |
| 89655-5 | Virus identified in Tissue by Shell vial culture |
| 41672-7 | cefoTEtan+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 5949-3 | aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma |
| 59798-9 | Ganciclovir [Mass/volume] in Plasma --peak |
| 50897-8 | pH of 24 hour Urine by Test strip |
| 30459-2 | Platelet mean diameter [Entitic length] in Blood |
| 30523-5 | Mycobacterium sp DNA [Presence] in Urine by NAA with probe detection |
| 21391-8 | Microscopic observation [Identifier] in Bone by Acid phosphatase stain |
| 31277-7 | Burkholderia pseudomallei IgM Ab [Units/volume] in Specimen |
| 51214-5 | CD10 cells/100 cells in Tissue |
| 51227-7 | CD11b cells/100 cells in Tissue |
| 42923-3 | Firebush IgE Ab/IgE total in Serum |
| 43194-0 | Gamma hydroxybutyrate [Mass/volume] in Serum or Plasma by Confirmatory method |
| 22093-9 | Infectious bronchitis virus Conn-42 Ab [Titer] in Serum |
| 22150-7 | Brucella abortus Ab [Titer] in Serum |
| 51674-0 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 51925-6 | Nevirapine [Mass/volume] in Serum or Plasma --peak |
| 43618-8 | Adenovirus Ab [Presence] in Serum by Complement fixation |
| 22402-2 | Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum |
| 52127-8 | Megaloblasts/100 cells in Bone marrow |
| 52815-8 | Nucleated cells [#/volume] in Pericardial fluid by Automated count |
| 4417-2 | Pseudoephedrine [Mass] of Dose |
| 32773-4 | CD24 cells [Presence] in Blood |
| 32786-6 | Thyroperoxidase Ab [Titer] in Serum or Plasma |
| 53078-2 | Dodecanoylcarnitine (C12) [Moles/volume] in Cerebral spinal fluid |
| 53139-2 | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood |
| 53337-2 | 17-Hydroxyprogesterone+Androstenedione/Cortisol [Molar ratio] in DBS |
| 44844-9 | Bacteria # 4 identified in Specimen by Culture |
| 44853-0 | Bacteria # 3 identified in Specimen by Anaerobe culture |
| 23978-0 | Borrelia burgdorferi IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 45382-9 | Epidermis Ab [Presence] in Serum |
| 46156-6 | Ascaris lumbricoides larva IgG Ab [Units/volume] in Serum |
| 4638-3 | Thermolabile hemoglobin/Hemoglobin.total in Red Blood Cells |
| 24242-0 | Toxoplasma gondii IgG Ab [Units/volume] in Serum --1st specimen |
| 24311-3 | Mycoplasma pneumoniae Ab [Titer] in Serum --2nd specimen |
| 34298-0 | Estrone (E1) [Moles/time] in 24 hour Urine |
| 56124-1 | Glucose [Mass/volume] in Urine --1 hour post meal |
| 25756-8 | Rotavirus IgM Ab [Units/volume] in Serum by Immunoassay |
| 35617-0 | Meperidine [Mass/volume] in Serum or Plasma by Screen method |
| 35747-5 | Hydrogen ion [Moles/volume] in Arterial blood |
| 56198-5 | Brazil Nut IgG4 Ab [Mass/volume] in Serum |
| 48063-2 | Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool by Immunoassay |
| 48243-0 | Penicillium notatum triggered leukotriene release [Mass/volume] by Leukocytes |
| 26063-8 | European tick borne encephalitis virus IgM Ab [Units/volume] in Serum |
| 3807-5 | Methylphenidate [Mass/volume] in Serum or Plasma |
| 38236-6 | CD3+TCR gamma delta+ cells/100 cells in Specimen |
| 56695-0 | Cephalexin IgE Ab [Units/volume] in Serum |
| 5698-6 | Molybdenum [Mass/volume] in Serum or Plasma |
| 57089-5 | Eosinophil cationic protein (ECP) [Mass/volume] in Nasal fluid |
| 4855-3 | HLA-Cw3 [Presence] |
| 48794-2 | Fibrosis stage |
| 4882-7 | HLA-Dw17(w7) [Presence] in Donor |
| 269-1 | Gentamicin [Susceptibility] by Serum bactericidal titer |
| 57441-8 | Toxoplasma gondii DNA [Presence] in Body fluid by NAA with probe detection |
| 57526-6 | 17-Hydroxycorticosteroids [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
| 49173-8 | Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Serum |
| 27993-5 | Sympathomimetics [Mass/volume] in Urine |
| 3896-8 | Oxymesterone [Mass/time] in 24 hour Urine |
| 3911-5 | Penicillin [Mass/volume] in Serum or Plasma |
| 39564-0 | Corticotropin [Mass/volume] in Plasma --1st specimen post XXX challenge |
| 57954-0 | Darunavir [Mass/volume] in Serum or Plasma |
| 49401-3 | Herpes virus 7 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
| 49468-2 | CD27 Ag [Presence] in Tissue by Immune stain |
| 29157-5 | Lutropin/Creatinine [Ratio] in 24 hour Urine |
| 29220-1 | Haptoglobin [Mass/volume] in Body fluid |
| 58630-5 | Corticotropin [Moles/volume] in Plasma --pre XXX challenge |
| 29722-6 | Chlamydophila pneumoniae Ag [Presence] in Specimen by Immunofluorescence |
| 50175-9 | Alloisoleucine [Moles/volume] in Body fluid |
| 50269-0 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --4 days post dose ifosfamide |
| 40838-5 | Argininosuccinate [Moles/volume] in Cerebral spinal fluid |
| 19189-0 | Cancer Ag 549 [Units/volume] in Serum or Plasma |
| 19195-7 | Prostate specific Ag [Units/volume] in Serum or Plasma |
| 19540-4 | Mephobarbital cutoff [Mass/volume] in Urine for Screen method |
| 20631-8 | Activated T cells lymphocytes/100 lymphocytes.small in Blood |
| 100398-7 | Goose meat IgG Ab [Units/volume] in Serum |
| 101138-6 | ER^a Ab [Presence] in Serum or Plasma |
| 101154-3 | Calprotectin [Mass/volume] in Serum or Plasma |
| 101192-3 | 5F-MDMB-PICA [Presence] in Urine by Confirmatory method |
| 101392-9 | ADA gene full mutation analysis in Blood or Tissue by Molecular genetics method |
| 101510-6 | Porcine DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 101516-3 | Salmonella dublin Ab in Specimen by Immunoassay |
| 12979-1 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --24 hour specimen |
| 102203-7 | Starfruit IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13471-8 | Cadmium/Creatinine [Mass Ratio] in Urine |
| 13479-1 | Benzoylecgonine/Creatinine [Mass Ratio] in Urine |
| 13771-1 | Metanephrines/Creatinine [Mass Ratio] in Urine |
| 13902-2 | Urate [Mass/volume] in Cerebral spinal fluid |
| 102328-2 | Goat milk IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14025-1 | HTLV I+II p36 Ab [Presence] in Serum by Immunoblot |
| 14209-1 | Francisella tularensis IgA Ab [Presence] in Serum |
| 14261-2 | Codeine [Presence] in Gastric fluid |
| 14648-0 | Chylomicrons [Moles/volume] in Serum or Plasma |
| 10374-7 | Helmet cells [Presence] in Blood by Light microscopy |
| 104073-2 | Multiple sulfatase deficiency enzymes panel - Leukocytes |
| 15050-8 | Creatinine [Moles/volume] in Amniotic fluid |
| 10578-3 | Glycerophosphocholine [Moles/volume] in Seminal plasma |
| 15461-7 | Bovine leukemia virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 10754-0 | Fat.microscopic observation [Identifier] in Tissue by Sudan IV stain |
| 16257-8 | Sodium urate crystals [Presence] in Stone by Infrared spectroscopy |
| 12207-7 | Cryoglobulin [Presence] in Serum by 1 week cold incubation |
| 1718-6 | Acyl CoA dehydrogenase [Enzymatic activity/volume] in Serum |
| 17486-2 | Progesterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 18372-3 | Potassium [Moles/time] in 6 hour Urine |
| 74696-6 | Magnesium [Moles/volume] in 12 hour Urine |
| 74844-2 | Baylisascaris sp IgG Ab [Presence] in Serum by Immunoassay |
| 92527-1 | little k Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 75083-6 | Aconitate [Moles/volume] in Serum or Plasma |
| 75384-8 | PMP22 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
| 76624-6 | Mitochondrial respiratory chain enzyme analysis [Interpretation] in Fibroblast Narrative |
| 93333-3 | Glycodeoxycholate [Moles/volume] in Serum or Plasma |
| 93395-2 | Klebsiella pneumoniae DNA [Presence] by NAA with probe detection in Positive blood culture |
| 61239-0 | Paprika IgE Ab/IgE total in Serum |
| 77337-4 | Trimipramine+Nortrimipramine [Moles/volume] in Specimen |
| 6242-2 | Sesame Seed IgE Ab [Units/volume] in Serum |
| 63152-3 | Bermuda grass IgG Ab [Mass/volume] in Serum |
| 94302-7 | Vortioxetine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 7893-1 | Gliadin Ab [Units/volume] in Serum |
| 95642-5 | Snowshoe hare virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 68369-8 | Nuclear Ab [Presence] in Pericardial fluid by Immunofluorescence |
| 96667-1 | HLA-DRB1 unresolved alleles [Type] by High resolution |
| 6948-4 | lamoTRIgine [Mass/volume] in Serum or Plasma |
| 70020-3 | Bacteroides fragilis DNA [Presence] in Blood by NAA with probe detection |
| 70285-2 | t(11;19)(q23;p13.1)(MLL,ELL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 82984-6 | GABABR IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 98401-3 | Yeast [Morphology] in Isolate by Light microscopy |
| 71679-5 | Eosinophils/Leukocytes [Pure number fraction] in Blood by Automated count |
| 72281-9 | Days in therapeutic INR range/Days INR result determined [Ratio] |
| 83075-2 | Alpha-1-Fetoprotein [Mass/volume] in Amniotic fluid by Immunoassay |
| 99369-1 | Cocksfoot IgG Ab [Mass/volume] in Serum |
| 72975-6 | Penicillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86571-7 | Influenza virus B RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 73067-1 | Amiodarone induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7325-4 | Fusarium moniliforme IgG Ab [Units/volume] in Serum |
| 87356-2 | Actinobacillus pleuropneumoniae serotype 12 Ab/Positive control in Serum by Immunoassay |
| 73622-3 | Faropenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 73752-8 | Reagin and Treponema pallidum IgG and IgM [Interpretation] in Serum or Plasma |
| 41684-2 | Cephaloridine [Susceptibility] by Gradient strip |
| 59637-9 | clonazePAM [Mass/volume] in Blood by Confirmatory method |
| 50928-1 | Uranium [Moles/volume] in Urine |
| 42242-8 | Ethanol [Presence] in Urine by Screen method |
| 60219-3 | Coenzyme Q10/Protein [Molar ratio] in Tissue |
| 60273-0 | Rotavirus RNA [Presence] in Isolate by NAA with probe detection |
| 21116-9 | Borrelia burgdorferi 66kD IgM Ab [Presence] in Serum by Immunoblot |
| 21509-5 | Saint Louis encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 22258-8 | Eastern equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid |
| 51691-4 | Opiates [Presence] in Blood by Screen method |
| 433-3 | Ristocetin [Susceptibility] by Disk diffusion (KB) |
| 43755-8 | Casts [#/area] in Urine sediment by Automated count |
| 22344-6 | Heterophile Ab after absorption [Titer] in Serum |
| 5275-3 | PCNA extractable nuclear Ab [Presence] in Serum by Immunoassay |
| 22891-6 | Bovine diarrhea virus Ab [Titer] in Serum |
| 23143-1 | Infectious bursal disease virus Ag [Presence] in Bursa of Fabricius by Immune diffusion (ID) |
| 53316-6 | Leukocytes [Presence] in Urine by Automated |
| 44418-2 | Vanillylmandelate/Creatine [Mass Ratio] in 24 hour Urine |
| 3325-8 | aMILoride [Mass/time] in 24 hour Urine |
| 33306-2 | Phosphatidate Ab [Presence] in Serum |
| 33393-0 | Coarse Granular Casts [#/area] in Urine sediment by Microscopy low power field |
| 53843-9 | Basement membrane zone BP230 IgG Ab [Units/volume] in Serum or Plasma |
| 33874-9 | EPINEPHrine/Creatinine [Molar ratio] in Urine collected for unspecified duration |
| 34160-2 | Creatine kinase [Presence] in Body fluid |
| 54240-7 | Influenza virus Ag [Presence] in Specimen |
| 54273-8 | Glucose [Moles/volume] in Serum or Plasma --3 hours post dose ornithine alpha-ketoglutarate |
| 46265-5 | Cryofibrinogen [Presence] in Plasma by 1 week cold incubation |
| 46268-9 | ABO and Rh group [Type] in Blood from Blood product unit--after transfusion reaction |
| 24404-6 | Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid by Immunoblot |
| 34606-4 | Minocycline [Mass/volume] in Cerebral spinal fluid |
| 55154-9 | Ethambutol+rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria |
| 55555-7 | Molybdenum [Moles/volume] in Blood |
| 47276-1 | Complement Sc5b-9 Ab [Presence] in Serum or Plasma |
| 35303-7 | Glucosylceramidase [Enzymatic activity/mass] in Specimen |
| 25642-0 | Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --1st specimen post XXX challenge |
| 25895-4 | Dehydroepiandrosterone (DHEA) [Moles/volume] in 24 hour Urine |
| 35384-7 | Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method |
| 56170-4 | Alternaria alternata IgG4 Ab [Mass/volume] in Serum |
| 56200-9 | Broccoli IgG4 Ab [Mass/volume] in Serum |
| 56212-4 | Cauliflower IgG4 Ab [Mass/volume] in Serum |
| 56321-3 | Common Millet IgG4 Ab [Mass/volume] in Serum |
| 26555-3 | Glucose [Mass/volume] in Serum or Plasma --3.5 hours post dose glucose |
| 26647-8 | Semliki Forest virus Ab [Presence] in Serum |
| 38157-4 | Parathyrin.intact [Mass/volume] in Serum or Plasma --5 minutes post excision |
| 56606-7 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --pre XXX challenge |
| 48421-2 | C reactive protein [Mass/volume] in Capillary blood |
| 26982-9 | CD4+CD25+ cells [#/volume] in Blood |
| 27250-0 | Phenmetrazine [Mass/volume] in Vitreous fluid |
| 49284-3 | Oligosaccharides pattern [Interpretation] in Urine Narrative |
| 29243-3 | Thiodiglycolate [Mass/volume] in Urine |
| 29351-4 | Rheumatoid factor [Presence] in Cerebral spinal fluid |
| 29407-4 | Nortriptyline [Mass/volume] in Gastric fluid |
| 40232-1 | Calcium [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 49991-3 | Borrelia burgdorferi 18/20kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 40734-6 | HLA Ab [Units/volume] in Serum |
| 58844-2 | Somatotropin [Mass/volume] in Serum or Plasma --20th specimen |
| 30025-1 | Coumaphos [Mass/volume] in Serum or Plasma |
| 30061-6 | Aspartate/Creatinine [Ratio] in Urine |
| 41154-6 | Giardia lamblia IgG Ab [Presence] in Serum |
| 12375-2 | cloZAPine+Norclozapine [Mass/volume] in Serum or Plasma |
| 100056-1 | Panipenem [Susceptibility] |
| 13040-1 | C peptide [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 101926-4 | Connective tissue growth factor [Mass/volume] in Serum by Immunoassay |
| 14211-7 | Hepatitis E virus IgG Ab [Presence] in Serum |
| 103008-9 | Ficus sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14961-7 | CD10 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 104309-0 | Ribociclib [Mass/volume] in Serum or Plasma |
| 104473-4 | Yersinia pseudotuberculosis 2 Ab [Presence] in Stool |
| 16479-8 | Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 11250-8 | Phenylethylmalonate [Mass/volume] in Serum or Plasma |
| 12299-4 | Ethinamate [Presence] in Urine |
| 17192-6 | CD72 cells/100 cells in Blood |
| 17894-7 | Bacteria # 3 identified in Sputum by Aerobe culture |
| 90327-8 | Porcine circovirus type 2d DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 7495-5 | Mite dust IgE Ab [Units/volume] in Serum |
| 91819-3 | Bacteria identified in Upper respiratory specimen by Aerobe culture |
| 75048-9 | Tetrahydrofolate [Moles/volume] in Cerebral spinal fluid |
| 76133-8 | Sugar absorption test panel [Molar ratio] - 5 hour Urine |
| 76141-1 | Reticulocyte corpuscular hemoglobin concentration mean [Mass/volume] in Blood |
| 61380-2 | Human papilloma virus 45 DNA [Presence] in Specimen by NAA with probe detection |
| 77383-8 | Influenza virus A Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
| 7803-0 | Acanthamoeba sp Ab [Presence] in Serum |
| 94341-5 | Glial nuclear type 1 IgG Ab [Titer] in Serum by Immunofluorescence |
| 94471-0 | VEGFA gene c.-1154A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 78990-9 | Flavin adenine dinucleotide [Moles/volume] in Serum or Plasma |
| 79497-4 | 3-Hydroxybenzoate [Moles/volume] in Serum or Plasma |
| 95409-9 | SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with probe detection |
| 7965-7 | Mumps virus Ab [Units/volume] in Serum |
| 8007-7 | Rickettsia typhi IgG Ab [Units/volume] in Serum |
| 96303-3 | Cryptococcus gattii+neoformans DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 6813-0 | Echovirus 16 Ab [Titer] in Serum by Complement fixation |
| 81110-9 | Leptospira weilii serovar Topaz Ab [Titer] in Serum by Agglutination |
| 96958-4 | SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N2 |
| 97204-2 | Oxidants [Mass/volume] in Urine |
| 69558-5 | Ma1 Ab [Presence] in Serum by Immunoblot |
| 6960-9 | Yersinia enterocolitica O:5 Ab [Titer] in Serum |
| 69918-1 | Thrombin time.high dose in Platelet poor plasma by Coagulation assay |
| 81623-1 | Calcium oxalate [Energy Difference] in 24 hour Urine |
| 9764-2 | Coxsackievirus B6 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 70143-3 | Cannabinoids [Mass/volume] in Urine by Screen method |
| 7232-2 | Clam IgG Ab [Units/volume] in Serum |
| 72478-1 | Synthetic cannabinoids panel - Urine by Confirmatory method |
| 85085-9 | Centrosomal nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
| 99385-7 | Hepatitis B virus surface Ag [log units/volume] in Serum or Plasma by Immunoassay |
| 99762-7 | Clot angle.kaolin induced in Blood by Resonance TEG |
| 99891-4 | Microorganism casts [Presence] in Urine sediment by Computer assisted method |
| 99965-6 | ASXL1 gene exon 13 full mutation analysis in Blood or Tissue by Sequencing |
| 86031-2 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 73016-8 | Gabapentin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73129-9 | Tamsulosin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73384-0 | Fenofibrate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87399-2 | Porcine teschovirus [Presence] in Specimen by Organism specific culture |
| 73699-1 | Number of prior CCHD screens [#] Qualitative |
| 87937-9 | Bacteria identified in Cerebral spinal fluid by Anaerobe culture |
| 87960-1 | Enterovirus RNA [Presence] in Body fluid by NAA with probe detection |
| 74035-7 | Abnormal Prion Protein [Identifier] in Tissue by Immune stain |
| 89575-5 | Troponin T.cardiac [Interpretation] in Serum or Plasma Qualitative by High sensitivity method |
| 41184-3 | Warfarin [Presence] in Serum or Plasma |
| 59462-2 | Clinical biochemist review of results |
| 59658-5 | diazePAM [Mass/mass] in Meconium by Confirmatory method |
| 59690-8 | Hydroxytriazolam [Mass/volume] in Blood |
| 59710-4 | Midazolam [Mass/volume] in Body fluid by Confirmatory method |
| 59765-8 | Tungsten [Mass/volume] in Blood |
| 50691-5 | Coxsackievirus A9+B1+B2+B3+B4+B5+B6 Ab [Titer] in Serum by Complement fixation |
| 50778-0 | Cancer Ag 15-3 [Units/volume] in Peritoneal fluid |
| 4249-9 | Etilefrine [Mass] of Dose |
| 6002-0 | Platelet factor 4 [Units/volume] in Platelet poor plasma |
| 21645-7 | CACNA1S gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 51062-8 | Cytoplasmic CD13 blasts/100 blasts in Blood |
| 22108-5 | Babesia sp IgM Ab [Units/volume] in Serum |
| 43821-8 | Amylase [Presence] in 24 hour Urine |
| 22347-9 | Histoplasma capsulatum Ab [Titer] in Serum |
| 3228-4 | Coagulation factor XI Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 52983-4 | Echinococcus sp IgG4 Ab [Units/volume] in Serum by Immunoassay |
| 52986-7 | Rubella virus IgG Ab avidity [Ratio] in Serum by Immunoassay |
| 4431-3 | Sulfamethoxazole [Mass] of Dose |
| 44369-7 | Hexokinase [Presence] in Plasma |
| 32651-2 | Ethion [Mass/volume] in Serum or Plasma |
| 53252-3 | Parainfluenza virus 1 RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 53376-0 | Hepatitis C virus IgM Ab [Units/volume] in Serum |
| 53922-1 | Thyroglobulin [Mass/volume] in Tissue fine needle aspirate |
| 45138-5 | Listeria monocytogenes O4b IgG Ab [Titer] in Serum |
| 23716-4 | Feline coronavirus Ab [Presence] in Serum by Immunoassay |
| 33751-9 | Surgical margin tumor involvement.lateral in Specimen by CAP cancer protocols |
| 3393-6 | Benzoylecgonine [Presence] in Urine |
| 33954-9 | Immune complex.IgG [Mass/volume] in Serum or Plasma |
| 33983-8 | U1 small nuclear ribonucleoprotein IgG Ab [Units/volume] in Serum |
| 54316-5 | Methylmalonylcarnitine (C4-DC)/Creatinine [Molar ratio] in Urine |
| 24172-9 | Polio virus 2 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen |
| 24353-5 | Glucose tolerance 2 hours gestational panel - Urine and Serum or Plasma |
| 24427-7 | Mycobacterium avium ss paratuberculosis [Presence] in Specimen by Organism specific culture |
| 34626-2 | 2-Methylcitrate [Moles/volume] in Amniotic fluid |
| 55135-8 | BCR-ABL1 kinase domain mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 47501-2 | Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum --1st specimen |
| 55832-0 | Cathepsin K [Moles/volume] in Serum or Plasma |
| 25951-5 | Lutropin [Units/volume] in Serum or Plasma by 1st IRP --9th specimen post XXX challenge |
| 25962-2 | Nickel/Creatinine [Molar ratio] in 24 hour Urine |
| 56201-7 | Brussel Sprouts IgG4 Ab [Mass/volume] in Serum |
| 56293-4 | Italian Cypress IgG4 Ab [Mass/volume] in Serum |
| 56352-8 | Pear IgG4 Ab [Mass/volume] in Serum |
| 26466-3 | Leukocytes [#/volume] in Body fluid |
| 56881-6 | Rickettsia typhi IgG Ab [Presence] in Serum by Immunofluorescence |
| 48860-1 | Rickettsia akari IgM Ab [Titer] in Serum by Immunofluorescence |
| 26924-1 | Cancer Ag 19-9 [Units/volume] in Body fluid |
| 26979-5 | Flurazepam [Mass/mass] in Meconium |
| 57445-9 | Spermatozoa Progressive Grade 1/100 spermatozoa in Semen --post concentration |
| 5755-4 | Vanadium [Mass/volume] in Red Blood Cells |
| 27277-3 | Methamphetamine [Mass/volume] in Vitreous fluid |
| 27340-9 | Cholesterol in HDL [Presence] in Serum or Plasma |
| 27865-5 | Follitropin [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 57762-7 | CD55+CD59 cells [Presence] in Blood by Agglutination |
| 4948-6 | HLA-DQ9(3) [Presence] in Donor |
| 40217-2 | Glucose [Moles/volume] in Serum or Plasma --28 hours post XXX challenge |
| 50131-2 | 3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Cerebral spinal fluid |
| 29961-0 | Asialoganglioside GM1 IgG Ab [Mass/volume] in Serum by Immunoassay |
| 40395-6 | Phentermine [Presence] in Gastric fluid |
| 40536-5 | Neutrophils/100 leukocytes in Peritoneal dialysis fluid by Manual count |
| 4056-8 | Timolol [Mass/volume] in Serum or Plasma |
| 19614-7 | N-desalkylflurazepam [Presence] in Urine by Screen method |
| 20460-2 | Cefuroxime Oral [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 12435-4 | Naphthalene [Mass/volume] in Serum or Plasma |
| 100105-6 | Filaria IgG and IgM panel - Serum |
| 12748-0 | Insulin [Mass/volume] in Serum or Plasma --4.5 hours post XXX challenge |
| 101285-5 | Pharyngeal pathogens DNA and RNA panel - Throat by NAA with non-probe detection |
| 12989-0 | Allyl alcohol [Mass/volume] in Serum or Plasma |
| 102142-7 | Red Imported Fire Ant IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102575-8 | Wild Rice IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14080-6 | Brucella canis IgM Ab [Titer] in Serum by Immunofluorescence |
| 102823-2 | Summer Squash IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14426-1 | Globulin [Mass/volume] in Cerebral spinal fluid |
| 14687-8 | Transfusion date |
| 104405-6 | Giardia lamblia trophozoites [Presence] in Stool by Microscopy |
| 10643-5 | Amoeba identified in Stool by Organism specific culture |
| 10664-1 | Filaria identified in Blood by Thin film |
| 16203-2 | ALPRAZolam [Presence] in Urine by Confirmatory method |
| 11089-0 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid |
| 16561-3 | Catecholamines [Mass/volume] in Plasma --6th specimen post XXX challenge |
| 16631-4 | aPTT in Blood by Coagulation 1:1 saline |
| 12247-3 | Pyruvate [Mass/volume] in Serum or Plasma |
| 16798-1 | Echovirus 14 Ab [Units/volume] in Serum |
| 17126-4 | CD24 cells/100 cells in Blood |
| 17232-0 | Lysozyme [Enzymatic activity/volume] in Tear |
| 17431-8 | PENTobarbital [Mass/volume] in Gastric fluid |
| 18956-3 | Norfloxacin [Susceptibility] |
| 1900-0 | Arylamidase [Enzymatic activity/volume] in Serum |
| 74474-8 | Middle East respiratory syndrome coronavirus (MERS-CoV) upE gene RNA [Presence] in Specimen by NAA with probe detection |
| 74475-5 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Interpretation] in Specimen Qualitative by NAA with probe detection |
| 91849-0 | Mycoplasma genitalium DNA [Presence] in Genital specimen by NAA with probe detection |
| 92639-4 | O-nortramadol [Mass/volume] in Urine by Confirmatory method |
| 60440-5 | Oseltamivir [Susceptibility] by Genotype method |
| 6098-8 | Dog dander IgE Ab [Units/volume] in Serum |
| 93480-2 | Cortisol post CRH stimulation panel - Serum or Plasma |
| 61417-2 | Imipramine/Creatinine [Mass Ratio] in Urine |
| 77766-4 | clonazePAM cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 63469-1 | Ganglioside GT1b IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 6438-6 | Influenza virus A+B Ag [Presence] in Specimen by Immunofluorescence |
| 95126-9 | Lipid and glucose panel - Serum or Plasma |
| 79689-6 | Allopurinol [Moles/volume] in Cerebral spinal fluid |
| 81121-6 | Murray Valley encephalitis virus Ab [Presence] in Serum |
| 6972-4 | 2,6 toluenediamine [Mass/volume] in Urine |
| 69820-9 | 2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --6 days post dose ifosfamide |
| 70284-5 | t(11;17)(q23;q21.1)(ZBTB16,RARA) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 97992-2 | Herpes virus 6 IgM Ab [Presence] in Serum by Immunofluorescence |
| 99017-6 | Enterococcus faecalis DNA [Presence] in Urine by NAA with probe detection |
| 99085-3 | Napsin A Ag [Presence] in Tissue by Immune stain |
| 85382-0 | Osmolarity in Tear |
| 73008-5 | Lansoprazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87710-0 | Rotavirus C VP7 gene [Nucleotide sequence] in Isolate by Sequencing |
| 88164-9 | Toxoplasma gondii DNA [Presence] in Ocular fluid by NAA with probe detection |
| 88628-3 | Human coronavirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 89661-3 | Microscopic observation [Identifier] in Upper respiratory specimen by Acid fast stain |
| 41443-3 | Enterocytozoon bieneusi DNA [Presence] in Specimen by NAA with probe detection |
| 50939-8 | Zinc [Moles/mass] in Hair |
| 60055-1 | Astemizole [Mass/volume] in Body fluid |
| 21071-6 | Antimony [Mass/volume] in 24 hour Urine |
| 31214-0 | Actinobacillus pleuropneumoniae serotype 5 Ab [Presence] in Serum |
| 51079-2 | CD14 blasts [Units/volume] in Specimen |
| 43051-2 | Colorado tick fever virus IgG Ab [Presence] in Serum |
| 3163-3 | Volume of 72 hour Stool |
| 31639-8 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Units/volume] in Serum --2nd specimen |
| 31857-6 | Infectious bursal disease virus Ag [Presence] in Specimen |
| 3187-2 | Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay |
| 434-1 | Ristocetin [Susceptibility] by Serum bactericidal titer |
| 22575-5 | Toxocara canis IgG Ab [Units/volume] in Serum |
| 32094-5 | Methanol [Moles/volume] in Specimen |
| 52954-5 | Cannabinoids [Moles/volume] in Urine |
| 43930-7 | Yersinia enterocolitica Ab [Presence] in Cerebral spinal fluid |
| 44090-9 | Escherichia coli O157:H7 [Presence] in Isolate by Organism specific culture |
| 22810-6 | Infectious bronchitis virus RNA [Presence] in Specimen by NAA with probe detection |
| 22982-3 | Capripox virus Ab [Presence] in Serum |
| 32702-3 | Muscle sarcolemma Ab [Presence] in Serum |
| 53299-4 | Calcium phosphate crystals [#/volume] in Urine by Computer assisted method |
| 23288-4 | Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Complement fixation |
| 23555-6 | Vesicular stomatitis virus Ab [Presence] in Serum |
| 53784-5 | Legionella pneumophila 1+2+3+4+5+6 IgM Ab [Titer] in Serum |
| 23958-2 | Dengue virus IgG Ab [Units/volume] in Serum |
| 33886-3 | Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --2H post incubation with 1:4 normal plasma |
| 33892-1 | aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --immediately after 1:4 addition of normal plasma |
| 24247-9 | Polio virus 3 Ab [Titer] in Serum --1st specimen |
| 2507-2 | Isoleucine [Presence] in Serum or Plasma |
| 34456-4 | Powassan virus RNA [Presence] in Blood by NAA with probe detection |
| 3458-7 | chlordiazePOXIDE [Presence] in Urine |
| 55226-5 | Pancreatic polypeptide [Moles/volume] in Serum or Plasma |
| 47192-0 | Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 47383-5 | Nuclear Ab [Presence] in Serum by Immunoassay |
| 3502-2 | Clostebol [Presence] in Urine |
| 55892-4 | Hypoxanthine phosphoribosyltransferase/Adenine phosphoribosyltransferase [Enzymatic activity ratio] in Amniotic fluid cells |
| 35500-8 | Pesticide and Insecticide panel [Mass/volume] - Urine |
| 3553-5 | Dibenzepin [Mass/volume] in Blood |
| 35599-0 | carBAMazepine [Mass/volume] in Serum or Plasma by Screen method |
| 48136-6 | Aspartate aminotransferase.macromolecular [Enzymatic activity/volume] in Serum or Plasma |
| 48297-6 | Chromotrope 2B triggered leukotriene release [Mass/volume] by Leukocytes |
| 26556-1 | CD103 cells/100 cells in Specimen |
| 35830-9 | Pirlimycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 3708-5 | Methotrimeprazine [Mass/volume] in Urine |
| 56623-2 | Echovirus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 48390-9 | B cell crossmatch [Presence] in Blood from Donor |
| 4853-8 | HLA-Cw2 [Presence] |
| 48677-9 | Cancer Ag 125 [Presence] in Tissue by Immune stain |
| 268-3 | Gentamicin [Susceptibility] by Disk diffusion (KB) |
| 26860-7 | Morphine [Mass/mass] in Meconium |
| 27198-1 | Bilirubin.total [Units/volume] in Amniotic fluid by Spectrophotometry direct |
| 27212-0 | DOPamine [Mass/volume] in 24 hour Urine |
| 38279-6 | Lymphocyte proliferation stimulated by 2.5 ug/mL Candida albicans [Units/volume] in Blood |
| 39777-8 | Urea [Moles/volume] in Serum or Plasma --pre dialysis |
| 40142-2 | Creatinine [Moles/volume] in Urine --4.5 hours post XXX challenge |
| 49924-4 | Alkaline phosphatase.macro/Alkaline phosphatase.total in Serum or Plasma |
| 50208-8 | Glucose [Mass/volume] in Serum or Plasma --10th specimen |
| 50560-2 | pH of Urine by Automated test strip |
| 4103-8 | Acebutolol [Mass] of Dose |
| 20645-8 | Histidine [Moles/volume] in Serum or Plasma |
| 100099-1 | Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot |
| 12502-1 | Allobarbital [Presence] in Stool |
| 12770-4 | Lead [Mass/mass] in Tissue |
| 101427-3 | Shigella sp DNA [Presence] in Stool by NAA with probe detection |
| 13187-0 | False ragweed IgG Ab [Units/volume] in Serum |
| 13207-6 | Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid by Immunoblot |
| 102121-1 | Bacteria.extended spectrum beta lactamase (ESBL) [Presence] in Stool based on lab data |
| 102155-9 | Avocado IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102176-5 | Beef IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13753-9 | Hexanoylglycine/Creatinine [Mass Ratio] in Urine |
| 102578-2 | Rye IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102808-3 | Orange roughy IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102879-4 | Lactoglobulin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102988-3 | Red dye IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15074-8 | Glucose [Moles/volume] in Blood |
| 104357-9 | Borrelia recurrentis DNA [Presence] in Specimen by Sequencing |
| 10665-8 | Fungus colony count [#/volume] in Specimen by Environmental culture |
| 10779-7 | Microscopic observation [Identifier] in Tissue by Carmine stain.Best |
| 16523-3 | Calcium [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge |
| 16648-8 | Copper [Mass/volume] in Body fluid |
| 11280-5 | Cabot rings [Presence] in Blood by Light microscopy |
| 90358-3 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Anorectal by NAA with probe detection |
| 90991-1 | Protein electrophoresis and M protein isotype panel - Serum or Plasma |
| 74977-0 | Transferrin [Mass/time] in 24 hour Urine |
| 91900-1 | Parasite [Presence] in Blood by Light microscopy |
| 76648-5 | Palladium [Mass/mass] in Hair |
| 92873-9 | Herpes simplex virus 2 DNA [Presence] in Blood by NAA with probe detection |
| 93686-4 | Psychosine [Moles/volume] in Cerebral spinal fluid |
| 61424-8 | Noroxycodone [Presence] in Urine by Confirmatory method |
| 77143-6 | Carbon dioxide, total [Moles/volume] in Serum, Plasma or Blood |
| 93739-1 | Red cabbage IgE Ab [Units/volume] in Serum |
| 78437-1 | FLUoxetine trough, FLUoxetine+norfluoxetine trough and Norfluoxetine panel - Serum or Plasma |
| 78536-0 | Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid --2 hour dwell specimen |
| 78834-9 | Hydroxylurasidone cutoff [Mass/volume] in Urine for Confirmatory method |
| 94766-3 | SARS-CoV-2 (COVID-19) N gene [Presence] in Serum or Plasma by NAA with probe detection |
| 63406-3 | Smith extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 6496-4 | Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid by Immunoassay |
| 79133-5 | 9-Hydroxyrisperidone [Mass/volume] in Body fluid |
| 65346-9 | Glucagon [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 95847-0 | Somatotropin [Mass/volume] in Serum by Immunoassay --90 minutes post dose macimorelin |
| 9626-3 | Propoxyphene + Norpropoxyphene [Mass/volume] in Serum or Plasma |
| 81176-0 | Distance of tumor from circumferential resection margin [Length] in Specimen by Macroscopy |
| 97105-1 | Chemokine (C-C motif) ligand 2 [Mass/volume] in Urine by Immunoassay |
| 82054-8 | Food Allergen Mix 12 (Mushroom+Pumpkin+Rice+Rye+Potato) IgE Ab [Units/volume] in Serum by Multidisk |
| 97626-6 | Neisseria gonorrhoeae DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 71635-7 | Neutrophils/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
| 98059-9 | Gilt-head bream IgE Ab [Units/volume] in Serum |
| 71672-0 | Monocytes/Leukocytes [Pure number fraction] in Blood by Manual count |
| 71783-5 | Yellow fever virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test |
| 72306-4 | Nicotinurate [Mass/volume] in Serum or Plasma |
| 99-2 | Cefoperazone [Susceptibility] by Minimum lethal concentration (MLC) |
| 73056-4 | Atenolol induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73503-5 | Bivalirudin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73637-1 | Plazomicin [Susceptibility] by Disk diffusion (KB) |
| 87946-0 | Borrelia sp identified in Tissue by Organism specific culture |
| 74111-6 | Brodifacoum [Presence] in Specimen by Screen method |
| 74309-6 | PRRSV ORF5 gene sequence homology to Ingelvac MLV in Isolate by Sequencing |
| 5973-3 | Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis |
| 50791-3 | Hemoglobin pattern [Interpretation] in Blood by Electrophoresis acid (pH 6.0) |
| 50973-7 | CD38+CD138+ cells [#/volume] in Blood |
| 4-2 | Almecillin [Susceptibility] by Disk diffusion (KB) |
| 4211-9 | Desethylamiodarone [Mass] of Dose |
| 42196-6 | Centromere Ab [Titer] in Serum |
| 42240-2 | CHD7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 21263-9 | Estradiol (E2) [Mass/time] in 24 hour Urine |
| 31268-6 | Borrelia burgdorferi IgG Ab [Presence] in Specimen |
| 51072-7 | CD135 blasts [Units/volume] in Bone marrow |
| 51370-5 | CD8+HLA-DR+ cells/100 cells in Tissue |
| 21792-7 | t(8;14)(q24;q32)(MYC,IGH) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 31747-9 | Bovine herpesvirus 1 Ag [Units/volume] in Specimen |
| 3192-2 | Coagulation factor V activated [Units/volume] in Platelet poor plasma by Coagulation assay |
| 32049-9 | Amobarbital [Presence] in Specimen |
| 432-5 | Ristocetin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 3221-9 | Coagulation factor X Ag actual/normal in Platelet poor plasma by Immunoassay |
| 32341-0 | Transcobalamin II [Moles/volume] in Serum |
| 44303-6 | Beta-2-Microglobulin/Creatinine [Mass Ratio] in 24 hour Urine |
| 22979-9 | Caprine herpesvirus 1 Ab [Presence] in Serum |
| 32608-2 | cloZAPine [Mass] of Dose |
| 44702-9 | Complement C1q Ab [Units/volume] in Serum |
| 23578-8 | Rabbit hemorrhagic disease virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 33589-3 | Phosphatidylinositol Ab [Units/volume] in Serum by Immunoassay |
| 53495-8 | Iron [Moles/volume] in Urine --post dose deferoxamine |
| 24169-5 | Polio virus 1 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen |
| 55221-6 | Carbohydrates [Presence] in Stool |
| 55420-4 | Hours after meal [Time] |
| 25114-0 | 2-Methylcitrate/Creatinine [Molar ratio] in Urine |
| 35314-4 | Lipase [Enzymatic activity/volume] in Body fluid --4th specimen post Sincalide |
| 55803-1 | Promyelocytes [#] in Cerebral spinal fluid by Manual count |
| 47723-2 | Phenylalanine/Amino acids.total in Amniotic fluid |
| 47792-7 | Tyrosine/Amino acids.total in Hair |
| 25712-1 | Leptospira interrogans sv Pomona Ab [Titer] in Serum by Complement fixation |
| 35360-7 | Triglyceride in Lipoprotein a [Mass/volume] in Serum or Plasma |
| 48247-1 | White Oak triggered leukotriene release [Mass/volume] by Leukocytes |
| 4833-0 | HLA-B44(12) [Presence] |
| 261-8 | Fusidate [Susceptibility] by Minimum lethal concentration (MLC) |
| 56765-1 | Oligoclonal Bands IgM [Presence] in Cerebral spinal fluid by Isoelectric focusing |
| 57093-7 | Cyclic citrullinated peptide IgA+IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 26814-4 | IgG.monoclonal [Mass/volume] in Serum |
| 27044-7 | 1-Methylhistidine [Moles/volume] in Urine |
| 4915-5 | HLA-Dw7 [Presence] |
| 39315-7 | Influenza virus A N5 neutralizing antibody [Presence] in Serum by Neutralization test |
| 582-7 | Streptococcus agalactiae [Presence] in Genital specimen by Organism specific culture |
| 49541-6 | Fasting status - Reported |
| 2903-3 | Pyrimidine-5'-Nucleotidase [Enzymatic activity/volume] in Blood |
| 58379-9 | fentaNYL+Norfentanyl [Presence] in Urine by Screen method |
| 49866-7 | Neuropeptide Y [Mass/volume] in Serum |
| 49989-7 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Body fluid by NAA with probe detection |
| 40323-8 | Glucose [Moles/volume] in Serum or Plasma --2 hours post dose triple bolus |
| 40917-7 | Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 19758-2 | Silk waste IgE Ab [Units/volume] in Serum |
| 100111-4 | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot |
| 100981-0 | Parvovirus B19 DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
| 1279-9 | P Ab [Presence] in Serum or Plasma |
| 101364-8 | Francisella tularensis DNA [Presence] in Blood by NAA with non-probe detection |
| 101388-7 | GP1BB full mutation analysis in Blood or Tissue by Molecular genetics method |
| 101539-5 | Tyrosine [Interpretation] in Plasma |
| 1328-4 | U Ag [Presence] on Red Blood Cells |
| 103051-9 | Codeine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14458-4 | Virus identified in Sputum by Culture |
| 14950-0 | Viscosity of Synovial fluid Qualitative |
| 16864-1 | Fibrinopeptide B beta (1-42) Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 1768-1 | Aldosterone [Mass/volume] in Serum or Plasma --upright |
| 18855-7 | 5-Fluorocytosine [Susceptibility] |
| 90360-9 | Trimethylamine N-oxide [Moles/volume] in Serum or Plasma by LC/MS/MS |
| 91808-6 | Microscopic observation [Identifier] in Upper respiratory specimen by Gram stain |
| 92791-3 | Candida auris DNA [Presence] by NAA with probe detection in Positive blood culture |
| 75069-5 | Hippurate [Moles/volume] in Serum or Plasma |
| 92853-1 | Adenovirus and Bocavirus DNA panel - Upper respiratory specimen by NAA with probe detection |
| 9316-1 | Western equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 61220-0 | Ascaris sp IgE Ab/IgE total in Serum |
| 62384-3 | Flanking normal region after end |
| 77674-0 | Gastrin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 63129-1 | Curry IgG Ab [Mass/volume] in Serum |
| 63215-8 | Cathepsin G Ab [Units/volume] in Serum by Immunoassay |
| 78843-0 | JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
| 94311-8 | SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N1 |
| 6505-2 | Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 79247-3 | Methylenedioxymethamphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 95271-3 | Bicarbonate [Moles/volume] in Body fluid --post secretin |
| 96407-2 | Pancreatic polypeptide [Mass/volume] in Serum or Plasma --30M post sham feeding |
| 680-9 | Microscopic observation [Identifier] in Specimen by Wet preparation |
| 6809-8 | Aspergillus fumigatus 6 Ab [Presence] in Serum by Immune diffusion (ID) |
| 69853-0 | 3-Hydroxyisobutyrate [Moles/volume] in Serum or Plasma |
| 70033-6 | Ragocytes/100 leukocytes in Synovial fluid by Manual count |
| 97971-6 | Conalbumin IgG4 Ab [Mass/volume] in Serum |
| 70103-7 | Methotrexate [Moles/volume] in Serum or Plasma --6th specimen |
| 70909-7 | Cryptococcus sp Ag [Presence] in Tissue by Immune stain |
| 71387-5 | Spermatozoa Motile [#] in Semen --post ejaculate |
| 99015-0 | Citrobacter koseri DNA [Presence] in Urine by NAA with probe detection |
| 72158-9 | Apo-transcobalamin I [Moles/volume] in Serum |
| 83059-6 | KRAS gene [VCF] in Cancer specimen by Sequencing |
| 99114-1 | Semliki Forest virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 72990-5 | Metoprolol induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73224-8 | OXcarbazepine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87586-4 | Tylvalosin [Mass/mass] in Specimen |
| 7360-1 | Gramma grass (Bouteloua gracilis) IgE Ab [Units/volume] in Serum |
| 73962-3 | Candida sp rRNA [Identifier] by FISH in Positive blood culture |
| 89-3 | Cefmetazole [Susceptibility] by Disk diffusion (KB) |
| 59878-9 | Chloral hydrate [Moles/volume] in Gastric fluid |
| 50935-6 | Vanadium [Moles/volume] in Red Blood Cells |
| 30471-7 | levETIRAcetam [Mass/volume] in Serum or Plasma |
| 30924-5 | Arsenic [Mass/volume] in Urine collected for unspecified duration |
| 31232-2 | Aspergillus niger Ab [Presence] in Body fluid |
| 31579-6 | Purkinje cells Ab [Units/volume] in Cerebral spinal fluid |
| 21673-9 | F8 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 21730-7 | PSAP gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 31850-1 | Herpes simplex virus 2 Ag [Presence] in Skin |
| 31990-5 | 14-3-3 Ag [Units/volume] in Cerebral spinal fluid |
| 5285-2 | Polio virus 3 neutralizing antibody [Titer] in Serum by Neutralization test |
| 44371-3 | Histamine/Creatinine [Molar ratio] in Urine |
| 44390-3 | Imipramine [Presence] in Specimen |
| 53123-6 | Potassium [Moles/time] in 1 hour Urine |
| 23280-1 | Mycoplasma meleagridis Ab [Presence] in Serum by Hemagglutination |
| 23611-7 | Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria |
| 33391-4 | Coxsackievirus A8 Ab [Units/volume] in Serum |
| 3339-9 | Amobarbital [Presence] in Urine |
| 33618-0 | Coproporphyrin 3/Coproporphyrin 1 [Mass Ratio] in 24 hour Stool |
| 53856-1 | DYSF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 4524-5 | Complement membrane attack complex (C5b-C6-C7-C8-C9n) [Mass/volume] in Plasma |
| 54322-3 | Octanoylcarnitine (C8) [Moles/volume] in Amniotic fluid |
| 2431-5 | Homocystine [Mass/volume] in Urine |
| 24432-7 | IgG.canine [Mass/volume] in Serum by Immune diffusion (ID) |
| 34376-4 | Strongyloides sp IgG Ab [Units/volume] in Serum by Immunoassay |
| 34706-2 | CFTR gene c.3199del6 [Presence] in Blood or Tissue by Molecular genetics method |
| 54477-5 | Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Cerebral spinal fluid |
| 54900-6 | IgA [Mass/volume] in Peritoneal fluid |
| 4744-9 | HLA-B41 [Presence] in Donor |
| 25142-1 | 5-Fluorocytosine [Mass/volume] in Serum or Plasma --peak |
| 25189-2 | Ciprofloxacin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 55815-5 | Dehydroepiandrosterone (DHEA) [Mass/volume] in 24 hour Urine |
| 47660-6 | Insulin [Units/volume] in Serum or Plasma --2.5 hours post dose glucose |
| 4788-6 | HLA-B w6 [Presence] in Donor |
| 25910-1 | Ethanolamine [Moles/volume] in 24 hour Urine |
| 35704-6 | Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid |
| 56310-6 | Lobster IgG4 Ab [Mass/volume] in Serum |
| 26446-5 | Blasts/100 leukocytes in Blood |
| 26537-1 | Glucose [Presence] in Urine by Test strip --2.5 hours post dose glucose |
| 56660-4 | Methyl formamide/Creatinine [Ratio] in Urine |
| 48818-9 | Karyotype [Identifier] in Blood or Tissue by High resolution Nominal |
| 3862-0 | Nordoxepin [Mass/volume] in Serum or Plasma |
| 57414-5 | Reticulin Ab [Presence] in Serum by Immunofluorescence |
| 57577-9 | Androstanolone [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin |
| 49302-3 | Protein Fractions [Interpretation] in Specimen by Immunofixation Narrative |
| 2793-8 | Phosphofructokinase F subunit/Phosphofructokinase.total in Platelets |
| 49364-3 | Hepatitis B virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
| 40088-7 | Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --baseline |
| 58751-9 | Treponema pallidum IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 49820-4 | 3-Hydroxyadipate/Creatinine [Molar ratio] in 24 hour Urine |
| 29955-2 | Legionella pneumophila IgG Ab [Units/volume] in Serum by Immunoassay |
| 40736-1 | La Crosse virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 58887-1 | Pyruvate [Mass/volume] in Blood --15 minutes post XXX challenge |
| 58900-2 | HIV 1+2 Ab+HIV1 p24 Ag [Units/volume] in Serum or Plasma by Immunoassay |
| 41061-3 | SDHD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19391-2 | Chlorpheniramine [Mass/volume] in Urine by Confirmatory method |
| 19742-6 | Hexahydrophthalic anhydride (HHPA) IgE Ab [Units/volume] in Serum |
| 2061-0 | Cerebroside sulfatase [Enzymatic activity/volume] in Urine |
| 100350-8 | Sesamum indicum 1 IgE Ab [Units/volume] in Serum |
| 100902-6 | Enterobacteriaceae.carbapenemase resistance phenotype.OXA-48 [Identifier] in Anal by Organism specific culture |
| 101831-6 | Beclomethasone dipropionate [Moles/volume] in Serum or Plasma |
| 14302-4 | Packed erythrocytes units available [#] |
| 102885-1 | Saffron IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14638-1 | Calculus analysis [Interpretation] in Stone |
| 15218-1 | Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Presence] in Serum by Multidisk |
| 15457-5 | Bordetella avium Ab [Titer] in Serum by Agglutination |
| 16122-4 | Colorado tick fever virus IgM Ab [Titer] in Serum |
| 1645-1 | Xylose [Mass/volume] in Blood --2 hours post 25 g xylose PO |
| 18391-3 | Paraldehyde [Mass/volume] in Urine |
| 74861-6 | Chromosome 17 copy number/nucleus in Tissue by FISH |
| 75041-4 | Pyridoxal [Moles/volume] in Serum or Plasma |
| 75116-4 | Decanoate (C10:0) [Entitic substance] in Red Blood Cells |
| 7539-0 | Oat triggered histamine release [Units/volume] in Blood |
| 61109-5 | Mitochondria DNA complex V targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 9348-4 | pH free acid of Gastric fluid |
| 61340-6 | Cottonseed IgE Ab/IgE total in Serum |
| 7867-5 | Echovirus 3 Ab [Units/volume] in Serum |
| 94388-6 | Neuronal nuclear type 2 IgG Ab [Presence] in Cerebral spinal fluid by Line blot |
| 63389-1 | Extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 6407-1 | Francisella tularensis IgM Ab [Presence] in Serum by Latex agglutination |
| 78963-6 | Mannose-6-phosphate isomerase [Enzymatic activity/mass] in Leukocytes |
| 94868-7 | Ganglioside GD1b IgG Ab [Presence] in Serum by Immunoassay |
| 95107-9 | Glucose [Mass/volume] in Serum or Plasma --4.5 hours post meal |
| 80203-3 | HIV 1 and 2 Ab [Identifier] in Serum, Plasma or Blood by Rapid immunoassay |
| 68406-8 | Abnormal lymphocytes/100 leukocytes in Vitreous fluid by Manual count |
| 8116-6 | CD19 cells [#/volume] in Blood |
| 9706-3 | Coxiella burnetii phase 1 IgA Ab [Titer] in Serum |
| 69727-6 | Tissue transglutaminase IgA + Gliadin peptides IgA and IgG [Interpretation] in Serum Narrative |
| 69796-1 | 17-Hydroxyprogesterone [Moles/volume] in Amniotic fluid |
| 82035-7 | Tree Allergen Mix 6 (Boxelder+Silver birch+American beech+White oak+California walnut) IgE Ab [Units/volume] in Serum by Multidisk |
| 71605-0 | Lymphocytes/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count |
| 82562-0 | Food Allergen Mix 76 (Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Units/volume] in Serum by Multidisk |
| 82583-6 | Wheat native (nTri a) 19+20+21 IgE Ab [Units/volume] in Serum |
| 82938-2 | Smith extractable nuclear D IgG Ab [Units/volume] in Serum |
| 98395-7 | Color.candida colony [Type] in Isolate by Culture |
| 99025-9 | Providencia rettgeri DNA [Presence] in Urine by NAA with probe detection |
| 71712-4 | Ebola virus IgM Ab [Presence] in Serum by Immunoassay |
| 71791-8 | Metanephrines [Moles/volume] in 24 hour Urine |
| 71829-6 | Hematocrit [Pure volume fraction] of Venous blood |
| 85506-4 | PTEN gene mutations found [Identifier] in Colorectal cancer specimen by Molecular genetics method Nominal |
| 73205-7 | Pioglitazone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73251-1 | Nafcillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87726-6 | Cytomegalovirus IgG Ab [Presence] in Serum or Plasma from Donor by Immunoassay |
| 73510-0 | Azithromycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73639-7 | Omadacycline [Susceptibility] by Disk diffusion (KB) |
| 88700-0 | Babesia microti IgG and IgM [Interpretation] in Serum |
| 88720-8 | Mycoplasma pneumoniae DNA [Presence] in Nasopharynx by NAA with probe detection |
| 88914-7 | Acanthamoeba sp DNA [Presence] in Tissue by NAA with probe detection |
| 41512-5 | Varicella zoster virus IgG Ab [Presence] in Serum by Immunofluorescence |
| 4173-1 | Chloramphenicol [Mass] of Dose |
| 59571-0 | Triglyceride [Moles/time] in 24 hour Urine |
| 42981-1 | Polio virus 1 Ab [Titer] in Body fluid |
| 43030-6 | Herpes simplex virus 1+2 IgM Ab [Units/volume] in Serum |
| 43189-0 | Baker's yeast IgA Ab [Titer] in Serum |
| 22241-4 | Cytomegalovirus Ab [Titer] in Serum or Plasma |
| 31820-4 | Equine infectious anemia virus Ag [Presence] in Specimen |
| 3189-8 | Coagulation factor IX Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 22499-8 | Measles virus Ab [Titer] in Serum |
| 53017-0 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum |
| 22909-6 | Bovine herpesvirus 1 Ag [Presence] in Specimen by Immune stain |
| 32706-4 | Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Urine |
| 44504-9 | Herpes simplex virus Ab [Presence] in Body fluid by Immunofluorescence |
| 5370-2 | Streptolysin O Ab [Units/volume] in Serum or Plasma |
| 5385-0 | Thyrotropin receptor Ab [Units/volume] in Serum |
| 340-0 | Miocamycin [Susceptibility] by Disk diffusion (KB) |
| 34178-4 | Phenothiazines [Presence] in Specimen |
| 54308-2 | Isovalerylglycine [Moles/volume] in Cerebral spinal fluid |
| 2475-2 | Indicans [Mass/volume] in Urine |
| 34296-4 | Estrogen/Creatinine [Molar ratio] in Urine |
| 55544-1 | hydrOXYzine [Moles/volume] in Serum or Plasma |
| 25103-3 | Glutaconate/Creatinine [Molar ratio] in Urine |
| 25174-4 | Amikacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 55604-3 | Microscopic observation [Identifier] in Endometrium by Cyto stain |
| 55644-9 | Cefotaxime+Sulbactam [Susceptibility] by Gradient strip |
| 5602-8 | Borate [Mass/volume] in Serum or Plasma |
| 47725-7 | Phenylalanine/Amino acids.total in Specimen |
| 47897-4 | Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose TRH |
| 35365-6 | Vitamin D+Metabolites [Mass/volume] in Serum or Plasma |
| 35379-7 | HNPCC genes mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 35504-0 | Para aminobenzoate in 6 hour Urine --6 hours post XXX bentiromide PO |
| 3561-8 | Digitoxin>6h post dose [Mass/volume] in Serum or Plasma |
| 56534-1 | Calcitonin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 47955-0 | EYA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 48135-8 | Acadesine [Presence] in Urine |
| 48246-3 | Olive Pollen triggered leukotriene release [Mass/volume] by Leukocytes |
| 35812-7 | Garenoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 56916-0 | Coxiella burnetii IgM Ab [Units/volume] in Serum by Immunofluorescence --2nd specimen |
| 383-0 | Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 57638-9 | Androsterone [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
| 57680-1 | Chlamydia sp IgG Ab [Presence] in Serum by Immunoassay --2nd specimen |
| 57839-3 | Activated clotting time.kaolin induced of Platelet poor plasma from Control |
| 4949-4 | HLA-DQ9(3) [Presence] |
| 49712-3 | Coccidioides sp Ab [Presence] in Serum by Latex agglutination |
| 2897-7 | Protoporphyrin [Presence] in Red Blood Cells |
| 2944-7 | Sialate [Mass/volume] in Urine |
| 4979-1 | HLA-DR2 [Presence] |
| 40435-0 | Fungus identified in Urine by Culture |
| 30003-8 | Microalbumin [Mass/volume] in 24 hour Urine |
| 30292-7 | Indinavir [Susceptibility] by Genotype method |
| 19424-1 | Dextromethamphetamine [Presence] in Urine by Confirmatory method |
| 20988-2 | Zinc phosphide [Mass/mass] in Gastrointestinal content |
| 100118-9 | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot |
| 101167-5 | Metonitazene/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 101426-5 | Respiratory syncytial virus B RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 12933-8 | Thyrotropin [Units/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 102096-5 | HLA-DQA1 SSO panel - Blood or Tissue by NAA with probe detection |
| 1022-3 | Fy sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 13476-7 | Silver/Creatinine [Mass Ratio] in Urine |
| 102707-7 | Celery IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102735-8 | Eggplant IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102738-2 | Fig IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14823-9 | Macrophages/100 leukocytes in Bronchial specimen by Manual count |
| 15338-7 | Other Antibiotic [Susceptibility] by Serum bactericidal titer --trough |
| 16546-4 | Captopril [Mass/volume] in Serum or Plasma |
| 11204-5 | Ulocladium chartarum IgE Ab [Units/volume] in Serum |
| 17155-3 | CD44 cells/100 cells in Blood |
| 17433-4 | pH of Specimen |
| 17554-7 | Measles virus IgA Ab [Units/volume] in Serum |
| 17857-4 | Rheumatoid factor [Titer] in Serum |
| 18296-4 | Glucose [Interpretation] in Serum or Plasma--post dose glucose |
| 90304-7 | CD3 cells/100 lymphocytes in Blood |
| 90441-7 | Bordetella pertussis and Bordetella parapertussis DNA panel - Nasopharynx |
| 92005-8 | Spinal muscular atrophy newborn screening panel |
| 60360-5 | Carrot IgG Ab [Mass/volume] in Serum |
| 60541-0 | Cytomegalovirus early Ag [Presence] in Specimen |
| 61125-1 | Monocytes/100 leukocytes in Specimen by Flow cytometry (FC) |
| 76575-0 | Bacterial 16S rRNA [Presence] in Specimen by NAA with probe detection |
| 7680-2 | Sage IgG Ab [Units/volume] in Serum |
| 6186-1 | Nettle IgE Ab [Units/volume] in Serum |
| 93867-0 | GABABR Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 94211-0 | NPC1 gene+NPC2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 94351-4 | PCA-2 IgG Ab [Titer] in Serum by Immunofluorescence |
| 6483-2 | Mycoplasma pneumoniae rRNA [Presence] in Specimen by Probe |
| 78983-4 | 4-Hydroxy-3-Methoxyphenyllactate [Moles/volume] in Cerebral spinal fluid |
| 9517-4 | Echovirus 18 Ab [Titer] in Serum by Complement fixation |
| 80515-0 | Kappa light chains.free [Mass/volume] in Serum by Nephelometry |
| 80682-8 | Entamoeba histolytica 18S rRNA [Presence] in Stool by NAA with probe detection |
| 80717-2 | B-cell CD27 and IgD subsets panel - Blood |
| 96594-7 | Glucose [Mass/volume] in DBS |
| 97216-6 | Alpha pyrrolidinovalerophenone [Presence] in Cord tissue by Screen method |
| 97750-4 | Cancer Ag 19-9 [Units/volume] in Aspirate |
| 82367-4 | Peripheral deiodinase activity [Moles/time] in Serum or Plasma by Calculated.SPINA |
| 82526-5 | 6-Beta naltrexol [Mass/volume] in Serum or Plasma |
| 98905-3 | Red blood cell membrane evaluation panel - Red Blood Cells |
| 72331-2 | Anucleated bodies/100 round cells in Prostatic fluid by Manual count |
| 85083-4 | Homogeneous nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
| 73356-8 | Haloperidol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73424-4 | Amphetamine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7358-5 | Kentucky blue grass triggered histamine release [Units/volume] in Blood |
| 74263-5 | Dabigatran [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 74354-2 | Epithelial cells/100 leukocytes in Sputum |
| 59591-8 | 7-Aminoclonazepam [Mass/volume] in Blood |
| 5073-2 | La Crosse virus Ab [Units/volume] in Serum |
| 50765-7 | Hemoglobin Hasharon/Hemoglobin.total in Blood by Electrophoresis |
| 50803-6 | Amikacin [Moles/volume] in Serum or Plasma --trough |
| 51028-9 | CD117 blasts [Units/volume] in Bone marrow |
| 42209-7 | Microscopic observation [Identifier] in Cerebral spinal fluid by Cyto stain |
| 21523-6 | Smith extractable nuclear IgG Ab [Presence] in Serum |
| 21624-2 | ATM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 31265-2 | Bordetella avium Ab [Units/volume] in Serum |
| 51220-2 | CD103 cells/100 cells in Cerebral spinal fluid |
| 51270-7 | CD25 cells/100 cells in Cerebral spinal fluid |
| 43193-2 | Legionella non-pneumophila Ab [Titer] in Serum by Immunofluorescence |
| 2209-5 | Dihydrofolate [Mass/volume] in Serum |
| 22141-6 | Bovine diarrhea virus 2 Ab [Titer] in Serum |
| 31981-4 | Varicella zoster virus Ag [Presence] in Skin |
| 32027-5 | Monocytes+Macrophages/100 leukocytes in Pericardial fluid by Manual count |
| 2250-9 | Estriol (E3).unconjugated [Mass/volume] in Serum or Plasma |
| 22535-9 | Schistosoma japonicum Ab [Titer] in Serum |
| 32271-9 | Taurine [Moles/volume] in Body fluid |
| 5213-4 | Heterophile Ab [Presence] in Serum by Latex agglutination |
| 52947-9 | Dextromethorphan [Presence] in Gastric fluid |
| 44053-7 | Phosphoglycerate kinase [Enzymatic activity/mass] in Red Blood Cells |
| 44340-8 | N-methylhistamine/Creatinine [Mass Ratio] in 24 hour Urine |
| 53248-1 | Plasmodium sp lactate dehydrogenase [Presence] in Blood |
| 53402-4 | 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBS |
| 33604-0 | Chlamydia trachomatis I IgM Ab [Titer] in Serum |
| 53938-7 | HLA-DQB1 [Type] |
| 44930-6 | Prolactin [Units/volume] in Serum or Plasma --2 hours post dose TRH IV |
| 45072-6 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Anal by Probe |
| 45359-7 | Length of time post dose |
| 24031-7 | 14-3-3 Ag [Presence] in Cerebral spinal fluid by Immunoblot |
| 33907-7 | Prolactin [Moles/volume] in Serum or Plasma --1 hour post 200 ug TRH IV |
| 54184-7 | Thiacetazone [Susceptibility] by Disk diffusion (KB) |
| 34678-3 | MT-RNR1 gene m.1555A>G [Presence] in Blood or Tissue by Molecular genetics method |
| 55510-2 | Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose glucose |
| 47478-3 | Rickettsia rickettsii IgM Ab [Titer] in Cerebral spinal fluid |
| 55839-5 | Cholesterol ester transfer protein [Units/volume] in Serum or Plasma |
| 25707-1 | Ketones [Mass/volume] in Urine by Test strip --4 hours post dose glucose |
| 25832-7 | Beta-N-acetylhexosaminidase.A activator [Interpretation] in Fibroblast |
| 3567-5 | Dimethyltryptamine [Mass/volume] in Serum or Plasma |
| 56224-9 | Cladosporium herbarum IgG4 Ab [Mass/volume] in Serum |
| 26058-8 | European tick borne encephalitis virus Ab [Titer] in Serum by Complement fixation |
| 2650-0 | N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/volume] in Serum |
| 48403-0 | Methadone+Metabolite [Mass/volume] in Serum or Plasma |
| 57100-0 | Follitropin [Units/volume] in Serum or Plasma --30 minutes post dose gonadotropin releasing hormone |
| 57180-2 | Neisseria gonorrhoeae DNA [Presence] in Nasopharynx by NAA with probe detection |
| 57434-3 | Liver kidney microsomal 1 Ab [Titer] in Serum by Immunofluorescence |
| 57686-8 | Cortisol [Mass/volume] in Saliva (oral fluid) --12th specimen |
| 27378-9 | pH of 24 hour Urine |
| 29337-3 | Morphine Free [Mass/volume] in Gastric fluid |
| 40185-1 | Glucose [Moles/volume] in Serum or Plasma --18.5 hours post XXX challenge |
| 40272-7 | Creatinine [Moles/volume] in Serum or Plasma --6 hours post XXX challenge |
| 58634-7 | Cortisol [Moles/volume] in Serum or Plasma --10 AM specimen |
| 50030-6 | Oak wood dust IgE Ab [Units/volume] in Serum |
| 4032-9 | Sotalol [Mass/time] in 24 hour Urine |
| 40735-3 | HTLV I+II IgG Ab [Presence] in Serum by Immunoblot |
| 40970-6 | VWF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19590-9 | Midazolam cutoff [Mass/volume] in Urine for Confirmatory method |
| 19639-4 | Oxazepam [Presence] in Urine by Confirmatory method |
| 20898-3 | Mycoplasma sp [Presence] in Milk by Organism specific culture |
| 100962-0 | Dengue virus Ab.IgG Panel - Serum, Plasma or Blood |
| 12730-8 | Interferon beta [Units/volume] in Serum or Plasma |
| 101413-3 | Bictegravir [Mass/volume] in Serum or Plasma by LC/MS/MS --trough |
| 13050-0 | Protein C/Coagulation factor IX [Mass Ratio] in Platelet poor plasma |
| 13344-7 | CD8+CD38+ cells/100 cells in Blood |
| 102062-7 | Branched PFOA isomers [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 1352-4 | Yt sup(b) Ag [Presence] on Red Blood Cells from Donor |
| 102461-1 | Nettle IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14407-1 | Phosphate [Mass/volume] in Gastric fluid |
| 1497-7 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
| 10426-5 | Transfuse whole blood [Volume] |
| 15369-2 | Lithium.saliva/Lithium.serum |
| 15480-7 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum by Agglutination |
| 16230-5 | N-desalkylflurazepam [Mass/volume] in Urine by Confirmatory method |
| 17054-8 | Legionella longbeachae 1 IgM Ab [Presence] in Serum |
| 17468-0 | Plutonium [Mass/volume] in Urine |
| 17732-9 | Trichinella spiralis Ab [Presence] in Serum by Latex agglutination |
| 90077-9 | Urinary pathogens identified in Isolate by Organism specific culture |
| 91120-6 | Antithrombin in Platelet poor plasma by Chromo.no addition of heparin |
| 74834-3 | MARS2 gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
| 912-6 | B Ab [Presence] in Serum or Plasma from Donor |
| 75235-2 | Vilazodone [Presence] in Urine |
| 75542-1 | Hepatitis A virus RNA [Interpretation] in Plasma from Donor Qualitative by NAA with probe detection |
| 6177-0 | Aedes mosquito IgE Ab [Units/volume] in Serum |
| 63271-1 | Liver kidney microsomal 1 Ab [Titer] in Body fluid by Immunofluorescence |
| 6439-4 | Influenza virus A+B+C Ag [Presence] in Throat by Immunoassay |
| 78878-6 | RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
| 6565-6 | Trichomonas vaginalis [Presence] in Genital specimen by Wet preparation |
| 97294-3 | Oxazepam [Presence] in Cord tissue by Confirmatory method |
| 97325-5 | Staphylococcus aureus VNTR pattern [Type] in Isolate or Specimen by Molecular genetics method |
| 97618-3 | Enterococcus faecium DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 97755-3 | Oxalate [Mass/volume] in Body fluid |
| 7069-8 | Allspice IgE Ab [Units/volume] in Serum |
| 7111-8 | Bahia grass triggered histamine release [Units/volume] in Blood |
| 82740-2 | Lysoganglioside GM1 IgG Ab [Titer] in Serum by Immunoassay |
| 98096-1 | Interleukin 33 [Mass/volume] in Serum or Plasma |
| 98392-4 | Sarcomatous pattern [Type] in carcinosarcoma |
| 98408-8 | Yeast identified in Isolate by NAA with probe detection |
| 72380-9 | LORazepam [Mass/volume] in Saliva (oral fluid) |
| 85773-0 | Escherichia coli DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 99451-7 | Horn beam IgG4 Ab [Mass/volume] in Serum |
| 99597-7 | SARS-CoV-2 (COVID-19) S protein IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 72670-3 | Metanephrine, Normetanephrine, 3-Methoxytyramine and Creatinine panel - Urine |
| 7285-0 | Dog epithelium IgG Ab [Units/volume] in Serum |
| 73869-0 | Alpha cortol [Moles/volume] in 24 hour Urine |
| 88149-0 | Microscopic observation [Identifier] in Nasopharynx by Gram stain |
| 41420-1 | Leishmania tropica Ab [Titer] in Serum by Immunofluorescence |
| 41633-9 | Clostridium botulinum toxin B botB gene [Presence] in Specimen by NAA with probe detection |
| 41687-5 | Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 5956-8 | Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma |
| 50634-5 | Balsam poplar IgE Ab [Units/volume] in Serum |
| 30426-1 | Macrophages/100 leukocytes in Cerebral spinal fluid |
| 30430-3 | Mesothelial cells/100 leukocytes in Pericardial fluid |
| 60147-6 | Pentane [Mass/mass] in Tissue |
| 60315-9 | Mesoridazine [Moles/volume] in Specimen |
| 2121-2 | Chylomicrons [Presence] in Serum or Plasma |
| 31498-9 | Ganglioside GM1 IgA Ab [Units/volume] in Serum |
| 42732-8 | Cardiolipin IgG Ab B2GP1 independent [Multiple of the median] in Serum |
| 21770-3 | Chromosome 12 trisomy [Presence] in Blood or Tissue by Cytogenetics |
| 22251-3 | Dengue virus 2 Ab [Presence] in Serum |
| 31995-4 | Basophils/100 leukocytes in Pleural fluid by Manual count |
| 51646-8 | Rabies virus RNA [Presence] in Specimen by NAA with probe detection |
| 4323-2 | Methocarbamol [Mass] of Dose |
| 22737-1 | Phenylalanine [Moles/volume] in Specimen |
| 43963-8 | CD4+CD45RA+ cells/100 cells in Cerebral spinal fluid |
| 43998-4 | Alpha-1-Fetoprotein [Multiple of the median] adjusted for diabetes in Serum or Plasma |
| 53176-4 | Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 44407-5 | Somatotropin/Creatinine [Mass Ratio] in Urine |
| 23210-8 | Listeria sp Ab [Presence] in Serum |
| 23577-0 | Rabbit hemorrhagic disease virus Ab [Presence] in Serum by Immunoassay |
| 53765-4 | Estrogen [Mass/volume] in Serum or Plasma by calculation |
| 45038-7 | Bacteria producing arginine decarboxylase [Presence] in Isolate |
| 23881-6 | Immune complex [Mass/volume] in Body fluid by Polyethylene glycol (PEG) assay |
| 33941-6 | Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection |
| 3425-6 | Cannabinoids [Presence] in Serum or Plasma |
| 46419-8 | Erythrocytes [#/area] in Urine sediment by Automated count |
| 24207-3 | Rickettsia spotted fever group IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 54915-4 | Iroko IgE Ab [Units/volume] in Serum |
| 55567-2 | Pheniramine [Moles/volume] in Serum or Plasma |
| 25171-0 | Bromide [Moles/volume] in Blood |
| 25314-6 | Androstenediol [Moles/time] in 24 hour Urine |
| 34955-5 | Western equine encephalitis virus IgG and IgM panel - Cerebral spinal fluid |
| 55837-9 | Chloride [Moles/volume] in 24 hour Stool |
| 25916-8 | Glucose [Moles/volume] in 24 hour Urine |
| 35444-9 | HIV 1 p55 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
| 56161-3 | Calculus analysis with calculus photography [Interpretation] in Stone |
| 37989-1 | Inhalant Allergen Mix 8 (Mugwort+Common silver birch+Cat dander+C herbarum+Dermatophagoides pteronyssinus+Dog dander+Timothy grass+Rye) IgE Ab [Presence] in Serum by Multidisk |
| 56657-0 | Tetrahydrocortisone [Moles/time] in 24 hour Urine |
| 56756-0 | Aldosterone [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge |
| 48781-9 | CYP21A2 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
| 26826-8 | Testosterone [Mass/volume] in 24 hour Urine |
| 57345-1 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --overnight |
| 57393-1 | CD11a cells/100 cells in Body fluid |
| 49005-2 | Calcium [Moles/volume] in Peritoneal dialysis fluid |
| 27875-4 | Insulin [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 38921-3 | MSH6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 39019-5 | Escherichia coli O157:H7 Ag [Presence] in Raw milk by Immunoassay |
| 58055-5 | Co sup(a) Ag [Presence] on Red Blood Cells |
| 49522-6 | Influenza virus A H3 Ag [Presence] in Isolate by Immunofluorescence |
| 49671-1 | Neisseria meningitidis DNA [Presence] in Specimen by NAA with probe detection |
| 49751-1 | Norbuprenorphine [Mass/volume] in Urine by Confirmatory method |
| 39785-1 | Potassium [Moles/volume] in Peritoneal dialysis fluid |
| 39967-5 | Creatinine [Mass/volume] in Serum or Plasma --6.5 hours post XXX challenge |
| 40152-1 | Glucose [Moles/volume] in Serum or Plasma --5 minutes pre XXX challenge |
| 58473-0 | Haemophilus influenzae serotype DNA [Identifier] in Specimen by NAA with probe detection |
| 58719-6 | Lymphocyte proliferation stimulated by 5 ug concanavalin A actual/normal in Blood |
| 50088-4 | 2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Cerebral spinal fluid |
| 29594-9 | CD45RO Ag [Presence] in Tissue by Immune stain |
| 29597-2 | Mephentermine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 59216-2 | Uridine/Creatinine [Molar ratio] in Urine |
| 59264-2 | Human papilloma virus 18 DNA [Presence] in Cervix by Probe with signal amplification |
| 50346-6 | Parvovirus B19 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 5049-2 | Ascaris lumbricoides Ab [Units/volume] in Serum by Immunoassay |
| 30105-1 | Trypanosoma cruzi IgM Ab [Titer] in Specimen |
| 30162-2 | Artichoke IgG Ab [Units/volume] in Serum |
| 19531-3 | Lysergate diethylamide cutoff [Mass/volume] in Urine for Confirmatory method |
| 19609-7 | Naltrexone [Presence] in Urine by Screen method |
| 1968-7 | Bilirubin.direct [Mass/volume] in Serum or Plasma |
| 20934-6 | Bovine parvovirus Ag [Presence] in Tissue by Immunofluorescence |
| 100843-2 | Liver fibrosis score in Serum or Plasma by Calculated.Agile3+ |
| 12639-1 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 101871-2 | IgLON5 IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 13652-3 | Zinc [Mass/mass] in Hair |
| 13838-8 | CD13 blasts/100 blasts in Blood |
| 13845-3 | CD5 blasts/100 blasts in Blood |
| 102323-3 | Gerbil IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102331-6 | Grape IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102415-7 | Lobster IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102437-1 | Green Nimitti IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102837-2 | Turkey feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14419-6 | Calcium [Moles/volume] in Gastric fluid |
| 10686-4 | Leishmania sp identified in Tissue by Giemsa stain |
| 15409-6 | Thallium [Mass/mass] in Nail |
| 15437-7 | Avian encephalomyelitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15496-3 | PRRSV Ab [Presence] in Serum by Immunofluorescence |
| 16299-0 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
| 16759-3 | Dicamba [Mass/volume] in Urine |
| 17196-7 | CD79a cells/100 cells in Blood |
| 18234-5 | Insulin [Presence] in Unknown substance |
| 18468-9 | Aspergillus fumigatus Ab [Presence] in Cerebral spinal fluid |
| 90914-3 | Docosahexaenoate (C22:6w3)/Fatty acids.C14-C22 in Blood |
| 92136-1 | Adenovirus B+C+E DNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 75582-7 | Fetal Prader-Willi syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
| 75660-1 | Polymorphonuclear cells [#] in Peritoneal fluid by Manual count |
| 63348-7 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
| 78236-7 | Cells.IGH gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 94492-6 | HLA-DQA1 and HLA-DQB1 typing panel - Blood or Tissue by Molecular genetics method |
| 94637-6 | Mycobacterium avium ss paratuberculosis Ab [Titer] in Serum by Complement fixation |
| 94829-9 | Epstein Barr virus DNA [log units/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 6494-9 | Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 64985-5 | Anisakis recombinant (rAni s) 1 IgE Ab [Units/volume] in Serum |
| 78970-1 | Phosphomannomutase 1 [Enzymatic activity/mass] in Leukocytes |
| 95360-4 | Rabbit hemorrhagic disease virus type 2 RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 6571-4 | Venezuelan equine encephalitis virus Ab [Units/volume] in Serum |
| 6726-4 | False oat grass IgE Ab [Units/volume] in Serum |
| 7955-8 | Legionella pneumophila 8 Ab [Titer] in Serum by Immunofluorescence |
| 79635-9 | N,N-dimethylarginine/Creatinine [Molar ratio] in Urine |
| 8051-5 | Venezuelan equine encephalitis virus IgM Ab [Units/volume] in Serum |
| 678-3 | Microscopic observation [Identifier] in Specimen by Trichrome stain |
| 81178-6 | Tissue block description and site Narrative |
| 9711-3 | Coxiella burnetii phase 2 IgM Ab [Titer] in Serum |
| 69556-9 | Ku Ab [Presence] in Serum by Immunoblot |
| 8175-2 | Tetrahydrocannabinol [Presence] in Urine by SAMHSA screen method |
| 97256-2 | HYDROmorphone Free [Presence] in Cord tissue by Screen method |
| 9789-9 | Carbamate pesticides [Type] in Serum or Plasma |
| 70140-9 | Benzodiazepines [Mass/volume] in Urine by Screen method |
| 70911-3 | Cryptococcus sp Ag [Presence] in Cerebral spinal fluid by Rapid immunoassay |
| 82849-1 | 11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
| 72361-9 | Methemoglobin/Hemoglobin.total in Arterial cord blood |
| 83115-6 | Testosterone [Moles/volume] in Serum or Plasma by Immunoassay |
| 99919-3 | Amorphous sediment [#/area] in Urine sediment by Automated count |
| 86041-1 | Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum --1st specimen |
| 73001-0 | Lisinopril induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73210-7 | Perphenazine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73631-4 | Tedizolid [Susceptibility] by Disk diffusion (KB) |
| 87968-4 | Microscopic observation [Identifier] in Body fluid by Giemsa stain |
| 73939-1 | HYDROcodone Free [Mass/volume] in Blood |
| 7438-5 | Kapok triggered histamine release [Units/volume] in Blood |
| 41260-1 | Western equine encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid |
| 415-0 | Pivampicillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 59751-8 | Temazepam [Mass/mass] in Stool by Confirmatory method |
| 5976-6 | Plasminogen activator inhibitor 1 [Mass/volume] in Platelet poor plasma by Chromogenic method |
| 30442-8 | Monocytes/100 leukocytes in Urine |
| 31164-7 | Ganglioside GQ1b Ab [Titer] in Serum |
| 42595-9 | Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 2134-5 | Coproporphyrin [Moles/volume] in Red Blood Cells |
| 2155-0 | Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis |
| 21646-5 | CBS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 31204-1 | Hepatitis B virus core IgM Ab [Presence] in Serum |
| 51229-3 | CD11b cells/100 cells in Bone marrow |
| 51465-3 | Paragonimus sp Ab [Titer] in Pleural fluid |
| 428-3 | rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 22094-7 | Infectious bronchitis virus Mass-41 Ab [Titer] in Serum |
| 51885-2 | Transfuse whole blood autologous units [#] |
| 22472-5 | Rickettsia (Proteus OXK) Ab [Presence] in Serum |
| 22652-2 | Glutamate [Moles/volume] in Cerebral spinal fluid |
| 32326-1 | Lutropin [Units/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 32375-8 | Cefmenoxime [Susceptibility] |
| 23207-4 | Leptospira subtype [Identifier] in Specimen |
| 32726-2 | Trypanosoma cruzi IgM Ab [Presence] in Serum |
| 32742-9 | CD117 cells/100 cells in Specimen |
| 33458-1 | Bilirubin.conjugated [Mass/volume] in Body fluid |
| 33494-6 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose lactose PO |
| 53508-8 | Decadienoylcarnitine (C10:2)/Creatinine [Molar ratio] in Urine |
| 53648-2 | Flavin mononucleotide [Mass/volume] in Blood |
| 23821-2 | Aspergillus fumigatus Ab [Presence] in Serum by Immune diffusion (ID) |
| 23843-6 | Cockatiel droppings Ab [Presence] in Serum by Immune diffusion (ID) |
| 24030-9 | Toxocara canis IgM Ab [Presence] in Serum |
| 33738-6 | Closest margin |
| 4628-4 | Hemoglobin Ypsilanti [Presence] in Blood |
| 46702-7 | Leukocytes [#/area] in Urine sediment by Automated count |
| 24228-9 | Coxsackievirus A16 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 47061-7 | Legionella pneumophila 14 IgG Ab [Titer] in Serum by Immunofluorescence |
| 47068-2 | Epstein Barr virus early IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 47178-9 | Parathyrin.intact [Moles/volume] in Serum or Plasma --baseline |
| 47284-5 | Platelets [#/volume] in Cord blood |
| 55899-9 | Immunoglobulin light chains.free [Presence] in Urine by Electrophoresis |
| 4776-1 | HLA-B61(40) [Presence] in Donor |
| 25751-9 | Rickettsia prowazekii IgG Ab [Titer] in Serum by Immunofluorescence |
| 35763-2 | Cefepime+Clavulanate [Susceptibility] by Gradient strip |
| 35765-7 | Cefetamet [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 56347-8 | Parrot feather IgG4 Ab [Mass/volume] in Serum |
| 48153-1 | Threitol/Creatinine [Molar ratio] in Urine |
| 5663-0 | Heavy metals positive [Identifier] in Urine by Screen method |
| 56891-5 | CD13+HLA-DR+ cells/100 cells in Specimen |
| 4845-4 | HLA-B8 [Presence] |
| 38594-8 | Epichlorohydrin [Mass/volume] in Air |
| 38652-4 | Carbonyl sulfide [Mass/volume] in Air |
| 57446-7 | Spermatozoa Immotile/100 spermatozoa in Semen --post concentration |
| 57608-2 | 6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
| 48992-2 | Glucose [Mass/volume] in Serum or Plasma --12 AM specimen |
| 49212-4 | Bartonella bacilliformis IgG Ab [Titer] in Serum |
| 49288-4 | Parathyrin [Interpretation] in Serum or Plasma Narrative |
| 276-6 | Hetacillin [Susceptibility] by Disk diffusion (KB) |
| 27817-6 | Beta 2 glycoprotein 1 Ab [Presence] in Serum by Immunoassay |
| 57841-9 | Erythrocytes [#/volume] in Dialysis fluid by Automated count |
| 49895-6 | Somatotropin [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 29916-4 | Cobalt [Mass/time] in 24 hour Urine |
| 40716-3 | Hairy cells [Presence] in Blood by Light microscopy |
| 50234-4 | Mixed cellular casts [Presence] in Urine by Computer assisted method |
| 50457-1 | Cortisol [Mass/volume] in Serum or Plasma --5th specimen |
| 40958-1 | Cryptosporidium parvum identified in Stool |
| 20465-1 | Choriogonadotropin [Multiple of the median] in Serum or Plasma |
| 20471-9 | Isopropanol [Presence] in Serum or Plasma by Screen method |
| 20636-7 | Alanine [Moles/volume] in Serum or Plasma |
| 12623-5 | Glucose [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge |
| 101098-2 | JMH Ag [Presence] on Red Blood Cells |
| 101201-2 | Measles virus IgG Ab index [Units/volume] in Serum and CSF |
| 101256-6 | Silica clotting time of Platelet poor plasma |
| 101458-8 | Septin-5 IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 13288-6 | Treponema pallidum Ab [Units/volume] in Blood by Immunofluorescence |
| 101848-0 | Budesonide [Moles/volume] in Urine |
| 102185-6 | Bloodworm IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102524-6 | Pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102628-5 | Thyme IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102667-3 | Brewer's yeast IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14616-7 | Nuclear Ab [Titer] in Synovial fluid |
| 15063-1 | Estriol (E3).conjugated [Moles/volume] in Serum or Plasma |
| 15481-5 | Leptospira interrogans sv Pomona Ab [Titer] in Serum by Agglutination |
| 10785-4 | Microscopic observation [Identifier] in Tissue by Fite-Faraco stain |
| 10917-3 | Zinc [Mass/mass] in Stool |
| 11067-6 | Bleeding time |
| 17113-2 | CD120B cells/100 cells in Blood |
| 17397-1 | Oxytriphylline [Mass/volume] in Serum or Plasma |
| 17973-9 | Bacteria # 5 identified in Urine by Culture |
| 18239-4 | Lupus erythematosus factor [Mass/volume] in Blood by Latex agglutination |
| 18967-0 | Phenethicillin [Susceptibility] |
| 74649-5 | Methylenedioxyethylamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 91821-9 | Adenovirus Ag [Presence] in Upper respiratory specimen by Rapid immunoassay |
| 75510-8 | aPTT.lupus sensitive with 1:1 PNP (LA mix) |
| 75693-2 | Fetal sex in Plasma cell-free DNA by Dosage of chromosome specific cell free (cf) DNA |
| 61244-0 | Chick Pea IgE Ab/IgE total in Serum |
| 77109-7 | AARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77129-5 | CERKL gene full mutation analysis in Blood or Tissue by Sequencing |
| 94053-6 | Mycobacterium tuberculosis complex resistance panel by Molecular genetics method |
| 63184-6 | White Ash IgG Ab [Mass/volume] in Serum |
| 63223-2 | DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence |
| 78013-0 | HLA-A and B and DRB and DQB1 panel [Type] - Blood or Tissue by Low resolution |
| 94335-7 | Desmoglein 1 and Desmoglein 3 IgG panel - Serum by Immunoassay |
| 94559-2 | SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Respiratory system specimen by NAA with probe detection |
| 63571-4 | Pancreatic islet cell Ab pattern [Interpretation] in Serum by Immunofluorescence |
| 64431-0 | KIR3DP1 gene full variant [Presence] in Blood or Tissue by Molecular genetics method |
| 79250-7 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 79260-6 | fentaNYL cutoff [Mass/volume] in Urine for Screen method |
| 6574-8 | Escherichia coli verotoxin 1 [Presence] in Stool |
| 66134-8 | Blasts [#/volume] in Blood from Fetus by Manual count |
| 95808-2 | Cholesterol and triglyceride and chylomicrons panel - Urine |
| 68459-7 | pH of Peritoneal fluid by Test strip |
| 97103-6 | Zygosity [Type] in Fetuses by Molecular genetics method |
| 6980-7 | Ampicillin+Sulbactam [Susceptibility] by Gradient strip |
| 82244-5 | Chromosome region 1p36 deletion in Blood or Tissue by FISH |
| 97655-5 | Hereditary breast and gynecologic cancer multigene analysis in Blood or Tissue by Molecular genetics method |
| 82561-2 | Food Allergen Mix 76 (Brazil nut+Coconut+Hazelnut+Almond) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 98116-7 | Chemokine (C-C motif) ligand 27 [Mass/volume] in Serum or Plasma |
| 98191-0 | Azlocillin IgE Ab [Units/volume] in Serum |
| 99020-0 | Klebsiella aerogenes DNA [Presence] in Urine by NAA with probe detection |
| 72450-0 | 3-Hydroxyisovalerate [Moles/volume] in Serum or Plasma |
| 85288-9 | Radial position of closest uninvolved mucosal margin [Angle] in Colorectal cancer specimen by Light microscopy |
| 99413-7 | cycloSPORINE [AUC] in Blood |
| 99522-5 | Circumference [Length] of Heart valve |
| 86711-9 | Porcine deltacoronavirus Ag [Presence] in Tissue by Immune stain |
| 87598-9 | Lasalocid [Mass/mass] in Specimen |
| 73664-5 | Yersinia adhesion protein YadA [Presence] in Isolate |
| 73676-9 | Voriconazole [Mass/volume] in Serum or Plasma --trough |
| 88019-5 | N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/volume] in DBS |
| 88264-7 | Klebsiella pneumoniae yggE gene [Presence] by Probe in Positive blood culture |
| 74418-5 | Measles virus IgG Ab [Units/volume] in Body fluid by Immunoassay |
| 59748-4 | Temazepam [Mass/volume] in Body fluid by Confirmatory method |
| 51030-5 | CD117 blasts [Units/volume] in Specimen |
| 31145-6 | Thyroxine (T4) [Moles/volume] in DBS |
| 4187-1 | CISplatin [Mass] of Dose |
| 21343-9 | HLA-DR+DQ [Type] |
| 31603-4 | Rickettsia rickettsii Ab [Units/volume] in Serum |
| 42949-8 | Toxoplasma gondii Ab [Titer] in Serum |
| 31711-5 | Adenovirus Ag [Presence] in Stool |
| 3171-6 | Dry weight [Mass/time] of 72 hour Stool |
| 5160-7 | Epstein Barr virus capsid IgM Ab [Titer] in Serum by Immunofluorescence |
| 51791-2 | Tetrahydrocannabinol [Presence] in Serum or Plasma by Confirmatory method |
| 43371-4 | Salmonella and Shigella sp identified in Stool by Organism specific culture |
| 43713-7 | Albumin [Presence] in Body fluid |
| 52923-0 | Selenium/Creatinine [Molar ratio] in Urine |
| 43988-5 | Clofazimine 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 53135-0 | Cholesterol in HDL [Moles/volume] in Dialysis fluid |
| 53283-8 | Mixed cellular casts [#/volume] in Urine by Computer assisted method |
| 5343-9 | Salmonella paratyphi C H Ab [Presence] in Serum by Latex agglutination |
| 33266-8 | Aspergillus sp Ab [Titer] in Urine |
| 53802-5 | Arbovirus IgG Ab [Interpretation] in Serum by Immunofluorescence Narrative |
| 53885-0 | Parvovirus B19 IgG Ab [Units/volume] in Body fluid |
| 44993-4 | Chlamydia trachomatis C IgA Ab [Presence] in Serum |
| 54009-6 | Lysosome Ab [Presence] in Serum by Immunofluorescence |
| 54340-5 | Tetradecanoylcarnitine (C14) [Moles/volume] in Amniotic fluid |
| 46273-9 | Appearance of Serum--after transfusion reaction |
| 4672-2 | Protein C Ag [Mass/volume] in Platelet poor plasma |
| 24158-8 | White+Black Pepper IgG Ab [Units/volume] in Serum |
| 34444-0 | Acarboxyprothrombin [Mass/volume] in Serum or Plasma |
| 47740-6 | Purine nucleoside phosphorylase [Enzymatic activity/mass] in Red Blood Cells |
| 47910-5 | Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose betaxolol+glucagon |
| 48000-4 | Chromosome [Identifier] in Blood or Tissue by Molecular genetics method |
| 26708-8 | Magnesium [Moles/mass] in Stool |
| 56671-1 | Alanine/Creatinine [Ratio] in 24 hour Urine |
| 48734-8 | CYBB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 488-7 | Temafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 27057-9 | Serotonin [Mass/volume] in Serum |
| 27194-0 | N-desalkylflurazepam [Mass/volume] in Vitreous fluid |
| 38596-3 | Ethylene glycol [Mass/volume] in Air |
| 57631-4 | Alpha cortolone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
| 48962-5 | Oxazepam [Mass/volume] in Specimen |
| 49216-5 | Hexokinase [Enzymatic activity/mass] in Red Blood Cells |
| 57694-2 | Cortisol [Mass/volume] in Saliva (oral fluid) --7th specimen |
| 2873-8 | Gamma globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis |
| 58491-2 | Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --2nd specimen post XXX challenge |
| 58633-9 | Cortisol [Mass/volume] in Serum or Plasma --10 AM specimen |
| 499-4 | Ticarcillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 29672-3 | Bordetella pertussis IgA Ab [Presence] in Serum |
| 29707-7 | Rickettsia akari Ab [Titer] in Serum by Immunofluorescence |
| 40726-2 | Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 50561-0 | Protein [Mass/volume] in Urine by Automated test strip |
| 30325-5 | Cytomegalovirus IgM Ab [Presence] in Serum or Plasma |
| 41156-1 | Coccidioides sp IgG Ab [Presence] in Specimen |
| 20452-9 | Thyrotropin [Presence] in Blood |
| 20962-7 | Serpulina hyodysenteria [Presence] in Spiral colon by Organism specific culture |
| 100404-3 | Horse meat IgG Ab [Units/volume] in Serum |
| 101299-6 | Streptococcus dysgalactiae subspecies equisimilis DNA [Presence] in Throat by NAA with non-probe detection |
| 13032-8 | C peptide [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 13397-5 | Glycine [Mass/volume] in Amniotic fluid |
| 102127-8 | Corticotropin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13636-6 | Ribosomal P Ab [Units/volume] in Serum |
| 102637-6 | Trimellitic anhydride (TMA) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14692-8 | Desipramine [Moles/volume] in Urine |
| 15035-9 | Calcitonin [Moles/volume] in Serum or Plasma |
| 104412-2 | Hepatitis A virus IgM Ab [Titer] in Serum |
| 10624-5 | Spermatozoa Rapid/100 spermatozoa in Semen |
| 10642-7 | Amoeba identified in Aspirate by Wet preparation |
| 10951-2 | Sericin IgE Ab [Units/volume] in Serum |
| 10968-6 | Glucose [Presence] in Urine by Test strip --4.5 hours post 75 g glucose PO |
| 11246-6 | oxyCODONE [Mass/volume] in Urine |
| 11469-4 | Bacillus anthracis [Presence] in Specimen by Organism specific culture |
| 17018-3 | Insulin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 17108-2 | CD118 cells/100 cells in Blood |
| 17754-3 | Tyrosine [Presence] in Blood |
| 18327-7 | Microscopic observation [Identifier] in Duodenal fluid by Other stain |
| 18329-3 | Neutrophil cytoplasmic IgA Ab [Units/volume] in Serum |
| 74-5 | Cefatrizine [Susceptibility] by Serum bactericidal titer |
| 74542-2 | Pyruvate kinase/Glucose-6-Phosphate dehydrogenase [Enzymatic activity ratio] in Red Blood Cells |
| 92494-4 | Kp sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 92534-7 | K Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 75034-9 | NPM1 gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal |
| 75365-7 | First and Second trimester integrated maternal screen [Interpretation] Narrative |
| 61142-6 | Trimellitic anhydride (TMA) IgG Ab [Mass/volume] in Serum |
| 61325-7 | European Hornet IgE Ab/IgE total in Serum |
| 61423-0 | Noroxycodone/Creatinine [Mass Ratio] in Urine |
| 77392-9 | Parainfluenza virus 3 Ag [Presence] in Nasopharynx by Immunofluorescence |
| 78018-9 | Toscana virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 7810-5 | Astrovirus Ag [Presence] in Stool by Immunoassay |
| 78690-5 | 5-Hydroxymethyluracil/Creatinine [Molar ratio] in Urine |
| 94586-5 | Dermatan sulfate and heparan sulfate and keratan sulfate panel - DBS |
| 6379-2 | Cytomegalovirus Ag [Presence] in Specimen by Immunoassay |
| 9486-2 | Sulfate [Mass/volume] in Water |
| 95275-4 | FGD4 gene full mutation analysis in Blood or Tissue by Sequencing |
| 95406-5 | SARS-CoV-2 (COVID-19) RNA [Presence] in Nose by NAA with probe detection |
| 95829-8 | Viable CD45 cells/100 CD45 cells in Blood product unit |
| 81156-2 | Coenzyme Q10.reduced/Coenzyme Q10 in Serum or Plasma |
| 81320-4 | Influenza virus A H5 Asian RNA [Cycle Threshold #] in Respiratory system specimen by Nucleic acid amplification using primer-probe set H5a |
| 96657-2 | HLA-DQB1 [Type] in Donor by High resolution |
| 69426-5 | Medical director review of results |
| 82415-1 | Ha Ab [Presence] in Serum by Line blot |
| 72428-6 | 4-Hydroxyphenylpyruvate [Moles/volume] in Serum or Plasma |
| 85303-6 | Body structure of origin [Anatomy] in Breast cancer specimen |
| 85487-7 | Sc1 Ag [Presence] on Red Blood Cells |
| 72634-9 | Temazepam [Presence] in Saliva (oral fluid) |
| 73237-0 | Nystatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73363-4 | Glimepride induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73454-1 | chlorproMAZINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 89508-6 | Intrinsic factor Ab [Presence] in Serum by Line blot |
| 50639-4 | Asian ladybug IgE Ab [Units/volume] in Serum |
| 21348-8 | HTLV I+II IgG Ab [Presence] in Serum by Immunoassay |
| 51064-4 | CD13 blasts/100 blasts in Bone marrow |
| 51365-5 | CD64 cells/100 cells in Bone marrow |
| 42760-9 | Inflammatory bowel disease Ab panel - Serum |
| 43069-4 | Burkholderia pseudomallei IgM Ab [Titer] in Specimen |
| 51696-3 | Corticotropin [Mass/volume] in Plasma --afternoon specimen |
| 5295-1 | Respiratory syncytial virus Ab [Titer] in Serum by Immunofluorescence |
| 4391-9 | Pheniramine [Mass] of Dose |
| 43947-1 | CD4+CD45+ cells/100 cells in Tissue |
| 43958-8 | CD3+HLA-DR+ cells [#/volume] in Cerebral spinal fluid |
| 44082-6 | Cryoglobulin IgA and IgG and IgM [Interpretation] in Serum |
| 22846-0 | Babesia bigemina Ab [Presence] in Serum by Immunoassay |
| 22868-4 | Bluetongue virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 22991-4 | Capripox virus DNA [Presence] in Specimen by RFLP |
| 23173-8 | Leptospira interrogans sv Canicola Ab [Presence] in Serum |
| 3274-8 | Heparin unfractionated [Units/volume] in Platelet poor plasma by Chromogenic method |
| 53149-1 | Iron/Creatinine [Molar ratio] in 24 hour Urine |
| 53289-5 | Mixed cellular casts [#/area] in Urine by Computer assisted method |
| 33619-8 | Deuteroporphyrin.semi-proto [Mass/time] in 24 hour Stool |
| 5364-5 | Sporothrix schenckii Ab [Units/volume] in Serum |
| 44984-3 | Chlamydia trachomatis L2 IgG Ab [Presence] in Serum |
| 24150-5 | Red Maple IgG Ab [Units/volume] in Serum |
| 55551-6 | Methylenedioxyamphetamine [Moles/volume] in Serum or Plasma |
| 47023-7 | CD19+CD23+ cells/100 cells in Specimen |
| 47386-8 | Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method |
| 25131-4 | Pyridinoline/Creatinine [Molar ratio] in 2 hour Urine |
| 25156-1 | Eosinophils [Presence] in Urine sediment by Light microscopy |
| 25280-9 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 25351-8 | Bismuth [Moles/volume] in Serum or Plasma |
| 35268-2 | Mycobacterium avium ss paratuberculosis Ab [Units/volume] in Serum by Immunoassay |
| 55642-3 | Cefonicid [Susceptibility] by Gradient strip |
| 5597-0 | Bismuth [Mass/volume] in Serum or Plasma |
| 47812-3 | 2-Methylglutaconate/Creatinine [Molar ratio] in Urine |
| 35538-8 | Baker's yeast IgG Ab [Mass/volume] in Serum |
| 35562-8 | Bile acid [Moles/volume] in Serum --fasting |
| 56280-1 | Haddock IgG4 Ab [Mass/volume] in Serum |
| 35851-5 | Tilmicosin [Susceptibility] |
| 38187-1 | Bile acid.dihydroxy [Moles/volume] in Serum or Plasma |
| 48796-7 | Hepatitis C virus FibroSURE panel - Serum or Plasma |
| 57334-5 | Calcium [Mass/volume] in 2 hour Urine |
| 57504-3 | 11-Deoxycortisol [Moles/volume] in Serum or Plasma --2 days post dose metyraPONE |
| 27292-2 | Ornithine [Moles/volume] in Urine |
| 57987-0 | Sweet potato IgE Ab/IgE total in Serum |
| 49535-8 | Influenza virus B RNA [Presence] in Isolate by NAA with probe detection |
| 40273-5 | Creatinine [Moles/volume] in Serum or Plasma --1 day post XXX challenge |
| 5859-4 | Herpes simplex virus identified in Specimen by Organism specific culture |
| 58689-1 | Cortisol [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge |
| 58720-4 | Lymphocyte proliferation stimulated by 2.0 ug concanavalin A actual/normal in Blood |
| 4978-3 | HLA-DR2 [Presence] in Donor |
| 50116-3 | 3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Urine |
| 29827-3 | Jamestown canyon virus IgG Ab [Units/volume] in Specimen |
| 29876-0 | 2-Methylcitrate [Presence] in Urine |
| 40644-7 | Leptospira borgpetersenii sv Sejroe Ab [Titer] in Serum by Agglutination |
| 40729-6 | Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay |
| 40996-1 | Alternaria alternata IgE Ab/IgE total in Serum |
| 41033-2 | Herpes simplex virus 1 Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 41134-8 | Influenza virus A N9 Ab [Presence] in Serum |
| 19377-1 | Butorphanol [Presence] in Urine by Screen method |
| 19713-7 | traMADol cutoff [Mass/volume] in Urine for Confirmatory method |
| 20676-3 | Bovine adenovirus 5 Ag [Presence] in Tissue by Immunofluorescence |
| 20697-9 | Amines.biogenic [Mass/mass] in Feed |
| 100667-5 | NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method |
| 12804-1 | Acid phosphatase [Enzymatic activity/volume] in Body fluid |
| 101199-8 | Protein.monoclonal band 5/Protein.total in Serum or Plasma by Electrophoresis |
| 101363-0 | Yersinia pestis DNA [Presence] in Blood by NAA with non-probe detection |
| 101527-0 | Porcine epidemic diarrhea virus S1 gene [Identifier] in Isolate by Sequencing |
| 13323-1 | Herpes simplex virus 2 Ab [Units/volume] in Serum by Immunofluorescence |
| 102596-4 | Silk waste IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103722-5 | Yellow fever virus RNA [Presence] in Blood by NAA with non-probe detection |
| 14867-6 | PARoxetine [Moles/volume] in Serum or Plasma |
| 15038-3 | Citrate [Moles/volume] in Serum or Plasma |
| 15161-3 | Complement C1 esterase inhibitor.functional [Presence] in Serum or Plasma |
| 16228-9 | Nordiazepam [Mass/volume] in Urine by Confirmatory method |
| 10878-7 | Iodine.protein bound [Mass/volume] in Serum or Plasma |
| 10906-6 | Saint Louis encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 16305-5 | 2-Methoxyethanol [Mass/volume] in Blood |
| 11242-5 | Mercaptopurine [Mass/volume] in Serum or Plasma |
| 12233-3 | Mesothelial cells/100 leukocytes in Cerebral spinal fluid by Manual count |
| 16777-5 | Dimethylacetamide [Presence] in Urine |
| 17067-0 | Legionella pneumophila 4 IgM Ab [Units/volume] in Serum |
| 17758-4 | Urea nitrogen [Mass/volume] in Vitreous fluid |
| 18230-3 | Histone H2a+H2b Ab [Units/volume] in Serum |
| 18331-9 | Neutrophil cytoplasmic IgM Ab [Units/volume] in Serum |
| 90826-9 | GABABR Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 91867-2 | Bordetella holmesii DNA [Presence] in Throat by NAA with probe detection |
| 6113-5 | Gum-Tree IgE Ab [Units/volume] in Serum |
| 61181-4 | Cells Counted Total [#] in Blood from Fetus |
| 7677-8 | Safflower IgG Ab [Units/volume] in Serum |
| 93456-2 | MT-45 [Mass/volume] in Urine by Confirmatory method |
| 9364-1 | Bordetella pertussis IgM Ab [Units/volume] in Serum |
| 77217-8 | Salivary gland protein 1 and Carbonic anhydrase 6 and Parotid secretory protein IgA and IgG and IgM panel - Serum by Immunoassay |
| 93944-7 | little c Ag [Presence] in Cord red blood cells |
| 7859-2 | Dengue virus Ab [Units/volume] in Serum |
| 78832-3 | Hydroxybupropion cutoff [Mass/volume] in Urine for Confirmatory method |
| 94746-5 | SARS-CoV-2 (COVID-19) RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 63386-7 | DNA double strand IgG Ab [Units/volume] in Pleural fluid by Flow cytometry (FC) |
| 78861-2 | Morphine [Z-score] in Urine |
| 790-6 | Erythrocytes [#/volume] in Blood by Manual count |
| 95559-1 | Evidence of adrenal cortical hormone excess [Presence] in 24 hour Urine |
| 95589-8 | Beta cortolone [Mass/time] in 24 hour Urine |
| 65336-0 | Tm Ab [Presence] in Serum or Plasma |
| 95688-8 | Dengue virus 1+2+3+4 IgM Ab [Presence] in Specimen by Immunoassay |
| 9577-8 | Saint Louis encephalitis virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 6759-5 | Glucose [Presence] in Urine by Test strip --6 hours post 75 g glucose PO |
| 80559-8 | Clarithromycin [Mass/volume] in DBS |
| 69933-0 | Ureaplasma parvum DNA [Presence] in Specimen by NAA with probe detection |
| 70082-3 | Interleukin 4 [Mass/volume] in Body fluid |
| 81738-7 | RNA polymerase III RP155 Ab [Presence] in Serum by Line blot |
| 9773-3 | Ergotamine [Mass/volume] in Serum or Plasma |
| 82449-0 | Titin Ab [Presence] in Serum by Line blot |
| 82738-6 | Dopamine receptor D2 IgG Ab [Titer] in Serum by Immunoassay |
| 82933-3 | Sjogrens syndrome-A extractable nuclear 52kD IgG Ab [Presence] in Serum by Line blot |
| 98021-9 | Rivalta test [Presence] in Body fluid |
| 98982-2 | 6-Hydroxybuspirone [Mass/volume] in Urine by Confirmatory method |
| 71853-6 | Oxygen saturation [Pure mass fraction] in Blood |
| 7211-6 | Mozzarella Cheese triggered histamine release [Units/volume] in Blood |
| 84906-7 | Bladder neck involvement of Prostate tumor |
| 99371-7 | Culex mosquito IgG Ab [Mass/volume] in Serum |
| 72794-1 | Methylone/Creatinine [Mass Ratio] in Urine |
| 85837-3 | Beta-lactam resistance ESBL blaPER gene [Presence] by Molecular method |
| 85961-1 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 86136-9 | Streptococcus pneumoniae Danish serotype 6A IgG Ab [Mass/volume] in Serum |
| 86205-2 | Whole exome sequence analysis in Blood or Tissue by Molecular genetics method |
| 87419-8 | Cytolethal distending toxin B+Vinculin Ab [Interpretation] in Serum Qualitative by Immunoassay |
| 87798-5 | Tulathromycin [Susceptibility] |
| 88231-6 | Microscopic observation [Identifier] in Bile fluid by Acid fast stain |
| 74439-1 | GABA free and total panel - Cerebral spinal fluid |
| 41229-6 | Yellow Jacket IgG Ab [Mass/volume] in Serum |
| 59593-4 | 7-Aminoclonazepam [Mass/volume] in Body fluid |
| 30901-3 | Cold agglutinin [Titer] in Serum or Plasma by Cord RBC agglutination |
| 59936-5 | Nicotine [Moles/volume] in Urine |
| 31435-1 | Hyaluronidase Ab [Units/volume] in Serum |
| 31549-9 | Parainfluenza virus 1 IgM Ab [Units/volume] in Serum |
| 51081-8 | CD15 blasts/100 blasts in Blood |
| 43047-0 | Coxsackievirus A7 Ab [Titer] in Body fluid |
| 31895-6 | Mumps virus Ag [Presence] in Skin |
| 5180-5 | Hepatitis A virus IgG Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
| 43396-1 | Cholesterol non HDL [Mass/volume] in Serum or Plasma |
| 22391-7 | Legionella pneumophila 6 IgG Ab [Titer] in Serum |
| 22500-3 | Measles virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 52966-9 | Bacteria identified in Anal by Culture |
| 44373-9 | Homocysteine [Presence] in Urine |
| 22978-1 | Caprine arthritis encephalitis virus DNA [Presence] in Specimen by NAA with probe detection |
| 32696-7 | Legionella pneumophila 1+2+3+4+5+6 Ab [Titer] in Serum |
| 53260-6 | Glomerular basement membrane Ab [Presence] in Serum by Immunofluorescence |
| 44502-3 | Herpes simplex virus 2 Ag [Presence] in Tissue |
| 44734-2 | Urea nitrogen/Creatinine [Mass Ratio] in Blood |
| 3332-4 | Amitriptyline [Presence] in Serum or Plasma |
| 33659-4 | Pipecolate/Creatinine [Ratio] in Urine |
| 54306-6 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Amniotic fluid |
| 54414-8 | Leukocyte-poor plateletpheresis units given [#] |
| 46983-3 | Ethanol [Mass/volume] in Urine by Confirmatory method |
| 24387-3 | Brucella sp IgG Ab [Presence] in Serum by Immunoassay |
| 3451-2 | cefTRIAXone [Mass/volume] in Serum or Plasma |
| 34700-5 | HIV reverse transcriptase+protease gene mutations tested for |
| 34707-0 | Chlamydophila pneumoniae rRNA [Presence] in Specimen by Probe |
| 55431-1 | HLA-B27 cells [#/volume] in Blood |
| 25101-7 | Fumarate/Creatinine [Molar ratio] in Urine |
| 34728-6 | Carbon dioxide, total [Moles/volume] in Blood by calculation |
| 47765-3 | Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose glucose PO |
| 25576-0 | C peptide [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 25745-1 | Rheumatoid factor [Presence] in Body fluid by Sheep Cell Agglutination |
| 25993-7 | Trichinella spiralis Ab [Titer] in Serum by Immunofluorescence |
| 35741-8 | Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL |
| 56494-8 | Lutropin [Units/volume] in Serum or Plasma --2 hours post XXX challenge |
| 48220-8 | Oat triggered leukotriene release [Mass/volume] by Leukocytes |
| 2620-3 | Methionine [Presence] in Blood |
| 56769-3 | Lymphocytes/100 leukocytes in Bronchial specimen by Flow cytometry (FC) |
| 48372-7 | Spermatozoa Isolated Head/100 spermatozoa in Semen |
| 26858-1 | CD3+CD56+ cells [#/volume] in Blood |
| 38554-2 | Spermatozoa.head Motile w IgA/100 spermatozoa in Semen by Immunobead |
| 389-7 | Oxytetracycline [Susceptibility] by Serum bactericidal titer |
| 38992-4 | Amylase [Units/volume] in 24 hour Urine |
| 39547-5 | Tuna IgE Ab/IgE total in Serum |
| 39609-3 | Blueberry IgE Ab/IgE total in Serum |
| 58071-2 | Rg sup(a) Ag [Presence] on Red Blood Cells |
| 49411-2 | JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
| 49579-6 | Aminocaproate [Presence] in Serum or Plasma |
| 49687-7 | Trichoderma viride IgG Ab [Mass/volume] in Serum |
| 4010-5 | Pyrilamine [Mass/volume] in Urine |
| 58724-6 | Lymphocyte proliferation stimulated by 5 ug pokeweed mitogen actual/normal in Blood |
| 49825-3 | 16-Alpha hydroxyestrone [Mass/volume] in Serum or Plasma |
| 50025-6 | Volatiles panel - Serum or Plasma |
| 50147-8 | Gamma aminobutyrate [Moles/volume] in Body fluid |
| 58865-7 | Somatotropin [Mass/volume] in Serum or Plasma --43rd specimen |
| 59060-4 | Inflammatory bowel disease Ab 7 [Interpretation] in Serum |
| 50518-0 | Prolactin [Mass/volume] in Serum or Plasma --2nd specimen |
| 40897-1 | CD3+CD56+ cells [#/volume] in Body fluid |
| 19601-4 | Morphine Free [Presence] in Urine by Screen method |
| 101422-4 | Human coronavirus OC43 RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 13482-5 | Aldosterone/Creatinine [Mass Ratio] in Urine |
| 13705-9 | Albumin/Creatinine [Mass Ratio] in 24 hour Urine |
| 14194-5 | Spermatozoa Progressive/100 spermatozoa in Semen |
| 14439-4 | Cholesterol [Mass/volume] in Cerebral spinal fluid |
| 14560-7 | Mycobacterium tuberculosis DNA [Presence] in Urine by NAA with probe detection |
| 14754-6 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g glucose PO |
| 103670-6 | Gabapentin [Presence] in Cord tissue by Confirmatory method |
| 14815-5 | Lipoprotein.beta [Moles/volume] in Serum or Plasma by calculation |
| 15064-9 | Estriol (E3).unconjugated [Moles/volume] in Serum or Plasma |
| 15095-3 | Testosterone [Moles/time] in 24 hour Urine |
| 10573-4 | Ferning [Type] in Cervical mucus |
| 16459-0 | Bicarbonate [Moles/volume] in Body fluid |
| 16474-9 | Bordetella pertussis Ab [Units/volume] in Serum by Complement fixation |
| 16852-6 | Etodolac [Mass/volume] in Serum or Plasma |
| 17592-7 | Smith extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
| 18394-7 | HLA-A24(9) [Presence] |
| 1885-3 | Apolipoprotein C [Mass/volume] in Serum or Plasma |
| 92666-7 | Growth hormone and glucose post cloNIDine stimulation panel - Serum or Plasma |
| 75572-8 | Fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
| 75581-9 | Fetal Prader-Willi syndrome prior risk [Likelihood] based on general population risk Narrative |
| 61113-7 | Immunoglobulin gene rearrangements in Blood or Tissue by Molecular genetics method Narrative |
| 75882-1 | Lupus anticoagulant three screening tests W Reflex [interpretation] |
| 93017-2 | Plasma cells with abnormal marker pattern [#] in Bone marrow by Flow cytometry (FC) |
| 61242-4 | Chaetomium globosum IgE Ab/IgE total in Serum |
| 77137-8 | Bilirubin.total [Moles/volume] in Serum, Plasma or Blood |
| 77343-2 | Gamma globulin [Mass/volume] by Electrophoresis in Urine collected for unspecified duration |
| 93872-0 | Tamoxifen metabolites pattern [Interpretation] in Serum or Plasma |
| 94274-8 | Bedaquiline [Susceptibility] |
| 6248-9 | Soybean IgE Ab [Units/volume] in Serum |
| 62848-7 | Mirtazapine+Normirtazapine [Mass/volume] in Serum or Plasma |
| 63334-7 | SCL-70 extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) |
| 7861-8 | Eastern equine encephalitis virus IgM Ab [Units/volume] in Serum |
| 94355-5 | Glial nuclear type 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 9435-9 | Isopropanol [Mass/mass] in Tissue |
| 79312-5 | Gamma butyrobetaine/Trimethyllysine [Molar ratio] in Serum or Plasma |
| 95149-1 | Hepatitis B virus surface Ag panel - Serum or Plasma |
| 66137-1 | Metamyelocytes [#/volume] in Blood from Fetus by Manual count |
| 67563-7 | Legionella micdadei DNA [Presence] in Specimen by NAA with probe detection |
| 6808-0 | Aspergillus fumigatus 1 Ab [Presence] in Serum by Immune diffusion (ID) |
| 80692-7 | HIV 1 proviral DNA reverse transcriptase and protease gene mutations detected [Identifier] in Blood mononuclear cells by Sequencing |
| 81100-0 | Leptospira interrogans sv Celledoni Ab [Titer] in Serum by Agglutination |
| 69561-9 | Thyrotropin [Units/volume] in Cord blood |
| 69726-8 | Tissue transglutaminase IgA + Gliadin peptides IgA and IgG panel - Serum |
| 82183-5 | Haemophilus influenzae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
| 70094-8 | Prostaglandin F2 alpha [Mass/volume] in Cerebral spinal fluid |
| 98061-5 | Wild garlic (Allium ursinum) IgE Ab [Units/volume] in Serum |
| 98986-3 | Chloride/Creatinine [Molar ratio] in 24 hour Urine |
| 71784-3 | Rift valley fever virus IgG Ab [Titer] in Serum by Immunoassay |
| 72357-7 | Microscopic observation [Presence] in Specimen by Acid fast stain |
| 85510-6 | NRAS gene mutations found [Identifier] in Colorectal cancer specimen by Molecular genetics method Nominal |
| 99512-6 | Weight of Brain |
| 99547-2 | Stenosis degree [Length fraction] in Distal right coronary artery by Autopsy |
| 85973-6 | Streptococcus pneumoniae Danish serotype 12F Ab [Presence] in Serum |
| 86016-3 | Streptococcus pneumoniae Danish serotype 18F IgG Ab [Mass/volume] in Serum |
| 73169-5 | raNITIdine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74119-9 | P504S Ag [Presence] in Tissue by Immune stain |
| 899-5 | Blood group antibody screen.cell II [Presence] in Serum or Plasma by Prewarmed |
| 41294-0 | S-phase cells [Presence] in Specimen |
| 59627-0 | cloBAZam [Mass/volume] in Blood by Confirmatory method |
| 51027-1 | CD117 blasts/100 blasts in Specimen |
| 4177-2 | Chlorothiazide [Mass] of Dose |
| 21577-2 | Transferrin.carbohydrate deficient.trisialo/Transferrin.total in Serum or Plasma |
| 21613-5 | Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection |
| 31186-0 | Platelet IgM Ab [Presence] in Serum |
| 31431-0 | HTLV I+II IgG Ab [Presence] in Serum |
| 22229-9 | Coxsackievirus B3 Ab [Titer] in Cerebral spinal fluid |
| 3162-5 | Volume [Mass/time] of 24 hour Stool |
| 43324-3 | Avian reovirus Ab [Presence] in Serum by Immunofluorescence |
| 32132-3 | Lactate [Moles/volume] in Arterial plasma |
| 43994-3 | Trisomy 18 risk [Likelihood] in Fetus |
| 33026-6 | Hemoglobin [Mass/volume] in Arterial cord blood by calculation |
| 53458-6 | Carbon dioxide [Partial pressure] in Nonbiological fluid |
| 33368-2 | Amylase [Enzymatic activity/volume] in Pericardial fluid |
| 23901-2 | Microscopic observation [Identifier] in Body fluid by Wet preparation |
| 54204-3 | Thiacetazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 54342-1 | Tiglylglycine [Moles/volume] in Cerebral spinal fluid |
| 46413-1 | Calcitonin [Mass/volume] in Serum or Plasma --7 minutes post 0.5 ug/kg pentagastrin IV |
| 24115-8 | Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunoassay |
| 24501-9 | Parrot droppings Ab [Presence] in Serum by Immune diffusion (ID) |
| 34657-7 | Spermatozoa Immotile [#/volume] in Semen |
| 54906-3 | Norovirus genogroup II RNA [Presence] in Stool by NAA with probe detection |
| 4739-9 | HLA-A3 [Presence] |
| 25190-0 | Clarithromycin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25513-3 | Renin [Enzymatic activity/volume] in Plasma --1st specimen post XXX challenge |
| 35164-3 | Alpha linolenate (C18:3w3) [Moles/volume] in Serum or Plasma |
| 55882-5 | Hydroxocobalamin [Moles/volume] in Body fluid |
| 4752-2 | HLA-B48 [Presence] in Donor |
| 4779-5 | HLA-B62(15) [Presence] |
| 35445-6 | HIV 1 p51 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
| 35745-9 | Fat/Total solids [Mass Ratio] in Stool |
| 56484-9 | Uroporphyrin [Mass/mass] in Stool |
| 48317-2 | Leishmania tropica IgM Ab [Titer] in Serum by Immunofluorescence |
| 26697-3 | Clostridioides difficile IgA Ab [Units/volume] in Serum |
| 35795-4 | Dirithromycin [Susceptibility] |
| 35809-3 | Fosfomycin [Susceptibility] by Gradient strip |
| 38193-9 | Amylase [Enzymatic activity/time] in Urine collected for unspecified duration |
| 48348-7 | 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma |
| 48587-0 | Collagen crosslinked C-telopeptide/Creatinine [Ratio] in Urine |
| 26802-9 | Midazolam [Mass/mass] in Hair |
| 38410-7 | Basement membrane zone Ab [Titer] in Serum |
| 57592-8 | Aldosterone [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 57651-2 | C peptide [Moles/volume] in Serum or Plasma --1.3 hours post XXX challenge |
| 49119-1 | Monosaccharides.sulfated [Presence] in Urine |
| 57995-3 | Leucine/Phenylalanine [Mass Ratio] in DBS |
| 49390-8 | Herpes virus 6 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
| 49690-1 | Mirtazapine [Mass/volume] in Urine |
| 29253-2 | Alpha-1-Fetoprotein [Multiple of the median] adjusted in Amniotic fluid |
| 29536-0 | West Nile virus IgM Ab [Units/volume] in Serum |
| 29694-7 | Leptospira interrogans sv Celledoni Ab [Presence] in Serum |
| 40722-1 | Hemosiderin [Presence] in Sputum |
| 50180-9 | Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV |
| 50412-6 | Neisseria gonorrhoeae rRNA [Presence] in Specimen from Donor by NAA with probe detection |
| 50529-7 | Parathyrin.intact [Mass/volume] in Serum or Plasma --5th specimen |
| 30291-9 | Efavirenz [Susceptibility] by Genotype method |
| 408-5 | Piperacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 40950-8 | Yersinia enterocolitica O:8 Ab [Presence] in Cerebral spinal fluid |
| 20827-2 | Gallotannin [Mass/mass] in Gastric fluid |
| 100389-6 | Pistachio IgG Ab [Units/volume] in Serum |
| 12740-7 | Insulin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 101736-7 | Calcium hydrogen phosphate dihydrate (CHPD) in 24 hour Urine |
| 101934-8 | Urate crystals [Energy Difference] in Urine |
| 14248-9 | Purkinje cells Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 1429-0 | Cortisol [Mass/volume] in Serum or Plasma --50 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 102916-4 | Hexahydrophthalic anhydride (HHPA) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14918-7 | Thyroglobulin [Moles/volume] in Serum or Plasma |
| 15167-0 | Complement C6 [Mass/volume] in Body fluid |
| 10668-2 | Fungus identified in Specimen by Environmental culture |
| 10677-3 | Herpes simplex virus 1 Ag [Presence] in Tissue by Immune stain |
| 15235-5 | Occupational Allergen Mix 1 (Chicken feather+Cow dander+Goose feather+Horse dander) IgE Ab [Presence] in Serum by Multidisk |
| 1602-2 | Norepinephrine [Mass/volume] in Plasma --10 minutes post standing |
| 16252-9 | HYDROcodone [Mass/volume] in Urine by Confirmatory method |
| 16318-8 | Acrylamide [Mass/volume] in Urine |
| 11154-2 | Cholinesterase [Enzymatic activity/volume] in Blood |
| 11589-9 | Brucella suis Ab [Units/volume] in Serum |
| 16941-7 | Herbicide [Identifier] in Specimen |
| 17047-2 | Latex Bencard IgE Ab [Units/volume] in Serum |
| 17696-6 | Tetrachlorodiphenylethane [Mass/volume] in Urine |
| 17810-3 | Prealbumin/Protein.total in Body fluid by Electrophoresis |
| 1787-1 | Alpha aminobutyrate [Presence] in Serum or Plasma |
| 18200-6 | Blastomyces dermatitidis IgM Ab [Presence] in Serum |
| 90072-0 | Haemophilus and Neisseria species identified in Isolate by Organism specific culture |
| 91081-0 | Candida sp DNA [Presence] in Specimen by NAA with probe detection |
| 91672-6 | ABCB1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 92511-5 | Co sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 76493-6 | Nitrazepam [Moles/volume] in Gastric fluid |
| 92951-3 | Streptococcus agalactiae DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection |
| 93421-6 | Glial fibrillary acidic protein alpha subunit IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 62372-8 | FISH probe vendor [Identifier] in Laboratory device |
| 77105-5 | HARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 93853-0 | N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/volume] in Urine |
| 63192-9 | Yellow Dock IgG Ab [Mass/volume] in Serum |
| 78002-3 | CD34 dose in hematopoietic progenitor cell transfusion [#/mass] per recipient body mass |
| 78837-2 | JWH-018 pentanoate (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
| 94445-4 | HLA-A IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC) |
| 79383-6 | Salmonella sp rpoD gene [Presence] in Stool by NAA with probe detection |
| 6580-5 | Vibrio sp identified in Water by Organism specific culture |
| 66124-9 | Testis Pathology biopsy report |
| 6658-9 | Microscopic observation [Identifier] in Tissue by Acridine orange stain |
| 80178-7 | S-adenosylmethionine and S-adenosylhomocystine panel - Serum or Plasma |
| 67837-5 | Cells Counted Total [#] in Bronchial specimen |
| 80639-8 | Gamma-amanitin [Mass/volume] in Urine |
| 96530-1 | Sandfly fever Naples virus IgM Ab [Presence] in Specimen by Immunoassay |
| 96670-5 | HLA-DRB3 and HLA-DRB4 and HLA DRB5 [Type] in Donor |
| 6952-6 | TOLBUTamide [Mass/volume] in Specimen |
| 81712-2 | Actin.filamentous Ab [Presence] in Serum by Line blot |
| 82223-9 | Cystathionine beta synthase [Enzymatic activity/mass] in Fibroblast |
| 9759-2 | Coxsackievirus B1 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 70089-8 | Interleukin 13 [Mass/volume] in Cerebral spinal fluid |
| 70139-1 | Barbiturates [Presence] in Urine by Screen method >300 ng/mL |
| 8261-0 | Service comment 19 |
| 71889-0 | Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial blood |
| 85092-5 | Liver diseases autoimmune IgG panel - Serum or Plasma by Line blot |
| 99918-5 | Amorphous sediment [Presence] in Urine sediment by Automated |
| 85981-9 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum --2nd specimen |
| 88517-8 | Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] corrected for background in Blood |
| 7429-4 | Isocyanate HDI IgE Ab [Units/volume] in Serum |
| 88910-5 | Taenia sp DNA [Presence] in Specimen by NAA with probe detection |
| 89506-0 | Nucleosome Ab [Presence] in Serum by Line blot |
| 89594-6 | Legionella pneumophila Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
| 89637-3 | Mycobacterium sp identified in Implanted device by Organism specific culture |
| 50914-1 | Strontium [Moles/volume] in Urine |
| 60138-5 | PARoxetine [Mass/mass] in Tissue |
| 21175-5 | Cephalexin [Mass/volume] in Specimen |
| 21218-3 | Complement total hemolytic CH50 [Units/volume] in Cerebral spinal fluid |
| 21279-5 | Follitropin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 31261-1 | Bluetongue virus 11 Ab [Units/volume] in Serum |
| 51093-3 | Cytoplasmic CD179a blasts [Units/volume] in Blood |
| 32220-6 | Liver kidney microsomal 1 Ab [Units/volume] in Serum |
| 53301-8 | Urate crystals [#/volume] in Urine by Computer assisted method |
| 5338-9 | Salmonella sp Ab [Titer] in Serum by Latex agglutination |
| 23509-3 | Trypanosoma equiperdum [Presence] in Body fluid by Light microscopy |
| 23536-6 | Trypanosoma sp identified in Blood by Concentration |
| 23539-0 | Tuberculosis reaction wheal [Diameter] --3 days post dose mammalian tuberculin intradermal |
| 33278-3 | Acetylcholine receptor blocking Ab [Moles/volume] in Serum |
| 5395-9 | Trichinella spiralis Ab [Titer] in Serum by Latex agglutination |
| 23807-1 | Albumin [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis |
| 23892-3 | Magnesium [Moles/time] in 24 hour Stool |
| 2404-2 | Hemopexin [Mass/volume] in Urine |
| 34058-8 | Glucose [Moles/volume] in Serum or Plasma --pre or post dose glucagon |
| 3418-1 | Butabarbital [Mass/volume] in Serum or Plasma |
| 4659-9 | Leukocyte phosphatase [Enzymatic activity/volume] in Leukocytes |
| 34429-1 | Timothy recombinant (rPhl p) 1 + 5b IgE Ab [Units/volume] in Serum |
| 55333-9 | little f Ab [Titer] in Serum or Plasma |
| 55353-7 | Hirudin [Mass/volume] in Platelet poor plasma by Chromogenic method |
| 47474-2 | Legionella pneumophila 9 IgM Ab [Titer] in Serum |
| 47593-9 | C peptide [Moles/volume] in Serum or Plasma --5 minutes pre dose glucose |
| 47600-2 | Ceruloplasmin [Moles/volume] in Serum or Plasma |
| 47697-8 | Mandelate/Creatinine [Molar ratio] in Urine |
| 25718-8 | Lutropin [Units/volume] in Serum or Plasma --1 hour post 100 ug luteinizing releasing hormone IV |
| 26484-6 | Monocytes [#/volume] in Blood |
| 26648-6 | Sindbis virus Ab [Presence] in Serum |
| 35791-3 | Difloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 38655-7 | 2-Chloroacetophenone [Mass/volume] in Air |
| 2747-4 | pH of Cerebral spinal fluid |
| 38739-9 | 1,3-Dichloropropene [Mass/volume] in Air |
| 57757-7 | IKBKG gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 57937-5 | Cholesterol in HDL 3a [Mass/volume] in Serum or Plasma |
| 57986-2 | Insulin-like growth factor [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 58039-9 | HLA-B SBT [Type] in Bone marrow by High resolution |
| 49369-2 | Hepatitis C virus RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 2842-3 | Prolactin [Mass/volume] in Serum or Plasma |
| 39983-2 | Creatinine [Mass/volume] in Urine --30 minutes post XXX challenge |
| 40150-5 | Glucose [Moles/volume] in Serum or Plasma --15 minutes pre XXX challenge |
| 49782-6 | Mononuclear cells/100 leukocytes in Pericardial fluid |
| 29650-9 | Rickettsia honei Ab [Titer] in Serum by Immunofluorescence |
| 29808-3 | Trivittatus virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 40582-9 | Cryoglobulin.IgG [Mass/volume] in Serum by 37 degree C incubation |
| 50461-3 | C peptide [Moles/volume] in Serum or Plasma --1st specimen |
| 29980-0 | Tin [Mass/time] in 24 hour Urine |
| 30166-3 | Thyroid stimulating immunoglobulins actual/normal in Serum |
| 1973-7 | Bilirubin.total [Mass/volume] in Cerebral spinal fluid |
| 20447-9 | HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 2102-2 | Chondroitin sulfate [Mass/volume] in Urine |
| 101065-1 | Co4 Ab [Presence] in Serum or Plasma |
| 101369-7 | Bacillus anthracis plasmid pXO1 DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 13182-1 | Mesquite IgG Ab [Units/volume] in Serum |
| 13259-7 | Leishmania brasilensis IgM Ab [Units/volume] in Serum |
| 101857-1 | predniSONE [Moles/volume] in Urine |
| 102292-0 | Elk or Moose Meat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102549-3 | Pyrethrum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102852-1 | Finch droppings IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102887-7 | Dry-rot Fungus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14802-3 | Isopropanol [Moles/volume] in Serum or Plasma |
| 14901-3 | raNITIdine [Presence] in Serum or Plasma |
| 16508-4 | Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge |
| 16521-7 | Calcium [Moles/volume] in Urine --3rd specimen post XXX challenge |
| 17416-9 | Parakeet droppings Ab [Units/volume] in Serum |
| 17501-8 | Protoporphyrin [Mass/volume] in Serum or Plasma |
| 18366-5 | Cytochrome C oxidase [Enzymatic activity/mass] in Tissue |
| 90244-5 | Natural killer cell cytotoxicity.IL-stimulated 15:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
| 747-6 | Myeloblasts/100 leukocytes in Blood by Manual count |
| 92504-0 | Fy sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 92778-0 | Staphylococcus sp DNA [Presence] by NAA with probe detection in Positive blood culture |
| 75696-5 | Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Anorectal specimen by Probe and signal amplification method |
| 6071-5 | Chicken meat IgE Ab [Units/volume] in Serum |
| 92883-8 | Parainfluenza virus 1+2+3+4 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 61225-9 | Aureobasidium pullulans IgE Ab/IgE total in Serum |
| 77619-5 | Fetal chromosome 13+18+21+Y aneuploidy [Presence] based on dosage of chromosome-specific cell-free DNA from Maternal plasma |
| 77629-4 | PARK7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 93752-4 | Atypical porcine pestivirus RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 94192-2 | SLC25A20 gene full mutation analysis in Blood or Tissue by Sequencing |
| 77777-1 | Normeperidine cutoff [Mass/volume] in Urine for Confirmatory method |
| 7787-5 | Yogurt IgE Ab [Units/volume] in Serum |
| 95177-2 | Avian reovirus Ab [Titer] in Serum by Immunoassay |
| 95596-3 | PCA-Tr Ab [Units/volume] in Cerebral spinal fluid by Line blot |
| 6676-1 | Enterobius vermicularis [Presence] in Anal by Pinworm exam |
| 79598-9 | Beta alanine and Beta aminoisobutyrate and Gamma aminobutyrate pattern [Interpretation] in Urine Narrative |
| 80100-1 | D-2-hydroxyglutarate/Creatinine [Molar ratio] in Urine |
| 80197-7 | Antihistamines [Presence] in Serum or Plasma by Screen method |
| 96411-4 | Pancreatic polypeptide [Mass/volume] in Serum or Plasma --10M post sham feeding |
| 96829-7 | SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen from Donor by NAA with probe detection |
| 96924-6 | Intercellular bridge nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 700-5 | Pneumocystis jiroveci Ag [Presence] in Specimen by Immunofluorescence |
| 82222-1 | Amylo-alpha-1,6-glucosidase [Enzymatic activity/mass] in Leukocytes |
| 7015-1 | Fusidate [Susceptibility] by Gradient strip |
| 82498-7 | TRBV5 gene segments/TRBV gene segments.total in Blood |
| 98062-3 | Sequencing study identifier |
| 98994-7 | Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma by Electrophoresis |
| 85622-9 | Zika virus RNA [Presence] in Serum or Plasma by NAA with probe detection |
| 99449-1 | European paper wasp IgG4 Ab [Mass/volume] in Serum |
| 72766-9 | oxyMORphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 88712-5 | Lipase [Enzymatic activity/volume] in Peritoneal dialysis fluid |
| 59902-7 | FLUoxetine [Moles/volume] in Urine |
| 50667-5 | Glucose tolerance [Interpretation] in Serum or Plasma Narrative |
| 21241-5 | diazePAM+Nordiazepam [Mass/volume] in Urine |
| 31365-0 | Endomysium Ab [Presence] in Serum |
| 31389-0 | Feline leukemia virus Ab [Units/volume] in Serum |
| 51078-4 | CD14 blasts [Units/volume] in Blood |
| 51599-9 | Methotrexate [Moles/volume] in Serum or Plasma --12 hours post dose |
| 5175-5 | Helicobacter pylori Ab [Titer] in Serum by Latex agglutination |
| 43632-9 | 6-Methylmercaptopurine [Presence] in Red Blood Cells |
| 4369-5 | Oxprenolol [Mass] of Dose |
| 32502-7 | CD10+CD19+ cells/100 cells in Blood |
| 5201-9 | Hepatitis D virus Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
| 53062-6 | Argininosuccinate [Moles/volume] in DBS |
| 43960-4 | CD3+HLA-DR+ cells [#/volume] in Tissue |
| 22961-7 | Burkholderia mallei reaction [Appearance] -2D post 0.1 mL mallein intradermal- |
| 32672-8 | Cold agglutinin [Presence] in Serum or Plasma |
| 33194-2 | Viable cells/100 cells in Specimen |
| 53112-9 | Carnitine free (C0)/Carnitine.total in Amniotic fluid |
| 44517-1 | Herpes simplex virus DNA [Presence] in Amniotic fluid by NAA with probe detection |
| 44550-2 | Human papilloma virus DNA [Presence] in Cervix by Probe |
| 4463-6 | Spermatozoa motility and count panel |
| 45026-2 | HLA-A2 SBT [Type] by High resolution |
| 45305-0 | Coproporphyrin 1 [Moles/mass] in Stool |
| 23674-5 | Bluetongue virus 17 neutralizing antibody [Titer] in Serum by Neutralization test |
| 24004-4 | Chlamydophila pneumoniae IgM Ab [Presence] in Serum |
| 34216-2 | 11-Ketoetiocholanolone [Moles/volume] in 24 hour Urine |
| 53974-2 | Erythrocyte morphology [Interpretation] in Urine sediment by Light microscopy Narrative |
| 24421-0 | Haemobartonella felis [Presence] in Blood by Light microscopy |
| 34311-1 | Galactose [Moles/volume] in Urine |
| 4729-0 | HLA-A29(19) [Presence] |
| 25575-2 | C peptide [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 25643-8 | Follitropin [Units/volume] in Serum or Plasma --2 hours post 100 ug luteinizing releasing hormone IV |
| 25913-5 | Fluoride/Creatinine [Molar ratio] in 24 hour Urine |
| 35559-4 | Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis |
| 2657-5 | Nitrite [Mass/volume] in Urine |
| 26605-6 | Beta aminoisobutyrate [Moles/volume] in Serum or Plasma |
| 374-9 | Ofloxacin [Susceptibility] by Minimum lethal concentration (MLC) |
| 5659-8 | Gold [Mass/volume] in Serum or Plasma |
| 48662-1 | Lymphocyte proliferation stimulated by phytohemagglutinin [Ratio] in Blood |
| 48836-1 | Respiratory allergen panel, US - Southern coastal California - Serum |
| 38281-2 | Lymphocyte proliferation stimulated by 2.41 ug/mL tetanus toxoid [Units/volume] in Blood |
| 3829-9 | Morphine Free [Mass/volume] in Urine |
| 57516-7 | 11-Hydroxyetiocholanolone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
| 49295-9 | Protein Fractions [Interpretation] in Cerebral spinal fluid by Electrophoresis Narrative |
| 2728-4 | Parathion [Mass/volume] in Serum or Plasma |
| 27885-3 | Lutropin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 57723-9 | Unique bar code number of Current sample |
| 57872-4 | Strychnine [Moles/volume] in Specimen |
| 49496-3 | BCR-ABL1 e1a1 fusion protein [Presence] in Blood or Tissue by Molecular genetics method |
| 49714-9 | Interleukin 8 [Mass/volume] in Body fluid |
| 49744-6 | Plasmodium ovale IgG Ab [Titer] in Serum by Immunofluorescence |
| 29359-7 | Parainfluenza virus 2 Ab [Titer] in Body fluid |
| 29494-2 | Demeclocycline [Mass/volume] in Specimen |
| 5868-5 | Parainfluenza virus 1 Ag [Presence] in Throat by Immunofluorescence |
| 58728-7 | Lymphocyte proliferation stimulated by 5 ug phytohemagglutin actual/normal in Blood |
| 49763-6 | Bilirubin.total [Mass/volume] in Pericardial fluid |
| 29688-9 | Orientia tsutsugamushi Karp Ab [Titer] in Serum |
| 40504-3 | Powassan virus Ab [Titer] in Serum by Complement fixation |
| 40514-2 | Saint Louis encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 30071-5 | Trichoderma viride IgG Ab [Units/volume] in Serum |
| 19326-8 | Alpha hydroxyalprazolam [Presence] in Urine by Confirmatory method |
| 100133-8 | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot |
| 100887-9 | Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection |
| 12824-9 | Prolactin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 1291-4 | P1 Ag [Presence] on Red Blood Cells |
| 13203-5 | Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 101752-4 | Tau protein/Tau protein.phosphorilated 181 [Mass Ratio] in Cerebral spinal fluid |
| 13733-1 | DOPamine/Creatinine [Mass Ratio] in Urine |
| 102368-8 | Pecan or Hickory Nut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102464-5 | White Oak IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14095-4 | Fibronectin aggregate IgG Ab [Units/volume] in Serum |
| 14927-8 | Triglyceride [Moles/volume] in Serum or Plasma |
| 104242-3 | T cell lymphoma multigene analysis in Blood or Tissue by Molecular genetics method |
| 104263-9 | Galactosylceramidase [Enzymatic activity/volume] in Serum by LC/MS/MS |
| 1560-2 | Insulin [Mass/volume] in Serum or Plasma --1 hour post dose TOLBUTamide IV |
| 12324-0 | hydrOXYzine [Presence] in Urine |
| 91087-7 | Fungal BT2 gene [Presence] in Isolate by NAA with probe detection |
| 7459-1 | Lentils IgG Ab [Units/volume] in Serum |
| 74774-1 | Glucose [Mass/volume] in Serum, Plasma or Blood |
| 74919-2 | Caffeine [Mass/volume] in Serum or Plasma --trough |
| 75-2 | ceFAZolin [Susceptibility] by Minimum lethal concentration (MLC) |
| 7535-8 | Valley Oak IgE Ab [Units/volume] in Serum |
| 93685-6 | Gas and Carbon monoxide and Electrolytes panel - Arterial blood |
| 61377-8 | Human papilloma virus 35 DNA [Presence] in Specimen by NAA with probe detection |
| 63163-0 | Paecilomyces sp IgG Ab [Mass/volume] in Serum |
| 7875-8 | Ehrlichia chaffeensis IgG Ab [Units/volume] in Serum by Immunoassay |
| 9451-6 | Hexacarboxylporphyrin [Mass/volume] in Serum or Plasma |
| 6346-1 | Chlamydia sp Ag [Presence] in Genital specimen by Immunofluorescence |
| 78888-5 | Trimeprazine [Mass/volume] in Urine |
| 78967-7 | Sedoheptulose/Creatinine [Molar ratio] in Urine |
| 79332-3 | L-2-hydroxyglutarate [Moles/volume] in DBS |
| 7934-3 | Japanese encephalitis virus Ab [Presence] in Serum by Immunoassay |
| 66874-9 | FMR1 gene activation in Blood by Molecular genetics method |
| 7979-8 | Parainfluenza virus 2 Ab [Units/volume] in Serum |
| 80148-0 | Tricyclic antidepressants [Presence] in Serum or Plasma by Screen method |
| 80195-1 | Ecgonine methyl ester [Mass/volume] in Serum or Plasma by Confirmatory method |
| 80695-0 | HIV 1 proviral DNA genotype in Mononuclear cells from whole blood |
| 82166-0 | Influenza virus A RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 7247-0 | Corn triggered histamine release [Units/volume] in Blood |
| 85039-6 | JAK2 gene.p.Val617Phe mutant/Normal in Bone marrow by Molecular genetics method |
| 99625-6 | PCA-2 Ab [Presence] in Serum by Line blot |
| 99773-4 | SARS coronavirus 2 stimulated gamma interferon release by T-cells.Spike Ag spot count [#] corrected for background in Blood |
| 99779-1 | Neisseria gonorrhoeae rRNA [Presence] in Conjunctival specimen by NAA with probe detection |
| 72739-6 | Nordiazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 86101-3 | Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 86104-7 | Streptococcus pneumoniae Danish serotype 10A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 87319-0 | Escherichia coli enteroaggregative astA gene [Presence] in Isolate by NAA with probe detection |
| 88193-8 | Influenza virus A RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 30433-7 | Metamyelocytes [#/volume] in Blood |
| 31115-9 | Aneuploid cell population 2/100 cells in Specimen |
| 31130-8 | Mumps virus soluble Ab [Titer] in Serum |
| 4248-1 | N-ethylnicotinamide [Mass] of Dose |
| 42660-1 | Alpha 2 laminin [Presence] in Tissue by Immune stain |
| 59933-2 | Mexiletine [Moles/volume] in Gastric fluid |
| 6015-2 | Wattle IgE Ab [Units/volume] in Serum |
| 43028-0 | Herpes simplex virus 2 Ab [Titer] in Serum |
| 21700-0 | Kallmann syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21805-7 | t(12;16)(q13;p11.2)(DDIT3,FUS) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 43386-2 | Neisseria sp identified in Anal by Organism specific culture |
| 22451-9 | PRRSV Ab [Presence] in Serum |
| 22493-1 | Rickettsia typhus group IgG Ab [Titer] in Serum |
| 51960-3 | DNA marker results panel |
| 523-1 | Vancomycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 5303-3 | Rickettsia (Proteus OX19) Ab [Presence] in Serum by Latex agglutination |
| 439-0 | Rosoxacin [Susceptibility] by Minimum lethal concentration (MLC) |
| 44247-5 | Spermatozoa Motile [#/area] in Vaginal fluid by Wet preparation |
| 4430-5 | sulfADIAZINE [Mass] of Dose |
| 22954-2 | Brucella suis rRNA [Presence] in Specimen by Probe |
| 53307-5 | Crystals unspecified [#/area] in Urine by Computer assisted method |
| 53473-5 | Eicosanoylcarnitine (C20) [Moles/volume] in Serum or Plasma |
| 448-1 | Sisomicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 33384-9 | Segmented neutrophils/100 leukocytes in Peritoneal fluid |
| 53542-7 | Dodeicosanoylcarnitine (C22) [Moles/volume] in Amniotic fluid |
| 45142-7 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
| 45227-6 | Blackberry IgE Ab/IgE total in Serum |
| 33831-9 | Lymphoblasts/100 leukocytes in Blood by Manual count |
| 338-4 | Miocamycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 33959-8 | Procalcitonin [Mass/volume] in Serum or Plasma |
| 2446-3 | Hydroxyproline [Mass/volume] in Serum or Plasma |
| 24488-9 | Epidermal Allergen Mix 73 (Chicken feather+Duck feather+Goose feather+Parrot feather) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 55366-9 | CD138+Lambda+ Cells/100 cells in Blood |
| 47132-6 | Thioridazine [Moles/volume] in Urine |
| 25371-6 | Cholesterol in VLDL [Moles/volume] in Serum or Plasma |
| 25374-0 | Chromium [Moles/volume] in Serum or Plasma |
| 25410-2 | Filaria IgG Ab [Units/volume] in Serum by Immunoassay |
| 25411-0 | Fleroxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 35078-5 | Unspecified cells [#/volume] in Body fluid |
| 35148-6 | Tetradecadienoate (C14:2) [Moles/volume] in Serum or Plasma |
| 55805-6 | cycloSPORINE [Mass/volume] in Blood by LC/MS/MS |
| 25578-6 | C peptide [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 2598-1 | Magnesium [Moles/volume] in Urine |
| 56337-9 | Onion IgG4 Ab [Mass/volume] in Serum |
| 47989-9 | Progesterone [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 48105-1 | Cortisol [Mass/volume] in Serum or Plasma --8 PM specimen |
| 26458-0 | Erythrocytes [#/volume] in Synovial fluid |
| 3614-5 | Ethoheptazine [Mass/volume] in Urine |
| 48613-4 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --15 minutes post dose lactose PO |
| 48622-5 | Urea nitrogen [Mass/volume] in Peritoneal fluid --24 hours post peritoneal dialysis |
| 48629-0 | Urea nitrogen [Mass/volume] in Venous blood --post dialysis |
| 27168-4 | Herpes virus 6 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 27186-6 | Lysozyme [Presence] in Stool |
| 57629-8 | Alpha cortolone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
| 49004-5 | Creatinine [Mass/volume] in Peritoneal dialysis fluid |
| 27324-3 | Amobarbital [Mass/mass] in Meconium |
| 494-5 | Temocillin [Susceptibility] by Serum bactericidal titer |
| 29254-0 | Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 49903-8 | Hippurate/Creatinine [Molar ratio] in 24 hour Urine |
| 29829-9 | La Crosse virus IgM Ab [Presence] in Specimen |
| 40352-7 | MT-ND5 gene m.13513G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 40492-1 | Plasma cells/100 leukocytes in Synovial fluid by Manual count |
| 50527-1 | Parathyrin.intact [Mass/volume] in Serum or Plasma --3rd specimen |
| 30045-9 | Mycobacterium sp identified in Dialysis fluid by Organism specific culture |
| 30320-6 | CD3+IL2R1+ cells [#/volume] in Blood |
| 4076-6 | Trimeperidine [Mass/volume] in Urine |
| 19712-9 | traMADol cutoff [Mass/volume] in Urine for Screen method |
| 19764-0 | Statement of adequacy [Interpretation] of Cervical or vaginal smear or scraping by Cyto stain |
| 20508-8 | Reagin Ab [Units/volume] in Serum or Plasma by RPR |
| 100392-0 | Duck meat IgG Ab [Units/volume] in Serum |
| 12451-1 | Ketones [Mass/volume] in Urine by Test strip --3 hours post XXX challenge |
| 12870-2 | HIV 1 gp34 Ab [Presence] in Serum by Immunoblot |
| 101248-3 | Pathologic casts [Presence] in Urine sediment by Light microscopy |
| 101558-5 | Escherichia coli enteroinvasive DNA [Presence] in Stool by NAA with probe detection |
| 13031-0 | Xylose [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
| 13455-1 | Lithium.plasma/Lithium.RBC [Mass Ratio] in Blood |
| 102308-4 | Firebush IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1023-1 | Fy sup(a) Ab [Presence] in Serum or Plasma from Donor |
| 14126-7 | HIV 1 gp120+gp160 Ab [Presence] in Serum by Immunoblot |
| 14164-8 | Immunosuppressive acidic protein [Mass/volume] in Serum or Plasma |
| 102669-9 | Salmon IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14736-3 | Gastrin [Moles/volume] in Serum or Plasma --15 minutes post 0.2 U/kg secretin |
| 103196-2 | Proteus vulgaris DNA [Presence] in Urine by NAA with probe detection |
| 10882-9 | Pentacarboxylporphyrins [Mass/volume] in Serum or Plasma |
| 16463-2 | Bile acid.dihydroxy [Mass/volume] in Serum or Plasma |
| 17474-8 | Porphobilinogen [Moles/volume] in Serum or Plasma |
| 18225-3 | Erythrocyte shape [Morphology] in Blood |
| 92506-5 | E Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 93424-0 | Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 63317-2 | Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) |
| 63435-2 | Brucella abortus Ab [Titer] in Cerebral spinal fluid by Antihuman globulin |
| 6413-9 | Giardia lamblia Ag [Presence] in Specimen by Immunoassay |
| 64419-5 | KIR gene allele 2DL5 [Presence] in Blood or Tissue by Molecular genetics method |
| 7927-7 | Influenza virus A Port Chalmers Ab [Units/volume] in Serum |
| 95273-9 | Aquaporin 4 water channel IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay |
| 97188-7 | Ryanodine receptor Ab [Presence] in Serum by Immunoblot |
| 69566-8 | Bacterial vaginosis associated bacterium 2 DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 82100-9 | Grass Allergen Mix 6 (Brome+Bermuda grass+Velvet grass+Perennial rye grass+Bahia grass+Johnson grass) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 98261-1 | Stromal invasion [Presence] in Endometrial cancer specimen |
| 71832-0 | Hematocrit [Pure volume fraction] of Arterial blood |
| 83130-5 | 11-Deoxytetrahydrocorticosterone/Creatinine [Molar ratio] in Urine |
| 726-0 | Hemoglobin [Mass/volume] in Urine |
| 85905-8 | Cancer pathology panel - Colorectal cancer specimen by CAP cancer protocols |
| 85974-4 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum by Immunoassay |
| 860-7 | A2 B Ag [Presence] on Red Blood Cells from Blood product unit |
| 73057-2 | Acetylsalicylate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87630-0 | Mevinphos [Mass/mass] in Specimen |
| 74096-9 | Tacrolimus [Mass/volume] in Blood by Immunoassay |
| 88698-6 | Protein electrophoresis panel - Body fluid |
| 41506-7 | Polio virus neutralizing Ab panel - Serum by Neutralization test |
| 50721-0 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 50857-2 | Histamine [Moles/volume] in 3 hour Urine |
| 31114-2 | Aneuploid cell population 1/100 cells in Specimen |
| 41851-7 | Thyme IgG Ab [Units/volume] in Serum |
| 60089-0 | Indium [Mass/volume] in Red Blood Cells |
| 51222-8 | CD105 cells/100 cells in Tissue |
| 51300-2 | CD3+CD4+ (T4 helper) cells/100 cells in Tissue |
| 42938-1 | CFTR gene allele 1 [Presence] in Blood or Tissue by Molecular genetics method |
| 42995-1 | Leptospira borgpetersenii sv Tarrasovi Ab [Titer] in Serum |
| 43086-8 | Babesia divergens Ab [Titer] in Serum |
| 21746-3 | BCL6 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 2219-4 | Dopamine beta-hydroxylase [Enzymatic activity/volume] in Serum or Plasma |
| 43802-8 | Estriol (E3) [Mass/volume] in 24 hour Urine |
| 32141-4 | Herpes simplex virus 1+2 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 32225-5 | Arginine [Moles/volume] in Body fluid |
| 32283-4 | Valproate Free/Valproate.total in Serum or Plasma |
| 32323-8 | Ketones [Moles/volume] in Specimen |
| 32496-2 | CD57 cells/100 cells in Tissue |
| 52920-6 | Tellurium/Creatinine [Molar ratio] in 24 hour Urine |
| 43940-6 | Kappa light chains.free [Mass/volume] in 24 hour Urine |
| 23065-6 | Epizootic hemorrhagic disease virus New Jersey Ab [Presence] in Serum |
| 23164-7 | Leptospira interrogans sv Australis Ab [Presence] in Serum |
| 33200-7 | Amyloid beta 42 peptide [Mass/volume] in Plasma |
| 53359-6 | Fat [#/area] in Urine by Computer assisted method |
| 44842-3 | Bacteria # 3 identified in Specimen by Culture |
| 23237-1 | Mycobacterium avium ss avium identified in Specimen by Bioassay |
| 33477-1 | Organic acids pattern [Interpretation] in Urine |
| 5394-2 | Treponema pallidum Ab [Titer] in Serum by Latex agglutination |
| 45010-6 | Chlamydia sp IgG Ab [Presence] in Cerebral spinal fluid |
| 45136-9 | Endomysium IgG Ab [Units/volume] in Serum |
| 23713-1 | Ethylene glycol [Presence] in Serum or Plasma |
| 33853-3 | Progesterone [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 33912-7 | Complement C1s actual/normal in Serum or Plasma |
| 54350-4 | Ascorbate+Dehydroascorbate [Moles/volume] in Serum or Plasma |
| 34615-5 | Iron.microscopic observation [Identifier] in Blood by Potassium ferrocyanide stain |
| 4702-7 | HLA-A36 [Presence] |
| 25083-7 | 2-Oxo,3-Methylvalerate/Creatinine [Molar ratio] in Urine |
| 3532-9 | Desipramine [Presence] in Serum or Plasma |
| 55665-4 | Colistimethate by Gradient strip |
| 25907-7 | Elastase.pancreatic [Mass/mass] in Stool |
| 25933-3 | Hydroxylysine/Creatinine [Molar ratio] in 24 hour Urine |
| 25938-2 | Isoleucine [Moles/volume] in 24 hour Urine |
| 26764-1 | Cannabinoids [Presence] in Hair |
| 56702-4 | Ciprofloxacin IgE Ab [Units/volume] in Serum |
| 48856-9 | Orientia tsutsugamushi Kato IgM Ab [Titer] in Serum by Immunofluorescence |
| 38437-0 | Cashew nut IgE Ab/IgE total in Serum |
| 38632-6 | 4-Biphenylamine [Mass/volume] in Air |
| 57399-8 | CD19+CD23+ cells/100 cells in Body fluid |
| 57610-8 | 6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/time] in 24 hour Urine --pre dose dexamethasone |
| 27400-1 | Hexacarboxylporphyrin [Mass/volume] in Urine |
| 39308-2 | Influenza virus A H7 Ab [Titer] in Serum by Hemagglutination inhibition |
| 58378-1 | Ethyl glucuronide [Mass/volume] in Urine by Confirmatory method |
| 28560-1 | Neuronal thread protein [Mass/volume] in Cerebral spinal fluid |
| 29222-7 | Mexiletine [Mass/volume] in Body fluid |
| 40595-1 | Prothrombin IgG Ab [Units/volume] in Serum or Plasma |
| 58878-0 | Somatotropin [Mass/volume] in Serum or Plasma --29th specimen |
| 59228-7 | Squamous cell carcinoma Ag [Mass/volume] in Cerebral spinal fluid |
| 1965-3 | Bile [Presence] in Stool |
| 12432-1 | Hydroxytriazolam [Mass/volume] in Urine |
| 100098-3 | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot |
| 100125-4 | Chlamydophila psittaci Ab panel - Serum |
| 13034-4 | C peptide [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 1509-9 | Glucose [Mass/volume] in Urine --1 hour post 75 g glucose PO |
| 15123-3 | Lipoprotein.pre-beta/total Lipoprotein in Serum or Plasma |
| 104306-6 | Sorafenib N-Oxide [Mass/volume] in Serum or Plasma |
| 10743-3 | Amyloid.microscopic observation [Identifier] in Tissue by Highman stain |
| 11018-9 | Microscopic observation [Identifier] in Blood or Marrow by Peroxidase stain |
| 17086-0 | Lithium [Mass/volume] in Body fluid |
| 17120-7 | CD17 cells/100 cells in Blood |
| 17516-6 | Renin [Enzymatic activity/volume] in Plasma --supine |
| 17913-5 | Bacteria # 5 identified in Wound deep by Aerobe culture |
| 90043-1 | t(14;20)(q32;q12)(IGH,MAFB) fusion transcript in Blood or Tissue by FISH |
| 74922-6 | N-acetyl-L-aspartate [Moles/volume] in Cerebral spinal fluid |
| 61079-0 | Flunitrazepam [Presence] in Specimen |
| 7600-0 | Phospholipase IgE Ab [Units/volume] in Serum |
| 92931-5 | LPA gene.c.5673A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 93358-0 | Polyclonal plasma cells/Cells counted in Bone marrow by Flow cytometry (FC) |
| 61393-5 | Human papilloma virus 6 DNA [Presence] in Specimen by NAA with probe detection |
| 62300-9 | Lysosomal storage disorders newborn screening panel |
| 77029-7 | Respiratory pathogens DNA and RNA 14 panel - Nasopharynx by NAA with probe detection |
| 77087-5 | TYROBP gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 94277-1 | Dog recombinant 6 IgE Ab [Units/volume] in Serum |
| 63356-0 | Smooth muscle Ab [Titer] in Body fluid by Immunofluorescence |
| 650-2 | Microscopic observation [Identifier] in Urine by Acid fast stain.Kinyoun |
| 78894-3 | Liver fibrosis score in Serum or Plasma Calculated by HepaScore |
| 79681-3 | Allopurinol/Creatinine [Molar ratio] in Urine |
| 80184-5 | Xanthopterin [Moles/volume] in Cerebral spinal fluid |
| 80698-4 | Viable CD34 cells/100 CD34 cells in Hematopoietic progenitor cells from Blood product unit |
| 80700-8 | CD25+CD127- (regulatory T) cells/100 CD3+CD4+ cells in Blood |
| 8088-7 | PCNA extractable nuclear Ab [Presence] in Serum |
| 96661-4 | HLA-DQB1 unresolved alleles [Type] by High resolution |
| 81658-7 | Suspected organism [Identifier] in Specimen |
| 97603-5 | Glial fibrillary acidic protein+Ubiquitin carboxyl-terminal hydrolase-L1 [Interpretation] in Plasma Qualitative |
| 82529-9 | SDHD gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 72334-6 | NPM1 gene c.960insCATG transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
| 99504-3 | Glucose [Mass/volume] in Interstitial fluid |
| 72755-2 | clonazePAM [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 73374-1 | FLUoxetine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86739-0 | Streptococcus suis DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 87592-2 | Sulfamethazine [Mass/mass] in Specimen |
| 87634-2 | Aldicarb [Mass/mass] in Specimen |
| 73873-2 | Androstenetriol [Moles/volume] in 24 hour Urine |
| 74424-3 | Enterovirus RNA [Cycle Threshold #] in Stool by NAA with probe detection |
| 5080-7 | Chlamydophila psittaci IgG Ab [Units/volume] in Serum |
| 60243-3 | Matrix metallopeptidase 9 [Mass/volume] in Serum |
| 31598-6 | Rickettsia honei Ab [Units/volume] in Serum |
| 51248-3 | CD14 cells/100 cells in Body fluid |
| 43342-5 | West Nile virus IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay |
| 43425-8 | Bartonella sp IgG Ab [Titer] in Cerebral spinal fluid |
| 4365-3 | Oxacillin [Mass] of Dose |
| 32156-2 | Calcium carbonate/Total in Stone |
| 32196-8 | Monocytes+Macrophages [Presence] in Synovial fluid by Light microscopy |
| 32336-0 | Potassium [Moles/volume] in Specimen |
| 5296-9 | Reticulin Ab [Units/volume] in Serum |
| 32716-3 | Sjogrens syndrome-A extractable nuclear Ab [Titer] in Serum |
| 44715-1 | Complement C4/Protein [Mass Ratio] in Synovial fluid |
| 44921-5 | Hemoglobin D/Hemoglobin.total in Blood by HPLC |
| 23684-4 | Brucella ovis Ab [Titer] in Serum |
| 33903-6 | Ketones [Presence] in Urine |
| 54192-0 | Cefotaxime+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 54304-1 | Isobutyrylglycine [Moles/volume] in Urine |
| 4639-1 | Unstable Hemoglobin [Presence] in Red Blood Cells |
| 2442-2 | Hydroxylysine [Mass/volume] in Serum or Plasma |
| 3466-0 | Chlorpheniramine [Mass/volume] in Serum or Plasma |
| 55301-6 | JAK2 gene exon 13 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55516-9 | Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose glucagon |
| 47150-8 | EPINEPHrine [Moles/volume] in Urine --6th specimen post XXX challenge |
| 25268-4 | Piperacillin [Mass/volume] in Specimen |
| 55702-5 | Paromomycin [Susceptibility] by Gradient strip |
| 47726-5 | Phytanate (C16:0(CH3)4)/Creatinine [Molar ratio] in Urine |
| 4783-7 | HLA-B64(14) [Presence] |
| 25979-6 | Serine [Moles/volume] in 24 hour Urine |
| 56304-9 | Lemon IgG4 Ab [Mass/volume] in Serum |
| 56367-6 | Rabbit epithelium IgG4 Ab [Mass/volume] in Serum |
| 56553-1 | Microalbumin [Mass/time] in 8 hour Urine |
| 48560-7 | Human papilloma virus genotype [Identifier] in Specimen by NAA with probe detection |
| 38451-1 | CFTR gene c.2789+5G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 39467-6 | Chloride [Moles/volume] in Peritoneal dialysis fluid |
| 39544-2 | Yellow Hornet IgE Ab/IgE total in Serum |
| 58084-5 | Vw Ab [Presence] in Serum or Plasma |
| 49688-5 | Glucose tolerance [Interpretation] in Serum or Plasma Narrative--post 75 g glucose PO |
| 39789-3 | Potassium [Moles/volume] in Venous blood |
| 29637-6 | Time last dose of Dose |
| 29663-2 | Dengue virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 40-6 | Azlocillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 58943-2 | Microscopic observation [Identifier] in Cerebral spinal fluid by Acid fast stain.Ziehl-Neelsen |
| 50446-4 | Corticotropin [Mass/volume] in Plasma --2nd specimen |
| 50537-0 | Thyrotropin [Units/volume] in Serum or Plasma --5th specimen |
| 30253-9 | Glucose [Moles/volume] in Serum or Plasma --3.6 hours post dose glucose |
| 41082-9 | MT-TK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19179-1 | Choriogonadotropin.beta subunit free [Moles/volume] in Amniotic fluid |
| 19359-9 | Cocaine [Presence] in Urine by Screen method |
| 100907-5 | Vancomycin resistant enterococcus [Identifier] in Specimen by Organism specific culture |
| 13193-8 | Aspergillus flavus Ab [Units/volume] in Cerebral spinal fluid |
| 13238-1 | Epstein Barr virus Ab [Units/volume] in Serum |
| 13256-3 | Leishmania donovani IgG Ab [Units/volume] in Serum |
| 101921-5 | Iohexol renal clearance in Serum or Plasma or Urine |
| 102161-7 | Basil IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13786-9 | Ornithine/Creatinine [Mass Ratio] in Urine |
| 102872-9 | Dog serum albumin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103643-3 | Iloperidone [Mass/volume] in Urine by Confirmatory method |
| 103844-7 | HBA1 and HBA2 gene deletion in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
| 104181-3 | Clostridium tetani toxin [Presence] in Serum or Plasma by Mouse bioassay |
| 104194-6 | Creatine [Moles/volume] in DBS |
| 14985-6 | I (intermediate) subtype [Presence] on Red Blood Cells |
| 15158-9 | Chloride [Moles/volume] in Stool |
| 10871-2 | Xylose [Mass/volume] in Blood --5 hours post 25 g xylose PO |
| 11207-8 | Alpha-1-Fetoprotein [Mass/volume] in Body fluid |
| 11222-7 | Pentacarboxylporphyrins [Presence] in Urine |
| 117-2 | cefOXitin [Susceptibility] by Disk diffusion (KB) |
| 1184-1 | little i Ab [Presence] in Serum or Plasma from Blood product unit |
| 16796-5 | Echovirus Ab [Units/volume] in Serum by Complement fixation |
| 16835-1 | Escherichia coli shiga-like toxin identified in Stool by Organism specific culture |
| 17183-5 | CD64 cells/100 cells in Blood |
| 17241-1 | Prolactin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 17580-2 | Ganglioside GQ1b IgG Ab [Presence] in Cerebral spinal fluid |
| 17669-3 | Sulfatide IgG Ab [Units/volume] in Serum by Immunoassay |
| 90428-4 | Microorganism preliminary growth [Presence] in Body fluid by Aerobic culture with antimicrobial neutralizer |
| 90799-8 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --4 hours post dose levothyroxine |
| 91041-4 | Cannabinoids [Presence] in Body fluid by Screen method |
| 7643-0 | Radish IgE Ab [Units/volume] in Serum |
| 76610-5 | Streptococcus agalactiae cfb gene [#/volume] in XXX.body fluid by NAA with probe detection |
| 928-2 | Blood product reaction [Type] |
| 92898-6 | Hepatitis B virus core Ab and surface and little e Ab and Ag panel - Serum or Plasma |
| 93193-1 | TPMT gene and NUDT15 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 93423-2 | Glial fibrillary acidic protein alpha subunit IgG Ab [Titer] in Serum by Immunofluorescence |
| 9392-2 | Quinethazone [Mass/volume] in Urine |
| 93929-8 | Rh antigens and K Ag post hematopoietic stem cell transplant panel - Blood |
| 9418-5 | Hydroxybupropion [Mass/volume] in Serum or Plasma |
| 78799-4 | Atenolol [Mass/volume] in Blood |
| 94411-6 | DRD2 gene c.-585A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 65354-3 | Proinsulin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 6603-5 | Influenza virus identified in Throat by Organism specific culture |
| 66769-1 | Triglyceride [Moles/volume] in Peritoneal fluid |
| 80382-5 | Influenza virus A Ag [Presence] in Upper respiratory specimen by Rapid immunoassay |
| 9642-0 | Creatine kinase.BB/Creatine kinase.total in Serum or Plasma |
| 96490-8 | Neuronal intermediate filament IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 96927-9 | Centrosomal nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 69927-2 | European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 70015-3 | Streptococcus sp DNA [Presence] in Blood by NAA with probe detection |
| 70040-1 | Polymorphonuclear cells/100 leukocytes in Synovial fluid by Automated count |
| 70048-4 | Polymorphonuclear cells [#/volume] in Peritoneal fluid by Automated count |
| 97280-2 | Morphine Free [Presence] in Cord tissue by Screen method |
| 7126-6 | Bayleaf IgG Ab [Units/volume] in Serum |
| 82854-1 | Prenanediolone+pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
| 98114-2 | Chemokine (C-X3-C motif) ligand 1 [Mass/volume] in Serum or Plasma |
| 99010-1 | Leptospira borgpetersenii sv Javanica Ab [Titer] in Serum by Agglutination |
| 991-0 | Do sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 72434-4 | 4,5-Dihydroxyhexanolactone [Moles/volume] in Serum or Plasma |
| 83003-4 | Recoverin IgG Ab [Presence] in Serum or Plasma by Line blot |
| 85081-8 | Multiple nuclear dots nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
| 73206-5 | Phenytoin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86954-5 | Foreign material [Presence] in Food |
| 73616-5 | Omadacycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 7379-1 | Wheat grass IgG Ab [Units/volume] in Serum |
| 73865-8 | Catecholamines 3 panel [Moles/volume] - Plasma |
| 88222-5 | Human metapneumovirus Ag [Presence] in Nasopharynx by Immunofluorescence |
| 73927-6 | JWH-073 butanoate (synthetic cannabinoid metabolite) [Presence] in Blood |
| 73974-8 | CD158e cells/100 cells in Specimen |
| 59680-9 | Gabapentin [Mass/volume] in Urine |
| 42197-4 | Centromere Ab [Titer] in Body fluid |
| 59948-0 | OXcarbazepine [Moles/volume] in Gastric fluid |
| 21471-8 | Pomegranate IgE Ab [Units/volume] in Serum |
| 31577-0 | Pseudorabies virus Ab [Units/volume] in Serum |
| 429-1 | rifAMPin [Susceptibility] by Disk diffusion (KB) |
| 4308-3 | Mephenytoin [Mass] of Dose |
| 31659-6 | Striated muscle Ab [Units/volume] in Serum |
| 32010-1 | Diuretics [Identifier] in Serum or Plasma by Screen method |
| 4332-3 | Mexiletine [Mass] of Dose |
| 43825-9 | Arsenic [Presence] in Gastric fluid |
| 3216-9 | Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
| 52997-4 | Terminal deoxyribonucleotidyl transferase cells/100 cells in Body fluid by Flow cytometry (FC) |
| 43954-7 | CD4+CD45RO+ cells [#/volume] in Body fluid |
| 22922-9 | Brucella abortus IgG1 Ab [Presence] in Serum by Immunoassay |
| 53272-1 | Transitional cells [Presence] in Urine by Computer assisted method |
| 53460-2 | Sebacylcarnitine (C10-DC) [Moles/volume] in Amniotic fluid |
| 44752-4 | Nuclear Ab [Units/volume] in Serum by Immunofluorescence (IF) rat kidney |
| 33709-7 | Clostridium botulinum toxin A [Presence] in Specimen |
| 53606-0 | Neisseria meningitidis DNA [Presence] in Blood by NAA with probe detection |
| 46111-1 | Mycoplasma sp DNA [Presence] in Body fluid by NAA with probe detection |
| 46192-1 | HTLV II IgG Ab [Presence] in Serum |
| 54490-8 | Pipecolate [Moles/volume] in Amniotic fluid |
| 47097-1 | Carbamazepine 10,11-epoxide free [Moles/volume] in Serum or Plasma |
| 47131-8 | Thioridazine [Moles/volume] in Gastric fluid |
| 25113-2 | Malate/Creatinine [Molar ratio] in Urine |
| 25162-9 | Hyaline casts [Presence] in Urine sediment by Light microscopy |
| 35058-7 | Hairy cells/100 leukocytes in Blood |
| 47747-1 | Serine/Amino acids.total in DBS |
| 47842-0 | Collection duration of Dialysis fluid |
| 25843-4 | Alanine [Moles/volume] in 24 hour Urine |
| 25987-9 | Testosterone Free [Moles/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
| 26006-7 | Borrelia burgdorferi Ab [Presence] in Serum by Hemagglutination |
| 35441-5 | HIV 1 gp120 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
| 56529-1 | Ma+Ta Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 48329-7 | chlorproPAMIDE [Presence] in Serum or Plasma |
| 35857-2 | Tylosin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 56601-8 | Hyaluronate [Mass/volume] in Peritoneal fluid |
| 56774-3 | Lymphocytes/100 leukocytes in Tissue |
| 5690-3 | Methanol [Presence] in Blood |
| 57014-3 | Iron/Creatinine [Mass Ratio] in 24 hour Urine |
| 48379-2 | Zopiclone [Moles/volume] in Serum or Plasma |
| 48641-5 | Phosphate [Mass/volume] in Serum or Plasma --pre dialysis |
| 26950-6 | 11-Hydroxyetiocholanolone [Mass/volume] in Urine |
| 27025-6 | glipiZIDE [Mass/volume] in Urine |
| 27224-5 | Barbiturates [Presence] in Vitreous fluid |
| 38517-9 | aPTT.factor substitution in Platelet poor plasma --2 hours post incubation |
| 57429-3 | CD3+TCR gamma delta+ cells/100 cells in Body fluid |
| 4900-7 | HLA-Dw25 [Presence] in Donor |
| 49063-1 | Microdeletion syndromes in Specimen by FISH Nominal |
| 49316-3 | Hemoglobin pattern [Interpretation] in Blood by Electrophoresis |
| 27928-1 | Echovirus 30 RNA [Presence] in Cerebral spinal fluid by Probe |
| 38752-2 | Polychlorinated biphenyl (PCB) [Mass/volume] in Air |
| 49445-0 | Toxoplasma gondii DNA [#/volume] in Bronchoalveolar lavage by NAA with probe detection |
| 49505-1 | Erythrocyte clumps [#/area] in Urine sediment by Automated count |
| 29507-1 | Alpha ketoglutarate/Creatinine [Molar ratio] in Urine |
| 58519-0 | C peptide [Moles/volume] in Serum or Plasma --5 hours post dose glucose |
| 58558-8 | Corticotropin [Moles/volume] in Plasma --1 hour post dose insulin IV |
| 50083-5 | Alpha aminoadipate [Moles/volume] in DBS |
| 29666-5 | Echovirus+Coxsackievirus IgA Ab [Presence] in Serum |
| 29848-9 | Eastern equine encephalitis virus IgG Ab [Presence] in Serum |
| 30318-0 | Base deficit in Blood |
| 19210-4 | Squamous cell carcinoma Ag [Moles/volume] in Pleural fluid |
| 19257-5 | Oxygen [Partial pressure] adjusted to patient's actual temperature in Mixed venous blood |
| 1958-8 | Beta-N-acetylhexosaminidase.I [Enzymatic activity/volume] in Serum |
| 20387-7 | Trimethoprim+Sulfamethoxazole [Susceptibility] by Method for Slow-growing mycobacteria |
| 12948-6 | Thyrotropin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 13072-4 | Phosphatidate IgA Ab [Units/volume] in Serum |
| 13304-1 | HLA-DR [Type] |
| 13399-1 | Homocystine [Mass/volume] in Amniotic fluid |
| 102199-7 | Cabbage IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13768-7 | Leucine/Creatinine [Mass Ratio] in Urine |
| 14018-6 | CD23 cells/100 cells in Blood |
| 14637-3 | Calcium [Moles/time] in 24 hour Urine |
| 103574-0 | Dog dander IgE panel - Serum or Plasma |
| 16123-2 | Cryptococcus sp Ab [Titer] in Cerebral spinal fluid |
| 1689-9 | 5'-Nucleotidase [Enzymatic activity/volume] in Amniotic fluid |
| 17415-1 | Parainfluenza virus A Ab [Units/volume] in Serum |
| 17729-5 | Treponema pallidum IgM Ab [Presence] in Serum by Immunofluorescence |
| 17823-6 | CD45 (Lymphs) cells/100 cells in Body fluid |
| 90810-3 | Candida tropicalis DNA [Presence] in Serum by NAA with probe detection |
| 74512-5 | Chemokine (C-C motif) ligand 18 [Mass/volume] in Serum |
| 74539-8 | Neisseria meningitidis serogroup A DNA [Presence] in Specimen by NAA with probe detection |
| 74673-5 | Ethanol [Presence] in Saliva (oral fluid) by Confirmatory method |
| 91897-9 | Doravirine [Susceptibility] by Genotype method |
| 60326-6 | OXcarbazepine [Moles/volume] in Specimen |
| 76-0 | ceFAZolin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 76081-9 | Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture |
| 76494-4 | Tacrolimus [Moles/volume] in Blood by Immunoassay |
| 61232-5 | Cauliflower IgE Ab/IgE total in Serum |
| 61326-5 | Cocklebur IgE Ab/IgE total in Serum |
| 93972-8 | Acetaminophen-cysteine adduct [Moles/volume] in Serum or Plasma |
| 94008-0 | Creatinine [Mass/volume] in Serum or Plasma --2 hours post dose vasopressin |
| 94287-0 | Leucine-rich glioma-inactivated protein 1 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 63210-9 | Actin smooth muscle Ab [Presence] in Serum by Immunoassay |
| 77934-8 | Cortisol [Moles/volume] in Serum or Plasma --9.5 hours post XXX challenge |
| 78771-3 | 9-Hydroxyrisperidone [Mass/mass] in Hair |
| 94430-6 | HLA-A and B and C (class I) IgG low risk [Identifier] in Serum or Plasma by Flow cytometry (FC) |
| 94739-0 | Prostate cancer grade group basis [Type] in Prostate tumor |
| 9483-9 | Selenium [Mass/volume] in Water |
| 94840-6 | Chloride [Moles/volume] in Urine from Fetus |
| 64096-1 | Colonies counted [#] in Amniotic fluid by Molecular genetics method |
| 646-0 | Microscopic observation [Identifier] in Sputum by Acid fast stain.Kinyoun modified |
| 79243-2 | Ethylone [Mass/volume] in Urine by Confirmatory method |
| 79290-3 | Creatine, guanidinoacetate and creatinine panel - Urine |
| 79325-7 | Pyridoxal phosphate and pyridoxal and pyridoxine panel - Serum or Plasma |
| 95185-5 | HLA-A1 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC) |
| 95380-2 | Influenza virus A and B and SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory system specimen by NAA with probe detection |
| 95566-6 | 5-Pregnenetriol [Z-score] in 24 hour Urine |
| 66138-9 | Band form neutrophils [#/volume] in Blood from Fetus by Manual count |
| 6678-7 | Microscopic observation [Identifier] in Tissue by Toluidine blue O stain |
| 79662-3 | Allopurinol [Moles/volume] in Serum or Plasma |
| 80156-3 | 3-Methoxytyramine/Creatinine [Molar ratio] in Urine |
| 8073-9 | Insulin bovine Ab [Units/volume] in Serum |
| 81103-4 | Leptospira interrogans sv Kremastos Ab [Titer] in Serum by Agglutination |
| 69873-8 | Service comment 46 |
| 70054-2 | Hantavirus dobrova IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 81620-7 | Differential panel - Bronchial specimen |
| 81836-9 | CTSK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 82179-3 | Bordetella pertussis.pertussis toxin promoter region [Presence] in Nasopharynx by NAA with non-probe detection |
| 72161-3 | Epithelial cells [Presence] in Specimen by Gram stain |
| 99471-5 | Common wasp recombinant (rVes v) 1 IgG Ab [Mass/volume] in Serum |
| 72796-6 | Mephedrone/Creatinine [Mass Ratio] in Urine |
| 73156-2 | Rosuvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73546-4 | Acetaminophen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73689-2 | Repaglinide [Mass/volume] in Urine |
| 73970-6 | Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
| 74441-7 | Porphobilinogen/Creatinine [Molar ratio] in 24 hour Urine |
| 59573-6 | Cannabinoids [Presence] in Gastric fluid |
| 50961-2 | Rabbit Ab [Titer] in Serum |
| 60033-8 | PIK3CA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21078-1 | Green Ash IgE Ab [Units/volume] in Serum |
| 3125-2 | Vasoactive intestinal peptide [Mass/volume] in Serum or Plasma |
| 51352-3 | CD19+CD58+ cells/100 cells in Tissue |
| 22295-0 | Epstein Barr virus early IgG Ab [Presence] in Serum |
| 31817-0 | Equine herpesvirus 1 Ag [Presence] in Specimen |
| 31893-1 | Mumps virus Ag [Presence] in Penis |
| 51803-5 | Fibrillarin Ab [Titer] in Serum by Immunofluorescence |
| 43350-8 | Avian metapneumovirus A Ab [Titer] in Serum |
| 43590-9 | Rabies virus Ab [Units/volume] in Serum by Immunoassay |
| 43601-4 | Ganglioside GD1b IgG Ab [Presence] in Serum |
| 4382-8 | Penicillin V potassium [Mass] of Dose |
| 23015-1 | Cowdria ruminantium rRNA [Presence] in Specimen by Probe |
| 23121-7 | Foot and mouth disease virus serotype [Identifier] in Tissue by NAA with probe detection |
| 53354-7 | Oval fat bodies (globules) [#/area] in Urine by Computer assisted method |
| 23218-1 | Lumpy skin disease virus Ag [Presence] in Tissue by Immunoassay |
| 33533-1 | Platelet aggregation ristocetin induced in Control Platelet rich plasma --Low dose |
| 33673-5 | Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of protamine sulfate |
| 33712-1 | Clostridium botulinum toxin A+B+E [Presence] in Specimen |
| 53786-0 | Microscopic observation [Identifier] in Stool by Wright stain |
| 23987-1 | Brucella abortus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 53979-1 | Actin Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 4679-7 | Reticulocytes/100 erythrocytes in Blood |
| 34341-8 | Mianserin+Normianserin [Mass/volume] in Serum or Plasma |
| 34474-7 | ABO and Rh group [Type] in Cord blood |
| 55306-5 | Fungus [Presence] in Nail by KOH preparation |
| 55537-5 | fentaNYL [Moles/volume] in Serum or Plasma |
| 471-3 | sulfiSOXAZOLE [Susceptibility] by Minimum lethal concentration (MLC) |
| 2523-9 | Lactate [Moles/volume] in Peritoneal fluid |
| 35043-9 | Variant lymphocytes [#/volume] in Cerebral spinal fluid |
| 55687-8 | Miocamycin [Susceptibility] by Gradient strip |
| 35471-2 | HLA Ab [Presence] |
| 56551-5 | PCA-Tr Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 48219-0 | Sesame Seed triggered leukotriene release [Mass/volume] by Leukocytes |
| 48324-8 | chlorproPAMIDE [Presence] in Specimen |
| 26573-6 | CD4+CD45+ cells/100 cells in Blood |
| 26682-5 | Glycolate [Presence] in Urine |
| 26709-6 | Xylose [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 56615-8 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 56630-7 | Brucella sp IgG Ab [Units/volume] in Serum by Immunoassay |
| 56779-2 | Ascorbate [Moles/volume] in Semen |
| 26910-0 | Alpha hydroxyalprazolam [Mass/mass] in Meconium |
| 27117-1 | Cadmium [Mass/mass] in Red Blood Cells |
| 2723-5 | Para aminohippurate renal clearance in 24 hour Urine and Serum or Plasma |
| 57398-0 | CD22+CD19+ cells/100 cells in Body fluid |
| 57423-6 | CD5 cells/100 cells in Body fluid |
| 49306-4 | Hamster Ova Penetration Test [Interpretation] in Semen Narrative |
| 38745-6 | Isocyanate MDI [Mass/volume] in Air |
| 38761-3 | Asphalt [Mass/volume] in Air |
| 38914-8 | RS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 4936-1 | HLA-DQ3 [Presence] in Donor |
| 40047-3 | Albumin [Mass/volume] in Serum or Plasma --45 minutes pre XXX challenge |
| 49784-2 | Onchocerca sp IgG Ab [Units/volume] in Serum |
| 40403-8 | Trimipramine [Presence] in Gastric fluid |
| 40407-9 | Uroporphyrin 1 isomer [Moles/time] in 24 hour Urine |
| 40491-3 | Neutrophils/100 leukocytes in Synovial fluid by Manual count |
| 58840-0 | Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma --baseline |
| 59033-1 | Ganglioside GM3 IgG Ab [Units/volume] in Serum by Immunoassay |
| 20992-4 | Bordetella pertussis Ab [Presence] in Specimen |
| 100390-4 | Sunflower Seed IgG Ab [Units/volume] in Serum |
| 13322-3 | Human papilloma virus IgM Ab [Presence] in Serum |
| 13424-7 | EPINEPHrine [Mass/volume] in Plasma --6th specimen post XXX challenge |
| 102106-2 | Glycolate [Moles/volume] in Serum or Plasma by Gas chromatography-mass spectrometry |
| 102184-9 | Blomia tropicalis IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13529-3 | Nucleated erythrocytes [#/volume] in Cerebral spinal fluid by Manual count |
| 1358-1 | Corticotropin [Mass/volume] in Plasma --1.5 hours post dose insulin IV |
| 13848-7 | CD3+CD26+ cells [#/volume] in Blood |
| 102397-7 | Kiwifruit IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14170-5 | Pituitary glycoprotein hormone.alpha subunit [Mass/volume] in Serum |
| 103155-8 | Single nucleotide polymorphisms.donor derived cf.dna/Single nucleotide polymorphisms.total cf dna in Blood from Donor |
| 10329-1 | Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
| 10360-6 | DNA single strand IgG Ab [Units/volume] in Serum |
| 103739-9 | EBV Lymphoproliferation multigene analysis in Blood or Tissue by Molecular genetics method |
| 14808-0 | Lead [Moles/volume] in Urine |
| 14980-7 | A variant subtype Ab [Presence] in Serum or Plasma from Blood product unit |
| 15076-3 | Glucose [Moles/volume] in Urine |
| 104364-5 | Chikungunya virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen |
| 10512-2 | Somatostatin Ag [Presence] in Tissue by Immune stain |
| 11598-0 | Toxoplasma gondii Ab [Units/volume] in Serum |
| 16780-9 | Disopyramide [Mass/volume] in Urine |
| 17310-4 | Myelin associated glycoprotein Ab [Presence] in Serum by Immunofluorescence |
| 18993-6 | Tetracycline [Susceptibility] |
| 90066-2 | Corynebacterium sp identified in Isolate by Organism specific culture |
| 90901-0 | HIV 1 RNA reverse transcriptase and protease and integrase gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing |
| 74578-6 | Pyruvate dehydrogenase complex [Enzymatic activity/mass] in Tissue |
| 74852-5 | Mesothelial cells/100 cells in Lymph node by Manual count |
| 91674-2 | CD3+CD16+CD56+ cells [#/volume] in Bone marrow |
| 92539-6 | Jk sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 7514-3 | Red mulberry IgE Ab [Units/volume] in Serum |
| 76416-7 | Sheep prion protein codon 171 [Type] in Blood by Genotype method |
| 92857-2 | Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 93696-3 | Liver steatosis grade in Serum or Plasma Qualitative |
| 77108-9 | AARS2 gene full mutation analysis in Blood or Tissue by Sequencing |
| 7718-0 | Zucchini IgE Ab [Units/volume] in Serum |
| 63289-3 | Myelin associated glycoprotein Ab [Units/volume] in Body fluid by Immunoassay |
| 7888-1 | Francisella tularensis Ab [Presence] in Serum |
| 79171-5 | Apple recombinant (rMal d) 4 IgE Ab [Units/volume] in Serum |
| 9522-4 | Entamoeba histolytica IgG Ab [Units/volume] in Serum by Immunoassay |
| 6687-8 | Citrate [Mass/time] in 24 hour Urine |
| 6696-9 | Thiothixene [Mass/volume] in Serum or Plasma |
| 80098-7 | Glucosamine/Creatinine [Molar ratio] in Urine |
| 67829-2 | Eosinophils [#/volume] in Pericardial fluid |
| 69040-4 | Chronic urticaria index panel - Serum or Plasma |
| 81311-3 | Cryoglobulin.IgA [Presence] in Serum |
| 96898-2 | SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection |
| 82474-8 | Borrelia mayonii oppA1 gene [Presence] in Specimen by NAA with non-probe detection |
| 82969-7 | PENTobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 72406-2 | Norchlordiazepoxide [Mass/volume] in Blood by Confirmatory method |
| 72458-3 | Myosin Ab [Presence] in Serum or Plasma by Immunoblot |
| 83128-9 | Hepatitis E virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 85331-7 | Progesterone receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain |
| 99447-5 | Common wasp recombinant (rVes v) 1 IgG4 Ab [Mass/volume] in Serum |
| 7277-7 | American house dust mite triggered histamine release [Units/volume] in Blood |
| 86122-9 | Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum |
| 87428-9 | Drugs of abuse screen W Reflex confirm panel - Urine |
| 87665-6 | Dieldrin [Mass/mass] in Specimen |
| 89519-3 | Ganglioside GM1 IgG+IgM Ab [Presence] in Serum by Line blot |
| 30458-4 | Plasma cells [#/volume] in Blood |
| 60162-5 | Phenacemide [Mass/volume] in Urine |
| 21301-7 | Giardia lamblia IgM Ab [Titer] in Serum by Immunofluorescence |
| 31399-9 | Ganglioside GD1a IgM Ab [Units/volume] in Serum |
| 42756-7 | Phosphatidylserine IgM Ab B2GP1 independent [Multiple of the median] in Serum |
| 2210-3 | Dihydrolipoamide acetyl transferase [Enzymatic activity/mass] in Tissue |
| 32013-5 | Eosinophils/100 leukocytes in Pericardial fluid by Manual count |
| 51511-4 | Lactate dehydrogenase 2/Lactate dehydrogenase.total in Cerebral spinal fluid by Electrophoresis |
| 51862-1 | Mold Allergen Mix 7 (Saccharopolyspora rectivirgula+Thermoactinomyces vulgaris) IgG Ab [Presence] in Serum by Multidisk |
| 43215-3 | Cortisol [Mass/volume] in Serum or Plasma --baseline |
| 43634-5 | 3-Methoxy-4-Hydroxyphenylglycol [Presence] in Urine |
| 32109-1 | Phenytoin Free [Moles/volume] in Serum or Plasma |
| 3219-3 | Coagulation factor X activity [Units/volume] in Platelet poor plasma by Chromogenic method |
| 5262-1 | Neutrophil cytoplasmic Ab [Units/volume] in Serum by Immunofluorescence |
| 5290-2 | Reagin Ab [Presence] in Cerebral spinal fluid by VDRL |
| 43886-1 | Bismuth [Presence] in Specimen |
| 43925-7 | Bordetella parapertussis [Presence] in Specimen by Organism specific culture |
| 4428-9 | Streptomycin [Mass] of Dose |
| 22904-7 | Bovine herpesvirus 1 neutralizing antibody [Presence] in Serum by Neutralization test |
| 32856-7 | Cytoplasmic CD22 cells/100 cells in Specimen |
| 3303-5 | Acetazolamide [Mass/time] in 24 hour Urine |
| 5306-6 | Rickettsia sp Ab [Titer] in Serum by Complement fixation |
| 5307-4 | Rickettsia rickettsii IgG Ab [Titer] in Serum by Immunofluorescence |
| 4458-6 | Valproate [Mass] of Dose |
| 44712-8 | Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Urine by Immunoassay |
| 23573-9 | Rabbit hemorrhagic disease virus [Presence] in Tissue by Electron microscopy |
| 45210-2 | Herpes simplex virus 2 IgM Ab [Presence] in Serum by Immunofluorescence |
| 4681-3 | Streptokinase [Enzymatic activity/volume] in Plasma |
| 46989-0 | CFTR gene targeted mutation analysis in Amniotic fluid by Molecular genetics method |
| 47171-4 | Norepinephrine [Moles/volume] in Plasma --6th specimen post XXX challenge |
| 47184-7 | Progesterone [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
| 47350-4 | Streptococcus pneumoniae Danish serotype 33F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 25254-4 | Ticarcillin [Mass/volume] in Specimen |
| 34958-9 | Eosinophils [#/volume] in Cerebral spinal fluid |
| 35073-6 | Basophils [#/volume] in Peritoneal fluid |
| 4754-8 | HLA-B w4 [Presence] in Donor |
| 56329-6 | Nectarine IgG4 Ab [Mass/volume] in Serum |
| 56395-7 | Sunflower Seed IgG4 Ab [Mass/volume] in Serum |
| 56502-8 | Somatotropin [Units/volume] in Serum or Plasma --7 hours post XXX challenge |
| 56703-2 | Piroxicam IgE Ab [Units/volume] in Serum |
| 56704-0 | Droperidol IgE Ab [Units/volume] in Serum |
| 5701-8 | Nickel [Mass/mass] in Hair |
| 38459-4 | Crystals [#/area] in Urine sediment by Microscopy high power field |
| 57324-6 | Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 57522-5 | 11-Hydroxyetiocholanolone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
| 49097-9 | Creatine [Mass/volume] in 24 hour Urine |
| 49130-8 | Cholesterol in HDL [Mass/volume] in Serum or Plasma by Electrophoresis |
| 49273-6 | Immunofixation for Body fluid Narrative |
| 4954-4 | HLA-DR12(5) [Presence] in Donor |
| 49724-8 | Aldolase [Enzymatic activity/volume] in Body fluid |
| 2832-4 | Pregnanediol [Mass/volume] in Amniotic fluid |
| 49828-7 | 2-Hydroxyestrone and 16-Alpha hydroxyestrone panel - Serum or Plasma |
| 29567-5 | West Nile virus IgM Ab [Presence] in Serum by Immunoassay |
| 29840-6 | La Crosse virus IgG Ab [Presence] in Cerebral spinal fluid |
| 50287-2 | 3-Dechloroethylifosfamide [Mass/volume] in Blood --3 days post dose ifosfamide |
| 40976-3 | Adenovirus DNA [Identifier] in Specimen by NAA with probe detection |
| 20994-0 | Choriogonadotropin [Interpretation] in Serum or Plasma |
| 100679-0 | Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 12578-1 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --3rd specimen |
| 12963-5 | Urea nitrogen [Mass/volume] in Peripheral blood |
| 13002-1 | Mesityl oxide [Mass/volume] in Blood |
| 13035-1 | C peptide [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 101753-2 | Dermatophytes DNA [Presence] in Specimen by NAA with probe detection |
| 101793-8 | Tianeptine [Mass/volume] in Urine by Confirmatory method |
| 13527-7 | Unidentified cells/100 leukocytes in Cerebral spinal fluid by Manual count |
| 102785-3 | Peach IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104196-1 | Creatine/Creatinine [Molar ratio] in DBS |
| 10437-2 | CD16 Ag [Presence] in Tissue by Immune stain |
| 10450-5 | Glucose [Mass/volume] in Serum or Plasma --10 hours fasting |
| 15487-2 | Mycoplasma meleagridis Ab [Presence] in Serum by Immunoassay |
| 1661-8 | 11-Ketoandrosterone [Mass/volume] in Serum |
| 1123-9 | Le sup(x) Ab [Presence] in Serum or Plasma from Donor |
| 1191-6 | little k Ab [Presence] in Serum or Plasma from Donor |
| 17107-4 | CD117 cells/100 cells in Blood |
| 17214-8 | CD99 cells/100 cells in Blood |
| 17308-8 | Myelin associated glycoprotein Ab [Units/volume] in Serum by Immunoblot |
| 89985-6 | ARIPiprazole [Presence] in Serum or Plasma by Screen method |
| 91037-2 | Methamphetamine+Methylenedioxymethamphetamine [Presence] in Urine by Screen method |
| 91142-0 | TPMT activity in RBC by production of 6-MMP riboside |
| 91806-0 | Mumps virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 91810-2 | Human metapneumovirus Ag [Presence] in Upper respiratory specimen by Immunofluorescence |
| 92547-9 | Di sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 60382-9 | Lime IgG Ab [Mass/volume] in Serum |
| 76132-0 | Sucrose/Creatinine [Molar ratio] in Urine |
| 7645-5 | Canyon Ragweed IgE Ab [Units/volume] in Serum |
| 92975-2 | Klebsiella aerogenes DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection |
| 77131-1 | CDHR1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 77163-4 | Alpha-1-Microglobulin [Moles/volume] in Urine |
| 93757-3 | Salmonella choleraesuis+infantis+typhimurium Ab/Positive control in Specimen by Immunoassay |
| 63343-8 | Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Body fluid by Immunoassay |
| 77929-8 | Cortisol [Moles/volume] in Serum or Plasma --3.5 hours post XXX challenge |
| 78800-0 | Atropine [Mass/mass] in Hair |
| 63414-7 | Pompe disease newborn screening panel |
| 79176-4 | Somatotropin [Units/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 79485-9 | 4-Hydroxyvalerate/Creatinine [Molar ratio] in Urine |
| 94863-8 | Transthyretin width at half peak height [Mass] in Blood |
| 6581-3 | Vibrio sp identified in Specimen by Organism specific culture |
| 80116-7 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Body fluid by Confirmatory method |
| 6745-4 | Segmented neutrophils [#/volume] in Body fluid by Manual count |
| 69869-6 | Service comment 42 |
| 97616-7 | Enterobacter cloacae complex DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 71641-5 | Macrophages/Leukocytes [Pure number fraction] in Body fluid by Manual count |
| 82725-3 | Natural killer cell cytotoxicity.6.25:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
| 82893-9 | Penfluridol [Mass/volume] in Serum or Plasma |
| 98052-4 | Minocycline IgE Ab [Units/volume] in Serum |
| 99103-4 | Tumor necrosis factor.alpha [Units/volume] in Serum or Plasma |
| 71717-3 | Brucella suis Ab [Titer] in Serum by Plate agglutination |
| 99432-7 | Cat recombinant (rFel d) 1 IgG4 Ab [Mass/volume] in Serum |
| 72946-7 | Tacrolimus induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86177-3 | Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 7321-3 | Housefly triggered histamine release [Units/volume] in Blood |
| 73244-6 | NIFEdipine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87715-9 | Influenza virus A HA gene [Nucleotide sequence] in Isolate by Sequencing |
| 73419-4 | Digoxin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73847-6 | 16-Ketoandrostenediol [Moles/volume] in 24 hour Urine |
| 88059-1 | Acetaminophen [Presence] in Blood by Screen method |
| 88221-7 | Chlamydia trachomatis DNA [Presence] in Throat by NAA with probe detection |
| 88450-2 | Babesia divergens+MO-1 strain 18S rRNA gene [Presence] in Blood by NAA with non-probe detection |
| 74404-5 | Eosinophils [#/volume] in Cord blood |
| 88587-1 | Legionella sp DNA [Identifier] in Tissue by NAA with probe detection |
| 4137-6 | Barbiturates [Mass] of Dose |
| 41505-9 | Parainfluenza virus Ag panel - Specimen by Immunofluorescence |
| 59598-3 | Acetazolamide [Mass/volume] in Blood |
| 59758-3 | Triazolam [Mass/volume] in Blood |
| 50798-8 | 17-Ketogenic steroids [Moles/volume] in 24 hour Urine |
| 3045-2 | Triglyceride+ester in IDL [Mass/volume] in Serum or Plasma |
| 42238-6 | Borrelia burgdorferi 23kD Ab [Presence] in Serum by Immunoblot |
| 31289-2 | Canine parvovirus IgM Ab [Units/volume] in Serum |
| 42989-4 | Mycoplasma pneumoniae IgG Ab [Titer] in Pleural fluid by Immunofluorescence |
| 31754-5 | Brucella sp Ag [Presence] in Placenta |
| 3199-7 | Coagulation factor VII activity [Units/volume] in Platelet poor plasma by Chromogenic method |
| 22721-5 | Glutamate [Moles/volume] in Specimen |
| 43910-9 | Ascaris sp IgM Ab [Presence] in Serum |
| 53201-0 | 3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 44424-0 | Methylenedioxymethamphetamine/Creatinine [Mass Ratio] in Urine |
| 44564-3 | Influenza virus A Ag [Presence] in Nose by Immunoassay |
| 53901-5 | USH2A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 23857-6 | Epidermis Ab [Interpretation] in Tissue by Immunofluorescence |
| 4579-9 | Hemoglobin F [Presence] in Blood |
| 24384-0 | little c Ab [Units/volume] in Serum or Plasma |
| 24456-6 | Deoxypyridinoline/Creatinine [Molar ratio] in 24 hour Urine |
| 34681-7 | Biopsy [Interpretation] in Muscle Narrative |
| 55293-5 | Linopristin+Flopristin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 55378-4 | Phosphate crystals amorphous [#/area] in Urine by Computer assisted method |
| 5557-4 | HLA-DR [Units/volume] in Leukocytes |
| 55599-5 | Leukocytes.disintegrated/100 leukocytes in Cerebral spinal fluid by Manual count |
| 4732-4 | HLA-A30(19) [Presence] in Donor |
| 25530-7 | Weight [Mass/time] of 24 hour Stool |
| 55682-9 | Isoconazole [Susceptibility] |
| 55770-2 | EGFR gene exon 20 insertion [Presence] in Blood or Tissue by Molecular genetics method |
| 55898-1 | Immunoglobulin light chains.free [Presence] in Serum by Immunofixation |
| 55907-0 | Alpha cortolone [Mass/volume] in 24 hour Urine |
| 25883-0 | Cortisol Free [Moles/volume] in 24 hour Urine by HPLC |
| 35558-6 | Cholinesterase panel [Enzymatic activity/volume] - Blood |
| 3556-8 | Dichlorphenamide [Mass/volume] in Urine |
| 56472-4 | Nucleated erythrocytes [#] in Specimen by Manual count |
| 565-2 | Colony count [#] in Specimen Qualitative by Visual count |
| 48038-4 | Pathologist interpretation of Synovial fluid tests |
| 35821-8 | Isepamicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 3764-8 | Metandienone [Presence] in Urine |
| 26972-0 | Herpes virus 7 IgG Ab [Titer] in Serum by Immunofluorescence |
| 2715-1 | Fractional oxyhemoglobin in Capillary blood |
| 57347-7 | Copper [Mass/volume] in Dialysis fluid |
| 48970-8 | ELN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 27265-8 | Giardia sp Ag [Presence] in Stool |
| 38696-1 | Ethylene oxide [Mass/volume] in Air |
| 57737-9 | Basement membrane Ab [Titer] in Serum by Immunofluorescence |
| 57764-3 | Microscopic exam [Interpretation] of Bone marrow by Cytology |
| 49330-4 | Renin [Enzymatic activity/volume] in Plasma --3 hours post XXX challenge |
| 29352-2 | Salicylates [Mass/volume] in Gastric fluid |
| 58502-6 | C peptide [Moles/volume] in Serum or Plasma --15 minutes pre XXX challenge |
| 59045-5 | ITGB3 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 50521-4 | Prolactin [Mass/volume] in Serum or Plasma --5th specimen |
| 30084-8 | Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay |
| 40766-8 | Coxsackievirus B IgM Ab [Titer] in Cerebral spinal fluid --1st specimen |
| 19235-1 | Base excess standard in Arterial blood by calculation |
| 19295-5 | Opiates [Presence] in Urine by Screen method |
| 19349-0 | Aprobarbital [Presence] in Urine by Screen method |
| 19453-0 | Dimetamphetamine [Presence] in Urine by Confirmatory method |
| 20393-5 | Sample hemolyzed [Presence] of Serum or Plasma Qualitative |
| 20678-9 | Alkaloid identified in Urine by Thin layer chromatography (TLC) |
| 12566-6 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 101215-2 | Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Line blot |
| 101312-7 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin |
| 1298-9 | Packed erythrocytes given [Volume] |
| 103019-6 | Silver Birch recombinant (rBet v) 2 + 4 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103037-8 | Codfish recombinant (rGad c) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14420-4 | Bilirubin.total [Mass/volume] in Dialysis fluid |
| 145-3 | Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 14683-7 | Creatinine [Moles/volume] in Urine |
| 1504-0 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g glucose PO |
| 104274-6 | Abnormal clonal sequences [Nucleotide sequence] in Specimen by Molecular genetics method Nominal |
| 10485-1 | Glucagon Ag [Presence] in Tissue by Immune stain |
| 1078-5 | Jk sup(b) Ag [Presence] on Red Blood Cells |
| 16982-1 | HTLV I+II Ab [Presence] in Serum by Immunoblot |
| 17286-6 | Monocytes/100 leukocytes in Synovial fluid by Manual count |
| 91815-1 | Bordetella pertussis DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 75042-2 | Pyridoxal [Moles/volume] in Cerebral spinal fluid |
| 75353-3 | Other cells/100 leukocytes in Body fluid by Manual count |
| 75403-6 | PDHA1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 60522-0 | Borrelia hermsii IgG+IgM Ab [Presence] in Serum |
| 61157-4 | Hepatitis B virus codon M204V [Presence] by Genotype method |
| 76338-3 | Porcine epidemic diarrhea virus RNA [Presence] in Specimen by NAA with probe detection |
| 76488-6 | IgE [Mass/volume] in Serum or Plasma by Immunoassay |
| 93233-5 | Intercellular substance IgG Ab [Presence] in Serum by Immunofluorescence |
| 6198-6 | Paper wasp IgE Ab [Units/volume] in Serum |
| 93719-3 | traMADol [Presence] in Meconium by Screen method |
| 93747-4 | Parainfluenza virus 1+2+3+4 IgG Ab [Presence] in Serum by Immunoassay |
| 7876-6 | Ehrlichia chaffeensis IgM Ab [Presence] in Serum |
| 94356-3 | Neuronal nuclear type 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 94485-0 | Parainfluenza virus 3 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 63465-9 | Brucella sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 643-7 | Microscopic observation [Identifier] in Pus by Gram stain |
| 78988-3 | Cortisol [Moles/mass] in Hair |
| 95228-3 | Promyelocytes/100 leukocytes in Stem cell product by Manual count |
| 8008-5 | Rickettsia typhi IgM Ab [Units/volume] in Serum |
| 96363-7 | Dextrorphan+Levorphanol [Presence] in Saliva (oral fluid) by Confirmatory method |
| 96485-8 | Neuronal intermediate filament light chain IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 96702-6 | Clot initiation.kaolin induced [Time] in Blood by US |
| 97151-5 | Enterovirus RNA [Presence] in Serum or Plasma by NAA with non-probe detection |
| 81690-0 | Legionella longbeachae 1 and 2 DNA [Identifier] in Specimen by NAA with probe detection |
| 97220-8 | Amphetamine [Presence] in Cord tissue by Screen method |
| 97770-2 | Bilirubin.total [Moles/volume] in Capillary blood |
| 97951-8 | Venezuelan equine encephalitis virus RNA [Presence] in Specimen by NAA with probe detection |
| 99033-3 | Candida albicans DNA [Presence] in Urine by NAA with probe detection |
| 84896-0 | Lymph node(s) [Presence] in Specimen |
| 99382-4 | Cancer Ag 50 [Units/volume] in Body fluid |
| 99541-5 | Stenosis degree [Length fraction] in Proximal left circumflex artery by Autopsy |
| 73071-3 | Alendronate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87409-9 | Ustekinumab Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 73629-8 | Tizoxanide [Susceptibility] by Disk diffusion (KB) |
| 73918-5 | JWH-073 (synthetic cannabinoid) [Presence] in Urine by Confirmatory method |
| 74319-5 | MICA*051 IgG Ab [Presence] in Serum |
| 74452-4 | Platelet distribution width [Entitic volume] in Cord blood by Automated count |
| 41227-0 | Xanthine [Moles/time] in 24 hour Urine |
| 41674-3 | cefoTEtan+Clavulanate [Susceptibility] by Gradient strip |
| 5062-5 | Borrelia burgdorferi IgG Ab [Units/volume] in Serum by Immunoassay |
| 304-6 | Lomefloxacin [Susceptibility] by Disk diffusion (KB) |
| 2129-5 | Citrulline [Presence] in Serum or Plasma |
| 2161-8 | Creatinine [Mass/volume] in Urine |
| 31459-1 | Legionella pneumophila 3 Ab [Units/volume] in Serum |
| 21707-5 | MT-ND4 gene p.Thr109Ala [Presence] in Blood or Tissue by Molecular genetics method |
| 31939-2 | Pneumocystis jiroveci Ag [Presence] in Sputum |
| 51720-1 | Potassium [Mass/time] in 24 hour Urine |
| 43310-2 | FBN2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 5217-5 | Histone Ab [Presence] in Serum by Immunofluorescence |
| 44375-4 | Homocysteine [Presence] in Blood |
| 22882-5 | Border disease virus Ag [Presence] in Blood by Immunoassay |
| 23075-5 | Equine arteritis virus Ag [Presence] in Specimen by Immune stain |
| 23077-1 | Equine arteritis virus Ag [Presence] in Tissue by Immunofluorescence |
| 3296-1 | Acepromazine [Mass/volume] in Serum or Plasma |
| 33030-8 | CD34 cells [#/volume] in Blood from Blood product unit |
| 44497-6 | Herpes simplex virus 2 Ag [Presence] in Vaginal fluid |
| 23333-8 | Ovine progressive pneumonia virus Ab [Presence] in Milk by Immunoassay |
| 23429-4 | Salmonella gallinarum Ab [Presence] in Serum by Agglutination |
| 53888-4 | PHEX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 451-5 | Spectinomycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 5400-7 | Vaccinia virus Ab [Units/volume] in Serum |
| 24283-4 | La Crosse virus Ab [Titer] in Serum --1st specimen |
| 24337-8 | Gas panel - Capillary blood |
| 47455-1 | Influenza virus A H6 Ab [Titer] in Serum |
| 3535-2 | Desipramine [Mass/volume] in Serum or Plasma --trough |
| 55612-6 | Follitropin [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 55824-7 | Allo-tetrahydrocorticosterone [Mass/time] in 24 hour Urine |
| 56038-3 | Lysozyme [Units] in 24 hour Urine |
| 4757-1 | HLA-B50(21) [Presence] |
| 56290-0 | House dust Greer IgG4 Ab [Mass/volume] in Serum |
| 26574-4 | 1-Methylhistidine/Creatinine [Molar ratio] in Urine |
| 3628-5 | Fenetylline [Mass/volume] in Urine |
| 56780-0 | CYP21A2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 48588-8 | Coccidioides sp rRNA [Presence] in Specimen by NAA with probe detection |
| 27136-1 | Opiates [Presence] in Vitreous fluid |
| 57594-4 | Aldosterone [Moles/volume] in Serum or Plasma --30 minutes pre XXX challenge |
| 57646-2 | C peptide [Moles/volume] in Serum or Plasma --190 minutes post XXX challenge |
| 27342-5 | Fasciola hepatica Ab [Titer] in Serum by Immunoassay |
| 39020-3 | Abnormal Prion Protein [Presence] in Tissue by Immune stain |
| 57791-6 | Organic acidemia conditions suspected [Identifier] in DBS |
| 5815-6 | Tyrosine crystals [Presence] in Urine sediment by Light microscopy |
| 29125-2 | Zalcitabine [Units/volume] in Serum or Plasma |
| 40094-5 | Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --4 hours post XXX challenge |
| 40238-8 | Calcium [Moles/volume] in Serum or Plasma --8 hours post XXX challenge |
| 58386-4 | Meperidine/Creatinine [Mass Ratio] in Urine |
| 58627-1 | Corticotropin [Mass/volume] in Plasma --pre dose metyraPONE |
| 29734-1 | Leptospira interrogans sv Szwajizak Ab [Presence] in Serum by Agglutination |
| 40600-9 | Alpha-1-acid glycoprotein [Presence] in Urine by Immunoelectrophoresis |
| 50585-9 | Triple bolus stimulation panel - Serum or Plasma |
| 3001-5 | Thiocyanate [Mass/volume] in Blood |
| 196-6 | Cloxacillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 19774-9 | Cytology study comment Cervical or vaginal smear or scraping Cyto stain |
| 102506-3 | Penicillium notatum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10343-2 | Temazepam [Mass/volume] in Serum or Plasma |
| 104199-5 | Immunoglobulin kappa light chain gene 2p11.2 rearrangement in Specimen by FISH |
| 10477-8 | Enolase.neuron specific Ag [Presence] in Tissue by Immune stain |
| 15-8 | Amoxicillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 10777-1 | Microscopic observation [Identifier] in Tissue by Brown and Brenn stain |
| 11042-9 | Creatinine [Mass/volume] in Serum or Plasma --pre dialysis |
| 11063-5 | Triosephosphate isomerase [Enzymatic activity/volume] in Red Blood Cells |
| 11144-3 | Homovanillate [Mass/volume] in Urine |
| 1223-7 | Mg Ag [Presence] on Red Blood Cells from Blood product unit |
| 16865-8 | Fibrinopeptide B beta (15-42) Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 17114-0 | CD122 cells/100 cells in Blood |
| 17408-6 | Human papilloma virus 45 Ag [Presence] in Specimen |
| 17844-2 | Estradiol (E2).albumin bound [Mass/volume] in Serum or Plasma |
| 18376-4 | Sodium [Moles/time] in 6 hour Urine |
| 90238-7 | Salicylcarnitine [Moles/volume] in Serum or Plasma |
| 90465-6 | 3-(4-fluorobenzoyl)propionate [Mass/volume] in Urine by Confirmatory method |
| 74585-1 | Coenzyme Q cytochrome C reductase (Complex III)/Citrate synthase [Enzymatic activity ratio] in Tissue |
| 74893-9 | Mannose/Creatinine [Molar ratio] in Urine |
| 92503-2 | Hy Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 92735-0 | Pibrentasvir [Susceptibility] by Genotype method |
| 75665-0 | Ova and parasites identified in Urine by Trichrome stain |
| 60338-1 | Warfarin [Moles/volume] in Specimen |
| 6045-9 | Black Pepper IgE Ab [Units/volume] in Serum |
| 60490-0 | UMOD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 60542-8 | Mupirocin 5 ug [Susceptibility] by Disk diffusion (KB) |
| 6061-6 | Carrot IgE Ab [Units/volume] in Serum |
| 75763-3 | Orphenadrine [Presence] in Serum or Plasma or Urine by Screen method |
| 76601-4 | Moraxella catarrhalis g1b gene [#/volume] in XXX.body fluid by NAA with probe detection |
| 61277-0 | Isocyanate HDI IgE Ab/IgE total in Serum |
| 61366-1 | Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection |
| 77147-7 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) |
| 7775-0 | Whitefish IgE Ab [Units/volume] in Serum |
| 6246-3 | Shrimp IgE Ab [Units/volume] in Serum |
| 63410-5 | DNA double strand Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 95197-0 | Interferon-gamma producing HLA-A1 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC) |
| 80114-2 | 2-Oxo-3-Hydroxy-Lysergate diethylamide [Mass/volume] in Blood by Confirmatory method |
| 80208-2 | Leishmania infantum+donovani IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 964-7 | C sup(x) Ag [Presence] on Red Blood Cells from Blood product unit |
| 96563-2 | Inner ear 68kD IgG Ab [Units/volume] in Serum by Immunoassay |
| 81756-9 | Lymphocyte proliferation.anti-CD3.maximum/CD3 in Blood by Flow cytometry (FC) |
| 9799-8 | Length of Stone |
| 9802-0 | Size [Entitic volume] of Stone |
| 98080-5 | SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Saliva (oral fluid) by NAA with probe detection |
| 85745-8 | Streptococcus pneumoniae Danish serotype 19F DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 86051-0 | Streptococcus pneumoniae Danish serotype 20A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 73103-4 | Triazolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88621-8 | Human coronavirus OC43 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 88972-5 | Broad casts [#/area] in Urine sediment |
| 41271-8 | Dermatophagoides sp IgE Ab [Units/volume] in Serum |
| 41709-7 | Oritavancin [Susceptibility] by Gradient strip |
| 41717-0 | Sulbactam [Susceptibility] by Gradient strip |
| 41727-9 | Aztreonam+Clavulanate [Susceptibility] |
| 59633-8 | cloBAZam [Mass/mass] in Tissue |
| 50674-1 | Spherocytes [Presence] in Cord blood by Light microscopy |
| 50986-9 | Horowitz index in Venous blood |
| 2115-4 | Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma |
| 2165-9 | Cryofibrinogen [Mass/volume] in Blood |
| 31521-8 | Myelin associated glycoprotein Ab [Presence] in Serum |
| 43024-9 | Herpes virus 6 IgG Ab [Titer] in Cerebral spinal fluid |
| 51699-7 | Endomysium IgG Ab [Titer] in Serum by Immunofluorescence |
| 51840-7 | Echovirus IgG Ab [Titer] in Serum by Immunofluorescence |
| 22350-3 | Histoplasma capsulatum IgE Ab [Presence] in Serum |
| 52996-6 | Terminal deoxyribonucleotidyl transferase cells/100 cells in Blood by Flow cytometry (FC) |
| 43972-9 | CD19 cells [#/volume] in Cerebral spinal fluid |
| 23047-4 | Eastern equine encephalitis virus Ag [Presence] in Brain by Complement fixation |
| 33047-2 | Tranquilizers [Presence] in Urine by Screen method |
| 3308-4 | Alphaprodine [Mass/volume] in Serum or Plasma |
| 44669-0 | Margin involvement in Breast tumor |
| 2326-7 | Gastric inhibitory polypeptide [Mass/volume] in Plasma |
| 53766-2 | Estrogen fraction panel - Serum or Plasma |
| 2383-8 | Glutathione [Mass/volume] in Red Blood Cells |
| 33877-2 | Tetrahydrobiopterin/Biopterin in Urine |
| 54278-7 | Glutarate [Moles/volume] in Cerebral spinal fluid |
| 24299-0 | Respiratory syncytial virus Ab [Titer] in Serum --2nd specimen |
| 47305-8 | BRST 2 Ag [Presence] in Tissue by Immune stain |
| 47319-9 | Myelin basic protein Ab [Units/volume] in Serum by Immunoassay |
| 25214-8 | Kanamycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25256-9 | Ganciclovir [Mass/volume] in Specimen |
| 25421-9 | Measles virus IgM Ab [Units/volume] in Serum by Immunoassay |
| 34965-4 | Osmotic fragility of Red Blood Cells--0.10% sodium chloride 24 hour 37 degree C incubation |
| 55813-0 | Alpha aminobutyrate/Amino acids.total in Serum or Plasma |
| 47890-9 | Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose arginine+insulin |
| 25842-6 | HIV 2 proviral DNA [Presence] in Specimen by NAA with probe detection |
| 35673-3 | Phosphate [Mass/volume] in Urine collected for unspecified duration |
| 26510-8 | Band form neutrophils/100 leukocytes in Body fluid |
| 48621-7 | Hexacarboxylporphyrin/Creatinine [Molar ratio] in 24 hour Urine |
| 4873-6 | HLA-Dw12 [Presence] |
| 27082-7 | Delavirdine [Mass/volume] in Serum or Plasma |
| 3846-3 | Naproxen [Mass/volume] in Serum or Plasma |
| 38631-8 | Allyl chloride [Mass/volume] in Air |
| 57323-8 | Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 49197-7 | Bartonella vinsonii berkhoffii IgG Ab [Titer] in Body fluid |
| 49274-4 | Immunoelectrophoresis for Serum or Plasma Narrative |
| 27311-0 | Codeine Free [Mass/mass] in Stool |
| 39003-9 | Cytomegalovirus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 39534-3 | Cryptosporidium sp Ag [Presence] in Stool by Immunofluorescence |
| 58073-8 | Wr sup(a) Ag [Presence] on Red Blood Cells |
| 4947-8 | HLA-DQ8(3) [Presence] |
| 49625-7 | CD59 Granulocytes [Interpretation] in Blood Qualitative |
| 58483-9 | BRAF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 40363-4 | Follitropin [Units/volume] in Serum or Plasma --2 hours post dose triple bolus |
| 20463-6 | Mycobacterium avium complex rRNA [Presence] in Specimen by NAA with probe detection |
| 20797-7 | Endotoxin identified in Specimen |
| 13043-5 | C peptide [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 101946-2 | Candida tropicalis DNA [Presence] in Urine by NAA with probe detection |
| 1359-9 | Corticotropin [Mass/volume] in Plasma --1 hour post 1 ug/kg CRH IV |
| 13640-8 | Vinyl chloride [Mass/volume] in Urine |
| 102409-0 | Lettuce IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102942-0 | Persimmon IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102975-0 | Rat epithelium, serum proteins + urine proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102977-6 | Dates IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10359-8 | Asialoganglioside GM1 IgM Ab [Titer] in Serum |
| 104303-3 | N-Desmethyl imatinib [Mass/volume] in Serum or Plasma |
| 15255-3 | Food Allergen Mix 9 (Kiwi+Melon+Banana+Almond+Grape) IgE Ab [Presence] in Serum by Multidisk |
| 16131-5 | Herpes simplex virus 2 DNA [Presence] in Specimen by NAA with probe detection |
| 16428-5 | Bacitracin [Mass/volume] in Serum or Plasma |
| 16491-3 | Brush border Ab [Presence] in Serum by Immunofluorescence |
| 16970-6 | Histoplasma capsulatum Ab [Presence] in Serum by Complement fixation |
| 90423-5 | Microorganism preliminary growth detection panel - Blood by Culture |
| 90449-0 | Norovirus genogroup I and II RNA [Identifier] in Specimen by NAA with probe detection |
| 75132-1 | Oxipurinol/Creatinine [Molar ratio] in Urine |
| 60329-0 | Promazine [Moles/volume] in Specimen |
| 6052-5 | Broccoli IgE Ab [Units/volume] in Serum |
| 76409-2 | Lymphocytes [#] in Body fluid by Manual count |
| 77740-9 | Norcotinine [Mass/volume] in Urine |
| 62441-1 | Nucleated erythrocytes/100 leukocytes [Ratio] in Cerebral spinal fluid by Automated count |
| 63216-6 | CV2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 78379-5 | Epipregnanolone [Moles/volume] in Urine |
| 9467-2 | Calcium [Mass/volume] in Water |
| 63374-3 | Fusarium roseum IgE Ab [Units/volume] in Serum |
| 79343-0 | Dimethylacetals pattern [Interpretation] in Red Blood Cells Narrative |
| 79400-8 | Vanillylmandelate [Moles/volume] in Cerebral spinal fluid |
| 95056-8 | Catecholamines supine and standing panel - Plasma |
| 95242-4 | Platelet aggregation ADP induced in Platelet rich plasma --1.2 umol/L |
| 79568-2 | ABCD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 8057-2 | Yellow fever virus RNA [Presence] in Serum by NAA with probe detection |
| 96968-3 | TNFAIP3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 9721-2 | Salivary gland Ab [Titer] in Serum |
| 97594-6 | CD3 cells/100 lymphocytes in Lower respiratory specimen by Flow cytometry (FC) |
| 97958-3 | London Plane IgG4 Ab [Mass/volume] in Serum |
| 7037-5 | Norfloxacin [Susceptibility] by Gradient strip |
| 71370-1 | Epidermal Allergen Mix 70 (Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) IgE Ab [Units/volume] in Serum by Multidisk |
| 82370-8 | Norbuprenorphine [Presence] in Gastric fluid by Screen method |
| 98105-0 | Interleukin 16 [Mass/volume] in Serum or Plasma |
| 85776-3 | Proteus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 86455-3 | Brucella sp Ab [Presence] in Serum by Acidified buffered plate agglutination |
| 87283-8 | Brachyspira hampsonii DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 87435-4 | Coccidioides immitis IgG and IgM panel - Serum or Plasma |
| 73482-2 | Carisoprodol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73498-8 | Bumetanide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73657-9 | Varicella zoster virus ORF36 genotype [Identifier] |
| 74351-8 | Glucose [Moles/volume] in Urine collected for unspecified duration |
| 89431-1 | CD25 cells/100 CD4 cells in Blood |
| 41667-7 | Biapenem [Susceptibility] by Gradient strip |
| 59638-7 | clonazePAM [Mass/volume] in Body fluid |
| 59814-4 | Glucose [Moles/volume] in Serum or Plasma --7 AM specimen |
| 59834-2 | Creatinine reduction ratio in Serum or Plasma |
| 50839-0 | Calcium/Creatinine [Molar ratio] in 24 hour Urine |
| 51043-8 | CD123 blasts/100 blasts in Bone marrow |
| 60104-7 | O-desmethylvenlafaxine [Mass/mass] in Tissue |
| 21598-8 | Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 31255-3 | Basement membrane IgG Ab [Presence] in Serum |
| 51138-6 | Cytoplasmic CD3 blasts/100 blasts in Blood |
| 21716-6 | NB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 32041-6 | Sjogrens syndrome-A extractable nuclear Ab+Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum |
| 51746-6 | Borrelia burgdorferi 49736 IgG Ab [Presence] in Serum by Immunoblot |
| 51799-5 | Adenosine deaminase [Enzymatic activity/volume] in Synovial fluid |
| 2245-9 | Estradiol (E2) [Moles/mass] in Tissue |
| 32332-9 | Neopterin/Biopterin [Molar ratio] in Urine |
| 52780-4 | Maximum clot firmness.extrinsic coagulation system activated.platelets inhibited [Length] in Blood by Rotational TEG |
| 52992-5 | Cytoplasmic CD79a cells/100 cells in Body fluid |
| 44042-0 | Basophils [Presence] in Pericardial fluid by Light microscopy |
| 22921-1 | Brucella abortus Ab [Units/volume] in Serum by Agglutination |
| 3302-7 | Acetazolamide [Mass/volume] in Urine |
| 3309-2 | Alphaprodine [Presence] in Urine |
| 445-7 | Roxithromycin [Susceptibility] by Disk diffusion (KB) |
| 44676-5 | Margin(s) involved by invasive carcinoma in Breast tumor |
| 33710-5 | Clostridium botulinum toxin E [Presence] in Specimen |
| 53573-2 | cycloSPORINE [Mass/volume] in Blood --post dose |
| 45272-2 | Sympathomimetics [Presence] in Urine by Confirmatory method |
| 237-8 | Erythromycin+Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 33829-3 | Lutropin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 33863-2 | Cystatin C [Mass/volume] in Serum or Plasma |
| 54188-8 | Posaconazole [Susceptibility] |
| 54284-5 | Glycerol [Moles/volume] in Body fluid |
| 2454-7 | Hypoxanthine phosphoribosyltransferase [Enzymatic activity/volume] in Red Blood Cells |
| 54908-9 | Cefminox [Susceptibility] |
| 25104-1 | Glutarate/Creatinine [Molar ratio] in Urine |
| 25337-7 | Taenia solium larva IgG Ab [Units/volume] in Serum |
| 55731-4 | Inject Rh immune globulin [Mass] |
| 47506-1 | Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum --1st specimen |
| 4765-4 | HLA-B55(22) [Presence] |
| 35364-9 | Lipase [Enzymatic activity/volume] in Body fluid --1st specimen post Sincalide |
| 35548-7 | Fusarium moniliforme IgG Ab [Mass/volume] in Serum |
| 56294-2 | Johnson grass IgG4 Ab [Mass/volume] in Serum |
| 26407-7 | Honey bee IgG4 Ab [Units/volume] in Serum |
| 26638-7 | Leishmania donovani Ab [Presence] in Serum |
| 35835-8 | Quinupristin+Dalfopristin [Susceptibility] by Disk diffusion (KB) |
| 56603-4 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 38241-6 | CD8+CD95+ cells [#/volume] in Blood |
| 38505-4 | Thyroglobulin recovery in Serum or Plasma |
| 57681-9 | Coxiella burnetii IgG Ab [Presence] in Serum by Immunofluorescence --1st specimen |
| 27286-4 | Triazolam [Mass/mass] in Stool |
| 27358-1 | Benzoylecgonine [Mass/volume] in Vitreous fluid |
| 28055-2 | Borrelia burgdorferi 45kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 38686-2 | Spermatozoa IgA+IgG Ab/100 spermatozoa in Specimen by Immunobead |
| 49840-2 | CD19+IgG+ cells/100 cells in Specimen |
| 50034-8 | Arbovirus neutralizing antibody [Identifier] in Specimen by Neutralization test |
| 50132-0 | 3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in DBS |
| 29653-3 | Dothiepin [Moles/volume] in Serum or Plasma |
| 29857-0 | Anaplasma phagocytophilum IgM Ab [Presence] in Serum |
| 29939-6 | Tellurium/Creatinine [Mass Ratio] in 24 hour Urine |
| 58921-8 | Glutamine+Histidine [Moles/volume] in Cerebral spinal fluid |
| 50351-6 | Australian pine IgE Ab/IgE total in Serum |
| 41153-8 | Giardia lamblia IgM Ab [Presence] in Serum |
| 19183-3 | Cytokeratin 19 [Units/volume] in Pleural fluid |
| 20779-5 | Bovine coronavirus Ag [Presence] in Tissue by Immunofluorescence |
| 20837-1 | Herbicide [Identifier] in Feed |
| 20959-3 | Sarcocystis neurona Ag [Presence] in Tissue by Immune stain |
| 12867-8 | Borrelia burgdorferi 58kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 101540-3 | AGA gene [Likelihood] in Serum by Calculation |
| 102275-5 | Date Palm Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13956-8 | Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection |
| 14315-6 | Benzoylecgonine [Presence] in Urine by Confirmatory method |
| 104331-4 | Bordetella pertussis IgA Ab [Titer] in Serum by Immunoassay --1st specimen |
| 154-5 | Cephaloglycin [Susceptibility] by Disk diffusion (KB) |
| 10791-2 | Microscopic observation [Identifier] in Tissue by Mallory-Heidenhain stain |
| 1086-8 | Js sup(b) Ab [Presence] in Serum or Plasma from Donor |
| 16426-9 | Babesia sp IgM Ab [Titer] in Serum |
| 16661-1 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --2 hours post XXX challenge |
| 112-3 | cefoTEtan [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 12309-1 | Naltrexone [Presence] in Urine |
| 16931-8 | Hematocrit/Hemoglobin [Ratio] of Blood by Automated count |
| 17679-2 | Taurine [Presence] in Cerebral spinal fluid |
| 90419-3 | Apolipoprotein CIII-0/Apolipoprotein CIII-2 [Mass Ratio] in Serum or Plasma |
| 90785-7 | Cystinuria panel - 24 hour Urine |
| 75769-0 | Promazine [Presence] in Blood or Urine by Screen method |
| 92860-6 | Chlamydophila pneumoniae and Mycoplasma pneumoniae DNA panel - Upper respiratory specimen by NAA with probe detection |
| 93226-9 | Coccidioides sp Ag [Mass/volume] in Serum or Plasma by Immunoassay |
| 93789-6 | Time to microorganism growth detection in Specimen |
| 63440-2 | PCA-Tr Ab [Presence] in Serum by Immunoblot |
| 6388-3 | Eastern equine encephalitis virus Ag [Presence] in Serum by Immunoassay |
| 64973-1 | Dog recombinant 5 IgE Ab [Units/volume] in Serum |
| 9594-3 | Borrelia burgdorferi 45kD IgG Ab [Presence] in Serum by Immunoblot |
| 9621-4 | Lipoprotein.pre-beta [Mass/volume] in Pleural fluid |
| 6754-6 | Glucose [Presence] in Urine by Test strip --30 minutes post 75 g glucose PO |
| 69828-2 | Methylsuccinate [Moles/volume] in Amniotic fluid |
| 8202-4 | Lead [Mass/mass] in Nail |
| 82221-3 | Alpha-methylacyl CoA racemase [Enzymatic activity/mass] in Fibroblast |
| 97619-1 | Escherichia coli DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 98073-0 | Natural killer and natural killer T cell subsets panel - Blood |
| 85296-2 | Tumor budding [Presence] in Cancer specimen by Light microscopy |
| 99604-1 | Band form neutrophils/100 leukocytes in Pleural fluid by Manual count |
| 85822-5 | Beta-lactam resistance AmpC blaCMY+blaMOX genes [Presence] by Molecular method |
| 85986-8 | Streptococcus pneumoniae Danish serotype 12F Ab [Units/volume] in Serum --2nd specimen |
| 73106-7 | Triamcinolone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73128-1 | Tamsulosin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73391-5 | Esomeprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87652-4 | Isofenphos [Mass/mass] in Specimen |
| 87654-0 | Heptachlor [Mass/mass] in Specimen |
| 73920-1 | JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Blood |
| 73922-7 | RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
| 41459-9 | SARS coronavirus [Presence] in Specimen |
| 41493-8 | Febrile agglutinin Ab panel [Titer] - Serum |
| 41720-4 | Tazobactam [Susceptibility] by Gradient strip |
| 50859-8 | Hydrogen ion [Moles/volume] in Venous cord blood |
| 3074-2 | Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma |
| 42250-1 | Variant lymphocytes/100 leukocytes in Blood by Automated count |
| 21223-3 | Cortisol [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 51404-2 | CD81 cells/100 cells in Body fluid |
| 2241-8 | Estradiol (E2) Free [Moles/mass] in Tissue |
| 22614-2 | Western equine encephalitis virus IgG Ab [Titer] in Serum |
| 22783-5 | African swine fever virus Ag [Presence] in Tissue by Immunofluorescence |
| 52130-2 | t(9;22)(q34.1;q11)(ABL1,BCR) b2a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
| 43907-5 | Argininosuccinate [Presence] in Serum or Plasma |
| 44080-0 | Chlamydophila pneumoniae IgG and IgM [Interpretation] in Serum |
| 22858-5 | Babesia sp identified in Tissue by Giemsa stain |
| 3322-5 | aMILoride [Mass/volume] in Serum or Plasma |
| 53269-7 | Yeast.budding [#/area] in Urine by Computer assisted method |
| 4459-4 | Vancomycin [Mass] of Dose |
| 44623-7 | Matted nodes by CAP cancer protocols |
| 23466-6 | Theileria equi Ab [Presence] in Serum by Immunofluorescence |
| 33387-2 | Segmented neutrophils/100 leukocytes in Pericardial fluid |
| 53704-3 | Mycobacterium bovis tuberculin stimulated gamma interferon-control stimulated gamma interferon [Units/volume] in Blood |
| 45291-2 | Coxsackievirus B2 Ab [Presence] in Body fluid |
| 34258-4 | Carnitine free (C0) [Moles/volume] in 24 hour Urine |
| 34270-9 | Cobalt/Creatinine [Molar ratio] in Urine |
| 54264-7 | Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose insulin IV |
| 24438-4 | Hexanoylglycine/Creatinine [Molar ratio] in Urine |
| 54935-2 | 1,2-Dichloroethane [Mass/volume] in Serum or Plasma |
| 55579-7 | Sotalol [Moles/volume] in Serum or Plasma |
| 47348-8 | Streptococcus pneumoniae Danish serotype 19A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 47352-0 | Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 35084-3 | Fetal lung maturity in Amniotic fluid |
| 55963-3 | Palmitoleylcarnitine (C16:1)/Creatinine [Molar ratio] in Urine |
| 47592-1 | C peptide [Moles/volume] in Serum or Plasma --5 minutes post dose glucose |
| 25645-3 | Follitropin [Units/volume] in Serum or Plasma --30 minutes post 100 ug luteinizing releasing hormone IV |
| 25865-7 | Aspartate/Creatinine [Molar ratio] in 24 hour Urine |
| 35386-2 | CV2 IgG Ab [Titer] in Serum |
| 47973-3 | TGFBR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 48015-2 | Individual allele panel |
| 48091-3 | Corticotropin [Mass/volume] in Plasma --12 AM specimen |
| 26616-3 | CD59 RBC [Presence] in Blood |
| 370-7 | Novobiocin [Susceptibility] by Minimum lethal concentration (MLC) |
| 3712-7 | Levorphanol [Mass/volume] in Urine |
| 38178-0 | Lambda light chains.free [Mass/volume] in Urine |
| 5679-6 | Lysergate diethylamide [Mass/volume] in Urine |
| 485-3 | Teicoplanin [Susceptibility] by Disk diffusion (KB) |
| 48806-4 | Salmonella sp+Shigella sp+Escherichia coli enterotoxic identified in Stool by Organism specific culture |
| 26833-4 | Hippurate [Presence] in Urine |
| 38618-5 | Styrene [Mass/volume] in Air |
| 48917-9 | Respiratory allergen panel, US - South Atlantic states b - Serum |
| 49320-5 | Beta-N-acetylhexosaminidase.A activator [Interpretation] in Fibroblast Narrative |
| 27889-5 | Somatotropin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 38896-7 | F9 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 58035-7 | Blueberry IgG Ab [Mass/volume] in Serum |
| 49418-7 | Papova virus SV 40 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
| 29154-2 | Choriogonadotropin.beta subunit [Units/volume] in Body fluid |
| 39779-4 | Urea [Moles/volume] in 24 hour Dialysis fluid |
| 58392-2 | Morphine/Creatinine [Mass Ratio] in Urine |
| 29786-1 | Jamestown canyon virus IgM Ab [Units/volume] in Specimen by Immunofluorescence |
| 40539-9 | Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count |
| 505-8 | Ticarcillin+Clavulanate [Susceptibility] by Disk diffusion (KB) |
| 204-8 | Colistin [Susceptibility] by Minimum lethal concentration (MLC) |
| 100832-5 | Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 12448-7 | Ketones [Mass/volume] in Urine by Test strip --fasting |
| 12729-0 | Interferon gamma [Units/volume] in Serum or Plasma |
| 101241-8 | Contactin-associated protein 2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 13309-0 | Duffy group Ag [Type] on Red Blood Cells |
| 102181-5 | Beta lactoglobulin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13466-8 | Lead/Creatinine [Mass Ratio] in Urine |
| 13876-8 | Beta-2 transferrin [Presence] in Body fluid |
| 102454-6 | Mucor racemosus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1402-7 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IV rapid |
| 102804-2 | Potato IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102989-1 | Yellow dye IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103181-4 | Herpes simplex virus 2 DNA [Presence] in Urine by NAA with probe detection |
| 15139-9 | Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Urine |
| 15179-5 | Fibrin D-dimer [Presence] in Platelet poor plasma |
| 10661-7 | Dinoflagellate identified in Water by Light microscopy |
| 15410-4 | Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay |
| 16149-7 | Aldosterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 16240-4 | PENTobarbital [Mass/volume] in Urine by Confirmatory method |
| 1096-7 | K Ag [Presence] on Red Blood Cells |
| 12270-5 | Uroporphyrin [Presence] in 24 hour Urine |
| 16955-7 | Herpes simplex virus 2 IgG Ab [Presence] in Serum by Immunoblot |
| 17202-3 | CD85 cells/100 cells in Blood |
| 17340-1 | Neuronal IgG Ab [Presence] in Body fluid by Immunoassay |
| 18357-4 | Methylenedioxymethamphetamine [Mass/volume] in Blood |
| 18434-1 | 1,2-Dichlorobenzene [Mass/volume] in Blood |
| 91057-0 | Tropheryma whipplei DNA [Presence] in Stool by NAA with probe detection |
| 74849-1 | Plasma cells/100 cells in Lymph node by Manual count |
| 75092-7 | Birth date of Fetus |
| 75509-0 | aPTT.lupus sensitive with 1:1 PNP actual/Normal (normalized LA mix) |
| 60470-2 | Toxocara canis Ab [Units/volume] in Body fluid |
| 61059-2 | Alpha-Phenyl-2-Piperidine acetate [Presence] in Specimen |
| 76339-1 | Porcine deltacoronavirus RNA [Presence] in Specimen by NAA with probe detection |
| 78820-8 | Cyclobenzaprine cutoff [Mass/volume] in Urine for Confirmatory method |
| 6355-2 | Chlamydia trachomatis Ag [Presence] in Specimen by Immunofluorescence |
| 79179-8 | Somatotropin [Units/volume] in Serum or Plasma --75 minutes post XXX challenge |
| 79483-4 | Vanilloylglycine/Creatinine [Molar ratio] in Urine |
| 66726-1 | Adenovirus DNA [Log #/volume] (viral load) in Genital specimen by NAA with probe detection |
| 96406-4 | Retinol binding protein [Mass/volume] in 24 hour Urine |
| 8119-0 | CD20 cells/100 cells in Blood |
| 96531-9 | Oropouche virus IgM Ab [Presence] in Specimen by Immunoassay |
| 96681-2 | Activated clotting time.diatomaceous earth+clay induced of Blood by Microviscometry |
| 96723-2 | Odor of Lower respiratory specimen |
| 9683-4 | 2-Methyl-2-Propanol [Mass/volume] in Specimen |
| 69836-5 | 3-Hydroxyadipate [Moles/volume] in Serum or Plasma |
| 81832-8 | SLC26A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 97221-6 | Amphetamine [Presence] in Cord tissue by Confirmatory method |
| 97272-9 | Methadone [Presence] in Cord tissue by Screen method |
| 97984-9 | Timothy recombinant (rPhl p) 1 + 5b IgG4 Ab [Mass/volume] in Serum |
| 9814-5 | Dextroamphetamine [Mass/volume] in Serum or Plasma |
| 987-8 | Di sup(b) Ab [Presence] in Serum or Plasma |
| 7189-4 | Cattail IgE Ab [Units/volume] in Serum |
| 99525-8 | Circumference [Length] of Aortic valve |
| 99912-8 | Bacilliform bacteria [Presence] in Urine sediment by Automated |
| 73650-4 | Ceftaroline [Susceptibility] by Disk diffusion (KB) |
| 73942-5 | Buprenorphine [Presence] in Saliva (oral fluid) by Screen method |
| 74307-0 | PRRSV ORF5 gene sequence homology to Lelystad in Isolate by Sequencing |
| 74368-2 | Apelin [Mass/volume] in Serum or Plasma |
| 88911-3 | Taenia solium larva DNA [Presence] in Tissue by NAA with probe detection |
| 59343-4 | Tadalafil [Mass/volume] in Serum or Plasma |
| 50975-2 | TCR alpha beta cells [#/volume] in Blood |
| 21111-0 | Beta-N-acetylhexosaminidase.B/Beta-n-acetylhexosaminidase.total in Serum or Plasma |
| 21367-8 | levoFLOXacin [Susceptibility] by Disk diffusion (KB) |
| 21405-6 | Mycobacterium sp DNA [Presence] in Bronchial specimen by NAA with probe detection |
| 42773-2 | Multiple drug resistant organism identified in Urine |
| 21799-2 | t(1;13)(p36.13;q14.1)(PAX7,FOXO1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 22136-6 | Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid |
| 51503-1 | Penicillin G procaine [Susceptibility] |
| 5174-8 | Helicobacter pylori Ab [Units/volume] in Serum by Immunoassay |
| 51778-9 | YY1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 32201-6 | Unidentified cells [#/volume] in Cerebral spinal fluid by Manual count |
| 43913-3 | Bordetella pertussis DNA [Presence] in Nasopharynx by NAA with probe detection |
| 44510-6 | Herpes simplex virus Ag [Presence] in Vaginal fluid |
| 23554-9 | Venezuelan equine encephalitis virus subtype [Identifier] in Specimen by Immunofluorescence |
| 33398-9 | Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Urine by Latex agglutination |
| 3343-1 | Amoxapine [Mass/volume] in Urine |
| 44901-7 | Malignant cells/100 cells in Liver by Manual count |
| 45015-5 | Adenosine monophosphate.cyclic [Moles/volume] in Urine --baseline |
| 45296-1 | Cortisol [Moles/volume] in Serum or Plasma --pre dose dexamethasone |
| 23919-4 | Osmotic fragility of Red Blood Cells--0.65% sodium chloride |
| 33854-1 | Progesterone [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 33876-4 | Sulfocysteine/Creatinine [Molar ratio] in Urine |
| 33884-8 | Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --1H post incubation with normal plasma |
| 5403-1 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay |
| 54359-5 | Bicarbonate [Moles/volume] in Plasma --post dialysis |
| 46137-6 | Triple phosphate crystals [#/area] in Urine sediment by Microscopy high power field |
| 2496-8 | Iodohippuran renal clearance in 24 hour Urine and Serum or Plasma |
| 34522-3 | Phosphorylase kinase [Enzymatic activity/volume] in Red Blood Cells |
| 54482-5 | Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Cerebral spinal fluid |
| 55101-0 | Respiratory pathogens panel - Specimen by Organism specific culture |
| 47272-0 | Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --5th specimen post XXX challenge |
| 25141-3 | Carnitine esters/Creatinine [Molar ratio] in Urine |
| 34973-8 | DNA index 2 in Serum or Plasma by Flow cytometry (FC) |
| 5603-6 | Borate [Mass/time] in 24 hour Urine |
| 47630-9 | Glutamine [Moles/volume] in DBS |
| 47834-7 | C peptide [Moles/volume] in Serum or Plasma --8 minutes post dose glucagon |
| 56273-6 | Grape IgG4 Ab [Mass/volume] in Serum |
| 56411-2 | Velvet grass IgG4 Ab [Mass/volume] in Serum |
| 56486-4 | Taenia solium IgG Ab [Units/volume] in Serum by Immunoassay |
| 36896-9 | West Nile virus polyvalent E Ab [Presence] in Specimen by Immunoassay |
| 56725-5 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot |
| 48416-2 | Alpha-1-acid glycoprotein [Mass/volume] in Body fluid |
| 26929-0 | Glycine [Moles/volume] in Amniotic fluid |
| 38323-2 | Lindane [Mass/volume] in Water |
| 57489-7 | 11-Ketoetiocholanolone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
| 57564-7 | 21-Deoxycortisol [Moles/volume] in Serum or Plasma --1 day post dose dexamethasone |
| 2797-9 | Phosphoglucomutase [Enzymatic activity/volume] in Serum |
| 28067-7 | Hemoglobin F [Presence] in Amniotic fluid |
| 29347-2 | Chloramphenicol [Mass/volume] in Gastric fluid |
| 29382-9 | Warfarin [Mass/volume] in Urine |
| 58438-3 | Cells [Type] in Urine sediment by Light microscopy |
| 49975-6 | Borrelia burgdorferi 34kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 40321-2 | Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose triple bolus |
| 58825-1 | Cortisol [Mass/volume] in Serum or Plasma --18th specimen |
| 59263-4 | Human papilloma virus 16 DNA [Presence] in Cervix by Probe with signal amplification |
| 30054-1 | Tyrosine/Creatinine [Ratio] in Urine |
| 30306-5 | Efavirenz [Susceptibility] |
| 40830-2 | Toxocara sp Ab [Units/volume] in Serum |
| 40906-0 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 41055-5 | SLC26A4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2001-6 | Calcium [Moles/volume] in 24 hour Stool |
| 2019-8 | Carbon dioxide [Partial pressure] in Arterial blood |
| 12359-6 | Benzodiazepines [Presence] in Stool |
| 100680-8 | Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 12484-2 | PHENobarbital [Presence] in Gastric fluid |
| 12646-6 | Glucose [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 13578-0 | Promazine [Presence] in Serum or Plasma |
| 14155-6 | Cholesterol in LDL [Percentile] |
| 14179-6 | Tissue polypeptide Ag [Mass/volume] in Serum or Plasma |
| 102802-6 | White Poplar IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14798-3 | Iron [Moles/volume] in Serum or Plasma |
| 10414-1 | Transfuse albumin [Volume] |
| 14843-7 | 6-Monoacetylmorphine (6-MAM) [Presence] in Gastric fluid |
| 15001-1 | Xylose [Moles/volume] in Serum or Plasma --1 hour post 25 g xylose PO |
| 104264-7 | Galactosylceramidase [Enzymatic activity/volume] in Cerebral spinal fluid by LC/MS/MS |
| 10534-6 | Diazoxide [Mass/volume] in Serum or Plasma |
| 15381-7 | Leishmania brasilensis IgM Ab [Titer] in Serum |
| 10717-7 | Streptococcus pneumoniae Ab [Units/volume] in Serum by Latex agglutination |
| 16545-6 | Capreomycin [Mass/volume] in Serum or Plasma |
| 1666-7 | 17-Hydroxycorticosteroids [Mass/volume] in Urine |
| 11575-8 | Cefmetazole [Susceptibility] by Gradient strip |
| 17007-6 | IgG [Presence] in Serum |
| 17186-8 | CD66c cells/100 cells in Blood |
| 17865-7 | Glucose [Mass/volume] in Serum or Plasma --8 hours fasting |
| 74504-2 | 16-Beta,18-dihydroxydehydroepiandrosterone [Moles/volume] in 24 hour Urine |
| 74637-0 | Protein.monoclonal band 2 [Mass/time] in 24 hour Urine by Electrophoresis |
| 74854-1 | HIV 1 proviral DNA [#/volume] (viral load) in Blood by NAA with probe detection |
| 75145-3 | Succinyladenosine [Moles/volume] in Serum or Plasma |
| 75766-6 | fluPHENAZine [Presence] in Blood or Urine by Screen method |
| 9378-1 | Glucose [Mass/volume] in Serum or Plasma --5.5 hours post 100 g glucose PO |
| 63259-6 | Ganglioside GT1b IgM Ab [Presence] in Serum by Immunoassay |
| 7786-7 | Yew IgE Ab [Units/volume] in Serum |
| 78205-2 | ALK gene rearrangements [Presence] in Blood or Tissue by FISH |
| 63366-9 | Thyrotropin receptor Ab [Units/volume] in Cerebral spinal fluid |
| 65362-6 | Magnesium [Moles/volume] corrected for albumin in Serum or Plasma |
| 8025-9 | Saint Louis encephalitis virus RNA [Presence] in Serum by NAA with probe detection |
| 6818-9 | Saccharopolyspora rectivirgula Ab [Presence] in Serum by Immune diffusion (ID) |
| 68925-7 | Cancer Ag 72-4 [Units/volume] in Cerebral spinal fluid |
| 80641-4 | Dothiepin+Nordothiepin [Mass/volume] in Serum or Plasma |
| 8098-6 | Thyroglobulin Ab [Units/volume] in Serum or Plasma |
| 96593-9 | Gamma glutamyl transferase [Enzymatic activity/volume] in DBS |
| 96705-9 | Clot stiffness reduction percent due to fibrinolysis in Blood by calculation |
| 69363-0 | SERPINA10 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 82247-8 | Chromosome region 7q11.23 deletion in Amniotic fluid or Chorionic villus sample by FISH |
| 8271-9 | Haemophilus influenzae C Ag [Presence] in Specimen by Immunofluorescence |
| 99089-5 | Escherichia coli K1 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 72218-1 | t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
| 72314-8 | Th-To IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 99403-8 | Cells.CD19+CD22+/100 cells in Bone marrow |
| 995-1 | Do sup(a) Ag [Presence] on Red Blood Cells from Donor |
| 72821-2 | Creatinine [Mass/time] by Calculated in Urine collected for unspecified duration |
| 87550-0 | Haloperidol and reduced haloperidol panel - Serum or Plasma |
| 73647-0 | Ceftolozane+Tazobactam [Susceptibility] by Disk diffusion (KB) |
| 88009-6 | Palmitoylcarnitine (C16)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma |
| 88127-6 | Herpes simplex virus identified in Cornea or Conjunctiva by Organism specific culture |
| 59921-7 | Mefenamate [Moles/volume] in Serum or Plasma |
| 21133-4 | Calcitonin [Mass/volume] in Serum or Plasma --2 minutes post 0.5 ug/kg pentagastrin IV |
| 31305-6 | Chlamydophila psittaci IgA Ab [Units/volume] in Cerebral spinal fluid |
| 31423-7 | Histone IgG Ab [Units/volume] in Serum |
| 31565-5 | Polio virus 1 Ab [Units/volume] in Body fluid |
| 31568-9 | Polio virus 3 Ab [Units/volume] in Cerebral spinal fluid |
| 51099-0 | CD179a blasts [Units/volume] in Blood |
| 5122-7 | Cytomegalovirus Ab [Units/volume] in Serum or Plasma by Immunofluorescence |
| 42921-7 | JC virus DNA [Presence] in Specimen by NAA with probe detection |
| 22194-5 | Chlamydia trachomatis B IgA Ab [Titer] in Serum |
| 22205-9 | Coccidioides immitis Ab [Presence] in Serum |
| 22264-6 | Echinococcus granulosus IgG Ab [Presence] in Serum |
| 51597-3 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
| 52822-4 | Eastern equine encephalitis virus IgG Ab [Presence] in Serum by Immunoassay |
| 4423-0 | Salicylates [Mass] of Dose |
| 32605-8 | Leptospira sp Ab [Titer] in Serum --2nd specimen |
| 32699-1 | Microscopic observation [Identifier] in Blood by Acid fast stain |
| 3288-8 | Prothrombin Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 33202-3 | CD11c cells/100 cells in Bone marrow |
| 53136-8 | Organic acids pattern [Interpretation] in Body fluid |
| 53353-9 | Urinalysis other formed elements panel [#/area] - Urine by Computer assisted method |
| 44539-5 | HTLV II Ab [Presence] in Serum by Immunoassay |
| 53533-6 | Herpes simplex virus IgG Ab [Presence] in Body fluid by Immunoassay |
| 53598-9 | Irritable bowel disease prognostic panel - Serum or Plasma by Immunoassay |
| 53806-6 | LDL apheresis procedure [Identifier] |
| 53927-0 | Neisseria gonorrhoeae rRNA [Presence] in Urethra by NAA with probe detection |
| 45012-2 | Chlamydia sp Ab [Presence] in Serum |
| 4535-1 | Cytotoxic percent reactive Ab [Presence] in Serum by Quick method |
| 23875-8 | Hexacarboxylporphyrin III [Mass/time] in unspecified time Stool |
| 54347-0 | Albumin [Moles/volume] in Serum or Plasma |
| 24203-2 | Legionella pneumophila Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 24360-0 | Hemoglobin and Hematocrit panel - Blood |
| 55355-2 | Osmolality of Urine--7 hours post fluid fast |
| 25302-1 | Alanine aminotransferase [Enzymatic activity/volume] in Body fluid |
| 34986-0 | Unidentified cells [#/volume] in Pericardial fluid |
| 55875-9 | Homocitrulline [Moles/volume] in Cerebral spinal fluid |
| 47714-1 | Ornithine [Moles/volume] in DBS |
| 26015-8 | Cholesterol in HDL 2 [Moles/volume] in Serum or Plasma |
| 56476-5 | Hemoglobin S/Hemoglobin.total in DBS |
| 48098-8 | Cortisol [Mass/volume] in Serum or Plasma --12 AM specimen |
| 26688-2 | Mercury/Creatinine [Mass Ratio] in 24 hour Urine |
| 56636-4 | Bordetella parapertussis IgM Ab [Titer] in Serum by Immunofluorescence |
| 48759-5 | 3-Hydroxyhexanoate (3-OH-C6:0) [Moles/volume] in Serum or Plasma |
| 38329-9 | Styrene [Mass/volume] in Water |
| 3844-8 | Nandrolone [Mass/volume] in Urine |
| 57408-7 | CD8+CD45RO+ cells/100 cells in Body fluid |
| 2766-4 | Phenylalanine [Mass/volume] in Urine |
| 38697-9 | Ethylene thiourea [Mass/volume] in Air |
| 38895-9 | ELA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 39562-4 | Glucose [Mass/volume] in Serum or Plasma --2nd specimen post dose lactose |
| 57693-4 | Cortisol [Mass/volume] in Saliva (oral fluid) --6th specimen |
| 4017-0 | quiNIDine [Mass/volume] in Serum or Plasma --trough |
| 58549-7 | Corticotropin [Moles/volume] in Plasma --15 minutes post XXX challenge |
| 58656-0 | Cortisol [Moles/volume] in Serum or Plasma --2 PM specimen |
| 58685-9 | Beta hydroxybutyrate [Moles/volume] in Vitreous fluid |
| 5869-3 | Parainfluenza virus 1 Ag [Presence] in Specimen by Immunofluorescence |
| 49944-2 | Somatotropin [Units/volume] in Serum or Plasma --10 PM specimen |
| 29917-2 | Selenium/Creatinine [Mass Ratio] in 24 hour Urine |
| 58905-1 | Nucleated cells [#/volume] in Pericardial fluid by Manual count |
| 50191-6 | Occult blood panel - Gastric fluid |
| 50444-9 | Somatotropin [Mass/volume] in Serum or Plasma --20 minutes post dose arginine |
| 50511-5 | Lutropin [Units/volume] in Serum or Plasma --3rd specimen |
| 30317-2 | Base deficit in Arterial cord blood |
| 1926-5 | Base excess in Capillary blood by calculation |
| 19334-2 | Amitriptyline cutoff [Mass/volume] in Urine for Confirmatory method |
| 1981-0 | Biotinidase [Presence] in Blood |
| 20972-6 | Strychnine [Mass/mass] in Tissue |
| 100700-4 | Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection |
| 101187-3 | ADB-BUTINACA [Mass/volume] in Urine by Confirmatory method |
| 101303-6 | Chikungunya virus RNA [Presence] in Blood by NAA with non-probe detection |
| 101509-8 | Colony count [#/volume] in Specimen by Culture Standard Plate Count |
| 13242-3 | Sporothrix schenckii IgM Ab [Units/volume] in Serum |
| 101917-3 | Troponin T.cardiac delta/Troponin T.cardiac in 6 hour Serum or Plasma --baseline |
| 13777-8 | Methylsuccinate/Creatinine [Mass Ratio] in Urine |
| 14070-7 | fluPHENAZine [Presence] in Urine |
| 14259-6 | 1-Pentanol [Mass/volume] in Blood |
| 102795-2 | Pickleweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14417-0 | Calcium [Moles/volume] in Peritoneal fluid |
| 103177-2 | Escherichia coli enterotoxigenic DNA [Presence] in Wound by NAA with probe detection |
| 104167-2 | TRCA+TCRD gene rearrangements in Bone marrow by FISH |
| 10773-0 | Microscopic observation [Identifier] in Tissue by Basic fuchsin stain |
| 10857-1 | Microsporidia identified in Specimen by Light microscopy |
| 11120-3 | Promyelocytes/100 cells in Bone marrow by Manual count |
| 16263-6 | Calcium oxalate dihydrate crystals [Presence] in Stone by Infrared spectroscopy |
| 16393-1 | Nuclear Ab [Units/volume] in Serum by Rodent substrate |
| 12289-5 | Drugs identified in Vitreous fluid by Screen method |
| 17246-0 | Mefenamate [Mass/volume] in Serum or Plasma |
| 17371-6 | Norepinephrine [Mass/volume] in Urine --4th specimen post XXX challenge |
| 17409-4 | Human papilloma virus 5 Ag [Presence] in Specimen |
| 17800-4 | Myelocytes/100 leukocytes in Body fluid |
| 18250-1 | Pentacarboxylporphyrins [Mass/volume] in Blood |
| 92528-9 | little e Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 61092-3 | Triazolam [Presence] in Gastric fluid |
| 61124-4 | Granulocytes/100 leukocytes in Specimen by Flow cytometry (FC) |
| 61248-1 | Orange IgE Ab/IgE total in Serum |
| 94115-3 | Alpha hydroxyalprazolam glucuronide [Presence] in Urine by Screen method |
| 94190-6 | BPGM gene full mutation analysis in Blood or Tissue by Sequencing |
| 6453-5 | Leptospira sp identified in Blood by Organism specific culture |
| 95086-5 | C peptide [Mass/volume] in Serum or Plasma --30 min post meal |
| 65337-8 | Tr sup(a) Ab [Presence] in Serum or Plasma |
| 65770-0 | Peanut native (nAra h) 2 IgE Ab [Units/volume] in Serum |
| 79570-8 | MLH1+MSH2+MSH6+PMS2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 79645-8 | L-serine/Creatinine [Molar ratio] in Urine |
| 79646-6 | Delta aminolevulinate [Moles/volume] in Serum or Plasma |
| 7985-5 | Polio virus 1 Ab [Units/volume] in Serum |
| 798-9 | Erythrocytes [#/volume] in Urine by Automated count |
| 8113-3 | CD16+CD57- cells/100 cells in Blood |
| 71621-7 | Basophils/Leukocytes [Pure number fraction] in Synovial fluid by Manual count |
| 98110-0 | Chemokine (C-C motif) ligand 7 [Mass/volume] in Serum or Plasma |
| 7209-0 | Mozzarella Cheese IgE Ab [Units/volume] in Serum |
| 72356-9 | Influenza virus A and B Ag [Identifier] in Specimen by Rapid immunoassay |
| 85379-6 | Purine/Pyrimidine [Ratio] in Red Blood Cells by Spectrophotometry |
| 7251-2 | Cotton linters IgE Ab [Units/volume] in Serum |
| 72624-0 | Rivaroxaban [Mass/volume] in Serum or Plasma |
| 72808-9 | JWH-018 carboxylated (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
| 73047-3 | ceFAZolin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73124-0 | Telmisartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73447-5 | Cimetidine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73720-5 | Pholcodine IgE Ab [Units/volume] in Serum |
| 7409-6 | Swine triggered histamine release [Units/volume] in Blood |
| 88848-7 | Microbiology CNAMTS panel - Urine |
| 89343-8 | CD19+CD38+IgM- cells [#/volume] in Blood |
| 4165-7 | Cefsulodin [Mass] of Dose |
| 41728-7 | Biapenem [Susceptibility] |
| 59317-8 | Ramelteon M-II [Mass/volume] in Serum or Plasma |
| 59563-7 | Protein.monoclonal band 4 [Mass/volume] in Urine by Electrophoresis |
| 31116-7 | Euploid+Aneuploid cells population 1/100 cells in Specimen |
| 42717-9 | Mycobacterium tuberculosis complex genotype [Identifier] in Isolate |
| 31173-8 | Mevinphos [Mass/volume] in Blood |
| 51493-5 | Cortisol [Mass/volume] in Saliva (oral fluid) --2nd specimen post XXX challenge |
| 43588-3 | Varicella zoster virus IgM Ab [Presence] in Serum by Immunofluorescence |
| 22515-1 | Salmonella arizonae Ab [Presence] in Serum |
| 2264-0 | Ethanolamine [Mass/volume] in Urine |
| 44023-0 | Bacteria [Presence] in Vaginal fluid by Wet preparation |
| 44404-2 | Silicon/Creatinine [Mass Ratio] in Urine |
| 3297-9 | Acetaminophen [Presence] in Serum or Plasma |
| 53165-7 | Formiminoglutamate [Moles/volume] in DBS |
| 53486-7 | Glucose [Moles/volume] in Serum or Plasma --1 hour post dose betaxolol |
| 44823-3 | Bartonella quintana IgM Ab [Units/volume] in Serum by Immunofluorescence |
| 23505-1 | Tritrichomonas foetus DNA [Presence] in Genital fluid by NAA with probe detection |
| 45266-4 | Chronic leukemia markers [Interpretation] in Specimen Narrative |
| 34202-2 | Linezolid [Mass/volume] in Serum or Plasma |
| 34252-7 | Borrelia garinii IgM Ab [Presence] in Serum by Immunoblot |
| 34581-9 | Calcium.ionized [Moles/volume] in Arterial blood |
| 54-7 | Butirosin [Susceptibility] by Serum bactericidal titer |
| 47279-5 | MCHC [Mass/volume] in Cord blood |
| 35475-3 | Transferrin.carbohydrate deficient.asialo/Transferrin.carbohydrate deficient.tetrasialo [Mass Ratio] in Serum or Plasma |
| 35626-1 | Norpropoxyphene [Mass/volume] in Serum or Plasma by Screen method |
| 56243-9 | Dandelion IgG4 Ab [Mass/volume] in Serum |
| 3621-0 | Etilefrine [Presence] in Urine |
| 56893-1 | CD13+HLA-DR+ cells/100 cells in Body fluid |
| 48413-9 | Alpha-1-Microglobulin [Mass/volume] in Serum or Plasma |
| 48551-6 | HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 400 copies/mL |
| 48837-9 | Respiratory allergen panel, US - California central valley - Serum |
| 26918-3 | PENTobarbital [Mass/mass] in Hair |
| 38338-0 | Cyanide [Mass/volume] in Water |
| 38600-3 | Hexachloroethane [Mass/volume] in Air |
| 57674-4 | Coxiella burnetii IgM Ab [Presence] in Serum by Immunofluorescence --2nd specimen |
| 27433-2 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 39532-7 | Inhibin B [Presence] in Serum or Plasma |
| 2851-4 | Prostaglandin E [Mass/volume] in Plasma |
| 40128-1 | Creatinine [Moles/volume] in Serum or Plasma --7 days post XXX challenge |
| 40226-3 | Calcium [Moles/volume] in Serum or Plasma --baseline |
| 49887-3 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 50020-7 | Microdeletion syndromes in Blood or Tissue by FISH |
| 59144-6 | CD5+CD23+ cells/100 cells in Blood |
| 59287-3 | Benzylpiperazine [Mass/volume] in Urine |
| 50375-5 | Nucleated cells [#/volume] in Bronchial specimen by Manual count |
| 30385-9 | Erythrocyte distribution width [Ratio] |
| 41091-0 | MEFV gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19253-4 | Trichinella spiralis Ab [Presence] in Serum by Immunoassay |
| 19291-4 | Cannabinoids cutoff [Mass/volume] in Urine for Screen method |
| 19472-0 | FLUoxetine cutoff [Mass/volume] in Urine for Screen method |
| 19579-2 | Methylphenidate cutoff [Mass/volume] in Urine for Screen method |
| 100373-0 | Eucheuma IgG Ab [Units/volume] in Serum |
| 1261-7 | N Ag [Presence] on Red Blood Cells |
| 1371-4 | Bromsulphthalein [Mass/volume] in Serum or Plasma |
| 14035-0 | Japanese Cedar IgE Ab [Units/volume] in Serum |
| 102776-2 | Olive IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14751-2 | Glucose [Moles/volume] in Serum or Plasma --1.5 hours post 50 g lactose PO |
| 103657-3 | Color of Spun Pericardial fluid |
| 1485-2 | Gastrin [Mass/volume] in Serum or Plasma --15 minutes post 0.2 U/kg secretin |
| 104297-7 | CYP3A4 gene c.6C>T [Presence] in Blood or Tissue by Molecular genetics method |
| 104298-5 | CYP3A4 gene.c.IVS10+12G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 104434-6 | Norovirus Ag [Presence] in Specimen |
| 10678-1 | Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immune stain |
| 15250-4 | Food Allergen Mix 20 (Barley+Rice+Rye+Wheat) IgE Ab [Presence] in Serum by Multidisk |
| 11079-1 | HIV 2 p26 Ab [Presence] in Serum by Immunoblot |
| 16346-9 | Alpha chlordane [Mass/volume] in Urine |
| 16481-4 | Borrelia burgdorferi IgG Ab [Units/volume] in Body fluid by Immunoassay |
| 16551-4 | Carbon dioxide, total [Moles/volume] in Capillary blood |
| 11170-8 | Dematiaceae IgE Ab [Units/volume] in Serum |
| 17448-2 | Phosphatidylethanolamine IgA Ab [Presence] in Serum |
| 18972-0 | Polymyxin B [Susceptibility] |
| 89987-2 | Vortioxetine [Presence] in Urine by Screen method |
| 91077-8 | Measles virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 74658-6 | oxyCODONE+oxyMORphone [Presence] in Saliva (oral fluid) by Confirmatory method |
| 74803-8 | Lactose challenge (hydrogen breath test) [Interpretation] in Exhaled gas |
| 7480-7 | Red Maple triggered histamine release [Units/volume] in Blood |
| 91814-4 | Bordetella sp Ag [Presence] in Upper respiratory specimen by Immunofluorescence |
| 606-4 | Bacteria identified in Cerebral spinal fluid by Culture |
| 61189-7 | INR in Platelet poor plasma from Fetus by Coagulation assay |
| 76581-8 | Streptococcus pyogenes csrS gene [Presence] in Swab specimen by NAA with probe detection |
| 76632-9 | Enterovirus sp [Presence] in Isolate by Immunofluorescence |
| 92985-1 | Enterobacter cloacae complex DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection |
| 9349-2 | pH total acid of Gastric fluid |
| 93493-5 | 3-Hydroxy-3-Methylglutaryl-coenzyme A reductase IgG Ab [Units/volume] in Serum by Immunoassay |
| 61307-5 | Pear IgE Ab/IgE total in Serum |
| 93773-0 | 11-Deoxycortisol [Moles/volume] in Saliva (oral fluid) |
| 94309-2 | SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen by NAA with probe detection |
| 94472-8 | VEGFA gene c.-1498C>G and c.-1498C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 635-3 | Bacteria identified in Specimen by Anaerobe culture |
| 79399-2 | Synovial fluid analysis panel - Synovial fluid |
| 9498-7 | Candida sp IgA Ab [Units/volume] in Serum |
| 6545-8 | Rickettsia sp identified in Sputum by Organism specific culture |
| 6611-8 | Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 80373-4 | Helicobacter pylori Ag [Presence] in Stool by Rapid immunoassay |
| 96419-7 | Cells.CD3-CD14+CD45+DOCK8+/100 Cells.CD3-CD14+CD45+ in Blood by Flow cytometry (FC) |
| 81278-4 | Meperidine and Normeperidine panel - Gastric fluid |
| 82213-0 | Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with non-probe detection |
| 82-8 | Cefixime [Susceptibility] by Serum bactericidal titer |
| 999-3 | DBG Ag [Presence] on Red Blood Cells |
| 72917-8 | HNA 5 genotype in Blood |
| 85966-0 | Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 73022-6 | Fexofenadine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73203-2 | Piperacillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87589-8 | Tiamulin [Mass/mass] in Specimen |
| 87808-2 | chlordiazePOXIDE [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 88056-7 | Aquaporin 4 water channel IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 88603-6 | Adenovirus Ag [Presence] in Lower respiratory specimen by Immunoassay |
| 88738-0 | RNA polymerase III RP155 Ab [Units/volume] in Serum by Line blot |
| 89344-6 | CD38+IgM- cells/100 CD19 cells in Blood |
| 89646-4 | Bartonella quintana DNA [Presence] in Implanted device by NAA with probe detection |
| 5086-4 | Chlamydia sp IgM Ab [Units/volume] in Serum |
| 30986-4 | Aspergillus fumigatus recombinant (rAsp f) 1 IgE Ab [Units/volume] in Serum |
| 42257-6 | Shigella dysenteriae Ag [Presence] in Isolate |
| 59943-1 | Nordoxepin [Moles/volume] in Gastric fluid |
| 31338-7 | Dengue virus 1 Ab [Units/volume] in Serum |
| 51215-2 | CD10 cells/100 cells in Cerebral spinal fluid |
| 43062-9 | Chlamydia trachomatis IgG Ab [Titer] in Cerebral spinal fluid |
| 22220-8 | Coxsackievirus A7 Ab [Titer] in Serum |
| 51484-4 | Hyaline casts [#/volume] in Urine by Automated count |
| 5161-5 | Erythrocyte Ab [Units/volume] in Serum |
| 51877-9 | Transfuse fresh frozen plasma units [#] |
| 43675-8 | Fatty acid mitochondrial (C8-C18) panel - Serum or Plasma |
| 2239-2 | Estradiol (E2) [Mass/volume] in Semen |
| 22442-8 | Plasmodium malariae Ab [Titer] in Serum |
| 32057-2 | Butalbital [Presence] in Specimen |
| 52897-6 | Platinum [Moles/volume] in Urine |
| 52917-2 | Tin/Creatinine [Molar ratio] in Urine |
| 32805-4 | Variant lymphocytes/100 leukocytes in Bronchial specimen by Manual count |
| 44452-1 | Borrelia burgdorferi Ab [Units/volume] in Serum by Immunoblot |
| 44870-4 | Histoplasma capsulatum Ag [Presence] in Urine by Radioimmunoassay (RIA) |
| 33646-1 | Methylenedianiline [Mass/volume] in Serum or Plasma |
| 53554-2 | Nitrogen [Mass/volume] in Air |
| 53714-2 | Glial nuclear type 1 Ab [Titer] in Cerebral spinal fluid |
| 53903-1 | Collection method - Specimen |
| 45168-2 | Malonate [Mass/volume] in Urine |
| 23878-2 | Anaplasma phagocytophilum IgM Ab [Titer] in Serum by Immunofluorescence |
| 3391-0 | Benzoylecgonine [Presence] in Serum or Plasma |
| 34226-1 | 3-Alpha-Androstanediol glucuronide/Creatinine [Molar ratio] in Urine |
| 53999-9 | Multiple nuclear dots nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
| 54397-5 | Glucose [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 4685-4 | Sulfhemoglobin/Hemoglobin.total in Blood |
| 24332-9 | Alkaline phosphatase isoenz panel - Serum or Plasma |
| 24414-5 | Estradiol (E2) [Mass/volume] in Serum or Plasma --baseline |
| 34288-1 | Estradiol (E2).unconjugated [Moles/volume] in 24 hour Urine |
| 34544-7 | Complement C3 and C4 panel [Mass/volume] - Serum or Plasma |
| 55470-9 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
| 55508-6 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose glucose |
| 35000-9 | Polymorphonuclear cells [#/volume] in Pleural fluid |
| 35012-4 | Segmented neutrophils [#/volume] in Pleural fluid |
| 35133-8 | Glutarate [Mass/volume] in Serum or Plasma |
| 47859-4 | Glucose [Moles/volume] in Serum or Plasma --5 minutes post dose glucose |
| 478-8 | Sulfonamide [Susceptibility] by Serum bactericidal titer |
| 35860-6 | Virginiamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 56558-0 | Aldosterone [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 56877-4 | Mepivacaine IgE Ab [Units/volume] in Serum |
| 26886-2 | ALPRAZolam [Mass/mass] in Hair |
| 38496-6 | Retinyl palmitate [Mass/volume] in Serum or Plasma |
| 38525-2 | Oligoclonal bands [Mass/volume] in Urine by Electrophoresis |
| 38574-0 | Beryllium [Mass/volume] in Air |
| 49037-5 | Respiratory syncytial virus IgG and IgM panel [Units/volume] - Serum |
| 27852-3 | Insulin [Units/volume] in Serum or Plasma --5 hours post XXX challenge |
| 40054-9 | Albumin [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
| 58804-6 | European paper wasp IgE Ab [Units/volume] in Serum |
| 29878-6 | Argininosuccinate/Creatinine [Molar ratio] in Urine |
| 29918-0 | Bismuth [Mass/time] in 24 hour Urine |
| 50204-7 | Iron [Mass/volume] in Serum or Plasma --7th specimen |
| 30216-6 | Coxsackievirus A2 Ab [Presence] in Serum |
| 30217-4 | Coxsackievirus A4 Ab [Presence] in Serum |
| 19771-5 | Screening techniques [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
| 20374-5 | Ampicillin+Sulbactam [Susceptibility] by Method for Slow-growing mycobacteria |
| 20657-3 | Taurine [Moles/volume] in Serum or Plasma |
| 12350-5 | Amphetamines [Presence] in Stool |
| 101232-7 | Glutamate decarboxylase 65 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 13984-0 | Alpha 1 globulin/Protein.total in 24 hour Urine by Electrophoresis |
| 14054-1 | Prostaglandin D2 [Mass/time] in 24 hour Urine |
| 14099-6 | Nickel [Mass/volume] in Urine |
| 1413-4 | Cortisol [Mass/volume] in Serum or Plasma --2 days post 500 ug corticotropin IM |
| 1428-2 | Cortisol [Mass/volume] in Serum or Plasma --50 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 103741-5 | Dysregulation autoimmune multigene analysis in Specimen by Molecular genetics method |
| 14891-6 | Propranolol [Moles/volume] in Serum or Plasma |
| 14954-2 | Xylose [Moles/time] in 5 hour Urine --post dose PO |
| 10817-5 | Microscopic observation [Identifier] in Tissue by Trichrome stain.Gomori-Wheatley |
| 10862-1 | Basement membrane Ab [Titer] in Serum |
| 11005-6 | Trimethoprim [Mass/volume] in Serum or Plasma |
| 16652-0 | Corticotropin [Mass/volume] in Amniotic fluid by Radioimmunoassay (RIA) |
| 11140-1 | Metanephrine [Moles/time] in 24 hour Urine |
| 17221-3 | CD235a cells/100 cells in Blood |
| 17539-8 | Rickettsia typhi Ab [Units/volume] in Serum by Latex agglutination |
| 17778-2 | Zinc [Mass/volume] in Leukocytes |
| 1782-2 | Alkaline phosphatase.renal [Enzymatic activity/volume] in Serum or Plasma |
| 18380-6 | Uroporphyrinogen decarboxylase [Entitic Catalytic Activity] in Red Blood Cells |
| 90426-8 | Microorganism preliminary growth [Presence] in Blood by Aerobic culture with antimicrobial neutralizer |
| 90460-7 | Hepatitis E virus RNA [Presence] in Serum or Plasma by NAA with probe detection |
| 90900-2 | HIV 1 proviral DNA integrase gene [Nucleotide sequence] in Blood mononuclear cells by Sequencing |
| 7463-3 | Easter lily IgE Ab [Units/volume] in Serum |
| 74769-1 | 5-Hydroxyindoleacetate [Moles/volume] in Platelet rich plasma |
| 6034-3 | Bahia grass IgE Ab [Units/volume] in Serum |
| 60580-8 | TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method |
| 7695-0 | Scotch broom IgE Ab [Units/volume] in Serum |
| 92957-0 | Respiratory syncytial virus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 93392-9 | Serratia marcescens DNA [Presence] by NAA with probe detection in Positive blood culture |
| 61251-5 | Japanese Cedar IgE Ab/IgE total in Serum |
| 77758-1 | 7-Hydroxyquetiapine cutoff [Mass/volume] in Urine for Confirmatory method |
| 94198-9 | DPYD gene full mutation analysis in Blood or Tissue by Sequencing |
| 63140-8 | Gelatin IgG Ab [Mass/volume] in Serum |
| 94390-2 | Neuronal nuclear type 1 IgG Ab [Presence] in Cerebral spinal fluid by Line blot |
| 94643-4 | SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 63367-7 | U1 small nuclear ribonucleoprotein Ab [Titer] in Serum by Immunoassay |
| 79313-3 | Gamma butyrobetaine/Trimethyllysine [Molar ratio] in Urine |
| 79471-9 | 1,4-Cyclohexanediol/Creatinine [Molar ratio] in Urine |
| 9487-0 | Zinc [Mass/volume] in Water |
| 9535-6 | Influenza virus B IgG Ab [Titer] in Serum |
| 95552-6 | 4p16.3 chromosome deletion in Blood or Tissue by FISH |
| 65339-4 | Wr sup(b) Ab [Presence] in Serum or Plasma |
| 95771-2 | GATA2 gene full mutation analysis in Blood or Tissue by Sequencing |
| 69011-5 | Cocaethylene [Mass/mass] in Meconium by Confirmatory method |
| 96507-9 | California encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay |
| 96646-5 | HLA-DPB1 [Type] in Donor by High resolution |
| 69322-6 | Health insurance plan benefits comment |
| 69369-7 | Blood group antibody screen [Presence] in Cord blood |
| 69849-8 | 2-Hydroxyisocaproate [Moles/volume] in Serum or Plasma |
| 97609-2 | Anaerococcus prevotii+vaginalis DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 7133-2 | Mung Bean IgE Ab [Units/volume] in Serum |
| 82511-7 | Mycobacterium bovis tuberculin stimulated gamma interferon [Units/volume] in Blood |
| 82514-1 | Hepatitis C virus genotype 3 NS5a gene mutations detected [Identifier] |
| 82549-7 | Food Allergen Mix 30A (Kiwi+Papaya+Mango+Banana+Avocado) IgE Ab [Units/volume] in Serum by Multidisk |
| 82913-5 | Centromere protein B IgG Ab [Presence] in Serum by Line blot |
| 82999-4 | PCA-Tr IgG Ab [Presence] in Serum or Plasma by Line blot |
| 9809-5 | Propoxyphene [Presence] in Gastric fluid |
| 98111-8 | Chemokine (C-C motif) ligand 4 [Mass/volume] in Serum or Plasma |
| 71873-4 | Hemoglobin A2/Hemoglobin.total [Pure mass fraction] in Blood by HPLC |
| 83108-1 | Natriuretic peptide.B prohormone N-Terminal [Moles/volume] in Serum or Plasma by Immunoassay |
| 99394-9 | Siderocytes [Presence] in Blood or Marrow by Prussian blue stain |
| 99619-9 | Polyunsaturated fatty acids [Moles/volume] in RBC.lysate |
| 86118-7 | Streptococcus pneumoniae Danish serotype 4 Ab [Mass/volume] in Serum --1st specimen |
| 87388-5 | Porcine sapelovirus [Presence] in Specimen by Organism specific culture |
| 87641-7 | o,p'- Dichlorodiphenyltrichloroethane [Mass/mass] in Specimen |
| 87823-1 | Naltrexone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 88541-8 | Adenovirus DNA [Presence] in Aspirate by NAA with probe detection |
| 73926-8 | JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Blood |
| 888-8 | Blood group antibodies identified in Serum or Plasma |
| 41756-8 | Fluorometholone [Mass/volume] in Serum or Plasma |
| 59605-6 | Alpha hydroxyalprazolam [Mass/mass] in Tissue |
| 50937-2 | Vanadium [Moles/time] in 24 hour Urine |
| 31008-6 | Food Allergen Mix 24 (Kiwi+Hazelnut+Banana+Shrimp) IgE Ab [Presence] in Serum by Multidisk |
| 31243-9 | Avian paramyxovirus 2 Ab [Units/volume] in Serum |
| 31509-3 | Mycoplasma capricolum ss capripneumonia Ab [Units/volume] in Serum |
| 51340-8 | CD45 (Lymphs) cells/100 cells in Bone marrow |
| 42857-3 | Calcium [Moles/volume] in Venous blood |
| 43294-8 | HTLV I+II p26 Ab [Presence] in Serum |
| 22400-6 | Leptospira interrogans sv Bratislava Ab [Titer] in Serum |
| 22606-8 | Varicella zoster virus IgM Ab [Titer] in Serum |
| 32145-5 | Phosphate crystals amorphous [#/area] in Urine sediment by Microscopy high power field |
| 32276-8 | Tyrosine [Moles/volume] in Vitreous fluid |
| 43853-1 | Legionella pneumophila 1+3+4+5+6+8 IgM Ab [Presence] in Serum |
| 43948-9 | CD4+CD45RO+ cells/100 cells in Specimen |
| 44415-8 | Tyrosine/Creatinine [Mass Ratio] in 24 hour Urine |
| 44679-9 | Margin(s) involved by invasive melanoma in Skin melanoma |
| 3333-2 | Amitriptyline [Mass/volume] in Serum or Plasma |
| 33416-9 | Coccidioides sp Ab [Presence] in Serum by Immunoassay |
| 53813-2 | Platelet aggregation ADP induced [Units/volume] in Blood |
| 24016-8 | La Crosse virus Ab [Interpretation] in Serum |
| 3413-2 | Buprenorphine [Mass/volume] in Serum or Plasma |
| 34158-6 | Histoplasma capsulatum Ag [Units/volume] in Cerebral spinal fluid |
| 24108-3 | Cancer Ag 19-9 [Units/volume] in Serum or Plasma |
| 47167-2 | Norepinephrine [Moles/volume] in Plasma --4th specimen post XXX challenge |
| 55928-6 | Iodine/Creatinine [Mass Ratio] in Urine |
| 47551-7 | Alanine [Moles/volume] in DBS |
| 47881-8 | Pyruvate carboxylase [Enzymatic activity/mass] in Leukocytes |
| 47908-9 | Somatotropin [Units/volume] in Serum or Plasma --2 hours pre dose propranolol+glucagon |
| 3580-8 | Doxepin [Presence] in Urine |
| 48811-4 | Protein fractions 3 panel - Serum or Plasma |
| 48861-9 | Rickettsia parkeri IgM Ab [Titer] in Serum by Immunofluorescence |
| 27019-9 | IgA.monoclonal [Presence] in Serum |
| 27197-3 | Benzodiazepines [Presence] in Vitreous fluid |
| 38278-8 | Lymphocyte proliferation stimulated by 1.0 ug/mL Candida albicans [Units/volume] in Blood |
| 38534-4 | COL5A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 49264-5 | Folate+Cyanocobalamin [Interpretation] in Serum or Blood Narrative |
| 27827-5 | Insulin [Units/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 28051-1 | 1,3,5-Trichlorobenzene [Mass/volume] in Serum or Plasma |
| 39303-3 | Influenza virus A H2 Ab [Titer] in Serum by Hemagglutination inhibition |
| 29393-6 | Gastrin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 49823-8 | 3-Hydroxyisovalerate/Creatinine [Molar ratio] in 24 hour Urine |
| 49826-1 | 2-Hydroxyestrone [Mass/volume] in Serum or Plasma |
| 49838-6 | Neural tube defect risk [Likelihood] in Population |
| 29919-8 | Chromium/Creatinine [Mass Ratio] in 24 hour Urine |
| 40635-5 | Kappa light chains [Presence] in Serum by Immunofixation |
| 5055-9 | Bacillus anthracis Ab [Units/volume] in Serum by Hemagglutination |
| 3012-2 | Thromboxane beta 2 [Mass/volume] in Serum or Plasma |
| 30357-8 | Palmitoleylcarnitine (C16:1) [Moles/volume] in Serum or Plasma |
| 41004-3 | Human coronavirus 229E Ag [Presence] in Specimen by Immunofluorescence |
| 41137-1 | Influenza virus A N6 Ab [Presence] in Serum |
| 19329-2 | Alpha hydroxyalprazolam cutoff [Mass/volume] in Urine for Screen method |
| 20863-7 | Iodine [Mass/volume] in Water |
| 100352-4 | Rosiglitazone [Presence] in Serum or Plasma |
| 101680-7 | Neonatal ABORh and Ab antibody panel - Blood from Newborn |
| 101903-3 | K Ag [Presence] on Red Blood Cells from Fetus |
| 13454-4 | Calcium-phosphorus product [(Moles/volume)*2] in Serum or Plasma |
| 13523-6 | Leukocytes other/100 leukocytes in Cerebral spinal fluid by Manual count |
| 102426-4 | Coastal Maple IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102610-3 | Stemphylium solani IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102932-1 | European house dust mite IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103611-0 | Sunitinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose |
| 103839-7 | Phentermine [Presence] in Meconium |
| 15057-3 | Androstanolone [Moles/volume] in Serum or Plasma |
| 1521-4 | Glucose [Mass/volume] in Serum or Plasma --2 hours post meal |
| 10516-3 | Thyrotropin Ag [Presence] in Tissue by Immune stain |
| 16207-3 | Meperidine [Presence] in Urine by Confirmatory method |
| 16729-6 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 17040-7 | Labetalol [Presence] in Serum or Plasma |
| 1758-2 | Albumin.glycated [Mass/volume] in Serum or Plasma |
| 17828-5 | CD16 cells/100 cells in Body fluid |
| 17918-4 | Bacteria # 4 identified in Wound shallow by Aerobe culture |
| 18493-7 | Ova and parasites identified in Stool by Concentration--3rd specimen |
| 74493-8 | PAX5 and CD5 Ag [Identifier] in Tissue by Immune stain |
| 74688-3 | Sodium [Moles/volume] in Serum or Plasma --post dialysis |
| 92690-7 | Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection |
| 92730-1 | Tacrolimus [Mass/volume] in Blood --1 hour post dose |
| 92777-2 | Staphylococcus aureus DNA [Presence] by NAA with probe detection in Positive blood culture |
| 75629-6 | Tumor necrosis factor receptor superfamily member 1A [Mass/volume] in Serum or Plasma |
| 93462-0 | Norcarfentanil [Mass/volume] in Urine by Confirmatory method |
| 93688-0 | Psychosine [Moles/volume] in DBS |
| 61404-0 | Staphylococcus aureus DNA [Presence] in Specimen by NAA with probe detection |
| 61428-9 | Nortriptyline [Mass/volume] in Urine by Confirmatory method |
| 9419-3 | HLA-DQ6 [Presence] |
| 63191-1 | Nettle IgG Ab [Mass/volume] in Serum |
| 63275-2 | Liver kidney microsomal 2 Ab [Titer] in Serum by Immunofluorescence |
| 77-8 | ceFAZolin [Susceptibility] by Disk diffusion (KB) |
| 78203-7 | BCL6 gene rearrangements [Presence] in Blood or Tissue by FISH |
| 6500-3 | Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 656-9 | Microscopic observation [Identifier] in Specimen by Acid fast stain.Ziehl-Neelsen |
| 79624-3 | 5-S-cysteinyldopa [Moles/volume] in Serum or Plasma |
| 79644-1 | L-homoserine/Creatinine [Molar ratio] in Urine |
| 8010-1 | Bartonella quintana IgM Ab [Units/volume] in Serum |
| 95827-2 | Viable CD3 cells/100 CD3 cells in Blood product unit |
| 96416-3 | Cells.CD3+CD14-CD45+DOCK8+/100 Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC) |
| 965-4 | C sup(x) Ag [Presence] on Red Blood Cells from Donor |
| 82082-9 | Grass Allergen Mix 4 (Sweet vernal grass+Velvet grass+Perennial rye grass+Common reed+Rye) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 71843-7 | Oxygen saturation [Pure mass fraction] Calculated from oxygen partial pressure in Arterial blood |
| 71875-9 | Hemoglobin A1c/Hemoglobin.total [Pure mass fraction] in Blood |
| 85509-8 | KRAS gene mutations found [Identifier] in Colorectal cancer specimen by Molecular genetics method Nominal |
| 99438-4 | English walnut recombinant (rJug r) 3 IgG4 Ab [Mass/volume] in Serum |
| 99928-4 | Leukocytes [Presence] in Body fluid by Automated |
| 72819-6 | Acetaminophen/Creatinine [Mass Ratio] in Urine |
| 7320-5 | Horse Fly IgG Ab [Units/volume] in Serum |
| 87800-9 | Pradofloxacin [Susceptibility] |
| 87972-6 | Microscopic observation [Identifier] in Sinus by Gram stain |
| 88268-8 | Pseudomonas aeruginosa sodA gene [Presence] by Probe in Positive blood culture |
| 885-4 | Am Ab [Presence] in Serum or Plasma from Blood product unit |
| 7423-7 | House dust triggered histamine release [Units/volume] in Blood |
| 74423-5 | Enterovirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 7445-0 | Lactalbumin alpha IgE Ab [Units/volume] in Serum |
| 88612-7 | Human coronavirus HKU1 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 89276-0 | Oxygen saturation in Arterial blood by Pulse oximetry --W exercise |
| 59645-2 | Cotinine [Presence] in Serum or Plasma by Screen method |
| 50790-5 | HIV 1 RNA tropism [Identifier] |
| 50829-1 | Boron [Moles/time] in 24 hour Urine |
| 50976-0 | TCR gamma delta cells [#/volume] in Blood |
| 21259-7 | Entamoeba histolytica Ab [Titer] in Serum by Hemagglutination |
| 21398-3 | Mononuclear cells [#/volume] in Synovial fluid by Manual count |
| 21513-7 | Salmonella paratyphi B H Ab [Titer] in Serum by Agglutination |
| 42805-2 | Fungus identified in Specimen |
| 43003-3 | Jamestown canyon virus IgM Ab [Titer] in Serum |
| 22279-4 | Echovirus 7 Ab [Titer] in Serum |
| 31922-8 | Ovine progressive pneumonia virus Ag [Presence] in Specimen |
| 4346-3 | Neopterin [Mass] of Dose |
| 43831-7 | Phenytoin [Presence] in Specimen |
| 32563-9 | IgG lymphocytes/100 lymphocytes in Cerebral spinal fluid |
| 53004-8 | Mitotic spindle apparatus Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 44359-8 | Glutamate/Creatinine [Mass Ratio] in 24 hour Urine |
| 32792-4 | Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 5325-6 | Rickettsia typhi IgM Ab [Titer] in Serum by Immunofluorescence |
| 44673-2 | DCIS.uninvolved margin distance.closest in Breast tumor |
| 2350-7 | Glucose [Mass/volume] in Urine |
| 53652-4 | pH of 4 hour Urine |
| 53702-7 | Mycobacterium bovis tuberculin stimulated gamma interferon-Mycobacterium avium tuberculin stimulated gamma interferon [Units/volume] in Blood |
| 46231-7 | ZAP70 cells/100 cells in Tissue |
| 46407-3 | Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post 1 g/kg glucose PO |
| 55254-7 | Heparin 5000 U/mL given [Volume] |
| 47281-1 | Leukocytes [#/volume] in Cord blood |
| 47317-3 | Interleukin 12 [Mass/volume] in Body fluid by Immunoassay |
| 25349-2 | Silver Birch IgG Ab [Units/volume] in Serum |
| 55691-0 | Ornidazole [Susceptibility] |
| 47622-6 | Glucose [Moles/volume] in Serum or Plasma --pre dose glucose |
| 56142-3 | MPL gene p.Trp515Leu+Trp515Lys [Presence] in Blood or Tissue by Molecular genetics method |
| 38413-1 | FGFR3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 38417-2 | Trans-cinnamoylglycine/Creatinine [Mass Ratio] in Urine |
| 38538-5 | Fatty acids.very long chain C26:1 (Hexacosenoate)/C22:0 (Docosanoate) [Mass Ratio] in Serum or Plasma |
| 38613-6 | Parathion [Mass/volume] in Air |
| 57330-3 | Corticotropin [Mass/volume] in Plasma --40 minutes post XXX challenge |
| 4893-4 | HLA-Dw21 [Presence] |
| 48956-7 | Methadone [Mass/volume] in Specimen by Confirmatory method |
| 27279-9 | Paraoxon [Mass/volume] in Serum or Plasma |
| 39479-1 | Glucose [Moles/volume] in Pericardial fluid |
| 58373-2 | Meprobamate [Presence] in Urine by Confirmatory method |
| 49526-7 | Influenza virus A H5 RNA [Presence] in Isolate by NAA with probe detection |
| 49704-0 | SH3TC2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 28549-4 | Yersinia sp identified in Stool by Organism specific culture |
| 29238-3 | Insulin [Units/volume] in Body fluid |
| 50111-4 | 3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Amniotic fluid |
| 59024-0 | Renin [Enzymatic activity/volume] in Plasma --supine+30 minutes post XXX challenge |
| 2999-1 | Thiamine [Mass/volume] in Serum or Plasma |
| 30186-1 | Dust Allergen Mix A (Cockroach+American house dust mite+European house dust mite+House dust Greer) IgE Ab [Units/volume] in Serum by Multidisk |
| 19320-1 | Tricyclic antidepressants confirm method [Identifier] in Urine |
| 20593-0 | CD19 cells/100 cells in Specimen |
| 100682-4 | Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 12592-2 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 101451-3 | Neurochondrin Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 13284-5 | Salmonella typhi H D Ab [Presence] in Serum |
| 135-4 | cefTAZidime [Susceptibility] by Serum bactericidal titer |
| 102402-5 | Latex glove extract ammoniated IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102622-8 | Mandarin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102633-5 | Trichoderma viride IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103044-4 | London Plane recombinant (rPla a) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103570-8 | AAV serotype rh74 Ab [Presence] in Serum or Plasma by Immunoassay |
| 104198-7 | Immunoglobulin lambda light chain gene 22q11.22 rearrangement in Specimen by FISH |
| 14840-3 | Trypanosoma sp identified in Cerebral spinal fluid by Wet preparation |
| 15194-4 | CD3-CD16+ cells/100 cells in Blood |
| 104466-8 | Yersinia enterocolitica O:5 Ab [Presence] in Stool |
| 11097-3 | Lindane [Mass/volume] in Serum or Plasma |
| 1684-0 | 3-Methoxy-4-Hydroxyphenylglycol [Mass/volume] in Urine |
| 1707-9 | Acetylcholine [Mass/volume] in Serum |
| 17538-0 | Rickettsia spotted fever group RNA [Presence] in Serum by Probe |
| 18303-8 | IgM [Presence] in Serum by Immunofixation |
| 91036-4 | Benzodiazepines [Presence] in Tissue by Screen method |
| 91798-9 | Parainfluenza virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 75561-1 | Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
| 75727-8 | HTR2A gene c.IVS2+54538A>G [Presence] in Blood or Tissue by Molecular genetics method |
| 60462-9 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 6084-8 | Colza IgE Ab [Units/volume] in Serum |
| 76693-1 | Bacteria identified in Blood product unit.autologous by Culture |
| 61276-2 | Insulin porcine IgE Ab/IgE total in Serum |
| 61398-4 | Escherichia coli DNA [Presence] in Specimen by NAA with probe detection |
| 9399-7 | Ribonucleoprotein extractable nuclear Ab [Titer] in Serum |
| 94199-7 | FGA gene full mutation analysis in Blood or Tissue by Sequencing |
| 637-9 | Plasmodium sp identified in Blood by Thick film |
| 78891-9 | Tricyclic antidepressants [Presence] in Hair |
| 78918-0 | 7-Hydroxyquetiapine [Z-score] in Urine |
| 65790-8 | American house dust mite native (nDer f) 1 IgE Ab [Units/volume] in Serum |
| 95777-9 | ACADS gene full mutation analysis in Blood or Tissue by Sequencing |
| 95918-9 | Fungal pathogens panel - Tissue by NAA with probe detection |
| 6764-5 | Fasting glucose [Presence] in Urine by Test strip |
| 68379-7 | Phenylbutazone [Moles/volume] in Urine |
| 9681-8 | 1-Naphthol [Mass/volume] in Serum or Plasma |
| 8167-9 | Tetrahydrocannabinol [Presence] in Meconium |
| 71369-3 | Neutrophils.dysplastic [Presence] in Blood by Light microscopy |
| 8275-0 | Cefpirome [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 98281-9 | Structured reporting protocol used |
| 84902-6 | Extraprostatic extension site [Anatomy] of Prostate tumor |
| 99424-4 | Penicillin G IgG4 Ab [Mass/volume] in Serum |
| 72758-6 | Amphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 72795-8 | Mephedrone [Mass/volume] in Urine by Confirmatory method |
| 86075-9 | Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 73541-5 | Alendronate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74088-6 | Heptacarboxylporphyrin III [Moles/mass] in Stool |
| 59823-5 | Tacrolimus [Mass/volume] in Serum or Plasma --2 hours post dose |
| 30484-0 | Tiglylglycine [Presence] in Urine |
| 41990-3 | Parainfluenza virus 4 IgG Ab [Presence] in Serum by Immunoassay |
| 42367-3 | Streptococcus pneumoniae Danish serotype 19B IgG Ab [Mass/volume] in Serum |
| 42500-9 | Fosamprenavir [Susceptibility] by Phenotype method |
| 60107-0 | OLANZapine [Mass/mass] in Tissue |
| 31175-3 | Metasystox [Mass/volume] in Blood |
| 31331-2 | Coxsackievirus B5 Ab [Units/volume] in Cerebral spinal fluid |
| 42803-7 | Bacteria identified in Isolate |
| 42928-2 | Filaria Ag [Presence] in Serum |
| 21723-2 | SERPINA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 22066-5 | PRSS1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 32512-6 | CD2 cells [#/volume] in Specimen |
| 22907-0 | Bovine herpesvirus 1 Ag [Presence] in Nose by Immunofluorescence |
| 23067-2 | Epizootic hemorrhagic disease virus RNA [Presence] in Blood by NAA with probe detection |
| 53273-9 | Urinalysis type of non-squamous epithelial cells panel [#/volume] - Urine by Computer assisted method |
| 53470-1 | Kynurenin [Moles/volume] in Serum or Plasma |
| 44436-4 | Ascaris lumbricoides larva IgG Ab [Units/volume] in Serum by Immunoassay |
| 23538-2 | Tuberculosis reaction wheal [Diameter] --3 days post dose avian tuberculin intradermal |
| 24237-0 | Mycoplasma pneumoniae Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 34599-1 | Methotrexate [Mass/volume] in Body fluid |
| 34639-5 | Epstein Barr virus capsid IgA Ab [Titer] in Cerebral spinal fluid |
| 55491-5 | Insulin [Moles/volume] in Serum or Plasma --2 hours post dose glucagon |
| 47821-4 | 3-Indolelactate/Creatinine [Molar ratio] in Urine |
| 47853-7 | Diphosphoglycerate phosphatase [Enzymatic activity/mass] in Red Blood Cells |
| 25859-0 | Anserine/Creatinine [Molar ratio] in 24 hour Urine |
| 35675-8 | Calcium [Mass/volume] in Urine collected for unspecified duration |
| 3568-3 | Dimethyltryptamine [Mass/volume] in Urine |
| 35732-7 | Histoplasma capsulatum H Ab [Presence] in Serum by Immune diffusion (ID) |
| 56497-1 | Choriogonadotropin.beta subunit [Units] in 24 hour Urine |
| 56536-6 | Thyroglobulin Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 26612-2 | Phosphoethanolamine [Moles/volume] in Serum or Plasma |
| 26740-1 | Hydroxyproline [Moles/volume] in Urine |
| 48721-5 | Bartonella henselae IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 48753-8 | 3-Hydroxydodecanoate.free (3-OH-C12:0) [Moles/volume] in Serum or Plasma |
| 26893-8 | Tetrahydrocannabinol [Mass/mass] in Meconium |
| 38585-6 | Acetone [Mass/volume] in Air |
| 49178-7 | Epstein Barr virus Ab [Presence] in Serum |
| 28046-1 | Cortisol [Presence] in Saliva (oral fluid) --2nd specimen |
| 28047-9 | Carbamate pesticides [Mass/volume] in Urine |
| 57705-6 | Congenital hypothyroidism newborn screening comment-discussion |
| 40087-9 | Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --2 hours pre XXX challenge |
| 4983-3 | HLA-DR4 [Presence] |
| 50050-4 | Hemicystine/Amino acids.total in Amniotic fluid |
| 29657-4 | Bordetella pertussis IgA Ab [Presence] in Serum by Immunoassay |
| 29903-2 | Cryptococcus sp Ag [Presence] in Serum by Immunoassay |
| 59146-1 | CD11c+CD25+ cells [#/volume] in Blood |
| 30268-7 | Zidovudine [Susceptibility] by Phenotype method |
| 30387-5 | Erythrocytes [#/volume] in Gastric fluid |
| 20683-9 | Ammonia [Mass/volume] in Ingesta |
| 101208-7 | Hepatitis E virus IgM Ab [Presence] in Serum or Plasma by Line blot |
| 13660-6 | Gonadotropin releasing hormone [Mass/volume] in Serum or Plasma |
| 13866-9 | Glucose [Mass/volume] in Serum or Plasma --5 hours post 50 g lactose PO |
| 102570-9 | Reindeer epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14167-1 | N-methylimidazoleacetate [Mass/time] in 24 hour Urine |
| 14337-0 | Phenytoin.total/Phenytoin.free [Mass Ratio] in Serum or Plasma |
| 102727-5 | Cow milk IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103116-0 | Cetuximab IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14505-2 | Human papilloma virus 16+18 Ag [Presence] in Penis |
| 14797-5 | Iron [Interpretation] in Serum or Plasma |
| 104133-4 | Ethanol [Presence] in Exhaled gas |
| 16165-3 | Glucose [Mass/volume] in Serum or Plasma --10 AM specimen |
| 10702-9 | Ova and parasites identified in Stool by Immune stain |
| 10755-7 | Fungus.microscopic observation [Identifier] in Tissue by Methenamine silver stain.Grocott |
| 108-1 | Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 10926-4 | Deer epithelium IgE Ab [Units/volume] in Serum |
| 12325-7 | Tetrahydrocortisone [Presence] in Urine |
| 909-2 | Ax Ab [Presence] in Serum or Plasma from Donor |
| 74863-2 | IgG.lambda [Mass/volume] in Serum or Plasma |
| 74901-0 | Gamma tocopherol [Entitic substance] in Red Blood Cells |
| 75640-3 | Lysozyme [Moles/volume] in 24 hour Urine |
| 76079-3 | Influenza virus B RNA [Presence] in Bronchoalveolar lavage by NAA with probe detection |
| 76136-1 | Lactulose [Moles/time] in 5 hour Urine --post XXX g sugar solution PO |
| 76595-8 | Candida albicans its gene [#/mass] in XXX.tissue by NAA with probe detection |
| 93402-6 | Cronobacter sakazakii DNA [Presence] by NAA with probe detection in Positive blood culture |
| 61258-0 | European house dust mite IgE Ab/IgE total in Serum |
| 78209-4 | CCND1 gene duplication [Interpretation] in Blood or Tissue by FISH Narrative |
| 78226-8 | MLL gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 6341-2 | Chlamydophila psittaci Ag [Presence] in Specimen by Immunofluorescence |
| 63430-3 | Human coronavirus RNA panel - Specimen by NAA with probe detection |
| 79198-8 | Somatotropin [Mass/volume] in Serum or Plasma --2.25 hours post dose arginine+insulin |
| 96259-7 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by Calculated by Martin-Hopkins |
| 80516-8 | Lambda light chains.free [Mass/volume] in Serum by Nephelometry |
| 80642-2 | Floxacillin Free [Mass/volume] in Serum or Plasma |
| 80659-6 | Activated clotting time (ACT) of Blood induced by Kaolin |
| 97192-9 | carBAMazepine [Moles/volume] in Serum or Plasma --trough |
| 69937-1 | Trichomonas vaginalis DNA [Presence] in Specimen by NAA with probe detection |
| 69947-0 | Triglyceride [Moles/volume] in Pericardial fluid |
| 70008-8 | Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 82140-5 | MYD88 gene p.Leu265Pro targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 97239-8 | N-desalkylflurazepam [Presence] in Cord tissue by Confirmatory method |
| 82402-9 | Ganglioside GD3 IgG Ab [Presence] in Serum by Line blot |
| 83083-6 | Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay |
| 99523-3 | Circumference [Length] of Pulmonary valve |
| 99596-9 | SARS-CoV-2 (COVID-19) N protein IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 99882-3 | Free lipid droplets [#/area] in Urine sediment by Computer assisted method |
| 7252-0 | Cotton linters triggered histamine release [Units/volume] in Blood |
| 72588-7 | Alpha 2 globulin/Protein.total [Pure mass fraction] in 24 hour Urine by Electrophoresis |
| 72836-0 | Vancomycin resistance vanC2+vanC3 genes [Presence] by Molecular method |
| 85818-3 | Clot formation+Clotting time of Blood by Thromboelastography |
| 86181-5 | Streptococcus pneumoniae Danish serotype 9N Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen |
| 73063-0 | amLODIPine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73198-4 | Pravastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73281-8 | Methyldopa induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73351-9 | hydroCHLOROthiazide+Losartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 735-1 | Variant lymphocytes/100 leukocytes in Blood by Manual count |
| 73632-2 | Solithromycin [Susceptibility] by Disk diffusion (KB) |
| 73733-8 | Bacteria biotype [Type] in Isolate |
| 73817-9 | Percent heparin inhibition [Ratio] in Serum |
| 88702-6 | Systemic sclerosis panel - Serum by Immunoassay |
| 89322-2 | Norbuprenorphine-3-glucuronide [Mass/volume] in Serum or Plasma by Confirmatory method |
| 41747-7 | Budesonide [Mass/volume] in Serum or Plasma |
| 59688-2 | Hydroxyethylflurazepam [Mass/mass] in Tissue |
| 50696-4 | Influenza virus A neutralizing antibody [Identifier] in Serum by Neutralization test |
| 30508-6 | Etiocholanolone/Creatinine [Mass Ratio] in Urine |
| 60127-8 | Paramethadione [Mass/volume] in Blood |
| 21402-3 | Mumps virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 31597-8 | Rickettsia conorii Ab [Units/volume] in Serum |
| 51708-6 | Intercellular substance Ab [Titer] in Serum by Immunofluorescence |
| 51901-7 | Oat IgG Ab [Mass/volume] in Serum |
| 22379-2 | Lassa virus IgM Ab [Presence] in Serum |
| 22706-6 | Isoleucine/Creatinine [Molar ratio] in Urine |
| 52880-2 | Cytoplasmic CD22 cells/100 cells in Cerebral spinal fluid |
| 52928-9 | Molybdenum/Creatinine [Molar ratio] in Urine |
| 53421-4 | Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --3rd specimen post XXX challenge |
| 44414-1 | Tryptophan/Creatinine [Mass Ratio] in 24 hour Urine |
| 44597-3 | IgG.monoclonal [Presence] in Serum by Immunofixation |
| 23523-4 | Trypanosoma evansi Ab [Presence] in Serum by Agglutination |
| 23643-0 | Trovafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 33567-9 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
| 23819-6 | Antibody coated bacteria [Presence] in Urine by Immunofluorescence |
| 33942-4 | Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 5407-2 | Yersinia enterocolitica O:3 Ab [Units/volume] in Serum |
| 54310-8 | Linoleoylcarnitine (C18:2)/Creatinine [Molar ratio] in Urine |
| 54409-8 | Direct antiglobulin test.complement C3+C4 specific reagent [Presence] on Red Blood Cells |
| 46086-5 | Creatinine [Moles/volume] in Dialysis fluid --2 hour specimen |
| 46235-8 | ZAP70 cells/100 cells in Blood |
| 34369-9 | Salmonella paratyphi C H Ab [Titer] in Serum by Agglutination |
| 55251-3 | HBA2 gene alpha 3.7kb deletion [Presence] in Blood by Molecular genetics method |
| 55322-2 | Fy sup(b) Ab [Titer] in Serum or Plasma |
| 47027-8 | DBA44 Ag [Presence] in Tissue by Immune stain |
| 47234-0 | Chlamydia trachomatis Ag [Presence] in Body fluid |
| 47439-5 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum --1st specimen |
| 35167-6 | Vaccenate (C18:1w7) [Moles/volume] in Serum or Plasma |
| 55765-2 | EGFR gene c.2156G>C+2155G>A+2155G>T [Presence] in Blood or Tissue by Molecular genetics method |
| 35678-2 | Sodium [Moles/volume] in Urine collected for unspecified duration |
| 5614-3 | Cesium [Mass/volume] in Blood |
| 48169-7 | Amikacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 26777-3 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose lactose PO |
| 3741-6 | Mefenorex [Presence] in Urine |
| 3808-3 | Methylphenidate [Presence] in Urine |
| 48667-0 | IgM.intrathecally synthesized [Mass/volume] in Serum and CSF |
| 57309-7 | PRNP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2768-0 | Phenylalanine/Tyrosine [Mass Ratio] in Serum or Plasma |
| 38924-7 | TBX5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 57915-1 | Bumble Bee IgE Ab/IgE total in Serum |
| 28593-2 | Gamma aminobutyrate/Creatinine [Ratio] in Urine |
| 29160-9 | Benzodiazepines [Mass/mass] in Meconium |
| 40063-0 | Albumin [Mass/volume] in Serum or Plasma --4 days post XXX challenge |
| 58637-0 | Cortisol [Mass/volume] in Saliva (oral fluid) --10th specimen post XXX challenge |
| 50095-9 | 21-Deoxycortisol [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin |
| 5014-6 | Herpes simplex virus DNA [Presence] in Specimen by NAA with probe detection |
| 4034-5 | Spironolactone [Mass/volume] in Urine |
| 40538-1 | Lymphocytes/100 leukocytes in Peritoneal dialysis fluid by Manual count |
| 58945-7 | Microscopic observation [Identifier] in Peritoneal fluid by Acid fast stain.Ziehl-Neelsen |
| 59194-1 | Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in Serum or Plasma |
| 19566-9 | Methylenedioxyamphetamine [Presence] in Urine by Confirmatory method |
| 100764-0 | Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal |
| 101372-1 | Yersinia pestis DNA [Presence] in Sputum by NAA with non-probe detection |
| 1304-5 | D Ab [Titer] in Serum or Plasma |
| 13787-7 | Orotate/Creatinine [Mass Ratio] in Urine |
| 102345-6 | Perennial rye grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102369-6 | Pecan or Hickory Tree IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102390-2 | Iodinebush IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13952-7 | Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay |
| 14490-7 | Virus identified in Semen by Immunofluorescence |
| 103185-5 | Human Rhinovirus 2 RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 104188-8 | Mucopolysaccharidosis type II newborn screening panel |
| 10623-7 | Spermatozoa Pin Head/100 spermatozoa in Semen |
| 1068-6 | Jk sup(a) Ab [Presence] in Serum or Plasma from Donor |
| 15434-4 | Avian adenovirus Ab [Presence] in Serum by Immune diffusion (ID) |
| 16124-0 | Cryptococcus sp Ab [Titer] in Serum |
| 10903-3 | Hyaluronidase Ab [Titer] in Serum |
| 11605-3 | Lymphocytic choriomeningitis virus Ab [Units/volume] in Serum |
| 12313-3 | Aprobarbital [Presence] in Urine |
| 17773-3 | Yeast [Presence] in Stool by Light microscopy |
| 18893-8 | cefTAZidime [Susceptibility] |
| 90808-7 | Candida krusei DNA [Presence] in Serum by NAA with probe detection |
| 91826-8 | Ova and parasites identified in Lower respiratory specimen by Light microscopy |
| 92693-1 | Rotavirus A RNA [Presence] in Stool by NAA with probe detection |
| 75733-6 | AXIN2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77640-1 | HLA class I and II IgG Ab in Serum or Plasma by Immunoassay [interpretation] Narrative |
| 63313-1 | Rheumatoid factor [Units/volume] in Body fluid by Sheep Cell Agglutination |
| 94374-6 | Klebsiella pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 94508-9 | SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 94534-5 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Respiratory system specimen by NAA with probe detection |
| 95651-6 | Yellow fever virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 6591-2 | Yellow fever virus neutralizing antibody [Units/volume] in Serum by Neutralization test |
| 6703-3 | 11-Ketoetiocholanolone [Mass/time] in 24 hour Urine |
| 67808-6 | Parainfluenza virus 1 Ag [Presence] in Isolate by Immunofluorescence |
| 6814-8 | Epstein Barr virus early IgG Ab [Presence] in Serum by Immunofluorescence |
| 8100-0 | Specimen preparation [Type] |
| 81207-3 | Amitriptyline and Nortriptyline panel - Gastric fluid |
| 9704-8 | Spermatozoa [Morphology] in Semen |
| 81863-3 | KCNH2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 97658-9 | 2,3-dinor 11 beta-Prostaglandin F2 alpha/Creatinine [Mass Ratio] in Urine |
| 7079-7 | Anchovy IgE Ab [Units/volume] in Serum |
| 85048-7 | Micafungin [Susceptibility] by Gradient strip |
| 73-7 | Cefatrizine [Susceptibility] by Disk diffusion (KB) |
| 73716-3 | Occupational Allergen Mix 6 (Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) IgE Ab [Units/volume] in Serum by Multidisk |
| 88173-0 | Microscopic observation [Presence] in Pleural fluid by Acid fast stain |
| 88585-5 | Legionella sp identified in Lower respiratory specimen by Organism specific culture |
| 88705-9 | Kanamycin 3.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 41734-5 | Dalbavancin [Susceptibility] |
| 50958-8 | Indirect antiglobulin test.unspecified reagent [Presence] in Serum or Plasma --after transfusion |
| 30528-4 | Heptacarboxylporphyrin [Presence] in Urine |
| 31156-3 | Hemoglobin Barts/Hemoglobin.total in Blood |
| 42528-0 | Phenothiazines [Mass/volume] in Serum or Plasma |
| 60012-2 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 60151-8 | PENTobarbital [Mass/volume] in Blood |
| 31430-2 | HIV 1 IgG Ab [Presence] in Cerebral spinal fluid |
| 51166-7 | CD34 blasts [Units/volume] in Specimen |
| 51320-0 | CD41 cells/100 cells in Body fluid |
| 42818-5 | CD38+ Lambda+ cells/100 cells in Blood |
| 42984-5 | Parainfluenza virus 1 Ab [Titer] in Serum --2nd specimen |
| 31712-3 | Adenovirus Ag [Presence] in Throat |
| 51483-6 | Casts [#/volume] in Urine by Automated count |
| 51839-9 | Treponema pallidum IgM Ab [Units/volume] in Serum by Immunoassay |
| 43741-8 | Temperature of Semen |
| 52942-0 | Antimony/Creatinine [Molar ratio] in 24 hour Urine |
| 43883-8 | Ampicillin [Presence] in Serum or Plasma |
| 32800-5 | Neisseria meningitidis serogroups C+w135 Ag [Presence] in Specimen by Latex agglutination |
| 44817-5 | Cytomegalovirus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 23222-3 | Lumpy skin disease virus Ag [Presence] in Specimen by Immune diffusion (ID) |
| 23404-7 | Rift valley fever virus Ag [Presence] in Tissue by Immunofluorescence |
| 33481-3 | Methane/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post dose lactose PO |
| 33595-0 | CD5+CD20+ cells [#/volume] in Blood |
| 33609-9 | Anaplasma phagocytophilum Ab [Titer] in Serum |
| 53594-8 | Chitobioside IgA Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 53637-5 | BOB1 Ag [Presence] in Tissue by Immune stain |
| 34213-9 | 11-Ketoandrosterone [Moles/volume] in 24 hour Urine |
| 53986-6 | Coarse speckled nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
| 24186-9 | Coxsackievirus B3 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 34396-2 | 11-Ketoetiocholanolone/Creatinine [Molar ratio] in Urine |
| 34632-0 | hydrALAZINE [Mass/volume] in Urine |
| 4707-6 | HLA-A68(28) [Presence] in Donor |
| 47133-4 | Trimipramine [Moles/volume] in Gastric fluid |
| 25348-4 | Beta aminoisobutyrate [Moles/time] in 24 hour Urine |
| 55953-4 | Octenoylcarnitine (C8:1) [Moles/volume] in Amniotic fluid |
| 25850-9 | Ammonia [Moles/volume] in 24 hour Urine |
| 56371-8 | Common Ragweed IgG4 Ab [Mass/volume] in Serum |
| 56517-6 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 26794-8 | Alpha aminobutyrate [Presence] in 24 hour Urine |
| 5684-6 | Manganese [Mass/volume] in Urine |
| 48374-3 | Spermatozoa Isolated Tail/100 spermatozoa in Semen |
| 38324-0 | Methoxychlor [Mass/volume] in Water |
| 57804-7 | Number of occult blood specimens recommended by testing kit protocol [#] in Stool |
| 57924-3 | Carboxy tetrahydrocannabinol [Presence] in Meconium |
| 28657-5 | Coagulation factor X activated actual/normal in Platelet poor plasma by Chromogenic method |
| 2874-6 | Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
| 29148-4 | carBAMazepine.bound [Mass/volume] in Serum or Plasma |
| 29228-4 | Tricyclic antidepressants [Mass/volume] in Body fluid |
| 29346-4 | Chloramphenicol [Mass/volume] in Urine |
| 49899-8 | Setomelanomma rostrata IgE Ab/IgE total in Serum |
| 500-9 | Ticarcillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 50172-6 | Aldosterone [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
| 29822-4 | Saint Louis encephalitis virus Ab [Titer] in Specimen |
| 58998-6 | Creatinine [Mass/time] in 18 hour Urine |
| 41151-2 | Hepatitis B virus e IgG Ab [Presence] in Serum |
| 19545-3 | Mescaline cutoff [Mass/volume] in Urine for Confirmatory method |
| 19599-0 | Morphine cutoff [Mass/volume] in Urine for Screen method |
| 20397-6 | Sparfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 20579-9 | Methanol [Presence] in Serum or Plasma by Screen method |
| 100157-7 | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing |
| 100963-8 | Dengue virus 1+2+3+4 nsP1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 12761-3 | Insulin [Mass/volume] in Serum or Plasma --8 minutes post XXX challenge |
| 101465-3 | Septin-7 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 101479-4 | Cefotaxime [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 102134-4 | Almond Tree IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1362-3 | Corticotropin [Mass/volume] in Plasma --30 minutes post 1 ug/kg CRH IV |
| 1365-6 | Corticotropin [Mass/volume] in Plasma --45 minutes post dose insulin IV |
| 102263-1 | Cryptococcus terreus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102340-7 | Kentucky blue grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102883-6 | Penicillium brevicompactum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102917-2 | Lactoferrin bovine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14497-2 | Virus identified in Penis by Immunofluorescence |
| 103176-4 | Escherichia coli enteroinvasive DNA [Presence] in Wound by NAA with probe detection |
| 14908-8 | Rh [Type] in Blood from Newborn |
| 16126-5 | Helicobacter pylori IgG Ab [Presence] in Serum |
| 11122-9 | Promonocytes/100 cells in Bone marrow by Manual count |
| 16516-7 | Calcium.ionized [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 16824-5 | Epstein Barr virus nuclear Ab [Presence] in Cerebral spinal fluid |
| 16973-0 | Histoplasma capsulatum IgM Ab [Presence] in Serum by Immune diffusion (ID) |
| 1912-5 | Aspartate [Presence] in Serum or Plasma |
| 90101-7 | Internal control result |
| 74651-1 | Methylenedioxymethamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 74808-7 | von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay --immediately after 1:1 addition of normal plasma |
| 7497-1 | Cheese mold type triggered histamine release [Units/volume] in Blood |
| 74974-7 | carBAMazepine free [Mass/volume] in Serum or Plasma --trough |
| 75001-8 | Coproporphyrin 3/Coproporphyrin.total in Stool |
| 91874-8 | Mycoplasma genitalium DNA [Presence] in Urethra by NAA with probe detection |
| 75813-6 | Promethazine [Presence] in Blood or Urine by Screen method |
| 7649-7 | Giant Ragweed triggered histamine release [Units/volume] in Blood |
| 93384-6 | Serratia sp DNA [Presence] by NAA with probe detection in Positive blood culture |
| 61281-2 | Squid IgE Ab/IgE total in Serum |
| 614-8 | Mycobacterial strain [Type] in Isolate by Mycobacterial subtyping |
| 77074-3 | C12orf65 gene full mutation analysis in Blood or Tissue by Sequencing |
| 77340-8 | Alpha 1 globulin [Mass/volume] by Electrophoresis in Urine collected for unspecified duration |
| 93737-5 | German turnip IgE Ab [Units/volume] in Serum |
| 94230-0 | GBA gene full mutation analysis in Blood or Tissue by Sequencing |
| 6313-1 | Blastomyces dermatitidis Ag [Presence] in Serum by Immunoassay |
| 6320-6 | Borrelia burgdorferi IgG Ab [Presence] in Serum by Immunoblot |
| 94312-6 | SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N2 |
| 94444-7 | HLA-B IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC) |
| 94497-5 | Packed erythrocytes [Volume] of Specimen |
| 94670-7 | Tetanus reaction wheal [Diameter] --1 day post tetanus toxoid intradermal |
| 6443-6 | Lactoferrin [Presence] in Stool by Latex agglutination |
| 79274-7 | 3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in Serum or Plasma |
| 6688-6 | Coxsackievirus A16 Ab [Titer] in Serum by Complement fixation |
| 79708-4 | Borrelia burgdorferi IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 97211-7 | 6-monoacetylmorphine free [Presence] in Cord tissue by Confirmatory method |
| 69960-3 | Grass Allergen Mix 4 (Sweet vernal grass+Velvet grass+Perennial rye grass+Common reed+Rye) IgE Ab [Units/volume] in Serum by Multidisk |
| 81805-4 | Allo-tetrahydrocorticosterone/Creatinine [Molar ratio] in Urine |
| 82572-9 | Silver Birch recombinant (rBet v) 6 IgE Ab [Units/volume] in Serum |
| 82918-4 | Jo-1 extractable nuclear IgG Ab [Presence] in Serum by Line blot |
| 7171-2 | Canary feather IgE Ab [Units/volume] in Serum |
| 7181-1 | Carrot triggered histamine release [Units/volume] in Blood |
| 85383-8 | EGFR gene c.2369C>T actual/normal in Plasma cell-free DNA by Molecular genetics method |
| 85628-6 | Neisseria meningitidis sodC gene [Presence] in Specimen by NAA with probe detection |
| 7263-7 | Cranberry IgG Ab [Units/volume] in Serum |
| 72697-6 | CYP3A5 gene c.6986A>G(*3) [Presence] in Blood or Tissue by Molecular genetics method |
| 85838-1 | Beta-lactam resistance ESBL blaSHV gene [Presence] by Molecular method |
| 73620-7 | Finafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 87768-8 | Rufinamide/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 87964-3 | Respiratory pathogens panel - Bronchoalveolar lavage by Immunofluorescence |
| 88170-6 | Microscopic observation [Identifier] in Cornea or Conjunctiva by Gram stain |
| 41608-1 | Prolactin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 59824-3 | Cyanide [Presence] in Urine |
| 30527-6 | Calcium [Mass/volume] in Total parental nutrition |
| 41852-5 | Microorganism or agent identified in Specimen |
| 42514-0 | Inhibin Ag [Presence] in Tissue by Immune stain |
| 60172-4 | Strontium [Mass/volume] in Blood |
| 60292-0 | Chloral hydrate [Moles/volume] in Specimen |
| 51386-1 | Plasma cells/100 leukocytes in Body fluid by Manual count |
| 43164-3 | Silica [Mass/volume] in Water |
| 21818-0 | t(8;14)(q24;q32)(MYC,IGH) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 22218-2 | Coxsackievirus A4 Ab [Titer] in Serum |
| 51651-8 | IgE Ab [Presence] in Serum or Plasma |
| 22488-1 | Rickettsia typhi IgG Ab [Presence] in Serum |
| 22578-9 | Toxoplasma gondii IgA Ab [Units/volume] in Serum |
| 32251-1 | Isoleucine [Moles/volume] in Body fluid |
| 32559-7 | Tau protein [Mass/volume] in Serum |
| 43989-3 | Clofazimine 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 33204-9 | Troponin T.cardiac [Presence] in Serum or Plasma |
| 33209-8 | CD235a cells/100 cells in Aspirate |
| 53101-2 | Kynurenate [Moles/volume] in Urine |
| 53128-5 | Bacterial casts [#/area] in Urine sediment by Microscopy low power field |
| 53397-6 | Methionine/Alloisoleucine+Isoleucine+Leucine+Hydroxyproline [Molar ratio] in DBS |
| 333-5 | Mezlocillin [Susceptibility] by Serum bactericidal titer |
| 33677-6 | Francisella tularensis [Presence] in Isolate by Organism specific culture |
| 53613-6 | Benzoylcarnitine (BzCn) [Moles/volume] in DBS |
| 53618-5 | ZAP70 cells [Presence] in Specimen |
| 45287-0 | Coxsackievirus B6 Ab [Presence] in Body fluid |
| 337-6 | Minocycline [Susceptibility] by Serum bactericidal titer |
| 33792-3 | Calcium [Moles/volume] in Urine --6th specimen post XXX challenge |
| 33920-0 | S Ab [Titer] in Serum or Plasma |
| 2478-6 | Inhibin [Mass/volume] in Serum or Plasma |
| 2499-2 | Iron [Mass/time] in 24 hour Urine |
| 34437-4 | Coxsackievirus B Ab [Titer] in Serum |
| 55473-3 | Cortisol [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
| 47430-4 | Cytomegalovirus Ab [Presence] in Serum or Plasma from Donor |
| 55620-9 | Bacampicillin [Susceptibility] by Gradient strip |
| 47822-2 | 3-Methyladipate/Creatinine [Molar ratio] in Urine |
| 47913-9 | Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose ornithine |
| 25761-8 | Insulin-like growth factor [Moles/volume] in Serum or Plasma --13th specimen post XXX challenge |
| 48179-6 | Reference change value 0.99 in unspecified time Population |
| 56586-1 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 26837-5 | diazePAM [Mass/mass] in Hair |
| 26850-8 | Oxazepam [Mass/volume] in Vitreous fluid |
| 57311-3 | CYP11B1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 49198-5 | Bartonella vinsonii berkhoffii IgM Ab [Titer] in Body fluid |
| 49289-2 | Porphyrins [Interpretation] in Serum or Plasma Narrative |
| 27877-0 | CD33+CD11b+ cells/100 cells in Blood |
| 28050-3 | 1,2,3-Trichlorobenzene [Mass/volume] in Serum or Plasma |
| 57875-7 | Cantaloupe IgG4 Ab [Mass/volume] in Serum |
| 5796-8 | Hyaline casts [#/area] in Urine sediment by Microscopy low power field |
| 29317-5 | Thyrotropin [Units/volume] in Serum or Plasma --1 hour post XXX challenge |
| 2946-2 | Sialidase [Enzymatic activity/mass] in Tissue |
| 29510-5 | 3-Hydroxyglutarate/Creatinine [Molar ratio] in Urine |
| 39781-0 | Urea [Moles/volume] in Peritoneal fluid |
| 40020-0 | Glucose [Mass/volume] in Serum or Plasma --20.5 hours post XXX challenge |
| 58486-2 | Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --7th specimen post XXX challenge |
| 58655-2 | Cortisol [Mass/volume] in Serum or Plasma --2 PM specimen |
| 58688-3 | Cortisol [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge |
| 49917-8 | Lymphocyte proliferation stimulated by 10 umol beryllium [Ratio] in Leukocytes --6 days post incubation |
| 50107-2 | 3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Urine |
| 29819-0 | Anaplasma phagocytophilum IgG Ab [Presence] in Serum by Immunoblot |
| 50307-8 | BCL10 Ag [Presence] in Tissue by Immune stain |
| 41093-6 | LHON syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19433-2 | Propoxyphene + Norpropoxyphene [Presence] in Urine by Screen method |
| 19747-5 | Mealworm IgE Ab [Units/volume] in Serum |
| 100791-3 | Hamster epithelium IgG Ab [Mass/volume] in Serum |
| 101424-0 | Influenza virus A H3 RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 101584-1 | Bacterial Vaginosis Associated Bacteria-2+Atopobium vaginae+Megasphaera sp type 1 DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 13654-9 | Epithelial cells.squamous [#/volume] in Urine sediment |
| 10241-8 | Oxygen content in Coronary sinus |
| 102901-6 | Jujube IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102919-8 | Staphylococcus aureus enterotoxin A IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103045-1 | Pellitory (Parietaria judaica) recombinant (rPar j) 2 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10371-3 | Bite cells [Presence] in Blood by Light microscopy |
| 14912-0 | Smudge cells/100 leukocytes in Blood by Manual count |
| 15148-0 | Alkaline phosphatase [Enzymatic activity/volume] in Body fluid |
| 104380-1 | Coxiella burnetii IgM Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 15274-4 | Weed Allergen Mix 5 (Common ragweed+Mugwort+Ox-eye daisy+Dandelion+Goldenrod) IgE Ab [Presence] in Serum by Multidisk |
| 10803-5 | Microscopic observation [Identifier] in Tissue by Quinacrine fluorescent stain |
| 11066-8 | Uroporphyrinogen III synthase [Enzymatic activity/volume] in Red Blood Cells |
| 17471-4 | PM-1 Ab [Units/volume] in Serum by Immunofluorescence |
| 17876-4 | Bacteria # 5 identified in Bone by Aerobe culture |
| 17964-8 | Bacteria # 2 identified in Stool by Culture |
| 17967-1 | Bacteria # 5 identified in Stool by Culture |
| 18-2 | Amoxicillin [Susceptibility] by Serum bactericidal titer |
| 90740-2 | Aggressive prostate cancer risk [Likelihood] in Serum or Plasma by Calculated.4Kscore |
| 74998-6 | 5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/mass] in Fibroblast |
| 91664-3 | Triangle bur ragweed (Ambrosia deltoidea) IgE Ab [Units/volume] in Serum |
| 91768-2 | Ova and parasites identified in Sputum by Light microscopy |
| 76039-7 | Interleukin 2 Receptor Soluble [Mass/volume] in Serum or Plasma |
| 61386-9 | Human papilloma virus 66 DNA [Presence] in Specimen by NAA with probe detection |
| 77111-3 | KARS gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 93886-0 | Methane/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose carbohydrate |
| 94235-9 | F7 gene full mutation analysis in Blood or Tissue by Sequencing |
| 63265-3 | Jo-1 extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) |
| 63278-6 | Mitochondria Ab [Titer] in Body fluid by Immunofluorescence |
| 7821-2 | Chlamydophila pneumoniae rRNA [Presence] in Serum by NAA with probe detection |
| 94605-3 | Equine herpesvirus 1 RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 65765-0 | Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum |
| 79588-0 | Prolylhydroxyproline [Moles/volume] in Serum or Plasma |
| 8035-8 | Strongyloides stercoralis IgG Ab [Presence] in Serum |
| 82241-1 | Chromosome region 17p11.2 deletion in Amniotic fluid or Chorionic villus sample by FISH |
| 97630-8 | Proteus sp DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 82462-3 | Silver [Moles/volume] in Blood |
| 98024-3 | Lecithin [#/area] in Prostatic fluid by Manual count |
| 717-9 | Hemoglobin [Presence] in Blood |
| 83110-7 | Progesterone [Moles/volume] in Serum or Plasma by Immunoassay |
| 7248-8 | Cultivated Corn IgE Ab [Units/volume] in Serum |
| 85826-6 | Carbapenem resistance blaOXA-24-like gene [Presence] by Molecular method |
| 72985-5 | Mycophenolate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87275-4 | Borrelia afzelii+burgdorferi+garinii IgG Ab [Presence] in Serum by Line blot |
| 73458-2 | Cephalexin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73514-2 | Atomoxetine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73862-5 | Allo-tetrahydrocortisol [Moles/time] in 24 hour Urine |
| 88577-2 | Legionella pneumophila DNA [Presence] in Tissue by NAA with probe detection |
| 88601-0 | Influenza virus types A and B panel - Lower respiratory specimen by NAA with probe detection |
| 41638-8 | Marburg virus RNA [Presence] in Specimen by NAA with probe detection |
| 31393-2 | Feline herpesvirus 1 Ab [Units/volume] in Serum |
| 5145-8 | Echovirus 6 Ab [Titer] in Serum by Complement fixation |
| 42886-2 | CD52 cells/100 cells in Bone marrow |
| 22069-9 | MT-ATP6 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 43691-5 | Cladosporium sp IgE Ab [Presence] in Serum |
| 22594-6 | Treponema pallidum IgM Ab [Units/volume] in Serum |
| 32256-0 | Lysine [Moles/volume] in Body fluid |
| 32333-7 | Phenylpropanolamine [Presence] in Specimen |
| 3242-5 | Recalcification time in Platelet poor plasma by Coagulation assay |
| 53058-4 | Dodecanoylcarnitine (C12) [Moles/volume] in Amniotic fluid |
| 23061-5 | Epizootic hemorrhagic disease virus Ag [Presence] in Specimen |
| 32839-3 | Parvovirus B19 IgM Ab [Units/volume] in Serum --2nd specimen |
| 33591-9 | Neuronal nuclear IgG Ab [Units/volume] in Serum by Flow cytometry (FC) |
| 45141-9 | Platelet associated Ab [Presence] in Blood by Flow cytometry (FC) |
| 23985-5 | Borrelia burgdorferi IgM band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot |
| 24087-9 | Iduronate-2-Sulfatase [Enzymatic activity/volume] in Serum or Plasma |
| 33985-3 | Bartonella henselae DNA [Presence] in Tissue by NAA with probe detection |
| 46207-7 | PKD1 gene+PKD2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 47003-9 | Varicella zoster virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 24182-8 | Coxsackievirus B2 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 34652-8 | Pancreatic islet cell Ab [Moles/volume] in Serum |
| 55965-8 | Palmitoleylcarnitine (C16:1) [Moles/volume] in Amniotic fluid |
| 47529-3 | Cytology report of Tissue Other stain |
| 25795-6 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 25879-8 | Copper [Moles/volume] in 24 hour Urine |
| 56376-7 | Red Snapper IgG4 Ab [Mass/volume] in Serum |
| 5649-9 | Fluoride [Mass/volume] in Serum or Plasma |
| 48054-1 | Kaolin activated time [Units/volume] in Blood |
| 4827-2 | HLA-B38(16) [Presence] |
| 35875-4 | Herpes simplex virus 1+2 Ab [Units/volume] in Cerebral spinal fluid |
| 3680-6 | HYDROcodone [Mass/volume] in Serum or Plasma |
| 3746-5 | Meperidine [Presence] in Urine |
| 5705-9 | Nickel [Mass/time] in 24 hour Urine |
| 48760-3 | 3-Hydroxy fatty acid panel - Serum or Plasma |
| 48943-5 | Cannabinoids [Presence] in Specimen by Confirmatory method |
| 49105-0 | Phenolphthalein [Mass/volume] in Specimen |
| 2786-2 | Phosphatidylglycerol [Mass/volume] in Amniotic fluid |
| 27988-5 | Aldosterone [Mass/volume] in Serum or Plasma --baseline |
| 38702-7 | Hexamethylene diisocyanate [Mass/volume] in Air |
| 49453-4 | Varicella zoster virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
| 40281-8 | Lactose [Moles/volume] in Serum or Plasma --30 minutes post dose lactose PO |
| 29747-3 | Tocopherols [Moles/volume] in Serum or Plasma |
| 2983-5 | Terminal deoxyribonucleotidyl transferase [Enzymatic activity/volume] in Plasma |
| 40617-3 | Campylobacter sp IgG Ab [Presence] in Serum by Immunoassay |
| 40743-7 | Plasma cells [Presence] in Blood by Light microscopy |
| 40807-0 | Phencyclidine [Presence] in Hair by Screen method |
| 41109-0 | FGD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 20629-2 | levoFLOXacin [Susceptibility] |
| 20688-8 | Aspergillus sp identified in Litter by Organism specific culture |
| 12984-1 | 2,4 toluenediamine [Mass/volume] in Blood |
| 13215-9 | Brucella canis IgM Ab [Units/volume] in Cerebral spinal fluid |
| 101763-1 | Trichophyton benhamiae (Afr.) DNA [Presence] in Specimen by NAA with probe detection |
| 13737-2 | Estriol (E3)/Creatinine [Mass Ratio] in 24 hour Urine |
| 14015-2 | Thyroxine (T4).prealbumin bound/Prealbumin [Mass Ratio] in Serum or Plasma |
| 14136-6 | CD34 cells [#/volume] in Blood |
| 14141-6 | Ketones [Presence] in Urine --6 hours post XXX challenge |
| 14220-8 | HTLV I p28 Ab [Presence] in Serum |
| 103577-3 | Albumin [Mass/volume] in Serum by Immunoassay |
| 14993-0 | O group [Presence] on Red Blood Cells from Donor |
| 1500-8 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst |
| 15043-3 | Cortisol [Moles/volume] in Urine |
| 104472-6 | Yersinia pseudotuberculosis 1 Ab [Presence] in Stool |
| 10645-0 | Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence |
| 16604-1 | Chloramphenicol [Mass/volume] in Serum or Plasma --trough |
| 11270-6 | Viral inclusion bodies [Identifier] in Specimen by Cyto stain |
| 17253-6 | Mercury [Mass/volume] in Milk |
| 1781-4 | Alkaline phosphatase.regan [Enzymatic activity/volume] in Serum or Plasma |
| 18289-9 | Erythrocytes [Morphology] in Cerebral spinal fluid by Light microscopy |
| 74516-6 | Calcium [Moles/volume] in Saliva (oral fluid) |
| 749-2 | Myelocytes/100 leukocytes in Blood by Manual count |
| 91127-1 | Maximum amplitude ADP induced [Length] in Blood by Resonance TEG |
| 91899-5 | Anaplasma phagocytophilum and Ehrlichia chaffeensis DNA panel - Blood |
| 7586-1 | Bell Pepper IgE Ab [Units/volume] in Serum |
| 61368-7 | Campylobacter jejuni DNA [Presence] in Specimen by NAA with probe detection |
| 61409-9 | Cyclobenzaprine [Presence] in Urine by Confirmatory method |
| 77209-5 | Salivary gland protein 1 IgM Ab [Units/volume] in Serum by Immunoassay |
| 77946-2 | CD42b cells/100 cells in Specimen |
| 94399-3 | Ethyl glucuronide [Mass/mass] in Meconium by Confirmatory method |
| 94619-4 | Bovine herpesvirus 1 [Presence] in Specimen by Organism specific culture |
| 63467-5 | Ganglioside GM3 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 63548-2 | Smith extractable nuclear B Ab [Units/volume] in Serum by Immunoassay |
| 6481-6 | Mycoplasma pneumoniae IgG Ab [Titer] in Serum by Immunofluorescence |
| 7917-8 | HIV 1 Ab [Presence] in Serum |
| 6532-6 | Rabies virus Ag [Presence] in Specimen by Immunofluorescence |
| 79691-2 | Oxipurinol [Moles/volume] in Cerebral spinal fluid |
| 96453-6 | Coagulation factor XI activity and inhibitor panel - Platelet poor plasma by Coagulation assay |
| 96467-6 | Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 69030-5 | Enterocyte IgG Ab [Presence] in Serum |
| 704-7 | Basophils [#/volume] in Blood by Automated count |
| 82917-6 | Bromperidol [Mass/volume] in Serum or Plasma --trough |
| 85315-0 | Extent of posterior margin carcinoma involvement in Breast cancer specimen Qualitative by Light microscopy |
| 73147-1 | Sotalol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73369-1 | Furosemide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87384-4 | Porcine parainfluenza virus 1 HN gene [Nucleotide sequence] in Isolate by Sequencing |
| 73505-0 | Benztropine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88192-0 | Crimean-Congo hemorrhagic fever virus RNA [Presence] in Serum by NAA with probe detection |
| 41498-7 | HIV 1 RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 41735-2 | Everninomicin [Susceptibility] |
| 5069-0 | Brucella melitensis Ab [Titer] in Serum by Latex agglutination |
| 30499-8 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum --2nd specimen |
| 60208-6 | Venlafaxine [Mass/volume] in Blood |
| 21201-9 | Chromium [Mass/volume] in 24 hour Urine |
| 21302-5 | Giardia lamblia Ag [Presence] in Stool by Immunoassay --2nd specimen |
| 51154-3 | CD30 blasts/100 blasts in Specimen |
| 5130-0 | DNA double strand Ab [Units/volume] in Serum |
| 5142-5 | Echovirus 4 neutralizing antibody [Titer] in Serum by Neutralization test |
| 51438-0 | Protein.monoclonal band 2 [Mass/volume] in 24 hour Urine by Electrophoresis |
| 31727-1 | Bacteroides fragilis Ag [Presence] in Specimen |
| 51915-7 | Herpes simplex virus IgG Ab [Titer] in Serum by Immunoassay |
| 43749-1 | SCO2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 22331-3 | Herpes simplex virus 1 Ab [Presence] in Cerebral spinal fluid |
| 52793-7 | Father's ABO group Type |
| 52911-5 | Magnesium [Moles/mass] in Tissue |
| 23062-3 | Epizootic hemorrhagic disease virus Ag [Presence] in Blood |
| 32750-2 | CD235a cells/100 cells in Specimen |
| 23308-0 | Myxoma virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 23322-1 | Ovine herpesvirus 2 Ab [Presence] in Serum by Complement fixation |
| 23418-7 | Salmonella abortus equi Ab [Presence] in Serum by Agglutination |
| 236-0 | Erythromycin+Sulfisoxazole [Susceptibility] by Minimum lethal concentration (MLC) |
| 5368-6 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay |
| 53884-3 | OTOF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 45027-0 | HLA-A2 panel - Blood |
| 45271-4 | Bordetella bronchiseptica DNA [Presence] in Nasopharynx by NAA with probe detection |
| 54223-3 | Lymphoma - CLL screen markers [Interpretation] in Specimen Narrative |
| 34354-1 | Phosphate/Creatinine [Molar ratio] in Urine |
| 552-0 | Brucella sp identified in Specimen by Organism specific culture |
| 3477-7 | Chlorprothixene [Mass/volume] in Urine |
| 3506-3 | Codeine [Mass/volume] in Serum or Plasma |
| 35172-6 | Mead acid (C20:3w9) [Moles/volume] in Serum or Plasma |
| 55896-5 | Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Chorionic villus sample |
| 47828-9 | Adiponectin [Mass/volume] in Serum or Plasma |
| 35645-1 | NSD1 gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
| 47999-8 | DNA region name [Identifier] |
| 48290-1 | Sodium nitrite triggered leukotriene release [Mass/volume] by Leukocytes |
| 4841-3 | HLA-B5 [Presence] |
| 38393-5 | Legionella sp identified in Pleural fluid by Organism specific culture |
| 38533-6 | TCOF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 38662-3 | Aluminum oxide [Mass/volume] in Air |
| 57380-8 | Potassium [Moles/time] in 12 hour Urine |
| 57642-1 | Androsterone [Mass/time] in 24 hour Urine --pre dose dexamethasone |
| 57786-6 | Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
| 49382-5 | Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
| 2831-6 | Pregnancy specific protein 1 [Mass/volume] in Serum |
| 28607-0 | Canine parvovirus Ab [Presence] in Stool by Hemagglutination inhibition |
| 2942-1 | Sex hormone binding globulin [Mass/volume] in Serum or Plasma |
| 5870-1 | Parainfluenza virus 2 Ag [Presence] in Throat by Immunofluorescence |
| 49901-2 | Heptacarboxylporphyrin III [Mass/time] in 24 hour Stool |
| 50450-6 | Corticotropin [Mass/volume] in Plasma --6th specimen |
| 19534-7 | Meperidine cutoff [Mass/volume] in Urine for Screen method |
| 195-8 | Clindamycin [Susceptibility] by Serum bactericidal titer |
| 2041-2 | Carnitine acyltransferase [Enzymatic activity/volume] in Serum or Plasma |
| 20726-6 | Brucella abortus Ab [Presence] in Serum by Card agglutination |
| 20859-5 | Infectious bronchitis virus serotype [Identifier] in Isolate by Neutralization test |
| 100681-6 | Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 12850-4 | Protein [Mass/volume] in Peritoneal dialysis fluid --8th specimen |
| 101452-1 | Neurochondrin Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 101521-3 | Hemorrhagic enteritis virus Ab/Positive control in Serum by Immunoassay |
| 13208-4 | Borrelia hermsii IgG Ab [Units/volume] in Serum |
| 102058-5 | Perfluorohexanoate [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 13594-7 | Prekallikrein (Fletcher Factor) [Presence] in Platelet poor plasma |
| 13880-0 | Collagen type 4 IgG Ab [Units/volume] in Serum |
| 14223-2 | HTLV I p53 Ab [Presence] in Serum |
| 10334-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma |
| 103671-4 | Mitragynine [Presence] in Cord tissue by Confirmatory method |
| 104189-6 | Mucopolysaccharidosis type II newborn screen interpretation newborn screen interpretation |
| 15055-7 | Deoxypyridinoline [Moles/time] in 24 hour Urine |
| 104282-9 | ABCB1 gene.c.2677G>T [Presence] in Blood or Tissue by Molecular genetics method |
| 12304-2 | Benzyl alcohol [Presence] in Serum or Plasma |
| 16761-9 | Protoporphyrin [Mass/volume] in Stool |
| 16879-9 | Francisella tularensis Ag [Presence] in Serum by Immunofluorescence |
| 17065-4 | Legionella pneumophila 3 IgM Ab [Units/volume] in Serum |
| 17432-6 | Tetrachloroethylene [Mass/volume] in Serum or Plasma |
| 90435-9 | Microorganism preliminary growth [Presence] in Blood by Aerobe culture |
| 60536-0 | HLA-DQ beta [Type] |
| 92889-5 | Chronic hepatitis differentiation between hepatitis B and C virus panel - Serum or Plasma |
| 93715-1 | Francisella tularensis IgG and IgM panel - Serum |
| 93850-6 | Pretomanid [Susceptibility] |
| 625-4 | Bacteria identified in Stool by Culture |
| 94554-3 | Soluble CD14 subtype [Mass/volume] in Serum, Plasma or Blood by Immunoassay |
| 79424-8 | Serial sputum smears for diagnosing pulmonary tuberculosis panel - by Acid fast stain |
| 6623-3 | Leishmania sp Ab [Presence] in Serum by Complement fixation |
| 66489-6 | CYP2C19 gene targeted mutation analysis in Blood by Molecular genetics method |
| 79509-6 | Decenedioate [Moles/volume] in Serum or Plasma |
| 95839-7 | Mononuclear cells.recovered/Mononuclear cells.total |
| 6762-9 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 50 g lactose PO |
| 70057-5 | Hantavirus saaremaa IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 82060-5 | Food Allergen Mix 18 (Peanut+Soybean+Peas) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 9723-8 | Spermatozoa IgA Ab [Units/volume] in Serum |
| 9775-8 | Moricizine [Mass/volume] in Serum or Plasma |
| 82584-4 | Dicarboxyhexenoylcarnitine (C6:1-DC)/Creatinine [Molar ratio] in Urine |
| 82736-0 | Calcium-calmodulin-dependent protein kinase II activity actual/normal in Serum |
| 82936-6 | Signal Recognition Particle (SRP) IgG Ab [Presence] in Serum by Line blot |
| 98112-6 | Chemokine (C-C motif) ligand 20 [Mass/volume] in Serum or Plasma |
| 98120-9 | Intercellular adhesion molecule 1 [Mass/volume] in Serum or Plasma |
| 98199-3 | Phenacetin IgE Ab [Units/volume] in Serum |
| 98391-6 | Percent sarcomatous component of carcinosarcoma |
| 83117-2 | Thyroglobulin IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 83321-0 | Pathology report intraoperative observation in Specimen Document |
| 7260-3 | Crab IgG Ab [Units/volume] in Serum |
| 72674-5 | Sulfamethoxazole [Mass/volume] in Serum or Plasma --trough |
| 87371-1 | Escherichia coli fedF gene [Presence] in Isolate by NAA with probe detection |
| 73697-5 | CCHD newborn screening protocol used [Type] |
| 73874-0 | Androstenetriol [Moles/time] in 24 hour Urine |
| 87927-0 | Bacterial susceptibility panel - Isolate by Minimum lethal concentration (MLC) |
| 88158-1 | Microscopic observation [Identifier] in Ocular fluid by Gram stain |
| 88631-7 | Microscopic observation [Presence] in Lower respiratory specimen by Acid fast stain.Kinyoun |
| 41196-7 | West Nile virus IgG Ab [Titer] in Body fluid |
| 59833-4 | Other Antibiotic [Susceptibility] by Minimum lethal concentration (MLC) |
| 59873-0 | Bromazepam [Moles/volume] in Gastric fluid |
| 50610-5 | Alpha-1-Fetoprotein [Multiple of the median] adjusted for multiple gestations in Serum or Plasma |
| 42359-0 | Streptococcus pneumoniae 14 serotypes IgG panel B [Mass/volume] - Serum |
| 60156-7 | Perfluorooctanoate [Mass/volume] in Blood |
| 60252-4 | MGMT gene methylation [Presence] in Tissue by Molecular genetics method |
| 21664-8 | CYP2D6 gene p.Gly169Ter [Presence] in Blood or Tissue by Molecular genetics method |
| 32494-7 | CD25 cells/100 cells in Tissue |
| 52876-0 | CD1a cells/100 cells in Tissue |
| 52881-0 | Cytoplasmic CD22 cells/100 cells in Tissue |
| 3262-3 | Fibrinopeptide B beta (15-42) Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
| 32729-6 | Beta 2 globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
| 53184-8 | Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS |
| 23520-0 | Trypanosoma evansi [Presence] in Aspirate by Wet preparation |
| 45132-8 | Chlamydia sp Ag [Presence] in Nasopharynx by Immunoassay |
| 23971-5 | Epstein Barr virus early IgG Ab [Titer] in Serum |
| 54360-3 | Bicarbonate [Moles/volume] in Peritoneal fluid |
| 24338-6 | Gas panel - Blood |
| 55383-4 | Insulin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 55591-2 | Chicken feather IgE Ab [Presence] in Serum |
| 4749-8 | HLA-B46 [Presence] |
| 55738-9 | Cefotiam hexetil [Susceptibility] |
| 47678-8 | Lactate dehydrogenase [Enzymatic activity/volume] in 24 hour Urine |
| 47873-5 | Propionyl CoA Carboxylase [Enzymatic activity/mass] in Amniotic fluid cells |
| 35641-0 | CD7 cells/100 cells in Bone marrow |
| 56247-0 | Dog epithelium IgG4 Ab [Mass/volume] in Serum |
| 56548-1 | U1 small nuclear ribonucleoprotein IgG Ab [Units/volume] in Serum by Immunoassay |
| 267-5 | Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 56616-6 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 48853-6 | Orientia tsutsugamushi Karp IgG Ab [Titer] in Serum by Immunofluorescence |
| 38615-1 | Phenol [Mass/volume] in Air |
| 57618-1 | 5-Alpha tetrahydrocortisol [Mass/time] in 24 hour Urine --pre dose dexamethasone |
| 57689-2 | Cortisol [Mass/volume] in Saliva (oral fluid) --4th specimen |
| 5802-4 | Nitrite [Presence] in Urine by Test strip |
| 28591-6 | Amino beta guanidinopropionate/Creatinine [Ratio] in Urine |
| 39990-7 | Creatinine [Mass/volume] in Urine --4 hours post XXX challenge |
| 49850-1 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --baseline |
| 40402-0 | traZODone [Presence] in Gastric fluid |
| 40423-6 | Methotrimeprazine [Presence] in Specimen |
| 41172-8 | Yeast.budding [#/area] in Urine sediment by Microscopy high power field |
| 19228-6 | Deoxyhemoglobin/Hemoglobin.total in Mixed venous blood |
| 19333-4 | Amitriptyline cutoff [Mass/volume] in Urine for Screen method |
| 19632-9 | Norpropoxyphene [Presence] in Urine by Screen method |
| 2038-8 | Carcinoembryonic Ag [Mass/volume] in Semen |
| 20846-2 | Bovine herpesvirus 1 Ag [Presence] in Tissue by Immunofluorescence |
| 101196-4 | Inflammatory cell infiltrate in Colorectal cancer specimen |
| 101352-3 | Borrelia burgdorferi Ab.IgG and IgM with reflex to immunoassay panel - Serum or Plasma |
| 12974-2 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --3rd specimen |
| 1380-5 | Calcium/Phosphate parathyroid-challenge test [Mass Ratio] in Serum |
| 13929-5 | Rheumatoid factor [Titer] in Synovial fluid by Sheep Cell Agglutination |
| 14068-1 | Triamterene+hydroCHLOROthiazide [Mass/volume] in Serum or Plasma |
| 14146-5 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 14227-3 | Salmonella typhi H D Ab [Titer] in Serum |
| 14350-3 | Specific gravity of Synovial fluid by Refractometry |
| 14691-0 | Desipramine [Moles/volume] in Serum or Plasma |
| 15207-4 | Sodium [Moles/volume] in Stool |
| 15419-5 | Service comment 28 |
| 16194-3 | Secobarbital [Presence] in Urine by Confirmatory method |
| 16229-7 | clonazePAM [Mass/volume] in Urine by Confirmatory method |
| 10825-8 | Myelin+Nerve cells.microscopic observation [Identifier] in Tissue by Luxol fast blue/Cresyl violet stain |
| 11576-6 | Erythromycin+Sulfisoxazole [Susceptibility] by Gradient strip |
| 17563-8 | Salmonella sp identified in Specimen by Organism specific culture |
| 1904-2 | Ascorbate [Presence] in Urine |
| 89973-2 | 7-Hydroxyfluphenazine [Mass/volume] in Urine by Confirmatory method |
| 90455-7 | Influenza virus types A and B panel - Cornea or Conjunctiva by NAA with probe detection |
| 90816-0 | Amphiphysin Ab [Units/volume] in Cerebral spinal fluid by Line blot |
| 91091-9 | Fungal ITS region [Presence] in Isolate by NAA with probe detection |
| 74643-8 | Aromatic solvents [Presence] in Urine |
| 7467-4 | Lipolase IgE Ab [Units/volume] in Serum |
| 91669-2 | CYP3A7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 91820-1 | Adenovirus DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 91861-5 | Chlamydia trachomatis Ag [Presence] in Aspirate by Immunofluorescence |
| 92530-5 | Lu sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 75544-7 | Noninvasive prenatal testing overall interpretation Qualitative |
| 75724-5 | CYP1A2 gene c.558C>A [Presence] in Blood or Tissue by Molecular genetics method |
| 93320-0 | Platelet surface glycoprotein disorders panel - Blood by Flow cytometry (FC) |
| 61316-6 | Goldenrod IgE Ab/IgE total in Serum |
| 61323-2 | Cranberry IgE Ab/IgE total in Serum |
| 62245-6 | Nucleated erythrocytes/100 leukocytes [Ratio] in Blood from Fetus by Automated count |
| 93931-4 | ABO group [Type] in Blood--post hematopoietic stem cell transplant |
| 6310-7 | Arbovirus identified in Specimen by Organism specific culture |
| 95160-8 | Avian paramyxovirus 1 Ab/Positive control in Serum by Immunoassay |
| 79589-8 | Aspartylglycosamine [Moles/volume] in Serum or Plasma |
| 7981-4 | Parvovirus B19 IgM Ab [Presence] in Serum |
| 80127-4 | Aluminum [Moles/volume] in Cerebral spinal fluid |
| 9613-1 | Cortisol [Mass/volume] in Serum or Plasma --2 hours post 250 ug corticotropin IM |
| 6855-1 | Common Reed IgE Ab [Units/volume] in Serum |
| 6891-6 | Testosterone.free+weakly bound/Testosterone.total in Serum or Plasma |
| 68916-6 | dRVVT W excess phospholipid actual/normal (normalized LA confirm) |
| 69793-8 | Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Amniotic fluid |
| 70021-1 | Salmonella typhi DNA [Presence] in Blood by NAA with probe detection |
| 82102-5 | Regional Allergen Mix 1 (Mugwort+Silver birch+Pellitory+Timothy+English plantain) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 82199-1 | Salmonella enterica+bongori DNA [Presence] in Stool by NAA with non-probe detection |
| 70090-6 | Interleukin 13 [Mass/volume] in Body fluid |
| 70276-1 | t(1;11)(p32;q23)(EPS15,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 8258-6 | Service comment 16 |
| 84898-6 | Dominant nodule plane [Anatomy] in Prostate tumor |
| 85337-4 | Estrogen receptor Ag [Presence] in Breast cancer specimen by Immune stain |
| 99517-5 | Weight of Liver |
| 86316-7 | Human RNase P RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 87474-3 | Chromium [Mass/mass] in Specimen |
| 41472-2 | carBAMazepine [Mass/volume] in DBS |
| 41860-8 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Serum or Plasma |
| 42215-4 | Nucleated erythrocytes/100 cells in Bone marrow by Manual count |
| 42343-4 | Toxoplasma gondii identified in Specimen by Other stain |
| 21378-5 | Malathion [Mass/volume] in Urine |
| 51176-6 | CD36 blasts in Bone marrow |
| 51228-5 | CD11b cells/100 cells in Cerebral spinal fluid |
| 22113-5 | Bluetongue virus Ab [Presence] in Serum |
| 31703-2 | West Nile virus IgM Ab [Presence] in Cerebral spinal fluid |
| 31944-2 | Porcine enterovirus Ag [Presence] in Specimen |
| 43208-8 | Invasive trophoblast Ag [Multiple of the median] in Serum or Plasma |
| 22324-8 | Hepatitis C virus 100-3 Ab [Presence] in Serum |
| 32368-3 | Ureaplasma sp identified in Specimen by Organism specific culture |
| 43992-7 | Anaplasma phagocytophilum Ab [Interpretation] in Serum by Immunofluorescence |
| 4401-6 | Pholedrine [Mass] of Dose |
| 22832-0 | Avian paramyxovirus 1 identified in Specimen by Bioassay |
| 44466-1 | Herpes simplex virus 1 [Presence] in Throat by Organism specific culture |
| 23265-2 | Mycoplasma capricolum ss capripneumonia Ab [Titer] in Serum by Complement fixation |
| 23327-0 | Ovine herpesvirus 2 DNA [Presence] in Tissue by NAA with probe detection |
| 53645-8 | Polio virus identified in Stool by Organism specific culture |
| 53780-3 | Chromium panel - Urine |
| 45069-2 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Genital specimen by Probe |
| 23686-9 | Canine adenovirus Ag [Presence] in Tissue by Immunofluorescence |
| 23934-3 | Staphylococcus aureus enterotoxin B Ab [Presence] in Serum |
| 34165-1 | Immature granulocytes [Presence] in Blood by Automated count |
| 53967-6 | Erythrocytes.dysmorphic/100 erythrocytes in Urine sediment by Light microscopy |
| 46725-8 | Tropheryma whipplei DNA [Presence] in Specimen by NAA with probe detection |
| 47008-8 | Platelet associated IgG Ab [Presence] in Serum by Immunoassay |
| 24179-4 | Coxsackievirus B1 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen |
| 3435-5 | Carboxy tetrahydrocannabinol [Presence] in Urine |
| 2602-1 | Malate dehydrogenase [Enzymatic activity/volume] in Serum |
| 56432-8 | Wormwood IgG4 Ab [Mass/volume] in Serum |
| 3684-8 | Hydroxychloroquine [Mass/volume] in Serum or Plasma |
| 3771-3 | Methadone [Presence] in Serum or Plasma |
| 56634-9 | Nuclear IgG Ab [Titer] in Serum by Immunofluorescence |
| 48816-3 | Staphylococcus aureus Panton-Valentine leukocidin gene [Presence] in Isolate or Specimen by Molecular genetics method |
| 57616-5 | 5-Alpha tetrahydrocortisol [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
| 27262-5 | Methaqualone [Mass/mass] in Meconium |
| 27382-1 | Porphobilinogen [Mass/volume] in 24 hour Urine |
| 27954-7 | Coxsackievirus B6 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe |
| 27962-0 | Butalbital [Mass/mass] in Meconium |
| 49695-0 | Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Venous cord blood |
| 40096-0 | Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --8 hours post XXX challenge |
| 401-0 | Phenethicillin [Susceptibility] by Disk diffusion (KB) |
| 58393-0 | HYDROcodone/Creatinine [Mass Ratio] in Urine |
| 58535-6 | Corticotropin [Moles/volume] in Plasma --10 PM specimen |
| 58671-9 | Cortisol [Moles/volume] in Saliva (oral fluid) --45 minutes post 1 ug/kg CRH IV |
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
| 40350-1 | MT-TL1 gene m.3291T>C [Presence] in Blood or Tissue by Molecular genetics method |
| 59160-2 | Cannabinoids [Mass/mass] in Hair |
| 50360-7 | Phenylpropionylglycine/Creatinine [Molar ratio] in 24 hour Urine |
| 1949-7 | Beta lipotropin [Mass/volume] in Serum or Plasma |
| 19620-4 | Nitrazepam [Presence] in Urine by Screen method |
| 101902-5 | little c Ag [Presence] on Red Blood Cells from Fetus |
| 101997-5 | Clot initiation.kaolin induced [Time] in Blood by Thromboelastography |
| 102273-0 | Dandelion IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14412-1 | Aspartate aminotransferase [Enzymatic activity/volume] in Gastric fluid |
| 14706-6 | Doxepin [Moles/volume] in Urine |
| 14777-7 | Heptacarboxylate [Moles/volume] in Stool |
| 14969-0 | CD7 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 15357-7 | Iron [Mass/mass] in Tissue |
| 16110-9 | 11-Deoxycorticosterone [Mass/time] in 24 hour Urine |
| 10891-0 | Oxyphenisatin [Mass/mass] in Stool |
| 11110-4 | Megakaryocytes/100 cells in Bone marrow by Manual count |
| 11470-2 | Clostridium botulinum toxin [Units/volume] in Stool |
| 17178-5 | CD6 cells/100 cells in Blood |
| 17222-1 | HLE lymphocytes/100 lymphocytes in Blood |
| 18280-8 | Background stain [Presence] in Blood by Light microscopy |
| 74889-7 | Phosphate [Moles/volume] in Saliva (oral fluid) |
| 74900-2 | Lactulose/Creatinine [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO |
| 61084-0 | Methylphenidate [Presence] in Gastric fluid |
| 61177-2 | Paraneoplastic Ab [Presence] in Serum by Immunofluorescence |
| 93236-8 | aPTT.lupus sensitive.excess phospholipid in Platelet poor plasma by Coagulation assay --post heparin neutralization |
| 93478-6 | Busulfan area under the curve panel - Plasma |
| 77727-6 | XXX allergen triggered histamine release [Units/volume] in Blood |
| 62469-2 | HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 63144-0 | Chicory IgG Ab [Mass/volume] in Serum |
| 63273-7 | Liver kidney microsomal 1 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 78847-1 | JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
| 94469-4 | F2 gene.c.20210G>A and c.1691G>A panel - Blood or Tissue by Molecular genetics method |
| 78971-9 | Phosphomannomutase 1 [Enzymatic activity/mass] in Fibroblast |
| 7899-8 | Hantavirus RNA [Presence] in Serum by NAA with probe detection |
| 80352-8 | Environment temperature during transport |
| 97193-7 | Phenytoin [Mass/volume] in Serum or Plasma --peak |
| 97206-7 | Tropheryma whipplei DNA [Presence] in Specimen by NAA with non-probe detection |
| 693-2 | Neisseria gonorrhoeae [Presence] in Vaginal fluid by Organism specific culture |
| 70066-6 | Mononuclear cells/100 leukocytes in Pleural fluid by Automated count |
| 7083-9 | Black Ant triggered histamine release [Units/volume] in Blood |
| 70866-9 | Rabies virus strain identified in Specimen by Immunofluorescence |
| 82743-6 | CD8+CD45RA+ cells [#/volume] in Blood |
| 82898-8 | Pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
| 7178-7 | Caraway IgE Ab [Units/volume] in Serum |
| 72111-8 | Sapovirus RNA [Presence] in Specimen by NAA with probe detection |
| 72368-4 | t(11;14)(q13;q32)(CCND1,IGH) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
| 85968-6 | Streptococcus pneumoniae Danish serotype 1 Ab [Mass/volume] in Serum --2nd specimen |
| 73217-2 | Papaverine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86735-8 | Porcine parvovirus DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 86899-2 | Vedolizumab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
| 87376-0 | Escherichia coli Stx1 toxin stx1 gene [Presence] in Isolate by NAA with probe detection |
| 88375-1 | Tildipirosin [Susceptibility] by Disk diffusion (KB) |
| 74093-6 | Gliquidone [Mass/volume] in Serum or Plasma |
| 74107-4 | Warfarin [Presence] in Specimen by Screen method |
| 74295-7 | Hydroxymethylglutaryl CoA lyase deficiency newborn screen interpretation |
| 88841-2 | Microbiology CNAMTS panel - Synovial fluid |
| 89543-3 | Laboratory ask at order entry panel |
| 41749-3 | CHIC2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 59898-7 | Disopyramide [Moles/volume] in Gastric fluid |
| 3041-1 | Trichloroacetate [Mass/volume] in Urine |
| 59967-0 | quiNINE [Moles/volume] in Gastric fluid |
| 6009-5 | Protein C Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 60263-1 | Enterovirus RNA [Presence] in Isolate by NAA with probe detection |
| 2120-4 | Chylomicrons [Mass/volume] in Serum or Plasma |
| 21387-6 | Methylhippurate [Mass/volume] in Urine |
| 31517-6 | Mycoplasma sp Ab [Units/volume] in Serum |
| 51106-3 | CD1a blasts/100 blasts in Bone marrow |
| 21777-8 | t(11;14)(q13;q32)(CCND1,IGH) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 31695-0 | Varicella zoster virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 31973-1 | Swine vesicular disease virus Ag [Presence] in Specimen |
| 4373-7 | Oxyphenbutazone [Mass] of Dose |
| 22763-7 | Ammonia [Mass/volume] in Plasma |
| 5248-0 | Mucor sp Ab [Units/volume] in Serum |
| 5304-1 | Rickettsia (Proteus OX2) Ab [Presence] in Serum by Latex agglutination |
| 43904-2 | Azinphos-methyl [Presence] in Urine |
| 22857-7 | Babesia sp DNA [Presence] in Tissue by NAA with probe detection |
| 53216-8 | Dicarboxytetradecanoylcarnitine (C14-DC) [Moles/volume] in DBS |
| 53424-8 | Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --6th specimen post XXX challenge |
| 44681-5 | Invasive melanoma.uninvolved margin.closest in Skin melanoma |
| 23456-7 | Taylorella equigenitalis Ag [Presence] in Specimen by Agglutination |
| 33318-7 | Spermatozoa IgM Ab [Presence] in Serum |
| 33459-9 | Toxoplasma gondii IgA Ab [Presence] in Serum |
| 53632-6 | Breast Cancer Ag 225 [Presence] in Tissue by Immune stain |
| 44997-5 | Chlamydia trachomatis Ab [Units/volume] in Serum --2nd specimen |
| 45099-9 | Chlamydia sp identified in Body fluid by Organism specific culture |
| 23905-3 | Mycophenolate [Mass/volume] in Serum or Plasma |
| 46433-9 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post 10 g lactulose PO |
| 46743-1 | Maple syrup urine disease newborn screen interpretation |
| 2470-3 | IgG/Albumin [Mass Ratio] in Cerebral spinal fluid |
| 34502-5 | VHL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55364-4 | CD5+CD19+CD38+ cells/100 cells in Blood |
| 55574-8 | Propoxyphene + Norpropoxyphene [Moles/volume] in Serum or Plasma |
| 47096-3 | Aluminum [Moles/volume] in Red Blood Cells |
| 2512-2 | Keratan sulfate [Mass/volume] in Urine |
| 25470-6 | Mercury [Moles/volume] in Saliva (oral fluid) |
| 3493-4 | clomiPRAMINE+Norclomipramine [Mass/volume] in Serum or Plasma |
| 34940-7 | Babesia microti IgG and IgM panel - Serum |
| 25-7 | Amphotericin B [Susceptibility] by Disk diffusion (KB) |
| 35495-1 | Citrate synthase [Enzymatic activity/mass] in Tissue |
| 48323-0 | TOLAZamide [Presence] in Specimen |
| 26489-5 | Mononuclear cells [#/volume] in Cerebral spinal fluid |
| 26602-3 | Tryptophan [Moles/volume] in Cerebral spinal fluid |
| 3637-6 | fentaNYL [Mass/volume] in Urine |
| 56914-5 | Corticotropin [Mass/volume] in Plasma --evening specimen |
| 5696-0 | Molybdenum [Mass/volume] in Blood |
| 48625-8 | Choriogonadotropin.intact [Presence] in Body fluid |
| 48835-3 | Respiratory allergen panel, US - Arid southwest - Serum |
| 491-1 | Temocillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 49299-1 | Protein Fractions [Interpretation] in Urine by Electrophoresis Narrative |
| 39314-0 | Influenza virus A N4 neutralizing antibody [Presence] in Serum by Neutralization test |
| 57702-3 | Infectious diseases newborn screen interpretation |
| 57783-3 | Dehydroepiandrosterone (DHEA) [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
| 57784-1 | Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
| 58363-3 | Alpha hydroxyalprazolam/Creatinine [Mass Ratio] in Urine |
| 49694-3 | Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial cord blood |
| 4014-7 | quiNIDine [Mass/volume] in Blood |
| 40168-7 | Glucose [Moles/volume] in Serum or Plasma --7.5 hours post XXX challenge |
| 40277-6 | Glucose [Moles/volume] in Serum or Plasma --1 hour post dose lactose PO |
| 58529-9 | Corticotropin [Moles/volume] in Plasma --1.5 hours post dose glucose |
| 58603-2 | Corticotropin [Moles/volume] in Plasma --4 AM specimen |
| 58790-7 | Coxsackievirus B IgM Ab [Titer] in Serum by Immunofluorescence |
| 50076-9 | 17-Ketosteroids [Mass/volume] in Urine --post dose dexamethasone |
| 40337-8 | Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose triple bolus |
| 40633-0 | Hemopexin [Presence] in Serum |
| 40654-6 | Neutrophils.hypogranulated [Presence] in Blood by Light microscopy |
| 40695-9 | Spermatozoa [#/volume] in Semen --post concentration |
| 40696-7 | Spermatozoa Motile [#/volume] in Semen --post concentration |
| 41057-1 | SHOX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19398-7 | chlorproMAZINE cutoff [Mass/volume] in Urine for Confirmatory method |
| 207-1 | Colistin [Susceptibility] by Serum bactericidal titer |
| 20723-3 | Brucella abortus Ab [Presence] in Serum by Rapid agglutination |
| 20922-1 | Organophosphate pesticides [Identifier] in Gastric fluid |
| 100045-4 | Cefozopran [Susceptibility] |
| 100391-2 | Dates IgG Ab [Units/volume] in Serum |
| 100807-7 | Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge |
| 12925-4 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 13127-6 | Cancer Ag DM/70K [Units/volume] in Serum or Plasma |
| 13146-6 | Streptococcus pneumoniae Danish serotype 6B Ab [Units/volume] in Serum --2nd specimen |
| 101746-6 | PCA-Tr Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 102088-2 | Torch Ab.IgG panel - Serum |
| 102305-0 | Meadow Fescue IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13994-9 | Beta globulin/Protein.total in Urine by Electrophoresis |
| 102819-0 | Red Snapper IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14374-3 | Polymorphonuclear cells/100 leukocytes in Pleural fluid by Manual count |
| 103191-3 | Mycobacterium kansasii DNA [Presence] in Wound by NAA with probe detection |
| 10387-9 | Autologous erythrocytes given [Volume] |
| 14865-0 | Parathyrin [Interpretation] in Serum or Plasma |
| 14875-9 | Phenylalanine [Moles/volume] in Serum or Plasma |
| 14974-0 | Mycobacterium sp DNA [Presence] in Specimen by NAA with probe detection |
| 15117-5 | Cadmium [Moles/volume] in Blood |
| 1632-9 | Somatotropin [Mass/volume] in Serum or Plasma --3 hours post 1 g/kg glucose PO |
| 16460-8 | Bicarbonate [Moles/volume] in Cerebral spinal fluid |
| 12285-3 | HLA-DP [Type] |
| 12327-3 | Ketamine [Presence] in Urine |
| 17314-6 | Myelin associated glycoprotein IgM Ab [Units/volume] in Serum by Immunoassay |
| 1767-3 | Aldosterone [Mass/volume] in Serum or Plasma --supine |
| 17808-7 | Tobramycin [Mass/volume] in Urine |
| 18324-4 | Cockatiel serum IgE Ab [Units/volume] in Serum |
| 18397-0 | Polio virus 1 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 90229-6 | Herpes simplex virus 1 and 2 Ab.IgG and IgM panel - Serum or Plasma |
| 91864-9 | Bartonella henselae DNA [Presence] in Aspirate by NAA with probe detection |
| 92767-3 | Listeria sp DNA [Presence] by NAA with probe detection in Positive blood culture |
| 75044-8 | Sepiapterin/Creatinine [Molar ratio] in Urine |
| 76402-7 | Myelocytes [#] in Body fluid by Manual count |
| 92964-6 | Mycoplasma pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
| 77064-4 | TAT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77096-6 | MRPS22 gene full mutation analysis in Blood or Tissue by Sequencing |
| 77164-2 | Karyotype [Identifier] in Products of Conception Nominal |
| 77771-4 | JWH-081 5-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
| 6492-3 | Neisseria meningitidis Ag [Presence] in Specimen by Immunofluorescence |
| 79450-3 | Adenine phosphoribosyltransferase [Enzymatic activity/substance] in Red Blood Cells |
| 95560-9 | Androsterone [Z-score] in 24 hour Urine |
| 95595-5 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Capillary blood |
| 6559-9 | Streptococcus pyogenes Ag [Presence] in Specimen by Immunofluorescence |
| 66131-4 | Norbuprenorphine [Presence] in Serum or Plasma by Confirmatory method |
| 80640-6 | Disopyramide+Nordisopyramide [Mass/volume] in Serum or Plasma |
| 96821-4 | Propylparaben IgE Ab [Units/volume] in Serum |
| 6909-6 | Mucin clot [Appearance] in Synovial fluid Qualitative |
| 6928-6 | Rheumatoid factor [Units/volume] in Serum by Immunoassay |
| 8176-0 | Cannabinoids [Mass/volume] in Unknown substance |
| 8198-4 | Copper [Mass/mass] in Tissue |
| 70154-0 | Hepatitis B virus surface Ag in Serum or Plasma by Confirmatory method |
| 82881-4 | Etiocholanolone/Androsterone [Molar ratio] in Urine |
| 7167-0 | Butterfly IgE Ab [Units/volume] in Serum |
| 71805-6 | Cortisol Free/Cortisone free [Molar ratio] in Urine |
| 72418-7 | Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Blood --pre-meal |
| 85101-4 | BRAF gene p.Val600Glu [Presence] in Bone marrow by Molecular genetics method |
| 72678-6 | Venlafaxine+O-desmethylvenlafaxine [Mass/volume] in Serum or Plasma --trough |
| 85930-6 | Date specimen sent to CDC |
| 86510-5 | Adenovirus DNA [Presence] in Tissue by NAA with probe detection |
| 87618-5 | Cyanide [Mass/mass] in Specimen |
| 87977-5 | Fungus identified in Pericardial fluid by Culture |
| 88885-9 | Delafloxacin [Susceptibility] |
| 4124-4 | Diethylpropion [Mass] of Dose |
| 50716-0 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 3065-0 | Trypsinogen [Presence] in Serum or Plasma |
| 6003-8 | Platelet factor 4 Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
| 31310-6 | Cockatiel droppings Ab [Presence] in Serum |
| 3156-7 | Volume of Amniotic fluid |
| 42914-2 | HER2 [Mass/volume] in Serum by Immunoassay |
| 43201-3 | BK virus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
| 21782-8 | t(12;21)(p13;q22.3)(ETV6,RUNX1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 31845-1 | Hepatitis B virus e Ag [Units/volume] in Serum |
| 31931-9 | Plasmodium vivax Ag [Units/volume] in Blood |
| 43443-1 | Bacterial Ag panel - Urine |
| 43816-8 | Amylase [Presence] in Body fluid |
| 5208-4 | Herpes simplex virus 2 Ab [Units/volume] in Serum by Immunoassay |
| 22989-8 | Capripox virus Ag [Presence] in Specimen by Immunofluorescence |
| 53144-2 | Somatotropin [Mass/volume] in Serum or Plasma --75 minutes post XXX challenge |
| 53250-7 | Influenza virus A RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 44569-2 | Influenza virus B Ab [Presence] in Body fluid |
| 23367-6 | PRRSV Ab [Presence] in Serum by Complement fixation |
| 53886-8 | Parvovirus B19 IgM Ab [Units/volume] in Body fluid |
| 45105-4 | Chlamydia sp Ag [Presence] in Anal |
| 24033-3 | Bordetella pertussis filamentous hemagglutinin IgG Ab [Units/volume] in Serum by Immunoassay |
| 24325-3 | Hepatic function 2000 panel - Serum or Plasma |
| 34459-8 | Saint Louis encephalitis virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 55558-1 | Nicotine [Moles/volume] in Serum or Plasma by Screen method |
| 4721-7 | HLA-A24(9) [Presence] in Donor |
| 47400-7 | Cocaine+Benzoylecgonine [Presence] in Urine by Confirmatory method |
| 34886-2 | Rabbit hemorrhagic disease virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 35071-0 | Basophils [#/volume] in Body fluid |
| 47717-4 | Parathyrin [Mass/volume] in Serum or Plasma --2 hours post dose calcium |
| 35665-9 | Acetone [Mass/volume] in Urine collected for unspecified duration |
| 56239-7 | Curry IgG4 Ab [Mass/volume] in Serum |
| 56499-7 | Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 48047-5 | Hemoglobin.gastrointestinal [Presence] in Vomitus |
| 3600-4 | Etafedrine [Mass/volume] in Urine |
| 56692-7 | Insulin [Mass/volume] in Serum or Plasma --1 day post XXX challenge |
| 4879-3 | HLA-Dw15 [Presence] |
| 27009-0 | Coccidioides sp IgG Ab [Units/volume] in Serum |
| 38565-8 | Spermatozoa.tail Tip Motile w IgM/100 spermatozoa in Semen by Immunobead |
| 57353-5 | Insulin [Units/volume] in Serum or Plasma --5 minutes post XXX challenge |
| 49131-6 | Chylomicrons/total Lipoprotein in Serum or Plasma |
| 38716-7 | Phosphine [Mass/volume] in Air |
| 39470-0 | Prochlorperazine [Moles/volume] in Serum or Plasma |
| 57959-9 | Drostanolone [Presence] in Urine |
| 49523-4 | Influenza virus A H3 RNA [Presence] in Isolate by NAA with probe detection |
| 2852-2 | Prostaglandin E1 [Mass/volume] in Serum or Plasma |
| 40056-4 | Albumin [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
| 4024-6 | Salicylates [Mass/volume] in Serum or Plasma |
| 58618-0 | Corticotropin [Moles/volume] in Plasma --post dose dexamethasone |
| 29697-0 | Leptospira interrogans sv Djasiman Ab [Presence] in Serum |
| 29802-6 | La Crosse virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 30202-6 | Brucella sp Ab [Presence] in Serum |
| 40817-9 | Tetrachlorodiphenylethane [Presence] in Serum or Plasma |
| 41039-9 | 3-Methylcrotonylglycine [Moles/volume] in Serum or Plasma |
| 1985-1 | Bromide [Mass/volume] in Urine |
| 20521-1 | Carboxy tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method |
| 21019-5 | Metanephrine [Mass/volume] in 24 hour Urine |
| 21044-3 | 5-Alpha tetrahydrocortisol [Mass/time] in 24 hour Urine |
| 100147-8 | Toxoplasma gondii Ab bands panel - Serum by Immunoblot |
| 101838-1 | Fluticasone propionate [Moles/volume] in Serum or Plasma |
| 101923-1 | Ravulizumab Monitoring Panel |
| 102195-5 | Budgerigar feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13641-6 | Codeine [Presence] in Urine by SAMHSA confirm method |
| 102254-0 | Cotton western IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102288-8 | Egg yolk IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14074-9 | Spironolactone [Mass/volume] in Serum or Plasma |
| 14780-1 | Hexacarboxylate [Moles/volume] in Stool |
| 14968-2 | CD5 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 15210-8 | Thyroglobulin Ab [Presence] in Serum |
| 10447-1 | M-5 Ag [Presence] in Tissue by Immune stain |
| 1527-1 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 75 g glucose PO |
| 16185-1 | chlordiazePOXIDE [Mass/volume] in Stool |
| 11078-3 | HIV 2 gp80 Ab [Presence] in Serum by Immunoblot |
| 16304-8 | 2-Hexanol/Creatinine [Mass Ratio] in Urine |
| 16469-9 | Bismuth/Creatinine [Mass Ratio] in Urine |
| 1229-4 | M Ag [Presence] on Red Blood Cells from Blood product unit |
| 17772-5 | Dimethylbenzene [Mass/volume] in Urine |
| 18314-5 | Morphology [Interpretation] in Blood Narrative |
| 18867-2 | Azlocillin [Susceptibility] |
| 18934-0 | Isoniazid [Susceptibility] |
| 92754-1 | Globotriaosylsphingosine [Moles/volume] in DBS |
| 75154-5 | Inosine [Moles/volume] in Cerebral spinal fluid |
| 60370-4 | Crab IgG Ab [Mass/volume] in Serum |
| 6200-0 | Pellitory (Parietaria officinalis) IgE Ab [Units/volume] in Serum |
| 7714-9 | Summer Squash IgE Ab [Units/volume] in Serum |
| 77360-6 | Triglyceride [Mass/mass] in 24 hour Stool |
| 63128-3 | Bayleaf IgG Ab [Mass/volume] in Serum |
| 63130-9 | Dates IgG Ab [Mass/volume] in Serum |
| 7848-5 | Taenia solium larva IgM Ab [Presence] in Cerebral spinal fluid |
| 94455-3 | Arsenobetaine [Mass/volume] in Urine |
| 63557-3 | Hepatitis B virus surface Ag [Units/volume] in Serum or Plasma by Immunoassay |
| 63559-9 | Signal Recognition Particle (SRP) Ab [Presence] in Serum or Plasma by Immunoblot |
| 64800-6 | Oxygen content in Arterial cord blood by calculation |
| 78960-2 | Aldosterone and renin concentration panel - Plasma |
| 79684-7 | Cytidine/Creatinine [Molar ratio] in Urine |
| 95764-7 | Candida auris DNA [Presence] in Urine by NAA with non-probe detection |
| 95957-7 | Rooibos IgE Ab [Units/volume] in Serum |
| 8053-1 | Western equine encephalitis virus IgM Ab [Units/volume] in Serum |
| 80539-0 | Morphine [Mass/mass] in Hair |
| 69792-0 | Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Cerebral spinal fluid |
| 97320-6 | Escherichia coli O157 DNA [Presence] in Stool by NAA with probe detection |
| 97945-0 | Color.mold colony [Type] in Isolate by Culture |
| 71597-9 | Lymphocytes/Leukocytes [Pure number fraction] in Bronchial specimen by Manual count |
| 82384-9 | Dengue virus 1+3 RNA [Presence] in Serum by NAA with probe detection |
| 82413-6 | Ganglioside GT1a IgM Ab [Presence] in Serum by Line blot |
| 82734-5 | AMPAR1 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 71893-2 | Cortisone [Moles/volume] in Saliva (oral fluid) --PM trough specimen |
| 85318-4 | ERBB2 gene duplication [Presence] in Breast cancer specimen by FISH |
| 72616-6 | Benzodiazepines [Presence] in Saliva (oral fluid) |
| 86228-4 | Ethyl sulfate [Presence] in Saliva (oral fluid) |
| 41478-9 | Bartonella henselae IgG and IgM panel - Serum |
| 50617-0 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --6 hours post XXX challenge |
| 50998-4 | CFTR gene mutations tested for [#] in Blood or Tissue by Molecular genetics method |
| 60175-7 | Sulfamethizole [Mass/volume] in Blood |
| 21278-7 | Follitropin [Units/volume] in Serum or Plasma --45 minutes post dose gonadotropin releasing hormone |
| 2149-3 | Creatine [Mass/volume] in Urine |
| 42977-9 | Porcine influenza virus A Ab [Titer] in Serum |
| 3186-4 | Coagulation factor IX activated [Units/volume] in Platelet poor plasma by Coagulation assay |
| 3190-6 | Coagulation factor IX Ag actual/normal in Platelet poor plasma by Immunoassay |
| 22349-5 | Histoplasma capsulatum IgA Ab [Units/volume] in Serum |
| 22387-5 | Legionella pneumophila 4 IgG Ab [Titer] in Serum |
| 32551-4 | Protein [Mass] in Urine collected for unspecified duration |
| 53057-6 | Decenoylcarnitine (C10:1) [Moles/volume] in Amniotic fluid |
| 4387-7 | Phenacetin [Mass] of Dose |
| 23009-4 | Cowdria ruminantium [Presence] in Brain by Giemsa stain |
| 32649-6 | Hydroxytriazolam [Mass/volume] in Serum or Plasma |
| 2327-5 | Gastrin releasing polypeptide [Mass/volume] in Cerebral spinal fluid |
| 23287-6 | Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Immunoassay |
| 23464-1 | Theileria equi Ab [Presence] in Serum by Immunoassay |
| 33549-7 | Hantavirus sin nombre Ab [Presence] in Serum |
| 53760-5 | Cladosporium sp IgE Ab [Units/volume] in Serum |
| 53804-1 | Arbovirus IgG panel - Serum by Immunofluorescence |
| 53955-1 | Escherichia coli O157 identified in Isolate by Organism specific culture |
| 45270-6 | Acute leukemia panel - Specimen by Flow cytometry (FC) |
| 45273-0 | Pregnancy associated plasma protein A multiple of the median [Percentile] |
| 34054-7 | Thyrotropin [Units/volume] in Serum or Plasma --pre or post dose TRH |
| 45379-5 | Eosinophils [Presence] in Stool by Light microscopy |
| 46181-4 | Coccidioides sp IgA Ab [Presence] in Serum |
| 24259-4 | Coxsackievirus B3 Ab [Titer] in Serum --1st specimen |
| 34338-4 | Mercury [Moles/volume] in Urine |
| 4717-5 | HLA-A1 [Presence] in Donor |
| 25365-8 | Carnosine [Moles/time] in 24 hour Urine |
| 35290-6 | RPS6KA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55715-7 | Spiramycin [Susceptibility] by Gradient strip |
| 35396-1 | Enterovirus RNA [Presence] in Tissue by NAA with probe detection |
| 56505-1 | Corticotropin [Mass/volume] in Plasma --45 minutes post XXX challenge |
| 26046-3 | 5-Hydroxypropafenone [Moles/volume] in Serum or Plasma |
| 35864-8 | Chronic lymphocytic leukemia gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 56966-5 | Phosphoethanolamine/Creatinine [Ratio] in 24 hour Urine |
| 38310-9 | Beryllium [Mass/volume] in Water |
| 38337-2 | Hexachlorocyclopentadiene [Mass/volume] in Water |
| 38602-9 | Hydrazine [Mass/volume] in Air |
| 2763-1 | Phenylalanine [Mass/volume] in Cerebral spinal fluid |
| 38755-5 | Dimethylbenzene [Mass/volume] in Air |
| 3916-4 | Pentazocine [Mass/volume] in Serum or Plasma |
| 39608-5 | Spermatozoa Immotile [#/area] in Semen by Microscopy high power field |
| 57867-4 | Pericyazine [Moles/volume] in Specimen |
| 28590-8 | Alpha aminobutyrate/Creatinine [Ratio] in Urine |
| 40107-5 | aPTT in Platelet poor plasma by Coagulation assay --6 hours post XXX challenge |
| 58497-9 | C peptide [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge |
| 58794-9 | 5-Hydroxytryptophan [Mass/volume] in 24 hour Urine |
| 49794-1 | t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points [Presence] in Bone marrow by Molecular genetics method |
| 49890-7 | HIV 1 RNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
| 29834-9 | Trivittatus virus Ab [Titer] in Cerebral spinal fluid |
| 40678-5 | Toxoplasma gondii IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 29985-9 | Barium [Mass/volume] in 24 hour Urine |
| 19159-3 | Urinalysis specimen collection method |
| 19605-5 | Nalbuphine [Presence] in Urine by Screen method |
| 19638-6 | Oxazepam [Presence] in Urine by Screen method |
| 20560-9 | Thioridazine [Mass/volume] in Urine by Confirmatory method |
| 20833-0 | Haemophilus paragallinarum serotype [Identifier] in Isolate |
| 12431-3 | Norfenfluramine [Mass/volume] in Serum or Plasma |
| 100113-0 | Helicobacter pylori Ab panel - Serum |
| 100114-8 | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot |
| 100835-8 | Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 101060-2 | An^a Ab [Presence] in Serum or Plasma |
| 12605-2 | Flurazepam [Presence] in Stool |
| 101342-4 | JC virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 101528-8 | Mycoplasma sp DNA [Identifier] in Isolate by Sequencing |
| 13420-5 | EPINEPHrine [Mass/volume] in Plasma --2nd specimen post XXX challenge |
| 101682-3 | T-cell lymphoma in Blood or Tissue Document by FISH |
| 14041-8 | Choriogonadotropin.beta subunit [Units/volume] in Cerebral spinal fluid |
| 14112-7 | CD25+CD19+ cells/100 cells in Blood |
| 102694-7 | Beta lactoglobulin IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10612-0 | Spermatozoa Large Oval Head/100 spermatozoa in Semen |
| 16155-4 | Gastrin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 10718-5 | Strongyloides sp Ab [Units/volume] in Serum by Immunoassay |
| 10744-1 | Amyloid.microscopic observation [Identifier] in Tissue by Vassar-culling stain |
| 16623-1 | Clofazimine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 16712-2 | Cytomegalovirus Ab [Units/volume] in Body fluid |
| 17896-2 | Bacteria # 5 identified in Sputum by Aerobe culture |
| 18385-5 | Butalbital [Presence] in Urine by Confirmatory method |
| 18962-1 | Oxytetracycline [Susceptibility] |
| 90239-5 | ST2.soluble [Mass/volume] in Serum by Immunoassay |
| 90846-7 | PCA-Tr Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 75017-4 | t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method |
| 92667-5 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose cloNIDine |
| 75066-1 | Pantothenate [Moles/volume] in Serum or Plasma |
| 75212-1 | Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS |
| 76137-9 | Platelet component distribution width [Mass/volume] in Blood by calculation |
| 61204-4 | Grass Allergen Mix 2 (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass+Bahia grass) IgE Ab/IgE total in Serum by Multidisk |
| 93951-2 | Rh antigens and K Ag panel - Blood |
| 77955-3 | Yellow fever virus IgM Ab [Presence] in Serum by Immunofluorescence |
| 78769-7 | HYDROcodone [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine |
| 9474-8 | Hexachlorobenzene [Mass/volume] in Serum or Plasma |
| 63547-4 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid |
| 78866-1 | Norbuprenorphine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 95671-4 | Sindbis virus IgG Ab [Presence] in Specimen by Immunoassay |
| 66449-0 | Annual mercury recombinant (rMer a) 1 IgE Ab [Units/volume] in Serum |
| 79519-5 | Pimelate [Moles/volume] in Serum or Plasma |
| 96293-6 | Sodium nitrite IgE Ab [Units/volume] in Serum |
| 6831-2 | Green Bean IgE Ab [Units/volume] in Serum |
| 97318-0 | Escherichia coli enteropathogenic DNA [Presence] in Stool by NAA with probe detection |
| 99018-4 | Enterococcus faecium DNA [Presence] in Urine by NAA with probe detection |
| 72768-5 | Zolpidem phenyl-4-carboxylate [Mass/volume] in Urine by Confirmatory method |
| 72888-1 | 3-epi-25-Hydroxyvitamin D3/25-hydroxyvitamin D.total in Serum or Plasma |
| 86240-9 | Aquaporin 4 water channel IgG Ab [Titer] in Cerebral spinal fluid by Flow cytometry (FC) |
| 86514-7 | Chikungunya virus RNA [Presence] in Amniotic fluid by NAA with probe detection |
| 87612-8 | Brodifacoum [Mass/mass] in Specimen |
| 7343-7 | Goldenrod triggered histamine release [Units/volume] in Blood |
| 7396-5 | Helminthosporium sp IgG Ab [Units/volume] in Serum |
| 7434-4 | Pinchot Juniper IgE Ab [Units/volume] in Serum |
| 41281-7 | Burr cells [#/volume] in Cerebral spinal fluid by Manual count |
| 59589-2 | 1-Hydroxymidazolam [Mass/volume] in Urine |
| 59760-9 | Triazolam [Mass/volume] in Body fluid |
| 30549-0 | Potassium [Moles/volume] in Total parental nutrition |
| 31009-4 | Food Allergen Mix 25A (Onion+Garlic+Sesame seed+Yeast) IgE Ab [Presence] in Serum by Multidisk |
| 42671-8 | Serotonin [Entitic mass] in Platelets |
| 60000-7 | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 60296-1 | cloBAZam [Moles/volume] in Specimen |
| 21554-1 | Terbufos [Mass/volume] in Urine |
| 31580-4 | Purkinje cells IgG Ab [Units/volume] in Serum |
| 51219-4 | CD10+CD19+ cells/100 cells in Body fluid |
| 51262-4 | CD16B cells/100 cells in Bone marrow |
| 51364-8 | CD64 cells/100 cells in Cerebral spinal fluid |
| 43269-0 | Ceftobiprole [Susceptibility] by Disk diffusion (KB) |
| 43338-3 | Infectious bronchitis virus JMK Ab [Titer] in Serum by Hemagglutination inhibition |
| 43360-7 | Bordetella sp Ag [Presence] in Specimen by Immunofluorescence |
| 22539-1 | Shigella flexneri Ab [Titer] in Serum |
| 22701-7 | Salicylates [Moles/volume] in Urine |
| 22756-1 | HLA-DR [Units/volume] in Cerebral spinal fluid |
| 32210-7 | Protein Fractions [Interpretation] in 24 hour Urine by Electrophoresis |
| 51953-8 | Collection date of Blood |
| 33329-4 | West Nile virus IgG Ab [Titer] in Serum |
| 33344-3 | Leukotriene E4 [Mass/volume] in Urine |
| 33627-1 | Tenofovir [Susceptibility] |
| 33658-6 | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 33708-9 | Clostridium botulinum toxin [Presence] in Specimen |
| 5382-7 | Thyroperoxidase Ab [Units/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
| 53912-2 | Microscopic observation [Identifier] in Body fluid by Rhodamine-auramine fluorochrome stain |
| 4504-7 | Complement C4d [Entitic number] in Red Blood Cells |
| 45329-0 | Glutathione reductase [Enzymatic activity/volume] in Serum |
| 24072-1 | Beta-N-acetylhexosaminidase.B [Enzymatic activity/mass] in Fibroblast |
| 53984-1 | Fine speckled nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
| 54191-2 | Cefotaxime+Sulbactam [Susceptibility] |
| 24176-0 | Adenovirus Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24323-8 | Comprehensive metabolic 2000 panel - Serum or Plasma |
| 24397-2 | Brucella sp IgM Ab [Presence] in Serum |
| 24428-5 | Mycoplasma hyopneumoniae Ab [Presence] in Serum by Immunoassay |
| 24470-7 | Hemoglobin A2+XXX/Hemoglobin.total in Blood by Electrophoresis |
| 34324-4 | Lactate [Moles/volume] in Urine |
| 34528-0 | PT panel - Platelet poor plasma by Coagulation assay |
| 34556-1 | Cell count panel - Body fluid |
| 34675-9 | Mitochondria Genes targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 54902-2 | IgM [Mass/volume] in Peritoneal fluid |
| 55573-0 | Promethazine [Moles/volume] in Serum or Plasma |
| 47290-2 | IgG subclass panel [Mass/volume] - Serum |
| 47359-5 | HIV 1 RNA [Presence] in Serum or Plasma from Donor by Probe with amplification |
| 56181-1 | Aspergillus niger IgG4 Ab [Mass/volume] in Serum |
| 26521-5 | Polymorphonuclear cells/100 leukocytes in Semen |
| 3775-4 | Methadone [Mass/time] in 24 hour Urine |
| 3813-3 | Methyprylon [Presence] in Urine |
| 56951-7 | Leishmania sp IgG Ab [Presence] in Serum by Immunofluorescence |
| 57009-3 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 483-8 | Teicoplanin [Susceptibility] by Minimum lethal concentration (MLC) |
| 2702-9 | Oxalate renal clearance in 24 hour Urine and Serum or Plasma |
| 38275-4 | Transmissible spongiform encephalopathy [Presence] in Brain by Light microscopy |
| 57463-2 | Cortisol [Mass/volume] in Serum or Plasma --12th specimen |
| 57684-3 | Cortisol [Mass/volume] in Saliva (oral fluid) --11th specimen |
| 3881-0 | Ouabain [Mass/volume] in Serum or Plasma |
| 3897-6 | Oxymetholone [Presence] in Urine |
| 39307-4 | Influenza virus A H6 Ab [Titer] in Serum by Hemagglutination inhibition |
| 39320-7 | Abnormal Prion Protein [Presence] in Tissue by Immunoblot |
| 28658-3 | Plasmin inhibitor actual/normal in Platelet poor plasma by Immunoassay |
| 2930-6 | Sarcosine [Presence] in Serum or Plasma |
| 58410-2 | CBC panel - Blood by Automated count |
| 5842-0 | Enterovirus identified in Stool by Organism specific culture |
| 58455-7 | Taenia solium Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 58617-2 | Corticotropin [Moles/volume] in Plasma --8th specimen post XXX challenge |
| 49785-9 | Onchocerca sp IgG2 Ab [Units/volume] in Serum by Immunoassay |
| 49849-3 | Hydroxylysine.free/Creatinine [Molar ratio] in 24 hour Urine |
| 49878-2 | Hepatitis B virus codon 180 [Identifier] by Genotype method |
| 49881-6 | Hepatitis B virus codon 236 [Identifier] by Genotype method |
| 50282-3 | 3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Amniotic fluid |
| 30327-1 | Decanoylcarnitine (C10) [Moles/volume] in Serum or Plasma |
| 40840-1 | Legionella pneumophila 1 Ab [Presence] in Serum |
| 19172-6 | Alpha-1-Fetoprotein [Units/volume] in Pleural fluid |
| 19751-7 | Mouse epithelium, serum proteins + urine proteins IgE Ab [Units/volume] in Serum |
| 20975-9 | Thallium [Mass/mass] in Tissue |
| 20987-4 | Yersinia sp identified in Dairy product by Organism specific culture |
| 12362-0 | Oxazepam [Presence] in Serum or Plasma |
| 100158-5 | Microalbumin [Mass/volume] in Urine collected for unspecified duration |
| 1006-6 | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells |
| 101116-2 | THSD7A Ag [Presence] in Tissue by Immunofluorescence |
| 101777-1 | Nannizzia incurvata DNA [Presence] in Specimen by NAA with probe detection |
| 101920-7 | Chronic lymphocytic leukemia gene targeted rearrangements in Blood or Marrow by FISH |
| 13661-4 | Ganglioside GD1b IgM Ab [Titer] in Serum |
| 102367-0 | Herring IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102431-4 | Marjoram IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14052-5 | Formate [Mass/volume] in Urine |
| 102757-2 | Karaya gum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103713-4 | Cell growth [Presence] of Chorionic villus sample Qualitative by Tissue culture |
| 11114-6 | Myelocytes/100 cells in Bone marrow by Manual count |
| 17388-0 | Organochlorine pesticides [Type] in Urine |
| 75573-6 | Comment on fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 61200-2 | Colorado tick fever virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 7686-9 | Saltbush IgE Ab [Units/volume] in Serum |
| 62369-4 | FISH probe name panel - Laboratory device |
| 9387-2 | Procyclidine [Mass/volume] in Serum or Plasma |
| 78204-5 | CCND1 gene duplication [Presence] in Blood or Tissue by FISH |
| 94305-0 | OxyMORphone and Noroxymorphone panel - Urine by Confirmatory method |
| 94426-4 | Dengue virus 1+2+3+4 3' UTR RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 6508-6 | Neisseria meningitidis Ag [Presence] in Cerebral spinal fluid |
| 65328-7 | LW sup(a) Ab [Presence] in Serum or Plasma |
| 79628-4 | Formiminoglutamate [Moles/volume] in Serum or Plasma |
| 80196-9 | Ecgonine methyl ester [Presence] in Blood by Screen method |
| 95824-9 | SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Saliva (oral fluid) by NAA with probe detection |
| 69038-8 | Lymphocyte proliferation.phytohemagglutinin.maximum/CD45 in Blood by Flow cytometry (FC) |
| 80710-7 | CD27-IgD+ cells/100 CD19+CD20+ cells in Blood |
| 97866-8 | Chikungunya virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 7084-7 | Fire Ant IgG Ab [Units/volume] in Serum |
| 82314-6 | Specimen sent to CDC |
| 8248-7 | Spermatozoa [Presence] in Urine sediment by Light microscopy |
| 98195-1 | Diatrizoate IgE Ab [Units/volume] in Serum |
| 83102-4 | IgE [Units/volume] in Serum or Plasma by Immunoassay |
| 85426-5 | Meropenem [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC) |
| 85976-9 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum by Immunoassay |
| 86066-8 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum --1st specimen |
| 73255-2 | Moxifloxacin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86720-0 | Actinobacillus pleuropneumoniae serotype 7 Ab [Titer] in Serum by Complement fixation |
| 86727-5 | Erysipelothrix sp strain 2 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73425-1 | Amphetamine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73646-2 | Danofloxacin [Susceptibility] by Disk diffusion (KB) |
| 88113-6 | Erythrocytes [Presence] in Cerebral spinal fluid by Gram stain |
| 74007-6 | CYP3A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 74278-3 | Mycobacterium tuberculosis stimulated gamma interferon ESAT-6 Ag spot count [#] in Blood |
| 50874-7 | Manganese [Moles/mass] in Hair |
| 30928-6 | Silver [Mass/volume] in Urine collected for unspecified duration |
| 30984-9 | Silver Birch recombinant (rBet v) 1 IgE Ab [Units/volume] in Serum |
| 3111-2 | Uroporphyrin 1 isomer [Mass/volume] in Red Blood Cells |
| 60132-8 | Parathion [Mass/volume] in Blood |
| 43742-6 | Time next dose |
| 22780-1 | African swine fever virus Ab [Presence] in Serum by Immunoassay |
| 32280-0 | Acylglycines [Presence] in Urine |
| 32301-4 | Beta-2-Microglobulin [Moles/volume] in Cerebral spinal fluid |
| 32355-0 | Bacteria identified in Specimen by Respiratory culture |
| 53014-7 | Nucleosome Ab [Units/volume] in Serum |
| 5302-5 | Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
| 43944-8 | CD4+CD45+ cells/100 cells in Bone marrow |
| 44013-1 | Metanephrine and Normetanephrine [Interpretation] in Urine |
| 22871-8 | Bluetongue virus Ag [Presence] in Specimen by Neutralization test |
| 23208-2 | Leptospira borgpetersenii sv Tarrasovi Ab [Presence] in Serum |
| 32682-7 | Hemoglobin F/Hemoglobin.total in Blood by Electrophoresis |
| 53384-4 | Powassan virus Ab [Presence] in Specimen |
| 44568-4 | Influenza virus B Ab [Presence] in Serum by Complement fixation |
| 53643-3 | Dichlorodiphenyltrichloroethane [Presence] in Gastric fluid |
| 46185-5 | Ehrlichia risticii Ab [Titer] in Serum |
| 34596-7 | 3-O-Methyldopa [Moles/volume] in Cerebral spinal fluid |
| 34649-4 | MERRF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 34708-8 | Chlamydia sp DNA [Presence] in Urine by NAA with probe detection |
| 472-1 | sulfiSOXAZOLE [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 47408-0 | Fosphenytoin [Mass/volume] in Serum or Plasma |
| 34884-7 | Haemophilus paragallinarum Ab [Units/volume] in Serum by Immunoassay |
| 35302-9 | HYAL1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 35787-1 | DAPTOmycin [Susceptibility] by Disk diffusion (KB) |
| 35788-9 | DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 47941-0 | Testosterone [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin |
| 26572-8 | CD2+CD7+ cells/100 cells in Blood |
| 26588-4 | Anserine [Moles/volume] in Cerebral spinal fluid |
| 2671-6 | Normetanephrine [Mass/time] in 24 hour Urine |
| 3730-9 | Lysergate diethylamide [Presence] in Serum or Plasma |
| 56988-9 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 56991-3 | Toxoplasma gondii IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay |
| 56994-7 | Tyrosine/Creatinine [Ratio] in 24 hour Urine |
| 26817-7 | Glucose [Mass/volume] in Serum or Plasma --11 hour post XXX challenge |
| 27022-3 | Para aminophenol/Creatinine [Mass Ratio] in Urine |
| 38573-2 | Acrylamide [Mass/volume] in Air |
| 49142-3 | La Crosse virus IgG and IgM [Interpretation] in Serum |
| 49151-4 | Rickettsia parkeri IgG Ab [Titer] in Serum |
| 27931-5 | Bile acid [Moles/volume] in Serum --2 hours post meal |
| 57927-6 | CDKN2A+CDK4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 58025-8 | Cultivated Rye IgE Ab/IgE total in Serum |
| 58075-3 | Yk sup(a) Ag [Presence] on Red Blood Cells |
| 2890-2 | Protein/Creatinine [Mass Ratio] in Urine |
| 50462-1 | C peptide [Moles/volume] in Serum or Plasma --2nd specimen |
| 30043-4 | Rosemary IgE Ab [Units/volume] in Serum |
| 40774-2 | Histoplasma capsulatum IgG Ab [Titer] in Cerebral spinal fluid --2nd specimen |
| 20444-6 | Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection |
| 21030-2 | Reagin Ab [Presence] in Serum from Donor by VDRL |
| 100678-2 | Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 12621-9 | Glucose [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 13188-8 | Mugwort IgG Ab [Units/volume] in Serum |
| 13250-6 | Herpes virus 6 IgG+IgM Ab [Units/volume] in Serum |
| 1342-5 | Yt sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 102018-9 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose glucagon |
| 102366-2 | Water Hemp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102457-9 | Mushroom IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14282-8 | Acylcarnitine [Moles/volume] in Serum or Plasma |
| 14409-7 | Aspartate aminotransferase [Enzymatic activity/volume] in Pleural fluid |
| 14487-3 | Mycoplasma sp and Ureaplasma sp [Identifier] in Urethra by Organism specific culture |
| 103157-4 | CD3 cells [#/volume] in Blood from Donor |
| 103625-0 | Mycobacterium marinum DNA [Presence] in Specimen by NAA with probe detection |
| 104424-7 | Leptospira sp IgM Ab [Titer] in Serum by Immunoassay --1st specimen |
| 10726-8 | Toxoplasma gondii [Presence] in Tissue by Giemsa stain |
| 10793-8 | Microscopic observation [Identifier] in Tissue by Methyl green stain |
| 10902-5 | HIV 2 gp36 Ab [Presence] in Serum by Immunoblot |
| 1097-5 | Kp sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 16378-2 | Androstenedione [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 11172-4 | Ferret epithelium IgE Ab [Units/volume] in Serum |
| 16912-8 | Glucose [Presence] in Urine --9th specimen post XXX challenge |
| 17048-0 | Latex glove extract IgE Ab [Units/volume] in Blood |
| 17156-1 | CD44R cells/100 cells in Blood |
| 17521-6 | Reticulin Ab [Presence] in Serum |
| 18192-5 | Bacteria [Presence] in Nose by Light microscopy |
| 18369-9 | Magnesium [Moles/time] in 4 hour Urine |
| 7456-7 | Lemon triggered histamine release [Units/volume] in Blood |
| 91676-7 | Giardia lamblia Ag [Presence] in Stool by Rapid immunoassay |
| 92698-0 | Gardnerella vaginalis DNA [Presence] in Vaginal fluid by Probe |
| 6035-0 | Banana IgE Ab [Units/volume] in Serum |
| 76631-1 | Albumin [Mass/volume] in Blood by Bromocresol purple (BCP) dye binding method |
| 92858-0 | Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 93452-1 | W-19 [Mass/volume] in Urine by Confirmatory method |
| 93492-7 | AMPAR2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 94112-0 | 7-Aminoclonazepam [Presence] in Urine by Screen method |
| 62859-4 | Rotavirus RNA [Presence] in Specimen by NAA with probe detection |
| 63111-9 | Herring IgG Ab [Mass/volume] in Serum |
| 78208-6 | BCL6 gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 94745-7 | SARS-CoV-2 (COVID-19) RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection |
| 64081-3 | FMRP cells/100 lymphocytes in Blood by Immune stain |
| 79245-7 | Triazolam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 956-3 | C sup(w) Ab [Presence] in Serum or Plasma from Donor |
| 65782-5 | Common ragweed native (nAmb a) 1 IgE Ab [Units/volume] in Serum |
| 66444-1 | Cockroach recombinant (rBla g) 4 IgE Ab [Units/volume] in Serum |
| 95920-5 | Galantamine [Mass/volume] in Serum, Plasma or Blood |
| 6846-0 | Latex glove extract buffered IgE Ab [Units/volume] in Serum |
| 80689-3 | HIV 1 RNA reverse transcriptase and protease and integrase gene mutations detected [Identifier] in Plasma by Sequencing |
| 69410-9 | Haemophilus influenzae [Identifier] in Specimen by Organism specific culture |
| 81819-5 | CLN5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 82182-7 | Escherichia coli K1 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
| 70169-8 | Hematocrit [Volume Fraction] of Pleural fluid |
| 7028-4 | Amdinocillin [Susceptibility] by Gradient strip |
| 72438-5 | 3-Methylglutarate [Moles/volume] in Cerebral spinal fluid |
| 99472-3 | Cockroach IgG Ab [Mass/volume] in Serum |
| 7254-6 | Black Cottonwood IgE Ab [Units/volume] in Serum |
| 73214-9 | PARoxetine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73338-6 | hydrOXYzine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88301-7 | Kappa light chains.free [Presence] in 24 hour Urine by Immunofixation |
| 74082-9 | Urea [Moles/time] in 12 hour Urine |
| 89328-9 | CD3+CD4+CD27-CD45RO+CD62L- cells [#/volume] in Blood |
| 896-1 | Blood group antibody screen [Presence] in Serum or Plasma by Cold absorption |
| 30537-5 | Myocardium Ab [Presence] in Serum |
| 30929-4 | Thallium [Mass/volume] in Urine collected for unspecified duration |
| 60096-5 | Loperamide [Mass/volume] in Urine |
| 2133-7 | Collagenase [Enzymatic activity/volume] in Serum |
| 21551-7 | t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 31339-5 | Dengue virus 2 Ab [Units/volume] in Serum |
| 21749-7 | Lambda LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 22107-7 | Babesia sp IgG Ab [Titer] in Serum |
| 2221-0 | Elastase.pancreatic [Enzymatic activity/volume] in Serum |
| 51814-2 | Legionella pneumophila IgM Ab [Units/volume] in Serum by Immunoassay |
| 43635-2 | 2-Hydroxyglutarate [Presence] in 24 hour Urine |
| 22327-1 | Hepatitis C virus Ab [Units/volume] in Serum |
| 22340-4 | Herpes simplex virus Ab [Titer] in Cerebral spinal fluid |
| 22660-5 | Homocystine [Moles/volume] in Cerebral spinal fluid |
| 32848-4 | Neisseria meningitidis serogroups A+Y Ag [Presence] in Specimen |
| 53449-5 | Cyclophosphamide [Mass/volume] in Serum or Plasma |
| 4482-6 | Complement C1r2+C1s2 [Units/volume] in Serum or Plasma |
| 2322-6 | Gamma glutamyl transferase [Enzymatic activity/volume] in Amniotic fluid |
| 23537-4 | Tuberculosis reaction wheal [Diameter] --2 days post dose mammalian tuberculin intradermal |
| 23604-2 | Tritrichomonas foetus [Presence] in Body fluid by Organism specific culture |
| 33262-7 | Metamyelocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
| 33409-4 | Variant lymphocytes/100 leukocytes in Pericardial fluid |
| 53514-6 | Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Control Fibroblast |
| 33825-1 | WBC casts [Presence] in Urine sediment by Light microscopy |
| 33975-4 | SARS coronavirus Urbani RNA [Presence] in Sputum by NAA with probe detection |
| 45386-0 | Epithelial casts [#/area] in Urine sediment by Microscopy high power field |
| 24475-6 | F2 gene c.20210G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 34398-8 | Biotin [Moles/volume] in Serum or Plasma |
| 47-1 | Bacampicillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 25305-4 | Alpha aminobutyrate [Moles/time] in 24 hour Urine |
| 25366-6 | cefOXitin [Susceptibility] by Method for Slow-growing mycobacteria |
| 35279-9 | Neutrophil cytoplasmic Ab [Presence] in Serum by Immunofluorescence |
| 35329-2 | pH of Body fluid--2nd specimen post Sincalide |
| 47861-0 | Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Amniotic fluid cells |
| 35637-8 | 4-Hydroxyglutethimide [Mass/volume] in Serum or Plasma by Screen method |
| 56398-1 | Sweet Vernal grass IgG4 Ab [Mass/volume] in Serum |
| 48253-9 | English plantain triggered leukotriene release [Mass/volume] by Leukocytes |
| 26768-2 | Clostridium perfringens IgM Ab [Units/volume] in Serum |
| 3631-9 | Fenfluramine [Mass/volume] in Urine |
| 3698-8 | Kanamycin [Mass/volume] in Serum or Plasma --peak |
| 56619-0 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 26842-5 | Iodine [Mass/volume] in 24 hour Urine |
| 26878-9 | ALPRAZolam [Mass/volume] in Vitreous fluid |
| 27163-5 | N-methylacetamide/Creatinine [Mass Ratio] in Urine |
| 5724-0 | Selenium [Mass/volume] in Serum or Plasma |
| 57372-5 | Osmolality of 12 hour Urine |
| 48980-7 | TSC2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 49014-4 | PAH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 28073-5 | 7-Aminoclonazepam [Mass/volume] in Urine |
| 39601-0 | Stemphylium botryosum IgE Ab/IgE total in Serum |
| 49433-6 | Parvovirus B19 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
| 49664-6 | HIV reverse transcriptase susceptibility panel by Phenotype method |
| 28645-0 | Carbon dioxide [Partial pressure] in Venous cord blood |
| 40271-9 | Creatinine [Moles/volume] in Serum or Plasma --5 hours post XXX challenge |
| 58408-6 | Erythrocyte morphology panel - Blood |
| 40400-4 | Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post dose triple bolus |
| 40529-0 | Amphetamines [Presence] in Hair |
| 40563-9 | Actin smooth muscle Ag [Presence] in Tissue by Immune stain |
| 5036-9 | Streptococcus pyogenes rRNA [Presence] in Specimen by Probe |
| 30123-4 | Testosterone.bound [Mass/volume] in Serum or Plasma |
| 40919-3 | Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 19203-9 | Prostate Specific Ag Free [Moles/volume] in Serum or Plasma |
| 19330-0 | Alpha hydroxyalprazolam cutoff [Mass/volume] in Urine for Confirmatory method |
| 1942-2 | Beta galactosidase [Enzymatic activity/mass] in Tissue |
| 19586-7 | Midazolam [Presence] in Urine by Confirmatory method |
| 2000-8 | Calcium [Moles/volume] in Serum or Plasma |
| 101082-6 | Evans Ab [Presence] in Serum or Plasma |
| 1254-2 | Major crossmatch.re-crossmatch [Interpretation] |
| 101245-9 | Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 13229-0 | Eastern equine encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13468-4 | Cobalt/Creatinine [Mass Ratio] in Urine |
| 13508-7 | Hematocrit [Volume Fraction] of Cerebral spinal fluid by Centrifugation |
| 102577-4 | Cultivated Rye IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14097-0 | Antimony [Mass/time] in 24 hour Urine |
| 14251-3 | Mitochondria M2 IgG Ab [Units/volume] in Serum |
| 14367-7 | Trichomonas vaginalis [Presence] in Vaginal fluid by Wet preparation |
| 103064-2 | Soybean recombinant (rGly m) 4 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14537-5 | Measles virus Ag [Presence] in Eye by Immunofluorescence |
| 14598-7 | Amitriptyline+Nortriptyline [Moles/volume] in Serum or Plasma |
| 103195-4 | Proteus vulgaris DNA [Presence] in Specimen by NAA with probe detection |
| 14930-2 | Triiodothyronine (T3) [Moles/volume] in Serum or Plasma |
| 15017-7 | Alkaline phosphatase.regan/Alkaline phosphatase.total in Serum or Plasma |
| 11060-1 | Reducing substances [Presence] in Stool |
| 16294-1 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --post XXX challenge |
| 16641-3 | Cockatiel droppings Ab [Units/volume] in Serum |
| 16808-8 | Anaplasma phagocytophilum IgG Ab [Units/volume] in Serum |
| 17140-5 | CD34+DR+ cells/100 cells in Blood |
| 17523-2 | Reticulin IgG Ab [Titer] in Serum |
| 17854-1 | Ganglioside GM1b IgM Ab [Titer] in Serum |
| 18287-3 | Donath Landsteiner Ab [Presence] in Control Serum and RBC |
| 90291-6 | EpCAM Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 91124-8 | Platelet function with adenosine diphosphate induction panel - Blood by Resonance TEG |
| 92668-3 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose cloNIDine |
| 60576-6 | t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Cerebral spinal fluid by Molecular genetics method |
| 775-7 | Platelet mean diameter [Entitic length] in Blood by Rees-Ecker |
| 93777-1 | Human papilloma virus 16+18 E6+E7 mRNA [Presence] in Tissue by Probe |
| 94184-9 | Yellow fever virus RNA [Presence] in Specimen by NAA with probe detection |
| 62482-5 | Herpes virus 6B DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 78753-1 | 11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Serum or Plasma by Screen method |
| 94662-4 | Coccidioides immitis IgG Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
| 63530-0 | Centromere Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 79174-9 | Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 95162-4 | Bordetella avium Ab/Positive control in Serum by Immunoassay |
| 66717-0 | Chlorhexidine IgE Ab [Units/volume] in Serum |
| 95845-4 | Nucleated cells [#/volume] in Sputum by Manual count |
| 67826-8 | Neutrophils [#/volume] in Pericardial fluid |
| 6830-4 | Aspergillus niger IgE Ab [Units/volume] in Serum |
| 81830-2 | AGL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 81835-1 | PEX7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 82053-0 | Food Allergen Mix 12 (Mushroom+Pumpkin+Rice+Rye+Potato) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 82071-2 | Food Allergen Mix 70 (Tarragon+Lovage+Marjoram+Thyme) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 7050-8 | sulfADIAZINE [Susceptibility] by Gradient strip |
| 82494-6 | TRBV10 gene segments/TRBV gene segments.total in Blood |
| 85992-6 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum by Immunoassay |
| 86504-8 | These questions three panel |
| 87724-1 | Complement C7.functional [Units/volume] in Serum or Plasma |
| 87947-8 | Borrelia sp DNA identified in Tissue by NAA with probe detection |
| 88155-7 | Microscopic observation [Identifier] in Ocular fluid by Acid fast stain |
| 89518-5 | Ganglioside GM1 IgM Ab [Presence] in Serum by Line blot |
| 59717-9 | Nordiazepam [Mass/volume] in Blood by Confirmatory method |
| 4190-5 | cloBAZam [Mass] of Dose |
| 42572-8 | 11-Deoxycortisol [Mass/volume] in Urine |
| 60290-4 | Caffeine [Moles/volume] in Specimen |
| 21266-2 | Ethion [Mass/volume] in Urine |
| 31539-0 | Neuronal nuclear type 2 Ab [Presence] in Serum |
| 51316-8 | CD4+CD7-CD49D- cells/100 cells in Blood |
| 32006-9 | Chlamydia trachomatis C Ab [Titer] in Serum |
| 51525-4 | Regional Allergen Mix 3 (Common Ragweed+Goosefoot+Bermuda grass+Perennial rye grass+English Plantain+Bahia grass) IgE Ab [Presence] in Serum by Multidisk |
| 51587-4 | Plasmodium sp [Presence] in Blood by Light microscopy |
| 43577-6 | Histamine/Creatinine [Ratio] in Urine |
| 2236-8 | Calciferol (Vit D2) [Mass/volume] in Serum or Plasma |
| 22456-8 | Pseudorabies virus Omnimark gene deletion Ab [Presence] in Serum |
| 2256-6 | Estrogen [Mass/time] in 24 hour Urine |
| 5291-0 | Reagin Ab [Units/volume] in Serum by VDRL |
| 23056-5 | Ehrlichia risticii Ab [Presence] in Serum |
| 32581-1 | Epidermal growth factor receptor Ag [Presence] in Tissue by Immune stain |
| 23544-0 | Venezuelan equine encephalitis virus Ab [Presence] in Serum |
| 53541-9 | Epithelial cells [Presence] in Blood by Light microscopy |
| 4581-5 | Hemoglobin G - Coushatta [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 46200-2 | Parainfluenza virus 3 Ab [Presence] in Cerebral spinal fluid |
| 4682-1 | Streptokinase [Titer] in Serum |
| 24449-1 | Carnitine esters [Moles/volume] in Urine |
| 34520-7 | Carbon dioxide, total [Moles/volume] in Cord blood |
| 47270-4 | Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --3rd specimen post XXX challenge |
| 47452-8 | Influenza virus A H3 Ab [Titer] in Serum |
| 25132-2 | Pyruvate/Creatinine [Molar ratio] in Urine |
| 25206-4 | Streptomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25264-3 | Ofloxacin [Mass/volume] in Specimen |
| 3523-8 | cycloSPORINE [Mass/volume] in Blood --12 hours post dose |
| 56008-6 | Platelet aggregation collagen induced in Blood --1 ug/mL |
| 25771-7 | Insulin-like growth factor [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 25914-3 | Gamma aminobutyrate [Moles/volume] in 24 hour Urine |
| 56913-7 | Corticotropin [Mass/volume] in Plasma --morning specimen |
| 48786-8 | Renin [Enzymatic activity/volume] in Plasma --30 minutes pre XXX challenge |
| 57341-0 | Chloride [Moles/volume] in 2 hour Urine |
| 49200-9 | Bartonella vinsonii berkhoffii IgM Ab [Titer] in Serum |
| 39599-6 | Epicoccum purpurascens IgE Ab/IgE total in Serum |
| 39613-5 | Silicone IgM Ab [Units/volume] in Serum by Immunoassay |
| 57952-4 | Honeydew melon IgE Ab/IgE total in Serum |
| 29401-7 | Disopyramide [Mass/volume] in Gastric fluid |
| 398-8 | Penicillin V [Susceptibility] by Serum bactericidal titer |
| 40207-3 | Glucose [Moles/volume] in Serum or Plasma --19 minutes post XXX challenge |
| 40212-3 | Glucose [Moles/volume] in Serum or Plasma --4.5 hours post XXX challenge |
| 58787-3 | Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum by Immunoassay |
| 50011-6 | Transfusion start time |
| 50021-5 | oxyCODONE [Mass/volume] in Serum, Plasma or Blood by Screen method |
| 58978-8 | Ganglioside GD3 IgM Ab [Units/volume] in Serum by Immunoassay |
| 50606-3 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --4 hours post XXX challenge |
| 30355-2 | Herpes simplex virus 1+2 IgM Ab [Presence] in Serum by Immunofluorescence |
| 19399-5 | clonazePAM [Presence] in Urine by Screen method |
| 19485-2 | HYDROcodone cutoff [Mass/volume] in Urine for Confirmatory method |
| 20410-7 | Amphetamines [Mass/volume] in Urine by Confirmatory method |
| 20423-0 | Beta lactamase organism identified in Isolate |
| 20609-4 | CD42 cells/100 cells in Specimen |
| 13415-5 | Taurine [Mass/volume] in Amniotic fluid |
| 13500-4 | Amino acid pattern [Interpretation] in Serum or Plasma |
| 102356-3 | Sweet gum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102449-6 | Moth IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14675-3 | Cortisol [Moles/volume] in Serum or Plasma |
| 14877-5 | Phenytoin [Moles/volume] in Serum or Plasma |
| 14987-2 | little i-1 subtype [Presence] on Red Blood Cells from Donor |
| 11085-8 | Schistosoma sp identified in Stool by Concentration |
| 11476-9 | Microscopic observation [Identifier] in Gastric fluid by Acid fast stain |
| 116-4 | cefOXitin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 12224-2 | Leukocytes [#/area] in Nose by Microscopy high power field |
| 1233-6 | Mi sup(a) Ag [Presence] on Red Blood Cells from Donor |
| 16990-4 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose glucose |
| 1714-5 | Prostatic acid phosphatase [Enzymatic activity/volume] in Serum |
| 18393-9 | quiNIDine+Quinine [Presence] in Urine |
| 91056-2 | Drugs of abuse panel - Hair |
| 75088-5 | 3-Indolelactate [Moles/volume] in Serum or Plasma |
| 61267-1 | False ragweed IgE Ab/IgE total in Serum |
| 61412-3 | Desipramine [Presence] in Urine by Confirmatory method |
| 62254-8 | Lipoprotein.pre-beta [Entitic length] in Serum or Plasma |
| 77036-2 | t(11;18)(q21;q21)(BIRC3,MALT1) fusion transcript in Blood or Tissue by FISH |
| 93854-8 | Gadolinium/Creatinine [Mass Ratio] in Urine |
| 93909-0 | Jk3 Ag [Presence] on Red Blood Cells |
| 94420-7 | Lactobacillus crispatus+gasseri+jensenii + Gardnerella vaginalis + Atopobium vaginae rRNA [Presence] in Vaginal fluid by NAA with probe detection |
| 79294-5 | D- and L-2-hydroxyglutarate panel - Cerebral spinal fluid |
| 67821-9 | Human metapneumovirus B RNA [Presence] in Specimen by NAA with probe detection |
| 81139-8 | CYP3A4 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 81199-2 | Beta-ureidopropionase [Enzymatic activity/mass] in Liver |
| 96804-0 | 24 hour predicted protein [Mass/time range] based on random Urine by calculation |
| 69831-6 | 3,4-Dihydroxyphenylacetate/Creatinine [Molar ratio] in Urine |
| 9763-4 | Coxsackievirus B5 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 70259-7 | Triglyceride in pericardial fluid/Triglyceride in serum |
| 82493-8 | TRBV11 gene segments/TRBV gene segments.total in Blood |
| 82888-9 | Ortho methylhippurate/Creatinine [Molar ratio] in Urine |
| 72432-8 | 4-Hydroxyphenylacetate [Moles/volume] in Serum or Plasma |
| 99927-6 | Erythrocytes [#/area] in Body fluid by Automated count |
| 73182-8 | QUEtiapine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87975-9 | Microscopic observation [Identifier] in Isolate by Gram stain |
| 88141-7 | Bacteria identified in Ocular fluid by Aerobe culture |
| 88204-3 | Respiratory syncytial virus A RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 88225-8 | Neisseria gonorrhoeae DNA [Presence] in Throat by NAA with probe detection |
| 88546-7 | Chlamydophila pneumoniae DNA [Presence] in Aspirate by NAA with probe detection |
| 88680-4 | Herpes simplex virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 89003-8 | HuD Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 59600-7 | Alpha hydroxyalprazolam [Mass/volume] in Blood by Confirmatory method |
| 50775-6 | Cancer Ag 125 [Units/volume] in Cerebral spinal fluid |
| 50925-7 | Titanium [Moles/mass] in Tissue |
| 5094-8 | Coccidioides immitis Ab [Units/volume] in Serum by Immunoassay |
| 51034-7 | CD11a blasts [Units/volume] in Bone marrow |
| 30551-6 | Propionylcarnitine (C3) [Moles/volume] in Serum or Plasma |
| 31019-3 | 10-Hydroxycarbazepine [Mass/volume] in Serum or Plasma |
| 59961-3 | Propoxyphene [Moles/volume] in Gastric fluid |
| 31316-3 | Coxiella burnetii phase 2 IgA Ab [Units/volume] in Serum |
| 31592-9 | Ribosomal P Ab [Presence] in Serum |
| 21732-3 | RB1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 51780-5 | HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 0.5 log copies/mL |
| 5190-4 | Hepatitis B virus e Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
| 22316-4 | Hepatitis B virus core Ab [Units/volume] in Serum |
| 5233-2 | Intrinsic factor Ab [Presence] in Serum by Radioimmunoassay (RIA) |
| 32855-9 | CD62 cells/100 cells in Specimen |
| 53143-4 | Hydrogen ion [Moles/volume] in Mixed venous blood |
| 53313-3 | Cystine crystals [#/area] in Urine by Computer assisted method |
| 53325-7 | Urinalysis type of crystal panel - Urine by Computer assisted method |
| 44446-3 | Basement membrane IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 44586-6 | IgA IgM Ab [Presence] in Serum or Plasma |
| 44636-9 | Invasive component size additional dimension 1 [Length] in Breast tumor |
| 44849-8 | Bacteria # 8 identified in Urine by Culture |
| 23209-0 | Leptospira borgpetersenii sv Tarrasovi Ab [Presence] in Serum by Agglutination |
| 33553-9 | Platelet aggregation ristocetin induced in Platelet rich plasma --600 ug/mL |
| 53722-5 | SLC26A4 gene p.Glu384Gly [Presence] in Blood by Molecular genetics method |
| 45108-8 | Chlamydia sp Ag [Presence] in Cervix by Immunofluorescence |
| 45143-5 | Methylenedioxyethylamphetamine [Mass/volume] in Urine by Confirmatory method |
| 45357-1 | Erythrocytes.filamented [Presence] in Blood by Light microscopy |
| 23780-0 | Strychnine [Mass/volume] in Specimen |
| 2379-6 | Glutathione S-transferase [Enzymatic activity/volume] in Red Blood Cells |
| 33762-6 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma |
| 33897-0 | Orientia tsutsugamushi IgM Ab [Presence] in Serum or Plasma |
| 24378-2 | Platelet aggregation EPINEPHrine induced [Presence] in Platelet rich plasma |
| 47054-2 | Legionella pneumophila 10 IgM Ab [Titer] in Serum by Immunofluorescence |
| 47267-0 | Adenosine monophosphate.cyclic [Moles/volume] in Urine --6th specimen post XXX challenge |
| 47581-4 | Biopterin [Moles/volume] in Cerebral spinal fluid |
| 2585-8 | Lysine [Mass/volume] in Serum or Plasma |
| 56383-3 | Salmon IgG4 Ab [Mass/volume] in Serum |
| 27077-7 | Enterococcus sp IgM Ab [Units/volume] in Serum |
| 38453-7 | CFTR gene c.3659delC [Presence] in Blood or Tissue by Molecular genetics method |
| 38478-4 | Biotinidase [Presence] in DBS |
| 28040-4 | Borrelia burgdorferi 41kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 3894-3 | Oxymesterone [Presence] in Urine |
| 39081-5 | Codfish IgE Ab/IgE total in Serum |
| 3994-1 | Propranolol [Mass/volume] in Urine |
| 40048-1 | Albumin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 40076-2 | Calcium [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge |
| 49788-3 | Potassium [Moles/volume] in Amniotic fluid |
| 29662-4 | Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay |
| 58968-9 | Asialoganglioside GM1 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 20749-8 | Carbamates [Presence] in Feed by Screen method |
| 21047-6 | 8-Hydroxyloxapine [Mass/volume] in Urine |
| 100060-3 | Tildipirosin [Susceptibility] |
| 100757-4 | Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing |
| 100895-2 | Rickettsia conorii IgG and IgM [Interpretation] in Serum |
| 12713-4 | Hemoglobin C+E+O+A2 region [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 101355-6 | Borrelia afzelii+burgdorferi+garinii IgM Ab [Presence] in Serum by Immunoassay |
| 13076-5 | Phosphatidylethanolamine IgG Ab [Units/volume] in Serum |
| 13467-6 | Selenium/Creatinine [Mass Ratio] in Urine |
| 13580-6 | Temazepam [Presence] in Serum or Plasma |
| 102380-3 | Horse epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14055-8 | Sodium [Moles/mass] in Stool |
| 14082-2 | Echinococcus sp IgG Ab [Units/volume] in Serum by Immunoblot |
| 14268-7 | Butyl acetate [Mass/volume] in Blood |
| 1028-0 | Fy sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
| 102927-1 | Wheat Bran IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1437-3 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 14429-5 | Globulin [Mass/volume] in Semen |
| 103951-0 | Motor neuron disease multigene analysis in Specimen by Molecular genetics method |
| 10549-4 | Pirmenol [Mass/volume] in Serum or Plasma |
| 1539-6 | Glucose [Mass/volume] in Serum or Plasma --4 hours post 75 g glucose PO |
| 16212-3 | Ethylamphetamine [Presence] in Urine by Confirmatory method |
| 16323-8 | Alanine [Presence] in Urine |
| 1749-1 | Albumin [Mass/volume] in Peritoneal fluid |
| 17759-2 | Urea nitrogen [Mass/volume] in Arterial blood --post dialysis |
| 18990-2 | Temafloxacin [Susceptibility] |
| 19058-7 | Allergens identified in Serum |
| 7494-8 | Common Millet IgG Ab [Units/volume] in Serum |
| 75015-8 | t(9;22)(q34.1;q11)(ABL1,BCR) b2a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 91671-8 | Transferrin.carbohydrate deficient.disialo/Transferrin.total standardized per IFCC-RMP for CDT in Serum or Plasma |
| 76084-3 | Parainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with probe detection |
| 77119-6 | RPGR gene full mutation analysis in Blood or Tissue by Sequencing |
| 93704-5 | Palmitoyl protein thioesterase 1 and Tripeptidyl peptidase 1 panel - Leukocytes |
| 63070-7 | TOP2A gene 17q21-22 deletion and duplication mutation analysis [Presence] in Tissue by FISH |
| 63256-2 | Ganglioside GT1a IgG+IgM Ab [Presence] in Serum by Immunoassay |
| 94395-1 | Influenza virus A H1 2009 pandemic RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 94692-1 | Dermatan sulfate/Creatinine [Ratio] in Urine |
| 63409-7 | DNA double strand Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 79382-8 | Campylobacter coli+jejuni+lari fusA gene [Presence] in Stool by NAA with probe detection |
| 79455-2 | Alpha-N-acetylgalactosaminidase [Enzymatic activity/volume] in DBS |
| 6528-4 | Rabies virus Ag [Presence] in Tissue by Immunofluorescence |
| 66453-2 | McD sup(d) Ab [Presence] in Serum or Plasma |
| 80215-7 | Beta blockers [Presence] in Body fluid by Screen method |
| 68439-9 | Gabapentin [Presence] in Urine |
| 806-0 | Leukocytes [#/volume] in Cerebral spinal fluid by Manual count |
| 81180-2 | Growth pattern [Type] in Tumor |
| 69488-5 | TNFRSF13B gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 6968-2 | Proteinase 3 Ab [Units/volume] in Serum |
| 81706-4 | Phosphatase and tensin homolog (PTEN) protein [Presence] in Cancer specimen by Immune stain |
| 97534-2 | Somatotropin [Mass/volume] in Serum or Plasma --3 hours post dose glucose |
| 7059-9 | Vancomycin [Susceptibility] by Gradient strip |
| 711-2 | Eosinophils [#/volume] in Blood by Automated count |
| 97979-9 | Apple recombinant (rMal d) 3 IgG4 Ab [Mass/volume] in Serum |
| 97988-0 | Chicken meat IgG4 Ab [Mass/volume] in Serum |
| 98038-3 | CFTR and FMR1 (CGG repeat) and SMN1 gene mutation analysis in Blood or Tissue by Molecular genetics method |
| 98902-0 | Methemoglobin and sulfhemoglobin panel - Blood |
| 99411-1 | Voltage-gated calcium channel Ab [Moles/volume] in Cerebral spinal fluid by Immunoassay |
| 99412-9 | Beta globulin [Mass/volume] in Serum or Plasma by Immunofixation |
| 996-9 | Do sup(a) Ag [Presence] on Red Blood Cells |
| 72778-4 | JWH-073 butanoate (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
| 728-6 | Hypochromia [Presence] in Blood by Light microscopy |
| 73006-9 | levETIRAcetam induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73317-0 | Lepirudin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87387-7 | Porcine parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection |
| 73545-6 | Acyclovir induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73576-1 | Anion gap 4 in Venous cord blood |
| 41413-6 | Babesia divergens Ab [Titer] in Serum by Immunofluorescence |
| 41600-8 | Bacteria [Presence] in Synovial fluid by Light microscopy |
| 59377-2 | 2-Methylacetoacetate/Creatinine [Molar ratio] in Urine |
| 5965-9 | Plasmin inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method |
| 59728-6 | Oxazepam [Mass/volume] in Body fluid by Confirmatory method |
| 50616-2 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --5.5 hours post XXX challenge |
| 50751-7 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post 0.1 U/kg insulin |
| 42499-4 | Fibrin D-dimer [Presence] in Cerebral spinal fluid |
| 51169-1 | CD34+CD117+ blasts/100 blasts in Specimen |
| 51242-6 | CD13+CD33+HLA-DR+ cells/100 cells in Cerebral spinal fluid |
| 2222-8 | Elastase.pancreatic 2 [Enzymatic activity/volume] in Serum |
| 51541-1 | Stachybotrys chartarum IgG Ab [Presence] in Serum |
| 43433-2 | Acylcarnitine panel - Serum or Plasma |
| 22467-5 | Respiratory syncytial virus IgM Ab [Titer] in Serum |
| 32168-7 | Color of Spun Cerebral spinal fluid |
| 32175-2 | Coarse Granular Casts [Presence] in Urine sediment by Light microscopy |
| 52979-2 | Trichinella spiralis IgG Ab [Titer] in Serum by Immunofluorescence |
| 53000-6 | Mitochondria M4 Ab [Units/volume] in Serum |
| 23111-8 | Foot and mouth disease virus Ag [Presence] in Throat by Immunoassay |
| 44692-2 | Microcalcifications in Breast tumor |
| 44750-8 | Ganglioside GM1 IgM Ab [Presence] in Serum |
| 33342-7 | Epithelial cells [#/area] in Urine sediment by Automated count |
| 33418-5 | Neuronal IgG Ab [Presence] in Serum |
| 53629-2 | Alpha cortol [Mass/time] in 24 hour Urine |
| 53860-3 | Fatty acids.very long chain C24:0 (Tetracosanoate) [Mass/volume] in Serum or Plasma |
| 23953-3 | Aspergillus sp Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 54262-1 | Glucose [Moles/volume] in Serum or Plasma --3 hours pre dose insulin IV |
| 4576-5 | Hemoglobin F/Hemoglobin.total in Blood |
| 46228-3 | Clenbuterol [Mass/volume] in Urine |
| 24380-8 | Platelet aggregation ristocetin induced [Presence] in Platelet rich plasma |
| 24434-3 | IgM.canine [Mass/volume] in Serum by Immune diffusion (ID) |
| 54937-8 | Chloroform [Mass/volume] in Serum or Plasma |
| 47320-7 | Baker's yeast IgA Ab [Units/volume] in Serum by Immunoassay |
| 35105-6 | Bromperidol [Mass/volume] in Serum or Plasma |
| 55673-8 | Econazole [Susceptibility] by Gradient strip |
| 47539-2 | 3-Methylhistidine [Moles/volume] in DBS |
| 25627-1 | Cortisol [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 37982-6 | Avian paramyxovirus [Presence] in Specimen by Organism specific culture |
| 38347-1 | XXX microorganism DNA [Identifier] in Specimen by NAA with probe detection |
| 57411-1 | Desmoglein 1 Ab [Units/volume] in Serum by Immunoassay |
| 57497-0 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --1 day post dose dexamethasone |
| 57575-3 | 3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
| 27328-4 | Somatotropin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 27881-2 | Somatotropin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 38908-0 | Poikilocytosis [Presence] in Blood by Automated count |
| 39013-8 | Rubella virus IgG Ab [Presence] in Cerebral spinal fluid |
| 39485-8 | pH of Capillary blood adjusted to patient's actual temperature |
| 57912-8 | Green Bean IgE Ab/IgE total in Serum |
| 49631-5 | ATN1 gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 29265-6 | Calcium [Moles/volume] corrected for albumin in Serum or Plasma |
| 40280-0 | Glucose [Moles/volume] in Serum or Plasma --3 hours post dose lactose PO |
| 49902-0 | Hexanoylglycine/Creatinine [Molar ratio] in 24 hour Urine |
| 50144-5 | 3-O-Methyldopa/Creatinine [Molar ratio] in Urine |
| 29873-7 | Isobutyrylglycine [Presence] in Urine |
| 4057-6 | Tobramycin [Mass/volume] in Serum or Plasma --peak |
| 58851-7 | Testosterone [Mass/volume] in Serum or Plasma --3 days post XXX challenge |
| 58970-5 | Ganglioside GD1a IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 41129-8 | Parvovirus B19 IgM Ab [Units/volume] in Serum --1st specimen |
| 19654-3 | Para hydroxyamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
| 19740-0 | Fox epithelium IgE Ab [Units/volume] in Serum |
| 20483-4 | Mitochondria Ab [Titer] in Serum |
| 20759-7 | Chromium [Mass/mass] in Tissue |
| 12426-3 | Brodifacoum [Mass/volume] in Serum or Plasma |
| 102112-0 | Melatonin [Moles/volume] in Saliva (oral fluid) by LC/MS/MS |
| 102572-5 | Rhodotorula spp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14224-0 | HTLV I rgp21 Ab [Presence] in Serum |
| 14332-1 | Para aminosalicylate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 14584-7 | Adenosine monophosphate.cyclic [Moles/time] in 24 hour Urine |
| 14747-0 | Glucose [Moles/volume] in Pleural fluid |
| 103159-0 | CD15 cells [#/volume] in Blood from Donor |
| 104062-5 | HISGT Histone genes targeted mutation analysis in Tumor by Molecular genetics method |
| 14820-5 | Lymphocytes/100 leukocytes in Pleural fluid by Manual count |
| 14941-9 | Uroporphyrin 1 isomer [Moles/volume] in Stool |
| 15066-4 | Fatty acids.nonesterified [Moles/volume] in Serum or Plasma |
| 10431-5 | B-cell Ag [Presence] in Tissue by Immune stain |
| 16245-3 | Hydroxyethylflurazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 10716-9 | Schistosoma sp identified in Specimen by Organism specific culture |
| 16644-7 | Codeine Free [Presence] in Serum or Plasma by Confirmatory method |
| 11571-7 | Rheumatoid arthritis nuclear Ab [Units/volume] in Serum |
| 16845-0 | Ethionamide [Mass/volume] in Serum or Plasma |
| 16936-7 | Hepatitis C virus IgG Ab [Units/volume] in Serum |
| 17036-5 | La Crosse virus Ab [Titer] in Serum |
| 17103-3 | CD106 cells/100 cells in Blood |
| 75038-0 | Bile acid pattern [Interpretation] in Serum or Plasma Narrative |
| 7527-5 | Nutmeg IgG Ab [Units/volume] in Serum |
| 75655-1 | Mononuclear cells [#] in Cerebral spinal fluid by Manual count |
| 60350-6 | Apricot IgG Ab [Mass/volume] in Serum |
| 76489-4 | IgG [Moles/volume] in Cerebral spinal fluid |
| 93085-9 | Dirofilaria immitis IgG Ab [Presence] in Serum by Immunoassay |
| 7705-7 | Johnson grass smut IgE Ab [Units/volume] in Serum |
| 93793-8 | Insulin [Units/volume] mean in Serum or Plasma |
| 63043-4 | Nuclei scored in Tissue |
| 63327-1 | Ribosomal P Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 78363-9 | Norhydrocodone [Presence] in Saliva (oral fluid) by Confirmatory method |
| 63428-7 | Escherichia coli Stx2 toxin stx2 gene [Presence] in Specimen by NAA with probe detection |
| 79228-3 | amLODIPine [Mass/volume] in Body fluid |
| 79314-1 | Gamma butyrobetaine/Trimethyllysine [Molar ratio] in DBS |
| 9531-5 | Influenza virus A Ab [Titer] in Cerebral spinal fluid |
| 67836-7 | Leukocytes other [#/volume] in Pleural fluid from Fetus |
| 68433-2 | Leukocytes other [#/volume] in Vitreous fluid by Manual count |
| 8108-3 | CD11c+CD20+ cells/100 cells in Blood |
| 69552-8 | Thromboelastography after addtion of heparinase panel - Blood |
| 69765-6 | Rubella virus IgM Ab [Presence] in Body fluid by Immunoassay |
| 82251-0 | Chromosome 3 and 7 and 17 aneuploidy and chromosome region 9p21 deletion in Urine by FISH |
| 97924-5 | Jamestown canyon virus RNA [Presence] in Specimen by NAA with probe detection |
| 82585-1 | Dicarboxyhexenoylcarnitine (C6:1-DC) [Moles/volume] in DBS |
| 82847-5 | 11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Androsterone+etiocholanolone [Molar ratio] in Urine |
| 7212-4 | Parmesan Cheese IgE Ab [Units/volume] in Serum |
| 72206-6 | Epstein Barr virus nuclear 1 IgG and IgM [Color Ratio] in Serum or Plasma by Rapid immunoassay |
| 72274-4 | t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
| 99406-1 | Cells.CD19+CD79b+/100 cells in Blood |
| 88195-3 | Influenza virus B RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 41264-3 | Viscosity of Cerebral spinal fluid Qualitative |
| 59723-7 | Nordiazepam [Mass/mass] in Tissue |
| 50861-4 | Hydrogen ion [Moles/volume] in Capillary blood |
| 50896-0 | pH of Body fluid by Test strip |
| 42636-1 | Urease [Presence] in Tissue --3 hours post incubation |
| 31422-9 | Highlands J virus Ab [Units/volume] in Specimen |
| 51321-8 | CD42 cells/100 cells in Tissue |
| 51335-8 | CD19+CD43+ cells/100 cells in Bone marrow |
| 42924-1 | Lactoferrin [Mass/volume] in Stool |
| 51681-5 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 4337-2 | Morphine [Mass] of Dose |
| 43736-8 | Fosamprenavir [Susceptibility] by Genotype method |
| 53006-3 | PCNA extractable nuclear Ab [Titer] in Serum by Immunofluorescence |
| 44278-0 | 16-Alpha hydroxydehydroepiandrosterone/Creatinine [Mass Ratio] in Urine |
| 53489-1 | Kynurenate [Moles/time] in 24 hour Urine |
| 53919-7 | Thyroglobulin Ab [Units/volume] in Tissue fine needle aspirate |
| 45047-8 | Cortisol [Moles/volume] in Serum or Plasma --12 AM specimen |
| 33748-5 | Distance from anal verge |
| 5396-7 | Triiodothyronine (T3) Ab [Units/volume] in Serum |
| 54233-2 | Metabolic panel.small animal - Serum or Plasma |
| 54314-0 | Malonylcarnitine (C3-DC)/Creatinine [Molar ratio] in Urine |
| 2466-1 | IgG subclass 1 [Mass/volume] in Serum |
| 47089-8 | Indicans [Moles/time] in 24 hour Urine |
| 47351-2 | Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 35636-0 | Amitriptyline [Mass/volume] in Serum or Plasma by Screen method |
| 56733-9 | PCNA extractable nuclear Ab [Presence] in Serum by Immunoblot |
| 48408-9 | Proteinase 3 IgG Ab [Units/volume] in Serum |
| 48634-0 | Coproporphyrin/Creatinine [Mass Ratio] in 24 hour Urine |
| 48784-3 | Herpes simplex virus 2 Ab [Presence] in Serum by Immunoassay |
| 26806-0 | Glutamine [Presence] in 24 hour Urine |
| 27162-7 | 1-Methylhistidine [Moles/volume] in Amniotic fluid |
| 27205-4 | Amphetamines [Presence] in Vitreous fluid |
| 57519-1 | 11-Hydroxyetiocholanolone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
| 57565-4 | 21-Deoxycortisol [Moles/volume] in Serum or Plasma --2 days post dose dexamethasone |
| 48957-5 | Methadone [Mass/volume] in Specimen |
| 392-1 | Penicillin G [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 5794-3 | Hemoglobin [Presence] in Urine by Test strip |
| 49519-2 | Influenza virus A H16 Ab [Titer] in Serum by Hemagglutination inhibition |
| 49585-3 | Alpha-1-Fetoprotein multiple of the median cutoff [Multiple of the median] in Serum or Plasma |
| 29500-6 | 2-Hydroxyadipate/Creatinine [Molar ratio] in Urine |
| 39795-0 | Trifluoperazine [Moles/volume] in Serum or Plasma |
| 49857-6 | SMN1 gene+SMN2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 40457-4 | Prothrombin Ab [Units/volume] in Serum or Plasma |
| 50464-7 | C peptide [Moles/volume] in Serum or Plasma --4th specimen |
| 41028-2 | Listeria monocytogenes O1 Ab [Titer] in Serum |
| 19378-9 | Butorphanol [Presence] in Urine by Confirmatory method |
| 19569-3 | Methylenedioxymethamphetamine [Presence] in Urine by Confirmatory method |
| 20721-7 | Brucella abortus Ab [Presence] in Semen by Agglutination |
| 20912-2 | Organochlorine pesticides [Presence] in Blood by Screen method |
| 102223-5 | Cheese cheddar type IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1383-9 | Calcium [Moles/volume] in Serum or Plasma --pre 2.4 mg/kg calcium short IV |
| 1399-5 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst |
| 102900-8 | Jackfruit IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14713-2 | Erythrocytes [#/volume] in Pericardial fluid by Manual count |
| 14926-0 | Triazolam [Moles/volume] in Serum or Plasma |
| 156-0 | Cephaloridine [Susceptibility] by Minimum lethal concentration (MLC) |
| 16366-7 | Diethylpropion [Mass/volume] in Serum or Plasma |
| 16702-3 | cycloSERINE [Mass/volume] in Urine |
| 12219-2 | Glucose [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis |
| 18269-1 | Immune complex [Units/volume] in Body fluid |
| 18971-2 | Pivampicillin [Susceptibility] |
| 91076-0 | Rabies virus Ag [Presence] in Tissue by Immunoassay |
| 74869-9 | IgA.kappa/IgA.lambda [Mass Ratio] in Serum or Plasma |
| 91831-8 | Human metapneumovirus Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
| 92140-3 | Parainfluenza virus 1 RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 93511-4 | Rickettsia rickettsii and Coxiella burnetii phase 1 and Coxiella burnetii phase 2 IgG panel - Serum |
| 6209-1 | Pecan or Hickory Tree IgE Ab [Units/volume] in Serum |
| 62308-2 | Krabbe disease newborn screen interpretation |
| 77730-0 | oxyCODONE [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 78741-6 | Pathologic casts [#/volume] in Urine by Automated count |
| 94552-7 | Isohexacarboxylporphyrin [Mass/time] in 24 hour Stool |
| 94832-3 | Varicella zoster virus DNA [log units/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 7951-7 | Legionella pneumophila 4 Ab [Titer] in Serum by Immunofluorescence |
| 67711-2 | Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS |
| 68930-7 | Albumin/Globulin [Mass Ratio] in Cerebral spinal fluid by Electrophoresis |
| 80611-7 | Phosphate [Moles/volume] in Urine collected for unspecified duration |
| 81125-7 | Platelet aggregation.ristocetin inhibitor [Presence] in Platelet poor plasma |
| 69939-7 | Trichophyton rubrum DNA [Presence] in Nail by NAA with probe detection |
| 81714-8 | Centromere protein A Ab [Presence] in Serum by Line blot |
| 82334-4 | Interleukin 17A [Mass/volume] in Serum or Plasma |
| 72364-3 | Lymphocytes/100 leukocytes in Vitreous fluid by Manual count |
| 99440-0 | Peanut recombinant (rAra h) 6 IgG4 Ab [Mass/volume] in Serum |
| 72945-9 | Tacrolimus induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73026-7 | Escitalopram induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87457-8 | Phosphate [Mass/mass] in Specimen |
| 73710-6 | Weed Allergen Mix 209 (Common ragweed+Western ragweed+Giant ragweed) IgE Ab [Units/volume] in Serum by Multidisk |
| 73833-6 | Legionella sp Ab [Presence] in Specimen by Immunofluorescence |
| 87828-0 | Crystals [Presence] in Urine |
| 87944-5 | Bacteria identified in Synovial fluid by Anaerobe culture |
| 87971-8 | Microscopic observation [Identifier] in Amniotic fluid by Gram stain |
| 88001-3 | Microscopic observation [Identifier] in Peritoneal dialysis fluid by Gram stain |
| 59653-6 | N-desalkylflurazepam [Mass/mass] in Tissue by Confirmatory method |
| 50637-8 | Coagulation factor XIII inhibitor [Presence] in Platelet poor plasma by Chromogenic method |
| 50892-9 | Palladium [Moles/mass] in Hair |
| 50996-8 | HBB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 30465-9 | Prolymphocytes/100 leukocytes in Blood |
| 31066-4 | Herpes simplex virus 1 IgG Ab [Units/volume] in Body fluid |
| 41898-8 | Vendor device model code of Glucose meter |
| 51049-5 | CD126 blasts/100 blasts in Bone marrow |
| 51233-5 | CD11c+CD19+ cells/100 cells in Cerebral spinal fluid |
| 51459-6 | Hepatitis E virus Ab [Units/volume] in Serum |
| 43175-9 | Chlamydia trachomatis L2 IgM Ab [Titer] in Serum by Immunofluorescence |
| 22111-9 | Bartonella henselae IgM Ab [Titer] in Serum |
| 22143-2 | Bovine herpesvirus 1 Ab [Titer] in Serum |
| 31963-2 | Rubella virus Ag [Presence] in Throat |
| 51773-0 | HEXA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 44276-4 | Equine adenovirus Ag [Titer] in Serum by Neutralization test |
| 23027-6 | Dermatophilus congolensis Ab [Presence] in Serum by Immunoassay |
| 5308-2 | Rickettsia rickettsii IgM Ab [Titer] in Serum by Immunofluorescence |
| 53334-9 | Crystals unspecified [Presence] in Urine by Computer assisted method |
| 5337-1 | Salivary gland Ab [Units/volume] in Serum |
| 4445-3 | Tobramycin [Mass] of Dose |
| 44600-5 | IgM [Presence] in 24 hour Urine by Immunofixation |
| 23339-5 | Paratuberculosis reaction wheal [Diameter] --3 days post 0.1 mL avian tuberculin intradermal |
| 53770-4 | Legionella pneumophila 1+2+3+4+5+6 IgG Ab [Titer] in Serum |
| 24007-7 | Epstein Barr virus early IgG Ab [Units/volume] in Serum |
| 33905-1 | Trichomonas sp [#/area] in Urine sediment by Microscopy high power field |
| 54162-3 | Cytoplasmic Ab pattern.PL-7+PL-12 [Titer] in Serum by Immunofluorescence |
| 54182-1 | Para aminosalicylate [Susceptibility] by Disk diffusion (KB) |
| 54187-0 | Posaconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 46199-6 | Parainfluenza virus 1 Ab [Titer] in Cerebral spinal fluid |
| 34492-9 | NOTCH3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 25126-4 | Phenylpyruvate/Creatinine [Molar ratio] in Urine |
| 55671-2 | Dibekacin [Susceptibility] by Disk diffusion (KB) |
| 26680-9 | Aspartate [Moles/volume] in Urine |
| 56790-9 | Insulin [Units/volume] in Serum or Plasma --36 hours post XXX challenge |
| 57000-2 | Yellow Jacket IgG4 Ab [Units/volume] in Serum |
| 48425-3 | Troponin T.cardiac [Mass/volume] in Blood |
| 49317-1 | Hemoglobin pattern [Interpretation] in Blood Narrative |
| 57691-8 | Cortisol [Mass/volume] in Saliva (oral fluid) --9th specimen |
| 58078-7 | IH Ab [Presence] in Serum or Plasma |
| 4940-3 | HLA-DQ5(1) [Presence] in Donor |
| 49457-5 | Androgen receptor Ag [Presence] in Tissue by Immune stain |
| 49674-5 | Lymphocyte proliferation stimulated by 10 umol beryllium [Ratio] in Blood --5 days post incubation |
| 29152-6 | Somatotropin [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
| 39794-3 | Tocainide [Moles/volume] in Serum or Plasma |
| 4018-8 | quiNINE [Mass/volume] in Blood |
| 58654-5 | Cortisol [Moles/volume] in Saliva (oral fluid) --1st specimen post XXX challenge |
| 4982-5 | HLA-DR4 [Presence] in Donor |
| 50053-8 | Hemicystine/Amino acids.total in Specimen |
| 40525-8 | Monocytes/100 leukocytes in Pericardial fluid by Manual count |
| 59297-2 | Lacosamide [Mass/volume] in Serum or Plasma |
| 50239-3 | Urate crystals amorphous [Presence] in Urine by Computer assisted method |
| 50335-9 | Alpha-beta crystallin Ag [Presence] in Tissue by Immune stain |
| 20448-7 | Insulin [Units/volume] in Serum or Plasma |
| 20635-9 | 3-Methylhistidine [Moles/volume] in Serum or Plasma |
| 20765-4 | Clostridium septicum Ag [Presence] in Tissue by Immunofluorescence |
| 100839-0 | Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma |
| 101403-4 | Borrelia burgdorferi.VlsE1+pepC10 IgG+IgM Ab [Presence] in Serum by Immunoassay |
| 101766-4 | Trichophyton erinacei DNA [Presence] in Specimen by NAA with probe detection |
| 101908-2 | AP-3 complex Ab [Titer] in Specimen |
| 13908-9 | Oxipurinol [Mass/volume] in Serum or Plasma |
| 102695-4 | Blueberry IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104116-9 | Multiple sulfatase deficiency [Enzymatic activity/volume] in DBS |
| 104293-6 | PDGFRA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 104334-8 | Bordetella pertussis.pertussis toxin IgG Ab [Titer] in Serum by Immunoassay --1st specimen |
| 15281-9 | Horse Bot Fly IgE Ab [Units/volume] in Serum |
| 1073-6 | Jk sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
| 170-1 | Cephradine [Susceptibility] by Disk diffusion (KB) |
| 17797-2 | Thyroid colloidal Ab [Units/volume] in Serum |
| 18258-4 | Trimethoprim IgE Ab [Units/volume] in Serum |
| 90045-6 | Treatment history of specimen [Identifier] in Semen |
| 92746-7 | 7-Alpha,12-alpha dihydroxycholest-4-en-3-one and 7-Alpha hydroxy-4-cholesten-3-one panel - Serum or Plasma |
| 75085-1 | Homogentisate/Creatinine [Molar ratio] in 24 hour Urine |
| 76087-6 | Parainfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with probe detection |
| 92962-0 | Proteus sp DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection |
| 93044-6 | Level of evidence |
| 61300-0 | Pea IgE Ab/IgE total in Serum |
| 93712-8 | Epstein Barr virus nuclear Ab [Presence] in Serum from Donor by Immunoassay |
| 93783-9 | Diffuse large B-cell lymphoma cell of origin [Type] in Tissue |
| 93815-9 | PROC gene full mutation analysis in Blood or Tissue by Sequencing |
| 9395-5 | SUFentanil [Mass/volume] in Serum or Plasma |
| 77952-0 | Trypanosoma cruzi Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 78534-5 | Glucose [Moles/volume] in Peritoneal dialysis fluid --2 hour dwell specimen |
| 7870-9 | Echovirus 40 Ab [Titer] in Serum |
| 94607-9 | Equine rhinitis A virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 64974-9 | Horse recombinant (rEqu c) 1 IgE Ab [Units/volume] in Serum |
| 78959-4 | Hyocholate [Moles/volume] in Serum or Plasma |
| 79490-9 | 3,4-Dihydroxyhydrocinnamate/Creatinine [Molar ratio] in Urine |
| 94875-2 | Nuclear IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 659-3 | Microscopic observation [Identifier] in Specimen by Carbol-fuchsin stain |
| 80147-2 | Tricyclic antidepressants [Presence] in Body fluid by Screen method |
| 96305-8 | Enterococcus faecium DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 96498-1 | La Crosse virus Ab.IgG and IgM panel - Cerebral spinal fluid |
| 67816-9 | Trisomy 18 + Trisomy 13 risk [Likelihood] in Fetus |
| 80606-7 | 14-Hydroxyclarithromycin [Mass/volume] in Serum or Plasma |
| 96969-1 | MYD88 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 97005-3 | Maximum amplitude kaolin+tissue factor induced [Length] in Blood by Resonance TEG |
| 97200-0 | Lipemic interference index of Cerebral spinal fluid |
| 69382-0 | t(9;22)(q34.1;q11)(ABL1,BCR) b3a2 fusion transcript/control transcript (International Scale) in Blood or Tissue by Molecular genetics method |
| 69481-0 | ACVRL1 gene+ENG gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
| 97516-9 | Acanthamoeba sp Ab [Presence] in Specimen by Immunofluorescence |
| 82720-4 | Natural killer cell cytotoxicity panel - Blood mononuclear cells |
| 9838-4 | Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence |
| 83052-1 | PD-L1 by clone 22C3 [Presence] in Tissue by Immune stain |
| 83088-5 | Cortisol [Mass/volume] in Serum or Plasma by Immunoassay |
| 85300-2 | Mitotic rate [Score] in Breast cancer specimen by Nottingham |
| 99518-3 | Weight of Pancreas |
| 99910-2 | Atypical crystals [#/area] in Urine sediment by Computer assisted method |
| 72694-3 | Cholinesterase activity panel - Serum or Plasma |
| 72828-7 | Chlamydia trachomatis and Neisseria gonorrhoeae DNA panel - Specimen |
| 7310-6 | Douglas Fir IgE Ab [Units/volume] in Serum |
| 73564-7 | Alpha hydroxytriazolam [Mass/mass] in Meconium by Confirmatory method |
| 73724-7 | Bile acid dihydroxy and trihydroxy panel - Serum or Plasma |
| 87948-6 | Clostridium botulinum [Presence] in Stool by Organism specific culture |
| 87991-6 | Acanthamoeba sp identified in Contact lens by Organism specific culture |
| 74126-4 | Mucin-4 (MUC-4) Ag [Presence] in Tissue by Immune stain |
| 41181-9 | Candida albicans reaction wheal [Diameter] --1 day post Candida albicans intradermal |
| 41464-9 | Amphetamines/Creatinine [Mass Ratio] in Urine |
| 59396-2 | Echovirus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 59679-1 | Flurazepam [Mass/mass] in Tissue by Confirmatory method |
| 5974-1 | Plasminogen activator inhibitor 1 [Units/volume] in Platelet poor plasma by Chromogenic method |
| 50870-5 | Isopropanol [Moles/volume] in Body fluid |
| 42641-1 | Babesia sp DNA [Presence] in Specimen by NAA with probe detection |
| 2141-0 | Corticotropin [Mass/volume] in Plasma |
| 21644-0 | CACNA1S gene p.Arg528His [Presence] in Blood or Tissue by Molecular genetics method |
| 51063-6 | Cytoplasmic CD13 blasts/100 blasts in Specimen |
| 42807-8 | Parasite identified in Isolate |
| 43114-8 | Porphyrin fractions [Interpretation] in 24 hour Urine |
| 22318-0 | Hepatitis B virus core IgG Ab [Units/volume] in Serum |
| 32161-2 | Catecholamines [Presence] in 24 hour Urine |
| 32362-6 | BK virus DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 32533-2 | CD3+CD4+ (T4 helper) cells/100 cells in Bone marrow |
| 44007-3 | CD55 and CD59 RBC [Interpretation] in Blood |
| 44065-1 | CD20+FMC7+ cells [#/volume] in Bone marrow |
| 44372-1 | Histidine/Creatinine [Mass Ratio] in 24 hour Urine |
| 44400-0 | Pyruvate/Creatinine [Mass Ratio] in 24 hour Urine |
| 23130-8 | Francisella tularensis DNA [Presence] in Tissue by NAA with probe detection |
| 32707-2 | Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Urine |
| 33024-1 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 1.2 g/kg lactose PO |
| 53447-9 | Carboxymefloquine [Mass/volume] in Serum or Plasma |
| 447-3 | Sisomicin [Susceptibility] by Minimum lethal concentration (MLC) |
| 44935-5 | Thyrotropin [Units/volume] in Serum or Plasma --15 minutes post dose TRH IV |
| 45093-2 | Chlamydia trachomatis [Presence] in Anal by Organism specific culture |
| 34151-1 | CD10+CD25+ cells [#/volume] in Blood |
| 24285-9 | Western equine encephalitis virus Ab [Titer] in Serum --1st specimen |
| 24492-1 | Tree Allergen Mix 4 (White oak+White elm+London plane or Maple leaf sycamore+Willow+Cottonwood) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 24506-8 | Dust Allergen Mix 2 (Cockroach+American house dust mite+European house dust mite+House dust Hollister Stier) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 2484-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma |
| 34366-5 | Protein/Creatinine [Ratio] in Urine |
| 34503-3 | Chromosome 15 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics |
| 34519-9 | HFE gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 34695-7 | Cholesterol in VLDL/Triglyceride [Ratio] in Serum or Plasma |
| 25560-4 | Allobarbital [Moles/volume] in Serum or Plasma |
| 35053-8 | Leukocytes other [#/volume] in Synovial fluid |
| 35451-4 | Herpes simplex virus identified in Nasopharynx by Organism specific culture |
| 35676-6 | Chloride [Moles/volume] in Urine collected for unspecified duration |
| 35743-4 | Eastern equine encephalitis virus IgG and IgM panel - Specimen |
| 48055-8 | Pneumocystis jiroveci [Presence] in Specimen by Calcofluor white |
| 56898-0 | CD5+FMC7+ cells/100 cells in Tissue |
| 27010-8 | Mesoporphyrin [Mass/time] in 24 hour Stool |
| 270-9 | Gramicidin D [Susceptibility] by Minimum lethal concentration (MLC) |
| 3836-4 | Nadolol [Presence] in Urine |
| 5735-6 | Silver [Mass/volume] in Urine |
| 57493-9 | 11-Deoxycorticosterone [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
| 49244-7 | Alpha 1 antitrypsin phenotype [Interpretation] in Serum or Plasma Narrative |
| 27294-8 | Carnosine [Moles/volume] in Urine |
| 3983-4 | Procainamide+N-acetylprocainamide [Mass/volume] in Serum or Plasma |
| 40158-8 | Glucose [Moles/volume] in Serum or Plasma --50 minutes post XXX challenge |
| 29775-4 | Insulin-like growth factor-I [Moles/volume] in Serum or Plasma |
| 40458-2 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor VIII depleted plasma |
| 59243-6 | Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 50297-1 | 4-Hydroxyifosfamide [Mass/volume] in Blood --5 days post dose ifosfamide |
| 50579-2 | Gastric analysis panel - Gastric fluid |
| 30038-4 | Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 30101-0 | Yersinia enterocolitica O:5 Ab [Titer] in Specimen |
| 19313-6 | Tricyclic antidepressants tested for in Urine by Screen method Nominal |
| 2005-7 | Calcium [Moles/time] in 2 hour Urine --12 hours fasting |
| 20980-9 | Venezuelan equine encephalitis virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 1014-0 | E sup(w) Ag [Presence] on Red Blood Cells from Donor |
| 101522-1 | Porcine deltacoronavirus S gene [Nucleotide sequence] in Isolate by Sequencing |
| 13864-4 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
| 13917-0 | Coccidioides immitis Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 14264-6 | Enflurane [Mass/volume] in Blood |
| 102954-5 | Romano Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15145-6 | Methionine+Tryptophan [Presence] in Urine |
| 11032-0 | Glucose [Mass/volume] in Serum or Plasma --45 minutes post 50 g lactose PO |
| 16820-3 | Entamoeba histolytica Ab [Units/volume] in Serum by Complement fixation |
| 17318-7 | Nalbuphine [Mass/volume] in Serum or Plasma |
| 91845-8 | Trichomonas vaginalis [Presence] in Genital specimen by Light microscopy |
| 75036-4 | 2-Hydroxyglutarate [Moles/volume] in Amniotic fluid |
| 75579-3 | Comment on fetal 22q11.2 deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 92933-1 | 9p21 g.22125503G>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 93435-6 | Busulfan [Mass/volume] in Plasma --1 hour post busulfan infusion completion |
| 77112-1 | PLOD3 gene full mutation analysis in Blood or Tissue by Sequencing |
| 63084-8 | Coconut IgG Ab [Mass/volume] in Serum |
| 63124-2 | Basil IgG Ab [Mass/volume] in Serum |
| 63232-3 | DNA double strand IgM Ab [Presence] in Body fluid by Immunofluorescence |
| 63248-9 | Ganglioside GM2 IgG Ab [Presence] in Serum by Immunoassay |
| 79143-4 | Mercury [Moles/mass] in Nail |
| 79170-7 | Cherry recombinant (rPru av) 1 IgE Ab [Units/volume] in Serum |
| 79212-7 | Fetal Microdeletions risk [interpretation] in Plasma cell-free DNA Qualitative by Sequencing |
| 95266-3 | Vitamin B6 and metabolites panel - Serum or Plasma |
| 95637-5 | Jamestown canyon virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 95652-4 | Venezuelan equine encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 95679-7 | Barmah forest virus IgM Ab [Presence] in Specimen by Immunoassay |
| 66120-7 | Thyroid Pathology biopsy report |
| 66499-5 | Cholesterol in VLDL.beta [Mass/volume] in Serum or Plasma |
| 6733-0 | Pigeon serum Ab [Presence] in Serum by Immune diffusion (ID) |
| 79514-6 | N-acetyltyrosine [Moles/volume] in Serum or Plasma |
| 79640-9 | Saccharopine/Creatinine [Molar ratio] in Urine |
| 80561-4 | cycloSPORINE [Mass/volume] in DBS |
| 81701-5 | Microsatellite instability marker MONO27 in Cancer specimen Qualitative |
| 82219-7 | 3-Methylglutaconyl-CoA hydratase [Enzymatic activity/mass] in Fibroblast |
| 70102-9 | Methotrexate [Moles/volume] in Serum or Plasma --5th specimen |
| 82921-8 | Liver cytosol IgG Ab [Presence] in Serum by Line blot |
| 9800-4 | Number of Stones |
| 71836-1 | Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Venous blood |
| 85511-4 | BRAF gene mutations found [Identifier] in Colorectal cancer specimen by Molecular genetics method Nominal |
| 72922-8 | HNA 1a/1a Ab [Presence] in Serum by Immunoassay |
| 86218-5 | Transmissible gastroenteritis virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 86343-1 | Streptococcus pneumoniae Danish serotype 6A+6B Ab [Mass/volume] in Serum --1st specimen |
| 73349-3 | HYDROcodone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73386-5 | Famotidine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86731-7 | Leptospira sp DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 7386-6 | Halibut IgG Ab [Units/volume] in Serum |
| 87774-6 | tiZANidine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 88731-5 | Ganglioside GM2 IgG+IgM Ab [Units/volume] in Serum by Immunoassay |
| 41640-4 | Ricin toxin IgG Ab [Presence] in Serum by Immunofluorescence |
| 41708-9 | Oritavancin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 59649-4 | N-desalkylflurazepam [Mass/volume] in Body fluid by Confirmatory method |
| 59673-4 | fentaNYL [Presence] in Urine by Screen method |
| 59880-5 | chlordiazePOXIDE [Moles/volume] in Gastric fluid |
| 42670-0 | pH of Vitreous fluid |
| 4280-4 | hydrOXYzine [Mass] of Dose |
| 4313-3 | Mesoridazine [Mass] of Dose |
| 43199-9 | Norfentanyl [Presence] in Urine |
| 21820-6 | t(9;11)(p22;q23)(MLLT3,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 51794-6 | Mitochondria M2 Ab [Titer] in Serum by Immunofluorescence |
| 51810-0 | Coxiella burnetii phase 1 IgG Ab [Units/volume] in Serum by Immunoassay |
| 43420-9 | Uranium dose assessment [Interpretation] in Urine |
| 22377-6 | Lassa virus IgG Ab [Presence] in Serum |
| 32131-5 | Hantavirus IgM Ab [Presence] in Serum |
| 32138-0 | Cystine/Total in Stone |
| 5203-5 | Herpes simplex virus Ab [Units/volume] in Serum by Latex agglutination |
| 44016-4 | Bile [Presence] in Body fluid |
| 22818-9 | Avian infectious laryngotracheitis virus Ag [Presence] in Trachea by Immunoassay |
| 23041-7 | Duck hepatitis virus 3 Ag [Presence] in Specimen by Immunofluorescence |
| 44521-3 | Herpes virus 6 IgG Ab [Presence] in Serum by Immunofluorescence |
| 44522-1 | Histoplasma capsulatum Ab [Presence] in Serum by Immunoassay |
| 44770-6 | Neuronal nuclear IgG Ab [Titer] in Serum by Immunofluorescence |
| 2353-1 | Glucose phosphate isomerase [Enzymatic activity/volume] in Serum |
| 23580-4 | Rabbit hemorrhagic disease virus Ag [Presence] in Tissue by Immunoassay |
| 23600-0 | Leptospira sp identified in Milk by Organism specific culture |
| 3344-9 | Amoxicillin [Mass/volume] in Serum or Plasma |
| 33694-1 | Clostridium botulinum [Presence] in Specimen by Organism specific culture |
| 5350-4 | Shigella sp Ab [Units/volume] in Serum |
| 53939-5 | CD4 stimulated ATP immune response [Mass/volume] in Blood |
| 23957-4 | Bartonella henselae IgG Ab [Titer] in Cerebral spinal fluid |
| 3384-5 | Benzfetamine [Mass/time] in 24 hour Urine |
| 2425-7 | Histidine ammonia lyase [Enzymatic activity/volume] in Serum |
| 2433-1 | Homogentisate [Mass/volume] in Urine |
| 34314-5 | Heptacarboxylporphyrin [Moles/volume] in Urine |
| 55578-9 | Sildenafil citrate [Moles/volume] in Serum or Plasma |
| 47232-4 | Influenza virus A Ab [Presence] in Serum --1st specimen |
| 3483-5 | Cimetidine [Presence] in Urine |
| 55858-5 | Estradiol (E2) [Moles/volume] in Body fluid |
| 25889-7 | Cysteate [Moles/volume] in 24 hour Urine |
| 2590-8 | Lysozyme [Mass/time] in 24 hour Urine |
| 3546-9 | Diamorphine [Presence] in Urine |
| 35580-0 | N-methyl valine [Mass/volume] in Blood |
| 35667-5 | Atomoxetine [Mass/volume] in Serum or Plasma |
| 56308-0 | Lima Bean IgG4 Ab [Mass/volume] in Serum |
| 56430-2 | Whitefish IgG4 Ab [Mass/volume] in Serum |
| 48001-2 | Cytogenetic (chromosome) location |
| 26503-3 | Neutrophils [#/volume] in Semen |
| 56639-8 | Methyl ethyl ketone [Moles/volume] in Urine |
| 48601-9 | OPA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 48756-1 | 3-Hydroxyoctanoate.free (3-OH-C8:0) [Moles/volume] in Serum or Plasma |
| 38548-4 | HLA-A locus [Type] |
| 57682-7 | Coxiella burnetii IgG Ab [Presence] in Serum by Immunofluorescence --2nd specimen |
| 2760-7 | Phenolsulphonphthalein [Mass/volume] in Urine |
| 27929-9 | Mandelate [Presence] in Urine |
| 38726-6 | Titanium tetrachloride [Mass/volume] in Air |
| 39533-5 | Deoxyhemoglobin [Mass/volume] in Blood |
| 400-2 | Phenethicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 40305-5 | Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose arginine |
| 58388-0 | Normeperidine [Presence] in Urine by Confirmatory method |
| 50016-5 | Sugar [Type] of Dose |
| 58923-4 | Perennial rye grass IgG Ab [Mass/volume] in Serum |
| 50294-8 | 4-Hydroxyifosfamide [Mass/volume] in Blood --2 days post dose ifosfamide |
| 50590-9 | Adenine phosphoribosyltransferase [Enzymatic activity/mass] in Trophoblasts |
| 13443-7 | Creatinine renal clearance in 8 hour Urine and Serum or Plasma |
| 13591-3 | Factor inhibitor XXX [Units/volume] in Platelet poor plasma by Coagulation assay |
| 13756-2 | Histamine/Creatinine [Mass Ratio] in 24 hour Urine |
| 1394-6 | Cortisol Free [Mass/volume] in 24 hour Urine --pre 50 ug corticotropin IM 3 day |
| 14096-2 | Intercalated disk Ab [Titer] in Serum by Immunofluorescence |
| 15000-3 | Thyrotropin [Units/volume] in Serum or Plasma --pre dose TRH IV |
| 15225-6 | Food Allergen Mix 72 (Fennel seed+Basil+Anise+Ginger) IgE Ab [Presence] in Serum by Multidisk |
| 104270-4 | J gene rearrangement [Identifier] in Specimen by Molecular genetics method Nominal |
| 10601-3 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus |
| 16147-1 | Aldosterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 10748-2 | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Verhoeff-Van Gieson stain |
| 16512-6 | Calcium.ionized [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 11277-1 | Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field |
| 12202-8 | Cryoglobulin [Presence] in Serum by 2 day cold incubation |
| 17137-1 | CD30 cells/100 cells in Blood |
| 17600-8 | Volume of 6 hour Urine |
| 17900-2 | Bacteria # 3 identified in Throat by Aerobe culture |
| 18232-9 | Hydrocorticosterone [Presence] in Urine |
| 90363-3 | Chlamydia trachomatis L1 IgM Ab [Titer] in Serum by Immunoassay |
| 90456-5 | Influenza virus types A and B panel - Cerebral spinal fluid by NAA with probe detection |
| 91070-3 | Hepatitis A virus RNA [Presence] in Stool by NAA with probe detection |
| 60425-6 | Human metapneumovirus Ag [Presence] in Specimen |
| 93805-0 | MDM2 gene copy number/nucleus in Tissue by FISH |
| 94285-4 | Contactin-associated protein 2 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 79206-9 | inv(2)(p21;p23)(EML4,ALK) fusion transcript [Presence] in Blood or Tissue by FISH |
| 95192-1 | Interferon-gamma producing CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC) |
| 7956-6 | Legionella pneumophila 9 Ab [Titer] in Serum by Immunofluorescence |
| 80183-7 | Xanthopterin [Moles/volume] in Serum or Plasma |
| 8028-3 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum by Immunoassay |
| 80350-2 | Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with non-probe detection |
| 96452-8 | Hepatocellular carcinoma risk panel - Serum or Plasma |
| 96666-3 | HLA-DRB1 unresolved alleles [Type] in Donor by High resolution |
| 96728-1 | Elastic fibers [#/volume] in Lower respiratory specimen by Manual count |
| 82048-0 | Epidermal Allergen Mix 70 (Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 82079-5 | Food Allergen Mix 9 (Kiwi+Melon+Banana+Almond+Grape) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 82091-0 | Occupational Allergen Mix 4 (Amylase+Soybean+Grain weevel+Wheat) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 70122-7 | Epithelial cells.squamous [Presence] in Body fluid |
| 7157-1 | Brazil Nut IgG Ab [Units/volume] in Serum |
| 7241-3 | Coconut triggered histamine release [Units/volume] in Blood |
| 85281-4 | Intratumoral lymphocytic response in Cancer specimen Qualitative by Light microscopy |
| 99774-2 | SARS coronavirus 2 stimulated gamma interferon release by T-cells.Nucleocapsid Ag spot count [#] corrected for background in Blood |
| 86044-5 | Streptococcus pneumoniae Danish serotype 2 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 86691-3 | Rotavirus B RNA [Presence] in Specimen by NAA with probe detection |
| 7305-6 | Endive IgG Ab [Units/volume] in Serum |
| 87478-4 | Cadmium [Mass/mass] in Specimen |
| 87780-3 | Ziprasidone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 88234-0 | Microscopic observation [Presence] in Synovial fluid by Acid fast stain |
| 74228-8 | Myelopoiesis assessment in Bone marrow Narrative |
| 74348-4 | Bacteria identified in Bone from Donor by Aerobe culture |
| 89306-5 | Nortapentadol [Presence] in Urine by Screen method |
| 59335-0 | Sibutramine [Mass/volume] in Serum or Plasma |
| 59737-7 | Selenium [Mass/mass] in Nail |
| 30440-2 | Monocytes Abnormal [#/volume] in Blood |
| 31600-0 | Rickettsia prowazekii IgM Ab [Units/volume] in Serum |
| 51155-0 | CD33 blasts/100 blasts in Bone marrow |
| 42890-4 | Myeloperoxidase cells/100 cells in Body fluid |
| 2189-9 | Cytosol aminopeptidase [Enzymatic activity/volume] in Urine |
| 2207-9 | Dicarboxylate, C6-C8-C10 [Mass/volume] in Urine |
| 51700-3 | Microscopic observation [Identifier] in Specimen by Lactophenol blue |
| 43404-3 | Chlamydia trachomatis DNA [Presence] in Specimen by Probe with signal amplification |
| 4349-7 | Nicotinamide [Mass] of Dose |
| 22413-9 | Mumps virus Ab [Titer] in Cerebral spinal fluid |
| 22501-1 | Measles virus IgG Ab [Titer] in Cerebral spinal fluid |
| 32364-2 | Herpes virus 8 DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 52765-5 | Thromboelastography without activation panel - Blood |
| 53053-5 | Carnitine [Moles/volume] in Amniotic fluid |
| 53091-5 | Nitrogen.nonprotein [Moles/volume] in Serum or Plasma |
| 53186-3 | Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 23351-0 | Peste des petits ruminants virus Ab [Presence] in Serum |
| 33571-1 | Jo-1 extractable nuclear IgG Ab [Units/volume] in Serum |
| 33692-5 | Yersinia pestis DNA [Presence] in Isolate by NAA with probe detection |
| 53740-7 | HLA-DRB1*17 [Presence] |
| 45281-3 | Echovirus 7 Ab [Presence] in Body fluid |
| 2400-0 | Guanine deaminase [Enzymatic activity/volume] in Blood |
| 3379-5 | Bendroflumethiazide [Mass/volume] in Urine |
| 2439-8 | Hydroxycalcidiol [Mass/volume] in Serum |
| 54936-0 | Carbon tetrachloride [Mass/volume] in Serum or Plasma |
| 54942-8 | N-ethyldiethanolamine [Mass/volume] in Urine |
| 47209-2 | Glucagon [Mass] of Dose |
| 47310-8 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 47477-5 | Rickettsia rickettsii IgG Ab [Titer] in Cerebral spinal fluid |
| 25091-0 | C peptide/Creatinine [Molar ratio] in Urine |
| 35154-4 | Hexadecadienoate (C16:2) [Moles/volume] in Serum or Plasma |
| 47761-2 | Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose glucose PO |
| 25767-5 | Insulin-like growth factor [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 35484-5 | Methyl parathion [Mass/volume] in Serum or Plasma |
| 35634-5 | Secobarbital [Mass/volume] in Serum or Plasma by Screen method |
| 35749-1 | DMPK phenotype [Type] in Blood or Tissue by Molecular genetics method |
| 56431-0 | Wine vinegar IgG4 Ab [Mass/volume] in Serum |
| 47936-0 | Somatotropin [Units/volume] in Serum or Plasma --pre dose ornithine |
| 48099-6 | Cortisol [Mass/volume] in Serum or Plasma --12 PM specimen |
| 26059-6 | European tick borne encephalitis virus IgG Ab [Units/volume] in Serum by Immunoassay |
| 26677-5 | Bartonella quintana Ab [Presence] in Serum |
| 363-2 | Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 37985-9 | West Nile virus RNA [Presence] in Specimen by Probe |
| 48506-0 | Platelet glycoprotein Ib/Ix Ab [Presence] in Serum by Immunoassay |
| 48845-2 | Bartonella elizabethae IgM Ab [Titer] in Serum by Immunofluorescence |
| 2717-7 | Fractional oxyhemoglobin in Plasma |
| 38495-8 | Phenylalanine+Tyrosine [Presence] in Urine |
| 57422-8 | CD40 cells/100 cells in Body fluid |
| 48926-0 | Respiratory allergen panel, US - Great plains states b - Serum |
| 5770-3 | Bilirubin.total [Presence] in Urine by Test strip |
| 49698-4 | pH of Arterial cord blood adjusted to patient's actual temperature |
| 29223-5 | PHENobarbital [Mass/volume] in Body fluid |
| 29385-2 | Nordiazepam [Mass/volume] in Gastric fluid |
| 39996-4 | Creatinine [Mass/volume] in Urine --1 day post XXX challenge |
| 40201-6 | Glucose [Moles/volume] in Serum or Plasma --6 minutes post XXX challenge |
| 58575-2 | Corticotropin [Moles/volume] in Plasma --2 hours post dose glucose |
| 49963-2 | Fibrillarin Ab [Presence] in Serum |
| 40680-1 | Treponema pallidum IgM Ab [Presence] in Serum by Immunoblot |
| 58872-3 | Somatotropin [Mass/volume] in Serum or Plasma --36th specimen |
| 50323-5 | MSH-2 Ag [Presence] in Tissue by Immune stain |
| 5048-4 | Nuclear Ab [Titer] in Serum by Immunofluorescence |
| 30000-4 | Microalbumin/Creatinine [Ratio] in Urine |
| 30041-8 | Turmeric IgE Ab [Units/volume] in Serum |
| 41099-3 | GLA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 20985-8 | Western equine encephalitis virus Ab [Presence] in Serum by Complement fixation |
| 100052-0 | Flomoxef [Susceptibility] |
| 12458-6 | Corticotropin [Mass/volume] in Plasma --2nd specimen post XXX challenge |
| 12583-1 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --8th specimen |
| 12766-2 | Insulin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 101308-5 | Glucose post arginine stimulation panel - Serum or Plasma |
| 101317-6 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --30 minutes post dose corticotropin |
| 13307-4 | HLA-DQ alpha [Type] |
| 13842-0 | CD20 blasts/100 blasts in Blood |
| 13867-7 | Renin [Enzymatic activity/volume] in Plasma --1 hour post 25 mg captopril PO |
| 103957-7 | Neuromuscular multigene analysis in Specimen by Molecular genetics method |
| 104286-0 | UGT1A1 gene.p.P229Q [Presence] in Blood or Tissue by Molecular genetics method |
| 10669-0 | Fungus identified in Specimen by Sticky tape for environmental fungus |
| 16153-9 | Gastrin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 11002-3 | Scopolamine [Presence] in Urine |
| 16671-0 | Cortisol [Mass/volume] in Serum or Plasma --1 minute post XXX challenge |
| 1143-7 | Lu sup(b) Ab [Presence] in Serum or Plasma from Donor |
| 11526-1 | Pathology study |
| 16890-6 | Gastrin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 16998-7 | HYDROmorphone [Mass/volume] in Urine by Confirmatory method |
| 17172-8 | CD52 cells/100 cells in Blood |
| 17663-6 | sulfADIAZINE IgE Ab [Units/volume] in Serum |
| 1778-0 | Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma |
| 18343-4 | 6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Screen method |
| 1860-6 | Angiotensin II [Mass/volume] in Plasma |
| 18904-3 | Chlortetracycline [Susceptibility] |
| 18988-6 | Talampicillin [Susceptibility] |
| 7481-5 | Red+Silver Maple IgE Ab [Units/volume] in Serum |
| 92488-6 | little s Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 75368-1 | Buprenorphine [Mass/volume] in Serum, Plasma or Blood |
| 75599-1 | Fetal 1p36 deletion prior risk [Likelihood] based on general population risk Narrative |
| 60380-3 | Lamb IgG Ab [Mass/volume] in Serum |
| 6124-2 | Giant Ragweed IgE Ab [Units/volume] in Serum |
| 61257-2 | Dermatophagoides microceras IgE Ab/IgE total in Serum |
| 6260-4 | Sweet gum IgE Ab [Units/volume] in Serum |
| 63350-3 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
| 63444-4 | Somatotropin [Mass/volume] in Serum or Plasma --7 hours post XXX challenge |
| 94874-5 | Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 95237-4 | Hepatitis C virus Ab [Interpretation] in Serum or Plasma |
| 65344-4 | Glucagon [Mass/volume] in Serum or Plasma --pre XXX challenge |
| 65762-7 | Hantavirus Ag [Presence] in Tissue by Immune stain |
| 79627-6 | N-alpha acetyllysine/Creatinine [Molar ratio] in Urine |
| 80364-3 | Chlamydia trachomatis rRNA [Presence] in Anorectal by NAA with probe detection |
| 68386-2 | Glomerular basement membrane IgG Ab [Presence] in Serum by Immunoassay |
| 68463-9 | Rilpivirine [Susceptibility] by Genotype method |
| 8154-7 | Amphetamines [Presence] in Unknown substance |
| 96918-8 | Fodrin alpha subunit IgA Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 97107-7 | Fibroblast growth factor 19 [Mass/volume] in Serum or Plasma by Immunoassay |
| 69903-3 | Service comment 76 |
| 97533-4 | Somatotropin post glucose stimulation panel - Serum or Plasma |
| 98042-5 | Chanterelles IgE Ab [Units/volume] in Serum |
| 7166-2 | Burweed IgE Ab [Units/volume] in Serum |
| 72383-3 | HER2 [Presence] in Tissue by Immunoassay |
| 83094-3 | Digoxin [Moles/volume] in Serum or Plasma by Immunoassay |
| 85323-4 | Response to neoadjuvant therapy in Breast cancer specimen Qualitative |
| 85541-1 | PRRSV Ingelvac MLV strain ORF5 gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 7255-3 | Western Cottonwood IgE Ab [Units/volume] in Serum |
| 85839-9 | Beta-lactam resistance ESBL blaTEM gene [Presence] by Molecular method |
| 86242-5 | Color of Nasal fluid |
| 86454-6 | N-nortramadol [Presence] in Urine |
| 73348-5 | HYDROcodone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73654-6 | Hepatitis C virus NS3 gene mutations detected [Identifier] by Genotype method |
| 87776-1 | Zaleplon/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 87973-4 | Microscopic observation [Identifier] in Semen by Gram stain |
| 88580-6 | Burkholderia sp identified in Lower respiratory specimen by Organism specific culture |
| 7393-2 | Helminthosporium interseminatum IgE Ab [Units/volume] in Serum |
| 74358-3 | Adenine phosphoribosyltransferase [Enzymatic activity/volume] in Serum or Plasma |
| 41470-6 | Atazanavir [Mass/volume] in Serum or Plasma |
| 4215-0 | Dextromoramide [Mass] of Dose |
| 60129-4 | Paraoxon [Mass/volume] in Blood |
| 21533-5 | Spermatozoa Motile/100 spermatozoa in Semen --3 hours post ejaculation |
| 31518-4 | Mycoplasma synoviae Ab [Units/volume] in Serum |
| 51209-5 | Tin [Mass/mass] in Hair |
| 43103-1 | CV2 IgG Ab [Units/volume] in Serum |
| 21684-6 | Gaucher 3 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 31723-0 | Avian leukosis virus Ag [Units/volume] in Egg yolk |
| 31840-2 | Haemophilus influenzae E Ag [Presence] in Specimen |
| 31883-2 | Measles virus Ag [Presence] in Sputum |
| 31945-9 | Pseudorabies virus Ag [Presence] in Specimen |
| 51501-5 | Estradiol (E2) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 43698-0 | Enterovirus identified in Specimen by Shell vial culture |
| 22670-4 | Alloisoleucine [Moles/volume] in Serum or Plasma |
| 32232-1 | Aspartate [Moles/volume] in Body fluid |
| 32270-1 | Serine [Moles/volume] in Body fluid |
| 5219-1 | Histoplasma capsulatum Ab [Titer] in Serum by Complement fixation |
| 52751-5 | aPTT.factor sensitive in Platelet poor plasma by Coagulation assay |
| 5301-7 | Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoassay |
| 23005-2 | Classical swine fever virus Ag [Presence] in Tissue by Immunofluorescence |
| 3319-1 | Amikacin [Mass/volume] in Serum or Plasma --peak |
| 53068-3 | Beta alanine [Moles/volume] in Body fluid |
| 53381-0 | Influenza virus A Ab [Identifier] in Serum |
| 23965-7 | Burkholderia pseudomallei IgG Ab [Titer] in Serum |
| 24018-4 | Neisseria meningitidis serogroup B Ag [Presence] in Urine |
| 539-7 | Mycobacterium sp identified in Sputum by Organism specific culture |
| 54212-6 | Cortisol [Moles/volume] in Serum or Plasma --3 days post dose dexamethasone |
| 54292-8 | Heptanoylcarnitine (C7) [Moles/volume] in Amniotic fluid |
| 34645-2 | Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection |
| 34650-2 | TSC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55484-0 | Insulin [Moles/volume] in Serum or Plasma --10 minutes post dose glucose IV |
| 47362-9 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Specimen from Donor by NAA with probe detection |
| 47463-5 | Legionella pneumophila 12 IgG Ab [Titer] in Serum |
| 25118-1 | Mevalonate/Creatinine [Molar ratio] in Urine |
| 25230-4 | Ethambutol 2.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 55834-6 | Cathepsin S [Mass/volume] in Serum or Plasma |
| 55894-0 | Hypoxanthine phosphoribosyltransferase/Adenine phosphoribosyltransferase [Enzymatic activity ratio] in Placenta |
| 35729-3 | Chlamydia sp DNA [Presence] in Specimen by NAA with probe detection |
| 56406-2 | Trichoderma viride IgG4 Ab [Mass/volume] in Serum |
| 48050-9 | Neutrophils [Presence] in Stool by Wright stain |
| 48181-2 | Reference change value 0.95 [#] in unspecified time Population |
| 48289-3 | Sodium benzoate triggered leukotriene release [Mass/volume] by Leukocytes |
| 3765-5 | Metandienone [Mass/volume] in Urine |
| 27036-3 | Norchlordiazepoxide [Mass/volume] in Urine |
| 27175-9 | glyBURIDE [Mass/volume] in Urine |
| 38576-5 | Butane [Mass/volume] in Air |
| 48938-5 | ALPRAZolam [Mass/volume] in Specimen |
| 39566-5 | Pregnanetriol/Creatinine [Mass Ratio] in 24 hour Urine |
| 49669-5 | Emtricitabine [Susceptibility] by Phenotype method |
| 58798-0 | Legionella pneumophila 2 IgM Ab [Units/volume] in Serum by Immunoassay |
| 29864-6 | 2-Oxo,3-Methylvalerate [Presence] in Urine |
| 40485-5 | Urate crystals [#/area] in Urine sediment by Microscopy low power field |
| 40639-7 | Lambda light chains [Presence] in Serum by Immunofixation |
| 59211-3 | Transcobalamin I+Transcobalamin III [Moles/volume] in Serum |
| 50301-1 | Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Urine |
| 50466-2 | C peptide [Moles/volume] in Serum or Plasma --6th specimen |
| 50522-2 | Prolactin [Mass/volume] in Serum or Plasma --6th specimen |
| 19173-4 | Alpha-1-Fetoprotein [Moles/volume] in Pleural fluid |
| 20604-5 | CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Specimen |
| 2081-8 | Cholecystokinin [Mass/volume] in Plasma |
| 20883-5 | Microscopic observation [Identifier] in Urine by Dark field examination |
| 100810-1 | Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge |
| 101339-0 | Cholesterol [Presence] in Fibroblast by Filipin stain |
| 101531-2 | Porcine epidemic diarrhea virus S1 gene IgA Ab [Units/volume] in Saliva (oral fluid) by Immunoassay |
| 13577-2 | PARoxetine [Presence] in Serum or Plasma |
| 102697-0 | Broccoli IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102751-5 | Haddock IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103012-1 | Aspergillus fumigatus recombinant (rAsp f) 2 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104113-6 | Heparan-N-sulfatase [Enzymatic activity/volume] in DBS |
| 104195-3 | Guanidinoacetate/Creatinine [Molar ratio] in DBS |
| 104241-5 | Plasma cell myeloma multigene analysis in Bone marrow by Molecular genetics method |
| 10775-5 | Microscopic observation [Identifier] in Tissue by Bleach stain |
| 10865-4 | Intercellular substance Ab [Presence] in Serum |
| 16721-3 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Saliva (oral fluid) |
| 17456-5 | Phosphatidylinositol IgM Ab [Presence] in Serum |
| 1806-9 | Amylase S1 [Enzymatic activity/volume] in Serum or Plasma |
| 905-0 | Blood group antigens absent [Identifier] in Blood product unit |
| 74506-7 | 16-Alpha hydroxypregnenolone [Moles/time] in 24 hour Urine |
| 74684-2 | Carbon dioxide, total [Moles/volume] in Serum or Plasma --post dialysis |
| 74887-1 | Stigmastanol [Moles/volume] in Serum or Plasma |
| 75128-9 | Uracil [Moles/volume] in Cerebral spinal fluid |
| 75217-0 | Biotinidase [Enzymatic activity/volume] in DBS |
| 60363-9 | Celery IgG Ab [Mass/volume] in Serum |
| 60681-4 | Cortisol Free [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin |
| 75819-3 | Erythrocyte chromasia [Identifier] in Blood by Light microscopy |
| 6197-8 | Paecilomyces sp IgE Ab [Units/volume] in Serum |
| 77092-5 | MRRF gene full mutation analysis in Blood or Tissue by Sequencing |
| 78047-8 | Cortisol [Moles/volume] in Serum or Plasma --24 hour post XXX challenge |
| 78687-1 | Platelet aggregation thrombin receptor activating peptide-6 induced [Units/volume] in Blood |
| 6351-1 | Chlamydia trachomatis Ag [Presence] in Conjunctival specimen by Immunofluorescence |
| 64966-5 | Wheat recombinant (rTri a) 14 IgE Ab [Units/volume] in Serum |
| 80609-1 | Linezolid [Mass/volume] in DBS |
| 81315-4 | Lactase [Enzymatic activity/mass] in Small intestine Tissue |
| 8139-8 | Amphetamines [Mass/volume] in Gastric fluid |
| 97170-5 | Adalimumab [Mass/volume] in Serum or Plasma --trough |
| 70218-3 | Triglyceride [Moles/volume] in Blood |
| 99308-9 | Acid alpha glucosidase cross-reactive immunologic material (CRIM) [Presence] in Leukocytes by Immunoblot |
| 86223-5 | Acetyl norfentanyl [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 73107-5 | Triamcinolone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73253-7 | Mycophenolate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 732-8 | Lymphocytes [#/volume] in Blood by Manual count |
| 73298-2 | Loperamide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73337-8 | Ibuprofen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86717-6 | Actinobacillus pleuropneumoniae serotype 1 Ab [Titer] in Serum by Complement fixation |
| 87594-8 | Penicillin [Mass/mass] in Specimen |
| 88518-6 | Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood |
| 73990-4 | 2,3',4',5-Tetrachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
| 74301-3 | Succinylacetone [Moles/volume] in DBS --post therapeutic diet |
| 89309-9 | Hydromorphone-3-glucuronide [Presence] in Urine by Screen method |
| 89636-5 | Mycobacterium sp identified in Lower respiratory specimen by Organism specific culture |
| 50695-6 | Treponema pallidum Ab [Titer] in Cerebral spinal fluid by Hemagglutination |
| 50934-9 | Vanadium [Moles/mass] in Hair |
| 50951-3 | Phosphoserine IgA Ab [Presence] in Serum or Plasma |
| 42672-6 | Debris [Presence] in Semen |
| 59913-4 | Imipramine [Moles/volume] in Gastric fluid |
| 5187-0 | Hepatitis B virus core Ab [Units/volume] in Serum by Immunoassay |
| 43398-7 | Gardnerella vaginalis+Prevotella sp morphotypes [Presence] in Vaginal fluid by Light microscopy |
| 43737-6 | Tipranavir [Susceptibility] by Genotype method |
| 22621-7 | Yersinia enterocolitica IgM Ab [Units/volume] in Serum |
| 22691-0 | Aspartate/Creatinine [Molar ratio] in Urine |
| 32074-7 | fluvoxaMINE [Presence] in Urine |
| 32523-3 | CD5+CD19+ cells/100 cells in Specimen |
| 53009-7 | Ribosomal Ab [Presence] in Serum by Immunofluorescence |
| 43878-8 | Bismuth [Presence] in 24 hour Urine |
| 53461-0 | Eicosanoylcarnitine (C20) [Moles/volume] in Amniotic fluid |
| 44439-8 | Aspergillus fumigatus 3 Ab [Units/volume] in Serum |
| 23277-7 | Mycoplasma gallisepticum Ag [Presence] in Specimen by Immune stain |
| 23898-0 | Mesothelial cells [Presence] in Cerebral spinal fluid by Light microscopy |
| 24085-3 | Heparan-N-sulfatase [Enzymatic activity/mass] in Fibroblast |
| 33953-1 | Immune complex IgA [Mass/volume] in Serum or Plasma |
| 55147-3 | t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
| 4731-6 | HLA-A2 [Presence] |
| 34942-3 | Borrelia burgdorferi IgG and IgM panel - Serum |
| 35271-6 | Candida sp Ag [Presence] in Serum by Latex agglutination |
| 47720-8 | pH of Cord blood adjusted to patient's actual temperature |
| 25963-0 | Norepinephrine [Moles/volume] in 24 hour Urine |
| 35585-9 | 2-Butoxyacetate [Mass/volume] in Urine |
| 26683-3 | Estazolam [Mass/volume] in Vitreous fluid |
| 3665-7 | Gentamicin [Mass/volume] in Serum or Plasma --trough |
| 56777-6 | Lipoprotein.pre-beta/Lipoprotein.beta [Mass Ratio] in Serum or Plasma |
| 57006-9 | Hepatitis C virus IgG Ab [Units/volume] in Serum by Immunoassay |
| 57087-9 | Biotinidase newborn screening panel |
| 57397-2 | CD19+CD20+ cells/100 cells in Body fluid |
| 48908-8 | Rickettsia parkeri IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 2798-7 | Phosphoglycerate kinase [Enzymatic activity/volume] in Serum |
| 3892-7 | Oxprenolol [Mass/time] in 24 hour Urine |
| 57759-3 | WAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 4967-6 | HLA-DR18(3) [Presence] |
| 29496-7 | Platelet associated IgA Ab [Presence] in Blood by Flow cytometry (FC) |
| 58405-2 | Hepatitis B virus surface Ab Signal/Cutoff in Serum |
| 58770-9 | Clostridium tetani toxoid IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 49821-2 | 3-Hydroxyglutarate/Creatinine [Molar ratio] in 24 hour Urine |
| 49832-9 | Specimen drawn [Date and time] of Serum or Plasma--1st specimen |
| 2980-1 | Taurine [Presence] in Serum or Plasma |
| 50267-4 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --2 days post dose ifosfamide |
| 30152-3 | Mannose-binding protein [Mass/volume] in Serum |
| 30344-6 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 1.2 g/kg lactose PO |
| 40888-0 | CD11c+CD19+ cells/100 cells in Body fluid |
| 41159-5 | Campylobacter sp IgG Ab [Presence] in Serum |
| 19249-2 | Lactose [Mass/volume] in Serum or Plasma --3 hours post 50 g lactose PO |
| 2082-6 | Cholestanol [Mass/volume] in Serum or Plasma |
| 20842-1 | Herbicide [Presence] in Feed by Screen method |
| 100687-3 | JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection |
| 13033-6 | C peptide [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 101757-3 | Trichophyton mentagrophytes DNA [Presence] in Specimen by NAA with probe detection |
| 102194-8 | Buckwheat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13924-6 | Calcitonin Ab [Presence] in Serum |
| 102330-8 | Goose feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102986-7 | Acremonium sp IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14543-3 | Measles virus Ag [Presence] in Penis by Immunofluorescence |
| 103953-6 | HIF2A gene targeted mutation analysis in Blood by Molecular genetics method |
| 14894-0 | Propylene glycol [Presence] in Serum or Plasma |
| 14911-2 | Sertraline [Moles/volume] in Serum or Plasma |
| 14977-3 | Immunoglobulin light chains.free [Type] in Urine |
| 14995-5 | Glucose [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
| 16198-4 | Diamorphine [Presence] in Urine by Confirmatory method |
| 16662-9 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --30 minutes post XXX challenge |
| 17813-7 | Alpha 2 globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
| 91122-2 | Maltose binding protein IgE Ab [Units/volume] in Serum |
| 74583-6 | Fatty acids.very long chain C24:0 (Tetracosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Fibroblast |
| 74655-2 | Norsertraline [Mass/volume] in Urine |
| 91125-5 | Maximum amplitude kaolin induced [Length] in Blood by Resonance TEG --after addition of heparinase |
| 91673-4 | CD3+CD16+CD56+ cells/100 cells in Bone marrow |
| 91707-0 | Corticotropin post CRH stimulation panel - Plasma |
| 918-3 | B variant subtype Ab [Presence] in Serum or Plasma from Donor |
| 92674-1 | CSF3R gene exons 14 and 17 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 6053-3 | Brome IgE Ab [Units/volume] in Serum |
| 75940-7 | Potassium [Mass/volume] in Blood |
| 76608-9 | Candida albicans its gene [#/volume] in XXX.body fluid by NAA with probe detection |
| 93748-2 | Fibrin monomer [Mass/volume] in Platelet poor plasma by Immunoassay |
| 9388-0 | Propylthiouracil [Mass/volume] in Serum or Plasma |
| 93993-4 | Osmolality of Serum or Plasma--4 hours post fluid fast |
| 6279-4 | White Bean IgE Ab [Units/volume] in Serum |
| 78790-3 | Amphetamine [Presence] in Body fluid by Screen method |
| 94362-1 | PCA-Tr IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 94384-5 | Amphiphysin IgG Ab [Presence] in Cerebral spinal fluid by Line blot |
| 94543-6 | Microscopic observation [Identifier] in Skin by Acid fast stain |
| 6386-7 | Dengue virus DNA [Presence] in Serum by Probe |
| 9515-8 | Diclofenac [Mass/volume] in Serum or Plasma |
| 65355-0 | Proinsulin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 79679-7 | 5-Aminoimidazole-4-carboxamide [Moles/volume] in Serum or Plasma |
| 96108-6 | Clofazimine [Susceptibility] by Genotype method |
| 96263-9 | aPTT.lupus sensitive.factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with 1:1 normal plasma |
| 68438-1 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma |
| 69886-0 | Service comment 59 |
| 81765-0 | Docosatrienoate (C22:3w9) [Entitic substance] in Red Blood Cells |
| 97252-1 | Flurazepam [Presence] in Cord tissue by Screen method |
| 97511-0 | Fungal Ab panel - Specimen by Immune diffusion (ID) |
| 71431-1 | Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection |
| 71656-3 | Blasts/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
| 82302-1 | Campylobacter sp [Presence] in Stool by Culture |
| 99095-2 | Streptococcus pyogenes DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 71671-2 | Neutrophils/Leukocytes [Pure number fraction] in Blood by Manual count |
| 71890-8 | Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Blood |
| 84919-0 | Chromosome 21 aneuploidy [Presence] in Amniotic fluid or Chorionic villus sample by FISH |
| 99139-8 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum by Line blot |
| 99617-3 | Saturated fatty acids [Moles/volume] in RBC.lysate |
| 85955-3 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum by Immunoassay |
| 73066-3 | Amitriptyline induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87637-5 | Fenchlorphos [Mass/mass] in Specimen |
| 73437-6 | Clindamycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88618-4 | Human coronavirus NL63 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 88986-5 | Elvitegravir [Mass/volume] in Serum or Plasma |
| 89487-3 | Fluoroquinolone [Susceptibility] by Genotype method |
| 50944-8 | Platelet aggregation ADP induced [Presence] in Platelet rich plasma --20 umol/L |
| 31151-4 | Alpha-2-Microglobulin [Mass/volume] in 24 hour Urine |
| 59985-2 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 60317-5 | Methotrimeprazine [Moles/volume] in Specimen |
| 21125-0 | Brush border Ab [Titer] in Serum by Immunofluorescence |
| 21512-9 | Salmonella paratyphi A H Ab [Titer] in Serum by Immunofluorescence |
| 21566-5 | TOLAZamide [Presence] in Serum or Plasma |
| 2157-6 | Creatine kinase [Enzymatic activity/volume] in Serum or Plasma |
| 51362-2 | CD61 cells/100 cells in Body fluid |
| 42873-0 | CD18 cells/100 cells in Tissue |
| 22209-1 | Coccidioides immitis IgG Ab [Presence] in Serum |
| 5186-2 | Hepatitis B virus core IgM Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
| 43624-6 | Acetylcholine receptor binding Ab [Presence] in Serum |
| 22732-2 | Salicylates [Moles/volume] in Specimen |
| 32077-0 | Glutethimide [Presence] in Specimen |
| 32267-7 | Proline [Moles/volume] in Body fluid |
| 52926-3 | Nickel/Creatinine [Molar ratio] in Urine |
| 43952-1 | CD4+CD45RO+ cells [#/volume] in Bone marrow |
| 22863-5 | Bacillus anthracis Ab [Presence] in Serum by Immunoassay |
| 32570-4 | Tetrahydroaldosterone/Creatinine [Mass Ratio] in 24 hour Urine |
| 32853-4 | Neuronal Ab [Units/volume] in Serum by Immunoassay |
| 23330-4 | Ovine progressive pneumonia virus Ab [Presence] in Serum by Immunoassay |
| 53935-3 | Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 23882-4 | Immune complex [Units/volume] in Body fluid by Conglutinin assay |
| 4557-5 | Hemoglobin Abruzzo [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 34510-8 | SDHB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 54919-6 | Magnesium [Mass/volume] in Semen |
| 55478-2 | Follitropin [Units/volume] in Serum or Plasma --4 hours post XXX challenge |
| 25180-1 | Ciprofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25386-4 | Creatinine [Moles/volume] in Body fluid |
| 47525-1 | Cytology report of Urine Cyto stain |
| 47562-4 | Arginine [Moles/volume] in DBS |
| 25742-8 | Prothrombin Fragment 1.2 [Moles/volume] in Serum or Plasma |
| 25808-7 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 25882-2 | Cortisol Free [Moles/volume] in 24 hour Urine by Radioimmunoassay (RIA) |
| 26464-8 | Leukocytes [#/volume] in Blood |
| 26545-4 | Glucose [Mass/volume] in Urine --6 hours post dose glucose |
| 26714-6 | Phenylpropanolamine [Mass/mass] in Meconium |
| 48391-7 | Carbon dioxide, total [Moles/volume] in Venous blood by calculation |
| 48852-8 | Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Serum by Immunofluorescence |
| 57511-8 | 11-Hydroxyandrosterone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
| 49286-8 | Organic acids pattern [Interpretation] in Serum or Plasma Narrative |
| 27927-3 | Butalbital [Mass/volume] in Vitreous fluid |
| 5781-0 | Crystals [type] in Synovial fluid by Light microscopy |
| 58070-4 | McC sup(a) Ab [Presence] in Serum or Plasma |
| 58370-8 | Carisoprodol+Meprobamate [Presence] in Urine by Screen method |
| 49480-7 | Herpes virus 8 latent nuclear Ag [Presence] in Tissue by Immune stain |
| 29334-0 | Aspergillus fumigatus 2 Ab [Presence] in Serum |
| 40148-9 | Glucose [Moles/volume] in Serum or Plasma --pre XXX challenge |
| 40342-8 | MT-TL1 gene m.3271T>C [Presence] in Blood or Tissue by Molecular genetics method |
| 40707-2 | Amphotericin B [Mass/volume] in Serum or Plasma --peak |
| 30289-3 | Nevirapine [Susceptibility] by Genotype method |
| 40979-7 | Human metapneumovirus Ag [Presence] in Specimen by Immunofluorescence |
| 19187-4 | Cancer Ag 27-29 [Units/volume] in Pleural fluid |
| 19242-7 | Corticotropin [Mass/volume] in Plasma --post XXX challenge |
| 19488-6 | HYDROmorphone cutoff [Mass/volume] in Urine for Confirmatory method |
| 20435-4 | Unidentified extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
| 20921-3 | Organophosphate pesticides [Identifier] in Specimen |
| 20951-0 | Salmonella sp serotype [Identifier] in Isolate by Agglutination |
| 12342-2 | oxyMORphone [Presence] in Serum or Plasma |
| 12614-4 | Glucose [Mass/volume] in Serum or Plasma --7 hours post meal |
| 13927-9 | Pancreatic islet cell Ab [Titer] in Serum |
| 103017-0 | Silver Birch recombinant (rBet v) 2 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14879-1 | Phosphate [Moles/volume] in Serum or Plasma |
| 104394-2 | European tick borne encephalitis virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen |
| 10514-8 | Synaptophysin Ag [Presence] in Tissue by Immune stain |
| 16293-3 | 11-Deoxycorticosteroids [Mass/volume] in Plasma |
| 16343-6 | Alpha aminoisobutyrate [Mass/volume] in Cerebral spinal fluid |
| 16477-2 | Borrelia burgdorferi Ab [Presence] in Body fluid |
| 17034-0 | Ketoprofen [Mass/volume] in Serum or Plasma |
| 1746-7 | Albumin [Mass/volume] in Cerebral spinal fluid |
| 177-6 | Chlortetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 19148-6 | RhoGam candidate (yes/no) |
| 74847-5 | Toxoplasma gondii IgE Ab [Presence] in Serum by Immunoassay |
| 92134-6 | Human metapneumovirus RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 61048-5 | Methylenedioxyethylamphetamine [Presence] in Urine |
| 92812-7 | Borrelia afzelii+burgdorferi+garinii IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 9369-0 | Camphor [Mass/volume] in Blood |
| 77115-4 | FKBP10 gene full mutation analysis in Blood or Tissue by Sequencing |
| 93799-5 | Chromosome 2 copy number/nucleus in Tissue by FISH |
| 7793-3 | Howell-Jolly bodies [Presence] in Blood by Light microscopy |
| 78776-2 | Acepromazine [Mass/mass] in Hair |
| 79281-2 | Arabinose/Creatinine [Molar ratio] in Urine |
| 80118-3 | Abacavir [Mass/volume] in Cord blood |
| 96287-8 | Macrolide Mix (Amphotericin B+Erythromycin+Nystatin+Spiramycin) IgE Ab [Units/volume] in Serum |
| 68440-7 | Gamma hydroxybutyrate [Moles/volume] in Urine |
| 6877-5 | Coproporphyrin 1 [Mass/time] in 24 hour Urine |
| 8076-2 | Jo-1 extractable nuclear Ab [Presence] in Serum |
| 8105-9 | CD5+CD8+ cells/100 cells in Blood |
| 813-6 | Leukocytes [#/volume] in Synovial fluid by Automated count |
| 97184-6 | Ravulizumab [Mass/volume] in Serum |
| 6947-6 | ISOtretinoin [Mass/volume] in Serum or Plasma |
| 697-3 | Neisseria gonorrhoeae [Presence] in Urethra by Organism specific culture |
| 97549-0 | Oxygen saturation in Central venous blood |
| 70252-2 | Islet cell 512 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 82864-0 | 3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone [Moles/time] in 24 hour Urine |
| 720-3 | Free Hemoglobin [Presence] in Plasma |
| 99399-8 | Zonulin [Mass/volume] in Stool |
| 99425-1 | Penicillin V IgG4 Ab [Mass/volume] in Serum |
| 86318-3 | Influenza virus B Yamagata lineage Ag [Presence] in Isolate by Hemagglutination inhibition |
| 73463-2 | Cefuroxime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73745-2 | Keyhole limpet hemocyanin IgA Ab [Mass/volume] in Serum |
| 88064-1 | Porcine epidemic diarrhea virus S1 gene [Nucleotide sequence] in Isolate by Sequencing |
| 74407-8 | Basophils/100 leukocytes in Cord blood |
| 89662-1 | Microscopic observation [Identifier] in Lower respiratory specimen by Acid fast stain |
| 30473-3 | Glutaconate [Presence] in Urine |
| 3053-6 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma |
| 42342-6 | Rickettsia (Proteus) Ab panel - Serum |
| 60049-4 | Acetaminophen [Mass/volume] in Body fluid |
| 21637-4 | BRCA1 gene.c.185 del AG [presence] in Blood or Tissue by Molecular genetics method |
| 3127-8 | Viscosity of Body fluid |
| 42992-8 | Mycoplasma pneumoniae IgG Ab [Titer] in Cerebral spinal fluid |
| 51655-9 | Hepatitis C virus RNA [Presence] in Body fluid by NAA with probe detection |
| 51669-0 | Parechovirus A RNA [Presence] in Specimen by NAA with probe detection |
| 3251-6 | Fibrin+Fibrinogen fragments [Units/volume] in Platelet poor plasma by Latex agglutination |
| 22828-8 | Influenza virus A subtype [Identifier] in Specimen by Immune diffusion (ID) |
| 22960-9 | Burkholderia mallei reaction [Appearance] -1D post 0.1 mL mallein intradermal- |
| 33201-5 | CD11c cells/100 cells in Tissue |
| 53267-1 | Urinalysis yeast variants panel [#/area] - Urine by Computer assisted method |
| 44549-4 | Human papilloma virus DNA [Presence] in Vaginal fluid by Probe with signal amplification |
| 33360-9 | Galactose 1 phosphate [Mass/mass] in Red Blood Cells |
| 33628-9 | Cidofovir [Susceptibility] |
| 53565-8 | Platelet aggregation ADP induced in Platelet rich plasma --100 umol/mL |
| 44903-3 | Malignant cells/100 cells in Bone marrow |
| 4518-7 | Complement factor D [Mass/volume] in Serum or Plasma |
| 23979-8 | Borrelia burgdorferi IgG band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot |
| 33754-3 | Surgical margin tumor involvement.deep in Specimen by CAP cancer protocols Narrative |
| 33924-2 | Neuronal nuclear type 3 Ab [Titer] in Serum |
| 34191-7 | Beta glucuronidase [Enzymatic activity/volume] in Specimen |
| 54420-5 | Frozen erythrocytes newborn units given [#] |
| 46427-1 | Beta fructofuranosidase [Enzymatic activity/mass] in Tissue |
| 24482-2 | Food Allergen Mix 20 (Barley+Rice+Rye+Wheat) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 55474-1 | Dehydroepiandrosterone (DHEA) [Moles/volume] in Serum or Plasma --baseline |
| 47369-4 | Calcitonin [Mass/volume] in Body fluid |
| 25155-3 | Cystine crystals [#/area] in Urine sediment by Microscopy high power field |
| 25318-7 | 1-Methylhistidine [Moles/time] in 24 hour Urine |
| 35055-3 | Histiocytes/100 leukocytes in Body fluid |
| 559-5 | Chlamydia sp identified in Urethra by Organism specific culture |
| 47629-1 | Glutamate/Amino acids.total in Specimen |
| 26595-9 | Hydroxylysine [Moles/volume] in Cerebral spinal fluid |
| 56727-1 | Olive recombinant (rOle e) 2 IgE Ab [Units/volume] in Serum |
| 56962-4 | Ovary IgG Ab [Presence] in Serum by Immunofluorescence |
| 27235-1 | PHENobarbital [Mass/mass] in Meconium |
| 38363-8 | Cefepime [Mass/volume] in Serum or Plasma |
| 49012-8 | Influenza virus A and B identified in Specimen by Bioassay |
| 27922-4 | Echovirus 4 RNA [Presence] in Cerebral spinal fluid |
| 38733-2 | Vinyl acetate [Mass/volume] in Air |
| 38904-9 | MFN2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 39355-3 | Cholinesterase.fluoride inhibited/Cholinesterase in Serum or Plasma |
| 57803-9 | Occult blood panel - Stool by Immunoassay |
| 2855-5 | Prostaglandin F2 [Mass/volume] in Serum or Plasma |
| 2891-0 | Protoporphyrin [Mass/time] in 24 hour Stool |
| 2904-1 | Pyrophosphate crystals [#/volume] in Synovial fluid |
| 2918-1 | Renin [Enzymatic activity/volume] in Plasma --upright |
| 29231-8 | Coxsackievirus B2 Ab [Titer] in Body fluid |
| 49837-8 | Dimethylphosphatidyl ethanolamine/Surfactant.total in Amniotic fluid |
| 49875-8 | California juniper IgE Ab [Units/volume] in Serum |
| 30026-9 | Dichlorvos [Mass/volume] in Serum or Plasma |
| 30066-5 | Glycine/Creatinine [Ratio] in Urine |
| 19289-8 | Cannabinoids [Presence] in Urine by Confirmatory method |
| 20475-0 | Cytomegalovirus IgG Ab [Interpretation] in Serum or Plasma |
| 100341-7 | Rubella virus IgG Ab index [Units/volume] in Serum and CSF |
| 100665-9 | NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method |
| 12657-3 | Glucose [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 13209-2 | Borrelia hermsii IgM Ab [Units/volume] in Serum |
| 13314-0 | Bacteria identified in Semen |
| 101925-6 | Epidermal growth factor [Mass/volume] in Urine by Immunoassay |
| 102138-5 | Ampicillin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102222-7 | American Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102522-0 | Loblolly Pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14165-5 | Lactate [Moles/volume] in Body fluid |
| 103040-2 | Lupin seed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103726-6 | Cells.chromosome region 20q12 deletion/Cells counted in Blood or Marrow by FISH |
| 14831-2 | Metanephrine/Creatinine [Molar ratio] in Urine |
| 14860-1 | Leukocytes other/100 leukocytes in Synovial fluid by Manual count |
| 10517-1 | Trypsin Ag [Presence] in Tissue by Immune stain |
| 16104-2 | Paper Mulberry IgE Ab [Units/volume] in Serum |
| 10799-5 | Microscopic observation [Identifier] in Tissue by Pentachrome stain.Movat |
| 1678-2 | 20-Hydroxyprogesterone [Mass/volume] in Serum |
| 17699-0 | Thebaine [Mass/volume] in Serum or Plasma |
| 89986-4 | Vortioxetine [Mass/volume] in Urine by Confirmatory method |
| 74697-4 | Acamprosate [Mass/volume] in Serum or Plasma |
| 74953-1 | Macroprolactin [Units/volume] in Serum or Plasma |
| 92994-3 | PROS1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 93365-5 | Genetic variant prognostic significance [Interpretation] in Blood or Tissue Narrative |
| 61337-2 | Chicken feather IgE Ab/IgE total in Serum |
| 62241-5 | Hematocrit [Volume Fraction] of Blood from Fetus by Automated count |
| 63217-4 | Cyclic citrullinated peptide IgG Ab [Units/volume] in Body fluid by Immunoassay |
| 78797-8 | Atazanavir [Mass/volume] in Serum or Plasma --trough |
| 94837-2 | Dengue virus 1+2+3+4 RNA [Presence] in Amniotic fluid by NAA with probe detection |
| 634-6 | Bacteria identified in Specimen by Aerobe culture |
| 95094-9 | Glucagon [Mass/volume] in Serum or Plasma --2.5 hours post meal |
| 80211-6 | Beryllium [Moles/volume] in Body fluid |
| 957-1 | C sup(w) Ab [Presence] in Serum or Plasma |
| 95710-0 | La Crosse virus IgA Ab [Presence] in Specimen by Immunoassay |
| 95717-5 | Barmah forest virus Ab [Presence] in Serum by Immunoassay |
| 68425-8 | Neutrophils [#/volume] in Pericardial fluid by Manual count |
| 97053-3 | Macrophage inflammatory protein 1 alpha [Mass/volume] in Serum or Plasma |
| 6918-7 | Chlamydia trachomatis IgA Ab [Titer] in Serum by Immunofluorescence |
| 69804-3 | 2-Oxoisocaproate [Moles/volume] in Cerebral spinal fluid |
| 82727-9 | Natural killer cell cytotoxicity.25:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
| 72340-3 | Bacteria [Presence] in Prostatic fluid by Light microscopy |
| 724-5 | Hemoglobin [Mass/volume] in Synovial fluid |
| 84900-0 | Other nodule quadrant [Anatomy] in Prostate tumor |
| 85507-2 | PIK3CA gene mutations found [Identifier] in Colorectal cancer specimen by Molecular genetics method Nominal |
| 72625-7 | Dabigatran [Mass/volume] in Serum or Plasma |
| 73552-2 | Drug induced platelet Ab [Interpretation] in Serum or Plasma Narrative |
| 88882-6 | Smith extractable nuclear B Ab [Presence] in Serum by Line blot |
| 89513-6 | RNA polymerase III Ab [Presence] in Serum by Line blot |
| 31006-0 | Food Allergen Mix 16 (Pineapple+Lemon+Strawberry+Pear) IgE Ab [Presence] in Serum by Multidisk |
| 42259-2 | Shigella sonnei Ag [Presence] in Isolate |
| 42524-9 | Mucus [Presence] in Stool by Light microscopy |
| 21337-1 | HIV 2 gp34 Ab [Presence] in Serum by Immunoblot |
| 21388-4 | Mevinphos [Mass/volume] in Urine |
| 43128-8 | Chloride panel - 24 hour Urine |
| 43185-8 | HIV 1 and 2 Ab band pattern [Interpretation] in Serum by Immunoblot |
| 21741-4 | TRAF3 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 22137-4 | Borrelia burgdorferi IgM Ab [Titer] in Serum |
| 31661-2 | Sulfate-3-Glucuronyl paragloboside Ab [Presence] in Serum |
| 51540-3 | Alternaria alternata IgG Ab [Presence] in Serum |
| 32240-4 | Fructose [Presence] in Urine |
| 32500-1 | CD10+CD19+ cells/100 cells in Bone marrow |
| 51992-6 | Heavy metals panel - Serum or Plasma |
| 52957-8 | Amphetamine [Moles/volume] in Urine |
| 23206-6 | Leptospira sp DNA [Presence] in Tissue by NAA with probe detection |
| 32833-6 | Monocytes+Macrophages/100 leukocytes in Bronchial specimen |
| 53096-4 | Carnitine free (C0)/Carnitine.total in Cerebral spinal fluid |
| 44487-7 | Herpes simplex virus 2 [Presence] in Genital specimen by Organism specific culture |
| 23526-7 | Trypanosoma evansi Ab [Presence] in Serum by Immunofluorescence |
| 54008-8 | Golgi apparatus Ab [Titer] in Serum by Immunofluorescence |
| 467-1 | Sulfamethoxazole [Susceptibility] by Minimum lethal concentration (MLC) |
| 24154-7 | Goosefoot IgG Ab [Units/volume] in Serum |
| 24230-5 | Coxsackievirus A7 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 2473-7 | IgM.monoclonal [Mass/volume] in Serum |
| 34358-2 | Pregnanediol [Moles/volume] in 24 hour Urine |
| 34576-9 | Adenovirus Ab [Titer] in Cerebral spinal fluid |
| 55309-9 | Yeast.pseudohyphae [Presence] in Sputum by KOH preparation |
| 47014-6 | CD21 Ag [Presence] in Tissue by Immune stain |
| 47065-8 | Rickettsia typhi IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 47261-3 | Creatinine [Mass/volume] in Urine --6th specimen post XXX challenge |
| 2517-1 | L-iditol dehydrogenase [Enzymatic activity/volume] in Serum |
| 55724-9 | Apolipoprotein A-I and A-II and B and C panel [Mass/volume] - Serum or Plasma |
| 25698-2 | Insulin [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 25828-5 | Palo verde IgE Ab [Units/volume] in Serum |
| 25943-2 | Lutropin [Units/volume] in Serum or Plasma by 1st IRP --1st specimen post XXX challenge |
| 35382-1 | HEXA gene p.Gly269Ser [Presence] in Blood or Tissue by Molecular genetics method |
| 35627-9 | Nortriptyline [Mass/volume] in Serum or Plasma by Screen method |
| 56342-9 | Oyster IgG4 Ab [Mass/volume] in Serum |
| 48012-9 | Reference sequence [Nucleotide sequence] in Blood or Tissue by Molecular genetics method Nominal |
| 26660-1 | Toxocara sp Ab [Presence] in Serum |
| 56605-9 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 4834-8 | HLA-B45(12) [Presence] in Donor |
| 26966-2 | Tyrosine [Moles/volume] in Urine |
| 57340-2 | Chloride [Moles/volume] in 12 hour Urine |
| 39460-1 | Bicarbonate [Moles/volume] standard in Arterial cord blood |
| 39602-8 | Hamster epithelium IgE Ab/IgE total in Serum |
| 57736-1 | CD154 cells/100 cells in Body fluid |
| 58231-2 | Phenylketonuria and variants/Biopterin defects newborn screening comment-discussion |
| 50104-9 | 3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Cerebral spinal fluid |
| 29962-8 | Asialoganglioside GM1 IgM Ab [Mass/volume] in Serum by Immunoassay |
| 59142-0 | CD11c-CD25+ cells/100 cells in Blood |
| 30117-6 | Terminal deoxyribonucleotidyl transferase cells/100 cells in Specimen by Immunoperoxidase stain |
| 19190-8 | Cancer Ag 549 [Units/volume] in Pleural fluid |
| 1957-0 | Beta-N-acetylhexosaminidase.B [Enzymatic activity/volume] in Serum or Plasma |
| 21011-2 | CD13 cells [#/volume] in Blood |
| 100715-2 | Prothipendyl [Mass/volume] in Serum or Plasma |
| 12852-0 | Bovine inner ear Ag [Presence] in Serum or Plasma by Immunoblot |
| 101180-8 | 2-methyl AP-237 [Presence] in Urine by Confirmatory method |
| 101382-0 | FH gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 12998-1 | Methylene chloride [Mass/volume] in Blood |
| 102200-3 | Cocoa IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13635-8 | Ribosomal Ab [Titer] in Serum |
| 13886-7 | Lactate dehydrogenase 1/Lactate dehydrogenase.total in Urine by Electrophoresis |
| 102485-0 | Queen Palm IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13951-9 | Hepatitis A virus Ab [Presence] in Serum by Immunoassay |
| 102728-3 | Crab IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103066-7 | Cyprinus carpio recombinant (rCyp c) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104400-7 | European tick borne encephalitis virus RNA [Presence] in Tissue postmortem by NAA with probe detection |
| 104425-4 | Leptospira sp IgM Ab [Titer] in Serum by Immunoassay --2nd specimen |
| 10463-8 | Amyloid A component Ag [Presence] in Tissue by Immune stain |
| 10670-8 | Giardia lamblia [Presence] in Stool by Organism specific culture |
| 1603-0 | Norepinephrine [Mass/volume] in Plasma --1 hour post 300 ug cloNIDine PO |
| 1618-8 | Prolactin [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV |
| 16191-9 | Butabarbital [Presence] in Urine by Confirmatory method |
| 16650-4 | Cilantro IgE Ab [Units/volume] in Serum |
| 11212-8 | Coproporphyrin [Mass/volume] in Urine |
| 17042-3 | Lactoglobulin IgE Ab [Units/volume] in Serum |
| 17083-7 | Lipoprotein.beta [Mass/volume] in Body fluid |
| 90894-7 | Noroxymorphone [Mass/volume] in Urine by Confirmatory method |
| 74520-8 | Complement alternate pathway AH50 actual/normal in Serum by Immunoassay |
| 76147-8 | Cefovecin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 93457-0 | AH-8529 [Mass/volume] in Urine by Confirmatory method |
| 93502-3 | NMDAR subunit 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 61255-6 | Bermuda grass IgE Ab/IgE total in Serum |
| 61298-6 | Spruce IgE Ab/IgE total in Serum |
| 6135-8 | Hamster epithelium IgE Ab [Units/volume] in Serum |
| 61392-7 | Human papilloma virus 82 DNA [Presence] in Specimen by NAA with probe detection |
| 78793-7 | ARIPiprazole [Mass/mass] in Hair |
| 63364-4 | Thyrotropin receptor Ab [Units/volume] in Cord blood |
| 63537-5 | Muscle specific receptor tyrosine kinase IgG Ab [Mass/volume] in Serum by Immunoassay |
| 78917-2 | Cells.FGFR1 gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 95425-5 | SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by NAA with probe detection |
| 80167-0 | 2-Amino-4-hydroxypteridine/Creatinine [Molar ratio] in Serum or Plasma |
| 96260-5 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with 1:1 normal plasma |
| 80694-3 | HIV 1 proviral DNA genotype [Interpretation] in Mononuclear cells from whole blood Narrative |
| 81111-7 | Murray Valley encephalitis virus IgG Ab [Presence] in Serum |
| 96795-0 | Hexacarboxylporphyrins [Moles/volume] in Urine |
| 8177-8 | Cannabinoids [Presence] in Unknown substance |
| 97873-4 | Herpes virus 8 IgM Ab [Presence] in Serum or Plasma |
| 82496-1 | TRBV7 gene segments/TRBV gene segments.total in Blood |
| 71718-1 | Enterococcus sp DNA [Presence] in Specimen by NAA with probe detection |
| 84871-3 | Epstein Barr virus capsid p18 IgG Ab [Presence] in Serum by Rapid immunoassay |
| 85267-3 | X-linked adrenoleukodystrophy (X-ALD) newborn screening panel |
| 99618-1 | Monounsaturated fatty acids [Moles/volume] in RBC.lysate |
| 72806-3 | JWH-073 carboxylated (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
| 87351-3 | Senecavirus A RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 87593-0 | Salinomycin [Mass/mass] in Specimen |
| 881-3 | ABO and Rh group [Type] in Blood from Blood product unit |
| 88627-5 | Human coronavirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 89339-6 | CD27+CD62L+ cells/100 CD3+CD8+ cells in Blood |
| 41190-0 | Waxy casts [Presence] in Urine by Computer assisted method |
| 41191-8 | Xylose [Mass/time] in 2 hour Urine --2 hours post dose xylose PO |
| 59807-8 | Phosphatidylglycerol [Moles/volume] in Amniotic fluid |
| 50883-8 | Molybdenum [Moles/volume] in Red Blood Cells |
| 50902-6 | Potassium [Moles/mass] in Hair |
| 30462-6 | Polymorphonuclear cells/100 leukocytes in Urine |
| 21525-1 | Sodium [Moles/volume] in 24 hour Urine |
| 31282-7 | Canine adenovirus 1 Ab [Presence] in Serum |
| 313-7 | Lymecycline [Susceptibility] by Serum bactericidal titer |
| 51096-6 | CD179a blasts/100 blasts in Blood |
| 513-2 | Trimethoprim [Susceptibility] by Disk diffusion (KB) |
| 43008-2 | HIV 1+2 IgM Ab [Units/volume] in Serum |
| 22077-2 | Acanthamoeba sp Ab [Presence] in Cornea |
| 2215-2 | Dipalmitoylphosphatidylcholine [Mass/volume] in Serum |
| 51539-5 | Candida albicans IgG Ab [Presence] in Serum |
| 51645-0 | Micromegakaryocytes [Presence] in Blood by Light microscopy |
| 51656-7 | Hepatitis C virus Ab Signal/Cutoff in Body fluid |
| 43370-6 | CFTR gene p.IVS8 PolyT [Presence] in Blood or Tissue by Molecular genetics method |
| 44062-8 | CD20+FMC7+ cells/100 cells in Cerebral spinal fluid |
| 22984-9 | Capripox virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 3273-0 | Heparin unfractionated [Units/volume] in Platelet poor plasma by Coagulation assay |
| 33006-8 | Cytomegalovirus DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 53185-5 | Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS |
| 234-5 | Erythromycin [Susceptibility] by Disk diffusion (KB) |
| 53611-0 | Toxoplasma gondii [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 5376-9 | Thermoactinomyces candidus Ab [Units/volume] in Serum |
| 53957-7 | Choriogonadotropin.tumor marker [Mass/volume] in Serum or Plasma |
| 44948-8 | Borrelia burgdorferi 34kD IgM Ab [Presence] in Serum by Immunoblot |
| 45307-6 | Deuteroporphyrin [Moles/mass] in Stool |
| 33817-8 | Insulin [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 33858-2 | Somatotropin [Units/volume] in Serum or Plasma |
| 54281-1 | Glutarylcarnitine (C5-DC) [Moles/volume] in Amniotic fluid |
| 54387-6 | Dihydroxycholestanoate [Moles/volume] in Body fluid |
| 4617-7 | Hemoglobin O - Arab [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 46432-1 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post 50 g lactose PO |
| 46744-9 | Organic acidemias newborn screen interpretation |
| 34330-1 | Lithium [Moles/volume] in 24 hour Urine |
| 34331-9 | Lithium/Creatinine [Molar ratio] in Urine |
| 54496-5 | Glucose [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 55323-0 | Jk sup(a) Ab [Titer] in Serum or Plasma |
| 47177-1 | Parathyrin.intact [Moles/volume] in Serum or Plasma --5 minutes post excision |
| 35178-3 | Omega 3 fatty acids (w3) [Moles/volume] in Serum or Plasma |
| 55935-1 | Lysine [Moles/mass] in Hair |
| 47689-5 | Lysine [Moles/volume] in DBS |
| 25719-6 | Lutropin [Units/volume] in Serum or Plasma --2 hours post 100 ug luteinizing releasing hormone IV |
| 26002-6 | Valine/Creatinine [Molar ratio] in 24 hour Urine |
| 35780-6 | Ceftiofur [Susceptibility] by Disk diffusion (KB) |
| 26529-8 | Cortisol [Mass/volume] in Serum or Plasma --24 hours post dose corticotropin |
| 36921-5 | Herpes simplex virus 1+2 IgG Ab [Presence] in Serum |
| 381-4 | Oleandomycin [Susceptibility] by Serum bactericidal titer |
| 48669-6 | Albumin and Immunoglobulin Quotient [Interpretation] in Serum and CSF |
| 26957-1 | Penicillium notatum IgG Ab [Mass/volume] in Serum |
| 2703-7 | Oxygen [Partial pressure] in Arterial blood |
| 38504-7 | Thyroglobulin Ab [Titer] in Serum by Immunofluorescence |
| 57387-3 | Urate [Mass/time] in 12 hour Urine |
| 4913-0 | HLA-Dw6 [Presence] |
| 2727-6 | Para nitrophenol [Mass/volume] in Urine |
| 27992-7 | Borrelia burgdorferi 23kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 3927-1 | Perphenazine [Mass/volume] in Serum or Plasma |
| 288-1 | Isoniazid [Susceptibility] by Disk diffusion (KB) |
| 29240-9 | Hyaluronate [Mass/volume] in Body fluid |
| 29392-8 | Gastrin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 40036-6 | Glucose [Mass/volume] in Serum or Plasma --5.5 hours post XXX challenge |
| 40078-8 | Calcium [Mass/volume] in Serum or Plasma --12 hours post XXX challenge |
| 29969-3 | Rubidium [Mass/time] in 24 hour Urine |
| 40389-9 | Nortriptyline [Presence] in Gastric fluid |
| 50562-8 | Specific gravity of Urine by Refractometry automated |
| 20757-1 | Chlamydia sp Ag [Presence] in Tissue by Immunofluorescence |
| 20944-5 | Bovine respiratory syncytial virus Ag [Presence] in Lung by Immunoassay |
| 12395-0 | Butorphanol [Mass/volume] in Urine |
| 100095-9 | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot |
| 101080-0 | En^a Ab [Presence] in Serum or Plasma |
| 12537-7 | Phenylglyoxylate [Mass/volume] in Urine |
| 101774-8 | Microsporum ferrugineum DNA [Presence] in Specimen by NAA with probe detection |
| 101825-8 | Brushite crystals [Saturation Fraction] in 24 hour Urine |
| 13574-9 | Norfluoxetine [Presence] in Serum or Plasma |
| 14065-7 | Diflunisal [Mass/volume] in Serum or Plasma |
| 14131-7 | PM-1 Ab [Presence] in Serum |
| 103010-5 | Trichosporon pullulans IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103079-0 | Soybean native (nGly m) 6 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103107-9 | Bromelin MUXF3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10427-3 | Transfuse whole blood autologous [Volume] |
| 104273-8 | Clonal cells rearrangements/Cells counted in Specimen by Molecular genetics method |
| 10500-7 | Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain |
| 10520-5 | Coagulation factor VI Ag [Presence] in Tissue by Immune stain |
| 15374-2 | Sulfonylurea [Presence] in Serum or Plasma |
| 10792-0 | Microscopic observation [Identifier] in Tissue by Methenamine silver stain.Jones |
| 16607-4 | Chlorine [Mass/volume] in Water |
| 17139-7 | CD32 cells/100 cells in Blood |
| 17392-2 | Osmium [Mass/volume] in Urine |
| 91063-8 | Bacteria identified in Platelets from Blood product unit by Aerobe culture |
| 91801-1 | Parainfluenza virus 2 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 92132-0 | Enterovirus A+B+C RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 75076-0 | Vanillate [Moles/volume] in Serum or Plasma |
| 60371-2 | Cucumber IgG Ab [Mass/volume] in Serum |
| 76022-3 | 8(9)-Cholestenol [Moles/volume] in Serum or Plasma |
| 76482-9 | Apolipoprotein B [Moles/volume] in Serum or Plasma |
| 77613-8 | Calcitonin [Moles/volume] in Serum or Plasma --1 minute post XXX challenge |
| 94690-5 | Chondroitin-6-sulfate/Creatinine [Ratio] in Urine |
| 95076-6 | C peptide [Mass/volume] in Serum or Plasma --15 min post meal |
| 95187-1 | CD107a+b expressing HLA-B35 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC) |
| 9528-1 | Histoplasma capsulatum IgA Ab [Units/volume] in Serum by Immunoassay |
| 95594-8 | 25-hydroxyvitamin D3 [Mass/volume] in Capillary blood |
| 6551-6 | Streptococcus agalactiae Ag [Presence] in Throat by Immunofluorescence |
| 68541-2 | HYDROmorphone [Mass/mass] in Meconium by Confirmatory method |
| 6863-5 | Prolymphocytes [#/volume] in Blood by Manual count |
| 96682-0 | Activated clotting time.glass bead induced of Blood by Microviscometry |
| 69896-9 | Service comment 69 |
| 81643-9 | von Willebrand factor (vWf) ristocetin cofactor/von Willebrand factor (vWf) Ag [Ratio] in Platelet poor plasma |
| 71639-9 | Monocytes+Macrophages/Leukocytes [Pure number fraction] in Body fluid by Manual count |
| 99030-9 | Staphylococcus epidermidis DNA [Presence] in Urine by NAA with probe detection |
| 84931-5 | GABABR Ab [Presence] in Serum by Immunofluorescence |
| 85049-5 | ESBL by cefotaxime to cefotaxime-clavulanate IC ratio [Presence] by ARD gradient strip |
| 99884-9 | Cholesterol crystals [#/volume] in Urine sediment by Computer assisted method |
| 86059-3 | Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum |
| 73258-6 | Montelukast induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73290-9 | Lovastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73577-9 | Anion gap 4 in Arterial cord blood |
| 7368-4 | Red top grass triggered histamine release [Units/volume] in Blood |
| 73754-4 | Adenovirus C DNA [Presence] in Nasopharynx by NAA with probe detection |
| 89365-1 | HIV 1 and 2 Ab panel - Serum, Plasma or Blood by Rapid immunoassay |
| 41395-5 | Collection date of Urine |
| 41628-9 | Burkholderia sp DNA [Presence] in Specimen by NAA with probe detection |
| 59656-9 | diazePAM [Mass/volume] in Body fluid |
| 31098-7 | Amikacin [Mass/volume] in Serum or Plasma --trough post extended interval dosing |
| 60121-1 | Pancuronium [Mass/volume] in Blood |
| 60274-8 | Rubella virus RNA [Presence] in Serum or Plasma by NAA with probe detection |
| 31230-6 | Aspergillus flavus Ab [Units/volume] in Serum |
| 42815-1 | Stachybotrys chartarum IgE Ab [Mass/volume] in Serum |
| 43297-1 | HTLV I+II p32 Ab [Presence] in Serum |
| 22342-0 | Herpes simplex virus IgG Ab [Interpretation] in Serum |
| 2259-0 | Estrone (E1) [Mass/volume] in Urine |
| 52771-3 | Clot formation.intrinsic coagulation system activated [Time] in Blood by Rotational TEG |
| 22826-2 | Influenza virus A identified in Specimen by Bioassay |
| 23118-3 | Foot and mouth disease virus serotype [Identifier] in Serum by Neutralization test |
| 3304-3 | Acetyldigitoxin [Mass/volume] in Serum or Plasma |
| 3314-2 | Alprenolol [Mass/volume] in Serum or Plasma |
| 33382-3 | Respiratory syncytial virus Ab [Titer] in Cerebral spinal fluid |
| 33400-3 | Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Serum by Latex agglutination |
| 33558-8 | Creatinine renal clearance in Urine and Serum or Plasma collected for unspecified duration |
| 33721-2 | Bone marrow Pathology biopsy report |
| 53779-5 | Arsenic.methylated [Mass/volume] in Urine |
| 33881-4 | Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --immediately after 1:4 addition of normal plasma |
| 4608-6 | Hemoglobin M - Iwate [Presence] in Blood |
| 46421-4 | Mucus [#/area] in Urine sediment by Microscopy high power field |
| 46728-2 | Weight of Water |
| 34529-8 | PT and aPTT panel - Platelet poor plasma by Coagulation assay |
| 55345-3 | VIM gene methylation [Presence] in Stool by Molecular genetics method |
| 55391-7 | Insulin [Moles/volume] in Serum or Plasma --4 minutes post XXX challenge |
| 25198-3 | Ethionamide 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 35662-6 | Glucose [Mass/volume] in Urine collected for unspecified duration |
| 56301-5 | Lactalbumin alpha IgG4 Ab [Mass/volume] in Serum |
| 56504-4 | Corticotropin [Mass/volume] in Plasma --15 minutes post XXX challenge |
| 26759-1 | CD4+CD45RA+ cells [#/volume] in Blood |
| 35824-2 | Nystatin [Susceptibility] by Disk diffusion (KB) |
| 4854-6 | HLA-Cw3 [Presence] in Donor |
| 26895-3 | Amphetamines [Mass/mass] in Meconium |
| 26955-5 | Aureobasidium pullulans IgG Ab [Mass/volume] in Serum |
| 27033-0 | Proline [Moles/volume] in Amniotic fluid |
| 27115-5 | Parvovirus B19 IgM Ab [Titer] in Cerebral spinal fluid |
| 38394-3 | Legionella sp identified in Urine by Organism specific culture |
| 38484-2 | Cysteine [Mass/time] in 24 hour Urine |
| 48935-1 | 11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Specimen |
| 49072-2 | Cocaethylene [Presence] in Hair |
| 39354-6 | Cholinesterase in Serum or Plasma --dibucaine/Cholinesterase |
| 3967-7 | Phenytoin [Presence] in Serum or Plasma |
| 57760-1 | Coagulation factor XIII inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
| 58364-1 | 7-Aminoclonazepam/Creatinine [Mass Ratio] in Urine |
| 49384-1 | Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
| 28598-1 | Alpha aminoadipate/Creatinine [Ratio] in Urine |
| 29355-5 | Reovirus Ab [Titer] in Body fluid by Complement fixation |
| 39790-1 | Potassium [Moles/volume] in Capillary blood |
| 39-8 | Azlocillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 4020-4 | quiNINE [Presence] in Urine |
| 58534-9 | Corticotropin [Mass/volume] in Plasma --10 PM specimen |
| 29807-5 | Anaplasma phagocytophilum IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 40530-8 | Ethanol [Presence] in Gastric fluid |
| 59233-7 | Testosterone [Moles/volume] in Cerebral spinal fluid |
| 50431-6 | Cortisol [Mass/volume] in Serum or Plasma --6 PM specimen |
| 30258-8 | Insulin [Units/volume] in Serum or Plasma --2.3 hours post XXX challenge |
| 41071-2 | PARK2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 1943-0 | Glucosylceramidase [Enzymatic activity/volume] in Leukocytes |
| 19695-6 | Secobarbital [Mass/volume] in Urine |
| 2009-9 | Cancer Ag 19-9 [Presence] in Serum or Plasma |
| 2036-2 | Carbonate dehydratase [Enzymatic activity/volume] in Red Blood Cells |
| 20627-6 | Turbidity [Presence] of Urine Qualitative |
| 20857-9 | IgG.equine [Mass/volume] in Colostrum by Immune diffusion (ID) |
| 12363-8 | carBAMazepine [Presence] in Urine |
| 100093-4 | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot |
| 100370-6 | Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection |
| 101630-2 | JAK2 gene rearrangements in Blood or Marrow by FISH |
| 101666-6 | Protein.monoclonal isotype [Identifier] in 24 hour Urine by MS.MALDI-TOF |
| 13607-7 | Glucose [Mass/volume] in Serum or Plasma --4 hours post 50 g lactose PO |
| 103080-8 | Wheat recombinant (rTri a) 14 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14390-9 | Amylase [Enzymatic activity/volume] in Dialysis fluid |
| 10327-5 | Eosinophils/100 leukocytes in Sputum by Manual count |
| 15149-8 | Ammonia [Moles/volume] in Body fluid |
| 15219-9 | Food Allergen Mix 3 (Oat+Buckwheat+Sesame seed+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk |
| 15479-9 | Leptospira interrogans sv Hardjo Ab [Titer] in Serum by Agglutination |
| 11199-7 | Silver IgE Ab [Units/volume] in Serum |
| 17437-5 | Phenolphthalein [Mass/volume] in Urine |
| 17880-6 | Bacteria # 4 identified in Bronchial specimen by Aerobe culture |
| 18198-2 | Blastomyces dermatitidis IgE Ab [Presence] in Serum |
| 90369-0 | Sample collection timing related to drug dose |
| 7483-1 | Maple syrup IgE Ab [Units/volume] in Serum |
| 91812-8 | Fungus identified in Upper respiratory specimen by Culture |
| 92500-8 | Jk sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 60345-6 | Viable CD34 cells/100 cells in Body fluid |
| 61120-2 | PM-SCL-100 IgG Ab [Units/volume] in Serum |
| 76667-5 | Protein [Mass/volume] in Cerebral spinal fluid --3rd tube |
| 93198-0 | 10q23 g.94645745G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 615-5 | Viral strain [Type] in Isolate by Viral subtyping |
| 77124-6 | GPR98 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77165-9 | Anaplasma phagocytophilum and Ehrlichia chaffeensis IgG panel [Titer] - Serum |
| 93806-8 | EWSR1 gene rearrangements in Tissue by FISH |
| 7826-1 | Coccidioides immitis IgG Ab [Units/volume] in Serum |
| 63556-5 | Fat [Mass/mass] in Stool |
| 64-6 | Cefadroxil [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 79227-5 | Amobarbital [Mass/volume] in Body fluid |
| 94856-2 | Microscopic observation [Presence] in Sputum by Acid fast stain --2nd specimen |
| 95564-1 | 16-Alpha hydroxydehydroepiandrosterone [Z-score] in 24 hour Urine |
| 66747-7 | Clotting time of Blood by Heparin protamine titration |
| 80205-8 | Japanese encephalitis+Tick-borne encephalitis+West Nile+Yellow fever virus IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 95765-4 | Candida auris DNA [Presence] in Specimen by NAA with non-probe detection |
| 95849-6 | Somatotropin [Mass/volume] in Serum by Immunoassay --45 minutes post dose macimorelin |
| 6786-8 | Kappa light chains [Presence] in Urine by Electrophoresis |
| 68988-5 | Local PFGE pattern [Identifier] in Isolate |
| 81175-2 | Distance of tumor from closest margin [Length] in Specimen by Macroscopy |
| 70075-7 | Interleukin 1 alpha [Mass/volume] in Cerebral spinal fluid |
| 8276-8 | Cefpirome [Susceptibility] by Disk diffusion (KB) |
| 98484-9 | Apolipoprotein E phenotype [Interpretation] in Cerebral spinal fluid Narrative |
| 71664-7 | Smudge cells/Leukocytes [Pure number fraction] in Blood by Manual count |
| 72748-7 | Meprobamate [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 72812-1 | Norfluoxetine/Creatinine [Mass Ratio] in Urine |
| 73718-9 | Occupational Allergen Mix 5 (Isocyanate HDI+MDI+TDI+Phthalic anhydride) IgE Ab [Units/volume] in Serum by Multidisk |
| 73842-7 | Tetrahydrodeoxycortisol [Moles/volume] in 24 hour Urine |
| 87959-3 | Adenovirus Ag [Presence] in Cerebral spinal fluid by Immunoassay |
| 88531-9 | Parainfluenza virus identified in Cornea or Conjunctiva by Organism specific culture |
| 74313-8 | PRRSV Ab/Positive control in Specimen by Immunoassay |
| 88836-2 | Microbiology CNAMTS panel - Throat |
| 88976-6 | WBC casts [#/area] in Urine sediment |
| 41658-6 | ABT492 [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 59330-1 | Norsibutramine [Mass/volume] in Blood |
| 309-5 | Loracarbef [Susceptibility] by Serum bactericidal titer |
| 4189-7 | Clindamycin [Mass] of Dose |
| 42219-6 | Chromium [Moles/volume] in Urine |
| 42328-5 | Bordetella pertussis IgA Ab [Units/volume] in Serum by Immunoassay |
| 42601-5 | Immune complex.IgG [Units/volume] in Synovial fluid by C1q binding assay |
| 2160-0 | Creatinine [Mass/volume] in Serum or Plasma |
| 43100-7 | Sjogrens syndrome-A and B extractable nuclear Ab panel - Serum |
| 22273-7 | Echovirus 19 Ab [Titer] in Serum |
| 31784-2 | Coxiella burnetii Ag [Presence] in Specimen |
| 31858-4 | Influenza virus A Ag [Presence] in Throat |
| 31938-4 | Pneumocystis jiroveci Ag [Presence] in Semen |
| 2253-3 | Estriol (E3) [Mass/time] in 24 hour Urine |
| 32070-5 | Ethanol [Moles/volume] in Specimen |
| 44002-4 | Choriogonadotropin [Multiple of the median] adjusted in Amniotic fluid |
| 32585-2 | Epstein Barr virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 32618-1 | 3-Methoxytyramine [Mass/time] in 24 hour Urine |
| 44661-7 | Depth of invasion by tumor [Length] in Skin melanoma |
| 33520-8 | Platelet aggregation collagen induced in Platelet rich plasma --High dose |
| 5377-7 | Laceyella sacchari Ab [Units/volume] in Serum |
| 5387-6 | Toxoplasma gondii Ab [Presence] in Serum by Sabin dye test |
| 44985-0 | Chlamydia trachomatis L2 IgA Ab [Presence] in Serum |
| 54189-6 | Posaconazole [Susceptibility] by Disk diffusion (KB) |
| 54376-9 | Cobalamin (Vitamin B12) [Moles/volume] in Body fluid |
| 54379-3 | Cystatin C/Creatinine [Ratio] in Urine |
| 46761-3 | Biotinidase deficiency newborn screen interpretation |
| 24122-4 | Leukocytes [#/volume] in Urine by Manual count |
| 24340-2 | Gas panel - Body fluid |
| 24431-9 | IgA.canine [Mass/volume] in Serum by Immune diffusion (ID) |
| 55576-3 | QUEtiapine [Moles/volume] in Serum or Plasma |
| 35107-2 | Norclobazam [Mass/volume] in Serum or Plasma |
| 47624-2 | Glutamate/Amino acids.total in Hair |
| 47711-7 | Neopterin/Creatinine [Molar ratio] in Urine |
| 25906-9 | DOPamine [Moles/volume] in 24 hour Urine |
| 48010-3 | Genechip ID [Identifier] in Blood or Tissue by Molecular genetics method |
| 48345-3 | HIV 1+O+2 Ab [Presence] in Serum or Plasma |
| 26570-2 | CD4+CD45+ cells [#/volume] in Blood |
| 35825-9 | Orbifloxacin [Susceptibility] by Disk diffusion (KB) |
| 36895-1 | Arbovirus Ab [Identifier] in Specimen by Immunofluorescence |
| 56562-2 | Somatotropin [Mass/volume] in Serum or Plasma --6.5 hours post XXX challenge |
| 56955-8 | Lysine/Creatinine [Ratio] in 24 hour Urine |
| 26970-4 | Reticulin IgG Ab [Presence] in Serum by Immunofluorescence |
| 2700-3 | Oxalate [Mass/volume] in Urine |
| 2820-9 | Potassium [Moles/volume] in Dialysis fluid |
| 39773-7 | Beta-2-Microglobulin/Creatinine [Molar ratio] in Urine |
| 39991-5 | Creatinine [Mass/volume] in Urine --4.5 hours post XXX challenge |
| 40116-6 | Creatinine [Moles/volume] in Serum or Plasma --30 minutes pre XXX challenge |
| 29542-8 | Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Amniotic fluid cells |
| 29665-7 | Rickettsia conorii Ab [Titer] in Serum by Immunofluorescence |
| 29744-0 | Cryofibrinogen [Presence] in Plasma by 3 day 37 degree C incubation |
| 40690-0 | Tumor Ag 90 [Units/volume] in Serum |
| 59253-5 | Homocysteine cysteine disulfide [Moles/volume] in Urine |
| 41150-4 | Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid |
| 19409-2 | Cocaethylene cutoff [Mass/volume] in Urine for Screen method |
| 100046-2 | Cefquinome [Susceptibility] |
| 12547-6 | Phorate [Mass/volume] in Serum or Plasma |
| 101462-0 | Septin-5 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 102122-9 | Oxygen/Gas total [Partial pressure] in Arterial blood and Inhaled gas |
| 14717-3 | Estriol (E3) [Moles/volume] in Urine |
| 14744-7 | Glucose [Moles/volume] in Cerebral spinal fluid |
| 14822-1 | Lymphocytes/100 leukocytes in Synovial fluid by Manual count |
| 104277-9 | MET gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 10881-1 | Pentacarboxylporphyrins [Mass/volume] in Red Blood Cells |
| 11094-0 | Dichlorodiphenyltrichloroethane [Mass/volume] in Serum or Plasma |
| 16480-6 | Borrelia burgdorferi IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 11588-1 | Brucella melitensis Ab [Units/volume] in Serum |
| 12239-0 | Oligosaccharides [Presence] in Urine |
| 17480-5 | Pregnenolone [Mass/volume] in Urine |
| 17749-3 | Tromethamine [Mass/volume] in Serum or Plasma |
| 17833-5 | Basophils/100 leukocytes in Synovial fluid |
| 17916-8 | Bacteria # 2 identified in Wound shallow by Aerobe culture |
| 18240-2 | 1,3-Dichlorobenzene [Mass/volume] in Blood |
| 19075-1 | Cells Counted Total [#] in Cerebral spinal fluid |
| 75004-2 | Food Allergen Mix fp73 (Beef+Chicken+Pork+Lamb) IgE Ab [Units/volume] in Serum by Multidisk |
| 75093-5 | Galactose [Mass/volume] in DBS --post therapeutic diet |
| 60381-1 | Lemon IgG Ab [Mass/volume] in Serum |
| 61029-5 | 7-Aminoclonazepam [Presence] in Serum or Plasma |
| 61201-0 | Mold Allergen Mix 1 (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) IgE Ab/IgE total in Serum by Multidisk |
| 6252-1 | Stemphylium botryosum IgE Ab [Units/volume] in Serum |
| 77942-1 | CD8+CD3- cells/100 cells in Specimen |
| 7817-0 | Borrelia burgdorferi IgG Ab [Units/volume] in Serum |
| 94429-8 | HLA-DP and DQ and DR (class II) IgG low risk [Identifier] in Serum or Plasma by Flow cytometry (FC) |
| 6463-4 | Bacteria identified in Specimen by Culture |
| 95130-1 | Aggressive prostate cancer risk [Score] by Calculated by ExoDx |
| 9555-4 | CD11c cells [#/volume] in Blood |
| 95694-6 | Cache valley virus IgA Ab [Presence] in Specimen by Immunoassay |
| 9630-5 | Venlafaxine [Mass/volume] in Serum or Plasma |
| 81098-6 | Leptospira borgpetersenii sv Arborea Ab [Titer] in Serum by Agglutination |
| 96800-8 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose arginine |
| 69842-3 | Alpha hydroxybutyrate [Moles/volume] in Cerebral spinal fluid |
| 82812-9 | Sodium [Mass/volume] in Red Blood Cells |
| 98046-6 | Lincomycin IgE Ab [Units/volume] in Serum |
| 98389-0 | Depth of stromal invasion/Cervical thickness [Length fraction] in Endometrial cancer specimen |
| 72401-3 | Propoxyphene [Presence] in Blood by Screen method |
| 99915-1 | Cocci bacteria [Presence] in Urine sediment by Automated |
| 99933-4 | Leukocyte clumps [Presence] in Body fluid by Automated |
| 72733-9 | HYDROmorphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 87498-2 | 3-Methoxytyramine.free/Creatinine [Molar ratio] in 24 hour Urine |
| 87990-8 | Acanthamoeba sp identified in Cerebral spinal fluid by Organism specific culture |
| 88582-2 | Bordetella sp identified in Nasopharynx by Organism specific culture |
| 59735-1 | Salicylamide [Mass/volume] in Blood |
| 21332-2 | HIV 1 p41 Ab [Titer] in Serum by Immunoblot |
| 2154-3 | Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis |
| 21575-6 | Transferrin.carbohydrate deficient.pentasialo/Transferrin.total in Serum or Plasma |
| 31406-2 | Glomerular basement membrane IgG Ab [Units/volume] in Serum |
| 51414-1 | Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in Serum or Plasma |
| 22257-0 | Eastern equine encephalitis virus Ab [Titer] in Serum |
| 32042-4 | Thyroperoxidase Ab [Presence] in Serum or Plasma |
| 4356-2 | Norepinephrine [Mass] of Dose |
| 4362-0 | Ofloxacin [Mass] of Dose |
| 32166-1 | Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma |
| 32257-8 | Methionine [Moles/volume] in Vitreous fluid |
| 32279-2 | Valine [Moles/volume] in Body fluid |
| 43847-3 | Chlamydophila sp Ab [Presence] in Serum by Immunofluorescence |
| 23039-1 | Duck hepatitis virus 3 Ab [Presence] in Serum |
| 32697-5 | Lymphocytes [#/volume] in Synovial fluid by Manual count |
| 32749-4 | Cyclin D1 cells/100 cells in Specimen |
| 53127-7 | Monocytes+Macrophages/100 leukocytes in Tissue |
| 44542-9 | HTLV II DNA [Presence] in Blood by NAA with probe detection |
| 23246-2 | Mycobacterium avium ss paratuberculosis DNA [Presence] in Stool by NAA with probe detection |
| 53500-5 | Ammonia [Moles/volume] in Water |
| 23659-6 | Apramycin [Susceptibility] |
| 23831-1 | Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum |
| 23867-5 | Hantavirus sin nombre IgG Ab [Titer] in Serum |
| 33832-7 | Lymphocytes Immunoblastic [#/volume] in Blood by Manual count |
| 34188-3 | Nucleated erythrocytes [Presence] in Blood |
| 34271-7 | Collagen crosslinked N-telopeptide [Mass/volume] in Urine |
| 54076-5 | Endocrine newborn screening panel |
| 24342-8 | Gas and Carbon monoxide panel - Capillary blood |
| 55160-6 | Adenovirus IgG and IgM panel - Serum |
| 55598-7 | Leukocytes.disintegrated/100 leukocytes in Body fluid by Manual count |
| 47092-2 | Natriuretic peptide B [Moles/volume] in Serum or Plasma |
| 35296-3 | PAX3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 25641-2 | Follitropin [Units/volume] in Serum or Plasma --1 hour post 100 ug luteinizing releasing hormone IV |
| 25915-0 | Gamma aminobutyrate/Creatinine [Molar ratio] in 24 hour Urine |
| 5623-4 | Chromium [Mass/volume] in Urine |
| 56448-4 | Chloride [Moles/volume] in Sweat by Screen method |
| 26694-0 | Clostridioides difficile IgM Ab [Units/volume] in Serum |
| 3682-2 | HYDROmorphone [Presence] in Serum or Plasma |
| 36903-3 | Chlamydia trachomatis and Neisseria gonorrhoeae DNA [Identifier] in Specimen by NAA with probe detection |
| 3823-2 | Morazone [Presence] in Urine |
| 56661-2 | Myelin basic protein [Mass/volume] in Serum |
| 48569-8 | Bacteria # 8 identified in Specimen by Aerobe culture |
| 48814-8 | Vancomycin resistance vanA gene [Presence] by Molecular method |
| 27026-4 | Benzoylecgonine [Mass/mass] in Meconium |
| 57427-7 | CD10+FMC7+ cells/100 cells in Body fluid |
| 4908-0 | HLA-Dw4 [Presence] in Donor |
| 38905-6 | MLL gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 39089-8 | PLP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 57840-1 | Eosinophils/100 leukocytes in Dialysis fluid by Manual count |
| 57922-7 | Carbon dioxide, total [Moles/volume] in Serum or Plasma by calculation |
| 49387-4 | Herpes virus 6 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
| 50134-6 | 3-Hydroxystearoylcarnitine (C18-OH)/Creatinine [Molar ratio] in Urine |
| 403-6 | Pipemidate [Susceptibility] by Minimum lethal concentration (MLC) |
| 59044-8 | ACE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 59217-0 | Beta-2-Microglobulin [Mass/volume] in Peritoneal fluid |
| 50252-6 | 3-Hydroxyisovalerylcarnitine (C5-OH)/Creatinine [Molar ratio] in Urine |
| 41075-3 | NPHS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19386-2 | chlordiazePOXIDE [Presence] in Urine by Confirmatory method |
| 20728-2 | Brucella abortus Ab [Presence] in Serum by Complement fixation |
| 20870-2 | Listeria sp [Presence] in Milk by Organism specific culture |
| 20930-4 | Paraquat [Mass/mass] in Tissue |
| 100027-2 | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 12516-1 | Catecholamines [Mass/volume] in Urine --2nd specimen post XXX challenge |
| 12921-3 | Testosterone [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 13627-5 | Erythrocytes [Presence] in Semen by Light microscopy |
| 13634-1 | Rheumatoid factor [Units/volume] in Synovial fluid |
| 13671-3 | Alpha hydroxybutyrate/Creatinine [Mass Ratio] in Urine |
| 13783-6 | Normetanephrine/Creatinine [Mass Ratio] in Urine |
| 102249-0 | Cola IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13968-3 | Penicillin [Susceptibility] by Disk diffusion (KB) |
| 104356-1 | Borrelia recurrentis DNA [Presence] in Specimen by NAA with probe detection |
| 16220-6 | Phenmetrazine [Presence] in Urine by Confirmatory method |
| 1077-7 | Jk sup(b) Ag [Presence] on Red Blood Cells from Donor |
| 16509-2 | Calcitonin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 16581-1 | Chlamydophila pneumoniae IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 17974-7 | Bacteria # 6 identified in Urine by Culture |
| 18238-6 | Lithium [Mass/mass] in Tissue |
| 90978-8 | Vilazodone [Mass/volume] in Serum or Plasma |
| 74482-1 | Reason for unsatisfactory specimen not related to sample quality of dried blood spot |
| 74529-9 | Dicarboxyhexenoylcarnitine (C6:1-DC) [Moles/volume] in Serum or Plasma |
| 74909-3 | Calcium oxalate dihydrate/Total in Stone |
| 92235-1 | Lab order result status |
| 92538-8 | Jk sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 7596-0 | White Pepper IgE Ab [Units/volume] in Serum |
| 93455-4 | IC-26 [Mass/volume] in Urine by Confirmatory method |
| 61403-2 | Stenotrophomonas maltophilia DNA [Presence] in Specimen by NAA with probe detection |
| 62246-4 | MCHC [Mass/volume] in Blood from Fetus by Automated count |
| 93855-5 | Iothalamate [Mass/volume] in Urine |
| 63151-5 | Food Allergen Mix 46 (Cashew+Pecan or Hickory nut+Chestnut+Walnut+Pistachio) IgG Ab [Mass/volume] in Serum by Multidisk |
| 63178-8 | Chaetomium globosum IgG Ab [Mass/volume] in Serum |
| 77928-0 | Cortisol [Moles/volume] in Serum or Plasma --75 minutes post XXX challenge |
| 7856-8 | Dengue virus 2 Ab [Presence] in Serum by Immunoassay |
| 94442-1 | HLA-A and B and C (class I) IgG with prozone effect [Identifier] in Serum or Plasma by Flow cytometry (FC) |
| 94502-2 | SARS-related coronavirus RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 79386-9 | Escherichia coli Stx1 toxin stx1 gene [Presence] in Stool by NAA with probe detection |
| 95210-1 | Anaplasma marginale Ab/Negative control in Serum by Immunoassay |
| 79655-7 | Cytosine [Moles/volume] in Serum or Plasma |
| 7994-7 | Rickettsia sp Ab [Units/volume] in Serum |
| 68951-3 | Pyruvate [Mass/volume] in Blood --20 minutes post XXX challenge |
| 96897-4 | SARS-CoV-2 (COVID-19) RNA panel - Oropharyngeal wash by NAA with probe detection |
| 69904-1 | Service comment 77 |
| 70018-7 | Staphylococcus haemolyticus DNA [Presence] in Blood by NAA with probe detection |
| 70027-8 | Dermatophytes chitin synthase 1 chs1 gene [Presence] in Nail by NAA with probe detection |
| 82162-9 | Human coronavirus NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 82902-8 | Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre XXX challenge |
| 85278-0 | Distance of carcinoma from closest surgical margin when all margins are uninvolved [Length] in Cancer specimen by Light microscopy |
| 86109-6 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum |
| 86126-0 | Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum --2nd specimen |
| 7326-2 | Fusarium oxysporum IgE Ab [Units/volume] in Serum |
| 73320-4 | Ketorolac induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87241-6 | Bacillus atrophaeus [Presence] in Laboratory device by Culture |
| 73608-2 | Tedizolid [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 73609-0 | Solithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 88579-8 | Mycoplasma pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 73998-7 | 25H-NBOMe [Presence] in Urine by Confirmatory method |
| 89331-3 | CD3+CD4+CD27+CD62L+ cells [#/volume] in Blood |
| 4128-5 | Anileridine [Mass] of Dose |
| 41637-0 | Ebola virus Ag [Presence] in Specimen by Immunofluorescence |
| 41654-5 | Hematocrit [Volume Fraction] of Venous blood |
| 59595-9 | 7-Aminoclonazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 59887-0 | Citalopram [Moles/volume] in Gastric fluid |
| 30423-8 | Lymphoma cells/100 leukocytes in Blood |
| 3086-6 | Urate [Mass/volume] in Urine |
| 31122-5 | CD235a cells [#/volume] in Blood |
| 42330-1 | Bordetella pertussis IgG Ab [Units/volume] in Serum by Immunoassay |
| 59909-2 | hydrOXYzine [Moles/volume] in Gastric fluid |
| 59945-6 | Nortriptyline [Moles/volume] in Gastric fluid |
| 60254-0 | Parainfluenza virus 1+2+3 RNA [Presence] in Specimen by NAA with probe detection |
| 31556-4 | Parietal cell IgG Ab [Presence] in Serum |
| 51314-3 | CD4+CD7-CD49D- cells/100 cells in Bone marrow |
| 4272-1 | Haloperidol [Mass] of Dose |
| 42957-1 | SARS coronavirus IgG Ab [Presence] in Serum |
| 31807-1 | Eastern equine encephalitis virus Ag [Presence] in Serum |
| 51673-2 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 51808-4 | Chlamydophila psittaci IgG Ab [Units/volume] in Serum by Immunoassay |
| 51913-2 | Hepatitis A virus IgG+IgM Ab [Presence] in Serum |
| 43406-8 | Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Specimen by Probe with signal amplification |
| 22674-6 | Transferrin [Moles/volume] in Serum or Plasma |
| 53013-9 | Bactericidal permeability increasing protein Ab [Presence] in Serum |
| 32727-0 | Urobilinogen [Units/volume] in Urine |
| 53203-6 | Hexenoylcarnitine (C6:1) [Moles/volume] in DBS |
| 5345-4 | Salmonella typhi H Ab [Presence] in Serum by Latex agglutination |
| 44450-5 | Beta cortolone/Creatinine [Mass Ratio] in Urine |
| 44819-1 | Leishmania donovani IgM Ab [Titer] in Serum by Immunofluorescence |
| 5355-3 | Smith extractable nuclear Ab [Presence] in Serum by Counterimmunoelectrophoresis (CIE) |
| 5380-1 | Thyroglobulin Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
| 23758-6 | Neospora caninum Ab [Titer] in Serum |
| 23816-2 | Other Antibiotic [Mass/volume] in Serum or Plasma |
| 54102-9 | Monoethyl methylphosphonate [Mass/volume] in Urine |
| 54294-4 | Fatty acids.very long chain C26:0 (Hexacosanoate)/Creatinine [Molar ratio] in Urine |
| 4684-7 | Sulfhemoglobin [Presence] in Blood |
| 24175-2 | Adenovirus Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24255-2 | Coxsackievirus B2 Ab [Titer] in Serum --1st specimen |
| 55596-1 | Goose feather IgE Ab [Presence] in Serum |
| 34930-8 | CD3+CD4+CD45RO+CD45RA+ cells/100 cells in Blood |
| 55690-2 | Oleandomycin [Susceptibility] by Gradient strip |
| 55900-5 | Immunoglobulin light chains.free [Presence] in Urine by Immunofixation |
| 47663-0 | Insulin [Units/volume] in Serum or Plasma --30 minutes post dose glucose |
| 25912-7 | Fluoride [Moles/volume] in 24 hour Urine |
| 56369-2 | False ragweed IgG4 Ab [Mass/volume] in Serum |
| 3728-3 | Loxapine [Mass/volume] in Serum or Plasma |
| 56565-5 | Somatotropin [Mass/volume] in Serum or Plasma --9 hours post XXX challenge |
| 56663-8 | 5-Hydroxytryptophan [Moles/time] in 24 hour Urine |
| 56956-6 | Magnesium/Creatinine [Ratio] in Urine |
| 48409-7 | T cell crossmatch [Presence] in Blood from Donor |
| 48730-6 | X linked heterotaxy [Identifier] in Blood or Tissue by FISH Narrative |
| 57312-1 | PRNP gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 57365-9 | Lactate [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 57583-7 | Aldosterone [Moles/volume] in Serum or Plasma --2 hours post 25 mg captopril PO |
| 3941-2 | Phendimetrazine [Mass/time] in 24 hour Urine |
| 58693-3 | Cortisol [Moles/volume] in Saliva (oral fluid) --6th specimen post XXX challenge |
| 49799-0 | Treponema pallidum DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 49888-1 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin |
| 49973-1 | Borrelia burgdorferi 31kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 40725-4 | Hepatitis B virus core IgG Ab [Presence] in Serum by Immunoassay |
| 58817-8 | Estradiol (E2) [Mass/volume] in Serum or Plasma --3rd specimen |
| 19226-0 | Deoxyhemoglobin/Hemoglobin.total in Capillary blood |
| 19760-8 | Clostridium tetani toxoid IgE Ab [Units/volume] in Serum |
| 20401-6 | Speckled nuclear Ab pattern [Titer] in Serum |
| 20817-3 | Escherichia coli K88 [Presence] in Small intestine Tissue by Immunofluorescence |
| 12434-7 | predniSONE [Mass/volume] in Serum or Plasma |
| 100429-0 | LRBA deficiency panel - Blood |
| 12452-9 | Epithelial cells [Presence] in Semen by Light microscopy |
| 12628-4 | Glucose [Mass/volume] in Peritoneal dialysis fluid |
| 12891-8 | Borrelia burgdorferi 41kD Ab [Presence] in Serum by Immunoblot |
| 12946-0 | Thyrotropin [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 13595-4 | Basophils/100 leukocytes in Nose |
| 14260-4 | Bromoform [Mass/volume] in Blood |
| 103178-0 | Enterovirus D68 RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 14991-4 | little i-2 subtype [Presence] on Red Blood Cells |
| 10631-0 | Testosterone [Moles/volume] in Semen |
| 11062-7 | Thyroxine (T4).albumin bound [Mass/volume] in Serum or Plasma |
| 16278-4 | Mycobacterium tuberculosis DNA [Presence] in Blood by NAA with probe detection |
| 17144-7 | CD4+CD69+ cells/100 cells in Blood |
| 17682-6 | Terpineol [Presence] in Blood |
| 17723-8 | Treponema pallidum Ab [Presence] in Serum by Immobilization |
| 17752-7 | Tryptophan [Presence] in Urine |
| 18217-0 | Epidermis IgA Ab [Presence] in Tissue |
| 7562-2 | Paper IgE Ab [Units/volume] in Serum |
| 61052-7 | Norfentanyl [Presence] in Serum or Plasma |
| 76479-5 | Acetylcholinesterase [Interpretation] in Amniotic fluid Narrative |
| 93354-9 | Neutrophil CD64 and Monocyte HLA DR panel - Blood by Flow cytometry (FC) |
| 9360-9 | Bartonella quintana IgG Ab [Titer] in Serum |
| 77756-5 | 7-Aminoclonazepam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 6292-7 | Complement decay accelerating factor [Presence] in Red Blood Cells |
| 77780-5 | oxyMORphone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
| 95128-5 | Edoxaban [Mass/volume] in Platelet poor plasma by Chromogenic method |
| 95602-9 | GABABR Ab [Titer] in Serum by Cell binding immunofluorescent assay |
| 65795-7 | Kiwi native (nAct d) 1 IgE Ab [Units/volume] in Serum |
| 80155-5 | Soluble CD27 [Units/volume] in Serum or Plasma |
| 80387-4 | HIV 1+2 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 96985-7 | Sex [Type] in Products of Conception by Molecular genetics method |
| 70294-4 | Entamoeba sp DNA [Identifier] in Specimen by Sequencing |
| 7092-0 | Apricot IgG Ab [Units/volume] in Serum |
| 7155-5 | Boxelder IgE Ab [Units/volume] in Serum |
| 72408-8 | Microscopic observation [Identifier] in Anal by Gram stain |
| 85380-4 | HIV immunoassay testing algorithm interpretation in Serum, Plasma or Blood |
| 86233-4 | HIV 1 Ab [Presence] in Serum, Plasma or Blood by Immunoblot |
| 86724-2 | Erysipelothrix rhusiopathiae [Presence] in Specimen by Organism specific culture |
| 87345-5 | Senecavirus A [Presence] in Specimen by Organism specific culture |
| 73504-3 | Benztropine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73701-5 | Multiple carboxylase deficiency (MCD) newborn screen interpretation |
| 88218-3 | Parechovirus RNA [Presence] in Stool by NAA with probe detection |
| 73895-5 | Hemoglobin [Entitic substance] in Reticulocytes by Automated count |
| 74359-1 | Cholesterol ester transfer protein actual/normal in Serum or Plasma |
| 88635-8 | Microscopic observation [Identifier] in Vomitus by Gram stain |
| 41621-4 | Arenavirus RNA [Presence] in Specimen by NAA with probe detection |
| 5063-3 | Borrelia burgdorferi IgG Ab [Titer] in Serum by Immunofluorescence |
| 30456-8 | Nonhematic cells/100 leukocytes in Cerebral spinal fluid |
| 42318-6 | GALT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 60238-3 | European Ash IgE Ab [Units/volume] in Serum |
| 21154-0 | CD11c cells/100 cells in Specimen |
| 21240-7 | Dextromethorphan [Mass/volume] in Urine |
| 21347-0 | HTLV I+II Ab band pattern [Interpretation] in Serum by Immunoblot |
| 31326-2 | Coxsackievirus B2 Ab [Units/volume] in Body fluid |
| 42793-0 | Mitogen-Activated protein kinase 9 Ag [Presence] in Tissue by Immune stain |
| 43286-4 | Spermatozoa IgG Ab/100 spermatozoa in Serum |
| 43302-9 | Platelet glycoprotein Ab [Presence] in Serum by Immunoassay |
| 22600-1 | Varicella zoster virus Ab [Presence] in Serum |
| 32345-1 | Uroporphyrin [Moles/volume] in Red Blood Cells |
| 5216-7 | Heterophile Ab after absorption [Titer] in Serum by Latex agglutination |
| 4389-3 | Phencyclidine [Mass] of Dose |
| 32719-7 | Spermatozoa IgG Ab [Presence] in Semen |
| 32734-6 | Beta 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis |
| 53340-6 | 17-Hydroxyprogesterone [Moles/volume] in DBS |
| 44690-6 | Invasive melanoma.location relative to closest uninvolved deep margin in Skin melanoma |
| 23263-7 | Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum by Immunoassay |
| 23292-6 | Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Tissue by Immune stain |
| 33287-4 | Glucose-6-Phosphate dehydrogenase [Presence] in DBS |
| 33411-0 | Free Hemoglobin [Presence] in Urine |
| 53946-0 | Escherichia coli shiga-like toxin identified in Specimen |
| 23662-0 | Babesia bigemina Ab [Presence] in Serum by Complement fixation |
| 23832-9 | Bordetella pertussis.pertussis toxin IgM Ab [Units/volume] in Serum |
| 34225-3 | 3-Alpha-Androstanediol glucuronide [Moles/volume] in Urine |
| 54305-8 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Cerebral spinal fluid |
| 4593-0 | Hemoglobin I [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 46408-1 | Somatotropin [Mass/volume] in Serum or Plasma --15 minutes pre dose arginine |
| 54928-7 | Tinidazole [Susceptibility] |
| 54934-5 | Ricinine [Mass/volume] in Urine |
| 25403-7 | Estrone (E1) [Moles/volume] in Urine |
| 35056-1 | Histiocytes [#/volume] in Cerebral spinal fluid |
| 55647-2 | Cefsulodin [Susceptibility] by Gradient strip |
| 47617-6 | Estradiol (E2) [Mass/volume] in Serum or Plasma --pre dose corticotropin |
| 25792-3 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 35677-4 | Potassium [Moles/volume] in Urine collected for unspecified duration |
| 5631-7 | Copper [Mass/volume] in Serum or Plasma |
| 26624-7 | Rickettsia conorii Ab [Presence] in Serum |
| 2668-2 | Norepinephrine [Mass/time] in 24 hour Urine |
| 3772-1 | Methadone [Mass/volume] in Serum or Plasma |
| 49240-5 | Patient symptoms [Interpretation] Narrative--pre dose lactose PO |
| 4925-4 | HLA-DPw3 [Presence] |
| 27957-0 | Pyruvate [Mass/volume] in Blood --4 hours post XXX challenge |
| 390-5 | Pefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 39459-3 | Bicarbonate [Moles/volume] standard in Venous cord blood |
| 3952-9 | Phenothiazines [Presence] in Serum or Plasma |
| 57779-1 | Disaccharidases [Interpretation] in Small intestine Tissue Narrative |
| 49753-7 | Norbuprenorphine [Mass/volume] in Urine |
| 2810-0 | Porphobilinogen [Mass/time] in 24 hour Urine |
| 2853-0 | Prostaglandin E2 [Mass/volume] in Serum or Plasma |
| 39986-5 | Creatinine [Mass/volume] in Urine --2 hours post XXX challenge |
| 58560-4 | Corticotropin [Moles/volume] in Plasma --1st specimen post XXX challenge |
| 58582-8 | Corticotropin [Moles/volume] in Plasma --30 minutes post dose glucagon |
| 40383-2 | Methyprylon [Presence] in Gastric fluid |
| 50216-1 | Glucose [Mass/volume] in Serum or Plasma --6th specimen |
| 19444-9 | diazePAM cutoff [Mass/volume] in Urine for Screen method |
| 20746-4 | Carbamates [Presence] in Specimen by Screen method |
| 20809-0 | Ergot alkaloid [Mass/mass] in Feed |
| 20910-6 | Organochlorine pesticides [Identifier] in Milk |
| 20970-0 | Strychnine [Presence] in Specimen |
| 13232-4 | Coxsackievirus A Ab [Units/volume] in Cerebral spinal fluid |
| 13659-8 | Epidermal growth factor receptor [Mass/mass] in Tissue |
| 13710-9 | Asparagine/Creatinine [Mass Ratio] in Urine |
| 14807-2 | Lead [Moles/volume] in Blood |
| 10410-9 | Plasma given [Type] |
| 15352-8 | Apolipoprotein E3 [Presence] in Blood |
| 16296-6 | 11-Hydroxyandrosterone [Mass/volume] in Serum or Plasma |
| 1210-4 | little s Ab [Presence] in Serum or Plasma |
| 16786-6 | DOPamine [Mass/volume] in Urine --4th specimen post XXX challenge |
| 16994-6 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --5 hours post dose glucose |
| 18231-1 | Histone H2a+H2b Ab [Presence] in Serum by Immunofluorescence |
| 19087-6 | Collection of urine specimen end time |
| 19114-8 | Lamellar bodies [#/volume] in Amniotic fluid |
| 91082-8 | Fungal 18s rRNA gene [Presence] in Specimen by NAA with probe detection |
| 74996-0 | Alkaline phosphatase.bone [Z-score] in Serum or Plasma |
| 7599-4 | Phadiatop IgE Ab [Units/volume] in Serum |
| 7697-6 | Sesame Seed triggered histamine release [Units/volume] in Blood |
| 61224-2 | Lenscale IgE Ab/IgE total in Serum |
| 77787-0 | Buprenorphine cutoff [Mass/volume] in Urine for Screen method |
| 78358-9 | Acyl CoA dehydrogenases [Enzymatic activity/mass] in Fibroblast by [9,10-3H] palmitate substrate |
| 63359-4 | Thyroglobulin Ab [Units/volume] in Body fluid by Immunoassay |
| 78881-0 | RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
| 79302-6 | D- and L-2-hydroxyglutarate pattern [Interpretation] in Amniotic fluid Narrative |
| 9549-7 | Legionella pneumophila 4 IgM Ab [Titer] in Serum by Immunofluorescence |
| 6704-1 | 11-Ketopregnanetriol [Mass/time] in 24 hour Urine |
| 68963-8 | Collection date and time of Specimen |
| 80632-3 | 2-Methylpropyl methylphosphonate [Mass/volume] in Blood |
| 81308-9 | Influenza virus A RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection |
| 81427-7 | Microscopic observation [Identifier] in Venous blood by Oil red O stain |
| 9657-8 | Echinococcus sp IgM Ab [Units/volume] in Serum by Immunoassay |
| 96896-6 | SARS-CoV-2 (COVID-19) clade [Type] in Specimen by Molecular genetics method |
| 70079-9 | Interleukin 3 [Mass/volume] in Serum or Plasma |
| 70175-5 | Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Amniotic fluid |
| 71658-9 | Neutrophils/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
| 98044-1 | Benzoate IgE Ab [Units/volume] in Serum |
| 98099-5 | Interleukin 21 [Mass/volume] in Serum or Plasma |
| 99062-2 | Acetylcholine receptor modulation Ab [Presence] in Serum by Flow cytometry (FC) |
| 84928-1 | NMDAR subunit 1 Ab [Presence] in Serum by Immunofluorescence |
| 86325-8 | Bordetella pertussis+parapertussis ptxS1 gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73064-8 | amLODIPine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87553-4 | Aspergillus fumigatus and Saccharopolyspora rectivirgula and Thermoactinomyces vulgaris IgG panel - Serum |
| 73674-4 | Streptococcus pneumoniae serotype [Type] in Isolate by Agglutination |
| 88555-8 | Galactomannan Ag [Presence] in Bronchoalveolar lavage |
| 74435-9 | Cholesterol.non-esterified/Cholesterol.total in Serum or Plasma by Gas chromatography |
| 74451-6 | Other cells/100 leukocytes in Blood from Fetus |
| 88899-0 | Adenovirus [Presence] in Cornea or Conjunctiva by Organism specific culture |
| 41683-4 | cefTRIAXone+Clavulanate [Susceptibility] by Gradient strip |
| 50899-4 | Platinum [Moles/mass] in Tissue |
| 31169-6 | Theobromine [Mass/volume] in Serum or Plasma |
| 42503-3 | Hantavirus Ab [Presence] in Serum |
| 42512-4 | IgE [Units/volume] in Urine |
| 42611-4 | Glucose [Mass/volume] in Urine --1 hour post dose lactose PO |
| 21206-8 | Sweet Clover IgE Ab [Units/volume] in Serum |
| 31276-9 | Burkholderia pseudomallei IgG Ab [Units/volume] in Specimen |
| 31503-6 | Mumps virus Ab [Presence] in Serum |
| 51273-1 | CD3 cells/100 cells in Tissue |
| 51276-4 | CD3+CD16+ cells/100 cells in Bone marrow |
| 42733-6 | Cardiolipin IgM Ab B2GP1 dependent [Multiple of the median] in Serum |
| 2186-5 | Cytochrome C oxidase [Enzymatic activity/volume] in Leukocytes |
| 31927-7 | Parainfluenza virus 3 Ag [Presence] in Throat |
| 4370-3 | oxyCODONE [Mass] of Dose |
| 5277-9 | Penicillium roqueforti Ab [Units/volume] in Serum |
| 5278-7 | Plasmodium falciparum Ab [Units/volume] in Serum |
| 44039-6 | Bacteria [Presence] in Eye by Light microscopy |
| 32647-0 | Nelfinavir [Mass/volume] in Serum or Plasma |
| 44530-4 | Histoplasma capsulatum yeast phase Ab [Presence] in Serum by Immune diffusion (ID) |
| 44555-1 | Kappa light chains.free [Presence] in Serum by Immunofixation |
| 23602-6 | Salmonella enteritidis [Presence] in Stool by Organism specific culture |
| 53739-9 | HLA-DQB1*9 [Presence] |
| 53747-2 | Cocaine panel - Urine |
| 53785-2 | Microscopic observation [Identifier] in Urine by Wright stain |
| 53929-6 | Glucose [Mass/volume] in Serum or Plasma --40 minutes post 50 g lactose PO |
| 45274-8 | Low molecular weight heparin induced platelet Ab [Presence] in Serum |
| 3374-6 | Barbiturate screen present [Identifier] in Urine |
| 3390-2 | Benzodiazepines [Presence] in Urine |
| 54346-2 | Albumin [Mass/volume] in Stool |
| 46978-3 | Salicylates [Mass/volume] in Serum or Plasma by Confirmatory method |
| 34631-2 | Cyproheptadine [Mass/volume] in Urine |
| 4719-1 | HLA-A23(9) [Presence] in Donor |
| 25324-5 | Arsenic/Creatinine [Molar ratio] in Urine |
| 25498-7 | Adenosine monophosphate.cyclic [Moles/volume] in Serum or Plasma |
| 35051-2 | Leukocytes other [#/volume] in Body fluid |
| 35293-0 | TYR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55640-7 | Cefetamet [Susceptibility] by Gradient strip |
| 56035-9 | Apolipoprotein A-I/Cholesterol in HDL [Mass Ratio] in Serum or Plasma |
| 47555-8 | Alanine/Amino acids.total in Serum or Plasma |
| 47731-5 | Prolactin [Mass/volume] in Serum or Plasma --2 hours post dose TRH IV |
| 25660-2 | Gastrin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 26000-0 | Uroporphyrin [Moles/volume] in 24 hour Urine |
| 35600-6 | chlordiazePOXIDE [Mass/volume] in Serum or Plasma by Screen method |
| 35807-7 | Florfenicol [Susceptibility] by Disk diffusion (KB) |
| 38198-8 | Bordetella pertussis Ag [Presence] in Nasopharynx by Immunofluorescence |
| 56598-6 | Epstein Barr virus early IgM Ab [Units/volume] in Serum by Immunoassay |
| 56996-2 | Urea/Creatinine [Mass Ratio] in 24 hour Urine |
| 48431-1 | Zinc [Molar amount] in unspecified time Semen |
| 38254-9 | Carbonated calcium phosphate [Presence] in Stone |
| 38345-5 | Sporothrix schenckii Ab [Titer] in Cerebral spinal fluid by Latex agglutination |
| 4895-9 | HLA-Dw22 [Presence] |
| 48964-1 | Propoxyphene [Mass/volume] in Specimen |
| 49049-0 | Collection time of Specimen |
| 49093-8 | Arbovirus IgG and IgM panel - Serum by Immunofluorescence |
| 49104-3 | Mycoplasma pneumoniae DNA [Units/volume] in Blood by NAA with probe detection |
| 27309-4 | Aspergillus flavus Ab [Titer] in Serum by Immune diffusion (ID) |
| 58774-1 | Alternaria alternata recombinant (rAlt a) 1 IgE Ab [Units/volume] in Serum |
| 40326-1 | Testosterone [Moles/volume] in Serum or Plasma --3 hours post dose triple bolus |
| 58822-8 | Cortisol [Mass/volume] in Serum or Plasma --22nd specimen |
| 50240-1 | Yeast.budding [Presence] in Urine by Computer assisted method |
| 50394-6 | Adenine phosphoribosyltransferase [Enzymatic activity/mass] in Chorionic villus sample |
| 50535-4 | Thyrotropin [Units/volume] in Serum or Plasma --3rd specimen |
| 3039-5 | Lipase [Enzymatic activity/volume] in Amniotic fluid |
| 41131-4 | Mumps virus IgM Ab [Presence] in Cerebral spinal fluid |
| 20527-8 | Ethylmorphine [Mass/volume] in Urine by Confirmatory method |
| 20770-4 | Coliform bacteria [#/volume] by Viability count |
| 100089-2 | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot |
| 1001-7 | DBG Ab [Presence] in Serum or Plasma from Donor |
| 100888-7 | Monkeypox virus clade II DNA [Presence] in Specimen by NAA with probe detection |
| 12534-4 | Thiazolidine-2-Thione-4-Carboxylic acid/Creatinine [Mass Ratio] in Urine |
| 12735-7 | Collagen Ab [Units/volume] in Urine |
| 101189-9 | ADB-BUTINACA [Presence] in Urine by Confirmatory method |
| 12943-7 | Thyrotropin [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 1018-1 | E Ab [Presence] in Serum or Plasma |
| 102143-5 | Apple IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102204-5 | Caraway IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14275-2 | Immune complex [Units/volume] in Serum or Plasma by C3b binding assay |
| 102828-1 | Sulfamethoxazole IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102884-4 | Abachi Wood Dust IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102963-6 | Phoma betae IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14451-9 | Virus identified in Eye by Culture |
| 14660-5 | Color of Peritoneal fluid |
| 14696-9 | Deuteroporphyrin [Moles/volume] in Stool |
| 104201-9 | Eszopiclone and Zopiclone [Mass/volume] in Urine by LC/MS/MS |
| 14852-8 | Norepinephrine [Moles/volume] in Plasma |
| 10487-7 | HMB-45 Ag [Presence] in Tissue by Immune stain |
| 16111-7 | Epinephrine+Norepinephrine [Mass/time] in 24 hour Urine |
| 16137-2 | Centromere Ab [Presence] in Serum |
| 11557-6 | Carbon dioxide [Partial pressure] in Blood |
| 18184-2 | Erythrocyte sedimentation rate by 2H Westergren method |
| 7460-9 | Lettuce IgG Ab [Units/volume] in Serum |
| 92785-5 | Cutibacterium acnes DNA [Presence] by NAA with probe detection in Positive blood culture |
| 6196-0 | Ox-eye daisy IgE Ab [Units/volume] in Serum |
| 77073-5 | ATP5A1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 62418-9 | Glucose/Insulin [Ratio] in Serum or Plasma |
| 63077-2 | Dog dander IgG Ab [Mass/volume] in Serum |
| 63300-8 | Nucleosome Ab [Presence] in Serum by Immunoassay |
| 63330-5 | Baker's yeast IgA Ab [Units/volume] in Body fluid by Immunoassay |
| 7879-0 | Ehrlichia sp Ab [Presence] in Serum |
| 94477-7 | Borrelia burgdorferi 49736 IgG bands [#] in Blood by Immunoblot |
| 79277-0 | 7-lathosterol [Moles/volume] in Serum or Plasma |
| 6514-4 | Human papilloma virus rRNA [Presence] in Genital specimen by NAA with probe detection |
| 79631-8 | L-homoserine [Moles/volume] in Serum or Plasma |
| 79678-9 | 5,6-Dihydrouridine/Creatinine [Molar ratio] in Urine |
| 6760-3 | Glucose [Mass/volume] in Serum or Plasma --6 hours post 75 g glucose PO |
| 68994-3 | Performing laboratory name |
| 80603-4 | Coagulation factor XI inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
| 694-0 | Neisseria gonorrhoeae [Presence] in Semen by Organism specific culture |
| 69838-1 | 2-Hydroxy-3-Methylvalerate [Moles/volume] in Cerebral spinal fluid |
| 69871-2 | Service comment 44 |
| 69877-9 | Service comment 50 |
| 81772-6 | European house dust mite IgG Ab [Mass/volume] in Serum |
| 97768-6 | Artifact [#/area] in Urine sediment by Light microscopy |
| 98253-8 | Myometrial invasion [Presence] in Endometrial cancer specimen |
| 98404-7 | Mold identified in Isolate by MS.MALDI-TOF |
| 98487-2 | Alzheimer's disease risk [Score] in Cerebral spinal fluid by calculation |
| 99007-7 | Leptospira interrogans sv Mankarso Ab [Titer] in Serum by Agglutination |
| 99061-4 | Cholesterol.esterified actual/normal in Fibroblast |
| 72419-5 | Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Blood --post meal |
| 83134-7 | 3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone/Creatinine [Molar ratio] in Urine |
| 85785-4 | Candida tropicalis DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 87318-2 | Escherichia coli eaeA gene [Presence] in Isolate by NAA with probe detection |
| 73746-0 | Keyhole limpet hemocyanin IgG Ab [Mass/volume] in Serum |
| 88186-2 | Ebola and Marburg virus RNA Panel - Blood by NAA with probe detection |
| 88543-4 | HIV 1 RNA protease gene mutations detected [Identifier] in Cerebral spinal fluid by Sequencing |
| 74106-6 | Proteinase 3 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 891-2 | Blood group antibody screen.cell I [Presence] in Serum or Plasma |
| 89326-3 | CD3+CD4+CD28+HLA DR+ cells [#/volume] in Blood |
| 89352-9 | CD27+IgD+IgM+ cells/100 CD19 cells in Blood |
| 41487-0 | Cryptosporidium parvum Ag [Presence] in Stool by Immunoassay |
| 4164-0 | cefOXitin [Mass] of Dose |
| 4170-7 | Cephalexin [Mass] of Dose |
| 30470-9 | Cardiolipin IgA Ab [Presence] in Serum |
| 31074-8 | CD30 cells [#/volume] in Blood |
| 42529-8 | Pigeon serum Ab [Presence] in Cerebral spinal fluid |
| 59973-8 | Thiocyanate [Moles/volume] in Urine |
| 60277-1 | Complement C3 Ag [Presence] in Tissue by Immunofluorescence |
| 21248-0 | Dobutamine [Mass/volume] in Serum or Plasma |
| 21571-5 | Toxoplasma gondii IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 21643-2 | CACNA1S gene p.Arg1239His [Presence] in Blood or Tissue by Molecular genetics method |
| 43063-7 | Chlamydia sp IgA Ab [Titer] in Serum |
| 43091-8 | Ascaris sp Ab [Titer] in Serum |
| 43266-6 | Leishmania chagasi K39 Ab [Presence] in Serum |
| 223-8 | Dicloxacillin [Susceptibility] by Serum bactericidal titer |
| 2276-4 | Ferritin [Mass/volume] in Serum or Plasma |
| 44296-2 | Alpha aminobutyrate/Creatinine [Mass Ratio] in 24 hour Urine |
| 22964-1 | Campylobacter fetus Ag [Presence] in Genital fluid by Immunofluorescence |
| 44658-3 | Dominant nodule additional dimension 1 in Prostate tumor |
| 2356-4 | Glucose-6-Phosphate dehydrogenase [Presence] in Red Blood Cells |
| 23584-6 | Western equine encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 53773-8 | Gamma globulin [Presence] in Urine by Electrophoresis |
| 53831-4 | CD59 deficient Granulocytes/100 cells in Blood |
| 53911-4 | Bacteria identified in Bile fluid by Culture |
| 44926-4 | Prolactin [Units/volume] in Serum or Plasma --1.5 hours post dose TRH IV |
| 2405-9 | Heparan sulfate [Presence] in Urine |
| 54454-4 | Arsenic fractions panel - Urine |
| 24137-2 | White Hickory IgG Ab [Units/volume] in Serum |
| 34310-3 | Galactose [Moles/volume] in 24 hour Urine |
| 34312-9 | Glucose/Creatinine [Molar ratio] in Urine |
| 34318-6 | HTLV I+II Ab [Titer] in Serum by Complement fixation |
| 55249-7 | HBA2 gene SEA deletion [Presence] in Blood by Molecular genetics method |
| 55539-1 | Flurbiprofen [Moles/volume] in Serum or Plasma |
| 4728-2 | HLA-A29(19) [Presence] in Donor |
| 35025-6 | Monocytes+Macrophages [#/volume] in Cerebral spinal fluid |
| 47504-6 | Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum --2nd specimen |
| 35737-6 | Microscopic observation [Identifier] in Amniotic fluid by Nile blue prusside |
| 56272-8 | Goose feather IgG4 Ab [Mass/volume] in Serum |
| 56525-9 | 5-Hydroxytryptophan [Mass/volume] in Urine |
| 4829-8 | HLA-B39(16) [Presence] |
| 35868-9 | 2-Oxoisovalerate [Moles/volume] in Serum or Plasma |
| 56929-3 | Hepatitis C virus NS3 Ab [Presence] in Serum by Immunoblot |
| 48388-3 | Heparin IgE Ab [Units/volume] in Serum |
| 4842-1 | HLA-B7 [Presence] in Donor |
| 48589-6 | Coccidioides sp rRNA [Presence] in Isolate by NAA with probe detection |
| 27043-9 | Glutamine [Moles/volume] in Urine |
| 57549-8 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --2 days post dose dexamethasone |
| 48922-9 | Respiratory allergen panel, US - West south central states - Serum |
| 49117-5 | Norovirus Ag [Presence] in Stool |
| 27867-1 | Insulin [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 27891-1 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --baseline |
| 28037-0 | Borrelia burgdorferi 39kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 39002-1 | Adipoylcarnitine (C6-DC) [Moles/volume] in Serum or Plasma |
| 39477-5 | fluPHENAZine [Moles/volume] in Serum or Plasma |
| 58020-9 | PKD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 49328-8 | Clavulanate IgE Ab [Units/volume] in Serum |
| 58578-6 | Corticotropin [Moles/volume] in Plasma --2 hours post XXX challenge |
| 50090-0 | 2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma |
| 29730-9 | Leptospira interrogans sv Shermani Ab [Presence] in Serum by Agglutination |
| 2996-7 | Tetrahydrodeoxycortisol [Mass/time] in 24 hour Urine |
| 40325-3 | Testosterone [Moles/volume] in Serum or Plasma --pre dose triple bolus |
| 40373-3 | Lutropin [Units/volume] in Serum or Plasma --15 minutes post dose triple bolus |
| 59158-6 | Ketones [Moles/volume] in Urine by Automated test strip |
| 50305-2 | Adipoylcarnitine+Methylglutarylcarnitine (C6-DC)/Creatinine [Molar ratio] in Urine |
| 30110-1 | Ecgonine methyl ester [Mass/volume] in Vitreous fluid |
| 30382-6 | Eosinophils/100 leukocytes in Stool |
| 4099-8 | Zimelidine [Mass/volume] in Serum or Plasma |
| 19322-7 | 6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Confirmatory method |
| 19707-9 | Thioridazine [Presence] in Urine by Confirmatory method |
| 20474-3 | Bacteria identified in Tissue by Biopsy culture |
| 20747-2 | Carbamates [Presence] in Ingesta by Screen method |
| 12796-9 | Oxalate [Mass/volume] in Urine --8th specimen post XXX challenge |
| 1315-1 | S Ab [Presence] in Serum or Plasma from Blood product unit |
| 101855-5 | Methylprednisolone [Moles/volume] in Urine |
| 1385-4 | Catecholamines Free fractionated [Mass/volume] in Plasma --1 hour post 300 ug cloNIDine PO |
| 102708-5 | Cheese cheddar type IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102748-1 | Grain elevator dust IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103034-5 | Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14389-1 | Amylase [Enzymatic activity/volume] in Cerebral spinal fluid |
| 14718-1 | Estriol (E3) [Moles/time] in 24 hour Urine |
| 10470-3 | Choriogonadotropin Ag [Presence] in Tissue by Immune stain |
| 10509-8 | Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain |
| 10802-7 | Microscopic observation [Identifier] in Tissue by Prussian blue stain |
| 1170-0 | little f Ag [Presence] on Red Blood Cells from Donor |
| 17686-7 | Testosterone.weakly bound [Mass/volume] in Serum or Plasma |
| 1774-9 | Fatty acids.very long chain C26:0 (Hexacosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Serum or Plasma |
| 18400-2 | Spermatozoa IgA Ab [Units/volume] in Cervical mucus |
| 90779-0 | Adalimumab Ab [Units/volume] in Serum by Immunoassay |
| 74575-2 | Pyruvate dehydrogenase E1 [Enzymatic activity/mass] in Tissue |
| 74657-8 | oxyCODONE [Presence] in Saliva (oral fluid) by Confirmatory method |
| 92024-9 | Plazomicin [Mass/volume] in Serum or Plasma --trough |
| 92507-3 | Do sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 92728-5 | Tacrolimus [Mass/volume] in Blood --4 hours post dose |
| 60366-2 | Chili Pepper IgG Ab [Mass/volume] in Serum |
| 7601-8 | Phthalic anhydride IgE Ab [Units/volume] in Serum |
| 7702-4 | Smelt IgE Ab [Units/volume] in Serum |
| 930-8 | Blood product reservation [Date and time] |
| 93199-8 | DPYD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 61378-6 | Human papilloma virus 39 DNA [Presence] in Specimen by NAA with probe detection |
| 77067-7 | SEPT9 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 9394-8 | risperiDONE+9-Hydroxyrisperidone [Mass/volume] in Serum or Plasma |
| 94128-6 | Vasopressin challenge post water deprivation panel - Urine and Serum or Plasma |
| 94267-2 | CD11b cells [Presence] in Blood |
| 63115-0 | Poppy Seed IgG Ab [Mass/volume] in Serum |
| 78384-5 | Cat dander native (nFel d) 1 IgE Ab [Units/volume] in Serum |
| 94352-2 | PCA-Tr IgG Ab [Titer] in Serum by Immunofluorescence |
| 94636-8 | Bovine respiratory syncytial virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 94661-6 | SARS-CoV-2 (COVID-19) Ab [Interpretation] in Serum or Plasma |
| 6466-7 | Microscopic observation [Identifier] in Duodenal fluid by Wet preparation |
| 7905-3 | Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test |
| 95555-9 | F7 gene p.Arg353Gln [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 95649-0 | Chikungunya virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 66763-4 | Choriogonadotropin.beta subunit [Units/volume] in Peritoneal fluid |
| 79634-2 | N6-Acetyl-L-lysine/Creatinine [Molar ratio] in Urine |
| 79700-1 | cis-11,14-Eicosadienoate (cis 11,14 C20:2w6) [Moles/volume] in Serum or Plasma |
| 807-8 | Leukocytes [#/volume] in Pleural fluid by Automated count |
| 96627-5 | HLA-A [Type] in Donor |
| 97524-3 | Cryptosporidium sp [Presence] in Water by Immunofluorescence |
| 70279-5 | t(5;17)(q25.1;q21.1)(NPM1,RARA) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 98269-4 | Site of adnexal involvement [Anatomy] in Endometrial cancer specimen |
| 71698-5 | Polymorphonuclear cells [#/volume] in Body fluid by Automated count |
| 84892-9 | Residual tumor classification [Type] in Cancer specimen |
| 99781-7 | Adalimumab and Adalimumab Ab panel - Serum or Plasma by Immunoassay |
| 85971-0 | Streptococcus pneumoniae Danish serotype 12F Ab [Mass/volume] in Serum |
| 87640-9 | Dichlorodiphenyldichloroethylene [Mass/mass] in Specimen |
| 73416-0 | dilTIAZem induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 50713-7 | Influenza virus.neuraminidase inhibitor resistance [Susceptibility] by Genotype method |
| 31039-1 | Moxifloxacin [Susceptibility] |
| 3114-6 | Uroporphyrinogen decarboxylase [Enzymatic activity/volume] in Plasma |
| 21342-1 | HLA-DR locus 2 [Type] |
| 51322-6 | CD42 cells/100 cells in Cerebral spinal fluid |
| 42932-4 | CD40 cells/100 cells in Specimen |
| 22191-1 | Chlamydia trachomatis IgG Ab [Titer] in Serum |
| 22222-4 | Coxsackievirus A9 Ab [Titer] in Serum |
| 22566-4 | Streptococcus pyogenes enzyme Ab [Presence] in Serum |
| 5272-0 | Parvovirus B19 Ab [Units/volume] in Serum by Immunoassay |
| 2282-2 | Folate [Mass/volume] in Blood |
| 33023-3 | CD34 cells/100 cells in Blood from Blood product unit |
| 53205-1 | Phenylacetylcarnitine (PheC2) [Moles/volume] in DBS |
| 44572-6 | Influenza virus B Ag [Presence] in Bronchial specimen by Immunofluorescence |
| 23372-6 | Porcine respiratory coronavirus Ab [Presence] in Serum |
| 23586-1 | Western equine encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 23747-9 | Heavy metals [Presence] in Specimen |
| 23961-6 | Bartonella quintana IgG Ab [Titer] in Cerebral spinal fluid |
| 24113-3 | Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 34480-4 | Blood group antibodies identified in Serum or Plasma by Cold incubation |
| 34664-3 | Clostridium botulinum toxin A Ab [Presence] in Serum |
| 47260-5 | Plasmodium sp DNA [Identifier] in Blood by NAA with probe detection |
| 47282-9 | MCV [Entitic volume] in Cord blood |
| 47360-3 | Reagin Ab [Presence] in Serum from Donor by RPR |
| 56003-7 | Platelet aggregation ADP induced ATP secretion [Presence] in Blood --10 umol/L |
| 3817-4 | Metoprolol [Mass/volume] in Urine |
| 57486-3 | 11-Ketoetiocholanolone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
| 27395-3 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum |
| 27418-3 | chlordiazePOXIDE [Mass/mass] in Stool |
| 38916-3 | Calicivirus RNA [Presence] in Specimen by NAA with probe detection |
| 39298-5 | Influenza virus A H11 Ab [Titer] in Serum by Hemagglutination inhibition |
| 40206-5 | Glucose [Moles/volume] in Serum or Plasma --16 minutes post XXX challenge |
| 49951-7 | Somatotropin [Units/volume] in Serum or Plasma --2:30 am specimen |
| 59212-1 | Alloisoleucine [Moles/volume] in Urine |
| 50270-8 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --5 days post dose ifosfamide |
| 50491-0 | Gastrin [Mass/volume] in Serum or Plasma --7th specimen |
| 30116-8 | Terminal deoxyribonucleotidyl transferase cells/100 cells in Cerebral spinal fluid by Immunoperoxidase stain |
| 30129-1 | Brucella sp Ab [Presence] in Serum --1st specimen |
| 30184-6 | Tree Allergen Mix 1 (Boxelder+Silver birch+White oak+White elm+California walnut) IgE Ab [Units/volume] in Serum by Multidisk |
| 41020-9 | Flunitrazepam [Presence] in Urine |
| 41143-9 | HIV 1 Ab [Units/volume] in Saliva (oral fluid) |
| 19244-3 | Character of Urine |
| 19324-3 | 6-Monoacetylmorphine (6-MAM) cutoff [Mass/volume] in Urine for Confirmatory method |
| 20522-9 | chlordiazePOXIDE [Mass/volume] in Urine by Confirmatory method |
| 20612-8 | CD7 cells/100 cells in Specimen |
| 101095-8 | IFC Ab [Presence] in Serum or Plasma |
| 12906-4 | Renin [Enzymatic activity/volume] in Plasma --8th specimen post XXX challenge |
| 12924-7 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 101663-3 | T-Cell acute lymphoblastic leukemia in Blood or Tissue by FISH |
| 13709-1 | Argininosuccinate/Creatinine [Mass Ratio] in Urine |
| 102421-5 | Mackerel IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1448-0 | Cortisol [Mass/volume] in Serum or Plasma --pre 500 ug dexamethasone PO 2.5 day low dose q6h |
| 103204-4 | External Steroid panel Serum or Plasma |
| 10419-0 | Transfuse factor VIII [Volume] |
| 10432-3 | CD30 Ag [Presence] in Tissue by Immune stain |
| 10630-2 | Spinnbarkeit [Length] in Cervical mucus |
| 11153-4 | Hematocrit [Volume Fraction] of Body fluid |
| 16746-0 | Nortrimipramine [Mass/volume] in Serum or Plasma |
| 17119-9 | CD16-CD34+ cells/100 cells in Blood |
| 17472-2 | Polybrominated biphenyl [Mass/volume] in Serum or Plasma |
| 17769-1 | Western equine encephalitis virus Ab [Titer] in Cerebral spinal fluid |
| 91084-4 | Fungal 18s rRNA gene [Presence] in Dermatologic specimen by NAA with probe detection |
| 74617-2 | 1,1-Dimethoxyoctadecane (DMA 18:0)/Octadecanoate (C18:0) [Molar ratio] in Red Blood Cells |
| 74903-6 | Fatty acids [Mass/time] in 24 hour Stool |
| 91675-9 | Giardia lamblia and Cryptosporidium parvum Ag panel - Stool by Rapid immunoassay |
| 75362-4 | Tapentadol glucuronide [Mass/volume] in Urine by Screen method |
| 75380-6 | SERPING1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 93418-2 | (8;8)(q13;q21)(HEY1,NCOA2) fusion transcript [Presence] in Tissue by Molecular genetics method |
| 93765-6 | Trimethylamine N-oxide [Molar amount] in Serum |
| 94272-2 | PCA-1 IgG Ab [Presence] in Cerebral spinal fluid by Line blot |
| 62436-1 | West Nile virus IgM Ab [Presence] in Body fluid by Immunoassay |
| 94550-1 | Hexacarboxylporphyrin I [Mass/time] in 24 hour Stool |
| 63379-2 | DNA double strand IgG Ab [Presence] in Serum |
| 63473-3 | Codfish recombinant (rGad c) 1 IgE Ab [Units/volume] in Serum |
| 652-8 | Microscopic observation [Identifier] in Urine by Acid fast stain.Ziehl-Neelsen |
| 69572-6 | ERCC1 Ag [Presence] in Tissue by Immune stain |
| 6959-1 | Yersinia enterocolitica O:3 Ab [Titer] in Serum |
| 82036-5 | Tree Allergen Mix 7 (Olive+Willow+Eastern white pine+Eucalyptus spp+Wattle+Cajeput) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 97554-0 | Methemoglobin/Hemoglobin.total in Central venous blood |
| 82741-0 | Pediatric autoimmune neuropsychiatric disorder associated with streptococcus (PANDAS) panel - Serum |
| 72475-7 | Methadone+Metabolite [Presence] in Saliva (oral fluid) by Confirmatory method |
| 72517-6 | Spermatozoa [#] in Semen --post ejaculate |
| 72993-9 | Methylphenidate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73282-6 | Methotrexate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87558-3 | Anaplasma phagocytophilum groEL gene [Presence] in Blood by NAA with non-probe detection |
| 73636-3 | Premafloxacin [Susceptibility] by Disk diffusion (KB) |
| 87999-9 | Microscopic observation [Identifier] in Contact lens by Gram stain |
| 88145-8 | Microscopic observation [Identifier] in Pericardial fluid by Acid fast stain |
| 88686-1 | Fungus identified in Bronchoalveolar lavage by Culture |
| 59334-3 | Dinorsibutramine [Mass/volume] in Serum or Plasma |
| 30532-6 | levoFLOXacin [Mass/volume] in Serum or Plasma --peak |
| 3088-2 | Urate renal clearance in 24 hour Urine and Serum or Plasma |
| 3112-0 | Uroporphyrin [Presence] in Urine |
| 42235-2 | Benzodiazepine metabolites [Presence] in Urine by Screen method |
| 60088-2 | Hyoscyamine [Mass/volume] in Urine |
| 31515-0 | Mycoplasma pneumoniae IgA Ab [Presence] in Serum |
| 31558-0 | Parvovirus B19 IgM Ab [Units/volume] in Cerebral spinal fluid |
| 51221-0 | CD103 cells/100 cells in Bone marrow |
| 31993-9 | Alpha-1-Fetoprotein [Presence] in Serum or Plasma |
| 43343-3 | West Nile virus IgM Ab [Titer] in Serum by Immunoassay |
| 43747-5 | OCA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 51993-4 | Metanephrine and Normetanephrine panel - Urine |
| 43844-0 | Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunofluorescence |
| 23272-8 | Mycoplasma capricolum ss capripneumonia rRNA [Presence] in Specimen by NAA with probe detection |
| 33678-4 | Francisella tularensis Ag [Presence] in Isolate by Immunofluorescence |
| 53789-4 | CFTR gene.p.IVS8 polyT 7T/9T [presence] in Blood or Tissue by Molecular genetics method |
| 54010-4 | Lysosome Ab [Titer] in Serum by Immunofluorescence |
| 54467-6 | Cholesterol in HDL 2a/Cholesterol in total HDL in Serum or Plasma by Electrophoresis |
| 24319-6 | Cardiolipin IgG and IgM panel - Serum |
| 34513-2 | NPHS1 gene targeted mutation analysis in Body fluid by Molecular genetics method |
| 34607-2 | Interferon beta Ab [Units/volume] in Serum or Plasma |
| 54497-3 | Glucose [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 55198-6 | Zygosity [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 47467-6 | Legionella pneumophila 14 IgG Ab [Titer] in Serum |
| 25271-8 | Sulfamethoxazole [Mass/volume] in Specimen |
| 25413-6 | Fluoride [Moles/time] in 24 hour Urine |
| 34893-8 | Aino virus Ab [Titer] in Serum |
| 35266-6 | Gleason score in Specimen Qualitative |
| 35304-5 | CLA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 5600-2 | Boldenone [Mass/volume] in Urine |
| 25568-7 | C peptide [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 35408-4 | Leishmania tropica IgG Ab [Presence] in Serum |
| 35416-7 | Echinococcus granulosus Ab [Presence] in Serum by Immunoblot |
| 56146-4 | Fungal Ab panel - Serum |
| 56298-3 | Kiwifruit IgG4 Ab [Mass/volume] in Serum |
| 56402-1 | Thyme IgG4 Ab [Mass/volume] in Serum |
| 48042-6 | Bisacodyl cutoff [Mass/mass] in Stool |
| 26633-8 | Legionella bozemaniae Ab [Presence] in Serum |
| 56645-5 | Vanillylmandelate/Creatine [Ratio] in 24 hour Urine |
| 56899-8 | CD5+FMC7+ cells/100 cells in Bone marrow |
| 27012-4 | Benzaldehyde [Presence] in Serum or Plasma |
| 38327-3 | Picloram [Mass/volume] in Water |
| 57474-9 | Calcitriol [Mass/volume] in Serum or Plasma --1 hour post dose calcium |
| 27903-4 | Coxsackievirus B2 Ab [Presence] in Cerebral spinal fluid |
| 39018-7 | Coliform bacteria [#/mass] in Specimen by Viability count |
| 391-3 | Penicillin G [Susceptibility] by Minimum lethal concentration (MLC) |
| 3932-1 | Phenazocine [Mass/volume] in Urine |
| 39535-0 | Hepatitis B virus surface Ab [Presence] in Serum by Radioimmunoassay (RIA) |
| 57747-8 | Erythrocytes [#/volume] in Urine by Automated test strip |
| 5791-9 | Fungi.yeastlike [#/area] in Urine sediment by Microscopy high power field |
| 49460-9 | Beta catenin Ag [Presence] in Tissue by Immune stain |
| 49485-6 | Platelet aggregation ristocetin induced in Platelet rich plasma --1800 ug/mL |
| 49601-8 | Hepatitis B virus DNA [log units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 40264-4 | Creatinine [Moles/volume] in Serum or Plasma --baseline |
| 49867-5 | Endothelin I [Mass/volume] in Serum or Plasma |
| 29933-9 | Vanadium/Creatinine [Mass Ratio] in 24 hour Urine |
| 40466-5 | Herpes simplex virus 1 IgM Ab [Presence] in Serum by Immunofluorescence |
| 40668-6 | Rubella virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 589-2 | Legionella sp identified in Bronchial specimen by Organism specific culture |
| 50544-6 | Everolimus [Mass/volume] in Blood |
| 19259-1 | Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Specimen by Latex agglutination |
| 1955-4 | Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Tissue |
| 1999-2 | Calcium [Moles/volume] in Semen |
| 100130-4 | Schistosoma mansoni Ab [Presence] in Serum by Immunoblot |
| 12494-1 | Amobarbital [Presence] in Stool |
| 12626-8 | Glucose [Mass/volume] in Serum or Plasma --14th specimen post XXX challenge |
| 101423-2 | Influenza virus A H1 RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 12927-0 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 101729-2 | JC virus DNA [Units/volume] (viral load) in Plasma by NAA with probe detection |
| 101771-4 | Epidermophyton floccosum DNA [Presence] in Specimen by NAA with probe detection |
| 101817-5 | Epstein Barr virus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 101959-5 | TCIRG1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 13788-5 | Oxalate/Creatinine [Mass Ratio] in 24 hour Urine |
| 13928-7 | Parathyrin Ab [Presence] in Serum |
| 14036-8 | Dermatophagoides microceras IgE Ab [Units/volume] in Serum |
| 102796-0 | Walleye Pike IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14694-4 | Norclomipramine [Moles/volume] in Serum or Plasma |
| 14956-7 | Microalbumin [Mass/time] in 24 hour Urine |
| 16239-6 | Amobarbital [Mass/volume] in Urine by Confirmatory method |
| 1627-9 | Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
| 16942-5 | Herpes simplex virus Ab [Presence] in Serum by Immunoblot |
| 16960-7 | Herpes simplex virus 2 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 17068-8 | Legionella pneumophila 5 Ab [Titer] in Serum |
| 17203-1 | CD86 cells/100 cells in Blood |
| 17256-9 | Mesoridazine [Mass/volume] in Urine |
| 17555-4 | Measles virus Ab [Units/volume] in Serum --1st specimen |
| 18420-0 | Chaetomium globosum IgG Ab [Units/volume] in Serum |
| 1902-6 | Ascorbate [Mass/volume] in Blood |
| 90320-3 | Aichivirus C RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 90903-6 | HIV 1 RNA integrase gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing |
| 90907-7 | Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells --after transfusion reaction |
| 74768-3 | 5-Hydroxytryptophan [Moles/volume] in Platelet rich plasma |
| 925-8 | Blood product disposition [Type] |
| 75240-2 | Meat fibers [#/area] in Stool by Microscopy low power field |
| 92887-9 | Torque teno virus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
| 94056-9 | Bacterial fabG1 gene drug resistance mutation [Identifier] by Molecular method |
| 94249-0 | Borrelia garinii+afzelii oppA2 gene [Presence] in Blood by NAA with non-probe detection |
| 78237-5 | Chromosome 8 copy number/nucleus in Blood or Tissue by FISH |
| 78798-6 | Atenolol [Mass/mass] in Hair |
| 63360-2 | Thyroglobulin Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 79270-5 | 3-Hydroxytrimethyl-L-lysine [Moles/volume] in DBS |
| 79279-6 | Alpha-aminoadipic semialdehyde [Moles/volume] in Serum or Plasma |
| 95053-5 | DOPamine [Mass/volume] in Plasma --supine |
| 68-7 | Cefamandole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 81258-6 | Sample variant allelic frequency [NFr] |
| 96710-9 | Clot [Presence] of Body fluid Qualitative |
| 6917-9 | Chlamydophila psittaci IgM Ab [Titer] in Serum by Immunofluorescence |
| 69577-5 | Hepatitis E virus RNA [Presence] in Blood by NAA with probe detection |
| 69816-7 | 2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --4 days post dose ifosfamide |
| 69929-8 | Respiratory syncytial virus IgA Ab [Presence] in Serum by Immunoassay |
| 97225-7 | Butalbital [Presence] in Cord tissue by Confirmatory method |
| 97251-3 | Flunitrazepam [Presence] in Cord tissue by Confirmatory method |
| 9748-5 | Dipyridamole [Mass/volume] in Specimen |
| 7099-5 | Asparagus IgE Ab [Units/volume] in Serum |
| 71691-0 | Hematopoietic progenitor cells [#/volume] in Blood by Automated count |
| 85777-1 | Serratia marcescens DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 99364-2 | Ovalbumin IgG Ab [Mass/volume] in Serum |
| 85842-3 | Beta-lactam resistance AmpC blaACT+blaMIR genes [Presence] by Molecular method |
| 86053-6 | Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum by Immunoassay |
| 73157-0 | Rosuvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87379-4 | Cannabinol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 88022-9 | 5-F PB-22 3-carboxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 74436-7 | D-Lactate [Moles/mass] in Stool |
| 88594-7 | Human coronavirus HKU1 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 89002-0 | GBU4-5 Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 41261-9 | Voltage-gated calcium channel IgG Ab [Presence] in Serum |
| 41284-1 | Epithelial cells.non-squamous [#/area] in Urine sediment by Microscopy high power field |
| 41496-1 | Herpes virus 6 IgG Ab [Titer] in Serum |
| 41647-9 | Carbon dioxide, total [Moles/volume] in Arterial blood by calculation |
| 41706-3 | Novobiocin [Susceptibility] by Gradient strip |
| 59876-3 | carBAMazepine [Presence] in Gastric fluid |
| 50652-7 | Food Allergen Mix 28 (Kiwi+Beef+Shrimp+Sesame seed) IgE Ab [Units/volume] in Serum by Multidisk |
| 50813-5 | Arsenic [Moles/mass] in Nail |
| 60249-0 | Androstanolone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 60294-6 | chlorproMAZINE [Moles/volume] in Specimen |
| 51263-2 | CD16B cells/100 cells in Body fluid |
| 43116-3 | Porphyrin fractions panel - 24 hour Urine |
| 51520-5 | Lactate dehydrogenase 5/Lactate dehydrogenase.total in Peritoneal fluid by Electrophoresis |
| 43573-5 | Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoblot |
| 43592-5 | Plum IgE Ab/IgE total in Serum |
| 2255-8 | Estrogen [Mass/volume] in Urine |
| 5288-6 | Rabies virus Ab [Units/volume] in Serum |
| 44330-9 | Isospora belli [Presence] in Stool |
| 32656-1 | Aflatoxin IgG Ab [Units/volume] in Serum or Plasma |
| 32835-1 | Cytomegalovirus IgG Ab [Ratio] in Serum or Plasma --1st specimen/2nd specimen |
| 53482-6 | Glucose [Moles/volume] in Serum or Plasma --3 hours post dose betaxolol |
| 33291-6 | Herpes simplex virus 1 IgG Ab [Presence] in Serum by Immunoblot |
| 4502-1 | Complement C4b binding protein [Units/volume] in Serum or Plasma |
| 45199-7 | Dodecanoylcarnitine (C12) [Moles/volume] in DBS |
| 54227-4 | Lymphoma - acute screen panel - Specimen by Flow cytometry (FC) |
| 3541-0 | Dextromoramide [Mass/volume] in Urine |
| 5633-3 | Copper [Mass/time] in 24 hour Urine |
| 26477-0 | Variant lymphocytes [#/volume] in Blood |
| 5674-7 | Lead [Mass/volume] in Red Blood Cells |
| 4867-8 | HLA-Cw9(w3) [Presence] |
| 26983-7 | CD4+HLA-DR+ cells [#/volume] in Blood |
| 38473-5 | 17-Hydroxyprogesterone [Mass/volume] in DBS |
| 38479-2 | Branched chain keto-acid dehydrogenase complex [Presence] in DBS |
| 38546-8 | HLA-B locus [Type] |
| 5723-2 | Selenium [Mass/volume] in Red Blood Cells |
| 57484-8 | 11-Ketoetiocholanolone [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
| 57547-2 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1 day post dose dexamethasone |
| 57560-5 | 21-Deoxycorticosterone [Moles/volume] in Serum or Plasma --pre dose corticotropin |
| 27936-4 | Lymphocytes/100 leukocytes in Sputum |
| 57894-8 | C peptide [Moles/volume] in Serum or Plasma --100 minutes post XXX challenge |
| 58089-4 | Glucose-6-Phosphate dehydrogenase newborn screen interpretation |
| 49547-3 | JC virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection |
| 4961-9 | HLA-DR15(2) [Presence] |
| 40508-4 | Jamestown canyon virus IgM Ab [Titer] in Serum by Neutralization test |
| 40568-8 | Metamyelocytes [#/volume] in Body fluid by Manual count |
| 40663-7 | Protein [Mass/time] in 12 hour Urine --upright |
| 30151-5 | Thyrotropin.long acting [Units/volume] in Serum or Plasma |
| 41145-4 | HIV 1 Ab [Presence] in Capillary blood |
| 19537-0 | Mephobarbital [Presence] in Urine by Confirmatory method |
| 19563-6 | Methylenediamine cutoff [Mass/volume] in Urine for Screen method |
| 20572-4 | Hemoglobin A/Hemoglobin.total in Blood by Electrophoresis |
| 12403-2 | Mephentermine [Mass/volume] in Blood |
| 13117-7 | Complement Sc5b-9 Ab [Units/volume] in Serum or Plasma |
| 131-3 | Cefsulodin [Mass/volume] in Serum or Plasma |
| 13837-0 | CD10 blasts/100 blasts in Blood |
| 102321-7 | Gelatin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14073-1 | Phenytoin [Mass/volume] in Saliva (oral fluid) |
| 14085-5 | Herpes simplex virus 2 [Presence] in Isolate by Immunofluorescence |
| 14292-7 | IgE [Moles/volume] in Serum |
| 10551-0 | Triamterene [Mass/volume] in Serum or Plasma |
| 1577-6 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 11034-6 | Acetylcholine receptor binding Ab [Moles/volume] in Serum |
| 16279-2 | Toxoplasma gondii DNA [Presence] in Blood by NAA with probe detection |
| 16313-9 | Acetylene [Mass/volume] in Blood |
| 16689-2 | Creatinine [Mass/time] in 48 hour Urine |
| 16740-3 | Dengue virus Ab [Presence] in Serum |
| 16894-8 | Gastrin [Mass/volume] in Serum or Plasma --25 minutes post XXX challenge |
| 17389-8 | Ornithine [Presence] in Urine |
| 17411-0 | Human papilloma virus 6 Ag [Presence] in Specimen |
| 18252-7 | predniSONE [Mass/time] in 24 hour Urine |
| 18273-3 | Blood group antibody screen [Presence] in Serum or Plasma from Blood product unit |
| 18432-5 | Tetrahydrocannabinol [Presence] in Stool by Screen method |
| 90830-1 | Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 7462-5 | Licorice IgE Ab [Units/volume] in Serum |
| 92756-6 | Cholestane-3-beta, 5-alpha, 6-beta triol [Moles/volume] in Blood |
| 61169-9 | Hepatitis B virus codon I233V [Presence] by Genotype method |
| 76676-6 | Appearance of Cerebral spinal fluid--2nd tube |
| 77008-1 | Human coronavirus 229E+OC43 RNA [Presence] in Nasopharynx by NAA with probe detection |
| 77144-4 | Alanine aminotransferase [Enzymatic activity/volume] in Serum, Plasma or Blood |
| 77752-4 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) cutoff [Mass/volume] in Urine for Screen method |
| 6271-1 | Turkey meat IgE Ab [Units/volume] in Serum |
| 94354-8 | Amphiphysin IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 78958-6 | Cathepsin A [Enzymatic activity/mass] in Leukocytes |
| 7912-9 | Herpes simplex virus 2 IgG Ab [Units/volume] in Serum |
| 9500-0 | Candida sp IgM Ab [Units/volume] in Serum |
| 9542-2 | Legionella pneumophila 1 IgM Ab [Titer] in Serum by Immunofluorescence |
| 96479-1 | IgLON5 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 96500-4 | Hyperoxaluria panel - Serum or Plasma |
| 68901-8 | Erythrocytes [Presence] in Dialysis fluid |
| 8075-4 | Insulin porcine Ab [Units/volume] in Serum |
| 8148-9 | Amphetamines [Presence] in Serum or Plasma by Confirmatory method |
| 97507-8 | Average glucose [Mass/volume] in Interstitial fluid during Reporting Period |
| 70152-4 | Triiodothyronine (T3)/Thyroxine (T4) [Mass Ratio] in Serum or Plasma |
| 82342-7 | F8 gene intron 1 inversion targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
| 82392-2 | Ej Ab [Presence] in Serum by Line blot |
| 82476-3 | Borrelia miyamotoi glpQ gene [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
| 82876-4 | Complement C1 esterase inhibitor [Units/volume] in Serum or Plasma by Chromogenic method |
| 99087-9 | Meningitis+Encephalitis pathogens panel - Cerebral spinal fluid by NAA with probe detection |
| 71797-5 | Protoporphyrin.zinc [Moles/volume] in Red Blood Cells |
| 85317-6 | DCIS.max dimension [Length] in Breast cancer specimen by Light microscopy |
| 86569-1 | Influenza virus A RNA [Presence] in Tissue by NAA with probe detection |
| 87723-3 | Complement C3.functional [Units/volume] in Serum or Plasma |
| 73408-7 | Docusate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73648-8 | cefTAZidime+Avibactam [Susceptibility] by Disk diffusion (KB) |
| 88530-1 | Parainfluenza virus 4 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 41515-8 | HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 75 copies/mL |
| 31030-0 | Testosterone/Epitestosterone [Mass Ratio] in Urine |
| 42182-6 | Gossypol bound [Mass/volume] in Specimen |
| 21185-4 | Chlamydia sp IgG Ab [Presence] in Serum |
| 2139-4 | Corticosterone [Mass/volume] in Serum or Plasma |
| 31384-1 | Feline calicivirus Ab [Units/volume] in Serum |
| 51313-5 | CD4+CD7-CD49D- cells/100 cells in Cerebral spinal fluid |
| 42802-9 | Age at menopause |
| 42891-2 | Choriogonadotropin [Units/volume] in Body fluid |
| 22261-2 | Eastern equine encephalitis virus IgM Ab [Titer] in Serum |
| 22297-6 | Epstein Barr virus nuclear Ab [Titer] in Serum |
| 43341-7 | Venezuelan equine encephalitis virus Ab [Titer] in Serum by Immunoassay |
| 4367-9 | Oxazepam [Mass] of Dose |
| 4374-5 | Para methylhippurate [Mass] of Dose |
| 22620-9 | Yersinia enterocolitica IgG Ab [Units/volume] in Serum |
| 22662-1 | Uroporphyrin [Moles/volume] in Serum or Plasma |
| 4409-9 | Procainamide [Mass] of Dose |
| 32578-7 | Bartonella quintana IgM Ab [Presence] in Serum |
| 3318-3 | Amdinocillin [Mass/volume] in Serum or Plasma |
| 53119-4 | Tyrosine crystals [#/area] in Urine sediment by Microscopy high power field |
| 4457-8 | Tripelennamine [Mass] of Dose |
| 44802-7 | Enolase.neuron specific [Mass/volume] in Cerebral spinal fluid |
| 23342-9 | Pasteurella multocida Ab [Titer] in Serum |
| 33371-6 | Variant lymphocytes/100 leukocytes in Synovial fluid |
| 23803-0 | Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgE Ab [Presence] in Serum by Multidisk |
| 33839-2 | Monoblasts [#/volume] in Blood by Manual count |
| 54196-1 | Mezlocillin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
| 24441-8 | Phenylpropionylglycine/Creatinine [Molar ratio] in Urine |
| 34377-2 | Sulthiame [Moles/volume] in Serum or Plasma |
| 47466-8 | Legionella pneumophila 13 IgM Ab [Titer] in Serum |
| 25213-0 | Kanamycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25219-7 | Isoniazid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25379-9 | Cobalt [Moles/time] in 24 hour Urine |
| 35295-5 | BTK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 35383-9 | Galactomannan Ag [Units/volume] in Serum or Plasma |
| 35452-2 | HIV 1 gp40 Ab [Presence] in Serum by Immunoblot |
| 35555-2 | Setomelanomma rostrata IgG Ab [Mass/volume] in Serum |
| 47960-0 | GLRA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 48079-8 | 3,6-Epoxydodecanedioate/Creatinine [Molar ratio] in Urine |
| 35818-4 | Grepafloxacin [Susceptibility] by Disk diffusion (KB) |
| 56561-4 | Somatotropin [Mass/volume] in Serum or Plasma --5.5 hours post XXX challenge |
| 48568-0 | Bacteria # 7 identified in Specimen by Aerobe culture |
| 27244-3 | Methylenedioxyamphetamine [Mass/mass] in Meconium |
| 38593-0 | 1,4-Dioxane [Mass/volume] in Air |
| 57396-4 | CD19+CD56+ cells/100 cells in Body fluid |
| 2778-9 | Phosphate [Mass/volume] in Urine |
| 27864-8 | Follitropin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 28042-0 | Organophosphate pesticides [Mass/volume] in Urine by Screen method |
| 38705-0 | Methanol [Mass/volume] in Air |
| 29380-3 | chlordiazePOXIDE [Mass/volume] in Gastric fluid |
| 40630-6 | Nucleated erythrocytes [Presence] in Blood by Light microscopy |
| 50306-0 | Allantoine [Moles/volume] in Urine |
| 50331-8 | WT-1 Ag [Presence] in Tissue by Immune stain |
| 4077-4 | Trimeperidine [Mass/time] in 24 hour Urine |
| 40841-9 | Tomato IgE Ab/IgE total in Serum |
| 4089-9 | Vancomycin Free [Mass/volume] in Serum or Plasma |
| 41035-7 | Norovirus RNA [Presence] in Specimen by Probe |
| 41115-7 | NOD2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 20477-6 | CD33+CD44+ cells/100 cells in Blood |
| 20594-8 | CD2 cells/100 cells in Specimen |
| 20917-1 | Organophosphate pesticides [Presence] in Blood by Screen method |
| 100116-3 | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot |
| 100797-0 | Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge |
| 100976-0 | Eosinophil derived neurotoxin [Mass/volume] in Serum or Plasma |
| 12807-4 | Phosphoserine [Mass/volume] in Cerebral spinal fluid |
| 101190-7 | 5F-MDMB-PICA [Mass/volume] in Urine by Confirmatory method |
| 101313-5 | 17-Hydroxyprogesterone post corticotropin stimulation panel - Serum or Plasma |
| 12975-9 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --5th specimen |
| 102517-0 | Pigeon feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14450-1 | Triglyceride [Mass/volume] in Urine |
| 103183-0 | Human papilloma virus 18 DNA [Presence] in Urine by NAA with probe detection |
| 104406-4 | Hantavirus IgG Ab [Titer] in Serum by Immunoassay --1st specimen |
| 16175-2 | Bartonella henselae IgM Ab [Presence] in Cerebral spinal fluid |
| 11235-9 | fentaNYL [Presence] in Urine |
| 11583-2 | Aspergillus fumigatus 1 Ab [Presence] in Serum |
| 12198-8 | Cryofibrinogen [Presence] in Plasma by 2 day cold incubation |
| 16980-5 | HTLV II DNA [Presence] in Specimen by NAA with probe detection |
| 90231-2 | Thymoma and myasthenia gravis antibody panel - Serum |
| 90829-3 | Glutamate decarboxylase 65 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
| 92126-2 | Mycoplasma pneumoniae DNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 75055-4 | Glutaryl CoA dehydrogenase [Enzymatic activity/mass] in Fibroblast |
| 755-9 | Neutrophils [#/volume] in Cerebral spinal fluid by Manual count |
| 60469-4 | Urate [Mass/volume] in Pleural fluid |
| 60478-5 | Sex of Tick |
| 60537-8 | CLCN5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 76070-2 | Adenovirus DNA [Presence] in Nasopharynx by NAA with probe detection |
| 76414-2 | Sheep prion protein codon 136 [Type] in Blood by Genotype method |
| 92849-9 | Herpes simplex virus 1 and 2 and Varicella zoster virus DNA panel - Cerebral spinal fluid by NAA with probe detection |
| 77085-9 | ALPL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77612-0 | C peptide [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 93741-7 | Balm IgE Ab [Units/volume] in Serum |
| 93766-4 | Cryptococcus sp Ag [Titer] in Urine by Rapid immunoassay |
| 94103-9 | Zolpidem phenyl-4-carboxylate [Presence] in Urine by Screen method |
| 95668-0 | Highlands J virus IgG Ab [Presence] in Specimen by Immunoassay |
| 96369-4 | Sertraline [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 69051-1 | Urinalysis specialist review of results |
| 97202-6 | Icteric interference index of Urine |
| 6955-9 | Bartonella henselae IgM Ab [Titer] in Serum by Immunofluorescence |
| 97523-5 | Hepatitis A virus RNA [Presence] in Specimen by NAA with probe detection |
| 97-6 | Cefonicid [Susceptibility] by Disk diffusion (KB) |
| 97972-4 | Peanut recombinant (rAra h) 8 IgG4 Ab [Mass/volume] in Serum |
| 82522-4 | Simeprevir [Susceptibility] by Genotype method |
| 82850-9 | Androsterone+etiocholanolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
| 85268-1 | X-linked adrenoleukodystrophy newborn screening comment-discussion |
| 85295-4 | Surgical margin tumor involvement.proximal [Presence] in Colorectal cancer specimen by Light microscopy |
| 72608-3 | Apixaban [Mass/volume] in Serum or Plasma |
| 85802-7 | Influenza virus A H1 Ag [Titer] in Isolate by Hemagglutination inhibition |
| 86340-7 | Streptococcus pneumoniae Danish serotype 6A+6B IgG Ab [Units/volume] in Serum by Immunoassay |
| 87326-5 | Porcine circovirus type 2 IgG Ab [Titer] in Serum by Immunoassay |
| 87646-6 | Methyl parathion [Mass/mass] in Specimen |
| 87796-9 | Sulfathiazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 73975-5 | CD158a cells/100 cells in Specimen |
| 74450-8 | Other cells [#/volume] in Cord blood |
| 88898-2 | Adenovirus [Presence] in Lower respiratory specimen by Organism specific culture |
| 89353-7 | CD19+CD27+ cells [#/volume] in Blood |
| 412-7 | Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 50987-7 | Horowitz index adjusted to patients actual temperature in Blood |
| 59964-7 | QUEtiapine [Moles/volume] in Gastric fluid |
| 21059-1 | Albumin [Mass/volume] in 24 hour Urine |
| 21132-6 | Calcitonin [Mass/volume] in Serum or Plasma --1 minute post 0.5 ug/kg pentagastrin IV |
| 51150-1 | CD3+CD16+CD56+ blasts/100 blasts in Blood |
| 51256-6 | CD16+CD57+ cells/100 cells in Tissue |
| 42888-8 | CD79b cells/100 cells in Body fluid |
| 21701-8 | Kallmann syndrome gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 22266-1 | Echovirus 1 Ab [Titer] in Serum |
| 43440-7 | Bartonella henselae and Bartonella quintana IgM panel [Titer] - Serum |
| 22728-0 | Cystine [Moles/volume] in Specimen |
| 5287-8 | Burkholderia pseudomallei Ab [Units/volume] in Serum by Hemagglutination |
| 32639-7 | FANCC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2332-5 | Gastrin.14 residue fragment [Mass/volume] in Serum or Plasma |
| 53555-9 | Specific gravity of Red Blood Cells |
| 44899-3 | Malignant cells/100 cells in Urine by Manual count |
| 45302-7 | Urea [Moles/volume] in Dialysis fluid |
| 34278-2 | Cystine [Moles/volume] in 24 hour Urine |
| 4573-2 | Hemoglobin E/Hemoglobin.total in Blood by Electrophoresis acid (pH 6.3) |
| 24293-3 | Parainfluenza virus 1 Ab [Titer] in Serum --1st specimen |
| 248-5 | Fluconazole [Susceptibility] by Minimum lethal concentration (MLC) |
| 34409-3 | Keratin Ab [Titer] in Serum by Immunofluorescence |
| 34582-7 | Candida sp IgA Ab [Presence] in Serum |
| 34647-8 | PPT1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55138-2 | Cortisol [Mass/volume] in Serum or Plasma --post dose dexamethasone PO overnight |
| 25137-1 | Succinylacetone/Creatinine [Molar ratio] in Urine |
| 4821-5 | HLA-B27 [Presence] |
| 48270-3 | ceFAZolin triggered leukotriene release [Mass/volume] by Leukocytes |
| 26507-4 | Band form neutrophils [#/volume] in Blood |
| 26550-4 | Glucose [Presence] in Urine by Test strip --4 hours post dose glucose |
| 3595-6 | ePHEDrine+Pseudoephedrine [Mass/volume] in Serum or Plasma |
| 56903-8 | Anserine/Creatinine [Ratio] in 24 hour Urine |
| 48683-7 | Streptococcus agalactiae DNA [Presence] in Specimen by NAA with probe detection |
| 5711-7 | Pentachlorophenol [Mass/volume] in Urine |
| 27410-0 | Spermatozoa Motile/100 spermatozoa in Semen --24 hours post ejaculation |
| 27977-8 | Norepinephrine/Creatinine [Molar ratio] in 24 hour Urine |
| 57750-2 | Amphiphysin Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 58042-3 | Phencyclidine [Presence] in Blood by Confirmatory method |
| 58088-6 | Acylcarnitine newborn screen interpretation |
| 49422-9 | Papova virus SV 40 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
| 2865-4 | Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
| 2898-5 | Protoporphyrin [Mass/volume] in Red Blood Cells |
| 58492-0 | Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --1st specimen post XXX challenge |
| 49919-4 | Interleukin 6 [Mass/volume] in Cerebral spinal fluid |
| 50023-1 | Hepatitis C virus RNA panel (viral load) in Serum or Plasma by NAA with probe detection |
| 50080-1 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin IM |
| 59237-8 | Prostate Specific Ag Free/Prostate specific Ag.total in Pleural fluid |
| 50176-7 | Alpha-2-Macroglobulin/Protein.total in Serum or Plasma |
| 1953-9 | Beta-2-Microglobulin [Mass/volume] in Urine |
| 20500-5 | Hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method |
| 20573-2 | Histoplasma capsulatum mycelial phase Ab [Titer] in Serum by Complement fixation |
| 20617-7 | Kappa lymphocytes/100 lymphocytes in Specimen |
| 20887-6 | Molybdenum [Mass/mass] in Tissue |
| 100115-5 | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot |
| 100152-8 | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |
| 100912-5 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype and Enterococcus species.vancomycin resistant panel |
| 12506-2 | Calcitonin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 12792-8 | Oxalate [Mass/volume] in Urine --4th specimen post XXX challenge |
| 12793-6 | Oxalate [Mass/volume] in Urine --5th specimen post XXX challenge |
| 12988-2 | Acrylamide [Mass/volume] in Blood |
| 13361-1 | Semen analysis panel |
| 13484-1 | Creatine/Creatinine [Mass Ratio] in Urine |
| 102772-1 | Mushroom IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15212-4 | Lipase [Enzymatic activity/volume] in Body fluid |
| 11125-2 | Platelet morphology finding [Identifier] in Blood |
| 16284-2 | Polio virus Ab [Units/volume] in Serum |
| 11594-9 | Echovirus 16 Ab [Units/volume] in Serum |
| 16882-3 | Gamma aminobutyrate [Presence] in Urine |
| 17406-0 | Human papilloma virus 43 Ag [Presence] in Specimen |
| 17847-5 | Lipoprotein.pre-beta [Presence] in Serum or Plasma |
| 18374-9 | Riboflavin [Mass/volume] in 24 hour Urine |
| 18412-7 | Stemphylium botryosum IgG Ab [Units/volume] in Serum |
| 91799-7 | Parainfluenza virus 4 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 91833-4 | Herpes simplex virus Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
| 92131-2 | Respiratory syncytial virus RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 92722-8 | Lipoprotein subparticle profile panel - Serum |
| 75141-2 | Acadesine [Moles/volume] in Cerebral spinal fluid |
| 60355-5 | Pinto Bean IgG Ab [Mass/volume] in Serum |
| 61071-7 | 7-Aminoflunitrazepam [Presence] in Gastric fluid |
| 76630-3 | Amylase [Enzymatic activity/volume] in Blood |
| 93684-9 | Ammonia [Moles/volume] in Arterial blood |
| 6231-5 | Rose Hip IgE Ab [Units/volume] in Serum |
| 9427-6 | Barbiturates [Mass/volume] in Gastric fluid |
| 77931-4 | Cortisol [Moles/volume] in Serum or Plasma --6 hours post XXX challenge |
| 94401-7 | ADRA2A gene c.-1252G>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 65781-7 | London Plane native (nPla a) 2 IgE Ab [Units/volume] in Serum |
| 80188-6 | JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method |
| 96420-5 | Daratumumab [Presence] in Serum by Immunofixation |
| 81147-1 | Specimen source patient identification [Interpretation] Narrative |
| 8135-6 | CD7 cells/100 cells in Blood |
| 69799-5 | 21-Deoxycorticosterone [Moles/volume] in Serum or Plasma |
| 69910-8 | Basophils+Mast cells/100 leukocytes in Body fluid |
| 9749-3 | Hemoglobin F [Units/volume] in Blood by Electrophoresis |
| 97732-2 | Enterovirus VP1 gene [Nucleotide sequence] in Isolate by Sequencing |
| 9786-5 | Microscopic observation [Identifier] in Blood or Marrow by Periodic acid-Schiff stain |
| 7074-8 | Alternaria sp IgE Ab [Units/volume] in Serum |
| 8243-8 | Styrene [Mass/volume] in Blood |
| 82974-7 | O-nortramadol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 82989-5 | Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 72405-4 | Cocaine [Mass/volume] in Blood by Confirmatory method |
| 72457-5 | Desmin Ab [Presence] in Serum or Plasma by Immunoblot |
| 99890-6 | Crystal casts [#/volume] in Urine sediment by Computer assisted method |
| 85958-7 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 73592-8 | Plazomicin [Susceptibility] |
| 87773-8 | Baclofen/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 89481-6 | Gentamicin [Susceptibility] by Genotype method |
| 59337-6 | Dinorsibutramine [Mass/volume] in Urine |
| 59613-0 | ALPRAZolam [Mass/mass] in Tissue |
| 50873-9 | Magnesium/Creatinine [Molar ratio] in 24 hour Urine |
| 50969-5 | Epstein Barr virus early diffuse IgG Ab [Units/volume] in Serum |
| 30464-2 | Prolymphocytes [#/volume] in Blood |
| 31153-0 | Coccidioides sp Ab [Presence] in Specimen by Immune diffusion (ID) |
| 21095-5 | BCL2 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 21128-4 | Cadmium [Mass/mass] in Nail |
| 51293-9 | CD33 cells/100 cells in Bone marrow |
| 43068-6 | Campylobacter sp IgA Ab [Presence] in Serum |
| 22169-7 | Chlamydophila pneumoniae IgA Ab [Titer] in Cerebral spinal fluid |
| 52768-9 | Clot formation [Time] in Blood by Thromboelastography |
| 52884-4 | Cytoplasmic CD3 cells/100 cells in Cerebral spinal fluid |
| 43843-2 | Brucella abortus IgG Ab [Units/volume] in Serum by Immunoassay |
| 4386-9 | Perphenazine [Mass] of Dose |
| 22800-7 | Anaplasma sp identified in Blood by Modified Giemsa stain |
| 22933-6 | Brucella melitensis Ab [Presence] in Serum by Agglutination |
| 53156-6 | Methionine/Phenylalanine [Molar ratio] in DBS |
| 53416-4 | Alpha naphthylesterase [Enzymatic activity/volume] in Blood |
| 54312-4 | Linoleoylcarnitine (C18:2) [Moles/volume] in Amniotic fluid |
| 54324-9 | Palmitoylcarnitine (C16) [Moles/volume] in Cerebral spinal fluid |
| 46959-3 | Synthetic glucocorticoid panel [Mass/volume] - Urine |
| 24489-7 | Tree Allergen Mix 2 (Boxelder+White oak+White elm+Cottonwood+Pecan/Hickory) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 55347-9 | Ecarin clotting time (ECT) in Blood by Coagulation assay |
| 47396-7 | Babesia microti DNA [Presence] in Specimen by NAA with probe detection |
| 25086-0 | Beta aminoisobutyrate/Creatinine [Molar ratio] in Urine |
| 35066-0 | Blasts [#/volume] in Pleural fluid |
| 35165-0 | Linoleate (C18:2w6) [Moles/volume] in Serum or Plasma |
| 55828-8 | Aliphatic carboxylate, C14-C26.esters [Presence] in Stool |
| 47863-6 | Lactate dehydrogenase [Enzymatic activity/time] in 24 hour Urine |
| 25854-1 | 1-Methylhistidine/Creatinine [Molar ratio] in 24 hour Urine |
| 35657-6 | Urea nitrogen/Body weight [Mass/kg/time] in 24 hour Urine |
| 56268-6 | Gluten IgG4 Ab [Mass/volume] in Serum |
| 48224-0 | Codfish triggered leukotriene release [Mass/volume] by Leukocytes |
| 4832-2 | HLA-B44(12) [Presence] in Donor |
| 3720-0 | Lithium [Presence] in Serum or Plasma |
| 27377-1 | Aspergillus flavus Ab [Presence] in Body fluid by Immune diffusion (ID) |
| 3938-8 | Phendimetrazine [Mass/volume] in Serum or Plasma |
| 57934-2 | Chikungunya virus IgM Ab [Presence] in Serum or Plasma |
| 58012-6 | Natalizumab Ab [Presence] in Serum |
| 40215-6 | Glucose [Moles/volume] in Serum or Plasma --26 hours post XXX challenge |
| 58893-9 | Vasopressin [Mass/volume] in Plasma --1.5 hours post XXX challenge |
| 40980-5 | Human metapneumovirus IgG Ab [Presence] in Serum by Immunoassay |
| 1983-6 | Bradykinin [Mass/volume] in Serum or Plasma |
| 20504-7 | Histiocytes/100 cells in Cerebral spinal fluid |
| 20626-8 | Reducing substances [Units/volume] in Urine by Test strip |
| 20894-2 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Complement fixation |
| 100688-1 | Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 12737-3 | Endothelin [Units/volume] in Serum or Plasma |
| 101-6 | Cefoperazone [Susceptibility] by Disk diffusion (KB) |
| 13441-1 | Creatinine renal clearance in 4 hour Urine and Serum or Plasma |
| 103842-1 | Phosphodiesterase 10A Ab [Presence] in Specimen by Immunofluorescence |
| 14870-0 | Pentacarboxylate [Moles/volume] in Plasma |
| 16270-1 | Calcium [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 1670-9 | 17-Hydroxyprogesterone [Mass/volume] in Urine |
| 12328-1 | Beta blockers [Identifier] in Urine |
| 17078-7 | Fatty acids.esterified [Mass/volume] in Serum or Plasma |
| 18377-2 | Sodium [Moles/time] in 12 hour Urine |
| 89974-0 | 7-Hydroxyfluphenazine [Presence] in Urine by Screen method |
| 90287-4 | Norovirus RNA [Presence] in Vomitus by NAA with probe detection |
| 7552-3 | Oregano IgE Ab [Units/volume] in Serum |
| 61093-1 | Triazolam [Presence] in Specimen |
| 623-9 | Bacteria identified in Sputum by Cystic fibrosis respiratory culture |
| 62419-7 | Galectin 3 [Mass/volume] in Serum or Plasma |
| 63241-4 | Ganglioside GM1 IgG Ab [Presence] in Body fluid by Immunoassay |
| 63345-3 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Body fluid by Flow cytometry (FC) |
| 78780-4 | Alminoprofen [Mass/volume] in Blood |
| 79194-7 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose arginine+insulin |
| 79468-5 | Thiopurine methyltransferase [Enzymatic activity/substance] in Red Blood Cells |
| 95217-6 | Nucleated erythrocytes/100 leukocytes in Stem cell product by Manual count |
| 9635-4 | Saint Louis encephalitis virus IgM Ab [Titer] in Specimen |
| 6821-3 | Thermoactinomyces vulgaris Ab [Presence] in Serum by Immune diffusion (ID) |
| 6827-0 | Bacitracin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 8060-6 | Adrenal cortex Ab [Units/volume] in Serum |
| 96714-1 | Epithelial cells.squamous [#/volume] in Bronchial specimen by Manual count |
| 6938-5 | IgA [Mass/volume] in Saliva (oral fluid) |
| 6992-2 | Cefpirome [Susceptibility] by Gradient strip |
| 82090-2 | Occupational Allergen Mix 3 (Alternaria alternata+Aspergillus fumigatus+rye pollen+wheat pollen) IgE Ab [Units/volume] in Serum by Multidisk |
| 97521-9 | Coccidioides sp Ab band pattern [Identifier] in Specimen by Immune diffusion (ID) |
| 97543-3 | Bicarbonate [Moles/volume] in Central venous blood |
| 7123-3 | Bayberry IgE Ab [Units/volume] in Serum |
| 98026-8 | Parasite identified in Prostatic fluid by Light microscopy |
| 9805-3 | Width of Stone |
| 99005-1 | Leptospira kirschneri sv Cynopteri Ab [Titer] in Serum by Agglutination |
| 72572-1 | Amylase.salivary/Amylase.total [Pure catalytic fraction] in Serum or Plasma |
| 72590-3 | Alpha 2 globulin/Protein.total [Pure mass fraction] in Serum or Plasma by Electrophoresis |
| 86206-0 | Whole genome sequence analysis in Blood or Tissue by Molecular genetics method |
| 73023-4 | Fenofibrate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88052-6 | Cells.CD4-CD8-CD45R+TCR alpha beta+/100 CD3 cells in Blood by Flow cytometry (FC) |
| 88178-9 | Coxiella burnetii DNA [Presence] in Tissue by NAA with probe detection |
| 88550-9 | Scedosporium apiospermum DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 73883-1 | Glycolate [Moles/time] in 24 hour Urine |
| 74473-0 | Middle East respiratory syndrome coronavirus (MERS-CoV) N2 gene RNA [Presence] in Specimen by NAA with probe detection |
| 88589-7 | Clostridium botulinum toxin [Identifier] in Serum by Mouse bioassay neutralization |
| 89648-0 | Chlamydia trachomatis [Presence] in Throat by Organism specific culture |
| 41293-2 | Clotted specimen |
| 59342-6 | Tadalafil [Mass/volume] in Blood |
| 51009-9 | CD3-CD16+CD56+CD244+ cells/100 cells in Bone marrow |
| 30509-4 | Androsterone/Creatinine [Mass Ratio] in Urine |
| 41998-6 | Hexacarboxylporphyrin [Mass/volume] in 24 hour Urine |
| 59965-4 | quiNINE [Moles/volume] in Serum or Plasma |
| 60037-9 | 1-Naphthol [Mass/volume] in Body fluid |
| 3132-8 | Xanthine [Mass/volume] in Urine |
| 31472-4 | Legionella pneumophila IgM Ab [Units/volume] in Serum |
| 51347-3 | CD56+CD57+ cells/100 cells in Bone marrow |
| 51537-9 | Silver Birch IgG Ab [Presence] in Serum |
| 51827-4 | Trypanosoma cruzi IgM Ab [Units/volume] in Serum by Immunoassay |
| 22445-1 | Polio virus 1 Ab [Titer] in Cerebral spinal fluid |
| 32561-3 | Tuberculosis reaction wheal [Diameter] --1 day post dose mammalian tuberculin intradermal |
| 23007-8 | Classical swine fever virus Ag [Presence] in Tissue by Immune stain |
| 32622-3 | Hyaluronidase Ab [Presence] in Serum |
| 32653-8 | DYS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 23587-9 | Western equine encephalitis virus IgM Ab [Presence] in Serum |
| 3331-6 | Amiodarone+Desethylamiodarone [Mass/volume] in Serum or Plasma |
| 53638-3 | CD45RB Ag [Presence] in Tissue by Immune stain |
| 4534-4 | Cyanmethemoglobin/Hemoglobin.total in Blood |
| 23995-4 | Epstein Barr virus early IgG Ab [Titer] in Serum by Immunofluorescence |
| 53993-2 | Centrosomal nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
| 46999-9 | Bacterial vaginosis and vaginitis rRNA panel - Vaginal fluid by Probe |
| 55481-6 | Insulin [Moles/volume] in Serum or Plasma --10 minutes pre dose glucose |
| 34740-1 | NEFL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55916-1 | Beta galactosidase [Enzymatic activity/volume] in DBS |
| 5607-7 | Boron [Mass/volume] in Serum or Plasma |
| 3558-4 | Dicoumarol [Mass/volume] in Serum or Plasma |
| 56416-1 | Western Water Hemp IgG4 Ab [Mass/volume] in Serum |
| 48244-8 | Red Cedar triggered leukotriene release [Mass/volume] by Leukocytes |
| 26518-1 | Polymorphonuclear cells/100 leukocytes in Body fluid |
| 3799-4 | Methoxyphenamine [Mass/volume] in Urine |
| 27005-8 | Xylose [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 57402-0 | CD42a cells/100 cells in Body fluid |
| 5744-8 | Thallium [Mass/volume] in Serum or Plasma |
| 5764-6 | Zinc [Mass/volume] in Urine |
| 48967-4 | Brucella abortus Ab [Presence] in Cerebral spinal fluid by Card agglutination |
| 49073-0 | Influenza virus A IgG Ab [Mass/volume] in Cerebral spinal fluid |
| 2779-7 | Phosphate [Mass/time] in 24 hour Urine |
| 58468-0 | Anise IgG4 Ab [Mass/volume] in Serum |
| 29630-1 | 3-Methylglutarate [Presence] in Urine |
| 29638-4 | Weight of Tissue |
| 29800-0 | Jamestown canyon virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 59209-7 | Gamma hydroxybutyrate [Moles/volume] in Serum or Plasma |
| 4082-4 | Trimipramine [Presence] in Serum or Plasma |
| 4085-7 | Tripelennamine [Mass/volume] in Serum or Plasma |
| 41052-2 | SPAST gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19419-1 | Dextroamphetamine [Presence] in Urine by Screen method |
| 19584-2 | Methyprylon cutoff [Mass/volume] in Urine for Confirmatory method |
| 198-2 | Cloxacillin [Susceptibility] by Disk diffusion (KB) |
| 100351-6 | Pioglitazone [Presence] in Serum or Plasma |
| 12538-5 | Nitrate [Mass/volume] in Blood |
| 12938-7 | Thyrotropin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 13376-9 | Methionine [Mass/volume] in Cerebral spinal fluid |
| 101801-9 | 2-Oxo-3-Hydroxy-Lysergate diethylamide [Presence] in Urine by Confirmatory method |
| 13836-2 | Neutrophils/100 leukocytes in Peritoneal fluid by Manual count |
| 102268-0 | Arizona Cypress IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102817-4 | Shark IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15202-5 | Potassium [Moles/volume] in Stool |
| 15230-6 | Grass Allergen Mix C (Brome+Bermuda grass+Velvet grass+Bahia grass+Timothy+Johnson grass) IgE Ab [Presence] in Serum by Multidisk |
| 15390-8 | Parainfluenza virus 1 IgM Ab [Presence] in Serum |
| 10794-6 | Microscopic observation [Identifier] in Tissue by Methyl green-pyronine Y stain |
| 10912-4 | Lead [Mass/volume] in Serum or Plasma |
| 10973-6 | 3 methoxy O desmethylencainide [Mass/volume] in Serum or Plasma |
| 10988-4 | fluvoxaMINE [Mass/volume] in Serum or Plasma |
| 11080-9 | HIV 2 p53 Ab [Presence] in Serum by Immunoblot |
| 11109-6 | Mast cells/100 cells in Bone marrow by Manual count |
| 16334-5 | Alfentanil [Mass/volume] in Urine |
| 11226-8 | Prorenin [Units/volume] in Plasma |
| 11573-3 | Rheumatoid factor IgM [Units/volume] in Serum |
| 12281-2 | Bacteria identified in Cervix by Anaerobe culture |
| 1720-2 | Adenine phosphoribosyltransferase [Enzymatic activity/volume] in Red Blood Cells |
| 17278-3 | Miconazole [Mass/volume] in Serum or Plasma |
| 1745-9 | Albumin [Mass/volume] in Amniotic fluid |
| 17514-1 | Renin [Enzymatic activity/volume] in Plasma --9th specimen post XXX challenge |
| 19098-3 | Erythrocytes [Presence] in Amniotic fluid |
| 91866-4 | Bacteria identified in Mouth by Aerobe culture |
| 92147-8 | Human coronavirus HKU1+OC43 RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 60491-8 | LCA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 61193-9 | Clarity of Pleural fluid from Fetus |
| 77149-3 | Dry weight/Total of 24 hour Stool |
| 77944-7 | CD11a cells/100 cells in Specimen |
| 788-0 | Erythrocyte distribution width [Ratio] by Automated count |
| 94556-8 | dRVVT excess phospholipid in Platelet poor plasma by Coagulation assay --post DOAC neutralization |
| 6497-2 | Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 78920-6 | cycloSPORINE [Moles/volume] in Blood by Immunoassay |
| 7943-4 | Lassa virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 94853-9 | West Nile virus IgG and IgM panel - Cerebral spinal fluid Qualitative |
| 8031-7 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum |
| 95775-3 | HGSNAT gene full mutation analysis in Blood or Tissue by Sequencing |
| 96261-3 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with 1:1 normal plasma |
| 67825-0 | Borrelia burgdorferi IgM bands [#] in Cerebral spinal fluid by Immunoblot |
| 68401-9 | Eosinophils [#/volume] in Synovial fluid by Manual count |
| 71640-7 | Mesothelial cells/Leukocytes [Pure number fraction] in Body fluid by Manual count |
| 82466-4 | riTUXimab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
| 8257-8 | Service comment 15 |
| 82732-9 | AMPAR1+AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 82855-8 | Prenanediolone+pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
| 9820-2 | Cryptococcus sp Ag [Titer] in Serum by Latex agglutination |
| 71716-5 | Brucella suis Ab [Titer] in Serum by Tube agglutination |
| 72313-0 | t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
| 73038-2 | Ciprofloxacin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87588-0 | Tilmicosin [Mass/mass] in Specimen |
| 87795-1 | Ormetoprim+Sulfadimethoxine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 87799-3 | Sulfadimethoxine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 88032-8 | Organophosphate panel - Specimen |
| 88915-4 | Filaria DNA [Presence] in Tissue by NAA with probe detection |
| 41447-4 | Plasmodium falciparum DNA [Presence] in Blood by NAA with probe detection |
| 59586-8 | HLA IgG Ab [Presence] in Serum by Immunofluorescence |
| 31028-4 | Amprenavir [Mass/volume] in Serum or Plasma |
| 60084-1 | Hydroxybupropion [Mass/volume] in Body fluid |
| 21490-8 | Rickettsia (Proteus OX2) Ab [Titer] in Serum by Latex agglutination |
| 31443-5 | Intrinsic factor blocking Ab [Units/volume] in Serum |
| 31812-1 | Entamoeba histolytica Ag [Units/volume] in Specimen |
| 51868-8 | Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of XXX |
| 32194-3 | Monocytes+Macrophages [Presence] in Pleural fluid by Light microscopy |
| 32340-2 | Sodium [Moles/volume] in Specimen |
| 44026-3 | Aspergillus flavus H Ab [Presence] in Serum by Immune diffusion (ID) |
| 44512-2 | Herpes simplex virus Ag [Presence] in Nose |
| 2357-2 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
| 23638-0 | Grepafloxacin [Susceptibility] |
| 53501-3 | Iron [Moles/volume] in Water |
| 53644-1 | Carbaryl [Presence] in Gastric fluid |
| 4490-9 | Complement C3b-C4b receptor [Entitic number] in Red Blood Cells |
| 44991-8 | Chlamydia trachomatis C IgM Ab [Presence] in Serum |
| 4517-9 | Complement factor Bb [Mass/volume] in Serum or Plasma |
| 33786-5 | Immature basophils/100 leukocytes in Blood by Manual count |
| 34150-3 | Mycoplasma fermentans DNA [Presence] in Blood by NAA with probe detection |
| 34176-8 | Tricyclic antidepressants [Presence] in Specimen |
| 54256-3 | Glucose [Moles/volume] in Serum or Plasma --8 minutes post dose glucagon |
| 46263-0 | 6-monoacetylmorphine free [Presence] in Serum or Plasma |
| 55332-1 | little c Ab [Titer] in Serum or Plasma |
| 55435-2 | Mononuclear cells immature [#/volume] in Blood by Manual count |
| 47291-0 | Fungus # 6 identified in Specimen by Culture |
| 25654-5 | Gastrin [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 2574-2 | Lipoprotein.beta [Mass/volume] in Serum or Plasma |
| 25837-6 | Herpes simplex virus 1 Ab [Titer] in Serum by Immunofluorescence |
| 26011-7 | Macroamylase/Amylase.total in Serum or Plasma |
| 48033-5 | TTR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 26713-8 | Phentermine [Mass/mass] in Meconium |
| 3604-6 | Etamivan [Mass/time] in 24 hour Urine |
| 5695-2 | Methanol [Mass/volume] in Urine |
| 48375-0 | Spermatozoa Short Tail/100 spermatozoa in Semen |
| 38255-6 | Cat dander IgE Ab/IgE total in Serum |
| 38339-8 | Benzene [Mass/volume] in Water |
| 38419-8 | CD21 cells/100 cells in Specimen |
| 5768-7 | Ascorbate [Mass/volume] in Urine by Test strip |
| 49015-1 | SCA15 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 38756-3 | 1,2-Dimethylbenzene [Mass/volume] in Air |
| 28604-7 | Phosphoethanolamine/Creatinine [Ratio] in Urine |
| 58678-4 | Cortisol [Mass/volume] in Saliva (oral fluid) --pre 1 ug/kg CRH IV |
| 29893-5 | HIV 1 Ab [Presence] in Serum or Plasma by Immunoassay |
| 29932-1 | Vanadium [Mass/time] in 24 hour Urine |
| 29972-7 | Strontium [Mass/time] in 24 hour Urine |
| 5912-1 | Creatine kinase isoenzymes [Interpretation] in Serum or Plasma |
| 30088-9 | Horse hair+Horse dander IgE Ab [Units/volume] in Serum |
| 19156-9 | Susceptibility method [Identifier] in Specimen |
| 19371-4 | Butabarbital cutoff [Mass/volume] in Urine for Screen method |
| 19597-4 | Morphine [Presence] in Urine by Screen method |
| 19726-9 | Aspergillus fumigatus IgG Ab [Presence] in Serum |
| 20611-0 | CD5 cells/100 cells in Specimen |
| 100425-8 | DiHydro T-Mas [Mass/volume] in Serum or Plasma |
| 101508-0 | Salmonella serogroup D1 [Presence] in Specimen by Immunoassay |
| 101650-0 | Prion disease risk [Interpretation] in Cerebral spinal fluid by Immunoassay Narrative |
| 12977-5 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --8th specimen |
| 13053-4 | Kaolin activated time [Units/volume] in Platelet poor plasma |
| 102030-4 | Ki-67 Nuclear Ag and p16INK4a Ag Ag [Presence] in Body fluid by Immune stain |
| 1344-1 | Yt sup(a) Ab [Presence] in Serum or Plasma |
| 13903-0 | Vasopressin [Mass/volume] in Urine |
| 102469-4 | Virginia Live Oak IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102512-1 | Perch IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14246-3 | Phosphatidylserine IgM Ab [Units/volume] in Serum |
| 102865-3 | Aspergillus versicolor IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104427-0 | Measles virus genotype [Identifier] in Specimen by Sequencing |
| 10542-9 | Metharbital [Mass/volume] in Serum or Plasma |
| 1581-8 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --pre 2 mg dexamethasone PO 2.5 day high dose q6h |
| 10729-2 | Trypanosoma sp identified in Blood by Light microscopy |
| 16415-2 | Aspergillus flavus Ab [Presence] in Cerebral spinal fluid |
| 17443-3 | Phenylpropanolamine [Mass/volume] in Urine |
| 17794-9 | Osmolality of Hyperal solution |
| 17925-9 | Bacteria identified in Wound deep by Anaerobe culture |
| 1807-7 | Amylase S2 [Enzymatic activity/volume] in Serum or Plasma |
| 18861-5 | Amoxicillin [Susceptibility] |
| 1890-3 | Arginase [Enzymatic activity/volume] in Red Blood Cells |
| 90235-3 | Heparan sulfate [Moles/volume] in DBS |
| 90269-2 | Microscopic observation [Identifier] in Milk by Acid fast stain |
| 907-6 | Blood group antigens present [Identifier] in Blood product unit |
| 74632-1 | Glycosaminoglycans [Presence] in 24 hour Urine |
| 75350-9 | Other cells/100 leukocytes in Peritoneal fluid by Manual count |
| 60494-2 | Influenza virus A H1 2009 pandemic and Influenza virus A swine origin RNA [Interpretation] in Specimen Qualitative by NAA with probe detection |
| 62333-0 | Severe combined immunodeficiency (SCID) newborn screening panel |
| 93870-4 | NMDAR subunit 1 Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 7832-9 | Coxiella burnetii phase 2 IgM Ab [Units/volume] in Serum |
| 78831-5 | Hydroxybupropion [Presence] in Urine by Confirmatory method |
| 78841-4 | JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
| 94532-9 | SARS-related coronavirus+MERS coronavirus RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 94585-7 | Herpes simplex virus 1 and 2 and Varicella zoster virus DNA panel - Specimen by NAA with non-probe detection |
| 636-1 | Bacteria identified in Specimen by Sterile body fluid culture |
| 6447-7 | Legionella pneumophila Ag [Presence] in Urine by Immunoassay |
| 79142-6 | Gamma hydroxybutyrate [Mass/volume] in Body fluid |
| 79459-4 | Dihydropteridine reductase [Enzymatic activity/mass] in Red Blood Cells |
| 67811-0 | Parainfluenza virus 4 Ag [Presence] in Isolate by Immunofluorescence |
| 97215-8 | Acetyl fentanyl [Presence] in Cord tissue by Confirmatory method |
| 69574-2 | Furazolidone [Susceptibility] |
| 81831-0 | LAMB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 8214-9 | Opiates [Presence] in Meconium |
| 97250-5 | Flunitrazepam [Presence] in Cord tissue by Screen method |
| 97968-2 | Ovalbumin IgG4 Ab [Mass/volume] in Serum |
| 82379-9 | Daclatasvir [Susceptibility] by Genotype method |
| 82988-7 | NMDAR IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 98256-1 | Extent of myometrial invasion in Endometrial cancer specimen Qualitative |
| 85335-8 | DCIS.additional dimension 2 [Length] in Breast cancer specimen by Light microscopy |
| 85679-9 | Haemophilus influenzae bex gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 72563-0 | Creatine kinase.MB/Creatine kinase.total [Pure catalytic fraction] in Serum or Plasma by Electrophoresis |
| 7283-5 | Yellow Dock triggered histamine release [Units/volume] in Blood |
| 85954-6 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum |
| 73520-9 | Argatroban induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73857-5 | Allo-pregnanediol [Moles/time] in 24 hour Urine |
| 89005-3 | NY-ESO-1 Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 89584-7 | Herpes simplex virus DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 42635-3 | Chromosome 12p tetrasomy [Presence] in Fixed tissue by Molecular genetics method |
| 31329-6 | Coxsackievirus B4 Ab [Units/volume] in Cerebral spinal fluid |
| 31478-1 | Leptospira interrogans sv Canicola Ab [Units/volume] in Serum |
| 51439-8 | Protein.monoclonal band 3 [Mass/volume] in 24 hour Urine by Electrophoresis |
| 31821-2 | Equine influenza virus A1 Ag [Units/volume] in Specimen |
| 31991-3 | Acylcarnitine [Presence] in Serum or Plasma |
| 51600-5 | Methotrexate [Moles/volume] in Serum or Plasma --24 hours post dose |
| 43390-4 | Streptococcus sp identified in Isolate |
| 43686-5 | Salivary gland IgA Ab [Units/volume] in Saliva (oral fluid) |
| 32822-9 | Epithelial cells.squamous/100 cells in Bronchial specimen by Light microscopy |
| 45173-2 | Thyrotropin.alpha subunit [Mass/volume] in Serum or Plasma |
| 33872-3 | Cystine [Moles/mass] in Leukocytes |
| 33986-1 | Bartonella henselae DNA [Presence] in Specimen by NAA with probe detection |
| 34203-0 | SCA12 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 54145-8 | Bacterial vaginosis and vaginitis DNA panel - Vaginal fluid by Probe with signal amplification |
| 34512-4 | NPHS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 54480-9 | Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Urine |
| 34885-4 | African horse sickness virus Ab [Presence] in Serum by Immunofluorescence |
| 56125-8 | Immunoglobulin light chains.free [Presence] in Serum |
| 25846-7 | Alpha aminoadipate [Moles/volume] in 24 hour Urine |
| 26672-6 | Ross River virus Ab [Presence] in Serum |
| 36904-1 | Inhibin A [Multiple of the median] adjusted in Serum or Plasma |
| 56728-9 | Thermoactinomyces vulgaris IgE Ab [Units/volume] in Serum |
| 48503-7 | Platelet glycoprotein Ib/Ix IgG Ab [Presence] in Blood by Immunoassay |
| 48886-6 | Bartonella vinsonii berkhoffii IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 26901-9 | Flurazepam [Mass/volume] in Vitreous fluid |
| 27251-8 | Phenylpropanolamine [Mass/volume] in Vitreous fluid |
| 57907-8 | Atazanavir+Ritonavir [Susceptibility] by Phenotype method |
| 58085-2 | Penicillin Parenteral [Susceptibility] |
| 28550-2 | Cortisol [Presence] in Urine |
| 40027-5 | Glucose [Mass/volume] in Serum or Plasma --9 minutes post XXX challenge |
| 58454-0 | Subtelomere analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 29687-1 | Orientia tsutsugamushi Gilliam Ab [Presence] in Serum |
| 40540-7 | Basophils/100 leukocytes in Peritoneal dialysis fluid by Manual count |
| 58995-2 | Magnesium [Mass/time] in 18 hour Urine |
| 19278-1 | Barbiturates confirm method [Identifier] in Urine |
| 19649-3 | oxyMORphone cutoff [Mass/volume] in Urine for Screen method |
| 101456-2 | Septin-7 IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 13225-8 | Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma --1st specimen |
| 13843-8 | CD33 blasts/100 blasts in Blood |
| 13874-3 | Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma |
| 14306-5 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 102820-8 | Sole IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102880-2 | Maleic anhydride IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14712-4 | EPINEPHrine [Moles/time] in 24 hour Urine |
| 10332-5 | Cortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM |
| 10340-8 | Molindone [Mass/volume] in Serum or Plasma |
| 15177-9 | DNA double strand Ab [Units/volume] in Body fluid |
| 15448-4 | Avian paramyxovirus 1 Ab [Titer] in Serum by Hemagglutination inhibition |
| 16129-9 | Hepatitis C virus IgG Ab [Presence] in Serum |
| 17841-8 | Amylase [Enzymatic activity/time] in 12 hour Urine |
| 17920-0 | Bacteria # 6 identified in Wound shallow by Aerobe culture |
| 18221-2 | EPINEPHrine [Mass/volume] in Urine --4th specimen post XXX challenge |
| 1845-7 | Ammonium ion [Moles/volume] in Plasma |
| 18912-6 | Colistin [Susceptibility] |
| 7487-2 | Mayfly IgE Ab [Units/volume] in Serum |
| 74980-4 | LORazepam [Mass/volume] in Serum or Plasma --trough |
| 75156-0 | Thymidine [Moles/volume] in Cerebral spinal fluid |
| 75266-7 | Glutarylcarnitine (C5-DC)/Octanoylcarnitine+Decanoylcarnitine (C8+C10) [Molar ratio] in DBS |
| 61064-2 | Triazolam [Presence] in Serum or Plasma |
| 9315-3 | Western equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 6243-0 | Sheep epithelium IgE Ab [Units/volume] in Serum |
| 62473-4 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
| 78812-5 | buPROPion cutoff [Mass/volume] in Urine for Confirmatory method |
| 6340-4 | Chlamydophila psittaci Ag [Presence] in Specimen by Immunoassay |
| 63544-1 | Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Body fluid |
| 79465-1 | Porphobilinogen synthase [Enzymatic activity/mass] in Red Blood Cells |
| 79491-7 | 3-Hydroxyphenylacetate [Moles/volume] in Serum or Plasma |
| 79508-8 | 4-Hydroxymandelate [Moles/volume] in Serum or Plasma |
| 96185-4 | Indoor respiratory allergen IgE panel - Serum |
| 6823-9 | Rheumatoid factor [Presence] in Synovial fluid by Latex agglutination |
| 72414-6 | Acetoacetate [Moles/volume] in Blood --pre-meal |
| 72451-8 | Barbiturates [Presence] in Saliva (oral fluid) by Confirmatory method |
| 83077-8 | Beta-2-Microglobulin [Mass/volume] in Urine by Immunoassay |
| 85302-8 | Growth pattern of DCIS [Type] in Breast cancer specimen by Light microscopy |
| 99389-9 | Choriogonadotropin.tumor marker [Units/volume] in Pleural fluid |
| 72566-3 | Cholinesterase.scoline inhibited/Cholinesterase [Pure catalytic fraction] in Serum or Plasma |
| 86098-1 | Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum |
| 86668-1 | Depth of deep margin involved by invasive melanoma [Length] in Skin melanoma by Light microscopy |
| 86733-3 | Porcine parvovirus [Presence] in Specimen by Organism specific culture |
| 88455-1 | California encephalitis virus Ab.IgG and IgM panel - Serum by Immunofluorescence |
| 88512-9 | Natural killer cell cytotoxicity.15:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
| 41210-6 | VWF gene p.Arg816Trp [Presence] in Blood or Tissue by Molecular genetics method |
| 41504-2 | Norfloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
| 50693-1 | Influenza virus A+B Ab [Titer] in Serum by Complement fixation |
| 42212-1 | Nucleolar nuclear Ab pattern [Titer] in Body fluid |
| 59970-4 | Strychnine [Moles/volume] in Gastric fluid |
| 60256-5 | Neisseria gonorrhoeae rRNA [Presence] in Urine by NAA with probe detection |
| 21070-8 | Other Antibiotic [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 31394-0 | Feline syncytial virus Ab [Units/volume] in Serum |
| 31486-4 | Leptospira sp IgM Ab [Units/volume] in Cerebral spinal fluid |
| 51110-5 | CD2 blasts/100 blasts in Bone marrow |
| 51202-0 | Platinum [Mass/volume] in Body fluid |
| 42933-2 | CD79a cells/100 cells in Specimen |
| 43015-7 | Histoplasma capsulatum yeast phase Ab [Titer] in Body fluid |
| 21685-3 | HADHB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 43280-7 | Hepatitis D virus Ag [Mass/volume] in Urine |
| 22564-9 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum --2nd specimen |
| 51956-1 | DNA region analysis test coverage panel |
| 22872-6 | Bluetongue virus Ag [Presence] in Blood |
| 33052-2 | Leukocytes [Presence] in Urine |
| 44733-4 | Triglyceride/Cholesterol in HDL [Mass Ratio] in Serum or Plasma |
| 23406-2 | Rift valley fever virus Ag [Presence] in Serum by Immune diffusion (ID) |
| 23504-4 | Tritrichomonas foetus DNA [Presence] in Specimen by NAA with probe detection |
| 33562-0 | Ampicillin [Mass/volume] in Serum or Plasma --peak |
| 33605-7 | Chlamydia trachomatis I Ab [Titer] in Serum |
| 45084-1 | Chlamydia trachomatis DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 45133-6 | Chlamydia sp Ag [Presence] in Nasopharynx |
| 45317-5 | Pentacarboxylate/Creatinine [Molar ratio] in Urine |
| 33977-0 | Fy sup(a) Ab [Titer] in Serum or Plasma |
| 53972-6 | Burr cells [Presence] in Urine sediment by Light microscopy |
| 24429-3 | Parasite identified in Blood |
| 54481-7 | Dicarboxystearoylcarnitine (C18-DC)/Creatinine [Molar ratio] in Urine |
| 47015-3 | CD31 Ag [Presence] in Tissue by Immune stain |
| 25542-2 | Toxoplasma gondii IgM Ab [Presence] in Serum |
| 55678-7 | Flumequine [Susceptibility] by Gradient strip |
| 55820-5 | Allo-pregnanediol [Mass/time] in 24 hour Urine |
| 56022-7 | ACE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 56126-6 | Copper [Mass/mass] in Liver |
| 47540-0 | 3-Methylhistidine [Moles/volume] in Body fluid |
| 35459-7 | T cell crossmatch [Interpretation] |
| 56351-0 | Peanut IgG4 Ab [Mass/volume] in Serum |
| 56533-3 | Insulin IgG Ab [Units/volume] in Serum |
| 48101-0 | Cortisol [Moles/volume] in Serum or Plasma --15 minutes pre 1 ug/kg CRH IV |
| 26449-9 | Eosinophils [#/volume] in Blood |
| 26696-5 | Morphine Free [Mass/mass] in Stool |
| 3824-0 | Morazone [Mass/volume] in Urine |
| 56878-2 | Phenylbutazone IgE Ab [Units/volume] in Serum |
| 57099-4 | Follitropin [Units/volume] in Serum or Plasma --1 hour post dose gonadotropin releasing hormone |
| 4864-5 | HLA-Cw8 [Presence] in Donor |
| 4889-2 | HLA-Dw1 [Presence] |
| 57632-2 | Alpha cortolone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
| 49056-5 | Shigella sp serotype [Identifier] in Isolate by Agglutination |
| 38715-9 | Phosgene [Mass/volume] in Air |
| 57969-8 | Ganglioside GD1a IgM Ab [Presence] in Serum |
| 49436-9 | Pneumocystis jiroveci DNA [#/volume] in Blood by NAA with probe detection |
| 49730-5 | Aspergillus sp Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
| 40124-0 | Creatinine [Moles/volume] in Serum or Plasma --16 hours post XXX challenge |
| 5864-4 | Influenza virus B Ag [Presence] in Throat by Immunoassay |
| 49966-5 | Polymorphonuclear cells/100 leukocytes in Pericardial fluid by Manual count |
| 50145-2 | 3-Dechloroethylifosfamide [Mass/volume] in Blood --pre dose ifosfamide |
| 58845-9 | Somatotropin [Mass/volume] in Serum or Plasma --19th specimen |
| 58957-2 | Heparin given [Type] |
| 59300-4 | Desloratadine [Mass/volume] in Serum or Plasma |
| 50236-9 | Phosphate crystals amorphous [Presence] in Urine by Computer assisted method |
| 50262-5 | Reticulocytes panel - Blood |
| 12483-4 | Tungsten [Presence] in Serum or Plasma |
| 101628-6 | Thyroglobulin heterophile Ab interference [Interpretation] in Serum Narrative |
| 102192-2 | Brussel Sprouts IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 134-7 | cefTAZidime [Susceptibility] by Disk diffusion (KB) |
| 102652-5 | Paper wasp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1400-1 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 1 ug/kg CRH IV |
| 102973-5 | Bean string IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14608-4 | Nuclear Ab [Presence] in Pleural fluid |
| 14761-1 | Glucose [Moles/volume] in Serum or Plasma --2 hours post meal |
| 104234-0 | Atomoxetine [Mass/volume] in Urine by Confirmatory method |
| 104288-6 | HLA-B gene.g.31431780T>G [Presence] in Blood or Tissue by Molecular genetics method |
| 104386-8 | Dengue virus IgM Ab [Titer] in Serum by Immunoassay --1st specimen |
| 15239-7 | Occupational Allergen Mix 5 (Isocyanate HDI+MDI+TDI+Phthalic anhydride) IgE Ab [Presence] in Serum by Multidisk |
| 15392-4 | Parainfluenza virus 2 IgG Ab [Presence] in Serum |
| 15399-9 | Neuronal nuclear IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 1576-8 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 16125-7 | Helicobacter pylori IgA Ab [Presence] in Serum |
| 10719-3 | Taenia solium adult Ab [Units/volume] in Serum by Immunoblot |
| 1163-5 | little e Ag [Presence] on Red Blood Cells from Blood product unit |
| 17110-8 | CD11b cells/100 cells in Blood |
| 17692-5 | Testosterone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 17829-3 | CD19 cells/100 cells in Body fluid |
| 18484-6 | Ku Ab [Presence] in Serum |
| 18888-8 | cefOXitin [Susceptibility] |
| 90782-4 | F2-Isoprostanes [Mass/volume] in Urine |
| 74627-1 | 1,1-Dimethoxyhexadecane (DMA 16:0) [Moles/mass] in Red Blood Cells |
| 74642-0 | 1,3-Dichlorobenzene [Mass/volume] in Serum or Plasma |
| 74821-0 | Chikungunya virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 75558-7 | Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
| 60458-7 | Collection time of Blood--6th specimen |
| 7671-1 | Saltwort IgG Ab [Units/volume] in Serum |
| 76773-1 | Heptacarboxylporphyrin [Moles/volume] in Serum or Plasma |
| 9345-0 | Coproporphyrin 3 [Mass/volume] in Urine |
| 62248-0 | Nucleated erythrocytes [#/volume] in Blood from Fetus by Automated count |
| 77028-9 | Influenza virus A H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with probe detection |
| 77211-1 | Carbonic anhydrase 6 IgA Ab [Units/volume] in Serum by Immunoassay |
| 77336-6 | Oxazepam [Moles/volume] in Specimen |
| 94367-0 | Streptococcus pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 94740-8 | Gleason scoring basis [Type] in Prostate tumor |
| 6344-6 | Chlamydia sp Ag [Presence] in Conjunctival specimen by Immunofluorescence |
| 79327-3 | Sterols pattern [Interpretation] in Serum or Plasma Narrative |
| 79419-8 | PMS2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 94858-8 | Glycerol [Moles/volume] in Serum by calculation |
| 65333-7 | Sc1 Ab [Presence] in Serum or Plasma |
| 65633-0 | Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Confirmatory method |
| 6583-9 | Virus identified in Semen by Culture |
| 6597-9 | Troponin T.cardiac [Mass/volume] in Venous blood |
| 6655-5 | Microscopic observation [Identifier] in Tissue by Acid fast stain.Kinyoun |
| 66768-3 | Leukocytes [#/volume] corrected for nucleated erythrocytes in Cord blood |
| 95967-6 | Freesia spp IgE Ab [Units/volume] in Serum |
| 6844-5 | Honey bee IgE Ab [Units/volume] in Serum |
| 68910-9 | Teratozoospermia index in Semen |
| 81733-8 | PM-SCL-75 Ab [Presence] in Serum by Line blot |
| 81838-5 | PEX1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 82206-4 | Cyclospora cayetanensis DNA [Presence] in Stool by NAA with non-probe detection |
| 97237-2 | Codeine Free [Presence] in Cord tissue by Confirmatory method |
| 7018-5 | Gentamicin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 98206-6 | Borrelia burgdorferi 21kD IgG Ab [Presence] in Serum by Immunoblot |
| 71695-1 | Immature granulocytes/100 leukocytes in Blood by Automated count |
| 99125-7 | Bunyamwera virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 72695-0 | Erythrocyte enzyme panel - Red Blood Cells |
| 73361-8 | glipiZIDE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73508-4 | Aztreonam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7353-6 | Bermuda grass IgG Ab [Units/volume] in Serum |
| 74310-4 | PRRSV strain identified in Isolate by Sequencing |
| 74455-7 | Blasts/100 leukocytes in Cord blood |
| 88727-3 | Recoverin Ab [Units/volume] in Serum by Line blot |
| 89660-5 | Microscopic observation [Identifier] in Implanted device by Acid fast stain |
| 41660-2 | ABT492 [Susceptibility] by Gradient strip |
| 59886-2 | Citalopram [Moles/volume] in Urine |
| 50680-8 | Paecilomyces variottii IgE Ab [Units/volume] in Serum |
| 41875-6 | Bordetella pertussis and Bordetella parapertussis DNA panel - Specimen by NAA with probe detection |
| 60038-7 | 1-Naphthol [Mass/mass] in Tissue |
| 42941-5 | GALT gene allele 2 [Presence] in Blood by Molecular genetics method |
| 2196-4 | Dehydroepiandrosterone (DHEA).unconjugated [Mass/volume] in Serum or Plasma |
| 51795-3 | Complement C1 esterase inhibitor bound Ab [Mass/volume] in Serum or Plasma |
| 51817-5 | Coxsackievirus B IgG Ab [Units/volume] in Serum by Immunoassay |
| 43244-3 | Herpes virus 6 DNA [Presence] in Serum by NAA with probe detection |
| 43357-3 | Chlamydia trachomatis D+E+F+G+H+I+J+K IgM Ab [Titer] in Serum by Immunofluorescence |
| 22452-7 | Pseudorabies virus Ab [Presence] in Serum |
| 22647-2 | Ornithine [Moles/volume] in Cerebral spinal fluid |
| 32123-2 | Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma |
| 4394-3 | Phenothiazines [Mass] of Dose |
| 44054-5 | Triosephosphate isomerase [Enzymatic activity/mass] in Red Blood Cells |
| 23013-6 | Cowdria ruminantium Ab [Presence] in Serum by Immunoblot |
| 44417-4 | Valine/Creatinine [Mass Ratio] in 24 hour Urine |
| 5391-8 | Toxoplasma gondii IgM Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 23791-7 | Vesicular stomatitis New Jersey virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 33793-1 | Calcium [Moles/volume] in Urine --7th specimen post XXX challenge |
| 54080-7 | Galactosemia newborn screening panel (SI units) |
| 4545-0 | Hematocrit [Volume Fraction] of Blood by Centrifugation |
| 46400-8 | Corticotropin [Mass/volume] in Plasma --15 minutes post 1 ug/kg CRH IV |
| 2429-9 | Homocystine [Presence] in Serum or Plasma |
| 34539-7 | Protein electrophoresis panel - Urine |
| 54495-7 | Glucose [Moles/volume] in Serum or Plasma --post dialysis |
| 55562-3 | Oxyphenbutazone [Moles/volume] in Serum or Plasma |
| 47227-4 | Blood.dried [Presence] of Stone Qualitative |
| 25438-3 | Hexacarboxylporphyrin [Moles/time] in 24 hour Urine |
| 47554-1 | Alanine/Amino acids.total in Amniotic fluid |
| 56469-0 | Cardiac heart disease risk [Ratio] in Serum or Plasma |
| 48041-8 | Anthraquinone cutoff [Mass/mass] in Stool |
| 26744-3 | Opiates [Mass/mass] in Meconium by Screen method |
| 3620-2 | N-ethylnicotinamide [Mass/volume] in Urine |
| 3795-2 | Methotrexate [Mass/volume] in Serum or Plasma --24 hours post dose |
| 48800-7 | Second trimester quad maternal screen panel - Serum or Plasma |
| 26931-6 | Complement C4 [Units/volume] in Serum or Plasma |
| 38283-8 | Lymphocyte proliferation stimulated by 9.67 ug/mL tetanus toxoid [Units/volume] in Blood |
| 38290-3 | 1,4-Dichlorobenzene [Mass/volume] in Water |
| 38332-3 | 1,2,4-Trichlorobenzene [Mass/volume] in Water |
| 2769-8 | Phenylketones [Presence] in Urine |
| 38754-8 | 2,4-Toluene diisocyanate [Mass/volume] in Air |
| 576-9 | Fungus identified in Synovial fluid by Culture |
| 49644-8 | SCA10 gene allele 2.ATTCT repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 49746-1 | Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma by Screen method |
| 29276-3 | Calcium [Presence] in Urine |
| 2940-5 | Serotonin [Mass/volume] in Plasma |
| 40120-8 | Creatinine [Moles/volume] in Serum or Plasma --8 hours post XXX challenge |
| 40717-1 | Haptoglobin [Presence] in Serum or Plasma |
| 50182-5 | Calcitonin [Mass/volume] in Serum or Plasma --2 minutes post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV |
| 50384-7 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (Schwartz) |
| 50425-8 | Corticotropin [Mass/volume] in Plasma --pre 100 ug CRH IV |
| 19468-8 | Flunitrazepam cutoff [Mass/volume] in Urine for Screen method |
| 20518-7 | Barbital [Mass/volume] in Urine by Confirmatory method |
| 20794-4 | Eastern equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Complement fixation |
| 100686-5 | JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 100911-7 | Campylobacter sp [Presence] in Stool by Organism specific culture |
| 12595-5 | Estradiol (E2) [Mass/volume] in Urine |
| 101472-9 | Catalase [Presence] in Urine |
| 12936-1 | Thyrotropin [Units/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 13004-7 | Hydrocarbons.halogenated.volatile [Identifier] in Blood |
| 13494-0 | Volume of 4 hour Dialysis fluid |
| 102309-2 | Fiscus sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10472-9 | Chromogranin Ag [Presence] in Tissue by Immune stain |
| 1093-4 | K Ab [Presence] in Serum or Plasma |
| 16696-7 | Cobalamin (Vitamin B12) [Mass/volume] in Urine --post XXX challenge |
| 1165-0 | little e Ag [Presence] on Red Blood Cells |
| 12242-4 | Phosphate [Mass/volume] in Body fluid |
| 16902-9 | Gliadin IgG Ab [Presence] in Serum |
| 16943-3 | Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 90075-3 | Non-Enterobacteriaceae identified in Isolate by Organism specific culture |
| 74883-0 | Ornithine [Moles/volume] in DBS --post therapeutic diet |
| 92747-5 | Lyso-sphingomyelin [Moles/volume] in Serum or Plasma |
| 75084-4 | Sebacate (C8) [Moles/volume] in Serum or Plasma |
| 75512-4 | dRVVT with 1:1 PNP actual/normal (normalized LA mix) |
| 75662-7 | Polymorphonuclear cells [#] in Synovial fluid by Manual count |
| 93508-0 | Hexacarboxylporphyrin III [Moles/time] in 24 hour Urine |
| 61278-8 | Isocyanate TDI IgE Ab/IgE total in Serum |
| 77366-3 | Metanephrine.free and Normetanephrine.free and 3-Methoxytyramine.free panel - Serum or Plasma |
| 9428-4 | Benzodiazepines [Mass/volume] in Urine |
| 6293-5 | Complement C4d [Presence] in Red Blood Cells |
| 7809-7 | Astrovirus [Presence] in Stool by Electron microscopy |
| 7840-2 | Coxsackievirus B5 Ab [Units/volume] in Serum |
| 64138-1 | Methylenedioxyamphetamine/Creatinine [Mass Ratio] in Urine |
| 79139-2 | Buprenorphine [Presence] in Blood by Screen method |
| 79481-8 | Hydantoin-5-propionate/Creatinine [Molar ratio] in Urine |
| 65771-8 | Peanut native (nAra h) 3 IgE Ab [Units/volume] in Serum |
| 66483-9 | Heparin unfractionated [Units/volume] in Platelet poor plasma |
| 79669-8 | Dihydrothymine [Moles/volume] in Serum or Plasma |
| 80137-3 | Antihistamines [Presence] in Body fluid by Screen method |
| 9606-5 | Taenia solium larva 39-42kD Ab [Presence] in Serum by Immunoblot |
| 96413-0 | Pancreatic polypeptide [Mass/volume] in Serum or Plasma --fasting |
| 97159-8 | 2-Hydroxyethylflurazepam [Mass/volume] in Urine by Confirmatory method |
| 8216-4 | Opiates [Presence] in Meconium by Screen method |
| 97954-2 | Rhinovirus+Enterovirus A+B+C RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 82354-2 | Human papilloma virus 16 and 18+45 E6+E7 mRNA [Identifier] in Cervix by NAA with probe detection |
| 82660-2 | Glutamate decarboxylase Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 72571-3 | Amylase.pancreatic/Amylase.total [Pure catalytic fraction] in Serum or Plasma |
| 73009-3 | Ibuprofen induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73236-2 | Nystatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73242-0 | Nitrofurantoin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87762-1 | Methcathinone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 73807-0 | B cell+T cell crossmatch.autologous [Interpretation] Qualitative by Complement dependent cytotoxicity |
| 74109-0 | 4-hydroxycoumarins [Presence] in Specimen by Screen method |
| 88922-0 | Actinomyces sp identified in Tissue by Organism specific culture |
| 59353-3 | Tapentadol [Mass/volume] in Body fluid |
| 5964-2 | Prothrombin time (PT) in Blood by Coagulation assay |
| 5971-7 | Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
| 51015-6 | CD1 blasts/100 blasts in Specimen |
| 4185-5 | Cimetidine [Mass] of Dose |
| 41857-4 | Vibrio parahaemolyticus DNA [Presence] in Specimen by NAA with probe detection |
| 4244-0 | Ethoheptazine [Mass] of Dose |
| 21093-0 | Basement membrane IgG Ab [Interpretation] in Serum by Immunofluorescence |
| 31292-6 | Chlamydia sp Ab [Units/volume] in Cerebral spinal fluid |
| 51383-8 | Leukocytes other [#/volume] in Blood by Automated count |
| 31984-8 | Venezuelan equine encephalitis virus Ag [Presence] in Specimen |
| 5183-9 | Hepatitis A virus Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 43627-9 | Acetazolamide [Presence] in Serum or Plasma |
| 4380-2 | Penicillin G potassium [Mass] of Dose |
| 32299-0 | Androstenedione [Moles/volume] in Serum or Plasma --baseline |
| 44280-6 | 17 Alpha-hydroxypregnanolone/Creatinine [Mass Ratio] in Urine |
| 32788-2 | Polymorphonuclear cells/Monocytes [Ratio] in Blood |
| 44529-6 | Histoplasma capsulatum mycelial phase Ab [Presence] in Serum by Immune diffusion (ID) |
| 23385-8 | Pseudorabies virus Ag [Presence] in Specimen by Immunofluorescence |
| 3340-7 | Amoxapine [Presence] in Serum or Plasma |
| 33893-9 | Karyotype [Identifier] in Bone marrow Nominal |
| 54239-9 | Cytopathic effect [Presence] in Specimen |
| 2502-3 | Iron saturation [Mass Fraction] in Serum or Plasma |
| 34667-6 | Heavy metals panel - Hair |
| 55162-2 | HTLV I+II Ab panel - Serum |
| 55222-4 | Microscopic observation [Identifier] in Aspirate by Rhodamine-auramine fluorochrome stain |
| 25191-8 | Clarithromycin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25322-9 | Arginine [Moles/time] in 24 hour Urine |
| 47657-2 | Insulin [Units/volume] in Serum or Plasma --1 hour post dose glucose |
| 2562-7 | Leucine [Mass/time] in 24 hour Urine |
| 35430-8 | Herpes simplex virus identified in Throat by Organism specific culture |
| 35703-8 | Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid |
| 56345-2 | Paprika IgG4 Ab [Mass/volume] in Serum |
| 56415-3 | Watermelon IgG4 Ab [Mass/volume] in Serum |
| 56468-2 | Pumpkin IgG4 Ab [Mass/volume] in Serum |
| 48557-3 | Origin of Stone |
| 48755-3 | 3-Hydroxydecanoate.free (3-OH-C10:0) [Moles/volume] in Serum or Plasma |
| 48798-3 | First trimester maternal screen panel - Serum or Plasma |
| 48846-0 | Bartonella vinsonii berkhoffii IgM Ab [Titer] in Serum by Immunofluorescence |
| 38400-8 | Parainfluenza virus 1+2+3 Ab [Presence] in Serum |
| 57475-6 | 11-Ketoandrosterone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
| 49272-8 | Immunoelectrophoresis for Cerebral spinal fluid Narrative |
| 38748-0 | Methylenedianiline [Mass/volume] in Air |
| 39004-7 | Epidermal growth factor receptor Ag [Presence] in Tissue |
| 57777-5 | Myeloperoxidase Ab and Proteinase 3 panel - Serum |
| 58009-2 | MPL gene p.Trp515 [Presence] in Blood or Tissue by Molecular genetics method |
| 58351-8 | Connective tissue growth factor [Mass/volume] in Urine |
| 28558-5 | Chlamydia trachomatis D+K IgM Ab [Titer] in Serum by Immunofluorescence |
| 29213-6 | Ceruloplasmin [Mass/volume] in Body fluid |
| 29262-3 | Abnormal lymphocytes [#/volume] in Blood by Manual count |
| 29325-8 | Cocaethylene [Mass/volume] in Vitreous fluid |
| 49969-9 | Cortisol [Molar concentration difference] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
| 50060-3 | Fatty acids.very long chain C24:0 (Tetracosanoate)/Creatinine [Molar ratio] in Urine |
| 50456-3 | Cortisol [Mass/volume] in Serum or Plasma --4th specimen |
| 50503-2 | Insulin [Units/volume] in Serum or Plasma --3rd specimen |
| 30103-6 | Yersinia enterocolitica O:9 Ab [Titer] in Specimen |
| 30182-0 | Tree Allergen Mix 7 (Olive+Willow+Eastern white pine+Eucalyptus spp+Wattle+Cajeput) IgE Ab [Units/volume] in Serum by Multidisk |
| 19381-3 | Carboxy tetrahydrocannabinol [Presence] in Urine by Screen method |
| 20548-4 | Methylphenidate [Mass/volume] in Urine by Confirmatory method |
| 20799-3 | Clostridium perfringens enterotoxin [Presence] in Body fluid |
| 100428-2 | Carnitine free and total and acylcarnitine panel - Urine |
| 12736-5 | Hyaluronate [Mass/volume] in Serum or Plasma |
| 12881-9 | Borrelia burgdorferi 47kD Ab [Presence] in Body fluid by Immunoblot |
| 12929-6 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 102574-1 | Rice IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102650-9 | English Walnut Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14076-4 | Complement total hemolytic CH100 [Presence] in Serum or Plasma by Immune diffusion (ID) |
| 102779-6 | Orange Tree IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14445-1 | Triglyceride [Mass/volume] in Amniotic fluid |
| 14577-1 | ABO and Rh group [Type] in Blood from Donor |
| 104179-7 | Clostridium tetani toxin [Presence] in Specimen by Endopeptidase Assay |
| 10945-4 | Papain IgE Ab [Units/volume] in Serum |
| 10964-5 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin IM |
| 16450-9 | Benzylhydrazine [Mass/volume] in Serum or Plasma |
| 16928-4 | Hantavirus puumala IgG+IgM Ab [Units/volume] in Serum |
| 17143-9 | CD39 cells/100 cells in Blood |
| 17970-5 | Bacteria # 2 identified in Urine by Culture |
| 90080-3 | Bictegravir [Susceptibility] by Genotype method |
| 90322-9 | Haemophilus parasuis serotype [Identifier] in Specimen by NAA with probe detection |
| 91115-6 | Cholesterol in LDL 4 [Moles/volume] in Serum or Plasma |
| 74842-6 | CD25 cells [#/volume] in Specimen |
| 92640-2 | M-chlorophenylpiperazine [Mass/volume] in Urine by Confirmatory method |
| 61196-2 | Albumin [Mass/volume] in Urine from Fetus |
| 76027-2 | Mannose-6-phosphate isomerase [Enzymatic activity/mass] in Fibroblast |
| 76148-6 | Pradofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 77018-0 | Noninvasive prenatal fetal 13 and 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing |
| 9363-3 | Bordetella pertussis IgG Ab [Units/volume] in Serum |
| 6269-5 | Tulip IgE Ab [Units/volume] in Serum |
| 63185-3 | Mesquite IgG Ab [Mass/volume] in Serum |
| 63267-9 | Jo-1 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 948-0 | C Ag [Presence] on Red Blood Cells |
| 95542-7 | SARS-CoV-2 (COVID-19) Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 95565-8 | 5-Pregnenetriol [Mass/time] in 24 hour Urine |
| 79592-2 | Homocitrulline/Creatinine [Molar ratio] in Urine |
| 959-7 | C sup(w) Ag [Presence] on Red Blood Cells from Donor |
| 80719-8 | T-cell naive and memory and effector (CD27 and CD45RA) subsets [Interpretation] in Blood Narrative |
| 69486-9 | LDLR gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
| 69741-7 | Differential panel - Pericardial fluid |
| 70861-0 | Rabies virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 71625-8 | Neutrophils/Leukocytes [Pure number fraction] in Synovial fluid by Manual count |
| 72464-1 | JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 838-3 | Ax Ag [Presence] on Red Blood Cells |
| 99122-4 | Bwamba virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 99972-2 | Hearing loss multigene analysis in Blood or Tissue by Molecular genetics method |
| 72747-9 | N-nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 72890-7 | Progesterone Free/Progesterone.total in Serum or Plasma |
| 72894-9 | Telavancin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 72991-3 | Metoclopramide induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87818-1 | Tapentadol [Presence] in Saliva (oral fluid) by Screen method |
| 88460-1 | Serotonin release 50 IU/mL heparin.low molecular weight [Units/volume] in Serum |
| 73948-2 | JWH-122 (synthetic cannabinoid) [Presence] in Blood |
| 74318-7 | PRRSV North American strain RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 74379-9 | Morphine [Mass/volume] in Unknown substance |
| 88845-3 | Microbiology CNAMTS panel - Specimen |
| 88863-6 | Lung cancer antibody panel - Serum or Plasma by Immunoassay |
| 89001-2 | CAGE Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 89503-7 | RNA polymerase III Ab [Units/volume] in Serum by Line blot |
| 41701-4 | Lomefloxacin [Susceptibility] by Gradient strip |
| 41711-3 | Ramoplanin [Susceptibility] by Gradient strip |
| 5989-9 | Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis |
| 50881-2 | Molybdenum [Moles/mass] in Hair |
| 30538-3 | Neutrophil cytoplasmic Ab.classic [Presence] in Serum |
| 30915-3 | Aneuploid cells/100 cells in Specimen by Flow cytometry (FC) |
| 42495-2 | Cytomegalovirus IgG Ab [Presence] in Cerebral spinal fluid |
| 51167-5 | CD34+CD117+ blasts/100 blasts in Bone marrow |
| 42775-7 | Multiple drug resistant organism identified in Sputum |
| 42940-7 | GALT gene allele 1 [Presence] in Blood by Molecular genetics method |
| 31762-8 | Capripox virus Ag [Presence] in Specimen |
| 51514-8 | Lactate dehydrogenase 3/Lactate dehydrogenase.total in Pleural fluid by Electrophoresis |
| 51867-0 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Blood or Tissue by FISH |
| 32186-9 | Microscopic observation [Identifier] in Penis by Tzanck smear |
| 5236-5 | Legionella pneumophila Ab [Presence] in Serum by Immunofluorescence |
| 2291-3 | Formate [Mass/volume] in Blood |
| 33034-0 | CD45 negative events [#] in Specimen |
| 53373-7 | Francisella tularensis Ab [Presence] in Isolate |
| 2330-9 | Gastrin.34 residue fragment [Mass/volume] in Serum or Plasma |
| 23799-0 | Epidermal Allergen Mix 73 (Chicken feather+Duck feather+Goose feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk |
| 24036-6 | Borrelia sp Ag [Presence] in Specimen by Immunofluorescence |
| 54231-6 | Semen analysis fertility panel |
| 4548-4 | Hemoglobin A1c/Hemoglobin.total in Blood |
| 46267-1 | Proteinase 3 Ab [Units/volume] in Serum by Immunoassay |
| 55316-4 | Yeast [Presence] in Sputum by KOH preparation |
| 25149-6 | Calcium phosphate crystals [#/area] in Urine sediment by Microscopy high power field |
| 47680-4 | Leucine/Amino acids.total in Hair |
| 47716-6 | Oxygen [Partial pressure] adjusted to patient's actual temperature in Cord blood |
| 25722-0 | Miconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 25731-1 | Plasmodium sp Ab [Titer] in Serum by Immunofluorescence |
| 5619-2 | Chromium [Mass/volume] in Blood |
| 56483-1 | Porphobilinogen [Mass/mass] in Stool |
| 48499-8 | Beta-trace protein [Mass/volume] in Serum or Plasma |
| 48576-3 | Hepatitis C virus RNA [Presence] in Specimen by Probe with signal amplification |
| 48741-3 | Bordetella pertussis [Presence] in Nasopharynx by Organism specific culture |
| 48839-5 | Respiratory allergen panel, US - Inland northwest a - Serum |
| 38621-9 | Toluene [Mass/volume] in Air |
| 57355-0 | Potassium [Moles/volume] in 12 hour Urine |
| 57626-4 | Alpha cortol [Mass/time] in 24 hour Urine --pre dose dexamethasone |
| 39572-3 | West Nile virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 57903-7 | Bg sup(a) Ab [Titer] in Serum or Plasma |
| 49651-3 | SCA7 gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 2836-5 | Pregnanetriol [Mass/time] in 24 hour Urine |
| 40145-5 | Creatinine [Moles/volume] in Urine --6 hours post XXX challenge |
| 40265-1 | Creatinine [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 29647-5 | Interferon beta Ab [Presence] in Serum or Plasma |
| 40393-1 | Pentazocine [Presence] in Gastric fluid |
| 40482-2 | Unidentified crystals [#/area] in Urine sediment by Microscopy low power field |
| 50197-3 | aPTT panel - Platelet poor plasma |
| 50482-9 | Follitropin [Units/volume] in Serum or Plasma --6th specimen |
| 40985-4 | Parainfluenza virus 3 IgG Ab [Presence] in Serum by Immunoassay |
| 41161-1 | Ascaris lumbricoides IgG Ab [Units/volume] in Serum |
| 20821-5 | Escherichia coli K99 [Presence] in Stool by Agglutination |
| 101529-6 | Mycoplasma sp DNA [Nucleotide sequence] in Isolate by Sequencing |
| 101590-8 | VKORC1 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 13332-2 | CD4+CD25+ cells/100 cells in Blood |
| 13821-4 | Urea nitrogen/Creatinine [Mass Ratio] in 24 hour Urine |
| 14066-5 | Dihydrocodeine [Presence] in Urine |
| 1419-1 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
| 102946-1 | Sardine (Sardinops melanosticta) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14758-7 | Glucose [Moles/volume] in Serum or Plasma --2 hours post 50 g lactose PO |
| 14819-7 | Lymphocytes/100 leukocytes in Bronchial specimen by Manual count |
| 14933-6 | Urate [Moles/volume] in Serum or Plasma |
| 16202-4 | Nordiazepam [Presence] in Urine by Confirmatory method |
| 11159-1 | Alkalase IgE Ab [Units/volume] in Serum |
| 17914-3 | Bacteria # 6 identified in Wound deep by Aerobe culture |
| 90293-2 | Liver cancer antibodies and AFP panel - Serum or Plasma by Immunoassay |
| 74528-1 | Dicarboxyeicosanoylcarnitine (C20-DC) [Moles/volume] in Serum or Plasma |
| 74533-1 | Fatty acid oxidation panel - Fibroblast |
| 92250-0 | Microorganism gene target region [Type] by Molecular method |
| 92744-2 | Hepatosplenomegaly due to lysosomal storage disorders screening panel - Blood |
| 61221-8 | Aspergillus niger IgE Ab/IgE total in Serum |
| 77250-9 | Mumps virus IgG and IgM panel - Serum |
| 7784-2 | Baker's yeast triggered histamine release [Units/volume] in Blood |
| 7865-9 | Echovirus 11 Ab [Units/volume] in Serum |
| 94558-4 | SARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory system specimen by Rapid immunoassay |
| 9476-3 | Hexanoylglycine [Moles/volume] in Urine |
| 95079-0 | Insulin [Units/volume] in Serum or Plasma --15 min post meal |
| 6557-3 | Streptococcus pyogenes Ag [Presence] in Throat by Immunofluorescence |
| 6570-6 | Varicella zoster virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 8014-3 | Rubella virus IgG Ab [Units/volume] in Serum |
| 8085-3 | Neutrophil cytoplasmic Ab.perinuclear [Units/volume] in Serum |
| 81115-8 | Murray Valley encephalitis virus Ab [Titer] in Serum |
| 96614-3 | HLA-A and B and C (class I) typing panel - Blood or Tissue from Donor by High resolution |
| 82127-2 | Respiratory pathogens DNA and RNA identified in Pleural fluid by NAA with probe detection |
| 82181-9 | Cryptococcus gattii+neoformans DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
| 97261-2 | LORazepam [Presence] in Cord tissue by Confirmatory method |
| 72665-3 | Trans,trans-muconic acid [Mass/volume] in Urine |
| 86204-5 | Porcine deltacoronavirus [Presence] in Specimen by Organism specific culture |
| 87543-5 | Beta-N-acetylhexosaminidase.A and beta-N-acetylhexosaminidase with reflex to HEXA gene panel [Enzymatic activity/mass] - Leukocytes |
| 88581-4 | Borrelia sp DNA [Identifier] in Cerebral spinal fluid by NAA with probe detection |
| 41477-1 | Bacterial sialidase [Presence] in Specimen |
| 59879-7 | chlordiazePOXIDE [Moles/volume] in Urine |
| 42331-9 | Nuclear IgG Ab [Units/volume] in Serum by Flow cytometry (FC) |
| 60187-2 | Thiethylperazine [Mass/volume] in Serum or Plasma |
| 60303-5 | Fenoprofen [Moles/volume] in Specimen |
| 21401-5 | Mumps virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 21565-7 | tiaGABine [Mass/volume] in Serum or Plasma |
| 51203-8 | Ropivacaine [Mass/volume] in Serum or Plasma |
| 5121-9 | Cytomegalovirus Ab [Titer] in Serum or Plasma by Latex agglutination |
| 32103-4 | PENTobarbital [Moles/volume] in Serum or Plasma |
| 52948-7 | cloBAZam [Presence] in Gastric fluid |
| 5297-7 | Rheumatoid factor [Presence] in Serum by Latex agglutination |
| 23024-3 | Coxiella burnetii DNA [Presence] in Specimen by NAA with probe detection |
| 33228-8 | WBC casts [#/area] in Urine by Computer assisted method |
| 4449-5 | Tranylcypromine [Mass] of Dose |
| 44545-2 | Human papilloma virus DNA [Presence] in Urethra by Probe |
| 44709-4 | Asialoganglioside GM1 IgM Ab [Units/volume] in Serum by Immunoassay |
| 53601-1 | HIV 1 p24 Ag [Units/volume] in Serum or Plasma by Immunoassay |
| 53761-3 | JAK2 gene.p.Val617Phe mutant/Normal in Blood or Tissue by Molecular genetics method |
| 45163-3 | Alternaria alternata Ab [Presence] in Serum |
| 23746-1 | Gossypol Free [Mass/volume] in Specimen |
| 54089-8 | Newborn screening panel American Health Information Community (AHIC) |
| 54400-7 | Glucose [Moles/volume] in Serum or Plasma --pre dose glucagon |
| 34356-6 | Porphobilinogen [Moles/volume] in 24 hour Urine |
| 4736-5 | HLA-A32(19) [Presence] in Donor |
| 25125-6 | Phenyllactate/Creatinine [Molar ratio] in Urine |
| 25173-6 | Thallium [Moles/volume] in Blood |
| 25217-1 | Isoniazid 0.1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 55929-4 | Isoleucine [Moles/mass] in Hair |
| 25762-6 | Insulin-like growth factor [Moles/volume] in Serum or Plasma --14th specimen post XXX challenge |
| 25976-2 | Proline/Creatinine [Molar ratio] in 24 hour Urine |
| 56315-5 | Boxelder IgG4 Ab [Mass/volume] in Serum |
| 48085-5 | 3-Hydroxydodecenedioate/Creatinine [Molar ratio] in Urine |
| 48095-4 | Corticotropin [Mass/volume] in Plasma --4 PM specimen |
| 35870-5 | 2-Oxoisocaproate [Moles/volume] in Serum or Plasma |
| 38162-4 | Coproporphyrin/Creatinine [Mass Ratio] in Urine |
| 56566-3 | Somatotropin [Mass/volume] in Serum or Plasma --9.5 hours post XXX challenge |
| 56718-0 | Islet cell 512 Ab [Units/volume] in Serum by Immunoassay |
| 48774-4 | Kappa light chains.free [Mass/volume] in Cerebral spinal fluid |
| 26920-9 | Amobarbital [Mass/mass] in Hair |
| 27241-9 | Mephobarbital [Mass/mass] in Stool |
| 38335-6 | Vinyl chloride [Mass/volume] in Water |
| 38388-5 | Complement C3 [Presence] in Serum or Plasma |
| 38424-8 | C peptide [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
| 3854-7 | Nicotine [Mass/volume] in Urine |
| 27295-5 | Cocaethylene [Mass/mass] in Stool |
| 2755-7 | pH of Stool |
| 27842-4 | Somatotropin [Mass/volume] in Serum or Plasma --19th specimen post XXX challenge |
| 3885-1 | Oxandrolone [Mass/time] in 24 hour Urine |
| 57771-8 | Paraneoplastic Ab [Interpretation] in Serum Narrative |
| 58074-6 | Wr sup(a) Ab [Presence] in Serum or Plasma |
| 58789-9 | Campylobacter jejuni IgG Ab [Titer] in Serum by Immunofluorescence |
| 29671-5 | Rickettsia honei Ab [Presence] in Serum |
| 58877-2 | Somatotropin [Mass/volume] in Serum or Plasma --30th specimen |
| 50451-4 | Corticotropin [Mass/volume] in Plasma --7th specimen |
| 30188-7 | Grass Allergen Mix 2 (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass+Bahia grass) IgE Ab [Units/volume] in Serum by Multidisk |
| 4097-2 | Volatile drugs positive [Identifier] in Urine by Screen method |
| 19194-0 | Enolase.neuron specific [Units/volume] in Pleural fluid |
| 20412-3 | Benzodiazepines [Mass/volume] in Urine by Confirmatory method |
| 20499-0 | Phosphatidylglycerol/Surfactant.total in Amniotic fluid |
| 20503-9 | CD22+CD11c+ cells/100 cells in Blood |
| 2055-2 | Catecholamines [Mass/volume] in Blood |
| 20646-6 | Homocystine [Moles/volume] in Serum or Plasma |
| 20792-8 | Eastern equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 100411-8 | Sugar Beet IgG Ab [Units/volume] in Serum |
| 12615-1 | Glucose [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 101775-5 | Nannizzia fulva DNA [Presence] in Specimen by NAA with probe detection |
| 101929-8 | Supersaturation panel - Urine |
| 13896-6 | Insulin-like growth factor-I [Units/volume] in Blood |
| 102302-7 | Fennel Fresh IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14151-5 | Bicarbonate [Moles/volume] in Cord blood |
| 10401-8 | Immune serum globulin given [Type] |
| 14851-0 | Norclozapine [Moles/volume] in Serum or Plasma |
| 104430-4 | Middle East respiratory syndrome coronavirus (MERS-CoV) [Presence] in Specimen by Neutralization test |
| 10590-8 | Spermatids [#/volume] in Semen by Sertoli cell barrier method (SCB) |
| 10769-8 | Microscopic observation [Identifier] in Tissue by Alizarin red S stain |
| 16643-9 | Cockatoo droppings Ab [Units/volume] in Serum |
| 12311-7 | Prazepam [Mass/volume] in Urine |
| 17026-6 | Isocyanate IgE Ab [Units/volume] in Serum |
| 17190-0 | CD69 cells/100 cells in Blood |
| 1755-8 | Albumin [Mass/time] in 24 hour Urine |
| 17935-8 | Bacteria # 2 identified in Blood by Anaerobe culture |
| 18498-6 | Microscopic observation [Identifier] in Breast fine needle aspirate by Cyto stain |
| 18991-0 | Temocillin [Susceptibility] |
| 90780-8 | inFLIXimab Ab [Units/volume] in Serum by Immunoassay |
| 74523-2 | Nonanoylcarnitine (C9) [Moles/volume] in Serum or Plasma |
| 91789-8 | Haemophilus ducreyi [Presence] in Genital specimen by Organism specific culture |
| 75241-0 | Procalcitonin [Mass/volume] in Serum or Plasma by Immunoassay |
| 7669-5 | Rice triggered histamine release [Units/volume] in Blood |
| 61209-3 | Mushroom IgE Ab/IgE total in Serum |
| 61271-3 | Soybean IgE Ab/IgE total in Serum |
| 77050-3 | SUGCT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77338-2 | Indocyanine green [Mass/volume] in Plasma --1 minute post dose indocyanine green |
| 77356-4 | Non-hematopoietic stem cells/100 leukocytes in Cerebral spinal fluid by Manual count |
| 7774-3 | Cow whey IgE Ab [Units/volume] in Serum |
| 93802-7 | 19q/19p chromosome deletion [# Ratio] in Tissue by FISH |
| 630-4 | Bacteria identified in Urine by Culture |
| 63227-3 | DNA double strand IgG Ab [Titer] in Body fluid by Immunofluorescence |
| 78532-9 | Creatinine [Moles/volume] in Peritoneal dialysis fluid --2 hour dwell specimen |
| 94647-5 | SARS-related coronavirus RNA [Presence] in Specimen by NAA with probe detection |
| 94668-1 | Reaction wheal [Diameter] --1 day post dose control intradermal |
| 6354-5 | Chlamydia trachomatis Ag [Presence] in Specimen by Immunoassay |
| 79234-1 | Butylone [Mass/volume] in Urine by Confirmatory method |
| 79457-8 | Beta glucuronidase [Enzymatic activity/volume] in DBS |
| 95600-3 | Contactin-associated protein 2 Ab [Titer] in Serum by Cell binding immunofluorescent assay |
| 95638-3 | California encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 66122-3 | Adrenal gland Pathology biopsy report |
| 96288-6 | Methylene blue IgE Ab [Units/volume] in Serum |
| 9645-3 | Metanephrine/Creatinine [Mass Ratio] in Urine |
| 6859-3 | Tobacco IgE Ab [Units/volume] in Serum |
| 97160-6 | Norclobazam [Mass/volume] in Urine by Confirmatory method |
| 69367-1 | Bordetella pertussis IgG Ab [Presence] in Serum by Immunoblot |
| 81632-2 | Immunoglobulin light chains.free panel - Serum by Nephelometry |
| 97238-0 | N-desalkylflurazepam [Presence] in Cord tissue by Screen method |
| 70-3 | Cefamandole [Susceptibility] by Serum bactericidal titer |
| 82597-6 | Chromosome painting analysis in Blood or Tissue by FISH |
| 82781-6 | Borrelia miyamotoi flaB gene [Presence] in Specimen by NAA with probe detection |
| 82923-4 | PML IgG Ab [Presence] in Serum by Line blot |
| 98219-9 | Treponema pallidum IgG and IgM and bands panel - Cerebral spinal fluid by Immunoblot |
| 98275-1 | Right pelvic lymph nodes positive [#] in Specimen |
| 72448-4 | 3-Hydroxysebacate ( 3-OH-C8) [Moles/volume] in Serum or Plasma |
| 72631-5 | Amobarbital [Presence] in Saliva (oral fluid) by Confirmatory method |
| 72667-9 | Mycophenolate [Mass/volume] in Serum or Plasma --trough |
| 73100-0 | Trimethoprim induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88269-6 | Staphylococcus aureus gyrB gene [Presence] by Probe in Positive blood culture |
| 73898-9 | CD8-CD57+ cells/100 lymphocytes in Blood by Flow cytometry (FC) |
| 74157-9 | Cannabinoids [Presence] in Serum, Plasma or Blood by Screen method |
| 74376-5 | 2,2',4,4',5,5'-Hexachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
| 42661-9 | Bacteria identified in Isolate by Pulsed-Field Gel Electrophoresis (PFGE) |
| 21249-8 | Dolichol [Mass/volume] in Urine |
| 21386-8 | Methamphetamine [Presence] in Urine by SAMHSA confirm method |
| 21492-4 | Rickettsia conorii IgG Ab [Titer] in Serum |
| 21510-3 | Saint Louis encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 42787-2 | HER4 Ag [Presence] in Tissue by Immune stain |
| 22291-9 | Epstein Barr virus capsid IgG Ab [Titer] in Cerebral spinal fluid |
| 43372-2 | Figure associated with report or note |
| 32211-5 | Reducing substances [Mass/volume] in Stool |
| 5327-2 | Bartonella henselae IgM Ab [Units/volume] in Serum |
| 53382-8 | Plasmodium falciparum IgM Ab [Titer] in Serum |
| 45101-3 | Chlamydia sp identified in Nasopharynx by Organism specific culture |
| 45106-2 | Chlamydia sp Ag [Presence] in Cervix by Immunoassay |
| 45220-1 | Lymphocytic choriomeningitis virus IgM Ab [Presence] in Serum |
| 453-1 | Spectinomycin [Susceptibility] by Disk diffusion (KB) |
| 33734-5 | Surgical margin tumor involvement.proximal by CAP cancer protocols |
| 3426-4 | Tetrahydrocannabinol [Presence] in Urine |
| 2413-3 | Hippuran renal clearance in 24 hour Urine and Serum or Plasma |
| 24275-0 | Saint Louis encephalitis virus Ab [Titer] in Serum --1st specimen |
| 34508-2 | PANK2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 34546-2 | Protein and Glucose panel [Mass/volume] - Cerebral spinal fluid |
| 47145-8 | EPINEPHrine [Moles/volume] in Urine --4th specimen post XXX challenge |
| 35131-2 | L-dopa decarboxylase [Enzymatic activity/volume] in Plasma |
| 35132-0 | MELAS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55819-7 | Adiponectin.high molecular weight [Mass/volume] in Serum or Plasma |
| 55853-6 | Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Cerebral spinal fluid |
| 47770-3 | Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose insulin IV |
| 35734-3 | Histoplasma capsulatum Ag [Presence] in Urine |
| 56455-9 | Gelatin IgG4 Ab [Mass/volume] in Serum |
| 48208-3 | Baker's yeast triggered leukotriene release [Mass/volume] by Leukocytes |
| 48316-4 | Leishmania tropica IgG Ab [Titer] in Serum by Immunofluorescence |
| 26480-4 | Lymphocytes/100 leukocytes in Pericardial fluid |
| 26662-7 | Bebaru virus Ab [Presence] in Serum |
| 35796-2 | Enrofloxacin [Susceptibility] by Gradient strip |
| 3703-6 | Ketobemidone [Mass/volume] in Urine |
| 38191-3 | Ammonium urate/Total in Stone |
| 56647-1 | Phenol/Creatinine [Ratio] in 24 hour Urine |
| 39310-8 | Influenza virus A H9 Ab [Titer] in Serum by Hemagglutination inhibition |
| 49456-7 | Alpha synuclein Ag [Presence] in Tissue by Immune stain |
| 40256-0 | Creatinine [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
| 40295-8 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
| 58778-2 | Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum |
| 50154-4 | Acetoacetate [Moles/volume] in Cerebral spinal fluid |
| 29725-9 | Leptospira interrogans sv Bulgarica Ab [Presence] in Serum by Agglutination |
| 40478-0 | MAPT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 58867-3 | Somatotropin [Mass/volume] in Serum or Plasma --41st specimen |
| 50559-4 | Hemoglobin [Mass/volume] in Urine by Automated test strip |
| 50597-4 | HPA-2 [Type] in Blood |
| 40916-9 | Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 19161-9 | Urobilinogen [Units/volume] in Urine by Test strip |
| 19549-5 | Mesoridazine cutoff [Mass/volume] in Urine for Confirmatory method |
| 100668-3 | NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method |
| 101498-4 | Amoxicillin+Clavulanate [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 101511-4 | Salmonella enterica serotype 1,4,[5],12:i:- [Cycle Threshold #] in Specimen by NAA with probe detection |
| 102059-3 | Perfluorobutane Sulfonic Acid [Mass/volume] in Serum or Plasma by LC/MS/MS |
| 102174-0 | Honey bee IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102220-1 | Chaetomium globosum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10423-2 | Transfuse platelets [Volume] |
| 10671-6 | Helminth identified in Specimen |
| 15385-8 | Leishmania mexicana IgM Ab [Titer] in Serum |
| 16181-0 | Tricyclic antidepressants [Mass/volume] in Urine by Confirmatory method |
| 10725-0 | Toxoplasma gondii DNA [Units/volume] in Body fluid by Probe with amplification |
| 10940-5 | Cow milk boiled IgE Ab [Units/volume] in Serum |
| 10980-1 | Cephapirin [Mass/volume] in Serum or Plasma |
| 16-6 | Amoxicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1213-8 | little s Ag [Presence] on Red Blood Cells |
| 16962-3 | Heterophile Ab [Presence] in Synovial fluid by Latex agglutination |
| 17072-0 | Legionella pneumophila 8 Ab [Presence] in Serum |
| 17296-5 | Mycobacterium tuberculosis complex rRNA [Presence] in Specimen by Probe |
| 17439-1 | Phenols [Mass/volume] in Blood |
| 17593-5 | Smooth muscle Ab [Presence] in Sweat |
| 1777-2 | Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma |
| 1877-0 | Apolipoprotein C-III [Mass/volume] in Serum or Plasma |
| 90915-0 | Arachidonate (C20:4w6)+Linoleate (C18:2w6)/Fatty acids.C14-C22 in Blood |
| 74841-8 | CD8+CD57+ cells/100 cells in Specimen |
| 92720-2 | Lipoprotein.pre-beta.subparticle.small [Moles/volume] in Serum |
| 7563-0 | Paprika IgE Ab [Units/volume] in Serum |
| 61303-4 | Kentucky blue grass IgE Ab/IgE total in Serum |
| 6218-2 | Pineapple IgE Ab [Units/volume] in Serum |
| 7711-5 | Spinach IgG Ab [Units/volume] in Serum |
| 93890-2 | Methane/Expired gas [Volume Fraction] in Exhaled gas --pre dose carbohydrate |
| 9409-4 | Anabolic steroids [Identifier] in Urine |
| 62464-3 | Enterovirus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 63421-2 | JAK2 gene exon 12 mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 79590-6 | Alpha aminoisobutyrate [Moles/volume] in Serum or Plasma |
| 79664-9 | N-carbamoyl beta alanine [Moles/volume] in Cerebral spinal fluid |
| 682-5 | Microscopic observation [Identifier] in Specimen by Wright Giemsa stain |
| 82243-7 | Chromosome region 17p13.3 deletion in Blood or Tissue by FISH |
| 97595-3 | CD3+CD4+ (T4 helper) cells/100 lymphocytes in Lower respiratory specimen by Flow cytometry (FC) |
| 97927-8 | Tahyna virus RNA [Presence] in Specimen by NAA with probe detection |
| 7046-6 | Roxithromycin [Susceptibility] by Gradient strip |
| 82409-4 | Ganglioside GM4 IgM Ab [Presence] in Serum by Line blot |
| 98047-4 | Lipoxygenase IgE Ab [Units/volume] in Serum |
| 71690-2 | Nucleated cells [#/volume] in Body fluid by Automated count |
| 7210-8 | Mozzarella Cheese IgG Ab [Units/volume] in Serum |
| 83067-9 | Chikungunya virus structural proteins (E1+E2) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 85309-3 | Distance of carcinoma from superior margin [Length] in Breast cancer specimen by Light microscopy |
| 85384-6 | Amisulpride [Mass/volume] in Serum or Plasma |
| 85536-1 | Mycoplasma hyopneumoniae DNA [#/volume] in Specimen by NAA with probe detection |
| 72591-1 | Alpha 2 globulin/Protein.total [Pure mass fraction] in Cerebral spinal fluid by Electrophoresis |
| 85983-5 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 86029-6 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum --2nd specimen |
| 86594-9 | Zika virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 74039-9 | Influenza virus A H3 RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 74400-3 | Monocytes/100 leukocytes in Cord blood |
| 42003-4 | Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by Probe with signal amplification |
| 42620-5 | Terminal deoxyribonucleotidyl transferase cells/100 cells in Bone marrow |
| 21225-8 | Cortisol [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 31323-9 | Coxsackievirus B1 Ab [Units/volume] in Cerebral spinal fluid |
| 51342-4 | CD5+CD19+ cells/100 cells in Body fluid |
| 43075-1 | Borrelia burgdorferi C6 Ab [Units/volume] in Serum |
| 51535-3 | Timothy IgG Ab [Presence] in Serum |
| 51544-5 | Penicillium sp IgG Ab [Presence] in Serum |
| 43248-4 | EPINEPHrine/Creatinine [Mass Ratio] in 24 hour Urine |
| 43277-3 | GDAP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 43278-1 | Glucose [Mass/volume] in Milk --2 hours post meal |
| 43751-7 | Moxifloxacin [Mass/volume] in Serum or Plasma |
| 22480-8 | Rickettsia typhus group IgG Ab [Titer] in Cerebral spinal fluid |
| 22644-9 | Serine [Moles/volume] in Cerebral spinal fluid |
| 32235-4 | Citrulline [Moles/volume] in Body fluid |
| 32562-1 | IgG lymphocytes/100 lymphocytes in Specimen |
| 32568-8 | Trichophyton reaction wheal [Diameter] --1 day post 50 ug trichophyton intradermal |
| 5260-5 | Myocardium Ab [Titer] in Serum by Immunofluorescence |
| 52774-7 | Clotting time.extrinsic coagulation system activated.fibrinolysis suppressed of Blood by Rotational TEG |
| 52961-0 | Paraquat [Presence] in Urine |
| 228-7 | Enoxacin [Susceptibility] by Minimum lethal concentration (MLC) |
| 23025-0 | Dermatophilus congolensis [Presence] in Skin by Giemsa stain |
| 23195-1 | Leptospira sp Ab [Presence] in Serum by Immunoassay |
| 33-1 | Ampicillin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
| 53280-4 | Casts type not specified [Presence] in Urine by Computer assisted method |
| 53367-9 | Coccidioides sp IgM Ab [Presence] in Specimen |
| 44806-8 | Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection |
| 2339-0 | Glucose [Mass/volume] in Blood |
| 23612-5 | Azithromycin [Susceptibility] by Method for Slow-growing mycobacteria |
| 33373-2 | Blasts/100 leukocytes in Pleural fluid |
| 45201-1 | Whole Egg IgG Ab [Mass/volume] in Serum |
| 23815-4 | Androstanediol [Mass/time] in 24 hour Urine |
| 54276-1 | Glucose [Moles/volume] in Serum or Plasma --1 hour post dose ornithine alpha-ketoglutarate |
| 34481-2 | Blood group antibodies identified in Serum or Plasma by Warm incubation |
| 25559-6 | Zolpidem [Moles/volume] in Serum or Plasma |
| 35060-3 | Eosinophils [#/volume] in Synovial fluid |
| 47618-4 | Follitropin [Units/volume] in Serum or Plasma --15 minutes post 100 ug luteinizing releasing hormone IV |
| 47698-6 | Mannitol/Creatinine [Molar ratio] in Urine |
| 26651-0 | Rhizopus arrhizus Ab [Presence] in Serum |
| 26655-1 | Entamoeba sp Ab [Presence] in Serum |
| 56641-4 | Threonine/Creatinine [Ratio] in 24 hour Urine |
| 56763-6 | Oligoclonal Bands IgM [Interpretation] in Serum or Plasma |
| 48364-4 | Morphine-3-Glucuronide [Moles/volume] in Serum or Plasma |
| 27892-9 | Butyrylglycine/Creatinine [Mass Ratio] in Urine |
| 38681-3 | Sperm Tail IgG Ab/100 spermatozoa in Specimen by Immunobead |
| 38736-5 | Animal hair+Epithelium [Mass/volume] in Air |
| 57825-2 | Cortisol Free [Mass/volume] in Serum or Plasma --PM trough specimen |
| 28647-6 | pH of Venous cord blood |
| 39791-9 | Sodium [Moles/volume] in Venous blood |
| 40166-1 | Glucose [Moles/volume] in Serum or Plasma --6.5 hours post XXX challenge |
| 58424-3 | Ethyl sulfate [Presence] in Urine by Screen method |
| 58779-0 | Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum |
| 29911-5 | Magnesium [Mass/volume] in Stool |
| 40369-1 | HYDROmorphone [Presence] in Gastric fluid |
| 40649-6 | Measles virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 59019-0 | HLA-DQA1 [Type] by High resolution |
| 59047-1 | F5 gene p.His1299Arg [Presence] in Blood or Tissue by Molecular genetics method |
| 59256-8 | Cytologist who read Cyto stain of Specimen |
| 50212-0 | Glucose [Mass/volume] in Serum or Plasma --2nd specimen |
| 20511-2 | Creatinine [Interpretation] in Urine |
| 101505-6 | Bacterial susceptibility panel by Minimum inhibitory concentration VOC detection |
| 101534-6 | Fungal 18s rRNA gene [Identifier] in Specimen by Sequencing |
| 101552-8 | Campylobacter coli DNA [Presence] in Stool by NAA with probe detection |
| 101669-0 | Protein.monoclonal isotype [Identifier] in Urine by MS.MALDI-TOF |
| 12935-3 | Thyrotropin [Units/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 101874-6 | GABAAR IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 102123-7 | Oxygen/Gas total [Partial pressure] adjusted to patient's actual temperature in Arterial blood and Inhaled gas |
| 102741-6 | Flounder IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14455-0 | Virus identified in Pleural fluid by Culture |
| 14673-8 | Coproporphyrin 3 [Moles/volume] in Urine |
| 103727-4 | Hereditary Motor Neuropathy multigene analysis in Blood or Tissue by Molecular genetics method |
| 104398-3 | European tick borne encephalitis virus IgM Ab [Titer] in Serum by Immunoassay |
| 15417-9 | Service comment 26 |
| 1617-0 | Prolactin [Mass/volume] in Serum or Plasma --3 hours post dose L-dopa PO |
| 16211-5 | Dihydrocodeine [Presence] in Urine by Confirmatory method |
| 16298-2 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 16438-4 | Benzaldehyde [Presence] in Urine |
| 16722-1 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 12206-9 | Cryoglobulin [Presence] in Serum by 6 day cold incubation |
| 16935-9 | Hepatitis B virus surface Ab [Units/volume] in Serum |
| 17524-0 | Reticulin IgG Ab [Titer] in Serum by Immunofluorescence |
| 17725-3 | Treponema pallidum Ab [Units/volume] in Serum by Latex agglutination |
| 18290-7 | Erythrocytes [Morphology] in Synovial fluid by Light microscopy |
| 748-4 | Myelocytes [#/volume] in Blood by Manual count |
| 92490-2 | little e Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 92683-2 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA panel - Genital specimen by NAA with probe detection |
| 75142-0 | Adenosine [Moles/volume] in Serum or Plasma |
| 61183-0 | Myeloperoxidase cells/100 cells in Blood |
| 93411-7 | COMT gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
| 6142-4 | Hornet venom IgE Ab [Units/volume] in Serum |
| 6228-1 | Red top grass IgE Ab [Units/volume] in Serum |
| 77110-5 | KARS gene full mutation analysis in Blood or Tissue by Sequencing |
| 77139-4 | Sodium [Moles/volume] in Serum, Plasma or Blood |
| 93940-5 | D Ag [Presence] on Red Blood Cells --during infancy |
| 94255-7 | Calcium [Mass/volume] in Sweat |
| 62484-1 | Herpes virus 6B DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 63325-5 | Ribosomal IgG Ab [Titer] in Serum by Immunoassay |
| 94415-7 | OPRM1 gene c.118A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 95277-0 | GJB1 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 9543-0 | Legionella pneumophila 1 Ag [Presence] in Urine by Radioimmunoassay (RIA) |
| 79574-0 | Folate and tryptophan and metabolites pattern [Interpretation] in Cerebral spinal fluid Narrative |
| 96475-9 | Rho GTPase-activating protein 26 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 6817-1 | Histoplasma capsulatum yeast phase Ab [Presence] in Serum |
| 96526-9 | Onyong-nyong virus IgM Ab [Presence] in Specimen by Immunoassay |
| 9662-8 | HIV 1 gp41 Ab [Presence] in Serum by Immunoblot |
| 69884-5 | Service comment 57 |
| 7036-7 | Nitrofurantoin [Susceptibility] by Gradient strip |
| 7107-6 | Aspergillus sp IgG Ab [Units/volume] in Serum |
| 7112-6 | Banana IgG Ab [Units/volume] in Serum |
| 71624-1 | Lymphocytes/Leukocytes [Pure number fraction] in Synovial fluid by Manual count |
| 82389-8 | 3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab [Presence] in Serum by Line blot |
| 98960-8 | Dehydroaripiprazole [Presence] in Urine by Confirmatory method |
| 85498-4 | Carbapenem resistance blaIMP gene [Presence] by Molecular method |
| 85579-1 | PRRSV European strain ORF5 gene [Presence] in Specimen by NAA with probe detection |
| 72809-7 | JWH-018 carboxylated (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
| 86110-4 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum by Immunoassay |
| 73516-7 | Atenolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73880-7 | Cortisone free [Moles/volume] in 24 hour Urine |
| 74101-7 | Tissue inhibitor of metalloproteinases 1 [Mass/volume] in Serum or Plasma by Immunoassay |
| 88725-7 | MDA5 Ab [Units/volume] in Serum by Line blot |
| 88975-8 | Fatty casts [#/area] in Urine sediment |
| 41618-0 | HLA Ab [Presence] in Serum by Flow cytometry (FC) |
| 60207-8 | Vanadium [Mass/mass] in Tissue |
| 60289-6 | Brompheniramine [Moles/volume] in Specimen |
| 31551-5 | Parainfluenza virus 2 IgM Ab [Units/volume] in Serum |
| 2227-7 | Enteropeptidase [Enzymatic activity/volume] in Plasma |
| 31626-5 | Sjogrens syndrome-B extractable nuclear IgG Ab [Presence] in Serum |
| 31666-1 | Sulfate-3-Glucuronyl paragloboside IgM Ab [Units/volume] in Serum |
| 31802-2 | Duck enteritis virus Ag [Presence] in Specimen |
| 31884-0 | Measles virus Ag [Presence] in Throat |
| 32034-1 | Polymorphonuclear cells [Presence] in Cerebral spinal fluid by Wright stain |
| 51609-6 | Xylose [Moles/volume] in Blood --30 minutes post XXX challenge |
| 43368-0 | Microsatellite instability [Identifier] in Tissue by Molecular genetics method Nominal |
| 22370-1 | Japanese encephalitis virus Ab [Presence] in Serum |
| 32543-1 | Creatinine [Molar amount] in Urine collected for unspecified duration |
| 5324-9 | Rickettsia typhi IgG Ab [Titer] in Serum by Immunofluorescence |
| 3389-4 | Benzodiazepines [Presence] in Serum or Plasma |
| 33987-9 | Heparin cofactor II actual/normal in Platelet poor plasma by Chromogenic method |
| 54209-2 | Hemoglobin C - Harlem/Hemoglobin.total in Blood |
| 46411-5 | Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose arginine |
| 24313-9 | Hepatitis 1996 panel - Serum |
| 24403-8 | Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid by Immunoblot |
| 3433-0 | carBAMazepine free [Mass/volume] in Serum or Plasma |
| 34475-4 | CD4+CD45RO+ cells [#/volume] in Blood |
| 55552-4 | Methylphenidate [Moles/volume] in Serum or Plasma |
| 55577-1 | Salicylamide [Moles/volume] in Serum or Plasma |
| 35323-5 | Protein [Mass/volume] in Body fluid --1st specimen post Sincalide |
| 56122-5 | IgG [Mass/volume] in Cord blood |
| 47801-6 | Valine/Amino acids.total in Cerebral spinal fluid |
| 25866-5 | Leptospira borgpetersenii sv Sejroe Ab [Titer] in Serum |
| 56196-9 | Blueberry IgG4 Ab [Mass/volume] in Serum |
| 56387-4 | Sheep Sorrel IgG4 Ab [Mass/volume] in Serum |
| 56482-3 | Insulin [Units/volume] in Serum or Plasma --baseline |
| 5697-8 | Molybdenum [Mass/mass] in Hair |
| 56978-0 | Serotonin [Mass/volume] in 24 hour Urine |
| 4849-6 | HLA-Cw11 [Presence] |
| 49221-5 | Catalase [Enzymatic activity/mass] in Red Blood Cells |
| 38749-8 | P-nitrobiphenyl [Mass/volume] in Air |
| 38919-7 | LITAF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 28592-4 | Beta aminoadipate/Creatinine [Ratio] in Urine |
| 29417-3 | Parainfluenza virus 1 Ab [Titer] in Body fluid |
| 58385-6 | Meperidine+Normeperidine [Presence] in Urine by Screen method |
| 58585-1 | Corticotropin [Moles/volume] in Plasma --30 minutes post dose insulin IV |
| 50039-7 | 5-Methyltetrahydrofolate/Folate in Serum or Plasma |
| 2981-9 | Taurine [Mass/volume] in Serum or Plasma |
| 40543-1 | Leukocytes other/100 leukocytes in Bronchial specimen by Manual count |
| 40602-5 | Alpha 1 antitrypsin [Presence] in Urine by Immunoelectrophoresis |
| 59220-4 | Chromogranin A [Units/volume] in Pleural fluid |
| 59291-5 | Levamisole [Mass/volume] in Blood |
| 30008-7 | Blood group antibody screen [Titer] in Serum or Plasma by Albumin technique |
| 40758-5 | Coxsackievirus A Ab [Titer] in Cerebral spinal fluid |
| 19462-1 | Ethylmorphine [Presence] in Urine by Screen method |
| 1993-5 | Calcium renal clearance in 24 hour Urine and Serum or Plasma |
| 101004-0 | Monkeypox virus lineage [Type] in Specimen by Sequencing |
| 13205-0 | Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 1322-7 | Transfusion volume |
| 1692-3 | 5-Hydroxyindoleacetate [Mass/volume] in Cerebral spinal fluid |
| 17482-1 | Procainamide [Mass/volume] in Urine |
| 17568-7 | Sarcosine [Presence] in Urine |
| 17570-3 | SCL-70 extractable nuclear IgG Ab [Presence] in Serum by Immunoassay |
| 17908-5 | Bacteria # 6 identified in Tissue by Aerobe culture |
| 18312-9 | Platelet satellitism [Presence] in Blood by Light microscopy |
| 18421-8 | Fusarium oxysporum IgG Ab [Units/volume] in Serum |
| 74824-4 | Powassan virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 92742-6 | Iron.microscopic observation [Identifier] in Bronchoalveolar lavage by Potassium ferrocyanide stain |
| 75654-4 | Manual differential comment [Interpretation] in Cerebral spinal fluid Narrative |
| 92859-8 | Chlamydophila pneumoniae and Mycoplasma pneumoniae DNA panel - Lower respiratory specimen by NAA with probe detection |
| 93494-3 | Buprenorphine [Presence] in Urine by Screen method |
| 61427-1 | Nortriptyline [Presence] in Urine by Confirmatory method |
| 6224-0 | Rat epithelium IgE Ab [Units/volume] in Serum |
| 93735-9 | Creatinine [Moles/volume] in 5 hour Urine |
| 94006-4 | Sodium [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin |
| 7845-1 | Taenia solium larva IgA Ab [Presence] in Serum |
| 94631-9 | Haemophilus somnus DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 79493-3 | 3-Hydroxysuberate.unsaturated [Moles/volume] in Serum or Plasma |
| 95168-1 | Avian infectious laryngotracheitis virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 7968-1 | Mumps virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 80376-7 | Rotavirus and Adenovirus Ag panel - Stool by Rapid immunoassay |
| 95687-0 | Chikungunya virus IgM Ab [Presence] in Specimen by Immunoassay |
| 95780-3 | TFEB gene rearrangements in Tissue by FISH |
| 68549-5 | U2 small nuclear ribonucleoprotein Ab [Presence] in Serum |
| 80621-6 | Zika virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test |
| 96623-4 | HLA-C unresolved alleles [Type] by High resolution |
| 96685-3 | Clot formation and Platelet function.glass bead induced post heparin neutralization panel - Blood by Microviscometry |
| 82171-0 | Parainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 70240-7 | Testosterone Free [Moles/volume] in Serum or Plasma by Detection limit <= 3.47 pmol/L |
| 71659-7 | Monocytes/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
| 82555-4 | Food Allergen Mix 6 (Buckwheat+Rice+Sesame seed+Wheat+Corn) IgE Ab [Units/volume] in Serum by Multidisk |
| 98106-8 | Brain-derived neurotrophic factor [Mass/volume] in Serum or Plasma |
| 71882-5 | Methemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial blood |
| 86193-0 | Pentedrone [Mass/volume] in Urine by Confirmatory method |
| 73069-7 | Allopurinol induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73407-9 | Donepezil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73723-9 | Riboflavin [Moles/volume] in Blood |
| 88114-4 | Leukocytes [Presence] in Cerebral spinal fluid by Gram stain |
| 88153-2 | Microscopic observation [Identifier] in Bone marrow by Acid fast stain |
| 41189-2 | Xylose [Mass/volume] in Serum or Plasma --fasting |
| 59787-2 | Catecholamines [Moles/volume] in Plasma |
| 3115-3 | Uroporphyrinogen III synthase [Enzymatic activity/volume] in Plasma |
| 4228-3 | Disopyramide [Mass] of Dose |
| 60082-5 | Gold [Mass/volume] in Red Blood Cells |
| 60148-4 | Pentane [Mass/volume] in Urine |
| 60221-9 | Intrinsic factor IgG Ab [Units/volume] in Serum |
| 31227-2 | Asialoganglioside GM1 IgM Ab [Units/volume] in Serum |
| 31359-3 | Echovirus 9 Ab [Units/volume] in Body fluid |
| 51149-3 | CD3+CD16+CD56+ blasts/100 blasts in Bone marrow |
| 51454-7 | Epstein Barr virus early diffuse Ab [Presence] in Cerebral spinal fluid |
| 43203-9 | Parainfluenza virus 1 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 22110-1 | Bartonella henselae IgG Ab [Titer] in Serum |
| 3202-9 | Coagulation factor VII+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 43238-5 | Treponema pallidum Ab [Presence] in Serum from Donor by Immunofluorescence |
| 43731-9 | Alkaline phosphatase.fetal+lung+lymphocyte [Presence] in Serum or Plasma |
| 22363-6 | HTLV I+II Ab [Units/volume] in Serum |
| 32273-5 | Threonine [Moles/volume] in Body fluid |
| 32369-1 | Clostridium perfringens enterotoxin [Identifier] in Specimen |
| 32514-2 | CD3+CD25+ cells/100 cells in Specimen |
| 32522-5 | CD13+CD33+ cells/100 cells in Specimen |
| 5300-9 | Rheumatoid factor [Titer] in Serum by Sheep Cell Agglutination |
| 23092-0 | Equine herpesvirus 4 Ag [Presence] in Specimen by Immunofluorescence |
| 32675-1 | Cytomegalovirus [Presence] in Bronchial specimen by Organism specific culture |
| 53109-5 | Docosenoate (C22:1)/Creatinine [Molar ratio] in Urine |
| 53401-6 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Octanoylcarnitine (C8) [Molar ratio] in DBS |
| 44815-9 | Brucella abortus IgM Ab [Units/volume] in Serum by Immunofluorescence |
| 33468-0 | West Nile virus Ab [Presence] in Specimen |
| 53543-5 | Dodeicosanoylcarnitine (C22) [Moles/volume] in DBS |
| 53583-1 | Echovirus IgM Ab [Units/volume] in Serum by Immunoassay |
| 53592-2 | Gamma 2 globulin.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis |
| 45175-7 | HIV nucleoside reverse transcriptase gene mutations detected [Identifier] |
| 54090-6 | Thyroid newborn screening panel |
| 54370-2 | Chloride [Mass/volume] in Body fluid |
| 55527-6 | buPROPion [Moles/volume] in Serum or Plasma |
| 25093-6 | Decadienediate/Creatinine [Molar ratio] in Urine |
| 25367-4 | cefTRIAXone [Susceptibility] by Method for Slow-growing mycobacteria |
| 25451-6 | Isoniazid [Moles/volume] in Serum or Plasma |
| 55740-5 | Cefotiam hexetil [Susceptibility] by Gradient strip |
| 25596-8 | Fosfomycin [Susceptibility] |
| 25720-4 | Lutropin [Units/volume] in Serum or Plasma --30 minutes post 100 ug luteinizing releasing hormone IV |
| 25853-3 | 1-Methylhistidine [Moles/volume] in 24 hour Urine |
| 25911-9 | Ethanolamine/Creatinine [Molar ratio] in 24 hour Urine |
| 35754-1 | Avilamycin [Susceptibility] by Disk diffusion (KB) |
| 47932-9 | Somatotropin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 47934-5 | Somatotropin [Units/volume] in Serum or Plasma --pre dose betaxolol+glucagon |
| 3748-1 | Meperidine [Mass/time] in 24 hour Urine |
| 3762-2 | Mesterolone [Mass/volume] in Urine |
| 56736-2 | Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 48354-5 | ARIPiprazole [Moles/volume] in Serum or Plasma |
| 57613-2 | 5-Alpha tetrahydrocortisol [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
| 49108-4 | Titanium [Mass/volume] in Specimen |
| 27260-9 | Schistosoma sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 3925-5 | PENTobarbital [Presence] in Urine |
| 49345-2 | BK virus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
| 49559-8 | TAU 4 Ag [Presence] in Tissue by Immune stain |
| 29292-0 | Hydrogen sulfide [Mass/volume] in Blood |
| 29322-5 | Rickettsia typhi IgM Ab [Presence] in Body fluid |
| 39783-6 | Urea/Creatinine [Molar ratio] in Serum or Plasma |
| 29960-2 | Ganglioside GM1 IgM Ab [Mass/volume] in Serum by Immunoassay |
| 40473-1 | Thermoactinomyces vulgaris 1 Ab [Presence] in Serum |
| 58855-8 | Somatotropin [Mass/volume] in Serum or Plasma --13th specimen |
| 3003-1 | Thiocyanate [Presence] in Serum or Plasma |
| 30112-7 | Amphetamine [Mass/volume] in Serum or Plasma |
| 30235-6 | 3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Serum or Plasma |
| 3040-3 | Lipase [Enzymatic activity/volume] in Serum or Plasma |
| 40793-2 | Alkaline phosphatase.placental [Presence] in Serum or Plasma |
| 40796-5 | Alkaline phosphatase.liver 1 [Presence] in Serum or Plasma |
| 40955-7 | Yersinia enterocolitica O:9 Ab [Titer] in Serum by Complement fixation |
| 19613-9 | Naltrexone cutoff [Mass/volume] in Urine for Confirmatory method |
| 20950-2 | Bovine rotavirus Ag [Presence] in Tissue by Immunofluorescence |
| 12996-5 | Dichlorodifluoroethane [Mass/volume] in Blood |
| 101979-3 | Cortisol post arginine stimulation panel - Serum or Plasma |
| 10248-3 | Oxygen content in Superior vena cava |
| 102537-8 | Poppy Seed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14349-5 | Specific gravity of Pleural fluid by Refractometry |
| 102806-7 | Rape Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14540-9 | Measles virus Ag [Presence] in Cervix by Immunofluorescence |
| 10680-7 | Herpes simplex virus identified in Cerebral spinal fluid by Electron microscopy |
| 16135-6 | Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum |
| 1615-4 | Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
| 16215-6 | Mephobarbital [Mass/volume] in Serum or Plasma by Confirmatory method |
| 16353-5 | Amino beta guanidinopropionate [Presence] in Urine |
| 11248-2 | Pergolide [Mass/volume] in Serum or Plasma |
| 17173-6 | CD53 cells/100 cells in Blood |
| 1747-5 | Albumin [Mass/volume] in Body fluid |
| 18356-6 | Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma |
| 90922-6 | Lysophosphatidylcholine(24:0) [Mass/volume] in DBS |
| 74890-5 | Inositol Free/Creatinine [Molar ratio] in Urine |
| 92770-7 | Streptococcus pyogenes DNA [Presence] by NAA with probe detection in Positive blood culture |
| 75638-7 | Homocarnosine [Moles/volume] in Cerebral spinal fluid |
| 93397-8 | Haemophilus influenzae DNA [Presence] by NAA with probe detection in Positive blood culture |
| 94531-1 | SARS-CoV-2 (COVID-19) RNA panel - Respiratory system specimen by NAA with probe detection |
| 94752-3 | RHCE gene allele Cc [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 79409-9 | Dothiepin+nordothiepin trough and dothiepin sulfoxide panel - Serum or Plasma |
| 9546-3 | Legionella pneumophila 3 IgG Ab [Titer] in Serum by Immunofluorescence |
| 65778-3 | Arizona Cypress native (nCup a) 1 IgE Ab [Units/volume] in Serum |
| 95836-3 | CD3 cells [#] in Blood product unit |
| 67566-0 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --with normal plasma 2H post incubation separate tubes |
| 80545-7 | Posaconazole [Mass/mass] in Hair |
| 81323-8 | Urine collection associated observations panel - 24 hour Urine |
| 81800-5 | 16-Ketoandrostenediol/Creatinine [Molar ratio] in Urine |
| 85298-8 | Body structure included in specimen [Anatomy] in Specimen |
| 85485-1 | Bg sup(b) Ag [Presence] on Red Blood Cells |
| 85737-5 | Bombay phenotype [Presence] on Red Blood Cells |
| 99907-8 | Urate crystals amorphous [#/volume] in Urine sediment by Computer assisted method |
| 72609-1 | Nonsteroidal antiinflammatory drugs [Presence] in Serum or Plasma by Screen method |
| 72820-4 | 5-Hydroxyindoleacetate [Mass/volume] in Urine by Confirmatory method |
| 86542-8 | Herpes simplex virus DNA [Presence] in Tissue by NAA with probe detection |
| 73162-0 | risperiDONE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73227-1 | Oxaliplatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74300-5 | Phenylalanine/Tyrosine [Molar ratio] in DBS --post therapeutic diet |
| 88606-9 | Herpes simplex virus identified in Lower respiratory specimen by Organism specific culture |
| 88622-6 | Cytomegalovirus [Presence] in Ocular fluid by Shell vial culture |
| 88687-9 | Fungus identified in Mouth by Culture |
| 41232-0 | West Nile virus Ab [Presence] in Serum |
| 59465-5 | Pathologist review of results |
| 31032-6 | Baker's yeast IgA Ab [Units/volume] in Serum |
| 599-1 | Bacteria identified in Blood product unit by Aerobe culture |
| 60111-2 | Oxyphenbutazone [Mass/volume] in Urine |
| 21570-7 | Toxoplasma gondii IgG Ab [Presence] in Serum by Sabin dye test |
| 31537-4 | Neuronal nuclear type 1 Ab [Units/volume] in Cerebral spinal fluid |
| 42759-1 | B lymphocytes [#/volume] in Bone marrow |
| 21775-2 | t(1;13)(p36.13;q14.1)(PAX7,FOXO1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 22296-8 | Epstein Barr virus nuclear Ab [Presence] in Serum |
| 31757-8 | Canarypox virus Ag [Presence] in Serum |
| 3196-3 | Coagulation factor VII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
| 517-3 | Trimethoprim+Sulfamethoxazole [Susceptibility] by Disk diffusion (KB) |
| 51842-3 | Plasmodium falciparum IgM Ab [Titer] in Serum by Immunofluorescence |
| 32288-3 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --baseline |
| 44324-2 | Iodine.inorganic [Presence] in Serum or Plasma |
| 32690-0 | Homocysteine [Moles/time] in 24 hour Urine |
| 53174-9 | Octenoylcarnitine (C8:1) [Moles/volume] in DBS |
| 53505-4 | Asparagine/Amino acids.total in Serum or Plasma |
| 53631-8 | Alpha cortol/Creatinine [Mass Ratio] in Urine |
| 24005-1 | Chlamydia sp identified in Bronchial specimen by Organism specific culture |
| 4556-7 | Hemoglobin Abruzzo [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 24232-1 | Coxsackievirus A9 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 34360-8 | Pregnanetriol [Moles/volume] in 24 hour Urine |
| 34637-9 | 5-Methyltetrahydrofolate [Mass/volume] in Cerebral spinal fluid |
| 3470-2 | Chlorphentermine [Mass/volume] in Urine |
| 54920-4 | Jumper ant IgE Ab [Units/volume] in Serum |
| 55433-7 | Immature cells/100 leukocytes in Blood |
| 25092-8 | Cystathionine/Creatinine [Molar ratio] in Urine |
| 25262-7 | Neomycin [Mass/volume] in Specimen |
| 3482-7 | Cimetidine [Mass/volume] in Serum or Plasma |
| 35335-9 | Chymotrypsin [Enzymatic activity/volume] in Body fluid --5th specimen post Sincalide |
| 55674-6 | Ethambutol 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 5612-7 | Cadmium [Mass/time] in 24 hour Urine |
| 47513-7 | Treponema pallidum IgG Ab [Presence] in Serum from Donor |
| 25857-4 | 3-Methylhistidine/Creatinine [Molar ratio] in 24 hour Urine |
| 4801-7 | HLA-B76(15) [Presence] |
| 48168-9 | 5-Hydroxyindoleacetate [Presence] in Urine |
| 48325-5 | Glimepride [Presence] in Serum or Plasma |
| 26463-0 | Large unstained cells/100 leukocytes in Blood |
| 56700-8 | Naproxen IgE Ab [Units/volume] in Serum |
| 56761-0 | Baker's yeast Ab [Titer] in Serum by Immunofluorescence |
| 27108-0 | Oleate (C18:1w9) [Presence] in Blood |
| 49283-5 | Metanephrine and Normetanephrine [Interpretation] in Urine Narrative |
| 27375-5 | Aspergillus fumigatus Ab [Presence] in Body fluid by Immune diffusion (ID) |
| 39558-2 | West Nile virus Ab [Presence] in Cerebral spinal fluid |
| 3958-6 | Phentermine [Mass/volume] in Urine |
| 58010-0 | MSH2 gene+MLH1 gene+MSH6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 5855-2 | Herpes simplex virus Ag [Presence] in Specimen by Immunofluorescence |
| 58783-2 | Herpes simplex virus 2 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 59274-1 | Oxygen content in Arterial blood by calculation |
| 40885-6 | CD19+CD103+ cells/100 cells in Blood |
| 19182-5 | Cytokeratin 19 [Units/volume] in Serum or Plasma |
| 19372-2 | Butabarbital cutoff [Mass/volume] in Urine for Confirmatory method |
| 19673-3 | Phenothiazines cutoff [Mass/volume] in Urine for Confirmatory method |
| 19682-4 | Psilocin [Presence] in Urine by Screen method |
| 20916-3 | Organochlorine pesticides [Presence] in Tissue by Screen method |
| 100747-5 | Legionella serogroup panel - Specimen |
| 12727-4 | prednisoLONE [Mass/volume] in Serum or Plasma |
| 101585-8 | Mycobacterium avium ss paratuberculosis DNA [Cycle Threshold #] in Stool by NAA with probe detection |
| 13164-9 | Human antimouse Ab [Units/volume] in Serum |
| 102482-7 | Ovalbumin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14271-1 | Character of Synovial fluid |
| 14475-8 | Bacteria identified in Cervix by Aerobe culture |
| 10722-7 | Torovirus [Identifier] in Stool by Electron microscopy |
| 122-2 | Cefpodoxime [Susceptibility] by Serum bactericidal titer |
| 17243-7 | Prolactin [Mass/volume] in Serum or Plasma --pre XXX challenge |
| 90362-5 | Chlamydia trachomatis L1 IgG Ab [Titer] in Serum by Immunoassay |
| 90739-4 | PHH GPI-Linked WBC and RBC Ag [Interpretation] in Blood Narrative |
| 74990-3 | Alpha 1 antitrypsin [Mass/time] in 24 hour Stool |
| 92245-0 | Microorganism resistance mutation nucleic acid change by Molecular method |
| 92536-2 | Js sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 75139-6 | Urate [Moles/volume] in Cerebral spinal fluid |
| 9324-5 | Taurine [Moles/volume] in 24 hour Urine |
| 93331-7 | Glycolithocholate [Moles/volume] in Serum or Plasma |
| 61335-6 | Goat milk IgE Ab/IgE total in Serum |
| 93745-8 | HTLV I+II IgG Ab [Presence] in Cerebral spinal fluid by Line blot |
| 63321-4 | Ribosomal Ab [Titer] in Body fluid by Immunofluorescence |
| 78702-8 | Multiple drug resistant gram negative organism [Identifier] in Specimen by Culture |
| 648-6 | Microscopic observation [Identifier] in Sputum by Gram stain |
| 799-7 | Erythrocytes [#/volume] in Urine by Manual count |
| 96109-4 | Delamanid [Susceptibility] by Genotype method |
| 6783-5 | IgM [Mass/volume] in Urine by Electrophoresis |
| 8059-8 | Adrenal Ab [Units/volume] in Serum |
| 80979-8 | Frataxin [Mass/volume] in Blood |
| 96980-8 | Comment on overall fetal aneuploidy risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 81870-8 | PSEN1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 97540-9 | Oxygen [Partial pressure] in Central venous blood |
| 70287-8 | t(16;21)(p11.2;q22.3)(FUS,ERG) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 72258-7 | Malondialdehyde [Entitic substance] in Platelets |
| 84895-2 | Seminal vesicles [Presence] in Specimen |
| 85096-6 | Myoglobin casts [Presence] in Urine sediment by Light microscopy |
| 99874-0 | Superficial transitional cells [#/volume] in Urine sediment by Computer assisted method |
| 72576-2 | Prostate Specific Ag Free/Prostate specific Ag.total [Pure mass fraction] in Serum or Plasma |
| 72969-9 | Piperacillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86221-9 | Colistin resistance mcr-1 gene [Presence] by Molecular method |
| 87449-5 | Sulfur [Mass/volume] in Specimen |
| 74084-5 | Glucose [Moles/volume] in Serum or Plasma --15 minutes post 50 g lactose PO |
| 41471-4 | Phenethicillin [Mass/volume] in Serum or Plasma |
| 41475-5 | Rickettsia rickettsii IgM Ab [Presence] in Serum by Immunoassay |
| 59639-5 | clonazePAM [Mass/volume] in Body fluid by Confirmatory method |
| 30904-7 | Cobalamin (Vitamin B12) [Units/volume] in 24 hour Urine --post dose cyanocobalamin |
| 4202-8 | Crotethamide [Mass] of Dose |
| 2124-6 | Chymotrypsin [Mass/volume] in Serum or Plasma |
| 21558-2 | Thallium [Mass/volume] in 24 hour Urine |
| 31351-0 | Echovirus 30 Ab [Units/volume] in Cerebral spinal fluid |
| 51339-0 | CD45 (Lymphs) cells/100 cells in Cerebral spinal fluid |
| 22217-4 | Coxsackievirus A21 Ab [Titer] in Serum |
| 31875-8 | Measles virus Ag [Presence] in Cerebral spinal fluid |
| 31932-7 | Pneumocystis jiroveci Ag [Presence] in Blood |
| 2238-4 | Estradiol (E2) [Mass/volume] in Saliva (oral fluid) |
| 22584-7 | Toxoplasma gondii IgM Ab [Titer] in Serum |
| 22685-2 | Tyrosine/Creatinine [Molar ratio] in Urine |
| 52970-1 | CV2 Ab [Units/volume] in Cerebral spinal fluid |
| 43976-0 | Measles virus Ab [Presence] in Serum by Immunoassay |
| 22947-6 | Brucella sp Ag [Presence] in Vaginal fluid by Immunofluorescence |
| 32592-8 | Cryoprecipitate poor plasma units available [#] |
| 3272-2 | LMW Heparin [Mass/time] in 24 hour Urine |
| 331-9 | Mezlocillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 53110-3 | 5-Hydroxytryptophan/Creatinine [Molar ratio] in 24 hour Urine |
| 44456-2 | Borrelia burgdorferi Ab [Units/volume] in Serum --1st specimen |
| 44837-3 | Epinephrine+Norepinephrine [Mass/volume] in 24 hour Urine |
| 33247-8 | Weight of Sweat |
| 33482-1 | Methane/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose lactose PO |
| 44884-5 | Malignant cells [#/volume] in Pleural fluid by Manual count |
| 44989-2 | Chlamydia trachomatis D+K IgG Ab [Presence] in Serum |
| 4511-2 | Complement total hemolytic CH50 [Units/volume] in Body fluid |
| 23741-2 | Francisella tularensis Ab [Titer] in Serum by Complement fixation |
| 23771-9 | Porcine parvovirus Ag [Presence] in Tissue by Immunofluorescence |
| 23972-3 | Epstein Barr virus early IgG Ab [Titer] in Cerebral spinal fluid |
| 34153-7 | Influenza virus A Ab [Units/volume] in Specimen |
| 4571-6 | Hemoglobin D - Punjab [Units/volume] in Blood by Electrophoresis alkaline (pH 8.9) |
| 46154-1 | Trichomonas vaginalis rRNA [Presence] in Specimen by NAA with probe detection |
| 46948-6 | Dexamethasone [Mass/volume] in Urine |
| 24125-7 | Androgen free Index in Serum or Plasma |
| 34317-8 | Histamine [Moles/volume] in 24 hour Urine |
| 34598-3 | Sialate [Presence] in Urine |
| 47125-0 | Primidone [Moles/volume] in Gastric fluid |
| 47162-3 | Norepinephrine [Moles/volume] in Plasma --3 hours post 300 ug cloNIDine PO |
| 47385-0 | Netilmicin [Mass/volume] in Serum or Plasma |
| 47423-9 | Aspergillus fumigatus B Ab [Presence] in Serum |
| 2516-3 | L-iditol dehydrogenase [Enzymatic activity/volume] in Amniotic fluid |
| 3505-5 | Codeine [Presence] in Serum or Plasma |
| 56041-7 | Beta defensin [Mass/mass] in Stool.wet |
| 35723-6 | Chlamydia sp rRNA [Presence] in Serum by Probe |
| 48086-3 | 3-Hydroxytetradecadienedioate/Creatinine [Molar ratio] in Urine |
| 48236-4 | European house dust mite triggered leukotriene release [Mass/volume] by Leukocytes |
| 2658-3 | Nitrogen [Mass/volume] in Exhaled gas |
| 3805-9 | MethylePHEDrine [Mass/time] in 24 hour Urine |
| 56611-7 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 48723-1 | Epstein Barr virus Ab [Presence] in Serum by Immunofluorescence |
| 26873-0 | Valine [Moles/volume] in Amniotic fluid |
| 27070-2 | Loratadine [Mass/volume] in Serum or Plasma |
| 38524-5 | Hemoglobin F/Hemoglobin.total in Blood by Electrophoresis alkaline (pH 8.9) |
| 57407-9 | CD8+CD45RA+ cells/100 cells in Body fluid |
| 57467-3 | Calcitriol [Mass/volume] in Serum or Plasma --pre dose calcium |
| 57664-5 | Lactate dehydrogenase [Enzymatic activity/volume] in Semen |
| 49158-9 | Rickettsia akari IgG Ab [Titer] in Body fluid |
| 38668-0 | N,N-Dimethylaniline [Mass/volume] in Air |
| 3920-6 | Pentetrazol [Presence] in Urine |
| 3984-2 | Prolintane [Presence] in Urine |
| 58444-1 | Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy |
| 58667-7 | Cortisol [Moles/volume] in Saliva (oral fluid) --4 AM specimen |
| 29643-4 | Myeloperoxidase Ab [Presence] in Serum by Immunoassay |
| 4042-8 | Sulfonamide [Mass/volume] in Urine |
| 59068-7 | RPS19 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method |
| 59153-7 | Cortisol [Moles/volume] in Serum or Plasma --5 hours post XXX challenge |
| 50361-5 | Phenylpyruvate/Creatinine [Molar ratio] in 24 hour Urine |
| 30120-0 | IgD lymphocytes [#/volume] in Leukocytes |
| 30334-7 | Echovirus 30 Ab [Presence] in Serum by Complement fixation |
| 40810-4 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --baseline |
| 19477-9 | Flurazepam cutoff [Mass/volume] in Urine for Confirmatory method |
| 100870-5 | Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method |
| 12802-5 | Propiomazine [Mass/volume] in Serum or Plasma |
| 12815-7 | Progesterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 101631-0 | JAK2 gene rearrangements in Blood or Tissue by FISH |
| 12942-9 | Thyrotropin [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 13060-9 | aPTT in Platelet poor plasma by Coagulation assay --4th specimen |
| 13082-3 | Phosphatidylinositol IgG Ab [Units/volume] in Serum |
| 13230-8 | Saint Louis encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 102101-3 | Acute myeloid leukemia in Blood or Tissue by FISH |
| 102144-3 | Apple Tree IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13930-3 | Rheumatoid factor [Titer] in Synovial fluid by Agglutination |
| 102299-5 | Gum-Tree IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102396-9 | Kapok IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102956-0 | Curvularia specifera IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14601-9 | Amoxapine+8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma |
| 103829-8 | Dihydrocodeine [Presence] in Meconium |
| 16236-2 | Butabarbital [Mass/volume] in Urine by Confirmatory method |
| 10937-1 | Marjoram IgE Ab [Units/volume] in Serum |
| 11040-3 | Cortisol Free [Mass/volume] in Urine |
| 16901-1 | Gliadin IgA Ab [Presence] in Serum |
| 17216-3 | Cytoplasmic CD3 cells/100 cells in Blood |
| 18387-1 | Diamorphine [Mass/volume] in Serum or Plasma |
| 90813-7 | AMPAR2 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 91031-5 | Methamphetamine+Methylenedioxymethamphetamine [Presence] in Meconium by Screen method |
| 74850-9 | Lymphoblasts/100 cells in Lymph node by Manual count |
| 7496-3 | Cheese mold type IgG Ab [Units/volume] in Serum |
| 92141-1 | Influenza virus B RNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 60436-3 | CD19+CD25+ cells [#/volume] in Blood |
| 77019-8 | Noninvasive prenatal fetal 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing |
| 77113-9 | PLOD3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 94193-0 | CDKN1C gene full mutation analysis in Blood or Tissue by Sequencing |
| 94288-8 | Leucine-rich glioma-inactivated protein 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 62434-6 | Saint Louis encephalitis virus IgM Ab [Presence] in Body fluid by Immunofluorescence |
| 64797-4 | Oxygen content in Venous cord blood by calculation |
| 79141-8 | Cathinone [Presence] in Urine by Screen method |
| 65792-4 | Horseradish native (nArm r) HRP IgE Ab [Units/volume] in Serum |
| 96497-3 | Glycine receptor alpha-1 subunit IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 68964-6 | LAN Ag [Presence] on Red Blood Cells |
| 9685-9 | Butanol [Mass/volume] in Specimen |
| 97156-4 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Genital specimen by Probe with signal amplification |
| 69783-9 | 2-Hydroxyphenylacetate [Moles/volume] in Serum or Plasma |
| 69945-4 | Insulin-like growth factor binding protein 1 [Presence] in Vaginal fluid |
| 97249-7 | fentaNYL [Presence] in Cord tissue by Confirmatory method |
| 97929-4 | Ross River virus RNA [Presence] in Specimen by NAA with probe detection |
| 7101-9 | Aspen IgE Ab [Units/volume] in Serum |
| 99019-2 | Escherichia coli DNA [Presence] in Urine by NAA with probe detection |
| 85098-2 | Nitisinone [Moles/volume] in DBS by LC/MS/MS |
| 72607-5 | Streptococcus agalactiae [Presence] in Vag+Rectum by Organism specific culture |
| 72623-2 | inFLIXimab Ab [Mass/volume] in Serum or Plasma |
| 85836-5 | Beta-lactam resistance ESBL blaGES gene [Presence] by Molecular method |
| 73231-3 | Ondansetron induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87333-1 | Porcine circovirus type 2 ORF2 gene [Nucleotide sequence] in Isolate by Sequencing |
| 87397-6 | Clostridium perfringens cpb gene [Presence] in Isolate by NAA with probe detection |
| 87943-7 | Bacteria identified in Sinus by Anaerobe culture |
| 7395-7 | Helminthosporium sp IgE Ab [Units/volume] in Serum |
| 50709-5 | Influenza virus B Ab [Titer] in Serum by Hemagglutination inhibition |
| 50938-0 | Vancomycin [Moles/volume] in Body fluid |
| 50982-8 | Horowitz index in Blood |
| 42374-9 | Neisseria meningitidis serogroup Y Ag [Presence] in Isolate by Agglutination |
| 21122-7 | Borrelia hermsii IgM Ab [Titer] in Serum by Immunofluorescence |
| 31468-2 | Legionella pneumophila 7 Ab [Units/volume] in Serum |
| 5125-0 | Cytomegalovirus IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 22287-7 | Entamoeba histolytica IgA Ab [Units/volume] in Serum |
| 43629-5 | 8-Hydroxyamoxapine [Presence] in Serum or Plasma |
| 2247-5 | Estriol (E3).conjugated [Mass/volume] in Serum or Plasma |
| 22764-5 | Actinobacillus pleuropneumoniae Ab [Presence] in Serum by Complement fixation |
| 51972-8 | Gas panel - Venous cord blood |
| 43859-8 | Bolasterone [Presence] in Specimen |
| 44355-6 | Etiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine |
| 53294-5 | Epithelial cells.non-squamous [#/area] in Urine sediment by Automated count |
| 53490-9 | Kynurenin [Moles/volume] in Urine |
| 4444-6 | Timolol [Mass] of Dose |
| 33369-0 | Variant lymphocytes/100 leukocytes in Peritoneal fluid |
| 23768-5 | Porcine influenza virus A Ab [Titer] in Serum by Hemagglutination inhibition |
| 2399-4 | Glycosaminoglycans [Mass/volume] in Urine |
| 24100-0 | Acid sphingomyelinase [Enzymatic activity/mass] in Fibroblast |
| 3397-7 | Cocaine [Presence] in Urine |
| 54487-4 | Glucose [Moles/volume] in Water |
| 47011-2 | Calretinin Ag [Presence] in Tissue by Immune stain |
| 25499-5 | Adrenal cortex Ab [Titer] in Serum by Immunofluorescence |
| 34993-6 | Smudge cells [#/volume] in Blood |
| 35082-7 | Large granular lymphocytes [#/volume] in Blood |
| 35561-0 | Protein.monoclonal band 2 [Mass/volume] in Urine |
| 56151-4 | Candida albicans IgA Ab [Units/volume] in Serum |
| 56328-8 | Mustard IgG4 Ab [Mass/volume] in Serum |
| 26558-7 | CD11c+CD25+ cells/100 cells in Specimen |
| 3582-4 | Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma |
| 3590-7 | Enoxacin [Mass/volume] in Serum or Plasma |
| 566-0 | Cryptosporidium sp Ag [Presence] in Specimen by Immunofluorescence |
| 26919-1 | Alpha aminobutyrate/Creatinine [Molar ratio] in Urine |
| 2695-5 | Osmolality of Urine |
| 48901-3 | Orientia tsutsugamushi Kato IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 27873-9 | Insulin [Units/volume] in Serum or Plasma --fasting |
| 3895-0 | Oxymesterone [Mass/volume] in Urine |
| 39472-6 | Creatinine [Moles/volume] in 24 hour Dialysis fluid |
| 402-8 | Phenethicillin [Susceptibility] by Serum bactericidal titer |
| 58411-0 | Clinical research drug XXX [Mass/volume] in Plasma |
| 58594-3 | Corticotropin [Mass/volume] in Plasma --3 hours post dose glucagon |
| 58601-6 | Corticotropin [Moles/volume] in Plasma --3 hours post XXX challenge |
| 58660-2 | Cortisol [Moles/volume] in Saliva (oral fluid) --2nd specimen post XXX challenge |
| 4996-5 | Cytomegalovirus DNA [Presence] in Blood by NAA with probe detection |
| 50096-7 | 21-Deoxycortisol [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
| 5886-7 | Virus identified in Stool by Culture |
| 5025-2 | Mycobacterium intracellulare rRNA [Presence] in Specimen by Probe |
| 50315-1 | Cytokeratin 5 Ag [Presence] in Tissue by Immune stain |
| 50448-0 | Corticotropin [Mass/volume] in Plasma --4th specimen |
| 19631-1 | Norfluoxetine cutoff [Mass/volume] in Urine for Confirmatory method |
| 19658-4 | PENTobarbital cutoff [Mass/volume] in Urine for Confirmatory method |
| 19716-0 | Triazolam cutoff [Mass/volume] in Urine for Screen method |
| 20502-1 | Clue cells [Presence] in Vaginal fluid by Wet preparation |
| 100850-7 | Neutrophils [#/volume] in Amniotic fluid by Manual count |
| 102325-8 | Gluten IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104076-5 | Basic metabolic with hemoglobin and hematocrit panel - Blood |
| 14925-2 | traZODone [Moles/volume] in Serum or Plasma |
| 15041-7 | Coproporphyrin [Moles/time] in 24 hour Urine |
| 10995-9 | Neomycin [Mass/volume] in Serum or Plasma |
| 11030-4 | Aspergillus fumigatus+Aspergillus niger IgE Ab [Units/volume] in Serum |
| 17177-7 | CD59 cells/100 cells in Blood |
| 17796-4 | Sodium [Moles/volume] in Hyperal solution |
| 74488-8 | p63 and Smooth muscle myosin heavy chain and Cytokeratin 8 Ag [Identifier] in Tissue by Immune stain |
| 916-7 | B Ag [Presence] on Red Blood Cells |
| 75562-9 | Fetal Trisomy 21 prior risk [Likelihood] Based on maternal age Narrative |
| 75976-1 | Fetal Chromosome 21 trisomy [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative |
| 934-0 | Blood product unit ID [#] |
| 93427-3 | GABABR IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
| 6149-9 | Insulin porcine IgE Ab [Units/volume] in Serum |
| 9389-8 | Pseudoephedrine [Mass/volume] in Serum or Plasma |
| 94296-1 | Norfluvoxamine [Presence] in Serum or Plasma by Screen method |
| 94817-4 | Striated muscle Ab [Titer] in Serum by Immunoassay |
| 64133-2 | PHENobarbital/Creatinine [Mass Ratio] in Urine |
| 64422-9 | KIR gene allele 2DS3 [Presence] in Blood or Tissue by Molecular genetics method |
| 79164-0 | CES1 gene c.428G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 793-0 | Erythrocytes [#/volume] in Pleural fluid by Manual count |
| 66750-1 | Clot angle in Blood by Thromboelastography --after addition of heparinase |
| 6731-4 | Paper wasp IgG Ab [Units/volume] in Serum |
| 79567-4 | Lysophosphatidylcholine(26:0) [Moles/volume] in DBS by LC/MS/MS |
| 79674-8 | Pseudouridine [Moles/volume] in Cerebral spinal fluid |
| 67867-2 | Babesia sp identified in Specimen |
| 8140-6 | Amphetamines [Presence] in Gastric fluid |
| 96650-7 | HLA-DPB1 unresolved alleles [Type] in Donor by High resolution |
| 81746-0 | Chromosome region 17p13.1 deletion in Blood or Tissue by FISH |
| 82203-1 | Escherichia coli Stx1 and Stx2 toxin stx1+stx2 genes [Presence] in Stool by NAA with non-probe detection |
| 97653-0 | Asian Hornet IgE Ab [Units/volume] in Serum |
| 97936-9 | Candida auris DNA [Presence] in Specimen by NAA with probe detection |
| 83090-1 | Cortisol [Moles/volume] in Serum or Plasma by Immunoassay |
| 85690-6 | Rubella virus genotype in Specimen |
| 7259-5 | Cow milk triggered histamine release [Units/volume] in Blood |
| 86100-5 | Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum --1st specimen |
| 86511-3 | Adenovirus DNA [Presence] in Blood by NAA with probe detection |
| 86537-8 | Hantavirus RNA [Presence] in Tissue by NAA with probe detection |
| 87422-2 | Glucose [Mass/volume] in Blood --post meal |
| 87443-8 | Hardness [Mass/volume] of Water by Calculation |
| 4146-7 | Bumetanide [Mass] of Dose |
| 41485-4 | Coxsackievirus B Ab panel [Titer] - Serum by Complement fixation |
| 59817-7 | Uroporphyrin 1 isomer/Creatinine [Molar ratio] in 24 hour Urine |
| 59867-2 | Amoxapine [Moles/volume] in Urine |
| 50889-5 | Nitrogen [Moles/volume] in 24 hour Urine |
| 30-7 | Ampicillin [Susceptibility] by Serum bactericidal titer |
| 42191-7 | Hepatitis A and B and C 7a panel - Serum |
| 21522-8 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum |
| 31450-0 | La Crosse virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 51306-9 | CD4+CD7- cells/100 cells in Blood |
| 42979-5 | Polio virus 3 Ab [Titer] in Body fluid |
| 31790-9 | Cryptococcus sp Ag [Presence] in Serum |
| 32028-3 | Monocytes+Macrophages/100 leukocytes in Pleural fluid by Manual count |
| 51530-4 | Lactalbumin alpha IgG Ab [Presence] in Serum |
| 51788-8 | Coccidioides sp Ab [Titer] in Serum by Immune diffusion (ID) |
| 4372-9 | Oxymetholone [Mass] of Dose |
| 44033-9 | Bilirubin.total [Presence] in 24 hour Urine by Test strip |
| 444-0 | Roxithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 23108-4 | Foot and mouth disease virus Ab [Presence] in Serum by Immunoassay |
| 23169-6 | Leptospira interrogans sv Bataviae Ab [Presence] in Serum by Agglutination |
| 33577-8 | Rheumatoid factor IgM [Titer] in Serum by Nephelometry |
| 45189-8 | Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 54157-3 | RNA polymerase I Ab [Titer] in Serum by Immunofluorescence |
| 4583-1 | Hemoglobin G - Georgia [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 46722-5 | ZAP70 cells [Presence] in Blood |
| 55393-3 | Lead [Moles/mass] in Nail |
| 47160-7 | Norepinephrine [Moles/volume] in Plasma --2nd specimen post XXX challenge |
| 3531-1 | Desipramine [Mass/volume] in Serum or Plasma |
| 25599-2 | Rotavirus IgG Ab [Units/volume] in Serum |
| 25925-9 | Histamine/Creatinine [Molar ratio] in 24 hour Urine |
| 35633-7 | Propranolol [Mass/volume] in Serum or Plasma by Screen method |
| 35708-7 | Alpha 1 globulin [Mass/volume] in 24 hour Urine by Electrophoresis |
| 3573-3 | Dipipanone [Presence] in Urine |
| 35735-0 | Neisseria gonorrhoeae DNA [Presence] in Conjunctival specimen by NAA with probe detection |
| 47948-5 | Thyrotropin [Units/volume] in Serum or Plasma --15 minutes post dose luteinizing releasing hormone IV |
| 3792-9 | Methotrexate [Mass/volume] in Cerebral spinal fluid |
| 3804-2 | MethylePHEDrine [Mass/volume] in Urine |
| 48674-6 | Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal |
| 48775-1 | Lambda light chains.free [Mass/volume] in Cerebral spinal fluid |
| 38523-7 | Fibrinopeptide A [Mass/volume] in Urine |
| 57310-5 | SRY gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 49080-5 | Kanamycin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 49162-1 | Rickettsia africae IgM Ab [Titer] in Serum |
| 2726-8 | Para nitrophenol [Presence] in Urine |
| 57860-9 | Diethylamine [Moles/volume] in Specimen |
| 49426-0 | Papova virus SV 40 DNA [#/volume] (viral load) in Stool by NAA with probe detection |
| 29353-0 | 17-Ketosteroids.total neutral [Mass/time] in 12 hour Urine |
| 58469-8 | Cells [#/volume] in Body fluid |
| 29604-6 | Cytomegalovirus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
| 29810-9 | Highlands J virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 40542-3 | Rubella virus Ab [Titer] in Cerebral spinal fluid by Latex agglutination |
| 40720-5 | Hemoglobin C [Presence] in Blood |
| 50348-2 | Parvovirus B19 DNA [Presence] in Blood by NAA with probe detection |
| 50390-4 | Coagulation factor II circulating inhibitor [Presence] in Platelet poor plasma |
| 30122-6 | Aeromonas sp [Presence] in Specimen by Organism specific culture |
| 30302-4 | Stavudine [Susceptibility] |
| 30332-1 | Dodecenoylcarnitine (C12:1) [Moles/volume] in Serum or Plasma |
| 40818-7 | 11-Deoxycorticosterone [Moles/volume] in 24 hour Urine |
| 19494-4 | Hydroxyethylflurazepam [Presence] in Urine by Confirmatory method |
| 19504-0 | Methotrimeprazine cutoff [Mass/volume] in Urine for Screen method |
| 101063-6 | Co3 Ag Ab [Presence] in Serum or Plasma |
| 101253-3 | Thrombin generation test [Interpretation] in Platelet poor plasma Narrative |
| 101389-5 | GP1BA gene full mutation analysis in Blood or Tissue by Molecular genetics method |
| 13023-7 | Trichlorofluoromethane [Mass/volume] in Blood |
| 101696-3 | Chlamydia trachomatis rRNA and Neisseria gonorrhoeae rRNA and Trichomonas vaginalis RNA and Candida sp RNA panel |
| 101919-9 | Iohexol disappearance panel - Urine and Serum or Plasma |
| 101927-2 | Calbindin D28K [Mass/volume] in Urine by Immunoassay |
| 1368-0 | Corticotropin [Mass/volume] in Plasma --pre dose insulin IV |
| 13832-1 | Dimethylbenzene/Creatinine [Mass Ratio] in Urine |
| 102902-4 | Litchi IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14610-0 | Nuclear Ab [Presence] in Synovial fluid |
| 14671-2 | Coproporphyrin 3 [Moles/volume] in Serum or Plasma |
| 16100-0 | Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 10740-9 | Aluminum.microscopic observation [Identifier] in Bone by Histomorphometry stain |
| 10750-8 | Connective tissue.microscopic observation [Identifier] in Tissue by Trichrome stain.Masson |
| 16715-5 | Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunofluorescence |
| 11173-2 | Fig IgE Ab [Units/volume] in Serum |
| 11261-5 | Bacteria identified in Vaginal fluid by Aerobe culture |
| 11597-2 | Treponema pallidum Ab [Units/volume] in Serum |
| 12286-1 | Drugs identified in Urine by Screen method |
| 16812-0 | Emetine [Presence] in Serum or Plasma |
| 17798-0 | Amikacin [Mass/volume] in Cerebral spinal fluid |
| 18188-3 | Acebutolol [Mass/volume] in Specimen |
| 93473-7 | Beta hydroxythiofentanyl [Mass/volume] in Urine by Confirmatory method |
| 62374-4 | Human reference sequence assembly version |
| 63168-9 | Aspergillus amstelodami IgG Ab [Mass/volume] in Serum |
| 77926-4 | Cortisol [Moles/volume] in Serum or Plasma --3 minutes post XXX challenge |
| 7804-8 | Actinomyces sp Ab [Units/volume] in Serum |
| 94308-4 | SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N2 |
| 6345-3 | Chlamydia sp Ag [Presence] in Genital specimen by Immunoassay |
| 63560-7 | Somatotropin [Mass/volume] in Serum or Plasma --8.5 hours post XXX challenge |
| 64136-5 | Pregabalin/Creatinine [Mass Ratio] in Urine |
| 7915-2 | Heterophile Ab after guinea pig cell absorption [Titer] in Serum |
| 6576-3 | Escherichia coli verotoxin 2 [Presence] in Stool |
| 79702-7 | cis-13-Eicosenoate (cis 13 C20:1w7) [Entitic substance] in Red Blood Cells |
| 95782-9 | ABCD1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 95846-2 | Cell count and Differential panel - Sputum by Manual count |
| 96408-0 | Pancreatic polypeptide [Mass/volume] in Serum or Plasma --25M post sham feeding |
| 96457-7 | Coagulation factor X activity and inhibitor panel - Platelet poor plasma by Coagulation assay |
| 97006-1 | Maximum amplitude kaolin+tissue factor induced [Length] in Blood |
| 81874-0 | SLC12A3 gene full mutation analysis in Blood or Tissue by Sequencing |
| 82040-7 | Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 82176-9 | Respiratory syncytial virus RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 97266-1 | Methylenedioxymethamphetamine [Presence] in Cord tissue by Screen method |
| 70087-2 | Interleukin 7 [Mass/volume] in Cerebral spinal fluid |
| 70177-1 | Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Urine |
| 70242-3 | Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection |
| 82841-8 | PCNA extractable nuclear IgG Ab [Titer] in Serum by Immunofluorescence |
| 98235-5 | Wild boar meat IgE Ab [Units/volume] in Serum |
| 72675-2 | Sotalol [Mass/volume] in Serum or Plasma --trough |
| 73278-4 | Methylphenidate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 875-5 | A,B Ab [Presence] in Serum or Plasma from Blood product unit |
| 73627-2 | Ceftaroline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 73921-9 | JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Blood |
| 74005-0 | Serotonin release 0.5 IU/mL heparin.unfractionated [Units/volume] in Serum |
| 74094-4 | Gliclazide [Mass/volume] in Serum or Plasma |
| 74225-4 | Cytochemical stains in Bone marrow Narrative |
| 7430-2 | Isocyanate MDI IgE Ab [Units/volume] in Serum |
| 89515-1 | Ganglioside GT1b IgM Ab [Presence] in Serum by Line blot |
| 41266-8 | Volatiles and gases [Identifier] in Blood |
| 305-3 | Lomefloxacin [Susceptibility] by Serum bactericidal titer |
| 41765-9 | SCN1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 60058-5 | Bismuth [Mass/volume] in Red Blood Cells |
| 60288-8 | Bromazepam [Moles/volume] in Specimen |
| 21089-8 | Babesia microti DNA [Presence] in Blood by NAA with probe detection |
| 2111-3 | Choriogonadotropin.beta subunit [Moles/volume] in Serum or Plasma |
| 31239-7 | Infectious bronchitis virus Mass-41 Ab [Units/volume] in Serum |
| 51290-5 | CD30 cells/100 cells in Body fluid |
| 51505-6 | Creatine kinase.BB [Enzymatic activity/volume] in Cerebral spinal fluid by Electrophoresis |
| 51648-4 | Monocytoid cells/100 leukocytes in Cerebral spinal fluid by Manual count |
| 51798-7 | Hepatitis E virus IgM Ab [Units/volume] in Serum |
| 44341-6 | Norepinephrine/Creatinine [Mass Ratio] in 24 hour Urine |
| 22851-0 | Babesia caballi Ab [Presence] in Serum by Immunofluorescence |
| 32613-2 | Carnitine free (C0)/Carnitine.total in Urine |
| 32660-3 | 6-Thioguanine [Entitic substance] in Red Blood Cells |
| 53349-7 | Thyroxine (T4) free [Mass/volume] in DBS |
| 53476-8 | Glucose [Moles/volume] in Serum or Plasma --2 hours post dose betaxolol |
| 53488-3 | 3-O-Methyldopa [Moles/volume] in 24 hour Urine |
| 23610-9 | Sparfloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
| 53928-8 | Glucose [Mass/volume] in Serum or Plasma --20 minutes post 50 g lactose PO |
| 45001-5 | Chlamydia trachomatis IgM Ab [Units/volume] in Serum by Immunoassay |
| 23921-0 | Osmotic fragility of Red Blood Cells--0.75% sodium chloride 24 hour 37 degree C incubation |
| 33828-5 | Lutropin [Units/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 4590-6 | Hemoglobin Hasharon [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 2424-0 | Histidine [Mass/time] in 24 hour Urine |
| 24329-5 | Electrolytes 3 panel - Urine |
| 2467-9 | IgG subclass 2 [Mass/volume] in Serum |
| 34297-2 | Estrone (E1) [Moles/volume] in 24 hour Urine |
| 55252-1 | Methoxsalen 0.02 mg/mL given [Volume] |
| 55319-8 | Yeast.pseudohyphae [Presence] in Bronchial specimen by KOH preparation |
| 55525-0 | Benzoylecgonine [Moles/volume] in Serum or Plasma |
| 47230-8 | Herpes simplex virus glycoprotein G IgG Ab [Presence] in Serum |
| 25204-9 | rifAMPin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25561-2 | 11-Deoxycorticosterone [Moles/volume] in Serum or Plasma |
| 47768-7 | Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose arginine |
| 25861-6 | Arginine/Creatinine [Molar ratio] in 24 hour Urine |
| 35539-6 | Cow milk IgG Ab [Mass/volume] in Serum |
| 48400-6 | Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immunofluorescence |
| 48865-0 | Ehrlichia ewingii DNA [Presence] in Specimen by NAA with probe detection |
| 38358-8 | A Ab [Titer] in Serum or Plasma by Antihuman globulin |
| 57641-3 | Androsterone [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
| 49263-7 | Fatty acids.very long chain pattern [Interpretation] in Serum or Plasma Narrative |
| 39297-7 | Influenza virus A H10 Ab [Titer] in Serum by Hemagglutination inhibition |
| 57914-4 | Beta lactoglobulin IgE Ab/IgE total in Serum |
| 58064-7 | Jr sup(a) Ag [Presence] on Red Blood Cells |
| 49427-8 | Parvovirus B19 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 286-5 | Isoniazid [Susceptibility] by Minimum lethal concentration (MLC) |
| 29386-0 | chlorproMAZINE [Mass/volume] in Gastric fluid |
| 40046-5 | Albumin [Mass/volume] in Serum or Plasma --pre XXX challenge |
| 58485-4 | Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --baseline |
| 5848-7 | Herpes simplex virus 2 Ag [Presence] in Skin by Immunofluorescence |
| 29563-4 | La Crosse virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 29614-5 | Phenmetrazine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 4047-7 | Theophylline [Mass/volume] in Blood |
| 40479-8 | Virus identified in Body fluid by Culture |
| 4048-5 | Theophylline [Mass/volume] in Saliva (oral fluid) |
| 40627-2 | Coproporphyrin [Mass/mass] in Stool |
| 41108-2 | FGF23 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19416-7 | Tetrahydrocannabinol [Presence] in Urine by Confirmatory method |
| 20989-0 | Zinc phosphide [Mass/mass] in Specimen |
| 100903-4 | Yeast and Candida sp identification panel - Specimen by Organism specific culture |
| 13431-2 | Norepinephrine [Mass/volume] in Plasma --7th specimen post XXX challenge |
| 13596-2 | Histiocytes [Presence] in Nose by Light microscopy |
| 13873-5 | Albumin.glycated/Albumin.total in Serum or Plasma |
| 102363-9 | Helminthosporium sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102503-0 | Penicillin G IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14307-3 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 102811-7 | Sage IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14783-5 | Homovanillate [Moles/time] in 24 hour Urine |
| 1039-7 | G Ag [Presence] on Red Blood Cells from Blood product unit |
| 14889-0 | Procainamide+N-acetylprocainamide [Moles/volume] in Serum or Plasma |
| 15157-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma by Dilution |
| 15200-9 | Osmolality of Body fluid |
| 104421-3 | Legionella sp Ag [Identifier] in Urine by Immunoassay |
| 10536-1 | Dipyridamole [Mass/volume] in Serum or Plasma |
| 10689-8 | Microscopic observation [Identifier] in Nail by KOH preparation |
| 11195-5 | Rapeseed IgE Ab [Units/volume] in Serum |
| 17327-8 | Neisseria meningitidis serogroup B Ab [Units/volume] in Serum |
| 17582-8 | Silver [Mass/volume] in Dialysis fluid |
| 1811-9 | Amylase/Creatinine renal clearance [Ratio] in 24 hour Urine and Serum or Plasma |
| 18325-1 | oxyMORphone [Presence] in Urine by Confirmatory method |
| 18414-3 | Psilocin [Presence] in Urine |
| 90835-0 | Myelin associated glycoprotein IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 90977-0 | Tianeptine [Mass/volume] in Serum or Plasma |
| 75607-2 | Paternal sample received Qualitative |
| 75712-0 | Microscopic description [Description] in Endomyocardium Narrative |
| 61082-4 | Methylenedioxyethylamphetamine [Presence] in Gastric fluid |
| 77214-5 | Parotid secretory protein IgA Ab [Units/volume] in Serum by Immunoassay |
| 94227-6 | AGXT gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 78807-5 | Barium [Moles/volume] in Serum or Plasma |
| 94618-6 | Bovine respiratory syncytial virus [Presence] in Specimen by Organism specific culture |
| 94730-9 | Hypnotics [Presence] in Saliva (oral fluid) by Confirmatory method |
| 79334-9 | Hypoglycemics.oral [Presence] in Hair by Screen method |
| 79375-2 | Microscopic observation [Identifier] in Sputum by Acid fast stain.Ziehl-Neelsen--2nd specimen |
| 80161-3 | 5-beta-cholestane-3-alpha,7-alpha,12-alpha,24,25-pentol/Creatinine [Ratio] in Urine |
| 95713-4 | Western equine encephalitis virus IgA Ab [Presence] in Specimen by Immunoassay |
| 80649-7 | Tetramethylenedisulfotetramine [Mass/volume] in Urine |
| 80681-0 | Cryptosporidium parvum+hominis oocyst wall protein COWP gene [Presence] in Stool by NAA with probe detection |
| 96680-4 | Activated clotting time.diatomaceous earth induced of Blood by Microviscometry |
| 70095-5 | Prostaglandin F2 alpha [Mass/volume] in Body fluid |
| 70206-8 | Codeine [Moles/volume] in Urine by Confirmatory method |
| 98121-7 | Protein/Creatinine Qualitative in Urine by Test strip |
| 71769-4 | Marburg virus IgG Ab [Presence] in Serum by Immunoassay |
| 72395-7 | Differential panel - Vitreous fluid |
| 72585-3 | Beta globulin/Protein.total [Pure mass fraction] in Urine by Electrophoresis |
| 72597-8 | Albumin/Protein.total [Pure mass fraction] in Urine by Electrophoresis |
| 72838-6 | Herpes simplex virus DNA [Identifier] in Specimen by NAA with probe detection |
| 72-9 | Cefatrizine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 72967-3 | QUEtiapine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86012-2 | Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
| 86736-6 | Porcine parvovirus type 1 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73937-5 | Norfentanyl [Mass/volume] in Blood by Confirmatory method |
| 59888-8 | cloBAZam [Moles/volume] in Urine |
| 50717-8 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 50757-4 | Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Blood |
| 51045-3 | CD123 blasts/100 blasts in Specimen |
| 3085-8 | Urate [Mass/volume] in Synovial fluid |
| 42322-8 | Hepatitis B virus S+pol gene [Identifier] in Serum or Plasma by NAA with probe detection |
| 21497-3 | Rickettsia typhus group IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 51188-1 | CD15 Ag [Presence] in Specimen by Immune stain |
| 2220-2 | Elastase.pancreatic Free [Enzymatic activity/volume] in Serum |
| 43818-4 | Beta-2-Microglobulin [Presence] in Serum |
| 22650-6 | Glycine [Moles/volume] in Cerebral spinal fluid |
| 32290-9 | Acetone [Presence] in Specimen |
| 43922-4 | Beta endorphin [Presence] in Serum or Plasma |
| 23053-2 | Echinococcus sp Ag [Presence] in Stool by Immunoassay |
| 3324-1 | aMILoride [Mass/volume] in Urine |
| 53379-4 | HIV 1 Ab [Presence] in Specimen |
| 23420-3 | Salmonella abortus ovis Ab [Presence] in Serum by Complement fixation |
| 23426-0 | Salmonella gallinarum Ab [Presence] in Blood by Agglutination |
| 33523-2 | Platelet aggregation ristocetin induced in Platelet rich plasma --Low dose |
| 53503-9 | Iron [Moles/mass] in Specimen |
| 45265-6 | Immunodeficiency markers [Interpretation] in Specimen Narrative |
| 23855-0 | Echinococcus granulosus IgE Ab [Units/volume] in Serum |
| 33916-8 | Trans-3-Hydroxycotinine [Mass/volume] in Urine |
| 3404-1 | Bolasterone [Mass/time] in 24 hour Urine |
| 46957-7 | Triamcinolone [Mass/volume] in Urine |
| 47424-7 | Aspergillus fumigatus H Ab [Presence] in Serum |
| 47845-3 | Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight |
| 25929-1 | Homocystine/Creatinine [Molar ratio] in 24 hour Urine |
| 35643-6 | Collagen type 2 Ab [Presence] in Serum by Immunoassay |
| 3576-6 | Disopyramide [Mass/volume] in Serum or Plasma |
| 56254-6 | Egg yolk IgG4 Ab [Mass/volume] in Serum |
| 26470-5 | Leukocytes other [#/volume] in Cerebral spinal fluid |
| 26515-7 | Platelets [#/volume] in Blood |
| 26698-1 | Listeria monocytogenes IgG Ab [Units/volume] in Serum |
| 27030-6 | Myelin associated glycoprotein IgM Ab [Units/volume] in Cerebral spinal fluid |
| 27056-1 | Citrulline [Moles/volume] in Urine |
| 57647-0 | C peptide [Moles/volume] in Serum or Plasma --3.3 hours post XXX challenge |
| 49210-8 | Bartonella bacilliformis IgG Ab [Titer] in Body fluid |
| 39559-0 | Legionella sp IgM Ab [Titer] in Serum |
| 49551-5 | Creatine kinase.MB [Mass/volume] in Blood |
| 58759-2 | Echovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 49835-2 | CD19+IgD+ cells/100 cells in Specimen |
| 58935-8 | Yersinia pseudotuberculosis Ab [Presence] in Serum by Agglutination |
| 3020-5 | Thyroxine binding globulin [Mass/volume] in Blood |
| 19279-9 | Benzodiazepines tested for in Urine by Screen method Nominal |
| 19341-7 | Amobarbital cutoff [Mass/volume] in Urine for Screen method |
| 12726-6 | Leucine-enkephalin [Units/volume] in Serum or Plasma |
| 101381-2 | BAP1 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 101524-7 | Mycoplasma hyopneumoniae [Titer] in Specimen |
| 13410-6 | Phosphoethanolamine [Mass/volume] in Amniotic fluid |
| 13934-5 | Butanol [Mass/volume] in Blood |
| 14124-2 | Bacteria [Presence] in Semen by Light microscopy |
| 102749-9 | Grape IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102993-3 | Mouse epithelium, serum proteins + urine proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14573-0 | 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine |
| 14646-4 | Cholesterol in HDL [Moles/volume] in Serum or Plasma |
| 10399-4 | I Ag [Presence] on Red Blood Cells from Donor |
| 15054-0 | Dehydroepiandrosterone (DHEA) [Moles/volume] in Serum or Plasma |
| 15436-9 | Avian encephalomyelitis virus Ab [Presence] in Serum by Immunoassay |
| 10728-4 | Trichomonas sp identified in Genital specimen by Organism specific culture |
| 16563-9 | Cathepsin D in Serum or Plasma |
| 17511-7 | Red dye IgE Ab [Units/volume] in Serum |
| 17960-6 | Bacteria # 3 identified in Peritoneal fluid by Culture |
| 91104-0 | aPTT.factor sensitive with 1:1 Pooled Normal Plasma in Platelet poor plasma by Coagulation assay |
| 74899-6 | Lactulose/Mannitol [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO |
| 91857-3 | Herpes simplex virus DNA [Presence] in Genital specimen by NAA with probe detection |
| 92501-6 | Jk sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 75107-3 | Pentadecanoate [Entitic substance] in Red Blood Cells |
| 75602-3 | Fetal 1p36 deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
| 76768-1 | Hemoglobin [Mass/volume] in Mixed venous blood by Oximetry |
| 62389-2 | Chromosome analysis master panel |
| 77368-9 | HIV 1 proviral DNA [Presence] in Semen by NAA with probe detection |
| 63095-4 | Honeydew melon IgG Ab [Mass/volume] in Serum |
| 63172-1 | Mucor plumbeus IgG Ab [Mass/volume] in Serum |
| 94642-6 | SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection |
| 95410-7 | SARS-CoV-2 (COVID-19) neutralizing antibody [Titer] in Serum by pVNT |
| 95604-5 | AMPAR1 Ab [Titer] in Serum by Cell binding immunofluorescent assay |
| 96267-0 | Delta aPTT W excess hexagonal phospholipid [Time] in Platelet poor plasma by Coagulation assay |
| 80542-4 | Norcitalopram [Mass/volume] in DBS |
| 80725-5 | Trichomonas sp [Presence] in Semen by Light microscopy |
| 96698-6 | Rate of fibrin formation.kaolin induced [Units] in Blood by Microviscometry |
| 96895-8 | SARS-CoV-2 (COVID-19) lineage [Identifier] in Specimen by Molecular genetics method |
| 69789-6 | 2-methyl-3-hydroxybutyrate (C5-OH) [Moles/volume] in Serum or Plasma |
| 97530-0 | Naegleria fowleri Ab [Presence] in Specimen by Immunofluorescence |
| 99098-6 | Blastomyces dermatitidis IgG Ab [Units/volume] in Serum by Immunoassay |
| 72316-3 | RNA polymerase III RP155 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 85486-9 | Bg sup(c) Ag [Presence] on Red Blood Cells |
| 99924-3 | Artifact [Presence] in Urine sediment by Computer assisted method |
| 73074-7 | Acetaminophen induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87631-8 | Mexacarbate [Mass/mass] in Specimen |
| 87712-6 | Rotavirus A VP7 gene [Nucleotide sequence] in Isolate by Sequencing |
| 73420-2 | Dicyclomine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73715-5 | Occupational Allergen Mix 1 (Chicken feather+Cow dander+Goose feather+Horse dander) IgE Ab [Units/volume] in Serum by Multidisk |
| 87822-3 | Naltrexone [Presence] in Saliva (oral fluid) by Screen method |
| 88376-9 | Gamithromycin [Susceptibility] by Disk diffusion (KB) |
| 88537-6 | Enterovirus identified in Pericardial fluid by Organism specific culture |
| 41201-5 | Voltage-gated calcium channel IgG Ab [Moles/volume] in Serum |
| 41669-3 | Cefamandole [Susceptibility] by Gradient strip |
| 59620-5 | chlordiazePOXIDE [Mass/volume] in Body fluid by Confirmatory method |
| 59685-8 | Hydroxyethylflurazepam [Mass/volume] in Body fluid by Confirmatory method |
| 30500-3 | Phosphatidylserine IgA Ab [Presence] in Serum |
| 31106-8 | Osmotic fragility of Red Blood Cells--0.50% sodium chloride 24 hour 37 degree C incubation |
| 31166-2 | Methyl isoamyl ketone [Mass/volume] in Urine |
| 42608-0 | CD10+CD20+ cells/100 cells in Bone marrow |
| 314-5 | Meclocycline [Susceptibility] by Minimum lethal concentration (MLC) |
| 42785-6 | FGFR1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 43098-3 | Yersinia sp Ab panel - Serum |
| 31770-1 | Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid |
| 51653-4 | Hepatitis E virus Ab [Presence] in Body fluid |
| 51662-5 | Core respiratory allergens panel - Serum |
| 43718-6 | Prostatic acid phosphatase [Presence] in Serum |
| 32183-6 | Hydroxyproline Free [Moles/volume] in Urine |
| 32218-0 | Cyclic citrullinated peptide Ab [Units/volume] in Serum by Immunoassay |
| 3241-7 | Coagulation factor XIII coagulum dissolution at 24 hours [Presence] in Platelet poor plasma by Coagulation assay |
| 3255-7 | Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay |
| 52120-3 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --with normal plasma 1H post incubation separate tubes |
| 32657-9 | Aflatoxin IgA Ab [Units/volume] in Serum or Plasma |
| 23641-4 | Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 33492-0 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose lactose PO |
| 53947-8 | Escherichia coli Stx1 and Stx2 toxin stx1 and stx2 and H7 flagellar fliC genes [Identifier] in Specimen by NAA with probe detection |
| 33925-9 | PCA-2 Ab [Titer] in Serum |
| 33968-9 | SARS coronavirus Urbani Ab [Presence] in Serum by Immunoassay |
| 34180-0 | Ethanol [Presence] in Urine by Confirmatory method |
| 54232-4 | Metabolic panel.large animal - Serum or Plasma |
| 4572-4 | Hemoglobin Denver [Presence] in Blood |
| 24147-1 | Epidermal Allergen Mix A (Chicken feather+Duck feather+Goose feather) IgE Ab [Units/volume] in Serum by Multidisk |
| 2430-7 | Homocystine [Mass/volume] in Serum or Plasma |
| 34473-9 | Neutrophils.vacuolated+Segmented [Presence] in Blood |
| 34594-2 | Schistosoma sp Ab [Titer] in Serum |
| 47263-9 | Adenosine monophosphate.cyclic [Moles/volume] in Urine --3rd specimen post XXX challenge |
| 25466-4 | Manganese [Moles/volume] in Blood |
| 35016-5 | Myelocytes [#/volume] in Body fluid |
| 355-8 | Neomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 35628-7 | Norverapamil [Presence] in Serum or Plasma by Screen method |
| 47958-4 | FLT3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 26455-6 | Erythrocytes [#/volume] in Body fluid |
| 26498-6 | Myelocytes/100 leukocytes in Blood |
| 57001-0 | Yersinia sp IgA Ab [Units/volume] in Serum by Immunoassay |
| 38259-8 | Cells Counted Total [#] in Peritoneal fluid |
| 57337-8 | Citrate [Mass/volume] in 12 hour Urine |
| 57363-4 | Lactate [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge |
| 49155-5 | Rickettsia akari IgM Ab [Titer] in Serum |
| 27414-2 | Fungus identified in Stool by Culture |
| 27949-7 | Lactate [Mass/volume] in Blood --4 hours post XXX challenge |
| 28008-1 | Cytomegalovirus DNA [Presence] in Blood by Probe with signal amplification |
| 57724-7 | Newborn screening short narrative summary |
| 49389-0 | Herpes virus 6 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
| 49500-2 | Calcium oxalate dihydrate/Total in Stone by Infrared spectroscopy |
| 49502-8 | Glucose-6-Phosphate dehydrogenase [Entitic Catalytic Activity] in Blood |
| 49683-6 | ERBB2 gene copy number/Chromosome 17 copy number in Tissue by FISH |
| 4973-4 | HLA-DR6 [Presence] |
| 29344-9 | LORazepam [Mass/volume] in Gastric fluid |
| 40193-5 | Glucose [Moles/volume] in Serum or Plasma --pre-meal |
| 49893-1 | Somatotropin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 49904-6 | Histoplasma capsulatum M Ab [Presence] in Cerebral spinal fluid |
| 40358-4 | Desipramine [Presence] in Gastric fluid |
| 40733-8 | HIV 1+2 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 59246-9 | Palmitoyl protein thioesterase [Enzymatic activity/volume] in DBS |
| 50421-7 | Cortisol [Mass/volume] in Serum or Plasma --pre 100 ug CRH IV |
| 1970-3 | Bilirubin.delta [Mass/volume] in Serum or Plasma |
| 20769-6 | Coliform bacteria [#/volume] in Water by Viability count |
| 101356-4 | Borrelia afzelii+burgdorferi+garinii Ab [Interpretation] in Serum by IA.MTTT |
| 101543-7 | Tumor necrosis factor ligand superfamily member 10 [Mass/volume] in Serum, Plasma or Blood |
| 101649-2 | Tau protein [Mass/volume] in Cerebral spinal fluid by Immunoassay |
| 101743-3 | PML Ab [Presence] in Serum |
| 102057-7 | Sphingolipid panel - Serum |
| 13700-0 | 5-Oxoproline/Creatinine [Mass Ratio] in Urine |
| 102248-2 | Coffee IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102381-1 | Horse serum proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102605-3 | Spruce IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102625-1 | Tea IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13975-8 | Alpha 2 globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
| 14184-6 | Atropine [Presence] in Urine |
| 14229-9 | P53 protein Ag [Presence] in Tissue by Immune stain |
| 102934-7 | Lactalbumin alpha IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14504-5 | Human papilloma virus 16+18 Ag [Presence] in Vaginal fluid |
| 15025-0 | Amylase S3/Amylase.total in Serum or Plasma |
| 16455-8 | Beta hydroxybutyrate [Moles/volume] in Cerebral spinal fluid |
| 17006-8 | IgA subclass 2 [Mass/volume] in Cerebral spinal fluid |
| 17716-2 | Toxoplasma gondii IgE Ab [Units/volume] in Serum |
| 75090-1 | Isocitrate [Moles/volume] in Serum or Plasma |
| 75590-0 | Fetal Angelman syndrome risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
| 76582-6 | Streptococcus agalactiae cfb gene [Presence] in Swab specimen by NAA with probe detection |
| 7673-7 | Rye triggered histamine release [Units/volume] in Blood |
| 61317-4 | Spinach IgE Ab/IgE total in Serum |
| 77031-3 | t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript in Blood or Tissue by FISH |
| 94202-9 | GRHPR gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
| 95159-0 | Avian metapneumovirus Ab/Positive control in Serum by Immunoassay |
| 95597-1 | Gelatinous bodies [Presence] in Semen by Microscopy |
| 6626-6 | Schistosoma japonicum Ab [Titer] in Serum by Complement fixation |
| 79528-6 | 5-Hydroxymethyl-2-Furoate [Moles/volume] in Serum or Plasma |
| 96665-5 | HLA-DRB1 [Type] in Donor |
| 9696-6 | 8-Hydroxyloxapine [Mass/volume] in Serum or Plasma |
| 69819-1 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --6 days post dose ifosfamide |
| 97597-9 | CD19 cells/100 lymphocytes in Lower respiratory specimen by Flow cytometry (FC) |
| 82377-3 | Ledipasvir [Susceptibility] by Genotype method |
| 98263-7 | Vaginal involvement [Presence] in Endometrial cancer specimen |
| 86317-5 | Influenza virus A H1 2009 pandemic RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73146-3 | Sotalol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87769-6 | tiaGABine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 88442-9 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --40 minutes post dose lactose PO |
| 88553-3 | Scedosporium prolificans DNA [Presence] in Isolate by NAA with probe detection |
| 73955-7 | UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Blood |
| 74352-6 | Cryoglobulin and cryofibrinogen panel - Serum and Plasma |
| 41433-4 | Cryptosporidium hominis DNA [Presence] in Specimen by NAA with probe detection |
| 50692-3 | Parainfluenza virus 1+2+3 Ab [Titer] in Serum by Complement fixation |
| 42220-4 | Chromium/Creatinine [Molar ratio] in Urine |
| 60167-4 | Platinum [Mass/volume] in Red Blood Cells |
| 51179-0 | CD36+CD235a+ blasts/100 blasts in Bone marrow |
| 31729-7 | Bladder tumor Ag [Presence] in Urine |
| 5189-6 | Hepatitis B virus e Ab [Units/volume] in Serum by Immunoassay |
| 22352-9 | Histoplasma capsulatum IgM Ab [Presence] in Serum |
| 22609-2 | Escherichia coli verotoxin 2 Ab [Titer] in Stool |
| 32143-0 | Triple phosphate/Total in Stone |
| 32223-0 | Alpha aminobutyrate [Moles/volume] in Body fluid |
| 52874-5 | CD1a cells/100 cells in Bone marrow |
| 4402-4 | Pindolol [Mass] of Dose |
| 23140-7 | Infectious bursal disease virus Ab [Titer] in Serum by Immune diffusion (ID) |
| 23151-4 | Leishmania reaction wheal [Diameter] --3 days post 0.1 mL leishmanin intradermal |
| 32823-7 | Columnar cells/100 cells in Bronchial specimen |
| 24073-9 | Beta-N-acetylhexosaminidase.B [Enzymatic activity/mass] in Leukocytes |
| 33973-9 | SARS coronavirus Urbani Ab [Units/volume] in Serum |
| 54079-9 | Galactosemia newborn screening panel |
| 54451-0 | CYP2C9 and VKORC1 [Interpretation] in Blood or Tissue by Molecular genetics method Narrative |
| 24222-2 | Parainfluenza virus 3 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 55178-8 | Calcium phosphate crystals [Presence] in Specimen by Light microscopy |
| 55199-4 | Cells karyotyped.total [#] in Blood or Tissue |
| 55231-5 | Electrolytes panel - Blood |
| 55372-7 | Hemoglobin Constant Spring/Hemoglobin.total in Blood |
| 3490-0 | Clofibrate [Mass/volume] in Serum or Plasma |
| 34996-9 | Promyelocytes [#/volume] in Body fluid |
| 5589-7 | Barium [Mass/volume] in Serum or Plasma |
| 25684-2 | Lambda light chains [Mass/time] in 24 hour Urine |
| 35589-1 | Furoate/Creatinine [Mass Ratio] in Urine |
| 35604-8 | Cyclobenzaprine [Mass/volume] in Serum or Plasma by Screen method |
| 378-0 | Oleandomycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 5668-9 | Isopropanol [Presence] in Serum or Plasma |
| 2716-9 | Fractional oxyhemoglobin in Venous blood |
| 38257-2 | Cells Counted Total [#] in Bone marrow |
| 49029-2 | Cortisol Free/Cortisone free [Mass Ratio] in Urine |
| 27386-2 | Blastomyces dermatitidis Ab [Presence] in Body fluid by Immune diffusion (ID) |
| 3908-1 | Pemoline [Presence] in Urine |
| 39475-9 | dimenhyDRINATE [Moles/volume] in Serum or Plasma |
| 2935-5 | Serine [Presence] in Serum or Plasma |
| 40114-1 | Creatinine [Moles/volume] in Serum or Plasma --1 hour pre XXX challenge |
| 40121-6 | Creatinine [Moles/volume] in Serum or Plasma --9 hours post XXX challenge |
| 29641-8 | Neutrophil Cytoplasmic Ab atypical [Presence] in Serum by Immunofluorescence |
| 40419-4 | Amphetamine+Methamphetamine [Presence] in Urine |
| 40519-1 | Histiocytes/100 cells in Pleural fluid by Manual count |
| 40610-8 | Beta-2 transferrin [Presence] in Cerebral spinal fluid |
| 59042-2 | TCR gamma delta cells/100 cells in Tissue |
| 59135-4 | Benzylpiperazine [Mass/volume] in Urine by Confirmatory method |
| 50391-2 | PTT circulating inhibitor [Presence] in Platelet poor plasma |
| 40912-8 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 41077-9 | NOTCH3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19572-7 | Methylenedioxymethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
| 12366-1 | Disopyramide [Presence] in Urine |
| 12525-2 | Norepinephrine [Mass/volume] in Plasma --1 hour post XXX challenge |
| 12916-3 | Porphobilinogen synthase [Enzymatic activity/volume] in Blood |
| 101155-0 | Alpha hydroxyetizolam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 101314-3 | 17-Hydroxypregnenolone and 17-Hydroxyprogesterone p corticotropin stim panel - Serum or Plasma |
| 102124-5 | Sesamum indicum 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102280-5 | Dill IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102848-9 | Yogurt IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103676-3 | Soluble triggering receptor expressed on myeloid cells-1 [Mass/volume] in Serum or Plasma by Immunoassay |
| 14885-8 | Pregnanediol [Moles/time] in 24 hour Urine |
| 1567-7 | Insulin [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO |
| 16411-1 | Aspartate [Presence] in Urine |
| 16653-8 | Corticotropin Canine [Mass/volume] in Plasma |
| 11200-3 | Escargot IgE Ab [Units/volume] in Serum |
| 12290-3 | Procyclidine [Presence] in Urine |
| 17461-5 | Phosphoserine [Presence] in Serum or Plasma |
| 90042-3 | Borrelia sp DNA [Presence] in Tick by NAA with probe detection |
| 91044-8 | oxyCODONE+oxyMORphone [Presence] in Body fluid by Screen method |
| 91795-5 | Respiratory syncytial virus A RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 92129-6 | Bordetella parapertussis DNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 92733-5 | Glecaprevir [Susceptibility] by Genotype method |
| 75578-5 | Fetal 22q11.2 deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
| 76068-6 | MBL2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 92838-2 | Satellite nodules [Presence] in Skin melanoma |
| 93771-4 | Calprotectin [Mass/volume] in Synovial fluid |
| 77765-6 | Citalopram+Escitalopram [Mass/volume] in Urine by Confirmatory method |
| 63413-9 | Thyroid colloidal Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 6384-2 | Dengue virus Ag [Presence] in Serum by Immunofluorescence |
| 64089-6 | Cells counted [#] in Chorionic villus sample by Molecular genetics method |
| 6430-3 | HIV identified in Semen by Organism specific culture |
| 96110-2 | Ethionamide [Susceptibility] by Genotype method |
| 96118-5 | SARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay |
| 67814-4 | Granulocytic cells/100 cells in Bone marrow by Manual count |
| 80591-1 | Influenza virus B NS gene [Presence] in Nasopharynx by NAA with probe detection |
| 69489-3 | VHL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 97585-4 | Carboxy tetrahydrocannabinol [Presence] in Cord tissue by Confirmatory method |
| 70172-2 | Neisseria meningitidis serogroup [Identifier] in Specimen |
| 82473-0 | Borrelia mayonii oppA1 gene [Presence] in Blood by NAA with non-probe detection |
| 82939-0 | Genetic variant details in Blood or Tissue by Molecular genetics method Narrative |
| 99048-1 | Metanephrine Free [Moles/volume] in Urine |
| 99118-2 | Sandfly fever Sicilian virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 72491-4 | Bile acid [Moles/volume] in Stool |
| 86056-9 | Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum --2nd specimen |
| 72994-7 | Methylphenidate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73002-8 | Lisinopril induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87439-6 | Zika virus IgA+IgG+IgM Ab [Interpretation] in Specimen Qualitative by Immunoassay |
| 7348-6 | Grape IgG Ab [Units/volume] in Serum |
| 73719-7 | Soybean native (nGly m) 5 IgE Ab [Units/volume] in Serum |
| 74337-7 | MICA*012 IgG Ab [Presence] in Serum |
| 88875-0 | Measles virus genotype A vaccine strain N gene [Presence] in Specimen by NAA with probe detection |
| 88892-5 | Meropenem+Vaborbactam [Susceptibility] |
| 5932-9 | Cholesterol [Presence] in Blood by Test strip |
| 59468-9 | MCH [Entitic substance] |
| 50886-1 | Nickel [Moles/mass] in Tissue |
| 30920-3 | Copper [Mass/volume] in Urine collected for unspecified duration |
| 60145-0 | Pentane [Mass/volume] in Body fluid |
| 60231-8 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose fructose PO |
| 43121-3 | Echovirus 6 Ab [Presence] in Serum |
| 3182-3 | Cardiolipin IgM Ab [Units/volume] in Serum by Immunoassay |
| 2266-5 | Etiocholanolone [Presence] in Urine |
| 3256-5 | Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
| 43850-7 | Coccidioides sp IgM Ab [Presence] in Serum by Immunoassay |
| 43880-4 | Bordetella pertussis filamentous hemagglutinin IgA Ab [Presence] in Serum |
| 44014-9 | Porphyrins [Interpretation] in Urine |
| 22808-0 | Infectious bronchitis virus [Presence] in Specimen by Electron microscopy |
| 22875-9 | Border disease virus Ab [Units/volume] in Serum by Immunoassay |
| 32713-0 | Potassium [Moles/volume] in Arterial blood |
| 5310-8 | Rickettsia spotted fever group Ab [Presence] in Serum by Latex agglutination |
| 23613-3 | Imipenem [Susceptibility] by Method for Slow-growing mycobacteria |
| 33693-3 | Yersinia pestis [Presence] in Isolate by Phage lysis |
| 2365-5 | Glutamate [Mass/volume] in Urine |
| 24096-0 | N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Leukocytes |
| 33904-4 | Neisseria gonorrhoeae rRNA [Presence] in Conjunctival specimen by Probe |
| 46155-8 | Ascaris lumbricoides adult IgG Ab [Units/volume] in Serum |
| 46412-3 | Somatotropin [Mass/volume] in Serum or Plasma --105 minutes post dose arginine |
| 46954-4 | Methylprednisolone [Mass/volume] in Urine |
| 24136-4 | Black Walnut IgG Ab [Units/volume] in Serum |
| 24512-6 | Tree Allergen Mix C (Berry juniper+Oneseed juniper+Rocky mountain juniper) IgE Ab [Units/volume] in Serum by Multidisk |
| 47152-4 | EPINEPHrine [Moles/volume] in Urine --7th specimen post XXX challenge |
| 47238-1 | Treponema pallidum IgG Ab [Presence] in Serum by Immunoassay |
| 2527-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Amniotic fluid |
| 35337-5 | Chymotrypsin [Enzymatic activity/volume] in Body fluid --3rd specimen post Sincalide |
| 35640-2 | CD5 cells/100 cells in Bone marrow |
| 5620-0 | Chromium [Mass/mass] in Hair |
| 48045-9 | Magnesium cutoff [Mass/mass] in Stool |
| 26603-1 | Asparagine [Moles/volume] in Cerebral spinal fluid |
| 26639-5 | Leishmania tropica Ab [Presence] in Serum |
| 26700-5 | Amino beta guanidinopropionate [Moles/time] in 24 hour Urine |
| 3629-3 | Fenetylline [Mass/time] in 24 hour Urine |
| 56589-5 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 48498-0 | Amyloid A [Mass/volume] in Serum or Plasma |
| 26851-6 | LORazepam [Mass/volume] in Vitreous fluid |
| 38558-3 | Spermatozoa.midpiece Motile w IgG/100 spermatozoa in Semen by Immunobead |
| 57336-0 | Beta hydroxybutyrate [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 2788-8 | Phosphoenolpyruvate carboxykinase [Enzymatic activity/volume] in Serum |
| 38931-2 | TRPS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 3915-6 | Pentazocine [Presence] in Serum or Plasma |
| 57776-7 | Gliadin peptide IgA and IgG panel - Serum |
| 29416-5 | Adenovirus Ab [Titer] in Body fluid |
| 29508-9 | 3-Hydroxyadipate/Creatinine [Molar ratio] in Urine |
| 39972-5 | Creatinine [Mass/volume] in Serum or Plasma --16 hours post XXX challenge |
| 40092-9 | Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --2 hours post XXX challenge |
| 40235-4 | Calcium [Moles/volume] in Serum or Plasma --5 hours post XXX challenge |
| 58797-2 | Yersinia enterocolitica Ab [Titer] in Serum by Complement fixation |
| 49913-7 | Legionella pneumophila IgG Ab [Presence] in Serum |
| 49958-2 | Somatotropin [Units/volume] in Serum or Plasma --6 AM specimen |
| 49992-1 | Borrelia burgdorferi 18/20kD IgG Ab [Presence] in Serum by Immunoblot |
| 29928-9 | Titanium [Mass/volume] in 24 hour Urine |
| 40550-6 | Hemoglobin H [Mass/volume] in Blood by Electrophoresis |
| 40698-3 | Mycoplasma sp identified in Specimen |
| 59035-6 | CD54 cells/100 cells in Body fluid |
| 50517-2 | Prolactin [Mass/volume] in Serum or Plasma --1st specimen |
| 41006-8 | Human coronavirus NL63 IgG Ab [Presence] in Serum by Immunoassay |
| 19298-9 | Opiates positive [Identifier] in Urine by Confirmatory method |
| 19585-9 | Midazolam [Presence] in Urine by Screen method |
| 12521-1 | Catecholamines [Mass/volume] in Urine --7th specimen post XXX challenge |
| 102154-2 | Aspergillus niger IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102627-7 | Saltwort IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102634-3 | Trichophyton sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14188-7 | Omeprazole [Mass/volume] in Serum or Plasma |
| 14329-7 | Mucus [Presence] in Sputum by Light microscopy |
| 14345-3 | Specific gravity of Amniotic fluid by Refractometry |
| 102886-9 | Seminal fluid IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14581-3 | Acetaminophen [Moles/volume] in Serum or Plasma |
| 14700-9 | diphenhydrAMINE+dimenhyDRINATE [Presence] in Serum or Plasma |
| 14949-2 | Vasopressin [Moles/volume] in Plasma |
| 14970-8 | Estrone (E1).bioavailable [Mass/volume] in Serum or Plasma |
| 10626-0 | Spermatozoa Slow/100 spermatozoa in Semen |
| 10810-0 | Microscopic observation [Identifier] in Tissue by Silver stain.Fontana-Masson |
| 16443-4 | Benzonatate [Mass/volume] in Serum |
| 16502-7 | C peptide [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 16695-9 | Cobalamin (Vitamin B12) [Mass/volume] in Blood |
| 16969-8 | Histone H2a+H2b Ab [Units/volume] in Serum by Immunofluorescence |
| 16986-2 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose glucose |
| 17130-6 | CD29 cells/100 cells in Blood |
| 17384-9 | Opiates [Mass/volume] in Urine by Confirmatory method |
| 17510-9 | Raisin IgE Ab [Units/volume] in Serum |
| 17745-1 | Trimellitic anhydride (TMA) IgM Ab [Units/volume] in Serum |
| 1810-1 | Amylase/Creatinine [Mass Ratio] in Serum or Plasma |
| 18481-2 | Streptococcus pyogenes Ag [Presence] in Throat |
| 92007-4 | T-cell receptor excision circle [Z-score] in DBS |
| 75645-2 | Butabarbital [Mass/volume] in Blood by Confirmatory method |
| 76030-6 | IDS gene full mutation analysis in Blood or Tissue by Sequencing |
| 9340-1 | Apolipoprotein B/Apolipoprotein A-I [Percentile] |
| 61214-3 | Common Ragweed IgE Ab/IgE total in Serum |
| 77495-0 | Bacillus cereus [Presence] in Specimen by Organism specific culture |
| 63197-8 | Weed Allergen Mix 5 (Common ragweed+Mugwort+Ox-eye daisy+Dandelion+Goldenrod) IgE Ab [Units/volume] in Serum by Multidisk |
| 63208-3 | Mugwort IgG Ab [Mass/volume] in Serum |
| 63228-1 | DNA double strand IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 94389-4 | Neuronal nuclear type 1 IgG Ab [Presence] in Serum by Line blot |
| 7945-9 | Lassa virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 9547-1 | Legionella pneumophila 3 IgM Ab [Titer] in Serum by Immunofluorescence |
| 79649-0 | Homocysteine cysteine disulfide/Creatinine [Molar ratio] in Urine |
| 80180-3 | S-adenosylmethionine and S-adenosylhomocystine pattern [Interpretation] in Cerebral spinal fluid Narrative |
| 8047-3 | Varicella zoster virus IgG Ab [Units/volume] in Serum |
| 8048-1 | Varicella zoster virus IgM Ab [Units/volume] in Serum |
| 96505-3 | Colorado tick fever virus IgM Ab [Presence] in Specimen by Immunoassay |
| 6812-2 | Dengue virus IgM Ab [Titer] in Serum |
| 6886-6 | IgA subclass 1 [Mass/volume] in Serum |
| 80614-1 | Baclofen [Moles/volume] in Specimen |
| 81149-7 | Zika virus envelope E gene [Presence] in Amniotic fluid by NAA with probe detection |
| 96556-6 | HIV 1 and 2 RNA [Identifier] in Serum or Plasma by NAA with probe detection |
| 96565-7 | sp100 Ab [Units/volume] in Serum by Immunoassay |
| 9713-9 | Shigella dysenteriae Ab [Titer] in Serum by Complement fixation |
| 81882-3 | TSC2 and PKD1 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
| 71616-7 | Neutrophils/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
| 82382-3 | Sofosbuvir [Susceptibility] by Genotype method |
| 98959-0 | Aspergillus fumigatus [Presence] in Isolate by MS.MALDI-TOF |
| 83057-0 | PD-L1 by clone SP142 [Presence] in Tissue by Immune stain |
| 72726-3 | t(4;14)(p16;q32)(FGFR3,IGH) fusion transcript [Identifier] in Blood or Tissue by FISH Nominal |
| 87497-4 | Meperidine [Presence] in Serum, Plasma or Blood by Screen method |
| 87585-6 | Virginiamycin [Mass/mass] in Specimen |
| 87599-7 | Florfenicol [Mass/mass] in Specimen |
| 87659-9 | Parathion [Mass/mass] in Specimen |
| 73466-5 | Ceftizoxime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73538-1 | Allopurinol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74281-7 | Mycobacterium tuberculosis stimulated gamma interferon and spot count panel - Blood |
| 74384-9 | Specimen container [Type] |
| 89965-8 | Trifluoperazine [Presence] in Urine by Screen method |
| 50827-5 | Boron [Moles/volume] in Body fluid |
| 30529-2 | Hexacarboxylporphyrin [Presence] in Urine |
| 42614-8 | Colorado tick fever virus Ab [Titer] in Cerebral spinal fluid |
| 21530-1 | Volume of 10 hour Urine |
| 51091-7 | Cytoplasmic CD179a blasts/100 blasts in Specimen |
| 22118-4 | Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid |
| 51711-0 | Leishmania sp Ab [Presence] in Body fluid |
| 22726-4 | Creatinine [Moles/volume] in Specimen |
| 5223-3 | HIV 1+2 Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 4397-6 | Phenylbutazone [Mass] of Dose |
| 22929-4 | Brucella canis Ab [Presence] in Serum by Immune diffusion (ID) |
| 44500-7 | Herpes simplex virus 2 Ag [Presence] in Cervix |
| 44654-2 | Tissue involved by tumor in Prostate tumor |
| 44858-9 | Bacteria # 6 identified in Specimen by Anaerobe culture |
| 23498-9 | Transmissible gastroenteritis virus RNA [Presence] in Specimen by Probe |
| 33630-5 | HIV protease gene mutations detected [Identifier] |
| 53854-6 | CPS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 45048-6 | Cortisol [Moles/volume] in Serum or Plasma --12 PM specimen |
| 33798-0 | Creatinine [Moles/time] in 2 hour Urine |
| 33815-2 | Insulin [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 54334-8 | Stearoylcarnitine (C18) [Moles/volume] in Cerebral spinal fluid |
| 4550-0 | Hemoglobin A2 [Moles/volume] in Blood by Chromatography column |
| 46083-2 | Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay |
| 24201-6 | Saint Louis encephalitis virus Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 24249-5 | Adenovirus Ab [Titer] in Serum --1st specimen |
| 34303-8 | Etiocholanolone/Creatinine [Molar ratio] in Urine |
| 34543-9 | Bilirubin direct and total panel [Mass/volume] - Serum or Plasma |
| 25249-4 | Clindamycin [Mass/volume] in Specimen |
| 55860-1 | Glucose [Mass/time] in 24 hour Stool |
| 25758-4 | Insulin-like growth factor [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 47952-7 | Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post dose luteinizing releasing hormone IV |
| 48279-4 | Propyphenazone triggered leukotriene release [Mass/volume] by Leukocytes |
| 2606-2 | Melanin [Presence] in Urine |
| 2616-1 | Methemoglobin/Hemoglobin.total in Capillary blood |
| 26512-4 | Neutrophils/100 leukocytes in Cerebral spinal fluid |
| 37425-6 | Abnormal Prion Protein [Presence] in Brain by Immunoassay |
| 56631-5 | Brucella sp IgM Ab [Units/volume] in Serum by Immunoassay |
| 27021-5 | Neisseria gonorrhoeae Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 38302-6 | Endrin [Mass/volume] in Water |
| 57567-0 | 25-hydroxyvitamin D3 [Moles/volume] in Serum or Plasma --2 hours post dose calcium |
| 49139-9 | California encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 49181-1 | Echinococcus granulosus Ab [Titer] in Serum |
| 49260-3 | Cryoglobulin IgA and IgG and IgM [Interpretation] in Serum Narrative |
| 57843-5 | Erythrocytes [#/volume] in Peritoneal fluid by Automated count |
| 49405-4 | Herpes virus 8 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
| 28641-9 | Bicarbonate [Moles/volume] in Venous cord blood |
| 28652-6 | Heparinoid [Units/volume] in Platelet poor plasma by Chromogenic method |
| 40262-8 | Glucose [Mass/volume] in Serum or Plasma --3 minutes pre XXX challenge |
| 58481-3 | Protein C Ag/Coagulation factor IX Ag [Mass Ratio] in Platelet poor plasma by Immunoassay |
| 58533-1 | Corticotropin [Moles/volume] in Plasma --10 AM specimen |
| 49932-7 | 3-Hydroxysuberate.unsaturated/Creatinine [Molar ratio] in Urine |
| 29576-6 | Bacterial susceptibility panel |
| 29997-4 | Basement membrane IgG Ab [Units/volume] in Serum by Immunoassay |
| 30075-6 | Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection |
| 30315-6 | Acid alpha glucosidase [Enzymatic activity/mass] in Small intestine Tissue |
| 40835-1 | Strawberry IgG Ab [Mass/volume] in Serum |
| 20567-4 | Ferritin [Mass/volume] in Serum or Plasma by Immunoassay |
| 126-3 | Cefprozil [Susceptibility] by Serum bactericidal titer |
| 101191-5 | 5F-MDMB-PICA/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 101453-9 | Neurochondrin Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 13233-2 | Coxsackievirus A2 Ab [Units/volume] in Cerebral spinal fluid |
| 13355-3 | Unspecified cells/100 leukocytes in Body fluid by Manual count |
| 102139-3 | Anchovy IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102169-0 | Red Kidney Bean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102276-3 | Deer epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102385-2 | House dust Hausstaub IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 1404-3 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
| 14532-6 | Rubella virus Ag [Presence] in Penis by Immunofluorescence |
| 103542-7 | Tubular reabsorption of phosphorus/Glomerular filtration rate [Mass/volume] in Urine and Serum or Plasma |
| 14878-3 | Phosphate [Presence] in Stone |
| 10804-3 | Microscopic observation [Identifier] in Tissue by Reticulin stain |
| 11037-9 | Alpha-N-acetylgalactosaminidase [Enzymatic activity/volume] in Serum or Plasma |
| 16637-1 | Coccidioides immitis IgE Ab [Units/volume] in Serum |
| 12238-2 | Neutrophils/100 leukocytes in Body fluid by Manual count |
| 17713-9 | Topiramate [Mass/volume] in Serum or Plasma |
| 17834-3 | Eosinophils/100 leukocytes in Synovial fluid |
| 1794-7 | Amylase [Enzymatic activity/volume] in Duodenal fluid |
| 18857-3 | Almecillin [Susceptibility] |
| 19052-0 | Borrelia burgdorferi DNA [Presence] in Urine by Probe with amplification |
| 74878-0 | Carnitine free (C0) [Moles/volume] in DBS --post therapeutic diet |
| 91868-0 | Bordetella parapertussis DNA [Presence] in Throat by NAA with probe detection |
| 75632-0 | Resistin [Mass/volume] in Serum or Plasma |
| 76020-7 | Delta dRVVT [Time] in Platelet poor plasma by Coagulation assay |
| 6192-9 | Olive Pollen IgE Ab [Units/volume] in Serum |
| 77121-2 | DFNB31 gene full mutation analysis in Blood or Tissue by Sequencing |
| 77631-0 | VAPB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 94224-3 | RET gene full mutation analysis in Blood or Tissue by Sequencing |
| 63089-7 | Parmesan Cheese IgG Ab [Mass/volume] in Serum |
| 63097-0 | Cottonseed IgG Ab [Mass/volume] in Serum |
| 63201-8 | Red Beet IgG Ab [Mass/volume] in Serum |
| 77959-5 | Yellow fever virus ns5 gene [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
| 78360-5 | Acyl CoA dehydrogenases [Enzymatic activity/mass] in Fibroblast by [9,10-3H] myristate substrate |
| 6442-8 | Influenza virus A+B+C Ag [Presence] in Specimen by Immunofluorescence |
| 95097-2 | Glucagon [Mass/volume] in Serum or Plasma --30 min post meal |
| 95209-3 | SARS-CoV+SARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory system specimen by Rapid immunoassay |
| 95575-7 | 17 Alpha-hydroxypregnanolone [Z-score] in 24 hour Urine |
| 65352-7 | Proinsulin [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 68465-4 | Insulin [Units/volume] in Serum or Plasma --1.75 hours post XXX challenge |
| 69031-3 | Enterocyte IgA Ab [Presence] in Serum |
| 96533-5 | Bwamba virus IgM Ab [Presence] in Specimen by Immunoassay |
| 96589-7 | Cholesterol.total/Cholesterol in HDL [Mass Ratio] in DBS |
| 81854-2 | CYP21A2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 70161-5 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Urine by NAA with probe detection |
| 70864-4 | Rabies virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 98124-1 | Neutrophil.PMA stimulated DHR panel by Flow cytometry (FC) |
| 99057-2 | SLC12A1 gene full mutation analysis in Blood by Molecular genetics method |
| 83082-8 | Cancer Ag 125 [Units/volume] in Serum or Plasma by Immunoassay |
| 83124-8 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma by Immunoassay |
| 99121-6 | Rift valley fever virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 72853-5 | Maribavir [Susceptibility] by Genotype method |
| 85809-2 | Bordetella pertussis and parapertussis and holmesii DNA panel - Specimen by NAA with probe detection |
| 86011-4 | Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum --1st specimen |
| 73123-2 | Terazosin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88230-8 | Mycoplasma genitalium DNA [Presence] in Throat by NAA with probe detection |
| 41513-3 | HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 400 copies/mL |
| 51007-3 | Direct antiglobulin test.unspecified reagent [Presence] on Red Blood Cells --after transfusion |
| 41761-8 | lamoTRIgine [Mass/volume] in Serum or Plasma by Screen method |
| 4235-8 | Enoxacin [Mass] of Dose |
| 59919-1 | lamoTRIgine [Moles/volume] in Urine |
| 59992-8 | Testosterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 60163-3 | Phenolphthalein [Mass/volume] in Serum or Plasma |
| 3149-2 | Oxygen [Partial pressure] in Inhaled gas |
| 51087-5 | CD16 blasts/100 blasts in Blood |
| 51163-4 | CD34 blasts/100 blasts in Specimen |
| 51351-5 | CD57 cells/100 cells in Body fluid |
| 42774-0 | Multiple drug resistant organism identified in Wound |
| 31702-4 | West Nile virus IgG Ab [Presence] in Specimen |
| 51792-0 | Citrate/Creatinine [Mass Ratio] in Urine collected for unspecified duration |
| 43689-9 | HLA-DQ2 and HLA-DQ8 [Interpretation] |
| 22351-1 | Histoplasma capsulatum IgG Ab [Units/volume] in Serum |
| 22586-2 | Treponema pallidum Ab [Presence] in Cerebral spinal fluid |
| 22651-4 | Lysine [Moles/volume] in Cerebral spinal fluid |
| 32115-8 | Theophylline [Moles/volume] in Serum or Plasma --peak |
| 32119-0 | Valproate Free [Moles/volume] in Serum or Plasma |
| 52819-0 | Nucleated cells [#/volume] in Pleural fluid by Automated count |
| 52877-8 | Cytoplasmic CD22 cells/100 cells in Blood |
| 43970-3 | CD3+CD4+ (T4 helper) cells/100 cells in Cerebral spinal fluid |
| 44084-2 | Fatty acids pattern [Interpretation] in Serum or Plasma |
| 22908-8 | Bovine herpesvirus 1 Ag [Units/volume] in Specimen by Neutralization test |
| 22943-5 | Brucella sp Ag [Presence] in Placenta by Immunofluorescence |
| 32816-1 | Microscopic observation [Identifier] in Specimen by Terminal deoxynucleotidyl transferase stain |
| 53286-1 | WBC casts [#/volume] in Urine by Computer assisted method |
| 53479-2 | Dihydroxycholestanoate [Moles/volume] in Serum or Plasma |
| 44841-5 | Bacteria # 2 identified in Specimen by Culture |
| 23278-5 | Mycoplasma gallisepticum Ag [Presence] in Specimen by Neutralization test |
| 33493-8 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose lactose PO |
| 33512-5 | Color of Specimen |
| 33578-6 | Dengue virus Ab [Titer] in Serum by Immunofluorescence |
| 4506-2 | Complement C5a [Mass/volume] in Plasma |
| 23781-8 | Swine influenza virus Ag [Presence] in Tissue by Immunofluorescence |
| 24086-1 | Heparan-N-sulfatase [Enzymatic activity/mass] in Leukocytes |
| 33917-6 | Nornicotine [Mass/volume] in Urine |
| 542-1 | Mycobacterium sp identified in Wound by Organism specific culture |
| 54415-5 | Transfuse leukocyte-poor platelets units [#] |
| 54419-7 | Whole blood pediatric units given [#] |
| 46097-2 | Time corticotropin given |
| 46424-8 | Hemolysis interference index of Serum or Plasma |
| 2418-2 | Histidine [Presence] in Blood |
| 34333-5 | Lutropin [Units/volume] in 24 hour Urine by 1st IRP |
| 344-2 | Moxalactam [Susceptibility] by Disk diffusion (KB) |
| 55313-1 | Yeast [Presence] in Vaginal fluid by KOH preparation |
| 47302-5 | Food Allergen Mix 7 (Onion+Garlic+Celery+Tomato+Yeast) IgE Ab [Units/volume] in Serum by Multidisk |
| 34891-2 | Salmonella enteritidis [Presence] in Specimen by Organism specific culture |
| 34970-4 | Ultrasound date |
| 25893-9 | Cysteine/Creatinine [Molar ratio] in 24 hour Urine |
| 56203-3 | Cabbage IgG4 Ab [Mass/volume] in Serum |
| 47940-2 | Testosterone [Mass/volume] in Serum or Plasma --12 hours post 5000 U HCG IM |
| 26735-1 | Rhodococcus equi Ab [Presence] in Serum by Immune diffusion (ID) |
| 56755-2 | Aldosterone [Mass/volume] in Serum or Plasma --100 minutes post XXX challenge |
| 56887-3 | Myoglobin [Moles/volume] in Serum or Plasma |
| 26996-9 | Complement C7 [Units/volume] in Serum or Plasma |
| 3855-4 | Nikethamide [Presence] in Urine |
| 4903-1 | HLA-Dw26 [Presence] |
| 49141-5 | California encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 49144-9 | Saint Louis encephalitis virus IgM Ab [Presence] in Body fluid |
| 49215-7 | PKHD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 49246-2 | Alpha-1-Fetoprotein interpretation in Serum or Plasma Narrative |
| 27403-5 | Gamma glutamyl transferase [Enzymatic activity/volume] in Urine |
| 38706-8 | Chloromethane [Mass/volume] in Air |
| 29281-3 | Glutathione reductase [Presence] in Red Blood Cells |
| 29789-5 | La Crosse virus IgG Ab [Presence] in Specimen by Immunofluorescence |
| 50378-9 | von Willebrand factor (vWf).collagen binding activity/von Willebrand factor Ag [Ratio] in Platelet poor plasma by Immunoassay |
| 50501-6 | Insulin [Units/volume] in Serum or Plasma --1st specimen |
| 40890-6 | CD25+CD19+ cells/100 cells in Body fluid |
| 19250-0 | Lipoprotein.alpha [Mass/volume] in Pleural fluid |
| 19718-6 | Trichlorothiazide [Presence] in Urine by Screen method |
| 210-5 | Cyclacillin [Susceptibility] by Disk diffusion (KB) |
| 101074-3 | CEVF Ab [Presence] in Serum or Plasma |
| 101205-3 | Plasmodium sp IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 101483-6 | cefTAZidime+Avibactam [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 101674-0 | OXA-48-like carbapenemase [Presence] in Isolate by Rapid immunoassay |
| 13204-3 | Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 101912-4 | Troponin T.cardiac delta [Mass concentration difference] in 2 hour Serum or Plasma |
| 102240-9 | Cladosporium herbarum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102327-4 | Goat epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102346-4 | Wild rye grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102930-5 | Cladosporium herbarum IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104269-6 | V gene rearrangement [Identifier] in Specimen by Molecular genetics method Nominal |
| 1094-2 | K Ag [Presence] on Red Blood Cells from Blood product unit |
| 11275-5 | Large granular lymphocytes/100 leukocytes in Blood by Manual count |
| 178-4 | Chlortetracycline [Susceptibility] by Disk diffusion (KB) |
| 1872-1 | Apolipoprotein B-150 [Mass/volume] in Serum or Plasma |
| 90271-8 | Bacteria identified in Pericardial fluid by Aerobe culture |
| 90851-7 | GJB2 gene full mutation analysis in Blood or Tissue by Sequencing |
| 91059-6 | Kingella kingae DNA [Presence] in Blood by NAA with probe detection |
| 74640-4 | Monoclonal band 3 observed [Identifier] in Serum or Plasma by Immunofixation |
| 92512-3 | Co sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 75390-5 | APP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 75756-7 | Bacteria identified in Isolate by MS.MALDI-TOF |
| 92815-0 | Borrelia afzelii+burgdorferi+garinii IgG panel - Serum and CSF |
| 93313-5 | Platelet glycoprotein disorder [Interpretation] in Blood by Flow cytometry (FC) Narrative |
| 61259-8 | Whitefaced Hornet IgE Ab/IgE total in Serum |
| 61389-3 | Human papilloma virus 69 DNA [Presence] in Specimen by NAA with probe detection |
| 94098-1 | Dense fine speckled 70 protein IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 9422-7 | Herpes simplex virus IgG Ab [Units/volume] in Serum |
| 94278-9 | Cat recombinant (rFel d) 7 IgE Ab [Units/volume] in Serum |
| 63531-8 | Centromere Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 78968-5 | Benperidol [Mass/volume] in Serum or Plasma |
| 6610-0 | Haemophilus influenzae A Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 66141-3 | Eosinophils [#/volume] in Blood from Fetus by Manual count |
| 66754-3 | Clot firmness [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude + heparinase |
| 79608-6 | 2-Methyltyrosine [Moles/volume] in Serum or Plasma |
| 96482-5 | Alpha-internexin IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 80590-3 | Influenza virus A H3 HA gene [Presence] in Nasopharynx by NAA with probe detection |
| 96508-7 | Bunyamwera virus IgG Ab [Presence] in Specimen by Immunoassay |
| 97514-4 | Entamoeba moshkovskii DNA [Presence] in Specimen by NAA with probe detection |
| 7073-0 | Amylase IgE Ab [Units/volume] in Serum |
| 82472-2 | Borrelia garinii+afzelii oppA1 gene [Presence] in Specimen by NAA with non-probe detection |
| 85305-1 | Distance of carcinoma from inferior margin [Length] in Breast cancer specimen by Light microscopy |
| 99516-7 | Weight of Spleen |
| 73151-3 | Simethicone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73392-3 | Escitalopram induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87562-5 | Ammonia nitrogen [Mass/mass] in Feed |
| 73562-1 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/mass] in Meconium by Confirmatory method |
| 89534-2 | Ribosomal P Ab [Presence] in Cerebral spinal fluid by Line blot |
| 89639-9 | Nocardia sp identified in Implanted device by Organism specific culture |
| 41276-7 | Anion gap in Blood |
| 41603-2 | Bacteria [Presence] in Pleural fluid by Light microscopy |
| 59828-4 | Bilirubin.total [Mass/volume] in Venous blood |
| 50752-5 | Cortisol [Mass/volume] in Serum or Plasma --15 minutes post dose insulin IV |
| 42213-9 | Smooth nuclear envelope nuclear Ab pattern [Titer] in Body fluid |
| 42666-8 | Fat.neutral [#/area] in Pleural fluid by Microscopy high power field |
| 59903-5 | FLUoxetine [Moles/volume] in Gastric fluid |
| 60133-6 | Parathion [Mass/volume] in Body fluid |
| 43056-1 | Cladosporium sp IgG Ab [Presence] in Serum |
| 21810-7 | t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points [Presence] in Blood or Tissue by Molecular genetics method |
| 31673-7 | Teichoate Ab [Units/volume] in Serum |
| 31800-6 | Dermatophilus congolensis Ag [Presence] in Exudate |
| 51714-4 | Microscopic observation [Identifier] in Blood by Giemsa stain |
| 43213-8 | Polychlorinated biphenyl (PCB) [Mass/volume] in Blood |
| 43301-1 | HTLV I+II p36 Ab [Presence] in Serum |
| 4368-7 | Oxedrine [Mass] of Dose |
| 43822-6 | Aspartate aminotransferase [Presence] in Body fluid |
| 32239-6 | Ethanolamine [Moles/volume] in Amniotic fluid |
| 44277-2 | 15 Beta, 17 Alpha-Dihydroxypregnanolone/Creatinine [Mass Ratio] in Urine |
| 23293-4 | Mycoplasma mycoides ss mycoides small colony DNA [Presence] in Specimen by NAA with probe detection |
| 33565-3 | Smith extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot |
| 33572-9 | Aureobasidium pullulans IgG Ab [Presence] in Serum |
| 53891-8 | PNKD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 45330-8 | Leptospira interrogans IgG Ab [Titer] in Serum by Immunofluorescence |
| 33870-7 | Bilirubin.total [Presence] in Specimen |
| 54260-5 | Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose insulin IV |
| 54290-2 | Heptanoylcarnitine (C7)/Creatinine [Molar ratio] in Urine |
| 24109-1 | Progesterone [Moles/volume] in Saliva (oral fluid) |
| 55234-9 | Alpha thalassemia gene panel - Blood by Molecular genetics method |
| 47274-6 | S100 calcium binding protein B [Mass/volume] in Cerebral spinal fluid |
| 35002-5 | Polymorphonuclear cells [#/volume] in Body fluid |
| 55864-3 | Glycolate [Moles/volume] in Body fluid |
| 47604-4 | Cortisol [Moles/volume] in Serum or Plasma --1.5 hours post 1 ug/kg CRH IV |
| 47870-1 | Prolactin [Mass/volume] in Serum or Plasma --2.5 hours post dose TRH IV |
| 25789-9 | Thyrotropin [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 35607-1 | diazePAM [Mass/volume] in Serum or Plasma by Screen method |
| 35622-0 | Nordiazepam [Mass/volume] in Serum or Plasma by Screen method |
| 56429-4 | Potato IgG4 Ab [Mass/volume] in Serum |
| 48110-1 | Glutathione.oxidized/Glutathione.reduced [Molar ratio] in Red Blood Cells |
| 26644-5 | Getah virus Ab [Presence] in Serum |
| 26730-2 | Isoleucine [Moles/volume] in Amniotic fluid |
| 57097-8 | Follitropin [Units/volume] in Serum or Plasma --10 minutes pre dose gonadotropin releasing hormone |
| 27178-3 | Phendimetrazine [Mass/volume] in Vitreous fluid |
| 3826-5 | Morphine [Presence] in Serum or Plasma |
| 38628-4 | Benzo alpha pyrene [Mass/volume] in Air |
| 38669-8 | Dichlorodiphenyldichloroethylene [Mass/volume] in Air |
| 38735-7 | 1,1-Dichloroethylene [Mass/volume] in Air |
| 3940-4 | Phendimetrazine [Mass/volume] in Urine |
| 4959-3 | HLA-DR14(6) [Presence] |
| 49636-4 | Ganglioside GM1 Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 40211-5 | Glucose [Moles/volume] in Serum or Plasma --3.5 hours post XXX challenge |
| 2976-9 | Sulfate.inorganic [Mass/volume] in Serum or Plasma |
| 58932-5 | Protoporphyrin [Mass/mass] in Stool |
| 50345-8 | Parvovirus B19 DNA [Presence] in Urine by NAA with probe detection |
| 20925-4 | Ova and parasites identified in Stool by McMaster concentration |
| 12488-3 | PENTobarbital [Presence] in Gastric fluid |
| 12825-6 | Prolactin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 12920-5 | Sulfate [Mass/volume] in 24 hour Urine |
| 101101-4 | Kx Ab [Presence] in Serum or Plasma |
| 101188-1 | ADB-BUTINACA/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 13067-4 | Nuclear Ab pattern [Interpretation] in Body fluid by Immunofluorescence |
| 102173-2 | White Bean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13444-5 | Calcium/Albumin [Mass Ratio] in Serum or Plasma |
| 13488-2 | aPTT in Control Platelet poor plasma by Coagulation assay |
| 13509-5 | Microscopic observation [Identifier] in Blood by Crystal violet stain |
| 13657-2 | Urate crystals amorphous [#/volume] in Urine sediment |
| 13796-8 | Phosphoserine/Creatinine [Mass Ratio] in Urine |
| 1024-9 | Fy sup(a) Ab [Presence] in Serum or Plasma |
| 103111-1 | Arizona Cypress native (nCup a) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103126-9 | Wheat native (nTri a) 19+20+21 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104219-1 | Spermatozoa Immotile/100 spermatozoa in Urine --post ejaculation |
| 10646-8 | Astrovirus [Identifier] in Stool by Electron microscopy |
| 11175-7 | Helminthosporium sativum IgE Ab [Units/volume] in Serum |
| 11185-6 | Maxatase IgE Ab [Units/volume] in Serum |
| 17873-1 | Bacteria # 2 identified in Bone by Aerobe culture |
| 18210-5 | Complement C1 esterase inhibitor bound IgG Ab [Mass/volume] in Serum or Plasma |
| 18469-7 | Methyclothiazide [Mass/volume] in Serum or Plasma |
| 18899-5 | Cephaloridine [Susceptibility] |
| 89995-5 | Trypanosoma cruzi IgG Ab [Presence] in Serum or Plasma from Donor by Immunoassay |
| 92716-0 | Lipoprotein.beta.subparticle.large-b [Moles/volume] in Serum |
| 92790-5 | Candida albicans DNA [Presence] by NAA with probe detection in Positive blood culture |
| 61102-0 | Influenza virus A and B Ag [Identifier] in Specimen by Immunofluorescence |
| 93369-7 | Krebs von den Lungen-6 [Units/volume] in Serum or Plasma by Immunoassay |
| 93432-3 | Blastomyces sp Ag [Mass/volume] in Bronchoalveolar lavage by Immunoassay |
| 77658-3 | Aneuploid cell population in G2 phase/100 cells in Cells.XXX by Flow cytometry (FC) |
| 94213-6 | PPOX gene full mutation analysis in Blood or Tissue by Sequencing |
| 94418-1 | UGT2B15 gene c.253G>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 94454-6 | Arsenite [Mass/volume] in Urine |
| 94578-2 | Clot strength TXA2 receptor inhibited [Length fraction] in Blood by calculation |
| 78880-2 | RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
| 6641-5 | Influenza virus A Mississippi Ab [Units/volume] in Serum by Hemagglutination inhibition |
| 80181-1 | S-adenosylmethionine and S-adenosylhomocystine pattern [Interpretation] in Serum or Plasma Narrative |
| 80372-6 | Hemoglobin.gastrointestinal [Presence] in Stool by Rapid immunoassay |
| 68367-2 | Bilirubin.total [Moles/volume] in Urine by Automated test strip |
| 68431-6 | Leukocytes other [#/volume] in Synovial fluid by Manual count |
| 6999-7 | Cefuroxime Parenteral [Susceptibility] by Gradient strip |
| 81883-1 | CNBP gene CCTG repeat analysis in Blood or Tissue by Molecular genetics method |
| 82165-2 | Human metapneumovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection |
| 97282-8 | Nordiazepam [Presence] in Cord tissue by Screen method |
| 8228-9 | Phencyclidine [Presence] in Gastric fluid |
| 82865-7 | 3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone [Moles/volume] in 24 hour Urine |
| 82935-8 | Oxazepam [Mass/volume] in Serum or Plasma --trough |
| 980-3 | Di sup(a) Ab [Presence] in Serum or Plasma from Donor |
| 87732-4 | KIT gene exon 13 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 73429-3 | Colchicine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7362-7 | Koehlers grass IgE Ab [Units/volume] in Serum |
| 88165-6 | Mycobacterium tuberculosis DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
| 73882-3 | Glycolate [Moles/volume] in 24 hour Urine |
| 74411-0 | Consistency of Lymph node |
| 59747-6 | Temazepam [Mass/volume] in Body fluid |
| 30902-1 | Fibrinogen [Mass/volume] in Platelet poor plasma by Heat denaturation |
| 42210-5 | Microscopic observation [Identifier] in Bronchial specimen by Cyto stain |
| 42589-2 | Borrelia burgdorferi DNA [Presence] in Body fluid by NAA with probe detection |
| 60003-1 | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --baseline |
| 60024-7 | Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid by Lactate to pyruvate reaction |
| 42792-2 | Mitogen-Activated protein kinase 8 Ag [Presence] in Tissue by Immune stain |
| 43181-7 | Arsenic organic [Mass/volume] in 24 hour Urine |
| 2181-6 | Cystinyl aminopeptidase [Enzymatic activity/volume] in Serum |
| 31719-8 | Infectious bronchitis virus Ag [Presence] in Specimen |
| 51781-3 | Carbon dioxide, total [Moles/volume] in Capillary blood by calculation |
| 43303-7 | Immune Complex C3d [Units/volume] in Serum or Plasma |
| 22403-0 | Leptospira interrogans sv Hardjo Ab [Titer] in Serum |
| 32105-9 | Perphenazine [Presence] in Urine |
| 32171-1 | Echinococcus sp IgG Ab [Presence] in Serum |
| 32374-1 | Cefotiam [Susceptibility] |
| 4392-7 | Phenmetrazine [Mass] of Dose |
| 32641-3 | SMPD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 32693-4 | Lactate [Moles/volume] in Blood |
| 32807-0 | Mononuclear cells/100 leukocytes in Bronchial specimen |
| 32811-2 | Microscopic observation [Identifier] in Bronchial specimen by Iron hematoxylin stain |
| 44453-9 | Borrelia burgdorferi Ab [Units/volume] in Cerebral spinal fluid by Immunoblot |
| 23569-7 | Vesicular stomatitis virus serotype [Identifier] in Specimen by Complement fixation |
| 33705-5 | Clostridium botulinum toxin B [Presence] in Specimen by Mouse bioassay neutralization |
| 45145-0 | Methdilazine [Presence] in Serum or Plasma |
| 45219-3 | Lymphocytic choriomeningitis virus IgG Ab [Presence] in Cerebral spinal fluid |
| 54270-4 | Glucose [Moles/volume] in Serum or Plasma --2.5 hour post dose ornithine alpha-ketoglutarate |
| 4623-5 | Hemoglobin S [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 24362-6 | Renal function 2000 panel - Serum or Plasma |
| 2453-9 | Hypoxanthine [Mass/volume] in Serum |
| 34472-1 | Cholesterol crystals [Presence] in Bile fluid by Light microscopy |
| 55156-4 | Minocycline [Susceptibility] by Method for Slow-growing mycobacteria |
| 47057-5 | Legionella pneumophila 12 IgG Ab [Titer] in Serum by Immunofluorescence |
| 25105-8 | Glycerate/Creatinine [Molar ratio] in Urine |
| 25267-6 | Penicillin [Mass/volume] in Specimen |
| 2544-5 | Lactate dehydrogenase 4 [Enzymatic activity/volume] in Serum or Plasma by Chemical separation |
| 55808-0 | 11-Deoxycorticosterone [Moles/time] in 24 hour Urine |
| 56123-3 | IgM [Mass/volume] in Urine |
| 47623-4 | Glutamate [Moles/volume] in DBS |
| 47872-7 | Prolactin [Units/volume] in Serum or Plasma --pre dose metoclopramide |
| 25968-9 | Pentacarboxylporphyrins [Moles/volume] in 24 hour Urine |
| 35777-2 | Ceftibuten [Susceptibility] by Disk diffusion (KB) |
| 56626-5 | Tetrachloroethylene [Moles/volume] in Blood |
| 38601-1 | Hexane [Mass/volume] in Air |
| 27268-2 | Hydroxydecanedioate [Presence] in Urine |
| 39464-3 | Carbon dioxide, total [Moles/volume] in Peritoneal dialysis fluid |
| 57955-7 | Darunavir+Ritonavir [Susceptibility] by Phenotype method |
| 4938-7 | HLA-DQ4 [Presence] in Donor |
| 49599-4 | CD55 Granulocytes [Presence] in Blood |
| 49610-9 | Streptococcus pyogenes DNA [Identifier] in Specimen by NAA with probe detection |
| 28554-4 | Triglyceride [Presence] in Serum or Plasma |
| 29244-1 | Thiodiglycolate/Creatinine [Mass Ratio] in Urine |
| 29261-5 | Abnormal lymphocytes/100 leukocytes in Blood by Manual count |
| 39979-0 | Creatinine [Mass/volume] in Urine --1.5 hours pre XXX challenge |
| 4993-2 | Chlamydia trachomatis rRNA [Presence] in Specimen by Probe |
| 50130-4 | 3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Urine |
| 29583-2 | Differential panel - Pleural fluid |
| 50454-8 | Cortisol [Mass/volume] in Serum or Plasma --2nd specimen |
| 50506-5 | Insulin [Units/volume] in Serum or Plasma --6th specimen |
| 50607-1 | Neisseria meningitidis serogroups Ag panel - Specimen by Latex agglutination |
| 30242-2 | Lactate [Mass/volume] in Arterial blood |
| 40851-8 | Normetanephrine Free [Moles/volume] in Serum or Plasma |
| 4106-1 | Acetazolamide [Mass] of Dose |
| 19431-6 | Propoxyphene cutoff [Mass/volume] in Urine for Screen method |
| 19484-5 | HYDROcodone cutoff [Mass/volume] in Urine for Screen method |
| 20585-6 | Lymphocytes [#/volume] in Specimen by Automated count |
| 20722-5 | Brucella abortus Ab [Titer] in Serum by Rivanol agglutination |
| 2077-6 | Chloride [Moles/volume] in Sweat |
| 20841-3 | Herbicide [Presence] in Tissue by Screen method |
| 101496-8 | Tobramycin [Susceptibility] by MIC.VOC detection in Positive blood culture |
| 13336-3 | CD4+CD45RA+ cells/100 cells in Blood |
| 13345-4 | CD8+CD11b+ cells/100 cells in Blood |
| 13519-4 | Basophils/100 leukocytes in Cerebral spinal fluid by Manual count |
| 13699-4 | 5-Hydroxyhexanoate/Creatinine [Mass Ratio] in Urine |
| 13740-6 | Ethanolamine/Creatinine [Mass Ratio] in Urine |
| 102420-7 | Lysozyme IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102443-9 | Cockspur IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13970-9 | Delta tocopherol [Mass/volume] in Serum or Plasma |
| 1621-2 | Prolactin [Mass/volume] in Serum or Plasma --pre dose insulin IV |
| 11473-6 | Cryptococcus sp Ag [Titer] in Specimen |
| 17171-0 | CD51 cells/100 cells in Blood |
| 17864-0 | Calcium.ionized [Mass/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE) |
| 90466-4 | 3-(4-fluorobenzoyl)propionate [Presence] in Urine by Screen method |
| 74780-8 | CPT1A gene c.1436C>T [Presence] in DBS by Molecular genetics method |
| 92526-3 | little s Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
| 75157-8 | Deoxyinosine [Moles/volume] in Cerebral spinal fluid |
| 75694-0 | Human papilloma virus 18+45 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection |
| 60456-1 | CD3+CD8+CD57+ cells/100 cells in Blood |
| 60539-4 | Tryptase.beta [Mass/volume] in Serum or Plasma |
| 6096-2 | European house dust mite IgE Ab [Units/volume] in Serum |
| 76665-9 | Protein [Mass/volume] in Cerebral spinal fluid --1st tube |
| 92856-4 | Bordetella parapertussis IS1001 DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 61275-4 | Hop IgE Ab/IgE total in Serum |
| 62319-9 | Niemann Pick disease A/B newborn screening comment-discussion |
| 93791-2 | Glucose [Mass/volume] mean in Serum or Plasma |
| 6290-1 | Complement membrane C3b-C4b cofactor protein [Presence] in Leukocytes |
| 7808-9 | Aspergillus sp Ab [Presence] in Serum |
| 94822-4 | SARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by Sequencing |
| 638-7 | Microscopic observation [Identifier] in Cerebral spinal fluid by India ink prep |
| 80145-6 | Silver [Moles/volume] in Body fluid |
| 96412-2 | Pancreatic polypeptide [Mass/volume] in Serum or Plasma --5M post sham feeding |
| 80723-0 | B-cell CD27 and IgD subsets [Interpretation] in Blood Narrative |
| 81629-8 | Gamma hydroxybutyrate [Presence] in Specimen by Confirmatory method |
| 97747-0 | Carcinoembryonic Ag [Mass/volume] in Aspirate |
| 85762-3 | Blood pathogens panel by NAA with non-probe detection in Positive blood culture |
| 99626-4 | PCA-2 Ab [Presence] in Cerebral spinal fluid by Line blot |
| 7274-4 | Daisy IgE Ab [Units/volume] in Serum |
| 86241-7 | Aquaporin 4 water channel IgG Ab [Titer] in Serum or Plasma by Flow cytometry (FC) |
| 87580-7 | Aflatoxin M1 [Mass/mass] in Specimen |
| 73638-9 | Ormetroprim+Sulfamethoxazole [Susceptibility] by Disk diffusion (KB) |
| 73672-8 | Salmonella sp phage type in Isolate |
| 88187-0 | Influenza virus A subtype [Identifier] in Cornea or Conjunctiva by NAA with probe detection |
| 7401-3 | Herring IgG Ab [Units/volume] in Serum |
| 74169-4 | Cocaine [Mass/volume] in Saliva (oral fluid) by Screen method |
| 74342-7 | MICA*006 IgG Ab [Presence] in Serum |
| 74394-8 | Normoblasts [#/volume] in Cord blood |
| 74428-4 | Metamyelocytes.neutrophilic/100 leukocytes in Blood by Manual count |
| 88689-5 | Pneumocystis jiroveci [Presence] in Lower respiratory specimen by Calcofluor white |
| 89638-1 | Nocardia sp identified in Lower respiratory specimen by Organism specific culture |
| 41243-7 | Yeast [#/area] in Body fluid by Microscopy high power field |
| 59403-6 | Ku Ab [Titer] in Serum by Immunofluorescence |
| 59659-3 | diazePAM [Mass/mass] in Stool by Confirmatory method |
| 31157-1 | Carboxyhemoglobin [Mass/volume] in Blood |
| 42607-2 | Prolactin monomeric [Mass/volume] in Serum or Plasma |
| 60001-5 | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 21395-9 | Monocytes+Macrophages/100 leukocytes in Synovial fluid by Manual count |
| 21418-9 | Neutrophil Ab [Presence] in Serum |
| 31294-2 | Chlamydia trachomatis B IgA Ab [Units/volume] in Serum |
| 51125-3 | CD22 blasts/100 blasts in Blood |
| 51328-3 | CD42b cells/100 cells in Body fluid |
| 32026-7 | Microscopic observation [Identifier] in Nose by Gram stain |
| 5162-3 | Fasciola hepatica Ab [Units/volume] in Serum |
| 43222-9 | Potassium/Creatinine [Ratio] in Urine |
| 32314-7 | Cortisol [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 52980-0 | Plasmodium sp IgG Ab [Titer] in Serum by Immunofluorescence |
| 23414-6 | Rinderpest virus Ag [Presence] in Exudate by Immunoelectrophoresis |
| 23634-9 | Erythropoietin (EPO) given [Units/volume] of Dose |
| 33621-4 | Tricarboxylporphyrin 3 [Mass/time] in 24 hour Stool |
| 53558-3 | Bacteria identified in Semen by Culture |
| 53790-2 | CILD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 24280-0 | Rickettsia typhi IgG Ab [Titer] in Serum --2nd specimen |
| 47252-2 | Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 4726-6 | HLA-A28 [Presence] in Donor |
| 25308-8 | Ammonia [Moles/time] in 24 hour Urine |
| 35135-3 | Adenosine triphosphate/Adenosine diphosphate [Mass Ratio] in Blood |
| 55725-6 | Cerebroside sulfatase and N-Acetylgalactosamine-4-Sulfatase panel [Enzymatic activity/volume] - Serum or Plasma |
| 4789-4 | HLA-B w6 [Presence] |
| 3802-6 | Methyldopa [Mass/volume] in Serum or Plasma |
| 38170-7 | CD18 cells/100 cells in Specimen |
| 56950-9 | Legionella pneumophila IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
| 48652-2 | Clostridium tetani toxoid IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 48685-2 | Para aminosalicylate 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 38397-6 | Crystals [type] in Amniotic fluid by Light microscopy |
| 38435-4 | Terminal deoxyribonucleotidyl transferase cells/100 cells in Specimen |
| 57418-6 | CD20 cells/100 cells in Body fluid |
| 57607-4 | 6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
| 57621-5 | Alpha cortol [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
| 49172-0 | Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Body fluid |
| 57988-8 | Iron [Mass/volume] in Cerebral spinal fluid |
| 58436-7 | Casts [Type] in Urine sediment by Light microscopy |
| 58758-4 | Chlamydophila pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 50002-5 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post XXX challenge |
| 40612-4 | Borrelia burgdorferi IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 58850-9 | Somatotropin [Mass/volume] in Serum or Plasma --14th specimen |
| 50407-6 | Other cells/100 leukocytes [Identifier] in Cerebral spinal fluid |
| 50534-7 | Thyrotropin [Units/volume] in Serum or Plasma --2nd specimen |
| 19722-8 | Trichlorothiazide cutoff [Mass/volume] in Urine for Screen method |
| 20923-9 | Organophosphate pesticides [Identifier] in Tissue |
| 101069-3 | CE Ab [Presence] in Serum or Plasma |
| 13394-2 | Cystine [Mass/volume] in Amniotic fluid |
| 102551-9 | Rabbit Bush IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102580-8 | Sage IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102671-5 | Grey Alder IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103098-0 | Latex recombinant (rHev b) 11 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 11027-0 | Propoxyphene [Mass/volume] in Meconium |
| 16514-2 | Calcium.ionized [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 11231-8 | Astemizole [Mass/volume] in Serum or Plasma |
| 1137-9 | Lu sup(a) Ag [Presence] on Red Blood Cells from Donor |
| 11609-5 | HTLV I Ab [Units/volume] in Serum |
| 12330-7 | Hypoglycemics.oral [Identifier] in Urine |
| 17200-7 | CD82 cells/100 cells in Blood |
| 18940-7 | Loracarbef [Susceptibility] |
| 19000-9 | Vancomycin [Susceptibility] |
| 91898-7 | Epizootic hemorrhagic disease virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 91-9 | Cefodizime [Susceptibility] by Minimum lethal concentration (MLC) |
| 61081-6 | Ketamine [Presence] in Gastric fluid |
| 75928-2 | Hemoglobin [Moles/volume] in Arterial blood |
| 77051-1 | IFITM5 gene full mutation analysis in Blood or Tissue by Sequencing |
| 77187-3 | Zirconium [Mass/volume] in Urine |
| 7733-9 | Tapioca IgE Ab [Units/volume] in Serum |
| 9406-0 | Albumin/Globulin [Mass Ratio] in 24 hour Urine |
| 63258-8 | Ganglioside GT1b IgG+IgM Ab [Presence] in Serum by Immunoassay |
| 78517-0 | Renin [Mass/volume] in Plasma --2 hours post XXX challenge |
| 7883-2 | Epstein Barr virus nuclear IgG Ab [Presence] in Serum |
| 94414-0 | MTHFR gene c.677C>T and c.1298A>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 94834-9 | Herpes simplex virus 1+2 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 94835-6 | Herpes simplex virus 1 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection |
| 63362-8 | Thyroperoxidase Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 6362-8 | Clostridioides difficile toxin A+B [Presence] in Stool by Cytotoxin tissue culture assay |
| 80171-2 | Pterins pattern [Interpretation] in Urine Narrative |
| 9616-4 | 17-Hydroxyprogesterone [Mass/time] in 24 hour Urine |
| 67710-4 | Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBS |
| 96513-7 | Sandfly fever Naples virus IgG Ab [Presence] in Specimen by Immunoassay |
| 96964-2 | EZH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 97022-8 | Clot strength arachidonate inhibited [Length fraction] in Blood by calculation |
| 69893-6 | Service comment 66 |
| 7077-1 | Alternaria alternata triggered histamine release [Units/volume] in Blood |
| 98244-7 | Spermatozoa Motile/100 spermatozoa in Urine by Light microscopy --post ejaculation |
| 71876-7 | Hemoglobin A/Hemoglobin.total [Pure mass fraction] in Blood |
| 72484-9 | BK virus subtype in Blood by NAA with probe detection |
| 85372-1 | Neutrophil.fMLP stimulated.DHR/Neutrophil.fMLP stimulated.total in Control Blood by Flow cytometry (FC) |
| 72656-2 | risperiDONE [Mass/volume] in Serum or Plasma --trough |
| 72669-5 | Mianserin [Mass/volume] in Serum or Plasma --trough |
| 72802-2 | JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
| 72839-4 | Famciclovir [Susceptibility] by Genotype method |
| 86160-9 | Streptococcus pneumoniae Danish serotype 8 Ab [Mass/volume] in Serum --2nd specimen |
| 73025-9 | Escitalopram induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73043-2 | cefTAZidime induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73246-1 | Niacin+Lovastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73325-3 | Isosorbide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 86701-0 | Rotavirus A RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 86858-8 | Dengue virus 2 neutralizing antibody [Titer] in Specimen by Neutralization test |
| 88233-2 | Babesia sp DNA [Presence] in Blood by NAA with probe detection |
| 88338-9 | Coccal bacteria [Presence] in Ear by Light microscopy |
| 7392-4 | Hazelnut triggered histamine release [Units/volume] in Blood |
| 4125-1 | Amphetaminil [Mass] of Dose |
| 41280-9 | Appearance of Spun Synovial fluid |
| 59816-9 | Neutrophils.immature/100 leukocytes in Body fluid |
| 50655-0 | Food Allergen Mix 24 (Kiwi+Hazelnut+Banana+Shrimp) IgE Ab [Units/volume] in Serum by Multidisk |
| 50758-2 | Herpes simplex virus 1 IgM Ab [Titer] in Serum by Immunofluorescence |
| 21480-9 | Propoxur [Mass/volume] in Urine |
| 31225-6 | Asialoganglioside GM1 Ab [Units/volume] in Serum |
| 31354-4 | Echovirus 4 Ab [Units/volume] in Cerebral spinal fluid |
| 51280-6 | CD3+CD56+ cells/100 cells in Bone marrow |
| 22072-3 | Gaucher 2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 31988-9 | Western equine encephalitis virus Ag [Presence] in Specimen |
| 4331-5 | Metoprolol [Mass] of Dose |
| 43578-4 | Complement C3 [Mass/volume] in Peritoneal fluid |
| 43626-1 | Acetohexamide [Presence] in Serum or Plasma |
| 32062-2 | chlorproPAMIDE [Moles/volume] in Serum or Plasma |
| 32126-5 | Propylene glycol [Moles/volume] in Urine |
| 44393-7 | Immune complex [Presence] in Serum or Plasma |
| 2312-7 | Galactose 1 phosphate [Mass/volume] in Red Blood Cells |
| 32837-7 | Parvovirus B19 IgG Ab [Units/volume] in Serum --2nd specimen |
| 53342-2 | 21-Deoxycortisol [Moles/volume] in DBS |
| 44532-0 | HIV 1 gp120 Ab [Presence] in Serum |
| 53640-9 | Chloride/Creatinine [Ratio] in 24 hour Urine |
| 2397-8 | Glycoproteins [Presence] in Urine |
| 33883-0 | Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --1H post incubation with 1:4 normal plasma |
| 54215-9 | Cortisol [Moles/volume] in Serum or Plasma --5 hours post dose corticotropin |
| 46990-8 | ASPA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 34427-5 | Methadone.R [Mass/volume] in Serum or Plasma |
| 54944-4 | Monofluoroacetate [Mass/volume] in Urine |
| 25289-0 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum --2nd specimen |
| 25535-6 | Teicoplanin [Moles/volume] in Serum or Plasma --trough |
| 35738-4 | Inhibin A [Multiple of the median] in Serum or Plasma |
| 56242-1 | European house dust mite IgG4 Ab [Mass/volume] in Serum |
| 48210-9 | Carrot triggered leukotriene release [Mass/volume] by Leukocytes |
| 26460-6 | Nucleated erythrocytes [#/volume] in Body fluid |
| 26846-6 | Perphenazine [Presence] in Serum or Plasma |
| 38242-4 | CD8+CD95+ cells/100 cells in Blood |
| 38571-6 | Barium [Mass/volume] in Air |
| 2738-3 | Pepsinogen II [Mass/volume] in Serum or Plasma |
| 39553-3 | Penicillin V IgE Ab/IgE total in Serum |
| 2844-9 | Proline [Presence] in Serum or Plasma |
| 40151-3 | Glucose [Moles/volume] in Serum or Plasma --10 minutes pre XXX challenge |
| 40174-5 | Glucose [Moles/volume] in Serum or Plasma --10.75 hours post XXX challenge |
| 49766-9 | Chymotrypsin [Presence] in Stool |
| 50112-2 | 3-Hydroxylinoleoylcarnitine (C18:2-OH)/Creatinine [Molar ratio] in Urine |
| 50152-8 | 5-Hydroxytryptophan/Creatinine [Molar ratio] in Urine |
| 29832-3 | Anaplasma phagocytophilum IgG Ab [Presence] in Specimen |
| 40467-3 | U1 small nuclear ribonucleoprotein IgG Ab [Units/volume] in Serum by Immunoblot |
| 40667-8 | Rubella virus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 50235-1 | Mucus [#/area] in Urine sediment by Automated count |
| 4095-6 | Verapamil [Presence] in Urine |
| 41017-5 | Protoporphyrin [Moles/volume] in Red Blood Cells |
| 21025-2 | Pathologist interpretation of Body fluid tests |
| 12381-0 | Oxazepam [Presence] in Stool |
| 100057-9 | Prothionamide [Susceptibility] |
| 12499-0 | PENTobarbital [Presence] in Stool |
| 12722-5 | Insulin-like growth factor binding protein 1 [Mass/volume] in Serum or Plasma |
| 101198-0 | Albumin [Mass/volume] in Serum or Plasma by Nephelometry |
| 101393-7 | CLCN7 gene full mutation analysis in Blood or Tissue by Molecular genetics method |
| 101475-2 | Creatinine [Moles/volume] in Venous blood |
| 13357-9 | Synovial cells [Units/volume] in Body fluid |
| 13406-4 | 1-Methylhistidine [Mass/volume] in Amniotic fluid |
| 102752-3 | Halibut IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102825-7 | Zucchini IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102860-4 | Water Chestnut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 104360-3 | Brucella sp Ab [Titer] in Serum by Immunoassay --1st specimen |
| 16844-3 | Ethinamate [Presence] in Serum or Plasma by Confirmatory method |
| 17479-7 | Prazepam [Mass/volume] in Urine by Confirmatory method |
| 17719-6 | traMADol [Mass/volume] in Urine |
| 18478-8 | Human papilloma virus 16+18 DNA [Presence] in Tissue by Probe |
| 18884-7 | Cefoperazone [Susceptibility] |
| 60348-0 | Almond IgG Ab [Mass/volume] in Serum |
| 61035-2 | Alpha hydroxyalprazolam [Presence] in Serum or Plasma |
| 76653-5 | Barium [Mass/mass] in Hair |
| 62240-7 | Erythrocytes [#/volume] in Blood from Fetus by Automated count |
| 62376-9 | Microarray platform version number Narrative |
| 93852-2 | N-Acetylgalactosamine-4-Sulfatase/N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity ratio] in Urine |
| 93932-2 | ABO and Rh group [Type] in Blood--post hematopoietic stem cell transplant |
| 77949-6 | Streptococcus pneumoniae Ag [Presence] in Urine by Rapid immunoassay |
| 78351-4 | Tetradecadienoate (C14:2) [Entitic substance] in Red Blood Cells |
| 6669-6 | Microscopic observation [Identifier] in Tissue by Macchiavello stain |
| 79617-7 | Glycylproline [Moles/volume] in Serum or Plasma |
| 6833-8 | Cat dander IgE Ab [Units/volume] in Serum |
| 6860-1 | Trichophyton rubrum IgE Ab [Units/volume] in Serum |
| 80966-5 | Tobramycin free [Mass/volume] in Serum or Plasma |
| 96764-6 | SARS-CoV-2 (COVID-19) E gene [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection |
| 82089-4 | Occupational Allergen Mix 3 (Alternaria alternata+Aspergillus fumigatus+rye pollen+wheat pollen) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 82204-9 | Escherichia coli O157 DNA [Presence] in Stool by NAA with non-probe detection |
| 97553-2 | Deoxyhemoglobin/Hemoglobin.total in Central venous blood |
| 82388-0 | 3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab [Units/volume] in Serum by Line blot |
| 85738-3 | Bombay phenotype [Presence] on Red Blood Cells from Blood product unit |
| 72792-5 | Methylphenidate/Creatinine [Mass Ratio] in Urine |
| 86089-0 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum --2nd specimen |
| 87306-7 | Clostridium perfringens cpe gene [Presence] in Isolate by NAA with probe detection |
| 73432-7 | cloNIDine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88116-9 | Escherichia coli gene panel - Specimen by NAA with probe detection |
| 73946-6 | JWH-200 (synthetic cannabinoid) [Presence] in Blood |
| 89321-4 | Buprenorphine-3-glucuronide [Mass/volume] in Serum or Plasma by Confirmatory method |
| 89872-6 | Bilirubin.total [Moles/volume] in Arterial blood |
| 4143-4 | Bolasterone [Mass] of Dose |
| 4161-6 | Cefoperazone [Mass] of Dose |
| 59612-2 | ALPRAZolam [Mass/mass] in Stool by Confirmatory method |
| 50722-8 | VKORC1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 42640-3 | Urease [Presence] in Tissue --1 day post incubation |
| 21209-2 | Coccidioides immitis Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
| 31293-4 | Chlamydia trachomatis IgA Ab [Units/volume] in Serum |
| 31411-2 | Herpes simplex virus 1+2 IgG Ab [Units/volume] in Serum |
| 31536-6 | Neuronal nuclear IgG Ab [Units/volume] in Serum |
| 51095-8 | CD179a blasts/100 blasts in Bone marrow |
| 51151-9 | CD3+CD16+CD56+ blasts/100 blasts in Specimen |
| 43125-4 | Nicotine and Metabolites panel [Mass/volume] - Urine |
| 43133-8 | Allopurinol and Oxipurinol panel [Mass/volume] - Serum or Plasma |
| 43579-2 | Complement C3 [Mass/volume] in Pleural fluid |
| 22355-2 | Histoplasma capsulatum yeast phase Ab [Units/volume] in Serum |
| 22654-8 | Citrulline [Moles/volume] in Cerebral spinal fluid |
| 32089-5 | Mephobarbital [Moles/volume] in Serum or Plasma |
| 52781-2 | Maximum clot firmness.intrinsic coagulation system activated [Length] in Blood by Rotational TEG |
| 52888-5 | Silicon [Moles/mass] in Tissue |
| 43980-2 | Rabies virus neutralizing antibody [Titer] in Serum by Neutralization test |
| 4414-9 | Propranolol [Mass] of Dose |
| 32819-5 | Microsporidia identified in Stool by Trichrome stain |
| 44631-0 | Specimen size additional dimension 2 in Breast tumor |
| 44662-5 | Depth of invasion by tumor cannot be determined comment in Skin melanoma Narrative |
| 23485-6 | Toxoplasma gondii Ab [Presence] in Serum by Agglutination |
| 23551-5 | Venezuelan equine encephalitis virus Ag [Presence] in Specimen by Complement fixation |
| 33300-5 | Naproxen [Presence] in Urine by Screen method |
| 53832-2 | CD55 deficient RBC/100 erythrocytes in Blood |
| 23899-8 | Methanol [Mass/volume] in Gastric fluid |
| 3385-2 | Benzodiazepines negative [Identifier] in Urine |
| 34204-8 | 11-Deoxycortisol [Moles/volume] in 24 hour Urine |
| 54353-8 | Beta 1 globulin [Mass/volume] in Urine by Electrophoresis |
| 55436-0 | Myeloblasts/100 leukocytes in Cerebral spinal fluid by Manual count |
| 55845-2 | Cortisol Free [Mass/volume] in 24 hour Urine by Radioimmunoassay (RIA) |
| 56132-4 | Cholesterol in HDL 2a [Moles/volume] in Serum or Plasma |
| 47502-0 | Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum --2nd specimen |
| 47874-3 | Propionyl CoA Carboxylase [Enzymatic activity/mass] in Fibroblast |
| 47921-2 | Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose growth hormone releasing factor |
| 25679-2 | Glucose [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 35534-7 | Corn IgG Ab [Mass/volume] in Serum |
| 48209-1 | Orange triggered leukotriene release [Mass/volume] by Leukocytes |
| 26500-9 | Neutrophils [#/volume] in Cerebral spinal fluid |
| 26609-8 | Gamma aminobutyrate [Moles/volume] in Serum or Plasma |
| 26774-0 | Flurazepam [Mass/mass] in Hair |
| 3585-7 | Doxylamine [Presence] in Serum or Plasma |
| 3593-1 | ePHEDrine [Mass/volume] in Urine |
| 56933-5 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hour post dose lactulose |
| 4866-0 | HLA-Cw9(w3) [Presence] in Donor |
| 57335-2 | Calcium [Mass/volume] in 12 hour Urine |
| 4918-9 | HLA-Dw9 [Presence] in Donor |
| 49514-3 | Acetaldehyde [Presence] in Gastric fluid |
| 2838-1 | Progesterone [Mass/volume] in Saliva (oral fluid) |
| 39970-9 | Creatinine [Mass/volume] in Serum or Plasma --10 hours post XXX challenge |
| 58717-0 | Lymphocyte proliferation stimulated by concanavalin A [Interpretation] in Blood |
| 29729-1 | Leptospira interrogans sv Panama Ab [Presence] in Serum by Agglutination |
| 40771-8 | Haemophilus influenzae Ag [Presence] in Urine |
| 20431-3 | Microscopic observation [Identifier] in Specimen by Smear |
| 20906-4 | Oleandrin [Mass/volume] in Ingesta |
| 100117-1 | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot |
| 100712-9 | Brexpiprazole [Mass/volume] in Serum or Plasma |
| 1244-3 | M1 Ab [Presence] in Serum or Plasma from Blood product unit |
| 101185-7 | 4F-MDMB-BINACA/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 101732-6 | JC virus DNA [log units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 101988-4 | Candida tropicalis DNA [Presence] in Body fluid by Probe.amp.tar |
| 13664-8 | Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Serum |
| 102677-2 | Apple IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103027-9 | Honeydew melon IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14619-1 | Appearance of Plasma |
| 103961-9 | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 15201-7 | Platelets Large Fragments [#/volume] in Blood by Manual count |
| 10655-9 | Coccidia identified in Duodenal fluid by Acid fast stain |
| 15285-0 | London Plane IgE Ab [Units/volume] in Serum |
| 1565-1 | Insulin [Mass/volume] in Serum or Plasma --30 minutes post dose TOLBUTamide IV |
| 10709-4 | Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence |
| 10849-8 | Chlamydia sp IgM Ab [Titer] in Serum by Immunofluorescence |
| 16860-9 | Fibrinopeptide A Ag [Units/volume] in Peritoneal fluid by Immunoassay |
| 16996-1 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose glucose |
| 17045-6 | Latex IgE Ab [Units/volume] in Blood |
| 17402-9 | Human papilloma virus 31 Ag [Presence] in Specimen |
| 17470-6 | PM-1 Ab [Presence] in Serum by Immunofluorescence |
| 17710-5 | Tin/Creatinine [Mass Ratio] in Urine |
| 17855-8 | Hemoglobin A1c/Hemoglobin.total in Blood by calculation |
| 18195-8 | Glucosylceramidase [Presence] in Tissue |
| 1858-0 | Angiotensin I [Mass/volume] in Plasma |
| 746-8 | Myeloblasts [#/volume] in Blood by Manual count |
| 61077-4 | fentaNYL [Presence] in Gastric fluid |
| 76672-5 | Glucose [Moles/volume] in Cerebral spinal fluid --4th tube |
| 93770-6 | Ceramide trihexoside [Molar ratio] in Urine |
| 93785-4 | Large B-cell lymphoma classification panel - Tissue |
| 63264-6 | Histone Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 94736-6 | Tissue block identifier [Identifier] in Specimen |
| 7906-1 | Hepatitis D virus RNA [Presence] in Serum by NAA with probe detection |
| 79220-0 | Steroid fractions interpretation in Serum or Plasma Narrative |
| 65351-9 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
| 66495-3 | Spermatozoa Abnormal head shape/100 spermatozoa in Semen |
| 79618-5 | L-serine [Moles/volume] in Serum or Plasma |
| 8023-4 | Saint Louis encephalitis virus Ab [Presence] in Serum by Immunoassay |
| 67822-7 | fentaNYL and Norfentanyl panel - Urine |
| 68467-0 | APOB+LDLR+PCSK9 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 6887-4 | Indicans [Mass/time] in 24 hour Urine |
| 68987-7 | Influenza virus A H5b RNA [Presence] in Specimen by NAA with probe detection |
| 80737-0 | Calculated panel reactive antibody - Serum |
| 96742-2 | SARS-CoV-2 (COVID-19) IgG Ab [Mass/volume] in Serum or Plasma by Immunoassay |
| 69803-5 | Alpha ketoglutarate [Moles/volume] in Serum or Plasma |
| 81816-1 | OPA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 81855-9 | DMPK gene CTG repeat analysis in Blood or Tissue by Molecular genetics method |
| 97615-9 | Cutibacterium avidum+granulosum DNA [Presence] in Synovial fluid by NAA with non-probe detection |
| 97765-2 | Cortisol [Moles/volume] in Serum or Plasma --post dose dexamethasone PO overnight |
| 7106-8 | Aspergillus sp IgE Ab [Units/volume] in Serum |
| 72437-7 | Phenyllactate [Moles/volume] in Serum or Plasma |
| 83056-2 | PD-L1 by clone 28-8 [Interpretation] in Tissue by Immune stain Narrative |
| 850-8 | A1 B Ag [Presence] on Red Blood Cells |
| 99274-3 | Flubromazepam [Mass/volume] in Urine by Confirmatory method |
| 72489-8 | Androstenedione [Moles/volume] in Saliva (oral fluid) |
| 72575-4 | Macroprolactin/Prolactin [Pure mass fraction] in Serum or Plasma |
| 73355-0 | hydrALAZINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87963-5 | HIV 1 RNA tropism [Identifier] in Cerebral spinal fluid |
| 88838-8 | Microbiology CNAMTS panel - Semen |
| 89654-8 | Parainfluenza virus identified in Upper respiratory specimen by Organism specific culture |
| 41462-3 | Taenia solium larva Ab [Presence] in Specimen by Immunoblot |
| 41474-8 | Diethylcarbamazepine [Mass/volume] in DBS |
| 59402-8 | Mi-1+Mi-2 Ab [Titer] in Serum by Immunofluorescence |
| 59570-2 | Urea nitrogen [Moles/volume] in Blood |
| 59622-1 | chlordiazePOXIDE [Mass/volume] in Serum or Plasma by Confirmatory method |
| 59730-2 | Oxazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 50770-7 | Ganglioside GM1 IgG Ab/IgM Ab [Ratio] in Serum by Immunoassay |
| 5087-2 | Chlamydia trachomatis Ab [Titer] in Serum by Complement fixation |
| 51031-3 | CD11a blasts/100 blasts in Bone marrow |
| 60054-4 | Amiodarone [Mass/volume] in Blood |
| 21293-6 | Gastrin [Mass/volume] in Serum or Plasma --45 minutes post 0.2 U/kg secretin |
| 31448-4 | La Crosse virus Ab [Units/volume] in Cerebral spinal fluid |
| 51073-5 | CD135 blasts [Units/volume] in Blood |
| 51399-4 | CD65w cells/100 cells in Body fluid |
| 51401-8 | CD81 cells/100 cells in Tissue |
| 21788-5 | t(21;22)(q22.3;q12.2)(ERG,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 31866-7 | Japanese encephalitis virus Ag [Presence] in Specimen |
| 51719-3 | Paromomycin [Susceptibility] |
| 51736-7 | oxyMORphone Free [Mass/volume] in Urine |
| 43223-7 | Sodium/Creatinine [Ratio] in Urine |
| 43249-2 | X ray dye crystals [Presence] in Urine sediment by Light microscopy |
| 4347-1 | Netilmicin [Mass] of Dose |
| 22329-7 | Hepatitis C virus c33c Ab [Presence] in Serum |
| 32054-9 | Butabarbital [Presence] in Specimen |
| 51991-8 | Referral lab test panel |
| 44098-2 | Microscopic observation [Identifier] in Specimen by Wayson stain |
| 44245-9 | Fungi.filamentous [#/area] in Vaginal fluid by Wet preparation |
| 3268-0 | Heparin cofactor II Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
| 23227-2 | Mareks disease virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 23343-7 | Pasteurella multocida Ag [Titer] in Specimen by Agglutination |
| 33349-2 | Pemoline [Mass/volume] in Urine by Confirmatory method |
| 45228-4 | Streptolysin O Ab [Mass/volume] in Serum |
| 45338-1 | Proinsulin/Insulin [Ratio] in Serum or Plasma |
| 23729-7 | Feline infectious peritonitis virus Ag [Presence] in Tissue by Immunofluorescence |
| 33864-0 | Elastase.leukocyte [Mass/volume] in Plasma |
| 53997-3 | Nuclear dots nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
| 54456-9 | Urea reduction ratio in Serum or Plasma |
| 46186-3 | Equine herpesvirus 1 Ab [Titer] in Cerebral spinal fluid |
| 4686-2 | Thromboglobulin [Mass/volume] in Plasma |
| 34688-2 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor XII depleted plasma |
| 55569-8 | Phentermine [Moles/volume] in Serum or Plasma |
| 47110-2 | Glutethimide [Moles/volume] in Gastric fluid |
| 47117-7 | Maprotiline [Moles/volume] in Gastric fluid |
| 473-9 | sulfiSOXAZOLE [Susceptibility] by Disk diffusion (KB) |
| 4748-0 | HLA-B46 [Presence] in Donor |
| 25202-3 | rifAMPin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 55669-6 | Dibekacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 25579-4 | C peptide [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 35668-3 | Gentamicin [Mass/volume] in Serum or Plasma |
| 56186-0 | Banana IgG4 Ab [Mass/volume] in Serum |
| 56390-8 | Soybean IgG4 Ab [Mass/volume] in Serum |
| 56492-2 | Insulin [Units/volume] in Serum or Plasma --6 minutes post XXX challenge |
| 48078-0 | 3,6-Epoxydecanedioate/Creatinine [Molar ratio] in Urine |
| 2660-9 | Nitrogen [Mass/time] in 24 hour Urine |
| 2672-4 | Octopamine [Moles/volume] in Urine |
| 56752-9 | APOB gene+LDLR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 48373-5 | Spermatozoa Angled Midpiece/100 spermatozoa in Semen |
| 27177-5 | Herpes virus 7 IgM Ab [Titer] in Serum by Immunofluorescence |
| 38438-8 | Aspergillus fumigatus IgE Ab/IgE total in Serum |
| 57507-6 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --45 minutes post 250 ug corticotropin |
| 49219-9 | Galactose [Mass/volume] in Red Blood Cells |
| 27907-5 | Cryptosporidium sp [Identifier] in Stool by Organism specific culture |
| 57891-4 | Pregnanediol [Mass/time] in 24 hour Urine --pre dose dexamethasone |
| 58054-8 | Ch sup(a) Ab [Presence] in Serum or Plasma |
| 49424-5 | Papova virus SV 40 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 40230-5 | Calcium [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 50091-8 | 2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH)/Creatinine [Molar ratio] in Urine |
| 50102-3 | 3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBS |
| 405-1 | Pipemidate [Susceptibility] by Disk diffusion (KB) |
| 4061-8 | TOLBUTamide [Mass/volume] in Serum or Plasma |
| 40721-3 | Hemoglobin F [Presence] in Specimen by Apt-Downey method |
| 58902-8 | F12 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 5042-7 | Adenovirus IgM Ab [Units/volume] in Serum |
| 19301-1 | Opiates screen method [Identifier] in Urine |
| 19553-7 | Methadone cutoff [Mass/volume] in Urine for Confirmatory method |
| 19558-6 | Methaqualone [Presence] in Urine by Screen method |
| 20493-3 | Histiocytes/100 cells in Body fluid by Light microscopy |
| 100058-7 | Prulifloxacin [Susceptibility] |
| 101176-6 | Normetanephrine Free/Creatinine [Molar ratio] in Serum or Plasma |
| 10247-5 | Oxygen content in Pulmonary wedge |
| 102560-0 | Southern Ragweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14293-5 | Insulin [Moles/volume] in Serum or Plasma --baseline |
| 14333-9 | Lead [Presence] in 24 hour Urine |
| 102688-9 | Mung Bean IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103026-1 | Cantaloupe IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14599-5 | Ammonium [Presence] in Stone |
| 103785-2 | Monocyte Chemoattractant Proteins 4 (MCP-4/CCL13) [Mass/volume] in Serum or Plasma by Immunoassay |
| 103954-4 | Peripheral neuropathy multigene analysis in Specimen by Molecular genetics method |
| 103956-9 | Parkinson Disease multigene analysis in Specimen by Molecular genetics method |
| 10557-7 | Adenosine triphosphate [Moles/volume] in Semen |
| 16193-5 | PENTobarbital [Presence] in Urine by Confirmatory method |
| 11130-2 | B lymphocytes [#/volume] in Blood |
| 16934-2 | Hepatitis B virus polymerase DNA [Presence] in Blood by NAA with probe detection |
| 16965-6 | Lindane [Mass/volume] in Blood |
| 17704-8 | Threonine [Presence] in Urine |
| 18313-7 | Coagulation of Semen by Visual observation |
| 18927-4 | Fusidate [Susceptibility] |
| 91828-4 | Mycoplasma genitalium DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 75271-7 | Other cells/100 cells in Lymph node by Manual count |
| 60582-4 | TCRB gene rearrangements [Presence] in Cerebral spinal fluid by Molecular genetics method |
| 61080-8 | Flurazepam [Presence] in Specimen |
| 7592-9 | Chili Pepper IgG Ab [Units/volume] in Serum |
| 61401-6 | Pseudomonas aeruginosa DNA [Presence] in Specimen by NAA with probe detection |
| 61420-6 | Norhydrocodone/Creatinine [Mass Ratio] in Urine |
| 77375-4 | Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Specimen by NAA with probe detection |
| 77399-4 | Human papilloma virus 16 DNA [Presence] in Cervix by NAA with probe detection |
| 78761-4 | 7-Aminoclonazepam [Mass/mass] in Hair |
| 7896-4 | Hantavirus hantaan IgM Ab [Units/volume] in Serum |
| 79456-0 | Arginase [Enzymatic activity/mass] in Red Blood Cells |
| 95244-0 | Platelet aggregation EPINEPHrine induced in Platelet rich plasma --1 umol/L |
| 6853-6 | Plum IgE Ab [Units/volume] in Serum |
| 688-2 | Neisseria gonorrhoeae [Presence] in Cervix by Organism specific culture |
| 69027-1 | Morphine [Mass/mass] in Meconium by Confirmatory method |
| 96596-2 | Cholesterol in HDL [Mass/volume] in DBS |
| 82042-3 | Weed Allergen Mix 5 (Common ragweed+Mugwort+Ox-eye daisy+Dandelion+Goldenrod) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 82062-1 | Food Allergen Mix 23 (Beef+Chicken meat+Pork+Turkey meat) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 97863-5 | Herpes virus 8 IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
| 71429-5 | Campylobacter sp DNA.diarrheagenic [Presence] in Stool by NAA with probe detection |
| 98399-9 | Fungus identified in Isolate by MS.MALDI-TOF |
| 71668-8 | Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count |
| 722-9 | Hemoglobin [Mass/volume] in Pleural fluid |
| 85425-7 | Lefamulin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 86217-7 | Rotavirus A VP6 capsid protein [Presence] in Specimen by Immunoassay |
| 73108-3 | traMADol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87285-3 | Brachyspira pilosicoli DNA [Presence] in Specimen by NAA with probe detection |
| 87445-3 | Fungus [Presence] in Food by Culture |
| 87713-4 | Rotavirus A VP4 gene [Nucleotide sequence] in Isolate by Sequencing |
| 73415-2 | diphenhydrAMINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73826-0 | Flurazepam+N-desalkylflurazepam [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 88196-1 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Stool by NAA with probe detection |
| 74098-5 | Endothelin [Moles/volume] in Serum or Plasma |
| 41682-6 | cefTRIAXone+Clavulanate [Susceptibility] by Disk diffusion (KB) |
| 30415-4 | Abnormal lymphocytes/100 leukocytes in Synovial fluid |
| 60262-3 | Dengue virus 1 RNA [Presence] in Serum by NAA with probe detection |
| 6030-1 | Budgerigar feather IgE Ab [Units/volume] in Serum |
| 21495-7 | Rickettsia spotted fever group IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 21569-9 | Toxoplasma gondii IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 31461-7 | Legionella pneumophila 4 Ab [Units/volume] in Serum |
| 42751-8 | Phosphatidylserine IgA Ab B2GP1 dependent [Multiple of the median] in Serum |
| 42752-6 | Phosphatidylserine IgA Ab B2GP1 independent [Multiple of the median] in Serum |
| 21801-6 | t(11;14)(q13;q32)(CCND1,IGH) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 51690-6 | Amphetamines [Presence] in Blood by Screen method |
| 51828-2 | Food Allergen Mix 74 (Herring+Cod+Plaice+Mackerel) IgE Ab [Units/volume] in Serum |
| 32289-1 | 7-Dehydrocholesterol [Moles/volume] in Serum or Plasma |
| 3244-1 | Clot Lysis [Time] in Platelet poor plasma by Coagulation assay |
| 44376-2 | Homocysteine [Presence] in DBS |
| 22899-9 | Bovine diarrhea virus RNA [Presence] in Tissue by Probe |
| 23001-1 | Chlamydophila psittaci DNA [Presence] in Specimen by NAA with probe detection |
| 53166-5 | Butyrylcarnitine+Isobutyrylcarnitine (C4) [Moles/volume] in DBS |
| 53191-3 | Tetradecenoylcarnitine (C14:1) [Moles/volume] in DBS |
| 53415-6 | Bilirubin.total [Presence] in Cerebral spinal fluid |
| 33522-4 | Platelet aggregation ristocetin induced in Platelet rich plasma --High dose |
| 53647-4 | Flavin adenine dinucleotide [Mass/volume] in Blood |
| 53782-9 | HTT gene CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 44882-9 | Malignant cells [#/volume] in Peritoneal fluid |
| 45020-5 | Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --4 hours post XXX challenge |
| 33765-9 | Leukocytes [#/volume] in Blood Product unit.platelet pheresis by Automated count |
| 33814-5 | Insulin [Units/volume] in Serum or Plasma --15th specimen post XXX challenge |
| 54181-3 | Nitroxoline [Susceptibility] by Disk diffusion (KB) |
| 4607-8 | Hemoglobin M - Hyde Park [Presence] in Blood |
| 24305-5 | Coxsackievirus A7 Ab [Titer] in Serum --2nd specimen |
| 34327-7 | Lead/Creatinine [Molar ratio] in Urine |
| 34334-3 | Lutropin/Creatinine [Ratio] in Urine |
| 34414-3 | Normianserin [Mass/volume] in Serum or Plasma |
| 47035-1 | NKI/C3 Ag [Presence] in Tissue by Immune stain |
| 47072-4 | Epstein Barr virus early IgA Ab [Titer] in Serum by Immunofluorescence |
| 55605-0 | Parakeet feather IgE Ab [Presence] in Serum |
| 55922-9 | IgG [Mass/volume] in Serum by Electrophoresis |
| 56037-5 | Protein phosphatase 3 [Enzymatic activity/volume] in Leukocytes |
| 47509-5 | Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum --1st specimen |
| 47816-4 | 3-Deoxytetronate/Creatinine [Molar ratio] in Urine |
| 56522-6 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 47998-0 | DNA sequence variation display name [Text] Narrative |
| 48028-5 | SERPINE1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 48308-1 | DNA double strand Ab [Units/volume] in Body fluid by Farr method |
| 26456-4 | Erythrocytes [#/volume] in Pleural fluid |
| 26459-8 | Nucleated erythrocytes [#/volume] in Cerebral spinal fluid |
| 26773-2 | Benzfetamine [Mass/mass] in Stool |
| 3685-5 | Hydroxymethoxyphenamine [Mass/volume] in Urine |
| 3760-6 | Mesoridazine [Mass/volume] in Serum or Plasma |
| 56932-7 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose lactulose |
| 48594-6 | Platelet glycoprotein IIb/IIIa Ab [Presence] in Blood by Immunoassay |
| 26997-7 | CD3+CD25+ cells [#/volume] in Blood |
| 38598-9 | Hexachlorobenzene [Mass/volume] in Air |
| 58026-6 | Selenium [Mass/volume] in Nonbiological fluid |
| 29242-5 | Measles virus IgG Ab [Units/volume] in Body fluid |
| 29324-1 | Cocaethylene [Mass/volume] in Gastric fluid |
| 40134-9 | Creatinine [Moles/volume] in Urine --30 minutes post XXX challenge |
| 49865-9 | Coagulation factor VIII activity actual/normal in Platelet poor plasma by Chromogenic method |
| 29684-8 | Rickettsia typhi Ab [Titer] in Serum |
| 29811-7 | Eastern equine encephalitis virus IgG Ab [Presence] in Serum by Immunofluorescence |
| 50274-0 | 3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Amniotic fluid |
| 50443-1 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes pre dose arginine |
| 40804-7 | Methamphetamine [Presence] in Saliva (oral fluid) by Screen method |
| 40824-5 | von Willebrand factor (vWf) cleaving protease inhibitor [Units/volume] in Platelet poor plasma |
| 19317-7 | Tricyclic antidepressants cutoff [Mass/volume] in Urine for Screen method |
| 19318-5 | Tricyclic antidepressants cutoff [Mass/volume] in Urine for Confirmatory method |
| 101803-5 | Malabsorption Evaluation Panel - Stool |
| 1354-0 | 11-Deoxycorticosteroids [Mass/volume] in Plasma --9 hours post 3 g metyraPONE PO overnight |
| 102272-2 | Ox-eye daisy IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14176-2 | Pyrroles [Mass/volume] in Urine |
| 14200-0 | Chlamydia trachomatis B IgG Ab [Titer] in Serum by Immunofluorescence |
| 14322-2 | Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 102871-1 | Cow milk IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103067-5 | Wheat recombinant (rTri a) 19 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103123-6 | Chum salmon roe IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 15033-4 | Ascorbate [Moles/time] in 24 hour Urine |
| 15220-7 | Food Allergen Mix A (Peanut+Cow milk+Egg white+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk |
| 15353-6 | Apolipoprotein E4 [Presence] in Blood |
| 1574-3 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --24 hours post 40 ug corticotropin IM BID 3 day |
| 10736-7 | Virus identified in Cerebral spinal fluid by Electron microscopy |
| 1647-7 | Tuberculosis reaction wheal [Diameter] --3 days post 25 TU intradermal |
| 12334-9 | Para aminophenol [Mass/volume] in Urine |
| 17604-0 | Volume of 24 hour Sweat |
| 1764-0 | Aldosterone [Mass/volume] in Urine |
| 17739-4 | Chloral hydrate [Presence] in Urine by Confirmatory method |
| 74614-9 | Fatty acids.very long chain C26:0 (Hexacosanoate) [Mass/mass] in Fibroblast |
| 91778-1 | Human metapneumovirus identified in Upper respiratory specimen by Organism specific culture |
| 92688-1 | Cryptosporidium parvum+hominis DNA [Presence] in Stool by NAA with probe detection |
| 75658-5 | Plasma cells/100 leukocytes in Bronchial specimen |
| 76412-6 | Sheep prion protein codon 141 [Type] in Blood by Genotype method |
| 7682-8 | Common Sagebrush IgG Ab [Units/volume] in Serum |
| 77010-7 | Urea [Molar ratio] in Serum or Plasma --post dialysis/pre dialysis |
| 92848-1 | Varicella zoster virus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
| 77084-2 | ALPL gene full mutation analysis in Blood or Tissue by Sequencing |
| 78694-7 | Dihydroorotate/Creatinine [Molar ratio] in Urine |
| 78824-0 | DULoxetine cutoff [Mass/volume] in Urine for Confirmatory method |
| 65784-1 | Saltwort native (nSal k) 1 IgE Ab [Units/volume] in Serum |
| 6651-4 | Meropenem [Susceptibility] by Minimum lethal concentration (MLC) |
| 80136-5 | Antihistamines [Presence] in Blood by Screen method |
| 68400-1 | Eosinophils [#/volume] in Pleural fluid by Manual count |
| 80605-9 | Desacetylrifampicin [Mass/volume] in DBS |
| 822-7 | Au sup(a) Ab [Presence] in Serum or Plasma from Donor |
| 9777-4 | Nalbuphine [Mass/volume] in Specimen |
| 72435-1 | 4,5-Dihydroxyhexanoate [Moles/volume] in Serum or Plasma |
| 99616-5 | Trienoate (C20:3w9)/Arachidonate (C20:4w6) [Molar ratio] in RBC.lysate |
| 72574-7 | Coproporphyrin/Porphyrins.total [Pure substance fraction] in 24 hour Urine |
| 72753-7 | HYDROcodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 85990-0 | Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum |
| 86072-6 | Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 86182-3 | Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 86577-4 | Measles virus RNA [Presence] in Urine by NAA with probe detection |
| 87611-0 | Bromadiolone [Mass/mass] in Specimen |
| 73401-2 | Enalapril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74320-3 | MICA*050 IgG Ab [Presence] in Serum |
| 89320-6 | CD25+CD45RO+CD127Low+ cells/100 CD4 cells in Blood |
| 50917-4 | Thallium [Moles/mass] in Hair |
| 60168-2 | Platinum [Mass/mass] in Tissue |
| 60242-5 | Ecarin clotting time (ECT) in Platelet poor plasma by Coagulation assay |
| 21171-4 | FMC7 cells/100 cells in Specimen |
| 21195-3 | Chlorzoxazone [Mass/volume] in Urine |
| 31207-4 | Progesterone receptor [Moles/mass] in Tissue |
| 51258-2 | CD16+CD57+ cells/100 cells in Bone marrow |
| 4286-1 | Insulin NPH [Mass] of Dose |
| 3168-2 | Volume [Flow] of 24 hour Urine |
| 31897-2 | Mumps virus Ag [Presence] in Throat |
| 5179-7 | Hepatitis A virus IgG Ab [Units/volume] in Serum by Immunoassay |
| 51856-3 | Staphylococcus aureus TSST-1 IgE Ab [Units/volume] in Serum |
| 43317-7 | Avian paramyxovirus 9 Ab [Titer] in Serum by Hemagglutination inhibition |
| 43407-6 | Bacteria identified in Wound deep by Culture |
| 3232-6 | Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay |
| 33238-7 | Triple phosphate crystals [Presence] in Urine by Computer assisted method |
| 44438-0 | Aspergillus fumigatus 1 Ab [Units/volume] in Serum |
| 44757-3 | Blood product units given [#] |
| 23434-4 | Salmonella pullorum Ab [Presence] in Serum by Immunoassay |
| 23546-5 | Venezuelan equine encephalitis virus IgM Ab [Presence] in Serum |
| 54034-4 | Anaplasma phagocytophilum Ag [Presence] in Tissue by Immune stain |
| 34412-7 | Mitochondria M9 Ab [Presence] in Serum |
| 55566-4 | Phenelzine [Moles/volume] in Serum or Plasma |
| 47165-6 | Norepinephrine [Moles/volume] in Urine --3rd specimen post XXX challenge |
| 55788-4 | Mononuclear cells [#/volume] in Bone marrow |
| 25733-7 | Procollagen type III [Units/volume] in Serum |
| 25950-7 | Lutropin [Units/volume] in Serum or Plasma by 1st IRP --8th specimen post XXX challenge |
| 48157-2 | Thymine/Creatinine [Molar ratio] in Urine |
| 48223-2 | Wheat triggered leukotriene release [Mass/volume] by Leukocytes |
| 26727-8 | ePHEDrine+Pseudoephedrine [Mass/mass] in Meconium |
| 3653-3 | Flurazepam [Mass/volume] in Serum or Plasma |
| 4883-5 | HLA-Dw17(w7) [Presence] |
| 27097-5 | 2-Methylbutyrylglycine/Creatinine [Mass Ratio] in Urine |
| 38670-6 | Orthocresol [Mass/volume] in Air |
| 38751-4 | 1,4-Benzenediamine [Mass/volume] in Air |
| 39550-9 | Horse dander IgE Ab/IgE total in Serum |
| 57845-0 | Leukocytes [#/volume] in Body fluid by Automated count |
| 49393-2 | Herpes virus 6 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
| 49397-3 | Herpes virus 7 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 29214-4 | Chloramphenicol [Mass/volume] in Body fluid |
| 39984-0 | Creatinine [Mass/volume] in Urine --1 hour post XXX challenge |
| 50019-9 | HLA-DP+DQ+DR (class II) [Type] |
| 50166-8 | Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Serum or Plasma |
| 58929-1 | HLA-DQB1*03:02 [Presence] |
| 5903-0 | Russell viper venom time in Control Platelet poor plasma by Coagulation assay |
| 50219-5 | Respiratory pathogens DNA and RNA 12a panel - Specimen by NAA with probe detection |
| 50388-8 | Neisseria gonorrhoeae rRNA [Presence] in Cervix by NAA with probe detection |
| 50458-9 | Cortisol [Mass/volume] in Serum or Plasma --6th specimen |
| 50481-1 | Follitropin [Units/volume] in Serum or Plasma --5th specimen |
| 30270-3 | Didanosine [Susceptibility] by Phenotype method |
| 40803-9 | Methamphetamine [Presence] in Hair by Screen method |
| 40937-5 | Zinc [Presence] in Serum or Plasma |
| 202-2 | Colistimethate by Disk diffusion (KB) |
| 20788-6 | Duck enteritis virus neutralizing antibody [Presence] in Serum by Neutralization test |
| 20815-7 | Escherichia coli K88 [Presence] in Small intestine Tissue by Agglutination |
| 2089-1 | Cholesterol in LDL [Mass/volume] in Serum or Plasma |
| 13219-1 | Chlamydia trachomatis G+F+K Ab [Units/volume] in Serum |
| 13278-7 | Schistosoma sp IgM Ab [Units/volume] in Serum |
| 1339-1 | Xg sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 101828-2 | Synthetic glucocorticoid panel - Serum or Plasma |
| 101985-0 | Candida parapsilosis DNA [Presence] in Body fluid by Probe.amp.tar |
| 102525-3 | Pine Nut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14156-4 | Coproporphyrin [Mass/mass] in 24 hour Stool |
| 10518-9 | Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain |
| 10841-5 | methazolAMIDE [Mass/volume] in Serum or Plasma |
| 10885-2 | Porphyrins [Mass/time] in 24 hour Urine |
| 16387-3 | Rifabutin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 11143-5 | Glucose [Mass/volume] in Serum or Plasma --45 minutes post 100 g glucose PO |
| 17326-0 | Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 1769-9 | Fatty acids.nonesterified [Mass/volume] in Serum or Plasma |
| 91083-6 | Fungal 18s rRNA gene [Presence] in Isolate by NAA with probe detection |
| 74864-0 | IgA.kappa [Mass/volume] in Serum or Plasma |
| 91705-4 | Corticotropin [Mass/volume] in Plasma --5 minutes pre 1 ug/kg CRH IV |
| 75061-2 | Malonate [Moles/volume] in Serum or Plasma |
| 7549-9 | Onion triggered histamine release [Units/volume] in Blood |
| 60407-4 | Sunflower Seed IgG Ab [Mass/volume] in Serum |
| 76481-1 | Alpha 1 antitrypsin [Moles/volume] in Serum or Plasma |
| 92835-8 | Associated nevus [Presence] in Skin melanoma |
| 93481-0 | Cortisol [Mass/volume] in Serum or Plasma --10 minutes post 1 ug/kg CRH IV |
| 6131-7 | Grapefruit IgE Ab [Units/volume] in Serum |
| 61348-9 | Cockatiel droppings IgE Ab/IgE total in Serum |
| 6180-4 | Mouse serum proteins IgE Ab [Units/volume] in Serum |
| 77033-9 | t(14;16)(q32;q23)(IGH,MAF) fusion transcript in Blood or Tissue by FISH |
| 77726-8 | Factor VIII+von Willebrand factor (vWf) ristocetin cofactor given [Units/volume] by FVIII dosing |
| 93856-3 | Enterovirus RNA [Presence] in Specimen by NAA with non-probe detection |
| 93878-7 | N-Stearoylsphingosine/N-Lignoceroylsphingosine [Molar ratio] in Plasma |
| 63214-1 | Bactericidal permeability increasing protein Ab [Presence] in Body fluid by Immunoassay |
| 78788-7 | amLODIPine [Mass/volume] in Urine |
| 94728-3 | DULoxetine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 65350-1 | Follitropin [Units/volume] in Serum or Plasma --pre or post XXX challenge |
| 79713-4 | TPMT gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
| 68418-3 | Mesothelial cells/100 leukocytes in Vitreous fluid by Manual count |
| 70168-0 | Hematocrit [Volume Fraction] of Synovial fluid |
| 7039-1 | Oxacillin [Susceptibility] by Gradient strip |
| 7055-7 | Tobramycin [Susceptibility] by Gradient strip |
| 7067-2 | Alfalfa Pollen IgE Ab [Units/volume] in Serum |
| 98246-2 | Spermatozoa Motile [#] in Urine by Light microscopy --post ejaculation |
| 99076-2 | Alpha-1-Microglobulin [Mass/volume] in 24 hour Urine |
| 85477-8 | Influenza virus A RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 85819-1 | Clot firmness reduction [Length fraction] in Blood by Thromboelastography --60 min p max clot amplitude + heparinase |
| 86080-9 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum |
| 87929-6 | Bacteria identified in Amniotic fluid by Aerobe culture |
| 87992-4 | Onchocerca sp IgG Ab [Presence] in Serum by Immunoassay |
| 88366-0 | Microscopic observation [Presence] in Vomitus by Acid fast stain |
| 88599-6 | Influenza virus A RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
| 89323-0 | APOB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 41511-7 | Trichomonas vaginalis Ag [Presence] in Vaginal fluid |
| 41615-6 | Xanthurenate [Mass/volume] in Serum or Plasma |
| 30560-7 | Stearoylcarnitine (C18) [Moles/volume] in Serum or Plasma |
| 306-1 | Loracarbef [Susceptibility] by Minimum lethal concentration (MLC) |
| 60245-8 | Androstanolone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 42917-5 | HIV 1 RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 43130-4 | Bile acid fractions panel [Moles/volume] - Serum or Plasma |
| 22097-0 | Avian paramyxovirus 1 Ab [Presence] in Serum |
| 31755-2 | Campylobacter fetus Ag [Presence] in Genital fluid |
| 4363-8 | Orphenadrine [Mass] of Dose |
| 32268-5 | Ribose [Presence] in Urine |
| 52949-5 | chlordiazePOXIDE [Presence] in Gastric fluid |
| 22881-7 | Border disease virus Ag [Presence] in Tissue by Immunoassay |
| 23012-8 | Cowdria ruminantium Ab [Presence] in Serum |
| 44843-1 | Bacteria # 2 identified in Specimen by Anaerobe culture |
| 33314-6 | Rheumatoid factor IgG [Units/volume] in Serum |
| 53991-6 | Nucleolar nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
| 4601-1 | Hemoglobin Kempsey [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 46234-1 | ZAP70 cells/100 cells in Bone marrow |
| 24250-3 | Adenovirus Ab [Titer] in Serum --2nd specimen |
| 24392-3 | Cortisol [Moles/volume] in Serum or Plasma --pre 1 mg dexamethasone PO overnight |
| 34349-1 | Oxalate [Moles/volume] in 24 hour Urine |
| 5594-7 | Beryllium [Mass/volume] in Serum or Plasma |
| 25600-8 | Rotavirus IgM Ab [Units/volume] in Serum |
| 35369-8 | SCA1 gene allele 1 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 35733-5 | Histoplasma capsulatum M Ab [Presence] in Serum by Immune diffusion (ID) |
| 48151-5 | Sedoheptitol/Creatinine [Molar ratio] in Urine |
| 26596-7 | Hydroxyproline [Moles/volume] in Cerebral spinal fluid |
| 3609-5 | Ethchlorvynol [Presence] in Serum or Plasma |
| 56610-9 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 39552-5 | Lamb IgE Ab/IgE total in Serum |
| 57963-1 | FLCN gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 3972-7 | Piperacillin [Mass/volume] in Serum or Plasma |
| 49900-4 | Heptacarboxylporphyrin I [Mass/time] in 24 hour Stool |
| 29720-0 | Orientia tsutsugamushi Litchfield Ab [Presence] in Serum by Immunofluorescence |
| 40503-5 | Sindbis virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 40737-9 | Mumps virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 58847-5 | Somatotropin [Mass/volume] in Serum or Plasma --17th specimen |
| 58898-8 | Renin [Enzymatic activity/volume] in Plasma --4 hours post XXX challenge |
| 59054-7 | Glucagon [Mass/volume] in Serum or Plasma --4th specimen fasting |
| 59199-0 | Deoxyadenosine/Creatinine [Molar ratio] in Urine |
| 50357-3 | Phenolphthalein [Presence] in Serum or Plasma |
| 50553-7 | Color of Urine by Auto |
| 19449-8 | Dihydrocodeine [Mass/volume] in Urine |
| 100736-8 | Acylcarnitine Analysis Post Mortem in Specimen Document |
| 100979-4 | Atopobium vaginae DNA [Presence] in Urine by NAA with probe detection |
| 12536-9 | Butyl nitrate [Presence] in Blood |
| 102029-6 | Somatotropin [Mass/volume] in Serum or Plasma --Fasting post dose insulin IV |
| 13814-9 | Taurine/Creatinine [Mass Ratio] in Urine |
| 13961-8 | Mercury [Presence] in 24 hour Urine |
| 14024-4 | HTLV I+II p32 Ab [Presence] in Serum by Immunoblot |
| 14947-6 | Vanillylmandelate [Moles/time] in 24 hour Urine |
| 104311-6 | Olaparib [Mass/volume] in Serum or Plasma |
| 1530-5 | Glucose [Mass/volume] in Serum or Plasma --3 hours post 100 g glucose PO |
| 15378-3 | Fungus identified in Isolate by Culture |
| 16301-4 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --baseline |
| 16488-9 | Brucella abortus IgG Ab [Units/volume] in Serum by Complement fixation |
| 12261-4 | Toxoplasma gondii IgG Ab [Titer] in Serum by Immunoassay |
| 17489-6 | Progesterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 17529-9 | Retinol [Mass/volume] in Serum or Plasma --6 hours post dose |
| 17807-9 | cycloSPORINE [Mass/volume] in Body fluid |
| 18413-5 | HLA-DR16 [Presence] |
| 7461-7 | Lettuce triggered histamine release [Units/volume] in Blood |
| 74988-7 | Hexacarboxylporphyrin [Moles/volume] in Red Blood Cells |
| 92780-6 | Listeria monocytogenes DNA [Presence] by NAA with probe detection in Positive blood culture |
| 60346-4 | Viable CD34 cells/100 CD34 cells in Body fluid |
| 60553-5 | Trypanosoma cruzi Ab [Presence] in Serum from Donor |
| 76577-6 | Staphylococcus aureus sau3AI gene [Presence] in Swab specimen by NAA with probe detection |
| 93399-4 | Fusobacterium necrophorum DNA [Presence] by NAA with probe detection in Positive blood culture |
| 617-1 | Bacteria identified in Placenta by Aerobe culture |
| 93701-1 | Colistin resistance mcr-2 gene [Presence] by Molecular method |
| 94007-2 | Potassium [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin |
| 63316-4 | U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay |
| 78010-6 | HIV 1 proviral DNA [Logarithmic entitic number] (viral load) in Mononuclear cells from unspecified specimen by NAA with probe detection |
| 94360-5 | Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 64090-4 | Chromosome analysis overall interpretation in Specimen Qualitative by Molecular genetics method |
| 64093-8 | ISCN band level [#] in Amniotic fluid Qualitative by Molecular genetics method |
| 64129-0 | N-desalkylflurazepam/Creatinine [Mass Ratio] in Urine |
| 64983-0 | Cockroach recombinant (rBla g) 2 IgE Ab [Units/volume] in Serum |
| 79182-2 | RNA polymerase III IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 79288-7 | Creatine and guanidinoacetate panel - Cerebral spinal fluid |
| 79415-6 | MSH2 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
| 95422-2 | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Respiratory system specimen by NAA with probe detection |
| 6671-2 | Microscopic observation [Identifier] in Tissue by Methenamine silver nitrate stain |
| 67128-9 | Abnormal leukocytes/100 leukocytes in Specimen by Flow cytometry (FC) |
| 96296-9 | Thuja spp IgE Ab [Units/volume] in Serum |
| 67708-8 | Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBS |
| 96534-3 | Heartland banyangvirus IgM Ab [Presence] in Specimen by Immunoassay |
| 69800-1 | Methyl ethyl ketone [Mass/volume] in Body fluid |
| 81707-2 | Dissection technique [Type] in Tissue |
| 81840-1 | POMGNT1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 97872-6 | Rabies virus Ab panel - Serum or Plasma |
| 7146-4 | Red Beet IgE Ab [Units/volume] in Serum |
| 82537-2 | RAF1 gene full mutation analysis in Blood or Tissue by Sequencing |
| 99082-0 | Coccidioides sp Ag [Mass/volume] in Body fluid by Immunoassay |
| 72163-9 | Leukocytes [Presence] in Specimen by Gram stain |
| 83104-0 | Mullerian inhibiting substance [Mass/volume] in Serum or Plasma by Immunoassay |
| 83105-7 | Mullerian inhibiting substance [Moles/volume] in Serum or Plasma by Immunoassay |
| 72508-5 | UGT1A1 gene c.A(TA)7TAA(*28) [Presence] in Blood or Tissue by Molecular genetics method |
| 7338-7 | Gluten IgG Ab [Units/volume] in Serum |
| 73580-3 | Anion gap 4 in Capillary blood |
| 73722-1 | Bile acid [Moles/volume] in Urine |
| 87961-9 | Varicella zoster virus DNA [Presence] in Body fluid by NAA with probe detection |
| 74089-4 | Pentacarboxylporphyrin III/Creatinine [Molar ratio] in Urine |
| 74397-1 | Reticulocytes/100 erythrocytes in Cord blood by Automated count |
| 50728-5 | Serotonin release 0.1 IU/mL heparin.unfractionated [Units/volume] in Serum |
| 3103-9 | Urobilin [Presence] in Urine |
| 21217-5 | Complement C4d [Mass/volume] in Plasma |
| 21316-5 | Grepafloxacin [Susceptibility] by Gradient strip |
| 42916-7 | Histoplasma capsulatum Ag [Units/volume] in Specimen by Immunoassay |
| 31960-8 | Rubella virus Ag [Presence] in Penis |
| 51793-8 | Xylose [Mass/volume] in Serum or Plasma --1 hour post 5 g xylose PO |
| 43820-0 | Bilirubin.direct [Presence] in Serum or Plasma |
| 44368-9 | Hexanoylglycine/Creatinine [Mass Ratio] in 24 hour Urine |
| 32659-5 | Aflatoxin IgE Ab [Units/volume] in Serum or Plasma |
| 32671-0 | Chlamydia sp Ag [Presence] in Vaginal fluid |
| 33063-9 | Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Levamisole inhibition |
| 53234-1 | Carnitine free (C0)/Stearoylcarnitine (C18) [Molar ratio] in DBS |
| 33394-8 | Myelin associated glycoprotein Ab [Titer] in Serum |
| 44987-6 | Chlamydia trachomatis G+F+K IgA Ab [Presence] in Serum |
| 45005-6 | Chlamydia trachomatis IgA Ab [Presence] in Serum |
| 2432-3 | Homogentisate [Presence] in Urine |
| 47154-0 | Lead [Moles/volume] in Urine --post EDTA therapy |
| 25467-2 | Manganese [Moles/volume] in Serum or Plasma |
| 55816-3 | 3,4-Dihydroxyphenylacetate [Moles/volume] in Urine |
| 56032-6 | Lithium [Moles/volume] in Gastric fluid |
| 47857-8 | Galactitol/Creatinine [Molar ratio] in Urine |
| 5637-4 | Cyanide [Mass/volume] in Urine |
| 57374-1 | Oxalate [Mass/volume] in 2 hour Urine |
| 57527-4 | 17-Hydroxycorticosteroids [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
| 57794-0 | Newborn screening test results panel - DBS |
| 49357-7 | Hepatitis B virus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 2860-5 | Protein nitrogen [Mass/time] in 24 hour Urine |
| 40171-1 | Glucose [Moles/volume] in Serum or Plasma --9 hours post XXX challenge |
| 58506-7 | C peptide [Moles/volume] in Serum or Plasma --2.5 hours post dose glucose |
| 29661-6 | Dengue virus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 58815-2 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --2nd specimen |
| 59224-6 | Prostate Specific Ag Free [Mass/volume] in Peritoneal fluid |
| 5053-4 | Aspergillus sp Ab [Titer] in Serum by Complement fixation |
| 3009-8 | Threonine [Mass/volume] in Urine |
| 30313-1 | Hemoglobin [Mass/volume] in Arterial blood |
| 30354-5 | Hemoglobin [Mass/volume] in Arterial cord blood |
| 40907-8 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
| 40998-7 | Calcium hydrogen phosphate dihydrate/Total in Stone |
| 1005-8 | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma |
| 100754-1 | Platelet disorders multigene analysis in Blood or Tissue by Sequencing |
| 1248-4 | M1 Ag [Presence] on Red Blood Cells from Donor |
| 12518-7 | Catecholamines [Mass/volume] in Urine --4th specimen post XXX challenge |
| 101366-3 | Ebola virus RNA [Presence] in Blood by NAA with non-probe detection |
| 101786-2 | Toxoplasma gondii DNA [Presence] in Serum by RT-PCR |
| 102177-3 | Beet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14792-6 | Imipramine+Desipramine [Presence] in Serum or Plasma |
| 103187-1 | Klebsiella pneumoniae DNA [Presence] in Respiratory system specimen by NAA with probe detection |
| 104240-7 | Histiocytic neoplasm multigene analysis in Blood or Tissue by Molecular genetics method |
| 10948-8 | Pigeon feather IgE Ab [Units/volume] in Serum |
| 11256-5 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum |
| 17331-0 | Neisseria meningitidis polyvalent Ab [Units/volume] in Serum |
| 17391-4 | Orthocresol [Mass/volume] in Blood |
| 17868-1 | Acylcarnitine/Creatinine [Ratio] in Urine |
| 17948-1 | Fungus # 3 identified in Specimen by Culture |
| 18233-7 | Influenza virus Ab [Units/volume] in Cerebral spinal fluid |
| 91706-2 | Corticotropin [Mass/volume] in Plasma --1 minute pre 1 ug/kg CRH IV |
| 61058-4 | Alpha-Phenyl-2-Piperidine acetate [Presence] in Urine |
| 61121-0 | CD8-CD57+ cells/100 cells in Blood |
| 75760-9 | Haloperidol [Presence] in Blood or Urine by Screen method |
| 77025-5 | Rhinovirus RNA [Presence] in Nasopharynx by NAA with probe detection |
| 92836-6 | Desmoplastic melanoma [Identifier] in Skin melanoma |
| 93238-4 | dRVVT excess phospholipid in Platelet poor plasma by Coagulation assay --post heparin neutralization |
| 9334-4 | Methanol [Mass/volume] in Blood |
| 9350-0 | Sulfhydryls [Presence] in Urine |
| 62366-0 | Recommended follow-up [Identifier] |
| 93740-9 | Chives IgE Ab [Units/volume] in Serum |
| 7796-6 | Platelet clump [Presence] in Blood by Light microscopy |
| 63436-0 | Paper wasp recombinant (rPol d) 5 IgE Ab [Units/volume] in Serum |
| 79131-9 | 1-Hydroxymidazolam [Mass/volume] in Body fluid |
| 6553-2 | Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 65752-8 | Liver Pathology biopsy report |
| 95722-5 | Glycine receptor Ab [Presence] in Serum or Plasma by Immunoassay |
| 95960-1 | Tetrachlorophthalic anhydride IgE Ab [Units/volume] in Serum |
| 68393-8 | Basophils [#/volume] in Pericardial fluid by Manual count |
| 6894-0 | Zidovudine [Mass/volume] in Serum or Plasma |
| 68982-8 | PFGE panel - Isolate |
| 80610-9 | A IgG Ab [Presence] in Serum or Plasma |
| 97234-9 | Cocaine [Presence] in Cord tissue by Screen method |
| 82335-1 | Cytokines panel - Serum or Plasma |
| 82481-3 | TRBV28 gene segment/TRBV gene segments.total in Blood |
| 9798-0 | Depth of Stone |
| 98984-8 | OXcarbazepine [Mass/volume] in Urine by Confirmatory method |
| 99867-4 | Acanthocytes [#/area] in Urine sediment by Computer assisted method |
| 86621-0 | Methicillin resistance mecC gene [Presence] by Molecular method |
| 73283-4 | Methotrexate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73858-3 | Allo-pregnanediol [Moles/volume] in 24 hour Urine |
| 74308-8 | PRRSV ORF5 gene sequence homology to Ingelvac ATP in Isolate by Sequencing |
| 89640-7 | Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay |
| 59401-0 | Echovirus IgG Ab [Units/volume] in Serum by Immunoassay |
| 59566-0 | Netilmicin [Moles/volume] in Serum or Plasma |
| 59592-6 | 7-Aminoclonazepam [Mass/volume] in Blood by Confirmatory method |
| 60291-2 | carBAMazepine [Presence] in Specimen |
| 21275-3 | Follitropin [Units/volume] in Serum or Plasma --15 minutes post dose gonadotropin releasing hormone |
| 31426-0 | Histoplasma capsulatum mycelial phase Ab [Units/volume] in Body fluid |
| 42913-4 | Hemoglobin.gastrointestinal [Presence] in Specimen --1st specimen |
| 43002-5 | Legionella pneumophila 1 IgM Ab [Titer] in Cerebral spinal fluid |
| 31949-1 | Respiratory syncytial virus Ag [Presence] in Throat |
| 51498-4 | Estradiol (E2) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 5153-2 | Epstein Barr virus early Ab [Presence] in Serum by Immunoassay |
| 4345-5 | Naproxen [Mass] of Dose |
| 43733-5 | 4-Hydroxybenzoate [Presence] in 24 hour Urine |
| 2258-2 | Estrone (E1) [Mass/volume] in Serum or Plasma |
| 52-1 | Butirosin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 5264-7 | Onchocerca sp Ab [Units/volume] in Serum |
| 2280-6 | Fibronectin [Mass/volume] in Plasma |
| 23138-1 | Histoplasma capsulatum farciminosum reaction wheal [Diameter] --3 days post dose intradermal |
| 32720-5 | Spermatozoa IgM Ab [Presence] in Semen |
| 32748-6 | CD90 cells/100 cells in Specimen |
| 53168-1 | Butyrylcarnitine+Isobutyrylcarnitine (C4)/Propionylcarnitine (C3) [Molar ratio] in DBS |
| 33340-1 | Zolpidem [Moles/volume] in Urine |
| 45192-2 | Carnitine esters/Carnitine.free (C0) [Molar ratio] in DBS |
| 46713-4 | Food Allergen Mix 20 (Barley+Rice+Rye+Wheat) IgE Ab [Units/volume] in Serum by Multidisk |
| 469-7 | Sulfamethoxazole [Susceptibility] by Disk diffusion (KB) |
| 24104-2 | Lymphoma cells/100 leukocytes in Blood by Manual count |
| 55480-8 | Insulin [Moles/volume] in Serum or Plasma --5 minutes pre dose glucose |
| 47102-9 | Copper [Moles/volume] in Red Blood Cells |
| 4715-9 | HLA-A11 [Presence] in Donor |
| 2547-8 | Lactate dehydrogenase 5 [Enzymatic activity/volume] in Serum or Plasma by Chemical separation |
| 34890-4 | Coliform bacteria [#/volume] in Specimen by Viability count |
| 35036-3 | Macrophages [#/volume] in Body fluid |
| 5586-3 | Arsenic [Mass/volume] in Urine |
| 56030-0 | Karyotype [Identifier] in Urine by FISH Narrative |
| 47602-8 | Citrate synthase [Enzymatic activity/mass] in Leukocytes |
| 25714-7 | Litchi IgE Ab [Units/volume] in Serum |
| 26022-4 | Enterovirus NOS Ab [Titer] in Serum by Complement fixation |
| 35429-0 | Herpes simplex virus identified in Stool by Organism specific culture |
| 48311-5 | Lysosomal enzymes screen [Identifier] in Blood |
| 2615-3 | Methemoglobin/Hemoglobin.total in Arterial blood |
| 56710-7 | Clarithromycin IgE Ab [Units/volume] in Serum |
| 48347-9 | levETIRAcetam [Moles/volume] in Serum or Plasma |
| 48624-1 | Bilirubin.total [Mass/volume] in Cord blood |
| 4881-9 | HLA-Dw16 [Presence] |
| 38521-1 | Coagulation factor VIII Ag actual/normal in Platelet poor plasma by Immunoassay |
| 49031-8 | CD59 RBC/100 erythrocytes in Blood |
| 27327-6 | Spermatozoa Motile/100 spermatozoa in Semen --12 hours post ejaculation |
| 2790-4 | Phosphoethanolamine [Mass/volume] in Urine |
| 38698-7 | Ethyleneimine [Mass/volume] in Air |
| 57788-2 | Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine --pre dose dexamethasone |
| 57792-4 | Fatty acid oxidation conditions suspected [Identifier] in DBS |
| 57981-3 | HYDROcodone [Presence] in Meconium |
| 49323-9 | Hemoglobin pattern [Interpretation] in Blood by Electrophesis citrate agar |
| 40224-8 | Calcium [Moles/volume] in Serum or Plasma --45 minutes pre XXX challenge |
| 58806-1 | Brucella sp Ab [Titer] in Cerebral spinal fluid by Agglutination |
| 49834-5 | Leucine [Presence] in Urine |
| 49910-3 | Isocitrate/Creatinine [Molar ratio] in 24 hour Urine |
| 29847-1 | Highlands J virus Ab [Titer] in Serum |
| 40661-1 | Protein.monoclonal [Mass/volume] in Urine by Electrophoresis |
| 58941-6 | Bilirubin [Mass/volume] in Skin |
| 5-9 | Almecillin [Susceptibility] by Serum bactericidal titer |
| 5023-7 | Mycobacterium avium ss avium rRNA [Presence] in Specimen by Probe |
| 50494-4 | Somatotropin [Mass/volume] in Serum or Plasma --2nd specimen |
| 30295-0 | Saquinavir [Susceptibility] by Genotype method |
| 40808-8 | Phencyclidine [Presence] in Saliva (oral fluid) by Screen method |
| 40848-4 | 3-Methylcrotonylglycine [Mass/time] in 24 hour Urine |
| 41041-5 | 3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Blood |
| 4107-9 | Acyclovir [Mass] of Dose |
| 1924-0 | Base deficit in Venous blood |
| 20981-7 | Verotoxin identified in Isolate |
| 12368-7 | Phenacetin [Presence] in Urine |
| 12820-7 | Progesterone [Mass/volume] in 24 hour Urine |
| 12922-1 | Testosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 13202-7 | Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 13548-3 | chlorproMAZINE [Presence] in Serum or Plasma |
| 102374-6 | Hop IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102410-8 | Lilac IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10242-6 | Oxygen content in Ductus arteriosus |
| 13960-0 | Coproporphyrin [Presence] in 24 hour Urine |
| 1412-6 | Cortisol [Mass/volume] in Serum or Plasma --26 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 102873-7 | Duck meat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102874-5 | Fenugreek IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102957-8 | Catfish IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14489-9 | Virus identified in Blood by Immunofluorescence |
| 14589-6 | Amylase isoenzymes [Interpretation] in Serum or Plasma |
| 14709-0 | Eosinophils/100 leukocytes in Bronchial specimen by Manual count |
| 14826-2 | Meperidine [Presence] in Gastric fluid |
| 15140-7 | Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Urine |
| 10886-0 | Prostate Specific Ag Free [Mass/volume] in Serum or Plasma |
| 16566-2 | ceFAZolin [Mass/volume] in Urine |
| 1208-8 | little s Ab [Presence] in Serum or Plasma from Blood product unit |
| 16816-1 | Enoxacin [Mass/volume] in Urine |
| 17055-5 | Legionella longbeachae 2 IgG Ab [Presence] in Serum |
| 17112-4 | CD120A cells/100 cells in Blood |
| 17133-0 | CD3+CD16+ cells/100 cells in Blood |
| 17160-3 | CD46 cells/100 cells in Blood |
| 18223-8 | EPINEPHrine [Mass/volume] in Urine --6th specimen post XXX challenge |
| 18953-0 | Neomycin [Susceptibility] |
| 18994-4 | Ticarcillin [Susceptibility] |
| 90908-5 | Eicosapentaenoate (C20:5w3)+Docosapentaenate (C22:5w3)+Docosahexaenoate (C22:6w3)/Fatty acids.C14-C22 risk [Interpretation] in Blood Qualitative |
| 74779-0 | Human papilloma virus 11 DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
| 91677-5 | Cryptosporidium parvum Ag [Presence] in Stool by Rapid immunoassay |
| 92697-2 | Gastrointestinal parasitic pathogens panel - Stool by NAA with probe detection |
| 92743-4 | Hepatosplenomegaly due to lysosomal storage disorders screening panel - Serum or Plasma |
| 75071-1 | Acetaminophen/Creatinine [Molar ratio] in Urine |
| 75122-2 | Deoxyadenosine [Moles/volume] in Serum or Plasma |
| 75153-7 | Thymine [Moles/volume] in Cerebral spinal fluid |
| 75718-7 | CYP1A2 gene c.3533G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 60334-0 | Thiocyanate [Moles/volume] in Specimen |
| 60434-8 | CD19+CD103+ cells [#/volume] in Blood |
| 76628-7 | Norovirus genogroup I and II RNA [Identifier] in Stool by NAA with probe detection |
| 7691-9 | Scallop IgE Ab [Units/volume] in Serum |
| 9366-6 | Arsenic [Mass/mass] in Specimen |
| 62321-5 | Severe combined immunodeficiency newborn screen interpretation |
| 77370-5 | Procollagen type I.N-terminal propeptide [Mass/volume] in Serum or Plasma by Immunoassay |
| 93835-7 | Coccidioides sp IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 94064-3 | Bacterial eis gene drug resistance mutation [Identifier] by Molecular method |
| 78806-7 | Alminoprofen [Mass/volume] in Body fluid |
| 94705-1 | Voltage-gated calcium channel P/Q type binding Ab [Moles/volume] in Serum by Immunoassay |
| 94718-4 | Alpha defensins 1+2+3 [Presence] in Synovial fluid by Immunoassay |
| 63455-0 | Coxiella burnetii phase 1 IgM Ab [Presence] in Serum by Immunofluorescence |
| 95659-9 | Adenovirus RNA [Presence] in Specimen by NAA with probe detection |
| 6659-7 | Microscopic observation [Identifier] in Tissue by Carbol-fuchsin stain |
| 68912-5 | Erythrocytes in 24 hour Urine sediment by Light microscopy |
| 80623-2 | Zika virus neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen |
| 6914-6 | Chlamydophila pneumoniae IgM Ab [Titer] in Serum by Immunofluorescence |
| 70039-3 | Polymorphonuclear cells/100 leukocytes in Peritoneal fluid by Automated count |
| 82519-0 | Dengue virus 1+3 and 2+4 panel - Serum by NAA with probe detection |
| 82557-0 | Food Allergen Mix 75 (Cow milk+Egg white+Cod+Wheat) IgE Ab [Presence] in Serum by Multidisk |
| 82563-8 | Food Allergen Mix 77 (Kiwi+Cashew nut+Hazel nut+Tomato+Sesame seed) IgE Ab [Presence] in Serum by Multidisk |
| 71865-0 | Hemoglobin F/Hemoglobin.total [Pure mass fraction] in Blood by Electrophoresis |
| 72210-8 | inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
| 73087-9 | Vancomycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73165-3 | Risedronate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73172-9 | Raloxifene induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73181-0 | Quinapril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 74033-2 | Arbovirus IgM Ab [Presence] in Serum by Immunofluorescence |
| 74335-1 | MICA*016 IgG Ab [Presence] in Serum |
| 42621-3 | Mycoplasma hominis DNA [Presence] in Blood by NAA with probe detection |
| 21300-9 | Giardia lamblia IgA Ab [Titer] in Serum by Immunofluorescence |
| 21654-9 | CFTR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 51443-0 | CD117 cells [Units/volume] in Blood |
| 4284-6 | Indomethacin [Mass] of Dose |
| 43048-8 | Coxsackievirus A9 Ab [Titer] in Body fluid |
| 31731-3 | Blastomyces dermatitidis Ag [Presence] in Serum |
| 51892-8 | ABO group [Type] in Cord blood |
| 22782-7 | African swine fever virus Ag [Presence] in Tissue by Agglutination |
| 5200-1 | Hepatitis D virus Ab [Units/volume] in Serum by Immunoassay |
| 52132-8 | t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
| 43849-9 | Coccidioides sp IgG Ab [Presence] in Serum by Immunoassay |
| 3321-7 | Amikacin [Mass/volume] in Serum or Plasma --trough |
| 53335-6 | Casts type not specified [#/area] in Urine by Computer assisted method |
| 23356-9 | Peste des petits ruminants virus Ag [Presence] in Tissue by Immunoelectrophoresis |
| 33309-6 | Phosphatidylinositol Ab [Presence] in Serum |
| 33402-9 | Coccidioides sp Ab [Titer] in Serum |
| 33651-1 | Cryoglobulin.IgM [Mass/volume] in Serum |
| 45181-5 | 19q chromosome deletion [Presence] in Blood or Tissue by Molecular genetics method |
| 54293-6 | Heptanoylcarnitine (C7) [Moles/volume] in Urine |
| 24214-9 | Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
| 2428-1 | Homocysteine [Mass/volume] in Serum or Plasma |
| 34454-9 | La Crosse virus RNA [Presence] in Blood by NAA with probe detection |
| 47070-8 | Rickettsia rickettsii IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 25167-8 | Coproporphyrin [Moles/volume] in Urine |
| 25178-5 | Amikacin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 34923-3 | Monoblasts/100 leukocytes in Blood |
| 55628-2 | Cefadroxil [Susceptibility] by Gradient strip |
| 47632-5 | Glycerol/Creatinine [Molar ratio] in Urine |
| 47919-6 | Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose arginine+insulin |
| 56385-8 | Scallop IgG4 Ab [Mass/volume] in Serum |
| 56479-9 | Superoxide dismutase [Enzymatic activity/mass] in Red Blood Cells |
| 48024-4 | AS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 48084-8 | 3-Hydroxydodecanedioate (3-OH-D-C12)/Creatinine [Molar ratio] in Urine |
| 48174-7 | Mycobacterium tuberculosis complex rRNA [Presence] in Specimen by NAA with probe detection |
| 263-4 | Fusidate [Susceptibility] by Disk diffusion (KB) |
| 3809-1 | Methylphenidate [Mass/volume] in Urine |
| 38386-9 | Color of Amniotic fluid |
| 38421-4 | C peptide [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 38597-1 | Heptachlor [Mass/volume] in Air |
| 49308-0 | Neutrophil cytoplasmic Ab pattern [Interpretation] in Serum by Immunofluorescence Narrative |
| 27923-2 | Coenzyme Q10 [Mass/volume] in Serum or Plasma |
| 5779-4 | Crystals [type] in Bile fluid by Light microscopy |
| 2901-7 | Pyridoxine congeners [Mass/volume] in Serum or Plasma |
| 29400-9 | Meperidine [Mass/volume] in Gastric fluid |
| 58607-3 | Corticotropin [Moles/volume] in Plasma --2 days post dose metyraPONE |
| 49972-3 | Collection time of Blood--2nd specimen |
| 29772-1 | Coxiella burnetii phase 2 Ab [Titer] in Serum by Complement fixation |
| 29950-3 | Nuclear IgG Ab [Presence] in Serum by Immunoassay |
| 5918-8 | Urea nitrogen [Mass/volume] in Dialysis fluid |
| 59250-1 | Tocopherols/Cholesterol [Molar ratio] in Serum or Plasma |
| 50200-5 | Iron [Mass/volume] in Serum or Plasma --3rd specimen |
| 50220-3 | Collection interval from baseline of Unspecified specimen |
| 50363-1 | Common Pigweed IgE Ab/IgE total in Serum |
| 5038-5 | Acetylcholine receptor blocking Ab [Titer] in Serum by Immunofluorescence |
| 50489-4 | Gastrin [Mass/volume] in Serum or Plasma --5th specimen |
| 40790-8 | Oil palm IgE Ab [Units/volume] in Serum |
| 40843-5 | Chicken meat IgE Ab/IgE total in Serum |
| 19420-9 | Dextroamphetamine [Presence] in Urine by Confirmatory method |
| 20472-7 | Eosinophils [Presence] in Specimen by Wright stain |
| 20553-4 | Norfluoxetine [Mass/volume] in Urine by Confirmatory method |
| 20862-9 | Influenza virus A Ab [Presence] in Serum by Hemagglutination inhibition |
| 12528-6 | Norepinephrine [Mass/volume] in Plasma --4 hours post XXX challenge |
| 12555-9 | Turpentine [Mass/volume] in Urine |
| 13356-1 | Fat [Presence] in Body fluid |
| 1019-9 | E Ag [Presence] on Red Blood Cells from Blood product unit |
| 102038-7 | ROS proto-oncogene 1 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 14300-8 | Plateletpheresis units available [#] |
| 14328-9 | Leukocytes [Presence] in Sputum by Light microscopy |
| 1461-3 | EPINEPHrine [Mass/volume] in Plasma --1 hour post 300 ug cloNIDine PO |
| 15047-4 | Creatine [Moles/time] in 24 hour Urine |
| 10650-0 | Candida sp DNA [Presence] in Blood by Probe with amplification |
| 15427-8 | Service comment 36 |
| 11020-5 | Microscopic observation [Identifier] in Blood or Marrow by Tartrate-resistant acid phosphatase stain |
| 16266-9 | Calcium hydrogen phosphate crystals [Presence] in Stone by Infrared spectroscopy |
| 16335-2 | Hydrocarbons Aliphatic [Identifier] in Blood |
| 16457-4 | Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in Leukocytes |
| 17075-3 | Lidocaine [Mass/volume] in Urine |
| 17498-7 | Beta globulin [Mass/volume] in Body fluid by Electrophoresis |
| 17533-1 | Rheumatoid arthritis nuclear Ab [Presence] in Serum by Immunofluorescence |
| 17712-1 | Toluene diisocyanate [Mass/volume] in Blood |
| 17751-9 | Tryptamine [Mass/volume] in Serum or Plasma |
| 17836-8 | Neutrophils/100 leukocytes in Synovial fluid |
| 90913-5 | Docosapentaenate (C22:5w3)/Fatty acids.C14-C22 in Blood |
| 75359-0 | Bacteria identified in Bone marrow by Anaerobe+Aerobe culture |
| 61108-7 | Mitochondria DNA complex I targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 76688-1 | Alpha-1-acid glycoprotein/Creatinine [Mass Ratio] in Urine |
| 7706-5 | Johnson grass smut IgG Ab [Units/volume] in Serum |
| 77736-7 | Mycobacterium abscessus complex clarithromycin resistance erm(41) gene [Interpretation] by Molecular method |
| 6318-0 | Borrelia burgdorferi Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 63188-7 | Cocklebur IgG Ab [Mass/volume] in Serum |
| 9454-0 | Herpes simplex virus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 63432-9 | Herpes simplex virus 1+2 IgM Ab [Units/volume] in Cerebral spinal fluid |
| 645-2 | Microscopic observation [Identifier] in Sputum by Acid fast stain.Kinyoun |
| 96371-0 | Tapentadol [Presence] in Saliva (oral fluid) by Confirmatory method |
| 9646-1 | Sulfide [Mass/volume] in Blood |
| 8087-9 | Parietal cell Ab [Units/volume] in Serum |
| 8104-2 | CD5+CD20+ cells/100 cells in Blood |
| 81152-1 | Chikungunya virus non-structural protein 1 (nsP1) RNA [Presence] in Serum by NAA with probe detection |
| 9666-9 | HIV 1 p31 Ab [Presence] in Serum by Immunoblot |
| 81639-7 | Heparin dose response slope in Blood by Coagulation assay |
| 81834-4 | SLC17A5 gene full mutation analysis in Blood or Tissue by Sequencing |
| 82198-3 | Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection |
| 71608-4 | Polymorphonuclear cells/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
| 82452-4 | U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot |
| 841-7 | A1 Ab [Presence] in Serum or Plasma |
| 85347-3 | Sentinel lymph nodes examined [#] in Cancer specimen by Light microscopy |
| 85496-8 | Streptococcus pneumoniae serotype [Identifier] in Specimen by NAA with probe detection |
| 85760-7 | Streptococcus pneumoniae Danish serotype 19A DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 85831-6 | Beta-lactam resistance ESBL blaBEL gene [Presence] by Molecular method |
| 73336-0 | Ibuprofen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87596-3 | Nicotine [Mass/mass] in Specimen |
| 87643-3 | o,p'- DDD [Mass/mass] in Specimen |
| 41185-0 | Xylose [Mass/volume] in Serum or Plasma --5 hours post dose xylose PO |
| 50618-8 | Phosphatidylcholine.saturated/Surfactant.total in Amniotic fluid |
| 41854-1 | Castor Bean DNA [Presence] in Specimen by NAA with probe detection |
| 59969-6 | Strychnine [Moles/volume] in Urine |
| 59976-1 | traZODone [Moles/volume] in Gastric fluid |
| 60042-9 | N-acetylprocainamide [Mass/volume] in Blood |
| 60276-3 | oxyCODONE+oxyMORphone cutoff [Mass/volume] in Urine for Screen method |
| 31263-7 | Bluetongue virus 17 Ab [Units/volume] in Serum |
| 42859-9 | Candida albicans Ab [Titer] in Serum |
| 42875-5 | CD22 cells/100 cells in Body fluid |
| 42960-5 | Salmonella typhi H Ab [Titer] in Serum |
| 22149-9 | Brucella abortus Ab [Presence] in Whey |
| 2230-1 | EPINEPHrine [Mass/volume] in Plasma |
| 43602-2 | Echinococcus granulosus Ab [Units/volume] in Serum by Immunoassay |
| 22513-6 | Saint Louis encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid |
| 22533-4 | Sarcocystis neurona Ab [Presence] in Body fluid |
| 32612-4 | Amino acids [Moles/volume] in Vitreous fluid |
| 32678-5 | Ehrlichia chaffeensis IgG Ab [Presence] in Cerebral spinal fluid |
| 53137-6 | Urea [Moles/time] in 1 hour Urine |
| 5320-7 | Rickettsia typhus group IgG Ab [Titer] in Serum by Immunofluorescence |
| 53270-5 | Urinalysis type of non-squamous epithelial cells panel - Urine by Computer assisted method |
| 44639-3 | Histologic type in Prostate tumor |
| 53775-3 | Hepatitis A virus Ab panel - Serum |
| 45066-8 | Creatinine and Glomerular filtration rate.predicted panel - Serum, Plasma or Blood |
| 45076-7 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Specimen by Probe |
| 45107-0 | Chlamydia sp Ag [Presence] in Cervix |
| 23872-5 | Heptacarboxylporphyrin I [Mass/time] in unspecified time Stool |
| 33984-6 | Coagulation factor X activity actual/normal in Platelet poor plasma by Chromogenic method |
| 24235-4 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum --2nd specimen |
| 24291-7 | Influenza virus B Ab [Titer] in Serum --1st specimen |
| 35069-4 | Basophils/100 leukocytes in Peritoneal fluid |
| 55719-9 | Ticarcillin+Sulbactam [Susceptibility] by Gradient strip |
| 56026-8 | Pyrazinamide 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 2568-4 | Phospholipid [Mass/volume] in Serum or Plasma |
| 266-7 | Gentamicin [Susceptibility] by Minimum lethal concentration (MLC) |
| 56747-9 | Azithromycin IgE Ab [Units/volume] in Serum |
| 48432-9 | Fructose [Molar amount] in unspecified time Semen |
| 48715-7 | Leishmania tropica IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 48890-8 | Coxiella burnetii phase 1 IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 3825-7 | Morazone [Mass/time] in 24 hour Urine |
| 5718-2 | Rubidium [Mass/volume] in Blood |
| 57362-6 | Lactate [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 57550-6 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --2 days post dose dexamethasone |
| 48973-2 | Leukocytes [Presence] in Stool by Methylene blue stain --2nd specimen |
| 49290-0 | Porphyrins [Interpretation] in Stool Narrative |
| 49292-6 | Porphyrin fractions [Interpretation] in 24 hour Urine Narrative |
| 39528-5 | Adenovirus DNA [Presence] in Specimen by NAA with probe detection |
| 49729-7 | Penicillin G IgG Ab [Mass/volume] in Serum |
| 58819-4 | Cortisol [Mass/volume] in Serum or Plasma --21st specimen |
| 59174-3 | QUEtiapine [Presence] in Urine |
| 30153-1 | Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum |
| 41066-2 | PRX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19379-7 | Butorphanol cutoff [Mass/volume] in Urine for Screen method |
| 20638-3 | Asparagine [Moles/volume] in Serum or Plasma |
| 12340-6 | Ethylene [Presence] in Blood |
| 100713-7 | Cariprazine [Mass/volume] in Serum or Plasma |
| 100874-7 | Basidiobolus sp [Presence] in Specimen |
| 12717-5 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 101402-6 | Phenylalanine and Tyrosine panel - Serum or Plasma |
| 102097-3 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine, Cystatin C and Urea-based formula (CKiD) |
| 1363-1 | Corticotropin [Mass/volume] in Plasma --30 minutes post dose insulin IV |
| 102379-5 | Horse dander IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102623-6 | Tapioca IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14214-1 | Histoplasma capsulatum exoantigen [Identifier] in Isolate |
| 102839-8 | Vanilla IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14446-9 | Triglyceride [Mass/volume] in Cerebral spinal fluid |
| 14565-6 | Hemoglobin.gastrointestinal [Presence] in Stool --3rd specimen |
| 14782-7 | Homovanillate [Moles/volume] in Urine |
| 104349-6 | Borrelia recurrentis [Presence] in Blood by Organism specific culture |
| 10515-5 | Thyroglobulin Ag [Presence] in Tissue by Immune stain |
| 10724-3 | Toxoplasma gondii IgE Ab [Units/volume] in Serum by Immunoassay |
| 11560-0 | Acetylcholine receptor binding Ab [Units/volume] in Serum |
| 186-7 | Ciprofloxacin [Susceptibility] by Disk diffusion (KB) |
| 90069-6 | Gram positive bacilli identified in Isolate by Organism specific culture |
| 91119-8 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:1 addition of normal plasma |
| 60550-1 | Fascin [Presence] in Tissue by Immune stain |
| 93975-1 | Urea nitrogen [Mass/volume] in Serum or Plasma --1 hour specimen |
| 63122-6 | Eel IgG Ab [Mass/volume] in Serum |
| 6314-9 | Bordetella pertussis Ab [Titer] in Specimen by Immunofluorescence |
| 63235-6 | DNA double strand IgM Ab [Units/volume] in Pleural fluid by Immunoassay |
| 77940-5 | Albumin [Mass/volume] by Electrophoresis in Urine collected for unspecified duration |
| 78986-7 | Prolactin.dimeric/Prolactin in Serum or Plasma |
| 79492-5 | Furoylglycine [Moles/volume] in Serum or Plasma |
| 6602-7 | Influenza virus identified in Sputum tracheal aspirate by Organism specific culture |
| 6782-7 | IgG/Albumin [Mass Ratio] in Serum |
| 69958-7 | Food Allergen Mix 15 (Orange+Apple+Banana+Peach) IgE Ab [Units/volume] in Serum by Multidisk |
| 81791-6 | Apple recombinant (rMal d) 3 IgE Ab [Units/volume] in Serum |
| 9787-3 | Sarcoptes scabiei identified in Skin by Light microscopy |
| 71598-7 | Neutrophils/Leukocytes [Pure number fraction] in Bronchial specimen by Manual count |
| 82423-5 | Ma+Ta Ab [Presence] in Serum by Line blot |
| 82513-3 | Hepatitis C virus genotype 3 [Presence] in Serum or Plasma by NAA with probe detection |
| 82587-7 | Leukocytes [#/volume] in Bone marrow by Automated count |
| 71787-6 | Staphylococcus aureus exfoliative toxin B etb gene [Presence] in Specimen by NAA with probe detection |
| 99435-0 | Cyprinus carpio recombinant (rCyp c) 1 IgG4 Ab [Mass/volume] in Serum |
| 86000-7 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum --2nd specimen |
| 86195-5 | 4-Ethylmethcathinone [Mass/volume] in Urine by Confirmatory method |
| 73427-7 | cycloSPORINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73617-3 | Nitazoxanide [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 73843-5 | Tetrahydrodeoxycortisol [Moles/time] in 24 hour Urine |
| 87775-3 | Metaxalone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 87834-8 | Protein.monoclonal band 2 [Mass/volume] in Urine by Immunofixation |
| 74091-0 | Heptacarboxylporphyrin III/Creatinine [Molar ratio] in Urine |
| 88717-4 | Candida sp identified in Isolate |
| 89537-5 | PCNA extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
| 59336-8 | Norsibutramine [Mass/volume] in Urine |
| 59642-9 | clonazePAM [Mass/mass] in Tissue by Confirmatory method |
| 50724-4 | Lymphoblasts/100 leukocytes in Bone marrow by Manual count |
| 50936-4 | Vanadium [Moles/volume] in Urine |
| 30443-6 | Mononuclear cells/100 leukocytes in Gastric fluid |
| 30898-1 | Plasma volume by Scintigraphy |
| 31017-7 | Tissue transglutaminase IgA Ab [Units/volume] in Serum |
| 41847-5 | Horseradish IgG Ab [Units/volume] in Serum |
| 2152-7 | Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis |
| 31582-0 | Reovirus Ab [Units/volume] in Body fluid |
| 21765-3 | SCA1 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 31793-3 | Cryptosporidium sp Ag [Units/volume] in Stool |
| 31843-6 | Helicobacter pylori Ag [Presence] in Stool |
| 31998-8 | Bordetella pertussis Ab [Presence] in Serum |
| 43316-9 | Avian paramyxovirus 8 Ab [Titer] in Serum by Hemagglutination inhibition |
| 43723-6 | 5,10-Methylenetetrahydrofolate reductase [Presence] in Serum |
| 32127-3 | raNITIdine [Presence] in Specimen |
| 32346-9 | Uroporphyrin [Moles/mass] in Stool |
| 5271-2 | Parietal cell Ab [Titer] in Serum by Immunofluorescence |
| 44344-0 | Ornithine/Creatinine [Mass Ratio] in 24 hour Urine |
| 32725-4 | Trypanosoma cruzi IgG Ab [Presence] in Serum |
| 3310-0 | Alphaprodine [Mass/volume] in Urine |
| 53385-1 | Snowshoe hare virus Ab [Presence] in Specimen |
| 53792-8 | PTPN11 gene mutations tier 3 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 45276-3 | Bacteria identified in Blood by Anaerobe culture 25 degree C incubation |
| 34656-9 | KEL gene targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
| 55141-6 | Fc epsilon RI + RII Ab [Units/volume] in Serum |
| 47426-2 | Aspergillus nidulans H Ab [Presence] in Serum |
| 34979-5 | Volume of Pleural fluid |
| 47750-5 | Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose glucose PO |
| 25664-4 | Glucose [Mass/volume] in Urine --1 hour post dose glucose |
| 26027-3 | Histiocytes [#/area] in Urine sediment by Microscopy high power field |
| 35552-9 | Rhizopus nigricans IgG Ab [Mass/volume] in Serum |
| 56375-9 | Red Beet IgG4 Ab [Mass/volume] in Serum |
| 56403-9 | Timothy IgG4 Ab [Mass/volume] in Serum |
| 2627-8 | Methylenetetrahydrofolate dehydrogenase NAD [Enzymatic activity/volume] in Serum |
| 3615-2 | Ethoheptazine [Mass/time] in 24 hour Urine |
| 56627-3 | Procollagen type III [Mass/volume] in Serum |
| 56650-5 | Chromium/Creatinine [Ratio] in Urine |
| 56886-5 | Indirect antiglobulin test.unspecified reagent [Titer] in Serum or Plasma |
| 56923-6 | Fasciola hepatica Ab [Presence] in Serum by Immunoassay |
| 48661-3 | Lymphocyte proliferation stimulated by 100 umol beryllium [Ratio] in Blood --5 days post incubation |
| 48684-5 | X and Y chromosome [Interpretation] in Blood or Marrow by FISH--post bone marrow transplant |
| 26798-9 | Succinate [Presence] in Urine |
| 26815-1 | Cocaethylene [Mass/mass] in Meconium |
| 57502-7 | 11-Deoxycortisol [Moles/volume] in Serum or Plasma --1 day post dose metyraPONE |
| 49121-7 | Erythrocyte inclusion bodies [Identifier] in Blood |
| 27863-0 | Insulin [Units/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 4988-2 | HLA-DR9 [Presence] in Donor |
| 50027-2 | Narcissus IgE Ab [Units/volume] in Serum |
| 29890-1 | Pseudorabies virus G1 gene deletion Ab [Presence] in Serum |
| 50303-7 | Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Cerebral spinal fluid |
| 40828-6 | Aspergillus fumigatus Ab [Presence] in Body fluid |
| 40915-1 | Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum by Immunoassay |
| 40978-9 | Human metapneumovirus RNA [Identifier] in Specimen by NAA with probe detection |
| 4109-5 | Alfentanil [Mass] of Dose |
| 19256-7 | Oxygen [Partial pressure] adjusted to patient's actual temperature in Capillary blood |
| 19496-9 | Hydroxyethylflurazepam cutoff [Mass/volume] in Urine for Confirmatory method |
| 100399-5 | Ostrich meat IgG Ab [Units/volume] in Serum |
| 100986-9 | HIV integrase failed codons [Identifier] by Genotype method |
| 101395-2 | Translocation analysis in Embryo by Molecular genetics method |
| 13044-3 | C peptide [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
| 1388-8 | Catecholamines Free fractionated [Mass/volume] in Plasma --pre 300 ug cloNIDine PO |
| 102849-7 | Alternaria sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102996-6 | Mace IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103053-5 | European house dust mite native (nDer p) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103102-0 | Alternaria alternata recombinant (rAlt a) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14467-5 | Chlamydia trachomatis [Presence] in Urine sediment by Organism specific culture |
| 14748-8 | Glucose [Moles/volume] in Peritoneal fluid |
| 103593-0 | Cell growth [Presence] of Amniocytes Qualitative by Tissue culture |
| 103835-5 | Norhydrocodone [Presence] in Meconium |
| 14924-5 | Transfusion reaction [Interpretation] in Plasma or RBC Narrative |
| 14979-9 | aPTT in Platelet poor plasma by Coagulation assay |
| 1522-2 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.5 g/kg glucose IV |
| 1554-5 | Glucose [Mass/volume] in Serum or Plasma --12 hours fasting |
| 16242-0 | Propoxyphene [Mass/volume] in Urine by Confirmatory method |
| 11053-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
| 12222-6 | Human papilloma virus Ag [Presence] in Genital specimen |
| 17153-8 | CD4+CD45RA+ cells/CD8 Cells [# Ratio] in Blood |
| 17665-1 | Sulfamedraxozole IgE Ab [Units/volume] in Serum |
| 18913-4 | Cyclacillin [Susceptibility] |
| 92483-7 | S Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
| 92765-7 | Adalimumab neutralizing antibody [Titer] in Serum by Bioassay |
| 75589-2 | Fetal Angelman syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
| 61099-8 | Collection date of Stool--3rd specimen |
| 61140-0 | Isocyanate MDI IgG Ab [Mass/volume] in Serum |
| 7623-2 | Poppy Seed IgE Ab [Units/volume] in Serum |
| 7690-1 | Allscale IgE Ab [Units/volume] in Serum |
| 92904-2 | N-nortramadol [Mass/volume] in Urine by Confirmatory method |
| 6132-5 | Green Coffee Bean IgE Ab [Units/volume] in Serum |
| 94239-1 | F11 gene full mutation analysis in Blood or Tissue by Sequencing |
| 778-1 | Platelets [#/volume] in Blood by Manual count |
| 78343-1 | Cells.MYB gene deletion/Cells counted in Blood or Tissue by FISH |
| 64117-5 | Most predominant hemoglobin in DBS |
| 95147-5 | Hepatitis B virus DNA panel - Serum or Plasma |
| 80157-1 | Etiocholanolone [Moles/volume] in Serum or Plasma |
| 80186-0 | JAK2 gene exon 12 targeted mutation analysis in Bone marrow by Molecular genetics method |
| 95956-9 | Lemon grass IgE Ab [Units/volume] in Serum |
| 9702-2 | Terbutaline [Mass/volume] in Serum or Plasma |
| 81779-1 | Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Creatinine [Molar ratio] in Urine |
| 7091-2 | Apricot IgE Ab [Units/volume] in Serum |
| 82576-0 | Cyclic citrullinated peptide IgA Ab [Units/volume] in Serum or Plasma |
| 98962-4 | Cariprazine [Presence] in Urine by Confirmatory method |
| 7288-4 | Dogwood pollen IgE Ab [Units/volume] in Serum |
| 86588-1 | Rabies virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 87655-7 | Heptachlor epoxide [Mass/mass] in Specimen |
| 73426-9 | cycloSPORINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 7356-9 | Canadian blue grass IgE Ab [Units/volume] in Serum |
| 88536-8 | Varicella zoster virus DNA [Presence] in Aspirate by NAA with probe detection |
| 73977-1 | Cancer related multigene analysis in Blood or Tissue by Molecular genetics method |
| 88626-7 | Human coronavirus OC43 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
| 88691-1 | Pneumocystis jiroveci Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
| 41480-5 | BK virus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
| 41665-1 | Biapenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 50877-0 | Mercury [Moles/mass] in Tissue |
| 3048-6 | Triglyceride [Mass/volume] in Serum or Plasma --fasting |
| 30899-9 | Blood volume by Scintigraphy |
| 30910-4 | Antimicrobials [Presence] in Urine |
| 3091-6 | Urea [Mass/volume] in Serum or Plasma |
| 4253-1 | Fenoprofen [Mass] of Dose |
| 31543-2 | Nuclear Ab [Units/volume] in Peritoneal fluid |
| 51409-1 | Fosamprenavir+Ritonavir [Susceptibility] by Genotype method |
| 42905-0 | Formate/Creatinine [Mass Ratio] in 24 hour Urine |
| 21784-4 | t(14;18)(q32;q21.3)(IGH,BCL2) cells/Cells.total in Blood or Tissue by Molecular genetics method |
| 43272-4 | Ceftobiprole [Susceptibility] |
| 23182-9 | Leptospira interrogans sv Hebdomadis Ab [Presence] in Serum by Agglutination |
| 23198-5 | Leptospira sp Ab [Titer] in Serum by Agglutination |
| 32857-5 | Cytoplasmic CD3 cells/100 cells in Specimen |
| 23399-9 | Rift valley fever virus Ab [Presence] in Serum by Immunoassay |
| 33465-6 | Francisella tularensis IgG Ab [Titer] in Serum |
| 53812-4 | Micafungin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 24040-8 | Taenia solium larva IgG band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot |
| 54220-9 | Immune response markers [Interpretation] in Specimen Narrative |
| 46248-1 | Borrelia burgdorferi IgG and IgM [Interpretation] in Serum by Immunoassay |
| 24310-5 | Mycoplasma pneumoniae Ab [Titer] in Serum --1st specimen |
| 34365-7 | Primidone+PHENobarbital [Moles/volume] in Serum or Plasma |
| 25183-5 | Ethionamide 11 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25541-4 | Topiramate [Moles/volume] in Serum or Plasma |
| 3495-9 | cloNIDine [Mass/volume] in Serum or Plasma |
| 25932-5 | Hydroxylysine [Moles/volume] in 24 hour Urine |
| 26738-5 | Phosphoserine [Moles/volume] in Urine |
| 26805-2 | Glutamate [Presence] in 24 hour Urine |
| 26994-4 | Phencyclidine [Mass/volume] in Milk |
| 27238-5 | Oxazepam [Mass/mass] in Stool |
| 3837-2 | Nadolol [Mass/volume] in Urine |
| 57360-0 | Lactate [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 57483-0 | 11-Ketoetiocholanolone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
| 5757-0 | Vanadium [Mass/volume] in Urine |
| 38718-3 | Phthalic anhydride [Mass/volume] in Air |
| 39025-2 | Influenza virus A hemagglutinin cDNA [Identifier] in Specimen by Sequencing |
| 57848-4 | Maltose [Presence] in Urine |
| 5820-6 | WBC casts [#/area] in Urine sediment by Microscopy low power field |
| 49398-1 | Herpes virus 7 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
| 29338-1 | Flecainide [Mass/volume] in Urine |
| 50157-7 | Acetylcarnitine (C2) [Moles/volume] in DBS |
| 40547-2 | Hemoglobin H [Presence] in Blood |
| 59064-6 | PAX6 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method |
| 50533-9 | Thyrotropin [Units/volume] in Serum or Plasma --1st specimen |
| 30257-0 | Insulin [Units/volume] in Serum or Plasma --1.6 hours post XXX challenge |
| 19510-7 | Levomethamphetamine [Presence] in Urine by Screen method |
| 1978-6 | Bilirubin.total [Mass/volume] in Urine |
| 20708-4 | Bovine papular stomatitis virus Ag [Presence] in Tissue by Immunofluorescence |
| 20907-2 | Organochlorine pesticides [Identifier] in Blood |
| 101186-5 | 4F-MDMB-BINACA [Presence] in Urine by Confirmatory method |
| 101410-9 | C peptide post XXX challenge panel - Serum |
| 101796-1 | Psilocin/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 102442-1 | Foxtail Millet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102504-8 | Penicillin V IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102775-4 | Oat IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14634-0 | C reactive protein [Titer] in Serum or Plasma |
| 14674-6 | Corticotropin [Moles/volume] in Plasma |
| 103691-2 | MDA5 Ab [Units/volume] in Serum by Immunoassay |
| 10507-2 | Prolactin Ag [Presence] in Tissue by Immune stain |
| 16440-0 | Benzene ring IgE Ab [Units/volume] in Serum |
| 11227-6 | Pyruvate kinase [Presence] in Blood |
| 17399-7 | Human papilloma virus 16 Ag [Presence] in Specimen |
| 17530-7 | Retrovirus identified in Specimen by Organism specific culture |
| 17972-1 | Bacteria # 4 identified in Urine by Culture |
| 90448-2 | Coccidioides sp IgM Ab [Units/volume] in Serum or Plasma |
| 90464-9 | Herpes simplex virus 1+2 IgM Ab [Presence] in Serum by Immunoassay |
| 7493-0 | Milk evaporated IgE Ab [Units/volume] in Serum |
| 92552-9 | Blood group Ag and Hemoglobin S inferred panel - Blood or Tissue from Donor by Molecular genetics method |
| 92649-3 | Naloxone [Presence] in Urine by Confirmatory method |
| 93332-5 | Glycohyodeoxycholate [Moles/volume] in Serum or Plasma |
| 93405-9 | Bacteroides fragilis DNA [Presence] by NAA with probe detection in Positive blood culture |
| 93916-5 | ABO and Rh group panel - Blood from Blood product unit |
| 93985-0 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose carbohydrate |
| 63101-0 | Duck meat IgG Ab [Mass/volume] in Serum |
| 63242-2 | Ganglioside GM1 IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 94350-6 | PCA-1 IgG Ab [Titer] in Serum by Immunofluorescence |
| 94576-6 | Mycobacterium tuberculosis complex species identified in Isolate by NAA with probe detection |
| 79397-6 | Mastic tree (Pistacia lentiscus) IgE Ab [Units/volume] in Serum |
| 6722-3 | Coffee IgG Ab [Units/volume] in Serum |
| 6749-6 | Glucose [Mass/volume] in Serum or Plasma --2.5 hours post 75 g glucose PO |
| 69575-9 | Campylobacter jejuni Ab [Presence] in Serum by Complement fixation |
| 69920-7 | Adenovirus IgA Ab [Presence] in Serum by Immunoassay |
| 81847-6 | C9orf72 gene GGGGCC repeat analysis in Amniotic fluid by Molecular genetics method |
| 70150-8 | Opiates [Mass/volume] in Urine by Screen method |
| 7113-4 | Banana triggered histamine release [Units/volume] in Blood |
| 9806-1 | 2,4-Dichlorophenoxyacetate [Mass/volume] in Urine |
| 85678-1 | Haemophilus influenzae acs gene [Cycle Threshold #] in Specimen by NAA with probe detection |
| 86230-0 | HYDROmorphone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 73062-2 | Amoxicillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87470-1 | Magnesium [Mass/mass] in Specimen |
| 73501-9 | Budesonide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73860-9 | Allo-tetrahydrocorticosterone [Moles/volume] in 24 hour Urine |
| 73884-9 | Steroid fractions interpretation in 24 hour Urine Narrative |
| 74299-9 | Tyrosine/Phenylalanine [Molar ratio] in DBS --post therapeutic diet |
| 74356-7 | Bacteria identified in Ventriculoperitoneal (VP) shunt by Culture |
| 74434-2 | Bilirubin.total/Total in Stone by Infrared spectroscopy |
| 42613-0 | Glucose [Mass/volume] in Urine --2 hours post dose lactose PO |
| 60283-9 | Amitriptyline [Moles/volume] in Specimen |
| 3134-4 | Xylose [Mass/volume] in Blood |
| 51061-0 | Cytoplasmic CD13 blasts/100 blasts in Bone marrow |
| 51076-8 | CD14 blasts/100 blasts in Specimen |
| 51323-4 | CD42 cells/100 cells in Bone marrow |
| 51397-8 | CD65w cells/100 cells in Cerebral spinal fluid |
| 31759-4 | Candida albicans Ag [Units/volume] in Serum |
| 3200-3 | Coagulation factor VII activity actual/normal [Molar ratio] in Platelet poor plasma by Coagulation assay |
| 51585-8 | Other cells [#/volume] in Blood by Manual count |
| 51737-5 | HYDROmorphone Free [Mass/volume] in Urine |
| 51741-7 | Blastomyces dermatitidis Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
| 51917-3 | Barley IgG Ab [Mass/volume] in Serum |
| 43218-7 | Nicotine+Cotinine [Presence] in Urine |
| 43400-1 | Lactobacillus sp morphotypes [Presence] in Vaginal fluid by Light microscopy |
| 32192-7 | Monocytes+Macrophages [Presence] in Body fluid by Light microscopy |
| 32204-0 | Unidentified cells [#/volume] in Peritoneal fluid by Manual count |
| 32286-7 | Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection |
| 52977-6 | Herpes simplex virus Ab [Units/volume] in Serum by Complement fixation |
| 52994-1 | Cytoplasmic CD79a cells/100 cells in Cerebral spinal fluid |
| 4433-9 | Sulfonamide [Mass] of Dose |
| 23148-0 | Japanese encephalitis virus Ag [Presence] in Specimen by Immunofluorescence |
| 32648-8 | Hydroxyethylflurazepam [Mass/volume] in Serum or Plasma |
| 53133-5 | Cholesterol in LDL [Moles/volume] in Body fluid |
| 53363-8 | Borrelia burgdorferi 49736 IgG Ab [Units/volume] in Serum |
| 44538-7 | HTLV I+II Ab [Presence] in Serum from Donor |
| 44714-4 | Complement C3/Protein [Mass Ratio] in Synovial fluid |
| 33516-6 | Immature reticulocytes/Reticulocytes.total in Blood |
| 33566-1 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunoblot |
| 23766-9 | Porcine circovirus Ag [Presence] in Tissue by Immunofluorescence |
| 23864-2 | Flunitrazepam [Mass/volume] in Serum or Plasma |
| 23879-0 | Immune complex [Units/volume] in Body fluid by C1q binding assay |
| 54073-2 | Hemoglobin C/Hemoglobin.total in DBS |
| 54277-9 | Glucose [Moles/volume] in Serum or Plasma --1.5 hour post dose ornithine alpha-ketoglutarate |
| 54394-2 | Glucose [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge |
| 55224-0 | Mycobacterium tuberculosis A60 Ab [Presence] in Serum by Immunoassay |
| 55312-3 | Yeast.pseudohyphae [Presence] in Vaginal fluid by KOH preparation |
| 25109-0 | Hydroxylysine/Creatinine [Molar ratio] in Urine |
| 25175-1 | Amikacin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 25205-6 | Streptomycin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 2539-5 | Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis |
| 25450-8 | Isoleucine [Moles/time] in 24 hour Urine |
| 25527-3 | Silver [Moles/volume] in Serum or Plasma |
| 34974-6 | DNA index 3 in Serum or Plasma by Flow cytometry (FC) |
| 47639-0 | Glycine/Amino acids.total in Specimen |
| 47646-5 | Histidine/Amino acids.total in Amniotic fluid |
| 47911-3 | Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose glucagon |
| 25817-8 | Xylose [Moles/volume] in Serum or Plasma --1.5 hours post dose xylose PO |
| 56230-6 | Common Reed IgG4 Ab [Mass/volume] in Serum |
| 5647-3 | Ethylene glycol [Mass/volume] in Urine |
| 56488-0 | Etiocholanolone [Mass/volume] in 24 hour Urine |
| 47933-7 | Somatotropin [Units/volume] in Serum or Plasma --pre dose arginine+insulin |
| 2628-6 | Methylenetetrahydrofolate dehydrogenase NADP [Enzymatic activity/volume] in Serum |
| 26445-7 | Basophils/100 leukocytes in Specimen |
| 3638-4 | Flecainide [Mass/volume] in Serum or Plasma |
| 3794-5 | Methotrexate [Mass/volume] in Serum or Plasma --1-2 weeks post dose |
| 38258-0 | Cells Counted Total [#] in Pleural fluid |
| 48971-6 | EYA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 49135-7 | Fractional excretion of sodium [Ratio] in Urine and Serum or Plasma |
| 38683-9 | Sperm Midpiece IgM Ab/100 spermatozoa in Specimen by Immunobead |
| 38910-6 | Schistocytes [Presence] in Blood by Automated count |
| 49606-7 | Hepatitis B virus DNA [log units/volume] (viral load) in Tissue by NAA with probe detection |
| 4966-8 | HLA-DR18(3) [Presence] in Donor |
| 29250-8 | Brucella sp Ab [Titer] in Serum --1st specimen |
| 29278-9 | Codeine [Presence] in Meconium |
| 39793-5 | Coproporphyrin 3/Coproporphyrin 1 [Molar ratio] in 24 hour Urine |
| 40229-7 | Calcium [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
| 40304-8 | Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose arginine |
| 50488-6 | Gastrin [Mass/volume] in Serum or Plasma --4th specimen |
| 40776-7 | Histoplasma capsulatum Ag [Presence] in Cerebral spinal fluid |
| 40811-2 | 11-Deoxycorticosterone [Presence] in Serum or Plasma |
| 40946-6 | Yersinia enterocolitica IgG Ab [Presence] in Serum |
| 19642-8 | oxyCODONE [Presence] in Urine by Screen method |
| 19724-4 | Abachi Wood Dust IgE Ab [Units/volume] in Serum |
| 1286-4 | P1 Ab [Presence] in Serum or Plasma from Blood product unit |
| 101353-1 | Borrelia burgdorferi Ab [Interpretation] in Serum Qualitative by IA.MTTT |
| 101414-1 | Lymphocyte TCR alpha beta double negative subsets panel - Blood |
| 101518-9 | Canine Parvovirus 2 DNA [Presence] in Specimen by NAA with probe detection |
| 12953-6 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 13318-1 | Escherichia coli enteroinvasive identified in Stool by Organism specific culture |
| 102408-2 | Lepidoglyphus destructor IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102439-7 | Cow milk boiled IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13966-7 | Cystine [Moles/time] in 24 hour Urine |
| 14004-6 | Prostaglandin A [Mass/time] in 24 hour Urine |
| 141-2 | cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 14574-8 | 8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma |
| 14622-5 | Ascorbate [Moles/volume] in Serum or Plasma |
| 14679-5 | Cortisol [Moles/volume] in Serum or Plasma --AM peak specimen |
| 104169-8 | D13S319 deletion in Bone marrow by FISH |
| 14830-4 | Mesothelial cells/100 leukocytes in Peritoneal fluid by Manual count |
| 15127-4 | Beta globulin/Protein.total in Synovial fluid by Electrophoresis |
| 15244-7 | Food Allergen Mix 13 (Carrot+White bean+Peas+Potato) IgE Ab [Presence] in Serum by Multidisk |
| 15420-3 | Service comment 29 |
| 16246-1 | Methadone [Mass/volume] in Urine by Confirmatory method |
| 10919-9 | Anisakis IgE Ab [Units/volume] in Serum |
| 16611-6 | Chlorpyrifos [Mass/volume] in Urine |
| 12312-5 | Cyclopropane [Mass/volume] in Blood |
| 16866-6 | Fibrinopeptide B beta (43-47) Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 16989-6 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3.5 hours post dose glucose |
| 1700-4 | Acetaldehyde [Mass/volume] in Blood |
| 17746-9 | Trimeprazine [Presence] in Serum or Plasma |
| 1825-9 | Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma |
| 90823-6 | Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 74911-9 | Sertraline [Mass/volume] in Serum or Plasma --trough |
| 60437-1 | CD5+CD23+ cells [#/volume] in Blood |
| 7631-5 | Povertyweed IgE Ab [Units/volume] in Serum |
| 76602-2 | Haemophilus influenzae lex2 gene [#/volume] in XXX.body fluid by NAA with probe detection |
| 77746-6 | HTLV I gp46-I Ab [Presence] in Serum or Plasma by Immunoblot |
| 93753-2 | Porcine cytomegalovirus DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 93868-8 | AMPAR2 Ab [Presence] in Serum by Cell binding immunofluorescent assay |
| 93934-8 | K Ag [Presence] on Red Blood Cells --during infancy |
| 63229-9 | DNA double strand IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 63339-6 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Body fluid by Immunoassay |
| 94630-1 | Mannheimia haemolytica DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 6486-5 | Mycoplasma sp identified in Specimen by Organism specific culture |
| 65761-9 | Lymphocyte subset interpretation in Blood by Flow cytometry (FC) |
| 96469-2 | Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 6742-1 | Erythrocyte morphology finding [Identifier] in Blood |
| 68977-8 | Pseudomonas aeruginosa elastase Ab [Titer] in Serum by Immunoassay |
| 80543-2 | Norclozapine [Mass/volume] in DBS |
| 80654-7 | Spermatozoa Progressive Grade 1+2/100 spermatozoa in Semen |
| 8125-7 | CD34 cells/100 cells in Blood |
| 96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
| 70141-7 | Benzodiazepines [Presence] in Urine by Screen method >200 ng/mL |
| 98248-8 | Primary or recurrent or distant metastasis [Type] in Tumor |
| 71762-9 | Rotavirus IgA Ab [Presence] in Serum by Immunoassay |
| 72323-9 | HLA-DP+DQ+DR (class II) IgG Ab [Presence] in Serum by Flow cytometry (FC) |
| 72467-4 | JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 99401-2 | Cells.CD19+FMC7+/100 cells in Bone marrow |
| 99545-6 | Stenosis degree [Length fraction] in Mid right coronary artery by Autopsy |
| 99546-4 | Circumference [Length] of Lower extremity |
| 86147-6 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum |
| 73152-1 | Sildenafil citrate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87555-9 | Sjogrens syndrome-A and B extractable nuclear IgG panel - Serum |
| 73966-4 | Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative |
| 74137-1 | Norfentanyl [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
| 59474-7 | Microscopic observation [Identifier] in Cerebral spinal fluid by Acridine orange stain |
| 30441-0 | Monocytes Abnormal/100 leukocytes in Blood |
| 21421-3 | Norketamine [Mass/volume] in Serum or Plasma |
| 31425-2 | Histoplasma capsulatum mycelial phase Ab [Units/volume] in Cerebral spinal fluid |
| 31663-8 | Sulfate-3-Glucuronyl paragloboside IgM Ab [Presence] in Cerebral spinal fluid |
| 31898-0 | Mumps virus Ag [Presence] in Urine sediment |
| 4324-0 | Methotrexate [Mass] of Dose |
| 22516-9 | Salmonella paratyphi A Ab [Presence] in Serum |
| 32140-6 | Hemoglobin F [Presence] in Blood by Kleihauer-Betke method |
| 32179-4 | Heptacarboxylporphyrin/Creatinine [Molar ratio] in 24 hour Urine |
| 53431-3 | Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --6th specimen post XXX challenge |
| 44657-5 | Dominant nodule.maximum.dimension in Prostate tumor |
| 44809-2 | Histoplasma capsulatum M Ab band pattern [Interpretation] in Serum by Immunoblot |
| 23281-9 | Mycoplasma mycoides ss capri Ab [Presence] in Serum by Complement fixation |
| 23344-5 | Pasteurella multocida rRNA [Presence] in Specimen by Probe |
| 5362-9 | Spermatozoa Ab [Units/volume] in Serum |
| 23860-0 | Erythrocytes [#/volume] in Body fluid by Automated count |
| 23896-4 | Mercury [Mass/mass] in Specimen |
| 24076-2 | Cerebroside sulfatase [Enzymatic activity/volume] in Serum or Plasma |
| 34143-8 | HLA-DQ locus 2 [Type] |
| 34172-7 | Streptococcus pneumoniae Danish serotype 6B Ab [Mass/volume] in Serum |
| 24406-1 | Aeromonas salmonicida serotype [Identifier] in Isolate |
| 24436-8 | 3-Methylcrotonylglycine/Creatinine [Molar ratio] in Urine |
| 34486-1 | Avian paramyxovirus 1 RNA [Presence] in Specimen by NAA with probe detection |
| 34542-1 | ACTH stimulation test using IV corticosteroids in Serum or Plasma |
| 2552-8 | Lactose [Mass/volume] in Serum or Plasma |
| 35033-0 | Mesothelial cells [#/volume] in Pleural fluid |
| 47671-3 | Isoleucine [Moles/volume] in DBS |
| 35476-1 | OKT3 blocking Ab [Titer] in Serum or Plasma by Flow cytometry (FC) |
| 48156-4 | Threo-4-Deoxytetronate/Creatinine [Molar ratio] in Urine |
| 26562-9 | CD19+CD38+ cells/100 cells in Specimen |
| 3697-0 | Isoniazid [Mass/volume] in Serum or Plasma |
| 37986-7 | California serogroup RNA [Presence] in Specimen by Probe |
| 486-1 | Teicoplanin [Susceptibility] by Serum bactericidal titer |
| 38312-5 | Tetrachloroethylene [Mass/volume] in Water |
| 57297-4 | HLA-Cw [Type] by High resolution |
| 57562-1 | 21-Deoxycorticosterone [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
| 57774-2 | Colorado tick fever virus IgG and IgM panel [Titer] - Serum |
| 5777-8 | Cholesterol crystals [Presence] in Urine sediment by Light microscopy |
| 57943-3 | Clenbuterol [Presence] in Urine |
| 49402-1 | Herpes virus 8 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
| 4964-3 | HLA-DR17(3) [Presence] in Donor |
| 2829-0 | Potassium [Moles/time] in 24 hour Urine |
| 29528-7 | Hippurate/Creatinine [Molar ratio] in Urine |
| 40160-4 | Glucose [Moles/volume] in Serum or Plasma --75 minutes post XXX challenge |
| 58517-4 | C peptide [Moles/volume] in Serum or Plasma --4 hours post dose glucose |
| 58690-9 | Cortisol [Mass/volume] in Serum or Plasma --12th specimen post XXX challenge |
| 58-8 | Capreomycin [Susceptibility] by Serum bactericidal titer |
| 498-6 | Tetracycline [Susceptibility] by Serum bactericidal titer |
| 29845-5 | Anaplasma phagocytophilum IgM Ab [Presence] in Cerebral spinal fluid |
| 40357-6 | Creatinine [Moles/time] in 24 hour Body fluid |
| 50582-6 | Glucose tolerance gestational panel - Urine and Serum or Plasma |
| 30113-5 | IgG lymphocytes [#/volume] in Leukocytes |
| 4090-7 | Vancomycin [Mass/volume] in Serum or Plasma --peak |
| 41015-9 | Human coronavirus OC43 IgG Ab [Presence] in Serum |
| 19434-0 | Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method |
| 2027-1 | Carbon dioxide, total [Moles/volume] in Venous blood |
| 12655-7 | Glucose [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 1305-2 | D Ag [Presence] in Blood |
| 101939-7 | Candida dubliniensis+lusitaniae+krusei+auris DNA [Presence] in Specimen by NAA with probe detection |
| 13947-7 | Coccidioides immitis IgG Ab [Presence] in Serum by Immunoassay |
| 14234-9 | Beta tubulin IgM Ab [Titer] in Serum |
| 102959-4 | Helminthosporium sp IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14741-3 | Gastrin [Moles/volume] in Serum or Plasma --5 minutes post 0.2 U/kg secretin |
| 10547-8 | Primidone+PHENobarbital [Mass/volume] in Serum or Plasma |
| 11081-7 | HIV 2 p56 Ab [Presence] in Serum by Immunoblot |
| 12196-2 | Cryofibrinogen [Presence] in Plasma by 4 hour cold incubation |
| 16807-0 | Echovirus 9 Ab [Units/volume] in Serum by Complement fixation |
| 16895-5 | Gastrin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 1704-6 | Acetoacetate [Presence] in Serum or Plasma |
| 17219-7 | Cytoplasmic Ig cells/100 cells in Blood |
| 17277-5 | metOLazone [Mass/volume] in Serum or Plasma |
| 18261-8 | Cholesterol in LDL [Mass/volume] in Serum or Plasma ultracentrifugate |
| 18396-2 | HIV 1 p24 Ag [Presence] in Serum or Plasma by Immunoassay |
| 18919-1 | Erythromycin [Susceptibility] |
| 1897-8 | Argininosuccinate [Mass/volume] in Urine |
| 89980-7 | Thiothixene [Presence] in Serum or Plasma by Screen method |
| 90828-5 | Glial nuclear type 1 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
| 74994-5 | Collagen crosslinked C-telopeptide [Z-score] in Serum or Plasma |
| 7533-3 | Interior Live Oak IgE Ab [Units/volume] in Serum |
| 75363-2 | Creatinine [Moles/volume] in Vitreous fluid |
| 75408-5 | Hepatitis B virus e Ag [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 7583-8 | Penicillium sp IgG Ab [Units/volume] in Serum |
| 77009-9 | Porphyrin fractions panel [Moles/volume] - Serum or Plasma |
| 93691-4 | Nonalcoholic steatohepatitis and fibrosis panel - Serum or Plasma |
| 77093-3 | MRRF gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 62437-9 | Nucleated erythrocytes [#/volume] in Cerebral spinal fluid by Automated count |
| 6291-9 | Complement iC3b receptors [Presence] in Leukocytes |
| 63315-6 | Rheumatoid factor IgM [Units/volume] in Body fluid by Immunoassay |
| 79320-8 | Lysophosphatidylcholine(26:0) [Moles/volume] in Cerebral spinal fluid |
| 95069-1 | Chromosome 1q and 9 and 11 and 15 aneuploidy and 13q deletion in Bone marrow by FISH |
| 95521-1 | SARS-CoV-2 (COVID-19) N gene [#/volume] (viral load) in Respiratory system specimen by NAA with probe detection |
| 95572-4 | 11-Deoxytetrahydrocorticosterone [Z-score] in 24 hour Urine |
| 9593-5 | Borrelia burgdorferi 41kD IgG Ab [Presence] in Serum by Immunoblot |
| 96301-7 | Bacteroides fragilis DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 6803-1 | HLA-DR15 [Presence] |
| 96816-4 | Tetracaine IgE Ab [Units/volume] in Serum |
| 81879-9 | t(11;22)(q24;q12.2)(FLI1,EWSR1) and t(21;22)(q22.3;q12.2)(ERG,EWSR1) fusion transcript in Blood or Tissue by Molecular genetics method |
| 70266-2 | Creatinine in peritoneal fluid/Creatinine in serum |
| 82581-0 | Food Allergen Mix 25B (Garlic, Celery, Sesame seed, Yeast) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 85753-2 | Streptococcus pneumoniae Danish serotypes 6C+6D DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 73037-4 | Ciprofloxacin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87329-9 | Porcine circovirus type 2 IgG Ab/Positive control in Serum by Immunoassay |
| 87392-7 | Porcine teschovirus RNA [Presence] in Specimen by NAA with probe detection |
| 73493-9 | Butalbital+Acetylsalicylate+Caffeine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88013-8 | Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16) [Molar ratio] in Serum or Plasma |
| 88440-3 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --10M post dose lactose PO |
| 74105-8 | Oxygen saturation Calculated from oxygen partial pressure in Mixed venous blood |
| 74403-7 | Normoblasts/100 leukocytes in Cord blood |
| 59316-0 | Ramelteon [Mass/volume] in Body fluid |
| 59339-2 | Stiripentol [Mass/volume] in Blood |
| 59884-7 | chlorproMAZINE [Moles/volume] in Urine |
| 30565-6 | Tetradecanoylcarnitine (C14) [Moles/volume] in Serum or Plasma |
| 59941-5 | Norclomipramine [Moles/volume] in Gastric fluid |
| 21194-6 | Chloride [Moles/volume] in 24 hour Urine |
| 21309-0 | Glucose [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 31462-5 | Legionella pneumophila 4 IgG Ab [Units/volume] in Serum |
| 31976-4 | Taylorella equigenitalis Ag [Presence] in Specimen |
| 51481-0 | Yeast [#/volume] in Urine by Automated count |
| 22326-3 | Hepatitis C virus 5-1-1 Ab [Presence] in Serum |
| 22645-6 | Proline [Moles/volume] in Cerebral spinal fluid |
| 32129-9 | risperiDONE [Presence] in Urine |
| 22784-3 | African swine fever virus Ag [Presence] in Specimen by Immunofluorescence |
| 5346-2 | Salmonella typhi O Ab [Presence] in Serum by Latex agglutination |
| 44462-0 | Insulin Free+Bound [Presence] in Serum or Plasma |
| 44840-7 | Fungus # 5 identified in Specimen by Culture |
| 23248-8 | Mycoplasma agalactiae neutralizing antibody [Presence] in Serum by Neutralization test |
| 33613-1 | Sjogrens syndrome-B extractable nuclear IgG Ab [Units/volume] in Serum |
| 53585-6 | Toxocara canis IgE Ab [Units/volume] in Serum |
| 45176-5 | HIV nonnucleoside reverse transcriptase gene mutations detected [Identifier] |
| 45321-7 | FMR1 gene allele 1 CGG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
| 33974-7 | SARS coronavirus Urbani Ab [Titer] in Serum |
| 54007-0 | Golgi apparatus Ab [Presence] in Serum by Immunofluorescence |
| 46718-3 | Aquaporin 4 water channel IgG Ab [Presence] in Cerebral spinal fluid |
| 24155-4 | Mango IgG Ab [Units/volume] in Serum |
| 25252-8 | Dicloxacillin [Mass/volume] in Specimen |
| 25274-2 | Amoxicillin [Mass/volume] in Specimen |
| 3514-7 | Crotethamide [Presence] in Urine |
| 55796-7 | Phosphatidylserine IgM Ab [Multiple of the median] in Serum |
| 47775-2 | Somatotropin [Units/volume] in Serum or Plasma --pre dose glucagon |
| 25870-7 | Beta aminoisobutyrate [Moles/volume] in 24 hour Urine |
| 35472-0 | HEXA gene c.1277insTATC [Presence] in Blood or Tissue by Molecular genetics method |
| 48321-4 | TOLBUTamide [Presence] in Specimen |
| 2622-9 | Methionine [Mass/volume] in Serum or Plasma |
| 26761-7 | Sodium renal clearance in 2 hour Urine and Serum or Plasma |
| 37993-3 | DNA double strand Ab [Mass/volume] in Serum by Radioimmunoassay (RIA) |
| 56659-6 | Para aminophenol/Creatinine [Ratio] in Urine |
| 48428-7 | Rumenate (C18:2 cis-9 trans-11) [Moles/volume] in Serum or Plasma |
| 26869-8 | oxyCODONE [Mass/mass] in Meconium |
| 27253-4 | Chlorphentermine [Mass/volume] in Vitreous fluid |
| 38541-9 | Spermatozoa Motile [Presence] in Semen --pre washing |
| 57358-4 | Lactate [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 49061-5 | Hepatic iron index |
| 27307-8 | Chlorphentermine [Mass/mass] in Stool |
| 27860-6 | Insulin [Units/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
| 49548-1 | Date referral lab test sent |
| 49693-5 | Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay |
| 40437-6 | HIV 1 p24 Ab [Presence] in Serum or Plasma by Immunoassay |
| 40669-4 | Rubella virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 58961-4 | Ganglioside GT1b IgM Ab [Units/volume] in Serum by Immunoassay |
| 58975-4 | Ganglioside GQ1b IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 41158-7 | Canine herpesvirus Ab [Presence] in Serum |
| 19393-8 | Chlorpheniramine cutoff [Mass/volume] in Urine for Screen method |
| 19500-8 | Ketamine cutoff [Mass/volume] in Urine for Confirmatory method |
| 20558-3 | Psilocin [Mass/volume] in Urine by Confirmatory method |
| 20569-0 | Creatine kinase.MB/Creatine kinase.total in Serum or Plasma |
| 100102-3 | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot |
| 101751-6 | Lithium [Moles/volume] in Blood by Inductively Coupled Plasma/Optical Emission Spectrometry (ICP/OES) |
| 101839-9 | Megestrol acetate [Moles/volume] in Serum or Plasma |
| 102206-0 | Carob IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 13632-5 | Insulin receptor Ab [Titer] in Serum |
| 13920-4 | HIV 2 p41 Ab [Presence] in Serum by Immunoblot |
| 102383-7 | House dust IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102416-5 | Spiny lobster IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14244-8 | Phosphatidylcholine IgM Ab [Presence] in Serum |
| 14366-9 | Trichomonas vaginalis [Presence] in Cervix by Wet preparation |
| 102951-1 | Kelp or Seaweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103020-4 | Oil palm IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14405-5 | Phosphate [Mass/volume] in Peritoneal fluid |
| 14756-1 | Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose |
| 103557-5 | SARS-CoV-2 (COVID-19) Mpro gene mutation detected [Identifier] in Specimen by Molecular genetics method Nominal |
| 104075-7 | Gas and Lactate panel - Venous blood |
| 14953-4 | Xylose [Moles/volume] in Blood --2 hours post 25 g xylose PO |
| 15183-7 | IgG [Mass/volume] in Body fluid |
| 17450-8 | Phosphatidylethanolamine IgM Ab [Presence] in Serum |
| 19105-6 | Glucose [Interpretation] in Serum or Plasma--3 hours post dose glucose |
| 60340-7 | Crystals.amorphous [Presence] in Urine sediment by Light microscopy |
| 61164-0 | Hepatitis B virus codon T184S [Presence] by Genotype method |
| 7577-0 | Peanut triggered histamine release [Units/volume] in Blood |
| 7594-5 | Green Pepper IgG Ab [Units/volume] in Serum |
| 92801-0 | Cryptococcus gattii DNA [Presence] by NAA with probe detection in Positive blood culture |
| 77385-3 | Parainfluenza virus 1 Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
| 63121-8 | Squid IgG Ab [Mass/volume] in Serum |
| 78349-8 | Lauroleate (C12:1) [Entitic substance] in Red Blood Cells |
| 78359-7 | Acyl CoA dehydrogenases.palmitate substrate/Acyl CoA dehydrogenases.myristate substrate [Enzymatic activity ratio] in Fibroblast |
| 94625-1 | Pasteurella multocida DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 94843-0 | Osmolality of Urine from Fetus |
| 63372-7 | Ketones [Presence] in Urine by Test strip --3 hours post dose glucose |
| 63390-9 | Extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
| 6394-1 | Echovirus 40 Ab [Titer] in Serum by Complement fixation |
| 64126-6 | Drugs identified in Meconium by Confirmatory method |
| 6507-8 | Neisseria meningitidis serogroup w135 Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 78869-5 | O-desmethylvenlafaxine cutoff [Mass/volume] in Urine for Confirmatory method |
| 9514-1 | Cytomegalovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 95705-0 | Chikungunya virus IgA Ab [Presence] in Specimen by Immunoassay |
| 68424-1 | Monocytes [#/volume] in Vitreous fluid by Manual count |
| 97150-7 | Prostate health index in Serum or Plasma by calculation |
| 7109-2 | Avocado IgG Ab [Units/volume] in Serum |
| 71614-2 | Monocytes/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
| 99137-2 | Rabies virus IgG Ab [Titer] in Specimen by Immunofluorescence |
| 73125-7 | Telmisartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73521-7 | Argatroban induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73645-4 | Faropenem [Susceptibility] by Disk diffusion (KB) |
| 7422-9 | House dust AP IgG Ab [Units/volume] in Serum |
| 894-6 | Blood group antibody screen.cell II [Presence] in Serum or Plasma |
| 89642-3 | Corynebacterium diphtheriae toxin IgG Ab [Presence] in Serum by Immunoassay |
| 41394-8 | Collection date of Stool |
| 41731-1 | Cefpodoxime+Clavulanate [Susceptibility] |
| 30434-5 | Microcytes [Presence] in Blood |
| 41878-0 | Dengue virus IgG and IgM panel - Serum by Immunoassay |
| 31226-4 | Asialoganglioside GM1 IgG Ab [Units/volume] in Serum |
| 31251-2 | Bartonella henselae IgM Ab [Units/volume] in Cerebral spinal fluid |
| 31485-6 | Leptospira sp IgG Ab [Units/volume] in Serum |
| 51158-4 | CD33 blasts [Units/volume] in Blood |
| 51361-4 | CD61 cells/100 cells in Bone marrow |
| 42817-7 | CD38+Kappa+ cells/100 cells in Blood |
| 2208-7 | Diethyl ether [Mass/volume] in Serum or Plasma |
| 22121-8 | Borrelia burgdorferi Ab [Units/volume] in Serum |
| 2218-6 | DOPamine [Mass/time] in 24 hour Urine |
| 31700-8 | West Nile virus Ab [Units/volume] in Specimen |
| 43753-3 | Spermatozoa IgM binding location [Identifier] in Semen |
| 22475-8 | Rickettsia spotted fever group Ab [Titer] in Serum |
| 32150-5 | Urate crystals amorphous [#/area] in Urine sediment by Microscopy high power field |
| 44286-3 | 3-Methylhistidine/Creatinine [Mass Ratio] in 24 hour Urine |
| 22794-2 | Anaplasma marginale Ab [Presence] in Serum by Immunofluorescence |
| 22799-1 | Anaplasma sp identified in Tissue by Modified Giemsa stain |
| 22912-0 | Bovine herpesvirus 1 Ag [Presence] in Tissue by Immune stain |
| 32691-8 | Anaplasma phagocytophilum IgG Ab [Titer] in Serum |
| 32764-3 | Clue cells [Presence] in Specimen by Wet preparation |
| 53114-5 | Fasting glucose [Moles/volume] in Urine |
| 44557-7 | Influenza virus A Ab [Presence] in Body fluid |
| 23337-9 | Ovine progressive pneumonia virus DNA [Presence] in Specimen by NAA with probe detection |
| 45016-3 | Adenosine monophosphate.cyclic [Moles/volume] in Urine --4 hours post XXX challenge |
| 45306-8 | Coproporphyrin 3 [Moles/mass] in Stool |
| 45367-0 | Lymphocyte proliferation stimulated by 20 ug concanavalin A in Blood |
| 24091-1 | Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Fibroblast |
| 33933-3 | Glutaraldehyde IgE Ab [Units/volume] in Serum |
| 34182-6 | Methaqualone metabolite [Presence] in Serum or Plasma by Confirmatory method |
| 54299-3 | Homocitrulline [Moles/volume] in Amniotic fluid |
| 54393-4 | Glucose [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 3457-9 | chlordiazePOXIDE [Mass/volume] in Serum or Plasma |
| 25556-2 | Xylose [Moles/volume] in Urine |
| 47700-0 | Methionine [Moles/volume] in DBS |
| 2594-0 | Magnesium [Moles/volume] in Cerebral spinal fluid |
| 47943-6 | Testosterone [Mass/volume] in Serum or Plasma --2 days post 5000 U HCG IM |
| 26061-2 | European tick borne encephalitis virus Ab [Titer] in Serum |
| 26425-9 | Lactalbumin alpha IgG4 Ab [Units/volume] in Serum |
| 3681-4 | HYDROcodone [Mass/volume] in Urine |
| 56567-1 | Somatotropin [Mass/volume] in Serum or Plasma --10 hours post XXX challenge |
| 26923-3 | Butabarbital [Mass/mass] in Hair |
| 27004-1 | Benzfetamine [Mass/mass] in Meconium |
| 38243-2 | Brucella abortus IgG Ab [Presence] in Serum |
| 38299-4 | Dioxin [Mass/volume] in Water |
| 38526-0 | Number of specimens tested of Stool |
| 57438-4 | CD56-CD138+ cells/100 cells in Body fluid |
| 49102-7 | Herpes virus 8 DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 49226-4 | lamiVUDine [Mass/volume] in Serum or Plasma |
| 49630-7 | Darunavir+Ritonavir [Susceptibility] by Genotype method |
| 29411-6 | Nordoxepin [Mass/volume] in Gastric fluid |
| 40289-1 | Insulin [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
| 50071-0 | 11-Deoxycortisol [Moles/volume] in Amniotic fluid |
| 40336-0 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose triple bolus |
| 58982-0 | Holm oak IgE Ab [Units/volume] in Serum |
| 59014-1 | Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Serum by Immunoblot |
| 50538-8 | Thyrotropin [Units/volume] in Serum or Plasma --6th specimen |
| 30400-6 | Hypochromia [Presence] in Blood |
| 20550-0 | Morphine Free [Mass/volume] in Urine by Confirmatory method |
| 20913-0 | Organochlorine pesticides [Presence] in Specimen by Screen method |
| 12401-6 | Ethinamate [Mass/volume] in Serum or Plasma |
| 100977-8 | JC virus Ab Index in Serum or Plasma by Immunoassay |
| 101102-2 | Kx Ag [Presence] on Red Blood Cells |
| 13349-6 | Leukocytes [#/volume] in Stool by Manual count |
| 102205-2 | Careless Weed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102393-6 | Isocyanate TDI IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102696-2 | Wheat Bran IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102962-8 | Phthalic anhydride IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103074-1 | Hazelnut recombinant (rCor a) 8 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14437-8 | Albumin/Globulin [Mass Ratio] in Synovial fluid |
| 103119-4 | English walnut recombinant (rJug r) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 10369-7 | Opiates [Mass/mass] in Hair |
| 103721-7 | West Nile virus RNA [Presence] in Blood by NAA with non-probe detection |
| 15022-7 | Amylase.P3/Amylase.total in Serum or Plasma |
| 104393-4 | European tick borne encephalitis virus IgA Ab index in Serum and CSF |
| 152-9 | Cephaloglycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 16113-3 | Progesterone receptor [Interpretation] in Tissue |
| 10859-7 | Trypanosoma sp [Identifier] in Blood by Acridine Orange + Giemsa Stain |
| 11107-0 | Variant lymphocytes/100 cells in Bone marrow by Manual count |
| 1667-5 | 17-Hydroxyketosteroids [Mass/volume] in Urine |
| 12199-6 | Cryofibrinogen [Presence] in Plasma by 3 day cold incubation |
| 1816-8 | Acid alpha glucosidase [Enzymatic activity/volume] in Leukocytes |
| 19151-0 | Specimen drawn [Date and time] of Serum or Plasma |
| 89976-5 | 7-Hydroxychlorpromazine [Mass/volume] in Urine by Confirmatory method |
| 90280-9 | Bacteria identified in Peritoneal dialysis fluid by Aerobe culture |
| 7550-7 | Orange triggered histamine release [Units/volume] in Blood |
| 61179-8 | Leukocyte morphology finding [Identifier] in Blood from Fetus |
| 7629-9 | Sweet potato triggered histamine release [Units/volume] in Blood |
| 9318-7 | Albumin/Creatinine [Mass Ratio] in Urine |
| 93225-1 | Coccidioides sp Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay |
| 9357-5 | Disulfiram [Mass/volume] in Urine |
| 62344-7 | Chromosome analysis.metaphase panel - Blood by FISH |
| 63351-1 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 63369-3 | Chronic urticaria index in Serum |
| 64977-2 | Alternaria alternata recombinant (rAlt a) 6 IgE Ab [Units/volume] in Serum |
| 80426-0 | Hepatitis D virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 8074-7 | Insulin human Ab [Units/volume] in Serum |
| 96671-3 | HLA-DRB3 and HLA-DRB4 and HLA DRB5 [Type] by High resolution |
| 96707-5 | Clot stiffness.fibrinogen contribution.tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited (elasticity) in Blood by US --post heparin neutralization |
| 96732-3 | Spermine [Presence] in Semen by Light microscopy |
| 97199-4 | Icteric interference index of Cerebral spinal fluid |
| 81804-7 | Allo-tetrahydrocortisol/Creatinine [Molar ratio] in Urine |
| 8195-0 | Cocaine [Presence] in Unknown substance |
| 8226-3 | Opiates [Presence] in Unknown substance by Screen method |
| 97273-7 | Methadone [Presence] in Cord tissue by Confirmatory method |
| 97310-7 | Zolpidem [Presence] in Cord tissue by Screen method |
| 70155-7 | Barbiturates [Presence] in Urine by Screen method >200 ng/mL |
| 70167-2 | Trichomonas vaginalis rRNA [Presence] in Urine by NAA with probe detection |
| 82397-1 | Ganglioside GD1a IgM Ab [Presence] in Serum by Line blot |
| 82861-6 | 11-Deoxytetrahydrocortisol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
| 72214-0 | t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
| 72402-1 | oxyCODONE [Presence] in Blood by Screen method |
| 83000-0 | Titin IgG Ab [Presence] in Serum or Plasma by Line blot |
| 99126-5 | NOTCH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 99448-3 | Green Nimitti IgG4 Ab [Mass/volume] in Serum |
| 99914-4 | Bacilliform bacteria [#/volume] in Urine sediment by Automated count |
| 72954-1 | Sildenafil citrate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73137-2 | sulfiSOXAZOLE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87447-9 | Vanadium [Mass/volume] in Specimen |
| 73517-5 | Atenolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88921-2 | Echinococcus granulosus Ab [Titer] in Serum by Complement fixation |
| 897-9 | Blood group antibody screen [Presence] in Serum or Plasma by Elution |
| 59727-8 | Oxazepam [Mass/volume] in Body fluid |
| 42245-1 | Hemoglobin A2/Hemoglobin.total in Blood by HPLC |
| 42642-9 | Amikacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| 60152-6 | PENTobarbital [Mass/volume] in Body fluid |
| 31246-2 | Babesia sp IgG Ab [Units/volume] in Serum |
| 51195-6 | Desbutylbupivacaine [Mass/volume] in Serum or Plasma |
| 43071-0 | Brucella canis IgM Ab [Titer] in Cerebral spinal fluid |
| 21754-7 | AR gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 31833-7 | Haemophilus influenzae A Ag [Presence] in Specimen |
| 23116-7 | Foot and mouth disease virus serotype [Identifier] in Tissue by Immunoassay |
| 53295-2 | Urinalysis type of crystal panel [#/volume] - Urine by Computer assisted method |
| 53427-1 | Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --2nd specimen post XXX challenge |
| 53634-2 | Beta cortol [Mass/time] in 24 hour Urine |
| 34243-6 | Androsterone/Creatinine [Molar ratio] in Urine |
| 54388-4 | Dihydroxycholestanoate [Moles/volume] in Urine |
| 4636-7 | Free Hemoglobin [Mass/volume] in Urine |
| 24509-2 | Aspergillus terreus Ab [Presence] in Serum by Immune diffusion (ID) |
| 34411-9 | Mitochondria M4 Ab [Presence] in Serum |
| 34425-9 | Silver Birch recombinant (rBet v) 1 + 2 IgE Ab [Units/volume] in Serum |
| 34668-4 | Prilocaine [Mass/volume] in Serum or Plasma |
| 551-2 | Brucella sp identified in Blood by Organism specific culture |
| 4706-8 | HLA-A66(10) [Presence] |
| 25311-2 | Amylase [Enzymatic activity/volume] in 24 hour Urine |
| 3575-8 | Dipipanone [Mass/time] in 24 hour Urine |
| 48018-6 | Gene studied [ID] |
| 48222-4 | Rye triggered leukotriene release [Mass/volume] by Leukocytes |
| 26427-5 | Lactoglobulin IgG4 Ab [Units/volume] in Serum |
| 35873-9 | Penicillin+Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 56582-0 | C peptide [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 48376-8 | Collagen type 1 Ab [Units/volume] in Serum |
| 48636-5 | Cholesterol in LDL pattern BII [Presence] in Serum or Plasma by Electrophoresis |
| 48728-0 | NCF1+NCF2+CYBB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 27058-7 | Beta alanine [Moles/volume] in Amniotic fluid |
| 57515-9 | 11-Hydroxyandrosterone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
| 49094-6 | Arbovirus IgG and IgM panel - Cerebral spinal fluid by Immunofluorescence |
| 49175-3 | Human bocavirus IgG Ab [Presence] in Specimen |
| 2948-8 | Sodium [Moles/volume] in Cerebral spinal fluid |
| 40225-5 | Calcium [Moles/volume] in Serum or Plasma --15 minutes pre XXX challenge |
| 58739-4 | Haemophilus influenzae serotype [Identifier] in Isolate by Agglutination |
| 49995-4 | Borrelia burgdorferi 83/93kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 29660-8 | Parvovirus B19 IgG Ab [Presence] in Serum by Immunoassay |
| 40528-2 | Opiates [Presence] in Hair |
| 40710-6 | Chlamydia trachomatis IgM Ab [Presence] in Serum by Immunoassay |
| 29993-3 | Eosinophils [Presence] in Sputum by Wright stain |
| 30024-4 | Carbophenothion [Mass/volume] in Serum or Plasma |
| 30142-4 | IgM [Presence] in 24 hour Urine by Immunoelectrophoresis |
| 30383-4 | Epithelial cells [#/volume] in Urine |
| 41022-5 | Citrate [Molar amount] in Urine collected for unspecified duration |
| 19739-2 | Fenugreek IgE Ab [Units/volume] in Serum |
| 19753-3 | Rat epithelium, serum proteins + urine proteins IgE Ab [Units/volume] in Serum |
| 1987-7 | C peptide [Mass/volume] in Urine |
| 20600-3 | CD30 cells/100 cells in Specimen |
| 20948-6 | Retinol [Mass/mass] in Tissue |
| 102615-2 | Sugar Cane IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102968-5 | Trichophyton sp IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102991-7 | American Cockroach IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14569-8 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma |
| 14825-4 | Maprotiline [Moles/volume] in Serum or Plasma |
| 15254-6 | Food Allergen Mix 8 (Brazil nut+Orange+Hazelnut+Apple+Cocoa) IgE Ab [Presence] in Serum by Multidisk |
| 10936-3 | Mare milk IgE Ab [Units/volume] in Serum |
| 11180-7 | Lupin IgE Ab [Units/volume] in Serum |
| 11251-6 | Piroxicam [Mass/volume] in Serum or Plasma |
| 17051-4 | Laxatives [Identifier] in Urine |
| 17835-0 | Monocytes/100 leukocytes in Synovial fluid |
| 17845-9 | Lipoprotein.alpha [Presence] in Serum or Plasma |
| 91859-9 | Herpes simplex virus 1 DNA [Presence] in Genital specimen by NAA with probe detection |
| 92651-9 | Pregabalin [Presence] in Urine by Confirmatory method |
| 75062-0 | Phenylacetate [Moles/volume] in Serum or Plasma |
| 7548-1 | Onion IgG Ab [Units/volume] in Serum |
| 92907-5 | MET gene copy number/Chromosome 7 copy number in Blood or Tissue by FISH |
| 9330-2 | Benzene [Mass/volume] in Blood |
| 94234-2 | F8 gene full mutation analysis in Blood or Tissue by Sequencing |
| 63346-1 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) |
| 9433-4 | Isoflurane [Mass/volume] in Blood |
| 94711-9 | Glutamate decarboxylase 65 Ab [Moles/volume] in Cerebral spinal fluid by Immunoassay |
| 64128-2 | Amobarbital/Creatinine [Mass Ratio] in Urine |
| 8026-7 | Stain method [Type] in Specimen |
| 8036-6 | Taenia saginata Ab [Units/volume] in Serum |
| 96258-9 | Cholesterol in LDL [Moles/volume] in Serum or Plasma by Calculated by Martin-Hopkins |
| 82096-9 | Food Allergen Mix 17 (Apple+Banana+Pear+Peach) IgE Ab RAST class [Presence] in Serum by Multidisk |
| 7008-6 | Doxycycline [Susceptibility] by Gradient strip |
| 71828-8 | Hematocrit [Pure volume fraction] of Body fluid |
| 7184-5 | Cat dander IgG Ab [Units/volume] in Serum |
| 72317-1 | RNA polymerase III RP11 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 72373-4 | Virus identified in Nasopharynx by Culture |
| 85742-5 | Streptococcus pneumoniae Danish serotype 3 DNA [Cycle Threshold #] in Specimen by NAA with probe detection |
| 72805-5 | JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
| 73052-3 | buPROPion induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73086-1 | Vancomycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87660-7 | Endrin [Mass/mass] in Specimen |
| 87670-6 | Carbamate panel - Specimen |
| 73871-6 | Alpha cortolone [Moles/volume] in Urine |
| 88365-2 | Glucose [Mass/volume] in Blood --pre-meal |
| 74277-5 | Mycobacterium tuberculosis stimulated gamma interferon CFP10 Ag spot count [#] in Blood |
| 89596-1 | Listeria monocytogenes DNA [Presence] in Blood by NAA with probe detection |
| 41453-2 | Human coronavirus Ag [Presence] in Specimen by Immunofluorescence |
| 50615-4 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --5 hours post XXX challenge |
| 31013-6 | Dehydrochlormethyltestosterone [Mass/volume] in Urine |
| 31109-2 | Osmotic fragility of Red Blood Cells--0.35% sodium chloride 24 hour 37 degree C incubation |
| 41997-8 | Heptacarboxylporphyrin [Mass/volume] in 24 hour Urine |
| 4239-0 | Etafedrine [Mass] of Dose |
| 42485-3 | Anion gap in Vitreous fluid |
| 31488-0 | Listeria sp Ab [Units/volume] in Cerebral spinal fluid |
| 51211-1 | Uranium [Mass/volume] in Body fluid |
| 51430-7 | Calcitonin [Mass/volume] in Serum or Plasma --pre or post XXX challenge |
| 22278-6 | Echovirus 6 Ab [Titer] in Serum |
| 51512-2 | Lactate dehydrogenase 2/Lactate dehydrogenase.total in Pleural fluid by Electrophoresis |
| 43287-2 | Spermatozoa IgG binding location [Identifier] in Semen |
| 43829-1 | Caffeine [Presence] in Specimen |
| 5231-6 | Influenza virus C Ab [Titer] in Serum by Complement fixation |
| 53275-4 | Transitional cells [#/volume] in Urine by Computer assisted method |
| 44627-8 | Extraprostatic extension by CAP cancer protocols |
| 23514-3 | Trypanosoma equiperdum Ab [Presence] in Serum by Immune diffusion (ID) |
| 33362-5 | Monocytes/100 leukocytes in Pleural fluid |
| 3349-8 | Amphetamines [Presence] in Urine |
| 33504-2 | Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --pre dose lactose PO |
| 33695-8 | Clostridium botulinum [Presence] in Isolate by Organism specific culture |
| 33950-7 | Magnesium/Creatinine [Molar ratio] in Urine |
| 46188-9 | Equine herpesvirus 3 Ab [Titer] in Serum |
| 46703-5 | Dihydrocodeine Free+Hydrocodol Free [Presence] in Serum or Plasma by Screen method |
| 46705-0 | Clostridium botulinum toxin gene [Identifier] in Specimen by NAA with probe detection |
| 24199-2 | Coxsackievirus B6 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen |
| 55397-4 | Short myasthenia gravis panel - Serum |
| 47059-1 | Legionella pneumophila 13 IgG Ab [Titer] in Serum by Immunofluorescence |
| 25377-3 | Recalcification time in Control Platelet poor plasma by Coagulation assay |
| 55787-6 | Lymphocytes [#] in Cerebral spinal fluid by Manual count |
| 47607-7 | Cortisol [Moles/volume] in Serum or Plasma --30 minutes post 1 ug/kg CRH IV |
| 47893-3 | Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose glucagon |
| 35505-7 | Lipoprotein.beta.subparticle [Type] in Serum or Plasma |
| 35543-8 | Pork IgG Ab [Mass/volume] in Serum |
| 35784-8 | Cephalexin [Susceptibility] by Gradient strip |
| 56166-2 | Gum arabic IgG4 Ab [Mass/volume] in Serum |
| 47942-8 | Testosterone [Mass/volume] in Serum or Plasma --1 day post 5000 U HCG IM |
| 3744-0 | Meperidine [Presence] in Serum or Plasma |
| 56609-1 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 48387-5 | Thyroglobulin recovery [Presence] in Serum or Plasma |
| 48844-5 | Bartonella elizabethae IgG Ab [Titer] in Serum by Immunofluorescence |
| 48867-6 | Orientia tsutsugamushi DNA [Presence] in Specimen by NAA with probe detection |
| 48895-7 | Ehrlichia chaffeensis IgM Ab [Titer] in Body fluid by Immunofluorescence |
| 38362-0 | Muscle specific receptor tyrosine kinase Ab [Presence] in Serum |
| 49100-1 | H2a-H2b DNA IgG Ab [Presence] in Serum |
| 27289-8 | Methamphetamine [Mass/mass] in Meconium |
| 39302-5 | Influenza virus A H15 Ab [Titer] in Serum by Hemagglutination inhibition |
| 39565-7 | Complement C4d [Mass/volume] in Plasma by Immunoassay |
| 2827-4 | Potassium [Moles/volume] in Sweat |
| 28640-1 | Bicarbonate [Moles/volume] in Arterial cord blood |
| 40104-2 | aPTT in Platelet poor plasma by Coagulation assay --2 hours post XXX challenge |
| 4995-7 | Cryptococcus neoformans rRNA [Presence] in Specimen by Probe |
| 49984-8 | Borrelia burgdorferi 37kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 5015-3 | Histoplasma capsulatum DNA [Presence] in Specimen by NAA with probe detection |
| 29782-0 | Trivittatus virus neutralizing antibody [Titer] in Specimen by Neutralization test |
| 29887-7 | Pasteurella multocida type [Identifier] in Isolate |
| 59189-1 | Methyl ethyl ketone/Creatinine [Molar ratio] in Urine |
| 50213-8 | Glucose [Mass/volume] in Serum or Plasma --3rd specimen |
| 50349-0 | Parvovirus B19 DNA [Presence] in Amniotic fluid by NAA with probe detection |
| 50396-1 | Molecular diagnostic major findings for display [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 41034-0 | Herpes simplex virus 2 Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 20603-7 | CD38 cells/100 cells in Specimen |
| 100041-3 | Aminoglycoside [Susceptibility] |
| 100889-5 | Monkeypox virus clade I DNA [Presence] in Specimen by NAA with probe detection |
| 12491-7 | Methohexital [Presence] in Serum or Plasma |
| 13267-0 | Mumps virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 102706-9 | Cefaclor IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102846-3 | Baker's yeast IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102910-7 | Staphylococcus aureus enterotoxin D IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14562-3 | Mycobacterium tuberculosis DNA [Presence] in Semen by NAA with probe detection |
| 104191-2 | Guanidinoacetate methyltransferase (GAMT) deficiency newborn screening panel |
| 15172-0 | Cryoglobulin.IgG [Units/volume] in Serum |
| 1697-2 | 6-Phosphogluconate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
| 16997-9 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post dose glucose |
| 17884-8 | Bacteria # 3 identified in Genital specimen by Aerobe culture |
| 74783-2 | Malignant cells [Presence] in Body fluid by Light microscopy |
| 91811-0 | Human bocavirus Ag [Presence] in Upper respiratory specimen by Immunofluorescence |
| 75887-0 | HCV antibody RIBA tests - Meaningful Use set by Immunoblot |
| 7655-4 | Southern Ragweed IgE Ab [Units/volume] in Serum |
| 7665-3 | Rhodotorula spp IgE Ab [Units/volume] in Serum |
| 77015-6 | Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free DNA by Sequencing Qualitative |
| 92955-4 | Serratia marcescens DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection |
| 61329-9 | Cucumber IgE Ab/IgE total in Serum |
| 618-9 | Bacteria identified in Pleural fluid by Culture |
| 62388-4 | Hemoglobin A1c/Hemoglobin.total in Blood by JDS/JSCC protocol |
| 93887-8 | Methane/Expired gas [Volume Fraction] in Exhaled gas --45 minutes post dose carbohydrate |
| 93906-6 | ABO and Rh group [Type] in Blood--during infancy |
| 63092-1 | Cheese cheddar type IgG Ab [Mass/volume] in Serum |
| 78777-0 | Alfentanil [Mass/mass] in Hair |
| 94574-1 | Heavy metals panel - Nail |
| 63448-5 | CD3+CD5+ cells/100 cells in Cerebral spinal fluid |
| 6448-5 | Legionella pneumophila Ag [Presence] in Urine by Radioimmunoassay (RIA) |
| 6474-1 | Microscopic observation [Identifier] in Urethra by Gram stain |
| 78882-8 | Sertraline cutoff [Mass/volume] in Urine for Confirmatory method |
| 95538-5 | Human papilloma virus 33+58 DNA [Presence] in Cervix by NAA with probe detection |
| 95660-7 | Eastern equine encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay |
| 66749-3 | Circulatory assist status [Identifier] |
| 6715-7 | Brewer's yeast IgG Ab [Units/volume] in Serum |
| 9595-0 | Borrelia burgdorferi 58kD IgG Ab [Presence] in Serum by Immunoblot |
| 6761-1 | Glucose [Presence] in Urine by Test strip --1.5 hours post 50 g lactose PO |
| 8150-5 | Amphetamines [Mass/volume] in Urine |
| 96803-2 | 24 hour predicted protein [Mass/time] based on random Urine by calculation |
| 96805-7 | Cobalamin (Vitamin B12) and folate panel - Serum |
| 81757-7 | Lymphocyte proliferation.Interleukin 2.maximum/CD3 in Blood by Flow cytometry (FC) |
| 97941-9 | Cycloheximide [Susceptibility] in Isolate Qualitative |
| 70860-2 | Rabies virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 82994-5 | MDA5 IgG Ab [Presence] in Serum by Line blot |
| 71847-8 | Oxygen saturation [Pure mass fraction] in Venous cord blood |
| 7198-5 | Celery triggered histamine release [Units/volume] in Blood |
| 83062-0 | PIK3CA gene [VCF] in Cancer specimen by Sequencing |
| 84930-7 | AMPAR2 Ab [Presence] in Serum by Immunofluorescence |
| 85321-8 | Glandular differentiation [Score] in Breast cancer specimen by Nottingham |
| 85835-7 | Beta-lactam resistance ESBL blaCTX-M-8+blaCTX-M-25 Group genes [Presence] by Molecular method |
| 86074-2 | Streptococcus pneumoniae Danish serotype 23F Ab [Mass/volume] in Serum --1st specimen |
| 87560-9 | Ehrlichia canis+ewingii groEL gene [Presence] in Blood by NAA with non-probe detection |
| 87-7 | Cefmetazole [Susceptibility] by Minimum lethal concentration (MLC) |
| 73411-1 | Dipyridamole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73712-2 | Food Allergen Mix 70 (Tarragon+Lovage+Marjoram+Thyme) IgE Ab [Units/volume] in Serum by Multidisk |
| 88161-5 | Toxoplasma gondii [Presence] in Ocular fluid by Organism specific culture |
| 59917-5 | Ketoprofen [Moles/volume] in Urine |
| 21252-2 | Echinococcus granulosus IgG Ab [Presence] in Serum by Immunoblot |
| 31822-0 | Equine influenza virus A2 Ag [Units/volume] in Specimen |
| 51883-7 | Transfuse whole blood units [#] |
| 22626-6 | Xylose [Mass/time] in 5 hour Urine --post 25 g xylose PO |
| 32325-3 | Lead [Moles/volume] in Red Blood Cells |
| 32330-3 | Mercury [Moles/volume] in Serum or Plasma |
| 52777-0 | Intrinsic coagulation system with heparin inhibition thromboelastography panel - Blood |
| 4437-0 | Tetracycline [Mass] of Dose |
| 32852-6 | carBAMazepine free/carBAMazepine.total in Serum or Plasma |
| 44447-1 | Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 23270-2 | Mycoplasma capricolum ss capripneumonia Ag [Presence] in Tissue |
| 23616-6 | Viomycin [Susceptibility] by Method for Slow-growing mycobacteria |
| 33502-6 | Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose lactose PO |
| 45004-9 | Chlamydia trachomatis IgA Ab [Presence] in Cerebral spinal fluid |
| 45267-2 | Acute leukemia markers [Interpretation] in Specimen Narrative |
| 33735-2 | Surgical margin tumor involvement.distant by CAP cancer protocols |
| 54168-0 | Cefoperazone+Sulbactam [Susceptibility] by Disk diffusion (KB) |
| 46274-7 | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells --after transfusion reaction |
| 47000-5 | Candida sp rRNA [Presence] in Vaginal fluid by Probe |
| 24507-6 | Aspergillus clavatus Ab [Presence] in Serum by Immune diffusion (ID) |
| 34309-5 | Fructose/Creatinine [Molar ratio] in Urine |
| 34704-7 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL |
| 54909-7 | Culex mosquito IgE Ab [Units/volume] in Serum |
| 55500-3 | Insulin [Moles/volume] in Serum or Plasma --30 minutes post dose glucagon |
| 47187-0 | Progesterone [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 47298-5 | Corynebacterium diphtheriae Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 35294-8 | PYGM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 55739-7 | Cefotiam hexetil [Susceptibility] by Disk diffusion (KB) |
| 25584-4 | Calcium [Moles/volume] in Urine --5 hours post 500 mg calcium PO |
| 35393-8 | Hantavirus IgM Ab [Units/volume] in Serum |
| 35493-6 | Ricin [Presence] in Specimen |
| 27121-3 | Streptococcus pneumoniae Danish serotype 18C Ab [Mass/volume] in Serum --2nd specimen |
| 38428-9 | Ibuprofen [Mass/volume] in Serum or Plasma --pre dose |
| 38468-5 | Chlamydia sp Ab [Presence] in Cerebral spinal fluid |
| 57455-8 | Taenia solium IgG Ab [Units/volume] in Serum |
| 27915-8 | Alpha-1-Antichymotrypsin [Units/volume] in Stool |
| 58091-0 | Glucose-6-Phosphate dehydrogenase newborn screen panel |
| 49491-4 | BCR-ABL1 b3a2 fusion protein [Presence] in Blood or Tissue by Molecular genetics method |
| 40071-3 | Calcium [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 40195-0 | Glucose [Moles/volume] in Serum or Plasma --13 minutes pre XXX challenge |
| 5840-4 | Enterovirus identified in Isolate by Immunofluorescence |
| 29686-3 | Orientia tsutsugamushi Gilliam Ab [Titer] in Serum |
| 29780-4 | West Nile virus IgM Ab [Presence] in Specimen |
| 29954-5 | Extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
| 40413-7 | Barbiturates [Presence] in Hair |
| 50264-1 | 17-Ketosteroids [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
| 5030-2 | Parvovirus B19 RNA [Presence] in Blood by NAA with probe detection |
| 40755-1 | Amiodarone [Mass/volume] in Serum or Plasma --peak |
| 41063-9 | RPS6KA3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 41117-3 | AS+PWS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 41124-9 | Toxoplasma gondii AC Ab [Units/volume] in Serum |
| 4112-9 | Alprenolol [Mass] of Dose |
| 19238-5 | Base excess standard in Mixed venous blood by calculation |
| 19283-1 | Benzodiazepines cutoff [Mass/volume] in Urine for Screen method |
| 20724-1 | Brucella abortus Ab [Presence] in Whey by Ring agglutination |
| 100751-7 | Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma |
| 101212-9 | Hantavirus hantaan IgG Ab [Presence] in Serum or Plasma by Line blot |
| 101637-7 | TCRB gene and TCRG gene rearrangements in Blood or Tissue by Molecular genetics method |
| 13272-0 | Neisseria meningitidis serogroup C Ab [Units/volume] in Serum |
| 13339-7 | CD8+CD56+ cells/100 cells in Blood |
| 13616-8 | Nitrite [Mass/volume] in Water |
| 102484-3 | Oyster IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14241-4 | Parietal cell Ab [Presence] in Serum |
| 14335-4 | Optical density of Amniotic fluid by Spectrophotometry |
| 102733-3 | Egg white IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102831-5 | Mandarin IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103036-0 | Monosodium glutamate (MSG) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103637-5 | Atlantic wreckfish IgE Ab [Units/volume] in Serum |
| 103663-1 | Salmonella and Shigella and Campylobacter and E. coli sp identified in Stool by Organism specific culture |
| 104431-2 | Mumps virus IgM Ab [Units/volume] in Serum and CSF |
| 10577-5 | Glucosidase [Enzymatic activity/volume] in Seminal plasma |
| 107-3 | Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC) |
| 11138-5 | Myeloid cells/Erythroid cells [# Ratio] in Bone marrow |
| 16526-6 | Calcium/Protein [Mass Ratio] in Serum or Plasma |
| 11265-6 | Salmonella paratyphi B Ab [Presence] in Serum by Agglutination |
| 17149-6 | CD42a cells/100 cells in Blood |
| 17373-2 | Norepinephrine [Mass/volume] in Urine --6th specimen post XXX challenge |
| 17499-5 | Gamma globulin [Mass/volume] in Body fluid by Electrophoresis |
| 17553-9 | Measles virus Ab [Units/volume] in Cerebral spinal fluid |
| 19065-2 | Benzoylecgonine cutoff [Mass/volume] in Urine |
| 74646-1 | Methamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method |
| 74683-4 | Ethyl sulfate [Presence] in Urine by Confirmatory method |
| 74699-0 | Cefuroxime [Susceptibility] by Disk diffusion (KB) |
| 60416-5 | Parainfluenza virus 3 RNA [Presence] in Isolate by NAA with probe detection |
| 93337-4 | Chenodeoxycholate+Cholate/Bile acid.total in 48 hour Stool |
| 61280-4 | Lettuce IgE Ab/IgE total in Serum |
| 61334-9 | Dog epithelium IgE Ab/IgE total in Serum |
| 7717-2 | Yellow Squash IgG Ab [Units/volume] in Serum |
| 77387-9 | Parainfluenza virus 3 Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
| 7750-3 | Tuna triggered histamine release [Units/volume] in Blood |
| 63319-8 | Ribonucleoprotein extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 6550-8 | Staphylococcus aureus Ab [Units/volume] in Serum |
| 672-6 | Microscopic observation [Identifier] in Specimen by Neisser stain |
| 96400-7 | Retinol binding protein/Creatinine [Mass Ratio] in 24 hour Urine |
| 96489-0 | Neuronal intermediate filament light chain IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
| 68410-0 | Macrophages [#/volume] in Pleural fluid by Manual count |
| 80596-0 | Rhinovirus 5' UTR RNA [Presence] in Nasopharynx by NAA with probe detection |
| 81146-3 | CYP3A4 and CYP3A5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 96654-9 | HLA-DQA1 [Type] by Low resolution |
| 6949-2 | Metaproterenol [Mass/volume] in Serum or Plasma |
| 69740-9 | Cell count panel - Pericardial fluid |
| 81827-8 | CNGB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 85277-2 | Distance of carcinoma from closest mucosal margin when all mucosal margins are uninvolved [Length] in Colorectal cancer specimen by Light microscopy |
| 72603-4 | Beta hydroxybutyrate + Acetoacetate [Moles/volume] in Blood |
| 87489-1 | AKB48 N-pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
| 87728-2 | Description of swab specimen Narrative |
| 87771-2 | Zonisamide/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 88172-2 | Microscopic observation [Presence] in Isolate by Acid fast stain |
| 73925-0 | AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
| 74350-0 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --20M post dose corticotropin |
| 41622-2 | Bacillus anthracis DNA [Identifier] in Specimen by NAA with probe detection |
| 59972-0 | Sulfamethoxazole [Moles/volume] in Gastric fluid |
| 60040-3 | Acebutolol [Mass/volume] in Serum or Plasma |
| 21574-9 | Transferrin.carbohydrate deficient.monosialo/Transferrin.total in Serum or Plasma |
| 31212-4 | Actinobacillus pleuropneumoniae serotype 1 Ab [Presence] in Serum |
| 31376-7 | Equine arteritis virus Ab [Units/volume] in Serum |
| 51101-4 | CD19 blasts/100 blasts in Bone marrow |
| 42927-4 | Myeloid cells/100 cells in Specimen |
| 42934-0 | CD83 cells/100 cells in Specimen |
| 43135-3 | 17-Ketosteroids and 17-Ketogenic steroids panel - 24 hour Urine |
| 22226-5 | Coxsackievirus B1 Ab [Titer] in Serum |
| 43417-5 | Microscopic observation [Identifier] in Esophageal brushing by Cyto stain |
| 22389-1 | Legionella pneumophila 5 IgG Ab [Titer] in Serum |
| 22431-1 | Neisseria meningitidis serogroup Y Ab [Titer] in Specimen |
| 22664-7 | Urea [Moles/volume] in Serum or Plasma |
| 22739-7 | Tyrosine [Moles/volume] in Specimen |
| 323-6 | Methicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 43984-4 | Benzoylecgonine [Presence] in Urine by Screen method >150 ng/mL |
| 53081-6 | Ammonia [Moles/volume] in Dialysis fluid |
| 53208-5 | Decatrienoylcarnitine (C10:3) [Moles/volume] in DBS |
| 53445-3 | Carnitine palmitoyltransferase 2/Citrate synthase [Enzymatic activity ratio] in Fibroblast |
| 44525-4 | Histoplasma capsulatum Ag [Presence] in Serum by Immunoassay |
| 44591-6 | IgD [Presence] in Urine by Immunofixation |
| 44670-8 | Margin involvement in Prostate tumor by CAP cancer protocols |
| 44846-4 | Bacteria # 6 identified in Specimen by Culture |
| 33653-7 | Beta galactosidase [Entitic Catalytic Activity] in Leukocytes |
| 53852-0 | COL2A1 gene+COL11A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 45218-5 | Lymphocytic choriomeningitis virus IgG Ab [Presence] in Serum |
| 33980-4 | Voltage-gated calcium channel P/Q type binding Ab [Moles/volume] in Serum |
| 24522-5 | EPINEPHrine/Creatinine [Molar ratio] in Urine |
| 34374-9 | Serotonin/Creatinine [Molar ratio] in Urine |
| 34659-3 | ATP7A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 47085-6 | Plasmodium sp DNA [Presence] in Blood by NAA with probe detection |
| 47425-4 | Aspergillus nidulans B Ab [Presence] in Serum |
| 3509-7 | Prochlorperazine [Mass/volume] in Serum or Plasma |
| 55618-3 | Atovaquone [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 55637-3 | Cefamandole+Sulbactam [Susceptibility] by Gradient strip |
| 47712-5 | Nitrogen [Presence] in Sweat |
| 25797-2 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 2597-3 | Magnesium [Moles/volume] in Red Blood Cells |
| 56184-5 | Avocado IgG4 Ab [Mass/volume] in Serum |
| 56478-1 | Ethanol [Mass/volume] in Blood by Gas chromatography |
| 48228-1 | Bovine serum albumin (BSA) triggered leukotriene release [Mass/volume] by Leukocytes |
| 4836-3 | HLA-B49(21) [Presence] in Donor |
| 48664-7 | Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation.derived |
| 38334-9 | 1,1,2-Trichloroethane [Mass/volume] in Water |
| 38359-6 | A Ab [Titer] in Serum or Plasma by Immediate spin |
| 38365-3 | Hexadecadienoate (C16:2)/Creatinine [Mass Ratio] in Urine |
| 38477-6 | Glucosylceramidase [Enzymatic activity/volume] in Serum or Plasma |
| 38566-6 | Spermatozoa Motile [Presence] in Semen --post washing |
| 57369-1 | Microalbumin [Mass/volume] in 12 hour Urine |
| 57496-2 | 11-Deoxycortisol [Moles/volume] in Serum or Plasma --1 day post dose dexamethasone |
| 49616-6 | Legionella sp DNA [Identifier] in Specimen by NAA with probe detection |
| 49737-0 | Sirolimus [Mass] of Dose |
| 40042-4 | Glucose [Mass/volume] in Serum or Plasma --30 hours post XXX challenge |
| 5003-9 | Epstein Barr virus DNA [Presence] in Tissue by Probe |
| 101646-8 | Candida albicans, C. dubliniensis, C. parapsilosis, and C. tropicalis DNA [Presence] in Vaginal fluid by NAA with probe detection |
| 13305-8 | HLA-DQ [Type] |
| 14173-9 | Progesterone Free [Mass/time] in 24 hour Urine |
| 103033-7 | Common wasp recombinant (rVes v) 5 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103109-5 | Russian olive IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14441-0 | Cholesterol [Mass/volume] in Peritoneal fluid |
| 15199-3 | Microcytes [Presence] in Blood by Automated count |
| 10673-2 | Hepatitis B virus core Ag [Presence] in Tissue by Immune stain |
| 16485-5 | Bromodiphenhydramine [Mass/volume] in Urine |
| 11210-2 | Cancer Ag 125 [Units/volume] in Body fluid |
| 16904-5 | Glucose [Presence] in Urine --1st specimen post XXX challenge |
| 17490-4 | Progesterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 1760-8 | Alcohol dehydrogenase [Enzymatic activity/volume] in Serum |
| 17872-3 | Tetrahydrocannabinol [Presence] in Urine by Confirm method >25 ng/mL |
| 18183-4 | Melatonin [Mass/time] in 24 hour Urine |
| 18487-9 | Broad casts [#/area] in Urine sediment by Microscopy low power field |
| 18496-0 | Ova and parasites identified in Stool by Trichrome stain--2nd specimen |
| 91029-9 | Cocaine+Benzoylecgonine [Presence] in Meconium by Screen method |
| 75023-2 | CD63 (Activated) Basophils/100 basophils in Blood by Flow cytometry (FC) |
| 7521-8 | Mustard IgG Ab [Units/volume] in Serum |
| 94146-8 | 2-Decenedioate/Creatinine [Molar ratio] in Urine |
| 7827-9 | Coccidioides immitis IgM Ab [Units/volume] in Serum |
| 63404-8 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 63542-5 | SCL-70 extractable nuclear Ab [Presence] in Body fluid |
| 6436-0 | Influenza virus A+B Ag [Presence] in Throat by Immunofluorescence |
| 95599-7 | Dipeptidyl aminopeptidase-like protein 6 Ab [Titer] in Serum by Cell binding immunofluorescent assay |
| 66497-9 | Spermatozoa Double forms/100 spermatozoa in Semen |
| 79566-6 | Collection method - DBS |
| 79692-0 | 2,8-dihydroxyadenine [Moles/volume] in Serum or Plasma |
| 80217-3 | Mycoplasma hyopneumoniae Ag [Presence] in Fixed tissue by Immune stain |
| 80365-0 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Anorectal by NAA with probe detection |
| 9573-7 | Respiratory syncytial virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 67828-4 | Macrophages [#/volume] in Pericardial fluid |
| 80517-6 | Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Serum by Nephelometry |
| 81105-9 | Leptospira interrogans sv Panama Ab [Titer] in Serum by Agglutination |
| 8200-8 | Gadolinium [Mass/volume] in Urine |
| 71840-3 | Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Blood |
| 72360-1 | Methemoglobin/Hemoglobin.total in Venous cord blood |
| 73195-0 | Primidone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 87385-1 | Porcine parainfluenza virus 1 F gene [Nucleotide sequence] in Isolate by Sequencing |
| 87650-8 | Methomyl [Mass/mass] in Specimen |
| 73825-2 | Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative |
| 88453-6 | HIV 1 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum, Plasma or Blood from Donor by NAA with probe detection |
| 89507-8 | Myeloperoxidase Ab [Presence] in Serum by Line blot |
| 41221-3 | Xanthurenate+Kynurenate [Mass/time] in 24 hour Urine |
| 41655-2 | Hematocrit [Volume Fraction] of Mixed venous blood |
| 50649-3 | Latex recombinant (rHev b) 6.02 IgE Ab [Units/volume] in Serum |
| 5102-9 | Coxsackievirus A9 neutralizing antibody [Titer] in Serum by Neutralization test |
| 30412-1 | Abnormal lymphocytes [#/volume] in Blood |
| 30436-0 | Monocytes+Macrophages/100 leukocytes in Cerebral spinal fluid |
| 30486-5 | Catecholamines [Mass/volume] in Plasma --baseline |
| 42509-0 | Histoplasma capsulatum Ab [Presence] in Pleural fluid by Immune diffusion (ID) |
| 42674-2 | Fat.neutral [#/area] in Urine by Microscopy high power field |
| 51121-2 | Cytoplasmic CD22 blasts [Units/volume] in Bone marrow |
| 42757-5 | Troponin I.cardiac [Mass/volume] in Blood |
| 21691-1 | HBB gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 22172-1 | Chlamydophila pneumoniae IgG Ab [Titer] in Serum |
| 31718-0 | Astrovirus Ag [Presence] in Stool |
| 43224-5 | Coccidioides sp Ab [Units/volume] in Serum by Complement fixation |
| 43281-5 | Hepatitis D virus Ag [Mass/volume] in Serum |
| 43339-1 | Porcine adenovirus Ab [Presence] in Serum by Immunofluorescence |
| 52985-9 | Leishmania sp IgG Ab [Titer] in Serum by Immunofluorescence |
| 44049-5 | Tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method |
| 4439-6 | Tetrahydrocortisone [Mass] of Dose |
| 23016-9 | Coxiella burnetii [Presence] in Placenta by Light microscopy |
| 32588-6 | Androstenedione [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
| 33241-1 | Calcium carbonate crystals [Presence] in Urine by Computer assisted method |
| 53420-6 | Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --2nd specimen post XXX challenge |
| 53438-8 | Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Fibroblast |
| 44595-7 | IgG [Presence] in 24 hour Urine by Immunofixation |
| 44651-8 | Tissue cores.positive.carcinoma in Tissue core |
| 44689-8 | Melanoma in situ.location relative to involved lateral margin |
| 23542-4 | Venezuelan equine encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 23615-8 | Vancomycin [Susceptibility] by Method for Slow-growing mycobacteria |
| 3371-2 | Barbital [Mass/volume] in Urine |
| 45348-0 | Date tick acquired |
| 23658-8 | Other Antibiotic [Susceptibility] |
| 23866-7 | Glutaraldehyde [Presence] in Urine |
| 54368-6 | Catalase [Enzymatic activity/volume] in Plasma |
| 4591-4 | Hemoglobin Hope [Presence] in Blood by Electrophoresis acid (pH 6.3) |
| 46132-7 | Glycosaminoglycans/Creatinine [Ratio] in Urine |
| 468-9 | Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 24202-4 | Saint Louis encephalitis virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
| 24454-1 | Collection duration of Gastric fluid |
| 25363-3 | Campylobacter fetus Ab [Titer] in Serum by Complement fixation |
| 34928-2 | Urobilinogen [Moles/volume] in Urine by Test strip |
| 47544-2 | 5-Hydroxyindoleacetate [Moles/volume] in Cerebral spinal fluid |
| 35616-2 | LORazepam [Mass/volume] in Serum or Plasma by Screen method |
| 56409-6 | Turkey IgG4 Ab [Mass/volume] in Serum |
| 4828-0 | HLA-B39(16) [Presence] in Donor |
| 56896-4 | CD33+CD34+ cells/100 cells in Bone marrow |
| 48349-5 | Pregabalin [Moles/volume] in Serum or Plasma |
| 26800-3 | Escherichia coli IgG Ab [Units/volume] in Serum |
| 27866-3 | 17-Ketogenic steroids [Mass/volume] in 24 hour Urine |
| 27901-8 | Lactobacillus sp IgM Ab [Units/volume] in Serum |
| 39085-6 | California Walnut Pollen IgE Ab/IgE total in Serum |
| 39598-8 | Curvularia lunata IgE Ab/IgE total in Serum |
| 57941-7 | Lime IgE Ab/IgE total in Serum |
| 28597-3 | Carnosine/Creatinine [Ratio] in Urine |
| 40082-0 | Calcium [Mass/volume] in Serum or Plasma --20 hours post XXX challenge |
| 40170-3 | Glucose [Moles/volume] in Serum or Plasma --8.5 hours post XXX challenge |
| 58657-8 | Cortisol [Mass/volume] in Saliva (oral fluid) --2 hours post 1 ug/kg CRH IV |
| 58659-4 | Cortisol [Moles/volume] in Serum or Plasma --2 hours post 1 ug/kg CRH IV |
| 49767-7 | Filaria IgG2 Ab [Units/volume] in Serum by Immunoassay |
| 49994-7 | Borrelia burgdorferi 18/20kD IgM Ab [Presence] in Serum by Immunoblot |
| 29812-5 | Jamestown canyon virus IgM Ab [Units/volume] in Serum by Immunofluorescence |
| 5899-0 | aPTT normal/actual in Platelet poor plasma by Coagulation assay |
| 59190-9 | 2-Hydroxycaproate/Creatinine [Molar ratio] in Urine |
| 30136-6 | Epstein Barr virus capsid IgG Ab [Presence] in Serum --2nd specimen |
| 19243-5 | Brucella abortus Ab [Units/volume] in Serum by Immunoassay |
| 19395-3 | chlorproMAZINE [Presence] in Urine by Screen method |
| 208-9 | Cyclacillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 21003-9 | Fungus identified in Specimen by Fungus stain |
| 14001-2 | IgE [Units/volume] in Cord blood |
| 14215-8 | HTLV I g46 Ab [Presence] in Serum |
| 102998-2 | Timothy recombinant (rPhl p) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 14424-6 | Bilirubin.total [Mass/volume] in Gastric fluid |
| 14527-6 | Rubella virus Ag [Presence] in Nose by Immunofluorescence |
| 14688-6 | Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma |
| 104228-2 | Alpha-Pyrrolidinoisohexanophenone [Mass/volume] in Urine by Confirmatory method |
| 10658-3 | Cyanobacterium identified in Water by Light microscopy |
| 15485-6 | Mycoplasma gallisepticum Ab [Presence] in Serum by Immunoassay |
| 10966-0 | Glucose [Presence] in Urine by Test strip --2.5 hours post 75 g glucose PO |
| 17640-4 | Streptococcus pneumoniae Danish serotype 7F Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen |
| 92008-2 | T-cell receptor excision circle [Multiple of the median] in DBS |
| 92761-6 | 7-Alpha hydroxy-4-cholesten-3-one [Moles/volume] in Serum or Plasma |
| 75637-9 | Glucose [Moles/volume] in Serum or Plasma --45 minutes post 50 g lactose PO |
| 7566-3 | Parakeet serum IgE Ab [Units/volume] in Serum |
| 6238-0 | Salt grass IgE Ab [Units/volume] in Serum |
| 77089-1 | GFM1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 77177-4 | IgG [Moles/volume] in Serum or Plasma |
| 78227-6 | PDGFRB gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 9473-0 | Heptachlorepoxide [Mass/volume] in Serum or Plasma |
| 94819-0 | SARS-CoV-2 (COVID-19) RNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
| 63452-7 | CD3-CD7+cells/100 cells in Tissue |
| 7894-9 | Haemophilus influenzae Ab [Units/volume] in Serum |
| 79299-4 | D- and L-2-hydroxyglutarate pattern [Interpretation] in Cerebral spinal fluid Narrative |
| 79472-7 | Phenylpropionylglycine [Moles/volume] in Serum or Plasma |
| 6664-7 | Microscopic observation [Identifier] in Tissue by Gram stain |
| 6736-3 | Tomato IgG Ab [Units/volume] in Serum |
| 69032-1 | Enterocyte IgM Ab [Presence] in Serum |
| 81150-5 | Dengue virus 1+2+3+4 5' UTR RNA [Presence] in Serum by NAA with probe detection |
| 69876-1 | Service comment 49 |
| 70017-9 | Parainfluenza virus 1+2+3+4 IgM Ab [Presence] in Serum by Immunoassay |
| 81649-6 | Cryptococcus sp rRNA gene [Presence] in Specimen by NAA with probe detection |
| 97598-7 | CD3-CD16+CD56+ (Natural killer) cells/100 lymphocytes in Lower respiratory specimen by Flow cytometry (FC) |
| 97858-5 | Coccidioides sp Ab [Titer] in Specimen by Complement fixation |
| 7152-2 | Blueberry IgE Ab [Units/volume] in Serum |
| 71592-0 | Hemoglobinopathies conditions suspected [Identifier] in DBS |
| 82479-7 | TRBV30 gene segment/TRBV gene segments.total in Blood |
| 73140-6 | Sulfamethoxazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 88025-2 | Tetradecenoylcarnitine (C14:1)/Carnitine.free (C0) [Molar ratio] in DBS |
| 7441-9 | Kiwifruit triggered histamine release [Units/volume] in Blood |
| 89366-9 | von Willebrand factor collagen binding adhesion inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method |
| 41486-2 | Coxsackievirus B neutralizing Ab panel [Titer] - Serum by Neutralization test |
| 30444-4 | Myeloblasts [#/volume] in Blood |
| 4221-8 | Digitoxin [Mass] of Dose |
| 42677-5 | Succinylacetone [Molar amount] in DBS |
| 51175-8 | CD36 blasts/100 blasts in Specimen |
| 22208-3 | Coccidioides immitis Ab [Titer] in Serum |
| 31965-7 | Rubella virus Ag [Presence] in Urethra |
| 51536-1 | Egg white IgG Ab [Presence] in Serum |
| 51858-9 | Budgerigar serum proteins+feathers+droppings IgG Ab [Presence] in Serum |
| 43411-8 | Bacteria identified in Aspirate by Culture |
| 22648-0 | Methionine [Moles/volume] in Cerebral spinal fluid |
| 22743-9 | Proline [Moles/volume] in Specimen |
| 32801-3 | Volume of Bronchial specimen |
| 44768-0 | Neuronal nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 23295-9 | Mycoplasma putrefaciens Ab [Presence] in Serum by Complement fixation |
| 2361-4 | Glucosylceramidase [Enzymatic activity/mass] in Tissue |
| 33327-8 | Varicella zoster virus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 33423-5 | Amphiphysin Ab [Units/volume] in Serum |
| 33564-6 | Smith extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
| 23682-8 | Brucella canis Ab [Titer] in Serum by Agglutination |
| 23717-2 | Feline coronavirus Ab [Presence] in Serum |
| 54311-6 | Linoleoylcarnitine (C18:2) [Moles/volume] in Cerebral spinal fluid |
| 4693-8 | HLA Ag absent [Identifier] |
| 2417-4 | Histamine [Mass/volume] in Urine |
| 34294-9 | Estrogen [Moles/volume] in 24 hour Urine |
| 34304-6 | Fluoride [Moles/volume] in Urine |
| 34329-3 | Fat [Mass/mass] in 24 hour Stool |
| 55348-7 | Cortisol [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 25359-1 | Cadmium [Moles/volume] in Serum or Plasma |
| 25472-2 | Mesoridazine [Moles/volume] in Serum or Plasma |
| 25510-9 | Proline [Moles/time] in 24 hour Urine |
| 25553-9 | Valine [Moles/time] in 24 hour Urine |
| 55966-6 | Palmitoleylcarnitine (C16:1) [Moles/volume] in Urine |
| 35457-1 | Maternal cell contamination [Identifier] in Amniotic fluid Nominal |
| 26675-9 | Legionella longbeachae 2 Ab [Presence] in Serum |
| 38160-8 | Porphyrins/Creatinine [Mass Ratio] in Urine |
| 56588-7 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 38433-9 | Ibuprofen [Mass/volume] in Serum or Plasma --2.5 hours post dose |
| 57300-6 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid) |
| 27829-1 | Somatotropin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 28057-8 | Borrelia burgdorferi 23kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
| 57925-0 | Chestnut IgE Ab/IgE total in Serum |
| 49336-1 | Adenovirus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
| 49739-6 | Honey bee IgG Ab [Mass/volume] in Serum |
| 40002-8 | Glucose [Mass/volume] in Serum or Plasma --80 minutes post XXX challenge |
| 40062-2 | Albumin [Mass/volume] in Serum or Plasma --3 days post XXX challenge |
| 58464-9 | Campesterol [Moles/volume] in Serum or Plasma |
| 5883-4 | Virus identified in Blood by Culture |
| 41070-4 | Peripheral neuropathy gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 19499-3 | Ketamine [Mass/volume] in Urine by Screen method |
| 2068-5 | Chloride [Moles/volume] in Amniotic fluid |
| 20856-1 | IgG.equine [Mass/volume] in Body fluid from Fetus by Immune diffusion (ID) |
| 12397-6 | Colchicine [Mass/volume] in Serum or Plasma |
| 100042-1 | Atovaquone [Susceptibility] |
| 13409-8 | Phenylalanine [Mass/volume] in Amniotic fluid |
| 102663-2 | Pussy Willow IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 102878-6 | Lactoglobulin IgA Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
| 103192-1 | Mycobacterium marinum DNA [Presence] in Wound by NAA with probe detection |
| 14916-1 | Thiocyanate [Moles/volume] in Serum or Plasma |
| 104267-0 | Protein.glycosylated [Presence] in Serum or Plasma |
| 15386-6 | Leishmania tropica IgG Ab [Titer] in Serum |
| 16150-5 | Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma |
| 11039-5 | C reactive protein [Presence] in Serum or Plasma |
| 18362-4 | Retinol binding protein [Mass/time] in 24 hour Urine |
| 90056-3 | Date and time lab result reported |
| 90253-6 | Measles virus IgG and IgM Ql panel - Serum |
| 75379-8 | Norbuprenorphine [Mass/mass] in Meconium by Confirmatory method |
| 7569-7 | Parsnip IgE Ab [Units/volume] in Serum |
| 6073-1 | Chocolate IgE Ab [Units/volume] in Serum |
| 76573-5 | Moraxella catarrhalis g1b gene [Presence] in Swab specimen by NAA with probe detection |
| 76673-3 | Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --1st tube |
| 92843-2 | FLT3 gene p.Asp835 mutations [Presence] in Blood or Tissue by Molecular genetics method |
| 61395-0 | Human papilloma virus 42 DNA [Presence] in Specimen by NAA with probe detection |
| 77071-9 | PLOD2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 93787-0 | Lymphocytic choriomeningitis virus IgG+IgM Ab [Presence] in Cerebral spinal fluid |
| 78809-1 | Benzylpiperazine [Mass/mass] in Hair |
| 79275-4 | 3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in Urine |
| 7972-3 | Neisseria meningitidis serogroup Y Ab [Presence] in Specimen |
| 9596-8 | Borrelia burgdorferi 66kD IgG Ab [Presence] in Serum by Immunoblot |
| 96107-8 | Bedaquiline [Susceptibility] by Genotype method |
| 68926-5 | Cancer Ag 72-4 [Units/volume] in Pericardial fluid |
| 96717-4 | pH of Prostatic fluid |
| 96811-5 | Heather IgE Ab [Units/volume] in Serum |
| 6971-6 | 2,4 toluenediamine [Mass/volume] in Urine |
| 69891-0 | Service comment 64 |
| 82390-6 | Centromere protein A Ab [Units/volume] in Serum by Line blot |
| 98247-0 | Spermatozoa Agglutinated [Presence] in Urine --post ejaculation |
| 85775-5 | Enterococcus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture |
| 99110-9 | Alpha-Phenyl-2-Piperidine acetate [Presence] in Urine by Screen method |
| 99464-0 | Sweet Vernal grass IgG Ab [Mass/volume] in Serum |
| 87412-3 | Brachyspira sp nox gene [Nucleotide sequence] in Isolate by Sequencing |
| 73409-5 | Docusate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
| 73889-8 | Tetrahydrocorticosterone [Moles/volume] in Urine |
| 88733-1 | Mi-2 beta Ab [Units/volume] in Serum by Line blot |
| 89523-5 | Ganglioside GT1b IgG Ab [Presence] in Serum by Line blot |
| 41722-0 | Telithromycin [Susceptibility] by Gradient strip |
| 59473-9 | Calcium.ionized [Mass/volume] adjusted to pH 7.4 in Venous blood by Ion-selective membrane electrode (ISE) |
| 59725-2 | Oxazepam [Mass/volume] in Blood |
| 59897-9 | Disopyramide [Moles/volume] in Urine |
| 31010-2 | Food Allergen Mix 70 (Tarragon+Lovage+Marjoram+Thyme) IgE Ab [Presence] in Serum by Multidisk |
| 31024-3 | Voltage-gated calcium channel Ab [Moles/volume] in Serum |
| 4195-4 | cloNIDine [Mass] of Dose |
| 2142-8 | Cortisol [Mass/volume] in Saliva (oral fluid) |
| 31353-6 | Echovirus 30 Ab [Presence] in Serum |
| 51086-7 | CD16 blasts/100 blasts in Bone marrow |
| 42788-0 | Insulin-like growth factor-I receptor Ag [Presence] in Tissue by Immune stain |
| 2195-6 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Urine |
| 31632-3 | Spermatozoa Ab [Presence] in Semen |
| 31746-1 | Bovine herpesvirus 1 Ag [Presence] in Specimen |
| 31760-2 | Candida sp Ag [Units/volume] in Serum |
| 51545-2 | Budgerigar droppings IgG Ab [Presence] in Serum |
| 22321-4 | Hepatitis B virus e Ab [Units/volume] in Serum |
| 22631-6 | Xylose/Xylose dose in 5 hour Urine --post 5 g xylose PO |
| 44032-1 | Aspergillus niger H Ab [Presence] in Serum by Immune diffusion (ID) |
| 23028-4 | Dermatophilus congolensis Ag [Presence] in Tissue by Immunofluorescence |
| 23113-4 | Foot and mouth disease virus Ag [Presence] in Throat by Complement fixation |
| 33016-7 | Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma |
| 44731-8 | Transferrin.carbohydrate deficient.asialo/Transferrin.carbohydrate deficient.disialo [Mass Ratio] in Serum or Plasma |
| 33650-3 | Cryoglobulin.IgA [Mass/volume] in Serum |
| 33669-3 | Trypsin [Titer] in Stool |
| 33809-5 | Insulin [Units/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 33895-4 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --2 hours post incubation |
| 54300-9 | Homocysteine [Moles/volume] in Amniotic fluid |
| 24153-9 | Kamut flour IgG Ab [Units/volume] in Serum |
| 24212-3 | Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
| 34564-5 | Cell count and Differential panel - Cerebral spinal fluid |
| 54901-4 | IgG [Mass/volume] in Peritoneal fluid |
| 55204-2 | Macroamylase [Presence] in Pleural fluid |
| 47032-8 | MyoD1 Ag [Presence] in Tissue by Immune stain |
| 3527-9 | Dantron [Mass/volume] in Urine |
| 55903-9 | IgD.monoclonal [Presence] in Serum by Immunoelectrophoresis |
| 56042-5 | Beta defensin [Mass/mass] in Stool.dried |
| 25671-9 | Glucose [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 25768-3 | Insulin-like growth factor [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 25900-2 | D-Lactate [Moles/volume] in Serum or Plasma --2nd specimen post excercise |
| 35573-5 | Procollagen+Collagen [Identifier] in Fibroblast by Electrophoresis |
| 56288-4 | Hop IgG4 Ab [Mass/volume] in Serum |
| 56353-6 | Pecan or Hickory Nut IgG4 Ab [Mass/volume] in Serum |
| 56433-6 | Yellow Hornet IgG4 Ab [Mass/volume] in Serum |
| 56515-0 | Plasmodium falciparum IgG Ab [Presence] in Serum by Immunofluorescence |
| 48250-5 | Pellitory (Parietaria judaica) triggered leukotriene release [Mass/volume] by Leukocytes |
| 26475-4 | Lymphocytes [#/volume] in Cerebral spinal fluid |
| 26752-6 | Creatinine renal clearance in 2 hour Urine and Serum or Plasma |
| 48553-2 | Muscle sarcolemma Ab [Units/volume] in Pleural fluid |
| 48610-0 | 7-Dehydrocholesterol [Mass/volume] in Amniotic fluid |
| 48820-5 | Karyotype [Identifier] in Cord blood Nominal |
| 26834-2 | Temazepam [Mass/mass] in Hair |
| 27221-1 | Norepinephrine [Mass/volume] in 24 hour Urine |
| 38405-7 | MT-ATP6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 38663-1 | Dichlorobenzidine [Mass/volume] in Air |
| 49257-9 | Catecholamines [Interpretation] in Plasma Narrative |
| 5798-4 | Leucine crystals [Presence] in Urine sediment by Light microscopy |
| 49449-2 | Toxoplasma gondii DNA [#/volume] in Serum or Plasma by NAA with probe detection |
| 40045-7 | Glucose [Mass/volume] in Serum or Plasma --2 days post XXX challenge |
| 49882-4 | Hepatitis B virus codon 80 [Identifier] by Genotype method |
| 29676-4 | Dengue virus IgG Ab [Presence] in Serum |
| 29680-6 | Rickettsia akari Ab [Titer] in Serum |
| 40313-9 | Cortisol [Moles/volume] in Serum or Plasma --45 minutes post dose triple bolus |
| 40377-4 | Lutropin [Units/volume] in Serum or Plasma --30 minutes post dose triple bolus |
| 50485-2 | Gastrin [Mass/volume] in Serum or Plasma --1st specimen |
| 29992-5 | Eosinophils [Presence] in Nose by Wright stain |
No Expansion for this valueset (Unknown Code System)
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |